PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Chanumolu, SK; Rout, C; Chauhan, RS				Chanumolu, Sree Krishna; Rout, Chittaranjan; Chauhan, Rajinder S.			UniDrug-Target: A Computational Tool to Identify Unique Drug Targets in Pathogenic Bacteria	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; ESSENTIAL GENES; PROTEIN; DISCOVERY; SUSCEPTIBILITY; DRUGGABILITY; DATABASE	Background: Targeting conserved proteins of bacteria through antibacterial medications has resulted in both the development of resistant strains and changes to human health by destroying beneficial microbes which eventually become breeding grounds for the evolution of resistances. Despite the availability of more than 800 genomes sequences, 430 pathways, 4743 enzymes, 9257 metabolic reactions and protein (three-dimensional) 3D structures in bacteria, no pathogen-specific computational drug target identification tool has been developed. Methods: A web server, UniDrug-Target, which combines bacterial biological information and computational methods to stringently identify pathogen-specific proteins as drug targets, has been designed. Besides predicting pathogen-specific proteins essentiality, chokepoint property, etc., three new algorithms were developed and implemented by using protein sequences, domains, structures, and metabolic reactions for construction of partial metabolic networks (PMNs), determination of conservation in critical residues, and variation analysis of residues forming similar cavities in proteins sequences. First, PMNs are constructed to determine the extent of disturbances in metabolite production by targeting a protein as drug target. Conservation of pathogen-specific protein's critical residues involved in cavity formation and biological function determined at domain-level with low-matching sequences. Last, variation analysis of residues forming similar cavities in proteins sequences from pathogenic versus non-pathogenic bacteria and humans is performed. Results: The server is capable of predicting drug targets for any sequenced pathogenic bacteria having fasta sequences and annotated information. The utility of UniDrug-Target server was demonstrated for Mycobacterium tuberculosis (H37Rv). The UniDrug-Target identified 265 mycobacteria pathogen-specific proteins, including 17 essential proteins which can be potential drug targets. Conclusions/Significance: UniDrug-Target is expected to accelerate pathogen-specific drug targets identification which will increase their success and durability as drugs developed against them have less chance to develop resistances and adverse impact on environment. The server is freely available at http://117.211.115.67/UDT/main.html. The standalone application (source codes) is available at http://www.bioinformatics.org/ftp/pub/bioinfojuit/UDT.rar.	[Chanumolu, Sree Krishna; Rout, Chittaranjan; Chauhan, Rajinder S.] Jaypee Univ Informat Technol, Dept Biotechnol & Bioinformat, Solan, Himachal Prades, India	Jaypee University of Information Technology	Chanumolu, SK (corresponding author), Jaypee Univ Informat Technol, Dept Biotechnol & Bioinformat, Solan, Himachal Prades, India.	rajinder.chauhan@juit.ac.in	chanumolu, sree/AAC-9600-2021; Chauhan, Rajinder Singh/HGB-5642-2022					Albrich WC, 2004, EMERG INFECT DIS, V10, P514, DOI 10.3201/eid1003.030252; Austen M, 2005, DRUG DISCOV TODAY, V10, P275, DOI 10.1016/S1359-6446(05)03368-4; Boyle-Vavra S, 2007, LAB INVEST, V87, P3, DOI 10.1038/labinvest.3700501; Bozdogan B, 2003, J ANTIMICROB CHEMOTH, V52, P864, DOI 10.1093/jac/dkg457; Brain RA, 2008, REV ENVIRON CONTAM T, V192, P67, DOI 10.1007/978-0-387-71724-1_3; Chan JNY, 2010, TRENDS PHARMACOL SCI, V31, P82, DOI 10.1016/j.tips.2009.11.002; Devasia RA, 2009, AM J RESP CRIT CARE, V180, P365, DOI 10.1164/rccm.200901-0146OC; Drews J, 1997, DRUG DISCOV TODAY, V2, P72, DOI 10.1016/S1359-6446(96)10051-9; Gao ZT, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-104; Gerdes S, 2006, CURR OPIN BIOTECH, V17, P448, DOI 10.1016/j.copbio.2006.08.006; Ghoshal Ujjala, 2006, Indian J Pathol Microbiol, V49, P620; Hajduk PJ, 2005, J MED CHEM, V48, P2518, DOI 10.1021/jm049131r; Hambly K, 2006, MOL DIVERS, V10, P273, DOI 10.1007/s11030-006-9035-3; Han LY, 2007, DRUG DISCOV TODAY, V12, P304, DOI 10.1016/j.drudis.2007.02.015; Hasan S, 2006, PLOS COMPUT BIOL, V2, P539, DOI 10.1371/journal.pcbi.0020061; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Ilag LL, 2002, DRUG DISCOV TODAY, V7, pS136, DOI 10.1016/S1359-6446(02)02429-7; Jackson RD, 2005, DRUG DISCOV TODAY, V10, P53, DOI 10.1016/S1359-6446(04)03303-3; Janowski Robert, 2009, Journal of Structural and Functional Genomics, V10, P137, DOI 10.1007/s10969-009-9060-4; Kim TY, 2010, METAB ENG, V12, P105, DOI 10.1016/j.ymben.2009.05.004; Kramer R, 2004, NAT REV DRUG DISCOV, V3, P965, DOI 10.1038/nrd1552; Li HL, 2006, NUCLEIC ACIDS RES, V34, pW219, DOI 10.1093/nar/gkl114; Li QL, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-353; Ohlstein EH, 2000, ANNU REV PHARMACOL, V40, P177, DOI 10.1146/annurev.pharmtox.40.1.177; Rahman SA, 2005, BIOINFORMATICS, V21, P1189, DOI 10.1093/bioinformatics/bti116; Rahman SA, 2006, BIOINFORMATICS, V22, P1767, DOI 10.1093/bioinformatics/btl181; Ryan TE, 2002, TRENDS BIOTECHNOL, V20, pS45, DOI 10.1016/S1471-1931(02)00199-4; Schmidtke P, 2010, NUCLEIC ACIDS RES, V38, pW582, DOI 10.1093/nar/gkq383; Sekirov I, 2008, INFECT IMMUN, V76, P4726, DOI 10.1128/IAI.00319-08; Shi R, 2007, MINI-REV MED CHEM, V7, P1177, DOI 10.2174/138955707782331740; Storteboom H, 2010, ENVIRON SCI TECHNOL, V44, P7397, DOI 10.1021/es101657s; Sugaya N, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-263; Vetting MW, 2008, ACTA CRYSTALLOGR F, V64, P978, DOI 10.1107/S1744309108031679; Walke DW, 2001, CURR OPIN BIOTECH, V12, P626, DOI 10.1016/S0958-1669(01)00271-3; Weiss K, 2009, INT J ANTIMICROB AG, V33, pS29, DOI 10.1016/S0924-8579(09)70013-5; Yeh W, 2004, GENOME RES, V14, P917, DOI 10.1101/gr.2050304; Zhang R, 2009, NUCLEIC ACIDS RES, V37, pD455, DOI 10.1093/nar/gkn858; Zhu F, 2010, NUCLEIC ACIDS RES, V38, pD787, DOI 10.1093/nar/gkp1014	38	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e32833	10.1371/journal.pone.0032833	http://dx.doi.org/10.1371/journal.pone.0032833			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22431985	Green Published, gold, Green Submitted			2022-12-25	WOS:000303198600028
J	Lerosey-Aubril, R; Hegna, TA; Kier, C; Bonino, E; Habersetzer, J; Carre, M				Lerosey-Aubril, Rudy; Hegna, Thomas A.; Kier, Carlo; Bonino, Enrico; Habersetzer, Joerg; Carre, Matthieu			Controls on Gut Phosphatisation: The Trilobites from the Weeks Formation Lagerstatte (Cambrian; Utah)	PLOS ONE			English	Article							DIGESTIVE-SYSTEM; BURGESS SHALE; SOFT-TISSUE; MIDGUT; MINERALIZATION; PRESERVATION; DECAY; CONCRETIONS; REMIPEDIA; GRANULES	Despite being internal organs, digestive structures are frequently preserved in Cambrian Lagerstatten. However, the reasons for their fossilisation and their biological implications remain to be thoroughly explored. This is particularly true with arthropods - typically the most diverse fossilised organisms in Cambrian ecosystems - where digestive structures represent an as-yet underexploited alternative to appendage morphology for inferences on their biology. Here we describe the phosphatised digestive structures of three trilobite species from the Cambrian Weeks Formation Lagerstatte (Utah). Their exquisite, three-dimensional preservation reveals unique details on trilobite internal anatomy, such as the position of the mouth and the absence of a differentiated crop. In addition, the presence of paired pygidial organs of an unknown function is reported for the first time. This exceptional material enables exploration of the relationships between gut phosphatisation and the biology of organisms. Indeed, soft-tissue preservation is unusual in these fossils as it is restricted to the digestive structures, which indicates that the gut played a central role in its own phosphatisation. We hypothesize that the gut provided a microenvironment where special conditions could develop and harboured a source of phosphorus. The fact that gut phosphatization has almost exclusively been observed in arthropods could be explained by their uncommon ability to store ions (including phosphorous) in their digestive tissues. However, in some specimens from the Weeks Formation, the phosphatisation extends to the entire digestive system, suggesting that trilobites might have had some biological particularities not observed in modern arthropods. We speculate that one of them might have been an increased capacity for ion storage in the gut tissues, related to the moulting of their heavily-mineralised carapace.	[Lerosey-Aubril, Rudy] Senckenberg Res Inst, Dept Palaeontol & Hist Geol, Frankfurt, Germany; [Hegna, Thomas A.] Yale Univ, Dept Geol & Geophys, New Haven, CT USA; [Hegna, Thomas A.] Western Illinois Univ, Dept Geol, Macomb, IL 61455 USA; [Kier, Carlo; Bonino, Enrico] Back Museum, Puerto Morelos, Quintana Roo, Mexico; [Habersetzer, Joerg] Senckenberg Res Inst, Dept Palaeoanthropol & Messel Res, Frankfurt, Germany; [Carre, Matthieu] Univ Montpellier 2, Inst Evolutionary Sci, Montpellier, France	Senckenberg Gesellschaft fur Naturforschung (SGN); Yale University; Western Illinois University; Senckenberg Gesellschaft fur Naturforschung (SGN); Universite de Montpellier	Lerosey-Aubril, R (corresponding author), Senckenberg Res Inst, Dept Palaeontol & Hist Geol, Frankfurt, Germany.	leroseyaubril@gmail.com	Lerosey-Aubril, Rudy/L-9347-2019; Carre, Matthieu/G-6324-2012; Hegna, Thomas/X-3568-2019	Lerosey-Aubril, Rudy/0000-0003-2256-1872; Carre, Matthieu/0000-0001-8178-7316; Hegna, Thomas/0000-0001-9067-8787	Senckenberg Research Institute; Back to the Past Museum, Yale University; University of Montpellier II (ISEM)	Senckenberg Research Institute; Back to the Past Museum, Yale University; University of Montpellier II (ISEM)	This work was financially supported by the Senckenberg Research Institute, the Back to the Past Museum, Yale University, and the University of Montpellier II (ISEM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON PA, 1988, PALEOBIOLOGY, V14, P331, DOI 10.1017/S0094837300012082; Babcock Loren E., 2007, Memoir of the Association of Australasian Palaeontologists, V34, P401; BECKER GL, 1974, J CELL BIOL, V61, P316, DOI 10.1083/jcb.61.2.316; Beebe MA, 1990, THESIS U KANSAS LAWR; Briggs DEG, 2003, ANNU REV EARTH PL SC, V31, P275, DOI 10.1146/annurev.earth.31.100901.144746; BRIGGS DEG, 1993, J GEOL SOC LONDON, V150, P1035, DOI 10.1144/gsjgs.150.6.1035; BRIGGS DEG, 1994, PALAIOS, V9, P431, DOI 10.2307/3515135; Briggs DEG, 1996, J GEOL SOC LONDON, V153, P665, DOI 10.1144/gsjgs.153.5.0665; Bruton David L., 1997, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V245, P1; BRUTON DL, 1981, PHILOS T ROY SOC B, V295, P619, DOI 10.1098/rstb.1981.0164; Butterfield NJ, 2002, PALEOBIOLOGY, V28, P155, DOI 10.1666/0094-8373(2002)028<0155:LGATIO>2.0.CO;2; Carpenter JH, 1999, CRUSTACEANA, V72, P979, DOI 10.1163/156854099503889; CHATTERTON BDE, 1994, J PALEONTOL, V68, P294, DOI 10.1017/S0022336000022897; Chatterton Brian D.E., 1997, P173; Correa JD, 2000, BRAZ J MED BIOL RES, V33, P217, DOI 10.1590/S0100-879X2000000200009; Correa JD, 2002, TISSUE CELL, V34, P315, DOI 10.1016/S0040816602000101; Degan Shu, 1995, Beringeria Special Issue, V2, P203; Dunne JA, 2008, PLOS BIOL, V6, P693, DOI 10.1371/journal.pbio.0060102; Fahrenbach WH, 2007, J MORPHOL, V268, P917, DOI 10.1002/jmor.10553; Fahrenbach W.H., 1999, P21; Fanenbruck M., 2003, THESIS RUHR U BOCHUM; Felgenhauer B.E., 1992, P225; Filimonova SA, 2009, ARTHROPOD STRUCT DEV, V38, P303, DOI 10.1016/j.asd.2009.01.002; Fortey RA, 1999, PALAEONTOLOGY, V42, P429, DOI 10.1111/1475-4983.00080; Garcia-Bellido DC, 2007, PALAEONTOLOGY, V50, P693, DOI 10.1111/j.1475-4983.2007.00649.x; Garcia-Bellido DC, 2009, ACTA PALAEONTOL POL, V54, P699, DOI 10.4202/app.2009.0024; Garcia-Bellido DC, 2009, PALAEONTOLOGY, V52, P1221, DOI 10.1111/j.1475-4983.2009.00914.x; GOURANTON J, 1968, J CELL BIOL, V37, P316, DOI 10.1083/jcb.37.2.316; GRAF F, 1985, CELL TISSUE RES, V242, P83; Green JM, 1832, AM J GEOLOGY NATURAL, V1, P558; GREENAWAY P, 1985, BIOL REV, V60, P425, DOI 10.1111/j.1469-185X.1985.tb00424.x; GREVEN H, 1976, CELL TISSUE RES, V166, P339; Hagadorn James W., 2002, P61; Hegna TA, 2010, LETHAIA, V43, P411, DOI 10.1111/j.1502-3931.2009.00204.x; Hof CHJ, 1997, PALAIOS, V12, P420, DOI 10.2307/3515381; HOPKIN SP, 1990, FUNCT ECOL, V4, P321, DOI 10.2307/2389593; Jell PA, 1978, ALCHERINGA, V2, P251, DOI 10.1080/03115517808527783; JENKINS T, 1973, Z PARASITENKD, V42, P165, DOI 10.1007/BF02482635; Klann AE, 2010, J MORPHOL, V271, P225, DOI 10.1002/jmor.10794; KOENEMANN S, TREATISE ZO IN PRESS, V5; Koenemann S, 2007, J CRUSTACEAN BIOL, V27, P534, DOI 10.1651/S-2809A.1; LAVALLARD R, 1967, CR ACAD SCI D NAT, V264, P929; Leanza, 1957, ORDOVICIAN TRILOBITE; LEE AP, 1995, P ROY SOC B-BIOL SCI, V261, P263, DOI 10.1098/rspb.1995.0146; Lerosey-Aubril R, 2011, LETHAIA, V44, P166, DOI 10.1111/j.1502-3931.2010.00233.x; LUDWIG M, 1988, PROTOPLASMA, V143, P43, DOI 10.1007/BF01282958; Martill D.M., 1994, KAUPIA, V2, P71; McNamara ME, 2009, PALAIOS, V24, P104, DOI 10.2110/palo.2008.p08-017r; Neues F, 2011, J STRUCT BIOL, V175, P10, DOI 10.1016/j.jsb.2011.03.019; Opik A. A., 1961, Palaeontology, V8, P410; OPIK AA, 1959, NATURE, V183, P1750, DOI 10.1038/1831750a0; Robison Richard A., 2011, Paleontological Contributions, P1; ROER R, 1984, AM ZOOL, V24, P893; Schram F.R., 1989, Crustacean Issues, V6, P115; SOHAL RS, 1976, TISSUE CELL, V8, P447, DOI 10.1016/0040-8166(76)90005-7; Thomas G, 1999, PARASITOL RES, V85, P274, DOI 10.1007/s004360050547; TURBECK BO, 1974, TISSUE CELL, V6, P627, DOI 10.1016/0040-8166(74)90005-6; Ushatinskaya GT, 2009, PALEONTOL J+, V43, P928, DOI 10.1134/S0031030109080115; Vannier J, 2002, LETHAIA, V35, P107, DOI 10.1080/002411602320183971; Walcott C. D., 1916, Smithsonian Institution Miscellaneous Collection, V64; Wilby Philip R., 1997, Geobios Memoire Special (Villeurbanne), V20, P493; Wilby Philip Richard, 1993, Kaupia Darmstaedter Beitraege zur Naturgeschichte, V2, P99; Wilby PR, 1996, GEOLOGY, V24, P787, DOI 10.1130/0091-7613(1996)024<0787:ROMMIT>2.3.CO;2; YAGER J, 1994, J CRUSTACEAN BIOL, V14, P752, DOI 10.2307/1548869; Zhu MY, 2004, P ROY SOC B-BIOL SCI, V271, pS277, DOI 10.1098/rsbl.2004.0194	65	65	66	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e32934	10.1371/journal.pone.0032934	http://dx.doi.org/10.1371/journal.pone.0032934			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22431989	Green Submitted, Green Published, gold			2022-12-25	WOS:000303198600032
J	Pan, WH; Khayhan, K; Hagen, F; Wahyuningsih, R; Chakrabarti, A; Chowdhary, A; Ikeda, R; Taj-Aldeen, SJ; Khan, Z; Imran, D; Sjam, R; Sriburee, P; Liao, WQ; Chaicumpar, K; Ingviya, N; Mouton, JW; Curfs-Breuker, I; Boekhout, T; Meis, JF; Klaassen, CHW				Pan, Weihua; Khayhan, Kantarawee; Hagen, Ferry; Wahyuningsih, Retno; Chakrabarti, Arunaloke; Chowdhary, Anuradha; Ikeda, Reiko; Taj-Aldeen, Saad J.; Khan, Ziauddin; Imran, Darma; Sjam, Ridhawati; Sriburee, Pojana; Liao, Wanqing; Chaicumpar, Kunyaluk; Ingviya, Natnicha; Mouton, Johan W.; Curfs-Breuker, Ilse; Boekhout, Teun; Meis, Jacques F.; Klaassen, Corne H. W.			Resistance of Asian Cryptococcus neoformans Serotype A Is Confined to Few Microsatellite Genotypes	PLOS ONE			English	Article							AMPLIFIED POLYMORPHIC DNA; ANTIFUNGAL SUSCEPTIBILITIES; MOLECULAR EPIDEMIOLOGY; VAR. NEOFORMANS; UNITED-STATES; CANDIDA SPP.; GATTII; VORICONAZOLE; FLUCONAZOLE; MENINGITIS	Background: Cryptococcus neoformans is a pathogenic yeast that causes cryptococcosis, a life threatening disease. The prevalence of cryptococcosis in Asia has been rising after the onset of the AIDS epidemic and estimates indicate more than 120 cases per 1,000 HIV-infected individuals per year. Almost all cryptococcal disease cases in both immunocompromised and immunocompetent patients in Asia are caused by C. neoformans var. grubii. Epidemiological studies on C. neoformans in pan-Asia have not been reported. The present work studies the genetic diversity of the fungus by microsatellite typing and susceptibility analysis of approximately 500 isolates from seven Asian countries. Methodology/Principal Findings: Genetic diversity of Asian isolates of C. neoformans was determined using microsatellite analysis with nine microsatellite markers. The analysis revealed eight microsatellite complexes (MCs) which showed different distributions among geographically defined populations. A correlation between MCs and HIV-status was observed. Microsatellite complex 2 was mainly associated with isolates from HIV-negative patients, whereas MC8 was associated with those from HIV-positive patients. Most isolates were susceptible to amphotericin B, itraconazole, voriconazole, posaconazole, and isavuconazole, but 17 (3.4%) and 10 (2%) were found to be resistant to 5-flucytosine and fluconazole, respectively. Importantly, five Indonesian isolates (approximately 12.5% from all Indonesian isolates investigated and 1% from the total studied isolates) were resistant to both antifungals. The majority of 5-flucytosine resistant isolates belonged to MC17. Conclusions: The findings showed a different distribution of genotypes of C. neoformans var. grubii isolates from various countries in Asia, as well as a correlation of the microsatellite genotypes with the original source of the strains and resistance to 5-flucytosine.	[Pan, Weihua; Liao, Wanqing] Second Mil Med Univ, Changzheng Hosp, Inst Dermatol & Med Mycol, Shanghai Key Lab Mol Med Mycol, Shanghai, Peoples R China; [Khayhan, Kantarawee; Hagen, Ferry; Boekhout, Teun] CBS KNAW Fungal Biodivers Ctr, Dept Yeast & Basidiomycete Res, Utrecht, Netherlands; [Khayhan, Kantarawee; Hagen, Ferry; Boekhout, Teun] Univ Med Ctr Utrecht, Dept Internal Med & Infect Dis, Eijkman Winkler Inst, Utrecht, Netherlands; [Khayhan, Kantarawee] Univ Phayao, Fac Med Sci, Dept Microbiol & Parasitol, Phayao, Thailand; [Wahyuningsih, Retno; Sjam, Ridhawati] Univ Indonesia, Fac Med, Dept Parasitol, Div Mycol, Jakarta, Indonesia; [Wahyuningsih, Retno] Christian Univ Indonesia, Fac Med, Dept Parasitol, Jakarta, Indonesia; [Chakrabarti, Arunaloke] Postgrad Inst Med Educ & Res, Dept Med Microbiol, Chandigarh 160012, India; [Chowdhary, Anuradha] Univ Delhi, Vallabhbhai Patel Chest Inst, Dept Med Mycol, Delhi 110007, India; [Ikeda, Reiko] Meiji Pharmaceut Univ, Dept Microbiol, Tokyo, Japan; [Taj-Aldeen, Saad J.] Hamad Med Corp, Dept Lab Med & Pathol, Div Microbiol, Mycol Unit, Doha, Qatar; [Khan, Ziauddin] Kuwait Univ, Ctr Hlth Sci, Fac Med, Dept Microbiol, Jabriya, Kuwait; [Imran, Darma] Univ Indonesia, Fac Med, Dept Neurol, Jakarta, Indonesia; [Imran, Darma] Cipto Mangunkusumo Hosp, Dept Neurol, Jakarta, Indonesia; [Sriburee, Pojana] Chiang Mai Univ, Fac Med, Dept Microbiol, Chiang Mai 50000, Thailand; [Chaicumpar, Kunyaluk] Khon Kaen Univ, Fac Med, Dept Microbiol, Khon Kaen, Thailand; [Ingviya, Natnicha] Prince Songkla Univ, Fac Med, Dept Pathol, Hat Yai, Thailand; [Mouton, Johan W.; Curfs-Breuker, Ilse; Meis, Jacques F.; Klaassen, Corne H. W.] Canisius Wilhelmina Hosp, Dept Med Microbiol & Infect Dis, Nijmegen, Netherlands; [Mouton, Johan W.; Meis, Jacques F.] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands	Naval Medical University; Royal Netherlands Academy of Arts & Sciences; Westerdijk Fungal Biodiversity Institute (KNAW); Utrecht University; Utrecht University Medical Center; University of Phayao; University of Indonesia; The Christian University of Indonesia; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; University of Delhi; Meiji Pharmaceutical University; Hamad Medical Corporation; Kuwait University; University of Indonesia; University of Indonesia; Chiang Mai University; Khon Kaen University; Prince of Songkla University; Canisius-Wilhelmina Hospital; Radboud University Nijmegen	Pan, WH (corresponding author), Second Mil Med Univ, Changzheng Hosp, Inst Dermatol & Med Mycol, Shanghai Key Lab Mol Med Mycol, Shanghai, Peoples R China.	panweihua@medmail.com.cn	Hagen, Ferry/B-9044-2009; Boekhout, Teunis/ABF-2538-2020; Meis, Jacques F/A-9241-2010; mouton, johan w/C-5915-2014; Chowdhary, Anuradha/ABF-1252-2020	Hagen, Ferry/0000-0002-5622-1916; Boekhout, Teunis/0000-0002-0476-3609; Meis, Jacques F/0000-0003-3253-6080; mouton, johan w/0000-0001-6736-4149; Chowdhary, Anuradha/0000-0002-2028-7462; Imran, Darma/0000-0002-4109-4192	National Natural Science Foundation of China [30970130, 80171335]; Odo van Vloten Foundation, The Netherlands; University of Phayao, Thailand; Gilead; Janssen Pharmaceutica; Merck; Pfizer; Schering-Plough; IIR-Pfizer	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Odo van Vloten Foundation, The Netherlands(Netherlands Government); University of Phayao, Thailand; Gilead(Gilead Sciences); Janssen Pharmaceutica(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck(Merck & Company); Pfizer(Pfizer); Schering-Plough(Merck & CompanySchering Plough Corporation); IIR-Pfizer	This work was supported by grants (no. 30970130 and no. 80171335) from the National Natural Science Foundation of China. FH was funded by the Odo van Vloten Foundation, The Netherlands. KK was granted by University of Phayao, Thailand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; JFM has been a consultant to Astellas, Basilea, Merck and Schering-Plough and received speaker's fees from Gilead, Janssen Pharmaceutica, Merck, Pfizer, and Schering-Plough. CHK received a grant from Pfizer. RW is currently receiving a grant from IIR-Pfizer for doing research on Cryptococcus. RW is a speaker for Pfizer and Astellas Pharma. All other authors: no potential conflicts of interest relating to employment, consultancy, patents, products in development or marketed products. The sponsors of the research played no decision-making role in the design, execution, analysis and reporting of the research. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Boekhout T, 2001, MICROBIOL-UK, V147, P891, DOI 10.1099/00221287-147-4-891; Bovers M, 2008, REV IBEROAM MICOL, V25, pS4, DOI 10.1016/S1130-1406(08)70019-6; Bovers M, 2006, FEMS YEAST RES, V6, P599, DOI 10.1111/j.1567-1364.2006.00082.x; Brandt ME, 2001, ANTIMICROB AGENTS CH, V45, P3065, DOI 10.1128/AAC.45.11.3065-3069.2001; Brouwer AE, 2004, LANCET, V363, P1764, DOI 10.1016/S0140-6736(04)16301-0; Casali AK, 2003, FEMS YEAST RES, V3, P405, DOI 10.1016/S1567-1356(03)00038-2; Chen JH, 2008, EMERG INFECT DIS, V14, P755, DOI 10.3201/eid1405.071312; Choi YH, 2010, FEMS YEAST RES, V10, P769, DOI 10.1111/j.1567-1364.2010.00648.x; Chottanapund Suthat, 2007, Journal of the Medical Association of Thailand, V90, P2104; Clinical and Laboratory Standards Institute, 2008, M27A3 CLIN LAB STAND; CURRIE BP, 1994, J CLIN MICROBIOL, V32, P1188, DOI 10.1128/JCM.32.5.1188-1192.1994; Day JN, 2011, J CLIN MICROBIOL, V49, P658, DOI 10.1128/JCM.01985-10; de Oliveira MTB, 2004, J CLIN MICROBIOL, V42, P1356, DOI 10.1128/JCM.42.3.1356-1359.2004; de Valk HA, 2007, J MICROBIOL METH, V69, P268, DOI 10.1016/j.mimet.2007.01.009; Delgado ACN, 2005, MYCOPATHOLOGIA, V159, P7, DOI 10.1007/s11046-004-9618-4; Diaz MR, 2005, FEMS YEAST RES, V5, P1129, DOI 10.1016/j.femsyr.2005.05.005; Franzot SP, 1997, J CLIN MICROBIOL, V35, P2243, DOI 10.1128/JCM.35.9.2243-2251.1997; Ganiem AR, 2009, AIDS, V23, P2309, DOI 10.1097/QAD.0b013e3283320de8; Garcia-Hermoso D, 1999, J CLIN MICROBIOL, V37, P3204, DOI 10.1128/JCM.37.10.3204-3209.1999; Goldman DL, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.5.e66; Hagen F, 2010, ANTIMICROB AGENTS CH, V54, P5139, DOI 10.1128/AAC.00746-10; Hazen KC, 2003, J CLIN MICROBIOL, V41, P5623, DOI 10.1128/JCM.41.12.5623-5632.2003; Illnait-Zaragozi MT, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-289; Illnait-Zaragozi MT, 2008, ANTIMICROB AGENTS CH, V52, P1580, DOI 10.1128/AAC.01384-07; Illnait-Zaragozi MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009124; Jain N, 2005, J CLIN MICROBIOL, V43, P5733, DOI 10.1128/JCM.43.11.5733-5742.2005; Kidd SE, 2004, P NATL ACAD SCI USA, V101, P17258, DOI 10.1073/pnas.0402981101; Klaassen CHW, 2009, MED MYCOL, V47, pS27, DOI 10.1080/13693780802382244; KWONCHUNG KJ, 1982, J CLIN MICROBIOL, V15, P535, DOI 10.1128/JCM.15.3.535-537.1982; Lin XR, 2006, ANNU REV MICROBIOL, V60, P69, DOI 10.1146/annurev.micro.60.080805.142102; Meyer W, 1999, ELECTROPHORESIS, V20, P1790, DOI 10.1002/(SICI)1522-2683(19990101)20:8&lt;1790::AID-ELPS1790&gt;3.0.CO;2-2; Meyer W, 2009, MED MYCOL, V47, P561, DOI 10.1080/13693780902953886; Nguyen MH, 1998, ANTIMICROB AGENTS CH, V42, P471; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Perea S, 2002, CLIN INFECT DIS, V35, P1073, DOI 10.1086/344058; Perfect JR, 2010, CLIN INFECT DIS, V50, P291, DOI 10.1086/649858; Perfect JR, 1999, DRUG RESIST UPDATE, V2, P259, DOI 10.1054/drup.1999.0090; Pfaller MA, 2005, J CLIN MICROBIOL, V43, P3807, DOI 10.1128/JCM.43.8.3807-3810.2005; Pfaller MA, 2005, J CLIN MICROBIOL, V43, P2163, DOI 10.1128/JCM.43.5.2163-2167.2005; Pfaller MA, 2004, DIAGN MICR INFEC DIS, V48, P201, DOI 10.1016/j.diagmicrobio.2003.09.008; Rudramurthy SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016086; Shen YZ, 2007, MYCOSES, V50, P475, DOI 10.1111/j.1439-0507.2007.01421.x; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Simwami SP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001343; Souza LKH, 2010, MYCOSES, V53, P62, DOI 10.1111/j.1439-0507.2008.01662.x; Springer DJ, 2010, EMERG INFECT DIS, V16, P14, DOI 10.3201/eid1601.090369; Sriburee P, 2004, MYCOPATHOLOGIA, V158, P25, DOI 10.1023/B:MYCO.0000038435.14281.f4; Sukroongreung S, 2001, J CLIN MICROBIOL, V39, P2060, DOI 10.1128/JCM.39.6.2060-2064.2001; Thompson GR, 2009, ANTIMICROB AGENTS CH, V53, P309, DOI 10.1128/AAC.01216-08; Vermes A, 2000, J ANTIMICROB CHEMOTH, V46, P171, DOI 10.1093/jac/46.2.171; Xu JP, 2011, CRYPTOCOCCUS: FROM HUMAN PATHOGEN TO MODEL YEAST, P287; YAMAMOTO Y, 1995, J CLIN MICROBIOL, V33, P3328, DOI 10.1128/JCM.33.12.3328-3332.1995	53	33	34	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2012	7	3							e32868	10.1371/journal.pone.0032868	http://dx.doi.org/10.1371/journal.pone.0032868			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930IA	22427900	Green Submitted, gold, Green Published			2022-12-25	WOS:000303129700017
J	Gupta, GD; Kumar, V				Gupta, Gagan Deep; Kumar, Vinay			Identification of Nucleic Acid Binding Sites on Translin-Associated Factor X (TRAX) Protein	PLOS ONE			English	Article							TB-RBP; CHROMOSOMAL TRANSLOCATIONS; RISC ACTIVATION; TESTIS-BRAIN; RNA; COMPLEX; DNA; SEQUENCE; COMPONENT; GENE	Translin and TRAX proteins play roles in very important cellular processes such as DNA recombination, spatial and temporal expression of mRNA, and in siRNA processing. Translin forms a homomeric nucleic acid binding complex and binds to ssDNA and RNA. However, a mutant translin construct that forms homomeric complex lacking nucleic acid binding activity is able to form fully active heteromeric translin-TRAX complex when co-expressed with TRAX. A substantial progress has been made in identifying translin sites that mediate its binding activity, while TRAX was thought not to bind DNA or RNA on its own. We here for the first time demonstrate nucleic acid binding to TRAX by crosslinking radiolabeled ssDNA to heteromeric translin-TRAX complex using UV-laser. The TRAX and translin, photochemically crosslinked with ssDNA, were individually detected on SDS-PAGE. We mutated two motifs in TRAX and translin, designated B2 and B3, to help define the nucleic acid binding sites in the TRAX sequence. The most pronounced effect was observed in the mutants of B3 motif that impaired nucleic acid binding activity of the heteromeric complexes. We suggest that both translin and TRAX are binding competent and contribute to the nucleic acid binding activity.	[Gupta, Gagan Deep; Kumar, Vinay] Bhabha Atom Res Ctr, High Pressure & Synchrotron Radiat Phys Div, Mumbai 400085, Maharashtra, India	Bhabha Atomic Research Center (BARC)	Gupta, GD (corresponding author), Bhabha Atom Res Ctr, High Pressure & Synchrotron Radiat Phys Div, Mumbai 400085, Maharashtra, India.	vinay@barc.gov.in		Gupta, Gagan Deep/0000-0003-2549-3190; Gupta, Gagan/0000-0002-1089-965X	Department of Atomic Energy, Government of India, India	Department of Atomic Energy, Government of India, India	This work was supported by the Department of Atomic Energy, Government of India, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aisiku OR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015001; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aoki K, 1999, FEBS LETT, V443, P363, DOI 10.1016/S0014-5793(99)00010-1; Aoki K, 1997, FEBS LETT, V401, P109, DOI 10.1016/S0014-5793(96)01444-5; AOKI K, 1995, NAT GENET, V10, P167, DOI 10.1038/ng0695-167; Chennathukuzhi V, 2003, MOL CELL BIOL, V23, P6419, DOI 10.1128/MCB.23.18.6419-6434.2003; Chennathukuzhi VM, 2001, J BIOL CHEM, V276, P13256, DOI 10.1074/jbc.M009707200; Chiaruttini C, 2009, P NATL ACAD SCI USA, V106, P16481, DOI 10.1073/pnas.0902833106; Claussen M, 2006, GENETICS, V174, P1337, DOI 10.1534/genetics.106.063016; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Eliahoo E, 2010, NUCLEIC ACIDS RES, V38, P2975, DOI 10.1093/nar/gkp1230; Erdemir T, 2002, J CELL SCI, V115, P207; Finkenstadt PM, 2002, J NEUROCHEM, V83, P202, DOI 10.1046/j.1471-4159.2002.01158.x; Finkenstadt PM, 2000, J NEUROCHEM, V75, P1754, DOI 10.1046/j.1471-4159.2000.0751754.x; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Gupta GD, 2008, FEBS J, V275, P4235, DOI 10.1111/j.1742-4658.2008.06571.x; Gupta GD, 2005, FEBS LETT, V579, P3141, DOI 10.1016/j.febslet.2005.05.007; Hwang S, 2007, BIOINFORMATICS, V23, P634, DOI 10.1093/bioinformatics/btl672; Jaendling A, 2010, BIOCHEM J, V429, P225, DOI 10.1042/BJ20100273; Kasai M, 1997, J BIOL CHEM, V272, P11402; Li Z, 2008, BBA-GENE REGUL MECH, V1779, P479, DOI 10.1016/j.bbagrm.2008.03.008; Liu Y, 2009, SCIENCE, V325, P750, DOI 10.1126/science.1176325; Lluis M, 2010, BIOCHEM BIOPH RES CO, V396, P709, DOI 10.1016/j.bbrc.2010.04.166; MILLER GL, 1959, ANAL CHEM, V31, P964, DOI 10.1021/ac60149a611; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; Schroer U, 2007, EUR J NEUROSCI, V26, P2169, DOI 10.1111/j.1460-9568.2007.05849.x; Sugiura I, 2004, ACTA CRYSTALLOGR D, V60, P674, DOI 10.1107/S0907444904002549; Sun CN, 2006, MOL PHARMACOL, V70, P454, DOI 10.1124/mol.105.021261; Taira E, 1998, J NEUROCHEM, V71, P471; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tian Y, 2011, NAT STRUCT MOL BIOL, V18, P658, DOI 10.1038/nsmb.2069; Wu XQ, 1999, BIOCHEMISTRY-US, V38, P11261, DOI 10.1021/bi990573s; Wu XQ, 1997, P NATL ACAD SCI USA, V94, P5640, DOI 10.1073/pnas.94.11.5640; Yang SC, 2004, J BIOL CHEM, V279, P12605, DOI 10.1074/jbc.M313133200; Ye XC, 2011, NAT STRUCT MOL BIOL, V18, P650, DOI 10.1038/nsmb.2032	35	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33035	10.1371/journal.pone.0033035	http://dx.doi.org/10.1371/journal.pone.0033035			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427937	Green Published, gold, Green Submitted			2022-12-25	WOS:000302381500079
J	Ibanez-Gijon, J; Jacobs, DM				Ibanez-Gijon, Jorge; Jacobs, David M.			Decision, Sensation, and Habituation: A Multi-Layer Dynamic Field Model for Inhibition of Return	PLOS ONE			English	Article							CONSEQUENCES	Inhibition of Return (IOR) is one of the most consistent and widely studied effects in experimental psychology. The effect refers to a delayed response to visual stimuli in a cued location after initial priming at that location. This article presents a dynamic field model for IOR. The model describes the evolution of three coupled activation fields. The decision field, inspired by the intermediate layer of the superior colliculus, receives endogenous input and input from a sensory field. The sensory field, inspired by earlier sensory processing, receives exogenous input. Habituation of the sensory field is implemented by a reciprocal coupling with a third field, the habituation field. The model generates IOR because, due to the habituation of the sensory field, the decision field receives a reduced target-induced input in cue-target-compatible situations. The model is consistent with single-unit recordings of neurons of monkeys that perform IOR tasks. Such recordings have revealed that IOR phenomena parallel the activity of neurons in the intermediate layer of the superior colliculus and that neurons in this layer receive reduced input in cue-target-compatible situations. The model is also consistent with behavioral data concerning temporal expectancy effects. In a discussion, the multi-layer dynamic field account of IOR is used to illustrate the broader view that behavior consists of a tuning of the organism to the environment that continuously and concurrently takes place at different spatiotemporal scales.	[Ibanez-Gijon, Jorge; Jacobs, David M.] Univ Autonoma Madrid, Fac Psicol, Madrid, Spain; [Ibanez-Gijon, Jorge] Univ Murcia, Fac Filosofia, Murcia, Spain	Autonomous University of Madrid; University of Murcia	Ibanez-Gijon, J (corresponding author), Univ Autonoma Madrid, Fac Psicol, Madrid, Spain.	david.jacobs@uam.es	Ibáñez-Gijón, Jorge/D-6882-2019; Jacobs, David M/C-5216-2011	Ibáñez-Gijón, Jorge/0000-0001-6897-6980; Jacobs, David M/0000-0003-2954-5293	Spanish Ministry of Science and Innovation [FFI2009-13416-C02-01, FFI2009-13416-C02-02]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This material is based upon work supported by projects FFI2009-13416-C02-01 and FFI2009-13416-C02-02 of the Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell AH, 2004, J NEUROPHYSIOL, V91, P2172, DOI 10.1152/jn.01080.2003; Berlucchi G, 2006, COGN NEUROPSYCHOL, V23, P1065, DOI 10.1080/02643290600588426; Danziger S, 1997, CONSCIOUS COGN, V6, P291, DOI 10.1006/ccog.1997.0312; Dodd MD, 2007, PSYCHOL RES-PSYCH FO, V71, P411, DOI 10.1007/s00426-005-0028-0; Dorris MC, 2002, J COGNITIVE NEUROSCI, V14, P1256, DOI 10.1162/089892902760807249; Dukewich KR, 2009, PSYCHON B REV, V16, P238, DOI 10.3758/PBR.16.2.238; Erlhagen W, 2002, PSYCHOL REV, V109, P545, DOI 10.1037//0033-295X.109.3.545; Fecteau JH, 2003, NAT REV NEUROSCI, V4, P435, DOI 10.1038/nrn1114; Fecteau JH, 2005, J COGNITIVE NEUROSCI, V17, P1714, DOI 10.1162/089892905774589235; Fecteau JH, 2004, J NEUROPHYSIOL, V92, P1728, DOI 10.1152/jn.00184.2004; Ibanez-Gijon J, 2011, REV PSICOL DEPORTE, V20, P667; Jacobs DM, 2009, ECOL PSYCHOL, V21, P245, DOI 10.1080/10407410903058302; KLEIN R, 1974, MEM COGNITION, V2, P431, DOI 10.3758/BF03196900; Klein RM, 2000, TRENDS COGN SCI, V4, P138, DOI 10.1016/S1364-6613(00)01452-2; Lupianez J, 2006, COGN NEUROPSYCHOL, V23, P1003, DOI 10.1080/02643290600588095; Perdikis D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002198; Perdikis D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016589; POSNER MI, 1985, COGNITIVE NEUROPSYCH, V2, P211, DOI 10.1080/02643298508252866; POSNER MI, 1984, ATTENTION PERFORM, V10, P531; Satel J, 2011, VISION RES, V51, P987, DOI 10.1016/j.visres.2011.02.013; Spencer JP, 2006, P 28 ANN C COGN SCI, P2180; Tabak J, 2000, J NEUROSCI, V20, P3041; Tipper C, 2005, COGNITION, V97, pB55, DOI 10.1016/j.cognition.2005.02.003; Trappenberg TP, 2001, J COGNITIVE NEUROSCI, V13, P256, DOI 10.1162/089892901564306; Travieso JID, 2010, INT J SPORT PSYCHOL, V41, P77; VALENZA E, 1994, INFANT BEHAV DEV, V17, P293, DOI 10.1016/0163-6383(94)90009-4; Vasconcelos JA, 1997, IEEE T MAGN, V33, P1860, DOI 10.1109/20.582645; Weaver B, 1998, PERCEPT PSYCHOPHYS, V60, P993, DOI 10.3758/BF03211934	28	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33169	10.1371/journal.pone.0033169	http://dx.doi.org/10.1371/journal.pone.0033169			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	920DF	22427980	Green Submitted, Green Published, gold			2022-12-25	WOS:000302381500105
J	Sun, YF; De Biasio, F; Qiao, HL; Iovinella, I; Yang, SX; Ling, Y; Riviello, L; Battaglia, D; Falabella, P; Yang, XL; Pelosi, P				Sun, Yu Feng; De Biasio, Filomena; Qiao, Hui Li; Iovinella, Immacolata; Yang, Shao Xiang; Ling, Yun; Riviello, Lea; Battaglia, Donatella; Falabella, Patrizia; Yang, Xin Ling; Pelosi, Paolo			Two Odorant-Binding Proteins Mediate the Behavioural Response of Aphids to the Alarm Pheromone (E)-beta-arnesene and Structural Analogues	PLOS ONE			English	Article							SWISS-MODEL; DROSOPHILA-MELANOGASTER; CHEMICAL COMMUNICATION; ACYRTHOSIPHON-PISUM; SENSITIVE NEURONS; SOLUBLE-PROTEINS; MYZUS-PERSICAE; ACTIVATION; ENVIRONMENT; CONTRIBUTE	Background: Aphids are agricultural pests of great economical interest. Alternatives to insecticides, using semiochemicals, are of difficult applications. In fact, sex pheromones are of little use as aphids reproduce partenogenetically most of the time. Besides, the alarm pheromone, (E)-beta-farnesene for a great number of species, is difficult to synthesize and unstable in the environment. The search for novel semiochemicals to be used in population control can be efficiently approached through the study of the olfactory system at the biochemical level. Recently odorant-binding proteins (OBPs) have been shown to play a central role in olfactory recognition, thus becoming the target of choice for designing new semiochemicals. Methodology/Principal Findings: To address the question of how the alarm message is recognised at the level of OBPs, we have tested 29 compounds, including (E)-beta-farnesene, in binding assays with 6 recombinant proteins and in behaviour experiments. We have found that good repellents bind OBP3 and/or OBP7, while non repellents present different spectra of binding. These results have been verified with two species of aphids, Acyrthosiphon pisum and Myzus persicae, both using (E)-beta-farnesene as the alarm pheromone. Conclusions: Our results represent further support to the idea (so far convincingly demonstrated only in Drosophila) that OBPs are involved in decoding the chemical information of odorants and pheromones, and for the first time provide such evidence in other insect species and using wild-type insects. Moreover, the data offer guidelines and protocols for the discovery of potential alarm pheromones, using ligand-binding assays as a preliminary screening before subjecting selected compounds to behaviour tests.	[Sun, Yu Feng; Qiao, Hui Li; Iovinella, Immacolata; Pelosi, Paolo] Dipartimento Biol Piante Agr, Pisa, Italy; [Sun, Yu Feng; Yang, Shao Xiang; Ling, Yun; Yang, Xin Ling] China Agr Univ, Dept Appl Chem, Coll Sci, Key Lab Pesticide Chem & Applicat,Minist Agr, Beijing 100094, Peoples R China; [De Biasio, Filomena; Riviello, Lea; Battaglia, Donatella; Falabella, Patrizia] Univ Basilicata, Dipartimento Biol Difesa & Biotecnol Agroforestal, I-85100 Potenza, Italy	China Agricultural University; Ministry of Agriculture & Rural Affairs; University of Basilicata	Sun, YF (corresponding author), Dipartimento Biol Piante Agr, Pisa, Italy.	yangxl@cau.edu.cn; ppelosi@agr.unipi.it	Rocco, Patricia/I-7460-2012; yang, xin/HGU-9981-2022; Yang, xinling/HHC-1621-2022	Rocco, Patricia/0000-0003-1412-7136; Battaglia, Donatella/0000-0001-5727-7375; Iovinella, Immacolata/0000-0002-5001-7842	National Key Project for Basic Research [2010CB126104]; National Natural Science Foundation of China [31071717]; Research Fund for the Doctoral Program of Higher Education of China [31071717, 21132003]; University of Pisa	National Key Project for Basic Research(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); University of Pisa	The authors acknowledge the financial support from the National Key Project for Basic Research (2010CB126104), the National Natural Science Foundation of China (31071717) and the Research Fund for the Doctoral Program of Higher Education of China (31071717, 21132003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Y.F. Sun thanks the University of Pisa for a one-year scholarship supporting her visit at the laboratory of P. Pelosi.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Beale MH, 2006, P NATL ACAD SCI USA, V103, P10509, DOI 10.1073/pnas.0603998103; Biessmann H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009471; Birkett MA, 2003, PHYTOCHEMISTRY, V62, P651, DOI 10.1016/S0031-9422(02)00568-X; BOWERS WS, 1972, SCIENCE, V177, P1121, DOI 10.1126/science.177.4054.1121; BUTT TM, 1990, CAN J BOT, V68, P2153, DOI 10.1139/b90-281; Calvello M, 2003, CELL MOL LIFE SCI, V60, P1933, DOI 10.1007/s00018-003-3186-5; Castellan NJ, 1988, NONPARAMETRIC STAT B; Dawson GW, 1996, BIOORGAN MED CHEM, V4, P351, DOI 10.1016/0968-0896(96)00012-0; Dewhirst SY, 2010, VITAM HORM, V83, P551, DOI 10.1016/S0083-6729(10)83022-5; EDWARDS LJ, 1973, NATURE, V241, P126, DOI 10.1038/241126b0; Forstner Maike, 2009, Int J Biol Sci, V5, P745; Francis F, 2005, J APPL ENTOMOL, V129, P6, DOI 10.1111/j.1439-0418.2005.00925.x; GIBSON RW, 1983, NATURE, V302, P608, DOI 10.1038/302608a0; GRIFFITHS DC, 1980, ENTOMOL EXP APPL, V27, P199, DOI 10.1007/BF00573895; Grosse-Wilde E, 2006, CHEM SENSES, V31, P547, DOI 10.1093/chemse/bjj059; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hori M, 2007, J APPL ENTOMOL, V131, P8, DOI 10.1111/j.1439-0418.2006.01130.x; Hori M, 1998, J CHEM ECOL, V24, P1425, DOI 10.1023/A:1020947414051; Kruse SW, 2003, NAT STRUCT BIOL, V10, P694, DOI 10.1038/nsb960; Lartigue A, 2003, J BIOL CHEM, V278, P30213, DOI 10.1074/jbc.M304688200; Laughlin JD, 2008, CELL, V133, P1255, DOI 10.1016/j.cell.2008.04.046; Matsuo T, 2007, PLOS BIOL, V5, P985, DOI 10.1371/journal.pbio.0050118; Mohl Claudia, 2002, Invertebrate Neuroscience, V4, P165, DOI 10.1007/s10158-002-0018-5; Pelletier J, 2010, J CHEM ECOL, V36, P245, DOI 10.1007/s10886-010-9762-x; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; PICKETT JA, 1980, J CHEM ECOL, V6, P349, DOI 10.1007/BF01402913; Pophof B, 2004, CHEM SENSES, V29, P117, DOI 10.1093/chemse/bjh012; Pophof B, 2002, NATURWISSENSCHAFTEN, V89, P515, DOI 10.1007/s00114-002-0364-5; Qiao HL, 2009, INSECT BIOCHEM MOLEC, V39, P414, DOI 10.1016/j.ibmb.2009.03.004; READ DP, 1970, CAN ENTOMOL, V102, P1567, DOI 10.4039/Ent1021567-12; Roy HE, 1999, J INVERTEBR PATHOL, V74, P69, DOI 10.1006/jipa.1999.4856; SAKUMA M, 1985, APPL ENTOMOL ZOOL, V20, P387, DOI 10.1303/aez.20.387; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sun YF, 2011, J AGR FOOD CHEM, V59, P2456, DOI 10.1021/jf104712c; Swarup S, 2011, GENES BRAIN BEHAV, V10, P648, DOI 10.1111/j.1601-183X.2011.00704.x; Tegoni M, 2004, TRENDS BIOCHEM SCI, V29, P257, DOI 10.1016/j.tibs.2004.03.003; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; Vogt Richard G., 2003, P391, DOI 10.1016/B978-012107151-6/50016-5; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031; Zhou JJ, 2010, INSECT MOL BIOL, V19, P113, DOI 10.1111/j.1365-2583.2009.00919.x	42	97	103	2	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e32759	10.1371/journal.pone.0032759	http://dx.doi.org/10.1371/journal.pone.0032759			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427877	Green Published, gold, Green Submitted			2022-12-25	WOS:000302381500039
J	Yndestad, A; Finsen, AV; Ueland, T; Husberg, C; Dahl, CP; Oie, E; Vinge, LE; Sjaastad, I; Sandanger, O; Ranheim, T; Dickstein, K; Kjekshus, J; Damas, JK; Fiane, AE; Hilfiker-Kleiner, D; Lipp, M; Gullestad, L; Christensen, G; Aukrust, P				Yndestad, Arne; Finsen, Alexandra Vanessa; Ueland, Thor; Husberg, Cathrine; Dahl, Christen P.; Oie, Erik; Vinge, Leif Erik; Sjaastad, Ivar; Sandanger, Oystein; Ranheim, Trine; Dickstein, Kenneth; Kjekshus, John; Damas, Jan Kristian; Fiane, Arnt E.; Hilfiker-Kleiner, Denise; Lipp, Martin; Gullestad, Lars; Christensen, Geir; Aukrust, Pal			The Homeostatic Chemokine CCL21 Predicts Mortality and May Play a Pathogenic Role in Heart Failure	PLOS ONE			English	Article							REGULATORY T-CELLS; MYOCARDIAL-INFARCTION; CCR7; EXPRESSION; ATHEROSCLEROSIS; MIGRATION; DISEASE; LIGAND; IL-10	Background: CCL19 and CCL21, acting through CCR7, are termed homeostatic chemokines. Based on their role in concerting immunological responses and their proposed involvement in tissue remodeling, we hypothesized that these chemokines could play a pathogenic role in heart failure (HF). Methodology/Principal Findings: Our main findings were: (i) Serum levels of CCL19 and particularly CCL21 were markedly raised in patients with chronic HF (n = 150) as compared with healthy controls (n = 20). A CCL21 level above median was independently associated with all-cause mortality. (ii) In patients with HF following acute myocardial infarction (MI; n = 232), high versus low CCL21 levels 1 month post-MI were associated with cardiovascular mortality, even after adjustment for established risk factors. (iii). Explanted failing human LV tissue (n = 29) had markedly increased expression of CCL21 as compared with non-failing myocardium (n = 5). (iv) Our studies in CCR7(-/-) mice showed improved survival and attenuated increase in markers of myocardial dysfunction and wall stress in post-MI HF after 1 week, accompanied by increased myocardial expression of markers of regulatory T cells. (v) Six weeks post-MI, there was an increase in markers of myocardial dysfunction and wall stress in CCR7 deficient mice. Conclusions/Significance: High serum levels of CCL21 are independently associated with mortality in chronic and acute post-MI HF. Our findings in CCR7 deficient mice may suggest that CCL21 is not only a marker, but also a mediator of myocardial failure. However, while short term inhibition of CCR7 may be beneficial following MI, a total lack of CCR7 during long-term follow-up could be harmful.	[Yndestad, Arne; Finsen, Alexandra Vanessa; Ueland, Thor; Dahl, Christen P.; Oie, Erik; Vinge, Leif Erik; Sandanger, Oystein; Ranheim, Trine; Damas, Jan Kristian; Aukrust, Pal] Univ Oslo, Rikshosp, Oslo Univ Hosp, Internal Med Res Inst, N-0027 Oslo, Norway; [Finsen, Alexandra Vanessa; Dahl, Christen P.; Oie, Erik; Vinge, Leif Erik; Kjekshus, John; Gullestad, Lars] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Cardiol, N-0027 Oslo, Norway; [Ueland, Thor] Univ Oslo, Rikshosp, Oslo Univ Hosp, Endocrinol Sect, N-0027 Oslo, Norway; [Fiane, Arnt E.] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Thorac & Cardiovasc Surg, N-0027 Oslo, Norway; [Aukrust, Pal] Univ Oslo, Rikshosp, Oslo Univ Hosp, Sect Clin Immunol & Infect Dis, N-0027 Oslo, Norway; [Husberg, Cathrine; Sjaastad, Ivar; Christensen, Geir] Oslo Univ Hosp Ulleval, Expt Med Res Inst, Oslo, Norway; [Yndestad, Arne; Finsen, Alexandra Vanessa; Husberg, Cathrine; Dahl, Christen P.; Oie, Erik; Vinge, Leif Erik; Sjaastad, Ivar; Sandanger, Oystein; Kjekshus, John; Gullestad, Lars; Christensen, Geir] Univ Oslo, Ctr Heart Failure Res, N-0027 Oslo, Norway; [Sjaastad, Ivar; Kjekshus, John; Fiane, Arnt E.; Gullestad, Lars; Christensen, Geir; Aukrust, Pal] Univ Oslo, Fac Med, N-0027 Oslo, Norway; [Dickstein, Kenneth] Stavanger Univ Hosp, Div Cardiol, Stavanger, Norway; [Dickstein, Kenneth] Univ Bergen, Fac Med, Bergen, Norway; [Hilfiker-Kleiner, Denise] Hannover Med Sch, Dept Cardiol & Angiol, D-3000 Hannover, Germany; [Lipp, Martin] Max Delbruck Ctr Mol Med, Dept Mol Tumor Genet & Immunogenet, Berlin, Germany	University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; University of Oslo; Stavanger University Hospital; University of Bergen; Hannover Medical School; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Yndestad, A (corresponding author), Univ Oslo, Rikshosp, Oslo Univ Hosp, Internal Med Res Inst, N-0027 Oslo, Norway.	Arne.Yndestad@rr-research.no		Sandanger, Oystein/0000-0001-7475-7362; Lipp, Martin/0000-0002-0087-2672	Norwegian Council of Cardiovascular Research; Research Council of Norway; University of Oslo; Medinnova Foundation; Helse Sor-Ost; Center for Heart Failure Research, University of Oslo, Oslo, Norway; Fondation Leducq; MSD Research Laboratories, West Point, Pennsylvania	Norwegian Council of Cardiovascular Research; Research Council of Norway(Research Council of Norway); University of Oslo; Medinnova Foundation; Helse Sor-Ost; Center for Heart Failure Research, University of Oslo, Oslo, Norway; Fondation Leducq(Leducq Foundation); MSD Research Laboratories, West Point, Pennsylvania	This work was supported by grants from the Norwegian Council of Cardiovascular Research, Research Council of Norway, University of Oslo, Medinnova Foundation, Helse Sor-Ost, Center for Heart Failure Research, University of Oslo, Oslo, Norway; Fondation Leducq and an unrestricted research grant from MSD Research Laboratories, West Point, Pennsylvania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Oufella H, 2006, NAT MED, V12, P178, DOI 10.1038/nm1343; Aukrust P, 2005, ANN MED, V37, P74, DOI 10.1080/07853890510007232; Bruhl H, 2008, RHEUMATOLOGY, V47, P1771, DOI 10.1093/rheumatology/ken383; Damas JK, 2007, ARTERIOSCL THROM VAS, V27, P614, DOI 10.1161/01.ATV.0000255581.38523.7c; Dickstein K, 2002, LANCET, V360, P752, DOI 10.1016/S0140-6736(02)09895-1; Feng G, 2009, CURR OPIN ORGAN TRAN, V14, P432, DOI 10.1097/MOT.0b013e32832c58f1; Finsen AV, 2005, J APPL PHYSIOL, V98, P680, DOI 10.1152/japplphysiol.00924.2004; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Kaur D, 2006, AM J RESP CRIT CARE, V174, P1179, DOI 10.1164/rccm.200603-394OC; Kawashima D, 2005, J CLIN PATHOL, V58, P1057, DOI 10.1136/jcp.2004.024828; Krishnamurthy P, 2009, CIRC RES, V104, pE9, DOI 10.1161/CIRCRESAHA.108.188243; Kvakan H, 2009, CIRCULATION, V119, P2904, DOI 10.1161/CIRCULATIONAHA.108.832782; Mann DL, 2002, CIRC RES, V91, P988, DOI 10.1161/01.RES.0000043825.01705.1B; Menning A, 2007, EUR J IMMUNOL, V37, P1575, DOI 10.1002/eji.200737201; Muller G, 2002, J LEUKOCYTE BIOL, V72, P1; O'Garra A, 2008, IMMUNOL REV, V223, P114, DOI 10.1111/j.1600-065X.2008.00635.x; Pierce EM, 2007, EUR RESPIR J, V29, P1082, DOI 10.1183/09031936.00122806; Randolph DA, 2006, ANNU REV MED, V57, P381, DOI 10.1146/annurev.med.57.121304.131337; Schneider MA, 2007, J EXP MED, V204, P735, DOI 10.1084/jem.20061405; Ueland T, 2005, EUR HEART J, V26, P1101, DOI 10.1093/eurheartj/ehi132	21	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33038	10.1371/journal.pone.0033038	http://dx.doi.org/10.1371/journal.pone.0033038			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427939	Green Published, gold, Green Accepted			2022-12-25	WOS:000302381500081
J	De Marco, P; Bartella, V; Vivacqua, A; Lappano, R; Santolla, MF; Morcavallo, A; Pezzi, V; Belfiore, A; Maggiolini, M				De Marco, P.; Bartella, V.; Vivacqua, A.; Lappano, R.; Santolla, M. F.; Morcavallo, A.; Pezzi, V.; Belfiore, A.; Maggiolini, M.			Insulin-like growth factor-I regulates GPER expression and function in cancer cells	ONCOGENE			English	Article						cancer cells; ER alpha; GPER; IGF-I; signal transduction	PROTEIN-COUPLED RECEPTOR; BREAST-CANCER; ESTROGEN-RECEPTOR; GENE-EXPRESSION; FACTOR SYSTEM; SIGNALING SYSTEMS; CCN FAMILY; IGF-I; GPR30; 17-BETA-ESTRADIOL	Functional cross talk between insulin-like growth factor-I (IGF-I) system and estrogen signaling has been largely reported, although the underlying molecular mechanisms remain to be fully elucidated. As GPR30/GPER mediates rapid cell responses to estrogens, we evaluated the potential of IGF-I to regulate GPER expression and function in estrogen receptor (ER)alpha-positive breast (MCF-7) and endometrial (Ishikawa) cancer cells. We found that IGF-I transactivates the GPER promoter sequence and upregulates GPER mRNA and protein levels in both cells types. Similar data were found, at least in part, in carcinoma-associated fibroblasts. The upregulation of GPER expression by IGF-I involved the IGF-IR/PKC delta/ERK/c-fos/AP1 transduction pathway and required ER alpha, as ascertained by specific pharmacological inhibitors and gene-silencing. In both MCF-7 and Ishikawa cancer cells, the IGF-I-dependent cell migration required GPER and its main target gene CTGF, whereas the IGF-I-induced proliferation required both GPER and cyclin D1. Our data demonstrate that the IGF-I system regulates GPER expression and function, triggering the activation of a signaling network that leads to the migration and proliferation of cancer cells. Oncogene (2013) 32, 678-688; doi:10.1038/onc.2012.97; published online 19 March 2012	[De Marco, P.; Bartella, V.; Vivacqua, A.; Lappano, R.; Santolla, M. F.; Pezzi, V.; Maggiolini, M.] Univ Calabria, Dept Pharmacobiol, I-87030 Arcavacata Di Rende, CS, Italy; [Morcavallo, A.; Belfiore, A.] Magna Graecia Univ Catanzaro, Dept Hlth, Catanzaro, Italy	University of Calabria; Magna Graecia University of Catanzaro	Maggiolini, M (corresponding author), Univ Calabria, Dept Pharmacobiol, Via P Bucci, I-87030 Arcavacata Di Rende, CS, Italy.	marcellomaggiolini@yahoo.it	Pezzi, Vincenzo/AAL-4017-2020; Maggiolini, Marcello/Z-4729-2019; vivacqua, adele/I-2771-2015; Santolla, Maria Francesca/AAH-5481-2020; Belfiore, Antonino/B-4652-2011; Lappano, Rosamaria/Z-4857-2019	vivacqua, adele/0000-0001-5333-8396; Belfiore, Antonino/0000-0002-6181-4193; pezzi, Vincenzo/0000-0003-2311-2286; Santolla, Maria Francesca/0000-0002-4838-5953; Lappano, Rosamaria/0000-0002-9374-9701; Maggiolini, Marcello/0000-0002-7485-854X	Associazione Italiana per la Ricerca sul Cancro (AIRC) [8925/2009, 10625/2009]; Fondazione Cassa di Risparmio di Calabria e Lucania; Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) [PRIN 2008PK2WCW/2008, PRIN 2008BKRFBH_005]	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Fondazione Cassa di Risparmio di Calabria e Lucania; Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work was supported by the Associazione Italiana per la Ricerca sul Cancro (AIRC, project no. 8925/2009 to MM and project no. 10625/2009 to AB; project Calabria 2011 to AB and MM) (http://www.airc.it/), Fondazione Cassa di Risparmio di Calabria e Lucania and Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) (project PRIN 2008PK2WCW/2008 to MM and project PRIN 2008BKRFBH_005 to AB) (http://www.istruzione.it/).	Akekawatchai C, 2005, J BIOL CHEM, V280, P39701, DOI 10.1074/jbc.M509829200; Albanito L, 2008, ENDOCRINOLOGY, V149, P3799, DOI 10.1210/en.2008-0117; Albanito L, 2007, CANCER RES, V67, P1859, DOI 10.1158/0008-5472.CAN-06-2909; Bai ZL, 2009, ARCH PHARM, V342, P133, DOI 10.1002/ardp.200800174; Baron S, 2007, J BIOL CHEM, V282, P11732, DOI 10.1074/jbc.M610079200; Belfiore A, 2007, CURR PHARM DESIGN, V13, P671, DOI 10.2174/138161207780249173; Belfiore A, 2008, J MAMMARY GLAND BIOL, V13, P381, DOI 10.1007/s10911-008-9099-z; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bradley LM, 2008, J STEROID BIOCHEM, V109, P185, DOI 10.1016/j.jsbmb.2007.10.006; Cascio S, 2007, J BIOL CHEM, V282, P3498, DOI 10.1074/jbc.M606244200; Chaqour B, 2006, J BIOL CHEM, V281, P20608, DOI 10.1074/jbc.M600214200; Cortez V, 2010, Minerva Ginecol, V62, P573; Cowley SM, 1997, J BIOL CHEM, V272, P19858, DOI 10.1074/jbc.272.32.19858; Dalle S, 2001, J BIOL CHEM, V276, P15688, DOI 10.1074/jbc.M010884200; Daub H, 1997, EMBO J, V16, P7032, DOI 10.1093/emboj/16.23.7032; Fagan D, 2008, J MAMMARY GLAND BIOL, V13, P423, DOI 10.1007/s10911-008-9098-0; Filardo EJ, 2006, CLIN CANCER RES, V12, P6359, DOI 10.1158/1078-0432.CCR-06-0860; Filardo EJ, 2000, MOL ENDOCRINOL, V14, P1649, DOI 10.1210/me.14.10.1649; Filardo EJ, 2002, MOL ENDOCRINOL, V16, P70, DOI 10.1210/me.16.1.70; Gerdes MJ, 2006, CANCER RES, V66, P7578, DOI 10.1158/0008-5472.CAN-06-1247; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Holbourn KP, 2008, TRENDS BIOCHEM SCI, V33, P461, DOI 10.1016/j.tibs.2008.07.006; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Kisfalvi K, 2009, CANCER RES, V69, P6539, DOI 10.1158/0008-5472.CAN-09-0418; KUMAR V, 1988, CELL, V55, P145, DOI 10.1016/0092-8674(88)90017-7; Lann D, 2008, J MAMMARY GLAND BIOL, V13, P371, DOI 10.1007/s10911-008-9100-x; Lappano R, 2011, NAT REV DRUG DISCOV, V10, P47, DOI 10.1038/nrd3320; Leask A, 2006, J CELL SCI, V119, P4803, DOI 10.1242/jcs.03270; LeRoith D, 2003, CANCER LETT, V195, P127, DOI 10.1016/S0304-3835(03)00159-9; Madeo A, 2010, CANCER RES, V70, P6036, DOI 10.1158/0008-5472.CAN-10-0408; Maggiolini M, 2004, J BIOL CHEM, V279, P27008, DOI 10.1074/jbc.M403588200; Maggiolini M, 2010, J ENDOCRINOL, V204, P105, DOI 10.1677/JOE-09-0242; Mawson A, 2005, MOL CELL ENDOCRINOL, V229, P161, DOI 10.1016/j.mce.2004.08.002; Mendoza RA, 2011, J ENDOCRINOL, V208, P1, DOI 10.1677/JOE-10-0235; Pandey DP, 2009, EMBO J, V28, P523, DOI 10.1038/emboj.2008.304; Pandini G, 1999, CLIN CANCER RES, V5, P1935; Pike MC, 2004, ONCOGENE, V23, P6379, DOI 10.1038/sj.onc.1207899; Prossnitz ER, 2009, MOL CELL ENDOCRINOL, V308, P32, DOI 10.1016/j.mce.2009.03.026; Recchia AG, 2011, J BIOL CHEM, V286, P10773, DOI 10.1074/jbc.M110.172247; Rosenzweig SA, 2010, BIOCHEM PHARMACOL, V80, P1115, DOI 10.1016/j.bcp.2010.06.013; Rozengurt E, 2010, CLIN CANCER RES, V16, P2505, DOI 10.1158/1078-0432.CCR-09-2229; Sirianni R, 2008, ENDOCRINOLOGY, V149, P5043, DOI 10.1210/en.2007-1593; Smith HO, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2007.01.004; Song RXD, 2007, ENDOCRINOLOGY, V148, P4091, DOI 10.1210/en.2007-0240; SOOS MA, 1993, BIOCHEM J, V290, P419, DOI 10.1042/bj2900419; STEWART AJ, 1990, J BIOL CHEM, V265, P21172; Stewart CEH, 1996, PHYSIOL REV, V76, P1005, DOI 10.1152/physrev.1996.76.4.1005; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; TSAI SY, 1989, CELL, V57, P443, DOI 10.1016/0092-8674(89)90919-7; Vivacqua A, 2006, MOL ENDOCRINOL, V20, P631, DOI 10.1210/me.2005-0280; Vivacqua A, 2006, MOL PHARMACOL, V70, P1414, DOI 10.1124/mol.106.026344; Vivacqua A, 2009, MOL ENDOCRINOL, V23, P1815, DOI 10.1210/me.2009-0120; Young SH, 2010, BIOCHEM BIOPH RES CO, V401, P154, DOI 10.1016/j.bbrc.2010.09.036; Zhang G, 2010, CANCER GENET CYTOGEN, V200, P140, DOI 10.1016/j.cancergencyto.2010.04.007	54	73	76	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 7	2013	32	6					678	688		10.1038/onc.2012.97	http://dx.doi.org/10.1038/onc.2012.97			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	101AF	22430216				2022-12-25	WOS:000315746700002
J	Zhou, Y; Cho, KJ; Plowman, SJ; Hancock, JF				Zhou, Yong; Cho, Kwang-Jin; Plowman, Sarah J.; Hancock, John F.			Nonsteroidal Anti-inflammatory Drugs Alter the Spatiotemporal Organization of Ras Proteins on the Plasma Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H-RAS; LIPID RAFTS; K-RAS; NANOCLUSTER FORMATION; FOREIGN MOLECULES; DOMAIN FORMATION; DYNAMICS; ASSOCIATION; ORIENTATION; ANESTHETICS	Ras proteins on the inner leaflet of the plasma membrane signal from transient nanoscale proteolipid assemblies called nanoclusters. Interactions between the Ras lipid anchors and plasma membrane phospholipids, cholesterol, and actin cytoskeleton contribute to the formation, stability, and dynamics of Ras nanoclusters. Many small biological molecules are amphiphilic and capable of intercalating into membranes and altering lipid immiscibility. In this study we systematically examined whether amphiphiles such as indomethacin influence Ras protein nanoclustering in intact plasma membrane. We found that indomethacin, a nonsteroidal anti-inflammatory drug, induced profound and complex effects on Ras spatial organization, all likely related to liquid-ordered domain stabilization. Indomethacin enhanced the clustering of H-Ras. GDP and N-Ras.GTP in cholesterol-dependent nanoclusters. Indomethacin also abrogated efficient GTP-dependent lateral segregation of H- and N-Ras between cholesterol-dependent and cholesterol-independent clusters, resulting in mixed heterotypic clusters of Ras proteins that normally are separated spatially. These heterotypic Ras nanoclusters showed impaired Raf recruitment and kinase activation resulting in significantly compromised MAPK signaling. All of the amphiphilic anti-inflammatory agents we tested had similar effects on Ras nanoclustering and signaling. The potency of these effects correlated with the membrane partition coefficients of the individual agents and was independent of COX inhibition. This study shows that biological amphiphiles have wide-ranging effects on plasma membrane heterogeneity and protein nanoclustering, revealing a novel mechanism of drug action that has important consequences for cell signaling.	[Zhou, Yong; Cho, Kwang-Jin; Plowman, Sarah J.; Hancock, John F.] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Hancock, JF (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Med Sch Bldg Ste 4-098,6431 Fannin St, Houston, TX 77030 USA.	John.F.Hancock@uth.tmc.edu	Cho, Kwang-jin/AAI-4923-2020	Zhou, Yong/0000-0002-0214-8151; Hancock, John/0000-0003-0542-4710	National Institutes of Health [GM066717]; Cancer Prevention Research Institute of Texas [RP100483]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066717] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention Research Institute of Texas; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM066717. This work was also supported by Grant RP100483 from the Cancer Prevention Research Institute of Texas.	Abankwa D, 2007, SEMIN CELL DEV BIOL, V18, P599, DOI 10.1016/j.semcdb.2007.08.003; Abankwa D, 2008, EMBO J, V27, P727, DOI 10.1038/emboj.2008.10; Abankwa D, 2010, P NATL ACAD SCI USA, V107, P1130, DOI 10.1073/pnas.0903907107; Ahearn IM, 2011, MOL CELL, V41, P173, DOI 10.1016/j.molcel.2011.01.001; Baker TL, 2003, J BIOL CHEM, V278, P19292, DOI 10.1074/jbc.M206956200; Bakht O, 2007, BIOPHYS J, V93, P4307, DOI 10.1529/biophysj.107.114967; Belanis L, 2008, MOL BIOL CELL, V19, P1404, DOI 10.1091/mbc.E07-10-1053; BenTal N, 1996, BIOPHYS J, V71, P561, DOI 10.1016/S0006-3495(96)79280-9; BESAG J, 1977, J ROYAL STAT SOC B, V39, P193, DOI DOI 10.1016/J.FORECO.2009.04.009; Bhagatji P, 2010, BIOPHYS J, V99, P3327, DOI 10.1016/j.bpj.2010.10.001; Chang CW, 2007, METHOD CELL BIOL, V81, P495, DOI 10.1016/S0091-679X(06)81024-1; Diggle PJ, 2000, ADV APPL PROBAB, V32, P331, DOI 10.1017/S0001867800009952; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Glaser M, 1996, J BIOL CHEM, V271, P26187, DOI 10.1074/jbc.271.42.26187; Gorfe AA, 2007, ANGEW CHEM INT EDIT, V46, P8234, DOI 10.1002/anie.200702379; Gorfe AA, 2007, J AM CHEM SOC, V129, P12280, DOI 10.1021/ja073949v; Gorfe AA, 2007, J MED CHEM, V50, P674, DOI 10.1021/jm061053f; Hancock JF, 2005, BIOCHEM J, V389, P1, DOI 10.1042/BJ20050231; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; Heerklotz H, 2002, BIOPHYS J, V83, P2693, DOI 10.1016/S0006-3495(02)75278-8; Heerklotz H, 2003, J MOL BIOL, V329, P793, DOI 10.1016/S0022-2836(03)00504-7; Inder K, 2008, MOL BIOL CELL, V19, P4776, DOI 10.1091/mbc.E08-04-0407; JORGENSEN K, 1991, ANN NY ACAD SCI, V625, P747, DOI 10.1111/j.1749-6632.1991.tb33908.x; JORGENSEN K, 1991, BIOCHIM BIOPHYS ACTA, V1067, P241, DOI 10.1016/0005-2736(91)90050-I; Jutila A, 2001, CHEM PHYS LIPIDS, V112, P151, DOI 10.1016/S0009-3084(01)00175-X; Kenworthy AK, 2004, J CELL BIOL, V165, P735, DOI 10.1083/jcb.200312170; Kholodenko BN, 2010, NAT REV MOL CELL BIO, V11, P414, DOI 10.1038/nrm2901; KIM JY, 1994, J BIOL CHEM, V269, P28214; Levental I, 2010, BIOCHEMISTRY-US, V49, P6305, DOI 10.1021/bi100882y; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Mor A, 2006, ANNU REV IMMUNOL, V24, P771, DOI 10.1146/annurev.immunol.24.021605.090723; Plowman SJ, 2008, MOL CELL BIOL, V28, P4377, DOI 10.1128/MCB.00050-08; Plowman SJ, 2005, P NATL ACAD SCI USA, V102, P15500, DOI 10.1073/pnas.0504114102; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; RIPLEY BD, 1977, J ROY STAT SOC B MET, V39, P172; Rocks O, 2010, CELL, V141, P458, DOI 10.1016/j.cell.2010.04.007; Rothwell PM, 2011, LANCET, V377, P31, DOI 10.1016/S0140-6736(10)62110-1; Roy S, 2005, MOL CELL BIOL, V25, P6722, DOI 10.1128/MCB.25.15.6722-6733.2005; Sawdy RJ, 2003, EUR J OBSTET GYN R B, V109, P33, DOI 10.1016/S0301-2115(02)00481-5; SEDGHI S, 1993, GUT, V34, P1191, DOI 10.1136/gut.34.9.1191; Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803; Tian TH, 2007, NAT CELL BIOL, V9, P905, DOI 10.1038/ncb1615; Tian TH, 2010, BIOPHYS J, V99, P534, DOI 10.1016/j.bpj.2010.04.055; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Wesolowska O, 2011, MOL MEMBR BIOL, V28, P103, DOI 10.3109/09687688.2010.533706; Yang W, 2010, MOL CELL PROTEOMICS, V9, P54, DOI 10.1074/mcp.M800448-MCP200; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Yeung T, 2006, SCIENCE, V313, P347, DOI 10.1126/science.1129551; Zhou Y, 2010, J BIOL CHEM, V285, P35188, DOI 10.1074/jbc.M110.141200; Zhou Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008811	51	42	43	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16586	16595		10.1074/jbc.M112.348490	http://dx.doi.org/10.1074/jbc.M112.348490			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22433858	Green Published, hybrid			2022-12-25	WOS:000304030900048
J	Pucci, M; Pasquariello, N; Battista, N; Di Tommaso, M; Rapino, C; Fezza, F; Zuccolo, M; Jourdain, R; Agro, AF; Breton, L; Maccarrone, M				Pucci, Mariangela; Pasquariello, Nicoletta; Battista, Natalia; Di Tommaso, Monia; Rapino, Cinzia; Fezza, Filomena; Zuccolo, Michela; Jourdain, Roland; Agro, Alessandro Finazzi; Breton, Lionel; Maccarrone, Mauro			Endocannabinoids Stimulate Human Melanogenesis via Type-1 Cannabinoid Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID AMIDE HYDROLASE; PROTEIN-KINASE; IN-VIVO; EPIDERMAL DIFFERENTIATION; CONTACT-DERMATITIS; HUMAN MELANOCYTES; MELANOMA-CELLS; CYCLIC-AMP; ANANDAMIDE; TRANSCRIPTION	We show that a fully functional endocannabinoid system is present in primary human melanocytes (normal human epidermal melanocyte cells), including anandamide (AEA), 2-arachidonoylglycerol, the respective target receptors (CB1, CB2, and TRPV1), and their metabolic enzymes. We also show that at higher concentrations AEA induces normal human epidermal melanocyte apoptosis (similar to 3-fold over controls at 5 mu M) through a TRPV1-mediated pathway that increases DNA fragmentation and p53 expression. However, at lower concentrations, AEA and other CB1-binding endocannabinoids dose-dependently stimulate melanin synthesis and enhance tyrosinase gene expression and activity (similar to 3-and similar to 2-fold over controls at 1 mu M). This CB1-dependent activity was fully abolished by the selective CB1 antagonist SR141716 or by RNA interference of the receptor. CB1 signaling engaged p38 and p42/44 mitogen-activated protein kinases, which in turn activated the cyclic AMP response element-binding protein and the microphthalmia-associated transcription factor. Silencing of tyrosinase or microphthalmia-associated transcription factor further demonstrated the involvement of these proteins in AEA-induced melanogenesis. In addition, CB1 activation did not engage the key regulator of skin pigmentation, cyclic AMP, showing a major difference compared with the regulation of melanogenesis by alpha-melanocyte-stimulating hormone through melanocortin 1 receptor.	[Pucci, Mariangela; Pasquariello, Nicoletta; Battista, Natalia; Di Tommaso, Monia; Rapino, Cinzia; Maccarrone, Mauro] Univ Teramo, Dept Biomed Sci, I-64100 Teramo, Italy; [Zuccolo, Michela; Jourdain, Roland; Breton, Lionel] LOreal Res & Innovat, F-92110 Clichy, France; [Fezza, Filomena; Agro, Alessandro Finazzi] Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, I-00133 Rome, Italy; [Agro, Alessandro Finazzi] Univ Campus Biomed Roma, CIR, I-00128 Rome, Italy; [Battista, Natalia; Fezza, Filomena; Maccarrone, Mauro] Santa Lucia Fdn, European Ctr Brain Res CERC, I-00143 Rome, Italy	University of Teramo; L'Oreal Group; University of Rome Tor Vergata; University Campus Bio-Medico - Rome Italy; IRCCS Santa Lucia	Maccarrone, M (corresponding author), Univ Teramo, Dept Biomed Sci, Piazza A Moro 45, I-64100 Teramo, Italy.	mmaccarrone@unite.it	Maccarrone, Mauro/K-5398-2012; Battista, Natalia/AAC-2529-2019; Pucci, Mariangela/K-6379-2016	Maccarrone, Mauro/0000-0002-3990-2963; Battista, Natalia/0000-0002-1936-6710; Pucci, Mariangela/0000-0003-4657-6075	L'Oreal Research and Innovation, Paris; Fondazione Cassa di Risparmio di Teramo	L'Oreal Research and Innovation, Paris; Fondazione Cassa di Risparmio di Teramo	This work was supported by L'Oreal Research and Innovation, Paris and by Fondazione Cassa di Risparmio di Teramo Grant 2009-2012 (to M.M.).	Abdel-Malek ZA, 2010, PIGM CELL MELANOMA R, V23, P171, DOI 10.1111/j.1755-148X.2010.00679.x; American Cancer Society, 2009, CANC FACTS FIG 2009; Bari M, 2005, J BIOL CHEM, V280, P12212, DOI 10.1074/jbc.M411642200; Berdyshev EV, 2001, FASEB J, V15, P2171, DOI 10.1096/fj.01-0181com; Bifulco M, 2002, NAT MED, V8, P547, DOI 10.1038/nm0602-547; Biro T, 2009, TRENDS PHARMACOL SCI, V30, P411, DOI 10.1016/j.tips.2009.05.004; Bisogno T, 2003, J CELL BIOL, V163, P463, DOI 10.1083/jcb.200305129; Blazquez C, 2006, FASEB J, V20, P2633, DOI 10.1096/fj.06-6638fje; BOUABOULA M, 1995, BIOCHEM J, V312, P637, DOI 10.1042/bj3120637; BRONNERFRASER M, 1988, NATURE, V335, P161, DOI 10.1038/335161a0; Busca R, 2000, EMBO J, V19, P2900, DOI 10.1093/emboj/19.12.2900; Busca R, 2000, PIGM CELL RES, V13, P60, DOI 10.1034/j.1600-0749.2000.130203.x; Casanova ML, 2003, J CLIN INVEST, V111, P43, DOI 10.1172/JCI200316116; Casu MA, 2005, BRAIN RES, V1048, P41, DOI 10.1016/j.brainres.2005.04.053; Cheli Y, 2010, PIGM CELL MELANOMA R, V23, P27, DOI 10.1111/j.1755-148X.2009.00653.x; Cheli Y, 2009, J BIOL CHEM, V284, P18699, DOI 10.1074/jbc.M109.005819; Choi TY, 2009, J DERMATOL SCI, V56, P128, DOI 10.1016/j.jdermsci.2009.07.002; Colombo G, 2009, J MOL NEUROSCI, V37, P111, DOI 10.1007/s12031-008-9114-2; Corre S, 2006, J INVEST DERMATOL, V126, P916, DOI 10.1038/sj.jid.5700190; Di Marzo V, 2008, REV PHYSIOL BIOCH P, V160, P1, DOI 10.1007/112_0505; Di Marzo V, 2010, CURR MED CHEM, V17, P1430; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; Dobrosi N, 2008, FASEB J, V22, P3685, DOI 10.1096/fj.07-104877; FELDER CC, 1993, P NATL ACAD SCI USA, V90, P7656, DOI 10.1073/pnas.90.16.7656; Fezza F, 2005, ANAL BIOCHEM, V339, P113, DOI 10.1016/j.ab.2004.12.005; Francavilla F, 2009, ENDOCRINOLOGY, V150, P4692, DOI 10.1210/en.2009-0057; Gattinoni S, 2010, BIOORG MED CHEM LETT, V20, P4406, DOI 10.1016/j.bmcl.2010.06.050; Guzman M, 2003, NAT REV CANCER, V3, P745, DOI 10.1038/nrc1188; Hanus LO, 2010, CURR MED CHEM, V17, P1341, DOI 10.2174/092986710790980096; Hemesath TJ, 1998, NATURE, V391, P298, DOI 10.1038/34681; Howlett AC, 2010, CURR MED CHEM, V17, P1382, DOI 10.2174/092986710790980023; Ibrahim MM, 2005, P NATL ACAD SCI USA, V102, P3093, DOI 10.1073/pnas.0409888102; Johnson SL, 2011, DEV BIOL, V350, P405, DOI 10.1016/j.ydbio.2010.12.004; Karsak M, 2007, SCIENCE, V316, P1494, DOI 10.1126/science.1142265; Khasabova IA, 2008, J NEUROSCI, V28, P11141, DOI 10.1523/JNEUROSCI.2847-08.2008; Kumagai A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026148; Kupczyk P, 2009, EXP DERMATOL, V18, P669, DOI 10.1111/j.1600-0625.2009.00923.x; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; Ligresti A, 2009, CURR OPIN CHEM BIOL, V13, P321, DOI 10.1016/j.cbpa.2009.04.615; Liu J, 2003, J BIOL CHEM, V278, P45034, DOI 10.1074/jbc.M306062200; Liu J, 2000, BIOCHEM J, V346, P835, DOI 10.1042/0264-6021:3460835; Liu JJ, 2010, PIGM CELL MELANOMA R, V23, P741, DOI 10.1111/j.1755-148X.2010.00775.x; Maccarrone M, 2003, J BIOL CHEM, V278, P33896, DOI 10.1074/jbc.M303994200; Maccarrone M, 2006, ENDOCANNABINOIDS: THE BRAIN AND BODY'S MARIJUANA AND BEYOND, P451; Maccarrone M, 2010, TRENDS BIOCHEM SCI, V35, P601, DOI 10.1016/j.tibs.2010.05.008; Magina S, 2011, ARCH DERMATOL RES, V303, P201, DOI 10.1007/s00403-011-1126-z; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; McKinney MK, 2005, ANNU REV BIOCHEM, V74, P411, DOI 10.1146/annurev.biochem.74.082803.133450; Navarrete M, 2008, NEURON, V57, P883, DOI 10.1016/j.neuron.2008.01.029; Oka S, 2006, J IMMUNOL, V177, P8796, DOI 10.4049/jimmunol.177.12.8796; Okamoto Y, 2009, VITAM HORM, V81, P1, DOI 10.1016/S0083-6729(09)81001-7; Park SY, 2010, BMB REP, V43, P824, DOI 10.5483/BMBRep.2010.43.12.824; Pasquariello N, 2009, J BIOL CHEM, V284, P29413, DOI 10.1074/jbc.M109.044412; Pasquariello N, 2009, VITAM HORM, V81, P441, DOI 10.1016/S0083-6729(09)81017-0; Paus R, 2006, J CLIN INVEST, V116, P1174, DOI 10.1172/JCI28553; Pertwee RG, 2010, CURR MED CHEM, V17, P1360, DOI 10.2174/092986710790980050; Petrosino S, 2009, CURR OPIN CHEM BIOL, V13, P309, DOI 10.1016/j.cbpa.2009.04.616; Pistis M, 2010, CURR MED CHEM, V17, P1450, DOI 10.2174/092986710790980014; Price ER, 1998, J BIOL CHEM, V273, P17983, DOI 10.1074/jbc.273.29.17983; Pucci M, 2011, EUR J DERMATOL, V21, P29, DOI 10.1684/ejd.2011.1266; Ross RA, 2009, TRENDS PHARMACOL SCI, V30, P156, DOI 10.1016/j.tips.2008.12.004; Scuderi MR, 2011, CANCER LETT, V310, P240, DOI 10.1016/j.canlet.2011.07.008; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Siegmund SV, 2006, J BIOL CHEM, V281, P10431, DOI 10.1074/jbc.M509706200; Simon GM, 2010, J BIOL CHEM, V285, P11051, DOI 10.1074/jbc.R109.097600; Simon JD, 2009, PIGM CELL MELANOMA R, V22, P563, DOI 10.1111/j.1755-148X.2009.00610.x; Smit N, 2009, INT J MOL SCI, V10, P5326, DOI 10.3390/ijms10125326; Sugawara K., 2012, J ALLERGY CLIN IMMUN, V129, P726; Tada A, 2002, J INVEST DERMATOL, V118, P316, DOI 10.1046/j.0022-202x.2001.01694.x; Telek A, 2007, FASEB J, V21, P3534, DOI 10.1096/fj.06-7689com; Wan P, 2011, MOL CELL BIOCHEM, V354, P241, DOI 10.1007/s11010-011-0823-4; Werz O, 2001, BLOOD, V97, P2487, DOI 10.1182/blood.V97.8.2487; Xiao L, 2007, ARCH DERMATOL RES, V299, P245, DOI 10.1007/s00403-007-0740-2; Xu WD, 2000, EXP CELL RES, V255, P135, DOI 10.1006/excr.2000.4803; Zorina Y, 2010, J BIOL CHEM, V285, P1358, DOI 10.1074/jbc.M109.049841	75	47	48	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15466	15478		10.1074/jbc.M111.314880	http://dx.doi.org/10.1074/jbc.M111.314880			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22431736	hybrid, Green Published			2022-12-25	WOS:000304006300028
J	Alaoui, SS; Dessirier, V; de Araujo, E; Alexaki, VI; Pelekanou, V; Lkhider, M; Stathopoulos, EN; Castanas, E; Bagot, M; Bensussan, A; Tsapis, A				Alaoui, Sanaa Sabour; Dessirier, Valerie; de Araujo, Elisabeth; Alexaki, Vassilia-Ismini; Pelekanou, Vassiliki; Lkhider, Mustapha; Stathopoulos, Efstathios N.; Castanas, Elias; Bagot, Martine; Bensussan, Armand; Tsapis, Andreas			TWEAK Affects Keratinocyte G2/M Growth Arrest and Induces Apoptosis through the Translocation of the AIF Protein to the Nucleus	PLOS ONE			English	Article							FACTOR RECEPTOR FAMILY; WEAK INDUCER; CELL-DEATH; TNF-ALPHA; EPIDERMAL-KERATINOCYTES; ENDOTHELIAL-CELLS; GENOTOXIC STRESS; KAPPA-B; NECROSIS; ACTIVATION	The soluble TNF-like weak inducer of apoptosis (TWEAK, TNFSF12) binds to the fibroblast growth factor-inducible 14 receptor (FN14, TNFRSF12A) on the cell membrane and induces multiple biological responses, such as proliferation, migration, differentiation, angiogenesis and apoptosis. Previous reports show that TWEAK, which does not contain a death domain in its cytoplasmic tail, induces the apoptosis of tumor cell lines through the induction of TNF alpha secretion. TWEAK induces apoptosis in human keratinocytes. Our experiments clearly demonstrate that TWEAK does not induce the secretion of TNF alpha or TRAIL proteins. The use of specific inhibitors and the absence of procaspase-3 cleavage suggest that the apoptosis of keratinocytes follows a caspase-and cathepsin B-independent pathway. Further investigation showed that TWEAK induces a decrease in the mitochondrial membrane potential of keratinocytes. Confocal microscopy showed that TWEAK induces the cleavage and the translocation of apoptosis inducing factor (AIF) from the mitochondria to the nucleus, thus initiating caspase-independent apoptosis. Moreover, TWEAK induces FOXO3 and GADD45 expression, cdc2 phosphorylation and cdc2 and cyclinB1 degradation, resulting in the arrest of cell growth at the G2/M phase. Finally, we report that TWEAK and FN14 are normally expressed in the basal layer of the physiological epidermis and are greatly enhanced in benign (psoriasis) and malignant (squamous cell carcinoma) skin pathologies that are characterized by an inflammatory component. TWEAK might play an essential role in skin homeostasis and pathology.	[Alaoui, Sanaa Sabour; Dessirier, Valerie; de Araujo, Elisabeth; Bagot, Martine; Bensussan, Armand; Tsapis, Andreas] INSERM, U976, Paris, France; [Alaoui, Sanaa Sabour; Dessirier, Valerie; de Araujo, Elisabeth; Bagot, Martine; Bensussan, Armand; Tsapis, Andreas] Univ Paris Diderot, Paris, France; [Alaoui, Sanaa Sabour; Lkhider, Mustapha] Univ Chouaib Doukkali, Dept Biol, El Jadida, Morocco; [Alexaki, Vassilia-Ismini; Pelekanou, Vassiliki; Castanas, Elias] Univ Crete, Sch Med, Lab Expt Endocrinol, Iraklion, Greece; [Pelekanou, Vassiliki; Stathopoulos, Efstathios N.] Univ Crete, Sch Med, Pathol Lab, Iraklion, Greece; [Bagot, Martine; Bensussan, Armand] Hop St Louis, Serv Dermatol, F-75475 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Chouaib Doukkali University of El Jadida; University of Crete; University of Crete; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Alaoui, SS (corresponding author), INSERM, U976, Paris, France.	andreas.tsapis@inserm.fr	Pelekanou, Vasiliki/AAB-9735-2021; Castanas, Elias/E-7007-2010; Bensussan, Armand/E-5434-2017; Alexaki, Vasileia Ismini/K-5527-2019	Pelekanou, Vasiliki/0000-0002-8431-1927; Castanas, Elias/0000-0002-8370-1835; Alexaki, Vasileia Ismini/0000-0003-3935-8985; Bensussan, Armand/0000-0002-0409-2497	INSERM; Ligue Contre le Cancer	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Ligue Contre le Cancer(Ligue nationale contre le cancer)	This work was supported by INSERM and Ligue Contre le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexaki VI, 2009, J IMMUNOL, V183, P5948, DOI 10.4049/jimmunol.0901186; Ando T, 2001, J BIOL CHEM, V276, P42971, DOI 10.1074/jbc.M106460200; Ando T, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2038; Banno T, 2004, J BIOL CHEM, V279, P32633, DOI 10.1074/jbc.M400642200; Bassoe CF, 2003, CYTOM PART B-CLIN CY, V51B, P21, DOI 10.1002/cyto.b.10003; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Browning JL, 1996, J EXP MED, V183, P867, DOI 10.1084/jem.183.3.867; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Charrier-Savournin FB, 2004, MOL BIOL CELL, V15, P3965, DOI 10.1091/mbc.E03-12-0871; Chicheportiche Y, 1997, J BIOL CHEM, V272, P32401, DOI 10.1074/jbc.272.51.32401; Christiano C, 2003, J BIOL CHEM, V278, P30057, DOI 10.1074/jbc.M301136200; Dai X, 2004, J INVEST DERMATOL, V122, P1356, DOI 10.1111/j.0022-202X.2004.22522.x; Daugas E, 2000, FASEB J, V14, P729, DOI 10.1096/fasebj.14.5.729; de Araujo E, 2011, EXP DERMATOL, V20, P107, DOI 10.1111/j.1600-0625.2010.01176.x; Dogra C, 2006, J BIOL CHEM, V281, P10327, DOI 10.1074/jbc.M511131200; Dogra C, 2007, FASEB J, V21, P1857, DOI 10.1096/fj.06-7537com; Donohue PJ, 2003, ARTERIOSCL THROM VAS, V23, P594, DOI 10.1161/01.ATV.0000062883.93715.37; Eby MT, 2000, J BIOL CHEM, V275, P15336, DOI 10.1074/jbc.275.20.15336; Grell M, 1999, EMBO J, V18, P3034, DOI 10.1093/emboj/18.11.3034; Harada N, 2002, BIOCHEM BIOPH RES CO, V299, P488, DOI 10.1016/S0006-291X(02)02670-0; Ikner A, 2011, J BIOL CHEM, V286, P21546, DOI 10.1074/jbc.M110.203745; Jakubowski A, 2002, J CELL SCI, V115, P267; Jin SQ, 2000, J BIOL CHEM, V275, P16602, DOI 10.1074/jbc.M000284200; Kaplan MJ, 2000, J IMMUNOL, V164, P2897, DOI 10.4049/jimmunol.164.6.2897; Kim DS, 2008, EXP DERMATOL, V17, P312, DOI 10.1111/j.1600-0625.2007.00646.x; Lynch CN, 1999, J BIOL CHEM, V274, P8455, DOI 10.1074/jbc.274.13.8455; Nakayama M, 2003, BIOCHEM BIOPH RES CO, V306, P819, DOI 10.1016/S0006-291X(03)01051-9; Nakayama M, 2000, J EXP MED, V192, P1373, DOI 10.1084/jem.192.9.1373; Notas G., 2011, J NUTR BIOCH; Pelekanou V, 2011, ANAL CELL PATHOL, V34, P49, DOI [10.3233/ACP-2011-0001, 10.1155/2011/108631]; Polek TC, 2003, J BIOL CHEM, V278, P32317, DOI 10.1074/jbc.M302518200; Prasad KVS, 1997, P NATL ACAD SCI USA, V94, P6346, DOI 10.1073/pnas.94.12.6346; Saitoh T, 2003, J BIOL CHEM, V278, P36005, DOI 10.1074/jbc.M304266200; Schneider P, 1999, EUR J IMMUNOL, V29, P1785, DOI 10.1002/(SICI)1521-4141(199906)29:06<1785::AID-IMMU1785>3.0.CO;2-U; Segaert S, 1997, J INVEST DERMATOL, V109, P46, DOI 10.1111/1523-1747.ep12276488; Sureda FX, 1999, BRAIN RES PROTOC, V4, P280, DOI 10.1016/S1385-299X(99)00030-6; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Vairapandi M, 2002, J CELL PHYSIOL, V192, P327, DOI 10.1002/jcp.10140; Vince JE, 2008, J CELL BIOL, V182, P171, DOI 10.1083/jcb.200801010; Wiley SR, 2001, IMMUNITY, V15, P837, DOI 10.1016/S1074-7613(01)00232-1; Wiley SR, 2003, CYTOKINE GROWTH F R, V14, P241, DOI 10.1016/S1359-6101(03)00019-4; Wilson CA, 2002, CELL DEATH DIFFER, V9, P1321, DOI 10.1038/sj.cdd.4401107; Winkles JA, 2008, NAT REV DRUG DISCOV, V7, P411, DOI 10.1038/nrd2488; Winkles JA, 2007, FRONT BIOSCI-LANDMRK, V12, P2761, DOI 10.2741/2270; Zhan QM, 1999, ONCOGENE, V18, P2892, DOI 10.1038/sj.onc.1202667; Zimmermann M, 2011, J ALLERGY CLIN IMMUN, V127, P200, DOI 10.1016/j.jaci.2010.11.005	48	35	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33609	10.1371/journal.pone.0033609	http://dx.doi.org/10.1371/journal.pone.0033609			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438963	gold, Green Published, Green Submitted			2022-12-25	WOS:000303309100069
J	Bucci, MP; Nassibi, N; Gerard, CL; Bui-Quoc, E; Seassau, M				Bucci, Maria Pia; Nassibi, Naziha; Gerard, Christophe-Loic; Bui-Quoc, Emmanuel; Seassau, Magali			Immaturity of the Oculomotor Saccade and Vergence Interaction in Dyslexic Children: Evidence from a Reading and Visual Search Study	PLOS ONE			English	Article							EYE-MOVEMENTS; BINOCULAR COORDINATION; DEVELOPMENTAL DYSLEXIA; ATTENTION; ACTIVATION; DEFICIT	Studies comparing binocular eye movements during reading and visual search in dyslexic children are, at our knowledge, inexistent. In the present study we examined ocular motor characteristics in dyslexic children versus two groups of non dyslexic children with chronological/reading age-matched. Binocular eye movements were recorded by an infrared system (mobileEBT (R), e(ye) BRAIN) in twelve dyslexic children (mean age 11 years old) and a group of chronological age-matched (N = 9) and reading age-matched (N = 10) non dyslexic children. Two visual tasks were used: text reading and visual search. Independently of the task, the ocular motor behavior in dyslexic children is similar to those reported in reading age-matched non dyslexic children: many and longer fixations as well as poor quality of binocular coordination during and after the saccades. In contrast, chronological age-matched non dyslexic children showed a small number of fixations and short duration of fixations in reading task with respect to visual search task; furthermore their saccades were well yoked in both tasks. The atypical eye movement's patterns observed in dyslexic children suggest a deficiency in the visual attentional processing as well as an immaturity of the ocular motor saccade and vergence systems interaction.	[Bucci, Maria Pia; Nassibi, Naziha] Univ Paris 05, CNRS, FRE 3292, Lab Psychol & Neuropsychol Cognit, Boulogne Billancourt, France; [Gerard, Christophe-Loic] Hop Robert Debre, Serv Psychopathol Enfant & Adolescent, F-75019 Paris, France; [Bui-Quoc, Emmanuel] Hop Robert Debre, Serv Ophtalmol, F-75019 Paris, France; [Seassau, Magali] E Ye BRAI, Ivry, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite	Bucci, MP (corresponding author), Univ Paris 05, CNRS, FRE 3292, Lab Psychol & Neuropsychol Cognit, Boulogne Billancourt, France.	maria-pia.bucci@parisdescartes.fr						Angelakis E, 2012, CLIN NEUROPHYSIOL, V121, P1792; Bosse ML, 2007, COGNITION, V104, P198, DOI 10.1016/j.cognition.2006.05.009; Bucci MP, 2008, GRAEF ARCH CLIN EXP, V246, P417, DOI 10.1007/s00417-007-0723-1; Bucci MP, 2006, VISION RES, V46, P3594, DOI 10.1016/j.visres.2006.06.001; Bucci MP, 2009, J OPHTHALMOL, V2009, DOI 10.1155/2009/325214; Bucci MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023125; Bucci MP, 2006, VISION RES, V46, P457, DOI 10.1016/j.visres.2005.05.004; Bucci MP, 2002, INVEST OPHTH VIS SCI, V43, P1040; Chevrie-Muller C, 1997, BATTERIE LANGAGE ORA; De Luca M, 1999, NEUROPSYCHOLOGIA, V37, P1407, DOI 10.1016/S0028-3932(99)00038-X; Dhar M, 2010, CORTEX, V46, P800, DOI 10.1016/j.cortex.2010.02.001; EDEN GF, 1994, VISION RES, V34, P1345, DOI 10.1016/0042-6989(94)90209-7; FIORAVANTI F, 1995, VISION RES, V35, P3217, DOI 10.1016/0042-6989(95)00152-5; GALABURDA AM, 1985, ANN NEUROL, V18, P222, DOI 10.1002/ana.410180210; Habib M, 2000, BRAIN, V123, P2373, DOI 10.1093/brain/123.12.2373; Hatzidaki A, 2011, DYSLEXIA, V17, P85, DOI 10.1002/dys.416; Heller D, 1999, CURRENT OCULOMOTOR R; Hutzler F, 2006, NEUROPSYCHOLOGIA, V44, P637, DOI 10.1016/j.neuropsychologia.2005.06.006; Hutzler F, 2004, BRAIN LANG, V89, P235, DOI 10.1016/S0093-934X(03)00401-2; Iles J, 2000, Dyslexia, V6, P163, DOI 10.1002/1099-0909(200007/09)6:3<163::AID-DYS150>3.0.CO;2-U; Jainta S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018694; Jainta S, 2010, J VISION, V10, DOI 10.1167/10.13.2; Kennedy A, 1998, Q J EXP PSYCHOL-A, V51, P135, DOI 10.1080/713755746; Kirkby JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027105; Levy-Schoen A, 1979, PROCESSING VISIBLE L; Li XH, 2009, CHINESE MED J-PEKING, V122, P267, DOI 10.3760/cma.j.issn.0366-6999.2009.03.006; Luna B, 2008, BRAIN COGNITION, V68, P293, DOI 10.1016/j.bandc.2008.08.019; Nicolson RI, 1999, LANCET, V353, P1662, DOI 10.1016/S0140-6736(98)09165-X; PAVLIDIS GT, 1981, NEUROPSYCHOLOGIA, V19, P57, DOI 10.1016/0028-3932(81)90044-0; Peyrin C, 2011, BRAIN LANG, V118, P128, DOI 10.1016/j.bandl.2010.06.005; Prado C, 2007, VISION RES, V47, P2521, DOI 10.1016/j.visres.2007.06.001; Rayner K, 1985, DEV NEUROPSYCHOL, V1, P3, DOI 10.1080/87565648509540294; Simos PG, 2001, DEV NEUROPSYCHOL, V19, P191, DOI 10.1207/S15326942DN1902_4; Skottun BC, 2010, CORTEX, V46, P799, DOI 10.1016/j.cortex.2009.12.006; Stein J, 1997, TRENDS NEUROSCI, V20, P147, DOI 10.1016/S0166-2236(96)01005-3; Stein JF., 1993, J RES READ, V16, P30, DOI [DOI 10.1111/J.1467-9817.1993.TB00033.X, 10.1111/j.1467-9817.1993.tb00033.x]; Trauzettel-Klosinski S, 2010, ACTA OPHTHALMOL, V88, P681, DOI 10.1111/j.1755-3768.2009.01523.x; Turkeltaub PE, 2003, NAT NEUROSCI, V6, P767, DOI 10.1038/nn1065; Vidyasagar TR, 2010, TRENDS COGN SCI, V14, P57, DOI 10.1016/j.tics.2009.12.003; Wilkins AJ, 2007, PERCEPTION, V36, P1788, DOI 10.1068/p5651; Yang Q, 2003, J VISION, V3, P554, DOI 10.1167/3.8.3	41	60	60	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33458	10.1371/journal.pone.0033458	http://dx.doi.org/10.1371/journal.pone.0033458			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	932RV	22438934	gold, Green Published			2022-12-25	WOS:000303309100048
J	Pan, L; Yoshii, Y; Otomo, A; Ogawa, H; Iwasaki, Y; Shang, HF; Hadano, S				Pan, Lei; Yoshii, Yasuhiro; Otomo, Asako; Ogawa, Haruko; Iwasaki, Yasuo; Shang, Hui-Fang; Hadano, Shinji			Different Human Copper-Zinc Superoxide Dismutase Mutants, SOD1(G93A) and SOD1(H46R), Exert Distinct Harmful Effects on Gross Phenotype in Mice	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; TRANSGENIC MOUSE MODEL; MOTOR-NEURON DISEASE; ALS-LINKED SOD1; PHYSICAL-ACTIVITY; CELL-DEATH; WILD-TYPE; GENE; PROGRESSION; ASTROCYTES	Amyotrophic lateral sclerosis (ALS) is a heterogeneous group of fatal neurodegenerative diseases characterized by a selective loss of motor neurons in the brain and spinal cord. Creation of transgenic mice expressing mutant Cu/Zn superoxide dismutase (SOD1), as ALS models, has made an enormous impact on progress of the ALS studies. Recently, it has been recognized that genetic background and gender affect many physiological and pathological phenotypes. However, no systematic studies focusing on such effects using ALS models other than SOD1(G93A) mice have been conducted. To clarify the effects of genetic background and gender on gross phenotypes among different ALS models, we here conducted a comparative analysis of growth curves and lifespans using congenic lines of SOD1(G93A) and SOD1(H46R) mice on two different genetic backgrounds; C57BL/6N (B6) and FVB/N (FVB). Copy number of the transgene and their expression between SOD1(G93A) and SOD1(H46R) lines were comparable. B6 congenic mutant SOD1 transgenic lines irrespective of their mutation and gender differences lived longer than corresponding FVB lines. Notably, the G93A mutation caused severer disease phenotypes than did the H46R mutation, where SOD1(G93A) mice, particularly on a FVB background, showed more extensive body weight loss and earlier death. Gender effect on survival also solely emerged in FVB congenic SOD1(G93A) mice. Conversely, consistent with our previous study using B6 lines, lack of Als2, a murine homolog for the recessive juvenile ALS causative gene, in FVB congenic SOD1(H46R), but not SOD1(G93A), mice resulted in an earlier death, implying a genetic background-independent but mutation-dependent phenotypic modification. These results indicate that SOD1(G93A)- and SOD1(H46R) -mediated toxicity and their associated pathogenic pathways are not identical. Further, distinctive injurious effects resulted from different SOD1 mutations, which are associated with genetic background and/or gender, suggests the presence of several genetic modifiers of disease expression in the mouse genome.	[Pan, Lei; Otomo, Asako; Hadano, Shinji] Tokai Univ, Sch Med, Dept Mol Life Sci, Isehara, Kanagawa 25911, Japan; [Pan, Lei; Otomo, Asako; Hadano, Shinji] Tokai Univ, Inst Med Sci, Isehara, Kanagawa 25911, Japan; [Yoshii, Yasuhiro; Iwasaki, Yasuo] Toho Univ, Omori Med Ctr, Dept Neurol, Ota Ku, Tokyo, Japan; [Ogawa, Haruko] Tokai Univ, Teaching & Res Support Ctr, Div Res & Dev, Isehara, Kanagawa 25911, Japan; [Shang, Hui-Fang] Sichuan Univ, W China Hosp, Dept Neurol, Chengdu 610064, Sichuan, Peoples R China; [Hadano, Shinji] Tokai Univ, Grad Sch Med, Res Ctr Brain & Nervous Dis, Isehara, Kanagawa 25911, Japan	Tokai University; Tokai University; Tokai University; Sichuan University; Tokai University	Pan, L (corresponding author), Tokai Univ, Sch Med, Dept Mol Life Sci, Isehara, Kanagawa 25911, Japan.	shinji@is.icc.u-tokai.ac.jp	Otomo, Asako/AAA-6374-2019; Hadano, Shinji/ABA-5052-2021	Otomo, Asako/0000-0002-7849-4309; Hadano, Shinji/0000-0002-4997-3968	Tokai University Educational System General Research Organization; Japan Society for the Promotion of Science; Daiichi-Sankyo Foundation of Life Science; Japan China Medical Association; Tokai University School of Medicine Research Aid; Tokai University	Tokai University Educational System General Research Organization; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Daiichi-Sankyo Foundation of Life Science; Japan China Medical Association; Tokai University School of Medicine Research Aid; Tokai University	This work was supported by Research and Study Project of Tokai University Educational System General Research Organization (SH), a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (SH), Daiichi-Sankyo Foundation of Life Science (SH), and Japan China Medical Association (SH). LP receives support for a Tokai University School of Medicine Research Aid. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Profs. Masashi Aoki (Tohoku University) and Yasuto Itoyama (National Center of Neurology and Psychiatry) for generously sharing SOD1<SUP>H46R</SUP> transgenic mice, and Prof. Joh-E Ikeda (Tokai University) for his invaluable and generous support.	Acevedo-Arozena A, 2011, DIS MODEL MECH, V4, P686, DOI 10.1242/dmm.007237; Al-Chalabi A, 1998, HUM MOL GENET, V7, P2045, DOI 10.1093/hmg/7.13.2045; Alexander GM, 2004, MOL BRAIN RES, V130, P7, DOI 10.1016/j.molbrainres.2004.07.002; Andersen PM, 1997, BRAIN, V120, P1723, DOI 10.1093/brain/120.10.1723; AOKI M, 1994, J NEUROL SCI, V126, P77, DOI 10.1016/0022-510X(94)90097-3; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Cudkowicz ME, 1997, ANN NEUROL, V41, P210, DOI 10.1002/ana.410410212; DALCANTO MC, 1995, BRAIN RES, V676, P25, DOI 10.1016/0006-8993(95)00063-V; Dion PA, 2009, NAT REV GENET, V10, P769, DOI 10.1038/nrg2680; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hadano S, 2006, HUM MOL GENET, V15, P233, DOI 10.1093/hmg/ddi440; Hadano S, 2001, NAT GENET, V29, P166, DOI 10.1038/ng1001-166; Hadano S, 2007, NEUROCHEM INT, V51, P74, DOI 10.1016/j.neuint.2007.04.010; Hadano S, 2010, NEUROSCI RES, V68, P131, DOI 10.1016/j.neures.2010.06.004; Hadano S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009805; Haidet-Phillips AM, 2011, NAT BIOTECHNOL, V29, P824, DOI 10.1038/nbt.1957; Haley RW, 2003, NEUROLOGY, V61, P750, DOI 10.1212/WNL.61.6.750; HAVERKAMP LJ, 1995, BRAIN, V118, P707, DOI 10.1093/brain/118.3.707; Heiman-Patterson TD, 2005, J NEUROL SCI, V236, P1, DOI 10.1016/j.jns.2005.02.006; Heiman-Patterson TD, 2011, AMYOTROPH LATERAL SC, V12, P79, DOI 10.3109/17482968.2010.550626; Kato S, 2008, ACTA NEUROPATHOL, V115, P97, DOI 10.1007/s00401-007-0308-4; Kunst CB, 2000, GENOMICS, V70, P181, DOI 10.1006/geno.2000.6379; Ludolph AC, 2010, AMYOTROPH LATERAL SC, V11, P38, DOI 10.3109/17482960903545334; Mahoney DJ, 2004, MUSCLE NERVE, V29, P656, DOI 10.1002/mus.20004; McCrate ME, 2008, NEUROMOL MED, V10, P108, DOI 10.1007/s12017-008-8030-5; Mitchell JD, 2007, LANCET, V369, P2031, DOI 10.1016/S0140-6736(07)60944-1; OGASAWARA M, 1993, NAT GENET, V5, P323, DOI 10.1038/ng1293-323; Otomo A, 2011, FEBS LETT, V585, P730, DOI 10.1016/j.febslet.2011.01.045; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Ratovitski T, 1999, HUM MOL GENET, V8, P1451, DOI 10.1093/hmg/8.8.1451; Reaume AG, 1996, NAT GENET, V13, P43, DOI 10.1038/ng0596-43; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Sasaki S, 2007, J NEUROPATH EXP NEUR, V66, P517, DOI 10.1097/01.jnen.0000263868.84188.3b; Schauwecker PE, 2005, BRAIN RES, V1040, P112, DOI 10.1016/j.brainres.2005.01.067; Schauwecker PE, 2002, EXP NEUROL, V178, P219, DOI 10.1006/exnr.2002.8038; Schauwecker PE, 1997, P NATL ACAD SCI USA, V94, P4103, DOI 10.1073/pnas.94.8.4103; Stam NC, 2008, EUR J NEUROSCI, V28, P717, DOI 10.1111/j.1460-9568.2008.06374.x; Strickland D, 1996, ACTA NEUROL SCAND, V94, P45, DOI 10.1111/j.1600-0404.1996.tb00038.x; Strom AL, 2008, J BIOL CHEM, V283, P22795, DOI 10.1074/jbc.M800276200; Traynor BJ, 1999, NEUROLOGY, V52, P504, DOI 10.1212/WNL.52.3.504; Turner BJ, 2008, PROG NEUROBIOL, V85, P94, DOI 10.1016/j.pneurobio.2008.01.001; Veldink JH, 2005, NEUROLOGY, V64, P241, DOI 10.1212/01.WNL.0000149513.82332.5C; Wooley CM, 2005, MUSCLE NERVE, V32, P43, DOI 10.1002/mus.20228; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Yoshii Y, 2011, NEUROSCI RES, V70, P321, DOI 10.1016/j.neures.2011.03.006	48	14	14	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33409	10.1371/journal.pone.0033409	http://dx.doi.org/10.1371/journal.pone.0033409			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438926	Green Submitted, Green Published, gold			2022-12-25	WOS:000303309100041
J	Budulac, SE; Vonk, JM; Postma, DS; Siedlinski, M; Timens, W; Boezen, MH				Budulac, Simona E.; Vonk, Judith M.; Postma, Dirkje S.; Siedlinski, Mateusz; Timens, Wim; Boezen, Marike H.			Nicotinic Acetylcholine Receptor Variants Are Related to Smoking Habits, but Not Directly to COPD	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; FAGERSTROM TOLERANCE QUESTIONNAIRE; LUNG-CANCER; GENERAL-POPULATION; GENOME-WIDE; ASSOCIATION; DEPENDENCE; CESSATION; POLYMORPHISMS; BUPROPION	Genome-wide association studies identified single nucleotide polymorphisms (SNPs) in the nicotinic acetylcholine receptors (nAChRs) cluster as a risk factor for nicotine dependency and COPD. We investigated whether SNPs in the nAChR cluster are associated with smoking habits and lung function decline, and if these potential associations are independent of each other. The SNPs rs569207, rs1051730 and rs8034191 in the nAChR cluster were analyzed in the Vlagtwedde-Vlaardingen cohort (n = 1,390) that was followed for 25 years. We used GEE and LME models to analyze the associations of the SNPs with quitting or restarting smoking and with the annual FEV1 decline respectively. Individuals homozygote (CC) for rs569207 were more likely to quit smoking (OR (95% CI) = 1.58 (1.05-2.38)) compared to wild-type (TT) individuals. Individuals homozygote (TT) for rs1051730 were less likely to quit smoking (0.64 (0.42; 0.97)) compared to wild-type (CC) individuals. None of the SNPs was significantly associated with the annual FEV1 decline in smokers and ex-smokers. We show that SNPs in the nAChR region are associated with smoking habits such as quitting smoking, but have no significant effect on the annual FEV1 decline in smokers and ex-smokers, suggesting a potential role of these SNPs in COPD development via smoking habits rather than via direct effects on lung function.	[Budulac, Simona E.; Vonk, Judith M.; Siedlinski, Mateusz; Boezen, Marike H.] Univ Groningen, Dept Epidemiol, Univ Med Ctr Groningen, Groningen, Netherlands; [Postma, Dirkje S.] Univ Groningen, Dept Pulmonol, Univ Med Ctr Groningen, Groningen, Netherlands; [Timens, Wim] Univ Groningen, Dept Pathol, Univ Med Ctr Groningen, Groningen, Netherlands; [Budulac, Simona E.; Vonk, Judith M.; Postma, Dirkje S.; Siedlinski, Mateusz; Timens, Wim; Boezen, Marike H.] Univ Groningen, Groningen Res Inst Asthma & COPD GRIAC, Univ Med Ctr Groningen, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen	Budulac, SE (corresponding author), Univ Groningen, Dept Epidemiol, Univ Med Ctr Groningen, Groningen, Netherlands.	h.m.boezen@epi.umcg.nl	Siedlinski, Mateusz/ABF-4244-2021; Vonk, Judith/K-8477-2019; Vonk, Judith M/ABA-3009-2020; Timens, Wim/K-5570-2013	Siedlinski, Mateusz/0000-0001-7682-6122; Vonk, Judith/0000-0001-7531-4547; Vonk, Judith M/0000-0001-7531-4547; Timens, Wim/0000-0002-4146-6363	Graduate School for Drug Exploration (GUIDE), University of Groningen, Groningen, The Netherlands	Graduate School for Drug Exploration (GUIDE), University of Groningen, Groningen, The Netherlands(Netherlands Government)	This work was supported by the Graduate School for Drug Exploration (GUIDE), University of Groningen, Groningen, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Batra V, 2003, CHEST, V123, P1730, DOI 10.1378/chest.123.5.1730; Boezen H Marike, 2009, Proc Am Thorac Soc, V6, P701, DOI 10.1513/pats.200907-058DP; Bondarev ML, 2003, EUR J PHARMACOL, V474, P85, DOI 10.1016/S0014-2999(03)02010-7; Caporaso N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004653; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Cerveri I, 2008, THORAX, V63, P1040, DOI 10.1136/thx.2008.095554; Chen XN, 2009, AM J MED GENET B, V150B, P926, DOI 10.1002/ajmg.b.30919; Cunningham JA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-741; Falcone M, 2011, NICOTINE TOB RES, V13, P498, DOI 10.1093/ntr/ntr012; Fryer JD, 1999, J PHARMACOL EXP THER, V288, P88; Grabus SD, 2006, PSYCHOPHARMACOLOGY, V184, P456, DOI 10.1007/s00213-006-0305-7; Heath A C, 1993, J Subst Abuse, V5, P221; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Heitjan DF, 2008, AM J MED GENET B, V147B, P712, DOI 10.1002/ajmg.b.30669; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Ingebrigtsen T, 2010, RESP MED; Keskitalo K, 2009, HUM MOL GENET, V18, P4007, DOI 10.1093/hmg/ddp322; Lambrechts D, 2010, AM J RESP CRIT CARE, V181, P486, DOI 10.1164/rccm.200909-1364OC; Le Foll B, 2006, PSYCHOPHARMACOLOGY, V184, P367, DOI 10.1007/s00213-005-0155-8; Mroziewicz Margaret, 2010, Addict Sci Clin Pract, V5, P17; Nakajima M, 1996, DRUG METAB DISPOS, V24, P1212; Pianezza ML, 1998, NATURE, V393, P750, DOI 10.1038/31623; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421; Piper ME, 2006, NICOTINE TOB RES, V8, P339, DOI 10.1080/14622200600672765; POMERLEAU CS, 1994, ADDICT BEHAV, V19, P33, DOI 10.1016/0306-4603(94)90049-3; Quaak M, 2009, EUR RESPIR J, V33, P468, DOI 10.1183/09031936.00056908; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Scanlon PD, 2000, AM J RESP CRIT CARE, V161, P381, DOI 10.1164/ajrccm.161.2.9901044; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; van Diemen CC, 2005, AM J RESP CRIT CARE, V172, P329, DOI 10.1164/rccm.200411-1486OC; van Diemen CC, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-89; Weiss RB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000125; Willemse BWM, 2004, EUR RESPIR J, V23, P464, DOI 10.1183/09031936.04.00012704; Young RP, 2008, EUR RESPIR J, V32, P1158, DOI 10.1183/09031936.00093908	35	14	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2012	7	3							e33386	10.1371/journal.pone.0033386	http://dx.doi.org/10.1371/journal.pone.0033386			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RU	22438921	Green Published, Green Submitted, gold			2022-12-25	WOS:000303309000024
J	de Filippis, I; de Lemos, APS; Hostetler, JB; Wollenberg, K; Sacchi, CT; Harrison, LH; Bash, MC; Prevots, DR				de Filippis, Ivano; de Lemos, Ana Paula S.; Hostetler, Jessica B.; Wollenberg, Kurt; Sacchi, Claudio T.; Harrison, Lee H.; Bash, Margaret C.; Prevots, D. Rebecca			Molecular Epidemiology of Neisseria meningitidis Serogroup B in Brazil	PLOS ONE			English	Article							FACTOR-H; MENINGOCOCCAL DISEASE; VACCINE CANDIDATE; SAO-PAULO; PROTEIN; DIVERSITY; STRAINS; NADA; PORA; IDENTIFICATION	Background: Neisseria meningitidis serogroup B has been predominant in Brazil, but no broadly effective vaccine is available to prevent endemic meningococcal disease. To understand genetic diversity among serogroup B strains in Brazil, we selected a nationally representative sample of clinical disease isolates from 2004, and a temporally representative sample for the state of Sao Paulo (1988-2006) for study (n = 372). Methods: We performed multi-locus sequence typing (MLST) and sequence analysis of five outer membrane protein (OMP) genes, including novel vaccine targets fHbp and nadA. Results: In 2004, strain B:4:P1.15,19 clonal complex ST-32/ET-5 (cc32) predominated throughout Brazil; regional variation in MLST sequence type (ST), fetA, and porB was significant but diversity was limited for nadA and fHbp. Between 1988 and 1996, the Sao Paulo isolates shifted from clonal complex ST-41/44/Lineage 3 (cc41/44) to cc32. OMP variation was associated with but not predicted by cc or ST. Overall, fHbp variant 1/subfamily B was present in 80% of isolates and showed little diversity. The majority of nadA were similar to reference allele 1. Conclusions: A predominant serogroup B lineage has circulated in Brazil for over a decade with significant regional and temporal diversity in ST, fetA, and porB, but not in nadA and fHbp.	[de Filippis, Ivano] Oswaldo Cruz Fdn FIOCRUZ, Natl Qual Control Inst INCQS, Rio De Janeiro, Brazil; [de Filippis, Ivano; Bash, Margaret C.] US FDA, Lab Bacterial Polysaccharides, CBER, Bethesda, MD 20014 USA; [de Filippis, Ivano; Prevots, D. Rebecca] NIAID, Epidemiol Unit, Lab Clin Infect Dis, Div Intramural Res,NIH, Bethesda, MD 20892 USA; [de Lemos, Ana Paula S.] IAL, Dept Bacteriol, Sao Paulo, Brazil; [Hostetler, Jessica B.] JCVI, Rockville, MD USA; [Wollenberg, Kurt] NIAID, Off Cyberinfrastruct & Computat Biol OCICB, NIH, Bethesda, MD 20892 USA; [Sacchi, Claudio T.] Adolfo Lutz Inst, Dept Immunol, Sao Paulo, Brazil; [Harrison, Lee H.] Univ Pittsburgh, Infect Dis Epidemiol Res Unit, Pittsburgh, PA USA	Fundacao Oswaldo Cruz; US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Instituto Adolfo Lutz; J. Craig Venter Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Instituto Adolfo Lutz; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	de Filippis, I (corresponding author), Oswaldo Cruz Fdn FIOCRUZ, Natl Qual Control Inst INCQS, Rio De Janeiro, Brazil.	rprevots@niaid.nih.gov	de Filippis, Ivano/X-8759-2019; Lemos, Ana Paula/ABE-6240-2021	de Filippis, Ivano/0000-0003-0610-8648; Wollenberg, Kurt/0000-0002-4973-9370; Prevots, D Rebecca/0000-0003-0339-9873; Tavares Sacchi, Claudio/0000-0002-5686-7979	Division of Intramural Research; Office of Global Research; National Institute of Allergy and Infectious Disease (NIAID), National Institutes of Health (NIH) [N01-AI30071]; Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA); NIAID [K24 AI52788]; Fogarty International Center, NIH [D43TW006592]; Fundacao de Amparo a Pesquisa (FAPESP) [07/00462-3]; Sanofi Pasteur; Novartis; Merck; Wyeth; GlaxoSmithKline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001036] Funding Source: NIH RePORTER	Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Global Research; National Institute of Allergy and Infectious Disease (NIAID), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA)(United States Department of Health & Human Services); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Fogarty International Center, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Fundacao de Amparo a Pesquisa (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Sanofi Pasteur; Novartis(Novartis); Merck(Merck & Company); Wyeth(Wyeth); GlaxoSmithKline(GlaxoSmithKline); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Division of Intramural Research, and the Office of Global Research, the National Institute of Allergy and Infectious Disease (NIAID), National Institutes of Health (NIH); the Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA); a career development award to Dr. Harrison, NIAID (K24 AI52788); a Fogarty International Center Global Infectious Diseases Research Training Program grant, NIH, to the University of Pittsburgh (D43TW006592); and by a grant from the Fundacao de Amparo a Pesquisa (FAPESP), to Sao Paulo, Brazil (07/00462-3). Microbial sequencing was supported through a contract to the J. Craig Venter Institute (N01-AI30071) from NIAID, NIH. Ivano de Filippis was a postdoctoral fellow at the NIH and FDA at the time this work was conducted. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Harrison receives research funding from Sanofi Pasteur; he has received consulting fees and speaking honoraria from Sanofi Pasteur, Novartis, Merck, Wyeth, and GlaxoSmithKline. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. None of the other authors have competing interests.	Baethgen LF, 2008, TROP MED INT HEALTH, V13, P31, DOI 10.1111/j.1365-3156.2007.01970.x; Bambini S, 2009, VACCINE, V27, P2794, DOI 10.1016/j.vaccine.2009.02.098; Barroso DE, 2010, BRAZ J INFECT DIS, V14, P242, DOI 10.1590/S1413-86702010000300008; Brehony C, 2007, FEMS MICROBIOL REV, V31, P15, DOI 10.1111/j.1574-6976.2006.00056.x; Comanducci M, 2004, INFECT IMMUN, V72, P4217, DOI 10.1128/IAI.72.7.4217-4223.2004; Comanducci M, 2002, J EXP MED, V195, P1445, DOI 10.1084/jem.20020407; Cordeiro SM, 2007, T ROY SOC TROP MED H, V101, P1147, DOI 10.1016/j.trstmh.2007.06.012; de Filippis I, 2005, DIAGN MICR INFEC DIS, V53, P161, DOI 10.1016/j.diagmicrobio.2005.06.015; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Findlow J, 2010, CLIN INFECT DIS, V51, P1127, DOI 10.1086/656741; Fletcher LD, 2004, INFECT IMMUN, V72, P2088, DOI 10.1128/IAI.72.4.2088-2100.2004; Giuliani MM, 2006, P NATL ACAD SCI USA, V103, P10834, DOI 10.1073/pnas.0603940103; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Holst J, 2009, VACCINE, V27, pB3, DOI 10.1016/j.vaccine.2009.04.071; Jiang HQ, 2010, VACCINE, V28, P6086, DOI 10.1016/j.vaccine.2010.06.083; Jolley KA, 2007, FEMS MICROBIOL REV, V31, P89, DOI 10.1111/j.1574-6976.2006.00057.x; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Keiser PB, 2011, VACCINE, V29, P1413, DOI 10.1016/j.vaccine.2010.12.039; Lucidarme J, 2010, CLIN VACCINE IMMUNOL, V17, P919, DOI 10.1128/CVI.00027-10; Madico G, 2006, J IMMUNOL, V177, P501, DOI 10.4049/jimmunol.177.1.501; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Masignani V, 2003, J EXP MED, V197, P789, DOI 10.1084/jem.20021911; Murphy E, 2009, J INFECT DIS, V200, P379, DOI 10.1086/600141; Pajon R, 2010, VACCINE, V28, P2122, DOI 10.1016/j.vaccine.2009.12.027; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Russell JE, 2008, MICROBIOL-SGM, V154, P1170, DOI 10.1099/mic.0.2007/014761-0; SACCHI CT, 1992, J CLIN MICROBIOL, V30, P1734, DOI 10.1128/JCM.30.7.1734-1738.1992; Sacchi CT, 1998, CLIN DIAGN LAB IMMUN, V5, P348, DOI 10.1128/CDLI.5.3.348-354.1998; Sacchi CT, 2001, J CLIN MICROBIOL, V39, P2897, DOI 10.1128/JCM.39.8.2897-2903.2001; de Lemos APS, 2007, J CLIN MICROBIOL, V45, P1266, DOI 10.1128/JCM.02510-06; SUKER J, 1994, MOL MICROBIOL, V12, P253, DOI 10.1111/j.1365-2958.1994.tb01014.x; Sutton G. G., 1995, GENOME SCI TECHNOL, V1, P9, DOI [10.1089/gst.1995.1.9, DOI 10.1089/GST.1995.1.9]; Swofford D., 2003, PHYLOGENETIC ANAL US; Thompson EAL, 2003, MICROBIOL-SGM, V149, P1849, DOI 10.1099/mic.0.26131-0; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Urwin R, 2004, INFECT IMMUN, V72, P5955, DOI 10.1128/IAI.72.10.5955-5962.2004; Urwin R, 1998, EPIDEMIOL INFECT, V120, P257, DOI 10.1017/S0950268898008656; Wang X, 2009, VACCINE, V29, P4739	39	28	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e33016	10.1371/journal.pone.0033016	http://dx.doi.org/10.1371/journal.pone.0033016			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22431994	Green Accepted, gold, Green Published			2022-12-25	WOS:000303198600037
J	Ahonkhai, AA; Noubary, F; Munro, A; Stark, R; Wilke, M; Freedberg, KA; Wood, R; Losina, E				Ahonkhai, Aima A.; Noubary, Farzad; Munro, Alison; Stark, Ruth; Wilke, Marisa; Freedberg, Kenneth A.; Wood, Robin; Losina, Elena			Not All Are Lost: Interrupted Laboratory Monitoring, Early Death, and Loss to Follow-Up (LTFU) in a Large South African Treatment Program	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY PROGRAMS; HIV-INFECTED PATIENTS; PRIMARY-CARE; MORTALITY; RETENTION; ROUTINE; SERVICE; TRENDS; UGANDA; TESTS	Background: Many HIV treatment programs in resource-limited settings are plagued by high rates of loss to follow-up (LTFU). Most studies have not distinguished between those who briefly interrupt, but return to care, and those more chronically lost to follow-up. Methods: We conducted a retrospective cohort study of 11,397 adults initiating antiretroviral therapy (ART) in 71 Southern African Catholic Bishops Conference/Catholic Relief Services HIV treatment clinics between January 2004 and December 2008. We distinguished among patients with early death, within the first 7 months on ART; patients with interruptions in laboratory monitoring (ILM), defined as missing visits in the first 7 months on ART, but returning to care by 12 months; and those LTFU, defined as missing all follow-up visits in the first 12 months on ART. We used multilevel logistic regression models to determine patient and clinic-level characteristics associated with these outcomes. Results: In the first year on ART, 60% of patients remained in care, 30% missed laboratory visits, and 10% suffered early death. Of the 3,194 patients who missed laboratory visits, 40% had ILM, resuming care by 12 months. After 12 months on ART, patients with ILM had a 30% increase in detectable viremia compared to those who remained in care. Risk of LTFU decreased with increasing enrollment year, and was lowest for patients who enrolled in 2008 compared to 2004 [OR 0.49, 95%CI 0.39-0.62]. Conclusions: In a large community-based cohort in South Africa, nearly 30% of patients miss follow-up visits for CD4 monitoring in the first year after starting ART. Of those, 40% have ILM but return to clinic with worse virologic outcomes than those who remain in care. The risk of chronic LTFU decreased with enrollment year. As ART availability increases, interruptions in care may become more common, and should be accounted for in addressing program LTFU.	[Ahonkhai, Aima A.; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Noubary, Farzad; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA; [Freedberg, Kenneth A.] Massachusetts Gen Hosp, Med Practice Educ Ctr, Boston, MA 02114 USA; [Munro, Alison] So African Catholic Bishops Conf, Pretoria, Gauteng, South Africa; [Stark, Ruth; Wilke, Marisa] Catholic Relief Serv S Africa, Johannesburg, Gauteng, South Africa; [Freedberg, Kenneth A.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Freedberg, Kenneth A.; Losina, Elena] Harvard Univ Ctr AIDS Res, Boston, MA USA; [Losina, Elena] Brigham & Womens Hosp, Dept Orthoped Surg, Boston, MA 02115 USA; [Wood, Robin] Univ Cape Town, Inst Infect Dis & Mol Med, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, Western Cape, South Africa; [Wood, Robin] Univ Cape Town, Dept Med, ZA-7925 Cape Town, Western Cape, South Africa; [Freedberg, Kenneth A.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Losina, Elena] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard University; Brigham & Women's Hospital; University of Cape Town; University of Cape Town; Boston University; Boston University	Ahonkhai, AA (corresponding author), Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA.	aahonkhai@partners.org		Losina, ELENA/0000-0002-3424-0892	National Institutes of Allergy and Infectious Disease [T32 A007433, R01 AI058736]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354, R01AI058736] Funding Source: NIH RePORTER	National Institutes of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported in part by National Institutes of Allergy and Infectious Disease (T32 A007433, R01 AI058736). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amuron B, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-290; ARMITAGE P, 1955, BIOMETRICS, V11, P375, DOI 10.2307/3001775; Bisson GP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001725; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Boulle A, 2008, B WORLD HEALTH ORGAN, V86, P678, DOI 10.2471/BLT.07.045294; Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Chi BH, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001111; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; Ekouevi DK, 2010, TROP MED INT HEALTH, V15, P34, DOI 10.1111/j.1365-3156.2010.02505.x; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Geng Elvin H, 2010, Curr HIV/AIDS Rep, V7, P234, DOI 10.1007/s11904-010-0061-5; Geng EH, 2010, JAIDS-J ACQ IMM DEF, V53, P405, DOI 10.1097/QAI.0b013e3181b843f0; Hedeker D, 2003, STAT MED, V22, P1433, DOI 10.1002/sim.1522; Kranzer K, 2011, UNSTRUCTURED TREATME; Kranzer K, 2010, JAIDS-J ACQ IMM DEF, V55, pE17, DOI 10.1097/QAI.0b013e3181f275fd; Lawn SD, 2006, CLIN INFECT DIS, V43, P770, DOI 10.1086/507095; Martin C, 2005, FAM PRACT, V22, P638, DOI 10.1093/fampra/cmi076; Mermin J, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6792; Mugavero MJ, 2009, CLIN INFECT DIS, V48, P248, DOI 10.1086/595705; Mugyenyi P, 2010, LANCET, V375, P123, DOI 10.1016/S0140-6736(09)62067-5; National Department of Health South Africa, 2004, NAT ANT TREATM GUID; Perron NJ, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-79; Republic of South Africa, 2010, COUNTR PROGR REP DEC; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Rosen S, 2010, TROP MED INT HEALTH, V15, P98, DOI 10.1111/j.1365-3156.2010.02512.x; Stark R, 2010, AIDS RELIEF S AFRICA; WHO, 2010, ANT THER HIV INF AD; World Health Organization, 2006, ANT THER HIV INF AD	30	28	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e32993	10.1371/journal.pone.0032993	http://dx.doi.org/10.1371/journal.pone.0032993			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427925	Green Published, gold, Green Submitted			2022-12-25	WOS:000302381500071
J	Chiang, EY; Kolumam, G; McCutcheon, KM; Young, J; Lin, ZH; Balazs, M; Grogan, JL				Chiang, Eugene Y.; Kolumam, Ganesh; McCutcheon, Krista M.; Young, Judy; Lin, Zhonghua; Balazs, Mercedesz; Grogan, Jane L.			In Vivo Depletion of Lymphotoxin-Alpha Expressing Lymphocytes Inhibits Xenogeneic Graft-versus-Host-Disease	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; B-CELL; HUMANIZATION; THERAPY; BINDING; MICE	Graft-versus-host disease (GVHD) is a major barrier to successful allogeneic hematopoietic cell transplantation and is largely mediated by activated donor lymphocytes. Lymphotoxin (LT)-alpha is expressed by subsets of activated T and B cells, and studies in preclinical models demonstrated that targeted depletion of these cells with a mouse anti-LT-alpha monoclonal antibody (mAb) was efficacious in inhibiting inflammation and autoimmune disease. Here we demonstrate that LT-alpha is also upregulated on activated human donor lymphocytes in a xenogeneic model of GVHD and targeted depletion of these donor cells ameliorated GVHD. A depleting humanized anti-LT-alpha mAb, designated MLTA3698A, was generated that specifically binds to LT-alpha in both the soluble and membrane-bound forms, and elicits antibody-dependent cellular cytotoxicity (ADCC) activity in vitro. Using a human peripheral blood mononuclear cell transplanted SCID (Hu-SCID) mouse model of GVHD, the anti-human LT-alpha mAb specifically depleted activated LT-expressing human donor T and B cells, resulting in prolonged survival of the mice. A mutation in the Fc region, rendering the mAb incapable of mediating ADCC, abolished all in vitro and in vivo effects. These data support a role for using a depleting anti-LT-alpha antibody in treating immune diseases such as GVHD and autoimmune diseases.	[Chiang, Eugene Y.; Lin, Zhonghua; Balazs, Mercedesz; Grogan, Jane L.] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; [Kolumam, Ganesh] Genentech Inc, Dept Tumor Biol & Angiogenesis, San Francisco, CA 94080 USA; [McCutcheon, Krista M.] Genentech Inc, Dept Antibody Engn, San Francisco, CA 94080 USA; [Young, Judy] Genentech Inc, Dept Assay & Automat Technol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Chiang, EY (corresponding author), Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA.	jgrogan@gene.com			Genentech, Inc.	Genentech, Inc.(Roche HoldingGenentech)	All authors are employees of Genentech, Inc., which develops and markets drugs for profit, and which has funded this work. The funders thus played roles in study design, data collection and analyses, decision to publish, and preparation of the manuscript.	Adams CW, 2006, CANCER IMMUNOL IMMUN, V55, P717, DOI 10.1007/s00262-005-0058-x; Alousi AM, 2010, LEUKEMIA LYMPHOMA, V51, P376, DOI 10.3109/10428190903586318; Browning JL, 1997, J IMMUNOL, V159, P3288; Busca A, 2011, EXPERT OPIN BIOL TH, V11, P687, DOI 10.1517/14712598.2011.566852; Carpenter PA, 2002, BLOOD, V99, P2712, DOI 10.1182/blood.V99.8.2712; Castellana NE, 2011, PROTEOMICS, V11, P395, DOI 10.1002/pmic.201000487; Chamian F, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-27; Chiang EY, 2009, NAT MED, V15, P766, DOI 10.1038/nm.1984; Chuntharapai A, 2001, CYTOKINE, V15, P250, DOI 10.1006/cyto.2001.0934; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; Deeg HJ, 2001, BLOOD, V98, P2052, DOI 10.1182/blood.V98.7.2052; Edinger M, 2003, NAT MED, V9, P1144, DOI 10.1038/nm915; Gramaglia I, 1999, J IMMUNOL, V162, P1333; Ho VT, 2008, BEST PRACT RES CL HA, V21, P223, DOI 10.1016/j.beha.2008.02.009; Iori AP, 2008, TRANSPLANTATION, V85, P386, DOI 10.1097/TP.0b013e3181622e36; Kanda J, 2011, INT J HEMATOL; Katschke KJ, 2007, J EXP MED, V204, P1319, DOI 10.1084/jem.20070432; Lo DJ, 2011, AM J TRANSPLANT, V11, P22, DOI 10.1111/j.1600-6143.2010.03317.x; MacMillan ML, 2007, BLOOD, V109, P2657, DOI 10.1182/blood-2006-08-013995; Messina C, 2008, BONE MARROW TRANSPL, V41, pS65, DOI 10.1038/bmt.2008.57; Paczesny S, 2010, BONE MARROW TRANSPL, V45, P1, DOI 10.1038/bmt.2009.328; Patriarca F, 2006, EXP HEMATOL, V34, P389, DOI 10.1016/j.exphem.2005.12.011; Pinana JL, 2006, BIOL BLOOD MARROW TR, V12, P1135, DOI 10.1016/j.bbmt.2006.06.010; Presta LG, 1997, CANCER RES, V57, P4593; SANDHU JS, 1995, TRANSPLANTATION, V60, P179; Sarantopoulos S, 2009, BLOOD, V113, P3865, DOI 10.1182/blood-2008-09-177840; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; SHPITZ B, 1994, J IMMUNOL METHODS, V169, P1, DOI 10.1016/0022-1759(94)90119-8; Tyndall A, 2008, BEST PRACT RES CL HA, V21, P281, DOI 10.1016/j.beha.2008.03.003; WARE CF, 1992, J IMMUNOL, V149, P3881; Ware CF, 2005, ANNU REV IMMUNOL, V23, P787, DOI 10.1146/annurev.immunol.23.021704.115719; Wilson J, 2009, J EXP MED, V206, P387, DOI 10.1084/jem.20070723	32	16	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33106	10.1371/journal.pone.0033106	http://dx.doi.org/10.1371/journal.pone.0033106			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427961	Green Submitted, Green Published, gold			2022-12-25	WOS:000302381500091
J	Coburn, LA; Gong, X; Singh, K; Asim, M; Scull, BP; Allaman, MM; Williams, CS; Rosen, MJ; Washington, MK; Barry, DP; Piazuelo, MB; Casero, RA; Chaturvedi, R; Zhao, ZM; Wilson, KT				Coburn, Lori A.; Gong, Xue; Singh, Kshipra; Asim, Mohammad; Scull, Brooks P.; Allaman, Margaret M.; Williams, Christopher S.; Rosen, Michael J.; Washington, M. Kay; Barry, Daniel P.; Piazuelo, M. Blanca; Casero, Robert A., Jr.; Chaturvedi, Rupesh; Zhao, Zhongming; Wilson, Keith T.			L-arginine Supplementation Improves Responses to Injury and Inflammation in Dextran Sulfate Sodium Colitis	PLOS ONE			English	Article							NITRIC-OXIDE PRODUCTION; HELICOBACTER-PYLORI; BOWEL-DISEASE; ULCERATIVE-COLITIS; CROHNS-DISEASE; INTESTINAL INFLAMMATION; MACROPHAGE APOPTOSIS; MONOCLONAL-ANTIBODY; PLASMA ARGININE; HOST-DEFENSE	Inflammatory bowel disease (IBD), consisting of Crohn's disease and ulcerative colitis (UC), results in substantial morbidity and is difficult to treat. New strategies for adjunct therapies are needed. One candidate is the semi-essential amino acid, Larginine (L-Arg), a complementary medicine purported to be an enhancer of immunity and vitality in the lay media. Using dextran sulfate sodium (DSS) as a murine colonic injury and repair model with similarities to human UC, we assessed the effect of L-Arg, as DSS induced increases in colonic expression of the y(+) cationic amino acid transporter 2 (CAT2) and L-Arg uptake. L-Arg supplementation improved the clinical parameters of survival, body weight loss, and colon weight, and reduced colonic permeability and the number of myeloperoxidase-positive neutrophils in DSS colitis. Luminex-based multi-analyte profiling demonstrated that there was a marked reduction in proinflammatory cytokine and chemokine expression with L-Arg treatment. Genomic analysis by microarray demonstrated that DSS-treated mice supplemented with L-Arg clustered more closely with mice not exposed to DSS than to those receiving DSS alone, and revealed that multiple genes that were upregulated or downregulated with DSS alone exhibited normalization of expression with L-Arg supplementation. Additionally, L-Arg treatment of mice with DSS colitis resulted in increased ex vivo migration of colonic epithelial cells, suggestive of increased capacity for wound repair. Because CAT2 induction was sustained during L-Arg treatment and inducible nitric oxide (NO) synthase (iNOS) requires uptake of L-Arg for generation of NO, we tested the effect of L-Arg in iNOS(-/-) mice and found that its benefits in DSS colitis were eliminated. These preclinical studies indicate that L-Arg supplementation could be a potential therapy for IBD, and that one mechanism of action may be functional enhancement of iNOS activity.	[Coburn, Lori A.; Singh, Kshipra; Asim, Mohammad; Scull, Brooks P.; Allaman, Margaret M.; Williams, Christopher S.; Barry, Daniel P.; Piazuelo, M. Blanca; Chaturvedi, Rupesh; Wilson, Keith T.] Vanderbilt Univ, Med Ctr, Dept Med, Div Gastroenterol Hepatol & Nutr, Nashville, TN 37203 USA; [Washington, M. Kay; Wilson, Keith T.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN USA; [Wilson, Keith T.] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN USA; [Gong, Xue; Zhao, Zhongming] Vanderbilt Univ, Med Ctr, Dept Biomed Informat, Nashville, TN USA; [Coburn, Lori A.; Singh, Kshipra; Asim, Mohammad; Williams, Christopher S.; Barry, Daniel P.; Chaturvedi, Rupesh; Wilson, Keith T.] Vet Affairs Tennessee Valley Healthcare Syst, Nashville, TN USA; [Casero, Robert A., Jr.] Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA; [Rosen, Michael J.] Vanderbilt Univ, Med Ctr, Dept Pediat, D Brent Polk Div Pediat Gastroenterol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Johns Hopkins University; Johns Hopkins Medicine; Vanderbilt University	Coburn, LA (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Gastroenterol Hepatol & Nutr, Nashville, TN 37203 USA.	keith.wilson@vanderbilt.edu	Allaman, Margaret/GNO-9854-2022; Williams, Christopher/W-3524-2019; Barry, Daniel P/B-5647-2008	Williams, Christopher/0000-0002-1541-579X; Barry, Daniel P/0000-0002-3972-3914; Rosen, Michael/0000-0002-5149-718X; Casero, Robert/0000-0001-5653-3306; Allaman, Margaret M./0000-0002-2803-1365; Wilson, Keith/0000-0003-4421-1830; Coburn, Lori/0000-0003-3249-9806	National Institutes of Health [R01AT004821, R01AT004821-S1, R01DK053620, P01CA028842, P01CA116087, R01CA051085, R01CA098454, T32DK007673]; Flow Cytometry Core of the Vanderbilt University Digestive Disease Research Center [P30DK058404]; Hormone Assay Core of the Vanderbilt Diabetes Research and Training Center [P60DK020593]; Office of Medical Research, Department of Veterans Affairs; Vanderbilt Digestive Disease Center [P30DK58404]; Vanderbilt Ingram Cancer Center [P30CA68485]; Vanderbilt Physician Scientist Development program; NATIONAL CANCER INSTITUTE [R01CA098454, R01CA051085, P30CA068485, P01CA116087, P01CA028842] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R01AT004821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404, K08DK080221, T32DK007673, P60DK020593, R01DK053620] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001453] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flow Cytometry Core of the Vanderbilt University Digestive Disease Research Center; Hormone Assay Core of the Vanderbilt Diabetes Research and Training Center; Office of Medical Research, Department of Veterans Affairs(US Department of Veterans Affairs); Vanderbilt Digestive Disease Center; Vanderbilt Ingram Cancer Center; Vanderbilt Physician Scientist Development program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institutes of Health grants R01AT004821, R01AT004821-S1, R01DK053620, P01CA028842, and P01CA116087 (to K. T. W.); R01CA051085 and R01CA098454 (to R. A. C.); T32DK007673 (L. A. C.); the Flow Cytometry Core of the Vanderbilt University Digestive Disease Research Center supported by P30DK058404; the Hormone Assay Core of the Vanderbilt Diabetes Research and Training Center (P60DK020593); and a Merit Review Grant from the Office of Medical Research, Department of Veterans Affairs (to K. T. W.). Microarray experiments were performed in the Vanderbilt Genome Sciences Resource, supported by the Vanderbilt Digestive Disease Center (P30DK58404) and the Vanderbilt Ingram Cancer Center (P30CA68485). L. A. C. was also supported by an Award from the Vanderbilt Physician Scientist Development program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADIBI SA, 1967, AM J CLIN NUTR, V20, P24, DOI 10.1093/ajcn/20.1.24; ALBINA JE, 1993, J SURG RES, V55, P97, DOI 10.1006/jsre.1993.1114; Barry DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029046; Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; Baumgart DC, 2007, LANCET, V369, P1641, DOI 10.1016/S0140-6736(07)60751-X; Binion DG, 2000, FREE RADICAL BIO MED, V29, P881, DOI 10.1016/S0891-5849(00)00391-9; Binion DG, 1998, AM J PHYSIOL-GASTR L, V275, pG592, DOI 10.1152/ajpgi.1998.275.3.G592; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bove PF, 2007, AM J RESP CELL MOL, V36, P138, DOI 10.1165/rcmb.2006-0253SM; Bussiere FI, 2005, J BIOL CHEM, V280, P2409, DOI 10.1074/jbc.C400498200; CASTILLO L, 1994, METABOLISM, V43, P114, DOI 10.1016/0026-0495(94)90166-X; CASTILLO L, 1993, P NATL ACAD SCI USA, V90, P7749, DOI 10.1073/pnas.90.16.7749; Chaturvedi AK, 2011, CANCER EPIDEM BIOMAR, V20, P1902, DOI 10.1158/1055-9965.EPI-11-0221; Chaturvedi R, 2004, J BIOL CHEM, V279, P40161, DOI 10.1074/jbc.M401370200; Chaturvedi R, 2007, INFECT IMMUN, V75, P4305, DOI 10.1128/IAI.00578-07; Chaturvedi R, 2010, GASTROENTEROLOGY, V139, P1686, DOI 10.1053/j.gastro.2010.06.060; Cheng Y, 2005, J BIOL CHEM, V280, P22492, DOI 10.1074/jbc.C500122200; Clark M, 2007, GASTROENTEROLOGY, V133, P312, DOI 10.1053/j.gastro.2007.05.006; Closs EI, 2004, J NUTR, V134, p2752S, DOI 10.1093/jn/134.10.2752S; Closs EI, 1997, NITRIC OXIDE-BIOL CH, V1, P65, DOI 10.1006/niox.1996.0106; Coman D, 2008, CLIN NUTR, V27, P489, DOI 10.1016/j.clnu.2008.05.007; Cross RK, 2003, INFLAMM BOWEL DIS, V9, P179, DOI 10.1097/00054725-200305000-00006; DOMEK MJ, 1995, SCAND J GASTROENTERO, V30, P1089, DOI 10.3109/00365529509101612; Fotiadis C, 2007, ACTA CHIR BELG, V107, P192, DOI 10.1080/00015458.2007.11680039; Gerner EW, 2007, BIOCHEM SOC T, V35, P322, DOI 10.1042/BST0350322; Gobert AP, 2004, J IMMUNOL, V173, P2109, DOI 10.4049/jimmunol.173.3.2109; Gookin JL, 2002, AM J PHYSIOL-GASTR L, V283, pG157, DOI 10.1152/ajpgi.00005.2001; Hong SKS, 2010, INFLAMM BOWEL DIS, V16, P105, DOI 10.1002/ibd.21035; Kakuda DK, 1999, BIOCHEM J, V340, P549, DOI 10.1042/0264-6021:3400549; Kavalukas SL, 2011, SURGERY; Kojouharoff G, 1997, CLIN EXP IMMUNOL, V107, P353, DOI 10.1111/j.1365-2249.1997.291-ce1184.x; Krieglstein CF, 2001, J EXP MED, V194, P1207, DOI 10.1084/jem.194.9.1207; Krieglstein CF, 2002, J CLIN INVEST, V110, P1773, DOI 10.1172/JCI200215256; Lewis ND, 2010, J IMMUNOL, V184, P2572, DOI 10.4049/jimmunol.0902436; Li H, 2002, AM J PHYSIOL-REG I, V282, pR64, DOI 10.1152/ajpregu.2002.282.1.R64; Li L, 2001, AM J PHYSIOL-CELL PH, V281, pC941, DOI 10.1152/ajpcell.2001.281.3.C941; Loftus CG, 2007, INFLAMM BOWEL DIS, V13, P254, DOI 10.1002/ibd.20029; Martin L, 2006, AM J PHYSIOL-CELL PH, V290, pC1364, DOI 10.1152/ajpcell.00520.2005; Mashimo H, 1999, AM J PHYSIOL-GASTR L, V277, pG745, DOI 10.1152/ajpgi.1999.277.4.G745; Mori M, 2007, J NUTR, V137, p1616S, DOI 10.1093/jn/137.6.1616S; Morris SM, 2004, J NUTR, V134, p2765S, DOI 10.1093/jn/134.10.2765S; Morris SM, 2004, J NUTR, V134, p2743S, DOI 10.1093/jn/134.10.2743S; Mouser JF, 1999, CLIN THER, V21, P932; Murthy S, 1999, ALIMENT PHARM THER, V13, P251; Nicholson B, 2001, J BIOL CHEM, V276, P15881, DOI 10.1074/jbc.M010030200; NIXON SE, 1970, BRIT J NUTR, V24, P241, DOI 10.1079/BJN19700024; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Packey CD, 2008, J INTERN MED, V263, P597, DOI 10.1111/j.1365-2796.2008.01962.x; PEGG AE, 1982, AM J PHYSIOL, V243, pC212, DOI 10.1152/ajpcell.1982.243.5.C212; Present DH, 1999, ALIMENT PHARM THERAP, V13, P23, DOI 10.1046/j.1365-2036.1999.00026.x; Present DH, 1999, NEW ENGL J MED, V340, P1398, DOI 10.1056/NEJM199905063401804; Rao JN, 2001, AM J PHYSIOL-CELL PH, V280, pC993, DOI 10.1152/ajpcell.2001.280.4.C993; Rhoads JM, 2004, GUT, V53, P514, DOI 10.1136/gut.2003.027540; ROSE WC, 1949, FED PROC, V8, P546; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Singh K, 2008, J BIOL CHEM, V283, P16752, DOI 10.1074/jbc.M710530200; Singh K, 2011, J BIOL CHEM, V286, P3839, DOI 10.1074/jbc.M110.176719; Sun Y, 2011, INT J RAD ONCOL BIOL; Theiss AL, 2009, GASTROENTEROLOGY, V137, P199, DOI 10.1053/j.gastro.2009.03.033; Tripathi P, 2010, INT J BIOL MED RES, V1, P15; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Verrey F, 2004, PFLUG ARCH EUR J PHY, V447, P532, DOI 10.1007/s00424-003-1086-z; Wang JY, 1997, AM J PHYSIOL-GASTR L, V272, pG713, DOI 10.1152/ajpgi.1997.272.4.G713; Weaver CT, 2007, SEMIN IMMUNOL, V19, P351, DOI 10.1016/j.smim.2008.01.001; Williams KL, 2001, GASTROENTEROLOGY, V120, P925, DOI 10.1053/gast.2001.22470; Wu GY, 1998, BIOCHEM J, V336, P1, DOI 10.1042/bj3360001; Yoo JS, 1997, INVEST OPHTH VIS SCI, V38, P520	67	106	111	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33546	10.1371/journal.pone.0033546	http://dx.doi.org/10.1371/journal.pone.0033546			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22428068	gold, Green Published, Green Submitted			2022-12-25	WOS:000302381500152
J	Lee, H; Leamey, CA; Sawatari, A				Lee, Hyunchul; Leamey, Catherine A.; Sawatari, Atomu			Perineuronal Nets Play a Role in Regulating Striatal Function in the Mouse	PLOS ONE			English	Article							PARVALBUMIN-CONTAINING NEURONS; CAUDATE-PUTAMEN LESIONS; PRIMARY VISUAL-CORTEX; EXTRACELLULAR-MATRIX; CHONDROITIN-SULFATE; BASAL GANGLIA; POSTNATAL-DEVELOPMENT; ENRICHED ENVIRONMENT; SYNAPTIC PLASTICITY; PARKINSONS-DISEASE	The striatum is the primary input nucleus of the basal ganglia, a collection of nuclei that play important roles in motor control and associative learning. We have previously reported that perineuronal nets (PNNs), aggregations of chondroitinsulfate proteoglycans (CSPGs), form in the matrix compartment of the mouse striatum during the second postnatal week. This period overlaps with important developmental changes, including the attainment of an adult-like gait. Here, we investigate the identity of the cells encapsulated by PNNs, characterize their topographical distribution and determine their function by assessing the impact of enzymatic digestion of PNNs on two striatum-dependent behaviors: ambulation and goal-directed spatial learning. We show PNNs are more numerous caudally, and that a substantial fraction (41%) of these structures surrounds parvalbumin positive (PV+) interneurons, while approximately 51% of PV+ cells are ensheathed by PNNs. The colocalization of these structures is greatest in dorsal, lateral and caudal regions of the striatum. Bilateral digestion of striatal PNNs led to an increase in both the width and variability of hind limb gait. Intriguingly, this also resulted in an improvement in the acquisition rate of the Morris water maze. Together, these data show that PNNs are associated with specific elements of striatal circuits and play a key role in regulating the function of this important structure in the mouse.	[Lee, Hyunchul] Univ Sydney, Discipline Physiol, Sch Med Sci, Sydney, NSW 2006, Australia; Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Lee, H (corresponding author), Univ Sydney, Discipline Physiol, Sch Med Sci, Sydney, NSW 2006, Australia.	atomu@medsci.usyd.edu.au		Leamey, Catherine/0000-0002-3390-4933; Lee, Hyunchul/0000-0002-1427-6521	University of Sydney Research and Development; Rebecca L. Cooper Medical Research Foundation	University of Sydney Research and Development(University of Sydney); Rebecca L. Cooper Medical Research Foundation	This work was funded by a University of Sydney Research and Development Grant and a Rebecca L. Cooper Medical Research Foundation grant (http://www.cooperfoundation.org.au/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpar A, 2006, BRAIN RES, V1120, P13, DOI 10.1016/j.brainres.2006.08.069; ALTMAN J, 1975, ANIM BEHAV, V23, P896, DOI 10.1016/0003-3472(75)90114-1; Balmer TS, 2009, J NEUROSCI, V29, P12878, DOI 10.1523/JNEUROSCI.2974-09.2009; Barnes TD, 2005, NATURE, V437, P1158, DOI 10.1038/nature04053; Berke JD, 2004, NEURON, V43, P883, DOI 10.1016/j.neuron.2004.08.035; Bracci E, 2002, J NEUROPHYSIOL, V87, P2190, DOI 10.1152/jn.00754.2001; Bruckner G, 1998, EXP BRAIN RES, V121, P300, DOI 10.1007/s002210050463; Bukalo O, 2001, NEUROSCIENCE, V104, P359, DOI 10.1016/S0306-4522(01)00082-3; Ciucci F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000475; CYNADER M, 1980, J NEUROPHYSIOL, V43, P1026, DOI 10.1152/jn.1980.43.4.1026; Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; DeLong MR, 2007, ARCH NEUROL-CHICAGO, V64, P20, DOI 10.1001/archneur.64.1.20; Devan BD, 1999, J NEUROSCI, V19, P2789; Devan BD, 1999, BEHAV BRAIN RES, V100, P5, DOI 10.1016/S0166-4328(98)00107-7; Dityatev A, 2003, NAT REV NEUROSCI, V4, P456, DOI 10.1038/nrn1115; Dityatev A, 2007, DEV NEUROBIOL, V67, P570, DOI 10.1002/dneu.20361; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; FENTRESS JC, 1981, ANAT EMBRYOL, V163, P275, DOI 10.1007/BF00315705; GATES MA, 1993, J CHEM NEUROANAT, V6, P179, DOI 10.1016/0891-0618(93)90040-B; Gerfen CR, 1996, HDB CHEM NEUROANATOM, P371, DOI [10.1016/S0924-8196(96)80004-2, DOI 10.1016/S0924-8196(96)80004-2]; Gogolla N, 2009, SCIENCE, V325, P1258, DOI 10.1126/science.1174146; GRUNER JA, 1980, EXP BRAIN RES, V40, P374; HARTIG W, 1992, NEUROREPORT, V3, P869; Hartig W, 1999, BRAIN RES, V842, P15, DOI 10.1016/S0006-8993(99)01784-9; HARTIG W, 1994, BRAIN RES, V635, P307, DOI 10.1016/0006-8993(94)91452-4; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hikosaka O, 2000, PHYSIOL REV, V80, P953, DOI 10.1152/physrev.2000.80.3.953; Hoffer ZS, 2001, J COMP NEUROL, V439, P87, DOI 10.1002/cne.1337; Horn AK, 2003, J COMP NEUROL, V455, P341, DOI 10.1002/cne.10495; KIMURA M, 1990, J NEUROPHYSIOL, V63, P1277, DOI 10.1152/jn.1990.63.6.1277; Klein A, 2009, BEHAV BRAIN RES, V199, P317, DOI 10.1016/j.bbr.2008.12.007; KUBOTA Y, 1993, J COMP NEUROL, V332, P499, DOI 10.1002/cne.903320409; Laplane D, 2001, MOVEMENT DISORD, V16, P810, DOI 10.1002/mds.1185; Lee H, 2011, EUR J NEUROSCI, V34, P1345, DOI 10.1111/j.1460-9568.2011.07852.x; Lee H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003020; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Luk KC, 2001, NEUROSCIENCE, V104, P93, DOI 10.1016/S0306-4522(01)00038-0; McRae PA, 2007, J NEUROSCI, V27, P5405, DOI 10.1523/JNEUROSCI.5425-06.2007; Metz GA, 2005, EUR J NEUROSCI, V22, P735, DOI 10.1111/j.1460-9568.2005.04238.x; MITCHELL JA, 1988, BEHAV NEUROSCI, V102, P504, DOI 10.1037/0735-7044.102.4.504; Mooney R, 2009, CURR OPIN NEUROBIOL, V19, P654, DOI 10.1016/j.conb.2009.10.004; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Nakano K, 2000, BRAIN DEV-JPN, V22, pS5; PACKARD MG, 1992, BEHAV NEUROSCI, V106, P439, DOI 10.1037/0735-7044.106.3.439; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Ramanathan S, 2002, J NEUROSCI, V22, P8158; Reimers S, 2007, EUR J NEUROSCI, V25, P2640, DOI 10.1111/j.1460-9568.2007.05514.x; Saghatelyan AK, 2001, MOL CELL NEUROSCI, V17, P226, DOI 10.1006/mcne.2000.0922; Sale A, 2004, NEUROPHARMACOLOGY, V47, P649, DOI 10.1016/j.neuropharm.2004.07.008; Samejima K, 2005, SCIENCE, V310, P1337, DOI 10.1126/science.1115270; Saunders NR, 1998, J NEUROSCI, V18, P339; Sawatari A, 2000, NEURON, V25, P459, DOI 10.1016/S0896-6273(00)80908-3; Schlosser B, 1999, J COMP NEUROL, V405, P185, DOI 10.1002/(SICI)1096-9861(19990308)405:2<185::AID-CNE4>3.0.CO;2-B; Senn C, 2002, MOL CELL NEUROSCI, V20, P712, DOI 10.1006/mcne.2002.1142; Simonetti T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006780; STEINBERG H, 1989, J PHARMACOL METHOD, V21, P103, DOI 10.1016/0160-5402(89)90028-4; Takahashi-Iwanaga H, 1998, J NEUROCYTOL, V27, P817, DOI 10.1023/A:1006955414939; Tang AC, 2001, LEARN MEMORY, V8, P257, DOI 10.1101/lm.43101; Thorn CA, 2010, NEURON, V66, P781, DOI 10.1016/j.neuron.2010.04.036; Tremblay L, 1998, J NEUROPHYSIOL, V80, P964, DOI 10.1152/jn.1998.80.2.964; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; WESTERGA J, 1990, DEV BRAIN RES, V57, P163, DOI 10.1016/0165-3806(90)90042-W; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Yin HH, 2009, NAT NEUROSCI, V12, P333, DOI 10.1038/nn.2261; Zorner B, 2010, NAT METHODS, V7, P701, DOI 10.1038/nmeth.1484	65	25	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e32747	10.1371/journal.pone.0032747	http://dx.doi.org/10.1371/journal.pone.0032747			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427872	Green Published, gold, Green Submitted			2022-12-25	WOS:000302381500037
J	Ptak, GE; Tacconi, E; Czernik, M; Toschi, P; Modlinski, JA; Loi, P				Ptak, Grazyna E.; Tacconi, Emanuela; Czernik, Marta; Toschi, Paola; Modlinski, Jacek A.; Loi, Pasqualino			Embryonic Diapause Is Conserved across Mammals	PLOS ONE			English	Article							DELAYED IMPLANTATION; ASYNCHRONOUS TRANSFER; BLASTOCYST; SURVIVAL; GROWTH; EXPRESSION; RECEPTOR; GENE; ESTABLISHMENT; ANANDAMIDE	Embryonic diapause (ED) is a temporary arrest of embryo development and is characterized by delayed implantation in the uterus. ED occurs in blastocysts of less than 2% of mammalian species, including the mouse (Mus musculus). If ED were an evolutionarily conserved phenomenon, then it should be inducible in blastocysts of normally non-diapausing mammals, such as domestic species. To prove this hypothesis, we examined whether blastocysts from domestic sheep (Ovis aries) could enter into diapause following their transfer into mouse uteri in which diapause conditions were induced. Sheep blastocysts entered into diapause, as demonstrated by growth arrest, viability maintenance and their ED-specific pattern of gene expression. Seven days after transfer, diapausing ovine blastocysts were able to resume growth in vitro and, after transfer to surrogate ewe recipients, to develop into normal lambs. The finding that non-diapausing ovine embryos can enter into diapause implies that this phenomenon is phylogenetically conserved and not secondarily acquired by embryos of diapausing species. Our study questions the current model of independent evolution of ED in different mammalian orders.	[Ptak, Grazyna E.; Tacconi, Emanuela; Czernik, Marta; Toschi, Paola; Loi, Pasqualino] Univ Teramo, Dept Comparat Biomed Sci, Teramo, Italy; [Ptak, Grazyna E.; Modlinski, Jacek A.] Polish Acad Sci, Inst Genet & Anim Breeding, Dept Expt Embryol, Jastrzebiec, Poland	University of Teramo; Institute of Genetics & Animal Biotechnology, Polish Academy of Sciences; Polish Academy of Sciences	Ptak, GE (corresponding author), Univ Teramo, Dept Comparat Biomed Sci, Teramo, Italy.	gptak@unite.it		CZERNIK, Marta Teresa/0000-0002-4535-4932; Ptak, Grazyna/0000-0003-1437-4698	European Research Council [210103]	European Research Council(European Research Council (ERC)European Commission)	This work was supported by the European Research Council (FP7/2007-2013)/Programme IDEAS GA no210103 to GEP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken R J, 1981, J Reprod Fertil Suppl, V29, P83; AITKEN RJ, 1975, J ANAT, V119, P369; BELLRINGER JF, 1980, J REPROD FERTIL, V59, P223, DOI 10.1530/jrf.0.0590223; Bischoff TLW, 1854, ENTWICKELUNGSGESCHIC; BRINKLOW BR, 1993, REPROD FERT DEVELOP, V5, P567, DOI 10.1071/RD9930567; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; CANIVENC R, 1979, NATURE, V278, P849, DOI 10.1038/278849a0; CHANG MC, 1968, J EXP ZOOL, V168, P49, DOI 10.1002/jez.1401680105; CONAWAY CH, 1971, BIOL REPROD, V4, P239, DOI 10.1093/biolreprod/4.3.239; COPP AJ, 1982, J REPROD FERTIL, V66, P681, DOI 10.1530/jrf.0.0660681; COUCOUVANIS E, 1995, CELL, V83, P279, DOI 10.1016/0092-8674(95)90169-8; DAS SK, 1994, DEVELOPMENT, V120, P1071; DICKMANN Z, 1960, J REPROD FERTIL, V1, P197, DOI 10.1530/jrf.0.0010197; DOYLE LL, 1963, FERTIL STERIL, V14, P215; DUKELOW WR, 1966, NATURE, V211, P211, DOI 10.1038/211211a0; ENDERS ROBERT K., 1952, PROC AMER PHIL SOC, V96, P691; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fischer B, 1986, J REPROD FERTIL, V86, P479; FORESMAN KR, 1978, BIOL REPROD, V18, P490, DOI 10.1095/biolreprod18.3.490; Gray CA, 2002, REPRODUCTION, V124, P289, DOI 10.1530/rep.0.1240289; Gulyas B. J., 1969, Biology of Reproduction, V1, P11, DOI 10.1095/biolreprod1.1.11; Hamatani T, 2004, P NATL ACAD SCI USA, V101, P10326, DOI 10.1073/pnas.0402597101; Hamlett GWD, 1935, Q REV BIOL, V10, P432, DOI 10.1086/394493; Hand SC, 2008, J EXP BIOL, V211, P1829, DOI 10.1242/jeb.000299; Joung SY, 2004, ZYGOTE, V12, P215, DOI 10.1017/S0967199404002795; KAUFMAN MH, 1983, J EMBRYOL EXP MORPH, V73, P249; KAUFMAN MH, 1977, NATURE, V265, P53, DOI 10.1038/265053a0; Kliem A, 1998, MOL REPROD DEV, V51, P402, DOI 10.1002/(SICI)1098-2795(199812)51:4&lt;402::AID-MRD7&gt;3.0.CO;2-9; Lataste MF, 1891, CR SOC BIOL, V9, P21; LAWSON RAS, 1983, J REPROD FERTIL, V67, P473, DOI 10.1530/jrf.0.0670473; Lopes FL, 2004, REPRODUCTION, V128, P669, DOI 10.1530/rep.1.00444; MAROIS G, 1982, ANN ENDOCRINOL-PARIS, V43, P41; MCLAREN A, 1968, J ENDOCRINOL, V42, P453, DOI 10.1677/joe.0.0420453; MCLAREN A, 1956, J EXP BIOL, V33, P394; Mead R A, 1981, J Reprod Fertil Suppl, V29, P11; MEAD RA, 1993, J EXP ZOOL, V266, P629, DOI 10.1002/jez.1402660611; Murray P, 2000, J CELL BIOL, V150, P1215, DOI 10.1083/jcb.150.5.1215; Navara CS, 2007, STEM CELLS, V25, P2695, DOI 10.1634/stemcells.2007-0286; PSYCHOYOS A, 1973, HDB PHYSL, P187; Ptak G, 2002, BIOL REPROD, V67, P1719, DOI 10.1095/biolreprod.102.006171; Renfree M B, 1981, J Reprod Fertil Suppl, V29, P67; RENFREE MB, 1979, NATURE, V278, P549, DOI 10.1038/278549a0; Renfree MB, 2000, REV REPROD, V5, P6, DOI 10.1530/ror.0.0050006; Renfree MB, 2000, ANNU REV PHYSIOL, V62, P353, DOI 10.1146/annurev.physiol.62.1.353; SANDELL M, 1990, Q REV BIOL, V65, P23, DOI 10.1086/416583; Scott IC, 2008, ANIM REPROD SCI, V109, P206, DOI 10.1016/j.anireprosci.2007.11.025; SHORT R. V., 1966, SYMP ZOOL SOC LONDON, V15, P173; Stewart CL, 1997, DEV GENET, V21, P91, DOI 10.1002/(SICI)1520-6408(1997)21:1&lt;91::AID-DVG11&gt;3.0.CO;2-D; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Sturmey RG, 2003, REPRODUCTION, V126, P197, DOI 10.1530/rep.0.1260197; Surani M A, 1981, J Reprod Fertil Suppl, V29, P159; Tammariello SP, 1998, GENE, V215, P425, DOI 10.1016/S0378-1119(98)00299-6; Tarin JJ, 1999, HUM REPROD, V14, P2434, DOI 10.1093/humrep/14.10.2434; TARKOWSKI AK, 1962, J EMBRYOL EXP MORPH, V10, P476; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thom MD, 2004, EVOLUTION, V58, P175; Turco MY, 2008, HUM REPROD, V23, P2331, DOI 10.1093/humrep/den258; TYNDALE-BISCOE C H, 1968, Australian Journal of Zoology, V16, P577, DOI 10.1071/ZO9680577; Vogel P, 1981, J Reprod Fertil Suppl, V29, P51; WADESMITH J, 1980, GEN COMP ENDOCR, V42, P509, DOI 10.1016/0016-6480(80)90218-X; Wang HB, 2003, P NATL ACAD SCI USA, V100, P14914, DOI 10.1073/pnas.2436379100; WEITLAUF HM, 1965, J REPROD FERTIL, V10, P203; WEITLAUF HM, 1974, J REPROD FERTIL, V39, P213, DOI 10.1530/jrf.0.0390213; WILDE MH, 1988, THERIOGENOLOGY, V30, P1069, DOI 10.1016/0093-691X(88)90281-6; Wilsher S, 2010, REPRODUCTION, V139, P575, DOI 10.1530/REP-09-0306	65	67	69	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33027	10.1371/journal.pone.0033027	http://dx.doi.org/10.1371/journal.pone.0033027			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427933	Green Published, gold, Green Submitted			2022-12-25	WOS:000302381500076
J	Cagnol, S; Rivard, N				Cagnol, S.; Rivard, N.			Oncogenic KRAS and BRAF activation of the MEK/ERK signaling pathway promotes expression of dual-specificity phosphatase 4 (DUSP4/MKP2) resulting in nuclear ERK1/2 inhibition	ONCOGENE			English	Article						ERK; KRAS; BRAF; DUSP; intestinal epithelial cells; colorectal cancer	INTESTINAL EPITHELIAL-CELLS; PROTEIN-TYROSINE PHOSPHATASES; COLON-CARCINOMA CELLS; MAP KINASE-ACTIVITY; COLORECTAL-CANCER; SPATIOTEMPORAL REGULATION; REGULATED KINASE; CELLULAR-TRANSFORMATION; PROTEASOMAL DEGRADATION; MESENCHYMAL TRANSITION	Gain-of-function mutations in KRAS and BRAF genes are found in up to 50% of colorectal cancers. These mutations result in the activation of the BRAF/MEK signaling pathway culminating in the stimulation of ERK1/2 mitogen-activated protein kinases. Upon activation, ERK1/2 translocate from the cytoplasm to the nucleus. This process has been shown to be required for the induction of many cellular responses, although the molecular mechanisms regulating ERK nuclear function, especially under oncogenic stimulation, remain to be explored. Herein, we examined the spatiotemporal regulation of ERK1/2 activity upon oncogenic activation of KRAS(G12V) and BRAF(V600E) in normal intestinal epithelial crypt cells (IECs). Results demonstrate that expression of these oncogenes markedly stimulated ERK1/2 activities and morphologically transformed IECs. Importantly however, ERK phosphorylation was not observed in the nucleus, but restricted to the cytoplasm of KRAS(G12V)- and BRAF(V600E)-transformed IECs. The absence of nuclear ERK phosphorylation was due to a vanadate-sensitive phosphatase activity. Nuclear ERK dephosphorylation was found to be tightly correlated with the rapid expression of DUSP4 phosphatase induced in an MEK-dependent manner. In addition, MEK-dependent phosphorylation of T361, T363, S390 and S395 residues highly stabilized DUSP4 protein. Finally, in human colorectal cancer cells, ERK1/2 activities were also confined to the cytoplasm and treatment with pervanadate reactivated ERK1/2 in the nucleus. Accordingly, DUSP4 mRNAs were found to be highly expressed, in an MEK-dependent manner, in all colorectal cancer cells analyzed. These findings indicate that DUSP4 functions as part of a negative feedback mechanism in the control of the duration and magnitude of nuclear ERK activation during intestinal tumorigenesis. Oncogene (2013) 32, 564-576; doi:10.1038/onc.2012.88; published online 19 March 2012	[Cagnol, S.; Rivard, N.] Univ Sherbrooke, Fac Med & Sci Sante, CIHR Team Digest Epithelium, Dept Anat & Biol Cellulaire, Sherbrooke, PQ J1H 5N4, Canada	University of Sherbrooke	Rivard, N (corresponding author), Univ Sherbrooke, Fac Med & Sci Sante, CIHR Team Digest Epithelium, Dept Anat & Biol Cellulaire, Sherbrooke, PQ J1H 5N4, Canada.	Nathalie.Rivard@USherbrooke.ca			Canadian Institutes of Health and Research [MT-14405]; Canadian Research Chair in Colorectal Cancer and Inflammatory Cell Signaling	Canadian Institutes of Health and Research(Canadian Institutes of Health Research (CIHR)); Canadian Research Chair in Colorectal Cancer and Inflammatory Cell Signaling	We thank Pierre Pothier for critical reading of the manuscript, and Anne Vezina and Etienne Lemieux for their technical assistance. This research was supported by a grant from the Canadian Institutes of Health and Research to NR (MT-14405). NR is a recipient of a Canadian Research Chair in Colorectal Cancer and Inflammatory Cell Signaling.	Adachi M, 1999, EMBO J, V18, P5347, DOI 10.1093/emboj/18.19.5347; Aliaga JC, 1999, AM J PHYSIOL-GASTR L, V277, pG631, DOI 10.1152/ajpgi.1999.277.3.G631; Andreolas C, 2008, INT J CANCER, V122, P1745, DOI 10.1002/ijc.23309; Armstrong SP, 2009, MOL ENDOCRINOL, V23, P510, DOI 10.1210/me.2008-0333; Avruch J, 2007, BBA-MOL CELL RES, V1773, P1150, DOI 10.1016/j.bbamcr.2006.11.006; Bergeron S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-271; Brami-Cherrier K, 2005, J NEUROSCI, V25, P11444, DOI 10.1523/JNEUROSCI.1711-05.2005; Brondello JM, 1997, J BIOL CHEM, V272, P1368, DOI 10.1074/jbc.272.2.1368; Brondello JM, 1999, SCIENCE, V286, P2514, DOI 10.1126/science.286.5449.2514; Cagnol S, 2006, APOPTOSIS, V11, P337, DOI 10.1007/s10495-006-4065-y; Caunt CJ, 2008, J BIOL CHEM, V283, P26612, DOI 10.1074/jbc.M801500200; Caunt CJ, 2008, J BIOL CHEM, V283, P6241, DOI 10.1074/jbc.M706624200; Caunt CJ, 2006, TRENDS ENDOCRIN MET, V17, P276, DOI 10.1016/j.tem.2006.07.008; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; De Roock W, 2011, LANCET ONCOL, V12, P594, DOI 10.1016/S1470-2045(10)70209-6; Ebisuya M, 2005, J CELL SCI, V118, P2997, DOI 10.1242/jcs.02505; Fang JY, 2005, LANCET ONCOL, V6, P322, DOI 10.1016/S1470-2045(05)70168-6; Formstecher E, 2001, DEV CELL, V1, P239, DOI 10.1016/S1534-5807(01)00035-1; Gaedcke J, 2010, GENE CHROMOSOME CANC, V49, P1024, DOI 10.1002/gcc.20811; Huyer G, 1997, J BIOL CHEM, V272, P843, DOI 10.1074/jbc.272.2.843; Ikenoue T, 2004, CANCER RES, V64, P3428, DOI 10.1158/0008-5472.CAN-03-3591; Jacobs D, 1999, GENE DEV, V13, P163, DOI 10.1101/gad.13.2.163; Jeffrey KL, 2007, NAT REV DRUG DISCOV, V6, P391, DOI 10.1038/nrd2289; Katagiri C, 2005, J BIOL CHEM, V280, P14716, DOI 10.1074/jbc.M500200200; Komatsu K, 2005, GASTROENTEROLOGY, V129, P577, DOI 10.1053/j.gastro.2005.06.003; Kondoh K, 2007, BBA-MOL CELL RES, V1773, P1227, DOI 10.1016/j.bbamcr.2006.12.002; Kucharska A, 2009, CELL SIGNAL, V21, P1794, DOI 10.1016/j.cellsig.2009.07.015; Lemieux E, 2009, INT J CANCER, V125, P1575, DOI 10.1002/ijc.24485; Lenormand P, 1998, J CELL BIOL, V142, P625, DOI 10.1083/jcb.142.3.625; Lin YW, 2006, J BIOL CHEM, V281, P915, DOI 10.1074/jbc.M508720200; Liu J, 2007, ONCOGENE, V26, P1954, DOI 10.1038/sj.onc.1209994; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Marchetti S, 2005, MOL CELL BIOL, V25, P854, DOI 10.1128/MCB.25.2.854-864.2005; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Mattison CP, 2000, GENE DEV, V14, P1229; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Murphy LO, 2004, MOL CELL BIOL, V24, P144, DOI 10.1128/MCB.24.1.144-153.2004; Nagasaka T, 2004, J CLIN ONCOL, V22, P4584, DOI 10.1200/JCO.2004.02.154; Nandan MO, 2008, GASTROENTEROLOGY, V134, P120, DOI 10.1053/j.gastro.2007.10.023; Nishimura T, 2008, TUMOR BIOL, V29, P343, DOI 10.1159/000176044; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Peng DJ, 2010, CELL CYCLE, V9, P4650, DOI 10.4161/cc.9.23.13957; Rajagopalan H, 2002, NATURE, V418, P934, DOI 10.1038/418934a; Ramos JW, 2008, INT J BIOCHEM CELL B, V40, P2707, DOI 10.1016/j.biocel.2008.04.009; Simoneau M, 2011, CELL SIGNAL, V23, P269, DOI 10.1016/j.cellsig.2010.09.011; Smakman N, 2005, BBA-REV CANCER, V1756, P103, DOI 10.1016/j.bbcan.2005.07.001; Smith ER, 2004, J CELL BIOL, V164, P689, DOI 10.1083/jcb.200312028; Vakiani E, 2011, J PATHOL, V223, P219, DOI 10.1002/path.2796; Vial E, 2003, J CELL SCI, V116, P4957, DOI 10.1242/jcs.00812; Voisin L, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-337; Volmat V, 2001, J CELL SCI, V114, P3433; Yeh JJ, 2009, MOL CANCER THER, V8, P834, DOI 10.1158/1535-7163.MCT-08-0972; Yuen ST, 2002, CANCER RES, V62, P6451	53	61	64	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JAN 31	2013	32	5					564	576		10.1038/onc.2012.88	http://dx.doi.org/10.1038/onc.2012.88			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	106SJ	22430215				2022-12-25	WOS:000316164700004
J	Galal, WC; Pan, M; Giulian, G; Yuan, W; Li, SW; Edwards, JL; Marino, JP; Kelman, Z; Hurwitz, J				Galal, Wiebke Chemnitz; Pan, Miao; Giulian, Gary; Yuan, Wei; Li, Shuwei; Edwards, James L.; Marino, John P.; Kelman, Zvi; Hurwitz, Jerard			Formation of dAMP-glycerol and dAMP-Tris Derivatives by Thermococcus kodakaraensis DNA Primase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETERODIMERIC PRIMASE; EUKARYOTIC PRIMASE; PRIMER SYNTHESIS; P58 SUBUNIT; INITIATION; DOMAIN; TRANSFERASE; POLYMERASE; MECHANISM; COMPLEX	In the presence of dATP, glycerol, and Tris buffer, the DNA primase isolated from Thermococcus kodakaraensis catalyzed the formation of dAMP and two products that were identified as dAMP-glycerol and dAMP-Tris. These products were formed by the T. kodakaraensis p41 catalytic subunit alone and the T. kodakaraensis p41-p46 complex in the absence of a DNA template. They were not formed with preparations containing the catalytically inactive p41 subunit. Similar glycerol and Tris derivatives as well as dNMPs were also formed with dGTP, dCTP, or dTTP. The mechanism contributing to the formation of these products and its implications in the initiation reaction catalyzed by the T. kodakaraensis primase are discussed.	[Galal, Wiebke Chemnitz; Hurwitz, Jerard] 5 Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY USA; [Pan, Miao; Giulian, Gary; Yuan, Wei; Li, Shuwei; Edwards, James L.; Marino, John P.; Kelman, Zvi] Inst Biosci & Biotechnol Res, Rockville, MD 20850 USA; [Marino, John P.; Kelman, Zvi] Natl Inst Stand & Technol, Rockville, MD 20850 USA	National Institute of Standards & Technology (NIST) - USA	Hurwitz, J (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Biol, 1275 York Ave, New York, NY 10065 USA.	j-hurwitz@ski.mskcc.org	Pan, Miao/E-7346-2012; Yuan, Wei/C-4938-2012		National Institutes of Health [GM034559]; National Science Foundation [MCB-0815646]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034559] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM034559 (to J. H.). This work was also supported by National Science Foundation Grant MCB-0815646 (to Z. K.).	Frick DN, 2001, ANNU REV BIOCHEM, V70, P39, DOI 10.1146/annurev.biochem.70.1.39; Galal WC, 2012, J BIOL CHEM, V287, P16209, DOI 10.1074/jbc.M111.338145; GLYNN IM, 1964, BIOCHEM J, V90, P147, DOI 10.1042/bj0900147; Hubscher U, 2002, ANNU REV BIOCHEM, V71, P133, DOI 10.1146/annurev.biochem.71.090501.150041; Ito N, 2003, GENES CELLS, V8, P913, DOI 10.1111/j.1365-2443.2003.00693.x; Iyer LM, 2005, NUCLEIC ACIDS RES, V33, P3875, DOI 10.1093/nar/gki702; Klinge S, 2007, NAT STRUCT MOL BIOL, V14, P875, DOI 10.1038/nsmb1288; Kornberg A., 1992, DNA REPLICATION, P415; Kuchta RD, 2010, BBA-PROTEINS PROTEOM, V1804, P1180, DOI 10.1016/j.bbapap.2009.06.011; Lao-Sirieix SH, 2004, J MOL BIOL, V344, P1251, DOI 10.1016/j.jmb.2004.10.018; Le Breton M, 2007, J MOL BIOL, V374, P1172, DOI 10.1016/j.jmb.2007.10.015; Liu LD, 2001, J BIOL CHEM, V276, P45484, DOI 10.1074/jbc.M106391200; Matsunaga F, 2003, EMBO REP, V4, P154, DOI 10.1038/sj.embor.embor732; Ramadan K, 2004, J MOL BIOL, V339, P395, DOI 10.1016/j.jmb.2004.03.056; SHEAFF RJ, 1993, BIOCHEMISTRY-US, V32, P3027, DOI 10.1021/bi00063a014; Weiner BE, 2007, J BIOL CHEM, V282, P33444, DOI 10.1074/jbc.M705826200; Yuan W, 2011, J CHROMATOGR A, V1218, P2561, DOI 10.1016/j.chroma.2011.02.063; Zerbe LK, 2002, BIOCHEMISTRY-US, V41, P4891, DOI 10.1021/bi016030b	18	6	6	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16220	16229		10.1074/jbc.M111.338160	http://dx.doi.org/10.1074/jbc.M111.338160			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22427647	Green Published, hybrid			2022-12-25	WOS:000304030900014
J	Slotman, JA; Almeida, ACD; Hassink, GC; van de Ven, RHA; van Kerkhof, P; Kuiken, HJ; Strous, GJ				Slotman, Johan A.; Almeida, Ana C. da Silva; Hassink, Gerco C.; van de Ven, Robert H. A.; van Kerkhof, Peter; Kuiken, Hendrik J.; Strous, Ger J.			Ubc13 and COOH Terminus of Hsp70-interacting Protein (CHIP) Are Required for Growth Hormone Receptor Endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN LIGASE CHIP; REPEAT-CONTAINING PROTEIN; QUALITY-CONTROL; CONJUGATING ENZYMES; DEPENDENT ENDOCYTOSIS; CHAPERONE FUNCTIONS; CARBOXYL-TERMINUS; C-CBL; DEGRADATION; BINDING	Growth hormone receptor (GHR) endocytosis is a highly regulated process that depends on the binding and activity of the multimeric ubiquitin ligase, SCF beta TrCP (Skp Cullin F-box). Despite a specific interaction between beta-transducin repeat-containing protein (beta TrCP) and the GHR, and a strict requirement for ubiquitination activity, the receptor is not an obligatory target for SCF beta TrCP-directed Lys(48) polyubiquitination. We now show that also Lys(63)-linked ubiquitin chain formation is required for GHR endocytosis. We identified both the ubiquitin-conjugating enzyme Ubc13 and the ubiquitin ligase COOH terminus of Hsp70 interacting protein ( CHIP) as being connected to this process. Ubc13 activity and its interaction with CHIP precede endocytosis of GHR. In addition to beta TrCP, CHIP interacts specifically with the cytosolic tails of the dimeric GHR, identifying both Ubc13 and CHIP as novel factors in the regulation of cell surface availability of GHR.	[Slotman, Johan A.; Almeida, Ana C. da Silva; Hassink, Gerco C.; van de Ven, Robert H. A.; van Kerkhof, Peter; Strous, Ger J.] Univ Med Ctr Utrecht, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands; [Slotman, Johan A.; Almeida, Ana C. da Silva; Hassink, Gerco C.; van de Ven, Robert H. A.; van Kerkhof, Peter; Strous, Ger J.] Inst Biomembranes, NL-3584 CX Utrecht, Netherlands; [Kuiken, Hendrik J.] Netherlands Canc Inst, Div Mol Carcinogenesis, NL-1066 CX Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Netherlands Cancer Institute	Strous, GJ (corresponding author), Univ Med Ctr Utrecht, Dept Cell Biol, Heidelberglaan 100,AZU H02-313, NL-3584 CX Utrecht, Netherlands.	gstrous@umcutrecht.nl		van Kerkhof, Peter/0000-0002-8954-2230; Slotman, Johan A./0000-0001-9705-9620	Netherlands Proteomics Centre [NPC3.1]; European Network of Excellence [LSHG-CT-2005-018683]; Marie Curie Network [MRTN-CT-2006-034555]	Netherlands Proteomics Centre; European Network of Excellence(European Commission); Marie Curie Network(European Commission)	This work was supported by the Netherlands Proteomics Centre NPC3.1, European Network of Excellence Grant LSHG-CT-2005-018683, and Marie Curie Network Grant MRTN-CT-2006-034555.	Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; BAXTER RC, 1985, ENDOCRINOLOGY, V117, P650, DOI 10.1210/endo-117-2-650; Brown RJ, 2005, NAT STRUCT MOL BIOL, V12, P814, DOI 10.1038/nsmb977; Brun J, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-24; Cliff MJ, 2005, J MOL BIOL, V346, P717, DOI 10.1016/j.jmb.2004.12.017; Cyr DM, 2002, TRENDS BIOCHEM SCI, V27, P368, DOI 10.1016/S0968-0004(02)02125-4; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Faresse N, 2010, AM J PHYSIOL-RENAL, V299, pF1462, DOI 10.1152/ajprenal.00285.2010; Galan JM, 1997, EMBO J, V16, P5847, DOI 10.1093/emboj/16.19.5847; Gent J, 2002, P NATL ACAD SCI USA, V99, P9858, DOI 10.1073/pnas.152294299; Govers R, 1999, EMBO J, V18, P28, DOI 10.1093/emboj/18.1.28; Graf C, 2010, BIOCHEMISTRY-US, V49, P2121, DOI 10.1021/bi901829f; Grove DE, 2009, MOL BIOL CELL, V20, P4059, DOI 10.1091/mbc.E08-09-0929; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hoeller D, 2006, NAT CELL BIOL, V8, P163, DOI 10.1038/ncb1354; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Hurley JH, 2011, ANNU REV BIOPHYS, V40, P119, DOI 10.1146/annurev-biophys-042910-155404; Kamsteeg EJ, 2006, P NATL ACAD SCI USA, V103, P18344, DOI 10.1073/pnas.0604073103; Kazazic M, 2009, TRAFFIC, V10, P235, DOI 10.1111/j.1600-0854.2008.00858.x; Kramer LB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014291; Lauwers E, 2010, TRENDS CELL BIOL, V20, P196, DOI 10.1016/j.tcb.2010.01.004; Le Bras S, 2011, TRAFFIC, V12, P149, DOI 10.1111/j.1600-0854.2010.01126.x; Maldonado-Baez L, 2006, TRENDS CELL BIOL, V16, P505, DOI 10.1016/j.tcb.2006.08.001; McDonough H, 2009, J BIOL CHEM, V284, P20649, DOI 10.1074/jbc.M109.011767; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Murata S, 2003, INT J BIOCHEM CELL B, V35, P572, DOI 10.1016/S1357-2725(02)00394-1; MURPHY LJ, 1984, ENDOCRINOLOGY, V115, P1625, DOI 10.1210/endo-115-4-1625; Nelson RF, 2006, J BIOL CHEM, V281, P20242, DOI 10.1074/jbc.M602423200; Nickerson DP, 2009, CURR OPIN CELL BIOL, V21, P543, DOI 10.1016/j.ceb.2009.05.007; Nie L, 2008, J BIOL CHEM, V283, P684, DOI 10.1074/jbc.M704981200; Paiva S, 2009, J BIOL CHEM, V284, P19228, DOI 10.1074/jbc.M109.008318; Parsons JL, 2008, MOL CELL, V29, P477, DOI 10.1016/j.molcel.2007.12.027; Pashkova N, 2010, MOL CELL, V40, P433, DOI 10.1016/j.molcel.2010.10.018; Polo S, 2002, NATURE, V416, P451, DOI 10.1038/416451a; Putters J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014676; Rosser MFN, 2007, J BIOL CHEM, V282, P22267, DOI 10.1074/jbc.M700513200; ROUPAS P, 1988, MOL CELL ENDOCRINOL, V57, P93, DOI 10.1016/0303-7207(88)90037-8; Schantl JA, 2003, BIOCHEM J, V373, P855, DOI 10.1042/BJ20021591; Sehat B, 2008, CANCER RES, V68, P5669, DOI 10.1158/0008-5472.CAN-07-6364; Soss SE, 2011, J BIOL CHEM, V286, P21277, DOI 10.1074/jbc.M111.224006; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Strous GJ, 1996, EMBO J, V15, P3806, DOI 10.1002/j.1460-2075.1996.tb00754.x; Tetzlaff JE, 2008, J BIOL CHEM, V283, P17962, DOI 10.1074/jbc.M802283200; Timsit YE, 2005, BIOCHEM BIOPH RES CO, V328, P550, DOI 10.1016/j.bbrc.2005.01.022; van Dam EM, 2002, J BIOL CHEM, V277, P48876, DOI 10.1074/jbc.M206271200; van den Eijnden MJM, 2006, J CELL SCI, V119, P3078, DOI 10.1242/jcs.03036; van Kerkhof P, 2002, ENDOCRINOLOGY, V143, P1243, DOI 10.1210/en.143.4.1243; van Kerkhof P, 2001, MOL BIOL CELL, V12, P2556, DOI 10.1091/mbc.12.8.2556; van Kerkhof P, 2007, J BIOL CHEM, V282, P20475, DOI 10.1074/jbc.M702610200; van Kerkhof P, 2011, EXP CELL RES, V317, P1071, DOI 10.1016/j.yexcr.2010.12.020; vanDelft S, 1997, J BIOL CHEM, V272, P14013, DOI 10.1074/jbc.272.22.14013; Varghese B, 2008, MOL CELL BIOL, V28, P5275, DOI 10.1128/MCB.00350-08; Vina-Vilaseca A, 2010, J BIOL CHEM, V285, P7645, DOI 10.1074/jbc.M109.058990; Wang L, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201814; Waterman H, 1999, J BIOL CHEM, V274, P22151, DOI 10.1074/jbc.274.32.22151; Windheim M, 2008, BIOCHEM J, V409, P723, DOI 10.1042/BJ20071338; Xu Z, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-26; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023; Zhu T, 2001, CELL SIGNAL, V13, P599, DOI 10.1016/S0898-6568(01)00186-3	59	26	27	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15533	15543		10.1074/jbc.M111.302521	http://dx.doi.org/10.1074/jbc.M111.302521			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22433856	Green Published, hybrid			2022-12-25	WOS:000304006300034
J	Birdsell, DN; Pearson, T; Price, EP; Hornstra, HM; Nera, RD; Stone, N; Gruendike, J; Kaufman, EL; Pettus, AH; Hurbon, AN; Buchhagen, JL; Harms, NJ; Chanturia, G; Gyuranecz, M; Wagner, DM; Keim, PS				Birdsell, Dawn N.; Pearson, Talima; Price, Erin P.; Hornstra, Heidie M.; Nera, Roxanne D.; Stone, Nathan; Gruendike, Jeffrey; Kaufman, Emily L.; Pettus, Amanda H.; Hurbon, Audriana N.; Buchhagen, Jordan L.; Harms, N. Jane; Chanturia, Gvantsa; Gyuranecz, Miklos; Wagner, David M.; Keim, Paul S.			Melt Analysis of Mismatch Amplification Mutation Assays (Melt-MAMA): A Functional Study of a Cost-Effective SNP Genotyping Assay in Bacterial Models	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; ALLELE-SPECIFIC PCR; POLYMERASE-CHAIN-REACTION; SYBR-GREEN-I; FRANCISELLA-TULARENSIS; LARGE-SCALE; DNA; DISCRIMINATION; IDENTIFICATION; FLUORESCENCE	Single nucleotide polymorphisms (SNPs) are abundant in genomes of all species and biologically informative markers extensively used across broad scientific disciplines. Newly identified SNP markers are publicly available at an ever-increasing rate due to advancements in sequencing technologies. Efficient, cost-effective SNP genotyping methods to screen sample populations are in great demand in well-equipped laboratories, but also in developing world situations. Dual Probe TaqMan assays are robust but can be cost-prohibitive and require specialized equipment. The Mismatch Amplification Mutation Assay, coupled with melt analysis (Melt-MAMA), is flexible, efficient and cost-effective. However, Melt-MAMA traditionally suffers from high rates of assay design failures and knowledge gaps on assay robustness and sensitivity. In this study, we identified strategies that improved the success of Melt-MAMA. We examined the performance of 185 Melt-MAMAs across eight different pathogens using various optimization parameters. We evaluated the effects of genome size and %GC content on assay development. When used collectively, specific strategies markedly improved the rate of successful assays at the first design attempt from similar to 50% to similar to 80%. We observed that Melt-MAMA accurately genotypes across a broad DNA range (similar to 100 ng to similar to 0.1 pg). Genomic size and %GC content influence the rate of successful assay design in an independent manner. Finally, we demonstrated the versatility of these assays by the creation of a duplex Melt-MAMA real-time PCR (two SNPs) and conversion to a size-based genotyping system, which uses agarose gel electrophoresis. Melt-MAMA is comparable to Dual Probe TaqMan assays in terms of design success rate and accuracy. Although sensitivity is less robust than Dual Probe TaqMan assays, Melt-MAMA is superior in terms of cost-effectiveness, speed of development and versatility. We detail the parameters most important for the successful application of Melt-MAMA, which should prove useful to the wider scientific community.	[Birdsell, Dawn N.; Pearson, Talima; Price, Erin P.; Hornstra, Heidie M.; Nera, Roxanne D.; Stone, Nathan; Gruendike, Jeffrey; Kaufman, Emily L.; Pettus, Amanda H.; Hurbon, Audriana N.; Buchhagen, Jordan L.; Wagner, David M.; Keim, Paul S.] No Arizona Univ, Ctr Microbial Genet & Genom, Flagstaff, AZ 86011 USA; [Chanturia, Gvantsa] Natl Ctr Dis Control & Publ Hlth, Tbilisi, Georgia; [Chanturia, Gvantsa] Ilia State Univ, Tbilisi, Georgia; [Keim, Paul S.] Translat Genom Res Inst, Phoenix, AZ USA; [Gyuranecz, Miklos] Hungarian Acad Sci, Vet Med Res Inst, H-1581 Budapest, Hungary; [Harms, N. Jane] Univ Saskatchewan, Western Coll Vet Med, Dept Vet Pathol, Saskatoon, SK S7N 0W0, Canada	Northern Arizona University; National Center for Disease Control & Public Health - Georgia; Ilia State University; Translational Genomics Research Institute; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Hungarian Veterinary Medical Research Institute; University of Saskatchewan	Birdsell, DN (corresponding author), No Arizona Univ, Ctr Microbial Genet & Genom, Flagstaff, AZ 86011 USA.	Paul.Keim@nau.edu	Price, Erin/N-2336-2013; Pearson, Talima/O-7840-2019	Price, Erin/0000-0002-1079-4882; Pearson, Talima/0000-0003-3696-041X; Wagner, David/0000-0003-2684-6007; Gyuranecz, Miklos/0000-0002-5698-5713	U.S. Department of Homeland Security [HSHQDC-10-C-00139]; National Institute of Allergy and Infectious Diseases; National Institutes of Health [N01-AI15447]; Northern Arizona University	U.S. Department of Homeland Security(United States Department of Homeland Security (DHS)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northern Arizona University	This work was funded by the U.S. Department of Homeland Security via award HSHQDC-10-C-00139, the National Institute of Allergy and Infectious Diseases, the National Institutes of Health under contract N01-AI15447, and the Cowden Endowment in Microbiology at Northern Arizona University. Note that the use of products/names does not constitute endorsement by the Department of Homeland Security of the United States. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreson R, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn290; Baskaran N, 1996, GENOME RES, V6, P633, DOI 10.1101/gr.6.7.633; Brun-Barale A, 2005, PEST MANAG SCI, V61, P549, DOI 10.1002/ps.1002; Casado-Diaz A, 2007, CLIN CHIM ACTA, V376, P155, DOI 10.1016/j.cca.2006.08.014; Cha R S, 1992, PCR Methods Appl, V2, P14; Dall'Ozzo S, 2003, J IMMUNOL METHODS, V277, P185, DOI 10.1016/S0022-1759(03)00123-6; Ding CM, 2009, METHODS MOL BIOL, V578, P245, DOI 10.1007/978-1-60327-411-1_16; Dobrin S, 2007, HIGH THROUGHPUT SNP; Emahazion T, 2001, TRENDS GENET, V17, P407, DOI 10.1016/S0168-9525(01)02342-3; Fonseca-Coronado S, 2012, J CLIN MICROBIOL, V50, P281, DOI 10.1128/JCM.05842-11; Fonseca-Coronado S, 2011, J CLIN MICROBIOL, V49, P2706, DOI 10.1128/JCM.00877-11; Foster JT, 2008, J CLIN MICROBIOL, V46, P296, DOI 10.1128/JCM.01496-07; Gaudet M, 2009, METHODS MOL BIOL, V578, P415, DOI 10.1007/978-1-60327-411-1_26; Henke W, 1997, NUCLEIC ACIDS RES, V25, P3957, DOI 10.1093/nar/25.19.3957; Hezard N, 1997, THROMB RES, V88, P59, DOI 10.1016/S0049-3848(97)00191-6; Hu YJ, 2007, ANAL BIOCHEM, V369, P54, DOI 10.1016/j.ab.2007.04.042; HUANG MM, 1992, NUCLEIC ACIDS RES, V20, P4567, DOI 10.1093/nar/20.17.4567; Kim S, 2007, ANNU REV BIOMED ENG, V9, P289, DOI 10.1146/annurev.bioeng.9.060906.152037; Kranaster R, 2007, CHEM-EUR J, V13, P6115, DOI 10.1002/chem.200601627; KWOK S, 1990, NUCLEIC ACIDS RES, V18, P999, DOI 10.1093/nar/18.4.999; Latorra D, 2003, HUM MUTAT, V22, P79, DOI 10.1002/humu.10228; Li BH, 2004, GENOMICS, V83, P311, DOI 10.1016/j.ygeno.2003.08.005; Martino A, 2010, J BIOMOL SCREEN, V15, P623, DOI 10.1177/1087057110365900; MCCONLOGUE L, 1988, NUCLEIC ACIDS RES, V16, P9869, DOI 10.1093/nar/16.20.9869; Monis PT, 2005, ANAL BIOCHEM, V340, P24, DOI 10.1016/j.ab.2005.01.046; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; Okimoto R, 1996, BIOTECHNIQUES, V21, P20; Pandya GA, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-213; Papp AC, 2003, BIOTECHNIQUES, V34, P1068, DOI 10.2144/03345dd03; Pirmohamed M, 2001, TRENDS PHARMACOL SCI, V22, P298, DOI 10.1016/S0165-6147(00)01717-X; Price EP, 2010, ELECTROPHORESIS, V31, P3881, DOI 10.1002/elps.201000379; Rodriguez-Castillo A, 2010, J CLIN MICROBIOL, V48, P1712, DOI 10.1128/JCM.00112-10; Schork NJ, 2000, CLIN GENET, V58, P250, DOI 10.1034/j.1399-0004.2000.580402.x; Shi MM, 2001, CLIN CHEM, V47, P164; Svensson K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008360; Van Ert MN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000461; Vogler AJ, 2009, LETT APPL MICROBIOL, V48, P140, DOI 10.1111/j.1472-765X.2008.02484.x; Vogler AJ, 2008, BIOTECHNIQUES, V44, P201, DOI 10.2144/000112815; Vogler AJ, 2009, J BACTERIOL, V191, P2474, DOI 10.1128/JB.01786-08; Waterfall CM, 2002, BIOTECHNIQUES, V33, P80, DOI 10.2144/02331st05; WU DY, 1989, P NATL ACAD SCI USA, V86, P2757, DOI 10.1073/pnas.86.8.2757	41	68	71	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e32866	10.1371/journal.pone.0032866	http://dx.doi.org/10.1371/journal.pone.0032866			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438886	Green Published, gold, Green Submitted			2022-12-25	WOS:000303309100017
J	Shruti, S; Urban-Ciecko, J; Fitzpatrick, JA; Brenner, R; Bruchez, MP; Barth, AL				Shruti, Sonal; Urban-Ciecko, Joanna; Fitzpatrick, James A.; Brenner, Robert; Bruchez, Marcel P.; Barth, Alison L.			The Brain-Specific Beta4 Subunit Downregulates BK Channel Cell Surface Expression	PLOS ONE			English	Article							CA2+-ACTIVATED K+ CHANNEL; ACTIVATED POTASSIUM CHANNELS; ENDOCYTIC TRAFFICKING SIGNALS; NEOCORTICAL PYRAMIDAL NEURONS; LARGE-CONDUCTANCE; ENDOPLASMIC-RETICULUM; TRANSMEMBRANE PROTEINS; TRANSMITTER RELEASE; NERVE-TERMINALS; SMOOTH-MUSCLE	The large-conductance K+ channel (BK channel) can control neural excitability, and enhanced channel currents facilitate high firing rates in cortical neurons. The brain-specific auxiliary subunit beta 4 alters channel Ca++- and voltage-sensitivity, and beta 4 knock-out animals exhibit spontaneous seizures. Here we investigate beta 4's effect on BK channel trafficking to the plasma membrane. Using a novel genetic tag to track the cellular location of the pore-forming BK alpha subunit in living cells, we find that beta 4 expression profoundly reduces surface localization of BK channels via a C-terminal ER retention sequence. In hippocampal CA3 neurons from C57BL/6 mice with endogenously high b4 expression, whole-cell BK channel currents display none of the characteristic properties of BK alpha+beta 4 channels observed in heterologous cells. Finally, beta 4 knock-out animals exhibit a 2.5-fold increase in whole-cell BK channel current, indicating that beta 4 also regulates current magnitude in vivo. Thus, we propose that a major function of the brain-specific beta 4 subunit in CA3 neurons is control of surface trafficking.	[Shruti, Sonal; Urban-Ciecko, Joanna; Barth, Alison L.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; [Fitzpatrick, James A.; Bruchez, Marcel P.] Carnegie Mellon Univ, Mol & Biosensor Imaging Ctr, Pittsburgh, PA 15213 USA; [Brenner, Robert] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA	Carnegie Mellon University; Carnegie Mellon University; University of Texas System; University of Texas Health San Antonio	Shruti, S (corresponding author), Brandeis Univ, Dept Biol, Waltham, MA 02254 USA.	bruchez@cmu.edu; barth@cmu.edu	Bruchez, Marcel P/C-2271-2009; Urban-Ciecko, Joanna/AFA-4378-2022; Fitzpatrick, James/C-2268-2009; Urban-Ciecko, Joanna/Q-3487-2016	Bruchez, Marcel P/0000-0002-7370-4848; Urban-Ciecko, Joanna/0000-0003-1676-2336; Fitzpatrick, James/0000-0002-7907-3602; Urban-Ciecko, Joanna/0000-0003-1676-2336; Brenner, Robert/0000-0002-1036-8031	Carnegie Mellon University; National Institutes of Health (NIH) [U54 RR022241]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR022241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052574] Funding Source: NIH RePORTER	Carnegie Mellon University; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Work was supported by start-up funds from Carnegie Mellon University and National Institutes of Health (NIH) U54 RR022241. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alle H, 2007, J NEUROSCI, V27, P942, DOI 10.1523/JNEUROSCI.4996-06.2007; Ashby MC, 2004, TRENDS NEUROSCI, V27, P257, DOI 10.1016/j.tins.2004.03.010; Bai JP, 2011, AM J PHYSIOL-CELL PH, V300, pC435, DOI 10.1152/ajpcell.00449.2010; Behrens R, 2000, FEBS LETT, V474, P99, DOI 10.1016/S0014-5793(00)01584-2; Bekisz M, 2010, EUR J NEUROSCI, V32, P1715, DOI 10.1111/j.1460-9568.2010.07453.x; Benhassine N, 2005, EUR J NEUROSCI, V21, P914, DOI 10.1111/j.1460-9568.2005.03934.x; Bi GQ, 1995, J CELL BIOL, V131, P1747, DOI 10.1083/jcb.131.6.1747; Bozza T, 2004, NEURON, V42, P9, DOI 10.1016/S0896-6273(04)00144-8; Brenner R, 2005, NAT NEUROSCI, V8, P1752, DOI 10.1038/nn1573; Brenner R, 2000, J BIOL CHEM, V275, P6453, DOI 10.1074/jbc.275.9.6453; Dopico AM, 1999, J PHYSIOL-LONDON, V519, P101, DOI 10.1111/j.1469-7793.1999.0101o.x; Du W, 2005, NAT GENET, V37, P733, DOI 10.1038/ng1585; Faber ESL, 2003, NEUROSCIENTIST, V9, P181, DOI 10.1177/1073858403009003011; Ghezzi A, 2010, P NATL ACAD SCI USA, V107, P16360, DOI 10.1073/pnas.1005439107; Gu N, 2007, J PHYSIOL-LONDON, V580, P859, DOI 10.1113/jphysiol.2006.126367; Ha TS, 2004, BIOPHYS J, V86, P2871, DOI 10.1016/S0006-3495(04)74339-8; Hammami S, 2009, J PHYSIOL-LONDON, V587, P2225, DOI 10.1113/jphysiol.2008.163550; Hasdemir B, 2005, J CELL BIOL, V171, P459, DOI 10.1083/jcb.200506005; Hu H, 2001, J NEUROSCI, V21, P9585, DOI 10.1523/JNEUROSCI.21-24-09585.2001; Isaacson JS, 2001, NEURON, V31, P1027, DOI 10.1016/S0896-6273(01)00428-7; ITIN C, 1995, EMBO J, V14, P2250, DOI 10.1002/j.1460-2075.1995.tb07219.x; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; Jin P, 2002, J BIOL CHEM, V277, P10014, DOI 10.1074/jbc.M107682200; Jin W, 2000, BRAIN RES, V860, P21, DOI 10.1016/S0006-8993(00)01943-0; Kang J, 1996, J NEUROPHYSIOL, V76, P188, DOI 10.1152/jn.1996.76.1.188; Kaufmann WA, 2010, NEUROSCIENCE, V169, P974, DOI 10.1016/j.neuroscience.2010.05.070; KNAUS HG, 1994, J BIOL CHEM, V269, P3921; KNAUS HG, 1994, BIOCHEMISTRY-US, V33, P5819, DOI 10.1021/bi00185a021; Lippiat JD, 2003, J MEMBRANE BIOL, V192, P141, DOI 10.1007/s00232-002-1070-0; Lorenz S, 2006, AM J MED GENET B; Ma D, 2002, CURR OPIN NEUROBIOL, V12, P287, DOI 10.1016/S0959-4388(02)00319-7; Matthews EA, 2009, LEARN MEMORY, V16, P106, DOI 10.1101/lm.1289809; Meera P, 2000, P NATL ACAD SCI USA, V97, P5562, DOI 10.1073/pnas.100118597; Meredith AL, 2006, NAT NEUROSCI, V9, P1041, DOI 10.1038/nn1740; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Misonou H, 2006, J COMP NEUROL, V496, P289, DOI 10.1002/cne.20931; Misonou H, 2004, NAT NEUROSCI, V7, P711, DOI 10.1038/nn1260; Nelson AB, 2003, NEURON, V40, P609, DOI 10.1016/S0896-6273(03)00641-X; Quirk JC, 2001, NEURON, V32, P13, DOI 10.1016/S0896-6273(01)00444-5; Raffaelli G, 2004, J PHYSIOL-LONDON, V557, P147, DOI 10.1113/jphysiol.2004.062661; Sanchez M, 1996, NEUROPHARMACOLOGY, V35, P963, DOI 10.1016/0028-3908(96)00137-2; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Sheehan JJ, 2009, EPILEPSIA, V50, P711, DOI 10.1111/j.1528-1167.2008.01888.x; SHEN KZ, 1994, PFLUG ARCH EUR J PHY, V426, P440, DOI 10.1007/BF00388308; SHIN J, 1991, P NATL ACAD SCI USA, V88, P1918, DOI 10.1073/pnas.88.5.1918; Shruti S, 2008, NEUROBIOL DIS, V30, P323, DOI 10.1016/j.nbd.2008.02.002; Smith MR, 2002, J NEUROPHYSIOL, V87, P2031, DOI 10.1152/jn.00821.2001; Snapp EL, 2006, P NATL ACAD SCI USA, V103, P6536, DOI 10.1073/pnas.0510657103; Szent-Gyorgyi C, 2008, NAT BIOTECHNOL, V26, P235, DOI 10.1038/nbt1368; Togo T, 1999, J CELL SCI, V112, P719; Toro B, 2006, NEUROSCIENCE, V142, P661, DOI 10.1016/j.neuroscience.2006.06.061; Torres YP, 2007, J BIOL CHEM, V282, P24485, DOI 10.1074/jbc.R700022200; Wallner M, 1996, P NATL ACAD SCI USA, V93, P14922, DOI 10.1073/pnas.93.25.14922; Wang B, 2006, J GEN PHYSIOL, V127, P449, DOI 10.1085/jgp.200509436; Wang B, 2009, J GEN PHYSIOL, V133, P283, DOI 10.1085/jgp.200810141; WANG G, 1992, J PHYSIOL-LONDON, V457, P47, DOI 10.1113/jphysiol.1992.sp019364; Wang SX, 2003, J BIOL CHEM, V278, P2713, DOI 10.1074/jbc.M208411200; Wang YW, 2002, J NEUROSCI, V22, P1550, DOI 10.1523/JNEUROSCI.22-05-01550.2002; Weiger TM, 2000, J NEUROSCI, V20, P3563, DOI 10.1523/JNEUROSCI.20-10-03563.2000; Womack MD, 2002, EUR J NEUROSCI, V16, P1214, DOI 10.1046/j.1460-9568.2002.02171.x; Wynne PM, 2009, J PHARM EXP THER; Xie JY, 1998, SCIENCE, V280, P443, DOI 10.1126/science.280.5362.443; Yang CT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006135; Yu SP, 1998, J NEUROSCI RES, V52, P612, DOI 10.1002/(SICI)1097-4547(19980601)52:5<612::AID-JNR13>3.0.CO;2-3; Zarei MM, 2007, NEUROSCIENCE, V147, P80, DOI 10.1016/j.neuroscience.2007.04.019	65	53	54	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33429	10.1371/journal.pone.0033429	http://dx.doi.org/10.1371/journal.pone.0033429			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438928	Green Published, gold, Green Submitted			2022-12-25	WOS:000303309100043
J	Lee, EY; Park, KS; Yoon, YJ; Lee, J; Moon, HG; Jang, SC; Choi, KH; Kim, YK; Gho, YS				Lee, Eun-Young; Park, Kyong-Su; Yoon, Yae Jin; Lee, Jaewook; Moon, Hyung-Geun; Jang, Su Chul; Choi, Kyoung-Ho; Kim, Yoon-Keun; Gho, Yong Song			Therapeutic Effects of Autologous Tumor-Derived Nanovesicles on Melanoma Growth and Metastasis	PLOS ONE			English	Article							DENDRITIC CELLS; IN-VIVO; REJECTION ANTIGENS; MEMBRANE-VESICLES; VACCINE DELIVERY; CANCER VACCINES; T-CELLS; EXOSOMES; IMMUNOTHERAPY; ERADICATION	Cancer vaccines with optimal tumor-associated antigens show promise for anti-tumor immunotherapy. Recently, nano-sized vesicles, such as exosomes derived from tumors, were suggested as potential antigen candidates, although the total yield of exosomes is not sufficient for clinical applications. In the present study, we developed a new vaccine strategy based on nano-sized vesicles derived from primary autologous tumors. Through homogenization and sonication of tumor tissues, we achieved high yields of vesicle-bound antigens. These nanovesicles were enriched with antigenic membrane targets but lacked nuclear autoantigens. Furthermore, these nanovesicles together with adjuvant activated dendritic cells in vitro, and induced effective anti-tumor immune responses in both primary and metastatic melanoma mouse models. Therefore, autologous tumor-derived nanovesicles may represent a novel source of antigens with high-level immunogenicity for use in acellular vaccines without compromising safety. Our strategy is cost-effective and can be applied to patient-specific cancer therapeutic vaccination.	[Lee, Eun-Young; Park, Kyong-Su; Yoon, Yae Jin; Lee, Jaewook; Moon, Hyung-Geun; Jang, Su Chul; Kim, Yoon-Keun; Gho, Yong Song] Pohang Univ Sci & Technol POSTECH, Dept Life Sci, Pohang, South Korea; [Lee, Eun-Young; Park, Kyong-Su; Yoon, Yae Jin; Lee, Jaewook; Moon, Hyung-Geun; Jang, Su Chul; Kim, Yoon-Keun; Gho, Yong Song] Pohang Univ Sci & Technol POSTECH, Div Mol & Life Sci, Pohang, South Korea; [Choi, Kyoung-Ho] Catholic Univ Korea, Dept Emergency Med, Coll Med, Seoul, South Korea	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Catholic University of Korea	Lee, EY (corresponding author), Pohang Univ Sci & Technol POSTECH, Dept Life Sci, Pohang, South Korea.	juinea@postech.ac.kr; ysgho@postech.ac.kr	Lee, Jaewook/AAO-9331-2020	Kyoung ho, Choi/0000-0003-2301-2250; Jang, Su Chul/0000-0003-3326-1007	Ministry of Health & Welfare, Republic of Korea [0820220]; National Research Foundation of Korea (NRF); Korea government (MEST) [20110016474]	Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This study was supported by a grant of the National R&D Program for Cancer Control (http://ncc.ncc.re.kr), Ministry of Health & Welfare, Republic of Korea (0820220) and by the National Research Foundation of Korea (NRF) grant (http://www.nrf.re.kr) funded by the Korea government (MEST) (No. 20110016474). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altin JG, 2006, METHODS, V40, P39, DOI 10.1016/j.ymeth.2006.05.027; Andre F, 2002, VACCINE, V20, pA28, DOI 10.1016/S0264-410X(02)00384-5; Bachmann MF, 2010, NAT REV IMMUNOL, V10, P787, DOI 10.1038/nri2868; Choi DS, 2007, J PROTEOME RES, V6, P4646, DOI 10.1021/pr070192y; Emens LA, 2006, INT REV IMMUNOL, V25, P415, DOI 10.1080/08830180600992423; Finn OJ, 2003, NAT REV IMMUNOL, V3, P630, DOI 10.1038/nri1150; GERCOVICH F G, 1975, Medical and Pediatric Oncology, V1, P277, DOI 10.1002/mpo.2950010310; Gilboa E, 2004, NAT REV CANCER, V4, P401, DOI 10.1038/nrc1359; Hodi FS, 2006, CLIN CANCER RES, V12, P673, DOI 10.1158/1078-0432.CCR-05-2616; Kotera Y, 2001, CANCER RES, V61, P8105; Kovar M, 2006, P NATL ACAD SCI USA, V103, P11671, DOI 10.1073/pnas.0603466103; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Mocellin S, 2004, EXP CELL RES, V299, P267, DOI 10.1016/j.yexcr.2004.06.017; Morelli AE, 2004, BLOOD, V104, P3257, DOI 10.1182/blood-2004-03-0824; Nishimura T, 1999, J EXP MED, V190, P617, DOI 10.1084/jem.190.5.617; Peek LJ, 2008, ADV DRUG DELIVER REV, V60, P915, DOI 10.1016/j.addr.2007.05.017; Pisani P, 1997, CANCER EPIDEM BIOMAR, V6, P387; PREHN RT, 1957, J NATL CANCER I, V18, P769; Rad FH, 2007, P NATL ACAD SCI USA, V104, P2837, DOI 10.1073/pnas.0611022104; Reddy ST, 2006, J CONTROL RELEASE, V112, P26, DOI 10.1016/j.jconrel.2006.01.006; Rivoltini L, 2002, IMMUNOL REV, V188, P97, DOI 10.1034/j.1600-065X.2002.18809.x; Schnurr M, 2002, CANCER RES, V62, P2347; Steinman RM, 2002, J CLIN INVEST, V109, P1519, DOI 10.1172/JCI200215962; Sugaya M, 2002, CHEST, V122, P282, DOI 10.1378/chest.122.1.282; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; van Elsas A, 1999, J EXP MED, V190, P355, DOI 10.1084/jem.190.3.355; Verdijk RM, 1999, J IMMUNOL, V163, P57; Wolfers J, 2001, NAT MED, V7, P297, DOI 10.1038/85438; Xiang XY, 2009, INT J CANCER, V124, P2621, DOI 10.1002/ijc.24249; Yu X, 2006, CANCER RES, V66, P4795, DOI 10.1158/0008-5472.CAN-05-4579; Zeelenberg IS, 2008, CANCER RES, V68, P1228, DOI 10.1158/0008-5472.CAN-07-3163; Zitvogel L, 1998, NAT MED, V4, P594, DOI 10.1038/nm0598-594	33	42	45	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2012	7	3							e33330	10.1371/journal.pone.0033330	http://dx.doi.org/10.1371/journal.pone.0033330			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RU	22438914	Green Published, Green Submitted, gold			2022-12-25	WOS:000303309000021
J	Ishigaki, Y; Nakamura, Y; Oikawa, Y; Yano, Y; Kuwabata, S; Nakagawa, H; Tomosugi, N; Takegami, T				Ishigaki, Yasuhito; Nakamura, Yuka; Oikawa, Yosaburo; Yano, Yasuhiro; Kuwabata, Susumu; Nakagawa, Hideaki; Tomosugi, Naohisa; Takegami, Tsutomu			Observation of Live Ticks (Haemaphysalis flava) by Scanning Electron Microscopy under High Vacuum Pressure	PLOS ONE			English	Article							LOW-EARTH-ORBIT; IONIC LIQUID; RAPID DECOMPRESSION; SURVIVE EXPOSURE; SPACE CONDITIONS; ACARI; TARSONEMIDAE; CHIMPANZEES; MITES; CELLS	Scanning electron microscopes (SEM), which image sample surfaces by scanning with an electron beam, are widely used for steric observations of resting samples in basic and applied biology. Various conventional methods exist for SEM sample preparation. However, conventional SEM is not a good tool to observe living organisms because of the associated exposure to high vacuum pressure and electron beam radiation. Here we attempted SEM observations of live ticks. During 1.5x10(-3) Pa vacuum pressure and electron beam irradiation with accelerated voltages (2-5 kV), many ticks remained alive and moved their legs. After 30-min observation, we removed the ticks from the SEM stage; they could walk actively under atmospheric pressure. When we tested 20 ticks (8 female adults and 12 nymphs), they survived for two days after SEM observation. These results indicate the resistance of ticks against SEM observation. Our second survival test showed that the electron beam, not vacuum conditions, results in tick death. Moreover, we describe the reaction of their legs to electron beam exposure. These findings open the new possibility of SEM observation of living organisms and showed the resistance of living ticks to vacuum condition in SEM. These data also indicate, for the first time, the usefulness of tick as a model system for biology under extreme condition.	[Ishigaki, Yasuhito; Nakamura, Yuka; Nakagawa, Hideaki; Tomosugi, Naohisa; Takegami, Tsutomu] Kanazawa Med Univ, Med Res Inst, Uchinada, Ishikawa 92002, Japan; [Oikawa, Yosaburo] Kanazawa Med Univ, Dept Med Zool, Uchinada, Ishikawa 92002, Japan; [Yano, Yasuhiro] Univ Fukui, Dept Pathol Sci, Fac Med Sci, Matsuoka Fukui, Japan; [Kuwabata, Susumu] Osaka Univ, Dept Appl Chem, Grad Sch Engn, Suita, Osaka, Japan; [Kuwabata, Susumu] Core Res Evolut Sci & Technol CREST, Japan Sci & Technol Agcy JST, Kawaguchi, Saitama, Japan	Kanazawa Medical University; Kanazawa Medical University; University of Fukui; Osaka University; Japan Science & Technology Agency (JST)	Ishigaki, Y (corresponding author), Kanazawa Med Univ, Med Res Inst, Uchinada, Ishikawa 92002, Japan.	tomosugi@kanazawa-med.ac.jp	Kuwabata, Susumu/N-3492-2018	Kuwabata, Susumu/0000-0002-4606-964X	Kanazawa Medical University [S2010-5, H2011-11]	Kanazawa Medical University	This research was funded by Kanazawa Medical University (S2010-5 and H2011-11). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	DUSBABEK F, 1975, Folia Parasitologica (Ceske Budejovice), V22, P375; Hetz SK, 2005, NATURE, V433, P516, DOI 10.1038/nature03106; HOLM AP, 1970, AEROSPACE MED, V41, P277; Horneck G, 2001, ORIGINS LIFE EVOL B, V31, P527, DOI 10.1023/A:1012746130771; Ishigaki Y, 2011, MICROSC RES TECHNIQ, V74, P1024, DOI 10.1002/jemt.20989; Ishigaki Y, 2011, MICROSC RES TECHNIQ, V74, P415, DOI 10.1002/jemt.20924; Jonsson KI, 2008, CURR BIOL, V18, pR729, DOI 10.1016/j.cub.2008.06.048; KOESTLER AG, 1968, J APPL PHYSIOL, V25, P153, DOI 10.1152/jappl.1968.25.2.153; Lareschi M, 2010, SYST PARASITOL, V76, P199, DOI 10.1007/s11230-010-9244-0; Locher N, 2010, PARASITOL RES, V107, P433, DOI 10.1007/s00436-010-1958-z; Maketon M, 2008, EXP APPL ACAROL, V46, P157, DOI 10.1007/s10493-008-9153-y; Mariana A, 2008, TROP BIOMED, V25, P217; Mobjerg N, 2011, ACTA PHYSIOL, V202, P409, DOI 10.1111/j.1748-1716.2011.02252.x; Ochoa R, 2005, EXP APPL ACAROL, V35, P239, DOI 10.1007/s10493-004-5080-8; Pasay C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012079; Persson D, 2011, J ZOOL SYST EVOL RES, V49, P90, DOI 10.1111/j.1439-0469.2010.00605.x; Raggio J, 2011, ASTROBIOLOGY, V11, P281, DOI 10.1089/ast.2010.0588; Sancho LG, 2007, ASTROBIOLOGY, V7, P443, DOI 10.1089/ast.2006.0046; STEPHENS LM, 1967, AEROSPACE MED, V38, P694; Tsuda T, 2011, CHEMBIOCHEM, V12, P2547, DOI 10.1002/cbic.201100476; Vidovic B, 2010, EXP APPL ACAROL, V52, P169, DOI 10.1007/s10493-010-9354-z; Wergin WP, 2000, SCANNING, V22, P145; Xu J, 2010, VET PARASITOL, V169, P399, DOI 10.1016/j.vetpar.2010.01.016; Yamaguti N, 1971, BRIGH YOUNG U SCI, P57; Zahler M, 1997, EXP APPL ACAROL, V21, P685, DOI 10.1023/A:1018412803414	25	9	9	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e32676	10.1371/journal.pone.0032676	http://dx.doi.org/10.1371/journal.pone.0032676			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22431980	Green Published, gold, Green Submitted			2022-12-25	WOS:000303198600023
J	Nakamura, K; Watanabe, H; Miyazaki, J; Takai, K; Kawagucci, S; Noguchi, T; Nemoto, S; Watsuji, T; Matsuzaki, T; Shibuya, T; Okamura, K; Mochizuki, M; Orihashi, Y; Ura, T; Asada, A; Marie, D; Koonjul, M; Singh, M; Beedessee, G; Bhikajee, M; Tamaki, K				Nakamura, Kentaro; Watanabe, Hiromi; Miyazaki, Junichi; Takai, Ken; Kawagucci, Shinsuke; Noguchi, Takuro; Nemoto, Suguru; Watsuji, Tomo-o; Matsuzaki, Takuya; Shibuya, Takazo; Okamura, Kei; Mochizuki, Masashi; Orihashi, Yuji; Ura, Tamaki; Asada, Akira; Marie, Daniel; Koonjul, Meera; Singh, Manvendra; Beedessee, Girish; Bhikajee, Mitrasen; Tamaki, Kensaku			Discovery of New Hydrothermal Activity and Chemosynthetic Fauna on the Central Indian Ridge at 186 degrees-206 degrees S	PLOS ONE			English	Article							VENT GASTROPOD; FLUIDS; DIVERSITY; FIELDS; KAIREI; BASIN	Indian Ocean hydrothermal vents are believed to represent a novel biogeographic province, and are host to many novel genera and families of animals, potentially indigenous to Indian Ocean hydrothermal systems. In particular, since its discovery in 2001, much attention has been paid to a so-called 'scaly-foot' gastropod because of its unique iron-sulfide-coated dermal sclerites and the chemosynthetic symbioses in its various tissues. Despite increasing interest in the faunal assemblages at Indian Ocean hydrothermal vents, only two hydrothermal vent fields have been investigated in the Indian Ocean. Here we report two newly discovered hydrothermal vent fields, the Dodo and Solitaire fields, which are located in the Central Indian Ridge (CIR) segments 16 and 15, respectively. Chemosynthetic faunal communities at the Dodo field are emaciated in size and composition. In contrast, at the Solitaire field, we observed faunal communities that potentially contained almost all genera found at CIR hydrothermal environments to date, and even identified previously unreported taxa. Moreover, a new morphotype of 'scaly-foot' gastropod has been found at the Solitaire field. The newly discovered 'scaly-foot' gastropod has similar morphological and anatomical features to the previously reported type that inhabits the Kairei field, and both types of 'scaly-foot' gastropods genetically belong to the same species according to analyses of their COI gene and nuclear SSU rRNA gene sequences. However, the new morphotype completely lacks an iron-sulfide coating on the sclerites, which had been believed to be a novel feature restricted to 'scaly-foot' gastropods. Our new findings at the two newly discovered hydrothermal vent sites provide important insights into the biodiversity and biogeography of ventendemic ecosystems in the Indian Ocean.	[Nakamura, Kentaro; Miyazaki, Junichi; Takai, Ken; Kawagucci, Shinsuke; Shibuya, Takazo] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Precambrian Ecosyst Lab PEL, Yokosuka, Kanagawa, Japan; [Watanabe, Hiromi] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Marine Biodivers Res Program, Yokosuka, Kanagawa, Japan; [Miyazaki, Junichi; Takai, Ken; Watsuji, Tomo-o] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Subsurface Geobiol Adv Res SUGAR Project, Yokosuka, Kanagawa, Japan; [Noguchi, Takuro; Matsuzaki, Takuya; Okamura, Kei] Kochi Univ, Ctr Adv Marine Core Res, Nanko Ku, Kochi 780, Japan; [Nemoto, Suguru] Enoshima Aquarium, Fujisawa, Kanagawa, Japan; [Mochizuki, Masashi; Ura, Tamaki; Asada, Akira] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo, Japan; [Orihashi, Yuji] Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, Tokyo 113, Japan; [Marie, Daniel; Singh, Manvendra; Beedessee, Girish; Bhikajee, Mitrasen] Mauritius Oceanog Inst, Quatre Bornes, Mauritius; [Koonjul, Meera] Albion Fisheries Res Ctr, Petite Riviere, Mauritius; [Tamaki, Kensaku] Univ Tokyo, Frontier Res Ctr Energy & Resources FRCER, Bunkyo Ku, Tokyo, Japan	Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Kochi University; University of Tokyo; University of Tokyo; University of Tokyo	Nakamura, K (corresponding author), Japan Agcy Marine Earth Sci & Technol JAMSTEC, Precambrian Ecosyst Lab PEL, Yokosuka, Kanagawa, Japan.	kentaron@jamstec.go.jp	Beedessee, Girish/AAC-1703-2021; Orihashi, Yuji/A-3352-2013; OKAMURA, Kei/C-7817-2011; Kawagucci, Shinsuke/H-4192-2013; kawagucci, shinsuke/H-6047-2013; Kawagucci, Shinsuke/O-7813-2019; Beedessee, Girish/B-7248-2015	Beedessee, Girish/0000-0003-4397-7471; OKAMURA, Kei/0000-0002-7796-4284; kawagucci, shinsuke/0000-0002-7807-024X; Beedessee, Girish/0000-0003-4397-7471; Shibuya, Takazo/0000-0002-1289-1328; Bhikajee, Mitrasen/0000-0002-5811-1171; Miyazaki, Junichi/0000-0001-5394-5129; Watanabe, Hiromi/0000-0001-5031-9018; Orihashi, Yuji/0000-0001-7715-3847; Nakamura, Kentaro/0000-0001-9115-589X	MEXT, Japan [20109001, 20109005, 21244077, 20246129]	MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grand-in-Aid for Science Research (No. 20109001 to KN, Nos. 20109005 and 21244077 to K. Takai and SK, No. 20246129 to K. Tamaki) from MEXT, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachraty C, 2009, DEEP-SEA RES PT I, V56, P1371, DOI 10.1016/j.dsr.2009.01.009; Chiodini G, 2001, GEOCHIM COSMOCHIM AC, V65, P2129, DOI 10.1016/S0016-7037(01)00583-X; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Copley JTP, 2007, J MAR BIOL ASSOC UK, V87, P1141, DOI 10.1017/S0025315407055956; Fabri MC, 2011, J MAR BIOL ASSOC UK, V91, P1, DOI 10.1017/S0025315410000731; Ferrini VL, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2008GC002047; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gallant RM, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001067; Gamo T, 2001, EARTH PLANET SC LETT, V193, P371, DOI 10.1016/S0012-821X(01)00511-8; German CR, 2008, EARTH PLANET SC LETT, V273, P332, DOI 10.1016/j.epsl.2008.06.048; German C.R., 2004, TREATISE GEOCHEMISTR, V6, p181?222; Goffredi SK, 2004, APPL ENVIRON MICROB, V70, P3082, DOI 10.1128/AEM.70.5.3082-3090.2004; Hashimoto J, 2001, ZOOL SCI, V18, P717, DOI 10.2108/zsj.18.717; Henry MS, 2008, DEEP-SEA RES PT I, V55, P679, DOI 10.1016/j.dsr.2008.02.001; Kawagucci S, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2008GC002082; Kojima S, 2001, BIOL BULL-US, V200, P298, DOI 10.2307/1543511; Kumagai H, 2008, GEOFLUIDS, V8, P239, DOI 10.1111/j.1468-8123.2008.00223.x; Lilley MD, 2003, NATURE, V422, P878, DOI 10.1038/nature01569; McCollom TM, 2008, AGU MONOGRAPH, P193; Murton BJ, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000798; Palumbi S. R., 1996, MOL SYSTEMATICS, V2, P205, DOI DOI 10.1080/17451000.2014.902536; Saegusa S, 2006, GEOFLUIDS, V6, P234, DOI 10.1111/j.1468-8123.2006.00143.x; SEEWALD JS, 1994, GEOCHIM COSMOCHIM AC, V58, P5065, DOI 10.1016/0016-7037(94)90232-1; Suzuki Y, 2006, EARTH PLANET SC LETT, V242, P39, DOI 10.1016/j.epsl.2005.11.029; Tao CH, 2012, GEOLOGY, V40, P47, DOI 10.1130/G32389.1; Tivey MK, 2007, OCEANOGRAPHY, V20, P50, DOI 10.5670/oceanog.2007.80; Van Dover CL, 2001, SCIENCE, V294, P818, DOI 10.1126/science.1064574; Vrijenhoek RC, 2010, MOL ECOL, V19, P4391, DOI 10.1111/j.1365-294X.2010.04789.x; Waren A, 2003, SCIENCE, V302, P1007, DOI 10.1126/science.1087696; Waren A., 2006, HDB DEEP SEA HYDROTH; Watanabe H, 2005, MAR ECOL PROG SER, V288, P233, DOI 10.3354/meps288233; Yao HM, 2010, P NATL ACAD SCI USA, V107, P987, DOI 10.1073/pnas.0912988107	32	67	69	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e32965	10.1371/journal.pone.0032965	http://dx.doi.org/10.1371/journal.pone.0032965			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22431990	Green Published, gold, Green Submitted			2022-12-25	WOS:000303198600033
J	Relton, CL; Groom, A; St Pourcain, B; Sayers, AE; Swan, DC; Embleton, ND; Pearce, MS; Ring, SM; Northstone, K; Tobias, JH; Trakalo, J; Ness, AR; Shaheen, SO; Smith, GD				Relton, Caroline L.; Groom, Alexandra; St Pourcain, Beate; Sayers, Adrian E.; Swan, Daniel C.; Embleton, Nicholas D.; Pearce, Mark S.; Ring, Susan M.; Northstone, Kate; Tobias, Jon H.; Trakalo, Joseph; Ness, Andy R.; Shaheen, Seif O.; Smith, George Davey			DNA Methylation Patterns in Cord Blood DNA and Body Size in Childhood	PLOS ONE			English	Article							EPIGENETIC MODIFICATIONS; INSULIN-RESISTANCE; PRENATAL EXPOSURE; MATERNAL DIET; GENE PROMOTER; TISSUE; PREGNANCY; RECEPTOR; OBESITY; BIRTH	Background: Epigenetic markings acquired in early life may have phenotypic consequences later in development through their role in transcriptional regulation with relevance to the developmental origins of diseases including obesity. The goal of this study was to investigate whether DNA methylation levels at birth are associated with body size later in childhood. Principal Findings: A study design involving two birth cohorts was used to conduct transcription profiling followed by DNA methylation analysis in peripheral blood. Gene expression analysis was undertaken in 24 individuals whose biological samples and clinical data were collected at a mean 6 standard deviation (SD) age of 12.35 (0.95) years, the upper and lower tertiles of body mass index (BMI) were compared with a mean (SD) BMI difference of 9.86 (2.37) kg/m(2). This generated a panel of differentially expressed genes for DNA methylation analysis which was then undertaken in cord blood DNA in 178 individuals with body composition data prospectively collected at a mean (SD) age of 9.83 (0.23) years. Twenty-nine differentially expressed genes (>1.2-fold and p<10(-4)) were analysed to determine DNA methylation levels at 1-3 sites per gene. Five genes were unmethylated and DNA methylation in the remaining 24 genes was analysed using linear regression with bootstrapping. Methylation in 9 of the 24 (37.5%) genes studied was associated with at least one index of body composition (BMI, fat mass, lean mass, height) at age 9 years, although only one of these associations remained after correction for multiple testing (ALPL with height, p(Corrected) = 0.017). Conclusions: DNA methylation patterns in cord blood show some association with altered gene expression, body size and composition in childhood. The observed relationship is correlative and despite suggestion of a mechanistic epigenetic link between in utero life and later phenotype, further investigation is required to establish causality.	[Relton, Caroline L.; Groom, Alexandra] Newcastle Univ, HNRC, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [St Pourcain, Beate; Northstone, Kate; Smith, George Davey] Univ Bristol, MRC Ctr Causal Anal Translat Epidemiol, Bristol, Avon, England; [Sayers, Adrian E.; Tobias, Jon H.] Univ Bristol, Musculoskeletal Res Unit, Sch Clin Sci, Bristol, Avon, England; [Swan, Daniel C.] Newcastle Univ, Bioinformat Support Unit, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Embleton, Nicholas D.] Royal Victoria Infirm, Newcastle Neonatal Serv, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Embleton, Nicholas D.; Pearce, Mark S.] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Ring, Susan M.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Trakalo, Joseph] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Ness, Andy R.] Univ Bristol, Sch Dent Sci, Bristol, Avon, England; [Shaheen, Seif O.] Queen Mary Univ London, Barts & London Sch Med & Dent, London, England	Newcastle University - UK; University of Bristol; University of Bristol; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; University of Bristol; University of Oxford; Wellcome Centre for Human Genetics; University of Bristol; University of London; Queen Mary University London	Relton, CL (corresponding author), Newcastle Univ, HNRC, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	alix.groom@ncl.ac.uk	Ness, Andy R/M-7612-2013; Relton, Caroline/AAC-5904-2019; Davey Smith, George/A-7407-2013; Northstone, Kate/A-8165-2011; Embleton, Nicholas/D-4905-2011; Tobias, Jon/E-2832-2014; Sayers, Adrian/AAU-8134-2020; St Pourcain, Beate/K-8004-2017	Ness, Andy R/0000-0003-3548-9523; Davey Smith, George/0000-0002-1407-8314; Northstone, Kate/0000-0002-0602-1983; Embleton, Nicholas/0000-0003-3750-5566; Tobias, Jon/0000-0002-7475-3932; Sayers, Adrian/0000-0001-7452-5043; St Pourcain, Beate/0000-0002-4680-3517; s, hema/0000-0002-3440-9475; Pearce, Mark/0000-0002-0583-3779; Swan, Daniel/0000-0001-8978-8129; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Relton, Caroline/0000-0003-2052-4840	Biotechnology and Biological Sciences Research Council [BB/F007981/1]; Nutricia UK; Novo Nordisk; Newcastle Hospitals; UK Medical Research Council [74882]; Wellcome Trust [076467]; University of Bristol; Asthma UK; BBSRC [BB/I025263/1, BB/I025751/1, BB/F007981/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I025263/1, BB/I025751/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Nutricia UK(Danone Nutricia); Novo Nordisk(Novo Nordisk); Newcastle Hospitals; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); University of Bristol; Asthma UK; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The study was supported by the Biotechnology and Biological Sciences Research Council, http://www.bbsrc.ac.uk/, (BB/F007981/1). The Preterm Birth Growth Study was originally funded by Nutricia UK; support for the follow up studies was provided by Novo Nordisk and Special Trustees of Newcastle Hospitals. The UK Medical Research Council, http://www.mrc.ac.uk, (Grant ref: 74882) the Wellcome Trust, http://www.wellcome.ac.uk, (Grant ref: 076467) and the University of Bristol provide core support for the Avon Longitudinal Study of Parents and Children. This DNA methylation analysis aspect of this study was specifically funded by Asthma UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccarelli A, 2010, CIRC-CARDIOVASC GENE, V3, P567, DOI 10.1161/CIRCGENETICS.110.958744; Baccarelli A, 2010, EPIDEMIOLOGY, V21, P819, DOI 10.1097/EDE.0b013e3181f20457; Barker DJP, 2002, TRENDS ENDOCRIN MET, V13, P364, DOI 10.1016/S1043-2760(02)00689-6; Barnes SK, 2011, PROG BIOPHYS MOL BIO, V106, P323, DOI 10.1016/j.pbiomolbio.2010.12.005; Bjornsson HT, 2008, JAMA-J AM MED ASSOC, V299, P2877, DOI 10.1001/jama.299.24.2877; Bouret SG, 2006, CLIN GENET, V70, P295, DOI 10.1111/j.1399-0004.2006.00684.x; Burdge GC, 2010, ANNU REV NUTR, V30, P315, DOI 10.1146/annurev.nutr.012809.104751; Cheung CL, 2009, J BONE MINER RES; Cooke RJ, 1998, PEDIATR RES, V43, P355, DOI 10.1203/00006450-199803000-00008; Derosa G, 2008, ENDOTHELIUM-J ENDOTH, V15, P219, DOI 10.1080/10623320802228815; Feinberg AP, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001262; Fryer AA, 2011, EPIGENETICS-US, V6, P86, DOI 10.4161/epi.6.1.13392; Gemma C, 2010, MOL GENET METAB, V100, P83, DOI 10.1016/j.ymgme.2010.02.004; Glowinska-Olszewska B, 2007, METABOLISM, V56, P799, DOI 10.1016/j.metabol.2007.01.011; Godfrey KM, 2011, DIABETES, V60, P1528, DOI 10.2337/db10-0979; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; Gomez-Ambrosi J, 2004, FASEB J, V18, P215, DOI 10.1096/fj.03-0591fje; Goseki-Sone M, 2005, J BONE MINER RES, V20, P773, DOI 10.1359/JBMR.041229; Groom A, 2011, DIABETES IN PRESS; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Kile ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013730; Knight JC, 2004, TRENDS GENET, V20, P113, DOI 10.1016/j.tig.2004.01.001; Kulkarni RN, 2007, CELL, V129, P241, DOI 10.1016/j.cell.2007.04.006; Langley-Evans SC, 2010, MED PRIN PRACT, V19, P87, DOI 10.1159/000273066; Lettre G, 2011, HUM GENET, V129, P465, DOI 10.1007/s00439-011-0969-x; Lewis SJ, 2009, BRIT J NUTR, V102, P493, DOI 10.1017/S0007114509231746; Lim AL, 2010, SEMIN CELL DEV BIOL, V21, P201, DOI 10.1016/j.semcdb.2009.10.008; Long JS, 2000, AM STAT, V54, P217, DOI 10.2307/2685594; Lui JC, 2008, AM J PHYSIOL-REG I, V295, pR189, DOI 10.1152/ajpregu.00182.2008; Mariman ECM, 2010, CELL MOL LIFE SCI, V67, P1277, DOI 10.1007/s00018-010-0263-4; Mathers JC, 2009, ADV EXP MED BIOL, V646, P119, DOI 10.1007/978-1-4020-9173-5_13; McGowan PO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014739; Meaburn EL, 2010, EPIGENETICS-US, V5, P578, DOI 10.4161/epi.5.7.12960; Meaney Michael J, 2005, Dialogues Clin Neurosci, V7, P103; Nicholls RD, 2000, J CLIN INVEST, V105, P413, DOI 10.1172/JCI9460; Oben JA, 2010, J HEPATOL, V52, P913, DOI 10.1016/j.jhep.2009.12.042; Oberlander TF, 2008, EPIGENETICS-US, V3, P97, DOI 10.4161/epi.3.2.6034; Ollikainen M, 2010, HUM MOL GENET, V19, P4176, DOI 10.1093/hmg/ddq336; Penman Alan D, 2006, Prev Chronic Dis, V3, pA74; Perera F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004488; Pietilainen KH, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050051; Plagemann A, 2010, J PERINAT MED, V38, P393, DOI [10.1515/JPM.2010.051, 10.1515/jpm.2010.051]; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Qiu J, 2007, BIOCHEM BIOPH RES CO, V352, P469, DOI 10.1016/j.bbrc.2006.11.049; Relton CL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000356; Relton CL, 2011, INT J EPIDE IN PRESS; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Sandovici I, 2011, P NATL ACAD SCI USA, V108, P5449, DOI 10.1073/pnas.1019007108; Smith GD, 2008, BASIC CLIN PHARMACOL, V102, P245, DOI 10.1111/j.1742-7843.2007.00191.x; Steer CD, 2009, J BONE MINER RES, V24, P117, DOI [10.1359/jbmr.080814, 10.1359/JBMR.080814]; Talens RP, 2010, FASEB J, V24, P3135, DOI 10.1096/fj.09-150490; Terry MB, 2008, CANCER EPIDEM BIOMAR, V17, P2306, DOI 10.1158/1055-9965.EPI-08-0312; Thornburg KL, 2010, ADV GENET, V71, P57, DOI [10.1016/B978-0-12-380864-6.00003-1, 10.1016/S0065-2660(10)71003-8]; Tobi EW, 2011, EPIGENETICS-US, V6, P171, DOI 10.4161/epi.6.2.13516; Tobi EW, 2009, HUM MOL GENET, V18, P4046, DOI 10.1093/hmg/ddp353; Tobias JH, 2005, OSTEOPOROSIS INT, V16, P1731, DOI 10.1007/s00198-005-1912-6; Toledo-Rodriguez M, 2010, AM J MED GENET B, V153B, P1350, DOI 10.1002/ajmg.b.31109; Turunen MP, 2009, BBA-GEN SUBJECTS, V1790, P886, DOI 10.1016/j.bbagen.2009.02.008; Tycko B, 2010, HUM MOL GENET, V19, pR210, DOI 10.1093/hmg/ddq376; Vucetic Z, 2011, NEUROPSYCHOPHARMACOL, V36, P1199, DOI 10.1038/npp.2011.4; Wang XL, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-87; Warner MJ, 2010, BIOCHEM J, V427, P333, DOI 10.1042/BJ20091861; Waterland RA, 2009, HORM RES, V71, P13, DOI 10.1159/000178030; WAYMIRE KG, 1995, NAT GENET, V11, P45, DOI 10.1038/ng0995-45; Wu HC, 2011, EPIGENETICS-US, V6, P76, DOI 10.4161/epi.6.1.13391; Zhu ZZ, 2012, INT J EPIDEMIOL, V41, P126, DOI 10.1093/ije/dyq154	66	104	106	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e31821	10.1371/journal.pone.0031821	http://dx.doi.org/10.1371/journal.pone.0031821			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22431966	Green Published, gold			2022-12-25	WOS:000303198600009
J	Kuo, SM; Burl, LR; Hu, ZH				Kuo, Shiu-Ming; Burl, Lana R.; Hu, Zihua			Cellular Phenotype-Dependent and -Independent Effects of Vitamin C on the Renewal and Gene Expression of Mouse Embryonic Fibroblasts	PLOS ONE			English	Article							L-ASCORBIC-ACID; REPLICATIVE SENESCENCE; TRANSPORTER ISOFORMS; OXIDATIVE STRESS; WERNER-SYNDROME; LEUKEMIA-CELLS; TUMOR-GROWTH; IN-VITRO; CANCER; SKIN	Vitamin C has been shown to delay the cellular senescence and was considered a candidate for chemoprevention and cancer therapy. To understand the reported contrasting roles of vitamin C: growth-promoting in the primary cells and growth-inhibiting in cancer cells, primary mouse embryonic fibroblasts (MEF) and their isogenic spontaneously immortalized fibroblasts with unlimited cell division potential were used as the model pair. We used microarray gene expression profiling to show that the immortalized MEF possess human cancer gene expression fingerprints including a pattern of up-regulation of inflammatory response-related genes. Using the MEF model, we found that a physiological treatment level of vitamin C (10(-5) M), but not other unrelated antioxidants, enhanced cell growth. The growth-promoting effect was associated with a pattern of enhanced expression of cell cycle-and cell division-related genes in both primary and immortalized cells. In the immortalized MEF, physiological treatment levels of vitamin C also enhanced the expression of immortalization-associated genes including a down-regulation of genes in the extracellular matrix functional category. In contrast, confocal immunofluorescence imaging of the primary MEF suggested an increase in collagen IV protein upon vitamin C treatment. Similar to the cancer cells, the growth-inhibitory effect of the redox-active form of vitamin C was preferentially observed in immortalized MEF. All effects of vitamin C required its intracellular presence since the transporter-deficient SVCT2-/- MEF did not respond to vitamin C. SVCT2-/- MEF divided and became immortalized readily indicating little dependence on vitamin C for the cell division. Immortalized SVCT2-/- MEF required higher concentration of vitamin C for the growth inhibition compared to the immortalized wildtype MEF suggesting an intracellular vitamin C toxicity. The relevance of our observation in aging and human cancer prevention was discussed.	[Kuo, Shiu-Ming; Burl, Lana R.] SUNY Buffalo, Dept Exercise & Nutr Sci, Buffalo, NY 14260 USA; [Kuo, Shiu-Ming] SUNY Buffalo, Dept Biochem, Buffalo, NY 14214 USA; [Hu, Zihua] SUNY Buffalo, Ctr Computat Res, Buffalo, NY 14260 USA; [Hu, Zihua] SUNY Buffalo, Dept Biostat, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Kuo, SM (corresponding author), SUNY Buffalo, Dept Exercise & Nutr Sci, Buffalo, NY 14260 USA.	smkuo@buffalo.edu			University at Buffalo	University at Buffalo	The work described was supported by University at Buffalo Mark Diamond Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2009, CLIN CANCER RES, V15, P425, DOI 10.1158/1078-0432.CCR-08-0149; Aoi J, 2011, CANCER RES, V71, P7502, DOI 10.1158/0008-5472.CAN-11-1758; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Balkwill F, 2010, CLIN PHARMACOL THER, V87, P401, DOI 10.1038/clpt.2009.312; Belin S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004409; Ben-David U, 2011, NAT REV CANCER, V11, P268, DOI 10.1038/nrc3034; Benvenuti S, 2002, MOL CELL PROTEOMICS, V1, P280, DOI 10.1074/mcp.M100028-MCP200; Borovski T, 2011, CANCER RES, V71, P634, DOI 10.1158/0008-5472.CAN-10-3220; Box C, 2010, SEMIN CANCER BIOL, V20, P128, DOI 10.1016/j.semcancer.2010.06.004; Cabanillas F, 2010, P R HEALTH SCI J, V29, P215; Chen Q, 2008, P NATL ACAD SCI USA, V105, P11105, DOI 10.1073/pnas.0804226105; Clement MV, 2001, ANTIOXID REDOX SIGN, V3, P157, DOI 10.1089/152308601750100687; COLLINS M, 1958, J NUTR, V64, P503, DOI 10.1093/jn/64.4.503; CURATOLO L, 1984, IN VITRO CELL DEV B, V20, P597; Davis T, 2007, ANN NY ACAD SCI, V1100, P455, DOI 10.1196/annals.1395.051; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Downie D, 2005, CLIN CANCER RES, V11, P7369, DOI 10.1158/1078-0432.CCR-05-0466; Duarte TL, 2009, FREE RADICAL BIO MED, V46, P78, DOI 10.1016/j.freeradbiomed.2008.09.028; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Gonzalez-Reyes S, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-665; Gross C, 2003, BIOL CHEM, V384, P267, DOI 10.1515/BC.2003.030; Harakeh S, 2007, ANTICANCER RES, V27, P289; Harvey S, 2005, ADV DEV BIOL, V15, P1; HATA RI, 1989, J CELL PHYSIOL, V138, P8, DOI 10.1002/jcp.1041380103; Hillier SM, 2009, CANCER RES, V69, P6932, DOI 10.1158/0008-5472.CAN-09-1682; Hosokawa M, 2008, CANCER SCI, V99, P1626, DOI 10.1111/j.1349-7006.2008.00869.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Intra J, 2007, CHEM-BIOL INTERACT, V169, P91, DOI 10.1016/j.cbi.2007.05.007; JENNESS R, 1984, COMP BIOCHEM PHYS B, V78, P167, DOI 10.1016/0305-0491(84)90162-7; Karlou M, 2010, NAT REV UROL, V7, P494, DOI 10.1038/nrurol.2010.134; Kashino G, 2003, FREE RADICAL BIO MED, V35, P438, DOI 10.1016/S0891-5849(03)00326-5; Katoh Y, 2006, INT J MOL MED, V17, P951; KEYOMARSI K, 1991, CANCER RES, V51, P3602; KUHL U, 1984, DIFFERENTIATION, V28, P164, DOI 10.1111/j.1432-0436.1984.tb00279.x; Kuo SM, 1996, CANCER LETT, V110, P41, DOI 10.1016/S0304-3835(96)04458-8; Kuo SM, 2004, J NUTR, V134, P2216; Kuo SM, 1997, CANCER LETT, V116, P131, DOI 10.1016/S0304-3835(97)00183-3; LASSERRE C, 1992, CANCER RES, V52, P5089; Lee SH, 2001, NAT GENET, V28, P42, DOI 10.1038/ng0501-42; Lin SY, 2006, MELANOMA RES, V16, P509, DOI 10.1097/01.cmr.0000232297.99160.9e; Maeda N, 2000, P NATL ACAD SCI USA, V97, P841, DOI 10.1073/pnas.97.2.841; Massip L, 2010, FASEB J, V24, P158, DOI 10.1096/fj.09-137133; McGuire BB, 2009, CURR OPIN UROL, V19, P441, DOI 10.1097/MOU.0b013e32832f0c68; Nakamura Y, 2009, NEOPLASMA, V56, P317, DOI 10.4149/neo_2009_04_317; Naugler WE, 2008, CURR OPIN GENET DEV, V18, P19, DOI 10.1016/j.gde.2008.01.020; Nowak G, 1996, AM J PHYSIOL-CELL PH, V271, pC2072, DOI 10.1152/ajpcell.1996.271.6.C2072; Ostrakhovitch EA, 2010, BREAST CANCER RES TR, V119, P773, DOI 10.1007/s10549-009-0372-7; Park S, 2006, J CELL BIOCHEM, V99, P1628, DOI 10.1002/jcb.20971; Pasonen-Seppanen S, 2001, HISTOCHEM CELL BIOL, V116, P287, DOI 10.1007/s004180100312; PETERSON GL, 1983, METHOD ENZYMOL, V91, P95; Pulukuri SM, 2009, ONCOGENE, V28, P2829, DOI 10.1038/onc.2009.134; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Schulz A, 2011, HAEMATOL-HEMATOL J, V96, P408, DOI 10.3324/haematol.2010.031377; Shay J, 2001, MOL GENETICS CANC, P483; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Shima A, 2011, EXP CELL RES, V317, P356, DOI 10.1016/j.yexcr.2010.11.001; Shin HJ, 2011, J CELL SCI, V124, P1077, DOI 10.1242/jcs.072207; Smith SK, 2004, CYTOGENET GENOME RES, V105, P455, DOI 10.1159/000078219; Solinas G, 2010, CANCER METAST REV, V29, P243, DOI 10.1007/s10555-010-9227-2; Sotiriou S, 2002, NAT MED, V8, P514, DOI 10.1038/nm0502-514; Steiling H, 2007, FREE RADICAL BIO MED, V43, P752, DOI 10.1016/j.freeradbiomed.2007.05.001; Sugimoto M, 2006, FREE RADICAL RES, V40, P213, DOI 10.1080/10715760500417005; Sugiura T, 2011, CELL BIOL INT, V35, P657, DOI 10.1042/CBI20100772; Telang S, 2007, NEOPLASIA, V9, P47, DOI 10.1593/neo.06664; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; van Beijnum Judy R, 2009, Front Biosci (Schol Ed), V1, P216; Verrax J, 2006, BIOCHEM PHARMACOL, V72, P671, DOI 10.1016/j.bcp.2006.05.025; Wasmuth HE, 2010, SEMIN LIVER DIS, V30, P215, DOI 10.1055/s-0030-1255351; Wasylyk C, 2002, MOL CELL BIOL, V22, P2687, DOI 10.1128/MCB.22.8.2687-2702.2002; Werle B, 2006, ONCOL REP, V16, P647; Winum JY, 2009, ANTI-CANCER AGENT ME, V9, P693, DOI 10.2174/187152009788680028	71	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2012	7	3							e32957	10.1371/journal.pone.0032957	http://dx.doi.org/10.1371/journal.pone.0032957			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930IA	22427916	Green Submitted, Green Published, gold			2022-12-25	WOS:000303129700022
J	Miller, NG; Wassenaar, LI; Hobson, KA; Norris, DR				Miller, Nathan G.; Wassenaar, Leonard I.; Hobson, Keith A.; Norris, D. Ryan			Migratory Connectivity of the Monarch Butterfly (Danaus plexippus): Patterns of Spring Re-Colonization in Eastern North America	PLOS ONE			English	Article							NATAL ORIGINS; HYDROGEN	Each year, millions of monarch butterflies (Danaus plexippus) migrate up to 3000 km from their overwintering grounds in central Mexico to breed in eastern North America. Malcolm et al. (1993) articulated two non-mutually exclusive hypotheses to explain how Monarchs re-colonize North America each spring. The 'successive brood' hypothesis proposes that monarchs migrate from Mexico to the Gulf Coast, lay eggs and die, leaving northern re-colonization of the breeding range to subsequent generations. The 'single sweep' hypothesis proposes that overwintering monarchs continue to migrate northward after arriving on the Gulf coast and may reach the northern portion of the breeding range, laying eggs along the way. To examine these hypotheses, we sampled monarchs throughout the northern breeding range and combined stable-hydrogen isotopes (delta D) to estimate natal origin with wing wear scores to differentiate between individuals born in the current vs. previous year. Similar to Malcolm et al. (1993), we found that the majority of the northern breeding range was re-colonized by the first generation of monarchs (90%). We also estimated that a small number of individuals (10%) originated directly from Mexico and, therefore adopted a sweep strategy. Contrary to Malcolm et al. (1993), we found that 62% of monarchs sampled in the Great Lakes originated from the Central U. S., suggesting that this region is important for sustaining production in the northern breeding areas. Our results provide new evidence of re-colonization patterns in monarchs and contribute important information towards identifying productive breeding regions of this unique migratory insect.	[Miller, Nathan G.; Norris, D. Ryan] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [Wassenaar, Leonard I.; Hobson, Keith A.] Environm Canada, Saskatoon, SK, Canada	University of Guelph; Environment & Climate Change Canada	Miller, NG (corresponding author), Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada.	rnorris@uoguelph.ca	Hobson, Keith/Q-9306-2019; Wassenaar, Leonard/AAY-7081-2020	Wassenaar, Leonard/0000-0001-5532-0771	Global Forest Science; Explorer's Club; American Wildlife Conservation Foundation; Ontario Graduate Scholarship in Science and Technology; Natural Sciences and Engineering Research Council of Canada; Environment Canada; Ontario Government	Global Forest Science; Explorer's Club; American Wildlife Conservation Foundation; Ontario Graduate Scholarship in Science and Technology; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Environment Canada(CGIAR); Ontario Government	This research was supported by grants from Global Forest Science (NGM, DRN): http://www.globalforestscience.org; The Explorer's Club (NGM): http://www.explorers.org; The American Wildlife Conservation Foundation (NGM): http://www.awcf1911.org/; Ontario Graduate Scholarship in Science and Technology (NGM): https://osap.gov.on.ca/OSAPPortal/en/OSAPStarttoFinish/GraduateStudents/index.htm; the Natural Sciences and Engineering Research Council of Canada (DRN): http://www.nserc-crsng.gc.ca/Index_eng.asp, Environment Canada (LIW, KAH), and an Early Researcher Award from the Ontario Government (DRN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altizer SM, 2004, MONARCH BUTTERFLY BIOLOGY AND CONSERVATION, P203; [Anonymous], 2020, ECONOMIST 0326; Bowen GJ, 2003, WATER RESOUR RES, V39, DOI 10.1029/2003WR002086; Brower Lincoln P., 1995, Journal of the Lepidopterists' Society, V49, P304; Davis AK, 2002, SOUTHEAST NAT, V1, P55, DOI 10.1656/1528-7092(2002)001[0055:AEOTMO]2.0.CO;2; Edwards WH, 1878, PSYCHE, V2, P169; Environment Canada, 2009, HIST WEATH DAT; Hobson KA, 1999, OECOLOGIA, V120, P397, DOI 10.1007/s004420050872; Hobson KA, 1997, OECOLOGIA, V109, P142, DOI 10.1007/s004420050068; Holland RA, 2006, SCIENCE, V313, P794, DOI 10.1126/science.1127272; Isard S.A., 2001, AEROBIOLOGIA, V17, P275; Journey North, 2009, 1 SPRING MILKW; MALCOLM SB, 1993, NAT HIS LOS-SERIES, P253; Martin TG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000751; McLaughlin RE, 1970, CRAMER J PROTOZOOL, V17, P300; NOAA, 2009, HIST WEATH STAT DAT; Russell RW, 1998, AM MIDL NAT, V140, P325, DOI 10.1674/0003-0031(1998)140[0325:MSMODO]2.0.CO;2; Scudder SH, 1881, BUTTERFLIES THEIR ST; Taylor CM, 2010, THEOR ECOL-NETH, V3, P65, DOI 10.1007/s12080-009-0054-4; URQUHART F A, 1976, Journal of the Lepidopterists' Society, V30, P153; USDA, 2009, PLANTS PROF WEBS ASC; Wassenaar LI, 2003, ISOT ENVIRON HEALT S, V39, P211, DOI 10.1080/1025601031000096781; Wassenaar LI, 1998, P NATL ACAD SCI USA, V95, P15436, DOI 10.1073/pnas.95.26.15436; Wunder MB, 2008, ECOL APPL, V18, P549, DOI 10.1890/07-0058.1	24	42	45	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2012	7	3							e31891	10.1371/journal.pone.0031891	http://dx.doi.org/10.1371/journal.pone.0031891			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930IA	22427813	Green Published, Green Submitted, gold			2022-12-25	WOS:000303129700005
J	Hsieh, LL; Cheng, KY; Hsieh, BT				Hsieh, Ling-Ling; Cheng, Kai-Yuan; Hsieh, Bor-Tsung			A Novel Thin NIPAM Gel Cassette Dosimeter for Photon-Beam Radiotherapy	PLOS ONE			English	Article							DOSE DISTRIBUTIONS; RADIATION; IMRT; NMR	The response of thin polymer gel cassettes (called NIPAM gels) to ionizing radiation was investigated in this study. The NIPAM gels were prepared from gelatin, N-isopropyl acrylamide, tetrakis (hydroxymethyl) phosphoniumchloride, and N, N'methylene-bis-acrylamide. Gel cassettes were irradiated in a phantom using a linear accelerator, and the polymerization morphology of irradiated NIPAM gel was characterized using scanning electron microscopy. The dose-response sensitivity of the NIPAM gels was evaluated using the differences in optical densities. The optical densities were obtained using a computer-controlled CCD camera that was connected to a planar illumination source for acquisition of optical transmission images. The central axis depth dose profiles of the phantom were extracted, and a comparison with ionization chamber measurements demonstrated similarities in profiles. The sensitivity, linearity of the response, accuracy, and reproducibility of the polymer gel cassettes were acceptable. However, the profiles of the half-blocked field irradiation showed no significant dispersion in the visible region. This study also extensively investigated the spatial stability of the NIPAM gel. The results showed that the gel cassette response remains stable for up to three months after irradiation.	[Hsieh, Ling-Ling; Cheng, Kai-Yuan; Hsieh, Bor-Tsung] Cent Taiwan Univ Sci & Technol, Dept Med Imaging & Radiol Sci, Taichung, Taiwan	Central Taiwan University Science & Technology	Hsieh, LL (corresponding author), Cent Taiwan Univ Sci & Technol, Dept Med Imaging & Radiol Sci, Taichung, Taiwan.	llhsieh@ctust.edu.tw			National Science Council of Taiwan [NSC 99-2632-B-166-001-MY3]; Central Taiwan University of Science and Technology [CTU100-PC-18]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Central Taiwan University of Science and Technology	This research was funded by the National Science Council of Taiwan (NSC 99-2632-B-166-001-MY3) and the Central Taiwan University of Science and Technology (CTU100-PC-18). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldock C, 1998, PHYS MED BIOL, V43, P695, DOI 10.1088/0031-9155/43/3/019; Baldock C, 2010, PHYS MED BIOL, V55, pR1, DOI 10.1088/0031-9155/55/5/R01; Chang KY, 2011, NUCL INSTRUM METH A, V652, P775, DOI 10.1016/j.nima.2010.09.099; Chang YJ, 2011, NUCL INSTRUM METH A, V652, P783, DOI 10.1016/j.nima.2010.09.097; Crescenti RA, 2007, MED PHYS, V34, P1286, DOI 10.1118/1.2712042; De Deene Y., 2004, Journal of Physics: Conference Series, V3, P34, DOI 10.1088/1742-6596/3/1/006; De Deene YH, 2001, PHYS MED BIOL, V46, P2801, DOI 10.1088/0031-9155/46/11/304; Doran SJ, 2001, PHYS MED BIOL, V46, P3191, DOI 10.1088/0031-9155/46/12/309; Fenkell L, 2008, RADIOTHER ONCOL, V89, P287, DOI 10.1016/j.radonc.2008.08.008; Gambarini G, 2006, RADIAT PROT DOSIM, V120, P144, DOI 10.1093/rpd/nci625; Gambarini G, 1999, NUCL INSTRUM METH A, V422, P643, DOI 10.1016/S0168-9002(98)00975-9; Hayashi S, 2010, RADIAT PHYS CHEM, V79, P803, DOI 10.1016/j.radphyschem.2010.01.014; Hilts M, 2000, PHYS MED BIOL, V45, P2559, DOI 10.1088/0031-9155/45/9/309; Jirasek A., 2006, Journal of Physics: Conference Series, V56, P263, DOI 10.1088/1742-6596/56/1/045; Kelly RG, 1998, MED PHYS, V25, P1741, DOI 10.1118/1.598356; Lodwick C, 2011, HEALTH PHYS, V100, P444; Maryanski MJ, 2001, PROC SPIE, V4320, P764, DOI 10.1117/12.430867; MARYANSKI MJ, 1993, MAGN RESON IMAGING, V11, P253, DOI 10.1016/0730-725X(93)90030-H; Massillon-JL G, 2010, APPL RADIAT ISOTOPES, V68, P144, DOI 10.1016/j.apradiso.2009.08.016; Massillon-JL G, 2009, PHYS MED BIOL, V54, P1661, DOI 10.1088/0031-9155/54/6/017; Mather ML, 2002, PHYS MED BIOL, V47, P1449, DOI 10.1088/0031-9155/47/9/302; Oldham M, 2003, MED PHYS, V30, P623, DOI 10.1118/1.1559835; Otto K, 2008, MED PHYS, V35, P310, DOI 10.1118/1.2818738; Schreiner L.J., 2009, J PHYS C SER, V164, P012001, DOI [10.1088/1742-6596/164/1/012001, DOI 10.1088/1742-6596/164/1/012001]; Sedaghat Mahbod, 2010, Journal of Physics: Conference Series, V250, DOI 10.1088/1742-6596/250/1/012017; Senden RJ, 2006, PHYS MED BIOL, V51, P3301, DOI 10.1088/0031-9155/51/14/001	26	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e31836	10.1371/journal.pone.0031836	http://dx.doi.org/10.1371/journal.pone.0031836			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427810	Green Submitted, Green Published, gold			2022-12-25	WOS:000302381500004
J	Munaut, C; Lorquet, S; Pequeux, C; Coulon, C; Le Goarant, J; Chantraine, F; Noel, AS; Goffin, F; Tsatsaris, V; Subtil, D; Foidart, JM				Munaut, Carine; Lorquet, Sophie; Pequeux, Christel; Coulon, Capucine; Le Goarant, Jeanne; Chantraine, Frederic; Noel, Agne S.; Goffin, Frederic; Tsatsaris, Vassilis; Subtil, Damien; Foidart, Jean-Michel			Differential Expression of Vegfr-2 and Its Soluble Form in Preeclampsia	PLOS ONE			English	Article							VASCULAR ENDOTHELIAL GROWTH; FACTOR RECEPTOR-2; ANTIANGIOGENIC FACTORS; ENDOGLIN; KDR; ANGIOGENESIS; PATHOGENESIS; PREDICTION	Background: Several studies have suggested that the main features of preeclampsia (PE) are consequences of endothelial dysfunction related to excess circulating anti-angiogenic factors, most notably, soluble sVEGFR-1 (also known as sFlt-1) and soluble endoglin (sEng), as well as to decreased PlGF. Recently, soluble VEGF type 2 receptor (sVEGFR-2) has emerged as a crucial regulator of lymphangiogenesis. To date, however, there is a paucity of information on the changes of VEGFR-2 that occur during the clinical onset of PE. Therefore, the aim of our study was to characterize the plasma levels of VEGFR-2 in PE patients and to perform VEGFR-2 immunolocalization in placenta. Methodology/Principal findings: By ELISA, we observed that the VEGFR-2 plasma levels were reduced during PE compared with normal gestational age matched pregnancies, whereas the VEGFR-1 and Eng plasma levels were increased. The dramatic drop in the VEGFR-1 levels shortly after delivery confirmed its placental origin. In contrast, the plasma levels of Eng and VEGFR-2 decreased only moderately during the early postpartum period. An RT-PCR analysis showed that the relative levels of VEGFR-1, sVEGFR-1 and Eng mRNA were increased in the placentas of women with severe PE. The relative levels of VEGFR-2 mRNA as well as expressing cells, were similar in both groups. We also made the novel finding that a recently described alternatively spliced VEGFR-2 mRNA variant was present at lower relative levels in the preeclamptic placentas. Conclusions/Significance: Our results indicate that the plasma levels of anti-angiogenic factors, particularly VEGFR-1 and VEGFR-2, behave in different ways after delivery. The rapid decrease in plasma VEGFR-1 levels appears to be a consequence of the delivery of the placenta. The persistent circulating levels of VEGFR-2 suggest a maternal endothelial origin of this peptide. The decreased VEGFR-2 plasma levels in preeclamptic women may serve as a marker of endothelial dysfunction.	[Munaut, Carine; Lorquet, Sophie; Pequeux, Christel; Chantraine, Frederic; Noel, Agne S.; Foidart, Jean-Michel] Univ Liege, Lab Tumor & Dev Biol, CHU, GIGA Canc, Liege, Belgium; [Lorquet, Sophie; Chantraine, Frederic; Goffin, Frederic; Foidart, Jean-Michel] Hop Citadelle, Dept Obstet & Gynecol, Liege, Belgium; [Coulon, Capucine; Le Goarant, Jeanne; Subtil, Damien] CHRU, Lille, France; [Tsatsaris, Vassilis] Hop Cochin St Vincent de Paul, AP HP, Paris, France	University of Liege; Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Munaut, C (corresponding author), Univ Liege, Lab Tumor & Dev Biol, CHU, GIGA Canc, Liege, Belgium.	c.munaut@ulg.ac.be	Munaut, Carine/K-8138-2019	Pequeux, Christel/0000-0001-8275-1489; Noel, Agnes/0000-0002-7670-6179	European 7th Research Framework Programme [HEALTH-2007-2.4.1-6, LSHM-CT-2004-512040]; Fonds de la RechercheScientifique (F.R.S.-FNRS, Belgium); "RegionWallonne" (NEOANGIO); Interuniversity Attraction Poles Programme - Belgian Science Policy (Brussels, Belgium); "FondsSpeciaux de la Recherche'' (University of Liege); "Fonds Leon Fredericq'' (University of Liege)	European 7th Research Framework Programme; Fonds de la RechercheScientifique (F.R.S.-FNRS, Belgium)(Fonds de la Recherche Scientifique - FNRS); "RegionWallonne" (NEOANGIO); Interuniversity Attraction Poles Programme - Belgian Science Policy (Brussels, Belgium)(Belgian Federal Science Policy Office); "FondsSpeciaux de la Recherche'' (University of Liege)(University of Liege); "Fonds Leon Fredericq'' (University of Liege)(University of Liege)	The research effort associated with this article was supported by the European 7th Research Framework Programme: HEALTH-2007-2.4.1-6 "MICROENVIMET'', Framework Programme 6-NOE n<SUP>o</SUP> LSHM-CT-2004-512040 "EMBIC", the "Fonds de la RechercheScientifique (F.R.S.-FNRS, Belgium), the D.G.T.R.E. from the "RegionWallonne" (NEOANGIO), the Interuniversity Attraction Poles Programme - Belgian Science Policy (Brussels, Belgium), the "FondsSpeciaux de la Recherche'' (University of Liege) and the "Fonds Leon Fredericq'' (University of Liege). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agatisa PK, 2004, AM J PHYSIOL-HEART C, V286, pH1389, DOI 10.1152/ajpheart.00298.2003; Ahmad S, 2004, CIRC RES, V95, P884, DOI 10.1161/01.RES.0000147365.86159.f5; Albuquerque RJC, 2009, NAT MED, V15, P1023, DOI 10.1038/nm.2018; Caniggia I, 1999, J CLIN INVEST, V103, P1641, DOI 10.1172/JCI6380; Chaiworapongsa T, 2008, J MATERN-FETAL NEO M, V21, P41, DOI 10.1080/14767050701831397; Clark DE, 1996, HUM REPROD, V11, P1090; Ebos JML, 2004, MOL CANCER RES, V2, P315; Ebos JML, 2008, CANCER RES, V68, P521, DOI 10.1158/0008-5472.CAN-07-3217; George M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017838; Gille H, 2001, J BIOL CHEM, V276, P3222, DOI 10.1074/jbc.M002016200; Grundmann M, 2008, AM J OBSTET GYNECOL, V198, pe311; Gu Y, 2008, J CLIN ENDOCR METAB, V93, P260, DOI 10.1210/jc.2007-1550; Helske S, 2001, MOL HUM REPROD, V7, P205, DOI 10.1093/molehr/7.2.205; Hladunewich MA, 2008, AM J PHYSIOL-RENAL, V294, pF614, DOI 10.1152/ajprenal.00470.2007; Lam C, 2005, HYPERTENSION, V46, P1077, DOI 10.1161/01.HYP.0000187899.34379.b0; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; Lim JH, 2008, OBSTET GYNECOL, V111, P1403, DOI 10.1097/AOG.0b013e3181719b7a; Lohela M, 2009, CURR OPIN CELL BIOL, V21, P154, DOI 10.1016/j.ceb.2008.12.012; Makkonen N, 2002, HYPERTENS PREGNANCY, V21, P51, DOI 10.1081/PRG-120002909; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Maynard S, 2008, ANNU REV MED, V59, P61, DOI 10.1146/annurev.med.59.110106.214058; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; Powe CE, 2011, CIRCULATION, V123, P2856, DOI 10.1161/CIRCULATIONAHA.109.853127; Reddy A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004453; Roberts JM, 2005, HYPERTENSION, V46, P1243, DOI 10.1161/01.HYP.0000188408.49896.c5; ROBERTS JM, 1989, AM J OBSTET GYNECOL, V161, P1200, DOI 10.1016/0002-9378(89)90665-0; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Swendeman S, 2008, CIRC RES, V103, P916, DOI 10.1161/CIRCRESAHA.108.184416; Takahashi H, 2005, CLIN SCI, V109, P227, DOI 10.1042/CS20040370; Tripathi R, 2009, YONSEI MED J, V50, P656, DOI 10.3349/ymj.2009.50.5.656; Tsatsaris V, 2003, J CLIN ENDOCR METAB, V88, P5555, DOI 10.1210/jc.2003-030528; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; Wallner W, 2007, CLIN SCI, V112, P51, DOI 10.1042/CS20060161; WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988; Zhou Y, 2002, AM J PATHOL, V160, P1405, DOI 10.1016/S0002-9440(10)62567-9	36	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33475	10.1371/journal.pone.0033475	http://dx.doi.org/10.1371/journal.pone.0033475			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22428059	gold, Green Submitted, Green Published			2022-12-25	WOS:000302381500146
J	Quan, XF; Wang, Y; Ma, XF; Liang, Y; Tian, WX; Ma, QY; Jiang, HZ; Zhao, YX				Quan, Xiaofang; Wang, Yi; Ma, Xiaofeng; Liang, Yan; Tian, Weixi; Ma, Qingyun; Jiang, Hezhong; Zhao, Youxing			alpha-Mangostin Induces Apoptosis and Suppresses Differentiation of 3T3-L1 Cells via Inhibiting Fatty Acid Synthase	PLOS ONE			English	Article							HYPOTHALAMIC MALONYL-COA; ADIPOSE-TISSUE; SIGNALING PATHWAY; FOOD-INTAKE; SYNTHETASE; EXPRESSION; MECHANISM; MITOCHONDRIA; XANTHONE; PROTEIN	alpha-Mangostin, isolated from the hulls of Garcinia mangostana L., was found to have in vitro cytotoxicity against 3T3-L1 cells as well as inhibiting fatty acid synthase (FAS, EC 2.3.1.85). Our studies showed that the cytotoxicity of alpha-mangostin with IC50 value of 20 mu M was incomplicated in apoptotic events including increase of cell membrane permeability, nuclear chromatin condensation and mitochondrial membrane potential (Delta Psi m) loss. This cytotoxicity was accompanied by the reduction of FAS activity in cells and could be rescued by 50 mM or 100 mM exogenous palmitic acids, which suggested that the apoptosis of 3T3-L1 preadipocytes induced by alpha-mangostin was via inhibition of FAS. Futhermore, alpha-mangostin could suppress intracellular lipid accumulation in the differentiating adipocytes and stimulated lipolysis in mature adipocytes, which was also related to its inhibition of FAS. In addition, 3T3-L1 preadipocytes were more susceptible to the cytotoxic effect of alpha-mangostin than mature adipocytes. Further studies showed that alpha-mangostin inhibited FAS probably by stronger action on the ketoacyl synthase domain and weaker action on the acetyl/malonyl transferase domain. These findings suggested that alpha-mangostin might be useful for preventing or treating obesity.	[Quan, Xiaofang; Wang, Yi; Ma, Xiaofeng; Liang, Yan; Tian, Weixi] Chinese Acad Sci, Grad Univ, Coll Life Sci, Beijing, Peoples R China; [Ma, Qingyun; Zhao, Youxing] Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Haikou, Peoples R China; [Jiang, Hezhong] Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources W China, Kunming, Peoples R China	Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Tropical Agricultural Sciences; Chinese Academy of Sciences; Kunming Institute of Botany, CAS	Quan, XF (corresponding author), Chinese Acad Sci, Grad Univ, Coll Life Sci, Beijing, Peoples R China.	maxiaofeng@gucas.ac.cn; zhaoyx1011@163.com	Quan, Xiaofang/G-9982-2017		Special Science and Technology Projects for Outstanding Young in Life Sciences [KSCX2-EW-Q-19]; Twelfth Five Year Plan Basic Frontier Project in Life Sciences [Y129015EA2]; Natural Science Foundation of Yunnan [2008CD159]; GUCAS [O95101PY00]; K.C. Wong Education Foundation, Hong Kong	Special Science and Technology Projects for Outstanding Young in Life Sciences; Twelfth Five Year Plan Basic Frontier Project in Life Sciences; Natural Science Foundation of Yunnan(Natural Science Foundation of Yunnan Province); GUCAS; K.C. Wong Education Foundation, Hong Kong	This work was supported by the Special Science and Technology Projects for Outstanding Young in Life Sciences (KSCX2-EW-Q-19), the Twelfth Five Year Plan Basic Frontier Project in Life Sciences (Y129015EA2), the Natural Science Foundation of Yunnan (2008CD159), the President Funding of GUCAS O95101PY00, as well as K.C. Wong Education Foundation, Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armani A, 2010, J CELL BIOCHEM, V110, P564, DOI 10.1002/jcb.22598; Bandyopadhyay S, 2006, CANCER RES, V66, P5934, DOI 10.1158/0008-5472.CAN-05-3197; Bray GA, 2000, NATURE, V404, P672, DOI 10.1038/35007544; Chairungsrilerd N, 1996, EUR J PHARMACOL, V314, P351, DOI 10.1016/S0014-2999(96)00562-6; Chao AC, 2011, J AGR FOOD CHEM, V59, P2086, DOI 10.1021/jf1042757; Couillard C, 2000, INT J OBESITY, V24, P782, DOI 10.1038/sj.ijo.0801227; DODDS PF, 1981, J BIOL CHEM, V256, P6282; Vazquez-Vela MEF, 2008, ARCH MED RES, V39, P715, DOI 10.1016/j.arcmed.2008.09.005; Gopalakrishnan G, 1997, J NAT PROD, V60, P519, DOI 10.1021/np970165u; Hu ZY, 2003, P NATL ACAD SCI USA, V100, P12624, DOI 10.1073/pnas.1834402100; Hwang JT, 2005, BIOCHEM BIOPH RES CO, V338, P694, DOI 10.1016/j.bbrc.2005.09.195; JAYAKUMAR A, 1995, P NATL ACAD SCI USA, V92, P8695, DOI 10.1073/pnas.92.19.8695; Jiang HZ, 2010, BIOORG MED CHEM LETT, V20, P6045, DOI 10.1016/j.bmcl.2010.08.061; Kaomongkolgit R, 2010, ARCH ORAL BIOL; Kaomongkolgit Ruchadaporn, 2009, J Oral Sci, V51, P401; Kim EK, 2002, AM J PHYSIOL-ENDOC M, V283, pE867, DOI 10.1152/ajpendo.00178.2002; Krajarng A, 2011, J AGR FOOD CHEM; KUMAR S, 1970, J BIOL CHEM, V245, P4732; Kurosaka K, 2003, J IMMUNOL, V171, P4672, DOI 10.4049/jimmunol.171.9.4672; Lee YB, 2010, J FOOD SCI, V75, pH13, DOI 10.1111/j.1750-3841.2009.01407.x; Liston P, 1996, NATURE, V379, P349, DOI 10.1038/379349a0; Loftus TM, 2000, SCIENCE, V288, P2379, DOI 10.1126/science.288.5475.2379; Magun R, 1998, DIABETES, V47, P1948, DOI 10.2337/diabetes.47.12.1948; Maier T, 2008, SCIENCE, V321, P1315, DOI 10.1126/science.1161269; Matsumoto K, 2004, BIOORGAN MED CHEM, V12, P5799, DOI 10.1016/j.bmc.2004.08.034; Menendez JA, 2004, INT J ONCOL, V24, P591; Nabandith Viengvansay, 2004, Asian Pac J Cancer Prev, V5, P433; Nakagawa Y, 2007, BIOORGAN MED CHEM, V15, P5620, DOI 10.1016/j.bmc.2007.04.071; Nguyen PTM, 2011, CAN J MICROBIOL, V57, P217, DOI 10.1139/W10-122; Pedraza-Chaverri J, 2008, FOOD CHEM TOXICOL, V46, P3227, DOI 10.1016/j.fct.2008.07.024; Pedraza-Chaverri J, 2009, EXP TOXICOL PATHOL, V61, P491, DOI 10.1016/j.etp.2008.11.002; Sakagami Y, 2005, PHYTOMEDICINE, V12, P203, DOI 10.1016/j.phymed.2003.09.012; Sampath PD, 2007, J BIOCHEM MOL TOXIC, V21, P336, DOI 10.1002/jbt.20199; Sanchez-Perez Y, 2010, CHEM-BIOL INTERACT, V188, P144, DOI 10.1016/j.cbi.2010.06.014; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; Schmid B, 2005, BIOCHEM BIOPH RES CO, V328, P1073, DOI 10.1016/j.bbrc.2005.01.067; Sethi JK, 2007, J LIPID RES, V48, P1253, DOI 10.1194/jlr.R700005-JLR200; Shih YW, 2010, CELL BIOCHEM BIOPHYS, V58, P31, DOI 10.1007/s12013-010-9091-2; Smith S, 2007, NAT PROD REP, V24, P1041, DOI 10.1039/b603600g; Sorisky A, 2000, INT J OBESITY, V24, pS3, DOI 10.1038/sj.ijo.0801491; SOULIE JM, 1984, J BIOL CHEM, V259, P134; Sun XB, 2010, J ENZYM INHIB MED CH, V25, P290, DOI 10.3109/14756360903179377; Thupari JN, 2002, P NATL ACAD SCI USA, V99, P9498, DOI 10.1073/pnas.132128899; TIAN WX, 1985, J BIOL CHEM, V260, P1375; Visscher TLS, 2001, ANNU REV PUBL HEALTH, V22, P355, DOI 10.1146/annurev.publhealth.22.1.355; Witkowski A, 1997, BIOCHEMISTRY-US, V36, P16338, DOI 10.1021/bi972242q; Wolfgang MJ, 2011, FEBS J, V278, P552, DOI 10.1111/j.1742-4658.2010.07978.x; Zecchin KG, 2011, LAB INVEST, V91, P232, DOI 10.1038/labinvest.2010.157; Zhao JO, 2011, MOL CELL BIOCHEM, V351, P19, DOI 10.1007/s11010-010-0707-z	49	49	49	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2012	7	3							e33376	10.1371/journal.pone.0033376	http://dx.doi.org/10.1371/journal.pone.0033376			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KX	22428036	Green Published, Green Submitted, gold			2022-12-25	WOS:000303062800054
J	Ceholski, DK; Trieber, CA; Young, HS				Ceholski, Delaine K.; Trieber, Catharine A.; Young, Howard S.			Hydrophobic Imbalance in the Cytoplasmic Domain of Phospholamban Is a Determinant for Lethal Dilated Cardiomyopathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC SARCOPLASMIC-RETICULUM; DEPENDENT PROTEIN-KINASE; HEART-FAILURE; CALCIUM-PUMP; HYPERTROPHIC CARDIOMYOPATHY; INHIBITORY FUNCTION; GENE-THERAPY; CO-CRYSTALS; CA2+ PUMP; PHOSPHORYLATION	The sarco(endo)plasmic reticulum calcium ATPase (SERCA) and its regulatory partner phospholamban (PLN) are essential for myocardial contractility. Arg(9) -> Cys (R9C) and Arg(14) deletion (R14del) mutations in PLN are associated with lethal dilated cardiomyopathy in humans. To better understand these mutations, we made a series of amino acid substitutions in the cytoplasmic domain of PLN and tested their ability to inhibit SERCA. R9C is a complete loss-of-function mutant of PLN, whereas R14del is a mild loss-of-function mutant. When combined with wild-type PLN to simulate heterozygous conditions, the mutants had a dominant negative effect on SERCA function. A series of targeted mutations in this region of the PLN cytoplasmic domain ((8)TRSAIRR(14)) demonstrated the importance of hydrophobic balance in proper PLN regulation of SERCA. We found that Arg(9) -> Leu and Thr(8) -> Cys substitutions mimicked the behavior of the R9C mutant, and an Arg(14) -> Ala substitution mimicked the behavior of the R14del mutant. The results reveal that the change in hydrophobicity resulting from the R9C and R14del mutations is sufficient to explain the loss of function and persistent interaction with SERCA. Hydrophobic imbalance in the cytoplasmic domain of PLN appears to be a predictor for the development and progression of dilated cardiomyopathy.	[Ceholski, Delaine K.; Trieber, Catharine A.; Young, Howard S.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; [Trieber, Catharine A.; Young, Howard S.] Univ Alberta, Natl Inst Nanotechnol, Edmonton, AB T6G 2M9, Canada	University of Alberta; National Research Council Canada; University of Alberta	Young, HS (corresponding author), Univ Alberta, Dept Biochem, 327 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.	hyoung@ualberta.ca		Trieber, Catharine/0000-0002-1336-1126; Young, Howard/0000-0002-5990-8422	Heart and Stroke Foundation; Canadian Institutes of Health Research (CIHR) [MOP53306]; Alberta Innovates-Technology Futures (AI-TF)	Heart and Stroke Foundation(Heart & Stroke Foundation of Canada); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alberta Innovates-Technology Futures (AI-TF)	This work was supported by grants from the Heart and Stroke Foundation and Canadian Institutes of Health Research (CIHR) Grant MOP53306.; Supported by Canada Graduate Scholarships from CIHR and Alberta Innovates-Technology Futures (AI-TF).	Akin BL, 2012, J BIOL CHEM, V287, P7582, DOI 10.1074/jbc.M111.334987; Bidwell P, 2011, J BIOL CHEM, V286, P35044, DOI 10.1074/jbc.M111.266759; Brittsan AG, 2000, J BIOL CHEM, V275, P12129, DOI 10.1074/jbc.275.16.12129; CANTILINA T, 1993, J BIOL CHEM, V268, P17018; Chen ZH, 2005, J BIOL CHEM, V280, P10530, DOI 10.1074/jbc.M414007200; Chen Z, 2007, J BIOL CHEM, V282, P20968, DOI 10.1074/jbc.M703516200; Chen ZH, 2010, J BIOL CHEM, V285, P3253, DOI 10.1074/jbc.M109.080820; COLYER J, 1991, J BIOL CHEM, V266, P17486; Dellefave L, 2010, CURR OPIN CARDIOL, V25, P198, DOI 10.1097/HCO.0b013e328337ba52; DeWitt MM, 2006, J AM COLL CARDIOL, V48, P1396, DOI 10.1016/j.jacc.2006.07.016; Douglas JL, 2005, PROTEIN EXPRES PURIF, V40, P118, DOI 10.1016/j.pep.2004.11.015; ELETR S, 1972, BIOCHIM BIOPHYS ACTA, V282, P174, DOI 10.1016/0005-2736(72)90321-5; Ferrington DA, 2002, BIOCHEMISTRY-US, V41, P13289, DOI 10.1021/bi026407t; FOWLER C, 1989, BIOCHIM BIOPHYS ACTA, V980, P348, DOI 10.1016/0005-2736(89)90323-4; Glaves JP, 2011, J MOL BIOL, V405, P707, DOI 10.1016/j.jmb.2010.11.014; Grunig E, 1998, J AM COLL CARDIOL, V31, P186, DOI 10.1016/S0735-1097(97)00434-8; Gustavsson M, 2011, BIOCHEMISTRY-US, V50, P10367, DOI 10.1021/bi200759y; Ha KN, 2011, P NATL ACAD SCI USA, V108, P2735, DOI 10.1073/pnas.1013987108; Haghighi K, 2006, P NATL ACAD SCI USA, V103, P1388, DOI 10.1073/pnas.0510519103; Haghighi K, 2003, J CLIN INVEST, V111, P869, DOI 10.1172/JCI200317892; Haghighi K, 2008, HUM MUTAT, V29, P640, DOI 10.1002/humu.20692; HASENFUSS G, 1994, CIRC RES, V75, P434, DOI 10.1161/01.RES.75.3.434; Hou ZJ, 2010, J MOL BIOL, V402, P210, DOI 10.1016/j.jmb.2010.07.023; INESI G, 1988, METHOD ENZYMOL, V157, P154; JAMES P, 1989, NATURE, V342, P90, DOI 10.1038/342090a0; Karim CB, 2006, J MOL BIOL, V358, P1032, DOI 10.1016/j.jmb.2006.02.051; Kimura Y, 1997, J BIOL CHEM, V272, P15061, DOI 10.1074/jbc.272.24.15061; Kirchberber M A, 1975, Recent Adv Stud Cardiac Struct Metab, V5, P103; Landstrom AP, 2011, AM HEART J, V161, DOI 10.1016/j.ahj.2010.08.001; Lockamy EL, 2011, BIOCHEM BIOPH RES CO, V408, P388, DOI 10.1016/j.bbrc.2011.04.023; LOUIS CF, 1987, NEUROCHEM RES, V12, P937, DOI 10.1007/BF00966316; Lu LP, 1998, BIOPOLYMERS, V47, P41, DOI 10.1002/(SICI)1097-0282(1998)47:1<41::AID-BIP6>3.0.CO;2-X; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Medeiros A, 2011, AM HEART J, V162, P1088, DOI 10.1016/j.ahj.2011.07.028; MEYER M, 1995, CIRCULATION, V92, P778, DOI 10.1161/01.CIR.92.4.778; Minamisawa S, 2003, BIOCHEM BIOPH RES CO, V304, P1, DOI 10.1016/S0006-291X(03)00526-6; Mishra S, 2002, J HEART LUNG TRANSPL, V21, P366, DOI 10.1016/S1053-2498(01)00390-4; Negash S, 2000, BIOCHEM J, V351, P195, DOI 10.1042/0264-6021:3510195; Negash S, 1996, BIOCHEMISTRY-US, V35, P11247, DOI 10.1021/bi960864q; Posch MG, 2009, HEART RHYTHM, V6, P480, DOI 10.1016/j.hrthm.2009.01.016; Rapti K, 2011, CAN J CARDIOL, V27, P265, DOI 10.1016/j.cjca.2011.02.005; REDDY LG, 1995, J BIOL CHEM, V270, P9390, DOI 10.1074/jbc.270.16.9390; Reddy LG, 1996, J BIOL CHEM, V271, P14964, DOI 10.1074/jbc.271.25.14964; Reddy LG, 1999, J BIOL CHEM, V274, P7649, DOI 10.1074/jbc.274.12.7649; Schmitt JP, 2003, SCIENCE, V299, P1410, DOI 10.1126/science.1081578; SIMMERMAN HKB, 1986, J BIOL CHEM, V261, P3333; Stokes DL, 2006, BIOPHYS J, V90, P4213, DOI 10.1529/biophysj.105.079640; STOKES DL, 1990, BIOPHYS J, V57, P1, DOI 10.1016/S0006-3495(90)82501-7; TOYOFUKU T, 1994, J BIOL CHEM, V269, P3088; Toyoshima C, 2003, P NATL ACAD SCI USA, V100, P467, DOI 10.1073/pnas.0237326100; Traaseth NJ, 2006, J MOL BIOL, V358, P1041, DOI 10.1016/j.jmb.2006.02.047; Trieber CA, 2005, BIOCHEMISTRY-US, V44, P3289, DOI 10.1021/bi047878d; Trieber CA, 2009, BIOCHEMISTRY-US, V48, P9287, DOI 10.1021/bi900852m; WARREN GB, 1974, P NATL ACAD SCI USA, V71, P622, DOI 10.1073/pnas.71.3.622; Young HS, 2001, BIOPHYS J, V81, P884, DOI 10.1016/S0006-3495(01)75748-7	55	35	36	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16521	16529		10.1074/jbc.M112.360859	http://dx.doi.org/10.1074/jbc.M112.360859			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22427649	Green Published, hybrid			2022-12-25	WOS:000304030900042
J	Dai, YM; Chen, H; Mo, C; Cui, LX; He, W				Dai, Yumei; Chen, Hui; Mo, Chen; Cui, Lianxian; He, Wei			Ectopically Expressed Human Tumor Biomarker MutS Homologue 2 Is a Novel Endogenous Ligand That Is Recognized by Human gamma delta T Cells to Induce Innate Anti-tumor/Virus Immunity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-MISMATCH REPAIR; B-CELLS; RECEPTOR; NKG2D; LYMPHOCYTES; PROTEIN; ACTIVATION; SURFACE; IDENTIFICATION; CYTOTOXICITY	Human (h) MutS homologue 2, a nuclear protein, is a critical element of the DNA mismatch repair system. Our previous studies suggest that hMSH2 might be a protein ligand for TCR gamma delta. Here, we show that hMSH2 is ectopically expressed on a large panel of epithelial tumor cells. We found that hMSH2 interacts with both TCR gamma delta and NKG2D and contributes to V delta 2 T cell-mediated cytolysis of tumor cells. Moreover, recombinant human MSH2 protein stimulates the proliferation and IFN-gamma secretion of V delta 2 T cells in vitro. Finally, hMSH2 expression is induced on the cell surface of Epstein-Barr virus-transformed lymphoblastoid cell lines, and the induction increases the sensitivity of these lymphoblastoid cell lines to gamma delta T cell-mediated cytolysis. Our data suggest that hMSH2 functions as a tumor-associated or virus infection-related antigen recognized by both V delta 2 TCR and NKG2D, and it plays a role in eliciting the immune responses of gamma delta T cells against tumor-and virus-infected cells. The recognition of ectopic surface-expressing endogenous antigen by TCR gamma delta and NKG2D may be an important mechanism of innate immune response to carcinogenesis and viral infection.	[Dai, Yumei; Chen, Hui; Mo, Chen; Cui, Lianxian; He, Wei] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Immunol, Beijing 100005, Peoples R China; [Dai, Yumei; Mo, Chen; Cui, Lianxian; He, Wei] Sch Peking Union Med Coll, Natl Key Lab Med Mol Biol, Beijing 100005, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	He, W (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Dept Immunol, 5 Dong Dan San Tiao, Beijing 100005, Peoples R China.	hewei@moh.gov.cn			National Natural Science Foundation [30930083]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by Grant 30930083 from the National Natural Science Foundation.	Acharya S, 1996, P NATL ACAD SCI USA, V93, P13629, DOI 10.1073/pnas.93.24.13629; Barral DC, 2007, NAT REV IMMUNOL, V7, P929, DOI 10.1038/nri2191; Bonneville M, 2010, NAT REV IMMUNOL, V10, P467, DOI 10.1038/nri2781; Botzler C, 1998, CELL STRESS CHAPERON, V3, P6, DOI 10.1379/1466-1268(1998)003<0006:DOELEO>2.3.CO;2; Chen H, 2008, J BIOL CHEM, V283, P12528, DOI 10.1074/jbc.M708067200; CHEUNG RK, 1993, VIROLOGY, V193, P700, DOI 10.1006/viro.1993.1178; CHUNG DC, 1995, GASTROENTEROLOGY, V109, P1685, DOI 10.1016/0016-5085(95)90660-6; DEPAOLI P, 1990, J INFECT DIS, V161, P1013, DOI 10.1093/infdis/161.5.1013; Eccleston J, 2011, J IMMUNOL, V186, P2336, DOI 10.4049/jimmunol.1003104; Gomes AQ, 2010, CANCER RES, V70, P10024, DOI 10.1158/0008-5472.CAN-10-3236; Gomes AQ, 2010, HAEMATOL-HEMATOL J, V95, P1397, DOI 10.3324/haematol.2009.020602; Groh V, 1999, P NATL ACAD SCI USA, V96, P6879, DOI 10.1073/pnas.96.12.6879; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; Groh V, 1998, SCIENCE, V279, P1737, DOI 10.1126/science.279.5357.1737; Halary F, 2005, J EXP MED, V201, P1567, DOI 10.1084/jem.20041851; Hirsh MI, 2008, AM J RESP CELL MOL, V39, P509, DOI 10.1165/rcmb.2008-0090TR; Jenkins MR, 2009, IMMUNITY, V31, P621, DOI 10.1016/j.immuni.2009.08.024; Knudsen NO, 2009, DNA REPAIR, V8, P682, DOI 10.1016/j.dnarep.2009.03.005; Kong Y, 2009, BLOOD, V114, P310, DOI 10.1182/blood-2008-12-196287; Kotsiopriftis M, 2005, J VIROL, V79, P7255, DOI 10.1128/JVI.79.11.7255-7261.2005; Kreslavsky T, 2010, SEMIN IMMUNOL, V22, P214, DOI 10.1016/j.smim.2010.04.001; Lanca T, 2010, BLOOD, V115, P2407, DOI 10.1182/blood-2009-08-237123; Meng Xialong, 2004, P R Health Sci J, V23, P103; Mookerjee-Basu J, 2010, J IMMUNOL, V184, P6920, DOI 10.4049/jimmunol.0904024; MULTHOFF G, 1995, INT J CANCER, V61, P272, DOI 10.1002/ijc.2910610222; Nedellec S, 2010, J IMMUNOL, V185, P55, DOI 10.4049/jimmunol.1000373; Peters AC, 2003, DNA REPAIR, V2, P427, DOI 10.1016/S1568-7864(03)00003-X; Poggi A, 2004, CANCER RES, V64, P9172, DOI 10.1158/0008-5472.CAN-04-2417; Rincon-Orozco B, 2005, J IMMUNOL, V175, P2144, DOI 10.4049/jimmunol.175.4.2144; Rolle A, 2003, J IMMUNOL, V171, P902, DOI 10.4049/jimmunol.171.2.902; Rouse BT, 2010, NAT REV IMMUNOL, V10, P514, DOI 10.1038/nri2802; Scotet E, 2005, IMMUNITY, V22, P71, DOI 10.1016/j.immuni.2004.11.012; Seifert M, 2008, J INVEST DERMATOL, V128, P203, DOI 10.1038/sj.jid.5700941; Spada FM, 2000, J EXP MED, V191, P937, DOI 10.1084/jem.191.6.937; STURM E, 1990, J IMMUNOL, V145, P3202; Thedrez A, 2007, IMMUNOL REV, V215, P123, DOI 10.1111/j.1600-065X.2006.00468.x; Vetter CS, 2002, J INVEST DERMATOL, V118, P600, DOI 10.1046/j.1523-1747.2002.01700.x; Viey E, 2005, J IMMUNOL, V174, P1338, DOI 10.4049/jimmunol.174.3.1338; Wilson IA, 2001, NAT IMMUNOL, V2, P579, DOI 10.1038/89718; Xi XY, 2009, J BIOL CHEM, V284, P27449, DOI 10.1074/jbc.M109.011684	41	44	49	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16812	16819		10.1074/jbc.M111.327650	http://dx.doi.org/10.1074/jbc.M111.327650			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22433851	Green Published, hybrid			2022-12-25	WOS:000304030900068
J	Ertekin, A; Aramini, JM; Rossi, P; Leonard, PG; Janjua, H; Xiao, R; Maglaqui, M; Lee, HW; Prestegard, JH; Montelione, GT				Ertekin, Asli; Aramini, James M.; Rossi, Paolo; Leonard, Paul G.; Janjua, Haleema; Xiao, Rong; Maglaqui, Melissa; Lee, Hsiau-Wei; Prestegard, James H.; Montelione, Gaetano T.			Human Cyclin-dependent Kinase 2-associated Protein 1 (CDK2AP1) Is Dimeric in Its Disulfide-reduced State, with Natively Disordered N-terminal Region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TORSION ANGLE DYNAMICS; NMR STRUCTURE; INTRINSIC DISORDER; TUMOR-SUPPRESSOR; KAPPA-B; GROWTH SUPPRESSOR; SOFTWARE SUITE; EXPRESSION; P12(DOC-1); MUTATION	CDK2AP1 (cyclin-dependent kinase 2-associated protein 1), corresponding to the gene doc-1 (deleted in oral cancer 1), is a tumor suppressor protein. The doc-1 gene is absent or down-regulated in hamster oral cancer cells and in many other cancer cell types. The ubiquitously expressed CDK2AP1 protein is the only known specific inhibitor of CDK2, making it an important component of cell cycle regulation during G(1)-to-S phase transition. Here, we report the solution structure of CDK2AP1 by combined methods of solution state NMR and amide hydrogen/deuterium exchange measurements with mass spectrometry. The homodimeric structure of CDK2AP1 includes an intrinsically disordered 60-residue N-terminal region and a four-helix bundle dimeric structure with reduced Cys-105 in the C-terminal region. The Cys-105 residues are, however, poised for disulfide bond formation. CDK2AP1 is phosphorylated at a conserved Ser-46 site in the N-terminal "intrinsically disordered" region by I kappa B kinase epsilon.	[Ertekin, Asli; Aramini, James M.; Rossi, Paolo; Leonard, Paul G.; Janjua, Haleema; Xiao, Rong; Maglaqui, Melissa; Montelione, Gaetano T.] Rutgers State Univ, CABM, Piscataway, NJ 08854 USA; [Ertekin, Asli; Aramini, James M.; Rossi, Paolo; Leonard, Paul G.; Janjua, Haleema; Xiao, Rong; Maglaqui, Melissa; Montelione, Gaetano T.] Rutgers State Univ, NE Struct Genom Consortium, Piscataway, NJ 08854 USA; [Ertekin, Asli] Rutgers State Univ, BioMaPS Inst Quantitat Biol, Piscataway, NJ 08854 USA; [Leonard, Paul G.; Montelione, Gaetano T.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA; [Leonard, Paul G.] Howard Hughes Med Inst, Athens, GA 30602 USA; [Lee, Hsiau-Wei; Prestegard, James H.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Lee, Hsiau-Wei; Prestegard, James H.] Univ Georgia, NE Struct Genom Consortium, Athens, GA 30602 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Howard Hughes Medical Institute; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Montelione, GT (corresponding author), Rutgers State Univ, CABM, 679 Hoes Lane, Piscataway, NJ 08854 USA.	guy@cabm.rutgers.edu	LEE, HSIAU-WEI/A-1415-2012	Montelione, Gaetano/0000-0002-9440-3059; Lee, Hsiau-Wei/0000-0002-6060-6341	National Institutes of Health from NIGMS [U54-GM-094597]; Jerome and Lorraine Aresty Cancer Biology Fellowship; National Institutes of Health [5 R90 DK071502]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R90DK071502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094597] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Jerome and Lorraine Aresty Cancer Biology Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Protein Structure Initiative Grant U54-GM-094597 from NIGMS.; Supported by a Jerome and Lorraine Aresty Cancer Biology Fellowship and a National Institutes of Health Interdisciplinary Research Workforce Fellowship 5 R90 DK071502.	Acton TB, 2011, METHOD ENZYMOL, V493, P21, DOI 10.1016/B978-0-12-381274-2.00002-9; Adli M, 2006, J BIOL CHEM, V281, P26976, DOI 10.1074/jbc.M603133200; Aramini JM, 2007, PROTEINS, V68, P789, DOI 10.1002/prot.21450; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buajeeb W, 2004, BIOCHEM BIOPH RES CO, V315, P998, DOI 10.1016/j.bbrc.2004.02.003; Choi MG, 2009, EUR SURG RES, V42, P223, DOI 10.1159/000208521; Cwikla SJ, 2000, J ORAL MAXIL SURG, V58, P406, DOI 10.1016/S0278-2391(00)90924-8; Daigo Y, 1997, GENE CHROMOSOME CANC, V20, P204, DOI 10.1002/(SICI)1098-2264(199710)20:2<204::AID-GCC12>3.0.CO;2-Q; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Dunker AK, 2001, NAT BIOTECHNOL, V19, P805, DOI 10.1038/nbt0901-805; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Eddy SF, 2005, CANCER RES, V65, P11375, DOI 10.1158/0008-5472.CAN-05-1602; Englander SW, 1996, CURR OPIN STRUC BIOL, V6, P18, DOI 10.1016/S0959-440X(96)80090-X; Ezeokonkwo C, 2011, RNA, V17, P652, DOI 10.1261/rna.2273111; Figueiredo ML, 2005, CLIN CANCER RES, V11, P3939, DOI 10.1158/1078-0432.CCR-04-2085; Fong JH, 2010, MOL BIOSYST, V6, P1821, DOI 10.1039/c005144f; Galea CA, 2008, BIOCHEMISTRY-US, V47, P7598, DOI 10.1021/bi8006803; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gokhale RS, 2000, CURR OPIN CHEM BIOL, V4, P22, DOI 10.1016/S1367-5931(99)00046-0; Guntert P, 2009, EUR BIOPHYS J BIOPHY, V38, P129, DOI 10.1007/s00249-008-0367-z; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hiscott J, 2007, CYTOKINE GROWTH F R, V18, P483, DOI 10.1016/j.cytogfr.2007.06.002; Huang YJ, 2005, J AM CHEM SOC, V127, P1665, DOI 10.1021/ja047109h; Huang YPJ, 2008, MOL CELL PROTEOMICS, V7, P2048, DOI 10.1074/mcp.M700550-MCP200; Hutti JE, 2009, MOL CELL, V34, P461, DOI 10.1016/j.molcel.2009.04.031; Israel A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000158; Kim Y, 2005, J BIOL CHEM, V280, P23273, DOI 10.1074/jbc.M412929200; Kim Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004518; Kornhaber GJ, 2006, J BIOMOL NMR, V34, P259, DOI 10.1007/s10858-006-0027-5; Kriwacki RW, 1996, P NATL ACAD SCI USA, V93, P11504, DOI 10.1073/pnas.93.21.11504; Lacy ER, 2004, NAT STRUCT MOL BIOL, V11, P358, DOI 10.1038/nsmb746; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laue TM, 1992, ROYAL SOC CHEM, P90; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Matsuo K, 2000, FASEB J, V14, P1318, DOI 10.1096/fj.14.10.1318; Moseley HNB, 2004, J BIOMOL NMR, V28, P341, DOI 10.1023/B:JNMR.0000015420.44364.06; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Pantazatos D, 2004, P NATL ACAD SCI USA, V101, P751, DOI 10.1073/pnas.0307204101; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Satyanarayana A, 2009, ONCOGENE, V28, P2925, DOI 10.1038/onc.2009.170; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Sharma D, 2000, J BIOMOL NMR, V18, P165, DOI 10.1023/A:1008398416292; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Sharma S, 2009, PROTEINS, V76, P882, DOI 10.1002/prot.22394; Shintani S, 2000, MOL CELL BIOL, V20, P6300, DOI 10.1128/MCB.20.17.6300-6307.2000; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Spraggon G, 2004, PROTEIN SCI, V13, P3187, DOI 10.1110/ps.04939904; Spruijt CG, 2010, MOL BIOSYST, V6, P1700, DOI 10.1039/c004108d; Stuart AC, 1999, J AM CHEM SOC, V121, P5346, DOI 10.1021/ja984172w; Terret ME, 2003, DEVELOPMENT, V130, P5169, DOI 10.1242/dev.00731; TODD R, 1995, FASEB J, V9, P1362, DOI 10.1096/fasebj.9.13.7557027; Tsuji T, 1998, J BIOL CHEM, V273, P6704, DOI 10.1074/jbc.273.12.6704; Valafar H, 2004, J MAGN RESON, V167, P228, DOI 10.1016/j.jmr.2003.12.012; Wang T. S, 1996, DNA REPLICATION EUKA; Wang YF, 2011, NAT CHEM BIOL, V7, P214, DOI 10.1038/NCHEMBIO.536; Xie HB, 2007, J PROTEOME RES, V6, P1882, DOI 10.1021/pr060392u; Yuan ZQ, 2003, ONCOGENE, V22, P6304, DOI 10.1038/sj.onc.1206609; Zhou HX, 2001, BIOCHEMISTRY-US, V40, P15069, DOI 10.1021/bi015795g; Zweckstetter M, 2000, J AM CHEM SOC, V122, P3791, DOI 10.1021/ja0000908	63	9	10	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16541	16549		10.1074/jbc.M112.343863	http://dx.doi.org/10.1074/jbc.M112.343863			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22427660	hybrid, Green Published			2022-12-25	WOS:000304030900044
J	Gavin, JM; Chen, JJ; Liao, H; Rollins, N; Yang, XF; Xu, Q; Ma, JY; Loke, HK; Lingaraj, T; Brownell, JE; Mallender, WD; Gould, AE; Amidon, BS; Dick, LR				Gavin, James M.; Chen, Jesse J.; Liao, Hua; Rollins, Neil; Yang, Xiaofeng; Xu, Qing; Ma, Jingya; Loke, Huay-Keng; Lingaraj, Trupti; Brownell, James E.; Mallender, William D.; Gould, Alexandra E.; Amidon, Benjamin S.; Dick, Lawrence R.			Mechanistic Studies on Activation of Ubiquitin and Di-ubiquitin-like Protein, FAT10, by Ubiquitin-like Modifier Activating Enzyme 6, Uba6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-ASSISTED INHIBITION; CRYSTAL-STRUCTURE; NATURAL-HISTORY; SUMO E1; NEDD8; INSIGHTS; PATHWAY; DEGRADATION; CONJUGATION; AFFINITY	Uba6 is a homolog of the ubiquitin-activating enzyme, Uba1, and activates two ubiquitin-like proteins (UBLs), ubiquitin and FAT10. In this study, biochemical and biophysical experiments were performed to understand the mechanisms of how Uba6 recognizes two distinct UBLs and catalyzes their activation and transfer. Uba6 is shown to undergo a three-step activation process and form a ternary complex with both UBLs, similar to what has been observed for Uba1. The catalytic mechanism of Uba6 is further supported by inhibition studies using a mechanism-based E1 inhibitor, Compound 1, which forms covalent adducts with both ubiquitin and FAT10. In addition, pre-steady state kinetic analysis revealed that the rates of UBL-adenylate (step 1) and thioester (step 2) formation are similar between ubiquitin and FAT10. However, distinct kinetic behaviors were also observed for ubiquitin and FAT10. FAT10 binds Uba6 with much higher affinity than ubiquitin while demonstrating lower catalytic activity in both ATP-PPi exchange and E1-E2 transthiolation assays. Also, Compound 1 is less potent with FAT10 as the UBL compared with ubiquitin in ATP-PPi exchange assays, and both a slow rate of covalent adduct formation and weak adduct binding to Uba6 contribute to the diminished potency observed for FAT10. Together with expression level analysis in IM-9 cells, this study sheds light on the potential role of cytokine-induced FAT10 expression in regulating Uba6 pathways.	[Gavin, James M.; Chen, Jesse J.; Liao, Hua; Rollins, Neil; Yang, Xiaofeng; Xu, Qing; Ma, Jingya; Loke, Huay-Keng; Lingaraj, Trupti; Brownell, James E.; Mallender, William D.; Gould, Alexandra E.; Amidon, Benjamin S.; Dick, Lawrence R.] Millennium Pharmaceut Inc, Discovery, Cambridge, MA 02139 USA	Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals	Gavin, JM (corresponding author), 40 Landsdowne St, Cambridge, MA 02139 USA.	james.gavin@mpi.com	Dick, Lawrence/ABA-8831-2021	Dick, Larry/0000-0002-6880-0405				Aichem A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1012; Bohnsack RN, 2003, J BIOL CHEM, V278, P26823, DOI 10.1074/jbc.M303177200; Brownell JE, 2010, MOL CELL, V37, P102, DOI 10.1016/j.molcel.2009.12.024; Bruzzese FJ, 2009, ANAL BIOCHEM, V394, P24, DOI 10.1016/j.ab.2009.07.011; Burroughs AM, 2009, PROTEINS, V75, P895, DOI 10.1002/prot.22298; Burroughs AM, 2012, FRONT BIOSCI-LANDMRK, V17, P1433, DOI 10.2741/3996; Chen JJ, 2011, J BIOL CHEM, V286, P40867, DOI 10.1074/jbc.M111.279984; Chiu YH, 2007, MOL CELL, V27, P1014, DOI 10.1016/j.molcel.2007.08.020; Fan WF, 1996, IMMUNOGENETICS, V44, P97, DOI 10.1007/s002510050095; Gong PF, 2010, J AM SOC NEPHROL, V21, P316, DOI 10.1681/ASN.2009050479; HAAS AL, 1982, J BIOL CHEM, V257, P2543; HAAS AL, 1982, J BIOL CHEM, V257, P329; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Hipp MS, 2004, J BIOL CHEM, V279, P16503, DOI 10.1074/jbc.M310114200; Hjerpe R, 2012, BIOCHEM J, V441, P927, DOI 10.1042/BJ20111671; Huang DT, 2007, NATURE, V445, P394, DOI 10.1038/nature05490; Jin JP, 2007, NATURE, V447, P1135, DOI 10.1038/nature05902; Kaiser SE, 2011, NAT METHODS, V8, P691, DOI [10.1038/NMETH.1649, 10.1038/nmeth.1649]; Lee I, 2008, CELL, V134, P268, DOI 10.1016/j.cell.2008.05.046; Lee PCW, 2011, MOL CELL, V43, P392, DOI 10.1016/j.molcel.2011.05.034; Li TW, 2011, ARCH BIOCHEM BIOPHYS, V509, P164, DOI 10.1016/j.abb.2011.02.017; Lois LM, 2005, EMBO J, V24, P439, DOI 10.1038/sj.emboj.7600552; Nagashima Y, 2011, J BIOL CHEM, V286, P29594, DOI 10.1074/jbc.M111.261032; Narasimhan J, 2005, J BIOL CHEM, V280, P27356, DOI 10.1074/jbc.M502814200; Olsen SK, 2010, NATURE, V463, P906, DOI 10.1038/nature08765; Pelzer C, 2007, J BIOL CHEM, V282, P23010, DOI 10.1074/jbc.C700111200; PICKART CM, 1994, J BIOL CHEM, V269, P7115; Raasi S, 1999, EUR J IMMUNOL, V29, P4030, DOI 10.1002/(SICI)1521-4141(199912)29:12<4030::AID-IMMU4030>3.0.CO;2-Y; Schlieker CD, 2008, P NATL ACAD SCI USA, V105, P18255, DOI 10.1073/pnas.0808756105; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Siepmann TJ, 2003, J BIOL CHEM, V278, P9448, DOI 10.1074/jbc.M211240200; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Streich FC, 2010, SUBCELL BIOCHEM, V54, P1, DOI 10.1007/978-1-4419-6676-6_1; Tokgoz Z, 2012, J BIOL CHEM, V287, P311, DOI 10.1074/jbc.M111.294975; Walden H, 2003, NATURE, V422, P330, DOI 10.1038/nature01456; Whitby FG, 1998, J BIOL CHEM, V273, P34983, DOI 10.1074/jbc.273.52.34983	37	32	36	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15512	15522		10.1074/jbc.M111.336198	http://dx.doi.org/10.1074/jbc.M111.336198			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22427669	Green Published, hybrid			2022-12-25	WOS:000304006300032
J	Chawla, B; Kumar, RR; Tyagi, N; Subramanian, G; Srinivasan, N; Park, MH; Madhubala, R				Chawla, Bhavna; Kumar, Ravi Ranjan; Tyagi, Nidhi; Subramanian, Gowri; Srinivasan, N.; Park, Myung Hee; Madhubala, Rentala			A Unique Modification of the Eukaryotic Initiation Factor 5A Shows the Presence of the Complete Hypusine Pathway in Leishmania donovani	PLOS ONE			English	Article							AMINO-ACID-RESIDUES; DEOXYHYPUSINE HYDROXYLASE; CELL-GROWTH; 3-DIMENSIONAL STRUCTURES; CONTAINING PROTEIN; IDENTIFICATION; SPERMIDINE; SYNTHASE; ENZYME; RECOGNITION	Deoxyhypusine hydroxylase (DOHH) catalyzes the final step in the post-translational synthesis of an unusual amino acid hypusine (N-(sic)-(4-amino-2-hydroxybutyl) lysine), which is present on only one cellular protein, eukaryotic initiation factor 5A (eIF5A). We present here the molecular and structural basis of the function of DOHH from the protozoan parasite, Leishmania donovani, which causes visceral leishmaniasis. The L. donovani DOHH gene is 981 bp and encodes a putative polypeptide of 326 amino acids. DOHH is a HEAT-repeat protein with eight tandem repeats of alpha-helical pairs. Four conserved histidine-glutamate sequences have been identified that may act as metal coordination sites. A similar to 42 kDa recombinant protein with a His-tag was obtained by heterologous expression of DOHH in Escherichia coli. Purified recombinant DOHH effectively catalyzed the hydroxylation of the intermediate, eIF5A-deoxyhypusine (eIF5A-Dhp), in vitro. L. donovani DOHH (LdDOHH) showed similar to 40.6% sequence identity with its human homolog. The alignment of L. donovani DOHH with the human homolog shows that there are two significant insertions in the former, corresponding to the alignment positions 159-162 (four amino acid residues) and 174-183 (ten amino acid residues) which are present in the variable loop connecting the N- and C-terminal halves of the protein, the latter being present near the substrate binding site. Deletion of the ten-amino-acid-long insertion decreased LdDOHH activity to 14% of the wild type recombinant LdDOHH. Metal chelators like ciclopirox olamine (CPX) and mimosine significantly inhibited the growth of L. donovani and DOHH activity in vitro. These inhibitors were more effective against the parasite enzyme than the human enzyme. This report, for the first time, confirms the presence of a complete hypusine pathway in a kinetoplastid unlike eubacteria and archaea. The structural differences between the L. donovani DOHH and the human homolog may be exploited for structure based design of selective inhibitors against the parasite.	[Chawla, Bhavna; Kumar, Ravi Ranjan; Subramanian, Gowri; Madhubala, Rentala] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India; [Tyagi, Nidhi; Srinivasan, N.] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Park, Myung Hee] NIDCR, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD USA	Jawaharlal Nehru University, New Delhi; Indian Institute of Science (IISC) - Bangalore; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Chawla, B (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India.	madhubala@mail.jnu.ac.in		Tyagi, Nidhi/0000-0002-2065-9051; V Subramanian, Gowri/0000-0002-4404-6401; madhubala, rentala/0000-0002-0034-399X	Council of Scientific and Industrial Research (CSIR), India; Department of Science and Technology (DST), India; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000608] Funding Source: NIH RePORTER	Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology (DST), India(Department of Science & Technology (India)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work is supported by a grant from the Council of Scientific and Industrial Research (CSIR), India to Dr. Madhubala. Dr. Madhubala is a JC Bose Fellow supported by the Department of Science and Technology (DST), India. Dr. Chawla, Ravi Ranjan Kumar and Nidhi Tyagi are supported by CSIR, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBRUZZESE A, 1986, J BIOL CHEM, V261, P3085; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andrus L, 1998, BIOCHEM PHARMACOL, V55, P1807, DOI 10.1016/S0006-2952(98)00053-7; BARTIG D, 1992, EUR J BIOCHEM, V204, P751, DOI 10.1111/j.1432-1033.1992.tb16690.x; Brochier C, 2004, GENE, V330, P169, DOI 10.1016/j.gene.2004.01.018; Chawla B, 2010, J BIOL CHEM, V285, P453, DOI 10.1074/jbc.M109.048850; CHEN KY, 1988, FEBS LETT, V229, P325, DOI 10.1016/0014-5793(88)81149-9; Clement PMJ, 2002, INT J CANCER, V100, P491, DOI 10.1002/ijc.10515; COOPER HL, 1983, P NATL ACAD SCI-BIOL, V80, P1854, DOI 10.1073/pnas.80.7.1854; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; HANAUSKEABEL HM, 1994, BBA-MOL CELL RES, V1221, P115, DOI 10.1016/0167-4889(94)90003-5; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Hoque M, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-90; Kang KR, 2007, J BIOL CHEM, V282, P8300, DOI 10.1074/jbc.M607495200; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kerscher B, 2010, AMINO ACIDS, V38, P471, DOI 10.1007/s00726-009-0406-9; Kim YS, 2006, J BIOL CHEM, V281, P13217, DOI 10.1074/jbc.M601081200; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee YB, 1999, BIOCHEM J, V340, P273, DOI 10.1042/0264-6021:3400273; Li WZ, 2001, BIOINFORMATICS, V17, P282, DOI 10.1093/bioinformatics/17.3.282; Mandal S, 2009, INDIAN J EXP BIOL, V47, P475; Mizuguchi K, 1998, BIOINFORMATICS, V14, P617, DOI 10.1093/bioinformatics/14.7.617; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; MURPHEY RJ, 1987, J BIOL CHEM, V262, P15033; Park JH, 2006, P NATL ACAD SCI USA, V103, P51, DOI 10.1073/pnas.0509348102; Park JH, 2003, J BIOL CHEM, V278, P32683, DOI 10.1074/jbc.M304247200; Park JH, 2011, METHODS MOL BIOL, V720, P207, DOI 10.1007/978-1-61779-034-8_13; Park MH, 1998, J BIOL CHEM, V273, P1677, DOI 10.1074/jbc.273.3.1677; PARK MH, 1982, J BIOL CHEM, V257, P7217; PARK MH, 1981, P NATL ACAD SCI-BIOL, V78, P2869, DOI 10.1073/pnas.78.5.2869; Patel PH, 2009, J CELL BIOL, V185, P1181, DOI 10.1083/jcb.200904161; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SALI A, 1995, MOL MED TODAY, V1, P270, DOI 10.1016/s1357-4310(95)91170-7; SCHNIER J, 1991, MOL CELL BIOL, V11, P3105, DOI 10.1128/MCB.11.6.3105; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Sugimoto A, 2004, DIFFERENTIATION, V72, P81, DOI 10.1111/j.1432-0436.2004.07202004.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vu VV, 2009, P NATL ACAD SCI USA, V106, P14814, DOI 10.1073/pnas.0904553106; Weir BA, 2004, MOL BIOL CELL, V15, P1656, DOI 10.1091/mbc.E03-06-0371; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Wolff EC, 2007, AMINO ACIDS, V33, P341, DOI 10.1007/s00726-007-0525-0	44	26	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33138	10.1371/journal.pone.0033138	http://dx.doi.org/10.1371/journal.pone.0033138			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438895	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000303309100024
J	Babayeva, ND; Baranovskaya, OI; Tahirov, TH				Babayeva, Nigar D.; Baranovskaya, Oxana I.; Tahirov, Tahir H.			Structural Basis of Ets1 Cooperative Binding to Widely Separated Sites on Promoter DNA	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; STROMELYSIN-1 PROMOTER; CRYSTAL-STRUCTURE; AUTO-INHIBITION; MURINE ETS-1; IN-VIVO; C-ETS; GENE; PROTEIN; SEQUENCES	Ets1 is a member of the Ets family of transcription factors. Ets1 is expressed in autoinhibited form and its DNA binding depends on partner proteins bound to adjacent sequences or the relative positioning of a second Ets-binding site (EBS). The autoinhibition of Ets1 is mediated by structural coupling of regions flanking the DNA-binding domain. The NMR structure of Ets1 revealed that the inhibitory regions comprised of helices HI1 and HI2 and H4 are packed together on the Ets domain to form an inhibitory module. The crystal structure of Ets1 unexpectedly revealed a homodimer in which homodimerisation occurs via swapping of HI1 helices. Modeling of DNA binding indicates that the Ets1 dimer can bind to two antiparallel pieces of DNA. To verify this, we crystallized and solved the structure of the complex comprised of Ets1 dimer and two pieces of DNA. DNA binding by Ets1 dimer resulted in formation of additional intermolecular protein center dot DNA interactions, implying that the complex formation is cooperative.	[Babayeva, Nigar D.; Baranovskaya, Oxana I.; Tahirov, Tahir H.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center	Babayeva, ND (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA.	ttahirov@unmc.edu		Tahirov, Tahir/0000-0002-1238-0069	National Institute of General Medical Sciences [R01GM082923]; Nebraska Department of Health and Human Services [LB506]; National Center for Research Resources at the National Institutes of Health [RR-15301]; U.S. Department of Energy, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082923] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Nebraska Department of Health and Human Services; National Center for Research Resources at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); U.S. Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of General Medical Sciences grant R01GM082923 and Nebraska Department of Health and Human Services grant LB506 to THT. This work was also based upon research conducted at the Northeastern Collaborative Access Team beamlines of the Advanced Photon Source, supported by award RR-15301 from the National Center for Research Resources at the National Institutes of Health. Use of the Advanced Photon Source is supported by the U.S. Department of Energy, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babayeva ND, 2010, CELL CYCLE, V9, P3054, DOI 10.4161/cc.9.14.12257; Baillat D, 2006, ONCOGENE, V25, P5764, DOI 10.1038/sj.onc.1209583; Baillat D, 2002, J BIOL CHEM, V277, P29386, DOI 10.1074/jbc.M200088200; Basuyaux JP, 1997, J BIOL CHEM, V272, P26188, DOI 10.1074/jbc.272.42.26188; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUTTICE G, 1993, J BIOL CHEM, V268, P7196; CHEN JH, 1985, MOL CELL BIOL, V5, P2993, DOI 10.1128/MCB.5.11.2993; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; DONALDSON LW, 1994, BIOCHEMISTRY-US, V33, P13509, DOI 10.1021/bi00250a001; Droge P, 2001, BIOESSAYS, V23, P179, DOI 10.1002/1521-1878(200102)23:2<179::AID-BIES1025>3.0.CO;2-6; Escalante CR, 2002, MOL CELL, V10, P1097, DOI 10.1016/S1097-2765(02)00703-7; Garvie CW, 2002, J BIOL CHEM, V277, P45529, DOI 10.1074/jbc.M206327200; Garvie CW, 2001, MOL CELL, V8, P1267, DOI 10.1016/S1097-2765(01)00410-5; Goetz TL, 2000, MOL CELL BIOL, V20, P81, DOI 10.1128/MCB.20.1.81-90.2000; Gu TL, 2000, MOL CELL BIOL, V20, P91, DOI 10.1128/MCB.20.1.91-103.2000; HAGMAN J, 1992, P NATL ACAD SCI USA, V89, P8889, DOI 10.1073/pnas.89.19.8889; Hodge DR, 1996, ONCOGENE, V12, P11; JANKNECHT R, 1993, BIOCHIM BIOPHYS ACTA, V1155, P346, DOI 10.1016/0304-419X(93)90014-4; Jonsen MD, 1996, MOL CELL BIOL, V16, P2065; Kim WY, 1999, EMBO J, V18, P1609, DOI 10.1093/emboj/18.6.1609; Lee GM, 2005, J BIOL CHEM, V280, P7088, DOI 10.1074/jbc.M410722200; LEPRINCE D, 1983, NATURE, V306, P395, DOI 10.1038/306395a0; LIM F, 1992, EMBO J, V11, P643, DOI 10.1002/j.1460-2075.1992.tb05096.x; Lu J, 2004, MOL CELL BIOL, V24, P428, DOI 10.1128/MCB.24.1.428-441.2004; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Mo Y, 2001, J MOL BIOL, V314, P495, DOI 10.1006/jmbi.2001.5138; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nikolajczyk BS, 1999, IMMUNITY, V11, P11, DOI 10.1016/S1074-7613(00)80077-1; NUNN MF, 1983, NATURE, V306, P391, DOI 10.1038/306391a0; NYE JA, 1992, GENE DEV, V6, P975, DOI 10.1101/gad.6.6.975; Ogata K, 2003, CURR OPIN STRUC BIOL, V13, P40, DOI 10.1016/S0959-440X(03)00012-5; PETERSEN JM, 1995, SCIENCE, V269, P1866, DOI 10.1126/science.7569926; Raouf A, 2000, ONCOGENE, V19, P6455, DOI 10.1038/sj.onc.1204037; Reisman D, 2001, GENE, V274, P129, DOI 10.1016/S0378-1119(01)00623-0; Sato M, 1998, ONCOGENE, V17, P1517, DOI 10.1038/sj.onc.1202064; Sato Y, 2001, CELL STRUCT FUNCT, V26, P19, DOI 10.1247/csf.26.19; SCHLEIF R, 1992, ANNU REV BIOCHEM, V61, P199, DOI 10.1146/annurev.bi.61.070192.001215; Seth A, 2005, EUR J CANCER, V41, P2462, DOI 10.1016/j.ejca.2005.08.013; Steger DJ, 1997, EMBO J, V16, P2463, DOI 10.1093/emboj/16.9.2463; SUN WW, 1995, J VIROL, V69, P4941, DOI 10.1128/JVI.69.8.4941-4949.1995; Tahirov TH, 2002, CELL, V108, P57, DOI 10.1016/S0092-8674(01)00636-5; TUCK SP, 1989, MOL CELL BIOL, V9, P2163, DOI 10.1128/MCB.9.5.2163; Vassylyev DG, 2007, NATURE, V448, P157, DOI 10.1038/nature05932; Venanzoni MC, 1996, ONCOGENE, V12, P1199; Wai PY, 2006, J BIOL CHEM, V281, P18973, DOI 10.1074/jbc.M511962200; WASYLYK C, 1992, GENE DEV, V6, P965, DOI 10.1101/gad.6.6.965; WASYLYK C, 1991, EMBO J, V10, P1127, DOI 10.1002/j.1460-2075.1991.tb08053.x; WOTTON D, 1994, MOL CELL BIOL, V14, P840, DOI 10.1128/MCB.14.1.840	48	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e33698	10.1371/journal.pone.0033698	http://dx.doi.org/10.1371/journal.pone.0033698			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22432043	Green Submitted, gold, Green Published			2022-12-25	WOS:000303198600086
J	Bruno, S; Grange, C; Collino, F; Deregibus, MC; Cantaluppi, V; Biancone, L; Tetta, C; Camussi, G				Bruno, Stefania; Grange, Cristina; Collino, Federica; Deregibus, Maria Chiara; Cantaluppi, Vincenzo; Biancone, Luigi; Tetta, Ciro; Camussi, Giovanni			Microvesicles Derived from Mesenchymal Stem Cells Enhance Survival in a Lethal Model of Acute Kidney Injury	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; CASPASE-1-DEFICIENT MICE; HORIZONTAL TRANSFER; IN-VITRO; PROTECT; REPAIR; APOPTOSIS; RECOVERY	Several studies demonstrated that treatment with mesenchymal stem cells (MSCs) reduces cisplatin mortality in mice. Microvesicles (MVs) released from MSCs were previously shown to favor renal repair in non lethal toxic and ischemic acute renal injury (AKI). In the present study we investigated the effects of MSC-derived MVs in SCID mice survival in lethal cisplatin-induced AKI. Moreover, we evaluated in vitro the effect of MVs on cisplatin-induced apoptosis of human renal tubular epithelial cells and the molecular mechanisms involved. Two different regimens of MV injection were used. The single administration of MVs ameliorated renal function and morphology, and improved survival but did not prevent chronic tubular injury and persistent increase in BUN and creatinine. Multiple injections of MVs further decreased mortality and at day 21 surviving mice showed normal histology and renal function. The mechanism of protection was mainly ascribed to an anti-apoptotic effect of MVs. In vitro studies demonstrated that MVs up-regulated in cisplatin-treated human tubular epithelial cells anti-apoptotic genes, such as Bcl-xL, Bcl2 and BIRC8 and down-regulated genes that have a central role in the execution-phase of cell apoptosis such as Casp1, Casp8 and LTA. In conclusion, MVs released from MSCs were found to exert a pro-survival effect on renal cells in vitro and in vivo, suggesting that MVs may contribute to renal protection conferred by MSCs.	[Bruno, Stefania; Grange, Cristina; Collino, Federica; Deregibus, Maria Chiara; Cantaluppi, Vincenzo; Biancone, Luigi; Camussi, Giovanni] Univ Turin, Dept Internal Med, Turin, Italy; [Bruno, Stefania; Grange, Cristina; Collino, Federica; Deregibus, Maria Chiara; Cantaluppi, Vincenzo; Biancone, Luigi; Camussi, Giovanni] Univ Turin, Ctr Mol Biotechnol, Turin, Italy; [Tetta, Ciro] Fresenius Med Care, Bad Homburg, Germany	University of Turin; University of Turin	Bruno, S (corresponding author), Univ Turin, Dept Internal Med, Turin, Italy.	giovanni.camussi@unito.it	Cantaluppi, Vincenzo/K-8531-2016; Collino, Federica/B-9956-2018; Camussi, Giovanni/J-7624-2016	Cantaluppi, Vincenzo/0000-0002-4120-3555; Collino, Federica/0000-0002-3619-7701; Camussi, Giovanni/0000-0003-2795-232X; BIANCONE, Luigi/0000-0002-7700-6350; GRANGE, CRISTINA/0000-0002-6960-5476; BRUNO, Stefania/0000-0002-8879-9536	Regione Piemonte; Piattaforme Biotecnologiche; Pi-Stem project; Fresenius Medical Care	Regione Piemonte(Regione Piemonte); Piattaforme Biotecnologiche; Pi-Stem project; Fresenius Medical Care	This work was supported by Regione Piemonte, Piattaforme Biotecnologiche, Pi-Stem project and by a grant form Fresenius Medical Care. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi B, 2007, J AM SOC NEPHROL, V18, P2486, DOI 10.1681/ASN.2007020140; Bonegio R, 2002, CURR OPIN NEPHROL HY, V11, P301, DOI 10.1097/00041552-200205000-00006; Bruno S, 2009, J AM SOC NEPHROL, V20, P1053, DOI 10.1681/ASN.2008070798; Camussi G, 2010, KIDNEY INT, V78, P838, DOI 10.1038/ki.2010.278; Cantaluppi V, 2008, J AM SOC NEPHROL, V19, P1904, DOI 10.1681/ASN.2007111209; Collino F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011803; Collino F, 2009, EXP CELL RES, V315, P2982, DOI 10.1016/j.yexcr.2009.06.010; Conaldi PG, 1998, J CLIN INVEST, V102, P2041, DOI 10.1172/JCI3480; Deregibus MC, 2007, BLOOD, V110, P2440, DOI 10.1182/blood-2007-03-078709; Dragovic RA, 2011, NANOMED-NANOTECHNOL, V7, P780, DOI 10.1016/j.nano.2011.04.003; Eliopoulos N, 2010, AM J PHYSIOL-RENAL, V299, pF1288, DOI 10.1152/ajprenal.00671.2009; Faubel S, 2004, KIDNEY INT, V66, P2202, DOI 10.1111/j.1523-1755.2004.66010.x; Gatti S, 2011, NEPHROL DIAL TRANSPL, V26, P1474, DOI 10.1093/ndt/gfr015; Herrera MB, 2010, J CELL MOL MED, V14, P1605, DOI 10.1111/j.1582-4934.2009.00860.x; Herrera MB, 2004, INT J MOL MED, V14, P1035; Humphreys BD, 2008, CELL STEM CELL, V2, P284, DOI 10.1016/j.stem.2008.01.014; Lange C, 2005, KIDNEY INT, V68, P1613, DOI 10.1111/j.1523-1755.2005.00573.x; Lieberthal W, 1999, CELL DEATH DIFFER, V270, pF700; Melnikov VY, 2001, J CLIN INVEST, V107, P1145, DOI 10.1172/JCI12089; Morel O, 2004, CURR OPIN HEMATOL, V11, P156, DOI 10.1097/01.moh.0000131441.10020.87; Morigi M, 2004, J AM SOC NEPHROL, V15, P1794, DOI 10.1097/01.ASN.0000128974.07460.34; Morigi M, 2008, STEM CELLS, V26, P2075, DOI 10.1634/stemcells.2007-0795; MORTON DB, 1985, VET REC, V116, P431, DOI 10.1136/vr.116.16.431; Pabla N, 2008, KIDNEY INT, V73, P994, DOI 10.1038/sj.ki.5002786; Picinich SC, 2007, EXPERT OPIN BIOL TH, V7, P965, DOI 10.1517/14712598.7.7.965; Quesenberry PJ, 2010, EXP HEMATOL, V38, P581, DOI 10.1016/j.exphem.2010.03.021; Ratajczak J, 2006, LEUKEMIA, V20, P1487, DOI 10.1038/sj.leu.2404296; Ratajczak J, 2006, LEUKEMIA, V20, P847, DOI 10.1038/sj.leu.2404132; Schorey JS, 2008, TRAFFIC, V9, P871, DOI 10.1111/j.1600-0854.2008.00734.x; Togel F, 2005, AM J PHYSIOL-RENAL, V289, pF31, DOI 10.1152/ajprenal.00007.2005; Yuan A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004722	31	358	390	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e33115	10.1371/journal.pone.0033115	http://dx.doi.org/10.1371/journal.pone.0033115			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22431999	gold, Green Published			2022-12-25	WOS:000303198600042
J	Flatz, R; Gonzalez-Suarez, M; Young, JK; Hernandez-Camacho, CJ; Immel, AJ; Gerber, LR				Flatz, Ramona; Gonzalez-Suarez, Manuela; Young, Julie K.; Hernandez-Camacho, Claudia J.; Immel, Aaron J.; Gerber, Leah R.			Weak Polygyny in California Sea Lions and the Potential for Alternative Mating Tactics	PLOS ONE			English	Article							ZALOPHUS-CALIFORNIANUS; REPRODUCTIVE-SYSTEMS; MICROSATELLITE LOCI; SEXUAL SELECTION; EVOLUTION; PATERNITY; BEHAVIOR; MALES; MODEL	Female aggregation and male territoriality are considered to be hallmarks of polygynous mating systems. The development of genetic parentage assignment has called into question the accuracy of behavioral traits in predicting true mating systems. In this study we use 14 microsatellite markers to explore the mating system of one of the most behaviorally polygynous species, the California sea lion (Zalophus californianus). We sampled a total of 158 female-pup pairs and 99 territorial males across two breeding rookeries (San Jorge and Los Islotes) in the Gulf of California, Mexico. Fathers could be identified for 30% of pups sampled at San Jorge across three breeding seasons and 15% of sampled pups at Los Islotes across two breeding seasons. Analysis of paternal relatedness between the pups for which no fathers were identified (sampled over four breeding seasons at San Jorge and two at Los Islotes) revealed that few pups were likely to share a father. Thirty-one percent of the sampled males on San Jorge and 15% of the sampled males on Los Islotes were assigned at least one paternity. With one exception, no male was identified as the father of more than two pups. Furthermore, at Los Islotes rookery there were significantly fewer pups assigned paternity than expected given the pool of sampled males (p<0.0001). Overall, we found considerably lower variation in male reproductive success than expected in a species that exhibits behavior associated with strongly polygynous mating. Low variation in male reproductive success may result from heightened mobility among receptive females in the Gulf of California, which reduces the ability of males to monopolize groups of females. Our results raise important questions regarding the adaptive role of territoriality and the potential for alternative mating tactics in this species.	[Flatz, Ramona; Gonzalez-Suarez, Manuela; Young, Julie K.; Hernandez-Camacho, Claudia J.; Immel, Aaron J.; Gerber, Leah R.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Flatz, R (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	Ramona.Flatz@gmail.com	Camacho, Claudia J. Hernández/Q-8914-2018; González-Suárez, Manuela/B-9740-2008	Camacho, Claudia J. Hernández/0000-0002-6309-9728; González-Suárez, Manuela/0000-0001-5069-8900; Gerber, Leah/0000-0002-6763-6842; Young, Julie/0000-0003-4522-0157	National Science Foundation [0347960]; European Community [235897]; Spanish Ministry of Science and Innovation [CGL2009-07301/BOS, BES-2010-034151]; Consejo Nacional de Ciencia y Tecnologia [95802]	National Science Foundation(National Science Foundation (NSF)); European Community(European Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The research was supported by the National Science Foundation (Grant no. 0347960 to LG). Dr. Gonzalez-Suarez was funded in part by the European Community's Seventh Framework Programme (FP7/2007-2013; http://cordis.europa.eu/fp7) under grant agreement nu 235897 and the Spanish Ministry of Science and Innovation (CGL2009-07301/BOS and BES-2010-034151). The authors are grateful for a grant provided to Dr. Hernandez-Camacho from Consejo Nacional de Ciencia y Tecnologia (Scholarship No. 95802). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen PJ, 1995, P ROY SOC LOND B BIO, V252, P199; Aurioles-Gamboa D, 1988, THESIS U CALIFORNIA; BARTHOLOMEW GA, 1970, EVOLUTION, V24, P546, DOI 10.1111/j.1558-5646.1970.tb01790.x; Boness D.J., 1991, P1; Buchanan FC, 1998, MOL ECOL, V7, P1083; Cassini MH, 1999, BEHAV ECOL, V10, P612, DOI 10.1093/beheco/10.5.612; Cassini MH, 2000, BEHAV PROCESS, V51, P93, DOI 10.1016/S0376-6357(00)00121-2; Cerchio S, 2005, ANIM BEHAV, V70, P267, DOI 10.1016/j.anbehav.2004.10.028; CLUTTONBROCK TH, 1978, NATURE, V273, P191, DOI 10.1038/273191a0; CLUTTONBROCK TH, 1991, NATURE, V351, P58; Coltman DW, 1996, MOL ECOL, V5, P161, DOI 10.1111/j.1365-294X.1996.tb00303.x; de Bruyn PJN, 2011, ANIM BEHAV, V82, P445, DOI 10.1016/j.anbehav.2011.06.006; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Flatz R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013873; Garcia-Aguilar MC, 2003, AQUAT MAMM, V29, P10; Gerber LR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012230; Gonzalez-Suarez M, 2009, MOL ECOL, V18, P1088, DOI 10.1111/j.1365-294X.2009.04093.x; Gonzalez-Suarez M, 2008, J MAMMAL, V89, P1521, DOI 10.1644/08-MAMM-A-109.1; Goodman SJ, 1997, ANIM GENET, V28, P310; Gross MR, 1996, TRENDS ECOL EVOL, V11, P92, DOI 10.1016/0169-5347(96)81050-0; Heath C, 1989, THESIS U CALIFORNIA; Hernandez-Velazquez FD, 2005, MOL ECOL NOTES, V5, P140, DOI 10.1111/j.1471-8286.2004.00858.x; Hoberecht LK, 2006, MAR MAMMAL SCI, V22, P683, DOI 10.1111/j.1748-7692.2006.00046.x; Hoffman JI, 2007, NATURE, V445, P912, DOI 10.1038/nature05558; Hoffman JI, 2005, MOL ECOL, V14, P599, DOI 10.1111/j.1365-294X.2004.02419.x; Hoffman JI, 2003, EVOLUTION, V57, P1917; Huebinger RM, 2007, MOL ECOL NOTES, V7, P1097, DOI 10.1111/j.1471-8286.2007.01790.x; Hughes C, 1998, ECOLOGY, V79, P383, DOI 10.1890/0012-9658(1998)079[0383:IMTWFM]2.0.CO;2; Jacobs DF, 2008, J MAMMAL, V89, P1212, DOI 10.1644/07-MAMM-A-171.1; le Boeuf B.J., 1991, P45; LEBOEUF BJ, 1986, NEW SCI, V109, P36; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; McEachern MB, 2009, ANIM BEHAV, V77, P449, DOI 10.1016/j.anbehav.2008.10.024; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; ODELL D K, 1975, Rapports et Proces-Verbaux des Reunions Conseil International pour l'Exploration de la Mer, V169, P374; ODELL DK, 1974, BEHAV BIOL, V10, P231, DOI 10.1016/S0091-6773(74)91851-3; Plaistow SJ, 2004, BEHAV ECOL, V15, P534, DOI 10.1093/beheco/arh029; Porschmann U, 2010, MOL ECOL, V19, P2574, DOI 10.1111/j.1365-294X.2010.04665.x; Ridgeway SH, HDB MARINE MAMMALS; Riedman M, PINNIPEDS SEALS SEA; Robertson KL, 2008, CAN J ZOOL, V86, P237, DOI 10.1139/Z07-136; Shuster SM, MATING SYSTEMS STRAT; Soto KH, 2011, MAR MAMMAL SCI, V27, P306, DOI 10.1111/j.1748-7692.2010.00405.x; Szteren D, 2006, LOW WAKE FI, P369; Taberlet P, 1999, TRENDS ECOL EVOL, V14, P323, DOI 10.1016/S0169-5347(99)01637-7; TRILLMICH F, 1984, BIOL J LINN SOC, V21, P209; Trillmich F, FUR SEALS MATERNAL S; Twiss SD, 2006, MOL ECOL, V15, P14; Valiere N, 2002, MOL ECOL NOTES, V2, P377, DOI 10.1046/j.1471-8286.2002.00228.x; Villegas-Amtmann S, 2009, J MAMMAL, V90, P1232, DOI 10.1644/08-MAMM-A-319.1; Weckerly FW, 1998, J MAMMAL, V79, P33, DOI 10.2307/1382840; Wolf JBW, 2006, CONSERV GENET, V7, P461, DOI 10.1007/s10592-005-9045-1; Young Julie K., 2008, Aquatic Mammals, V34, P102, DOI 10.1578/AM.34.1.2008.102	53	16	16	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e33654	10.1371/journal.pone.0033654	http://dx.doi.org/10.1371/journal.pone.0033654			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22432039	Green Published, Green Accepted, gold			2022-12-25	WOS:000303198600082
J	Antipova, O; Orgel, JPRO				Antipova, Olga; Orgel, Joseph P. R. O.			Non-Enzymatic Decomposition of Collagen Fibers by a Biglycan Antibody and a Plausible Mechanism for Rheumatoid Arthritis	PLOS ONE			English	Article							II COLLAGEN; MATRIX-METALLOPROTEINASE; SMALL PROTEOGLYCANS; FIBRIL STRUCTURE; IN-SITU; CARTILAGE; DECORIN; DEGRADATION; LAMPREY; MICE	Rheumatoid arthritis (RA) is a systemic autoimmune inflammatory and destructive joint disorder that affects tens of millions of people worldwide. Normal healthy joints maintain a balance between the synthesis of extracellular matrix (ECM) molecules and the proteolytic degradation of damaged ones. In the case of RA, this balance is shifted toward matrix destruction due to increased production of cleavage enzymes and the presence of (autoimmune) immunoglobulins resulting from an inflammation induced immune response. Herein we demonstrate that a polyclonal antibody against the proteoglycan biglycan (BG) causes tissue destruction that may be analogous to that of RA affected tissues. The effect of the antibody is more potent than harsh chemical and/or enzymatic treatments designed to mimic arthritis-like fibril de-polymerization. In RA cases, the immune response to inflammation causes synovial fibroblasts, monocytes and macrophages to produce cytokines and secrete matrix remodeling enzymes, whereas B cells are stimulated to produce immunoglobulins. The specific antigen that causes the RA immune response has not yet been identified, although possible candidates have been proposed, including collagen types I and II, and proteoglycans (PG's) such as biglycan. We speculate that the initiation of RA associated tissue destruction in vivo may involve a similar non-enzymatic decomposition of collagen fibrils via the immunoglobulins themselves that we observe here ex vivo.	[Antipova, Olga; Orgel, Joseph P. R. O.] IIT, Pritzker Inst Biomed Sci & Engn, Chicago, IL 60616 USA	Illinois Institute of Technology	Antipova, O (corresponding author), IIT, Pritzker Inst Biomed Sci & Engn, Chicago, IL 60616 USA.	olga.antipova@gmail.com; orgel@iit.edu			U.S. Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-ENG-38]; National Institutes of Health [RR-08630]; National Science Foundation [MCB-0644015 CAREER]; US Army Research Laboratory; US Army Research Office [W911NF 09-1-0378]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR008630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103622] Funding Source: NIH RePORTER	U.S. Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); US Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); US Army Research Office; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Basic Energy Sciences, Office of Science, under contract No. W-31-109-ENG-38. BioCAT is a National Institutes of Health-supported Research Center RR-08630. The content is solely the responsibility of the authors and does not necessarily reflect the official views of the National Center for Research Resources or the National Institutes of Health. This work was also supported by the National Science Foundation (Grant #MCB-0644015 CAREER). This material is based on the work supported by, or in part by, the US Army Research Laboratory and the US Army Research Office under contract/grant number W911NF 09-1-0378. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameye L, 2002, FASEB J, V16, DOI 10.1096/fj.01-0848com; Antipova O, 2010, J BIOL CHEM, V285, P7087, DOI 10.1074/jbc.M109.060400; BRODSKY B, 1994, J MOL BIOL, V243, P38, DOI 10.1006/jmbi.1994.1628; Buckwalter J A, 1988, Electron Microsc Rev, V1, P87; Chen WB, 2002, J BIOL CHEM, V277, P36118, DOI 10.1074/jbc.M203709200; CLAFFEY W, 1977, BIOPHYS J, V19, P63, DOI 10.1016/S0006-3495(77)85562-8; Clark JM, 1997, MICROSC RES TECHNIQ, V37, P299, DOI 10.1002/(SICI)1097-0029(19970515)37:4<299::AID-JEMT5>3.0.CO;2-G; Comper W.D., 1996, EXTRACELLULAR MATRIX; COX RW, 1973, J CELL SCI, V12, P933; EIKENBERRY EF, 1984, J MOL BIOL, V176, P261, DOI 10.1016/0022-2836(84)90424-8; Furukawa T, 2009, SPINE, V34, pE911, DOI 10.1097/BRS.0b013e3181b7c7ec; Gyorgy B, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2507; Holmes DF, 2006, P NATL ACAD SCI USA, V103, P17249, DOI 10.1073/pnas.0608417103; IOZZO RV, 2000, PROTEOGLYCANS; KELLY J, 1988, J BIOL CHEM, V263, P980; KRAJICKOVA J, 1988, ANN RHEUM DIS, V47, P468, DOI 10.1136/ard.47.6.468; KRESINA TF, 1986, ANN RHEUM DIS, V45, P60, DOI 10.1136/ard.45.1.60; Landewe RBM, 2006, ANN RHEUM DIS, V65, P40, DOI 10.1136/ard.2004.035196; Lark MW, 1997, J CLIN INVEST, V100, P93, DOI 10.1172/JCI119526; Marchant JK, 1996, J CELL BIOL, V135, P1415, DOI 10.1083/jcb.135.5.1415; Melrose J, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2453; MITCHELL NS, 1978, J BONE JOINT SURG AM, V60, P349, DOI 10.2106/00004623-197860030-00014; Orgel JPRO, 2011, CONNECT TISSUE RES, V52, P18, DOI 10.3109/03008207.2010.511354; Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103; Orgel JPRO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007028; Otero M, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2292; Pasteels J., 1958, TRAITE ZOOLOGIE ANAT, VXIII, P106; Perumal S, 2008, P NATL ACAD SCI USA, V105, P2824, DOI 10.1073/pnas.0710588105; Polgar A, 2003, RHEUMATOLOGY, V42, P522, DOI 10.1093/rheumatology/keg168; Price JS, 1999, ARTHRITIS RHEUM-US, V42, P137, DOI 10.1002/1529-0131(199901)42:1<137::AID-ANR17>3.0.CO;2-0; Robinson PS, 2005, J BIOMECH ENG-T ASME, V127, P181, DOI 10.1115/1.1835363; SCOTT JE, 1991, INT J BIOL MACROMOL, V13, P157, DOI 10.1016/0141-8130(91)90041-R; Scott JE, 1996, BIOCHEMISTRY-US, V35, P8795, DOI 10.1021/bi960773t; Scott PG, 1997, BBA-GEN SUBJECTS, V1336, P254, DOI 10.1016/S0304-4165(97)00040-8; SHEREN SB, 1986, COMP BIOCHEM PHYS B, V85, P5, DOI 10.1016/0305-0491(86)90214-2; Shintani S, 2000, J MOL EVOL, V51, P363, DOI 10.1007/s002390010098; TODA G, 1987, Gastroenterologia Japonica, V22, P303; Vynios DH, 2001, BIOCHIMIE, V83, P899, DOI 10.1016/S0300-9084(01)01332-3	38	20	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2012	7	3							e32241	10.1371/journal.pone.0032241	http://dx.doi.org/10.1371/journal.pone.0032241			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930IA	22427827	Green Published, gold, Green Submitted			2022-12-25	WOS:000303129700009
J	Fondon, JW; Martin, A; Richards, S; Gibbs, RA; Mittelman, D				Fondon, John W., III; Martin, Andy; Richards, Stephen; Gibbs, Richard A.; Mittelman, David			Analysis of Microsatellite Variation in Drosophila melanogaster with Population-Scale Genome Sequencing	PLOS ONE			English	Article							TANDEM REPEATS; GENETIC-VARIATION; INSTABILITY; INSERTIONS; EVOLUTION	Genome sequencing technologies promise to revolutionize our understanding of genetics, evolution, and disease by making it feasible to survey a broad spectrum of sequence variation on a population scale. However, this potential can only be realized to the extent that methods for extracting and interpreting distinct forms of variation can be established. The error profiles and read length limitations of early versions of next-generation sequencing technologies rendered them ineffective for some sequence variant types, particularly microsatellites and other tandem repeats, and fostered the general misconception that such variants are inherently inaccessible to these platforms. At the same time, tandem repeats have emerged as important sources of functional variation. Tandem repeats are often located in and around genes, and frequent mutations in their lengths exert quantitative effects on gene function and phenotype, rapidly degrading linkage disequilibrium between markers and traits. Sensitive identification of these variants in large-scale next-gen sequencing efforts will enable more comprehensive association studies capable of revealing previously invisible associations. We present a population-scale analysis of microsatellite repeats using whole-genome data from 158 inbred isolates from the Drosophila Genetics Reference Panel, a collection of over 200 extensively phenotypically characterized isolates from a single natural population, to uncover processes underlying repeat mutation and to enable associations with behavioral, morphological, and life-history traits. Analysis of repeat variation from next-generation sequence data will also enhance studies of genome stability and neurodegenerative diseases.	[Fondon, John W., III] Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA; [Martin, Andy; Mittelman, David] Virginia Tech, Virginia Bioinformat Inst, Blacksburg, VA USA; [Richards, Stephen; Gibbs, Richard A.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Mittelman, David] Virginia Tech, Dept Biol Sci, Blacksburg, VA USA; [Richards, Stephen; Gibbs, Richard A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	University of Texas System; University of Texas Arlington; Virginia Polytechnic Institute & State University; Baylor College of Medicine; Virginia Polytechnic Institute & State University; Baylor College of Medicine	Fondon, JW (corresponding author), Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA.	fondon@uta.edu; david.mittelman@vt.edu			NVIDIA Foundation; National Institutes of Health/National Human Genome Research Institute [HG003273]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER	NVIDIA Foundation; National Institutes of Health/National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by an award through the NVIDIA Foundation's "Compute the Cure" program to DM, and by a U54 grant from the National Institutes of Health/National Human Genome Research Institute to RAG (HG003273). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers CA, 2011, GENOME RES, V21, P961, DOI 10.1101/gr.112326.110; Albrecht A, 2005, CURR OPIN GENET DEV, V15, P285, DOI 10.1016/j.gde.2005.04.003; Albrecht AN, 2004, HUM MOL GENET, V13, P2351, DOI 10.1093/hmg/ddh277; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Axford MM, 2011, J MED GENET, V48, P438, DOI 10.1136/jmg.2010.085944; Bashir A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000051; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Castel AL, 2010, NAT REV MOL CELL BIO, V11, P165, DOI 10.1038/nrm2854; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Fondon JW, 1998, P NATL ACAD SCI USA, V95, P7514, DOI 10.1073/pnas.95.13.7514; Gemayel R, 2010, ANNU REV GENET, V44, P445, DOI 10.1146/annurev-genet-072610-155046; GERBER HP, 1994, SCIENCE, V263, P808, DOI 10.1126/science.8303297; Hannan AJ, 2010, TRENDS GENET, V26, P59, DOI 10.1016/j.tig.2009.11.008; Hile SE, 2008, NUCLEIC ACIDS RES, V36, P688, DOI 10.1093/nar/gkm1089; Kelkar YD, 2010, GENOME BIOL EVOL, V2, P620, DOI 10.1093/gbe/evq046; Korol A, 2006, P NATL ACAD SCI USA, V103, P18184, DOI 10.1073/pnas.0608777103; Legendre M, 2007, GENOME RES, V17, P1787, DOI 10.1101/gr.6554007; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lynch HT, 2009, CLIN GENET, V76, P1, DOI 10.1111/j.1399-0004.2009.01230.x; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McIver LJ, 2011, GENOMICS, V97, P193, DOI 10.1016/j.ygeno.2011.01.001; Mills RE, 2006, GENOME RES, V16, P1182, DOI 10.1101/gr.4565806; Mills RE, 2011, GENOME RES, V21, P830, DOI 10.1101/gr.115907.110; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Mittelman D, 2009, P NATL ACAD SCI USA, V106, P9607, DOI 10.1073/pnas.0902420106; Orr HT, 2009, J BIOL CHEM, V284, P7405, DOI 10.1074/jbc.R800067200; Reuschenbach M, 2010, FAM CANCER, V9, P173, DOI 10.1007/s10689-009-9307-z; Sainudiin R, 2004, GENETICS, V168, P383, DOI 10.1534/genetics.103.022665; Sawyer LA, 1997, SCIENCE, V278, P2117, DOI 10.1126/science.278.5346.2117; Schug MD, 1997, NAT GENET, V15, P99, DOI 10.1038/ng0197-99; Verstrepen KJ, 2005, NAT GENET, V37, P986, DOI 10.1038/ng1618; Vinces MD, 2009, SCIENCE, V324, P1213, DOI 10.1126/science.1170097; Wells RD, 2005, NUCLEIC ACIDS RES, V33, P3785, DOI 10.1093/nar/gki697	38	26	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33036	10.1371/journal.pone.0033036	http://dx.doi.org/10.1371/journal.pone.0033036			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427938	Green Submitted, Green Published, gold			2022-12-25	WOS:000302381500080
J	Hsieh, PF; Lin, TL; Yang, FL; Wu, MC; Pan, YJ; Wu, SH; Wang, JT				Hsieh, Pei-Fang; Lin, Tzu-Lung; Yang, Feng-Ling; Wu, Meng-Chuan; Pan, Yi-Jiun; Wu, Shih-Hsiung; Wang, Jin-Town			Lipopolysaccharide O1 Antigen Contributes to the Virulence in Klebsiella pneumoniae Causing Pyogenic Liver Abscess	PLOS ONE			English	Article							D-GALACTAN-I; CAPSULAR POLYSACCHARIDE; SEROTYPE O1-K20; BIOSYNTHESIS; RESISTANCE; GENE; STRAINS; IDENTIFICATION; INFECTIONS; BACTEREMIA	Klebsiella pneumoniae is the common cause of a global emerging infectious disease, community-acquired pyogenic liver abscess (PLA). Capsular polysaccharide (CPS) and lipopolysaccharide (LPS) are critical for this microorganism's ability to spread through the blood and to cause sepsis. While CPS type K1 is an important virulence factor in K. pneumoniae causing PLA, the role of LPS in PLA is not clear. Here, we characterize the role of LPS O antigen in the pathogenesis of K. pneumoniae causing PLA. NTUH-K2044 is a LPS O1 clinical strain; the presence of the O antigen was shown via the presence of 1,3-galactan in the LPS, and of sequences that align with the wb gene cluster, known to produce O-antigen. Serologic analysis of K. pneumoniae clinical isolates demonstrated that the O1 serotype was more prevalent in PLA strains than that in non-tissue-invasive strains (38/42 vs. 9/32, P<0.0001). O1 serotype isolates had a higher frequency of serum resistance, and mutation of the O1 antigen changed serum resistance in K. pneumoniae. A PLA-causing strain of CPS capsular type K2 and LPS serotype O1 (i.e., O1:K2 PLA strain) deleted for the O1 synthesizing genes was profoundly attenuated in virulence, as demonstrated in separate mouse models of septicemia and liver abscess. Immunization of mice with the K2044 magA-mutant (K-1(-) O-1) against LPS O1 provided protection against infection with an O1:K2 PLA strain, but not against infection with an O1 K1 PLA strain. Our findings indicate that the O1 antigen of PLA-associated K. pneumoniae contributes to virulence by conveying resistance to serum killing, promoting bacterial dissemination to and colonization of internal organs after the onset of bacteremia, and could be a useful vaccine candidate against infection by an O1:K2 PLA strain.	[Hsieh, Pei-Fang; Lin, Tzu-Lung; Wu, Meng-Chuan; Pan, Yi-Jiun; Wang, Jin-Town] Natl Taiwan Univ, Coll Med, Dept Microbiol, Taipei 10764, Taiwan; [Yang, Feng-Ling; Wu, Shih-Hsiung] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Wang, Jin-Town] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan	National Taiwan University; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University Hospital	Hsieh, PF (corresponding author), Natl Taiwan Univ, Coll Med, Dept Microbiol, Taipei 10764, Taiwan.	wangjt@ntu.edu.tw		Pan, Yi-Jiun/0000-0002-2522-7805	National Taiwan University; National Science Council in Taiwan; Department of Medical Research at NTUH	National Taiwan University(National Taiwan University); National Science Council in Taiwan(Ministry of Science and Technology, Taiwan); Department of Medical Research at NTUH	This study was supported by National Taiwan University and the National Science Council in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Yi-Li Liu and I-Ching Huang for technical support with DNA sequencing (supported in part by the Department of Medical Research at NTUH).	Alberti S, 1996, INFECT IMMUN, V64, P4726; BRONNER D, 1994, MOL MICROBIOL, V14, P505, DOI 10.1111/j.1365-2958.1994.tb02185.x; Cai SS, 2009, J IMMUNOL, V183, P6629, DOI 10.4049/jimmunol.0901033; Chuang YP, 2006, J INFECT DIS, V193, P645, DOI 10.1086/499968; Chung DR, 2007, J INFECTION, V54, P578, DOI 10.1016/j.jinf.2006.11.008; CLARKE BR, 1992, J BACTERIOL, V174, P4614, DOI 10.1128/JB.174.14.4614-4621.1992; Clements A, 2008, VACCINE, V26, P5649, DOI 10.1016/j.vaccine.2008.07.100; Cortes G, 2002, INFECT IMMUN, V70, P2583, DOI 10.1128/IAI.70.5.2583-2590.2002; DOMENICO P, 1989, INFECT IMMUN, V57, P3778, DOI 10.1128/IAI.57.12.3778-3782.1989; Fang CT, 2004, J EXP MED, V199, P697, DOI 10.1084/jem.20030857; Gierczynski R., 2005, Medycyna Doswiadczalna i Mikrobiologia, V57, P383; Guan S, 2001, J BACTERIOL, V183, P3318, DOI 10.1128/JB.183.11.3318-3327.2001; Hansen DS, 1999, J CLIN MICROBIOL, V37, P56, DOI 10.1128/JCM.37.1.56-62.1999; Hsieh PF, 2008, J INFECT DIS, V197, P1717, DOI 10.1086/588383; Hsieh PF, 2010, J INFECT DIS, V202, P52, DOI 10.1086/653079; Kelly RF, 1996, J BACTERIOL, V178, P5205, DOI 10.1128/jb.178.17.5205-5214.1996; Koplin R, 1997, J BIOL CHEM, V272, P4121, DOI 10.1074/jbc.272.7.4121; Kos V, 2010, J BIOL CHEM, V285, P19668, DOI 10.1074/jbc.M110.122598; Lugo JZ, 2007, SHOCK, V27, P186, DOI 10.1097/01.shk.0000238058.23837.21; MCCALLUM KL, 1989, INFECT IMMUN, V57, P3816, DOI 10.1128/IAI.57.12.3816-3822.1989; MERINO S, 1992, INFECT IMMUN, V60, P2529, DOI 10.1128/IAI.60.6.2529-2535.1992; Pan YJ, 2008, J CLIN MICROBIOL, V46, P2231, DOI 10.1128/JCM.01716-07; Pan YJ, 2011, INFECT IMMUN, V79, P997, DOI 10.1128/IAI.00906-10; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rukavina T, 1997, INFECT IMMUN, V65, P1754, DOI 10.1128/IAI.65.5.1754-1760.1997; Sahly H, 2004, ANTIMICROB AGENTS CH, V48, P3477, DOI 10.1128/AAC.48.9.3477-3482.2004; SCHNAITMAN CA, 1993, MICROBIOL REV, V57, P655, DOI 10.1128/MMBR.57.3.655-682.1993; Shankar-Sinha S, 2004, INFECT IMMUN, V72, P1423, DOI 10.1128/IAI.72.3.1423-1430.2004; TOMAS JM, 1986, INFECT IMMUN, V54, P85; Trautmann M, 1997, CLIN DIAGN LAB IMMUN, V4, P550, DOI 10.1128/CDLI.4.5.550-555.1997; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Tsai FC, 2008, EMERG INFECT DIS, V14, P1592, DOI 10.3201/eid1410.071254; Vinogradov E, 2002, J BIOL CHEM, V277, P25070, DOI 10.1074/jbc.M202683200; WHITFIELD C, 1991, J BACTERIOL, V173, P1420, DOI 10.1128/jb.173.4.1420-1431.1991; WHITFIELD C, 1995, TRENDS MICROBIOL, V3, P178, DOI 10.1016/S0966-842X(00)88917-9; WILLIAMS P, 1988, J MED MICROBIOL, V26, P29, DOI 10.1099/00222615-26-1-29; Wu KM, 2009, J BACTERIOL, V191, P4492, DOI 10.1128/JB.00315-09; Yang FL, 2011, J BIOL CHEM, V286, P21041, DOI 10.1074/jbc.M111.222091	38	49	58	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33155	10.1371/journal.pone.0033155	http://dx.doi.org/10.1371/journal.pone.0033155			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427976	Green Submitted, Green Published, gold			2022-12-25	WOS:000302381500101
J	Lamarque, MH; Papoin, J; Finizio, AL; Lentini, G; Pfaff, AW; Candolfi, E; Dubremetz, JF; Lebrun, M				Lamarque, Mauld H.; Papoin, Julien; Finizio, Anne-Laure; Lentini, Gaelle; Pfaff, Alexander W.; Candolfi, Ermanno; Dubremetz, Jean-Francois; Lebrun, Maryse			Identification of a New Rhoptry Neck Complex RON9/RON10 in the Apicomplexa Parasite Toxoplasma gondii	PLOS ONE			English	Article							PARASITOPHOROUS VACUOLE; MOVING JUNCTION; HOST-CELLS; PROTEIN; INVASION; SECRETION; VIRULENCE; DOMAIN; ORGANELLES; MEMBRANE	Apicomplexan parasites secrete and inject into the host cell the content of specialized secretory organelles called rhoptries, which take part into critical processes such as host cell invasion and modulation of the host cell immune response. The rhoptries are structurally and functionally divided into two compartments. The apical duct contains rhoptry neck (RON) proteins that are conserved in Apicomplexa and are involved in formation of the moving junction (MJ) driving parasite invasion. The posterior bulb contains rhoptry proteins (ROPs) unique to an individual genus and, once injected in the host cell act as effector proteins to co-opt host processes and modulate parasite growth and virulence. We describe here two new RON proteins of Toxoplasma gondii, RON9 and RON10, which form a high molecular mass complex. In contrast to the other RONs described to date, this complex was not detected at the MJ during invasion and therefore was not associated to the MJ complex RON2/4/5/8. Disruptions of either RON9 or RON10 gene leads to the retention of the partner in the ER followed by subsequent degradation, suggesting that the RON9/RON10 complex formation is required for proper sorting to the rhoptries. Finally, we show that the absence of RON9/RON10 has no significant impact on the morphology of rhoptry, on the invasion and growth in fibroblasts in vitro or on virulence in vivo. The conservation of RON9 and RON10 in Coccidia and Cryptosporidia suggests a specific relation with development in intestinal epithelial cells.	[Lamarque, Mauld H.; Papoin, Julien; Finizio, Anne-Laure; Lentini, Gaelle; Dubremetz, Jean-Francois; Lebrun, Maryse] Univ Montpellier 2, CNRS, UMR 5235, F-34095 Montpellier, France; [Pfaff, Alexander W.; Candolfi, Ermanno] Univ Strasbourg, EA 4438, Inst Parasitol & Pathol Tropicale, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Lamarque, MH (corresponding author), Univ Montpellier 2, CNRS, UMR 5235, F-34095 Montpellier, France.	mylebrun@univ-montp2.fr	Lebrun, Maryse/I-7728-2016	Lentini, Gaelle/0000-0003-0836-9972; Lebrun, Maryse/0000-0002-0962-0156	The French National Research "Infectious diseases, immunity and Environment" ANR-MIE; ANR-MIE	The French National Research "Infectious diseases, immunity and Environment" ANR-MIE(French National Research Agency (ANR)); ANR-MIE(French National Research Agency (ANR))	This work was supported by a research grant from The French National Research "Infectious diseases, immunity and Environment" ANR-MIE-2009 to ML. MHL is supported by The ANR-MIE-2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2009, J BIOL CHEM, V284, P33683, DOI 10.1074/jbc.M109.044024; AIKAWA M, 1978, J CELL BIOL, V77, P72, DOI 10.1083/jcb.77.1.72; Al-Khodor S, 2010, TRENDS MICROBIOL, V18, P132, DOI 10.1016/j.tim.2009.11.004; Alexander DL, 2005, PLOS PATHOG, V1, P137, DOI 10.1371/journal.ppat.0010017; Baldi DL, 2000, EMBO J, V19, P2435, DOI 10.1093/emboj/19.11.2435; Beck JR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001094; BECKERS CJM, 1994, J CELL BIOL, V127, P947, DOI 10.1083/jcb.127.4.947; Belizario JE, 2008, CURR PROTEIN PEPT SC, V9, P210, DOI 10.2174/138920308784534023; Besteiro S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002416; Besteiro S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000309; Boothroyd JC, 2008, NAT REV MICROBIOL, V6, P79, DOI 10.1038/nrmicro1800; Borowski H, 2008, TRENDS PARASITOL, V24, P509, DOI 10.1016/j.pt.2008.08.002; Bradley PJ, 2005, J BIOL CHEM, V280, P34245, DOI 10.1074/jbc.M504158200; Bradley PJ, 2001, INT J PARASITOL, V31, P1177, DOI 10.1016/S0020-7519(01)00242-9; Cameron C, 1999, VIROLOGY, V264, P298, DOI 10.1006/viro.1999.0001; Carey KL, 2004, EUKARYOT CELL, V3, P1320, DOI 10.1128/EC.3.5.1320-1330.2004; Carruthers VB, 1997, EUR J CELL BIOL, V73, P114; Cerede O, 2005, J EXP MED, V201, P453, DOI 10.1084/jem.20041672; COUVREUR G, 1988, PARASITOLOGY, V97, P1, DOI 10.1017/S0031182000066695; Donald RGK, 1998, MOL BIOCHEM PARASIT, V91, P295, DOI 10.1016/S0166-6851(97)00210-7; Dubremetz JF, 2007, CELL MICROBIOL, V9, P841, DOI 10.1111/j.1462-5822.2007.00909.x; Dubremetz JF, 2009, INT J PARASITOL, V39, P883, DOI 10.1016/j.ijpara.2009.02.009; El Hajj H, 2007, PLOS PATHOG, V3, P200, DOI 10.1371/journal.ppat.0030014; El Hajj H, 2007, CELL MICROBIOL, V9, P54, DOI 10.1111/j.1462-5822.2006.00767.x; Garcia-Reguet N, 2000, CELL MICROBIOL, V2, P353, DOI 10.1046/j.1462-5822.2000.00064.x; Gilberger TW, 2003, J CELL BIOL, V162, P317, DOI 10.1083/jcb.200301046; Gilbert LA, 2007, EUKARYOT CELL, V6, P73, DOI 10.1128/EC.00309-06; Hakansson S, 2001, EMBO J, V20, P3132, DOI 10.1093/emboj/20.12.3132; Heiges M, 2006, NUCLEIC ACIDS RES, V34, pD419, DOI 10.1093/nar/gkj078; Herm-Gotz A, 2002, EMBO J, V21, P2149, DOI 10.1093/emboj/21.9.2149; Hu K, 2002, MOL BIOL CELL, V13, P593, DOI 10.1091/mbc.01-06-0309; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Kafsack BFC, 2004, MOL BIOCHEM PARASIT, V136, P309, DOI 10.1016/j.molbiopara.2004.04.004; Kirkitadze MD, 2001, IMMUNOL REV, V180, P146, DOI 10.1034/j.1600-065X.2001.1800113.x; Kissinger JC, 2003, NUCLEIC ACIDS RES, V31, P234, DOI 10.1093/nar/gkg072; Labesse G, 2009, STRUCTURE, V17, P139, DOI 10.1016/j.str.2008.11.005; Lamarque M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001276; Lebrun M., 2007, P265, DOI 10.1016/B978-012369542-0/50013-1; Lebrun M, 2005, CELL MICROBIOL, V7, P1823, DOI 10.1111/j.1462-5822.2005.00646.x; LERICHE MA, 1991, MOL BIOCHEM PARASIT, V45, P249, DOI 10.1016/0166-6851(91)90092-K; Lodoen MB, 2010, CELL MICROBIOL, V12, P55, DOI 10.1111/j.1462-5822.2009.01378.x; Mann T, 2001, MOL BIOCHEM PARASIT, V115, P257, DOI 10.1016/S0166-6851(01)00289-4; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; O'Hara Steven P., 2008, V47, P92; O'Keeffe AH, 2005, MOL BIOCHEM PARASIT, V140, P61, DOI 10.1016/j.molbiopara.2004.12.003; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Riglar DT, 2011, CELL HOST MICROBE, V9, P9, DOI 10.1016/j.chom.2010.12.003; Saeij JPJ, 2007, NATURE, V445, P324, DOI 10.1038/nature05395; Saeij JPJ, 2006, SCIENCE, V314, P1780, DOI 10.1126/science.1133690; Santos JM, 2009, INT J PARASITOL, V39, P153, DOI 10.1016/j.ijpara.2008.10.007; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Singh S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000746; Srivastava A, 2010, MOL BIOCHEM PARASIT, V174, P66, DOI 10.1016/j.molbiopara.2010.06.003; Taylor S, 2006, SCIENCE, V314, P1776, DOI 10.1126/science.1133643; Tonkin ML, 2011, SCIENCE, V333, P463, DOI 10.1126/science.1204988; Turetzky JM, 2010, INT J PARASITOL, V40, P1037, DOI 10.1016/j.ijpara.2010.02.014; VANDENHOFF MJB, 1992, NUCLEIC ACIDS RES, V20, P2902, DOI 10.1093/nar/20.11.2902; Werden SJ, 2008, BBA-PROTEINS PROTEOM, V1784, P228, DOI 10.1016/j.bbapap.2007.08.001	58	18	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e32457	10.1371/journal.pone.0032457	http://dx.doi.org/10.1371/journal.pone.0032457			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427839	Green Published, Green Submitted, gold			2022-12-25	WOS:000302381500018
J	Vieira, J; Jones, AR; Danon, A; Sakuma, M; Hoang, N; Robles, D; Tait, S; Heyes, DJ; Picot, M; Yoshii, T; Helfrich-Forster, C; Soubigou, G; Coppee, JY; Klarsfeld, A; Rouyer, F; Scrutton, NS; Ahmad, M				Vieira, Jacqueline; Jones, Alex R.; Danon, Antoine; Sakuma, Michiyo; Hoang, Nathalie; Robles, David; Tait, Shirley; Heyes, Derren J.; Picot, Marie; Yoshii, Taishi; Helfrich-Foerster, Charlotte; Soubigou, Guillaume; Coppee, Jean-Yves; Klarsfeld, Andre; Rouyer, Francois; Scrutton, Nigel S.; Ahmad, Margaret			Human Cryptochrome-1 Confers Light Independent Biological Activity in Transgenic Drosophila Correlated with Flavin Radical Stability	PLOS ONE			English	Article							MAMMALIAN CRY1; ARABIDOPSIS; PROTEIN; PHOTORECEPTOR; RHYTHM; GENES; RESISTANCE; PHOTOLYASE; MECHANISM; CLOCK	Cryptochromes are conserved flavoprotein receptors found throughout the biological kingdom with diversified roles in plant development and entrainment of the circadian clock in animals. Light perception is proposed to occur through flavin radical formation that correlates with biological activity in vivo in both plants and Drosophila. By contrast, mammalian (Type II) cryptochromes regulate the circadian clock independently of light, raising the fundamental question of whether mammalian cryptochromes have evolved entirely distinct signaling mechanisms. Here we show by developmental and transcriptome analysis that Homo sapiens cryptochrome - 1 (HsCRY1) confers biological activity in transgenic expressing Drosophila in darkness, that can in some cases be further stimulated by light. In contrast to all other cryptochromes, purified recombinant HsCRY1 protein was stably isolated in the anionic radical flavin state, containing only a small proportion of oxidized flavin which could be reduced by illumination. We conclude that animal Type I and Type II cryptochromes may both have signaling mechanisms involving formation of a flavin radical signaling state, and that light independent activity of Type II cryptochromes is a consequence of dark accumulation of this redox form in vivo rather than of a fundamental difference in signaling mechanism.	[Vieira, Jacqueline; Danon, Antoine; Hoang, Nathalie; Robles, David; Ahmad, Margaret] Univ Paris 06, Paris, France; [Jones, Alex R.; Sakuma, Michiyo; Tait, Shirley; Heyes, Derren J.; Scrutton, Nigel S.] Univ Manchester, Manchester Interdisciplinary Bioctr, Manchester, Lancs, England; [Jones, Alex R.; Sakuma, Michiyo; Tait, Shirley; Heyes, Derren J.; Scrutton, Nigel S.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Picot, Marie; Klarsfeld, Andre; Rouyer, Francois] CNRS UPR 2216 NGI, Inst Neurobiol Alfred Fessard, Gif Sur Yvette, France; [Yoshii, Taishi] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan; [Helfrich-Foerster, Charlotte] Univ Wurzburg, Bioctr, Wurzburg, Germany; [Soubigou, Guillaume; Coppee, Jean-Yves] Inst Pasteur, Genomes & Genet Dept, Paris, France; [Ahmad, Margaret] Penn State Univ, Media, PA USA	UDICE-French Research Universities; Sorbonne Universite; University of Manchester; University of Manchester; Okayama University; University of Wurzburg; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Vieira, J (corresponding author), Univ Paris 06, Paris, France.	margaret.ahmad@upmc.fr	Danon, Antoine/F-7790-2018; Rouyer, François/L-9043-2018; Yoshii, Taishi/C-2766-2015; Jones, Alex/AFQ-8212-2022	Danon, Antoine/0000-0001-6311-6076; Rouyer, François/0000-0001-5641-397X; Yoshii, Taishi/0000-0002-7057-7986; Tait, Shirley/0000-0002-3053-9547; Ahmad, Margaret/0000-0003-4524-5813; PICOT, Marie/0000-0002-5331-9723; Jones, Alex/0000-0001-6021-7824; Helfrich-Forster, Charlotte/0000-0002-0859-9092; Klarsfeld, Andre/0000-0001-9293-4887; Heyes, Derren/0000-0002-7453-1571	Le Centre national de la recherche scientifique; ACI/BCMS; National Science Foundation [0848311]; Electromagnetic Fields Biological Research Trust (EMF BRT); German Research Foundation [GRK 640]; European Union [018741]; BBSRC [BB/D01963X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D01963X/1] Funding Source: researchfish	Le Centre national de la recherche scientifique(Centre National de la Recherche Scientifique (CNRS)); ACI/BCMS; National Science Foundation(National Science Foundation (NSF)); Electromagnetic Fields Biological Research Trust (EMF BRT)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); German Research Foundation(German Research Foundation (DFG)); European Union(European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding is acknowledged from the Le Centre national de la recherche scientifique, ACI/BCMS and National Science Foundation (#0848311) to MA, from the Electromagnetic Fields Biological Research Trust (EMF BRT) to NS, and from the German Research Foundation (GRK 640) and the European Union (6th framework Project EUCLOCK, no. 018741) to CH, NH is recipient of an ACI/BCMS fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000435; Balland V, 2009, J AM CHEM SOC, V131, P426, DOI 10.1021/ja806540j; Banerjee R, 2007, J BIOL CHEM, V282, P14916, DOI 10.1074/jbc.M700616200; Berndt A, 2007, J BIOL CHEM, V282, P13011, DOI 10.1074/jbc.M608872200; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bouly JP, 2007, J BIOL CHEM, V282, P9383, DOI 10.1074/jbc.M609842200; Busza A, 2004, SCIENCE, V304, P1503, DOI 10.1126/science.1096973; Chaves I, 2006, MOL CELL BIOL, V26, P1743, DOI 10.1128/MCB.26.5.1743-1753.2006; Chaves I, 2011, ANNU REV PLANT BIOL, V62, P335, DOI 10.1146/annurev-arplant-042110-103759; Collins B, 2006, CURR BIOL, V16, P441, DOI 10.1016/j.cub.2006.01.034; CRONMILLER C, 1993, MECH DEVELOP, V42, P159, DOI 10.1016/0925-4773(93)90005-I; Danon A, 2006, P NATL ACAD SCI USA, V103, P17036, DOI 10.1073/pnas.0608139103; Dolezelova E, 2007, GENETICS, V177, P329, DOI 10.1534/genetics.107.076513; Emery P, 2000, NATURE, V404, P456, DOI 10.1038/35006558; Foley LE, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1364; Gegear RJ, 2008, NATURE, V454, P1014, DOI 10.1038/nature07183; Gegear RJ, 2010, NATURE, V463, P804, DOI 10.1038/nature08719; Gobert V, 2003, SCIENCE, V302, P2126, DOI 10.1126/science.1085432; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Hoang N, 2008, PLOS BIOL, V6, P1559, DOI 10.1371/journal.pbio.0060160; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.2307/2336325; Hsu DS, 1996, BIOCHEMISTRY-US, V35, P13871, DOI 10.1021/bi962209o; Ivanchenko M, 2001, J BIOL RHYTHM, V16, P205, DOI 10.1177/074873001129001917; Jain N, 2003, BIOINFORMATICS, V19, P1945, DOI 10.1093/bioinformatics/btg264; Jeong RD, 2010, P NATL ACAD SCI USA, V107, P13538, DOI 10.1073/pnas.1004529107; Kaneko M, 1998, CURR OPIN NEUROBIOL, V8, P652, DOI 10.1016/S0959-4388(98)80095-0; Kaplow ME, 2007, J NEUROGENET, V21, P105, DOI 10.1080/01677060701503140; Kaushik R, 2007, PLOS BIOL, V5, P1257, DOI 10.1371/journal.pbio.0050146; Kondoh M, 2011, J MOL BIOL IN PRESS; Krishnan B, 2001, NATURE, V411, P313, DOI 10.1038/35077094; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Liedvogel M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001106; Lin CT, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-220; Liu B, 2010, CURR OPIN PLANT BIOL, V13, P578, DOI 10.1016/j.pbi.2010.09.005; MASSEY V, 1966, BIOCHEMISTRY-US, V5, P3181, DOI 10.1021/bi00874a016; Muller P, 2011, JBC             0405; Okamura H, 1999, SCIENCE, V286, P2531, DOI 10.1126/science.286.5449.2531; Ozgur S, 2003, BIOCHEMISTRY-US, V42, P2926, DOI 10.1021/bi026963n; Ozgur S, 2006, BIOCHEMISTRY-US, V45, P13369, DOI 10.1021/bi061556n; Ozturk N, 2011, P NATL ACAD SCI USA, V108, P516, DOI 10.1073/pnas.1017093108; Ozturk N, 2009, P NATL ACAD SCI USA, V106, P2841, DOI 10.1073/pnas.0813028106; Paranjpe DA, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-5; RUBIN GM, 1985, COLD SPRING HARB SYM, V50, P329, DOI 10.1101/SQB.1985.050.01.042; Sancar A, 2004, ADV PROTEIN CHEM, V69, P73; Sancar A, 2010, FEBS LETT, V584, P2618, DOI 10.1016/j.febslet.2010.03.017; Song SH, 2007, J BIOL CHEM, V282, P17608, DOI 10.1074/jbc.M702874200; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Tamanini F, 2007, COLD SPRING HARB SYM, V72, P133, DOI 10.1101/sqb.2007.72.066; Tamanini Filippo, 2007, Methods Mol Biol, V362, P443; TANAKA N, 1993, MOL CELL BIOL, V13, P4531, DOI 10.1128/MCB.13.8.4531; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; vanVickle-Chavez SJ, 2007, J BIOL CHEM, V282, P10561, DOI 10.1074/jbc.M609314200; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Wu L, 2010, MOL PLANT, V3, P539, DOI 10.1093/mp/ssp107; Xu P, 2009, PLANT PHYSIOL, V149, P760, DOI 10.1104/pp.108.132217; Yagita K, 2001, SCIENCE, V292, P278, DOI 10.1126/science.1059542; Yang YJ, 2008, MOL PLANT, V1, P167, DOI 10.1093/mp/ssm018; Yu XH, 2007, P NATL ACAD SCI USA, V104, P7289, DOI 10.1073/pnas.0701912104; Zhu HS, 2005, CURR BIOL, V15, pR953, DOI 10.1016/j.cub.2005.11.030	60	23	24	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e31867	10.1371/journal.pone.0031867	http://dx.doi.org/10.1371/journal.pone.0031867			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427812	gold, Green Published, Green Submitted			2022-12-25	WOS:000302381500005
J	Sanders, AP; Flood, K; Chiang, S; Herring, AH; Wolf, L; Fry, RC				Sanders, Alison P.; Flood, Kaye; Chiang, Shu; Herring, Amy H.; Wolf, Leslie; Fry, Rebecca C.			Towards Prenatal Biomonitoring in North Carolina: Assessing Arsenic, Cadmium, Mercury, and Lead Levels in Pregnant Women	PLOS ONE			English	Article							CORD BLOOD; BIRTH-WEIGHT; EXPOSURE; CHILDREN; MORTALITY; HEALTH; CANCER; AMERICAN; INFANTS; METALS	Exposure to toxic metals during the prenatal period carries the potential for adverse developmental effects to the fetus, yet such exposure remains largely unmonitored in the United States. The aim of this study was to assess maternal exposure to four toxic metals (arsenic (As), cadmium (Cd), mercury (Hg), and lead (Pb)) in a cohort of pregnant women in North Carolina. We analyzed blood samples submitted to the North Carolina Department of Health and Human Services for blood typing to assess toxic metal levels in pregnant women (n = 211) across six North Carolina counties. Whole blood metal concentrations were measured by inductively coupled plasma mass spectrometry. The association between maternal characteristics, including county of residence, age, and race, and metal exposure was analyzed using multiple linear regression analysis. A large fraction of the blood samples showed detectable levels for each of the four metals. Specifically, As (65.7%), Cd (57.3%), Hg (63.8%), and Pb (100%) were detected in blood samples. Moreover, compared with adult females participating in the Fourth National Report on Human Exposure to Environmental Chemicals and guidelines for pregnant women, some women in the sample population exceeded benchmark levels of Cd, Hg, and Pb. Evidence from this pilot study indicates that pregnant women in North Carolina are exposed to As, Cd, Hg, and Pb and suggests that factors related to maternal county of residence and race may impact maternal exposure levels. As increased levels of one or more of these metals in utero have been associated with detrimental developmental and reproductive outcomes, further study is clearly warranted to establish the impacts to newborns.	[Sanders, Alison P.; Fry, Rebecca C.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Environm Sci & Engn, Chapel Hill, NC 27515 USA; [Flood, Kaye; Chiang, Shu; Wolf, Leslie] N Carolina Dept Hlth & Human Serv, State Lab Publ Hlth, Raleigh, NC USA; [Herring, Amy H.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Biostat, Chapel Hill, NC USA; [Herring, Amy H.] Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Sanders, AP (corresponding author), Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Environm Sci & Engn, Chapel Hill, NC 27515 USA.	rfry@email.unc.edu		Fry, Rebecca/0000-0003-0899-9018; Sanders, Alison/0000-0001-8252-4016; Herring, Amy/0000-0003-1552-8871	Pfizer, Inc.; NIEHS [T32-ES007017, P30-ES010126]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007017, P30ES010126, P42ES005948, R01ES019315] Funding Source: NIH RePORTER	Pfizer, Inc.(Pfizer); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was funded in part by a Public Health Scholar Award to RCF from Pfizer, Inc. and by the NIEHS (T32-ES007017 and P30-ES010126). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Toxic Substances and Disease Registry (ATSDR), 2007, TOX PROF LEAD; Alexander GR, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.1.e61; ATSDR, 2007, TOX PROF ARS; ATSDR, 2010, CERCLA PRIOR LIST HA; ATSDR (Agency for Toxic Substances and Disease Registry), 2008, TOX PROF CADM; ATSDR (Agency for Toxic Substances and Disease Registry), 1999, TOX PROF MERC; BRFSS, 2005, RES 2004 N C BEHAV R; CDC, 2008, LAB PROC MAN LEAD CA; CDC (Centers for Disease Control and Prevention), 2009, 4 NAT REP HUM EXP EN; CDC (Centers for Disease Control and Prevention), 2010, GUID ID MAN LEAD EXP; Clifton JC, 2007, PEDIATR CLIN N AM, V54, P237, DOI 10.1016/j.pcl.2007.02.005; Concha G, 1998, TOXICOL SCI, V44, P185, DOI 10.1006/toxs.1998.2486; Concha G, 1998, ENVIRON HEALTH PERSP, V106, P355, DOI 10.2307/3434042; EPA, 2010, METHYLM EXP; FRERY N, 1993, TOXICOLOGY, V79, P109, DOI 10.1016/0300-483X(93)90124-B; Fry RC, 2007, PLOS GENET, V3, P2180, DOI 10.1371/journal.pgen.0030207; Gerhardsson L, 2010, J ENVIRON HEALTH, V72, P37; Guan HA, 2010, BIOMED ENVIRON SCI, V23, P458, DOI 10.1016/S0895-3988(11)60008-1; Hightower JM, 2006, ENVIRON HEALTH PERSP, V114, P173, DOI 10.1289/ehp.8464; Huyck KL, 2007, J OCCUP ENVIRON MED, V49, P1097, DOI 10.1097/JOM.0b013e3181566ba0; Jarup Lars, 1998, Scandinavian Journal of Work Environment and Health, V24, P1; Jedrychowski W, 2006, ANN EPIDEMIOL, V16, P439, DOI 10.1016/j.annepidem.2005.06.059; Landrigan PJ, 2002, ENVIRON HEALTH PERSP, V110, P721, DOI 10.1289/ehp.02110721; Liaw J, 2008, CANCER EPIDEM BIOMAR, V17, P1982, DOI 10.1158/1055-9965.EPI-07-2816; Liu J, 2008, TOXICOL SCI, V105, P24, DOI 10.1093/toxsci/kfn120; Mahaffey KR, 2009, ENVIRON HEALTH PERSP, V117, P47, DOI 10.1289/ehp.11674; McShane WJ, 2008, SPECTROCHIM ACTA B, V63, P638, DOI 10.1016/j.sab.2008.03.016; Miranda ML, 2011, INT J ENV RES PUB HE, V8, P698, DOI 10.3390/ijerph8030698; Miranda ML, 2002, ENVIRON HEALTH PERSP, V110, P947, DOI 10.1289/ehp.02110947; NCDHHS, 2010, RAC ETHN HLTH DISP N; NCDHHS, 2009, N CAR STRAT PLAN ELI; NCDHHS, 2011, N CAR STAT LAB PUBL; Nordberg GF, 2005, TOXICOL APPL PHARM, V206, P191, DOI 10.1016/j.taap.2004.11.028; NORMAN EH, 1994, PEDIATRICS, V94, P59; Quansah R, 2009, INT ARCH OCC ENV HEA, V82, P529, DOI 10.1007/s00420-008-0349-6; Ramon R, 2011, ENVIRON INT, V37, P597, DOI 10.1016/j.envint.2010.12.004; Rice DC, 2010, J EXPO SCI ENV EPID, V20, P634, DOI 10.1038/jes.2010.42; Rollin HB, 2009, J ENVIRON MONITOR, V11, P618, DOI 10.1039/b816236k; Ronchetti R, 2006, ACTA PAEDIATR, V95, P45, DOI 10.1080/08035320600886224; Rudge CV, 2009, J ENVIRON MONITOR, V11, P1322, DOI 10.1039/b903805a; Salpietro CD, 2002, J PERINAT MED, V30, P395, DOI 10.1515/JPM.2002.061; Sanders AP, 2012, ENVIRON INT, V38, P10, DOI 10.1016/j.envint.2011.08.005; Sexton K, 2007, ENVIRON HEALTH PERSP, V115, P825, DOI 10.1289/ehp.9333; Smith AH, 2006, ENVIRON HEALTH PERSP, V114, P1293, DOI 10.1289/ehp.8832; Thompson J, 2008, REPROD TOXICOL, V25, P304, DOI 10.1016/j.reprotox.2008.02.001; Tokar EJ, 2011, TOXICOL SCI, V120, pS192, DOI 10.1093/toxsci/kfq342; Trasande L, 2005, ENVIRON HEALTH PERSP, V113, P590, DOI 10.1289/ehp.7743; Vahter M, 2008, BASIC CLIN PHARMACOL, V102, P204, DOI 10.1111/j.1742-7843.2007.00168.x; Waalkes MP, 2008, ENVIRON HEALTH PERSP, V116, pA104, DOI 10.1289/ehp.11276	49	53	53	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2012	7	3							e31354	10.1371/journal.pone.0031354	http://dx.doi.org/10.1371/journal.pone.0031354			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KX	22427803	gold, Green Published, Green Submitted			2022-12-25	WOS:000303062800005
J	Scarafone, N; Pain, C; Fratamico, A; Gaspard, G; Yilmaz, N; Filee, P; Galleni, M; Matagne, A; Dumoulin, M				Scarafone, Natacha; Pain, Coralie; Fratamico, Anthony; Gaspard, Gilles; Yilmaz, Nursel; Filee, Patrice; Galleni, Moreno; Matagne, Andre; Dumoulin, Mireille			Amyloid-Like Fibril Formation by PolyQ Proteins: A Critical Balance between the PolyQ Length and the Constraints Imposed by the Host Protein	PLOS ONE			English	Article							EXPANDED GLUTAMINE REPEATS; A BETA-LACTAMASES; POLYGLUTAMINE TRACTS; IN-VITRO; NEURODEGENERATIVE DISORDERS; INTRANUCLEAR INCLUSIONS; AGGREGATION KINETICS; MAMMALIAN-CELLS; FUSION PROTEINS; HUMAN LYSOZYME	Nine neurodegenerative disorders, called polyglutamine (polyQ) diseases, are characterized by the formation of intranuclear amyloid-like aggregates by nine proteins containing a polyQ tract above a threshold length. These insoluble aggregates and/or some of their soluble precursors are thought to play a role in the pathogenesis. The mechanism by which polyQ expansions trigger the aggregation of the relevant proteins remains, however, unclear. In this work, polyQ tracts of different lengths were inserted into a solvent-exposed loop of the beta-lactamase BlaP and the effects of these insertions on the properties of BlaP were investigated by a range of biophysical techniques. The insertion of up to 79 glutamines does not modify the structure of BlaP; it does, however, significantly destabilize the enzyme. The extent of destabilization is largely independent of the polyQ length, allowing us to study independently the effects intrinsic to the polyQ length and those related to the structural integrity of BlaP on the aggregating properties of the chimeras. Only chimeras with 55Q and 79Q readily form amyloid-like fibrils; therefore, similarly to the proteins associated with diseases, there is a threshold number of glutamines above which the chimeras aggregate into amyloid-like fibrils. Most importantly, the chimera containing 79Q forms amyloid-like fibrils at the same rate whether BlaP is folded or not, whereas the 55Q chimera aggregates into amyloid-like fibrils only if BlaP is unfolded. The threshold value for amyloid-like fibril formation depends, therefore, on the structural integrity of the beta-lactamase moiety and thus on the steric and/or conformational constraints applied to the polyQ tract. These constraints have, however, no significant effect on the propensity of the 79Q tract to trigger fibril formation. These results suggest that the influence of the protein context on the aggregating properties of polyQ disease-associated proteins could be negligible when the latter contain particularly long polyQ tracts.	[Scarafone, Natacha; Pain, Coralie; Fratamico, Anthony; Matagne, Andre; Dumoulin, Mireille] Univ Liege, Inst Chem, Ctr Prot Engn, Lab Enzymol & Prot Folding, Liege, Belgium	University of Liege	Scarafone, N (corresponding author), Univ Liege, Inst Chem, Ctr Prot Engn, Lab Enzymol & Prot Folding, Liege, Belgium.	mdumoulin@ulg.ac.be		Matagne, Andre/0000-0001-6417-6791	Fonds de la Recherche Fondamentale et Collective (FRFC) [2.4530.09]; Fonds de la Recherche Scientifique [1.C039.09, MIS-F.4505.11]; Belgian program of Interuniversity Attraction Poles; FRIA	Fonds de la Recherche Fondamentale et Collective (FRFC)(Fonds de la Recherche Scientifique - FNRS); Fonds de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Belgian program of Interuniversity Attraction Poles; FRIA(Fonds de la Recherche Scientifique - FNRS)	This work was supported by grants from the Fonds de la Recherche Fondamentale et Collective (FRFC 2.4530.09 to AM), the Fonds de la Recherche Scientifique (1.C039.09 and MIS-F.4505.11 to MD), and the Belgian program of Interuniversity Attraction Poles administered by the Federal Office for Scientific Technical and Cultural Affairs (PAI number P6/19). N.S. and C.P. are recipients of a FRIA fellowship. M.D. is a Research Associate of the Fonds de la Recherche Scientifique (FRS-F.N.R.S, Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	AMBLER RP, 1991, BIOCHEM J, V276, P269, DOI 10.1042/bj2760269; Bennett MJ, 2002, P NATL ACAD SCI USA, V99, P11634, DOI 10.1073/pnas.182393899; Bhattacharyya A, 2006, J MOL BIOL, V355, P524, DOI 10.1016/j.jmb.2005.10.053; Bulone D, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000111; Chen S, 2001, J MOL BIOL, V311, P173, DOI 10.1006/jmbi.2001.4850; Cooper JK, 1998, HUM MOL GENET, V7, P783, DOI 10.1093/hmg/7.5.783; Crick SL, 2006, P NATL ACAD SCI USA, V103, P16764, DOI 10.1073/pnas.0608175103; Darnell G, 2007, J MOL BIOL, V374, P688, DOI 10.1016/j.jmb.2007.09.023; Diaz-Hernandez M, 2004, J NEUROSCI, V24, P9361, DOI 10.1523/JNEUROSCI.2365-04.2004; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Dumoulin M, 2003, NATURE, V424, P783, DOI 10.1038/nature01870; Dumoulin M, 2002, PROTEIN SCI, V11, P500, DOI 10.1110/ps.34602; Dumoulin M, 2006, ACCOUNTS CHEM RES, V39, P603, DOI 10.1021/ar050070g; El Hajjaji H, 2009, J MOL BIOL, V386, P60, DOI 10.1016/j.jmb.2008.11.046; Ellisdon AM, 2007, J MOL BIOL, V368, P595, DOI 10.1016/j.jmb.2007.02.058; Ellisdon AM, 2006, J BIOL CHEM, V281, P16888, DOI 10.1074/jbc.M601470200; HAN KK, 1977, BIOCHIMIE, V59, P557, DOI 10.1016/S0300-9084(77)80166-1; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Hollenbach B, 1999, PHILOS T ROY SOC B, V354, P991, DOI 10.1098/rstb.1999.0450; Ignatova Z, 2006, J BIOL CHEM, V281, P12959, DOI 10.1074/jbc.M511523200; Ignatova Z, 2007, J BIOL CHEM, V282, P36736, DOI 10.1074/jbc.M703682200; Johnson SM, 2005, ACCOUNTS CHEM RES, V38, P911, DOI 10.1021/ar020073i; Kim MW, 2009, STRUCTURE, V17, P1205, DOI 10.1016/j.str.2009.08.002; Klein FAC, 2007, J MOL BIOL, V371, P235, DOI 10.1016/j.jmb.2007.05.028; KNOX JR, 1991, J MOL BIOL, V220, P435, DOI 10.1016/0022-2836(91)90023-Y; Ladurner AG, 1997, J MOL BIOL, V273, P330, DOI 10.1006/jmbi.1997.1304; Lakhani VV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000772; Martindale D, 1998, NAT GENET, V18, P150, DOI 10.1038/ng0298-150; Masino L, 2002, FEBS LETT, V513, P267, DOI 10.1016/S0014-5793(02)02335-9; MATAGNE A, 1990, BIOCHEM J, V265, P131, DOI 10.1042/bj2650131; Mossuto MF, 2010, J MOL BIOL, V402, P783, DOI 10.1016/j.jmb.2010.07.005; Mukai H, 2005, P NATL ACAD SCI USA, V102, P10887, DOI 10.1073/pnas.0409283102; Nagai Y, 2007, NAT STRUCT MOL BIOL, V14, P332, DOI 10.1038/nsmb1215; Nozaki K, 2001, NEUROREPORT, V12, P3357, DOI 10.1097/00001756-200110290-00042; Olshina MA, 2010, J BIOL CHEM, V285, P21807, DOI 10.1074/jbc.M109.084434; Ordway JM, 1997, CELL, V91, P753, DOI 10.1016/S0092-8674(00)80464-X; Ordway JM, 1996, BIOTECHNIQUES, V21, P609; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Pace C. N., 1997, PROTEIN STRUCTURE PR, V2, P299; PACE CN, 1990, TRENDS BIOTECHNOL, V8, P93, DOI 10.1016/0167-7799(90)90146-O; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; Robertson AL, 2010, CURR MED CHEM, V17, P3058; Robertson AL, 2011, J MOL BIOL, V413, P879, DOI 10.1016/j.jmb.2011.09.014; Robertson AL, 2008, BIOPHYS J, V95, P5922, DOI 10.1529/biophysj.108.138487; Robitaille Y, 1997, BRAIN PATHOL, V7, P901, DOI 10.1111/j.1750-3639.1997.tb00893.x; Ross CA, 1997, NEURON, V19, P1147, DOI 10.1016/S0896-6273(00)80405-5; Sanchez I, 2003, NATURE, V421, P373, DOI 10.1038/nature01301; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Saunders HM, 2011, PROTEIN SCI, V20, P1675, DOI 10.1002/pro.698; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Serpell LC, 1999, METHOD ENZYMOL, V309, P526; Sharma D, 1999, FEBS LETT, V456, P181, DOI 10.1016/S0014-5793(99)00933-3; Takahashi T, 2008, HUM MOL GENET, V17, P345, DOI 10.1093/hmg/ddm311; Tanaka M, 2001, J BIOL CHEM, V276, P45470, DOI 10.1074/jbc.M107502200; Thakur AK, 2009, NAT STRUCT MOL BIOL, V16, P380, DOI 10.1038/nsmb.1570; Tobelmann MD, 2008, PROTEIN ENG DES SEL, V21, P161, DOI 10.1093/protein/gzm078; Tobelmann MD, 2011, BIOPHYS J, V100, P2773, DOI 10.1016/j.bpj.2011.04.028; Vandenameele J, 2010, BIOCHEMISTRY-US, V49, P4264, DOI 10.1021/bi100369d; Vandevenne M, 2008, PROTEIN ENG DES SEL, V21, P443, DOI 10.1093/protein/gzn021; Vandevenne M, 2007, PROTEIN SCI, V16, P2260, DOI 10.1110/ps.072912407; Vitalis A, 2007, BIOPHYS J, V93, P1923, DOI 10.1529/biophysj.107.110080; Wetzel R, 2010, PROTEIN MISFOLDING D, P305; Williams AJ, 2008, TRENDS NEUROSCI, V31, P521, DOI 10.1016/j.tins.2008.07.004; Yang W, 2002, HUM MOL GENET, V11, P2905, DOI 10.1093/hmg/11.23.2905; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	65	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2012	7	3							e31253	10.1371/journal.pone.0031253	http://dx.doi.org/10.1371/journal.pone.0031253			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KX	22438863	Green Published, Green Submitted, gold			2022-12-25	WOS:000303062800003
J	Tu, CT; Yang, TC; Huang, HY; Tsai, HJ				Tu, Chi-Tang; Yang, Tzu-Ching; Huang, Hsing-Yen; Tsai, Huai-Jen			Zebrafish arl6ip1 Is Required for Neural Crest Development during Embryogenesis	PLOS ONE			English	Article							BARDET-BIEDL-SYNDROME; TRANSCRIPTION FACTOR FOXD3; XENOPUS EMBRYOS; NERVOUS-SYSTEM; PROGENITOR CELLS; INDUCTION; GENE; SPECIFICATION; EXPRESSION; MIGRATION	Background: Although the embryonic expression pattern of ADP ribosylation factor-like 6 interacting protein 1 (Arl6ip1) has been reported, its function in neural crest development is unclear. Methods/Principal Findings: We found that knockdown of Arl6ip1 caused defective embryonic neural crest derivatives that were particularly severe in craniofacial cartilages. Expressions of the ectodermal patterning factors msxb, dlx3b, and pax3 were normal, but the expressions of the neural crest specifier genes foxd3, snai1b, and sox10 were greatly reduced. These findings suggest that arl6ip1 is essential for specification of neural crest derivatives, but not neural crest induction. Furthermore, we revealed that the streams of crestin-and sox10-expressing neural crest cells, which migrate ventrally from neural tube into trunk, were disrupted in arl6ip1 morphants. This migration defect was not only in the trunk neural crest, but also in the enteric tract where the vagal-derived neural crest cells failed to populate the enteric nervous system. We found that this migration defect was induced by dampened Shh signaling, which may have resulted from defective cilia. These data further suggested that arl6ip1 is required for neural crest migration. Finally, by double-staining of TUNEL and crestin, we confirmed that the loss of neural crest cells could not be attributed to apoptosis. Conclusions/Significance: Therefore, we concluded that arl6ip1 is required for neural crest migration and sublineage specification.	[Tu, Chi-Tang; Yang, Tzu-Ching; Huang, Hsing-Yen; Tsai, Huai-Jen] Natl Taiwan Univ, Inst Mol & Cellular Biol, Taipei 10764, Taiwan	National Taiwan University	Tu, CT (corresponding author), Natl Taiwan Univ, Inst Mol & Cellular Biol, Taipei 10764, Taiwan.	hjtsai@ntu.edu.tw			National Science Council, Republic of China [NSC98-2313-B-002-020-MY3]	National Science Council, Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by the National Science Council, Republic of China, under grant NSC98-2313-B-002-020-MY3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amack JD, 2004, CURR BIOL, V14, P685, DOI 10.1016/j.cub.2004.04.002; Aybar MJ, 2003, DEVELOPMENT, V130, P483, DOI 10.1242/dev.00238; Bang AG, 1997, DEVELOPMENT, V124, P2075; Barembaum M, 2005, SEMIN CELL DEV BIOL, V16, P642, DOI 10.1016/j.semcdb.2005.06.006; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Bolande RP, 1997, PEDIATR PATHOL LAB M, V17, P1, DOI 10.1080/107710497174994; Cheng YC, 2000, DEV BRAIN RES, V121, P233, DOI 10.1016/S0165-3806(00)00049-3; Cheung M, 2005, DEV CELL, V8, P179, DOI 10.1016/j.devcel.2004.12.010; Cole LK, 2001, DEV BIOL, V240, P123, DOI 10.1006/dbio.2001.0432; Cornell RA, 2000, DEVELOPMENT, V127, P2873; del Barrio MG, 2002, DEVELOPMENT, V129, P1583; Dottori M, 2001, DEVELOPMENT, V128, P4127; Dutton KA, 2001, DEVELOPMENT, V128, P4113; Ekker SC, 2001, GENESIS, V30, P89, DOI 10.1002/gene.1038; Elworthy S, 2005, MECH DEVELOP, V122, P659, DOI 10.1016/j.mod.2004.12.008; Endo Y, 2002, DEVELOPMENT, V129, P863; Fan YL, 2004, NAT GENET, V36, P989, DOI 10.1038/ng1414; Honore SM, 2003, DEV BIOL, V260, P79, DOI 10.1016/S0012-1606(03)00247-1; Huang HY, 2009, DEV DYNAM, V238, P232, DOI 10.1002/dvdy.21832; Huang P, 2009, DEVELOPMENT, V136, P3089, DOI 10.1242/dev.041343; Huang X, 2004, DEV BIOL, V275, P1, DOI 10.1016/j.ydbio.2004.07.033; Inoue A, 2002, CANCER CELL, V2, P279, DOI 10.1016/S1535-6108(02)00155-1; Kelsh RN, 2002, RES PRO CEL, V40, P216; Kelsh RN, 2000, DEVELOPMENT, V127, P515; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Knecht AK, 2002, NAT REV GENET, V3, P453, DOI 10.1038/nrg819; Kos R, 2001, DEVELOPMENT, V128, P1467; LaBonne C, 2000, DEV BIOL, V221, P195, DOI 10.1006/dbio.2000.9609; LIEM KF, 1995, CELL, V82, P969, DOI 10.1016/0092-8674(95)90276-7; Lin CY, 2006, DEV BIOL, V299, P594, DOI 10.1016/j.ydbio.2006.08.042; Lui HM, 2003, MOL CANCER RES, V1, P508; Marchant L, 1998, DEV BIOL, V198, P319, DOI 10.1006/dbio.1998.8902; Mayor R, 1997, DEV BIOL, V189, P1, DOI 10.1006/dbio.1997.8634; MAYOR R, 1995, DEVELOPMENT, V121, P767; Monsoro-Burq AH, 2003, DEVELOPMENT, V130, P3111, DOI 10.1242/dev.00531; Montero-Balaguer M, 2006, DEV DYNAM, V235, P3199, DOI 10.1002/dvdy.20959; Neuhauss SCF, 1996, DEVELOPMENT, V123, P357; Nguyen VH, 1998, DEV BIOL, V199, P93, DOI 10.1006/dbio.1998.8927; O'Brien EK, 2004, DEV BIOL, V265, P246, DOI 10.1016/j.ydbio.2003.09.029; Pettersson M, 2000, GENOMICS, V68, P351, DOI 10.1006/geno.2000.6278; Pietri T, 2004, DEVELOPMENT, V131, P3871, DOI 10.1242/dev.01264; Pohl BS, 2001, MECH DEVELOP, V103, P93, DOI 10.1016/S0925-4773(01)00334-3; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Sasai N, 2001, DEVELOPMENT, V128, P2525; SCHILLING TF, 1994, DEVELOPMENT, V120, P483; Shen H, 1997, DEV BIOL, V188, P248, DOI 10.1006/dbio.1997.8617; Stewart RA, 2006, DEV BIOL, V292, P174, DOI 10.1016/j.ydbio.2005.12.035; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Tobin JL, 2008, P NATL ACAD SCI USA, V105, P6714, DOI 10.1073/pnas.0707057105; Trainor PA, 2000, NAT REV NEUROSCI, V1, P116, DOI 10.1038/35039056; Ungos JM, 2003, DEVELOPMENT, V130, P5351, DOI 10.1242/dev.00722; Villanueva S, 2002, DEV BIOL, V241, P289, DOI 10.1006/dbio.2001.0485; Wu WS, 2005, CELL, V123, P641, DOI 10.1016/j.cell.2005.09.029; Yen HJ, 2006, HUM MOL GENET, V15, P667, DOI 10.1093/hmg/ddi468	54	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2012	7	3							e32899	10.1371/journal.pone.0032899	http://dx.doi.org/10.1371/journal.pone.0032899			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KX	22427906	Green Published, gold, Green Submitted			2022-12-25	WOS:000303062800035
J	Zhou, C; Licciulli, S; Avila, JL; Cho, M; Troutman, S; Jiang, P; Kossenkov, AV; Showe, LC; Liu, Q; Vachani, A; Albelda, SM; Kissil, JL				Zhou, C.; Licciulli, S.; Avila, J. L.; Cho, M.; Troutman, S.; Jiang, P.; Kossenkov, A. V.; Showe, L. C.; Liu, Q.; Vachani, A.; Albelda, S. M.; Kissil, J. L.			The Rac1 splice form Rac1b promotes K-ras-induced lung tumorigenesis	ONCOGENE			English	Article						Ras; Rac1; Rac1b; lung cancer; mouse model	CELL-SURVIVAL; CANCER; EXPRESSION; GTPASES; VARIANT; RHO; PROGRESSION; ACTIVATION; ADHESION; ISOFORM	Rac1b, an alternative splice form of Rac1, has been previously shown to be upregulated in colon and breast cancer cells, suggesting an oncogenic role for Rac1b in these cancers. Our analysis of NSCLC tumor and matched normal tissue samples indicates Rac1b is upregulated in a significant fraction of lung tumors in correlation with mutational status of K-ras. To directly assess the oncogenic potential of Rac1b in vivo, we employed a mouse model of lung adenocarcinoma, in which the expression of Rac1b can be conditionally activated specifically in the lung. Although expression of Rac1b alone is insufficient to drive tumor initiation, the expression of Rac1b synergizes with an oncogenic allele of K-ras resulting in increased cellular proliferation and accelerated tumor growth. Finally, we show that in contrast to our previous findings demonstrating a requirement for Rac1 in K-ras-driven cell proliferation, Rac1b is not required in this context. Given the partially overlapping spectrum of downstream effectors regulated by Rac1 and Rac1b, our findings further delineate the signaling pathways downstream of Rac1 that are required for K-ras driven tunnorigenesis. Oncogene (2013) 32, 903-909; doi:10.1038/onc.2012.99; published online 19 March 2012	[Zhou, C.; Licciulli, S.; Avila, J. L.; Cho, M.; Troutman, S.; Kossenkov, A. V.; Showe, L. C.; Liu, Q.; Kissil, J. L.] Wistar Inst Anat & Biol, Mol & Cellular Oncogenesis Program, Philadelphia, PA 19104 USA; [Avila, J. L.; Kissil, J. L.] Univ Penn, Sch Med, Cell & Mol Biol Grad Grp, Philadelphia, PA 19104 USA; [Jiang, P.] Wistar Inst Anat & Biol, Anim Transgen Core Facil, Philadelphia, PA 19104 USA; [Vachani, A.; Albelda, S. M.] Univ Penn, Sch Med, Thorac Oncol Res Lab, Philadelphia, PA 19104 USA	The Wistar Institute; University of Pennsylvania; The Wistar Institute; University of Pennsylvania	Kissil, JL (corresponding author), Wistar Inst Anat & Biol, Mol & Cellular Oncogenesis Program, 3601 Spruce St, Philadelphia, PA 19104 USA.	jkissil@wistar.org			 [CA124495]; NATIONAL CANCER INSTITUTE [R01CA124495, P30CA010815] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024693] Funding Source: NIH RePORTER	; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank Dr Derek Radisky for sharing the pEYFP-C1-mRac1b vector and members of the Kissil and Albelda labs for technical assistance. We thank the Wistar Transgenics and Animal core facilities. This work was supported by Grant CA124495 (JLK).	Dummler B, 2009, CANCER METAST REV, V28, P51, DOI 10.1007/s10555-008-9168-1; Esufali S, 2007, CANCER RES, V67, P2469, DOI 10.1158/0008-5472.CAN-06-2843; Fiegen D, 2004, J BIOL CHEM, V279, P4743, DOI 10.1074/jbc.M310281200; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Jordan P, 1999, ONCOGENE, V18, P6835, DOI 10.1038/sj.onc.1203233; Kissil JL, 2007, CANCER RES, V67, P8089, DOI 10.1158/0008-5472.CAN-07-2300; Lozano E, 2008, J CELL SCI, V121, P933, DOI 10.1242/jcs.016121; Matos P, 2005, EXP CELL RES, V305, P292, DOI 10.1016/j.yexcr.2004.12.029; Matos P, 2003, J BIOL CHEM, V278, P50442, DOI 10.1074/jbc.M308215200; Matos P, 2008, GASTROENTEROLOGY, V135, P899, DOI 10.1053/j.gastro.2008.05.052; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Orlichenko L, 2010, J BIOL CHEM, V285, P19153, DOI 10.1074/jbc.M109.099382; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Schnelzer A, 2000, ONCOGENE, V19, P3013, DOI 10.1038/sj.onc.1203621; Singh A, 2004, ONCOGENE, V23, P9369, DOI 10.1038/sj.onc.1208182; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Walmsley MJ, 2003, SCIENCE, V302, P459, DOI 10.1126/science.1089709; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118	20	74	75	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	FEB 14	2013	32	7					903	909		10.1038/onc.2012.99	http://dx.doi.org/10.1038/onc.2012.99			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	112GQ	22430205	Green Accepted			2022-12-25	WOS:000316581100010
J	Veldhoen, RA; Banman, SL; Hemmerling, DR; Odsen, R; Simmen, T; Simmonds, AJ; Underhill, DA; Goping, IS				Veldhoen, R. A.; Banman, S. L.; Hemmerling, D. R.; Odsen, R.; Simmen, T.; Simmonds, A. J.; Underhill, D. A.; Goping, I. S.			The chemotherapeutic agent paclitaxel inhibits autophagy through two distinct mechanisms that regulate apoptosis	ONCOGENE			English	Article						autophagy; paclitaxel; apoptosis	PROGRAMMED CELL-DEATH; BREAST-CANCER; RAT-LIVER; ANTIMITOTIC DRUGS; GENE-EXPRESSION; CARCINOMA-CELLS; MITOTIC BLOCK; MICROTUBULES; LYSOSOMES; FUSION	Anti-mitotic agents such as paclitaxel and docetaxel are widely used for the treatment of breast, ovarian and lung cancers. Although paclitaxel induces apoptosis, this drug also modulates autophagy. How autophagy affects paclitaxel activity, is unclear. We discovered that paclitaxel inhibited autophagy through two distinct mechanisms dependent on cell cycle stage. In mitotic cells, paclitaxel blocked activation of the class III phosphatidyl inositol 3 kinase, Vps34, a critical initiator of autophagosome formation. In non-mitotic paclitaxel-treated cells, autophagosomes were generated but their movement and maturation was inhibited. Chemically or genetically blocking autophagosome formation diminished paclitaxel-induced cell death suggesting that autophagosome accumulation sensitized cells to paclitaxel toxicity. In line with these observations, we identified that primary breast tumors that expressed diminished levels of autophagy-initiating genes were resistant to taxane therapy, identifying possible mechanisms and prognostic markers of clinical chemotherapeutic resistance. Oncogene (2013) 32, 736-746; doi:10.1038/onc.2012.92; published online 19 March 2012	[Veldhoen, R. A.; Banman, S. L.; Odsen, R.; Goping, I. S.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; [Hemmerling, D. R.] Concordia Univ Coll, Dept Biol & Environm Sci, Edmonton, AB, Canada; [Simmen, T.; Simmonds, A. J.] Univ Alberta, Dept Cell Biol, Edmonton, AB T6G 2H7, Canada; [Underhill, D. A.; Goping, I. S.] Univ Alberta, Dept Oncol, Edmonton, AB T6G 2H7, Canada	University of Alberta; Concordia University - Canada; University of Alberta; University of Alberta	Goping, IS (corresponding author), Univ Alberta, Dept Biochem, Fac Med & Dent, Edmonton, AB T6G 2H7, Canada.	igoping@ualberta.ca	Veldhoen, Richard/M-8168-2019	Veldhoen, Richard/0000-0003-4643-2960; Simmonds, Andrew/0000-0001-7165-9302; Underhill, Darrell/0000-0003-0957-7407	Canadian Breast Cancer Foundation; Alberta Cancer Foundation/Alberta Innovates-Health Solutions [25011]	Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); Alberta Cancer Foundation/Alberta Innovates-Health Solutions	This work was supported by operating grants from the Canadian Breast Cancer Foundation and Alberta Cancer Foundation/Alberta Innovates-Health Solutions (project #25011) awarded to ISG. We thank Dr Junying Yuan for the kind gift of the anti-phospho T159 Vps34 antibody. We thank the Gaping lab, Simmen lab and Signal Transduction Research Group for valuable discussions. Owing to journal reference restraints, we apologize to those investigators whose work was not cited.	Apel A, 2008, CANCER RES, V68, P1485, DOI 10.1158/0008-5472.CAN-07-0562; APLIN A, 1992, J CELL PHYSIOL, V152, P458, DOI 10.1002/jcp.1041520304; ARSTILA AU, 1974, EXP CELL RES, V87, P249, DOI 10.1016/0014-4827(74)90477-7; Blagosklonny MV, 1999, INT J CANCER, V83, P151, DOI 10.1002/(SICI)1097-0215(19991008)83:2<151::AID-IJC1>3.0.CO;2-5; Blajeski AL, 2001, EXP CELL RES, V270, P277, DOI 10.1006/excr.2001.5349; Bursch W, 1996, CARCINOGENESIS, V17, P1595, DOI 10.1093/carcin/17.8.1595; Chang JC, 2003, LANCET, V362, P362, DOI 10.1016/S0140-6736(03)14023-8; Craik AC, 2010, ONCOGENE, V29, P5381, DOI 10.1038/onc.2010.272; Czernick M, 2009, BIOCHEM BIOPH RES CO, V379, P145, DOI 10.1016/j.bbrc.2008.12.025; Debnath J, 2005, AUTOPHAGY, V1, P66, DOI 10.4161/auto.1.2.1738; Derry WB, 1998, CANCER RES, V58, P1177; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eskelinen EL, 2002, TRAFFIC, V3, P878, DOI 10.1034/j.1600-0854.2002.31204.x; Fass E, 2006, J BIOL CHEM, V281, P36303, DOI 10.1074/jbc.M607031200; Furuya T, 2010, MOL CELL, V38, P500, DOI 10.1016/j.molcel.2010.05.009; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Gorka M, 2005, ANTI-CANCER DRUG, V16, P777; Gump JM, 2011, TRENDS CELL BIOL, V21, P387, DOI 10.1016/j.tcb.2011.03.007; Jordan MA, 1996, CANCER RES, V56, P816; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; JORDAN MA, 1993, P NATL ACAD SCI USA, V90, P9552, DOI 10.1073/pnas.90.20.9552; Kimura S, 2008, CELL STRUCT FUNCT, V33, P109, DOI 10.1247/csf.08005; Kochl R, 2006, TRAFFIC, V7, P129, DOI 10.1111/j.1600-0854.2005.00368.x; Lanni JS, 1998, MOL CELL BIOL, V18, P1055, DOI 10.1128/MCB.18.2.1055; Levine B, 2008, AUTOPHAGY, V4, P600, DOI 10.4161/auto.6260; Liu LY, 2009, CELL CYCLE, V8, P1616, DOI 10.4161/cc.8.10.8577; MARZELLA L, 1980, EXP CELL RES, V128, P291, DOI 10.1016/0014-4827(80)90065-8; Minn AJ, 1996, GENE DEV, V10, P2621, DOI 10.1101/gad.10.20.2621; Mizushima N, 2007, ANNU REV NUTR, V27, P19, DOI 10.1146/annurev.nutr.27.061406.093749; MORTIMORE GE, 1987, ANNU REV NUTR, V7, P539, DOI 10.1146/annurev.nu.07.070187.002543; Paglin S, 2001, CANCER RES, V61, P439; PFEIFER U, 1978, J CELL BIOL, V78, P152, DOI 10.1083/jcb.78.1.152; Shi J, 2008, CANCER RES, V68, P3269, DOI 10.1158/0008-5472.CAN-07-6699; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Wang TH, 2000, CANCER, V88, P2619, DOI 10.1002/1097-0142(20000601)88:11<2619::AID-CNCR26>3.0.CO;2-J; Webb JL, 2004, INT J BIOCHEM CELL B, V36, P2541, DOI 10.1016/j.biocel.2004.02.003; Xi GM, 2011, CANCER LETT, V307, P141, DOI 10.1016/j.canlet.2011.03.026; Xie R, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-89; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707	40	92	95	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	FEB 7	2013	32	6					736	746		10.1038/onc.2012.92	http://dx.doi.org/10.1038/onc.2012.92			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	101AF	22430212				2022-12-25	WOS:000315746700007
J	Baumgartner, F; Woess, C; Pedit, V; Tzankov, A; Labi, V; Villunger, A				Baumgartner, F.; Woess, C.; Pedit, V.; Tzankov, A.; Labi, V.; Villunger, A.			Minor cell-death defects but reduced tumor latency in mice lacking the BH3-only proteins Bad and Bmf	ONCOGENE			English	Article						apoptosis; BH3-only proteins; Bad; Bmf; hematopoiesis; cancer	GLUCOCORTICOID-INDUCED APOPTOSIS; BCL-2 PROTEINS; BH3 DOMAINS; BIM; HOMEOSTASIS; PUMA; SUPPRESSION; ACTIVATION; RECEPTOR; COMPLEX	Proapoptotic Bcl-2 family members of the Bcl-2 homology (BH)3-only subgroup are critical for the establishment and maintenance of tissue homeostasis and can mediate apoptotic cell death in response to developmental cues or exogenously induced forms of cell stress. On the basis of the biochemical experiments as well as genetic studies in mice, the BH3-only proteins Bad and Bmf have been implicated in different proapoptotic events such as those triggered by glucose- or trophic factor-deprivation, glucocorticoids, or histone deacetylase inhibition, as well as suppression of B-cell lymphomagenesis upon aberrant expression of c-Myc. To address possible redundancies in cell death regulation and tumor suppression, we generated compound mutant mice lacking both genes. Our studies revealed lack of redundancy in most paradigms of lymphocyte apoptosis tested in tissue culture. Only spontaneous cell death of thymocytes kept in low glucose or that of pre-B cells deprived of cytokines was significantly delayed when both genes were lacking. Of note, despite these minor apoptosis defects we observed compromised lymphocyte homeostasis in vivo that affected mainly the B-cell lineage. Long-term follow-up revealed significantly reduced latency to spontaneous tumor formation in aged mice when both genes were lacking. Together our study suggests that Bad and Bmf co-regulate lymphocyte homeostasis and limit spontaneous transformation by mechanisms that may not exclusively be linked to the induction of lymphocyte apoptosis. Oncogene (2013) 32, 621-630; doi:10.1038/onc.2012.78; published online 19 March 2012	[Baumgartner, F.; Woess, C.; Pedit, V.; Labi, V.; Villunger, A.] Med Univ Innsbruck, Bioctr, Div Dev Immunol, A-6020 Innsbruck, Austria; [Tzankov, A.] Univ Basel, Inst Pathol, Basel, Switzerland	Medical University of Innsbruck; University of Basel	Villunger, A (corresponding author), Med Univ Innsbruck, Bioctr, Div Dev Immunol, A-6020 Innsbruck, Austria.	andreas.villunger@i-med.ac.at	Tzankov, Alexandar/H-5656-2019; Labi, Verena/V-2766-2019	Tzankov, Alexandar/0000-0002-1100-3819; Labi, Verena/0000-0001-7538-1520; Klepsch, Victoria/0000-0003-4146-4664	Tiroler Krebshilfe; Tiroler Wissenschaftsfond (TWF); Austrian Science Fund, FWF [Y212-B12, P23510-B19, SFB021]; Integrated Center for Research and Therapy (IFTZ) of the Innsbruck Medical University; Austrian Academy of Science (OAW); Austrian Science Fund (FWF) [P 23510] Funding Source: researchfish	Tiroler Krebshilfe; Tiroler Wissenschaftsfond (TWF); Austrian Science Fund, FWF(Austrian Science Fund (FWF)); Integrated Center for Research and Therapy (IFTZ) of the Innsbruck Medical University; Austrian Academy of Science (OAW); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank A Strasser and the late S Korsemeyer for the mice and reagents. I Gaggl for mouse genotyping, C Soratroi for technical assistance, K Rossi for animal care and G Bock for cell sorting. This work was supported by grants from the 'Tiroler Krebshilfe' to FB and CW, the 'Tiroler Wissenschaftsfond' (TWF) to VL, as well as the Austrian Science Fund, FWF (Y212-B12; P23510-B19; SFB021) to AV and the Integrated Center for Research and Therapy (IFTZ) of the Innsbruck Medical University to AV and FB. CW is a recipient of a DOC-fFORTE doctoral fellowship sponsored by the Austrian Academy of Science (OAW).	Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Coultas L, 2004, MOL CELL BIOL, V24, P1570, DOI 10.1128/MCB.24.4.1570-1581.2004; Danial NN, 2008, ONCOGENE, V27, pS53, DOI 10.1038/onc.2009.44; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Erlacher M, 2005, BLOOD, V106, P4131, DOI 10.1182/blood-2005-04-1595; Erlacher M, 2006, J EXP MED, V203, P2939, DOI 10.1084/jem.20061552; Frenzel A, 2010, BLOOD, V115, P995, DOI 10.1182/blood-2009-03-212670; Gilmore AP, 2002, J BIOL CHEM, V277, P27643, DOI 10.1074/jbc.M108863200; Gramantieri L, 2009, CLIN CANCER RES, V15, P5073, DOI 10.1158/1078-0432.CCR-09-0092; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Hubner A, 2010, MOL CELL BIOL, V30, P98, DOI 10.1128/MCB.01155-09; Kelly PN, 2010, CELL DEATH DIFFER, V17, P1655, DOI 10.1038/cdd.2010.43; Kuroda J, 2006, P NATL ACAD SCI USA, V103, P14907, DOI 10.1073/pnas.0606176103; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Labi V, 2008, J EXP MED, V205, P641, DOI 10.1084/jem.20071658; Lee JW, 2004, CARCINOGENESIS, V25, P1371, DOI 10.1093/carcin/bgh145; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Pinon JD, 2008, ONCOGENE, V27, pS41, DOI 10.1038/onc.2009.42; Ploner C, 2008, LEUKEMIA, V22, P370, DOI 10.1038/sj.leu.2405039; Puthalakath H, 2001, SCIENCE, V293, P1829, DOI 10.1126/science.1062257; Ranger AM, 2003, P NATL ACAD SCI USA, V100, P9324, DOI 10.1073/pnas.1533446100; Stambolic V, 2001, MOL CELL, V8, P317, DOI 10.1016/S1097-2765(01)00323-9; Teo K, 2007, BJU INT, V100, P691, DOI 10.1111/j.1464-410X.2007.07001.x; Villunger A, 2000, J IMMUNOL, V165, P1337, DOI 10.4049/jimmunol.165.3.1337; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang P, 2012, DIABETES-METAB RES, V28, P109, DOI 10.1002/dmrr.1291; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhao YX, 2008, J BIOL CHEM, V283, P36344, DOI 10.1074/jbc.M803580200	33	12	12	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 31	2013	32	5					621	630		10.1038/onc.2012.78	http://dx.doi.org/10.1038/onc.2012.78			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	106SJ	22430207	Green Accepted			2022-12-25	WOS:000316164700009
J	Origanti, S; Cai, SR; Munir, AZ; White, LS; Piwnica-Worms, H				Origanti, S.; Cai, S-R; Munir, A. Z.; White, L. S.; Piwnica-Worms, H.			Synthetic lethality of Chk1 inhibition combined with p53 and/or p21 loss during a DNA damage response in normal and tumor cells	ONCOGENE			English	Article						cell cycle; checkpoints; apoptosis; cancer	ONCOGENE-INDUCED SENESCENCE; S-PHASE; POTENT INHIBITOR; CDK INHIBITORS; DEFECTIVE P53; CHECKPOINT; UCN-01; CDC25A; 7-HYDROXYSTAUROSPORINE; PHOSPHORYLATION	Cell cycle checkpoints ensure genome integrity and are frequently compromised in human cancers. A therapeutic strategy being explored takes advantage of checkpoint defects in p53-deficient tumors in order to sensitize them to DNA-damaging agents by eliminating Chk1-mediated checkpoint responses. Using mouse models, we demonstrated that p21 is a key determinant of how cells respond to the combination of DNA damage and Chk1 inhibition (combination therapy) in normal cells as well as in tumors. Loss of p21 sensitized normal cells to the combination therapy much more than did p53 loss and the enhanced lethality was partially blocked by CDK inhibition. In addition, basal pools of p21 (p53 independent) provided p53 null cells with protection from the combination therapy. Our results uncover a novel p53-independent function for p21 in protecting cells from the lethal effects of DNA damage followed by Chk1 inhibition. As p21 levels are low in a significant fraction of colorectal tumors, they are predicted to be particularly sensitive to the combination therapy. Results reported in this study support this prediction. Oncogene (2013) 32, 577-588; doi:10.1038/onc.2012.84; published online 19 March 2012	[Origanti, S.; Cai, S-R; Munir, A. Z.; White, L. S.; Piwnica-Worms, H.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Origanti, S.; Cai, S-R; Munir, A. Z.; White, L. S.; Piwnica-Worms, H.] Washington Univ, Sch Med, BRIGHT Inst, St Louis, MO 63110 USA; [Piwnica-Worms, H.] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Piwnica-Worms, H (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, Box 8228,660 South Euclid Ave, St Louis, MO 63110 USA.	hpiwnica@wustl.edu	Piwnica-Worms, Helen/C-5214-2012	Origanti, Sofia/0000-0002-6953-0160	NIH [GM047017]; KOMEN Foundation; Washington University [P50 CA94056]; NATIONAL CANCER INSTITUTE [P50CA094056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047017] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); KOMEN Foundation(Susan G. Komen Breast Cancer Foundation); Washington University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr B Vogelstein for providing the HCT116 cell lines. This study was supported in part by NIH GM047017, the KOMEN Foundation and P50 CA94056 to the Molecular Imaging Center at Washington University. HP-W is a Research Professor of the American Cancer Society.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Bunch RT, 1996, CLIN CANCER RES, V2, P791; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Eastman A, 2004, J CELL BIOCHEM, V91, P223, DOI 10.1002/jcb.10699; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Ferguson AT, 2000, P NATL ACAD SCI USA, V97, P6049, DOI 10.1073/pnas.100566997; Fikaris AJ, 2006, J BIOL CHEM, V281, P34759, DOI 10.1074/jbc.M606737200; Fracasso PM, 2011, CANCER CHEMOTH PHARM, V67, P1225, DOI 10.1007/s00280-010-1410-1; Gilad O, 2010, CANCER RES, V70, P9693, DOI 10.1158/0008-5472.CAN-10-2286; Goga A, 2007, NAT MED, V13, P820, DOI 10.1038/nm1606; Goloudina A, 2003, CELL CYCLE, V2, P473, DOI 10.4161/cc.2.5.482; Hassepass I, 2003, J BIOL CHEM, V278, P29824, DOI 10.1074/jbc.M302704200; Kohn EA, 2002, J BIOL CHEM, V277, P26553, DOI 10.1074/jbc.M202040200; Kohn EA, 2003, CANCER RES, V63, P31; Lam MH, 2004, CANCER CELL, V6, P45, DOI 10.1016/j.ccr.2004.06.015; Levesque AA, 2008, MOL CANCER THER, V7, P252, DOI 10.1158/1535-7163.MCT-07-2066; Levesque AA, 2007, CARCINOGENESIS, V28, P13, DOI 10.1093/carcin/bgl214; LUO Y, 1995, NATURE, V375, P159, DOI 10.1038/375159a0; Ma CX, 2011, TRENDS MOL MED, V17, P88, DOI 10.1016/j.molmed.2010.10.009; PARKER LL, 1992, SCIENCE, V257, P1955, DOI 10.1126/science.1384126; Perez RP, 2006, CLIN CANCER RES, V12, P7079, DOI 10.1158/1078-0432.CCR-06-0197; Raynaud FI, 2004, MOL CANCER THER, V3, P353; Rodriguez R, 2006, MOL BIOL CELL, V17, P402, DOI 10.1091/mbc.E05-07-0594; Sedelnikova OA, 2003, CANCER BIOL THER, V2, P233; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shimuta K, 2002, EMBO J, V21, P3694, DOI 10.1093/emboj/cdf357; Sorensen CS, 2003, CANCER CELL, V3, P247, DOI 10.1016/S1535-6108(03)00048-5; Tapia C, 2006, AM J SURG PATHOL, V30, P83, DOI 10.1097/01.pas.0000183572.94140.43; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Tse AN, 2007, CLIN CANCER RES, V13, P591, DOI 10.1158/1078-0432.CCR-06-1424; Cespedes MV, 2007, AM J PATHOL, V170, P1077, DOI 10.2353/ajpath.2007.060773; WALDMAN T, 1995, CANCER RES, V55, P5187; Wang QZ, 1996, J NATL CANCER I, V88, P956, DOI 10.1093/jnci/88.14.956; Xu B, 2001, MOL CELL BIOL, V21, P3445, DOI 10.1128/MCB.21.10.3445-3450.2001; Zabludoff SD, 2008, MOL CANCER THER, V7, P2955, DOI 10.1158/1535-7163.MCT-08-0492; Zhao H, 2002, P NATL ACAD SCI USA, V99, P14795, DOI 10.1073/pnas.182557299	39	48	49	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 31	2013	32	5					577	588		10.1038/onc.2012.84	http://dx.doi.org/10.1038/onc.2012.84			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	106SJ	22430210	Green Accepted, Green Submitted			2022-12-25	WOS:000316164700005
J	Girotto, S; Sturlese, M; Bellanda, M; Tessari, I; Cappellini, R; Bisaglia, M; Bubacco, L; Mammi, S				Girotto, Stefania; Sturlese, Mattia; Bellanda, Massimo; Tessari, Isabella; Cappellini, Rekha; Bisaglia, Marco; Bubacco, Luigi; Mammi, Stefano			Dopamine-derived Quinones Affect the Structure of the Redox Sensor DJ-1 through Modifications at Cys-106 and Cys-53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL PARKINSONS-DISEASE; CYSTEINE-SULFINIC ACID; REGULATING KINASE 1; PROTEIN DJ-1; MITOCHONDRIAL LOCALIZATION; MOLECULAR SIMULATION; CRYSTAL-STRUCTURE; OXIDATIVE STRESS; ALPHA-SYNUCLEIN; CELL-DEATH	The physiological role of DJ-1, a protein involved in familial Parkinson disease is still controversial. One of the hypotheses proposed indicates a sensor role for oxidative stress, through oxidation of a conserved cysteine residue (Cys-106). The association of DJ-1 mutations with Parkinson disease suggests a loss of function, specific to dopaminergic neurons. Under oxidative conditions, highly reactive dopamine quinones (DAQs) can be produced, which can modify cysteine residues. In cellular models, DJ-1 was found covalently modified by dopamine. We analyzed the structural modifications induced on human DJ-1 by DAQs in vitro. We described the structural perturbations induced by DAQ adduct formation on each of the three cysteine residues of DJ-1 using specific mutants. Cys-53 is the most reactive residue and forms a covalent dimer also in SH-SY5Y DJ-1-transfected cells, but modification of Cys-106 induces the most severe structural perturbations; Cys-46 is not reactive. The relevance of these covalent modifications to the several functions ascribed to DJ-1 is discussed in the context of the cell response to a dopamine-derived oxidative insult.	[Tessari, Isabella; Cappellini, Rekha; Bisaglia, Marco; Bubacco, Luigi] Univ Padua, Dept Biol, I-35121 Padua, Italy; [Girotto, Stefania; Sturlese, Mattia; Bellanda, Massimo; Mammi, Stefano] Univ Padua, Dept Chem Sci, I-35131 Padua, Italy	University of Padua; University of Padua	Bubacco, L (corresponding author), Univ Padua, Dept Biol, Via Ugo Bassi 58B, I-35121 Padua, Italy.	luigi.bubacco@unipd.it; stefano.mammi@unipd.it	Tessari, Isabella/K-7847-2016; Bubacco, Luigi/B-5602-2012; Sturlese, Mattia/P-9473-2019	Tessari, Isabella/0000-0002-5823-645X; Bubacco, Luigi/0000-0001-7927-9208; Sturlese, Mattia/0000-0003-3944-0313	University of Padova Progetto di Ricerca di Ateneo [CPDA 087059]; Progetto di Ricerca di Ateneo [CPDA 103503]; Ministero Istruzione Universita Ricerca, Progetti di Ricerca di Interesse Nazionale [2008 5SYP79]	University of Padova Progetto di Ricerca di Ateneo; Progetto di Ricerca di Ateneo; Ministero Istruzione Universita Ricerca, Progetti di Ricerca di Interesse Nazionale(Ministry of Education, Universities and Research (MIUR))	This work was supported by University of Padova Progetto di Ricerca di Ateneo 2008 Grant CPDA 087059 and Progetto di Ricerca di Ateneo 2010 Grant CPDA 103503 and by Ministero Istruzione Universita Ricerca, Progetti di Ricerca di Interesse Nazionale, 2008 Grant 2008 5SYP79.	Akagawa M, 2006, BIOCHEMISTRY-US, V45, P15120, DOI 10.1021/bi0614434; Anderson PC, 2008, BIOCHEMISTRY-US, V47, P9380, DOI 10.1021/bi800677k; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Bisaglia M, 2007, J BIOL CHEM, V282, P15597, DOI 10.1074/jbc.M610893200; Blackinton J, 2009, J BIOL CHEM, V284, P6476, DOI 10.1074/jbc.M806599200; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Cha SS, 2008, J BIOL CHEM, V283, P34069, DOI 10.1074/jbc.M804243200; Chen J, 2010, HUM MOL GENET, V19, P2395, DOI 10.1093/hmg/ddq113; Choi J, 2006, J BIOL CHEM, V281, P10816, DOI 10.1074/jbc.M509079200; da Costa CA, 2007, CURR MOL MED, V7, P650, DOI 10.2174/156652407782564426; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Dodson MW, 2007, CURR OPIN NEUROBIOL, V17, P331, DOI 10.1016/j.conb.2007.04.010; Greenamyre JT, 2004, SCIENCE, V304, P1120, DOI 10.1126/science.1098966; HASTINGS TG, 1994, J NEUROCHEM, V63, P1126; Hastings TG, 1996, P NATL ACAD SCI USA, V93, P1956, DOI 10.1073/pnas.93.5.1956; Herrera FE, 2007, J BIOL CHEM, V282, P24905, DOI 10.1074/jbc.M701013200; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Irrcher I, 2010, HUM MOL GENET, V19, P3734, DOI 10.1093/hmg/ddq288; Jin JH, 2005, MOL BRAIN RES, V134, P119, DOI 10.1016/j.molbrainres.2004.10.003; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Junn E, 2005, P NATL ACAD SCI USA, V102, P9691, DOI 10.1073/pnas.0409635102; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; LaVoie MJ, 2005, NAT MED, V11, P1214, DOI 10.1038/nm1314; Lesage S, 2009, HUM MOL GENET, V18, pR48, DOI 10.1093/hmg/ddp012; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Logan T, 2010, BIOCHEMISTRY-US, V49, P5624, DOI 10.1021/bi902164h; Malgieri G, 2008, PROTEIN SCI, V17, P855, DOI 10.1110/ps.073411608; Martinat C, 2004, PLOS BIOL, V2, P1754, DOI 10.1371/journal.pbio.0020327; Meulener M, 2005, CURR BIOL, V15, P1572, DOI 10.1016/j.cub.2005.07.064; Mo JS, 2010, J CELL BIOCHEM, V110, P229, DOI 10.1002/jcb.22530; Moore DJ, 2005, HUM MOL GENET, V14, P71, DOI 10.1093/hmg/ddi007; Neumann M, 2004, ACTA NEUROPATHOL, V107, P489, DOI 10.1007/s00401-004-0834-2; Olzmann JA, 2004, J BIOL CHEM, V279, P8506, DOI 10.1074/jbc.M311017200; PAZ MA, 1991, J BIOL CHEM, V266, P689; Samii A, 2004, LANCET, V363, P1783, DOI 10.1016/S0140-6736(04)16305-8; Shen XM, 1996, CHEM RES TOXICOL, V9, P1117, DOI 10.1021/tx960052v; Shendelman S, 2004, PLOS BIOL, V2, P1764, DOI 10.1371/journal.pbio.0020362; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Van Laar VS, 2009, NEUROBIOL DIS, V34, P487, DOI 10.1016/j.nbd.2009.03.004; Waak J, 2009, J BIOL CHEM, V284, P14245, DOI 10.1074/jbc.M806902200; Waragai M, 2006, BIOCHEM BIOPH RES CO, V345, P967, DOI 10.1016/j.bbrc.2006.05.011; Wilson MA, 2003, P NATL ACAD SCI USA, V100, P9256, DOI 10.1073/pnas.1133288100; Witt AC, 2008, BIOCHEMISTRY-US, V47, P7430, DOI 10.1021/bi800282d; Xu J, 2005, HUM MOL GENET, V14, P1231, DOI 10.1093/hmg/ddi134; Zhang L, 2005, HUM MOL GENET, V14, P2063, DOI 10.1093/hmg/ddi211; Zhou WB, 2006, J MOL BIOL, V356, P1036, DOI 10.1016/j.jmb.2005.12.030	49	46	46	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18738	18749		10.1074/jbc.M111.311589	http://dx.doi.org/10.1074/jbc.M111.311589			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22431735	hybrid, Green Published			2022-12-25	WOS:000306411600082
J	Coic, YM; Baleux, F; Poyraz, O; Thibeaux, R; Labruyere, E; Chretien, F; Sobhani, I; Lazure, T; Wyplosz, B; Schneider, G; Mulard, L; Sansonetti, PJ; Marteyn, BS				Coic, Yves-Marie; Baleux, Francoise; Poyraz, Oemer; Thibeaux, Roman; Labruyere, Elisabeth; Chretien, Fabrice; Sobhani, Iradj; Lazure, Thierry; Wyplosz, Benjamin; Schneider, Gunter; Mulard, Laurence; Sansonetti, Philippe J.; Marteyn, Benoit S.			Design of a Specific Colonic Mucus Marker Using a Human Commensal Bacterium Cell Surface Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY-BOWEL-DISEASE; GASTROINTESTINAL-TRACT; INTESTINAL MUCUS; IN-VIVO; EXPRESSION; MUCIN; MUC5AC; CARCINOMAS; THICKNESS; VIRULENCE	Imaging living cells and organs requires innovative, specific, efficient, and well tolerated fluorescent markers targeting cellular components. Such tools will allow proceeding to the dynamic analysis of cells and the adaptation of tissues to environmental cues. In this study, we have identified and synthesized a novel non-toxic fluorescent marker allowing a specific fluorescent staining of the human colonic mucus. Our strategy to identify a molecule able to specifically bind to the human colonic mucus was on the basis of the mucus adhesion properties of commensal bacteria. We identified and characterized the mucus-binding property of a 70-amino acid domain (MUB70) expressed on the surface of Lactobacillus strains. The chemical synthesis of MUB70 was achieved using the human commensal bacterium Lactobacillus reuteri AF120104 protein as a template. The synthesized Cy5-conjugated MUB70 marker specifically stained the colonic mucus on fixed human, rabbit, and guinea pig tissues. Interestingly, murine tissue was not stained, suggesting significant differences in the composition of the murine colonic mucus. In addition, this marker stained the mucus of living cultured human colonic cells (HT29-MTX) and human colonic tissue explants. Using a biotinylated derivative of MUB70, we demonstrated that this peptide binds specifically to Muc2, the most abundant secreted mucin, through its glycosylated moieties. Hence, Cy5-MUB70 is a novel and specific fluorescent marker for mammalian colonic mucus. It may be used for live imaging analysis but also, as demonstrated in this study, as a marker for the diagnosis and the prognosis of colonic mucinous carcinomas.	[Marteyn, Benoit S.] Inst Pasteur, Unite Pathogenie Microbienne Mol, INSERM, U786, F-75724 Paris 15, France; [Coic, Yves-Marie; Baleux, Francoise; Mulard, Laurence] Inst Pasteur, Unite Chim Biomol, INSERM, F-75724 Paris 15, France; [Thibeaux, Roman; Labruyere, Elisabeth] Inst Pasteur, Unite Biol Cellulaire Parasitisme, INSERM, F-75724 Paris 15, France; [Chretien, Fabrice] Inst Pasteur, Unite Histol Humaine & Modeles Anim, INSERM, F-75724 Paris 15, France; [Coic, Yves-Marie; Mulard, Laurence] Inst Pasteur, Dept Biotechnol, CNRS, URA 2128, F-75724 Paris 15, France; [Poyraz, Oemer; Schneider, Gunter] Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; [Sobhani, Iradj] Hop Henri Mondor, AP HP, Serv Hepathol & Gastroenterol, F-94000 Creteil, France; [Thibeaux, Roman; Chretien, Fabrice; Lazure, Thierry; Wyplosz, Benjamin] Hop Bicetre, AP HP, F-94275 Le Kremlin Bicetre, France; [Sansonetti, Philippe J.] Coll France, F-75231 Paris 05, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Karolinska Institutet; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; College de France	Marteyn, BS (corresponding author), Inst Pasteur, Unite Pathogenie Microbienne Mol, INSERM, U786, 28 Rue Dr Roux, F-75724 Paris 15, France.	marteyn@pasteur.fr	SOBHANI, Iradj/A-3973-2013; Chretien, fabrice B/D-4035-2018; Marteyn, Benoit S/M-3763-2017; Thibeaux, Roman/AAW-7667-2020	Chretien, fabrice B/0000-0002-2794-1383; Thibeaux, Roman/0000-0002-4872-0088; Schneider, Gunter/0000-0003-0622-5713; Marteyn, Benoit/0000-0001-5638-702X; Wyplosz, Benjamin/0000-0002-9779-9044	European Research Council [232798, 222720]; Ministere de l'Enseignement Superieur et de la Recherche	European Research Council(European Research Council (ERC)European Commission); Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission)	This work was supported by FP7 European Research Council "HOMEOEPITH" Grant 232798 and FP7 Tornado Grant 222720 (to B. M.). This work was also supported by a PhD fellowship from the Ministere de l'Enseignement Superieur et de la Recherche (to R. T.).	Allen A, 1998, INT J BIOCHEM CELL B, V30, P797, DOI 10.1016/S1357-2725(98)00028-4; Bansal D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000551; Bergstrom KSB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000902; Boekhorst J, 2006, MICROBIOL-SGM, V152, P273, DOI 10.1099/mic.0.28415-0; Cardona V, 2008, INT J PEPT RES THER, V14, P285, DOI 10.1007/s10989-008-9154-z; Chan WC, 2000, FMOC SOLID PHASE PEP; Faure M, 2004, DIGEST DIS SCI, V49, P339, DOI 10.1023/B:DDAS.0000017462.75257.70; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Johnson T, 1995, J Pept Sci, V1, P11, DOI 10.1002/psc.310010104; Karlsson NG, 1996, GLYCOCONJUGATE J, V13, P823, DOI 10.1007/BF00702346; Khattab AZM, 2011, MED ONCOL, V28, pS207, DOI 10.1007/s12032-010-9699-5; Lau SK, 2004, AM J CLIN PATHOL, V122, P61, DOI 10.1309/9R6673QEC06D86Y4; Lauer Janelle L., 1995, Letters in Peptide Science, V1, P197, DOI 10.1007/BF00117955; LESUFFLEUR T, 1994, CRIT REV ONCOL HEMAT, V17, P153, DOI 10.1016/1040-8428(94)90053-1; LESUFFLEUR T, 1990, CANCER RES, V50, P6334; MacKenzie DA, 2009, J BIOL CHEM, V284, P32444, DOI 10.1074/jbc.M109.040907; Marteyn B, 2011, CELL MICROBIOL, V13, P171, DOI 10.1111/j.1462-5822.2010.01549.x; Marteyn B, 2010, NATURE, V465, P355, DOI 10.1038/nature08970; Mergler M, 2003, J PEPT SCI, V9, P36, DOI 10.1002/psc.430; Mesquita P, 2004, AM J SURG PATHOL, V28, P1254, DOI 10.1097/01.pas.0000135517.50095.7f; Mukhopadhyay P, 2011, BBA-REV CANCER, V1815, P224, DOI 10.1016/j.bbcan.2011.01.001; MUTTER M, 1995, PEPTIDE RES, V8, P145; Ouwehand AC, 2001, INT J FOOD MICROBIOL, V64, P119, DOI 10.1016/S0168-1605(00)00440-2; PACKMAN LC, 1994, PEPTIDE RES, V7, P125; Park SY, 2009, ONCOL REP, V22, P649, DOI 10.3892/or_00000485; Pretzer G, 2005, J BACTERIOL, V187, P6128, DOI 10.1128/JB.187.17.6128-6136.2005; Robbe C, 2003, J BIOL CHEM, V278, P46337, DOI 10.1074/jbc.M302529200; Roos S, 2002, MICROBIOL-SGM, V148, P433, DOI 10.1099/00221287-148-2-433; RUBINSTEIN A, 1994, PHARM RES-DORDR, V11, P794, DOI 10.1023/A:1018961204325; Schultsz C, 1999, GASTROENTEROLOGY, V117, P1089, DOI 10.1016/S0016-5085(99)70393-8; Shaoul R, 2004, J PEDIATR GASTR NUTR, V38, P488, DOI 10.1097/00005176-200405000-00006; Strugala V, 2008, INT J CLIN PRACT, V62, P762, DOI 10.1111/j.1742-1241.2007.01665.x; Travo A, 2010, HISTOPATHOLOGY, V56, P921, DOI 10.1111/j.1365-2559.2010.03563.x; TYTGAT KMAJ, 1994, GASTROENTEROLOGY, V107, P1352, DOI 10.1016/0016-5085(94)90537-1; Van Klinken BJW, 1999, AM J PHYSIOL-GASTR L, V276, pG115, DOI 10.1152/ajpgi.1999.276.1.G115; Wong WM, 1999, GUT, V44, P890, DOI 10.1136/gut.44.6.890; Zhang SL, 1998, CLIN CANCER RES, V4, P295	37	16	19	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15916	15922		10.1074/jbc.M111.310003	http://dx.doi.org/10.1074/jbc.M111.310003			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22427651	Green Published, hybrid			2022-12-25	WOS:000304006300070
J	Jalan-Sakrikar, N; Bartlett, RK; Baucum, AJ; Colbran, RJ				Jalan-Sakrikar, Nidhi; Bartlett, Ryan K.; Baucum, Anthony J., II; Colbran, Roger J.			Substrate-selective and Calcium-independent Activation of CaMKII by alpha-Actinin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-II; HIPPOCAMPAL-NEURONS; REGULATORY PHOSPHORYLATION; SYNAPTIC PLASTICITY; BINDING DOMAIN; NR2B SUBUNIT; RECEPTOR; NMDA; CALMODULIN; CALCIUM/CALMODULIN	Protein-protein interactions are thought to modulate the efficiency and specificity of Ca2+/calmodulin (CaM)-dependent protein kinase II (CaMKII) signaling in specific subcellular compartments. Here we show that the F-actin-binding protein alpha-actinin targets CaMKII alpha to F-actin in cells by binding to the CaMKII regulatory domain, mimicking CaM. The interaction with alpha-actinin is blocked by CaMKII autophosphorylation at Thr-306, but not by autophosphorylation at Thr-305, whereas autophosphorylation at either site blocks Ca2+/CaM binding. The binding of alpha-actinin to CaMKII is Ca2+-independent and activates the phosphorylation of a subset of substrates in vitro. In intact cells, alpha-actinin selectively stabilizes CaMKII association with GluN2B-containing glutamate receptors and enhances phosphorylation of Ser-1303 in GluN2B, but inhibits CaMKII phosphorylation of Ser-831 in glutamate receptor GluA1 subunits by competing for activation by Ca2+/CaM. These data show that Ca2+-independent binding of alpha-actinin to CaMKII differentially modulates the phosphorylation of physiological targets that play key roles in long-term synaptic plasticity.	[Colbran, Roger J.] Vanderbilt Univ, Med Ctr, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Colbran, Roger J.] Vanderbilt Univ, Vanderbilt Brain Inst, Sch Med, Nashville, TN 37232 USA; [Colbran, Roger J.] Vanderbilt Univ, Vanderbilt Kennedy Ctr Res Human Dev, Sch Med, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Colbran, RJ (corresponding author), Vanderbilt Univ, Med Ctr, Sch Med, Dept Mol Physiol & Biophys, 702 Light Hall, Nashville, TN 37232 USA.	ryan.k.bartlett@monsanto.com; roger.colbran@vanderbilt.edu	Colbran, Roger/AAU-7708-2021; Jalan-Sakrikar, Nidhi/S-8653-2019; Baucum, Anthony/I-5109-2013	Colbran, Roger/0000-0001-7401-8244; Jalan-Sakrikar, Nidhi/0000-0001-6795-0121; Baucum, Anthony/0000-0002-4756-9865	National Institutes of Health [R01-MH063232, T32-DK07563]; AHA [0815090E, 0625289B]; NIH [CA68485, DK20593, DK58404, HD15052, DK59637, EY08126]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD015052] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK059637, P30DK058404, U2CDK059637, T32DK007563, P30DK020593, P60DK020593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063232] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part by National Institutes of Health Grants R01-MH063232 (to R. J. C.) and T32-DK07563 (to R. K. B.), and AHA Grants 0815090E (to N. J.-S.) and 0625289B (to R. K. B.). Fluorescence microscopy was performed in the VUMC Cell Imaging Shared Resource, supported by NIH grants CA68485, DK20593, DK58404, HD15052, DK59637, and EY08126.	Allison DW, 2000, J NEUROSCI, V20, P4545, DOI 10.1523/JNEUROSCI.20-12-04545.2000; Allison DW, 1998, J NEUROSCI, V18, P2423; Atkinson RA, 2001, NAT STRUCT BIOL, V8, P853, DOI 10.1038/nsb1001-853; Barria A, 1997, J BIOL CHEM, V272, P32727, DOI 10.1074/jbc.272.52.32727; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Baucum AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031554; Baucum AJ, 2010, MOL CELL PROTEOMICS, V9, P1243, DOI 10.1074/mcp.M900387-MCP200; Bayer KM, 2001, BIOCHEM BIOPH RES CO, V289, P917, DOI 10.1006/bbrc.2001.6063; Bayer KU, 2006, J NEUROSCI, V26, P1164, DOI 10.1523/JNEUROSCI.3116-05.2006; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; BLANCHARD A, 1989, J MUSCLE RES CELL M, V10, P280, DOI 10.1007/BF01758424; Cheng DM, 2006, MOL CELL PROTEOMICS, V5, P1158, DOI 10.1074/mcp.D500009-MCP200; Colbran RJ, 2004, BIOCHEM J, V378, P1, DOI 10.1042/BJ20031547; COLBRAN RJ, 1993, J BIOL CHEM, V268, P7163; Dhavan R, 2002, J NEUROSCI, V22, P7879; Elgersma Y, 2002, NEURON, V36, P493, DOI 10.1016/S0896-6273(02)01007-3; ERONDU NE, 1985, J NEUROSCI, V5, P3270; Evans TIA, 2009, PROTEINS, V76, P47, DOI 10.1002/prot.22317; Feng BH, 2011, BRAIN RES, V1419, P46, DOI 10.1016/j.brainres.2011.08.051; Fink CC, 2003, NEURON, V39, P283, DOI 10.1016/S0896-6273(03)00428-8; Forest A, 2008, BIOCHEMISTRY-US, V47, P10587, DOI 10.1021/bi8007033; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Griffith Leslie C, 2003, Mol Interv, V3, P386, DOI 10.1124/mi.3.7.386; Halt AR, 2012, EMBO J, V31, P1203, DOI 10.1038/emboj.2011.482; Hoffman L, 2011, EMBO J, V30, P1251, DOI 10.1038/emboj.2011.40; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; Jama AM, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.157057; Jiao YX, 2008, J NEUROCHEM, V105, P1746, DOI 10.1111/j.1471-4159.2008.05280.x; Jiao YX, 2011, J BIOL CHEM, V286, P24806, DOI 10.1074/jbc.M110.216010; KHOORY W, 1993, J CELL SCI, V106, P703; Kristensen AS, 2011, NAT NEUROSCI, V14, P727, DOI 10.1038/nn.2804; Krupp JJ, 1999, J NEUROSCI, V19, P1165; Leonard AS, 2002, J BIOL CHEM, V277, P48441, DOI 10.1074/jbc.M205164200; Lin YC, 2008, P NATL ACAD SCI USA, V105, P15791, DOI 10.1073/pnas.0804399105; MEADOR WE, 1993, SCIENCE, V262, P1718, DOI 10.1126/science.8259515; Merrill MA, 2007, BIOCHEMISTRY-US, V46, P8485, DOI 10.1021/bi0623025; Michailidis IE, 2007, J NEUROSCI, V27, P5523, DOI 10.1523/JNEUROSCI.4378-06.2007; O'Leary H, 2011, J BIOL CHEM, V286, P31272, DOI 10.1074/jbc.M111.233668; Okamoto KI, 2007, P NATL ACAD SCI USA, V104, P6418, DOI 10.1073/pnas.0701656104; Pi HJ, 2010, P NATL ACAD SCI USA, V107, P14437, DOI 10.1073/pnas.1009268107; Pi HJ, 2010, J NEUROSCI, V30, P8704, DOI 10.1523/JNEUROSCI.0133-10.2010; Pradeep KK, 2009, BIOCHEM J, V419, P123, DOI 10.1042/BJ20081707; Robison AJ, 2005, J BIOL CHEM, V280, P39316, DOI 10.1074/jbc.M508189200; Robison AJ, 2005, J BIOL CHEM, V280, P35329, DOI 10.1074/jbc.M502191200; Sanhueza M, 2011, J NEUROSCI, V31, P9170, DOI 10.1523/JNEUROSCI.1250-11.2011; Sessoms-Sikes S, 2005, MOL CELL NEUROSCI, V29, P139, DOI 10.1016/j.mcn.2005.01.006; Shen K, 1998, NEURON, V21, P593, DOI 10.1016/S0896-6273(00)80569-3; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; Shifman JM, 2006, P NATL ACAD SCI USA, V103, P13968, DOI 10.1073/pnas.0606433103; Sjoblom B, 2008, CELL MOL LIFE SCI, V65, P2688, DOI 10.1007/s00018-008-8080-8; Soderling TR, 2001, CHEM REV, V101, P2341, DOI 10.1021/cr0002386; Strack S, 2000, J BIOL CHEM, V275, P25061, DOI 10.1074/jbc.C000319200; Strack S, 2000, J BIOL CHEM, V275, P23798, DOI 10.1074/jbc.M001471200; Strack S, 1998, J BIOL CHEM, V273, P20689, DOI 10.1074/jbc.273.33.20689; Swulius MT, 2008, CELL MOL LIFE SCI, V65, P2637, DOI 10.1007/s00018-008-8086-2; Walikonis RS, 2001, J NEUROSCI, V21, P423, DOI 10.1523/JNEUROSCI.21-02-00423.2001; Wyszynski M, 1997, NATURE, V385, P439, DOI 10.1038/385439a0; Wyszynski M, 1998, J NEUROSCI, V18, P1383; Yuste R, 2000, NAT NEUROSCI, V3, P653, DOI 10.1038/76609; Zhang S, 1998, NEURON, V21, P443, DOI 10.1016/S0896-6273(00)80553-X; Zhou Y, 2007, J NEUROSCI, V27, P13843, DOI 10.1523/JNEUROSCI.4486-07.2007	62	33	34	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15275	15283		10.1074/jbc.M112.351817	http://dx.doi.org/10.1074/jbc.M112.351817			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22427672	hybrid, Green Published			2022-12-25	WOS:000304006300011
J	Jones, MB; Nasirikenari, M; Lugade, AA; Thanavala, Y; Lau, JTY				Jones, Mark B.; Nasirikenari, Mehrab; Lugade, Amit A.; Thanavala, Yasmin; Lau, Joseph T. Y.			Anti-inflammatory IgG Production Requires Functional P1 Promoter in beta-Galactoside alpha 2,6-Sialyltransferase 1 (ST6Gal-1) Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOGLOBULIN-G GALACTOSYLATION; INTRAVENOUS IMMUNOGLOBULIN; SIALYLTRANSFERASE; EXPRESSION; INFLAMMATION; SIALYLATION; DEFICIENCY; MICE; PROFILE	The anti-inflammatory properties associated with intravenous immunoglobulin therapy require the sialic acid modification of the N-glycan of the Fc domain of IgG. Sialylation of the Fc fragment is mediated by beta-galactoside alpha 2,6-sialyltransferase 1 (ST6Gal-1), acting on the Gal(beta 4)GlcNAc terminal structure of the biantennary N-glycans on the Fc domain. However, little is known regarding the in vivo regulation of Fc sialylation and its role in the progression of inflammatory processes. Here, we report that decreased Fc sialylation of circulatory IgG accompanies the acute phase response elicited by turpentine exposure or upon acute exposure to either nontypeable Haemophilus influenzae or ovalbumin. However, Fc sialylation was increased 3-fold from the base line upon transition to chronic inflammation by repeated exposure to challenge. The P1 promoter of the ST6Gal-1 gene is critical for Fc sialylation, but P1 does not drive ST6Gal-1 expression in B cells. The Siat1 Delta P1 mouse, with a dysfunctional P1 promoter, was unable to produce sialylated Fc in the systemic circulation, despite the presence of Gal(beta 4) GlcNAc termini on the Fc glycans. The major contribution of P1 action is to synthesize ST6Gal-1 enzymes that are deposited into the systemic circulation. The data strongly indicate that this pool of extracellular ST6Gal-1 in the blood impacts the sialylation of IgG Fc and that defective Fc sialylation is likely a major contributing mechanism for the proinflammatory tendencies previously noted in Siat1 Delta P1 animals.	[Jones, Mark B.; Nasirikenari, Mehrab; Lau, Joseph T. Y.] Roswell Pk Canc Inst, Dept Mol & Cellular Biol, Buffalo, NY 14263 USA; [Lugade, Amit A.; Thanavala, Yasmin] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute	Lau, JTY (corresponding author), Roswell Pk Canc Inst, Dept Mol & Cellular Biol, Elm & Carlton St, Buffalo, NY 14263 USA.	joseph.lau@roswellpark.org			National Institutes of Health [R01AI38193, P01HL107146, R01 AI069379]; National Cancer Institute Cancer Center [CA16056]; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107146] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI069379, R01AI056082] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AI38193 and P01HL107146 (to J. T. Y. L.) and R01 AI069379 (to Y. T). The core facilities used in this work were supported in part by National Cancer Institute Cancer Center Support Grant CA16056 to the Roswell Park Cancer Institute.	Anthony RM, 2008, SCIENCE, V320, P373, DOI 10.1126/science.1154315; Anthony RM, 2011, NATURE, V475, P110, DOI 10.1038/nature10134; Anthony RM, 2008, P NATL ACAD SCI USA, V105, P19571, DOI 10.1073/pnas.0810163105; Appenheimer MM, 2003, GLYCOBIOLOGY, V13, P591, DOI 10.1093/glycob/cwg066; BAUMANN H, 1994, IMMUNOL TODAY, V15, P74, DOI 10.1016/0167-5699(94)90137-6; Blomme B, 2011, AM J PHYSIOL-GASTR L, V300, pG833, DOI 10.1152/ajpgi.00228.2010; Bruhns P, 2003, IMMUNITY, V18, P573, DOI 10.1016/S1074-7613(03)00080-3; Dalziel M, 2001, GLYCOBIOLOGY, V11, P407, DOI 10.1093/glycob/11.5.407; Gregoire-Gauthier J, 2012, BONE MARROW TRANSPL, V47, P439, DOI 10.1038/bmt.2011.93; Hennet T, 1998, P NATL ACAD SCI USA, V95, P4504, DOI 10.1073/pnas.95.8.4504; Hu YP, 1997, GLYCOCONJUGATE J, V14, P407, DOI 10.1023/A:1018535014976; Jones MB, 2010, J BIOL CHEM, V285, P25009, DOI 10.1074/jbc.M110.104406; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Kotz K, 1996, ELECTROPHORESIS, V17, P533, DOI 10.1002/elps.1150170321; Lugade AA, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00010; Lugade AA, 2011, ADV EXP MED BIOL, V780, P125, DOI 10.1007/978-1-4419-5632-3_11; Lugade AA, 2011, AM J RESP CELL MOL, V45, P557, DOI 10.1165/rcmb.2010-0321OC; Martin LT, 2002, J BIOL CHEM, V277, P32930, DOI 10.1074/jbc.M203362200; Murphy TF, 2003, CURR OPIN INFECT DIS, V16, P129, DOI 10.1097/00001432-200304000-00009; Nasirikenari M, 2006, BLOOD, V108, P3397, DOI 10.1182/blood-2006-04-014779; Nasirikenari M, 2010, J LEUKOCYTE BIOL, V87, P457, DOI 10.1189/jlb.1108704; Samuelson P, 2001, SCIENCE, V293, P2028, DOI 10.1126/science.1063764; Sokos DR, 2002, BIOL BLOOD MARROW TR, V8, P117, DOI 10.1053/bbmt.2002.v8.pm11939601; Stadlmann J, 2010, J CLIN IMMUNOL, V30, pS15, DOI 10.1007/s10875-010-9409-2; Stadlmann J, 2009, PROTEOMICS, V9, P4143, DOI 10.1002/pmic.200800931; Sullivan K M, 1996, Biol Blood Marrow Transplant, V2, P44; SULLIVAN KM, 1990, NEW ENGL J MED, V323, P705, DOI 10.1056/NEJM199009133231103; van de Geijn FE, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2892; Wuensch SA, 2000, GLYCOBIOLOGY, V10, P67, DOI 10.1093/glycob/10.1.67	29	43	43	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15365	15370		10.1074/jbc.M112.345710	http://dx.doi.org/10.1074/jbc.M112.345710			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22427662	hybrid, Green Published			2022-12-25	WOS:000304006300018
J	Ashe, K				Ashe, Katy			Elevated Mercury Concentrations in Humans of Madre de Dios, Peru	PLOS ONE			English	Article							TAPAJOS RIVER-BASIN; BRAZILIAN AMAZON; HUMAN HAIR; FISH; CONTAMINATION; METHYLMERCURY; INHABITANTS; SPECIATION; EXPOSURE; HEALTH	The enormous increase in practically unregulated mining in Madre de Dios Peru is leading to massive release of liquid elemental mercury to the environment. Rapidly increasing global prices for gold are causing a massive upsurge in artisanal mining in the Peruvian Amazon, considered to be one of the most biodiverse places on the planet. This study identifies the current levels of mercury in the human population, through identifying levels of total mercury in human hair in mining zones of Madre de Dios Department and in the nearby city of Puerto Maldonado. A regression analysis reveals that fish consumption, gender, and location of residence were significant indicators of mercury levels; while duration of residence and age had no significant relationship to mercury levels. Increased fish consumption levels were the strongest indicators of increased total mercury levels across the entire population. The levels of total mercury in hair was significantly (alpha = 0.05) higher in mining zones, than Puerto Maldonado. In both areas men had significantly higher levels than women, likely due to a difference in metabolism or varying levels of direct involvement in gold mining-a male predominated industry. This is the first study to show the health threat that mercury poses to this region, however further research needs to be done to gain a more refined understanding of the predominant routes of exposure in this population.	Stanford Univ, Dept Civil & Environm Engn, Stanford, CA 94305 USA	Stanford University	Ashe, K (corresponding author), Stanford Univ, Dept Civil & Environm Engn, Stanford, CA 94305 USA.	kashe@stanford.edu			Stanford Undergraduate Research Program; Morrison Institute for Population and Resource Studies; Anthropology Department at Stanford University; QuestBridge Foundation	Stanford Undergraduate Research Program; Morrison Institute for Population and Resource Studies; Anthropology Department at Stanford University; QuestBridge Foundation	Funding for this project came from the Stanford Undergraduate Research Program, the Morrison Institute for Population and Resource Studies, the Tambopata Summer Research Opportunity Program in the Anthropology Department at Stanford University, and the QuestBridge Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAGI H, 1995, WATER AIR SOIL POLL, V80, P85, DOI 10.1007/BF01189656; Barbosa AC, 1998, ENVIRON TOXICOL PHAR, V6, P71, DOI 10.1016/S1382-6689(98)00031-3; BARBOSA AC, 1995, WATER AIR SOIL POLL, V80, P109, DOI 10.1007/BF01189660; Barbosa AC, 1998, ARCH ENVIRON CON TOX, V34, P100, DOI 10.1007/s002449900291; Barbosa AC, 2001, ARCH ENVIRON CON TOX, V40, P439, DOI 10.1007/s002440010195; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Brooks WE, 2007, 20071252 US GEOL SUR; Comercio EI, 2009, COMERCIO        1110; Fraser B, 2009, ENVIRON SCI TECHNOL, V43, P7162, DOI 10.1021/es902347z; Harada M, 1998, ENVIRON RES, V77, P160, DOI 10.1006/enrs.1998.3837; Harada M, 2001, ENVIRON INT, V27, P285, DOI 10.1016/S0160-4120(01)00059-9; Kehrig HD, 1998, ENVIRON RES, V77, P84, DOI 10.1006/enrs.1998.3836; Leino T, 1995, SCI TOTAL ENVIRON, V175, P119, DOI 10.1016/0048-9697(95)04908-J; Malm O, 1998, ENVIRON RES, V77, P73, DOI 10.1006/enrs.1998.3828; Malm O, 1995, SCI TOTAL ENVIRON, V175, P141, DOI 10.1016/0048-9697(95)04910-X; McCullagh P, 1989, GEN LINEAR MODELS; Pellizzari ED, 1999, J EXPO ANAL ENV EPID, V9, P393, DOI 10.1038/sj.jea.7500056; Santos ECO, 2002, ENVIRON RES, V90, P6, DOI 10.1006/enrs.2002.4366; StataCorp, 2019, STATA STAT SOFTWARE; Swenson JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018875; [Tekran Inc Tekran Inc.], 2002, TEKR SER 2600 TOT ME, P100; Telmer KM, 2009, MERCURY FATE AND TRANSPORT IN THE GLOBAL ATMOSPHERE, P131, DOI 10.1007/978-0-387-93958-2_6; Tukey JW, 1977, EXPLORATORY DATA ANA; WHO (World Health Organization), 1976, ENV HLTH CRIT; Yasutake A, 2003, TOHOKU J EXP MED, V199, P161, DOI 10.1620/tjem.199.161	25	77	78	3	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33305	10.1371/journal.pone.0033305	http://dx.doi.org/10.1371/journal.pone.0033305			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438911	Green Published, gold, Green Submitted			2022-12-25	WOS:000303309100031
J	Gilbert, C; McCafferty, DJ; Giroud, S; Ancel, A; Blanc, S				Gilbert, Caroline; McCafferty, Dominic J.; Giroud, Sylvain; Ancel, Andre; Blanc, Stephane			Private Heat for Public Warmth: How Huddling Shapes Individual Thermogenic Responses of Rabbit Pups	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; SYRIAN GOLDEN-HAMSTERS; INFANT NORWAY RATS; NEWBORN DOMESTIC RABBITS; NEW-BORN RABBITS; INFRARED THERMOGRAPHY; LITTER HUDDLE; NONSHIVERING THERMOGENESIS; ULTRASONIC VOCALIZATION; ENERGETIC BENEFITS	Background: Within their litter, young altricial mammals compete for energy (constraining growth and survival) but cooperate for warmth. The aim of this study was to examine the mechanisms by which huddling in altricial infants influences individual heat production and loss, while providing public warmth. Although considered as a textbook example, it is surprising to note that physiological mechanisms underlying huddling are still not fully characterised. Methodology/Principal Findings: The brown adipose tissue (BAT) contribution to energy output was assessed as a function of the ability of rabbit (Oryctolagus cuniculus) pups to huddle (placed in groups of 6 and 2, or isolated) and of their thermoregulatory capacities (non-insulated before 5 days old and insulated at ca. 10 days old). BAT contribution of pups exposed to cold was examined by combining techniques of infrared thermography (surface temperature), indirect calorimetry (total energy expenditure, TEE) and telemetry (body temperature). Through local heating, the huddle provided each pup whatever their age with an ambient "public warmth" in the cold, which particularly benefited non-insulated pups. Huddling allowed pups facing a progressive cold challenge to buffer the decreasing ambient temperature by delaying the activation of their thermogenic response, especially when fur-insulated. In this way, huddling permitted pups to effectively shift from a non-insulated to a pseudo-insulated thermal state while continuously allocating energy to growth. The high correlation between TEE and the difference in surface temperatures between BAT and back areas of the body reveals that energy loss for non-shivering thermogenesis is the major factor constraining the amount of energy allocated to growth in non-insulated altricial pups. Conclusions/Significance: By providing public warmth with minimal individual costs at a stage of life when pups are the most vulnerable, huddling buffers cold challenges and ensures a constant allocation of energy to growth by reducing BAT activation.	[Gilbert, Caroline] Univ Paris Est, Ecole Natl Vet Alfort, UMR 7179, CNRS,MNHN, Maisons Alfort, France; [McCafferty, Dominic J.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland; [Giroud, Sylvain] Univ Vet Med, Res Inst Wildlife Ecol, Vienna, Austria; [Ancel, Andre; Blanc, Stephane] Univ Strasbourg, IPHC, Strasbourg, France; [Ancel, Andre; Blanc, Stephane] CNRS, UMR 7178, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ecole Nationale Veterinaire d'Alfort (ENVA); Museum National d'Histoire Naturelle (MNHN); University of Glasgow; University of Veterinary Medicine Vienna; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Gilbert, C (corresponding author), Univ Paris Est, Ecole Natl Vet Alfort, UMR 7179, CNRS,MNHN, Maisons Alfort, France.	cgilbert@vet-alfort.fr	Giroud, Sylvain/AAG-6430-2019	Giroud, Sylvain/0000-0001-6621-7462; McCafferty, Dominic/0000-0002-3079-3326; Gilbert, Caroline/0000-0002-9957-405X	Centre National de la Recherche Scientifique (CNRS), France; BDI-CNRS	Centre National de la Recherche Scientifique (CNRS), France(Centre National de la Recherche Scientifique (CNRS)); BDI-CNRS	This research was funded by the Centre National de la Recherche Scientifique (CNRS), France, http://www.cnrs.fr/. CG was supported by a BDI-CNRS fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTS JR, 1978, J COMP PHYSIOL PSYCH, V92, P231, DOI 10.1037/h0077459; Bautista A, 2005, ANIM BEHAV, V70, P1011, DOI 10.1016/j.anbehav.2005.01.015; Bautista A, 2003, DEV PSYCHOBIOL, V43, P208, DOI 10.1002/dev.10134; Bautista A, 2008, BEHAV ECOL SOCIOBIOL, V62, P331, DOI 10.1007/s00265-007-0420-4; Bautista A, 2010, DEV PSYCHOBIOL, V52, P35, DOI 10.1002/dev.20409; BERNARD E, 1964, BIOL NEONATORUM, V7, P172; BLUMBERG MS, 1992, DEV PSYCHOBIOL, V25, P497, DOI 10.1002/dev.420250704; Blumberg MS, 1996, BEHAV NEUROSCI, V110, P305, DOI 10.1037/0735-7044.110.2.305; Blumberg MS, 1998, DEV PSYCHOBIOL, V33, P107, DOI 10.1002/(SICI)1098-2302(199809)33:2<107::AID-DEV2>3.0.CO;2-N; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; CANNON B, 1986, BIOCHEM SOC T, V14, P233, DOI 10.1042/bst0140233; Coureaud G, 2000, REPROD NUTR DEV, V40, P19, DOI 10.1051/rnd:2000117; DAWKINS MJR, 1964, J PHYSIOL-LONDON, V172, P216, DOI 10.1113/jphysiol.1964.sp007414; Drummond H, 2000, ETHOLOGY, V106, P511, DOI 10.1046/j.1439-0310.2000.00554.x; Gilbert C, 2007, AM J PHYSIOL-REG I, V293, pR867, DOI 10.1152/ajpregu.00081.2007; Gilbert C, 2010, BIOL REV, V85, P545, DOI 10.1111/j.1469-185X.2009.00115.x; Haig D, 2008, CURR BIOL, V18, pR172, DOI 10.1016/j.cub.2007.12.040; HAMMEL HT, 1955, AM J PHYSIOL, V182, P369, DOI 10.1152/ajplegacy.1955.182.2.369; HAYES JP, 1992, PHYSIOL ZOOL, V65, P742, DOI 10.1086/physzool.65.4.30158537; HEIM T, 1966, J PHYSIOL-LONDON, V186, P42, DOI 10.1113/jphysiol.1966.sp008019; HUDSON R, 1982, BEHAVIOUR, V79, P255, DOI 10.1163/156853982X00292; Hudson R, 2008, BEHAV ECOL SOCIOBIOL, V62, P299, DOI 10.1007/s00265-007-0417-z; Hudson R, 2011, DEV PSYCHOBIOL, V53, P564, DOI 10.1002/dev.20535; HULL D, 1965, J PHYSIOL-LONDON, V181, P449, DOI 10.1113/jphysiol.1965.sp007773; Jackson DM, 2001, J THERM BIOL, V26, P85, DOI 10.1016/S0306-4565(00)00023-1; JANSKY L, 1973, BIOL REV, V48, P85; Jilge B, 2000, J BIOL RHYTHM, V15, P329, DOI 10.1177/074873000129001431; Jilge B, 2001, LAB ANIM-UK, V35, P364, DOI 10.1258/0023677011911831; LINCOLN DW, 1974, PHYSIOL BEHAV, V13, P711, DOI 10.1016/0031-9384(74)90247-9; McCafferty DJ, 2011, COMP BIOCHEM PHYS A, V158, P337, DOI 10.1016/j.cbpa.2010.09.012; Mccafferty DJ, 2007, MAMMAL REV, V37, P207, DOI 10.1111/j.1365-2907.2007.00111.x; Mock D. W., 1997, EVOLUTION SIBLING RI; MOHLER FS, 1988, AM J PHYSIOL, V254, pR389, DOI 10.1152/ajpregu.1988.254.2.R389; Mucino E, 2009, DEV PSYCHOBIOL, V51, P24, DOI 10.1002/dev.20339; Nedergaard J, 2001, BIOCHEM SOC T, V29, P756; NICHOLLS DG, 1984, PHYSIOL REV, V64, P1, DOI 10.1152/physrev.1984.64.1.1; Oya A, 1997, J PERINAT MED, V25, P447, DOI 10.1515/jpme.1997.25.5.447; Reyes-Meza V, 2011, PHYSIOL BEHAV, V104, P778, DOI 10.1016/j.physbeh.2011.07.019; Rodel HG, 2008, OECOLOGIA, V155, P677, DOI 10.1007/s00442-008-0958-5; Rodel HG, 2008, PHYSIOL BEHAV, V95, P441, DOI 10.1016/j.physbeh.2008.07.011; Rodel HG, 2008, PHYSIOL BEHAV, V93, P826, DOI 10.1016/j.physbeh.2007.11.047; Rodel HG, 2009, PHYSIOL BEHAV, V97, P495, DOI 10.1016/j.physbeh.2009.04.005; SCHMIDTNIELSEN K, 1997, ANIMAL PHYSL ADAPTAT, P241; Sokoloff G, 2000, BEHAV NEUROSCI, V114, P585; Sokoloff G, 2002, J COMP PSYCHOL, V116, P240, DOI 10.1037/0735-7036.116.3.240; Sokoloff G, 2002, J COMP PSYCHOL, V116, P228, DOI 10.1037//0735-7036.116.3.228; Sokoloff G, 2001, DEV PSYCHOBIOL, V39, P65, DOI 10.1002/dev.1030; Speakman JR, 1998, ZOOL-ANAL COMPLEX SY, V101, P224; STANIER MW, 1975, COMP BIOCHEM PHYS A, V51, P79, DOI 10.1016/0300-9629(75)90416-8; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; White CR, 2003, P NATL ACAD SCI USA, V100, P4046, DOI 10.1073/pnas.0436428100; ZARROW MX, 1965, SCIENCE, V150, P1835, DOI 10.1126/science.150.3705.1835	52	29	29	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33553	10.1371/journal.pone.0033553	http://dx.doi.org/10.1371/journal.pone.0033553			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438947	Green Published, Green Accepted, gold			2022-12-25	WOS:000303309100056
J	Huang, KH; Kuo, KL; Chen, SC; Weng, TI; Chuang, YT; Tsai, YC; Pu, YS; Chiang, CK; Liu, SH				Huang, Kuo-How; Kuo, Kuan-Lin; Chen, Shyh-Chyan; Weng, Te-I; Chuang, Yuan-Ting; Tsai, Yu-Chieh; Pu, Yeong-Shiau; Chiang, Chih-Kang; Liu, Shing-Hwa			Down-Regulation of Glucose-Regulated Protein (GRP) 78 Potentiates Cytotoxic Effect of Celecoxib in Human Urothelial Carcinoma Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; URINARY-BLADDER CANCER; NON-COXIB ANALOG; IN-VITRO; INDUCED APOPTOSIS; CYCLOOXYGENASE-2 INHIBITORS; COMBINATION; DEATH; VIVO; METHOTREXATE	Celecoxib is a selective cyclooxygenase-2 (COX-2) inhibitor that has been reported to elicit anti-proliferative response in various tumors. In this study, we aim to investigate the antitumor effect of celecoxib on urothelial carcinoma (UC) cells and the role endoplasmic reticulum (ER) stress plays in celecoxib-induced cytotoxicity. The cytotoxic effects were measured by MTT assay and flow cytometry. The cell cycle progression and ER stress-associated molecules were examined by Western blot and flow cytometry. Moreover, the cytotoxic effects of celecoxib combined with glucose-regulated protein (GRP) 78 knockdown (siRNA), (-)-epigallocatechin gallate (EGCG) or MG132 were assessed. We demonstrated that celecoxib markedly reduces the cell viability and causes apoptosis in human UC cells through cell cycle G1 arrest. Celecoxib possessed the ability to activate ER stress-related chaperones (IRE-1 alpha and GRP78), caspase-4, and CCAAT/enhancer binding protein homologous protein (CHOP), which were involved in UC cell apoptosis. Down-regulation of GRP78 by siRNA, co-treatment with EGCG (a GRP78 inhibitor) or with MG132 (a proteasome inhibitor) could enhance celecoxib-induced apoptosis. We concluded that celecoxib induces cell cycle G1 arrest, ER stress, and eventually apoptosis in human UC cells. The down-regulation of ER chaperone GRP78 by siRNA, EGCG, or proteosome inhibitor potentiated the cytotoxicity of celecoxib in UC cells. These findings provide a new treatment strategy against UC.	[Huang, Kuo-How; Chiang, Chih-Kang; Liu, Shing-Hwa] Natl Taiwan Univ, Coll Med, Grad Inst Toxicol, Taipei 10764, Taiwan; [Huang, Kuo-How; Kuo, Kuan-Lin; Chen, Shyh-Chyan; Weng, Te-I; Chuang, Yuan-Ting; Tsai, Yu-Chieh; Pu, Yeong-Shiau; Chiang, Chih-Kang; Liu, Shing-Hwa] Natl Taiwan Univ Hosp, Taipei, Taiwan; [Huang, Kuo-How; Kuo, Kuan-Lin; Chen, Shyh-Chyan; Chuang, Yuan-Ting; Pu, Yeong-Shiau; Liu, Shing-Hwa] Natl Taiwan Univ, Coll Med, Dept Urol, Taipei 10764, Taiwan; [Weng, Te-I] Natl Taiwan Univ, Coll Med, Dept Forens Med, Taipei 10764, Taiwan; [Tsai, Yu-Chieh] Natl Taiwan Univ, Coll Med, Dept Oncol, Taipei 10764, Taiwan; [Chiang, Chih-Kang] Natl Taiwan Univ, Coll Med, Dept Integrated Diagnost & Therapeut, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University	Huang, KH (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Toxicol, Taipei 10764, Taiwan.	kuohowhuang@gmail.com; shinghwaliu@ntu.edu.tw		Weng, Te-I/0000-0002-8797-1672; Huang, Kuo-How/0000-0002-0989-0578; Kuo, Kuan-Lin/0000-0001-7204-3032; PU, YEONG-SHIAU/0000-0002-2859-3966; TSAI, YU-CHIEH/0000-0002-9285-7655; CHIANG, CHIH-KANG/0000-0001-9021-4616; LIU, SHING-HWA/0000-0002-9976-1197	Taiwan National Science Council [NSC 98-2314-B-002-056]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by a grant from Taiwan National Science Council (NSC 98-2314-B-002-056). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhim Z, 2011, BRIT J CANCER, V105, P393, DOI 10.1038/bjc.2011.262; Chen ST, 2010, LEUKEMIA RES, V34, P250, DOI 10.1016/j.leukres.2009.09.028; CHRISTIAN BJ, 1987, CANCER RES, V47, P6066; Cusimano A, 2010, CELL CYCLE, V9, P1399, DOI 10.4161/cc.9.7.11254; Dannenberg AJ, 2003, CANCER CELL, V4, P431, DOI 10.1016/S1535-6108(03)00310-6; Davies NM, 2000, CLIN PHARMACOKINET, V38, P225, DOI 10.2165/00003088-200038030-00003; Dhawan D, 2008, MOL CANCER THER, V7, P897, DOI 10.1158/1535-7163.MCT-07-0313; Dhawan D, 2010, MOL CANCER THER, V9, P1371, DOI 10.1158/1535-7163.MCT-10-0049; Dovedi SJ, 2008, EUR UROL, V54, P621, DOI 10.1016/j.eururo.2008.01.013; Egger L, 2007, CELL DEATH DIFFER, V14, P1172, DOI 10.1038/sj.cdd.4402125; Ermakova SP, 2006, CANCER RES, V66, P9260, DOI 10.1158/0008-5472.CAN-06-1586; Ferrandina G, 2003, CLIN CANCER RES, V9, P4324; Gee J, 2006, ONCOL REP, V15, P471; Gee JR, 2009, ANTICANCER RES, V29, P3769; HARKER WG, 1985, J CLIN ONCOL, V3, P1463, DOI 10.1200/JCO.1985.3.11.1463; Hour TC, 2004, ANTI-CANCER DRUG, V15, P779, DOI 10.1097/00001813-200409000-00007; Huang SB, 2010, AUTOPHAGY, V6, P256, DOI 10.4161/auto.6.2.11124; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jendrossek V, 2003, FASEB J, V17, P1547, DOI 10.1096/fj.02-0947fje; Kardosh A, 2008, CANCER RES, V68, P843, DOI 10.1158/0008-5472.CAN-07-5555; Kulkarni P, 2011, J CELL BIOCHEM, V112, P1949, DOI 10.1002/jcb.23115; Kulp SK, 2004, CANCER RES, V64, P1444, DOI 10.1158/0008-5472.CAN-03-2396; Latini DM, 2010, UROLOGY, V75, P334, DOI 10.1016/j.urology.2009.09.051; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; Leese PT, 2000, J CLIN PHARMACOL, V40, P124, DOI 10.1177/00912700022008766; Li JZ, 2006, CURR MOL MED, V6, P45, DOI 10.2174/156652406775574523; Liu XG, 2004, JNCI-J NATL CANCER I, V96, P1769, DOI 10.1093/jnci/djh322; Menter DG, 2010, CLIN CANCER RES, V16, P1384, DOI 10.1158/1078-0432.CCR-09-0788; Mohammed SI, 2006, MOL CANCER THER, V5, P329, DOI 10.1158/1535-7163.MCT-05-0117; Mohammed SI, 2002, CANCER RES, V62, P356; Pyrko P, 2007, MOL CANCER THER, V6, P1262, DOI 10.1158/1535-7163.MCT-06-0629; Qin J, 2009, BIOMED PHARMACOTHER, V63, P241, DOI 10.1016/j.biopha.2008.04.007; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Schonthal AH, 2009, CANCER LETT, V275, P163, DOI 10.1016/j.canlet.2008.07.005; STERNBERG CN, 1989, CANCER, V64, P2448, DOI 10.1002/1097-0142(19891215)64:12<2448::AID-CNCR2820641209>3.0.CO;2-7; Tsutsumi S, 2006, ONCOGENE, V25, P1018, DOI 10.1038/sj.onc.1209139; Tsutsumi S, 2004, CELL DEATH DIFFER, V11, P1009, DOI 10.1038/sj.cdd.4401436; Virrey JJ, 2008, MOL CANCER RES, V6, P1268, DOI 10.1158/1541-7786.MCR-08-0060; von der Maase H, 2000, J CLIN ONCOL, V18, P3068, DOI 10.1200/JCO.2000.18.17.3068; Williams CS, 2000, CANCER RES, V60, P6045; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Yu Hong-Jeng, 1992, Journal of the Formosan Medical Association, V91, P608	42	24	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33615	10.1371/journal.pone.0033615	http://dx.doi.org/10.1371/journal.pone.0033615			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438966	gold, Green Published, Green Submitted			2022-12-25	WOS:000303309100072
J	Kapoor, M; Wang, JC; Bertelsen, S; Bucholz, K; Budde, JP; Hinrichs, A; Agrawal, A; Brooks, A; Chorlian, D; Dick, D; Hesselbrock, V; Foroud, T; Kramer, J; Kuperman, S; Manz, N; Nurnberger, J; Porjesz, B; Rice, J; Tischfield, J; Xuei, XL; Schuckit, M; Edenberg, HJ; Bierut, LJ; Goate, AM				Kapoor, Manav; Wang, Jen-Chyong; Bertelsen, Sarah; Bucholz, Kathy; Budde, John P.; Hinrichs, Anthony; Agrawal, Arpana; Brooks, Andrew; Chorlian, David; Dick, Danielle; Hesselbrock, Victor; Foroud, Tatiana; Kramer, John; Kuperman, Samuel; Manz, Niklas; Nurnberger, John, Jr.; Porjesz, Bernice; Rice, John; Tischfield, Jay; Xuei, Xiaoling; Schuckit, Marc; Edenberg, Howard J.; Bierut, Laura J.; Goate, Alison M.			Variants Located Upstream of CHRNB4 on Chromosome 15q25.1 Are Associated with Age at Onset of Daily Smoking and Habitual Smoking	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; NICOTINE-DEPENDENCE; LUNG-CANCER; SUSCEPTIBILITY LOCUS; ALCOHOL; RISK; INITIATION; GENETICS; GENES; ADOLESCENT	Several genome-wide association and candidate gene studies have linked chromosome 15q24-q25.1 (a region including the CHRNA5-CHRNA3-CHRNB4 gene cluster) with alcohol dependence, nicotine dependence and smoking-related illnesses such as lung cancer and chronic obstructive pulmonary disease. To further examine the impact of these genes on the development of substance use disorders, we tested whether variants within and flanking the CHRNA5-CHRNA3-CHRNB4 gene cluster affect the transition to daily smoking (individuals who smoked cigarettes 4 or more days per week) in a cross sectional sample of adolescents and young adults from the COGA (Collaborative Study of the Genetics of Alcoholism) families. Subjects were recruited from families affected with alcoholism (either as a first or second degree relative) and the comparison families. Participants completed the SSAGA interview, a comprehensive assessment of alcohol and other substance use and related behaviors. Using the Quantitative trait disequilibrium test (QTDT) significant association was detected between age at onset of daily smoking and variants located upstream of CHRNB4. Multivariate analysis using a Cox proportional hazards model further revealed that these variants significantly predict the age at onset of habitual smoking among daily smokers. These variants were not in high linkage disequilibrium (0.28<r(2)<0.56) with variants that have previously been reported to affect risk for nicotine dependence and smoking related diseases in adults. The data suggests that an age-associated relationship underlies the association of SNPs in CHRNB4 with onset of chronic smoking behaviors in adolescents and young adults and may improve genetic information that will lead to better prevention and intervention for substance use disorders among adolescents and young adults.	[Kapoor, Manav; Wang, Jen-Chyong; Bertelsen, Sarah; Bucholz, Kathy; Budde, John P.; Hinrichs, Anthony; Agrawal, Arpana; Rice, John; Bierut, Laura J.; Goate, Alison M.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Brooks, Andrew; Tischfield, Jay] Rutgers State Univ, Dept Genet, Piscataway, NJ USA; [Chorlian, David; Manz, Niklas; Porjesz, Bernice] Suny Downstate Med Ctr, Dept Psychiat & Behav Sci, Brooklyn, NY 11203 USA; [Dick, Danielle] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA USA; [Hesselbrock, Victor] Univ Connecticut, Dept Psychiat, Farmington, CT 06107 USA; [Foroud, Tatiana; Xuei, Xiaoling; Edenberg, Howard J.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN USA; [Kramer, John; Kuperman, Samuel; Nurnberger, John, Jr.] Univ Iowa, Coll Med, Dept Psychiat, Iowa City, IA 52242 USA; [Schuckit, Marc] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA	Washington University (WUSTL); Rutgers State University New Brunswick; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Virginia Commonwealth University; University of Connecticut; Indiana University System; Indiana University-Purdue University Indianapolis; University of Iowa; University of California System; University of California San Diego	Kapoor, M (corresponding author), Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA.	goatea@psychiatry.wustl.edu	Xuei, Xiaoling/L-8564-2019; Bierut, Laura Jean/W-6806-2019; Manz, Niklas/A-3234-2009	Bierut, Laura Jean/0000-0002-9952-4810; Manz, Niklas/0000-0003-1483-915X; Kuperman, Samuel/0000-0002-5995-1981; Nurnberger, John/0000-0002-7674-1767; Budde, John/0000-0001-7778-7276; Edenberg, Howard/0000-0003-0344-9690; Goate, Alison/0000-0002-0576-2472; Tischfield, Jay/0000-0003-3217-8287	National Institutes of Health (NIH) from National Institute on Alcohol Abuse and Alcoholism (NIAAA) [U10AA008401]; National Institute on Drug Abuse (NIDA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U10AA008401, K02AA018755] Funding Source: NIH RePORTER	National Institutes of Health (NIH) from National Institute on Alcohol Abuse and Alcoholism (NIAAA); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This national collaborative study is supported by the National Institutes of Health (NIH) Grant U10AA008401 from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) and the National Institute on Drug Abuse (NIDA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Baker TB, 2009, NICOTINE TOB RES, V11, P785, DOI 10.1093/ntr/ntp064; Berrettine W, 2008, MOL PSYCHIATR, V13, P368, DOI 10.1038/sj.mp.4002154; Bierut LJ, 2008, AM J PSYCHIAT, V165, P1163, DOI 10.1176/appi.ajp.2008.07111711; Bierut LJ, 2007, HUM MOL GENET, V16, P24, DOI 10.1093/hmg/ddl441; Bierut LJ, 1998, ARCH GEN PSYCHIAT, V55, P982, DOI 10.1001/archpsyc.55.11.982; Bruschweiler-Li L, 2010, NEUROSCIENCE, V166, P864, DOI 10.1016/j.neuroscience.2010.01.026; BUCHOLZ KK, 1994, J STUD ALCOHOL, V55, P149, DOI 10.15288/jsa.1994.55.149; Centers for Disease Control (CDC), 2010, CURR CIG SMOK AD AG, P1135; Dani JA, 2005, NAT NEUROSCI, V8, P1465, DOI 10.1038/nn1580; Dick DM, 2007, J ABNORM PSYCHOL, V116, P213, DOI 10.1037/0021-843X.116.1.213; Ducci F, 2011, BIOL PSYCHIAT, V69, P650, DOI 10.1016/j.biopsych.2010.09.055; Ehringer MA, 2007, AM J MED GENET B, V144B, P596, DOI 10.1002/ajmg.b.30464; Frahm S, 2011, NEURON, V70, P522, DOI 10.1016/j.neuron.2011.04.013; Glick SD, 2002, EUR J PHARMACOL, V448, P185, DOI 10.1016/S0014-2999(02)01944-1; Hesselbrock M, 1999, ADDICTION, V94, P1361, DOI 10.1046/j.1360-0443.1999.94913618.x; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; John U, 2004, ADDICT BEHAV, V29, P857, DOI 10.1016/j.addbeh.2004.02.053; Johnson EO, 2010, ADDICTION, V105, P2014, DOI 10.1111/j.1360-0443.2010.03074.x; Kendler KS, 1999, PSYCHOL MED, V29, P299, DOI 10.1017/S0033291798008022; Koopmans JR, 1999, BEHAV GENET, V29, P383, DOI 10.1023/A:1021618719735; Lessov CN, 2004, PSYCHOL MED, V34, P865, DOI 10.1017/S0033291703001582; Lessov-Schlaggar CN, 2008, BIOCHEM PHARMACOL, V75, P178, DOI 10.1016/j.bcp.2007.08.018; Liu PY, 2008, JNCI-J NATL CANCER I, V100, P1326, DOI 10.1093/jnci/djn268; Mokdad AH, 2004, PUBLIC HEALTH REP, V119, P356, DOI 10.1016/j.phr.2004.04.015; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; O'Loughlin J, 2003, AM J PREV MED, V25, P219, DOI 10.1016/S0749-3797(03)00198-3; Saccone NL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001053; Saccone NL, 2009, CANCER RES, V69, P6848, DOI 10.1158/0008-5472.CAN-09-0786; Schlaelpfer IR, 2008, BIOL PSYCHIAT, V63, P1039, DOI 10.1016/j.biopsych.2007.10.024; Stevens VL, 2008, CANCER EPIDEM BIOMAR, V17, P3517, DOI 10.1158/1055-9965.EPI-08-0585; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; True WR, 1999, ARCH GEN PSYCHIAT, V56, P655, DOI 10.1001/archpsyc.56.7.655; US Department of Health and Human Services (USDHHS), 2010, TOB SMOK CAUS DIS BI; Wang JC, 2009, HUM MOL GENET, V18, P3125, DOI 10.1093/hmg/ddp231; Weiss RB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000125	37	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33513	10.1371/journal.pone.0033513	http://dx.doi.org/10.1371/journal.pone.0033513			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438940	gold, Green Published			2022-12-25	WOS:000303309100052
J	Palusa, S; Ndaluka, C; Bowen, RA; Wilusz, CJ; Wilusz, J				Palusa, Saiprasad; Ndaluka, Christina; Bowen, Richard A.; Wilusz, Carol J.; Wilusz, Jeffrey			The 3 ' Untranslated Region of the Rabies Virus Glycoprotein mRNA Specifically Interacts with Cellular PCBP2 Protein and Promotes Transcript Stability	PLOS ONE			English	Article							AU-RICH ELEMENTS; GENE-EXPRESSION; POLY(C)-BINDING PROTEIN-2; POLY(RC)-BINDING PROTEIN; BINDING-PROTEIN; KH-DOMAIN; IN-VITRO; REPLICATION; POLIOVIRUS; DEGRADATION	Viral polymerase entry and pausing at intergenic junctions is predicted to lead to a defined polarity in the levels of rhabdovirus gene expression. Interestingly, we observed that the rabies virus glycoprotein mRNA is differentially over-expressed based on this model relative to other transcripts during infection of 293T cells. During infection, the rabies virus glycoprotein mRNA also selectively interacts with the cellular poly(rC)-binding protein 2 (PCBP2), a factor known to influence mRNA stability. Reporter assays performed both in electroporated cells and in a cell-free RNA decay system indicate that the conserved portion of the 3' UTR of the rabies virus glycoprotein mRNA contains an RNA stability element. PCBP2 specifically interacts with reporter transcripts containing this 72 base 3' UTR sequence. Furthermore, the PCBP2 interaction is directly associated with the stability of reporter transcripts. Therefore, we conclude that PCBP2 specifically and selectively interacts with the rabies virus glycoprotein mRNA and that this interaction may contribute to the post-transcriptional regulation of glycoprotein expression.	[Palusa, Saiprasad; Ndaluka, Christina; Wilusz, Carol J.; Wilusz, Jeffrey] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Ndaluka, Christina; Bowen, Richard A.] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University	Palusa, S (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	jeffrey.wilusz@colostate.edu	Wilusz, Carol/AAC-2901-2021; Wilusz, Carol/F-7241-2017		National Institutes of Health; Rocky Mountain Regional Center of Excellence in Biodefense [AI065357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065357] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rocky Mountain Regional Center of Excellence in Biodefense; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant funding associated with the Rocky Mountain Regional Center of Excellence in Biodefense awarded to JW (AI065357). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertini AAV, 2011, ADV VIRUS RES, V79, P1, DOI 10.1016/B978-0-12-387040-7.00001-9; Bergman N, 2007, NAT STRUCT MOL BIOL, V14, P824, DOI 10.1038/nsmb1287; Cheadle C, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-75; Dickson AM, 2011, TRENDS GENET, V27, P286, DOI 10.1016/j.tig.2011.04.003; Dinh PX, 2011, J VIROL, V85, P9459, DOI 10.1128/JVI.05179-11; Djuranovic S, 2011, SCIENCE, V331, P550, DOI 10.1126/science.1191138; Dolken L, 2008, RNA, V14, P1959, DOI 10.1261/rna.1136108; Du ZH, 2008, J BIOL CHEM, V283, P28757, DOI 10.1074/jbc.M803046200; Fenn S, 2007, NUCLEIC ACIDS RES, V35, P2651, DOI 10.1093/nar/gkm139; Fitzgerald KD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002127; Fontanes V, 2009, VIROLOGY, V394, P82, DOI 10.1016/j.virol.2009.08.012; Ford LP, 1999, GENE DEV, V13, P188, DOI 10.1101/gad.13.2.188; Friedel CC, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp542; Fujimura K, 2009, BBA-MOL CELL RES, V1793, P878, DOI 10.1016/j.bbamcr.2009.02.002; Gao M, 2000, MOL CELL, V5, P479, DOI 10.1016/S1097-2765(00)80442-6; Gao M, 2001, EMBO J, V20, P1134, DOI 10.1093/emboj/20.5.1134; Ghosh D, 2008, P NATL ACAD SCI USA, V105, P11673, DOI 10.1073/pnas.0803182105; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Kong J, 2003, MOL CELL BIOL, V23, P1125, DOI 10.1128/MCB.23.4.1125-1134.2003; Morimoto K, 1999, J VIROL, V73, P510, DOI 10.1128/JVI.73.1.510-518.1999; Morris AR, 2010, WIRES SYST BIOL MED, V2, P162, DOI 10.1002/wsbm.54; Mukherjee D, 2002, EMBO J, V21, P165, DOI 10.1093/emboj/21.1.165; Mukherjee N, 2011, MOL CELL, V43, P327, DOI 10.1016/j.molcel.2011.06.007; Ogram SA, 2010, VIROLOGY, V397, P14, DOI 10.1016/j.virol.2009.11.006; Perera R, 2007, J VIROL, V81, P8919, DOI 10.1128/JVI.01013-07; RAVKOV EV, 1995, VIROLOGY, V206, P718, DOI 10.1016/S0042-6822(95)80095-6; Sarmento L, 2005, J NEUROVIROL, V11, P571, DOI 10.1080/13550280500385310; Schnell MJ, 2010, NAT REV MICROBIOL, V8, P51, DOI 10.1038/nrmicro2260; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sean P, 2009, VIROLOGY, V389, P45, DOI 10.1016/j.virol.2009.03.012; Silvera D, 1999, J BIOL CHEM, V274, P38163, DOI 10.1074/jbc.274.53.38163; Toyoda H, 2007, J VIROL, V81, P10017, DOI 10.1128/JVI.00516-07; Waggoner SA, 2003, MOL CELL BIOL, V23, P7055, DOI 10.1128/MCB.23.19.7055-7067.2003; Waggoner SA, 2009, J BIOL CHEM, V284, P9039, DOI 10.1074/jbc.M806986200; Wang LY, 2011, J VIROL, V85, P7954, DOI 10.1128/JVI.00339-11; Whelan SPJ, 2004, CURR TOP MICROBIOL, V283, P61; WILUSZ J, 1988, CELL, V52, P221, DOI 10.1016/0092-8674(88)90510-7; Wu XF, 2007, VIRUS RES, V129, P91, DOI 10.1016/j.virusres.2007.06.022; Xu L, 2009, MOL PHARMACOL, V76, P872, DOI 10.1124/mol.109.057596; You FP, 2009, NAT IMMUNOL, V10, P1300, DOI 10.1038/ni.1815	41	18	19	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33561	10.1371/journal.pone.0033561	http://dx.doi.org/10.1371/journal.pone.0033561			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438951	gold, Green Submitted, Green Published			2022-12-25	WOS:000303309100060
J	Zanoni, BC; Phungula, T; Zanoni, HM; France, H; Cook, EF; Feeney, ME				Zanoni, Brian C.; Phungula, Thuli; Zanoni, Holly M.; France, Holly; Cook, E. Francis; Feeney, Margaret E.			Predictors of Poor CD4 and Weight Recovery in HIV-Infected Children Initiating ART in South Africa	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HIV-1-INFECTED CHILDREN; IMMUNE RECONSTITUTION; LYMPHOID-TISSUE; EARLY MORTALITY; T-CELLS; GROWTH; ACTIVATION; HAART; DISEASE	Objective: To identify baseline demographic and clinical risk factors associated with poor CD4 and weight response after initiation of antiretroviral therapy (ART) in a cohort of human immunodeficiency virus (HIV)-infected children in KwaZulu-Natal, South Africa. Methods: We performed a retrospective cohort study of 674 children initiating antiretroviral therapy at McCord and St. Mary's hospitals in KwaZulu-Natal, South Africa, from August 2003 to December 2008. We extracted data from paper charts and electronic medical records to assess risk factors associated with CD4 and weight response using logistic regression. Results: From the initial cohort of 901 children,10 years old initiating ART between August 2003 and December 2008, we analyzed 674 children with complete baseline data. Viral suppression rates (<400 copies/ml) were 84% after six months of therapy and 88% after 12 months of therapy. Seventy-three percent of children achieved CD4 recovery after six months and 89% after 12 months. Weight-for-age Z-score (WAZ) improvements were seen in 58% of children after six months of ART and 64% after 12 months. After six months of ART, lower baseline hemoglobin (p = 0.037), presence of chronic diarrhea (p = 0.007), and virologic failure (p = 0.046) were all associated with poor CD4 recovery by multivariate logistic regression. After 12 months of ART, poor CD4 recovery was associated with higher baseline CD4% (p = 0.005), chronic diarrhea (p = 0.02), and virologic failure (p<0.001). Age less than 3 years at ART initiation (p = 0.0003), higher baseline CD4% (p<0.001), and higher baseline WAZ (p<0.001) were all associated with poor WAZ improvements after 6 months by multivariate logistic regression. Conclusion: The presence of chronic diarrhea at baseline, independent of nutritional status and viral response, predicts poor CD4 recovery. Age at initiation of ART is an important factor in early WAZ response to ART, while viral suppression strongly predicts CD4 recovery but not WAZ improvement.	[Zanoni, Brian C.] Ragon Inst MGH MIT & Harvard, Charlestown, MA 02129 USA; [Zanoni, Brian C.] Harvard Univ, Sch Med, Boston, MA USA; [Zanoni, Brian C.; Phungula, Thuli; Zanoni, Holly M.; France, Holly; Feeney, Margaret E.] McCord Hosp, Sinikithemba Clin, Durban, South Africa; [Zanoni, Brian C.; Phungula, Thuli; Zanoni, Holly M.; France, Holly; Feeney, Margaret E.] McCord Hosp, Philani Program, Durban, South Africa; [Cook, E. Francis] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Feeney, Margaret E.] Univ Calif San Francisco, Div Expt Med, San Francisco, CA 94143 USA	Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; University of California System; University of California San Francisco	Zanoni, BC (corresponding author), Ragon Inst MGH MIT & Harvard, Charlestown, MA 02129 USA.	margaret.feeney@ucsf.edu	Zanoni, Brian/AAI-4916-2021		Sullivan Family Foundation; Elizabeth Glaser Pediatric AIDS Foundation; Jewelers for Children Elizabeth Glaser Scientist Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354] Funding Source: NIH RePORTER	Sullivan Family Foundation; Elizabeth Glaser Pediatric AIDS Foundation; Jewelers for Children Elizabeth Glaser Scientist Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was generously supported by the Sullivan Family Foundation and the Elizabeth Glaser Pediatric AIDS Foundation (to MEF). MEF is the recipient of the Jewelers for Children Elizabeth Glaser Scientist Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandyopadhyay A, 2008, ANN TROP PAEDIATR, V28, P279, DOI 10.1179/146532808X375440; Banerjee T, 2010, ANN TROP PAEDIATR, V30, P27, DOI 10.1179/146532810X12637745451915; Barreiro P, 2002, AIDS, V16, P245, DOI 10.1097/00002030-200201250-00014; Bong CN, 2007, AIDS, V21, P1805, DOI 10.1097/QAD.0b013e3282c3a9e4; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Callens SFJ, 2009, PEDIATR INFECT DIS J, V28, P35, DOI 10.1097/INF.0b013e318184eeb9; Dillingham RA, 2009, AM J TROP MED HYG, V80, P1060, DOI 10.4269/ajtmh.2009.80.1060; Eisenhut M, 2007, AIDS, V21, P1227, DOI 10.1097/QAD.0b013e32812685d2; Guadalupe M, 2003, J VIROL, V77, P11708, DOI 10.1128/JVI.77.21.11708-11717.2003; Guillen S, 2007, PEDIATR INFECT DIS J, V26, P334, DOI 10.1097/01.inf.0000257427.19764.ff; Hainaut M, 2003, PEDIATR INFECT DIS J, V22, P62, DOI 10.1097/00006454-200301000-00016; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Kabue MM, 2008, AIDS PATIENT CARE ST, V22, P245, DOI 10.1089/apc.2007.0049; Kekitiinwa A, 2008, JAIDS-J ACQ IMM DEF, V49, P384, DOI 10.1097/QAI.0b013e31818cdef5; Kiboneka A, 2008, AIDS, V22, P2493, DOI 10.1097/QAD.0b013e328318f148; Kovacs A, 2005, J INFECT DIS, V192, P296, DOI 10.1086/430922; Kugathasan S, 1998, J PEDIATR-US, V133, P675, DOI 10.1016/S0022-3476(98)70111-8; Lederman MM, 2011, J INFECT DIS, V204, P1217, DOI 10.1093/infdis/jir507; Machado DM, 2007, BRAZ J INFECT DIS, V11, P16, DOI 10.1590/S1413-86702007000100006; Naidoo R, 2010, PEDIATR INFECT DIS J, V29, P511, DOI 10.1097/INF.0b013e3181d1e989; Newell ML, 2006, J INFECT DIS, V193, P954, DOI 10.1086/500842; Diniz LMO, 2011, J PEDIAT-BRAZIL, V87, P131, DOI [10.2223/JPED.2064, 10.1590/S0021-75572011000200008]; PENEDOPITA M, 1991, J PEDIATR GASTR NUTR, V12, P56, DOI 10.1097/00005176-199101000-00012; Rosenblatt HM, 2005, J INFECT DIS, V192, P445, DOI 10.1086/431597; Rouet F, 2006, AIDS, V20, P2315, DOI 10.1097/QAD.0b013e328010943b; Salvatore S, 2008, NUTRITION, V24, P1205, DOI 10.1016/j.nut.2008.04.011; South African National Department of Health, 2010, GUID MAN HIV CHILDR; South African National Department of Health, 2004, NAT ANT TREATM GUID; Wamalwa DC, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-33; Weigel R, 2010, TROP MED INT HEALTH, V15, P934, DOI 10.1111/j.1365-3156.2010.02561.x; World Health Organization, 2010, ANT THER HIV INF INF; World Health Organization, 2006, ANT THER HIV INF AD; Zanoni BC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022706; Zulu I, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-156	34	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33611	10.1371/journal.pone.0033611	http://dx.doi.org/10.1371/journal.pone.0033611			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438965	Green Submitted, Green Published, gold			2022-12-25	WOS:000303309100071
J	Cardoso, AM; Cavalcante, JJV; Vieira, RP; Lima, JL; Grieco, MAB; Clementino, MM; Vasconcelos, ATR; Garcia, ES; de Souza, W; Albano, RM; Martins, OB				Cardoso, Alexander M.; Cavalcante, Janaina J. V.; Vieira, Ricardo P.; Lima, Joyce L.; Grieco, Maria Angela B.; Clementino, Maysa M.; Vasconcelos, Ana Tereza R.; Garcia, Eloi S.; de Souza, Wanderley; Albano, Rodolpho M.; Martins, Orlando B.			Gut Bacterial Communities in the Giant Land Snail Achatina fulica and Their Modification by Sugarcane-Based Diet	PLOS ONE			English	Article							MICROBIOME; ENVIRONMENT; POPULATION; GASTROPODA; DIVERSITY; ECOLOGY; FLORA	The invasive land snail Achatina fulica is one of the most damaging agricultural pests worldwide representing a potentially serious threat to natural ecosystems and human health. This species is known to carry parasites and harbors a dense and metabolically active microbial community; however, little is known about its diversity and composition. Here, we assessed for the first time the complexity of bacterial communities occurring in the digestive tracts of field-collected snails (FC) by using culture-independent molecular analysis. Crop and intestinal bacteria in FC were then compared to those from groups of snails that were reared in the laboratory (RL) on a sugarcane-based diet. Most of the sequences recovered were novel and related to those reported for herbivorous gut. Changes in the relative abundance of Bacteroidetes and Firmicutes were observed when the snails were fed a high-sugar diet, suggesting that the snail gut microbiota can influence the energy balance equation. Furthermore, this study represents a first step in gaining a better understanding of land snail gut microbiota and shows that this is a complex holobiont system containing diverse, abundant and active microbial communities.	[Cardoso, Alexander M.; Cavalcante, Janaina J. V.; Grieco, Maria Angela B.; Garcia, Eloi S.; de Souza, Wanderley; Martins, Orlando B.] Inst Nacl Metrol Qualidade & Tecnol, Rio De Janeiro, Brazil; [Vieira, Ricardo P.; Lima, Joyce L.; Martins, Orlando B.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio De Janeiro, Brazil; [Clementino, Maysa M.] Fundacao Oswaldo Cruz, Inst Nacl Controle Qualidade Saude, Rio De Janeiro, Brazil; [Vasconcelos, Ana Tereza R.] Lab Nacl Comp Cient, Rio De Janeiro, Brazil; [Garcia, Eloi S.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Rio De Janeiro, Brazil; [de Souza, Wanderley] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil; [Albano, Rodolpho M.] Univ Estado Rio de Janeiro, Dept Bioquim, BR-20550011 Rio De Janeiro, Brazil	Instituto Nacional de Metrologia, Qualidade e Tecnologia (INMETRO); Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Laboratorio Nacional de Computacao Cientifica (LNCC); Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; Universidade do Estado do Rio de Janeiro	Cardoso, AM (corresponding author), Inst Nacl Metrol Qualidade & Tecnol, Rio De Janeiro, Brazil.	amcardoso@bioqmed.ufrj.br	Clementino, Maysa/C-1944-2009; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; Cardoso, Alexander/AAX-2505-2021; Vasconcelos, Ana Tereza R/I-1011-2012; Cardoso, Alexander/S-6687-2017; Cavalcante, Janaina/X-8657-2018	Vasconcelos, Ana Tereza R/0000-0002-4632-2086; Cardoso, Alexander/0000-0003-2974-0232; B. Grieco, Maria Angela/0000-0002-7099-3787; Albano, Rodolpho/0000-0002-0643-901X; Cavalcante, Janaina/0000-0002-6059-7684	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashelford KE, 2006, APPL ENVIRON MICROB, V72, P5734, DOI 10.1128/AEM.00556-06; Charrier M, 1998, CAN J MICROBIOL, V44, P20, DOI 10.1139/cjm-44-1-20; CHARRIER M, 1980, ANN NUTR ALIMENT, V34, P147; Charrier M, 2006, BIOL RES, V39, P669, DOI 10.4067/S0716-97602006000500010; Dubilier N, 2001, NATURE, V411, P298, DOI 10.1038/35077067; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; GHOSE KRISHNA CHANDRA, 1963, TRANS AMER MICROSCOP SOC, V82, P149, DOI 10.2307/3223991; Gonzalez A, 2011, EMBO REP, V12, P775, DOI 10.1038/embor.2011.137; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Guo X, 2008, LETT APPL MICROBIOL, V47, P367, DOI 10.1111/j.1472-765X.2008.02408.x; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Lv S, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000520; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Van Horn DJ, 2011, J MOLLUS STUD, V0, P1; Vieira RP, 2008, ENVIRON MICROBIOL, V10, P189, DOI 10.1111/j.1462-2920.2007.01443.x; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Weiss B, 2011, TRENDS PARASITOL, V27, P514, DOI 10.1016/j.pt.2011.05.001; Worthen PL, 2006, APPL ENVIRON MICROB, V72, P4775, DOI 10.1128/AEM.00356-06; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Zanol J, 2010, BIOTA NEOTROP, V10, P447, DOI 10.1590/S1676-06032010000300038	28	45	49	4	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2012	7	3							e33440	10.1371/journal.pone.0033440	http://dx.doi.org/10.1371/journal.pone.0033440			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RU	22438932	Green Submitted, Green Published, gold			2022-12-25	WOS:000303309000026
J	Tavella, S; Ruggiu, A; Giuliani, A; Brun, F; Canciani, B; Manescu, A; Marozzi, K; Cilli, M; Costa, D; Liu, Y; Piccardi, F; Tasso, R; Tromba, G; Rustichelli, F; Cancedda, R				Tavella, Sara; Ruggiu, Alessandra; Giuliani, Alessandra; Brun, Francesco; Canciani, Barbara; Manescu, Adrian; Marozzi, Katia; Cilli, Michele; Costa, Delfina; Liu, Yi; Piccardi, Federica; Tasso, Roberta; Tromba, Giuliana; Rustichelli, Franco; Cancedda, Ranieri			Bone Turnover in Wild Type and Pleiotrophin-Transgenic Mice Housed for Three Months in the International Space Station (ISS)	PLOS ONE			English	Article							STIMULATING FACTOR-I; HB-GAM PLEIOTROPHIN; BED-REST; CALCIUM HOMEOSTASIS; GENE-EXPRESSION; TRABECULAR BONE; QUANTITATIVE-ANALYSIS; OSTEOBLAST PHENOTYPE; DIVERSE FUNCTIONS; CANCELLOUS BONE	Bone is a complex dynamic tissue undergoing a continuous remodeling process. Gravity is a physical force playing a role in the remodeling and contributing to the maintenance of bone integrity. This article reports an investigation on the alterations of the bone microarchitecture that occurred in wild type (Wt) and pleiotrophin-transgenic (PTN-Tg) mice exposed to a near-zero gravity on the International Space Station (ISS) during the Mice Drawer System (MDS) mission, to date, the longest mice permanence (91 days) in space. The transgenic mouse strain over-expressing pleiotrophin (PTN) in bone was selected because of the PTN positive effects on bone turnover. Wt and PTN-Tg control animals were maintained on Earth either in a MDS payload or in a standard vivarium cage. This study revealed a bone loss during spaceflight in the weight-bearing bones of both strains. For both Tg and Wt a decrease of the trabecular number as well as an increase of the mean trabecular separation was observed after flight, whereas trabecular thickness did not show any significant change. Non weight-bearing bones were not affected. The PTN-Tg mice exposed to normal gravity presented a poorer trabecular organization than Wt mice, but interestingly, the expression of the PTN transgene during the flight resulted in some protection against microgravity's negative effects. Moreover, osteocytes of the Wt mice, but not of Tg mice, acquired a round shape, thus showing for the first time osteocyte space-related morphological alterations in vivo. The analysis of specific bone formation and resorption marker expression suggested that the microgravity-induced bone loss was due to both an increased bone resorption and a decreased bone deposition. Apparently, the PTN transgene protection was the result of a higher osteoblast activity in the flight mice.	[Tavella, Sara; Ruggiu, Alessandra; Canciani, Barbara; Costa, Delfina; Liu, Yi; Tasso, Roberta; Cancedda, Ranieri] Univ Genoa, Dipartimento Oncol Biol & Genet, Genoa, Italy; [Tavella, Sara; Ruggiu, Alessandra; Canciani, Barbara; Cilli, Michele; Costa, Delfina; Liu, Yi; Piccardi, Federica; Tasso, Roberta; Cancedda, Ranieri] Ist Nazl Ric Canc, I-16132 Genoa, Italy; [Giuliani, Alessandra; Manescu, Adrian; Marozzi, Katia; Rustichelli, Franco] Univ Politecn Marche, Dipartimento Sci Clin Specialist & Odontostomatol, Ancona, Italy; [Giuliani, Alessandra; Manescu, Adrian; Marozzi, Katia; Rustichelli, Franco] Consorzio Nazl Interuniv Sci Fis Materia, Ancona Unit, Ancona, Italy; [Brun, Francesco] Univ Trieste, Dept Ind Engn & Informat Technol, Trieste, Italy; [Brun, Francesco; Tromba, Giuliana] Sincrotrone Trieste SCpA, Trieste, Italy; [Manescu, Adrian; Marozzi, Katia] Ist Nazl Biostrutture & Biosistemi, Rome, Italy	University of Genoa; University of Genoa; IRCCS AOU San Martino IST; Marche Polytechnic University; University of Trieste; Elettra Sincrotrone Trieste	Tavella, S (corresponding author), Univ Genoa, Dipartimento Oncol Biol & Genet, Genoa, Italy.	sara.tavella@unige.it	Cilli, Michele/AAB-8529-2019; Tavella, Sara/D-3011-2017; Giuliani, Alessandra/O-9097-2018; Canciani, Barbara/AAJ-6943-2020; costa, delfina/AAF-9915-2019; Tasso, Roberta/AFL-4297-2022; Brun, Francesco/ABD-3891-2020; Tasso, Roberta/J-7237-2016	Tavella, Sara/0000-0003-1478-4910; Giuliani, Alessandra/0000-0003-4177-7441; Canciani, Barbara/0000-0003-1942-1174; Brun, Francesco/0000-0003-0155-5326; Tasso, Roberta/0000-0003-0956-7006; Cilli, Michele/0000-0003-4083-8986; Manescu, Adrian/0000-0001-6922-289X; costa, delfina/0000-0002-7923-826X	Italian Space Agency (ASI)	Italian Space Agency (ASI)(Agenzia Spaziale Italiana (ASI))	The MDS hardware development and the MDS experiment preparation and execution were supported by grants and contracts from the Italian Space Agency (ASI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo JV, 2010, TISSUE ENG PT A, V16, P557, DOI 10.1089/ten.TEA.2009.0223; BIKLE DD, 1994, AM J PHYSIOL-ENDOC M, V267, pE822, DOI 10.1152/ajpendo.1994.267.6.E822; Brun F, 2010, NUCL INSTRUM METH A, V615, P326, DOI 10.1016/j.nima.2010.02.063; CANN CE, 1983, AM J PHYSIOL, V244, pR327, DOI 10.1152/ajpregu.1983.244.3.R327; Carmeliet G, 1999, FASEB J, V13, pS129, DOI 10.1096/fasebj.13.9001.s129; Deuel TF, 2002, ARCH BIOCHEM BIOPHYS, V397, P162, DOI 10.1006/abbi.2001.2705; DONALDSON C L, 1970, Metabolism Clinical and Experimental, V19, P1071, DOI 10.1016/0026-0495(70)90032-6; Evans GL, 1998, J APPL PHYSIOL, V84, P2132, DOI 10.1152/jappl.1998.84.6.2132; GOLDSMITH RS, 1969, METABOLIS, V18, P349, DOI 10.1016/0026-0495(69)90064-X; Guignandon A, 1997, BONE, V20, P109, DOI 10.1016/S8756-3282(96)00337-7; Guignandon A, 1997, EXP CELL RES, V236, P66, DOI 10.1006/excr.1997.3703; Hashimoto-Gotoh T, 2004, J BONE MINER METAB, V22, P278, DOI 10.1007/s00774-003-0485-8; Hughes-Fulford M, 2003, ADV SPACE RES-SERIES, V32, P1585, DOI 10.1016/S0273-1177(03)90399-1; Hughes-Fulford Millie, 2002, Adv Space Biol Med, V8, P129; HughesFulford M, 1996, EXP CELL RES, V224, P103, DOI 10.1006/excr.1996.0116; Im GI, 2004, BIOMATERIALS, V25, P4105, DOI 10.1016/j.biomaterials.2003.11.024; Imai S, 1998, J CELL BIOL, V143, P1113, DOI 10.1083/jcb.143.4.1113; Imai S, 2009, BONE, V44, P785, DOI 10.1016/j.bone.2009.01.004; JEE WSS, 1983, AM J PHYSIOL, V244, pR310, DOI 10.1152/ajpregu.1983.244.3.R310; KADOMATSU K, 1988, BIOCHEM BIOPH RES CO, V151, P1312, DOI 10.1016/S0006-291X(88)80505-9; Lang T, 2004, J BONE MINER RES, V19, P1006, DOI 10.1359/JBMR.040307; LEBLANC A, 1995, BONE, V16, pS301, DOI 10.1016/S8756-3282(95)80193-6; LEBLANC A, 1987, CALCIFIED TISSUE INT, V41, P259, DOI 10.1007/BF02555226; LEBLANC AD, 1990, J BONE MINER RES, V5, P843; Liedert A, 2004, BIOCHEM BIOPH RES CO, V319, P951, DOI 10.1016/j.bbrc.2004.05.087; Liedert A, 2009, BIOCHEM BIOPH RES CO, V387, P289, DOI 10.1016/j.bbrc.2009.07.002; Masuda H, 1997, BIOCHEM BIOPH RES CO, V238, P528, DOI 10.1006/bbrc.1997.7188; MINAIRE P, 1974, CALC TISS RES, V17, P57, DOI 10.1007/BF02547214; MITSIADIS TA, 1995, DEVELOPMENT, V121, P37; MOREY ER, 1978, SCIENCE, V201, P1138, DOI 10.1126/science.150643; NAKAMOTO M, 1992, J BIOCHEM-TOKYO, V112, P346, DOI 10.1093/oxfordjournals.jbchem.a123903; NISHIMURA Y, 1994, ACTA PHYSIOL SCAND, V150, P27; ODGAARD A, 1993, BONE, V14, P173, DOI 10.1016/8756-3282(93)90245-6; Patterson-Buckendahl P E, 1985, Physiologist, V28, pS227; STEIN GS, 1993, ENDOCR REV, V14, P424, DOI 10.1210/er.14.4.424; STEWART AF, 1982, NEW ENGL J MED, V306, P1136, DOI 10.1056/NEJM198205133061903; Takada Junichi, 2008, Clin Calcium, V18, P1427, DOI CliCa081014271433; Tare RS, 2002, BIOCHEM BIOPH RES CO, V298, P324, DOI 10.1016/S0006-291X(02)02456-7; Tare RS, 2002, J BONE MINER RES, V17, P2009, DOI 10.1359/jbmr.2002.17.11.2009; TEZUKA K, 1990, BIOCHEM BIOPH RES CO, V173, P246, DOI 10.1016/S0006-291X(05)81048-4; TURNER RT, 1995, AVIAT SPACE ENVIR MD, V66, P770; VANDERWIEL HE, 1991, BONE MINER, V13, P123, DOI 10.1016/0169-6009(91)90079-F; VANDERWINDEN JM, 1992, ANAT EMBRYOL, V186, P387; Vico L, 1998, BONE, V22, p95S, DOI 10.1016/S8756-3282(98)00017-9; Vico L, 2000, LANCET, V355, P1607, DOI 10.1016/S0140-6736(00)02217-0; VICO L, 1987, BONE MINER, V2, P383; VICO L, 1988, AM J PHYSIOL, V255, pR243, DOI 10.1152/ajpregu.1988.255.2.R243; VICO L, 1992, J BONE MINER RES, V7, pS445, DOI 10.1002/jbmr.5650071415; Vico L., 2006, Journal of Musculoskeletal & Neuronal Interactions, V6, P317; VICO L, 1987, BONE, V8, P95, DOI 10.1016/8756-3282(87)90077-9; VIGNY M, 1989, EUR J BIOCHEM, V186, P733, DOI 10.1111/j.1432-1033.1989.tb15267.x; WRONSKI TJ, 1987, AM J PHYSIOL, V252, pR252, DOI 10.1152/ajpregu.1987.252.2.R252; WRONSKI TJ, 1983, METAB BONE DIS RELAT, V4, P347; WRONSKI TJ, 1983, MED SCI SPORT EXER, V15, P410; Xing WR, 2005, J CELL BIOCHEM, V96, P1049, DOI 10.1002/jcb.20606; Yang XB, 2003, J BONE MINER RES, V18, P47, DOI 10.1359/jbmr.2003.18.1.47; Zayzafoon M, 2005, IMMUNOL REV, V208, P267, DOI 10.1111/j.0105-2896.2005.00330.x; Zerath E, 2000, J BONE MINER RES, V15, P1310, DOI 10.1359/jbmr.2000.15.7.1310; Zerwekh JE, 1998, J BONE MINER RES, V13, P1594, DOI 10.1359/jbmr.1998.13.10.1594; Zhang N, 1999, Curr Opin Hematol, V6, P44, DOI 10.1097/00062752-199901000-00008; Zhang Ping, 2008, Genomics Proteomics & Bioinformatics, V6, P4, DOI 10.1016/S1672-0229(08)60016-9	61	71	75	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2012	7	3							e33179	10.1371/journal.pone.0033179	http://dx.doi.org/10.1371/journal.pone.0033179			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RU	22438896	Green Published, Green Submitted, gold			2022-12-25	WOS:000303309000012
J	Bolle, LJ; de Jong, CAF; Bierman, SM; van Beek, PJG; van Keeken, OA; Wessels, PW; van Damme, CJG; Winter, HV; de Haan, D; Dekeling, RPA				Bolle, Loes J.; de Jong, Christ A. F.; Bierman, Stijn M.; van Beek, Pieter J. G.; van Keeken, Olvin A.; Wessels, Peter W.; van Damme, Cindy J. G.; Winter, Hendrik V.; de Haan, Dick; Dekeling, Rene P. A.			Common Sole Larvae Survive High Levels of Pile-Driving Sound in Controlled Exposure Experiments	PLOS ONE			English	Article							DOVER SOLE; HEARING-LOSS; SHIP NOISE; FISH; BAY; BISCAY; WATER; GROWTH; EGGS	In view of the rapid extension of offshore wind farms, there is an urgent need to improve our knowledge on possible adverse effects of underwater sound generated by pile-driving. Mortality and injuries have been observed in fish exposed to loud impulse sounds, but knowledge on the sound levels at which (sub-)lethal effects occur is limited for juvenile and adult fish, and virtually non-existent for fish eggs and larvae. A device was developed in which fish larvae can be exposed to underwater sound. It consists of a rigid-walled cylindrical chamber driven by an electro-dynamical sound projector. Samples of up to 100 larvae can be exposed simultaneously to a homogeneously distributed sound pressure and particle velocity field. Recorded pile-driving sounds could be reproduced accurately in the frequency range between 50 and 1000 Hz, at zero to peak pressure levels up to 210 dB re 1 mu Pa-2 (zero to peak pressures up to 32 kPa) and single pulse sound exposure levels up to 186 dB re 1 mu Pa(2)s. The device was used to examine lethal effects of sound exposure in common sole (Solea solea) larvae. Different developmental stages were exposed to various levels and durations of pile-driving sound. The highest cumulative sound exposure level applied was 206 dB re 1 mu Pa(2)s, which corresponds to 100 strikes at a distance of 100 m from a typical North Sea pile-driving site. The results showed no statistically significant differences in mortality between exposure and control groups at sound exposure levels which were well above the US interim criteria for non-auditory tissue damage in fish. Although our findings cannot be extrapolated to fish larvae in general, as interspecific differences in vulnerability to sound exposure may occur, they do indicate that previous assumptions and criteria may need to be revised.	[Bolle, Loes J.; Bierman, Stijn M.; van Keeken, Olvin A.; van Damme, Cindy J. G.; Winter, Hendrik V.; de Haan, Dick] IMARES, Ijmuiden, Netherlands; [de Jong, Christ A. F.; van Beek, Pieter J. G.; Wessels, Peter W.] TNO, The Hague, Netherlands; [Dekeling, Rene P. A.] Def Mat Org, The Hague, Netherlands; [Dekeling, Rene P. A.] Minist Infrastruct & Environm DG Water, The Hague, Netherlands	Wageningen University & Research; Netherlands Organization Applied Science Research	Bolle, LJ (corresponding author), IMARES, Ijmuiden, Netherlands.	loes.bolle@wur.nl	Bierman, Stijn M/F-8281-2010; Jong, Christ/GRJ-7329-2022	Jong, Christ/0000-0003-0834-1072; van Damme, Cindy/0000-0003-3878-0455; Winter, Hendrik V./0000-0003-1358-5899	Dutch Ministry of Economic Affairs, Agriculture and Innovation; Dutch Ministry of Infrastructure and Environment	Dutch Ministry of Economic Affairs, Agriculture and Innovation; Dutch Ministry of Infrastructure and Environment	This study was commissioned by the Centre for Water Management, Rijkswaterstaat, the Netherlands, as part of the 'Shortlist Masterplan Wind' research programme on the ecological impact of offshore wind farms in the North Sea. This research programme was funded by the Dutch Ministry of Economic Affairs, Agriculture and Innovation, and the Dutch Ministry of Infrastructure and Environment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainslie MA, 2009, 2009C085 TNO; Akamatsu T, 2002, J ACOUST SOC AM, V112, P3073, DOI 10.1121/1.1515799; ALMAGHAZACHI SJ, 1984, J EXP MAR BIOL ECOL, V82, P35, DOI 10.1016/0022-0981(84)90137-0; AMARA R, 1993, J FISH BIOL, V43, P17; Amoser S, 2003, J ACOUST SOC AM, V113, P2170, DOI 10.1121/1.1557212; [Anonymous], 2011, 2011C235 TNODV; Bolle LJ, 2009, MAR ECOL PROG SER, V390, P195, DOI 10.3354/meps08177; Booman C, 1996, 31996 HAVF; BOULHIC M, 1992, ANN I OCEANOGR PARIS, V68, P117; BOULHIC M, 1992, AQUACULTURE, V102, P373, DOI 10.1016/0044-8486(92)90190-V; Caltrans, 2010, MAD RIV BRIDG REPL P; Caltrans, 2001, SAN FRANC OAKL BAY B; CHAMPALBERT G, 1995, J MAR BIOL ASSOC UK, V75, P93, DOI 10.1017/S0025315400015228; Dalen J., 2007, 20070512 DNV; de Jong CAF, 2008, MONRPT033DTS20070338; Dickey-Collas M, 2009, MAR ECOL PROG SER, V390, P183, DOI 10.3354/meps08172; Erftemeijer PLA, 2009, MAR ECOL PROG SER, V390, P167, DOI 10.3354/meps08173; FONDS M, 1979, MAR ECOL PROG SER, V1, P91, DOI 10.3354/meps001091; Govoni JJ, 2008, J COASTAL RES, V24, P228, DOI 10.2112/05-0518.1; Graham AL, 2008, AQUAT CONSERV, V18, P1315, DOI 10.1002/aqc.941; Halvorsen M. B., 2011, PREDICTING MITIGATIN; Harding D., 1978, Rapports et Proces-Verbaux des Reunions Conseil International pour l'Exploration de la Mer, V172, P102; HORWOOD J, 1993, ADV MAR BIOL, V29, P215, DOI 10.1016/S0065-2881(08)60132-7; Inger R, 2009, J APPL ECOL, V46, P1145, DOI 10.1111/j.1365-2664.2009.01697.x; Lagardere F, 1999, ENVIRON BIOL FISH, V56, P213, DOI 10.1023/A:1007581818941; McCauley RD, 2003, J ACOUST SOC AM, V113, P638, DOI 10.1121/1.1527962; MCGURK MD, 1986, MAR ECOL PROG SER, V34, P227, DOI 10.3354/meps034227; Meager JJ, 2011, J FISH BIOL, V78, P1437, DOI 10.1111/j.1095-8649.2011.02951.x; Nehls G, ENG012007 COWRIE BIO; Oestman R, 2011, TECHNICAL GUIDANCE A; Palazzi R, 2006, AQUACULTURE, V255, P495, DOI 10.1016/j.aquaculture.2006.01.042; Popper AN, 2009, J FISH BIOL, V75, P455, DOI 10.1111/j.1095-8649.2009.02319.x; Popper AN, 2003, MAR TECHNOL SOC J, V37, P35, DOI 10.4031/002533203787537050; Popper AN, 2009, INTEGR ZOOL, V4, P43, DOI 10.1111/j.1749-4877.2008.00134.x; Prins TC, 2009, Z4832 DELT; Rogers PH, 2008, BIOACOUSTICS, V17, P331; Ruggerone G.T., 2008, BEHAV RESPONSE SURVI; Slabbekoorn H, 2010, TRENDS ECOL EVOL, V25, P419, DOI 10.1016/j.tree.2010.04.005; Slotte A, 2004, FISH RES, V67, P143, DOI 10.1016/j.fishres.2003.09.046; Smith ME, 2004, J EXP BIOL, V207, P427, DOI 10.1242/jeb.00755; Southall B. L., 2008, AQUAT MAMM, V17, P273, DOI [DOI 10.1578/AM.33.4.2007.411, 10.1578/AM, DOI 10.1578/AM]; Vasconcelos RO, 2007, J EXP BIOL, V210, P2104, DOI 10.1242/jeb.004317; WESTON DE, 1976, J SOUND VIB, V47, P473, DOI 10.1016/0022-460X(76)90874-9; Wysocki LE, 2006, BIOL CONSERV, V128, P501, DOI 10.1016/j.biocon.2005.10.020	44	46	47	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e33052	10.1371/journal.pone.0033052	http://dx.doi.org/10.1371/journal.pone.0033052			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22431996	Green Published, gold, Green Submitted			2022-12-25	WOS:000303198600039
J	Castelo-Branco, MTL; Soares, IDP; Lopes, DV; Buongusto, F; Martinusso, CA; do Rosario, A; Souza, SAL; Gutfilen, B; Fonseca, LMB; Elia, C; Madi, K; Schanaider, A; Rossi, MID; Souza, HSP				Castelo-Branco, Morgana T. L.; Soares, Igor D. P.; Lopes, Daiana V.; Buongusto, Fernanda; Martinusso, Cesonia A.; do Rosario, Alyson, Jr.; Souza, Sergio A. L.; Gutfilen, Bianca; Fonseca, Lea Mirian B.; Elia, Celeste; Madi, Kalil; Schanaider, Alberto; Rossi, Maria Isabel D.; Souza, Heitor S. P.			Intraperitoneal but Not Intravenous Cryopreserved Mesenchymal Stromal Cells Home to the Inflamed Colon and Ameliorate Experimental Colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ACID-INDUCED COLITIS; REGULATORY T-CELLS; STEM-CELLS; BONE-MARROW; ADIPOSE-TISSUE; RAT MODEL; ENDOTHELIAL-CELLS; CROHNS-DISEASE; IN-VITRO	Background and Aims: Mesenchymal stromal cells (MSCs) were shown to have immunomodulatory activity and have been applied for treating immune-mediated disorders. We compared the homing and therapeutic action of cryopreserved subcutaneous adipose tissue (AT-MSCs) and bone marrow-derived mesenchymal stromal cells (BM-MSCs) in rats with trinitrobenzene sulfonic acid (TNBS)-induced colitis. Methods: After colonoscopic detection of inflammation AT-MSCs or BM-MSCs were injected intraperitoneally. Colonoscopic and histologic scores were obtained. Density of collagen fibres and apoptotic rates were evaluated. Cytokine levels were measured in supernatants of colon explants. For cell migration studies MSCs and skin fibroblasts were labelled with Tc-99m or CM-DiI and injected intraperitonealy or intravenously. Results: Intraperitoneal injection of AT-MSCs or BM-MSCs reduced the endoscopic and histopathologic severity of colitis, the collagen deposition, and the epithelial apoptosis. Levels of TNF-alpha and interleukin-1 beta decreased, while VEGF and TGF-beta did not change following cell-therapy. Scintigraphy showed that MSCs migrated towards the inflamed colon and the uptake increased from 0.5 to 24 h.Tc-99m-MSCs injected intravenously distributed into various organs, but not the colon. Cm-DiI-positive MSCs were detected throughout the colon wall 72 h after inoculation, predominantly in the submucosa and muscular layer of inflamed areas. Conclusions: Intraperitoneally injected cryopreserved MSCs home to and engraft into the inflamed colon and ameliorate TNBS-colitis.	[Castelo-Branco, Morgana T. L.; Soares, Igor D. P.] Univ Fed Rio de Janeiro, Lab Imunol Celular, Inst Ciencias Biomed, Rio De Janeiro, Brazil; [Soares, Igor D. P.; Buongusto, Fernanda; Martinusso, Cesonia A.; do Rosario, Alyson, Jr.; Elia, Celeste; Souza, Heitor S. P.] Univ Fed Rio de Janeiro, Lab Multidisciplinar Pesquisa, Dept Clin Med, Rio De Janeiro, Brazil; [Lopes, Daiana V.; Rossi, Maria Isabel D.] Univ Fed Rio de Janeiro, Lab Imunohematol, Dept Clin Med, Rio De Janeiro, Brazil; [Souza, Sergio A. L.; Gutfilen, Bianca; Fonseca, Lea Mirian B.] Univ Fed Rio de Janeiro, Nucl Med Serv, LMCM, Dept Radiol, Rio De Janeiro, Brazil; [Madi, Kalil] Univ Fed Rio de Janeiro, Dept Patol, Rio De Janeiro, Brazil; [Schanaider, Alberto] Univ Fed Rio de Janeiro, Lab Cirurgia Expt, Dept Cirurgia, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Castelo-Branco, MTL (corresponding author), Univ Fed Rio de Janeiro, Lab Imunol Celular, Inst Ciencias Biomed, Rio De Janeiro, Brazil.	hsouza@hucff.ufrj.br	de Souza, Heitor Siffert Pereira/G-3297-2012; Rossi, Maria Isabel D/J-4802-2012; de Souza, Sergio Augusto Lopes/A-9431-2013; Gutfilen, Bianca/C-3116-2013; Petrone, Igor/AAV-2680-2021	de Souza, Heitor Siffert Pereira/0000-0002-3647-7324; Rossi, Maria Isabel D/0000-0003-3432-8453; de Souza, Sergio Augusto Lopes/0000-0002-7901-4805; Vieira Lopes Alves, Daiana/0000-0002-1936-1952	Brazilian Research Council (CNPq); FAPERJ (Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro)	Brazilian Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ (Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by grants from the Brazilian Research Council (CNPq, http://www.cnpq.br/) and the FAPERJ (Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro, http://www.faperj.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Ando Y, 2008, INFLAMM BOWEL DIS, V14, P826, DOI 10.1002/ibd.20382; Andoh A, 2005, J GASTROENTEROL, V40, P1089, DOI 10.1007/s00535-005-1727-4; ARNOLD F, 1991, PHARMACOL THERAPEUT, V52, P407, DOI 10.1016/0163-7258(91)90034-J; Bamba S, 2006, J PATHOL, V209, P265, DOI 10.1002/path.1967; da Fonseca LMB, 2009, CIRCULATION, V120, P539, DOI 10.1161/CIRCULATIONAHA.109.863084; Bartholomew A, 2002, EXP HEMATOL, V30, P42, DOI 10.1016/S0301-472X(01)00769-X; Baumgart DC, 2007, LANCET, V369, P1641, DOI 10.1016/S0140-6736(07)60751-X; Bazzoni F, 2010, EUR J IMMUNOL, V40, P2360, DOI 10.1002/eji.200940294; Becker C, 2006, NAT PROTOC, V1, P2900, DOI 10.1038/nprot.2006.446; Begue B, 2006, GASTROENTEROLOGY, V130, P1962, DOI 10.1053/j.gastro.2006.03.022; Belmiro CLR, 2009, J BIOL CHEM, V284, P11267, DOI 10.1074/jbc.M807211200; BERESFORD JN, 1992, J CELL SCI, V102, P341; Bernardo ME, 2007, J CELL PHYSIOL, V211, P121, DOI 10.1002/jcp.20911; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Bu P, 2001, J IMMUNOL, V166, P6399, DOI 10.4049/jimmunol.166.10.6399; Carvalho AB, 2008, STEM CELLS, V26, P1307, DOI 10.1634/stemcells.2007-0941; Casiraghi F, 2008, J IMMUNOL, V181, P3933, DOI 10.4049/jimmunol.181.6.3933; De Becker A, 2007, HAEMATOLOGICA, V92, P440, DOI 10.3324/haematol.10475; Di Sabatino A, 2007, GASTROENTEROLOGY, V133, P137, DOI 10.1053/j.gastro.2007.04.069; Dignass AU, 1996, GUT, V38, P687, DOI 10.1136/gut.38.5.687; DOLBER PC, 1993, J HISTOCHEM CYTOCHEM, V41, P465, DOI 10.1177/41.3.7679127; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Gonzalez MA, 2009, GASTROENTEROLOGY, V136, P978, DOI 10.1053/j.gastro.2008.11.041; Gonzalez-Rey E, 2009, GUT, V58, P929, DOI 10.1136/gut.2008.168534; Hahm KB, 2001, GUT, V49, P190, DOI 10.1136/gut.49.2.190; Hemmrich K, 2006, CELLS TISSUES ORGANS, V184, P117, DOI 10.1159/000099618; Khalil PN, 2007, GASTROENTEROLOGY, V132, P944, DOI 10.1053/j.gastro.2006.12.029; Koutroubakis IE, 2006, INFLAMM BOWEL DIS, V12, P515, DOI 10.1097/00054725-200606000-00012; Li LL, 2009, MOL BIOL REP, V36, P725, DOI 10.1007/s11033-008-9235-2; Lienenluke B, 2001, BRIT J PHARMACOL, V133, P1414, DOI 10.1038/sj.bjp.0704193; Marchetti M, 2008, THROMB RES, V121, P637, DOI 10.1016/j.thromres.2007.06.015; Mei SHJ, 2010, AM J RESP CRIT CARE, V182, P1047, DOI 10.1164/rccm.201001-0010OC; Meirelles LD, 2009, TISSUE ENG PT A, V15, P221, DOI 10.1089/ten.tea.2008.0103; Nagaya N, 2005, CIRCULATION, V112, P1128, DOI 10.1161/CIRCULATIONAHA.104.500447; Nasef A, 2007, TRANSPLANTATION, V84, P231, DOI 10.1097/01.tp.0000267918.07906.08; Nau GJ, 2002, P NATL ACAD SCI USA, V99, P1503, DOI 10.1073/pnas.022649799; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Neurath MF, 1996, NAT MED, V2, P998, DOI 10.1038/nm0996-998; Newman Robert E., 2009, Inflammation & Allergy Drug Targets, V8, P110; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Planat-Benard V, 2004, CIRCULATION, V109, P656, DOI 10.1161/01.CIR.0000114522.38265.61; Plumas J, 2005, LEUKEMIA, V19, P1597, DOI 10.1038/sj.leu.2403871; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Prevosto C, 2007, HAEMATOLOGICA, V92, P881, DOI 10.3324/haematol.11240; Puissant N, 2005, BRIT J HAEMATOL, V129, P118, DOI 10.1111/j.1365-2141.2005.05409.x; Ruemmele FM, 1998, J CELL PHYSIOL, V176, P120, DOI 10.1002/(SICI)1097-4652(199807)176:1<120::AID-JCP14>3.3.CO;2-O; Ruster B, 2006, BLOOD, V108, P3938, DOI 10.1182/blood-2006-05-025098; Sands BE, 2004, NEW ENGL J MED, V350, P876, DOI 10.1056/NEJMoa030815; Schrepfer S, 2007, TRANSPL P, V39, P573, DOI 10.1016/j.transproceed.2006.12.019; Semont A, 2006, ADV EXP MED BIOL, V585, P19; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Tse WT, 2003, TRANSPLANTATION, V75, P389, DOI 10.1097/01.TP.0000045055.63901.A9; Vereecke L, 2010, J EXP MED, V207, P1513, DOI 10.1084/jem.20092474; Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226; Wynn RF, 2004, BLOOD, V104, P2643, DOI 10.1182/blood-2004-02-0526; Yanez R, 2006, STEM CELLS, V24, P2582, DOI 10.1634/stemcells.2006-0228; Yue G, 2001, J PHARMACOL EXP THER, V297, P915; Zarjou A, 2011, AM J PHYSIOL-RENAL, V300, pF254, DOI 10.1152/ajprenal.00594.2010	59	94	100	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e33360	10.1371/journal.pone.0033360	http://dx.doi.org/10.1371/journal.pone.0033360			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22432015	Green Submitted, Green Published, gold			2022-12-25	WOS:000303198600058
J	Chansela, P; Goto-Inoue, N; Zaima, N; Hayasaka, T; Sroyraya, M; Kornthong, N; Engsusophon, A; Tamtin, M; Chaisri, C; Sobhon, P; Setou, M				Chansela, Piyachat; Goto-Inoue, Naoko; Zaima, Nobuhiro; Hayasaka, Takahiro; Sroyraya, Morakot; Kornthong, Napamanee; Engsusophon, Attakorn; Tamtin, Montakan; Chaisri, Chatchawalee; Sobhon, Prasert; Setou, Mitsutoshi			Composition and Localization of Lipids in Penaeus merguiensis Ovaries during the Ovarian Maturation Cycle as Revealed by Imaging Mass Spectrometry	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; TIGER PRAWN; VISUALIZATION; ACCUMULATION; SEMISULCATUS; PERFORMANCE; TECHNOLOGY; EXPRESSION; DECAPODA; TISSUES	Ovary maturation, oocyte differentiation, and embryonic development in shrimp are highly dependent on nutritional lipids taken up by female broodstocks. These lipids are important as energy sources as well as for cell signaling. In this study, we report on the compositions of major lipids, i.e. phosphatidylcholines (PCs), triacylglycerols (TAGs), and fatty acids (FAs), in the ovaries of the banana shrimp, Penaeus merguiensis, during ovarian maturation. Thin-layer chromatography analysis showed that the total PC and TAG signal intensities increased during ovarian maturation. Further, by using gas chromatography, we found that (1) FAs 14:0, 16:1, 18:1, 18:2, 20:1, and 22:6 proportionally increased as ovarian development progressed to more mature stages; (2) FAs 16:0, 18:0, 20:4, and 20:5 proportionally decreased; and (3) FAs 15:0, 17:0, and 20:2 remained unchanged. By using imaging mass spectrometry, we found that PC 16:0/16:1 and TAG 18:1/18:2/22:6 were detected in oocytes stages 1 and 2. PCs 16:1/20:4, 16:0/22:6, 18:3/22:6, 18:1/22:6, 20:5/22:6, and 22:6/22:6 and TAGs 16:0/16:1/18:3, 16:0/18:1/18:3, 16:0/18:1/18:1, and 16:0/18:2/22:6 were present in all stages of oocytes. In contrast, the PC-and TAG-associated FAs 20:4, 20:5, and 22:6 showed high signal intensities in stage 3 and 4 oocytes. These FAs may act as nutrition sources as well as signaling molecules for developing embryos and the hatching process. Knowledge of lipid compositions and localization could be helpful for formulating the diet for female broodstocks to promote fecundity and larval production.	[Chansela, Piyachat; Sroyraya, Morakot; Kornthong, Napamanee; Engsusophon, Attakorn; Sobhon, Prasert] Mahidol Univ, Fac Sci, Dept Anat, Bangkok 10400, Thailand; [Chansela, Piyachat; Hayasaka, Takahiro; Sroyraya, Morakot; Setou, Mitsutoshi] Hamamatsu Univ Sch Med, Dept Cell Biol & Anat, Hamamatsu, Shizuoka 4312102, Japan; [Goto-Inoue, Naoko] Tokyo Metropolitan Univ, Grad Sch Hlth Promot Sci, Hachioji, Tokyo, Japan; [Zaima, Nobuhiro] Kinki Univ, Dept Appl Biol Chem, Nara, Japan; [Tamtin, Montakan; Chaisri, Chatchawalee] Coastal Fisheries Res & Dev Bur, Coastal Aquat Feed Res Inst, Dept Fisheries, Petchaburi, Thailand	Mahidol University; Hamamatsu University School of Medicine; Tokyo Metropolitan University; Kindai University (Kinki University)	Chansela, P (corresponding author), Mahidol Univ, Fac Sci, Dept Anat, Bangkok 10400, Thailand.	setou@hama-med.ac.jp	Kornthong, Napamanee/J-4827-2014	Kornthong, Napamanee/0000-0002-0422-2546	Office of the Higher Education Commission (OHEC); Thailand Research Fund; Mahidol University; The Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN); Japan Science and Technology Agency	Office of the Higher Education Commission (OHEC); Thailand Research Fund(Thailand Research Fund (TRF)); Mahidol University; The Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by: 1. Grant from the Project for Higher Education Research Promotion and National Research University Development, Office of the Higher Education Commission (OHEC) (http://www.nru.mua.go.th/main/page_home.php). 2. Distinguished Research Professor Grant (co-funded by the Thailand Research Fund, Mahidol University and OHEC) to Dr. Sobhon (http://www.mua.go.th/). 3. OHEC-Ph.D. scholarship to Dr. Chansela (http://www.research.mua.go.th/main/index.php). 4. The Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN) to Dr. Zaima (http://www.jsps.go.jp/english/e-grants/index.html). 5. SENTAN grant from the Japan Science and Technology Agency to Dr. Setou. (http://www.jst.go.jp/EN/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAVA VR, 1993, NIPPON SUISAN GAKK, V59, P345, DOI 10.2331/suisan.59.345; Andersson M, 2008, NAT METHODS, V5, P101, DOI [10.1038/nmeth1145, 10.1038/NMETH1145]; Bitton DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008949; Cavalli RO, 1999, AQUACULTURE, V179, P387, DOI 10.1016/S0044-8486(99)00173-8; Cavalli RO, 2001, AQUACULTURE, V193, P311, DOI 10.1016/S0044-8486(00)00497-X; CHANDUMPAI A, 1991, MAR BIOL, V108, P235, DOI 10.1007/BF01344338; Chansela P, 2011, PEPTIDES, DOI [10.1016/j. physletb.2003.1010.1071, DOI 10.1016/J.PHYSLETB.2003.1010.1071]; CLARKE A, 1977, J EXP MAR BIOL ECOL, V28, P297, DOI 10.1016/0022-0981(77)90099-5; CLARKE A, 1979, J EXP MAR BIOL ECOL, V38, P1, DOI 10.1016/0022-0981(79)90084-4; Enomoto H, 2011, ANAL BIOANAL CHEM, V400, P1913, DOI 10.1007/s00216-011-4924-4; Glencross BD, 2001, AQUACULT NUTR, V7, P59, DOI 10.1046/j.1365-2095.2001.00168.x; Goto-Inoue N, 2010, IMAGING MASS SPECTROMETRY: PROTOCOLS FOR MASS MICROSCOPY, P169, DOI 10.1007/978-4-431-09425-8_13; Goto-Inoue N, 2010, METHOD ENZYMOL, V478, P287, DOI 10.1016/S0076-6879(10)78014-9; Graeve M, 2003, POLAR BIOL, V26, P55, DOI 10.1007/s00300-002-0440-5; Hayasaka T, 2009, LIPIDS, V44, P837, DOI 10.1007/s11745-009-3331-5; Hoang T, 2002, J THERM BIOL, V27, P433, DOI 10.1016/S0306-4565(02)00013-X; Huang JH, 2008, AQUAC RES, V39, P240, DOI 10.1111/j.1365-2109.2007.01868.x; Jaya-Ram A, 2008, AQUACULTURE, V277, P275, DOI 10.1016/j.aquaculture.2008.02.027; Martin B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004146; McDonnell LA, 2007, MASS SPECTROM REV, V26, P606, DOI 10.1002/mas.20124; Meunpol O, 2010, FISHERIES SCI, V76, P281, DOI 10.1007/s12562-009-0208-8; Murayama Chihiro, 2009, Biophys Rev, V1, P131, DOI 10.1007/s12551-009-0015-6; Murphy RC, 2009, J LIPID RES, V50, pS317, DOI 10.1194/jlr.R800051-JLR200; Phongdara Amornrat, 1999, Science Asia, V25, P143, DOI 10.2306/scienceasia1513-1874.1999.25.143; Ravid T, 1999, J EXP BIOL, V202, P1819; Rustan A. C, 2001, ENCY LIFE SCI, P1, DOI [10.1038/npg.els.0003894, DOI 10.1038/NPG.ELS.0003894]; Stoeckli M, 2001, NAT MED, V7, P493, DOI 10.1038/86573; Sugiura Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017952; Sugiura Y, 2009, J LIPID RES, V50, P1776, DOI 10.1194/jlr.M900047-JLR200; Sugiura Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003232; TESHIMA S, 1983, B JPN SOC SCI FISH, V49, P957; Uawisetwathana U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024427; Vasagam KPK, 2005, AQUACULTURE, V250, P317, DOI 10.1016/j.aquaculture.2005.02.035; Wouters R, 2001, AQUACULTURE, V198, P307, DOI 10.1016/S0044-8486(01)00522-1; Wouters R, 2001, AQUACULTURE, V202, P1, DOI 10.1016/S0044-8486(01)00570-1; Yanar Y, 2005, FOOD SCI TECHNOL INT, V11, P391, DOI 10.1177/1082013205058245; Zaima N, 2011, ANAL BIOANAL CHEM, V400, P1865, DOI 10.1007/s00216-011-4818-5; Zaima N, 2011, J OLEO SCI, V60, P93, DOI 10.5650/jos.60.93; Zaima N, 2009, J OLEO SCI, V58, P415, DOI 10.5650/jos.58.415	39	18	21	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e33154	10.1371/journal.pone.0033154	http://dx.doi.org/10.1371/journal.pone.0033154			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22432001	Green Submitted, Green Published, gold			2022-12-25	WOS:000303198600044
J	Cickova, H; Pastor, B; Kozanek, M; Martinez-Sanchez, A; Rojo, S; Takac, P				Cickova, Helena; Pastor, Berta; Kozanek, Milan; Martinez-Sanchez, Anabel; Rojo, Santos; Takac, Peter			Biodegradation of Pig Manure by the Housefly, Musca domestica: A Viable Ecological Strategy for Pig Manure Management	PLOS ONE			English	Article							BLACK SOLDIER FLY; POULTRY MANURE; POPULATION-DENSITY; ANIMAL PRODUCTION; DIPTERA; LARVAE; STRATIOMYIDAE; OVIPOSITION; FECUNDITY; POLLUTION	The technology for biodegradation of pig manure by using houseflies in a pilot plant capable of processing 500-700 kg of pig manure per week is described. A single adult cage loaded with 25,000 pupae produced 177.7 +/- 32.0 ml of eggs in a 15-day egg-collection period. With an inoculation ratio of 0.4-1.0 ml eggs/kg of manure, the amount of eggs produced by a single cage can suffice for the biodegradation of 178-444 kg of manure. Larval development varied among four different types of pig manure (centrifuged slurry, fresh manure, manure with sawdust, manure without sawdust). Larval survival ranged from 46.9 +/- 2.1%, in manure without sawdust, to 76.8 +/- 11.9% in centrifuged slurry. Larval development took 6-11 days, depending on the manure type. Processing of 1 kg of wet manure produced 43.9-74.3 g of housefly pupae and the weight of the residue after biodegradation decreased to 0.18-0.65 kg, with marked differences among manure types. Recommendations for the operation of industrial-scale biodegradation facilities are presented and discussed.	[Cickova, Helena; Kozanek, Milan; Takac, Peter] Slovak Acad Sci, Inst Zool, Bratislava, Slovakia; [Cickova, Helena; Takac, Peter] Scientica Sro, Bratislava, Slovakia; [Pastor, Berta; Martinez-Sanchez, Anabel; Rojo, Santos] Univ Alicante, Dept Ciencias Ambientales & Recursos Nat, Inst Biodiversidad CIBIO, E-03080 Alicante, Spain	Slovak Academy of Sciences; Universitat d'Alacant	Cickova, H (corresponding author), Slovak Acad Sci, Inst Zool, Bratislava, Slovakia.	helena.cickova@savba.sk	Rojo, Santos/L-9717-2014; MARTÍNEZ-SÁNCHEZ, ANABEL A/H-1376-2014	Rojo, Santos/0000-0003-2160-9643; MARTÍNEZ-SÁNCHEZ, ANABEL A/0000-0003-1497-8571	grant LIFE-ECODIPTERA [LIFE05-ENV/E/000302]; Slovak Research and Development Agency [VMSP-II-0025-09]; Alpuente farm (Spain)	grant LIFE-ECODIPTERA; Slovak Research and Development Agency(Slovak Research and Development Agency); Alpuente farm (Spain)	This study was financially supported by the grant LIFE-ECODIPTERA (LIFE05-ENV/E/000302) and by the Slovak Research and Development Agency, Grant No. VMSP-II-0025-09: The development and testing of the technology for the biodegradation of livestock manure. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are thankful to Jana Mikusiakova and Sona Rohacova (IZ SAS), C. Perez and P. Hurtado (University of Alicante), and Manuel Lainez, Ricardo Suay and Sonia Martinez (CTA-IVIA) for their technical assistance, the owner of Alpuente farm (Spain) for his valuable support, and Larry Newton (University of Georgia) and Leonard James Beans Foy (Alicante, Spain) for reviewing the manuscript and language corrections.	Barnard DR, 1998, ENVIRON ENTOMOL, V27, P600, DOI 10.1093/ee/27.3.600; BEARD R L, 1973, Environmental Entomology, V2, P801, DOI 10.1093/ee/2.5.801; BOOTH DC, 1984, ENVIRON ENTOMOL, V13, P421, DOI 10.1093/ee/13.2.421; CALVERT CC, 1979, J ANIM SCI, V48, P178, DOI 10.2527/jas1979.481178x; Campos ME, 2001, THESIS U LLEIDA LERI; Choudhary M, 1996, WASTE MANAGE RES, V14, P581, DOI 10.1177/0734242X9601400606; Cortina J, 2002, ANAPORC, V219, P90; Diener S, 2009, WASTE MANAGE RES, V27, P603, DOI 10.1177/0734242X09103838; EBY HJ, 1978, T ASAE, V21, P395, DOI 10.13031/2013.35311; ELBOUSHY AR, 1991, BIORESOURCE TECHNOL, V38, P45, DOI 10.1016/0960-8524(91)90220-E; Farkas R, 1998, ENVIRON ENTOMOL, V27, P695, DOI 10.1093/ee/27.3.695; FLETCHER MG, 1990, J MED ENTOMOL, V27, P922, DOI 10.1093/jmedent/27.5.922; FOSGATE OT, 1972, J DAIRY SCI, V55, P870, DOI 10.3168/jds.S0022-0302(72)85586-3; FURMAN DP, 1959, J ECON ENTOMOL, V52, P917, DOI 10.1093/jee/52.5.917; Geden CJ, 2001, P WORKSH LINC NEBR A; Hanski I., 1987, P837; INIGUEZCOVARRUBIAS G, 1994, J APPL ANIM RES, V6, P65, DOI 10.1080/09712119.1994.9706025; Mallin MA, 2003, POPUL ENVIRON, V24, P369, DOI 10.1023/A:1023690824045; Martinez S, 2008, 1 C ESP GEST INT DEY; Melse RW, 2005, BIOSYST ENG, V92, P47, DOI 10.1016/j.biosystemseng.2005.05.004; MILLER BF, 1974, BRIT POULTRY SCI, V15, P231, DOI 10.1080/00071667408416100; Morgan P.B., 1986, Miscellaneous Publications of the Entomological Society of America, P77; Myers HM, 2008, ENVIRON ENTOMOL, V37, P11, DOI 10.1603/0046-225X(2008)37[11:DOBSFD]2.0.CO;2; Nuov S., 1995, Aquaculture Research, V26, P601, DOI 10.1111/j.1365-2109.1995.tb00950.x; OHNISNI S, 1976, JPN J GENET, V51, P305, DOI 10.1266/jjg.51.305; OLECHOWICZ E, 1976, Ekologia polska, V24, P125; Pastor B, 2011, EUR J ENTOMOL, V108, P587, DOI 10.14411/eje.2011.076; Putman RJ, 1983, STUDIES BIOL; Sanchez M, 2001, THESIS U VALLADOLID; SHEPPARD DC, 1994, BIORESOURCE TECHNOL, V50, P275, DOI 10.1016/0960-8524(94)90102-3; Sorokoletov O.N., 2006, THESIS NOVOSIBIRSK S; Valdecantos A, 2002, PORCI, V71, P43; VALIELA I, 1974, AM MIDL NAT, V92, P370, DOI 10.2307/2424302; WILLIAMS PEV, 1995, ANIM FEED SCI TECH, V53, P135, DOI 10.1016/0377-8401(95)02017-T; Yadav A, 2011, BIORESOURCE TECHNOL, V102, P2874, DOI 10.1016/j.biortech.2010.10.083	35	45	52	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e32798	10.1371/journal.pone.0032798	http://dx.doi.org/10.1371/journal.pone.0032798			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22431982	Green Submitted, Green Published, gold			2022-12-25	WOS:000303198600025
J	Conde, E; Alegre, L; Blanco-Sanchez, I; Saenz-Morales, D; Aguado-Fraile, E; Ponte, B; Ramos, E; Saiz, A; Jimenez, C; Ordonez, A; Lopez-Cabrera, M; del Peso, L; de Landazuri, MO; Liano, F; Selgas, R; Sanchez-Tomero, JA; Garcia-Bermejo, ML				Conde, Elisa; Alegre, Laura; Blanco-Sanchez, Ignacio; Saenz-Morales, David; Aguado-Fraile, Elia; Ponte, Belen; Ramos, Edurne; Saiz, Ana; Jimenez, Carlos; Ordonez, Angel; Lopez-Cabrera, Manuel; del Peso, Luis; de Landazuri, Manuel O.; Liano, Fernando; Selgas, Rafael; Antonio Sanchez-Tomero, Jose; Laura Garcia-Bermejo, Maria			Hypoxia Inducible Factor 1-Alpha (HIF-1 Alpha) Is Induced during Reperfusion after Renal Ischemia and Is Critical for Proximal Tubule Cell Survival	PLOS ONE			English	Article							EPITHELIAL-CELLS; GENE-EXPRESSION; NITRIC-OXIDE; KIDNEY; INJURY; ACTIVATION; FACTOR-1-ALPHA; ERYTHROPOIETIN; IDENTIFICATION; INVOLVEMENT	Acute tubular necrosis (ATN) caused by ischemia/reperfusion (I/R) during renal transplantation delays allograft function. Identification of factors that mediate protection and/or epithelium recovery could help to improve graft outcome. We studied the expression, regulation and role of hypoxia inducible factor 1-alpha (HIF-1 alpha), using in vitro and in vivo experimental models of I/R as well as human post-transplant renal biopsies. We found that HIF-1 alpha is stabilized in proximal tubule cells during ischemia and unexpectedly in late reperfusion, when oxygen tension is normal. Both inductions lead to gene expression in vitro and in vivo. In vitro interference of HIF-1 alpha promoted cell death and in vivo interference exacerbated tissue damage and renal dysfunction. In pos-transplant human biopsies, HIF-1 alpha was expressed only in proximal tubules which exhibited normal renal structure with a significant negative correlation with ATN grade. In summary, using experimental models and human biopsies, we identified a novel HIF-1 alpha induction during reperfusion with a potential critical role in renal transplant.	[Conde, Elisa; Alegre, Laura; Blanco-Sanchez, Ignacio; Saenz-Morales, David; Aguado-Fraile, Elia; Ponte, Belen; Ramos, Edurne; Saiz, Ana; Laura Garcia-Bermejo, Maria] Univ Alcala de Henares, Dept Syst Disorders & Canc, Inst Ramon y Cajal Invest Sanitaria IRYCIS, Madrid, Spain; [Alegre, Laura; Antonio Sanchez-Tomero, Jose] Inst Invest Princesa IP, Dept Nephrol, Madrid, Spain; [Jimenez, Carlos; Selgas, Rafael] Hosp La Paz IdIPaz, Dept Nephrol, Madrid, Spain; [Ordonez, Angel; de Landazuri, Manuel O.] Inst Invest Princesa IP, Dept Immunol, Madrid, Spain; [Lopez-Cabrera, Manuel] CSIC UAM, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [del Peso, Luis] Univ Autonoma Madrid, Sch Med, Inst Biomed Res Alberto Sols, CSIC UAM,Dept Biochem,Hosp La Paz IdiPAZ,HIV Unit, Madrid, Spain; [Liano, Fernando] Hosp Ramon & Cajal, Dept Nephrol, Madrid, Spain	Universidad de Alcala; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Hospital Universitario Ramon y Cajal	Conde, E (corresponding author), Univ Alcala de Henares, Dept Syst Disorders & Canc, Inst Ramon y Cajal Invest Sanitaria IRYCIS, Madrid, Spain.	mgarciab.hrc@salud.madrid.org	Conde-Moreno, Elisa/AAG-2295-2021; SANCHEZ TOMERO, JOSE ANTONIO/Q-9346-2017; García-Bermejo, María Laura/E-1542-2015; Cabrera, Manuel López/AAA-5463-2019; MORENO, ELISA CONDE/H-7853-2017; del Peso, Luis/K-9391-2014	Conde-Moreno, Elisa/0000-0002-3751-9602; García-Bermejo, María Laura/0000-0002-8167-2276; MORENO, ELISA CONDE/0000-0002-3751-9602; del Peso, Luis/0000-0003-4014-5688; Saiz Gonzalez, Ana/0000-0001-7110-450X; Ramos, Edurne/0000-0001-5388-0281; Jimenez, Carlos/0000-0002-9680-3259; Lopez Cabrera, Manuel/0000-0002-0976-9719	Fondo de Investigacion Sanitaria [FIS PI06/539, FIS PS09/02183]; Fundacion Medica de Investigacion Mutua Madrilena, FMMA [185/2006]; Comunidad de Madrid CAM S-SAL [0311/2006]	Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Fundacion Medica de Investigacion Mutua Madrilena, FMMA; Comunidad de Madrid CAM S-SAL(Comunidad de Madrid)	This work was supported by grants from Fondo de Investigacion Sanitaria FIS PI06/539, FIS PS09/02183, from Fundacion Medica de Investigacion Mutua Madrilena, FMMA 185/2006 and from Comunidad de Madrid CAM S-SAL 0311/2006 to MLGB; MOL and LP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Tejado M, 2002, J BIOL CHEM, V277, P13508, DOI 10.1074/jbc.M200017200; Aragones J, 2001, J BIOL CHEM, V276, P10548, DOI 10.1074/jbc.M006180200; Arcasoy MO, 2008, BRIT J HAEMATOL, V141, P14, DOI 10.1111/j.1365-2141.2008.07014.x; Arsham AM, 2002, J BIOL CHEM, V277, P15162, DOI 10.1074/jbc.M111162200; Basile DP, 2005, AM J PHYSIOL-RENAL, V288, pF953, DOI 10.1152/ajprenal.00329.2004; Bernhardt WM, 2009, P NATL ACAD SCI USA, V106, P21276, DOI 10.1073/pnas.0903978106; Breen EC, 2007, J CELL BIOCHEM, V102, P1358, DOI 10.1002/jcb.21579; Cai ZQ, 2004, CIRCULATION, V109, P2050, DOI 10.1161/01.CIR.0000127954.98131.23; Dehne N, 2009, EXP CELL RES, V315, P1791, DOI 10.1016/j.yexcr.2009.03.019; Harada H, 2009, J BIOL CHEM, V284, P5332, DOI 10.1074/jbc.M806653200; Hill P, 2008, J AM SOC NEPHROL, V19, P39, DOI 10.1681/ASN.2006090998; Johnson DW, 2006, NEPHROLOGY, V11, P306, DOI 10.1111/j.1440-1797.2006.00585.x; Kellum JA, 2008, CRIT CARE MED, V36, pS141, DOI 10.1097/CCM.0b013e318168c4a4; Kwon DS, 2006, EUR J CELL BIOL, V85, P1189, DOI 10.1016/j.ejcb.2006.06.001; Matsumoto M, 2003, J AM SOC NEPHROL, V14, P1825, DOI 10.1097/01.ASN.0000074239.22357.06; Molina A, 2005, J AM SOC NEPHROL, V16, P374, DOI 10.1681/ASN.2004070528; Nangaku M, 2007, J MOL MED, V85, P1325, DOI 10.1007/s00109-007-0278-y; Natarajan R, 2005, BIOCHEM CELL BIOL, V83, P597, DOI 10.1139/o05-047; Ojo AO, 1997, TRANSPLANTATION, V63, P968, DOI 10.1097/00007890-199704150-00011; Olmos G, 2009, CELL MOL LIFE SCI, V66, P2167, DOI 10.1007/s00018-009-0039-x; Pescador N, 2005, BIOCHEM J, V390, P189, DOI 10.1042/BJ20042121; Rosenberger C, 2007, J AM SOC NEPHROL, V18, P343, DOI 10.1681/ASN.2006070792; Rudnicki M, 2009, LAB INVEST, V89, P337, DOI 10.1038/labinvest.2008.158; Saenz-Morales D, 2006, EXP CELL RES, V312, P3711, DOI 10.1016/j.yexcr.2006.05.024; Saenz-Morales D, 2010, KIDNEY INT, V77, P781, DOI 10.1038/ki.2010.10; Saenz-Morales D, 2009, CELL PHYSIOL BIOCHEM, V23, P285, DOI 10.1159/000218175; Sandau KB, 2001, J BIOL CHEM, V276, P39805, DOI 10.1074/jbc.M107689200; Semenza GL, 2001, TRENDS MOL MED, V7, P345, DOI 10.1016/S1471-4914(01)02090-1; Serra-Perez A, 2010, J BIOL CHEM, V285, P18217, DOI 10.1074/jbc.M110.101048; Waikar SS, 2009, J AM SOC NEPHROL, V20, P672, DOI 10.1681/ASN.2008070669; Weidemann A, 2008, J AM SOC NEPHROL, V19, P486, DOI 10.1681/ASN.2007040419; Yang CC, 2009, TRANSPLANTATION, V88, P1251, DOI 10.1097/TP.0b013e3181bb4a07; Zhong H, 2000, CANCER RES, V60, P1541; Zhou J, 2004, J BIOL CHEM, V279, P13506, DOI 10.1074/jbc.M310164200	34	116	123	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e33258	10.1371/journal.pone.0033258	http://dx.doi.org/10.1371/journal.pone.0033258			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22432008	Green Published, gold, Green Submitted			2022-12-25	WOS:000303198600051
J	Santos, DM; Xavier, JM; Morgado, AL; Sola, S; Rodrigues, CMP				Santos, Daniela M.; Xavier, Joana M.; Morgado, Ana L.; Sola, Susana; Rodrigues, Cecilia M. P.			Distinct Regulatory Functions of Calpain 1 and 2 during Neural Stem Cell Self-Renewal and Differentiation	PLOS ONE			English	Article							G1 PHASE DURATION; NEURONAL DIFFERENTIATION; PC12 CELLS; NS CELLS; CALCIUM OSCILLATIONS; RAT-BRAIN; GROWTH; NEUROGENESIS; ACTIVATION; CLEAVAGE	Calpains are calcium regulated cysteine proteases that have been described in a wide range of cellular processes, including apoptosis, migration and cell cycle regulation. In addition, calpains have been implicated in differentiation, but their impact on neural differentiation requires further investigation. Here, we addressed the role of calpain 1 and calpain 2 in neural stem cell (NSC) self-renewal and differentiation. We found that calpain inhibition using either the chemical inhibitor calpeptin or the endogenous calpain inhibitor calpastatin favored differentiation of NSCs. This effect was associated with significant changes in cell cycle-related proteins and may be regulated by calcium. Interestingly, calpain 1 and calpain 2 were found to play distinct roles in NSC fate decision. Calpain 1 expression levels were higher in self-renewing NSC and decreased with differentiation, while calpain 2 increased throughout differentiation. In addition, calpain 1 silencing resulted in increased levels of both neuronal and glial markers, beta-III Tubulin and glial fibrillary acidic protein (GFAP). Calpain 2 silencing elicited decreased levels of GFAP. These results support a role for calpain 1 in repressing differentiation, thus maintaining a proliferative NSC pool, and suggest that calpain 2 is involved in glial differentiation.	[Santos, Daniela M.; Xavier, Joana M.; Morgado, Ana L.; Sola, Susana; Rodrigues, Cecilia M. P.] Univ Lisbon, Fac Pharm, Res Inst Med & Pharmaceut Sci iMed UL, P-1699 Lisbon, Portugal; [Sola, Susana; Rodrigues, Cecilia M. P.] Univ Lisbon, Fac Pharm, Dept Biochem & Human Biol, P-1699 Lisbon, Portugal	Universidade de Lisboa; Universidade de Lisboa	Santos, DM (corresponding author), Univ Lisbon, Fac Pharm, Res Inst Med & Pharmaceut Sci iMed UL, P-1699 Lisbon, Portugal.	susana.sola@ff.ul.pt	Rodrigues, Cecilia MP/M-3572-2013; Solá, Susana/M-5251-2013; iMed.ULisboa, CellFun/A-4244-2014; Morgado, Ana Luísa/A-8683-2015; Solá, Susana/AAI-4580-2021; Santos, Daniela/W-3903-2019	Rodrigues, Cecilia MP/0000-0002-4829-754X; Solá, Susana/0000-0003-2036-797X; Morgado, Ana Luísa/0000-0003-3153-4665; Solá, Susana/0000-0003-2036-797X; Moutinho Dos Santos, Daniela/0000-0002-3740-1305	Fundacao para a Ciencia e a Tecnologia (FCT), Lisbon, Portugal [PTDC/SAU-NMC/117877/2010, Pest-OE/SAU/UI4013/2011]; FCT [SFRH/BD/42008/2007, SFRH/BD/68368/2010, SFRH/BD/80060/2011]	Fundacao para a Ciencia e a Tecnologia (FCT), Lisbon, Portugal(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by grants PTDC/SAU-NMC/117877/2010 and Pest-OE/SAU/UI4013/2011 from Fundacao para a Ciencia e a Tecnologia (FCT), Lisbon, Portugal. D.M.S, J.M.X., and A. L. M. were recipients of Ph.D. fellowships SFRH/BD/42008/2007, SFRH/BD/68368/2010, and SFRH/BD/80060/2011, respectively, from FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.W	Ahmed S, 2009, J CELL BIOCHEM, V106, P1, DOI 10.1002/jcb.21972; Akashiba H, 2006, J NEUROCHEM, V99, P733, DOI 10.1111/j.1471-4159.2006.04100.x; Aranha MM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-514; Aranha MM, 2009, J CELL BIOCHEM, V107, P748, DOI 10.1002/jcb.22172; Bakshi A, 2005, BRAIN RES, V1065, P8, DOI 10.1016/j.brainres.2005.09.059; Chen ZP, 2001, J VIROL, V75, P3613, DOI 10.1128/JVI.75.8.3613-3625.2001; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; de Azevedo-Pereira RL, 2011, STEM CELLS DEV, V20, P1859, DOI 10.1089/scd.2010.0186; Demarchi F, 2007, CELL CYCLE, V6, P136; Dourdin N, 1997, EXP CELL RES, V235, P385, DOI 10.1006/excr.1997.3684; Fernando P, 2005, FASEB J, V19, P1671, DOI 10.1096/fj.04-2981fje; Ferreira A, 2011, MOL MED, V17, P676, DOI 10.2119/molmed.2010.00220; Franco SJ, 2005, J CELL SCI, V118, P3829, DOI 10.1242/jcs.02562; Fujita J, 2008, CELL STEM CELL, V2, P595, DOI 10.1016/j.stem.2008.04.001; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Glaser T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000298; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; HAMAKUBO T, 1986, J NEUROSCI, V6, P3103, DOI 10.1523/jneurosci.06-11-03103.1986; Hodges H, 2007, CELL TRANSPLANT, V16, P101; Joy J, 2006, BIOL CHEM, V387, P329, DOI 10.1515/BC.2006.044; Kashiwagi A, 2011, CALCIFIED TISSUE INT, V89, P36, DOI 10.1007/s00223-011-9491-3; Kashiwagi A, 2010, MOL CELL BIOL, V30, P2799, DOI 10.1128/MCB.00157-10; Khan QA, 2002, MOL CARCINOGEN, V33, P1, DOI 10.1002/mc.10013; Krasilnikov MA, 2000, BIOCHEMISTRY-MOSCOW+, V65, P59; Leeb C, 2011, CELL PROLIFERAT, V44, P9, DOI 10.1111/j.1365-2184.2010.00725.x; Leloup L, 2010, J BIOL CHEM, V285, P33549, DOI 10.1074/jbc.M110.123604; Lenos MG, 2010, TRENDS CELL BIOL, V20, P577, DOI 10.1016/j.tcb.2010.07.004; Levkau B, 1998, MOL CELL, V1, P553, DOI 10.1016/S1097-2765(00)80055-6; Li ZG, 2006, DEV GROWTH DIFFER, V48, P513, DOI 10.1111/j.1440-169x.2006.00889.x; Liu J, 2008, SCI SIGNAL, V1, DOI [10.1126/stke.114re1, 10.1126/scisignal.123tr3]; Mazeres G, 2006, CELL MOTIL CYTOSKEL, V63, P193, DOI 10.1002/cm.20116; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Ohnuma S, 2003, NEURON, V40, P199, DOI 10.1016/S0896-6273(03)00632-9; Ojeda L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023414; OSHIMA M, 1989, J BIOL CHEM, V264, P20811; Patel YM, 2000, J BIOL CHEM, V275, P17653, DOI 10.1074/jbc.M910445199; Patel YM, 1999, P NATL ACAD SCI USA, V96, P1279, DOI 10.1073/pnas.96.4.1279; PINTER M, 1994, NEUROSCI LETT, V170, P91, DOI 10.1016/0304-3940(94)90246-1; Pollard SM, 2006, CEREB CORTEX, V16, pI112, DOI 10.1093/cercor/bhj167; Pratt T, 2000, DEV BIOL, V228, P19, DOI 10.1006/dbio.2000.9935; Qin QY, 2010, P NATL ACAD SCI USA, V107, P13883, DOI 10.1073/pnas.1008652107; Ray SK, 2002, J NEUROSCI RES, V70, P561, DOI 10.1002/jnr.10414; Raynaud F, 2006, FEBS J, V273, P3437, DOI 10.1111/j.1742-4658.2006.05352.x; Resende RR, 2010, BBA-MOL CELL RES, V1803, P246, DOI 10.1016/j.bbamcr.2009.11.008; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rietze RL, 2006, METHOD ENZYMOL, V419, P3, DOI 10.1016/S0076-6879(06)19001-1; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; SAITO Y, 1994, FEBS LETT, V353, P327, DOI 10.1016/0014-5793(94)01075-7; Salomoni P, 2010, TRENDS CELL BIOL, V20, P578, DOI 10.1016/j.tcb.2010.07.003; Salomoni P, 2010, TRENDS CELL BIOL, V20, P233, DOI 10.1016/j.tcb.2010.01.006; Santella L, 1998, CELL CALCIUM, V23, P123, DOI 10.1016/S0143-4160(98)90110-5; Sato A, 2010, NEUROSCI LETT, V470, P115, DOI 10.1016/j.neulet.2009.12.067; Schiappacassi M, 2008, MOL CANCER THER, V7, P1164, DOI 10.1158/1535-7163.MCT-07-2154; SCHOLLMEYER JE, 1986, EXP CELL RES, V163, P413, DOI 10.1016/0014-4827(86)90072-8; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Singh US, 2003, J BIOL CHEM, V278, P391, DOI 10.1074/jbc.M206361200; Spiliotopoulos D, 2009, NEUROBIOL DIS, V34, P320, DOI 10.1016/j.nbd.2009.02.007; Su LT, 2010, J MOL BIOL, V396, P858, DOI 10.1016/j.jmb.2010.01.014; Vaisid T, 2005, BBA-MOL CELL RES, V1743, P223, DOI 10.1016/j.bbamcr.2005.01.001; Wang B, 2009, NEUROSCI LETT, V461, P252, DOI 10.1016/j.neulet.2009.06.020; WATT F, 1993, NUCLEIC ACIDS RES, V21, P5092, DOI 10.1093/nar/21.22.5092; Wendt A, 2004, BIOL CHEM, V385, P465, DOI 10.1515/BC.2004.054; Wu SM, 2011, NAT CELL BIOL, V13, P497, DOI 10.1038/ncb0511-497; Yajima Y, 2002, BIOL CHEM, V383, P757, DOI 10.1515/BC.2002.079; Zadran S, 2010, MOL NEUROBIOL, V42, P143, DOI 10.1007/s12035-010-8145-1; Zadran S, 2010, J NEUROSCI, V30, P1086, DOI 10.1523/JNEUROSCI.5120-09.2010; Zatz M, 2005, NEW ENGL J MED, V352, P2413, DOI 10.1056/NEJMra043361	69	40	43	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e33468	10.1371/journal.pone.0033468	http://dx.doi.org/10.1371/journal.pone.0033468			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22432027	gold, Green Submitted, Green Published			2022-12-25	WOS:000303198600070
J	Bellei, B; Pitisci, A; Izzo, E; Picardo, M				Bellei, Barbara; Pitisci, Angela; Izzo, Enzo; Picardo, Mauro			Inhibition of Melanogenesis by the Pyridinyl Imidazole Class of Compounds: Possible Involvement of the Wnt/beta-Catenin Signaling Pathway	PLOS ONE			English	Article							HUMAN SKIN PIGMENTATION; MAP KINASE INHIBITORS; B16 MELANOMA-CELLS; BETA-CATENIN; TRANSCRIPTION FACTOR; CYCLIC-AMP; NEURAL CREST; P38 MAPK; WNT; PHOSPHORYLATION	While investigating the role of p38 MAPK in regulating melanogenesis, we found that pyridinyl imidazole inhibitors class compounds as well as the analog compound SB202474, which does not inhibit p38 MAPK, suppressed both alpha-MSH-induced melanogenesis and spontaneous melanin synthesis. In this study, we demonstrated that the inhibitory activity of the pyridinyl imidazoles correlates with inhibition of the canonical Wnt/beta-catenin pathway activity. Imidazole-treated cells showed a reduction in the level of Tcf/Lef target genes involved in the beta-catenin signaling network, including ubiquitous genes such as Axin2, Lef1, and Wisp1 as well as cell lineage-restricted genes such as microphthalmia-associated transcription factor and dopachrome tautomerase. Although over-expression of the Wnt signaling pathway effector beta-catenin slightly restored the melanogenic program, the lack of complete reversion suggested that the imidazoles interfered with beta-catenin-dependent transcriptional activity rather than with beta-catenin expression. Accordingly, we did not observe any significant change in beta-catenin protein expression. The independence of p38 MAPK activity from the repression of Wnt/beta-catenin signaling pathway was confirmed by small interfering RNA knockdown of p38 MAPK expression, which by contrast, stimulated beta-catenin-driven gene expression. Our data demonstrate that the small molecule pyridinyl imidazoles possess two distinct and opposite mechanisms that modulate b-catenin dependent transcription: a p38 inhibition-dependent effect that stimulates the Wnt pathway by increasing beta-catenin protein expression and an off-target mechanism that inhibits the pathway by repressing beta-catenin protein functionality. The p38-independent effect seems to be dominant and, at least in B16-F0 cells, results in a strong block of the Wnt/beta-catenin signaling pathway.	[Bellei, Barbara; Pitisci, Angela; Izzo, Enzo; Picardo, Mauro] Ist Ricovero & Cura Carattere Sci, San Gallicano Dermatol Inst, Lab Cutaneous Physiopathol, Rome, Italy	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG)	Bellei, B (corresponding author), Ist Ricovero & Cura Carattere Sci, San Gallicano Dermatol Inst, Lab Cutaneous Physiopathol, Rome, Italy.	bellei@ifo.it	Pitisci, Angela/AAH-9415-2019; Picardo, Mauro/A-6978-2011; Bellei, Barbara/K-5288-2016	Picardo, Mauro/0000-0003-4899-6639; Bellei, Barbara/0000-0002-3883-5500	Ministero della Salute, Italy [onc-ord/32/07]	Ministero della Salute, Italy(Ministry of Health, Italy)	This project was partially supported by onc-ord/32/07 Grant from Ministero della Salute, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Bellei B, 2008, CELL SIGNAL, V20, P1750, DOI 10.1016/j.cellsig.2008.06.001; Bellei B, 2011, PIGM CELL MELANOMA R, V24, P309, DOI 10.1111/j.1755-148X.2010.00800.x; Bellei B, 2010, J BIOL CHEM, V285, P7288, DOI 10.1074/jbc.M109.070573; Bertolotto C, 1998, ONCOGENE, V16, P1665, DOI 10.1038/sj.onc.1201685; Bertolotto C, 1998, MOL CELL BIOL, V18, P694, DOI 10.1128/MCB.18.2.694; Biechele TL, 2010, CHEM BIOL, V17, P1177, DOI 10.1016/j.chembiol.2010.08.012; Bikkavilli RK, 2008, J CELL SCI, V121, P3598, DOI 10.1242/jcs.032854; Birkenkamp KU, 2000, BRIT J PHARMACOL, V131, P99, DOI 10.1038/sj.bjp.0703534; Bondurand N, 2000, HUM MOL GENET, V9, P1907, DOI 10.1093/hmg/9.13.1907; Cervenka I, 2011, MOL CELL BIOL, V31, P179, DOI 10.1128/MCB.00550-10; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Costin GE, 2007, FASEB J, V21, P976, DOI 10.1096/fj.06-6649rev; Daugherty RL, 2007, PHYSIOLOGY, V22, P303, DOI 10.1152/physiol.00020.2007; Dickinson LA, 1998, P NATL ACAD SCI USA, V95, P12890, DOI 10.1073/pnas.95.22.12890; Eguchi M, 2005, MED CHEM, V1, P467, DOI 10.2174/1573406054864098; Eichhoff OM, 2011, PIGM CELL MELANOMA R, V24, P631, DOI 10.1111/j.1755-148X.2011.00871.x; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Hachiya A, 2004, AM J PATHOL, V165, P2099, DOI 10.1016/S0002-9440(10)63260-9; HEARING VJ, 1991, FASEB J, V5, P2902, DOI 10.1096/fasebj.5.14.1752358; Hino S, 2005, MOL CELL BIOL, V25, P9063, DOI 10.1128/MCB.25.20.9063-9072.2005; Ho AK, 2001, BIOCHEM PHARMACOL, V62, P1605, DOI 10.1016/S0006-2952(01)00839-5; Huang M, 2002, J BIOL CHEM, V277, P28364, DOI 10.1074/jbc.C200321200; Huber WE, 2003, TISSUE RESTRICTED CA; Ikeya M, 1997, NATURE, V389, P966, DOI 10.1038/40146; Jin TR, 2008, CELL SIGNAL, V20, P1697, DOI 10.1016/j.cellsig.2008.04.014; Kikuchi A, 2006, EXP MOL MED, V38, P1, DOI 10.1038/emm.2006.1; Kim DS, 2007, ARCH PHARM RES, V30, P581, DOI 10.1007/BF02977652; Land EJ, 2004, METHOD ENZYMOL, V378, P88; Lepourcelet M, 2004, CANCER CELL, V5, P91, DOI 10.1016/S1535-6108(03)00334-9; Ma H, 2005, ONCOGENE, V24, P3619, DOI 10.1038/sj.onc.1208433; McMillan M, 2005, DRUG DISCOV TODAY, V10, P1467, DOI 10.1016/S1359-6446(05)03613-5; MEDRANO EE, 1994, MOL BIOL CELL, V5, P497, DOI 10.1091/mbc.5.4.497; Menon MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023054; Miyamura Y, 2007, PIGM CELL RES, V20, P2, DOI 10.1111/j.1600-0749.2006.00358.x; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Saito H, 2002, J BIOL CHEM, V277, P28787, DOI 10.1074/jbc.M203719200; Schepsky A, 2006, MOL CELL BIOL, V26, P8914, DOI 10.1128/MCB.02299-05; Shanware NP, 2009, BMB REP, V42, P142, DOI 10.5483/BMBRep.2009.42.3.142; Shibazaki M, 2004, J BIOL CHEM, V279, P3869, DOI 10.1074/jbc.M305880200; Shitashige M, 2008, CANCER SCI, V99, P631, DOI 10.1111/j.1349-7006.2007.00716.x; Singh SK, 2005, PIGM CELL RES, V18, P113, DOI 10.1111/j.1600-0749.2005.00219.x; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2009, EXP DERMATOL, V18, P760, DOI 10.1111/j.1600-0625.2009.00892.x; Supekova L, 2002, CHEM BIOL, V9, P821, DOI 10.1016/S1074-5521(02)00174-6; Takahashi-Yanaga F, 2010, CLIN CANCER RES, V16, P3153, DOI 10.1158/1078-0432.CCR-09-2943; Takeda K, 2000, J BIOL CHEM, V275, P14013, DOI 10.1074/jbc.C000113200; Teo JL, 2010, ADV DRUG DELIVER REV, V62, P1149, DOI 10.1016/j.addr.2010.09.012; Thorne CA, 2010, NAT CHEM BIOL, V6, P829, DOI 10.1038/NCHEMBIO.453; van Veelen W, 2011, GUT, V60, P1204, DOI 10.1136/gut.2010.233460; Verkaar F, 2011, CHEM BIOL, V18, P485, DOI 10.1016/j.chembiol.2011.01.015; Watanabe A, 1998, NAT GENET, V18, P283, DOI 10.1038/ng0398-283; Widlund HR, 2002, J CELL BIOL, V158, P1079, DOI 10.1083/jcb.200202049; WINDER A, 1994, CELL MOL BIOL RES, V40, P613; Wu JL, 2003, TRENDS NEUROSCI, V26, P40, DOI 10.1016/S0166-2236(02)00011-5; Yamaguchi Y, 2004, J CELL BIOL, V165, P275, DOI 10.1083/jcb.200311122; Yamaguchi Y, 2007, J INVEST DERMATOL, V127, P1217, DOI 10.1038/sj.jid.5700629; Yasumoto K, 1997, J BIOL CHEM, V272, P503	60	26	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2012	7	3							e33021	10.1371/journal.pone.0033021	http://dx.doi.org/10.1371/journal.pone.0033021			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930IA	22427932	Green Published, gold, Green Submitted			2022-12-25	WOS:000303129700026
J	Iguchi, T; Yagi, H; Wang, CC; Sato, M				Iguchi, Tokuichi; Yagi, Hideshi; Wang, Chen-Chi; Sato, Makoto			A Tightly Controlled Conditional Knockdown System Using the Tol2 Transposon-Mediated Technique	PLOS ONE			English	Article							IN-VIVO ELECTROPORATION; JAPANESE MEDAKA FISH; EMBRYONIC STEM-CELLS; GENE-TRANSFER SYSTEM; AC-LIKE ELEMENT; NEURONAL MIGRATION; CHICKEN EMBRYOS; EXPRESSION; BRAIN; TRANSGENES	Background: Gene knockdown analyses using the in utero electroporation method have helped reveal functional aspects of genes of interest in cortical development. However, the application of this method to analyses in later stages of brain development or in the adult brain is still difficult because the amount of injected plasmids in a cell decreases along with development due to dilution by cell proliferation and the degradation of the plasmids. Furthermore, it is difficult to exclude the influence of earlier knockdown effects. Methodology/Principal Findings: We developed a tightly controlled conditional knockdown system using a newly constructed vector, pT2K-TBI-shRNAmir, based on a Tol2 transposon-mediated gene transfer methodology with the tetracycline-inducible gene expression technique, which allows us to maintain a transgene for a long period of time and induce the knockdown of the gene of interest. We showed that expression of the endogenous amyloid precursor protein (APP) was sharply decreased by our inducible, stably integrated knockdown system in PC12 cells. Moreover, we induced an acute insufficiency of Dab1 with our system and observed that radial migration was impaired in the developing cerebral cortex. Such inhibitory effects on radial migration were not observed without induction, indicating that our system tightly controlled the knockdown, without any expression leakage in vivo. Conclusions/Significance: Our system enables us to investigate the brain at any of the later stages of development or in the adult by utilizing a knockdown technique with the aid of the in utero electroporation gene transfer methodology. Furthermore, we can perform knockdown analyses free from the influence of undesired earlier knockdown effects.	[Iguchi, Tokuichi; Yagi, Hideshi; Wang, Chen-Chi; Sato, Makoto] Univ Fukui, Div Cell Biol & Neurosci, Dept Morphol & Physiol Sci, Fac Med Sci, Fukui 910, Japan; [Iguchi, Tokuichi; Sato, Makoto] Univ Fukui, Res & Educ Program Life Sci, Fukui 910, Japan; [Sato, Makoto] Univ Fukui, Fac Med Sci, Child Dev Res Ctr, Fukui 910, Japan	University of Fukui; University of Fukui; University of Fukui	Iguchi, T (corresponding author), Univ Fukui, Div Cell Biol & Neurosci, Dept Morphol & Physiol Sci, Fac Med Sci, Fukui 910, Japan.	makosato@u-fukui.ac.jp		Yagi, Hideshi/0000-0002-8506-8965; Iguchi, Tokuichi/0000-0003-4025-8770	University of Fukui; Ministry of Education, Culture, Sports, Science and Technology of Japan [21390052, 21700402]; Grants-in-Aid for Scientific Research [23500386] Funding Source: KAKEN	University of Fukui; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the FUKUI BRAIN PROJECT, Research and Education Program for Life Science, University of Fukui, and Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (KAKENHI 21390052 and 21700402). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agha-Mohammadi S, 2004, J GENE MED, V6, P817, DOI 10.1002/jgm.566; Bauer M, 2009, GENE THER, V16, P142, DOI 10.1038/gt.2008.123; Fame RM, 2011, TRENDS NEUROSCI, V34, P41, DOI 10.1016/j.tins.2010.10.002; Hodges JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024149; Hou XB, 2011, DEV GROWTH DIFFER, V53, P69, DOI 10.1111/j.1440-169X.2010.01229.x; Howell BW, 1997, NATURE, V389, P733, DOI 10.1038/39607; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Jossin Y, 2011, NAT NEUROSCI, V14, P697, DOI 10.1038/nn.2816; Kawakami K, 2004, GENETICS, V166, P895, DOI 10.1534/genetics.166.2.895; Kawakami K, 2000, P NATL ACAD SCI USA, V97, P11403, DOI 10.1073/pnas.97.21.11403; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; McBride JL, 2008, P NATL ACAD SCI USA, V105, P5868, DOI 10.1073/pnas.0801775105; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Molnar Z, 2011, NAT NEUROSCI, V14, P538, DOI 10.1038/nn.2817; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Morimura T, 2009, BRAIN RES, V1304, P26, DOI 10.1016/j.brainres.2009.09.087; Nagano T, 2004, J NEUROSCI, V24, P9648, DOI 10.1523/JNEUROSCI.2363-04.2004; Paddison PJ, 2004, NAT METHODS, V1, P163, DOI 10.1038/nmeth1104-163; Ranscht B, 2000, INT J DEV NEUROSCI, V18, P643, DOI 10.1016/S0736-5748(00)00030-7; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Sato Y, 2007, DEV BIOL, V305, P616, DOI 10.1016/j.ydbio.2007.01.043; Sheldon M, 1997, NATURE, V389, P730, DOI 10.1038/39601; Shi Y, 2003, TRENDS GENET, V19, P9, DOI 10.1016/S0168-9525(02)00005-7; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Tullio AN, 2001, J COMP NEUROL, V433, P62, DOI 10.1002/cne.1125; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; Wang W, 2008, P NATL ACAD SCI USA, V105, P9290, DOI 10.1073/pnas.0801017105; Watanabe T, 2007, DEV BIOL, V305, P625, DOI 10.1016/j.ydbio.2007.01.042; Yokota Y, 2011, DEV BIOL, V353, P382, DOI 10.1016/j.ydbio.2011.02.001; Yoshida A, 2010, GENES CELLS, V15, P501, DOI 10.1111/j.1365-2443.2010.01397.x; Young P, 2008, NAT NEUROSCI, V11, P721, DOI 10.1038/nn.2118; Young-Pearse TL, 2007, J NEUROSCI, V27, P14459, DOI 10.1523/JNEUROSCI.4701-07.2007; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5	35	10	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2012	7	3							e33380	10.1371/journal.pone.0033380	http://dx.doi.org/10.1371/journal.pone.0033380			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930IA	22428039	Green Published, gold			2022-12-25	WOS:000303129700056
J	Chen, SY; Zhang, YJ; Wang, XL; Sun, JY; Xue, Y; Zhang, P; Zhou, H; Qu, LH				Chen, Shao-Yu; Zhang, Yi-Jun; Wang, Xiu-Ling; Sun, Jian-Yun; Xue, Yan; Zhang, Peng; Zhou, Hui; Qu, Liang-Hu			Extremely Low Genetic Diversity Indicating the Endangered Status of Ranodon sibiricus (Amphibia: Caudata) and Implications for Phylogeography	PLOS ONE			English	Article							DNA-SEQUENCE DATA; CLIMATIC OSCILLATIONS; LANDSCAPE GENETICS; POPULATION-GROWTH; CONTROL REGION; CYTOCHROME-B; CONSERVATION; MICROSATELLITE; SALAMANDER; BIOGEOGRAPHY	Background: The Siberian salamander (Ranodon sibiricus), distributed in geographically isolated areas of Central Asia, is an ideal alpine species for studies of conservation and phylogeography. However, there are few data regarding the genetic diversity in R. sibiricus populations. Methodology/Principal Findings: We used two genetic markers (mtDNA and microsatellites) to survey all six populations of R. sibiricus in China. Both of the markers revealed extreme genetic uniformity among these populations. There were only three haplotypes in the mtDNA, and the overall nucleotide diversity in the mtDNA was 0.00064, ranging from 0.00000 to 0.00091 for the six populations. Although we recovered 70 sequences containing microsatellite repeats, there were only two loci that displayed polymorphism. We used the approximate Bayesian computation (ABC) method to study the demographic history of the populations. This analysis suggested that the extant populations diverged from the ancestral population approximately 120 years ago and that the historical population size was much larger than the present population size; i.e., R. sibiricus has experienced dramatic population declines. Conclusion/Significance: Our findings suggest that the genetic diversity in the R. sibiricus populations is the lowest among all investigated amphibians. We conclude that the isolation of R. sibiricus populations occurred recently and was a result of recent human activity and/or climatic changes. The Pleistocene glaciation oscillations may have facilitated intraspecies genetic homogeneity rather than enhanced divergence. A low genomic evolutionary rate and elevated inbreeding frequency may have also contributed to the low genetic variation observed in this species. Our findings indicate the urgency of implementing a protection plan for this endangered species.	[Chen, Shao-Yu; Zhang, Yi-Jun; Sun, Jian-Yun; Xue, Yan; Zhang, Peng; Zhou, Hui; Qu, Liang-Hu] Sun Yat Sen Univ, State Key Lab Biocontrol, Key Lab Gene Engn, Minist Educ, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Xiu-Ling] Xinjiang Normal Univ, Dept Biol, Xinjiang, Peoples R China	Sun Yat Sen University; Xinjiang Normal University	Chen, SY (corresponding author), Sun Yat Sen Univ, State Key Lab Biocontrol, Key Lab Gene Engn, Minist Educ, Guangzhou 510275, Guangdong, Peoples R China.	lssqlh@mail.sysu.edu.cn	Zhang, Yijun/J-5485-2017; Zhang, Peng/F-9664-2013	Zhang, Yijun/0000-0001-7971-2200; Qu, Liang-Hu/0000-0003-3657-2863; Zhou, Hui/0000-0001-9157-3792	National Natural Science Foundation of China [30771151, 30830066]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (No. 30771151 and 30830066) to Liang-Hu Qu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford RA, 2001, NATURE, V412, P499, DOI 10.1038/35087658; Allen AP, 2006, P NATL ACAD SCI USA, V103, P9130, DOI 10.1073/pnas.0603587103; Avise JC, 2009, J BIOGEOGR, V36, P3, DOI 10.1111/j.1365-2699.2008.02032.x; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beebee TJC, 2005, HEREDITY, V95, P423, DOI 10.1038/sj.hdy.6800736; Beheregaray LB, 2008, MOL ECOL, V17, P3754, DOI 10.1111/j.1365-294X.2008.03857.x; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; BISHOP DW, 1947, J HERED, V38, P291; Blaustein AR, 2007, BIOSCIENCE, V57, P437, DOI 10.1641/B570517; Bohonak AJ, 2011, MOL ECOL, V20, P2477, DOI 10.1111/j.1365-294X.2011.05122.x; Bryja J, 2010, MOL ECOL, V19, P4708, DOI 10.1111/j.1365-294X.2010.04844.x; Caccone A, 1997, SYST BIOL, V46, P126, DOI 10.2307/2413640; Chappell DE, 2004, CONSERV GENET, V5, P759, DOI 10.1007/s10592-004-1976-4; Chiucchi JE, 2010, MOL ECOL, V19, P5345, DOI 10.1111/j.1365-294X.2010.04860.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cornuet JM, 2008, BIOINFORMATICS, V24, P2713, DOI 10.1093/bioinformatics/btn514; Crespi EJ, 2003, MOL ECOL, V12, P969, DOI 10.1046/j.1365-294X.2003.01797.x; Csillery K, 2010, TRENDS ECOL EVOL, V25, P410, DOI 10.1016/j.tree.2010.04.001; DeSalle R, 2004, NAT REV GENET, V5, P702, DOI 10.1038/nrg1425; Dubey S, 2010, MOL ECOL, V19, P886, DOI 10.1111/j.1365-294X.2010.04539.x; Ehlers J, 2004, QUATERNARY GLACIAT 3; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fernando P, 2006, CONSERV GENET, V7, P439, DOI 10.1007/s10592-006-9139-4; Ficetola GF, 2005, ANIM CONSERV, V8, P33, DOI 10.1017/S1367943004001805; Frankham R, 1996, CONSERV BIOL, V10, P1500, DOI 10.1046/j.1523-1739.1996.10061500.x; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Fraser DJ, 2001, MOL ECOL, V10, P2741, DOI 10.1046/j.1365-294X.2001.t01-1-01411.x; Fu JZ, 2001, COPEIA, P1100, DOI 10.1643/0045-8511(2001)001[1100:GDOEBC]2.0.CO;2; Fu YX, 1997, GENETICS, V147, P915; Gao H, 2009, BIOL RES, V42, P365, DOI [/S0716-97602009000300011, 10.4067/S0716-97602009000300011]; Glenn TC, 2005, METHOD ENZYMOL, V395, P202, DOI 10.1016/S0076-6879(05)95013-1; Goebel AM, 1999, MOL PHYLOGENET EVOL, V11, P163, DOI 10.1006/mpev.1998.0538; Hare MP, 2001, TRENDS ECOL EVOL, V16, P700, DOI 10.1016/S0169-5347(01)02326-6; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hitchings SP, 1997, HEREDITY, V79, P117, DOI 10.1038/hdy.1997.134; Hoelzel AR, 2002, P ROY SOC B-BIOL SCI, V269, P1467, DOI 10.1098/rspb.2002.2033; IUCN, 2009, 2009 IUCN RED LIST T; Johnson JA, 2009, MOL ECOL, V18, P54, DOI [10.1111/j.1365-294X.2009.04240.x, 10.1111/j.1365-294X.2008.04012.x]; Lehmkuhl FMK, 2004, PERMAFROST PERIGLAC, V10, p[243, 65]; Li Yue, 2004, Acta Zoologica Sinica, V50, P464; Lunt DH, 1999, MOL ECOL, V8, P891, DOI 10.1046/j.1365-294X.1999.00636.x; Makowsky R, 2009, GENETICA, V135, P169, DOI 10.1007/s10709-008-9267-5; Matsui M, 2008, MOL PHYLOGENET EVOL, V49, P318, DOI 10.1016/j.ympev.2008.07.020; Matsui M, 2007, MOL PHYLOGENET EVOL, V44, P204, DOI 10.1016/j.ympev.2006.11.031; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Nims BD, 2008, CONSERV GENET, V9, P1413, DOI 10.1007/s10592-007-9465-1; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Qiu YX, 2011, MOL PHYLOGENET EVOL, V59, P225, DOI 10.1016/j.ympev.2011.01.012; Qu Lianghu, 1999, Acta Scientiarum Naturalium Universitatis Sunyatseni, V38, P1; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Riberon A, 2001, MOL ECOL, V10, P2555, DOI 10.1046/j.1365-294X.2001.01373.x; Richter SC, 2009, COPEIA, P799, DOI 10.1643/CH-09-070; Rodriguez R, 2011, MOL ECOL, V20, P3785, DOI 10.1111/j.1365-294X.2011.05231.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rogers AR, 1996, MOL BIOL EVOL, V13, P895, DOI 10.1093/molbev/13.7.895; Rosenbaum PA, 2007, CONSERV GENET, V8, P331, DOI 10.1007/s10592-006-9172-3; ROZEN S, 1997, PRIMER 3 0; Schultz JK, 2009, J HERED, V100, P25, DOI 10.1093/jhered/esn077; Semlitsch RD, 2000, J WILDLIFE MANAGE, V64, P615, DOI 10.2307/3802732; Shi Y, 2002, QUATERN INT, V97-8, P79, DOI 10.1016/S1040-6182(02)00053-8; Stinchcombe J, 2002, CONSERV ECOL, V6; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Sullivan J, 2000, AM NAT, V155, P755, DOI 10.1086/303362; TAJIMA F, 1989, GENETICS, V123, P585; TEMPLETON AR, 1992, GENETICS, V132, P619; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Vargas-Ramirez M, 2007, CONTRIB ZOOL, V76, P1; Verdu P, 2009, CURR BIOL, V19, P312, DOI 10.1016/j.cub.2008.12.049; Vucetich JA, 1997, EVOLUTION, V51, P2017, DOI 10.1111/j.1558-5646.1997.tb05123.x; VUILLEUMIER SB, 1971, SCIENCE, V173, P771, DOI 10.1126/science.173.3999.771; Wake DB, 2007, P NATL ACAD SCI USA, V104, P8201, DOI 10.1073/pnas.0702506104; WAKE DB, 1991, SCIENCE, V253, P860, DOI 10.1126/science.253.5022.860; Wang IJ, 2011, MOL ECOL, V20, P2480, DOI 10.1111/j.1365-294X.2011.05123.x; Wang IJ, 2010, MOL ECOL, V19, P2605, DOI 10.1111/j.1365-294X.2010.04715.x; Wang IJ, 2009, MOL ECOL, V18, P3847, DOI 10.1111/j.1365-294X.2009.04338.x; Wang Xiuling, 2000, Sichuan Journal of Zoology, V19, P146; Wang XL, 2006, J XINJIANG NORMAL U, P25; Williams RN, 2008, BIOL LETTERS, V4, P549, DOI 10.1098/rsbl.2008.0233; Xie F, 2007, SCI CHINA SER C, V50, P265, DOI 10.1007/s11427-007-0021-5; Yang SJ, 2009, PROG NAT SCI-MATER, V19, P789, DOI 10.1016/j.pnsc.2008.10.006; Yang YQ, 2002, TECTONICS, V21, DOI 10.1029/2001TC001300; Yeh FC, 2000, POPGENE 32 MICROSOFT; Yuan GY, 2006, ENV PROTECTION XINJI, V28, P19; Yuan L, 2009, J XINJIANG NORMAL U, V28, P15; Zeng XM, 2006, BIOCHEM SYST ECOL, V34, P467, DOI 10.1016/j.bse.2006.01.006; Zhang P, 2006, P NATL ACAD SCI USA, V103, P7360, DOI 10.1073/pnas.0602325103; Zhang Y, 2007, THESIS U ZHEJIANG	89	22	25	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33378	10.1371/journal.pone.0033378	http://dx.doi.org/10.1371/journal.pone.0033378			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22428037	gold, Green Published, Green Submitted			2022-12-25	WOS:000302381500136
J	Crane, DD; Scott, DP; Bosio, CM				Crane, Deborah D.; Scott, Dana P.; Bosio, Catharine M.			Generation of a Convalescent Model of Virulent Francisella tularensis Infection for Assessment of Host Requirements for Survival of Tularemia	PLOS ONE			English	Article							LIVE VACCINE STRAIN; INNATE IMMUNE-RESPONSE; KNOCK-OUT MICE; T-CELL SUBSETS; LISTERIA-MONOCYTOGENES; INTRACELLULAR BACTERIUM; AEROSOL INFECTION; DENDRITIC CELLS; RESPIRATORY-INFECTION; INTERLEUKIN-12 IL-12	Francisella tularensis is a facultative intracellular bacterium and the causative agent of tularemia. Development of novel vaccines and therapeutics for tularemia has been hampered by the lack of understanding of which immune components are required to survive infection. Defining these requirements for protection against virulent F. tularensis, such as strain SchuS4, has been difficult since experimentally infected animals typically die within 5 days after exposure to as few as 10 bacteria. Such a short mean time to death typically precludes development, and therefore assessment, of immune responses directed against virulent F. tularensis. To enable identification of the components of the immune system that are required for survival of virulent F. tularensis, we developed a convalescent model of tularemia in C57Bl/6 mice using low dose antibiotic therapy in which the host immune response is ultimately responsible for clearance of the bacterium. Using this model we demonstrate alpha bTCR(+) cells, gamma delta TCR+ cells, and B cells are necessary to survive primary SchuS4 infection. Analysis of mice deficient in specific soluble mediators shows that IL-12p40 and IL-12p35 are essential for survival of SchuS4 infection. We also show that IFN-gamma is required for survival of SchuS4 infection since mice lacking IFN-gamma R succumb to disease during the course of antibiotic therapy. Finally, we found that both CD4(+) and CD8(+) cells are the primary producers of IFN-gamma and that gamma delta TCR+ cells and NK cells make a minimal contribution toward production of this cytokine throughout infection. Together these data provide a novel model that identifies key cells and cytokines required for survival or exacerbation of infection with virulent F. tularensis and provides evidence that this model will be a useful tool for better understanding the dynamics of tularemia infection.	[Crane, Deborah D.; Bosio, Catharine M.] NIAID, Intracellular Parasites Lab, Rocky Mt Labs, NIH, Hamilton, MT USA; [Scott, Dana P.] NIAID, Vet Pathol Sect, Rocky Mt Vet Branch, Rocky Mt Labs,NIH, Hamilton, MT USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Crane, DD (corresponding author), NIAID, Intracellular Parasites Lab, Rocky Mt Labs, NIH, Hamilton, MT USA.	bosioc@niaid.nih.gov	Bosio, Catharine/D-7456-2015		National Institutes of Health, National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001013] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Anderson RV, 2010, VACCINE, V28, P6562, DOI 10.1016/j.vaccine.2010.07.072; Andersson H, 2006, J MED MICROBIOL, V55, P263, DOI 10.1099/jmm.0.46313-0; ANTHONY LSD, 1987, MICROB PATHOGENESIS, V2, P3, DOI 10.1016/0882-4010(87)90110-0; ANTHONY LSD, 1991, INFECT IMMUN, V59, P3291, DOI 10.1128/IAI.59.9.3291-3296.1991; Aranda EA, 2001, CLIN MICROBIOL INFEC, V7, P167, DOI 10.1046/j.1469-0691.2001.00234.x; Bakshi CS, 2008, VACCINE, V26, P5276, DOI 10.1016/j.vaccine.2008.07.051; Bauler TJ, 2011, J IMMUNOL, V187, P1845, DOI 10.4049/jimmunol.1100377; Ben Nasr A, 2006, J LEUKOCYTE BIOL, V80, P774, DOI 10.1189/jlb.1205755; Bosio CM, 2007, J IMMUNOL, V178, P4538, DOI 10.4049/jimmunol.178.7.4538; Bosio CM, 2001, INFECT IMMUN, V69, P194, DOI 10.1128/IAI.69.1.194-203.2001; BUCHMEIER NA, 1985, P NATL ACAD SCI USA, V82, P7404, DOI 10.1073/pnas.82.21.7404; BURKE DS, 1977, J INFECT DIS, V135, P55, DOI 10.1093/infdis/135.1.55; Butchar JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002924; Chase JC, 2010, INFECT IMMUN, V78, P154, DOI 10.1128/IAI.00750-09; Chase JC, 2009, INFECT IMMUN, V77, P180, DOI 10.1128/IAI.00879-08; Chen WX, 2004, MICROB PATHOGENESIS, V37, P185, DOI 10.1016/j.micpath.2004.06.010; Chen WX, 2004, MICROB PATHOGENESIS, V36, P311, DOI 10.1016/j.micpath.2004.02.003; Chen WX, 2003, VACCINE, V21, P3690, DOI 10.1016/S0264-410X(03)00386-4; Clemens DL, 2004, INFECT IMMUN, V72, P3204, DOI 10.1128/IAI.72.6.3204-3217.2004; Cole LE, 2008, J IMMUNOL, V180, P6885, DOI 10.4049/jimmunol.180.10.6885; Cole LE, 2006, J IMMUNOL, V176, P6888, DOI 10.4049/jimmunol.176.11.6888; Conlan JW, 2005, VACCINE, V23, P2477, DOI 10.1016/j.vaccine.2004.10.034; Conlan JW, 2003, MICROB PATHOGENESIS, V34, P239, DOI 10.1016/S0882-4010(03)00046-9; Conlan JW, 2002, MICROB PATHOGENESIS, V32, P127, DOI 10.1006/mpat.2001.0489; CONLAN JW, 1994, INFECT IMMUN, V62, P5603, DOI 10.1128/IAI.62.12.5603-5607.1994; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Cowley SC, 2010, J IMMUNOL, V184, P5791, DOI 10.4049/jimmunol.1000362; Crane DD, 2009, J IMMUNOL, V183, P4593, DOI 10.4049/jimmunol.0901655; DENIS M, 1991, J LEUKOCYTE BIOL, V50, P495, DOI 10.1002/jlb.50.5.495; Duckett NS, 2005, INFECT IMMUN, V73, P2306, DOI 10.1128/IAI.73.4.2306-2311.2005; EIGELSBACH H, 1961, J IMMUNOL, V87, P415; Elkins KL, 1999, INFECT IMMUN, V67, P6002, DOI 10.1128/IAI.67.11.6002-6007.1999; Elkins KL, 2002, INFECT IMMUN, V70, P1936, DOI 10.1128/IAI.70.4.1936-1948.2002; Elkins KL, 1996, INFECT IMMUN, V64, P3288, DOI 10.1128/IAI.64.8.3288-3293.1996; ENDERLIN G, 1994, CLIN INFECT DIS, V19, P42, DOI 10.1093/clinids/19.1.42; FORTIER AH, 1992, INFECT IMMUN, V60, P817, DOI 10.1128/IAI.60.3.817-825.1992; FOSHAY L, 1946, AM J MED, V1, P180, DOI 10.1016/0002-9343(46)90036-8; Frank GM, 2010, INVEST OPHTH VIS SCI, V51, P3591, DOI 10.1167/iovs.09-4368; GILLESSEN S, 1995, EUR J IMMUNOL, V25, P200, DOI 10.1002/eji.1830250133; Hall JD, 2008, INFECT IMMUN, V76, P5843, DOI 10.1128/IAI.01176-08; Harris S., 1992, ANN N Y ACAD SCI, V666, P21; HARTY JT, 1995, IMMUNITY, V3, P109, DOI 10.1016/1074-7613(95)90163-9; Henry T, 2010, J IMMUNOL, V184, P3755, DOI 10.4049/jimmunol.0902065; Ho LP, 2008, EUR J IMMUNOL, V38, P1913, DOI 10.1002/eji.200738017; Huang MTH, 2010, J IMMUNOL, V185, P5476, DOI 10.4049/jimmunol.1002154; Hunter CA, 2005, NAT REV IMMUNOL, V5, P521, DOI 10.1038/nri1648; Ireland R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000921; Joyee AG, 2008, AM J RESP CRIT CARE, V178, P745, DOI 10.1164/rccm.200804-517OC; KAUFMANN SHE, 1994, IMMUNOBIOLOGY, V191, P509, DOI 10.1016/S0171-2985(11)80457-2; Ketavarapu JM, 2008, P NATL ACAD SCI USA, V105, P9313, DOI 10.1073/pnas.0707636105; Kirimanjeswara GS, 2007, J IMMUNOL, V179, P532, DOI 10.4049/jimmunol.179.1.532; Klimpel GR, 2008, VACCINE, V26, P6874, DOI 10.1016/j.vaccine.2008.09.077; KuoLee R, 2008, CLIN EXP ALLERGY, V38, P1003, DOI 10.1111/j.1365-2222.2008.02956.x; LADEL CH, 1994, J IMMUNOL, V153, P3116; LeBien TW, 2008, BLOOD, V112, P1570, DOI 10.1182/blood-2008-02-078071; Lin YY, 2009, IMMUNITY, V31, P799, DOI 10.1016/j.immuni.2009.08.025; Lindgren H, 2004, J MED MICROBIOL, V53, P953, DOI 10.1099/jmm.0.45685-0; Lindgren H, 2007, INFECT IMMUN, V75, P1303, DOI 10.1128/IAI.01717-06; Lopez MC, 2004, CELL IMMUNOL, V232, P75, DOI 10.1016/j.cellimm.2005.02.001; Malik M, 2007, J IMMUNOL, V178, P1013, DOI 10.4049/jimmunol.178.2.1013; Mara-Koosham G, 2011, INFECT IMMUN, V79, P1770, DOI 10.1128/IAI.00605-10; McCoy G, 1912, J INFECT DIS, V10, P61, DOI 10.1093/infdis/10.1.61; MCCRUMB FR, 1961, BACTERIOL REV, V25, P262, DOI 10.1128/MMBR.25.3.262-267.1961; MCCRUMB FR, 1957, T ASSOC AM PHYSICIAN, V70, P74; Novelli F, 2004, CYTOKINE GROWTH F R, V15, P367, DOI 10.1016/j.cytogfr.2004.03.009; Oliveira SC, 1998, BRAZ J MED BIOL RES, V31, P77, DOI 10.1590/S0100-879X1998000100010; OLSUFJEV NG, 1982, J HYG EPID MICROB IM, V26, P291; Pappu R, 2011, IMMUNOLOGY; PARKER RR, 1926, PUB HLTH REP, V41, P1341; Parsa KVL, 2006, PLOS PATHOG, V2, P681, DOI 10.1371/journal.ppat.0020071; Reljic R, 2007, J INTERF CYTOK RES, V27, P353, DOI 10.1089/jir.2006.0103; RHINEHARTJONES TR, 1994, INFECT IMMUN, V62, P3129, DOI 10.1128/IAI.62.8.3129-3137.1994; RISI GF, 1995, CLIN INFECT DIS, V20, P174, DOI 10.1093/clinids/20.1.174; Sada-Ovalle I, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000239; Santic M, 2005, CELL MICROBIOL, V7, P957, DOI 10.1111/j.1462-5822.2005.00529.x; Savitt AG, 2009, CLIN VACCINE IMMUNOL, V16, P414, DOI 10.1128/CVI.00362-08; Sharma J, MICROB PATHOG, V51, P39; Shirey KA, 2008, J IMMUNOL, V181, P4159, DOI 10.4049/jimmunol.181.6.4159; Sjostedt A, 2005, FRANCISELLA, P200; Skold M, 2003, INFECT IMMUN, V71, P5447, DOI 10.1128/IAI.71.10.5447-5455.2003; Snyder MJ, 1957, T ASSOC AM PHYSICIAN, V70, P74; Tarnvik A, 2003, EUR RESPIR J, V21, P361, DOI 10.1183/09031936.03.00088903; Telepnev M, 2003, CELL MICROBIOL, V5, P41, DOI 10.1046/j.1462-5822.2003.00251.x; TRINCHIERI G, 1995, ANNU REV IMMUNOL, V13, P251, DOI 10.1146/annurev.immunol.13.1.251; Ulland TK, 2010, J IMMUNOL, V185, P2670, DOI 10.4049/jimmunol.1001610; WENGER JD, 1989, ANN INTERN MED, V110, P888, DOI 10.7326/0003-4819-110-11-888; Woolard MD, 2008, INFECT IMMUN, V76, P2651, DOI 10.1128/IAI.01412-07; Yee D, 1996, J IMMUNOL, V157, P5042; Zhang D, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/239740	90	31	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33349	10.1371/journal.pone.0033349	http://dx.doi.org/10.1371/journal.pone.0033349			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22428026	Green Published, Green Submitted, gold			2022-12-25	WOS:000302381500130
J	Farnsworth, ML; Miller, RS; Pedersen, K; Lutman, MW; Swafford, SR; Riggs, PD; Webb, CT				Farnsworth, Matthew L.; Miller, Ryan S.; Pedersen, Kerri; Lutman, Mark W.; Swafford, Seth R.; Riggs, Philip D.; Webb, Colleen T.			Environmental and Demographic Determinants of Avian Influenza Viruses in Waterfowl across the Contiguous United States	PLOS ONE			English	Article							WILD BIRDS; SEASONAL-CHANGES; A VIRUS; PATHOGENICITY; SURVEILLANCE; PERSISTENCE; POULTRY; TRANSMISSION; H5N1; INFECTION	Outbreaks of avian influenza in North American poultry have been linked to wild waterfowl. A first step towards understanding where and when avian influenza viruses might emerge from North American waterfowl is to identify environmental and demographic determinants of infection in their populations. Laboratory studies indicate water temperature as one determinant of environmental viral persistence and we explored this hypothesis at the landscape scale. We also hypothesized that the interval apparent prevalence in ducks within a local watershed during the overwintering season would influence infection probabilities during the following breeding season within the same local watershed. Using avian influenza virus surveillance data collected from 19,965 wild waterfowl across the contiguous United States between October 2006 and September 2009 We fit Logistic regression models relating the infection status of individual birds sampled on their breeding grounds to demographic characteristics, temperature, and interval apparent prevalence during the preceding overwintering season at the local watershed scale. We found strong support for sex, age, and species differences in the probability an individual duck tested positive for avian influenza virus. In addition, we found that for every seven days the local minimum temperature fell below zero, the chance an individual would test positive for avian influenza virus increased by 5.9 percent. We also found a twelve percent increase in the chance an individual would test positive during the breeding season for every ten percent increase in the interval apparent prevalence during the prior overwintering season. These results suggest that viral deposition in water and sub-freezing temperatures during the overwintering season may act as determinants of individual level infection risk during the subsequent breeding season. Our findings have implications for future surveillance activities in waterfowl and domestic poultry populations. Further study is needed to identify how these drivers might interact with other host-specific infection determinants, such as species phylogeny, immunological status, and behavioral characteristics.	[Farnsworth, Matthew L.; Miller, Ryan S.; Riggs, Philip D.] Anim & Plant Hlth Inspect Serv, USDA, Vet Serv, Ctr Epidemiol, Ft Collins, CO USA; [Farnsworth, Matthew L.; Miller, Ryan S.; Riggs, Philip D.] Anim & Plant Hlth Inspect Serv, USDA, Vet Serv, Ctr Anim Hlth, Ft Collins, CO USA; [Pedersen, Kerri; Lutman, Mark W.; Swafford, Seth R.] Anim & Plant Hlth Inspect Serv, USDA, Wildlife Serv, Natl Wildlife Dis Program, Ft Collins, CO USA; [Webb, Colleen T.] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Colorado State University	Farnsworth, ML (corresponding author), Anim & Plant Hlth Inspect Serv, USDA, Vet Serv, Ctr Epidemiol, Ft Collins, CO USA.	matt.farnsworth@aphis.usda.gov	Miller, Ryan/H-9848-2019	Miller, Ryan/0000-0003-3892-0251				Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Boyce WM, 2009, COMP IMMUNOL MICROB, V32, P275, DOI 10.1016/j.cimid.2008.01.002; Breban R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000346; Brown JD, 2007, AVIAN DIS, V51, P285, DOI 10.1637/7636-042806R.1; Brown JD, 2009, VET MICROBIOL, V136, P20, DOI 10.1016/j.vetmic.2008.10.027; Bulaga LL, 2003, AVIAN DIS, V47, P1169, DOI 10.1637/0005-2086-47.s3.1169; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Campitelli L, 2004, VIROLOGY, V323, P24, DOI 10.1016/j.virol.2004.02.015; Capua I, 2004, AVIAN PATHOL, V33, P393, DOI 10.1080/03079450410001724085; Costa TP, 2010, AVIAN DIS, V54, P581, DOI 10.1637/8692-031309-ResNote.1; Costa TP, 2011, AVIAN PATHOL, V40, P119, DOI 10.1080/03079457.2010.540002; DeLiberto TJ, 2009, INTEGR ZOOL, V4, P426, DOI 10.1111/j.1749-4877.2009.00180.x; Deviche P, 2006, AUK, V123, P548, DOI 10.1642/0004-8038(2006)123[548:TTTFMD]2.0.CO;2; Doherty PF, 2002, BEHAV ECOL, V13, P543, DOI 10.1093/beheco/13.4.543; Garamszegi LZ, 2007, P ROY SOC B-BIOL SCI, V274, P2003, DOI 10.1098/rspb.2007.0124; Garber L, 2007, PREV VET MED, V80, P120, DOI 10.1016/j.prevetmed.2007.01.012; Garber L, 2007, AVIAN DIS, V51, P417, DOI 10.1637/7571-033106R.1; HAASE E, 1983, J STEROID BIOCHEM, V19, P731, DOI 10.1016/0022-4731(83)90004-3; HAASE E, 1985, J EXP ZOOL, V234, P301, DOI 10.1002/jez.1402340216; HALL RD, 1978, POULTRY SCI, V57, P1088, DOI 10.3382/ps.0571088; HALVORSON D, 1983, AVIAN DIS, V27, P77, DOI 10.2307/1590374; Halvorson DA, 2009, REV SCI TECH OIE, V28, P359, DOI 10.20506/rst.28.1.1866; HALVORSON DA, 1985, APPL ENVIRON MICROB, V49, P914, DOI 10.1128/AEM.49.4.914-919.1985; Hanson BA, 2003, AVIAN DIS, V47, P867, DOI 10.1637/0005-2086-47.s3.867; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Ip HS, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-71; Jacob JP, 2008, J APPL POULTRY RES, V17, P412, DOI 10.3382/japr.2007-00057; Johnson Douglas H., 1992, P446; Johnson Douglas H., 1996, P391, DOI 10.1016/B978-012178075-3/50014-3; Keawcharoen J, 2011, EMERG INFECT DIS, V17, P1016, DOI [10.3201/eid1705.100880, 10.3201/eid/1706.100880]; Klein SL, 2004, PARASITE IMMUNOL, V26, P247, DOI 10.1111/j.0141-9838.2004.00710.x; Lebarbenchon C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026566; LEVY KJ, 1975, PSYCHOL BULL, V82, P177, DOI 10.1037/h0076376; Matthysse J.C., 1974, Search Agric, V4, P1; Mullaney R, 2003, AVIAN DIS, V47, P1096, DOI 10.1637/0005-2086-47.s3.1096; National Oceanic and Atmospheric Administration, 2011, NAT CLIM DAT; Nazir J, 2011, APPL ENVIRON MICROB, V77, P4981, DOI 10.1128/AEM.00415-11; Nazir J, 2010, AVIAN DIS, V54, P720, DOI 10.1637/8754-033109-ResNote.1; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Pantin-Jackwood MJ, 2007, VIRUS RES, V130, P151, DOI 10.1016/j.virusres.2007.06.006; Pasick J, 2010, AVIAN DIS, V54, P440, DOI 10.1637/8800-040109-Reg.1; PAULKE E, 1978, GEN COMP ENDOCR, V34, P381, DOI 10.1016/0016-6480(78)90278-2; Pedersen K, 2010, AVIAN DIS, V54, P405, DOI 10.1637/8693-031309-Reg.1; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; Perdue ML, 2005, AVIAN DIS, V49, P317, DOI 10.1637/7390-060305R.1; Peters A, 2004, AM NAT, V164, P51, DOI 10.1086/421302; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rohani P, 2009, P NATL ACAD SCI USA, V106, P10365, DOI 10.1073/pnas.0809026106; Saif Y., 2008, DIS POULTRY, V12th ed., P452; Senn DA, 2005, WAG UR FRON, V8, P19; Senne DA, 2007, AVIAN DIS, V51, P167, DOI 10.1637/7621-042606R1.1; Slota KE, 2011, AVIAN DIS, V55, P180, DOI 10.1637/9509-082310-Reg.1; Stallknecht DE, 2010, AVIAN DIS, V54, P461, DOI 10.1637/8760-033109-Reg.1; STALLKNECHT DE, 1990, AVIAN DIS, V34, P406, DOI 10.2307/1591428; STALLKNECHT DE, 1990, AVIAN DIS, V34, P412, DOI 10.2307/1591429; Swayne D.E., 2008, AVIAN INFLUENZA; Terregino C, 2007, AVIAN PATHOL, V36, P337, DOI 10.1080/03079450701488345; Trock SC, 2003, AVIAN DIS, V47, P76; United States Department of Agriculture WS, 2006, WILDL SERV STA UNPUB, P1; United States Geological Survey, 2011, WAT BOUND DAT; USDA APHIS NAHMS, 2007, REF MAN PRACT SMALL; VanDalen KK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012851; Wallensten A, 2007, EMERG INFECT DIS, V13, P404, DOI 10.3201/eid1303.061130; Webster RG, 1997, ARCH VIROL, P105; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992	66	32	33	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e32729	10.1371/journal.pone.0032729	http://dx.doi.org/10.1371/journal.pone.0032729			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427870	Green Published, gold, Green Submitted			2022-12-25	WOS:000302381500036
J	Lutti, A; Stadler, J; Josephs, O; Windischberger, C; Speck, O; Bernarding, J; Hutton, C; Weiskopf, N				Lutti, Antoine; Stadler, Joerg; Josephs, Oliver; Windischberger, Christian; Speck, Oliver; Bernarding, Johannes; Hutton, Chloe; Weiskopf, Nikolaus			Robust and Fast Whole Brain Mapping of the RF Transmit Field B1 at 7T	PLOS ONE			English	Article							RADIOFREQUENCY FIELD; STEADY-STATE; MRI; OPTIMIZATION; ARRAYS; FMRI; T-1; 3T	In-vivo whole brain mapping of the radio frequency transmit field B-1(+) is a key aspect of recent method developments in ultra high field MRI. We present an optimized method for fast and robust in-vivo whole-brain B-1(+) mapping at 7T. The method is based on the acquisition of stimulated and spin echo 3D EPI images and was originally developed at 3T. We further optimized the method for use at 7T. Our optimization significantly improved the robustness of the method against large B-1(+) deviations and off-resonance effects present at 7T. The mean accuracy and precision of the optimized method across the brain was high with a bias less than 2.6 percent unit (p.u.) and random error less than 0.7 p.u. respectively.	[Lutti, Antoine; Josephs, Oliver; Hutton, Chloe; Weiskopf, Nikolaus] UCL, UCL Inst Neurol, Wellcome Trust Ctr Neuroimaging, London, England; [Stadler, Joerg] Leibniz Inst Neurobiol, Special Lab Noninvas Brain Imaging, Magdeburg, Germany; [Windischberger, Christian] Med Univ Vienna, MR Ctr Excellence, Ctr Med Phys & Biomed Engn, Vienna, Austria; [Speck, Oliver] Univ Magdeburg, Dept Biomed Magnet Resonance, Inst Expt Phys, D-39106 Magdeburg, Germany; [Bernarding, Johannes] Univ Magdeburg, Fac Med, Inst Biometry & Med Informat, D-39106 Magdeburg, Germany	University of London; University College London; Leibniz Institut fur Neurobiologie (LIN); Medical University of Vienna; Otto von Guericke University; Otto von Guericke University	Lutti, A (corresponding author), UCL, UCL Inst Neurol, Wellcome Trust Ctr Neuroimaging, London, England.	a.lutti@ucl.ac.uk	Weiskopf, Nikolaus/B-9357-2008; Jovicich, Jorge/D-2293-2010; Lutti, Antoine/O-6777-2017; Speck, Oliver/F-1406-2013	Weiskopf, Nikolaus/0000-0001-5239-1881; Lutti, Antoine/0000-0003-3281-5477; Speck, Oliver/0000-0002-6019-5597; Windischberger, Christian/0000-0002-9944-0190; Stadler, Jorg/0000-0003-4313-129X	Wellcome Trust [079866/Z/06/Z]; BMBF (German Federal Ministry of Education and Research) [13N9208]; MAN-BIOPSY of the Medical University of Vienna; University of Vienna, Austria [SO76300004]	Wellcome Trust(Wellcome TrustEuropean Commission); BMBF (German Federal Ministry of Education and Research)(Federal Ministry of Education & Research (BMBF)); MAN-BIOPSY of the Medical University of Vienna; University of Vienna, Austria	This study was financially supported by the Wellcome Trust (http://www.wellcome.ac.uk/, grant number 079866/Z/06/Z), the BMBF (German Federal Ministry of Education and Research, project number 13N9208) and the MAN-BIOPSY research cluster of the Medical University of Vienna and the University of Vienna, Austria (SO76300004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriany G, 2005, MAGN RESON MED, V53, P434, DOI 10.1002/mrm.20321; Cunningham CH, 2006, MAGN RESON MED, V55, P1326, DOI 10.1002/mrm.20896; Dick F, 2010, P C SOC NEUROSCIENCE, P580; Dowell NG, 2007, MAGN RESON MED, V58, P622, DOI 10.1002/mrm.21368; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; HANICKE W, 1990, MED PHYS, V17, P1004, DOI 10.1118/1.596452; Helms G, 2008, MAGN RESON MED, V60, P739, DOI 10.1002/mrm.21676; Helms G, 2008, MAGN RESON MED, V59, P667, DOI 10.1002/mrm.21542; Hutton C, 2011, NEUROIMAGE, V57, P101, DOI 10.1016/j.neuroimage.2011.04.018; Hutton C, 2002, NEUROIMAGE, V16, P217, DOI 10.1006/nimg.2001.1054; Jiru F, 2006, MAGN RESON MED, V56, P1375, DOI 10.1002/mrm.21083; Katscher U, 2003, MAGNET RESON MED, V49, P144, DOI 10.1002/mrm.10353; Lutti A, 2010, MAGN RESON MED, V64, P229, DOI 10.1002/mrm.22421; Ma C, 2009, C P IEEE ENG MED BIO, P4064; Marques JP, 2010, NEUROIMAGE, V49, P1271, DOI 10.1016/j.neuroimage.2009.10.002; Metzger GJ, 2008, MAGN RESON MED, V59, P396, DOI 10.1002/mrm.21476; Sacolick LI, 2010, MAGN RESON MED, V63, P1315, DOI 10.1002/mrm.22357; Vaughan JT, 2001, MAGN RESON MED, V46, P24, DOI 10.1002/mrm.1156; Vaughan TT, 2009, MAGN RESON MED, V61, P244, DOI 10.1002/mrm.21751; Vaughan T, 2006, MAGN RESON MED, V56, P1274, DOI 10.1002/mrm.21073; Wang JH, 2006, MAGN RESON MED, V56, P463, DOI 10.1002/mrm.20947; Wright PJ, 2008, MAGN RESON MATER PHY, V21, P121, DOI 10.1007/s10334-008-0104-8; Yarnykh VL, 2007, MAGN RESON MED, V57, P192, DOI 10.1002/mrm.21120; Yarnykh VL, 2010, MAGN RESON MED, V63, P1610, DOI 10.1002/mrm.22394; Zelinski AC, 2008, J MAGN RESON IMAGING, V28, P1005, DOI 10.1002/jmri.21548	25	79	81	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e32379	10.1371/journal.pone.0032379	http://dx.doi.org/10.1371/journal.pone.0032379			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427831	Green Published, Green Submitted, gold			2022-12-25	WOS:000302381500014
J	McMenamin, SK; Hadly, EA				McMenamin, Sarah K.; Hadly, Elizabeth A.			Ancient DNA Assessment of Tiger Salamander Population in Yellowstone National Park	PLOS ONE			English	Article							AMBYSTOMA-TIGRINUM; MITOCHONDRIAL-DNA; GENETIC DIVERSITY; POCKET GOPHERS; HISTORY; CLIMATE; FOSSILS; SIMCOAL	Recent data indicates that blotched tiger salamanders (Ambystoma tigrinum melanostictum) in northern regions of Yellowstone National Park are declining due to climate-related habitat changes. In this study, we used ancient and modern mitochondrial haplotype diversity to model the effective size of this amphibian population through recent geological time and to assess past responses to climatic changes in the region. Using subfossils collected from a cave in northern Yellowstone, we analyzed > 700 base pairs of mitochondrial sequence from 16 samples ranging in age from 100 to 3300 years old and found that all shared an identical haplotype. Although mitochondrial diversity was extremely low within the living population, we still were able to detect geographic subdivision within the local area. Using serial coalescent modelling with Bayesian priors from both modern and ancient genetic data we simulated a range of probable population sizes and mutation rates through time. Our simulations suggest that regional mitochondrial diversity has remained relatively constant even through climatic fluctuations of recent millennia.	[McMenamin, Sarah K.; Hadly, Elizabeth A.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Stanford University	McMenamin, SK (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	skmcmena@u.washington.edu	McMenamin, Sarah/ABD-0228-2022; McMenamin, Sarah/A-3480-2011	McMenamin, Sarah/0000-0002-1154-5810	Stanford Center for Evolutionary Studies; Sigma Xi Society [G20071091712537615, G20061041426504729]	Stanford Center for Evolutionary Studies; Sigma Xi Society	This work was funded by the Stanford Center for Evolutionary Studies (no grant number or URL; contact: Ward Watt wbwatt@stanford.edu) and by two Grant-in-Aid of Research grants from the Sigma Xi Society (grant numbers G20071091712537615 and G20061041426504729; http://www.sigmaxi.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CNK, 2005, BIOINFORMATICS, V21, P1733, DOI 10.1093/bioinformatics/bti154; Bos DH, 2008, EVOLUTION, V62, P1458, DOI 10.1111/j.1558-5646.2008.00364.x; Brotherton P, 2007, NUCLEIC ACIDS RES, V35, P5717, DOI 10.1093/nar/gkm588; Bruzgul Judsen E., 2005, BMC Ecology, V5, P7, DOI 10.1186/1472-6785-5-7; Carranza S., 2003, Systematics and Biodiversity, V1, P327, DOI 10.1017/S1477200003001221; Chan YL, 2005, BIOL LETT-UK, V1, P423, DOI 10.1098/rsbl.2005.0354; Chan YL, 2006, PLOS GENET, V2, P451, DOI 10.1371/journal.pgen.0020059; Church SA, 2003, EVOLUTION, V57, P372; de Bruyn M, 2011, TRENDS ECOL EVOL, V26, P405, DOI 10.1016/j.tree.2011.03.021; Excoffier L, 2000, J HERED, V91, P506, DOI 10.1093/jhered/91.6.506; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fulton TL, 2012, SETTING ANCIENT DNA; Hadly EA, 1997, BIOL J LINN SOC, V60, P277; Hadly EA, 1999, PALAEOGEOGR PALAEOCL, V149, P389, DOI 10.1016/S0031-0182(98)00214-4; Hadly EA, 2004, PLOS BIOL, V2, P1600, DOI 10.1371/journal.pbio.0020290; Hadly EA, 1998, P NATL ACAD SCI USA, V95, P6893, DOI 10.1073/pnas.95.12.6893; Hadly EA, 2003, J MAMMAL, V84, P403, DOI 10.1644/1545-1542(2003)084<0403:ADEOPP>2.0.CO;2; Hadly EA, 2001, EVOL ECOL RES, V3, P477; Hadly EA, 1996, QUATERNARY RES, V46, P298, DOI 10.1006/qres.1996.0068; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; Koch E.D., 1995, AMPHIBIANS REPTILES; Lorenzen ED, 2011, NATURE, V479, P359, DOI 10.1038/nature10574; McMenamin SK, 2008, P NATL ACAD SCI USA, V105, P16988, DOI 10.1073/pnas.0809090105; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Porder S, 2003, PALEOBIOLOGY, V29, P197, DOI 10.1666/0094-8373(2003)029<0197:MTOOFA>2.0.CO;2; Ramakrishnan U, 2009, MOL ECOL, V18, P1310, DOI 10.1111/j.1365-294X.2009.04092.x; Rodriguez R, 2011, MOL ECOL, V20, P3785, DOI 10.1111/j.1365-294X.2011.05231.x; Samuels AK, 2005, GENE, V349, P43, DOI 10.1016/j.gene.2004.12.037; Shaffer HB, 1996, EVOLUTION, V50, P417, DOI 10.1111/j.1558-5646.1996.tb04503.x; Smith CI, 2003, J HUM EVOL, V45, P203, DOI 10.1016/S0047-2484(03)00106-4; Smith CI, 2001, NATURE, V410, P771, DOI 10.1038/35071177; Smouse PE, 2008, MOL ECOL, V17, P3389, DOI 10.1111/j.1365-294X.2008.03839.x; Spaeth PA, 2009, J MAMMAL, V90, P571, DOI 10.1644/08-MAMM-A-204R2.1; Spear SF, 2005, MOL ECOL, V14, P2553, DOI 10.1111/j.1365-294X.2005.02573.x; Spear SF, 2006, CONSERV GENET, V7, P605, DOI 10.1007/s10592-005-9095-4; Stiller M, 2006, P NATL ACAD SCI US; TEMPLETON AR, 1995, GENETICS, V140, P767; Van Tuinen M, 2008, MOL ECOL, V17, P1776, DOI 10.1111/j.1365-294X.2008.03671.x; Varley JD, 1981, HIST FISH STOCKING A; Winters M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021247; Yang DY, 2006, MOL ECOL NOTES, V6, P605, DOI 10.1111/j.1471-8286.2006.01370.x	41	4	4	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e32763	10.1371/journal.pone.0032763	http://dx.doi.org/10.1371/journal.pone.0032763			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427878	Green Published, gold			2022-12-25	WOS:000302381500040
J	Murciano, C; Moyes, DL; Runglall, M; Tobouti, P; Islam, A; Hoyer, LL; Naglik, JR				Murciano, Celia; Moyes, David L.; Runglall, Manohursingh; Tobouti, Priscila; Islam, Ayesha; Hoyer, Lois L.; Naglik, Julian R.			Evaluation of the Role of Candida albicans Agglutinin-Like Sequence (Als) Proteins in Human Oral Epithelial Cell Interactions	PLOS ONE			English	Article							GENE FAMILY; EXPRESSION; VIRULENCE; ADHESION	The fungus C. albicans uses adhesins to interact with human epithelial surfaces in the processes of colonization and pathogenesis. The C. albicans ALS (agglutinin-like sequence) gene family encodes eight large cell-surface glycoproteins (Als1-Als7 and Als9) that have adhesive function. This study utilized C. albicans Delta als mutant strains to investigate the role of the Als family in oral epithelial cell adhesion and damage, cytokine induction and activation of a MAPK-based (MKP1/c-Fos) signaling pathway that discriminates between yeast and hyphae. Of the eight Delta als mutants tested, only the Delta als3 strain showed significant reductions in oral epithelial cell adhesion and damage, and cytokine production. High fungal: epithelial cell multiplicities of infection were able to rescue the cell damage and cytokine production phenotypes, demonstrating the importance of fungal burden in mucosal infections. Despite its adhesion, damage and cytokine induction phenotypes, the Delta als3 strain induced MKP1 phosphorylation and c-Fos production to a similar extent as control cells. Our data demonstrate that Als3 is involved directly in epithelial adhesion but indirectly in cell damage and cytokine induction, and is not the factor targeted by oral epithelial cells to discriminate between the yeast and hyphal form of C. albicans.	[Murciano, Celia; Moyes, David L.; Runglall, Manohursingh; Tobouti, Priscila; Islam, Ayesha; Naglik, Julian R.] Kings Coll London, Inst Dent, Dept Oral Immunol, London WC2R 2LS, England; [Hoyer, Lois L.] Univ Illinois, Dept Pathobiol, Urbana, IL USA	University of London; King's College London; University of Illinois System; University of Illinois Urbana-Champaign	Murciano, C (corresponding author), Kings Coll London, Inst Dent, Dept Oral Immunol, London WC2R 2LS, England.	celia.murciano@kcl.ac.uk; julian.naglik@kcl.ac.uk	Murciano, Celia/K-8816-2014; Hoyer, Lois/G-2004-2015	Murciano, Celia/0000-0003-0035-5306; Moyes, David/0000-0002-1657-918X; /0000-0002-3948-9697; Runglall, Manohursingh/0000-0002-0549-9029; Hoyer, Lois/0000-0002-0827-4984; Naglik, Julian/0000-0002-8072-7917	National Institutes of Dental and Craniofacial Research (NIDCR) [DE17514, DE14158]; Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014158, R01DE017514] Funding Source: NIH RePORTER	National Institutes of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Dental and Craniofacial Research (NIDCR) grants DE17514 (to JRN) and DE14158 (to LLH). The authors also acknowledge financial support from the Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calderone RA, 2001, TRENDS MICROBIOL, V9, P327, DOI 10.1016/S0966-842X(01)02094-7; Calderone RA., 2002, CANDIDA CANDIDIASIS; Coleman DA, 2010, MICROBIOL-SGM, V156, P3645, DOI 10.1099/mic.0.043851-0; Coleman DA, 2009, J MICROBIOL METH, V78, P71, DOI 10.1016/j.mimet.2009.05.002; FONZI WA, 1993, GENETICS, V134, P717; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Hoyer LL, 1998, CURR GENET, V33, P451, DOI 10.1007/s002940050359; Hoyer LL, 2001, TRENDS MICROBIOL, V9, P176, DOI 10.1016/S0966-842X(01)01984-9; Hoyer LL, 2008, MED MYCOL, V46, P1, DOI 10.1080/13693780701435317; Kapteyn JC, 2000, MOL MICROBIOL, V35, P601, DOI 10.1046/j.1365-2958.2000.01729.x; Liu YP, 2011, EUKARYOT CELL, V10, P168, DOI 10.1128/EC.00279-10; Moreno-Ruiz E, 2009, CELL MICROBIOL, V11, P1179, DOI 10.1111/j.1462-5822.2009.01319.x; Moyes DL, 2012, MED MICROBIOL IMMUN, V201, P93, DOI 10.1007/s00430-011-0209-y; Moyes DL, 2010, CELL HOST MICROBE, V8, P225, DOI 10.1016/j.chom.2010.08.002; Murad AMA, 2000, YEAST, V16, P325, DOI 10.1002/1097-0061(20000315)16:4&lt;325::AID-YEA538&gt;3.0.CO;2-#; Murciano C, 2011, INFECT IMMUN, V79, P4902, DOI 10.1128/IAI.05591-11; Naglik J, 2004, CELL MICROBIOL, V6, P915, DOI 10.1111/j.1462-5822.2004.00439.x; Naglik JR, 2003, MICROBIOL MOL BIOL R, V67, P400, DOI 10.1128/MMBR.67.3.400-428.2003; Naglik JR, 2006, J MED MICROBIOL, V55, P1323, DOI 10.1099/jmm.0.46737-0; Naglik JR, 2011, MICROBES INFECT, V13, P963, DOI 10.1016/j.micinf.2011.06.009; Naglik JR, 2008, MICROBIOL-SGM, V154, P3266, DOI 10.1099/mic.0.2008/022293-0; Odds FC., 1988, CANDIDA CANDIDOSIS; Phan QT, 2007, PLOS BIOL, V5, P543, DOI 10.1371/journal.pbio.0050064; RUPNIAK HT, 1985, J NATL CANCER I, V75, P621; Salgado PS, 2011, P NATL ACAD SCI USA, V108, P15775, DOI 10.1073/pnas.1103496108; Schaller M, 2006, NAT PROTOC, V1, P2767, DOI 10.1038/nprot.2006.474; Sheppard DC, 2004, J BIOL CHEM, V279, P30480, DOI 10.1074/jbc.M401929200; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Soll David R., 2002, P123; Stylianou E, 1998, INT J BIOCHEM CELL B, V30, P1075, DOI 10.1016/S1357-2725(98)00081-8; Weindl G, 2007, J CLIN INVEST, V117, P3664, DOI 10.1172/JCI28115; Zakikhany K, 2007, CELL MICROBIOL, V9, P2938, DOI 10.1111/j.1462-5822.2007.01009.x; Zhao X, 2005, MICROBIOL-SGM, V151, P1619, DOI 10.1099/mic.0.27763-0; Zhao X, 2011, FEMS IMMUNOL MED MIC; Zhao XM, 2007, MICROBIOL-SGM, V153, P2342, DOI 10.1099/mic.0.2006/005017-0; Zhao X, 2007, MED MYCOL, V45, P429, DOI 10.1080/13693780701377162; Zhao X, 2006, MICROBIOL-SGM, V152, P2287, DOI 10.1099/mic.0.28959-0; Zhao XM, 2004, MICROBIOL-SGM, V150, P2415, DOI 10.1099/mic.0.26943-0	38	77	89	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33362	10.1371/journal.pone.0033362	http://dx.doi.org/10.1371/journal.pone.0033362			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22428031	gold, Green Published, Green Submitted			2022-12-25	WOS:000302381500132
J	Ribassin-Majed, L; Lounes, R; Clemencon, S				Ribassin-Majed, Laureen; Lounes, Rachid; Clemencon, Stephan			Efficacy of Vaccination against HPV Infections to Prevent Cervical Cancer in France: Present Assessment and Pathways to Improve Vaccination Policies	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS VACCINATION; COST-EFFECTIVENESS; NATURAL-HISTORY; HERD-IMMUNITY; IMPACT; WOMEN; MODEL; POPULATION; PREVALENCE; DISEASE	Background: Seventy percent of sexually active individuals will be infected with Human Papillomavirus (HPV) during their lifetime. These infections are incriminated for almost all cervical cancers. In France, 3,068 new cases of cervical cancer and 1,067 deaths from cervical cancer occurred in 2005. Two vaccines against HPV infections are currently available and vaccination policies aim to decrease the incidence of HPV infections and of cervical cancers. In France, vaccine coverage has been reported to be low. Methods: We developed a dynamic model for the heterosexual transmission of Human Papillomavirus types 16 and 18, which are covered by available vaccines. A deterministic model was used with stratification on gender, age and sexual behavior. Immunity obtained from vaccination was taken into account. The model was calibrated using French data of cervical cancer incidence. Results: In view of current vaccine coverage and screening, we expected a 32% and 83% reduction in the incidence of cervical cancers due to HPV 16/18, after 20 years and 50 years of vaccine introduction respectively. Vaccine coverage and screening rates were assumed to be constant. However, increasing vaccine coverage in women or vaccinating girls before 14 showed a better impact on cervical cancer incidence. On the other hand, performing vaccination in men improves the effect on cervical cancer incidence only moderately, compared to strategies in females only. Conclusion: While current vaccination policies may significantly decrease cervical cancer incidence, other supplementary strategies in females could be considered in order to improve vaccination efficacy.	[Ribassin-Majed, Laureen; Lounes, Rachid] Univ Paris 05, CNRS, UMR 8145, Lab Math Appl Paris 5, Paris, France; [Clemencon, Stephan] Telecom ParisTech, CNRS, UMR 5141, Lab Traitement & Commun Informat, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); IMT - Institut Mines-Telecom; Institut Polytechnique de Paris	Ribassin-Majed, L (corresponding author), Univ Paris 05, CNRS, UMR 8145, Lab Math Appl Paris 5, Paris, France.	laureen.majed@parisdescartes.fr						BAJOS N., 2008, ENQUETE SEXUALITE FR; Barnabas RV, 2006, PLOS MED, V3, P624, DOI 10.1371/journal.pmed.0030138; Belot A, 2008, REV EPIDEMIOL SANTE, V56, P159, DOI 10.1016/j.respe.2008.03.117; Bergeron C, 2008, INT J TECHNOL ASSESS, V24, P10, DOI 10.1017/S0266462307080026; Brisson M, 2007, VACCINE, V25, P5399, DOI 10.1016/j.vaccine.2007.04.086; Brisson M, 2011, J INFECT DIS, V204, P372, DOI 10.1093/infdis/jir285; Brotherton JML, 2008, COMMUN DIS INTELL, V32, P457; Brown DR, 2009, J INFECT DIS, V199, P926, DOI 10.1086/597307; Castellsague X, 2011, BRIT J CANCER, V105, P28, DOI 10.1038/bjc.2011.185; Castle PE, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4127; Clifford G, 2006, VACCINE, V24, P26, DOI 10.1016/j.vaccine.2006.05.026; Clifford GM, 2003, BRIT J CANCER, V88, P63, DOI 10.1038/sj.bjc.6600688; Denis F, 2006, CURR TOP MICROBIOL, V304, P115; Duport N, 2008, DONNEES EPIDEMIOLOGI; Duport N, 2006, DONNEES EPIDEMIOLOGI; ECCA European Cervical Cancer Association, HPV VACC EUR; El Hasnaoui A, 2011, INT J PUBLIC HLTH; Elbasha EH, 2007, EMERG INFECT DIS, V13, P28, DOI 10.3201/eid1301.060438; Elbasha EH, 2010, VACCINE, V28, P6858, DOI 10.1016/j.vaccine.2010.08.030; Fagot JP, 2011, VACCINE, V29, P3610, DOI 10.1016/j.vaccine.2011.02.064; Foresta C, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4514; Garnett GP, 2005, J INFECT DIS, V191, pS97, DOI 10.1086/425271; GARNETT GP, 1993, SEX TRANSM DIS, V20, P181, DOI 10.1097/00007435-199307000-00001; Goldhaber-Fiebert Jeremy D, 2007, Popul Health Metr, V5, P11, DOI 10.1186/1478-7954-5-11; Goldie SJ, 2003, INT J CANCER, V106, P896, DOI 10.1002/ijc.11334; Guizard AVTB, 2008, ESTIMATION INCIDENCE; Haut conseil de la sante publique, 2007, AV COM TECHN VACC CO; Hethcote HW, 1997, MATH BIOSCI, V145, P89, DOI 10.1016/S0025-5564(97)00014-X; Hughes JP, 2002, EPIDEMIOLOGY, V13, P631, DOI 10.1097/00001648-200211000-00006; Insinga RP, 2007, VACCINE, V26, P128, DOI 10.1016/j.vaccine.2007.10.056; Jin XW, 2011, CLEV CLIN J MED, V78, P737, DOI 10.3949/ccjm.78a.11033; Jit M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a769; Kemp TJ, 2011, VACCINE, V29, P2011, DOI 10.1016/j.vaccine.2011.01.001; Kohli M, 2007, BRIT J CANCER, V96, P143, DOI 10.1038/sj.bjc.6603501; Munoz N, 2000, J CLIN VIROL, V19, P1, DOI 10.1016/S1386-6532(00)00125-6; Munoz N, 2010, JNCI-J NATL CANCER I, V102, P325, DOI 10.1093/jnci/djp534; Myers ER, 2000, AM J EPIDEMIOL, V151, P1158, DOI 10.1093/oxfordjournals.aje.a010166; Nielson CM, 2009, CANCER EPIDEM BIOMAR, V18, P1077, DOI 10.1158/1055-9965.EPI-08-0447; Pannier-Stockman C, 2008, J CLIN VIROL, V42, P353, DOI 10.1016/j.jcv.2008.03.022; Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4; Parkin DM, 1999, INT J CANCER, V80, P827, DOI 10.1002/(SICI)1097-0215(19990315)80:6&lt;827::AID-IJC6&gt;3.0.CO;2-P; Peto J, 2004, BRIT J CANCER, V91, P942, DOI 10.1038/sj.bjc.6602049; Ralston Howe E, 2009, AM J OBSTET GYNECOL, V245, pe241; Rambout L, 2007, CAN MED ASSOC J, V177, P469, DOI 10.1503/cmaj.070948; Remontet L, 2003, REV EPIDEMIOL SANTE, V51, P3; Suarez E, 2008, VACCINE, V26, pF29, DOI 10.1016/j.vaccine.2008.05.069; SYRJANEN K, 1990, SEX TRANSM DIS, V17, P15, DOI 10.1097/00007435-199017010-00004; Taira AV, 2004, EMERG INFECT DIS, V10, P1915, DOI 10.3201/eid1011.040222; UK Department of Health, 2010, HPV VACC PROGR PROV	49	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e32251	10.1371/journal.pone.0032251	http://dx.doi.org/10.1371/journal.pone.0032251			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427828	Green Published, gold			2022-12-25	WOS:000302381500011
J	Santos, PS; Nascimento, R; Rodrigues, LP; Santos, FAA; Faria, PCB; Martins, JRS; Brito-Madurro, AG; Madurro, JM; Goulart, LR				Santos, Paula S.; Nascimento, Rafael; Rodrigues, Luciano P.; Santos, Fabiana A. A.; Faria, Paula C. B.; Martins, Joao R. S.; Brito-Madurro, Ana G.; Madurro, Joao M.; Goulart, Luiz R.			Functional Epitope Core Motif of the Anaplasma marginale Major Surface Protein 1a and Its Incorporation onto Bioelectrodes for Antibody Detection	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; NEUTRALIZATION-SENSITIVE EPITOPE; IMPEDIMETRIC IMMUNOSENSOR; BOVINE ANAPLASMOSIS; PHAGE; PEPTIDES; CATTLE; INFECTION; DIAGNOSIS; ADHESION	Anaplasmosis, a persistent intraerythrocytic infection of cattle by Anaplasma marginale, causes severe anemia and a higher rate of abortion, resulting in significant loss to both dairy and beef industries. Clinical diagnosis is based on symptoms and confirmatory laboratory tests are required. Currently, all the diagnostic assays have been developed with whole antigens with indirect ELISA based on multiple epitopes. In a pioneer investigation we demonstrated the use of critical motifs of an epitope as biomarkers for immunosensor applications. Mimotopes of the MSP1a protein functional epitope were obtained through Phage Display after three cycles of selection of a 12-mer random peptide library against the neutralizing monoclonal antibody 15D2. Thirty-nine clones were randomly selected, sequenced, translated and aligned with the native sequence. The consensus sequence SxSSQSEASTSSQLGA was obtained, which is located in C-terminal end of the 28-aa repetitive motif of the MSP1a protein, but the alignment and sequences' variation among mimotopes allowed us to map the critical motif STSSxL within the consensus sequence. Based on these results, two peptides were chemically synthesized: one based on the critical motif (STSSQL, Am1) and the other based on the consensus sequence aligned with the native epitope (SEASTSSQLGA, Am2). Sera from 24 infected and 52 healthy animals were tested by ELISA for reactivity against Am1 and Am2, which presented sensitivities of 96% and 100%, respectively. The Am1 peptide was incorporated onto a biolectrode (graphite modified with poly-3-hydroxyphenylacetic acid) and direct serum detection was demonstrated by impedance, differential pulse voltammetry, and atomic force microscopy. The electrochemical sensor system proved to be highly effective in discriminating sera from positive and negative animals. These immunosensors were highly sensitive and selective for positive IgG, contaminants did not affect measurements, and were based on a simple, fast and reproducible electrochemical system.	[Santos, Paula S.; Nascimento, Rafael; Santos, Fabiana A. A.; Goulart, Luiz R.] Univ Fed Uberlandia, Inst Genet & Bioquim, Lab Nanobiotecnol, BR-38400 Uberlandia, MG, Brazil; [Rodrigues, Luciano P.; Brito-Madurro, Ana G.; Madurro, Joao M.] Univ Fed Uberlandia, Inst Quim, Lab Filmes Polimer & Nanotecnol, BR-38400 Uberlandia, MG, Brazil; [Faria, Paula C. B.] Univ Fed Minas Gerais, Lab Leishmanioses, Belo Horizonte, MG, Brazil; [Martins, Joao R. S.] Inst Pesquisas Vet Desiderio Finamor, Parasitol Lab, Eldorado Do Sul, Brazil	Universidade Federal de Uberlandia; Universidade Federal de Uberlandia; Universidade Federal de Minas Gerais	Santos, PS (corresponding author), Univ Fed Uberlandia, Inst Genet & Bioquim, Lab Nanobiotecnol, Av Engenheiro Dinz 1178,CP 593, BR-38400 Uberlandia, MG, Brazil.	lrgoulart@ufu.br	Madurro, Ana/AAH-4588-2019; Nascimento, Rafael/AAF-5801-2020; Santos, Paula/D-6011-2013; Rodrigues, Luciano Pereira/C-1526-2018; Faria, Paula/N-2655-2013; Goulart, Luiz R/G-7357-2012; Nascimento, Rafael/E-2167-2011; Rodrigues, Luciano/Z-3922-2019; Madurro, João M/G-4080-2012	Nascimento, Rafael/0000-0003-3650-9354; Santos, Paula/0000-0003-2650-6635; Faria, Paula/0000-0003-1474-9496; Goulart, Luiz R/0000-0002-1803-4861; Nascimento, Rafael/0000-0003-3650-9354; Rodrigues, Luciano/0000-0002-9488-5000; Madurro, João M/0000-0002-2304-4482; Brito-Madurro, Ana Graci/0000-0003-3698-9845	Universidade Federal de Uberlandia; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do estado de Minas Gerais (FAPEMIG); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Universidade Federal de Uberlandia; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The work was supported by Universidade Federal de Uberlandia, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a Pesquisa do estado de Minas Gerais (FAPEMIG) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJAYI SA, 1978, RES VET SCI, V25, P76, DOI 10.1016/S0034-5288(18)33012-1; ALLRED DR, 1990, P NATL ACAD SCI USA, V87, P3220, DOI 10.1073/pnas.87.8.3220; Araujo FR, 2005, MEM I OSWALDO CRUZ, V100, P765, DOI 10.1590/S0074-02762005000700016; Barbas C. F., 2001, PHAGE DISPLAY LAB MA; BARRY DN, 1986, AUST VET J, V63, P76, DOI 10.1111/j.1751-0813.1986.tb02934.x; Corona Belkis, 2011, Rev Salud Anim., V33, P24; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; de la Fuente J, 2003, VET MICROBIOL, V91, P265, DOI 10.1016/S0378-1135(02)00309-7; de la Fuente J, 2001, INT J PARASITOL, V31, P145, DOI 10.1016/S0020-7519(00)00162-4; de la Fuente Jose, 2005, Anim Health Res Rev, V6, P75; Ehrlich GK, 2001, J BIOCHEM BIOPH METH, V49, P443, DOI 10.1016/S0165-022X(01)00212-3; Ekici OD, 2011, AFR J MICROBIOL RES, V5, P1188; FELICI F, 1993, GENE, V128, P21, DOI 10.1016/0378-1119(93)90148-V; Fosgate GT, 2010, J VET DIAGN INVEST, V22, P192, DOI 10.1177/104063871002200204; Huang J, 2011, MOLECULES, V16, P694, DOI 10.3390/molecules16010694; Jacobson RH, 1998, REV SCI TECH OIE, V17, P469, DOI 10.20506/rst.17.2.1119; JONES EW, 1966, J AM VET MED ASSOC, V149, P1624; Kay BK, 1998, DRUG DISCOV TODAY, V3, P370, DOI 10.1016/S1359-6446(98)01220-3; KENNEDY MW, 1990, IMMUNOLOGY, V71, P317; Kocan KM, 2010, VET PARASITOL, V167, P95, DOI 10.1016/j.vetpar.2009.09.012; Kocan KM, 2004, PARASITOLOGY, V129, pS285, DOI 10.1017/S0031182003004700; Lesinski GB, 2001, J MICROBIOL METH, V47, P135, DOI 10.1016/S0167-7012(01)00290-1; Lindholm-Sethson B, 2010, ANAL BIOANAL CHEM, V398, P2341, DOI 10.1007/s00216-010-4027-7; Madruga CR, 2000, PESQUISA VET BRASIL, V20, P109, DOI 10.1590/S0100-736X2000000300004; Mandava S, 2004, PROTEOMICS, V4, P1439, DOI 10.1002/pmic.200300680; Marana ERM, 2009, REV BRAS PARASITOL V, V18, P5, DOI 10.4322/rbpv.01802002; MCGAREY DJ, 1994, INFECT IMMUN, V62, P4594, DOI 10.1128/IAI.62.10.4594-4601.1994; Melo ESP, 2007, PESQUI VET BRASIL, V27, P301, DOI 10.1590/S0100-736X2007000700008; Munodzana D, 1998, INFECT IMMUN, V66, P2619, DOI 10.1128/IAI.66.6.2619-2624.1998; Murthy KK, 1999, BIOTECHNIQUES, V26, P142, DOI 10.2144/99261rr03; NAKAMURA Y, 1988, TROP ANIM HEALTH PRO, V20, P259, DOI 10.1007/BF02239994; OBERLE SM, 1988, INFECT IMMUN, V56, P1567, DOI 10.1128/IAI.56.6.1567-1573.1988; Oliveira RML, 2010, J MATER SCI, V45, P475, DOI 10.1007/s10853-009-3964-z; Ouerghi O, 2002, BIOELECTROCHEMISTRY, V56, P131, DOI 10.1016/S1567-5394(02)00029-4; PALMER GH, 1987, INT J PARASITOL, V17, P1279, DOI 10.1016/0020-7519(87)90093-2; Park JY, 2009, SENSORS-BASEL, V9, P9513, DOI 10.3390/s91209513; Radi AE, 2009, BIOSENS BIOELECTRON, V24, P1888, DOI 10.1016/j.bios.2008.09.021; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; SCOTT JK, 1990, SCIENCE, V249, P386, DOI 10.1126/science.1696028; Silva M, 2006, ANN NY ACAD SCI, V1081, P379, DOI 10.1196/annals.1373.056; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Smith GP, 1997, CHEM REV, V97, P391, DOI 10.1021/cr960065d; Wu J, 2010, ANAL CHEM, V82, P8235, DOI 10.1021/ac101657h; Zhang MY, 2001, J VIROL METHODS, V91, P139, DOI 10.1016/S0166-0934(00)00262-7	44	16	20	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33045	10.1371/journal.pone.0033045	http://dx.doi.org/10.1371/journal.pone.0033045			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427942	Green Published, Green Submitted, gold			2022-12-25	WOS:000302381500084
J	Task, K; Jaramillo, M; Banerjee, I				Task, Keith; Jaramillo, Maria; Banerjee, Ipsita			Population Based Model of Human Embryonic Stem Cell (hESC) Differentiation during Endoderm Induction	PLOS ONE			English	Article							DEFINITIVE ENDODERM; REGULATORY NETWORK; MESENDODERM; EXPRESSION; RECEPTOR; LINEAGE	The mechanisms by which human embryonic stem cells (hESC) differentiate to endodermal lineage have not been extensively studied. Mathematical models can aid in the identification of mechanistic information. In this work we use a population-based modeling approach to understand the mechanism of endoderm induction in hESC, performed experimentally with exposure to Activin A and Activin A supplemented with growth factors ( basic fibroblast growth factor (FGF2) and bone morphogenetic protein 4 (BMP4)). The differentiating cell population is analyzed daily for cellular growth, cell death, and expression of the endoderm proteins Sox17 and CXCR4. The stochastic model starts with a population of undifferentiated cells, wherefrom it evolves in time by assigning each cell a propensity to proliferate, die and differentiate using certain user defined rules. Twelve alternate mechanisms which might describe the observed dynamics were simulated, and an ensemble parameter estimation was performed on each mechanism. A comparison of the quality of agreement of experimental data with simulations for several competing mechanisms led to the identification of one which adequately describes the observed dynamics under both induction conditions. The results indicate that hESC commitment to endoderm occurs through an intermediate mesendoderm germ layer which further differentiates into mesoderm and endoderm, and that during induction proliferation of the endoderm germ layer is promoted. Furthermore, our model suggests that CXCR4 is expressed in mesendoderm and endoderm, but is not expressed in mesoderm. Comparison between the two induction conditions indicates that supplementing FGF2 and BMP4 to Activin A enhances the kinetics of differentiation than Activin A alone. This mechanistic information can aid in the derivation of functional, mature cells from their progenitors. While applied to initial endoderm commitment of hESC, the model is general enough to be applicable either to a system of adult stem cells or later stages of ESC differentiation.	[Task, Keith; Banerjee, Ipsita] Univ Pittsburgh, Dept Chem Engn, Pittsburgh, PA 15261 USA; [Jaramillo, Maria; Banerjee, Ipsita] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Task, K (corresponding author), Univ Pittsburgh, Dept Chem Engn, Pittsburgh, PA 15261 USA.	ipb1@pitt.edu			National Institutes of Health (NIH) [DP2 116520]; Oak Ridge Associated Universities (ORAU); University of Pittsburgh; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oak Ridge Associated Universities (ORAU); University of Pittsburgh(University of Pittsburgh); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the National Institutes of Health (NIH; www.nih.gov) New Innovator Award DP2 116520, the Oak Ridge Associated Universities (ORAU; www.orau.org) Ralph Powe Award, and University of Pittsburgh internal funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee I, 2010, BIOINFORMATICS, V26, P1332, DOI 10.1093/bioinformatics/btq139; Chng ZZ, 2010, CELL STEM CELL, V6, P59, DOI 10.1016/j.stem.2009.11.015; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; de Caestecker M, 2004, CYTOKINE GROWTH F R, V15, P1, DOI 10.1016/j.cytogfr.2003.10.004; Degasperi A, 2008, LECT NOTES COMPUT SC, V5016, P1; FREEDMAN D, 1981, Z WAHRSCHEINLICHKEIT, V57, P453, DOI 10.1007/BF01025868; Glauche I, 2007, STEM CELLS, V25, P1791, DOI 10.1634/stemcells.2007-0025; Grapin-Botton A, 2000, TRENDS GENET, V16, P124, DOI 10.1016/S0168-9525(99)01957-5; Grapin-Botton A, 2008, STEM BOOK; Gutenkunst RN, 2007, PLOS COMPUT BIOL, V3, P1871, DOI 10.1371/journal.pcbi.0030189; Kanai-Azuma M, 2002, DEVELOPMENT, V129, P2367; Kubo A, 2004, DEVELOPMENT, V131, P1651, DOI 10.1242/dev.01044; Loose M, 2004, DEV BIOL, V271, P467, DOI 10.1016/j.ydbio.2004.04.014; McGrath KE, 1999, DEV BIOL, V213, P442, DOI 10.1006/dbio.1999.9405; McLean AB, 2007, STEM CELLS, V25, P29, DOI 10.1634/stemcells.2006-0219; Nelson TJ, 2008, STEM CELLS, V26, P1464, DOI 10.1634/stemcells.2007-0808; Phillips BW, 2007, STEM CELLS DEV, V16, P561, DOI 10.1089/scd.2007.0029; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Rodaway A, 2001, CELL, V105, P169, DOI 10.1016/S0092-8674(01)00307-5; Roeder I, 2002, EXP HEMATOL, V30, P853, DOI 10.1016/S0301-472X(02)00832-9; Tada S, 2005, DEVELOPMENT, V132, P4363, DOI 10.1242/dev.02005; Takenaga M, 2007, J CELL SCI, V120, P2078, DOI 10.1242/jcs.004127; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Touboul T, 2010, HEPATOLOGY, V51, P1754, DOI 10.1002/hep.23506; Wells JM, 1999, ANNU REV CELL DEV BI, V15, P393, DOI 10.1146/annurev.cellbio.15.1.393; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167; Yusuf F, 2005, ANAT EMBRYOL, V210, P35, DOI 10.1007/s00429-005-0013-9	28	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e32975	10.1371/journal.pone.0032975	http://dx.doi.org/10.1371/journal.pone.0032975			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427920	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000302381500069
J	Zhao, XX; Ross, EJ; Wang, YY; Horwitz, BH				Zhao, Xixing; Ross, Erik J.; Wang, Yanyan; Horwitz, Bruce H.			Nfkb1 Inhibits LPS-Induced IFN-beta and IL-12 p40 Production in Macrophages by Distinct Mechanisms	PLOS ONE			English	Article							NF-KAPPA-B; ACTIVATED PROTEIN-KINASE; DNA-BINDING SUBUNIT; NF-KAPPA-B1 P105; DENDRITIC CELLS; INDUCED COLITIS; HELICOBACTER-HEPATICUS; IMMUNE-RESPONSES; P50/P105 SUBUNIT; PRECURSOR P105	Background: Nfkb1-deficient murine macrophages express higher levels of IFN-beta and IL-12 p40 following LPS stimulation than control macrophages, but the molecular basis for this phenomenon has not been completely defined. Nfkb1 encodes several gene products including the NF-kappa B subunit p50 and its precursor p105. p50 is derived from the N-terminal of 105, and p50 homodimers can exhibit suppressive activity when overexpressed. The C-terminal region of p105 is necessary for LPS-induced ERK activation and it has been suggested that ERK activity inhibits both IFN-beta and IL-12 p40 following LPS stimulation. However, the contributions of p50 and the C-terminal domain of p105 in regulating endogenous IFN-beta(Ifnb) and IL-12 p40 (Il12b) gene expression in macrophages following LPS stimulation have not been directly compared. Methodology/Principal Findings: We have used recombinant retroviruses to express p105, p50, and the C-terminal domain of p105 (p105 Delta N) in Nfkb1-deficient murine bone marrow-derived macrophages at near endogenous levels. We found that both p50 and p105 Delta N inhibited expression of Ifnb, and that inhibition of Ifnb by p105 Delta N depended on ERK activation, because a mutant of p105 Delta N (p105 Delta NS930A) that lacks a key serine necessary to support ERK activation failed to inhibit. In contrast, only p105 Delta N but not p50 inhibited Il12b expression. Surprisingly, p105 Delta NS930A retained inhibitory activity for Il12b, indicating that ERK activation was not necessary for inhibition. The differential effects of p105 Delta NS930A on Ifnb and Il12b expression inversely correlated with the function of one of its binding partners, c-Rel. This raised the possibility that p105 Delta NS930A influences gene expression by interfering with the function of c-Rel. Conclusions: These results demonstrate that Nfkb1 exhibits multiple gene-specific inhibitory functions following TLR stimulation of murine macrophages.	[Zhao, Xixing; Ross, Erik J.; Wang, Yanyan; Horwitz, Bruce H.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Horwitz, Bruce H.] Childrens Hosp, Div Emergency Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital	Zhao, XX (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.	bhorwitz@rics.bwh.harvard.edu			National Institutes of Health [AI52267]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052267] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant AI52267 to BHH. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2003, J IMMUNOL, V171, P4984, DOI 10.4049/jimmunol.171.10.4984; Beinke S, 2004, MOL CELL BIOL, V24, P9658, DOI 10.1128/MCB.24.21.9658-9667.2004; Cao SJ, 2006, J BIOL CHEM, V281, P26041, DOI 10.1074/jbc.M602222200; Cheng CS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001501; Dillon S, 2004, J IMMUNOL, V172, P4733, DOI 10.4049/jimmunol.172.8.4733; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; Erdman SE, 2001, J IMMUNOL, V166, P1443, DOI 10.4049/jimmunol.166.3.1443; GERONDAKIS S, 1993, CELL GROWTH DIFFER, V4, P617; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; GHOSH S, 1990, CELL, V62, P1019, DOI 10.1016/0092-8674(90)90276-K; Goriely S, 2006, BLOOD, V107, P1078, DOI 10.1182/blood-2005-06-2416; GRILLI M, 1993, INT REV CYTOL, V143, P1; GRUMONT RJ, 1994, P NATL ACAD SCI USA, V91, P4367, DOI 10.1073/pnas.91.10.4367; Hagemann T, 2008, J EXP MED, V205, P1261, DOI 10.1084/jem.20080108; HATADA EN, 1992, P NATL ACAD SCI USA, V89, P2489, DOI 10.1073/pnas.89.6.2489; Heissmeyer V, 2001, MOL CELL BIOL, V21, P1024, DOI 10.1128/MCB.21.4.1024-1035.2001; INOUE J, 1992, CELL, V68, P1109, DOI 10.1016/0092-8674(92)90082-N; Kaiser F, 2009, J EXP MED, V206, P1863, DOI 10.1084/jem.20091059; KANG SM, 1992, SCIENCE, V256, P1452, DOI 10.1126/science.1604322; KIERAN M, 1990, CELL, V62, P1007, DOI 10.1016/0092-8674(90)90275-J; Lang V, 2003, MOL CELL BIOL, V23, P402, DOI 10.1128/MCB.23.1.402-413.2003; LIOU HC, 1992, EMBO J, V11, P3003, DOI 10.1002/j.1460-2075.1992.tb05370.x; Maruyama S, 2003, J IMMUNOL, V170, P997, DOI 10.4049/jimmunol.170.2.997; Masumi A, 2002, FEBS LETT, V531, P348, DOI 10.1016/S0014-5793(02)03556-1; MURPHY TL, 1995, MOL CELL BIOL, V15, P5258; Porta C, 2009, P NATL ACAD SCI USA, V106, P14978, DOI 10.1073/pnas.0809784106; RICE NR, 1992, CELL, V71, P243, DOI 10.1016/0092-8674(92)90353-E; Salmeron A, 2001, J BIOL CHEM, V276, P22215, DOI 10.1074/jbc.M101754200; Sanjabi S, 2000, P NATL ACAD SCI USA, V97, P12705, DOI 10.1073/pnas.230436397; Tomczak MF, 2006, J IMMUNOL, V176, P1244, DOI 10.4049/jimmunol.176.2.1244; Tomczak MF, 2003, J IMMUNOL, V171, P1484, DOI 10.4049/jimmunol.171.3.1484; Tomczak MF, 2006, J IMMUNOL, V177, P7332, DOI 10.4049/jimmunol.177.10.7332; Wang Y, 2008, J IMMUNOL, V180, P8118, DOI 10.4049/jimmunol.180.12.8118; Waterfield MR, 2003, MOL CELL, V11, P685, DOI 10.1016/S1097-2765(03)00070-4; Yang HT, 2011, J IMMUNOL, V186, P1989, DOI 10.4049/jimmunol.1001003; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	36	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e32811	10.1371/journal.pone.0032811	http://dx.doi.org/10.1371/journal.pone.0032811			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427889	Green Submitted, Green Published, gold			2022-12-25	WOS:000302381500050
J	David, A; Das, SR; Gibbs, JS; Bennink, JR; Yewdell, JW				David, Alexandre; Das, Suman R.; Gibbs, James S.; Bennink, Jack R.; Yewdell, Jonathan W.			Cysteinyl-tRNA Deacylation Can Be Uncoupled from Protein Synthesis	PLOS ONE			English	Article							RIBONUCLEIC-ACID SYNTHETASE; IN-VIVO; CELLS; RECOGNITION; TRANSLATION; INHIBITION; ABSENCE	Aminoacyl-tRNA synthetases (ARSs) are critical components of protein translation, providing ribosomes with aminoacyl-tRNAs. In return, ribosomes release uncharged tRNAs as ARS substrates. Here, we show that tRNA deacylation can be uncoupled from protein synthesis in an amino acid specific manner. While tRNAs coupled to radiolabeled Met, Leu Lys, or Ser are stable in cells following translation inhibition with arsenite, radiolabeled Cys is released from tRNA at a high rate. We discuss possible translation independent functions for tRNA(Cys).	[David, Alexandre; Das, Suman R.; Gibbs, James S.; Bennink, Jack R.; Yewdell, Jonathan W.] NIAID, Viral Dis Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	David, A (corresponding author), NIAID, Viral Dis Lab, Bethesda, MD 20892 USA.	jyewdell@nih.gov	Das, Suman R/C-8760-2009; yewdell, jyewdell@nih.gov jonathan/A-1702-2012; David, Alexandre/B-2447-2013; David, Alexandre/AAL-2758-2021; Das, Suman/ABB-7273-2020	David, Alexandre/0000-0003-3365-1339; David, Alexandre/0000-0003-3365-1339; Das, Suman/0000-0003-2496-9724	Division of Intramural Research, National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000542, ZIAAI000653] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was generously supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASPEN AJ, 1978, BIOCHIM BIOPHYS ACTA, V518, P482, DOI 10.1016/0005-2787(78)90166-1; Chen LC, 1999, ANAL BIOCHEM, V269, P179, DOI 10.1006/abio.1999.4023; Chen WS, 1999, J EXP MED, V189, P1757, DOI 10.1084/jem.189.11.1757; David A, 2011, J BIOL CHEM; ELDRED EW, 1972, J BIOL CHEM, V247, P2961; Jones TE, 2011, P NATL ACAD SCI USA, V108, P6933, DOI 10.1073/pnas.1019033108; KAPPEN LS, 1973, P NATL ACAD SCI USA, V70, P22, DOI 10.1073/pnas.70.1.22; Kedersha N, 2002, BIOCHEM SOC T, V30, P963, DOI 10.1042/BST0300963; Lerner RS, 2006, RNA, V12, P775, DOI 10.1261/rna.2318906; Meadows L, 1997, IMMUNITY, V6, P273, DOI 10.1016/S1074-7613(00)80330-1; Netzer N, 2009, NATURE, V462, P522, DOI 10.1038/nature08576; Quevillon S, 1999, J MOL BIOL, V285, P183, DOI 10.1006/jmbi.1998.2316; Ruan BF, 2005, J BIOL CHEM, V280, P25887, DOI 10.1074/jbc.M502174200; Schimmel P, 2001, COLD SPRING HARB SYM, V66, P161, DOI 10.1101/sqb.2001.66.161; SCHREIER AA, 1972, BIOCHEMISTRY-US, V11, P1582, DOI 10.1021/bi00759a006; STAPULIONIS R, 1995, P NATL ACAD SCI USA, V92, P7158, DOI 10.1073/pnas.92.16.7158; Staschke KA, 2010, J BIOL CHEM, V285, P16893, DOI 10.1074/jbc.M110.121947; Stephens SB, 2008, MOL BIOL CELL, V19, P623, DOI 10.1091/mbc.E07-07-0677; Stephens SB, 2005, MOL BIOL CELL, V16, P5819, DOI 10.1091/mbc.E05-07-0685; VARSHNEY U, 1991, J BIOL CHEM, V266, P24712	20	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2012	7	3							e33072	10.1371/journal.pone.0033072	http://dx.doi.org/10.1371/journal.pone.0033072			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KX	22427952	Green Published, Green Submitted, gold			2022-12-25	WOS:000303062800042
J	Rodriguez-Lopez, MJ; Garzo, E; Bonani, JP; Fernandez-Munoz, R; Moriones, E; Fereres, A				Jose Rodriguez-Lopez, Maria; Garzo, Elisa; Patrick Bonani, Jean; Fernandez-Munoz, Rafael; Moriones, Enrique; Fereres, Alberto			Acylsucrose-Producing Tomato Plants Forces Bemisia tabaci to Shift Its Preferred Settling and Feeding Site	PLOS ONE			English	Article							WILD TOMATO; ARGENTIFOLII HOMOPTERA; GLANDULAR TRICHOMES; WHITEFLY HOMOPTERA; APHID RESISTANCE; SPIDER-MITE; BEHAVIOR; ALEYRODIDAE; PENETRATION; OVIPOSITION	Background: The whitefly Bemisia tabaci (Genn.) causes dramatic damage to plants by transmitting yield-limiting virus diseases. Previous studies proved that the tomato breeding line ABL 14-8 was resistant to B. tabaci, the vector of tomato yellow leaf curl disease (TYLCD). This resistance is based on the presence of type IV glandular trichomes and acylsucrose production. These trichomes deter settling and probing of B. tabaci in ABL 14-8, which reduces primary and secondary spread of TYLCD. Methodology/Principal Findings: Whitefly settlement preference was evaluated on the adaxial and abaxial leaf surfaces of nearly-isogenic tomato lines with and without B. tabaci-resistance traits, 'ABL 14-8 and Moneymaker' respectively, under non-choice and free-choice conditions. In addition, the Electrical Penetration Graph technique was used to study probing and feeding activities of B. tabaci on the adaxial and abaxial leaf surfaces of the same genotypes. B. tabaci preferred to settle on the abaxial than on the adaxial surface of 'Moneymaker' leaves, whereas no such preference was observed on ABL 14-8 tomato plants at the ten-leaf growth stage. Furthermore, B. tabaci preferred to feed on the abaxial than on the adaxial leaf surface of Moneymarker' susceptible tomato plants as shown by a higher number of sustained phloem feeding ingestion events and a shorter time to reach the phloem. However, B. tabaci standard probing and feeding behavior patterns were altered in ABL 14-8 plants and whiteflies were unable to feed from the phloem and spent more time in non-probing activities when exposed to the abaxial leaf surface. Conclusions/Significance: The distorted behavior of B. tabaci on ABL 14-8 protects tomato plants from the transmission of phloem-restricted viruses such as Tomato yellow leaf curl virus (TYLCV), and forces whiteflies to feed on the adaxial side of leaves where they feed less efficiently and become more vulnerable to natural enemies.	[Jose Rodriguez-Lopez, Maria; Fernandez-Munoz, Rafael; Moriones, Enrique] Consejo Super Invest Cient IHSM UMA CSIC, Inst Hortofruticultura Subtrop & Mediterranea La, Malaga, Spain; [Jose Rodriguez-Lopez, Maria; Garzo, Elisa; Patrick Bonani, Jean; Fereres, Alberto] CSIC, ICA, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Malaga; CSIC-UMA - Instituto de Hortofruticultura Subtropical y Mediterranea La Mayora (IHSM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias Agrarias (ICA)	Rodriguez-Lopez, MJ (corresponding author), Consejo Super Invest Cient IHSM UMA CSIC, Inst Hortofruticultura Subtrop & Mediterranea La, Malaga, Spain.	a.fereres@csic.es	Fereres, Alberto/G-6542-2012; Fernandez-Munoz, Rafael/F-3714-2010; Fereres, Alberto/GZG-4690-2022; Fereres, Alberto/F-8206-2013; Fereres, Alberto/F-2990-2011; MORIONES, ENRIQUE/Q-6090-2017; Garzo, Elisa/G-3047-2015	Fereres, Alberto/0000-0001-6012-3270; Fernandez-Munoz, Rafael/0000-0002-4054-8949; Fereres, Alberto/0000-0001-6012-3270; MORIONES, ENRIQUE/0000-0003-0295-7845; Garzo, Elisa/0000-0001-8626-5832	Ministerio de Ciencia e Innovacion, Spain [AGL2007-66760-C02-02/AGR, AGL2007-66399-CO3-02/AGR, AGL2010-22287-C02-01/AGR]; FEDER; Consejeria de Innovacion y Ciencia, Junta de Andalucia, Spain [AGR-214, AGR-129]; FEDER-FSE; Ministerio de Ciencia e Innovacion	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FEDER(European Commission); Consejeria de Innovacion y Ciencia, Junta de Andalucia, Spain(Junta de Andalucia); FEDER-FSE(European Social Fund (ESF)European Commission); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was partially financed by Ministerio de Ciencia e Innovacion projects AGL2007-66760-C02-02/AGR, AGL2007-66399-CO3-02/AGR, and AGL2010-22287-C02-01/AGR, Spain (co-financed by FEDER). This work was also partially supported by funding for research groups AGR-214 and AGR-129 from Consejeria de Innovacion y Ciencia, Junta de Andalucia, Spain (co-financed by FEDER-FSE). M. J. Rodriguez-Lopez was recipient of a Ph.D. fellowship and additional funding from the Ministerio de Ciencia e Innovacion, which supported a stay in the laboratory of A. Fereres. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba JM, 2006, THESIS U MALAGA; Backus EA, 2007, ANN ENTOMOL SOC AM, V100, P296, DOI 10.1603/0013-8746(2007)100[296:LHHMFO]2.0.CO;2; CALABRESE EJ, 1976, ANN ENTOMOL SOC AM, V69, P1145, DOI 10.1093/aesa/69.6.1145; Fereres A, 2011, RECENT ADVANCES IN PLANT VIROLOGY, P237; Fereres A, 2009, VIRUS RES, V141, P158, DOI 10.1016/j.virusres.2008.10.020; Fernandez-Munoz R, 2003, J AM SOC HORTIC SCI, V128, P188, DOI 10.21273/JASHS.128.2.0188; GIBSON RW, 1983, NATURE, V302, P608, DOI 10.1038/302608a0; GOFFREDA JC, 1988, ENTOMOL EXP APPL, V48, P101, DOI 10.1007/BF00185621; GOFFREDA JC, 1989, J CHEM ECOL, V15, P2135, DOI 10.1007/BF01207444; GOFFREDA JC, 1989, THEOR APPL GENET, V78, P210, DOI 10.1007/BF00288801; Guershon M, 2006, ENTOMOL EXP APPL, V121, P15, DOI 10.1111/j.1570-8703.2006.00455.x; Hartman JB, 1999, PLANT BREEDING, V118, P531, DOI 10.1046/j.1439-0523.1999.00435.x; HAWTHORNE DJ, 1992, ENTOMOL EXP APPL, V65, P65, DOI 10.1007/BF00189718; HEINZ KM, 1995, J ECON ENTOMOL, V88, P1494, DOI 10.1093/jee/88.5.1494; JANSSEN JAM, 1989, ENTOMOL EXP APPL, V52, P69, DOI 10.1007/BF00163943; Jiang YX, 1999, J ECON ENTOMOL, V92, P357, DOI 10.1093/jee/92.2.357; Jiang YX, 2000, ANN ENTOMOL SOC AM, V93, P573, DOI 10.1603/0013-8746(2000)093[0573:CBWHAF]2.0.CO;2; Johnson DD, 1999, ENTOMOL EXP APPL, V92, P257, DOI 10.1023/A:1003844802227; Kant MR, 2004, PLANT PHYSIOL, V135, P483, DOI 10.1104/pp.103.038315; Lei H, 1998, ENTOMOL EXP APPL, V88, P73, DOI 10.1023/A:1003215227403; Lei H, 1999, ENTOMOL EXP APPL, V92, P299, DOI 10.1023/A:1003806417443; LIEDL BE, 1995, J ECON ENTOMOL, V88, P742, DOI 10.1093/jee/88.3.742; Maluf WR, 2010, CROP SCI, V50, P439, DOI 10.2135/cropsci2009.01.0045; Alba JM, 2009, EXP APPL ACAROL, V47, P35, DOI 10.1007/s10493-008-9192-4; MCLEAN DL, 1964, NATURE, V202, P1358, DOI 10.1038/2021358a0; Oriani MAD, 2010, NEOTROP ENTOMOL, V39, P1002, DOI 10.1590/S1519-566X2010000600024; PRADO E, 1994, ENTOMOL EXP APPL, V72, P157, DOI 10.1007/BF02383550; RODRIGUEZ AE, 1993, J ECON ENTOMOL, V86, P34, DOI 10.1093/jee/86.1.34; Rodriguez-Lopez MJ, 2011, PHYTOPATHOLOGY, V101, P1191, DOI 10.1094/PHYTO-01-11-0028; Sarria E, 2009, COMPUT ELECTRON AGR, V67, P35, DOI 10.1016/j.compag.2009.02.006; Sarria E, 2010, PLANT BIOLOGY, V12, P503, DOI 10.1111/j.1438-8677.2009.00239.x; Simmons AM, 2002, ANN ENTOMOL SOC AM, V95, P464, DOI 10.1603/0013-8746(2002)095[0464:SOCOBT]2.0.CO;2; Tjallingii W.F., 1990, P89; Tjallingii W.F., 1988, P95; TJALLINGII WF, 1978, ENTOMOL EXP APPL, V24, P721, DOI 10.1007/BF02385128; TJALLINGII WF, 1995, PROCEEDINGS OF THE SECTION EXPERIMENTAL AND APPLIED ENTOMOLOGY OF THE NETHERLANDS ENTOMOLOGICAL SOCIETY (N.E.V.), VOL 6, 1995, P163; TJALLINGII WF, 1985, ENTOMOL EXP APPL, V38, P187, DOI 10.1007/BF00361931; Wagner GJ, 2004, ANN BOT-LONDON, V93, P3, DOI 10.1093/aob/mch011; Walker G.P., 2000, P14; WALKER GP, 1988, ANN ENTOMOL SOC AM, V81, P365, DOI 10.1093/aesa/81.2.365; Walling LL, 2009, ADV BOT RES, V51, P551, DOI 10.1016/S0065-2296(09)51013-0	41	37	37	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2012	7	3							e33064	10.1371/journal.pone.0033064	http://dx.doi.org/10.1371/journal.pone.0033064			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KX	22427950	gold, Green Published, Green Submitted			2022-12-25	WOS:000303062800041
J	Lauber, B; Leukel, C; Gollhofer, A; Taube, W				Lauber, Benedikt; Leukel, Christian; Gollhofer, Albert; Taube, Wolfgang			Time to Task Failure and Motor Cortical Activity Depend on the Type of Feedback in Visuomotor Tasks	PLOS ONE			English	Article							VISUAL FEEDBACK; CORTEX; MONKEY; INFORMATION; ACQUISITION; ACTIVATION; MOVEMENTS; HUMANS; MUSCLE; CELLS	The present study aimed to elucidate whether the type of feedback influences the performance and the motor cortical activity when executing identical visuomotor tasks. For this purpose, time to task failure was measured during position-and force-controlled muscular contractions. Subjects received either visual feedback about the force produced by pressing a force transducer or about the actual position between thumb and index finger. Participants were instructed to either match the force level of 30% MVC or the finger position corresponding to the thumb and index finger angle at this contraction intensity. Subjects demonstrated a shorter time to task failure when they were provided with feedback about their joint position (11.5 +/- 6.2 min) instead of force feedback (19.2 +/- 12.8 min; P = 0.01). To test differences in motor cortical activity between position-and force-controlled contractions, subthreshold transcranial magnetic stimulation (subTMS) was applied while executing submaximal (20% MVC) contractions. SubTMS resulted in a suppression of the first dorsal interosseus muscle (FDI) EMG in both tasks. However, the mean suppression for the position-controlled task was significantly greater (18.6 +/- 9.4% vs. 13.3 +/- 7.5%; P = 0.025) and lasted longer (13.9 +/- 7.5 ms vs. 9.3 +/- 4.3 ms; P = 0.024) compared to the force-controlled task. The FDI background EMG obtained without stimulation was comparable in all conditions. The present results demonstrate that the presentation of different feedback modalities influences the time to task failure as well as the cortical activity. As only the feedback was altered but not the mechanics of the task, the present results add to the body of evidence that suggests that the central nervous system processes force and position information in different ways.	[Lauber, Benedikt; Leukel, Christian; Gollhofer, Albert] Univ Freiburg, Dept Sport Sci, D-79106 Freiburg, Germany; [Leukel, Christian; Taube, Wolfgang] Univ Fribourg, Dept Med Movement & Sports Sci, CH-1700 Fribourg, Switzerland	University of Freiburg; University of Fribourg	Lauber, B (corresponding author), Univ Freiburg, Dept Sport Sci, Hugstetter Str 55, D-79106 Freiburg, Germany.	Benedict.lauber@sport.uni-freiburg.de	Albert, Gollhofer/V-3291-2019; Gollhofer, Albert/ABF-5766-2020; Taube, Wolfgang/E-4018-2012	Taube, Wolfgang/0000-0002-8802-2065	Bundesinstitut fur Sportwissenschaft [FKZ: IIA1-070611/09]; Landesgraduiertenforderung Baden-Wurttemberg	Bundesinstitut fur Sportwissenschaft; Landesgraduiertenforderung Baden-Wurttemberg	This study was supported by the Bundesinstitut fur Sportwissenschaft (FKZ: IIA1-070611/09) and the Landesgraduiertenforderung Baden-Wurttemberg (Christian Leukel). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonnard M, 2007, EUR J NEUROSCI, V25, P872, DOI 10.1111/j.1460-9568.2007.05320.x; CHENEY PD, 1984, J PHYSIOL-LONDON, V349, P249, DOI 10.1113/jphysiol.1984.sp015155; DAVEY NJ, 1994, J PHYSIOL-LONDON, V477, P223, DOI 10.1113/jphysiol.1994.sp020186; Debaere F, 2003, NEUROIMAGE, V19, P764, DOI 10.1016/S1053-8119(03)00148-4; Di Lazzaro V, 1998, EXP BRAIN RES, V119, P265; Enoka RM, 2011, J ELECTROMYOGR KINES, V21, P208, DOI 10.1016/j.jelekin.2010.10.006; EVARTS EV, 1976, J NEUROPHYSIOL, V39, P1069, DOI 10.1152/jn.1976.39.5.1069; Hinder MR, 2008, BRAIN RES, V1197, P123, DOI 10.1016/j.brainres.2007.12.067; Hinder MR, 2010, EXP BRAIN RES, V201, P191, DOI 10.1007/s00221-009-2025-9; Hopper DM, 2003, PHYS THER SPORT, V4, P182, DOI 10.1016/S1466-853X(03)00068-3; Hunter SK, 2004, EXERC SPORT SCI REV, V32, P44, DOI 10.1097/00003677-200404000-00002; Hunter SK, 2002, J NEUROPHYSIOL, V88, P3087, DOI 10.1152/jn.00232.2002; JONES EG, 1975, J COMP NEUROL, V160, P205, DOI 10.1002/cne.901600204; Klass M, 2009, J NEUROPHYSIOL, P1096; LEE TD, 1995, J MOTOR BEHAV, V27, P263, DOI 10.1080/00222895.1995.9941716; Maluf KS, 2005, EXP BRAIN RES, V167, P165, DOI 10.1007/s00221-005-0017-y; Milner TE, 2006, J NEUROPHYSIOL, V96, P526, DOI 10.1152/jn.00022.2006; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pearce AJ, 2009, J SCI MED SPORT, V12, P280, DOI 10.1016/j.jsams.2007.12.005; Petersen NC, 2001, SUPPRESSION EMG ACTI, P651; Petersen NC, 2011, RESP PHYSIOL NEUROBI, V175, P265, DOI 10.1016/j.resp.2010.11.014; Porter R, 1993, CORTICOSPINAL FUNCTI; Puttemans V, 2005, J NEUROSCI, V25, P4270, DOI 10.1523/JNEUROSCI.3866-04.2005; Rudroff T, 2010, EXP BRAIN RES, V203, P307, DOI 10.1007/s00221-010-2233-3; Rudroff T, 2010, EXP BRAIN RES, V202, P111, DOI 10.1007/s00221-009-2116-7; Scott SH, 2003, CURR OPIN NEUROBIOL, V13, P671, DOI 10.1016/j.conb.2003.10.012; Seifert T, 2010, ACTA PHYSIOL, V199, P317, DOI 10.1111/j.1748-1716.2010.02098.x; SOLOMONOW M, 1988, EXP NEUROL, V100, P470, DOI 10.1016/0014-4886(88)90032-5; Staudenmann D, 2009, PRONATION SUPINATION, P231; Swinnen SP, 2002, NAT REV NEUROSCI, V3, P350, DOI 10.1038/nrn807; SWINNEN SP, 1993, J EXP PSYCHOL LEARN, V19, P1328, DOI 10.1037/0278-7393.19.6.1328; WINSTEIN CJ, 1991, PHYS THER, V71, P140, DOI 10.1093/ptj/71.2.140; WOOD CA, 1992, J HUM MOVEMENT STUD, V22, P213; Zuur AT, 2010, CONTRIBUTION AFFEREN	34	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2012	7	3							e32433	10.1371/journal.pone.0032433	http://dx.doi.org/10.1371/journal.pone.0032433			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KX	22427836	gold, Green Published, Green Submitted			2022-12-25	WOS:000303062800019
J	Lou, E; Fujisawa, S; Morozov, A; Barlas, A; Romin, Y; Dogan, Y; Gholami, S; Moreira, AL; Manova-Todorova, K; Moore, MAS				Lou, Emil; Fujisawa, Sho; Morozov, Alexei; Barlas, Afsar; Romin, Yevgeniy; Dogan, Yildirim; Gholami, Sepideh; Moreira, Andre L.; Manova-Todorova, Katia; Moore, Malcolm A. S.			Tunneling Nanotubes Provide a Unique Conduit for Intercellular Transfer of Cellular Contents in Human Malignant Pleural Mesothelioma	PLOS ONE			English	Article							MEMBRANE NANOTUBES; FASCIN IMMUNOREACTIVITY; ORGANELLE TRANSFER; PROTEOMIC ANALYSIS; PROSTATE-CANCER; TUMOR-CELLS; COMMUNICATION; METASTASIS; MECHANISM; INVASION	Tunneling nanotubes are long, non-adherent F-actin-based cytoplasmic extensions which connect proximal or distant cells and facilitate intercellular transfer. The identification of nanotubes has been limited to cell lines, and their role in cancer remains unclear. We detected tunneling nanotubes in mesothelioma cell lines and primary human mesothelioma cells. Using a low serum, hyperglycemic, acidic growth medium, we stimulated nanotube formation and bidirectional transfer of vesicles, proteins, and mitochondria between cells. Notably, nanotubes developed between malignant cells or between normal mesothelial cells, but not between malignant and normal cells. Immunofluorescent staining revealed their actin-based assembly and structure. Metformin and an mTor inhibitor, Everolimus, effectively suppressed nanotube formation. Confocal microscopy with 3-dimensional reconstructions of sectioned surgical specimens demonstrated for the first time the presence of nanotubes in human mesothelioma and lung adenocarcinoma tumor specimens. We provide the first evidence of tunneling nanotubes in human primary tumors and cancer cells and propose that these structures play an important role in cancer cell pathogenesis and invasion.	[Lou, Emil; Morozov, Alexei] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Lou, Emil; Morozov, Alexei; Dogan, Yildirim; Moore, Malcolm A. S.] Mem Sloan Kettering Canc Ctr, Moore Lab, Dept Cell Biol, Sloan Kettering Inst, New York, NY 10021 USA; [Gholami, Sepideh] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Moreira, Andre L.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Lou, E (corresponding author), Univ Minnesota, Div Hematol Oncol & Transplantat, Minneapolis, MN USA.	emil-lou@umn.edu		Lou, Emil/0000-0002-1607-1386	Baker Street Foundation, San Francisco, California; Baker Street Foundation	Baker Street Foundation, San Francisco, California; Baker Street Foundation	Financial support was provided by the Baker Street Foundation, San Francisco, California. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors gratefully acknowledge the Baker Street Foundation for its generous funding and support of this project. We wish to thank Zsolt Lazar, Ph.D., Tao Tong, Sanghoon Oh, Ph.D. and Jiang-Cheng Wang, Ph.D. of the Molecular Cytology Core Facility at the Memorial Sloan-Kettering Cancer Center (MSKCC) for their helpful suggestions, expertise, and assistance with time-lapse imaging and immunofluorescence; Mesruh Turkekul and Ning Fan for assistance with immunofluorescent staining; Nina Lampen for preparation of cells for electron microscopy evaluation; Alan Hall, Ph.D for helpful discussion; Yuman Fong, M. D. for providing mesothelioma cell lines; Valerie Rusch, M. D., Robert J. Downey, M. D., and David Finley, M. D. of the Thoracic Surgery Service at MSKCC, for providing primary pleural effusion specimens; Prasad Adusumilli, M. D. for providing an additional MSTO-211H GFP-transduced cell line; and Ms. Katherine DeBeer for administrative assistance and support.	Adams JC, 2004, TRENDS CARDIOVAS MED, V14, P221, DOI 10.1016/j.tcm.2004.06.002; Adams JC, 2004, CURR OPIN CELL BIOL, V16, P590, DOI 10.1016/j.ceb.2004.07.009; ALGRAIN M, 1993, J CELL BIOL, V120, P129, DOI 10.1083/jcb.120.1.129; Ambudkar SV, 2005, TRENDS PHARMACOL SCI, V26, P385, DOI 10.1016/j.tips.2005.06.001; ANDREOLI C, 1994, J CELL SCI, V107, P2509; Aratyn YS, 2007, MOL BIOL CELL, V18, P3928, DOI 10.1091/mbc.E07-04-0346; Arkwright PD, 2010, CELL RES, V20, P72, DOI 10.1038/cr.2009.112; Bard MP, 2004, AM J RESP CELL MOL, V31, P114, DOI 10.1165/rcmb.2003-0238OC; Beckner ME, 2005, LAB INVEST, V85, P1457, DOI 10.1038/labinvest.3700355; Beltramo E, 2006, EXP EYE RES, V83, P989, DOI 10.1016/j.exer.2006.05.008; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Bukoreshtliev NV, 2009, FEBS LETT, V583, P1481, DOI 10.1016/j.febslet.2009.03.065; Castro MAA, 2005, CELL BIOL INT, V29, P929, DOI 10.1016/j.cellbi.2005.05.013; Chen L, 2010, NATURE, V464, P1062, DOI 10.1038/nature08978; Chinnery HR, 2008, J IMMUNOL, V180, P5779, DOI 10.4049/jimmunol.180.9.5779; Darnel AD, 2009, CLIN CANCER RES, V15, P1376, DOI 10.1158/1078-0432.CCR-08-1789; Davis DM, 2008, NAT REV MOL CELL BIO, V9, P431, DOI 10.1038/nrm2399; Davis DM, 2009, NAT REV IMMUNOL, V9, P543, DOI 10.1038/nri2602; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; Domhan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021283; Dubey GP, 2011, CELL, V144, P590, DOI 10.1016/j.cell.2011.01.015; Eugenin EA, 2009, CELL IMMUNOL, V254, P142, DOI 10.1016/j.cellimm.2008.08.005; Faoro L, 2010, J BIOL CHEM, V285, P18575, DOI 10.1074/jbc.M109.075085; Galkina SI, 2010, CELL ADHES MIGR, V4, P32, DOI 10.4161/cam.4.1.10314; Gerdes HH, 2009, NAT CELL BIOL, V11, P235, DOI 10.1038/ncb0309-235; Gousset K, 2009, NAT CELL BIOL, V11, P328, DOI 10.1038/ncb1841; Gurke S, 2008, EXP CELL RES, V314, P3669, DOI 10.1016/j.yexcr.2008.08.022; Hase K, 2009, NAT CELL BIOL, V11, P1427, DOI 10.1038/ncb1990; He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802; Hegmans JPJJ, 2004, AM J PATHOL, V164, P1807, DOI 10.1016/S0002-9440(10)63739-X; Jung S, 2011, EXP CELL RES; Kim EK, 2011, ONCOGENE; Koyanagi M, 2005, CIRC RES, V96, P1039, DOI 10.1161/01.RES.0000168650.23479.0c; MartinezZaguilan R, 1996, CLIN EXP METASTAS, V14, P176, DOI 10.1007/BF00121214; Minn AJ, 2007, P NATL ACAD SCI USA, V104, P6740, DOI 10.1073/pnas.0701138104; Nagorny P, 2010, TETRAHEDRON LETT, V51, P3873, DOI 10.1016/j.tetlet.2010.05.056; Onfelt B, 2006, J IMMUNOL, V177, P8476, DOI 10.4049/jimmunol.177.12.8476; Pelosi G, 2003, LUNG CANCER-J IASLC, V42, P203, DOI 10.1016/S0169-5002(03)00294-0; Pelosi G, 2003, BRIT J CANCER, V88, P537, DOI 10.1038/sj.bjc.6600731; Plotnikov EY, 2010, EXP CELL RES, V316, P2447, DOI 10.1016/j.yexcr.2010.06.009; Polette M, 2007, CELLS TISSUES ORGANS, V185, P61, DOI 10.1159/000101304; Pontes B, 2008, EUR BIOPHYS J BIOPHY, V37, P121, DOI 10.1007/s00249-007-0184-9; Ratajczak J, 2006, LEUKEMIA, V20, P1487, DOI 10.1038/sj.leu.2404296; REDDEL RR, 1989, J NATL CANCER I, V81, P945, DOI 10.1093/jnci/81.12.945; Rudnicka D, 2009, NAT IMMUNOL, V10, P933, DOI 10.1038/ni0909-933; Rudnicka D, 2009, J VIROL, V83, P6234, DOI 10.1128/JVI.00282-09; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Rutka JT, 2008, NEOPLASIA, V10, P149, DOI 10.1593/neo.07909; Salter RD, 2006, IMMUNOL RES, V36, P211, DOI 10.1385/IR:36:1:211; Sherer NM, 2008, TRENDS CELL BIOL, V18, P414, DOI 10.1016/j.tcb.2008.07.003; Shukla A, 2009, AM J PATHOL, V175, P2197, DOI 10.2353/ajpath.2009.090400; Sowinski S, 2008, NAT CELL BIOL, V10, P211, DOI 10.1038/ncb1682; Sowinski S, 2011, METHODS, V53, P27, DOI 10.1016/j.ymeth.2010.04.002; Spees JL, 2006, P NATL ACAD SCI USA, V103, P1283, DOI 10.1073/pnas.0510511103; Stern R, 2002, EXP CELL RES, V276, P24, DOI 10.1006/excr.2002.5508; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; TSUKITA S, 1994, J CELL BIOL, V126, P391, DOI 10.1083/jcb.126.2.391; Veranic P, 2008, BIOPHYS J, V95, P4416, DOI 10.1529/biophysj.108.131375; Vidulescu C, 2004, J CELL MOL MED, V8, P388, DOI 10.1111/j.1582-4934.2004.tb00328.x; Vignjevic D, 2003, J CELL BIOL, V160, P951, DOI 10.1083/jcb.200208059; Vignjevic D, 2006, J CELL BIOL, V174, P863, DOI 10.1083/jcb.200603013; Wang Y, 2011, CELL DEATH DIFFER, V18, P732, DOI 10.1038/cdd.2010.147; Watkins SC, 2005, IMMUNITY, V23, P309, DOI 10.1016/j.immuni.2005.08.009; Xu WF, 2009, NAT IMMUNOL, V10, P1008, DOI 10.1038/ni.1753; Yasuda K, 2010, AM J PATHOL, V176, P1685, DOI 10.2353/ajpath.2010.091071; Zani BG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008930; Zu YL, 2002, ULTRASTRUCT PATHOL, V26, P403, DOI 10.1080/01913120290104719	67	252	256	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2012	7	3							e33093	10.1371/journal.pone.0033093	http://dx.doi.org/10.1371/journal.pone.0033093			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KX	22427958	Green Published, gold, Green Submitted			2022-12-25	WOS:000303062800044
J	Nuebel, U; Nitsche, A; Layer, F; Strommenger, B; Witte, W				Nuebel, Ulrich; Nitsche, Andreas; Layer, Franziska; Strommenger, Birgit; Witte, Wolfgang			Single-Nucleotide Polymorphism Genotyping Identifies a Locally Endemic Clone of Methicillin-Resistant Staphylococcus aureus	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; REAL-TIME PCR; UNITED-STATES; SPREAD; MRSA; EMERGENCE	We developed, tested, and applied a TaqMan real-time PCR assay for interrogation of three single-nucleotide polymorphisms that differentiate a clade (termed 't003-X') within the radiation of methicillin-resistant Staphylococcus aureus (MRSA) ST225. The TaqMan assay achieved 98% typeability and results were fully concordant with DNA sequencing. By applying this assay to 305 ST225 isolates from an international collection, we demonstrate that clade t003-X is endemic in a single acute-care hospital in Germany at least since 2006, where it has caused a substantial proportion of infections. The strain was also detected in another hospital located 16 kilometers away. Strikingly, however, clade t003-X was not found in 62 other hospitals throughout Germany nor among isolates from other countries, and, hence, displayed a very restricted geographical distribution. Consequently, our results show that SNP-typing may be useful to identify and track MRSA clones that are specific to individual healthcare institutions. In contrast, the spatial dissemination pattern observed here had not been resolved by other typing procedures, including multilocus sequence typing (MLST), spa typing, DNA macrorestriction, and multilocus variable-number tandem repeat analysis (MLVA).	[Nuebel, Ulrich; Layer, Franziska; Strommenger, Birgit; Witte, Wolfgang] Robert Koch Inst, Fachgebiet Nosokomiale Infektionen, Wernigerode, Germany; [Nitsche, Andreas] Robert Koch Inst, Zentrum Biol Sicherheit, Berlin, Germany	Robert Koch Institute; Robert Koch Institute	Nuebel, U (corresponding author), Robert Koch Inst, Fachgebiet Nosokomiale Infektionen, Wernigerode, Germany.	nuebelu@rki.de		Layer, Franziska/0000-0002-4613-6478; Nitsche, Andreas/0000-0001-8185-3176				[Anonymous], 2010, ANTIMICROBIAL RESIST; Cookson B, 2011, INT J ANTIMICROB AG, V37, P195, DOI 10.1016/j.ijantimicag.2010.10.023; de Kraker MEA, 2011, ANTIMICROB AGENTS CH, V55, P1598, DOI 10.1128/AAC.01157-10; Dennesen PJW, 1998, ANN MED, V30, P176, DOI 10.3109/07853899808999401; Dulon M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-138; Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599; Grundmann H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000215; Gunson RN, 2008, J CLIN VIROL, V43, P372, DOI 10.1016/j.jcv.2008.08.020; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Holt KE, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-144; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Kock R, 2010, EUROSURVEILLANCE, V15, P12, DOI 10.2807/ese.15.41.19688-en; Koreen L, 2004, J CLIN MICROBIOL, V42, P792, DOI 10.1128/JCM.42.2.792-799.2004; Kutyavin IV, 2000, NUCLEIC ACIDS RES, V28, P655, DOI 10.1093/nar/28.2.655; Lucet JC, 2010, CLIN INFECT DIS, V51, P585, DOI 10.1086/655695; Marshall C, 2004, J HOSP INFECT, V56, P253, DOI 10.1016/j.jhin.2004.02.001; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Morelli G, 2010, NAT GENET, V42, P1140, DOI 10.1038/ng.705; Murchan S, 2003, J CLIN MICROBIOL, V41, P1574, DOI 10.1128/JCM.41.4.1574-1585.2003; Neuzil P, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl416; Nubel U, 2008, P NATL ACAD SCI USA, V105, P14130, DOI 10.1073/pnas.0804178105; Nubel U, 2011, INT J MED MICROBIOL, V301, P614, DOI 10.1016/j.ijmm.2011.09.007; Nubel U, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000855; Okinaka RT, 2008, EMERG INFECT DIS, V14, P653, DOI 10.3201/eid1404.070984; Rubinovitch B, 2001, J HOSP INFECT, V47, P9, DOI 10.1053/jhin.2000.0873; Schouls LM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005082; Strommenger B, 2008, J CLIN MICROBIOL, V46, P574, DOI 10.1128/JCM.01599-07; THOMPSON RL, 1982, ANN INTERN MED, V97, P309, DOI 10.7326/0003-4819-97-3-309; Willems RJ, 2011, FEMS MICROBIOL REV; Witte W, 2008, INT J MED MICROBIOL, V298, P365, DOI 10.1016/j.ijmm.2007.10.005	31	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2012	7	3							e32698	10.1371/journal.pone.0032698	http://dx.doi.org/10.1371/journal.pone.0032698			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KX	22427866	gold, Green Submitted, Green Published			2022-12-25	WOS:000303062800027
J	Trombetta, M; Bonetti, S; Boselli, M; Turrini, F; Malerba, G; Trabetti, E; Pignatti, P; Bonora, E; Bonadonna, RC				Trombetta, Maddalena; Bonetti, Sara; Boselli, MariaLinda; Turrini, Fabiola; Malerba, Giovanni; Trabetti, Elisabetta; Pignatti, PierFranco; Bonora, Enzo; Bonadonna, Riccardo C.			CACNA1E Variants Affect Beta Cell Function in Patients with Newly Diagnosed Type 2 Diabetes. The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 3	PLOS ONE			English	Article							CA(V)2.3 ALPHA-1E SUBUNIT; INSULIN-SECRETION; GLUCOSE-TOLERANCE; CA2+ CHANNELS; SENSITIVITY; MODEL; HYPERGLYCEMIA; RELEASE	Background: Genetic variability of the major subunit (CACNA1E) of the voltage-dependent Ca2+ channel Ca(V)2.3 is associated to risk of type 2 diabetes, insulin resistance and impaired insulin secretion in nondiabetic subjects. The aim of the study was to test whether CACNA1E common variability affects beta cell function and/or insulin sensitivity in patients with newly diagnosed type 2 diabetes. Methodology/Principal Findings: In 595 GAD-negative, drug naive patients (mean +/- SD; age: 58.5 +/- 10.2 yrs; BMI: 29.9 +/- 5 kg/m(2), HbA1c: 7.0 +/- 1.3) with newly diagnosed type 2 diabetes we: 1. genotyped 10 tag SNPs in CACNA1E region reportedly covering similar to 93% of CACNA1E common variability: rs558994, rs679931, rs2184945, rs10797728, rs3905011, rs12071300, rs175338, rs3753737, rs2253388 and rs4652679; 2. assessed clinical phenotypes, insulin sensitivity by the euglycemic insulin clamp and beta cell function by state-of-art modelling of glucose/C-peptide curves during OGTT. Five CACNA1E tag SNPs (rs10797728, rs175338, rs2184945, rs3905011 and rs4652679) were associated with specific aspects of beta cell function (p<0.05-0.01). Both major alleles of rs2184945 and rs3905011 were each (p<0.01 and p<0.005, respectively) associated to reduced proportional control with a demonstrable additive effect (p<0.005). In contrast, only the major allele of rs2253388 was related weakly to more severe insulin resistance (p<0.05). Conclusions/Significance: In patients with newly diagnosed type 2 diabetes CACNA1E common variability is strongly associated to beta cell function. Genotyping CACNA1E might be of help to infer the beta cell functional phenotype and to select a personalized treatment.	[Trombetta, Maddalena; Bonetti, Sara; Boselli, MariaLinda; Turrini, Fabiola; Bonora, Enzo; Bonadonna, Riccardo C.] Univ Verona, Dept Med, I-37100 Verona, Italy; [Trombetta, Maddalena; Bonora, Enzo; Bonadonna, Riccardo C.] Azienda Osped Univ Integrata Verona, Verona, Italy; [Malerba, Giovanni; Trabetti, Elisabetta; Pignatti, PierFranco] Univ Verona, Dept Life & Reprod Sci, I-37100 Verona, Italy	University of Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona	Trombetta, M (corresponding author), Univ Verona, Dept Med, I-37100 Verona, Italy.	sara.bonetti@univr.it; riccardo.bonadonna@univr.it	Malerba, Giovanni/T-3278-2019; Trombetta, Maddalena/AAA-9257-2022; Bonora, Enzo/AAA-5300-2022; pignatti, pier/B-4736-2012	Trombetta, Maddalena/0000-0002-0825-1117; Bonadonna, Riccardo/0000-0002-9809-1005; Malerba, Giovanni/0000-0001-8705-8560; BONORA, Enzo/0000-0003-1074-5164	European Foundation for the Study of Diabetes/Novartis; University of Verona	European Foundation for the Study of Diabetes/Novartis; University of Verona	This study was supported in part by a research grant of the European Foundation for the Study of Diabetes/Novartis Programme (to RCB), and in part by research grants of University of Verona (to RCB and EB). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonadonna RC, 2010, J CLIN ENDOCR METAB, V95, P5028, DOI 10.1210/jc.2010-1041; Bonetti S, 2011, J CLIN ENDOCR METAB, V96, pE389, DOI 10.1210/jc.2010-1677; Bonetti S, 2011, DIABETES CARE; Bonora E, 2004, DIABETIC MED, V21, P52, DOI 10.1046/j.1464-5491.2003.01068.x; Cali AMG, 2008, J CLIN ENDOCR METAB, V93, P1767, DOI 10.1210/jc.2007-1722; Cobelli C, 2007, AM J PHYSIOL-ENDOC M, V293, pE1, DOI 10.1152/ajpendo.00421.2006; Cretti A, 2001, EUR J CLIN INVEST, V31, P405, DOI 10.1046/j.1365-2362.2001.00827.x; Davidovich O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-36; Hanson RL, 2000, AM J EPIDEMIOL, V151, P190; Holmkvist J, 2007, DIABETOLOGIA, V50, P2467, DOI 10.1007/s00125-007-0846-2; Jing XJ, 2005, J CLIN INVEST, V115, P146, DOI 10.1172/JCI200522518; Lin Charles H., 2009, V496, P129, DOI 10.1007/978-1-59745-553-4_10; Mari A, 2001, DIABETES, V50, pS164, DOI 10.2337/diabetes.50.2007.S164; Matsuda Y, 2001, BIOCHEM BIOPH RES CO, V289, P791, DOI 10.1006/bbrc.2001.6051; Muller YL, 2007, DIABETES, V56, P3089, DOI 10.2337/db07-0587; Pereverzev A, 2002, MOL ENDOCRINOL, V16, P884, DOI 10.1210/me.16.4.884; Pereverzev A, 2002, EUR J ENDOCRINOL, V146, P881, DOI 10.1530/eje.0.1460881; Saccomani MP, 1996, AM J PHYSIOL-ENDOC M, V270, pE170, DOI 10.1152/ajpendo.1996.270.1.E170; Targher G, 2001, DIABETES CARE, V24, P1961, DOI 10.2337/diacare.24.11.1961; Weiss R, 2005, DIABETES, V54, P1735, DOI 10.2337/diabetes.54.6.1735; WILLIAMS ME, 1994, J BIOL CHEM, V269, P22347; Yang SN, 2005, J CLIN INVEST, V115, P16, DOI 10.1172/JCI200523970	22	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2012	7	3							e32755	10.1371/journal.pone.0032755	http://dx.doi.org/10.1371/journal.pone.0032755			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KX	22427875	gold, Green Published, Green Submitted			2022-12-25	WOS:000303062800030
J	Ho, PWL; Ho, JWM; Tse, HM; So, DHF; Yiu, DCW; Liu, HF; Chan, KH; Kung, MHW; Ramsden, DB; Ho, SL				Ho, Philip Wing-Lok; Ho, Jessica Wing-Man; Tse, Ho-Man; So, Danny Hon-Fai; Yiu, David Chi-Wai; Liu, Hui-Fang; Chan, Koon-Ho; Kung, Michelle Hiu-Wai; Ramsden, David Boyer; Ho, Shu-Leong			Uncoupling Protein-4 (UCP4) Increases ATP Supply by Interacting with Mitochondrial Complex II in Neuroblastoma Cells	PLOS ONE			English	Article							ELECTRON-TRANSPORT CHAIN; OXIDATIVE STRESS; NEURONS; OXYGEN; DEFICIENCY; MPP+; PHOSPHORYLATION; DYSFUNCTION; DEPOLARIZATION; ASSOCIATION	Mitochondrial uncoupling protein-4 (UCP4) protects against Complex I deficiency as induced by 1-methyl-4-phenylpyridinium (MPP+), but how UCP4 affects mitochondrial function is unclear. Here we investigated how UCP4 affects mitochondrial bioenergetics in SH-SY5Y cells. Cells stably overexpressing UCP4 exhibited higher oxygen consumption (10.1%, p<0.01), with 20% greater proton leak than vector controls (p<0.01). Increased ATP supply was observed in UCP4-overexpressing cells compared to controls (p<0.05). Although state 4 and state 3 respiration rates of UCP4-overexpressing and control cells were similar, Complex II activity in UCP4-overexpressing cells was 30% higher (p<0.05), associated with protein binding between UCP4 and Complex II, but not that of either Complex I or IV. Mitochondrial ADP consumption by succinate-induced respiration was 26% higher in UCP4-overexpressing cells, with 20% higher ADP:O ratio (p<0.05). ADP/ATP exchange rate was not altered by UCP4 overexpression, as shown by unchanged mitochondrial ADP uptake activity. UCP4 overexpression retained normal mitochondrial morphology in situ, with similar mitochondrial membrane potential compared to controls. Our findings elucidate how UCP4 overexpression increases ATP synthesis by specifically interacting with Complex II. This highlights a unique role of UCP4 as a potential regulatory target to modulate mitochondrial Complex II and ATP output in preserving existing neurons against energy crisis.	[Ho, Philip Wing-Lok; Ho, Jessica Wing-Man; Tse, Ho-Man; So, Danny Hon-Fai; Yiu, David Chi-Wai; Liu, Hui-Fang; Chan, Koon-Ho; Kung, Michelle Hiu-Wai; Ho, Shu-Leong] Univ Hong Kong, Univ Dept Med, Div Neurol, Hong Kong, Hong Kong, Peoples R China; [Ramsden, David Boyer] Univ Birmingham, Sch Med, Birmingham, W Midlands, England; [Ramsden, David Boyer] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Ho, Philip Wing-Lok; Ho, Jessica Wing-Man; Chan, Koon-Ho; Ho, Shu-Leong] Univ Hong Kong, Res Ctr Heart Brain Hormone & Hlth Aging HBHA, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Birmingham; University of Birmingham; University of Hong Kong	Ho, PWL (corresponding author), Univ Hong Kong, Univ Dept Med, Div Neurol, Hong Kong, Hong Kong, Peoples R China.	hwl2002@hku.hk	Ho, Philip Wing-Lok/K-5814-2013; Ho, Shu-Leong/AFK-8146-2022; /C-4136-2009	Ho, Philip Wing-Lok/0000-0001-7794-0146; /0000-0001-6783-5668	Henry G Leong Professorship in Neurology; Donation Fund for Neurology Research; University of Hong Kong (CRCG, HKU) [200901159008]; University of Hong Kong	Henry G Leong Professorship in Neurology; Donation Fund for Neurology Research; University of Hong Kong (CRCG, HKU); University of Hong Kong(University of Hong Kong)	This project is financially supported by the Henry G Leong Professorship in Neurology (SLH); the Donation Fund for Neurology Research (SLH); Seed Funding for Basic Research, University of Hong Kong (CRCG, HKU 200901159008; PWL Ho). PWL Ho is supported by a Research Assistant Professorship, JWM Ho and HF Liu are supported by a postdoctoral fellowship from the University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam-Vizi V, 2005, ANTIOXID REDOX SIGN, V7, P1140, DOI 10.1089/ars.2005.7.1140; Adams SH, 2000, J NUTR, V130, P711, DOI 10.1093/jn/130.4.711; Andrews ZB, 2005, NAT REV NEUROSCI, V6, P829, DOI 10.1038/nrn1767; Andrews ZB, 2005, J NEUROSCI, V25, P184, DOI 10.1523/JNEUROSCI.4269-04.2005; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Barrientos Antoni, 2009, Curr Protoc Hum Genet, VChapter 19, DOI 10.1002/0471142905.hg1903s63; Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4; Brand MD, 2010, DIABETES OBES METAB, V12, P134, DOI 10.1111/j.1463-1326.2010.01264.x; Brand MD, 2005, BIOCHEM J, V392, P353, DOI 10.1042/BJ20050890; Brand MD, 2004, BIOCHEM SOC SYMP, V71, P203; Brand MD, 2005, CELL METAB, V2, P85, DOI 10.1016/j.cmet.2005.06.002; Brookes PS, 2005, FREE RADICAL BIO MED, V38, P12, DOI 10.1016/j.freeradbiomed.2004.10.016; Brookes PS, 1997, J MEMBRANE BIOL, V155, P167, DOI 10.1007/s002329900168; Chan SL, 2006, J BIOL CHEM, V281, P37391, DOI 10.1074/jbc.M605552200; Chu ACY, 2009, FREE RADICAL BIO MED, V46, P810, DOI 10.1016/j.freeradbiomed.2008.12.015; Distelmaier F, 2009, BRAIN, V132, P833, DOI 10.1093/brain/awp058; DUAN J, 1989, BIOCHEM PHARMACOL, V38, P3873, DOI 10.1016/0006-2952(89)90598-4; Echtay KS, 2007, FREE RADICAL BIO MED, V43, P1351, DOI 10.1016/j.freeradbiomed.2007.08.011; Esteves TC, 2005, BBA-BIOENERGETICS, V1709, P35, DOI 10.1016/j.bbabio.2005.06.002; Gnaiger E, 2002, BIOCHEM SOC T, V30, P252, DOI 10.1042/BST0300252; Guzman JN, 2010, NATURE, V468, P696, DOI 10.1038/nature09536; HATEFI Y, 1975, FED PROC, V34, P1699; Herrero-Mendez A, 2009, NAT CELL BIOL, V11, P747, DOI 10.1038/ncb1881; Hinkle PC, 2005, BBA-BIOENERGETICS, V1706, P1, DOI 10.1016/j.bbabio.2004.09.004; Ho JWM, 2010, FREE RADICAL BIO MED, V49, P192, DOI 10.1016/j.freeradbiomed.2010.04.002; Ho PWL, 2006, J NEUROSCI RES, V84, P1358, DOI 10.1002/jnr.21034; Ho PWL, 2010, NEUROTOX RES, V17, P332, DOI 10.1007/s12640-009-9109-y; Ho PWL, 2005, J NEUROSCI RES, V81, P261, DOI 10.1002/jnr.20569; Horsefield R, 2006, J BIOL CHEM, V281, P7309, DOI 10.1074/jbc.M508173200; Jaburek M, 1999, J BIOL CHEM, V274, P26003, DOI 10.1074/jbc.274.37.26003; Kim-Han JS, 2001, J NEUROCHEM, V79, P658, DOI 10.1046/j.1471-4159.2001.00604.x; Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Krauss S, 2005, NAT REV MOL CELL BIO, V6, P248, DOI 10.1038/nrm1592; Kwok KHH, 2010, FREE RADICAL BIO MED, V49, P1023, DOI 10.1016/j.freeradbiomed.2010.06.017; Lim YA, 2010, PROTEOMICS, V10, P1621, DOI 10.1002/pmic.200900651; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Liu D, 2006, NEUROMOL MED, V8, P389, DOI 10.1385/NMM:8:3:389; Mao WG, 1999, FEBS LETT, V443, P326, DOI 10.1016/S0014-5793(98)01713-X; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; Mookerjee SA, 2010, MECH AGEING DEV, V131, P463, DOI 10.1016/j.mad.2010.03.010; Moreira PI, 2004, BIOCHEM PHARMACOL, V68, P195, DOI 10.1016/j.bcp.2004.03.019; Mouaffak F, 2011, PHARMACOGENOMICS, V12, P185, DOI 10.2217/PGS.10.179; Navarro A, 2009, J BIOENERG BIOMEMBR, V41, P517, DOI 10.1007/s10863-009-9250-6; NegreSalvayre A, 1997, FASEB J, V11, P809, DOI 10.1096/fasebj.11.10.9271366; PARKER WD, 1989, ANN NEUROL, V26, P719, DOI 10.1002/ana.410260606; Rhein V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012359; Ricquier D, 2000, J PHYSIOL-LONDON, V529, P3, DOI 10.1111/j.1469-7793.2000.00003.x; ROLFE DFS, 1994, BBA-BIOENERGETICS, V1188, P405, DOI 10.1016/0005-2728(94)90062-0; Sanchez-Blanco A, 2006, GENETICS, V172, P1699, DOI 10.1534/genetics.105.053389; Schapira AHV, 1996, CURR OPIN NEUROL, V9, P260, DOI 10.1097/00019052-199608000-00003; SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x; Smorodchenko A, 2009, BBA-BIOMEMBRANES, V1788, P2309, DOI 10.1016/j.bbamem.2009.07.018; Szolnoki Z, 2011, ACTA NEUROL SCAND, V123, P352, DOI 10.1111/j.1600-0404.2010.01391.x; Szolnoki Z, 2009, NEUROMOL MED, V11, P101, DOI 10.1007/s12017-009-8071-4; Wei ZL, 2009, NEUROTOX RES, V16, P14, DOI 10.1007/s12640-009-9039-8; Xu RS, 2011, BRAIN RES, V1372, P133, DOI 10.1016/j.brainres.2010.11.056; Yasuno K, 2007, AM J MED GENET B, V144B, P250, DOI 10.1002/ajmg.b.30443; Yin Y, 2010, J BIOL CHEM, V285, P17038, DOI 10.1074/jbc.M110.104364; Yu XX, 2000, FASEB J, V14, P1611, DOI 10.1096/fj.14.11.1611; Zhang M, 2006, LIFE SCI, V79, P1428, DOI 10.1016/j.lfs.2006.04.012	61	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32810	10.1371/journal.pone.0032810	http://dx.doi.org/10.1371/journal.pone.0032810			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22427795	Green Submitted, Green Published, gold			2022-12-25	WOS:000303003500104
J	Ben-Aissa, K; Patino-Lopez, G; Belkina, NV; Maniti, O; Rosales, T; Hao, JJ; Kruhlak, MJ; Knutson, JR; Picart, C; Shaw, S				Ben-Aissa, Khadija; Patino-Lopez, Genaro; Belkina, Natalya V.; Maniti, Ofelia; Rosales, Tilman; Hao, Jian-Jiang; Kruhlak, Michael J.; Knutson, Jay R.; Picart, Catherine; Shaw, Stephen			Activation of Moesin, a Protein That Links Actin Cytoskeleton to the Plasma Membrane, Occurs by Phosphatidylinositol 4,5-bisphosphate (PIP2) Binding Sequentially to Two Sites and Releasing an Autoinhibitory Linker	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN HOMOLOGY DOMAINS; ERM PROTEINS; FERM DOMAIN; STRUCTURAL BASIS; IN-VIVO; EZRIN; PHOSPHORYLATION; EZRIN/RADIXIN/MOESIN; PHOSPHOINOSITIDES; RECOGNITION	Many cellular processes depend on ERM (ezrin, moesin, and radixin) proteins mediating regulated linkage between plasma membrane and actin cytoskeleton. Although conformational activation of the ERM protein is mediated by the membrane PIP2, the known properties of the two described PIP2-binding sites do not explain activation. To elucidate the structural basis of possible mechanisms, we generated informative moesin mutations and tested three attributes: membrane localization of the expressed moesin, moesin binding to PIP2, and PIP2-induced release of moesin autoinhibition. The results demonstrate for the first time that the POCKET containing inositol 1,4,5-trisphosphate on crystal structure (the "POCKET" Lys-63, Lys-278 residues) mediates all three functions. Furthermore the second described PIP2-binding site (the "PATCH," Lys253/Lys-254, Lys-262/Lys-263) is also essential for all three functions. In native autoinhibited ERM proteins, the POCKET is a cavity masked by an acidic linker, which we designate the "FLAP." Analysis of three mutant moesin constructs predicted to influence FLAP function demonstrated that the FLAP is a functional autoinhibitory region. Moreover, analysis of the cooperativity and stoichiometry demonstrate that the PATCH and POCKET do not bind PIP2 simultaneously. Based on our data and supporting published data, we propose a model of progressive activation of autoinhibited moesin by a single PIP2 molecule in the membrane. Initial transient binding of PIP2 to the PATCH initiates release of the FLAP, which enables transition of the same PIP2 molecule into the newly exposed POCKET where it binds stably and completes the conformational activation.	[Shaw, Stephen] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Rosales, Tilman; Knutson, Jay R.] NHLBI, Lab Mol Biophys, NIH, Bethesda, MD 20892 USA; [Maniti, Ofelia; Picart, Catherine] Grenoble Inst Technol, F-38016 Grenoble, France; [Maniti, Ofelia; Picart, Catherine] LMGP, CNRS, UMR 5628, F-38016 Grenoble, France	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble	Shaw, S (corresponding author), NCI, Expt Immunol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	Shaws@mail.nih.gov	Patiño López, Genaro/GQI-4414-2022; Maniti, Ofélia/AAQ-5624-2021; Patino-Lopez, Genaro/O-3484-2018	Patino-Lopez, Genaro/0000-0002-8716-722X; PICART, Catherine/0000-0003-0130-1000; PICART, Catherine/0000-0002-4854-6366	National Institutes of Health of the NCI; National Institutes of Health of NHLBI; National Institutes of Health of Agence Nationale de la Recherche [ANR-08-PCVI-026]; European Research Council [GA259370]; NATIONAL CANCER INSTITUTE [ZICBC010915] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006066, ZIAHL001452, ZIAHL006065, ZIAHL006067] Funding Source: NIH RePORTER	National Institutes of Health of the NCI; National Institutes of Health of NHLBI; National Institutes of Health of Agence Nationale de la Recherche(French National Research Agency (ANR)); European Research Council(European Research Council (ERC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Programs of the NCI and NHLBI and Agence Nationale de la Recherche (ANR-08-PCVI-026) and by the European Research Council (GA259370).	Amieva MR, 1999, J CELL SCI, V112, P111; Balaji S, 2005, NUCLEIC ACIDS RES, V33, P3994, DOI 10.1093/nar/gki709; Balla T, 2005, J CELL SCI, V118, P2093, DOI 10.1242/jcs.02387; Barret C, 2000, J CELL BIOL, V151, P1067, DOI 10.1083/jcb.151.5.1067; Belkina NV, 2009, P NATL ACAD SCI USA, V106, P4707, DOI 10.1073/pnas.0805963106; Blin G, 2008, BIOPHYS J, V94, P1021, DOI 10.1529/biophysj.107.110213; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Cozier GE, 2004, CURR TOP MICROBIOL, V282, P49; Fievet B, 2007, BBA-MOL CELL RES, V1773, P653, DOI 10.1016/j.bbamcr.2006.06.013; Fievet BT, 2004, J CELL BIOL, V164, P653, DOI 10.1083/jcb.200307032; Finnerty CM, 2004, J CELL SCI, V117, P1547, DOI 10.1242/jcs.01038; Hamada K, 2000, EMBO J, V19, P4449, DOI 10.1093/emboj/19.17.4449; Hao JJ, 2009, J CELL BIOL, V184, P451, DOI 10.1083/jcb.200807047; Harden TK, 2006, ANNU REV PHARMACOL, V46, P355, DOI 10.1146/annurev.pharmtox.46.120604.141223; Hicks SN, 2008, MOL CELL, V31, P383, DOI 10.1016/j.molcel.2008.06.018; Hirao M, 1996, J CELL BIOL, V135, P37, DOI 10.1083/jcb.135.1.37; Hokanson DE, 2006, MOL BIOL CELL, V17, P4856, DOI 10.1091/mbc.e06-05-0449; Hughes SC, 2007, CURR OPIN CELL BIOL, V19, P51, DOI 10.1016/j.ceb.2006.12.004; INGLEY E, 1994, J CELL BIOCHEM, V56, P436, DOI 10.1002/jcb.240560403; Jayaraman B, 2007, BIOCHEMISTRY-US, V46, P12174, DOI 10.1021/bi701281e; Kunda P, 2008, CURR BIOL, V18, P91, DOI 10.1016/j.cub.2007.12.051; Lai CL, 2010, J MOL BIOL, V402, P301, DOI 10.1016/j.jmb.2010.07.037; Lemmon MA, 2001, BIOCHEM SOC T, V29, P377, DOI 10.1042/BST0290377; Li QZ, 2007, J MOL BIOL, V365, P1446, DOI 10.1016/j.jmb.2006.10.075; Li Z, 2009, BIOPHYS J, V97, P155, DOI 10.1016/j.bpj.2009.04.037; Morales FC, 2007, MOL CELL BIOL, V27, P2527, DOI 10.1128/MCB.01372-06; Mori T, 2008, J BIOL CHEM, V283, P29602, DOI 10.1074/jbc.M803606200; Nakamura F, 1995, J BIOL CHEM, V270, P31377, DOI 10.1074/jbc.270.52.31377; Niggli V, 2008, INT J BIOCHEM CELL B, V40, P344, DOI 10.1016/j.biocel.2007.02.012; Patino-Lopez G, 2010, J BIOL CHEM, V285, P8675, DOI 10.1074/jbc.M109.086959; Pearson MA, 2000, CELL, V101, P259, DOI 10.1016/S0092-8674(00)80836-3; Raghunathan D, 2012, J BIOENERG BIOMEMBR, V44, P213, DOI 10.1007/s10863-012-9410-y; Reczek D, 1998, J BIOL CHEM, V273, P18452, DOI 10.1074/jbc.273.29.18452; Roch F, 2010, J CELL SCI, V123, P2057, DOI 10.1242/jcs.064550; Yonemura S, 2002, J CELL SCI, V115, P2569	35	37	37	4	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16311	16323		10.1074/jbc.M111.304881	http://dx.doi.org/10.1074/jbc.M111.304881			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22433855	Green Published, hybrid			2022-12-25	WOS:000304030900023
J	Kessl, JJ; Jena, N; Koh, Y; Taskent-Sezgin, H; Slaughter, A; Feng, L; de Silva, S; Wu, L; Le Grice, SFJ; Engelman, A; Fuchs, JR; Kvaratskhelia, M				Kessl, Jacques J.; Jena, Nivedita; Koh, Yasuhiro; Taskent-Sezgin, Humeyra; Slaughter, Alison; Feng, Lei; de Silva, Suresh; Wu, Li; Le Grice, Stuart F. J.; Engelman, Alan; Fuchs, James R.; Kvaratskhelia, Mamuka			Multimode, Cooperative Mechanism of Action of Allosteric HIV-1 Integrase Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; IN-VITRO; CATALYTIC DOMAIN; STRUCTURAL BASIS; COACTIVATOR P75; DNA INTEGRATION; BINDING DOMAIN; LEDGF/P75; PROTEIN; IDENTIFICATION	The multifunctional HIV-1 enzyme integrase interacts with viral DNA and its key cellular cofactor LEDGF to effectively integrate the reverse transcript into a host cell chromosome. These interactions are crucial for HIV-1 replication and present attractive targets for antiviral therapy. Recently, 2-(quinolin-3-yl) acetic acid derivatives were reported to selectively inhibit the integrase-LEDGF interaction in vitro and impair HIV-1 replication in infected cells. Here, we show that this class of compounds impairs both integrase-LEDGF binding and LEDGF-independent integrase catalytic activities with similar IC50 values, defining them as bona fide allosteric inhibitors of integrase function. Furthermore, we show that 2-(quinolin-3-yl) acetic acid derivatives block the formation of the stable synaptic complex between integrase and viral DNA by allosterically stabilizing an inactive multimeric form of integrase. In addition, these compounds inhibit LEDGF binding to the stable synaptic complex. This multimode mechanism of action concordantly results in cooperative inhibition of the concerted integration of viral DNA ends in vitro and HIV-1 replication in cell culture. Our findings, coupled with the fact that high cooperativity of antiviral inhibitors correlates with their increased instantaneous inhibitory potential, an important clinical parameter, argue strongly that improved 2-(quinolin-3-yl) acetic acid derivatives could exhibit desirable clinical properties.	[Kessl, Jacques J.; Slaughter, Alison; Feng, Lei; Kvaratskhelia, Mamuka] Ohio State Univ, Coll Pharm, Ctr Retrovirus Res, Columbus, OH 43210 USA; [Kessl, Jacques J.; Slaughter, Alison; Feng, Lei; Kvaratskhelia, Mamuka] Ohio State Univ, Coll Pharm, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Jena, Nivedita; Fuchs, James R.] Ohio State Univ, Coll Pharm, Div Med Chem & Pharmacognosy, Columbus, OH 43210 USA; [Koh, Yasuhiro; Engelman, Alan] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02215 USA; [Koh, Yasuhiro; Engelman, Alan] Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA; [de Silva, Suresh; Wu, Li] NCI, HIV Drug Resistance Program, Frederick, MD 21702 USA; [Taskent-Sezgin, Humeyra; Le Grice, Stuart F. J.] Ohio State Univ, Dept Vet Biosci, Ctr Retrovirus Res, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Ohio; Ohio State University	Kvaratskhelia, M (corresponding author), Ohio State Univ, Coll Pharm, Ctr Retrovirus Res, 500 W 12Th Ave, Columbus, OH 43210 USA.	kvaratskhelia.1@osu.edu	Wu, Li/E-4330-2011; Kessl, Jacques/AAV-2526-2021; Wu, Li/ABB-2813-2020; Kessl, Jacques/J-6073-2015; Fuchs, James Robert/B-4625-2012; Jena, Nivedita/F-4945-2012	Wu, Li/0000-0002-5468-2487; Wu, Li/0000-0002-5468-2487; Fuchs, James/0000-0002-8743-6389	National Institutes of Health [AI081581, AI062520, CA100730, AI097044, AI039394]; NCI, National Institutes of Health, Department of Health and Human Services; NATIONAL CANCER INSTITUTE [P01CA100730, ZIABC010494] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI097044, R01AI062520, P30AI060354, R01AI039394, R37AI039394, R01AI081581] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI, National Institutes of Health, Department of Health and Human Services; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants AI081581, AI062520, and CA100730 (to M. K.), AI097044 (to J. J. K. and J. R. F.), AI039394 (to A. E.); the Intramural Research Program of the NCI, National Institutes of Health, Department of Health and Human Services (to H. T. S. and S. F. J. L. G.).	Al-Mawsawi LQ, 2006, P NATL ACAD SCI USA, V103, P10080, DOI 10.1073/pnas.0511254103; Briones MS, 2010, IMMUNOL RES, V48, P14, DOI 10.1007/s12026-010-8164-z; Brown P. O., 1997, P161; Cai ML, 1997, NAT STRUCT BIOL, V4, P567, DOI 10.1038/nsb0797-567; Cherepanov P, 2005, P NATL ACAD SCI USA, V102, P17308, DOI 10.1073/pnas.0506924102; Cherepanov P, 2004, J BIOL CHEM, V279, P48883, DOI 10.1074/jbc.M406307200; Cherepanov P, 2007, NUCLEIC ACIDS RES, V35, P113, DOI 10.1093/nar/gkl885; Christ F, 2010, NAT CHEM BIOL, V6, P442, DOI 10.1038/nchembio.370; DYDA F, 1994, SCIENCE, V266, P1981, DOI 10.1126/science.7801124; EIJKELENBOOM APAM, 1995, NAT STRUCT BIOL, V2, P807, DOI 10.1038/nsb0995-807; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Engelman A., 2011, HIV 1 INTEGRASE, P67, DOI [10.1002/9781118015377.ch6, DOI 10.1002/9781118015377.CH6]; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; Hare S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000259; Hayouka Z, 2007, P NATL ACAD SCI USA, V104, P8316, DOI 10.1073/pnas.0700781104; Hill A.V., 1910, J PHYSIOL-LONDON, V40, piv; Johnson AA, 2004, CURR TOP MED CHEM, V4, P1059, DOI 10.2174/1568026043388394; Kessl JJ, 2011, NUCLEIC ACIDS RES, V39, P9009, DOI 10.1093/nar/gkr581; Kessl JJ, 2009, MOL PHARMACOL, V76, P824, DOI 10.1124/mol.109.058883; Krishnan L, 2010, P NATL ACAD SCI USA, V107, P15910, DOI 10.1073/pnas.1002346107; Li M, 2006, EMBO J, V25, P1295, DOI 10.1038/sj.emboj.7601005; Li X, 2012, J VIROL, V86, P3861, DOI 10.1128/JVI.06386-11; Maertens G, 2003, J BIOL CHEM, V278, P33528, DOI 10.1074/jbc.M303594200; Malet I, 2008, ANTIMICROB AGENTS CH, V52, P1351, DOI 10.1128/AAC.01228-07; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mckee CJ, 2008, J BIOL CHEM, V283, P31802, DOI 10.1074/jbc.M805843200; Michel F, 2009, EMBO J, V28, P980, DOI 10.1038/emboj.2009.41; Molteni V, 2001, ACTA CRYSTALLOGR D, V57, P536, DOI 10.1107/S0907444901001652; Murray JM, 2007, AIDS, V21, P2315, DOI 10.1097/QAD.0b013e3282f12377; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nettleship Joanne E., 2008, V426, P299, DOI 10.1007/978-1-60327-058-8_19; Nilsen BM, 1996, J VIROL, V70, P1580, DOI 10.1128/JVI.70.3.1580-1587.1996; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pandey KK, 2007, J VIROL, V81, P3969, DOI 10.1128/JVI.02322-06; Shen L, 2008, NAT MED, V14, P762, DOI 10.1038/nm1777; Shen L, 2009, TRENDS PHARMACOL SCI, V30, P610, DOI 10.1016/j.tips.2009.09.003; Tsantrizos YS, 2007, International Patent Application, Patent No. [PCT/CA2007/000845, 2007000845]; Tsiang M, 2009, J BIOL CHEM, V284, P33580, DOI 10.1074/jbc.M109.040121; Turlure F, 2006, NUCLEIC ACIDS RES, V34, P1653, DOI 10.1093/nar/gkl052	40	144	145	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16801	16811		10.1074/jbc.M112.354373	http://dx.doi.org/10.1074/jbc.M112.354373			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22437836	Green Published, hybrid			2022-12-25	WOS:000304030900067
J	Gou, ZY; Liu, RR; Zhao, GP; Zheng, MQ; Li, P; Wang, HH; Zhu, Y; Chen, JL; Wen, J				Gou, Zhongyong; Liu, Ranran; Zhao, Guiping; Zheng, Maiqing; Li, Peng; Wang, Huihua; Zhu, Yun; Chen, Jilan; Wen, Jie			Epigenetic Modification of TLRs in Leukocytes Is Associated with Increased Susceptibility to Salmonella enteritidis in Chickens	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-2; ENTERICA SEROVAR ENTERITIDIS; GENE-EXPRESSION; INNATE IMMUNITY; UP-REGULATION; NEGATIVE REGULATION; EPITHELIAL-CELLS; MAST-CELLS; HOST; METHYLATION	Toll-like receptors (TLRs) signaling pathways are the first lines in defense against Salmonella enteritidis (S. enteritidis) infection but the molecular mechanism underlying susceptibility to S. enteritidis infection in chicken remains unclear. SPF chickens injected with S. enteritidis were partitioned into two groups, one consisted of those from Salmonella-susceptible chickens (died within 5 d after injection, n = 6), the other consisted of six Salmonella-resistant chickens that survived for 15 d after injection. The present study shows that the bacterial load in susceptible chickens was significantly higher than that in resistant chickens and TLR4, TLR2-1 and TLR21 expression was strongly diminished in the leukocytes of susceptible chickens compared with those of resistant chickens. The induction of expression of pro-inflammatory cytokine genes, IL-6 and IFN-beta, was greatly enhanced in the resistant but not in susceptible chickens. Contrasting with the reduced expression of TLR genes, those of the zinc finger protein 493 (ZNF493) gene and Toll-interacting protein (TOLLIP) gene were enhanced in the susceptible chickens. Finally, the expression of TLR4 in peripheral blood mononuclear cells (PBMCs) infected in vitro with S. enteritidis increased significantly as a result of treatment with 5-Aza-2-deoxycytidine (5-Aza-dc) while either 5-Aza-dc or trichostatin A was effective in up-regulating the expression of TLR21 and TLR2-1. DNA methylation, in the predicted promoter region of TLR4 and TLR21 genes, and an exonic CpG island of the TLR2-1 gene was significantly higher in the susceptible chickens than in resistant chickens. Taken together, the results demonstrate that ZNF493-related epigenetic modification in leukocytes probably accounts for increased susceptibility to S. enteritidis in chickens by diminishing the expression and response of TLR4, TLR21 and TLR2-1.	[Gou, Zhongyong; Liu, Ranran; Zhao, Guiping; Zheng, Maiqing; Li, Peng; Wang, Huihua; Zhu, Yun; Chen, Jilan; Wen, Jie] Chinese Acad Agr Sci, Inst Anim Sci, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS	Gou, ZY (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, Beijing 100193, Peoples R China.	jiewen@iascaas.net.cn		Zhao, Guiping/0000-0002-1510-6903; Wen, Jie/0000-0001-7460-4219	National Natural Science Foundation of China [30871776]; National Key Technology RD Program [2011BAD28B03]; China Agriculture Research System [CARS-42]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology RD Program(National Key Technology R&D Program); China Agriculture Research System	This research was supported by National Natural Science Foundation of China (No. 30871776) and the National Key Technology R&D Program (2011BAD28B03) and the China Agriculture Research System (CARS-42). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abasht B, 2008, VET IMMUNOL IMMUNOP, V123, P314, DOI 10.1016/j.vetimm.2008.02.010; Abasht B, 2009, POULTRY SCI, V88, P744, DOI 10.3382/ps.2008-00419; Abreu MT, 2001, J IMMUNOL, V167, P1609, DOI 10.4049/jimmunol.167.3.1609; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Arpaia N, 2011, CELL, V144, P675, DOI 10.1016/j.cell.2011.01.031; Ayyanathan K, 2003, GENE DEV, V17, P1855, DOI 10.1101/gad.1102803; Babu S, 2006, J IMMUNOL, V176, P3885, DOI 10.4049/jimmunol.176.7.3885; Brownlie R, 2009, MOL IMMUNOL, V46, P3163, DOI 10.1016/j.molimm.2009.06.002; Collier-Hyams LS, 2002, J IMMUNOL, V169, P2846, DOI 10.4049/jimmunol.169.6.2846; Cook DN, 2004, NAT IMMUNOL, V5, P975, DOI 10.1038/ni1116; Deng SX, 2008, AVIAN DIS, V52, P88, DOI 10.1637/8102-090107-Reg; GONZALEZZULUETA M, 1995, CANCER RES, V55, P4531; HALFORD S, 1995, GENOMICS, V25, P322, DOI 10.1016/0888-7543(95)80149-G; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Hausmann M, 2002, GASTROENTEROLOGY, V122, P1987, DOI 10.1053/gast.2002.33662; Herman JG, 1997, CANCER RES, V57, P837; Hisano M, 2003, NUCLEIC ACIDS RES, V31, P4797, DOI 10.1093/nar/gkg670; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; HUE NT, 2006, AM SOC MICROBIOL, V38, P56; Jakobsson J, 2008, NEURON, V60, P818, DOI 10.1016/j.neuron.2008.09.036; Janeway CA, 1999, CURR BIOL, V9, pR879, DOI 10.1016/S0960-9822(00)80073-1; Kabelitz D, 2007, CURR OPIN IMMUNOL, V19, P39, DOI 10.1016/j.coi.2006.11.007; Kinjyo I, 2002, IMMUNITY, V17, P583, DOI 10.1016/S1074-7613(02)00446-6; Lazarevic V, 2005, J IMMUNOL, V175, P1107, DOI 10.4049/jimmunol.175.2.1107; Li P, 2010, VET MICROBIOL, V143, P346, DOI 10.1016/j.vetmic.2009.12.008; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; LINDELL KA, 1994, POULTRY SCI, V73, P757, DOI 10.3382/ps.0730757; Liu Y, 2001, INFECT IMMUN, V69, P2788, DOI 10.1128/IAI.69.5.2788-2796.2001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorenz E, 2002, ARCH INTERN MED, V162, P1028, DOI 10.1001/archinte.162.9.1028; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Melmed G, 2003, J IMMUNOL, V170, P1406, DOI 10.4049/jimmunol.170.3.1406; Monack DM, 2004, NAT REV MICROBIOL, V2, P747, DOI 10.1038/nrmicro955; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Shuto T, 2006, FASEB J, V20, P782, DOI 10.1096/fj.05-4934fje; Sripathy SP, 2006, MOL CELL BIOL, V26, P8623, DOI 10.1128/MCB.00487-06; Takahashi K, 2009, J IMMUNOL, V183, P6522, DOI 10.4049/jimmunol.0901271; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; Weiss DS, 2004, J IMMUNOL, V172, P4463, DOI 10.4049/jimmunol.172.7.4463; Werling D, 2009, TRENDS IMMUNOL, V30, P124, DOI 10.1016/j.it.2008.12.001; Wigley P, 2001, INFECT IMMUN, V69, P7873, DOI 10.1128/IAI.69.12.7873-7879.2001; Wiznerowicz M, 2007, J BIOL CHEM, V282, P34535, DOI 10.1074/jbc.M705898200; Yang HW, 2010, CELL PHYSIOL BIOCHEM, V26, P337, DOI 10.1159/000320557; Yang HW, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-37	46	43	45	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33627	10.1371/journal.pone.0033627	http://dx.doi.org/10.1371/journal.pone.0033627			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438967	gold, Green Submitted, Green Published			2022-12-25	WOS:000303309100073
J	Morag, N; Saroya, Y; Braverman, Y; Klement, E; Gottlieb, Y				Morag, Neta; Saroya, Yonatan; Braverman, Yehuda; Klement, Eyal; Gottlieb, Yuval			Molecular Identification, Phylogenetic Status, and Geographic Distribution of Culicoides oxystoma (Diptera: Ceratopogonidae) in Israel	PLOS ONE			English	Article							AFRICAN HORSE SICKNESS; POLYMERASE-CHAIN-REACTION; BITING MIDGES DIPTERA; BLUETONGUE VIRUS; OBSOLETUS COMPLEX; SCOTICUS DIPTERA; IMICOLA; TRANSMISSION; VECTORS; INFECTION	Culicoides oxystoma (Diptera: Ceratopogonidae) is an important vector species, reported mainly from Asia, with high potential to transmit viral diseases affecting livestock. In Japan, many arboviruses have been isolated from C. oxystoma, suggesting it as a key player in the epidemiology of several Culicoides-borne diseases. Over the years, C. oxystoma has also been reported in the Middle East region, including Israel. In this region, however, C. oxystoma cannot be easily distinguished morphologically from its sibling species included in the Culicoides schultzei complex. We therefore used genomic data for species identification and phylogeny resolution. Phylogenetic analyses based on internal transcribed spacer 1 (ITS-1) of ribosomal DNA and the mitochondrial gene encoding cytochrome oxidase subunit I (COI) showed that C. oxystoma from Israel is closely related to C. oxystoma from Japan. Using differential probing PCR, we showed that C. oxystoma is distributed all over the country, especially in Mediterranean climate regions. Culicoides oxystoma is less common or even absent in arid regions, while the other genetic cluster of C. schultzei complex was found only in the east of the country (mostly arid and semiarid regions). The molecular finding of C. oxystoma in wide geographical regions, together with its high proportion in the general Culicoides population and its vectoring potential, imply that it may be an important vector species in the Middle East.	[Morag, Neta; Saroya, Yonatan; Braverman, Yehuda; Klement, Eyal; Gottlieb, Yuval] Hebrew Univ Jerusalem, Koret Sch Vet Med, Robert H Smith Fac Agr Food & Environm, IL-76100 Rehovot, Israel	Hebrew University of Jerusalem	Morag, N (corresponding author), Hebrew Univ Jerusalem, Koret Sch Vet Med, Robert H Smith Fac Agr Food & Environm, IL-76100 Rehovot, Israel.	yuvalgd@yahoo.com	Gottlieb, Yuval/H-6461-2013; Klement, Eyal/H-8388-2019	Klement, Eyal/0000-0002-2384-2345	BARD [IS-4185-09]	BARD(US-Israel Binational Science Foundation)	This work was funded by research grant No. IS-4185-09 from BARD, The United States-Israel Binational Agricultural Research and Development fund to YG (www.bard-isus.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1990, CURR TOP MICROBIOL; Boorman J., 1989, Fauna of Saudi Arabia, V10, P160; Braverman Y, 1996, J AM MOSQUITO CONTR, V12, P437; BRAVERMAN Y, 1981, INSECT SCI APPL, V2, P157, DOI 10.1017/S1742758400000953; BRAVERMAN Y, 1985, J MED ENTOMOL, V22, P476, DOI 10.1093/jmedent/22.5.476; BRAVERMAN Y, 1979, REFUAH VET, V36, P121; BRAVERMAN Y, 1985, P191; Braverman Y., 1981, Israel Journal of Entomology, V15, P13; Braverman Y, 1991, C INT AS SUD EUR PAR; BRAVERMANN Y, 1976, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V14, P179; Callot J, 1969, Bull. Soc. Path. exot., V62, P118; Cetre-Sossah C, 2004, VET RES, V35, P325, DOI 10.1051/vetres:2004015; Cetre-Sossah C, 2008, RES VET SCI, V85, P372, DOI 10.1016/j.rvsc.2007.12.001; Cornet M., 1981, Israel Journal of Entomology, V15, P110; Cornet Michel, 1994, Bulletin de la Societe Entomologique de France, V99, P149; Dallas JF, 2003, MED VET ENTOMOL, V17, P379, DOI 10.1111/j.1365-2915.2003.00454.x; DeBlauwe I, 2012, MED VET ENTOMOL, V26, P83, DOI 10.1111/j.1365-2915.2011.00979.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Frohlich DR, 1999, MOL ECOL, V8, P1683, DOI 10.1046/j.1365-294x.1999.00754.x; Fu H, 1999, ARCH VIROL, V144, P747, DOI 10.1007/s007050050540; Goldreich Y., 2012, CLIMATE ISRAEL OBSER; Gomulski LM, 2006, MED VET ENTOMOL, V20, P229, DOI 10.1111/j.1365-2915.2006.00620.x; Gomulski LM, 2005, SYST ENTOMOL, V30, P619, DOI 10.1111/j.1365-3113.2005.00286.x; Kaufmann C, 2011, MED VET ENTOMOL, V25, P32, DOI 10.1111/j.1365-2915.2010.00927.x; Kedmi M, 2010, J DAIRY SCI, V93, P2486, DOI 10.3168/jds.2009-2850; Mathieu B, 2007, J MED ENTOMOL, V44, P1019, DOI 10.1603/0022-2585(2007)44[1019:MIOWES]2.0.CO;2; Mathieu B, 2011, VET PARASITOL, V182, P297, DOI 10.1016/j.vetpar.2011.05.052; Matsumoto Y, 2009, MED VET ENTOMOL, V23, P47, DOI 10.1111/j.1365-2915.2008.00789.x; Matsumoto Y, 2009, J MED ENTOMOL, V46, P1099, DOI 10.1603/033.046.0517; Mayo CE, 2012, VET MICROBIOL, V155, P158, DOI 10.1016/j.vetmic.2011.08.029; Mellor PS, 2000, ANNU REV ENTOMOL, V45, P307, DOI 10.1146/annurev.ento.45.1.307; MELLOR PS, 1995, ANN TROP MED PARASIT, V89, P1; MELLOR PS, 1981, ACTA VIROL, V25, P401; MELLOR PS, 1984, J HYG-CAMBRIDGE, V93, P621, DOI 10.1017/S0022172400065190; Monaco F, 2010, VET ITAL, V46, P215; Nolan DV, 2007, VET MICROBIOL, V124, P82, DOI 10.1016/j.vetmic.2007.03.019; Nolan DV, 2004, VETER ITAL SER, V40, P352; Pages N, 2005, J MED ENTOMOL, V42, P1026, DOI 10.1603/0022-2585(2005)042[1026:DOCOAC]2.0.CO;2; Perrin A, 2006, MED VET ENTOMOL, V20, P219, DOI 10.1111/j.1365-2915.2006.00616.x; Stephan A, 2009, PARASITOL RES, V105, P367, DOI 10.1007/s00436-009-1407-z; TAMURA K, 1992, MOL BIOL EVOL, V9, P678; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Velthuis AGJ, 2010, PREV VET MED, V93, P294, DOI 10.1016/j.prevetmed.2009.11.007; Wenk CE, 2012, VET PARASITOL, V184, P258, DOI 10.1016/j.vetpar.2011.08.034; Wirth W.W., 1985, Progress in Clinical and Biological Research, V178, P151; WIRTH WW, 1968, ANN ENTOMOL SOC AM, V61, P783, DOI 10.1093/aesa/61.3.783; Yanase T, 2005, J MED ENTOMOL, V42, P63, DOI 10.1603/0022-2585(2005)042[0063:IOBAFC]2.0.CO;2	47	27	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33610	10.1371/journal.pone.0033610	http://dx.doi.org/10.1371/journal.pone.0033610			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438964	gold, Green Published, Green Submitted			2022-12-25	WOS:000303309100070
J	Mauzy, MJ; Enomoto, S; Lancto, CA; Abrahamsen, MS; Rutherford, MS				Mauzy, Mary J.; Enomoto, Shinichiro; Lancto, Cheryl A.; Abrahamsen, Mitchell S.; Rutherford, Mark S.			The Cryptosporidium Parvum Transcriptome during In Vitro Development	PLOS ONE			English	Article							TOXOPLASMA-GONDII; DNA-REPLICATION; PLASMODIUM-FALCIPARUM; CELL-CYCLE; PROTEIN; GENE; GENOME; EXPRESSION; COMPLEX; ORIGIN	Cryptosporidiosis is caused by an obligate intracellular parasite that has eluded global transcriptional or proteomic analysis of the intracellular developmental stages. The transcript abundance for 3,302 genes (87%) of the Cryptosporidium parvum protein coding genome was elucidated over a 72 hr infection within HCT8 cells using Real Time-PCR. The parasite had detectable transcription of all genes in vitro within at least one time point tested, and adjacent genes were not co-regulated. Five genes were not detected within the first 24 hr of infection, one containing two AP2 domains. The fewest genes detected were at 2 hr post infection, while 30% (985) of the genes have their highest expression at 48 and/or 72 hr. Nine expression clusters were formed over the entire 72 hr time course and indicate patterns of transcriptional increases at each of the 7 time points collected except 36 hr, including genes paralleling parasite 18S rRNA transcript levels. Clustering within only the first 24 hr of infection indicates spikes in expression at each of the 4 time points, a group paralleling 18S rRNA transcript levels, and a cluster with peaks at both 6 and 24 hr. All genes were classified into 18 functional categories, which were unequally distributed across clusters. Expression of metabolic, ribosomal and proteasome proteins did not parallel 18S rRNA levels indicating distinct biochemical profiles during developmental stage progression. Proteins involved in translation are over-represented at 6 hr, while structural proteins are over-represented at 12 hr. Standardization methods identified 107 genes with <80% at a single of its total expression at a single time point over 72 hr. This comprehensive transcriptome of the intracellular stages of C. parvum provides insight for understanding its complex development following parasitization of intestinal epithelial cells.	[Mauzy, Mary J.; Enomoto, Shinichiro; Lancto, Cheryl A.; Abrahamsen, Mitchell S.; Rutherford, Mark S.] Univ Minnesota, Coll Vet Med, Dept Vet & Biomed Sci, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Mauzy, MJ (corresponding author), Univ Minnesota, Coll Vet Med, Dept Vet & Biomed Sci, St Paul, MN 55108 USA.	ruthe003@umn.edu			National Institute of Allergy and Infectious Diseases (NIAID) [R01A1065246]; USDA-CSREES [2005-38420-15675]	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); USDA-CSREES(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	This work was supported by National Institute of Allergy and Infectious Diseases (NIAID) grant R01A1065246. Dr. Mauzy was supported by USDA-CSREES National Needs Fellowship 2005-38420-15675. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen MS, 2004, SCIENCE, V304, P441, DOI 10.1126/science.1094786; Abrahamsen MS, 1999, MOL BIOCHEM PARASIT, V104, P141, DOI 10.1016/S0166-6851(99)00081-X; Agop-Nersesian C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000270; Balaji S, 2005, NUCLEIC ACIDS RES, V33, P3994, DOI 10.1093/nar/gki709; Behnke MS, 2008, MOL MICROBIOL, V68, P1502, DOI 10.1111/j.1365-2958.2008.06249.x; Behnke MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012354; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Bernstein KA, 2007, MOL BIOL CELL, V18, P953, DOI 10.1091/mbc.E06-06-0512; Bishop R, 2005, NUCLEIC ACIDS RES, V33, P5503, DOI 10.1093/nar/gki818; Borowski H, 2010, PARASITOLOGY, V137, P13, DOI 10.1017/S0031182009990837; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Cai XM, 2005, ANTIMICROB AGENTS CH, V49, P4437, DOI 10.1128/AAC.49.11.4437-4442.2005; Chappell CL, 2006, AM J TROP MED HYG, V75, P851, DOI 10.4269/ajtmh.2006.75.851; Chatterjee A, 2010, EUKARYOT CELL, V9, P84, DOI 10.1128/EC.00288-09; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Cleary MD, 2002, EUKARYOT CELL, V1, P329, DOI 10.1128/EC.1.3.329-340.2002; Deng MQ, 2004, INT J PARASITOL, V34, P73, DOI 10.1016/j.ijpara.2003.10.001; Deng MQ, 2002, INFECT IMMUN, V70, P6987, DOI 10.1128/IAI.70.12.6987-6995.2002; Denton H, 1996, FEMS MICROBIOL LETT, V137, P103, DOI 10.1111/j.1574-6968.1996.tb08090.x; DEROJAS MO, 1985, T ROY SOC TROP MED H, V79, P792, DOI 10.1016/0035-9203(85)90119-1; Dubey JP, 1990, CRYPTOSPORIDIOSIS MA; Dueber EC, 2011, NUCLEIC ACIDS RES, V39, P3621, DOI 10.1093/nar/gkq1308; Duncker BP, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-214; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; FAYER R, 1997, CRYPTOSPORIDIUM CRYP; Fontaine M, 2003, FEMS MICROBIOL LETT, V226, P237, DOI 10.1016/S0378-1097(03)00538-X; Frost FJ, 2004, ANN EPIDEMIOL, V14, P473, DOI 10.1016/j.annepidem.2003.06.002; Gordon JL, 2008, EUKARYOT CELL, V7, P1500, DOI 10.1128/EC.00064-08; Grainge I, 2006, J MOL BIOL, V363, P355, DOI 10.1016/j.jmb.2006.07.076; GRITZMACHER CA, 1984, J BACTERIOL, V160, P1165, DOI 10.1128/JB.160.3.1165-1167.1984; Hall N, 2005, CURR OPIN GENET DEV, V15, P609, DOI 10.1016/j.gde.2005.09.001; Heiges M, 2006, NUCLEIC ACIDS RES, V34, pD419, DOI 10.1093/nar/gkj078; HIRANO T, 1994, CELL, V79, P449, DOI 10.1016/0092-8674(94)90254-2; Jenkins MC, 2011, PARASITOL RES, V109, P509, DOI 10.1007/s00436-011-2308-5; Jensen BC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-482; Joe A, 1998, INFECT IMMUN, V66, P3429, DOI 10.1128/IAI.66.7.3429-3432.1998; Jorgensen P, 2004, GENE DEV, V18, P2491, DOI 10.1101/gad.1228804; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; Kubista Mikael, 2006, Molecular Aspects of Medicine, V27, P95, DOI 10.1016/j.mam.2005.12.007; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Li HL, 2003, PARASITOL INT, V52, P41, DOI 10.1016/S1383-5769(02)00079-X; Liu J, 2008, INFECT IMMUN, V76, P3784, DOI 10.1128/IAI.00308-08; Maechler M., 2011, CLUSTER ANAL BASICS; Maiorano D, 2006, CURR OPIN CELL BIOL, V18, P130, DOI 10.1016/j.ceb.2006.02.006; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Mehra P, 2005, BIOCHEM BIOPH RES CO, V337, P955, DOI 10.1016/j.bbrc.2005.09.131; MOORE SA, 1988, J BIOL CHEM, V263, P9674; Oliveros JC, 2007, VENNY INTERACTIVE TO; Patterson S, 2006, MOL BIOCHEM PARASIT, V145, P50, DOI 10.1016/j.molbiopara.2005.09.006; Putignani L, 2008, MOL BIOCHEM PARASIT, V157, P98, DOI 10.1016/j.molbiopara.2007.09.004; R Development Core Team, 2009, R FDN STAT COMP; Sanderson SJ, 2008, PROTEOMICS, V8, P1398, DOI 10.1002/pmic.200700804; Santos JM, 2009, INT J PARASITOL, V39, P153, DOI 10.1016/j.ijpara.2008.10.007; Schroeder AA, 1998, GENE, V216, P327, DOI 10.1016/S0378-1119(98)00360-6; SGD Project, 2010, SACCH GEN DAT; Snelling WJ, 2007, MOL CELL PROTEOMICS, V6, P346, DOI 10.1074/mcp.M600372-MCP200; Stahlberg A, 2004, CLIN CHEM, V50, P509, DOI 10.1373/clinchem.2003.026161; Striepen B, 2007, PLOS PATHOG, V3, P691, DOI 10.1371/journal.ppat.0030078; Strong WB, 2000, CONTRIB MICROBIOL, V6, P92, DOI 10.1159/000060358; Sutani T, 1999, GENE DEV, V13, P2271, DOI 10.1101/gad.13.17.2271; Templeton TJ, 2004, GENOME RES, V14, P1686, DOI 10.1101/gr.2615304; Thompson RCA, 2005, ADV PARASIT, V59, P77, DOI 10.1016/S0065-308X(05)59002-X; Tosini F, 2004, MOL BIOCHEM PARASIT, V134, P137, DOI 10.1016/j.molbiopara.2003.11.014; UPTON SJ, 1995, J CLIN MICROBIOL, V33, P371, DOI 10.1128/JCM.33.2.371-375.1995; Wakaguri H, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-312; Warnes GR, 2009, GPLOTS VARIOUS R PRO, V2, P4; Xu P, 2004, NATURE, V431, P1107, DOI 10.1038/nature02977; Xu T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S11-S13; Yamagishi J, 2011, PARASITOL INT, V60, P199, DOI 10.1016/j.parint.2011.03.001; YANG SM, 1995, MOL BIOCHEM PARASIT, V73, P291, DOI 10.1016/0166-6851(95)00124-J; Yuda M, 2010, MOL MICROBIOL, V75, P854, DOI 10.1111/j.1365-2958.2009.07005.x	72	74	74	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2012	7	3							e31715	10.1371/journal.pone.0031715	http://dx.doi.org/10.1371/journal.pone.0031715			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RU	22438867	Green Published, gold, Green Submitted			2022-12-25	WOS:000303309000002
J	Dempsey, WP; Fraser, SE; Pantazis, P				Dempsey, William P.; Fraser, Scott E.; Pantazis, Periklis			PhOTO Zebrafish: A Transgenic Resource for In Vivo Lineage Tracing during Development and Regeneration	PLOS ONE			English	Article							HEART REGENERATION; CELLS; DEDIFFERENTIATION; PROLIFERATION; BLASTEMA; GFP	Background: Elucidating the complex cell dynamics (divisions, movement, morphological changes, etc.) underlying embryonic development and adult tissue regeneration requires an efficient means to track cells with high fidelity in space and time. To satisfy this criterion, we developed a transgenic zebrafish line, called PhOTO, that allows photoconvertible optical tracking of nuclear and membrane dynamics in vivo. Methodology: PhOTO zebrafish ubiquitously express targeted blue fluorescent protein (FP) Cerulean and photoconvertible FP Dendra2 fusions, allowing for instantaneous, precise targeting and tracking of any number of cells using Dendra2 photoconversion while simultaneously monitoring global cell behavior and morphology. Expression persists through adulthood, making the PhOTO zebrafish an excellent tool for studying tissue regeneration: after tail fin amputation and photoconversion of a similar to 100 mu m stripe along the cut area, marked differences seen in how cells contribute to the new tissue give detailed insight into the dynamic process of regeneration. Photoconverted cells that contributed to the regenerate were separated into three distinct populations corresponding to the extent of cell division 7 days after amputation, and a subset of cells that divided the least were organized into an evenly spaced, linear orientation along the length of the newly regenerating fin. Conclusions/Significance: PhOTO zebrafish have wide applicability for lineage tracing at the systems-level in the early embryo as well as in the adult, making them ideal candidate tools for future research in development, traumatic injury and regeneration, cancer progression, and stem cell behavior.	[Dempsey, William P.; Fraser, Scott E.] CALTECH, Div Biol, Beckman Inst 139 74, Pasadena, CA 91125 USA; [Dempsey, William P.; Pantazis, Periklis] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Basel, Switzerland	California Institute of Technology; Swiss Federal Institutes of Technology Domain; ETH Zurich	Dempsey, WP (corresponding author), CALTECH, Div Biol, Beckman Inst 139 74, Pasadena, CA 91125 USA.	periklis.pantazis@bsse.ethz.ch	Fraser, Scott/Y-3406-2019; Pantazis, Periklis/AAR-1795-2021	Fraser, Scott/0000-0002-5377-0223; Pantazis, Periklis (Laki)/0000-0002-8367-9332	Caltech	Caltech	WPD was supported by a Caltech Rosen Scholar Graduate fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blum N, 2012, DEVELOPMENT, V139, P107, DOI 10.1242/dev.065391; Buckingham ME, 2011, DEV CELL, V21, P394, DOI 10.1016/j.devcel.2011.07.019; Campos C, 2011, DEV DYNAM, V240, P820, DOI 10.1002/dvdy.22574; Caneparo L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020230; Caron SJC, 2008, DEVELOPMENT, V135, P3259, DOI 10.1242/dev.023200; Chertkov M, 2010, P NATL ACAD SCI USA, V107, P7663, DOI 10.1073/pnas.0910994107; Collins RT, 2010, NAT METHODS, V7, P219, DOI [10.1038/NMETH.1423, 10.1038/nmeth.1423]; D'Angelo MA, 2009, CELL, V136, P284, DOI 10.1016/j.cell.2008.11.037; Donnelly MLL, 2001, J GEN VIROL, V82, P1027, DOI 10.1099/0022-1317-82-5-1027; Guo CY, 2002, GENESIS, V32, P8, DOI 10.1002/gene.10021; Gurskaya NG, 2006, NAT BIOTECHNOL, V24, P461, DOI 10.1038/nbt1191; Higashijima S, 1997, DEV BIOL, V192, P289, DOI 10.1006/dbio.1997.8779; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kawakami K, 1999, GENE, V240, P239, DOI 10.1016/S0378-1119(99)00444-8; Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493; Kikuchi K, 2011, DEVELOPMENT, V138, P2895, DOI 10.1242/dev.067041; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; Knopf F, 2011, DEV CELL, V20, P713, DOI 10.1016/j.devcel.2011.04.014; LeClair EE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008737; Ma EY, 2009, CURR BIOL, V19, pR381, DOI 10.1016/j.cub.2009.03.057; McMahon A, 2008, SCIENCE, V322, P1546, DOI 10.1126/science.1167094; Nechiporuk A, 2002, DEVELOPMENT, V129, P2607; Pantazis P, 2010, P NATL ACAD SCI USA, V107, P14535, DOI 10.1073/pnas.1004748107; Pantazis P, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2770478; Planchon TA, 2011, NAT METHODS, V8, P417, DOI [10.1038/NMETH.1586, 10.1038/nmeth.1586]; Poss KD, 2000, DEV DYNAM, V219, P282, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1045>3.3.CO;2-3; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Poss KD, 2010, NAT REV GENET, V11, P710, DOI 10.1038/nrg2879; Preibisch S, 2010, NAT METHODS, V7, P418, DOI 10.1038/nmeth0610-418; Ramachandran R, 2010, J COMP NEUROL, V518, P4196, DOI 10.1002/cne.22448; Rizzi B, 2009, INT J BIOMED IMAGING, V2009, DOI 10.1155/2009/968986; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Sood R, 2010, BLOOD, V115, P2806, DOI 10.1182/blood-2009-08-236729; Stern CD, 2006, INT J DEV BIOL, V50, P3, DOI 10.1387/ijdb.052095cs; Swoger J, 2011, J BIOPHOTONICS, V4, P122, DOI 10.1002/jbio.201000087; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Thummel R, 2006, DEV DYNAM, V235, P336, DOI 10.1002/dvdy.20630; Truong TV, 2011, NAT METHODS, V8, P757, DOI 10.1038/nmeth.1652; Tryon RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021010; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; WOO K, 1995, CURR OPIN GENET DEV, V5, P439, DOI 10.1016/0959-437X(95)90046-J; WOO K, 1995, DEVELOPMENT, V121, P2595; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhao Y, 2011, INT J DEV BIOL, V55, P477, DOI 10.1387/ijdb.103225yz	45	37	38	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e32888	10.1371/journal.pone.0032888	http://dx.doi.org/10.1371/journal.pone.0032888			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22431986	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000303198600029
J	Erickson, GM; Gignac, PM; Steppan, SJ; Lappin, AK; Vliet, KA; Brueggen, JD; Inouye, BD; Kledzik, D; Webb, GJW				Erickson, Gregory M.; Gignac, Paul M.; Steppan, Scott J.; Lappin, A. Kristopher; Vliet, Kent A.; Brueggen, John D.; Inouye, Brian D.; Kledzik, David; Webb, Grahame J. W.			Insights into the Ecology and Evolutionary Success of Crocodilians Revealed through Bite-Force and Tooth-Pressure Experimentation	PLOS ONE			English	Article							ALLIGATOR-MISSISSIPPIENSIS; AMERICAN ALLIGATORS; FEEDING-BEHAVIOR; PERFORMANCE; CROCODYLIA; HISTORY	Background: Crocodilians have dominated predatory niches at the water-land interface for over 85 million years. Like their ancestors, living species show substantial variation in their jaw proportions, dental form and body size. These differences are often assumed to reflect anatomical specialization related to feeding and niche occupation, but quantified data are scant. How these factors relate to biomechanical performance during feeding and their relevance to crocodilian evolutionary success are not known. Methodology/Principal Findings: We measured adult bite forces and tooth pressures in all 23 extant crocodilian species and analyzed the results in ecological and phylogenetic contexts. We demonstrate that these reptiles generate the highest bite forces and tooth pressures known for any living animals. Bite forces strongly correlate with body size, and size changes are a major mechanism of feeding evolution in this group. Jaw shape demonstrates surprisingly little correlation to bite force and pressures. Bite forces can now be predicted in fossil crocodilians using the regression equations generated in this research. Conclusions/Significance: Critical to crocodilian long-term success was the evolution of a high bite-force generating musculo-skeletal architecture. Once achieved, the relative force capacities of this system went essentially unmodified throughout subsequent diversification. Rampant changes in body size and concurrent changes in bite force served as a mechanism to allow access to differing prey types and sizes. Further access to the diversity of near-shore prey was gained primarily through changes in tooth pressure via the evolution of dental form and distributions of the teeth within the jaws. Rostral proportions changed substantially throughout crocodilian evolution, but not in correspondence with bite forces. The biomechanical and ecological ramifications of such changes need further examination.	[Erickson, Gregory M.; Gignac, Paul M.; Steppan, Scott J.; Inouye, Brian D.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Lappin, A. Kristopher] Calif State Polytech Univ Pomona, Dept Biol Sci, Pomona, CA 91768 USA; [Vliet, Kent A.] Univ Florida, Dept Biol, Gainesville, FL USA; [Brueggen, John D.; Kledzik, David] St Augustine Alligator Farm Zool Pk, St Augustine, FL USA; [Webb, Grahame J. W.] Charles Darwin Univ, Wildlife Management Int, Darwin, NT 0909, Australia; [Webb, Grahame J. W.] Charles Darwin Univ, Sch Environm Res, Darwin, NT 0909, Australia	State University System of Florida; Florida State University; California State University System; California State Polytechnic University Pomona; State University System of Florida; University of Florida; Charles Darwin University; Charles Darwin University	Erickson, GM (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.	gerickson@bio.fsu.edu	Steppan, Scott J./AAR-7865-2020		Committee for Research and Exploration of the National Geographic Society; National Science Foundation [IOB-0623791/BIO326U-02, EAR 04418649, EAR 0959029, DEB-0841447]; College of Arts and Sciences at FSU; Department of Biology at UF	Committee for Research and Exploration of the National Geographic Society(National Geographic Society); National Science Foundation(National Science Foundation (NSF)); College of Arts and Sciences at FSU; Department of Biology at UF	This research was partially supported by a grant from the Committee for Research and Exploration of the National Geographic Society presented to GME, National Science Foundation grants, IOB-0623791/BIO326U-02 presented to AKL, EAR 04418649 and EAR 0959029 presented to GME, and DEB-0841447 to SJS, and finally research funds from the College of Arts and Sciences at FSU and Department of Biology at UF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RM, 1981, SCI PROGRESS-UK, V67, P109; Anderson PSL, 2007, BIOL LETTERS, V3, P76, DOI 10.1098/rsbl.2006.0569; Binder WJ, 2000, J ZOOL, V252, P273, DOI 10.1111/j.1469-7998.2000.tb00622.x; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Borteiro C, 2009, STUD NEOTROP FAUNA E, V44, P31, DOI 10.1080/01650520802507572; Brochu CA, 2003, ANNU REV EARTH PL SC, V31, P357, DOI 10.1146/annurev.earth.31.100901.141308; Brochu CA, 2001, AM ZOOL, V41, P564, DOI 10.1668/0003-1569(2001)041[0564:CSISAT]2.0.CO;2; Brochu CA, 1999, J VERTEBR PALEONTOL, V19, P9, DOI 10.1080/02724634.1999.10011201; Brochu CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009333; BUSBEY AB, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P173; Carter DR, 2001, SKELETAL FUNCTION FO; Endo H, 2002, ANAT HISTOL EMBRYOL, V31, P206, DOI 10.1046/j.1439-0264.2002.00396.x; Erickson GM, 2004, J ZOOL, V262, P21, DOI 10.1017/S0952836903004400; Erickson GM, 1996, COPEIA, P739; Erickson GM, 2003, J ZOOL, V260, P317, DOI 10.1017/S0952836903003819; Erickson GM, 2002, ANAT RECORD, V268, P115, DOI 10.1002/ar.10145; Erickson GM, 1996, NATURE, V382, P706, DOI 10.1038/382706a0; Farlow JO, 2005, J VERTEBR PALEONTOL, V25, P354, DOI 10.1671/0272-4634(2005)025[0354:FDABSO]2.0.CO;2; Frey E., 1982, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V164, P194; Gatesy J, 2004, SYST BIOL, V53, P342, DOI 10.1080/10635150490423971; Gatesy J, 2008, MOL PHYLOGENET EVOL, V48, P1232, DOI 10.1016/j.ympev.2008.02.009; Huchzermeyer F.W., 2003, CROCODILES BIOL HUSB; IORDANSKY N. N., 1964, ANAT ANZ, V115, P256; KEMBEL SW, 2009, PICANTE R TOOLS INTE; King F. W., 1989, CROCODILIAN TUATARA; Lucas P., 2004, DENT FUNCTIONAL MORP; MADDISON DR, MACCLADE 4 ANAL PHYL; Maddison W.P., 2008, MESQUITE MODULAR SYS; MAGNUSSON WE, 1991, J HERPETOL, V25, P41, DOI 10.2307/1564793; McAliley LR, 2006, MOL PHYLOGENET EVOL, V39, P16, DOI 10.1016/j.ympev.2006.01.012; Mchenry CR, 2006, ANAT REC PART A, V288A, P827, DOI 10.1002/ar.a.20360; Meganathan PR, 2010, MOL PHYLOGENET EVOL, V57, P393, DOI 10.1016/j.ympev.2010.06.011; Meredith RW, 2011, MOL PHYLOGENET EVOL, V60, P183, DOI 10.1016/j.ympev.2011.03.026; Midford PE, PDAP PDTREE PACKAGE; Milian-Garcia Y, 2011, J EXP ZOOL PART A, V315A, P358, DOI 10.1002/jez.683; Mook C. C., 1941, ANN CARNEGIE MUS, V28, P207; Neill W. T., 1971, LAST RULING REPTILES; PARRISH JM, 1987, PALEOBIOLOGY, V13, P396; Pierce SE, 2008, J MORPHOL, V269, P840, DOI 10.1002/jmor.10627; Pooley A.C., 1989, P76; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; R Development Core Team, 2009, R FDN STAT COMP; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Sanderson MJ, 2006, BIOINFORMATICS, V22, P1004, DOI 10.1093/bioinformatics/btl044; Schumacher GH, 1973, BIOL REPTILIA, V4, P101; SNODGRASS JM, 1967, SHARKS SKATES RAYS, P331; SWOFFORD DL, PAUP PHYLOGENETIC AN; THORBJARNARSON JB, 1990, J HERPETOL, V24, P99, DOI 10.2307/1564301; Webb G., 1989, CROCODILES AUSTR; WEBB GJW, 1978, AUST J ZOOL, V26, P1; Wermuth H, 1978, BESTIMMEN KROKODILEN; Zhang M, 2011, MOL PHYLOGENET EVOL, V60, P62, DOI 10.1016/j.ympev.2011.03.029	52	127	133	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e31781	10.1371/journal.pone.0031781	http://dx.doi.org/10.1371/journal.pone.0031781			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22431965	Green Submitted, Green Published, gold			2022-12-25	WOS:000303198600008
J	Ungvari, I; Hullam, G; Antal, P; Kiszel, PS; Gezsi, A; Hadadi, E; Virag, V; Hajos, G; Millinghoffer, A; Nagy, A; Kiss, A; Semsei, AF; Temesi, G; Melegh, B; Kisfali, P; Szell, M; Bikov, A; Galffy, G; Tamasi, L; Falus, A; Szalai, C				Ungvari, Ildiko; Hullam, Gabor; Antal, Peter; Kiszel, Petra Sz; Gezsi, Andras; Hadadi, Eva; Virag, Viktor; Hajos, Gergely; Millinghoffer, Andras; Nagy, Adrienne; Kiss, Andras; Semsei, Agnes F.; Temesi, Gergely; Melegh, Bela; Kisfali, Peter; Szell, Marta; Bikov, Andras; Galffy, Gabriella; Tamasi, Lilla; Falus, Andras; Szalai, Csaba			Evaluation of a Partial Genome Screening of Two Asthma Susceptibility Regions Using Bayesian Network Based Bayesian Multilevel Analysis of Relevance	PLOS ONE			English	Article							SIZE-CONTROL; GENE; ASSOCIATION; RECEPTOR; POLYMORPHISMS; EXPRESSION; LINKAGE; ATOPY; INDUCTION; DISCOVERY	Genetic studies indicate high number of potential factors related to asthma. Based on earlier linkage analyses we selected the 11q13 and 14q22 asthma susceptibility regions, for which we designed a partial genome screening study using 145 SNPs in 1201 individuals (436 asthmatic children and 765 controls). The results were evaluated with traditional frequentist methods and we applied a new statistical method, called Bayesian network based Bayesian multilevel analysis of relevance (BN-BMLA). This method uses Bayesian network representation to provide detailed characterization of the relevance of factors, such as joint significance, the type of dependency, and multi-target aspects. We estimated posteriors for these relations within the Bayesian statistical framework, in order to estimate the posteriors whether a variable is directly relevant or its association is only mediated. With frequentist methods one SNP (rs3751464 in the FRMD6 gene) provided evidence for an association with asthma (OR = 1.43(1.2-1.8); p = 3610 24). The possible role of the FRMD6 gene in asthma was also confirmed in an animal model and human asthmatics. In the BN-BMLA analysis altogether 5 SNPs in 4 genes were found relevant in connection with asthma phenotype: PRPF19 on chromosome 11, and FRMD6, PTGER2 and PTGDR on chromosome 14. In a subsequent step a partial dataset containing rhinitis and further clinical parameters was used, which allowed the analysis of relevance of SNPs for asthma and multiple targets. These analyses suggested that SNPs in the AHNAK and MS4A2 genes were indirectly associated with asthma. This paper indicates that BN-BMLA explores the relevant factors more comprehensively than traditional statistical methods and extends the scope of strong relevance based methods to include partial relevance, global characterization of relevance and multi-target relevance.	[Ungvari, Ildiko; Kiszel, Petra Sz; Gezsi, Andras; Hadadi, Eva; Virag, Viktor; Falus, Andras] Semmelweis Univ, Dept Genet Cell & Immunobiol, Budapest, Hungary; [Hullam, Gabor; Antal, Peter; Hajos, Gergely; Millinghoffer, Andras] Univ Technol & Econ, Dept Measurement & Informat Syst, Budapest, Hungary; [Nagy, Adrienne; Kiss, Andras; Szalai, Csaba] Heim Pal Children Hosp, Budapest, Hungary; [Semsei, Agnes F.; Falus, Andras; Szalai, Csaba] Semmelweis Univ, Hungarian Acad Sci, Inflammat Biol & Immunogenom Res Grp, Budapest, Hungary; [Temesi, Gergely; Szalai, Csaba] Csertex Res Lab, Budapest, Hungary; [Melegh, Bela; Kisfali, Peter] Univ Pecs, Dept Med Genet, Pecs, Hungary; [Szell, Marta] Hungarian Acad Sci, Dermatol Res Grp, Szeged, Hungary; [Bikov, Andras; Galffy, Gabriella; Tamasi, Lilla] Semmelweis Univ, Dept Pulmonol, Budapest, Hungary	Semmelweis University; Budapest University of Technology & Economics; Hungarian Academy of Sciences; Semmelweis University; University of Pecs; Hungarian Academy of Sciences; Semmelweis University	Ungvari, I (corresponding author), Semmelweis Univ, Dept Genet Cell & Immunobiol, Budapest, Hungary.	genomika.cs@gmail.com	Bikov, Andras/I-1719-2019; Hadadi, Eva/P-7322-2018; Antal, Peter/G-7894-2012; Kiss, András/K-5649-2017; Temesi, Gergely/H-7240-2012	Bikov, Andras/0000-0002-8983-740X; Hadadi, Eva/0000-0002-5253-814X; Antal, Peter/0000-0002-4370-2198; Kiss, András/0000-0002-7453-3163; Temesi, Gergely/0000-0002-3423-2200; Semsei, Agnes F./0000-0002-8709-2459; Falus, Andras/0000-0002-6843-6789; Hullam, Gabor/0000-0002-4765-2351	OTKA (Hungarian Scientific Research Fund) [K81941]; ETT (Ministry of Health, Hungary) [415/2009]; OTKAPD [76348]; Hungarian Academy of Science; NKTH (National Research and Technology) [TECH_08-A1/2-2008-0120]; New Szechenyi Plan [TAMOP-4.2.1/B-09/1/KMR-2010-0002];  [TS/2 044707]	OTKA (Hungarian Scientific Research Fund)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); ETT (Ministry of Health, Hungary); OTKAPD(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Academy of Science(Hungarian Academy of Sciences); NKTH (National Research and Technology)(National Office for Research and Technology); New Szechenyi Plan; 	This study was supported by OTKA (Hungarian Scientific Research Fund): K81941 (Dr. Szalai); TS/2 044707 (Dr. Falus); and ETT (Ministry of Health, Hungary) 415/2009 (Dr. Szalai), OTKAPD (Hungarian Scientific Research Fund): 76348 (Dr. Antal), Bolyai Grant (Hungarian Academy of Science): (Dr. Antal) and NKTH (National Research and Technology) TECH_08-A1/2-2008-0120: (Dr. Falus). This work is connected to the scientific program of the Development of quality-oriented and harmonized R+D+I strategy and functional model at BME project. This project is supported by the New Szechenyi Plan (Project ID: TAMOP-4.2.1/B-09/1/KMR-2010-0002). Web pages for the funding organizations: OTKA: http://www.otka.hu/NKTH: www.nih.gov.hu ETT: http://www.ett.hu/palyazat.htm Bolyai Grant: http://www.bolyaitestamentum.hu/?m=24 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliferis CF, 2010, J MACH LEARN RES, V11, P171; Antal P, 2010, IMMUNOMICS REV, V3, P157, DOI 10.1007/978-1-4419-0540-6_11; ANTAL P, 2006, P 3 EUR WORKSH PROB, P9; Antal P., 2008, P C WORKSH J MACH LE, P74; COOPER GF, 1992, MACH LEARN, V9, P309, DOI 10.1007/BF00994110; Daniels SE, 1996, NATURE, V383, P247, DOI 10.1038/383247a0; de Boer WI, 2008, CAN J PHYSIOL PHARM, V86, P105, DOI [10.1139/Y08-004, 10.1139/y08-004]; Denham S, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-38; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Friedman N, 2003, MACH LEARN, V50, P95, DOI 10.1023/A:1020249912095; Friedman N, 1999, UNCERTAINTY IN ARTIFICIAL INTELLIGENCE, PROCEEDINGS, P196; Friedman N, 1999, ARTIFICIAL INTELLIGENCE AND STATISTICS 99, PROCEEDINGS, P197; Ge XN, 2010, J IMMUNOL, V185, P1205, DOI 10.4049/jimmunol.1000039; Gelman Andrew, 1995, BAYESIAN DATA ANAL; Giudici P, 2003, MACH LEARN, V50, P127, DOI 10.1023/A:1020202028934; Glymour C, COMPUTATION CAUSATIO; Heallen T, 2011, SCIENCE, V332, P458, DOI 10.1126/science.1199010; Hill MR, 1996, HUM MOL GENET, V5, P959, DOI 10.1093/hmg/5.7.959; Holgate Stephen T, 2009, Proc Am Thorac Soc, V6, P655, DOI 10.1513/pats.200907-072DP; Holgate ST, 2009, IMMUNITY, V31, P362, DOI 10.1016/j.immuni.2009.08.013; Honda K, 2003, J EXP MED, V198, P533, DOI 10.1084/jem.20022218; Huang JL, 2004, HUM MOL GENET, V13, P2691, DOI 10.1093/hmg/ddh279; Hullam G, 2010, JMLR WORKSH CONF PRO, V8, P30; John G.H., 1994, MACH LEARN P 11 INT; Kamada F, 2007, INT ARCH ALLERGY IMM, V144, P275, DOI 10.1159/000106316; Kim IY, 2010, BIOCHEM BIOPH RES CO, V403, P428, DOI 10.1016/j.bbrc.2010.11.048; Ku MS, 2011, CLIN EXP ALLERGY, V41, P794, DOI 10.1111/j.1365-2222.2010.03679.x; Legerski RJ, 2009, CELL CYCLE, V8, P3448, DOI 10.4161/cc.8.21.9760; Leung TF, 2009, PEDIAT ALLERG IMM-UK, V20, P556, DOI 10.1111/j.1399-3038.2008.00835.x; Li H, 2009, J INVEST ALLERG CLIN, V19, P391; Li XN, 2010, J ALLERGY CLIN IMMUN, V125, P328, DOI 10.1016/j.jaci.2009.11.018; Liu JS, 2001, MONTE CARLO STRATEGI, pxvi; Madigan D, 1996, COMMUN STAT THEORY, V25, P2493, DOI 10.1080/03610929608831853; Marsh DG, 1997, NAT GENET, V15, P389; Michel S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013894; Moore JH, 2006, J THEOR BIOL, V241, P252, DOI 10.1016/j.jtbi.2005.11.036; Moore JH, 2010, BIOINFORMATICS, V26, P445, DOI 10.1093/bioinformatics/btp713; Oguma T, 2004, NEW ENGL J MED, V351, P1752, DOI 10.1056/NEJMoa031785; Park BL, 2010, BMB REP, V43, P445, DOI 10.5483/BMBRep.2010.43.6.445; Park HW, 2007, CLIN EXP ALLERGY, V37, P1609, DOI 10.1111/j.1365-2222.2007.02820.x; Pe'er D, 2001, Bioinformatics, V17 Suppl 1, pS215; PEARL J, 1988, PROBABILISTIC REASON, pR19; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Ricci G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016912; Stephens M, 2009, NAT REV GENET, V10, P681, DOI 10.1038/nrg2615; Sturm EM, 2008, J IMMUNOL, V181, P7273, DOI 10.4049/jimmunol.181.10.7273; Thomas NS, 2000, AM J RESP CRIT CARE, V162, P1268, DOI 10.1164/ajrccm.162.4.9909078; Tolgyesi G, 2009, INT IMMUNOL, V21, P967, DOI 10.1093/intimm/dxp063; Tsamardinos I, 2003, P ART INT STAT, P334; Voglauer R, 2006, EXP CELL RES, V312, P746, DOI 10.1016/j.yexcr.2005.11.025; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Xing H, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001105; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zhu SK, 2000, AM J RESP CRIT CARE, V161, P1655, DOI 10.1164/ajrccm.161.5.9906086	54	35	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e33573	10.1371/journal.pone.0033573	http://dx.doi.org/10.1371/journal.pone.0033573			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22432035	gold, Green Published, Green Submitted			2022-12-25	WOS:000303198600078
J	Anjubault, T; Martin, J; Hubert, FX; Chauvin, C; Heymann, D; Josien, R				Anjubault, Thomas; Martin, Jerome; Hubert, Francois-Xavier; Chauvin, Camille; Heymann, Dominique; Josien, Regis			Constitutive Expression of TNF-Related Activation-Induced Cytokine (TRANCE)/Receptor Activating NF-kappa B Ligand (RANK)-L by Rat Plasmacytoid Dendritic Cells	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; FACTOR FAMILY-MEMBER; INTERFERON-PRODUCING CELLS; T-CELLS; OSTEOCLAST DIFFERENTIATION; OSTEOPROTEGERIN LIGAND; BONE LOSS; TRANCE; SUBSETS; RECEPTOR	Plasmacytoid dendritic cells (pDCs) are a subset of DCs whose major function relies on their capacity to produce large amount of type I IFN upon stimulation via TLR 7 and 9. This function is evolutionary conserved and place pDC in critical position in the innate immune response to virus. Here we show that rat pDC constitutively express TNF-related activation-induced cytokine (TRANCE) also known as Receptor-activating NF-kappa B ligand (RANKL). TRANCE/RANKL is a member of the TNF superfamily which plays a central role in osteoclastogenesis through its interaction with its receptor RANK. TRANCE/RANK interaction are also involved in lymphoid organogenesis as well as T cell/DC cross talk. Unlike conventional DC, rat CD4(high) pDC were shown to constitutively express TRANCE/RANKL both at the mRNA and the surface protein level. TRANCE/RANKL was also induced on the CD4(low) subsets of pDC following activation by CpG. The secreted form of TRANCE/RANKL was also produced by rat pDC. Of note, levels of mRNA, surface and secreted TRANCE/RANKL expression were similar to that observed for activated T cells. TRANCE/RANKL expression was found on pDC in all lymphoid organs as well blood and BM with a maximum expression in mesenteric lymph nodes. Despite this TRANCE/RANKL expression, we were unable to demonstrate in vitro osteoclastogenesis activity for rat pDC. Taken together, these data identifies pDC as novel source of TRANCE/RANKL in the immune system.	[Anjubault, Thomas; Martin, Jerome; Hubert, Francois-Xavier; Chauvin, Camille; Josien, Regis] INSERM UMR 1064, Nantes, France; [Anjubault, Thomas; Martin, Jerome; Hubert, Francois-Xavier; Chauvin, Camille; Josien, Regis] CHU Nantes, ITUN, F-44035 Nantes 01, France; [Martin, Jerome; Josien, Regis] CHU Nantes, Immunol Lab, F-44035 Nantes 01, France; [Heymann, Dominique] INSERM UMR 791, Nantes, France; [Heymann, Dominique; Josien, Regis] Univ Nantes, Fac Med, Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite	Anjubault, T (corresponding author), Thermo Fisher Sci, Clin Diagnost Div, Cergy Pontoise, France.	Regis.josien@univ-nantes.fr	Martin, Jerome/GZG-4189-2022; Josien, Regis/U-4405-2019; Heymann, Dominique/AAC-6014-2019; Josien, Regis/L-7468-2015	Heymann, Dominique/0000-0001-7777-0669; Josien, Regis/0000-0001-7900-7413; Martin, Jerome/0000-0003-0068-8776	Fondation de Cooperation Scientifique CENTAURE; Progreffe Foundation	Fondation de Cooperation Scientifique CENTAURE; Progreffe Foundation	This study was supported in part by Fondation de Cooperation Scientifique CENTAURE. TA was supported by the Progreffe Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Asselin-Paturel C, 2005, J EXP MED, V202, P461, DOI 10.1084/jem.20051395; Avnet S, 2007, INT J ONCOL, V30, P469; Bachmann MF, 1999, J EXP MED, V189, P1025, DOI 10.1084/jem.189.7.1025; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Blasius AL, 2006, BLOOD, V107, P2474, DOI 10.1182/blood-2005-09-3746; Chaperot L, 2006, J IMMUNOL, V176, P248, DOI 10.4049/jimmunol.176.1.248; Choi Y, 2001, EUR J IMMUNOL, V31, P2179, DOI 10.1002/1521-4141(200107)31:7<2179::AID-IMMU2179>3.0.CO;2-X; Cisse B, 2008, CELL, V135, P37, DOI 10.1016/j.cell.2008.09.016; Emery JG, 1998, J BIOL CHEM, V273, P14363, DOI 10.1074/jbc.273.23.14363; FACCHETTI F, 1988, AM J PATHOL, V133, P15; Grouard G, 1997, J EXP MED, V185, P1101, DOI 10.1084/jem.185.6.1101; Hadeiba H, 2008, NAT IMMUNOL, V9, P1253, DOI 10.1038/ni.1658; Hubert FX, 2006, J IMMUNOL, V177, P1007, DOI 10.4049/jimmunol.177.2.1007; Hubert FX, 2004, J IMMUNOL, V172, P7485, DOI 10.4049/jimmunol.172.12.7485; Josien R, 2000, J EXP MED, V191, P495, DOI 10.1084/jem.191.3.495; Josien R, 1999, J IMMUNOL, V162, P2562; Kawai T, 2006, AM J PATHOL, V169, P987, DOI 10.2353/ajpath.2006.060180; Kim D, 2000, J EXP MED, V192, P1467, DOI 10.1084/jem.192.10.1467; Kong YY, 1999, NATURE, V402, P304, DOI 10.1038/35005552; Kramer JM, 2007, J PERIODONTOL, V78, P1083, DOI 10.1902/jop.2007.060392; Kuwajima S, 2006, NAT IMMUNOL, V7, P740, DOI 10.1038/ni1348; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lane PJL, 2006, INT J HEMATOL, V83, P12, DOI 10.1532/IJH97.05117; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Lum L, 1999, J BIOL CHEM, V274, P13613, DOI 10.1074/jbc.274.19.13613; Matsui T, 2009, J IMMUNOL, V182, P6815, DOI 10.4049/jimmunol.0802008; Pulendran B, 2004, IMMUNOL REV, V199, P227, DOI 10.1111/j.0105-2896.2004.00144.x; Schwab N, 2010, J IMMUNOL, V184, P5368, DOI 10.4049/jimmunol.0903662; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Tan W, 2011, NATURE, V470, P548, DOI 10.1038/nature09707; Theill LE, 2002, ANNU REV IMMUNOL, V20, P795, DOI 10.1146/annurev.immunol.20.100301.064753; Treilleux I, 2004, CLIN CANCER RES, V10, P7466, DOI 10.1158/1078-0432.CCR-04-0684; Voisine C, 2002, J IMMUNOL, V169, P2284, DOI 10.4049/jimmunol.169.5.2284; Wong BR, 1997, J EXP MED, V186, P2075, DOI 10.1084/jem.186.12.2075; Yang GX, 2005, J IMMUNOL, V174, P3197, DOI 10.4049/jimmunol.174.6.3197; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Yoneyama H, 2005, J EXP MED, V202, P425, DOI 10.1084/jem.20041961	39	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2012	7	3							e33713	10.1371/journal.pone.0033713	http://dx.doi.org/10.1371/journal.pone.0033713			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930IA	22428075	Green Published, gold			2022-12-25	WOS:000303129700072
J	Suenaga, K; Lee, KY; Nakamori, M; Tatsumi, Y; Takahashi, MP; Fujimura, H; Jinnai, K; Yoshikawa, H; Du, HQ; Ares, M; Swanson, MS; Kimura, T				Suenaga, Koichi; Lee, Kuang-Yung; Nakamori, Masayuki; Tatsumi, Yoshiki; Takahashi, Masanori P.; Fujimura, Harutoshi; Jinnai, Kenji; Yoshikawa, Hiroo; Du, Hongqing; Ares, Manuel, Jr.; Swanson, Maurice S.; Kimura, Takashi			Muscleblind-Like 1 Knockout Mice Reveal Novel Splicing Defects in the Myotonic Dystrophy Brain	PLOS ONE			English	Article							PROTEIN-KINASE-II; BINDING-PROTEIN; NUCLEAR FOCI; MOUSE MODELS; TYPE-1; TAU; REPEAT; CELLS; OVEREXPRESSION; DOUBLECORTIN	Myotonic dystrophy type 1 (DM1) is a multi-systemic disorder caused by a CTG trinucleotide repeat expansion (CTG(exp)) in the DMPK gene. In skeletal muscle, nuclear sequestration of the alternative splicing factor muscleblind-like 1 (MBNL1) explains the majority of the alternative splicing defects observed in the HSA(LR) transgenic mouse model which expresses a pathogenic range CTG(exp). In the present study, we addressed the possibility that MBNL1 sequestration by CUG(exp) RNA also contributes to splicing defects in the mammalian brain. We examined RNA from the brains of homozygous Mbnl1(Delta E3/Delta E3) knockout mice using splicing-sensitive microarrays. We used RT-PCR to validate a subset of alternative cassette exons identified by microarray analysis with brain tissues from Mbnl1(Delta E3/Delta E3) knockout mice and post-mortem DM1 patients. Surprisingly, splicing-sensitive microarray analysis of Mbnl1(Delta E3/Delta E3) brains yielded only 14 candidates for mis-spliced exons. While we confirmed that several of these splicing events are perturbed in both Mbnl1 knockout and DM1 brains, the extent of splicing mis-regulation in the mouse model was significantly less than observed in DM1. Additionally, several alternative exons, including Grin1 exon 4, App exon 7 and Mapt exons 3 and 9, which have previously been reported to be aberrantly spliced in human DM1 brain, were spliced normally in the Mbnl1 knockout brain. The sequestration of MBNL1 by CUG(exp) RNA results in some of the aberrant splicing events in the DM1 brain. However, we conclude that other factors, possibly other MBNL proteins, likely contribute to splicing mis-regulation in the DM1 brain.	[Suenaga, Koichi; Tatsumi, Yoshiki; Yoshikawa, Hiroo; Kimura, Takashi] Hyogo Coll Med, Dept Internal Med, Div Neurol, Nishinomiya, Hyogo 6638501, Japan; [Lee, Kuang-Yung; Swanson, Maurice S.] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL USA; [Lee, Kuang-Yung] Chang Gung Mem Hosp, Dept Neurol, Keelung, Taiwan; [Nakamori, Masayuki; Takahashi, Masanori P.] Osaka Univ, Grad Sch Med, Dept Neurol, Suita, Osaka, Japan; [Fujimura, Harutoshi] Natl Hosp Org Toneyama Hosp, Dept Neurol, Toyonaka, Osaka, Japan; [Jinnai, Kenji] Natl Hosp Org Hyogo Chuo Hosp, Dept Neurol, Ohara, Hyogo, Japan; [Ares, Manuel, Jr.] Univ Calif Santa Cruz, Sinsheimer Labs, RNA Ctr, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA	Hyogo College of Medicine; State University System of Florida; University of Florida; Chang Gung Memorial Hospital; Osaka University; University of California System; University of California Santa Cruz	Kimura, T (corresponding author), Hyogo Coll Med, Dept Internal Med, Div Neurol, Nishinomiya, Hyogo 6638501, Japan.	kimura@hyo-med.ac.jp	Takahashi, Masanori/O-8946-2019; Nakamori, Masayuki/ABE-2169-2020	Takahashi, Masanori/0000-0002-5513-5012; Nakamori, Masayuki/0000-0003-4714-3044; Swanson, Maurice/0000-0001-6245-5367; Ares, Manny/0000-0002-2552-9168	Ministry of Health Labour and Welfare [22-118]; JSPS [23591258]; National Institutes of Health (NIH) [NS058901, GM084317]; Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP [22-7]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046799] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS058901] Funding Source: NIH RePORTER	Ministry of Health Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP(National Center for Neurology & Psychiatry - Japan); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	TK was supported by Research Grant for Intractable Disease from the Ministry of Health Labour and Welfare 22-118 and Grants-in-aid for Scientific Research from JSPS 23591258. MSS was supported by the National Institutes of Health (NIH) grant NS058901. MA was supported by the NIH grant GM084317. KJ was supported by the Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP 22-7. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burgess HA, 2002, J BIOL CHEM, V277, P17696, DOI 10.1074/jbc.M111981200; Castel AL, 2011, HUM MOL GENET, V20, P1, DOI 10.1093/hmg/ddq427; Ciafaloni E, 2008, NEUROLOGY, V70, P226, DOI 10.1212/01.wnl.0000296827.20167.98; Dhaenens CM, 2008, EXP NEUROL, V210, P467, DOI 10.1016/j.expneurol.2007.11.020; Dhaenens CM, 2011, BBA-MOL BASIS DIS, V1812, P732, DOI 10.1016/j.bbadis.2011.03.010; Donai H, 2000, MOL BRAIN RES, V85, P189, DOI 10.1016/S0169-328X(00)00221-7; Du HQ, 2010, NAT STRUCT MOL BIOL, V17, P187, DOI 10.1038/nsmb.1720; Fardaei M, 2002, HUM MOL GENET, V11, P805, DOI 10.1093/hmg/11.7.805; Gebbink MFBG, 1997, J CELL BIOL, V137, P1603, DOI 10.1083/jcb.137.7.1603; Gomes-Pereira M, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030052; Gonzalez I, 2000, NEUROLOGY, V54, P1218; Harper PS, 2001, MYOTONIC DYSTROPHY; Ho TH, 2004, EMBO J, V23, P3103, DOI 10.1038/sj.emboj.7600300; Jiang H, 2004, HUM MOL GENET, V13, P3079, DOI 10.1093/hmg/ddh327; Kalsotra A, 2008, P NATL ACAD SCI USA, V105, P20333, DOI 10.1073/pnas.0809045105; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; Kataoka M, 2004, EUR J BIOCHEM, V271, P2241, DOI 10.1111/j.1432-1033.2004.04161.x; Lebre AS, 2001, HUM MOL GENET, V10, P1201, DOI 10.1093/hmg/10.11.1201; Leroy O, 2006, BBA-MOL BASIS DIS, V1762, P460, DOI 10.1016/j.bbadis.2005.12.003; Lin PT, 2000, J NEUROSCI, V20, P9152; Mankodi A, 2000, SCIENCE, V289, P1769, DOI 10.1126/science.289.5485.1769; Matynia A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009857; Meola G, 2007, MUSCLE NERVE, V36, P294, DOI 10.1002/mus.20800; Mulder J, 2004, MOL BIOL CELL, V15, P5516, DOI 10.1091/mbc.E04-04-0275; Nomura K, 2003, J NEUROSCI RES, V72, P384, DOI 10.1002/jnr.10581; ONO S, 1989, ACTA NEUROPATHOL, V77, P350, DOI 10.1007/BF00687369; Ono S, 1996, NEUROLOGY, V46, P228, DOI 10.1212/WNL.46.1.228; Ribon V, 1998, MOL CELL BIOL, V18, P872, DOI 10.1128/MCB.18.2.872; Sergeant N, 2001, HUM MOL GENET, V10, P2143, DOI 10.1093/hmg/10.19.2143; Sicot G, 2011, HUM MOL GENET, V20, pR116, DOI 10.1093/hmg/ddr343; Sugnet CW, 2006, PLOS COMPUT BIOL, V2, P22, DOI 10.1371/journal.pcbi.0020004; Takeuchi Y, 2004, J NEUROSCI RES, V75, P480, DOI 10.1002/jnr.20010; Vermersch P, 1996, NEUROLOGY, V47, P711, DOI 10.1212/WNL.47.3.711; Xu XD, 2005, CELL, V120, P59, DOI 10.1016/j.cell.2004.11.036	34	60	60	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2012	7	3							e33218	10.1371/journal.pone.0033218	http://dx.doi.org/10.1371/journal.pone.0033218			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930IA	22427994	Green Published, gold, Green Submitted			2022-12-25	WOS:000303129700040
J	Kang, JH; Chang, YC; Maurizi, MR				Kang, Jeong Han; Chang, Young-Chae; Maurizi, Michael R.			4-O-Carboxymethyl Ascochlorin Causes ER Stress and Induced Autophagy in Human Hepatocellular Carcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED-PROTEIN RESPONSE; SIGNALING PATHWAY; GENE-EXPRESSION; LON PROTEASE; IN-VIVO; ACTIVATION; APOPTOSIS; CHOP; AS-6	The synthetic derivative of ascochlorin, 4-O-carboxymethyl ascochlorin (AS-6) is an agonist of the nuclear hormone receptor PPAR gamma and has been shown to induce differentiation in mouse pre-adipocytes and to ameliorate type II diabetes in a murine model. AS-6 was cytotoxic when added at micromolar concentrations to cultures of three different human cancer cell lines. We used gel electrophoresis and mass spectrometry to identify proteins with altered expression in human hepatocarcinoma cells (HepG2) cells after 12 h in the presence of AS-6 and found 58 proteins that were differentially expressed. Many of the proteins showing increased expression in cells treated with AS-6 are involved in protein quality control, including glucose-regulated protein 78 (GRP78/BiP), a regulator of ER stress responses, and the transcriptional regulator CHOP, which mediates ER stress-induced apoptosis. Cells treated with AS-6 undergo an autophagic response accompanied by increased expression of beclin1, ATG5, and LC3-II and autophagosome formation marked by the appearance of large vesicles containing LC3-II. Grp78 induction was inhibited when the PPAR gamma antagonist, GW9662, was added together with AS-6, and autophagy and cell death were partially blocked. 3-methyl-adenine (3-MA), an inhibitor of phosphatidyl inositol 3-kinase (PI3-kinase) prevented induction of ATG5 and activation of LC3-II and blocked autophagosome formation. 3-MA also blocked induction of GRP78 and CHOP, suggesting that PI3-kinase, which is known to mediate ER stress-induced autophagy, also plays a role in initiating apoptosis in response to ER stress. Together these data establish that the cytotoxicity of AS-6 operates by a mechanism dependent on ER stress-induced autophagy and apoptosis.	[Kang, Jeong Han; Maurizi, Michael R.] NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA; [Chang, Young-Chae] Catholic Univ Daegu, Sch Med, Dept Pathol, Res Inst Biomed Engn, Namgu 705718, Daegu, South Korea	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Catholic University of Daegu	Maurizi, MR (corresponding author), NCI, Cell Biol Lab, NIH, Bldg 37,Room 2128,37 Convent Dr, Bethesda, MD 20892 USA.	mmaurizi@helix.nih.gov	Kang, Jeong-Han/J-3541-2019	Kang, Jeong-Han/0000-0002-9693-0696	Center for Cancer Research, NCI, National Institutes of Health, Bethesda, MD; NATIONAL CANCER INSTITUTE [ZIABC005597] Funding Source: NIH RePORTER	Center for Cancer Research, NCI, National Institutes of Health, Bethesda, MD; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the Center for Cancer Research, NCI, National Institutes of Health, Bethesda, MD.	Aldridge JE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000874; Backer JM, 2008, BIOCHEM J, V410, P1, DOI 10.1042/BJ20071427; Berry EA, 2010, BBA-BIOENERGETICS, V1797, P360, DOI 10.1016/j.bbabio.2009.12.003; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Chen SN, 2010, BBA-REV CANCER, V1806, P220, DOI 10.1016/j.bbcan.2010.07.003; Ding WX, 2007, J BIOL CHEM, V282, P4702, DOI 10.1074/jbc.M609267200; Entingh AJ, 2001, ENDOCRINOLOGY, V142, P221, DOI 10.1210/en.142.1.221; Fu MG, 2002, BIOCHEM BIOPH RES CO, V294, P597, DOI 10.1016/S0006-291X(02)00533-8; Graves JD, 1998, EMBO J, V17, P2224, DOI 10.1093/emboj/17.8.2224; Hendershot LM, 2004, MT SINAI J MED, V71, P289; Hong S, 2005, J BIOL CHEM, V280, P25202, DOI 10.1074/jbc.M413985200; Hori O, 2002, J CELL BIOL, V157, P1151, DOI 10.1083/jcb.200108103; HOSOKAWA T, 1985, BIOCHEM BIOPH RES CO, V127, P247, DOI 10.1016/S0006-291X(85)80151-0; HOSOKAWA T, 1985, DIABETES, V34, P267, DOI 10.2337/diabetes.34.3.267; Jeong JH, 2009, INT J CANCER, V124, P2797, DOI 10.1002/ijc.24259; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kang JH, 2007, J CELL BIOCHEM, V102, P506, DOI 10.1002/jcb.21312; Kang JH, 2006, J PROTEOME RES, V5, P2620, DOI 10.1021/pr060111i; Kang JH, 2006, PROTEOMICS, V6, P1261, DOI 10.1002/pmic.200500290; Kowluru A, 2005, DIABETES, V54, P3523, DOI 10.2337/diabetes.54.12.3523; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Li J, 2008, CELL DEATH DIFFER, V15, P1460, DOI 10.1038/cdd.2008.81; Nakajima H, 2007, J ANTIBIOT, V60, P682, DOI 10.1038/ja.2007.87; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Park KG, 2006, LIFE SCI, V80, P120, DOI 10.1016/j.lfs.2006.08.030; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Qiu YF, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000514; Rusten TE, 2004, DEV CELL, V7, P179, DOI 10.1016/j.devcel.2004.07.005; Saito S, 2003, BIOCHEM BIOPH RES CO, V311, P17, DOI 10.1016/j.bbrc.2003.09.161; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; TAMURA G, 1968, J ANTIBIOT, V21, P539, DOI 10.7164/antibiotics.21.539; Tanida I, 2008, AUTOPHAGY, V4, P131, DOI 10.4161/auto.5233; Togashi M, 2002, J ANTIBIOT, V55, P417, DOI 10.7164/antibiotics.55.417; WANG N, 1994, J BIOL CHEM, V269, P29308; Wang XZ, 1996, SCIENCE, V272, P1347, DOI 10.1126/science.272.5266.1347; Yan L, 2005, P NATL ACAD SCI USA, V102, P13807, DOI 10.1073/pnas.0506843102; Yorimitsu T, 2007, AUTOPHAGY, V3, P160, DOI 10.4161/auto.3653; Yoshiuchi K, 2009, ENDOCR J, V56, P1103, DOI 10.1507/endocrj.K09E-140; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	42	28	29	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15661	15671		10.1074/jbc.M112.358473	http://dx.doi.org/10.1074/jbc.M112.358473			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22433868	Green Published, hybrid			2022-12-25	WOS:000304006300045
J	Huang, SW; Chan, MY; Hsu, WL; Huang, CC; Tsai, CH				Huang, Shih-Wei; Chan, Meng-Yu; Hsu, Wei-Li; Huang, Chin-Cheng; Tsai, Ching-Hsiu			The 3 '-Terminal Hexamer Sequence of Classical swine fever virus RNA Plays a Role in Negatively Regulating the IRES-Mediated Translation	PLOS ONE			English	Article							RIBOSOME ENTRY SITE; 3' UNTRANSLATED REGION; TRACT-BINDING PROTEIN; HEPATITIS-C; 3'-UNTRANSLATED REGION; ENHANCES TRANSLATION; DEPENDENT TRANSLATION; PHYLOGENETIC ANALYSIS; LA AUTOANTIGEN; MESSENGER-RNA	The 3' untranslated region (UTR) is usually involved in the switch of the translation and replication for a positive-sense RNA virus. To understand the 3' UTR involved in an internal ribosome entry site (IRES)-mediated translation in Classical swine fever virus (CSFV), we first confirmed the predicted secondary structure (designated as SLI, SLII, SLIII, and SLIV) by enzymatic probing. Using a reporter assay in which the luciferase expression is under the control of CSFV 5' and 3' UTRs, we found that the 3' UTR harbors the positive and negative regulatory elements for translational control. Unlike other stem loops, SLI acts as a repressor for expression of the reporter gene. The negative cis-acting element in SLI is further mapped to the very 3'-end hexamer CGGCCC sequence. Further, the CSFV IRES-mediated translation can be enhanced by the heterologous 3'-ends such as the poly(A) or the 3' UTR of Hepatitis C virus (HCV). Interestingly, such an enhancement was repressed by flanking this hexamer to the end of poly(A) or HCV 3' UTR. After sequence comparison and alignment, we have found that this hexamer sequence could hypothetically base pair with the sequence in the IRES IIId1, the 40 S ribosomal subunit binding site for the translational initiation, located at the 5' UTR. In conclusion, we have found that the 3'-end terminal sequence can play a role in regulating the translation of CSFV.	[Huang, Shih-Wei; Chan, Meng-Yu; Tsai, Ching-Hsiu] Natl Chung Hsing Univ, Grad Inst Biotechnol, Taichung 40227, Taiwan; [Hsu, Wei-Li] Natl Chung Hsing Univ, Grad Inst Microbiol & Publ Hlth, Taichung 40227, Taiwan; [Huang, Chin-Cheng] Council Agr, Anim Hlth Res Inst, Dept Hog Cholera, Taipei, Taiwan; [Tsai, Ching-Hsiu] China Med Univ, Grad Inst Med Lab Sci & Biotechnol, Taichung, Taiwan	National Chung Hsing University; National Chung Hsing University; China Medical University Taiwan	Huang, SW (corresponding author), Natl Chung Hsing Univ, Grad Inst Biotechnol, Taichung 40227, Taiwan.	chtsai1@dragon.nchu.edu.tw	Hsu, Wei-Li/CAF-3821-2022	Hsu, Wei-Li/0000-0002-1392-163X	National Science Council (NSC) [96-2752-B-005-012-PAE, 97-2752-B-005-004-PAE]	National Science Council (NSC)(Ministry of Science and Technology, Taiwan)	This work was supported by grants from National Science Council (NSC 96-2752-B-005-012-PAE and 97-2752-B-005-004-PAE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALI N, 1995, J VIROL, V69, P6367, DOI 10.1128/JVI.69.10.6367-6375.1995; Bjorklund HV, 1998, VIRUS GENES, V16, P307, DOI 10.1023/A:1008095109033; Blyn LB, 1997, J VIROL, V71, P6243, DOI 10.1128/JVI.71.8.6243-6246.1997; Bradrick SS, 2007, RNA, V13, P1582, DOI 10.1261/rna.556107; Bradrick SS, 2006, NUCLEIC ACIDS RES, V34, P1293, DOI 10.1093/nar/gkl019; Bung C, 2010, FEBS LETT, V584, P837, DOI 10.1016/j.febslet.2010.01.015; Cheng CP, 1999, J MOL BIOL, V288, P555, DOI 10.1006/jmbi.1999.2716; Chiu WW, 2005, J VIROL, V79, P8303, DOI 10.1128/JVI.79.13.8303-8315.2005; Costa-Mattioli M, 2004, MOL CELL BIOL, V24, P6861, DOI 10.1128/mcb.24.15.6861-6870.2004; Daijogo S, 2011, ADV VIRUS RES, V80, P1, DOI 10.1016/B978-0-12-385987-7.00001-4; Deng MC, 2005, VET MICROBIOL, V106, P187, DOI 10.1016/j.vetmic.2004.12.014; DENG RT, 1993, NUCLEIC ACIDS RES, V21, P1949, DOI 10.1093/nar/21.8.1949; Edgil D, 2006, VIRUS RES, V119, P43, DOI 10.1016/j.virusres.2005.10.012; Fraser CS, 2007, NAT REV MICROBIOL, V5, P29, DOI 10.1038/nrmicro1558; Fraser CS, 2009, NAT STRUCT MOL BIOL, V16, P397, DOI 10.1038/nsmb.1572; Friebe P, 2005, J VIROL, V79, P380, DOI 10.1128/JVI.79.1.380-392.2005; Isken O, 2004, RNA, V10, P1637, DOI 10.1261/rna.7290904; Isken O, 2003, EMBO J, V22, P5655, DOI 10.1093/emboj/cdg562; Isken O, 2007, RNA, V13, P1675, DOI 10.1261/rna.594207; Ito T, 1998, J VIROL, V72, P8789, DOI 10.1128/JVI.72.11.8789-8796.1998; Kikuchi K, 2005, NUCLEIC ACIDS RES, V33, P683, DOI 10.1093/nar/gki215; Kim YK, 2001, NUCLEIC ACIDS RES, V29, P5009, DOI 10.1093/nar/29.24.5009; Kolupaeva VG, 2000, RNA, V6, P1791, DOI 10.1017/S1355838200000662; Lin YJ, 2007, VIRUS GENES, V35, P737, DOI 10.1007/s11262-007-0154-4; Liu Y, 2009, BBA-GENE REGUL MECH, V1789, P495, DOI 10.1016/j.bbagrm.2009.09.007; Locker N, 2007, EMBO J, V26, P795, DOI 10.1038/sj.emboj.7601549; Lourenco S, 2008, FEBS J, V275, P4179, DOI 10.1111/j.1742-4658.2008.06566.x; Lukavsky PJ, 2009, VIRUS RES, V139, P166, DOI 10.1016/j.virusres.2008.06.004; Moennig V, 2000, VET MICROBIOL, V73, P93, DOI 10.1016/S0378-1135(00)00137-1; Moormann RJM, 1996, J VIROL, V70, P763, DOI 10.1128/JVI.70.2.763-770.1996; Nadar M, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-340; Pan CH, 2005, ARCH VIROL, V150, P1101, DOI 10.1007/s00705-004-0485-6; Paton DJ, 2003, RES VET SCI, V75, P169, DOI 10.1016/S0034-5288(03)00076-6; Pestova TV, 1998, GENE DEV, V12, P67, DOI 10.1101/gad.12.1.67; Romero-Lopez C, 2009, RNA, V15, P1740, DOI 10.1261/rna.1680809; Schepens B, 2005, NUCLEIC ACIDS RES, V33, P6884, DOI 10.1093/nar/gki1000; SILBERKLANG M, 1977, NUCLEIC ACIDS RES, V4, P4091, DOI 10.1093/nar/4.12.4091; Song YT, 2006, J VIROL, V80, P11579, DOI 10.1128/JVI.00675-06; Tallet-Lopez B, 2003, NUCLEIC ACIDS RES, V31, P734, DOI 10.1093/nar/gkg139; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang LY, 2011, J VIROL, V85, P7954, DOI 10.1128/JVI.00339-11; Weinlich S, 2009, RNA, V15, P1528, DOI 10.1261/rna.1578409; Xiao M, 2004, VIRUS RES, V102, P191, DOI 10.1016/j.virusres.2004.01.029; Xiao M, 2009, J GEN VIROL, V90, P2923, DOI 10.1099/vir.0.014472-0; Zhu ZL, 2010, VIRUS RES, V153, P106, DOI 10.1016/j.virusres.2010.07.013; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	46	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e33764	10.1371/journal.pone.0033764	http://dx.doi.org/10.1371/journal.pone.0033764			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22432046	gold, Green Published, Green Submitted			2022-12-25	WOS:000303198600089
J	Kernaleguen, L; Cazelles, B; Arnould, JPY; Richard, P; Guinet, C; Cherel, Y				Kernaleguen, Laetitia; Cazelles, Bernard; Arnould, John P. Y.; Richard, Pierre; Guinet, Christophe; Cherel, Yves			Long-Term Species, Sexual and Individual Variations in Foraging Strategies of Fur Seals Revealed by Stable Isotopes in Whiskers	PLOS ONE			English	Article							SEASONAL-CHANGES; ARCTOCEPHALUS-GAZELLA; NITROGEN-BALANCE; PHOCA-VITULINA; TROPHIC NICHE; POPULATION; SPECIALIZATION; PREDATORS; PATTERNS; CARBON	Background: Individual variations in the use of the species niche are an important component of diversity in trophic interactions. A challenge in testing consistency of individual foraging strategy is the repeated collection of information on the same individuals. Methodology/Principal Findings: The foraging strategies of sympatric fur seals (Arctocephalus gazella and A. tropicalis) were examined using the stable isotope signature of serially sampled whiskers. Most whiskers exhibited synchronous delta C-13 and delta N-15 oscillations that correspond to the seal annual movements over the long term (up to 8 years). delta C-13 and delta N-15 values were spread over large ranges, with differences between species, sexes and individuals. The main segregating mechanism operates at the spatial scale. Most seals favored foraging in subantarctic waters (where the Crozet Islands are located) where they fed on myctophids. However, A. gazella dispersed in the Antarctic Zone and A. tropicalis more in the subtropics. Gender differences in annual time budget shape the seal movements. Males that do not perform any parental care exhibited large isotopic oscillations reflecting broad annual migrations, while isotopic values of females confined to a limited foraging range during lactation exhibited smaller changes. Limited inter-individual isotopic variations occurred in female seals and in male A. tropicalis. In contrast, male A. gazella showed large inter-individual variations, with some males migrating repeatedly to high-Antarctic waters where they fed on krill, thus meaning that individual specialization occurred over years. Conclusions/Significance: Whisker isotopic signature yields unique long-term information on individual behaviour that integrates the spatial, trophic and temporal dimensions of the ecological niche. The method allows depicting the entire realized niche of the species, including some of its less well-known components such as age-, sex-, individual- and migration-related changes. It highlights intrapopulation heterogeneity in foraging strategies that could have important implications for likely demographic responses to environmental variability.	[Kernaleguen, Laetitia; Guinet, Christophe; Cherel, Yves] CNRS, Ctr Etud Biol Chize, Villiers En Bois, France; [Cazelles, Bernard] Univ Paris 06, CNRS, Ecole Normale Super, Paris, France; [Arnould, John P. Y.] Deakin Univ, Sch Life & Environm Sci, Burwood, Vic, Australia; [Richard, Pierre] Univ La Rochelle, CNRS, La Rochelle, France; [Cazelles, Bernard] Univ Paris 06, Inst Rech Dev, Bondy, France	Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Deakin University; Centre National de la Recherche Scientifique (CNRS); La Rochelle Universite; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Sorbonne Universite	Kernaleguen, L (corresponding author), CNRS, Ctr Etud Biol Chize, Villiers En Bois, France.	cherel@cebc.cnrs.fr	Guinet, Christophe/AAR-8457-2020; Cazelles, Bernard/B-1572-2013; Richard, Pierre J/N-6482-2014	Cazelles, Bernard/0000-0002-7972-361X; Richard, Pierre J/0000-0002-0393-9967	Agence Nationale de la Recherche; Institut Polaire Francais Paul Emile Victor [109]	Agence Nationale de la Recherche(French National Research Agency (ANR)); Institut Polaire Francais Paul Emile Victor	Financial support was provided by the Agence Nationale de la Recherche (program IPSOS-SEAL, C. Guinet) and by the Institut Polaire Francais Paul Emile Victor (Program no. 109, H. Weimerskirch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnould JPY, 2011, MAR ECOL PROG SER, V422, P291, DOI 10.3354/meps08933; Arnould JPY, 1996, PHYSIOL ZOOL, V69, P93, DOI 10.1086/physzool.69.1.30164202; Bailleul F, 2005, MAR ECOL PROG SER, V293, P273, DOI 10.3354/meps293273; Bearhop S, 2000, MAR ECOL PROG SER, V195, P261, DOI 10.3354/meps195261; Bearhop S, 2004, J ANIM ECOL, V73, P1007, DOI 10.1111/j.0021-8790.2004.00861.x; Begon M., 2009, ECOLOGY INDIVIDUALS; Best PB, 1996, MAR BIOL, V124, P483, DOI 10.1007/BF00351030; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Boyd IL, 2002, MAR ECOL PROG SER, V242, P285, DOI 10.3354/meps242285; Boyd IL, 1998, CAN J FISH AQUAT SCI, V55, P845, DOI 10.1139/cjfas-55-4-845; Bradshaw CJA, 2004, ANIM BEHAV, V68, P1349, DOI 10.1016/j.anbehav.2003.12.013; Cazelles B, 2003, J ANIM ECOL, V72, P953, DOI 10.1046/j.1365-2656.2003.00763.x; Cazelles B, 2008, OECOLOGIA, V156, P287, DOI 10.1007/s00442-008-0993-2; Cerling TE, 2009, P NATL ACAD SCI USA, V106, P8093, DOI 10.1073/pnas.0902192106; Cherel Y, 2006, BIOL LETTERS, V2, P301, DOI 10.1098/rsbl.2006.0445; Cherel Y, 2005, ECOLOGY, V86, P2881, DOI 10.1890/05-0562; Cherel Y, 2002, MAR BIOL, V141, P1117, DOI 10.1007/s00227-002-0907-5; Cherel Y, 2009, BIOL LETTERS, V5, P830, DOI 10.1098/rsbl.2009.0552; Cherel Y, 2007, J ANIM ECOL, V76, P826, DOI 10.1111/j.1365-2656.2007.01238.x; Cherel Y, 2007, MAR ECOL PROG SER, V329, P281, DOI 10.3354/meps329281; Fuller BT, 2005, RAPID COMMUN MASS SP, V19, P2497, DOI 10.1002/rcm.2090; Fuller BT, 2004, RAPID COMMUN MASS SP, V18, P2889, DOI 10.1002/rcm.1708; Gonzalez-Solis J, 2007, AQUAT CONSERV, V17, pS22, DOI 10.1002/aqc.911; Green K, 1997, MARINE MAMMAL RESEARCH IN THE SOUTHERN HEMISPHERE, VOL 1, P105; Green K, 1997, MARINE MAMMAL RESEARCH IN THE SOUTHERN HEMISPHERE, VOL 1, P97; Higdon JW, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-216; Hirons AC, 2001, CAN J ZOOL, V79, P1053, DOI 10.1139/z01-055; HOBSON KA, 1994, J ANIM ECOL, V63, P786, DOI 10.2307/5256; Hobson KA, 1996, CAN J FISH AQUAT SCI, V53, P528, DOI 10.1139/cjfas-53-3-528; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Iacumin P, 2005, PALAEOGEOGR PALAEOCL, V218, P317, DOI 10.1016/j.palaeo.2004.12.021; Jaeger A, 2010, RAPID COMMUN MASS SP, V24, P3456, DOI 10.1002/rcm.4792; Jaeger A, 2010, MAR ECOL PROG SER, V401, P269, DOI 10.3354/meps08380; Kingston JJ, 2007, CONSERV GENET, V8, P1133, DOI 10.1007/s10592-006-9269-8; Lowther AD, 2011, MAR ECOL PROG SER, V443, P249, DOI 10.3354/meps09392; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.1; Newsome SD, 2010, MAR MAMMAL SCI, V26, P509, DOI 10.1111/j.1748-7692.2009.00354.x; Newsome SD, 2009, ECOLOGY, V90, P961, DOI 10.1890/07-1812.1; Page B, 2005, MAR ECOL PROG SER, V304, P249, DOI 10.3354/meps304249; Phillips RA, 2005, ECOLOGY, V86, P2386, DOI 10.1890/04-1885; PIANKA ER, 1969, ECOLOGY, V50, P1012, DOI 10.2307/1936893; Pinheiro J, 2001, MIXED EFFECTS MODELS; POLIS GA, 1984, AM NAT, V123, P541, DOI 10.1086/284221; Quillfeldt P, 2010, BEHAV ECOL SOCIOBIOL, V64, P1157, DOI 10.1007/s00265-010-0931-2; Rubenstein DR, 2004, TRENDS ECOL EVOL, V19, P256, DOI 10.1016/j.tree.2004.03.017; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; SHINE R, 1989, Q REV BIOL, V64, P419, DOI 10.1086/416458; Smith TB, 1996, ANNU REV ECOL SYST, V27, P111, DOI 10.1146/annurev.ecolsys.27.1.111; Staniland Iain J., 2005, P53; Staniland IJ, 2008, ANIM BEHAV, V75, P1581, DOI 10.1016/j.anbehav.2007.10.012; Tiunov AV, 2010, RAPID COMMUN MASS SP, V24, P3146, DOI 10.1002/rcm.4755; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Vander Zanden HB, 2010, BIOL LETTERS, V6, P711, DOI 10.1098/rsbl.2010.0124; Wickens P, 1997, MAR MAMMAL SCI, V13, P241, DOI 10.1111/j.1748-7692.1997.tb00631.x; Zhao LY, 2004, MAR ECOL PROG SER, V281, P267, DOI 10.3354/meps281267	56	75	75	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e32916	10.1371/journal.pone.0032916	http://dx.doi.org/10.1371/journal.pone.0032916			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22431988	gold, Green Published			2022-12-25	WOS:000303198600031
J	Tang, YQ; Li, Y; Zhao, JY; Chi, CQ; Huang, LX; Dong, HP; Wu, XL				Tang, Yue-Qin; Li, Yan; Zhao, Jie-Yu; Chi, Chang-Qiao; Huang, Li-Xin; Dong, Han-Ping; Wu, Xiao-Lei			Microbial Communities in Long-Term, Water-Flooded Petroleum Reservoirs with Different in situ Temperatures in the Huabei Oilfield, China	PLOS ONE			English	Article							CONTINENTAL HIGH-TEMPERATURE; SP-NOV.; GEN.-NOV.; NORTH-SEA; MOLECULAR CHARACTERIZATION; PHYLOGENETIC DIVERSITY; DEGRADING BACTERIA; CRUDE-OIL; SEQUENCE; IDENTIFICATION	The distribution of microbial communities in the Menggulin (MGL) and Ba19 blocks in the Huabei Oilfield, China, were studied based on 16S rRNA gene analysis. The dominant microbes showed obvious block-specific characteristics, and the two blocks had substantially different bacterial and archaeal communities. In the moderate-temperature MGL block, the bacteria were mainly Epsilonproteobacteria and Alphaproteobacteria, and the archaea were methanogens belonging to Methanolinea, Methanothermobacter, Methanosaeta, and Methanocella. However, in the high-temperature Ba19 block, the predominant bacteria were Gammaproteobacteria, and the predominant archaea were Methanothermobacter and Methanosaeta. In spite of shared taxa in the blocks, differences among wells in the same block were obvious, especially for bacterial communities in the MGL block. Compared to the bacterial communities, the archaeal communities were much more conserved within blocks and were not affected by the variation in the bacterial communities.	[Tang, Yue-Qin; Li, Yan; Zhao, Jie-Yu; Chi, Chang-Qiao; Wu, Xiao-Lei] Peking Univ, Dept Energy & Resources Engn, Coll Engn, Beijing 100871, Peoples R China; [Tang, Yue-Qin] Sichuan Univ, Coll Architecture & Environm, Chengdu 610064, Sichuan, Peoples R China; [Huang, Li-Xin; Dong, Han-Ping] China Natl Petr Corp, Res Inst Petr Explorat & Dev Langfang, Beijing, Peoples R China	Peking University; Sichuan University; China National Petroleum Corporation	Tang, YQ (corresponding author), Peking Univ, Dept Energy & Resources Engn, Coll Engn, Beijing 100871, Peoples R China.	xiaolei_wu@pku.edu.cn	Zhao, Jieyu/I-1112-2014; Wu, Xiao-Lei/G-6882-2011	Zhao, Jieyu/0000-0001-9707-2227; Wu, Xiao-Lei/0000-0002-9897-6903	National High Technology Research and Development Program of China [2009AA063501]; National Natural Science Foundation of China [30870086, 31070107]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National High Technology Research and Development Program of China (2009AA063501) and the National Natural Science Foundation of China (30870086 and 31070107). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balkwill DL, 1997, INT J SYST BACTERIOL, V47, P191, DOI 10.1099/00207713-47-1-191; Chaillan F, 2004, RES MICROBIOL, V155, P587, DOI 10.1016/j.resmic.2004.04.006; Chou JH, 2008, INT J SYST EVOL MICR, V58, P946, DOI 10.1099/ijs.0.65434-0; Collado L, 2011, INT J SYST EVOL MICR, V61, P2155, DOI 10.1099/ijs.0.025668-0; Dahle H, 2008, ANTON LEEUW INT J G, V93, P37, DOI 10.1007/s10482-007-9177-z; De Wever H, 2000, APPL ENVIRON MICROB, V66, P2297, DOI 10.1128/AEM.66.6.2297-2301.2000; Ficker M, 1999, APPL ENVIRON MICROB, V65, P5576; Fritz I, 2005, INT J SYST EVOL MICR, V55, P479, DOI 10.1099/ijs.0.02852-0; Gittel A, 2009, APPL ENVIRON MICROB, V75, P7086, DOI 10.1128/AEM.01123-09; Grabowski A, 2005, FEMS MICROBIOL ECOL, V54, P427, DOI 10.1016/j.femsec.2005.05.007; Grosskopf R, 1998, APPL ENVIRON MICROB, V64, P960; Han Ping, 2009, Yingyong Shengtai Xuebao, V20, P1202; Ito T, 2004, APPL ENVIRON MICROB, V70, P3122, DOI 10.1128/AEM.70.5.3122-3129.2004; Kalmbach S, 1999, INT J SYST BACTERIOL, V49, P769, DOI 10.1099/00207713-49-2-769; Kaster KM, 2009, ANTON LEEUW INT J G, V96, P423, DOI 10.1007/s10482-009-9356-1; Kodama Y, 2003, APPL ENVIRON MICROB, V69, P107, DOI 10.1128/AEM.69.1.107-112.2003; Li H, 2006, FEMS MICROBIOL LETT, V257, P92, DOI 10.1111/j.1574-6968.2006.00149.x; Li H, 2007, CURR MICROBIOL, V55, P382, DOI 10.1007/s00284-007-9002-y; Li H, 2007, FEMS MICROBIOL ECOL, V60, P74, DOI 10.1111/j.1574-6941.2006.00266.x; Liu RY, 2010, PROCESS BIOCHEM, V45, P744, DOI 10.1016/j.procbio.2010.01.010; Nazina TN, 1995, GEOMICROBIOL J, V13, P181, DOI 10.1080/01490459509378016; Nilsen RK, 1996, APPL ENVIRON MICROB, V62, P1793, DOI 10.1128/AEM.62.5.1793-1798.1996; Ollivier B, 2005, PETROLEUM MICROBIOLOGY, P71; Orphan VJ, 2000, APPL ENVIRON MICROB, V66, P700, DOI 10.1128/AEM.66.2.700-711.2000; Pham VD, 2009, ENVIRON MICROBIOL, V11, P176, DOI 10.1111/j.1462-2920.2008.01751.x; Ren HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023258; Salinas MB, 2004, INT J SYST EVOL MICR, V54, P645, DOI 10.1099/ijs.0.02732-0; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sette LD, 2007, ANTON LEEUW INT J G, V91, P253, DOI 10.1007/s10482-006-9115-5; Sikorski J, 2010, STAND GENOMIC SCI, V2, P149, DOI 10.4056/sigs.671209; Song BK, 2000, APPL ENVIRON MICROB, V66, P3446, DOI 10.1128/AEM.66.8.3446-3453.2000; Spring S, 2005, INT J SYST EVOL MICR, V55, P621, DOI 10.1099/ijs.0.63356-0; STETTER KO, 1993, NATURE, V365, P743, DOI 10.1038/365743a0; Stolz A, 2000, INT J SYST EVOL MICR, V50, P35, DOI 10.1099/00207713-50-1-35; Sung Y, 2006, APPL ENVIRON MICROB, V72, P2775, DOI 10.1128/AEM.72.4.2775-2782.2006; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Van Hamme JD, 2003, MICROBIOL MOL BIOL R, V67, P503, DOI 10.1128/MMBR.67.4.503-549.2003; Vandamme P., 2005, BERGEYS MANUAL SYSTE, P1161; Voordouw G, 1996, APPL ENVIRON MICROB, V62, P1623, DOI 10.1128/AEM.62.5.1623-1629.1996; Watanabe K, 2000, APPL ENVIRON MICROB, V66, P4803, DOI 10.1128/AEM.66.11.4803-4809.2000; WILLEMS A, 1989, INT J SYST BACTERIOL, V39, P319, DOI 10.1099/00207713-39-3-319; Wirsen CO, 2002, APPL ENVIRON MICROB, V68, P316, DOI 10.1128/AEM.68.1.316-325.2002; Wu XL, 2006, ENVIRON MICROBIOL, V8, P394, DOI 10.1111/j.1462-2920.2005.00904.x; Yan QX, 2010, INT J SYST EVOL MICR, V60, P2724, DOI 10.1099/ijs.0.020362-0; Youssef N, 2009, ADV APPL MICROBIOL, V66, P141, DOI 10.1016/S0065-2164(08)00806-X; Yu SL, 2010, J BIOSCI BIOENG, V110, P500, DOI 10.1016/j.jbiosc.2010.05.005; Zengler K, 1999, NATURE, V401, P266, DOI 10.1038/45777; Zhang F, 2010, APPL MICROBIOL BIOT, V88, P1413, DOI 10.1007/s00253-010-2841-7	49	62	68	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e33535	10.1371/journal.pone.0033535	http://dx.doi.org/10.1371/journal.pone.0033535			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22432032	gold, Green Published, Green Submitted			2022-12-25	WOS:000303198600075
J	Viikov, K; Jasnovidova, O; Tamm, T; Sedman, J				Viikov, Katrin; Jasnovidova, Olga; Tamm, Tiina; Sedman, Juhan			C-Terminal Extension of the Yeast Mitochondrial DNA Polymerase Determines the Balance between Synthesis and Degradation	PLOS ONE			English	Article							PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; STRAND DISPLACEMENT SYNTHESIS; SACCHAROMYCES-CEREVISIAE; ACCESSORY SUBUNIT; GAMMA MUTATIONS; EXCISION-REPAIR; HUMAN-DISEASE; ACTIVE-SITE; REPLICATION; PROTEIN	Saccharomyces cerevisiae mitochondrial DNA polymerase (Mip1) contains a C-terminal extension (CTE) of 279 amino acid residues. The CTE is required for mitochondrial DNA maintenance in yeast but is absent in higher eukaryotes. Here we use recombinant Mip1 C-terminal deletion mutants to investigate functional importance of the CTE. We show that partial removal of the CTE in Mip1 Delta 216 results in strong preference for exonucleolytic degradation rather than DNA polymerization. This disbalance in exonuclease and polymerase activities is prominent at suboptimal dNTP concentrations and in the absence of correctly pairing nucleotide. Mip1 Delta 216 also displays reduced ability to synthesize DNA through double-stranded regions. Full removal of the CTE in Mip1 Delta 279 results in complete loss of Mip1 polymerase activity, however the mutant retains its exonuclease activity. These results allow us to propose that CTE functions as a part of Mip1 polymerase domain that stabilizes the substrate primer end at the polymerase active site, and is therefore required for efficient mitochondrial DNA replication in vivo.	[Viikov, Katrin; Jasnovidova, Olga; Tamm, Tiina; Sedman, Juhan] Univ Tartu, Dept Biochem, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia	University of Tartu	Viikov, K (corresponding author), Univ Tartu, Dept Biochem, Inst Mol & Cell Biol, Ulikooli 18, EE-50090 Tartu, Estonia.	jsedman@ebc.ee	Tamm, Tiina/D-4004-2014; Sedman, Juhan/H-1820-2011	Jasnovidova, Olga/0000-0002-8362-7647; Sedman, Juhan/0000-0003-2081-1452; Tamm, Tiina/0000-0001-9943-2097	Estonian Science Foundation [7013, 8845]	Estonian Science Foundation	This work has been supported by grants 7013 and 8845 from Estonian Science Foundation http://www.etf.ee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andraos N, 2004, J BIOL CHEM, V279, P50609, DOI 10.1074/jbc.M408428200; Baruffini E, 2007, BBA-MOL BASIS DIS, V1772, P1225, DOI 10.1016/j.bbadis.2007.10.002; Baruffini E, 2006, HUM MOL GENET, V15, P2846, DOI 10.1093/hmg/ddl219; Baruffini E, 2011, MITOCHONDRION, V11, P182, DOI 10.1016/j.mito.2010.09.007; BERNAD A, 1989, CELL, V59, P219, DOI 10.1016/0092-8674(89)90883-0; BLANCO L, 1989, J BIOL CHEM, V264, P8935; Carrodeguas JA, 1999, MOL CELL BIOL, V19, P4039; ERIKSSON S, 1995, J BIOL CHEM, V270, P18929, DOI 10.1074/jbc.270.32.18929; Farge G, 2007, NUCLEIC ACIDS RES, V35, P902, DOI 10.1093/nar/gkl1116; Ferraro P, 2006, P NATL ACAD SCI USA, V103, P18586, DOI 10.1073/pnas.0609020103; Foury F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027847; GENGA A, 1986, J BIOL CHEM, V261, P9328; Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d; He ZG, 2003, J BIOL CHEM, V278, P29538, DOI 10.1074/jbc.M304318200; Hudson G, 2006, HUM MOL GENET, V15, pR244, DOI 10.1093/hmg/ddl233; Imoto S, 2008, BIOCHEMISTRY-US, V47, P4306, DOI 10.1021/bi7021427; ITO J, 1990, NUCLEIC ACIDS RES, V18, P6716, DOI 10.1093/nar/18.22.6716; Johnson AA, 2000, BIOCHEMISTRY-US, V39, P1702, DOI 10.1021/bi992104w; Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455; Kamtekar S, 2004, MOL CELL, V16, P609, DOI 10.1016/j.molcel.2004.10.019; Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257; Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050; Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197; Lucas P, 2004, MITOCHONDRION, V4, P13, DOI 10.1016/j.mito.2004.04.001; Luo NG, 2005, J BIOL CHEM, V280, P2491, DOI 10.1074/jbc.M411447200; Maga G, 2001, P NATL ACAD SCI USA, V98, P14298, DOI 10.1073/pnas.251193198; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Perez-Arnaiz P, 2006, NUCLEIC ACIDS RES, V34, P3107, DOI 10.1093/nar/gkl402; Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200; Prasad R, 2000, J BIOL CHEM, V275, P4460, DOI 10.1074/jbc.275.6.4460; Sedman T, 2000, MOL CELL BIOL, V20, P1816, DOI 10.1128/MCB.20.5.1816-1824.2000; Simossis VA, 2005, NUCLEIC ACIDS RES, V33, pW289, DOI 10.1093/nar/gki390; Singh K, 2007, J BIOL CHEM, V282, P10594, DOI 10.1074/jbc.M611242200; Stuart GR, 2006, HUM MOL GENET, V15, P363, DOI 10.1093/hmg/ddi454; Stumpf JD, 2011, CELL MOL LIFE SCI, V68, P219, DOI 10.1007/s00018-010-0530-4; Stumpf JD, 2010, HUM MOL GENET, V19, P2123, DOI 10.1093/hmg/ddq089; Szczepanowska K, 2010, HUM MOL GENET, V19, P3516, DOI 10.1093/hmg/ddq267; Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034; Viikov K, 2011, MITOCHONDRION, V11, P119, DOI 10.1016/j.mito.2010.08.007; WERNETTE CM, 1986, J BIOL CHEM, V261, P4764; Young MJ, 2006, YEAST, V23, P101, DOI 10.1002/yea.1344; Zhu YL, 2003, J VIROL, V77, P10147, DOI 10.1128/JVI.77.18.10147-10153.2003	42	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e33482	10.1371/journal.pone.0033482	http://dx.doi.org/10.1371/journal.pone.0033482			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22432028	Green Published, Green Submitted, gold			2022-12-25	WOS:000303198600071
J	Glenn, A; Bodri, MS				Glenn, Anthony; Bodri, Michael S.			Fungal Endophyte Diversity in Sarracenia	PLOS ONE			English	Article							NORTHERN PITCHER PLANT; MOLECULAR CHARACTERIZATION; METABOLITES; EXPRESSION; CARNIVORY; PURPUREA; ALTERS	Fungal endophytes were isolated from 4 species of the carnivorous pitcher plant genus Sarracenia: S. minor, S. oreophila, S. purpurea, and S. psittacina. Twelve taxa of fungi, 8 within the Ascomycota and 4 within the Basidiomycota, were identified based on PCR amplification and sequencing of the internal transcribed spacer sequences of nuclear ribosomal DNA (ITS rDNA) with taxonomic identity assigned using the NCBI nucleotide megablast search tool. Endophytes are known to produce a large number of metabolites, some of which may contribute to the protection and survival of the host. We speculate that endophyte-infected Sarracenia may benefit from their fungal associates by their influence on nutrient availability from within pitchers and, possibly, by directly influencing the biota within pitchers.	[Glenn, Anthony] USDA ARS, Russell Res Ctr, Toxicol & Mycotoxin Res Unit, Athens, GA 30613 USA; [Bodri, Michael S.] N Georgia Coll & State Univ, Dept Biol, Dahlonega, GA USA	United States Department of Agriculture (USDA); University System of Georgia; North Georgia College & State University	Glenn, A (corresponding author), USDA ARS, Russell Res Ctr, Toxicol & Mycotoxin Res Unit, Athens, GA 30613 USA.	Michael.Bodri@northgeorgia.edu		Glenn, Anthony/0000-0001-8329-1306	Georgia Native Plant Society	Georgia Native Plant Society	Dr. Bodri was supported by a Jeane Reaves Research Grant from the Georgia Native Plant Society (http://www.gnps.org/geninfo/Grants.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, MICROBIAL ROOT ENDOP; BENZING DH, 2000, BROMELIACEAE PROFILE; BRUNNER F, 1992, MYCOL RES, V96, P723, DOI 10.1016/S0953-7562(09)80440-1; Butler JL, 2007, FUNCT ECOL, V21, P835, DOI 10.1111/j.1365-2435.2007.01307.x; Butler JL, 2008, ECOLOGY, V89, P898, DOI 10.1890/07-1314.1; Clay K, 1999, SCIENCE, V285, P1742, DOI 10.1126/science.285.5434.1742; CROWDER AA, 1990, J ECOL, V78, P233, DOI 10.2307/2261048; Darwin C., 1875, INSECTIVOROUS PLANTS; Davis EC, 2003, AM J BOT, V90, P1661, DOI 10.3732/ajb.90.11.1661; Du MZ, 2005, MYCOLOGIA, V97, P641, DOI 10.3852/mycologia.97.3.641; Ellison AM, 2009, J EXP BOT, V60, P19, DOI 10.1093/jxb/ern179; Ellison AM, 2002, P NATL ACAD SCI USA, V99, P4409, DOI 10.1073/pnas.022057199; Ernst M, 2003, MOL PLANT MICROBE IN, V16, P580, DOI 10.1094/MPMI.2003.16.7.580; Farnsworth EJ, 2008, J ECOL, V96, P213, DOI 10.1111/j.1365-2745.2007.01313.x; Faulkner AA, 2006, 91 ANN M EC SOC AM M; FREEMAN S, 1993, SCIENCE, V260, P75, DOI 10.1126/science.260.5104.75; Gallie DR, 1997, PLANT PHYSIOL, V115, P1461, DOI 10.1104/pp.115.4.1461; GIVNISH TJ, 1984, AM NAT, V124, P479, DOI 10.1086/284289; Glenn AE, 1998, MYCOL RES, V102, P483, DOI 10.1017/S0953756297005236; Gray SM, 2006, HYDROBIOLOGIA, V573, P173, DOI 10.1007/s10750-006-0265-2; HEPBURN JS, 1927, T WAGNER FREE I SCI, V11, P49; Hooker J. D., 1859, T LINN SOC LOND, V22, P415, DOI [10.1111/j.1096-3642.1856.tb00113.x, DOI 10.1111/J.1096-3642.1856.TB00113.X]; Karagatzides JD, 2009, AM J BOT, V96, P1612, DOI 10.3732/ajb.0900054; Karagatzides JD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006164; Koopman MM, 2010, APPL ENVIRON MICROB, V76, P1851, DOI 10.1128/AEM.02440-09; Li HM, 2004, MYCOLOGIA, V96, P526, DOI 10.2307/3762172; Lloyd FE, 1976, CARNIVOROUS PLANTS; Lu H, 2000, PLANT SCI, V151, P67, DOI 10.1016/S0168-9452(99)00199-5; Macias-Rubalcava ML, 2008, PHYTOCHEMISTRY, V69, P1185, DOI 10.1016/j.phytochem.2007.12.006; MANTLE PG, 1987, PENICILLIUM ACREMONI, P161; Murali TS, 2006, CAN J MICROBIOL, V52, P673, DOI 10.1139/W06-020; NOBLE HM, 1991, MYCOL RES, V95, P1439, DOI 10.1016/S0953-7562(09)80401-2; Okane I., 1997, Research Communications - Institute for Fermentation, Osaka, P45; Omacini M, 2001, NATURE, V409, P78, DOI 10.1038/35051070; Peterson CN, 2008, ENVIRON MICROBIOL, V10, P2257, DOI 10.1111/j.1462-2920.2008.01648.x; Quilliam RS, 2010, MYCORRHIZA, V20, P341, DOI 10.1007/s00572-009-0288-4; Rodriguez RJ, 2009, NEW PHYTOL, V182, P314, DOI 10.1111/j.1469-8137.2009.02773.x; Rodriguez RJ, 2008, ISME J, V2, P404, DOI 10.1038/ismej.2007.106; Rukachaisirikul V, 2008, PHYTOCHEMISTRY, V69, P783, DOI 10.1016/j.phytochem.2007.09.006; Rungjindamai N, 2008, FUNGAL DIVERS, V33, P139; SCHULZ B, 1995, MYCOL RES, V99, P1007, DOI 10.1016/S0953-7562(09)80766-1; Siragusa AJ, 2007, MICROB ECOL, V54, P324, DOI 10.1007/s00248-006-9205-y; SMITH CS, 1989, APPL ENVIRON MICROB, V55, P2326, DOI 10.1128/AEM.55.9.2326-2332.1989; Stone JK, 2000, BOOK SOIL P, P3; Strobel GA, 1999, MICROBIOL-UK, V145, P1919, DOI 10.1099/13500872-145-8-1919; Suryanarayanan T. S., 2009, Fungal Biology Reviews, V23, P9, DOI 10.1016/j.fbr.2009.07.001; Sutton BC., 1980, COELOMYCETES FUNGI I; Tan RX, 2001, NAT PROD REP, V18, P448, DOI 10.1039/b100918o; Verkley GJM, 2004, STUD MYCOL, P323; Vicente F, 2009, MYCOL RES, V113, P754, DOI 10.1016/j.mycres.2009.02.011; Wakefield AE, 2005, ECOLOGY, V86, P1737, DOI 10.1890/04-1673; Zhang Y, 2009, STUD MYCOL, P85, DOI 10.3114/sim.2009.64.04; Zou WX, 2000, J NAT PROD, V63, P1529, DOI 10.1021/np000204t	53	18	19	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2012	7	3							e32980	10.1371/journal.pone.0032980	http://dx.doi.org/10.1371/journal.pone.0032980			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930IA	22427921	gold, Green Published, Green Submitted			2022-12-25	WOS:000303129700023
J	Yuan, XH; Wang, YC; Jin, WJ; Zhao, BB; Chen, CF; Yang, J; Wang, JF; Guo, YY; Liu, JJ; Zhang, D; Gong, LL; He, YW				Yuan, Xiao-Hui; Wang, Ying-Chen; Jin, Wen-Jing; Zhao, Bin-Bin; Chen, Cai-Feng; Yang, Jian; Wang, Jing-Fei; Guo, Ying-Ying; Liu, Jing-Jun; Zhang, Ding; Gong, Lu-Lu; He, You-Wen			Structure-Based High-Throughput Epitope Analysis of Hexon Proteins in B and C Species Human Adenoviruses (HAdVs)	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; PHYLOGENETIC ANALYSIS; PREDICTION; CELL; EPIDEMIOLOGY; FEATURES; SYSTEMS; SURFACE; GENE; AREA	Human adenoviruses (HAdVs) are the etiologic agent of many human infectious diseases. The existence of at least 54 different serotypes of HAdVs has resulted in difficulties in clinical diagnosis. Acute respiratory tract disease (ARD) caused by some serotypes from B and C species is particularly serious. Hexon, the main coat protein of HAdV, contains the major serotype-specific B cell epitopes; however, few studies have addressed epitope mapping in most HAdV serotypes. In this study, we utilized a novel and rapid method for the modeling of homologous proteins based on the phylogenetic tree of protein families and built three-dimensional (3D) models of hexon proteins in B and C species HAdVs. Based on refined hexon structures, we used reverse evolutionary trace (RET) bioinformatics analysis combined with a specially designed hexon epitope screening algorithm to achieve high-throughput epitope mapping of all 13 hexon proteins in B and C species HAdVs. This study has demonstrated that all of the epitopes from the 13 hexon proteins are located in the proteins' tower regions; however, the exact number, location, and size of the epitopes differ among the HAdV serotypes.	[Yuan, Xiao-Hui; Jin, Wen-Jing; Zhao, Bin-Bin; Chen, Cai-Feng; Yang, Jian; Liu, Jing-Jun; Zhang, Ding; Gong, Lu-Lu; He, You-Wen] Chinese Acad Med Sci, Inst Pathogen Biol, Minist Hlth, Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China; [Yuan, Xiao-Hui; Jin, Wen-Jing; Zhao, Bin-Bin; Chen, Cai-Feng; Yang, Jian; Liu, Jing-Jun; Zhang, Ding; Gong, Lu-Lu; He, You-Wen] Peking Union Med Coll, Beijing 100021, Peoples R China; [Wang, Ying-Chen] Harbin Med Univ, Sch Publ Hlth, Dept Hygien Microbiol, Harbin, Rojmegen, Peoples R China; [Wang, Jing-Fei; Guo, Ying-Ying] Chinese Acad Agr Sci, Harbin Vet Res Inst, Harbin, Heilongjiang, Peoples R China; [He, You-Wen] Duke Univ, Med Ctr, Dept Immunol, Durham, NC USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Harbin Medical University; Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; Duke University	Yuan, XH (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, Minist Hlth, Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China.	youwen.he@duke.edu	Xiaohui, Yuan/D-7374-2016		Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China	Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China	This study was funded by the Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001485; Aoki Koki, 2002, International Ophthalmology Clinics, V42, P49; Biere B, 2010, J CLIN VIROL, V47, P366, DOI 10.1016/j.jcv.2010.01.005; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Bublil EM, 2007, PROTEINS, V68, P294, DOI 10.1002/prot.21387; Chatterjee S, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2841127; CHEATHAM TE, 1995, J AM CHEM SOC, V117, P4193, DOI 10.1021/ja00119a045; Chocholousova J, 2006, J COMPUT CHEM, V27, P719, DOI 10.1002/jcc.20387; Coutsias EA, 2004, J COMPUT CHEM, V25, P1849, DOI 10.1002/jcc.20110; Ebner K, 2005, J VIROL, V79, P12635, DOI 10.1128/JVI.79.20.12635-12642.2005; Erdman DD, 2002, EMERG INFECT DIS, V8, P269, DOI 10.3201/eid0803.010190; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Frietze KM, 2010, J VIROL, V84, P11310, DOI 10.1128/JVI.00512-10; Gellert A, 2006, J MOL GRAPH MODEL, V24, P319, DOI 10.1016/j.jmgm.2005.09.015; Houng HSH, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-116; Jones MS, 2007, J VIROL, V81, P5978, DOI 10.1128/JVI.02650-06; Kaneko H, 2011, BRIT J OPHTHALMOL, V95, P32, DOI 10.1136/bjo.2009.178772; Knapp B, 2010, J COMPUT CHEM, V31, P2868, DOI 10.1002/jcc.21581; Kohl M, 2011, METHODS MOL BIOL, V696, P413, DOI 10.1007/978-1-60761-987-1_26; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lichtarge O, 1996, J MOL BIOL, V257, P342, DOI 10.1006/jmbi.1996.0167; Lu X, 2006, ARCH VIROL, V151, P1587, DOI 10.1007/s00705-005-0722-7; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; MacKerell Alexander D. Jr., 2000, Biopolymers, V56, P257, DOI 10.1002/1097-0282(2000)56:4<257::AID-BIP10029>3.0.CO;2-W; Madisch I, 2005, J VIROL, V79, P15265, DOI 10.1128/JVI.79.24.15265-15276.2005; MELLMANRUBIN TL, 1995, AM J OPHTHALMOL, V119, P652, DOI 10.1016/S0002-9394(14)70229-6; Mizuta K, 2009, VIRUS RES, V140, P32, DOI 10.1016/j.virusres.2008.10.014; Pichla-Gollon SL, 2007, J VIROL, V81, P1680, DOI 10.1128/JVI.02023-06; Rauschhuber C, 2011, J GEN VIROL, V92, P669, DOI 10.1099/vir.0.026542-0; Rebelo-De-Andrade H, 2010, J CLIN MICROBIOL, V48, P1391, DOI 10.1128/JCM.02019-09; Rux JJ, 2000, MOL THER, V1, P18, DOI 10.1006/mthe.1999.0001; Rux JJ, 2003, J VIROL, V77, P9553, DOI 10.1128/JVI.77.17.9553-9566.2003; Saffari B, 2008, PROTEIN PEPTIDE LETT, V15, P280; Sapay N, 2011, J COMPUT CHEM, V32, P1400, DOI 10.1002/jcc.21726; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; SCHMITZ H, 1983, AM J EPIDEMIOL, V117, P455, DOI 10.1093/oxfordjournals.aje.a113563; Seto D, 2011, J VIROL, V30, P30; Siebert HC, 1996, J MOL MODEL, V2, P446; Spassov VZ, 2008, PROTEIN ENG DES SEL, V21, P91, DOI 10.1093/protein/gzm083; Sweredoski MJ, 2008, BIOINFORMATICS, V24, P1459, DOI 10.1093/bioinformatics/btn199; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Venselaar H, 2010, EUR BIOPHYS J BIOPHY, V39, P551, DOI 10.1007/s00249-009-0531-0; Violon D, 1997, INVEST RADIOL, V32, P126, DOI 10.1097/00004424-199702000-00009; Walsh MP, 2010, J CLIN MICROBIOL, V48, P991, DOI 10.1128/JCM.01694-09; Yap FC, 2010, ANIM BIOTECHNOL, V21, P226, DOI 10.1080/10495398.2010.506334; Yuan XH, 2011, CHEM J CHINESE U, V32, P1838; Yuan XH, 2009, VACCINE, V27, P5103, DOI 10.1016/j.vaccine.2009.06.041	49	22	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2012	7	3							e32938	10.1371/journal.pone.0032938	http://dx.doi.org/10.1371/journal.pone.0032938			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930IA	22427913	Green Published, gold, Green Submitted			2022-12-25	WOS:000303129700020
J	Bassity, E; Clark, TG				Bassity, Elizabeth; Clark, Theodore G.			Functional Identification of Dendritic Cells in the Teleost Model, Rainbow Trout (Oncorhynchus mykiss)	PLOS ONE			English	Article							MIXED-LEUKOCYTE REACTION; COLONY-STIMULATING FACTOR; PERIPHERAL LYMPHOID ORGANS; CATFISH IMMUNE-RESPONSES; ANTIGEN-PRESENTING CELLS; T-CELL; B-CELL; CHANNEL CATFISH; IN-VIVO; INFLAMMATORY RESPONSE	Dendritic cells are specialized antigen presenting cells that bridge innate and adaptive immunity in mammals. This link between the ancient innate immune system and the more evolutionarily recent adaptive immune system is of particular interest in fish, the oldest vertebrates to have both innate and adaptive immunity. It is unknown whether dendritic cells co-evolved with the adaptive response, or if the connection between innate and adaptive immunity relied on a fundamentally different cell type early in evolution. We approached this question using the teleost model organism, rainbow trout (Oncorhynchus mykiss), with the aim of identifying dendritic cells based on their ability to stimulate naive T cells. Adapting mammalian protocols for the generation of dendritic cells, we established a method of culturing highly motile, non-adherent cells from trout hematopoietic tissue that had irregular membrane processes and expressed surface MHCII. When side-by-side mixed leukocyte reactions were performed, these cells stimulated greater proliferation than B cells or macrophages, demonstrating their specialized ability to present antigen and therefore their functional homology to mammalian dendritic cells. Trout dendritic cells were then further analyzed to determine if they exhibited other features of mammalian dendritic cells. Trout dendritic cells were found to have many of the hallmarks of mammalian DCs including tree-like morphology, the expression of dendritic cell markers, the ability to phagocytose small particles, activation by toll-like receptor-ligands, and the ability to migrate in vivo. As in mammals, trout dendritic cells could be isolated directly from the spleen, or larger numbers could be derived from hematopoietic tissue and peripheral blood mononuclear cells in vitro.	[Bassity, Elizabeth; Clark, Theodore G.] Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA	Cornell University	Bassity, E (corresponding author), Trudeau Inst Inc, POB 59, Saranac Lake, NY 12983 USA.	tgc3@cornell.edu			Vertebrate Genomics Initiative at Cornell University; National Institutes of Health under Ruth L. Kirshstein National Research Service [5 T32 AI007643]; Department of Microbiology and Immunology at Cornell University; Cornell University Agricultural Experiment Station; Cooperative State Research, Education and Extension Service, U.S. Department of Agriculture [NYC-433404]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007643] Funding Source: NIH RePORTER	Vertebrate Genomics Initiative at Cornell University; National Institutes of Health under Ruth L. Kirshstein National Research Service; Department of Microbiology and Immunology at Cornell University; Cornell University Agricultural Experiment Station; Cooperative State Research, Education and Extension Service, U.S. Department of Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support for EB came from the Vertebrate Genomics Initiative at Cornell University and from the National Institutes of Health under Ruth L. Kirshstein National Research Service Award 5 T32 AI007643. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Heatlh. Additional support for this project came from the Department of Microbiology and Immunology at Cornell University and from the Cornell University Agricultural Experiment Station federal formula funds, Project No. NYC-433404 received from Cooperative State Research, Education and Extension Service, U.S. Department of Agriculture. Any opinions, findings, conclusions, or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the view of the U.S. Department of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anandasabapathy N, 2011, J EXP MED, V208, P1695, DOI 10.1084/jem.20102657; ANDERSON KV, 1985, CELL, V42, P779, DOI 10.1016/0092-8674(85)90274-0; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Barr M, 2011, FISH SHELLFISH IMMUN, V31, P727, DOI 10.1016/j.fsi.2011.06.018; Berchtold S, 1999, FEBS LETT, V461, P211, DOI 10.1016/S0014-5793(99)01465-9; BERCZI I, 1966, CAN J MICROBIOL, V12, P1070, DOI 10.1139/m66-143; Boltana S, 2009, FISH SHELLFISH IMMUN, V26, P651, DOI 10.1016/j.fsi.2008.11.011; Cain KD, 2002, DEV COMP IMMUNOL, V26, P181, DOI 10.1016/S0145-305X(01)00063-5; Cao WP, 2005, BIOCHEM J, V385, P85, DOI 10.1042/BJ20040741; CASPI RR, 1984, DEV COMP IMMUNOL, V8, P631, DOI 10.1016/0145-305X(84)90095-8; CROWLEY M, 1989, CELL IMMUNOL, V118, P108, DOI 10.1016/0008-8749(89)90361-4; DELUCA D, 1983, EUR J IMMUNOL, V13, P546, DOI 10.1002/eji.1830130706; DeWitte-Orr SJ, 2007, FISH SHELLFISH IMMUN, V22, P487, DOI 10.1016/j.fsi.2006.06.008; Dieu MC, 1998, J EXP MED, V188, P373, DOI 10.1084/jem.188.2.373; Donate C, 2007, FISH SHELLFISH IMMUN, V23, P877, DOI 10.1016/j.fsi.2007.03.016; FLECHNER ER, 1988, CELL IMMUNOL, V111, P183, DOI 10.1016/0008-8749(88)90062-7; Ganassin RC, 1996, FISH SHELLFISH IMMUN, V6, P17, DOI 10.1006/fsim.1996.0003; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Goetz FW, 2004, MOL IMMUNOL, V41, P1199, DOI 10.1016/j.molimm.2004.06.005; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Hansen JD, 2009, MOL IMMUNOL, V46, P457, DOI 10.1016/j.molimm.2008.10.007; Hartmann G, 1999, P NATL ACAD SCI USA, V96, P9305, DOI 10.1073/pnas.96.16.9305; Haugarvoll E, 2006, PIGM CELL RES, V19, P214, DOI 10.1111/j.1600-0749.2006.00297.x; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Heufler C, 1996, EUR J IMMUNOL, V26, P659, DOI 10.1002/eji.1830260323; Iliev DB, 2005, FEBS LETT, V579, P6519, DOI 10.1016/j.febslet.2005.10.061; Iliev DB, 2005, MOL IMMUNOL, V42, P1215, DOI 10.1016/j.molimm.2004.11.023; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; INABA K, 1992, J EXP MED, V175, P1157, DOI 10.1084/jem.175.5.1157; KAASTRUP P, 1988, DEV COMP IMMUNOL, V12, P801, DOI 10.1016/0145-305X(88)90054-7; Kollner B, 2004, DEV COMP IMMUNOL, V28, P1049, DOI 10.1016/j.dci.2004.03.004; KOZLOW EJ, 1993, BLOOD, V81, P454, DOI 10.1182/blood.V81.2.454.454; Kruse M, 2000, J EXP MED, V191, P1581, DOI 10.1084/jem.191.9.1581; Kuwano Y, 2007, INT IMMUNOL, V19, P977, DOI 10.1093/intimm/dxm067; Lechmann M, 2008, P NATL ACAD SCI USA, V105, P11887, DOI 10.1073/pnas.0806335105; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lovy J, 2008, ANAT REC, V291, P456, DOI 10.1002/ar.20674; Lovy J, 2009, FISH SHELLFISH IMMUN, V27, P365, DOI 10.1016/j.fsi.2009.01.006; LU L, 1995, IMMUNOLOGY, V84, P127; LU L, 1994, J EXP MED, V179, P1823, DOI 10.1084/jem.179.6.1823; Lugo-Villarino G, 2010, P NATL ACAD SCI USA, V107, P15850, DOI 10.1073/pnas.1000494107; Lund FE, 2002, J IMMUNOL, V169, P5236, DOI 10.4049/jimmunol.169.9.5236; Martin SAM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-150; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Meloni S, 2006, FISH SHELLFISH IMMUN, V20, P739, DOI 10.1016/j.fsi.2005.10.001; Miller N, 1998, IMMUNOL REV, V166, P187, DOI 10.1111/j.1600-065X.1998.tb01263.x; MILLER NW, 1986, IMMUNOLOGY, V59, P123; Muzio M, 2000, J LEUKOCYTE BIOL, V67, P450, DOI 10.1002/jlb.67.4.450; Ohta Y, 2004, J IMMUNOL, V173, P4553, DOI 10.4049/jimmunol.173.7.4553; Pettersen EF, 2008, FISH SHELLFISH IMMUN; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; Prazma CM, 2007, J IMMUNOL, V179, P4550, DOI 10.4049/jimmunol.179.7.4550; Purcell MK, 2006, COMP BIOCHEM PHYS D, V1, P77, DOI 10.1016/j.cbd.2005.07.003; Roca FJ, 2008, J IMMUNOL, V181, P5071, DOI 10.4049/jimmunol.181.7.5071; Romani N, 1996, J IMMUNOL METHODS, V196, P137, DOI 10.1016/0022-1759(96)00078-6; Rumfelt LL, 2002, SCAND J IMMUNOL, V56, P130, DOI 10.1046/j.1365-3083.2002.01116.x; Sallusto F, 1998, EUR J IMMUNOL, V28, P2760, DOI 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Secombes C, 2008, FISH SHELLFISH IMMUN, V25, P409, DOI 10.1016/j.fsi.2008.05.001; Sepulcre MP, 2007, MOL IMMUNOL, V44, P2009, DOI 10.1016/j.molimm.2006.09.022; Sepulcre MP, 2009, J IMMUNOL, V182, P1836, DOI 10.4049/jimmunol.0801755; SIZEMORE RC, 1984, J IMMUNOL, V133, P2920; STEINMAN RM, 1973, J EXP MED, V137, P1142, DOI 10.1084/jem.137.5.1142; STEINMAN RM, 1979, J EXP MED, V149, P1, DOI 10.1084/jem.149.1.1; STEINMAN RM, 1978, P NATL ACAD SCI USA, V75, P5132, DOI 10.1073/pnas.75.10.5132; Tsujita T, 2004, J BIOL CHEM, V279, P48588, DOI 10.1074/jbc.M407634200; Utke K, 2007, FISH SHELLFISH IMMUN, V22, P182, DOI 10.1016/j.fsi.2006.04.008; Vallejo A.N., 1991, Developmental Immunology (Reading), V1, P137, DOI 10.1155/1991/32534; VALLEJO AN, 1991, IMMUNOLOGY, V74, P165; VALLEJO AN, 1993, DEV COMP IMMUNOL, V17, P229, DOI 10.1016/0145-305X(93)90042-O; VALLEJO AN, 1990, CELL IMMUNOL, V130, P364, DOI 10.1016/0008-8749(90)90279-Z; VANVOORHIS WC, 1982, J EXP MED, V155, P1172, DOI 10.1084/jem.155.4.1172; Wells JW, 2008, J IMMUNOL, V181, P3422, DOI 10.4049/jimmunol.181.5.3422; Wilson HL, 2000, EXP HEMATOL, V28, P193, DOI 10.1016/S0301-472X(99)00146-0; Wittamer V, 2011, BLOOD, V117, P7126, DOI 10.1182/blood-2010-11-321448; Yamashiro S, 2000, BLOOD, V96, P3958, DOI 10.1182/blood.V96.12.3958.h8003958_3958_3963; Zhang YA, 2009, J IMMUNOL, V183, P83, DOI 10.4049/jimmunol.0900605; ZHOU LJ, 1995, J IMMUNOL, V154, P3821	78	103	109	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33196	10.1371/journal.pone.0033196	http://dx.doi.org/10.1371/journal.pone.0033196			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427987	gold, Green Published, Green Submitted			2022-12-25	WOS:000302381500109
J	Erman, A; Lakota, K; Mrak-Poljsak, K; Blango, MG; Krizan-Hergouth, V; Mulvey, MA; Sodin-Semrl, S; Veranic, P				Erman, Andreja; Lakota, Katja; Mrak-Poljsak, Katjusa; Blango, Matthew G.; Krizan-Hergouth, Veronika; Mulvey, Matthew A.; Sodin-Semrl, Snezna; Veranic, Peter			Uropathogenic Escherichia coli Induces Serum Amyloid A in Mice following Urinary Tract and Systemic Inoculation	PLOS ONE			English	Article							ACUTE-PHASE RESPONSE; MEMBRANE PROTEIN-A; HEPATITIS-C VIRUS; ZEBRAFISH; PERSISTENCE; CHALLENGE; INFECTION; INVASION; TISSUE; ENTRY	Serum amyloid A (SAA) is an acute phase protein involved in the homeostasis of inflammatory responses and appears to be a vital host defense component with protective anti-infective properties. SAA expression remains poorly defined in many tissues, including the urinary tract which often faces bacterial challenge. Urinary tract infections (UTIs) are usually caused by strains of uropathogenic Escherichia coli (UPEC) and frequently occur among otherwise healthy individuals, many of whom experience bouts of recurrent and relapsing infections despite the use of antibiotics. To date, whether SAA is present in the infected urothelium and whether or not the induction of SAA can protect the host against UPEC is unclear. Here we show, using mouse models coupled with immunofluorescence microscopy and quantitative RT-PCR, that delivery of UPEC either directly into the urinary tract via catheterization or systemically via intraperitoneal injection triggers the expression of SAA. As measured by ELISA, serum levels of SAA1/2 were also transiently elevated in response to UTI, but circulating SAA3 levels were only up-regulated substantially following intraperitoneal inoculation of UPEC. In in vitro assays, physiological relevant levels of SAA1/2 did not affect the growth or viability of UPEC, but were able to block biofilm formation by the uropathogens. We suggest that SAA functions as a critical host defense against UTIs, preventing the formation of biofilms both upon and within the urothelium and possibly providing clinicians with a sensitive serological marker for UTI.	[Erman, Andreja; Veranic, Peter] Univ Ljubljana, Fac Med, Inst Cell Biol, Ljubljana, Slovenia; [Lakota, Katja; Mrak-Poljsak, Katjusa; Sodin-Semrl, Snezna] Univ Med Ctr Ljubljana, Dept Rheumatol, Ljubljana, Slovenia; [Blango, Matthew G.; Mulvey, Matthew A.] Univ Utah, Dept Pathol, Div Microbiol & Immunol, Salt Lake City, UT USA; [Krizan-Hergouth, Veronika] Univ Ljubljana, Fac Med, Inst Microbiol & Immunol, Ljubljana, Slovenia	University of Ljubljana; University Medical Centre Ljubljana; Utah System of Higher Education; University of Utah; University of Ljubljana	Erman, A (corresponding author), Univ Ljubljana, Fac Med, Inst Cell Biol, Ljubljana, Slovenia.	ssodin1@yahoo.com	Veranic, Peter/I-6276-2015; Blango, Matthew/AAY-2384-2020; Lakota, Katja/AAH-8033-2020; Sodin-Semrl, Snezna/AAJ-8954-2020	Veranic, Peter/0000-0003-1999-9988; Blango, Matthew/0000-0001-8015-9019; Lakota, Katja/0000-0002-8062-7908; Mulvey, Matthew/0000-0002-6016-7510	Ministry of High Education, Science and Technology of Slovenia; National Institutes of Health (NIH) Public Health Service (USA) [DK068585, AI095647]; NIH Microbial Pathogenesis Training [T32 AI055434]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095647, T32AI055434] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068585] Funding Source: NIH RePORTER	Ministry of High Education, Science and Technology of Slovenia; National Institutes of Health (NIH) Public Health Service (USA); NIH Microbial Pathogenesis Training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Ministry of High Education, Science and Technology of Slovenia and National Institutes of Health (NIH) Public Health Service grants DK068585 and AI095647 (USA). M.G.B. was supported by NIH Microbial Pathogenesis Training Grant T32 AI055434. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badolato R, 2000, J LEUKOCYTE BIOL, V67, P381, DOI 10.1002/jlb.67.3.381; Blango MG, 2010, ANTIMICROB AGENTS CH, V54, P1855, DOI 10.1128/AAC.00014-10; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bower JM, 2009, INFECT IMMUN, V77, P2104, DOI 10.1128/IAI.01200-08; Cai ZH, 2007, J VIROL, V81, P6128, DOI 10.1128/JVI.02627-06; CASL MT, 1993, ANN CLIN BIOCHEM, V30, P272, DOI 10.1177/000456329303000308; Eckhardt ERM, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-133; Eto DS, 2006, CELL MICROBIOL, V8, P704, DOI 10.1111/j.1462-5822.2006.00691.x; Gardiner GE, 2009, FEMS IMMUNOL MED MIC, V55, P404, DOI 10.1111/j.1574-695X.2009.00539.x; Gunther J, 2009, VET RES, V40, DOI 10.1051/vetres/2009014; Hari-Dass R, 2005, J BIOL CHEM, V280, P18562, DOI 10.1074/jbc.M500490200; Hirakura Y, 2002, AMYLOID, V9, P13, DOI 10.3109/13506120209072440; Jorgensen JB, 2000, DEV COMP IMMUNOL, V24, P553, DOI 10.1016/S0145-305X(00)00022-7; Kramer HB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000893; Kulesus RR, 2008, INFECT IMMUN, V76, P3019, DOI 10.1128/IAI.00022-08; Lakota K, 2011, AUTOIMMUNITY, V44, P149, DOI 10.3109/08916934.2010.487504; Lavie M, 2006, HEPATOLOGY, V44, P1626, DOI 10.1002/hep.21406; Lin B, 2007, MOL IMMUNOL, V44, P295, DOI 10.1016/j.molimm.2006.03.001; Lloyd AL, 2007, J BACTERIOL, V189, P3532, DOI 10.1128/JB.01744-06; Meijer AH, 2005, MOL IMMUNOL, V42, P1185, DOI 10.1016/j.molimm.2004.11.014; Misse D, 2007, J IMMUNOL, V178, P407, DOI 10.4049/jimmunol.178.1.407; Mulvey MA, 2001, INFECT IMMUN, V69, P4572, DOI 10.1128/IAI.69.7.4572-4579.2001; NAKAYAMA T, 1993, CLIN CHEM, V39, P293; Nicholson TF, 2009, INFECT IMMUN, V77, P5245, DOI 10.1128/IAI.00670-09; Notebaert S, 2008, COMP IMMUNOL MICROB, V31, P551, DOI 10.1016/j.cimid.2007.10.004; Ordas A, 2011, FISH SHELLFISH IMMUN, V31, P716, DOI 10.1016/j.fsi.2010.08.022; Orro T, 2004, COMP IMMUNOL MICROB, V27, P413, DOI 10.1016/j.cimid.2004.01.005; Prasadarao NV, 1996, INFECT IMMUN, V64, P146, DOI 10.1128/IAI.64.1.146-153.1996; Reigstad CS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005842; Renckens R, 2006, J INFECT DIS, V193, P187, DOI 10.1086/498876; Shah C, 2006, BLOOD, V108, P1751, DOI 10.1182/blood-2005-11-011932; Smith SGJ, 2007, FEMS MICROBIOL LETT, V273, P1, DOI 10.1111/j.1574-6968.2007.00778.x; Soto SM, 2006, CLIN MICROBIOL INFEC, V12, P1034, DOI 10.1111/j.1469-0691.2006.01543.x; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; Wang LM, 2002, P NATL ACAD SCI USA, V99, P15947, DOI 10.1073/pnas.252508399; Wu HH, 2009, J NEUROPATH EXP NEUR, V68, P677, DOI 10.1097/NEN.0b013e3181a77d1e; Wu ZF, 2010, MICROB PATHOGENESIS, V48, P178, DOI 10.1016/j.micpath.2010.02.007	37	16	16	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e32933	10.1371/journal.pone.0032933	http://dx.doi.org/10.1371/journal.pone.0032933			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427910	Green Submitted, Green Published, gold			2022-12-25	WOS:000302381500063
J	Liu, XL; Zhang, PF; Ding, SF; Wang, Y; Zhang, M; Zhao, YX; Ni, M; Zhang, Y				Liu, Xiao Ling; Zhang, Peng Fei; Ding, Shi Fang; Wang, Yan; Zhang, Mei; Zhao, Yu Xia; Ni, Mei; Zhang, Yun			Local Gene Silencing of Monocyte Chemoattractant Protein-1 Prevents Vulnerable Plaque Disruption in Apolipoprotein E-Knockout Mice	PLOS ONE			English	Article							RECEPTOR-DEFICIENT MICE; RNA INTERFERENCE; ANTISENSE OLIGONUCLEOTIDES; IN-VIVO; ATHEROSCLEROSIS; EXPRESSION; CHEMOKINES; RUPTURE; MCP-1; ATHEROGENESIS	Monocyte chemoattractant protein-1 (MCP-1), a CC chemokine (CCL2), has been demonstrated to play important roles in atherosclerosis and becoming an important therapeutic target for atherosclerosis. The present study was undertaken to test the hypothesis that local RNAi of MCP-1 by site-specific delivery of adenovirus-mediated small hairpin RNA (shRNA) may enhance plaque stability and prevent plaque disruption in ApoE(-/-) mice. We designed an adenovirus-mediated shRNA against mouse MCP-1 (rAd5-MCP-1-shRNA). Male apolipoprotein E-knockout (ApoE(-/-)) mice (n = 120) were fed a high-fat diet and vulnerable plaques were induced by perivascular placement of constrictive collars around the carotid artery, intraperitoneal injection of lipopolysaccharide and stress stimulation. Mice were randomly divided into RNA interference (Ad-MCP-1i) group receiving local treatment of rAd5-MCP-1-shRNA suspension, Ad-EGFP group receiving treatment of rAd5-mediated negative shRNA and mock group receiving treatment of saline. Two weeks after treatment, plaque disruption rates were significantly lower in the Ad-MCP-1i group than in the Ad-EGFP group (13.3% vs. 60.0%, P = 0.01), and local MCP-1 expression was significantly inhibited in the Ad-MCP-1i group confirmed by immunostaining, qRT-PCR and western blot (P < 0.001). Compared with the Ad-EGFP group, carotid plaques in the Ad-MCP-1i group showed increased levels of collagen and smooth muscle cells, and decreased levels of lipid and macrophages. The expression of inflammatory cytokines and activities of matrix metalloproteinases (MMPs) were lower in the Ad-MCP-1i group than in the Ad-EGFP group. In conclusion, site-specific delivery of adenoviral-mediated shRNA targeting mouse MCP-1 downregulated MCP-1 expression, turned a vulnerable plaque into a more stable plaque phenotype and prevented plaque disruption. A marked suppression of the local inflammatory cytokine expression may be the central mechanism involved.	[Liu, Xiao Ling] Shandong Univ, Qilu Hosp, Key Lab Cardiovasc Remodeling & Funct Res, Chinese Minist Educ, Jinan 250100, Shandong, Peoples R China; Shandong Univ, Qilu Hosp, Chinese Minist Hlth, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong University	Liu, XL (corresponding author), Shandong Univ, Qilu Hosp, Key Lab Cardiovasc Remodeling & Funct Res, Chinese Minist Educ, Jinan 250100, Shandong, Peoples R China.	yun-zhang@163.com; nimei999@163.com	Liu, Xiaoling/HGD-3566-2022		National 973 Basic Research Program of China [2011CB503906, 2012CB518603]; National High-tech Research and Development Program of China [2012AA020827]; Program of Introducing Talents of Discipline to Universities [B07035]; National Natural Science Foundation of China for Innovative Research Group [81021001]; National Natural Science of China [60831003]; National Natural Science Foundation of China [30900607, 30873325, 30971096, 30972809, 81100206, 81173251]; Natural Science Foundation of Shandong Province [2009ZRA01003]	National 973 Basic Research Program of China(National Basic Research Program of China); National High-tech Research and Development Program of China(National High Technology Research and Development Program of China); Program of Introducing Talents of Discipline to Universities(Ministry of Education, China - 111 Project); National Natural Science Foundation of China for Innovative Research Group(National Natural Science Foundation of China (NSFC)); National Natural Science of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This work was supported by the National 973 Basic Research Program of China (Nos. 2011CB503906, 2012CB518603), the National High-tech Research and Development Program of China (No. 2012AA020827), the Program of Introducing Talents of Discipline to Universities (No. B07035), the State Program of National Natural Science Foundation of China for Innovative Research Group (No. 81021001), the State Key Program of National Natural Science of China (No. 60831003), grants of the National Natural Science Foundation of China (Nos. 30900607, 30873325, 30971096, 30972809, 81100206, 81173251) and the Natural Science Foundation of Shandong Province (2009ZRA01003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello RJ, 1999, ARTERIOSCL THROM VAS, V19, P1518, DOI 10.1161/01.ATV.19.6.1518; Aiello RJ, 2010, ATHEROSCLEROSIS, V208, P370, DOI 10.1016/j.atherosclerosis.2009.08.017; Bertrand JR, 2002, BIOCHEM BIOPH RES CO, V296, P1000, DOI 10.1016/S0006-291X(02)02013-2; Chen YL, 1999, ATHEROSCLEROSIS, V143, P115, DOI 10.1016/S0021-9150(98)00285-8; Dourron HM, 2005, AM J PHYSIOL-HEART C, V288, pH946, DOI 10.1152/ajpheart.00413.2004; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Falk E, 2007, ARTERIOSCL THROM VAS, V27, P969, DOI 10.1161/01.ATV.0000261572.33474.e0; Gosling J, 1999, J CLIN INVEST, V103, P773, DOI 10.1172/JCI5624; Gu L, 1998, MOL CELL, V2, P275, DOI 10.1016/S1097-2765(00)80139-2; Haft JI, 2003, CIRCULATION, V107, pE65, DOI 10.1161/01.CIR.0000057851.87508.28; Inoue S, 2002, CIRCULATION, V106, P2700, DOI 10.1161/01.CIR.0000038140.80105.AD; Jackson CL, 2007, ARTERIOSCL THROM VAS, V27, P714, DOI 10.1161/01.ATV.0000261873.86623.e1; JIANG YL, 1992, J IMMUNOL, V148, P2423; Kao SC, 2004, J BIOL CHEM, V279, P1942, DOI 10.1074/jbc.M309219200; Kowala MC, 2000, ATHEROSCLEROSIS, V149, P323, DOI 10.1016/S0021-9150(99)00342-1; Kraaijeveld AO, 2007, CURR PHARM DESIGN, V13, P1039, DOI 10.2174/138161207780487584; Lewis DL, 2002, NAT GENET, V32, P107, DOI 10.1038/ng944; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ni M, 2009, AM J PHYSIOL-HEART C, V296, pH1598, DOI 10.1152/ajpheart.01202.2008; Niu JL, 2009, CLIN SCI, V117, P95, DOI 10.1042/CS20080581; Paroo Z, 2004, TRENDS BIOTECHNOL, V22, P390, DOI 10.1016/j.tibtech.2004.06.004; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; Rosenfeld M.E., 2007, VULNERABLE ATHEROSCL, P105; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Schecter AD, 1997, J BIOL CHEM, V272, P28568, DOI 10.1074/jbc.272.45.28568; Senn C, 2005, EUR J PHARMACOL, V522, P30, DOI 10.1016/j.ejphar.2005.08.021; Sheikine Y, 2004, ANN MED, V36, P98, DOI 10.1080/07853890310019961; Song EW, 2003, NAT MED, V9, P347, DOI 10.1038/nm828; von der Thusen JH, 2001, CIRCULATION, V103, P1164, DOI 10.1161/01.CIR.103.8.1164; Yadav A, 2010, CLIN CHIM ACTA, V411, P1570, DOI 10.1016/j.cca.2010.07.006; Zender L, 2003, P NATL ACAD SCI USA, V100, P7797, DOI 10.1073/pnas.1330920100; Zhong L, 2008, J CELL MOL MED, V12, P2362, DOI 10.1111/j.1582-4934.2008.00261.x	33	31	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33497	10.1371/journal.pone.0033497	http://dx.doi.org/10.1371/journal.pone.0033497			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22428064	Green Published, Green Submitted, gold			2022-12-25	WOS:000302381500149
J	Shanmugam, MK; Ong, TH; Kumar, AP; Lun, CK; Ho, PC; Wong, PTH; Hui, KM; Sethi, G				Shanmugam, Muthu K.; Ong, Tina H.; Kumar, Alan Prem; Lun, Chang K.; Ho, Paul C.; Wong, Peter T. H.; Hui, Kam M.; Sethi, Gautam			Ursolic Acid Inhibits the Initiation, Progression of Prostate Cancer and Prolongs the Survival of TRAMP Mice by Modulating Pro-Inflammatory Pathways	PLOS ONE			English	Article							TRANSGENIC ADENOCARCINOMA; MOUSE PROSTATE; IN-VITRO; METASTASIS; MODEL; CARCINOGENESIS; SUPPRESSION; ACTIVATION; GROWTH; INTERLEUKIN-6	Prostate cancer is one of the leading causes of cancer death among men worldwide. In this study, using transgenic adenocarcinoma of mouse prostate (TRAMP) mice, the effect of diet enriched with 1% w/w ursolic acid (UA) was investigated to evaluate the stage specific chemopreventive activity against prostate cancer. We found that TRAMP mice fed with UA diet for 8 weeks (weeks 4 to 12) delayed formation of prostate intraepithelial neoplasia (PIN). Similarly, mice fed with UA diet for 6 weeks (weeks 12 to 18) inhibited progression of PIN to adenocarcinoma as determined by hematoxylin and eosin staining. Finally, TRAMP mice fed with UA diet for 12 weeks (weeks 24 to 36) demonstrated markedly reduced tumor growth without any significant effects on total body weight and prolonged overall survival. With respect to the molecular mechanism, we found that UA down-regulated activation of various pro-inflammatory mediators including, NF-kappa B, STAT3, AKT and IKK alpha/beta phosphorylation in the dorsolateral prostate (DLP) tissues that correlated with the reduction in serum levels of TNF-alpha and IL-6. In addition, UA significantly down-regulated the expression levels of cyclin D1 and COX-2 but up-regulated the levels of caspase-3 as revealed by immunohistochemical analysis of tumor tissue sections. Finally, UA was detected in serum samples obtained from various mice groups fed with enriched diet in nanogram quantity indicating that it is well absorbed in the GI tract. Overall, our findings provide strong evidence that UA can be an excellent agent for both the prevention and treatment of prostate cancer.	[Shanmugam, Muthu K.; Kumar, Alan Prem; Wong, Peter T. H.; Sethi, Gautam] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117595, Singapore; [Ong, Tina H.; Hui, Kam M.] Natl Canc Ctr, Humphrey Oei Inst Canc Res, Div Cellular & Mol Res, Singapore, Singapore; [Kumar, Alan Prem; Sethi, Gautam] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore; [Kumar, Alan Prem] Univ Western Australia, Sch Anat & Human Biol, Perth, WA 6009, Australia; [Lun, Chang K.; Ho, Paul C.] Natl Univ Singapore, Dept Pharm, Singapore 117548, Singapore	National University of Singapore; National Cancer Centre Singapore (NCCS); National University of Singapore; University of Western Australia; National University of Singapore	Shanmugam, MK (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117595, Singapore.	cmrhkm@nccs.com.sg; phcgs@nus.edu.sg	Chang, Kai Lun/H-9335-2012; Ho, Paul C/O-9652-2014; Ong, Hooi Tin/J-7710-2017; Kumar, Alan Prem/ABE-7492-2020; Sethi, Gautam/F-2372-2011	Ho, Paul C/0000-0001-9213-7116; Kumar, Alan Prem/0000-0002-3754-5712; Hui, Kam/0000-0003-1820-1399; Sethi, Gautam/0000-0002-8677-8475	National Medical Research Council of Singapore [R-184-000-168-275, R-184-000-201-275, R-713-000-119-275]; Cancer Science Institute of Singapore [R-713-001-011-271]; Biomedical Research Council of Singapore; Singapore Millennium Foundation	National Medical Research Council of Singapore(National Medical Research Council, Singapore); Cancer Science Institute of Singapore; Biomedical Research Council of Singapore(Agency for Science Technology & Research (A*STAR)); Singapore Millennium Foundation(Singapore Millennium Foundation)	This work was supported by grants from National Medical Research Council of Singapore [R-184-000-168-275 and R-184-000-201-275] to GS. APK was supported by grants from the National Medical Research Council of Singapore [Grant R-713-000-119-275] and Cancer Science Institute of Singapore, Experimental Therapeutics I Program [Grant R-713-001-011-271]. KMH was supported by a grant from the National Medical Research Council of Singapore, Biomedical Research Council of Singapore, and the Singapore Millennium Foundation. The funders has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2006, BIOCHEM PHARMACOL, V71, P1397, DOI 10.1016/j.bcp.2006.02.009; Aggarwal BB, 2006, BIOCHEM PHARMACOL, V72, P1605, DOI 10.1016/j.bcp.2006.06.029; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Chen LW, 2001, JNCI-J NATL CANCER I, V93, P1872, DOI 10.1093/jnci/93.24.1872; Cho HJ, 2011, MOL CARCINOGEN, V50, P100, DOI 10.1002/mc.20698; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; De Marzo AM, 1999, AM J PATHOL, V155, P1985, DOI 10.1016/S0002-9440(10)65517-4; Deeb D, 2011, CARCINOGENESIS, V32, P757, DOI 10.1093/carcin/bgr030; Gann PH, 1999, CANCER RES, V59, P1225; Garcia GE, 2006, CLIN CANCER RES, V12, P980, DOI 10.1158/1078-0432.CCR-05-2068; Gingrich JR, 1999, PROSTATE CANCER P D, V2, P70, DOI 10.1038/sj/pcan/4500296; Gingrich JR, 1997, CANCER RES, V57, P4687; Gupta S, 2001, P NATL ACAD SCI USA, V98, P10350, DOI 10.1073/pnas.171326098; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kassi E, 2009, CANCER INVEST, V27, P723, DOI 10.1080/07357900802672712; Lessard L, 2005, BRIT J CANCER, V93, P1019, DOI 10.1038/sj.bjc.6602796; Liao QF, 2005, YAKUGAKU ZASSHI, V125, P509, DOI 10.1248/yakushi.125.509; Liu J, 1995, J ETHNOPHARMACOL, V49, P57, DOI 10.1016/0378-8741(95)90032-2; Mentor-Marcel R, 2001, CANCER RES, V61, P6777; Okamoto M, 1997, CANCER RES, V57, P141; Palapattu GS, 2005, CARCINOGENESIS, V26, P1170, DOI 10.1093/carcin/bgh317; Pathak AK, 2007, MOL CANCER RES, V5, P943, DOI 10.1158/1541-7786.MCR-06-0348; Shanmugam MK, 2011, INT J CANCER, V129, P1552, DOI 10.1002/ijc.26120; Shanmugam MK, 2011, J MOL MED, V89, P713, DOI 10.1007/s00109-011-0746-2; Singh RP, 2008, CLIN CANCER RES, V14, P7773, DOI 10.1158/1078-0432.CCR-08-1309; Singh SV, 2008, CANCER RES, V68, P9503, DOI 10.1158/0008-5472.CAN-08-1677; Singh SV, 2009, CANCER RES, V69, P2117, DOI 10.1158/0008-5472.CAN-08-3502; Slusarz A, 2010, CANCER RES, V70, P3382, DOI 10.1158/0008-5472.CAN-09-3012; Vasto S, 2008, FUTURE ONCOL, V4, P637, DOI 10.2217/14796694.4.5.637; Xia YY, 2011, J CHROMATOGR B, V879, P219, DOI 10.1016/j.jchromb.2010.11.037; Zerbini LF, 2003, CANCER RES, V63, P2206; Zha S, 2001, CANCER RES, V61, P8617; Zhang YX, 2010, MOL CARCINOGEN, V49, P374, DOI 10.1002/mc.20610	33	106	112	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e32476	10.1371/journal.pone.0032476	http://dx.doi.org/10.1371/journal.pone.0032476			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427843	Green Published, Green Submitted, gold			2022-12-25	WOS:000302381500019
J	Toenshoff, ER; Kvellestad, A; Mitchell, SO; Steinum, T; Falk, K; Colquhoun, DJ; Horn, M				Toenshoff, Elena R.; Kvellestad, Agnar; Mitchell, Susan O.; Steinum, Terje; Falk, Knut; Colquhoun, Duncan J.; Horn, Matthias			A Novel Betaproteobacterial Agent of Gill Epitheliocystis in Seawater Farmed Atlantic Salmon (Salmo salar)	PLOS ONE			English	Article							CANDIDATUS-CLAVOCHLAMYDIA-SALMONICOLA; SERIOLA-DUMERILI RISSO; PISCICHLAMYDIA SALMONIS; CULTURED AMBERJACK; FRESH-WATER; DISEASE; LIGHT; CHLAMYDIALES; INFECTION; BACTERIA	Epitheliocystis, a disease characterised by cytoplasmic bacterial inclusions (cysts) in the gill and less commonly skin epithelial cells, has been reported in many marine and freshwater fish species and may be associated with mortality. Previously, molecular and ultrastructural analyses have exclusively associated members of the Chlamydiae with such inclusions. Here we investigated a population of farmed Atlantic salmon from the west coast of Norway displaying gill epitheliocystis. Although 'Candidatus Piscichlamydia salmonis', previously reported to be present in such cysts, was detected by PCR in most of the gill samples analysed, this bacterium was found to be a rare member of the gill microbiota, and not associated with the observed cysts as demonstrated by fluorescence in situ hybridization assays. The application of a broad range 16 S rRNA targeted PCR assay instead identified a novel betaproteobacterium as an abundant member of the gill microbiota. Fluorescence in situ hybridization demonstrated that this bacterium, tentatively classified as 'Candidatus Branchiomonas cysticola', was the cyst-forming agent in these samples. While histology and ultrastructure of 'Ca. B. cysticola' cysts revealed forms similar to the reticulate and intermediate bodies described in earlier reports from salmon in seawater, no elementary bodies typical of the chlamydial developmental cycle were observed. In conclusion, this study identified a novel agent of epitheliocystis in sea-farmed Atlantic salmon and demonstrated that these cysts can be caused by bacteria phylogenetically distinct from the Chlamydiae.	[Toenshoff, Elena R.; Horn, Matthias] Univ Vienna, Dept Microbial Ecol, Vienna, Austria; [Kvellestad, Agnar] Norwegian Sch Vet Sci, Dept Basic Sci & Aquat Med, Oslo, Norway; [Mitchell, Susan O.] Vet Aqua Int, Oranmore, Ireland; [Mitchell, Susan O.] Trinity Coll Dublin, Sch Nat Sci, Dept Zool, Dublin, Ireland; [Steinum, Terje; Falk, Knut; Colquhoun, Duncan J.] Norwegian Vet Inst, Dept Lab Serv, Oslo, Norway	University of Vienna; Norwegian University of Life Sciences; Trinity College Dublin; Norwegian Veterinary Institute	Toenshoff, ER (corresponding author), Univ Vienna, Dept Microbial Ecol, Vienna, Austria.	duncan.colquhoun@vetinst.no	Falk, Knut/D-2952-2012; Horn, Matthias/G-1136-2011; Steinum, Terje Marken/AAE-1179-2020	Falk, Knut/0000-0002-9830-3493; Horn, Matthias/0000-0002-8309-5855; Steinum, Terje Marken/0000-0001-5377-9765	Austrian Science Fund (FWF) [Y277-B03]; Research Council of Norway [164771/S40, 163427/S40]; National Veterinary Institute [2010038]; Austrian Science Fund (FWF) [Y 277] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Research Council of Norway(Research Council of Norway); National Veterinary Institute; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was funded by Austrian Science Fund (FWF) grant Y277-B03 and The Research Council of Norway, grant no. 164771/S40, 163427/S40 and National Veterinary Institute, project no. 2010038. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bancroft G.D., 1996, THEORY PRACTICE PATH, V4th ed.; BRADLEY TM, 1988, DIS AQUAT ORGAN, V4, P9, DOI 10.3354/dao004009; Chiu CH, 2001, J MED MICROBIOL, V50, P594, DOI 10.1099/0022-1317-50-7-594; CRESPO S, 1990, AQUACULTURE, V90, P197, DOI 10.1016/0044-8486(90)90245-I; Daims H, 2005, MOL MICROBIAL ECOLOG, P213; Draghi A, 2004, J CLIN MICROBIOL, V42, P5286, DOI 10.1128/JCM.42.11.5286-5297.2004; Draghi A, 2007, DIS AQUAT ORGAN, V76, P27, DOI 10.3354/dao076027; Draghi A, 2010, DIS AQUAT ORGAN, V89, P39, DOI 10.3354/dao02171; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; FRYER JL, 1994, ZOOL STUD, V33, P95; GRAU A, 1991, AQUACULTURE, V95, P1, DOI 10.1016/0044-8486(91)90067-H; Groff JM, 1996, J VET DIAGN INVEST, V8, P172, DOI 10.1177/104063879600800206; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HOFFMAN GL, 1969, ANTON VAN LEE J M S, V35, P146, DOI 10.1007/BF02219125; Horn M, 2008, ANNU REV MICROBIOL, V62, P113, DOI 10.1146/annurev.micro.62.081307.162818; ISHIKAWA H, 1982, INSECT BIOCHEM, V12, P613, DOI 10.1016/0020-1790(82)90048-8; Karlsen M, 2008, ENVIRON MICROBIOL, V10, P208, DOI 10.1111/j.1462-2920.2007.01445.x; Kvellestad A, 2005, DIS AQUAT ORGAN, V67, P47, DOI 10.3354/dao067047; Loy A, 2007, NUCLEIC ACIDS RES, V35, pD800, DOI 10.1093/nar/gkl856; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Meijer A, 2006, APPL ENVIRON MICROB, V72, P284, DOI 10.1128/AEM.72.1.284-290.2006; Mitchell SO, 2010, J FISH DIS, V33, P665, DOI 10.1111/j.1365-2761.2010.01171.x; MIYAZAKI T, 1986, B JPN SOC SCI FISH, V52, P199; MOLNAR K, 1981, J FISH DIS, V4, P325, DOI 10.1111/j.1365-2761.1981.tb01140.x; MURRAY RGE, 1995, INT J SYST BACTERIOL, V45, P186, DOI 10.1099/00207713-45-1-186; Nowak BF, 2006, J FISH DIS, V29, P573, DOI 10.1111/j.1365-2761.2006.00747.x; Nylund A, 1998, J AQUAT ANIM HEALTH, V10, P43, DOI 10.1577/1548-8667(1998)010&lt;0043:AMSOTE&gt;2.0.CO;2; PAPERNA I, 1977, AQUACULTURE, V10, P169, DOI 10.1016/0044-8486(77)90018-7; Polkinghorne A, 2010, DIS AQUAT ORGAN, V91, P75, DOI 10.3354/dao02255; ROURKE AW, 1984, J FISH DIS, V7, P301, DOI 10.1111/j.1365-2761.1984.tb00935.x; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Schramm A, 2002, ENVIRON MICROBIOL, V4, P713, DOI 10.1046/j.1462-2920.2002.00364.x; Steinum T, 2010, DIS AQUAT ORGAN, V91, P201, DOI 10.3354/dao02266; Steinum T, 2009, AQUACULTURE, V293, P172, DOI 10.1016/j.aquaculture.2009.05.006; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Turnbull J. F., 1993, P237; Ward ME, 1998, SYSTEMATIC BACTERIOL, P1331; WOLKE RE, 1970, J COMP PATHOL, V80, P559, DOI 10.1016/0021-9975(70)90053-8; Zhou JZ, 1996, APPL ENVIRON MICROB, V62, P316, DOI 10.1128/AEM.62.2.316-322.1996	40	57	58	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e32696	10.1371/journal.pone.0032696	http://dx.doi.org/10.1371/journal.pone.0032696			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427865	Green Published, Green Submitted, gold			2022-12-25	WOS:000302381500033
J	Goel, S; Chin, EN; Fakhraldeen, SA; Berry, SM; Beebe, DJ; Alexander, CM				Goel, Shruti; Chin, Emily N.; Fakhraldeen, Saja A.; Berry, Scott M.; Beebe, David J.; Alexander, Caroline M.			Both LRP5 and LRP6 Receptors Are Required to Respond to Physiological Wnt Ligands in Mammary Epithelial Cells and Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM-CELLS; CORECEPTOR LRP6; IN-VITRO; PROTEINS; MECHANISM; PATHWAY; MOUSE; EXPRESSION; GLAND; PHOSPHORYLATION	A canonical Wnt signal maintains adult mammary ductal stem cell activity, and this signal requires the Wnt signaling reception, LRP5. However, previous data from our laboratory have shown that LRP5 and LRP6 are co-expressed in mammary basal cells and that LRP6 is active, leading us to question why LRP6 is insufficient to mediate canonical signaling in the absence of LRP5. Here, we show that at endogenous levels of LRP5 and LRP6 both receptors are required to signal in response to some Wnt ligands both in vitro (in mouse embryonic fibroblasts and mammary epithelial cells) and in vivo (in mammary outgrowths). This subgroup of canonical ligands includes Wnt1, Wnt9b, and Wnt10b; the latter two are expressed in mammary gland. In contrast, the ligand commonly used experimentally, Wnt3a, prefers LRP6 and requires just one receptor regardless of cellular context. When either LRP5 or LRP6 is overexpressed, signaling remains ligand-dependent, but the requirement for both receptors is abrogated (regardless of ligand type). We have documented an LRP5-6 heteromer using immiscible filtration assisted by surface tension (IFAST) immunoprecipitation. Together, our data imply that under physiological conditions some Wnt ligands require both receptors to be present to generate a canonical signal. We have designed a model to explain our results based on the resistance of LRP5-6 heteromers to a selective inhibitor of E1/2-binding Wnt-LRP6 interaction. These data have implications for stem cell biology and for the analysis of the oncogenicity of LRP receptors that are often overexpressed in breast tumors.	[Goel, Shruti; Chin, Emily N.; Fakhraldeen, Saja A.; Alexander, Caroline M.] Univ Wisconsin, McArdle Lab Canc Res, Madison, WI 53706 USA; [Berry, Scott M.; Beebe, David J.] Univ Wisconsin, Dept Biomed Engn, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Alexander, CM (corresponding author), Univ Wisconsin, McArdle Lab Canc Res, 1400 Univ Ave, Madison, WI 53706 USA.	alexander@oncology.wisc.edu		Fakhraldeen, Saja/0000-0003-3919-0270	Era of Hope Scholar Grant [W81XWH-06-1-0491]; Kuwait Ministry of Higher Education	Era of Hope Scholar Grant; Kuwait Ministry of Higher Education	This work was supported by Era of Hope Scholar Grant W81XWH-06-1-0491 to C. M. A.) and a scholarship from the Kuwait Ministry of Higher Education (to S. F.).	Ai LB, 2006, CARCINOGENESIS, V27, P1341, DOI 10.1093/carcin/bgi379; Alexander C. M., 2012, COLD SPRING IN PRESS; Arce L, 2006, ONCOGENE, V25, P7492, DOI 10.1038/sj.onc.1210056; Badders NM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006594; Bennett CN, 2003, BIOCHEM BIOPH RES CO, V302, P12, DOI 10.1016/S0006-291X(03)00092-5; Berry SM, 2011, LAB CHIP, V11, P1747, DOI 10.1039/c1lc00004g; Bienz M, 2003, NAT CELL BIOL, V5, P179, DOI 10.1038/ncb0303-179; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Bjorklund P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004243; Bourhis E, 2011, STRUCTURE, V19, P1433, DOI 10.1016/j.str.2011.07.005; Brennan K, 2004, ONCOGENE, V23, P4873, DOI 10.1038/sj.onc.1207642; Brennan KR, 2004, J MAMMARY GLAND BIOL, V9, P119, DOI 10.1023/B:JOMG.0000037157.94207.33; Britt KL, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2245; Bryja V, 2009, MOL BIOL CELL, V20, P924, DOI 10.1091/mbc.E08-07-0711; Callahan R, 2008, J MAMMARY GLAND BIOL, V13, P309, DOI 10.1007/s10911-008-9092-6; Chen S, 2011, DEV CELL, V21, P848, DOI 10.1016/j.devcel.2011.09.007; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; DU SJ, 1995, MOL CELL BIOL, V15, P2625; Ettenberg SA, 2010, P NATL ACAD SCI USA, V107, P15473, DOI 10.1073/pnas.1007428107; Geyer FC, 2011, MODERN PATHOL, V24, P209, DOI 10.1038/modpathol.2010.205; Gong Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012682; Gonzalez-Sancho JM, 2004, MOL CELL BIOL, V24, P4757, DOI 10.1128/MCB.24.11.4757-4768.2004; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Hendrickx M, 2008, DEV GROWTH DIFFER, V50, P229, DOI [10.1111/j.1440-169x.2008.01016.x, 10.1111/j.1440-169X.2008.01016.x]; Holmen SL, 2002, J BIOL CHEM, V277, P34727, DOI 10.1074/jbc.M204989200; Humphreys RC, 1997, CELL GROWTH DIFFER, V8, P839; Itasaki N, 2003, DEVELOPMENT, V130, P4295, DOI 10.1242/dev.00674; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Khan Z, 2007, MOL CELL BIOL, V27, P7291, DOI 10.1128/MCB.00773-07; Kim S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019310; Kim YC, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-55; Kim YC, 2008, CANCER RES, V68, P10145, DOI 10.1158/0008-5472.CAN-08-2992; Lindvall C, 2006, J BIOL CHEM, V281, P35081, DOI 10.1074/jbc.M607571200; Lindvall C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005813; Liu CC, 2010, P NATL ACAD SCI USA, V107, P5136, DOI 10.1073/pnas.0911220107; Liu GZ, 2003, MOL CELL BIOL, V23, P5825, DOI 10.1128/MCB.23.16.5825-5835.2003; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDonald BT, 2008, J BIOL CHEM, V283, P16115, DOI 10.1074/jbc.M800327200; MacDonald BT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023537; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Mason JJ, 2010, J OSTEOPOROS, V2010, DOI 10.4061/2010/460120; Matsuda Y, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2317; Mi KH, 2005, J CELL BIOCHEM, V95, P328, DOI 10.1002/jcb.20400; Niehrs C, 2010, CELL MOL LIFE SCI, V67, P2551, DOI 10.1007/s00018-010-0329-3; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schlange T, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1769; Schweizer L, 2003, BMC CELL BIOL, V4, DOI 10.1186/1471-2121-4-4; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shimizu H, 1997, CELL GROWTH DIFFER, V8, P1349; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Suzuki H, 2008, BRIT J CANCER, V98, P1147, DOI 10.1038/sj.bjc.6604259; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Wei Q, 2007, J BIOL CHEM, V282, P15903, DOI 10.1074/jbc.M701927200; Welm Bryan E, 2008, Cell Stem Cell, V2, P90, DOI 10.1016/j.stem.2007.10.002; WONG GT, 1994, MOL CELL BIOL, V14, P6278, DOI 10.1128/MCB.14.9.6278; Wright WE, 2006, NAT PROTOC, V1, P2088, DOI 10.1038/nprot.2006.374; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540; Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020; Zhang J, 2010, ONCOGENE, V29, P539, DOI 10.1038/onc.2009.339	65	47	48	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16454	16466		10.1074/jbc.M112.362137	http://dx.doi.org/10.1074/jbc.M112.362137			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22433869	Green Published, hybrid			2022-12-25	WOS:000304030900036
J	Manaster, I; Goldman-Wohl, D; Greenfield, C; Nachmani, D; Tsukerman, P; Hamani, Y; Yagel, S; Mandelboim, O				Manaster, Irit; Goldman-Wohl, Debra; Greenfield, Caryn; Nachmani, Daphna; Tsukerman, Pinchas; Hamani, Yaron; Yagel, Simcha; Mandelboim, Ofer			MiRNA-Mediated Control of HLA-G Expression and Function	PLOS ONE			English	Article							NK CELLS; MICRORNAS; RECEPTOR; ANTIGEN; RECOGNITION; TRANSCRIPTS; COMPLEXES; KIR2DL4	HLA-G is a non-classical HLA class-Ib molecule expressed mainly by the extravillous cytotrophoblasts ( EVT) of the placenta. The expression of HLA-G on these fetal cells protects the EVT cells from immune rejection and is therefore important for a healthy pregnancy. The mechanisms controlling HLA-G expression are largely unknown. Here we demonstrate that miR-148a and miR-152 down-regulate HLA-G expression by binding its 3'UTR and that this down-regulation of HLA-G affects LILRB1 recognition and consequently, abolishes the LILRB1-mediated inhibition of NK cell killing. We further demonstrate that the C/G polymorphism at position +3142 of HLA-G 3'UTR has no effect on the miRNA targeting of HLA-G. We show that in the placenta both miR-148a and miR-152 miRNAs are expressed at relatively low levels, compared to other healthy tissues, and that the mRNA levels of HLA-G are particularly high and we therefore suggest that this might enable the tissue specific expression of HLA-G.	[Manaster, Irit; Nachmani, Daphna; Tsukerman, Pinchas; Mandelboim, Ofer] Hebrew Univ Jerusalem, Hadassah Med Sch, IMRIC, Lautenberg Ctr Gen & Tumor Immunol, IL-91010 Jerusalem, Israel; [Goldman-Wohl, Debra; Greenfield, Caryn; Hamani, Yaron; Yagel, Simcha] Hadassah Hebrew Univ Med Ctr, Ctr Human Placenta Res, Dept Obstet & Gynecol, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Manaster, I (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, IMRIC, Lautenberg Ctr Gen & Tumor Immunol, IL-91010 Jerusalem, Israel.	oferm@ekmd.huji.ac.il		Mandelboim, Ofer/0000-0002-9354-1855; Tsukerman, Pinchas/0000-0002-5813-7048	Israeli Science Foundation; Israeli Science Foundation (Morasha); Croatia Israel Research Grant; MOST-DKFZ; Rosetrees Trust; Israel Cancer Association [20100003]; ICRF; Association for International Cancer Research (AICR); Hadassah University Medical Center; Worldwide Cancer Research [10-0003] Funding Source: researchfish	Israeli Science Foundation(Israel Science Foundation); Israeli Science Foundation (Morasha)(Israel Science Foundation); Croatia Israel Research Grant; MOST-DKFZ; Rosetrees Trust(Rosetrees Trust); Israel Cancer Association; ICRF; Association for International Cancer Research (AICR); Hadassah University Medical Center; Worldwide Cancer Research	This study was supported by grants from the Israeli Science Foundation and the Israeli Science Foundation (Morasha), the Croatia Israel Research Grant, the MOST-DKFZ Research Grant, the Rosetrees Trust, the Israel Cancer Association (20100003), the ICRF professorship grant, and the Association for International Cancer Research (AICR) (all to O.M.). O.M. is a Crown Professor of Molecular Immunology. Y.H. is supported by the Hadassah University Medical Center internal grant fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achdout H, 2010, J VIROL, V84, P3993, DOI 10.1128/JVI.02289-09; Bandres E, 2007, DNA CELL BIOL, V26, P273, DOI 10.1089/dna.2006.0544; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Carosella ED, 2011, CELL MOL LIFE SCI, V68, P353, DOI 10.1007/s00018-010-0579-0; Chen Y, 2010, J GASTROINTEST SURG, V14, P1170, DOI 10.1007/s11605-010-1202-2; Donadi EA, 2011, CELL MOL LIFE SCI, V68, P369, DOI 10.1007/s00018-010-0580-7; FUJII T, 1994, J IMMUNOL, V153, P5516; Goldman-Wohl D, 2009, J REPROD IMMUNOL, V82, P96, DOI 10.1016/j.jri.2009.05.002; Gomez-Lozano N, 2003, EUR J IMMUNOL, V33, P639, DOI 10.1002/eji.200323741; Gonen-Gross T, 2005, J IMMUNOL, V175, P4866, DOI 10.4049/jimmunol.175.8.4866; Gonen-Gross T, 2003, J IMMUNOL, V171, P1343, DOI 10.4049/jimmunol.171.3.1343; Gonen-Gross T, 2007, HUM IMMUNOL, V68, P227, DOI 10.1016/j.humimm.2006.10.013; Hanna J, 2003, BLOOD, V102, P1569, DOI 10.1182/blood-2003-02-0517; Hanna J, 2007, TRENDS IMMUNOL, V28, P201, DOI 10.1126/scitranslmed.3006850; Hanna J, 2006, NAT MED, V12, P1065, DOI 10.1038/nm1452; Hviid TVF, 2006, HUM REPROD UPDATE, V12, P209, DOI 10.1093/humupd/dmi048; ISHITANI A, 1992, P NATL ACAD SCI USA, V89, P3947, DOI 10.1073/pnas.89.9.3947; King A, 1996, AM J REPROD IMMUNOL, V35, P258; Kulkarni S, 2011, NATURE, V472, P495, DOI 10.1038/nature09914; LeMaoult J, 2005, FASEB J, V19, P662, DOI 10.1096/fj.04-1617fje; Mandelboim O, 1999, P NATL ACAD SCI USA, V96, P5640, DOI 10.1073/pnas.96.10.5640; MCMASTER MT, 1995, J IMMUNOL, V154, P3771; Mouillet JF, 2011, BIRTH DEFECTS RES A; Paul P, 2000, HUM IMMUNOL, V61, P1138, DOI 10.1016/S0198-8859(00)00197-X; Rajagopalan S, 2006, PLOS BIOL, V4, P70, DOI 10.1371/journal.pbio.0040009; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Rizzo R, 2011, CELL MOL LIFE SCI, V68, P341, DOI 10.1007/s00018-010-0578-1; SHIMIZU Y, 1989, J IMMUNOL, V142, P3320; Stern N, 2005, J IMMUNOL, V174, P6692, DOI 10.4049/jimmunol.174.11.6692; Stern-Ginossar N, 2007, SCIENCE, V317, P376, DOI 10.1126/science.1140956; Tan Z, 2007, AM J HUM GENET, V81, P829, DOI 10.1086/521200; van der Meer A, 2004, MOL HUM REPROD, V10, P189, DOI 10.1093/molehr/gah032; Veit TD, 2009, TRANSPL IMMUNOL, V20, P229, DOI 10.1016/j.trim.2008.11.001; Zhu XM, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.03.002	35	110	121	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33395	10.1371/journal.pone.0033395	http://dx.doi.org/10.1371/journal.pone.0033395			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438923	Green Published, Green Submitted, gold			2022-12-25	WOS:000303309100039
J	Pace, E; Ferraro, M; Minervini, MI; Vitulo, P; Pipitone, L; Chiappara, G; Siena, L; Montalbano, AM; Johnson, M; Gjomarkaj, M				Pace, Elisabetta; Ferraro, Maria; Minervini, Marta Ida; Vitulo, Patrizio; Pipitone, Loredana; Chiappara, Giuseppina; Siena, Liboria; Montalbano, Angela Marina; Johnson, Malcolm; Gjomarkaj, Mark			Beta Defensin-2 Is Reduced in Central but Not in Distal Airways of Smoker COPD Patients	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; TOLL-LIKE RECEPTOR-4; EPITHELIAL-CELLS; HOST-DEFENSE; BETA-DEFENSIN-2; EXPRESSION; INNATE; INFLAMMATION; TOLL-LIKE-RECEPTOR-2; LIPOPOLYSACCHARIDE	Background: Altered pulmonary defenses in chronic obstructive pulmonary disease (COPD) may promote distal airways bacterial colonization. The expression/activation of Toll Like receptors (TLR) and beta 2 defensin (HBD2) release by epithelial cells crucially affect pulmonary defence mechanisms. Methods: The epithelial expression of TLR4 and of HBD2 was assessed in surgical specimens from current smokers COPD (s-COPD; n = 17), ex-smokers COPD (ex-s-COPD; n = 8), smokers without COPD (S; n = 12), and from non-smoker non-COPD subjects (C; n = 13). Results: In distal airways, s-COPD highly expressed TLR4 and HBD2. In central airways, S and s-COPD showed increased TLR4 expression. Lower HBD2 expression was observed in central airways of s-COPD when compared to S and to ex-s-COPD. s-COPD had a reduced HBD2 gene expression as demonstrated by real-time PCR on micro-dissected bronchial epithelial cells. Furthermore, HBD2 expression positively correlated with FEV1/FVC ratio and inversely correlated with the cigarette smoke exposure. In a bronchial epithelial cell line (16 HBE) IL-1 beta significantly induced the HBD2 mRNA expression and cigarette smoke extracts significantly counteracted this IL-1 mediated effect reducing both the activation of NFkB pathway and the interaction between NFkB and HBD2 promoter. Conclusions: This study provides new insights on the possible mechanisms involved in the alteration of innate immunity mechanisms in COPD.	[Pace, Elisabetta; Ferraro, Maria; Chiappara, Giuseppina; Siena, Liboria; Montalbano, Angela Marina; Gjomarkaj, Mark] CNR, Inst Biomed & Mol Immunol, Palermo, Italy; [Minervini, Marta Ida] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA; [Vitulo, Patrizio; Pipitone, Loredana] ISMETT, Mediterranean Inst Transplantat & High Specialise, Palermo, Italy; [Johnson, Malcolm] GlaxoSmithKline Res & Dev Ltd, Uxbridge, Middx, England	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biomedicina e di Immunologia Molecolare "Alberto Monroy" (IBIM-CNR); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; IRCCS Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione (ISMETT); GlaxoSmithKline	Pace, E (corresponding author), CNR, Inst Biomed & Mol Immunol, Palermo, Italy.	pace@ibim.cnr.it	Pace, Elisabetta/AAL-2537-2020; Montalbano, Angela Marina/AAY-3905-2020; Ferraro, Maria/AAX-8156-2020; Vitulo, Patrizio/K-7500-2016	Pace, Elisabetta/0000-0003-1141-9010; Montalbano, Angela Marina/0000-0001-5950-4834; SIENA, LIBORIA/0000-0002-3182-9503; CHIAPPARA, GIUSEPPINA/0000-0002-7226-5660; Vitulo, Patrizio/0000-0003-1699-0208; FERRARO, MARIA/0000-0003-2533-7446	Italian National Research Council; GlaxoSmithKline [CDS014]	Italian National Research Council(Consiglio Nazionale delle Ricerche (CNR)); GlaxoSmithKline(GlaxoSmithKline)	This work was supported by the Italian National Research Council and by a GlaxoSmithKline grant to MG for Center of Excellence in COPD (CDS014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Biragyn A, 2002, SCIENCE, V298, P1025, DOI 10.1126/science.1075565; Boodoo S, 2006, AM J PHYSIOL-LUNG C, V291, pL479, DOI 10.1152/ajplung.00518.2005; Bruno A, 2005, EUR RESPIR J, V26, P398, DOI 10.1183/09031936.05.00092404; Busacker A, 2009, CHEST, V135, P48, DOI 10.1378/chest.08-0049; Chiappara G, 2007, ALLERGY, V62, P787, DOI 10.1111/j.1398-9995.2007.01417.x; COSIO MG, 1980, AM REV RESPIR DIS, V122, P265; COZENS AL, 1992, IN VITRO CELL DEV-AN, V28A, P735; Curtis Jeffrey L, 2007, Proc Am Thorac Soc, V4, P512, DOI 10.1513/pats.200701-002FM; Doz E, 2008, J IMMUNOL, V180, P1169, DOI 10.4049/jimmunol.180.2.1169; Droemann D, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-68; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; Hamilton L M, 2001, Monaldi Arch Chest Dis, V56, P48; Herr C, 2009, THORAX, V64, P144, DOI 10.1136/thx.2008.102681; Hogg JC, 2004, LANCET, V364, P709, DOI 10.1016/S0140-6736(04)16900-6; Imler JL, 2001, TRENDS CELL BIOL, V11, P304, DOI 10.1016/S0962-8924(01)02004-9; Kanda N, 2008, ENDOCRINOLOGY, V149, P5189, DOI 10.1210/en.2008-0343; Kao CY, 2008, J BIOL CHEM, V283, P15309, DOI [10.1074/jbc.M708289200, 10.1074/jbc.M804331200]; Kato A, 2007, CURR OPIN IMMUNOL, V19, P711, DOI 10.1016/j.coi.2007.08.004; Kim Victor, 2008, Proc Am Thorac Soc, V5, P478, DOI 10.1513/pats.200802-014ET; Kolble K, 2000, J MOL MED-JMM, V78, pB24; Lapperre TS, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-85; MacRedmond R, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-116; Miotto D, 2002, THORAX, V57, P146, DOI 10.1136/thorax.57.2.146; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Niyonsaba F, 2004, IMMUNOLOGY, V111, P273, DOI 10.1111/j.0019-2805.2004.01816.x; O'Donnell R, 2006, THORAX, V61, P448, DOI 10.1136/thx.2004.024463; Pace E, 2008, J IMMUNOL, V181, P7292, DOI 10.4049/jimmunol.181.10.7292; Pace E, 2008, IMMUNOLOGY, V124, P401, DOI 10.1111/j.1365-2567.2007.02788.x; Pace E, 2006, EUR J CANCER, V42, P2382, DOI 10.1016/j.ejca.2006.03.022; Pace E, 2011, CELL IMMUNOL, V268, P47, DOI 10.1016/j.cellimm.2011.02.004; Pace E, 2011, HUM IMMUNOL, V72, P54, DOI 10.1016/j.humimm.2010.09.009; Petecchia L, 2009, CHEST, V135, P1502, DOI 10.1378/chest.08-1780; Pons J, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-64; Saetta M, 1998, AM J RESP CRIT CARE, V157, P822, DOI 10.1164/ajrccm.157.3.9709027; Sethi S, 2006, AM J RESP CRIT CARE, V173, P991, DOI 10.1164/rccm.200509-1525OC; Sethi S, 2001, CLIN MICROBIOL REV, V14, P336, DOI 10.1128/CMR.14.2.336-363.2001; Sha Q, 2004, AM J RESP CELL MOL, V31, P358, DOI 10.1165/rcmb.2003-0388OC; Sullivan SD, 2000, CHEST, V117, P5; Zhang WY, 2011, RESPIROLOGY, V16, P508, DOI 10.1111/j.1440-1843.2010.01920.x; Zhang XC, 2006, J CLIN INVEST, V116, P3050, DOI 10.1172/JCI28139	41	55	56	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33601	10.1371/journal.pone.0033601	http://dx.doi.org/10.1371/journal.pone.0033601			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438960	Green Published, gold			2022-12-25	WOS:000303309100068
J	Tian, WP; Zhao, M; Li, M; Song, TB; Zhang, M; Quan, L; Li, SB; Sun, ZS				Tian, Weiping; Zhao, Mei; Li, Min; Song, Tianbao; Zhang, Min; Quan, Li; Li, Shengbin; Sun, Zhong Sheng			Reversal of Cocaine-Conditioned Place Preference through Methyl Supplementation in Mice: Altering Global DNA Methylation in the Prefrontal Cortex	PLOS ONE			English	Article							GENE-EXPRESSION; DRUG-ADDICTION; BEHAVIORAL SENSITIZATION; REWARD; BINDING; CHROMATIN; MORPHINE; MOUSE; RAT; HYPOMETHYLATION	Analysis of global methylation in cells has revealed correlations between overall DNA methylation status and some biological states. Recent studies suggest that epigenetic regulation through DNA methylation could be responsible for neuroadaptations induced by addictive drugs. However, there is no investigation to determine global DNA methylation status following repeated exposure to addictive drugs. Using mice conditioned place preference (CPP) procedure, we measured global DNA methylation level in the nucleus accumbens (NAc) and the prefrontal cortex (PFC) associated with drug rewarding effects. We found that cocaine-, but not morphine- or food-CPP training decreased global DNA methylation in the PFC. Chronic treatment with methionine, a methyl donor, for 25 consecutive days prior to and during CPP training inhibited the establishment of cocaine, but not morphine or food CPP. We also found that both mRNA and protein level of DNMT (DNA methytransferase) 3b in the PFC were downregulated following the establishment of cocaine CPP, and the downregulation could be reversed by repeated administration of methionine. Our study indicates a crucial role of global PFC DNA hypomethylation in the rewarding effects of cocaine. Reversal of global DNA hypomethylation could significantly attenuate the rewarding effects induced by cocaine. Our results suggest that methionine may have become a potential therapeutic target to treat cocaine addiction.	[Tian, Weiping; Song, Tianbao; Li, Shengbin] Xi An Jiao Tong Univ, Sch Med, Dept Forens Sci, Xian 710049, Shanxi, Peoples R China; [Zhao, Mei] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China; [Zhang, Min; Quan, Li] Capital Inst Pediat, Dept Mol Immunol, Beijing, Peoples R China; [Sun, Zhong Sheng] Chinese Acad Sci, Beijing Inst Life Sci, Beijing, Peoples R China; [Li, Min; Sun, Zhong Sheng] Wenzhou Med Coll, Inst Genom Med, Wenzhou, Peoples R China	Xi'an Jiaotong University; Chinese Academy of Sciences; Institute of Psychology, CAS; Capital Institute of Pediatrics (CIP); Chinese Academy of Sciences; Wenzhou Medical University	Tian, WP (corresponding author), Xi An Jiao Tong Univ, Sch Med, Dept Forens Sci, Xian 710049, Shanxi, Peoples R China.	shbinlee@mail.xjtu.edu.cn; sunzs@psych.ac.cn	Sun, Zhongsheng/AAS-4883-2020	Sun, Zhongsheng/0000-0002-7640-5026	Natural Science Foundation of China [30870821, 81071078]; Institute of Psychology and Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Institute of Psychology and Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences	This work was supported by Natural Science Foundation of China Grants (30870821 and 81071078), Youth Development Funding (O9KF015001) from the Institute of Psychology and Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anier K, 2010, NEUROPSYCHOPHARMACOL, V35, P2450, DOI 10.1038/npp.2010.128; Bardo MT, 2000, PSYCHOPHARMACOLOGY, V153, P31, DOI 10.1007/s002130000569; Barik J, 2010, BIOL PSYCHIAT, V68, P231, DOI 10.1016/j.biopsych.2010.03.037; Barros M, 2011, ADDICT BIOL, V9, P1369; Black YD, 2006, J NEUROSCI, V26, P9656, DOI 10.1523/JNEUROSCI.2391-06.2006; Chao J, 2004, ANNU REV MED, V55, P113, DOI 10.1146/annurev.med.55.091902.103730; COMB M, 1990, NUCLEIC ACIDS RES, V18, P3975, DOI 10.1093/nar/18.13.3975; Detich N, 2003, J BIOL CHEM, V278, P20812, DOI 10.1074/jbc.M211813200; Dunn BK, 2003, ANN NY ACAD SCI, V983, P28, DOI 10.1111/j.1749-6632.2003.tb05960.x; Feng JA, 2010, NAT NEUROSCI, V13, P1039, DOI 10.1038/nn0910-1039; Freeman WM, 2008, NEUROPSYCHOPHARMACOL, V33, P1807, DOI 10.1038/sj.npp.1301577; Gadd CA, 2003, J NEUROSCI, V23, P8271, DOI 10.1523/jneurosci.23-23-08271.2003; Hoffmann MJ, 2005, BIOCHEM CELL BIOL, V83, P296, DOI 10.1139/o05-036; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; INAMDAR NM, 1991, PLANT MOL BIOL, V17, P111, DOI 10.1007/BF00036811; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; Kumar A, 2005, NEURON, V48, P303, DOI 10.1016/j.neuron.2005.09.023; Levy D, 2007, J NEUROSCI, V27, P14179, DOI 10.1523/JNEUROSCI.4477-07.2007; Lin KY, 2011, BEHAV BRAIN RES, V220, P126, DOI 10.1016/j.bbr.2011.01.031; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; MUCHA RF, 1982, BRAIN RES, V243, P91, DOI 10.1016/0006-8993(82)91123-4; Muller U, 2002, ZOOLOGY, V105, P313, DOI 10.1078/0944-2006-00075; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Nestler EJ, 2004, NEUROPHARMACOLOGY, V47, P24, DOI 10.1016/j.neuropharm.2004.06.031; Nielsen DA, 2009, NEUROPSYCHOPHARMACOL, V34, P867, DOI 10.1038/npp.2008.108; Piechota M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r48; Pradet-Balade B, 2001, TRENDS BIOCHEM SCI, V26, P225, DOI 10.1016/S0968-0004(00)01776-X; Pum ME, 2008, PSYCHOPHARMACOLOGY, V201, P391, DOI 10.1007/s00213-008-1296-3; Quinlivan EP, 2008, ANAL BIOCHEM, V373, P383, DOI 10.1016/j.ab.2007.09.031; Renthal W, 2007, NEURON, V56, P517, DOI 10.1016/j.neuron.2007.09.032; Romieu P, 2008, J NEUROSCI, V28, P9342, DOI 10.1523/JNEUROSCI.0379-08.2008; Song LG, 2005, ANAL CHEM, V77, P504, DOI 10.1021/ac0489420; Szyf M, 2009, ANNU REV PHARMACOL, V49, P243, DOI 10.1146/annurev-pharmtox-061008-103102; Tremolizzo L, 2002, P NATL ACAD SCI USA, V99, P17095, DOI 10.1073/pnas.262658999; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Tsytsykova AV, 2007, J BIOL CHEM, V282, P11629, DOI 10.1074/jbc.M611418200; Tzschentke TM, 1998, BEHAV BRAIN RES, V97, P115, DOI 10.1016/S0166-4328(98)00034-5; Tzschentke TM, 1999, EUR J NEUROSCI, V11, P4099, DOI 10.1046/j.1460-9568.1999.00834.x; Tzschentke TM, 1998, PROG NEUROBIOL, V56, P613, DOI 10.1016/S0301-0082(98)00060-4; Ventura R, 2005, SYNAPSE, V58, P211, DOI 10.1002/syn.20197; Walters CL, 2001, J NEUROSCI, V21, P9438, DOI 10.1523/JNEUROSCI.21-23-09438.2001; Weaver ICG, 2005, J NEUROSCI, V25, P11045, DOI 10.1523/JNEUROSCI.3652-05.2005	42	68	72	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33435	10.1371/journal.pone.0033435	http://dx.doi.org/10.1371/journal.pone.0033435			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438930	Green Published, gold, Green Submitted			2022-12-25	WOS:000303309100045
J	Afonso, C; Paixao, VB; Costa, RM				Afonso, Cristina; Paixao, Vitor B.; Costa, Rui M.			Chronic Toxoplasma Infection Modifies the Structure and the Risk of Host Behavior	PLOS ONE			English	Article							OPEN-FIELD TEST; LATENT TOXOPLASMOSIS; GONDII; RATS; ANXIETY; BRAIN; DIFFERENTIATION; BRADYZOITES; EXPANSION; MICE	The intracellular parasite Toxoplasma has an indirect life cycle, in which felids are the definitive host. It has been suggested that this parasite developed mechanisms for enhancing its transmission rate to felids by inducing behavioral modifications in the intermediate rodent host. For example, Toxoplasma-infected rodents display a reduction in the innate fear of predator odor. However, animals with Toxoplasma infection acquired in the wild are more often caught in traps, suggesting that there are manipulations of intermediate host behavior beyond those that increase predation by felids. We investigated the behavioral modifications of Toxoplasma-infected mice in environments with exposed versus non-exposed areas, and found that chronically infected mice with brain cysts display a plethora of behavioral alterations. Using principal component analysis, we discovered that most of the behavioral differences observed in cyst-containing animals reflected changes in the microstructure of exploratory behavior and risk/unconditioned fear. We next examined whether these behavioral changes were related to the presence and distribution of parasitic cysts in the brain of chronically infected mice. We found no strong cyst tropism for any particular brain area but found that the distribution of Toxoplasma cysts in the brain of infected animals was not random, and that particular combinations of cyst localizations changed risk/unconditioned fear in the host. These results suggest that brain cysts in animals chronically infected with Toxoplasma alter the fine structure of exploratory behavior and risk/unconditioned fear, which may result in greater capture probability of infected rodents. These data also raise the possibility that selective pressures acted on Toxoplasma to broaden its transmission between intermediate predator hosts, in addition to felid definitive hosts.	[Afonso, Cristina; Paixao, Vitor B.; Costa, Rui M.] Inst Gulbenkian Ciencias, Champalimaud Neurosci Programme, Oeiras, Portugal	Fundacao Champalimaud; Instituto Gulbenkian de Ciencia	Afonso, C (corresponding author), Inst Gulbenkian Ciencias, Champalimaud Neurosci Programme, Oeiras, Portugal.	ruicosta@fchampalimaud.org		Costa, Rui M./0000-0003-0495-8374; Paixao, Vitor/0000-0003-3722-0747; Afonso, Cristina/0000-0003-2021-6856	Champalimaud Neuroscience Programme; European Research Council [STG 243393]; portuguese Fundacao para a Ciencia e Tecnologia	Champalimaud Neuroscience Programme; European Research Council(European Research Council (ERC)European Commission); portuguese Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by the Champalimaud Neuroscience Programme and European Research Council (STG 243393). CA and VBP are supported by a postdoctoral fellowship from the portuguese Fundacao para a Ciencia e Tecnologia. RMC is an investigator for the Champalimaud Neuroscience Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berdoy M, 2000, P ROY SOC B-BIOL SCI, V267, P1591, DOI 10.1098/rspb.2000.1182; BEVERLEY JKA, 1976, VET REC, V99, P123, DOI 10.1136/vr.99.7.123; Boothroyd JC, 2009, MEM I OSWALDO CRUZ, V104, P179, DOI 10.1590/S0074-02762009000200009; Choleris E, 2001, NEUROSCI BIOBEHAV R, V25, P235, DOI 10.1016/S0149-7634(01)00011-2; Darde ML, 1996, CURR TOP MICROBIOL, V219, P27; DEROUIN F, 1987, J CLIN MICROBIOL, V25, P1597, DOI 10.1128/JCM.25.9.1597-1600.1987; Di Cristina M, 2008, INFECT IMMUN, V76, P3491, DOI 10.1128/IAI.00254-08; Drai D, 2001, BEHAV BRAIN RES, V125, P133, DOI 10.1016/S0166-4328(01)00290-X; Dubey JP, 2003, INT J PARASITOL, V33, P1437, DOI 10.1016/S0020-7519(03)00141-3; Dubey JP, 1998, CLIN MICROBIOL REV, V11, P267, DOI 10.1128/CMR.11.2.267; Flegr J, 2003, BIOL PSYCHOL, V63, P253, DOI 10.1016/S0301-0511(03)00075-9; Flegr J, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-11; FLEGR J, 1994, FOLIA PARASIT, V41, P122; Flegr J, 2007, SCHIZOPHRENIA BULL, V33, P757, DOI 10.1093/schbul/sbl074; Gaykema RPA, 2004, BRAIN BEHAV IMMUN, V18, P238, DOI 10.1016/j.bbi.2003.08.002; Gonzalez LE, 2007, BEHAV BRAIN RES, V177, P70, DOI 10.1016/j.bbr.2006.11.012; HAY J, 1983, ANN TROP MED PARASIT, V77, P483, DOI 10.1080/00034983.1983.11811741; Hunn JP, 2011, MAMM GENOME, V22, P43, DOI 10.1007/s00335-010-9293-3; HUTCHISON WM, 1980, ANN TROP MED PARASIT, V74, P337, DOI 10.1080/00034983.1980.11687350; HUTCHISON WM, 1980, ANN TROP MED PARASIT, V74, P507, DOI 10.1080/00034983.1980.11687376; HUTCHISON WM, 1969, BMJ-BRIT MED J, V4, P806, DOI 10.1136/bmj.4.5686.806-b; Lyte M, 1998, PHYSIOL BEHAV, V65, P63, DOI 10.1016/S0031-9384(98)00145-0; Ma Y, 2005, NEUROSCIENCE, V135, P1203, DOI 10.1016/j.neuroscience.2005.07.014; Munoz M, 2011, IMMUNOL REV, V240, P269, DOI 10.1111/j.1600-065X.2010.00992.x; Poulin R, 2010, ADV STUD BEHAV, V41, P151, DOI 10.1016/S0065-3454(10)41005-0; Prandovszky E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023866; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Rodgers RJ, 1997, NEUROSCI BIOBEHAV R, V21, P801, DOI 10.1016/S0149-7634(96)00058-9; Sibley LD, 1996, CURR TOP MICROBIOL, V219, P3; STIBBS HH, 1985, ANN TROP MED PARASIT, V79, P153, DOI 10.1080/00034983.1985.11811902; Su C, 2003, SCIENCE, V299, P414, DOI 10.1126/science.1078035; Vyas A, 2007, P NATL ACAD SCI USA, V104, P6442, DOI 10.1073/pnas.0608310104; WALSH RN, 1976, PSYCHOL BULL, V83, P482, DOI 10.1037/0033-2909.83.3.482; Webster JP, 2007, SCHIZOPHRENIA BULL, V33, P752, DOI 10.1093/schbul/sbl073; Webster JP, 2010, FOLIA PARASIT, V57, P95, DOI 10.14411/fp.2010.012; WEBSTER JP, 1994, PARASITOLOGY, V109, P37, DOI 10.1017/S003118200007774X; Webster JP, 2001, MICROBES INFECT, V3, P1037, DOI 10.1016/S1286-4579(01)01459-9; Wendte JM, 2011, VET PARASITOL, V182, P96, DOI 10.1016/j.vetpar.2011.07.018	38	59	63	2	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e32489	10.1371/journal.pone.0032489	http://dx.doi.org/10.1371/journal.pone.0032489			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22431975	Green Submitted, Green Published, gold			2022-12-25	WOS:000303198600018
J	Madhurantakam, C; Duru, AD; Sandalova, T; Webb, JR; Achour, A				Madhurantakam, Chaithanya; Duru, Adil D.; Sandalova, Tatyana; Webb, John R.; Achour, Adnane			Inflammation-Associated Nitrotyrosination Affects TCR Recognition through Reduced Stability and Alteration of the Molecular Surface of the MHC Complex	PLOS ONE			English	Article							CLASS-I MOLECULES; POSTTRANSLATIONAL PROTEIN MODIFICATIONS; STRUCTURAL BASIS; TYROSINE NITRATION; CRYSTAL-STRUCTURE; T-CELLS; HUMAN BETA(2)-MICROGLOBULIN; PHOSPHORYLATED PEPTIDES; 3-DIMENSIONAL STRUCTURE; RECEPTOR SPECIFICITY	Nitrotyrosination of proteins, a hallmark of inflammation, may result in the production of MHC-restricted neoantigens that can be recognized by T cells and bypass the constraints of immunological self-tolerance. Here we biochemically and structurally assessed how nitrotyrosination of the lymphocytic choriomeningitis virus (LCMV)-associated immunodominant MHC class I-restricted epitopes gp33 and gp34 alters T cell recognition in the context of both H-2D(b) and H-2K(b). Comparative analysis of the crystal structures of H-2K(b)/gp34 and H-2K(b)/NY-gp34 demonstrated that nitrotyrosination of p3Y in gp34 abrogates a hydrogen bond interaction formed with the H-2K(b) residue E152. As a consequence the conformation of the TCR-interacting E152 was profoundly altered in H-2K(b)/NY-gp34 when compared to H-2K(b)/gp34, thereby modifying the surface of the nitrotyrosinated MHC complex. Furthermore, nitrotyrosination of gp34 resulted in structural over-packing, straining the overall conformation and considerably reducing the stability of the H-2K(b)/NY-gp34 MHC complex when compared to H-2K(b)/gp34. Our structural analysis also indicates that nitrotyrosination of the main TCR-interacting residue p4Y in gp33 abrogates recognition of H-2D(b)/gp33-NY complexes by H-2D(b)/gp33-specific T cells through sterical hindrance. In conclusion, this study provides the first structural and biochemical evidence for how MHC class I-restricted nitrotyrosinated neoantigens may enable viral escape and break immune tolerance.	[Madhurantakam, Chaithanya; Duru, Adil D.; Sandalova, Tatyana; Achour, Adnane] Karolinska Inst, Karolinska Univ Hosp Huddinge, Dept Med Huddinge, Ctr Infect Med, Stockholm, Sweden; [Webb, John R.] British Columbia Canc Agcy, Trev & Joyce Deeley Res Ctr, Victoria, BC, Canada	Karolinska Institutet; Karolinska University Hospital; British Columbia Cancer Agency	Madhurantakam, C (corresponding author), Karolinska Inst, Karolinska Univ Hosp Huddinge, Dept Med Huddinge, Ctr Infect Med, Stockholm, Sweden.	adnane.achour@ki.se	Madhurantakam, Chaithanya/AAP-5197-2020; Madhurantakam, Chaithanya/F-3652-2010	Sandalova, Tatyana/0000-0002-7694-6420; Achour, Adnane/0000-0003-0432-710X; Madhurantakam, Chaithanya/0000-0002-1967-8538; Duru, Adil/0000-0002-5844-913X	Canadian Institute of Health Research; Swedish Research Council; Swedish Cancer Society; Swedish Childhood Cancer Foundation; Swedish National Board of Health	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Swedish Childhood Cancer Foundation(European Commission); Swedish National Board of Health	This work was supported by grants from the Canadian Institute of Health Research to RJW, the Swedish Research Council to AA, the Swedish Cancer Society to AA, the Swedish Childhood Cancer Foundation to AA and the Swedish National Board of Health to AA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abello N, 2009, J PROTEOME RES, V8, P3222, DOI 10.1021/pr900039c; Achour A, 2006, J MOL BIOL, V356, P382, DOI 10.1016/j.jmb.2005.11.068; Achour A, 2002, IMMUNITY, V17, P757, DOI 10.1016/S1074-7613(02)00478-8; Achour A, 1999, ACTA CRYSTALLOGR D, V55, P260, DOI 10.1107/S0907444998005265; Andersen MH, 1999, J IMMUNOL, V163, P3812; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Aulak KS, 2001, P NATL ACAD SCI USA, V98, P12056, DOI 10.1073/pnas.221269198; Backlund J, 2002, P NATL ACAD SCI USA, V99, P9960, DOI 10.1073/pnas.132254199; BECKMANN JS, 1994, BIOL CHEM H-S, V375, P81, DOI 10.1515/bchm3.1994.375.2.81; Birnboim HC, 2003, J IMMUNOL, V171, P528, DOI 10.4049/jimmunol.171.2.528; Bouvier M, 1998, PROTEINS, V33, P97, DOI 10.1002/(SICI)1097-0134(19981001)33:1<97::AID-PROT9>3.0.CO;2-I; BOUVIER M, 1994, SCIENCE, V265, P398, DOI 10.1126/science.8023162; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burkhardt Harald, 2001, Trends in Immunology, V22, P291, DOI 10.1016/S1471-4906(01)01935-4; Butler JS, 2009, BIOCHEMISTRY-US, V48, P3497, DOI 10.1021/bi900039e; Ceriello A, 2001, DIABETOLOGIA, V44, P834; COLLINS EJ, 1994, NATURE, V371, P626, DOI 10.1038/371626a0; Cuzzocrea S, 2002, EUR J PHARMACOL, V453, P119, DOI 10.1016/S0014-2999(02)02338-5; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Deribe YL, 2010, NAT STRUCT MOL BIOL, V17, P666, DOI 10.1038/nsmb.1842; Doyle HA, 2001, TRENDS IMMUNOL, V22, P443, DOI 10.1016/S1471-4906(01)01976-7; Drew B, 2002, ANN NY ACAD SCI, V959, P66, DOI 10.1111/j.1749-6632.2002.tb02084.x; Engelhard VH, 2006, CURR OPIN IMMUNOL, V18, P92, DOI 10.1016/j.coi.2005.11.015; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Gauba V, 2011, P NATL ACAD SCI USA, V108, P12821, DOI 10.1073/pnas.1110042108; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Giorgio S, 1996, PHOTOCHEM PHOTOBIOL, V63, P750, DOI 10.1111/j.1751-1097.1996.tb09626.x; Hardy LL, 2008, J IMMUNOL, V180, P5956, DOI 10.4049/jimmunol.180.9.5956; Haurum JS, 1999, J EXP MED, V190, P145, DOI 10.1084/jem.190.1.145; Herzog J, 2005, P NATL ACAD SCI USA, V102, P7928, DOI 10.1073/pnas.0502255102; HUBER R, 1989, BIOCHEMISTRY-US, V28, P8951, DOI 10.1021/bi00449a001; Im H, 2004, PROTEIN ENG DES SEL, V17, P325, DOI 10.1093/protein/gzh036; Insaidoo FK, 2011, J BIOL CHEM, V286, P40163, DOI 10.1074/jbc.M111.283564; ISCHIROPOULOS H, 1995, FEBS LETT, V364, P279, DOI 10.1016/0014-5793(95)00307-U; ISCHIROPOULOS H, 1992, ARCH BIOCHEM BIOPHYS, V298, P431, DOI 10.1016/0003-9861(92)90431-U; Kopec J, 2011, J STRUCT BIOL, V175, P216, DOI 10.1016/j.jsb.2011.04.006; Kotturi MF, 2008, J IMMUNOL, V181, P2124, DOI 10.4049/jimmunol.181.3.2124; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Liversidge J, 2002, AM J PATHOL, V160, P905, DOI 10.1016/S0002-9440(10)64913-9; Loeser RF, 2002, ARTHRITIS RHEUM, V46, P2349, DOI 10.1002/art.10496; Marrack P, 2008, CURR OPIN IMMUNOL, V20, P203, DOI 10.1016/j.coi.2008.03.008; Masopust D, 2007, J VIROL, V81, P2002, DOI 10.1128/JVI.01459-06; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meadows L, 1997, IMMUNITY, V6, P273, DOI 10.1016/S1074-7613(00)80330-1; Montfort WR, 1997, PHARMACOL THERAPEUT, V76, P29, DOI 10.1016/S0163-7258(97)00099-5; Nakazawa H, 2000, FREE RADICAL RES, V33, P771, DOI 10.1080/10715760000301291; Noiri E, 2001, AM J PHYSIOL-RENAL, V281, pF948, DOI 10.1152/ajprenal.0071.2001; Ohmori H, 2005, AUTOIMMUN REV, V4, P224, DOI 10.1016/j.autrev.2004.11.011; Petersen J, 2009, J MOL MED, V87, P1045, DOI 10.1007/s00109-009-0526-4; Pieper GM, 2002, BIODRUGS, V16, P37, DOI 10.2165/00063030-200216010-00004; Pierce RA, 1999, J IMMUNOL, V163, P6360; Reiser JB, 2000, NAT IMMUNOL, V1, P291, DOI 10.1038/79728; Ribet D, 2010, CELL, V143, P694, DOI 10.1016/j.cell.2010.11.019; Sandalova T, 2005, ACTA CRYSTALLOGR F, V61, P1090, DOI 10.1107/S1744309105037942; Sandalova T, 2005, J BIOL CHEM, V280, P27069, DOI 10.1074/jbc.M500927200; Seet BT, 2006, NAT REV MOL CELL BIO, V7, P473, DOI 10.1038/nrm1960; Shishehbor Mehdi H, 2004, Curr Atheroscler Rep, V6, P243, DOI 10.1007/s11883-004-0038-1; Smith KJ, 1999, BRAIN PATHOL, V9, P69; ter Steege JCA, 1998, FREE RADICAL BIO MED, V25, P953, DOI 10.1016/S0891-5849(98)00184-1; Tissot AC, 2000, J MOL BIOL, V302, P873, DOI 10.1006/jmbi.2000.4501; Utz PJ, 1998, ARTHRITIS RHEUM, V41, P1152, DOI 10.1002/1529-0131(199807)41:7<1152::AID-ART3>3.0.CO;2-L; UY R, 1977, SCIENCE, V198, P890, DOI 10.1126/science.337487; van der Vliet A, 1999, AM J RESP CRIT CARE, V160, P1; van Stipdonk MJB, 2009, CANCER RES, V69, P7784, DOI 10.1158/0008-5472.CAN-09-1724; Velloso LM, 2004, J IMMUNOL, V172, P5504, DOI 10.4049/jimmunol.172.9.5504; Ventura S, 2002, NAT STRUCT BIOL, V9, P485, DOI 10.1038/nsb799; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Yague J, 2001, J BIOL CHEM, V276, P43699, DOI 10.1074/jbc.M105981200; Zachariae U, 2006, STRUCTURE, V14, P1469, DOI 10.1016/j.str.2006.08.001; Zarling AL, 2000, J EXP MED, V192, P1755, DOI 10.1084/jem.192.12.1755	70	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e32805	10.1371/journal.pone.0032805	http://dx.doi.org/10.1371/journal.pone.0032805			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22431983	Green Published, Green Submitted, gold			2022-12-25	WOS:000303198600026
J	Cutter, JL; Cohen, NT; Wang, J; Sloan, AE; Cohen, AR; Panneerselvam, A; Schluchter, M; Blum, G; Bogyo, M; Basilion, JP				Cutter, Jennifer L.; Cohen, Nathan T.; Wang, Jing; Sloan, Andrew E.; Cohen, Alan R.; Panneerselvam, Ashok; Schluchter, Mark; Blum, Galia; Bogyo, Matthew; Basilion, James P.			Topical Application of Activity-based Probes for Visualization of Brain Tumor Tissue	PLOS ONE			English	Article							GLIOBLASTOMA-MULTIFORME; PROTEASE ACTIVITY; CATHEPSIN-B; CYSTEINE CATHEPSINS; MALIGNANT GLIOMA; SURVIVAL; RESECTION; EXTENT; PROGRESSION; SURGERY	Several investigators have shown the utility of systemically delivered optical imaging probes to image tumors in small animal models of cancer. Here we demonstrate an innovative method for imaging tumors and tumor margins during surgery. Specifically, we show that optical imaging probes topically applied to tumors and surrounding normal tissue rapidly differentiate between tissues. In contrast to systemic delivery of optical imaging probes which label tumors uniformly over time, topical probe application results in rapid and robust probe activation that is detectable as early as 5 minutes following application. Importantly, labeling is primarily associated with peri-tumor spaces. This methodology provides a means for rapid visualization of tumor and potentially infiltrating tumor cells and has potential applications for directed surgical excision of tumor tissues. Furthermore, this technology could find use in surgical resections for any tumors having differential regulation of cysteine cathepsin activity.	[Cutter, Jennifer L.; Cohen, Nathan T.; Wang, Jing; Basilion, James P.] Case Western Reserve Univ, Dept Radiol, Natl Fdn Canc Res Ctr Mol Imaging, Cleveland, OH 44106 USA; [Basilion, James P.] Case Western Reserve Univ, Dept Biomed Engn, Natl Fdn Canc Res Ctr Mol Imaging, Cleveland, OH 44106 USA; [Sloan, Andrew E.] Stanford Univ, Sch Med, Dept Neurol Surg, Stanford, CA 94305 USA; [Cohen, Alan R.] Stanford Univ, Sch Med, Univ Hosp Case Med Ctr, Stanford, CA 94305 USA; [Panneerselvam, Ashok; Schluchter, Mark] Stanford Univ, Sch Med, Dept Epidemiol & Biostat, Stanford, CA 94305 USA; [Blum, Galia; Bogyo, Matthew] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Bogyo, Matthew] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Case Western Reserve University; Case Western Reserve University; Stanford University; Case Western Reserve University; Stanford University; Stanford University; Stanford University; Stanford University	Cutter, JL (corresponding author), Medpace, Cincinnati, OH USA.	james.basilion@case.edu	Cohen, Nathan T./GWM-4240-2022; Sloan, Andrew/AAE-9842-2020; Cohen, Nathan T./ABD-1620-2021; Basilion, James/ABB-6732-2021	Cohen, Nathan T./0000-0002-1410-3487; Cohen, Nathan T./0000-0002-1410-3487; Bogyo, Matthew/0000-0003-3753-4412	Wallace H. Coulter Translational Partners Grant Program Award; Northeastern Ohio Animal Imaging Resource Center, an National Institutes of Health (NIH) of the Case Center for Imaging Research [R24CA110943]; National Cancer Institute (NCI) [CA101954, CA116257]; Ivy Brain Tumor Foundation; Cancer Genome Atlas (TCGA); NIH [R01 EB005011-04]; NIH Roadmap National Technology center for Networks and Pathways [U54020843-05];  [ROI CA109620-01A1]; NATIONAL CANCER INSTITUTE [R01CA109620, R01CA116257, K08CA101954, R24CA110943] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005011] Funding Source: NIH RePORTER	Wallace H. Coulter Translational Partners Grant Program Award; Northeastern Ohio Animal Imaging Resource Center, an National Institutes of Health (NIH) of the Case Center for Imaging Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ivy Brain Tumor Foundation; Cancer Genome Atlas (TCGA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Roadmap National Technology center for Networks and Pathways(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by a Wallace H. Coulter Translational Partners Grant Program Award to JPB, ROI CA109620-01A1 awarded to JPB and was facilitated by the infrastructure and resources provided by the Northeastern Ohio Animal Imaging Resource Center, an National Institutes of Health (NIH) funded program R24CA110943, part of the Case Center for Imaging Research. This work was also supported by funding from National Cancer Institute (NCI) Grants CA101954, CA116257, the Ivy Brain Tumor Foundation, and the Cancer Genome Atlas (TCGA) awarded to AES. Additional funding for this project includes a NIH R01 EB005011-04 and a NIH Roadmap National Technology center for Networks and Pathways grant U54020843-05 awarded to MB. The content of the project described is solely the responsibility of the authors and does not necessarily represent the views of the NCI or the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2002, CANCER GENE THER, V9, P228, DOI 10.1038/sj.cgt.7700437; Alencar H, 2007, RADIOLOGY, V244, P232, DOI 10.1148/radiol.2441052114; Barker FG, 1998, NEUROSURGERY, V42, P709, DOI 10.1097/00006123-199804000-00013; Black PM, 1997, NEUROSURGERY, V41, P831, DOI 10.1097/00006123-199710000-00013; Blum G, 2005, NAT CHEM BIOL, V1, P203, DOI 10.1038/nchembio728; Blum G, 2007, NAT CHEM BIOL, V3, P668, DOI 10.1038/nchembio.2007.26; Blum G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006374; Claus EB, 2005, CANCER-AM CANCER SOC, V103, P1227, DOI 10.1002/cncr.20867; De Grand AM, 2003, TECHNOL CANCER RES T, V2, P553, DOI 10.1177/153303460300200607; Demchik LL, 1999, INT J DEV NEUROSCI, V17, P483, DOI 10.1016/S0736-5748(99)00011-8; Figueiredo JL, 2006, INT J CANCER, V118, P2672, DOI 10.1002/ijc.21713; Funovics M, 2003, ANAL BIOANAL CHEM, V377, P956, DOI 10.1007/s00216-003-2199-0; Gao CY, 2004, J CELL SCI, V117, P4089, DOI 10.1242/jcs.01271; Gocheva V, 2006, GENE DEV, V20, P543, DOI 10.1101/gad.1407406; Haglund MM, 1996, NEUROSURGERY, V38, P308, DOI 10.1097/00006123-199602000-00015; Joyce JA, 2004, CELL CYCLE, V3, P1516, DOI 10.4161/cc.3.12.1289; Keles GE, 1999, SURG NEUROL, V52, P371, DOI 10.1016/S0090-3019(99)00103-2; Kircher MF, 2003, CANCER RES, V63, P8122; Kirsch DG, 2007, NAT MED, V13, P992, DOI 10.1038/nm1602; Knauth M, 1999, AM J NEURORADIOL, V20, P1547; Laws ER, 2003, J NEUROSURG, V99, P467, DOI 10.3171/jns.2003.99.3.0467; Lee BT, 2010, J RECONSTR MICROSURG, V26, P59, DOI 10.1055/s-0029-1244805; Levicar N, 2003, ACTA NEUROCHIR, V145, P825, DOI 10.1007/s00701-003-0097-z; Levicar N, 2002, CANCER DETECT PREV, V26, P42, DOI 10.1016/S0361-090X(02)00015-6; McPherson Christopher M, 2005, J Natl Compr Canc Netw, V3, P705; MIKKELSEN T, 1995, J NEUROSURG, V83, P285, DOI 10.3171/jns.1995.83.2.0285; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Ntziachristos V, 2011, PHILOS T R SOC A, V369, P4666, DOI 10.1098/rsta.2011.0270; Ntziachristos V, 2010, NAT METHODS, V7, P603, DOI [10.1038/NMETH.1483, 10.1038/nmeth.1483]; Palermo C, 2008, TRENDS PHARMACOL SCI, V29, P22, DOI 10.1016/j.tips.2007.10.011; Pichlmeier U, 2008, NEURO-ONCOLOGY, V10, P1025, DOI 10.1215/15228517-2008-052; Razansky D, 2012, CURRENT PHARM BIOTEC; Ries L MD, 2008, SEER CANC STAT REV 1; Sawaya R, 2001, Clin Neurosurg, V48, P10; Sega EI, 2008, CANCER METAST REV, V27, P655, DOI 10.1007/s10555-008-9155-6; Strojnik T, 2005, CANCER DETECT PREV, V29, P448, DOI 10.1016/j.cdp.2005.07.006; Stummer W, 2006, LANCET ONCOL, V7, P392, DOI 10.1016/S1470-2045(06)70665-9; Stummer W, 2008, NEUROSURGERY, V62, P564, DOI [10.1227/01.NEU.0000297118.47076.5F, 10.1227/01.NEU.0000346230.80425.3A, 10.1227/01.neu.0000317304.31579.17]; Troyan SL, 2009, ANN SURG ONCOL, V16, P2943, DOI 10.1245/s10434-009-0594-2; Tung CH, 1999, BIOCONJUGATE CHEM, V10, P892, DOI 10.1021/bc990052h; Upadhyay R, 2007, RADIOLOGY, V245, P523, DOI 10.1148/radiol.2452061613; Urano Y, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002823; van Dam GM, 2011, NAT MED, V17, P1315, DOI 10.1038/nm.2472; van den Bent MJ, 2005, EJC SUPPL, V3, P134; Veiseh M, 2007, CANCER RES, V67, P6882, DOI 10.1158/0008-5472.CAN-06-3948; Weissleder R, 2003, NAT MED, V9, P123, DOI 10.1038/nm0103-123; Wirtz CR, 2000, NEUROSURGERY, V46, P1112, DOI 10.1097/00006123-200005000-00017	47	62	65	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2012	7	3							e33060	10.1371/journal.pone.0033060	http://dx.doi.org/10.1371/journal.pone.0033060			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930IA	22427947	Green Published, gold, Green Submitted			2022-12-25	WOS:000303129700030
J	Sinclair, D; Fullerton, JM; Webster, MJ; Weickert, CS				Sinclair, Duncan; Fullerton, Janice M.; Webster, Maree J.; Weickert, Cynthia Shannon			Glucocorticoid Receptor 1B and 1C mRNA Transcript Alterations in Schizophrenia and Bipolar Disorder, and Their Possible Regulation by GR Gene Variants	PLOS ONE			English	Article							DORSOLATERAL PREFRONTAL CORTEX; MAJOR DEPRESSION; PSYCHIATRIC-ILLNESS; PSYCHOSOCIAL STRESS; NEUROTROPHIC FACTOR; RAT HIPPOCAMPUS; MOOD DISORDERS; POLYMORPHISMS; EXPRESSION; BRAIN	Abnormal patterns of HPA axis activation, under basal conditions and in response to stress, are found in individuals with schizophrenia and bipolar disorder. Altered glucocorticoid receptor (GR) mRNA and protein expression in the dorsolateral prefrontal cortex (DLPFC) in psychiatric illness have also been reported, but the cause of these abnormalities is not known. We quantified expression of GR mRNA transcript variants which employ different 5' promoters, in 35 schizophrenia cases, 31 bipolar disorder cases and 34 controls. We also explored whether sequence variation within the NR3C1 (GR) gene is related to GR mRNA variant expression. Total GR mRNA was decreased in the DLPFC in schizophrenia cases relative to controls (15.1%, p<0.0005) and also relative to bipolar disorder cases (8.9%, p<0.05). GR-1B mRNA was decreased in schizophrenia cases relative to controls (20.2%, p<0.05), while GR-1C mRNA was decreased in both schizophrenia and bipolar disorder cases relative to controls (16.1% and 17.2% respectively, both p<0.005). A dose-dependent effect of rs10052957 genotype on GR-1B mRNA expression was observed, where CC homozygotes displayed 18.4% lower expression than TC heterozygotes (p<0.05), and 31.8% lower expression than TT homozygotes (p<0.005). Similarly, a relationship between rs6190 (R23K) genotype and GR-1C expression was seen, with 24.8% lower expression in GG homozygotes than GA heterozygotes (p<0.01). We also observed an effect of rs41423247 (Bcl1) SNP on expression of 67 kDa GR alpha isoform, the most abundant GR alpha isoform in the DLPFC. These findings suggest possible roles for the GR-1B and GR-1C promoter regions in mediating GR gene expression changes in psychotic illness, and highlight the potential importance of sequence variation within the NR3C1 gene in modulating GR mRNA expression in the DLPFC.	[Sinclair, Duncan; Fullerton, Janice M.; Weickert, Cynthia Shannon] Schizophrenia Res Inst, Sydney, NSW, Australia; [Sinclair, Duncan; Fullerton, Janice M.; Weickert, Cynthia Shannon] Neurosci Res Australia, Sydney, NSW, Australia; [Sinclair, Duncan; Weickert, Cynthia Shannon] Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia; [Fullerton, Janice M.] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; [Webster, Maree J.] Uniformed Serv Univ Hlth Sci, Stanley Lab Brain Res, Bethesda, MD USA	Neuroscience Research Australia; University of New South Wales Sydney; University of New South Wales Sydney; Uniformed Services University of the Health Sciences - USA	Sinclair, D (corresponding author), Schizophrenia Res Inst, Sydney, NSW, Australia.	d.sinclair@neura.edu.au	Fullerton, Janice/F-8485-2013; Weickert, Cynthia Shannon/G-3171-2011	Fullerton, Janice/0000-0003-4014-4490; Shannon Weickert, Cynthia/0000-0002-4560-0259; Sinclair, Duncan/0000-0001-5961-1007	Schizophrenia Research Institute; NSW Health; Macquarie Group Foundation; Neuroscience Research Australia; University of New South Wales; Stanley Medical Research Institute [09R-2158]; Australian Postgraduate Award	Schizophrenia Research Institute; NSW Health; Macquarie Group Foundation; Neuroscience Research Australia; University of New South Wales; Stanley Medical Research Institute; Australian Postgraduate Award(Australian Government)	This work was supported by the Schizophrenia Research Institute; utilising funding from NSW Health and the Macquarie Group Foundation, Neuroscience Research Australia, and the University of New South Wales. Grant support was also received from the Stanley Medical Research Institute (grant # 09R-2158). DS is supported by an Australian Postgraduate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agid O, 1999, MOL PSYCHIATR, V4, P163, DOI 10.1038/sj.mp.4000473; Binder EB, 2009, PSYCHONEUROENDOCRINO, V34, P99, DOI 10.1016/j.psyneuen.2009.05.021; Bradley AJ, 2010, J PSYCHOPHARMACOL, V24, P91, DOI 10.1177/1359786810385491; Breslin MB, 2001, MOL ENDOCRINOL, V15, P1381, DOI 10.1210/me.15.8.1381; Brouwer JP, 2006, PSYCHONEUROENDOCRINO, V31, P1154, DOI 10.1016/j.psyneuen.2006.08.001; Cannon M, 2002, ARCH GEN PSYCHIAT, V59, P449, DOI 10.1001/archpsyc.59.5.449; Cannon M, 2002, AM J PSYCHIAT, V159, P1080, DOI 10.1176/appi.ajp.159.7.1080; Carvalho LA, 2010, EUR NEUROPSYCHOPHARM, V20, P379, DOI 10.1016/j.euroneuro.2010.02.006; Carvalho LA, 2008, STRESS, V11, P411, DOI 10.1080/10253890701850759; Datson NA, 2001, EUR J NEUROSCI, V14, P675, DOI 10.1046/j.0953-816x.2001.01685.x; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; DeRijk RH, 2008, EUR J PHARMACOL, V583, P303, DOI 10.1016/j.ejphar.2007.11.072; Eastwood SL, 2001, BRAIN RES BULL, V55, P569, DOI 10.1016/S0361-9230(01)00530-5; Focking M, 2011, ARCH GEN PSYCHIAT, V68, P477, DOI 10.1001/archgenpsychiatry.2011.43; Gallagher P, 2007, SCHIZOPHR RES, V90, P258, DOI 10.1016/j.schres.2006.11.020; Hansson AC, 2000, EUR J NEUROSCI, V12, P2918, DOI 10.1046/j.1460-9568.2000.00185.x; Koper JW, 1997, HUM GENET, V99, P663, DOI 10.1007/s004390050425; Kumsta R, 2007, BIOL PSYCHIAT, V62, P863, DOI 10.1016/j.biopsych.2007.04.013; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Nunez BS, 2002, MOL CELL ENDOCRINOL, V189, P191, DOI 10.1016/S0303-7207(01)00676-1; Perlman WR, 2004, BIOL PSYCHIAT, V56, P844, DOI 10.1016/j.biopsych.2004.09.006; Presul E, 2007, J MOL ENDOCRINOL, V38, P79, DOI 10.1677/jme.1.02183; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rajkowska G, 2001, BIOL PSYCHIAT, V49, P741, DOI 10.1016/S0006-3223(01)01080-0; Rimol LM, 2010, BIOL PSYCHIAT, V68, P41, DOI 10.1016/j.biopsych.2010.03.036; Rosmond P, 2000, METABOLISM, V49, P1197, DOI 10.1053/meta.2000.7712; Schaaf MJM, 1998, BRAIN RES, V813, P112, DOI 10.1016/S0006-8993(98)01010-5; SELEMON LD, 1995, ARCH GEN PSYCHIAT, V52, P805; Sinclair D, 2011, NEUROPSYCHOPHARMACOL, V36, P2698, DOI 10.1038/npp.2011.160; Spijker AT, 2009, BIPOLAR DISORD, V11, P95, DOI 10.1111/j.1399-5618.2008.00647.x; Spijker AT, 2011, PSYCHONEURO IN PRESS, DOI [10.1016/j.psyneuen.2011.1003.1020, DOI 10.1016/J.PSYNEUEN.2011.1003.1020]; Stevens A, 2004, J CLIN ENDOCR METAB, V89, P892, DOI 10.1210/jc.2003-031235; Thompson M, 2011, J PSYCHIATR NEUROSCI, V36, P195, DOI 10.1503/jpn.100048; Tian SY, 2007, NEUROSCI LETT, V411, P123, DOI 10.1016/j.neulet.2006.10.031; Turner JD, 2005, J MOL ENDOCRINOL, V35, P283, DOI 10.1677/jme.1.01822; van Rossum EFC, 2006, BIOL PSYCHIAT, V59, P681, DOI 10.1016/j.biopsych.2006.02.007; van Rossum EFC, 2004, CLIN ENDOCRINOL, V61, P573, DOI 10.1111/j.1365-2265.2004.02132.x; van West D, 2006, NEUROPSYCHOPHARMACOL, V31, P620, DOI 10.1038/sj.npp.1300898; van West D, 2010, PSYCHIAT RES, V179, P64, DOI 10.1016/j.psychres.2009.04.002; Watson S, 2004, BRIT J PSYCHIAT, V184, P496, DOI 10.1192/bjp.184.6.496; Webster MJ, 2002, MOL PSYCHIATR, V7, P985, DOI 10.1038/sj.mp.4001139; Weickert CS, 2003, MOL PSYCHIATR, V8, P592, DOI 10.1038/sj.mp.4001308; Weickert CS, 2001, CEREB CORTEX, V11, P136, DOI 10.1093/cercor/11.2.136; Weickert CS, 2010, AUST NZ J PSYCHIAT, V44, P59, DOI 10.3109/00048670903393662; Willour VL, 2009, MOL PSYCHIATR, V14, P261, DOI 10.1038/sj.mp.4002141; Wust S, 2004, J CLIN ENDOCR METAB, V89, P565, DOI 10.1210/jc.2003-031148; ZONG J, 1990, MOL CELL BIOL, V10, P5580, DOI 10.1128/MCB.10.10.5580	47	50	50	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2012	7	3							e31720	10.1371/journal.pone.0031720	http://dx.doi.org/10.1371/journal.pone.0031720			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930IA	22427805	Green Published, Green Submitted, gold			2022-12-25	WOS:000303129700004
J	Sun, YA; Ning, BA; Liu, M; Gao, XJ; Fan, XJ; Liu, JQ; Gao, ZX				Sun, Yanan; Ning, Baoan; Liu, Ming; Gao, Xianjun; Fan, Xianjun; Liu, Jianqing; Gao, Zhixian			Selection of Diethylstilbestrol-Specific Single-Chain Antibodies from a Non-Immunized Mouse Ribosome Display Library	PLOS ONE			English	Article							IN-VITRO; ANTIHAPTEN ANTIBODIES; PROTEINS; FRAGMENT	Single chain variable fragments (scFvs) against diethylstilbestrol (DES) were selected from the splenocytes of non-immunized mice by ribosome display technology. A naive library was constructed and engineered to allow in vitro transcription and translation using an E. coli lysate system. Alternating selection in solution and immobilization in microtiter wells was used to pan mRNA-ribosome-antibody (ARM) complexes. After seven rounds of ribosome display, the expression vector pTIG-TRX containing the selected specific scFv DNAs were transformed into Escherichia coli BL21 (DE3) for expression. Twenty-six positive clones were screened and five clones had high antibody affinity and specificity to DES as evidenced by indirect competitive ELISA. Sequence analysis showed that these five DES-specific scFvs had different amino acid sequences, but the CDRs were highly similar. Surface plasmon resonance (SPR) analysis was used to determine binding kinetics of one clone (30-1). The measured K-D was 3.79 mu M. These results indicate that ribosome display technology can be used to efficiently isolate hapten-specific antibody (Ab) fragments from a naive library; this study provides a methodological framework for the development of novel immunoassays for multiple environmental pollutants with low molecular weight detection using recombinant antibodies.	[Sun, Yanan] Tianjin Med Univ, Dept Biochem & Mol Biol, Tianjin, Peoples R China; [Ning, Baoan; Liu, Ming; Fan, Xianjun; Gao, Zhixian] Acad Mil Med Sci, Inst Hyg & Environm Med, Tianjin Key Lab Risk Assessment & Control Technol, Tianjin, Peoples R China; [Gao, Xianjun] Tianjin Med Univ, Res Ctr Basic Med Sci, Tianjin, Peoples R China; [Liu, Jianqing] Tian Jin Univ, Sch Chem Engn & Technol, Tianjin, Peoples R China	Tianjin Medical University; Academy of Military Medical Sciences - China; Tianjin Medical University	Sun, YA (corresponding author), Tianjin Med Univ, Dept Biochem & Mol Biol, Tianjin, Peoples R China.	Gaozhx@163.com			Nature Science Fund of China [20907074]	Nature Science Fund of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Nature Science Fund of China (Nos. 20907074). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amstutz P, 2002, J AM CHEM SOC, V124, P9396, DOI 10.1021/ja025870q; BARBAS CF, 1993, GENE, V137, P57, DOI 10.1016/0378-1119(93)90251-W; Binz HK, 2004, NAT BIOTECHNOL, V22, P575, DOI 10.1038/nbt962; Brichta J, 2005, VET MED-CZECH, V50, P231, DOI 10.17221/5620-VETMED; Charlton K, 2001, BIOSENS BIOELECTRON, V16, P639, DOI 10.1016/S0956-5663(01)00192-0; Dall'Acqua W, 1998, CURR OPIN STRUC BIOL, V8, P443, DOI 10.1016/S0959-440X(98)80121-8; de Haard HJ, 1999, J BIOL CHEM, V274, P18218, DOI 10.1074/jbc.274.26.18218; Dorsam H, 1997, FEBS LETT, V414, P7, DOI 10.1016/S0014-5793(97)00966-6; GIUSTI RM, 1995, ANN INTERN MED, V122, P778, DOI 10.7326/0003-4819-122-10-199505150-00008; Hanes J, 2000, METHOD ENZYMOL, V328, P404, DOI 10.1016/S0076-6879(00)28409-7; He Mingyue, 2002, Briefings in Functional Genomics & Proteomics, V1, P204, DOI 10.1093/bfgp/1.2.204; He MY, 1999, J IMMUNOL METHODS, V231, P105, DOI 10.1016/S0022-1759(99)00144-1; Kobayashi N, 2001, ADV CLIN CHEM, V36, P139, DOI 10.1016/S0065-2423(01)36027-4; Kramer K, 2002, J IMMUNOL METHODS, V266, P209, DOI 10.1016/S0022-1759(02)00116-3; Lamla T, 2003, J MOL BIOL, V329, P381, DOI 10.1016/S0022-2836(03)00432-7; Li Y, 2000, J IMMUNOL METHODS, V236, P133, DOI 10.1016/S0022-1759(99)00227-6; Matsuura T, 2003, FEBS LETT, V539, P24, DOI 10.1016/S0014-5793(03)00178-9; MATTHEAKIS LC, 1994, P NATL ACAD SCI USA, V91, P9022, DOI 10.1073/pnas.91.19.9022; MCCAFFERTY J, 1996, ANTIBODY ENG PRACTIC; Moghaddam A, 2001, J IMMUNOL METHODS, V254, P169, DOI 10.1016/S0022-1759(01)00413-6; Persson H, 2006, J MOL BIOL, V357, P607, DOI 10.1016/j.jmb.2006.01.004; Pfaffl MW, 2003, ANAL CHIM ACTA, V483, P401, DOI 10.1016/S0003-2670(02)01255-2; Qi YH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006427; Schaffitzel C, 1999, J IMMUNOL METHODS, V231, P119, DOI 10.1016/S0022-1759(99)00149-0; Sheedy C, 2007, BIOTECHNOL ADV, V25, P333, DOI 10.1016/j.biotechadv.2007.02.003; Strachan G, 2002, FEMS MICROBIOL LETT, V210, P257, DOI 10.1111/j.1574-6968.2002.tb11190.x; Vaughan TJ, 1996, NAT BIOTECHNOL, V14, P309, DOI 10.1038/nbt0396-309; Yang LM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002092; Yau KYF, 2003, J IMMUNOL METHODS, V281, P161, DOI 10.1016/j.jim.2003.07.011	29	8	10	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2012	7	3							e33186	10.1371/journal.pone.0033186	http://dx.doi.org/10.1371/journal.pone.0033186			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930IA	22427984	gold, Green Submitted, Green Published			2022-12-25	WOS:000303129700036
J	Andersson, P; Tong, SYC; Bell, JM; Turnidge, JD; Giffard, PM				Andersson, Patiyan; Tong, Steven Y. C.; Bell, Jan M.; Turnidge, John D.; Giffard, Philip M.			Minim Typing - A Rapid and Low Cost MLST Based Typing Tool for Klebsiella pneumoniae	PLOS ONE			English	Article							RESOLUTION MELTING ANALYSIS; STAPHYLOCOCCUS-AUREUS; CAMPYLOBACTER-JEJUNI; DIVERSITY; IDENTIFICATION; DIAGNOSTICS; BACTERIA; AMPLICON; EBURST	Here we report a single nucleotide polymorphism (SNP) based genotyping method for Klebsiella pneumoniae utilising high-resolution melting (HRM) analysis of fragments within the multilocus sequence typing (MLST) loci. The approach is termed mini-MLST or Minim typing and it has previously been applied to Streptococcus pyogenes, Staphylococcus aureus and Enterococcus faecium. Six SNPs were derived from concatenated MLST sequences on the basis of maximisation of the Simpsons Index of Diversity (D). DNA fragments incorporating these SNPs and predicted to be suitable for HRM analysis were designed. Using the assumption that HRM alleles are defined by G+C content, Minim typing using six fragments was predicted to provide a D = 0.979 against known STs. The method was tested against 202 K. pneumoniae using a blinded approach in which the MLST analyses were performed after the HRM analyses. The HRM-based alleles were indeed in accordance with G+C content, and the Minim typing identified known STs and flagged new STs. The tonB MLST locus was determined to be very diverse, and the two Minim fragments located herein contribute greatly to the resolving power. However these fragments are refractory to amplification in a minority of isolates. Therefore, we assessed the performance of two additional formats: one using only the four fragments located outside the tonB gene (D = 0.929), and the other using HRM data from these four fragments in conjunction with sequencing of the tonB MLST fragment (D = 0.995). The HRM assays were developed on the Rotorgene 6000, and the method was shown to also be robust on the LightCycler 480, allowing a 384-well high through-put format. The assay provides rapid, robust and low-cost typing with fully portable results that can directly be related to current MLST data. Minim typing in combination with molecular screening for antibiotic resistance markers can be a powerful surveillance tool kit.	[Andersson, Patiyan; Tong, Steven Y. C.; Giffard, Philip M.] Charles Darwin Univ, Menzies Sch Hlth Res, Trop & Emerging Infect Dis Div, Darwin, NT 0909, Australia; [Andersson, Patiyan; Bell, Jan M.; Turnidge, John D.] Womens & Childrens Hosp, SA Pathol, Adelaide, SA, Australia; [Turnidge, John D.] Univ Adelaide, Dept Pathol, Adelaide, SA, Australia; [Turnidge, John D.] Univ Adelaide, Dept Paediat, Adelaide, SA, Australia; [Turnidge, John D.] Univ Adelaide, Dept Mol & Biochem Sci, Adelaide, SA, Australia	Charles Darwin University; Menzies School of Health Research; SA Pathology; Womens & Childrens Hospital Australia; University of Adelaide; University of Adelaide; University of Adelaide	Andersson, P (corresponding author), Charles Darwin Univ, Menzies Sch Hlth Res, Trop & Emerging Infect Dis Div, Darwin, NT 0909, Australia.	patiyan.andersson@menzies.edu.au	Tong, Steven/N-2353-2013; Giffard, Philip/N-2293-2013	Tong, Steven/0000-0002-1368-8356; Giffard, Phil/0000-0002-3030-9127	Australian National Health and Medical Research Council [390121]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by project grant 390121 from the Australian National Health and Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson P, 2009, ANTIMICROB AGENTS CH, V53, P2679, DOI 10.1128/AAC.00063-09; Bell JM, 2010, ANTIMICROB AGENTS CH, V54, P1378, DOI 10.1128/AAC.01476-09; Brisse S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004982; Carrico JA, 2006, J CLIN MICROBIOL, V44, P2524, DOI 10.1128/JCM.02536-05; Chung DR, 2008, J CLIN MICROBIOL, V46, P4061, DOI 10.1128/JCM.01577-08; Chung DR, 2011, EUR J CLIN MICROBIOL; Diancourt L, 2005, J CLIN MICROBIOL, V43, P4178, DOI 10.1128/JCM.43.8.4178-4182.2005; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Grundmann H, 2001, J CLIN MICROBIOL, V39, P4190, DOI 10.1128/JCM.39.11.4190-4192.2001; Hanage WP, 2006, J THEOR BIOL, V239, P210, DOI 10.1016/j.jtbi.2005.08.035; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Herrmann MG, 2007, CLIN CHEM, V53, P1544, DOI 10.1373/clinchem.2007.088120; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Lilliebridge RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019749; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Merchant-Patel S, 2010, APPL ENVIRON MICROB, V76, P493, DOI 10.1128/AEM.01164-09; Montgomery JL, 2010, EXPERT REV MOL DIAGN, V10, P219, DOI [10.1586/erm.09.84, 10.1586/ERM.09.84]; Price EP, 2007, APPL ENVIRON MICROB, V73, P3431, DOI 10.1128/AEM.02702-06; Reed GH, 2007, PHARMACOGENOMICS, V8, P597, DOI 10.2217/14622416.8.6.597; Richardson LJ, 2010, CLIN MICROBIOL INFEC; Robertson GA, 2004, J MED MICROBIOL, V53, P35, DOI 10.1099/jmm.0.05365-0; Rozen S, 2000, Methods Mol Biol, V132, P365; Siu LK, 2011, J CLIN MICROBIOL, V49, P3761, DOI 10.1128/JCM.00977-11; Stephens AJ, 2008, CLIN CHEM, V54, P432, DOI 10.1373/clinchem.2007.093658; Tong SYC, 2009, CLIN MICROBIOL INFEC, V15, P1126, DOI 10.1111/j.1469-0691.2009.02732.x; Tong SYC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029189; Tong SYC, 2010, DIAGN MICR INFEC DIS, V67, P399, DOI 10.1016/j.diagmicrobio.2010.03.015; Turner KME, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-30; Wittwer CT, 2009, HUM MUTAT, V30, P857, DOI 10.1002/humu.20951; Woodford N, 2011, FEMS MICROBIOL REV, V35, P736, DOI 10.1111/j.1574-6976.2011.00268.x	30	17	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33530	10.1371/journal.pone.0033530	http://dx.doi.org/10.1371/journal.pone.0033530			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22428067	gold, Green Published			2022-12-25	WOS:000302381500151
J	Chang, HH; Tai, TS; Lu, B; Iannaccone, C; Cernadas, M; Weinblatt, M; Shadick, N; Miaw, SC; Ho, IC				Chang, Hui-Hsin; Tai, Tzong-Shyuan; Lu, Bing; Iannaccone, Christine; Cernadas, Manuela; Weinblatt, Michael; Shadick, Nancy; Miaw, Shi-Chuen; Ho, I-Cheng			PTPN22.6, a Dominant Negative Isoform of PTPN22 and Potential Biomarker of Rheumatoid Arthritis	PLOS ONE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; GENETIC-VARIATION; DOMAIN; REGULATOR; VARIANT	PTPN22 is a tyrosine phosphatase and functions as a damper of TCR signals. A C-to-T single nucleotide polymorphism (SNP) located at position 1858 of human PTPN22 cDNA and converting an arginine (R620) to tryptophan (W620) confers the highest risk of rheumatoid arthritis among non-HLA genetic variations that are known to be associated with this disease. The effect of the R-to-W conversion on the phosphatase activity of PTPN22 protein and the impact of the minor T allele of the C1858T SNP on the activation of T cells has remained controversial. In addition, how the overall activity of PTPN22 is regulated and how the R-to-W conversion contributes to rheumatoid arthritis is still poorly understood. Here we report the identification of an alternative splice form of human PTPN22, namely PTPN22.6. It lacks the nearly entire phosphatase domain and can function as a dominant negative isoform of the full length PTPN22. Although conversion of R620 to W620 in the context of PTPN22.1 attenuated T cell activation, expression of the tryptophan variant of PTPN22.6 reciprocally led to hyperactivation of human T cells. More importantly, the level of PTPN22.6 in peripheral blood correlates with disease activity of rheumatoid arthritis. Our data depict a model that can reconcile the conflicting observations on the functional impact of the C1858T SNP and also suggest that PTPN22.6 is a novel biomarker of rheumatoid arthritis.	[Chang, Hui-Hsin; Tai, Tzong-Shyuan; Lu, Bing; Iannaccone, Christine; Weinblatt, Michael; Shadick, Nancy; Ho, I-Cheng] Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Cernadas, Manuela] Brigham & Womens Hosp, Dept Pulm & Crit Care Med, Boston, MA 02115 USA; [Chang, Hui-Hsin; Tai, Tzong-Shyuan; Lu, Bing; Iannaccone, Christine; Cernadas, Manuela; Weinblatt, Michael; Shadick, Nancy; Ho, I-Cheng] Harvard Univ, Sch Med, Boston, MA USA; [Miaw, Shi-Chuen] Natl Taiwan Univ, Coll Med, Grad Inst Immunol, Taipei 10764, Taiwan	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; National Taiwan University	Chang, HH (corresponding author), Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA.	iho@partners.org		MIAW, SHI-CHUEN/0000-0003-1347-9367	Within Our Reach campaign of American College of Rheumatology; NIH [R01 AI051461]; National Science Council, Taiwan [NSC 97-2320-B-002-014-MY3]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051461] Funding Source: NIH RePORTER	Within Our Reach campaign of American College of Rheumatology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is support by a grant from the Within Our Reach campaign (http://www.withinourreach.info/Rosen_MAR09.html) of American College of Rheumatology (ICH), a NIH R01 AI051461 (MC), a grant (NSC 97-2320-B-002-014-MY3) from National Science Council, Taiwan (SCM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Carlton VEH, 2005, AM J HUM GENET, V77, P567, DOI 10.1086/468189; Chung SA, 2007, AUTOIMMUNITY, V40, P582, DOI 10.1080/08916930701510848; Cohen S, 1999, BLOOD, V93, P2013, DOI 10.1182/blood.V93.6.2013.406k25_2013_2024; Fiorillo E, 2010, J BIOL CHEM, V285, P26506, DOI 10.1074/jbc.M110.111104; Ghose R, 2001, NAT STRUCT BIOL, V8, P998, DOI 10.1038/nsb1101-998; Gjorloff-Wingren A, 1999, EUR J IMMUNOL, V29, P3845, DOI 10.1002/(SICI)1521-4141(199912)29:12<3845::AID-IMMU3845>3.0.CO;2-U; Gregersen PK, 2006, SEMIN IMMUNOL, V18, P214, DOI 10.1016/j.smim.2006.03.009; Hasegawa K, 2004, SCIENCE, V303, P685, DOI 10.1126/science.1092138; Hill RJ, 2002, EXP HEMATOL, V30, P237, DOI 10.1016/S0301-472X(01)00794-9; Huang JJ, 2010, RHEUMATOL INT; Hughes LB, 2010, ARTHRITIS RHEUM-US, V62, P3547, DOI 10.1002/art.27732; Iannaccone CK, 2011, RHEUMATOLOGY, V50, P40, DOI 10.1093/rheumatology/keq263; Kang BY, 2005, MOL CELL BIOL, V25, P554, DOI 10.1128/MCB.25.2.554-562.2005; Kunz M, 2011, CRIT REV IMMUNOL, V31, P99, DOI 10.1615/CritRevImmunol.v31.i2.20; Liu YG, 2009, BIOCHEMISTRY-US, V48, P7525, DOI 10.1021/bi900332f; Moisan J, 2007, J EXP MED, V204, P2825, DOI 10.1084/jem.20070994; Rieck M, 2007, J IMMUNOL, V179, P4704, DOI 10.4049/jimmunol.179.7.4704; Vang T, 2005, NAT GENET, V37, P1317, DOI 10.1038/ng1673; Wu JS, 2006, J BIOL CHEM, V281, P11002, DOI 10.1074/jbc.M600498200; Zhang JY, 2011, NAT GENET, V43, P902, DOI 10.1038/ng.904; Zikherman J, 2009, J IMMUNOL, V182, P4093, DOI 10.4049/jimmunol.0803317	23	27	35	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33067	10.1371/journal.pone.0033067	http://dx.doi.org/10.1371/journal.pone.0033067			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427951	Green Submitted, gold, Green Published			2022-12-25	WOS:000302381500087
J	Du, HX; Bao, ZM; Hou, R; Wang, S; Su, HL; Yan, JJ; Tian, ML; Li, Y; Wei, W; Lu, W; Hu, XL; Wang, S; Hu, JJ				Du, Huixia; Bao, Zhenmin; Hou, Rui; Wang, Shan; Su, Hailin; Yan, Jingjing; Tian, Meilin; Li, Yan; Wei, Wen; Lu, Wei; Hu, Xiaoli; Wang, Shi; Hu, Jingjie			Transcriptome Sequencing and Characterization for the Sea Cucumber Apostichopus japonicus (Selenka, 1867)	PLOS ONE			English	Article							GENETIC-LINKAGE MAP; RAPID TRANSCRIPTOME; EXPRESSION; ANNOTATION; EVOLUTION; DISCOVERY; PROTEINS; LESSONS; MARKERS; GROWTH	Background: Sea cucumbers are a special group of marine invertebrates. They occupy a taxonomic position that is believed to be important for understanding the origin and evolution of deuterostomes. Some of them such as Apostichopus japonicus represent commercially important aquaculture species in Asian countries. Many efforts have been devoted to increasing the number of expressed sequence tags (ESTs) for A. japonicus, but a comprehensive characterization of its transcriptome remains lacking. Here, we performed the large-scale transcriptome profiling and characterization by pyrosequencing diverse cDNA libraries from A. japonicus. Results: In total, 1,061,078 reads were obtained by 454 sequencing of eight cDNA libraries representing different developmental stages and adult tissues in A. japonicus. These reads were assembled into 29,666 isotigs, which were further clustered into 21,071 isogroups. Nearly 40% of the isogroups showed significant matches to known proteins based on sequence similarity. Gene ontology (GO) and KEGG pathway analyses recovered diverse biological functions and processes. Candidate genes that were potentially involved in aestivation were identified. Transcriptome comparison with the sea urchin Strongylocentrotus purpuratus revealed similar patterns of GO term representation. In addition, 4,882 putative orthologous genes were identified, of which 202 were not present in the non-echinoderm organisms. More than 700 simple sequence repeats (SSRs) and 54,000 single nucleotide polymorphisms (SNPs) were detected in the A. japonicus transcriptome. Conclusion: Pyrosequencing was proven to be efficient in rapidly identifying a large set of genes for the sea cucumber A. japonicus. Through the large-scale transcriptome sequencing as well as public EST data integration, we performed a comprehensive characterization of the A. japonicus transcriptome and identified candidate aestivation-related genes. A large number of potential genetic markers were also identified from the A. japonicus transcriptome. This transcriptome resource would lay an important foundation for future genetic or genomic studies on this species.	[Du, Huixia; Bao, Zhenmin; Hou, Rui; Wang, Shan; Su, Hailin; Yan, Jingjing; Tian, Meilin; Li, Yan; Wei, Wen; Lu, Wei; Hu, Xiaoli; Wang, Shi; Hu, Jingjie] Ocean Univ China, Coll Marine Life Sci, Key Lab Marine Genet & Breeding, Qingdao, Peoples R China; [Li, Yan] Beijing Genom Inst Shenzhen, Shenzhen, Peoples R China	Ocean University of China; Beijing Genomics Institute (BGI)	Du, HX (corresponding author), Ocean Univ China, Coll Marine Life Sci, Key Lab Marine Genet & Breeding, Qingdao, Peoples R China.	swang@ouc.edu.cn; hujingjie@ouc.edu.cn	Su, Hailin/D-1352-2017; wang, meng/GWZ-9558-2022	Su, Hailin/0000-0002-0284-2071; 	National Key Technology R&D Program of China [2011BAD13B05, 2011BAD13B06]; National High Technology Research and Development Program of China [2012AA10A412]	National Key Technology R&D Program of China(National Key Technology R&D Program); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	Financial support for this work was provided by the National Key Technology R&D Program of China (2011BAD13B05 and 2011BAD13B06), and the National High Technology Research and Development Program of China (2012AA10A412). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bottjer DJ, 2006, SCIENCE, V314, P956, DOI 10.1126/science.1132310; Buckley KM, 2008, J IMMUNOL, V181, P8585, DOI 10.4049/jimmunol.181.12.8585; Choe S, 1963, STUDY SEA CUCUMBER M, P133; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Coppe A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-635; Dolmatov IY, 2009, CELL TISSUE RES, V336, P41, DOI 10.1007/s00441-009-0761-6; Ettensohn CA, 2009, DEVELOPMENT, V136, P11, DOI 10.1242/dev.023564; Freeman RM, 2008, BIOL BULL-US, V214, P284, DOI 10.2307/25470670; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Hou R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021560; Ji TT, 2008, AQUACULTURE, V283, P180, DOI 10.1016/j.aquaculture.2008.07.006; Kawahara-Miki R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026043; Kawashima T, 2009, GENOME RES, V19, P1393, DOI 10.1101/gr.087072.108; Kofler R, 2007, BIOINFORMATICS, V23, P1683, DOI 10.1093/bioinformatics/btm157; Kukekova AV, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-482; Lange C, 2011, MOL BIOL EVOL, V28, P1687, DOI 10.1093/molbev/msq349; Li F., 1996, FISH CHINA, V3, P49, DOI DOI 10.1152/AJPCELL.1998.275.1.C1; Li Q, 2009, ANIM GENET, V40, P678, DOI 10.1111/j.1365-2052.2009.01900.x; Liao YL., 1997, FAUNA SINICA ECHINOD; Liu Y., 1996, J FISH SCI CHINA, V3, P41; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MARUSHKINA NB, 1978, TSITOLOGIYA+, V20, P426; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Milan M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-234; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; O'Neil ST, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-310; Rismani-Yazdi H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-148; Romualdi C, 2003, PHYSIOL GENOMICS, V12, P159, DOI 10.1152/physiolgenomics.00096.2002; Ruppert EE, 1994, INVERTEBRATE ZOOLOGY, P96; Shukaluk AI, 2001, RUSS J MAR BIOL, V27, P202; Sloan N. A., 1984, ECHINODERMATA, P109, DOI 10.1201/9781003079224-14; Smith LC, 2010, DIS MODEL MECH, V3, P274, DOI 10.1242/dmm.004697; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Sun L, 2011, COMP BIOCHEM PHYS D, V6, P195, DOI 10.1016/j.cbd.2011.03.002; Sun WJ, 2010, CONSERV GENET RESOUR, V2, P141, DOI 10.1007/s12686-010-9270-x; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wang FY, 2008, AQUACULTURE, V285, P238, DOI 10.1016/j.aquaculture.2008.08.033; Wang H, 2010, PROTEOMICS, V10, P2972, DOI 10.1002/pmic.201000056; Wang S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r126; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Yang AF, 2009, AQUACULTURE, V296, P193, DOI 10.1016/j.aquaculture.2009.08.016; Yang AF, 2010, FISH SHELLFISH IMMUN, V29, P839, DOI 10.1016/j.fsi.2010.07.023; Yang HS, 2006, J EXP MAR BIOL ECOL, V330, P505, DOI 10.1016/j.jembe.2005.09.010; Yang HS, 2005, AQUAC RES, V36, P1085, DOI 10.1111/j.1365-2109.2005.01325.x; Zhan AB, 2007, MOL ECOL NOTES, V7, P1345, DOI 10.1111/j.1471-8286.2007.01876.x; Zhang QL, 1998, CULTIVATION TECHNIQU, P22; Zheng FX, 2006, HYDROBIOLOGIA, V571, P109, DOI 10.1007/s10750-006-0231-z; Zhou ZC, 2011, FISH SHELLFISH IMMUN, V31, P540, DOI 10.1016/j.fsi.2011.06.023	51	127	134	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33311	10.1371/journal.pone.0033311	http://dx.doi.org/10.1371/journal.pone.0033311			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22428017	Green Submitted, gold, Green Published			2022-12-25	WOS:000302381500125
J	Fu, H; Liu, LG; Zhang, XB; Zhu, YF; Zhao, LN; Peng, JP; He, HX; Jin, Q				Fu, Hua; Liu, Liguo; Zhang, Xiaobing; Zhu, Yafang; Zhao, Lina; Peng, Junping; He, Hongxuan; Jin, Qi			Common Changes in Global Gene Expression Induced by RNA Polymerase Inhibitors in shigella flexneri	PLOS ONE			English	Article							TERMINATION FACTOR-RHO; ESCHERICHIA-COLI; TRANSCRIPTIONAL PROFILE; PROTEOMIC ANALYSIS; LOCALIZATION; PROTEIN; SALMONELLA; RIFAXIMIN; ICSA	Characterization of expression profile of organisms in response to antimicrobials provides important information on the potential mechanism of action of the drugs. The special expression signature can be used to predict whether other drugs act on the same target. Here, the common response of Shigella flexneri to two inhibitors of RNA polymerase was examined using gene expression profiling. Consistent with similar effects of the two drugs, the gene expression profiles indicated that responses of the bacteria to these drugs were roughly the same, with 225 genes affected commonly. Of them, 88 were induced and 137 were repressed. Real-time PCR was performed for selected genes to verify the microarray results. Analysis of the expression data revealed that more than 30% of the plasmid-encoded genes on the array were up-regulated by the antibiotics including virF regulon, other virulence-related genes, and genes responsible for plasmid replication, maintenance, and transfer. In addition, some chromosome-encoded genes involved in virulence and genes acquired from horizontal transfer were also significantly up-regulated. However, the expression of genes encoding the beta-subunit of RNA polymerase was increased moderately. The repressed genes include those that code for products associated with the ribosome, citrate cycle, glycolysis, thiamine biosynthesis, purine metabolism, fructose metabolism, mannose metabolism, and cold shock proteins. This study demonstrates that the two antibiotics induce rapid cessation of RNA synthesis resulting in inhibition of translation components. It also indicates that the production of virulence factors involved in intercellular dissemination, tissue invasion and inflammatory destruction may be enhanced through derepressing horizontal transfer genes by the drugs.	[Fu, Hua; Liu, Liguo; Zhang, Xiaobing; Zhu, Yafang; Peng, Junping; Jin, Qi] Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China; [Fu, Hua; Liu, Liguo; Zhang, Xiaobing; Zhu, Yafang; Peng, Junping; Jin, Qi] Peking Union Med Coll, Beijing 100021, Peoples R China; [Liu, Liguo; He, Hongxuan] Chinese Acad Sci, Inst Zool, Natl Res Ctr Wildlife Born Dis, Beijing, Peoples R China; [Zhao, Lina] Hebei United Univ, Coll Life Sci, Dept Biol Engn, Tangshan, Hebei, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Sciences; Institute of Zoology, CAS; North China University of Science & Technology	Fu, H (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China.	hehx@ioz.ac.cn; zdsys@vip.sina.com			Ministry of Science and Technology of China [2009CB522603, 2011CB504901]	Ministry of Science and Technology of China(Ministry of Science and Technology, China)	Financial support for this work came from the National Basic Research Program from the Ministry of Science and Technology of China grant (Accession numbers: 2009CB522603 and 2011CB504901; http://www.973.gov.cn/AreaBody.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS CC, 1991, J BACTERIOL, V173, P7429, DOI 10.1128/jb.173.23.7429-7435.1991; BENJELLOUNTOUIMI Z, 1995, MOL MICROBIOL, V17, P123, DOI 10.1111/j.1365-2958.1995.mmi_17010123.x; Beraud M, 2010, MOL CELL PROTEOMICS, V9, P2601, DOI 10.1074/mcp.M110.002493; Brazas MD, 2005, DRUG DISCOV TODAY, V10, P1245, DOI 10.1016/S1359-6446(05)03566-X; Cardinale CJ, 2008, SCIENCE, V320, P935, DOI 10.1126/science.1152763; d'Hauteville H, 2002, J IMMUNOL, V168, P5240, DOI 10.4049/jimmunol.168.10.5240; Fu H, 2007, APPL MICROBIOL BIOT, V77, P657, DOI 10.1007/s00253-007-1180-9; Fu H, 2010, FEMS MICROBIOL LETT, V303, P169, DOI 10.1111/j.1574-6968.2009.01872.x; GOLDBERG MB, 1993, J BACTERIOL, V175, P2189, DOI 10.1128/JB.175.8.2189-2196.1993; Jin Q, 2002, NUCLEIC ACIDS RES, V30, P4432, DOI 10.1093/nar/gkf566; Koo HL, 2010, CURR OPIN GASTROEN, V26, P17, DOI 10.1097/MOG.0b013e328333dc8d; Lin JT, 2005, ANTIMICROB AGENTS CH, V49, P1915, DOI 10.1128/AAC.49.5.1915-1926.2005; MATSUMOTO Y, 1986, J BACTERIOL, V166, P945, DOI 10.1128/jb.166.3.945-958.1986; Melnikow E, 2008, VET MICROBIOL, V131, P277, DOI 10.1016/j.vetmic.2008.03.007; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Peng JP, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-218; Rodriguez-Garcia A, 2007, PROTEOMICS, V7, P2410, DOI 10.1002/pmic.200600883; SANDERS WE, 1976, ANN INTERN MED, V85, P82, DOI 10.7326/0003-4819-85-1-82; Santapaola D, 2006, J BACTERIOL, V188, P1620, DOI 10.1128/JB.188.4.1620-1627.2006; Schneider DA, 2003, CURR OPIN MICROBIOL, V6, P151, DOI 10.1016/S1369-5274(03)00038-9; Senneville E, 2011, CLIN INFECT DIS, V53, P334, DOI 10.1093/cid/cir402; Sur D, 2004, INDIAN J MED RES, V120, P454; Taylor DN, 2006, CLIN INFECT DIS, V42, P1283, DOI 10.1086/503039; Wilson W, 1999, P NATL ACAD SCI USA, V96, P12833, DOI 10.1073/pnas.96.22.12833; Yim G, 2006, J BACTERIOL, V188, P7988, DOI 10.1128/JB.00791-06	25	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33240	10.1371/journal.pone.0033240	http://dx.doi.org/10.1371/journal.pone.0033240			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22428000	gold, Green Published, Green Submitted			2022-12-25	WOS:000302381500115
J	Hale, JD; Fairbrass, AJ; Matthews, TJ; Sadler, JP				Hale, James D.; Fairbrass, Alison J.; Matthews, Tom J.; Sadler, Jon P.			Habitat Composition and Connectivity Predicts Bat Presence and Activity at Foraging Sites in a Large UK Conurbation	PLOS ONE			English	Article							URBAN LANDSCAPE PATTERN; PIPISTRELLUS-PIPISTRELLUS; GRADIENT ANALYSIS; SPATIAL HETEROGENEITY; COMPACT CITY; CONSERVATION; URBANIZATION; BIODIVERSITY; FRAMEWORK; CHIROPTERA	Background: Urbanization is characterized by high levels of sealed land-cover, and small, geometrically complex, fragmented land-use patches. The extent and density of urbanized land-use is increasing, with implications for habitat quality, connectivity and city ecology. Little is known about densification thresholds for urban ecosystem function, and the response of mammals, nocturnal and cryptic taxa are poorly studied in this respect. Bats (Chiroptera) are sensitive to changing urban form at a species, guild and community level, so are ideal model organisms for analyses of this nature. Methodology/Principal Findings: We surveyed bats around urban ponds in the West Midlands conurbation, United Kingdom (UK). Sites were stratified between five urban land classes, representing a gradient of built land-cover at the 1 km 2 scale. Models for bat presence and activity were developed using land-cover and land-use data from multiple radii around each pond. Structural connectivity of tree networks was used as an indicator of the functional connectivity between habitats. All species were sensitive to measures of urban density. Some were also sensitive to landscape composition and structural connectivity at different spatial scales. These results represent new findings for an urban area. The activity of Pipistrellus pipistrellus (Schreber 1774) exhibited a non-linear relationship with the area of built land-cover, being much reduced beyond the threshold of similar to 60% built surface. The presence of tree networks appears to mitigate the negative effects of urbanization for this species. Conclusions/Significance: Our results suggest that increasing urban density negatively impacts the study species. This has implications for infill development policy, built density targets and the compact city debate. Bats were also sensitive to the composition and structure of the urban form at a range of spatial scales, with implications for land-use planning and management. Protecting and establishing tree networks may improve the resilience of some bat populations to urban densification.	[Hale, James D.; Sadler, Jon P.] Univ Birmingham, Sch Geog Earth & Environm Sci, Birmingham, W Midlands, England; [Fairbrass, Alison J.] Univ London Imperial Coll Sci Technol & Med, Ascot, Berks, England; [Matthews, Tom J.] Univ Oxford, Sch Geog & Environm, Oxford, England	University of Birmingham; Imperial College London; University of Oxford	Hale, JD (corresponding author), Univ Birmingham, Sch Geog Earth & Environm Sci, Birmingham, W Midlands, England.	j.hale@bham.ac.uk; j.p.sadler@bham.ac.uk	Fairbrass, Alison/K-6563-2016	Fairbrass, Alison/0000-0002-4907-9683; Sadler, Jonathan/0000-0003-0443-4458; Hale, James/0000-0001-9662-1853; Matthews, Thomas/0000-0002-7624-244X	National Lottery (UK) [EP/E0216030]; EPSRC [EP/F007426/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/F007426/1] Funding Source: researchfish	National Lottery (UK); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This research was undertaken as part of the Urban Futures (SUE2) program (EP/E0216030) (grant holder JPS) (http://www.epsrc.ac.uk/) and the OPAL (Open Air Laboratories) project (http://www.opalexplorenature.org/), which is funded by The National Lottery (UK) through the Big Lottery Fund (http://www.biglotteryfund.org.uk/) (for additional volunteer field assistants). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altringham JD, BRIT BATS; Angold PG, 2006, SCI TOTAL ENVIRON, V360, P196, DOI 10.1016/j.scitotenv.2005.08.035; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 2010, WORLD URB PROSP 2009; Avila-Flores R, 2005, J MAMMAL, V86, P1193, DOI 10.1644/04-MAMM-A-085R1.1; Bates AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023459; Beyer HL, 2004, HAWTHS ANAL TOOLS AR; Blair RB, 1996, ECOL APPL, V6, P506, DOI 10.2307/2269387; Boughey K, BIOL CONSER IN PRESS; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Burton E, 2000, URBAN STUD, V37, P1969, DOI 10.1080/00420980050162184; Cadenasso ML, 2007, FRONT ECOL ENVIRON, V5, P80, DOI 10.1890/1540-9295(2007)5[80:SHIUER]2.0.CO;2; Conroy MJ, 2003, CONSERV ECOL, V8; Corben C, 2009, ANALOOKW BAT CALL AN; Corben C, 2007, WEATHER PROTECTION A; Cornulier T, 2011, METHODS ECOL EVOL, V2, P86, DOI 10.1111/j.2041-210X.2010.00054.x; Croci S, 2008, CONDOR, V110, P223, DOI 10.1525/cond.2008.8409; Cushman SA, 2004, ECOL APPL, V14, P1090, DOI 10.1890/03-5131; Dallimer M, 2011, BIOL LETTERS, V7, P763, DOI 10.1098/rsbl.2011.0025; Davidson-Watts I, 2006, J ZOOLOGY, V268; Davidson-Watts I, 2006, BIOL CONSERV, V133, P118, DOI 10.1016/j.biocon.2006.05.027; Dietz M, 2006, ACTA CHIROPTEROL, V8, P403, DOI 10.3161/1733-5329(2006)8[403:SSDPOF]2.0.CO;2; Downs NC, 2006, ACTA CHIROPTEROL, V8, P169, DOI 10.3161/1733-5329(2006)8[169:TUBBOH]2.0.CO;2; Duguay S, 2007, LANDSCAPE ECOL, V22, P589, DOI 10.1007/s10980-006-9050-x; Eigenbrod F, 2011, P ROY SOC B-BIOL SCI, V278, P3201, DOI 10.1098/rspb.2010.2754; Eigenbrod F, 2008, LANDSCAPE ECOL, V23, P159, DOI 10.1007/s10980-007-9174-7; Ernstson H, 2010, AMBIO, V39, P531, DOI 10.1007/s13280-010-0081-9; Evans KL, 2011, GLOBAL CHANGE BIOL, V17, P32, DOI 10.1111/j.1365-2486.2010.02247.x; Fernandez-Juricic E, 2000, CONSERV BIOL, V14, P513, DOI 10.1046/j.1523-1739.2000.98600.x; Fischer J, 2009, ACTA CHIROPTEROL, V11, P127, DOI 10.3161/150811009X465749; FitzGibbon SI, 2007, LANDSCAPE ECOL, V22, P1513, DOI 10.1007/s10980-007-9139-x; Fleury AM, 1997, LANDSCAPE URBAN PLAN, V37, P163, DOI 10.1016/S0169-2046(97)80002-3; Gagne SA, 2007, LANDSCAPE ECOL, V22, P205, DOI 10.1007/s10980-006-9012-3; Gaisler J, 1998, J ZOOL, V244, P439, DOI 10.1111/j.1469-7998.1998.tb00048.x; Garden JG, 2010, LANDSCAPE ECOL, V25, P1013, DOI 10.1007/s10980-010-9476-z; Gehrt SD, 2003, ECOL APPL, V13, P939, DOI 10.1890/02-5188; Gehrt SD, 2004, ECOL APPL, V14, P625, DOI 10.1890/03-5013; Goddard MA, 2010, TRENDS ECOL EVOL, V25, P90, DOI 10.1016/j.tree.2009.07.016; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Hahs AK, 2006, LANDSCAPE URBAN PLAN, V78, P435, DOI 10.1016/j.landurbplan.2005.12.005; Hastie TJ., 1990, GEN ADDITIVE MODELS; Hostetler Mark, 2000, Urban Ecosystems, V4, P25, DOI 10.1023/A:1009587719462; Hourigan CL, 2008, WILDLIFE RES, V35, P768, DOI 10.1071/WR07154; Irwin EG, 2007, P NATL ACAD SCI USA, V104, P20672, DOI 10.1073/pnas.0705527105; Jenkins EV, 1998, ANIM BEHAV, V56, P909, DOI 10.1006/anbe.1998.0858; Kapfer G, 2008, MAMM BIOL, V73, P267, DOI 10.1016/j.mambio.2007.01.001; Lawton J.H., 2010, MAKING SPACE NATURE; LIMPENS HJG, 1991, MYOTIS, V29, P63; Lookingbill TR, 2010, BIOL CONSERV, V143, P974, DOI 10.1016/j.biocon.2010.01.011; Luck M, 2002, LANDSCAPE ECOL, V17, P327, DOI 10.1023/A:1020512723753; Marzluff JM, 2001, RESTOR ECOL, V9, P280, DOI 10.1046/j.1526-100x.2001.009003280.x; McCullagh P., 1989, GEN LINEAR MODELS, V(2nd), DOI [10.1007/978-1-4899-3242-6, https://doi.org/10.1007/978-1-4899-3242-6, DOI 10.1007/978-1-4899-3242-6]; McDonnell Mark J., 1997, Urban Ecosystems, V1, P21, DOI 10.1023/A:1014359024275; McDonnell MJ, 2008, LANDSCAPE ECOL, V23, P1143, DOI 10.1007/s10980-008-9253-4; MCDONNELL MJ, 1990, ECOLOGY, V71, P1232, DOI 10.2307/1938259; McKinney M. L., 2008, Urban Ecosystems, V11, P161, DOI 10.1007/s11252-007-0045-4; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; Neuman M, 2005, J PLAN EDUC RES, V25, P11, DOI 10.1177/0739456X04270466; Niemela J, 2009, LANDSCAPE URBAN PLAN, V92, P65, DOI 10.1016/j.landurbplan.2009.05.016; Nystrom M, 2001, ECOSYSTEMS, V4, P406, DOI 10.1007/s10021-001-0019-y; O'Hara RB, 2010, METHODS ECOL EVOL, V1, P118, DOI 10.1111/j.2041-210X.2010.00021.x; Oprea M, 2009, BIODIVERS CONSERV, V18, P2361, DOI 10.1007/s10531-009-9593-7; Ordnance Survey, 2008, OS MAST TOP LAY GML; Owen SM, 2006, LANDSCAPE URBAN PLAN, V78, P311, DOI 10.1016/j.landurbplan.2005.11.002; Pascual-Hortal L, 2006, LANDSCAPE ECOL, V21, P959, DOI 10.1007/s10980-006-0013-z; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012; Robinson RA, 2002, J APPL ECOL, V39, P157, DOI 10.1046/j.1365-2664.2002.00695.x; Russ J., 1999, BATS BRITAIN IRELAND; Sadler J., 2010, URBAN ECOL, P230; Sadler JP, 2006, J BIOGEOGR, V33, P1126, DOI 10.1111/j.1365-2699.2006.01476.x; Sattler T, 2007, J APPL ECOL, V44, P1188, DOI 10.1111/j.1365-2664.2007.01328.x; Scheffer M, 2010, NATURE, V467, P411, DOI 10.1038/467411a; Scott SJ, 2010, J ZOOL, V280, P371, DOI 10.1111/j.1469-7998.2009.00670.x; Shanahan DF, 2011, BIOL CONSERV, V144, P722, DOI 10.1016/j.biocon.2010.10.014; Simon M., 2004, ECOLOGY CONSERVATION; Small E, 2006, SCI TOTAL ENVIRON, V360, P205, DOI 10.1016/j.scitotenv.2005.08.051; Stone EL, 2009, CURR BIOL, V19, P1123, DOI 10.1016/j.cub.2009.05.058; Threlfall C, 2011, ECOGRAPHY, V34, P814, DOI 10.1111/j.1600-0587.2010.06939.x; Threlfall CG, 2012, BIOL CONSERV, V146, P41, DOI 10.1016/j.biocon.2011.11.026; Tischendorf L, 2000, OIKOS, V90, P7, DOI 10.1034/j.1600-0706.2000.900102.x; Tischendorf L, 2001, LANDSCAPE ECOL, V16, P235, DOI 10.1023/A:1011112719782; Tratalos J, 2007, GLOBAL CHANGE BIOL, V13, P1685, DOI 10.1111/j.1365-2486.2007.01390.x; Tremblay MA, 2009, J APPL ECOL, V46, P1314, DOI 10.1111/j.1365-2664.2009.01717.x; Turner T, 2006, LANDSCAPE URBAN PLAN, V76, P240, DOI 10.1016/j.landurbplan.2004.09.035; Vaughan N, 1997, J APPL ECOL, V34, P716, DOI 10.2307/2404918; Verboom B, 1999, CAN J ZOOL, V77, P1393, DOI 10.1139/cjz-77-9-1393; Verboom B, 1997, LANDSCAPE ECOL, V12, P117, DOI 10.1007/BF02698211; Wheater C. Philip, 2000, USING STAT UNDERSTAN; Williams NSG, 2009, J ECOL, V97, P4, DOI 10.1111/j.1365-2745.2008.01460.x; Zhang LQ, 2004, LANDSCAPE URBAN PLAN, V69, P1, DOI 10.1016/j.landurbplan.2003.08.006; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x; Zuur Alain F., 2009, P1	92	76	78	7	200	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33300	10.1371/journal.pone.0033300	http://dx.doi.org/10.1371/journal.pone.0033300			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22428015	Green Published, Green Submitted, gold			2022-12-25	WOS:000302381500124
J	Huang, XY; Shi, GM; Devbhandari, RP; Ke, AW; Wang, YW; Wang, XY; Wang, Z; Shi, YH; Xiao, YS; Ding, ZB; Dai, Z; Xu, Y; Jia, WP; Tang, ZY; Fan, J; Zhou, J				Huang, Xiao-Yong; Shi, Guo-Ming; Devbhandari, Ranjan Prasad; Ke, Ai-Wu; Wang, Yuwei; Wang, Xiao-Ying; Wang, Zheng; Shi, Ying-Hong; Xiao, Yong-Sheng; Ding, Zhen-Bin; Dai, Zhi; Xu, Yang; Jia, Wei-Ping; Tang, Zhao-You; Fan, Jia; Zhou, Jian			Low Level of Low-Density Lipoprotein Receptor-Related Protein 1 Predicts an Unfavorable Prognosis of Hepatocellular Carcinoma after Curative Resection	PLOS ONE			English	Article							ALPHA(2)-MACROGLOBULIN RECEPTOR; CELL-MIGRATION; ALPHA-2-MACROGLOBULIN RECEPTOR; MATRIX METALLOPROTEINASES; DECREASED EXPRESSION; INVASION; MATRIX-METALLOPROTEINASE-9; OVEREXPRESSION; CD151	Background: Low-density lipoprotein receptor-related protein 1 (LRP1) is a multifunctional receptor involved in receptor-mediated endocytosis and cell signaling. The aim of this study was to elucidate the expression and mechanism of LRP1 in hepatocellular carcinoma (HCC). Methods: LRP1 expression in 4 HCC cell lines and 40 HCC samples was detected. After interruption of LRP1 expression in a HCC cell line either with specific lentiviral-mediated shRNA LRP1 or in the presence of the LRP1-specific chaperone, receptor-associated protein (RAP), the role of LRP1 in the migration and invasion of HCC cells was assessed in vivo and in vitro, and the expression of matrix metalloproteinase (MMP) 9 in cells and the bioactivity of MMP9 in the supernatant were assayed. The expression and prognostic value of LRP1 were investigated in 327 HCC specimens. Results: Low LRP1 expression was associated with poor HCC prognosis, with low expression independently related to shortened overall survival and increased tumor recurrence rate. Expression of LRP1 in non-recurrent HCC samples was significantly higher than that in early recurrent samples. LRP1 expression in HCC cell lines was inversely correlated with their metastatic potential. After inhibition of LRP1, low-metastatic SMCC-7721 cells showed enhanced migration and invasion and increased expression and bioactivity of MMP9. Correlation analysis showed a negative correlation between LRP1 and MMP9 expression in HCC patients. The prognostic value of LRP1 expression was validated in the independent data set. Conclusions: LRP1 modulated the level of MMP9 and low level of LRP1 expression was associated with aggressiveness and invasiveness in HCCs. LRP1 offered a possible strategy for tumor molecular therapy.	[Huang, Xiao-Yong; Shi, Guo-Ming; Devbhandari, Ranjan Prasad; Ke, Ai-Wu; Wang, Yuwei; Wang, Xiao-Ying; Wang, Zheng; Shi, Ying-Hong; Xiao, Yong-Sheng; Ding, Zhen-Bin; Dai, Zhi; Xu, Yang; Tang, Zhao-You; Fan, Jia; Zhou, Jian] Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Shanghai 200433, Peoples R China; [Huang, Xiao-Yong; Shi, Guo-Ming; Dai, Zhi; Fan, Jia; Zhou, Jian] Fudan Univ, Zhongshan Hosp, Shanghai Key Lab Organ Transplantat, Shanghai 200433, Peoples R China; [Jia, Wei-Ping] Shanghai Jiao Tong Univ, Dept Endocrinol & Metab, Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China; [Fan, Jia; Zhou, Jian] Fudan Univ, Ctr Canc, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Huang, Xiao-Yong; Fan, Jia; Zhou, Jian] Fudan Univ, Key Lab Carcinogenesis & Canc Invas, Minist Educ, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Shanghai Jiao Tong University; Fudan University; Fudan University	Huang, XY (corresponding author), Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Shanghai 200433, Peoples R China.	jiafan99@yahoo.com; zhou.jian@zs-hospital.sh.cn	Fan, Jia/C-6689-2017; Shi, Ying-Hong/B-7063-2017	Ke, Ai-Wu/0000-0002-7964-6909	National Natural Science Foundation of China [81071741, 30972949]; National 973 Program [2011CB504001]; Ph.D. Programs Foundation of Ministry of Education of China [20090071120025]; China Postdoctoral Science Foundation [201003236]; Shanghai Municipal Natural Science Foundation [11ZR1428300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 Program(National Basic Research Program of China); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Shanghai Municipal Natural Science Foundation	This work was supported by the National Natural Science Foundation of China (81071741 and 30972949), the National 973 Program (2011CB504001), the Ph.D. Programs Foundation of Ministry of Education of China (20090071120025), the Special Program of China Postdoctoral Science Foundation (201003236) and the Shanghai Municipal Natural Science Foundation (11ZR1428300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arii S, 1996, HEPATOLOGY, V24, P316; Barnes H, 2001, J BIOL CHEM, V276, P19119, DOI 10.1074/jbc.M011437200; Dedieu S, 2008, MOL CELL BIOL, V28, P2980, DOI 10.1128/MCB.02238-07; Desrosiers RR, 2006, PEDIATR BLOOD CANCER, V46, P40, DOI 10.1002/pbc.20566; Devbhandari RP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024901; deVries TJ, 1996, CANCER RES, V56, P1432; Ding ZB, 2009, CANCER-AM CANCER SOC, V115, P4753, DOI 10.1002/cncr.24513; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Foca C, 2000, MOL HUM REPROD, V6, P921, DOI 10.1093/molehr/6.10.921; Greenaway J, 2007, J CELL PHYSIOL, V210, P807, DOI 10.1002/jcp.20904; Hahn-Dantona E, 2001, J BIOL CHEM, V276, P15498, DOI 10.1074/jbc.M100121200; Herz J, 2002, ANNU REV BIOCHEM, V71, P405, DOI 10.1146/annurev.biochem.71.110601.135342; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Huang XY, 2010, CANCER-AM CANCER SOC, V116, P5440, DOI 10.1002/cncr.25485; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; KANCHA RK, 1994, ONCOL RES, V6, P365; Ke AW, 2011, GASTROENTEROLOGY, V140, P1629, DOI 10.1053/j.gastro.2011.02.008; Ke AW, 2009, HEPATOLOGY, V49, P491, DOI 10.1002/hep.22639; Langlois B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011584; Llovet JM, 2008, JNCI-J NATL CANCER I, V100, P698, DOI 10.1093/jnci/djn134; Meng H, 2011, CLIN CANCER RES, V17, P2426, DOI 10.1158/1078-0432.CCR-10-2385; MOESTRUP SK, 1992, CELL TISSUE RES, V269, P375, DOI 10.1007/BF00353892; Shi GM, 2008, J CANCER RES CLIN, V134, P1155, DOI 10.1007/s00432-008-0407-1; Shi GM, 2010, HEPATOLOGY, V52, P183, DOI 10.1002/hep.23661; Sid B, 2006, INT J BIOCHEM CELL B, V38, P1729, DOI 10.1016/j.biocel.2006.04.005; Sohda T, 2008, J GASTROEN HEPATOL, V23, pE153, DOI 10.1111/j.1440-1746.2007.05115.x; Song HS, 2009, BIOCHEM BIOPH RES CO, V388, P400, DOI 10.1016/j.bbrc.2009.08.020; Song H, 2009, CANCER RES, V69, P879, DOI 10.1158/0008-5472.CAN-08-3379; Song PM, 2008, WORLD J GASTROENTERO, V14, P5816, DOI 10.3748/wjg.14.5816; STRICKLAND DK, 1990, J BIOL CHEM, V265, P17401; Takayama Y, 2005, J BIOL CHEM, V280, P18504, DOI 10.1074/jbc.M410265200; Wittekind C, 2006, PATHOLOGE, V27, P289, DOI 10.1007/s00292-006-0834-1; Wu LH, 2004, J CELL BIOCHEM, V93, P1169, DOI 10.1002/jcb.20288; Xu Z, 2003, CELL RES, V13, P343, DOI 10.1038/sj.cr.7290179	34	17	18	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e32775	10.1371/journal.pone.0032775	http://dx.doi.org/10.1371/journal.pone.0032775			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427881	gold, Green Published, Green Submitted			2022-12-25	WOS:000302381500043
J	Lim, S; Bae, E; Kim, HS; Kim, TA; Byun, K; Kim, B; Hong, S; Im, JP; Yun, C; Lee, B; Lee, B; Park, SH; Letterio, J; Kim, SJ				Lim, Seunghwan; Bae, Eunjin; Kim, Hae-Suk; Kim, Tae-Aug; Byun, Kyunghee; Kim, Byungchul; Hong, Suntaek; Im, Jong Pil; Yun, Chohee; Lee, Bona; Lee, Bonghee; Park, Seok Hee; Letterio, John; Kim, Seong-Jin			TRAF6 Mediates IL-1 beta/LPS-Induced Suppression of TGF-beta Signaling through Its Interaction with the Type III TGF-beta Receptor	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; NF-KAPPA-B; TRANSCRIPTIONAL REGULATION; INDEPENDENT ACTIVATION; HEPATOMA-CELLS; CANCER; GENE; DIFFERENTIATION; POLYMORPHISMS; INFLAMMATION	Transforming growth factor-beta 1 (TGF-beta 1) is an important anti-inflammatory cytokine that modulates and resolves inflammatory responses. Recent studies have demonstrated that inflammation enhances neoplastic risk and potentiates tumor progression. In the evolution of cancer, pro-inflammatory cytokines such as IL-1 beta must overcome the anti-inflammatory effects of TGF-beta to boost pro-inflammatory responses in epithelial cells. Here we show that IL-1 beta or Lipopolysaccharide (LPS) suppresses TGF-beta-induced anti-inflammatory signaling in a NF-kappa B-independent manner. TRAF6, a key molecule in IL-1 beta signaling, mediates this suppressive effect through interaction with the type III TGF-beta receptor (T beta RIII), which is TGF-beta-dependent and requires type I TGF-beta receptor (T beta RI) kinase activity. T beta RI phosphorylates T beta RIII at residue S829, which promotes the TRAF6/T beta RIII interaction and consequent sequestration of T beta RIII from the T beta RII/T beta RI complex. Our data indicate that IL-1 beta enhances the pro-inflammatory response by suppressing TGF-beta signaling through TRAF6-mediated sequestration of T beta RIII, which may be an important contributor to the early stages of tumor progression.	[Lim, Seunghwan; Kim, Hae-Suk; Im, Jong Pil; Yun, Chohee; Lee, Bona; Letterio, John; Kim, Seong-Jin] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; [Bae, Eunjin; Lee, Bona; Kim, Seong-Jin] CHA Univ, CHA Canc Inst, Seoul, South Korea; [Bae, Eunjin; Byun, Kyunghee; Hong, Suntaek; Lee, Bonghee; Kim, Seong-Jin] Gachon Univ Med & Sci, Lee Gil Ya Canc & Diabet Inst, Songdo, Incheon, South Korea; [Kim, Tae-Aug] NCI, Lab Canc & Stem Cell Biol, Bethesda, MD 20892 USA; [Kim, Byungchul] Kangwon Natl Univ, Coll Nat Sci, Dept Biochem, Chunchon, South Korea; [Im, Jong Pil] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Im, Jong Pil] Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea; [Park, Seok Hee] Sungkyunkwan Univ, Dept Mol Biol, Suwon, South Korea	Case Western Reserve University; Pochon Cha University; Gachon University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Kangwon National University; Seoul National University (SNU); Seoul National University (SNU); Sungkyunkwan University (SKKU)	Lim, S (corresponding author), Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA.	kimsj@cha.ac.kr		Lim, Seunghwan/0000-0001-8920-0890	National Research Foundation of Korea [20090081756]; Korea Science and Engineering Foundation (KOSEF) [ROA-2007-000-20047-0]	National Research Foundation of Korea(National Research Foundation of Korea); Korea Science and Engineering Foundation (KOSEF)(Korea Science and Engineering Foundation)	This work is supported in part by grants from National Research Foundation of Korea (Bio Technology Research & Development Program 20090081756 to S-JK, SH and SHP) and from Korea Science and Engineering Foundation (KOSEF) (ROA-2007-000-20047-0 to SHP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Benus GFJD, 2005, MOL BIOL CELL, V16, P3501, DOI 10.1091/mbc.E04-11-1033; Bitzer M, 2000, GENE DEV, V14, P187; Blobe GC, 2001, J BIOL CHEM, V276, P24627, DOI 10.1074/jbc.M100188200; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Cejas PJ, 2010, BLOOD, V115, P4750, DOI 10.1182/blood-2009-09-242768; Chen W, 2003, SCIENCE, V301, P1394, DOI 10.1126/science.1083195; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Choi KC, 2006, NAT IMMUNOL, V7, P1057, DOI 10.1038/ni1383; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dong M, 2007, J CLIN INVEST, V117, P206, DOI 10.1172/JCI29293; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; Gatza CE, 2010, CELL SIGNAL, V22, P1163, DOI 10.1016/j.cellsig.2010.01.016; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Hahm KB, 2001, GUT, V49, P190, DOI 10.1136/gut.49.2.190; Han SU, 2008, ONCOGENE, V27, P675, DOI 10.1038/sj.onc.1210686; Hong S, 2007, NAT IMMUNOL, V8, P504, DOI 10.1038/ni1451; Im YH, 2001, CANCER RES, V61, P6665; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kim BC, 2002, MOL CELL BIOL, V22, P1369, DOI 10.1128/MCB.22.5.1369-1378.2002; Lee BH, 2000, J CELL BIOCHEM, V76, P437, DOI 10.1002/(SICI)1097-4644(20000301)76:3<437::AID-JCB11>3.0.CO;2-2; Letterio JJ, 1996, J LEUKOCYTE BIOL, V59, P769, DOI 10.1002/jlb.59.6.769; LOPEZCASILLAS F, 1993, CELL, V73, P1435, DOI 10.1016/0092-8674(93)90368-Z; Macarthur M, 2004, AM J PHYSIOL-GASTR L, V286, pG515, DOI 10.1152/ajpgi.00475.2003; Moon JA, 2006, KIDNEY INT, V70, P1234, DOI 10.1038/sj.ki.5001775; Roman-Blas JA, 2007, OSTEOARTHR CARTILAGE, V15, P1367, DOI 10.1016/j.joca.2007.04.011; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; Voronov E, 2003, P NATL ACAD SCI USA, V100, P2645, DOI 10.1073/pnas.0437939100; Walsh MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004064; Wang YY, 2006, NAT IMMUNOL, V7, P139, DOI 10.1038/ni1294; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002	34	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e32705	10.1371/journal.pone.0032705	http://dx.doi.org/10.1371/journal.pone.0032705			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427868	gold, Green Published, Green Submitted			2022-12-25	WOS:000302381500035
J	McGuire, MM; Yatsenko, A; Hoffner, L; Jones, M; Surti, U; Rajkovic, A				McGuire, Megan M.; Yatsenko, Alexander; Hoffner, Lori; Jones, Mirka; Surti, Urvashi; Rajkovic, Aleksandar			Whole Exome Sequencing in a Random Sample of North American Women with Leiomyomas Identifies MED12 Mutations in Majority of Uterine Leiomyomas	PLOS ONE			English	Article							X-CHROMOSOME INACTIVATION; RENAL-CELL CANCER; CYTOGENETIC ABNORMALITIES; GENE; FH; FREQUENCY; FIBROIDS; MEDIATOR; KINASES; CDK8	Uterine leiomyomas (uterine fibroids) arise from smooth muscle tissue in the majority of women by age 45. It is common for these clonal tumors to develop from multiple locations within the uterus, leading to a variety of symptoms such as pelvic pain, abnormal uterine bleeding, and infertility. We performed whole exome sequencing on genomic DNA from five pairs of leiomyomas and corresponding normal myometrium to determine genetic variations unique to leiomyomas. Whole exome sequencing revealed that the gene encoding transcription factor MED12 (Mediator complex subunit 12) harbored heterozygous missense mutations caused by single nucleotide variants in highly conserved codon 44 of exon 2 in two of five leiomyomas. Sanger re-sequencing of MED12 among these five leiomyomas confirmed the two single nucleotide variants and detected a 42 base-pair deletion within exon 2 of MED12 in a third leiomyoma. MED12 was sequenced in an additional 143 leiomyomas and 73 normal myometrial tissues. Overall, MED12 was mutated in 100/148 (67%) of the genotyped leiomyomas: 79/148 (53%) leiomyomas exhibited heterozygous missense single nucleotide variants, 17/148 (11%) leiomyomas exhibited heterozygous in-frame deletions/insertion-deletions, 2/148 (1%) leiomyomas exhibited intronic heterozygous single nucleotide variants affecting splicing, and 2/148 (1%) leiomyomas exhibited heterozygous deletions/insertion-deletions spanning the intron 1-exon 2 boundary which affected the splice acceptor site. Mutations were not detected in MED12 in normal myometrial tissue. MED12 mutations were equally distributed among karyotypically normal and abnormal uterine leiomyomas and were identified in leiomyomas from both black and white American women. Our studies show an association between MED12 mutations and leiomyomas in ethnically and racially diverse American women.	[McGuire, Megan M.; Yatsenko, Alexander; Hoffner, Lori; Surti, Urvashi; Rajkovic, Aleksandar] Univ Pittsburgh, Magee Womens Res Inst, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15260 USA; [Jones, Mirka] Magee Womens Hosp UPMC, Dept Gynecol Pathol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute	McGuire, MM (corresponding author), Univ Pittsburgh, Magee Womens Res Inst, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15260 USA.	rajkovic@upmc.edu		Yatsenko, Alexander/0000-0002-1690-0172	Magee-Womens Research Institute and Foundation	Magee-Womens Research Institute and Foundation	Magee-Womens Research Institute and Foundation provided the funding that has supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowden W, 2009, MOL HUM REPROD, V15, P563, DOI 10.1093/molehr/gap050; Brosens I, 1998, FERTIL STERIL, V69, P232, DOI 10.1016/S0015-0282(97)00472-X; Canevari RA, 2005, AM J OBSTET GYNECOL, V193, P1395, DOI 10.1016/j.ajog.2005.02.097; CRAMER SF, 1990, AM J CLIN PATHOL, V94, P435, DOI 10.1093/ajcp/94.4.435; Flake GP, 2003, ENVIRON HEALTH PERSP, V111, P1037, DOI 10.1289/ehp.5787; Guarnaccia MM, 2001, CLIN OBSTET GYNECOL, V44, P385, DOI 10.1097/00003081-200106000-00024; HASHIMOTO K, 1995, GYNECOL OBSTET INVES, V40, P204, DOI 10.1159/000292336; HUG K, 1994, GENE CHROMOSOME CANC, V11, P263, DOI 10.1002/gcc.2870110409; Ishwad CS, 1997, GENE CHROMOSOME CANC, V19, P156, DOI 10.1002/(SICI)1098-2264(199707)19:3<156::AID-GCC4>3.0.CO;2-X; Knuesel MT, 2009, MOL CELL BIOL, V29, P650, DOI 10.1128/MCB.00993-08; Lehtonen R, 2004, AM J PATHOL, V164, P17, DOI 10.1016/S0002-9440(10)63091-X; Lyon MF, 1999, CURR BIOL, V9, pR235, DOI 10.1016/S0960-9822(99)80151-1; Makinen N, 2011, ONCOTARGET, V2, P966; Makinen N, 2011, SCIENCE, V334, P252, DOI 10.1126/science.1208930; Malik S, 2005, TRENDS BIOCHEM SCI, V30, P256, DOI 10.1016/j.tibs.2005.03.009; Malumbres M, 2011, PHYSIOL REV, V91, P973, DOI 10.1152/physrev.00025.2010; Markowski DN, 2012, INT J CANC; NILBERT M, 1990, CANCER GENET CYTOGEN, V45, P63, DOI 10.1016/0165-4608(90)90067-K; NILBERT M, 1990, GENE CHROMOSOME CANC, V2, P3, DOI 10.1002/gcc.2870020103; REIN MS, 1991, OBSTET GYNECOL, V77, P923; Rickert P, 1999, ONCOGENE, V18, P1093, DOI 10.1038/sj.onc.1202399; Risheg H, 2007, NAT GENET, V39, P451, DOI 10.1038/ng1992; Rocha PP, 2010, DEVELOPMENT, V137, P2723, DOI 10.1242/dev.053660; Schwartz CE, 2007, J MED GENET, V44, P472, DOI 10.1136/jmg.2006.048637; Tomlinson IPM, 2002, NAT GENET, V30, P406, DOI 10.1038/ng849; Wei MH, 2006, J MED GENET, V43, P18, DOI 10.1136/jmg.2005.033506	26	99	106	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33251	10.1371/journal.pone.0033251	http://dx.doi.org/10.1371/journal.pone.0033251			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22428002	Green Published, gold, Green Accepted			2022-12-25	WOS:000302381500116
J	Perreault, ML; Fan, T; Alijaniaram, M; O'Dowd, BF; George, SR				Perreault, Melissa L.; Fan, Theresa; Alijaniaram, Mohammed; O'Dowd, Brian F.; George, Susan R.			Dopamine D1-D2 Receptor Heteromer in Dual Phenotype GABA/Glutamate-Coexpressing Striatal Medium Spiny Neurons: Regulation of BDNF, GAD67 and VGLUT1/2	PLOS ONE			English	Article							PARKINSONS-DISEASE; NEUROTROPHIC FACTOR; PROJECTION NEURONS; SUBSTANTIA-NIGRA; MESSENGER-RNAS; QUANTAL SIZE; MOUSE MODEL; RAT MODEL; D1; EXPRESSION	In basal ganglia a significant subset of GABAergic medium spiny neurons (MSNs) coexpress D1 and D2 receptors (D1R and D2R) along with the neuropeptides dynorphin (DYN) and enkephalin (ENK). These coexpressing neurons have been recently shown to have a region-specific distribution throughout the mesolimbic and basal ganglia circuits. While the functional relevance of these MSNs remains relatively unexplored, they have been shown to exhibit the unique property of expressing the dopamine D1-D2 receptor heteromer, a novel receptor complex with distinct pharmacology and cell signaling properties. Here we showed that MSNs coexpressing the D1R and D2R also exhibited a dual GABA/glutamate phenotype. Activation of the D1R-D2R heteromer in these neurons resulted in the simultaneous, but differential regulation of proteins involved in GABA and glutamate production or vesicular uptake in the nucleus accumbens (NAc), ventral tegmental area (VTA), caudate putamen and substantia nigra (SN). Additionally, activation of the D1R-D2R heteromer in NAc shell, but not NAc core, differentially altered protein expression in VTA and SN, regions rich in dopamine cell bodies. The identification of a MSN with dual inhibitory and excitatory intrinsic functions provides new insights into the neuroanatomy of the basal ganglia and demonstrates a novel source of glutamate in this circuit. Furthermore, the demonstration of a dopamine receptor complex with the potential to differentially regulate the expression of proteins directly involved in GABAergic inhibitory or glutamatergic excitatory activation in VTA and SN may potentially provide new insights into the regulation of dopamine neuron activity. This could have broad implications in understanding how dysregulation of neurotransmission within basal ganglia contributes to dopamine neuronal dysfunction.	[Perreault, Melissa L.; Fan, Theresa; Alijaniaram, Mohammed; O'Dowd, Brian F.; George, Susan R.] Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Perreault, Melissa L.; Fan, Theresa; Alijaniaram, Mohammed; O'Dowd, Brian F.; George, Susan R.] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada; [George, Susan R.] Univ Toronto, Dept Med, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University of Toronto	Perreault, ML (corresponding author), Ctr Addict & Mental Hlth, Toronto, ON, Canada.	s.george@utoronto.ca	George, Susan/W-7494-2019; George, Susan R/P-9669-2018; Perreault, Melissa L/N-2867-2017	Perreault, Melissa L/0000-0002-5775-8950	National Institute on Drug Abuse; Canadian Institutes on Health Research; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA007223] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Canadian Institutes on Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by a grant from the National Institute on Drug Abuse (to SRG and BFO) and a Canadian Institutes on Health Research Postdoctoral Fellowship (to MLP). SRG holds a Canada Research Chair in Molecular Neuroscience. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizman O, 2000, NAT NEUROSCI, V3, P226, DOI 10.1038/72929; Akbarian S, 2006, BRAIN RES REV, V52, P293, DOI 10.1016/j.brainresrev.2006.04.001; Anderson SM, 2008, NAT NEUROSCI, V11, P344, DOI 10.1038/nn2054; Andringa G, 1999, PSYCHOPHARMACOLOGY, V146, P328, DOI 10.1007/s002130051124; Bahi A, 2008, PSYCHOPHARMACOLOGY, V199, P169, DOI 10.1007/s00213-008-1164-1; Berlanga ML, 2005, J COMP NEUROL, V492, P34, DOI 10.1002/cne.20684; Bertran-Gonzalez J, 2008, J NEUROSCI, V28, P5671, DOI 10.1523/JNEUROSCI.1039-08.2008; CALABRESI P, 1992, NEUROSCI LETT, V142, P95, DOI 10.1016/0304-3940(92)90628-K; Capper-Loup C, 2002, J NEUROSCI, V22, P6218; Culver KE, 2000, PSYCHOPHARMACOLOGY, V151, P202, DOI 10.1007/s002139900346; DeBoer P, 1996, J PHARMACOL EXP THER, V277, P775; Deng YP, 2006, J CHEM NEUROANAT, V32, P101, DOI 10.1016/j.jchemneu.2006.07.001; DEVENEY AM, 1995, BRIT J PHARMACOL, V116, P2120, DOI 10.1111/j.1476-5381.1995.tb16420.x; Dong E, 2005, P NATL ACAD SCI USA, V102, P12578, DOI 10.1073/pnas.0505394102; Doyle S, 2010, J BIOL CHEM, V285, P14366, DOI 10.1074/jbc.M109.080069; FLETCHER GH, 1987, NEUROSCIENCE, V23, P1001, DOI 10.1016/0306-4522(87)90175-8; GNANALINGHAM KK, 1995, PSYCHOPHARMACOLOGY, V117, P287, DOI 10.1007/BF02246103; GNANALINGHAM KK, 1995, PSYCHOPHARMACOLOGY, V117, P403, DOI 10.1007/BF02246211; Graham DL, 2007, NAT NEUROSCI, V10, P1029, DOI 10.1038/nn1929; Graham DL, 2009, BIOL PSYCHIAT, V65, P696, DOI 10.1016/j.biopsych.2008.09.032; Gutierrez R, 2003, PROG NEUROBIOL, V71, P337, DOI 10.1016/j.pneurobio.2003.11.004; Hasbi A, 2009, P NATL ACAD SCI USA, V106, P21377, DOI 10.1073/pnas.0903676106; Hashimoto T, 2005, J NEUROSCI, V25, P372, DOI 10.1523/JNEUROSCI.4035-04.2005; HU XT, 1990, J NEUROSCI, V10, P2318; Khan ZU, 2000, NEUROSCIENCE, V100, P689, DOI 10.1016/S0306-4522(00)00274-8; Kundakovic M, 2009, MOL PHARMACOL, V75, P342, DOI 10.1124/mol.108.051763; Lee SP, 2004, J BIOL CHEM, V279, P35671, DOI 10.1074/jbc.M401923200; LESTER J, 1993, BRAIN RES, V621, P106, DOI 10.1016/0006-8993(93)90303-5; Levivier M, 1995, J NEUROSCI, V15, P7810, DOI 10.1523/jneurosci.15-12-07810.1995; MEADORWOODRUFF JH, 1991, NEUROPSYCHOPHARMACOL, V5, P231; Moechars D, 2006, J NEUROSCI, V26, P12055, DOI 10.1523/JNEUROSCI.2556-06.2006; Novak G, 2010, SYNAPSE, V64, P794, DOI 10.1002/syn.20786; Perreault ML, 2010, J BIOL CHEM, V285, P36625, DOI 10.1074/jbc.M110.159954; Pillai A, 2008, SCHIZOPHR RES, V100, P325, DOI 10.1016/j.schres.2007.11.030; Rashid AJ, 2007, P NATL ACAD SCI USA, V104, P654, DOI 10.1073/pnas.0604049104; SHULTS CW, 1995, NEUROREPORT, V6, P1109, DOI 10.1097/00001756-199505300-00009; Surmeier DJ, 1996, J NEUROSCI, V16, P6579, DOI 10.1523/jneurosci.16-20-06579.1996; TSUKAHARA T, 1995, NEUROSURGERY, V37, P733, DOI 10.1227/00006123-199510000-00018; TSUKAHARA T, 1995, NEUROSURGERY, V37, P739; Uchida T, 2005, METHOD FIND EXP CLIN, V27, P31, DOI 10.1358/mf.2005.27.1.875434; Veldic M, 2007, SCHIZOPHR RES, V91, P51, DOI 10.1016/j.schres.2006.11.029; Verma V, 2010, J BIOL CHEM, V285, P35092, DOI 10.1074/jbc.M109.088625; WALTERS JR, 1987, SCIENCE, V236, P719; Wang HB, 2006, J CHEM NEUROANAT, V31, P178, DOI 10.1016/j.jchemneu.2006.01.003; WHITE FJ, 1988, PHARMACOL BIOCHEM BE, V30, P189, DOI 10.1016/0091-3057(88)90442-X; WHITE LE, 1994, J COMP NEUROL, V339, P328, DOI 10.1002/cne.903390303; Wilson NR, 2005, J NEUROSCI, V25, P6221, DOI 10.1523/JNEUROSCI.3003-04.2005; Zhang H, 2007, NEUROPHARMACOLOGY, V53, P125, DOI 10.1016/j.neuropharm.2007.04.004; Zhang XH, 2009, J NEUROSCI, V29, P7766, DOI 10.1523/JNEUROSCI.0389-09.2009; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	50	46	49	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33348	10.1371/journal.pone.0033348	http://dx.doi.org/10.1371/journal.pone.0033348			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22428025	gold, Green Submitted, Green Published			2022-12-25	WOS:000302381500129
J	Stuck, MW; Conley, SM; Naash, MI				Stuck, Michael W.; Conley, Shannon M.; Naash, Muna I.			Defects in the Outer Limiting Membrane Are Associated with Rosette Development in the Nrl(-/-) Retina	PLOS ONE			English	Article							NUCLEAR RECEPTOR NR2E3; CONE-ROD DYSTROPHY; MOUSE RETINA; MAMMALIAN RETINA; CRUMBS HOMOLOG-1; TRANSGENIC MICE; PHOTORECEPTOR DEVELOPMENT; TRANSCRIPTION FACTOR; RAT RETINA; FACTOR NRL	The neural retinal leucine zipper (Nrl) knockout mouse is a widely used model to study cone photoreceptor development, physiology, and molecular biology in the absence of rods. In the Nrl(-/-) retina, rods are converted into functional cone-like cells. The Nrl(-/-) retina is characterized by large undulations of the outer nuclear layer (ONL) commonly known as rosettes. Here we explore the mechanism of rosette development in the Nrl(-/-) retina. We report that rosettes first appear at postnatal day (P)8, and that the structure of nascent rosettes is morphologically distinct from what is seen in the adult retina. The lumen of these nascent rosettes contains a population of aberrant cells protruding into the subretinal space that induce infolding of the ONL. Morphologically adult rosettes do not contain any cell bodies and are first detected at P15. The cells found in nascent rosettes are photoreceptors in origin but lack inner and outer segments. We show that the adherens junctions between photoreceptors and Muller glia which comprise the retinal outer limiting membrane (OLM) are not uniformly formed in the Nrl(-/-) retina and thus allow protrusion of a population of developing photoreceptors into the subretinal space where their maturation becomes delayed. These data suggest that the rosettes of the Nrl(-/-) retina arise due to defects in the OLM and delayed maturation of a subset of photoreceptors, and that rods may play an important role in the proper formation of the OLM.	[Stuck, Michael W.; Conley, Shannon M.; Naash, Muna I.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73190 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Stuck, MW (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73190 USA.	muna-naash@ouhsc.edu			National Institutes of Health [EY10609, EY018656, EY018512]; Core Grant for Vision Research [EY12190]; Foundation Fighting Blindness; NATIONAL EYE INSTITUTE [F32EY018512, R01EY018656, R55EY010609, R01EY010609, R56EY010609, P30EY012190] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Core Grant for Vision Research; Foundation Fighting Blindness(European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants from the National Institutes of Health [EY10609 (MIN), EY018656 (MIN), and EY018512 (SMC)], Core Grant for Vision Research EY12190, and the Foundation Fighting Blindness (MIN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Brown BM, 2010, INVEST OPHTH VIS SCI, V51, P2372, DOI 10.1167/iovs.09-4895; Cai X, 2010, FASEB J, V24, P1178, DOI 10.1096/fj.09-139147; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P263, DOI 10.1002/cne.901880205; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Chakraborty D, 2010, HUM MOL GENET, V19, P4799, DOI 10.1093/hmg/ddq410; Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3; Cheng H, 2011, HUM MOL GENET, V20, P4102, DOI 10.1093/hmg/ddr334; Chuang JZ, 2010, MOL BIOL CELL, V21, P3017, DOI 10.1091/mbc.E09-10-0907; Daniele LL, 2005, INVEST OPHTH VIS SCI, V46, P2156, DOI 10.1167/iovs.04-1427; den Hollander AI, 1999, NAT GENET, V23, P217, DOI 10.1038/13848; den Hollander AI, 2001, AM J HUM GENET, V69, P198; Ding XQ, 2004, HUM MOL GENET, V13, P2075, DOI 10.1093/hmg/ddh211; Farjo R, 2006, J CELL BIOL, V173, P59, DOI 10.1083/jcb.200509036; Farjo R, 2007, J COMP NEUROL, V504, P619, DOI 10.1002/cne.21476; Freund CL, 1997, CELL, V91, P543, DOI 10.1016/S0092-8674(00)80440-7; Furukawa T, 1999, NAT GENET, V23, P466, DOI 10.1038/70591; Gosens I, 2008, EXP EYE RES, V86, P713, DOI 10.1016/j.exer.2008.02.005; Haider NB, 2001, HUM MOL GENET, V10, P1619, DOI 10.1093/hmg/10.16.1619; Koike C, 2007, MOL CELL BIOL, V27, P8318, DOI 10.1128/MCB.01209-07; Li J, 2002, INVEST OPHTH VIS SCI, V43, P573; McGinnis JF, 1999, J NEUROSCI RES, V55, P252, DOI 10.1002/(SICI)1097-4547(19990115)55:2<252::AID-JNR13>3.0.CO;2-N; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Mehalow AK, 2003, HUM MOL GENET, V12, P2179, DOI 10.1093/hmg/ddg232; Meuleman J, 2004, BIOCHEM SOC T, V32, P828, DOI 10.1042/BST0320828; NAASH MI, 1993, P NATL ACAD SCI USA, V90, P5499, DOI 10.1073/pnas.90.12.5499; Nagelhus EA, 1998, J NEUROSCI, V18, P2506; Nikonov SS, 2008, NEURON, V59, P462, DOI 10.1016/j.neuron.2008.06.011; Oh ECT, 2008, BRAIN RES, V1236, P16, DOI 10.1016/j.brainres.2008.01.028; Oh ECT, 2007, P NATL ACAD SCI USA, V104, P1679, DOI 10.1073/pnas.0605934104; Omori Y, 2006, CURR BIOL, V16, P945, DOI 10.1016/j.cub.2006.03.058; RICH KA, 1995, EXP EYE RES, V61, P235, DOI 10.1016/S0014-4835(05)80043-0; Roger JE, 2012, J NEUROSCI, V32, P528, DOI 10.1523/JNEUROSCI.3591-11.2012; Swaroop A, 2010, NAT REV NEUROSCI, V11, P563, DOI 10.1038/nrn2880; van de Pavert SA, 2004, J CELL SCI, V117, P4169, DOI 10.1242/jcs.01301; West EL, 2008, EXP EYE RES, V86, P601, DOI 10.1016/j.exer.2008.01.004; Wright AF, 2010, NAT REV GENET, V11, P273, DOI 10.1038/nrg2717; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215; Zhu XM, 2003, J NEUROSCI, V23, P6152, DOI 10.1523/JNEUROSCI.23-14-06152.2003; Zhu XM, 2002, MOL VIS, V8, P462	40	35	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e32484	10.1371/journal.pone.0032484	http://dx.doi.org/10.1371/journal.pone.0032484			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427845	Green Submitted, gold, Green Published			2022-12-25	WOS:000302381500021
J	Krenek, S; Petzoldt, T; Berendonk, TU				Krenek, Sascha; Petzoldt, Thomas; Berendonk, Thomas U.			Coping with Temperature at the Warm Edge - Patterns of Thermal Adaptation in the Microbial Eukaryote Paramecium caudatum	PLOS ONE			English	Article							EVOLUTIONARY ADAPTATION; CLIMATE-CHANGE; DROSOPHILA-MELANOGASTER; GENETIC-VARIATION; ESCHERICHIA-COLI; MOUNTAIN PASSES; RAPOPORTS RULE; TRADE-OFFS; TOLERANCE; IMPACTS	Background: Ectothermic organisms are thought to be severely affected by global warming since their physiological performance is directly dependent on temperature. Latitudinal and temporal variations in mean temperatures force ectotherms to adapt to these complex environmental conditions. Studies investigating current patterns of thermal adaptation among populations of different latitudes allow a prediction of the potential impact of prospective increases in environmental temperatures on their fitness. Methodology/Principal Findings: In this study, temperature reaction norms were ascertained among 18 genetically defined, natural clones of the microbial eukaryote Paramecium caudatum. These different clones have been isolated from 12 freshwater habitats along a latitudinal transect in Europe and from 3 tropical habitats (Indonesia). The sensitivity to increasing temperatures was estimated through the analysis of clone specific thermal tolerances and by relating those to current and predicted temperature data of their natural habitats. All investigated European clones seem to be thermal generalists with a broad thermal tolerance and similar optimum temperatures. The weak or missing co-variation of thermal tolerance with latitude does not imply local adaptation to thermal gradients; it rather suggests adaptive phenotypic plasticity among the whole European subpopulation. The tested Indonesian clones appear to be locally adapted to the less variable, tropical temperature regime and show higher tolerance limits, but lower tolerance breadths. Conclusions/Significance: Due to the lack of local temperature adaptation within the European subpopulation, P. caudatum genotypes at the most southern edge of their geographic range seem to suffer from the predicted increase in magnitude and frequency of summer heat waves caused by climate change.	[Krenek, Sascha; Petzoldt, Thomas; Berendonk, Thomas U.] Tech Univ Dresden, Inst Hydrobiol, D-01062 Dresden, Germany; [Krenek, Sascha; Berendonk, Thomas U.] Univ Leipzig, Inst Biol, Leipzig, Germany	Technische Universitat Dresden; Leipzig University	Krenek, S (corresponding author), Tech Univ Dresden, Inst Hydrobiol, D-01062 Dresden, Germany.	Sascha.Krenek@TU-Dresden.de	Krenek, Sascha/M-7294-2015; Petzoldt, Thomas U/C-6198-2009	Krenek, Sascha/0000-0002-5062-4140; Petzoldt, Thomas U/0000-0002-4951-6468	German Research Foundation (DFG) [BE 2299/3-3, SPP 1162]; DFG [BE 2299/5-1]	German Research Foundation (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	This study was supported by grant BE 2299/3-3 within the German Research Foundation (DFG) priority programme "Aquashift'' (SPP 1162) and in part by grant BE 2299/5-1 within the DFG priority programme "Host-Parasite Coevolution - Rapid Reciprocal Adaptation and its Genetic Basis'' (SPP 1399). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo-Bediako A, 2000, P ROY SOC B-BIOL SCI, V267, P739, DOI 10.1098/rspb.2000.1065; Anderson AR, 2005, GENET RES, V85, P15, DOI 10.1017/S0016672304007281; Andrushchyshyn OP, 2009, GLOBAL CHANGE BIOL, V15, P2518, DOI 10.1111/j.1365-2486.2009.01911.x; Angilletta MJ, 2002, J THERM BIOL, V27, P199, DOI 10.1016/S0306-4565(01)00084-5; Bailey MJ, 1995, MOL ECOL, V4, P755, DOI 10.1111/j.1365-294X.1995.tb00276.x; Barriopedro D, 2011, SCIENCE, V332, P220, DOI 10.1126/science.1201224; Barth D, 2006, J EUKARYOT MICROBIOL, V53, P20, DOI 10.1111/j.1550-7408.2005.00068.x; Bennett A.F., 1996, ANIMALS TEMPERATURE; Bennett A.F., 1987, COMP PHYSL LIFE WATE; BENNETT AF, 1992, EVOLUTION, V46, P16, DOI 10.1111/j.1558-5646.1992.tb01981.x; BENNETT AF, 1993, EVOLUTION, V47, P1, DOI 10.1111/j.1558-5646.1993.tb01194.x; Bolstad PV, 1997, ECOL MODEL, V94, P287, DOI 10.1016/S0304-3800(96)00021-X; Bonebrake TC, 2010, P NATL ACAD SCI USA, V107, P12581, DOI 10.1073/pnas.0911841107; BOUCHER P, 1984, HYDROBIOLOGIA, V119, P149, DOI 10.1007/BF00011954; Bouin P. A., 1897, ARCH ANAT MICROSC, V1, P225; Bryant SR, 2002, ECOL ENTOMOL, V27, P424, DOI 10.1046/j.1365-2311.2002.00422.x; Buckley LB, 2008, AM NAT, V171, pE1, DOI 10.1086/523949; Carriere Y, 2001, AM NAT, V157, P570, DOI 10.1086/319931; Christoffersen K, 2006, HYDROBIOLOGIA, V560, P259, DOI 10.1007/s10750-005-1221-2; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Cooper BS, 2008, J THERM BIOL, V33, P320, DOI 10.1016/j.jtherbio.2008.04.001; Cossins A. R., 1987, Temperature biology of animals.; Danks HV, 2006, CAN ENTOMOL, V138, P1; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Dillon ME, 2010, NATURE, V467, P704, DOI 10.1038/nature09407; Dobzhansky T., 1950, American Scientist, V38, P209; Edgerly JS, 2005, FUNCT ECOL, V19, P255, DOI 10.1111/j.1365-2435.2005.00957.x; Efron B, 1994, INTRO BOOTSTRAP; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; ELLIOTT JM, 1994, FRESHWATER BIOL, V32, P593, DOI 10.1111/j.1365-2427.1994.tb01150.x; Foissner W, 1999, AGR ECOSYST ENVIRON, V74, P95, DOI 10.1016/S0167-8809(99)00032-8; Fox JW, 2001, J ANIM ECOL, V70, P80; Frazier MR, 2006, AM NAT, V168, P512, DOI 10.1086/506977; FROST TM, 1995, LINKING SPECIES & ECOSYSTEMS, P224; Gaston KJ, 1999, OIKOS, V84, P309, DOI 10.2307/3546727; Ghalambor CK, 2007, FUNCT ECOL, V21, P394, DOI 10.1111/j.1365-2435.2007.01283.x; Ghalambor CK, 2006, INTEGR COMP BIOL, V46, P5, DOI 10.1093/icb/icj003; Gibert P, 2001, PHYSIOL BIOCHEM ZOOL, V74, P429, DOI 10.1086/320429; Gilchrist GW, 1996, EVOLUTION, V50, P1560, DOI [10.2307/2410892, 10.1111/j.1558-5646.1996.tb03928.x]; Govindasamy B, 2003, CLIM DYNAM, V21, P391, DOI 10.1007/s00382-003-0340-6; Guerra D, 1997, GENET SEL EVOL, V29, P497, DOI 10.1051/gse:19970406; Hamilton W.J., 1973, LIFES COLOR CODE; Harmon JP, 2009, SCIENCE, V323, P1347, DOI 10.1126/science.1167396; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Helmuth B, 2005, ANNU REV PHYSIOL, V67, P177, DOI 10.1146/annurev.physiol.67.040403.105027; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoffmann AA, 2003, J THERM BIOL, V28, P175, DOI 10.1016/S0306-4565(02)00057-8; Houghton JT, 1990, SCI ASSESSMENT CLIMA; HUEY RB, 1984, EVOLUTION, V38, P441, DOI 10.1111/j.1558-5646.1984.tb00302.x; HUEY RB, 1989, TRENDS ECOL EVOL, V4, P131, DOI 10.1016/0169-5347(89)90211-5; International Panel on Climate Change (IPCC), 2007, CLIM CHANG 2007 4 AS; Irwin JT, 2003, OIKOS, V100, P71, DOI 10.1034/j.1600-0706.2003.11738.x; Jackson MW, 2004, MOL ECOL, V13, P3609, DOI 10.1111/j.1365-294X.2004.02343.x; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; Jessup CM, 2004, TRENDS ECOL EVOL, V19, P189, DOI 10.1016/j.tree.2004.01.008; Jump AS, 2009, TRENDS ECOL EVOL, V24, P694, DOI 10.1016/j.tree.2009.06.007; Kearney M, 2009, P NATL ACAD SCI USA, V106, P3835, DOI 10.1073/pnas.0808913106; KIMURA MT, 1994, J NAT HIST, V28, P401, DOI 10.1080/00222939400770181; Knies JL, 2009, AM NAT, V173, P419, DOI 10.1086/597224; Krenek S, 2011, EUR J PROTISTOL, V47, P124, DOI 10.1016/j.ejop.2010.12.001; Kristensen TN, 2008, P NATL ACAD SCI USA, V105, P216, DOI 10.1073/pnas.0708074105; LACTIN DJ, 1995, ENVIRON ENTOMOL, V24, P68, DOI 10.1093/ee/24.1.68; Legendre P, 1998, NUMERICAL ECOLOGY; LEROI AM, 1994, EVOLUTION, V48, P1222, DOI 10.1111/j.1558-5646.1994.tb05307.x; LETCHER AJ, 1994, AM NAT, V144, P30, DOI 10.1086/285659; Levins R., 1968, EVOLUTION CHANGING E; Little C, 1990, TERRESTRIAL INVASION; Livingstone DM, 1998, J PALEOLIMNOL, V19, P181, DOI 10.1023/A:1007904817619; LIVINGSTONE DM, 1993, PROC INT ASSOC THEOR, V25, P75; MANTEL N, 1967, CANCER RES, V27, P209; Norf H, 2007, OECOLOGIA, V151, P341, DOI 10.1007/s00442-006-0545-6; Norf H, 2010, FEMS MICROBIOL ECOL, V74, P361, DOI 10.1111/j.1574-6941.2010.00948.x; Oksanen J., 2011, VEGAN COMMUNITY ECOL; Parmesan C, 2000, B AM METEOROL SOC, V81, P443, DOI 10.1175/1520-0477(2000)081<0443:IOEWAC>2.3.CO;2; Petchey OL, 1999, NATURE, V402, P69, DOI 10.1038/47023; Pinheiro J, 2008, R PACKAGE VERSION, V57, P1; Pinheiro J, 2000, MIXED EFFECTS MODELS; Portner HO, 2006, PHYSIOL BIOCHEM ZOOL, V79, P295, DOI 10.1086/499986; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; R Core Team, 2021, R LANG ENV STAT COMP; Raisanen J, 2002, J CLIMATE, V15, P2395, DOI 10.1175/1520-0442(2002)015<2395:CICIIT>2.0.CO;2; Savage VM, 2004, AM NAT, V163, P429, DOI 10.1086/381872; Schar C, 2004, NATURE, V427, P332, DOI 10.1038/nature02300; Sherr EB, 2002, ANTON LEEUW INT J G, V81, P293, DOI 10.1023/A:1020591307260; Sinclair BJ, 2001, OIKOS, V93, P286, DOI 10.1034/j.1600-0706.2001.930211.x; Sonneborn T. M., 1970, Methods Cell Physiol., V4, P241, DOI 10.1016/S0091-679X(08)61758-6; Sorensen JG, 2001, FUNCT ECOL, V15, P289, DOI 10.1046/j.1365-2435.2001.00525.x; Stevens GC, 1996, J BIOGEOGR, V23, P149, DOI 10.1046/j.1365-2699.1996.00977.x; Sunday JM, 2011, P ROY SOC B-BIOL SCI, V278, P1823, DOI 10.1098/rspb.2010.1295; Terblanche JS, 2007, P ROY SOC B-BIOL SCI, V274, P2935, DOI 10.1098/rspb.2007.0985; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; Wang H, 2011, METAANALYSIS ECOLOGY, V14, P419; Williams JW, 2007, P NATL ACAD SCI USA, V104, P5738, DOI 10.1073/pnas.0606292104	93	32	32	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2012	7	3							e30598	10.1371/journal.pone.0030598	http://dx.doi.org/10.1371/journal.pone.0030598			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KX	22427799	gold, Green Published, Green Submitted			2022-12-25	WOS:000303062800001
J	Zhao, N; Liu, H; Lilly, B				Zhao, Ning; Liu, Hua; Lilly, Brenda			Reciprocal Regulation of Syndecan-2 and Notch Signaling in Vascular Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROVASCULAR ENDOTHELIAL-CELLS; GENE-EXPRESSION; GROWTH-FACTOR; ANGIOGENESIS; MIGRATION; MICE; PHYSIOLOGY; MUTATION; DEFECTS; PATHWAY	Vascular cell interactions mediated through cell surface receptors play a critical role in the assembly and maintenance of blood vessels. These signaling interactions transmit important information that alters cell function through changes in protein dynamics and gene expression. Here, we identify syndecan-2 (SDC2) as a gene whose expression is induced in smooth muscle cells upon physical contact with endothelial cells. Syndecan-2 is a heparan sulfate proteoglycan that is known to be important for developmental processes, including angiogenesis. Our results show that endothelial cells induce mRNA expression of syndecan-2 in smooth muscle cells by activating Notch receptor signaling. Both NOTCH2 and NOTCH3 contribute to the increased expression of syndecan-2 and are themselves sufficient to promote its expression independent of endothelial cells. Syndecan family members serve as coreceptors for signaling molecules, and interestingly, our data show that syndecan-2 regulates Notch signaling and physically interacts with NOTCH3. Notch activity is attenuated in smooth muscle cells made deficient in syndecan-2, and this specifically prevents expression of the differentiation marker smooth muscle alpha-actin. These results show a novel mechanism in which Notch receptors control their own activity by inducing the expression of syndecan-2, which then acts to propagate Notch signaling by direct receptor interaction.	[Zhao, Ning; Lilly, Brenda] Ohio State Univ, Nationwide Childrens Hosp, Ctr Cardiovasc & Pulm Res, Columbus, OH 43205 USA; [Zhao, Ning; Lilly, Brenda] Ohio State Univ, Dept Pediat, Columbus, OH 43205 USA; [Liu, Hua] Med Coll Georgia, Vasc Biol Ctr, Augusta, GA 30912 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University System of Georgia; Augusta University	Lilly, B (corresponding author), Nationwide Childrens Hosp Res Inst, 700 Childrens Dr, Columbus, OH 43205 USA.	brenda.lilly@nationwidechildrens.org	LILLY, BRENDA/N-6867-2015	LILLY, BRENDA/0000-0002-3125-7496; Zhao, Ning/0000-0001-6514-234X	National Institutes of Health [R01 HL076428]; Nationwide Children's Hospital; American Heart Association [09PRE2220351]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076428] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nationwide Children's Hospital(Ohio State University); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL076428 (to B. L.). This work was also supported by Nationwide Children's Hospital funds (to B. L.) and American Heart Association Predoctoral Fellowship 09PRE2220351 (to H. L.).	Alexopoulou AN, 2007, INT J BIOCHEM CELL B, V39, P505, DOI 10.1016/j.biocel.2006.10.014; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Arrington CB, 2009, DEVELOPMENT, V136, P3143, DOI 10.1242/dev.031492; Baron M, 2003, SEMIN CELL DEV BIOL, V14, P113, DOI 10.1016/S1084-9521(02)00179-9; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Brouillard P, 2003, CLIN GENET, V63, P340, DOI 10.1034/j.1399-0004.2003.00092.x; Chen E, 2004, BLOOD, V103, P1710, DOI 10.1182/blood-2003-06-1783; Chen LG, 2004, J BIOL CHEM, V279, P15715, DOI 10.1074/jbc.C300430200; Choi S, 2009, BIOCHEM BIOPH RES CO, V384, P231, DOI 10.1016/j.bbrc.2009.04.093; CizmeciSmith G, 1997, ARTERIOSCL THROM VAS, V17, P172, DOI 10.1161/01.ATV.17.1.172; Couchman JR, 2010, ANNU REV CELL DEV BI, V26, P89, DOI 10.1146/annurev-cellbio-100109-104126; Domenga V, 2004, GENE DEV, V18, P2730, DOI 10.1101/gad.308904; Essner JJ, 2006, INT J BIOCHEM CELL B, V38, P152, DOI 10.1016/j.biocel.2005.08.012; Fears CY, 2006, J BIOL CHEM, V281, P14533, DOI 10.1074/jbc.C600075200; Fischer A, 2007, NUCLEIC ACIDS RES, V35, P4583, DOI 10.1093/nar/gkm477; Fukai N, 2009, ARTERIOSCL THROM VAS, V29, P1356, DOI 10.1161/ATVBAHA.109.190132; Gaengel K, 2009, ARTERIOSCL THROM VAS, V29, P630, DOI 10.1161/ATVBAHA.107.161521; Granes F, 1999, EXP CELL RES, V248, P439, DOI 10.1006/excr.1999.4437; Gridley T, 2007, DEVELOPMENT, V134, P2709, DOI 10.1242/dev.004184; Gridley T, 2010, CURR TOP DEV BIOL, V92, P277, DOI 10.1016/S0070-2153(10)92009-7; Halden Y, 2004, BIOCHEM J, V377, P533, DOI 10.1042/BJ20030729; High FA, 2008, P NATL ACAD SCI USA, V105, P1955, DOI 10.1073/pnas.0709663105; Ikesue M, 2011, ARTERIOSCL THROM VAS, V31, P1066, DOI 10.1161/ATVBAHA.110.217703; Kennard S, 2008, J BIOL CHEM, V283, P1324, DOI 10.1074/jbc.M706651200; Kramer KL, 2002, DEV CELL, V2, P115, DOI 10.1016/S1534-5807(01)00107-1; Krebs LT, 2003, GENESIS, V37, P139, DOI 10.1002/gene.10241; Li YX, 2009, CIRCULATION, V119, P2686, DOI 10.1161/CIRCULATIONAHA.108.790485; Lilly B, 2009, PHYSIOL GENOMICS, V36, P69, DOI 10.1152/physiolgenomics.90318.2008; Liu H, 2010, CIRC RES, V107, P860, DOI 10.1161/CIRCRESAHA.110.218271; Liu H, 2009, CIRC RES, V104, P466, DOI 10.1161/CIRCRESAHA.108.184846; McCright B, 2001, DEVELOPMENT, V128, P491; Mombouli JV, 1999, J MOL CELL CARDIOL, V31, P61, DOI 10.1006/jmcc.1998.0844; Morrow D, 2008, CIRC RES, V103, P1370, DOI 10.1161/CIRCRESAHA.108.187534; Noguer O, 2009, EXP CELL RES, V315, P795, DOI 10.1016/j.yexcr.2008.11.016; Pisconti A, 2010, J CELL BIOL, V190, P427, DOI 10.1083/jcb.201003081; Rauch BH, 2005, J BIOL CHEM, V280, P17507, DOI 10.1074/jbc.M410848200; Tkachenko E, 2005, CIRC RES, V96, P488, DOI 10.1161/01.RES.0000159708.71142.c8; Varadkar PA, 2009, GENESIS, V47, P573, DOI 10.1002/dvg.20537; Weng AP, 2003, MOL CELL BIOL, V23, P655, DOI 10.1128/MCB.23.2.655-664.2003	39	23	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16111	16120		10.1074/jbc.M111.322107	http://dx.doi.org/10.1074/jbc.M111.322107			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22437834	hybrid, Green Published			2022-12-25	WOS:000304030900004
J	Aghazadeh, Y; Rone, MB; Blonder, J; Ye, XY; Veenstra, TD; Hales, DB; Culty, M; Papadopoulos, V				Aghazadeh, Yasaman; Rone, Malena B.; Blonder, Josip; Ye, Xiaoying; Veenstra, Timothy D.; Hales, D. Buck; Culty, Martine; Papadopoulos, Vassilios			Hormone-induced 14-3-3 gamma Adaptor Protein Regulates Steroidogenic Acute Regulatory Protein Activity and Steroid Biosynthesis in MA-10 Leydig Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BENZODIAZEPINE RECEPTOR; MITOCHONDRIAL PROTEIN; CHOLESTEROL-BINDING; ADRENAL-CORTEX; TUMOR-CELLS; STAR ACTS; KINASE-C; PHOSPHORYLATION; EXPRESSION; MECHANISM	Cholesterol is the sole precursor of steroid hormones in the body. The import of cholesterol to the inner mitochondrial membrane, the rate-limiting step in steroid biosynthesis, relies on the formation of a protein complex that assembles at the outer mitochondrial membrane called the transduceosome. The transduceosome contains several mitochondrial and cytosolic components, including the steroidogenic acute regulatory protein (STAR). Human chorionic gonadotropin (hCG) induces de novo synthesis of STAR, a process shown to parallel maximal steroid production. In the hCG-dependent steroidogenic MA-10 mouse Leydig cell line, the 14-3-3 gamma protein was identified in native mitochondrial complexes by mass spectrometry and immunoblotting, and its levels increased in response to hCG treatment. The 14-3-3 proteins bind and regulate the activity of many proteins, acting via target protein activation, modification and localization. In MA-10 cells, cAMPinduces 14-3-3 gamma expression parallel to STAR expression. Silencing of 14-3-3 gamma expression potentiates hormone-induced steroidogenesis. Binding motifs of 14-3-3 gamma were identified in components of the transduceosome, including STAR. Immunoprecipitation studies demonstrate a hormone-dependent interaction between 14-3-3 gamma and STAR that coincides with reduced 14-3-3 gamma homodimerization. The binding site of 14-3-3 gamma on STAR was identified to be Ser-194 in the STAR-related sterol binding lipid transfer (START) domain, the site phosphorylated in response to hCG. Taken together, these results demonstrate that 14-3-3 gamma negatively regulates steroidogenesis by binding to Ser-194 of STAR, thus keeping STAR in an unfolded state, unable to induce maximal steroidogenesis. Over time 14-3-3 gamma homodimerizes and dissociates from STAR, allowing this protein to induce maximal mitochondrial steroid formation.	[Aghazadeh, Yasaman; Rone, Malena B.; Culty, Martine; Papadopoulos, Vassilios] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ H3G 1A4, Canada; [Aghazadeh, Yasaman; Rone, Malena B.; Culty, Martine; Papadopoulos, Vassilios] McGill Univ, Dept Med, Montreal, PQ H3G 1A4, Canada; [Culty, Martine; Papadopoulos, Vassilios] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1A4, Canada; [Papadopoulos, Vassilios] McGill Univ, Dept Biochem, Montreal, PQ H3G 1A4, Canada; [Blonder, Josip; Ye, Xiaoying; Veenstra, Timothy D.] NCI, Lab Prote & Analyt Technol, Adv Technol Program, SAIC Frederick Inc,NIH, Frederick, MD 21702 USA; [Hales, D. Buck] So Illinois Univ, Sch Med, Dept Physiol, Carbondale, IL 62901 USA	McGill University; McGill University; McGill University; McGill University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Southern Illinois University System; Southern Illinois University	Papadopoulos, V (corresponding author), McGill Univ, Ctr Hlth, Res Inst, 1650 Cedar Ave,C10-148, Montreal, PQ H3G 1A4, Canada.	vassilios.papadopoulos@mcgill.ca	Papadopoulos, Vassilios/AAI-2613-2019	Papadopoulos, Vassilios/0000-0002-1183-8568	Canadian Institutes of Health Research [MOP102647]; Canada Research Chair in Biochemical Pharmacology; Le Fonds de la Recherche du Quebec-Sante; Research Institute of McGill University Health Centre	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Biochemical Pharmacology; Le Fonds de la Recherche du Quebec-Sante; Research Institute of McGill University Health Centre	This work was supported by Canadian Institutes of Health Research Grant MOP102647 and a Canada Research Chair in Biochemical Pharmacology (to V. P.). The Research Institute of McGill University Health Centre was supported by a Center grant from Le Fonds de la Recherche du Quebec-Sante.; Supported in part by a predoctoral fellowship from the Research Institute of McGill University Health Centre.; Supported in part by a postdoctoral fellowship from the Research Institute of McGill University Health Centre.	Aitken A, 2002, BIOCHEM SOC T, V30, P351, DOI 10.1042/bst0300351; Aitken A, 2002, PLANT MOL BIOL, V50, P993, DOI 10.1023/A:1021261931561; Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; ALAM R, 1994, J BIOCHEM-TOKYO, V116, P416, DOI 10.1093/oxfordjournals.jbchem.a124541; Alpy F, 2005, J CELL SCI, V118, P2791, DOI 10.1242/jcs.02485; Arakane F, 1997, J BIOL CHEM, V272, P32656, DOI 10.1074/jbc.272.51.32656; Arakane F, 1996, P NATL ACAD SCI USA, V93, P13731, DOI 10.1073/pnas.93.24.13731; Arakane F, 1998, J BIOL CHEM, V273, P16339, DOI 10.1074/jbc.273.26.16339; Arakane F, 1998, ENDOCR RES, V24, P463, DOI 10.3109/07435809809032634; Baker BY, 2005, J BIOL CHEM, V280, P41753, DOI 10.1074/jbc.M510241200; BAKKER GH, 1983, MOL CELL ENDOCRINOL, V33, P243, DOI 10.1016/0303-7207(83)90170-3; Bose HS, 1999, P NATL ACAD SCI USA, V96, P7250, DOI 10.1073/pnas.96.13.7250; Bose HS, 2002, NATURE, V417, P87, DOI 10.1038/417087a; Bose M, 2008, J BIOL CHEM, V283, P8837, DOI 10.1074/jbc.M709221200; Bridges Dave, 2004, Sci STKE, V2004, pre10, DOI 10.1126/stke.2422004re10; BROWN AS, 1992, MOL CELL ENDOCRINOL, V83, P1, DOI 10.1016/0303-7207(92)90189-D; CLARK BJ, 1995, MOL ENDOCRINOL, V9, P1346, DOI 10.1210/me.9.10.1346; CLARK BJ, 1994, J BIOL CHEM, V269, P28314; Dalal SN, 1999, MOL CELL BIOL, V19, P4465; Dyson MT, 2008, BIOL REPROD, V78, P267, DOI 10.1095/biolreprod.107.064238; Eilers AL, 2002, MOL CELL BIOL, V22, P8514, DOI 10.1128/MCB.22.24.8514-8526.2002; EPSTEIN LF, 1991, J BIOL CHEM, V266, P19739; Fleury A, 2004, J STEROID BIOCHEM, V91, P259, DOI 10.1016/j.jsbmb.2004.04.010; Ganguly S, 2005, P NATL ACAD SCI USA, V102, P1222, DOI 10.1073/pnas.0406871102; HACHIYA N, 1994, EMBO J, V13, P5146, DOI 10.1002/j.1460-2075.1994.tb06844.x; HACHIYA N, 1995, NATURE, V376, P705, DOI 10.1038/376705a0; HACHIYA N, 1993, EMBO J, V12, P1579, DOI 10.1002/j.1460-2075.1993.tb05802.x; Hansson V, 1999, J STEROID BIOCHEM, V69, P367, DOI 10.1016/S0960-0760(99)00077-1; HARTUNG S, 1995, BIOCHEM BIOPH RES CO, V215, P646, DOI 10.1006/bbrc.1995.2513; Hauet T, 2005, MOL ENDOCRINOL, V19, P540, DOI 10.1210/me.2004-0307; Hurley JH, 2000, CURR OPIN STRUC BIOL, V10, P737; Ichimura T, 1997, FEBS LETT, V413, P273, DOI 10.1016/S0014-5793(97)00910-1; Jefcoate C, 2002, J CLIN INVEST, V110, P881, DOI 10.1172/JCI200216771; Jo Y, 2005, BIOL REPROD, V73, P244, DOI 10.1095/biolreprod.104.037721; Johnson C, 2010, BIOCHEM J, V427, P69, DOI 10.1042/BJ20091834; Kallen CB, 1998, MOL CELL ENDOCRINOL, V145, P39, DOI 10.1016/S0303-7207(98)00167-1; Lee JH, 2011, J BIOL CHEM, V286, P5136, DOI 10.1074/jbc.M110.190470; Li H, 2001, MOL ENDOCRINOL, V15, P2211, DOI 10.1210/me.15.12.2211; Li H, 2001, P NATL ACAD SCI USA, V98, P1267, DOI 10.1073/pnas.031461598; LIN D, 1995, SCIENCE, V267, P1828, DOI 10.1126/science.7892608; LIU D, 1995, NATURE, V376, P191, DOI 10.1038/376191a0; Liu J, 2003, J STEROID BIOCHEM, V85, P275, DOI 10.1016/S0960-0760(03)00213-9; Liu J, 2006, J BIOL CHEM, V281, P38879, DOI 10.1074/jbc.M608820200; Liu MY, 2002, CANCER RES, V62, P6475; Manna PR, 2003, J MOL ENDOCRINOL, V30, P381, DOI 10.1677/jme.0.0300381; MARTENS GJM, 1992, BIOCHEM BIOPH RES CO, V184, P1456, DOI 10.1016/S0006-291X(05)80046-4; Mathieu AP, 2002, J MOL ENDOCRINOL, V29, P327, DOI 10.1677/jme.0.0290327; Mathieu AP, 2002, ENDOCR RES, V28, P419, DOI 10.1081/ERC-120016817; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Papadopoulos V, 2007, MOL CELL ENDOCRINOL, V265, P59, DOI 10.1016/j.mce.2006.12.004; PON LA, 1986, J BIOL CHEM, V261, P6594; Radhakrishnan VM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011433; Rittinger K, 1999, MOL CELL, V4, P153, DOI 10.1016/S1097-2765(00)80363-9; Rone MB, 2009, BIOCHEMISTRY-US, V48, P6909, DOI 10.1021/bi900854z; Rone MB, 2009, BBA-MOL CELL BIOL L, V1791, P646, DOI 10.1016/j.bbalip.2009.03.001; Rosenquist M, 2000, J MOL EVOL, V51, P446, DOI 10.1007/s002390010107; Shen YH, 2003, MOL BIOL CELL, V14, P4721, DOI 10.1091/mbc.E02-12-0821; Stocco DM, 1996, ENDOCR REV, V17, P221, DOI 10.1210/er.17.3.221; STOCCO DM, 1991, J BIOL CHEM, V266, P19731; SUGAWARA T, 1995, BIOCHEMISTRY-US, V34, P12506, DOI 10.1021/bi00039a004; TOKER A, 1992, EUR J BIOCHEM, V206, P453, DOI 10.1111/j.1432-1033.1992.tb16946.x; Tsujishita Y, 2000, NAT STRUCT BIOL, V7, P408; Tuckey RC, 2002, J BIOL CHEM, V277, P47123, DOI 10.1074/jbc.M206965200; Tzivion G, 2001, ONCOGENE, V20, P6331, DOI 10.1038/sj.onc.1204777; Xiao Bing, 1995, Nature (London), V376, P188, DOI 10.1038/376188a0; Yacoubian TA, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.4; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0	68	36	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15380	15394		10.1074/jbc.M112.339580	http://dx.doi.org/10.1074/jbc.M112.339580			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22427666	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000304006300020
J	Feng, SS; Knodler, A; Ren, JQ; Zhang, J; Zhang, XY; Hong, YJ; Huang, SH; Peranen, J; Guo, W				Feng, Shanshan; Knoedler, Andreas; Ren, Jinqi; Zhang, Jian; Zhang, Xiaoyu; Hong, Yujuan; Huang, Shaohui; Peranen, Johan; Guo, Wei			A Rab8 Guanine Nucleotide Exchange Factor-Effector Interaction Network Regulates Primary Ciliogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMARY CILIUM; CILIARY MEMBRANE; SECRETORY VESICLES; SIGNALING CENTER; EXOCYST COMPLEX; MDCK CELLS; GTPASE; SEC2P; TRANSPORT; PROTEIN	Primary cilia are microtubule-based solitary membrane projections on the cell surface that play important roles in signaling and development. Recent studies have demonstrated that polarized vesicular trafficking involving the small GTPase Rab8 and its guanine nucleotide exchange factor Rabin8 is essential for primary ciliogenesis. In this study, we show that a highly conserved region of Rabin8 is pivotal for its activation as a guanine nucleotide exchange factor for Rab8. In addition, in its activated conformation, Rabin8 interacts with Sec15, a subunit of the exocyst and downstream effector of Rab8. Expression of constitutively activated Rab8 promotes the association of Sec15 with Rabin8. Using immunofluorescence microscopy, we found that Sec15 co-localized with Rab8 along the primary cilium. Inhibition of Sec15 function in cells led to defects in primary ciliogenesis. The Rabin8-Rab8-Sec15 interaction may couple the activation of Rab8 to the recruitment of the Rab8 effector and is involved in the regulation of vesicular trafficking for primary cilium formation.	[Feng, Shanshan; Knoedler, Andreas; Ren, Jinqi; Zhang, Jian; Zhang, Xiaoyu; Hong, Yujuan; Guo, Wei] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Huang, Shaohui] Univ Penn, Sch Med, Inst Environm Med, Philadelphia, PA 19104 USA; [Huang, Shaohui] Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; [Peranen, Johan] Univ Helsinki, Inst Biotechnol, FIN-00014 Helsinki, Finland	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Helsinki	Guo, W (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	guowei@sas.upenn.edu	Ren, Jinqi/D-5545-2015; Zhang, xiaoyu/GXA-3206-2022; Shaohui Huang, Shaohui Huang Huang Shaohui/AAW-4531-2021; FENG, SHANSHAN/D-1344-2013	Ren, Jinqi/0000-0001-7461-0491; 	National Institutes of Health [R01 GM64690]; American Heart Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111128, R01GM064690] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM64690 and the American Heart Association (to W.G.).	Berbari NF, 2009, CURR BIOL, V19, pR526, DOI 10.1016/j.cub.2009.05.025; Bryant DM, 2010, NAT CELL BIOL, V12, P1035, DOI 10.1038/ncb2106; Das A, 2011, TRENDS CELL BIOL, V21, P383, DOI 10.1016/j.tcb.2011.03.006; Dong G, 2007, MOL CELL, V25, P455, DOI 10.1016/j.molcel.2007.01.013; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Guo W, 1999, EMBO J, V18, P1071, DOI 10.1093/emboj/18.4.1071; Guo W, 2000, TRENDS CELL BIOL, V10, P251, DOI 10.1016/S0962-8924(00)01754-2; Hattula K, 2005, METHOD ENZYMOL, V403, P284, DOI 10.1016/S0076-6879(05)03024-7; Hattula K, 2002, MOL BIOL CELL, V13, P3268, DOI 10.1091/mbc.E02-03-0143; He B, 2009, CURR OPIN CELL BIOL, V21, P537, DOI 10.1016/j.ceb.2009.04.007; Horiuchi H, 1997, CELL, V90, P1149, DOI 10.1016/S0092-8674(00)80380-3; Hsu SC, 2004, INT REV CYTOL, V233, P243, DOI 10.1016/S0074-7696(04)33006-8; Knodler A, 2010, P NATL ACAD SCI USA, V107, P6346, DOI 10.1073/pnas.1002401107; Lippe R, 2001, MOL BIOL CELL, V12, P2219, DOI 10.1091/mbc.12.7.2219; Marshall WF, 2008, J CELL BIOL, V180, P17, DOI 10.1083/jcb.200710085; Medkova M, 2006, MOL BIOL CELL, V17, P2757, DOI 10.1091/mbc.E05-10-0917; Mizuno-Yamasaki E, 2010, DEV CELL, V18, P828, DOI 10.1016/j.devcel.2010.03.016; Munson M, 2006, NAT STRUCT MOL BIOL, V13, P577, DOI 10.1038/nsmb1097; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nachury MV, 2010, ANNU REV CELL DEV BI, V26, P59, DOI 10.1146/annurev.cellbio.042308.113337; Ortiz D, 2002, J CELL BIOL, V157, P1005, DOI 10.1083/jcb.200201003; Overgaard CE, 2009, MOL BIOL CELL, V20, P102, DOI 10.1091/mbc.E08-07-0741; Oztan A, 2007, MOL BIOL CELL, V18, P3978, DOI 10.1091/mbc.E07-02-0097; Pazour GJ, 2008, CURR TOP DEV BIOL, V85, P115, DOI 10.1016/S0070-2153(08)00805-3; Peranen J, 2011, CYTOSKELETON, V68, P527, DOI 10.1002/cm.20529; Poteryaev D, 2010, CELL, V141, P497, DOI 10.1016/j.cell.2010.03.011; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Rogers KK, 2004, BIOCHEM BIOPH RES CO, V319, P138, DOI 10.1016/j.bbrc.2004.04.165; Roth D, 1998, MOL BIOL CELL, V9, P1725, DOI 10.1091/mbc.9.7.1725; SALMINEN A, 1989, J CELL BIOL, V109, P1023, DOI 10.1083/jcb.109.3.1023; Satir P, 2010, J CELL SCI, V123, P499, DOI 10.1242/jcs.050377; Sato Y, 2007, P NATL ACAD SCI USA, V104, P8305, DOI 10.1073/pnas.0701550104; Seals DF, 2000, P NATL ACAD SCI USA, V97, P9402, DOI 10.1073/pnas.97.17.9402; Vega IE, 2001, J NEUROSCI, V21, P3839, DOI 10.1523/JNEUROSCI.21-11-03839.2001; WalchSolimena C, 1997, J CELL BIOL, V137, P1495, DOI 10.1083/jcb.137.7.1495; Westlake CJ, 2011, P NATL ACAD SCI USA, V108, P2759, DOI 10.1073/pnas.1018823108; Whyte JRC, 2002, J CELL SCI, V115, P2627; Wu SY, 2005, NAT STRUCT MOL BIOL, V12, P879, DOI 10.1038/nsmb987; Wurmser AE, 2000, J CELL BIOL, V151, P551, DOI 10.1083/jcb.151.3.551; Yoshimura S, 2007, J CELL BIOL, V178, P363, DOI 10.1083/jcb.200703047; Zhang XM, 2004, J BIOL CHEM, V279, P43027, DOI 10.1074/jbc.M402264200; Zhu HP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009226; Zhu HP, 2009, MOL BIOL CELL, V20, P4720, DOI 10.1091/mbc.E09-06-0453; Zuo XF, 2009, MOL BIOL CELL, V20, P2522, DOI 10.1091/mbc.E08-07-0772	44	87	87	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15602	15609		10.1074/jbc.M111.333245	http://dx.doi.org/10.1074/jbc.M111.333245			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22433857	hybrid, Green Published			2022-12-25	WOS:000304006300040
J	Demontis, GC; Aruta, C; Comitato, A; De Marzo, A; Marigo, V				Demontis, Gian Carlo; Aruta, Claudia; Comitato, Antonella; De Marzo, Anna; Marigo, Valeria			Functional and Molecular Characterization of Rod-like Cells from Retinal Stem Cells Derived from the Adult Ciliary Epithelium	PLOS ONE			English	Article							CYCLIC-GMP; IN-VITRO; EXPRESSES COMPONENTS; CONE PHOTORECEPTORS; LIGHT ADAPTATION; PROGENITOR CELLS; MAMMALIAN EYE; ION CHANNELS; DIFFERENTIATION; PHOTOTRANSDUCTION	In vitro generation of photoreceptors from stem cells is of great interest for the development of regenerative medicine approaches for patients affected by retinal degeneration and for high throughput drug screens for these diseases. In this study, we show unprecedented high percentages of rod-fated cells from retinal stem cells of the adult ciliary epithelium. Molecular characterization of rod-like cells demonstrates that they lose ciliary epithelial characteristics but acquire photoreceptor features. Rod maturation was evaluated at two levels: gene expression and electrophysiological functionality. Here we present a strong correlation between phototransduction protein expression and functionality of the cells in vitro. We demonstrate that in vitro generated rod-like cells express cGMP-gated channels that are gated by endogenous cGMP. We also identified voltage-gated channels necessary for rod maturation and viability. This level of analysis for the first time provides evidence that adult retinal stem cells can generate highly homogeneous rod-fated cells.	[Demontis, Gian Carlo] Univ Pisa, Dept Psychiat Neurobiol Pharmacol & Biotechnol, Pisa, Italy; [Aruta, Claudia; Comitato, Antonella; De Marzo, Anna; Marigo, Valeria] Univ Modena & Reggio Emilia, Dept Biomed Sci, Modena, Italy	University of Pisa; Universita di Modena e Reggio Emilia	Demontis, GC (corresponding author), Univ Pisa, Dept Psychiat Neurobiol Pharmacol & Biotechnol, Pisa, Italy.	valeria.marigo@unimore.it	Marigo, Valeria/B-7947-2015; Demontis, Gian Carlo A.G./K-6963-2016	Marigo, Valeria/0000-0002-4428-2084; Demontis, Gian Carlo A.G./0000-0001-7641-0426	Fondazione Telethon [GGP06096]; Italian Ministry [2006053302_003]; Fondazione Cassa di Risparmio di Modena; European Union [LSHG-CT-2005-512036]; Italian Ministry of Education [2006053302_002]; Fondazione ARPA	Fondazione Telethon(Fondazione TelethonEuropean Commission); Italian Ministry; Fondazione Cassa di Risparmio di Modena; European Union(European Commission); Italian Ministry of Education; Fondazione ARPA	V.M. was supported by research grants GGP06096 from Fondazione Telethon, research grant 2006053302_003 from the Italian Ministry, Progetti di ricerca a carattere internazionale from Fondazione Cassa di Risparmio di Modena and by the European Union (grant n. LSHG-CT-2005-512036). G. C. D. was supported by research grant 2006053302_002 from the Italian Ministry of Education and by Fondazione ARPA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad I, 2000, BIOCHEM BIOPH RES CO, V270, P517, DOI 10.1006/bbrc.2000.2473; Allocca M, 2007, J VIROL, V81, P11372, DOI 10.1128/JVI.01327-07; ALTSHULER D, 1993, DEVELOPMENT, V119, P1317; Applebury ML, 2007, DEV DYNAM, V236, P1203, DOI 10.1002/dvdy.21155; Aruta C, 2011, PIGM CELL MELANOMA R, V24, P233, DOI 10.1111/j.1755-148X.2010.00793.x; Bertazolli R, 2001, BIOCHEM BIOPH RES CO, V284, P317, DOI 10.1006/bbrc.2001.4970; Bosl MR, 2001, EMBO J, V20, P1289, DOI 10.1093/emboj/20.6.1289; Cangiano L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001327; Cicero SA, 2009, P NATL ACAD SCI USA, V106, P6685, DOI 10.1073/pnas.0901596106; Coles BLK, 2004, P NATL ACAD SCI USA, V101, P15772, DOI 10.1073/pnas.0401596101; COOK NJ, 1987, P NATL ACAD SCI USA, V84, P585, DOI 10.1073/pnas.84.2.585; De Marzo A, 2010, ADV EXP MED BIOL, V664, P621, DOI 10.1007/978-1-4419-1399-9_71; DEMONTIS GC, 1995, BIOPHYS J, V69, P439, DOI 10.1016/S0006-3495(95)79917-9; Demontis GC, 2005, J NEUROSCI METH, V146, P13, DOI 10.1016/j.jneumeth.2005.01.007; Demontis GC, 2009, INVEST OPHTH VIS SCI, V50, P1948, DOI 10.1167/iovs.08-2659; FESENKO EE, 1985, NATURE, V313, P310, DOI 10.1038/313310a0; FRINGS S, 1995, NEURON, V15, P169, DOI 10.1016/0896-6273(95)90074-8; Ghosh S, 2004, NEUROSCI LETT, V370, P7, DOI 10.1016/j.neulet.2004.07.026; Giordano F, 2007, MOL VIS, V13, P1842; Gualdoni S, 2010, STEM CELLS, V28, P1048, DOI 10.1002/stem.423; Hyatt GA, 1996, P NATL ACAD SCI USA, V93, P13298, DOI 10.1073/pnas.93.23.13298; Inoue T, 2010, STEM CELLS, V28, P489, DOI 10.1002/stem.279; KANEKO A, 1989, J PHYSIOL-LONDON, V410, P613, DOI 10.1113/jphysiol.1989.sp017551; Karasawa Y, 2004, JPN J OPHTHALMOL, V48, P542, DOI 10.1007/s10384-004-0122-7; KAUPP UB, 1989, NATURE, V342, P762, DOI 10.1038/342762a0; LAMB TD, 1992, J PHYSIOL-LONDON, V449, P719, DOI 10.1113/jphysiol.1992.sp019111; Lamba DA, 2006, P NATL ACAD SCI USA, V103, P12769, DOI 10.1073/pnas.0601990103; Lamba DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008763; Lan L, 2009, STEM CELLS, V27, P2146, DOI 10.1002/stem.167; MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161; MATTHEWS G, 1988, J PHYSIOL-LONDON, V403, P389, DOI 10.1113/jphysiol.1988.sp017255; Moe MC, 2009, EXP EYE RES, V88, P30, DOI 10.1016/j.exer.2008.09.020; Mussolino C, 2011, EMBO MOL MED, V3, P118, DOI 10.1002/emmm.201000119; Nymark S, 2005, J PHYSIOL-LONDON, V567, P923, DOI 10.1113/jphysiol.2005.090662; Osakada F, 2008, NAT BIOTECHNOL, V26, P215, DOI 10.1038/nbt1384; PICONES A, 1995, BIOPHYS J, V69, P120, DOI 10.1016/S0006-3495(95)79881-2; RATTO GM, 1991, NATURE, V351, P654, DOI 10.1038/351654a0; Sanges D, 2006, P NATL ACAD SCI USA, V103, P17366, DOI 10.1073/pnas.0606276103; SESTI F, 1994, J PHYSIOL-LONDON, V474, P203, DOI 10.1113/jphysiol.1994.sp020014; Tropepe V, 2000, SCIENCE, V287, P2032, DOI 10.1126/science.287.5460.2032; Xiong WH, 2002, J GEN PHYSIOL, V120, P817, DOI 10.1085/jgp.20028702; Zhang J, 2004, BIOCHEM PHARMACOL, V68, P867, DOI 10.1016/j.bcp.2004.05.015; Zhao X, 2002, BIOCHEM BIOPH RES CO, V297, P177, DOI 10.1016/S0006-291X(02)02126-5	43	24	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e33338	10.1371/journal.pone.0033338	http://dx.doi.org/10.1371/journal.pone.0033338			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22432014	Green Published, gold, Green Submitted			2022-12-25	WOS:000303198600057
J	Martins, AJ; Ribeiro, CDEM; Bellinato, DF; Peixoto, AA; Valle, D; Lima, JBP				Martins, Ademir Jesus; Dutra e Mello Ribeiro, Camila; Bellinato, Diogo Fernandes; Peixoto, Alexandre Afranio; Valle, Denise; Pereira Lima, Jose Bento			Effect of Insecticide Resistance on Development, Longevity and Reproduction of Field or Laboratory Selected Aedes aegypti Populations	PLOS ONE			English	Article							FEMALE ANOPHELES-GAMBIAE; AN-STEPHENSI MOSQUITOS; HCH DIELDRIN RESISTANT; DELTAMETHRIN RESISTANCE; PYRETHROID RESISTANCE; INHERITANCE; FITNESS; DIPTERA; LEPIDOPTERA; PERMETHRIN	Aedes aegypti dispersion is the major reason for the increase in dengue transmission in South America. In Brazil, control of this mosquito strongly relies on the use of pyrethroids and organophosphates against adults and larvae, respectively. In consequence, many Ae. aegypti field populations are resistant to these compounds. Resistance has a significant adaptive value in the presence of insecticide treatment. However some selected mechanisms can influence important biological processes, leading to a high fitness cost in the absence of insecticide pressure. We investigated the dynamics of insecticide resistance and its potential fitness cost in five field populations and in a lineage selected for deltamethrin resistance in the laboratory, for nine generations. For all populations the life-trait parameters investigated were larval development, sex ratio, adult longevity, relative amount of ingested blood, rate of ovipositing females, size of egglaying and eggs viability. In the five natural populations, the effects on the life-trait parameters were discrete but directly proportional to resistance level. In addition, several viability parameters were strongly affected in the laboratory selected population compared to its unselected control. Our results suggest that mechanisms selected for organophosphate and pyrethroid resistance caused the accumulation of alleles with negative effects on different life-traits and corroborate the hypothesis that insecticide resistance is associated with a high fitness cost.	[Martins, Ademir Jesus; Dutra e Mello Ribeiro, Camila; Bellinato, Diogo Fernandes; Valle, Denise; Pereira Lima, Jose Bento] Fiocruz MS, Lab Fisiol & Controle Artropodes Vetores, Inst Oswaldo Cruz, BR-21045900 Rio De Janeiro, Brazil; [Martins, Ademir Jesus; Dutra e Mello Ribeiro, Camila; Bellinato, Diogo Fernandes; Valle, Denise; Pereira Lima, Jose Bento] Inst Biol Exercito, Entomol Lab, Rio De Janeiro, Brazil; [Martins, Ademir Jesus; Peixoto, Alexandre Afranio; Valle, Denise; Pereira Lima, Jose Bento] Pronex Rede Dengue, CNPq, Rio De Janeiro, Brazil; [Martins, Ademir Jesus; Peixoto, Alexandre Afranio; Valle, Denise] CNPq, Inst Nacl Ciencia & Tecnol Entomol Mol INCT EM, Rio De Janeiro, Brazil; [Peixoto, Alexandre Afranio] Fiocruz MS, Lab Biol Mol Insetos, Inst Oswaldo Cruz, BR-21045900 Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Martins, AJ (corresponding author), Fiocruz MS, Lab Fisiol & Controle Artropodes Vetores, Inst Oswaldo Cruz, BR-21045900 Rio De Janeiro, Brazil.	dvalle@ioc.fiocruz.br; jbento@ioc.fiocruz.br	Martins, Ademir J./B-4117-2009; Martins, Ademir/W-3251-2019; Valle, Denise/F-5069-2013	Martins, Ademir/0000-0001-5739-1215; 	Secretaria de Vigilancia em Saude/Ministerio da Saude (SVS/MS); Fundacao Oswaldo Cruz (Fiocruz); Vice-Presidencia de Pesquisa e Laboratorios de Referencia/Fundacao Oswaldo Cruz (VPPLR/Fiocruz); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Financiadora de Estudos e Projetos do Rio de Janeiro (Faperj); Howard Hughes Medical Institute (HHMI)	Secretaria de Vigilancia em Saude/Ministerio da Saude (SVS/MS); Fundacao Oswaldo Cruz (Fiocruz); Vice-Presidencia de Pesquisa e Laboratorios de Referencia/Fundacao Oswaldo Cruz (VPPLR/Fiocruz); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Financiadora de Estudos e Projetos do Rio de Janeiro (Faperj); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute)	This work was supported by the Programa Nacional de Controle da Dengue/Secretaria de Vigilancia em Saude/Ministerio da Saude (PNCD/SVS/MS), Programa de Desenvolvimento Tecnologico em Saude Publica/Fundacao Oswaldo Cruz (PDTSP/Fiocruz), Vice-Presidencia de Pesquisa e Laboratorios de Referencia/Fundacao Oswaldo Cruz (VPPLR/Fiocruz), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Financiadora de Estudos e Projetos do Rio de Janeiro (Faperj), and the Howard Hughes Medical Institute (HHMI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedi ZH, 1961, MOSQ NEWS, V21, P4; Agnew P, 1999, EVOL ECOL, V13, P67, DOI 10.1023/A:1006586131235; Bouvier JC, 2001, HEREDITY, V87, P456, DOI 10.1046/j.1365-2540.2001.00928.x; BREWER MJ, 1991, J ECON ENTOMOL, V84, P1638, DOI 10.1093/jee/84.6.1638; CARRIERE Y, 1994, P ROY SOC B-BIOL SCI, V258, P35, DOI 10.1098/rspb.1994.0138; Charlesworth B., 1994, EVOLUTION AGE STRUCT, V2nd ed, edited by C. Cannings, F. C. Hoppensteadt, and L. A. Segel.; Corbel V, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-22; da-Cunha MP, 2005, MEM I OSWALDO CRUZ, V100, P441, DOI 10.1590/S0074-02762005000400017; Davies AG, 1996, GENETICS, V143, P1321; delPilarValencia M, 1996, CRYOBIOLOGY, V33, P142, DOI 10.1006/cryo.1996.0014; Farnesi LC, 2009, MEM I OSWALDO CRUZ, V104, P124, DOI 10.1590/S0074-02762009000100020; Fisher R.A., 1958, GENETICAL THEORY NAT; Foster SP, 2003, HEREDITY, V91, P98, DOI 10.1038/sj.hdy.6800285; HARTBERG W K, 1970, Evolution, V24, P692, DOI 10.1111/j.1558-5646.1970.tb01805.x; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; HOLLOWAY GJ, 1990, HEREDITY, V64, P323, DOI 10.1038/hdy.1990.40; Kumar S, 2002, ARCH INSECT BIOCHEM, V50, P1, DOI 10.1002/arch.10021; Lima JBP, 2003, AM J TROP MED HYG, V68, P329, DOI 10.4269/ajtmh.2003.68.329; Lourenco-de-Oliveira R., 2005, DINAMICA DOENCAS INF, P75; Martins AJ, 2009, TROP MED INT HEALTH, V14, P1351, DOI 10.1111/j.1365-3156.2009.02378.x; Martins AJ, 2009, AM J TROP MED HYG, V81, P108, DOI 10.4269/ajtmh.2009.81.108; Mebrahtu YB, 1997, AM J TROP MED HYG, V56, P456, DOI 10.4269/ajtmh.1997.56.456; Melo-Santos MAV, 2010, ACTA TROP, V113, P180, DOI 10.1016/j.actatropica.2009.10.015; Montella IR, 2007, AM J TROP MED HYG, V77, P467, DOI 10.4269/ajtmh.2007.77.467; MS-Brasil, 2006, REUN TECN DISC STAT; Rodriguez MM, 2005, J AM MOSQUITO CONTR, V21, P437, DOI 10.2987/8756-971X(2006)21[437:PISOAA]2.0.CO;2; ROWLAND M, 1991, MED VET ENTOMOL, V5, P193, DOI 10.1111/j.1365-2915.1991.tb00542.x; ROWLAND M, 1991, MED VET ENTOMOL, V5, P207, DOI 10.1111/j.1365-2915.1991.tb00543.x; Saavedra-Rodriguez K, 2007, INSECT MOL BIOL, V16, P785, DOI 10.1111/j.1365-2583.2007.00774.x; Saavedra-Rodriguez K, 2012, INSECT MOL BIOL, V21, P61, DOI 10.1111/j.1365-2583.2011.01113.x; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Urmila J, 2001, INDIAN J MED RES, V113, P103	32	91	94	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e31889	10.1371/journal.pone.0031889	http://dx.doi.org/10.1371/journal.pone.0031889			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22431967	Green Published, Green Submitted, gold			2022-12-25	WOS:000303198600010
J	Strelnikov, K; Barone, P				Strelnikov, Kuzma; Barone, Pascal			Stable Modality-Specific Activity Flows As Reflected by the Neuroenergetic Approach to the fMRI Weighted Maps	PLOS ONE			English	Article							BRAIN ACTIVITY; BOLD FMRI; FREQUENCY; LANGUAGE; SPEECH	This article uses the ideas of neuroenergetic and neural field theories to detect stimulation-driven energy flows in the brain during face and auditory word processing. In this analysis, energy flows are thought to create the stable gradients of the fMRI weighted summary images. The sources, from which activity spreads in the brain during face processing, were detected in the occipital cortex. The following direction of energy flows in the frontal cortex was described: the right inferior frontal = >the left inferior frontal = >the triangular part of the left inferior frontal cortex = >the left operculum. In the left operculum, a localized circuit was described. For auditory word processing, the sources of activity flows were detected bilaterally in the middle superior temporal regions, they were also detected in the left posterior superior temporal cortex. Thus, neuroenergetic assumptions may give a novel perspective for the analysis of neuroimaging data.	[Strelnikov, Kuzma] Hop Purpan, Toulouse, France; [Strelnikov, Kuzma; Barone, Pascal] Fac Med Rangueil, CNRS, UMR 5549, Toulouse, France	CHU de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Strelnikov, K (corresponding author), Hop Purpan, Toulouse, France.	kuzma@cerco.ups-tlse.fr	BARONE, Pascal/AHE-2323-2022; Barone, Pascal/A-4008-2009	BARONE, Pascal/0000-0003-0125-7468; Strelnikov, Kuzma/0000-0002-6613-2300	CNRS; ANR (Agence Nationale de la Recherche) [ANR-06-Neuro-021-04]	CNRS(Centre National de la Recherche Scientifique (CNRS)); ANR (Agence Nationale de la Recherche)(French National Research Agency (ANR))	Funding: CNRS Atip+ program to KS and BP; ANR (Agence Nationale de la Recherche) Hearing Loss, ANR-06-Neuro-021-04 to PB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buice MA, 2009, PROG BIOPHYS MOL BIO, V99, P53, DOI 10.1016/j.pbiomolbio.2009.07.003; Demonet JF, 2005, PHYSIOL REV, V85, P49, DOI 10.1152/physrev.00049.2003; Fox CJ, 2009, HUM BRAIN MAPP, V30, P1637, DOI 10.1002/hbm.20630; Friederici AD, 2004, BRAIN LANG, V89, P267, DOI 10.1016/S0093-934X(03)00351-1; Friston KJ, 2010, NAT REV NEUROSCI, V11, P127, DOI 10.1038/nrn2787; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Goloshevsky AG, 2008, BRAIN RES, V1195, P67, DOI 10.1016/j.brainres.2007.11.036; Heeger DJ, 2000, NAT NEUROSCI, V3, P631, DOI 10.1038/76572; Henson RNA, 2002, CEREB CORTEX, V12, P178, DOI 10.1093/cercor/12.2.178; Hyder F, 2002, P NATL ACAD SCI USA, V99, P10771, DOI 10.1073/pnas.132272299; Jin DQ, 2011, NEURAL COMPUT, V23, P2032, DOI 10.1162/NECO_a_00153; Kepecs A, 2002, J NEUROSCI, V22, P9053; Kiebel S, 2004, HUMAN BRAIN FUNCTION, Vxvi; La Camera G, 2008, BIOL CYBERN, V99, P279, DOI 10.1007/s00422-008-0272-7; Liu ZM, 2010, NEUROIMAGE, V50, P1054, DOI 10.1016/j.neuroimage.2010.01.017; Maurer D, 2007, NEUROPSYCHOLOGIA, V45, P1438, DOI 10.1016/j.neuropsychologia.2006.11.016; PETRAS J. M., 1965, TRANS AMER NEUROL ASS, V90, P274; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; Rees G, 2000, NAT NEUROSCI, V3, P716, DOI 10.1038/76673; Schneider E. D., 2005, COOL ENERGY FLOW THE; SCHNEIDER ED, 1994, MATH COMPUT MODEL, V19, P25, DOI 10.1016/0895-7177(94)90188-0; Smith AJ, 2002, P NATL ACAD SCI USA, V99, P10765, DOI 10.1073/pnas.132272199; Strelnikov K, 2010, CEREB CORTEX, V20, P1217, DOI 10.1093/cercor/bhp183; Strelnikov K, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-122; Strelnikov K, 2010, BRAIN COGNITION, V72, P449, DOI 10.1016/j.bandc.2009.12.008; Tschacher W, 2007, NEW IDEAS PSYCHOL, V25, P1, DOI 10.1016/j.newideapsych.2006.09.002; Van Belle G, 2010, NEUROPSYCHOLOGIA, V48, P2620, DOI 10.1016/j.neuropsychologia.2010.04.034	27	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e33462	10.1371/journal.pone.0033462	http://dx.doi.org/10.1371/journal.pone.0033462			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22432026	Green Submitted, Green Published, gold			2022-12-25	WOS:000303198600069
J	Teng, H; Chopp, M; Hozeska-Solgot, A; Shen, LH; Lu, M; Tang, C; Zhang, ZG				Teng, Hua; Chopp, Michael; Hozeska-Solgot, Ann; Shen, Lihong; Lu, Mei; Tang, Clark; Zhang, Zheng Gang			Tissue Plasminogen Activator and Plasminogen Activator Inhibitor 1 Contribute to Sonic Hedgehog-Induced In Vitro Cerebral Angiogenesis	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; ENDOTHELIAL-CELLS; MATRIX METALLOPROTEINASES; ISCHEMIC-STROKE; EXPRESSION; MECHANISMS; STRATEGIES; PROTEASES; PATHWAY; VEGF	The molecular mechanisms underlying cerebral angiogenesis have not been fully investigated. Using primary mouse brain endothelial cells (MBECs) and a capillary-like tube formation assay, we investigated whether the sonic hedgehog (Shh) signaling pathway is coupled with the plasminogen/plasmin system in mediating cerebral angiogenesis. We found that incubation of MBECs with recombinant human Shh (rhShh) substantially increased the tube formation in naive MBECs. This was associated with increases in tissue plasminogen activator (tPA) activation and reduction of plasminogen activator inhibitor 1 (PAI-1). Blockage of the Shh pathway with cyclopamine abolished the induction of tube formation and the effect of rhShh on tPA and PAI-1. Addition of PAI-1 reduced rhShh-augmented tube formation. Genetic ablation of tPA in MBECs impaired tube formation and downregulated of vascular endothelial growth factor (VEGF) and angiopoietin 1 (Ang1). Addition of rhShh to tPA-/- MBECs only partially restored the tube formation and upregulated Ang1, but not VEGF, although rhShh increased VEGF and Ang1 expression on wild-type MBECs. Complete restoration of tube formation in tPA-/- MBECs was observed only when both exogenous Shh and tPA were added. The present study provides evidence that tPA and PAI-1 contribute to Shh-induced in vitro cerebral angiogenesis.	[Teng, Hua; Chopp, Michael; Hozeska-Solgot, Ann; Shen, Lihong; Tang, Clark; Zhang, Zheng Gang] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI USA; [Lu, Mei] Henry Ford Hosp, Dept Biostat & Res Epidemiol, Detroit, MI 48202 USA	Henry Ford Health System; Henry Ford Hospital; Oakland University; Henry Ford Health System; Henry Ford Hospital	Teng, H (corresponding author), Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA.	zhazh@neuro.hfh.edu	zhang, zheng/HCH-9684-2022		U.S. National Institutes of Health [PO1 NS23393, RO1 AG037506, RO1 NS075156]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075156, P01NS023393] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG037506] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the U.S. National Institutes of Health (PO1 NS23393 to MC, RO1 AG037506 to MC, and RO1 NS075156 to ZGZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adibhatla RM, 2008, CNS NEUROL DISORD-DR, V7, P243, DOI 10.2174/187152708784936608; Ahn MY, 1999, BRAIN RES, V837, P169, DOI 10.1016/S0006-8993(99)01645-5; Alvarez JI, 2011, SCIENCE, V334, P1727, DOI 10.1126/science.1206936; Asai J, 2006, CIRCULATION, V113, P2413, DOI 10.1161/CIRCULATIONAHA.105.603167; Bajou K, 2001, J CELL BIOL, V152, P777, DOI 10.1083/jcb.152.4.777; Byrd N, 2002, DEVELOPMENT, V129, P361; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Castellino FJ, 2005, THROMB HAEMOSTASIS, V93, P647, DOI 10.1160/TH04-12-0842; Devy L, 2002, FASEB J, V16, DOI 10.1096/fj.01-0552com; Dupont DM, 2009, FRONT BIOSCI-LANDMRK, V14, P1337, DOI 10.2741/3312; Dyer MA, 2001, DEVELOPMENT, V128, P1717; Kanda S, 2003, J BIOL CHEM, V278, P8244, DOI 10.1074/jbc.M210635200; Kim JA, 2003, THROMB RES, V112, P159, DOI 10.1016/j.thromres.2003.10.021; Krishnan V, 1997, SCIENCE, V278, P1947, DOI 10.1126/science.278.5345.1947; KRUPINSKI J, 1994, STROKE, V25, P1794, DOI 10.1161/01.STR.25.9.1794; Labied S, 2011, PHYSIOL GENOMICS, V43, P188, DOI 10.1152/physiolgenomics.00147.2010; Lee SW, 2007, INT J MOL MED, V19, P445; Li PC, 2012, J VASC SURG; Liu XS, 2006, J CEREBR BLOOD F MET, V26, P787, DOI 10.1038/sj.jcbfm.9600227; Mignatti P, 1996, ENZYME PROTEIN, V49, P117, DOI 10.1159/000468621; MISKIN R, 1981, ANAL BIOCHEM, V118, P252, DOI 10.1016/0003-2697(81)90187-1; Nagase T, 2005, GENES CELLS, V10, P595, DOI 10.1111/j.1365-2443.2005.00861.x; Ohki M, 2010, BLOOD, V115, P4302, DOI 10.1182/blood-2009-08-236851; Pola R, 2001, NAT MED, V7, P706, DOI 10.1038/89083; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Slevin M, 2000, STROKE, V31, P1863, DOI 10.1161/01.STR.31.8.1863; Teng H, 2008, J CEREBR BLOOD F MET, V28, P764, DOI 10.1038/sj.jcbfm.9600573; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Wang L, 2006, J NEUROSCI, V26, P5996, DOI 10.1523/JNEUROSCI.5380-05.2006; Xin HQ, 2011, J CEREBR BLOOD F MET, V31, P2181, DOI 10.1038/jcbfm.2011.116; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369; Zhang ZG, 2002, J CEREBR BLOOD F MET, V22, P379, DOI 10.1097/00004647-200204000-00002	32	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e33444	10.1371/journal.pone.0033444	http://dx.doi.org/10.1371/journal.pone.0033444			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22432023	gold, Green Published, Green Submitted			2022-12-25	WOS:000303198600066
J	Cordova, FM; Aguiar, AS; Peres, TV; Lopes, MW; Goncalves, FM; Remor, AP; Lopes, SC; Pilati, C; Latini, AS; Prediger, RDS; Erikson, KM; Aschner, M; Leal, RB				Cordova, Fabiano M.; Aguiar, Aderbal S., Jr.; Peres, Tanara V.; Lopes, Mark W.; Goncalves, Filipe M.; Remor, Aline P.; Lopes, Samantha C.; Pilati, Celso; Latini, Alexandra S.; Prediger, Rui D. S.; Erikson, Keith M.; Aschner, Michael; Leal, Rodrigo B.			In Vivo Manganese Exposure Modulates Erk, Akt and Darpp-32 in the Striatum of Developing Rats, and Impairs Their Motor Function	PLOS ONE			English	Article							MEDIUM SPINY NEURONS; PC12 CELLS; INDUCED APOPTOSIS; MAP KINASE; ENERGY-METABOLISM; OXIDATIVE-STRESS; NERVOUS-SYSTEM; NITRIC-OXIDE; PARENTERAL-NUTRITION; SYNAPTIC PLASTICITY	Manganese (Mn) is an essential metal for development and metabolism. However, exposures to high Mn levels may be toxic, especially to the central nervous system (CNS). Neurotoxicity is commonly due to occupational or environmental exposures leading to Mn accumulation in the basal ganglia and a Parkinsonian-like disorder. Younger individuals are more susceptible to Mn toxicity. Moreover, early exposure may represent a risk factor for the development of neurodegenerative diseases later in life. The present study was undertaken to investigate the developmental neurotoxicity in an in vivo model of immature rats exposed to Mn (5, 10 and 20 mg/kg; i.p.) from postnatal day 8 (PN8) to PN12. Neurochemical analysis was carried out on PN14. We focused on striatal alterations in intracellular signaling pathways, oxidative stress and cell death. Moreover, motor alterations as a result of early Mn exposure (PN8-12) were evaluated later in life at 3-, 4- and 5-weeks-of-age. Mn altered in a dose-dependent manner the activity of key cell signaling elements. Specifically, Mn increased the phosphorylation of DARPP-32-Thr-34, ERK1/2 and AKT. Additionally, Mn increased reactive oxygen species (ROS) production and caspase activity, and altered mitochondrial respiratory chain complexes I and II activities. Mn (10 and 20 mg/kg) also impaired motor coordination in the 3(rd), 4(th) and 5(th) week of life. Trolox (TM), an antioxidant, reversed several of the Mn altered parameters, including the increased ROS production and ERK1/2 phosphorylation. However, Trolox (TM) failed to reverse the Mn (20 mg/kg)-induced increase in AKT phosphorylation and motor deficits. Additionally, Mn (20 mg/kg) decreased the distance, speed and grooming frequency in an open field test; Trolox (TM) blocked only the decrease of grooming frequency. Taken together, these results establish that short-term exposure to Mn during a specific developmental window (PN8-12) induces metabolic and neurochemical alterations in the striatum that may modulate later-life behavioral changes. Furthermore, some of the molecular and behavioral events, which are perturbed by early Mn exposure are not directly related to the production of oxidative stress.	[Cordova, Fabiano M.; Peres, Tanara V.; Lopes, Mark W.; Goncalves, Filipe M.; Remor, Aline P.; Latini, Alexandra S.; Leal, Rodrigo B.] Univ Fed Santa Catarina, Ctr Ciencias Biol, Dept Bioquim, Florianopolis, SC, Brazil; [Aguiar, Aderbal S., Jr.; Lopes, Samantha C.; Prediger, Rui D. S.] Univ Fed Santa Catarina, Dept Farmacol, Florianopolis, SC, Brazil; [Pilati, Celso] Univ Estado Santa Catarina, Ctr Ciencias Agrovet, Lages, Brazil; [Cordova, Fabiano M.] Univ Fed Tocantins, Ctr Ciencia Anim, Araguaina, Brazil; [Erikson, Keith M.] Univ N Carolina, Dept Nutr, Greensboro, NC 27412 USA; [Aschner, Michael] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA	Universidade Federal de Santa Catarina (UFSC); Universidade Federal de Santa Catarina (UFSC); Universidade do Estado de Santa Catarina; Universidade Federal do Tocantins (UFT); University of North Carolina; University of North Carolina Greensboro; Vanderbilt University	Cordova, FM (corresponding author), Univ Fed Santa Catarina, Ctr Ciencias Biol, Dept Bioquim, Florianopolis, SC, Brazil.	rbleal@gmail.com	Prediger, Rui/CAG-4328-2022; Peres, Tanara Vieira/A-3898-2019; Latini, Alexandra/Y-8067-2019; Goncalves, Filipe Marques/F-7243-2019; Prediger, Rui Daniel/AAV-3419-2020; Leal, Rodrigo Bainy/AAL-1938-2020; Aguiar, Aderbal Silva/C-6484-2008; Prediger, Rui D/C-4036-2013; Latini, Alexandra/P-2637-2019; Remor, Aline/N-7780-2015; de Cordova, Fabiano/F-9884-2012; Lopes, Mark William/F-3109-2015	Prediger, Rui/0000-0001-5102-0296; Peres, Tanara Vieira/0000-0003-0199-8653; Latini, Alexandra/0000-0003-4255-3589; Prediger, Rui Daniel/0000-0002-7547-6463; Aguiar, Aderbal Silva/0000-0002-6825-3333; Prediger, Rui D/0000-0002-7547-6463; Remor, Aline/0000-0002-6881-6255; de Cordova, Fabiano/0000-0003-4735-4108; Leal, Rodrigo/0000-0003-2536-6888; Marques Goncalves, Filipe/0000-0002-7246-9217; Lopes, Mark William/0000-0002-5292-8455	National Council for Scientific and Technological Development (CNPq) Brazil [305194/2010-0]; Coordination for the Training and Improvement of Higher Education Personnel (CAPES)/PROCAD [167/2007]; Studies and Projects Financing Agency (FINEP) [IBN 01.06.0842-00]; INCT-National Institute of Science and Technology for Excitotoxicity and Neuroprotection; Santa Catarina Research Fundation (FAPESC); National Institute of Environmental Health Sciences (NIEHS) [R01 ES10563]	National Council for Scientific and Technological Development (CNPq) Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Training and Improvement of Higher Education Personnel (CAPES)/PROCAD(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Studies and Projects Financing Agency (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); INCT-National Institute of Science and Technology for Excitotoxicity and Neuroprotection; Santa Catarina Research Fundation (FAPESC); National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Council for Scientific and Technological Development (CNPq) Brazil (#305194/2010-0); Coordination for the Training and Improvement of Higher Education Personnel (CAPES)/PROCAD (#167/2007); Studies and Projects Financing Agency (FINEP) IBN 01.06.0842-00 and INCT-National Institute of Science and Technology for Excitotoxicity and Neuroprotection; Santa Catarina Research Fundation (FAPESC); National Institute of Environmental Health Sciences (NIEHS) R01 ES10563 (MA). RBL, ASL and RDSP are recipients of CNPq fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar AS, 2009, BRAIN RES BULL, V79, P452, DOI 10.1016/j.brainresbull.2009.05.005; Ahn JH, 2007, P NATL ACAD SCI USA, V104, P2979, DOI 10.1073/pnas.0611532104; Anderson JG, 2007, ENVIRON TOXICOL PHAR, V23, P179, DOI 10.1016/j.etap.2006.08.006; Andersson M, 2005, J NEUROSCI, V25, P8432, DOI 10.1523/JNEUROSCI.1289-05.2005; Aschner Judy L., 2005, Molecular Aspects of Medicine, V26, P353, DOI 10.1016/j.mam.2005.07.003; Aschner M, 2007, TOXICOL APPL PHARM, V221, P131, DOI 10.1016/j.taap.2007.03.001; Aschner M, 2009, NEUROMOL MED, V11, P252, DOI 10.1007/s12017-009-8083-0; Avila DS, 2008, NEUROTOXICOLOGY, V29, P1062, DOI 10.1016/j.neuro.2008.08.004; Bae JH, 2006, NEUROSCI LETT, V398, P151, DOI 10.1016/j.neulet.2005.12.067; Bagh MB, 2011, BIOGERONTOLOGY, V12, P119, DOI 10.1007/s10522-010-9301-8; BANDY B, 1990, FREE RADICAL BIO MED, V8, P523, DOI 10.1016/0891-5849(90)90152-9; Barros MH, 2004, J BIOL CHEM, V279, P49883, DOI 10.1074/jbc.M408918200; Benedetto A, 2009, CHEM REV, V109, P4862, DOI 10.1021/cr800536y; Bjerrum OJ, CRC HDB IMMUNOBLOTTI; Bondy SC, 2005, J NEUROSCI RES, V81, P605, DOI 10.1002/jnr.20589; Borgkvist A, 2008, NEUROPHARMACOLOGY, V54, P31, DOI 10.1016/j.neuropharm.2007.06.025; Borgkvist A, 2007, NEUROSCI BIOBEHAV R, V31, P79, DOI 10.1016/j.neubiorev.2006.03.003; Botsakis K, 2010, NEUROCHEM INT, V56, P245, DOI 10.1016/j.neuint.2009.10.007; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Burton NC, 2009, ENVIRON HEALTH PERSP, V117, P325, DOI [10.1289/ehp.0800035, 10.1289/ehp.1173c25]; Cai TJ, 2011, TOXICOL SCI, V119, P169, DOI 10.1093/toxsci/kfq308; Cai TJ, 2010, BRAIN RES, V1359, P201, DOI 10.1016/j.brainres.2010.08.055; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen MK, 2006, NEUROTOXICOLOGY, V27, P229, DOI 10.1016/j.neuro.2005.10.008; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; Chu CT, 2004, EUR J BIOCHEM, V271, P2060, DOI 10.1111/j.1432-1033.2004.04132.x; Cordova FM, 2004, BRAIN RES, V998, P65, DOI 10.1016/j.brainres.2003.11.012; Cowan KJ, 2003, J EXP BIOL, V206, P1107, DOI 10.1242/jeb.00220; Crittenden PL, 2011, J APPL TOXICOL, V31, P1, DOI 10.1002/jat.1552; de Oliveira MR, 2007, BRAIN RES, V1169, P112, DOI 10.1016/j.brainres.2007.07.008; Dobson AW, 2004, ANN NY ACAD SCI, V1012, P115, DOI 10.1196/annals.1306.009; Dorman DC, 2000, J APPL TOXICOL, V20, P179, DOI 10.1002/(SICI)1099-1263(200005/06)20:3<179::AID-JAT631>3.0.CO;2-C; Erikson KM, 2007, PHARMACOL THERAPEUT, V113, P369, DOI 10.1016/j.pharmthera.2006.09.002; Erikson KM, 2002, NEUROTOXICOLOGY, V23, P281, DOI 10.1016/S0161-813X(02)00041-4; Fitsanakis VA, 2008, TOXICOL SCI, V103, P116, DOI 10.1093/toxsci/kfn019; Fitsanakis VA, 2010, NEUROTOX RES, V18, P124, DOI 10.1007/s12640-009-9130-1; Garcia SJ, 2006, TOXICOL SCI, V92, P516, DOI 10.1093/toxsci/kfl017; Gerfen C. R., 2004, RAT NERVOUS SYSTEM, P445; Gonzalez LE, 2008, NEUROCHEM INT, V53, P408, DOI 10.1016/j.neuint.2008.09.008; GOTTLIEB A, 1977, BIOL NEONATE, V32, P166; Grandjean P, 2006, LANCET, V368, P2167, DOI 10.1016/S0140-6736(06)69665-7; Graybiel AM, 2005, CURR OPIN NEUROBIOL, V15, P638, DOI 10.1016/j.conb.2005.10.006; Greengard P, 2001, SCIENCE, V294, P1024, DOI 10.1126/science.294.5544.1024; Greengard P, 1999, NEURON, V23, P435, DOI 10.1016/S0896-6273(00)80798-9; Grimaldi Filho G, 1981, TECNICA HISTOLOGICA; Guilarte TR, 2006, EXP NEUROL, V202, P381, DOI 10.1016/j.expneurol.2006.06.015; Hafeman D, 2007, ENVIRON HEALTH PERSP, V115, P1107, DOI 10.1289/ehp.10051; Hardy G, 2009, GASTROENTEROLOGY, V137, pS29, DOI 10.1053/j.gastro.2009.08.011; Hardy G, 2009, NUTRITION, V25, P1073, DOI 10.1016/j.nut.2009.03.004; HAUSLADEN A, 1994, J BIOL CHEM, V269, P29405; He L, 2006, MOL PHARMACOL, V70, P171, DOI 10.1124/mol.106.021521; Heddi A, 1999, J BIOL CHEM, V274, P22968, DOI 10.1074/jbc.274.33.22968; Hernandez R.B., 2011, TOXICOL SCI; Hirata Y, 2004, BRAIN RES, V1021, P241, DOI 10.1016/j.brainres.2004.06.064; Ito Y, 2006, BRAIN RES, V1099, P1, DOI 10.1016/j.brainres.2006.03.126; Jang BC, 2009, TOXICOL IN VITRO, V23, P120, DOI 10.1016/j.tiv.2008.11.005; Jones DC, 2008, BIOCHEM PHARMACOL, V76, P569, DOI 10.1016/j.bcp.2008.05.010; Kannurpatti SS, 2000, NEUROCHEM RES, V25, P1527, DOI 10.1023/A:1026602100160; Kilbride SM, 2008, BBA-BIOENERGETICS, V1777, P783, DOI 10.1016/j.bbabio.2008.05.445; Latchoumycandane C, 2005, J PHARMACOL EXP THER, V313, P46, DOI 10.1124/jpet.104.078469; Latini A, 2005, NEUROSCIENCE, V135, P111, DOI 10.1016/j.neuroscience.2005.05.013; Lazrishvili I L, 2009, Neurosci Behav Physiol, V39, P7, DOI 10.1007/s11055-008-9092-4; Lebel M, 2010, NEUROBIOL DIS, V38, P59, DOI 10.1016/j.nbd.2009.12.027; Li Y, 2010, BRAIN RES BULL, V81, P428, DOI 10.1016/j.brainresbull.2009.11.007; Liao SL, 2007, NEUROCHEM INT, V50, P905, DOI 10.1016/j.neuint.2006.09.016; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lucaciu CM, 1997, BBA-BIOMEMBRANES, V1328, P90, DOI 10.1016/S0005-2736(97)00039-4; Lucchini R, 2009, NEUROTOXICOLOGY, V30, P1144, DOI 10.1016/j.neuro.2009.10.003; McDougall SA, 2008, NEUROSCIENCE, V154, P848, DOI 10.1016/j.neuroscience.2008.03.070; Mcdougall SA, 2011, SYNAPSE, V65, P583, DOI 10.1002/syn.20877; Menezes JA, 2009, REV PANAM SALUD PUBL, V26, P541, DOI 10.1590/S1020-49892009001200010; Mielke K, 2000, PROG NEUROBIOL, V61, P45, DOI 10.1016/S0301-0082(99)00042-8; Milatovic D., 2009, CURR PROTOC TOXICOL, V14, DOI DOI 10.1002/0471140856.TX; Milatovic D, 2007, TOXICOL SCI, V98, P198, DOI 10.1093/toxsci/kfm095; Milatovic D, 2009, TOXICOL APPL PHARM, V240, P219, DOI 10.1016/j.taap.2009.07.004; Morello M, 2008, NEUROTOXICOLOGY, V29, P60, DOI 10.1016/j.neuro.2007.09.001; Moreno JA, 2009, TOXICOL SCI, V112, P405, DOI 10.1093/toxsci/kfp221; Moreno JA, 2009, TOXICOL SCI, V112, P394, DOI 10.1093/toxsci/kfp220; Morrow JD, 1999, METHOD ENZYMOL, V300, P3; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Nishi A, 2000, P NATL ACAD SCI USA, V97, P12840, DOI 10.1073/pnas.220410397; Normandin L, 2002, TOXICOL APPL PHARM, V183, P135, DOI 10.1006/taap.2002.9464; Park EJ, 2010, TOXICOL IN VITRO, V24, P472, DOI 10.1016/j.tiv.2009.09.022; Perl DP, 2007, J NEUROPATH EXP NEUR, V66, P675, DOI 10.1097/nen.0b013e31812503cf; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Polissidis A, 2010, INT J NEUROPSYCHOPH, V13, P1175, DOI 10.1017/S1461145709991003; Posser T, 2007, ARCH TOXICOL, V81, P407, DOI 10.1007/s00204-007-0177-6; Posser T, 2009, J NEUROCHEM, V110, P848, DOI 10.1111/j.1471-4159.2009.06185.x; Prabhakaran K, 2008, BRAIN RES BULL, V76, P361, DOI 10.1016/j.brainresbull.2008.03.004; Qi Z, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-26; Radi R, 2002, BIOL CHEM, V383, P401, DOI 10.1515/BC.2002.044; Rao KVR, 2010, GLIA, V58, P1490, DOI 10.1002/glia.21023; Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.2307/3454543; Rivera-Mancia S, 2011, BIOMETALS, V24, P811, DOI 10.1007/s10534-011-9454-1; ROCHA JBT, 1995, TOXICOLOGY, V100, P27, DOI 10.1016/0300-483X(95)03054-J; RODIER PM, 1995, ENVIRON HEALTH PERSP, V103, P73, DOI 10.2307/3432351; Roth JA, 2003, BIOCHEM PHARMACOL, V66, P1, DOI 10.1016/S0006-2952(03)00145-X; Roth JA, 2009, NEUROMOL MED, V11, P281, DOI 10.1007/s12017-009-8088-8; Santamaria AB, 2008, INDIAN J MED RES, V128, P484; Santini E, 2007, J NEUROSCI, V27, P6995, DOI 10.1523/JNEUROSCI.0852-07.2007; Sauer H, 2003, FREE RADICAL BIO MED, V35, P586, DOI 10.1016/S0891-5849(03)00360-5; Schneider JS, 2009, BRAIN RES, V1258, P86, DOI 10.1016/j.brainres.2008.12.035; Schuck PF, 2007, NEUROSCI RES, V57, P277, DOI 10.1016/j.neures.2006.10.013; Shin HJ, 2010, TOXICOL IN VITRO, V24, P1208, DOI 10.1016/j.tiv.2010.02.008; Siddappa AJM, 2002, J NEUROSCI RES, V68, P761, DOI 10.1002/jnr.10246; Sidoryk-Wegrzynowicz M, 2009, J NEUROCHEM, V110, P822, DOI 10.1111/j.1471-4159.2009.06172.x; Sriram K, 2010, FASEB J, V24, P4989, DOI 10.1096/fj.10-163964; Subramaniam S, 2006, NEUROSCIENCE, V138, P1055, DOI 10.1016/j.neuroscience.2005.12.013; Suzuki H, 2003, NEUROPEDIATRICS, V34, P200; Svenningsson P, 2004, ANNU REV PHARMACOL, V44, P269, DOI 10.1146/annurev.pharmtox.44.101802.121415; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; Takeda A, 1999, J NEUROSCI RES, V56, P93, DOI 10.1002/(SICI)1097-4547(19990401)56:1<93::AID-JNR12>3.3.CO;2-G; Tamm C, 2008, TOXICOL SCI, V101, P310, DOI 10.1093/toxsci/kfm267; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Tolosa EMC, 2003, MANUAL TECNICAS HIST, V1; van der Heide LP, 2006, PROG NEUROBIOL, V79, P205, DOI 10.1016/j.pneurobio.2006.06.003; Waetzig V, 2004, NEUROSCI LETT, V361, P64, DOI 10.1016/j.neulet.2004.02.041; Waetzig V, 2006, PROG NEUROBIOL, V80, P84, DOI 10.1016/j.pneurobio.2006.08.002; Walaas SI, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00050; Wasserman GA, 2008, BASIC CLIN PHARMACOL, V102, P212, DOI 10.1111/j.1742-7843.2007.00187.x; Weber S, 2002, NEUROTOXICOLOGY, V23, P169, DOI 10.1016/S0161-813X(02)00014-1; Witte ME, 2009, J PATHOL, V219, P193, DOI 10.1002/path.2582; Xu B, 2010, J BIOCHEM MOL TOXIC, V24, P1, DOI 10.1002/jbt.20306; Yin ZB, 2008, BRAIN RES, V1203, P1, DOI 10.1016/j.brainres.2008.01.079; Zhang FL, 2008, ENVIRON TOXICOL PHAR, V26, P232, DOI 10.1016/j.etap.2008.04.003; Zhang SR, 2004, TOXICOL IN VITRO, V18, P71, DOI 10.1016/j.tiv.2003.09.002; ZHANG Y, 1990, J BIOL CHEM, V265, P16330; Zuse A, 2007, EUR J PHARMACOL, V575, P34, DOI 10.1016/j.ejphar.2007.07.050	128	67	68	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2012	7	3							e33057	10.1371/journal.pone.0033057	http://dx.doi.org/10.1371/journal.pone.0033057			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930IA	22427945	Green Published, gold			2022-12-25	WOS:000303129700028
J	Yamazaki, T; Nagao, S				Yamazaki, Tadashi; Nagao, Soichi			A Computational Mechanism for Unified Gain and Timing Control in the Cerebellum	PLOS ONE			English	Article							ADAPTIVE FILTER MODEL; NEURAL-NETWORK MODEL; VESTIBULOOCULAR REFLEX; PARALLEL FIBER; PURKINJE-CELLS; GRANULE CELLS; NUCLEAR NEURONS; ADAPTATION; CORTEX; RESPONSES	Precise gain and timing control is the goal of cerebellar motor learning. Because the basic neural circuitry of the cerebellum is homogeneous throughout the cerebellar cortex, a single computational mechanism may be used for simultaneous gain and timing control. Although many computational models of the cerebellum have been proposed for either gain or timing control, few models have aimed to unify them. In this paper, we hypothesize that gain and timing control can be unified by learning of the complete waveform of the desired movement profile instructed by climbing fiber signals. To justify our hypothesis, we adopted a large-scale spiking network model of the cerebellum, which was originally developed for cerebellar timing mechanisms to explain the experimental data of Pavlovian delay eyeblink conditioning, to the gain adaptation of optokinetic response (OKR) eye movements. By conducting large-scale computer simulations, we could reproduce some features of OKR adaptation, such as the learning-related change of simple spike firing of model Purkinje cells and vestibular nuclear neurons, simulated gain increase, and frequency-dependent gain increase. These results suggest that the cerebellum may use a single computational mechanism to control gain and timing simultaneously.	[Yamazaki, Tadashi] RIKEN Brain Sci Inst, RIKEN BSI TOYOTA Collaborat Ctr, Strateg Planning Unit, Lab Motor Learning Control, Wako, Saitama, Japan	RIKEN	Yamazaki, T (corresponding author), RIKEN Brain Sci Inst, RIKEN BSI TOYOTA Collaborat Ctr, Strateg Planning Unit, Lab Motor Learning Control, Wako, Saitama, Japan.	pone11@neuralgorithm.org			RIKEN; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [20700301]	RIKEN; Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by RIKEN and a Grant-in-Aid for Young Scientists B (20700301) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizenman CD, 1999, J NEUROPHYSIOL, V82, P1697, DOI 10.1152/jn.1999.82.4.1697; ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; Arenz A, 2008, SCIENCE, V321, P977, DOI 10.1126/science.1158391; Barmack NH, 2008, J NEUROSCI, V28, P1140, DOI 10.1523/JNEUROSCI.3942-07.2008; Bengtsson F, 2007, J NEUROPHYSIOL, V98, P1697, DOI 10.1152/jn.00057.2007; Bengtsson F, 2009, P NATL ACAD SCI USA, V106, P2389, DOI 10.1073/pnas.0808428106; Braitenberg V, 1997, BEHAV BRAIN SCI, V20, P229, DOI 10.1017/S0140525X9700143X; BULLOCK D, 1994, NEURAL NETWORKS, V7, P1101, DOI 10.1016/S0893-6080(05)80161-3; BUONOMANO DV, 1994, NEURAL COMPUT, V6, P38, DOI 10.1162/neco.1994.6.1.38; Chadderton P, 2004, NATURE, V428, P856, DOI 10.1038/nature02442; CHAPEAUBLONDEAU F, 1991, BIOL CYBERN, V65, P267, DOI 10.1007/BF00206224; CHEN C, 1995, LEARN MEMORY, V2, P185, DOI 10.1101/lm.2.3-4.185; Christian KM, 2003, LEARN MEMORY, V10, P427, DOI 10.1101/lm.59603; Coesmans M, 2004, NEURON, V44, P691, DOI 10.1016/j.neuron.2004.10.031; Dean P, 2002, P ROY SOC B-BIOL SCI, V269, P1895, DOI 10.1098/rspb.2002.2103; Dean P, 2010, NAT REV NEUROSCI, V11, P30, DOI 10.1038/nrn2756; DESMOND JE, 1988, BIOL CYBERN, V58, P405, DOI 10.1007/BF00361347; DEZEEUW CI, 1995, EUR J NEUROSCI, V7, P2322; Fiala JC, 1996, J NEUROSCI, V16, P3760; FUJITA M, 1982, BIOL CYBERN, V45, P207, DOI 10.1007/BF00336193; FUJITA M, 1982, BIOL CYBERN, V45, P195, DOI 10.1007/BF00336192; Garenne Andre, 2004, J Integr Neurosci, V3, P301, DOI 10.1142/S0219635204000555; Gerstner W., 2002, SPIKING NEURON MODEL; Gluck MA, 1990, NEUROSCIENCE CONNECT, P131; GOMI H, 1992, BIOL CYBERN, V68, P105, DOI 10.1007/BF00201432; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; Hofstotter C, 2002, EUR J NEUROSCI, V16, P1361, DOI 10.1046/j.1460-9568.2002.02182.x; Honda T, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002087; Hong S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002770; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.ne.12.030189.000505; Ito M, 1998, TRENDS COGN SCI, V2, P313, DOI 10.1016/S1364-6613(98)01222-4; Ito M, 1984, CEREBELLUM NEURAL CO; Ito M, 2008, NAT REV NEUROSCI, V9, P304, DOI 10.1038/nrn2332; Iwashita M, 2001, NEUROSCI RES, V39, P299, DOI 10.1016/S0168-0102(00)00228-5; Jirenhed DA, 2007, J NEUROSCI, V27, P2493, DOI 10.1523/JNEUROSCI.4202-06.2007; Jirenhed DA, 2011, J NEUROSCI, V31, P9070, DOI 10.1523/JNEUROSCI.1653-11.2011; Jorntell H, 2006, J NEUROSCI, V26, P11786, DOI 10.1523/JNEUROSCI.2939-06.2006; LARSONPRIOR LJ, 1995, NEUROSCIENCE, V67, P867, DOI 10.1016/0306-4522(94)00074-F; Lev-Ram V, 2003, P NATL ACAD SCI USA, V100, P15989, DOI 10.1073/pnas.2636935100; LISBERGER SG, 1992, NATURE, V360, P159, DOI 10.1038/360159a0; LISBERGER SG, 1983, J NEUROSCI, V3, P1234; LISBERGER SG, 1994, J NEUROPHYSIOL, V72, P974, DOI 10.1152/jn.1994.72.2.974; MAEKAWA K, 1981, BRAIN RES, V210, P17, DOI 10.1016/0006-8993(81)90881-7; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Mathy A, 2009, NEURON, V62, P388, DOI 10.1016/j.neuron.2009.03.023; Mauk MD, 1997, LEARN MEMORY, V4, P130, DOI 10.1101/lm.4.1.130; Medina JF, 2000, J NEUROSCI, V20, P5516, DOI 10.1523/JNEUROSCI.20-14-05516.2000; MIYASHITA Y, 1984, J PHYSIOL-LONDON, V351, P251, DOI 10.1113/jphysiol.1984.sp015243; MOORE JW, 1989, BIOL CYBERN, V62, P17, DOI 10.1007/BF00217657; MOUGINOT D, 1995, NEUROSCIENCE, V64, P699, DOI 10.1016/0306-4522(94)00456-F; NAGAO S, 1988, EXP BRAIN RES, V73, P489, DOI 10.1007/BF00406606; NAGAO S, 1983, EXP BRAIN RES, V53, P36; Rancz EA, 2007, NATURE, V450, P1245, DOI 10.1038/nature05995; Raymond JL, 1998, J NEUROSCI, V18, P9112; SAKURAI, 1987, J PHYSL, V394, P463; Shutoh F, 2006, NEUROSCIENCE, V139, P767, DOI 10.1016/j.neuroscience.2005.12.035; Steuber V, 2004, J COMPUT NEUROSCI, V17, P149, DOI 10.1023/B:JCNS.0000037678.26155.b5; Sugihara I, 2004, J NEUROSCI, V24, P8771, DOI 10.1523/JNEUROSCI.1961-04.2004; Svensson P, 2010, J NEUROPHYSIOL, V103, P1329, DOI 10.1152/jn.00524.2009; Tabata H, 2002, J NEUROPHYSIOL, V87, P2176, DOI 10.1152/jn.00168.2001; THACH WT, 1968, J NEUROPHYSIOL, V31, P785, DOI 10.1152/jn.1968.31.5.785; Yamazaki T, 2005, NEURAL COMPUT, V17, P1032, DOI 10.1162/0899766053491850; Yamazaki T, 2007, EUR J NEUROSCI, V26, P2279, DOI 10.1111/j.1460-9568.2007.05837.x; Yamazaki T, 2007, NEURAL NETWORKS, V20, P290, DOI 10.1016/j.neunet.2007.04.004	64	46	47	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2012	7	3							e33319	10.1371/journal.pone.0033319	http://dx.doi.org/10.1371/journal.pone.0033319			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930IA	22438912	Green Published, Green Submitted, gold			2022-12-25	WOS:000303129700051
J	Biasini, E; Turnbaugh, JA; Massignan, T; Veglianese, P; Forloni, G; Bonetto, V; Chiesa, R; Harris, DA				Biasini, Emiliano; Turnbaugh, Jessie A.; Massignan, Tania; Veglianese, Pietro; Forloni, Gianluigi; Bonetto, Valentina; Chiesa, Roberto; Harris, David A.			The Toxicity of a Mutant Prion Protein Is Cell-Autonomous, and Can Be Suppressed by Wild-Type Prion Protein on Adjacent Cells	PLOS ONE			English	Article							CULTURED-CELLS; TRUNCATED PRP; MICE; ATAXIA; EXPRESSION; DISEASE; PHYSIOLOGY; DOMAIN; STATE	Insight into the normal function of PrPC, and how it can be subverted to produce neurotoxic effects, is provided by PrP molecules carrying deletions encompassing the conserved central region. The most neurotoxic of these mutants, Delta 105-125 (called Delta CR), produces a spontaneous neurodegenerative illness when expressed in transgenic mice, and this phenotype can be dose-dependently suppressed by co-expression of wild-type PrP. Whether the toxic activity of Delta CR PrP and the protective activity or wild-type PrP are cell-autonomous, or can be exerted on neighboring cells, is unknown. To investigate this question, we have utilized co-cultures of differentiated neural stem cells derived from mice expressing Delta CR or wild-type PrP. Cells from the two kinds of mice, which are marked by the presence or absence of GFP, are differentiated together to yield neurons, astrocytes, and oligodendrocytes. As a surrogate read-out of Delta CR PrP toxicity, we assayed sensitivity of the cells to the cationic antibiotic, Zeocin. In a previous study, we reported that cells expressing Delta CR PrP are hypersensitive to the toxic effects of several cationic antibiotics, an effect that is suppressed by co-expression of wild type PrP, similar to the rescue of the neurodegenerative phenotype observed in transgenic mice. Using this system, we find that while Delta CR-dependent toxicity is cell-autonomous, the rescuing activity of wild-type PrP can be exerted in trans from nearby cells. These results provide important insights into how Delta CR PrP subverts a normal physiological function of PrPC, and the cellular mechanisms underlying the rescuing process.	[Biasini, Emiliano; Turnbaugh, Jessie A.; Massignan, Tania; Harris, David A.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Biasini, Emiliano; Massignan, Tania; Bonetto, Valentina; Chiesa, Roberto] Dulbecco Telethon Inst, Milan, Italy; [Biasini, Emiliano; Veglianese, Pietro; Forloni, Gianluigi; Chiesa, Roberto] Mario Negri Inst Pharmacol Res, Dept Neurosci, Milan, Italy; [Massignan, Tania; Bonetto, Valentina] Mario Negri Inst Pharmacol Res, Dept Biochem & Mol Pharmacol, Milan, Italy	Boston University; Fondazione Telethon; Dulbecco Telethon Institute (DTI); Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Biasini, E (corresponding author), Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA.	biasini@bu.edu; dharris@bu.edu	Bonetto, Valentina/ABB-6383-2020; Veglianese, Pietro/R-1871-2019; Biasini, Emiliano/A-3147-2011; Veglianese, Pietro/AAA-7394-2020; Chiesa, Roberto/G-1561-2017; Bonetto, Valentina/I-4694-2018; Forloni, Gianluigi/AAB-2115-2020	Bonetto, Valentina/0000-0003-0456-2054; Veglianese, Pietro/0000-0002-0183-9428; Biasini, Emiliano/0000-0002-3927-6341; Chiesa, Roberto/0000-0002-3842-3733; Bonetto, Valentina/0000-0003-0456-2054; Forloni, Gianluigi/0000-0001-5374-3914; Harris, David/0000-0002-6985-5790; massignan, tania/0000-0002-6176-2696	NIH [NS040975, NS052526]; Fondazione Telethon [TCR08005, TCR08002, GFP04007]; Fondazione Monzino; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065244, R01NS040975, R01NS052526] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondazione Telethon(Fondazione TelethonEuropean Commission); Fondazione Monzino; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the NIH to DAH (NS040975 and NS052526), from the Fondazione Telethon to RC (TCR08005), VB (TCR08002), and EB (GFP04007), and by a fellowship from the Fondazione Monzino to EB. VB and RC are Associate Telethon Scientists (Dulbecco Telethon Institute, Fondazione Telethon). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann F, 2007, EMBO J, V26, P538, DOI 10.1038/sj.emboj.7601510; Biasini E, 2012, TRENDS NEUROSCI, V35, P92, DOI 10.1016/j.tins.2011.10.002; BORCHELT DR, 1993, GLYCOBIOLOGY, V3, P319, DOI 10.1093/glycob/3.4.319; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; Bremer J, 2010, NAT NEUROSCI, V13, P310, DOI 10.1038/nn.2483; Chesebro B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000800; Christensen HM, 2009, J NEUROCHEM, V108, P44, DOI 10.1111/j.1471-4159.2008.05719.x; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; DAHLSTRAND J, 1995, DEV BRAIN RES, V84, P109, DOI 10.1016/0165-3806(94)00162-S; Flechsig E, 2003, EMBO J, V22, P3095, DOI 10.1093/emboj/cdg285; Harris DA, 2006, NEURON, V50, P353, DOI 10.1016/j.neuron.2006.04.020; HARRIS DA, 1993, BIOCHEMISTRY-US, V32, P1009, DOI 10.1021/bi00055a003; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Li AM, 2007, EMBO J, V26, P548, DOI 10.1038/sj.emboj.7601507; Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007; Liu T, 2002, J BIOL CHEM, V277, P47671, DOI 10.1074/jbc.M207458200; Louis Sharon A, 2005, Methods Mol Biol, V290, P265; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Mallucci GR, 2007, NEURON, V53, P325, DOI 10.1016/j.neuron.2007.01.005; Massignan T, 2011, METHODS, V53, P214, DOI 10.1016/j.ymeth.2010.11.005; Massignan T, 2010, J BIOL CHEM, V285, P7752, DOI 10.1074/jbc.M109.064949; Moore RC, 1999, J MOL BIOL, V292, P797, DOI 10.1006/jmbi.1999.3108; Parkin ET, 2004, J BIOL CHEM, V279, P11170, DOI 10.1074/jbc.M312105200; Pasupuleti M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007358; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Race B, 2009, EXP NEUROL, V217, P347, DOI 10.1016/j.expneurol.2009.03.017; Rossi D, 2001, EMBO J, V20, P694, DOI 10.1093/emboj/20.4.694; Santuccione A, 2005, J CELL BIOL, V169, P341, DOI 10.1083/jcb.200409127; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; Solomon IH, 2012, PRION, V6, P40, DOI 10.4161/pri.6.1.18627; Solomon IH, 2011, J BIOL CHEM, V286, P14724, DOI 10.1074/jbc.M110.214973; Solomon IH, 2010, J BIOL CHEM, V285, P26719, DOI 10.1074/jbc.M110.134619; Turnbaugh JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025675; Wadia JS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003314; Weissmann C, 2004, NAT REV MICROBIOL, V2, P861, DOI 10.1038/nrmicro1025; Westergard L, 2007, BBA-MOL BASIS DIS, V1772, P629, DOI 10.1016/j.bbadis.2007.02.011; Westergard L, 2011, J NEUROSCI, V31, P14005, DOI 10.1523/JNEUROSCI.1243-11.2011	37	12	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33472	10.1371/journal.pone.0033472	http://dx.doi.org/10.1371/journal.pone.0033472			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22428057	gold, Green Published			2022-12-25	WOS:000302381500145
J	Kurdian, M; Herrero-Fresneda, I; Lloberas, N; Gimenez-Bonafe, P; Coria, V; Grande, MT; Boggia, J; Malacrida, L; Torras, J; Arevalo, MA; Gonzalez-Martinez, F; Lopez-Novoa, JM; Grinyo, J; Noboa, O				Kurdian, Melania; Herrero-Fresneda, Inmaculada; Lloberas, Nuria; Gimenez-Bonafe, Pepita; Coria, Virginia; Grande, Maria T.; Boggia, Jose; Malacrida, Leonel; Torras, Joan; Arevalo, Miguel A.; Gonzalez-Martinez, Francisco; Lopez-Novoa, Jose M.; Grinyo, Josep; Noboa, Oscar			Delayed mTOR Inhibition with Low Dose of Everolimus Reduces TGF beta Expression, Attenuates Proteinuria and Renal Damage in the Renal Mass Reduction Model	PLOS ONE			English	Article							FOCAL SEGMENTAL GLOMERULOSCLEROSIS; POLYCYSTIC KIDNEY-DISEASE; MAMMALIAN TARGET; RAT MODEL; TUBULOINTERSTITIAL FIBROSIS; OBSTRUCTIVE NEPHROPATHY; URETERAL OBSTRUCTION; REMNANT KIDNEY; PROGRESSION; SIROLIMUS	Background: The immunosuppressive mammalian target of rapamycin (mTOR) inhibitors are widely used in solid organ transplantation, but their effect on kidney disease progression is controversial. mTOR has emerged as one of the main pathways regulating cell growth, proliferation, differentiation, migration, and survival. The aim of this study was to analyze the effects of delayed inhibition of mTOR pathway with low dose of everolimus on progression of renal disease and TGF beta expression in the 5/6 nephrectomy model in Wistar rats. Methods: This study evaluated the effects of everolimus (0.3 mg/k/day) introduced 15 days after surgical procedure on renal function, proteinuria, renal histology and mechanisms of fibrosis and proliferation. Results: Everolimus treated group (EveG) showed significantly less proteinuria and albuminuria, less glomerular and tubulointerstitial damage and fibrosis, fibroblast activation cell proliferation, when compared with control group (CG), even though the EveG remained with high blood pressure. Treatment with everolimus also diminished glomerular hypertrophy. Everolimus effectively inhibited the increase of mTOR developed in 5/6 nephrectomy animals, without changes in AKT mRNA or protein abundance, but with an increase in the pAKT/AKT ratio. Associated with this inhibition, everolimus blunted the increased expression of TGF beta observed in the remnant kidney model. Conclusion: Delayed mTOR inhibition with low dose of everolimus significantly prevented progressive renal damage and protected the remnant kidney. mTOR and TGF beta mRNA reduction can partially explain this anti fibrotic effect. mTOR can be a new target to attenuate the progression of chronic kidney disease even in those nephropathies of non-immunologic origin.	[Kurdian, Melania; Coria, Virginia; Boggia, Jose; Gonzalez-Martinez, Francisco; Noboa, Oscar] Univ Republica, Fac Med, Hosp Clin, Ctr Nefrol, Montevideo, Uruguay; [Kurdian, Melania; Boggia, Jose; Malacrida, Leonel; Noboa, Oscar] Univ Republica, Fac Med, Hosp Clin, Dept Fisiopatol, Montevideo, Uruguay; [Herrero-Fresneda, Inmaculada; Lloberas, Nuria; Torras, Joan; Grinyo, Josep] Hosp Univ Bellvitge, Dept Med, Lab Nefrol Expt, Barcelona, Spain; [Gimenez-Bonafe, Pepita] Univ Barcelona, Fac Med, Dept Ciencias Fisiol 2, E-08007 Barcelona, Spain; [Grande, Maria T.; Arevalo, Miguel A.] Univ Salamanca, Fac Med, Dept Anat & Histol Humanas, E-37008 Salamanca, Spain; [Lopez-Novoa, Jose M.] Univ Salamanca, Dept Fisiol & Farmacol, Inst Reina Sofia Invest Nefrol, E-37008 Salamanca, Spain	Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; University of Salamanca; University of Salamanca	Kurdian, M (corresponding author), Univ Republica, Fac Med, Hosp Clin, Ctr Nefrol, Montevideo, Uruguay.	onoboa@hc.edu.uy	Noboa, Oscar/Q-8150-2019; Lopez-Novoa, Jose M/A-3672-2008; Lloberas, Nuria/U-7497-2019; Malacrida, Leonel/AAO-1082-2020; Torras, Joan/AAH-8131-2021; Grande, M Teresa/L-2205-2014	Noboa, Oscar/0000-0002-0975-9924; Malacrida, Leonel/0000-0001-6253-9229; Grande, M Teresa/0000-0001-7447-328X; Boggia de Izaguirre, Jose Gabriel/0000-0002-1564-8534; Lopez-Novoa, Jose M./0000-0002-6211-7269; Gimenez-Bonafe, Pepita/0000-0002-4713-903X	Spanish Society of Nephrology [S/C/OP/76/16]; Ministry of Science and Innovation [SAF2010-15881]; Novartis (Novartis) [071160-001141-05]; International Society of Nephrology	Spanish Society of Nephrology; Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Novartis (Novartis); International Society of Nephrology	This work was supported by: Grant PDT Conycit Uruguay S/C/OP/76/16 (I.P.O. Noboa) Fellow Grant by the Spanish Society of Nephrology (M. Kurdian); Grant SAF2010-15881, Ministry of Science and Innovation (to JM Lopez-Novoa); Grant to the School of Medicine Uruguay by Novartis (Novartis) 071160-001141-05; and International Society of Nephrology Sister Centre Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonegio RGB, 2005, J AM SOC NEPHROL, V16, P2063, DOI 10.1681/ASN.2004030180; Bottinger EP, 2002, J AM SOC NEPHROL, V13, P2600, DOI 10.1097/01.ASN.0000033611.79556.AE; Daniel C, 2000, EXP NEPHROL, V8, P52; Dickmann F, 2007, NEPHROL DIAL TRANSPL, V22, P2316, DOI 10.1093/ndt/gfm181; Diekmann F, 2007, J AM SOC NEPHROL, V18, P2653, DOI 10.1681/ASN.2007010087; Dunn C, 2006, DRUGS, V66, P547, DOI 10.2165/00003495-200666040-00009; Eddy AA, 2005, ADV CHRONIC KIDNEY D, V12, P353, DOI 10.1053/j.ackd.2005.07.011; Flores O, 1998, EXP NEPHROL, V6, P39; Gadola L, 2004, KIDNEY INT, V65, P1224, DOI 10.1111/j.1523-1755.2004.00496.x; Grande MT, 2009, NAT REV NEPHROL, V5, P319, DOI 10.1038/nrneph.2009.74; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Herrero-Fresneda I, 2000, TRANSPLANTATION, V70, P1624, DOI 10.1097/00007890-200012150-00015; Junaid A, 1997, J AM SOC NEPHROL, V8, P1732; Kaneku Hugo K, 2006, Clin Transpl, P1; Kramer S, 2008, AM J PHYSIOL-RENAL, V294, pF440, DOI 10.1152/ajprenal.00379.2007; Letavernier E, 2007, CLIN J AM SOC NEPHRO, V2, P326, DOI 10.2215/CJN.03751106; Letavernier Emmanuel, 2008, Transplant Rev (Orlando), V22, P125, DOI 10.1016/j.trre.2007.12.001; Li C, 2009, NAT REV NEPHROL; Lieberthal W, 2001, AM J PHYSIOL-RENAL, V281, pF693, DOI 10.1152/ajprenal.2001.281.4.F693; Lieberthal W, 2009, J AM SOC NEPHROL, V20, P2493, DOI 10.1681/ASN.2008111186; Lloberas N, 2006, J AM SOC NEPHROL, V17, P1395, DOI 10.1681/ASN.2005050549; Masseroli M, 1998, LAB INVEST, V78, P511; McTaggart RA, 2003, AM J TRANSPLANT, V3, P416, DOI 10.1034/j.1600-6143.2003.00078.x; Morales J, 2007, TRANSPL P, V39, P591, DOI 10.1016/j.transproceed.2006.12.026; Nakagawa S, 2010, BIOCHEM PHARMACOL, V79, P67, DOI 10.1016/j.bcp.2009.07.015; Nankivell Brian J., 2003, New England Journal of Medicine, V349, P2326, DOI 10.1056/NEJMoa020009; NATH KA, 1992, AM J KIDNEY DIS, V20, P1; Ng YY, 1998, KIDNEY INT, V54, P864, DOI 10.1046/j.1523-1755.1998.00076.x; Ponticelli C, 2008, TRANSPL INT, V21, P2, DOI 10.1111/j.1432-2277.2007.00524.x; Rahimi RA, 2009, CANCER RES, V69, P84, DOI 10.1158/0008-5472.CAN-08-2146; Rangan GK, 2007, NEPHROL DIAL TRANSPL, V22, P2175, DOI 10.1093/ndt/gfm191; Rovira J, 2009, TRANSPLANTATION, V88, P646, DOI 10.1097/TP.0b013e3181b24463; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schanstra JP, 2002, J CLIN INVEST, V110, P371, DOI 10.1172/JCI200215493; Shihab FS, 2004, KIDNEY INT, V65, P1262, DOI 10.1111/j.1523-1755.2004.00498.x; Strutz F, 2006, NEPHROL DIAL TRANSPL; Taal MW, 2001, AM J PHYSIOL-RENAL, V280, pF343, DOI 10.1152/ajprenal.2001.280.2.F343; Tao YX, 2005, J AM SOC NEPHROL, V16, P46, DOI 10.1681/ASN.2004080660; Grande MT, 2010, KIDNEY INT, V77, P509, DOI 10.1038/ki.2009.498; Torras J, 2009, NEPHROL DIAL TRANSPL; TURPEINEN U, 1987, CLIN CHEM, V33, P1756; VENIANT M, 1994, KIDNEY INT, V46, P421, DOI 10.1038/ki.1994.290; Vogelbacher R, 2007, TRANSPLANTATION, V84, P1492, DOI 10.1097/01.tp.0000282866.92367.99; Vollenbroker B, 2009, AM J PHYSIOL-RENAL, V296, pF418, DOI 10.1152/ajprenal.90319.2008; Wang SN, 2010, AM J PHYSIOL-RENAL, V298, pF142, DOI 10.1152/ajprenal.00320.2009; Wittmann S, 2008, NEPHRON EXP NEPHROL, V108, P45, DOI 10.1159/000116112; Wu MJ, 2006, KIDNEY INT, V69, P2029, DOI 10.1038/sj.ki.5000161; Zafar I, 2009, NEPHROL DIAL TRANSPL, V24, P2349, DOI 10.1093/ndt/gfp129; Zhang G, 2001, EXP NEPHROL, V9, P71	50	30	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e32516	10.1371/journal.pone.0032516	http://dx.doi.org/10.1371/journal.pone.0032516			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427849	Green Published, Green Submitted, gold			2022-12-25	WOS:000302381500024
J	Kwon, S; Kim, D; Park, BK; Cho, S; Kim, KD; Kim, YE; Park, CS; Ahn, HJ; Seo, JN; Choi, KC; Kim, DS; Lee, Y; Kwon, HJ				Kwon, Sanghoon; Kim, Dongbum; Park, Byoung Kwon; Cho, Sunhee; Kim, Kwang Dong; Kim, Young-Eun; Park, Cheung-Seog; Ahn, Hyun-Jong; Seo, Jae-Nam; Choi, Kyung-Chan; Kim, Doo-Sik; Lee, Younghee; Kwon, Hyung-Joo			Prevention and Therapy of Hepatocellular Carcinoma by Vaccination with TM4SF5 Epitope-CpG-DNA-Liposome Complex without Carriers	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; GENE-TRANSCRIPTION; DELIVERY-SYSTEMS; IMMUNE-RESPONSE; DENDRITIC CELLS; INNATE IMMUNITY; BACTERIAL-DNA; IN-VIVO; OLIGODEOXYNUCLEOTIDES; PEPTIDE	Although peptide vaccines have been actively studied in various animal models, their efficacy in treatment is limited. To improve the efficacy of peptide vaccines, we previously formulated an efficacious peptide vaccine without carriers using the natural phosphodiester bond CpG-DNA and a special liposome complex (Lipoplex(O)). Here, we show that immunization of mice with a complex consisting of peptide and Lipoplex(O) without carriers significantly induces peptide-specific IgG2a production in a CD4(+) cells-and Th1 differentiation-dependent manner. The transmembrane 4 superfamily member 5 protein (TM4SF5) has gained attention as a target for hepatocellular carcinoma (HCC) therapy because it induces uncontrolled growth of human HCC cells via the loss of contact inhibition. Monoclonal antibodies specific to an epitope of human TM4SF5 (hTM4SF5R2-3) can recognize native mouse TM4SF5 and induce functional effects on mouse cancer cells. Pre-immunization with a complex of the hTM4SF5R2-3 epitope and Lipoplex(O) had prophylactic effects against tumor formation by HCC cells implanted in an mouse tumor model. Furthermore, therapeutic effects were revealed regarding the growth of HCC when the vaccine was injected into mice after tumor formation. These results suggest that our improved peptide vaccine technology provides a novel prophylaxis measure as well as therapy for HCC patients with TM4SF5-positive tumors.	[Kwon, Sanghoon; Kim, Dongbum; Park, Byoung Kwon; Cho, Sunhee; Kwon, Hyung-Joo] Hallym Univ, Coll Med, Dept Microbiol, Gangwon Do, South Korea; [Kim, Kwang Dong] Gyeongsang Natl Univ, PMBBRC, Div Appl Life Sci, Program BK21, Jinju, South Korea; [Kim, Young-Eun; Lee, Younghee] Chungbuk Natl Univ, Coll Nat Sci, Dept Biochem, Chungbuk, South Korea; [Park, Cheung-Seog; Ahn, Hyun-Jong] Kyung Hee Univ, Coll Med, Dept Microbiol, Seoul, South Korea; [Seo, Jae-Nam; Choi, Kyung-Chan] Hallym Univ, Coll Med, Dept Pathol, Gangwon Do, South Korea; [Kim, Doo-Sik] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul 120749, South Korea; [Kwon, Hyung-Joo] Hallym Univ, Coll Med, Ctr Med Sci Res, Gangwon Do, South Korea	Hallym University; Gyeongsang National University; Chungbuk National University; Kyung Hee University; Hallym University; Yonsei University; Hallym University	Kwon, S (corresponding author), Hallym Univ, Coll Med, Dept Microbiol, Gangwon Do, South Korea.	yhl4177@cbnu.ac.kr; hjookwon@hallym.ac.kr			Stem Cell Research Center [SC2260]; National Research Foundation [20090081761, 20090083296, 2009-0093812]; Ministry of Education, Science and Technology in the Republic of Korea	Stem Cell Research Center; National Research Foundation; Ministry of Education, Science and Technology in the Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by a grant (SC2260) from the Stem Cell Research Center of the 21st Century Frontier Research Program, and grants from the National Research Foundation (20090081761, 20090083296, 2009-0093812) funded by the Ministry of Education, Science and Technology in the Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albiger B, 2007, CELL MICROBIOL, V9, P633, DOI 10.1111/j.1462-5822.2006.00814.x; ALLEY MC, 1988, CANCER RES, V48, P589; Ben-Yedidia T, 1999, INT IMMUNOL, V11, P1043, DOI 10.1093/intimm/11.7.1043; Ben-Yedidia T, 2007, EXPERT REV VACCINES, V6, P939, DOI 10.1586/14760584.6.6.939; BenYedidia T, 1997, CURR OPIN BIOTECH, V8, P442, DOI 10.1016/S0958-1669(97)80066-3; Bhan U, 2007, J IMMUNOL, V179, P3937, DOI 10.4049/jimmunol.179.6.3937; Bhowmick S, 2010, J CONTROL RELEASE, V141, P199, DOI 10.1016/j.jconrel.2009.09.018; Bijker MS, 2007, EXPERT REV VACCINES, V6, P591, DOI 10.1586/14760584.6.4.591; Bode C, 2011, EXPERT REV VACCINES, V10, P499, DOI [10.1586/erv.10.174, 10.1586/ERV.10.174]; Cai GF, 2000, J IMMUNOL, V165, P2619, DOI 10.4049/jimmunol.165.5.2619; Carson DA, 1997, J EXP MED, V186, P1621, DOI 10.1084/jem.186.10.1621; Chang JS, 2001, VACCINE, V19, P3608, DOI 10.1016/S0264-410X(01)00104-9; Chikh G, 2002, BIOSCIENCE REP, V22, P339, DOI 10.1023/A:1020151025412; Chu RS, 1997, J EXP MED, V186, P1623, DOI 10.1084/jem.186.10.1623; Davis HL, 1998, J IMMUNOL, V160, P870; Deng GM, 1999, NAT MED, V5, P702, DOI 10.1038/9554; Felnerova D, 2004, CURR OPIN BIOTECH, V15, P518, DOI 10.1016/j.copbio.2004.10.005; FINKELMAN FD, 1988, J IMMUNOL, V140, P1022; Gregoriadis G, 1996, J DRUG TARGET, V3, P469, DOI 10.3109/10611869609015966; Gursel I, 2001, J IMMUNOL, V167, P3324, DOI 10.4049/jimmunol.167.6.3324; Heikenwalder M, 2004, NAT MED, V10, P187, DOI 10.1038/nm987; Henriksen-Lacey M, 2011, EXPERT OPIN DRUG DEL, V8, P505, DOI 10.1517/17425247.2011.558081; JIN FS, 1991, J IMMUNOL, V146, P1806; Kim D, 2011, BMB REP, V44, P607, DOI 10.5483/BMBRep.2011.44.9.607; Kim D, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-29; Kim D, 2009, BIOCHEM BIOPH RES CO, V379, P362, DOI 10.1016/j.bbrc.2008.12.063; Kim H, 2012, CANCER LETT, V314, P198, DOI 10.1016/j.canlet.2011.09.030; Klinman DM, 2004, IMMUNOL REV, V199, P201, DOI 10.1111/j.0105-2896.2004.00148.x; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Krieg AM, 1998, J IMMUNOL, V161, P2428; Krug A, 2004, IMMUNITY, V21, P107, DOI 10.1016/j.immuni.2004.06.007; Lee KW, 2006, MOL IMMUNOL, V43, P2107, DOI 10.1016/j.molimm.2005.12.004; Lee KW, 2004, MOL IMMUNOL, V41, P955, DOI 10.1016/j.molimm.2004.06.022; Lee SA, 2008, J CLIN INVEST, V118, P1354, DOI 10.1172/JCI33768; Lee SA, 2011, FRONT BIOSCI-LANDMRK, V16, P1752, DOI 10.2741/3818; Lee SA, 2009, HEPATOLOGY, V49, P1316, DOI 10.1002/hep.22777; Lekishvili T, 2008, J CELL SCI, V121, P685, DOI 10.1242/jcs.020347; Li WM, 2003, VACCINE, V21, P3319, DOI 10.1016/S0264-410X(03)00172-5; Linehan LA, 1998, J IMMUNOL, V161, P302; Lipford GB, 2000, J IMMUNOL, V165, P1228, DOI 10.4049/jimmunol.165.3.1228; Matsukawa A, 2001, J EXP MED, V193, P679, DOI 10.1084/jem.193.6.679; Mbow ML, 2010, CURR OPIN IMMUNOL, V22, P411, DOI 10.1016/j.coi.2010.04.004; Motomura Y, 2008, INT J ONCOL, V32, P985; Muller-Pillasch F, 1998, GENE, V208, P25, DOI 10.1016/S0378-1119(97)00633-1; Nakatsura T, 2003, BIOCHEM BIOPH RES CO, V306, P16, DOI 10.1016/S0006-291X(03)00908-2; Schreiber TH, 2010, SEMIN IMMUNOL, V22, P105, DOI 10.1016/j.smim.2010.02.001; Simoes S, 2004, ADV DRUG DELIVER REV, V56, P947, DOI 10.1016/j.addr.2003.10.038; SNAPPER CM, 1987, SCIENCE, V236, P944, DOI 10.1126/science.3107127; Stamm LM, 1998, J IMMUNOL, V161, P6180; Suzuki Y, 2004, CANCER RES, V64, P8754, DOI 10.1158/0008-5472.CAN-04-1691; Walker PS, 1999, P NATL ACAD SCI USA, V96, P6970, DOI 10.1073/pnas.96.12.6970; Wurster AL, 2000, ONCOGENE, V19, P2577, DOI 10.1038/sj.onc.1203485; Yoshiji H, 1999, CANCER RES, V59, P4413; Yoshiji H, 2001, CLIN CANCER RES, V7, P1073; ZARET KS, 1988, P NATL ACAD SCI USA, V85, P9076, DOI 10.1073/pnas.85.23.9076	55	23	26	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33121	10.1371/journal.pone.0033121	http://dx.doi.org/10.1371/journal.pone.0033121			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427965	Green Published, gold, Green Submitted			2022-12-25	WOS:000302381500095
J	Takayama, K; Ooto, S; Hangai, M; Arakawa, N; Oshima, S; Shibata, N; Hanebuchi, M; Inoue, T; Yoshimura, N				Takayama, Kohei; Ooto, Sotaro; Hangai, Masanori; Arakawa, Naoko; Oshima, Susumu; Shibata, Naohisa; Hanebuchi, Masaaki; Inoue, Takashi; Yoshimura, Nagahisa			High-Resolution Imaging of the Retinal Nerve Fiber Layer in Normal Eyes Using Adaptive Optics Scanning Laser Ophthalmoscopy	PLOS ONE			English	Article							LIVING HUMAN EYE; COHERENCE TOMOGRAPHY; STRATUS OCT; THICKNESS; BUNDLES; PHOTOGRAPHY; POLARIMETRY; DEFECTS; PRIMATE; CELLS	Purpose: To conduct high-resolution imaging of the retinal nerve fiber layer (RNFL) in normal eyes using adaptive optics scanning laser ophthalmoscopy (AO-SLO). Methods: AO-SLO images were obtained in 20 normal eyes at multiple locations in the posterior polar area and a circular path with a 3-4-mm diameter around the optic disc. For each eye, images focused on the RNFL were recorded and a montage of AO-SLO images was created. Results: AO-SLO images for all eyes showed many hyperreflective bundles in the RNFL. Hyperreflective bundles above or below the fovea were seen in an arch from the temporal periphery on either side of a horizontal dividing line to the optic disc. The dark lines among the hyperreflective bundles were narrower around the optic disc compared with those in the temporal raphe. The hyperreflective bundles corresponded with the direction of the striations on SLO red-free images. The resolution and contrast of the bundles were much higher in AO-SLO images than in red-free fundus photography or SLO red-free images. The mean hyperreflective bundle width around the optic disc had a double-humped shape; the bundles at the temporal and nasal sides of the optic disc were narrower than those above and below the optic disc (P<0.001). RNFL thickness obtained by optical coherence tomography correlated with the hyperreflective bundle widths on AO-SLO (P<0.001) Conclusions: AO-SLO revealed hyperreflective bundles and dark lines in the RNFL, believed to be retinal nerve fiber bundles and Muller cell septa. The widths of the nerve fiber bundles appear to be proportional to the RNFL thickness at equivalent distances from the optic disc.	[Takayama, Kohei; Ooto, Sotaro; Hangai, Masanori; Arakawa, Naoko; Yoshimura, Nagahisa] Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto, Japan; [Oshima, Susumu; Shibata, Naohisa; Hanebuchi, Masaaki] NIDEK, Gamagori, Japan; [Inoue, Takashi] Hamamatsu Photon KK, Cent Res Lab, Hamakita, Japan	Kyoto University; Nidek Co., Ltd; Hamamatsu Photonics	Takayama, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto, Japan.	ohoto@kuhp.kyoto-u.ac.jp			New Energy and Industrial Technology Development Organization, Kawasaki, Japan [P05002]	New Energy and Industrial Technology Development Organization, Kawasaki, Japan(New Energy and Industrial Technology Development Organization (NEDO))	Supported by a grant from the New Energy and Industrial Technology Development Organization (P05002), Kawasaki, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DR., 1999, AUTOMATED STATIC PER; BENNETT AG, 1994, GRAEF ARCH CLIN EXP, V232, P361, DOI 10.1007/BF00175988; Bowd C, 2006, INVEST OPHTH VIS SCI, V47, P2889, DOI 10.1167/iovs.05-1489; Budenz DL, 2007, OPHTHALMOLOGY, V114, P1046, DOI 10.1016/j.ophtha.2006.08.046; Burns SA, 2007, J OPT SOC AM A, V24, P1313, DOI 10.1364/JOSAA.24.001313; Carroll J, 2004, P NATL ACAD SCI USA, V101, P8461, DOI 10.1073/pnas.0401440101; Cense B, 2009, OPT EXPRESS, V17, P4095, DOI 10.1364/OE.17.004095; Choi SS, 2008, INVEST OPHTH VIS SCI, V49, P2103, DOI 10.1167/iovs.07-0980; Choi SS, 2006, INVEST OPHTH VIS SCI, V47, P2080, DOI 10.1167/iovs.05-0997; Duncan JL, 2007, INVEST OPHTH VIS SCI, V48, P3283, DOI 10.1167/iovs.06-1422; Ferguson RD, 2010, J OPT SOC AM A, V27, pA265, DOI 10.1364/JOSAA.27.00A265; Franze K, 2007, P NATL ACAD SCI USA, V104, P8287, DOI 10.1073/pnas.0611180104; Frenkel S, 2005, EYE, V19, P491, DOI 10.1038/sj.eye.6701569; Haung H, 2009, P SOC PHOTO-OPT INS, V7156; Hirasawa H, 2010, ARCH OPHTHALMOL-CHIC, V128, P1420, DOI 10.1001/archophthalmol.2010.244; Hong SM, 2007, OPHTHALMOLOGY, V114, P210, DOI 10.1016/j.ophtha.2006.09.021; Inoue T, 2007, P SOC PHOTO-OPT INS, V6478; JONAS JB, 1990, INVEST OPHTH VIS SCI, V31, P736; Kaliner E, 2007, OPHTHALMOLOGY, V114, P2259, DOI 10.1016/j.ophtha.2007.01.028; Kawaguchi I, 2006, INVEST OPHTH VIS SCI, V47, P2911, DOI 10.1167/iovs.05-1169; Kerrigan-Baumrind LA, 2000, INVEST OPHTH VIS SCI, V41, P741; Kitaguchi Y, 2008, OPHTHALMOLOGY, V115, P1771, DOI 10.1016/j.ophtha.2008.03.026; Kocaoglu OP, 2011, VISION RES, V51, P1835, DOI 10.1016/j.visres.2011.06.013; Kurokawa K, 2010, OPT EXPRESS, V18, P8515, DOI 10.1364/OE.18.008515; Leung CKS, 2008, INVEST OPHTH VIS SCI, V49, P4886, DOI 10.1167/iovs.07-1187; Marmor MF, 2008, ARCH OPHTHALMOL-CHIC, V126, P907, DOI 10.1001/archopht.126.7.907; MIGLIOR S, 1994, AM J OPHTHALMOL, V118, P16, DOI 10.1016/S0002-9394(14)72837-5; Morgan JE, 1990, BR J OPHTHALMOL, V82, P684; OGDEN TE, 1983, INVEST OPHTH VIS SCI, V24, P85; OGDEN TE, 1984, INVEST OPHTH VIS SCI, V25, P19; OGDEN TE, 1978, INVEST OPHTH VIS SCI, V17, P499; Ooto S, 2011, INVEST OPHTH VIS SCI, V52, P5541, DOI 10.1167/iovs.11-7251; Ooto S, 2011, OPHTHALMOLOGY, V118, P873, DOI 10.1016/j.ophtha.2010.08.032; Ooto S, 2010, OPHTHALMOLOGY, V117, P1800, DOI 10.1016/j.ophtha.2010.01.042; Pallikaris A, 2003, INVEST OPHTH VIS SCI, V44, P4580, DOI 10.1167/iovs.03-0094; Parikh RS, 2007, OPHTHALMOLOGY, V114, P921, DOI 10.1016/j.ophtha.2007.01.023; Pocock GM, 2009, INVEST OPHTH VIS SCI, V50, P5238, DOI 10.1167/iovs.08-3263; QUIGLEY HA, 1982, ARCH OPHTHALMOL-CHIC, V100, P807; RADIUS RL, 1979, ARCH OPHTHALMOL-CHIC, V97, P1154; RADIUS RL, 1979, ARCH OPHTHALMOL-CHIC, V97, P948; Roorda A, 2002, OPT EXPRESS, V10, P405, DOI 10.1364/OE.10.000405; Roorda A, 1999, NATURE, V397, P520, DOI 10.1038/17383; Roorda A, 2002, J VISION, V2, P404, DOI 10.1167/2.5.4; Sakamoto A, 2008, OPHTHALMOLOGY, V115, P1071, DOI 10.1016/j.ophtha.2007.09.001; Savini G, 2007, ARCH OPHTHALMOL-CHIC, V125, P901, DOI 10.1001/archopht.125.7.901; Tam J, 2011, BIOMED OPT EXPRESS, V2, P781, DOI 10.1364/BOE.2.000781; Tan O, 2008, OPHTHALMOLOGY, V115, P949, DOI 10.1016/j.ophtha.2007.08.011; Tan O, 2009, OPHTHALMOLOGY, V116, P2305, DOI 10.1016/j.ophtha.2009.05.025; Toyoda H, 2001, P SOC PHOTO-OPT INS, V4416, P256, DOI 10.1117/12.427061; Wolfing JI, 2006, OPHTHALMOLOGY, V113, P1014, DOI 10.1016/j.ophtha.2006.01.056; Yoon MK, 2009, INVEST OPHTH VIS SCI, V50, P1838, DOI 10.1167/iovs.08-2029; Zawadzki RJ, 2007, J OPT SOC AM A, V24, P1373, DOI 10.1364/JOSAA.24.001373	52	47	49	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33158	10.1371/journal.pone.0033158	http://dx.doi.org/10.1371/journal.pone.0033158			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427978	Green Published, gold, Green Submitted			2022-12-25	WOS:000302381500103
J	Trenor, B; Cardona, K; Gomez, JF; Rajamani, S; Ferrero, JM; Belardinelli, L; Saiz, J				Trenor, Beatriz; Cardona, Karen; Gomez, Juan F.; Rajamani, Sridharan; Ferrero, Jose M., Jr.; Belardinelli, Luiz; Saiz, Javier			Simulation and Mechanistic Investigation of the Arrhythmogenic Role of the Late Sodium Current in Human Heart Failure	PLOS ONE			English	Article							TORSADES-DE-POINTES; LATE NA+ CURRENT; CARDIAC SARCOPLASMIC-RETICULUM; HUMAN VENTRICULAR MYOCYTES; TRANSIENT OUTWARD CURRENT; RATE DEPENDENCE; ACTION-POTENTIALS; RATE ADAPTATION; CELLULAR BASIS; I-KR	Heart failure constitutes a major public health problem worldwide. The electrophysiological remodeling of failing hearts sets the stage for malignant arrhythmias, in which the role of the late Na+ current (I-NaL) is relevant and is currently under investigation. In this study we examined the role of I-NaL in the electrophysiological phenotype of ventricular myocytes, and its proarrhythmic effects in the failing heart. A model for cellular heart failure was proposed using a modified version of Grandi et al. model for human ventricular action potential that incorporates the formulation of I-NaL. A sensitivity analysis of the model was performed and simulations of the pathological electrical activity of the cell were conducted. The proposed model for the human I-NaL and the electrophysiological remodeling of myocytes from failing hearts accurately reproduce experimental observations. The sensitivity analysis of the modulation of electrophysiological parameters of myocytes from failing hearts due to ion channels remodeling, revealed a role for I-NaL in the prolongation of action potential duration (APD), triangulation of the shape of the AP, and changes in Ca2+ transient. A mechanistic investigation of intracellular Na+ accumulation and APD shortening with increasing frequency of stimulation of failing myocytes revealed a role for the Na+/K+ pump, the Na+/Ca2+ exchanger and I-NaL. The results of the simulations also showed that in failing myocytes, the enhancement of I-NaL increased the reverse rate-dependent APD prolongation and the probability of initiating early afterdepolarizations. The electrophysiological remodeling of failing hearts and especially the enhancement of the I-NaL prolong APD and alter Ca2+ transient facilitating the development of early afterdepolarizations. An enhanced I-NaL appears to be an important contributor to the electrophysiological phenotype and to the dysregulation of [Ca2+]ihomeostasis of failing myocytes.	[Trenor, Beatriz; Cardona, Karen; Gomez, Juan F.; Ferrero, Jose M., Jr.; Saiz, Javier] Univ Politecn Valencia, Inst Invest Interuniv Bioingn & Tecnol Orientada, E-46071 Valencia, Spain; [Rajamani, Sridharan; Belardinelli, Luiz] Gilead Sci Inc, Dept Biol, Palo Alto, CA USA	Universitat Politecnica de Valencia; Gilead Sciences	Trenor, B (corresponding author), Univ Politecn Valencia, Inst Invest Interuniv Bioingn & Tecnol Orientada, E-46071 Valencia, Spain.	btrenor@eln.upv.es	Saiz, Javier/I-1295-2015; Ferrero, Jose M/I-2034-2015; Gomez, Juan F/B-5228-2017; Gómez, Juan F/ABA-8500-2020; Trenor, Beatriz/H-1716-2015	Saiz, Javier/0000-0002-9850-0825; Ferrero, Jose M/0000-0003-4200-9225; Gomez, Juan F/0000-0003-0253-4842; Gómez, Juan F/0000-0003-0253-4842; Trenor, Beatriz/0000-0001-9166-6112	European Commission [DG-INFSO-224381]; Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica del Ministerio de Ciencia e Innovacion of Spain [TEC2008-02090]; Programa de Apoyo a la Investigacion y Desarrollo, de la Universidad Politecnica de Valencia [PAID-06-09-2843, PAID-06-11-2002]; Direccion General de Politica Cientifica de la Generalitat Valenciana [GV/2010/078]	European Commission(European CommissionEuropean Commission Joint Research Centre); Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica del Ministerio de Ciencia e Innovacion of Spain; Programa de Apoyo a la Investigacion y Desarrollo, de la Universidad Politecnica de Valencia; Direccion General de Politica Cientifica de la Generalitat Valenciana	This work was partially supported by the European Commission preDiCT grant (DG-INFSO-224381), by the Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica del Ministerio de Ciencia e Innovacion of Spain (TEC2008-02090), by the Programa de Apoyo a la Investigacion y Desarrollo (PAID-06-09-2843, PAID-06-11-2002) de la Universidad Politecnica de Valencia, by the Direccion General de Politica Cientifica de la Generalitat Valenciana (GV/2010/078). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was also supported by Gilead Sciences Palo Alto. Dr. Rajamani and Dr. Belardinelli are employees of Gilead Sciences and have collaborated in the study design and manuscript preparation. No additional external funding received for this study.	Antoons G, 2007, J ELECTROCARDIOL, V40, pS8, DOI 10.1016/j.jelectrocard.2007.05.022; Antoons G, 2010, J AM COLL CARDIOL, V55, P801, DOI 10.1016/j.jacc.2009.10.033; Baartscheer A, 2003, CARDIOVASC RES, V57, P986, DOI 10.1016/S0008-6363(02)00848-9; Bers DM, 2006, ANN NY ACAD SCI, V1080, P165, DOI 10.1196/annals.1380.015; BEUCKELMANN DJ, 1992, CIRCULATION, V85, P1046, DOI 10.1161/01.CIR.85.3.1046; BEUCKELMANN DJ, 1993, CIRC RES, V73, P379, DOI 10.1161/01.RES.73.2.379; Biliczki P, 2002, BRIT J PHARMACOL, V137, P361, DOI 10.1038/sj.bjp.0704881; Bundgaard H, 1996, MOL CELL BIOCHEM, V164, P277, DOI 10.1007/BF00408668; Cardona K, 2010, IEEE ENG MED BIO, P3237, DOI 10.1109/IEMBS.2010.5627184; Carmeliet E, 2004, CELL CALCIUM, V35, P557, DOI 10.1016/j.ceca.2004.01.010; Carro J, 2011, PHILOS T R SOC A, V369, P4205, DOI 10.1098/rsta.2011.0127; Curran J, 2010, J MOL CELL CARDIOL, V49, P25, DOI 10.1016/j.yjmcc.2010.03.013; Despa S, 2002, CIRCULATION, V105, P2543, DOI 10.1161/01.CIR.0000016701.85760.97; Dorian P, 2000, EUROPACE, V2, P277, DOI 10.1053/eupc.2000.0114; DROUIN E, 1995, J AM COLL CARDIOL, V26, P185, DOI 10.1016/0735-1097(95)00167-X; Eisner DA, 2009, EXP PHYSIOL, V94, P520, DOI 10.1113/expphysiol.2008.044008; Faber GM, 2000, BIOPHYS J, V78, P2392, DOI 10.1016/S0006-3495(00)76783-X; Glukhov AV, 2010, CIRC RES, V106, P981, DOI 10.1161/CIRCRESAHA.109.204891; Grandi E, 2007, BIOPHYS J, V93, P3835, DOI 10.1529/biophysj.107.114868; Grandi E, 2010, J MOL CELL CARDIOL, V48, P112, DOI 10.1016/j.yjmcc.2009.09.019; HASENFUSS G, 1994, CIRC RES, V75, P434, DOI 10.1161/01.RES.75.3.434; Hund TJ, 2010, J CLIN INVEST, V120, P3508, DOI 10.1172/JCI43621; Hund TJ, 2004, CIRCULATION, V110, P3168, DOI 10.1161/01.CIR.0000147231.69595.D3; Janse MJ, 2004, CARDIOVASC RES, V61, P208, DOI 10.1016/j.cardiores.2003.11.018; JANUARY CT, 1988, CIRC RES, V62, P563, DOI 10.1161/01.RES.62.3.563; Levi AJ, 1997, J CARDIOVASC ELECTR, V8, P700, DOI 10.1111/j.1540-8167.1997.tb01834.x; Li GR, 2004, HEART RHYTHM, V1, P460, DOI 10.1016/j.hrthm.2004.06.003; Li GR, 2002, AM J PHYSIOL-HEART C, V283, pH1031, DOI 10.1152/ajpheart.00105.2002; Li GR, 1998, AM J PHYSIOL-HEART C, V275, pH369, DOI 10.1152/ajpheart.1998.275.2.H369; Maltsev VA, 2006, CARDIOVASC RES, V69, P116, DOI 10.1016/j.cardiores.2005.08.015; Maltsev VA, 2001, J MOL CELL CARDIOL, V33, P923, DOI 10.1006/jmcc.2001.1355; Maltsev VA, 1998, CIRCULATION, V98, P2545, DOI 10.1161/01.CIR.98.23.2545; Maltsev VA, 2007, EUR J HEART FAIL, V9, P219, DOI 10.1016/j.ejheart.2006.08.007; Milberg P, 2008, HEART RHYTHM, V5, P1444, DOI 10.1016/j.hrthm.2008.06.017; Nabauer M, 1996, CIRCULATION, V93, P168, DOI 10.1161/01.CIR.93.1.168; Nagatomo T, 2000, MOL PHARMACOL, V57, P101; Nagatomo T, 1998, AM J PHYSIOL-HEART C, V275, pH2016, DOI 10.1152/ajpheart.1998.275.6.H2016; Noble D, 1998, CAN J CARDIOL, V14, P123; O'Hara T, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002061; Piacentino V, 2003, CIRC RES, V92, P651, DOI 10.1161/01.RES.0000062469.83985.9B; Pieske B, 2002, CIRCULATION, V106, P447, DOI 10.1161/01.CIR.0000023042.50192.F4; Pogwizd SM, 2003, CARDIOVASC RES, V57, P887, DOI 10.1016/S0008-6363(02)00735-6; Priebe L, 1998, CIRC RES, V82, P1206, DOI 10.1161/01.RES.82.11.1206; Pueyo E, 2010, AM J PHYSIOL-HEART C, V298, pH1577, DOI 10.1152/ajpheart.00936.2009; Rajamani S, 2009, HEART RHYTHM; Reinecke H, 1996, CARDIOVASC RES, V31, P48, DOI 10.1016/0008-6363(95)00176-X; Romero L, 2009, AM J PHYSL HEART CIR; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; SCHWINGER RHG, 1995, CIRCULATION, V92, P3220, DOI 10.1161/01.CIR.92.11.3220; Shannon TR, 2005, BIOPHYS J, V89, P4096, DOI 10.1529/biophysj.105.068734; Shannon TR, 2004, BIOPHYS J, V87, P3351, DOI 10.1529/biophysj.104.047449; So PS, 2008, BRIT J PHARMACOL, V155, P1185, DOI 10.1038/bjp.2008.354; ten Tusscher KHWJ, 2006, AM J PHYSIOL-HEART C, V291, pH1088, DOI 10.1152/ajpheart.00109.2006; ten Tusscher KHWJ, 2004, AM J PHYSIOL-HEART C, V286, pH1573, DOI 10.1152/ajpheart.00794.2003; Tomaselli GF, 2004, CIRC RES, V95, P754, DOI 10.1161/01.RES.0000145047.14691.db; Tomaselli GF, 1999, CARDIOVASC RES, V42, P270, DOI 10.1016/S0008-6363(99)00017-6; Undrovinas AI, 2002, J MOL CELL CARDIOL, V34, P1477, DOI 10.1006/jmcc.2002.2100; Undrovinas AI, 1999, CELL MOL LIFE SCI, V55, P494, DOI 10.1007/s000180050306; Undrovinas Albertas I, 2006, J Cardiovasc Electrophysiol, V17 Suppl 1, pS169; Undrovinas NA, 2010, J PHYSIOL SCI, V60, P245, DOI 10.1007/s12576-010-0092-0; Valdivia CR, 2005, J MOL CELL CARDIOL, V38, P475, DOI 10.1016/j.yjmcc.2004.12.012; von Lewinski D, 2007, EUR J HEART FAIL, V9, P1086, DOI 10.1016/j.ejheart.2007.08.004; Wagner S, 2011, CIRC RES, V108, P555, DOI 10.1161/CIRCRESAHA.110.221911; Weber CR, 2003, CIRCULATION, V108, P2224, DOI 10.1161/01.CIR.0000095274.72486.94; WETTWER E, 1994, CIRC RES, V75, P473, DOI 10.1161/01.RES.75.3.473; Winslow RL, 1999, CIRC RES, V84, P571, DOI 10.1161/01.RES.84.5.571; Wu L, 2004, J PHARMACOL EXP THER, V310, P599, DOI 10.1124/jpet.104.066100; Wu L, 2011, CIRCULATION, V123, P1713, DOI 10.1161/CIRCULATIONAHA.110.000661; Wu L, 2009, AM J PHYSIOL-HEART C, V297, pH1048, DOI 10.1152/ajpheart.00467.2009; Wu L, 2008, HEART RHYTHM, V5, P1726, DOI 10.1016/j.hrthm.2008.09.008; Zaza A, 2008, PHARMACOL THERAPEUT, V119, P326, DOI 10.1016/j.pharmthera.2008.06.001; Zhang Y, 2005, P ANN INT IEEE EMBS, P337; Zygmunt AC, 2001, AM J PHYSIOL-HEART C, V281, pH689, DOI 10.1152/ajpheart.2001.281.2.H689	73	45	45	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e32659	10.1371/journal.pone.0032659	http://dx.doi.org/10.1371/journal.pone.0032659			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427860	Green Published, gold, Green Submitted			2022-12-25	WOS:000302381500031
J	Galian, C; Bjorkholm, P; Bulleid, N; von Heijne, G				Galian, Carmen; Bjorkholm, Patrik; Bulleid, Neil; von Heijne, Gunnar			Efficient Glycosylphosphatidylinositol (GPI) Modification of Membrane Proteins Requires a C-terminal Anchoring Signal of Marginal Hydrophobicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XAA-THR SEQUONS; MATRIX METALLOPROTEINASES; GLYCOSYLATION EFFICIENCY; STRUCTURAL REQUIREMENTS; ER MEMBRANE; DE-NOVO; PEPTIDE; ATTACHMENT; TRANSAMIDASE; SEQUENCES	Many plasma membrane proteins are anchored to the membrane via a C-terminal glycosylphosphatidylinositol (GPI) moiety. The GPI anchor is attached to the protein in the endoplasmic reticulum by transamidation, a reaction in which a C-terminal GPI-attachment signal is cleaved off concomitantly with addition of the GPI moiety. GPI-attachment signals are poorly conserved on the sequence level but are all composed of a polar segment that includes the GPI-attachment site followed by a hydrophobic segment located at the very C terminus of the protein. Here, we show that efficient GPI modification requires that the hydrophobicity of the C-terminal segment is "marginal": less hydrophobic than type II transmembrane anchors and more hydrophobic than the most hydrophobic segments found in secreted proteins. We further show that the GPI-attachment signal can be modified by the transamidase irrespective of whether it is first released into the lumen of the endoplasmic reticulum or is retained in the endoplasmic reticulum membrane.	[Galian, Carmen; Bjorkholm, Patrik; von Heijne, Gunnar] Stockholm Univ, Dept Biochem & Biophys, Ctr Biomembrane Res, SE-10691 Stockholm, Sweden; [Bulleid, Neil] Univ Glasgow, CMVLS, Inst Mol Cell & Syst Biol, Glasgow G12 8QQ, Lanark, Scotland; [von Heijne, Gunnar] Stockholm Univ, Sci Life Lab, SE-17177 Solna, Sweden	Stockholm University; University of Glasgow; Stockholm University	von Heijne, G (corresponding author), Stockholm Univ, Dept Biochem & Biophys, Ctr Biomembrane Res, SE-10691 Stockholm, Sweden.	gunnar@dbb.su.se	von Heijne, Gunnar/F-5576-2011; von Heijne, Gunnar/AAH-9389-2019	von Heijne, Gunnar/0000-0002-4490-8569; Bjorkholm, Patrik/0000-0002-9131-4122; Bulleid, Neil/0000-0002-9839-5279	Swedish Cancer Foundation; Swedish Research Council; Swedish Foundation for Strategic Research; European Research Council [ERC-2008-AdG 232648]	Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); European Research Council(European Research Council (ERC)European Commission)	This work was supported by grants from the Swedish Cancer Foundation, Swedish Research Council, Swedish Foundation for Strategic Research, and European Research Council Grant ERC-2008-AdG 232648 (to G. v. H.).	BERGER J, 1988, J BIOL CHEM, V263, P10016; Bitinaite J., 2009, CURR PROTOC MOL BIOL, V86, P3211; Brinckerhoff CE, 2002, NAT REV MOL CELL BIO, V3, P207, DOI 10.1038/nrm763; CARAS IW, 1991, J CELL BIOL, V113, P77, DOI 10.1083/jcb.113.1.77; CARAS IW, 1989, SCIENCE, V243, P1196, DOI 10.1126/science.2466338; Chen R, 2003, J CELL BIOCHEM, V88, P1025, DOI 10.1002/jcb.10439; Chen R, 2002, J CELL BIOCHEM, V84, P68, DOI 10.1002/jcb.1267; Cruz-Garcia F, 2003, SEED SCI RES, V13, P209, DOI 10.1079/SSR2003138; Dalley JA, 2003, J BIOL CHEM, V278, P51749, DOI 10.1074/jbc.M303978200; Doering T. L., 2001, CURR PROTOC MOL BIOL, V22, P1781; Eisenhaber B, 1998, PROTEIN ENG, V11, P1155, DOI 10.1093/protein/11.12.1155; Eisenhaber B, 1999, J MOL BIOL, V292, P741, DOI 10.1006/jmbi.1999.3069; GERBER LD, 1992, J BIOL CHEM, V267, P12168; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; HOWELL S, 1994, J BIOL CHEM, V269, P16993; JOHANSSON M, 1993, MOL GEN GENET, V239, P251, DOI 10.1007/BF00281625; KODUKULA K, 1991, J BIOL CHEM, V266, P4464; KOZLOSKY CJ, 1995, ONCOGENE, V10, P299; Lundin C, 2007, FEBS LETT, V581, P3809, DOI 10.1016/j.febslet.2007.07.003; Meri S, 1996, BIOCHEM J, V316, P923, DOI 10.1042/bj3160923; Monne M, 1999, EUR J BIOCHEM, V263, P264, DOI 10.1046/j.1432-1327.1999.00498.x; MORAN P, 1991, J CELL BIOL, V115, P1595, DOI 10.1083/jcb.115.6.1595; Newstead S, 2007, P NATL ACAD SCI USA, V104, P13936, DOI 10.1073/pnas.0704546104; NILSSON I, 1994, J CELL BIOL, V126, P1127, DOI 10.1083/jcb.126.5.1127; Nilsson I, 1998, J MOL BIOL, V284, P1165, DOI 10.1006/jmbi.1998.2217; Nilsson I, 2000, J BIOL CHEM, V275, P17338, DOI 10.1074/jbc.M002317200; NILSSON I, 1993, J BIOL CHEM, V268, P5798; NILSSON IM, 1991, J BIOL CHEM, V266, P3408; Norholm MHH, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-21; Ohishi K, 2000, MOL BIOL CELL, V11, P1523, DOI 10.1091/mbc.11.5.1523; Orlean P, 2007, J LIPID RES, V48, P993, DOI 10.1194/jlr.R700002-JLR200; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pierleoni A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-392; Poisson Guylaine, 2007, Genomics Proteomics & Bioinformatics, V5, P121, DOI 10.1016/S1672-0229(07)60022-9; ROTHMAN JE, 1977, NATURE, V269, P775, DOI 10.1038/269775a0; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Sohail A, 2008, CANCER METAST REV, V27, P289, DOI 10.1007/s10555-008-9129-8; Toh YK, 2011, J STRUCT BIOL, V173, P271, DOI 10.1016/j.jsb.2010.11.026; UDENFRIEND S, 1995, ANNU REV BIOCHEM, V64, P563, DOI 10.1146/annurev.bi.64.070195.003023; Vainauskas S, 2002, J BIOL CHEM, V277, P30535, DOI 10.1074/jbc.M205402200; Vidugiriene J, 2001, EUR J BIOCHEM, V268, P2290, DOI 10.1046/j.1432-1327.2001.02106.x; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671; Walmsley AR, 2001, EMBO J, V20, P703, DOI 10.1093/emboj/20.4.703; Walmsley AR, 2003, GLYCOBIOLOGY, V13, P641, DOI 10.1093/glycob/cwg080; Wang JY, 1999, J MOL BIOL, V286, P1303, DOI 10.1006/jmbi.1999.2584; YAN W, 1995, BIOCHEMISTRY-US, V34, P14594, DOI 10.1021/bi00044a039; Yan W, 1998, J MOL BIOL, V275, P25, DOI 10.1006/jmbi.1997.1447	48	25	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16399	16409		10.1074/jbc.M112.350009	http://dx.doi.org/10.1074/jbc.M112.350009			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22431723	Green Published, hybrid			2022-12-25	WOS:000304030900031
J	Colombrita, C; Onesto, E; Megiorni, F; Pizzuti, A; Baralle, FE; Buratti, E; Silani, V; Ratti, A				Colombrita, Claudia; Onesto, Elisa; Megiorni, Francesca; Pizzuti, Antonio; Baralle, Francisco E.; Buratti, Emanuele; Silani, Vincenzo; Ratti, Antonia			TDP-43 and FUS RNA-binding Proteins Bind Distinct Sets of Cytoplasmic Messenger RNAs and Differently Regulate Their Post-transcriptional Fate in Motoneuron-like Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; ENDOTHELIAL GROWTH-FACTOR; STRESS GRANULES; MUTATIONS; ALS; TARGETS; DROSOPHILA; FUS/TLS; VEGF	The RNA-binding proteins TDP-43 and FUS form abnormal cytoplasmic aggregates in affected tissues of patients with amyotrophic lateral sclerosis and frontotemporal lobar dementia. TDP-43 and FUS localize mainly in the nucleus where they regulate pre-mRNA splicing, but they are also involved in mRNA transport, stability, and translation. To better investigate their cytoplasmic activities, we applied an RNA immunoprecipitation and chip analysis to define the mRNAs associated to TDP-43 and FUS in the cytoplasmic ribonucleoprotein complexes from motoneuronal NSC-34 cells. We found that they bind different sets of mRNAs although converging on common cellular pathways. Bioinformatics analyses identified the (UG)(n) consensus motif in 80% of 3'-UTR sequences of TDP-43 targets, whereas for FUS the binding motif was less evident. By in vitro assays we validated binding to selected target 3'-UTRs, including Vegfa and Grn for TDP-43, and Vps54, Nvl, and Taf15 for FUS. We showed that TDP-43 has a destabilizing activity on Vegfa and Grn mRNAs and may ultimately affect progranulin protein content, whereas FUS does not affect mRNA stability/translation of its targets. We also demonstrated that three different point mutations in TDP-43 did not change the binding affinity for Vegfa and Grn mRNAs or their protein level. Our data indicate that TDP-43 and FUS recognize distinct sets of mRNAs and differently regulate their fate in the cytoplasm of motoneuron-like cells, therefore suggesting complementary roles in neuronal RNA metabolism and neurodegeneration.	[Colombrita, Claudia; Onesto, Elisa; Silani, Vincenzo; Ratti, Antonia] IRCCS Ist Auxol Italiano, Dept Neurol, I-20149 Milan, Italy; [Colombrita, Claudia; Onesto, Elisa; Silani, Vincenzo; Ratti, Antonia] IRCCS Ist Auxol Italiano, Neurosci Lab, I-20149 Milan, Italy; [Megiorni, Francesca; Pizzuti, Antonio] Univ Roma La Sapienza, Dept Expt Med, I-00161 Rome, Italy; [Baralle, Francisco E.; Buratti, Emanuele] Int Ctr Genet Engn & Biotechnol, I-34149 Trieste, Italy; [Silani, Vincenzo; Ratti, Antonia] Univ Milan, Dept Neurol Sci, Dino Ferrari Ctr, I-20122 Milan, Italy	IRCCS Istituto Auxologico Italiano; IRCCS Istituto Auxologico Italiano; Sapienza University Rome; International Center for Genetic Engineering & Biotechnology (ICGEB); University of Milan	Ratti, A (corresponding author), IRCCS Ist Auxol Italiano, Dept Neurol, Via Zucchi 18, I-20095 Milan, Italy.	antonia.ratti@unimi.it	Megiorni, Francesca/AAC-1597-2019; Silani, Vincenzo/P-4421-2017; Buratti, Emanuele/K-4691-2016; colombrita, claudia/A-3295-2009	Megiorni, Francesca/0000-0003-3705-3248; Silani, Vincenzo/0000-0002-7698-3854; Buratti, Emanuele/0000-0002-1356-9074; colombrita, claudia/0000-0001-6567-8910; PIZZUTI, Antonio/0000-0003-3245-1925	Italian Agency of Research on ALS (AriSLA); Fondazione CARIPLO [2008-2307]	Italian Agency of Research on ALS (AriSLA); Fondazione CARIPLO(Fondazione Cariplo)	This work was supported by the Italian Agency of Research on ALS (AriSLA) (Grant RBPALS) and Fondazione CARIPLO (Grant 2008-2307).	Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Ayala YM, 2005, J MOL BIOL, V348, P575, DOI 10.1016/j.jmb.2005.02.038; Ayala YM, 2008, J CELL SCI, V121, P3778, DOI 10.1242/jcs.038950; Ayala YM, 2011, EMBO J, V30, P277, DOI 10.1038/emboj.2010.310; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Belly A, 2005, NEUROSCI LETT, V379, P152, DOI 10.1016/j.neulet.2004.12.071; Besse F, 2008, NAT REV MOL CELL BIO, V9, P971, DOI 10.1038/nrm2548; Borroni B, 2008, REJUV RES, V11, P773, DOI 10.1089/rej.2008.0711; Bosco DA, 2010, HUM MOL GENET, V19, P4160, DOI 10.1093/hmg/ddq335; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Buratti E, 2010, RNA BIOL, V7, P420, DOI 10.4161/rna.7.4.12205; Colombrita C, 2011, ARCH ITAL BIOL, V149, P83, DOI 10.4449/aib.v149i1.1261; Colombrita C, 2009, J NEUROCHEM, V111, P1051, DOI 10.1111/j.1471-4159.2009.06383.x; Corrado L, 2009, HUM MUTAT, V30, P688, DOI 10.1002/humu.20950; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Da Cruz S, 2011, CURR OPIN NEUROBIOL, V21, P904, DOI 10.1016/j.conb.2011.05.029; Devos D, 2004, NEUROLOGY, V62, P2127, DOI 10.1212/01.WNL.0000129913.44351.A3; Dormann D., 2011, TRENDS NEUR IN PRESS; Dormann D, 2010, EMBO J, V29, P2841, DOI 10.1038/emboj.2010.143; Elden AC, 2010, NATURE, V466, P1069, DOI 10.1038/nature09320; Fiesel FC, 2010, EMBO J, V29, P209, DOI 10.1038/emboj.2009.324; Fujii R, 2005, J CELL SCI, V118, P5755, DOI 10.1242/jcs.02692; Fujii R, 2005, CURR BIOL, V15, P587, DOI 10.1016/j.cub.2005.01.058; Gal J, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.06.010; Gass J., 2012, BRAIN RES IN PRESS; Gorba T, 2006, EXP CELL RES, V312, P3060, DOI 10.1016/j.yexcr.2006.06.020; Grillo G, 2010, NUCLEIC ACIDS RES, V38, pD75, DOI 10.1093/nar/gkp902; Hoell JI, 2011, NAT STRUCT MOL BIOL, V18, P1428, DOI 10.1038/nsmb.2163; Irwin D, 2009, J NEUROL SCI, V276, P9, DOI 10.1016/j.jns.2008.08.024; Jiao J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010551; Kawahara Y, 2012, P NATL ACAD SCI USA, V109, P3347, DOI 10.1073/pnas.1112427109; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Kim SH, 2010, J BIOL CHEM, V285, P34097, DOI 10.1074/jbc.M110.154831; Kovar Heinrich, 2011, Sarcoma, V2011, P1, DOI 10.1155/2011/837474; Kryndushkin D, 2011, PROTEIN CELL, V2, P223, DOI 10.1007/s13238-011-1525-0; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Lambrechts D, 2003, NAT GENET, V34, P383, DOI 10.1038/ng1211; Lanson NA, 2011, HUM MOL GENET, V20, P2510, DOI 10.1093/hmg/ddr150; Lerga A, 2001, J BIOL CHEM, V276, P6807, DOI 10.1074/jbc.M008304200; Levy NS, 1998, J BIOL CHEM, V273, P6417, DOI 10.1074/jbc.273.11.6417; Ling SC, 2010, P NATL ACAD SCI USA, V107, P13318, DOI 10.1073/pnas.1008227107; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Mackenzie IRA, 2010, LANCET NEUROL, V9, P995, DOI 10.1016/S1474-4422(10)70195-2; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; Nagahama M, 2004, MOL BIOL CELL, V15, P5712, DOI 10.1091/mbc.E04-08-0692; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Rademakers R, 2008, HUM MOL GENET, V17, P3631, DOI 10.1093/hmg/ddn257; Ratti A, 2008, J BIOL CHEM, V283, P7531, DOI 10.1074/jbc.M706082200; Sathasivam S, 2008, NEUROSCI RES, V62, P71, DOI 10.1016/j.neures.2008.06.008; Schmitt-John T, 2005, NAT GENET, V37, P1213, DOI 10.1038/ng1661; Sephton CF, 2011, J BIOL CHEM, V286, P1204, DOI 10.1074/jbc.M110.190884; Sharma A, 2005, EXP CELL RES, V309, P185, DOI 10.1016/j.yexcr.2005.05.014; Sleegers K, 2008, NEUROLOGY, V71, P253, DOI 10.1212/01.wnl.0000289191.54852.75; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Strong MJ, 2007, MOL CELL NEUROSCI, V35, P320, DOI 10.1016/j.mcn.2007.03.007; Sun ZH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000614; Ticozzi N, 2011, AM J MED GENET B, V156B, P285, DOI 10.1002/ajmg.b.31158; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; van Blitterswijk M, 2010, NEUROGENETICS, V11, P275, DOI 10.1007/s10048-010-0239-4; Van Damme P, 2008, J CELL BIOL, V181, P37, DOI 10.1083/jcb.200712039; Wang IF, 2008, J NEUROCHEM, V105, P797, DOI 10.1111/j.1471-4159.2007.05190.x; Wang JW, 2011, J CLIN INVEST, V121, P4118, DOI 10.1172/JCI57883; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Xiao SX, 2011, MOL CELL NEUROSCI, V47, P167, DOI 10.1016/j.mcn.2011.02.013	67	184	186	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15635	15647		10.1074/jbc.M111.333450	http://dx.doi.org/10.1074/jbc.M111.333450			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22427648	hybrid, Green Published			2022-12-25	WOS:000304006300043
J	Chicharro, D; Ledberg, A				Chicharro, Daniel; Ledberg, Anders			When Two Become One: The Limits of Causality Analysis of Brain Dynamics	PLOS ONE			English	Article							GRANGER CAUSALITY; EFFECTIVE CONNECTIVITY; STATISTICAL ASSESSMENT; MODELS; DIAGRAMS; CORTEX	Biological systems often consist of multiple interacting subsystems, the brain being a prominent example. To understand the functions of such systems it is important to analyze if and how the subsystems interact and to describe the effect of these interactions. In this work we investigate the extent to which the cause-and-effect framework is applicable to such interacting subsystems. We base our work on a standard notion of causal effects and define a new concept called natural causal effect. This new concept takes into account that when studying interactions in biological systems, one is often not interested in the effect of perturbations that alter the dynamics. The interest is instead in how the causal connections participate in the generation of the observed natural dynamics. We identify the constraints on the structure of the causal connections that determine the existence of natural causal effects. In particular, we show that the influence of the causal connections on the natural dynamics of the system often cannot be analyzed in terms of the causal effect of one subsystem on another. Only when the causing subsystem is autonomous with respect to the rest can this interpretation be made. We note that subsystems in the brain are often bidirectionally connected, which means that interactions rarely should be quantified in terms of cause-and-effect. We furthermore introduce a framework for how natural causal effects can be characterized when they exist. Our work also has important consequences for the interpretation of other approaches commonly applied to study causality in the brain. Specifically, we discuss how the notion of natural causal effects can be combined with Granger causality and Dynamic Causal Modeling (DCM). Our results are generic and the concept of natural causal effects is relevant in all areas where the effects of interactions between subsystems are of interest.	[Chicharro, Daniel; Ledberg, Anders] Univ Pompeu Fabra, Ctr Brain & Cognit, Dept Informat & Commun Technol, Barcelona, Spain	Pompeu Fabra University; University of Barcelona	Chicharro, D (corresponding author), Univ Pompeu Fabra, Ctr Brain & Cognit, Dept Informat & Commun Technol, Barcelona, Spain.	chicharro31@yahoo.es; anders.ledberg@gmail.com		Ledberg, Anders/0000-0003-3827-8721; Chicharro, Daniel/0000-0002-4038-258X	European Union [269921 (BrainScaleS)]; Spanish government	European Union(European Commission); Spanish government(Spanish GovernmentEuropean Commission)	The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 269921 (BrainScaleS). AL is supported by the Ramon y Cajal program from the Spanish government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AERTSEN AMHJ, 1989, J NEUROPHYSIOL, V61, P900, DOI 10.1152/jn.1989.61.5.900; Amblard PO, 2011, J COMPUT NEUROSCI, V30, P7, DOI 10.1007/s10827-010-0231-x; Ay N, 2008, ADV COMPLEX SYST, V11, P17, DOI 10.1142/S0219525908001465; Benabid AL, 2003, CURR OPIN NEUROBIOL, V13, P696, DOI 10.1016/j.conb.2003.11.001; Besserve M, 2010, J COMPUT NEUROSCI, V29, P547, DOI 10.1007/s10827-010-0236-5; Bressler SL, 2008, J NEUROSCI, V28, P10056, DOI 10.1523/JNEUROSCI.1776-08.2008; Bressler SL, 2011, NEUROIMAGE, V58, P323, DOI 10.1016/j.neuroimage.2010.02.059; Brovelli A, 2004, P NATL ACAD SCI USA, V101, P9849, DOI 10.1073/pnas.0308538101; Buehlmann A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000934; Cai ZH, 2008, BIOMETRICS, V64, P695, DOI 10.1111/j.1541-0420.2007.00949.x; Chavez M, 2003, J NEUROSCI METH, V124, P113, DOI 10.1016/S0165-0270(02)00367-9; Chicharro D, 2011, BIOL CYBERN, V105, P331, DOI 10.1007/s00422-011-0469-z; Dahlhaus R, 2000, METRIKA, V51, P157, DOI 10.1007/s001840000055; Daunizeau J, 2011, NEUROIMAGE, V58, P312, DOI 10.1016/j.neuroimage.2009.11.062; David O, 2011, NEUROIMAGE, V58, P306, DOI 10.1016/j.neuroimage.2009.09.073; Eichler M, 2005, PHILOS T R SOC B, V360, P953, DOI 10.1098/rstb.2005.1641; Eichler M, 2007, J ECONOMETRICS, V137, P334, DOI 10.1016/j.jeconom.2005.06.032; Eichler M, 2010, LIFETIME DATA ANAL, V16, P3, DOI 10.1007/s10985-009-9143-3; EVARTS EV, 1966, J NEUROPHYSIOL, V29, P1011, DOI 10.1152/jn.1966.29.6.1011; Friston Karl J., 1994, Human Brain Mapping, V2, P56, DOI 10.1002/hbm.460020107; Friston KJ, 2010, NEUROIMAGE, V52, P752, DOI 10.1016/j.neuroimage.2009.12.068; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Galles D, 1997, ARTIF INTELL, V97, P9, DOI 10.1016/S0004-3702(97)00047-7; Gourieroux C, 1987, ANN EC STAT, V6-7, P470; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; GRANGER CWJ, 1980, J ECON DYN CONTROL, V2, P329, DOI 10.1016/0165-1889(80)90069-X; GRANGER CWJ, 1963, INFORM CONTROL, V6, P28, DOI 10.1016/S0019-9958(63)90092-5; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; HUBEL DH, 1959, J PHYSIOL-LONDON, V148, P574, DOI 10.1113/jphysiol.1959.sp006308; Kaiser A, 2002, PHYSICA D, V166, P43, DOI 10.1016/S0167-2789(02)00432-3; Kaminski M, 2001, BIOL CYBERN, V85, P145, DOI 10.1007/s004220000235; KAMINSKI MJ, 1991, BIOL CYBERN, V65, P203, DOI 10.1007/BF00198091; Kayser C, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.007.2009; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; LIN JH, 1991, IEEE T INFORM THEORY, V37, P145, DOI 10.1109/18.61115; Lizier JT, 2010, EUR PHYS J B, V73, P605, DOI 10.1140/epjb/e2010-00034-5; Logothetis NK, 2010, NAT NEUROSCI, V13, P1283, DOI 10.1038/nn.2631; Lohmann G, 2012, NEUROIMAGE, V59, P2322, DOI 10.1016/j.neuroimage.2011.09.025; Lungarella M, 2007, INT J BIFURCAT CHAOS, V17, P903, DOI 10.1142/S0218127407017628; Lungarella M, 2006, PLOS COMPUT BIOL, V2, P1301, DOI 10.1371/journal.pcbi.0020144; MARKO H, 1973, IEEE T COMMUN, VCO21, P1345, DOI 10.1109/TCOM.1973.1091610; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P374, DOI 10.1152/jn.1957.20.4.374; Palus M, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.056211; Pearl J, 1990, P 6 C UNC ART INT CA, P220; Pearl J, 2009, CAUSALITY MODELS REA, DOI DOI 10.1017/CBO9780511803161; Ramsey JD, 2010, NEUROIMAGE, V49, P1545, DOI 10.1016/j.neuroimage.2009.08.065; RISSANEN J, 1987, IEEE T INFORM THEORY, V33, P598, DOI 10.1109/TIT.1987.1057325; Robins JM, 1997, LECT NOTES STAT, V120, P69, DOI DOI 10.1007/978-1-4612-1842-5_4; Roebroeck A, 2005, NEUROIMAGE, V25, P230, DOI 10.1016/j.neuroimage.2004.11.017; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; RUBIN DB, 1974, J EDUC PSYCHOL, V66, P688, DOI 10.1037/h0037350; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Seth AK, 2007, NEURAL COMPUT, V19, P910, DOI 10.1162/neco.2007.19.4.910; Sillito A, 2006, TRENDS NEUROSCI, V29; Solo V, 2008, P 47 IEEE C DEC CONT, P4639; Sompolinsky H, 1997, CURR OPIN NEUROBIOL, V7, P514, DOI 10.1016/S0959-4388(97)80031-1; Thomas MC, 2006, ELEMENTS INFORM THEO; Valdes-Sosa PA, 2011, NEUROIMAGE, V58, P339, DOI 10.1016/j.neuroimage.2011.03.058; Verdes PF, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.026222; Vicente R, 2011, J COMPUT NEUROSCI, V30, P45, DOI 10.1007/s10827-010-0262-3; WILSON HR, 1972, BIOPHYS J, V12, P1, DOI 10.1016/S0006-3495(72)86068-5; Wright S, 1920, J AGRIC RES, V20, P0557	62	46	46	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e32466	10.1371/journal.pone.0032466	http://dx.doi.org/10.1371/journal.pone.0032466			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438878	Green Published, gold, Green Submitted			2022-12-25	WOS:000303309100010
J	Zoller, B; Li, XJ; Sundquist, J; Sundquist, K				Zoller, Bengt; Li, Xinjun; Sundquist, Jan; Sundquist, Kristina			Risk of Subsequent Coronary Heart Disease in Patients Hospitalized for Immune-Mediated Diseases: A Nationwide Follow-Up Study from Sweden	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; ACUTE MYOCARDIAL-INFARCTION; RHEUMATOID-ARTHRITIS; ACCELERATED ATHEROSCLEROSIS; CARDIOVASCULAR MORBIDITY; INFLAMMATION; MORTALITY; REGISTER; STROKE; WOMEN	Background: Certain immune-mediated diseases (IMDs), such as rheumatoid arthritis and systemic lupus erythematosus, have been linked to cardiovascular disorders. We examined whether there is an association between 32 different IMDs and risk of subsequent hospitalization for coronary heart disease (CHD) related to coronary atherosclerosis in a nationwide follow up study in Sweden. Methods and Findings: All individuals in Sweden hospitalized with a main diagnosis of an IMD (n = 336,479) without previous or coexisting CHD, between January 1, 1964 and December 31 2008, were followed for first hospitalization for CHD. The reference population was the total population of Sweden. Standardized incidence ratios (SIRs) for CHD were calculated. Overall risk of CHD during the first year after hospitalization for an IMD was 2.92 (95% CI 2.84-2.99). Twenty-seven of the 32 IMDs studied were associated with an increased risk of CHD during the first year after hospitalization. The overall risk of CHD decreased over time, from 1.75 after 1-5 years (95% CI 1.73-1.78), to 1.43 after 5-10 years (95% CI 1.41-1.46) and 1.28 after 10+ years (95% CI 1.26-1.30). Females generally had higher SIRs than males. The IMDs for which the SIRs of CDH were highest during the first year after hospitalization included chorea minor 6.98 (95% CI 1.32-20.65), systemic lupus erythematosus 4.94 (95% CI 4.15-5.83), rheumatic fever 4.65 (95% CI 3.53-6.01), Hashimoto's thyroiditis 4.30 (95% CI 3.87-4.75), polymyositis/dermatomyositis 3.81 (95% CI 2.62-5.35), polyarteritis nodosa 3.81 (95% CI 2.72-5.19), rheumatoid arthritis 3.72 (95% CI 3.56-3.88), systemic sclerosis 3.44 (95% CI 2.86-4.09), primary biliary cirrhosis 3.32 (95% CI 2.34-4.58), and autoimmune hemolytic anemia 3.17 (95% CI 2.16-4.47). Conclusions: Most IMDs are associated with increased risk of CHD in the first year after hospital admission. Our findings suggest that many hospitalized IMDs are tightly linked to coronary atherosclerosis.	[Zoller, Bengt; Li, Xinjun; Sundquist, Jan; Sundquist, Kristina] Lund Univ Reg Skane, Clin Res Ctr, Skane Univ Hosp, Ctr Primary Hlth Care Res, Malmo, Sweden; [Sundquist, Jan] Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA	Lund University; Skane University Hospital; Stanford University	Zoller, B (corresponding author), Lund Univ Reg Skane, Clin Res Ctr, Skane Univ Hosp, Ctr Primary Hlth Care Res, Malmo, Sweden.	bengt.zoller@med.lu.se	Zöller, Bengt/H-8856-2012; Zöller, Bengt/M-3217-2019	Zöller, Bengt/0000-0002-8250-5613; Zöller, Bengt/0000-0002-8250-5613; Li, Xinjun/0000-0002-5559-4657	Swedish Research Council [2008-3110, 2008-2638]; Swedish Council for Working Life and Social Research [2006-0386, 2007-1754, 2007-1962]; Formas [2006-4255-6596-99, 2007-1352]; Region Skane [REGSKANE-124611]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Formas(Swedish Research Council Formas); Region Skane	This work was supported by grants from the Swedish Research Council (2008-3110 and 2008-2638), the Swedish Council for Working Life and Social Research (2006-0386, 2007-1754 and 2007-1962), and Formas (2006-4255-6596-99 and 2007-1352), and from Region Skane (REGSKANE-124611). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], NAT RIKTL HJARTSJ 20; Asanuma Y, 2003, NEW ENGL J MED, V349, P2407, DOI 10.1056/NEJMoa035611; El-Gabalawy H, 2010, J RHEUMATOL, V37, P2, DOI 10.3899/jrheum.091461; Gabriel SE, 2008, AM J MED, V121, P9, DOI 10.1016/j.amjmed.2008.06.011; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Jilma B, 2005, THROMB HAEMOSTASIS, V94, P797, DOI 10.1160/T04-10-0652; Levy L, 2008, CLIN EXP RHEUMATOL, V26, P673; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Libby P, 2008, AM J MED, V121, P21, DOI 10.1016/j.amjmed.2008.06.014; LINDBLAD U, 1993, SCAND J SOC MED, V21, P3, DOI 10.1177/140349489302100102; Lopez-Pedrera C, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/974648; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Manzi S, 1997, AM J EPIDEMIOL, V145, P408; National Board of Health and Welfare, 1998, SWED HOSP DISCH REG; National Board of Health and Welfare, 2000, VAL DIAGN SWED IN CA; O'Keefe JH, 2009, MAYO CLIN PROC, V84, P741, DOI 10.1016/S0025-6196(11)60525-9; Roman MJ, 2003, NEW ENGL J MED, V349, P2399, DOI 10.1056/NEJMoa035471; Rosen M, 2005, HANDBOOK OF EPIDEMIOLOGY, P231; Rothman K., 1998, MODERN EPIDEMIOLOGY; Shoenfeld Y, 2005, CIRCULATION, V112, P3337, DOI 10.1161/CIRCULATIONAHA.104.507996; Solomon DH, 2003, CIRCULATION, V107, P1303, DOI 10.1161/01.CIR.0000054612.26458.B2; van Leuven SI, 2008, RHEUMATOLOGY, V47, P3, DOI 10.1093/rheumatology/kem202; van Leuven SI, 2007, J LIPID RES, V48, P2640, DOI 10.1194/jlr.M700176-JLR200; Vaudo G, 2005, ARTHRITIS RHEUM-US, V52, P3890, DOI 10.1002/art.21475; Vizzardi E, 2010, ACTA CARDIOL, V65, P337, DOI 10.2143/AC.65.3.2050351; Westlake SL, 2011, RHEUMATOLOGY, V50, P518, DOI 10.1093/rheumatology/keq316; Westlake SL, 2010, RHEUMATOLOGY, V49, P295, DOI 10.1093/rheumatology/kep366; White HD, 2008, LANCET, V372, P570, DOI 10.1016/S0140-6736(08)61237-4; Xu J, 2010, HAMOSTASEOLOGIE, V30, P5	29	105	109	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33442	10.1371/journal.pone.0033442	http://dx.doi.org/10.1371/journal.pone.0033442			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438933	gold, Green Submitted, Green Published			2022-12-25	WOS:000303309100047
J	Bosson, A; Soleilhac, JM; Valiron, O; Job, D; Andrieux, A; Moutin, MJ				Bosson, Anouk; Soleilhac, Jean-Marc; Valiron, Odile; Job, Didier; Andrieux, Annie; Moutin, Marie-Jo			Cap-Gly Proteins at Microtubule Plus Ends: Is EB1 Detyrosination Involved?	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; GROWING MICROTUBULES; TUBULIN; ORGANIZATION; CLIP-170	Localization of CAP-Gly proteins such as CLIP170 at microtubule+ends results from their dual interaction with alpha-tubulin and EB1 through their C-terminal amino acids -EEY. Detyrosination (cleavage of the terminal tyrosine) of alpha-tubulin by tubulin-carboxypeptidase abolishes CLIP170 binding. Can detyrosination affect EB1 and thus regulate the presence of CLIP170 at microtubule+ends as well? We developed specific antibodies to discriminate tyrosinated vs detyrosinated forms of EB1 and detected only tyrosinated EB1 in fibroblasts, astrocytes, and total brain tissue. Over-expressed EB1 was not detyrosinated in cells and chimeric EB1 with the eight C-terminal amino acids of alpha-tubulin was only barely detyrosinated. Our results indicate that detyrosination regulates CLIPs interaction with alpha-tubulin, but not with EB1. They highlight the specificity of carboxypeptidase toward tubulin.	[Bosson, Anouk; Soleilhac, Jean-Marc; Valiron, Odile; Job, Didier; Andrieux, Annie; Moutin, Marie-Jo] Univ Grenoble 1, INSERM, Grenoble Inst Neurosci, iRTSV GPC,CEA,U836, Grenoble, France	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Bosson, A (corresponding author), Univ Grenoble 1, INSERM, Grenoble Inst Neurosci, iRTSV GPC,CEA,U836, Grenoble, France.	moutinm@ujf-grenoble.fr	Moutin, Marie-Jo/P-7518-2017; ANDRIEUX, ANNIE/B-2134-2017	Moutin, Marie-Jo/0000-0003-2681-9818; ANDRIEUX, ANNIE/0000-0002-4022-6405; Soleilhac, jean-marc/0000-0001-8072-8496	ANR (Agence Nationale de la Recherche) [Blan07-2_187328]; Association Recherche sur le Cancer [4892, 7927]	ANR (Agence Nationale de la Recherche)(French National Research Agency (ANR)); Association Recherche sur le Cancer	This work was supported by the ANR (Agence Nationale de la Recherche) 'TyrTIPs' (Blan07-2_187328) and by Association Recherche sur le Cancer (4892 and 7927). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Badin-Larcon AC, 2004, P NATL ACAD SCI USA, V101, P5577, DOI 10.1073/pnas.0307917101; Bieling P, 2008, J CELL BIOL, V183, P1223, DOI 10.1083/jcb.200809190; Bu W, 2003, J BIOL CHEM, V278, P49721, DOI 10.1074/jbc.M306194200; Caudron F, 2008, J CELL SCI, V121, P1506, DOI 10.1242/jcs.023374; Erck C, 2005, P NATL ACAD SCI USA, V102, P7853, DOI 10.1073/pnas.0409626102; Fonrose X, 2007, CANCER RES, V67, P3371, DOI 10.1158/0008-5472.CAN-06-3732; Gache V, 2005, BIOCHEM BIOPH RES CO, V327, P35, DOI 10.1016/j.bbrc.2004.11.138; Honnappa S, 2009, CELL, V138, P366, DOI 10.1016/j.cell.2009.04.065; Komarova Y, 2005, MOL BIOL CELL, V16, P5334, DOI 10.1091/mbc.E05-07-0614; Lansbergen G, 2006, TRAFFIC, V7, P499, DOI 10.1111/j.1600-0854.2006.00400.x; Mialhe A, 2001, CANCER RES, V61, P5024; Morrison EE, 2007, CELL MOL LIFE SCI, V64, P307, DOI 10.1007/s00018-007-6360-3; Neukirchen D, 2011, J NEUROSCI, V31, P1528, DOI 10.1523/JNEUROSCI.3983-10.2011; PATURLELAFANECHERE L, 1994, J CELL SCI, V107, P1529; Peris L, 2006, J CELL BIOL, V174, P839, DOI 10.1083/jcb.200512058; Valiron O, 2010, J BIOL CHEM, V285, P17507, DOI 10.1074/jbc.M109.099515; WEHLAND J, 1983, J CELL BIOL, V97, P1476, DOI 10.1083/jcb.97.5.1476	18	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e33490	10.1371/journal.pone.0033490	http://dx.doi.org/10.1371/journal.pone.0033490			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22432029	Green Published, Green Submitted, gold			2022-12-25	WOS:000303198600072
J	Caron, MMJ; Emans, PJ; Surtel, DAM; Cremers, A; Voncken, JW; Welting, TJM; van Rhijn, LW				Caron, Marjolein M. J.; Emans, Pieter J.; Surtel, Don A. M.; Cremers, Andy; Voncken, Jan Willem; Welting, Tim J. M.; van Rhijn, Lodewijk W.			Activation of NF-kappa B/p65 Facilitates Early Chondrogenic Differentiation during Endochondral Ossification	PLOS ONE			English	Article							NF-KAPPA-B; MESENCHYMAL STEM-CELLS; NECROSIS-FACTOR-ALPHA; CHONDROCYTE-SPECIFIC ENHANCER; GROWTH-PLATE CHONDROGENESIS; TNF-ALPHA; DEPENDENT MECHANISM; PROGENITOR CELLS; GENE-EXPRESSION; BONE-FORMATION	Background: NF-kappa B/p65 has been reported to be involved in regulation of chondrogenic differentiation. However, its function in relation to key chondrogenic factor Sox9 and onset of chondrogenesis during endochondral ossification is poorly understood. We hypothesized that the early onset of chondrogenic differentiation is initiated by transient NF-kappa B/p65 signaling. Methodology/Principal Findings: The role of NF-kappa B/p65 in early chondrogenesis was investigated in different in vitro, ex vivo and in vivo endochondral models: ATDC5 cells, hBMSCs, chicken periosteal explants and growth plates of 6 weeks old mice. NF-kappa B/p65 activation was manipulated using pharmacological inhibitors, RNAi and activating agents. Gene expression and protein expression analysis, and (immuno) histochemical stainings were employed to determine the role of NF-kappa B/p65 in the chondrogenic phase of endochondral development. Our data show that chondrogenic differentiation is facilitated by early transient activation of NF-kappa B/p65. NF-kappa B/p65-mediated signaling determines early expression of Sox9 and facilitates the subsequent chondrogenic differentiation programming by signaling through key chondrogenic pathways. Conclusions/Significance: The presented data demonstrate that NF-kappa B/p65 signaling, as well as its intensity and timing, represents one of the transcriptional regulatory mechanisms of the chondrogenic developmental program of chondroprogenitor cells during endochondral ossification. Importantly, these results provide novel possibilities to improve the success of cartilage and bone regenerative techniques.	[Caron, Marjolein M. J.; Emans, Pieter J.; Surtel, Don A. M.; Cremers, Andy; Welting, Tim J. M.; van Rhijn, Lodewijk W.] Maastricht Univ, Med Ctr, Caphri Sch Publ Hlth & Primary Care, Dept Orthopaed Surg, Maastricht, Netherlands; [Voncken, Jan Willem] Maastricht Univ, Med Ctr, Dept Mol Genet, GROW Sch Oncol & Dev Biol, Maastricht, Netherlands	Maastricht University; Maastricht University	Caron, MMJ (corresponding author), Maastricht Univ, Med Ctr, Caphri Sch Publ Hlth & Primary Care, Dept Orthopaed Surg, Maastricht, Netherlands.	t.welting@maastrichtuniversity.nl			Dutch Arthritis Association [LLP14]; Dutch Stichting Annafonds [07/07, 08/42]	Dutch Arthritis Association; Dutch Stichting Annafonds	This work is financially supported by the Dutch Arthritis Association (grant LLP14) (http://www.reumafonds.nl) and the Dutch Stichting Annafonds (grants 07/07 and 08/42) (http://www.annafonds.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad V, 2002, ENDOCRINOLOGY, V143, P1851, DOI 10.1210/en.143.5.1851; Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; ATSUMI T, 1990, CELL DIFFER DEV, V30, P109, DOI 10.1016/0922-3371(90)90079-C; Aung A, 2011, ARTHRITIS RHEUM-US, V63, P148, DOI 10.1002/art.30086; Baldik Y, 2005, BONE, V37, P32, DOI 10.1016/j.bone.2004.10.002; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Chen L, 2005, DIFFERENTIATION, V73, P350, DOI 10.1111/j.1432-0436.2005.00038.x; Crisostomo PR, 2008, AM J PHYSIOL-CELL PH, V294, pC675, DOI 10.1152/ajpcell.00437.2007; Croitoru-Lamoury J, 2007, J INTERF CYTOK RES, V27, P53, DOI 10.1089/jir.2006.0037; Diwan AD, 2000, J BONE MINER RES, V15, P342, DOI 10.1359/jbmr.2000.15.2.342; EINHORN TA, 1995, J BONE MINER RES, V10, P1272; Emans PJ, 2010, P NATL ACAD SCI USA, V107, P3418, DOI 10.1073/pnas.0907774107; Feng JQ, 2003, J BIOL CHEM, V278, P29130, DOI 10.1074/jbc.M212296200; Franchimont N, 1997, ENDOCRINOLOGY, V138, P3380, DOI 10.1210/en.138.8.3380; Fukui N, 2003, J BONE JOINT SURG AM, V85A, P59, DOI 10.2106/00004623-200300003-00011; Fukui N, 2006, J BIOL CHEM, V281, P27229, DOI 10.1074/jbc.M603385200; Gerstenfeld LC, 2003, J BONE MINER RES, V18, P1584, DOI 10.1359/jbmr.2003.18.9.1584; Gerstenfeld LC, 2001, CELLS TISSUES ORGANS, V169, P285, DOI 10.1159/000047893; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; Grau AM, 2006, CELL SIGNAL, V18, P1041, DOI 10.1016/j.cellsig.2005.08.021; GRUNDNES O, 1993, ACTA ORTHOP SCAND, V64, P340, DOI 10.3109/17453679308993640; Han Y, 2008, MOL CELL BIOL, V28, P4999, DOI 10.1128/MCB.00695-08; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Huang WD, 2000, MOL CELL BIOL, V20, P4149, DOI 10.1128/MCB.20.11.4149-4158.2000; Kock LM, 2010, OSTEOARTHR CARTILAGE, V18, P1528, DOI 10.1016/j.joca.2010.09.001; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lefebvre V, 2001, OSTEOARTHR CARTILAGE, V9, pS69, DOI 10.1053/joca.2001.0447; Lefebvre V, 1998, MATRIX BIOL, V16, P529; Lefebvre V, 1998, EMBO J, V17, P5718, DOI 10.1093/emboj/17.19.5718; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Mackie EJ, 2008, INT J BIOCHEM CELL B, V40, P46, DOI 10.1016/j.biocel.2007.06.009; MOUNTZIARIS PM, 2008, TISSUE ENG B; Naik AA, 2009, J BONE MINER RES, V24, P251, DOI 10.1359/JBMR.081002; Novack DV, 2011, CELL RES, V21, P169, DOI 10.1038/cr.2010.159; ODRISCOLL SW, 1994, J BONE JOINT SURG AM, V76A, P1042, DOI 10.2106/00004623-199407000-00013; Park M, 2007, NAT CELL BIOL, V9, P287, DOI 10.1038/ncb1538; Pevsner-Fischer M, 2007, BLOOD, V109, P1422, DOI 10.1182/blood-2006-06-028704; Romas E, 2002, BONE, V30, P340, DOI 10.1016/S8756-3282(01)00682-2; Rundle CH, 2006, BONE, V38, P521, DOI 10.1016/j.bone.2005.09.015; Schallmoser K, 2008, TISSUE ENG PT C-METH, V14, P185, DOI 10.1089/ten.tec.2008.0060; Simon AM, 2007, J BONE JOINT SURG AM, V89A, P500, DOI 10.2106/JBJS.F.00127; Stevens MM, 2005, P NATL ACAD SCI USA, V102, P11450, DOI 10.1073/pnas.0504705102; Sugimori K, 2005, J BONE MINER METAB, V23, P411, DOI 10.1007/s00774-005-0622-7; Ulivi V, 2008, J CELL BIOCHEM, V104, P1393, DOI 10.1002/jcb.21717; Ushita M, 2009, OSTEOARTHR CARTILAGE, V17, P1065, DOI 10.1016/j.joca.2009.02.003; van der Kraan PM, 2007, OSTEOARTHR CARTILAGE, V15, P237, DOI 10.1016/j.joca.2006.11.006; Wang MJ, 2006, AM J PHYSIOL-REG I, V291, pR880, DOI 10.1152/ajpregu.00280.2006; Wehling N, 2009, ARTHRITIS RHEUM-US, V60, P801, DOI 10.1002/art.24352; Wu S, 2007, J BIOL CHEM, V282, P33698, DOI 10.1074/jbc.M702991200; Wu SF, 2008, J BIOL CHEM, V283, P34037, DOI 10.1074/jbc.M803754200; Yoon BS, 2004, J CELL BIOCHEM, V93, P93, DOI 10.1002/jcb.20211; Zhang XP, 2002, J CLIN INVEST, V109, P1405, DOI 10.1172/JCI200215681; Zhu W, 2002, J BONE MINER RES, V17, P1470, DOI 10.1359/jbmr.2002.17.8.1470; Zuscik MJ, 2008, J CLIN INVEST, V118, P429, DOI 10.1172/JCI34174	54	45	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33467	10.1371/journal.pone.0033467	http://dx.doi.org/10.1371/journal.pone.0033467			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22428055	Green Published, Green Submitted, gold			2022-12-25	WOS:000302381500144
J	Matsumoto, M; Bennett, CL; Isonishi, A; Qureshi, Z; Hori, Y; Hayakawa, M; Yoshida, Y; Yagi, H; Fujimura, Y				Matsumoto, Masanori; Bennett, Charles L.; Isonishi, Ayami; Qureshi, Zaina; Hori, Yuji; Hayakawa, Masaki; Yoshida, Yoko; Yagi, Hideo; Fujimura, Yoshihiro			Acquired Idiopathic ADAMTS13 Activity Deficient Thrombotic Thrombocytopenic Purpura in a Population from Japan	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; FACTOR-CLEAVING PROTEASE; PLASMA-EXCHANGE; UREMIC SYNDROME; MICROANGIOPATHIES; ANTIBODIES; FEATURES; COHORT; TITER	Thrombotic thrombocytopenic purpura (TTP) is a type of thrombotic microangiopathy (TMA). Studies report that the majority of TTP patients present with a deficiency of ADAMTS13 activity. In a database of TMA patients in Japan identified between 1998 and 2008, 186 patients with first onset of acquired idiopathic (ai) ADAMTS13-deficient TTP (ADAMTS13 activity <5%) were diagnosed. The median age of onset of TTP in this group of patients was 54 years, 54.8% were female, 75.8% had renal involvement, 79.0% had neurologic symptoms, and 97.8% had detectable inhibitors to ADAMTS13 activity. Younger patients were less likely to present with renal or neurologic dysfunction (p < 0.01), while older patients were more likely to die during the TTP hospitalization (p < 0.05). Findings from this cohort in Japan differ from those reported previously from the United States, Europe, and Korea with respect to age at onset (two decades younger in the other cohort) and gender composition (60% to 100% female in the other cohort). We conclude that in one of the largest cohorts of ai-TTP with severe deficiency of ADAMTS13 activity reported to date, demographic characteristics differ in Japanese patients relative to those reported from a large Caucasian registry from Western societies. Additional studies exploring these findings are needed.	[Matsumoto, Masanori; Isonishi, Ayami; Hori, Yuji; Hayakawa, Masaki; Yoshida, Yoko; Yagi, Hideo; Fujimura, Yoshihiro] Nara Med Univ, Dept Blood Transfus Med, Kashihara, Nara 634, Japan; [Bennett, Charles L.; Qureshi, Zaina] Univ S Carolina, S Carolina Coll Pharm, S Carolina Ctr Econ Excellence Medicat Safety & E, Columbia, SC 29208 USA; [Bennett, Charles L.; Qureshi, Zaina] Univ S Carolina, S Carolina Coll Pharm, So Network Adverse React SONAR, Columbia, SC 29208 USA	Nara Medical University; Medical University of South Carolina; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Medical University of South Carolina; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Matsumoto, M (corresponding author), Nara Med Univ, Dept Blood Transfus Med, Kashihara, Nara 634, Japan.	malon@naramed-u.ac.jp	YAGI, HIDEO/AAK-7548-2021	Isonishi, Ayami/0000-0003-3750-0482	Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor, and Welfare of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by research grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan and from the Ministry of Health, Labor, and Welfare of Japan. Y.F. is a member of clinical advisory boards for Baxter BioScience, no other funders had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMOROSI EL, 1966, MEDICINE, V45, P139, DOI 10.1097/00005792-196603000-00003; Bohm M, 2005, BRIT J HAEMATOL, V129, P644, DOI 10.1111/j.1365-2141.2005.05512.x; Coppo P, 2004, MEDICINE, V83, P233, DOI 10.1097/01.md.0000133622.03370.07; Ferrari S, 2007, BLOOD, V109, P2815, DOI 10.1182/blood-2006-02-006064; Fujimura Y, 2010, INTERNAL MED, V49, P7, DOI 10.2169/internalmedicine.49.2706; Furlan M, 1998, NEW ENGL J MED, V339, P1578, DOI 10.1056/NEJM199811263392202; Furlan M, 1996, BLOOD, V87, P4223, DOI 10.1182/blood.V87.10.4223.bloodjournal87104223; Hovinga JAK, 2010, BLOOD, V115, P1500, DOI 10.1182/blood-2009-09-243790; Jang MJ, 2011, INT J HEMATOL, V93, P163, DOI 10.1007/s12185-011-0771-5; KASPER CK, 1975, THROMB DIATH HAEMOST, V34, P612; Kato S, 2006, TRANSFUSION, V46, P1444, DOI 10.1111/j.1537-2995.2006.00914.x; Kinoshita S, 2001, INT J HEMATOL, V74, P101, DOI 10.1007/BF02982558; Levy GG, 2001, NATURE, V413, P488, DOI 10.1038/35097008; Scheiflinger F, 2003, BLOOD, V102, P3241, DOI 10.1182/blood-2003-05-1616; Scully M, 2008, BRIT J HAEMATOL, V142, P819, DOI 10.1111/j.1365-2141.2008.07276.x; Tsai HM, 2000, AM J HEMATOL, V65, P251, DOI 10.1002/1096-8652(200011)65:3<251::AID-AJH13>3.0.CO;2-2; Tsai HM, 1998, NEW ENGL J MED, V339, P1585, DOI 10.1056/NEJM199811263392203; Vesely SK, 2003, BLOOD, V102, P60, DOI 10.1182/blood-2003-01-0193; Veyradier A, 2001, BLOOD, V98, P1765, DOI 10.1182/blood.V98.6.1765; Wyllie BF, 2006, BRIT J HAEMATOL, V132, P204, DOI 10.1111/j.1365-2141.2005.05857.x; Zheng XL, 2004, BLOOD, V103, P4043, DOI 10.1182/blood-2003-11-4035	21	38	38	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33029	10.1371/journal.pone.0033029	http://dx.doi.org/10.1371/journal.pone.0033029			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427934	Green Submitted, gold, Green Published			2022-12-25	WOS:000302381500077
J	Rasgon, JL				Rasgon, Jason L.			Wolbachia Induces Male-Specific Mortality in the Mosquito Culex pipiens (LIN Strain)	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; PLASMODIUM-FALCIPARUM MALARIA; T-CELL IMMUNITY; BURKITTS-LYMPHOMA; INTERLEUKIN-10 RESPONSES; GAMBIAN CHILDREN; INTERFERON-GAMMA; ADHESIVE PROTEIN; B-CELLS; INFECTION	Background: Wolbachia are maternally inherited endosymbionts that infect a diverse range of invertebrates, including insects, arachnids, crustaceans and filarial nematodes. Wolbachia are responsible for causing diverse reproductive alterations in their invertebrate hosts that maximize their transmission to the next generation. Evolutionary theory suggests that due to maternal inheritance, Wolbachia should evolve toward mutualism in infected females, but strict maternal inheritance means there is no corresponding force to select for Wolbachia strains that are mutualistic in males. Methodology/Principal findings: Using cohort life-table analysis, we demonstrate that in the mosquito Culex pipiens (LIN strain), Wolbachia-infected females show no fitness costs due to infection. However, Wolbachia induces up to a 30% reduction in male lifespan. Conclusions/significance: These results indicate that the Wolbachia infection of the Culex pipiens LIN strain is virulent in a sex-specific manner. Under laboratory situations where mosquitoes generally mate at young ages, Wolbachia strains that reduce male survival could evolve by drift because increased mortality in older males is not a significant selective force.	[Rasgon, Jason L.] Penn State Univ, Dept Entomol, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; [Rasgon, Jason L.] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Rasgon, JL (corresponding author), Penn State Univ, Dept Entomol, Ctr Infect Dis Dynam, University Pk, PA 16802 USA.	jlr54@psu.edu		Rasgon, Jason/0000-0002-4050-8429	NIH/NIAID [AI070178, GM020092]; Bloomberg Family Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI070178] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM020092] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bloomberg Family Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by grants from the NIH/NIAID (AI070178 and GM020092) and the Bloomberg Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Raddad LJ, 2006, SCIENCE, V314, P1603, DOI 10.1126/science.1132338; Bloland PB, 1999, AM J TROP MED HYG, V60, P641, DOI 10.4269/ajtmh.1999.60.641; Brady G, 2008, POSTGRAD MED J, V84, P372, DOI 10.1136/jcp.2007.047977; BURKITT D, 1966, BMJ-BRIT MED J, V1, P569, DOI 10.1136/bmj.1.5487.569; BURKITT DP, 1969, JNCI-J NATL CANCER I, V42, P19; Chene A, 2007, PLOS PATHOG, V3, P826, DOI 10.1371/journal.ppat.0030080; De-The G, 1979, Epidemiol Rev, V1, P32; Donati D, 2006, J INFECT DIS, V193, P971, DOI 10.1086/500839; FACER CA, 1989, ADV CANCER RES, V53, P33; GUNAPALA DE, 1990, PARASITOL RES, V76, P531, DOI 10.1007/BF00931060; Hislop AD, 2002, J EXP MED, V195, P893, DOI 10.1084/jem.20011692; Kafuko G W, 1969, East Afr Med J, V46, P414; KAFUKO GW, 1970, INT J CANCER, V6, P1, DOI 10.1002/ijc.2910060102; KLEIN G, 1982, SCAND J INFECT DIS, P15; LAM KMC, 1991, LANCET, V337, P876, DOI 10.1016/0140-6736(91)90203-2; Legoff J, 2004, J CLIN IMMUNOL, V24, P125, DOI 10.1023/B:JOCI.0000019777.75784.6f; Moormann AM, 2009, PARASITE IMMUNOL, V31, P547, DOI 10.1111/j.1365-3024.2009.01137.x; Moormann AM, 2006, AM J TROP MED HYG, V74, P585, DOI 10.4269/ajtmh.2006.74.585; Moormann AM, 2005, J INFECT DIS, V191, P1233, DOI 10.1086/428910; Moormann AM, 2007, J INFECT DIS, V195, P799, DOI 10.1086/511984; Moormann AM, 2009, AM J TROP MED HYG, V81, P489, DOI 10.4269/ajtmh.2009.81.489; MORROW RH, 1976, JNCI-J NATL CANCER I, V56, P479, DOI 10.1093/jnci/56.3.479; MORROW RH, 1976, CANCER RES, V36, P667; MOSS DJ, 1978, INT J CANCER, V22, P662, DOI 10.1002/ijc.2910220604; MOSS DJ, 1983, INT J CANCER, V31, P727, DOI 10.1002/ijc.2910310609; Munz C, 2005, EPSTEIN-BARR VIRUS, P197; Njie R, 2009, J INFECT DIS, V199, P31, DOI 10.1086/594373; Piriou E, 2009, J MED VIROL, V81, P1088, DOI 10.1002/jmv.21485; Rasti N, 2005, SCAND J IMMUNOL, V61, P461, DOI 10.1111/j.1365-3083.2005.01589.x; Rickinson A, 2007, FIELDS VIROLOGY; ROBERTS DE, 1985, J TROP PEDIATRICS, V31, P209, DOI 10.1093/tropej/31.4.209; Rochford R, 2005, NAT REV MICROBIOL, V3, P182, DOI 10.1038/nrmicro1089; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; WHITTLE HC, 1984, NATURE, V312, P449, DOI 10.1038/312449a0; WHITTLE HC, 1990, CLIN EXP IMMUNOL, V80, P213, DOI 10.1111/j.1365-2249.1990.tb05236.x; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452	36	9	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e30381	10.1371/journal.pone.0030381	http://dx.doi.org/10.1371/journal.pone.0030381			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427798	gold, Green Published, Green Submitted			2022-12-25	WOS:000302381500003
J	Bailleul, D; Ollier, S; Huet, S; Gardarin, A; Lecomte, J				Bailleul, Diane; Ollier, Sebastien; Huet, Sylvie; Gardarin, Antoine; Lecomte, Jane			Seed Spillage from Grain Trailers on Road Verges during Oilseed Rape Harvest: An Experimental Survey	PLOS ONE			English	Article							SPATIAL-PATTERNS; LAND-USE; DISPERSAL; POPULATIONS; GRASSLAND; VEHICLES; PLANTS; DETERMINANTS; PERSISTENCE; VOLUNTEER	Context: Anthropogenic vectors enhance the natural dispersal capacity of plant seeds significantly in terms of quantity and distance. Human-mediated seed dispersal (i.e. anthropochory) greatly increases the dispersal of crop species across agroecosystems. In the case of oilseed rape (OSR), spillage of seeds from grain trailers during harvest has never been quantified. Methods: Our experimental approach involved establishing 85 seed trap-sites on the road verges of an agricultural area around the grain silo of Selommes (Loir-et-Cher, France). We recorded OSR spillage during harvest and applied a linear model to the data. Results: The amount of seed spilled was related positively to the area of the OSR fields served by the road, whereas the amount of seed spilled decreased with other variables, such as distance from the trap-site to the verge of the road and to the nearest field. The distance to the grain silo, through local and regional effects, affected seed loss. Local effects from fields adjacent to the road resulted in a cumulative spillage on one-lane roads. On two-lane roads, spillage was nearly constant whatever the distance to the silo due to a mixture of these local effects and of grain trailers that joined the road from more distant fields. From the data, we predicted the number of seeds lost from grain trailers on one road verge in the study area. We predicted a total spillage of 2.05x10(6) seeds (+/- 4.76x10(5)) along the road length, which represented a mean of 404 +/- 94 seeds per m(2). Conclusion: Containment of OSR seeds will always be challenging. However, seed spillage could be reduced if grain trailers were covered and filled with less seed. Reducing distances travelled between fields and silos could also limit seed loss.	[Bailleul, Diane; Ollier, Sebastien; Gardarin, Antoine; Lecomte, Jane] Univ Paris 11, Unite Ecol Systemat & Evolut, Orsay, France; [Huet, Sylvie] INRA, Dept Math & Informat Appl, Jouy En Josas, France	AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Bailleul, D (corresponding author), Univ Paris 11, Unite Ecol Systemat & Evolut, Orsay, France.	jane.lecomte@u-psud.fr	Colbach, Nathalie/C-6677-2014	Colbach, Nathalie/0000-0002-3791-037X	Agence Nationale de la Recherche [ANR-06-POGM-04]	Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was funded by the Agence Nationale de la Recherche (project GMBioImpact, ANR-06-POGM-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aono Mitsuko, 2006, Environmental Biosafety Research, V5, P77, DOI 10.1051/ebr:2006017; Beckie HJ, 2010, CROP PROT, V29, P509, DOI 10.1016/j.cropro.2009.11.013; Bullock JM, 2002, DISPERSAL ECOLOGY, P279; Bullock JM, 2003, ECOGRAPHY, V26, P692, DOI 10.1034/j.1600-0587.2003.03525.x; CLIFFORD H. T., 1956, Proceedings of the Botanical Society of the British Isles, V2, P129; CLIFFORD HT, 1959, J ECOL, V47, P311, DOI 10.2307/2257368; Colbach N, 2001, AGR ECOSYST ENVIRON, V83, P255, DOI 10.1016/S0167-8809(00)00175-4; Colbach N, 2009, ENVIRON SCI POLLUT R, V16, P348, DOI 10.1007/s11356-008-0080-6; CRAWLEY MJ, 1995, P ROY SOC B-BIOL SCI, V259, P49, DOI 10.1098/rspb.1995.0008; Crawley MJ, 2004, P ROY SOC B-BIOL SCI, V271, P1909, DOI 10.1098/rspb.2004.2814; Cutway HB, 2010, PLANT ECOL, V210, P153, DOI 10.1007/s11258-010-9746-5; Garnier A, 2008, BASIC APPL ECOL, V9, P533, DOI 10.1016/j.baae.2007.08.014; GHERSA CM, 1993, WEED RES, V33, P79, DOI 10.1111/j.1365-3180.1993.tb01920.x; Hochrein H, 2008, CORRIDORS PLANT INVA; Hodkinson DJ, 1997, J APPL ECOL, V34, P1484, DOI 10.2307/2405264; Kalwij JM, 2008, APPL VEG SCI, V11, P491, DOI 10.3170/2008-7-18555; Kawata M, 2009, ENVIRON SCI POLLUT R, V16, P120, DOI 10.1007/s11356-008-0074-4; Knispel AL, 2010, ENVIRON SCI POLLUT R, V17, P13, DOI 10.1007/s11356-009-0219-0; Lemke A, 2009, J APPL ECOL, V46, P1122, DOI 10.1111/j.1365-2664.2009.01691.x; LONSDALE WM, 1994, BIOL CONSERV, V69, P277, DOI 10.1016/0006-3207(94)90427-8; Lu B-R, 2008, ICBEG COLLECTION BIO, P4; Lutman PJW, 2005, P ROY SOC B-BIOL SCI, V272, P1909, DOI 10.1098/rspb.2005.3166; MCCANNY SJ, 1988, WEED RES, V28, P67, DOI 10.1111/j.1365-3180.1988.tb00788.x; Middelhoff U, 2011, ECOL INDIC, V11, P974, DOI 10.1016/j.ecolind.2009.03.006; Nathan R, 2000, TRENDS ECOL EVOL, V15, P278, DOI 10.1016/S0169-5347(00)01874-7; Nishizawa Toru, 2009, Environmental Biosafety Research, V8, P33, DOI 10.1051/ebr/2009001; Ozinga WA, 2004, J ECOL, V92, P767, DOI 10.1111/j.0022-0477.2004.00916.x; Pauchard A, 2004, CONSERV BIOL, V18, P238, DOI 10.1111/j.1523-1739.2004.00300.x; Pessel FD, 2001, THEOR APPL GENET, V102, P841, DOI 10.1007/s001220100583; Pivard S, 2008, J APPL ECOL, V45, P476, DOI 10.1111/j.1365-2664.2007.01358.x; Pivard S, 2006, PROCESSUS ECOLOGIQUE; Pivard S, 2008, ECOL MODEL, V212, P147, DOI 10.1016/j.ecolmodel.2007.10.012; Price JS, 1996, J AGR ENG RES, V65, P183, DOI 10.1006/jaer.1996.0091; Saji Hikaru, 2005, Environmental Biosafety Research, V4, P217, DOI 10.1051/ebr:2006003; Schafer MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025736; SCHMIDT W, 1989, VEGETATIO, V80, P147, DOI 10.1007/BF00048038; SCHUPP EW, 1995, ECOSCIENCE, V2, P267, DOI 10.1080/11956860.1995.11682293; Soons MB, 2004, ECOLOGY, V85, P3056, DOI 10.1890/03-0522; Soons MB, 2004, ECOLOGY, V85, P3069, DOI 10.1890/03-0398; Squire GR, 2011, ENVIRON SCI POLLUT R, V18, P111, DOI 10.1007/s11356-010-0376-1; Strykstra RJ, 1997, ACTA BOT NEERL, V46, P387; Thiede DA, 1996, AM J BOT, V83, P856, DOI 10.2307/2446262; von der Lippe M, 2008, DIVERS DISTRIB, V14, P18, DOI 10.1111/j.1472-4642.2007.00401.x; Von der Lippe M, 2007, CONSERV BIOL, V21, P986, DOI 10.1111/j.1523-1739.2007.00722.x; von der Lippe M, 2007, ECOGRAPHY, V30, P483, DOI 10.1111/j.2007.0906-7590.05072.x; Wichmann MC, 2009, P ROY SOC B-BIOL SCI, V276, P523, DOI 10.1098/rspb.2008.1131; Yoshimura Yasuyuki, 2006, Environmental Biosafety Research, V5, P67, DOI 10.1051/ebr:2006019; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751; Zwaenepoel A, 2006, BASIC APPL ECOL, V7, P83, DOI 10.1016/j.baae.2005.04.003	49	22	25	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2012	7	3							e32752	10.1371/journal.pone.0032752	http://dx.doi.org/10.1371/journal.pone.0032752			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KX	22427873	gold, Green Submitted, Green Published			2022-12-25	WOS:000303062800029
J	Wightman, PJ; Jackson, GR; Dipple, KM				Wightman, Patrick J.; Jackson, George R.; Dipple, Katrina M.			Glycerol Hypersensitivity in a Drosophila Model for Glycerol Kinase Deficiency Is Affected by Mutations in Eye Pigmentation Genes	PLOS ONE			English	Article							SIMPLE MENDELIAN DISORDERS; FAT-METABOLISM; MOLECULAR CHARACTERIZATION; SUBCELLULAR-LOCALIZATION; ABC TRANSPORTER; NA+/K+ ATPASE; EXPRESSION; MELANOGASTER; COMPLEX; DESICCATION	Glycerol kinase plays a critical role in metabolism by converting glycerol to glycerol 3-phosphate in an ATP dependent reaction. In humans, glycerol kinase deficiency results in a wide range of phenotypic variability; patients can have severe metabolic and CNS abnormalities, while others possess hyperglycerolemia and glyceroluria with no other apparent phenotype. In an effort to help understand the pathogenic mechanisms underlying the phenotypic variation, we have created a Drosophila model for glycerol kinase deficiency by RNAi targeting of dGyk (CG18374) and dGK (CG7995). As expected, RNAi flies have reduced glycerol kinase RNA expression, reduced phosphorylation activity and elevated glycerol levels. Further investigation revealed these flies to be hypersensitive to fly food supplemented with glycerol. Due to the hygroscopic nature of glycerol, we predict glycerol hypersensitivity is a result of greater susceptibility to desiccation, suggesting glycerol kinase to play an important role in desiccation resistance in insects. To evaluate a role for genetic modifier loci in determining severity of the glycerol hypersensitivity observed in knockdown flies, we performed a preliminary screen of lethal transposon insertion mutant flies using a glycerol hypersensitive survivorship assay. We demonstrate that this type of screen can identify both enhancer and suppressor genetic loci of glycerol hypersensitivity. Furthermore, we found that the glycerol hypersensitivity phenotype can be enhanced or suppressed by null mutations in eye pigmentation genes. Taken together, our data suggest proteins encoded by eye pigmentation genes play an important role in desiccation resistance and that eye pigmentation genes are strong modifiers of the glycerol hypersensitive phenotype identified in our Drosophila model for glycerol kinase deficiency.	[Wightman, Patrick J.; Dipple, Katrina M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Jackson, George R.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Jackson, George R.] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst Neurosci & Human Behav, Brain Res Inst, Los Angeles, CA 90095 USA; [Jackson, George R.] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst Neurosci & Human Behav, Ctr Neurobehav Genet, Los Angeles, CA 90095 USA; [Dipple, Katrina M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Mattel Childrens Hosp, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Wightman, PJ (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA.	kdipple@mednet.ucla.edu			University of California Los Angeles Faculty Senate	University of California Los Angeles Faculty Senate	This work was funded in part by a University of California Los Angeles Faculty Senate grant. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS V, 1991, BIOCHEM MED METAB B, V45, P271, DOI 10.1016/0885-4505(91)90032-G; Ambegaokar SS, 2010, GENETICS, V186, P435, DOI 10.1534/genetics.110.119545; Bharucha KN, 2009, PEDIATR RES, V65, P132, DOI 10.1203/PDR.0b013e318191fc68; BRAND AH, 1993, DEVELOPMENT, V118, P401; Canavoso LE, 2001, ANNU REV NUTR, V21, P23, DOI 10.1146/annurev.nutr.21.1.23; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Dipple KM, 2001, HUM GENET, V109, P55, DOI 10.1007/s004390100545; Dipple KM, 2000, AM J HUM GENET, V66, P1729, DOI 10.1086/302938; Dipple KM, 2000, MOL GENET METAB, V71, P43, DOI 10.1006/mgme.2000.3052; Doyle WA, 1996, EUR J BIOCHEM, V239, P782, DOI 10.1111/j.1432-1033.1996.0782u.x; DREESEN TD, 1988, MOL CELL BIOL, V8, P5206, DOI 10.1128/MCB.8.12.5206; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; FISCHER JA, 1988, NATURE, V332, P853, DOI 10.1038/332853a0; Folk DG, 2001, J EXP BIOL, V204, P3323; Genova JL, 2003, J CELL BIOL, V161, P979, DOI 10.1083/jcb.200212054; Gibbs AG, 1997, J EXP BIOL, V200, P1821; Greenspan R.J., 2004, FLY PUSHING THEORY P; Gutierrez E, 2007, NATURE, V445, P275, DOI 10.1038/nature05382; Han D, 2002, BIOCHEM J, V368, P333; Hrdlicka L, 2002, GENESIS, V34, P51, DOI 10.1002/gene.10125; Huq AHMM, 1997, HUM MOL GENET, V6, P1803, DOI 10.1093/hmg/6.11.1803; HURLEY JH, 1993, SCIENCE, V259, P673, DOI 10.1126/science.8430315; Kalmus H, 1941, PROC R SOC SER B-BIO, V130, P185, DOI 10.1098/rspb.1941.0011; Kuwada N, 2005, BIOCHEM BIOPH RES CO, V335, P247, DOI 10.1016/j.bbrc.2005.07.066; Laprise P, 2009, NATURE, V459, P1141, DOI 10.1038/nature08067; LEBOVITZ RM, 1989, EMBO J, V8, P193, DOI 10.1002/j.1460-2075.1989.tb03364.x; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mackenzie SM, 1999, BBA-BIOMEMBRANES, V1419, P173, DOI 10.1016/S0005-2736(99)00064-4; Mackenzie SM, 2000, GENETICA, V108, P239, DOI 10.1023/A:1004115718597; MacLennan NK, 2009, MOL GENET METAB, V98, P203, DOI 10.1016/j.ymgme.2009.05.004; MacLennan NK, 2006, HUM MOL GENET, V15, P405, DOI 10.1093/hmg/ddi457; Agosto JAM, 2006, MOL GENET METAB, V88, P334, DOI 10.1016/j.ymgme.2006.01.002; Matthews KA, 2005, NAT REV GENET, V6, P179, DOI 10.1038/nrg1554; MCCABE ERB, 1977, BIOCHEM BIOPH RES CO, V78, P1327, DOI 10.1016/0006-291X(77)91437-1; McCabe ERB, 2001, DISORDERS GLYCEROL M, P2217; Nagel AC, 2002, DEV GENES EVOL, V212, P93, DOI 10.1007/s00427-002-0210-y; OHARE K, 1984, J MOL BIOL, V180, P437, DOI 10.1016/0022-2836(84)90021-4; OKAMOTO K, 1994, J BIOCHEM-TOKYO, V115, P862, DOI 10.1093/oxfordjournals.jbchem.a124431; OKAMOTO K, 1993, BIOCHEM BIOPH RES CO, V193, P848, DOI 10.1006/bbrc.1993.1703; Okamura T, 2007, MOL BIOL CELL, V18, P1519, DOI 10.1091/mbc.E06-10-0909; Ollmann M, 2000, CELL, V101, P91, DOI 10.1016/S0092-8674(00)80626-1; Ooi CE, 1997, EMBO J, V16, P4508; Ormo M, 1998, BIOCHEMISTRY-US, V37, P16565, DOI 10.1021/bi981616s; Palladino MJ, 2003, J NEUROSCI, V23, P1276, DOI 10.1523/JNEUROSCI.23-04-01276.2003; Philip BN, 2010, J INSECT PHYSIOL, V56, P679, DOI 10.1016/j.jinsphys.2009.12.003; Rahib L, 2007, EUR J HUM GENET, V15, P646, DOI 10.1038/sj.ejhg.5201801; Rodenburg KW, 2005, BBA-MOL CELL BIOL L, V1736, P10, DOI 10.1016/j.bbalip.2005.07.002; Rozen S, 2000, Methods Mol Biol, V132, P365; Sargent CA, 2000, J MED GENET, V37, P434, DOI 10.1136/jmg.37.6.434; SEARLES LL, 1986, P NATL ACAD SCI USA, V83, P404, DOI 10.1073/pnas.83.2.404; Sjarif DR, 2000, J INHERIT METAB DIS, V23, P529, DOI 10.1023/A:1005660826652; SONDERGAARD L, 1993, TRENDS GENET, V9, P193, DOI 10.1016/0168-9525(93)90113-V; Sriram G, 2005, AM J HUM GENET, V76, P911, DOI 10.1086/430799; Sriram G, 2010, METAB ENG, V12, P332, DOI 10.1016/j.ymben.2010.04.001; St Johnston D, 2002, NAT REV GENET, V3, P176, DOI 10.1038/nrg751; SULLIVAN DT, 1974, J EXP ZOOL, V188, P225, DOI 10.1002/jez.1401880210; TEARLE RG, 1989, GENETICS, V122, P595; Yamaguchi M, 1999, ONCOGENE, V18, P6767, DOI 10.1038/sj.onc.1203113	61	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2012	7	3							e31779	10.1371/journal.pone.0031779	http://dx.doi.org/10.1371/journal.pone.0031779			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KX	22427807	Green Published, Green Submitted, gold			2022-12-25	WOS:000303062800006
J	Ferrante, P; Ballottari, M; Bonente, G; Giuliano, G; Bassi, R				Ferrante, Paola; Ballottari, Matteo; Bonente, Giulia; Giuliano, Giovanni; Bassi, Roberto			LHCBM1 and LHCBM2/7 Polypeptides, Components of Major LHCII Complex, Have Distinct Functional Roles in Photosynthetic Antenna System of Chlamydomonas reinhardtii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-HARVESTING COMPLEX; PROTEIN-KINASE STT7; PHOTOSYSTEM-II; CHLOROPHYLL ANTENNA; STATE TRANSITIONS; HIGHER-PLANTS; HYDROGEN-PRODUCTION; MOLECULAR-HYDROGEN; GRANA MEMBRANES; CARBON-DIOXIDE	The photosystem II antenna of Chlamydomonas reinhardtii is composed of monomeric and trimeric complexes, the latter encoded by LHCBM genes. We employed artificial microRNA technology to specifically silence the LHCBM2 and LHCBM7 genes, encoding identical mature polypeptides, and the LHCBM1 gene. As a control, we studied the npq5 mutant, deficient in the LHCBM1 protein. The organization of LHCII complexes, functional antenna size, capacity for photoprotection, thermal energy dissipation and state transitions, and resistance to reactive oxygen species was studied in the various genotypes. Silencing of the LHCBM2/7 genes resulted in a decrease of an LHCII protein with an apparent molecular mass of 22 kDa, whereas silencing/lack of LHCBM1 caused the decrease/disappearance of a 23-kDa protein. A decrease in the abundance of trimeric LHCII complexes and in functional antenna size was observed in bothLHCBM2/7andLHCBM1knockouts. In agreement with previous data, depletion of LHCBM1 decreased the capacity for excess energy dissipation but not the ability to perform state transitions. The opposite was true for LHCBM2/7, implying that this polypeptide has a different functional role from LHCBM1. The abundance of LHCBM1 and LHCBM2/7 is in both cases correlated with resistance to superoxide anion, whereas only LHCBM1 is also involved in singlet oxygen scavenging. These results suggest that different LHCBM components have well defined, non-redundant functions despite their high homology, implying that engineering of LHCBM proteins can be an effective strategy for manipulating the light harvesting system of Chlamydomonas reinhardtii.	[Ballottari, Matteo; Bonente, Giulia; Bassi, Roberto] Univ Verona, Dept Biotechnol, I-37134 Verona, Italy; [Ferrante, Paola; Giuliano, Giovanni] Casaccia Res Ctr, ENEA Italian Natl Agcy New Technol Energy & Susta, I-00123 Rome, Italy; [Bassi, Roberto] ICG3 Juelich Res Ctr, D-52425 Julich, Germany	University of Verona; Italian National Agency New Technical Energy & Sustainable Economics Development	Bassi, R (corresponding author), Univ Verona, Dept Biotechnol, Str Le Grazie 15, I-37134 Verona, Italy.	roberto.bassi@univr.it	Ballottari, Matteo/N-1916-2019; Giuliano, Giovanni/A-2701-2012	Ballottari, Matteo/0000-0001-8410-3397; Giuliano, Giovanni/0000-0002-2486-0510; bassi, roberto/0000-0002-4140-8446; Ferrante, Paola/0000-0003-3071-2212	Italian Ministry of Agriculture; Euopean Union [245070 FP7-KBBE-2009-3 SUNBIOPATH]	Italian Ministry of Agriculture; Euopean Union	This work was supported by the Italian Ministry of Agriculture, Hydrobio project, and by Euopean Union Project 245070 FP7-KBBE-2009-3 SUNBIOPATH.	Andersson J, 2003, PLANT J, V35, P350, DOI 10.1046/j.1365-313X.2003.01811.x; Avenson TJ, 2008, J BIOL CHEM, V283, P3550, DOI 10.1074/jbc.M705645200; Ballottari M, 2012, BBA-BIOENERGETICS, V1817, P143, DOI 10.1016/j.bbabio.2011.06.005; Baroli I, 2004, J BIOL CHEM, V279, P6337, DOI 10.1074/jbc.M312919200; BASSI R, 1989, EUR J CELL BIOL, V50, P84; BASSI R, 1991, PLANTA, V183, P423, DOI 10.1007/BF00197742; Bonente G, 2012, J BIOL CHEM, V287, P5833, DOI 10.1074/jbc.M111.304279; Bonente G, 2011, PHOTOSYNTH RES, V108, P107, DOI 10.1007/s11120-011-9660-2; Bonente G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000577; Caffarri S, 2005, PROTEOMICS, V5, P758, DOI 10.1002/pmic.200402008; Caffarri S, 2009, EMBO J, V28, P3052, DOI 10.1038/emboj.2009.232; Cardol P, 2008, P NATL ACAD SCI USA, V105, P7881, DOI 10.1073/pnas.0802762105; Choi SP, 2010, BIORESOURCE TECHNOL, V101, P5330, DOI 10.1016/j.biortech.2010.02.026; Croce R, 2002, BBA-BIOENERGETICS, V1556, P29, DOI 10.1016/S0005-2728(02)00304-3; DAINESE P, 1991, J BIOL CHEM, V266, P8136; Dall'Osto L, 2005, PLANT CELL, V17, P1217, DOI 10.1105/tpc.104.030601; Dall'Osto L, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-32; Dall'Osto L, 2007, J BIOL CHEM, V282, P35056, DOI 10.1074/jbc.M704729200; Dall'Osto L, 2007, PLANT CELL, V19, P1048, DOI 10.1105/tpc.106.049114; Dall'Osto L, 2010, MOL PLANT, V3, P576, DOI 10.1093/mp/ssp117; Damkjaer JT, 2009, PLANT CELL, V21, P3245, DOI 10.1105/tpc.108.064006; de Bianchi S, 2008, PLANT CELL, V20, P1012, DOI 10.1105/tpc.107.055749; Dekker JP, 2005, BBA-BIOENERGETICS, V1706, P12, DOI 10.1016/j.bbabio.2004.09.009; DemmigAdams B, 1996, PHYSIOL PLANTARUM, V98, P253, DOI 10.1034/j.1399-3054.1996.980206.x; Depege N, 2003, SCIENCE, V299, P1572, DOI 10.1126/science.1081397; Elrad D, 2004, CURR GENET, V45, P61, DOI 10.1007/s00294-003-0460-x; Elrad D, 2002, PLANT CELL, V14, P1801, DOI 10.1105/tpc.002154; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Fischer N, 2001, MOL GENET GENOMICS, V265, P888, DOI 10.1007/s004380100485; Fleischmann MM, 1999, J BIOL CHEM, V274, P30987, DOI 10.1074/jbc.274.43.30987; Fristedt R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010963; Gaffron H, 1939, NATURE, V143, P204, DOI 10.1038/143204a0; Gaffron H, 1940, AM J BOT, V27, P273, DOI 10.2307/2436697; Harrer R, 1998, EUR J BIOCHEM, V255, P196, DOI 10.1046/j.1432-1327.1998.2550196.x; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; Iwai M, 2010, NATURE, V464, P1210, DOI 10.1038/nature08885; Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706; Kim EH, 2009, BBA-BIOENERGETICS, V1787, P973, DOI 10.1016/j.bbabio.2009.04.009; KINDLE KL, 1990, P NATL ACAD SCI USA, V87, P1228, DOI 10.1073/pnas.87.3.1228; Kovacs L, 2006, PLANT CELL, V18, P3106, DOI 10.1105/tpc.106.045641; Lagarde D, 2000, APPL ENVIRON MICROB, V66, P64, DOI 10.1128/AEM.66.1.64-72.2000; Lemeille S, 2010, PHOTOSYNTH RES, V106, P33, DOI 10.1007/s11120-010-9538-8; Lemeille S, 2009, PLOS BIOL, V7, P664, DOI 10.1371/journal.pbio.1000045; Melis A, 2004, PHOTOSYNTH RES, V80, P401, DOI 10.1023/B:PRES.0000030421.31730.cb; Melis A, 2000, PLANT PHYSIOL, V122, P127, DOI 10.1104/pp.122.1.127; Melis A, 2009, PLANT SCI, V177, P272, DOI 10.1016/j.plantsci.2009.06.005; Minagawa J, 2004, PHOTOSYNTH RES, V82, P241, DOI 10.1007/s11120-004-2079-2; Mitra M, 2008, OPT EXPRESS, V16, P21807, DOI 10.1364/OE.16.021807; Molnar A, 2009, PLANT J, V58, P165, DOI 10.1111/j.1365-313X.2008.03767.x; Morosinotto T, 2005, J BIOL CHEM, V280, P31050, DOI 10.1074/jbc.M502935200; Morosinotto T, 2002, J BIOL CHEM, V277, P36253, DOI 10.1074/jbc.M205062200; Morris EP, 1997, STRUCTURE, V5, P837, DOI 10.1016/S0969-2126(97)00237-2; Mozzo M, 2008, J BIOL CHEM, V283, P6184, DOI 10.1074/jbc.M708961200; Mussgnug JH, 2007, PLANT BIOTECHNOL J, V5, P802, DOI 10.1111/j.1467-7652.2007.00285.x; Nguyen AV, 2008, EUKARYOT CELL, V7, P1965, DOI 10.1128/EC.00418-07; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Niyogi KK, 1997, PLANT CELL, V9, P1369, DOI 10.2307/3870388; Peers G, 2009, NATURE, V462, P518, DOI 10.1038/nature08587; Peterman EJG, 1997, BIOCHEMISTRY-US, V36, P12208, DOI 10.1021/bi9711689; Polle JEW, 2000, PLANTA, V211, P335, DOI 10.1007/s004250000279; Polle JEW, 2002, INT J HYDROGEN ENERG, V27, P1257, DOI 10.1016/S0360-3199(02)00116-7; Polle JEW, 2001, PLANT CELL PHYSIOL, V42, P482, DOI 10.1093/pcp/pce058; Rasala BA, 2010, PLANT BIOTECHNOL J, V8, P719, DOI 10.1111/j.1467-7652.2010.00503.x; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Stauber EJ, 2003, EUKARYOT CELL, V2, P978, DOI 10.1128/EC.2.5.978-994.2003; SUEOKA N, 1960, P NATL ACAD SCI USA, V46, P83, DOI 10.1073/pnas.46.1.83; SUNDBY C, 1986, BIOCHIM BIOPHYS ACTA, V851, P475, DOI 10.1016/0005-2728(86)90084-8; Takahashi H, 2006, P NATL ACAD SCI USA, V103, P477, DOI 10.1073/pnas.0509952103; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tetali SD, 2007, PLANTA, V225, P813, DOI 10.1007/s00425-006-0392-z; Tokutsu R, 2009, J BIOL CHEM, V284, P7777, DOI 10.1074/jbc.M809360200; Turkina Maria V., 2007, V355, P305; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Wang ZT, 2009, EUKARYOT CELL, V8, P1856, DOI 10.1128/EC.00272-09	74	64	65	0	25	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16276	16288		10.1074/jbc.M111.316729	http://dx.doi.org/10.1074/jbc.M111.316729			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22431727	Green Published, hybrid			2022-12-25	WOS:000304030900020
J	Fu, K; Mende, Y; Bhetwal, BP; Baker, S; Perrino, BA; Wirth, B; Fisher, SA				Fu, Kang; Mende, Ylva; Bhetwal, Bhupal P.; Baker, Salah; Perrino, Brian A.; Wirth, Brunhilde; Fisher, Steven A.			Tra2 beta Protein Is Required for Tissue-specific Splicing of a Smooth Muscle Myosin Phosphatase Targeting Subunit Alternative Exon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; LIGHT-CHAIN PHOSPHATASE; SIGNALING PATHWAYS; PORTAL-VEIN; IN-SITU; EXPRESSION; ISOFORM; RAT; HYPERTENSION; MECHANISMS	Alternative splicing of the smooth muscle myosin phosphatase targeting subunit (Mypt1) exon 23 (E23) is tissue-specific and developmentally regulated and, thus, an attractive model for the study of smooth muscle phenotypic specification. We have proposed that Tra2 beta functions as a tissue-specific activator of Mypt1 E23 splicing on the basis of concordant expression patterns and Tra2 beta activation of Mypt1 E23 mini-gene splicing in vitro. In this study we examined the relationship between Tra2 beta and Mypt1 E23 splicing in vivo in the mouse. Tra2 beta was 2- to 5-fold more abundant in phasic smooth muscle tissues, such as the portal vein, small intestine, and small mesenteric artery, in which Mypt1 E23 is predominately included as compared with the tonic smooth muscle tissues, such as the aorta and inferior vena cava, in which Mypt1 E23 is predominately skipped. Tra2 beta was up-regulated in the small intestine postnatally, concordant with a switch to Mypt1 E23 splicing. Targeting of Tra2 beta in smooth muscle cells using SM22 alpha-Cre caused a substantial reduction in Mypt1 E23 inclusion specifically in the intestinal smooth muscle of heterozygotes, indicating sensitivity to Tra2 beta gene dosage. The switch to the Mypt1 E23 skipped isoform coding for the C-terminal leucine zipper motif caused increased sensitivity of the muscle to the relaxant effects of 8-Br-cyclic guanosine monophosphate (cGMP). We conclude that Tra2 beta is necessary for the tissue-specific splicing of Mypt1 E23 in the phasic intestinal smooth muscle. Tra2 beta, by regulating the splicing of Mypt1 E23, sets the sensitivity of smooth muscle to cGMP-mediated relaxation.	[Fu, Kang; Fisher, Steven A.] Case Western Reserve Univ, Dept Med Cardiol, Cleveland, OH 44106 USA; [Fisher, Steven A.] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Mende, Ylva; Wirth, Brunhilde] Univ Cologne, Inst Genet, Inst Human Genet, D-50931 Cologne, Germany; [Mende, Ylva; Wirth, Brunhilde] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Bhetwal, Bhupal P.; Baker, Salah; Perrino, Brian A.] Univ Nevada, Sch Med, Ctr Biomed Res Excellence, Dept Physiol & Cell Biol, Reno, NV 89557 USA	Case Western Reserve University; Case Western Reserve University; University of Cologne; University of Cologne; Nevada System of Higher Education (NSHE); University of Nevada Reno	Fisher, SA (corresponding author), Univ Maryland, Sch Med, S-003C HSF-2,20 Penn St, Baltimore, MD 21201 USA.	SFisher1@medicine.umaryland.edu	Wirth, Brunhilde/H-3192-2019	BAKER, SAL/0000-0002-1514-6876; Wirth, Brunhilde/0000-0003-4051-5191	National Institutes of Health [RO1 HL-66171, GM103513, CMMC D7]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103513] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 HL-66171 (to S. A. F.), GM103513 (to B. A. P.), and CMMC D7 (to B. W.).	Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622; Bhetwal BP, 2011, NEUROGASTROENT MOTIL, V23, pE425, DOI 10.1111/j.1365-2982.2011.01769.x; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Braun T, 2011, NAT REV MOL CELL BIO, V12, P349, DOI 10.1038/nrm3118; Chen XH, 2003, CELL BIOL INT, V27, P491, DOI 10.1016/S1065-6995(03)00072-6; Clery A, 2011, NAT STRUCT MOL BIOL, V18, P443, DOI 10.1038/nsmb.2001; Dirksen WP, 2000, AM J PHYSIOL-CELL PH, V278, pC589, DOI 10.1152/ajpcell.2000.278.3.C589; Eto M, 2009, J BIOL CHEM, V284, P35273, DOI 10.1074/jbc.R109.059972; Fisher SA, 2010, PHYSIOL GENOMICS, V42A, P169, DOI 10.1152/physiolgenomics.00111.2010; Frei E, 2009, AM J PHYSIOL-GASTR L, V297, pG834, DOI 10.1152/ajpgi.00095.2009; Gabella G, 2002, RES PRO CEL, V38, P1; Gooding C, 2008, ADV EXP MED BIOL, V644, P27; Grassie ME, 2011, ARCH BIOCHEM BIOPHYS, V510, P147, DOI 10.1016/j.abb.2011.01.018; Grellscheid S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002390; Grellscheid SN, 2011, NUCLEIC ACIDS RES, V39, P8092, DOI 10.1093/nar/gkr495; Hartshorne DJ, 2004, J BIOL CHEM, V279, P37211, DOI 10.1074/jbc.R400018200; Hofmann Y, 2000, P NATL ACAD SCI USA, V97, P9618, DOI 10.1073/pnas.160181697; Huang QQ, 2004, J BIOL CHEM, V279, P597, DOI 10.1074/jbc.M308496200; Kalsotra A, 2011, NAT REV GENET, V12, P715, DOI 10.1038/nrg3052; Karim SM, 2004, CIRC RES, V95, P612, DOI 10.1161/01.RES.0000142736.39359.58; Khatri JJ, 2001, J BIOL CHEM, V276, P37250, DOI 10.1074/jbc.M105275200; Lepore JJ, 2005, GENESIS, V41, P179, DOI 10.1002/gene.20112; LJUNG B, 1979, ACTA PHYSIOL SCAND, V106, P271, DOI 10.1111/j.1748-1716.1979.tb06398.x; Lu Y, 2008, AM J PHYSIOL-CELL PH, V294, pC564, DOI 10.1152/ajpcell.00285.2007; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; McKee AE, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-14; Mende Y, 2010, HUM MOL GENET, V19, P2154, DOI 10.1093/hmg/ddq094; Nayler O, 1998, GENOMICS, V53, P191, DOI 10.1006/geno.1998.5471; O'Gorman W, 2005, J BIOL CHEM, V280, P36920, DOI 10.1074/jbc.M505791200; Ogut O, 2003, J MOL CELL CARDIOL, V35, P347, DOI 10.1016/S0022-2828(03)00045-2; Ogut O, 2000, AM J PHYSIOL-CELL PH, V279, pC1722, DOI 10.1152/ajpcell.2000.279.6.C1722; Park KJ, 2006, AM J PHYSIOL-CELL PH, V290, pC1411, DOI 10.1152/ajpcell.00447.2005; Payne MC, 2006, J MOL CELL CARDIOL, V40, P274, DOI 10.1016/j.yjmcc.2005.07.009; Payne MC, 2004, AM J PHYSIOL-HEART C, V286, pH1801, DOI 10.1152/ajpheart.00696.2003; Qureshi S, 2010, NEUROGASTROENT MOTIL, V22, DOI 10.1111/j.1365-2982.2009.01406.x; Schiaffino S, 2007, PHYSIOLOGY, V22, P269, DOI 10.1152/physiol.00009.2007; Sciabica KS, 2006, NUCLEIC ACIDS RES, V34, P6612, DOI 10.1093/nar/gkl984; Shirangi TR, 2007, DEV BIOL, V306, P10, DOI 10.1016/j.ydbio.2007.03.022; Shukla S, 2008, CIRC RES, V103, P485, DOI 10.1161/CIRCRESAHA.108.178384; SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0; Stoilov P, 2004, HUM MOL GENET, V13, P509, DOI 10.1093/hmg/ddh051; Surks HK, 2003, J BIOL CHEM, V278, P51484, DOI 10.1074/jbc.M305622200; Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583; Tacke R, 1998, CELL, V93, P139, DOI 10.1016/S0092-8674(00)81153-8; TSAO C, 1971, ANAT RECORD, V171, P457, DOI 10.1002/ar.1091710403; Venables JP, 2005, HUM MOL GENET, V14, P2289, DOI 10.1093/hmg/ddi233; Verhulst EC, 2010, CURR OPIN GENET DEV, V20, P376, DOI 10.1016/j.gde.2010.05.001; Yuen S, 2011, J BIOL CHEM, V286, P37274, DOI 10.1074/jbc.M111.282905; Zhang HY, 2007, CIRC RES, V100, P730, DOI 10.1161/01.RES.0000260189.38975.35	49	14	15	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16575	16585		10.1074/jbc.M111.325761	http://dx.doi.org/10.1074/jbc.M111.325761			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22437831	Green Published, hybrid			2022-12-25	WOS:000304030900047
J	Li, R; Chen, DF; Zhou, R; Jia, SN; Yang, JS; Clegg, JS; Yang, WJ				Li, Ran; Chen, Dian-Fu; Zhou, Rong; Jia, Sheng-Nan; Yang, Jin-Shu; Clegg, James S.; Yang, Wei-Jun			Involvement of Polo-like Kinase 1 (Plk1) in Mitotic Arrest by Inhibition of Mitogen-activated Protein Kinase-Extracellular Signal-regulated Kinase-Ribosomal S6 Kinase 1 (MEK-ERK-RSK1) Cascade	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS OOCYTE MATURATION; CELL-CYCLE ARREST; DNA-DAMAGE; MAP KINASE; ARTEMIA-FRANCISCANA; METAPHASE ARREST; BRINE SHRIMP; EMBRYOS; MOS; IDENTIFICATION	Cell division is controlled through cooperation of different kinases. Of these, polo-like kinase 1 (Plk1) and p90 ribosomal S6 kinase 1 (RSK1) play key roles. Plk1 acts as a G(2)/M trigger, and RSK1 promotes G(1) progression. Although previous reports show that Plk1 is suppressed by RSK1 during meiosis in Xenopus oocytes, it is still not clear whether this is the case during mitosis or whether Plk1 counteracts the effects of RSK1. Few animal models are available for the study of controlled and transient cell cycle arrest. Here we show that encysted embryos (cysts) of the primitive crustacean Artemia are ideal for such research because they undergo complete cell cycle arrest when they enter diapause (a state of obligate dormancy). We found that Plk1 suppressed the activity of RSK1 during embryonic mitosis and that Plk1 was inhibited during embryonic diapause and mitotic arrest. In addition, studies on HeLa cells using Plk1 siRNA interference and overexpression showed that phosphorylation of RSK1 increased upon interference and decreased after overexpression, suggesting that Plk1 inhibits RSK1. Taken together, these findings provide insights into the regulation of Plk1 during cell division and Artemia diapause cyst formation and the correlation between the activity of Plk1 and RSK1.	[Li, Ran; Chen, Dian-Fu; Zhou, Rong; Jia, Sheng-Nan; Yang, Jin-Shu; Yang, Wei-Jun] Zhejiang Univ, Key Lab Conservat Biol Endangered Wildlife, Minist Educ, Hangzhou 310058, Zhejiang, Peoples R China; [Li, Ran; Chen, Dian-Fu; Zhou, Rong; Jia, Sheng-Nan; Yang, Jin-Shu; Yang, Wei-Jun] Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Clegg, James S.] Univ Calif Davis, Sect Mol & Cellular Biol, Bodega Bay, CA 94923 USA; [Clegg, James S.] Univ Calif Davis, Bodega Marine Lab, Bodega Bay, CA 94923 USA	Zhejiang University; Zhejiang University; University of California System; University of California Davis; University of California System; University of California Davis	Yang, WJ (corresponding author), Zhejiang Univ, Key Lab Conservat Biol Endangered Wildlife, Minist Educ, Hangzhou 310058, Zhejiang, Peoples R China.	w_jyang@cls.zju.edu.cn		Yang, Jin-Shu/0000-0001-6680-7737; Yang, Wei-Jun/0000-0002-4591-8830; Li, Ran/0000-0002-8787-352X	National Natural Sciences Foundation of China [40876069, 40730212]; National Basic Research Program of China (973 Program) [2010CB833803]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by the National Natural Sciences Foundation of China (Grants 40876069 and 40730212) and the National Basic Research Program of China (973 Program Grant 2010CB833803).	Abatzopoulos T. J., 2002, ARTEMIA BASIC APPL B, P129; Bahassi EM, 2002, ONCOGENE, V21, P6633, DOI 10.1038/sj.onc.1205850; Bhatt RR, 1999, SCIENCE, V286, P1362, DOI 10.1126/science.286.5443.1362; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; CLEGG JS, 1995, EXP CELL RES, V219, P1, DOI 10.1006/excr.1995.1197; COLEMAN TR, 1994, CURR OPIN CELL BIOL, V6, P877, DOI 10.1016/0955-0674(94)90060-4; Crowe JH, 2005, INTEGR COMP BIOL, V45, P810, DOI 10.1093/icb/45.5.810; Dai JQ, 2008, J BIOL CHEM, V283, P1705, DOI 10.1074/jbc.M707853200; Dai L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020187; Dai ZM, 2011, BIOSCIENCE REP, V31, P17, DOI 10.1042/BSR20090141; Dalby KN, 1998, J BIOL CHEM, V273, P1496, DOI 10.1074/jbc.273.3.1496; DONOHUE PJ, 1995, J BIOL CHEM, V270, P10351, DOI 10.1074/jbc.270.17.10351; Eckerdt F, 2005, ONCOGENE, V24, P267, DOI 10.1038/sj.onc.1208273; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Ferrell JE, 1999, BIOESSAYS, V21, P833, DOI 10.1002/(SICI)1521-1878(199910)21:10<833::AID-BIES5>3.0.CO;2-P; Frodin M, 1999, MOL CELL ENDOCRINOL, V151, P65, DOI 10.1016/S0303-7207(99)00061-1; Gebauer F, 1997, BIOESSAYS, V19, P23, DOI 10.1002/bies.950190106; GOLSTEYN RM, 1995, J CELL BIOL, V129, P1617, DOI 10.1083/jcb.129.6.1617; Gotoh Y, 1995, Prog Cell Cycle Res, V1, P287; GOTOH Y, 1995, J BIOL CHEM, V270, P25898, DOI 10.1074/jbc.270.43.25898; Gross SD, 1999, SCIENCE, V286, P1365, DOI 10.1126/science.286.5443.1365; Gumireddy K, 2005, CANCER CELL, V7, P275, DOI 10.1016/j.ccr.2005.02.009; HACCARD O, 1993, SCIENCE, V262, P1262, DOI 10.1126/science.8235656; HAMANAKA R, 1995, J BIOL CHEM, V270, P21086, DOI 10.1074/jbc.270.36.21086; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Inoue D, 2005, EMBO J, V24, P1057, DOI 10.1038/sj.emboj.7600567; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Lei M, 2008, ONCOGENE, V27, P3935, DOI 10.1038/onc.2008.36; Liang P, 1999, DEV BIOL, V207, P445, DOI 10.1006/dbio.1998.9138; Liby K, 2001, DNA SEQUENCE, V11, P527, DOI 10.3109/10425170109041337; Liu XQ, 2003, CELL CYCLE, V2, P424, DOI 10.4161/cc.2.5.505; Ma S, 2003, MOL CANCER RES, V1, P376; Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185; Nakajo N, 2000, GENE DEV, V14, P328; NAKANISHI Yu.H., 1962, ANNOT ZOOL JAPON, V35, P223; Nambu Z, 2004, J EXP ZOOL PART A, V301A, P542, DOI 10.1002/jez.a.80; Okumura E, 2002, NAT CELL BIOL, V4, P111, DOI 10.1038/ncb741; Pahlavan G, 2000, DEV BIOL, V220, P392, DOI 10.1006/dbio.2000.9656; Palmer A, 1998, EMBO J, V17, P5037, DOI 10.1093/emboj/17.17.5037; Qian YW, 1998, MOL CELL BIOL, V18, P4262, DOI 10.1128/MCB.18.7.4262; SAGATA N, 1989, NATURE, V342, P512, DOI 10.1038/342512a0; Sagata N, 1997, BIOESSAYS, V19, P13, DOI 10.1002/bies.950190105; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seki A, 2008, SCIENCE, V320, P1655, DOI 10.1126/science.1157425; SIMMONS DL, 1992, MOL CELL BIOL, V12, P4164, DOI 10.1128/MCB.12.9.4164; Singh B, 1997, Prog Cell Cycle Res, V3, P251; Spankuch B, 2004, JNCI-J NATL CANCER I, V96, P862, DOI 10.1093/jnci/djh146; Takai N, 2005, ONCOGENE, V24, P287, DOI 10.1038/sj.onc.1208272; Vempati RK, 2010, J BIOL CHEM, V285, P28553, DOI 10.1074/jbc.M110.149393; WATANABE N, 1991, NATURE, V352, P247, DOI 10.1038/352247a0; Xie SQ, 2001, J BIOL CHEM, V276, P43305, DOI 10.1074/jbc.M106050200; Xie SQ, 2002, CELL CYCLE, V1, P424, DOI 10.4161/cc.1.6.271; Yodmuang S, 2006, BIOCHEM BIOPH RES CO, V341, P351, DOI 10.1016/j.bbrc.2005.12.186	53	23	24	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15923	15934		10.1074/jbc.M111.312413	http://dx.doi.org/10.1074/jbc.M111.312413			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22427657	Green Published, hybrid			2022-12-25	WOS:000304006300071
J	Nucifora, LG; Burke, KA; Feng, X; Arbez, N; Zhu, SS; Miller, J; Yang, GC; Ratovitski, T; Delannoy, M; Muchowski, PJ; Finkbeiner, S; Legleiter, J; Ross, CA; Poirier, MA				Nucifora, Leslie G.; Burke, Kathleen A.; Feng, Xia; Arbez, Nicolas; Zhu, Shanshan; Miller, Jason; Yang, Guocheng; Ratovitski, Tamara; Delannoy, Michael; Muchowski, Paul J.; Finkbeiner, Steven; Legleiter, Justin; Ross, Christopher A.; Poirier, Michelle A.			Identification of Novel Potentially Toxic Oligomers Formed in Vitro from Mammalian-derived Expanded huntingtin Exon-1 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL FRAGMENTS; CAG REPEAT LENGTH; MUTANT HUNTINGTIN; TRANSGENIC MICE; POLYGLUTAMINE AGGREGATION; NEUROLOGIC ABNORMALITIES; TRINUCLEOTIDE REPEAT; CLINICAL PROGRESSION; MOUSE MODEL; WILD-TYPE	Huntington disease is a genetic neurodegenerative disorder that arises from an expanded polyglutamine region in the N terminus of the HD gene product, huntingtin. Protein inclusions comprised of N-terminal fragments of mutant huntingtin are a characteristic feature of disease, though are likely to play a protective role rather than a causative one in neurodegeneration. Soluble oligomeric assemblies of huntingtin formed early in the aggregation process are candidate toxic species in HD. In the present study, we established an in vitro system to generate recombinant huntingtin in mammalian cells. Using both denaturing and native gel analysis, we have identified novel oligomeric forms of mammalian-derived expanded huntingtin exon-1 N-terminal fragment. These species are transient and were not previously detected using bacterially expressed exon-1 protein. Importantly, these species are recognized by 3B5H10, an antibody that recognizes a two-stranded hairpin conformation of expanded polyglutamine believed to be associated with a toxic form of huntingtin. Interestingly, comparable oligomeric species were not observed for expanded huntingtin shortstop, a 117-amino acid fragment of huntingtin shown previously in mammalian cell lines and transgenic mice, and here in primary cortical neurons, to be non-toxic. Further, we demonstrate that expanded huntingtin shortstop has a reduced ability to form amyloid-like fibrils characteristic of the aggregation pathway for toxic expanded polyglutamine proteins. Taken together, these data provide a possible candidate toxic species in HD. In addition, these studies demonstrate the fundamental differences in early aggregation events between mutant huntingtin exon-1 and shortstop proteins that may underlie the differences in toxicity.	[Nucifora, Leslie G.; Feng, Xia; Arbez, Nicolas; Zhu, Shanshan; Ratovitski, Tamara; Ross, Christopher A.; Poirier, Michelle A.] Johns Hopkins Univ, Sch Med, Childrens Med Surg Ctr, Dept Psychiat,Div Neurobiol, Baltimore, MD 21287 USA; [Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21287 USA; [Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21287 USA; [Delannoy, Michael] Johns Hopkins Univ, Sch Med, Johns Hopkins Sch Med Microscope Facil, Baltimore, MD 21287 USA; [Burke, Kathleen A.; Legleiter, Justin] W Virginia Univ, C Eugene Bennett Dept Chem, Morgantown, WV 26506 USA; [Legleiter, Justin] W Virginia Univ, Ctr Neurosci, Morgantown, WV 26506 USA; [Miller, Jason] Univ Calif San Francisco, Chem & Chem Biol Grad Program, San Francisco, CA 94158 USA; [Miller, Jason] Univ Calif San Francisco, Med Scientist Training Program, San Francisco, CA 94158 USA; [Miller, Jason; Yang, Guocheng; Muchowski, Paul J.; Finkbeiner, Steven] Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Muchowski, Paul J.] Univ Calif San Francisco, Dept Biochem, San Francisco, CA 94158 USA; [Muchowski, Paul J.] Univ Calif San Francisco, Dept Biophys, San Francisco, CA 94158 USA; [Muchowski, Paul J.; Finkbeiner, Steven] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Finkbeiner, Steven] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; West Virginia University; West Virginia University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Poirier, MA (corresponding author), Johns Hopkins Univ, Sch Med, Childrens Med Surg Ctr, Dept Psychiat,Div Neurobiol, 8-121 600 N Wolfe St, Baltimore, MD 21287 USA.	mpoirie1@jhmi.edu	Nucifora, Leslie/X-2716-2019; Ross, Christopher A/H-8395-2013	Miller, Jason/0000-0002-2784-9560; Legleiter, Justin/0000-0002-5262-1867; Feng, Xia/0000-0003-2460-192X	National Institutes of Health [R01NS053679, P01NS16375, NS0547533, 2NS45091, 1S10RR021200]; National Institutes of Health-NIGMS UCSF; University of California at San Francisco Hillblom Center for the Biology of Aging; Hereditary Disease Foundation; Huntington's Disease Society of America Coalition for the Cure; CHDI, Inc.; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR021200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039074, R01NS045091, P01NS016375, R01NS053679] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health-NIGMS UCSF; University of California at San Francisco Hillblom Center for the Biology of Aging(University of California System); Hereditary Disease Foundation; Huntington's Disease Society of America Coalition for the Cure; CHDI, Inc.; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01NS053679 (to M. A. P.), P01NS16375 (to C. A. R.), NS0547533 (to P. J. M.), 2NS45091 (to S. F.), 1S10RR021200 (to M. D.), the National Institutes of Health-NIGMS UCSF Medical Scientist Training Program (to J. M.), and a fellowship from the University of California at San Francisco Hillblom Center for the Biology of Aging (to J. M.). This work was also supported by the Hereditary Disease Foundation, the Huntington's Disease Society of America Coalition for the Cure, and by CHDI, Inc.	Aiken CT, 2009, J BIOL CHEM, V284, P29427, DOI 10.1074/jbc.M109.013193; Arawaka S, 2010, CURR PHARM BIOTECHNO, V11, P158, DOI 10.2174/138920110790909713; Burke KA, 2011, METHODS, V53, P275, DOI 10.1016/j.ymeth.2010.12.028; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; Gekko K., 1979, J PHYS CHEM-US, V83, P2707; Gu XF, 2009, NEURON, V64, P828, DOI 10.1016/j.neuron.2009.11.020; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Heiser V, 2000, P NATL ACAD SCI USA, V97, P6739, DOI 10.1073/pnas.110138997; Ho LW, 2001, J MED GENET, V38, P450, DOI 10.1136/jmg.38.7.450; Irvine GB, 2008, MOL MED, V14, P451, DOI 10.2119/2007-00100.Irvine; Kar K, 2011, NAT STRUCT MOL BIOL, V18, P328, DOI 10.1038/nsmb.1992; Khoshnan A, 2002, P NATL ACAD SCI USA, V99, P1002, DOI 10.1073/pnas.022631799; Kim YJ, 2001, P NATL ACAD SCI USA, V98, P12784, DOI 10.1073/pnas.221451398; Ko J, 2001, BRAIN RES BULL, V56, P319, DOI 10.1016/S0361-9230(01)00599-8; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Kuemmerle S, 1999, ANN NEUROL, V46, P842; Legleiter J, 2004, J COLLOID INTERF SCI, V278, P96, DOI 10.1016/j.jcis.2004.05.009; Legleiter J, 2010, J BIOL CHEM, V285, P14777, DOI 10.1074/jbc.M109.093708; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Olshina MA, 2010, J BIOL CHEM, V285, P21807, DOI 10.1074/jbc.M109.084434; Peters MF, 2001, J BIOL CHEM, V276, P3188, DOI 10.1074/jbc.M008099200; Peters-Libeu C, 2005, ACTA CRYSTALLOGR F, V61, P1065, DOI 10.1107/S1744309105036547; Poirier MA, 2005, HUM MOL GENET, V14, P765, DOI 10.1093/hmg/ddi071; Poirier MA, 2002, J BIOL CHEM, V277, P41032, DOI 10.1074/jbc.M205809200; Ratovitski T, 2007, CELL CYCLE, V6, P2970, DOI 10.4161/cc.6.23.4992; Ratovitski T, 2009, J BIOL CHEM, V284, P10855, DOI 10.1074/jbc.M804813200; Ravikumar Brinda, 2006, Molecular Aspects of Medicine, V27, P520, DOI 10.1016/j.mam.2006.08.008; Ravina B, 2008, MOVEMENT DISORD, V23, P1223, DOI 10.1002/mds.21988; Rosenblatt A, 2006, NEUROLOGY, V66, P1016, DOI 10.1212/01.wnl.0000204230.16619.d9; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Ross CA, 1997, MEDICINE, V76, P305, DOI 10.1097/00005792-199709000-00001; Sanchez I, 2003, NATURE, V421, P373, DOI 10.1038/nature01301; Sathasivam K, 2010, HUM MOL GENET, V19, P65, DOI 10.1093/hmg/ddp467; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Slow EJ, 2005, P NATL ACAD SCI USA, V102, P11402, DOI 10.1073/pnas.0503634102; SQUIRE PG, 1979, ARCH BIOCHEM BIOPHYS, V196, P165, DOI 10.1016/0003-9861(79)90563-0; Tebbenkamp ATN, 2011, HUM MOL GENET, V20, P2770, DOI 10.1093/hmg/ddr176; Tebbenkamp ATN, 2011, HUM MOL GENET, V20, P1633, DOI 10.1093/hmg/ddr040; Thakur AK, 2009, NAT STRUCT MOL BIOL, V16, P380, DOI 10.1038/nsmb.1570; Wacker JL, 2009, J NEUROSCI, V29, P9104, DOI 10.1523/JNEUROSCI.2250-09.2009; Wacker JL, 2004, NAT STRUCT MOL BIOL, V11, P1215, DOI 10.1038/nsmb860; Waldron-Roby E, 2012, J NEUROSCI, V32, P183, DOI 10.1523/JNEUROSCI.1305-11.2012; Walsh DM, 2005, BIOCHEM SOC T, V33, P1087, DOI 10.1042/BST0331087; Wanker EE, 1999, METHOD ENZYMOL, V309, P375; Weiss A, 2008, J NEUROCHEM, V104, P846, DOI 10.1111/j.1471-4159.2007.05032.x; Zhang QC, 2011, J BIOL CHEM, V286, P8188, DOI 10.1074/jbc.M110.192013; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	52	75	77	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					16017	16028		10.1074/jbc.M111.252577	http://dx.doi.org/10.1074/jbc.M111.252577			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22433867	Green Published, hybrid			2022-12-25	WOS:000304006300079
J	Bar, KJ; Rachow, T; Schulz, S; Bassarab, K; Haufe, S; Berger, S; Koch, K; Voss, A				Baer, Karl-Juergen; Rachow, Tobias; Schulz, Steffen; Bassarab, Katharina; Haufe, Stefanie; Berger, Sandy; Koch, Kathrin; Voss, Andreas			The Phrenic Component of Acute Schizophrenia - A Name and Its Physiological Reality	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; RESPIRATORY SINUS ARRHYTHMIA; AUTONOMIC NERVOUS-SYSTEM; BLOOD-PRESSURE; NONLINEAR COMPLEXITY; 1ST-DEGREE RELATIVES; VAGAL ACTIVITY; MODULATION; MECHANISMS; DYNAMICS	Decreased heart rate variability (HRV) was shown for unmedicated patients with schizophrenia and their first-degree relatives, implying genetic associations. This is known to be an important risk factor for increased cardiac mortality in other diseases. The interaction of cardio-respiratory function and respiratory physiology has never been investigated in the disease although it might be closely related to the pattern of autonomic dysfunction. We hypothesized that increased breathing rates and reduced cardio-respiratory coupling in patients with acute schizophrenia would be associated with low vagal function. We assessed variability of breathing rates and depth, HRV and cardio-respiratory coupling in patients, their first-degree relatives and controls at rest. Control subjects were investigated a second time by means of a stress task to identify stress-related changes of cardio-respiratory function. A total of 73 subjects were investigated, consisting of 23 unmedicated patients, 20 healthy, first-degree relatives and 30 control subjects matched for age, gender, smoking and physical fitness. The LifeShirt (R), a multi-function ambulatory device, was used for data recording (30 minutes). Patients breathe significantly faster (p < .001) and shallower (p < .001) than controls most pronouncedly during exhalation. Patients' breathing is characterized by a significantly increased amount of middle- (p < .001), high- (p < .001), and very high frequency fluctuations (p < .001). These measures correlated positively with positive symptoms as assessed by the PANSS scale (e. g., middle frequency: r = 521; p < .01). Cardio-respiratory coupling was reduced in patients only, while HRV was decreased in patients and healthy relatives in comparison to controls. Respiratory alterations might reflect arousal in acutely ill patients, which is supported by comparable physiological changes in healthy subjects during stress. Future research needs to further investigate these findings with respect to their physiological consequences for patients. These results are invaluable for researchers studying changes of biological signals prone to the influence of breathing rate and rhythm (e. g., functional imaging).	[Baer, Karl-Juergen; Rachow, Tobias; Bassarab, Katharina; Haufe, Stefanie; Berger, Sandy; Koch, Kathrin] Univ Hosp, Dept Psychiat & Psychotherapy, Jena, Germany; [Schulz, Steffen; Voss, Andreas] Univ Appl Sci, Dept Med Engn & Biotechnol, Jena, Germany	Friedrich Schiller University of Jena	Bar, KJ (corresponding author), Univ Hosp, Dept Psychiat & Psychotherapy, Jena, Germany.	Karl-Juergen.Baer@med.uni-jena.de	Schulz, Steffen/CAH-9340-2022; Koch, Kathrin/F-4870-2010	Schulz, Steffen/0000-0002-0847-6623; Voss, Andreas/0000-0002-0236-0830				Antonius D, 2011, SCHIZOPHR RES, V127, P273, DOI 10.1016/j.schres.2010.10.007; Arne M, 2010, RESP MED, V104, P550, DOI 10.1016/j.rmed.2009.10.023; Bar KJ, 2008, CLIN NEUROPHYSIOL, V119, P2209, DOI 10.1016/j.clinph.2008.06.012; Bar KJ, 2008, PSYCHIAT RES, V157, P255, DOI 10.1016/j.psychres.2007.04.021; Bar KJ, 2007, SCHIZOPHR RES, V95, P115, DOI 10.1016/j.schres.2007.05.034; Bar KJ, 2007, CLIN NEUROPHYSIOL, V118, P2009, DOI 10.1016/j.clinph.2007.06.012; Bar KJ, 2006, BIOMED TECH, V51, P237, DOI 10.1515/BMT.2006.045; Bar KJ, 2010, SCHIZOPHRENIA BULL, V36, P1050, DOI 10.1093/schbul/sbp024; Bar KJ, 2007, J APPL PHYSIOL, V102, P1051, DOI 10.1152/japplphysiol.00811.2006; Bar KJ, 2005, J PSYCHIATR RES, V39, P519, DOI 10.1016/j.jpsychires.2004.12.007; Baumert M, 2004, METHOD INFORM MED, V43, P202, DOI 10.1055/s-0038-1633859; Baumert M, 2002, MED BIOL ENG COMPUT, V40, P241, DOI 10.1007/BF02348131; BERGER RD, 1989, AM J PHYSIOL, V256, pH142, DOI 10.1152/ajpheart.1989.256.1.H142; Berger S, 2010, PROG NEURO-PSYCHOPH, V34, P1294, DOI 10.1016/j.pnpbp.2010.07.013; Berger S, 2010, PROG NEURO-PSYCHOPH, V34, P406, DOI 10.1016/j.pnpbp.2010.01.009; BERNTSON GG, 1993, PSYCHOPHYSIOLOGY, V30, P183, DOI 10.1111/j.1469-8986.1993.tb01731.x; Bianciardi M, 2009, NEUROIMAGE, V45, P160, DOI 10.1016/j.neuroimage.2008.10.034; Boettger MK, 2010, ANN NONINVAS ELECTRO, V15, P165, DOI 10.1111/j.1542-474X.2010.00358.x; Boke O, 2008, INT J PSYCHIAT MED, V38, P103, DOI 10.2190/PM.38.1.j; Caminal P, 2010, ANN BIOMED ENG, V38, P2542, DOI 10.1007/s10439-010-0027-1; Camm AJ, 1996, CIRCULATION, V93, P1043; Carry PY, 1997, CHEST, V111, P910, DOI 10.1378/chest.111.4.910; Castro MN, 2009, SCHIZOPHR RES, V109, P134, DOI 10.1016/j.schres.2008.12.026; Chang JS, 2010, PROG NEURO-PSYCHOPH, V34, P924, DOI 10.1016/j.pnpbp.2010.04.017; First M. B., 1997, STRUCTURED CLIN INTE; FULWILER CE, 1984, BRAIN RES REV, V7, P229, DOI 10.1016/0165-0173(84)90012-2; GROSSMAN P, 1990, PSYCHOPHYSIOLOGY, V27, P702, DOI 10.1111/j.1469-8986.1990.tb03198.x; GROSSMAN P, 1990, PSYCHOPHYSIOLOGY, V27, P404, DOI 10.1111/j.1469-8986.1990.tb02335.x; Grossman Paul, 2004, Stud Health Technol Inform, V108, P133; Guz A, 1997, RESP PHYSIOL, V109, P197, DOI 10.1016/S0034-5687(97)00050-9; Hadziefendic S, 1999, J AUTONOM NERV SYST, V76, P135, DOI 10.1016/S0165-1838(99)00020-X; Hempel RJ, 2005, J PSYCHIATR RES, V39, P509, DOI 10.1016/j.jpsychires.2004.11.004; Hennekens CH, 2005, AM HEART J, V150, P1115, DOI 10.1016/j.ahj.2005.02.007; Homma I, 2008, EXP PHYSIOL, V93, P1011, DOI 10.1113/expphysiol.2008.042424; Jindal R, 2005, J PSYCHIATR NEUROSCI, V30, P393; Kabir MM, ANN BIOMED IN PRESS; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; KLEIGER RE, 1987, AM J CARDIOL, V59, P256, DOI 10.1016/0002-9149(87)90795-8; Kolotylova T, 2010, PSYCHOTHER PSYCH MED, V60, P64, DOI 10.1055/s-0028-1103297; KONNO K, 1967, J APPL PHYSIOL, V22, P407, DOI 10.1152/jappl.1967.22.3.407; Koponen H, 2008, NORD J PSYCHIAT, V62, P342, DOI 10.1080/08039480801959323; Lalley PM, 2008, RESP PHYSIOL NEUROBI, V164, P160, DOI 10.1016/j.resp.2008.02.004; LeBlanc J, 2004, PHYSIOL BEHAV, V82, P647, DOI 10.1016/j.physbeh.2004.05.014; Malaspina D, 1997, BIOL PSYCHIAT, V41, P612, DOI 10.1016/S0006-3223(96)00161-8; Mujica-Parodi LR, 2005, NEUROPSYCHOBIOLOGY, V51, P10, DOI 10.1159/000082850; Nardi AE, 2009, RESP PHYSIOL NEUROBI, V167, P133, DOI 10.1016/j.resp.2008.07.011; Okada T, 2003, J CLIN PSYCHOPHARM, V23, P441, DOI 10.1097/01.jcp.0000088901.24613.b8; Paterson AS, 1935, J NEUROL PSYCHOPATHO, V16, P36; Peupelmann J, 2009, SCHIZOPHR RES, V112, P153, DOI 10.1016/j.schres.2009.03.042; Porta A, 1999, BIOL CYBERN, V81, P119, DOI 10.1007/s004220050549; Porta A, 2000, MED BIOL ENG COMPUT, V38, P180, DOI 10.1007/BF02344774; Pramanik T, 2009, J ALTERN COMPLEM MED, V15, P293, DOI 10.1089/acm.2008.0440; Rachow T, 2011, PSYCHOPHYSIOLOGY, V48, P1323, DOI 10.1111/j.1469-8986.2011.01210.x; Ramirez JM, 1996, CURR OPIN NEUROBIOL, V6, P817, DOI 10.1016/S0959-4388(96)80033-X; SACKNER MA, 1989, J APPL PHYSIOL, V66, P410, DOI 10.1152/jappl.1989.66.1.410; Shea SA, 1996, EXP PHYSIOL, V81, P1; Toichi M, 1999, INT J PSYCHOPHYSIOL, V31, P147, DOI 10.1016/S0167-8760(98)00047-6; van den Aardweg JG, 2002, AM J RESP CRIT CARE, V165, P1041, DOI 10.1164/ajrccm.165.8.2104100; Voss A, 2009, PHILOS T R SOC A, V367, P277, DOI 10.1098/rsta.2008.0232; Wilhelm FH, 2003, BEHAV MODIF, V27, P671, DOI 10.1177/0145445503256321; Williams LM, 2004, AM J PSYCHIAT, V161, P480, DOI 10.1176/appi.ajp.161.3.480; Wittkower E, 1934, J MENT SCI, V80, P692, DOI 10.1192/bjp.80.331.692; YANG KL, 1991, NEW ENGL J MED, V324, P1445, DOI 10.1056/NEJM199105233242101; Yasui Y, 2004, BRAIN RES, V1016, P129, DOI 10.1016/j.brainres.2004.04.080; Yeragani VK, 2002, NEUROPSYCHOBIOLOGY, V46, P111, DOI 10.1159/000066388	65	43	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33459	10.1371/journal.pone.0033459	http://dx.doi.org/10.1371/journal.pone.0033459			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	932RV	22438935	Green Submitted, Green Published, gold			2022-12-25	WOS:000303309100049
J	Kim, JS; Holmes, RK				Kim, Ju-Sim; Holmes, Randall K.			Characterization of OxyR as a Negative Transcriptional Regulator That Represses Catalase Production in Corynebacterium diphtheriae	PLOS ONE			English	Article							INTRACELLULAR HYDROGEN-PEROXIDE; ESCHERICHIA-COLI; NEISSERIA-MENINGITIDIS; SUPEROXIDE-DISMUTASE; POSITIVE CONTROL; EXPRESSION; GENE; TOXIN; IDENTIFICATION; ACTIVATION	Corynebacterium diphtheriae and Corynebacterium glutamicum each have one gene (cat) encoding catalase. In-frame Delta cat mutants of C. diphtheriae and C. glutamicum were hyper-sensitive to growth inhibition and killing by H2O2. In C. diphtheriae C7(beta), both catalase activity and cat transcription decreased similar to 2-fold during transition from exponential growth to early stationary phase. Prototypic OxyR in Escherichia coli senses oxidative stress and it activates katG transcription and catalase production in response to H2O2. In contrast, exposure of C. diphtheriae C7(beta) to H2O2 did not stimulate transcription of cat. OxyR from C. diphtheriae and C. glutamicum have 52% similarity with E. coli OxyR and contain homologs of the two cysteine residues involved in H2O2 sensing by E. coli OxyR. In-frame Delta oxyR deletion mutants of C. diphtheriae C7(beta), C. diphtheriae NCTC13129, and C. glutamicum were much more resistant than their parental wild type strains to growth inhibition by H2O2. In the C. diphtheriae C7(beta) Delta oxyR mutant, cat transcripts were about 8-fold more abundant and catalase activity was about 20-fold greater than in the C7(beta) wild type strain. The oxyR gene from C. diphtheriae or C. glutamicum, but not from E. coli, complemented the defect in Delta oxyR mutants of C. diphtheriae and C. glutamicum and decreased their H2O2 resistance to the level of their parental strains. Gel-mobility shift, DNaseI footprint, and primer extension assays showed that purified OxyR from C. diphtheriae C7(beta) bound, in the presence or absence of DTT, to a sequence in the cat promoter region that extends from nucleotide position 255 to 210 with respect to the +1 nucleotide in the cat ORF. These results demonstrate that OxyR from C. diphtheriae or C. glutamicum functions as a transcriptional repressor of the cat gene by a mechanism that is independent of oxidative stress induced by H2O2.	[Kim, Ju-Sim; Holmes, Randall K.] Univ Colorado, Sch Med, Dept Microbiol, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Kim, JS (corresponding author), Univ Colorado, Sch Med, Dept Microbiol, Aurora, CO 80045 USA.	Randall.Holmes@ucdenver.edu			National Institutes of Health [R37AI014107]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI014107] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by grant R37AI014107 from the National Institutes of Health (http://www.nih.gov/). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health. No other grant supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKSDALE WL, 1954, J BACTERIOL, V67, P220, DOI 10.1128/JB.67.2.220-232.1954; Cannio R, 2000, FRONT BIOSCI-LANDMRK, V5, pD768, DOI 10.2741/cannio; Cerdeno-Tarraga AM, 2003, NUCLEIC ACIDS RES, V31, P6516, DOI 10.1093/nar/gkg874; CHRISTMAN MF, 1985, CELL, V41, P753, DOI 10.1016/S0092-8674(85)80056-8; El Shafey HM, 2008, MICROBIOL RES, V163, P80, DOI 10.1016/j.micres.2006.05.005; GOETHALS K, 1992, P NATL ACAD SCI USA, V89, P1646, DOI 10.1073/pnas.89.5.1646; Gonzalez-Flecha B, 1999, J BACTERIOL, V181, P3833; GonzalezFlecha B, 1997, J BACTERIOL, V179, P382, DOI 10.1128/jb.179.2.382-388.1997; GREENBERG JT, 1990, P NATL ACAD SCI USA, V87, P6181, DOI 10.1073/pnas.87.16.6181; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HIDALGO E, 1994, EMBO J, V13, P138, DOI 10.1002/j.1460-2075.1994.tb06243.x; HIDALGO E, 1995, J BIOL CHEM, V270, P20908, DOI 10.1074/jbc.270.36.20908; Holmes RK, 2000, J INFECT DIS, V181, pS156, DOI 10.1086/315554; Ieva R, 2008, MOL MICROBIOL, V70, P1152, DOI 10.1111/j.1365-2958.2008.06468.x; Kalinowski J, 2003, J BIOTECHNOL, V104, P5, DOI 10.1016/S0168-1656(03)00154-8; KEEN NT, 1988, GENE, V70, P191, DOI 10.1016/0378-1119(88)90117-5; Kim JS, 2000, BBA-GENE STRUCT EXPR, V1493, P200, DOI 10.1016/S0167-4781(00)00178-0; Kunkle CA, 2003, J BACTERIOL, V185, P6826, DOI 10.1128/JB.185.23.6826-6840.2003; Lee JH, 2004, MOL MICROBIOL, V51, P1745, DOI 10.1111/j.1365-2958.2003.03946.x; Lee JH, 1997, INFECT IMMUN, V65, P4273, DOI 10.1128/IAI.65.10.4273-4280.1997; Merkamm M, 2001, J BACTERIOL, V183, P1284, DOI 10.1128/JB.2001.183.4.1284-1295.2001; NELSON DP, 1972, ANAL BIOCHEM, V49, P474, DOI 10.1016/0003-2697(72)90451-4; Oram DM, 2006, J BACTERIOL, V188, P2959, DOI 10.1128/JB.188.8.2959-2973.2006; Oram DM, 2002, J BACTERIOL, V184, P5723, DOI 10.1128/JB.184.20.5723-5732.2002; Oram M, 2007, GENE, V391, P53, DOI 10.1016/j.gene.2006.12.003; PARSEK MR, 1994, J BIOL CHEM, V269, P11279; Patek M, 2011, J BIOTECHNOL, V154, P101, DOI 10.1016/j.jbiotec.2011.01.017; Pomposiello PJ, 2001, TRENDS BIOTECHNOL, V19, P109, DOI 10.1016/S0167-7799(00)01542-0; PRENTKI P, 1984, GENE, V29, P303, DOI 10.1016/0378-1119(84)90059-3; Sainsbury S, 2009, NUCLEIC ACIDS RES, V37, P4545, DOI 10.1093/nar/gkp445; SAK BD, 1989, P NATL ACAD SCI USA, V86, P3271, DOI 10.1073/pnas.86.9.3271; Sambrook J, 2001, MOL CLONING LAB MANU; SCHAFER A, 1994, APPL ENVIRON MICROB, V60, P756; SCHELL MA, 1993, ANNU REV MICROBIOL, V47, P597, DOI 10.1146/annurev.micro.47.1.597; SCHELLHORN HE, 1995, FEMS MICROBIOL LETT, V131, P113, DOI 10.1111/j.1574-6968.1995.tb07764.x; SCHMITT MP, 1991, INFECT IMMUN, V59, P1899, DOI 10.1128/IAI.59.6.1899-1904.1991; Seib KL, 2007, MOL MICROBIOL, V63, P54, DOI 10.1111/j.1365-2958.2006.05478.x; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; STORZ G, 1990, TRENDS GENET, V6, P363, DOI 10.1016/0168-9525(90)90278-E; Storz G, 1999, CURR OPIN MICROBIOL, V2, P188, DOI 10.1016/S1369-5274(99)80033-2; TAI SPS, 1990, MICROB PATHOGENESIS, V9, P267, DOI 10.1016/0882-4010(90)90015-I; TAI TN, 1988, PLASMID, V19, P175, DOI 10.1016/0147-619X(88)90037-6; TARTAGLIA LA, 1989, J MOL BIOL, V210, P709, DOI 10.1016/0022-2836(89)90104-6; Ton-That H, 2003, MOL MICROBIOL, V50, P1429, DOI 10.1046/j.1365-2958.2003.03782.x; Tseng HJ, 2003, INFECT IMMUN, V71, P550, DOI 10.1128/IAI.71.1.550-556.2003; WAYNE LG, 1986, ANAL BIOCHEM, V157, P89, DOI 10.1016/0003-2697(86)90200-9; Zaim J, 2003, NUCLEIC ACIDS RES, V31, P1444, DOI 10.1093/nar/gkg234; Zeller T, 2007, J BACTERIOL, V189, P3784, DOI 10.1128/JB.01795-06; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718; Zheng M, 2001, J BACTERIOL, V183, P4562, DOI 10.1128/JB.183.15.4562-4570.2001	50	29	29	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e31709	10.1371/journal.pone.0031709	http://dx.doi.org/10.1371/journal.pone.0031709			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438866	Green Published, gold, Green Submitted			2022-12-25	WOS:000303309100004
J	Yang, D; Li, SY; Yeung, CM; Chang, RCC; So, KF; Wong, D; Lo, ACY				Yang, Di; Li, Suk-Yee; Yeung, Chung-Man; Chang, Raymond Chuen-Chung; So, Kwok-Fai; Wong, David; Lo, Amy C. Y.			Lycium barbarum Extracts Protect the Brain from Blood-Brain Barrier Disruption and Cerebral Edema in Experimental Stroke	PLOS ONE			English	Article							FOCAL ISCHEMIA; MATRIX-METALLOPROTEINASE; MEDICINE; INJURY; MODEL; LEADS; POLYSACCHARIDES; OVEREXPRESSION; ENDOTHELIN-1; MECHANISMS	Background and Purpose: Ischemic stroke is a destructive cerebrovascular disease and a leading cause of death. Yet, no ideal neuroprotective agents are available, leaving prevention an attractive alternative. The extracts from the fruits of Lycium barbarum (LBP), a Chinese anti-aging medicine and food supplement, showed neuroprotective function in the retina when given prophylactically. We aim to evaluate the protective effects of LBP pre-treatment in an experimental stroke model. Methods: C57BL/6N male mice were first fed with either vehicle (PBS) or LBP (1 or 10 mg/kg) daily for 7 days. Mice were then subjected to 2-hour transient middle cerebral artery occlusion (MCAO) by the intraluminal method followed by 22-hour reperfusion upon filament removal. Mice were evaluated for neurological deficits just before sacrifice. Brains were harvested for infarct size estimation, water content measurement, immunohistochemical analysis, and Western blot experiments. Evans blue (EB) extravasation was determined to assess blood-brain barrier (BBB) disruption after MCAO. Results: LBP pre-treatment significantly improved neurological deficits as well as decreased infarct size, hemispheric swelling, and water content. Fewer apoptotic cells were identified in LBP-treated brains by TUNEL assay. Reduced EB extravasation, fewer IgG-leaky vessels, and up-regulation of occludin expression were also observed in LBP-treated brains. Moreover, immunoreactivity for aquaporin-4 and glial fibrillary acidic protein were significantly decreased in LBP-treated brains. Conclusions: Seven-day oral LBP pre-treatment effectively improved neurological deficits, decreased infarct size and cerebral edema as well as protected the brain from BBB disruption, aquaporin-4 up-regulation, and glial activation. The present study suggests that LBP may be used as a prophylactic neuroprotectant in patients at high risk for ischemic stroke.	[Yang, Di; Li, Suk-Yee; Yeung, Chung-Man; Wong, David; Lo, Amy C. Y.] Univ Hong Kong, Li Ka Shing Fac Med, Inst Eye, Hong Kong, Hong Kong, Peoples R China; [Chang, Raymond Chuen-Chung; So, Kwok-Fai] Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Chang, Raymond Chuen-Chung; So, Kwok-Fai; Wong, David; Lo, Amy C. Y.] Univ Hong Kong, Li Ka Shing Fac Med, Res Ctr Heart Brain Hormone & Hlth Aging, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Yang, D (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Inst Eye, Hong Kong, Hong Kong, Peoples R China.	amylo@hkucc.hku.hk	Lo, Amy C. Y./C-1195-2009; Chang, Raymond Chuen-Chung/C-1107-2009	Lo, Amy C. Y./0000-0003-4239-6851; Chang, Raymond Chuen-Chung/0000-0001-8538-7993; So, Kwok-Fai/0000-0003-4039-4246	University of Hong Kong; Azalea Endowment Fund	University of Hong Kong(University of Hong Kong); Azalea Endowment Fund	This study was supported by the University Development Fund from The University of Hong Kong to the Eye Institute and by the Azalea (1972) Endowment Fund to RCC and KFS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahi M, 2000, J CEREBR BLOOD F MET, V20, P452, DOI 10.1097/00004647-200003000-00002; Ayata C, 2002, J CLIN NEUROSCI, V9, P113, DOI 10.1054/jocn.2001.1031; Badaut T, 2002, J CEREBR BLOOD F MET, V22, P367, DOI 10.1097/00004647-200204000-00001; Balami JS, 2011, LANCET NEUROL, V10, P357, DOI 10.1016/S1474-4422(10)70313-6; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Brouns R, 2011, EUR NEUROL, V65, P23, DOI 10.1159/000321965; Chan HC, 2007, EXP NEUROL, V203, P269, DOI 10.1016/j.expneurol.2006.05.031; Chang RCC, 2008, CELL MOL NEUROBIOL, V28, P643, DOI 10.1007/s10571-007-9181-x; Elango C, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-97; Freeman WD, 2010, SEMIN NEUROL, V30, P501, DOI 10.1055/s-0030-1268863; Ho YS, 2010, J ALZHEIMERS DIS, V19, P813, DOI 10.3233/JAD-2010-1280; Hu CF, 2010, J NAT PROD, V73, P1489, DOI 10.1021/np1001847; Huang XJ, 2009, CELL MOL NEUROBIOL, V29, P1211, DOI 10.1007/s10571-009-9417-z; HUANG ZH, 1994, SCIENCE, V265, P1883, DOI 10.1126/science.7522345; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; KIMELBERG HK, 1995, J NEUROSURG, V83, P1051, DOI 10.3171/jns.1995.83.6.1051; Kondoh T, 2011, BRAIN RES BULL, V84, P69, DOI 10.1016/j.brainresbull.2010.11.005; Latour LL, 2004, ANN NEUROL, V56, P468, DOI 10.1002/ana.20199; Li JJ, 2011, CLIN EXP PHARMACOL P, V38, P776, DOI 10.1111/j.1440-1681.2011.05591.x; Li SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016380; Li SY, 2009, INVEST OPHTH VIS SCI, V50, P836, DOI 10.1167/iovs.08-2310; Lo ACY, 2005, J CEREBR BLOOD F MET, V25, P998, DOI 10.1038/sj.jcbfm.9600108; Lo ACY, 2007, J CEREBR BLOOD F MET, V27, P1496, DOI 10.1038/sj.jcbfm.9600452; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Potterat O, 2010, PLANTA MED, V76, P7, DOI 10.1055/s-0029-1186218; Romanic AM, 1998, STROKE, V29, P1020, DOI 10.1161/01.STR.29.5.1020; Schmerbach K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015052; Simard JM, 2007, LANCET NEUROL, V6, P258, DOI 10.1016/S1474-4422(07)70055-8; Spatz M, 2010, ACTA NEUROCHIR SUPPL, V106, P21, DOI 10.1007/978-3-211-98811-4_3; Sumii T, 2002, STROKE, V33, P831, DOI 10.1161/hs0302.104542; Taniguchi M, 2000, MOL BRAIN RES, V78, P131, DOI 10.1016/S0169-328X(00)00084-X; Yeung CM, 2010, J NEUROSCI RES, V88, P2026, DOI 10.1002/jnr.22349; Yeung PKK, 2009, J CEREBR BLOOD F MET, V29, P1891, DOI 10.1038/jcbfm.2009.175; Yu MS, 2007, INT J MOL MED, V20, P261; Yu MS, 2005, EXP GERONTOL, V40, P716, DOI 10.1016/j.exger.2005.06.010; Zhao BQ, 2006, NAT MED, V12, P441, DOI 10.1038/nm1387; Zhou ZY, 2010, J ETHNOPHARMACOL, V131, P154, DOI 10.1016/j.jep.2010.06.023; ZIVIN JA, 1991, ARCH NEUROL-CHICAGO, V48, P1235, DOI 10.1001/archneur.1991.00530240039014	39	45	52	4	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33596	10.1371/journal.pone.0033596	http://dx.doi.org/10.1371/journal.pone.0033596			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438957	Green Published, Green Submitted, gold			2022-12-25	WOS:000303309100065
J	Leach, RJ; O'Neill, RG; Fitzpatrick, JL; Williams, JL; Glass, EJ				Leach, Richard J.; O'Neill, Ronan G.; Fitzpatrick, Julie L.; Williams, John L.; Glass, Elizabeth J.			Quantitative Trait Loci Associated with the Immune Response to a Bovine Respiratory Syncytial Virus Vaccine	PLOS ONE			English	Article							FEEDLOT CATTLE; MOUTH-DISEASE; CALVES; REPLICATION; FORMULATION; PARAMETERS; RESISTANCE; HAPLOTYPES; PROTECTION; INDUCTION	Infectious disease is an important problem for animal breeders, farmers and governments worldwide. One approach to reducing disease is to breed for resistance. This linkage study used a Charolais-Holstein F2 cattle cross population (n = 501) which was genotyped for 165 microsatellite markers (covering all autosomes) to search for associations with phenotypes for Bovine Respiratory Syncytial Virus (BRSV) specific total-IgG, IgG1 and IgG2 concentrations at several time-points pre- and post-BRSV vaccination. Regions of the bovine genome which influenced the immune response induced by BRSV vaccination were identified, as well as regions associated with the clearance of maternally derived BRSV specific antibodies. Significant positive correlations were detected within traits across time, with negative correlations between the pre- and post-vaccination time points. The whole genome scan identified 27 Quantitative Trait Loci (QTL) on 13 autosomes. Many QTL were associated with the Thymus Helper 1 linked IgG2 response, especially at week 2 following vaccination. However the most significant QTL, which reached 5% genome-wide significance, was on BTA 17 for IgG1, also 2 weeks following vaccination. All animals had declining maternally derived BRSV specific antibodies prior to vaccination and the levels of BRSV specific antibody prior to vaccination were found to be under polygenic control with several QTL detected. Heifers from the same population (n = 195) were subsequently immunised with a 40-mer Foot-and-Mouth Disease Virus peptide (FMDV) in a previous publication. Several of these QTL associated with the FMDV traits had overlapping peak positions with QTL in the current study, including the QTL on BTA23 which included the bovine Major Histocompatibility Complex (BoLA), and QTL on BTA9 and BTA24, suggesting that the genes underlying these QTL may control responses to multiple antigens. These results lay the groundwork for future investigations to identify the genes underlying the variation in clearance of maternal antibody and response to vaccination.	[Leach, Richard J.; Williams, John L.; Glass, Elizabeth J.] Univ Edinburgh, Roslin Inst, Dept Genet & Genom, Easter Bush, Midlothian, Scotland; [Leach, Richard J.; Williams, John L.; Glass, Elizabeth J.] Univ Edinburgh, Royal Dick Sch Vet Studies, Easter Bush, Midlothian, Scotland; [O'Neill, Ronan G.] Dept Agr Fisheries & Food, Celbridge, Kildare, Ireland; [Fitzpatrick, Julie L.] Moredun Res Inst, Edinburgh EH17 7JH, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; Moredun Research Institute	Leach, RJ (corresponding author), ARS, USDA, US Meat Anim Res Ctr, Clay Ctr, NE 68933 USA.	richard.j.leach@ars.usda.gov	Glass, Elizabeth J/L-4612-2016	Glass, Elizabeth J/0000-0002-6183-0185; Williams, John/0000-0001-5188-7957	Pfizer Animal Health CASE studentship; Biotechnology and Biological Sciences Research Council (Institute Strategic); Scottish government Rural and Environment Research and Analysis Directorate (RERAD); Meat and Livestock Commission (MLC); Department for Environment, Food and Rural Affairs (DEFRA) for LINK; Cariplo Foundation; BBSRC [BBS/E/D/20241863] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/20241863] Funding Source: researchfish	Pfizer Animal Health CASE studentship; Biotechnology and Biological Sciences Research Council (Institute Strategic); Scottish government Rural and Environment Research and Analysis Directorate (RERAD); Meat and Livestock Commission (MLC)(Meat and Livestock Australia); Department for Environment, Food and Rural Affairs (DEFRA) for LINK; Cariplo Foundation(Fondazione Cariplo); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was undertaken with a Pfizer Animal Health CASE studentship, and supported by the Biotechnology and Biological Sciences Research Council (Institute Strategic Grant funding), the Scottish government Rural and Environment Research and Analysis Directorate (RERAD), the Meat and Livestock Commission (MLC; now devolved to EBLEX, HybuCig Cymru/Meat Promotion Wales (HCC), Quality Meat Scotland (QMS)) and the Department for Environment, Food and Rural Affairs (DEFRA) for LINK funding for the animal studies. JLW acknowledges the Cariplo Foundation for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitz M, 1972, HDB MAT FUNCTIONS FO; Band MR, 2000, GENOME RES, V10, P1359, DOI 10.1101/gr.145900; Baxter R, 2009, VACCINE, V28, P28, DOI 10.1016/j.vaccine.2009.09.131; Bowland SL, 2000, CAN VET J, V41, P33; Carine L, 2008, VACCINE, V26, P4840, DOI 10.1016/j.vaccine.2008.06.100; Casas E, 2006, J ANIM SCI, V84, P3180, DOI 10.2527/jas.2006-200; Casas E, 2011, ANIM GENET, V42, P571, DOI 10.1111/j.1365-2052.2011.02189.x; CHURCHILL GA, 1994, GENETICS, V138, P963; Clawson ML, 2004, MAMM GENOME, V15, P227, DOI 10.1007/s00335-003-2320-x; Davies G, 2009, ANIMAL, V3, P415, DOI 10.1017/S1751731108003522; DIMARCHI R, 1986, SCIENCE, V232, P639, DOI 10.1126/science.3008333; Ellis JA, 2001, VET CLIN N AM-FOOD A, V17, P535, DOI 10.1016/S0749-0720(15)30005-0; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Fulton Robert W., 2009, Animal Health Research Reviews, V10, P131, DOI 10.1017/S146625230999017X; Gershwin Laurel J., 2007, Animal Health Research Reviews, V8, P207, DOI 10.1017/S1466252307001405; Gershwin LJ, 2000, AM J VET RES, V61, P291, DOI 10.2460/ajvr.2000.61.291; GLASS EJ, 1991, IMMUNOLOGY, V74, P594; Glass EJ, 2010, VET IMMUNOL IN PRESS; Glass Elizabeth J., 2004, Animal Health Research Reviews, V5, P197, DOI 10.1079/AHR200469; Glass EJ, 2010, BREEDING FOR DISEASE RESISTANCE IN FARM ANIMALS, 3RD EDITION, P88, DOI 10.1079/9781845935559.0088; Green P, 1990, CRIMAP 2 4; Guo YM, 2008, ANIM GENET, V39, P486, DOI 10.1111/j.1365-2052.2008.01756.x; Gutierrez-Gil B, 2008, ANIM GENET, V39, P51, DOI 10.1111/j.1365-2052.2007.01682.x; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Heringstad B, 2007, J DAIRY SCI, V90, P2419, DOI 10.3168/jds.2006-805; Hung LY, 2008, CRIT REV IMMUNOL, V28, P269, DOI 10.1615/CritRevImmunol.v28.i4.10; Ihara N, 2004, GENOME RES, V14, P1987, DOI 10.1101/gr.2741704; Janssen R, 2007, J INFECT DIS, V196, P826, DOI 10.1086/520886; Kalina WV, 2005, VACCINE, V23, P4625, DOI 10.1016/j.vaccine.2005.04.032; KIMMAN TG, 1989, VET IMMUNOL IMMUNOP, V22, P145, DOI 10.1016/0165-2427(89)90057-3; Laegreid WW, 2002, MAMM GENOME, V13, P704, DOI 10.1007/s00335-002-2219-y; Leach RJ, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-107; Lewin HA, 1999, IMMUNOL REV, V167, P145, DOI 10.1111/j.1600-065X.1999.tb01388.x; Mapletoft JW, 2006, VIROLOGY, V353, P316, DOI 10.1016/j.virol.2006.06.001; Meyer G, 2008, COMP IMMUNOL MICROB, V31, P191, DOI 10.1016/j.cimid.2007.07.008; Minozzi G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011117; Miyairi I, 2008, CLIN MICROBIOL REV, V21, P686, DOI 10.1128/CMR.00017-08; MUGGLICOCKETT NE, 1992, J ANIM SCI, V70, P2013, DOI 10.2527/1992.7072013x; NORMAN LM, 1981, J ANIM SCI, V53, P1465, DOI 10.2527/jas1982.5361465x; O'Neill RG, 2007, VET REC, V161, P269, DOI 10.1136/vr.161.8.269; O'Neill RG, 2006, VACCINE, V24, P4007, DOI 10.1016/j.vaccine.2005.11.049; Oumouna M, 2005, J VIROL, V79, P2024, DOI 10.1128/JVI.79.4.2024-2032.2005; Pamilo P, 1998, HEREDITY, V81, P381, DOI 10.1046/j.1365-2540.1998.00395.x; Platt R, 2006, AM J VET RES, V67, P1179, DOI 10.2460/ajvr.67.7.1179; ResSpecies, 2006, ROSL; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schneider MJ, 2010, J ANIM SCI, V88, P1220, DOI 10.2527/jas.2008-1755; Seaton G, 2006, P 8 WORLD C GEN APPL; Siegrist CA, 2003, VACCINE, V21, P3406, DOI 10.1016/S0264-410X(03)00342-6; Snowder GD, 2007, J ANIM SCI, V85, P1885, DOI 10.2527/jas.2007-0008; Snowder GD, 2006, J ANIM SCI, V84, P1999, DOI 10.2527/jas.2006-046; Snowder GD, 2005, J ANIM SCI, V83, P507; Srikumaran Subramaniam, 2007, Animal Health Research Reviews, V8, P215, DOI 10.1017/S1466252307001326; STOTT EJ, 1985, ARCH VIROL, V84, P1, DOI 10.1007/BF01310552; TAYLOR G, 1995, J VIROL, V69, P6658, DOI 10.1128/JVI.69.11.6658-6664.1995; Valarcher JF, 2007, VET RES, V38, P153, DOI 10.1051/vetres:2006053; Verschoor CP, 2009, MAMM GENOME, V20, P447, DOI 10.1007/s00335-009-9198-1; Visscher PM, 1996, GENETICS, V143, P1013; Weinberg CR, 1999, AM J HUM GENET, V65, P229, DOI 10.1086/302466; West K, 1999, VACCINE, V18, P907, DOI 10.1016/S0264-410X(99)00324-2; Zanella Ricardo, 2011, Frontiers in Genetics, V2, P82, DOI 10.3389/fgene.2011.00082; Zhang C, 2004, GENETICS, V167, P1863, DOI 10.1534/genetics.104.026401	62	13	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2012	7	3							e33526	10.1371/journal.pone.0033526	http://dx.doi.org/10.1371/journal.pone.0033526			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RU	22438944	Green Published, Green Submitted, gold			2022-12-25	WOS:000303309000031
J	Renfrew, PD; Choi, EJ; Bonneau, R; Kuhlman, B				Renfrew, P. Douglas; Choi, Eun Jung; Bonneau, Richard; Kuhlman, Brian			Incorporation of Noncanonical Amino Acids into Rosetta and Use in Computational Protein-Peptide Interface Design	PLOS ONE			English	Article							SIDE-CHAIN CONFORMATIONS; GLOBULAR PROTEIN; ENERGY FUNCTION; CALPAIN SYSTEM; PREDICTION; CALPASTATIN; INHIBITION; SPECIFICITY; COMPLEXES; RESOURCE	Noncanonical amino acids (NCAAs) can be used in a variety of protein design contexts. For example, they can be used in place of the canonical amino acids (CAAs) to improve the biophysical properties of peptides that target protein interfaces. We describe the incorporation of 114 NCAAs into the protein-modeling suite Rosetta. We describe our methods for building backbone dependent rotamer libraries and the parameterization and construction of a scoring function that can be used to score NCAA containing peptides and proteins. We validate these additions to Rosetta and our NCAA-rotamer libraries by showing that we can improve the binding of a calpastatin derived peptides to calpain-1 by substituting NCAAs for native amino acids using Rosetta. Rosetta (executables and source), auxiliary scripts and code, and documentation can be found at (http://www.rosettacommons.org/).	[Renfrew, P. Douglas; Bonneau, Richard] NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Renfrew, P. Douglas; Bonneau, Richard] NYU, Courant Inst Math Sci, Dept Comp Sci, New York, NY 10012 USA; [Choi, Eun Jung; Kuhlman, Brian] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC USA	New York University; New York University; University of North Carolina; University of North Carolina Chapel Hill	Renfrew, PD (corresponding author), NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA.	bkuhlman@email.unc.edu	Bonneau, Richard/ABD-6737-2021; Bonneau, Richard/GZL-2900-2022		National Science Foundation Division of Biological Infrastructure [0820757]; National Institutes of Health (NIH) [RC4 AI092765-01, GM073960]; NIH Nanomedicine [PN2-EY016586-06]; NATIONAL EYE INSTITUTE [PN2EY016586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [RC4AI092765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073960] Funding Source: NIH RePORTER	National Science Foundation Division of Biological Infrastructure(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Nanomedicine; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation Division of Biological Infrastructure 0820757, National Institutes of Health (NIH) RC4 AI092765-01, NIH Nanomedicine PN2-EY016586-06, and NIH GM073960. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker PJ, 2011, CHEMBIOCHEM, V12, P1845, DOI 10.1002/cbic.201100221; Banerjee R, 2009, PROTEINS, V76, P184, DOI 10.1002/prot.22337; BOCK A, 1991, MOL MICROBIOL, V5, P515, DOI 10.1111/j.1365-2958.1991.tb00722.x; Bradley P, 2005, SCIENCE, V309, P1868, DOI 10.1126/science.1113801; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Butterfoss GL, 2009, J AM CHEM SOC, V131, P16798, DOI 10.1021/ja905267k; Carragher NO, 2006, CURR PHARM DESIGN, V12, P615, DOI 10.2174/138161206775474314; Chen HM, 2007, J COMPUT CHEM, V28, P612, DOI 10.1002/jcc.20542; Chowdry AB, 2007, J COMPUT CHEM, V28, P2378, DOI 10.1002/jcc.20727; Cohen FE, 1997, PROTEIN SCI PUBLICAT, V6, P1661; Creasy DM, 2004, PROTEOMICS, V4, P1534, DOI 10.1002/pmic.200300744; Dahiyat BI, 1997, SCIENCE, V278, P82, DOI 10.1126/science.278.5335.82; Diksic M, 2001, J PSYCHIATR NEUROSCI, V26, P293; Dunbrack RL, 2002, CURR OPIN STRUC BIOL, V12, P431, DOI 10.1016/S0959-440X(02)00344-5; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; Fung HB, 2004, CLIN THER, V26, P352, DOI 10.1016/S0149-2918(04)90032-X; Garavelli JS, 2004, PROTEOMICS, V4, P1527, DOI 10.1002/pmic.200300777; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Gordon DB, 1999, CURR OPIN STRUC BIOL, V9, P509, DOI 10.1016/S0959-440X(99)80072-4; Hanna RA, 2008, NATURE, V456, P409, DOI 10.1038/nature07451; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-41; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Horng JC, 2003, J AM CHEM SOC, V125, P9286, DOI 10.1021/ja0353199; Jain T, 2006, PROTEIN SCI, V15, P2029, DOI 10.1110/ps.062165906; Karanicolas J, 2009, CURR OPIN STRUC BIOL, V19, P458, DOI 10.1016/j.sbi.2009.07.005; Kortemme T, 2003, J MOL BIOL, V326, P1239, DOI 10.1016/S0022-2836(03)00021-4; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Kuhlman B, 2001, P NATL ACAD SCI USA, V98, P10687, DOI 10.1073/pnas.181354398; Lazaridis T, 1999, PROTEINS, V35, P133, DOI 10.1002/(SICI)1097-0134(19990501)35:2<133::AID-PROT1>3.0.CO;2-N; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.0.CO;2-2; Lovell SC, 1999, P NATL ACAD SCI USA, V96, P400, DOI 10.1073/pnas.96.2.400; Mandell DJ, 2009, NAT METHODS, V6, P551, DOI 10.1038/nmeth0809-551; MILTON RCD, 1992, SCIENCE, V256, P1445, DOI 10.1126/science.1604320; Moldoveanu T, 2008, NATURE, V456, P404, DOI 10.1038/nature07353; Neria E, 1996, J CHEM PHYS, V105, P1902, DOI 10.1063/1.472061; Petrella RJ, 1998, FOLD DES, V3, P353, DOI 10.1016/S1359-0278(98)00050-9; Press W. H., 1992, ART SCI COMPUTING; Renfrew PD, 2008, PROTEINS, V71, P1637, DOI 10.1002/prot.21845; Rohl CA, 2004, NUMERICAL COMPUTER D, P66; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Saez ME, 2006, DRUG DISCOV TODAY, V11, P917, DOI 10.1016/j.drudis.2006.08.009; Srinivasan G, 2002, SCIENCE, V296, P1459, DOI 10.1126/science.1069588; Storr SJ, 2011, NAT REV CANCER, V11, P364, DOI 10.1038/nrc3050; Todd B, 2003, J MOL BIOL, V328, P131, DOI 10.1016/S0022-2836(03)00274-2; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Wang KKW, 1996, ADV EXP MED BIOL, V389, P95	52	71	73	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e32637	10.1371/journal.pone.0032637	http://dx.doi.org/10.1371/journal.pone.0032637			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22431978	gold, Green Published, Green Submitted			2022-12-25	WOS:000303198600021
J	Al Akhrass, F; Al Wohoush, I; Chaftari, AM; Reitzel, R; Jiang, Y; Ghannoum, M; Tarrand, J; Hachem, R; Raad, I				Al Akhrass, Fadi; Al Wohoush, Iba; Chaftari, Anne-Marie; Reitzel, Ruth; Jiang, Ying; Ghannoum, Mahmoud; Tarrand, Jeffrey; Hachem, Ray; Raad, Issam			Rhodococcus Bacteremia in Cancer Patients Is Mostly Catheter Related and Associated with Biofilm Formation	PLOS ONE			English	Article							EQUI INFECTIONS; MENINGITIS; LOCK	Rhodococcus is an emerging cause of opportunistic infection in immunocompromised patients, most commonly causing cavitary pneumonia. It has rarely been reported as a cause of isolated bacteremia. However, the relationship between bacteremia and central venous catheter is unknown. Between 2002 and 2010, the characteristics and outcomes of seventeen cancer patients with Rhodococcus bacteremia and indwelling central venous catheters were evaluated. Rhodococcus bacteremias were for the most part (94%) central line-associated bloodstream infection (CLABSI). Most of the bacteremia isolates were Rhodococcus equi (82%). Rhodococcus isolates formed heavy microbial biofilm on the surface of polyurethane catheters, which was reduced completely or partially by antimicrobial lock solution. All CLABSI patients had successful response to catheter removal and antimicrobial therapy. Rhodococcus species should be added to the list of biofilm forming organisms in immunocompromised hosts and most of the Rhodococcus bacteremias in cancer patients are central line associated.	[Al Akhrass, Fadi; Al Wohoush, Iba; Chaftari, Anne-Marie; Reitzel, Ruth; Jiang, Ying; Hachem, Ray; Raad, Issam] Univ Texas MD Anderson Canc Ctr, Dept Infect Dis, Houston, TX 77030 USA; [Tarrand, Jeffrey] Univ Texas MD Anderson Canc Ctr, Dept Microbiol, Houston, TX 77030 USA; [Ghannoum, Mahmoud] Case Western Reserve Univ, Univ Hosp Case Med Ctr, Ctr Med Mycol, Dept Dermatol, Cleveland, OH 44106 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Case Western Reserve University; Case Western Reserve University Hospital	Al Akhrass, F (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Infect Dis, Houston, TX 77030 USA.	rhachem@mdanderson.org						Baba H, 2009, J CLIN MICROBIOL, V47, P2667, DOI 10.1128/JCM.00294-09; Chaiban G, 2005, J ANTIMICROB CHEMOTH, V55, P51, DOI 10.1093/jac/dkh499; Chandra J, 2008, 48 ANN INT C ANT AG; Chen XY, 2009, J ZHEJIANG UNIV-SC B, V10, P933, DOI 10.1631/jzus.B0920214; Cid Ana, 2002, Haematologica, V87, pECR03; DEMARAIS PL, 1995, CLIN INFECT DIS, V20, P167, DOI 10.1093/clinids/20.1.167; GOODFELLOW M, 1977, J GEN MICROBIOL, V100, P99, DOI 10.1099/00221287-100-1-99; GOPAUL D, 1988, DIAGN MICR INFEC DIS, V10, P185, DOI 10.1016/0732-8893(88)90039-9; Gray KJ, 2000, J INFECTION, V41, P227, DOI 10.1053/jinf.2000.0730; Guerrero Rosalinda, 2011, J Med Case Rep, V5, P358, DOI 10.1186/1752-1947-5-358; Halbert ND, 2005, AM J VET RES, V66, P1380, DOI 10.2460/ajvr.2005.66.1380; Hsueh PR, 1998, CLIN INFECT DIS, V27, P370, DOI 10.1086/514667; Kedlaya I, 2001, CLIN INFECT DIS, V32, pE39, DOI 10.1086/318520; Kuhn DM, 2002, ANTIMICROB AGENTS CH, V46, P1773, DOI 10.1128/AAC.46.6.1773-1780.2002; Langer AJ, 2010, DIAGN MICR INFEC DIS, V67, P95, DOI 10.1016/j.diagmicrobio.2010.01.006; Maki DG, 2010, CRIT CARE MED; Mermel LA, 2001, INFECT CONT HOSP EP, V22, P222, DOI 10.1086/501893; Munoz P, 2008, DIAGN MICR INFEC DIS, V60, P197, DOI 10.1016/j.diagmicrobio.2007.09.004; O'Grady NP, 2011, CLIN INFECT DIS, V52, pE162, DOI 10.1093/cid/cir257; Perez M G V, 2002, Transpl Infect Dis, V4, P52, DOI 10.1034/j.1399-3062.2002.01001.x; Raad I, 2011, CRIT CARE M IN PRESS, V39; Raad I, 2007, ANTIMICROB AGENTS CH, V51, P1656, DOI 10.1128/AAC.00350-06; Raad I, 2007, ANTIMICROB AGENTS CH, V51, P78, DOI 10.1128/AAC.00154-06; Roda RH, 2009, DIAGN MICR INFEC DIS, V63, P96, DOI 10.1016/j.diagmicrobio.2008.08.024; Safdar N, 2006, CLIN INFECT DIS, V43, P474, DOI 10.1086/505976; SCOTT MA, 1995, AM J CLIN PATHOL, V103, P649; Scotton PG, 2000, CLIN INFECT DIS, V30, P223, DOI 10.1086/313628; Torres-Tortosa M, 2003, CHEST, V123, P1970, DOI 10.1378/chest.123.6.1970; VERVILLE TD, 1994, MEDICINE, V73, P119, DOI 10.1097/00005792-199405000-00001; VONBELOW H, 1991, AM J OPHTHALMOL, V112, P596, DOI 10.1016/S0002-9394(14)76866-7; Weinstock DM, 2002, CLIN INFECT DIS, V34, P1379, DOI 10.1086/340259; Yamshchikov AV, 2010, LANCET INFECT DIS, V10, P350, DOI 10.1016/S1473-3099(10)70068-2	32	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2012	7	3							e32945	10.1371/journal.pone.0032945	http://dx.doi.org/10.1371/journal.pone.0032945			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930IA	22427914	Green Published, gold, Green Submitted			2022-12-25	WOS:000303129700021
J	Sonveaux, P; Copetti, T; De Saedeleer, CJ; Vegran, F; Verrax, J; Kennedy, KM; Moon, EJ; Dhup, S; Danhier, P; Frerart, F; Gallez, B; Ribeiro, A; Michiels, C; Dewhirst, MW; Feron, O				Sonveaux, Pierre; Copetti, Tamara; De Saedeleer, Christophe J.; Vegran, Frederique; Verrax, Julien; Kennedy, Kelly M.; Moon, Eui Jung; Dhup, Suveera; Danhier, Pierre; Frerart, Francoise; Gallez, Bernard; Ribeiro, Anthony; Michiels, Carine; Dewhirst, Mark W.; Feron, Olivier			Targeting the Lactate Transporter MCT1 in Endothelial Cells Inhibits Lactate-Induced HIF-1 Activation and Tumor Angiogenesis	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; HYPOXIA-INDUCIBLE FACTOR-1; GROWTH-FACTOR; AEROBIC GLYCOLYSIS; GENE-EXPRESSION; AUTOCRINE LOOP; HIF-1-ALPHA; OXYGEN; CANCER; METABOLISM	Switching to a glycolytic metabolism is a rapid adaptation of tumor cells to hypoxia. Although this metabolic conversion may primarily represent a rescue pathway to meet the bioenergetic and biosynthetic demands of proliferating tumor cells, it also creates a gradient of lactate that mirrors the gradient of oxygen in tumors. More than a metabolic waste, the lactate anion is known to participate to cancer aggressiveness, in part through activation of the hypoxia-inducible factor-1 (HIF-1) pathway in tumor cells. Whether lactate may also directly favor HIF-1 activation in endothelial cells (ECs) thereby offering a new druggable option to block angiogenesis is however an unanswered question. In this study, we therefore focused on the role in ECs of monocarboxylate transporter 1 (MCT1) that we previously identified to be the main facilitator of lactate uptake in cancer cells. We found that blockade of lactate influx into ECs led to inhibition of HIF-1-dependent angiogenesis. Our demonstration is based on the unprecedented characterization of lactate-induced HIF-1 activation in normoxic ECs and the consecutive increase in vascular endothelial growth factor receptor 2 (VEGFR2) and basic fibroblast growth factor (bFGF) expression. Furthermore, using a variety of functional assays including endothelial cell migration and tubulogenesis together with in vivo imaging of tumor angiogenesis through intravital microscopy and immunohistochemistry, we documented that MCT1 blockers could act as bona fide HIF-1 inhibitors leading to anti-angiogenic effects. Together with the previous demonstration of MCT1 being a key regulator of lactate exchange between tumor cells, the current study identifies MCT1 inhibition as a therapeutic modality combining antimetabolic and anti-angiogenic activities.	[Sonveaux, Pierre; Copetti, Tamara; De Saedeleer, Christophe J.; Vegran, Frederique; Verrax, Julien; Dhup, Suveera; Frerart, Francoise; Feron, Olivier] UCL, Inst Expt & Clin Res IREC, Brussels, Belgium; [Sonveaux, Pierre; Kennedy, Kelly M.; Dewhirst, Mark W.] Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC USA; [Danhier, Pierre; Gallez, Bernard] UCL, LDRI, Nucl Magnet Resonance Res Grp, Brussels, Belgium; [Moon, Eui Jung] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Ribeiro, Anthony] Duke Univ, Med Ctr, Dept Radiol & Biochem, Durham, NC USA; [Michiels, Carine] Univ Namur FUNDP, Lab Biochem & Cellular Biol, Namur, Belgium	Universite Catholique Louvain; Duke University; Universite Catholique Louvain; Duke University; Duke University; University of Namur	Sonveaux, P (corresponding author), UCL, Inst Expt & Clin Res IREC, Brussels, Belgium.	pierre.sonveaux@uclouvain.be	Moon, Eui Jung/AAM-3223-2021; VEGRAN, Frédérique/H-4792-2017; Verrax, Julien/A-5749-2008; VEGRAN, Frederique/O-9986-2018; FERON, Olivier/AAM-6395-2020; Dewhirst, Mark/Q-1302-2019; Dhup, Suveera/AAU-7630-2021	Moon, Eui Jung/0000-0001-7916-7978; VEGRAN, Frederique/0000-0002-4377-1441; FERON, Olivier/0000-0001-5360-0286; Dewhirst, Mark/0000-0003-3459-6546; Danhier, Pierre/0000-0002-9028-8399; Dhup, Suveera/0000-0002-6689-6597; Sonveaux, Pierre/0000-0001-6484-8834	European Research Council [243188]; NIH/NCI [CA40355-24, CA40355-25]; Fonds National de la Recherche Scientifique (F.R.S.-FNRS); Action de Recherche Concertee from the Communaute Francaise de Belgique; Region Wallonne de Belgique; Fondation Belge contre le Cancer; J. Maisin Foundation; St. Luc Foundation; NATIONAL CANCER INSTITUTE [R01CA040355, P01CA042745] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Fonds National de la Recherche Scientifique (F.R.S.-FNRS)(Fonds de la Recherche Scientifique - FNRS); Action de Recherche Concertee from the Communaute Francaise de Belgique; Region Wallonne de Belgique; Fondation Belge contre le Cancer; J. Maisin Foundation; St. Luc Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the European Research Council (FP7/2007-2013 European Research Council Independent Researcher Starting Grant No. 243188 TUMETABO to P. Sonveaux), the NIH/NCI (CA40355-24 and CA40355-25 to M. W. Dewhirst), the Fonds National de la Recherche Scientifique (F.R.S.-FNRS), an Action de Recherche Concertee from the Communaute Francaise de Belgique (to P. Sonveaux and O. Feron), the NEOANGIO research program from the Region Wallonne de Belgique (to O. Feron), the Fondation Belge contre le Cancer (200-2008 to P. Sonveaux and O. Feron), and the J. Maisin and St. Luc Foundations (to O. Feron). O. Feron is a Research Director, P. Sonveaux and B. F. Jordan are Research Associates, J. Verrax is a Postdoctoral Researcher, and P. Danhier is a Research Fellow of the F.R.S.-FNRS. C. De Saedeleer is a Televie Research Fellow. For this study, P. Sonveaux was also supported by a fellowship from the Belgian American Educational Foundation (BAEF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; BERTRAM JS, 1980, CANCER LETT, V11, P63, DOI 10.1016/0304-3835(80)90130-5; Bouzin C, 2007, J IMMUNOL, V178, P1505, DOI 10.4049/jimmunol.178.3.1505; Brahimi-Horn MC, 2007, J MOL MED-JMM, V85, P1301, DOI 10.1007/s00109-007-0281-3; Brouet A, 2001, CIRC RES, V89, P866, DOI 10.1161/hh2201.100319; Calvani M, 2006, BLOOD, V107, P2705, DOI 10.1182/blood-2005-09-3541; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Constant JS, 2000, WOUND REPAIR REGEN, V8, P353, DOI 10.1046/j.1524-475x.2000.00353.x; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; Del Prete E, 2004, PHYSIOL BEHAV, V80, P489, DOI 10.1016/j.physbeh.2003.10.007; Deudero JJP, 2008, J BIOL CHEM, V283, P11435, DOI 10.1074/jbc.M703875200; Dewhirst MW, 1996, BRIT J CANCER, V74, pS247; Diepart C, 2010, ANAL BIOCHEM, V396, P250, DOI 10.1016/j.ab.2009.09.029; Dimmeler S, 2000, FEBS LETT, V477, P258, DOI 10.1016/S0014-5793(00)01657-4; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Elvidge GP, 2006, J BIOL CHEM, V281, P15215, DOI 10.1074/jbc.M511408200; Feron O, 1996, J BIOL CHEM, V271, P22810, DOI 10.1074/jbc.271.37.22810; Feron O, 2009, RADIOTHER ONCOL, V92, P329, DOI 10.1016/j.radonc.2009.06.025; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Fox JEM, 2000, J PHYSIOL-LONDON, V529, P285, DOI 10.1111/j.1469-7793.2000.00285.x; Fraisl P, 2009, DEV CELL, V16, P167, DOI 10.1016/j.devcel.2009.01.003; Gordan JD, 2007, CANCER CELL, V12, P108, DOI 10.1016/j.ccr.2007.07.006; GREEN H, 1964, NATURE, V204, P347, DOI 10.1038/204347a0; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; Halestrap AP, 2004, PFLUG ARCH EUR J PHY, V447, P619, DOI 10.1007/s00424-003-1067-2; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Hunt TK, 2007, ANTIOXID REDOX SIGN, V9, P1115, DOI 10.1089/ars.2007.1674; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Julien C, 2004, BRIT J CANCER, V91, P374, DOI 10.1038/sj.bjc.6601908; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Koukourakis MI, 2006, CANCER RES, V66, P632, DOI 10.1158/0008-5472.CAN-05-3260; Le Bras A, 2007, ONCOGENE, V26, P7480, DOI 10.1038/sj.onc.1210566; Li F, 2007, MOL CELL, V26, P63, DOI 10.1016/j.molcel.2007.02.024; Lu HS, 2005, J BIOL CHEM, V280, P41928, DOI 10.1074/jbc.M508718200; Lu HS, 2002, J BIOL CHEM, V277, P23111, DOI 10.1074/jbc.M202487200; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Martinive P, 2006, MOL CANCER THER, V5, P1620, DOI 10.1158/1535-7163.MCT-05-0472; Masson Veronique, 2002, Biological Procedures Online, V4, P24, DOI 10.1251/bpo30; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Paulusma CC, 2005, BBA-MOL BASIS DIS, V1741, P11, DOI 10.1016/j.bbadis.2005.04.006; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Quintero M, 2006, P NATL ACAD SCI USA, V103, P5379, DOI 10.1073/pnas.0601026103; Rauch C, 2010, CELL BIOCHEM BIOPHYS, V56, P73, DOI 10.1007/s12013-009-9072-5; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 1998, CURR OPIN GENET DEV, V8, P588, DOI 10.1016/S0959-437X(98)80016-6; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Semenza GL, 2009, BLOOD, V114, P2015, DOI 10.1182/blood-2009-05-189985; Sonveaux P, 2003, CANCER RES, V63, P1012; Sonveaux P, 2002, FASEB J, V16, P1979, DOI 10.1096/fj.02-0487fje; Sonveaux P, 2004, CIRC RES, V95, P154, DOI 10.1161/01.RES.0000136344.27825.72; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; Tang N, 2004, CANCER CELL, V6, P485, DOI 10.1016/j.ccr.2004.09.026; TAPER HS, 1966, CANCER RES, V26, P143; Trabold O, 2003, WOUND REPAIR REGEN, V11, P504, DOI 10.1046/j.1524-475X.2003.11621.x; Unruh A, 2003, ONCOGENE, V22, P3213, DOI 10.1038/sj.onc.1206385; Vegran F, 2011, CANCER RES, V71, P2550, DOI 10.1158/0008-5472.CAN-10-2828; Walenta S, 2004, CURR MED CHEM, V11, P2195, DOI 10.2174/0929867043364711; Walenta S, 2001, INT J RADIAT ONCOL, V51, P840, DOI 10.1016/S0360-3016(01)01700-X; WILBERS KH, 1979, BIOCHIM BIOPHYS ACTA, V554, P400, DOI 10.1016/0005-2736(79)90380-8; WILKINSON JH, 1972, ENZYME, V13, P170, DOI 10.1159/000459658; WU R, 1959, J BIOL CHEM, V234, P1036; Xiong M, 1998, AM J PATHOL, V153, P587, DOI 10.1016/S0002-9440(10)65601-5	66	316	331	6	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2012	7	3							e33418	10.1371/journal.pone.0033418	http://dx.doi.org/10.1371/journal.pone.0033418			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930IA	22428047	Green Submitted, Green Published, gold			2022-12-25	WOS:000303129700060
J	Chung, TT; Yeh, CB; Li, YC; Su, SC; Chien, MH; Yang, SF; Hsieh, YH				Chung, Tsung-Te; Yeh, Chao-Bin; Li, Yi-Ching; Su, Shih-Chi; Chien, Ming-Hsien; Yang, Shun-Fa; Hsieh, Yi-Hsien			Effect of RECK Gene Polymorphisms on Hepatocellular Carcinoma Susceptibility and Clinicopathologic Features	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE REGULATOR; MEDIATED DOWN-REGULATION; CYSTEINE-RICH PROTEIN; KAZAL MOTIFS RECK; CELL LUNG-CANCER; CLINICAL-SIGNIFICANCE; PROMOTER POLYMORPHISMS; PROGNOSTIC INDICATOR; SUPPRESSOR GENE; EXPRESSION	Background: The reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) down-regulation has been confirmed in numerous human cancers and is clinically associated with metastasis. This study investigates the potential associations of RECK single-nucleotide polymorphisms (SNPs) with hepatocellular carcinoma (HCC) susceptibility and its clinicopathologic characteristics. Methodology/Principal Findings: A total of 135 HCC cancer patients and 501 cancer-free controls were analyzed for four RECK SNPs (rs10814325, rs16932912, rs11788747, and rs10972727) using real-time PCR and PCR-RFLP genotyping analysis. After adjusting for other co-variants, the individuals carrying RECK promoter rs10814325 inheriting at least one C allele had a 1.85-fold [95% confidence interval (CI), 1.03-3.36] risk of developing HCC compared to TT wild type carriers. The HCC patients, who carried rs11788747 with at least one G allele, had a higher distant metastasis risk than wild type probands. Conclusions: RECK gene polymorphisms might be a risk factor increasing HCC susceptibility and distant metastasis in Taiwan.	[Chung, Tsung-Te; Yang, Shun-Fa] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Chung, Tsung-Te] Show Chwan Mem Hosp, Dept Otolaryngol, Changhua, Taiwan; [Yeh, Chao-Bin] Chung Shan Med Univ, Sch Med, Dept Emergency Med, Taichung, Taiwan; [Yeh, Chao-Bin] Chung Shan Med Univ Hosp, Dept Emergency Med, Taichung, Taiwan; [Li, Yi-Ching] Chung Shan Med Univ, Dept Pharmacol, Taichung, Taiwan; [Su, Shih-Chi] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA; [Chien, Ming-Hsien] Taipei Med Univ, Wan Fang Hosp, Taipei, Taiwan; [Chien, Ming-Hsien] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Hsieh, Yi-Hsien] Chung Shan Med Univ Hosp, Dept Biochem, Sch Med, Taichung, Taiwan; [Hsieh, Yi-Hsien] Chung Shan Med Univ, Inst Biochem & Biotechnol, Taichung, Taiwan; [Hsieh, Yi-Hsien] Chung Shan Med Univ Hosp, Clin Lab, Taichung, Taiwan	Chung Shan Medical University; Show Chwan Memorial Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; University of Texas System; UTMD Anderson Cancer Center; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital	Chung, TT (corresponding author), Chung Shan Med Univ, Inst Med, Taichung, Taiwan.	hyhsien@csmu.edu.tw	Yang, Shun-Fa/AAN-1519-2020	Yang, Shun-Fa/0000-0002-0365-7927; Yeh, Chao-Bin/0000-0002-3978-5576				Chang HC, 2007, CANCER SCI, V98, P169, DOI 10.1111/j.1349-7006.2006.00367.x; Chen TY, 2011, ANN SURG ONCOL, V18, P2348, DOI 10.1245/s10434-011-1574-x; Chien MH, 2011, J SURG ONCOL, V104, P299, DOI 10.1002/jso.21929; Chung TT, 2011, CARCINOGENESIS, V32, P1063, DOI 10.1093/carcin/bgr083; Eisenberg I, 2002, CYTOGENET GENOME RES, V97, P58, DOI 10.1159/000064042; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Furumoto K, 2001, HEPATOLOGY, V33, P189, DOI 10.1053/jhep.2001.21048; Lei HX, 2007, BREAST CANCER RES TR, V103, P61, DOI 10.1007/s10549-006-9345-2; Li SL, 2007, WORLD J GASTROENTERO, V13, P6076, DOI 10.3748/wjg.13.6076; Li Yiqing, 2005, J Huazhong Univ Sci Technolog Med Sci, V25, P552; Long NK, 2008, ORAL ONCOL, V44, P1052, DOI 10.1016/j.oraloncology.2008.02.004; Masui T, 2003, CLIN CANCER RES, V9, P1779; Murugan RS, 2009, ANTICANCER RES, V29, P2301; Noda M, 2003, CANCER METAST REV, V22, P167, DOI 10.1023/A:1023043315031; Oh J, 2001, CELL, V107, P789, DOI 10.1016/S0092-8674(01)00597-9; Okabe H, 2001, CANCER RES, V61, P2129; Qi Min, 2010, Zhonghua Zhong Liu Za Zhi, V32, P283; Rabien A, 2007, EUR UROL, V51, P1259, DOI 10.1016/j.eururo.2006.05.050; Sasahara RM, 1999, BIOCHEM BIOPH RES CO, V264, P668, DOI 10.1006/bbrc.1999.1552; Sasahara RM, 1999, BRAZ J MED BIOL RES, V32, P891, DOI 10.1590/S0100-879X1999000700014; Schmidt CM, 1997, BIOCHEM BIOPH RES CO, V236, P54, DOI 10.1006/bbrc.1997.6840; Song SY, 2006, EUR J CANCER, V42, P101, DOI 10.1016/j.ejca.2005.09.016; Takahashi C, 1998, P NATL ACAD SCI USA, V95, P13221, DOI 10.1073/pnas.95.22.13221; Takemoto N, 2007, LUNG CANCER, V58, P376, DOI 10.1016/j.lungcan.2007.07.004; Takenaka K, 2004, EUR J CANCER, V40, P1617, DOI 10.1016/j.ejca.2004.02.028; Takeuchi T, 2004, CLIN CANCER RES, V10, P5572, DOI 10.1158/1078-0432.CCR-03-0656; Vauthey JN, 2002, J CLIN ONCOL, V20, P1527, DOI 10.1200/JCO.20.6.1527; Weng CJ, 2010, ANN SURG ONCOL, V17, P3394, DOI 10.1245/s10434-010-1124-y; Weng CJ, 2010, ANN SURG ONCOL, V17, P1808, DOI 10.1245/s10434-009-0904-8; Xu JD, 2010, J ORTHOP RES, V28, P1621, DOI 10.1002/jor.21178; Zavras AI, 2011, ANN SURG ONCOL, V18, P1478, DOI 10.1245/s10434-010-1431-3	33	21	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33517	10.1371/journal.pone.0033517	http://dx.doi.org/10.1371/journal.pone.0033517			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22428065	gold, Green Submitted, Green Published			2022-12-25	WOS:000302381500150
J	Edlund, A; Ek, K; Breitholtz, M; Gorokhova, E				Edlund, Anna; Ek, Karin; Breitholtz, Magnus; Gorokhova, Elena			Antibiotic-Induced Change of Bacterial Communities Associated with the Copepod Nitocra spinipes	PLOS ONE			English	Article							ENVIRONMENTAL RISK-ASSESSMENT; 16S RIBOSOMAL DNA; CYTOPLASMIC INCOMPATIBILITY; HARPACTICOID COPEPODS; SEX-RATIOS; CARDINIUM; SYMBIONT; GUT; PHARMACEUTICALS; POPULATIONS	Environmental pressures, such as physical factors, diet and contaminants may affect interactions between microbial symbionts and their multicellular hosts. Despite obvious relevance, effects of antimicrobial contaminants on host-symbiont relations in non-target aquatic organisms are largely unknown. We show that exposure to antibiotics had negative effects on survival and juvenile development of the copepod Nitocra spinipes and caused significant alterations in copepod-associated bacterial communities. The significant positive correlations between indices of copepod development and bacterial diversity indicate that disruption of the microflora was likely to be an important factor behind retarded juvenile development in the experimental animals. Moreover, as evidenced by ribotype distribution in the bacterial clone libraries, the exposure to antibiotics caused a shift in dominance from Betaproteobacteria to Cardinium bacteria; the latter have been shown to cause reproductive manipulations in various terrestrial arthropods. Thus, in addition to providing evidence that the antibiotic-induced perturbation of the microbial community associates with reductions in fitness-related traits of the host, this study is the first record of a copepod serving as a host for endosymbiotic Cardinium. Taken together, our results suggest that (1) antimicrobial substances and possibly other stressors can affect micobiome and symbiont-mediated interactions in copepods and other hosts, and (2) Cardinium endosymbionts may occur in other copepods and affect reproduction of their hosts.	[Edlund, Anna] Stockholm Univ, Dept Syst Ecol, S-10691 Stockholm, Sweden; [Ek, Karin; Breitholtz, Magnus; Gorokhova, Elena] Stockholm Univ, Dept Appl Environm Sci, S-10691 Stockholm, Sweden	Stockholm University; Stockholm University	Edlund, A (corresponding author), Stockholm Univ, Dept Syst Ecol, S-10691 Stockholm, Sweden.	elena.gorokhova@itm.su.se	Gorokhova, Elena/E-7105-2018	Gorokhova, Elena/0000-0002-4192-6956; Breitholtz, Magnus/0000-0002-4984-8323; Edlund, Anna/0000-0002-3394-4804	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS); Swedish Foundation for Strategic Environmental Research (MISTRA); Department of Systems Ecology, Stockholm University	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)(Swedish Research Council Formas); Swedish Foundation for Strategic Environmental Research (MISTRA)(Swedish Foundation for Strategic Research); Department of Systems Ecology, Stockholm University	This research was supported by grants from the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS) to EG, Swedish Foundation for Strategic Environmental Research (MISTRA) through the MistraPharma programme (MB), and the Department of Systems Ecology, Stockholm University (AE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2010, PLANT SOIL, V336, P363, DOI 10.1007/s11104-010-0488-x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Falconer SB, 2011, NAT CHEM BIOL, V7, P416, DOI [10.1038/nchembio.590, 10.1038/NCHEMBIO.590]; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Ferrari B, 2004, ENVIRON TOXICOL CHEM, V23, P1344, DOI 10.1897/03-246; Geib SM, 2009, ENVIRON ENTOMOL, V38, P686, DOI 10.1603/022.038.0320; Giordano R, 2010, ENVIRON ENTOMOL, V39, P1170, DOI 10.1603/EN10027; Gotoh T, 2007, HEREDITY, V98, P13, DOI 10.1038/sj.hdy.6800881; GREEN RH, 1974, YALE J BIOL MED, V47, P166; Grung M, 2008, ECOTOX ENVIRON SAFE, V71, P328, DOI 10.1016/j.ecoenv.2007.10.015; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Gusmao LFM, 2009, J PLANKTON RES, V31, P1101, DOI 10.1093/plankt/fbp059; Hagstrom A, 2002, APPL ENVIRON MICROB, V68, P3628, DOI 10.1128/AEM.68.7.3628-3633.2002; Haine ER, 2008, P ROY SOC B-BIOL SCI, V275, P353, DOI 10.1098/rspb.2007.1211; Halling-Sorensen B, 2000, J ANTIMICROB CHEMOTH, V46, P53, DOI 10.1093/jac/46.suppl_1.53; HARRIS JM, 1993, MICROB ECOL, V25, P195, DOI 10.1007/BF00171889; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; Hirst AG, 2010, LIMNOL OCEANOGR, V55, P2193, DOI 10.4319/lo.2010.55.5.2193; Homonnay ZG, 2011, J BASIC MICROB, V51, P1; Hunter MS, 2003, P ROY SOC B-BIOL SCI, V270, P2185, DOI 10.1098/rspb.2003.2475; Jeon S, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-222; Knuckey RM, 2005, AQUACULTURE, V249, P339, DOI 10.1016/j.aquaculture.2005.02.053; Kummerer K, 2009, CHEMOSPHERE, V75, P417, DOI 10.1016/j.chemosphere.2008.11.086; Kuhlmann I, 1996, CYTOTECHNOLOGY, V19, P95, DOI 10.1007/BF00749764; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Kurtti TJ, 1996, J INVERTEBR PATHOL, V67, P318, DOI 10.1006/jipa.1996.0050; Lambo AJ, 2006, J BASIC MICROB, V46, P94, DOI 10.1002/jobm.200510006; Magurran A E, 1988, ECOLOGICAL DIVERSITY; Morimoto S, 2006, CURR MICROBIOL, V52, P324, DOI 10.1007/s00284-005-0349-7; MUYZER G, 1995, ARCH MICROBIOL, V164, P165, DOI 10.1007/BF02529967; Nakamura Y, 2009, APPL ENVIRON MICROB, V75, P6757, DOI 10.1128/AEM.01583-09; Parsons T.R., 1977, BIOL OCEANOGRAPHIC P, Vsecond; Provencher LM, 2005, ANN ENTOMOL SOC AM, V98, P629, DOI 10.1603/0013-8746(2005)098[0629:PITANC]2.0.CO;2; Raisuddin S, 2007, AQUAT TOXICOL, V83, P161, DOI 10.1016/j.aquatox.2007.04.005; Rawls JF, 2007, P NATL ACAD SCI USA, V104, P7622, DOI 10.1073/pnas.0702386104; RIEPER M, 1982, MAR ECOL PROG SER, V7, P303, DOI 10.3354/meps007303; Robinson AA, 2005, ENVIRON TOXICOL CHEM, V24, P423, DOI 10.1897/04-210R.1; Ros VID, 2009, HEREDITY, V102, P413, DOI 10.1038/hdy.2009.4; Russell JA, 2009, P NATL ACAD SCI USA, V106, P21236, DOI 10.1073/pnas.0907926106; Sachs JL, 2011, TRENDS ECOL EVOL, V26, P202, DOI 10.1016/j.tree.2011.01.010; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Stottrup JG, 2000, AQUAC RES, V31, P703, DOI 10.1046/j.1365-2109.2000.318488.x; Straughan DJ, 2000, J HERED, V91, P8, DOI 10.1093/jhered/91.1.8; Tang K, 2009, BIOL LETTERS, V5, P549, DOI 10.1098/rsbl.2009.0076; Tang KW, 2010, AQUAT MICROB ECOL, V61, P261, DOI 10.3354/ame01424; THISTLE D, 1990, MAR BIOL, V107, P443, DOI 10.1007/BF01313427; Toft C, 2010, NAT REV GENET, V11, P465, DOI 10.1038/nrg2798; USTACH JF, 1982, J EXP MAR BIOL ECOL, V64, P203, DOI 10.1016/0022-0981(82)90010-7; van der Grinten E, 2010, CHEMOSPHERE, V80, P1, DOI 10.1016/j.chemosphere.2010.04.011; Voordouw MJ, 2008, EVOL ECOL RES, V10, P1007; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; Wilberforce EM, 2003, SOIL BIOL BIOCHEM, V35, P1143, DOI 10.1016/S0038-0717(03)00176-7; WILSON E O, 1992; Wollenberger L, 2000, CHEMOSPHERE, V40, P723, DOI 10.1016/S0045-6535(99)00443-9; Wust PK, 2011, ISME J, V5, P92, DOI 10.1038/ismej.2010.99; Zchori-Fein E, 2004, INT J SYST EVOL MICR, V54, P961, DOI 10.1099/ijs.0.02957-0; Zchori-Fein E, 2004, MOL ECOL, V13, P2009, DOI 10.1111/j.1365-294X.2004.02203.x	60	20	20	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33107	10.1371/journal.pone.0033107	http://dx.doi.org/10.1371/journal.pone.0033107			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427962	Green Submitted, Green Published, gold			2022-12-25	WOS:000302381500092
J	Knorr, RL; Dimova, R; Lipowsky, R				Knorr, Roland L.; Dimova, Rumiana; Lipowsky, Reinhard			Curvature of Double-Membrane Organelles Generated by Changes in Membrane Size and Composition	PLOS ONE			English	Article							AUTOPHAGOSOME FORMATION; ENDOPLASMIC-RETICULUM; ELECTRON-MICROSCOPY; FUSION; YEAST; VESICLES; SHEETS; GOLGI; SHAPE; CELL	Transient double-membrane organelles are key players in cellular processes such as autophagy, reproduction, and viral infection. These organelles are formed by the bending and closure of flat, double-membrane sheets. Proteins are believed to be important in these morphological transitions but the underlying mechanism of curvature generation is poorly understood. Here, we describe a novel mechanism for this curvature generation which depends primarily on three membrane properties: the lateral size of the double-membrane sheets, the molecular composition of their highly curved rims, and a possible asymmetry between the two flat faces of the sheets. This mechanism is evolutionary advantageous since it does not require active processes and is readily available even when resources within the cell are restricted as during starvation, which can induce autophagy and sporulation. We identify pathways for protein-assisted regulation of curvature generation, organelle size, direction of bending, and morphology. Our theory also provides a mechanism for the stabilization of large double-membrane sheet-like structures found in the endoplasmic reticulum and in the Golgi cisternae.	[Knorr, Roland L.; Dimova, Rumiana; Lipowsky, Reinhard] Max Planck Inst Colloids & Interfaces, Potsdam, Germany	Max Planck Society	Knorr, RL (corresponding author), Max Planck Inst Colloids & Interfaces, Sci Pk Golm, Potsdam, Germany.	dimova@mpikg.mpg.de	Dimova, Rumiana/C-4330-2008	Dimova, Rumiana/0000-0002-3872-8502; Lipowsky, Reinhard/0000-0001-8417-8567	German Science Foundation [IGRTG 1524]	German Science Foundation(German Research Foundation (DFG))	The work was supported by the German Science Foundation within the framework of IGRTG 1524. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Bains M, 2009, J BIOL CHEM, V284, P20398, DOI 10.1074/jbc.M109.011791; Barlowe C, 2010, CELL, V143, P665, DOI 10.1016/j.cell.2010.11.011; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Coluccio AE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002873; Dippold HC, 2009, CELL, V139, P337, DOI 10.1016/j.cell.2009.07.052; Fengsrud M, 2000, EUR J CELL BIOL, V79, P871, DOI 10.1078/0171-9335-00125; Frost A, 2009, CELL, V137, P191, DOI 10.1016/j.cell.2009.04.010; Geng JF, 2008, J CELL BIOL, V182, P129, DOI 10.1083/jcb.200711112; Gov N, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.011104; Gracia RS, 2010, SOFT MATTER, V6, P1472, DOI 10.1039/b920629a; Gruhn T, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.011903; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; Hayashi-Nishino M, 2009, NAT CELL BIOL, V11, P1433, DOI 10.1038/ncb1991; HELFRICH W, 1973, Z NATURFORSCH C, VC 28, P693, DOI 10.1515/znc-1973-11-1209; Juhasz G, 2006, PLOS BIOL, V4, P161, DOI 10.1371/journal.pbio.0040036; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kochl R, 2006, TRAFFIC, V7, P129, DOI 10.1111/j.1600-0854.2005.00368.x; Komatsu M, 2010, FEBS LETT, V584, P1374, DOI 10.1016/j.febslet.2010.02.017; Kovacs AL, 2000, CELL TISSUE RES, V302, P253, DOI 10.1007/s004410000275; Ladinsky MS, 1999, J CELL BIOL, V144, P1135, DOI 10.1083/jcb.144.6.1135; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; LIPOWSKY R, 1991, NATURE, V349, P475, DOI 10.1038/349475a0; Longatti A, 2009, CELL DEATH DIFFER, V16, P956, DOI 10.1038/cdd.2009.39; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Miller S, 2008, NAT REV MICROBIOL, V6, P363, DOI 10.1038/nrmicro1890; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Moreau K, 2011, CELL, V146, P303, DOI 10.1016/j.cell.2011.06.023; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Nair U, 2011, CELL, V146, P290, DOI 10.1016/j.cell.2011.06.022; Nakamura T, 2008, MOL BIOL CELL, V19, P3544, DOI 10.1091/mbc.E08-04-0414; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Nishida Y, 2009, NATURE, V461, P654, DOI 10.1038/nature08455; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pedersen KW, 1999, J VIROL, V73, P2016, DOI 10.1128/JVI.73.3.2016-2026.1999; Reggiori F, 2005, CURR OPIN CELL BIOL, V17, P415, DOI 10.1016/j.ceb.2005.06.007; Rocks O, 2010, CELL, V141, P458, DOI 10.1016/j.cell.2010.04.007; SEIFERT U, 1994, PHYS REV E, V49, P3124, DOI 10.1103/PhysRevE.49.3124; SEIFERT U, 1991, PHYS REV A, V44, P1182, DOI 10.1103/PhysRevA.44.1182; Shibata Y, 2010, CELL, V143, P774, DOI 10.1016/j.cell.2010.11.007; Shimoda C, 2004, J CELL SCI, V117, P389, DOI 10.1242/jcs.00980; Simonsen A, 2009, J CELL BIOL, V186, P773, DOI 10.1083/jcb.200907014; Stagg SM, 2008, CELL, V134, P474, DOI 10.1016/j.cell.2008.06.024; Subramani S, 2007, CELL, V130, P18, DOI 10.1016/j.cell.2007.06.041; Voeltz GK, 2007, NAT REV MOL CELL BIO, V8, P258, DOI 10.1038/nrm2119; West M, 2011, J CELL BIOL, V193, P333, DOI 10.1083/jcb.201011039; Xie ZP, 2008, MOL BIOL CELL, V19, P3290, DOI 10.1091/mbc.E07-12-1292; Yen WL, 2010, J CELL BIOL, V188, P101, DOI 10.1083/jcb.200904075; Yla-Anttila P, 2009, MONITORING AUTOPHAGY, P143; Yla-Anttila P, 2009, METHOD ENZYMOL, V452, P143, DOI 10.1016/S0076-6879(08)03610-0	51	40	40	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e32753	10.1371/journal.pone.0032753	http://dx.doi.org/10.1371/journal.pone.0032753			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427874	gold, Green Published, Green Submitted			2022-12-25	WOS:000302381500038
J	Niedtfeld, I; Kirsch, P; Schulze, L; Herpertz, SC; Bohus, M; Schmahl, C				Niedtfeld, Inga; Kirsch, Peter; Schulze, Lars; Herpertz, Sabine C.; Bohus, Martin; Schmahl, Christian			Functional Connectivity of Pain-Mediated Affect Regulation in Borderline Personality Disorder	PLOS ONE			English	Article							EMOTION REGULATION; SELF-INJURY; DEFAULT-MODE; AMYGDALA; DYSREGULATION; DYSFUNCTION; CINGULATE; RESPONSES; MEMORY; EVENT	Affective instability and self-injurious behavior are important features of Borderline Personality Disorder. Whereas affective instability may be caused by a pattern of limbic hyperreactivity paired with dysfunctional prefrontal regulation mechanisms, painful stimulation was found to reduce affective arousal at the neural level, possibly underlying the soothing effect of pain in BPD. We used psychophysiological interactions to analyze functional connectivity of (para-) limbic brain structures (i.e. amygdala, insula, anterior cingulate cortex) in Borderline Personality Disorder in response to painful stimulation. Therefore, we re-analyzed a dataset from 20 patients with Borderline Personality Disorder and 23 healthy controls who took part in an fMRI-task inducing negative (versus neutral) affect and subsequently applying heat pain (versus warmth perception). Results suggest an enhanced negative coupling between limbic as well as paralimbic regions and prefrontal regions, specifically with the medial and dorsolateral prefrontal cortex, when patients experienced pain in addition to emotional arousing pictures. When neutral pictures were combined with painful heat sensation, we found positive connectivity in Borderline Personality Disorder between (para-) limbic brain areas and parts of the basal ganglia (lentiform nucleus, putamen), as well areas involved in self-referential processing (precuneus and posterior cingulate). We found further evidence for alterations in the emotion regulation process in Borderline Personality Disorder, in the way that pain improves the inhibition of limbic activity by prefrontal areas. This study provides new insights in pain processing in BPD, including enhanced coupling of limbic structures and basal ganglia.	[Niedtfeld, Inga; Bohus, Martin; Schmahl, Christian] Heidelberg Univ, Med Fac Mannheim, Dept Psychosomat Med, Cent Inst Mental Hlth Mannheim, Heidelberg, Germany; [Kirsch, Peter] Heidelberg Univ, Med Fac Mannheim, Dept Clin Psychol, Cent Inst Mental Hlth Mannheim, Heidelberg, Germany; [Schulze, Lars] Free Univ Berlin, Berlin, Germany; [Herpertz, Sabine C.] Heidelberg Univ, Dept Gen Psychiat, Ctr Psychosocial Med, Heidelberg, Germany	Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Free University of Berlin; Ruprecht Karls University Heidelberg	Niedtfeld, I (corresponding author), Heidelberg Univ, Med Fac Mannheim, Dept Psychosomat Med, Cent Inst Mental Hlth Mannheim, Heidelberg, Germany.	inga.niedtfeld@zi-mannheim.de	Kirsch, Peter/C-2499-2008; Schmahl, Christian/E-8760-2012; Niedtfeld, Inga/GLV-3573-2022; Herpertz, Sabine C/AAW-4885-2020	Kirsch, Peter/0000-0002-0817-1248; Herpertz, Sabine C/0000-0001-9676-1928; Schulze, Lars/0000-0003-4720-2411; Schmahl, Christian/0000-0003-0141-0821; Niedtfeld, Inga/0000-0002-6118-1664	Deutsche Forschungsgemeinschaft [SCHM 1526/8-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Preparation of this manuscript was supported by a grant from the Deutsche Forschungsgemeinschaft (SCHM 1526/8-1) to CS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Banks SJ, 2007, SOC COGN AFFECT NEUR, V2, P303, DOI 10.1093/scan/nsm029; Bender S, 2007, NEUROIMAGE, V38, P367, DOI 10.1016/j.neuroimage.2007.07.044; Boettiger CA, 2005, J NEUROSCI, V25, P2723, DOI 10.1523/JNEUROSCI.3697-04.2005; Bohus M, 2000, PSYCHIAT RES, V95, P251, DOI 10.1016/S0165-1781(00)00179-7; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Breiter HC, 1996, NEURON, V17, P875, DOI 10.1016/S0896-6273(00)80219-6; Bresin K, 2010, MOTIV EMOTION, V34, P280, DOI 10.1007/s11031-010-9168-7; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Chapman AL, 2006, BEHAV RES THER, V44, P371, DOI 10.1016/j.brat.2005.03.005; DeLaFuente JM, 1997, J PSYCHIATR RES, V31, P531, DOI 10.1016/S0022-3956(97)00001-0; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Donegan NH, 2003, BIOL PSYCHIAT, V54, P1284, DOI 10.1016/S0006-3223(03)00636-X; Driessen M, 2009, PSYCHOL MED, V39, P507, DOI 10.1017/S0033291708003358; Ebner-Priemer UW, 2007, PSYCHIAT RES, V150, P265, DOI 10.1016/j.psychres.2006.04.014; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Grahn JA, 2009, BEHAV BRAIN RES, V199, P53, DOI 10.1016/j.bbr.2008.11.020; Gratz KL, 2004, J PSYCHOPATHOL BEHAV, V26, P41, DOI 10.1023/B:JOBA.0000007455.08539.94; Gross JJ, 2002, PSYCHOPHYSIOLOGY, V39, P281, DOI 10.1017/S0048577201393198; Hariri AR, 2003, BIOL PSYCHIAT, V53, P494, DOI 10.1016/S0006-3223(02)01786-9; Hayasaka S, 2004, NEUROIMAGE, V23, P54, DOI 10.1016/j.neuroimage.2004.04.035; Herpertz SC, 2001, BIOL PSYCHIAT, V50, P292, DOI 10.1016/S0006-3223(01)01075-7; Hollin GJS, 2009, J PAIN, V10, P1058, DOI 10.1016/j.jpain.2009.03.015; Kleindienst N, 2008, J NERV MENT DIS, V196, P230, DOI 10.1097/NMD.0b013e3181663026; Klonsky ED, 2007, CLIN PSYCHOL REV, V27, P226, DOI 10.1016/j.cpr.2006.08.002; Koenigsberg HW, 2010, NEUROPSYCHOLOGIA, V48, P1813, DOI 10.1016/j.neuropsychologia.2010.03.002; Koenigsberg HW, 2009, BIOL PSYCHIAT, V66, P854, DOI 10.1016/j.biopsych.2009.06.010; Kong J, 2010, PAIN, V148, P257, DOI 10.1016/j.pain.2009.11.008; Lang P. J., 2005, INT AFFECTIVE PICTUR; Levine D, 1997, J NERV MENT DIS, V185, P240, DOI 10.1097/00005053-199704000-00004; Lieb K, 2004, LANCET, V364, P453, DOI 10.1016/S0140-6736(04)16770-6; Limberg A, 2011, BIOL PSYCHIAT, V69, P574, DOI 10.1016/j.biopsych.2010.10.024; Linehan M., 2014, DBT SKILLS TRAINING; Linehan M. M., 1993, COGNITIVE BEHAV TREA; Loranger A. W, 1999, INT PERSONALITY DISO; Ludascher P, 2007, PSYCHIAT RES, V149, P291, DOI 10.1016/j.psychres.2005.04.009; Mayer JS, 2007, NEUROIMAGE, V36, P441, DOI 10.1016/j.neuroimage.2007.03.007; McRae K, 2010, J COGNITIVE NEUROSCI, V22, P248, DOI 10.1162/jocn.2009.21243; Minzenberg MJ, 2007, PSYCHIAT RES-NEUROIM, V155, P231, DOI 10.1016/j.pscychresns.2007.03.006; New AS, 2007, NEUROPSYCHOPHARMACOL, V32, P1629, DOI 10.1038/sj.npp.1301283; Niedtfeld I, 2009, CURR PSYCHIATRY REV, V5, P48, DOI 10.2174/157340009787315262; Niedtfeld I, 2010, BIOL PSYCHIAT, V68, P383, DOI 10.1016/j.biopsych.2010.04.015; Nock MK, 2004, J CONSULT CLIN PSYCH, V72, P885, DOI 10.1037/0022-006X.72.5.885; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; Ochsner KN, 2007, HDB EMOTION REGULATI, P135; Pessoa L, 2002, P NATL ACAD SCI USA, V99, P11458, DOI 10.1073/pnas.172403899; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Schmahl C, 2006, ARCH GEN PSYCHIAT, V63, P659, DOI 10.1001/archpsyc.63.6.659; Schmahl C, 2006, J PSYCHIATR RES, V40, P419, DOI 10.1016/j.jpsychires.2005.08.011; Schulze L, 2011, BIOL PSYCHIAT, V69, P564, DOI 10.1016/j.biopsych.2010.10.025; Sheppes G, 2007, PERS SOC PSYCHOL B, V33, P1518, DOI 10.1177/0146167207305537; Silbersweig D, 2007, AM J PSYCHIAT, V164, P1832, DOI 10.1176/appi.ajp.2007.06010126; Skodol AE, 2002, BIOL PSYCHIAT, V51, P936, DOI 10.1016/S0006-3223(02)01324-0; Stiglmayr CE, 2005, ACTA PSYCHIAT SCAND, V111, P372, DOI 10.1111/j.1600-0447.2004.00466.x; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vogt BA, 2005, PROG BRAIN RES, V150, P205, DOI 10.1016/S0079-6123(05)50015-3; Vogt BA, 1996, EUR J NEUROSCI, V8, P1461, DOI 10.1111/j.1460-9568.1996.tb01608.x; Welch SS, 2008, J CONSULT CLIN PSYCH, V76, P45, DOI 10.1037/0022-006X.76.1.45; Wingenfeld K, 2009, PSYCHONEUROENDOCRINO, V34, P571, DOI 10.1016/j.psyneuen.2008.10.024; Wittchen H.U., 1997, SKID STRUKTURIERTES; Zanarini MC, 2008, ACTA PSYCHIAT SCAND, V117, P177, DOI 10.1111/j.1600-0447.2008.01155.x	62	65	66	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33293	10.1371/journal.pone.0033293	http://dx.doi.org/10.1371/journal.pone.0033293			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	920DF	22428013	gold, Green Submitted, Green Published			2022-12-25	WOS:000302381500122
J	Osisami, M; Ali, W; Frohman, MA				Osisami, Mary; Ali, Wahida; Frohman, Michael A.			A Role for Phospholipase D3 in Myotube Formation	PLOS ONE			English	Article							PLASMA-CELL DIFFERENTIATION; ENDOPLASMIC-RETICULUM; TRANSCRIPTION FACTOR; SIGNALING PATHWAYS; D DEFINES; PROTEIN; STRESS; MEMBRANE; THAPSIGARGIN; VESICLES	Phospholipase D3 (PLD3) is a non-classical, poorly characterized member of the PLD superfamily of signaling enzymes. PLD3 is a type II glycoprotein associated with the endoplasmic reticulum, is expressed in a wide range of tissues and cells, and undergoes dramatic upregulation in neurons and muscle cells during differentiation. Using an in vitro skeletal muscle differentiation system, we define the ER-tethering mechanism and report that increased PLD3 expression enhances myotube formation, whereas a putatively dominant-negative PLD3 mutant isoform reduces myotube formation. ER stress, which also enhances myotube formation, is shown here to increase PLD3 expression levels. PLD3 protein was observed to localize to a restricted set of subcellular membrane sites in myotubes that may derive from or constitute a subdomain of the endoplasmic reticulum. These findings suggest that PLD3 plays a role in myogenesis during myotube formation, potentially in the events surrounding ER reorganization.	[Osisami, Mary; Frohman, Michael A.] SUNY Stony Brook, Ctr Dev Genet, Grad Program Genet, Stony Brook, NY 11794 USA; [Ali, Wahida; Frohman, Michael A.] SUNY Stony Brook, Grad Program Mol & Cellular Pharmacol, Stony Brook, NY 11794 USA; [Ali, Wahida; Frohman, Michael A.] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Osisami, M (corresponding author), SUNY Stony Brook, Ctr Dev Genet, Grad Program Genet, Stony Brook, NY 11794 USA.	Michael@pharm.stonybrook.edu		Hanel, Wahida/0000-0003-0196-8040	National Institute of Health [GM071520, GM084251]; National Institute of Health NRSA [DK072557]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F31DK072557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084251, R01GM071520] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Health NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by National Institute of Health grants GM071520 and GM084251 to MAF and an individual National Institute of Health NRSA fellowship (DK072557) to MO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basseri S, 2009, J LIPID RES, V50, P2486, DOI 10.1194/jlr.M900216-JLR200; Bi K, 1997, CURR BIOL, V7, P301, DOI 10.1016/S0960-9822(06)00153-9; BLASCO R, 1991, J VIROL, V65, P5910, DOI 10.1128/JVI.65.11.5910-5920.1991; Buckley BJ, 1997, AM J PHYSIOL-CELL PH, V273, pC1298, DOI 10.1152/ajpcell.1997.273.4.C1298; Carozzi AJ, 2000, TRAFFIC, V1, P326, DOI 10.1034/j.1600-0854.2000.010406.x; Chen YG, 1997, J CELL BIOL, V138, P495, DOI 10.1083/jcb.138.3.495; Choi SY, 2006, NAT CELL BIOL, V8, P1255, DOI 10.1038/ncb1487; Colley WC, 1997, CURR BIOL, V7, P191, DOI 10.1016/S0960-9822(97)70090-3; Du GW, 2004, MOL BIOL CELL, V15, P1024, DOI 10.1091/mbc.E03-09-0673; Du GW, 2003, J CELL BIOL, V162, P305, DOI 10.1083/jcb.200302033; Eckert D, 2005, J VIROL, V79, P15084, DOI 10.1128/JVI.79.24.15084-15090.2005; FLUCHER BE, 1991, DEV BIOL, V145, P77, DOI 10.1016/0012-1606(91)90214-N; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Hamamura K, 2008, J BONE MINER METAB, V26, P231, DOI 10.1007/s00774-007-0825-1; HAMMOND SM, 1995, J BIOL CHEM, V270, P29640; Hansen JM, 2007, CELL BIOL INT, V31, P546, DOI 10.1016/j.cellbi.2006.11.027; Horsley V, 2004, CELLS TISSUES ORGANS, V176, P67, DOI 10.1159/000075028; Hsieh YH, 2007, BIOCHEM BIOPH RES CO, V359, P643, DOI 10.1016/j.bbrc.2007.05.154; Huang HY, 2011, DEV CELL, V20, P376, DOI 10.1016/j.devcel.2011.01.004; Huang P, 2005, MOL BIOL CELL, V16, P2614, DOI 10.1091/mbc.E04-12-1124; Hughes WE, 2004, J BIOL CHEM, V279, P27534, DOI 10.1074/jbc.M403012200; Husain M, 2002, J VIROL, V76, P7777, DOI 10.1128/JVI.76.15.7777-7789.2002; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Iwakoshi NN, 2003, IMMUNOL REV, V194, P29, DOI 10.1034/j.1600-065X.2003.00057.x; Jenkins GM, 2005, CELL MOL LIFE SCI, V62, P2305, DOI 10.1007/s00018-005-5195-z; Li MQ, 2000, MOL CELL BIOL, V20, P5096, DOI 10.1128/MCB.20.14.5096-5106.2000; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Muliyil S, 2011, DEVELOPMENT, V138, P3043, DOI 10.1242/dev.060731; Munck A, 2005, FEBS J, V272, P1718, DOI 10.1111/j.1742-4658.2005.04601.x; Nagaoka-Yasuda R, 2007, FREE RADICAL BIO MED, V43, P781, DOI 10.1016/j.freeradbiomed.2007.05.008; Nakanishi K, 2007, FASEB J, V21, P2994, DOI 10.1096/fj.06-6408com; Pathre P, 2003, EMBO J, V22, P4059, DOI 10.1093/emboj/cdg390; Pedersen KM, 1998, J BIOL CHEM, V273, P31494, DOI 10.1074/jbc.273.47.31494; RALSTON E, 1993, J CELL BIOL, V120, P399, DOI 10.1083/jcb.120.2.399; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Rose K, 1995, P NATL ACAD SCI USA, V92, P12151, DOI 10.1073/pnas.92.26.12151; Sorrentino V, 2004, BBA-MOL CELL RES, V1742, P113, DOI 10.1016/j.bbamcr.2004.08.016; Sung TC, 1997, EMBO J, V16, P4519, DOI 10.1093/emboj/16.15.4519; TASSIN AM, 1985, J CELL BIOL, V101, P630, DOI 10.1083/jcb.101.2.630; Tomczak KK, 2003, FASEB J, V17, P403, DOI 10.1096/f.03-0568fje; Towler MC, 2004, TRAFFIC, V5, P129, DOI 10.1111/j.1600-0854.2003.00164.x; Yip KHM, 2005, J BONE MINER RES, V20, P1462, DOI 10.1359/JBMR.050324; Yoshikawa F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013932	43	34	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33341	10.1371/journal.pone.0033341	http://dx.doi.org/10.1371/journal.pone.0033341			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22428023	Green Published, Green Submitted, gold			2022-12-25	WOS:000302381500127
J	Gomez, G; Lee, JH; Veldman, MB; Lu, J; Xiao, XS; Lin, S				Gomez, Gustavo; Lee, Jae-Hyung; Veldman, Matthew B.; Lu, Jing; Xiao, Xinshu; Lin, Shuo			Identification of Vascular and Hematopoietic Genes Downstream of etsrp by Deep Sequencing in Zebrafish	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEIN; IN-SITU HYBRIDIZATION; MICROARRAY ANALYSIS; TRANSCRIPTOME ANALYSIS; ENDOTHELIAL-CELLS; LYSOZYME GENE; EXPRESSION; FAMILY; ANGIOGENESIS; EVOLUTION	The transcription factor etsrp/Er71/Etv2 is a master control gene for vasculogenesis in all species studied to date. It is also required for hematopoiesis in zebrafish and mice. Several novel genes expressed in vasculature have been identified through transcriptional profiling of zebrafish embryos overexpressing etsrp by microarrays. Here we re-examined this transcriptional profile by Illumina RNA-sequencing technology, revealing a substantially increased number of candidate genes regulated by etsrp. Expression studies of 50 selected candidate genes from this dataset resulted in the identification of 39 new genes that are expressed in vascular cells. Regulation of these genes by etsrp was confirmed by their ectopic induction in etsrp overexpressing and decreased expression in etsrp deficient embryos. Our studies demonstrate the effectiveness of the RNA-sequencing technology to identify biologically relevant genes in zebrfish and produced a comprehensive profile of genes previously unexplored in vascular endothelial cell biology.	[Gomez, Gustavo; Veldman, Matthew B.; Lu, Jing; Lin, Shuo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90024 USA; [Lee, Jae-Hyung; Xiao, Xinshu] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Gomez, G (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90024 USA.	shuolin@ucla.edu	Lee, Jae-Hyung/AAI-9813-2020	Gomez, Gustavo/0000-0001-9294-4276; Lee, Jae-Hyung/0000-0002-5085-6988; Xiao, Xinshu/0000-0002-9362-8029	National Institutes of Health (NIH) [F31HL091713, DK54508]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F31HL091713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054508, Z01DK054508] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health (NIH) (F31HL091713 to GAG and DK54508 to SL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanes H, 2011, GENOME RES; Adams J, 2000, TRENDS CELL BIOL, V10, P17, DOI 10.1016/S0962-8924(99)01673-6; Aday AW, 2011, DEV BIOL; Avruch J, 2009, J BIOL CHEM, V284, P11001, DOI 10.1074/jbc.R800073200; BIRKENBACH M, 1993, J VIROL, V67, P2209, DOI 10.1128/JVI.67.4.2209-2220.1993; Braybrook C, 2001, GENOMICS, V72, P128, DOI 10.1006/geno.2000.6478; Choi SJ, 2007, J BIOL CHEM, V282, P36024, DOI 10.1074/jbc.M707639200; Covassin L, 2006, DEV BIOL, V299, P551, DOI 10.1016/j.ydbio.2006.08.020; Eckfeld K, 2004, CANCER RES, V64, P8688, DOI 10.1158/0008-5472.CAN-04-2065; Engelse MA, 2008, ANGIOGENESIS, V11, P153, DOI 10.1007/s10456-007-9086-9; Fonseca MI, 2001, J LEUKOCYTE BIOL, V70, P793; Gatto D, 2009, IMMUNITY, V31, P259, DOI 10.1016/j.immuni.2009.06.016; Gomez GA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004994; Grosskurth SE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002857; Gupta G, 2007, INT J CANCER, V120, P1739, DOI 10.1002/ijc.22463; Hegedus Z, 2009, MOL IMMUNOL, V46, P2918, DOI 10.1016/j.molimm.2009.07.002; Hikima J, 2001, BBA-GENE STRUCT EXPR, V1520, P35, DOI 10.1016/S0167-4781(01)00248-2; Irwin DM, 2003, J MOL EVOL, V56, P234, DOI 10.1007/s00239-002-2396-z; Jalagadugula G, 2010, BLOOD, V116, P6037, DOI 10.1182/blood-2010-06-289850; Kanamoto T, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-70; Kataoka H, 2011, BLOOD; KUMAR CC, 1989, BIOCHEMISTRY-US, V28, P4027, DOI 10.1021/bi00435a059; Lamarche-Vane N, 1998, J BIOL CHEM, V273, P29172, DOI 10.1074/jbc.273.44.29172; Lee D, 2008, CELL STEM CELL, V2, P497, DOI 10.1016/j.stem.2008.03.008; Lee SJ, 2008, FASEB J, V22, P3706, DOI 10.1096/fj.08-106088; Li FQ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-429; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Licht AH, 2010, J CLIN INVEST, V120, P2307, DOI 10.1172/JCI41749; Liu F, 2008, CIRC RES, V103, P1147, DOI 10.1161/CIRCRESAHA.108.179713; Mathavan S, 2005, PLOS GENET, V1, P260, DOI 10.1371/journal.pgen.0010029; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; NAKANO T, 1991, BIOCHIM BIOPHYS ACTA, V1090, P273, DOI 10.1016/0167-4781(91)90118-6; Neuhaus H, 2010, DEV DYNAM, V239, P3436, DOI 10.1002/dvdy.22487; ORDAS A, 2010, FISH SHELLFISH IMMUN; Pereira JP, 2009, NATURE, V460, P1122, DOI 10.1038/nature08226; Petrenko O, 1999, IMMUNITY, V10, P691, DOI 10.1016/S1074-7613(00)80068-0; Pham VN, 2007, DEV BIOL, V303, P772, DOI 10.1016/j.ydbio.2006.10.030; Phng LK, 2009, DEV CELL, V16, P70, DOI 10.1016/j.devcel.2008.12.009; Proulx K, 2010, DEV BIOL, V348, P34, DOI 10.1016/j.ydbio.2010.08.036; Qian F, 2005, DEV DYNAM, V233, P1163, DOI 10.1002/dvdy.20444; Ren X, 2010, BLOOD, V115, P5338, DOI 10.1182/blood-2009-09-244640; RICHARDSON RT, 1994, DEV BIOL, V165, P688, DOI 10.1006/dbio.1994.1285; Rodriguez F, 2008, DEV BIOL, V324, P122, DOI 10.1016/j.ydbio.2008.09.011; Rosenkilde MM, 2006, J BIOL CHEM, V281, P13199, DOI 10.1074/jbc.M602245200; Salanga MC, 2010, DEV DYNAM, V239, P1178, DOI 10.1002/dvdy.22277; Soares AR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-195; STAINIER DYR, 1994, TRENDS CARDIOVAS MED, V4, P207, DOI 10.1016/1050-1738(94)90036-1; Stockhammer OW, 2010, MOL IMMUNOL, V48, P179, DOI 10.1016/j.molimm.2010.08.011; Straughn JM, 2004, INT J CANCER, V108, P805, DOI 10.1002/ijc.11617; Sumanas S, 2006, PLOS BIOL, V4, P60, DOI 10.1371/journal.pbio.0040010; Sumanas S, 2005, BLOOD, V106, P534, DOI 10.1182/blood-2004-12-4653; Sumanas S, 2008, BLOOD, V111, P4500, DOI 10.1182/blood-2007-09-110569; Tcherkezian J, 2006, BIOL CELL, V98, P445, DOI 10.1042/BC20050101; Thisse B, 2004, METHOD CELL BIOL, V77, P505; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Topczewska JM, 2003, GENE EXPR PATTERNS, V3, P169, DOI 10.1016/S1567-133X(03)00009-7; Wang L, 2005, P NATL ACAD SCI USA, V102, P13484, DOI 10.1073/pnas.0504420102; Wang L, 2007, P NATL ACAD SCI USA, V104, P1248, DOI 10.1073/pnas.0609149104; Weber GJ, 2005, BLOOD, V106, P521, DOI 10.1182/blood-2004-11-4541; Weinstein BM, 2002, SEMIN CELL DEV BIOL, V13, P515, DOI 10.1016/S1084952102001052; Wen Y, 2001, BIOCHEM J, V357, P25, DOI 10.1042/0264-6021:3570025; Wheeler DL, 2003, NUCLEIC ACIDS RES, V31, P28, DOI 10.1093/nar/gkg033; Wong KS, 2009, DEV DYNAM, V238, P1836, DOI 10.1002/dvdy.21990; XUE FY, 1993, CELL, V72, P681, DOI 10.1016/0092-8674(93)90397-9; Zakrzewska A, 2010, BLOOD, V116, pE1, DOI 10.1182/blood-2010-01-262873	65	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e31658	10.1371/journal.pone.0031658	http://dx.doi.org/10.1371/journal.pone.0031658			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438865	Green Published, gold, Green Submitted			2022-12-25	WOS:000303309100003
J	Rodriguez-Perez, J; Larrinaga, AR; Santamaria, L				Rodriguez-Perez, Javier; Larrinaga, Asier R.; Santamaria, Luis			Effects of Frugivore Preferences and Habitat Heterogeneity on Seed Rain: A Multi-Scale Analysis	PLOS ONE			English	Article							HOME-RANGE; DISPERSAL; BEHAVIOR; SELECTION; PATTERNS; RECRUITMENT; DYNAMICS; DISTANCE; MECHANISMS; MODELS	Seed rain mediated by frugivores is influenced by (1) the seed-deposition distances following fruit ingestion, (2) the disperser activity, as determined by its behaviour and habitat preferences, and (3) the structure of the habitat within the landscape. Here, we evaluated such components using the fleshy-fruited shrub Ephedra fragilis and the frugivorous Balearic lizard Podarcis lilfordi. We estimated seed-deposition patterns based on the displacements and habitat preferences of lizards, derived from visual surveys and telemetry data. The influence of variables potentially determining lizard habitat preference (i.e., height, slope, four measures of habitat abundance and four measures of habitat fragmentation) was evaluated at three spatial scales: 'home-range' (c. 2.5-10*10(3) m(2); telemetry data), 'within home-range' (c. 100 m(2); telemetry data) and 'microhabitat' (<100 m(2); visual survey). Cumulative lizard displacement (from each telemetric location to the initial capture point) saturated before the peak of seed defecation (seed-retention time), indicating that lizard home-range size and habitat preferences were the main determinants of the spread and shape of seed shadows. Shrub cover was positively correlated with habitat preference at the three scales of analysis, whereas slope was negatively correlated at the home-range scale. Model scenarios indicated that spatially-aggregated seed rain emerged when we incorporated the joint effect of habitat preference at the two largest (home-range and within home-range) scales. We conclude that, in order to predict seed rain in animal dispersed plants, it is important to consider the multi-scale effects of habitat preference by frugivores.	[Rodriguez-Perez, Javier; Larrinaga, Asier R.; Santamaria, Luis] IMEDEA, Inst Mediterrani Estudis Avancats, Mallorca, Balearic Island, Spain; [Rodriguez-Perez, Javier] UFZ Helmholtz Ctr Environm Res, Dept Ecol Modeling, Leipzig, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Rodriguez-Perez, J (corresponding author), Univ Oviedo, Depto Biol Organismos & Sistemas, E-33071 Oviedo, Spain.	jvr.rodriguez@gmail.com	Javier Rodríguez-Pérez, Ph.D. Biology/C-9773-2009; Traveset, Anna V/D-7802-2011; Larrinaga, Asier/B-3826-2013; Santamaria, Luis/C-1438-2012	Javier Rodríguez-Pérez, Ph.D. Biology/0000-0002-1292-9090; Larrinaga, Asier/0000-0001-6813-8784; Santamaria, Luis/0000-0002-5072-2912	Direccion General de Investigacion Cientifica y Tecnica, Ministerio de Educacion y Ciencia [FP-2001-1819]; Natural Park of Dragonera (Govern Insular de Mallorca); EU [PIEF-GA-2009-237097]	Direccion General de Investigacion Cientifica y Tecnica, Ministerio de Educacion y Ciencia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Natural Park of Dragonera (Govern Insular de Mallorca); EU(European Commission)	JRP was supported by grant FP-2001-1819 (Direccion General de Investigacion Cientifica y Tecnica, Ministerio de Educacion y Ciencia), a research grant of the Natural Park of Dragonera (Govern Insular de Mallorca) and by a Marie Curie Intra European Fellowship (Grant Agreement Number PIEF-GA-2009-237097, EU 7th Framework Programme). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baskin C.C, 2001, SEEDS ECOLOGY BIOGEO; Borger L, 2008, ECOL LETT, V11, P637, DOI 10.1111/j.1461-0248.2008.01182.x; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Campos-Arceiz A, 2008, ECOLOGY, V89, P2684, DOI 10.1890/07-1573.1; CASTILLA AM, 1991, OECOLOGIA, V85, P366, DOI 10.1007/BF00320612; Cody ML, 2000, J VEG SCI, V11, P351, DOI 10.2307/3236627; Cooper WE, 2004, HERPETOLOGICA, V60, P321, DOI 10.1655/04-20; Cousens R, 2008, DISPERSAL IN PLANTS: A POPULATION PERSPECTIVE, P1; Cousens RD, 2010, FUNCT ECOL, V24, P1163, DOI 10.1111/j.1365-2435.2010.01747.x; Dennis AJ, 2007, ESTIMATING DISPERSAL, P201; Diaz JA, 2004, FUNCT ECOL, V18, P867, DOI 10.1111/j.0269-8463.2004.00916.x; Diego-Rasilla FJ, 2003, FOLIA ZOOL, V52, P87; Fragoso JMV, 1997, J ECOL, V85, P519, DOI 10.2307/2960574; Hastie T., 2009, UNSUPERVISED LEARNIN; HEWS DK, 1993, ANIM BEHAV, V46, P279, DOI 10.1006/anbe.1993.1189; Higgins SI, 2003, ECOLOGY, V84, P1945, DOI 10.1890/01-0616; Keitt TH, 2003, LANDSCAPES CHANGE; Koike S, 2011, OIKOS, V120, P280, DOI 10.1111/j.1600-0706.2010.18626.x; Manly B.F.J., 2002, RESOURCE SELECTION A; Mayor SJ, 2009, ECOSCIENCE, V16, P238, DOI 10.2980/16-2-3238; Murphy HT, 2008, BIOL INVASIONS, V10, P925, DOI 10.1007/s10530-008-9246-x; Nathan R, 2008, TRENDS ECOL EVOL, V23, P638, DOI 10.1016/j.tree.2008.08.003; Pysek P, 2005, ECOSCIENCE, V12, P302, DOI 10.2980/i1195-6860-12-3-302.1; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Development Core Team, 2009, R FDN STAT COMP; Revilla E, 2008, P NATL ACAD SCI USA, V105, P19120, DOI 10.1073/pnas.0801725105; Rodriguez-Perez J, 2005, FUNCT ECOL, V19, P699, DOI 10.1111/j.0269-8463.2005.00971.x; Rodriguez-Perez J, 2011, ECOGRAPHY IN PRESS; Russo SE, 2006, ECOLOGY, V87, P3160, DOI 10.1890/0012-9658(2006)87[3160:IABISD]2.0.CO;2; Russo SE, 2004, ECOL LETT, V7, P1058, DOI 10.1111/j.1461-0248.2004.00668.x; Saez Encarna, 1995, Herpetological Review, V26, P121; Santamaria L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001008; SAS Institute, 2000, SAS STAT SOFTW US GU; Scheers H, 2002, OECOLOGIA, V132, P323, DOI 10.1007/s00442-002-0970-0; Spiegel O, 2007, ECOL LETT, V10, P718, DOI 10.1111/j.1461-0248.2007.01062.x; Thuiller W, 2008, PERSPECT PLANT ECOL, V9, P137, DOI 10.1016/j.ppees.2007.09.004; Valcu M, 2010, OECOLOGIA, V162, P609, DOI 10.1007/s00442-009-1509-4; WALDSCHMIDT S, 1983, OECOLOGIA, V57, P1, DOI 10.1007/BF00379553; Wang BC, 2002, TRENDS ECOL EVOL, V17, P379, DOI 10.1016/S0169-5347(02)02541-7; Wenny DG, 2001, EVOL ECOL RES, V3, P51; Westcott DA, 2005, OECOLOGIA, V146, P57, DOI 10.1007/s00442-005-0178-1; Westcott DA, 2008, DIVERS DISTRIB, V14, P432, DOI 10.1111/j.1472-4642.2007.00416.x; Zug G. R., 2001, HERPETOLOGY, P57	43	22	24	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33246	10.1371/journal.pone.0033246	http://dx.doi.org/10.1371/journal.pone.0033246			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438902	Green Published, gold			2022-12-25	WOS:000303309100027
J	Zhao, ZG; Ni, YX; Chen, J; Zhong, J; Yu, H; Xu, XS; He, HB; Yan, ZC; Scholze, A; Liu, DY; Zhu, ZM; Tepel, M				Zhao, Zhigang; Ni, Yinxing; Chen, Jing; Zhong, Jian; Yu, Hao; Xu, Xingsen; He, Hongbo; Yan, Zhencheng; Scholze, Alexandra; Liu, Daoyan; Zhu, Zhiming; Tepel, Martin			Increased Migration of Monocytes in Essential Hypertension Is Associated with Increased Transient Receptor Potential Channel Canonical Type 3 Channels	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION PATHWAYS; PERIPHERAL-BLOOD MONOCYTES; SMOOTH-MUSCLE; CELL-MIGRATION; CHEMOTAXIS; CHEMOATTRACTANT; EXPRESSION; CALCIUM; ATHEROSCLEROSIS; NEUTROPHILS	Increased transient receptor potential canonical type 3 (TRPC3) channels have been observed in patients with essential hypertension. In the present study we tested the hypothesis that increased monocyte migration is associated with increased TRPC3 expression. Monocyte migration assay was performed in a microchemotaxis chamber using chemoattractants formylated peptide Met-Leu-Phe (fMLP) and tumor necrosis factor-alpha (TNF-alpha). Proteins were identified by immunoblotting and quantitative in-cell Western assay. The effects of TRP channel-inhibitor 2-aminoethoxydiphenylborane (2-APB) and small interfering RNA knockdown of TRPC3 were investigated. We observed an increased fMLP-induced migration of monocytes from hypertensive patients compared with normotensive control subjects (246+/-14% vs 151+/-10%). The TNF-alpha-induced migration of monocytes in patients with essential hypertension was also significantly increased compared to normotensive control subjects (221+/-20% vs 138+/-18%). In the presence of 2-APB or after siRNA knockdown of TRPC3 the fMLP-induced monocyte migration was significantly blocked. The fMLP-induced changes of cytosolic calcium were significantly increased in monocytes from hypertensive patients compared to normotensive control subjects. The fMLP-induced monocyte migration was significantly reduced in the presence of inhibitors of tyrosine kinase and phosphoinositide 3-kinase. We conclude that increased monocyte migration in patients with essential hypertension is associated with increased TRPC3 channels.	[Zhao, Zhigang; Ni, Yinxing; Chen, Jing; Zhong, Jian; Yu, Hao; Xu, Xingsen; He, Hongbo; Yan, Zhencheng; Liu, Daoyan; Zhu, Zhiming] Third Mil Med Univ, Chongqing Inst Hypertens, Daping Hosp, Dept Hypertens & Endocrinol,Ctr Hypertens & Metab, Chongqing, Peoples R China; [Scholze, Alexandra; Tepel, Martin] Charite, Dept Nephrol, Berlin, Germany; [Scholze, Alexandra; Tepel, Martin] Univ So Denmark, Inst Mol Med, Odense, Denmark	Army Medical University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Southern Denmark	Zhao, ZG (corresponding author), Third Mil Med Univ, Chongqing Inst Hypertens, Daping Hosp, Dept Hypertens & Endocrinol,Ctr Hypertens & Metab, Chongqing, Peoples R China.	ldy_liudaoyan@yahoo.com; zhuzm@yahoo.com	Tepel, Martin/GRS-9581-2022; Scholze, Alexandra/ABD-2442-2020	Scholze, Alexandra/0000-0002-3100-8692; Tepel, Martin/0000-0002-0086-0997	973 Program [2011CB503902, 2012CB517806]; Natural Science Foundation of China [30871058, 30900619]; Natural Science Foundation of Chongqing (CSTC) [2008BB5016]; Chinese Medical Association [07060700078]; Else-Kroner-Fresenius-Stiftung	973 Program(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Chongqing (CSTC)(Natural Science Foundation of ChongqingNatural Science Foundation Project of CQ CSTC); Chinese Medical Association; Else-Kroner-Fresenius-Stiftung	This study was funded by 973 Program (grant no. 2011CB503902 and 2012CB517806); Natural Science Foundation of China (grant no. 30871058 and 30900619); Natural Science Foundation of Chongqing (CSTC, 2008BB5016) and Chinese Medical Association Clinical Research Grant (no. 07060700078). This study was supported in part by Else-Kroner-Fresenius-Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bejarano I, 2007, MOL CELL BIOCHEM, V296, P77, DOI 10.1007/s11010-006-9301-9; Brechard S, 2008, CELL CALCIUM, V44, P492, DOI 10.1016/j.ceca.2008.03.002; Chen AY, 2010, AM J PHYSIOL-CELL PH, V299, pC1441, DOI 10.1152/ajpcell.00157.2010; Chen XP, 2010, J CELL MOL MED, V14, P2483, DOI 10.1111/j.1582-4934.2009.00890.x; Dietrich A, 2005, MOL CELL BIOL, V25, P6980, DOI 10.1128/MCB.25.16.6980-6989.2005; Dorffel Y, 1999, HYPERTENSION, V34, P113, DOI 10.1161/01.HYP.34.1.113; Dunzendorfer S, 2000, IMMUNOL LETT, V71, P5, DOI 10.1016/S0165-2478(99)00161-3; Dzau VJ, 2001, HYPERTENSION, V37, P1047, DOI 10.1161/01.HYP.37.4.1047; Fine JS, 2001, INFLAMMATION, V25, P61, DOI 10.1023/A:1007152903135; Gleissner CA, 2007, HYPERTENSION, V50, P276, DOI 10.1161/HYPERTENSIONAHA.107.089854; Gruen ML, 2007, AM J PHYSIOL-CELL PH, V293, pC1481, DOI 10.1152/ajpcell.00062.2007; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; HernandezPresa M, 1997, CIRCULATION, V95, P1532; Ishibashi M, 2004, CIRC RES, V94, P1203, DOI 10.1161/01.RES.0000126924.23467.A3; Kahler CM, 2001, INT IMMUNOPHARMACOL, V1, P1351, DOI 10.1016/S1567-5769(01)00067-4; Kim MK, 2008, FEBS LETT, V582, P3379, DOI 10.1016/j.febslet.2008.09.023; Li XH, 2010, ARTERIOSCL THROM VAS, V30, P582, DOI 10.1161/ATVBAHA.109.202044; Liu DY, 2007, AM J HYPERTENS, V20, P1111, DOI 10.1016/j.amjhyper.2007.04.004; Liu DY, 2006, J HYPERTENS, V24, P1105, DOI 10.1097/01.hjh.0000226201.73065.14; Liu DY, 2009, HYPERTENSION, V53, P70, DOI 10.1161/HYPERTENSIONAHA.108.116947; Liu XX, 2010, J NEUROSCI, V30, P4197, DOI 10.1523/JNEUROSCI.4187-09.2010; Ma HT, 2001, J BIOL CHEM, V276, P18888, DOI 10.1074/jbc.M100944200; Makino A, 2006, AM J PHYSIOL-CELL PH, V290, pC1633, DOI 10.1152/ajpcell.00576.2005; Marketou ME, 2010, J HUM HYPERTENS, V24, P306, DOI 10.1038/jhh.2009.95; Mosheimer BA, 2005, J CLIN ENDOCR METAB, V90, P2964, DOI 10.1210/jc.2004-1895; Mosheimer BA, 2004, ARTHRITIS RHEUM-US, V50, P2309, DOI 10.1002/art.20352; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Noma H, 2009, IMMUNOLOGY, V128, pe487, DOI 10.1111/j.1365-2567.2008.03012.x; Orie NN, 1999, EXP PHYSIOL, V84, P515; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Schilling T, 2009, J CELL PHYSIOL, V221, P325, DOI 10.1002/jcp.21857; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; SunderPlassmann G, 1996, IMMUNOL INVEST, V25, P49, DOI 10.3109/08820139609059290; Thilo F, 2008, ARCH BIOCHEM BIOPHYS, V471, P57, DOI 10.1016/j.abb.2007.12.006; Thilo F, 2009, J HYPERTENS, V27, P1217, DOI 10.1097/HJH.0b013e32832a5a9f; Wilkerson MK, 2006, AM J PHYSIOL-HEART C, V290, pH240, DOI 10.1152/ajpheart.01191.2004; Wu HZ, 2009, CIRCULATION, V119, P2708, DOI 10.1161/CIRCULATIONAHA.108.823740; Xi XP, 1999, ARTERIOSCL THROM VAS, V19, P73, DOI 10.1161/01.ATV.19.1.73; Yang D, 2000, J IMMUNOL, V165, P2694, DOI 10.4049/jimmunol.165.5.2694	39	26	28	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e32628	10.1371/journal.pone.0032628	http://dx.doi.org/10.1371/journal.pone.0032628			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438881	Green Submitted, Green Published, gold			2022-12-25	WOS:000303309100014
J	Aubry, C; Corr, SC; Wienerroither, S; Goulard, C; Jones, R; Jamieson, AM; Decker, T; O'Neill, LAJ; Dussurget, O; Cossart, P				Aubry, Camille; Corr, Sinead C.; Wienerroither, Sebastian; Goulard, Celine; Jones, Ruth; Jamieson, Amanda M.; Decker, Thomas; O'Neill, Luke A. J.; Dussurget, Olivier; Cossart, Pascale			Both TLR2 and TRIF Contribute to Interferon-beta Production during Listeria Infection	PLOS ONE			English	Article							N-ACETYLGLUCOSAMINE DEACETYLASE; INNATE IMMUNE SENSOR; I INTERFERON; STREPTOCOCCUS-PNEUMONIAE; MONOCYTOGENES INFECTION; INTRACELLULAR DNA; CYTOSOLIC DNA; RECOGNITION; PEPTIDOGLYCAN; RNA	Synthesis of interferon-beta (IFN-beta) is an innate response to cytoplasmic infection with bacterial pathogens. Our recent studies showed that Listeria monocytogenes limits immune detection and IFN-beta synthesis via deacetylation of its peptidoglycan, which renders the bacterium resistant to lysozyme degradation. Here, we examined signaling requirements for the massive IFN-beta production resulting from the infection of murine macrophages with a mutant strain of L. monocytogenes, Delta pgdA, which is unable to modify its peptidoglycan. We report the identification of unconventional signaling pathways to the IFN-beta gene, requiring TLR2 and bacterial internalization. Induction of IFN-beta was independent of the Mal/TIRAP adaptor protein but required TRIF and the transcription factors IRF3 and IRF7. These pathways were stimulated to a lesser degree by wild-type L. monocytogenes. They operated in both resident and inflammatory macrophages derived from the peritoneal cavity, but not in bone marrow-derived macrophages. The novelty of our findings thus lies in the first description of TLR2 and TRIF as two critical components leading to the induction of the IFN-beta gene and in uncovering that individual macrophage populations adopt different strategies to link pathogen recognition signals to IFN-beta gene expression.	[Aubry, Camille; Goulard, Celine; Dussurget, Olivier; Cossart, Pascale] Inst Pasteur, Unite Interact Bacteries Cellules, Paris, France; [Aubry, Camille; Goulard, Celine; Dussurget, Olivier; Cossart, Pascale] INSERM, U604, Paris, France; [Aubry, Camille; Dussurget, Olivier] Univ Paris Diderot, Paris, France; [Aubry, Camille; Goulard, Celine; Dussurget, Olivier; Cossart, Pascale] INRA, USC2020, Paris, France; [Corr, Sinead C.; Jones, Ruth; O'Neill, Luke A. J.] Trinity Coll Dublin, Sch Biochem & Immunol, Trinity Biomed Sci Inst, Dublin, Ireland; [Wienerroither, Sebastian; Jamieson, Amanda M.; Decker, Thomas] Univ Vienna, Max F Perutz Labs, Dept Genet Microbiol & Immunobiol, Vienna, Austria	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; INRAE; Trinity College Dublin; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Aubry, C (corresponding author), INRA MICALIS, Jouy En Josas, France.	olivier.dussurget@pasteur.fr; pascale.cossart@pasteur.fr	Jamieson, Amanda/U-7169-2019	Jamieson, Amanda/0000-0002-5781-9231; Dussurget, Olivier/0000-0001-9924-0837; Corr, Sinead/0000-0001-9930-5039; O'Neill, Luke/0000-0002-4333-2748	Institut Pasteur; Inserm; INRA; ERC [233348]; Fondation Pasteur-Weizmann; Fondation le Roch Les Mousquetaires; Science Foundation Ireland; Irish Research Council for Science, Engineering and Technology [RS/2005/190]; Austrian Research Foundation [SFB-28, P20522-B05]; Austrian Science Fund (FWF) [F 2803] Funding Source: researchfish	Institut Pasteur(European Commission); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); INRA; ERC(European Research Council (ERC)European Commission); Fondation Pasteur-Weizmann; Fondation le Roch Les Mousquetaires; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Irish Research Council for Science, Engineering and Technology(Irish Research Council for Science, Engineering and TechnologyCGIAR); Austrian Research Foundation(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Work in PC's laboratory received financial support from Institut Pasteur (http://www.pasteur.fr), Inserm (http://www.inserm.fr), INRA (http://www.inra.fr), ERC (Advanced Grant 233348, http://erc.europa.eu/), Fondation Pasteur-Weizmann and Fondation le Roch Les Mousquetaires (http://www.fondationleroch-lesmousquetaires.org/). PC is an international research scholar of the Howard Hughes Medical Institute (http://www.hhmi.org/). CA is a doctoral fellow of the Ministere de l'Enseignement Superieur et de la Recherche. Work in LO's laboratory was supported by Science Foundation Ireland (http://www.sfi.ie/) and the Irish Research Council for Science, Engineering and Technology (RS/2005/190, http://www.ircset.ie/). Work in TD's laboratory was funded by the Austrian Research Foundation (grants SFB-28 and P20522-B05, http://www.fwf.ac.at). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; ALFORD CE, 1991, J EXP MED, V174, P459, DOI 10.1084/jem.174.2.459; Barbalat R, 2009, NAT IMMUNOL, V10, P1200, DOI 10.1038/ni.1792; Boneca IG, 2007, P NATL ACAD SCI USA, V104, P997, DOI 10.1073/pnas.0609672104; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Charrel-Dennis M, 2008, CELL HOST MICROBE, V4, P543, DOI 10.1016/j.chom.2008.11.002; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Cole LE, 2010, J LEUKOCYTE BIOL, V87, P275, DOI 10.1189/jlb.0909619; Creagh EM, 2006, TRENDS IMMUNOL, V27, P352, DOI 10.1016/j.it.2006.06.003; Decker T, 2005, NAT REV IMMUNOL, V5, P675, DOI 10.1038/nri1684; Derbigny WA, 2010, J IMMUNOL, V185, P6689, DOI 10.4049/jimmunol.1001548; Dietrich N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010250; Hornung V, 2010, NAT REV IMMUNOL, V10, P123, DOI 10.1038/nri2690; Janot L, 2008, J INFECT DIS, V198, P115, DOI 10.1086/588815; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kenny EF, 2009, J IMMUNOL, V183, P3642, DOI 10.4049/jimmunol.0901140; Lauer P, 2002, J BACTERIOL, V184, P4177, DOI 10.1128/JB.184.15.4177-4186.2002; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; McCaffrey RL, 2004, P NATL ACAD SCI USA, V101, P11386, DOI 10.1073/pnas.0403215101; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; O'Connell RM, 2005, J IMMUNOL, V174, P1602, DOI 10.4049/jimmunol.174.3.1602; O'Neill LAJ, 2009, CELL, V138, P428, DOI 10.1016/j.cell.2009.07.021; O'Riordan M, 2002, P NATL ACAD SCI USA, V99, P13861, DOI 10.1073/pnas.202476699; Panne D, 2008, CURR OPIN STRUC BIOL, V18, P236, DOI 10.1016/j.sbi.2007.12.002; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Psylinakis E, 2005, J BIOL CHEM, V280, P30856, DOI 10.1074/jbc.M407426200; Rasmussen SB, 2009, APMIS, V117, P323, DOI 10.1111/j.1600-0463.2009.02456.x; Rehwinkel J, 2010, SCIENCE, V327, P284, DOI 10.1126/science.1185068; Rutz M, 2004, EUR J IMMUNOL, V34, P2541, DOI 10.1002/eji.200425218; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Stockinger S, 2004, J IMMUNOL, V173, P7416, DOI 10.4049/jimmunol.173.12.7416; Stockinger S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000355; Torres D, 2004, INFECT IMMUN, V72, P2131, DOI 10.1128/IAI.72.4.2131-2139.2004; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Vincent MJ, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-69; Vollmer W, 2000, J BIOL CHEM, V275, P20496, DOI 10.1074/jbc.M910189199; Vollmer W, 2002, INFECT IMMUN, V70, P7176, DOI 10.1128/IAI.70.12.7176-7178.2002; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P287, DOI 10.1111/j.1574-6976.2007.00088.x; Wang G, 2009, J BIOL CHEM, V284, P6790, DOI 10.1074/jbc.M808071200; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yang PY, 2010, NAT IMMUNOL, V11, P487, DOI 10.1038/ni.1876; Zhang ZQ, 2011, IMMUNITY, V34, P866, DOI 10.1016/j.immuni.2011.03.027; Zhong B, 2006, VIROLOGY, V352, P14, DOI 10.1016/j.virol.2006.04.029	44	47	47	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e33299	10.1371/journal.pone.0033299	http://dx.doi.org/10.1371/journal.pone.0033299			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22432012	gold, Green Published, Green Submitted			2022-12-25	WOS:000303198600055
J	Curnoe, D; Xueping, J; Herries, AIR; Bai, KN; Tacon, PSC; Zhende, B; Fink, D; Yunsheng, Z; Hellstrom, J; Yun, L; Cassis, G; Bing, S; Wroe, S; Shi, H; Parr, WCH; Shengmin, H; Rogers, N				Curnoe, Darren; Xueping, Ji; Herries, Andy I. R.; Kanning, Bai; Tacon, Paul S. C.; Zhende, Bao; Fink, David; Yunsheng, Zhu; Hellstrom, John; Yun, Luo; Cassis, Gerasimos; Bing, Su; Wroe, Stephen; Shi, Hong; Parr, William C. H.; Shengmin, Huang; Rogers, Natalie			Human Remains from the Pleistocene-Holocene Transition of Southwest China Suggest a Complex Evolutionary History for East Asians	PLOS ONE			English	Article							PESTERA CU OASE; HOMO-SAPIENS; HUMAN DISPERSALS; GENETIC HISTORY; SOUTHEAST-ASIA; CAVE; AFRICA; MIDDLE; AGE; NEANDERTHAL	Background: Later Pleistocene human evolution in East Asia remains poorly understood owing to a scarcity of well described, reliably classified and accurately dated fossils. Southwest China has been identified from genetic research as a hotspot of human diversity, containing ancient mtDNA and Y-DNA lineages, and has yielded a number of human remains thought to derive from Pleistocene deposits. We have prepared, reconstructed, described and dated a new partial skull from a consolidated sediment block collected in 1979 from the site of Longlin Cave (Guangxi Province). We also undertook new excavations at Maludong (Yunnan Province) to clarify the stratigraphy and dating of a large sample of mostly undescribed human remains from the site. Methodology/Principal Findings: We undertook a detailed comparison of cranial, including a virtual endocast for the Maludong calotte, mandibular and dental remains from these two localities. Both samples probably derive from the same population, exhibiting an unusual mixture of modern human traits, characters probably plesiomorphic for later Homo, and some unusual features. We dated charcoal with AMS radiocarbon dating and speleothem with the Uranium-series technique and the results show both samples to be from the Pleistocene-Holocene transition: similar to 14.3-11.5 ka. Conclusions/Significance: Our analysis suggests two plausible explanations for the morphology sampled at Longlin Cave and Maludong. First, it may represent a late-surviving archaic population, perhaps paralleling the situation seen in North Africa as indicated by remains from Dar-es-Soltane and Temara, and maybe also in southern China at Zhirendong. Alternatively, East Asia may have been colonised during multiple waves during the Pleistocene, with the Longlin-Maludong morphology possibly reflecting deep population substructure in Africa prior to modern humans dispersing into Eurasia.	[Curnoe, Darren; Cassis, Gerasimos; Wroe, Stephen; Parr, William C. H.; Rogers, Natalie] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Xueping, Ji] Yunnan Inst Cultural Relics & Archeol, Kunming, Yunnan, Peoples R China; [Xueping, Ji] Yunnan Univ, Archeol Res Ctr, Kunming, Yunnan, Peoples R China; [Herries, Andy I. R.] La Trobe Univ, Archaeomagnetism Lab, Archaeol Program, Sch Hist & European Studies, Melbourne, Vic, Australia; [Kanning, Bai; Yunsheng, Zhu] Honghe Prefectural Inst Cultural Rel, Mengzi, Yunnan, Peoples R China; [Tacon, Paul S. C.] Griffith Univ, Pl Evolut & Rock Art Heritage Unit, Sch Humanities, Southport, Qld 4215, Australia; [Zhende, Bao; Yun, Luo] Mengzi Inst Cultural Rel, Mengzi, Yunnan, Peoples R China; [Fink, David] Australian Nucl Sci & Technol Org, Inst Environm Res, Sydney, NSW, Australia; [Hellstrom, John] Univ Melbourne, Sch Earth Sci, Melbourne, Vic, Australia; [Bing, Su; Shi, Hong] Chinese Acad Sci, State Key Lab Genet Resources & Evolut, Kunming Inst Zool, Kunming, Peoples R China; [Bing, Su; Shi, Hong] Chinese Acad Sci, Kunming Primate Res Ctr, Kunming, Peoples R China; [Shengmin, Huang] Youjiang Nationalities Museum, Baise, Guangxi, Peoples R China	University of New South Wales Sydney; Yunnan University; La Trobe University; Griffith University; Australian Nuclear Science & Technology Organisation; University of Melbourne; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; Youjiang Medical University for Nationalities	Curnoe, D (corresponding author), Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia.	d.curnoe@unsw.edu.au; jxping@public.km.yn.cn	Wroe, Stephen/A-4462-2010; fink, David/A-9518-2012; Hellstrom, John C/B-1770-2008	Wroe, Stephen/0000-0002-5813-9182; Hellstrom, John C/0000-0001-9427-3525; Herries, Andy/0000-0002-2905-2002; Wroe, Stephen/0000-0002-6365-5915; Curnoe, Darren/0000-0001-8622-4141; Cassis, Gerasimos/0000-0003-0519-664X; Tacon, Paul/0000-0002-0280-4366	Australian Research Council	Australian Research Council(Australian Research Council)	This research was funded by the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Rached L, 2011, SCIENCE, V334, P89, DOI 10.1126/science.1209202; Bailey Shara E., 2002, Anatomical Record, V269, P148, DOI 10.1002/ar.10116; Barker G, 2007, J HUM EVOL, V52, P243, DOI 10.1016/j.jhevol.2006.08.011; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Bookstein F. L., 1997, MORPHOMETRIC TOOLS L; Brauer G., 2004, MISCELANEA HOMENAJE, VIII, P59; Burklein S, 2011, J ENDODONT, V37, P158, DOI 10.1016/j.joen.2010.10.010; Carbonell E, 2005, P NATL ACAD SCI USA, V102, P5674, DOI 10.1073/pnas.0501841102; Carson EA, 2006, AM J PHYS ANTHROPOL, V131, P169, DOI 10.1002/ajpa.20424; Cheng H, 2000, CHEM GEOL, V169, P17, DOI 10.1016/S0009-2541(99)00157-6; Clark PU, 2009, SCIENCE, V325, P710, DOI 10.1126/science.1172873; Coppens Y, 2008, CR PALEVOL, V7, P51, DOI 10.1016/j.crpv.2007.12.004; Crevecoeur I., 2004, ANTHROPOLOGIE, V42, P203; Crevecoeur I, 2009, AM J PHYS ANTHROPOL, V140, P347, DOI 10.1002/ajpa.21080; DARROCH JN, 1985, BIOMETRIKA, V72, P241, DOI 10.2307/2336077; Dennell R, 2010, NATURE, V468, P512, DOI 10.1038/468512a; Detroit F, 2004, CR PALEVOL, V3, P705, DOI 10.1016/j.crpv.2004.06.004; Dizon E, 2002, CURR ANTHROPOL, V43, P660, DOI 10.1086/342432; Dobson SD, 2002, J HUM EVOL, V43, P67, DOI 10.1006/jhev.2002.0563; Fink D, 2004, NUCL INSTRUM METH B, V223, P109, DOI 10.1016/j.nimb.2004.04.025; Grine FE, 2007, SCIENCE, V315, P226, DOI 10.1126/science.1136294; Grine FE, 1998, J HUM EVOL, V35, P95, DOI 10.1006/jhev.1998.0225; Gunz P, 2009, J HUM EVOL, V57, P48, DOI 10.1016/j.jhevol.2009.04.004; Gunz P, 2009, P NATL ACAD SCI USA, V106, P6094, DOI 10.1073/pnas.0808160106; Hans M.G., 2008, ESSENTIALS FACIAL GR; Harvati K, 2003, J HUM EVOL, V45, P465, DOI 10.1016/j.jhevol.2003.09.005; Harvati K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024024; Hellstrom J, 2003, J ANAL ATOM SPECTROM, V18, P1346, DOI 10.1039/b308781f; Hellstrom J, 2006, QUAT GEOCHRONOL, V1, P289, DOI 10.1016/j.quageo.2007.01.004; Herries AIR, 2010, J HUM EVOL, V59, P306, DOI 10.1016/j.jhevol.2010.07.012; Herries AIR, 2009, TERRA AUSTRALIS, V28, P235; Howells WW, 1996, AM J PHYS ANTHROPOL, V101, P441, DOI 10.1002/ajpa.1331010302; HOWELLS WW, 1989, PAPERS PEABODY MUSEU, V79; Hua Q, 2001, RADIOCARBON, V43, P275; Jacobs Z, 2011, J ARCHAEOL SCI, V38, P3631, DOI 10.1016/j.jas.2011.08.033; Kaifu Y, 2012, QUATERN INT, V248, P2, DOI 10.1016/j.quaint.2011.02.017; Kong QP, 2011, MOL BIOL EVOL, V28, P513, DOI 10.1093/molbev/msq219; Kupczik K, 2010, J HUM EVOL, V59, P525, DOI 10.1016/j.jhevol.2010.05.009; Lahr M. M, 1996, EVOLUTION MODERN HUM; Lam YM, 1998, AM J PHYS ANTHROPOL, V100, P545; Liu W, 2010, P NATL ACAD SCI USA, V107, P19201, DOI 10.1073/pnas.1014386107; Mavarez J, 2008, MOL ECOL, V17, P4181, DOI 10.1111/j.1365-294X.2008.03898.x; Millard AR, 2008, J HUM EVOL, V54, P848, DOI 10.1016/j.jhevol.2007.11.002; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Parr WCH, 2011, J THEOR BIOL, V272, P64, DOI 10.1016/j.jtbi.2010.11.030; Parr WCH, 2009, THESIS U LONDON; Rasmussen M, 2011, SCIENCE, V334, P94, DOI 10.1126/science.1211177; Reich D, 2011, AM J HUM GENET, V89, P516, DOI 10.1016/j.ajhg.2011.09.005; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Ruto A, 2009, THESIS U LONDON; Mijares AS, 2010, J HUM EVOL, V59, P123, DOI 10.1016/j.jhevol.2010.04.008; Schwartz JH, 2000, J HUM EVOL, V38, P367, DOI 10.1006/jhev.1999.0339; Shang H, 2007, P NATL ACAD SCI USA, V104, P6573, DOI 10.1073/pnas.0702169104; Sherwood RJ, 2008, J HUM EVOL, V54, P909, DOI 10.1016/j.jhevol.2008.02.009; Sjovold T., 1984, MULTIVARIATE STAT ME, P223, DOI DOI 10.1007/978-94-009-6357-3_14; SMITH FH, 1980, AM J PHYS ANTHROPOL, V53, P589, DOI 10.1002/ajpa.1330530414; SMITH FH, 1992, PHILOS T ROY SOC B, V337, P243, DOI 10.1098/rstb.1992.0102; Sokal R. R, 1981, BIOMETRY; Stoneking M, 2010, CURR BIOL, V20, pR188, DOI 10.1016/j.cub.2009.11.052; Stuiver M, 2005, CALIB 6 0 WWW PROGRA; Tattersall I, 2008, EVOL ANTHROPOL, V17, P49, DOI 10.1002/evan.20153; TOWNSEND GC, 1978, AM J PHYS ANTHROPOL, V49, P497, DOI 10.1002/ajpa.1330490409; Trinkaus E, 2005, ANNU REV ANTHROPOL, V34, P207, DOI 10.1146/annurev.anthro.34.030905.154913; Trinkaus E, 2003, J HUM EVOL, V45, P245, DOI 10.1016/j.jhevol.2003.08.003; Trinkaus E, 2008, AM J PHYS ANTHROPOL, V135, P371, DOI 10.1002/ajpa.20753; Trinkaus E, 2007, P NATL ACAD SCI USA, V104, P7367, DOI 10.1073/pnas.0702214104; Walden J., 1999, TECH GUIDE, V6; Weaver TD, 2007, J HUM EVOL, V53, P135, DOI 10.1016/j.jhevol.2007.03.001; Wu X.Z., 1995, HUMAN EVOLUTION CHIN; Zhang X, 1991, MAT HUMAN ORIGIN PRE, P234; Zhong H, 2011, MOL BIOL EVOL, V28, P717, DOI 10.1093/molbev/msq247	71	49	58	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e31918	10.1371/journal.pone.0031918	http://dx.doi.org/10.1371/journal.pone.0031918			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	931EO	22431968	Green Published, gold			2022-12-25	WOS:000303198600011
J	Funck-Brentano, T; Lin, H; Hay, E; Kioon, MDA; Schiltz, C; Hannouche, D; Nizard, R; Liote, F; Orcel, P; de Vernejoul, MC; Cohen-Solal, ME				Funck-Brentano, Thomas; Lin, Hilene; Hay, Eric; Kioon, Marie-Dominique Ah; Schiltz, Corinne; Hannouche, Didier; Nizard, Remy; Liote, Frederic; Orcel, Philippe; de Vernejoul, Marie-Christine; Cohen-Solal, Martine Esther			Targeting Bone Alleviates Osteoarthritis in Osteopenic Mice and Modulates Cartilage Catabolism	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; SUBCHONDRAL BONE; ARTICULAR-CARTILAGE; KNEE OSTEOARTHRITIS; GENE HAPLOTYPE; MURINE MODEL; II COLLAGEN; DEGRADATION; OSTEOPROTEGERIN; EXPRESSION	Objective: Subchondral bone modifications occur early in the development of osteoarthritis (OA). The level of bone resorption might impact cartilage remodeling. We therefore assessed the in vivo and in vitro effects of targeting bone resorption in OA and cartilage metabolism. Methods: OA was induced by meniscectomy (MNX) in ovariectomized osteopenic mice (OP) treated with estradiol (E2), pamidronate (PAM), or phosphate buffered saline (PBS) for 6 weeks. We assessed the subchondral bone and cartilage structure and the expression of cartilage matrix proteases. To assess the involvement of bone soluble factors in cartilage metabolism, supernatant of human bone explants pre-treated with E2 or PAM were transferred to cartilage explants to assess proteoglycan release and aggrecan cleavage. OPG/RANKL mRNA expression was assessed in bone explants by real-time quantitative PCR. The role of osteoprotegerin (OPG) in the bone-cartilage crosstalk was tested using an OPG neutralizing antibody. Results: Bone mineral density of OP mice and osteoclast number were restored by E2 and PAM (p<0.05). In OP mice, E2 and PAM decreased ADAMTS-4 and -5 expression, while only PAM markedly reduced OA compared to PBS (2.0+/-0.63 vs 5.2+/-0.95; p<0.05). OPG/RANKL mRNA was increased in human bone explants treated with both drugs (2.2-3.7-fold). Moreover, supernatants from bone explants cultured with E2 or PAM reduced aggrecan cleavage and cartilage proteoglycan release (73+/-8.0% and 80+/-22% of control, respectively, p<0.05). This effect was reversed with osteoprotegerin blockade. Conclusion: The inhibition of bone resorption by pamidronate in osteopenic mice alleviates the histological OA score with a reduction in the expression of aggrecanases. Bone soluble factors, such as osteoprotegerin, impact the cartilage response to catabolic factors. This study further highlights the importance of subchondral bone in the regulation of joint cartilage damage in OA.	[Funck-Brentano, Thomas; Lin, Hilene; Hay, Eric; Kioon, Marie-Dominique Ah; Schiltz, Corinne; Liote, Frederic; de Vernejoul, Marie-Christine; Cohen-Solal, Martine Esther] Hop Lariboisiere, Ctr Viggo Petersen, INSERM, U606, F-75475 Paris, France; [Funck-Brentano, Thomas; Lin, Hilene; Hay, Eric; Kioon, Marie-Dominique Ah; Schiltz, Corinne; Hannouche, Didier; Nizard, Remy; Liote, Frederic; Orcel, Philippe; de Vernejoul, Marie-Christine; Cohen-Solal, Martine Esther] Univ Paris 07, Hop Lariboisiere, Paris, France; [Hannouche, Didier; Nizard, Remy] Hop Lariboisiere, Ctr Viggo Petersen, Dept Orthoped, F-75475 Paris, France; [Orcel, Philippe] Hop Lariboisiere, Ctr Viggo Petersen, Dept Rheumatol, F-75475 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite	Funck-Brentano, T (corresponding author), Hop Lariboisiere, Ctr Viggo Petersen, INSERM, U606, F-75475 Paris, France.	martine.cohen-solal@inserm.fr	Nizard, Remy/R-5845-2019; Funck-Brentano, Thomas/AAS-7201-2020; Funck-Brentano, Thomas/Q-5736-2016; Liote, Frederic/AAD-6926-2020; Cohen-Solal, Martine/P-7808-2017	Funck-Brentano, Thomas/0000-0001-7684-2405; Funck-Brentano, Thomas/0000-0001-7684-2405; ORCEL, Philippe/0000-0001-7028-1133; Hay, Eric/0000-0002-0131-9983; Liote, Frederic/0000-0003-4419-0726; Ah Kioon, Marie Dominique/0000-0003-2319-0444; Hannouche, Didier/0000-0003-2060-2394; Cohen-Solal, Martine/0000-0002-8582-8258	INSERM; Societe Francaise de Rhumatologie; Fondation pour la Recherche Medicale	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Societe Francaise de Rhumatologie; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	TFB was supported by INSERM, "Societe Francaise de Rhumatologie" and "Fondation pour la Recherche Medicale". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellido M, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3103; Bergink AP, 2003, ARTHRITIS RHEUM, V48, P1913, DOI 10.1002/art.11046; Bobinac D, 2003, BONE, V32, P284, DOI 10.1016/S8756-3282(02)00982-1; Botter SM, 2011, ARTHRITIS RHEUM-US, V63, P2690, DOI 10.1002/art.30307; Byron CR, 2010, AM J VET RES, V71, P615, DOI 10.2460/ajvr.71.6.615; Calvo E, 2007, OSTEOARTHR CARTILAGE, V15, P69, DOI 10.1016/j.joca.2006.06.006; Cirillo DJ, 2006, ARTHRITIS RHEUM-US, V54, P3194, DOI 10.1002/art.22138; Claassen H, 2006, BONE, V39, P310, DOI 10.1016/j.bone.2006.02.067; Crema MD, 2010, RADIOLOGY, V256, P855, DOI 10.1148/radiol.10091467; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Funck-Brentano T, 2011, CYTOKINE GROWTH F R, V22, P91, DOI 10.1016/j.cytogfr.2011.04.003; Fytili P, 2005, CLIN GENET, V68, P268, DOI 10.1111/j.1399-0004.2005.00495.x; Glasson SS, 2010, OSTEOARTHR CARTILAGE, V18, pS17, DOI 10.1016/j.joca.2010.05.025; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; Hayami T, 2004, ARTHRITIS RHEUM-US, V50, P1193, DOI 10.1002/art.20124; Jiao K, 2011, BONE, V48, P362, DOI 10.1016/j.bone.2010.09.010; Jin SY, 2004, ARTHRITIS RES THER, V6, pR415, DOI 10.1186/ar1207; Kadri A, 2008, ARTHRITIS RHEUM-US, V58, P2379, DOI 10.1002/art.23638; Kadri A, 2010, ANN RHEUM DIS, V69, P1533, DOI 10.1136/ard.2009.124586; Lian K, 2007, OSTEOARTHR CARTILAGE, V15, P972, DOI 10.1016/j.joca.2007.02.020; Ma HL, 2007, OSTEOARTHR CARTILAGE, V15, P695, DOI 10.1016/j.joca.2006.11.005; Moreno-Rubio J, 2010, ARTHRITIS RHEUM-US, V62, P478, DOI 10.1002/art.27204; Oestergaard S, 2006, ARTHRITIS RHEUM-US, V54, P2441, DOI 10.1002/art.22009; Pelletier JP, 2004, BONE, V34, P527, DOI 10.1016/j.bone.2003.11.021; RADIN EL, 1986, CLIN ORTHOP RELAT R, P34; RADIN EL, 1973, J BIOMECH, V6, P51, DOI 10.1016/0021-9290(73)90037-7; Richette P, 2007, ANN RHEUM DIS, V66, P345, DOI 10.1136/ard.2006.059550; Richmond RS, 2000, ARTHRITIS RHEUM, V43, P2081, DOI 10.1002/1529-0131(200009)43:9<2081::AID-ANR20>3.0.CO;2-I; Riggs BL, 2000, J CLIN INVEST, V106, P1203, DOI 10.1172/JCI11468; Roemer FW, 2009, ANN RHEUM DIS, V68, P1461, DOI 10.1136/ard.2008.096834; Roman-Blas JA, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2791; Shimizu S, 2007, ARTHRITIS RHEUM-US, V56, P3358, DOI 10.1002/art.22941; Sniekers YH, 2008, OSTEOARTHR CARTILAGE, V16, P533, DOI 10.1016/j.joca.2008.01.002; Sniekers YH, 2009, OSTEOARTHR CARTILAGE, V17, P1356, DOI 10.1016/j.joca.2009.04.008; Stanton H, 2005, NATURE, V434, P648, DOI 10.1038/nature03417; Tat SK, 2009, RHEUMATOLOGY, V48, P1482, DOI 10.1093/rheumatology/kep300; Tortorella MD, 2001, OSTEOARTHR CARTILAGE, V9, P539, DOI 10.1053/joca.2001.0427; Ushiyama T, 1999, OSTEOARTHR CARTILAGE, V7, P560, DOI 10.1053/joca.1999.0260	38	42	47	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e33543	10.1371/journal.pone.0033543	http://dx.doi.org/10.1371/journal.pone.0033543			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22432033	Green Submitted, Green Published, gold			2022-12-25	WOS:000303198600076
J	Shao, ZQ; Zhang, YM; Feng, XY; Wang, B; Chen, JQ				Shao, Zhu-Qing; Zhang, Yan-Mei; Feng, Xue-Ying; Wang, Bin; Chen, Jian-Qun			Synonymous Codon Ordering: A Subtle but Prevalent Strategy of Bacteria to Improve Translational Efficiency	PLOS ONE			English	Article							AMINOACYL-TRANSFER-RNA; ESCHERICHIA-COLI; GENE-EXPRESSION; USAGE BIAS; URIDINE-5-OXYACETIC ACID; MAMMALIAN TRANSLATION; INDIVIDUAL CODONS; SELECTION; GENOME; ANTICODON	Background: In yeast coding sequences, once a particular codon has been used, subsequent occurrence of the same amino acid tends to use codons sharing the same tRNA. Such a phenomenon of co-tRNA codons pairing bias (CTCPB) is also found in some other eukaryotes but it is not known whether it occurs in prokaryotes. Methodology/Principal Findings: In this study, we focused on a total of 773 bacterial genomes to investigate their synonymous codon pairing preferences. After calculating the actual frequencies of synonymous codon pairs and comparing them with their expected values, we detected an obvious pairing bias towards identical codon pairs. This seems consistent with the previously reported CTCPB phenomenon, since identical codons are certainly read by the same tRNA. However, among co-tRNA but non-identical codon pairs, only 22 were often found overrepresented, suggesting that many co-tRNA codons actually do not preferentially pair together in prokaryotes. Therefore, the previously reported co-tRNA codons pairing rule needs to be more rigorously defined. The affinity differences between a tRNA anticodon and its readable codons should be taken into account. Moreover, both within-gene-shuffling tests and phylogenetic analyses support the idea that translational selection played an important role in shaping the observed synonymous codon pairing pattern in prokaryotes. Conclusions: Overall, a high level of synonymous codon pairing bias was detected in 73% investigated bacterial species, suggesting the synonymous codon ordering strategy has been prevalently adopted by prokaryotes to improve their translational efficiencies. The findings in this study also provide important clues to better understand the complex dynamics of translational process.	[Shao, Zhu-Qing; Zhang, Yan-Mei; Feng, Xue-Ying; Wang, Bin; Chen, Jian-Qun] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China	Nanjing University	Shao, ZQ (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China.	binwang@nju.edu.cn; chenjq@nju.edu.cn		Shao, Zhu-Qing/0000-0002-0431-0669	National Natural Science Foundation of China [30870176, 30930008, 31000105]; National Postdoctoral Science Foundation of China [20090461092, 201003570]; Nanjing University; Postgraduate Students Innovation Project of Jiangsu Province [CXZZ11_0038]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation); Nanjing University(Nanjing University); Postgraduate Students Innovation Project of Jiangsu Province	This work was supported by the National Natural Science Foundation of China (30870176, 30930008) to JQC, National Postdoctoral Science Foundation of China (20090461092, 201003570), National Natural Science Foundation of China (31000105), and Nanjing University Start Grant to BW, and the Postgraduate Students Innovation Project of Jiangsu Province (CXZZ11_0038) to ZQS. http://www.nsfc.gov.cn/Portal0/default152.htm; http://www.chinapostdoctor.org.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agris PF, 2007, J MOL BIOL, V366, P1, DOI 10.1016/j.jmb.2006.11.046; BONEKAMP F, 1989, J BACTERIOL, V171, P5812, DOI 10.1128/jb.171.11.5812-5816.1989; Cannarrozzi G, 2010, CELL, V141, P355, DOI 10.1016/j.cell.2010.02.036; Coleman JR, 2008, SCIENCE, V320, P1784, DOI 10.1126/science.1155761; CURRAN JF, 1989, J MOL BIOL, V209, P65, DOI 10.1016/0022-2836(89)90170-8; dos Reis M, 2003, NUCLEIC ACIDS RES, V31, P6976, DOI 10.1093/nar/gkg897; Duret L, 2000, TRENDS GENET, V16, P287, DOI 10.1016/S0168-9525(00)02041-2; Gabriel K, 1996, SCIENCE, V271, P195, DOI 10.1126/science.271.5246.195; Gaucher EA, 2001, P NATL ACAD SCI USA, V98, P548, DOI 10.1073/pnas.98.2.548; GRANTHAM R, 1981, NUCLEIC ACIDS RES, V9, pR43; GRANTHAM R, 1980, NUCLEIC ACIDS RES, V8, pR49, DOI 10.1093/nar/8.1.197-c; Grosjean H, 2010, FEBS LETT, V584, P252, DOI 10.1016/j.febslet.2009.11.052; Gu WJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000664; GUTMAN GA, 1989, P NATL ACAD SCI USA, V86, P3699, DOI 10.1073/pnas.86.10.3699; HALL MN, 1982, NATURE, V295, P616, DOI 10.1038/295616a0; IKEMURA T, 1981, J MOL BIOL, V151, P389, DOI 10.1016/0022-2836(81)90003-6; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; IRVIN JD, 1972, BIOCHEMISTRY-US, V11, P1915, DOI 10.1021/bi00760a028; IRWIN B, 1995, J BIOL CHEM, V270, P22801, DOI 10.1074/jbc.270.39.22801; KOLASKAR AS, 1986, J BIOMOL STRUCT DYN, V3, P725, DOI 10.1080/07391102.1986.10508458; Kothe U, 2007, MOL CELL, V25, P167, DOI 10.1016/j.molcel.2006.11.014; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Kyriacou SV, 2008, MOL CELL, V29, P419, DOI 10.1016/j.molcel.2007.11.038; Marck C, 2002, RNA, V8, P1189, DOI 10.1017/S1355838202022021; Merhej V, 2011, BIOL REV, V86, P379, DOI 10.1111/j.1469-185X.2010.00151.x; Monot M, 2009, NAT GENET, V41, P1282, DOI 10.1038/ng.477; Moukadiri I, 2009, NUCLEIC ACIDS RES, V37, P7177, DOI 10.1093/nar/gkp762; Moura G, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r28; MURAO K, 1970, BIOCHEM BIOPH RES CO, V38, P657, DOI 10.1016/0006-291X(70)90631-5; Nasvall SJ, 2007, RNA, V13, P2151, DOI 10.1261/rna.731007; Nasvall SJ, 2004, RNA, V10, P1662, DOI 10.1261/rna.7106404; NEGRUTSKII BS, 1991, P NATL ACAD SCI USA, V88, P4991, DOI 10.1073/pnas.88.11.4991; Nishimura S, 2006, J BIOSCIENCES, V31, P465, DOI 10.1007/BF02705186; OHASHI Z, 1970, BIOCHEM BIOPH RES CO, V40, P866, DOI 10.1016/0006-291X(70)90983-6; Percudani R, 1997, J MOL BIOL, V268, P322, DOI 10.1006/jmbi.1997.0942; Petrushenko ZM, 2002, EUR J BIOCHEM, V269, P4811, DOI 10.1046/j.1432-1033.2002.03178.x; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Ran WQ, 2010, MOL BIOL EVOL, V27, P2129, DOI 10.1093/molbev/msq102; Rocha EPC, 2004, GENOME RES, V14, P2279, DOI 10.1101/gr.2896904; SHARP PM, 1988, NUCLEIC ACIDS RES, V16, P8207, DOI 10.1093/nar/16.17.8207; SHARP PM, 1986, NUCLEIC ACIDS RES, V14, P7737, DOI 10.1093/nar/14.19.7737; Sorensen MA, 2005, J MOL BIOL, V354, P16, DOI 10.1016/j.jmb.2005.08.076; SORENSEN MA, 1991, J MOL BIOL, V222, P265, DOI 10.1016/0022-2836(91)90211-N; STAPULIONIS R, 1995, P NATL ACAD SCI USA, V92, P7158, DOI 10.1073/pnas.92.16.7158; Takai K, 1996, NUCLEIC ACIDS RES, V24, P2894, DOI 10.1093/nar/24.15.2894; Tuller T, 2010, CELL, V141, P344, DOI 10.1016/j.cell.2010.03.031; Tuller T, 2010, P NATL ACAD SCI USA, V107, P3645, DOI 10.1073/pnas.0909910107; Vieira-Silva S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000808; Vishnoi A, 2010, GENOME RES, V20, P1574, DOI 10.1101/gr.109595.110; Wang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022714; Welch M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007002; Zhang FL, 2010, SCIENCE, V329, P1534, DOI 10.1126/science.1191701	52	23	27	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e33547	10.1371/journal.pone.0033547	http://dx.doi.org/10.1371/journal.pone.0033547			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22432034	Green Submitted, Green Published, gold			2022-12-25	WOS:000303198600077
J	Ugajin, A; Kiya, T; Kunieda, T; Ono, M; Yoshida, T; Kubo, T				Ugajin, Atsushi; Kiya, Taketoshi; Kunieda, Takekazu; Ono, Masato; Yoshida, Tadaharu; Kubo, Takeo			Detection of Neural Activity in the Brains of Japanese Honeybee Workers during the Formation of a "Hot Defensive Bee Ball"	PLOS ONE			English	Article							IMMEDIATE-EARLY GENE; LONG-TERM-MEMORY; MUSHROOM BODIES; TEMPERATURE PREFERENCE; FEEDBACK NEURONS; APIS-MELLIFERA; DROSOPHILA; BODY; COCKROACH; PAINLESS	Anti-predator behaviors are essential to survival for most animals. The neural bases of such behaviors, however, remain largely unknown. Although honeybees commonly use their stingers to counterattack predators, the Japanese honeybee (Apis cerana japonica) uses a different strategy to fight against the giant hornet (Vespa mandarinia japonica). Instead of stinging the hornet, Japanese honeybees form a "hot defensive bee ball" by surrounding the hornet en masse, killing it with heat. The European honeybee (A. mellifera ligustica), on the other hand, does not exhibit this behavior, and their colonies are often destroyed by a hornet attack. In the present study, we attempted to analyze the neural basis of this behavior by mapping the active brain regions of Japanese honeybee workers during the formation of a hot defensive bee ball. First, we identified an A. cerana homolog Acks = Apis cerana kakusei of kakusei, an immediate early gene that we previously identified from A. mellifera, and showed that Acks has characteristics similar to kakusei and can be used to visualize active brain regions in A. cerana. Using Acks as a neural activity marker, we demonstrated that neural activity in the mushroom bodies, especially in Class II Kenyon cells, one subtype of mushroom body intrinsic neurons, and a restricted area between the dorsal lobes and the optic lobes was increased in the brains of Japanese honeybee workers involved in the formation of a hot defensive bee ball. In addition, workers exposed to 46 degrees C heat also exhibited Acks expression patterns similar to those observed in the brains of workers involved in the formation of a hot defensive bee ball, suggesting that the neural activity observed in the brains of workers involved in the hot defensive bee ball mainly reflects thermal stimuli processing.	[Ugajin, Atsushi; Kunieda, Takekazu; Kubo, Takeo] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 113, Japan; [Kiya, Taketoshi] Kanazawa Univ, Grad Sch Nat Sci & Technol, Div Life Sci, Kanazawa, Ishikawa 9201192, Japan; [Ono, Masato] Tamagawa Univ, Grad Sch Agr, Lab Appl Entomol & Zool, Machida, Tokyo, Japan; [Yoshida, Tadaharu] Tamagawa Univ, Honeybee Sci Res Ctr, Machida, Tokyo, Japan	University of Tokyo; Kanazawa University	Ugajin, A (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 113, Japan.	ono@agr.tamagawa.ac.jp; stkubo@biol.s.u-tokyo.ac.jp	Kunieda, Takekazu/G-4946-2014; Kiya, Taketoshi/ABE-6519-2020; KUBO, TAKEO/G-4951-2014; Kiya, Taketoshi/J-9032-2015	Kiya, Taketoshi/0000-0002-5709-8016; Ugajin, Atsushi/0000-0003-1834-3565; Kubo, Takeo/0000-0002-5914-5269; Kunieda, Takekazu/0000-0002-6256-1335	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Grants-in-Aid for Scientific Research [24780047] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Grant-in-Aid for Scientific Research (B) and Grant-in-Aid for Scientific Research on Innovative Areas "Systems Molecular Ethology" from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Akalal DBG, 2010, J NEUROSCI, V30, P16699, DOI 10.1523/JNEUROSCI.1882-10.2010; Blum AL, 2009, CURR BIOL, V19, P1341, DOI 10.1016/j.cub.2009.07.016; Fahrbach SE, 2006, ANNU REV ENTOMOL, V51, P209, DOI 10.1146/annurev.ento.51.110104.150954; Free J. B., 1987, PHEROMONES SOCIAL BE; Gallio M, 2011, CELL, V144, P614, DOI 10.1016/j.cell.2011.01.028; Ganeshina O, 2001, J COMP NEUROL, V437, P335, DOI 10.1002/cne.1287; Grunewald B, 1999, J COMP NEUROL, V404, P114; Grunewald B, 1999, J COMP PHYSIOL A, V185, P565, DOI 10.1007/s003590050417; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Hong ST, 2008, NATURE, V454, P771, DOI 10.1038/nature07090; Horita H, 2010, J COMP NEUROL, V518, P2873, DOI 10.1002/cne.22370; JANSSEN R, 1992, NEUROSCI BIOBEHAV R, V16, P399, DOI 10.1016/S0149-7634(05)80209-X; Kavaliers M, 2001, NEUROSCI BIOBEHAV R, V25, P577, DOI 10.1016/S0149-7634(01)00042-2; Kawakita A, 2008, APIDOLOGIE, V39, P163, DOI 10.1051/apido:2007046; Kawazoe Y, 1999, FEBS LETT, V455, P271, DOI 10.1016/S0014-5793(99)00900-X; Kiya T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000371; Kiya T, 2008, INSECT MOL BIOL, V17, P531, DOI 10.1111/j.1365-2583.2008.00821.x; Kiya T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008833; Kohno K, 2010, J NEUROSCI, V30, P12219, DOI 10.1523/JNEUROSCI.2001-10.2010; Kovacs KJ, 2008, J NEUROENDOCRINOL, V20, P665, DOI 10.1111/j.1365-2826.2008.01734.x; Kubik S, 2007, LEARN MEMORY, V14, P758, DOI 10.1101/lm.698107; Lee Y, 2005, NAT GENET, V37, P305, DOI 10.1038/ng1513; Li YS, 1999, J COMP NEUROL, V409, P647, DOI 10.1002/(SICI)1096-9861(19990712)409:4<647::AID-CNE9>3.0.CO;2-3; Li YS, 1997, J COMP NEUROL, V387, P631; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Lozano VC, 2001, J COMP PHYSIOL A, V187, P249, DOI 10.1007/s003590100196; MATSUURA M, 1988, APPL ENTOMOL ZOOL, V23, P428, DOI 10.1303/aez.23.428; Menzel R, 2001, LEARN MEMORY, V8, P53, DOI 10.1101/lm.38801; Mizunami M, 1998, J COMP NEUROL, V402, P501; MOBBS PG, 1982, PHILOS T ROY SOC B, V298, P309, DOI 10.1098/rstb.1982.0086; OKADA ICHIJI, 1961, BULL FAC AGRIC TAMAGAWA UNIV, V2, P73; ONO M, 1995, NATURE, V377, P334, DOI 10.1038/377334a0; Pascual A, 2001, SCIENCE, V294, P1115, DOI 10.1126/science.1064200; Ratcliffe JM, 2008, NATURE, V455, P96, DOI 10.1038/nature07087; Rosenzweig M, 2005, GENE DEV, V19, P419, DOI 10.1101/gad.1278205; Rosenzweig M, 2008, P NATL ACAD SCI USA, V105, P14668, DOI 10.1073/pnas.0805041105; Rundus AS, 2007, P NATL ACAD SCI USA, V104, P14372, DOI 10.1073/pnas.0702599104; RYBAK J, 1993, J COMP NEUROL, V334, P444, DOI 10.1002/cne.903340309; Sakata S, 2002, EUR J NEUROSCI, V15, P735, DOI 10.1046/j.1460-9568.2002.01905.x; Sokabe T, 2008, J NEUROSCI, V28, P9929, DOI 10.1523/JNEUROSCI.2757-08.2008; Strausfeld NJ, 2002, J COMP NEUROL, V450, P4, DOI 10.1002/cne.10285; Sugahara M, 2009, NATURWISSENSCHAFTEN, V96, P1133, DOI 10.1007/s00114-009-0575-0; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Viswanath V, 2003, NATURE, V423, P822, DOI 10.1038/423822a; Warzecha AK, 1999, J EXP BIOL, V202, P3161; Winston M., 1987, The biology of the honey bee.; Xu SY, 2006, GENES BRAIN BEHAV, V5, P602, DOI 10.1111/j.1601-183X.2006.00213.x; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672	49	25	26	3	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e32902	10.1371/journal.pone.0032902	http://dx.doi.org/10.1371/journal.pone.0032902			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22431987	Green Published, gold, Green Submitted			2022-12-25	WOS:000303198600030
J	Collins, CM; Speck, SH				Collins, Christopher M.; Speck, Samuel H.			Tracking Murine Gammaherpesvirus 68 Infection of Germinal Center B Cells In Vivo	PLOS ONE			English	Article							FLUORESCENT PROTEIN; STEM-CELLS; LATENCY; ESTABLISHMENT; PATHOGENESIS; MOUSE; HOST; MICE	Infection of mice with murine gammaherpesvirus 68 (MHV68) provides a tractable small animal model to study various aspects of persistent gammaherpesvirus infection. We have previously utilized a transgenic MHV68 that expresses enhanced yellow fluorescent protein (EYFP) to identify infected cells. While this recombinant MHV68 has been useful for identifying infected cell populations by flow cytometry, it has been suboptimal for identification of infected cells in tissue sections due to the high solubility of EYFP. Efficient detection of EYFP expressed from the MHV68 genome in tissue sections requires fixation of whole organs prior to sectioning, which frequently leads to over-fixation of some cellular antigens precluding their detection. To circumvent this issue, we describe the generation and characterization of a transgenic MHV68 harboring a fusion gene composed of the EYFP coding sequence fused to the histone H2B open reading frame. Because the H2bYFP fusion protein is tightly bound in nucleosomes in the nucleus it does not freely diffuse out of unfixed tissue sections, and thus eliminates the need for tissue fixation. We have used the MHV68-H2bYFP recombinant virus to assess the location and distribution of virus infected B cells in germinal centers during the peak of MHV68 latency in vivo. These analyses show that the physical location of distinct populations of infected germinal center B cells correlates well with their surface phenotype. Furthermore, analysis of the distribution of virus infection within germinal center B cell populations revealed that ca. 70% of MHV68 infected GC B cells are rapidly dividing centroblasts, while ca. 20% have a clear centrocyte phenotype. Finally, we have shown that marking of infected cells with MHV68-H2bYFP is extended long after the onset of latency - which should facilitate studies to track MHV68 latently infected cells at late times post-infection.	[Collins, Christopher M.; Speck, Samuel H.] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Collins, Christopher M.; Speck, Samuel H.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA	Emory University; Emory University	Speck, SH (corresponding author), Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA.	sspeck@emory.edu	Speck, Samuel/L-5893-2019		National Institutes of Health (NIH) [R01 CA095318, CA52004, CA087650, CA095318, AI05057, AI073830]; NATIONAL CANCER INSTITUTE [R01CA095318, R01CA087650, R01CA052004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI005057, R01AI058057, R01AI073830] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by National Institutes of Health (NIH) grant R01 CA095318. SHS was supported by NIH R01 grants CA52004, CA087650, CA095318, AI05057, and AI073830. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton E, 2011, ANNU REV IMMUNOL, V29, P351, DOI 10.1146/annurev-immunol-072710-081639; Bowden RJ, 1997, J GEN VIROL, V78, P1675, DOI 10.1099/0022-1317-78-7-1675; Clambey ET, 2000, J VIROL, V74, P1973, DOI 10.1128/JVI.74.4.1973-1984.2000; Collins CM, 2009, J VIROL, V83, P6484, DOI 10.1128/JVI.00297-09; Dauner JG, 2009, J IMMUNOL METHODS, V340, P116, DOI 10.1016/j.jim.2008.10.010; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Fraser ST, 2005, GENESIS, V42, P162, DOI 10.1002/gene.20139; Gierasch WW, 2006, J VIROL METHODS, V135, P197, DOI 10.1016/j.jviromet.2006.03.014; Hughes DJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001321; Hughes DJ, 2010, J GEN VIROL, V91, P867, DOI 10.1099/vir.0.017327-0; Hughes DJ, 2010, J VIROL, V84, P3949, DOI 10.1128/JVI.02085-09; Krug LT, 2009, J VIROL, V83, P4732, DOI 10.1128/JVI.00111-09; Liang XZ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002220; Liang XZ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000677; Marques S, 2003, J VIROL, V77, P7308, DOI 10.1128/JVI.77.13.7308-7318.2003; Moser JM, 2005, J VIROL, V79, P9480, DOI 10.1128/JVI.79.15.9480-9491.2005; Nutt SL, 2011, NAT IMMUNOL, V12, P472, DOI 10.1038/ni.2019; Richner JM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002150; Schaniel C, 2009, ANN NY ACAD SCI, V1176, P26, DOI 10.1111/j.1749-6632.2009.04608.x; Schwickert TA, 2009, J EXP MED, V206, P2907, DOI 10.1084/jem.20091225; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Virgin HW, 1999, J VIROL, V73, P2321, DOI 10.1128/JVI.73.3.2321-2332.1999; Virgin HW, 1997, J VIROL, V71, P5894, DOI 10.1128/JVI.71.8.5894-5904.1997; Weck KE, 1996, J VIROL, V70, P6775, DOI 10.1128/JVI.70.10.6775-6780.1996; Weck KE, 1999, J VIROL, V73, P4651, DOI 10.1128/JVI.73.6.4651-4661.1999; Weck KE, 1999, J VIROL, V73, P3273, DOI 10.1128/JVI.73.4.3273-3283.1999; Willer DO, 2003, J VIROL, V77, P8310, DOI 10.1128/JVI.77.15.8310-8321.2003	27	52	52	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2012	7	3							e33230	10.1371/journal.pone.0033230	http://dx.doi.org/10.1371/journal.pone.0033230			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930IA	22427999	gold, Green Published, Green Submitted			2022-12-25	WOS:000303129700042
J	Ignatev, A; Bhargav, SP; Vahokoski, J; Kursula, P; Kursula, I				Ignatev, Alexander; Bhargav, Saligram Prabhakar; Vahokoski, Juha; Kursula, Petri; Kursula, Inari			The Lasso Segment Is Required for Functional Dimerization of the Plasmodium Formin 1 FH2 Domain	PLOS ONE			English	Article							SECONDARY STRUCTURE; HIGH-RESOLUTION; CRYSTAL-STRUCTURES; STRUCTURAL BASIS; ACTIN; PROTEIN; PROFILIN; NUCLEATION; MECHANISM; COMPLEX	Apicomplexan parasites, such as the malaria-causing Plasmodium species, utilize a unique way of locomotion and host cell invasion. This substrate-dependent gliding motility requires rapid cycling of actin between the monomeric state and very short, unbranched filaments. Despite the crucial role of actin polymerization for the survival of the malaria parasite, the majority of Plasmodium cellular actin is present in the monomeric form. Plasmodium lacks most of the canonical actin nucleators, and formins are essentially the only candidates for this function in all Apicomplexa. The malaria parasite has two formins, containing conserved formin homology (FH) 2 and rudimentary FH1 domains. Here, we show that Plasmodium falciparum formin 1 associates with and nucleates both mammalian and Plasmodium actin filaments. Although Plasmodium profilin alone sequesters actin monomers, thus inhibiting polymerization, its monomer-sequestering activity does not compete with the nucleating activity of formin 1 at an equimolar profilin-actin ratio. We have determined solution structures of P. falciparum formin 1 FH2 domain both in the presence and absence of the lasso segment and the FH1 domain, and show that the lasso is required for the assembly of functional dimers.	[Ignatev, Alexander; Bhargav, Saligram Prabhakar; Vahokoski, Juha; Kursula, Petri; Kursula, Inari] Univ Oulu, Dept Biochem, Oulu, Finland; [Kursula, Petri] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Kursula, Petri; Kursula, Inari] Univ Hamburg, Dept Chem, Ctr Struct Syst Biol, Helmholtz Ctr Infect Res, Hamburg, Germany; [Kursula, Petri; Kursula, Inari] German Elect Synchrotron DESY, Hamburg, Germany	Finland National Institute for Health & Welfare; University of Oulu; University of Oulu; Helmholtz Association; Helmholtz-Center for Infection Research; University of Hamburg; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY)	Ignatev, A (corresponding author), Univ Oulu, Dept Biochem, Oulu, Finland.	inari.kursula@helmholtz-hzi.de	Kursula, Petri/AAF-4563-2020; Kursula, Petri/K-1058-2012; Kursula, Inari/AHB-9980-2022; Kursula, Inari/F-7140-2013	Kursula, Petri/0000-0001-8529-3751; Kursula, Petri/0000-0001-8529-3751; Kursula, Inari/0000-0001-5236-7056; Kursula, Inari/0000-0001-5236-7056	European Community [226716]; Academy of Finland; European Commission; International Incoming Fellowship; Centre for International Mobility; Sigrid Juselius Foundation; City of Hamburg Research and Science Foundation; German Federal Ministry of Education and Research; Finnish Cultural Foundation	European Community(European Commission); Academy of Finland(Academy of Finland); European Commission(European CommissionEuropean Commission Joint Research Centre); International Incoming Fellowship; Centre for International Mobility; Sigrid Juselius Foundation(Sigrid Juselius Foundation); City of Hamburg Research and Science Foundation; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science)	Synchrotron data collection was supported by the European Community (FP7/2007-2013) under grant agreement no 226716 (MAX-Lab). In addition, this work has been financially supported by the Academy of Finland (I.K., P.K.), the European Commission FP7 Marie Curie European Reintegration (I.K.) and International Incoming Fellowship (A.I.) programs, the Centre for International Mobility and the Finnish Cultural Foundation (S.P.B.), the Sigrid Juselius Foundation (I.K., P.K.), the City of Hamburg Research and Science Foundation (P.K.), and the German Federal Ministry of Education and Research (I.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barko S, 2010, J BIOL CHEM, V285, P13154, DOI 10.1074/jbc.M109.093914; Baum J, 2008, CELL HOST MICROBE, V3, P188, DOI 10.1016/j.chom.2008.02.006; Bergman LW, 2003, J CELL SCI, V116, P39, DOI 10.1242/jcs.00194; Bieniossek Christoph, 2008, Curr Protoc Protein Sci, VChapter 5, DOI 10.1002/0471140864.ps0520s51; Bieniossek C, 2009, NAT METHODS, V6, P447, DOI [10.1038/NMETH.1326, 10.1038/nmeth.1326]; Bushell ESC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000539; Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816; COMPTON LA, 1986, ANAL BIOCHEM, V155, P155, DOI 10.1016/0003-2697(86)90241-1; Daher W, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001132; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Ganter M, 2009, MOL MICROBIOL, V74, P1356, DOI 10.1111/j.1365-2958.2009.06828.x; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Hliscs M, 2010, J BIOL CHEM, V285, P11572, DOI 10.1074/jbc.M109.054916; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Kovar DR, 2006, CURR OPIN CELL BIOL, V18, P11, DOI 10.1016/J.CEB.2005.12.011; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Kucera K, 2010, J MOL BIOL, V403, P616, DOI 10.1016/j.jmb.2010.09.022; Kursula I, 2008, STRUCTURE, V16, P1638, DOI 10.1016/j.str.2008.09.008; Kursula P, 2008, J MOL BIOL, V375, P270, DOI 10.1016/j.jmb.2007.10.050; Lees JG, 2004, ANAL BIOCHEM, V332, P285, DOI 10.1016/j.ab.2004.06.002; Lees JG, 2006, BIOINFORMATICS, V22, P1955, DOI 10.1093/bioinformatics/btl327; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; Neidt EM, 2009, J BIOL CHEM, V284, P673, DOI 10.1074/jbc.M804201200; Nezami A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012992; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Otomo T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012896; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Paul AS, 2009, CELL MOTIL CYTOSKEL, V66, P606, DOI 10.1002/cm.20379; Peranen J, 1996, ANAL BIOCHEM, V236, P371, DOI 10.1006/abio.1996.0187; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Pring M, 2003, BIOCHEMISTRY-US, V42, P486, DOI 10.1021/bi026520j; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Sagot I, 2002, NAT CELL BIOL, V4, P626, DOI 10.1038/ncb834; Sattler JM, 2011, EUR J CELL BIOL, V90, P966, DOI 10.1016/j.ejcb.2010.11.011; Schatten H, 2003, MICROSC MICROANAL, V9, P330, DOI 10.1017/S143192760030095; Schmitz S, 2005, J MOL BIOL, V349, P113, DOI 10.1016/j.jmb.2005.03.056; Schuler H, 2006, TRAFFIC, V7, P1433, DOI 10.1111/j.1600-0854.2006.00484.x; Schuler H, 2005, MOL BIOL CELL, V16, P4013, DOI 10.1091/mbc.E05-02-0086; Shimada A, 2004, MOL CELL, V13, P511, DOI 10.1016/S1097-2765(04)00059-0; Sibley LD, 2004, SCIENCE, V304, P248, DOI 10.1126/science.1094717; Singh BK, 2011, J BIOL CHEM, V286, P28256, DOI 10.1074/jbc.M111.211730; Skillman KM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002280; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Tardieux I, 1998, FEBS LETT, V441, P251, DOI 10.1016/S0014-5793(98)01557-9; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; WESSELING JG, 1989, MOL BIOCHEM PARASIT, V35, P167, DOI 10.1016/0166-6851(89)90119-9; Xu YW, 2004, CELL, V116, P711, DOI 10.1016/S0092-8674(04)00210-7; Yamashita M, 2007, GENES CELLS, V12, P1255, DOI 10.1111/j.1365-2443.2007.01132.x	53	15	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2012	7	3							e33586	10.1371/journal.pone.0033586	http://dx.doi.org/10.1371/journal.pone.0033586			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930IA	22428073	Green Published, Green Submitted, gold			2022-12-25	WOS:000303129700070
J	Candelaria, M; de la Cruz-Hernandez, E; Taja-Chayeb, L; Perez-Cardenas, E; Trejo-Becerril, C; Gonzalez-Fierro, A; Chavez-Blanco, A; Soto-Reyes, E; Dominguez, G; Trujillo, JE; Diaz-Chavez, J; Duenas-Gonzalez, A				Candelaria, Myrna; de la Cruz-Hernandez, Erick; Taja-Chayeb, Lucia; Perez-Cardenas, Enrique; Trejo-Becerril, Catalina; Gonzalez-Fierro, Aurora; Chavez-Blanco, Alma; Soto-Reyes, Ernesto; Dominguez, Guadalupe; Trujillo, Jaenai E.; Diaz-Chavez, Jose; Duenas-Gonzalez, Alfonso			DNA Methylation-Independent Reversion of Gemcitabine Resistance by Hydralazine in Cervical Cancer Cells	PLOS ONE			English	Article							EQUILIBRATIVE NUCLEOSIDE TRANSPORTER-1; TUMOR-SUPPRESSOR GENES; RNA EXPRESSION LEVELS; DEOXYCYTIDINE KINASE; HISTONE METHYLTRANSFERASE; RIBONUCLEOTIDE REDUCTASE; EPIGENETIC THERAPY; IN-VITRO; CHEMOTHERAPY RESISTANCE; MAGNESIUM VALPROATE	Background: Down regulation of genes coding for nucleoside transporters and drug metabolism responsible for uptake and metabolic activation of the nucleoside gemcitabine is related with acquired tumor resistance against this agent. Hydralazine has been shown to reverse doxorubicin resistance in a model of breast cancer. Here we wanted to investigate whether epigenetic mechanisms are responsible for acquiring resistance to gemcitabine and if hydralazine could restore gemcitabine sensitivity in cervical cancer cells. Methodology/Principal Findings: The cervical cancer cell line CaLo cell line was cultured in the presence of increasing concentrations of gemcitabine. Down-regulation of hENT1 & dCK genes was observed in the resistant cells (CaLoGR) which was not associated with promoter methylation. Treatment with hydralazine reversed gemcitabine resistance and led to hENT1 and dCK gene reactivation in a DNA promoter methylation-independent manner. No changes in HDAC total activity nor in H3 and H4 acetylation at these promoters were observed. ChIP analysis showed H3K9m2 at hENT1 and dCK gene promoters which correlated with hyper-expression of G9A histone methyltransferase at RNA and protein level in the resistant cells. Hydralazine inhibited G9A methyltransferase activity in vitro and depletion of the G9A gene by iRNA restored gemcitabine sensitivity. Conclusions/Significance: Our results demonstrate that acquired gemcitabine resistance is associated with DNA promoter methylation-independent hENT1 and dCK gene down-regulation and hyper-expression of G9A methyltransferase. Hydralazine reverts gemcitabine resistance in cervical cancer cells via inhibition of G9A histone methyltransferase.	[Candelaria, Myrna] Inst Nacl Cancerol, Div Clin Res, Mexico City, DF, Mexico; [de la Cruz-Hernandez, Erick; Taja-Chayeb, Lucia; Perez-Cardenas, Enrique; Trejo-Becerril, Catalina; Gonzalez-Fierro, Aurora; Chavez-Blanco, Alma; Soto-Reyes, Ernesto; Dominguez, Guadalupe; Trujillo, Jaenai E.; Diaz-Chavez, Jose] Inst Nacl Cancerol, Basic Res Div, Mexico City, DF, Mexico; [Duenas-Gonzalez, Alfonso] Inst Invest Biomed UNAM, Inst Nacl Cancerol, Unit Biomed Res Canc, Mexico City, DF, Mexico	Instituto Nacional de Cancerologia (INCAN); Instituto Nacional de Cancerologia (INCAN); Instituto Nacional de Cancerologia (INCAN); Universidad Nacional Autonoma de Mexico	Candelaria, M (corresponding author), Inst Nacl Cancerol, Div Clin Res, Mexico City, DF, Mexico.	alfonso_duenasg@yahoo.com	Díaz-Chávez, José/HGU-7481-2022; De la Cruz-Hernandez, Erick/E-1487-2019	De la Cruz-Hernandez, Erick/0000-0001-5236-7347; Soto-Reyes, Ernesto/0000-0002-4219-6406; Diaz-Chavez, Jose/0000-0001-9583-3790; Dominguez-Gomez, Guadalupe/0000-0003-3906-4493	Psicofarma S.A. de C.V	Psicofarma S.A. de C.V	This work was partly supported by Psicofarma S.A. de C.V. The funders had a role in data collection, but not in study design, data analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abdulla P, 2007, NUCLEOS NUCLEOT NUCL, V26, P99, DOI 10.1080/15257770601052331; Achiwa H, 2004, CANCER SCI, V95, P753, DOI 10.1111/j.1349-7006.2004.tb03257.x; ANTONSSON BE, 1987, CANCER RES, V47, P3672; Arce C, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000098; AVRAMIS VI, 1989, CANCER CHEMOTH PHARM, V24, P203; Barnes K, 2006, CIRC RES, V99, P510, DOI 10.1161/01.RES.0000238359.18495.42; Bergman AM, 2005, CANCER RES, V65, P9510, DOI 10.1158/0008-5472.CAN-05-0989; Boukovinas I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003695; Caceres-Cortes JR, 2001, CANCER RES, V61, P6281; Candelaria M, 2007, ANN ONCOL, V18, P1529, DOI 10.1093/annonc/mdm204; Candelaria M, 2010, MED ONCOL, V27, P1133, DOI 10.1007/s12032-009-9349-y; Candelaria M, 2007, EJC SUPPL, V5, P37, DOI 10.1016/S1359-6349(07)70014-9; Chavez-Blanco A, 2011, INT J ONCOL, V39, P1491, DOI 10.3892/ijo.2011.1144; CHEN EH, 1995, J CLIN INVEST, V95, P1660, DOI 10.1172/JCI117841; De la Cruz-Hernandez E, 2011, ONCOL REP, V25, P399, DOI 10.3892/or.2010.1086; Duenas-Gonzalez A, 2011, EXPERT OPIN DRU 0928, P28; Galmarini Carlos Maria, 2004, BMC Pharmacology, V4, P8, DOI 10.1186/1471-2210-4-8; Gati WP, 1997, BLOOD, V90, P346; Giovannetti E, 2006, CANCER RES, V66, P3928, DOI 10.1158/0008-5472.CAN-05-4203; Griffiths M, 1997, BIOCHEM J, V328, P739, DOI 10.1042/bj3280739; Huang Y, 2007, P NATL ACAD SCI USA, V104, P8023, DOI 10.1073/pnas.0700720104; Huo HR, 2010, CANCER RES, V70, P8726, DOI 10.1158/0008-5472.CAN-10-0755; Inoue T, 2009, CELL CYCLE, V8, P1279, DOI 10.4161/cc.8.8.8245; Jiang ZP, 2010, MED HYPOTHESES, V74, P92, DOI 10.1016/j.mehy.2009.07.036; Jordheim LP, 2005, MOL CANCER THER, V4, P1268, DOI 10.1158/1535-7163.MCT-05-0121; Kikuchi R, 2006, MOL PHARMACOL, V70, P887, DOI 10.1124/mol.106.025494; KONG XB, 1991, MOL PHARMACOL, V39, P250; Kroep JR, 2002, MOL CANCER THER, V1, P371; Law AYS, 2008, EXP CELL RES, V314, P1823, DOI 10.1016/j.yexcr.2008.03.001; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Liu F, 2010, J MED CHEM, V53, P5844, DOI 10.1021/jm100478y; Ma J, 2010, CANCER GENE THER, V17, P523, DOI 10.1038/cgt.2010.18; Manome Y, 1996, NAT MED, V2, P567, DOI 10.1038/nm0596-567; Mini E, 2006, ANN ONCOL, V17, pV7, DOI 10.1093/annonc/mdj941; NYCE J, 1989, CANCER RES, V49, P5829; Nyce JW, 1997, MUTAT RES-REV MUTAT, V386, P153, DOI 10.1016/S1383-5742(96)00051-8; Oguri T, 2007, CANCER LETT, V256, P112, DOI 10.1016/j.canlet.2007.06.012; Ohhashi S, 2008, ANTICANCER RES, V28, P2205; Ougolkov AV, 2008, CLIN CANCER RES, V14, P6790, DOI 10.1158/1078-0432.CCR-08-1013; Park JY, 2008, PANCREAS, V36, pE32, DOI 10.1097/MPA.0b013e3181630ffe; Peters GJ, 2010, NUCLEOS NUCLEOT NUCL, V29, P408, DOI 10.1080/15257771003730078; Provenzano MJ, 2007, OTOLARYNG HEAD NECK, V137, P722, DOI 10.1016/j.otohns.2007.07.030; Schroder JK, 1996, LEUKEMIA, V10, P1919; Sebastiani V, 2006, CLIN CANCER RES, V12, P2492, DOI 10.1158/1078-0432.CCR-05-2655; Segura-Pacheco B, 2003, CLIN CANCER RES, V9, P1596; Segura-Pacheco B, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-32; Shutoh M, 2005, CANCER-AM CANCER SOC, V104, P1609, DOI 10.1002/cncr.21392; Singh N, 2009, CHEMMEDCHEM, V4, P792, DOI 10.1002/cmdc.200900017; Song YH, 2009, CANCER CHEMOTH PHARM, V63, P605, DOI 10.1007/s00280-008-0773-z; Souglakos J, 2008, BRIT J CANCER, V98, P1710, DOI 10.1038/sj.bjc.6604344; Spratlin J, 2004, CLIN CANCER RES, V10, P6956, DOI 10.1158/1078-0432.CCR-04-0224; Wang X, 2009, TUMOR BIOL, V30, P8, DOI 10.1159/000197911; Wong A, 2009, DRUG METAB REV, V41, P77, DOI 10.1080/03602530902741828; Worm J, 2001, J BIOL CHEM, V276, P39990, DOI 10.1074/jbc.M103181200; Wozniak RJ, 2007, ONCOGENE, V26, P77, DOI 10.1038/sj.onc.1209763; Wu H, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008570, 10.1371/journal.pone.0013316]; Yoshida T, 2010, DRUG METAB DISPOS, V38, P1814, DOI 10.1124/dmd.110.034397; Zambrano P, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-44	58	35	37	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e29181	10.1371/journal.pone.0029181	http://dx.doi.org/10.1371/journal.pone.0029181			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427797	Green Published, gold, Green Submitted			2022-12-25	WOS:000302381500002
J	Carrier, G; Le Cunff, L; Dereeper, A; Legrand, D; Sabot, F; Bouchez, O; Audeguin, L; Boursiquot, JM; This, P				Carrier, Gregory; Le Cunff, Loic; Dereeper, Alexis; Legrand, Delphine; Sabot, Francois; Bouchez, Olivier; Audeguin, Laurent; Boursiquot, Jean-Michel; This, Patrice			Transposable Elements Are a Major Cause of Somatic Polymorphism in Vitis vinifera L.	PLOS ONE			English	Article							COPY NUMBER VARIATION; GENETIC DIVERSITY; GENOME SEQUENCE; GRAPEVINE; EXPRESSION; DYNAMICS; EVOLUTION; DISCOVERY; MULTIPLE; FAMILIES	Through multiple vegetative propagation cycles, clones accumulate mutations in somatic cells that are at the origin of clonal phenotypic diversity in grape. Clonal diversity provided clones such as Cabernet-Sauvignon N degrees 470, Chardonnay N degrees 548 and Pinot noir N degrees 777 which all produce wines of superior quality. The economic impact of clonal selection is therefore very high: since approx. 95% of the grapevines produced in French nurseries originate from the French clonal selection. In this study we provide the first broad description of polymorphism in different clones of a single grapevine cultivar, Pinot noir, in the context of vegetative propagation. Genome sequencing was performed using 454 GS-FLX methodology without a priori, in order to identify and quantify for the first time molecular polymorphisms responsible for clonal variability in grapevine. New generation sequencing (NGS) was used to compare a large portion of the genome of three Pinot noir clones selected for their phenotypic differences. Reads obtained with NGS and the sequence of Pinot noir ENTAV-INRA (R) 115 sequenced by Velasco et al., were aligned on the PN40024 reference sequence. We then searched for molecular polymorphism between clones. Three types of polymorphism (SNPs, Indels, mobile elements) were found but insertion polymorphism generated by mobile elements of many families displayed the highest mutational event with respect to clonal variation. Mobile elements inducing insertion polymorphism in the genome of Pinot noir were identified and classified and a list is presented in this study as potential markers for the study of clonal variation. Among these, the dynamic of four mobile elements with a high polymorphism level were analyzed and insertion polymorphism was confirmed in all the Pinot clones registered in France.	[Carrier, Gregory; Le Cunff, Loic; Legrand, Delphine; Audeguin, Laurent] IFV INRA Montpellier SupAgro, UMT Geno Vigne, Montpellier, France; [Dereeper, Alexis; Boursiquot, Jean-Michel; This, Patrice] INRA, UMR AGAP, F-34060 Montpellier, France; [Sabot, Francois] IRD UM2 CIRAD, UMR DIADE, Montpellier, France; [Bouchez, Olivier] INRA Auzeville, Plateforme GenoToul, Castanet Tolosan, France	INRAE; Institut Agro; Montpellier SupAgro; INRAE; Universite de Montpellier; CIRAD; Universite de Montpellier; INRAE	Carrier, G (corresponding author), IFV INRA Montpellier SupAgro, UMT Geno Vigne, Montpellier, France.	gregory.carrier@supagro.inra.fr	Sabot, Francois/B-7820-2010	Sabot, Francois/0000-0002-8522-7583; carrier, gregory/0000-0001-6859-5707	French Ministry of Research and Higher Education; French Ministry of Food, Agriculture and Fisheries; IFV (Institut Francais de la Vigne et du Vin)	French Ministry of Research and Higher Education; French Ministry of Food, Agriculture and Fisheries; IFV (Institut Francais de la Vigne et du Vin)	This work was funded by the French Ministry of Research and Higher Education and the French Ministry of Food, Agriculture and Fisheries; including a PhD grant from the IFV (Institut Francais de la Vigne et du Vin) for GC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atanur SS, 2010, GENOME RES, V20, P791, DOI 10.1101/gr.103499.109; Boursiquot JM, 2007, CATALOGUE VARIETES C; Carrier G, 2011, AM J BOT, V98, pE13, DOI 10.3732/ajb.1000371; Chen N, 2002, USING REPEATMASKER I; DeBarry JD, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-235; Eichler EE, 2003, SCIENCE, V301, P793, DOI 10.1126/science.1086132; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Feschotte C, 2002, NAT REV GENET, V3, P329, DOI 10.1038/nrg793; Forneck A, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P581, DOI 10.1007/978-90-481-2770-2_27; Fournier-Level A, 2010, HEREDITY, V104, P351, DOI 10.1038/hdy.2009.148; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Gore MA, 2009, PLANT GENOME-US, V2, P121, DOI 10.3835/plantgenome2009.01.0002; Haaf T, 2006, CURR TOP MICROBIOL, V310, P13; Hocquigny S, 2004, GENOME, V47, P579, DOI 10.1139/G04-006; Huang WC, 2008, GENOME RES, V18, P1538, DOI 10.1101/gr.076067.108; Imazio S, 2002, PLANT BREEDING, V121, P531, DOI 10.1046/j.1439-0523.2002.00762.x; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Jurka J, 2000, TRENDS GENET, V16, P418, DOI 10.1016/S0168-9525(00)02093-X; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Kidwell MG, 2002, GENETICA, V115, P49, DOI 10.1023/A:1016072014259; Knox M, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-10; Kobayashi S, 2005, J JPN SOC HORTIC SCI, V74, P196, DOI 10.2503/jjshs.74.196; Labra M, 2004, PLANT BREEDING, V123, P180, DOI 10.1046/j.1439-0523.2003.00965.x; Le Cunff L, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-31; Ledergerber C, 2010, BRIEFINGS BIOINFORMA; Llorens C, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-41; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; McGovern PE, 2003, ANCIENT WINE SEARCH; McKey D, 2010, NEW PHYTOL, V186, P318, DOI 10.1111/j.1469-8137.2010.03210.x; McNally KL, 2006, PLANT PHYSIOL, V141, P26, DOI 10.1104/pp.106.077313; Moisy C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-469; Moncada X, 2006, GENOME, V49, P1459, DOI 10.1139/G06-102; Myles S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008219; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Nordborg M, 2008, NATURE, V456, P720, DOI 10.1038/nature07629; Orive ME, 2001, THEOR POPUL BIOL, V59, P235, DOI 10.1006/tpbi.2001.1515; Pelsy F, 2010, THEOR APPL GENET, V120, P1219, DOI 10.1007/s00122-009-1250-8; Perrier X., 2006, DARWIN SOFTWARE; Piegu B, 2006, GENOME RES, V16, P1262, DOI 10.1101/gr.5290206; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Sabot F, 2011, PLANT J, V66, P241, DOI 10.1111/j.1365-313X.2011.04492.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; This P, 2006, TRENDS GENET, V22, P511, DOI 10.1016/j.tig.2006.07.008; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; Velasco R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001326; Verries C, 2000, GENOME, V43, P366, DOI 10.1139/gen-43-2-366; Waugh R, 1997, MOL GEN GENET, V253, P687, DOI 10.1007/s004380050372; Wegscheider E, 2009, AM J ENOL VITICULT, V60, P104; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	57	58	65	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e32973	10.1371/journal.pone.0032973	http://dx.doi.org/10.1371/journal.pone.0032973			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427919	Green Published, gold			2022-12-25	WOS:000302381500068
J	Deisig, N; Kropf, J; Vitecek, S; Pevergne, D; Rouyar, A; Sandoz, JC; Lucas, P; Gadenne, C; Anton, S; Barrozo, R				Deisig, Nina; Kropf, Jan; Vitecek, Simon; Pevergne, Delphine; Rouyar, Angela; Sandoz, Jean-Christophe; Lucas, Philippe; Gadenne, Christophe; Anton, Sylvia; Barrozo, Romina			Differential Interactions of Sex Pheromone and Plant Odour in the Olfactory Pathway of a Male Moth	PLOS ONE			English	Article							HONEYBEE ANTENNAL LOBE; AGROTIS-IPSILON; RECEPTOR NEURONS; MOUSE MAIN; MIXTURES; RESPONSES; INHIBITION; INSECT; LEPIDOPTERA; REPRESENTATION	Most animals rely on olfaction to find sexual partners, food or a habitat. The olfactory system faces the challenge of extracting meaningful information from a noisy odorous environment. In most moth species, males respond to sex pheromone emitted by females in an environment with abundant plant volatiles. Plant odours could either facilitate the localization of females (females calling on host plants), mask the female pheromone or they could be neutral without any effect on the pheromone. Here we studied how mixtures of a behaviourally-attractive floral odour, heptanal, and the sex pheromone are encoded at different levels of the olfactory pathway in males of the noctuid moth Agrotis ipsilon. In addition, we asked how interactions between the two odorants change as a function of the males' mating status. We investigated mixture detection in both the pheromone-specific and in the general odorant pathway. We used a) recordings from individual sensilla to study responses of olfactory receptor neurons, b) in vivo calcium imaging with a bath-applied dye to characterize the global input response in the primary olfactory centre, the antennal lobe and c) intracellular recordings of antennal lobe output neurons, projection neurons, in virgin and newly-mated males. Our results show that heptanal reduces pheromone sensitivity at the peripheral and central olfactory level independently of the mating status. Contrarily, heptanal-responding olfactory receptor neurons are not influenced by pheromone in a mixture, although some post-mating modulation occurs at the input of the sexually isomorphic ordinary glomeruli, where general odours are processed within the antennal lobe. The results are discussed in the context of mate localization.	[Deisig, Nina; Kropf, Jan; Vitecek, Simon; Pevergne, Delphine; Rouyar, Angela; Lucas, Philippe; Gadenne, Christophe; Anton, Sylvia; Barrozo, Romina] INRA, UMR Physiol Insecte Signalisat & Commun 1272, F-78026 Versailles, France; [Deisig, Nina; Kropf, Jan; Vitecek, Simon; Pevergne, Delphine; Rouyar, Angela; Lucas, Philippe; Gadenne, Christophe; Anton, Sylvia; Barrozo, Romina] Univ Paris 06, Paris, France; [Sandoz, Jean-Christophe] Univ Toulouse 3, CNRS, UMR 5169, Res Ctr Anim Cognit, F-31062 Toulouse, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Deisig, N (corresponding author), INRA, UMR Physiol Insecte Signalisat & Commun 1272, Route St Cyr, F-78026 Versailles, France.	sylvia.anton@angers.inra.fr	Sandoz, Jean-Christophe/A-6085-2012; Lucas, Philippe/I-6020-2016; Deisig, Nina/T-9267-2019	Sandoz, Jean-Christophe/0000-0002-5423-9645; Deisig, Nina/0000-0002-9052-0258; Barrozo, Romina B-/0000-0002-5796-6354; Vitecek, Simon/0000-0002-7637-563X	INRA; CONICET	INRA; CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by research grants from INRA ("Projet Jeune Equipe", "Projet SPE") to SA and CG, a post-doctoral grant (INRA) and a research fellow grant (CONICET) to RBB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton S., 1999, INSECT OLFACTION, P98; Barrozo RB, 2011, EUR J NEUROSCI, V33, P1841, DOI 10.1111/j.1460-9568.2011.07678.x; Barrozo RB, 2010, J EXP BIOL, V213, P2933, DOI 10.1242/jeb.043430; Barrozo RB, 2010, J EXP BIOL, V213, P1100, DOI 10.1242/jeb.040139; Baum MJ, 2009, ANNU REV PHYSIOL, V71, P141, DOI 10.1146/annurev.physiol.010908.163137; Carlsson MA, 2007, CHEM SENSES, V32, P433, DOI 10.1093/chemse/bjm009; Chaffiol A, 2012, J EXP BIOL IN PRESS; Christensen TA, 2002, CURR OPIN NEUROBIOL, V12, P393, DOI 10.1016/S0959-4388(02)00336-7; Deisig N, 2006, EUR J NEUROSCI, V24, P1161, DOI 10.1111/j.1460-9568.2006.04959.x; Deisig N, 2010, J NEUROPHYSIOL, V103, P2185, DOI 10.1152/jn.00342.2009; DENOTTER CJ, 1978, ENTOMOL EXP APPL, V24, P570, DOI 10.1007/BF02385110; Derby CD, 2000, PHYSIOL BEHAV, V69, P203, DOI 10.1016/S0031-9384(00)00202-X; Duchamp-Viret P, 2003, EUR J NEUROSCI, V18, P2690, DOI 10.1111/j.1460-9568.2003.03001.x; Gadenne C, 2001, P ROY SOC B-BIOL SCI, V268, P1631, DOI 10.1098/rspb.2001.1710; Galizia CG, 1998, EUR J NEUROSCI, V10, P2964, DOI 10.1111/j.1460-9568.1998.00303.x; Hansson BS, 2000, ANNU REV ENTOMOL, V45, P203, DOI 10.1146/annurev.ento.45.1.203; Hildebrand J.G., 1980, RECEPTORS NEUROTRANS, P261; Jarriault D, 2010, CHEM SENSES, V35, P705, DOI 10.1093/chemse/bjq069; Jarriault D, 2009, HORM BEHAV, V56, P185, DOI 10.1016/j.yhbeh.2009.04.005; Jarriault D, 2009, J EXP BIOL, V212, P1191, DOI 10.1242/jeb.024166; KAISSLING KE, 1989, J COMP PHYSIOL A, V165, P147, DOI 10.1007/BF00619189; Kuebler LS, 2011, FRONT NEURAL CIRCUIT, V5, DOI 10.3389/fncir.2011.00007; Lei H, 2008, J CHEM ECOL, V34, P915, DOI 10.1007/s10886-008-9487-2; Lin DY, 2005, NATURE, V434, P470, DOI 10.1038/nature03414; Namiki S, 2008, J COMP PHYSIOL A, V194, P501, DOI 10.1007/s00359-008-0325-3; Ochieng SA, 2002, J COMP PHYSIOL A, V188, P325, DOI 10.1007/s00359-002-0308-8; Olsen SR, 2008, NATURE, V452, P956, DOI 10.1038/nature06864; Party V, 2009, CHEM SENSES, V34, P763, DOI 10.1093/chemse/bjp060; Picimbon JF, 1997, J CHEM ECOL, V23, P211, DOI 10.1023/B:JOEC.0000006355.13207.91; Pophof B, 2002, CHEM SENSES, V27, P435, DOI 10.1093/chemse/27.5.435; Reddy GVP, 2004, TRENDS PLANT SCI, V9, P253, DOI 10.1016/j.tplants.2004.03.009; Riffell JA, 2009, CURR BIOL, V19, P335, DOI 10.1016/j.cub.2009.01.041; Rospars JP, 2008, J NEUROSCI, V28, P2659, DOI 10.1523/JNEUROSCI.4670-07.2008; Rouyar A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026443; Sachse S, 2003, EUR J NEUROSCI, V18, P2119, DOI 10.1046/j.1460-9568.2003.02931.x; SCHNEIDER D, 1964, ANNU REV ENTOMOL, V9, P103, DOI 10.1146/annurev.en.09.010164.000535; Slotnick B, 2010, EUR J NEUROSCI, V31, P1108, DOI 10.1111/j.1460-9568.2010.07141.x; Su CY, 2011, P NATL ACAD SCI USA, V108, P5075, DOI 10.1073/pnas.1100369108; Tabor R, 2004, J NEUROSCI, V24, P6611, DOI 10.1523/JNEUROSCI.1834-04.2004; Trona F, 2010, J EXP BIOL, V213, P4291, DOI 10.1242/jeb.047365; Varela N, 2011, J EXP BIOL, V214, P637, DOI 10.1242/jeb.047316; Vickers NJ, 2001, NATURE, V410, P466, DOI 10.1038/35068559; Xu FQ, 2005, J COMP NEUROL, V489, P491, DOI 10.1002/cne.20652; ZHU YC, 1993, ENVIRON ENTOMOL, V22, P162, DOI 10.1093/ee/22.1.162	44	55	61	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33159	10.1371/journal.pone.0033159	http://dx.doi.org/10.1371/journal.pone.0033159			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427979	Green Published, gold			2022-12-25	WOS:000302381500104
J	Mattila, HR; Rios, D; Walker-Sperling, VE; Roeselers, G; Newton, ILG				Mattila, Heather R.; Rios, Daniela; Walker-Sperling, Victoria E.; Roeselers, Guus; Newton, Irene L. G.			Characterization of the Active Microbiotas Associated with Honey Bees Reveals Healthier and Broader Communities when Colonies are Genetically Diverse	PLOS ONE			English	Article							APIS-MELLIFERA; GUT MICROBIOTA; CHEMICAL-COMPOSITION; EFFECTIVE PATERNITY; NUTRITIONAL CONTENT; PRUNUS-DULCIS; ACID BACTERIA; POLLEN; HYMENOPTERA; EVOLUTION	Recent losses of honey bee colonies have led to increased interest in the microbial communities that are associated with these important pollinators. A critical function that bacteria perform for their honey bee hosts, but one that is poorly understood, is the transformation of worker-collected pollen into bee bread, a nutritious food product that can be stored for long periods in colonies. We used 16S rRNA pyrosequencing to comprehensively characterize in genetically diverse and genetically uniform colonies the active bacterial communities that are found on honey bees, in their digestive tracts, and in bee bread. This method provided insights that have not been revealed by past studies into the content and benefits of honey bee-associated microbial communities. Colony microbiotas differed substantially between sampling environments and were dominated by several anaerobic bacterial genera never before associated with honey bees, but renowned for their use by humans to ferment food. Colonies with genetically diverse populations of workers, a result of the highly promiscuous mating behavior of queens, benefited from greater microbial diversity, reduced pathogen loads, and increased abundance of putatively helpful bacteria, particularly species from the potentially probiotic genus Bifidobacterium. Across all colonies, Bifidobacterium activity was negatively correlated with the activity of genera that include pathogenic microbes; this relationship suggests a possible target for understanding whether microbes provide protective benefits to honey bees. Within-colony diversity shapes microbiotas associated with honey bees in ways that may have important repercussions for colony function and health. Our findings illuminate the importance of honey bee-bacteria symbioses and examine their intersection with nutrition, pathogen load, and genetic diversity, factors that are considered key to understanding honey bee decline.	[Mattila, Heather R.; Rios, Daniela; Walker-Sperling, Victoria E.] Wellesley Coll, Dept Biol Sci, Wellesley, MA 02181 USA; [Roeselers, Guus] TNO, Microbiol & Syst Biol Grp, Zeist, Netherlands; [Newton, Irene L. G.] Indiana Univ, Dept Biol, Bloomington, IN USA	Wellesley College; Netherlands Organization Applied Science Research; Indiana University System; Indiana University Bloomington	Mattila, HR (corresponding author), Wellesley Coll, Dept Biol Sci, Wellesley, MA 02181 USA.	irnewton@indiana.edu	Newton, Irene/H-5939-2019; Roeselers, Guus/J-2971-2012	Newton, Irene/0000-0002-7118-0374; Roeselers, Guus/0000-0002-4725-6105	Brachman-Hoffman Awards (Wellesley College); Essex County Beekeepers Association (Massachusetts)	Brachman-Hoffman Awards (Wellesley College); Essex County Beekeepers Association (Massachusetts)	Funding was provided by Brachman-Hoffman Awards to HRM and ILGN (Wellesley College), and a grant from the Essex County Beekeepers Association (Massachusetts). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babendreier D, 2007, FEMS MICROBIOL ECOL, V59, P600, DOI 10.1111/j.1574-6941.2006.00249.x; Belloy L, 2007, APIDOLOGIE, V38, P136, DOI [10.1051/apido:2006069, 10.1051/apido:2007039]; Berg RD, 1996, TRENDS MICROBIOL, V4, P430, DOI 10.1016/0966-842X(96)10057-3; Beutler R., 1949, Z VERGL PHYSIOL, V32, P383; Biavati B, FAMILY BIFIDOBACTERI, P322; Biosca EG, 2003, PHYTOPATHOLOGY, V93, P485, DOI 10.1094/PHYTO.2003.93.4.485; Bjorkroth, GEN LEUCONOSTOC OENO, P267; Bromenshenk JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013181; Brown MV, 2005, ENVIRON MICROBIOL, V7, P1466, DOI 10.1111/j.1462-2920.2005.00835.x; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Camazine S, 1998, AM BEE J, V138, P677; Chandler JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002272; Cook SM, 2003, ECOL ENTOMOL, V28, P622, DOI 10.1046/j.1365-2311.2003.00548.x; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; CRAILSHEIM K, 1992, J INSECT PHYSIOL, V38, P409, DOI 10.1016/0022-1910(92)90117-V; Crotti E, 2010, APPL ENVIRON MICROB, V76, P6963, DOI 10.1128/AEM.01336-10; Crutsinger GM, 2008, OECOLOGIA, V158, P65, DOI 10.1007/s00442-008-1130-y; Crutsinger GM, 2008, OIKOS, V117, P255, DOI 10.1111/j.2007.0030-1299.16276.x; Daims H, 1999, SYST APPL MICROBIOL, V22, P434, DOI 10.1016/S0723-2020(99)80053-8; DAY S, 1990, J APICULT RES, V29, P138, DOI 10.1080/00218839.1990.11101210; Dillon R, 2002, RES MICROBIOL, V153, P503, DOI 10.1016/S0923-2508(02)01361-X; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Dodd SJ, 2006, APPL ENVIRON MICROB, V72, P6584, DOI 10.1128/AEM.00954-06; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Evans JD, 2004, J ECON ENTOMOL, V97, P752, DOI 10.1603/0022-0493(2004)097[0752:BPIAIR]2.0.CO;2; Fierer N, 2011, AM J BOT, V98, P439, DOI 10.3732/ajb.1000498; FLYG C, 1980, J GEN MICROBIOL, V120, P173; Forsgren E, 2010, APIDOLOGIE, V41, P99, DOI 10.1051/apido/2009065; Frank DN, 2011, INFLAMM BOWEL DIS, V17, P179, DOI 10.1002/ibd.21339; Gheldof N, 2002, J AGR FOOD CHEM, V50, P5870, DOI 10.1021/jf0256135; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; GILLIAM M, 1979, APIDOLOGIE, V10, P43, DOI 10.1051/apido:19790106; GILLIAM M, 1990, APIDOLOGIE, V21, P89, DOI 10.1051/apido:19900201; GILLIAM M, 1979, APIDOLOGIE, V10, P269, DOI 10.1051/apido:19790304; Gilliam M, 1997, FEMS MICROBIOL LETT, V155, P1; Girard MB, 2011, INSECT SOC, V58, P77, DOI 10.1007/s00040-010-0118-x; Gokarn RR, 1997, APPL BIOCHEM BIOTECH, V68, P69, DOI 10.1007/BF02785981; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hammes W, GEN LACTOBACILLUS CA, P320; Han YJ, 2007, PROG CHEM, V19, P1153; HAYDAK MH, 1970, ANNU REV ENTOMOL, V15, P143, DOI 10.1146/annurev.en.15.010170.001043; HAYDAK MYKOLA H., 1950, ANN ENT SOC AMERICA, V43, P361; Henderson AR, 2005, CLIN CHIM ACTA, V359, P1, DOI 10.1016/j.cccn.2005.04.002; Herbert E, HONEY BEE NUTR, P197; Herbert E.W., 1992, HIVE HONEY BEE, P197; HERBERT EW, 1978, APIDOLOGIE, V9, P33, DOI 10.1051/apido:19780103; Hughes WOH, 2008, SCIENCE, V320, P1213, DOI 10.1126/science.1156108; Human H, 2006, PHYTOCHEMISTRY, V67, P1486, DOI 10.1016/j.phytochem.2006.05.023; Hurst MRH, 2004, J BACTERIOL, V186, P5116, DOI 10.1128/jb.186.15.5116-5128.2004; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Janmaat AF, 2000, INSECT SOC, V47, P177, DOI 10.1007/PL00001698; Jeyaprakash A, 2003, J INVERTEBR PATHOL, V84, P96, DOI 10.1016/j.jip.2003.08.007; Johnson MTJ, 2007, OIKOS, V116, P941, DOI 10.1111/j.0030-1299.2007.15773.x; Jones JC, 2004, SCIENCE, V305, P402, DOI 10.1126/science.1096340; Jones SE, 2010, P NATL ACAD SCI USA, V107, P5881, DOI 10.1073/pnas.0912765107; Kacaniova M, 2004, FOLIA MICROBIOL, V49, P169, DOI 10.1007/BF02931394; Kaznowski A, 2005, J APICULT RES, V44, P10, DOI 10.1080/00218839.2005.11101139; Koch H, 2011, P NATL ACAD SCI USA, V108, P19288, DOI 10.1073/pnas.1110474108; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Kopecny J, 2010, FOLIA MICROBIOL, V55, P336, DOI 10.1007/s12223-010-0053-2; Kovacs A, 2011, MICROB ECOL, V61, P423, DOI 10.1007/s00248-010-9787-2; Kronauer DJC, 2007, EVOLUTION, V61, P413, DOI 10.1111/j.1558-5646.2007.00040.x; Kunieda T, 2006, INSECT MOL BIOL, V15, P563, DOI 10.1111/j.1365-2583.2006.00677.x; Lane D, 16S 23S RRNA SEQUENC, P115; Lanzen A, 2011, FEMS MICROBIOL ECOL, V77, P577, DOI 10.1111/j.1574-6941.2011.01138.x; Lednicka D, 2000, SYST APPL MICROBIOL, V23, P292, DOI 10.1016/S0723-2020(00)80017-X; Lennon JT, 2011, NAT REV MICROBIOL, V9, P119, DOI 10.1038/nrmicro2504; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; LOPER GM, 1980, APIDOLOGIE, V11, P63, DOI 10.1051/apido:19800108; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Martin FPJ, 2008, MOL SYSTEMS BIOL, V4; Martinson VG, 2011, MOL ECOL, V20, P619, DOI 10.1111/j.1365-294X.2010.04959.x; Mattila HR, 2008, P ROY SOC B-BIOL SCI, V275, P809, DOI 10.1098/rspb.2007.1620; Mattila HR, 2007, SCIENCE, V317, P362, DOI 10.1126/science.1143046; Mattila HR, 2011, BEHAV ECOL SOCIOBIOL, V65, P799, DOI 10.1007/s00265-010-1083-0; Mattila HR, 2010, BEHAV ECOL SOCIOBIOL, V64, P875, DOI 10.1007/s00265-010-0904-5; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; McCarren J, 2010, P NATL ACAD SCI USA, V107, P16420, DOI 10.1073/pnas.1010732107; Meixner MD, 2010, J APICULT RES, V49, P85, DOI 10.3896/IBRA.1.49.1.12; MICHENER CD, 1974, SOCIAL BEHAV BEES; Mills DA, 2006, AM J ENOL VITICULT, V57, p390A; Mohr KI, 2006, ENVIRON MICROBIOL, V8, P258, DOI 10.1111/j.1462-2920.2005.00893.x; Moran NA, 1998, BIOSCIENCE, V48, P295, DOI 10.2307/1313356; Moritz RFA, 1996, NATURE, V384, P31, DOI 10.1038/384031a0; Mueller UG, 2001, Q REV BIOL, V76, P169, DOI 10.1086/393867; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Naug D, 2009, BIOL CONSERV, V142, P2369, DOI 10.1016/j.biocon.2009.04.007; Ochman H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000546; OHERRIN SM, 1993, APPL ENVIRON MICROB, V59, P748, DOI 10.1128/AEM.59.3.748-755.1993; Oldroyd BP, 2007, PLOS BIOL, V5, P1195, DOI 10.1371/journal.pbio.0050168; OLDROYD BP, 1992, ANN ENTOMOL SOC AM, V85, P335, DOI 10.1093/aesa/85.3.335; Olofsson T, 2010, NOVEL BACTERIA ISOLA; Olofsson TC, 2009, J APICULT RES, V48, P233, DOI 10.3896/IBRA.1.48.4.02; Palmer KA, 2003, NATURWISSENSCHAFTEN, V90, P265, DOI 10.1007/s00114-003-0418-3; Potts SG, 2010, J APICULT RES, V49, P15, DOI 10.3896/IBRA.1.49.1.02; Rodriguez-Blanco A, 2009, FEMS MICROBIOL ECOL, V67, P30, DOI 10.1111/j.1574-6941.2008.00591.x; Roeselers G, 2011, ISME J, V5, P1595, DOI 10.1038/ismej.2011.38; Roulston TH, 2000, PLANT SYST EVOL, V222, P187, DOI 10.1007/BF00984102; Roulston TH, 2002, EVOL ECOL, V16, P49, DOI 10.1023/A:1016048526475; Sanz Y, 2007, FEMS IMMUNOL MED MIC, V51, P562, DOI 10.1111/j.1574-695X.2007.00337.x; Schloss PD, 2011, APPL ENVIRON MICROB, V77, P3219, DOI 10.1128/AEM.02810-10; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schweitzer JA, 2011, POPUL ECOL, V53, P35, DOI 10.1007/s10144-010-0252-3; Seeley TD, 2007, P ROY SOC B-BIOL SCI, V274, P67, DOI 10.1098/rspb.2006.3702; Stackebrandt E, FAMILY SUCCINIVIBRIO, P419; STANDIFER LN, 1980, APIDOLOGIE, V11, P163, DOI 10.1051/apido:19800206; Suen G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001129; Tarpy DR, 2002, ANN ENTOMOL SOC AM, V95, P513, DOI 10.1603/0013-8746(2002)095[0513:SEEPAE]2.0.CO;2; Tarpy DR, 2006, NATURWISSENSCHAFTEN, V93, P195, DOI 10.1007/s00114-006-0091-4; Tarpy DR, 2004, INSECT SOC, V51, P203, DOI 10.1007/s00040-004-0734-4; Turyanitsa A. I., 1996, Mikrobiolohichnyi Zhurnal, V58, P73; Vaishampayan PA, 2010, GENOME BIOL EVOL, V2, P53, DOI 10.1093/gbe/evp057; vanEngelsdorp D, 2011, J APICULT RES, V50, P1, DOI 10.3896/IBRA.1.50.1.01; vanEngelsdorp D, 2010, J ECON ENTOMOL, V103, P1517, DOI 10.1603/EC09429; vanEngelsdorp D, 2010, J APICULT RES, V49, P7, DOI 10.3896/IBRA.1.49.1.03; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Vanengelsdorp D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004071; Vanengelsdorp D, 2009, J INVERTEBR PATHOL, V101, P147, DOI 10.1016/j.jip.2009.03.008; Vasquez A, 2009, J APICULT RES, V48, P189, DOI 10.3896/IBRA.1.48.3.07; Villesen P, 2002, P ROY SOC B-BIOL SCI, V269, P1541, DOI 10.1098/rspb.2002.2044; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Yamamoto T, 1989, J JAPAN VET MED ASS, V42, P249; ZOURARI A, 1992, LAIT, V72, P1	125	95	107	1	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e32962	10.1371/journal.pone.0032962	http://dx.doi.org/10.1371/journal.pone.0032962			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427917	Green Published, gold			2022-12-25	WOS:000302381500067
J	Walker, RH; Moore, C; Davies, G; Dirling, LB; Koch, RJ; Meshul, CK				Walker, Ruth H.; Moore, Cindy; Davies, Georgia; Dirling, Lisa B.; Koch, Rick J.; Meshul, Charles K.			Effects of Subthalamic Nucleus Lesions and Stimulation upon Corticostriatal Afferents in the 6-Hydroxydopamine- Lesioned Rat	PLOS ONE			English	Article							HIGH-FREQUENCY STIMULATION; DEEP-BRAIN-STIMULATION; MEDIUM SPINY NEURONS; INDUCED CONTRALATERAL ROTATIONS; EXTRACELLULAR GLUTAMATE LEVELS; TIME-DEPENDENT CHANGES; NIGRA PARS RETICULATA; HEMI-PARKINSON RATS; L-DOPA TREATMENT; STRIATAL GLUTAMATE	Abnormalities of striatal glutamate neurotransmission may play a role in the pathophysiology of Parkinson's disease and may respond to neurosurgical interventions, specifically stimulation or lesioning of the subthalamic nucleus (STN). The major glutamatergic afferent pathways to the striatum are from the cortex and thalamus, and are thus likely to be sources of striatal neuronally-released glutamate. Corticostriatal terminals can be distinguished within the striatum at the electron microscopic level as their synaptic vesicles contain the vesicular glutamate transporter, VGLUT1. The majority of terminals which are immunolabeled for glutamate but are not VGLUT1 positive are likely to be thalamostriatal afferents. We compared the effects of short term, high frequency, STN stimulation and lesioning in 6-hydroxydopamine (6OHDA)-lesioned rats upon striatal terminals immunolabeled for both presynaptic glutamate and VGLUT1. 6OHDA lesions resulted in a small but significant increase in the proportions of VGLUT1-labeled terminals making synapses on dendritic shafts rather than spines. STN stimulation for one hour, but not STN lesions, increased the proportion of synapses upon spines. The density of presynaptic glutamate immuno-gold labeling was unchanged in both VGLUT1-labeled and -unlabeled terminals in 6OHDA-lesioned rats compared to controls. Rats with 6OHDA lesions+STN stimulation showed a decrease in nerve terminal glutamate immuno-gold labeling in both VGLUT1-labeled and -unlabeled terminals. STN lesions resulted in a significant decrease in the density of presynaptic immuno-gold-labeled glutamate only in VGLUT1-labeled terminals. STN interventions may achieve at least part of their therapeutic effect in PD by normalizing the location of corticostriatal glutamatergic terminals and by altering striatal glutamatergic neurotransmission.	[Walker, Ruth H.; Davies, Georgia; Koch, Rick J.] James J Peters Vet Affairs Med Ctr, Dept Neurol, Bronx, NY USA; [Walker, Ruth H.] Mt Sinai Sch Med, Dept Neurol, New York, NY USA; [Moore, Cindy; Dirling, Lisa B.; Meshul, Charles K.] Oregon Hlth & Sci Univ, Vet Affairs Med Ctr, Neurocytol Lab, Res Serv, Portland, OR 97201 USA; [Meshul, Charles K.] Oregon Hlth & Sci Univ, Dept Behav Neurosci & Pathol, Portland, OR 97201 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Icahn School of Medicine at Mount Sinai; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Oregon Health & Science University	Walker, RH (corresponding author), James J Peters Vet Affairs Med Ctr, Dept Neurol, Bronx, NY USA.	ruth.walker@mssm.edu			Department of Veterans Affairs	Department of Veterans Affairs(US Department of Veterans Affairs)	This work was funded by Department of Veterans Affairs Merit awards to RHW and CKM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aymerich MS, 2006, EUR J NEUROSCI, V23, P2099, DOI 10.1111/j.1460-9568.2006.04741.x; Baker DA, 2002, J NEUROSCI, V22, P9134; Barroso-Chinea P, 2008, J CHEM NEUROANAT, V35, P101, DOI 10.1016/j.jchemneu.2007.08.001; Barroso-Chinea P, 2007, J COMP NEUROL, V501, P703, DOI 10.1002/cne.21265; BENAZZOUZ A, 1995, NEUROSCI LETT, V189, P77, DOI 10.1016/0304-3940(95)11455-6; Benazzouz A, 2000, NEUROSCIENCE, V99, P289, DOI 10.1016/S0306-4522(00)00199-8; Beurrier C, 2001, J NEUROPHYSIOL, V85, P1351, DOI 10.1152/jn.2001.85.4.1351; Bianchi L, 2003, EUR J NEUROSCI, V18, P856, DOI 10.1046/j.1460-9568.2003.02795.x; Biggs CS, 1997, NEUROSCI BIOBEHAV R, V21, P497, DOI 10.1016/S0149-7634(96)00032-2; Carlson JD, 2010, J NEUROPHYSIOL, V103, P962, DOI 10.1152/jn.00363.2009; CASTANEDA E, 1990, J NEUROSCI, V10, P1847; Centonze D, 2005, NEUROSCIENCE, V133, P831, DOI 10.1016/j.neuroscience.2005.03.006; Chung EKY, 2008, J COMP NEUROL, V511, P421, DOI 10.1002/cne.21852; Corsi C, 2003, EUR J PHARMACOL, V464, P33, DOI 10.1016/S0014-2999(03)01352-9; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Day M, 2006, NAT NEUROSCI, V9, P251, DOI 10.1038/nn1632; Doig NM, 2010, J NEUROSCI, V30, P14610, DOI 10.1523/JNEUROSCI.1623-10.2010; FOSNAUGH JS, 1995, J NEUROCHEM, V64, P2377; Fremeau RT, 2004, TRENDS NEUROSCI, V27, P98, DOI 10.1016/j.tins.2003.11.005; Fujiyama F, 2004, EUR J NEUROSCI, V20, P3322, DOI 10.1111/j.1460-9568.2004.03807.x; Garcia BG, 2010, CEREB CORTEX, V20, P2423, DOI 10.1093/cercor/bhp317; Garcia L, 2005, TRENDS NEUROSCI, V28, P209, DOI 10.1016/j.tins.2005.02.005; Gubellini P, 2006, EUR J NEUROSCI, V24, P1802, DOI 10.1111/j.1460-9568.2006.05047.x; Hahn PJ, 2010, J COMPUT NEUROSCI, V28, P425, DOI 10.1007/s10827-010-0225-8; Hashimoto T, 2003, J NEUROSCI, V23, P1916; HerreraMarschitz M, 1996, J NEUROCHEM, V66, P1726; HOLLERMAN JR, 1990, BRAIN RES, V533, P203, DOI 10.1016/0006-8993(90)91341-D; INGHAM CA, 1993, EXP BRAIN RES, V93, P17, DOI 10.1007/BF00227776; Ingham CA, 1998, J NEUROSCI, V18, P4732; INGHAM CA, 1989, BRAIN RES, V503, P334, DOI 10.1016/0006-8993(89)91686-7; Jonkers N, 2002, BRAIN RES, V926, P149, DOI 10.1016/S0006-8993(01)03147-X; Konradi C, 2004, NEUROBIOL DIS, V17, P219, DOI 10.1016/j.nbd.2004.07.005; Kuhn AA, 2008, J NEUROSCI, V28, P6165, DOI 10.1523/JNEUROSCI.0282-08.2008; Lacey CJ, 2005, NEUROSCIENCE, V136, P1083, DOI 10.1016/j.neuroscience.2005.07.013; Lee KH, 2007, BRAIN RES, V1162, P121, DOI 10.1016/j.brainres.2007.06.021; Li S, 2007, J NEUROPHYSIOL, V98, P3525, DOI 10.1152/jn.00808.2007; Lievens JC, 2001, J NEUROCHEM, V79, P893, DOI 10.1046/j.1471-4159.2001.00644.x; LINDEFORS N, 1990, NEUROSCI LETT, V115, P248, DOI 10.1016/0304-3940(90)90463-J; Magarinos-Ascone C, 2002, NEUROSCIENCE, V115, P1109, DOI 10.1016/S0306-4522(02)00538-9; Massie A, 2008, NEUROREPORT, V19, P1589, DOI 10.1097/WNR.0b013e328312181c; Massie A, 2010, NEUROCHEM INT, V57, P572, DOI 10.1016/j.neuint.2010.07.004; Massie A, 2010, NEUROCHEM INT, V57, P111, DOI 10.1016/j.neuint.2010.04.019; MCGEORGE AJ, 1989, NEUROSCIENCE, V29, P503, DOI 10.1016/0306-4522(89)90128-0; McIntyre CC, 2004, CLIN NEUROPHYSIOL, V115, P1239, DOI 10.1016/j.clinph.2003.12.024; MESHUL CK, 1994, BRAIN RES, V648, P181, DOI 10.1016/0006-8993(94)91117-7; Meshul CK, 2002, EXP NEUROL, V175, P257, DOI 10.1006/exnr.2002.7900; Meshul CK, 1999, NEUROSCIENCE, V88, P1, DOI 10.1016/S0306-4522(98)00189-4; Meshul CK, 2000, NEUROSCIENCE, V96, P91, DOI 10.1016/S0306-4522(99)90481-5; Miyachi S, 2006, NEUROSCI RES, V56, P300, DOI 10.1016/j.neures.2006.07.012; Morari M, 1996, NEUROSCIENCE, V72, P89, DOI 10.1016/0306-4522(95)00556-0; Moss J, 2008, J NEUROSCI, V28, P11221, DOI 10.1523/JNEUROSCI.2780-08.2008; Nambu A, 2002, NEUROSCI RES, V43, P111, DOI 10.1016/S0168-0102(02)00027-5; Neely MD, 2007, NEUROSCIENCE, V149, P457, DOI 10.1016/j.neuroscience.2007.06.044; Paul G, 2000, NEUROREPORT, V11, P441, DOI 10.1097/00001756-200002280-00003; Paxinos G., RAT BRAIN STEREOTAXI, VSeventh; PHEND KD, 1992, J HISTOCHEM CYTOCHEM, V40, P1011, DOI 10.1177/40.7.1376741; Picconi B, 2004, BRAIN, V127, P1661, DOI 10.1093/brain/awh190; Raju DV, 2008, EUR J NEUROSCI, V27, P1647, DOI 10.1111/j.1460-9568.2008.06136.x; Raju DV, 2006, J COMP NEUROL, V499, P231, DOI 10.1002/cne.21099; Raju DV, DIFFERENTIAL LOCALIZ, P601; Robelet S, 2004, EUR J NEUROSCI, V20, P1255, DOI 10.1111/j.1460-9568.2004.03591.x; Robinson S, 2003, EXP NEUROL, V180, P73, DOI 10.1016/S0014-4886(02)00050-X; Schang AY, 2010, CORRELATES ANAL MOTO, P55; See RE, 2002, J NEUROCHEM, V82, P172, DOI 10.1046/j.1471-4159.2002.00974.x; Sgambato-Faure V, 2005, J NEUROPATH EXP NEUR, V64, P936, DOI 10.1097/01.jnen.0000186922.42592.b7; SMITH Y, 1994, J COMP NEUROL, V344, P1, DOI 10.1002/cne.903440102; Stephens B, 2005, NEUROSCIENCE, V132, P741, DOI 10.1016/j.neuroscience.2005.01.007; Tai CH, 2003, FASEB J, V17, P1820, DOI 10.1096/fj.03-0163com; Tan A, 2000, J NEUROCHEM, V74, P2074, DOI 10.1046/j.1471-4159.2000.0742074.x; Tian XY, 2010, MOL CELL NEUROSCI, V44, P94, DOI 10.1016/j.mcn.2010.01.012; Touchon JC, 2004, SYNAPSE, V51, P287, DOI 10.1002/syn.10306; Villalba RM, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00133; Villalba RM, 2011, J COMP NEUROL, V519, P989, DOI 10.1002/cne.22563; Villalba RM, 2009, EXP NEUROL, V215, P220, DOI 10.1016/j.expneurol.2008.09.025; Waldau B, 2011, STEREOT FUNCT NEUROS, V89, P48, DOI 10.1159/000323340; Walker RH, 2009, NEUROREPORT, V20, P770, DOI 10.1097/WNR.0b013e32832ad556; Walker RH, 2009, SYNAPSE, V63, P136, DOI 10.1002/syn.20592; Zaja-Milatovic S, 2005, NEUROLOGY, V64, P545, DOI 10.1212/01.WNL.0000150591.33787.A4	78	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e32919	10.1371/journal.pone.0032919	http://dx.doi.org/10.1371/journal.pone.0032919			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427909	Green Published, Green Submitted, gold			2022-12-25	WOS:000302381500062
J	Marshak, S; Meynard, MM; De Vries, YA; Kidane, AH; Cohen-Cory, S				Marshak, Sonya; Meynard, Margarita M.; De Vries, Ymkje A.; Kidane, Adhanet H.; Cohen-Cory, Susana			Cell-Autonomous Alterations in Dendritic Arbor Morphology and Connectivity Induced by Overexpression of MeCP2 in Xenopus Central Neurons In Vivo	PLOS ONE			English	Article							CPG-BINDING PROTEIN-2; RETT-SYNDROME; MENTAL-RETARDATION; MOUSE MODEL; SYNAPTIC CONNECTIVITY; NEUROLOGICAL SYMPTOMS; HIPPOCAMPAL-NEURONS; DELAYED MATURATION; BDNF TRANSCRIPTION; SYSTEM DEVELOPMENT	Methyl CpG binding protein-2 (MeCP2) is an essential epigenetic regulator in human brain development. Mutations in the MeCP2 gene have been linked to Rett syndrome, a severe X-linked progressive neurodevelopmental disorder, and one of the most common causes of mental retardation in females. MeCP2 duplication and triplication have also been found to affect brain development, indicating that both loss of function and gain in MeCP2 dosage lead to similar neurological phenotypes. Here, we used the Xenopus laevis visual system as an in vivo model to examine the consequence of increased MeCP2 expression during the morphological maturation of individual central neurons in an otherwise intact brain. Single-cell overexpression of wild-type human MeCP2 was combined with time-lapse confocal microscopy imaging to study dynamic mechanisms by which MeCP2 influences tectal neuron dendritic arborization. Analysis of neurons co-expressing DsRed2 demonstrates that MeCP2 overexpression specifically interfered with dendritic elaboration, decreasing the rates of branch addition and elimination over a 48 hour observation period. Moreover, dynamic analysis of neurons co-expressing wt-hMeCP2 and PSD95-GFP revealed that even though neurons expressing wt-hMeCP2 possessed significantly fewer dendrites and simpler morphologies than control neurons at the same developmental stage, postsynaptic site density in wt-hMeCP2-expressing neurons was similar to controls and increased at a rate higher than controls. Together, our in vivo studies support an early, cell-autonomous role for MeCP2 during the morphological differentiation of neurons and indicate that perturbations in MeCP2 gene dosage result in deficits in dendritic arborization that can be compensated, at least in part, by synaptic connectivity changes.	[Marshak, Sonya; Meynard, Margarita M.; De Vries, Ymkje A.; Kidane, Adhanet H.; Cohen-Cory, Susana] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92717 USA	University of California System; University of California Irvine	Marshak, S (corresponding author), Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92717 USA.	scohenco@uci.edu			March of Dimes Foundation [6-FY07-321]; National Eye Institute (National Institutes of Health) [EY-019112]; NATIONAL EYE INSTITUTE [R01EY011912, R01EY019112] Funding Source: NIH RePORTER	March of Dimes Foundation(March of Dimes); National Eye Institute (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in part by research Grant No. 6-FY07-321 from the March of Dimes Foundation and by the grant EY-019112 from the National Eye Institute (National Institutes of Health). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsina B, 2001, NAT NEUROSCI, V4, P1093, DOI 10.1038/nn735; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; ARMSTRONG D, 1995, J NEUROPATH EXP NEUR, V54, P195, DOI 10.1097/00005072-199503000-00006; ARMSTRONG DD, 1992, BRAIN DEV-JPN, V14, pS89; Asaka Y, 2006, NEUROBIOL DIS, V21, P217, DOI 10.1016/j.nbd.2005.07.005; Ballas N, 2009, NAT NEUROSCI, V12, P311, DOI 10.1038/nn.2275; Balmer D, 2003, J MOL MED-JMM, V81, P61, DOI 10.1007/s00109-002-0396-5; Belichenko NP, 2009, NEUROBIOL DIS, V34, P71, DOI 10.1016/j.nbd.2008.12.016; Belichenko PV, 2009, J COMP NEUROL, V514, P240, DOI 10.1002/cne.22009; BELICHENKO PV, 1994, NEUROREPORT, V5, P1509, DOI 10.1097/00001756-199407000-00025; BELICHENKO PV, 1995, J NEUROSCI METH, V57, P55, DOI 10.1016/0165-0270(94)00125-Z; Ben-Shachar S, 2009, HUM MOL GENET, V18, P2431, DOI 10.1093/hmg/ddp181; Boggio Elena M, 2010, Front Synaptic Neurosci, V2, P28, DOI 10.3389/fnsyn.2010.00028; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chang QA, 2006, NEURON, V49, P341, DOI 10.1016/j.neuron.2005.12.027; Chao HT, 2007, NEURON, V56, P58, DOI 10.1016/j.neuron.2007.08.018; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Chao HT, 2009, P NATL ACAD SCI USA, V106, P4577, DOI 10.1073/pnas.0901518106; Chapleau CA, 2009, NEUROBIOL DIS, V35, P219, DOI 10.1016/j.nbd.2009.05.001; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; Cohen DRS, 2003, MOL CELL NEUROSCI, V22, P417, DOI 10.1016/S1044-7431(03)00026-5; Cohen-Cory S, 2004, INT J DEV BIOL, V48, P947, DOI 10.1387/ijdb.041883sc; CohenCory S, 1996, DEV BIOL, V179, P102, DOI 10.1006/dbio.1996.0244; Collins AL, 2004, HUM MOL GENET, V13, P2679, DOI 10.1093/hmg/ddh282; Coverdale LE, 2004, DEV BRAIN RES, V153, P281, DOI 10.1016/j.devbrainres.2004.08.009; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; Degano AL, 2009, MOL CELL NEUROSCI, V42, P243, DOI 10.1016/j.mcn.2009.07.009; del Gaudio D, 2006, GENET MED, V8, P784, DOI 10.1097/01.gim.0000250502.28516.3c; Friez MJ, 2006, PEDIATRICS, V118, pE1687, DOI 10.1542/peds.2006-0395; Fukuda T, 2005, J NEUROPATH EXP NEUR, V64, P537, DOI 10.1093/jnen/64.6.537; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Hite KC, 2009, BIOCHEM CELL BIOL, V87, P219, DOI 10.1139/O08-115; Hossain S, 2011, DEV NEUROBIOL; Hu B, 2005, DEVELOPMENT, V132, P4285, DOI 10.1242/dev.02017; Jugloff DGM, 2005, NEUROBIOL DIS, V19, P18, DOI 10.1016/j.nbd.2004.11.002; Jung BP, 2003, J NEUROBIOL, V55, P86, DOI 10.1002/neu.10201; Kishi N, 2004, MOL CELL NEUROSCI, V27, P306, DOI 10.1016/j.mcn.2004.07.006; Kishi N, 2010, EXP NEUROL, V222, P51, DOI 10.1016/j.expneurol.2009.12.007; Kline DD, 2010, J NEUROSCI, V30, P5303, DOI 10.1523/JNEUROSCI.5503-09.2010; Larimore JL, 2009, NEUROBIOL DIS, V34, P199, DOI 10.1016/j.nbd.2008.12.011; Lugtenberg D, 2006, J MED GENET, V43, P362, DOI 10.1136/jmg.2005.036178; Marshak S, 2007, J NEUROSCI, V27, P2444, DOI 10.1523/JNEUROSCI.4434-06.2007; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Moretti P, 2006, J NEUROSCI, V26, P319, DOI 10.1523/JNEUROSCI.2623-05.2006; Mullaney BC, 2004, NEUROSCIENCE, V123, P939, DOI 10.1016/j.neuroscience.2003.11.025; Nelson ED, 2006, CURR BIOL, V16, P710, DOI 10.1016/j.cub.2006.02.062; Niell CM, 2004, ANNU REV PHYSIOL, V66, P771, DOI 10.1146/annurev.physiol.66.082602.095217; Nieuwkoop PD., 1956, DEVELOPMENT, DOI [DOI 10.1242/DEV.200356, 10.1242/dev.200356]; Samaco RC, 2011, J NEUROSCI, V31, P7951, DOI 10.1523/JNEUROSCI.0169-11.2011; Samaco RC, 2009, P NATL ACAD SCI USA, V106, P21966, DOI 10.1073/pnas.0912257106; Sanchez AL, 2006, DEVELOPMENT, V133, P2477, DOI 10.1242/dev.02409; Shahbazian MD, 2002, NEURON, V35, P243, DOI 10.1016/S0896-6273(02)00768-7; Shepherd GM, 2011, CURR OPIN NEUROBIOL; Smrt RD, 2007, NEUROBIOL DIS, V27, P77, DOI 10.1016/j.nbd.2007.04.005; Stancheva I, 2003, MOL CELL, V12, P425, DOI 10.1016/S1097-2765(03)00276-4; Tao HW, 2005, NEURON, V45, P829, DOI 10.1016/j.neuron.2005.01.046; Tripodi M, 2008, PLOS BIOL, V6, P2172, DOI 10.1371/journal.pbio.0060260; Van Esch H, 2005, AM J HUM GENET, V77, P442, DOI 10.1086/444549; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	62	17	19	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2012	7	3							e33153	10.1371/journal.pone.0033153	http://dx.doi.org/10.1371/journal.pone.0033153			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KX	22427975	Green Published, gold			2022-12-25	WOS:000303062800048
J	Chew, YC; Adhikary, G; Wilson, GM; Xu, W; Eckert, RL				Chew, Yap Ching; Adhikary, Gautam; Wilson, Gerald M.; Xu, Wen; Eckert, Richard L.			Sulforaphane Induction of p21(Cip1) Cyclin-dependent Kinase Inhibitor Expression Requires p53 and Sp1 Transcription Factors and Is p53-dependent	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER CELLS; HISTONE DEACETYLASE INHIBITORS; CASPASE-MEDIATED APOPTOSIS; P21(WAF1/CIP1) EXPRESSION; EPITHELIAL-CELLS; SKIN CARCINOGENESIS; HUMAN KERATINOCYTES; SIGNALING PATHWAYS; PC-3 XENOGRAFTS; CARCINOMA CELLS	Sulforaphane (SFN) is an important cancer preventive agent derived from cruciferous vegetables. We show that SFN treatment suppresses normal human keratinocyte proliferation via a mechanism that involves increased expression of p21(Cip1). SFN treatment produces a concentration-dependent increase in p21(Cip1) promoter activity via a mechanism that involves stabilization of the p53 protein leading to increased p53 binding to the p21(Cip1) promoter p53 response elements. The proximal p21(Cip1) promoter GC-rich Sp1 factor binding elements are also required, as the SFN-dependent increase is lost when these sites are mutated. SFN treatment increases Sp1 binding to these elements, and the response is enhanced in the presence of exogenous Sp1 and reduced in the presence of Delta N-Sp3. CpG island methylation alters p21(Cip1) promoter activity some systems; however, expression in SFN-treated keratinocytes does not involve changes in proximal promoter methylation. The promoter is minimally methylated, and the methylation level is not altered by SFN treatment. This study indicates that SFN increases p21(Cip1) promoter transcription via a mechanism that involves SFN-dependent stabilization of p53 and increased p53 and Sp1 binding to their respective response elements in the p21(Cip1) promoter. These results are in marked contrast to the mechanisms observed in skin cancer cell lines and suggest that SFN may protect normal keratinocytes from damage while causing cancer cells to undergo apoptosis.	[Chew, Yap Ching; Adhikary, Gautam; Wilson, Gerald M.; Xu, Wen; Eckert, Richard L.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Eckert, Richard L.] Univ Maryland, Sch Med, Dept Dermatol, Baltimore, MD 21201 USA; [Eckert, Richard L.] Univ Maryland, Sch Med, Dept Obstet & Gynecol & Reprod Sci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Eckert, RL (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, 108 N Greene St, Baltimore, MD 21201 USA.	reckert@umaryland.edu	Wilson, Gerald/AAF-3874-2019	Wilson, Gerald/0000-0002-1273-7507; Chew, Yap Ching/0000-0002-1686-6541	National Institutes of Health [R01 AR046494]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046494] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AR046494 (to R. E.).	Abukhdeir Abde M., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000744; Adhikary G, 2005, INVEST OPHTH VIS SCI, V46, P3109, DOI 10.1167/iovs.05-0053; Ahmed NU, 1997, J CUTAN PATHOL, V24, P223, DOI 10.1111/j.1600-0560.1997.tb01585.x; Aliouat-Denis CM, 2005, MOL CANCER RES, V3, P627, DOI 10.1158/1541-7786.MCR-05-0121; Balasubramanian S, 2011, MOL PHARMACOL, V80, P870, DOI 10.1124/mol.111.072363; Banks EB, 1999, BIOCHEM J, V337, P507, DOI 10.1042/0264-6021:3370507; Banks EB, 1998, BIOCHEM J, V331, P61, DOI 10.1042/bj3310061; Bhamre S, 2009, PROSTATE, V69, P181, DOI 10.1002/pros.20869; Brooks CL, 2011, PROTEIN CELL, V2, P456, DOI 10.1007/s13238-011-1063-9; Charlot JF, 2006, APOPTOSIS, V11, P813, DOI 10.1007/s10495-006-5876-6; Chen MJ, 2012, EVID-BASED COMPL ALT, V2012, P1, DOI 10.1155/2012/415231; Cheng F, 2009, MOL BIOL CELL, V20, P319, DOI 10.1091/mbc.E08-07-0681; Chew YC, 2011, J BIOL CHEM, V286, P28772, DOI 10.1074/jbc.M110.205245; Cho SD, 2005, NUTR CANCER, V52, P213, DOI 10.1207/s15327914nc5202_11; Clarke JD, 2011, MOL NUTR FOOD RES, V55, P999, DOI 10.1002/mnfr.201000547; Dashwood RH, 2006, CARCINOGENESIS, V27, P344, DOI 10.1093/carcin/bgi253; Dashwood RH, 2007, SEMIN CANCER BIOL, V17, P363, DOI 10.1016/j.semcancer.2007.04.001; DATTO MB, 1995, J BIOL CHEM, V270, P28623, DOI 10.1074/jbc.270.48.28623; Devgan V, 2005, GENE DEV, V19, P1485, DOI 10.1101/gad.341405; Dinkova-Kostova AT, 2006, CANCER LETT, V240, P243, DOI 10.1016/j.canlet.2005.09.012; Eftmova T, 2002, J BIOL CHEM, V277, P31753, DOI 10.1074/jbc.M205098200; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; ELDEIRY WS, 1995, CANCER RES, V55, P2910; Esposito F, 1997, EUR J BIOCHEM, V245, P730, DOI 10.1111/j.1432-1033.1997.00730.x; FRIED RM, 1988, ENDOCRINOLOGY, V122, P2467, DOI 10.1210/endo-122-6-2467; Gao XQ, 2001, P NATL ACAD SCI USA, V98, P15221, DOI 10.1073/pnas.261572998; Go JH, 2003, MODERN PATHOL, V16, P752, DOI 10.1097/01.MP.0000081728.21368.85; Gorospe M, 1999, GENE EXPRESSION, V7, P377; Hamsa TP, 2011, DRUG CHEM TOXICOL, V34, P332, DOI 10.3109/01480545.2010.538694; Hauser P, 2004, MOL CANCER RES, V2, P96; Helton ES, 2007, J CELL BIOCHEM, V100, P883, DOI 10.1002/jcb.21091; Herman-Antosiewicz A, 2007, MOL CANCER THER, V6, P1673, DOI 10.1158/1535-7163.MCT-06-0807; Ho E, 2009, J NUTR, V139, P2393, DOI 10.3945/jn.109.113332; Inohara S, 1996, BRIT J DERMATOL, V135, P717; Jakubikova J, 2005, BIOCHEM PHARMACOL, V69, P1543, DOI 10.1016/j.bcp.2005.03.015; Jeon YK, 2011, BBA-PROTEINS PROTEOM, V1814, P1340, DOI 10.1016/j.bbapap.2011.05.015; Kawamata N, 2005, EUR J HAEMATOL, V74, P424, DOI 10.1111/j.1600-0609.2005.00417.x; Kim JH, 2010, J CLIN BIOCHEM NUTR, V46, P60, DOI 10.3164/jcbn.09-65; Koutsodontis G, 2002, BIOCHEMISTRY-US, V41, P12771, DOI 10.1021/bi026141q; Kwak MK, 2010, TOXICOL APPL PHARM, V244, P66, DOI 10.1016/j.taap.2009.08.028; Kwak MK, 2003, MOL CELL BIOL, V23, P8786, DOI 10.1128/MCB.23.23.8786-8794.2003; Kwak MK, 2001, MUTAT RES-FUND MOL M, V480, P305, DOI 10.1016/S0027-5107(01)00190-7; Lee TH, 2000, ONCOGENE, V19, P3766, DOI 10.1038/sj.onc.1203715; Majid S, 2008, CANCER RES, V68, P2736, DOI 10.1158/0008-5472.CAN-07-2290; Mandal S, 2010, J CELL PHYSIOL, V224, P28, DOI 10.1002/jcp.22078; Matsuta M, 1997, J DERMATOL SCI, V14, P233, DOI 10.1016/S0923-1811(96)00579-8; McVean M, 2000, CARCINOGENESIS, V21, P633, DOI 10.1093/carcin/21.4.633; Meeran SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011457; Myzak MC, 2006, CARCINOGENESIS, V27, P811, DOI 10.1093/carcin/bgi265; Myzak MC, 2006, FASEB J, V20, P506, DOI 10.1096/fj.05-4785fje; Myzak MC, 2004, CANCER RES, V64, P5767, DOI 10.1158/0008-5472.CAN-04-1326; Myzak MC, 2007, EXP BIOL MED, V232, P227; Nakano K, 1997, J BIOL CHEM, V272, P22199, DOI 10.1074/jbc.272.35.22199; Ocker M, 2007, INT J BIOCHEM CELL B, V39, P1367, DOI 10.1016/j.biocel.2007.03.001; Okuyama R, 2004, J INVEST DERM SYMP P, V9, P248, DOI 10.1111/j.1087-0024.2004.09308.x; Park JW, 2001, BIOCHEM BIOPH RES CO, V280, P244, DOI 10.1006/bbrc.2000.4105; Prowse DM, 1997, J BIOL CHEM, V272, P1308, DOI 10.1074/jbc.272.2.1308; RENBAUM P, 1990, NUCLEIC ACIDS RES, V18, P1145, DOI 10.1093/nar/18.5.1145; Sakao K, 2012, J CELL BIOCHEM, V113, P599, DOI 10.1002/jcb.23386; Schavinsky-Khrapunsky Y, 2003, ONCOGENE, V22, P5315, DOI 10.1038/sj.onc.1206782; SCHWALLER J, 1995, J CLIN INVEST, V95, P973, DOI 10.1172/JCI117806; Shen GX, 2006, CANCER CHEMOTH PHARM, V57, P317, DOI 10.1007/s00280-005-0050-3; Shibata A, 2010, J NUTR BIOCHEM, V21, P702, DOI 10.1016/j.jnutbio.2009.04.007; Singh AV, 2004, CARCINOGENESIS, V25, P83, DOI 10.1093/carcin/bgg178; Traka M, 2005, J NUTR, V135, P1865, DOI 10.1093/jn/135.8.1865; UDVADIA AJ, 1995, P NATL ACAD SCI USA, V92, P3953, DOI 10.1073/pnas.92.9.3953; Wagner AE, 2010, EXP DERMATOL, V19, P137, DOI 10.1111/j.1600-0625.2009.00928.x; Weinberg WC, 1999, CANCER RES, V59, P2050; Wong PP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008369; Wu JH, 2004, ONCOGENE, V23, P8088, DOI 10.1038/sj.onc.1207996; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Xu CJ, 2006, CANCER RES, V66, P8293, DOI 10.1158/0008-5472.CAN-06-0300; Ying JM, 2004, BLOOD, V103, P743, DOI 10.1182/blood-2003-09-3193; Yokota T, 2004, ONCOGENE, V23, P5340, DOI 10.1038/sj.onc.1207689; Zeng YX, 1997, NAT GENET, V15, P78, DOI 10.1038/ng0197-78; Zhu M, 2004, MOL CARCINOGEN, V41, P179, DOI 10.1002/mc.20052	76	39	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16168	16178		10.1074/jbc.M111.305292	http://dx.doi.org/10.1074/jbc.M111.305292			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22427654	Green Published, hybrid			2022-12-25	WOS:000304030900009
J	Gupta, S; Pawaria, S; Lu, C; Hade, MD; Singh, C; Yeh, SR; Dikshit, KL				Gupta, Sanjay; Pawaria, Sudesh; Lu, Changyuan; Hade, Mangesh Dattu; Singh, Chaahat; Yeh, Syun-Ru; Dikshit, Kanak L.			An Unconventional Hexacoordinated Flavohemoglobin from Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-LACTATE DEHYDROGENASE; ESCHERICHIA-COLI FLAVOHEMOGLOBIN; RESONANCE RAMAN-SPECTROSCOPY; NITRIC-OXIDE; BACTERIAL HEMOGLOBINS; CAMPYLOBACTER-JEJUNI; NITROSATIVE STRESS; RESPIRATORY ENZYME; PURIFICATION; ADAPTATION	Being an obligate aerobe, Mycobacterium tuberculosis faces a number of energetic challenges when it encounters hypoxia and environmental stress during intracellular infection. Consequently, it has evolved innovative strategies to cope with these unfavorable conditions. Here, we report a novel flavohemoglobin (MtbFHb) from M. tuberculosis that exhibits unique features within its heme and reductase domains distinct from conventional FHbs, including the absence of the characteristic hydrogen bonding interactions within the proximal heme pocket and mutations in the FAD and NADH binding regions of the reductase domain. In contrast to conventional FHbs, it has a hexacoordinate low-spin heme with a proximal histidine ligand lacking imidazolate character and a distal heme pocket with a relatively low electrostatic potential. Additionally, MtbFHb carries a new FAD binding site in its reductase domain similar to that of D-lactate dehydrogenase (D-LDH). When overexpressed in Escherichia coli or Mycobacterium smegmatis, MtbFHb remained associated with the cell membrane and exhibited D-lactate: phenazine methosulfate reductase activity and oxidized D-lactate into pyruvate by converting the heme iron from Fe3+ to Fe2+ in a FAD-dependent manner, indicating electron transfer from D-lactate to the heme via FAD cofactor. Under oxidative stress, MtbFHb-expressing cells exhibited growth advantage with reduced levels of lipid peroxidation. Given the fact that D-lactate is a byproduct of lipid peroxidation and that M. tuberculosis lacks the gene encoding D-LDH, we propose that the novel D-lactate metabolizing activity of MtbFHb uniquely equips M. tuberculosis to balance the stress level by protecting the cell membrane from oxidative damage via cycling between the Fe3+/Fe2+ redox states.	[Gupta, Sanjay; Pawaria, Sudesh; Hade, Mangesh Dattu; Singh, Chaahat; Dikshit, Kanak L.] CSIR, Inst Microbial Technol, Chandigarh 160036, India; [Lu, Changyuan; Yeh, Syun-Ru] Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); Yeshiva University; Albert Einstein College of Medicine	Dikshit, KL (corresponding author), CSIR, Inst Microbial Technol, Sect 39 A, Chandigarh 160036, India.	kanak@imtech.res.in	Hade, Mangesh/AAF-7217-2019; Hade, Mangesh/ABD-8535-2021	Hade, Mangesh/0000-0002-5937-9049; Yeh, Syun-Ru/0000-0002-9858-386X	Council of Scientific and Industrial Research [SIP-10]; National Science Foundation [0956358]; DST; Council of Scientific & Industrial Research, India	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); National Science Foundation(National Science Foundation (NSF)); DST(Department of Science & Technology (India)); Council of Scientific & Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by Council of Scientific and Industrial Research under Supra institutional project SIP-10 (to K. L. D.) and National Science Foundation Grant 0956358 (to S.-R. Y.).; Supported by DST.; Supported by the Council of Scientific & Industrial Research, India.	Ali MA, 2000, FREE RADICAL RES, V32, P429, DOI 10.1080/10715760000300431; Anaraku Y., 1987, TRENDS BIOCHEM SCI, V12, P262; Appleby C A, 1978, Methods Enzymol, V52, P157; Bentrup KHZ, 2001, TRENDS MICROBIOL, V9, P597, DOI 10.1016/S0966-842X(01)02238-7; Berney M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008614; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bonamore A, 2003, J BIOL CHEM, V278, P22272, DOI 10.1074/jbc.M301285200; Bonamore A, 2008, IUBMB LIFE, V60, P19, DOI 10.1002/iub.9; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; D'Angelo P, 2004, BIOPHYS J, V86, P3882, DOI 10.1529/biophysj.103.034876; Dym O, 2001, PROTEIN SCI, V10, P1712, DOI 10.1110/ps.12801; Dym O, 2000, P NATL ACAD SCI USA, V97, P9413, DOI 10.1073/pnas.97.17.9413; Egawa T, 2005, J INORG BIOCHEM, V99, P72, DOI 10.1016/j.jinorgbio.2004.10.017; Frey AD, 2002, APPL ENVIRON MICROB, V68, P4835, DOI 10.1128/AEM.68.10.4835-4840.2002; Frey AD, 2003, FEMS MICROBIOL REV, V27, P525, DOI 10.1016/S0168-6445(03)00056-1; FUTAI M, 1977, J BIOL CHEM, V252, P5820; Gardner PR, 1998, P NATL ACAD SCI USA, V95, P10378, DOI 10.1073/pnas.95.18.10378; GEORGE KM, 1995, J BIOL CHEM, V270, P27292, DOI 10.1074/jbc.270.45.27292; Gupta S, 2011, IUBMB LIFE, V63, P337, DOI 10.1002/iub.460; Hausladen A, 1998, P NATL ACAD SCI USA, V95, P14100, DOI 10.1073/pnas.95.24.14100; Horikiri S, 2004, BIOSCI BIOTECH BIOCH, V68, P516, DOI 10.1271/bbb.68.516; Hunte C, 2005, BIOCHEM SOC T, V33, P938, DOI 10.1042/BST0330938; Jackson M, 2007, TUBERCULOSIS, V87, P78, DOI 10.1016/j.tube.2006.05.003; JAHNKE LL, 1986, J BACTERIOL, V167, P238, DOI 10.1128/jb.167.1.238-242.1986; Kimura S, 2001, J BIOCHEM, V130, P481, DOI 10.1093/oxfordjournals.jbchem.a003010; Lewis JA, 2006, J BACTERIOL, V188, P5479, DOI 10.1128/JB.00514-06; Lu CY, 2008, METHOD ENZYMOL, V437, P255, DOI 10.1016/S0076-6879(07)37014-6; Manjunatha Ujjini, 2009, Commun Integr Biol, V2, P215; MARKWELL JP, 1978, J BACTERIOL, V133, P593, DOI 10.1128/JB.133.2.593-600.1978; Megehee JA, 2006, MICROBIOL-SGM, V152, P823, DOI 10.1099/mic.0.28723-0; Membrillo-Hernandez J, 1999, J BIOL CHEM, V274, P748, DOI 10.1074/jbc.274.2.748; Mowat CG, 2010, ARCH BIOCHEM BIOPHYS, V493, P37, DOI 10.1016/j.abb.2009.10.005; Mukai M, 2001, J BIOL CHEM, V276, P7272, DOI 10.1074/jbc.M009280200; OLSON ST, 1979, BIOCHEMISTRY-US, V18, P4714, DOI 10.1021/bi00588a036; Ouellett H, 2002, P NATL ACAD SCI USA, V99, P5902, DOI 10.1073/pnas.092017799; Pathania R, 2002, J BIOL CHEM, V277, P15293, DOI 10.1074/jbc.M111478200; Pathania R, 2002, MOL MICROBIOL, V45, P1303, DOI 10.1046/j.1365-2958.2002.03095.x; Pawaria S, 2008, APPL ENVIRON MICROB, V74, P3512, DOI 10.1128/AEM.02663-07; Pinchuk GE, 2009, P NATL ACAD SCI USA, V106, P2874, DOI 10.1073/pnas.0806798106; Rachman H, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000029; Rinaldi AC, 2006, BIOCHEMISTRY-US, V45, P4069, DOI 10.1021/bi052277n; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Schwab U, 2009, MICROB PATHOGENESIS, V46, P185, DOI 10.1016/j.micpath.2008.12.006; Singh R, 2004, J BIOL CHEM, V279, P43098, DOI 10.1074/jbc.M406374200; Tailleux L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001403; Thomas MT, 2011, ENVIRON MICROBIOL, V13, P48, DOI 10.1111/j.1462-2920.2010.02307.x; ThonyMeyer L, 1997, MICROBIOL MOL BIOL R, V61, P337; Tischler AD, 2010, CURR OPIN MICROBIOL, V13, P93, DOI 10.1016/j.mib.2009.12.007; Voskuil MI, 2004, TUBERCULOSIS, V84, P218, DOI 10.1016/j.tube.2004.02.003; Zahrt TC, 2002, ANTIOXID REDOX SIGN, V4, P141, DOI 10.1089/152308602753625924; Zhou SM, 2009, BIOCHEM BIOPH RES CO, V381, P7, DOI 10.1016/j.bbrc.2009.01.112	52	10	11	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16435	16446		10.1074/jbc.M111.329920	http://dx.doi.org/10.1074/jbc.M111.329920			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22437825	hybrid, Green Published			2022-12-25	WOS:000304030900034
J	Koles, K; Nunnari, J; Korkut, C; Barria, R; Brewer, C; Li, YH; Leszyk, J; Zhang, B; Budnik, V				Koles, Kate; Nunnari, John; Korkut, Ceren; Barria, Romina; Brewer, Cassandra; Li, Yihang; Leszyk, John; Zhang, Bing; Budnik, Vivian			Mechanism of Evenness Interrupted (Evi)-Exosome Release at Synaptic Boutons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOSIN-V; DROSOPHILA PHOTORECEPTORS; MULTIVESICULAR ENDOSOMES; GENE-EXPRESSION; NERVOUS WRECK; B-LYMPHOCYTES; RAB GTPASES; T-CELLS; EXOSOMES; PROTEIN	Wnt signaling plays critical roles during synaptic development and plasticity. However, the mechanisms by which Wnts are released and travel to target cells are unresolved. During synaptic development, the secretion of Drosophila Wnt1, Wingless, requires the function of Evenness Interrupted (Evi)/Wls, a Wingless-binding protein that is secreted along with Wingless at the neuromuscular junction. Given that Evi is a transmembrane protein, these studies suggested the presence of a novel vesicular mechanism of trans-synaptic communication, potentially in the form of exosomes. To establish the mechanisms for the release of Evi vesicles, we used a dsRNA assay in cultured cells to screen for genes that when down-regulated prevent the release of Evi vesicles. We identified two proteins, Rab11 and Syntaxin 1A (Syx1A), that were required for Evi vesicle release. To determine whether the same mechanisms were used in vivo at the neuromuscular junction, we altered the activity of Rab11 and Syx1A in motoneurons and determined the impact on Evi release. We found that Syx1A, Rab11, and its effector Myosin5 were required for proper Evi vesicle release. Furthermore, ultrastructural analysis of synaptic boutons demonstrated the presence of multivesicular bodies, organelles involved in the production and release of exosomes, and these multivesicular bodies contained Evi. We also used mass spectrometry, electron microscopy, and biochemical techniques to characterize the exosome fraction from cultured cells. Our studies revealed that secreted Evi vesicles show remarkable conservation with exosomes in other systems. In summary, our observations unravel some of the in vivo mechanisms required for Evi vesicle release.	[Koles, Kate; Nunnari, John; Korkut, Ceren; Barria, Romina; Brewer, Cassandra; Li, Yihang; Budnik, Vivian] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA; [Leszyk, John] Univ Massachusetts, Sch Med, Prote Core, Worcester, MA 01605 USA; [Zhang, Bing] Univ Oklahoma, Dept Zool, Norman, OK 73019 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Oklahoma System; University of Oklahoma - Norman	Koles, K (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, 364 Plantat St, Worcester, MA 01605 USA.	kate.koles@umassmed.edu; Vivian.budnik@umassmed.edu		Tezer, Ceren/0000-0001-9276-3264	National Institutes of Health [R01 MH0700000, R01 NS06878]; Mizutani Foundation [090054]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070000] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mizutani Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 MH0700000 (to V. B.) and Grant R01 NS06878 (to the B. Z. laboratory). This work was also supported by Mizutani Foundation Grant 090054 (to K. K.).	Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Aline F, 2004, INFECT IMMUN, V72, P4127, DOI 10.1128/IAI.72.7.4127-4137.2004; Babst M, 2011, CURR OPIN CELL BIOL, V23, P452, DOI 10.1016/j.ceb.2011.04.008; Bartscherer K, 2006, CELL, V125, P523, DOI 10.1016/j.cell.2006.04.009; Bhattacharya S, 2002, P NATL ACAD SCI USA, V99, P13867, DOI 10.1073/pnas.202335999; BRAND AH, 1993, DEVELOPMENT, V118, P401; Budnik V, 1996, NEURON, V17, P627, DOI 10.1016/S0896-6273(00)80196-8; Chan CC, 2011, CURR BIOL, V21, P1704, DOI 10.1016/j.cub.2011.08.058; Coombs GS, 2010, J CELL SCI, V123, P3357, DOI 10.1242/jcs.072132; Deregibus MC, 2007, BLOOD, V110, P2440, DOI 10.1182/blood-2007-03-078709; Desnos C, 2007, BIOL CELL, V99, P411, DOI 10.1042/BC20070021; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; Fang Y, 2007, PLOS BIOL, V5, P1267, DOI 10.1371/journal.pbio.0050158; Graf ER, 2009, NEURON, V64, P663, DOI 10.1016/j.neuron.2009.11.002; Harden N, 1996, MOL CELL BIOL, V16, P1896; Hawari FI, 2004, P NATL ACAD SCI USA, V101, P1297, DOI 10.1073/pnas.0307981100; Hsu C, 2010, J CELL BIOL, V189, P223, DOI 10.1083/jcb.200911018; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Hwang I, 2011, FRONT BIOSCI-LANDMRK, V16, P411, DOI 10.2741/3695; JIA XX, 1993, J NEUROBIOL, V24, P1025, DOI 10.1002/neu.480240804; Johnstone RM, 2006, BLOOD CELL MOL DIS, V36, P315, DOI 10.1016/j.bcmd.2005.12.001; Johnstone RM, 2005, BLOOD CELL MOL DIS, V34, P214, DOI 10.1016/j.bcmd.2005.03.002; Khodosh R, 2006, DEVELOPMENT, V133, P4655, DOI 10.1242/dev.02650; Koles K, 2004, J BIOL CHEM, V279, P4346, DOI 10.1074/jbc.M309912200; Kolotuev I, 2009, TRAFFIC, V10, P803, DOI [10.1111/j.1600-0854.2009.00871.x, 10.1111/j.1600-0854.2008.00871.x]; Kopczynski CC, 1996, SCIENCE, V271, P1867, DOI 10.1126/science.271.5257.1867; Korkut C, 2009, CELL, V139, P393, DOI 10.1016/j.cell.2009.07.051; Lachenal G, 2011, MOL CELL NEUROSCI, V46, P409, DOI 10.1016/j.mcn.2010.11.004; Lagow RD, 2007, PLOS BIOL, V5, P800, DOI 10.1371/journal.pbio.0050072; Lee TH, 2011, SEMIN IMMUNOPATHOL, V33, P455, DOI 10.1007/s00281-011-0250-3; Li BX, 2007, J CELL BIOL, V177, P659, DOI 10.1083/jcb.200610157; Littleton JT, 1998, NEURON, V21, P401, DOI 10.1016/S0896-6273(00)80549-8; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lubec G, 2007, CHEM REV, V107, P3568, DOI 10.1021/cr068213f; Matsuo H, 2004, SCIENCE, V303, P531, DOI 10.1126/science.1092425; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Nolte-'t Hoen ENM, 2009, BLOOD, V113, P1977, DOI 10.1182/blood-2008-08-174094; O'Connor-Giles KM, 2008, NEURON, V58, P507, DOI 10.1016/j.neuron.2008.03.007; O'Connor-Giles KM, 2008, FLY, V2, DOI 10.4161/fly.7133; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Perrimon N, 1996, GENETICS, V144, P1681; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Rodal AA, 2008, J NEUROSCI, V28, P8316, DOI 10.1523/JNEUROSCI.2304-08.2008; Rohn JL, 2011, J CELL BIOL, V194, P789, DOI 10.1083/jcb.201103168; Roland JT, 2011, P NATL ACAD SCI USA, V108, P2789, DOI 10.1073/pnas.1010754108; Sahu R, 2011, DEV CELL, V20, P131, DOI 10.1016/j.devcel.2010.12.003; Sathyanarayanan S, 2008, GENE DEV, V22, P1522, DOI 10.1101/gad.1652308; Satoh AK, 2005, DEVELOPMENT, V132, P1487, DOI 10.1242/dev.01704; Savina A, 2005, TRAFFIC, V6, P131, DOI 10.1111/j.1600-0854.2004.00257.x; Schluter OM, 2006, J NEUROSCI, V26, P1239, DOI 10.1523/JNEUROSCI.3553-05.2006; SCHULZE KL, 1995, CELL, V80, P311, DOI 10.1016/0092-8674(95)90414-X; Simpson RJ, 2008, PROTEOMICS, V8, P4083, DOI 10.1002/pmic.200800109; Simpson RJ, 2009, EXPERT REV PROTEOMIC, V6, P267, DOI [10.1586/epr.09.17, 10.1586/EPR.09.17]; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; Subra C, 2010, J LIPID RES, V51, P2105, DOI 10.1194/jlr.M003657; Tamai K, 2010, BIOCHEM BIOPH RES CO, V399, P384, DOI 10.1016/j.bbrc.2010.07.083; Thery Clotilde, 2011, F1000 Biol Rep, V3, P15, DOI 10.3410/B3-15; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Trybus KM, 2008, CELL MOL LIFE SCI, V65, P1378, DOI 10.1007/s00018-008-7507-6; Tsuda M, 2006, FEBS LETT, V580, P3296, DOI 10.1016/j.febslet.2006.05.005; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Watanabe M, 2005, MOL BIOL CELL, V16, P4519, DOI 10.1091/mbc.E05-03-0252; Wendler F, 2010, EMBO J, V29, P304, DOI 10.1038/emboj.2009.350; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451; Wu CC, 2004, MOL BIOL CELL, V15, P2907, DOI 10.1091/mbc.E04-02-0101; Yates JR, 2005, NAT REV MOL CELL BIO, V6, P702, DOI 10.1038/nrm1711; Zhang J, 2007, GENETICS, V176, P1307, DOI 10.1534/genetics.106.066761	72	187	194	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16820	16834		10.1074/jbc.M112.342667	http://dx.doi.org/10.1074/jbc.M112.342667			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22437826	Green Published, hybrid			2022-12-25	WOS:000304030900069
J	Perez, B; Paquette, N; Paidassi, H; Zhai, B; White, K; Skvirsky, R; Lacy-Hulbert, A; Stuart, LM				Perez, Beatriz; Paquette, Nicholas; Paidassi, Helena; Zhai, Bo; White, Kristin; Skvirsky, Rachel; Lacy-Hulbert, Adam; Stuart, Lynda M.			Apoptotic Cells Can Deliver Chemotherapeutics to Engulfing Macrophages and Suppress Inflammatory Cytokine Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; CALRETICULIN EXPOSURE; CLEARANCE; IMMUNOGENICITY; PHAGOCYTOSIS; NEUTROPHILS; CANCER; BETA	Immunosuppression via cell-cell contact with apoptotic cells is a well studied immunological phenomenon. Although the original studies of immune repression used primary cells, which undergo spontaneous cell death or apoptosis in response to irradiation, more recent studies have relied on chemotherapeutic agents to induce apoptosis in cell lines. In this work, we demonstrate that Jurkat cells induced to die with actinomycin D suppressed inflammatory cytokine production by macrophages, whereas cells treated with etoposide did not. This immune repression mediated by actinomycin D-treated cells did not require phagocytosis or cell-cell contact and thus occurs through a different mechanism from that seen with primary apoptotic neutrophils. Moreover, cells induced to die with etoposide and then treated for a short time with actinomycin D also suppressed macrophage responses, indicating that suppression was mediated by actinomycin D independent of the mechanism of cell death. Finally, phagocytosis of actinomycin D-treated cells caused apoptosis in macrophages, and suppression could be blocked by inhibition of caspase activity in the target macrophage. Together, these data indicate that apoptotic cells act as "Trojan horses," delivering actinomycin D to engulfing macrophages. Suppression of cytokine production by macrophages is therefore due to exposure to actinomycin D from apoptotic cells and is not the result of cell-receptor interactions. These data suggest that drug-induced death may not be an appropriate surrogate for the immunosuppressive activity of apoptotic cells. Furthermore, these effects of cytotoxic drugs on infiltrating immune phagocytes may have clinical ramifications for their use as antitumor therapies.	[Perez, Beatriz; Paquette, Nicholas; Paidassi, Helena; Lacy-Hulbert, Adam; Stuart, Lynda M.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Program Dev Immunol, Boston, MA 02114 USA; [Zhai, Bo; White, Kristin] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Cutaneous Biol Res Ctr, Boston, MA 02114 USA; [Perez, Beatriz; Skvirsky, Rachel] Univ Massachusetts Boston, Dept Biol, Boston, MA 02125 USA; [Paidassi, Helena] Univ Edinburgh, MRC Ctr Inflammat Res, Edinburgh EH16 4TJ, Midlothian, Scotland	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Massachusetts System; University of Massachusetts Boston; University of Edinburgh	Stuart, LM (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Program Dev Immunol, Jackson 14,55 Fruit St, Boston, MA 02114 USA.	lstuart@partners.org	Paidassi, Helena/M-5739-2014	Lacy-Hulbert, Adam/0000-0003-2162-0156; Paidassi, Helena/0000-0001-9915-4365	National Institutes of Health [RO1AI79198, U24A1082660, NIH R25GM076321, 5RO1 GM069541]; National Science Foundation [EHR0412390]; NIH/NERCE [U54AI057159]; UK Medical Research Council [G0802069]; Medical Research Council [G0802069] Funding Source: researchfish; MRC [G0802069] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079198, U54AI057159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069541, R25GM076321] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NIH/NERCE; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1AI79198 and U24A1082660 (to L. M. S.), NIH R25GM076321 (to R. S.), and 5RO1 GM069541 (to K. W.) and a National Science Foundation Grant EHR0412390 (to R. S.). Additionally, N. P. was supported by NIH/NERCE Grant U54AI057159, and H. P. was supported by UK Medical Research Council Grant G0802069.	Burden DA, 1998, BBA-GENE STRUCT EXPR, V1400, P139, DOI 10.1016/S0167-4781(98)00132-8; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Herrmann M, 1998, ARTHRITIS RHEUM-US, V41, P1241, DOI 10.1002/1529-0131(199807)41:7<1241::AID-ART15>3.0.CO;2-H; Imbert TF, 1998, BIOCHIMIE, V80, P207, DOI 10.1016/S0300-9084(98)80004-7; Kozmar A, 2010, J INNATE IMMUN, V2, P248, DOI 10.1159/000295790; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Lucas M, 2003, J IMMUNOL, V171, P2610, DOI 10.4049/jimmunol.171.5.2610; Lucas M, 2006, J IMMUNOL, V177, P4047, DOI 10.4049/jimmunol.177.6.4047; O'Brien BA, 2002, CELL DEATH DIFFER, V9, P457, DOI 10.1038/sj.cdd.4400973; Obeid M, 2007, CELL DEATH DIFFER, V14, P1848, DOI 10.1038/sj.cdd.4402201; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Pan JX, 2001, BBA-GEN SUBJECTS, V1527, P1, DOI 10.1016/S0304-4165(01)00152-0; Ren Y, 2003, ARTHRITIS RHEUM, V48, P2888, DOI 10.1002/art.11237; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Stuart LM, 2002, J IMMUNOL, V168, P1627, DOI 10.4049/jimmunol.168.4.1627; Vandivier RW, 2002, CHEST, V121, p89S, DOI 10.1378/chest.121.3_suppl.89S; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; WARING MJ, 1981, ANNU REV BIOCHEM, V50, P159, DOI 10.1146/annurev.bi.50.070181.001111	19	8	8	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					16029	16036		10.1074/jbc.M112.340489	http://dx.doi.org/10.1074/jbc.M112.340489			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22433861	hybrid, Green Published			2022-12-25	WOS:000304006300080
J	Meng, ZW; Lou, SS; Tan, J; Xu, K; Jia, Q; Zheng, W				Meng, Zhaowei; Lou, Shanshan; Tan, Jian; Xu, Ke; Jia, Qiang; Zheng, Wei			Nuclear Factor-Kappa B Inhibition Can Enhance Apoptosis of Differentiated Thyroid Cancer Cells Induced by I-131	PLOS ONE			English	Article							IN-VITRO; CARCINOMA; DEHYDROXYMETHYLEPOXYQUINOMICIN; PROGRESSION; BORTEZOMIB; THERAPIES; TARGET; LINE; RNA	Objective: To evaluate changes of nuclear factor-kappa B (NF-kappa B) during radioiodine 131(I-131) therapy and whether NF-kappa B inhibition could enhance I-131-induced apoptosis in differentiated thyroid cancer (DTC) cells in a synergistic manner. Methods: Three human DTC cell lines were used. NF-kappa B inhibition was achieved by using a NF-kappa B inhibitor (Bay 11-7082) or by p65 siRNA transfection. Methyl-thiazolyl-tetrazolium assay was performed for cell viability assessment. DNA-binding assay, luciferase reporter assay, and Western blot were adopted to determine function and expression changes of NF-kappa B. Then NF-kappa B regulated anti-apoptotic factors XIAP, cIAP1, and Bcl-xL were measured. Apoptosis was analyzed by Western blot for caspase 3 and PARP, and by flow cytometry as well. An iodide uptake assay was performed to determine whether NF-kappa B inhibition could influence radioactive iodide uptake. Results: The methyl-thiazolyl-tetrazolium assay showed significant decrease of viable cells by combination therapy than by mono-therapies. The DNA-binding assay and luciferase reporter assay showed enhanced NF-kappa B function and reporter gene activities due to I-131, yet significant suppression was achieved by NF-kappa B inhibition. Western blot proved I-131 could increase nuclear NF-kappa B concentration, while NF-kappa B inhibition reduced NF-kappa B concentration. Western blot also demonstrated significant up-regulation of XIAP, cIAP1, and Bcl-xL after I-131 therapy. And inhibition of NF-kappa B could significantly down-regulate these factors. Finally, synergism induced by combined therapy was displayed by significant enhancements of cleaved caspase 3 and PARP from Western blot, and of Annexin V positively staining from flow cytometry. The iodine uptake assay did not show significant changes when NF-kappa B was inhibited. Conclusion: We demonstrated that I-131 could induce NF-kappa B activation, which would attenuate I-131 efficacy in DTC cells. NF-kappa B inhibition by Bay 11-7082 or by p65 siRNA transfection was effective in suppressing NF-kappa B regulated anti-apoptotic changes and in combined regimen apoptosis was achieved synergistically.	[Meng, Zhaowei; Lou, Shanshan; Tan, Jian; Jia, Qiang; Zheng, Wei] Tianjin Med Univ, Gen Hosp, Dept Nucl Med, Tianjin, Peoples R China; [Lou, Shanshan] Tianjin Normal Univ, Tianjin, Peoples R China; [Xu, Ke] Tianjin Med Univ, Gen Hosp, Tianjin Lung Canc Inst, Tianjin Key Lab Lung Canc Metastasis & Tumor Micr, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Normal University; Tianjin Medical University	Meng, ZW (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Nucl Med, Tianjin, Peoples R China.	james_mencius@hotmail.com	Meng, Zhaowei/AAE-4732-2022; Zheng, Wei/AAB-4413-2021	Zheng, Wei/0000-0003-1206-9243; Migliaccio, Antimo/0000-0002-4197-2055	China National Natural Science Foundation [30900376]; Tianjin Science and Technology Committee Foundation [10JCZDJC19000]; Tianjin Medical University [2008KY20]	China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Tianjin Science and Technology Committee Foundation; Tianjin Medical University	This investigation was supported by China National Natural Science Foundation grant 30900376, Key Project of Tianjin Science and Technology Committee Foundation grant 10JCZDJC19000, Tianjin Medical University Scientific Research grant 2008KY20, and Tianjin Medical University New Century Excellent Talent Program (awarded to ZM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Davies L, 2006, JAMA-J AM MED ASSOC, V295, P2164, DOI 10.1001/jama.295.18.2164; Duan JM, 2007, MOL CANCER THER, V6, P37, DOI 10.1158/1535-7163.MCT-05-0285; Durante C, 2006, J CLIN ENDOCR METAB, V91, P2892, DOI 10.1210/jc.2005-2838; Eustatia-Rutten CFA, 2006, J CLIN ENDOCR METAB, V91, P313, DOI 10.1210/jc.2005-1322; Ganti AK, 2006, REV RECENT CLIN TRIA, V1, P133, DOI 10.2174/157488706776876526; Guo J, 2004, CLIN CANCER RES, V10, P3333, DOI 10.1158/1078-0432.CCR-03-0366; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kucharczak J, 2003, ONCOGENE, V22, P8961, DOI 10.1038/sj.onc.1207230; Marx K, 2006, NUCL MED COMMUN, V27, P353, DOI 10.1097/01.mnm.0000199475.08407.e2; Meng ZW, 2008, ENDOCRINOLOGY, V149, P5357, DOI 10.1210/en.2008-0279; Mitsiades CS, 2006, J CLIN ENDOCR METAB, V91, P4013, DOI 10.1210/jc.2005-2472; Namba H, 2007, ARQ BRAS ENDOCRINOL, V51, P843, DOI 10.1590/S0004-27302007000500023; O'Neill CJ, 2010, ONCOLOGIST, V15, P146, DOI 10.1634/theoncologist.2009-0190; Pacifico F, 2004, J BIOL CHEM, V279, P54610, DOI 10.1074/jbc.M403492200; Pacifico F, 2010, MOL CELL ENDOCRINOL, V321, P29, DOI 10.1016/j.mce.2009.10.010; Palona I, 2006, ENDOCRINOLOGY, V147, P5699, DOI 10.1210/en.2006-0400; Pfister DG, 2008, J CLIN ONCOL, V26, P4701, DOI 10.1200/JCO.2008.17.3682; Starenki D, 2004, J CLIN ENDOCR METAB, V89, P410, DOI 10.1210/jc.2003-031216; Starenki DV, 2004, CLIN CANCER RES, V10, P6821, DOI 10.1158/1078-0432.CCR-04-0463; Tan J, 2009, CLIN NUCL MED, V34, P615, DOI 10.1097/RLU.0b013e3181b06b2d; Visconti R, 1997, ONCOGENE, V15, P1987, DOI 10.1038/sj.onc.1201373; Wang CM, 2012, MOL CELL BIOCHEM, V359, P125, DOI 10.1007/s11010-011-1006-z; WEISS SJ, 1984, ENDOCRINOLOGY, V114, P1090, DOI 10.1210/endo-114-4-1090; Woyach JA, 2009, ENDOCR-RELAT CANCER, V16, P715, DOI 10.1677/ERC-08-0335; Wu W, 2010, TUMOR BIOL, V31, P605, DOI 10.1007/s13277-010-0076-y; Wu XA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-269	27	34	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33597	10.1371/journal.pone.0033597	http://dx.doi.org/10.1371/journal.pone.0033597			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438958	Green Published, gold, Green Submitted			2022-12-25	WOS:000303309100066
J	Hubert, N; Meyer, CP; Bruggemann, HJ; Guerin, F; Komeno, RJL; Espiau, B; Causse, R; Williams, JT; Planes, S				Hubert, Nicolas; Meyer, Christopher P.; Bruggemann, Henrich J.; Guerin, Fabien; Komeno, Roberto J. L.; Espiau, Benoit; Causse, Romain; Williams, Jeffrey T.; Planes, Serge			Cryptic Diversity in Indo-Pacific Coral-Reef Fishes Revealed by DNA-Barcoding Provides New Support to the Centre-of-Overlap Hypothesis	PLOS ONE			English	Article							BIODIVERSITY HOTSPOTS; MARINE BIODIVERSITY; HISTORICAL BIOGEOGRAPHY; CONSERVATION; PATTERNS; PHYLOGEOGRAPHY; CONSEQUENCES; TELEOSTEI; DIVERSIFICATION; MITOCHONDRIAL	Diversity in coral reef fishes is not evenly distributed and tends to accumulate in the Indo-Malay-Philippines Archipelago (IMPA). The comprehension of the mechanisms that initiated this pattern is in its infancy despite its importance for the conservation of coral reefs. Considering the IMPA either as an area of overlap or a cradle of marine biodiversity, the hypotheses proposed to account for this pattern rely on extant knowledge about taxonomy and species range distribution. The recent large-scale use of standard molecular data (DNA barcoding), however, has revealed the importance of taking into account cryptic diversity when assessing tropical biodiversity. We DNA barcoded 2276 specimens belonging to 668 coral reef fish species through a collaborative effort conducted concomitantly in both Indian and Pacific oceans to appraise the importance of cryptic diversity in species with an Indo-Pacific distribution range. Of the 141 species sampled on each side of the IMPA, 62 presented no spatial structure whereas 67 exhibited divergent lineages on each side of the IMPA with K2P distances ranging between 1% and 12%, and 12 presented several lineages with K2P distances ranging between 3% and 22%. Thus, from this initial pool of 141 nominal species with Indo-Pacific distribution, 79 dissolved into 165 biological units among which 162 were found in a single ocean. This result is consistent with the view that the IMPA accumulates diversity as a consequence of its geological history, its location on the junction between the two main tropical oceans and the presence of a land bridge during glacial times in the IMPA that fostered allopatric divergence and secondary contacts between the Indian and Pacific oceans.	[Hubert, Nicolas; Bruggemann, Henrich J.] Univ La Reunion, Lab ECOMAR, Fac Sci & Technol, St Denis, Reunion, France; [Hubert, Nicolas; Espiau, Benoit; Planes, Serge] Univ Perpignan, CNRS EPHE, CRIOBE CBETM, F-66025 Perpignan, France; [Meyer, Christopher P.] Smithsonian Inst, Dept Invertebrate Zool, Natl Museum Nat Hist, Washington, DC 20560 USA; [Guerin, Fabien] Univ La Reunion, UMR PVBMT, Fac Sci & Technol, St Denis, Reunion, France; [Komeno, Roberto J. L.] Univ Toliara, Inst Halieut & Sci Marines, Toliara, Madagascar; [Causse, Romain] Museum Natl Hist Nat, Dept Milieux & Peuplements Aquat, F-75231 Paris, France; [Williams, Jeffrey T.] Smithsonian Inst, Dept Vertebrate Zool, Natl Museum Nat Hist, Washington, DC 20560 USA	University of La Reunion; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite Perpignan Via Domitia; Smithsonian Institution; Smithsonian National Museum of Natural History; University of La Reunion; Museum National d'Histoire Naturelle (MNHN); Smithsonian Institution; Smithsonian National Museum of Natural History	Hubert, N (corresponding author), Univ La Reunion, Lab ECOMAR, Fac Sci & Technol, St Denis, Reunion, France.	nicolas.hubert@ird.fr	PLANES, Serge/ABF-1360-2021	Meyer, Christopher/0000-0003-2501-7952; Hubert, Nicolas/0000-0001-9248-3377	French 'Agence Nationale de Recherche' (ANR) [ANR-06-BDIV-002]; Gordon and Betty Moore Foundation; National Museum of Natural History; UMR PVBMT, Universite de la Reunion; Florida Museum of Natural History; University of California Berkeley - Gump Station, Moorea; Universite Paul Sabatier, Toulouse; French 'Agence Nationale de Recherche' (ANR) [ANR-06-BDIV-002]; Gordon and Betty Moore Foundation; National Museum of Natural History; UMR PVBMT, Universite de la Reunion; Florida Museum of Natural History; University of California Berkeley - Gump Station, Moorea; Universite Paul Sabatier, Toulouse	French 'Agence Nationale de Recherche' (ANR)(French National Research Agency (ANR)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); National Museum of Natural History(Smithsonian InstitutionSmithsonian National Museum of Natural History); UMR PVBMT, Universite de la Reunion; Florida Museum of Natural History; University of California Berkeley - Gump Station, Moorea; Universite Paul Sabatier, Toulouse; French 'Agence Nationale de Recherche' (ANR)(French National Research Agency (ANR)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); National Museum of Natural History(Smithsonian InstitutionSmithsonian National Museum of Natural History); UMR PVBMT, Universite de la Reunion; Florida Museum of Natural History; University of California Berkeley - Gump Station, Moorea; Universite Paul Sabatier, Toulouse	Funding was provided by the French 'Agence Nationale de Recherche' (ANR programme BIOTAS, no. ANR-06-BDIV-002) and by the Gordon and Betty Moore Foundation. We thank the Leonard P. Schultz Fund, National Museum of Natural History for providing travel funding for J. T. Williams. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We thank Dominique Strasberg (UMR PVBMT, Universite de la Reunion), Gustav Paulay (Florida Museum of Natural History), Neil Davies (University of California Berkeley - Gump Station, Moorea) and Christophe Thebaut (Universite Paul Sabatier, Toulouse) for their support; Julien Grignon, David Lecchini, Vanessa Messmer and Rene Galzin from the USR 3278 - CRIOBE (Moorea) for their help during the field sampling in French Polynesia; Jean Maharavo (Centre National de Recherches sur l'Environnement - CNRO, B. P. 7139, Fiadanana - Antananarivo, Madagascar) for his assistance in obtaining research and export permissions in Madagascar; Gisele Bakara (CNRO) for providing assistance in sample collection; the French 'Affaires Maritimes' in Reunion and GIP 'Reserve Naturelle Marine de la Reunion' for delivering sampling permits in Reunion including protected areas; the 'Centre National de Recherches Oceanographiques' (CNRO), B. P. 68, Nosy-Be, Madagascar for providing infrastructure; the french 'Marine Nationale' and 'Forces armees de la zone Sud de l'ocean Indien (FAZSOI) for their logistic support and transport of materials; Christian Desgranges of the NGO 'Coup de pouce' and Herve Prigent for assistance in Nosy-Be. We wish to thank also Dirk Steinke and Robert Hanner (Biodiversity Institute of Ontario) for their support in the Barcode of Life data systems (BOLD); Joyce Gross and John Deck (Museum of Vertebrate Zoology, Berkeley) for their support in the Moorea Biocode database; Amy Driskell, Lee Weigt and Jeff Hunt (Laboratory of Analytical Biology, Smithsonian) for sequencing; Patrice Pruvost (Museum National d'Histoire Naturelle, Paris) for his supports with vouchers storage.	Alfaro ME, 2007, EVOLUTION, V61, P2104, DOI 10.1111/j.1558-5646.2007.00182.x; Baldwin CC, 2009, ZOOTAXA, P1; Barber PH, 2005, MOL PHYLOGENET EVOL, V35, P235, DOI 10.1016/j.ympev.2004.10.004; Bellwood DR, 2009, J BIOGEOGR, V36, P569, DOI 10.1111/j.1365-2699.2008.02029.x; Bellwood DR, 2001, SCIENCE, V292, P1532, DOI 10.1126/science.1058635; Briggs JC, 1999, J BIOGEOGR, V26, P777, DOI 10.1046/j.1365-2699.1999.00322.x; Carpenter KE, 2005, ENVIRON BIOL FISH, V72, P467, DOI 10.1007/s10641-004-3154-4; Carpenter Kent E., 2011, Journal of Marine Biology, V2011, P1; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Chase JM, 2002, NATURE, V416, P427, DOI 10.1038/416427a; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Drew J, 2008, CONSERV BIOL, V22, P965, DOI 10.1111/j.1523-1739.2008.01011.x; Drew J, 2009, MOL PHYLOGENET EVOL, V53, P335, DOI 10.1016/j.ympev.2009.04.014; ESCHMEYER W. N., 2011, CATALOG FISHES ELECT; Froese R., 2012, FISHBASE; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Grenyer R, 2006, NATURE, V444, P93, DOI 10.1038/nature05237; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; Hubert N, 2011, ECOL EVOL, V1, P229, DOI 10.1002/ece3.19; Hughes TP, 2002, ECOL LETT, V5, P775, DOI 10.1046/j.1461-0248.2002.00383.x; Kuriiwa K, 2007, MOL PHYLOGENET EVOL, V45, P69, DOI 10.1016/j.ympev.2007.04.018; Leray M, 2010, EVOLUTION, V64, P1218, DOI 10.1111/j.1558-5646.2009.00917.x; Lieske E, 2009, GUIDE POISSONS RECIF; Loreau M, 2003, P NATL ACAD SCI USA, V100, P12765, DOI 10.1073/pnas.2235465100; Lourie SA, 2004, J BIOGEOGR, V31, P1975, DOI 10.1111/j.1365-2699.2004.01153.x; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; McCafferty S, 2002, MOL ECOL, V11, P1377, DOI 10.1046/j.1365-294X.2002.01533.x; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; MCMILLAN WO, 1995, P ROY SOC B-BIOL SCI, V260, P229, DOI 10.1098/rspb.1995.0085; Messmer V, 2005, CORAL REEFS, V24, P392, DOI 10.1007/s00338-005-0001-9; Mora C, 2003, NATURE, V421, P933, DOI 10.1038/nature01393; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Randall J.E., 2005, REEF SHORE FISHES S; Read CI, 2006, MOL PHYLOGENET EVOL, V38, P808, DOI 10.1016/j.ympev.2005.08.001; Reaka ML, 2008, P NATL ACAD SCI USA, V105, P11474, DOI 10.1073/pnas.0802594105; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Rocha LA, 2008, J FISH BIOL, V72, P1101, DOI 10.1111/j.1095-8649.2007.01770.x; Santini F, 2002, J BIOGEOGR, V29, P189, DOI 10.1046/j.1365-2699.2002.00669.x; Schindel DE, 2005, NATURE, V435, P17, DOI 10.1038/435017b; Smith MA, 2008, P NATL ACAD SCI USA, V105, P12359, DOI 10.1073/pnas.0805319105; Smith MA, 2007, P NATL ACAD SCI USA, V104, P4967, DOI 10.1073/pnas.0700050104; SPRINGER VG, 1990, B MAR SCI, V47, P631; Steinke D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006300; Taquet M., 2007, POISSONS OCEAN INDIE; Tilman D, 2000, NATURE, V405, P208, DOI 10.1038/35012217; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Ward RD, 2008, AQUAT BIOL, V3, P71, DOI 10.3354/ab00068; Winters KL, 2010, MAR BIOL, V157, P1679, DOI 10.1007/s00227-010-1442-4; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	52	130	142	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2012	7	3							e28987	10.1371/journal.pone.0028987	http://dx.doi.org/10.1371/journal.pone.0028987			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RU	22438862	gold, Green Published, Green Submitted			2022-12-25	WOS:000303309000001
J	Binai, N; O'Reilly, S; Griffiths, B; van Laar, JM; Hugle, T				Binai, Nadine; O'Reilly, Steven; Griffiths, Bridget; van Laar, Jacob M.; Huegle, Thomas			Differentiation Potential of CD14(+) Monocytes into Myofibroblasts in Patients with Systemic Sclerosis	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; IDIOPATHIC PULMONARY-FIBROSIS; MUSCLE ACTIN EXPRESSION; CIRCULATING MONOCYTES; DENDRITIC CELLS; GM-CSF; FIBROBLASTS; RECEPTOR; TISSUE; SKIN	Background: Circulating monocytes are a highly plastic and functionally heterogeneic cell type with an activated phenotype in patients with systemic sclerosis (SSc). CD14(+) monocytes have the potential to differentiate into extra-cellular matrix (ECM) producing cells, possibly participating in fibrogenesis. Aim: To study the effect of GM-CSF, IL-4 and endothelin -1 (ET-1) alone or in combination on monocyte differentiation into myofibroblasts. Methods: CD14(+) cells were isolated from peripheral blood from 14 SSc patients and healthy controls by positive selection and incubated with different combinations of GM-CSF, IL-4 and ET-1 for 14 days. Type-1 collagen and alpha-SMA were detected by Western blot, qPCR and confocal microscopy. HLA-DR, CD11c and CD14 expression was analysed by flow cytometry. A collagen gel contraction assay was performed for functional myofibroblast assessment. Results: GM-CSF both induced collagen and alpha-SMA expression after 14 days. ET-1 further increased GM-CSF-induced collagen expression in a dose dependent manner up to 30-fold. IL-4/GM-CSF combination leads to a more DC-like phenotype of monocytes associated with reduced collagen and alpha-SMA expression compared to GM-CSF alone. Collagen and alpha-SMA expression was higher in monocytes from SSc patients and monocytes were more prone to obtain a spindle form. In contrast to controls, ET-1 and IL-4 alone were sufficient to induce alpha-SMA expression in monocytes from SSc patients. Despite the induction of alpha-SMA expression, monocyte-derived myofibroblasts only had a moderate capability of contraction in functional analyses. Conclusion: SSc monocytes display increased maturation towards myofibroblasts demonstrated by their phenotype and alpha-SMA expression when compared to monocytes from healthy controls, however only with minor functional contraction properties.	[Binai, Nadine; O'Reilly, Steven; van Laar, Jacob M.; Huegle, Thomas] Newcastle Univ, Musculoskeletal Res Grp, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Griffiths, Bridget] Freeman Rd Hosp, Newcastle Upon Tyne, Tyne & Wear, England; [Huegle, Thomas] Univ Basel, Felix Platter Spital, Dept Rheumatol, Basel, Switzerland	Newcastle University - UK; Newcastle Freeman Hospital; Newcastle University - UK; University of Basel	Binai, N (corresponding author), Newcastle Univ, Musculoskeletal Res Grp, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	Thomas.huegle@unibas.ch	Binai, Nadine/D-8285-2013; O'Reilly, Steven/AAX-7038-2020	O'Reilly, Steven/0000-0001-7483-740X	AERA from Actelion; Actelion	AERA from Actelion; Actelion	This study was supported by an AERA research grant from Actelion, to cover a 1-year salary for N.B. as well as consumables. Actelion had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Yes, the authors have the following competing interest. This study was supported by Actelion. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Akagawa KS, 2002, INT J HEMATOL, V76, P27, DOI 10.1007/BF02982715; Ashitani J, 1999, THORAX, V54, P1015, DOI 10.1136/thx.54.11.1015; Bucala Richard, 2008, J Am Coll Radiol, V5, P36, DOI 10.1016/j.jacr.2007.08.016; Cebon J, 1994, Curr Opin Hematol, V1, P228; Chitta S, 2008, IMMUNOL LETT, V116, P41, DOI 10.1016/j.imlet.2007.11.013; Conti L, 2008, IMMUNOBIOLOGY, V213, P859, DOI 10.1016/j.imbio.2008.07.017; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; Hermes B, 2001, J INVEST DERMATOL, V116, P387, DOI 10.1046/j.1523-1747.2001.01284.x; Higashi-Kuwata N, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3066; Katebi M, 2008, INFLAMMATION, V31, P299, DOI 10.1007/s10753-008-9078-y; KRALING BM, 1995, PATHOBIOLOGY, V63, P48, DOI 10.1159/000163933; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Manetti M, 2007, ARTHRITIS RHEUM-US, V56, P3442, DOI 10.1002/art.22940; Mathai SK, 2010, LAB INVEST, V90, P812, DOI 10.1038/labinvest.2010.73; Postiglione L, 2002, J RHEUMATOL, V29, P94; Reilkoff RA, 2011, NAT REV IMMUNOL, V11, P427, DOI 10.1038/nri2990; Saito A, 2003, INT ARCH ALLERGY IMM, V132, P168, DOI 10.1159/000073718; SALLERFORS B, 1994, LEUKEMIA LYMPHOMA, V13, P235, DOI 10.3109/10428199409056287; Shahar I, 1999, INT J IMMUNOPHARMACO, V21, P759, DOI 10.1016/S0192-0561(99)00056-9; Shephard P, 2004, THROMB HAEMOSTASIS, V92, P262, DOI 10.1160/TH03-11-0669; Sheridan CM, 2001, AM J PATHOL, V159, P1555, DOI 10.1016/S0002-9440(10)62540-0; Tabata H, 1997, INT J DERMATOL, V36, P272, DOI 10.1046/j.1365-4362.1997.00171.x; Tourkina E, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-15; Varga J, 2007, J CLIN INVEST, V117, P557, DOI 10.1172/JCI31139; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Xing Z, 1997, AM J PATHOL, V150, P59; Xu SW, 2004, MOL BIOL CELL, V15, P2707, DOI 10.1091/mbc.E03-12-0902; York MR, 2007, ARTHRITIS RHEUM-US, V56, P1010, DOI 10.1002/art.22382; Zhao Y, 2003, P NATL ACAD SCI USA, V100, P2426, DOI 10.1073/pnas.0536882100	29	33	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e33508	10.1371/journal.pone.0033508	http://dx.doi.org/10.1371/journal.pone.0033508			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22432031	Green Published, gold, Green Submitted			2022-12-25	WOS:000303198600074
J	Bowling, DL; Sundararajan, J; Han, S; Purves, D				Bowling, Daniel Liu; Sundararajan, Janani; Han, Shui'er; Purves, Dale			Expression of Emotion in Eastern and Western Music Mirrors Vocalization	PLOS ONE			English	Article								In Western music, the major mode is typically used to convey excited, happy, bright or martial emotions, whereas the minor mode typically conveys subdued, sad or dark emotions. Recent studies indicate that the differences between these modes parallel differences between the prosodic and spectral characteristics of voiced speech sounds uttered in corresponding emotional states. Here we ask whether tonality and emotion are similarly linked in an Eastern musical tradition. The results show that the tonal relationships used to express positive/excited and negative/subdued emotions in classical South Indian music are much the same as those used in Western music. Moreover, tonal variations in the prosody of English and Tamil speech uttered in different emotional states are parallel to the tonal trends in music. These results are consistent with the hypothesis that the association between musical tonality and emotion is based on universal vocal characteristics of different affective states.	[Bowling, Daniel Liu; Sundararajan, Janani; Han, Shui'er; Purves, Dale] Duke Natl Univ Singapore, Neurosci & Behav Disorders Program, Grad Med Sch Singapore, Singapore, Singapore; [Bowling, Daniel Liu; Purves, Dale] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Bowling, Daniel Liu; Purves, Dale] Duke Univ, Med Ctr, Ctr Cognit Neurosci, Levine Sci Res Ctr, Durham, NC 27710 USA	National University of Singapore; Duke University; Duke University	Bowling, DL (corresponding author), Duke Natl Univ Singapore, Neurosci & Behav Disorders Program, Grad Med Sch Singapore, Singapore, Singapore.			Bowling, Daniel/0000-0002-5303-5472	National Science Foundation [BCS-0924181]; Duke-National University of Singapore Graduate Medical School; Direct For Social, Behav & Economic Scie [0924181] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Duke-National University of Singapore Graduate Medical School(National University of Singapore); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This work was supported by a grant from the National Science Foundation [BCS-0924181] and a block grant to DP from Duke-National University of Singapore Graduate Medical School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldwell E, 2003, HARMONY VOICE LEADIN, P19; Balkwill LL, 1999, MUSIC PERCEPT, V17, P43, DOI 10.2307/40285811; Banumathy R, 2002, SRUTI MANJARI 1; Banumathy R, 2002, SRUTI MANJARI 2; Becker J, 2001, MUSIC EMOTION THEORY, P135; Boersma P., 2021, PRAAT DOING PHONETIC; Bowling DL, 2010, J ACOUST SOC AM, V127, P491, DOI 10.1121/1.3268504; Chelladurai PT, 2010, SPLENDOUR S INDIAN M, P31; Cooke D, 1959, LANGUAGE MUSIC, P89; Crowder R. G., 1984, PSYCHOMUSICOLOGY, V4, P3, DOI DOI 10.1037/H0094207; Curtis ME, 2010, EMOTION, V10, P335, DOI 10.1037/a0017928; Danielou, 1980, RAGAS NO INDIAN MUSI, P40; Darwin C, 2009, EXPRESSION EMOTIONS, P88; Hevner K, 1935, AM J PSYCHOL, V47, P103, DOI 10.2307/1416710; JURGENS U, 1979, BEHAVIOUR, V69, P89; Juslin PN, 2003, PSYCHOL BULL, V129, P770, DOI 10.1037/0033-2909.129.5.770; MathWorks Inc, 2009, MATL VERS R2009A COM; Miller TE, 2008, GARLAND HDB SE ASIAN, V256, P384; Papousek M., 1992, NONVERBAL VOCAL COMM, P230; Patel AD, 2008, MUSIC LANGUAGE BRAIN, P313; PORTER FL, 1986, CHILD DEV, V57, P790, DOI 10.2307/1130355; Ramanathan S, 1988, DIVYA NAMA KIRTANA 2; Ramanathan S, 1985, SHYAMA SASTRIGAL ARI; Ramanathan S, 1988, DIVYA NAMA KIRTANA 1; Randel D. M., 1986, NEW HARVARD DICT MUS; Rowell, 1992, MUSIC MUSICAL THOUGH, P327; Sambamurthy P, 1999, S INDIAN MUSIC, P160; SCHERER KR, 1995, J VOICE, V9, P235, DOI 10.1016/S0892-1997(05)80231-0; Spencer H, 1857, FRASERS MAGAZINE, V56, P396, DOI DOI 10.1017/S0140525X08005293; Swift, 1990, J SOC ASIAN MUSIC, V21-2, P71; Touma Habib Hassan, 1996, MUSIC ARABS; Varadan P, 2005, KRTIMANIMALAI SRI TY; Varadan P, 2005, KRTIMANIMALAI SRI TY, VI; Zarlino G, 1968, ART COUNTERPOINT, P21	34	61	62	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e31942	10.1371/journal.pone.0031942	http://dx.doi.org/10.1371/journal.pone.0031942			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	931EO	22431970	Green Published, Green Submitted, gold			2022-12-25	WOS:000303198600013
J	Jakob, S; Ohmayer, U; Neueder, A; Hierlmeier, T; Perez-Fernandez, J; Hochmuth, E; Deutzmann, R; Griesenbeck, J; Tschochner, H; Milkereit, P				Jakob, Steffen; Ohmayer, Uli; Neueder, Andreas; Hierlmeier, Thomas; Perez-Fernandez, Jorge; Hochmuth, Eduard; Deutzmann, Rainer; Griesenbeck, Joachim; Tschochner, Herbert; Milkereit, Philipp			Interrelationships between Yeast Ribosomal Protein Assembly Events and Transient Ribosome Biogenesis Factors Interactions in Early Pre-Ribosomes	PLOS ONE			English	Article							ESCHERICHIA-COLI RIBOSOMES; RNA-PROCESSING COMPLEXES; SMALL-SUBUNIT PROCESSOME; SMALL NUCLEOLAR RNA; EUKARYOTIC RIBOSOME; U3 SNORNP; RIBONUCLEOPROTEIN COMPLEXES; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; SSU PROCESSOME	Early steps of eukaryotic ribosome biogenesis require a large set of ribosome biogenesis factors which transiently interact with nascent rRNA precursors (pre-rRNA). Most likely, concomitant with that initial contacts between ribosomal proteins (r-proteins) and ribosome precursors (pre-ribosomes) are established which are converted into robust interactions between pre-rRNA and r-proteins during the course of ribosome maturation. Here we analysed the interrelationship between r-protein assembly events and the transient interactions of ribosome biogenesis factors with early pre-ribosomal intermediates termed 90S pre-ribosomes or small ribosomal subunit (SSU) processome in yeast cells. We observed that components of the SSU processome UTP-A and UTP-B sub-modules were recruited to early pre-ribosomes independently of all tested r-proteins. On the other hand, groups of SSU processome components were identified whose association with early pre-ribosomes was affected by specific r-protein assembly events in the head-platform interface of the SSU. One of these components, Noc4p, appeared to be itself required for robust incorporation of r-proteins into the SSU head domain. Altogether, the data reveal an emerging network of specific interrelationships between local r-protein assembly events and the functional interactions of SSU processome components with early pre-ribosomes. They point towards some of these components being transient primary pre-rRNA in vivo binders and towards a role for others in coordinating the assembly of major SSU domains.	[Jakob, Steffen; Ohmayer, Uli; Neueder, Andreas; Hierlmeier, Thomas; Perez-Fernandez, Jorge; Griesenbeck, Joachim; Tschochner, Herbert; Milkereit, Philipp] Univ Regensburg, Lehrstuhl Biochem 3, Regensburg, Germany; [Hochmuth, Eduard; Deutzmann, Rainer] Univ Regensburg, Lehrstuhl Biochem 1, Regensburg, Germany	University of Regensburg; University of Regensburg	Jakob, S (corresponding author), Univ Regensburg, Lehrstuhl Biochem 3, Regensburg, Germany.	Joachim.Griesenbeck@vkl.uni-regensburg.de; Herbert.Tschochner@vkl.uni-regensburg.de; Philipp.Milkereit@vkl.uni-regensburg.de	Neueder, Andreas/K-4319-2015; Perez-Fernandez, Jorge/F-6937-2010	Neueder, Andreas/0000-0002-2389-5236; Perez-Fernandez, Jorge/0000-0002-0018-5493; Griesenbeck, Joachim/0000-0002-7817-6095	German Research Foundation [FOR1068, SFB 960]	German Research Foundation(German Research Foundation (DFG))	This work was supported by grants from the German Research Foundation (FOR1068 and SFB 960). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adilakshmi T, 2008, NATURE, V455, P1268, DOI 10.1038/nature07298; Agalarov SC, 1998, P NATL ACAD SCI USA, V95, P999, DOI 10.1073/pnas.95.3.999; BaudinBaillieu A, 1997, MOL CELL BIOL, V17, P5023, DOI 10.1128/MCB.17.9.5023; Ben-Shem A, 2010, SCIENCE, V330, P1203, DOI 10.1126/science.1194294; Bernstein KA, 2004, EUKARYOT CELL, V3, P1619, DOI 10.1128/EC.3.6.1619-1626.2004; Bohnsack MT, 2008, EMBO REP, V9, P1230, DOI 10.1038/embor.2008.184; Buchhaupt M, 2006, MOL GENET GENOMICS, V276, P273, DOI 10.1007/s00438-006-0132-x; CHOOI WY, 1981, P NATL ACAD SCI-BIOL, V78, P4823, DOI 10.1073/pnas.78.8.4823; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Dosil M, 2004, J BIOL CHEM, V279, P37385, DOI 10.1074/jbc.M404909200; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fayet-Lebaron E, 2009, EMBO J, V28, P1260, DOI 10.1038/emboj.2009.79; Ferreira-Cerca S, 2005, MOL CELL, V20, P263, DOI 10.1016/j.molcel.2005.09.005; Ferreira-Cerca S, 2007, MOL CELL, V28, P446, DOI 10.1016/j.molcel.2007.09.029; Gallagher JEG, 2004, GENE DEV, V18, P2506, DOI 10.1101/gad.1226604; Grandi P, 2002, MOL CELL, V10, P105, DOI 10.1016/S1097-2765(02)00579-8; Granneman S, 2006, MOL CELL BIOL, V26, P1183, DOI 10.1128/MCB.26.4.1183-1194.2006; Granneman S, 2003, NUCLEIC ACIDS RES, V31, P1877, DOI 10.1093/nar/gkg300; Granneman S, 2010, EMBO J; Granneman S, 2009, P NATL ACAD SCI USA, V106, P9613, DOI 10.1073/pnas.0901997106; HELD WA, 1974, J BIOL CHEM, V249, P3103; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; HEROLD M, 1987, J BIOL CHEM, V262, P8826; Hughes JMX, 1996, J MOL BIOL, V259, P645, DOI 10.1006/jmbi.1996.0346; Karbstein K, 2006, J MOL BIOL, V356, P432, DOI 10.1016/j.jmb.2005.11.052; Karbstein K, 2005, MOL CELL, V20, P633, DOI 10.1016/j.molcel.2005.09.017; Karbstein K, 2011, CURR OPIN CHEM BIOL, V15, P657, DOI 10.1016/j.cbpa.2011.07.023; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Krogan NJ, 2004, MOL CELL, V13, P225, DOI 10.1016/S1097-2765(04)00003-6; Kuhn H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008370; Lamanna AC, 2011, J MOL BIOL, V405, P3, DOI 10.1016/j.jmb.2010.09.064; Liu PCC, 2001, MOL BIOL CELL, V12, P3644, DOI 10.1091/mbc.12.11.3644; Merl J, 2010, NUCL ACIDS RES; Meyer B, 2011, NUCLEIC ACIDS RES, V39, P1526, DOI 10.1093/nar/gkq931; Milkereit P, 2003, J BIOL CHEM, V278, P4072, DOI 10.1074/jbc.M208898200; MORRISSEY JP, 1993, MOL CELL BIOL, V13, P2469, DOI 10.1128/MCB.13.4.2469; Neueder A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010194; NIERHAUS KH, 1991, BIOCHIMIE, V73, P739, DOI 10.1016/0300-9084(91)90054-5; NOWOTNY V, 1988, BIOCHEMISTRY-US, V27, P7051, DOI 10.1021/bi00418a057; O'Donohue MF, 2010, J CELL BIOL, V190, P853, DOI 10.1083/jcb.201005117; Oeffinger M, 2007, NAT METHODS, V4, P951, DOI 10.1038/NMETH1101; Peng WT, 2003, CELL, V113, P919, DOI 10.1016/S0092-8674(03)00466-5; Perez-Fernandez J, 2007, MOL CELL BIOL, V27, P5414, DOI 10.1128/MCB.00380-07; Perez-Fernandez J, 2011, NUCLEIC ACIDS RES, V39, P8105, DOI 10.1093/nar/gkr508; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; Recht MI, 2004, J MOL BIOL, V344, P395, DOI 10.1016/j.jmb.2004.09.009; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; SAMAHA RR, 1994, P NATL ACAD SCI USA, V91, P7884, DOI 10.1073/pnas.91.17.7884; Sambrook J., 2002, MOL CLONING LAB MANU; Strunk BS, 2011, SCIENCE, V333, P1449, DOI 10.1126/science.1208245; Strunk BS, 2009, POWERING RIBOSOME AS; Sykes MT, 2009, ANNU REV BIOPHYS, V38, P197, DOI 10.1146/annurev.biophys.050708.133615; TRAPMAN J, 1975, EXP CELL RES, V90, P95, DOI 10.1016/0014-4827(75)90361-4; Turner AJ, 2009, MOL CELL BIOL, V29, P3007, DOI 10.1128/MCB.00029-09; UDEM SA, 1972, J MOL BIOL, V65, P227, DOI 10.1016/0022-2836(72)90279-3; Venema J, 2000, RNA, V6, P1660, DOI 10.1017/S1355838200001369; Venema J, 1997, MOL CELL BIOL, V17, P3398, DOI 10.1128/MCB.17.6.3398; Wegierski T, 2001, RNA, V7, P1254, DOI 10.1017/S1355838201012079; WEITZMANN CJ, 1993, FASEB J, V7, P177, DOI 10.1096/fasebj.7.1.7916699; Wery M, 2009, RNA, V15, P406, DOI 10.1261/rna.1402709; Wilmes GM, 2008, MOL CELL, V32, P735, DOI 10.1016/j.molcel.2008.11.012	64	27	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e32552	10.1371/journal.pone.0032552	http://dx.doi.org/10.1371/journal.pone.0032552			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22431976	Green Published, gold, Green Submitted			2022-12-25	WOS:000303198600019
J	Voorham, JMD; Rodenhuis-Zybert, IA; Nunez, NVA; Colpitts, TM; van der Ende-Metselaar, H; Fikrig, E; Diamond, MS; Wilschut, J; Smit, JM				Voorham, Julia M. da Silva; Rodenhuis-Zybert, Izabela A.; Nunez, Nilda Vanesa Ayala; Colpitts, Tonya M.; van der Ende-Metselaar, Heidi; Fikrig, Erol; Diamond, Michael S.; Wilschut, Jan; Smit, Jolanda M.			Antibodies against the Envelope Glycoprotein Promote Infectivity of Immature Dengue Virus Serotype 2	PLOS ONE			English	Article							WEST-NILE-VIRUS; BORNE ENCEPHALITIS-VIRUS; MONOCLONAL-ANTIBODIES; MEMBRANE-FUSION; HEMORRHAGIC-FEVER; PROTEIN PRM; DOMAIN-III; NEUTRALIZATION; PARTICLES; CLEAVAGE	Cross-reactive dengue virus (DENV) antibodies directed against the envelope (E) and precursor membrane (prM) proteins are believed to contribute to the development of severe dengue disease by facilitating antibody-dependent enhancement of infection. We and others recently demonstrated that anti-prM antibodies render essentially non-infectious immature DENV infectious in Fc gamma-receptor-expressing cells. Immature DENV particles are abundantly present in standard (st) virus preparations due to inefficient processing of prM to M during virus maturation. Structural analysis has revealed that the E protein is exposed in immature particles and this prompted us to investigate whether antibodies to E render immature particles infectious. To this end, we analyzed the enhancing properties of 27 anti-E antibodies directed against distinct structural domains. Of these, 23 bound to immature particles, and 15 enhanced infectivity of immature DENV in a furin-dependent manner. The significance of these findings was subsequently tested in vivo using the well-established West Nile virus (WNV) mouse model. Remarkably, mice injected with immature WNV opsonized with anti-E mAbs or immune serum produced a lethal infection in a dose-dependent manner, whereas in the absence of antibody immature WNV virions caused no morbidity or mortality. Furthermore, enhancement infection studies with standard (st) DENV preparations opsonized with anti-E mAbs in the presence or absence of furin inhibitor revealed that prM-containing particles present within st virus preparations contribute to antibody-dependent enhancement of infection. Taken together, our results support the notion that antibodies against the structural proteins prM and E both can promote pathogenesis by enhancing infectivity of prM-containing immature and partially mature flavivirus particles.	[Voorham, Julia M. da Silva; Rodenhuis-Zybert, Izabela A.; Nunez, Nilda Vanesa Ayala; van der Ende-Metselaar, Heidi; Wilschut, Jan; Smit, Jolanda M.] Univ Med Ctr Groningen, Dept Med Microbiol, Mol Virol Sect, NL-9713 AV Groningen, Netherlands; [Voorham, Julia M. da Silva; Rodenhuis-Zybert, Izabela A.; Nunez, Nilda Vanesa Ayala; van der Ende-Metselaar, Heidi; Wilschut, Jan; Smit, Jolanda M.] Univ Groningen, Groningen, Netherlands; [Colpitts, Tonya M.; Fikrig, Erol] Yale Univ, Sch Med, Dept Med, Med Inst,Sect Infect Dis, New Haven, CT 06510 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol & Pathol & Immunol, St Louis, MO USA	University of Groningen; University of Groningen; Yale University; Washington University (WUSTL)	Voorham, JMD (corresponding author), Univ Med Ctr Groningen, Dept Med Microbiol, Mol Virol Sect, NL-9713 AV Groningen, Netherlands.	jolanda.smit@umcg.nl	Rodenhuis-Zybert, Izabela A/N-7967-2017; Rodenhuis-Zybert, Izabela/AAD-3379-2021; Diamond, Michael/AAH-1733-2019	Rodenhuis-Zybert, Izabela A/0000-0002-7820-8624; Rodenhuis-Zybert, Izabela/0000-0002-7820-8624; Diamond, Michael/0000-0002-8791-3165; Colpitts, Tonya/0000-0003-3915-1554	Pediatric Dengue Vaccine Initiative; Dutch Organization for Scientific research (NWO-Earth and Life Sciences); Natinal Institutes of Health [U01 AI061373, R01-AI077955]; Dutch Organization for Scientific research (NWO-zonMW); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI077955, U01AI061373] Funding Source: NIH RePORTER	Pediatric Dengue Vaccine Initiative; Dutch Organization for Scientific research (NWO-Earth and Life Sciences)(Netherlands Organization for Scientific Research (NWO)); Natinal Institutes of Health; Dutch Organization for Scientific research (NWO-zonMW)(Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Pediatric Dengue Vaccine Initiative, by the Dutch Organization for Scientific research (NWO-Earth and Life Sciences and NWO-zonMW), and by Natinal Institutes of Health grants U01 AI061373 and R01-AI077955 (MSD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SL, 2001, J VIROL, V75, P4268, DOI 10.1128/JVI.75.9.4268-4275.2001; Bai FW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000610; Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007; Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064; Cherrier MV, 2009, EMBO J, V28, P3269, DOI 10.1038/emboj.2009.245; Chu JJH, 2005, J GEN VIROL, V86, P405, DOI 10.1099/vir.0.80411-0; Crill WD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004991; Crill WD, 2001, J VIROL, V75, P7769, DOI 10.1128/JVI.75.16.7769-7773.2001; Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181; Diamond MS, 2000, J VIROL, V74, P7814, DOI 10.1128/JVI.74.17.7814-7823.2000; Elshuber S, 2003, J GEN VIROL, V84, P183, DOI 10.1099/vir.0.18723-0; GARTEN W, 1994, BIOCHIMIE, V76, P217, DOI 10.1016/0300-9084(94)90149-X; Gubler D.J., 2007, FIELDS VIROLOGY, VVolume 1; GUIRAKHOO F, 1992, VIROLOGY, V191, P921, DOI 10.1016/0042-6822(92)90267-S; Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4; Halstead SB, 2002, EMERG INFECT DIS, V8, P1474, DOI 10.3201/eid0812.020170; HALSTEAD SB, 1977, NATURE, V265, P739, DOI 10.1038/265739a0; HEINZ FX, 1994, VIROLOGY, V198, P109, DOI 10.1006/viro.1994.1013; Junjhon J, 2008, J VIROL, V82, P10776, DOI 10.1128/JVI.01180-08; Junjhon J, 2010, J VIROL, V84, P8353, DOI 10.1128/JVI.00696-10; KLIKS SC, 1988, AM J TROP MED HYG, V38, P411, DOI 10.4269/ajtmh.1988.38.411; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Lei HY, 2001, J BIOMED SCI, V8, P377, DOI 10.1007/BF02255946; Lorenz IC, 2002, J VIROL, V76, P5480, DOI 10.1128/JVI.76.11.5480-5491.2002; Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100; Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165; Moesker B, 2010, J GEN VIROL, V91, P389, DOI 10.1099/vir.0.015255-0; Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067; Nelson S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000060; OCHIAI H, 1988, J VIROL, V62, P20, DOI 10.1128/JVI.62.1.20-26.1988; Oliphant T, 2007, J VIROL, V81, P11828, DOI 10.1128/JVI.00643-07; Oliphant T, 2006, J VIROL, V80, P12149, DOI 10.1128/JVI.01732-06; Pierson TC, 2007, CELL HOST MICROBE, V1, P135, DOI 10.1016/j.chom.2007.03.002; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; Rodenhuis-Zybert IA, J VIROL; Rodenhuis-Zybert IA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000718; Schieffelin JS, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-28; Stiasny K, 2006, J VIROL, V80, P9557, DOI 10.1128/JVI.00080-06; Sukupolvi-Petty S, 2010, J VIROL, V84, P9227, DOI 10.1128/JVI.01087-10; SUNG SSJ, 1985, J IMMUNOL, V135, P1981; Throsby M, 2006, J VIROL, V80, P6982, DOI 10.1128/JVI.00551-06; van der Schaar HM, 2007, J VIROL, V81, P12019, DOI 10.1128/JVI.00300-07; World Health Organization, 2009, DENGUE GUIDELINES DI; Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019; Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270; Zhang Y, 2007, J VIROL, V81, P6141, DOI 10.1128/JVI.00037-07; Zheng A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001157; Zybert IA, 2008, J GEN VIROL, V89, P3047, DOI 10.1099/vir.0.2008/002535-0	48	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e29957	10.1371/journal.pone.0029957	http://dx.doi.org/10.1371/journal.pone.0029957			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22431958	Green Published, Green Submitted, gold			2022-12-25	WOS:000303198600001
J	Nayak, S; Roberts, MS; Greenspan, SL				Nayak, Smita; Roberts, Mark S.; Greenspan, Susan L.			Impact of Generic Alendronate Cost on the Cost-Effectiveness of Osteoporosis Screening and Treatment	PLOS ONE			English	Article							FRACTURE INTERVENTION TRIAL; QUALITY-OF-LIFE; SERVICES TASK-FORCE; VERTEBRAL FRACTURES; POSTMENOPAUSAL WOMEN; HIP FRACTURE; RANDOMIZED-TRIAL; HEALTH; RISK; THERAPY	Introduction: Since alendronate became available in generic form in the Unites States in 2008, its price has been decreasing. The objective of this study was to investigate the impact of alendronate cost on the cost-effectiveness of osteoporosis screening and treatment in postmenopausal women. Methods: Microsimulation cost-effectiveness model of osteoporosis screening and treatment for U. S. women age 65 and older. We assumed screening initiation at age 65 with central dual-energy x-ray absorptiometry (DXA), and alendronate treatment for individuals with osteoporosis; with a comparator of "no screening" and treatment only after fracture occurrence. We evaluated annual alendronate costs of $20 through $800; outcome measures included fractures; nursing home admission; medication adverse events; death; costs; quality-adjusted life-years (QALYs); and incremental cost-effectiveness ratios (ICERs) in 2010 U. S. dollars per QALY gained. A lifetime time horizon was used, and direct costs were included. Base-case and sensitivity analyses were performed. Results: Base-case analysis results showed that at annual alendronate costs of $200 or less, osteoporosis screening followed by treatment was cost-saving, resulting in lower total costs than no screening as well as more QALYs (10.6 additional quality-adjusted life-days). When assuming alendronate costs of $400 through $800, screening and treatment resulted in greater lifetime costs than no screening but was highly cost-effective, with ICERs ranging from $714 per QALY gained through $13,902 per QALY gained. Probabilistic sensitivity analyses revealed that the cost-effectiveness of osteoporosis screening followed by alendronate treatment was robust to joint input parameter estimate variation at a willingness-to-pay threshold of $50,000/QALY at all alendronate costs evaluated. Conclusions: Osteoporosis screening followed by alendronate treatment is effective and highly cost-effective for postmenopausal women across a range of alendronate costs, and may be cost-saving at annual alendronate costs of $200 or less.	[Nayak, Smita; Roberts, Mark S.] Univ Pittsburgh, Sch Med, Dept Med, Div Gen Internal Med,Sect Decis Sci & Clin Syst M, Pittsburgh, PA 15260 USA; [Roberts, Mark S.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Hlth Policy & Management, Pittsburgh, PA USA; [Greenspan, Susan L.] Univ Pittsburgh, Sch Med, Dept Med, Div Endocrinol & Metab, Pittsburgh, PA USA; [Greenspan, Susan L.] Univ Pittsburgh, Sch Med, Dept Med, Div Geriatr Med, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Nayak, S (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, Div Gen Internal Med,Sect Decis Sci & Clin Syst M, Pittsburgh, PA 15260 USA.	nayaks@upmc.edu	Golmohamad, Ramez/E-4848-2014	Golmohamad, Ramez/0000-0002-9958-7037	National Institute of Arthritis and Musculoskeletal and Skin Diseases [1R01AR060809-01]; National Center for Research Resources (National Institutes of Health) [KL2 RR024154]; National Institutes of Health Roadmap for Medical Research [KL2 RR024154]; National Institute of Diabetes and Digestive and Kidney Diseases [K24 DK062895]; Merck Co.; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060809] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK062895] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024827] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Center for Research Resources (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Merck Co.(Merck & Company); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by grant 1R01AR060809-01 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (Dr. Nayak); grant KL2 RR024154 from the National Center for Research Resources (a component of the National Institutes of Health) and National Institutes of Health Roadmap for Medical Research (Dr. Nayak); and grant K24 DK062895 from the National Institute of Diabetes and Digestive and Kidney Diseases (Dr. Greenspan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: Dr. Greenspan has consulted for and received research funding from Merck & Co. The funding from Merck & Co. was not for this specific study. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials..	[Anonymous], US CONS PRIC IND MED; [Anonymous], GE FIN NURS HOM COST; Arias Elizabeth, 2007, Natl Vital Stat Rep, V56, P1; Barrett JA, 1999, J CLIN EPIDEMIOL, V52, P243, DOI 10.1016/S0895-4356(98)00167-X; Black DM, 2006, JAMA-J AM MED ASSOC, V296, P2927, DOI 10.1001/jama.296.24.2927; Black DM, 2000, J CLIN ENDOCR METAB, V85, P4118, DOI 10.1210/jc.85.11.4118; Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; Braithwaite RS, 2003, J AM GERIATR SOC, V51, P364, DOI 10.1046/j.1532-5415.2003.51110.x; Brazier JE, 2002, OSTEOPOROSIS INT, V13, P768, DOI 10.1007/s001980200107; BRAZIER JE, 2000, PROSPECTIVE STUDY HL; Burge R, 2007, J BONE MINER RES, V22, P465, DOI [10.1359/jbmr.061113, 10.1359/JBMR.061113]; Calonge N, 2011, ANN INTERN MED, V154, P356, DOI 10.7326/0003-4819-154-5-201103010-00307; Corliss GR, 2004, LONG TERM CARE EXPER; CUMMINGS SR, 1989, ARCH INTERN MED, V149, P2445, DOI 10.1001/archinte.149.11.2445; Cummings SR, 1998, JAMA-J AM MED ASSOC, V280, P2077, DOI 10.1001/jama.280.24.2077; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; Dolan P, 1999, OSTEOPOROSIS INT, V9, P196, DOI 10.1007/s001980050136; FITZGERALD JF, 1988, NEW ENGL J MED, V319, P1392, DOI 10.1056/NEJM198811243192106; Fleurence RL, 2007, PHARMACOECONOMICS, V25, P913, DOI 10.2165/00019053-200725110-00003; FRYBACK DG, 1993, MED DECIS MAKING, V13, P89, DOI 10.1177/0272989X9301300202; Gabriel SE, 2002, OSTEOPOROSIS INT, V13, P323, DOI 10.1007/s001980200033; Hanmer J, 2006, MED DECIS MAKING, V26, P391, DOI 10.1177/0272989X06290497; Heron Melonie, 2009, Natl Vital Stat Rep, V57, P1; Johnell O, 2004, OSTEOPOROSIS INT, V15, P38, DOI 10.1007/s00198-003-1490-4; Kanis JA, 2012, OSTEOPOROSIS INT, V23, P213, DOI 10.1007/s00198-011-1796-6; Kanis JA, 2004, OSTEOPOROSIS INT, V15, P20, DOI 10.1007/s00198-003-1463-7; Karpf David B., 1997, JAMA (Journal of the American Medical Association), V277, P1159, DOI 10.1001/jama.277.14.1159; LIBERMAN UA, 1995, NEW ENGL J MED, V333, P1437, DOI 10.1056/NEJM199511303332201; Liu H, 2006, ARCH INTERN MED, V166, P1209, DOI 10.1001/archinte.166.11.1209; Looker AC, 1998, OSTEOPOROSIS INT, V8, P468, DOI 10.1007/s001980050093; Lu Y, 2001, J BONE MINER RES, V16, P901, DOI 10.1359/jbmr.2001.16.5.901; MELTON LJ, 1993, OSTEOPOROSIS INT, V3, P113, DOI 10.1007/BF01623271; Mobley LR, 2006, MED DECIS MAKING, V26, P194, DOI 10.1177/0272989X06286478; National Osteoporosis Foundation, 2005, OST FAST FACTS; Nayak S, 2011, ANN INTERN MED, V155, P751, DOI 10.7326/0003-4819-155-11-201112060-00007; Nelson HD, 2002, ANN INTERN MED, V137, P529, DOI 10.7326/0003-4819-137-6-200209170-00015; Oleksik A, 2000, J BONE MINER RES, V15, P1384, DOI 10.1359/jbmr.2000.15.7.1384; Recker RR, 2005, MAYO CLIN PROC, V80, P856, DOI 10.4065/80.7.856; Russell LB, 2009, HEALTH AFFAIR, V28, P42, DOI 10.1377/hlthaff.28.1.42; Schousboe John T, 2007, Curr Rheumatol Rep, V9, P50, DOI 10.1007/s11926-007-0022-1; Schousboe JT, 2005, J AM GERIATR SOC, V53, P1697, DOI 10.1111/j.1532-5415.2005.53504.x; Schousboe JT, 2005, ANN INTERN MED, V142, P734, DOI 10.7326/0003-4819-142-9-200505030-00008; Schwartz AV, 2010, J BONE MINER RES, V25, P976, DOI 10.1002/jbmr.11; Solomon DH, 2005, ARCH INTERN MED, V165, P2414, DOI 10.1001/archinte.165.20.2414; Tosteson ANA, 2001, OSTEOPOROSIS INT, V12, P1042, DOI 10.1007/s001980170015; Tosteson ANA, 2001, OSTEOPOROSIS INT, V12, P849, DOI 10.1007/s001980170036; Tosteson ANA, 2008, AM J MANAG CARE, V14, P605; US Congress Office of Technology Assessment, 1994, OTABPH120 US C; *US DEP HHS OFF SU, 2004, BON HLTH OST REP SUR; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; Woolf SH, 2009, JAMA-J AM MED ASSOC, V301, P536, DOI 10.1001/jama.2009.51	51	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2012	7	3							e32879	10.1371/journal.pone.0032879	http://dx.doi.org/10.1371/journal.pone.0032879			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	930IA	22427903	gold, Green Published, Green Accepted			2022-12-25	WOS:000303129700019
J	Buddhala, C; Suarez, M; Modi, J; Prentice, H; Ma, ZY; Tao, R; Wu, JY				Buddhala, Chandana; Suarez, Marjorie; Modi, Jigar; Prentice, Howard; Ma, Zhiyuan; Tao, Rui; Wu, Jang Yen			Calpain Cleavage of Brain Glutamic Acid Decarboxylase 65 Is Pathological and Impairs GABA Neurotransmission	PLOS ONE			English	Article							STIFF-PERSON-SYNDROME; SYNAPTIC VESICLES; PROTEIN-PHOSPHORYLATION; PRESYNAPTIC CLUSTERS; FUNCTIONAL-ANALYSIS; CYSTEINE RESIDUES; GENE-EXPRESSION; 65-KDA ISOFORM; MICE DEFICIENT; GAD65	Previously, we have shown that the GABA synthesizing enzyme, L-glutamic acid decarboxylase 65 (GAD65) is cleaved to form its truncated form (tGAD65) which is 2-3 times more active than the full length form (fGAD65). The enzyme responsible for cleavage was later identified as calpain. Calpain is known to cleave its substrates either under a transient physiological stimulus or upon a sustained pathological insult. However, the precise role of calpain cleavage of fGAD65 is poorly understood. In this communication, we examined the cleavage of fGAD65 under diverse pathological conditions including rats under ischemia/reperfusion insult as well as rat brain synaptosomes and primary neuronal cultures subjected to excessive stimulation with high concentration of KCI. We have shown that the formation of tGAD65 progressively increases with increasing stimulus concentration both in rat brain synaptosomes and primary rat embryo cultures. More importantly, direct cleavage of synaptic vesicle - associated fGAD65 by calpain was demonstrated and the resulting tGAD65 bearing the active site of the enzyme was detached from the synaptic vesicles. Vesicular GABA transport of the newly synthesized GABA was found to be reduced in calpain treated SVs. Furthermore, we also observed that the levels of tGAD65 in the focal cerebral ischemic rat brain tissue increased corresponding to the elevation of local glutamate as indicated by microdialysis. Moreover, the levels of tGAD65 was also proportional to the degree of cell death when the primary neuronal cultures were exposed to high KCl. Based on these observations, we conclude that calpain-mediated cleavage of fGAD65 is pathological, presumably due to decrease in the activity of synaptic vesicle - associated fGAD65 resulting in a decrease in the GABA synthesis - packaging coupling process leading to reduced GABA neurotransmission.	[Buddhala, Chandana; Suarez, Marjorie; Modi, Jigar; Prentice, Howard; Ma, Zhiyuan; Tao, Rui; Wu, Jang Yen] Florida Atlantic Univ, Charles E Schmidt Coll Med, Dept Biomed Sci, Boca Raton, FL 33431 USA	State University System of Florida; Florida Atlantic University	Buddhala, C (corresponding author), Florida Atlantic Univ, Charles E Schmidt Coll Med, Dept Biomed Sci, Boca Raton, FL 33431 USA.	jwu@fau.edu	Ma, ZhiYuan/GWN-1061-2022		James and Esther King Biomedical Research Program, State of Florida [09KW-11]; Schmidt Foundation, Florida Atlantic University	James and Esther King Biomedical Research Program, State of Florida; Schmidt Foundation, Florida Atlantic University	This work has been supported by the James and Esther King Biomedical Research Program, State of Florida (Grant # 09KW-11 http://floridabiomed.com/funding_ je.html#callgrant) and the Schmidt Foundation, Florida Atlantic University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ando K, 2005, J NEUROCHEM, V94, P651, DOI 10.1111/j.1471-4159.2005.03160.x; Asada H, 1996, BIOCHEM BIOPH RES CO, V229, P891, DOI 10.1006/bbrc.1996.1898; BAO J, 1995, J BIOL CHEM, V270, P6464, DOI 10.1074/jbc.270.12.6464; Baptista MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010139; Battaglioli G, 2005, NEUROCHEM RES, V30, P989, DOI 10.1007/s11064-005-6772-0; Berti R, 2002, J CEREBR BLOOD F MET, V22, P1068, DOI 10.1097/00004647-200209000-00004; Bizat N, 2003, J BIOL CHEM, V278, P43245, DOI 10.1074/jbc.M305057200; Blomgren K, 2001, J BIOL CHEM, V276, P10191, DOI 10.1074/jbc.M007807200; Borgers M, 1983, Am J Emerg Med, V1, P154, DOI 10.1016/0735-6757(83)90083-9; Burbelo PD, 2008, BIOCHEM BIOPH RES CO, V366, P1, DOI 10.1016/j.bbrc.2007.11.077; Chattopadhyay S, 2002, HUM MOL GENET, V11, P1421, DOI 10.1093/hmg/11.12.1421; Ching KH, 2010, J NEUROIMMUNOL, V222, P87, DOI 10.1016/j.jneuroim.2010.02.015; CHRISTGAU S, 1992, J CELL BIOL, V118, P309, DOI 10.1083/jcb.118.2.309; Crocker SJ, 2003, J NEUROSCI, V23, P4081; de Jong P J, 1984, Adv Neurol, V40, P427; Fenalti G, 2007, NAT STRUCT MOL BIOL, V14, P280, DOI 10.1038/nsmb1228; Franekova V, 2008, NEUROCHEM INT, V52, P1436, DOI 10.1016/j.neuint.2008.04.001; Gomes JR, 2011, J NEUROSCI, V31, P4622, DOI 10.1523/JNEUROSCI.3541-10.2011; HELL JW, 1990, J BIOL CHEM, V265, P2111; Hsu CC, 1999, J BIOL CHEM, V274, P24366, DOI 10.1074/jbc.274.34.24366; Hsu CC, 2000, J BIOL CHEM, V275, P20822, DOI 10.1074/jbc.M001403200; Jin H, 2003, P NATL ACAD SCI USA, V100, P4293, DOI 10.1073/pnas.0730698100; Kanaani J, 1999, J BIOL CHEM, V274, P37200, DOI 10.1074/jbc.274.52.37200; Kanaani J, 2004, J CELL SCI, V117, P2001, DOI 10.1242/jcs.01030; Kanaani J, 2010, J CELL BIOL, V190, P911, DOI 10.1083/jcb.200912101; Kash SF, 1997, P NATL ACAD SCI USA, V94, P14060, DOI 10.1073/pnas.94.25.14060; Kash SF, 1999, P NATL ACAD SCI USA, V96, P1698, DOI 10.1073/pnas.96.4.1698; Kleppner S R, 2001, Expert Opin Ther Targets, V5, P219, DOI 10.1517/14728222.5.2.219; Kobayashi T, 2003, J CLIN ENDOCR METAB, V88, P4768, DOI 10.1210/jc.2002-021529; Lastres-Becker I, 2002, SYNAPSE, V44, P23, DOI 10.1002/syn.10054; Lewis DA, 1999, BIOL PSYCHIAT, V46, P616, DOI 10.1016/S0006-3223(99)00061-X; Liu J, 2008, SCI SIGNAL, V1, DOI [10.1126/stke.114re1, 10.1126/scisignal.123tr3]; MARTIN DL, 1993, J NEUROCHEM, V60, P395, DOI 10.1111/j.1471-4159.1993.tb03165.x; Monnerie H, 2008, EXP NEUROL, V213, P145, DOI 10.1016/j.expneurol.2008.05.013; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; Pinal CS, 1998, PERSPECT DEV NEUROBI, V5, P109; Raju R, 2005, J IMMUNOL, V175, P7755, DOI 10.4049/jimmunol.175.11.7755; Ray SK, 2002, J NEUROSCI RES, V69, P197, DOI 10.1002/jnr.10265; Ray SK, 2003, CNS NEUROL DISORD-DR, V2, P173, DOI 10.2174/1568007033482887; Sha D, 2005, MOL BRAIN RES, V136, P255, DOI 10.1016/j.molbrainres.2005.02.005; Sha D, 2008, BRAIN RES, V1207, P9, DOI 10.1016/j.brainres.2008.02.033; SHI YG, 1994, J CELL BIOL, V124, P927, DOI 10.1083/jcb.124.6.927; SHYU KG, 1995, BIOCHEM BIOPH RES CO, V211, P241, DOI 10.1006/bbrc.1995.1802; SOMOGYI R, 1995, J NEUROSCI, V15, P2575; SPOKES EGS, 1980, J NEUROL SCI, V48, P303, DOI 10.1016/0022-510X(80)90103-3; Takamori S, 2000, J NEUROSCI, V20, P4904; Tian N, 1999, P NATL ACAD SCI USA, V96, P12911, DOI 10.1073/pnas.96.22.12911; Vemuganti R, 2005, NEUROCHEM INT, V47, P136, DOI 10.1016/j.neuint.2005.04.015; Vosler PS, 2008, MOL NEUROBIOL, V38, P78, DOI 10.1007/s12035-008-8036-x; Walls AB, 2010, J NEUROCHEM, V115, P1398, DOI 10.1111/j.1471-4159.2010.07043.x; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; WANG Y, 1994, NEUROSCI LETT, V180, P175, DOI 10.1016/0304-3940(94)90515-0; Watanabe M, 2002, INT REV CYTOL, V213, P1; Wei JN, 2006, J NEUROCHEM, V98, P1688, DOI 10.1111/j.1471-4159.2006.04074.x; Wei JN, 2005, J NEUROCHEM, V93, P624, DOI 10.1111/j.1471-4159.2005.03046.x; Wei JN, 2004, BIOCHEMISTRY-US, V43, P6182, DOI 10.1021/bi0496992; Wei JN, 2003, J BIOMED SCI, V10, P617, DOI 10.1159/000073527; Wong CGT, 2003, ANN NEUROL, V54, pS3, DOI 10.1002/ana.10696; Wu H, 2005, BRAIN RES, V1038, P123, DOI 10.1016/j.brainres.2005.01.058; Wu H, 2007, BRAIN RES, V1154, P80, DOI 10.1016/j.brainres.2007.04.008; WU JY, 1986, BRAIN RES, V373, P1, DOI 10.1016/0006-8993(86)90309-4	61	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33002	10.1371/journal.pone.0033002	http://dx.doi.org/10.1371/journal.pone.0033002			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427928	Green Submitted, Green Published, gold			2022-12-25	WOS:000302381500073
J	Qiu, JZ; Niu, XD; Wang, JF; Xing, Y; Leng, BF; Dong, J; Li, HG; Luo, MJ; Zhang, Y; Dai, XH; Luo, YH; Deng, XM				Qiu, Jiazhang; Niu, Xiaodi; Wang, Jianfeng; Xing, Yan; Leng, Bingfeng; Dong, Jing; Li, Hongen; Luo, Mingjing; Zhang, Yu; Dai, Xiaohan; Luo, Yonghuang; Deng, Xuming			Capsaicin Protects Mice from Community-Associated Methicillin-Resistant Staphylococcus aureus Pneumonia	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; ALPHA-TOXIN; VIRULENCE FACTORS; SIGNAL-TRANSDUCTION; UNITED-STATES; CHEMOTHERAPY; INFECTIONS; EMERGENCE; HEMOLYSIN; MODEL	Background: alpha-toxin is one of the major virulence factors secreted by most Staphylococcus aureus strains, which played a central role in the pathogenesis of S. aureus pneumonia. The aim of this study was to investigate the impact of capsaicin on the production of alpha-toxin by community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) strain USA 300 and to further assess its performance in the treatment of CA-MRSA pneumonia in a mouse model. Methodology/Principal Findings: The in vitro effects of capsaicin on alpha-toxin production by S. aureus USA 300 were determined using hemolysis, western blot, and real-time RT-PCR assays. The influence of capsaicin on the alpha-toxin-mediated injury of human alveolar epithelial cells was determined using viability and cytotoxicity assays. Mice were infected intranasally with S. aureus USA 300; the in vivo protective effects of capsaicin against S. aureus pneumonia were assessed by monitoring the mortality, histopathological changes and cytokine levels. Low concentrations of capsaicin substantially decreased the production of alpha-toxin by S. aureus USA 300 without affecting the bacterial viability. The addition of capsaicin prevented alpha-toxin-mediated human alveolar cell (A549) injury in co-culture with S. aureus. Furthermore, the in vivo experiments indicated that capsaicin protected mice from CA-MRSA pneumonia caused by strain USA 300. Conclusions/Significance: Capsaicin inhibits the production of alpha-toxin by CA-MRSA strain USA 300 in vitro and protects mice from CA-MRSA pneumonia in vivo. However, the results need further confirmation with other CA-MRSA lineages. This study supports the views of anti-virulence as a new antibacterial approach for chemotherapy.	[Qiu, Jiazhang; Wang, Jianfeng; Xing, Yan; Leng, Bingfeng; Dong, Jing; Li, Hongen; Luo, Mingjing; Zhang, Yu; Dai, Xiaohan; Deng, Xuming] Jilin Univ, Coll Anim Sci & Vet Med, Inst Zoonosis, Key Lab Zoonosis,Minist Educ, Changchun 130023, Peoples R China; [Luo, Yonghuang] Southwest Univ, Coll Pharmaceut Sci, Chongqing, Peoples R China; [Niu, Xiaodi] Jilin Univ, Dept Food Qual & Safety, Changchun 130023, Peoples R China	Jilin University; Southwest University - China; Jilin University	Qiu, JZ (corresponding author), Jilin Univ, Coll Anim Sci & Vet Med, Inst Zoonosis, Key Lab Zoonosis,Minist Educ, Changchun 130023, Peoples R China.	luoyonghuang@sohu.com; dengxm@jlu.edu.cn	Xiaohan, Dai/AAR-1217-2021		National Nature Science Foundation of China [31072168]; Chongqing Engineering Technology Research Centre of Veterinary Drug (CSTC) [2009CB1010]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Engineering Technology Research Centre of Veterinary Drug (CSTC)(Natural Science Foundation Project of CQ CSTC)	This work was supported by the National Nature Science Foundation of China (No. 31072168) and Chongqing Engineering Technology Research Centre of Veterinary Drug (CSTC, 2009CB1010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELNOUR A, 1993, INFECT IMMUN, V61, P3879, DOI 10.1128/IAI.61.9.3879-3885.1993; Alksne LE, 2000, CURR OPIN BIOTECH, V11, P625, DOI 10.1016/S0958-1669(00)00155-5; [Anonymous], 2005, M100S15 CLSINCCLS; Athanassa Z, 2008, EUR RESPIR J, V31, P625, DOI 10.1183/09031936.00081007; Bartlett AH, 2008, J INFECT DIS, V198, P1529, DOI 10.1086/592758; BHAKDI S, 1991, MICROBIOL REV, V55, P733, DOI 10.1128/MMBR.55.4.733-751.1991; BRAMLEY AJ, 1989, INFECT IMMUN, V57, P2489, DOI 10.1128/IAI.57.8.2489-2494.1989; CALLEGAN MC, 1994, INFECT IMMUN, V62, P2478, DOI 10.1128/IAI.62.6.2478-2482.1994; Cegelski L, 2008, NAT REV MICROBIOL, V6, P17, DOI 10.1038/nrmicro1818; Chan PF, 1998, J BACTERIOL, V180, P6232; Chatterjee S, 2010, FEMS MICROBIOL LETT, V306, P54, DOI 10.1111/j.1574-6968.2010.01931.x; CHEUNG AL, 1994, J CLIN INVEST, V94, P1815, DOI 10.1172/JCI117530; Cichewicz RH, 1996, J ETHNOPHARMACOL, V52, P61, DOI 10.1016/0378-8741(96)01384-0; DeLeo FR, 2008, J EXP MED, V205, P271, DOI 10.1084/jem.20080167; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Escaich S, 2008, CURR OPIN CHEM BIOL, V12, P400, DOI 10.1016/j.cbpa.2008.06.022; George EA, 2008, J AM CHEM SOC, V130, P4914, DOI 10.1021/ja711126e; Herold BC, 1998, JAMA-J AM MED ASSOC, V279, P593, DOI 10.1001/jama.279.8.593; Kazakova SV, 2005, NEW ENGL J MED, V352, P468, DOI 10.1056/NEJMoa042859; Kennedy AD, 2010, J INFECT DIS, V202, P1050, DOI 10.1086/656043; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kuehnert MJ, 2005, EMERG INFECT DIS, V11, P868; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li M, 2009, P NATL ACAD SCI USA, V106, P5883, DOI 10.1073/pnas.0900743106; Liang XD, 2009, INFECT IMMUN, V77, P977, DOI 10.1128/IAI.00920-08; Marra Andrea, 2006, Drugs R D, V7, P1, DOI 10.2165/00126839-200607010-00001; Micek ST, 2005, CHEST, V128, P2732, DOI 10.1378/chest.128.4.2732; Nguyen HM, 2010, J ANTIMICROB CHEMOTH, V65, P24, DOI 10.1093/jac/dkp377; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; Padmanabhan RA, 2005, CLEV CLIN J MED, V72, P235, DOI 10.3949/ccjm.72.3.235; Paul M, 2009, INFECT DIS CLIN N AM, V23, P277, DOI 10.1016/j.idc.2009.01.004; Qiu JZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009736; Rasko DA, 2010, NAT REV DRUG DISCOV, V9, P117, DOI 10.1038/nrd3013; Sambanthamoorthy K, 2006, MICROBIOL-SGM, V152, P2559, DOI 10.1099/mic.0.29071-0; Seybold U, 2006, CLIN INFECT DIS, V42, P647, DOI 10.1086/499815; Shah S, 2008, LETT APPL MICROBIOL, V46, P181, DOI 10.1111/j.1472-765X.2007.02296.x; Stevens DL, 2007, J INFECT DIS, V195, P202, DOI 10.1086/510396; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; Voyich JM, 2006, J INFECT DIS, V194, P1761, DOI 10.1086/509506; Wardenburg JB, 2008, J EXP MED, V205, P287, DOI 10.1084/jem.20072208; Wardenburg JB, 2007, NAT MED, V13, P1405, DOI 10.1038/nm1207-1405; Worlitzsch D, 2001, ANTIMICROB AGENTS CH, V45, P196, DOI 10.1128/AAC.45.1.196-202.2001; Wright JS, 2005, P NATL ACAD SCI USA, V102, P1691, DOI 10.1073/pnas.0407661102; Wunderink RG, 2003, CHEST, V124, P1789, DOI 10.1378/chest.124.5.1789	45	33	33	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33032	10.1371/journal.pone.0033032	http://dx.doi.org/10.1371/journal.pone.0033032			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427935	Green Published, Green Submitted, gold			2022-12-25	WOS:000302381500078
J	Collerton, J; Kingston, A; Bond, J; Davies, K; Eccles, MP; Jagger, C; Kirkwood, TBL; Newton, JL				Collerton, Joanna; Kingston, Andrew; Bond, John; Davies, Karen; Eccles, Martin P.; Jagger, Carol; Kirkwood, Thomas B. L.; Newton, Julia L.			The Personal and Health Service Impact of Falls in 85 Year Olds: Cross-Sectional Findings from the Newcastle 85+Cohort Study	PLOS ONE			English	Article							BASE-LINE FINDINGS; POSITIONAL VERTIGO; ELDERLY PERSONS; RISK-FACTORS; PEOPLE; POPULATION; SYNCOPE; ADULTS; COSTS; FEAR	Introduction: Falls are common in older people and increase in prevalence with advancing old age. There is limited knowledge about their impact in those aged 85 years and older, the fastest growing age group of the population. We investigated the prevalence and impact of falls, and the overlap between falls, dizziness and blackouts, in a population-based sample of 85 year olds. Methods: Design: Cross-sectional analysis of baseline data from Newcastle 85+ Cohort Study. Setting: Primary care, North-East England. Participants: 816 men and women aged 85 years. Measurements: Structured interview with research nurse. Cost-consequence analysis of fall-related healthcare costs. Results: Over 38% (313/816) of participants had fallen at least once in the previous 12 months and of these: 10.6% (33/312) sustained a fracture, 30.1% (94/312) attended an emergency department, and 12.8% (40/312) were admitted to hospital. Only 37.2% (115/309) of fallers had specifically discussed their falls problem with their general practitioner and only 12.7% (39/308) had seen a falls specialist. The average annual healthcare cost per faller was estimated at 202 pound (inter-quartile range 174- pound 231) pound or US$329 ($284-$377). 'Worry about falling' was experienced by 42.0% (128/305) of fallers, 'loss of confidence' by 40.0% (122/305), and 'going out less often' by 25.9% (79/305); each was significantly more common in women, odds ratios (95% confidence interval) for women: men of 2.63 (1.45-4.55), 4.00 (2.27-7.14), and 2.86 (1.54-5.56) respectively. Dizziness and blackouts were reported by 40.0% (318/796) and 6.4% (52/808) of participants respectively. There was marked overlap in the report of falls, dizziness and blackouts. Conclusions: Falls in 85 year olds are very common, associated with considerable psychological and physical morbidity, and have high impact on healthcare services. Wider use of fall prevention services is needed. Significant expansion in acute and preventative services is required in view of the rapid growth in this age group.	[Collerton, Joanna; Kingston, Andrew; Bond, John; Davies, Karen; Eccles, Martin P.; Jagger, Carol; Kirkwood, Thomas B. L.; Newton, Julia L.] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Bond, John; Eccles, Martin P.] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Newton, Julia L.] Newcastle Upon Tyne Hosp NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust	Collerton, J (corresponding author), Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	joanna.collerton@ncl.ac.uk	Eccles, Martin P/AAD-4029-2020	Jagger, Carol/0000-0002-6377-9926; Davies, Karen/0000-0002-2820-9397; Kingston, Andrew/0000-0003-4211-7007; Newton, Julia/0000-0002-1249-5253	UK Medical Research Council (URL); UK Biotechnology and Biological Sciences Research Council (URL);  [G0500997]; MRC [MR/J50001X/1, G0500997] Funding Source: UKRI; Medical Research Council [G0700718B, G0500997, MR/J50001X/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10260] Funding Source: researchfish	UK Medical Research Council (URL); UK Biotechnology and Biological Sciences Research Council (URL); ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The baseline phase of the Newcastle 85+ Study was supported by a joint grant from the UK Medical Research Council (URL http://www.mrc.ac.uk/index.htm) and the UK Biotechnology and Biological Sciences Research Council (URL http://bbsrc.ac.uk/); Grant Reference G0500997. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Geriatrics Society, 2010, PREV FALLS OLD PERS; Bootsma-van der Wiel A, 2002, J AM GERIATR SOC, V50, P1405; Chang JT, 2004, BRIT MED J, V328, P680, DOI 10.1136/bmj.328.7441.680; Cheal B., 2001, AUSTR OCCUPAT THER J, V48, P80, DOI DOI 10.1046/J.1440-1630.2001.00250.X].AUSTRALIAN; Collerton Joanna, 2007, BMC Geriatr, V7, P14, DOI 10.1186/1471-2318-7-14; Collerton J, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4904; Curtis L, 2007, UNIT COSTS HLTH SOCI; Davies K, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-64; Delbaere K, 2004, AGE AGEING, V33, P368, DOI 10.1093/ageing/afh106; Delbaere K, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4165; Fleming Jane, 2008, BMC Geriatr, V8, P6, DOI 10.1186/1471-2318-8-6; Fleming J, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2227; Gillespie Lesley D, 2012, Cochrane Database Syst Rev, pCD007146, DOI 10.1002/14651858.CD007146.pub3; Government Actuary's Department, 2009, NAT POP PROJ 2008 BA; Hampton JL, 2002, BRIT J GEN PRACT, V52, P884; Jagger C, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-21; Jung D, 2009, WESTERN J NURS RES, V31, P6, DOI 10.1177/0193945908320466; Kenny RA, 2002, AGE AGEING, V31, P272, DOI 10.1093/ageing/31.4.272; Lach HW, 2005, PUBLIC HEALTH NURS, V22, P45, DOI 10.1111/j.0737-1209.2005.22107.x; Lawrence RH, 1998, J AGING HEALTH, V10, P267, DOI 10.1177/089826439801000301; Lawson J, 2005, QJM-INT J MED, V98, P357, DOI 10.1093/qjmed/hci057; Lawson J, 2008, AGE AGEING, V37, P585, DOI 10.1093/ageing/afn151; Lehtola S, 2006, ARCH GERONTOL GERIAT, V42, P217, DOI 10.1016/j.archger.2005.07.002; LIU BA, 1995, J AM GERIATR SOC, V43, P1141, DOI 10.1111/j.1532-5415.1995.tb07016.x; LUUKINEN H, 1995, J AM GERIATR SOC, V43, P871, DOI 10.1111/j.1532-5415.1995.tb05529.x; MCINTOSH S, 1993, AGE AGEING, V22, P53, DOI 10.1093/ageing/22.1.53; McNamee P, 1999, SOC SCI MED, V48, P331, DOI 10.1016/S0277-9536(98)00351-7; *NAT I CLIN EXC, 2004, CLIN PRACT GUID ASS; National Centre for Social Research Department of Epidemiology and Public Health at the Royal Free and University College Medical School, 2005, HLTH SURV ENGL 2005; Newton J, 2001, Expert Rev Pharmacoecon Outcomes Res, V1, P187, DOI 10.1586/14737167.1.2.187; Newton JL, 2006, EMERG MED J, V23, P479, DOI 10.1136/emj.2005.028803; Parry SW, 2009, HEART, V95, P416, DOI 10.1136/hrt.2007.136457; Rizzo JA, 1998, MED CARE, V36, P1174, DOI 10.1097/00005650-199808000-00006; Scuffham P, 2003, J EPIDEMIOL COMMUN H, V57, P740, DOI 10.1136/jech.57.9.740; Shaw FE, 1997, POSTGRAD MED J, V73, P635, DOI 10.1136/pgmj.73.864.635; TINETTI ME, 1993, JAMA-J AM MED ASSOC, V269, P65, DOI 10.1001/jama.269.1.65; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; Tinetti ME, 1997, NEW ENGL J MED, V337, P1279, DOI 10.1056/NEJM199710303371806; UK Parliament, 2005, MENT CAP ACT 2005; United Nations Department of Economic and Social Affairs, 2002, WORLD POP AG 1950 20; van Bemmel T, 2005, J CLIN EPIDEMIOL, V58, P63, DOI 10.1016/j.jclinepi.2004.06.007; Vellas BJ, 1997, AGE AGEING, V26, P189, DOI 10.1093/ageing/26.3.189; Wagert PV, 2009, ARCH GERONTOL GERIAT, V49, P390, DOI 10.1016/j.archger.2008.12.005	43	16	16	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2012	7	3							e33078	10.1371/journal.pone.0033078	http://dx.doi.org/10.1371/journal.pone.0033078			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	929KX	22427954	Green Published, gold, Green Submitted			2022-12-25	WOS:000303062800043
J	Bhat, KH; Chaitanya, CK; Parveen, N; Varman, R; Ghosh, S; Mukhopadhyay, S				Bhat, Khalid Hussain; Chaitanya, Chinta Krishna; Parveen, Nazia; Varman, Raja; Ghosh, Sudip; Mukhopadhyay, Sangita			Proline-Proline-Glutamic Acid (PPE) Protein Rv1168c of Mycobacterium tuberculosis Augments Transcription from HIV-1 Long Terminal Repeat Promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; GENE-EXPRESSION; T-CELL; PRODUCTIVE INFECTION; IMMUNE-RESPONSES; MONOCYTE SUBSET; DENDRITIC CELLS; TYPE-1	Cells of the monocyte/macrophage lineage are shown to play a role in the pathogenesis of human immunodeficiency virus (HIV). The occurrence of HIV type 1 (HIV-1) infection is found to be accelerated in people infected with Mycobacterium tuberculosis, but the mechanism by which mycobacterial protein(s) induces HIV-1 LTR trans-activation is not clearly understood. We show here that the M. tuberculosis proline-proline-glutamic acid (PPE) protein Rv1168c (PPE17) can augment transcription from HIV-1 LTR in monocyte/macrophage cells. Rv1168c interacts specifically with Toll-like receptor-2 (TLR2) resulting in downstream activation of nuclear factor-kappa B (NF-kappa B) resulting in HIV-1 LTR trans-activation. Another PPE protein, Rv1196 (PPE18), was also found to interact with TLR2 but had no effect on HIV-1 LTR trans-activation because of its inability to activate the NF-kappa B signaling pathway. In silico docking analyses and mutation experiments have revealed that the N-terminal domain of Rv1168c specifically interacts with LRR motifs 15-20 of TLR2, and this site of interaction is different from that of Rv1196 protein (LRR motifs 11-15), indicating that the site of interaction on TLR2 dictates the downstream signaling events leading to activation of NF-kappa B. This information may help in understanding the mechanism of pathogenesis of HIV-1 during M. tuberculosis co-infection.	[Bhat, Khalid Hussain; Chaitanya, Chinta Krishna; Parveen, Nazia; Varman, Raja; Mukhopadhyay, Sangita] Ctr DNA Fingerprinting & Diagnost, Mol Cell Biol Lab, Hyderabad 500001, Andhra Pradesh, India; [Ghosh, Sudip] Natl Inst Nutr, Mol Biol Unit, Hyderabad 500007, Andhra Pradesh, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Indian Council of Medical Research (ICMR); ICMR - National Institute of Nutrition (NIN)	Mukhopadhyay, S (corresponding author), Ctr DNA Fingerprinting & Diagnost, Mol Cell Biol Lab, Bldg 7,Gruhakalpa 5-4-399-B, Hyderabad 500001, Andhra Pradesh, India.	sangita@cdfd.org.in		Bhat, Dr. Khalid Hussain/0000-0002-0952-7496; Parveen, Nazia/0000-0002-2918-9498; Chinta, Krishna C./0000-0001-8425-2456; Mukhopadhyay, Sangita/0000-0002-5511-3315	Indian Council of Medical Research, Government of India; Department of Biotechnology, Government of India; Department of Biotechnology; Council of Scientific and Industrial Research, India	Indian Council of Medical Research, Government of India(Indian Council of Medical Research (ICMR)); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Department of Biotechnology; Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported in part by grants from the Indian Council of Medical Research, Government of India, the Department of Biotechnology, Government of India, and a core grant to the Centre for DNA Fingerprinting and Diagnostics by the Department of Biotechnology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Supported by Research Fellowship from the Council of Scientific and Industrial Research, India.	Abdallah AM, 2006, MOL MICROBIOL, V62, P667, DOI 10.1111/j.1365-2958.2006.05409.x; Asin S, 2001, J VIROL, V75, P11408, DOI 10.1128/JVI.75.23.11408-11416.2001; Bacon J, 2004, TUBERCULOSIS, V84, P205, DOI 10.1016/j.tube.2003.12.011; Bafica A, 2003, J IMMUNOL, V171, P1123, DOI 10.4049/jimmunol.171.3.1123; Balboa L, 2011, J LEUKOCYTE BIOL, V90, P69, DOI 10.1189/jlb.1010577; Bansal K, 2010, J BIOL CHEM, V285, P36511, DOI 10.1074/jbc.M110.158055; Basu S, 2007, J BIOL CHEM, V282, P1039, DOI 10.1074/jbc.M604379200; Bernier R, 1998, J GEN VIROL, V79, P1353, DOI 10.1099/0022-1317-79-6-1353; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Brennan MJ, 2002, TRENDS MICROBIOL, V10, P246, DOI 10.1016/S0966-842X(02)02335-1; Brown A, 2006, J LEUKOCYTE BIOL, V80, P1127, DOI 10.1189/jlb.0206126; Choudhary RK, 2003, INFECT IMMUN, V71, P6338, DOI 10.1128/IAI.71.11.6338-6343.2003; Cohen OJ, 1997, IMMUNOL REV, V159, P31, DOI 10.1111/j.1600-065X.1997.tb01005.x; Coiras M, 2009, NAT REV MICROBIOL, V7, P798, DOI 10.1038/nrmicro2223; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Coleman CM, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-51; de Noronha ALL, 2008, PATHOL RES PRACT, V204, P155, DOI 10.1016/j.prp.2007.10.008; Delogu G, 2004, FEMS MICROBIOL LETT, V239, P33, DOI 10.1016/j.femsle.2004.08.015; Delogu G, 2006, MICROBES INFECT, V8, P2061, DOI 10.1016/j.micinf.2006.03.015; Dhiman R, 2011, J IMMUNOL, V186, P1638, DOI 10.4049/jimmunol.1003146; Diedrich CR, 2011, INFECT IMMUN, V79, P1407, DOI 10.1128/IAI.01126-10; Doherty TM, 1999, J IMMUNOL, V163, P1506; DUH EJ, 1989, P NATL ACAD SCI USA, V86, P5974, DOI 10.1073/pnas.86.15.5974; Ellery PJ, 2007, J IMMUNOL, V178, P6581, DOI 10.4049/jimmunol.178.10.6581; Equils O, 2003, J IMMUNOL, V170, P5159, DOI 10.4049/jimmunol.170.10.5159; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Garrait V, 1997, J IMMUNOL, V159, P2824; GARTNER S, 1986, SCIENCE, V233, P215, DOI 10.1126/science.3014648; Gey van Pittius NC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-95; Ghassemi M, 2000, AIDS RES HUM RETROV, V16, P435, DOI 10.1089/088922200309098; Guex N., 1996, Experientia (Basel), V52, pA26; He MM, 2005, SCIENCE, V310, P1022, DOI 10.1126/science.1116304; Homolka S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000988; Igarashi T, 2001, P NATL ACAD SCI USA, V98, P658, DOI 10.1073/pnas.021551798; Jacque JM, 1996, J VIROL, V70, P2930; Jagodzinski PP, 2001, FOLIA HISTOCHEM CYTO, V39, P47; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Jo EK, 2007, CELL MICROBIOL, V9, P1087, DOI 10.1111/j.1462-5822.2007.00914.x; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Khan N, 2006, BLOOD, V107, P1513, DOI 10.1182/blood-2005-04-1707; Khan N, 2008, CLIN VACCINE IMMUNOL, V15, P974, DOI 10.1128/CVI.00485-07; Khan N, 2008, CELL MICROBIOL, V10, P1711, DOI 10.1111/j.1462-5822.2008.01161.x; Khan N, 2007, INT IMMUNOL, V19, P477, DOI 10.1093/intimm/dxm012; Kilareski EM, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-118; Kitaura H, 2001, FEMS IMMUNOL MED MIC, V31, P97, DOI 10.1016/S0928-8244(01)00249-8; KOYANAGI Y, 1988, SCIENCE, V241, P1673, DOI 10.1126/science.3047875; Kwan CK, 2011, CLIN MICROBIOL REV, V24, P351, DOI 10.1128/CMR.00042-10; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lawn SD, 2002, MICROBES INFECT, V4, P635, DOI 10.1016/S1286-4579(02)01582-4; Li YJ, 2005, CELL MICROBIOL, V7, P539, DOI 10.1111/j.1462-5822.2004.00484.x; Lopez-Gatell H, 2007, AM J EPIDEMIOL, V165, P1134, DOI 10.1093/aje/kwk116; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Meng GX, 2003, J BIOL CHEM, V278, P39822, DOI 10.1074/jbc.M304766200; Mizuguchi K, 1998, BIOINFORMATICS, V14, P617, DOI 10.1093/bioinformatics/14.7.617; MOLINA JM, 1989, J CLIN INVEST, V84, P733, DOI 10.1172/JCI114230; Moriuchi M, 1998, J CLIN INVEST, V102, P1540, DOI 10.1172/JCI4151; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Mukhopadhyay S, 2002, J IMMUNOL, V168, P2914, DOI 10.4049/jimmunol.168.6.2914; Muttucumaru DGN, 2004, TUBERCULOSIS, V84, P239, DOI 10.1016/j.tube.2003.12.006; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; Nair S, 2011, J IMMUNOL, V186, P5413, DOI 10.4049/jimmunol.1000773; Nair S, 2009, J IMMUNOL, V183, P6269, DOI 10.4049/jimmunol.0901367; Newton V, 2009, VET MICROBIOL, V135, P394, DOI 10.1016/j.vetmic.2008.09.066; Orenstein JM, 1997, SCIENCE, V276, P1857, DOI 10.1126/science.276.5320.1857; Pecora ND, 2006, J IMMUNOL, V177, P422, DOI 10.4049/jimmunol.177.1.422; Pereira LA, 2000, NUCLEIC ACIDS RES, V28, P663, DOI 10.1093/nar/28.3.663; POMERANTZ RJ, 1990, J EXP MED, V172, P253, DOI 10.1084/jem.172.1.253; Ramakrishnan L, 2000, SCIENCE, V288, P1436, DOI 10.1126/science.288.5470.1436; Ritchie DW, 1999, J COMPUT CHEM, V20, P383, DOI 10.1002/(SICI)1096-987X(199903)20:4<383::AID-JCC1>3.0.CO;2-M; ROULSTON A, 1995, MICROBIOL REV, V59, P481, DOI 10.1128/MMBR.59.3.481-505.1995; ROY S, 1988, J LEUKOCYTE BIOL, V43, P91, DOI 10.1002/jlb.43.1.91; Sampson SL, 2001, TUBERCULOSIS, V81, P305, DOI 10.1054/tube.2001.0304; Sanchez D, 2010, CELL IMMUNOL, V260, P128, DOI 10.1016/j.cellimm.2009.10.007; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; SCHRECK R, 1992, J EXP MED, V175, P1181, DOI 10.1084/jem.175.5.1181; SCHWARTZ S, 1989, P NATL ACAD SCI USA, V86, P7200, DOI 10.1073/pnas.86.18.7200; SELWYN PA, 1989, NEW ENGL J MED, V320, P545, DOI 10.1056/NEJM198903023200901; SHATTOCK RJ, 1994, J GEN VIROL, V75, P849, DOI 10.1099/0022-1317-75-4-849; Shen Y, 2004, J VIROL, V78, P14023, DOI 10.1128/JVI.78.24.14023-14032.2004; Singh KK, 2005, INFECT IMMUN, V73, P5004, DOI 10.1128/IAI.73.8.5004-5014.2005; Sorgen PL, 2002, P NATL ACAD SCI USA, V99, P14037, DOI 10.1073/pnas.182552199; Sweet L, 2006, J LEUKOCYTE BIOL, V80, P415, DOI 10.1189/jlb.1205702; Thieblemont N, 1995, EUR J IMMUNOL, V25, P3418, DOI 10.1002/eji.1830251232; Thomas DJ, 2006, J PHARM PRACT, V19, P10, DOI 10.1177/0897190005284100; TOOSSI Z, 1993, J EXP MED, V177, P1511, DOI 10.1084/jem.177.5.1511; Toossi Z, 1999, CLIN EXP IMMUNOL, V117, P324; UN Joint Programme on HIV/AIDS, 2010, GLOB REP UNAIDS REP; Voskuil MI, 2004, TUBERCULOSIS, V84, P256, DOI 10.1016/j.tube.2003.12.014; Wagner DH, 2002, P NATL ACAD SCI USA, V99, P3782, DOI 10.1073/pnas.052247099; Wahl SM, 1999, J INFECT DIS, V179, pS457, DOI 10.1086/314814; Wahl SM, 1998, P NATL ACAD SCI USA, V95, P12574, DOI 10.1073/pnas.95.21.12574; Williams BG, 2005, P NATL ACAD SCI USA, V102, P9619, DOI 10.1073/pnas.0501615102; Yu MY, 2009, MINI-REV MED CHEM, V9, P60, DOI 10.2174/138955709787001677; ZHANG YH, 1995, J CLIN INVEST, V95, P2324, DOI 10.1172/JCI117924; Zhou SH, 2010, ANTIVIR RES, V87, P295, DOI 10.1016/j.antiviral.2010.06.011; Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510	96	26	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16930	16946		10.1074/jbc.M111.327825	http://dx.doi.org/10.1074/jbc.M111.327825			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22427668	Green Published, hybrid			2022-12-25	WOS:000304030900078
J	Dunn-Siegrist, I; Tissieres, P; Drifte, G; Bauer, J; Moutel, S; Pugin, J				Dunn-Siegrist, Irene; Tissieres, Pierre; Drifte, Genevieve; Bauer, Jacques; Moutel, Stephane; Pugin, Jerome			Toll-like Receptor Activation of Human Cells by Synthetic Triacylated Lipid A-like Molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-NEGATIVE BACTERIA; CRYSTAL-STRUCTURE; BIOPHYSICAL CHARACTERIZATION; TLR4-MD-2 COMPLEX; DENDRITIC CELLS; SEPTIC SHOCK; SOLUBLE MD-2; WHOLE-BLOOD; LIPOPOLYSACCHARIDE; TLR4	Recognition of microbial molecules by mammalian host receptors is essential to mount an immune response. Hexaacylated LPS is the prototypic example of a bacterial molecule recognized by the receptor complex TLR4/MD-2 with its lipid A moiety, whereas bacterial lipopeptides are recognized by TLR2. Here we show that a series of synthetic triacylated lipid A-like molecules are weak Toll-like receptor (TLR) agonists (mainly TLR2 agonists) but very potent TLR4/MD-2 antagonists (submicromolar range). Not only do they block human cell responses to LPS but also to whole Gram-negative bacteria, and they inhibit the phagocytosis of Gram-negative bacteria. These compounds may represent promising immunomodulatory agents.	[Dunn-Siegrist, Irene; Tissieres, Pierre; Drifte, Genevieve; Pugin, Jerome] Univ Geneva, Fac Med, Intens Care Lab, CH-1211 Geneva 14, Switzerland; [Dunn-Siegrist, Irene; Tissieres, Pierre; Drifte, Genevieve; Pugin, Jerome] Univ Geneva, Fac Med, Dept Microbiol & Mol Med, CH-1211 Geneva 14, Switzerland; [Bauer, Jacques; Moutel, Stephane] OM Pharma, CH-1217 Meyrin, Switzerland	University of Geneva; University of Geneva; Vifor Pharma	Pugin, J (corresponding author), Hop Univ Geneve, Site E,Rue Gabrielle Perret Gentil 4, CH-1211 Geneva 14, Switzerland.	jerome.pugin@unige.ch	Bauer, Jacques/M-9971-2015	Bauer, Jacques/0000-0003-2772-6111	Swiss National Foundation [122034]	Swiss National Foundation(Swiss National Science Foundation (SNSF))	This work was supported by Swiss National Foundation for Scientific Research Grant 122034 (to J. P.).	Ahn JH, 2007, BIOORG MED CHEM LETT, V17, P2622, DOI 10.1016/j.bmcl.2007.01.111; Airhart CL, 2008, MICROBIOL-SGM, V154, P2131, DOI 10.1099/mic.0.2008/017566-0; Bas S, 2008, J IMMUNOL, V180, P1158, DOI 10.4049/jimmunol.180.2.1158; Brandenburg K, 2003, CARBOHYD RES, V338, P2477, DOI 10.1016/j.carres.2003.08.008; Brandenburg K, 2002, BIOPHYS J, V83, P322, DOI 10.1016/S0006-3495(02)75172-2; Brandenburg K, 2000, EUR J BIOCHEM, V267, P3370, DOI 10.1046/j.1432-1327.2000.01370.x; Bryant CE, 2007, VET IMMUNOL IMMUNOP, V116, P182, DOI 10.1016/j.vetimm.2007.01.013; Byl B, 2003, INT IMMUNOPHARMACOL, V3, P417, DOI 10.1016/S1567-5769(03)00008-0; Cristofaro P, 2006, DRUGS, V66, P15, DOI 10.2165/00003495-200666010-00002; Dunn-Siegrist I, 2007, J BIOL CHEM, V282, P34817, DOI 10.1074/jbc.M706440200; Elson G, 2007, BLOOD, V109, P1574, DOI 10.1182/blood-2006-06-032961; Gradisar H, 2007, J LEUKOCYTE BIOL, V82, P968, DOI 10.1189/jlb.1206727; Howe J, 2006, FEBS J, V273, P5101, DOI 10.1111/j.1742-4658.2006.05507.x; Jain V, 2008, BLOOD, V111, P4637, DOI 10.1182/blood-2007-11-126862; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Kim JI, 2005, J BIOL CHEM, V280, P11347, DOI 10.1074/jbc.M414607200; KOVACH NL, 1990, J EXP MED, V172, P77, DOI 10.1084/jem.172.1.77; Lembo A, 2008, J IMMUNOL, V180, P7574, DOI 10.4049/jimmunol.180.11.7574; Martin OR, 2006, J MED CHEM, V49, P6000, DOI 10.1021/jm060482a; Mascarell L, 2007, VACCINE, V26, P108, DOI 10.1016/j.vaccine.2007.10.050; Meng JM, 2010, J BIOL CHEM, V285, P27935, DOI 10.1074/jbc.M110.134668; Meng JM, 2010, J BIOL CHEM, V285, P8695, DOI 10.1074/jbc.M109.075127; Muroi M, 2002, INFECT IMMUN, V70, P3546, DOI 10.1128/IAI.70.7.3546-3550.2002; Nakata T, 2006, CELL MICROBIOL, V8, P1899, DOI 10.1111/j.1462-5822.2006.00756.x; Netea MG, 2002, TRENDS IMMUNOL, V23, P135, DOI 10.1016/S1471-4906(01)02169-X; Opal SM, 2002, CRIT CARE, V6, P125; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Pugin J, 2004, BLOOD, V104, P4071, DOI 10.1182/blood-2003-04-1290; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Savoy F, 2006, IMMUNOBIOLOGY, V211, P767, DOI 10.1016/j.imbio.2006.06.001; Schromm AB, 2007, J BIOL CHEM, V282, P11030, DOI 10.1074/jbc.M700287200; Shin HJ, 2007, MOL CELLS, V24, P119; Singer P, 2008, INTENS CARE MED, V34, P1580, DOI 10.1007/s00134-008-1142-4; Stover AG, 2004, J BIOL CHEM, V279, P4440, DOI 10.1074/jbc.M310760200; Tissieres P, 2008, BLOOD, V111, P2122, DOI 10.1182/blood-2007-06-097782; Triantafilou M, 2004, BIOCHEM J, V381, P527, DOI 10.1042/BJ20040172; Veran J, 2004, IMMUNOBIOLOGY, V209, P67, DOI 10.1016/j.imbio.2004.02.003; Walsh C, 2008, J IMMUNOL, V181, P1245, DOI 10.4049/jimmunol.181.2.1245; Wong SW, 2009, J BIOL CHEM, V284, P27384, DOI 10.1074/jbc.M109.044065	40	14	17	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16121	16131		10.1074/jbc.M112.348383	http://dx.doi.org/10.1074/jbc.M112.348383			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22433865	Green Published, hybrid			2022-12-25	WOS:000304030900005
J	Cao, Q; Wang, XJ; Liu, CW; Liu, DF; Li, LF; Gao, YQ; Su, XD				Cao, Qin; Wang, Xiao-Jun; Liu, Cheng-Wen; Liu, Dai-Fei; Li, Lan-Fen; Gao, Yi-Qin; Su, Xiao-Dong			Inhibitory Mechanism of Caspase-6 Phosphorylation Revealed by Crystal Structures, Molecular Dynamics Simulations, and Biochemical Assays	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICHAEL ACCEPTORS; IN-VITRO; ACTIVATION; CLEAVAGE; DEATH; SYSTEM; SITE; P53	The apoptotic effector caspase-6 (CASP6) has been clearly identified as a drug target due to its strong association with neurodegeneration and axonal pruning events as well as its crucial roles in Huntington disease and Alzheimer disease. CASP6 activity is suppressed by ARK5-mediated phosphorylation at Ser(257) with an unclear mechanism. In this work, we solved crystal structures of Delta proCASP6S257E and p20/p10S257E, which mimicked the phosphorylated CASP6 zymogen and activated CASP6, respectively. The structural investigation combined with extensive biochemical assay and molecular dynamics simulation studies revealed that phosphorylation on Ser(257) inhibited self-activation of CASP6 zymogen by "locking" the enzyme in the TEVD193-bound "inhibited state." The structural and biochemical results also showed that phosphorylation on Ser(257) inhibited the CASP6 activity by steric hindrance. These results disclosed the inhibition mechanism of CASP6 phosphorylation and laid the foundation for a new strategy of rational CASP6 drug design.	[Liu, Cheng-Wen; Gao, Yi-Qin] Peking Univ, Coll Chem & Mol Engn, Inst Theoret & Computat Chem, Beijing 100871, Peoples R China; [Cao, Qin; Wang, Xiao-Jun; Liu, Dai-Fei; Li, Lan-Fen; Su, Xiao-Dong] Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res & Biodynam Op, Beijing 100871, Peoples R China	Peking University; Peking University	Gao, YQ (corresponding author), Peking Univ, Coll Chem & Mol Engn, Inst Theoret & Computat Chem, Beijing 100871, Peoples R China.	gaoyq@pku.edu.cn; xdsu@pku.edu.cn	Liu, Chengwen/F-5166-2019; gao, yi/HCI-8298-2022; Liu, Daifei/W-3833-2017	Liu, Chengwen/0000-0002-3930-7793; 	National Basic Research Program of China 973 [2011CB911103]; National High Technology 863 Program [2006AA02A317]; National Natural Science Foundation of China (Canada-China Joint Health Initiative) [30711120581, 21125311, 91027044]	National Basic Research Program of China 973(National Basic Research Program of China); National High Technology 863 Program; National Natural Science Foundation of China (Canada-China Joint Health Initiative)	This work was supported by grants from the National Basic Research Program of China 973 Grant 2011CB911103 (to X.-D. S.), National High Technology 863 Program 2006AA02A317 (to X.-D. S.), and National Natural Science Foundation of China (Canada-China Joint Health Initiative 30711120581 (to X.-D. S.) and 21125311, 91027044 (to Y.-Q. G.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albrecht S, 2007, AM J PATHOL, V170, P1200, DOI 10.2353/ajpath.2007.060974; [Anonymous], 2008, AMBER 10; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baumgartner R, 2009, BIOCHEM J, V423, P429, DOI 10.1042/BJ20090540; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Chu WH, 2009, J MED CHEM, V52, P2188, DOI 10.1021/jm900135r; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Ekici OD, 2006, J MED CHEM, V49, P5728, DOI 10.1021/jm0601405; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Graham RK, 2011, TRENDS NEUROSCI, V34, P646, DOI 10.1016/j.tins.2011.09.001; Graham RK, 2010, J NEUROSCI, V30, P15019, DOI 10.1523/JNEUROSCI.2071-10.2010; Guo HS, 2004, AM J PATHOL, V165, P523, DOI 10.1016/S0002-9440(10)63317-2; Hou X, 2011, ONCOGENE, V30, P2933, DOI 10.1038/onc.2011.19; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Klaiman G, 2008, MOL CELL PROTEOMICS, V7, P1541, DOI 10.1074/mcp.M800007-MCP200; Klaiman G, 2009, BBA-MOL CELL RES, V1793, P592, DOI 10.1016/j.bbamcr.2008.12.004; Kurokawa M, 2009, CELL, V138, P838, DOI 10.1016/j.cell.2009.08.021; Lee AW, 2010, J BIOL CHEM, V285, P31974, DOI 10.1074/jbc.M110.152744; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; MacLachan TK, 2002, P NATL ACAD SCI USA, V99, P9492, DOI 10.1073/pnas.132241599; McStay GP, 2008, CELL DEATH DIFFER, V15, P322, DOI 10.1038/sj.cdd.4402260; Muller I, 2011, BIOORG MED CHEM LETT, V21, P5244, DOI 10.1016/j.bmcl.2011.07.041; Muller I, 2011, J MOL BIOL, V410, P307, DOI 10.1016/j.jmb.2011.05.020; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pop C, 2009, J BIOL CHEM, V284, P21777, DOI 10.1074/jbc.R800084200; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; Suzuki A, 2004, ONCOGENE, V23, P7067, DOI 10.1038/sj.onc.1207963; Vaidya S, 2011, J MOL BIOL, V406, P75, DOI 10.1016/j.jmb.2010.11.031; Wang XJ, 2010, EMBO REP, V11, P841, DOI 10.1038/embor.2010.141; Yan N, 2005, ANNU REV CELL DEV BI, V21, P35, DOI 10.1146/annurev.cellbio.21.012704.131040; Yang LJ, 2006, J PHYS CHEM B, V110, P13166, DOI 10.1021/jp060163v	35	27	27	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15371	15379		10.1074/jbc.M112.351213	http://dx.doi.org/10.1074/jbc.M112.351213			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22433863	Green Published, hybrid			2022-12-25	WOS:000304006300019
J	Sen, A; Alkon, DL; Nelson, TJ				Sen, Abhik; Alkon, Daniel L.; Nelson, Thomas J.			Apolipoprotein E3 (ApoE3) but Not ApoE4 Protects against Synaptic Loss through Increased Expression of Protein Kinase C epsilon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; AMYLOID PRECURSOR PROTEIN; ACTIVATES PKC-EPSILON; ALZHEIMERS-DISEASE; BETA PEPTIDE; MEMORY IMPAIRMENTS; TRANSGENIC MICE; ALPHA; NEURONS; BINDING	Synaptic loss is the earliest pathological change in Alzheimer disease (AD) and is the pathological change most directly correlated with the degree of dementia. ApoE4 is the major genetic risk factor for the age-dependent form of AD, which accounts for 95% of cases. Here we show that in synaptic networks formed from primary hippocampal neurons in culture, apoE3, but not apoE4, prevents the loss of synaptic networks produced by amyloid beta oligomers (amylospheroids). Specific activators of PKC epsilon, such as 8-(2-(2-pentyl-cyclopropylmethyl)-cyclopropyl)-octanoic acid methyl ester and bryostatin 1, protected against synaptic loss by amylospheroids, whereas PKC epsilon inhibitors blocked this synaptic protection and also blocked the protection by apoE3. Blocking LRP1, an apoE receptor on the neuronal membrane, also blocked the protection by apoE. ApoE3, but not apoE4, induced the synthesis of PKC epsilon mRNA and expression of the PKC epsilon protein. Amyloid beta specifically blocked the expression of PKC epsilon but had no effect on other isoforms. These results suggest that protection against synaptic loss by apoE is mediated by a novel intracellular PKC epsilon pathway. This apoE pathway may account for much of the protective effect of apoE and reduced risk for the age-dependent form of AD. This finding supports the potential efficacy of newly developed therapeutics for AD.	[Sen, Abhik; Alkon, Daniel L.; Nelson, Thomas J.] Blanchette Rockefeller Neurosci Inst, Morgantown, WV 26505 USA		Nelson, TJ (corresponding author), Blanchette Rockefeller Neurosci Inst, 8 Med Ctr Dr, Morgantown, WV 26505 USA.	tjnelson@brni-jhu.org	Sen, Abhik/L-2067-2017	Sen, Abhik/0000-0003-4048-0566				Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Bour A, 2008, BEHAV BRAIN RES, V193, P174, DOI 10.1016/j.bbr.2008.05.008; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Cedazo-Minguez A, 2003, J NEUROCHEM, V87, P1152, DOI 10.1046/j.1471-4159.2003.02088.x; Cerf E, 2011, FASEB J, V25, P1585, DOI 10.1096/fj.10-175976; COLE G, 1988, BRAIN RES, V452, P165, DOI 10.1016/0006-8993(88)90021-2; Deshpande A, 2006, J NEUROSCI, V26, P6011, DOI 10.1523/JNEUROSCI.1189-06.2006; Dinamarca MC, 2006, MOL PSYCHIATR, V11, P1032, DOI 10.1038/sj.mp.4001866; Dumanis SB, 2009, J NEUROSCI, V29, P15317, DOI 10.1523/JNEUROSCI.4026-09.2009; Fagan AM, 1996, J BIOL CHEM, V271, P30121, DOI 10.1074/jbc.271.47.30121; Favit A, 1998, P NATL ACAD SCI USA, V95, P5562, DOI 10.1073/pnas.95.10.5562; Fernandez-Chacon R, 1999, ANNU REV PHYSIOL, V61, P753, DOI 10.1146/annurev.physiol.61.1.753; Fuentealba RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011884; Hartman RE, 2001, EXP NEUROL, V170, P326, DOI 10.1006/exnr.2001.7715; Hayashi H, 2007, J NEUROSCI, V27, P1933, DOI 10.1523/JNEUROSCI.5471-06.2007; Hayashi H, 2009, J BIOL CHEM, V284, P29605, DOI 10.1074/jbc.M109.039560; Hongpaisan J, 2007, P NATL ACAD SCI USA, V104, P19571, DOI 10.1073/pnas.0709311104; Hongpaisan J, 2011, J NEUROSCI, V31, P630, DOI 10.1523/JNEUROSCI.5209-10.2011; Hoshi M, 2003, P NATL ACAD SCI USA, V100, P6370, DOI 10.1073/pnas.1237107100; Janz R, 1999, NEURON, V24, P687, DOI 10.1016/S0896-6273(00)81122-8; Ji Y, 2003, NEUROSCIENCE, V122, P305, DOI 10.1016/j.neuroscience.2003.08.007; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Jolly-Tornetta C, 2000, BIOCHEMISTRY-US, V39, P7428, DOI 10.1021/bi0003846; Kanno T, 2006, J LIPID RES, V47, P1146, DOI 10.1194/jlr.M500329-JLR200; Kanno T, 2009, J CELL PHYSIOL, V221, P183, DOI 10.1002/jcp.21838; Kelly BL, 2007, NEUROSCIENCE, V147, P60, DOI 10.1016/j.neuroscience.2007.03.047; Kim J, 2009, NEURON, V64, P632, DOI 10.1016/j.neuron.2009.11.013; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; KINOUCHI T, 1995, FEBS LETT, V364, P203, DOI 10.1016/0014-5793(95)00392-M; Kuo YM, 1996, J BIOL CHEM, V271, P4077; LADU MJ, 1994, J BIOL CHEM, V269, P23403; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lanni C, 2004, EUR J BIOCHEM, V271, P3068, DOI 10.1111/j.1432-1033.2004.04240.x; Lee W, 2004, MOL CELL NEUROSCI, V26, P222, DOI 10.1016/j.mcn.2003.10.020; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Ling M, 2005, J BIOL CHEM, V280, P17910, DOI 10.1074/jbc.M412036200; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; Mehta KD, 2002, MOL CELL BIOL, V22, P3783, DOI 10.1128/MCB.22.11.3783-3793.2002; NATHAN BP, 1994, SCIENCE, V264, P850, DOI 10.1126/science.8171342; Nelson TJ, 2009, TRENDS BIOCHEM SCI, V34, P136, DOI 10.1016/j.tibs.2008.11.006; Nelson TJ, 2009, J BIOL CHEM, V284, P34514, DOI 10.1074/jbc.M109.016683; Nimmrich V, 2008, J NEUROSCI, V28, P788, DOI 10.1523/JNEUROSCI.4771-07.2008; Noguchi A, 2009, J BIOL CHEM, V284, P32895, DOI 10.1074/jbc.M109.000208; Pfrieger FW, 2003, BBA-BIOMEMBRANES, V1610, P271, DOI 10.1016/S0005-2736(03)00024-5; Raffai RL, 2001, P NATL ACAD SCI USA, V98, P11587, DOI 10.1073/pnas.201279298; Rapp A, 2006, BIOCHIMIE, V88, P473, DOI 10.1016/j.biochi.2005.10.007; Sakono M, 2010, FEBS J, V277, P1348, DOI 10.1111/j.1742-4658.2010.07568.x; Selkoe DJ, 2001, J ALZHEIMERS DIS, V3, P75, DOI 10.3233/JAD-2001-3111; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shimizu T, 2011, CELL PHYSIOL BIOCHEM, V27, P149, DOI 10.1159/000325217; SLACK BE, 1993, ANN NY ACAD SCI, V695, P128, DOI 10.1111/j.1749-6632.1993.tb23040.x; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P8098, DOI 10.1073/pnas.90.17.8098; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Sun MK, 2009, ARCH PHARM, V342, P689, DOI 10.1002/ardp.200900050; Tokuda T, 2000, BIOCHEM J, V348, P359, DOI 10.1042/0264-6021:3480359; Volmer R, 2006, PLOS PATHOG, V2, P195, DOI 10.1371/journal.ppat.0020019; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Ye SM, 2005, P NATL ACAD SCI USA, V102, P18700, DOI 10.1073/pnas.0508693102; Yeon SW, 2001, BIOCHEM BIOPH RES CO, V280, P782, DOI 10.1006/bbrc.2000.4181; Zhu GF, 2001, BIOCHEM BIOPH RES CO, V285, P997, DOI 10.1006/bbrc.2001.5273	61	47	51	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15947	15958		10.1074/jbc.M111.312710	http://dx.doi.org/10.1074/jbc.M111.312710			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22427674	Green Published, hybrid			2022-12-25	WOS:000304006300073
J	Geng, S; Zhong, YW; Wang, S; Liu, H; Zou, Q; Xie, XP; Li, CF; Yu, QL; He, ZH; Wang, B				Geng, Shuang; Zhong, Yiwei; Wang, Shuang; Liu, Hu; Zou, Qiang; Xie, Xiaoping; Li, Chaofan; Yu, Qingling; He, Zhonghuai; Wang, Bin			Amiloride Enhances Antigen Specific CTL by Faciliting HBV DNA Vaccine Entry into Cells	PLOS ONE			English	Article							PLASMID DNA; DENDRITIC CELLS; GENE-GUN; IMMUNE-RESPONSES; T-CELLS; ENDOCYTOSIS; EXPRESSION; PERFORIN; DELIVERY; IMMUNIZATION	The induction of relatively weak immunity by DNA vaccines in humans can be largely attributed to the low efficiency of transduction of somatic cells. Although formulation with liposomes has been shown to enhance DNA transduction of cultured cells, little, if any, effect is observed on the transduction of somatic tissues and cells. To improve the rate of transduction, DNA vaccine delivery by gene gun and the recently developed electroporation techniques have been employed. We report here that to circumvent requirement for such equipment, amiloride, a drug that is prescribed for hypertension treatment, can accelerate plasmid entry into antigen presenting cells (APCs) both in vitro and in vivo. The combination induced APCs more dramatically in both maturation and cytokine secretion. Amiloride enhanced development of full CD8 cytolytic function including induction of high levels of antigen specific CTL and expression of IFN-gamma+perforin+granzymeB+ in CD8+ T cells. Thus, amiloride is a facilitator for DNA transduction into host cells which in turn enhances the efficiency of the immune responses.	[Geng, Shuang; Wang, Shuang; Liu, Hu; Zou, Qiang; Xie, Xiaoping; Li, Chaofan; Wang, Bin] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Zhong, Yiwei; Wang, Bin] Fudan Univ, Shanghai Med Coll, Key Lab Med Mol Virol MOH & MOE, Shanghai 200433, Peoples R China; [Yu, Qingling; He, Zhonghuai] Beijing Advaccine Biotechnol, Beijing, Peoples R China	China Agricultural University; Fudan University	Geng, S (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	bwang3@cau.edu.cn	Xie, Xiaoping/K-5710-2018; Li, Chaofan/GMX-4943-2022	Xie, Xiaoping/0000-0001-6616-1059; Li, Chaofan/0000-0002-5426-1498	Beijing Advaccine Biotechnology	Beijing Advaccine Biotechnology	This work was supported by the Innovative R&D program funding from Beijing Advaccine Biotechnology to BW (www.advaccine.com.cn). The funders had no role in study design, data collection and analysis, decision to publish the manuscript.	Aberle JH, 1999, J IMMUNOL, V163, P6756; Belperron AA, 1999, INFECT IMMUN, V67, P5163, DOI 10.1128/IAI.67.10.5163-5169.1999; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; BROWN SE, 1986, BRIT MED J, V292, P159, DOI 10.1136/bmj.292.6514.159; Chattopadhyay PK, 2009, J LEUKOCYTE BIOL, V85, P88, DOI 10.1189/jlb.0208107; CONEY L, 1994, VACCINE, V12, P1545, DOI 10.1016/0264-410X(94)90082-5; DIFABIO S, 1994, INT IMMUNOL, V6, P11, DOI 10.1093/intimm/6.1.11; Donnelly JJ, 2005, J IMMUNOL, V175, P633, DOI 10.4049/jimmunol.175.2.633; Donnelly JJ, 1997, ANNU REV IMMUNOL, V15, P617, DOI 10.1146/annurev.immunol.15.1.617; Donnelly JJ, 2000, AM J RESP CRIT CARE, V162, pS190, DOI 10.1164/ajrccm.162.supplement_3.15tac10; Du XG, 2007, J GENE MED, V9, P136, DOI 10.1002/jgm.1004; Feltquate DM, 1998, J CELL BIOCHEM, P304; FYNAN EF, 1993, P NATL ACAD SCI USA, V90, P11478, DOI 10.1073/pnas.90.24.11478; Geiger RC, 2006, GENE THER, V13, P725, DOI 10.1038/sj.gt.3302693; Gong Q, 2007, J BIOL CHEM, V282, P13087, DOI 10.1074/jbc.M700767200; Gurunathan S, 2000, ANNU REV IMMUNOL, V18, P927, DOI 10.1146/annurev.immunol.18.1.927; Haddad D, 2000, J IMMUNOL, V165, P3772, DOI 10.4049/jimmunol.165.7.3772; Hirao LA, 2008, VACCINE, V26, P440, DOI 10.1016/j.vaccine.2007.10.041; Hood SJ, 2007, CIRCULATION, V116, P268, DOI 10.1161/CIRCULATIONAHA.107.690396; Ignatovich IA, 2003, J BIOL CHEM, V278, P42625, DOI 10.1074/jbc.M301431200; Jeng RL, 2001, CURR BIOL, V11, pR691, DOI 10.1016/S0960-9822(01)00410-9; Johnson BJ, 2003, P NATL ACAD SCI USA, V100, P2657, DOI 10.1073/pnas.0538056100; Karkada M, 2010, VACCINE, V28, P6176, DOI 10.1016/j.vaccine.2010.07.025; Koivusalo M, 2010, J CELL BIOL, V188, P547, DOI 10.1083/jcb.200908086; Lanzetti L, 2001, EXP CELL RES, V271, P45, DOI 10.1006/excr.2001.5369; Leitner WW, 2009, BLOOD, V113, P37, DOI 10.1182/blood-2008-01-136267; Lohr F, 2001, CANCER RES, V61, P3281; Makedonas G, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000798; Makedonas G, 2009, J IMMUNOL, V182, P5560, DOI 10.4049/jimmunol.0803945; Nomura T, 1997, CANCER RES, V57, P2681; Ondrej V, 2007, ACTA BIOCHIM POL, V54, P657, DOI 10.18388/abp.2007_3239; Paul L, 2000, ADV EXP MED BIOL, V479, P175; Pilling AM, 2002, TOXICOL PATHOL, V30, P298, DOI 10.1080/01926230252929864; Piriou L, 2000, CYTOMETRY, V41, P289, DOI 10.1002/1097-0320(20001201)41:4<289::AID-CYTO7>3.0.CO;2-5; Qian ZM, 2002, PHARMACOL REV, V54, P561, DOI 10.1124/pr.54.4.561; Qualmann B, 2002, INT REV CYTOL, V220, P93; Rejman J, 2006, J LIPOSOME RES, V16, P237, DOI 10.1080/08982100600848819; Rice J, 1999, VACCINE, V17, P3030, DOI 10.1016/S0264-410X(99)00171-1; Rocha-Zavaleta L, 2002, J MED VIROL, V66, P86, DOI 10.1002/jmv.2115; Schirmbeck R, 2002, J IMMUNOL, V168, P6253, DOI 10.4049/jimmunol.168.12.6253; Shacklett BL, 2004, J IMMUNOL, V173, P641, DOI 10.4049/jimmunol.173.1.641; Shedlock DJ, 2000, J LEUKOCYTE BIOL, V68, P793; Smith KA, 2009, VACCINE, V27, P2603, DOI 10.1016/j.vaccine.2009.02.038; Vandenbroucke RE, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm440; Wan YH, 2001, J IMMUNOL, V167, P5027, DOI 10.4049/jimmunol.167.9.5027; WANG B, 1993, P NATL ACAD SCI USA, V90, P4156, DOI 10.1073/pnas.90.9.4156; Weissman D, 2000, J IMMUNOL, V165, P4710, DOI 10.4049/jimmunol.165.8.4710; Widera G, 2000, J IMMUNOL, V164, P4635, DOI 10.4049/jimmunol.164.9.4635; Yang Z, 2008, BIOCONJUGATE CHEM, V19, P1987, DOI 10.1021/bc800144a	49	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33015	10.1371/journal.pone.0033015	http://dx.doi.org/10.1371/journal.pone.0033015			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438887	Green Submitted, gold, Green Published			2022-12-25	WOS:000303309100018
J	Owen, LA; Uehara, H; Cahoon, J; Huang, W; Simonis, J; Ambati, BK				Owen, Leah A.; Uehara, Hironori; Cahoon, Judd; Huang, Wei; Simonis, Jacquelyn; Ambati, Balamurali K.			Morpholino-Mediated Increase in Soluble Flt-1 Expression Results in Decreased Ocular and Tumor Neovascularization	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MACULAR DEGENERATION; BREAST-CANCER; CHOROIDAL NEOVASCULARIZATION; RETINAL NEOVASCULARIZATION; FACTOR RECEPTOR-1; NONHUMAN PRIMATE; VEGF; ANGIOGENESIS; METASTASIS	Background: Angiogenesis is a key process in several ocular disorders and cancers. Soluble Flt-1 is an alternatively spliced form of the Flt-1 gene that retains the ligand-binding domain, but lacks the membrane-spanning and intracellular kinase domains of the full-length membrane bound Flt-1 (mbFlt-1) protein. Thus, sFlt-1 is an endogenous inhibitor of VEGF-A mediated angiogenesis. Synthetic mopholino oligomers directed against splice site targets can modulate splice variant expression. We hypothesize that morpholino-induced upregulation of sFlt-1 will suppress angiogenesis in clinically relevant models of macular degeneration and breast cancer. Methods and Findings: In vivo morpholino constructs were designed to target murine exon/intron 13 junction of the Flt-1 transcript denoted VEGFR1_MOe13; standard nonspecific morpholino was used as control. After nucleofection of endothelial and breast adenocarcinoma cell lines, total RNA was extracted and real-time RT-PCR performed for sFlt-1 and mbFlt-1. Intravitreal injections of VEGFR1_MOe13 or control were done in a model of laser-induced choroidal neovascularization and intratumoral injections were performed in MBA-MD-231 xenografts in nude mice. VEGFR1_MOe13 elevated sFlt-1 mRNA expression and suppressed mbFlt-1 mRNA expression in vitro in multiple cellular backgrounds (p<0.001). VEGFR1_MOe13 also elevated sFlt/mbFlt-1 ratio in vivo after laser choroidal injury 5.5 fold (p<0.001) and suppressed laser-induced CNV by 50% (p = 0.0179). This latter effect was reversed by RNAi of sFlt-1, confirming specificity of morpholino activity through up-regulation of sFlt-1. In the xenograft model, VEGFR1_MOe13 regressed tumor volume by 88.9%, increased sFlt-1 mRNA expression, and reduced vascular density by 50% relative to control morpholino treatment (p<0.05). Conclusions: Morpholino oligomers targeting the VEGFR1 mRNA exon/intron 13 junction promote production of soluble FLT-1 over membrane bound FLT-1, resulting in suppression of lesional volume in laser induced CNV and breast adenocarcinoma. Thus, morpholino manipulation of alternative splicing offers translational potential for therapy of angiogenic disorders.	[Owen, Leah A.; Uehara, Hironori; Cahoon, Judd; Huang, Wei; Simonis, Jacquelyn; Ambati, Balamurali K.] Univ Utah, Dept Ophthalmol, Moran Eye Ctr, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Owen, LA (corresponding author), Univ Utah, Dept Ophthalmol, Moran Eye Ctr, Salt Lake City, UT 84112 USA.	bala.ambati@utah.edu		Owen, Leah/0000-0003-3802-3868	Research to Prevent Blindness Physician-Scientist Award; National Eye Institute [5R01EY017950]; Veterans Affairs Merit Award; NATIONAL EYE INSTITUTE [R01EY017950, P30EY014800] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK091317] Funding Source: NIH RePORTER	Research to Prevent Blindness Physician-Scientist Award(Research to Prevent Blindness (RPB)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Veterans Affairs Merit Award(US Department of Veterans Affairs); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by a Research to Prevent Blindness Physician-Scientist Award, National Eye Institute 5R01EY017950, and a Veterans Affairs Merit Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahman MH, 2010, EXP EYE RES, V91, P837, DOI 10.1016/j.exer.2010.10.013; AIELLO LP, 1995, P NATL ACAD SCI USA, V92, P10457, DOI 10.1073/pnas.92.23.10457; Alter J, 2006, NAT MED, V12, P175, DOI 10.1038/nm1345; Ambati BK, 2006, NATURE, V443, P993, DOI 10.1038/nature05249; Bertin S, 2010, CANCER LETT, V298, P264, DOI 10.1016/j.canlet.2010.07.017; Bressler Neil M, 2004, JAMA, V291, P1900, DOI 10.1001/jama.291.15.1900; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Cao YH, 2008, J MOL MED, V86, P785, DOI 10.1007/s00109-008-0337-z; Elkin M, 2004, JNCI-J NATL CANCER I, V96, P875, DOI 10.1093/jnci/djh140; FOLKMAN J, 1972, ANN SURG, V175, P409, DOI 10.1097/00000658-197203000-00014; Gasparini G, 2000, Oncologist, V5 Suppl 1, P37; Giovannini M, 2010, CRIT REV ONCOL HEMAT, V76, P13, DOI 10.1016/j.critrevonc.2009.12.004; GREEN WR, 1986, OPHTHALMOLOGY, V93, P1169; Hasumi Y, 2002, CANCER RES, V62, P2019; HAWKINS BS, 1991, ARCH OPHTHALMOL-CHIC, V109, P1109; Hou X, 2010, P NATL ACAD SCI USA, V107, P12216, DOI 10.1073/pnas.1004143107; KENDALL RL, 1993, P NATL ACAD SCI USA, V90, P10705, DOI 10.1073/pnas.90.22.10705; Kinali M, 2009, LANCET NEUROL, V8, P918, DOI 10.1016/S1474-4422(09)70211-X; Kishuku M, 2009, J IMMUNOL, V183, P8176, DOI 10.4049/jimmunol.0803849; Krzystolik MG, 2002, ARCH OPHTHALMOL-CHIC, V120, P338; la Cour M, 2002, DRUG AGING, V19, P101, DOI 10.2165/00002512-200219020-00003; Lai CM, 2005, MOL THER, V12, P659, DOI 10.1016/j.ymthe.2005.04.022; Lukason M, 2011, MOL THER, V19, P260, DOI 10.1038/mt.2010.230; Miles DW, 2010, J CLIN ONCOL, V28, P3239, DOI 10.1200/JCO.2008.21.6457; MILLER H, 1990, INVEST OPHTH VIS SCI, V31, P899; Morcos PA, 2008, BIOTECHNIQUES, V45, P613, DOI 10.2144/000113005; Nieto Y, 2007, BRIT J CANCER, V97, P391, DOI 10.1038/sj.bjc.6603875; Nissen LJ, 2007, J CLIN INVEST, V117, P2766, DOI 10.1172/JCI32479; Ozaki H, 1997, EXP EYE RES, V64, P505, DOI 10.1006/exer.1996.0239; Penfold PL, 2001, PROG RETIN EYE RES, V20, P385, DOI 10.1016/S1350-9462(00)00025-2; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Ruffini F, 2011, BRIT J DERMATOL, V164, P1061, DOI 10.1111/j.1365-2133.2010.10200.x; Sazani P, 2010, INT J TOXICOL, V29, P143, DOI 10.1177/1091581809359206; Tolentino MJ, 2002, AM J OPHTHALMOL, V133, P373, DOI 10.1016/S0002-9394(01)01381-2; Wong CG, 2001, CURR EYE RES, V22, P140, DOI 10.1076/ceyr.22.2.140.5528; Yin HF, 2010, MOL THER, V18, P1822, DOI 10.1038/mt.2010.151	36	30	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2012	7	3							e33576	10.1371/journal.pone.0033576	http://dx.doi.org/10.1371/journal.pone.0033576			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RU	22438952	Green Published, gold, Green Submitted			2022-12-25	WOS:000303309000032
J	Jami, E; Mizrahi, I				Jami, Elie; Mizrahi, Itzhak			Composition and Similarity of Bovine Rumen Microbiota across Individual Animals	PLOS ONE			English	Article							BACTERIAL DIVERSITY; PREVOTELLA-RUMINICOLA; POPULATION; INSIGHTS; FECES	The bovine rumen houses a complex microbiota which is responsible for cattle's remarkable ability to convert indigestible plant mass into food products. Despite this ecosystem's enormous significance for humans, the composition and similarity of bacterial communities across different animals and the possible presence of some bacterial taxa in all animals' rumens have yet to be determined. We characterized the rumen bacterial populations of 16 individual lactating cows using tag amplicon pyrosequencing. Our data showed 51% similarity in bacterial taxa across samples when abundance and occurrence were analyzed using the Bray-Curtis metric. By adding taxon phylogeny to the analysis using a weighted UniFrac metric, the similarity increased to 82%. We also counted 32 genera that are shared by all samples, exhibiting high variability in abundance across samples. Taken together, our results suggest a core microbiome in the bovine rumen. Furthermore, although the bacterial taxa may vary considerably between cow rumens, they appear to be phylogenetically related. This suggests that the functional requirement imposed by the rumen ecological niche selects taxa that potentially share similar genetic features.	[Jami, Elie; Mizrahi, Itzhak] Agr Res Org, Dept Ruminant Sci, Inst Anim Sci, IL-50250 Bet Dagan, Israel; [Jami, Elie] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, George S Wise Fac Life Sci, Ramat Aviv, Israel	VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; Tel Aviv University	Jami, E (corresponding author), Agr Res Org, Dept Ruminant Sci, Inst Anim Sci, IL-50250 Bet Dagan, Israel.	itzhakm@agri.gov.il		Jami, Elie/0000-0002-2839-0843				Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Avgustin G, 1997, INT J SYST BACTERIOL, V47, P284, DOI 10.1099/00207713-47-2-284; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; Cai YP, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr349; Callaway TR, 2010, J ANIM SCI, V88, P3977, DOI 10.2527/jas.2010-2900; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; DEHORITY BA, 1980, APPL ENVIRON MICROB, V39, P376, DOI 10.1128/AEM.39.2.376-381.1980; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fernando SC, 2010, APPL ENVIRON MICROB, V76, P7482, DOI 10.1128/AEM.00388-10; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Flint HJ, 1997, TRENDS MICROBIOL, V5, P483, DOI 10.1016/S0966-842X(97)01159-1; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Kim M, 2011, FEMS MICROBIOL ECOL, V76, P49, DOI 10.1111/j.1574-6941.2010.01029.x; Li M, 2009, J APPL MICROBIOL, V107, P1924, DOI 10.1111/j.1365-2672.2009.04376.x; Li WZ, 2001, BIOINFORMATICS, V17, P282, DOI 10.1093/bioinformatics/17.3.282; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Purushe J, 2010, MICROB ECOL, V60, P721, DOI 10.1007/s00248-010-9692-8; Ramsak A, 2000, FEMS MICROBIOL ECOL, V33, P69, DOI 10.1111/j.1574-6941.2000.tb00728.x; Stevenson DM, 2007, APPL MICROBIOL BIOT, V75, P165, DOI 10.1007/s00253-006-0802-y; Sun YJ, 2012, BRIEF BIOINFORM, V13, P107, DOI 10.1093/bib/bbr009; Sundset M, 2009, MICROB ECOL, V57, P335, DOI 10.1007/s00248-008-9414-7; Tajima K, 1999, FEMS MICROBIOL ECOL, V29, P159, DOI 10.1111/j.1574-6941.1999.tb00607.x; Tajima K, 2001, APPL ENVIRON MICROB, V67, P2766, DOI 10.1128/AEM.67.6.2766-2774.2001; Taniguchi M, 2010, COMP BIOCHEM PHYS D, V5, P274, DOI 10.1016/j.cbd.2010.07.004; Walter J, 2000, APPL ENVIRON MICROB, V66, P297, DOI 10.1128/AEM.66.1.297-303.2000; Wanapat M, 2009, CURR MICROBIOL, V58, P294, DOI 10.1007/s00284-008-9322-6; Welkie DG, 2010, ANAEROBE, V16, P94, DOI 10.1016/j.anaerobe.2009.07.002	29	353	404	8	166	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e33306	10.1371/journal.pone.0033306	http://dx.doi.org/10.1371/journal.pone.0033306			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22432013	Green Published, gold, Green Submitted			2022-12-25	WOS:000303198600056
J	Marsit, CJ; Maccani, MA; Padbury, JF; Lester, BM				Marsit, Carmen J.; Maccani, Matthew A.; Padbury, James F.; Lester, Barry M.			Placental 11-Beta Hydroxysteroid Dehydrogenase Methylation Is Associated with Newborn Growth and a Measure of Neurobehavioral Outcome	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; 11-BETA-HYDROXYSTEROID DEHYDROGENASE; MATERNAL STRESS; PRENATAL STRESS; TYPE-2; GLUCOCORTICOIDS; EXPRESSION; DEPRESSION; ANXIETY; UNIT	Background: There is growing evidence that the intrauterine environment can impact the neurodevelopment of the fetus through alterations in the functional epigenome of the placenta. In the placenta, the HSD11B2 gene encoding the 11-beta hydroxysteroid dehydrogenase enzyme, which is responsible for the inactivation of maternal cortisol, is regulated by DNA methylation, and has been shown to be susceptible to stressors from the maternal environment. Methodology/Principal Findings: We examined the association between DNA methylation of the HSD11B2 promoter region in the placenta of 185 healthy newborn infants and infant and maternal characteristics, as well as the association between this epigenetic variability and newborn neurobehavioral outcome assessed with the NICU Network Neurobehavioral Scales. Controlling for confounders, HSD11B2 methylation extent is greatest in infants with the lowest birthweights (P = 0.04), and this increasing methylation was associated with reduced scores of quality of movement (P = 0.04). Conclusions/Significance: These results suggest that factors in the intrauterine environment which contribute to birth outcome may be associated with placental methylation of the HSD11B2 gene and that this epigenetic alteration is in turn associated with a prospectively predictive early neurobehavioral outcome, suggesting in some part a mechanism for the developmental origins of infant neurological health.	[Marsit, Carmen J.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Epidemiol & Biostat Sect,Dept Pharmacol & Toxicol, Hanover, NH 03756 USA; [Marsit, Carmen J.] Dartmouth Coll, Hitchcock Med Ctr, Dept Community & Family Med, Epidemiol & Biostat Sect,Dartmouth Med Sch, Hanover, NH 03756 USA; [Maccani, Matthew A.] Rhode Isl Hosp, Div Behav Genet, Providence, RI USA; [Maccani, Matthew A.] Brown Univ, Ctr Alcohol & Addict Studies, Providence, RI 02912 USA; [Padbury, James F.; Lester, Barry M.] Women & Infants Hosp Rhode Isl, Dept Pediat, Providence, RI 02908 USA; [Lester, Barry M.] Women & Infants Hosp Rhode Isl, Brown Ctr Study Children Risk, Providence, RI 02908 USA; [Padbury, James F.; Lester, Barry M.] Brown Alpert Med Sch, Providence, RI USA	Dartmouth College; Dartmouth College; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Women & Infants Hospital Rhode Island; Brown University; Women & Infants Hospital Rhode Island; Brown University	Marsit, CJ (corresponding author), Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Epidemiol & Biostat Sect,Dept Pharmacol & Toxicol, Hanover, NH 03756 USA.	Carmen.J.Marsit@dartmouth.edu		Marsit, Carmen/0000-0003-4566-150X	National Institutes of Health from NCRR [P20 RR018728]; National Institute of Mental Health [MH094609]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094609] Funding Source: NIH RePORTER	National Institutes of Health from NCRR; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health grants from the NCRR (P20 RR018728) and the National Institute of Mental Health (R01 MH094609). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alati R, 2007, AM J EPIDEMIOL, V165, P575, DOI 10.1093/aje/kwk036; Alikhani-Koopaei R, 2004, J CLIN INVEST, V114, P1146, DOI 10.1172/JCI200421647; Barker D. J. P, 1998, MOTHERS BABIES HLTH; BARKER DJP, 1989, LANCET, V2, P577; BARKER DJP, 1988, BRIT MED J, V297, P134, DOI 10.1136/bmj.297.6641.134-b; BENEDIKTSSON R, 1993, LANCET, V341, P339, DOI 10.1016/0140-6736(93)90138-7; Blackmon LR, 2002, PEDIATRICS, V109, P330; Cannon TD, 2002, DEV PSYCHOPATHOL, V14, P653, DOI 10.1017/S0954579402003139; Cheung YB, 2002, SOC SCI MED, V55, P937, DOI 10.1016/S0277-9536(01)00225-8; Cheung YB, 2002, BMJ-BRIT MED J, V325, P749, DOI 10.1136/bmj.325.7367.749; Doyle LW, 2010, NEONATOLOGY, V98, P289, DOI 10.1159/000286212; El-Dib M, 2011, J PERINATOL; Ellman LM, 2008, DEV PSYCHOBIOL, V50, P232, DOI 10.1002/dev.20293; Fenton Tanis R, 2003, BMC Pediatr, V3, P13; Filiberto AC, 2011, EPIGENETICS-US, V6, P566, DOI 10.4161/epi.6.5.15236; Gale CR, 2004, BRIT J PSYCHIAT, V184, P28, DOI 10.1192/bjp.184.1.28; Glover V, 2009, PSYCHONEUROENDOCRINO, V34, P430, DOI 10.1016/j.psyneuen.2008.10.005; Holmes MC, 2006, NEUROSCIENCE, V137, P865, DOI 10.1016/j.neuroscience.2005.09.037; Lester BM, 2009, DEV NEUROSCI-BASEL, V31, P23, DOI 10.1159/000207491; Lester BM, 2004, PEDIATRICS, V113, P631; Liu J, 2010, PEDIATRICS, V125, pE90, DOI 10.1542/peds.2009-0204; Lucassen PJ, 2009, EUR J NEUROSCI, V29, P97, DOI 10.1111/j.1460-9568.2008.06543.x; Mairesse J, 2007, AM J PHYSIOL-ENDOC M, V292, pE1526, DOI 10.1152/ajpendo.00574.2006; Murphy VE, 2002, J CLIN ENDOCR METAB, V87, P1660, DOI 10.1210/jc.87.4.1660; PETRAGLIA F, 1991, ANN NY ACAD SCI, V622, P331; Ponder KL, 2011, DEV PSYCHOBIOL, V53, P711, DOI 10.1002/dev.20549; Robins Jared C, 2011, Front Biosci (Elite Ed), V3, P690, DOI 10.2741/e279; Salisbury AL, 2009, CLIN PERINATOL, V36, P595, DOI 10.1016/j.clp.2009.06.002; Sandman Curt A, 2011, Int J Pept, V2011, P837596, DOI 10.1155/2011/837596; Sarkar S, 2001, AM J PHYSIOL-REG I, V281, pR1966, DOI 10.1152/ajpregu.2001.281.6.R1966; Seckl JR, 2007, NAT CLIN PRACT ENDOC, V3, P479, DOI 10.1038/ncpendmet0515; Seckl JR, 2004, ANN NY ACAD SCI, V1032, P63, DOI 10.1196/annals.1314.006; Shams M, 1998, HUM REPROD, V13, P799, DOI 10.1093/humrep/13.4.799; Shum D, 2008, ARCH CLIN NEUROPSYCH, V23, P103, DOI 10.1016/j.acn.2007.08.006; Stephens BE, 2010, J PEDIATR-US, V156, P366, DOI 10.1016/j.jpeds.2009.09.042; Talge NM, 2007, J CHILD PSYCHOL PSYC, V48, P245, DOI 10.1111/j.1469-7610.2006.01714.x; Thompson C, 2001, BRIT J PSYCHIAT, V179, P450, DOI 10.1192/bjp.179.5.450; Tronick EZ, 2004, PEDIATRICS, V113, P676; Welberg LAM, 2005, J ENDOCRINOL, V186, pR7, DOI 10.1677/joe.1.06374; Welberg LAM, 2000, EUR J NEUROSCI, V12, P1047, DOI 10.1046/j.1460-9568.2000.00958.x; Welberg LAM, 2001, J NEUROENDOCRINOL, V13, P113, DOI 10.1046/j.1365-2826.2001.00601.x; Wiles NJ, 2005, BRIT J PSYCHIAT, V187, P21, DOI 10.1192/bjp.187.1.21; Yen SS, 1991, REPROD ENDOCRINOLOGY, P936; YEN SSC, 1994, J REPROD MED, V39, P277	44	140	141	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e33794	10.1371/journal.pone.0033794	http://dx.doi.org/10.1371/journal.pone.0033794			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22432047	Green Submitted, Green Published, gold			2022-12-25	WOS:000303198600090
J	Bialecka-Fornal, M; Lee, HJ; DeBerg, HA; Gandhi, CS; Phillips, R				Bialecka-Fornal, Maja; Lee, Heun Jin; DeBerg, Hannah A.; Gandhi, Chris S.; Phillips, Rob			Single-Cell Census of Mechanosensitive Channels in Living Bacteria	PLOS ONE			English	Article							RESPONSE REGULATOR RSSB; ESCHERICHIA-COLI; PROTEIN EXPRESSION; LARGE-CONDUCTANCE; SIGMA(S) PROTEOLYSIS; STATIONARY-PHASE; GENE-EXPRESSION; MSCL; SUBUNIT; LOCALIZATION	Bacteria are subjected to a host of different environmental stresses. One such insult occurs when cells encounter changes in the osmolarity of the surrounding media resulting in an osmotic shock. In recent years, a great deal has been learned about mechanosensitive (MS) channels which are thought to provide osmoprotection in these circumstances by opening emergency release valves in response to membrane tension. However, even the most elementary physiological parameters such as the number of MS channels per cell, how MS channel expression levels influence the physiological response of the cells, and how this mean number of channels varies from cell to cell remain unanswered. In this paper, we make a detailed quantitative study of the expression of the mechanosensitive channel of large conductance (MscL) in different media and at various stages in the growth history of bacterial cultures. Using both quantitative fluorescence microscopy and quantitative Western blots our study complements earlier electrophysiology-based estimates and results in the following key insights: i) the mean number of channels per cell is much higher than previously estimated, ii) measurement of the single-cell distributions of such channels reveals marked variability from cell to cell and iii) the mean number of channels varies under different environmental conditions. The regulation of MscL expression displays rich behaviors that depend strongly on culturing conditions and stress factors, which may give clues to the physiological role of MscL. The number of stress-induced MscL channels and the associated variability have far reaching implications for the in vivo response of the channels and for modeling of this response. As shown by numerous biophysical models, both the number of such channels and their variability can impact many physiological processes including osmoprotection, channel gating probability, and channel clustering.	[Bialecka-Fornal, Maja; Lee, Heun Jin; Phillips, Rob] CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA; [DeBerg, Hannah A.] Univ Illinois, Dept Phys, Urbana, IL USA; [DeBerg, Hannah A.] Univ Illinois, Ctr Phys Living Cells, Urbana, IL USA; [Gandhi, Chris S.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Phillips, Rob] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; California Institute of Technology; California Institute of Technology	Bialecka-Fornal, M (corresponding author), CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA.	phillips@pboc.caltech.edu			National Institutes of Health (NIH) [R01 GM084211, DP1 OD000217]; Caltech Provost's office; National Science Foundation; Marine Biology Laboratory in Woods Hole, Massachusetts; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R13GM085967, R01GM084211] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000217] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Caltech Provost's office; National Science Foundation(National Science Foundation (NSF)); Marine Biology Laboratory in Woods Hole, Massachusetts; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	RP, MBF, and HJL were supported by National Institutes of Health (NIH) grant R01 GM084211 and NIH Director's Pioneer Award grant DP1 OD000217. MBF was supported by a Caltech Provost's office fellowship. HAD was supported by a National Science Foundation graduate research fellowship and the physiology course at the Marine Biology Laboratory in Woods Hole, Massachusetts. CSG was supported by NIH grant R01 GM084211. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker G, 2000, MOL MICROBIOL, V35, P657, DOI 10.1046/j.1365-2958.2000.01736.x; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Blount P, 1999, Methods Enzymol, V294, P458; Blount P, 1996, P NATL ACAD SCI USA, V93, P11652, DOI 10.1073/pnas.93.21.11652; Blount P, 1997, J BIOL CHEM, V272, P32150, DOI 10.1074/jbc.272.51.32150; Booth Ian R., 2005, P291; Boucher PA, 2009, BIOPHYS J, V97, P2761, DOI 10.1016/j.bpj.2009.08.054; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; Chiang CS, 2004, BIOPHYS J, V86, P2846, DOI 10.1016/S0006-3495(04)74337-4; Choi PJ, 2008, SCIENCE, V322, P442, DOI 10.1126/science.1161427; Digman MA, 2009, P NATL ACAD SCI USA, V106, P2170, DOI 10.1073/pnas.0806036106; Drepper T, 2010, APPL ENVIRON MICROB, V76, P5990, DOI 10.1128/AEM.00701-10; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Fraenkel DG, 2003, CURR OPIN MICROBIOL, V6, P198, DOI 10.1016/S1369-5274(03)00023-7; Friedman N, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.168302; Gandhi CS, 2011, PROTEIN SCI, V20, P313, DOI 10.1002/pro.562; Garcia HG, 2011, BIOPHYS J, V101, P535, DOI 10.1016/j.bpj.2011.06.026; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gillespie PG, 2001, NATURE, V413, P194, DOI 10.1038/35093011; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Grage SL, 2011, BIOPHYS J, V100, P1252, DOI 10.1016/j.bpj.2011.01.023; Hase CC, 1997, BIOCHEM BIOPH RES CO, V232, P777, DOI 10.1006/bbrc.1997.6370; Hengge R, 2008, ADV EXP MED BIOL, V631, P40, DOI 10.1007/978-0-387-78885-2_4; Hengge R, 2011, BACTERIAL STRESS RESPONSES, 2ND EDITION, P251; Hengge-Aronis R, 2002, MICROBIOL MOL BIOL R, V66, P373, DOI 10.1128/MMBR.66.3.373-395.2002; Hengge-Aronis R, 1999, CURR OPIN MICROBIOL, V2, P148, DOI 10.1016/S1369-5274(99)80026-5; Kern W., 1993, HDB SEMICONDUCTOR WA; Klauck E, 2001, MOL MICROBIOL, V40, P1381, DOI 10.1046/j.1365-2958.2001.02482.x; LANGE R, 1994, GENE DEV, V8, P1600, DOI 10.1101/gad.8.13.1600; Levina N, 1999, EMBO J, V18, P1730, DOI 10.1093/emboj/18.7.1730; Liu MZ, 2005, J BIOL CHEM, V280, P15921, DOI 10.1074/jbc.M414050200; Liu ZF, 2009, NATURE, V461, P120, DOI 10.1038/nature08277; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; Malmstrom J, 2009, NATURE, V460, P762, DOI 10.1038/nature08184; Mandel MJ, 2005, J BACTERIOL, V187, P434, DOI 10.1128/JB.187.2.434-442.2005; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Norman C, 2005, EUR BIOPHYS J BIOPHY, V34, P396, DOI 10.1007/s00249-005-0475-y; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Pedraza JM, 2008, SCIENCE, V319, P339, DOI 10.1126/science.1144331; Perozo E, 2003, CURR OPIN STRUC BIOL, V13, P432, DOI 10.1016/S0959-440X(03)00106-4; Phillips R., 2009, PHYS BIOL CELL; Rogers SS, 2007, PHYS BIOL, V4, P220, DOI 10.1088/1478-3975/4/3/008; Romantsov T, 2007, MOL MICROBIOL, V64, P1455, DOI 10.1111/j.1365-2958.2007.05727.x; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Sanchez A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001100; Schumann U, 2010, P NATL ACAD SCI USA, V107, P12664, DOI 10.1073/pnas.1001405107; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Schweder T, 1996, J BACTERIOL, V178, P470, DOI 10.1128/jb.178.2.470-476.1996; Sharan SK, 2009, NAT PROTOC, V4, P206, DOI 10.1038/nprot.2008.227; Snapp Erik L, 2003, Curr Protoc Cell Biol, VChapter 21, DOI 10.1002/0471143030.cb2101s19; Steinbacher S, 2007, CURR TOP MEMBR, V58, P1, DOI 10.1016/S1063-5823(06)58001-9; Stokes NR, 2003, P NATL ACAD SCI USA, V100, P15959, DOI 10.1073/pnas.2536607100; Sukharev SI, 1999, J GEN PHYSIOL, V113, P525, DOI 10.1085/jgp.113.4.525; SUKHAREV SI, 1994, NATURE, V368, P265, DOI 10.1038/368265a0; TAKAYANAGI Y, 1994, MOL GEN GENET, V243, P525, DOI 10.1007/BF00284200; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; Ursell T, BILAYER ELASTICITY P; Ursell T, 2007, PLOS COMPUT BIOL, V3, P803, DOI 10.1371/journal.pcbi.0030081; Ursell Tristan, 2008, V1, P37, DOI 10.1007/978-1-4020-6426-5_2; Wu JQ, 2005, SCIENCE, V310, P310, DOI 10.1126/science.1113230; Zhou YN, 1998, J BACTERIOL, V180, P1154, DOI 10.1128/JB.180.5.1154-1158.1998	64	32	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2012	7	3							e33077	10.1371/journal.pone.0033077	http://dx.doi.org/10.1371/journal.pone.0033077			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930IA	22427953	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000303129700031
J	Iwata, T; Taniguchi, H; Kuwajima, M; Taniguchi, T; Okuda, Y; Sukeno, A; Ishimoto, K; Mizusawa, N; Yoshimoto, K				Iwata, Takeo; Taniguchi, Hisaaki; Kuwajima, Masamichi; Taniguchi, Takako; Okuda, Yuko; Sukeno, Akiko; Ishimoto, Kyoko; Mizusawa, Noriko; Yoshimoto, Katsuhiko			The Action of D-Dopachrome Tautomerase as an Adipokine in Adipocyte Lipid Metabolism	PLOS ONE			English	Article							MIGRATION INHIBITORY FACTOR; ACTIVATED PROTEIN-KINASE; FATTY-ACID OXIDATION; ADIPOSE-TISSUE; INSULIN-RESISTANCE; MACROPHAGE; GLUCOSE; HOMOLOG; OBESITY; MIF	Adipose tissue is a critical exchange center for complex energy transactions involving triacylglycerol storage and release. It also has an active endocrine role, releasing various adipose-derived cytokines (adipokines) that participate in complex pathways to maintain metabolic and vascular health. Here, we found D-dopachrome tautomerase (DDT) as an adipokine secreted from human adipocytes by a proteomic approach. DDT mRNA levels in human adipocytes were negatively correlated with obesity-related clinical parameters such as BMI, and visceral and subcutaneous fat areas. Experiments using SGBS cells, a human preadipocyte cell line, revealed that DDT mRNA levels were increased in an adipocyte differentiation-dependent manner and DDT was secreted from adipocytes. In DDT knockdown adipocytes differentiated from SGBS cells that were infected with the adenovirus expressing shRNA against the DDT gene, mRNA levels of genes involved in both lipolysis and lipogenesis were slightly but significantly increased. Furthermore, we investigated AMP-activated protein kinase (AMPK) signaling, which phosphorylates and inactivates enzymes involved in lipid metabolism, including hormone-sensitive lipase (HSL) and acetyl-CoA carboxylase (ACC), in DDT knockdown adipocytes. The AMPK phosphorylation of HSL Ser-565 and ACC Ser-79 was inhibited in DDT knockdown cells and recovered in the cells treated with recombinant DDT (rDDT), suggesting that down-regulated DDT in adipocytes brings about a state of active lipid metabolism. Furthermore, administration of rDDT in db/db mice improved glucose intolerance and decreased serum free fatty acids levels. In the adipose tissue from rDDT-treated db/db mice, not only increased levels of HSL phosphorylated by AMPK, but also decreased levels of HSL phosphorylated by protein kinase A (PKA), which phosphorylates HSL to promote its activity, were observed. These results suggested that DDT acts on adipocytes to regulate lipid metabolism through AMPK and/or PKA pathway(s) and improves glucose intolerance caused by obesity.	[Iwata, Takeo; Mizusawa, Noriko; Yoshimoto, Katsuhiko] Univ Tokushima, Dept Med Pharmacol, Inst Hlth Biosci, Grad Sch, Tokushima 770, Japan; [Taniguchi, Hisaaki; Taniguchi, Takako; Okuda, Yuko] Univ Tokushima, Inst Enzyme Res, Div Dis Prote, Tokushima 770, Japan; [Kuwajima, Masamichi; Sukeno, Akiko] Univ Tokushima, Dept Clin Biol & Med, Inst Hlth Biosci, Grad Sch, Tokushima 770, Japan; [Kuwajima, Masamichi] Taijukai Kaisei Gen Hosp, Sakaide, Japan; [Ishimoto, Kyoko] Univ Tokushima, Dept Orthodont & Dentofacial Orthoped, Inst Hlth Biosci, Grad Sch, Tokushima 770, Japan	Tokushima University; Tokushima University; Tokushima University; Tokushima University	Iwata, T (corresponding author), Univ Tokushima, Dept Med Pharmacol, Inst Hlth Biosci, Grad Sch, Tokushima 770, Japan.	yoshimot@dent.tokushima-u.ac.jp	Taniguchi, Hisaaki/I-9171-2012		Knowledge Cluster Initiative from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [22890124, 22370042, 24792290] Funding Source: KAKEN	Knowledge Cluster Initiative from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research and the Knowledge Cluster Initiative from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assifi MM, 2005, AM J PHYSIOL-ENDOC M, V289, pE794, DOI 10.1152/ajpendo.00144.2005; Atsumi T, 2007, J IMMUNOL, V179, P5399, DOI 10.4049/jimmunol.179.8.5399; BLOOM BR, 1966, SCIENCE, V153, P80, DOI 10.1126/science.153.3731.80; CALANDRA T, 1994, J EXP MED, V179, P1895, DOI 10.1084/jem.179.6.1895; Carling D, 2008, INT J OBESITY, V32, pS55, DOI 10.1038/ijo.2008.124; Coleman AM, 2008, J IMMUNOL, V181, P2330, DOI 10.4049/jimmunol.181.4.2330; Djouder N, 2010, EMBO J, V29, P469, DOI 10.1038/emboj.2009.339; GARTON AJ, 1990, EUR J BIOCHEM, V191, P245, DOI 10.1111/j.1432-1033.1990.tb19116.x; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Hardie DG, 2006, J PHYSIOL-LONDON, V574, P7, DOI 10.1113/jphysiol.2006.108944; HE GP, 1995, NATURE, V378, P92, DOI 10.1038/378092a0; Hertzel AV, 2000, TRENDS ENDOCRIN MET, V11, P175; Hiyoshi M, 2009, TOXICOLOGY, V255, P6, DOI 10.1016/j.tox.2008.09.016; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; Hurley RL, 2006, J BIOL CHEM, V281, P36662, DOI 10.1074/jbc.M606676200; Iwata T, 2009, BIOCHEM BIOPH RES CO, V388, P511, DOI 10.1016/j.bbrc.2009.08.024; Kleemann R, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/610479; Koska J, 2009, INT J OBESITY, V33, P842, DOI 10.1038/ijo.2009.106; Krempler F, 2000, ARTERIOSCL THROM VAS, V20, P443, DOI 10.1161/01.ATV.20.2.443; Londos C, 1999, ANN NY ACAD SCI, V892, P155, DOI 10.1111/j.1749-6632.1999.tb07794.x; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; Merk M, 2011, P NATL ACAD SCI USA, V108, pE577, DOI 10.1073/pnas.1102941108; Miller EJ, 2008, NATURE, V451, P578, DOI 10.1038/nature06504; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Nishihira J, 1998, BIOCHEM BIOPH RES CO, V243, P538, DOI 10.1006/bbrc.1998.8123; ODH G, 1993, BIOCHEM BIOPH RES CO, V197, P619, DOI 10.1006/bbrc.1993.2524; Ronti T, 2006, CLIN ENDOCRINOL, V64, P355, DOI 10.1111/j.1365-2265.2006.02474.x; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rosengren E, 1996, MOL MED, V2, P143, DOI 10.1007/BF03402210; Skurk T, 2005, ENDOCRINOLOGY, V146, P1006, DOI 10.1210/en.2004-0924; Sonesson B, 2003, EXP DERMATOL, V12, P278, DOI 10.1034/j.1600-0625.2003.120307.x; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Strey CW, 2005, PROTEOMICS, V5, P318, DOI 10.1002/pmic.200400913; Sugimoto H, 1999, BIOCHEMISTRY-US, V38, P3268, DOI 10.1021/bi982184o; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; UNGER RH, 1995, DIABETES, V44, P863, DOI 10.2337/diabetes.44.8.863; Uysal KT, 2000, ENDOCRINOLOGY, V141, P3388, DOI 10.1210/en.141.9.3388; Verschuren L, 2009, CIRC RES, V105, P99, DOI 10.1161/CIRCRESAHA.109.199166; Wabitsch M, 2001, INT J OBESITY, V25, P8, DOI 10.1038/sj.ijo.0801520; Woods A, 2000, MOL CELL BIOL, V20, P6704, DOI 10.1128/MCB.20.18.6704-6711.2000; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yang F, 2008, J HEPATOL, V48, P12, DOI 10.1016/j.jhep.2007.06.021; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	43	31	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33402	10.1371/journal.pone.0033402	http://dx.doi.org/10.1371/journal.pone.0033402			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22428043	gold, Green Published, Green Submitted			2022-12-25	WOS:000302381500139
J	Jia, LM; Yan, WG; Zhu, CS; Agrama, HA; Jackson, A; Yeater, K; Li, XB; Huang, BH; Hu, BL; McClung, A; Wu, DX				Jia, Limeng; Yan, Wengui; Zhu, Chengsong; Agrama, Hesham A.; Jackson, Aaron; Yeater, Kathleen; Li, Xiaobai; Huang, Bihu; Hu, Biaolin; McClung, Anna; Wu, Dianxing			Allelic Analysis of Sheath Blight Resistance with Association Mapping in Rice	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; GENOME-WIDE ASSOCIATION; ORYZA-SATIVA; LINKAGE DISEQUILIBRIUM; DISEASE RESISTANCE; JAPONICA RICE; CORE SUBSET; QTLS; GENES; QUANTIFICATION	Sheath blight (ShB) caused by the soil-borne pathogen Rhizoctonia solani is one of the most devastating diseases in rice world-wide. Global attention has focused on examining individual mapping populations for quantitative trait loci (QTLs) for ShB resistance, but to date no study has taken advantage of association mapping to examine hundreds of lines for potentially novel QTLs. Our objective was to identify ShB QTLs via association mapping in rice using 217 sub-core entries from the USDA rice core collection, which were phenotyped with a micro-chamber screening method and genotyped with 155 genome-wide markers. Structure analysis divided the mapping panel into five groups, and model comparison revealed that PCA5 with genomic control was the best model for association mapping of ShB. Ten marker loci on seven chromosomes were significantly associated with response to the ShB pathogen. Among multiple alleles in each identified loci, the allele contributing the greatest effect to ShB resistance was named the putative resistant allele. Among 217 entries, entry GSOR 310389 contained the most putative resistant alleles, eight out of ten. The number of putative resistant alleles presented in an entry was highly and significantly correlated with the decrease of ShB rating (r = -0.535) or the increase of ShB resistance. Majority of the resistant entries that contained a large number of the putative resistant alleles belonged to indica, which is consistent with a general observation that most ShB resistant accessions are of indica origin. These findings demonstrate the potential to improve breeding efficiency by using marker-assisted selection to pyramid putative resistant alleles from various loci in a cultivar for enhanced ShB resistance in rice.	[Jia, Limeng; Li, Xiaobai; Wu, Dianxing] Zhejiang Univ, State Key Lab Rice Biol, Inst Nucl Agr Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Jia, Limeng; Agrama, Hesham A.] Univ Arkansas, Rice Res & Extens Ctr, Stuttgart, AR USA; [Jia, Limeng; Yan, Wengui; Jackson, Aaron; McClung, Anna] ARS, Dale Bumpers Natl Rice Res Ctr, USDA, Stuttgart, AR USA; [Zhu, Chengsong] Kansas State Univ, Dept Agron, Manhattan, KS 66506 USA; [Yeater, Kathleen] ARS, USDA, So Plains Area, College Stn, TX USA; [Huang, Bihu] Univ Arkansas Pine Bluff, Pine Bluff, AR USA; [Hu, Biaolin] Jiangxi Acad Agr Sci, Rice Res Inst, Nanchang, Peoples R China	Zhejiang University; University of Arkansas System; University of Arkansas Fayetteville; United States Department of Agriculture (USDA); Kansas State University; United States Department of Agriculture (USDA); University of Arkansas System; University Arkansas Pine Bluff	Jia, LM (corresponding author), Zhejiang Univ, State Key Lab Rice Biol, Inst Nucl Agr Sci, Hangzhou 310003, Zhejiang, Peoples R China.	Wengui.Yan@ars.usda.gov; dxwu@zju.edu.cn	Li, Xiaobai/AAB-7604-2021	Li, Xiaobai/0000-0001-9615-3543; Jackson, Aaron/0000-0002-5540-9255	United States Department of Agriculture	United States Department of Agriculture(United States Department of Agriculture (USDA))	This study was solely supported by the United States Department of Agriculture in-house funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrama HA, 2008, EUPHYTICA, V160, P339, DOI 10.1007/s10681-007-9535-y; Agrama HA, 2007, MOL BREEDING, V19, P341, DOI 10.1007/s11032-006-9066-6; Agrama H. A., 2010, Natural Science, V2, P247, DOI 10.4236/ns.2010.24036; Agrama HA, 2009, PLANT BREEDING, V128, P551, DOI 10.1111/j.1439-0523.2009.01631.x; Agrama HA, 2009, CROP SCI, V49, P1336, DOI 10.2135/cropsci2008.06.0551; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Bergelson J, 2010, NAT REV GENET, V11, P867, DOI 10.1038/nrg2896; Brachi B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000940; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Channamallikarjuna V, 2010, MOL BREEDING, V25, P155, DOI 10.1007/s11032-009-9316-5; Che KP, 2003, THEOR APPL GENET, V106, P293, DOI 10.1007/s00122-002-1001-6; Cockram J, 2010, P NATL ACAD SCI USA, V107, P21611, DOI 10.1073/pnas.1010179107; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Eizenga GC, 2002, PLANT DIS, V86, P808, DOI 10.1094/PDIS.2002.86.7.808; Falush D, 2003, GENETICS, V164, P1567; Han Yue-Peng, 2002, Acta Genetica Sinica, V29, P622; Hittalmani S, 2000, THEOR APPL GENET, V100, P1121, DOI 10.1007/s001220051395; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Jia LM, 2011, CROP SCI, V51, P1507, DOI 10.2135/cropsci2010.10.0581; Jia Y, 2007, PLANT DIS, V91, P485, DOI 10.1094/PDIS-91-5-0485; Jin L, 2010, THEOR APPL GENET, V121, P475, DOI 10.1007/s00122-010-1324-7; Kunihiro Yasufumi, 2002, Acta Genetica Sinica, V29, P50; Li XB, 2011, PLANTA, V234, P347, DOI 10.1007/s00425-011-1405-0; LI ZK, 1995, THEOR APPL GENET, V91, P382, DOI 10.1007/BF00220903; Liu G, 2009, PHYTOPATHOLOGY, V99, P1078, DOI 10.1094/PHYTO-99-9-1078; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Loan LC, 2004, OMONRICE, V12, P1; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; Mackay I, 2007, TRENDS PLANT SCI, V12, P57, DOI 10.1016/j.tplants.2006.12.001; Manosalva PM, 2009, PLANT PHYSIOL, V149, P286, DOI 10.1104/pp.108.128348; MARCHETTI MA, 1991, PLANT DIS, V75, P773, DOI 10.1094/PD-75-0773; Mather KA, 2007, GENETICS, V177, P2223, DOI 10.1534/genetics.107.079616; Mazzucato A, 2008, THEOR APPL GENET, V116, P657, DOI 10.1007/s00122-007-0699-6; McClung AM, 1997, CROP SCI, V37, P629, DOI 10.2135/cropsci1997.0011183X003700020058x; Mew TW, 2004, CRIT REV PLANT SCI, V23, P103, DOI 10.1080/07352680490433231; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Nordborg M, 2008, NATURE, V456, P720, DOI 10.1038/nature07629; Pan XB, 1999, CROP SCI, V39, P338, DOI 10.2135/cropsci1999.0011183X003900020006x; Pan XB, 1999, CHINESE SCI BULL, V44, P1783, DOI 10.1007/BF02886159; Pinson SRM, 2005, CROP SCI, V45, P503, DOI 10.2135/cropsci2005.0503; Prasad B, 2008, PLANT DIS, V92, P1503, DOI 10.1094/PDIS-92-11-1503; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Rohlf F. J., 2000, NTSYS PC NUMERICAL T; SAS Institute, 2006, SAS SYST WIND VERS 9; Sato H, 2004, BREEDING SCI, V54, P265, DOI 10.1270/jsbbs.54.265; Savary S, 2006, ANNU REV PHYTOPATHOL, V44, P89, DOI 10.1146/annurev.phyto.44.070505.143342; Sharma A, 2009, CROP SCI, V49, P256, DOI 10.2135/cropsci2008.03.0124; Shehzad T, 2009, BREEDING SCI, V59, P217, DOI 10.1270/jsbbs.59.217; Singh S, 2001, THEOR APPL GENET, V102, P1011, DOI 10.1007/s001220000495; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tan Cai-Xia, 2005, Acta Genetica Sinica, V32, P399; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; Wamishe Yeshi A., 2007, Frontiers of Agriculture in China, V1, P361, DOI 10.1007/s11703-007-0061-4; Wang ML, 2009, THEOR APPL GENET, V120, P13, DOI 10.1007/s00122-009-1155-6; Wen WW, 2009, THEOR APPL GENET, V119, P459, DOI 10.1007/s00122-009-1052-z; Wisser RJ, 2011, P NATL ACAD SCI USA, V108, P7339, DOI 10.1073/pnas.1011739108; Xie J, 2010, GENET RESOUR CROP EV, V57, P597, DOI 10.1007/s10722-009-9498-z; Xie XueWen, 2008, Acta Agronomica Sinica, V34, P1885, DOI 10.1016/S1875-2780(09)60013-4; Xin ZG, 2003, BIOTECHNIQUES, V34, P820, DOI 10.2144/03344rr04; Yan JB, 2010, NAT GENET, V42, P322, DOI 10.1038/ng.551; Yan WG, 2009, MOL BREEDING, V24, P277, DOI 10.1007/s11032-009-9290-y; Yan W, 2007, CROP SCI, V47, P869, DOI 10.2135/cropsci2006.07.0444; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Yu JM, 2006, CURR OPIN BIOTECH, V17, P155, DOI 10.1016/j.copbio.2006.02.003; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhao KY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030004; Zhao MJ, 2006, CROP SCI, V46, P1039, DOI 10.2135/cropsci2005.0166; Zhu CS, 2008, PLANT GENOME-US, V1, P5, DOI 10.3835/plantgenome2008.02.0089; Zou JH, 2000, THEOR APPL GENET, V101, P569, DOI 10.1007/s001220051517; Zuo Shi-min, 2007, Chinese Journal of Rice Science, V21, P136; Zuo SM, 2008, J GENET GENOMICS, V35, P499, DOI 10.1016/S1673-8527(08)60068-5	73	78	84	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e32703	10.1371/journal.pone.0032703	http://dx.doi.org/10.1371/journal.pone.0032703			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427867	Green Published, gold, Green Submitted			2022-12-25	WOS:000302381500034
J	Zhang, XW; Wang, XH; Zhu, HY; Kranias, EG; Tang, YL; Peng, TQ; Chang, J; Fan, GC				Zhang, Xiaowei; Wang, Xiaohong; Zhu, Hongyan; Kranias, Evangelia G.; Tang, Yaoliang; Peng, Tianqing; Chang, Jiang; Fan, Guo-Chang			Hsp20 Functions as a Novel Cardiokine in Promoting Angiogenesis via Activation of VEGFR2	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; ENDOTHELIAL-CELLS; SECRETORY PATHWAY; OXIDATIVE STRESS; APOPTOSIS; EXOSOMES; CARDIOPROTECTION; TRAFFICKING; HYPERTROPHY; DOXORUBICIN	Heat shock proteins (Hsps) are well appreciated as intrinsic protectors of cardiomyocytes against numerous stresses. Recent studies have indicated that Hsp20 (HspB6), a small heat shock protein, was increased in blood from cardiomyopathic hamsters. However, the exact source of the increased circulating Hsp20 and its potential role remain obscure. In this study, we observed that the circulating Hsp20 was increased in a transgenic mouse model with cardiac-specific overexpression of Hsp20, compared with wild-type mice, suggesting its origin from cardiomyocytes. Consistently, culture media harvested from Hsp20-overexpressing cardiomyocytes by Ad. Hsp20 infection contained an increased amount of Hsp20, compared to control media. Furthermore, we identified that Hsp20 was secreted through exosomes, independent of the endoplasmic reticulum-Golgi pathway. To investigate whether extracellular Hsp20 promotes angiogenesis, we treated human umbilical vein endothelial cells (HUVECs) with recombinant human Hsp20 protein, and observed that Hsp20 dose-dependently promoted HUVEC proliferation, migration and tube formation. Moreover, a protein binding assay and immunostaining revealed an interaction between Hsp20 and VEGFR2. Accordingly, stimulatory effects of Hsp20 on HUVECs were blocked by a VEGFR2 neutralizing antibody and CBO-P11 (a VEGFR inhibitor). These in vitro data are consistent with the in vivo findings that capillary density was significantly enhanced in Hsp20-overexpressing hearts, compared to non-transgenic hearts. Collectively, our findings demonstrate that Hsp20 serves as a novel cardiokine in regulating myocardial angiogenesis through activation of the VEGFR signaling cascade.	[Zhang, Xiaowei; Wang, Xiaohong; Zhu, Hongyan; Kranias, Evangelia G.; Fan, Guo-Chang] Univ Cincinnati, Coll Med, Dept Pharmacol & Cell Biophys, Cincinnati, OH 45267 USA; [Tang, Yaoliang] Univ Cincinnati, Coll Med, Dept Internal Med, Cincinnati, OH 45267 USA; [Peng, Tianqing] Lawson Hlth Res Inst, Toronto, ON, Canada; [Chang, Jiang] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Zhang, XW (corresponding author), Univ Cincinnati, Coll Med, Dept Pharmacol & Cell Biophys, Cincinnati, OH 45267 USA.	fangg@ucmail.uc.edu	Peng, Tianqing/G-3340-2011; Fan, Guo-Chang/E-1153-2012	Fan, Guo-Chang/0000-0002-0439-8277; Zhang, Xiao-Wei/0000-0002-9903-6980; Tang, Yaoliang/0000-0002-8372-1545; Chang, Jiang/0000-0003-3707-7557	National Institutes of Health [HL-087861]; National Institute of Environmental Health Sciences [P30-ES006096]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL094844, R01HL087861, K02HL098956, R01HL102314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006096] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by National Institutes of Health grant HL-087861 (GF) and National Institute of Environmental Health Sciences grant P30-ES006096. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bikfalvi A, 2004, BIOCHEM PHARMACOL, V68, P1017, DOI 10.1016/j.bcp.2004.05.030; Brophy CM, 1999, J VASC SURG, V29, P326, DOI 10.1016/S0741-5214(99)70385-X; Calderwood SK, 2007, FEBS LETT, V581, P3689, DOI 10.1016/j.febslet.2007.04.044; Chernik IS, 2007, MOL CELL BIOCHEM, V295, P9, DOI 10.1007/s11010-006-9266-8; Dancourt J, 2010, ANNU REV BIOCHEM, V79, P777, DOI 10.1146/annurev-biochem-061608-091319; Doroudgar S, 2011, TRENDS MOL MED, V17, P207, DOI 10.1016/j.molmed.2010.12.003; Edwards HV, 2011, CELL SIGNAL, V23, P1447, DOI 10.1016/j.cellsig.2011.05.009; Eldh M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015353; Fan GC, 2005, TRENDS CARDIOVAS MED, V15, P138, DOI 10.1016/j.tcm.2005.05.004; Fan GC, 2005, CIRCULATION, V111, P1792, DOI 10.1161/01.CIR.0000160851.41872.C6; Fan GC, 2004, CIRC RES, V94, P1474, DOI 10.1161/01.RES.0000129179.66631.00; Fan GC, 2008, CIRC RES, V103, P1270, DOI 10.1161/CIRCRESAHA.108.182832; Fan GC, 2006, CIRC RES, V99, P1233, DOI 10.1161/01.RES.0000251074.19348.af; Fan GC, 2011, J MOL CELL CARDIOL, V51, P574, DOI 10.1016/j.yjmcc.2010.09.013; Gangalum RK, 2011, J BIOL CHEM, V286, P3261, DOI 10.1074/jbc.M110.160135; Glembotski CC, 2011, J MOL CELL CARDIOL, V51, P512, DOI 10.1016/j.yjmcc.2010.10.008; Gupta S, 2007, AM J PHYSIOL-HEART C, V292, pH3052, DOI 10.1152/ajpheart.01355.2006; Hecker JG, 2011, CELL STRESS CHAPERON, V16, P119, DOI 10.1007/s12192-010-0224-8; Keller S, 2006, IMMUNOL LETT, V107, P102, DOI 10.1016/j.imlet.2006.09.005; Kim SC, 2009, CIRC RES, V105, P1186, DOI 10.1161/CIRCRESAHA.109.209643; Kozawa O, 2002, LIFE SCI, V72, P113, DOI 10.1016/S0024-3205(02)02144-6; Lai RC, 2010, STEM CELL RES, V4, P214, DOI 10.1016/j.scr.2009.12.003; Lancaster GI, 2005, J BIOL CHEM, V280, P23349, DOI 10.1074/jbc.M502017200; Latchman DS, 2001, CARDIOVASC RES, V51, P637, DOI 10.1016/S0008-6363(01)00354-6; Niwa M, 1999, LIFE SCI, V66, pPL7; Record M, 2011, BIOCHEM PHARMACOL, V81, P1171, DOI 10.1016/j.bcp.2011.02.011; Savina A, 2002, J CELL SCI, V115, P2505; Schmitt E, 2007, J LEUKOCYTE BIOL, V81, P15, DOI 10.1189/jlb.0306167; Shan YX, 2003, J MOL CELL CARDIOL, V35, P1135, DOI 10.1016/S0022-2828(03)00229-3; Sin YY, 2011, J MOL CELL CARDIOL, V50, P872, DOI 10.1016/j.yjmcc.2011.02.006; Song XM, 2010, BIOCHEM BIOPH RES CO, V398, P111, DOI 10.1016/j.bbrc.2010.06.046; Tessier DJ, 2003, J SURG RES, V111, P152, DOI 10.1016/S0022-4804(03)00113-6; Uchida C, 2009, CURR PHARM DESIGN, V15, P411, DOI 10.2174/138161209787315800; Vrijsen KR, 2010, J CELL MOL MED, V14, P1064, DOI 10.1111/j.1582-4934.2010.01081.x; Wang XH, 2009, STEM CELLS, V27, P3021, DOI 10.1002/stem.230; Wang XH, 2009, J MOL CELL CARDIOL, V47, P382, DOI 10.1016/j.yjmcc.2009.05.016; Willis MS, 2010, CIRCULATION, V122, P1740, DOI 10.1161/CIRCULATIONAHA.110.942250; Zhan R, 2009, BIOCHEM BIOPH RES CO, V387, P229, DOI 10.1016/j.bbrc.2009.06.095; Zhang XW, 2010, J MOL CELL CARDIOL, V49, P841, DOI 10.1016/j.yjmcc.2010.08.007	39	54	58	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e32765	10.1371/journal.pone.0032765	http://dx.doi.org/10.1371/journal.pone.0032765			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427880	gold, Green Published, Green Submitted			2022-12-25	WOS:000302381500042
J	Hart, SP; Rossi, AG; Haslett, C; Dransfield, I				Hart, Simon P.; Rossi, Adriano G.; Haslett, Christopher; Dransfield, Ian			Characterization of the Effects of Cross-Linking of Macrophage CD44 Associated with Increased Phagocytosis of Apoptotic PMN	PLOS ONE			English	Article							NEUTROPHIL APOPTOSIS; LUNG INFLAMMATION; ADHESION MOLECULE; HYALURONIC-ACID; IN-VIVO; CELLS; RESOLUTION; CLEARANCE; RECEPTOR; DISEASE	Control of macrophage capacity for apoptotic cell clearance by soluble mediators such as cytokines, prostaglandins and lipoxins, serum proteins, and glucocorticoids may critically determine the rate at which inflammation resolves. Previous studies suggested that macrophage capacity for clearance of apoptotic neutrophils was profoundly altered following binding of CD44 antibodies. We have used a number of different approaches to further define the mechanism by which CD44 rapidly and specifically augment phagocytosis of apoptotic neutrophils. Use of Fab' fragments unequivocally demonstrated a requirement for cross-linking of macrophage surface CD44. The molecular mechanism of CD44-augmented phagocytosis was shown to be opsonin-independent and to be distinct from the Mer/protein S pathway induced by glucocorticoids and was not functional for clearance of apoptotic eosinophils. CD44-cross-linking also altered macrophage migration and induced cytoskeletal re-organisation together with phosphorylation of paxillin and activation of Rac2. Investigation of signal transduction pathways that might be critical for CD44 augmentation of phagocytosis revealed that Ca2+ signalling, PI-3 kinase pathways and altered cAMP signalling were not involved, but did implicate a key role for tyrosine phosphorylation events. Finally, although CD44 antibodies were able to augment phagocytosis of apoptotic neutrophils by murine peritoneal and bone marrow-derived macrophages, we did not observe a difference in the clearance of neutrophils following induction of peritonitis with thioglycollate in CD44-deficient animals. Together, these data demonstrate that CD44 cross-linking induces a serum opsonin-independent mechanism of macrophage phagocytosis of apoptotic neutrophils that is associated with reduced macrophage migration and cytoskeletal reorganisation.	[Hart, Simon P.] Univ Hull, Castle Hill Hosp, Hull York Med Sch, Div Cardiovasc & Resp Studies, Kingston Upon Hull HU6 7RX, N Humberside, England; [Rossi, Adriano G.; Haslett, Christopher; Dransfield, Ian] Univ Edinburgh, Queens Med Res Inst, Ctr Inflammat Res, Edinburgh, Midlothian, Scotland; [Rossi, Adriano G.; Haslett, Christopher; Dransfield, Ian] MRC, Edinburgh, Midlothian, Scotland	University of Hull; University of York - UK; University of Edinburgh	Hart, SP (corresponding author), Univ Hull, Castle Hill Hosp, Hull York Med Sch, Div Cardiovasc & Resp Studies, Kingston Upon Hull HU6 7RX, N Humberside, England.	i.dransfield@ed.ac.uk		Dransfield, Ian/0000-0001-5848-7059; Hart, Simon/0000-0003-4606-9559	Medical Research Council; Wellcome Trust; MRC [G0601481, G108/460, G0901697] Funding Source: UKRI; Medical Research Council [G108/460, G0901697, G0601481] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding was provided by the Medical Research Council (www.mrc.ac.uk) and the Wellcome Trust (www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	BAZIL V, 1992, J IMMUNOL, V149, P747; Bellingan GJ, 1996, J IMMUNOL, V157, P2577; Bourguignon LYW, 2000, J BIOL CHEM, V275, P1829, DOI 10.1074/jbc.275.3.1829; Brown SJ, 2007, AM J GASTROENTEROL, V102, P2058, DOI 10.1111/j.1572-0241.2007.01343.x; Cascao R, 2010, AUTOIMMUN REV, V9, P531, DOI 10.1016/j.autrev.2009.12.013; Cuff CA, 2001, J CLIN INVEST, V108, P1031, DOI 10.1172/JCI12455; Dransfield DT, 1997, EMBO J, V16, P35, DOI 10.1093/emboj/16.1.35; DRANSFIELD I, 1995, BLOOD, V85, P3264, DOI 10.1182/blood.V85.11.3264.bloodjournal85113264; DRANSFIELD I, 1994, J IMMUNOL, V153, P1254; Dransfield I, 1997, TECHNIQUES APOPTOSIS; Elliott MR, 2010, J CELL BIOL, V189, P1059, DOI 10.1083/jcb.201004096; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Giles KM, 2001, J IMMUNOL, V167, P976, DOI 10.4049/jimmunol.167.2.976; Godson C, 2000, J IMMUNOL, V164, P1663, DOI 10.4049/jimmunol.164.4.1663; HABETS GGM, 1994, CELL, V77, P537, DOI 10.1016/0092-8674(94)90216-X; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hart SP, 2008, METHODS, V44, P280, DOI 10.1016/j.ymeth.2007.11.009; Hart SP, 1997, J IMMUNOL, V159, P919; Haslett C, 1997, BRIT MED BULL, V53, P669; HASLETT C, 1992, CLIN SCI, V83, P639, DOI 10.1042/cs0830639; Ilangumaran S, 1998, BLOOD, V91, P3901; Jersmann HPA, 2003, CYTOM PART A, V51A, P7, DOI 10.1002/cyto.a.10005; LESLEY J, 1990, EXP CELL RES, V187, P224, DOI 10.1016/0014-4827(90)90085-O; Leverrier Y, 2003, J BIOL CHEM, V278, P38437, DOI 10.1074/jbc.M306649200; Leverrier Y, 2001, CURR BIOL, V11, P195, DOI 10.1016/S0960-9822(01)00047-1; Matthay MA, 2011, ANNU REV PATHOL-MECH, V6, P147, DOI 10.1146/annurev-pathol-011110-130158; McColl A, 2009, J IMMUNOL, V183, P2167, DOI 10.4049/jimmunol.0803503; Michlewska S, 2009, FASEB J, V23, P844, DOI 10.1096/fj.08-121228; Munoz LE, 2010, NAT REV RHEUMATOL, V6, P280, DOI 10.1038/nrrheum.2010.46; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Rossi AG, 2006, NAT MED, V12, P1056, DOI 10.1038/nm1468; Rossi AG, 1998, J IMMUNOL, V160, P3562; Rothlin CV, 2010, CURR OPIN IMMUNOL, V22, P740, DOI 10.1016/j.coi.2010.10.001; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; Stoop R, 2002, EUR J IMMUNOL, V32, P2532, DOI 10.1002/1521-4141(200209)32:9<2532::AID-IMMU2532>3.0.CO;2-A; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Taylor PR, 2000, J EXP MED, V192, P359, DOI 10.1084/jem.192.3.359; Teder P, 2002, SCIENCE, V296, P155, DOI 10.1126/science.1069659; TSUKITA S, 1994, J CELL BIOL, V126, P391, DOI 10.1083/jcb.126.2.391; UNDERHILL C, 1992, J CELL SCI, V103, P293; van der Windt GJW, 2010, AM J PATHOL, V177, P2483, DOI 10.2353/ajpath.2010.100562; van der Windt GJW, 2010, INFECT IMMUN, V78, P115, DOI 10.1128/IAI.00949-09; Walker Annemieke, 2005, Current Drug Targets - Inflammation and Allergy, V4, P447, DOI 10.2174/1568010054526278; WHYTE MKB, 1993, J IMMUNOL, V150, P5124; Wynn TA, 2011, J EXP MED, V208, P1339, DOI 10.1084/jem.20110551; Yago T, 2010, P NATL ACAD SCI USA, V107, P9204, DOI 10.1073/pnas.1003110107	49	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2012	7	3							e33142	10.1371/journal.pone.0033142	http://dx.doi.org/10.1371/journal.pone.0033142			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KX	22427969	Green Published, Green Submitted, gold			2022-12-25	WOS:000303062800046
J	Raczynski, AR; Muthupalani, S; Schlieper, K; Fox, JG; Tannenbaum, SR; Schauer, DB				Raczynski, Arkadiusz R.; Muthupalani, Sureshkumar; Schlieper, Katherine; Fox, James G.; Tannenbaum, Steven R.; Schauer, David B.			Enteric Infection with Citrobacter rodentium Induces Coagulative Liver Necrosis and Hepatic Inflammation Prior to Peak Infection and Colonic Disease	PLOS ONE			English	Article							NEUTROPHIL TRAFFICKING; MICE; INJURY; EXPRESSION; MODEL; INTERLEUKIN-10; IL-6; SUSCEPTIBILITY; TRANSLOCATION; COLONIZATION	Acute and chronic forms of inflammation are known to affect liver responses and susceptibility to disease and injury. Furthermore, intestinal microbiota has been shown critical in mediating inflammatory host responses in various animal models. Using C. rodentium, a known enteric bacterial pathogen, we examined liver responses to gastrointestinal infection at various stages of disease pathogenesis. For the first time, to our knowledge, we show distinct liver pathology associated with enteric infection with C. rodentium in C57BL/6 mice, characterized by increased inflammation and hepatitis index scores as well as prominent periportal hepatocellular coagulative necrosis indicative of thrombotic ischemic injury in a subset of animals during the early course of C. rodentium pathogenesis. Histologic changes in the liver correlated with serum elevation of liver transaminases, systemic and liver resident cytokines, as well as signal transduction changes prior to peak bacterial colonization and colonic disease. C. rodentium infection in C57BL/6 mice provides a potentially useful model to study acute liver injury and inflammatory stress under conditions of gastrointestinal infection analogous to enteropathogenic E. coli infection in humans.	[Raczynski, Arkadiusz R.; Schlieper, Katherine; Fox, James G.; Tannenbaum, Steven R.; Schauer, David B.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Muthupalani, Sureshkumar; Fox, James G.; Schauer, David B.] MIT, Div Comparat Med, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Raczynski, AR (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	raczynsa@gmail.com	Muthupalani, Sureshkumar/C-7244-2015		United States Army Research Office through the Institute for Soldier Nanotechnology [6915539]; National Institutes of Health [P01 CA026731, P30 ES02109, ES-070220]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER	United States Army Research Office through the Institute for Soldier Nanotechnology; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The United States Army Research Office through the Institute for Soldier Nanotechnology grant 6915539 (SRT) and National Institutes of Health grants P01 CA026731 (SRT, JGF, DBS), P30 ES02109 and Toxicology Training grant ES-070220 supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asfaha S, 2001, AM J PHYSIOL-GASTR L, V281, pG635, DOI 10.1152/ajpgi.2001.281.3.G635; Borenshtein D, 2008, CURR OPIN GASTROEN, V24, P32, DOI 10.1097/MOG.0b013e3282f2b0fb; Borenshtein D, 2007, INFECT IMMUN, V75, P3271, DOI 10.1128/IAI.01810-06; Bourdi M, 2002, HEPATOLOGY, V35, P289, DOI 10.1053/jhep.2002.30956; Bourdi M, 2007, CHEM RES TOXICOL, V20, P208, DOI 10.1021/tx060228l; Chaluvadi MR, 2009, DRUG METAB DISPOS, V37, P366, DOI 10.1124/dmd.108.024240; Choi S, 2005, CURR OPIN GASTROEN, V21, P702, DOI 10.1097/01.mog.0000182863.96421.47; Crispe IN, 2009, ANNU REV IMMUNOL, V27, P147, DOI 10.1146/annurev.immunol.021908.132629; DEITCH EA, 1987, ARCH SURG-CHICAGO, V122, P185; Douglas DB, 2010, HEPATOLOGY, V51, P2162, DOI 10.1002/hep.23576; Feng DC, 2009, BIOCHEM PHARMACOL, V77, P277, DOI 10.1016/j.bcp.2008.09.028; Fielding CA, 2008, J IMMUNOL, V181, P2189, DOI 10.4049/jimmunol.181.3.2189; Flynn AN, 2008, MICROB PATHOGENESIS, V45, P98, DOI 10.1016/j.micpath.2007.12.004; Fox JG, 2011, MUCOSAL IMMUNOL, V4, P22, DOI 10.1038/mi.2010.61; Fox JG, 1996, INFECT IMMUN, V64, P1548, DOI 10.1128/IAI.64.5.1548-1558.1996; FOX JG, 1994, J CLIN MICROBIOL, V32, P1238, DOI 10.1128/JCM.32.5.1238-1245.1994; FUENTES ME, 1995, J IMMUNOL, V155, P5769; Gabele E, 2011, J HEPATOL, V55, P1391, DOI 10.1016/j.jhep.2011.02.035; Garrett WS, 2010, CELL, V140, P859, DOI 10.1016/j.cell.2010.01.023; Ghaem-Maghami M, 2001, INFECT IMMUN, V69, P5597, DOI 10.1128/IAI.69.9.5597-5605.2001; Higgins LM, 1999, INFECT IMMUN, V67, P3031, DOI 10.1128/IAI.67.6.3031-3039.1999; Jaeschke H, 2006, AM J PHYSIOL-GASTR L, V290, pG1083, DOI 10.1152/ajpgi.00568.2005; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jones SA, 2005, J IMMUNOL, V175, P3463, DOI 10.4049/jimmunol.175.6.3463; Kato A, 2000, INFLAMM RES, V49, P275, DOI 10.1007/PL00000207; Luperchio SA, 2001, MICROBES INFECT, V3, P333, DOI 10.1016/S1286-4579(01)01387-9; Luyendyk JP, 2004, HEPATOLOGY, V40, P1342, DOI 10.1002/hep.20492; Mcbee ME, 2008, INFECT IMMUN, V76, P4851, DOI 10.1128/IAI.00745-08; Mcbee ME, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013277; McLoughlin RM, 2003, J CLIN INVEST, V112, P598, DOI 10.1172/JCI200317129; Morgan ET, 2008, DRUG METAB DISPOS, V36, P205, DOI 10.1124/dmd.107.018747; Mundy R, 2005, CELL MICROBIOL, V7, P1697, DOI 10.1111/j.1462-5822.2005.00625.x; Rajani R, 2010, ALIMENT PHARM THER, V32, P1154, DOI 10.1111/j.1365-2036.2010.04454.x; Richardson TA, 2006, DRUG METAB DISPOS, V34, P354, DOI 10.1124/dmd.105.007393; Richardson TA, 2006, DRUG METAB DISPOS, V34, P351, DOI 10.1124/dmd.105.007435; Roth RA, 2003, J PHARMACOL EXP THER, V307, P1, DOI 10.1124/jpet.102.041624; Roth RA, 1997, TOXICOL APPL PHARM, V147, P300, DOI 10.1006/taap.1997.8301; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Son G, 2010, GASTROENT RES PRACT, V2010, DOI 10.1155/2010/453563; Thompson PA, 2010, J LIPID RES, V51, P2672, DOI 10.1194/jlr.M007435; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Vallance BA, 2003, INFECT IMMUN, V71, P3443, DOI 10.1128/IAI.71.6.3443-3453.2003; Wiles S, 2004, CELL MICROBIOL, V6, P963, DOI 10.1111/j.1462-5822.2004.00414.x; Zhang Q, 2010, MICROB PATHOGENESIS, V48, P28, DOI 10.1016/j.micpath.2009.10.002; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	46	14	14	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2012	7	3							e33099	10.1371/journal.pone.0033099	http://dx.doi.org/10.1371/journal.pone.0033099			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KX	22427959	Green Published, gold, Green Submitted			2022-12-25	WOS:000303062800045
J	Papakostas, K; Frillingos, S				Papakostas, Konstantinos; Frillingos, Stathis			Substrate Selectivity of YgfU, a Uric Acid Transporter from Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-SCANNING ANALYSIS; XANTHINE PERMEASE; ASPERGILLUS-NIDULANS; SIGNATURE MOTIF; FUNCTIONAL-CHARACTERIZATION; KLEBSIELLA-PNEUMONIAE; PURINE TRANSPORTERS; RUT PATHWAY; BACTERIAL; RESIDUES	The ubiquitous nucleobase-ascorbate transporter (NAT/NCS2) family includes more than 2,000 members, but only 15 have been characterized experimentally. Escherichia coli has 10 members, of which the uracil permease UraA and the xanthine permeases XanQ and XanP are functionally known. Of the remaining members, YgfU is closely related in sequence and genomic locus with XanQ. We analyzed YgfU and showed that it is a proton-gradient dependent, low-affinity (K-m 0.5 mM), and high-capacity transporter for uric acid. It also shows a low capacity for transport of xanthine at 37 degrees C but not at 25 degrees C. Based on the set of positions delineated as important from our previous Cys-scanning analysis of permease XanQ, we subjected YgfU to rationally designed site-directed mutagenesis. The results show that the conserved His-37 (TM1), Glu-270 (TM8), Asp-298 (TM9), and Gln-318 and Asn-319 (TM10) are functionally irreplaceable, and Thr-100 (TM3) is essential for the uric acid selectivity because its replacement with Ala allows efficient uptake of xanthine. The key role of these residues is corroborated by the conservation pattern and homology modeling on the recently described x-ray structure of permease UraA. In addition, site-specific replacements at TM8 (S271A, M274D, V282S) impair expression in the membrane, and V320N (TM10) inactivates the permease, whereas R327G (TM10) or S426N (TM14) reduces the affinity for uric acid (4-fold increased K-m). Our study shows that comprehensive analysis of structure-function relationships in a newly characterized transporter can be accomplished with relatively few site-directed replacements, based on the knowledge available from Cys-scanning mutagenesis of a prototypic homolog.	[Papakostas, Konstantinos; Frillingos, Stathis] Univ Ioannina, Sch Med, Biol Chem Lab, GR-45110 Ioannina, Greece	University of Ioannina	Frillingos, S (corresponding author), Univ Ioannina, Sch Med, Biol Chem Lab, GR-45110 Ioannina, Greece.	efriligo@cc.uoi.gr	Frillingos, Stathis/AAQ-3148-2021		EVOTRANS; European Union; Hellenic Ministry of Education, Lifelong Learning and Religious Affairs	EVOTRANS; European Union(European Commission); Hellenic Ministry of Education, Lifelong Learning and Religious Affairs	This work was supported by the research project EVOTRANS co-funded by the European Union-European Social Fund (ESF) and National Sources, in the framework of program "Thalis" through the Operational Program "Education and Life-long Learning" of the Hellenic Ministry of Education, Lifelong Learning and Religious Affairs, in the context of the National Strategic Reference Framework (SRF).	Amillis S, 2011, J MOL BIOL, V411, P567, DOI 10.1016/j.jmb.2011.06.024; ANDERSEN PS, 1995, J BACTERIOL, V177, P2008, DOI 10.1128/jb.177.8.2008-2013.1995; BURTON K, 1994, P ROY SOC B-BIOL SCI, V255, P153, DOI 10.1098/rspb.1994.0022; Cecchetto G, 2004, J BIOL CHEM, V279, P3132, DOI 10.1074/jbc.M308826200; Cho BK, 2011, NUCLEIC ACIDS RES, V39, P6456, DOI 10.1093/nar/gkr307; Cusa E, 1999, J BACTERIOL, V181, P7479, DOI 10.1128/JB.181.24.7479-7484.1999; de la Riva L, 2008, J BACTERIOL, V190, P7892, DOI 10.1128/JB.01022-08; Diallinas G, 1998, EMBO J, V17, P3827, DOI 10.1093/emboj/17.14.3827; FELLE H, 1980, BIOCHEMISTRY-US, V19, P3585, DOI 10.1021/bi00556a026; Georgopoulou E, 2010, J BIOL CHEM, V285, P19422, DOI 10.1074/jbc.M110.120543; Gournas C, 2011, FUNGAL GENET BIOL, V48, P840, DOI 10.1016/j.fgb.2011.03.004; Granseth E, 2005, J MOL BIOL, V352, P489, DOI 10.1016/j.jmb.2005.07.053; Hennebry SC, 2009, FEBS J, V276, P5367, DOI 10.1111/j.1742-4658.2009.07246.x; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; KABACK HR, 1974, ARCH BIOCHEM BIOPHYS, V160, P215, DOI 10.1016/S0003-9861(74)80028-7; Karatza P, 2005, MOL MEMBR BIOL, V22, P251, DOI 10.1080/09687860500092927; Karatza P, 2006, J BIOL CHEM, V281, P39881, DOI 10.1074/jbc.M605748200; Karena E, 2011, J BIOL CHEM, V286, P39595, DOI 10.1074/jbc.M111.299164; Karena E, 2009, J BIOL CHEM, V284, P24257, DOI 10.1074/jbc.M109.030734; Kim KS, 2010, J BACTERIOL, V192, P4089, DOI 10.1128/JB.00201-10; Kosti V, 2010, J MOL BIOL, V397, P1132, DOI 10.1016/j.jmb.2010.02.037; Koukaki M, 2005, J MOL BIOL, V350, P499, DOI 10.1016/j.jmb.2005.04.076; Lee Y, 2005, FEBS LETT, V579, P4769, DOI 10.1016/j.febslet.2005.07.056; Loh KD, 2006, P NATL ACAD SCI USA, V103, P5114, DOI 10.1073/pnas.0600521103; Lu FR, 2011, NATURE, V472, P243, DOI 10.1038/nature09885; Mansfield TA, 2009, FEBS LETT, V583, P481, DOI 10.1016/j.febslet.2008.12.048; Mermelekas G, 2010, J BIOL CHEM, V285, P35011, DOI 10.1074/jbc.M110.170415; O'Leary SE, 2009, BIOCHEMISTRY-US, V48, P3033, DOI 10.1021/bi900160b; Ormazabal V, 2010, J BIOL CHEM, V285, P36471, DOI 10.1074/jbc.M110.155630; Papageorgiou L, 2008, J MOL BIOL, V382, P1121, DOI 10.1016/j.jmb.2008.08.005; Papakostas K, 2008, J BIOL CHEM, V283, P13666, DOI 10.1074/jbc.M800261200; Parales RE, 2010, J BACTERIOL, V192, P4086, DOI 10.1128/JB.00573-10; Pope SD, 2009, J BACTERIOL, V191, P1006, DOI 10.1128/JB.01281-08; Ramazzina I, 2006, NAT CHEM BIOL, V2, P144, DOI 10.1038/nchembio768; Rintoul MR, 2002, J MOL BIOL, V324, P599, DOI 10.1016/S0022-2836(02)01134-8; Schultz AC, 2001, J BACTERIOL, V183, P3293, DOI 10.1128/JB.183.11.3293-3302.2001; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; TEATHER RM, 1980, EUR J BIOCHEM, V108, P223, DOI 10.1111/j.1432-1033.1980.tb04715.x; Tsukaguchi H, 1999, NATURE, V399, P70, DOI 10.1038/19986; Varma S, 2008, BIOCHEMISTRY-US, V47, P2952, DOI 10.1021/bi701666q; Xi HL, 2000, J BACTERIOL, V182, P5332, DOI 10.1128/JB.182.19.5332-5341.2000; Yamamoto S, 2010, J BIOL CHEM, V285, P6522, DOI 10.1074/jbc.M109.032961; Zanotti G, 2006, J MOL BIOL, V363, P1, DOI 10.1016/j.jmb.2006.07.079	44	28	29	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15684	15695		10.1074/jbc.M112.355818	http://dx.doi.org/10.1074/jbc.M112.355818			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22437829	hybrid, Green Published			2022-12-25	WOS:000304006300047
J	Beitnes, ACR; Raki, M; Brottveit, M; Lundin, KEA; Jahnsen, FL; Sollid, LM				Beitnes, Ann-Christin Roberg; Raki, Melinda; Brottveit, Margit; Lundin, Knut Erik Aslaksen; Jahnsen, Frode Lars; Sollid, Ludvig Magne			Rapid Accumulation of CD14(+)CD11c(+) Dendritic Cells in Gut Mucosa of Celiac Disease after in vivo Gluten Challenge	PLOS ONE			English	Article							HUMAN MONOCYTE SUBSETS; REACTIVE T-CELLS; GLIADIN; ACTIVATION; TISSUE; SPRUE; STIMULATION; EOSINOPHILS; SENSITIVITY; RESPONSES	Background: Of antigen-presenting cells (APCs) expressing HLA-DQ molecules in the celiac disease (CD) lesion, CD11c(+) dendritic cells (DCs) co-expressing the monocyte marker CD14 are increased, whereas other DC subsets (CD1c(+) or CD103(+)) and CD163(+)CD11c(-) macrophages are all decreased. It is unclear whether these changes result from chronic inflammation or whether they represent early events in the gluten response. We have addressed this in a model of in vivo gluten challenge. Methods: Treated HLA-DQ2(+) CD patients (n = 12) and HLA-DQ2(+) gluten-sensitive control subjects (n = 12) on a gluten-free diet (GFD) were orally challenged with gluten for three days. Duodenal biopsies obtained before and after gluten challenge were subjected to immunohistochemistry. Single cell digests of duodenal biopsies from healthy controls (n = 4), treated CD (n = 3) and untreated CD (n = 3) patients were analyzed by flow cytometry. Results: In treated CD patients, the gluten challenge increased the density of CD14(+)CD11c(+) DCs, whereas the density of CD103(+)CD11c(+) DCs and CD163(+)CD11c(-) macrophages decreased, and the density of CD1c(+)CD11c(+) DCs remained unchanged. Most CD14(+)CD11c(+) DCs co-expressed CCR2. The density of neutrophils also increased in the challenged mucosa, but in most patients no architectural changes or increase of CD3(+) intraepithelial lymphocytes (IELs) were found. In control tissue no significant changes were observed. Conclusions: Rapid accumulation of CD14(+)CD11c(+) DCs is specific to CD and precedes changes in mucosal architecture, indicating that this DC subset may be directly involved in the immunopathology of the disease. The expression of CCR2 and CD14 on the accumulating CD11c(+) DCs indicates that these cells are newly recruited monocytes.	[Beitnes, Ann-Christin Roberg; Raki, Melinda; Lundin, Knut Erik Aslaksen; Jahnsen, Frode Lars; Sollid, Ludvig Magne] Univ Oslo, Rikshosp, Oslo Univ Hosp, Ctr Immune Regulat, N-0027 Oslo, Norway; [Beitnes, Ann-Christin Roberg; Raki, Melinda; Lundin, Knut Erik Aslaksen; Sollid, Ludvig Magne] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Immunol, N-0027 Oslo, Norway; [Brottveit, Margit] Oslo Univ Hosp Ulleval, Dept Med, Oslo, Norway; [Sollid, Ludvig Magne] Univ Oslo, Dept Immunol, Oslo, Norway; [Lundin, Knut Erik Aslaksen] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Med, N-0027 Oslo, Norway; [Jahnsen, Frode Lars] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Pathol, N-0027 Oslo, Norway; [Sollid, Ludvig Magne] Univ Oslo, Ctr Immune Regulat, Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo	Beitnes, ACR (corresponding author), Univ Oslo, Rikshosp, Oslo Univ Hosp, Ctr Immune Regulat, N-0027 Oslo, Norway.	Ann-Christin.Beitnes@rr-research.no	Sollid, Ludvig/N-9691-2015; Lundin, Knut E. A./AAW-9519-2021	Sollid, Ludvig/0000-0001-8860-704X; Lundin, Knut E. A./0000-0003-1713-5545	Oslo University Hospital - Rikshospitalet; Research Council of Norway	Oslo University Hospital - Rikshospitalet; Research Council of Norway(Research Council of Norway)	This study was supported by grants from Oslo University Hospital - Rikshospitalet and the Research Council of Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arentz-Hansen H, 2000, J EXP MED, V191, P603, DOI 10.1084/jem.191.4.603; Beitnes ACR, 2011, SCAND J IMMUNOL, V74, P186, DOI 10.1111/j.1365-3083.2011.02549.x; Bodd M, 2010, MUCOSAL IMMUNOL, V3, P594, DOI 10.1038/mi.2010.36; Brottveit M, 2011, AM J GASTROENTEROL, V106, P1318, DOI 10.1038/ajg.2011.23; Cheong C, 2010, CELL, V143, P416, DOI 10.1016/j.cell.2010.09.039; DHESI I, 1984, VIRCHOWS ARCH A, V403, P173, DOI 10.1007/BF00695233; Diosdado B, 2007, CLIN GASTROENTEROL H, V5, P574, DOI 10.1016/j.cgh.2006.11.014; HALSTENSEN TS, 1993, SCAND J IMMUNOL, V38, P581, DOI 10.1111/j.1365-3083.1993.tb03245.x; HUITFELDT HS, 1985, HISTOCHEMISTRY, V83, P381, DOI 10.1007/BF00509196; Jabri B, 2009, NAT REV IMMUNOL, V9, P858, DOI 10.1038/nri2670; JAHNSEN FL, 1994, J IMMUNOL METHODS, V173, P77, DOI 10.1016/0022-1759(94)90285-2; LEIGH RJ, 1985, SCAND J GASTROENTERO, V20, P715, DOI 10.3109/00365528509089201; Maiuri L, 2003, LANCET, V362, P30, DOI 10.1016/S0140-6736(03)13803-2; MARSH MN, 1992, GASTROENTEROLOGY, V102, P330, DOI 10.1016/0016-5085(92)91819-P; MARSH MN, 1985, GASTROENTEROLOGY, V89, P92, DOI 10.1016/0016-5085(85)90749-8; MICKLEM KJ, 1991, AM J PATHOL, V139, P1297; Molberg O, 2000, METH MOLEC MED, V41, P105, DOI 10.1385/1-59259-082-9:105; Oberhuber G, 1999, EUR J GASTROEN HEPAT, V11, P1185, DOI 10.1097/00042737-199910000-00019; Palova-Jelinkova L, 2005, J IMMUNOL, V175, P7038, DOI 10.4049/jimmunol.175.10.7038; Rakhimova M, 2009, J CLIN IMMUNOL, V29, P29, DOI 10.1007/s10875-008-9228-x; Raki M, 2005, CLIN EXP IMMUNOL, V142, P333, DOI 10.1111/j.1365-2249.2005.02915.x; Raki M, 2006, GASTROENTEROLOGY, V131, P428, DOI 10.1053/j.gastro.2006.06.002; Schuppan D, 2009, GASTROENTEROLOGY, V137, P1912, DOI 10.1053/j.gastro.2009.09.008; Schwartzkopff F, 2010, INNATE IMMUN; Shan L, 2002, SCIENCE, V297, P2275, DOI 10.1126/science.1074129; Shantsila E, 2011, J THROMB HAEMOST, V9, P1056, DOI 10.1111/j.1538-7836.2011.04244.x; Sollid LM, 2002, NAT REV IMMUNOL, V2, P647, DOI 10.1038/nri885; SPITS H, 1984, EUR J IMMUNOL, V14, P299, DOI 10.1002/eji.1830140404; Tallone T, 2011, J CARDIOVASC TRANSL, V4, P211, DOI 10.1007/s12265-011-9256-4; Troncone R, 2011, J INTERN MED, V269, P582, DOI 10.1111/j.1365-2796.2011.02385.x; Walker MM, 2011, HISTOPATHOLOGY, V59, P166, DOI 10.1111/j.1365-2559.2010.03680.x; Wang JE, 2001, INFECT IMMUN, V69, P2402, DOI 10.1128/IAI.69.4.2402-2406.2001; Wong KL, 2011, BLOOD, V118, pE15, DOI 10.1182/blood-2010-12-326355	33	47	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33556	10.1371/journal.pone.0033556	http://dx.doi.org/10.1371/journal.pone.0033556			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438948	Green Submitted, Green Published, gold			2022-12-25	WOS:000303309100057
J	Sun, C; Fang, H; Xie, T; Auth, RD; Patel, N; Murray, PR; Snoy, PJ; Frucht, DM				Sun, Chen; Fang, Hui; Xie, Tao; Auth, Roger D.; Patel, Nayana; Murray, Patrick R.; Snoy, Philip J.; Frucht, David M.			Anthrax Lethal Toxin Disrupts Intestinal Barrier Function and Causes Systemic Infections with Enteric Bacteria	PLOS ONE			English	Article							BACILLUS-ANTHRACIS; KAPPA-B	A variety of intestinal pathogens have virulence factors that target mitogen activated protein kinase (MAPK) signaling pathways, including Bacillus anthracis. Anthrax lethal toxin (LT) has specific proteolytic activity against the upstream regulators of MAPKs, the MAPK kinases (MKKs). Using a murine model of intoxication, we show that LT causes the dose-dependent disruption of intestinal epithelial integrity, characterized by mucosal erosion, ulceration, and bleeding. This pathology correlates with an LT-dependent blockade of intestinal crypt cell proliferation, accompanied by marked apoptosis in the villus tips. C57BL/6J mice treated with intravenous LT nearly uniformly develop systemic infections with commensal enteric organisms within 72 hours of administration. LT-dependent intestinal pathology depends upon its proteolytic activity and is partially attenuated by co-administration of broad spectrum antibiotics, indicating that it is both a cause and an effect of infection. These findings indicate that targeting of MAPK signaling pathways by anthrax LT compromises the structural integrity of the mucosal layer, serving to undermine the effectiveness of the intestinal barrier. Combined with the well-described immunosuppressive effects of LT, this disruption of the intestinal barrier provides a potential mechanism for host invasion via the enteric route, a common portal of entry during the natural infection cycle of Bacillus anthracis.	[Sun, Chen; Fang, Hui; Xie, Tao; Auth, Roger D.; Frucht, David M.] US FDA, Cell Biol Lab, Div Monoclonal Antibodies, Off Biotechnol Prod,Ctr Drug Evaluat & Res, Bethesda, MD 20014 USA; [Patel, Nayana; Murray, Patrick R.] NIH, Dept Lab Med, Warren Magnusen Clin Ctr, Bethesda, MD 20892 USA; [Snoy, Philip J.] US FDA, Div Vet Serv, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA	US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; US Food & Drug Administration (FDA)	Sun, C (corresponding author), US FDA, Cell Biol Lab, Div Monoclonal Antibodies, Off Biotechnol Prod,Ctr Drug Evaluat & Res, Bethesda, MD 20014 USA.	david.frucht@fda.hhs.gov			United States government	United States government	The United States government provided the funding to support this work. The information presented in this manuscript reflects the work of the authors and does not necessarily represent the policy of the United States Food and Drug Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbibe L, 2007, NAT IMMUNOL, V8, P47, DOI 10.1038/ni1423; Baron EJ, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P1; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Brook Itzhak, 2002, Mil Med, V167, P105; Dainiak Nicholas, 2003, Hematology Am Soc Hematol Educ Program, P473; Fang H, 2005, J IMMUNOL, V174, P4966, DOI 10.4049/jimmunol.174.8.4966; Fang H, 2006, J IMMUNOL, V176, P6155, DOI 10.4049/jimmunol.176.10.6155; Fang H, 2010, J IMMUNOL, V185, P5463, DOI 10.4049/jimmunol.1002471; Fasanella A, 2010, VET MICROBIOL, V140, P318, DOI 10.1016/j.vetmic.2009.08.016; Franz DR, 2009, MOL ASPECTS MED, V30, P503, DOI 10.1016/j.mam.2009.07.002; Glomski IJ, 2007, PLOS PATHOG, V3, P699, DOI 10.1371/journal.ppat.0030076; Guichard A, 2010, NATURE, V467, P854, DOI 10.1038/nature09446; Jernigan DB, 2002, EMERG INFECT DIS, V8, P1019, DOI 10.3201/eid0810.020353; Khan S A, 2001, J Natl Cancer Inst Monogr, P31, DOI 10.1093/oxfordjournals.jncimonographs.a003437; Kiratisin P, 2003, EUR J CLIN MICROBIOL, V22, P628, DOI 10.1007/s10096-003-1003-6; Kolsto AB, 2009, ANNU REV MICROBIOL, V63, P451, DOI 10.1146/annurev.micro.091208.073255; Lin SL, 2003, CELL MICROBIOL, V5, P267, DOI 10.1046/j.1462-5822.2003.t01-1-00274.x; MILLER SI, 1980, AM J MED, V68, P649, DOI 10.1016/0002-9343(80)90250-8; Mittal R, 2006, P NATL ACAD SCI USA, V103, P18574, DOI 10.1073/pnas.0608995103; Moayeri M, 2003, J CLIN INVEST, V112, P670, DOI [10.1172/JCI200317991, 10.1172/JCI17991]; Moayeri M, 2009, MOL ASPECTS MED, V30, P439, DOI 10.1016/j.mam.2009.07.003; Okugawa S, 2011, INFECT IMMUN, V79, P118, DOI 10.1128/IAI.00963-10; RINK RD, 1977, CIRC SHOCK, V4, P259; Schuller BW, 2006, P NATL ACAD SCI USA, V103, P3787, DOI 10.1073/pnas.0600133103; Shan L, 2007, CELL HOST MICROBE, V1, P167, DOI 10.1016/j.chom.2007.04.008; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Tournier JN, 2009, MOL ASPECTS MED, V30, P456, DOI 10.1016/j.mam.2009.06.002; Turnbull PCB, 2002, CURR TOP MICROBIOL, V271, P1; Warfel JM, 2005, AM J PATHOL, V166, P1871, DOI 10.1016/S0002-9440(10)62496-0; Xie T, 2011, TOXINS, V3, P591, DOI 10.3390/toxins3060591; Xu LX, 2008, J IMMUNOL, V180, P4139, DOI 10.4049/jimmunol.180.6.4139; Xu LX, 2007, INT J BIOCHEM CELL B, V39, P20, DOI 10.1016/j.biocel.2006.08.010; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728	33	16	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33583	10.1371/journal.pone.0033583	http://dx.doi.org/10.1371/journal.pone.0033583			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438953	Green Published, gold, Green Submitted			2022-12-25	WOS:000303309100061
J	Szule, JA; Harlow, ML; Jung, JH; De-Miguel, FF; Marshall, RM; McMahan, UJ				Szule, Joseph A.; Harlow, Mark L.; Jung, Jae Hoon; De-Miguel, Francisco F.; Marshall, Robert M.; McMahan, Uel J.			Regulation of Synaptic Vesicle Docking by Different Classes of Macromolecules in Active Zone Material	PLOS ONE			English	Article							FROG NEUROMUSCULAR-JUNCTION; ELECTRON TOMOGRAPHY; MEMBRANE-FUSION; TRANSMITTER RELEASE; PRESYNAPTIC CYTOMATRIX; CRYSTAL-STRUCTURE; CALCIUM-CHANNELS; SNARE COMPLEX; 3 DIMENSIONS; ARCHITECTURE	The docking of synaptic vesicles at active zones on the presynaptic plasma membrane of axon terminals is essential for their fusion with the membrane and exocytosis of their neurotransmitter to mediate synaptic impulse transmission. Dense networks of macromolecules, called active zone material, (AZM) are attached to the presynaptic membrane next to docked vesicles. Electron tomography has shown that some AZM macromolecules are connected to docked vesicles, leading to the suggestion that AZM is somehow involved in the docking process. We used electron tomography on the simply arranged active zones at frog neuromuscular junctions to characterize the connections of AZM to docked synaptic vesicles and to search for the establishment of such connections during vesicle docking. We show that each docked vesicle is connected to 10-15 AZM macromolecules, which fall into four classes based on several criteria including their position relative to the presynaptic membrane. In activated axon terminals fixed during replacement of docked vesicles by previously undocked vesicles, undocked vesicles near vacated docking sites on the presynaptic membrane have connections to the same classes of AZM macromolecules that are connected to docked vesicles in resting terminals. The number of classes and the total number of macromolecules to which the undocked vesicles are connected are inversely proportional to the vesicles' distance from the presynaptic membrane. We conclude that vesicle movement toward and maintenance at docking sites on the presynaptic membrane are directed by an orderly succession of stable interactions between the vesicles and distinct classes of AZM macromolecules positioned at different distances from the membrane. Establishing the number, arrangement and sequence of association of AZM macromolecules involved in vesicle docking provides an anatomical basis for testing and extending concepts of docking mechanisms provided by biochemistry.	[Szule, Joseph A.; Harlow, Mark L.; Jung, Jae Hoon; De-Miguel, Francisco F.; Marshall, Robert M.; McMahan, Uel J.] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; [Jung, Jae Hoon] Stanford Univ, Sch Humanities & Sci, Dept Phys, Stanford, CA 94305 USA; [Szule, Joseph A.; Harlow, Mark L.; Jung, Jae Hoon; Marshall, Robert M.; McMahan, Uel J.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; [De-Miguel, Francisco F.] Univ Nacl Autonoma Mexico, Inst Fisiol Celular Neurociencias, Mexico City 04510, DF, Mexico	Stanford University; Stanford University; Texas A&M University System; Texas A&M University College Station; Universidad Nacional Autonoma de Mexico	Szule, JA (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA.	grantser@tamu.edu	de Miguel, Francisco Fernández/AAT-8913-2020		National Institute of Neurological Disorders and Stroke [NS014506, NS007158]; National Institute of Mental Health [MH068065]; Natural Sciences and Engineering Research Council of Canada; Direccion General de Asuntos del Personal Academico of the Universidad Nacional Autonoma de Mexico; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH068065] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS014506] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Direccion General de Asuntos del Personal Academico of the Universidad Nacional Autonoma de Mexico; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was funded by the National Institute of Neurological Disorders and Stroke (NS014506 and NS007158), The National Institute of Mental Health (Human Brain Project/Neuroinformatics, MH068065), a postdoctoral fellowship from the Natural Sciences and Engineering Research Council of Canada (to JAS), and a fellowship from the Direccion General de Asuntos del Personal Academico of the Universidad Nacional Autonoma de Mexico (to FFM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arfken GB, 1985, MATH METHODS PHYS, Vxxii; CasesLanghoff C, 1996, EUR J CELL BIOL, V69, P214; COHEN MW, 1991, J NEUROSCI, V11, P1032; COUTEAUX R, 1970, Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences Serie D Sciences Naturelles, V271, P2346; Dieck ST, 1998, J CELL BIOL, V142, P499, DOI 10.1083/jcb.142.2.499; Fernandez-Busnadiego R, 2010, J CELL BIOL, V188, P145, DOI 10.1083/jcb.200908082; Frank J, 2006, ELECT TOMOGRAPHY MET, Vxiv; Gabriel T, 2011, J NEUROSCI, V31, P11563, DOI 10.1523/JNEUROSCI.1447-11.2011; Gaffield MA, 2011, J NEUROPHYSIOL, V106, P599, DOI 10.1152/jn.00123.2011; Geppert M, 1997, NATURE, V387, P810, DOI 10.1038/42954; Gerber SH, 2008, SCIENCE, V321, P1507, DOI 10.1126/science.1163174; Giraudo CG, 2006, SCIENCE, V313, P676, DOI 10.1126/science.1129450; Graf ER, 2009, NEURON, V64, P663, DOI 10.1016/j.neuron.2009.11.002; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Gustafsson JS, 2002, J COMP NEUROL, V450, P167, DOI 10.1002/cne.10310; Harlow ML, 2001, NATURE, V409, P479, DOI 10.1038/35054000; HEUSER JE, 1979, J CELL BIOL, V81, P275, DOI 10.1083/jcb.81.2.275; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; HEUSER JE, 1974, J NEUROCYTOL, V3, P109, DOI 10.1007/BF01111936; HEUSER JE, 1981, J CELL BIOL, V88, P564, DOI 10.1083/jcb.88.3.564; HIROKAWA N, 1989, J CELL BIOL, V108, P111, DOI 10.1083/jcb.108.1.111; Iancu CV, 2005, J STRUCT BIOL, V151, P288, DOI 10.1016/j.jsb.2005.07.004; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Katz B, 1969, RELEASE NEURAL TRANS, Vix; Ladinsky MS, 1999, J CELL BIOL, V144, P1135, DOI 10.1083/jcb.144.6.1135; LANDIS DMD, 1988, NEURON, V1, P201, DOI 10.1016/0896-6273(88)90140-7; LUTHER PK, 1988, ULTRAMICROSCOPY, V24, P7, DOI 10.1016/0304-3991(88)90322-1; Ma C, 2011, NAT STRUCT MOL BIOL, V18, P542, DOI 10.1038/nsmb.2047; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; MATTEOLI M, 1991, J CELL BIOL, V115, P625, DOI 10.1083/jcb.115.3.625; May AP, 2001, J BIOL CHEM, V276, P21991, DOI 10.1074/jbc.R100013200; MILLER TM, 1984, J CELL BIOL, V98, P685, DOI 10.1083/jcb.98.2.685; Nagwaney S, 2009, J COMP NEUROL, V513, P457, DOI 10.1002/cne.21975; Ostermeier C, 1999, CELL, V96, P363, DOI 10.1016/S0092-8674(00)80549-8; Paddock BE, 2008, J NEUROSCI, V28, P7458, DOI 10.1523/JNEUROSCI.0197-08.2008; PENCZEK P, 1995, ULTRAMICROSCOPY, V60, P393, DOI 10.1016/0304-3991(95)00078-X; Peters A, 1991, FINE STRUCTURE NERVO, Vxviii; PUMPLIN DW, 1981, P NATL ACAD SCI-BIOL, V78, P7210, DOI 10.1073/pnas.78.11.7210; Ress D, 1999, J ELECTRON MICROSC, V48, P277, DOI 10.1093/oxfordjournals.jmicro.a023679; Ress DB, 2004, STRUCTURE, V12, P1763, DOI 10.1016/j.str.2004.07.022; Rizo J, 2002, NAT REV NEUROSCI, V3, P641, DOI 10.1038/nrn898; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; ROBITAILLE R, 1993, J PHYSIOLOGY-PARIS, V87, P15, DOI 10.1016/0928-4257(93)90020-T; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; Schoch S, 2006, CELL TISSUE RES, V326, P379, DOI 10.1007/s00441-006-0244-y; Siksou L, 2007, J NEUROSCI, V27, P6868, DOI 10.1523/JNEUROSCI.1773-07.2007; Siksou L, 2011, CURR OPIN NEUROBIOL, V21, P261, DOI 10.1016/j.conb.2010.12.003; Sosinsky GE, 2008, J STRUCT BIOL, V161, P359, DOI 10.1016/j.jsb.2007.09.002; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; Stigloher C, 2011, J NEUROSCI, V31, P4388, DOI 10.1523/JNEUROSCI.6164-10.2011; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sunderland WJ, 2000, J NEUROSCI, V20, P1009, DOI 10.1523/JNEUROSCI.20-03-01009.2000; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Zampighi GA, 2008, J NEUROSCI, V28, P4151, DOI 10.1523/JNEUROSCI.4639-07.2008; Zhai RG, 2004, PHYSIOLOGY, V19, P262, DOI 10.1152/physiol.00014.2004	59	48	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33333	10.1371/journal.pone.0033333	http://dx.doi.org/10.1371/journal.pone.0033333			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438915	gold, Green Published, Green Submitted			2022-12-25	WOS:000303309100034
J	Feng, J; Yang, W				Feng, Jing; Yang, Wei			Effects of Particulate Air Pollution on Cardiovascular Health: A Population Health Risk Assessment	PLOS ONE			English	Article							LATENT STRUCTURE-ANALYSIS; ULTRAFINE PARTICLES; HOSPITAL ADMISSIONS; UNITED-STATES; RESPIRATORY-DISEASES; HEART-DISEASE; TERM EXPOSURE; MORTALITY; CITIES; MICE	Particulate matter (PM) air pollution is increasingly recognized as an important and modifiable risk factor for adverse health outcomes including cardiovascular disease (CVD). However, there are still gaps regarding large population risk assessment. Results from the nationwide Behavioral Risk Factor Surveillance System (BRFSS) were used along with air quality monitoring measurements to implement a systematic evaluation of PM-related CVD risks at the national and regional scales. CVD status and individual-level risk factors were collected from more than 500,000 BRFSS respondents across 2,231 contiguous U. S. counties for 2007 and 2009. Chronic exposures to PM pollutants were estimated with spatial modeling from measurement data. CVD outcomes attributable to PM pollutants were assessed by mixed-effects logistic regression and latent class regression (LCR), with adjustment for multicausality. There were positive associations between CVD and PM after accounting for competing risk factors: the multivariable-adjusted odds for the multiplicity of CVD outcomes increased by 1.32 (95% confidence interval: 1.23-1.43) and 1.15 (1.07-1.22) times per 10 mg/m(3) increase in PM2.5 and PM10 respectively in the LCR analyses. After controlling for spatial confounding, there were moderate estimated effects of PM exposure on multiple cardiovascular manifestations. These results suggest that chronic exposures to ambient particulates are important environmental risk factors for cardiovascular morbidity.	[Feng, Jing; Yang, Wei] Univ Nevada, Sch Community Hlth Sci, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno	Feng, J (corresponding author), Univ Nevada, Sch Community Hlth Sci, Reno, NV 89557 USA.	weiyang@unr.edu						Agresti A, 2000, SOCIOL METHODOL, V30, P27, DOI 10.1111/0081-1750.t01-1-00075; Agresti A., 2013, CATEGORICAL DATA ANA, V3rd; [Anonymous], 2002, UND HLTH EFF COMP PA; Beelen R, 2009, SCI TOTAL ENVIRON, V407, P1852, DOI 10.1016/j.scitotenv.2008.11.048; Bell ML, 2007, ENVIRON HEALTH PERSP, V115, P989, DOI 10.1289/ehp.9621; Brook RD, 2002, CIRCULATION, V105, P1534, DOI 10.1161/01.CIR.0000013838.94747.64; BURNETT RT, 1995, AM J EPIDEMIOL, V142, P15, DOI 10.1093/oxfordjournals.aje.a117540; Burnett RT, 2000, INHAL TOXICOL, V12, P15, DOI 10.1080/089583700750019495; Centers for Disease Control and Prevention (CDC), 1998, BEH RISK FACT SURV S; Chen LC, 2005, INHAL TOXICOL, V17, P217, DOI 10.1080/08958370590912815; CLOGG CC, 1984, J AM STAT ASSOC, V79, P762, DOI 10.2307/2288706; Cozzi E, 2006, AM J PHYSIOL-HEART C, V291, pH894, DOI 10.1152/ajpheart.01362.2005; DAYTON CM, 1988, J AM STAT ASSOC, V83, P173, DOI 10.2307/2288938; Delfino RJ, 2005, ENVIRON HEALTH PERSP, V113, P934, DOI 10.1289/ehp.7938; Dockery D W, 1993, N Engl J Med, V329, P1753, DOI 10.1056/NEJM199312093292401; Dominici F, 2006, JAMA-J AM MED ASSOC, V295, P1127, DOI 10.1001/jama.295.10.1127; FORMANN A, 1982, Biometrical Journal, V24, P171, DOI 10.1002/bimj.4710240209; Goldberg MS, 2001, ENVIRON HEALTH PERSP, V109, P487, DOI 10.2307/3454658; GOODMAN LA, 1974, BIOMETRIKA, V61, P215, DOI 10.2307/2334349; Isaaks E.H., 1989, APPL GEOSTATISTICS; Kim S, 2002, J AIR WASTE MANAGE, V52, P297, DOI 10.1080/10473289.2002.10470781; Krewski D., 2000, REANALYSIS HARVARD 6; LEENAERS H, 1990, CATENA, V17, P535, DOI 10.1016/0341-8162(90)90028-C; LEFOHN AS, 1988, ENVIRON POLLUT, V53, P27, DOI 10.1016/0269-7491(88)90023-1; Liao DP, 2006, ENVIRON HEALTH PERSP, V114, P1374, DOI 10.1289/ehp.9169; Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409; MORRIS RD, 1995, AM J PUBLIC HEALTH, V85, P1361, DOI 10.2105/AJPH.85.10.1361; NELSON DE, 1998, P SECT SURV RES METH, P214; Oberdorster G, 2001, INT ARCH OCC ENV HEA, V74, P1; Ostro B, 1995, ENVIRON RES, V70, P98, DOI 10.1006/enrs.1995.1053; Ostro B, 2007, ENVIRON HEALTH PERSP, V115, P13, DOI 10.1289/ehp.9281; Peters A, 2000, EPIDEMIOLOGY, V11, P11, DOI 10.1097/00001648-200001000-00005; Peters A, 2001, CIRCULATION, V103, P2810; Polichetti G, 2009, TOXICOLOGY, V261, P1, DOI 10.1016/j.tox.2009.04.035; Pope CA, 2006, CIRCULATION, V114, P2443, DOI 10.1161/CIRCULATIONAHA.106.636977; POPE CA, 1995, AM J RESP CRIT CARE, V151, P669, DOI 10.1164/ajrccm/151.3_Pt_1.669; Pope CA, 1999, AM J RESP CRIT CARE, V159, P365, DOI 10.1164/ajrccm.159.2.9702103; Pope CA, 2001, ENVIRON HEALTH PERSP, V109, P711, DOI 10.2307/3454788; Powell-Griner E, 1998, P SECT SURV RES METH, P219; Samet J M, 2000, Res Rep Health Eff Inst, V94, P5; Schwartz J, 1999, EPIDEMIOLOGY, V10, P17, DOI 10.1097/00001648-199901000-00005; SCHWARTZ J, 1995, AM J EPIDEMIOL, V142, P23, DOI 10.1093/oxfordjournals.aje.a117541; Sun QH, 2005, JAMA-J AM MED ASSOC, V294, P3003, DOI 10.1001/jama.294.23.3003; Tankersley CG, 2008, AM J PHYSIOL-REG I, V295, pR252, DOI 10.1152/ajpregu.00697.2007; U.S. Environmental Protection Agency Technology Transfer Network (TTN) Air Quality System (AQS) website, TECHN TRANSF NETW TT; Vermunt JK, 2001, MULTILEVEL MODELLING, V13, P6, DOI DOI 10.1080/00273171.2012.658339; Yang W, 2009, MUTAT RES-GEN TOX EN, V674, P45, DOI 10.1016/j.mrgentox.2008.10.005; Zanobetti A, 2000, ENVIRON HEALTH PERSP, V108, P1071, DOI 10.2307/3434961; Zeger SL, 2008, ENVIRON HEALTH PERSP, V116, P1614, DOI 10.1289/ehp.11449; Zeger SL, 2007, MORTALITY MEDICARE P	50	24	25	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e33385	10.1371/journal.pone.0033385	http://dx.doi.org/10.1371/journal.pone.0033385			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22432017	gold, Green Submitted, Green Published			2022-12-25	WOS:000303198600060
J	Tomter, AB; Zoppellaro, G; Bell, CB; Barra, AL; Andersen, NH; Solomon, EI; Andersson, KK				Tomter, Ane B.; Zoppellaro, Giorgio; Bell, Caleb B., III; Barra, Anne-Laure; Andersen, Niels H.; Solomon, Edward I.; Andersson, K. Kristoffer			Spectroscopic Studies of the Iron and Manganese Reconstituted Tyrosyl Radical in Bacillus Cereus Ribonucleotide Reductase R2 Protein	PLOS ONE			English	Article							HIGH-FIELD EPR; HERPES-SIMPLEX-VIRUS; HIGH-FREQUENCY EPR; ELECTRON-PARAMAGNETIC-RESONANCE; SMALL INORGANIC MODELS; ESCHERICHIA-COLI; CORYNEBACTERIUM-AMMONIAGENES; ACTIVE FORM; MANGANESE(IV)/IRON(III) COFACTOR; MYCOBACTERIUM-TUBERCULOSIS	Ribonucleotide reductase (RNR) catalyzes the rate limiting step in DNA synthesis where ribonucleotides are reduced to the corresponding deoxyribonucleotides. Class Ib RNRs consist of two homodimeric subunits: R1E, which houses the active site; and R2F, which contains a metallo cofactor and a tyrosyl radical that initiates the ribonucleotide reduction reaction. We studied the R2F subunit of B. cereus reconstituted with iron or alternatively with manganese ions, then subsequently reacted with molecular oxygen to generate two tyrosyl-radicals. The two similar X-band EPR spectra did not change significantly over 4 to 50 K. From the 285 GHz EPR spectrum of the iron form, a g(1)-value of 2.0090 for the tyrosyl radical was extracted. This g(1)-value is similar to that observed in class Ia E. coli R2 and class Ib R2Fs with iron-oxygen cluster, suggesting the absence of hydrogen bond to the phenoxyl group. This was confirmed by resonance Raman spectroscopy, where the stretching vibration associated to the radical (C-O, v(7a) = 1500 cm(-1)) was found to be insensitive to deuterium-oxide exchange. Additionally, the O-18-sensitive Fe-O-Fe symmetric stretching (483 cm(-1)) of the metallo-cofactor was also insensitive to deuterium-oxide exchange indicating no hydrogen bonding to the di-iron-oxygen cluster, and thus, different from mouse R2 with a hydrogen bonded cluster. The HF-EPR spectrum of the manganese reconstituted RNR R2F gave a g(1)-value of similar to 2.0094. The tyrosyl radical microwave power saturation behavior of the iron-oxygen cluster form was as observed in class Ia R2, with diamagnetic di-ferric cluster ground state, while the properties of the manganese reconstituted form indicated a magnetic ground state of the manganese-cluster. The recent activity measurements (Crona et al., (2011) J Biol Chem 286: 33053-33060) indicates that both the manganese and iron reconstituted RNR R2F could be functional. The manganese form might be very important, as it has 8 times higher activity.	[Tomter, Ane B.; Zoppellaro, Giorgio; Andersen, Niels H.; Andersson, K. Kristoffer] Univ Oslo, Dept Mol Biosci, Oslo, Norway; [Bell, Caleb B., III; Solomon, Edward I.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Barra, Anne-Laure] CNRS, Lab Natl Champs Magnet Intenses, LNCMI G, UPR 3228, Grenoble, France	University of Oslo; Stanford University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Tomter, AB (corresponding author), Univ Oslo, Dept Mol Biosci, Oslo, Norway.	k.k.andersson@imbv.uio.no	Zoppellaro, Giorgio/F-8453-2012	Zoppellaro, Giorgio/0000-0003-2304-2564; Andersen, Niels Hojmark/0000-0003-3668-2800; Solomon, Edward/0000-0003-0291-3199	European Community [PIEF-GA-2009-235237]; Research Council of Norway [177661/V30, 214239/F20]; Cancer Foundation of Norway; NSF [MCB- 0342807]; Div Of Molecular and Cellular Bioscience [0919027] Funding Source: National Science Foundation	European Community(European Commission); Research Council of Norway(Research Council of Norway); Cancer Foundation of Norway; NSF(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by The PEOPLE Marie Curie Actions Intra-European Fellowship within the 7th European Community Framework Programme (PIEF-GA-2009-235237 to GZ), the Research Council of Norway (www.rcn.no)(Grant 177661/V30 and 214239/F20 to KKA), the Cancer Foundation of Norway (www.kreftforeningen.no)(to KKA), and the NSF-Biophysics Program (Grant MCB- 0342807 to EIS). The Raman instrument and laser equipment in Oslo was funded by a grant from the Research Council of Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard P, 1996, J AM CHEM SOC, V118, P895, DOI 10.1021/ja9529192; Andersson K. K., 1995, ADV INORG CHEM, V43, P359; Andersson K.K., 2008, RIBONUCLEOTIDE REDUC; Andersson KK, 2003, J BIOL INORG CHEM, V8, P235, DOI 10.1007/s00775-002-0429-0; Andersson KK, 2002, SPECTROCHIM ACTA A, V58, P1101, DOI 10.1016/S1386-1425(01)00700-4; ATTA M, 1994, J AM CHEM SOC, V116, P6429, DOI 10.1021/ja00093a051; BACKES G, 1989, BIOCHEMISTRY-US, V28, P1923, DOI 10.1021/bi00430a074; Barra AL, 2004, BIO MAGN RE, V22, P145; Boal AK, 2010, SCIENCE, V329, P1526, DOI 10.1126/science.1190187; BOLLINGER JM, 1995, METHOD ENZYMOL, V258, P278; CASTNER TG, 1959, PHYS REV, V115, P1506, DOI 10.1103/PhysRev.115.1506; Cotruvo JA, 2008, P NATL ACAD SCI USA, V105, P14383, DOI 10.1073/pnas.0807348105; Cotruvo JA, 2010, BIOCHEMISTRY-US, V49, P1297, DOI 10.1021/bi902106n; Cox N, 2010, J AM CHEM SOC, V132, P11197, DOI 10.1021/ja1036995; Crona M, 2011, J BIOL CHEM, V286, P33053, DOI 10.1074/jbc.M111.278119; Davydov RM, 1997, BIOCHEMISTRY-US, V36, P9093, DOI 10.1021/bi9700375; Dorlet P, 2000, BIOCHEMISTRY-US, V39, P7826, DOI 10.1021/bi000175l; Ehling-Schulz M, 2004, MOL NUTR FOOD RES, V48, P479, DOI 10.1002/mnfr.200400055; Eklund H, 2001, PROG BIOPHYS MOL BIO, V77, P177, DOI 10.1016/S0079-6107(01)00014-1; Eriksson M, 1998, BIOCHEMISTRY-US, V37, P13359, DOI 10.1021/bi981380s; Fairman JW, 2011, NAT STRUCT MOL BIOL, V18, P316, DOI 10.1038/nsmb.2007; Galander M, 2006, J BIOL CHEM, V281, P31743, DOI 10.1074/jbc.M605089200; Galli C, 1996, J MAGN RESON SER B, V110, P284, DOI 10.1006/jmrb.1996.0044; GALLI C, 1995, J AM CHEM SOC, V117, P740, DOI 10.1021/ja00107a017; Gallicchio VS, 2005, EXPERT OPIN THER PAT, V15, P659, DOI 10.1517/13543776.15.6.659; GERFEN GJ, 1993, J AM CHEM SOC, V115, P6420, DOI 10.1021/ja00067a071; Hanson MA, 1999, J AM CHEM SOC, V121, P6755, DOI 10.1021/ja990995p; Himo F, 1997, BIOPHYS J, V72, P1556, DOI 10.1016/S0006-3495(97)78803-9; Hirsh DJ, 2007, NAT PROTOC, V2, P1770, DOI 10.1038/nprot.2007.255; Hoganson CW, 1996, J AM CHEM SOC, V118, P4672, DOI 10.1021/ja953979a; Hogbom M, 2004, SCIENCE, V305, P245, DOI 10.1126/science.1098419; Hogbom M, 2003, P NATL ACAD SCI USA, V100, P3209, DOI 10.1073/pnas.0536684100; Hogbom M, 2002, BIOCHEMISTRY-US, V41, P1381, DOI 10.1021/bi011429l; Huque Y, 2000, J BIOL CHEM, V275, P25365, DOI 10.1074/jbc.M002751200; Jiang W, 2007, BIOCHEMISTRY-US, V46, P8709, DOI 10.1021/bi700906g; Jiang W, 2007, J AM CHEM SOC, V129, P7504, DOI 10.1021/ja072528a; Jiang W, 2007, SCIENCE, V316, P1188, DOI 10.1126/science.1141179; Johansson R, 2010, FEBS J, V277, P4265, DOI 10.1111/j.1742-4658.2010.07815.x; Jordan A, 1998, ANNU REV BIOCHEM, V67, P71, DOI 10.1146/annurev.biochem.67.1.71; Kolberg M, 2004, BBA-PROTEINS PROTEOM, V1699, P1, DOI 10.1016/j.bbapap.2004.02.007; Liu A, 1998, BIOCHEMISTRY-US, V37, P16369, DOI 10.1021/bi981471p; Lundin D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-589; Makinen MW, 1987, MET IONS BIOL SYST, P129; McCreery R.L., 2005, RAMAN SPECTROSCOPY C, VVolume 225; Nocentini G, 1996, CRIT REV ONCOL HEMAT, V22, P89, DOI 10.1016/1040-8428(95)00187-5; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Offenbacher AR, 2009, J AM CHEM SOC, V131, P7496, DOI 10.1021/ja901908j; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; PORTIS AM, 1953, PHYS REV, V91, P1071, DOI 10.1103/PhysRev.91.1071; REICHARD P, 1993, SCIENCE, V260, P1773, DOI 10.1126/science.8511586; Rofougaran R, 2006, J BIOL CHEM, V281, P27705, DOI 10.1074/jbc.M605573200; Rohr AK, 2010, THESIS U OSLO OSLO; Rohr AK, 2010, ANGEW CHEM INT EDIT, V49, P2324, DOI 10.1002/anie.200907143; ROVA U, 1995, BIOCHEMISTRY-US, V34, P4267, DOI 10.1021/bi00013a016; SAHLIN M, 1987, BIOCHEMISTRY-US, V26, P5541, DOI 10.1021/bi00391a049; Schmidt PP, 1996, J BIOL CHEM, V271, P23615, DOI 10.1074/jbc.271.39.23615; Shao J, 2006, CURR CANCER DRUG TAR, V6, P409, DOI 10.2174/156800906777723949; Sjoberg BM, 1997, STRUCT BOND, V88, P139; SJOBERG BM, 1978, J BIOL CHEM, V253, P6863; Sjoberg BM, 2010, SCIENCE, V329, P1475, DOI 10.1126/science.1196347; Strand KR, 2004, J BIOL CHEM, V279, P46794, DOI 10.1074/jbc.M407346200; Svistunenko DA, 2004, BIOPHYS J, V87, P582, DOI 10.1529/biophysj.104.041046; Svistunenko DA, 2009, PHYS CHEM CHEM PHYS, V11, P6600, DOI 10.1039/b905522c; Tomter A. B., 2010, SPECTROSCOPIC STUDIE; Tomter AB, 2008, BIOCHEMISTRY-US, V47, P11300, DOI 10.1021/bi801212f; Tomter AB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025022; Tong WH, 1996, J AM CHEM SOC, V118, P2107, DOI 10.1021/ja952764y; Torrents E, 2005, P NATL ACAD SCI USA, V102, P17946, DOI 10.1073/pnas.0506410102; Un S, 2005, MAGN RESON CHEM, V43, pS229, DOI 10.1002/mrc.1660; Un S, 2001, J AM CHEM SOC, V123, P3048, DOI 10.1021/ja003650b; Uppsten M, 2004, FEBS LETT, V569, P117, DOI 10.1016/j.febslet.2004.05.059; van Dam PJ, 1998, J AM CHEM SOC, V120, P5080, DOI 10.1021/ja9737127; Voevodskaya N, 2007, FEBS LETT, V581, P3351, DOI 10.1016/j.febslet.2007.06.023; WILLING A, 1988, EUR J BIOCHEM, V170, P603, DOI 10.1111/j.1432-1033.1988.tb13740.x; Wilson EB, 1934, PHYS REV, V45, P0706, DOI 10.1103/PhysRev.45.706; Zhang Y, 2011, BIOCHEMISTRY-US, V50, P5615, DOI 10.1021/bi200348q; Zoppellaro G, 2008, J AM CHEM SOC, V130, P15348, DOI 10.1021/ja8033312	77	22	22	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e33436	10.1371/journal.pone.0033436	http://dx.doi.org/10.1371/journal.pone.0033436			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22432022	Green Published, Green Submitted, gold			2022-12-25	WOS:000303198600065
J	Goulart, MR; Pluhar, GE; Ohlfest, JR				Goulart, Michelle R.; Pluhar, G. Elizabeth; Ohlfest, John R.			Identification of Myeloid Derived Suppressor Cells in Dogs with Naturally Occurring Cancer	PLOS ONE			English	Article							ACCUMULATION; INFLAMMATION; MECHANISMS; EXPRESSION; CARCINOMA	Dogs with naturally occurring cancer represent an important large animal model for drug development and testing novel immunotherapies. However, poorly defined immunophenotypes of canine leukocytes have limited the study of tumor immunology in dogs. The accumulation of myeloid derived suppressor cells (MDSCs) is known to be a key mechanism of immune suppression in tumor-bearing mice and in human patients. We sought to identify MDSCs in the blood of dogs with cancer. Peripheral blood mononuclear cells (PBMCs) from dogs with advanced or early stage cancer and from age-matched healthy controls were analyzed by flow cytometry and microscopy. Suppressive function was tested in T cell proliferation and cytokine elaboration assays. Semi-quantitative RT-PCR was used to identify potential mechanisms responsible for immunosuppression. PBMCs from dogs with advanced or metastatic cancer exhibited a significantly higher percentage of CD11b(+)CD14(-)MHCII(-) cells compared to dogs diagnosed with early stage non-metastatic tumors and healthy dogs. These CD11b(+)CD14(-)MHCII(-) cells constitute a subpopulation of activated granulocytes that co-purify with PBMCs, display polymorphonuclear granulocyte morphology, and demonstrate a potent ability to suppress proliferation and IFN-gamma production in T cells from normal and tumor-bearing donors. Furthermore, these cells expressed hallmark suppressive factors of human MDSC including ARG1, iNOS2, TGF-beta and IL-10. In summary our data demonstrate that MDSCs accumulate in the blood of dogs with advanced cancer and can be measured using this three-marker immunophenotype, thereby enabling prospective studies that can monitor MDSC burden.	[Ohlfest, John R.] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Goulart, Michelle R.; Pluhar, G. Elizabeth] Univ Minnesota, Dept Vet Clin Sci, St Paul, MN 55108 USA; [Ohlfest, John R.] Univ Minnesota, Dept Neurosurg, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Ohlfest, JR (corresponding author), Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA.	Ohlfe001@umn.edu		Rodrigues Goulart, Michelle/0000-0001-8333-3908	National Institutes of Health (NIH) [R21-NS055738]; American Cancer Society [RSG-09-189-01-LIB]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS055738] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants to Dr. Ohlfest from the National Institutes of Health (NIH R21-NS055738), and the American Cancer Society (RSG-09-189-01-LIB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almand B, 2001, J IMMUNOL, V166, P678, DOI 10.4049/jimmunol.166.1.678; Biller BJ, 2007, VET IMMUNOL IMMUNOP, V116, P69, DOI 10.1016/j.vetimm.2006.12.002; Bronte V, 2000, BLOOD, V96, P3838, DOI 10.1182/blood.V96.12.3838.h8003838_3838_3846; Bunt SK, 2007, CANCER RES, V67, P10019, DOI 10.1158/0008-5472.CAN-07-2354; Diaz-Montero CM, 2009, CANCER IMMUNOL IMMUN, V58, P49, DOI 10.1007/s00262-008-0523-4; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Hanson EM, 2009, J IMMUNOL, V183, P937, DOI 10.4049/jimmunol.0804253; Khanna C, 2006, NAT BIOTECHNOL, V24, P1065, DOI 10.1038/nbt0906-1065b; Khanna C, 2009, CLIN CANCER RES, V15, P3645, DOI 10.1158/1078-0432.CCR-09-0132; Ko JS, 2009, CLIN CANCER RES, V15, P2148, DOI 10.1158/1078-0432.CCR-08-1332; Molon B, 2011, J EXP MED, V208, P1949, DOI 10.1084/jem.20101956; Nagaraj S, 2010, J IMMUNOL, V184, P3106, DOI 10.4049/jimmunol.0902661; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Paoloni M, 2008, NAT REV CANCER, V8, P147, DOI 10.1038/nrc2273; Rodriguez PC, 2008, IMMUNOL REV, V222, P180, DOI 10.1111/j.1600-065X.2008.00608.x; Rodriguez PC, 2009, CANCER RES, V69, P1553, DOI 10.1158/0008-5472.CAN-08-1921; Schmielau J, 2001, CANCER RES, V61, P4756; Serafini P, 2006, SEMIN CANCER BIOL, V16, P53, DOI 10.1016/j.semcancer.2005.07.005; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791; Youn JI, 2010, EUR J IMMUNOL, V40, P2969, DOI 10.1002/eji.201040895	20	31	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2012	7	3							e33274	10.1371/journal.pone.0033274	http://dx.doi.org/10.1371/journal.pone.0033274			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930IA	22428007	Green Published, gold, Green Submitted			2022-12-25	WOS:000303129700046
J	Levison, JH; Orrell, C; Gallien, S; Kuritzkes, DR; Fu, N; Losina, E; Freedberg, KA; Wood, R				Levison, Julie H.; Orrell, Catherine; Gallien, Sebastien; Kuritzkes, Daniel R.; Fu, Naishin; Losina, Elena; Freedberg, Kenneth A.; Wood, Robin			Virologic Failure of Protease Inhibitor-Based Second-Line Antiretroviral Therapy without Resistance in a Large HIV Treatment Program in South Africa	PLOS ONE			English	Article							DRUG-RESISTANCE; REVERSE-TRANSCRIPTASE; LOPINAVIR-RITONAVIR; EARLY MORTALITY; PATIENTS LOST; FOLLOW-UP; CLADE-C; OUTCOMES; MUTATIONS; ADULTS	Background: We investigated the prevalence of wild-type virus (no major drug resistance) and drug resistance mutations at second-line antiretroviral treatment (ART) failure in a large HIV treatment program in South Africa. Methodology/ Principal Findings: HIV-infected patients >= 15 years of age who had failed protease inhibitor (PI)-based second-line ART (2 consecutive HIV RNA tests >1000 copies/ml on lopinavir/ritonavir, didanosine, and zidovudine) were identified retrospectively. Patients with virologic failure were continued on second-line ART. Genotypic testing for drug resistance was performed on frozen plasma samples obtained closest to and after the date of laboratory confirmed second-line ART failure. Of 322 HIV-infected patients on second-line ART, 43 were adults with confirmed virologic failure, and 33 had available plasma for viral sequencing. HIV-1 RNA subtype C predominated (n = 32, 97%). Mean duration on ART (SD) prior to initiation of second-line ART was 23 (17) months, and time from second-line ART initiation to failure was 10 (9) months. Plasma samples were obtained 7(9) months from confirmed failure. At second-line failure, 22 patients (67%) had wild-type virus. There was no major resistance to PIs found. Eleven of 33 patients had a second plasma sample taken 8 (5.5) months after the first. Median HIV-1 RNA and the genotypic resistance profile were unchanged. Conclusions/ Significance: Most patients who failed second-line ART had wild-type virus. We did not observe evolution of resistance despite continuation of PI-based ART after failure. Interventions that successfully improve adherence could allow patients to continue to benefit from second-line ART therapy even after initial failure.	[Levison, Julie H.; Fu, Naishin; Losina, Elena; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA; [Levison, Julie H.; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Orrell, Catherine; Wood, Robin] Univ Cape Town, Dept Med, Desmond Tutu HIV Ctr, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Levison, Julie H.; Gallien, Sebastien; Kuritzkes, Daniel R.] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Losina, Elena; Freedberg, Kenneth A.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Losina, Elena; Freedberg, Kenneth A.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Gallien, Sebastien; Kuritzkes, Daniel R.; Losina, Elena; Freedberg, Kenneth A.] Harvard Univ, Ctr AIDS Res, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of Cape Town; Harvard University; Brigham & Women's Hospital; Boston University; Boston University; Harvard University	Levison, JH (corresponding author), Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA.	jlevison@partners.org	Orrell, Catherine/AAF-3405-2019; Gallien, Sébastien/F-9930-2015	Orrell, Catherine/0000-0003-1134-7475; Gallien, Sébastien/0000-0002-8033-0936; Losina, ELENA/0000-0002-3424-0892	United States National Institute of Allergy and Infectious Diseases [NIAID T32 AI007433, R01AI058736, K24 A1062476]; National Center for Research Resources [K24 RR016482]; Harvard University Center for AIDS Research [P30-AI060354]; Virology Specialty Laboratory from AIDS Clinical Trials Group [U01 AI068636]; "Agence Nationale de Recherche sur le SIDA" (French National Agency for Research on AIDS), France; Abbott; Boehringer Ingelheim; Gilead; GlaxoSmithKline; Merck; ViiV; NATIONAL CENTER FOR RESEARCH RESOURCES [K24RR016482] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI062476, U01AI068636, R01AI058736, P30AI060354, T32AI007433] Funding Source: NIH RePORTER	United States National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Harvard University Center for AIDS Research; Virology Specialty Laboratory from AIDS Clinical Trials Group; "Agence Nationale de Recherche sur le SIDA" (French National Agency for Research on AIDS), France; Abbott(Abbott Laboratories); Boehringer Ingelheim(Boehringer Ingelheim); Gilead(Gilead Sciences); GlaxoSmithKline(GlaxoSmithKline); Merck(Merck & Company); ViiV; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was supported by the United States National Institute of Allergy and Infectious Diseases (NIAID T32 AI007433, R01AI058736, K24 A1062476), the National Center for Research Resources (K24 RR016482), Harvard University Center for AIDS Research (P30-AI060354), Virology Specialty Laboratory subcontract from the AIDS Clinical Trials Group (U01 AI068636). SG was a recipient of the "Agence Nationale de Recherche sur le SIDA" (French National Agency for Research on AIDS) Fellowship Grant for Post-Graduate Studies, France. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following competing interest: DRK is a consultant to and has received honoraria or research support from Abbott, Boehringer Ingelheim, Gilead, GlaxoSmithKline, Merck and ViiV. This does not alter the authors' adherence to all the PloS ONE policies on sharing data and materials. All other authors have declared that no competing interests exist.	Barreiro P, 2004, AIDS PATIENT CARE ST, V18, P329, DOI 10.1089/1087291041444087; Bekker LG, 2006, SAMJ S AFR MED J, V96, P315; Bellocchi MC, 2005, J MED VIROL, V76, P452, DOI 10.1002/jmv.20382; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; Decloedt EH, 2011, ANTIMICROB AGENTS CH, V55, P3195, DOI 10.1128/AAC.01598-10; El-Khatib Z, 2010, AIDS, V24, P1679, DOI 10.1097/QAD.0b013e32833a097b; FOX M, 2009, J ACQ IMMUN DEF SYND, V53, P500; Frater AJ, 2001, AIDS, V15, P1493, DOI 10.1097/00002030-200108170-00006; Geng EH, 2010, JAIDS-J ACQ IMM DEF, V53, P405, DOI 10.1097/QAI.0b013e3181b843f0; Grossman Z, 2001, AIDS, V15, P1453, DOI 10.1097/00002030-200108170-00001; Gupta R, 2008, CLIN INFECT DIS, V47, P712, DOI 10.1086/590943; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Hosseinipour MC, 2010, HIV MED, V11, P510, DOI 10.1111/j.1468-1293.2010.00825.x; Johnson Victoria A, 2010, Top HIV Med, V18, P156; Kantor R, 2005, PLOS MED, V2, P325, DOI 10.1371/journal.pmed.0020112; Kunches LM, 2001, J ACQ IMMUN DEF SYND, V28, P150, DOI 10.1097/00126334-200110010-00006; Lawn SD, 2005, AIDS, V19, P2141, DOI 10.1097/01.aids.0000194802.89540.e1; Levison JH, 2011, ANTIVIR THER, V16, P853, DOI 10.3851/IMP1819; Li JF, 2011, J INFECT DIS, V203, P798, DOI 10.1093/infdis/jiq126; Li JZ, 2011, JAMA-J AM MED ASSOC, V305, P1327, DOI 10.1001/jama.2011.375; Long L, 2010, AIDS, V24, P915, DOI 10.1097/QAD.0b013e3283360976; Marconi VC, 2008, CLIN INFECT DIS, V46, P1589, DOI 10.1086/587109; Miller CM, 2010, TROP MED INT HEALTH, V15, P48, DOI 10.1111/j.1365-3156.2010.02514.x; Mo HM, 2005, J VIROL, V79, P3329, DOI 10.1128/JVI.79.6.3329-3338.2005; Murphy RA, 2010, AIDS, V24, P1007, DOI 10.1097/QAD.0b013e3283333639; Nash D, 2008, AIDS, V22, P2291, DOI 10.1097/QAD.0b013e3283121ca9; National Department of Health South Africa, 2010, CLIN GUID MAN HIV AI; Orrell C, 2007, ANTIVIR THER, V12, P83; Orrell C, 2009, ANTIVIR THER, V14, P523; Pasquet A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013414; Ross LL, 2010, J ANTIMICROB CHEMOTH, V65, P307, DOI 10.1093/jac/dkp419; UNAIDS Joint United Nations Programme on HIV/AIDS, 2010, COUNTR FACT SHEETS S; Velazquez-Campoy A, 2001, P NATL ACAD SCI USA, V98, P6062, DOI 10.1073/pnas.111152698; Vergne L, 2000, J CLIN MICROBIOL, V38, P3919, DOI 10.1128/JCM.38.11.3919-3925.2000; Wallis CL, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/769627; Wallis CL, 2010, J VIROL METHODS, V163, P505, DOI 10.1016/j.jviromet.2009.11.011; Walmsley S, 2002, NEW ENGL J MED, V346, P2039, DOI 10.1056/NEJMoa012354; Walmsley Sharon, 2002, J Int Assoc Physicians AIDS Care (Chic), V1, P95, DOI 10.1177/154510970200100304; World Health Organisation, 2007, PRIOR 2 LIN ANT DRUG; World Health Organization, 2010, UN ACC SCAL PRIOR HI	40	50	51	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2012	7	3							e32144	10.1371/journal.pone.0032144	http://dx.doi.org/10.1371/journal.pone.0032144			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930IA	22427821	Green Published, gold, Green Submitted			2022-12-25	WOS:000303129700006
J	Paul, CPL; Zuiderbaan, HA; Doulabi, BZ; van der Veen, AJ; van de Ven, PM; Smit, TH; Helder, MN; van Royen, BJ; Mullender, MG				Paul, Cornelis P. L.; Zuiderbaan, Hendrik A.; Doulabi, Behrouz Zandieh; van der Veen, Albert J.; van de Ven, Peter M.; Smit, Theo H.; Helder, Marco N.; van Royen, Barend J.; Mullender, Margriet G.			Simulated-Physiological Loading Conditions Preserve Biological and Mechanical Properties of Caprine Lumbar Intervertebral Discs in Ex Vivo Culture	PLOS ONE			English	Article							LOW-BACK-PAIN; VERTEBRAL END-PLATE; IN-VITRO; GENE-EXPRESSION; ARTICULAR CHONDROCYTES; MOTION SEGMENTS; CELL APOPTOSIS; ORGAN-CULTURE; ANIMAL-MODELS; DEGENERATION	Low-back pain (LBP) is a common medical complaint and associated with high societal costs. Degeneration of the intervertebral disc (IVD) is assumed to be an important causal factor of LBP. IVDs are continuously mechanically loaded and both positive and negative effects have been attributed to different loading conditions. In order to study mechanical loading effects, degeneration-associated processes and/or potential regenerative therapies in IVDs, it is imperative to maintain the IVDs' structural integrity. While in vivo models provide comprehensive insight in IVD biology, an accompanying organ culture model can focus on a single factor, such as loading and may serve as a prescreening model to reduce life animal testing. In the current study we examined the feasibility of organ culture of caprine lumbar discs, with the hypothesis that a simulated-physiological load will optimally preserve IVD properties. Lumbar caprine IVDs (n = 175) were cultured in a bioreactor up to 21 days either without load, low dynamic load (LDL), or with simulated-physiological load (SPL). IVD stiffness was calculated from measurements of IVD loading and displacement. IVD nucleus, inner-and outer annulus were assessed for cell viability, cell density and gene expression. The extracellular matrix (ECM) was analyzed for water, glycosaminoglycan and total collagen content. IVD biomechanical properties did not change significantly with loading conditions. With SPL, cell viability, cell density and gene expression were preserved up to 21 days. Both unloaded and LDL resulted in decreased cell viability, cell density and significant changes in gene expression, yet no differences in ECM content were observed in any group. In conclusion, simulated-physiological loading preserved the native properties of caprine IVDs during a 21-day culture period. The characterization of caprine IVD response to culture in the LDCS under SPL conditions paves the way for controlled analysis of degeneration-and regeneration-associated processes in the future.	[Paul, Cornelis P. L.; Zuiderbaan, Hendrik A.; Doulabi, Behrouz Zandieh; van der Veen, Albert J.; Smit, Theo H.; Helder, Marco N.; van Royen, Barend J.; Mullender, Margriet G.] Vrije Univ Amsterdam, Med Ctr, Dept Orthoped Surg, Amsterdam, Netherlands; [Paul, Cornelis P. L.; Smit, Theo H.; Helder, Marco N.; van Royen, Barend J.; Mullender, Margriet G.] Vrije Univ Amsterdam, Med Ctr, Res Inst MOVE, Amsterdam, Netherlands; [Doulabi, Behrouz Zandieh] Acad Ctr Dent Amsterdam, Fac Oral Cell Biol, NL-1066 EA Amsterdam, Netherlands; [van der Veen, Albert J.] Vrije Univ Amsterdam, Med Ctr, Dept Phys & Med Technol, Amsterdam, Netherlands; [van de Ven, Peter M.] Vrije Univ Amsterdam, Med Ctr, Dept Epidemiol & Biostatist, Amsterdam, Netherlands; [Smit, Theo H.; Helder, Marco N.; van Royen, Barend J.; Mullender, Margriet G.] Vrije Univ Amsterdam, Med Ctr, Skeletal Tissue Engn Grp Amsterdam, Amsterdam, Netherlands; [Mullender, Margriet G.] Vrije Univ Amsterdam, Med Ctr, Dept Plast Reconstruct & Hand Surg, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Academic Center for Dentistry Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Paul, CPL (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Orthoped Surg, Amsterdam, Netherlands.	m.mullender@vumc.nl	Smit, Theo/N-7534-2019; van Royen, Barend/W-4864-2019; Paul/O-8870-2017; Mullender, Margriet/H-7756-2012; Smit, Theodoor/AAX-6657-2020	Smit, Theo/0000-0002-8906-7433; van Royen, Barend/0000-0002-6548-7214; Zandieh Doulabi, Behrouz/0000-0002-0290-3241	Dutch Government ZonMw [11400090]	Dutch Government ZonMw	This work is supported by the Dutch Government ZonMw Program "Alternatives for life animal testing'' (grant number 11400090). The development of the LDCS is supported by the Government led consortium for the development of BioMedical Materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MA, 2000, SPINE, V25, P1625, DOI 10.1097/00007632-200007010-00005; Adams MA, 2006, BIORHEOLOGY, V43, P537; Adams MA, 2006, SPINE, V31, P2151, DOI 10.1097/01.brs.0000231761.73859.2c; Adams MA, 2009, MATRIX BIOL, V28, P384, DOI 10.1016/j.matbio.2009.06.004; Ala-Kokko L, 2002, ANN MED, V34, P42, DOI 10.1080/078538902317338634; Alini M, 2008, EUR SPINE J, V17, P2, DOI 10.1007/s00586-007-0414-y; Battie MC, 2006, J BONE JOINT SURG AM, V88A, P3, DOI 10.2106/JBJS.E.01313; Battie MC, 2009, SPINE J, V9, P47, DOI 10.1016/j.spinee.2008.11.011; Beckstein JC, 2008, SPINE, V33, pE166, DOI 10.1097/BRS.0b013e318166e001; Berman BM, 2010, NEW ENGL J MED, V363, P454, DOI 10.1056/NEJMct0806114; Bibby SRS, 2005, SPINE, V30, P487, DOI 10.1097/01.brs.0000154619.38122.47; Brisby H, 2006, J BONE JOINT SURG AM, V88A, P68, DOI 10.2106/JBJS.E.01282; BUCKWALTER JA, 1995, SPINE, V20, P1307, DOI 10.1097/00007632-199506000-00022; Chen J, 2002, BIOCHEM BIOPH RES CO, V293, P932, DOI 10.1016/S0006-291X(02)00314-5; Cheung KMC, 2009, SPINE, V34, P934, DOI 10.1097/BRS.0b013e3181a01b3f; Dehne T, 2010, GENE, V462, P8, DOI 10.1016/j.gene.2010.04.006; Dormans K. W., 2004, P 14 EUR SOC BIOM ES, P224; Elder BD, 2009, TISSUE ENG PART B-RE, V15, P43, DOI 10.1089/ten.teb.2008.0435; Freemont AJ, 2009, RHEUMATOLOGY, V48, P5, DOI 10.1093/rheumatology/ken396; Gantenbein B, 2006, SPINE, V31, P2665, DOI 10.1097/01.brs.0000244620.15386.df; Gawri R, 2011, SPINE, V36, P1835, DOI 10.1097/BRS.0b013e3181f81314; Hancock MJ, 2010, SPINE, V35, P1925, DOI 10.1097/BRS.0b013e3181d60598; Haschtmann D, 2008, EUR SPINE J, V17, P289, DOI 10.1007/s00586-007-0509-5; Haschtmann D, 2006, SPINE, V31, P2918, DOI 10.1097/01.brs.0000247954.69438.ae; Haschtmann D, 2006, J ORTHOP RES, V24, P1957, DOI 10.1002/jor.20243; Hoogendoorn R, 2008, SPINE, V33, P1714, DOI 10.1097/BRS.0b013e31817d2468; Iatridis JC, 2006, J BONE JOINT SURG AM, V88A, P41, DOI 10.2106/JBJS.E.01407; Ishihara H, 1997, AM J PHYSIOL-CELL PH, V272, pC1499; Jim B, 2011, EUR SPINE J, V20, P1244, DOI 10.1007/s00586-011-1721-x; Johnson WEB, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2405; Junger S, 2009, SPINE, V34, P1264, DOI 10.1097/BRS.0b013e3181a0193d; Kalichman L, 2008, JOINT BONE SPINE, V75, P388, DOI 10.1016/j.jbspin.2007.11.002; Kalichman L, 2008, JOINT BONE SPINE, V75, P383, DOI 10.1016/j.jbspin.2007.11.003; Katz JN, 2006, J BONE JOINT SURG AM, V88A, P21, DOI 10.2106/JBJS.E.01273; Kauppila LI, 2009, EUR J VASC ENDOVASC, V37, P661, DOI 10.1016/j.ejvs.2009.02.006; Korecki CL, 2007, EUR SPINE J, V16, P1029, DOI 10.1007/s00586-007-0327-9; Le Maitre CL, 2009, J TISSUE ENG REGEN M, V3, P461, DOI 10.1002/term.180; Lee CR, 2006, SPINE, V31, P515, DOI 10.1097/01.brs.0000201302.59050.72; Lee CR, 2005, ANAL BIOCHEM, V341, P372, DOI 10.1016/j.ab.2004.10.005; Lin CWC, 2011, EUR SPINE J, V20, P1012, DOI 10.1007/s00586-010-1675-4; Lin Z, 2008, J ORTHOP RES, V26, P1230, DOI 10.1002/jor.20523; Lotz JC, 2000, SPINE, V25, P1477, DOI 10.1097/00007632-200006150-00005; Lotz JC, 2004, SPINE, V29, P2742, DOI 10.1097/01.brs.0000146498.04628.f9; Luoma K, 2000, SPINE, V25, P487, DOI 10.1097/00007632-200002150-00016; Luoma K, 2009, SKELETAL RADIOL, V38, P237, DOI 10.1007/s00256-008-0611-8; MacLean JJ, 2007, J BIOMECH, V40, P55, DOI 10.1016/j.jbiomech.2005.11.013; MacLean JJ, 2005, J ORTHOP RES, V23, P1120, DOI 10.1016/j.orthres.2005.01.020; Magnier C, 2009, J BIOMECH, V42, P100, DOI 10.1016/j.jbiomech.2008.10.034; Marinelli NL, 2010, AM J NEURORADIOL, V31, P1278, DOI 10.3174/ajnr.A2080; Mwale F, 2011, SPINE, V36, pE131, DOI 10.1097/BRS.0b013e3181d52b9e; Neidlinger-Wilke C, 2009, SPINE, V34, P663, DOI 10.1097/BRS.0b013e318194e20c; Paassilta P, 2001, JAMA-J AM MED ASSOC, V285, P1843, DOI 10.1001/jama.285.14.1843; Rannou F, 2004, AM J PATHOL, V164, P915, DOI 10.1016/S0002-9440(10)63179-3; Risbud MV, 2010, DEV DYNAM, V239, P2141, DOI 10.1002/dvdy.22350; Roelofs PDDM, 2008, SPINE, V33, P1766, DOI 10.1097/BRS.0b013e31817e69d3; Roughley PJ, 2002, BIOCHEM SOC T, V30, P869, DOI 10.1042/BST0300869; Schizas C, 2010, EUR CELLS MATER, V20, P306; Setton LA, 2006, J BONE JOINT SURG AM, V88A, P52, DOI 10.2106/JBJS.F.00001; Shirazi-Adl A, 2010, J BIOMECH, V43, P1330, DOI 10.1016/j.jbiomech.2010.01.023; Stokes IAF, 2004, SPINE, V29, P2724, DOI 10.1097/01.brs.0000146049.52152.da; Strobel S, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2942; Torzilli PA, 2010, OSTEOARTHR CARTILAGE, V18, P97, DOI 10.1016/j.joca.2009.07.012; van den Eerenbeemt KD, 2010, EUR SPINE J, V19, P1262, DOI 10.1007/s00586-010-1445-3; van der Veen AJ, 2007, J BIOMECH, V40, P2230, DOI 10.1016/j.jbiomech.2006.10.018; van der Veen AJ, 2008, J BIOMECH, V41, P1260, DOI 10.1016/j.jbiomech.2008.01.010; Vonk LA, 2010, MATRIX BIOL, V29, P209, DOI 10.1016/j.matbio.2009.12.001; Vonk LA, 2010, J CELL BIOCHEM, V110, P260, DOI 10.1002/jcb.22533; Walsh AJL, 2004, J BIOMECH, V37, P329, DOI 10.1016/S0021-9290(03)00290-2	68	67	70	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2012	7	3							e33147	10.1371/journal.pone.0033147	http://dx.doi.org/10.1371/journal.pone.0033147			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930IA	22427972	Green Published, gold, Green Submitted			2022-12-25	WOS:000303129700034
J	Sanchis-Moysi, J; Idoate, F; Serrano-Sanchez, JA; Dorado, C; Calbet, JAL				Sanchis-Moysi, Joaquin; Idoate, Fernando; Serrano-Sanchez, Jose A.; Dorado, Cecilia; Calbet, Jose A. L.			Muscle Hypertrophy in Prepubescent Tennis Players: A Segmentation MRI Study	PLOS ONE			English	Article							UPPER EXTREMITY; ELBOW FUNCTION; STRENGTH; CHILDREN; VOLUMES; FOREARM; ACTIVATION; KINEMATICS; ANATOMY; MASS	Purpose: To asses if tennis at prepubertal age elicits the hypertrophy of dominant arm muscles. Methods: The volume of the muscles of both arms was determined using magnetic resonance imaging (MRI) in 7 male prepubertal tennis players (TP) and 7 non-active control subjects (CG) (mean age 11.0 +/- 0.8 years, Tanner 1-2). Results: TP had 13% greater total muscle volume in the dominant than in the contralateral arm. The magnitude of inter-arm asymmetry was greater in TP than in CG (13 vs 3%, P<0.001). The dominant arm of TP was 16% greater than the dominant arm of CG (P<0.01), whilst non-dominant arms had similar total muscle volumes in both groups (P = 0.25), after accounting for height as covariate. In TP, dominant deltoid (11%), forearm supinator (55%) and forearm flexors (21%) and extensors (25%) were hypertrophied compared to the contralateral arm (P<0.05). In CG, the dominant supinator muscle was bigger than its contralateral homonimous (63%, P<0.05). Conclusions: Tennis at prepubertal age is associated with marked hypertrophy of the dominant arm, leading to a marked level of asymmetry (+13%), much greater than observed in non-active controls (+3%). Therefore, tennis particpation at prepubertal age is associated with increased muscle volumes in dominant compared to the non-dominant arm, likely due to selectively hypertrophy of the loaded muscles.	[Sanchis-Moysi, Joaquin; Serrano-Sanchez, Jose A.; Dorado, Cecilia; Calbet, Jose A. L.] Univ Las Palmas Gran Canaria, Dept Phys Educ, Las Palmas Gran Canaria, Spain; [Idoate, Fernando] Clin San Miguel, Dept Radiol, Pamplona, Spain	Universidad de Las Palmas de Gran Canaria	Sanchis-Moysi, J (corresponding author), Univ Las Palmas Gran Canaria, Dept Phys Educ, Las Palmas Gran Canaria, Spain.	jsanchis@def.ulpgc.es	SANCHIS-MOYSI, JOAQUIN/H-7017-2015; Serrano-Sanchez, Jose A/L-3691-2014; Idoate Saralegui, Fernando/K-7485-2013; Cecilia, Dorado-Garcia/B-4586-2010; Dorado García, Cecilia/ABC-2792-2021; Sanchis-Moysi, Joaquin/B-5561-2012; Calbet, Jose A L/H-6693-2015	SANCHIS-MOYSI, JOAQUIN/0000-0001-6602-7087; Serrano-Sanchez, Jose A/0000-0002-4868-8751; Idoate Saralegui, Fernando/0000-0001-5600-6055; Cecilia, Dorado-Garcia/0000-0001-6616-6810; Calbet, Jose A L/0000-0002-9215-6234; antunez, Ariel/0000-0002-2548-7885	Real Madrid - Universidad Europea de Madrid Research Chair [2009/04RM]; Ministerio de Ciencia e Innovacion [DEP2010-21866]	Real Madrid - Universidad Europea de Madrid Research Chair; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This study was granted by Real Madrid - Universidad Europea de Madrid Research Chair (2009/04RM) and Ministerio de Ciencia e Innovacion (DEP2010-21866). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2000, EUR J APPL PHYSIOL O, V81, P174, DOI 10.1007/s004210050027; Bancroft LW, 2007, SEMIN MUSCULOSKEL R, V11, P16, DOI 10.1055/s-2007-984410; BENKIBLER W, 1988, CLIN SPORT MED, V7, P403; BLACKWELL JR, 1994, J BIOMECH, V27, P509, DOI 10.1016/0021-9290(94)90062-0; Boles CA, 2000, AM J ROENTGENOL, V174, P151, DOI 10.2214/ajr.174.1.1740151; Calbet JAL, 1998, CALCIFIED TISSUE INT, V62, P491, DOI 10.1007/s002239900467; CHINN CJ, 1974, PHYS THER, V54, P474, DOI 10.1093/ptj/54.5.474; Chow JW, 1999, MED SCI SPORT EXER, V31, P846, DOI 10.1097/00005768-199906000-00013; Cools AM, 2008, BRIT J SPORT MED, V42, P165, DOI 10.1136/bjsm.2007.036830; Daly RM, 2004, BONE, V34, P281, DOI 10.1016/j.bone.2003.11.009; DUKE PM, 1980, PEDIATRICS, V66, P918; Elliot BC, 2002, TENNIS, P1; Faigenbaum AD, 2010, BRIT J SPORT MED, V44, P56, DOI 10.1136/bjsm.2009.068098; Fry NR, 2007, J PEDIATR ORTHOPED, V27, P769, DOI 10.1097/BPO.0b013e3181558943; Fukunaga Tetsuo, 1992, Annals of Physiological Anthropology, V11, P357; GIANGARRA CE, 1993, AM J SPORT MED, V21, P394, DOI 10.1177/036354659302100312; Gjovaag TF, 2009, MED SCI SPORT EXER, V41, P129, DOI 10.1249/MSS.0b013e3181844e42; Granacher U, 2011, INT J SPORTS MED, V32, P357, DOI 10.1055/s-0031-1271677; HATHER BM, 1991, ACTA PHYSIOL SCAND, V143, P177, DOI 10.1111/j.1748-1716.1991.tb09219.x; HENNIG EM, 1992, MED SCI SPORT EXER, V24, P1134; Holzbaur KRS, 2007, J BIOMECH, V40, P742, DOI 10.1016/j.jbiomech.2006.11.011; Hoshikawa Y, J PHYSL ANTHR, V30, P47; Kibler W, 1995, ADV OPER ORTHOP, P249; Knudson D, 1997, INT J SPORTS MED, V18, P79, DOI 10.1055/s-2007-972599; Lampe R, 2006, BRAIN DEV-JPN, V28, P500, DOI 10.1016/j.braindev.2006.02.009; Lee RC, 2000, AM J CLIN NUTR, V72, P796, DOI 10.1093/ajcn/72.3.796; Mavidis A, 2007, J SPORT SCI, V25, P1501, DOI 10.1080/02640410701213442; McNee AE, 2009, DEV MED CHILD NEUROL, V51, P429, DOI 10.1111/j.1469-8749.2008.03230.x; MORRIS M, 1989, AM J SPORT MED, V17, P241, DOI 10.1177/036354658901700215; Priest J D, 1976, Am J Sports Med, V4, P28; RAMSAY JA, 1990, MED SCI SPORT EXER, V22, P605, DOI 10.1249/00005768-199010000-00011; Renstrom P, 2002, TENNIS, P233; Sanchis-Moysi J, 2010, INT J SPORTS MED, V31, P416, DOI 10.1055/s-0030-1248331; Sanchis-Moysi J, 2010, SCAND J MED SCI SPOR, V20, P524, DOI 10.1111/j.1600-0838.2009.00969.x; Sanchis-Moysi J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015858; Sanchis-Moysi J, 2010, EUR J APPL PHYSIOL, V110, P83, DOI 10.1007/s00421-010-1470-2; Small EW, 2008, PEDIATRICS, V121, P835, DOI 10.1542/peds.2007-3790; Stackhouse SK, 2005, MUSCLE NERVE, V31, P594, DOI 10.1002/mus.20302; STRIZAK AM, 1983, AM J SPORT MED, V11, P234, DOI 10.1177/036354658301100410; Wei SH, 2006, CLIN J SPORT MED, V16, P129, DOI 10.1097/00042752-200603000-00008; Wiley ME, 1998, DEV MED CHILD NEUROL, V40, P100, DOI 10.1111/j.1469-8749.1998.tb15369.x	41	21	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2012	7	3							e33622	10.1371/journal.pone.0033622	http://dx.doi.org/10.1371/journal.pone.0033622			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930IA	22428074	Green Submitted, Green Published, gold			2022-12-25	WOS:000303129700071
J	Bionaz, M; Periasamy, K; Rodriguez-Zas, SL; Everts, RE; Lewin, HA; Hurley, WL; Loor, JJ				Bionaz, Massimo; Periasamy, Kathiravan; Rodriguez-Zas, Sandra L.; Everts, Robin E.; Lewin, Harris A.; Hurley, Walter L.; Loor, Juan J.			Old and New Stories: Revelations from Functional Analysis of the Bovine Mammary Transcriptome during the Lactation Cycle	PLOS ONE			English	Article							CLASS-II ANTIGENS; GENE-EXPRESSION; DAIRY-COWS; CELL-PROLIFERATION; AMINO-ACID; GLAND DEVELOPMENT; MILK-PRODUCTION; BLOOD-FLOW; PROTEIN; SYNAPTOTAGMIN	The cow mammary transcriptome was explored at 230, 215, 1, 15, 30, 60, 120, 240, and 300 d relative to parturition. A total of 6,382 differentially expressed genes (DEG) at a false discovery rate <= 0.001 were found throughout lactation. The greatest number of DEG (>3,500 DEG) was observed at 60 and 120 d vs. -30 d with the largest change between consecutive time points observed at -15 vs. 1 d and 120 vs. 240 d. Functional analysis of microarray data was performed using the Dynamic Impact Approach (DIA). The DIA analysis of KEGG pathways uncovered as the most impacted and induced 'Galactose metabolism', 'Glycosylphosphatidylinositol (GPI)-anchor biosynthesis', and 'PPAR signaling'; whereas, 'Antigen processing and presentation' was among the most inhibited. The integrated interpretation of the results suggested an overall increase in metabolism during lactation, particularly synthesis of carbohydrates and lipid. A marked degree of utilization of amino acids as energy source, an increase of protein export, and a decrease of the protein synthesis machinery as well cell cycle also were suggested by the DIA analysis. The DIA analysis of Gene Ontology and other databases uncovered an induction of Golgi apparatus and angiogenesis, and the inhibition of both immune cell activity/migration and chromosome modifications during lactation. All of the highly-impacted and activated functions during lactation were evidently activated at the onset of lactation and inhibited when milk production declined. The overall analysis indicated that the bovine mammary gland relies heavily on a coordinated transcriptional regulation to begin and end lactation. The functional analysis using DIA underscored the importance of genes associated with lactose synthesis, lipid metabolism, protein synthesis, Golgi, transport, cell cycle/death, epigenetic regulation, angiogenesis, and immune function during lactation.	[Bionaz, Massimo; Periasamy, Kathiravan; Rodriguez-Zas, Sandra L.; Everts, Robin E.; Lewin, Harris A.; Hurley, Walter L.; Loor, Juan J.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Bionaz, Massimo; Rodriguez-Zas, Sandra L.; Lewin, Harris A.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Periasamy, Kathiravan] IAEA, Seibersdorf Labs Joint FAO IAEA, Anim Prod & Hlth Sect, Div Nucl Tech Food & Agr, A-1400 Vienna, Austria; [Loor, Juan J.] Univ Illinois, Div Nutr Sci, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; International Atomic Energy Agency; University of Illinois System; University of Illinois Urbana-Champaign	Bionaz, M (corresponding author), Univ Illinois, Dept Anim Sci, 328 Mumford Hall, Urbana, IL 61801 USA.	massimobionaz@hotmail.edu; jloor@illinois.edu	Loor, Juan J./H-3760-2012; LEWIN, HARRIS/HGC-6543-2022; Bionaz, Massimo/I-4222-2018	Loor, Juan J./0000-0003-1586-4365; LEWIN, HARRIS/0000-0002-1043-7287; Bionaz, Massimo/0000-0002-0674-1892; Rodriguez-Zas, Sandra/0000-0003-1122-4758	Cooperative State Research, Education, and Extension Service, United States Department of Agriculture [ILLU-538-307, ILLU-538-391]; Department of Science and Technology, Govemment of India; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068946] Funding Source: NIH RePORTER	Cooperative State Research, Education, and Extension Service, United States Department of Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Department of Science and Technology, Govemment of India(Department of Science & Technology (India)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for the gene expression and bioinformatics analysis was provided by the Cooperative State Research, Education, and Extension Service, United States Department of Agriculture, under Hatch projects ILLU-538-307 and ILLU-538-391 (both to JJL). A BOYSCAST Fellowship, Department of Science and Technology, Govemment of India, provided financial support for KP. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Rojas A, 2009, ONCOL REP, V22, P981, DOI 10.3892/or_00000525; Alford D, 1996, J MAMMARY GLAND BIOL, V1, P207, DOI 10.1007/BF02013644; Bar D, 2008, J DAIRY SCI, V91, P2205, DOI 10.3168/jds.2007-0573; Bauman DE, 2006, J DAIRY SCI, V89, P1235, DOI 10.3168/jds.S0022-0302(06)72192-0; BAUMRUCKER CR, 1985, J DAIRY SCI, V68, P2436, DOI 10.3168/jds.S0022-0302(85)81119-X; Benjamini Y, 1995, J ROY STAT SOC, V57, P289; Bequette BJ, 1998, J DAIRY SCI, V81, P2540, DOI 10.3168/jds.S0022-0302(98)70147-X; Bionaz M, 2007, PHYSIOL GENOMICS, V29, P312, DOI 10.1152/physiolgenomics.00223.2006; Bionaz M, 2011, BIOINFORM BIOL INSIG, V5, P83, DOI 10.4137/BBI.S7003; Bionaz M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-366; Callahan R, 2004, J MAMMARY GLAND BIOL, V9, P145, DOI 10.1023/B:JOMG.0000037159.63644.81; Capuco AV, 2003, J ANIM SCI, V81, P18; Capuco AV, 2001, J DAIRY SCI, V84, P2177, DOI 10.3168/jds.S0022-0302(01)74664-4; Chatterjee S, 2001, CELL MOL LIFE SCI, V58, P1969, DOI 10.1007/PL00000831; Clarkson RWE, 2004, BREAST CANCER RES, V6, pR92, DOI 10.1186/bcr754; DAVIS CL, 1983, BIOCH LACTATION, P3; Delehedde M, 2001, J MAMMARY GLAND BIOL, V6, P253, DOI 10.1023/A:1011367423085; DEPETERS EJ, 1992, J DAIRY SCI, V75, P2043, DOI 10.3168/jds.S0022-0302(92)77964-8; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Finucane KA, 2008, FUNCT INTEGR GENOMIC, V8, P251, DOI 10.1007/s10142-008-0074-y; FITZPATRICK JL, 1994, J DAIRY SCI, V77, P2940, DOI 10.3168/jds.S0022-0302(94)77235-0; FITZPATRICK JL, 1993, IMMUNOL LETT, V35, P7, DOI 10.1016/0165-2478(93)90140-W; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; GIBBONS GF, 1983, BIOCHEM J, V212, P843, DOI 10.1042/bj2120843; Gotze A, 2010, J DAIRY SCI, V93, P38, DOI 10.3168/jds.2008-1781; GROSVENOR C E, 1974, P227; GROSVENOR CE, 1993, ENDOCR REV, V14, P710, DOI 10.1210/edrv-14-6-710; KELLER JM, 1993, BIOL CELL, V77, P77, DOI 10.1016/S0248-4900(05)80177-7; Kunz C, 1998, ANN NUTR METAB, V42, P189, DOI 10.1159/000012732; Lemay DG, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-56; Lewis MT, 2004, J MAMMARY GLAND BIOL, V9, P165, DOI 10.1023/B:JOMG.0000037160.24731.35; Lindau M, 2003, J GEN PHYSIOL, V122, P251, DOI 10.1085/jgp.200308909; Linzell J.L., 1974, LACTATION, V1, P143; Liu F, 2003, FRONT BIOSCI-LANDMRK, V8, pS1280, DOI 10.2741/1149; LONG CA, 1980, LIPIDS, V15, P853, DOI 10.1007/BF02534376; Loor JJ, 2007, PHYSIOL GENOMICS, V32, P105, DOI 10.1152/physiolgenomics.00188.2007; Loor JJ, 2011, J MAMMARY GLAND BIOL, V16, P305, DOI 10.1007/s10911-011-9232-2; Mani O, 2010, AM J PHYSIOL-REG I, V299, pR642, DOI 10.1152/ajpregu.00723.2009; Mather I. H., 1983, Biochemistry of lactation, P231; MEPHAM TB, 1982, J DAIRY SCI, V65, P287, DOI 10.3168/jds.S0022-0302(82)82191-7; Mepham TB, 1983, PHYSL ASPECT LACTATI, P3; Mepham TB, 1987, PHYSL LACTATION, pxvi; Mercier J-C, 1983, BIOCH LACTATION, P177; MILLER PS, 1991, J DAIRY SCI, V74, P3791, DOI 10.3168/jds.S0022-0302(91)78571-8; Moyes KM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-542; NEWBURG DS, 1992, LIPIDS, V27, P923, DOI 10.1007/BF02535874; Nguyen DAD, 1998, J MAMMARY GLAND BIOL, V3, P233, DOI 10.1023/A:1018707309361; Norgaard JV, 2008, J DAIRY SCI, V91, P2319, DOI 10.3168/jds.2007-0767; Orlean P, 2007, J LIPID RES, V48, P993, DOI 10.1194/jlr.R700002-JLR200; Paulsson KM, 2004, CELL MOL LIFE SCI, V61, P2446, DOI 10.1007/s00018-004-4113-0; Pedrioli PGA, 2008, EMBO REP, V9, P1196, DOI 10.1038/embor.2008.209; Pitelka D. R., 1983, Biochemistry of lactation, P29; Prosser CG, 1996, J DAIRY SCI, V79, P1184, DOI 10.3168/jds.S0022-0302(96)76472-X; Purup S, 2007, J DAIRY RES, V74, P58, DOI 10.1017/S0022029906002093; Rauw WM, 1998, LIVEST PROD SCI, V56, P15, DOI 10.1016/S0301-6226(98)00147-X; Rizo J, 2006, TRENDS CELL BIOL, V16, P339, DOI 10.1016/j.tcb.2006.04.006; Rudolph MC, 2003, J MAMMARY GLAND BIOL, V8, P287, DOI 10.1023/B:JOMG.0000010030.73983.57; Rupp R, 2003, VET RES, V34, P671, DOI 10.1051/vetres:2003020; Schwartz YB, 2008, CURR OPIN CELL BIOL, V20, P266, DOI 10.1016/j.ceb.2008.03.002; SEELIG LL, 1980, BIOL REPROD, V22, P1211, DOI 10.1093/biolreprod/22.5.1211; Shennan DB, 2000, PHYSIOL REV, V80, P925, DOI 10.1152/physrev.2000.80.3.925; Singh K, 2010, J MAMMARY GLAND BIOL, V15, P101, DOI 10.1007/s10911-010-9164-2; Sladek Z, 2006, ANAT HISTOL EMBRYOL, V35, P116, DOI 10.1111/j.1439-0264.2005.00647.x; Sonnino S, 2007, GLYCOBIOLOGY, V17, p1R, DOI 10.1093/glycob/cwl052; Sreenath AS, 2005, CLIN BIOCHEM, V38, P436, DOI 10.1016/j.clinbiochem.2005.01.009; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Tao N, 2008, J DAIRY SCI, V91, P3768, DOI 10.3168/jds.2008-1305; Tao N, 2009, J DAIRY SCI, V92, P2991, DOI 10.3168/jds.2008-1642; VanHouten JN, 2005, J MAMMARY GLAND BIOL, V10, P129, DOI 10.1007/s10911-005-5396-y; Vorbach C, 2006, BIOESSAYS, V28, P606, DOI 10.1002/bies.20423; Wappelhorst O, 2002, NUTRITION, V18, P316, DOI 10.1016/S0899-9007(01)00798-5; Wickramasinghe S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018895; Wiley AS, 2007, ECOL FOOD NUTR, V46, P281, DOI 10.1080/03670240701407657; Woodward WA, 2005, J CELL SCI, V118, P3585, DOI 10.1242/jcs.02532; Zarzynska J, 2008, J PHYSIOL PHARMACOL, V59, P275	75	96	100	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33268	10.1371/journal.pone.0033268	http://dx.doi.org/10.1371/journal.pone.0033268			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22428004	Green Published, gold, Green Submitted			2022-12-25	WOS:000302381500117
J	Bongrand, C; Sansonetti, PJ; Parsot, C				Bongrand, Clotilde; Sansonetti, Philippe J.; Parsot, Claude			Characterization of the Promoter, MxiE Box and 5 ' UTR of Genes Controlled by the Activity of the Type III Secretion Apparatus in Shigella flexneri	PLOS ONE			English	Article							MESSENGER-RNA; UNTRANSLATED REGION; VIRULENCE GENE; STEM-LOOP; PLASMID; TRANSCRIPTION; EXPRESSION; IPAB; PROTEINS; SYSTEM	Activation of the type III secretion apparatus (T3SA) of Shigella flexneri, upon contact of the bacteria with host cells, and its deregulation, as in ipaB mutants, specifically increases transcription of a set of effector-encoding genes controlled by MxiE, an activator of the AraC family, and IpgC, the chaperone of the IpaB and IpaC translocators. Thirteen genes carried by the virulence plasmid (ospB, ospC1, ospD2, ospD3, ospE1, ospE2, ospF, ospG, virA, ipaH1.4, ipaH4.5, ipaH7.8 and ipaH9.8) and five genes carried by the chromosome (ipaHa-e) are regulated by the T3SA activity. A conserved 17-bp MxiE box is present 5' of most of these genes. To characterize the promoter activity of these MxiE box-containing regions, similar similar to 67-bp DNA fragments encompassing the MxiE box of 14 MxiE-regulated genes were cloned 59 of lacZ in a promoter probe plasmid; beta-galactosidase activity detected in wild-type and ipaB strains harboring these plasmids indicated that most MxiE box-carrying regions contain a promoter regulated by the T3SA activity and that the relative strengths of these promoters cover an eightfold range. The various MxiE boxes exhibiting up to three differences as compared to the MxiE box consensus sequence were introduced into the ipaH9.8 promoter without affecting its activity, suggesting that they are equally efficient in promoter activation. In contrast, all nucleotides conserved among MxiE boxes were found to be involved in MxiE-dependent promoter activity. In addition, we present evidence that the 59 UTRs of four MxiE-regulated genes enhance expression of the downstream gene, presumably by preventing degradation of the mRNA, and the 59 UTRs of two other genes carry an ancillary promoter.	[Bongrand, Clotilde; Sansonetti, Philippe J.; Parsot, Claude] Inst Pasteur, Unite Pathogenie Microbienne Mol, Paris, France; [Bongrand, Clotilde; Sansonetti, Philippe J.; Parsot, Claude] INSERM, U786, Paris, France; [Bongrand, Clotilde] Univ Paris Diderot, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Bongrand, C (corresponding author), Inst Pasteur, Unite Pathogenie Microbienne Mol, Paris, France.	claude.parsot@pasteur.fr		Bongrand, Clotilde/0000-0003-0775-641X	Institut Pasteur [024009]	Institut Pasteur(European Commission)	This work was fully supported by the Institut Pasteur (account 024009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER B, 1989, MOL MICROBIOL, V3, P627, DOI 10.1111/j.1365-2958.1989.tb00210.x; ALLAOUI A, 1992, MOL MICROBIOL, V6, P1605, DOI 10.1111/j.1365-2958.1992.tb00885.x; ALLAOUI A, 1993, MOL MICROBIOL, V7, P59, DOI 10.1111/j.1365-2958.1993.tb01097.x; Ashida H, 2007, MOL MICROBIOL, V63, P680, DOI 10.1111/j.1365-2958.2006.05547.x; Ashida H, 2009, CURR TOP MICROBIOL, V337, P231, DOI 10.1007/978-3-642-01846-6_8; Bahrani FK, 1997, INFECT IMMUN, V65, P4005, DOI 10.1128/IAI.65.10.4005-4010.1997; Blocker A, 1999, J CELL BIOL, V147, P683, DOI 10.1083/jcb.147.3.683; Bricker AL, 1999, J BACTERIOL, V181, P3587, DOI 10.1128/JB.181.11.3587-3590.1999; Brutinel ED, 2008, CURR OPIN MICROBIOL, V11, P128, DOI 10.1016/j.mib.2008.02.010; Buchrieser C, 2000, MOL MICROBIOL, V38, P760, DOI 10.1046/j.1365-2958.2000.02179.x; Buysse JM, 1995, MICROB PATHOGENESIS, V19, P335, DOI 10.1016/S0882-4010(96)80005-2; CHEN LH, 1991, J BACTERIOL, V173, P4578, DOI 10.1128/jb.173.15.4578-4586.1991; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Demers B, 1998, EMBO J, V17, P2894, DOI 10.1093/emboj/17.10.2894; Dorman CJ, 2001, INT J MED MICROBIOL, V291, P89, DOI 10.1078/1438-4221-00105; EMORY SA, 1992, GENE DEV, V6, P135, DOI 10.1101/gad.6.1.135; FARINHA MA, 1990, J BACTERIOL, V172, P3496, DOI 10.1128/jb.172.6.3496-3499.1990; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Jin Q, 2002, NUCLEIC ACIDS RES, V30, P4432, DOI 10.1093/nar/gkf566; Kane CD, 2002, J BACTERIOL, V184, P4409, DOI 10.1128/JB.184.16.4409-4419.2002; Kim DW, 2005, P NATL ACAD SCI USA, V102, P14046, DOI 10.1073/pnas.0504466102; Le Gall T, 2005, MICROBIOL-SGM, V151, P951, DOI 10.1099/mic.0.27639-0; Loh E, 2006, TRENDS MICROBIOL, V14, P294, DOI 10.1016/j.tim.2006.05.001; Mathews David H, 2007, Curr Protoc Nucleic Acid Chem, VChapter 11, DOI 10.1002/0471142700.nc1102s28; Mavris M, 2002, J BACTERIOL, V184, P6751, DOI 10.1128/JB.184.24.6751-6759.2002; Mavris M, 2002, MOL MICROBIOL, V43, P1543, DOI 10.1046/j.1365-2958.2002.02836.x; MENARD R, 1993, J BACTERIOL, V175, P5899; MENARD R, 1994, CELL, V79, P515, DOI 10.1016/0092-8674(94)90260-7; MENARD R, 1994, EMBO J, V13, P5293, DOI 10.1002/j.1460-2075.1994.tb06863.x; Miller VL, 2002, CURR OPIN MICROBIOL, V5, P211, DOI 10.1016/S1369-5274(02)00303-X; Parsot C, 2005, MOL MICROBIOL, V56, P1627, DOI 10.1111/j.1365-2958.2005.04645.x; Parsot C, 2005, FEMS MICROBIOL LETT, V252, P11, DOI 10.1016/j.femsle.2005.08.046; Penno C, 2005, MOL MICROBIOL, V56, P204, DOI 10.1111/j.1365-2958.2004.04530.x; Pilonieta MC, 2008, J BACTERIOL, V190, P2249, DOI 10.1128/JB.01824-07; PLATT T, 1972, P NATL ACAD SCI USA, V69, P897, DOI 10.1073/pnas.69.4.897; SANSONETTI PJ, 1982, INFECT IMMUN, V35, P852, DOI 10.1128/IAI.35.3.852-860.1982; Shen A, 2005, MOL MICROBIOL, V57, P1460, DOI 10.1111/j.1365-2958.2005.04780.x; Stritzker J, 2005, J BACTERIOL, V187, P2836, DOI 10.1128/JB.187.8.2836-2845.2005; Wong KKY, 2004, CELL MICROBIOL, V6, P155, DOI 10.1046/j.1462-5822.2003.00348.x	39	24	24	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e32862	10.1371/journal.pone.0032862	http://dx.doi.org/10.1371/journal.pone.0032862			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427898	Green Published, gold, Green Submitted			2022-12-25	WOS:000302381500057
J	Browne, CJ; Morley, JW; Parsons, CH				Browne, Cherylea J.; Morley, John W.; Parsons, Carl H.			Tracking the Expression of Excitatory and Inhibitory Neurotransmission-Related Proteins and Neuroplasticity Markers after Noise Induced Hearing Loss	PLOS ONE			English	Article							AUDITORY BRAIN-STEM; DORSAL COCHLEAR NUCLEUS; RECEPTOR SUBUNIT COMPOSITION; PERMANENT THRESHOLD SHIFT; INFERIOR COLLICULUS; ACOUSTIC TRAUMA; GENE-EXPRESSION; MESSENGER-RNAS; TINNITUS; RAT	Excessive exposure to loud noise can damage the cochlea and create a hearing loss. These pathologies coincide with a range of CNS changes including reorganisation of frequency representation, alterations in the pattern of spontaneous activity and changed expression of excitatory and inhibitory neurotransmitters. Moreover, damage to the cochlea is often accompanied by acoustic disorders such as hyperacusis and tinnitus, suggesting that one or more of these neuronal changes may be involved in these disorders, although the mechanisms remain unknown. We tested the hypothesis that excessive noise exposure increases expression of markers of excitation and plasticity, and decreases expression of inhibitory markers over a 32-day recovery period. Adult rats (n = 25) were monaurally exposed to a loud noise (16 kHz, 1/10th octave band pass (115 dB SPL)) for 1-hour, or left as non-exposed controls (n = 5). Animals were euthanased at either 0, 4, 8, 16 or 32 days following acoustic trauma. We used Western Blots to quantify protein levels of GABA(A) receptor subunit alpha 1 (GABA(A)alpha 1), Glutamic-Acid Decarboxylase-67 (GAD-67), N-Methyl-D-Aspartate receptor subunit 2A (NR2A), Calbindin (Calb1) and Growth Associated Protein 43 (GAP-43) in the Auditory Cortex (AC), Inferior Colliculus (IC) and Dorsal Cochlear Nucleus (DCN). Compared to sham-exposed controls, noise-exposed animals had significantly (p<0.05): lower levels of GABA(A)alpha 1 in the contralateral AC at day-16 and day-32, lower levels of GAD-67 in the ipsilateral DCN at day-4, lower levels of Calb1 in the ipsilateral DCN at day-0, lower levels of GABA(A)alpha 1 in the ipsilateral AC at day-4 and day-32. GAP-43 was reduced in the ipsilateral AC for the duration of the experiment. These complex fluctuations in protein expression suggests that for at least a month following acoustic trauma the auditory system is adapting to a new pattern of sensory input.	[Browne, Cherylea J.; Morley, John W.; Parsons, Carl H.] Univ Western Sydney, Sch Med, Dept Anat & Cell Biol, Sydney, NSW, Australia	Western Sydney University	Browne, CJ (corresponding author), Univ Western Sydney, Sch Med, Dept Anat & Cell Biol, Sydney, NSW, Australia.	c.parsons@uws.edu.au		Browne, Cherylea/0000-0001-6758-685X; Morley, John/0000-0001-9246-853X	University of Western Sydney [pg82909]	University of Western Sydney	This work was supported by a University of Western Sydney project grant pg82909. C.J. Browne is the recipient of a UWS post-graduate research award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado JC, 2005, NEUROSCIENCE, V136, P957, DOI 10.1016/j.neuroscience.2005.04.022; Arun P, 2007, REPEATED BLAST EXPOS, P20910; AXELSSON A, 1985, British Journal of Audiology, V19, P271, DOI 10.3109/03005368509078983; Basta D, 2005, NEUROSCI LETT, V381, P199, DOI 10.1016/j.neulet.2005.02.034; Bauer CA, 2003, OTOLARYNG CLIN N AM, V36, P267, DOI 10.1016/S0030-6665(02)00171-8; Bauer CA, 2008, J NEUROSCI RES, V86, P2564, DOI 10.1002/jnr.21699; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; BENOWITZ LI, 1991, PROG BRAIN RES, V89, P69; Caspary DM, 1999, NEUROSCIENCE, V93, P307, DOI 10.1016/S0306-4522(99)00121-9; Chang H, 2002, HEARING RES, V164, P59, DOI 10.1016/S0378-5955(01)00410-5; CLARK WW, 1991, J ACOUST SOC AM, V90, P155, DOI 10.1121/1.401309; Coordes A, 2011, J NEUROTRAUMA; DeRidder MN, 2006, NEUROBIOL DIS, V22, P165, DOI 10.1016/j.nbd.2005.10.011; Dong S, 2010, BRAIN RES, V1342, P24, DOI 10.1016/j.brainres.2010.04.067; Dong S, 2009, NEUROSCIENCE, V159, P1164, DOI 10.1016/j.neuroscience.2009.01.043; Dong SY, 2010, EUR J NEUROSCI, V31, P1616, DOI 10.1111/j.1460-9568.2010.07183.x; Edge ASB, 2008, CURR OPIN NEUROBIOL, V18, P377, DOI 10.1016/j.conb.2008.10.001; ERLANDER MG, 1991, NEURON, V7, P91, DOI 10.1016/0896-6273(91)90077-D; Forster CR, 2000, J COMP NEUROL, V416, P173, DOI 10.1002/(SICI)1096-9861(20000110)416:2<173::AID-CNE4>3.0.CO;2-V; Groschel M, 2010, J NEUROTRAUM, V27, P1499, DOI 10.1089/neu.2009.1246; Harrison RV, 1998, EXP BRAIN RES, V123, P449, DOI 10.1007/s002210050589; HEIZMANN CW, 1992, GEN PHYSIOL BIOPHYS, V11, P411; House J W, 1981, Ciba Found Symp, V85, P204; Idrizbegovic E, 1999, NEUROSCI LETT, V259, P49, DOI 10.1016/S0304-3940(98)00911-2; Idrizbegovic E, 1998, BRAIN RES, V800, P86, DOI 10.1016/S0006-8993(98)00504-6; Illing RB, 1997, J COMP NEUROL, V382, P116, DOI 10.1002/(SICI)1096-9861(19970526)382:1<116::AID-CNE8>3.0.CO;2-4; Irvine DRF, 2005, INT REV NEUROBIOL, V70, P435, DOI 10.1016/S0074-7742(05)70013-1; Izquierdo MA, 2008, NEUROSCIENCE, V154, P355, DOI 10.1016/j.neuroscience.2008.01.057; KALTENBACH JA, 1992, HEARING RES, V59, P213, DOI 10.1016/0378-5955(92)90118-7; Kaltenbach JA, 2005, HEARING RES, V206, P200, DOI 10.1016/j.heares.2005.02.013; Kim JJ, 2004, J NEUROSCI RES, V77, P829, DOI 10.1002/jnr.20211; Kumar A, 2009, NOISE HEALTH, V11, P132, DOI 10.4103/1463-1741.53357; Kurmis Andrew P., 2007, International Journal of Occupational Medicine and Environmental Health, V20, P127, DOI 10.2478/v10001-007-0016-2; Lin HW, 2011, JARO-J ASSOC RES OTO, V12, P605, DOI 10.1007/s10162-011-0277-0; Marianowski R, 2000, HEARING RES, V150, P1, DOI 10.1016/S0378-5955(00)00166-0; Matthies C, 1997, NEUROSURGERY, V40, P919, DOI 10.1097/00006123-199705000-00007; MATTSON MP, 1991, NEURON, V6, P41, DOI 10.1016/0896-6273(91)90120-O; McIlvain VA, 2003, J COMP NEUROL, V462, P252, DOI 10.1002/cne.10725; MEIRI KF, 1986, P NATL ACAD SCI USA, V83, P3537, DOI 10.1073/pnas.83.10.3537; Milbrandt JC, 2000, HEARING RES, V147, P251, DOI 10.1016/S0378-5955(00)00135-0; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Mossop JE, 2000, HEARING RES, V147, P183, DOI 10.1016/S0378-5955(00)00054-X; Mulders WHAM, 2009, NEUROSCIENCE, V164, P733, DOI 10.1016/j.neuroscience.2009.08.036; Muly SM, 2004, J NEUROSCI RES, V75, P585, DOI 10.1002/jnr.20011; Nordmann AS, 2000, HEARING RES, V139, P13, DOI 10.1016/S0378-5955(99)00163-X; Norena AJ, 2003, HEARING RES, V183, P137, DOI 10.1016/S0378-5955(03)00225-9; Parrish-Aungst S, 2007, J COMP NEUROL, V501, P825, DOI 10.1002/cne.21205; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Peng JH, 2007, J OTOLARYNGOL, V36, P181, DOI 10.2310/7070.2007.0032; Puel JL, 1998, NEUROREPORT, V9, P2109, DOI 10.1097/00001756-199806220-00037; Pujol R, 1999, ANN NY ACAD SCI, V884, P249, DOI 10.1111/j.1749-6632.1999.tb08646.x; ROBERTSON D, 1989, J COMP NEUROL, V282, P456, DOI 10.1002/cne.902820311; Seki S, 2003, HEARING RES, V180, P28, DOI 10.1016/S0378-5955(03)00074-1; STRITTMATTER SM, 1995, CELL, V80, P445, DOI 10.1016/0092-8674(95)90495-6; Sun YJ, 2010, NATURE, V465, P927, DOI 10.1038/nature09079; Suneja SK, 1998, EXP NEUROL, V151, P273, DOI 10.1006/exnr.1998.6812; Syka J, 2000, HEARING RES, V139, P59, DOI 10.1016/S0378-5955(99)00175-6; Tan J, 2007, NEUROSCIENCE, V145, P715, DOI 10.1016/j.neuroscience.2006.11.067; Turner JG, 2006, BEHAV NEUROSCI, V120, P188, DOI 10.1037/0735-7044.120.1.188; Wang H, 2009, NEUROSCIENCE, V164, P747, DOI 10.1016/j.neuroscience.2009.08.026; WATANABE M, 1992, NEUROREPORT, V3, P1138, DOI 10.1097/00001756-199212000-00027; Weisz N, 2007, PROG BRAIN RES, V166, P61, DOI 10.1016/S0079-6123(07)66006-3; Yang W, 1998, Zhonghua Yi Xue Za Zhi, V78, P30; Zettel ML, 2003, HEARING RES, V183, P57, DOI 10.1016/S0378-5955(03)00216-8	64	39	41	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33272	10.1371/journal.pone.0033272	http://dx.doi.org/10.1371/journal.pone.0033272			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22428005	gold, Green Published			2022-12-25	WOS:000302381500118
J	Brusslan, JA; Alvarez-Canterbury, AMR; Nair, NU; Rice, JC; Hitchler, MJ; Pellegrini, M				Brusslan, Judy A.; Alvarez-Canterbury, Ana M. Rus; Nair, Nishanth Ulhas; Rice, Judd C.; Hitchler, Michael J.; Pellegrini, Matteo			Genome-Wide Evaluation of Histone Methylation Changes Associated with Leaf Senescence in Arabidopsis	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; GENE-EXPRESSION; FLORAL TRANSITION; CHROMATIN; PROTEINS; IDENTIFICATION; REVEALS; TRIMETHYLATION; DEMETHYLASES; REPRESSION	Leaf senescence is the orderly dismantling of older tissue that allows recycling of nutrients to developing portions of the plant and is accompanied by major changes in gene expression. Histone modifications correlate to levels of gene expression, and this study utilizes ChIP-seq to classify activating H3K4me3 and silencing H3K27me3 marks on a genome-wide scale for soil-grown mature and naturally senescent Arabidopsis leaves. ChIPnorm was used to normalize data sets and identify genomic regions with significant differences in the two histone methylation patterns, and the differences were correlated to changes in gene expression. Genes that showed an increase in the H3K4me3 mark in older leaves were senescence up-regulated, while genes that showed a decrease in the H3K4me3 mark in the older leaves were senescence down-regulated. For the H3K27me3 modification, genes that lost the H3K27me3 mark in older tissue were senescence up-regulated. Only a small number of genes gained the H3K27me3 mark, and these were senescence down-regulated. Approximately 50% of senescence up-regulated genes lacked the H3K4me3 mark in both mature and senescent leaf tissue. Two of these genes, SAG12 and At1g73220, display strong senescence up-regulation without the activating H3K4me3 histone modification. This study provides an initial epigenetic framework for the developmental transition into senescence.	[Brusslan, Judy A.; Alvarez-Canterbury, Ana M. Rus] Calif State Univ Long Beach, Dept Biol Sci, Long Beach, CA 90840 USA; [Nair, Nishanth Ulhas] Ecole Polytech Fed Lausanne, Sch Comp & Commun Sci, Lab Computat Biol & Bioinformat, Lausanne, Switzerland; [Rice, Judd C.] Univ So Calif, Norris Canc Ctr, Los Angeles, CA USA; [Hitchler, Michael J.] Kaiser Permanente, Dept Radiat Oncol, Los Angeles, CA USA; [Pellegrini, Matteo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA USA	California State University System; California State University Long Beach; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Southern California; Kaiser Permanente; University of California System; University of California Los Angeles	Brusslan, JA (corresponding author), Calif State Univ Long Beach, Dept Biol Sci, Long Beach, CA 90840 USA.	Judy.Brusslan@csulb.edu	Nair, Nishanth Ulhas/AFZ-7133-2022	Nair, Nishanth Ulhas/0000-0002-8832-0329; Pellegrini, Matteo/0000-0001-9355-9564	National Institutes of Health, National Institute of General Medical Sciences [1SC2GM092281, 1R01GM075094, F32GM085907]; University of California Los Angeles-United States Department of Energy Center for Genomics and Proteomics; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075094, SC2GM092281, R25GM071638, F32GM085907] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of California Los Angeles-United States Department of Energy Center for Genomics and Proteomics; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	JAB and AMRA-C were funded by National Institutes of Health, National Institute of General Medical Sciences 1SC2GM092281. JCR and MJH were funded by National Institutes of Health, National Institute of General Medical Sciences 1R01GM075094. MJH was funded by National Institutes of Health, National Institute of General Medical Sciences F32GM085907. MP was funded by the University of California Los Angeles-United States Department of Energy Center for Genomics and Proteomics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ay N, 2009, PLANT J, V58, P333, DOI [10.1111/j.0960-7412.2009.03782.x, 10.1111/j.1365-313X.2008.03782.x]; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bratzel F, 2010, CURR BIOL, V20, P1853, DOI 10.1016/j.cub.2010.09.046; Breeze E, 2011, PLANT CELL, V23, P873, DOI 10.1105/tpc.111.083345; Buchanan-Wollaston V, 2005, PLANT J, V42, P567, DOI 10.1111/j.1365-313X.2005.02399.x; Buzas DM, 2011, PLANT J, V65, P872, DOI 10.1111/j.1365-313X.2010.04471.x; Charron JBF, 2009, PLANT CELL, V21, P3732, DOI 10.1105/tpc.109.066845; Choi J, 2009, PLANT J, V57, P918, DOI 10.1111/j.1365-313X.2008.03776.x; Choi K, 2011, PLANT CELL, V23, P289, DOI 10.1105/tpc.110.075911; Gu XF, 2009, PLANT J, V57, P522, DOI 10.1111/j.1365-313X.2008.03709.x; Guo Y, 2004, PLANT CELL ENVIRON, V27, P521, DOI 10.1111/j.1365-3040.2003.01158.x; Guo YF, 2006, PLANT J, V46, P601, DOI 10.1111/j.1365-313X.2006.02723.x; Heo JB, 2011, SCIENCE, V331, P76, DOI 10.1126/science.1197349; Hinderhofer K, 2001, PLANTA, V213, P469, DOI 10.1007/s004250000512; Holec S, 2012, PLANT PHYSIOL, V158, P35, DOI 10.1104/pp.111.186445; Hong EH, 2009, MOL CELLS, V27, P481, DOI 10.1007/s10059-009-0054-7; Hsieh TF, 2003, TRENDS PLANT SCI, V8, P439, DOI 10.1016/S1360-1385(03)00189-4; Jeong JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008033; Jiang D, 2011, PLOS GENETICS, P7; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Kim DH, 2009, ANNU REV CELL DEV BI, V25, P277, DOI 10.1146/annurev.cellbio.042308.113411; Kim JM, 2010, PLANT CELL ENVIRON, V33, P604, DOI 10.1111/j.1365-3040.2009.02076.x; Lafos M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002040; Lim PO, 2007, PLANT J, V52, P1140, DOI 10.1111/j.1365-313X.2007.03317.x; Liu XC, 2011, NUCLEIC ACIDS RES, V39, pD1103, DOI 10.1093/nar/gkq1169; Lu FL, 2008, J INTEGR PLANT BIOL, V50, P886, DOI 10.1111/j.1744-7909.2008.00692.x; Lu FL, 2011, NAT GENET, V43, P715, DOI 10.1038/ng.854; Miao Y, 2004, PLANT MOL BIOL, V55, P853, DOI 10.1007/s11103-005-2142-1; Miao Y, 2010, PLANT J, V63, P179, DOI 10.1111/j.1365-313X.2010.04233.x; Noh B, 2004, PLANT CELL, V16, P2601, DOI 10.1105/tpc.104.025353; Noh YS, 1999, PLANT MOL BIOL, V41, P181, DOI 10.1023/A:1006342412688; Oh SY, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000077; Org T, 2009, HUM MOL GENET, V18, P4699, DOI 10.1093/hmg/ddp433; Pagnussat GC, 2005, DEVELOPMENT, V132, P603, DOI 10.1242/dev.01595; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rodrigues JCM, 2010, SEX PLANT REPROD, V23, P123, DOI 10.1007/s00497-009-0131-2; Saleh A, 2008, NAT PROTOC, V3, P1018, DOI 10.1038/nprot.2008.66; Smith E, 2010, MOL CELL, V40, P689, DOI 10.1016/j.molcel.2010.11.031; Sui P, 2011, PLANT J; Sun B, 2009, GENE DEV, V23, P1791, DOI 10.1101/gad.1800409; Swiezewski S, 2009, NATURE, V462, P799, DOI 10.1038/nature08618; Ulhas Nair N, 2012, PLOS ONE; Van der Graaff E, 2006, PLANT PHYSIOL, V141, P776, DOI 10.1104/pp.106.079293; Wu K, 2008, J EXP BOT, V59, P225, DOI 10.1093/jxb/erm300; Xiang Y, 2007, P NATL ACAD SCI USA, V104, P19226, DOI 10.1073/pnas.0700735104; Yang S-D, 2011, PLANT CELL; Yang WN, 2010, PLANT J, V62, P663, DOI 10.1111/j.1365-313X.2010.04182.x; Yu XF, 2008, P NATL ACAD SCI USA, V105, P7618, DOI 10.1073/pnas.0802254105; Zhang K, 2011, PLANT PHYSL; Zhang XY, 2007, PLOS BIOL, V5, P1026, DOI 10.1371/journal.pbio.0050129; Zhang XY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r62	51	58	61	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33151	10.1371/journal.pone.0033151	http://dx.doi.org/10.1371/journal.pone.0033151			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427974	gold, Green Published, Green Submitted			2022-12-25	WOS:000302381500100
J	Choudhary, S; Quin, MB; Sanders, MA; Johnson, ET; Schmidt-Dannert, C				Choudhary, Swati; Quin, Maureen B.; Sanders, Mark A.; Johnson, Ethan T.; Schmidt-Dannert, Claudia			Engineered Protein Nano-Compartments for Targeted Enzyme Localization	PLOS ONE			English	Article							SALMONELLA-ENTERICA; BACTERIAL MICROCOMPARTMENTS; TRANSCRIPTIONAL ACTIVATOR; ETHANOLAMINE UTILIZATION; SYNTHETIC BIOLOGY; ESCHERICHIA-COLI; EUT OPERON; ORGANELLES; TYPHIMURIUM; 1,2-PROPANEDIOL	Compartmentalized co-localization of enzymes and their substrates represents an attractive approach for multi-enzymatic synthesis in engineered cells and biocatalysis. Sequestration of enzymes and substrates would greatly increase reaction efficiency while also protecting engineered host cells from potentially toxic reaction intermediates. Several bacteria form protein-based polyhedral microcompartments which sequester functionally related enzymes and regulate their access to substrates and other small metabolites. Such bacterial microcompartments may be engineered into protein-based nano-bioreactors, provided that they can be assembled in a non-native host cell, and that heterologous enzymes and substrates can be targeted into the engineered compartments. Here, we report that recombinant expression of Salmonella enterica ethanolamine utilization (eut) bacterial microcompartment shell proteins in E. coli results in the formation of polyhedral protein shells. Purified recombinant shells are morphologically similar to the native Eut microcompartments purified from S. enterica. Surprisingly, recombinant expression of only one of the shell proteins (EutS) is sufficient and necessary for creating properly delimited compartments. Co-expression with EutS also facilitates the encapsulation of EGFP fused with a putative Eut shell-targeting signal sequence. We also demonstrate the functional localization of a heterologous enzyme (beta-galactosidase) targeted to the recombinant shells. Together our results provide proof-of-concept for the engineering of protein nano-compartments for biosynthesis and biocatalysis.	[Choudhary, Swati; Quin, Maureen B.; Johnson, Ethan T.; Schmidt-Dannert, Claudia] Univ Minnesota, Dept Biochem Mol Biol & Biophys, St Paul, MN 55108 USA; [Sanders, Mark A.] Univ Minnesota, Univ Imaging Ctr, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Choudhary, S (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, St Paul, MN 55108 USA.	schmi232@umn.edu		Quin, Maureen/0000-0001-7193-639X	University of Minnesota's Institute on the Environment; Biocatalysis Initiative the BioTechnology Institute (University of Minnesota); Office of Naval Research [N00014-10-1-0157]	University of Minnesota's Institute on the Environment; Biocatalysis Initiative the BioTechnology Institute (University of Minnesota); Office of Naval Research(Office of Naval Research)	This research was supported by the University of Minnesota's Institute on the Environment, Biocatalysis Initiative the BioTechnology Institute (University of Minnesota), and the Office of Naval Research (grant #N00014-10-1-0157). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertin Y, 2011, ENVIRON MICROBIOL, V13, P365, DOI 10.1111/j.1462-2920.2010.02334.x; Bobik TA, 1999, J BACTERIOL, V181, P5967, DOI 10.1128/JB.181.19.5967-5975.1999; Bonacci W, 2011, P NATL ACAD SCI 1219; Brinsmade SR, 2005, J BACTERIOL, V187, P8039, DOI 10.1128/JB.187.23.8039-8046.2005; Buan NR, 2004, J BACTERIOL, V186, P5708, DOI 10.1128/JB.186.17.5708-5714.2004; Burbulis IE, 1999, P NATL ACAD SCI USA, V96, P12929, DOI 10.1073/pnas.96.22.12929; Cheng SQ, 2008, BIOESSAYS, V30, P1084, DOI 10.1002/bies.20830; Cheng SQ, 2011, J BACTERIOL, V193, P1385, DOI 10.1128/JB.01473-10; Crowley CS, 2008, STRUCTURE, V16, P1324, DOI 10.1016/j.str.2008.05.013; Dueber JE, 2009, NAT BIOTECHNOL, V27, P753, DOI 10.1038/nbt.1557; Fan CG, 2010, P NATL ACAD SCI USA, V107, P7509, DOI 10.1073/pnas.0913199107; Fontes CMGA, 2010, ANNU REV BIOCHEM, V79, P655, DOI 10.1146/annurev-biochem-091208-085603; Havemann GD, 2003, J BACTERIOL, V185, P5086, DOI 10.1128/JB.185.17.5086-5095.2003; Keasling JD, 2008, ACS CHEM BIOL, V3, P64, DOI 10.1021/cb7002434; Kerfeld CA, 2010, ANNU REV MICROBIOL, V64, P391, DOI 10.1146/annurev.micro.112408.134211; Kofoid E, 1999, J BACTERIOL, V181, P5317, DOI 10.1128/JB.181.17.5317-5329.1999; Lopez-Gallego F, 2010, CURR OPIN CHEM BIOL, V14, P174, DOI 10.1016/j.cbpa.2009.11.023; Marasco EK, 2006, J BIOL CHEM, V281, P31583, DOI 10.1074/jbc.M606299200; Menon BB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003570; Mori K, 2004, J BACTERIOL, V186, P6845, DOI 10.1128/JB.186.20.6845-6854.2004; Munoz TE, 2004, J NEUROSCI METH, V137, P133, DOI 10.1016/j.jneumeth.2004.02.020; Papapostolou D, 2009, MOL BIOSYST, V5, P723, DOI 10.1039/b902440a; Parsons JB, 2010, MOL CELL, V38, P305, DOI 10.1016/j.molcel.2010.04.008; Penrod JT, 2006, J BACTERIOL, V188, P2865, DOI 10.1128/JB.188.8.2865-2874.2006; Penrod JT, 2004, J BACTERIOL, V186, P6885, DOI 10.1128/JB.186.20.6885-6890.2004; Price GD, 2008, J EXP BOT, V59, P1441, DOI 10.1093/jxb/erm112; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; ROOF DM, 1992, J BACTERIOL, V174, P6634, DOI 10.1128/JB.174.20.6634-6643.1992; Savage DF, 2010, SCIENCE, V327, P1258, DOI 10.1126/science.1186090; Schmidt-Dannert C, 2000, NAT BIOTECHNOL, V18, P750, DOI 10.1038/77319; SHEPPARD DE, 1994, J BACTERIOL, V176, P1287, DOI 10.1128/jb.176.5.1287-1296.1994; Shetty Reshma P, 2008, J Biol Eng, V2, P5, DOI 10.1186/1754-1611-2-5; Shively JM, 1998, CAN J BOT, V76, P906, DOI 10.1139/b98-088; Sriramulu DD, 2008, J BACTERIOL, V190, P4559, DOI 10.1128/JB.01535-07; Starai VJ, 2005, MICROBIOL-SGM, V151, P3793, DOI 10.1099/mic.0.28156-0; Steinmann B, 2010, APPL ENVIRON MICROB, V76, P5563, DOI 10.1128/AEM.00612-10; STOJILJKOVIC I, 1995, J BACTERIOL, V177, P1357, DOI 10.1128/jb.177.5.1357-1366.1995; Takenoya M, 2010, J BACTERIOL, V192, P6056, DOI 10.1128/JB.00652-10; Tanaka S, 2008, SCIENCE, V319, P1083, DOI 10.1126/science.1151458; Tanaka S, 2010, SCIENCE, V327, P81, DOI 10.1126/science.1179513; Urano N, 2011, APPL MICROBIOL BIOT, V89, P739, DOI 10.1007/s00253-010-2924-5; Vick JE, 2011, APPL MICROBIOL BIOT, V92, P1275, DOI 10.1007/s00253-011-3633-4; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; Webster Paul, 2007, Methods Mol Biol, V369, P47; Worsdorfer B, 2011, SCIENCE, V331, P589, DOI 10.1126/science.1199081; Yeates TO, 2008, NAT REV MICROBIOL, V6, P681, DOI 10.1038/nrmicro1913; Yeates TO, 2011, CURR OPIN STRUC BIOL, V21, P223, DOI 10.1016/j.sbi.2011.01.006; Yeates TO, 2010, ANNU REV BIOPHYS, V39, P185, DOI 10.1146/annurev.biophys.093008.131418	49	106	109	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33342	10.1371/journal.pone.0033342	http://dx.doi.org/10.1371/journal.pone.0033342			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22428024	Green Published, Green Submitted, gold			2022-12-25	WOS:000302381500128
J	Hart, LB; Rotstein, DS; Wells, RS; Allen, J; Barleycorn, A; Balmer, BC; Lane, SM; Speakman, T; Zolman, ES; Stolen, M; McFee, W; Goldstein, T; Rowles, TK; Schwacke, LH				Hart, Leslie Burdett; Rotstein, Dave S.; Wells, Randall S.; Allen, Jason; Barleycorn, Aaron; Balmer, Brian C.; Lane, Suzanne M.; Speakman, Todd; Zolman, Eric S.; Stolen, Megan; McFee, Wayne; Goldstein, Tracey; Rowles, Teri K.; Schwacke, Lori H.			Skin Lesions on Common Bottlenose Dolphins (Tursiops truncatus) from Three Sites in the Northwest Atlantic, USA	PLOS ONE			English	Article							INDIAN RIVER LAGOON; PHYSICAL DEFORMITIES; SOUTH-CAROLINA; HARBOR SEALS; RIGHT WHALES; DISEASE; LACAZIOSIS; PREVALENCE; EPIDEMIOLOGY; LOBOMYCOSIS	Skin disease occurs frequently in many cetacean species across the globe; methods to categorize lesions have relied on photo-identification (photo-id), stranding, and by-catch data. The current study used photo-id data from four sampling months during 2009 to estimate skin lesion prevalence and type occurring on bottlenose dolphins (Tursiops truncatus) from three sites along the southeast United States coast [Sarasota Bay, FL (SSB); near Brunswick and Sapelo Island, GA (BSG); and near Charleston, SC (CHS)]. The prevalence of lesions was highest among BSG dolphins (P = 0.587) and lowest in SSB (P = 0.380), and the overall prevalence was significantly different among all sites (p < 0.0167). Logistic regression modeling revealed a significant reduction in the odds of lesion occurrence for increasing water temperatures (OR = 0.92; 95% CI: 0.906-0.938) and a significantly increased odds of lesion occurrence for BSG dolphins (OR = 1.39; 95% CI: 1.203-1.614). Approximately one-third of the lesioned dolphins from each site presented with multiple types, and population differences in lesion type occurrence were observed (p < 0.05). Lesions on stranded dolphins were sampled to determine the etiology of different lesion types, which included three visually distinct samples positive for herpesvirus. Although generally considered non-fatal, skin disease may be indicative of animal health or exposure to anthropogenic or environmental threats, and photo-id data provide an efficient and cost-effective approach to document the occurrence of skin lesions in free-ranging populations.	[Hart, Leslie Burdett; Schwacke, Lori H.] Med Univ S Carolina, Dept Med, Div Biostat & Epidemiol, Charleston, SC 29425 USA; [Hart, Leslie Burdett; Lane, Suzanne M.; Speakman, Todd; Zolman, Eric S.; Schwacke, Lori H.] Natl Ocean Serv, NOAA, Hollings Marine Lab, Charleston, SC USA; [Rotstein, Dave S.; Rowles, Teri K.] Natl Marine Fisheries Serv, NOAA, Off Protected Resources, Silver Spring, MD USA; [Rotstein, Dave S.] Marine Mammal Pathol Serv, Olney, MD USA; [Wells, Randall S.; Allen, Jason; Barleycorn, Aaron; Balmer, Brian C.] Mote Marine Lab, Chicago Zool Soc, Sarasota, FL 34236 USA; [Balmer, Brian C.] Univ N Carolina, Dept Biol & Marine Biol, Wilmington, NC 28401 USA; [Stolen, Megan] Hubbs SeaWorld Res Inst, Melbourne Beach, FL USA; [McFee, Wayne] NOAA, Coastal Marine Mammal Stranding Assessments Progr, Natl Ctr Coastal Ocean Sci, Ctr Coastal Environm Hlth & Biomol Res, Charleston, SC USA; [Goldstein, Tracey] Univ Calif Davis, Sch Vet Med, Wildlife Hlth Ctr, Davis, CA 95616 USA	Medical University of South Carolina; National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; National Oceanic Atmospheric Admin (NOAA) - USA; Mote Marine Laboratory & Aquarium; University of North Carolina; University of North Carolina Wilmington; National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; National Centers for Coastal Ocean Science (NOOCS); University of California System; University of California Davis	Hart, LB (corresponding author), Med Univ S Carolina, Dept Med, Div Biostat & Epidemiol, Charleston, SC 29425 USA.	leslie.burdett@noaa.gov		rotstein, david/0000-0001-7438-2281; McFee, Wayne/0000-0002-5781-2961; Balmer, Brian/0000-0001-9734-4042	National Oceanic and Atmospheric Administration's Center of Excellence for Oceans and Human Health at the Hollings Marine Laboratory, Charleston, South Carolina	National Oceanic and Atmospheric Administration's Center of Excellence for Oceans and Human Health at the Hollings Marine Laboratory, Charleston, South Carolina	Funding for this project was provided by the National Oceanic and Atmospheric Administration's Center of Excellence for Oceans and Human Health at the Hollings Marine Laboratory, Charleston, South Carolina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER J R, 1992, Aquatic Mammals, V18, P27; Balmer B, J WILDLIFE IN PRESS; Balmer BC, 2011, SCI TOTAL ENVIRON, V409, P2094, DOI 10.1016/j.scitotenv.2011.01.052; BARR B, 1989, J WILDLIFE DIS, V25, P608, DOI 10.7589/0090-3558-25.4.608; Bearzi M, 2009, AMBIO, V38, P66, DOI 10.1579/0044-7447-38.2.66; deSwart RL, 1996, ENVIRON HEALTH PERSP, V104, P823, DOI 10.1289/ehp.96104s4823; Drummond A., 2010, GENEIOUS PRO; Durden WN, 2009, J WILDLIFE DIS, V45, P849, DOI 10.7589/0090-3558-45.3.849; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FLOM JO, 1979, J WILDLIFE DIS, V15, P593, DOI 10.7589/0090-3558-15.4.593; Frangiamore CS, 2004, NEW GEORGIA ENCY; GERACI JR, 1979, CAN J COMP MED, V43, P399; Gulland FMD, 2005, MARINE MAMMAL RESEARCH: CONSERVATION BEYOND CRISIS, P47; Hamilton PK, 2005, DIS AQUAT ORGAN, V68, P71, DOI 10.3354/dao068071; Hart LB, 2011, DIS AQUAT ORGAN, V95, P49, DOI 10.3354/dao02345; Hart LB, 2010, DIS AQUAT ORGAN, V90, P105, DOI 10.3354/dao02224; Harzen Stefan, 1997, Aquatic Mammals, V23, P59; Hersh SL., 1990, BOTTLENOSE DOLPHIN, P129, DOI [10.1016/B978-0-12-440280-5.50010-X, DOI 10.1016/B978-0-12-440280-5.50010-X]; Horne J, 2007, MULTIPLE COMPARISONS, P17; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; IRVINE AB, 1981, FISH B-NOAA, V79, P671; KIMBROUGH R, 1978, ENVIRON HEALTH PERSP, V24, P173, DOI 10.2307/3428809; Kiszka J, 2009, DIS AQUAT ORGAN, V84, P151, DOI 10.3354/dao02037; Kucklick J, 2011, ENVIRON SCI TECHNOL, V45, P4270, DOI 10.1021/es1042244; LAHVIS GP, 1995, ENVIRON HEALTH PERSP, V103, P67, DOI 10.2307/3432414; Maldini D, 2010, AMBIO, V39, P455, DOI 10.1007/s13280-010-0066-8; MIGAKI G, 1971, J AM VET MED ASSOC, V159, P578; Nemoto T, 1977, Scientific Rep. Whales Res. Inst., Tokyo, VNo. 29, P101; Nollens HH, 2006, J WILDLIFE DIS, V42, P23, DOI 10.7589/0090-3558-42.1.23; Pettis HM, 2004, CAN J ZOOL, V82, P8, DOI [10.1139/z03-207, 10.1139/Z03-207]; Reif JS, 2006, JAVMA-J AM VET MED A, V228, P104, DOI 10.2460/javma.228.1.104; ROPP SL, 1995, J CLIN MICROBIOL, V33, P2069, DOI 10.1128/JCM.33.8.2069-2076.1995; Rosner B., 2006, FUNDAMENTALS BIOSTAT; Ross P, 1996, TOXICOLOGY, V112, P157, DOI 10.1016/0300-483X(96)03396-3; Rotstein DS, 2009, EMERG INFECT DIS, V15, P588, DOI 10.3201/eid1504.081358; Rowe Lucy E., 2010, Endangered Species Research, V11, P83, DOI 10.3354/esr00256; Scott M.D., 1990, P489; Speakman Todd R., 2010, Journal of Cetacean Research and Management, V11, P153; Urian K.W., 1999, STATUS PHOTO IDENTIF; Van Bressem MF, 2009, MAR ENVIRON RES, V67, P63, DOI 10.1016/j.marenvres.2008.11.002; Van Bressem MFO, 2006, DIS AQUAT ORGAN, V68, P149, DOI 10.3354/dao068149; Van Bressem MF, 2009, DIS AQUAT ORGAN, V85, P225, DOI 10.3354/dao02080; Van Bressem Marie-Francoise, 2007, Latin American Journal of Aquatic Mammals, V6, P7; Van Bressem MF, 2003, DIS AQUAT ORGAN, V56, P171, DOI 10.3354/dao056171; Van Bressem MF, 1999, DIS AQUAT ORGAN, V38, P53, DOI 10.3354/dao038053; VanBressem MF, 1996, MAR MAMMAL SCI, V12, P371; VanDevanter DR, 1996, J CLIN MICROBIOL, V34, P1666, DOI 10.1128/JCM.34.7.1666-1671.1996; Vos J G, 1972, Environ Health Perspect, V1, P105, DOI 10.2307/3428162; Wells R.S., 1990, Reports of the International Whaling Commission Special Issue, P407; Wells R.S., 1991, P199; Wells R.S., 1987, Current Mammalogy, V1, P247; Wells RS, 2009, ZOO BIOL, V28, P635, DOI 10.1002/zoo.20252; Wells RS, 2003, ANIMAL SOCIAL COMPLEXITY, P32; Wilson B, 1997, AMBIO, V26, P243; Wilson B, 1999, P ROY SOC B-BIOL SCI, V266, P1077, DOI 10.1098/rspb.1999.0746; Wursig B., 1990, Reports of the International Whaling Commission Special Issue, P43; ZINKL JG, 1977, ARCH ENVIRON CON TOX, V5, P217, DOI 10.1007/BF02220905; Zolman ES, 2002, MAR MAMMAL SCI, V18, P879, DOI 10.1111/j.1748-7692.2002.tb01079.x	58	39	41	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33081	10.1371/journal.pone.0033081	http://dx.doi.org/10.1371/journal.pone.0033081			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427955	Green Submitted, Green Published, gold			2022-12-25	WOS:000302381500088
J	Salinas-de-Leon, P; Jones, T; Bell, JJ				Salinas-de-Leon, Pelayo; Jones, Timothy; Bell, James J.			Successful Determination of Larval Dispersal Distances and Subsequent Settlement for Long-Lived Pelagic Larvae	PLOS ONE			English	Article							CORAL-REEF FISH; MARINE POPULATIONS; PROPAGULE DISPERSAL; MUSSEL LARVAE; CONNECTIVITY; RETENTION; RESERVES; IDENTIFICATION; RECRUITMENT; INVERTEBRATE	Despite its importance, we still have a poor understanding of the level of connectivity between marine populations in most geographical locations. Taking advantage of the natural features of the southeast coast of New Zealand's North Island, we deployed a series of settlement stations and conducted plankton tows to capture recent settlers and planktonic larvae of the common intertidal gastropod Austrolittorina cincta (6-8 week larval period). Satellite image analysis and ground truthing surveys revealed the absence of suitable intertidal rocky shore habitat for A. cincta over a 100 km stretch of coastline between Kapiti Island to the south and Wanganui to the north. Fifteen settlement stations (3 replicates x 5 sites), which were used to mimic intertidal habitat suitable for A. cincta, were deployed for two months around and north of Kapiti Island (at 0.5, 1, 5, 15, 50 km). In addition, we also conducted plankton tows at each settlement station when the stations were first deployed to collect A. cincta larvae in the water column. On collection, all newly settled gastropods and larvae in the plankton samples were individually isolated, and a species-specific microsatellite marker was used to positively identify A. cincta individuals. Most of the positively identified A. cincta settlers and larvae were collected at the first three sampling stations (< 5 km). However, low numbers of A. cincta settlers and larvae were also recorded at the two more distant locations (15 and 50 km). Dispersal curves modeled from our data suggested that < 1% of gastropod larvae would travel more than 100 km. While our data show that most larvae are retained close to their natal populations (< 5 km), a small proportion of larvae are able to travel much larger geographic distances. Our estimates of larval dispersal and subsequent settlement are one of only a few for marine species with a long-lived larva.	[Salinas-de-Leon, Pelayo; Jones, Timothy; Bell, James J.] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand	Victoria University Wellington	Salinas-de-Leon, P (corresponding author), Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand.	james.bell@vuw.ac.nz	Jones, Timothy/C-1921-2013	Bell, James/0000-0001-9996-945X	Victoria University of Wellington [31977]	Victoria University of Wellington	This work was funded by the Victoria University of Wellington Research Fund (URF Grant Number: 31977; www.vuw.ac.nz). in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison GW, 2003, ECOL APPL, V13, pS8; Almany GR, 2007, SCIENCE, V316, P742, DOI 10.1126/science.1140597; Anderson MJ, 2001, CAN J FISH AQUAT SCI, V58, P626, DOI 10.1139/cjfas-58-3-626; [Anonymous], MOL ECOLOGY RESOURCE, V11, P1124, DOI [10.1111/j.1755-0998.2011.03068.x, DOI 10.1111/J.1755-0998.2011.03068.X]; Becker BJ, 2007, P NATL ACAD SCI USA, V104, P3267, DOI 10.1073/pnas.0611651104; Bell JJ, 2005, P ROY SOC B-BIOL SCI, V272, P1067, DOI 10.1098/rspb.2005.3051; Chiswell SM, 2010, CONT SHELF RES, V30, P515, DOI 10.1016/j.csr.2010.01.004; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; DAVIS AR, 1989, J EXP MAR BIOL ECOL, V127, P189, DOI 10.1016/0022-0981(89)90184-6; Dethier MN, 2003, CONSERV BIOL, V17, P1024, DOI 10.1046/j.1523-1739.2003.01606.x; Gilg MR, 2007, MAR ECOL PROG SER, V351, P151, DOI 10.3354/meps07145; HEATH R A, 1974, New Zealand Journal of Marine and Freshwater Research, V8, P691; Hellberg ME, 2007, CORAL REEFS, V26, P463, DOI 10.1007/s00338-007-0205-2; HELLBERG ME, 1995, MAR BIOL, V123, P573, DOI 10.1007/BF00349236; Hellberg ME, 2002, B MAR SCI, V70, P273; Hobbs NT, 2006, ECOL APPL, V16, P5, DOI 10.1890/04-0645; Jones GP, 2005, CURR BIOL, V15, P1314, DOI 10.1016/j.cub.2005.06.061; Kinlan BP, 2003, ECOLOGY, V84, P2007, DOI 10.1890/01-0622; KNOWLTON N, 1986, B MAR SCI, V39, P213; Knutsen H, 2004, P ROY SOC LOND B BIO, V271, P1137; Levin LA, 2006, INTEGR COMP BIOL, V46, P282, DOI 10.1093/icb/icj024; Lunn D, 2009, STAT MED, V28, P3049, DOI 10.1002/sim.3680; McQuaid CD, 2000, MAR ECOL PROG SER, V201, P211, DOI 10.3354/meps201211; Morgan TS, 2001, MAR BIOL, V139, P967; Neubauer P, 2011, THESIS VICTORIA U WE; O'Hara RB, 2010, METHODS ECOL EVOL, V1, P118, DOI 10.1111/j.2041-210X.2010.00021.x; OLSON RR, 1985, ECOLOGY, V66, P30, DOI 10.2307/1941304; Palumbi SR, 2003, ECOL APPL, V13, pS146; Palumbi SR, 2004, ANNU REV ENV RESOUR, V29, P31, DOI 10.1146/annurev.energy.29.062403.102254; Phillips NE, 2008, J EXP MAR BIOL ECOL, V362, P90, DOI 10.1016/j.jembe.2008.06.006; Planes S, 2009, P NATL ACAD SCI USA, V106, P5693, DOI 10.1073/pnas.0808007106; QUELLER DC, 1993, TRENDS ECOL EVOL, V8, P285, DOI 10.1016/0169-5347(93)90256-O; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Salinas-de-Leon P, 2011, THESIS VICTORIA U WE; Shanks AL, 2003, ECOL APPL, V13, pS159; Swearer SE, 1999, NATURE, V402, P799, DOI 10.1038/45533; Taylor MS, 2003, SCIENCE, V299, P107, DOI 10.1126/science.1079365; Thorrold SR, 2002, B MAR SCI, V70, P291; THORSON G, 1950, BIOL REV, V25, P1, DOI 10.1111/j.1469-185X.1950.tb00585.x; Tioho H, 2001, MAR ECOL PROG SER, V213, P79, DOI 10.3354/meps213079; Vander Veur J, 2010, THESIS VICTORIA U WE; Zhan AB, 2008, MOL ECOL RESOUR, V8, P790, DOI 10.1111/j.1755-0998.2007.02066.x; Zhang JB, 2004, J EXP MAR BIOL ECOL, V298, P3, DOI 10.1016/S0022-0981(03)00341-1	43	4	4	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e32788	10.1371/journal.pone.0032788	http://dx.doi.org/10.1371/journal.pone.0032788			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427885	gold, Green Published, Green Submitted			2022-12-25	WOS:000302381500046
J	Scarborough, P; Allender, S; Rayner, M; Goldacre, M				Scarborough, Peter; Allender, Steven; Rayner, Mike; Goldacre, Michael			Contribution of Climate and Air Pollution to Variation in Coronary Heart Disease Mortality Rates in England	PLOS ONE			English	Article							CARDIOVASCULAR MORTALITY; MYOCARDIAL-INFARCTION; RISK-FACTORS; EXPOSURE; WARDS; COLD	There are substantial geographic variations in coronary heart disease (CHD) mortality rates in England that may in part be due to differences in climate and air pollution. An ecological cross-sectional multi-level analysis of male and female CHD mortality rates in all wards in England (1999-2004) was conducted to estimate the relative strength of the association between CHD mortality rates and three aspects of the physical environment - temperature, hours of sunshine and air quality. Models were adjusted for deprivation, an index measuring the healthiness of the lifestyle of populations, and urbanicity. In the fully adjusted model, air quality was not significantly associated with CHD mortality rates, but temperature and sunshine were both significantly negatively associated (p < 0.05), suggesting that CHD mortality rates were higher in areas with lower average temperature and hours of sunshine. After adjustment for the unhealthy lifestyle of populations and deprivation, the climate variables explained at least 15% of large scale variation in CHD mortality rates. The results suggest that the climate has a small but significant independent association with CHD mortality rates in England.	[Scarborough, Peter; Allender, Steven; Rayner, Mike] Univ Oxford, Dept Publ Hlth, British Heart Fdn Hlth Promot Res Grp, Oxford, England; [Goldacre, Michael] Univ Oxford, Dept Publ Hlth, Unit Hlth Care Epidemiol, Oxford, England	University of Oxford; University of Oxford	Scarborough, P (corresponding author), Univ Oxford, Dept Publ Hlth, British Heart Fdn Hlth Promot Res Grp, Oxford, England.	peter.scarborough@dph.ox.ac.uk	Allender, Steven/G-9881-2011; Scarborough, Peter/ABD-6111-2021	Scarborough, Peter/0000-0002-2378-2944; Allender, Steven/0000-0002-4842-3294	British Heart Foundation	British Heart Foundation(British Heart Foundation)	PS, SA and MR were supported by the British Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allender S., 2008, CORONARY HEART DIS S; Allender S, 2012, J EPIDEMIOL COMMUN H, V66, P803, DOI 10.1136/jech.2010.116723; Bell ML, 2009, CIRCULATION, V120, P949, DOI 10.1161/CIRCULATIONAHA.109.851113; Bhaskaran K, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3823; Bush T., 2008, NAEI UK EMISSION MAP; CARSTAIRS V R M, 1990, Health Bulletin (Edinburgh), V48, P162; Cressie N, 2000, SPATIAL EPIDEMIOLOGY; Dibben C, 2004, HLTH POVERTY INDEX; Griffiths Clare, 2004, Health Stat Q, P14; Grimes DS, 1996, QJM-INT J MED, V89, P579; Keatinge WR, 1997, LANCET, V349, P1341, DOI 10.1016/S0140-6736(96)12338-2; Lawlor DA, 2003, J EPIDEMIOL COMMUN H, V57, P134, DOI 10.1136/jech.57.2.134; Lynch J, 2005, ANNU REV PUBL HEALTH, V26, P1, DOI 10.1146/annurev.publhealth.26.021304.144505; Maheswaran R, 2005, EUR HEART J, V26, P2543, DOI 10.1093/eurheartj/ehi457; Maheswaran R, 1999, HEART, V82, P455, DOI 10.1136/hrt.82.4.455; Mercer JB, 2003, ENVIRON RES, V92, P8, DOI 10.1016/S0013-9351(02)00009-9; Morgan Oliver, 2006, Health Stat Q, P28; Morris RW, 2001, HEART, V86, P277, DOI 10.1136/heart.86.3.277; Neighbourhood statistics, 2001, COMB AIR QUAL IND 20; *ODPM, 2004, ENGL IND DEPR 2004; Office for National Statistics (ONS), 2001, AR CLASS STAT WARDS; POCOCK SJ, 1980, BRIT MED J, V280, P1243, DOI 10.1136/bmj.280.6226.1243; Pope C, 2005, CORONARY HEART DIS E; Pope CA, 2004, CIRCULATION, V109, P71, DOI 10.1161/01.CIR.0000108927.80044.7F; Scarborough P, 2011, HEALTH PLACE, V17, P691, DOI 10.1016/j.healthplace.2010.12.007; Scarborough P, 2008, REGIONAL SOCIAL DIFF; Scarborough P, 2009, HEALTH PLACE, V15, P596, DOI 10.1016/j.healthplace.2008.10.003; Stieb DM, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-25; Subramanian SV, 2009, INT J EPIDEMIOL, V38, P342, DOI 10.1093/ije/dyn359; The Meteorological Office, 2011, RAINF SUNSH TEMP TIM; Toledano M, 2005, CORONARY HEART DIS E; Twigg L, 2004, SMOKING EPIDEMIC ENG	32	10	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e32787	10.1371/journal.pone.0032787	http://dx.doi.org/10.1371/journal.pone.0032787			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427884	Green Published, gold, Green Submitted			2022-12-25	WOS:000302381500045
J	Weiss, SL; Yu, M; Jennings, L; Haymond, S; Zhang, G; Wainwright, MS				Weiss, Scott L.; Yu, Min; Jennings, Lawrence; Haymond, Shannon; Zhang, Gang; Wainwright, Mark S.			Pilot Study of the Association of the DDAH2-449G Polymorphism with Asymmetric Dimethylarginine and Hemodynamic Shock in Pediatric Sepsis	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHESIS; COMMON GENETIC-VARIATION; SEPTIC SHOCK; ARGININE DERIVATIVES; RISK-FACTOR; DIMETHYLAMINOHYDROLASE; ADMA; CHILDREN; DISEASE; NITRITE/NITRATE	Background: Genetic variability in the regulation of the nitric oxide (NO) pathway may influence hemodynamic changes in pediatric sepsis. We sought to determine whether functional polymorphisms in DDAH2, which metabolizes the NO synthase inhibitor asymmetric dimethylarginine (ADMA), are associated with susceptibility to sepsis, plasma ADMA, distinct hemodynamic states, and vasopressor requirements in pediatric septic shock. Methodology/Principal Findings: In a prospective study, blood and buccal swabs were obtained from 82 patients <= 18 years (29 with severe sepsis/septic shock plus 27 febrile and 26 healthy controls). Plasma ADMA was measured using tandem mass spectrometry. DDAH2 gene was partially sequenced to determine the -871 6g/7g insertion/deletion and -449G/C single nucleotide polymorphisms. Shock type ("warm'' versus "cold'') was characterized by clinical assessment. The -871 7g allele was more common in septic (17%) then febrile (4%) and healthy (8%) patients, though this was not significant after controlling for sex and race (p = 0.96). ADMA did not differ between -871 6g/7g genotypes. While genotype frequencies also did not vary between groups for the -449G/C SNP (p = 0.75), septic patients with at least one -449G allele had lower ADMA (median, IQR 0.36, 0.30-0.41 mu mol/L) than patients with the -449CC genotype (0.55, 0.49-0.64 mu mol/L, p = 0.008) and exhibited a higher incidence of "cold'' shock (45% versus 0%, p = 0.01). However, after controlling for race, the association with shock type became non-significant (p = 0.32). Neither polymorphism was associated with inotrope score or vasoactive infusion duration. Conclusions/Significance: The -449G polymorphism in the DDAH2 gene was associated with both low plasma ADMA and an increased likelihood of presenting with "cold'' shock in pediatric sepsis, but not with vasopressor requirement. Race, however, was an important confounder. These results support and justify the need for larger studies in racially homogenous populations to further examine whether genotypic differences in NO metabolism contribute to phenotypic variability in sepsis pathophysiology.	[Weiss, Scott L.; Wainwright, Mark S.] Childrens Mem Hosp, Dept Pediat, Div Crit Care, NW Feinberg Sch Med, Chicago, IL 60614 USA; [Yu, Min; Jennings, Lawrence; Haymond, Shannon] Childrens Mem Hosp, Dept Pathol & Lab Med, NW Feinberg Sch Med, Chicago, IL 60614 USA; [Zhang, Gang] Childrens Mem Res Ctr, Chicago, IL USA; [Wainwright, Mark S.] Childrens Mem Hosp, Dept Pediat, Div Neurol, NW Feinberg Sch Med, Chicago, IL 60614 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine	Weiss, SL (corresponding author), Childrens Mem Hosp, Dept Pediat, Div Crit Care, NW Feinberg Sch Med, Chicago, IL 60614 USA.	WeissS@email.chop.edu		Weiss, Scott/0000-0002-7040-3281	Medical Research Junior Board Foundation; Department of Pathology and Laboratory Medicine; Colman Family Grant; National Center for Research Resources, National Institutes of Health [UL1RR025741]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER	Medical Research Junior Board Foundation; Department of Pathology and Laboratory Medicine; Colman Family Grant; National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Financial support was provided by the Medical Research Junior Board Foundation (MSW), the Department of Pathology and Laboratory Medicine (LJ, SH), the Colman Family Grant (SLW), and by grant UL1RR025741 from the National Center for Research Resources, National Institutes of Health (MSW, SLW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhary S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009462; Akbar F, 2005, MOL HUM REPROD, V11, P73, DOI 10.1093/molehr/gah116; Argaman Z, 2003, CRIT CARE MED, V31, P591, DOI 10.1097/01.CCM.0000050291.37714.74; Bai YY, 2009, CLIN SCI, V117, P273, DOI 10.1042/CS20090005; Boger RH, 2005, CLIN CHEM LAB MED, V43, P1124, DOI 10.1515/CCLM.2005.196; Brierley J, 2008, PEDIATRICS, V122, P752, DOI 10.1542/peds.2007-1979; Brierley J, 2009, CRIT CARE MED, V37, P666, DOI 10.1097/CCM.0b013e31819323c6; Brooks ER, 2009, PEDIATR NEPHROL, V24, P129, DOI 10.1007/s00467-008-0972-1; Ceneviva G, 1998, PEDIATRICS, V102, part. no., DOI 10.1542/peds.102.2.e19; Chan JR, 2000, ARTERIOSCL THROM VAS, V20, P1040, DOI 10.1161/01.ATV.20.4.1040; Davis JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017260; Dayoub H, 2003, CIRCULATION, V108, P3042, DOI 10.1161/01.CIR.0000101924.04515.2E; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; deWerra I, 1997, CRIT CARE MED, V25, P607, DOI 10.1097/00003246-199704000-00009; Gaies MG, 2010, PEDIATR CRIT CARE ME, V11, P234, DOI 10.1097/PCC.0b013e3181b806fc; Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2; Hu XL, 2011, ARTERIOSCL THROM VAS, V31, P1540, DOI 10.1161/ATVBAHA.110.222638; Iapichino G, 2010, MINERVA ANESTESIOL, V76, P325; Jones LC, 2003, BIOCHEM BIOPH RES CO, V310, P836, DOI 10.1016/j.bbrc.2003.09.097; KrafteJacobs B, 1997, CRIT CARE MED, V25, P1588, DOI 10.1097/00003246-199709000-00030; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Leiper J, 2002, P NATL ACAD SCI USA, V99, P13527, DOI 10.1073/pnas.212269799; Leteurtre S, 2003, LANCET, V362, P192, DOI 10.1016/S0140-6736(03)13908-6; Lu CW, 2007, NITRIC OXIDE-BIOL CH, V16, P94, DOI 10.1016/j.niox.2006.07.006; Maas R, 2009, PHARMACOL RES, V60, P488, DOI 10.1016/j.phrs.2009.07.013; MacAllister RJ, 1996, BRIT J PHARMACOL, V119, P1533, DOI 10.1111/j.1476-5381.1996.tb16069.x; Nijveldt RJ, 2003, CLIN NUTR, V22, P23, DOI 10.1054/clnu.2002.0613; O'Dwyer MJ, 2006, CRIT CARE, V10, DOI 10.1186/cc5053; Palm F, 2007, AM J PHYSIOL-HEART C, V293, pH3227, DOI 10.1152/ajpheart.00998.2007; PARKER MM, 1987, CRIT CARE MED, V15, P923, DOI 10.1097/00003246-198710000-00006; POLLACK MM, 1985, CRIT CARE MED, V13, P454, DOI 10.1097/00003246-198506000-00002; Ryan R, 2006, ANN THORAC SURG, V82, P895, DOI 10.1016/j.athoracsur.2006.04.029; Schulze F, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.06.005; Slater A, 2003, INTENS CARE MED, V29, P278, DOI 10.1007/s00134-002-1601-2; Tran CTL, 2003, ATHEROSCLEROSIS SUPP, V4, P33, DOI 10.1016/S1567-5688(03)00032-1; Valkonen VP, 2005, VASC MED, V10, pS45, DOI 10.1177/1358836X0501000107; Vincent JL, 2000, AM J RESP CRIT CARE, V161, P1781, DOI 10.1164/ajrccm.161.6.9812004; Wang D, 2007, CIRC RES, V101, P627, DOI 10.1161/CIRCRESAHA.107.158915; Wang J, 2006, CELL MOL LIFE SCI, V63, P2838, DOI 10.1007/s00018-006-6271-8; Wang S, 2007, CLIN CHEM LAB MED, V45, P1305, DOI 10.1515/CCLM.2007.277; Weiss S, 2012, CRITICAL CA IN PRESS; Wilcken DEL, 2007, MOL GENET METAB, V91, P309, DOI 10.1016/j.ymgme.2007.04.017; WONG HR, 1995, CRIT CARE MED, V23, P835, DOI 10.1097/00003246-199505000-00010; Yeo TW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000868	44	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33355	10.1371/journal.pone.0033355	http://dx.doi.org/10.1371/journal.pone.0033355			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22428028	Green Published, gold, Green Submitted			2022-12-25	WOS:000302381500131
J	da Costa, TPS; Tieu, W; Yap, MY; Pendini, NR; Polyak, SW; Pedersen, DS; Morona, R; Turnidge, JD; Wallace, JC; Wilce, MCJ; Booker, GW; Abell, AD				da Costa, Tatiana P. Soares; Tieu, William; Yap, Min Y.; Pendini, Nicole R.; Polyak, Steven W.; Pedersen, Daniel Sejer; Morona, Renato; Turnidge, John D.; Wallace, John C.; Wilce, Matthew C. J.; Booker, Grant W.; Abell, Andrew D.			Selective inhibition of Biotin Protein Ligase from Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPRESSOR DIMERIZATION; ESCHERICHIA-COLI; TERMINAL DOMAIN; BAD BUGS; IDENTIFICATION; ANTIBIOTICS; ADENYLATE; GENES; BIOSYNTHESIS; ATTACHMENT	There is a well documented need to replenish the antibiotic pipeline with new agents to combat the rise of drug resistant bacteria. One strategy to combat resistance is to discover new chemical classes immune to current resistance mechanisms that inhibit essential metabolic enzymes. Many of the obvious drug targets that have no homologous isozyme in the human host have now been investigated. Bacterial drug targets that have a closely related human homologue represent a new frontier in antibiotic discovery. However, to avoid potential toxicity to the host, these inhibitors must have very high selectivity for the bacterial enzyme over the human homolog. We have demonstrated that the essential enzyme biotin protein ligase (BPL) from the clinically important pathogen Staphylococcus aureus could be selectively inhibited. Linking biotin to adenosine via a 1,2,3 triazole yielded the first BPL inhibitor selective for S. aureus BPL over the human equivalent. The synthesis of new biotin 1,2,3-triazole analogues using click chemistry yielded our most potent structure (K-t 90 nM) with a > 1100-fold selectivity for the S. aureus BPL over the human homologue. X-ray crystallography confirmed the mechanism of inhibitor binding. Importantly, the inhibitor showed cytotoxicity against S. aureus but not cultured mammalian cells. The biotin 1,2,3-triazole provides a novel pharmacophore for future medicinal chemistry programs to develop this new antibiotic class.	[da Costa, Tatiana P. Soares; Pendini, Nicole R.; Polyak, Steven W.; Morona, Renato; Turnidge, John D.; Wallace, John C.; Booker, Grant W.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia; [Tieu, William; Pedersen, Daniel Sejer; Abell, Andrew D.] Univ Adelaide, Sch Chem & Phys, Adelaide, SA 5005, Australia; [Yap, Min Y.; Pendini, Nicole R.; Wilce, Matthew C. J.] Monash Univ, Sch Biomed Sci, Clayton, Vic 3800, Australia; [Turnidge, John D.] SA Pathol Womens & Childrens Hosp, Adelaide, SA 5006, Australia	University of Adelaide; University of Adelaide; Monash University; SA Pathology	Polyak, SW (corresponding author), Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia.	steven.polyak@adelaide.edu.au	Pedersen, Daniel Sejer/A-5974-2009; Polyak, Steven W./G-3185-2011; Tieu, William/Z-1790-2019; , John/AAP-5150-2020; Morona, Renato/B-7746-2013; Polyak, Steven W/A-7488-2019	Pedersen, Daniel Sejer/0000-0003-3926-7047; Polyak, Steven W./0000-0002-8458-5194; Tieu, William/0000-0002-7161-4152; Morona, Renato/0000-0001-7009-7440; Polyak, Steven W/0000-0002-8458-5194; Soares da Costa, Tatiana P./0000-0002-6275-7485	National Health and Medical Research Council of Australia [565506, 1011806]; Adelaide Research and Innovation's Commercial Accelerator Scheme; Carlsberg Foundation	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Adelaide Research and Innovation's Commercial Accelerator Scheme; Carlsberg Foundation(Carlsberg Foundation)	This work was supported by the National Health and Medical Research Council of Australia (applications 565506 and 1011806) and Adelaide Research and Innovation's Commercial Accelerator Scheme.; Supported by the Carlsberg Foundation. Present address: Dept. of Medicinal Chemistry, University of Copenhagen, Universitetsparken 2, Copenhagen, 2100 Denmark.	Bagautdinov B, 2005, J MOL BIOL, V353, P322, DOI 10.1016/j.jmb.2005.08.032; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bernier S, 2005, BIOORGAN MED CHEM, V13, P69, DOI 10.1016/j.bmc.2004.09.055; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Brown PH, 2004, J MOL BIOL, V337, P857, DOI 10.1016/j.jmb.2004.01.041; Byun Y, 2008, NUCLEOS NUCLEOT NUCL, V27, P244, DOI 10.1080/15257770701845238; Campbell JW, 2001, ANNU REV MICROBIOL, V55, P305, DOI 10.1146/annurev.micro.55.1.305; Chapman-Smith A, 1999, J NUTR, V129, p477S, DOI 10.1093/jn/129.2.477S; Chapman-Smith A, 2001, PROTEIN SCI, V10, P2608, DOI 10.1110/ps.ps.22401; Chaudhuri RR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-291; Chen LQ, 2010, J MED CHEM, V53, P4768, DOI 10.1021/jm100424m; Colman PM, 2009, ANNU REV BIOCHEM, V78, P95, DOI 10.1146/annurev.biochem.78.082207.084029; Comstock LR, 2002, TETRAHEDRON, V58, P6019, DOI 10.1016/S0040-4020(02)00590-2; Cooper MA, 2011, NATURE, V472, P32, DOI 10.1038/472032a; Corona C, 2006, ORG LETT, V8, P1883, DOI 10.1021/ol060458r; Costantino L, 2006, CURR MED CHEM, V13, P65, DOI 10.2174/092986706775197944; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Duckworth BP, 2011, CHEM BIOL, V18, P1432, DOI 10.1016/j.chembiol.2011.08.013; El-Sagheer AH, 2010, CHEM SOC REV, V39, P1388, DOI 10.1039/b901971p; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forrest AK, 2000, BIOORG MED CHEM LETT, V10, P1871, DOI 10.1016/S0960-894X(00)00360-7; Forsyth RA, 2002, MOL MICROBIOL, V43, P1387, DOI 10.1046/j.1365-2958.2002.02832.x; Frearson JA, 2007, TRENDS PARASITOL, V23, P589, DOI 10.1016/j.pt.2007.08.019; Freiberg C, 2006, ANTIMICROB AGENTS CH, V50, P2707, DOI 10.1128/AAC.00012-06; Gupta V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009222; Hurdle JG, 2005, ANTIMICROB AGENTS CH, V49, P4821, DOI 10.1128/AAC.49.12.4821-4833.2005; Ji YD, 2001, SCIENCE, V293, P2266, DOI 10.1126/science.1063566; Jitrapakdee S, 2008, BIOCHEM J, V413, P369, DOI 10.1042/BJ20080709; Lee J, 1999, BIOORG MED CHEM LETT, V9, P1365, DOI 10.1016/S0960-894X(99)00206-1; Mayende L, 2012, J MOL MED, V90, P81, DOI 10.1007/s00109-011-0811-x; Meldal M, 2008, CHEM REV, V108, P2952, DOI 10.1021/cr0783479; Naganathan S, 2007, J MOL BIOL, V373, P96, DOI 10.1016/j.jmb.2007.07.020; Parsons JB, 2011, P NATL ACAD SCI USA, V108, P15378, DOI 10.1073/pnas.1109208108; Patrone JD, 2009, J AM CHEM SOC, V131, P16340, DOI 10.1021/ja906537f; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Pendini NR, 2008, BBA-PROTEINS PROTEOM, V1784, P973, DOI 10.1016/j.bbapap.2008.03.011; Pendini NR, 2008, ACTA CRYSTALLOGR F, V64, P520, DOI 10.1107/S1744309108012244; Polyak SW, 2012, APPL MICROBIOL BIOT, V93, P983, DOI 10.1007/s00253-011-3796-z; Polyak SW, 2001, J BIOL CHEM, V276, P3037, DOI 10.1074/jbc.M003968200; Polyak SW, 1999, J BIOL CHEM, V274, P32847, DOI 10.1074/jbc.274.46.32847; Poupaert J, 2005, CURR MED CHEM, V12, P877, DOI 10.2174/0929867053507388; Raman K, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-109; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Schreiber M, 2009, CURR OPIN CELL BIOL, V21, P325, DOI 10.1016/j.ceb.2009.01.026; Slavoff SA, 2008, J AM CHEM SOC, V130, P1160, DOI 10.1021/ja076655i; Somu RV, 2006, J MED CHEM, V49, P31, DOI 10.1021/jm051060o; Streaker ED, 2003, J MOL BIOL, V325, P937, DOI 10.1016/S0022-2836(02)01308-6; Tian Y, 2008, BIOCHEMISTRY-US, V47, P12434, DOI 10.1021/bi801311d; Triola G, 2009, BIOORGAN MED CHEM, V17, P1079, DOI 10.1016/j.bmc.2008.02.046; Tron CM, 2009, J MOL BIOL, V387, P129, DOI 10.1016/j.jmb.2008.12.086; Turnidge JD, 2009, MED J AUSTRALIA, V191, P368, DOI 10.5694/j.1326-5377.2009.tb02841.x; von Itzstein M, 2007, NAT REV DRUG DISCOV, V6, P967, DOI 10.1038/nrd2400; Wood ZA, 2006, J MOL BIOL, V357, P509, DOI 10.1016/j.jmb.2005.12.066; Xu Y, 1995, BIOCHEMISTRY-US, V34, P16624, DOI 10.1021/bi00051a010; Yonath A, 2005, ANNU REV BIOCHEM, V74, P649, DOI 10.1146/annurev.biochem.74.082803.133130; Yu XY, 1999, BIOORG MED CHEM LETT, V9, P375, DOI 10.1016/S0960-894X(98)00738-0	56	39	42	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17823	17832		10.1074/jbc.M112.356576	http://dx.doi.org/10.1074/jbc.M112.356576			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22437830	hybrid, Green Published			2022-12-25	WOS:000306373000080
J	Chen, M; Drury, JE; Christianson, DW; Penning, TM				Chen, Mo; Drury, Jason E.; Christianson, David W.; Penning, Trevor M.			Conversion of Human Steroid 5 beta-Reductase (AKR1D1) into 3 beta-Hydroxysteroid Dehydrogenase by Single Point Mutation E120H EXAMPLE OF PERFECT ENZYME ENGINEERING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KETO REDUCTASE SUPERFAMILY; CYTOSOLIC HYDROXYSTEROID DEHYDROGENASES; CRYSTAL-STRUCTURE; DELTA(5)-3-KETOSTEROID ISOMERASE; SUBSTRATE-SPECIFICITY; TESTOSTERONE; MECHANISM; DEFINES; BINDING; IDENTIFICATION	Human aldo-keto reductase 1D1 (AKR1D1) and AKR1C enzymes are essential for bile acid biosynthesis and steroid hormone metabolism. AKR1D1 catalyzes the 5 beta-reduction of Delta(4)-3-ketosteroids, whereas AKR1C enzymes are hydroxysteroid dehydrogenases (HSDs). These enzymes share high sequence identity and catalyze 4-pro-(R)-hydride transfer from NADPH to an electrophilic carbon but differ in that one residue in the conserved AKR catalytic tetrad, His(120) (AKR1D1 numbering), is substituted by a glutamate in AKR1D1. We find that the AKR1D1 E120H mutant abolishes 5 beta-reductase activity and introduces HSD activity. However, the E120H mutant unexpectedly favors dihydrosteroids with the 5 alpha-configuration and, unlike most of the AKR1C enzymes, shows a dominant stereochemical preference to act as a 3 beta-HSD as opposed to a 3 alpha-HSD. The catalytic efficiency achieved for 3 beta-HSD activity is higher than that observed for any AKR to date. High resolution crystal structures of the E120H mutant in complex with epiandrosterone, 5 beta-dihydrotestosterone, and Delta(4)-androstene-3,17-dione elucidated the structural basis for this functional change. The glutamate-histidine substitution prevents a 3-ketosteroid from penetrating the active site so that hydride transfer is directed toward the C3 carbonyl group rather than the Delta(4)-double bond and confers 3 beta-HSD activity on the 5 beta-reductase. Structures indicate that stereospecificity of HSD activity is achieved because the steroid flips over to present its alpha-face to the A-face of NADPH. This is in contrast to the AKR1C enzymes, which can invert stereochemistry when the steroid swings across the binding pocket. These studies show how a single point mutation in AKR1D1 can introduce HSD activity with unexpected configurational and stereochemical preference.	[Chen, Mo; Drury, Jason E.; Penning, Trevor M.] Univ Penn, Perelman Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; [Chen, Mo; Drury, Jason E.; Penning, Trevor M.] Univ Penn, Perelman Sch Med, Ctr Excellence Environm Toxicol, Philadelphia, PA 19104 USA; [Christianson, David W.] Univ Penn, Dept Chem, Roy & Diana Vagelos Labs, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Penning, TM (corresponding author), Univ Penn, Perelman Sch Med, Dept Pharmacol, 130C John Morgan Bldg,3620 Hamilton Walk, Philadelphia, PA 19104 USA.	penning@upenn.edu		Penning, Trevor/0000-0002-3937-1066	National Institutes of Health (NIH) [R01-DK40715, P30-ES013508, GM-056838]; NIH, NIDDK [F32DK089827]; National Center for Research Resources, National Institutes of Health [RR-15301, P41RR012408]; United States Department of Energy [DE-AC02-06CH11357]; Offices of Biological and Environmental Research and of Basic Energy Sciences of the United States Department of Energy; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301, P41RR012408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK089827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056838] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); United States Department of Energy(United States Department of Energy (DOE)); Offices of Biological and Environmental Research and of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grants R01-DK40715 and P30-ES013508 (to T. M. P.), NIH Grant GM-056838 (to D. W. C.), and NIH, NIDDK, Grant F32DK089827 (to M. C.).; We thank Dr. Julie A. Aaron for assistance in data collecting and processing and Dr. Yi Jin for helpful discussions. Part of this work was based upon research conducted at the Advanced Photon Source on the Northeastern Collaborative Access Team beamline 24_ID_C (supported by National Center for Research Resources, National Institutes of Health, Grant RR-15301). Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy Office of Science by Argonne National Laboratory, was supported by the United States Department of Energy under Contract DE-AC02-06CH11357. Part of this work was based upon research conducted at beamline X29 of the National Synchrotron Light Source. Financial support comes principally from the Offices of Biological and Environmental Research and of Basic Energy Sciences of the United States Department of Energy and from National Center for Research Resources, National Institutes of Health, Grant P41RR012408.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bennett MJ, 1997, STRUCTURE, V5, P799, DOI 10.1016/S0969-2126(97)00234-7; BERSEUS O, 1967, EUR J BIOCHEM, V2, P503, DOI 10.1111/j.1432-1033.1967.tb00164.x; Bertilsson G, 1998, P NATL ACAD SCI USA, V95, P12208, DOI 10.1073/pnas.95.21.12208; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen M, 2011, STEROIDS, V76, P484, DOI 10.1016/j.steroids.2011.01.003; Cho HS, 1999, J BIOL CHEM, V274, P32863, DOI 10.1074/jbc.274.46.32863; Couture JF, 2003, J MOL BIOL, V331, P593, DOI 10.1016/S0022-2836(03)00762-9; Di Costanzo L, 2008, J BIOL CHEM, V283, P16830, DOI 10.1074/jbc.M801778200; Di Costanzo L, 2009, MOL CELL ENDOCRINOL, V301, P191, DOI 10.1016/j.mce.2008.09.013; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faucher F, 2008, BIOCHEMISTRY-US, V47, P8261, DOI 10.1021/bi800572s; GRANICK S, 1967, P NATL ACAD SCI USA, V57, P1463, DOI 10.1073/pnas.57.5.1463; Jez JM, 1998, BIOCHEMISTRY-US, V37, P9695, DOI 10.1021/bi980294p; Jez JM, 1997, BIOCHEM J, V326, P625, DOI 10.1042/bj3260625; Jin Y, 2006, STEROIDS, V71, P380, DOI 10.1016/j.steroids.2005.12.002; Jin Y, 2001, BIOCHEMISTRY-US, V40, P10161, DOI 10.1021/bi010919a; Jin Y, 2011, BIOCHEM J, V437, P53, DOI 10.1042/BJ20101804; Jin Y, 2009, J BIOL CHEM, V284, P10013, DOI 10.1074/jbc.M809465200; Kim SW, 1997, BIOCHEMISTRY-US, V36, P14030, DOI 10.1021/bi971546+; KONDO KH, 1994, EUR J BIOCHEM, V219, P357, DOI 10.1111/j.1432-1033.1994.tb19947.x; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEVERE RD, 1967, P NATL ACAD SCI USA, V58, P985, DOI 10.1073/pnas.58.3.985; March J., 1984, ADV ORGANIC CHEM REA, P694; Massiah MA, 1998, BIOCHEMISTRY-US, V37, P14701, DOI 10.1021/bi981447b; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moore LB, 2000, J BIOL CHEM, V275, P15122, DOI 10.1074/jbc.M001215200; Nahoum V, 2001, J BIOL CHEM, V276, P42091, DOI 10.1074/jbc.M105610200; NORYMBERSKI JK, 1955, J CHEM SOC, P3426, DOI 10.1039/jr9550003426; OKUDA A, 1984, J BIOL CHEM, V259, P7519; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Penning TM, 2000, BIOCHEM J, V351, P67, DOI 10.1042/0264-6021:3510067; Penning TM, 2007, ARCH BIOCHEM BIOPHYS, V464, P241, DOI 10.1016/j.abb.2007.04.024; Qiu W, 2004, MOL ENDOCRINOL, V18, P1798, DOI 10.1210/me.2004-0032; RUSSELL DW, 1992, BIOCHEMISTRY-US, V31, P4737, DOI 10.1021/bi00135a001; Schlegel BP, 1998, BIOCHEMISTRY-US, V37, P3538, DOI 10.1021/bi9723055; Sheehan PM, 2005, MOL HUM REPROD, V11, P495, DOI 10.1093/molehr/gah201; Simard J, 2005, ENDOCR REV, V26, P525, DOI 10.1210/er.2002-0050; Steckelbroeck S, 2004, J BIOL CHEM, V279, P10784, DOI 10.1074/jbc.M313308200; Thorn A, 2008, J BIOL CHEM, V283, P17260, DOI 10.1074/jbc.M706185200; Wu ZR, 1997, SCIENCE, V276, P415, DOI 10.1126/science.276.5311.415; Zhao QJ, 1997, BIOCHEMISTRY-US, V36, P14616, DOI 10.1021/bi971549m	42	14	16	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16609	16622		10.1074/jbc.M111.338780	http://dx.doi.org/10.1074/jbc.M111.338780			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22437839	hybrid, Green Published			2022-12-25	WOS:000304030900050
J	Niere, M; Mashimo, M; Agledal, L; Dolle, C; Kasamatsu, A; Kato, J; Moss, J; Ziegler, M				Niere, Marc; Mashimo, Masato; Agledal, Line; Dolle, Christian; Kasamatsu, Atsushi; Kato, Jiro; Moss, Joel; Ziegler, Mathias			ADP-ribosylhydrolase 3 (ARH3), Not Poly(ADP-ribose) Glycohydrolase (PARG) Isoforms, Is Responsible for Degradation of Mitochondrial Matrix-associated Poly(ADP-ribose)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOSIS-INDUCING FACTOR; DNA-DAMAGE; CELL-DEATH; MAMMALIAN-CELLS; PROTEIN; IDENTIFICATION; LOCALIZATION; POLYMERASE; RIBOSYLATION; RIBOSE	Important cellular processes are regulated by poly(ADP-ribosyl)ation. This protein modification is catalyzed mainly by nuclear poly(ADP-ribose) polymerase (PARP) 1 in response to DNA damage. Cytosolic PARP isoforms have been described, whereas the presence of poly(ADP-ribose) (PAR) metabolism in mitochondria is controversial. PAR is degraded by poly(ADPribose) glycohydrolase (PARG). Recently, ADP-ribosylhydrolase 3 (ARH3) was also shown to catalyze PAR-degradation in vitro. PARG is encoded by a single, essential gene. One nuclear and three cytosolic isoforms result from alternative splicing. The presence and origin of a mitochondrial PARG is still unresolved. We establish here the genetic background of a human mitochondrial PARG isoform and investigate the molecular basis for mitochondrial poly(ADP-ribose) degradation. In common with a cytosolic 60-kDa human PARG isoform, the mitochondrial protein did not catalyze PAR degradation because of the absence of exon 5-encoded residues. In mice, we identified a transcript encoding an inactive cytosolic 52-kDa PARG lacking the mitochondrial targeting sequence and a substantial portion of exon 5. Thus, mammalian PARG genes encode isoforms that do not catalyze PAR degradation. On the other hand, embryonic fibroblasts from ARH3(-/-) mice lack most of the mitochondrial PAR degrading activity detected in wild-type cells, demonstrating a potential involvement of ARH3 in PAR metabolism.	[Niere, Marc; Agledal, Line; Dolle, Christian; Ziegler, Mathias] Univ Bergen, Dept Mol Biol, N-5020 Bergen, Norway; [Mashimo, Masato; Kasamatsu, Atsushi; Kato, Jiro; Moss, Joel] NHLBI, Cardiovasc & Pulm Branch, NIH, Bethesda, MD 20892 USA	University of Bergen; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Ziegler, M (corresponding author), Univ Bergen, Dept Mol Biol, Postbox 7803, N-5020 Bergen, Norway.	mathias.ziegler@mbi.uib.no		Mashimo, Masato/0000-0003-3922-7344; Ziegler, Mathias/0000-0001-6961-2396	National Heart, Lung, and Blood Institute, National Institutes of Health; Norwegian Cancer Society; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000659] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Norwegian Cancer Society(Norwegian Cancer Society); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported, in whole or in part, by the Intramural Research Program, National Heart, Lung, and Blood Institute, National Institutes of Health. This work was also supported by the Norwegian Cancer Society.	Affar EB, 2001, J BIOL CHEM, V276, P2935, DOI 10.1074/jbc.M007269200; Alano CC, 2004, J BIOL CHEM, V279, P18895, DOI 10.1074/jbc.M313329200; ALVAREZGONZALEZ R, 1987, BIOCHEMISTRY-US, V26, P3218, DOI 10.1021/bi00385a042; Ame JC, 1999, J BIOL CHEM, V274, P17860, DOI 10.1074/jbc.274.25.17860; Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Blenn C, 2006, BIOCHEM J, V396, P419, DOI 10.1042/BJ20051696; Bonicalzi ME, 2005, CELL MOL LIFE SCI, V62, P739, DOI 10.1007/s00018-004-4505-1; Botta D, 2010, BIOCHEMISTRY-US, V49, P7674, DOI 10.1021/bi100973m; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chiarugi A, 2002, TRENDS PHARMACOL SCI, V23, P122, DOI 10.1016/S0165-6147(00)01902-7; Cipriani G, 2005, J BIOL CHEM, V280, P17227, DOI 10.1074/jbc.M414526200; Corda D, 2003, EMBO J, V22, P1953, DOI 10.1093/emboj/cdg209; Cortes U, 2004, MOL CELL BIOL, V24, P7163, DOI 10.1128/MCB.24.16.7163-7178.2004; Dantzer F, 2006, METHOD ENZYMOL, V409, P493, DOI 10.1016/S0076-6879(05)09029-4; David KK, 2009, FRONT BIOSCI-LANDMRK, V14, P1116, DOI 10.2741/3297; Di Girolamo M, 2005, FEBS J, V272, P4565, DOI 10.1111/j.1742-4658.2005.04876.x; Dolle C, 2010, CELL MOL LIFE SCI, V67, P433, DOI 10.1007/s00018-009-0190-4; Haince JF, 2006, BBA-MOL CELL RES, V1763, P226, DOI 10.1016/j.bbamcr.2005.11.015; Hassa PO, 2006, MICROBIOL MOL BIOL R, V70, P789, DOI 10.1128/MMBR.00040-05; Hassa PO, 2002, CELL MOL LIFE SCI, V59, P1534, DOI 10.1007/s00018-002-8527-2; Imai S, 2010, TRENDS PHARMACOL SCI, V31, P212, DOI 10.1016/j.tips.2010.02.003; Kickhoefer VA, 1999, J CELL BIOL, V146, P917, DOI 10.1083/jcb.146.5.917; Koh DW, 2004, P NATL ACAD SCI USA, V101, P17699, DOI 10.1073/pnas.0406182101; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; Lin WS, 1997, J BIOL CHEM, V272, P11895, DOI 10.1074/jbc.272.18.11895; Lyons RJ, 2001, J BIOL CHEM, V276, P17172, DOI 10.1074/jbc.M009756200; Malanga M, 2005, BIOCHEM CELL BIOL, V83, P354, DOI 10.1139/o05-038; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; Meyer RG, 2007, EXP CELL RES, V313, P2920, DOI 10.1016/j.yexcr.2007.03.043; Meyer-Ficca ML, 2004, EXP CELL RES, V297, P521, DOI 10.1016/j.yexcr.2004.03.050; Mueller-Dieckmann C, 2006, P NATL ACAD SCI USA, V103, P15026, DOI 10.1073/pnas.0606762103; Niere M, 2008, MOL CELL BIOL, V28, P814, DOI 10.1128/MCB.01766-07; Oka S, 2006, J BIOL CHEM, V281, P705, DOI 10.1074/jbc.M510290200; Ono T, 2006, P NATL ACAD SCI USA, V103, P16687, DOI 10.1073/pnas.0607911103; Patel CN, 2005, BIOCHEM J, V388, P493, DOI 10.1042/BJ20040942; Rouleau M, 2007, J CELL BIOCHEM, V100, P385, DOI 10.1002/jcb.21051; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Seman M, 2004, CURR MED CHEM, V11, P857, DOI 10.2174/0929867043455611; Smith S, 1999, J CELL SCI, V112, P3649; Winstall E, 1999, EXP CELL RES, V251, P372, DOI 10.1006/excr.1999.4594; Ying WH, 2005, J NEUROSCI RES, V79, P216, DOI 10.1002/jnr.20289; Yu SW, 2006, P NATL ACAD SCI USA, V103, P18314, DOI 10.1073/pnas.0606528103; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221	43	92	98	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16088	16102		10.1074/jbc.M112.349183	http://dx.doi.org/10.1074/jbc.M112.349183			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22433848	Green Published, hybrid			2022-12-25	WOS:000304030900002
J	Arosio, P; Owczarz, M; Muller-Spath, T; Rognoni, P; Beeg, M; Wu, H; Salmona, M; Morbidelli, M				Arosio, Paolo; Owczarz, Marta; Mueller-Spaeth, Thomas; Rognoni, Paola; Beeg, Marten; Wu, Hua; Salmona, Mario; Morbidelli, Massimo			In Vitro Aggregation Behavior of a Non-Amyloidogenic lambda Light Chain Dimer Deriving from U266 Multiple Myeloma Cells	PLOS ONE			English	Article							FIBRIL FORMATION; DEPOSITION DISEASE; PHYSIOLOGICAL CONDITIONS; AMORPHOUS AGGREGATION; INSULIN FIBRILLATION; HOFMEISTER SERIES; PROTEIN; STABILITY; GLYCOSAMINOGLYCANS; BETA(2)-MICROGLOBULIN	Excessive production of monoclonal light chains due to multiple myeloma can induce aggregation-related disorders, such as light chain amyloidosis (AL) and light chain deposition diseases (LCDD). In this work, we produce a non-amyloidogenic IgE lambda light chain dimer from human mammalian cells U266, which originated from a patient suffering from multiple myeloma, and we investigate the effect of several physicochemical parameters on the in vitro stability of this protein. The dimer is stable in physiological conditions and aggregation is observed only when strong denaturating conditions are applied (acidic pH with salt at large concentration or heating at melting temperature T-m at pH 7.4). The produced aggregates are spherical, amorphous oligomers. Despite the larger beta-sheet content of such oligomers with respect to the native state, they do not bind Congo Red or ThT. The impossibility to obtain fibrils from the light chain dimer suggests that the occurrence of amyloidosis in patients requires the presence of the light chain fragment in the monomer form, while dimer can form only amorphous oligomers or amorphous deposits. No aggregation is observed after denaturant addition at pH 7.4 or at pH 2.0 with low salt concentration, indicating that not a generic unfolding but specific conformational changes are necessary to trigger aggregation. A specific anion effect in increasing the aggregation rate at pH 2.0 is observed according to the following order: SO4->> Cl- >H2PO4-, confirming the peculiar role of sulfate in promoting protein aggregation. It is found that, at least for the investigated case, the mechanism of the sulfate effect is related to protein secondary structure changes induced by anion binding.	[Arosio, Paolo; Owczarz, Marta; Mueller-Spaeth, Thomas; Beeg, Marten; Wu, Hua; Morbidelli, Massimo] ETH, Inst Chem & Bioengn, Dept Chem & Appl Biosci, Zurich, Switzerland; [Salmona, Mario] Ist Ric Farmacol Mario Negri, Dept Mol Biochem & Pharmacol, Milan, Italy; [Rognoni, Paola] Univ Pavia, Amyloid Res & Treatment Ctr, Fdn IRCCS Policlin San Matteo, I-27100 Pavia, Italy	Swiss Federal Institutes of Technology Domain; ETH Zurich; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; IRCCS Fondazione San Matteo; University of Pavia	Arosio, P (corresponding author), ETH, Inst Chem & Bioengn, Dept Chem & Appl Biosci, Zurich, Switzerland.	massimo.morbidelli@chem.ethz.ch	salmona, mario/AAA-7116-2020; Wu, Hua/A-3760-2013; salmona, mario/ABI-4066-2020; Beeg, Marten/AAA-9269-2020; Rognoni, Paola/P-9092-2019	salmona, mario/0000-0002-9098-9873; Wu, Hua/0000-0002-2805-4612; Beeg, Marten/0000-0001-7201-6704; Morbidelli, Massimo/0000-0002-0112-414X; Rognoni, Paola/0000-0001-6350-1919	Swiss National Science Foundation [200020-126487/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Financial support was provided by the Swiss National Science Foundation (Grant No. 200020-126487/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2004, J BIOL CHEM, V279, P14999, DOI 10.1074/jbc.M313134200; Ahmad A, 2003, BIOCHEMISTRY-US, V42, P11404, DOI 10.1021/bi034868o; Alvarado UR, 2001, J CRYST GROWTH, V223, P407, DOI 10.1016/S0022-0248(00)01011-3; Arosio P, 2011, PHARM RES-DORDR, V28, P1884, DOI 10.1007/s11095-011-0416-7; Baden EM, 2008, J BIOL CHEM, V283, P15853, DOI 10.1074/jbc.M705347200; Bellotti V, 2000, J STRUCT BIOL, V130, P280, DOI 10.1006/jsbi.2000.4248; Borysik AJ, 2007, KIDNEY INT, V72, P174, DOI 10.1038/sj.ki.5002270; Bostrom M, 2004, CURR OPIN COLLOID IN, V9, P48, DOI 10.1016/j.cocis.2004.05.001; BUXBAUM J, 1992, HEMATOL ONCOL CLIN N, V6, P323, DOI 10.1016/S0889-8588(18)30347-2; Buxbaum JN, 2001, AMYLOID, V8, P84, DOI 10.3109/13506120109007349; Calamai M, 2005, BIOPHYS J, V89, P4201, DOI 10.1529/biophysj.105.068726; Chiti F, 2001, J BIOL CHEM, V276, P46714, DOI 10.1074/jbc.M107040200; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Curtis RA, 2006, CHEM ENG SCI, V61, P907, DOI 10.1016/j.ces.2005.04.007; Gabrielson JP, 2007, J PHARM SCI-US, V96, P268, DOI 10.1002/jps.20760; IKEYAMA S, 1986, MOL IMMUNOL, V23, P159; Kaplan B, 2008, CLIN CHEM LAB MED, V46, P335, DOI 10.1515/CCLM.2008.068; Kaplan B, 2007, BRIT J HAEMATOL, V136, P723, DOI 10.1111/j.1365-2141.2006.06488.x; Khurana R, 2001, BIOCHEMISTRY-US, V40, P3525, DOI 10.1021/bi001782b; Kim YS, 2002, J BIOL CHEM, V277, P27240, DOI 10.1074/jbc.M202492200; Kim YS, 2001, J BIOL CHEM, V276, P1626, DOI 10.1074/jbc.M007766200; Kim YS, 2000, J BIOL CHEM, V275, P1570, DOI 10.1074/jbc.275.3.1570; Leung N, 2008, KIDNEY INT, V73, P1282, DOI 10.1038/ki.2008.108; McLaughlin RW, 2006, AMYLOID, V13, P45; McLaughlin RW, 2006, PROTEIN SCI, V15, P1710, DOI 10.1110/ps.051997606; Meng XY, 2008, J MOL BIOL, V381, P989, DOI 10.1016/j.jmb.2008.06.062; Merlini G, 2004, J INTERN MED, V255, P159, DOI 10.1046/j.1365-2796.2003.01262.x; Morris AM, 2009, BBA-PROTEINS PROTEOM, V1794, P375, DOI 10.1016/j.bbapap.2008.10.016; Motamedi-Shad N, 2009, J BIOL CHEM, V284, P29921, DOI 10.1074/jbc.M109.018747; Nieva J, 2008, BIOCHEMISTRY-US, V47, P7695, DOI 10.1021/bi800333s; NILSSON K, 1970, CLIN EXP IMMUNOL, V7, P477; NILSSON K, 1971, CLIN EXP IMMUNOL, V9, P785; Nilsson MR, 2004, METHODS, V34, P151, DOI 10.1016/j.ymeth.2004.03.012; Noborn F, 2010, AMYLOID, V17, P40; Obici L, 2005, BBA-PROTEINS PROTEOM, V1753, P11, DOI 10.1016/j.bbapap.2005.08.014; Powers ET, 2008, BIOPHYS J, V94, P379, DOI 10.1529/biophysj.107.117168; Qin ZJ, 2007, BIOCHEMISTRY-US, V46, P3521, DOI 10.1021/bi061716v; Raman B, 2005, BIOCHEMISTRY-US, V44, P1288, DOI 10.1021/bi048029t; Randles EG, 2009, J MOL BIOL, V389, P199, DOI 10.1016/j.jmb.2009.04.010; Roberts CJ, 2007, BIOTECHNOL BIOENG, V98, P927, DOI 10.1002/bit.21627; Seshadri S, 1999, METHOD ENZYMOL, V309, P559; Sikkink LA, 2008, BIOPHYS CHEM, V135, P25, DOI 10.1016/j.bpc.2008.02.019; Sikkink LA, 2008, AMYLOID, V15, P29, DOI 10.1080/13506120701815324; Sipe JD, AMYLOID PROTEINS, P527; Souillac PO, 2003, BIOCHEMISTRY-US, V42, P8094, DOI 10.1021/bi034652m; Souillac PO, 2002, J BIOL CHEM, V277, P12657, DOI 10.1074/jbc.M109230200; Souillac PO, 2002, J BIOL CHEM, V277, P12666, DOI 10.1074/jbc.M109229200; Stevens FJ, 2000, CELL MOL LIFE SCI, V57, P441, DOI 10.1007/PL00000706; Suk JY, 2006, BIOCHEMISTRY-US, V45, P2234, DOI 10.1021/bi0519295; Wall J, 1999, BIOCHEMISTRY-US, V38, P14101, DOI 10.1021/bi991131j; Yang H, 2006, LANGMUIR, V22, P8553, DOI 10.1021/la061238p; Zhang YJ, 2006, CURR OPIN CHEM BIOL, V10, P658, DOI 10.1016/j.cbpa.2006.09.020	52	15	15	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e33372	10.1371/journal.pone.0033372	http://dx.doi.org/10.1371/journal.pone.0033372			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22432016	Green Submitted, Green Published, gold			2022-12-25	WOS:000303198600059
J	Chua, KN; Sim, WJ; Racine, V; Lee, SY; Goh, BC; Thiery, JP				Chua, Kian-Ngiap; Sim, Wen-Jing; Racine, Victor; Lee, Shi-Yun; Goh, Boon Cher; Thiery, Jean Paul			A Cell-Based Small Molecule Screening Method for Identifying Inhibitors of Epithelial-Mesenchymal Transition in Carcinoma	PLOS ONE			English	Article							TGF-BETA; CANCER; TUMOR; SCATTERING	Epithelial Mesenchymal Transition (EMT) is a crucial mechanism for carcinoma progression, as it provides routes for in situ carcinoma cells to dissociate and become motile, leading to localized invasion and metastatic spread. Targeting EMT therefore represents an important therapeutic strategy for cancer treatment. The discovery of oncogene addiction in sustaining tumor growth has led to the rapid development of targeted therapeutics. Whilst initially optimized as anti-proliferative agents, it is likely that some of these compounds may inhibit EMT initiation or sustenance, since EMT is also modulated by similar signaling pathways that these compounds were designed to target. We have developed a novel screening assay that can lead to the identification of compounds that can inhibit EMT initiated by growth factor signaling. This assay is designed as a high-content screening assay where both cell growth and cell migration can be analyzed simultaneously via time-course imaging in multi-well plates. Using this assay, we have validated several compounds as viable EMT inhibitors. In particular, we have identified compounds targeting ALK5, MEK, and SRC as potent inhibitors that can interfere with EGF, HGF, and IGF-1 induced EMT signaling. Overall, this EMT screening method provides a foundation for improving the therapeutic value of recently developed compounds in advanced stage carcinoma.	[Chua, Kian-Ngiap; Goh, Boon Cher; Thiery, Jean Paul] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore; [Sim, Wen-Jing; Racine, Victor; Thiery, Jean Paul] ASTAR, Inst Mol & Cell Biol, Singapore, Singapore; [Lee, Shi-Yun] ASTAR, Ctr Expt Therapeut, Singapore, Singapore; [Goh, Boon Cher] Natl Univ Singapore Hosp, Dept Hematol Oncol, Singapore 117548, Singapore	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Agency for Science Technology & Research (A*STAR); A*STAR - Experimental Drug Development Centre (EDDC); Experimental Therapeutics Centre; National University of Singapore	Chua, KN (corresponding author), Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore.	jpthiery@imcb.a-star.edu.sg	Thiery, Jean Paul/M-9387-2019; Racine, Victor/I-4576-2014; Thiery, Jean Paul/H-1550-2011	Racine, Victor/0000-0002-1486-8973; Thiery, Jean Paul/0000-0003-0478-5020; Chua, Kian Ngiap/0000-0002-2622-0605	Agency for Science, Technology, and Research, Singapore; Cancer Science Institute, National University of Singapore, Singapore	Agency for Science, Technology, and Research, Singapore(Agency for Science Technology & Research (A*STAR)); Cancer Science Institute, National University of Singapore, Singapore(National University of Singapore)	This work was supported in part by the Agency for Science, Technology, and Research, Singapore and the Cancer Science Institute, National University of Singapore, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora A, 2005, J PHARMACOL EXP THER, V315, P971, DOI 10.1124/jpet.105.084145; Bamborough P, 2008, J MED CHEM, V51, P7898, DOI 10.1021/jm8011036; Barr S, 2008, CLIN EXP METASTAS, V25, P685, DOI 10.1007/s10585-007-9121-7; BELLUSCI S, 1994, J CELL SCI, V107, P1277; Beucher S., 1993, MATH MORPHOLOGY IMAG, P433, DOI DOI 10.1201/9781482277234-12; Bidard FC, 2008, CLIN CANCER RES, V14, P3306, DOI 10.1158/1078-0432.CCR-07-4749; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Chen Hong-Chen, 2004, V294, P15; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Chua KN, 2011, ADV DRUG DELIVER REV, V63, P558, DOI 10.1016/j.addr.2011.02.003; Chua KN., 2007, DRUG DISCOV TODAY DI, V4, P261; Collins CS, 2006, P NATL ACAD SCI USA, V103, P3775, DOI 10.1073/pnas.0600040103; Grotegut S, 2006, EMBO J, V25, P3534, DOI 10.1038/sj.emboj.7601213; Hochhaus A, 2008, BLOOD, V111, P1039, DOI 10.1182/blood-2007-07-103523; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Inglese J, 2007, NAT CHEM BIOL, V3, P438, DOI 10.1038/nchembio0807-438; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li YA, 2010, ONCOL REP, V24, P1019, DOI 10.3892/or_00000950; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Moriya C, 2011, J INVEST DERMATOL, V131, P655, DOI 10.1038/jid.2010.361; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Padua D, 2009, CELL RES, V19, P89, DOI 10.1038/cr.2008.316; Ponzo MG, 2009, P NATL ACAD SCI USA, V106, P12903, DOI 10.1073/pnas.0810402106; Reese DE, 2002, CIRC RES, V91, P761, DOI 10.1161/01.RES.0000038961.53759.3C; RODIER JM, 1995, J CELL BIOL, V131, P761, DOI 10.1083/jcb.131.3.761; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Shinto O, 2010, BRIT J CANCER, V102, P844, DOI 10.1038/sj.bjc.6605561; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Starck JL, 1998, IMAGE PROCESSING DAT, P307; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Yang AD, 2006, CANCER RES, V66, P46, DOI 10.1158/0008-5472.CAN-05-3086; Yarrow JC, 2005, CHEM BIOL, V12, P385, DOI 10.1016/j.chembiol.2005.01.015; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366	37	68	69	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e33183	10.1371/journal.pone.0033183	http://dx.doi.org/10.1371/journal.pone.0033183			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22432005	Green Published, Green Submitted, gold			2022-12-25	WOS:000303198600048
J	Medeiros, LCS; De Souza, W; Jiao, CG; Barrabin, H; Miranda, K				Soares Medeiros, Lia Carolina; De Souza, Wanderley; Jiao, Chengge; Barrabin, Hector; Miranda, Kildare			Visualizing the 3D Architecture of Multiple Erythrocytes Infected with Plasmodium at Nanoscale by Focused Ion Beam-Scanning Electron Microscopy	PLOS ONE			English	Article							3-DIMENSIONAL RECONSTRUCTION; MALARIA PARASITE; MAURERS CLEFTS; FALCIPARUM; MORPHOLOGY; TISSUE; ULTRASTRUCTURE; TOMOGRAPHY; PATHWAYS; VIVAX	Different methods for three-dimensional visualization of biological structures have been developed and extensively applied by different research groups. In the field of electron microscopy, a new technique that has emerged is the use of a focused ion beam and scanning electron microscopy for 3D reconstruction at nanoscale resolution. The higher extent of volume that can be reconstructed with this instrument represent one of the main benefits of this technique, which can provide statistically relevant 3D morphometrical data. As the life cycle of Plasmodium species is a process that involves several structurally complex developmental stages that are responsible for a series of modifications in the erythrocyte surface and cytoplasm, a high number of features within the parasites and the host cells has to be sampled for the correct interpretation of their 3D organization. Here, we used FIB-SEM to visualize the 3D architecture of multiple erythrocytes infected with Plasmodium chabaudi and analyzed their morphometrical parameters in a 3D space. We analyzed and quantified alterations on the host cells, such as the variety of shapes and sizes of their membrane profiles and parasite internal structures such as a polymorphic organization of hemoglobin-filled tubules. The results show the complex 3D organization of Plasmodium and infected erythrocyte, and demonstrate the contribution of FIB-SEM for the obtainment of statistical data for an accurate interpretation of complex biological structures.	[Soares Medeiros, Lia Carolina; De Souza, Wanderley; Miranda, Kildare] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Ultraestrutura Celular Hertha Meyer, BR-21941 Rio De Janeiro, Brazil; [Soares Medeiros, Lia Carolina; De Souza, Wanderley; Miranda, Kildare] Univ Fed Rio de Janeiro, Inst Nacl Ciencia & Tecnol Biol Estrutural & Bioi, Rio De Janeiro, Brazil; [Soares Medeiros, Lia Carolina; Barrabin, Hector] Univ Fed Rio de Janeiro, Lab Membranas Transportadoras, Inst Bioquim Med, Rio De Janeiro, Brazil; [De Souza, Wanderley; Miranda, Kildare] Inst Nacl Metrol Normalizacao & Qualidade Ind INM, Lab Biotecnol, Rio De Janeiro, Brazil; [Jiao, Chengge] FEI Co, Eindhoven, Netherlands	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Thermo Fisher Scientific; FEI Company	Medeiros, LCS (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Ultraestrutura Celular Hertha Meyer, BR-21941 Rio De Janeiro, Brazil.	kmiranda@biof.ufrj.br			Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); CNPq/Brazil; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq/Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by grants to the authors form the following Brazilian agencies: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Programa Jovens Pesquisadores CNPq/Brazil and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attias M, 1996, CELL STRUCT FUNCT, V21, P297, DOI 10.1247/csf.21.297; Bannister LH, 2000, PARASITOL TODAY, V16, P427, DOI 10.1016/S0169-4758(00)01755-5; Barcena M, 2009, SEMIN CELL DEV BIOL, V20, P920, DOI 10.1016/j.semcdb.2009.07.008; Bennett AE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000591; Bhattacharjee S, 2008, BLOOD, V111, P2418, DOI 10.1182/blood-2007-09-115279; Bracho C, 2002, PARASITOL RES, V88, P253, DOI 10.1007/s00436-001-0537-8; Bracho C, 2001, EUR J CELL BIOL, V80, P164, DOI 10.1078/0171-9335-00137; Charpian S, 2008, TRAFFIC, V9, P157, DOI 10.1111/j.1600-0854.2007.00648.x; Coggan JS, 2005, SCIENCE, V309, P446, DOI 10.1126/science.1108239; De Winter DAM, 2009, J MICROSC-OXFORD, V233, P372, DOI 10.1111/j.1365-2818.2009.03139.x; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Desbois G, 2008, GEOFLUIDS, V8, P60, DOI 10.1111/j.1468-8123.2007.00205.x; Drobne D, 2008, ULTRAMICROSCOPY, V108, P663, DOI 10.1016/j.ultramic.2007.10.010; Elliott DA, 2008, P NATL ACAD SCI USA, V105, P2463, DOI 10.1073/pnas.0711067105; Eshar S, 2011, TRENDS PARASITOL, V27, P548, DOI 10.1016/j.pt.2011.08.002; FUJIOKA H, 1993, EXP PARASITOL, V76, P302, DOI 10.1006/expr.1993.1036; Giannuzzi L. A., 1999, J PROCESS ANAL CHEM, V4, P162; Giannuzzi LA, 2007, J ORAL MAXIL SURG, V65, P737, DOI 10.1016/j.joms.2006.10.025; Hanssen E, 2011, J STRUCT BI IN PRESS; Hanssen E, 2011, J STRUCT BIOL, V173, P161, DOI 10.1016/j.jsb.2010.08.013; Hanssen E, 2010, INT J PARASITOL, V40, P123, DOI 10.1016/j.ijpara.2009.09.004; Hekking LHP, 2009, J MICROSC-OXFORD, V235, P336, DOI 10.1111/j.1365-2818.2009.03274.x; Hohmann-Marriott MF, 2009, NAT METHODS, V6, P729, DOI [10.1038/NMETH.1367, 10.1038/nmeth.1367]; Hopkins J, 1999, PROTIST, V150, P283, DOI 10.1016/S1434-4610(99)70030-1; Knott G, 2008, J NEUROSCI, V28, P2959, DOI 10.1523/JNEUROSCI.3189-07.2008; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lacomble S, 2009, J CELL SCI, V122, P1081, DOI 10.1242/jcs.045740; Lamers E, 2010, TISSUE EN C IN PRESS; Leser V, 2010, PROTOPLASMA, V246, P41, DOI 10.1007/s00709-010-0118-8; MACKENSTEDT U, 1989, PARASITOL RES, V75, P528, DOI 10.1007/BF00931161; Maurer G., 1900, Zentralblatt fuer Bakteriologie, Vxxviii, P114; Mishchenko Y, 2009, J NEUROSCI METH, V176, P276, DOI 10.1016/j.jneumeth.2008.09.006; Nalla RK, 2005, MICRON, V36, P672, DOI 10.1016/j.micron.2005.05.011; Schaffer M, 2007, ULTRAMICROSCOPY, V107, P587, DOI 10.1016/j.ultramic.2006.11.007; Sivel VGM, 2004, J MICROSC-OXFORD, V214, P237, DOI 10.1111/j.0022-2720.2004.01329.x; SJOSTRAND FS, 1958, J ULTRA MOL STRUCT R, V2, P122, DOI 10.1016/S0022-5320(58)90050-9; SLOMIANNY C, 1986, J PARASITOL, V72, P595, DOI 10.2307/3281516; SLOMIANNY C, 1985, PARASITOLOGY, V90, P579, DOI 10.1017/S0031182000055578; Slomianny G, 1900, BLOOD CELLS, V16, P369; Soto G E, 1994, Neuroimage, V1, P230, DOI 10.1006/nimg.1994.1008; Sousa AA, 2011, J STRUCT BIOL, V174, P107, DOI 10.1016/j.jsb.2010.10.017; STERLING CR, 1975, J PARASITOL, V61, P177, DOI 10.2307/3278987; Tilley L, 2008, TRAFFIC, V9, P187, DOI 10.1111/j.1600-0854.2007.00684.x; van Ooij C, 2007, CELL MICROBIOL, V9, P573, DOI 10.1111/j.1462-5822.2006.00875.x; Weiner A, 2011, CELL MICROBIOL, V13, P967, DOI 10.1111/j.1462-5822.2011.01592.x; Wickert H, 2004, EUR J CELL BIOL, V83, P567, DOI 10.1078/0171-9335-00432; Wickert H, 2007, TRENDS PARASITOL, V23, P502, DOI 10.1016/j.pt.2007.08.008; World Health Organization, 2010, WORLD MAL REP 2010; YOUNG RJ, 1993, J MICROSC-OXFORD, V172, P81, DOI 10.1111/j.1365-2818.1993.tb03396.x	49	25	25	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e33445	10.1371/journal.pone.0033445	http://dx.doi.org/10.1371/journal.pone.0033445			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22432024	Green Published, gold, Green Submitted			2022-12-25	WOS:000303198600067
J	Fowler, KD; Kuchroo, VK; Chakraborty, AK				Fowler, Kevin D.; Kuchroo, Vijay K.; Chakraborty, Arup K.			A Model for How Signal Duration Can Determine Distinct Outcomes of Gene Transcription Programs	PLOS ONE			English	Article							POSITIVE-FEEDBACK; NETWORK MOTIFS; SPECIFICITY; DIFFERENTIATION; MECHANISM; PATHWAY	The reason why IL-6 induces a pro-inflammatory response, while IL-10 induces an anti-inflammatory response, despite both cytokines activating the same transcription factor, STAT3, is not well understood. It is known that IL-6 induces a transient STAT3 signal and that IL-10 induces a sustained STAT3 signal due to the STAT3-induced inhibitor SOCS3's ability to bind to the IL-6R and not the IL-10R. We sought to develop a general transcriptional network that is capable of translating sustained signals into one response, while translating transient signals into a second response. The general structure of such a network is that the transcription factor STAT3 can induce both an inflammatory response and an anti-inflammatory response by inducing two different genes. The anti-inflammatory gene can bind to and inhibit the inflammatory gene's production and the inflammatory gene can bind to its own promoter and induce its own transcription in the absence of the signal. One prediction that can be made from such a network is that in SOCS3-/- mice, where IL-6 induces a sustained STAT3 signal, that IL-6 would act as an anti-inflammatory cytokine, which has indeed been observed experimentally in the literature.	[Fowler, Kevin D.; Chakraborty, Arup K.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] MIT, Ragon Inst MGH, Boston, MA USA; [Kuchroo, Vijay K.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Fowler, KD (corresponding author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.	arupc@mit.edu			National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by a National Institutes of Health Director's Pioneer Award to Dr. Chakraborty). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Artyomov MN, 2007, P NATL ACAD SCI USA, V104, P18958, DOI 10.1073/pnas.0706110104; Bateman E, 1998, PROG NUCLEIC ACID RE, V60, P133, DOI 10.1016/S0079-6603(08)60892-2; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Behar M, 2007, P NATL ACAD SCI USA, V104, P16146, DOI 10.1073/pnas.0703894104; Behar M, 2007, BIOPHYS J, V93, P806, DOI 10.1529/biophysj.107.107516; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Boros J, 2009, GENOME RES, V19, P1963, DOI 10.1101/gr.093047.109; Das J, 2009, CELL, V136, P337, DOI 10.1016/j.cell.2008.11.051; El Kasmi KC, 2006, J IMMUNOL, V177, P7880, DOI 10.4049/jimmunol.177.11.7880; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Kamimura D, 2004, REV PHYSIOL BIOCH P, V149, P1, DOI 10.1007/s10254-003-0012-2; Kholodenko BN, 2007, NAT CELL BIOL, V9, P247, DOI 10.1038/ncb0307-247; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Losick R, 2008, SCIENCE, V320, P65, DOI 10.1126/science.1147888; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; McClean MN, 2007, NAT GENET, V39, P409, DOI 10.1038/ng1957; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Muller MR, 2010, NAT REV IMMUNOL, V10, P645, DOI 10.1038/nri2818; Murphy LO, 2004, MOL CELL BIOL, V24, P144, DOI 10.1128/MCB.24.1.144-153.2004; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Murray PJ, 2005, P NATL ACAD SCI USA, V102, P8686, DOI 10.1073/pnas.0500419102; Okkenhaug K, 2003, NAT REV IMMUNOL, V3, P317, DOI 10.1038/nri1056; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089; Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093	30	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2012	7	3							e33018	10.1371/journal.pone.0033018	http://dx.doi.org/10.1371/journal.pone.0033018			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930IA	22427931	Green Published, gold, Green Submitted			2022-12-25	WOS:000303129700025
J	Liu, EB; Wadford, DA; Seto, J; Vu, M; Hudson, NR; Thrasher, L; Torres, S; Dyer, DW; Chodosh, J; Seto, D; Jones, MS				Liu, Elizabeth B.; Wadford, Debra A.; Seto, Jason; Vu, Maria; Hudson, Nolan Ryan; Thrasher, Lisa; Torres, Sarah; Dyer, David W.; Chodosh, James; Seto, Donald; Jones, Morris S.			Computational and Serologic Analysis of Novel and Known Viruses in Species Human Adenovirus D in Which Serology and Genomics Do Not Correlate	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; EPIDEMIC KERATOCONJUNCTIVITIS; MOLECULAR EVOLUTION; PROVIDES EVIDENCE; RECOMBINATION; IDENTIFICATION; INFECTION; STRAINS; TYPE-15; SYSTEM	In November of 2007 a human adenovirus (HAdV) was isolated from a bronchoalveolar lavage (BAL) sample recovered from a biopsy of an AIDS patient who presented with fever, cough, tachycardia, and expiratory wheezes. To better understand the isolated virus, the genome was sequenced and analyzed using bioinformatic and phylogenomic analysis. The results suggest that this novel virus, which is provisionally named HAdV-D59, may have been created from multiple recombination events. Specifically, the penton, hexon, and fiber genes have high nucleotide identity to HAdV-D19C, HAdV-D25, and HAdV-D56, respectively. Serological results demonstrated that HAdV-D59 has a neutralization profile that is similar yet not identical to that of HAdV-D25. Furthermore, we observed a two-fold difference between the ability of HAdV-D15 and HAdV-D25 to be neutralized by reciprocal antiserum indicating that the two hexon proteins may be more similar in epitopic conformation than previously assumed. In contrast, hexon loops 1 and 2 of HAdV-D15 and HAdV-D25 share 79.13 and 92.56 percent nucleotide identity, respectively. These data suggest that serology and genomics do not always correlate.	[Liu, Elizabeth B.; Seto, Jason; Seto, Donald; Jones, Morris S.] George Mason Univ, Sch Syst Biol, Manassas, VA 20110 USA; [Wadford, Debra A.; Vu, Maria] Calif Dept Publ Hlth, Viral & Rickettsial Dis Lab, Richmond, CA USA; [Hudson, Nolan Ryan; Thrasher, Lisa; Torres, Sarah] Travis AFB, David Grant USAF Med Ctr, Fairfield, CA USA; [Dyer, David W.] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73190 USA; [Chodosh, James] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Howe Lab, Boston, MA USA	George Mason University; California Department of Public Health; United States Department of Defense; United States Air Force; University of Oklahoma System; University of Oklahoma Health Sciences Center; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary	Jones, MS (corresponding author), George Mason Univ, Sch Syst Biol, Manassas, VA 20110 USA.	drmorrisj@yahoo.com		Wadford, Debra/0000-0002-8630-427X	United States Air Force Surgeon General [FDG20040024E]; Research to Prevent Blindness, Inc.;  [R01EY013124];  [P30EY014104]; NATIONAL EYE INSTITUTE [R01EY013124, P30EY014104] Funding Source: NIH RePORTER	United States Air Force Surgeon General; Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); ; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was financially supported by grant R01EY013124 (DWD, DS, MSJ and JC) and P30EY014104 (JC). LS, NRH, and MSJ were supported by United States Air Force Surgeon General grant FDG20040024E. JC is also funded by an unrestricted grant to the Department of Ophthalmology, Harvard Medical School, from Research to Prevent Blindness, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADRIAN T, 1989, INTERVIROLOGY, V30, P169, DOI 10.1159/000150089; ADRIAN T, 1985, INTERVIROLOGY, V23, P15, DOI 10.1159/000149562; CRAMBLETT HG, 1960, PEDIATRICS, V25, P822; CRAWFORDMIKSZA LK, 1994, J CLIN MICROBIOL, V32, P2331, DOI 10.1128/JCM.32.9.2331-2334.1994; Echavarria M, PRINCIPLES PRACTICE; Henquell C, 2009, J CLIN VIROL, V45, P345, DOI 10.1016/j.jcv.2009.04.019; HIERHOLZER JC, 1991, ARCH VIROL, V121, P179, DOI 10.1007/BF01316753; HIERHOLZER JC, 1981, J CLIN MICROBIOL, V13, P395, DOI 10.1128/JCM.13.2.395-397.1981; Ishiko H, 2009, J CLIN MICROBIOL, V47, P2678, DOI 10.1128/JCM.r00313-09; Jones MS, 2007, J VIROL, V81, P5978, DOI 10.1128/JVI.02650-06; KIBRICK S, 1957, ANN NY ACAD SCI, V67, P311, DOI 10.1111/j.1749-6632.1957.tb46055.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu EB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024491; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Madisch I, 2005, J VIROL, V79, P15265, DOI 10.1128/JVI.79.24.15265-15276.2005; Metzgar D, 2010, J CLIN MICROBIOL, V48, P1397, DOI 10.1128/JCM.01600-09; MONTEFIORI DC, 1988, J CLIN MICROBIOL, V26, P231, DOI 10.1128/JCM.26.2.231-235.1988; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Robinson CM, 2011, INFECT GENET EVOL, V11, P1208, DOI 10.1016/j.meegid.2011.04.031; Robinson CM, 2011, VIROLOGY, V409, P141, DOI 10.1016/j.virol.2010.10.020; Robinson CM, 2009, J VIROL, V83, P8980, DOI 10.1128/JVI.00786-09; Robinson CM, 2009, VIRUS RES, V139, P122, DOI 10.1016/j.virusres.2008.10.001; ROSEN L, 1961, P SOC EXP BIOL MED, V107, P434, DOI 10.3181/00379727-107-26648; ROSEN L, 1960, AM J HYG, V71, P120, DOI 10.1093/oxfordjournals.aje.a120085; ROWE WP, 1953, P SOC EXP BIOL MED, V84, P570, DOI 10.3181/00379727-84-20714; Rux JJ, 2004, HUM GENE THER, V15, P1167, DOI 10.1089/hum.2004.15.1167; Seto D, 2011, J VIROL, V85, P5701, DOI 10.1128/JVI.00354-11; Walsh MP, 2011, J CLIN MICROBIOL, V49, P3482, DOI 10.1128/JCM.00156-11; Walsh MP, 2010, J CLIN MICROBIOL, V48, P991, DOI 10.1128/JCM.01694-09; Walsh MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005635; WIGAND R, 1987, J VIROL METHODS, V16, P161, DOI 10.1016/0166-0934(87)90001-2; WIGAND R, 1968, ARCH GES VIRUSFORSCH, V24, P245, DOI 10.1007/BF01241296	32	26	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2012	7	3							e33212	10.1371/journal.pone.0033212	http://dx.doi.org/10.1371/journal.pone.0033212			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930IA	22427992	Green Published, Green Submitted, gold			2022-12-25	WOS:000303129700038
J	Galindo, P; Rodriguez-Gomez, I; Gonzalez-Manzano, S; Duenas, M; Jimenez, R; Menendez, C; Vargas, F; Tamargo, J; Santos-Buelga, C; Perez-Vizcaino, F; Duarte, J				Galindo, Pilar; Rodriguez-Gomez, Isabel; Gonzalez-Manzano, Susana; Duenas, Montserrat; Jimenez, Rosario; Menendez, Carmen; Vargas, Felix; Tamargo, Juan; Santos-Buelga, Celestino; Perez-Vizcaino, Francisco; Duarte, Juan			Glucuronidated Quercetin Lowers Blood Pressure in Spontaneously Hypertensive Rats via Deconjugation	PLOS ONE			English	Article							PREVENTS ENDOTHELIAL DYSFUNCTION; FLAVONOID QUERCETIN; DIETARY FLAVONOIDS; VASCULAR FUNCTION; METABOLITES; PLASMA; ARTERIES; IDENTIFICATION; HYPERTROPHY; MACROPHAGE	Background: Chronic oral quercetin reduces blood pressure and restores endothelial dysfunction in hypertensive animals. However, quercetin (aglycone) is usually not present in plasma, because it is rapidly metabolized into conjugated, mostly inactive, metabolites. The aim of the study is to analyze whether deconjugation of these metabolites is involved in the blood pressure lowering effect of quercetin. Methodology/Principal Findings: We have analyzed the effects on blood pressure and vascular function in vitro of the conjugated metabolites of quercetin (quercetin-3-glucuronide, Q3GA; isorhamnetin-3-glucuronide, I3GA; and quercetin-3'-sulfate, Q3'S) in spontaneously hypertensive rats (SHR). Q3GA and I3GA (1 mg/kg i.v.), but not Q3'S, progressively reduced mean blood pressure (MBP), measured in conscious SHR. The hypotensive effect of Q3GA was abolished in SHR treated with the specific inhibitor of beta-glucuronidase, saccharic acid 1,4-lactone (SAL, 10 mg/ml). In mesenteric arteries, unlike quercetin, Q3GA had no inhibitory effect in the contractile response to phenylephrine after 30 min of incubation. However, after 1 hour of incubation Q3GA strongly reduced this contractile response and this effect was prevented by SAL. Oral administration of quercetin (10 mg/Kg) induced a progressive decrease in MBP, which was also suppressed by SAL. Conclusions: Conjugated metabolites are involved in the in vivo antihypertensive effect of quercetin, acting as molecules for the plasmatic transport of quercetin to the target tissues. Quercetin released from its glucuronidated metabolites could be responsible for its vasorelaxant and hypotensive effect.	[Galindo, Pilar; Jimenez, Rosario; Duarte, Juan] Univ Granada, Sch Pharm, Dept Pharmacol, Granada, Spain; [Rodriguez-Gomez, Isabel; Vargas, Felix] Univ Granada, Dept Physiol, Sch Med, Granada, Spain; [Gonzalez-Manzano, Susana; Duenas, Montserrat; Santos-Buelga, Celestino] Univ Salamanca, Fac Farm, Grp Invest Polifenoles, E-37007 Salamanca, Spain; [Menendez, Carmen; Tamargo, Juan; Perez-Vizcaino, Francisco] Univ Complutense Madrid, Dept Pharmacol, Sch Med, Inst Invest,Sanit Hosp Clin San Carlos, Madrid, Spain; [Menendez, Carmen; Perez-Vizcaino, Francisco] Ciber Enfermedades Respiratorias, Madrid, Spain	University of Granada; University of Granada; University of Salamanca; Complutense University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Galindo, P (corresponding author), Univ Granada, Sch Pharm, Dept Pharmacol, Granada, Spain.	jmduarte@ugr.es	Gónzalez-Manzano, Susana/H-8966-2015; Duarte, Juan/K-6472-2014; JIMENEZ, ROSARIO/K-9701-2014; Rodriguez-Gomez, Isabel/K-8829-2014; Santos-Buelga, Celestino/A-1071-2008; Dueñas, M./A-8976-2016; Tamargo, Juan/J-7772-2016; Santos-Buelga, Celestino/U-1358-2019; Duarte, Juan/AAH-1574-2020; Perez-Vizcaino, Francisco/A-9735-2011	Duarte, Juan/0000-0002-9153-5857; JIMENEZ, ROSARIO/0000-0003-3872-2669; Rodriguez-Gomez, Isabel/0000-0001-6490-6643; Santos-Buelga, Celestino/0000-0001-6592-5299; Dueñas, M./0000-0001-6000-9259; Tamargo, Juan/0000-0002-7979-7758; Duarte, Juan/0000-0002-9153-5857; Perez-Vizcaino, Francisco/0000-0001-6309-7418; Gonzalez Manzano, Susana/0000-0002-5739-515X	Spanish Ministerio de Ciencia e Innovacion [AGL2007-66108, SAF2008-03948, AGL2009-12001, SAF2010-22066, CSD2007-00063]; Junta de Andalucia [P06-CTS-01555]; Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III [Red HERACLES RD06/0009, REDinREN RD06/0016/0017]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Junta de Andalucia(Junta de Andalucia); Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III(Instituto de Salud Carlos III)	This work was supported by Grants from the Spanish Ministerio de Ciencia e Innovacion (AGL2007-66108, SAF2008-03948, AGL2009-12001 and SAF2010-22066) and Consolider-Ingenio 2010 Programme (CSD2007-00063), Junta de Andalucia (Proyecto de Excelencia P06-CTS-01555), and Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III (Red HERACLES RD06/0009 and Red de Investigacion Renal, REDinREN RD06/0016/0017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoi W, 2004, BIOCHEM BIOPH RES CO, V315, P892, DOI 10.1016/j.bbrc.2004.01.150; Cogolludo A, 2007, CARDIOVASC RES, V73, P424, DOI 10.1016/j.cardiores.2006.09.008; Crettol S, 2010, CURR PHARM DESIGN, V16, P204, DOI 10.2174/138161210790112674; da Silva EL, 1998, FEBS LETT, V430, P405, DOI 10.1016/S0014-5793(98)00709-1; Dauchet L, 2009, NAT REV CARDIOL, V6, P599, DOI 10.1038/nrcardio.2009.131; Day AJ, 2001, FREE RADICAL RES, V35, P941, DOI 10.1080/10715760100301441; DUARTE J, 1993, EUR J PHARMACOL, V239, P1, DOI 10.1016/0014-2999(93)90968-N; Duarte J, 2001, BRIT J PHARMACOL, V133, P117, DOI 10.1038/sj.bjp.0704064; DUARTE J, 1994, EUR J PHARMACOL, V262, P149, DOI 10.1016/0014-2999(94)90038-8; Duenas M, 2008, EUR FOOD RES TECHNOL, V227, P1069, DOI 10.1007/s00217-008-0821-2; Edwards RL, 2007, J NUTR, V137, P2405, DOI 10.1093/jn/137.11.2405; Egert S, 2009, BRIT J NUTR, V102, P1065, DOI 10.1017/S0007114509359127; Fittkau M, 2004, J CANCER RES CLIN, V130, P388, DOI 10.1007/s00432-004-0557-8; Galisteo M, 2004, PLANTA MED, V70, P334, DOI 10.1055/s-2004-818945; Garcia-Saura MF, 2005, MOL CELL BIOCHEM, V270, P147, DOI 10.1007/s11010-005-4503-0; GRYGLEWSKI RJ, 1987, BIOCHEM PHARMACOL, V36, P317, DOI 10.1016/0006-2952(87)90288-7; HERTOG MGL, 1993, NUTR CANCER, V20, P21, DOI 10.1080/01635589309514267; HERTOG MGL, 1993, LANCET, V342, P1007, DOI 10.1016/0140-6736(93)92876-U; Jalili T, 2006, J CARDIOVASC PHARM, V47, P531, DOI 10.1097/01.fjc.0000211746.78454.50; Jones DJL, 2005, BIOORGAN MED CHEM, V13, P6727, DOI 10.1016/j.bmc.2005.07.021; Kawai Y, 2008, J BIOL CHEM, V283, P9424, DOI 10.1074/jbc.M706571200; Keli SO, 1996, ARCH INTERN MED, V156, P637, DOI 10.1001/archinte.156.6.637; Khoo NKH, 2010, FREE RADICAL BIO MED, V49, P339, DOI 10.1016/j.freeradbiomed.2010.04.022; Kroon PA, 2004, AM J CLIN NUTR, V80, P15; Li L, 2008, PHARMACOL RES, V58, P196, DOI 10.1016/j.phrs.2008.06.009; Lodi F, 2008, PLANTA MED, V74, P741, DOI 10.1055/s-2008-1074525; Lodi F, 2009, ATHEROSCLEROSIS, V204, P34, DOI 10.1016/j.atherosclerosis.2008.08.007; Lotito SB, 2006, FREE RADICAL BIO MED, V41, P1727, DOI 10.1016/j.freeradbiomed.2006.04.033; Machha A, 2005, J CARDIOVASC PHARM, V46, P36, DOI 10.1097/01.fjc.0000162769.83324.c1; Mackraj I, 2008, J CARDIOVASC PHARM, V51, P239, DOI 10.1097/FJC.0b013e318162011f; Manach C, 1999, FREE RADICAL BIO MED, V27, P1259, DOI 10.1016/S0891-5849(99)00159-8; Manach C, 1998, FEBS LETT, V426, P331, DOI 10.1016/S0014-5793(98)00367-6; Menendez C, 2011, MOL NUTR FOOD RES, V55, P1780, DOI 10.1002/mnfr.201100378; Michihara A, 2005, BIOL PHARM BULL, V28, P947, DOI 10.1248/bpb.28.947; Mochizuki M, 2004, BIOFACTORS, V22, P201, DOI 10.1002/biof.5520220142; Moon JH, 2001, FREE RADICAL BIO MED, V30, P1274, DOI 10.1016/S0891-5849(01)00522-6; Mullen W, 2006, BRIT J NUTR, V96, P107, DOI 10.1079/BJN20061809; MULVANY MJ, 1977, CIRC RES, V41, P19, DOI 10.1161/01.RES.41.1.19; Nomura Y, 2002, HYPERTENS RES, V25, P231, DOI 10.1291/hypres.25.231; NYBORG NCB, 1988, HYPERTENSION, V11, P635, DOI 10.1161/01.HYP.11.6.635; O'Leary KA, 2001, FEBS LETT, V503, P103, DOI 10.1016/S0014-5793(01)02684-9; Perez-Vizcaino F, 2002, J PHARMACOL EXP THER, V302, P66, DOI 10.1124/jpet.302.1.66; Perez-Vizcaino F, 2010, MOL ASPECTS MED, V31, P478, DOI 10.1016/j.mam.2010.09.002; Plumb GW, 2003, METHODS POLYPHENOL A; Romero M, 2010, EUR J PHARMACOL, V627, P242, DOI 10.1016/j.ejphar.2009.11.006; Sampson L, 2002, J AM DIET ASSOC, V102, P1414, DOI 10.1016/S0002-8223(02)90314-7; Sanchez M, 2006, J HYPERTENS, V24, P75, DOI 10.1097/01.hjh.0000198029.22472.d9; Scalbert A, 2000, J NUTR, V130, p2073S, DOI 10.1093/jn/130.8.2073S; Schewe T, 2008, ARCH BIOCHEM BIOPHYS, V476, P102, DOI 10.1016/j.abb.2008.03.004; Shimoi K, 2001, DRUG METAB DISPOS, V29, P1521; Sullivan JC, 2007, AM J PHYSIOL-REG I, V293, pR1573, DOI 10.1152/ajpregu.00429.2007; Williamson G, 2005, AM J CLIN NUTR, V81, p243S, DOI [10.1093/ajcn/81.1.243S, 10.1093/ajcn/81.1.230S]; Yamamoto Y, 2006, BIOSCI BIOTECH BIOCH, V70, P933, DOI 10.1271/bbb.70.933	53	94	94	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e32673	10.1371/journal.pone.0032673	http://dx.doi.org/10.1371/journal.pone.0032673			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427863	Green Submitted, Green Published, gold			2022-12-25	WOS:000302381500032
J	Lelievre, EC; Plestant, C; Boscher, C; Wolff, E; Mege, RM; Birbes, H				Lelievre, Elise C.; Plestant, Charlotte; Boscher, Cecile; Wolff, Emeline; Mege, Rene-Marc; Birbes, Helene			N-Cadherin Mediates Neuronal Cell Survival through Bim Down-Regulation	PLOS ONE			English	Article							BCL-2 FAMILY-MEMBER; PROAPOPTOTIC ACTIVITY; BH3-ONLY PROTEIN; ADHESION; ACTIVATION; PROMOTES; ANOIKIS; PATHWAY; PHOSPHORYLATION; GROWTH	N-cadherin is a major adhesion molecule involved in the development and plasticity of the nervous system. N-cadherin-mediated cell adhesion regulates neuroepithelial cell polarity, neuronal precursor migration, growth cone migration and synaptic plasticity. In vitro, it has been involved in signaling events regulating processes such as cell mobility, proliferation and differentiation. N-cadherin has also been implicated in adhesion-dependent protection against apoptosis in non-neuronal cells. In this study, we investigated if the engagement of N-cadherin participates to the control of neuronal cells survival/death balance. We observed that plating either primary mouse spinal cord neurons or primary rat hippocampal neurons on N-cadherin recombinant substrate greatly enhances their survival compared to non-specific adhesion on poly-L-lysine. We show that N-cadherin engagement, in the absence of other survival factors (cell-matrix interactions and serum), protects GT1-7 neuronal cells against apoptosis. Using this cell line, we then searched for the signaling pathways involved in the survival effect of N-cadherin engagement. The PI3-kinase/Akt survival pathway and its downstream effector Bad are not involved, as no phosphorylation of Akt or Bad proteins in response to N-cadherin engagement was observed. In contrast, N-cadherin engagement activated the Erk1/2 MAP kinase pathway. Moreover, N-cadherin ligation mediated a 2-fold decrease in the level of the pro-apoptotic protein Bim-EL whereas the level of the anti-apoptotic protein Bcl-2 was unchanged. Inhibition of Mek1/2 kinases with U0126, and the resulting inhibition of Erk1/2 phosphorylation, induced the increase of both the level of Bim-EL and apoptosis of cells seeded on the N-cadherin substrate, suggesting that Erk phosphorylation is necessary for cell survival. Finally, the overexpression of a phosphorylation defective form of Bim-EL prevented N-cadherin-engagement induced cell survival. In conclusion, our results show that N-cadherin engagement mediates neuronal cell survival by enhancing the MAP kinase pathway and down-regulating the pro-apoptotic protein Bim-EL.	[Lelievre, Elise C.; Plestant, Charlotte; Boscher, Cecile; Wolff, Emeline; Mege, Rene-Marc; Birbes, Helene] INSERM, UMRS 839, Paris, France; [Lelievre, Elise C.; Plestant, Charlotte; Boscher, Cecile; Wolff, Emeline; Mege, Rene-Marc; Birbes, Helene] Univ Paris 06, Paris, France; [Lelievre, Elise C.; Plestant, Charlotte; Boscher, Cecile; Wolff, Emeline; Mege, Rene-Marc; Birbes, Helene] Inst Fer Moulin, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Lelievre, EC (corresponding author), INSERM, UMRS 839, Paris, France.	rene-marc.mege@inserm.fr; helene.birbes@inserm.fr	Mege, Rene Marc/M-9569-2013	Mege, Rene-Marc/0000-0001-8128-5543	INSERM (Institut National de la Sante et Recherche Medicale), Universite Pierre et Marie Curie; AFM (Association Francaise contre les Myopathies); ARC (Association Francaise de Recherche contre le Cancer); French Research Ministry; ARC	INSERM (Institut National de la Sante et Recherche Medicale), Universite Pierre et Marie Curie; AFM (Association Francaise contre les Myopathies)(Association Francaise contre les Myopathies); ARC (Association Francaise de Recherche contre le Cancer); French Research Ministry(Ministry of Research, France); ARC(Australian Research Council)	This work was supported by institutional funding from INSERM (Institut National de la Sante et Recherche Medicale), Universite Pierre et Marie Curie, as well as grants from AFM (Association Francaise contre les Myopathies) and ARC (Association Francaise de Recherche contre le Cancer). Dr. Lelievre, Dr. Plestant and Dr. Boscher have been supported by French Research Ministry graduate student fellowships. ARC provided also Dr. Boscher with a PhD fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachelder RE, 2001, J BIOL CHEM, V276, P34702, DOI 10.1074/jbc.M102806200; Bard L, 2008, J NEUROSCI, V28, P5879, DOI 10.1523/JNEUROSCI.5331-07.2008; Benson DL, 1998, J NEUROSCI, V18, P6892; Benson DL, 2000, TRENDS CELL BIOL, V10, P473, DOI 10.1016/S0962-8924(00)01838-9; Benson DL, 2001, NAT REV NEUROSCI, V2, P899, DOI 10.1038/35104078; Bergin E, 2000, AM J PHYSIOL-RENAL, V278, pF758, DOI 10.1152/ajprenal.2000.278.5.F758; Birbes H, 2001, FASEB J, V15, P2669, DOI 10.1096/fj.01-0539com; Biswas SC, 2002, J BIOL CHEM, V277, P49511, DOI 10.1074/jbc.M208086200; Boscher C, 2008, CELL SIGNAL, V20, P1061, DOI 10.1016/j.cellsig.2008.01.008; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Doonan F, 2007, J NEUROSCI, V27, P10887, DOI 10.1523/JNEUROSCI.0903-07.2007; Ewings KE, 2007, EMBO J, V26, P2856, DOI 10.1038/sj.emboj.7601723; Fouquet S, 2004, J BIOL CHEM, V279, P43061, DOI 10.1074/jbc.M405095200; Fukazawa H, 2004, MOL CANCER THER, V3, P1281; Gavalda N, 2008, MOL CELL NEUROSCI, V37, P663, DOI 10.1016/j.mcn.2007.12.013; Gavard J, 2004, J BIOL CHEM, V279, P36795, DOI 10.1074/jbc.M401705200; Gavard J, 2004, J CELL SCI, V117, P257, DOI 10.1242/jcs.00857; Grossmann J, 2002, APOPTOSIS, V7, P247, DOI 10.1023/A:1015312119693; GUMBINER B, 1988, J CELL BIOL, V107, P1575, DOI 10.1083/jcb.107.4.1575; HERMISTON ML, 1995, J CELL BIOL, V129, P489, DOI 10.1083/jcb.129.2.489; Hofmann C, 2007, GASTROENTEROLOGY, V132, P587, DOI 10.1053/j.gastro.2006.11.017; Kadowaki M, 2007, DEV BIOL, V304, P22, DOI 10.1016/j.ydbio.2006.12.014; Kang HG, 2007, CANCER RES, V67, P3094, DOI 10.1158/0008-5472.CAN-06-3259; Kantak SS, 1998, J BIOL CHEM, V273, P16953, DOI 10.1074/jbc.273.27.16953; Koutsouki E, 2005, ARTERIOSCL THROM VAS, V25, P982, DOI 10.1161/01.ATV.0000163183.27658.4b; Lambert M, 2000, J CELL SCI, V113, P2207; Ley R, 2003, J BIOL CHEM, V278, P18811, DOI 10.1074/jbc.M301010200; Ley R, 2004, J BIOL CHEM, V279, P8837, DOI 10.1074/jbc.M311578200; Luciano F, 2003, ONCOGENE, V22, P6785, DOI 10.1038/sj.onc.1206792; Marani M, 2004, ONCOGENE, V23, P2431, DOI 10.1038/sj.onc.1207364; Marthiens V, 2002, MOL CELL NEUROSCI, V20, P458, DOI 10.1006/mcne.2002.1130; Martin SS, 2004, BBA-MOL CELL RES, V1692, P145, DOI 10.1016/j.bbamcr.2004.02.008; McFall A, 2001, MOL CELL BIOL, V21, P5488, DOI 10.1128/MCB.21.16.5488-5499.2001; Mege RM, 2006, CURR OPIN CELL BIOL, V18, P541, DOI 10.1016/j.ceb.2006.08.004; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; Peluso JJ, 1996, ENDOCRINOLOGY, V137, P1196, DOI 10.1210/en.137.4.1196; Poulain FE, 2007, MOL CELL NEUROSCI, V34, P137, DOI 10.1016/j.mcn.2006.10.012; Putcha GV, 2001, NEURON, V29, P615, DOI 10.1016/S0896-6273(01)00238-0; Puthalakath H, 2002, CELL DEATH DIFFER, V9, P505, DOI 10.1038/sj.cdd.4400998; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Rak Janusz, 1999, Neoplasia (New York), V1, P23, DOI 10.1038/sj.neo.7900001; Redies C, 2003, J PHYSIOL-PARIS, V97, P5, DOI 10.1016/j.jphysparis.2003.10.002; Reginato MJ, 2003, NAT CELL BIOL, V5, P733, DOI 10.1038/ncb1026; Riehl R, 1996, NEURON, V17, P837, DOI 10.1016/S0896-6273(00)80216-0; Scheid MP, 1999, J BIOL CHEM, V274, P31108, DOI 10.1074/jbc.274.43.31108; Shen XD, 2004, AM J PATHOL, V165, P1315, DOI 10.1016/S0002-9440(10)63390-1; Shinjyo T, 2001, MOL CELL BIOL, V21, P854, DOI 10.1128/MCB.21.3.854-864.2001; Skaper SD, 2004, MOL CELL NEUROSCI, V26, P17, DOI 10.1016/j.mcn.2003.12.015; Stehbens SJ, 2009, FRONT BIOSCI-LANDMRK, V14, P3159, DOI 10.2741/3442; Takeichi M, 1997, DEV NEUROSCI-BASEL, V19, P86, DOI 10.1159/000111189; Takeichi M, 2007, NAT REV NEUROSCI, V8, P11, DOI 10.1038/nrn2043; Tepass U, 2000, NAT REV MOL CELL BIO, V1, P91, DOI 10.1038/35040042; Thoumine O, 2006, MOL BIOL CELL, V17, P862, DOI 10.1091/mbc.E05-04-0335; Tran NL, 2002, J BIOL CHEM, V277, P32905, DOI 10.1074/jbc.M200300200; Uchida N, 1996, J CELL BIOL, V135, P767, DOI 10.1083/jcb.135.3.767; Wang LY, 2009, ARCH BIOCHEM BIOPHYS, V481, P116, DOI 10.1016/j.abb.2008.10.021; Weston CR, 2003, ONCOGENE, V22, P1281, DOI 10.1038/sj.onc.1206261; Whitfield J, 2001, NEURON, V29, P629, DOI 10.1016/S0896-6273(01)00239-2	60	22	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33206	10.1371/journal.pone.0033206	http://dx.doi.org/10.1371/journal.pone.0033206			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427990	Green Published, Green Submitted, gold			2022-12-25	WOS:000302381500111
J	Temiyasathit, S; Tang, WJ; Leucht, P; Anderson, CT; Monica, SD; Castillo, AB; Helms, JA; Stearns, T; Jacobs, CR				Temiyasathit, Sara; Tang, W. Joyce; Leucht, Philipp; Anderson, Charles T.; Monica, Stefanie D.; Castillo, Alesha B.; Helms, Jill A.; Stearns, Tim; Jacobs, Christopher R.			Mechanosensing by the Primary Cilium: Deletion of Kif3A Reduces Bone Formation Due to Loading	PLOS ONE			English	Article							INTRAFLAGELLAR TRANSPORT; FLUID-FLOW; POLYCYSTIN-1; EXPRESSION; SKELETOGENESIS; LOCALIZATION; OSTEOPOROSIS; DISRUPTION; OSTEOCYTES; CARTILAGE	Primary cilia, solitary microtubule-based structures that grow from the centriole and extend into the extracellular space, have increasingly been implicated as sensors of a variety of biochemical and biophysical signals. Mutations in primary cilium-related genes have been linked to a number of rare developmental disorders as well as dysregulation of cell proliferation. We propose that primary cilia are also important in mechanically regulated bone formation in adults and that their malfunction could play a role in complex multi-factorial bone diseases, such as osteoporosis. In this study, we generated mice with an osteoblast-and osteocyte-specific knockout of Kif3a, a subunit of the kinesin II intraflagellar transport (IFT) protein; IFT is required for primary cilia formation, maintenance, and function. These Col alpha 1(I) 2.3-Cre;Kif3a(fl/fl) mice exhibited no obvious morphological skeletal abnormalities. Skeletally mature Col alpha 1(I) 2.3-Cre;Kif3a(fl/fl) and control mice were exposed to 3 consecutive days of cyclic axial ulna loading, which resulted in a significant increase in bone formation in both the conditional knockouts and controls. However, Col alpha 1(I) 2.3-Cre;Kif3a(fl/fl) mice did exhibit decreased formation of new bone in response to mechanical ulnar loading compared to control mice. These results suggest that primary cilia act as cellular mechanosensors in bone and that their function may be critical for the regulation of bone physiology due to mechanical loading in adults.	[Temiyasathit, Sara; Tang, W. Joyce; Castillo, Alesha B.; Jacobs, Christopher R.] US Dept Vet Affairs, Bone & Joint Rehabil R&D Ctr, Palo Alto, CA USA; [Temiyasathit, Sara; Jacobs, Christopher R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Stearns, Tim] Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; [Jacobs, Christopher R.] Columbia Univ, Dept Biomed Engn, New York, NY USA; [Stearns, Tim] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Castillo, Alesha B.; Jacobs, Christopher R.] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA; [Leucht, Philipp] Stanford Univ, Dept Orthopaed Surg, Stanford, CA 94305 USA; [Monica, Stefanie D.; Helms, Jill A.] Stanford Univ, Dept Surg Plast & Reconstruct Surg, Stanford, CA 94305 USA; [Anderson, Charles T.] Univ Calif Berkeley, Energy Biosci Inst, Berkeley, CA 94720 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Stanford University; Columbia University; Stanford University; Stanford University; Stanford University; Stanford University; University of California System; University of California Berkeley	Temiyasathit, S (corresponding author), US Dept Vet Affairs, Bone & Joint Rehabil R&D Ctr, Palo Alto, CA USA.	crj2111@columbia.edu	Castillo, Alesha B/A-8728-2014; Castillo, Alesha B./AAC-9961-2019; Leucht, Philipp/H-7238-2019	Castillo, Alesha B/0000-0002-1371-7567; Castillo, Alesha B./0000-0002-1371-7567; Leucht, Philipp/0000-0002-8409-8513; Helms, Jill/0000-0002-0463-396X; Stearns, Tim/0000-0002-0671-6582; Anderson, Charles/0000-0001-7481-3571	National Institutes of Health [R21AR054156]; Department of Veterans Affairs; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR054156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052022] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a National Institutes of Health grant R21AR054156 (CRJ), and ST was granted a fellowship by the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berbari NF, 2009, CURR BIOL, V19, pR526, DOI 10.1016/j.cub.2009.05.025; Burge R, 2007, J BONE MINER RES, V22, P465, DOI [10.1359/jbmr.061113, 10.1359/JBMR.061113]; Colnot C, 2006, BIOCHEM BIOPH RES CO, V350, P557, DOI 10.1016/j.bbrc.2006.09.079; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Corbit KC, 2008, NAT CELL BIOL, V10, P70, DOI 10.1038/ncb1670; Dacquin R, 2002, DEV DYNAM, V224, P245, DOI 10.1002/dvdy.10100; DUNCAN RL, 1994, AM J PHYSIOL-RENAL, V267, pF909, DOI 10.1152/ajprenal.1994.267.6.F909; Genetos DC, 2007, J CELL PHYSIOL, V212, P207, DOI 10.1002/jcp.21021; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Haycraft CJ, 2007, DEVELOPMENT, V134, P307, DOI 10.1242/dev.02732; Hou B, 2009, BONE, V44, P1121, DOI 10.1016/j.bone.2009.02.018; Huang CJ, MOL CELL BIOCH, V360, P121; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Ingber DE, 2003, ANN MED, V35, P564, DOI 10.1080/07853890310016333; Ishijima M, 2001, J EXP MED, V193, P399, DOI 10.1084/jem.193.3.399; Kenny AM, 2000, RHEUM DIS CLIN N AM, V26, P569, DOI 10.1016/S0889-857X(05)70157-5; Kolpakova-Hart E, 2007, DEV BIOL, V309, P273, DOI 10.1016/j.ydbio.2007.07.018; KONDO S, 1994, J CELL BIOL, V125, P1095, DOI 10.1083/jcb.125.5.1095; Kovacs JJ, 2008, SCIENCE, V320, P1777, DOI 10.1126/science.1157983; Koyama E, 2007, DEVELOPMENT, V134, P2159, DOI 10.1242/dev.001586; Kwon RY, 2010, FASEB J, V24, P2859, DOI 10.1096/fj.09-148007; Lancaster MA, 2011, NAT CELL BIOL, V13, P700, DOI 10.1038/ncb2259; Lin FM, 2003, P NATL ACAD SCI USA, V100, P5286, DOI 10.1073/pnas.0836980100; Litzenberger JB, 2009, CELLULAR MO IN PRESS; Malone AMD, 2007, P NATL ACAD SCI USA, V104, P13325, DOI 10.1073/pnas.0700636104; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; Masyuk AI, 2006, GASTROENTEROLOGY, V131, P911, DOI 10.1053/j.gastro.2006.07.003; May SR, 2005, DEV BIOL, V287, P378, DOI 10.1016/j.ydbio.2005.08.050; McGarry JG, 2005, BIOCHEM BIOPH RES CO, V330, P341, DOI 10.1016/j.bbrc.2005.02.175; McGlashan SR, 2010, CELL BIOL INT, V34, P441, DOI 10.1042/CBI20090094; McGrath J, 2003, CELL, V114, P61, DOI 10.1016/S0092-8674(03)00511-7; MCLEOD MJ, 1980, TERATOLOGY, V22, P299, DOI 10.1002/tera.1420220306; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nonaka S, 2002, NATURE, V418, P96, DOI 10.1038/nature00849; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Phillips JA, 2008, MATRIX BIOL, V27, P609, DOI 10.1016/j.matbio.2008.05.003; Praetorius HA, 2001, J MEMBRANE BIOL, V184, P71, DOI 10.1007/s00232-001-0075-4; Praetorius HA, 2003, J MEMBRANE BIOL, V191, P193, DOI 10.1007/s00232-002-1055-z; Praetorius HA, 2003, J MEMBRANE BIOL, V191, P69, DOI 10.1007/s00232-002-1042-4; Robling AG, 2002, BONE, V31, P562, DOI 10.1016/S8756-3282(02)00871-2; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Schneider L, 2005, CURR BIOL, V15, P1861, DOI 10.1016/j.cub.2005.09.012; Scholey JM, 2003, ANNU REV CELL DEV BI, V19, P423, DOI 10.1146/annurev.cellbio.19.111401.091318; SELBY PB, 1987, STAIN TECHNOL, V62, P143, DOI 10.3109/10520298709107984; SHEEHAN DC, 1980, THEORY PRACTICE HIST, P103; Song B, 2007, DEV BIOL, V305, P202, DOI 10.1016/j.ydbio.2007.02.003; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Wang Y., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P332; Wiesner C, 2010, BLOOD, V116, P1559, DOI 10.1182/blood-2009-12-257089; Wilson PD, 2004, NEW ENGL J MED, V350, P151, DOI 10.1056/NEJMra022161; Xiao ZS, 2008, J BIOL CHEM, V283, P12624, DOI 10.1074/jbc.M710407200; Xiao ZS, 2006, J BIOL CHEM, V281, P30884, DOI 10.1074/jbc.M604772200; Xiao ZS, 2010, J BIOL CHEM, V285, P1177, DOI 10.1074/jbc.M109.050906	55	69	71	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33368	10.1371/journal.pone.0033368	http://dx.doi.org/10.1371/journal.pone.0033368			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22428034	gold, Green Published, Green Submitted			2022-12-25	WOS:000302381500135
J	Joshi, AS; Thompson, MN; Fei, N; Huttemann, M; Greenberg, ML				Joshi, Amit S.; Thompson, Morgan N.; Fei, Naomi; Huettemann, Maik; Greenberg, Miriam L.			Cardiolipin and Mitochondrial Phosphatidylethanolamine Have Overlapping Functions in Mitochondrial Fusion in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYNAMIN-RELATED GTPASE; LINKED CARDIOSKELETAL MYOPATHY; WD REPEAT PROTEIN; BARTH-SYNDROME; PHOSPHATIDYLSERINE DECARBOXYLASE; LYMPHOBLAST MITOCHONDRIA; TEMPERATURE SENSITIVITY; CARRIER PROTEIN; YEAST REQUIRES; INNER MEMBRANE	The two non-bilayer forming mitochondrial phospholipids cardiolipin (CL) and phosphatidylethanolamine (PE) play crucial roles in maintaining mitochondrial morphology. We have shown previously that CL and PE have overlapping functions, and the loss of both is synthetically lethal. Because the lack of CL does not lead to defects in the mitochondrial network in Saccharomyces cerevisiae, we hypothesized that PE may compensate for CL in the maintenance of mitochondrial tubular morphology and fusion. To test this hypothesis, we constructed a conditional mutant crd1 Delta psd1 Delta containing null alleles of CRD1 (CL synthase) and PSD1 (mitochondrial phosphatidylserine decarboxylase), in which the wild type CRD1 gene is expressed on a plasmid under control of the TETOFF promoter. In the presence of tetracycline, the mutant exhibited highly fragmented mitochondria, loss of mitochondrial DNA, and reduced membrane potential, characteristic of fusion mutants. Deletion of DNM1, required for mitochondrial fission, restored the tubular mitochondrial morphology. Loss of CL and mitochondrial PE led to reduced levels of small and large isoforms of the fusion protein Mgm1p, possibly accounting for the fusion defect. Taken together, these data demonstrate for the first time in vivo that CL and mitochondrial PE are required to maintain tubular mitochondrial morphology and have overlapping functions in mitochondrial fusion.	[Joshi, Amit S.; Thompson, Morgan N.; Fei, Naomi; Greenberg, Miriam L.] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA; [Huettemann, Maik] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48201 USA	Wayne State University; Wayne State University	Greenberg, ML (corresponding author), 5047 Gullen Mall Biol Sci Bldg, Detroit, MI 48202 USA.	mlgreen@sun.science.wayne.edu		Huttemann, Maik/0000-0001-6310-7081	National Institutes of Health [R21 HL 084218]; Barth Syndrome Foundation; Wayne State University Graduate Enhancement Research Fellowship; Graduate Enhancement Research Funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL084218] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barth Syndrome Foundation; Wayne State University Graduate Enhancement Research Fellowship; Graduate Enhancement Research Funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R21 HL 084218. This work was also supported by grants from The Barth Syndrome Foundation (to M. L. G.) and by Wayne State University Graduate Enhancement Research Fellowship and Graduate Enhancement Research Funds (to A. S. J.).	Acehan D, 2007, LAB INVEST, V87, P40, DOI 10.1038/labinvest.3700480; Acehan D, 2011, J BIOL CHEM, V286, P899, DOI 10.1074/jbc.M110.171439; ARDAIL D, 1990, J BIOL CHEM, V265, P18797; Ban T, 2010, HUM MOL GENET, V19, P2113, DOI 10.1093/hmg/ddq088; Barth PG, 1996, J INHERIT METAB DIS, V19, P157, DOI 10.1007/BF01799418; Bleazard W, 1999, NAT CELL BIOL, V1, P298, DOI 10.1038/13014; BOLHUIS PA, 1991, AM J HUM GENET, V48, P481; Brink-van der Laan EV, 2004, BBA-BIOMEMBRANES, V1666, P275, DOI 10.1016/j.bbamem.2004.06.010; Burgermeister M, 2004, BBA-MOL CELL BIOL L, V1686, P161, DOI 10.1016/j.bbalip.2004.09.007; CHEN DC, 1992, CURR GENET, V21, P83, DOI 10.1007/BF00318659; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Chen L, 2009, CARDIOVASC RES, V84, P91, DOI 10.1093/cvr/cvp181; Chen SL, 2010, J BIOL CHEM, V285, P10397, DOI 10.1074/jbc.M110.100784; Chen S, 2008, MOL BIOL CELL, V19, P5047, DOI 10.1091/mbc.E08-05-0486; Claypool SM, 2008, J CELL BIOL, V182, P937, DOI 10.1083/jcb.200801152; CULLIS PR, 1979, BIOCHIM BIOPHYS ACTA, V559, P399, DOI 10.1016/0304-4157(79)90012-1; DeVay RM, 2009, J CELL BIOL, V186, P793, DOI 10.1083/jcb.200906098; Dorn GW, 2011, CIRC RES, V108, P12, DOI 10.1161/CIRCRESAHA.110.236745; Duvezin-Caubet S, 2006, J BIOL CHEM, V281, P37972, DOI 10.1074/jbc.M606059200; Furt F, 2009, INT J BIOCHEM CELL B, V41, P1828, DOI 10.1016/j.biocel.2009.02.005; Gebert N, 2009, CURR BIOL, V19, P2133, DOI 10.1016/j.cub.2009.10.074; Gohil VM, 2009, J CELL BIOL, V184, P468, DOI 10.1083/jcb.200901127; Gohil VM, 2005, J BIOL CHEM, V280, P35410, DOI 10.1074/jbc.M505478200; Gonzalvez F, 2007, APOPTOSIS, V12, P877, DOI 10.1007/s10495-007-0718-8; GUAN KL, 1993, CURR GENET, V24, P141, DOI 10.1007/BF00324678; Herlan M, 2004, J CELL BIOL, V165, P167, DOI 10.1083/jcb.200403022; Herlan M, 2003, J BIOL CHEM, V278, P27781, DOI 10.1074/jbc.M211311200; Hermann GJ, 1998, J CELL BIOL, V143, P359, DOI 10.1083/jcb.143.2.359; Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048; Hoppins S, 2009, J CELL BIOL, V184, P569, DOI 10.1083/jcb.200809099; Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199; Kuroda T, 2011, MOL MICROBIOL, V80, P248, DOI 10.1111/j.1365-2958.2011.07569.x; Ludovico P, 2001, MICROBIOL-SGM, V147, P3335, DOI 10.1099/00221287-147-12-3335; Meeusen S, 2004, SCIENCE, V305, P1747, DOI 10.1126/science.1100612; Mitra K, 2009, P NATL ACAD SCI USA, V106, P11960, DOI 10.1073/pnas.0904875106; Mozdy AD, 2000, J CELL BIOL, V151, P367, DOI 10.1083/jcb.151.2.367; Nunnari J, 1997, MOL BIOL CELL, V8, P1233, DOI 10.1091/mbc.8.7.1233; Ong SB, 2010, CIRCULATION, V121, P2012, DOI 10.1161/CIRCULATIONAHA.109.906610; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Osman C, 2009, J CELL BIOL, V184, P583, DOI 10.1083/jcb.200810189; RAND RP, 1972, BIOCHIM BIOPHYS ACTA, V225, P484, DOI 10.1016/0005-2736(72)90152-6; Rapaport D, 1998, J BIOL CHEM, V273, P20150, DOI 10.1074/jbc.273.32.20150; Rujiviphat J, 2009, J BIOL CHEM, V284, P28682, DOI 10.1074/jbc.M109.044933; Schlame M, 2009, BBA-BIOMEMBRANES, V1788, P2080, DOI 10.1016/j.bbamem.2009.04.019; SCHULLER C, 1994, EMBO J, V13, P4382, DOI 10.1002/j.1460-2075.1994.tb06758.x; Sesaki H, 2004, J BIOL CHEM, V279, P28298, DOI 10.1074/jbc.M401363200; Sesaki H, 1999, J CELL BIOL, V147, P699, DOI 10.1083/jcb.147.4.699; Sesaki H, 2001, J CELL BIOL, V152, P1123, DOI 10.1083/jcb.152.6.1123; Tamura Y, 2009, J CELL BIOL, V185, P1029, DOI 10.1083/jcb.200812018; Tieu Q, 2000, J CELL BIOL, V151, P353, DOI 10.1083/jcb.151.2.353; Tieu Q, 2002, J CELL BIOL, V158, P445, DOI 10.1083/jcb.200205031; TROTTER PJ, 1995, J BIOL CHEM, V270, P6071, DOI 10.1074/jbc.270.11.6071; TROTTER PJ, 1995, J BIOL CHEM, V270, P6062, DOI 10.1074/jbc.270.11.6062; TROTTER PJ, 1993, J BIOL CHEM, V268, P21416; Vaden DL, 2005, ANAL BIOCHEM, V338, P162, DOI 10.1016/j.ab.2004.11.020; Westermann B, 2000, YEAST, V16, P1421, DOI 10.1002/1097-0061(200011)16:15<1421::AID-YEA624>3.3.CO;2-L; WILLINGHAM MC, 1984, J HISTOCHEM CYTOCHEM, V32, P455, DOI 10.1177/32.4.6323574; Wong ED, 2003, J CELL BIOL, V160, P303, DOI 10.1083/jcb.200209015; Wong ED, 2000, J CELL BIOL, V151, P341, DOI 10.1083/jcb.151.2.341; Xu Y, 2005, LAB INVEST, V85, P823, DOI 10.1038/labinvest.3700274; Zhong Q, 2004, J BIOL CHEM, V279, P32294, DOI 10.1074/jbc.M403275200; Zhong Q, 2007, J BIOL CHEM, V282, P15946, DOI 10.1074/jbc.M701055200; Zhou JM, 2009, J BIOL CHEM, V284, P18106, DOI 10.1074/jbc.M109.003236; Zick M, 2009, FEBS LETT, V583, P2237, DOI 10.1016/j.febslet.2009.05.053	64	133	134	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17589	17597		10.1074/jbc.M111.330167	http://dx.doi.org/10.1074/jbc.M111.330167			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22433850	Green Published, hybrid			2022-12-25	WOS:000306373000057
J	Kamimura, M; Saito, H; Niwa, R; Niimi, T; Toyoda, K; Ueno, C; Kanamori, Y; Shimura, S; Kiuchi, M				Kamimura, Manabu; Saito, Hitoshi; Niwa, Ryusuke; Niimi, Teruyuki; Toyoda, Kinuko; Ueno, Chihiro; Kanamori, Yasushi; Shimura, Sachiko; Kiuchi, Makoto			Fungal Ecdysteroid-22-oxidase, a New Tool for Manipulating Ecdysteroid Signaling and Insect Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEROID-HORMONE INACTIVATION; EUROPEAN CORN-BORER; PROTHORACIC GLANDS; ECDYSONE SYNTHESIS; MOLECULAR-CLONING; BOMBYX-MORI; CYTOCHROME-P450 ENZYME; EMBRYONIC-DEVELOPMENT; BIOSYNTHETIC-PATHWAY; GENE-EXPRESSION	Steroid hormones ecdysteroids regulate varieties of developmental processes in insects. Although the ecdysteroid titer can be increased experimentally with ease, its artificial reduction, although desirable, is very difficult to achieve. Here we characterized the ecdysteroid-inactivating enzyme ecdysteroid-22-oxidase (E22O) from the entomopathogenic fungus Nomuraea rileyi and used it to develop methods for reducing ecdysteroid titer and thereby controlling insect development. K-m and K-cat values of the purified E22O for oxidizing ecdysone were 4.4 mu M and 8.4/s, respectively, indicating that E22O can inactivate ecdysone more efficiently than other ecdysteroid inactivating enzymes characterized so far. The cloned E22O cDNA encoded a FAD-dependent oxidoreductase. Injection of recombinant E22O into the silkworm Bombyx mori interfered with larval molting and metamorphosis. In the hemolymph of E22O-injected pupae, the titer of hormonally active 20-hydroxyecdysone decreased and concomitantly large amounts of inactive 22-dehydroecdysteroids accumulated. E22O injection also prevented molting of various other insects. In the larvae of the crambid moth Haritalodes basipunctalis, E22O injection induced a diapause-like developmental arrest, which, as in normal diapause, was broken by chilling. Transient expression of the E22O gene by in vivo lipofection effectively decreased the 20-hydroxyecdysone titer and blocked molting in B. mori. Transgenic expression of E22O in Drosophila melanogaster caused embryonic morphological defects, phenotypes of which were very similar to those of the ecdysteroid synthesis deficient mutants. Thus, as the first available simple but versatile tool for reducing the internal ecdysteroid titer, E22O could find use in controlling a broad range of ecdysteroid-associated developmental and physiological phenomena.	[Kamimura, Manabu] Natl Inst Agrobiol Sci, Div Insect Sci, Tsukuba, Ibaraki 3058634, Japan; [Niwa, Ryusuke] Univ Tsukuba, Grad Sch Life & Environm Sci, Initiat Promot Young Scientists Independent Res, Tsukuba, Ibaraki 3058572, Japan; [Niimi, Teruyuki] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan	National Institute of Agrobiological Sciences - Japan; University of Tsukuba; Nagoya University	Kamimura, M (corresponding author), Natl Inst Agrobiol Sci, Div Insect Sci, 1-2 Owashi, Tsukuba, Ibaraki 3058634, Japan.	kamimura@affrc.go.jp		Niimi, Teruyuki/0000-0003-3981-0177	Ministry of Agriculture, Forestry and Fisheries; Ministry of Education, Culture, Sports, Science, and Technology of Japanese government;  [21580070];  [22380039]	Ministry of Agriculture, Forestry and Fisheries(Ministry of Agriculture Forestry & Fisheries - Japan); Ministry of Education, Culture, Sports, Science, and Technology of Japanese government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; 	This work was supported by a grant-in-aid (Bio Design Program) from the Ministry of Agriculture, Forestry and Fisheries, Grants-in-aid for Scientific Research 21580070 and 22380039, and the Special Coordination Funds for Promotion Science and Technology from the Ministry of Education, Culture, Sports, Science, and Technology of Japanese government.	BEAN DW, 1983, J INSECT PHYSIOL, V29, P687, DOI 10.1016/0022-1910(83)90043-4; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bialecki M, 2002, DEV CELL, V3, P209, DOI 10.1016/S1534-5807(02)00204-6; BOWEN MF, 1984, J EXP BIOL, V108, P9; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chavez VM, 2000, DEVELOPMENT, V127, P4115; CLARET J, 1978, CR ACAD SCI D NAT, V286, P639; Cory JS, 2002, EXPTL BIOL REV, P233; Denlinger DL., 2004, COMP MOL INSECT SCI, V3, P615; Endo K, 1997, ZOOL SCI, V14, P127, DOI 10.2108/zsj.14.127; Evans OP, 1998, BIOCHEM J, V330, P1265; GELMAN DB, 1983, COMP BIOCHEM PHYS A, V76, P367, DOI 10.1016/0300-9629(83)90339-0; Gibbens YY, 2011, DEVELOPMENT, V138, P2693, DOI 10.1242/dev.063412; Guittard E, 2011, DEV BIOL, V349, P35, DOI 10.1016/j.ydbio.2010.09.023; Jin JM, 2010, MOL MICROBIOL, V76, P456, DOI 10.1111/j.1365-2958.2010.07109.x; KADONOOKUDA K, 1987, DEV GROWTH DIFFER, V29, P527; Kanamori Y, 2010, J BIOL CHEM, V285, P36933, DOI 10.1074/jbc.M110.180398; Kiuchi M, 2003, ARCH INSECT BIOCHEM, V52, P35, DOI 10.1002/arch.10060; Lafont R., 2005, COMPREHENSIVE MOL IN, V3, P125, DOI DOI 10.1016/B0-44-451924-6/00035-1; Maeda S, 2008, COMP BIOCHEM PHYS B, V149, P507, DOI 10.1016/j.cbpb.2007.11.015; MORIBAYASHI A, 1988, COMP BIOCHEM PHYS A, V91, P157; Namiki T, 2005, BIOCHEM BIOPH RES CO, V337, P367, DOI 10.1016/j.bbrc.2005.09.043; Niwa R, 2004, J BIOL CHEM, V279, P35942, DOI 10.1074/jbc.M404514200; Niwa R, 2010, DEVELOPMENT, V137, P1991, DOI 10.1242/dev.045641; Ono H, 2006, DEV BIOL, V298, P555, DOI 10.1016/j.ydbio.2006.07.023; OREILLY DR, 1995, INSECT BIOCHEM MOLEC, V25, P541, DOI 10.1016/0965-1748(94)00105-Q; Ou QX, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001160; Petryk A, 2003, P NATL ACAD SCI USA, V100, P13773, DOI 10.1073/pnas.2336088100; Raikhel A, 2005, COMPREHENSIVE MOL IN, V3, P433; Reeves CD, 2008, APPL ENVIRON MICROB, V74, P5121, DOI 10.1128/AEM.00478-08; Rewitz KF, 2010, DEV CELL, V19, P895, DOI 10.1016/j.devcel.2010.10.021; RICHARD DS, 1987, J INSECT PHYSIOL, V33, P115, DOI 10.1016/0022-1910(87)90083-7; Riddiford L.M., 1985, P37; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Sonobe H, 2004, ZOOL SCI, V21, P503, DOI 10.2108/zsj.21.503; Sonobe H, 2006, J BIOL CHEM, V281, P29513, DOI 10.1074/jbc.M604035200; Sullivan AA, 2003, MOL ENDOCRINOL, V17, P2125, DOI 10.1210/me.2002-0430; TAKEDA S, 1986, Bulletin of the Sericultural Experiment Station (Tokyo), V30, P361; Takeuchi H, 2000, BIOCHEM J, V349, P239, DOI 10.1042/0264-6021:3490239; Takeuchi H, 2001, J BIOL CHEM, V276, P26819, DOI 10.1074/jbc.M104291200; Warren JT, 2004, INSECT BIOCHEM MOLEC, V34, P991, DOI 10.1016/j.ibmb.2004.06.009; Warren JT, 2002, P NATL ACAD SCI USA, V99, P11043, DOI 10.1073/pnas.162375799; WARREN JT, 1986, INSECT BIOCHEM, V16, P65, DOI 10.1016/0020-1790(86)90080-6; Yang HJ, 2011, ARCH INSECT BIOCHEM, V78, P17, DOI 10.1002/arch.20436; Yoshiyama T, 2006, DEVELOPMENT, V133, P2565, DOI 10.1242/dev.02428; Yoshiyama-Yanagawa T, 2011, J BIOL CHEM, V286, P25756, DOI 10.1074/jbc.M111.244384; Zhou XF, 2004, J EXP BIOL, V207, P1151, DOI 10.1242/jeb.00855	47	18	20	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16488	16498		10.1074/jbc.M112.341180	http://dx.doi.org/10.1074/jbc.M112.341180			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22427652	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000304030900039
J	Onder, O; Humphrey, PT; McOmber, B; Korobova, F; Francella, N; Greenbaum, DC; Brisson, D				Oender, Oezlem; Humphrey, Parris T.; McOmber, Brian; Korobova, Farida; Francella, Nicholas; Greenbaum, Doron C.; Brisson, Dustin			OspC Is Potent Plasminogen Receptor on Surface of Borrelia burgdorferi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYME-DISEASE SPIROCHETE; PROTEIN-C; EXTRACELLULAR-MATRIX; ACTIVATION SYSTEM; MASS-SPECTROMETRY; IXODES-SCAPULARIS; CRYSTAL-STRUCTURE; SALIVARY-GLANDS; EXPRESSION; INFECTION	Host-derived proteases are crucial for the successful infection of vertebrates by several pathogens, including the Lyme disease spirochete bacterium, Borrelia burgdorferi. B. burgdorferi must traverse tissue barriers in the tick vector during transmission to the host and during dissemination within the host, and it must disrupt immune challenges to successfully complete its infectious cycle. It has been proposed that B. burgdorferi can accomplish these tasks without an endogenous extra-cytoplasmic protease by commandeering plasminogen, the highly abundant precursor of the vertebrate protease plasmin. However, the molecular mechanism by which B. burgdorferi immobilizes plasminogen to its surface remains obscure. The data presented here demonstrate that the outer surface protein C (OspC) of B. burgdorferi is a potent plasminogen receptor on the outer membrane of the bacterium. OspC-expressing spirochetes readily bind plasminogen, whereas only background levels of plasminogen are detectable on OspC-deficient strains. Furthermore, plasminogen binding by OspC-expressing spirochetes can be significantly reduced using anti-OspC antibodies. Co-immuno-fluorescence staining assays demonstrate that wild-type bacteria immobilize plasminogen only if they are actively expressing OspC regardless of the expression of other surface proteins. The co-localization of plasminogen and OspC on OspC-expressing spirochetes further implicates OspC as a biologically relevant plasminogen receptor on the surface of live B. burgdorferi.	[Oender, Oezlem] Univ Penn, Dept Biol, Leidy Labs 326, Philadelphia, PA 19104 USA; [Greenbaum, Doron C.] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Onder, O (corresponding author), Univ Penn, Dept Biol, Leidy Labs 326, 433 S Univ Ave, Philadelphia, PA 19104 USA.	ozlem@sas.upenn.edu; dbrisson@sas.upenn.edu	Onder, Ozlem/AAA-5301-2020; Brisson, Dustin/B-2428-2008	Brisson, Dustin/0000-0002-9493-7579; Onder, Ozlem/0000-0003-0850-1216	National Institutes of Health [AI076342]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076342] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI076342.	Alverson J, 2003, MOL MICROBIOL, V48, P1665, DOI 10.1046/j.1365-2958.2003.03537.x; Babb K, 2004, J BACTERIOL, V186, P2745, DOI 10.1128/JB.186.9.2745-2756.2004; BARBOUR AG, 1983, INFECT IMMUN, V41, P795, DOI 10.1128/IAI.41.2.795-804.1983; Blevins JS, 2007, APPL ENVIRON MICROB, V73, P1501, DOI 10.1128/AEM.02454-06; Boyle MDP, 1997, THROMB HAEMOSTASIS, V77, P1; Brissette CA, 2009, INFECT IMMUN, V77, P300, DOI 10.1128/IAI.01133-08; BURGDORFER W, 1982, SCIENCE, V216, P1317, DOI 10.1126/science.7043737; Burns LH, 2010, NUCLEIC ACIDS RES, V38, P5443, DOI 10.1093/nar/gkq284; Carroll JA, 1999, INFECT IMMUN, V67, P3181, DOI 10.1128/IAI.67.7.3181-3187.1999; CEDERHOLMWILLIAMS SA, 1981, J CLIN PATHOL, V34, P979, DOI 10.1136/jcp.34.9.979; Coleman JL, 1999, J LAB CLIN MED, V134, P567, DOI 10.1016/S0022-2143(99)90095-1; COLEMAN JL, 1995, INFECT IMMUN, V63, P2478, DOI 10.1128/IAI.63.7.2478-2484.1995; Coleman JL, 1999, INFECT IMMUN, V67, P3929, DOI 10.1128/IAI.67.8.3929-3936.1999; Coleman JL, 1997, CELL, V89, P1111, DOI 10.1016/S0092-8674(00)80298-6; Demain AL, 2009, BIOTECHNOL ADV, V27, P297, DOI 10.1016/j.biotechadv.2009.01.008; Dykhuizen DE, 2008, AM J TROP MED HYG, V78, P806, DOI 10.4269/ajtmh.2008.78.806; Earnhart CG, 2010, MOL MICROBIOL, V76, P393, DOI 10.1111/j.1365-2958.2010.07103.x; Eicken C, 2001, J BIOL CHEM, V276, P10010, DOI 10.1074/jbc.M010062200; El-Hage N, 2002, J BACTERIOL, V184, P4536, DOI 10.1128/JB.184.16.4536-4543.2002; Elias AF, 2002, INFECT IMMUN, V70, P2139, DOI 10.1128/IAI.70.4.2139-2150.2002; FINGERLE V, 1995, J CLIN MICROBIOL, V33, P1867, DOI 10.1128/JCM.33.7.1867-1869.1995; Fingerle V, 2007, INT J MED MICROBIOL, V297, P97, DOI 10.1016/j.ijmm.2006.11.003; FUCHS H, 1994, P NATL ACAD SCI USA, V91, P12594, DOI 10.1073/pnas.91.26.12594; FUCHS R, 1992, MOL MICROBIOL, V6, P503, DOI 10.1111/j.1365-2958.1992.tb01495.x; Gebbia JA, 1999, J CLIN INVEST, V103, P81, DOI 10.1172/JCI5171; Gilmore RD, 2000, INFECT IMMUN, V68, P411, DOI 10.1128/IAI.68.1.411-414.2000; GOGUEN JD, 1995, INFECT AGENT DIS, V4, P47; Grab DJ, 2005, INFECT IMMUN, V73, P1014, DOI 10.1128/IAI.73.2.1014-1022.2005; Grimm D, 2004, P NATL ACAD SCI USA, V101, P3142, DOI 10.1073/pnas.0306845101; Hallstrom T, 2010, J INFECT DIS, V202, P490, DOI 10.1086/653825; HU LT, 1995, INFECT IMMUN, V63, P3491, DOI 10.1128/IAI.63.9.3491-3496.1995; Hu LT, 1997, INFECT IMMUN, V65, P4989, DOI 10.1128/IAI.65.12.4989-4995.1997; Inaba K, 2009, J BIOCHEM, V146, P591, DOI 10.1093/jb/mvp102; KLEMPNER MS, 1995, J INFECT DIS, V171, P1258, DOI 10.1093/infdis/171.5.1258; Klempner MS, 1996, J INFECT DIS, V174, P97, DOI 10.1093/infdis/174.1.97; Kumaran D, 2001, EMBO J, V20, P971, DOI 10.1093/emboj/20.5.971; Kumru OS, 2011, J BACTERIOL, V193, P5759, DOI 10.1128/JB.05622-11; Lagal V, 2006, MICROBES INFECT, V8, P645, DOI 10.1016/j.micinf.2005.08.017; Lahteenmaki K, 2005, TRENDS MICROBIOL, V13, P79, DOI 10.1016/j.tim.2004.12.003; Lahteenmaki K, 2001, FEMS MICROBIOL REV, V25, P531, DOI 10.1111/j.1574-6976.2001.tb00590.x; MASUZAWA T, 1994, FEMS MICROBIOL LETT, V123, P319, DOI 10.1111/j.1574-6968.1994.tb07242.x; MIGNATTI P, 1993, PHYSIOL REV, V73, P161, DOI 10.1152/physrev.1993.73.1.161; Moriarty TJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000090; Narasimhan S, 2002, J BACTERIOL, V184, P3122, DOI 10.1128/JB.184.11.3122-3125.2002; Nordstrand A, 2001, INFECT IMMUN, V69, P5832, DOI 10.1128/IAI.69.9.5832-5839.2001; Onder O, 2008, MOL CELL PROTEOMICS, V7, P875, DOI 10.1074/mcp.M700433-MCP200; Pal U, 2004, J CLIN INVEST, V113, P220, DOI 10.1172/JCI200419894; PLOW EF, 1995, FASEB J, V9, P939, DOI 10.1096/fasebj.9.10.7615163; Plow EF, 1999, FIBRINOLYSIS PROTEOL, V13, P49, DOI 10.1016/S0268-9499(99)90079-6; Radolf JD, 2008, MOL MICROBIOL, V69, P1, DOI 10.1111/j.1365-2958.2008.06226.x; Rooijakkers SHM, 2005, MICROBES INFECT, V7, P476, DOI 10.1016/j.micinf.2004.12.014; Sarkar A, 2011, J BACTERIOL, V193, P5365, DOI 10.1128/JB.01496-10; SCHWAN TG, 1995, P NATL ACAD SCI USA, V92, P2909, DOI 10.1073/pnas.92.7.2909; Schwan TG, 2000, J CLIN MICROBIOL, V38, P382; Seemanapalli SV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015830; Seinost G, 1999, INFECT IMMUN, V67, P3518, DOI 10.1128/IAI.67.7.3518-3524.1999; Sun HM, 2004, SCIENCE, V305, P1283, DOI 10.1126/science.1101245; Tilly K, 2006, INFECT IMMUN, V74, P3554, DOI 10.1128/IAI.01950-05; Tokarz R, 2004, INFECT IMMUN, V72, P5419, DOI 10.1128/IAI.72.9.5419-5432.2004; TRAVIS J, 1995, TRENDS MICROBIOL, V3, P405, DOI 10.1016/S0966-842X(00)88988-X; Wiener MC, 2004, ANAL CHEM, V76, P6085, DOI 10.1021/ac0493875; Wormser GP, 2008, J INFECT DIS, V198, P1358, DOI 10.1086/592279; Xie F, 2011, J BIOL CHEM, V286, P25443, DOI 10.1074/jbc.R110.199703; Xu QL, 2008, MOL MICROBIOL, V69, P15, DOI 10.1111/j.1365-2958.2008.06264.x; Zuckert Wolfram R, 2007, Curr Protoc Microbiol, VChapter 12, DOI 10.1002/9780471729259.mc12c01s4	65	72	73	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16860	16868		10.1074/jbc.M111.290775	http://dx.doi.org/10.1074/jbc.M111.290775			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22433849	Green Published, hybrid			2022-12-25	WOS:000304030900072
J	Sun, DD; Huang, J; Zhang, Z; Gao, HK; Li, JY; Shen, M; Cao, F; Wang, HC				Sun, Dongdong; Huang, Jie; Zhang, Zheng; Gao, Haokao; Li, Jiayi; Shen, Min; Cao, Feng; Wang, Haichang			Luteolin Limits Infarct Size and Improves Cardiac Function after Myocardium Ischemia/Reperfusion Injury in Diabetic Rats	PLOS ONE			English	Article							INDUCED APOPTOSIS; CONTRACTILE FUNCTION; INHIBITORY FACTOR; CARDIOMYOCYTE; ISCHEMIA; SURVIVAL; PHOSPHORYLATION; ANTIOXIDANT; FLAVONOIDS; PROTECTS	Background: The present study was to investigate the effects and mechanism of Luteolin on myocardial infarct size, cardiac function and cardiomyocyte apoptosis in diabetic rats with myocardial ischemia/reperfusion (I/R) injury. Methodology/Principal Findings: Diabetic rats underwent 30 minutes of ischemia followed by 3 h of reperfusion. Animals were pretreated with or without Luteolin before coronary artery ligation. The severity of myocardial I/R induced LDH release, arrhythmia, infarct size, cardiac function impairment, cardiomyocyte apoptosis were compared. Western blot analysis was performed to elucidate the target proteins of Luteolin. The inflammatory cytokine production were also examined in ischemic myocardium underwent I/R injury. Our results revealed that Luteolin administration significantly reduced LDH release, decreased the incidence of arrhythmia, attenuated myocardial infarct size, enhanced left ventricular ejection fraction and decreased myocardial apoptotic death compared with I/R group. Western blot analysis showed that Luteolin treatment up-regulated anti-apoptotic proteins FGFR2 and LIF expression, increased BAD phosphorylation while decreased the ratio of Bax to Bcl-2. Luteolin treatment also inhibited MPO expression and inflammatory cytokine production including IL-6, IL-1a and TNF-a. Moreover, co-administration of wortmannin and Luteolin abolished the beneficial effects of Luteolin. Conclusions/Significance: This study indicates that Luteolin preserves cardiac function, reduces infarct size and cardiomyocyte apoptotic rate after I/R injury in diabetic rats. Luteolin exerts its action by up-regulating of anti-apoptotic proteins FGFR2 and LIF expression, activating PI3K/Akt pathway while increasing BAD phosphorylation and decreasing ratio of Bax to Bcl-2.	[Sun, Dongdong; Huang, Jie; Zhang, Zheng; Gao, Haokao; Li, Jiayi; Shen, Min; Cao, Feng; Wang, Haichang] Fourth Mil Med Univ, Dept Cardiol, Xijing Hosp, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University	Sun, DD (corresponding author), Fourth Mil Med Univ, Dept Cardiol, Xijing Hosp, Xian 710032, Shaanxi, Peoples R China.	wintersun3@gmail.com; wanghc3@yahoo.cn			National Nature Science Foundation of China [81100579, 30970845, 81090274]; China Scholarship Council	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council)	This work was supported by National Nature Science Foundation of China (No. 81100579, No. 30970845, No. 81090274) and China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao F, 2009, EUR HEART J, V30, P1986, DOI 10.1093/eurheartj/ehp220; Chae IH, 2004, CLIN CHIM ACTA, V341, P83, DOI 10.1016/j.cccn.2003.11.009; Donahoe SM, 2007, JAMA-J AM MED ASSOC, V298, P765, DOI 10.1001/jama.298.7.765; Dong JW, 2003, CELL RES, V13, P385, DOI 10.1038/sj.cr.7290184; Fang F, 2011, PHARMACOLOGY, V88, P149, DOI 10.1159/000330068; Feldman AM, 2000, J AM COLL CARDIOL, V35, P537, DOI 10.1016/S0735-1097(99)00600-2; Fu JJ, 2007, EUR J PHARMACOL, V568, P213, DOI 10.1016/j.ejphar.2007.04.031; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Lancel S, 2005, CIRCULATION, V111, P2596, DOI 10.1161/CIRCULATIONAHA.104.490979; Lee WL, 2000, DIABETES CARE, V23, P962, DOI 10.2337/diacare.23.7.962; Li LY, 2009, J AGR FOOD CHEM, V57, P7282, DOI 10.1021/jf901716j; Liang JL, 2010, CLIN EXP PHARMACOL P, V37, P969, DOI 10.1111/j.1440-1681.2010.05420.x; Liao PH, 2011, CIRC J, V75, P443, DOI 10.1253/circj.CJ-10-0381; Lopez-Lazaro M, 2009, MINI-REV MED CHEM, V9, P31, DOI 10.2174/138955709787001712; Matsunaga S, 2009, J MOL CELL CARDIOL, V46, P663, DOI 10.1016/j.yjmcc.2009.01.015; Middleton E, 2000, PHARMACOL REV, V52, P673; Negoro S, 2001, CIRCULATION, V103, P555, DOI 10.1161/01.CIR.103.4.555; Park YJ, 2007, CHEM PHARM BULL, V55, P1065, DOI 10.1248/cpb.55.1065; Qi LL, 2011, EUR J PHARMACOL, V668, P201, DOI 10.1016/j.ejphar.2011.06.020; RUMP AFE, 1994, GEN PHARMACOL, V25, P1137, DOI 10.1016/0306-3623(94)90129-5; RUMP AFE, 1995, GEN PHARMACOL-VASC S, V26, P603, DOI 10.1016/0306-3623(94)00209-6; Seelinger G, 2008, PLANTA MED, V74, P1667, DOI 10.1055/s-0028-1088314; Shiraishi I, 2004, CIRC RES, V94, P884, DOI 10.1161/01.RES.0000124394.01180.BE; Song JQ, 2009, APOPTOSIS, V14, P1299, DOI 10.1007/s10495-009-0398-7; Sun DD, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-4; WALKER MJA, 1988, CARDIOVASC RES, V22, P447, DOI 10.1093/cvr/22.7.447; Wang XH, 2010, CIRCULATION, V122, P1308, DOI 10.1161/CIRCULATIONAHA.110.964684; Wu Y, 2011, MOL BIOL REP, V38, P4327, DOI 10.1007/s11033-010-0558-4; Xagorari A, 2001, J PHARMACOL EXP THER, V296, P181; Younce CW, 2010, CARDIOVASC RES, V87, P665, DOI 10.1093/cvr/cvq102; Yu XY, 2010, EXP CELL RES, V316, P2903, DOI 10.1016/j.yexcr.2010.07.004; Zou YZ, 2003, CIRCULATION, V108, P748, DOI 10.1161/01.CIR.0000081773.76337.44	32	89	93	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e33491	10.1371/journal.pone.0033491	http://dx.doi.org/10.1371/journal.pone.0033491			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22432030	Green Submitted, gold, Green Published			2022-12-25	WOS:000303198600073
J	Bastug, T; Heinzelmann, G; Kuyucak, S; Salim, M; Vandenberg, RJ; Ryan, RM				Bastug, Turgut; Heinzelmann, Germano; Kuyucak, Serdar; Salim, Marietta; Vandenberg, Robert J.; Ryan, Renae M.			Position of the Third Na+ Site in the Aspartate Transporter Glt(Ph) and the Human Glutamate Transporter, EAAT1	PLOS ONE			English	Article							EXTRACELLULAR GATE; MOLECULAR-DYNAMICS; PYROCOCCUS-HORIKOSHII; SUBSTRATE-BINDING; CHLORIDE CHANNEL; ION-BINDING; FREE-ENERGY; RESIDUE; HOMOLOG; STOICHIOMETRY	Glutamate transport via the human excitatory amino acid transporters is coupled to the co-transport of three Na+ ions, one H+ and the counter-transport of one K+ ion. Transport by an archaeal homologue of the human glutamate transporters, Glt(Ph), whose three dimensional structure is known is also coupled to three Na+ ions but only two Na+ ion binding sites have been observed in the crystal structure of GltPh. In order to fully utilize the Glt(Ph) structure in functional studies of the human glutamate transporters, it is essential to understand the transport mechanism of Glt(Ph) and accurately determine the number and location of Na+ ions coupled to transport. Several sites have been proposed for the binding of a third Na+ ion from electrostatic calculations and molecular dynamics simulations. In this study, we have performed detailed free energy simulations for GltPh and reveal a new site for the third Na+ ion involving the side chains of Threonine 92, Serine 93, Asparagine 310, Aspartate 312, and the backbone of Tyrosine 89. We have also studied the transport properties of alanine mutants of the coordinating residues Threonine 92 and Serine 93 in Glt(Ph), and the corresponding residues in a human glutamate transporter, EAAT1. The mutant transporters have reduced affinity for Na+ compared to their wild type counterparts. These results confirm that Threonine 92 and Serine 93 are involved in the coordination of the third Na+ ion in Glt(Ph) and EAAT1.	[Bastug, Turgut; Heinzelmann, Germano; Kuyucak, Serdar] Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia; [Bastug, Turgut] TOBB Univ Econ & Technol, Fac Arts & Sci, Ankara, Turkey; [Salim, Marietta; Vandenberg, Robert J.; Ryan, Renae M.] Univ Sydney, Sch Med Sci, Transporter Biol Grp, Discipline Pharmacol, Sydney, NSW 2006, Australia; [Salim, Marietta; Vandenberg, Robert J.; Ryan, Renae M.] Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia	University of Sydney; TOBB Ekonomi ve Teknoloji University; University of Sydney; University of Sydney	Bastug, T (corresponding author), Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia.	renae.ryan@sydney.edu.au	Vandenberg, Robert John/E-6018-2016; Kuyucak, Serdar/AAH-8417-2021; BAŞTUĞ, TURGUT/W-9745-2018; Ryan, Renae/AAC-3540-2021; Heinzelmann, Germano/C-3460-2016	Vandenberg, Robert John/0000-0003-1523-4814; BAŞTUĞ, TURGUT/0000-0001-9123-9292; Ryan, Renae/0000-0002-8680-4610; Heinzelmann, Germano/0000-0001-7168-6941; Kuyucak, Serdar/0000-0003-4315-9532	Australian Research Council [DP1092729]; Turkish Scientific and Technical Research Council; National Health and Medical Research Counci [571093]	Australian Research Council(Australian Research Council); Turkish Scientific and Technical Research Council(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); National Health and Medical Research Counci(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants from the Australian Research Council (#DP1092729) and the Turkish Scientific and Technical Research Council. RMR is supported by a National Health and Medical Research Council Career Development Fellowship (#571093). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastug T, 2006, BIOPHYS J, V90, P3941, DOI 10.1529/biophysj.105.074633; Bendahan A, 2000, J BIOL CHEM, V275, P37436, DOI 10.1074/jbc.M006536200; BEVERIDGE DL, 1989, ANNU REV BIOPHYS BIO, V18, P431, DOI 10.1146/annurev.bb.18.060189.002243; Boresch S, 2003, J PHYS CHEM B, V107, P9535, DOI 10.1021/jp0217839; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Gaillard I, 1996, BIOCHEMISTRY-US, V35, P6150, DOI 10.1021/bi953005v; Groeneveld M, 2010, BIOCHEMISTRY-US, V49, P3511, DOI 10.1021/bi100430s; Herman MA, 2007, J NEUROSCI, V27, P9736, DOI 10.1523/JNEUROSCI.3009-07.2007; Holley DC, 2009, PHILOS T R SOC B, V364, P155, DOI 10.1098/rstb.2008.0246; Huang ZJ, 2008, BIOPHYS J, V95, P2292, DOI 10.1529/biophysj.108.133421; Huang ZJ, 2010, BIOPHYS J, V99, P1416, DOI 10.1016/j.bpj.2010.06.052; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; KARPLUS M, 1981, MACROMOLECULES, V14, P325, DOI 10.1021/ma50003a019; Kavanaugh MP, 1997, J BIOL CHEM, V272, P1703, DOI 10.1074/jbc.272.3.1703; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Larsson HP, 2010, P NATL ACAD SCI USA, V107, P13912, DOI 10.1073/pnas.1006289107; Levy LM, 1998, J NEUROSCI, V18, P9620, DOI 10.1523/jneurosci.18-23-09620.1998; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; McKinzie AA, 2010, METHODS MOL BIOL, V637, P277, DOI 10.1007/978-1-60761-700-6_15; Meier T, 2005, SCIENCE, V308, P659, DOI 10.1126/science.1111199; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Rosental N, 2006, J BIOL CHEM, V281, P27905, DOI 10.1074/jbc.M600331200; Ryan RM, 2007, NAT STRUCT MOL BIOL, V14, P365, DOI 10.1038/nsmb1230; Ryan RM, 2009, J BIOL CHEM, V284, P17540, DOI 10.1074/jbc.M109.005926; Ryan RM, 2004, J BIOL CHEM, V279, P20742, DOI 10.1074/jbc.M304433200; Seal RP, 2000, NEURON, V25, P695, DOI 10.1016/S0896-6273(00)81071-5; Shrivastava IH, 2008, J BIOL CHEM, V283, P28680, DOI 10.1074/jbc.M800889200; Tao Z, 2006, J BIOL CHEM, V281, P10263, DOI 10.1074/jbc.M510739200; Tao Z, 2010, J BIOL CHEM, V285, P17725, DOI 10.1074/jbc.M110.121798; VANDENBERG RJ, 1995, J BIOL CHEM, V270, P17668, DOI 10.1074/jbc.270.30.17668; Vandenberg RJ, 1998, BRIT J PHARMACOL, V123, P1593, DOI 10.1038/sj.bjp.0701776; Wadiche JI, 1998, J NEUROSCI, V18, P7650; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zarbiv R, 1998, J BIOL CHEM, V273, P14231, DOI 10.1074/jbc.273.23.14231; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0	39	59	59	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2012	7	3							e33058	10.1371/journal.pone.0033058	http://dx.doi.org/10.1371/journal.pone.0033058			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930IA	22427946	gold, Green Published, Green Submitted			2022-12-25	WOS:000303129700029
J	Chao, YQ; Fan, CX; Liang, YJ; Gao, B; Zhang, SC				Chao, Yeqing; Fan, Chunxin; Liang, Yujun; Gao, Bei; Zhang, Shicui			A Novel Serpin with Antithrombin-Like Activity in Branchiostoma japonicum: Implications for the Presence of a Primitive Coagulation System	PLOS ONE			English	Article							VERTEBRATE BLOOD-COAGULATION; AMINO-ACID-SEQUENCE; AMPHIOXUS; IDENTIFICATION; EVOLUTION; PROTEIN; EXPRESSION; THROMBIN; ORIGIN; INACTIVATION	Serine protease inhibitors, or serpins, are a group of widely distributed proteins with similar structures that use conformational change to inhibit proteases. Antithrombin (AT) is a member of the serine protease inhibitor superfamily and a major coagulation inhibitor in all vertebrates, but its evolutionary origin remains elusive. In this study we isolated for the first time a cDNA encoding an antithrombin homolog, BjATl, from the protochordate Branchiostoma japonicum. The deduced protein BjATl consisted of 338 amino acids sharing 36.7% to 41.1% identity to known vertebrate ATs. BjATl contains a potential N-linked glycosylation site, two potential heparin binding sites and the reactive center loop with the absolutely conserved sequence Gly-Arg-Ser; all of these are features characteristic of ATs. All three phylogenetic trees constructed using Neighbor-Joining, Maximum-Likelihood and Bayesian-Inference methods also placed BjATl together with ATs. Moreover, BjATl expressed in yeast cells was able to inhibit bovine thrombin activity by forming a SDS-stable BjATl-thrombin complex. It also displays a concentration-dependent inhibition of thrombin that is accelerated by heparin. Furthermore, BjATl was predominantly expressed in the hepatic caecum and hind-gut, agreeing with the expression pattern of AT in mammalian species. All these data clearly demonstrate that BjATl is an ortholog of vertebrate ATs, suggesting that a primitive coagulation system emerged in the protochordate.	[Chao, Yeqing; Fan, Chunxin; Liang, Yujun; Gao, Bei; Zhang, Shicui] Ocean Univ China, Dept Marine Biol, Qingdao, Peoples R China	Ocean University of China	Chao, YQ (corresponding author), Ocean Univ China, Dept Marine Biol, Qingdao, Peoples R China.	sczhang@ouc.edu.cn		Liang, Yujun/0000-0002-1253-8364; Fan, Chunxin/0000-0002-8673-4595	Ministry of Science and Technology (MOST) [2008AA09Z411, 30730072]; Natural Science Foundation of China (NSFC)	Ministry of Science and Technology (MOST)(Ministry of Science and Technology, China); Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by grants (2008AA09Z411; 30730072) of the Ministry of Science and Technology (MOST) and Natural Science Foundation of China (NSFC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Andersen O, 2000, EUR J BIOCHEM, V267, P1651, DOI 10.1046/j.1432-1327.2000.01171.x; Backovic M, 2002, J PROTEOME RES, V1, P367, DOI 10.1021/pr025515z; BEELER DL, 1986, BLOOD, V67, P1488; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burland T G, 2000, Methods Mol Biol, V132, P71; CARRELL R, 1985, TRENDS BIOCHEM SCI, V10, P20, DOI 10.1016/0968-0004(85)90011-8; CHAN TK, 1981, THROMB HAEMOSTASIS, V46, P504; DANIELSSON A, 1983, BIOCHEM J, V213, P345, DOI 10.1042/bj2130345; DANIELSSON A, 1982, BIOCHEM J, V207, P21, DOI 10.1042/bj2070021; Davidson CJ, 2003, J THROMB HAEMOST, V1, P1487, DOI 10.1046/j.1538-7836.2003.00334.x; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DOOLITTLE RF, 1962, AM J PHYSIOL, V203, P964, DOI 10.1152/ajplegacy.1962.203.5.964; DOOLITTLE RF, 1993, THROMB HAEMOSTASIS, V70, P24; DOOLITTLE RF, 1990, ADV EXP MED BIOL, V281, P25; Doolittle RF, 2008, J MOL EVOL, V66, P185, DOI 10.1007/s00239-008-9074-8; ErsdalBadju E, 1997, J BIOL CHEM, V272, P19393, DOI 10.1074/jbc.272.31.19393; Fair DS, 1984, BLOOD, V46, P504; Fan CX, 2007, INT J BIOCHEM CELL B, V39, P450, DOI 10.1016/j.biocel.2006.09.013; Frost CL, 2002, INT J BIOCHEM CELL B, V34, P1164, DOI 10.1016/S1357-2725(02)00037-7; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Hammar J., 1898, ANAT ANZEIGER, V14, P602; Hanumanthaiah R, 2002, BLOOD CELL MOL DIS, V29, P57, DOI 10.1006/bcmd.2002.0534; Holland ND, 2003, DEV BIOL, V255, P128, DOI 10.1016/S0012-1606(02)00050-7; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; Jiang Y, 2003, P NATL ACAD SCI USA, V100, P7527, DOI 10.1073/pnas.0932632100; KOURTEVA Y, 1995, THROMB RES, V78, P521, DOI 10.1016/0049-3848(95)00085-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; Li H, 2006, INVERTEBR BIOL, V125, P172, DOI 10.1111/j.1744-7410.2006.00050.x; Liang YJ, 2006, ACTA ZOOL-STOCKHOLM, V87, P141, DOI 10.1111/j.1463-6395.2006.00228.x; Liang YJ, 2006, CELL TISSUE RES, V323, P537, DOI 10.1007/s00441-005-0088-x; Liu MY, 2009, BIOSCIENCE REP, V29, P385, DOI 10.1042/BSR20080173; MACHOVICH R, 1976, THROMB HAEMOSTASIS, V36, P503; Mak P, 1996, COMP BIOCHEM PHYS B, V115, P135, DOI 10.1016/0305-0491(96)00114-9; Mann KG, 2006, BLOOD CELL MOL DIS, V36, P108, DOI 10.1016/j.bcmd.2005.12.034; MEJDOUB H, 1991, J PROTEIN CHEM, V10, P205, DOI 10.1007/BF01024785; Mochizuki S, 2001, PROTEIN EXPRES PURIF, V23, P55, DOI 10.1006/prep.2001.1479; Nakayama Y, 2000, THROMB RES, V100, P179, DOI 10.1016/S0049-3848(00)00330-3; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Niessen RWLM, 1997, THROMB HAEMOSTASIS, V78, P1088; Picard V, 1999, J BIOL CHEM, V274, P4586, DOI 10.1074/jbc.274.8.4586; RAHR H, 1979, ACTA ZOOL-STOCKHOLM, V60, P1; REMOLDODONNELL E, 1993, FEBS LETT, V315, P105, DOI 10.1016/0014-5793(93)81143-N; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruppert EE, 1997, MICROSCOPIC ANATOMY, V15, P349; Silverman GA, 2004, CELL MOL LIFE SCI, V61, P301, DOI 10.1007/s00018-003-3240-3; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Theopold U, 2004, TRENDS IMMUNOL, V25, P289, DOI 10.1016/j.it.2004.03.004; TOKUNAGA F, 1994, J BIOCHEM-TOKYO, V116, P1164, DOI 10.1093/oxfordjournals.jbchem.a124644; TRAVIS J, 1983, ANNU REV BIOCHEM, V52, P655, DOI 10.1146/annurev.bi.52.070183.003255; Wang C, 2001, INFLAMMOPHARMACOLOGY, V9, P241; Welsch U., 1975, S ZOOLOGICAL SOC LON, V36, P17; WU JK, 1992, THROMB HAEMOSTASIS, V68, P291	54	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e32392	10.1371/journal.pone.0032392	http://dx.doi.org/10.1371/journal.pone.0032392			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427833	gold, Green Submitted, Green Published			2022-12-25	WOS:000302381500015
J	Fulkerson, JR; Whittall, JB; Carlson, ML				Fulkerson, Justin R.; Whittall, Justen B.; Carlson, Matthew L.			Reproductive Ecology and Severe Pollen Limitation in the Polychromic Tundra Plant, Parrya nudicaulis (Brassicaceae)	PLOS ONE			English	Article							HIGH TEMPERATE ANDES; POLLINATION ECOLOGY; FLOWER COLOR; SELF-FERTILIZATION; RAPHANUS-SATIVUS; BREEDING SYSTEMS; ARCTIC PLANTS; HIGH-LATITUDE; CENTRAL CHILE; LIFE-HISTORY	Pollen limitation is predicted to be particularly severe in tundra habitats. Numerous reproductive patterns associated with alpine and arctic species, particularly mechanisms associated with reproductive assurance, are suggested to be driven by high levels of pollen limitation. We studied the reproductive ecology of Parrya nudicaulis, a species with relatively large sexual reproductive investment and a wide range of floral pigmentation, in tundra habitats in interior montane Alaska to estimate the degree of pollen limitation. The plants are self-compatible and strongly protandrous, setting almost no seed in the absence of pollinators. Supplemental hand pollinations within pollinator exclusion cages indicated no cage effect on seed production. Floral visitation rates were low in both years of study and particularly infrequent in 2010. A diversity of insects visited P. nudicaulis, though syrphid and muscid flies composed the majority of all visits. Pollen-ovule ratios and levels of heterozygosity are consistent with a mixed mating system. Pollen limitation was severe; hand pollinations increased seed production per plant five-fold. Seed-to-ovule ratios remained low following hand pollinations, indicating resource limitation is likely to also be responsible for curtailing seed set. We suggest that pollen limitation in P. nudicaulis may be the result of selection favoring an overproduction of ovules as a bet-hedging strategy in this environmental context of highly variable pollen receipt.	[Fulkerson, Justin R.; Carlson, Matthew L.] Univ Alaska Anchorage, Dept Biol Sci, Anchorage, AK 99508 USA; [Whittall, Justen B.] Santa Clara Univ, Dept Biol, Santa Clara, CA 95053 USA; [Carlson, Matthew L.] Univ Alaska Anchorage, Alaska Nat Heritage Program, Anchorage, AK USA	University of Alaska System; University of Alaska Anchorage; Santa Clara University; University of Alaska System; University of Alaska Anchorage	Fulkerson, JR (corresponding author), Univ Alaska Anchorage, Dept Biol Sci, Anchorage, AK 99508 USA.	jrfulkerson@alaska.edu	Fulkerson, Justin R/AAB-9487-2021	Fulkerson, Justin/0000-0003-2666-9979	Arctic Institute of North America; University of Alaska Anchorage Graduate Student Association; University of Alaska Anchorage; National Science Foundation [IPY-0733078]	Arctic Institute of North America; University of Alaska Anchorage Graduate Student Association; University of Alaska Anchorage; National Science Foundation(National Science Foundation (NSF))	Funding was provided by the Arctic Institute of North America Grants-In-Aid Program (http://www.arctic.ucalgary.ca/), the University of Alaska Anchorage Graduate Student Association, Alaska Natural Heritage Program-University of Alaska Anchorage (http://aknhp.uaa.alaska.edu/), and a National Science Foundation award (IPY-0733078) (http://www.nsf.gov/) to MLC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; AIZEN MA, 1994, ECOLOGY, V75, P330, DOI 10.2307/1939538; Aizen MA, 2007, ECOLOGY, V88, P271, DOI 10.1890/06-1017; ALSHEHBAZ IA, 2010, FLORA N AM, V7, P511; ARROYO MTK, 1982, AM J BOT, V69, P82, DOI 10.2307/2442833; ARROYO MTK, 1985, PLANT SYST EVOL, V149, P187, DOI 10.1007/BF00983305; Ashman TL, 2004, ECOLOGY, V85, P2408, DOI 10.1890/03-8024; BELL KL, 1980, ARCTIC ALPINE RES, V12, P1, DOI 10.2307/1550585; Bergman P, 1996, ARCTIC ALPINE RES, V28, P196, DOI 10.2307/1551760; BILLINGS W D, 1974, Arctic and Alpine Research, V6, P129, DOI 10.2307/1550081; BILLINGS WD, 1968, BIOL REV, V43, P481, DOI 10.1111/j.1469-185X.1968.tb00968.x; BLISS L. C., 1962, ARCTIC, V15, P117; Bliss L. C., 1971, ANNU REV ECOL SYST, V2, P405, DOI [10.1146/annurev.es.02.110171.002201, DOI 10.1146/ANNUREV.ES.02.110171.002201]; Brown AO, 2009, AM J BOT, V96, P1096, DOI 10.3732/ajb.0800102; Buchmann S.L., 1997, FORGOTTEN POLLINATOR; BURD M, 1994, BOT REV, V60, P83, DOI 10.1007/BF02856594; BURD M, 1995, EVOLUTION, V49, P100, DOI 10.1111/j.1558-5646.1995.tb05962.x; Burd M, 2009, AM J BOT, V96, P1159, DOI 10.3732/ajb.0800183; Carlson ML, 2008, ARCT ANTARCT ALP RES, V40, P39, DOI 10.1657/1523-0430(06-080)[CARLSON]2.0.CO;2; Chittka L, 2001, NATURE, V411, P653, DOI 10.1038/35079676; Crawford R.M.M., 1989, STUDIES PLANT SURVIV; CRUDEN RW, 1977, EVOLUTION, V31, P32, DOI 10.1111/j.1558-5646.1977.tb00979.x; Dick CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018230; Dodd Shana C., 2000, Madrono, V47, P116; Elberling H, 2001, NORD J BOT, V21, P277, DOI 10.1111/j.1756-1051.2001.tb00769.x; Elberling H, 1999, ECOGRAPHY, V22, P314, DOI 10.1111/j.1600-0587.1999.tb00507.x; Garcia-Camacho R, 2009, ARCT ANTARCT ALP RES, V41, P103, DOI [10.1657/1938-4246(08-028)[GARCIA-CAMACHO]2.0.CO;2, 10.1657/1523-0430-41.1.103]; German DA, 2011, PLANT SYST EVOL, V294, P65, DOI 10.1007/s00606-011-0452-0; Gigord LDB, 2001, P NATL ACAD SCI USA, V98, P6253, DOI 10.1073/pnas.111162598; Gomez JM, 2010, J ECOL, V98, P1243, DOI 10.1111/j.1365-2745.2010.01691.x; Grabas GP, 1999, ECOSCIENCE, V6, P230, DOI 10.1080/11956860.1999.11682524; HAIG D, 1988, AM NAT, V131, P757, DOI 10.1086/284817; Harder LD, 2010, PHILOS T R SOC B, V365, P529, DOI 10.1098/rstb.2009.0226; Harder LD, 2000, P ROY SOC B-BIOL SCI, V267, P315, DOI 10.1098/rspb.2000.1002; HERRERA CM, 1987, OIKOS, V50, P79, DOI 10.2307/3565403; HOCKING B, 1968, OIKOS, V19, P359, DOI 10.2307/3565022; Hulten E, 1968, FLORA ALASKA NEIGHBO; INOUYE DW, 1988, AUST J ECOL, V13, P191, DOI 10.1111/j.1442-9993.1988.tb00968.x; JOHNSON PL, 1969, ARCTIC, V22, P341; JOHNSTON MO, 1991, ECOLOGY, V72, P1500, DOI 10.2307/1941123; Kannely A., 2005, Madrono, V52, P267, DOI 10.3120/0024-9637(2005)52[267:PAQOEP]2.0.CO;2; Kearns C. A., 1993, TECHNIQUES POLLINATI; KEVAN PG, 1972, J ECOL, V60, P831, DOI 10.2307/2258569; Knight TM, 2005, ANNU REV ECOL EVOL S, V36, P467, DOI 10.1146/annurev.ecolsys.36.102403.115320; Knight TM, 2006, AM J BOT, V93, P271, DOI 10.3732/ajb.93.2.271; Lloyd D. G., 1980, Demography and evolution in plant populations., P67; Love A., 1959, PROBLEMS PLEISTOCENE, V1, P82; Lundgren R, 2005, ARCT ANTARCT ALP RES, V37, P514, DOI 10.1657/1523-0430(2005)037[0514:TDAHCW]2.0.CO;2; Martins Emilia P., 1996, P22; MCGUIRE AD, 1991, AM J BOT, V78, P214, DOI 10.2307/2445244; MelendezAckerman E, 1997, ECOLOGY, V78, P2532, DOI 10.1890/0012-9658(1997)078[2532:HBAMOS]2.0.CO;2; MOLAU U, 1993, ARCTIC ALPINE RES, V25, P391, DOI 10.2307/1551922; Morgan MT, 2005, EVOLUTION, V59, P1143, DOI 10.1111/j.0014-3820.2005.tb01050.x; Mosquin T., 1966, EVOLUTION CANADAS FL, P43; MOSQUIN THEODORE, 1967, CAN FIELD NATUR, V81, P201; Narbona E, 2010, AM J BOT, V97, P672, DOI 10.3732/ajb.0900259; Olesen JM, 2002, ECOLOGY, V83, P2416, DOI 10.2307/3071803; Parker IM, 1997, ECOLOGY, V78, P1457, DOI 10.1890/0012-9658(1997)078[1457:PLOCSS]2.0.CO;2; Philipp M, 1996, ARCTIC ALPINE RES, V28, P403, DOI 10.2307/1551851; Porcher E, 2005, J EVOLUTION BIOL, V18, P497, DOI 10.1111/j.1420-9101.2005.00905.x; PRESTON RE, 1986, AM J BOT, V73, P1732, DOI 10.2307/2444239; Richards A.J, 1997, PLANT BREEDING SYSTE; Royal Horticultural Society (RHS), 2007, RHS COL CHART; SPSS, 2009, PASW STAT 18 0 0; STANTON ML, 1987, AM J BOT, V74, P178, DOI 10.2307/2444019; STENSTROM M, 1992, ARCTIC ALPINE RES, V24, P337, DOI 10.2307/1551289; Stevens M, 2007, BIOL J LINN SOC, V90, P211, DOI 10.1111/j.1095-8312.2007.00725.x; Strauss S.Y., 2006, ECOLOGY EVOLUTION FL, P120; SWALES DE, 1979, RHODORA, V81, P363; Tepedino VJ, 2007, PLANT ECOL, V193, P59, DOI 10.1007/s11258-006-9248-7; TIKHMENEV EA, 1984, SOV J ECOL+, V15, P166; TIKHMENEV EA, 1981, SOV J ECOL+, V12, P271; TOTLAND O, 1993, CAN J BOT, V71, P1072, DOI 10.1139/b93-124; Totland O, 2001, ECOLOGY, V82, P2233, DOI 10.1890/0012-9658(2001)082[2233:EDPLAS]2.0.CO;2; Totland O, 1999, ECOSCIENCE, V6, P173, DOI 10.1080/11956860.1999.11682518; TOTLAND O, 1994, ARCTIC ALPINE RES, V26, P66, DOI 10.2307/1551879; Tsang ACW, 2005, CAN J BOT, V83, P1645, DOI 10.1139/b05-131; VOSS DH, 1992, HORTSCIENCE, V27, P1256, DOI 10.21273/HORTSCI.27.12.1256; WASER NM, 1981, EVOLUTION, V35, P376, DOI 10.1111/j.1558-5646.1981.tb04896.x; Whittall J, 2009, NEW PHYTOL, V182, P5, DOI 10.1111/j.1469-8137.2009.02796.x; WIENS D, 1984, OECOLOGIA, V64, P47, DOI 10.1007/BF00377542; YOUNG HJ, 1990, CAN J BOT, V68, P480, DOI 10.1139/b90-064; Zhou TY, 2001, FLORA CHINA, V8; ZIMMERMAN M, 1988, AM NAT, V131, P723, DOI 10.1086/284815	84	24	26	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e32790	10.1371/journal.pone.0032790	http://dx.doi.org/10.1371/journal.pone.0032790			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427886	Green Published, Green Submitted, gold			2022-12-25	WOS:000302381500047
J	Hudoklin, S; Jezernik, K; Neumuller, J; Pavelka, M; Romih, R				Hudoklin, Samo; Jezernik, Kristijan; Neumueller, Josef; Pavelka, Margit; Romih, Rok			Electron Tomography of Fusiform Vesicles and Their Organization in Urothelial Cells	PLOS ONE			English	Article							MAMMALIAN URINARY-BLADDER; TRANSITIONAL EPITHELIAL-CELLS; EXPANSION-CONTRACTION CYCLE; ASYMMETRIC UNIT MEMBRANE; LUMENAL PLASMA-MEMBRANE; UMBRELLA CELLS; LUMINAL MEMBRANE; APICAL MEMBRANE; UROPLAKIN-IB; RAT	The formation of fusiform vesicles (FVs) is one of the most distinctive features in the urothelium of the urinary bladder. FVs represent compartments for intracellular transport of urothelial plaques, which modulate the surface area of the superficial urothelial ( umbrella) cells during the distension-contraction cycle. We have analysed the three-dimensional (3D) structure of FVs and their organization in umbrella cells of mouse urinary bladders. Compared to chemical fixation, high pressure freezing gave a new insight into the ultrastructure of urothelial cells. Electron tomography on serial sections revealed that mature FVs had a shape of flattened discs, with a diameter of up to 1.2 mu m. The lumen between the two opposing asymmetrically thickened membranes was very narrow, ranging from 5 nm to 10 nm. Freeze-fracturing and immunolabelling confirmed that FVs contain two opposing urothelial plaques connected by a hinge region that made an omega shaped curvature. In the central cytoplasm, 4-15 FVs were often organized into stacks. In the subapical cytoplasm, FVs were mainly organized as individual vesicles. Distension-contraction cycles did not affect the shape of mature FVs; however, their orientation changed from parallel in distended to perpendicular in contracted bladder with respect to the apical plasma membrane. In the intermediate cells, shorter and more dilated immature FVs were present. The salient outcome from this research is the first comprehensive, high resolution 3D view of the ultrastructure of FVs and how they are organized differently depending on their location in the cytoplasm of umbrella cells. The shape of mature FVs and their organization into tightly packed stacks makes them a perfect storage compartment, which transports large amounts of urothelial plaques while occupying a small volume of umbrella cell cytoplasm.	[Hudoklin, Samo; Jezernik, Kristijan; Romih, Rok] Univ Ljubljana, Fac Med, Inst Cell Biol, Ljubljana, Slovenia; [Neumueller, Josef; Pavelka, Margit] Med Univ Vienna, Ctr Anat & Cell Biol, Dept Cell Biol & Ultrastruct Res, Vienna, Austria	University of Ljubljana; Medical University of Vienna	Hudoklin, S (corresponding author), Univ Ljubljana, Fac Med, Inst Cell Biol, Ljubljana, Slovenia.	rok.romih@mf.uni-lj.si			Ministry of Education and Sport, Government of Republic of Slovenia, Slovenia [3311-04-831450]; Slovenian Research Agency [BI-AT/07-08-019]	Ministry of Education and Sport, Government of Republic of Slovenia, Slovenia; Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported by the Ministry of Education and Sport, Government of Republic of Slovenia, Slovenia (grant no. 3311-04-831450), and by the Slovenian Research Agency (project: BI-AT/07-08-019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Apodaca G, 2004, TRAFFIC, V5, P117, DOI 10.1046/j.1600-0854.2003.00156.x; Baumeister W, 1999, TRENDS CELL BIOL, V9, P81, DOI 10.1016/S0962-8924(98)01423-8; Chen YR, 2003, P NATL ACAD SCI USA, V100, P14012, DOI 10.1073/pnas.2436350100; CHLAPOWSKI FJ, 1972, J CELL BIOL, V53, P92, DOI 10.1083/jcb.53.1.92; Clegg ED, 1990, HISTOLOGICAL HISTOPA, P277; Derganc J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026824; Gibson A, 1998, J CELL BIOL, V143, P81, DOI 10.1083/jcb.143.1.81; HICKS RM, 1966, J CELL BIOL, V30, P623, DOI 10.1083/jcb.30.3.623; HICKS RM, 1965, J CELL BIOL, V26, P25, DOI 10.1083/jcb.26.1.25; HICKS RM, 1975, BIOL REV, V50, P215, DOI 10.1111/j.1469-185X.1975.tb01057.x; Hu CCA, 2005, MOL BIOL CELL, V16, P3937, DOI 10.1091/mbc.E05-02-0136; Hu P, 2000, J CELL BIOL, V151, P961, DOI 10.1083/jcb.151.5.961; Hudoklin S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023636; Kachar B, 1999, J MOL BIOL, V285, P595, DOI 10.1006/jmbi.1998.2304; KOSS LG, 1969, LAB INVEST, V21, P154; Kreft ME, 2010, PROTOPLASMA, V246, P3, DOI 10.1007/s00709-010-0112-1; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Ladinsky MS, 1999, J CELL BIOL, V144, P1135, DOI 10.1083/jcb.144.6.1135; LEWIS SA, 1984, J MEMBRANE BIOL, V82, P123, DOI 10.1007/BF01868937; LEWIS SA, 1982, NATURE, V297, P685, DOI 10.1038/297685a0; LIN JH, 1994, J BIOL CHEM, V269, P1775; Marsh BJ, 2001, BIOCHEM SOC T, V29, P461, DOI 10.1042/BST0290461; Marsh BJ, 2007, METHOD CELL BIOL, V79, P193, DOI 10.1016/S0091-679X(06)79008-2; McIntosh R, 2005, TRENDS CELL BIOL, V15, P43, DOI 10.1016/j.tcb.2004.11.009; Min GW, 2006, J CELL BIOL, V173, P975, DOI 10.1083/jcb.200602086; MINSKY BD, 1978, J CELL BIOL, V77, P685, DOI 10.1083/jcb.77.3.685; Monaghan P, 1998, J MICROSC-OXFORD, V192, P248, DOI 10.1046/j.1365-2818.1998.00387.x; NOACK W, 1975, ACTA ANAT, V93, P171; PORTER KR, 1967, PROTOPLASMA, V63, P262, DOI 10.1007/BF01248042; PORTER KR, 1963, INTRO FINE STRUCTURE; SARIKAS SN, 1986, CELL TISSUE RES, V246, P109; SARIKAS SN, 1989, CELL TISSUE RES, V258, P393; SEVERS NJ, 1979, J ULTRA MOL STRUCT R, V69, P279, DOI 10.1016/S0022-5320(79)90117-5; STAEHELIN LA, 1972, J CELL BIOL, V53, P73, DOI 10.1083/jcb.53.1.73; Sung CH, 2010, J CELL BIOL, V190, P953, DOI 10.1083/jcb.201006020; SURYA B, 1990, J CELL SCI, V97, P419; Truschel ST, 2002, MOL BIOL CELL, V13, P830, DOI 10.1091/mbc.01-09-0435; Tu LY, 2006, J CELL SCI, V119, P5077, DOI 10.1242/jcs.03285; Tu LY, 2002, MOL BIOL CELL, V13, P4221, DOI 10.1091/mbc.E02-04-0211; VANDENBOSCH M, 1981, J MICROSC-OXFORD, V121, P239, DOI 10.1111/j.1365-2818.1981.tb01219.x; Vanhecke D, 2008, METHOD CELL BIOL, V88, P151, DOI 10.1016/S0091-679X(08)00409-3; Veranic P, 2004, EUR J CELL BIOL, V83, P27, DOI 10.1078/0171-9335-00351; Veranic P, 2002, CELL MOTIL CYTOSKEL, V53, P317, DOI 10.1002/cm.10077; WU XR, 1993, J CELL SCI, V106, P31; WU XR, 1994, J BIOL CHEM, V269, P13716; WU XR, 1990, J BIOL CHEM, V265, P19170; YU J, 1990, J CELL BIOL, V111, P1207, DOI 10.1083/jcb.111.3.1207; YU J, 1994, J CELL BIOL, V125, P171, DOI 10.1083/jcb.125.1.171	49	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e32935	10.1371/journal.pone.0032935	http://dx.doi.org/10.1371/journal.pone.0032935			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427911	Green Submitted, Green Published, gold			2022-12-25	WOS:000302381500064
J	Reeder, NMM; Pessier, AP; Vredenburg, VT				Reeder, Natalie M. M.; Pessier, Allan P.; Vredenburg, Vance T.			A Reservoir Species for the Emerging Amphibian Pathogen Batrachochytrium dendrobatidis Thrives in a Landscape Decimated by Disease	PLOS ONE			English	Article							CHYTRID FUNGUS; INFECTIOUS-DISEASE; RANA-CATESBEIANA; IMMUNE DEFENSES; CHYTRIDIOMYCOSIS; DECLINES; FROG; EXTINCTION; MORTALITY; DYNAMICS	Chytridiomycosis, a disease caused by the fungal pathogen Batrachochytrium dendrobatidis (Bd), is driving amphibian declines and extinctions in protected areas globally. The introduction of invasive reservoir species has been implicated in the spread of Bd but does not explain the appearance of the pathogen in remote protected areas. In the high elevation (>1500 m) Sierra Nevada of California, the native Pacific chorus frog, Pseudacris regilla, appears unaffected by chytridiomycosis while sympatric species experience catastrophic declines. We investigated whether P. regilla is a reservoir of Bd by comparing habitat occupancy before and after a major Bd outbreak and measuring infection in P. regilla in the field, monitoring susceptibility of P. regilla to Bd in the laboratory, examining tissues with histology to determine patterns of infection, and using an innovative soak technique to determine individual output of Bd zoospores in water. Pseudacris regilla persists at 100% of sites where a sympatric species has been extirpated from 72% in synchrony with a wave of Bd. In the laboratory, P. regilla carried loads of Bd as much as an order of magnitude higher than loads found lethal to sympatric species. Histology shows heavy Bd infection in patchy areas next to normal skin, a possible mechanism for tolerance. The soak technique was 77.8% effective at detecting Bd in water and showed an average output of 68 zoospores per minute per individual. The results of this study suggest P. regilla should act as a Bd reservoir and provide evidence of a tolerance mechanism in a reservoir species.	[Reeder, Natalie M. M.; Vredenburg, Vance T.] San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA; [Pessier, Allan P.] San Diego Zoo Global, Inst Conservat Res, Wildlife Dis Labs, San Diego, CA USA	California State University System; San Francisco State University	Reeder, NMM (corresponding author), San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA.	ReederN@gmail.com		Vredenburg, Vance/0000-0002-9682-1190	National Science Foundation [EF-0723563]	National Science Foundation(National Science Foundation (NSF))	This work was funded by National Science Foundation Ecology of Infectious Disease Program Grant EF-0723563 (nsf.gov). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Berger L, 2005, DIS AQUAT ORGAN, V68, P51, DOI 10.3354/dao068051; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Briggs CJ, 2010, P NATL ACAD SCI USA, V107, P9695, DOI 10.1073/pnas.0912886107; Carey C, 2006, ECOHEALTH, V3, P5, DOI 10.1007/s10393-005-0006-4; Cushman SA, 2006, BIOL CONSERV, V128, P231, DOI 10.1016/j.biocon.2005.09.031; Daszak P, 2004, HERPETOL J, V14, P201; Davidson EW, 2003, COPEIA, P601, DOI 10.1643/CP-02-120R1; Fisher Matthew C., 2007, Fungal Biology Reviews, V21, P2, DOI 10.1016/j.fbr.2007.02.002; Hanselmann R, 2004, BIOL CONSERV, V120, P115, DOI 10.1016/j.biocon.2004.02.013; Harris RN, 2006, ECOHEALTH, V3, P53, DOI 10.1007/s10393-005-0009-1; Kriger KM, 2007, CONSERV BIOL, V21, P1280, DOI 10.1111/j.1523-1739.2007.00777.x; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Padgett-Flohr GE, 2009, DIS AQUAT ORGAN, V83, P1, DOI 10.3354/dao02003; Pessier AP, 1999, J VET DIAGN INVEST, V11, P194, DOI 10.1177/104063879901100219; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; Rachowicz LJ, 2006, ECOLOGY, V87, P1671, DOI 10.1890/0012-9658(2006)87[1671:EIDAAP]2.0.CO;2; Ramsey JP, 2010, INFECT IMMUN, V78, P3981, DOI 10.1128/IAI.00402-10; Retallick RWR, 2004, PLOS BIOL, V2, P1965, DOI 10.1371/journal.pbio.0020351; Rollins-Smith LA, 2005, DEV COMP IMMUNOL, V29, P589, DOI 10.1016/j.dci.2004.11.004; Rosenblum EB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006494; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Stice MJ, 2010, J WILDLIFE DIS, V46, P70, DOI 10.7589/0090-3558-46.1.70; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Vazquez VM, 2009, DIS AQUAT ORGAN, V84, P1, DOI 10.3354/dao02026; Voyles J, 2011, MICROBES INFECT, V13, P25, DOI 10.1016/j.micinf.2010.09.015; Voyles J, 2009, SCIENCE, V326, P582, DOI 10.1126/science.1176765; Vredenburg VT, 2007, J ZOOL, V271, P361, DOI 10.1111/j.1469-7998.2006.00258.x; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Vredenburg VT, 2004, P NATL ACAD SCI USA, V101, P7646, DOI 10.1073/pnas.0402321101; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Weldon C, 2004, EMERG INFECT DIS, V10, P2100, DOI 10.3201/eid1012.030804; Woodhams DC, 2007, ANIM CONSERV, V10, P409, DOI 10.1111/j.1469-1795.2007.00130.x; Woodhams DC, 2007, BIOL CONSERV, V138, P390, DOI 10.1016/j.biocon.2007.05.004	34	120	124	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33567	10.1371/journal.pone.0033567	http://dx.doi.org/10.1371/journal.pone.0033567			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22428071	Green Published, gold			2022-12-25	WOS:000302381500155
J	Ehrlund, A; Jonsson, P; Vedin, LL; Williams, C; Gustafsson, JA; Treuter, E				Ehrlund, Anna; Jonsson, Philip; Vedin, Lise-Lotte; Williams, Cecilia; Gustafsson, Jan-Ake; Treuter, Eckardt			Knockdown of SF-1 and RNF31 Affects Components of Steroidogenesis, TGF beta, and Wnt/beta-catenin Signaling in Adrenocortical Carcinoma Cells	PLOS ONE			English	Article							REGULATORY PROTEIN EXPRESSION; FACTOR-I; NUCLEAR RECEPTOR; TARGET GENES; ADRENAL DEVELOPMENT; GONADAL DEVELOPMENT; FACTOR-1 GENE; TRANSCRIPTION; PROLIFERATION; GROWTH	The orphan nuclear receptor Steroidogenic Factor-1 (SF-1, NR5A1) is a critical regulator of development and homeostasis of the adrenal cortex and gonads. We recently showed that a complex containing E3 ubiquitin ligase RNF31 and the known SF-1 corepressor DAX-1 (NR0B1) interacts with SF-1 on target promoters and represses transcription of steroidogenic acute regulatory protein (StAR) and aromatase (CYP19) genes. To further evaluate the role of SF-1 in the adrenal cortex and the involvement of RNF31 in SF-1-dependent pathways, we performed genome-wide gene-expression analysis of adrenocortical NCI-H295R cells where SF-1 or RNF31 had been knocked down using RNA interference. We find RNF31 to be deeply connected to cholesterol metabolism and steroid hormone synthesis, strengthening its role as an SF-1 coregulator. We also find intriguing evidence of negative crosstalk between SF-1 and both transforming growth factor (TGF) beta and Wnt/beta-catenin signaling. This crosstalk could be of importance for adrenogonadal development, maintenance of adrenocortical progenitor cells and the development of adrenocortical carcinoma. Finally, the SF-1 gene profile can be used to distinguish malignant from benign adrenocortical tumors, a finding that implicates SF-1 in the development of malignant adrenocortical carcinoma.	[Ehrlund, Anna; Vedin, Lise-Lotte; Gustafsson, Jan-Ake; Treuter, Eckardt] Karolinska Inst, Dept Biosci & Nutr, Ctr Biosci, Huddinge, Sweden; [Jonsson, Philip; Williams, Cecilia; Gustafsson, Jan-Ake] Univ Houston, Dept Biol & Biochem, Ctr Nucl Receptors & Cell Signaling, Houston, TX USA; [Ehrlund, Anna] Huddinge Univ Hosp, Karolinska Inst, Dept Med, S-14186 Huddinge, Sweden	Karolinska Institutet; University of Houston System; University of Houston; Karolinska Institutet	Ehrlund, A (corresponding author), Karolinska Inst, Dept Biosci & Nutr, Ctr Biosci, Huddinge, Sweden.	ceciliawilliams@uh.edu	Williams, Cecilia/A-6677-2009	Williams, Cecilia/0000-0002-0602-2062; Jonsson, Philip/0000-0002-1537-0624; Treuter, Eckardt/0000-0002-4147-8989	Center for Biosciences; Swedish Cancer Society; Swedish Research Council; Texas Emerging Technology Fund [300-9-1958]	Center for Biosciences; Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Texas Emerging Technology Fund	This work was supported by grants from the Center for Biosciences, the Swedish Cancer Society, the Swedish Research Council and The Texas Emerging Technology Fund, under agreement no. 300-9-1958. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Botrugno OA, 2004, MOL CELL, V15, P499, DOI 10.1016/j.molcel.2004.07.009; Campbell LA, 2008, MOL CELL BIOL, V28, P7476, DOI 10.1128/MCB.00103-08; Chen WY, 2004, J BIOL CHEM, V279, P38730, DOI 10.1074/jbc.M405006200; Dammer EB, 2007, MOL ENDOCRINOL, V21, P415, DOI 10.1210/me.2006-0361; de Reynies A, 2009, J CLIN ONCOL, V27, P1108, DOI 10.1200/JCO.2008.18.5678; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Derebecka-Holysz N, 2008, MOL CELL BIOCHEM, V307, P65, DOI 10.1007/s11010-007-9585-4; Ding X, 2006, J BIOL CHEM, V281, P26540, DOI 10.1074/jbc.M600931200; Doghman M, 2008, J CLIN ENDOCR METAB, V93, P3222, DOI 10.1210/jc.2008-0247; Doghman M, 2007, MOL ENDOCRINOL, V21, P2968, DOI 10.1210/me.2007-0120; Doghman M, 2009, J CLIN ENDOCR METAB, V94, P2178, DOI 10.1210/jc.2008-2163; Edvardsson K, 2011, MOL ENDOCRINOL; Ehrlund A, 2009, MOL CELL BIOL, V29, P2230, DOI 10.1128/MCB.00743-08; Figueiredo BC, 2005, J CLIN ENDOCR METAB, V90, P615, DOI 10.1210/jc.2004-0942; Fottner C, 2004, HORM METAB RES, V36, P397, DOI 10.1055/s-2004-814563; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Gummow BM, 2003, J BIOL CHEM, V278, P26572, DOI 10.1074/jbc.M212677200; Hammer GD, 1999, MOL CELL, V3, P521, DOI 10.1016/S1097-2765(00)80480-3; Hanley NA, 1999, MECH DEVELOP, V87, P175, DOI 10.1016/S0925-4773(99)00123-9; Hanley NA, 2001, MOL ENDOCRINOL, V15, P57, DOI 10.1210/me.15.1.57; Hoivik EA, 2010, MOL CELL ENDOCRINOL, V315, P27, DOI 10.1016/j.mce.2009.07.003; Hoyle C, 2002, MOL ENDOCRINOL, V16, P747, DOI 10.1210/me.16.4.747; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jeays-Ward K, 2003, DEVELOPMENT, V130, P3663, DOI 10.1242/dev.00591; Kawabe K, 1999, MOL ENDOCRINOL, V13, P1267, DOI 10.1210/me.13.8.1267; Kim AC, 2008, DEVELOPMENT, V135, P2593, DOI 10.1242/dev.021493; Kim AC, 2009, ENDOCR REV, V30, P241, DOI 10.1210/er.2008-0039; Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X; Komatsu T, 2004, MOL ENDOCRINOL, V18, P2451, DOI 10.1210/me.2004-0173; Krylova IN, 2005, CELL, V120, P343, DOI 10.1016/j.cell.2005.01.024; Lalli E, 2010, J MOL ENDOCRINOL, V44, P301, DOI 10.1677/JME-09-0143; Lehmann TP, 2005, ENDOCR RES, V31, P71, DOI 10.1080/07435800500229110; Li Y, 2005, MOL CELL, V17, P491, DOI 10.1016/j.molcel.2005.02.002; Liakos P, 2003, J ENDOCRINOL, V176, P69, DOI 10.1677/joe.0.1760069; Lichtenauer UD, 2007, ENDOCRINOLOGY, V148, P693, DOI 10.1210/en.2006-0681; Logie A, 1999, J MOL ENDOCRINOL, V23, P23, DOI 10.1677/jme.0.0230023; LUO XR, 1994, CELL, V77, P481, DOI 10.1016/0092-8674(94)90211-9; Manna PR, 2009, ENDOCRINOLOGY, V150, P187, DOI 10.1210/en.2008-0368; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; MOROHASHI K, 1994, MOL ENDOCRINOL, V8, P643, DOI 10.1210/me.8.5.643; Pianovski MAD, 2006, EUR J CANCER, V42, P1040, DOI 10.1016/j.ejca.2006.01.022; Ramayya MS, 1997, J CLIN ENDOCR METAB, V82, P1799, DOI 10.1210/jc.82.6.1799; SADOVSKY Y, 1995, P NATL ACAD SCI USA, V92, P10939, DOI 10.1073/pnas.92.24.10939; Salisbury TB, 2007, MOL ENDOCRINOL, V21, P963, DOI 10.1210/me.2006-0383; Schimmer BP, 2010, MOL ENDOCRINOL, V24, P1322, DOI 10.1210/me.2009-0519; Schnabel CA, 2003, GENESIS, V37, P123, DOI 10.1002/gene.10235; Sugawara T, 2006, J ENDOCRINOL, V191, P327, DOI 10.1677/joe.1.06601; Tissier F, 2005, CANCER RES, V65, P7622, DOI 10.1158/0008-5472.CAN-05-0593; Urs AN, 2007, MOL CELL ENDOCRINOL, V265, P174, DOI 10.1016/j.mce.2006.12.016; Urs AN, 2006, ENDOCRINOLOGY, V147, P5249, DOI 10.1210/en.2006-0355; Venteclef N, 2010, GENE DEV, V24, P381, DOI 10.1101/gad.545110; Vilain E, 1997, BIOCHEM MOL MED, V61, P1, DOI 10.1006/bmme.1997.2601; Wang W, 2005, P NATL ACAD SCI USA, V102, P7505, DOI 10.1073/pnas.0409482102; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Wilkin F, 2000, J CLIN ENDOCR METAB, V85, P2048, DOI 10.1210/jc.85.5.2048; Winnay JN, 2006, MOL ENDOCRINOL, V20, P147, DOI 10.1210/me.2005-0215; Yang WH, 2009, MOL CELL BIOL, V29, P613, DOI 10.1128/MCB.00295-08; Yu RN, 1998, MOL ENDOCRINOL, V12, P1010, DOI 10.1210/me.12.7.1010; Zubair M, 2006, MOL CELL BIOL, V26, P4111, DOI 10.1128/MCB.00222-06	60	21	21	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2012	7	3							e32080	10.1371/journal.pone.0032080	http://dx.doi.org/10.1371/journal.pone.0032080			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KX	22427816	Green Submitted, Green Published, gold			2022-12-25	WOS:000303062800012
J	Subramani, A; Floudas, CA				Subramani, Ashwin; Floudas, Christodoulos A.			beta-sheet Topology Prediction with High Precision and Recall for beta and Mixed alpha/beta Proteins	PLOS ONE			English	Article							SANDWICH-LIKE PROTEINS; GLOBULAR-PROTEINS; PLEATED SHEETS; STRAND ARRANGEMENTS; TERTIARY STRUCTURE; CLASSIFICATION; FOLD; OPTIMIZATION; CONFORMATION; MOTIFS	The prediction of the correct beta-sheet topology for pure beta and mixed alpha/beta proteins is a critical intermediate step toward the three dimensional protein structure prediction. The predicted beta sheet topology provides distance constraints between sequentially separated residues, which reduces the three dimensional search space for a protein structure prediction algorithm. Here, we present a novel mixed integer linear optimization based framework for the prediction of beta-sheet topology in beta and mixed alpha/beta proteins. The objective is to maximize the total strand-to-strand contact potential of the protein. A large number of physical constraints are applied to provide biologically meaningful topology results. The formulation permits the creation of a rank-ordered list of preferred beta-sheet arrangements. Finally, the generated topologies are re-ranked using a fully atomistic approach involving torsion angle dynamics and clustering. For a large, non-redundant data set of 2102 beta and mixed alpha/beta proteins with at least 3 strands taken from the PDB, the proposed approach provides the top 5 solutions with average precision and recall greater than 78%. Consistent results are obtained in the beta-sheet topology prediction for blind targets provided during the CASP8 and CASP9 experiments, as well as for actual and predicted secondary structures. The beta-sheet topology prediction algorithm, BeST, is available to the scientific community at http://selene.princeton.edu/BeST/.	[Subramani, Ashwin; Floudas, Christodoulos A.] Princeton Univ, Dept Chem & Biol Engn, Princeton, NJ 08544 USA	Princeton University	Subramani, A (corresponding author), Princeton Univ, Dept Chem & Biol Engn, Princeton, NJ 08544 USA.	floudas@titan.princeton.edu			National Science Foundation; National Institutes of Health [R01 GM52032, R24 GM069736]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM069736, R01GM052032] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	CAF gratefully acknowledges financial support from the National Science Foundation and National Institutes of Health (R01 GM52032; R24 GM069736). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asogawa M, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P48; Aydin Z, 2011, IEEE ACM T COMPUT BI, V8, P395, DOI 10.1109/TCBB.2008.140; Baldwin RL, 1999, TRENDS BIOCHEM SCI, V24, P77, DOI 10.1016/S0968-0004(98)01345-0; Baldwin RL, 1999, TRENDS BIOCHEM SCI, V24, P26, DOI 10.1016/S0968-0004(98)01346-2; Cheng JL, 2005, BIOINFORMATICS, V21, pI75, DOI 10.1093/bioinformatics/bti1004; Chiang YS, 2007, PROTEINS, V68, P915, DOI 10.1002/prot.21473; CHOTHIA C, 1990, ANNU REV BIOCHEM, V59, P1007, DOI 10.1146/annurev.bi.59.070190.005043; COHEN FE, 1982, J MOL BIOL, V156, P821, DOI 10.1016/0022-2836(82)90144-9; Crippen G, 1988, DISTANCE GEOMETRY MO; DILL KA, 1993, P NATL ACAD SCI USA, V90, P1942, DOI 10.1073/pnas.90.5.1942; DiMaggio PA, 2010, TOXICOL SCI, V118, P251, DOI 10.1093/toxsci/kfq233; DiMaggio PA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-458; Floudas CA, 2007, BIOTECHNOL BIOENG, V97, P207, DOI 10.1002/bit.21411; Floudas CA, 2006, CHEM ENG SCI, V61, P966, DOI 10.1016/j.ces.2005.04.009; Fokas AS, 2005, P NATL ACAD SCI USA, V102, P15851, DOI 10.1073/pnas.0507335102; Glyakina AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028464; Grainger B, 2010, J COMPUT BIOL, V17, P1371, DOI 10.1089/cmb.2009.0265; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; HOLM L, 1992, PROTEIN SCI, V1, P1691, DOI 10.1002/pro.5560011217; Honig B, 1999, J MOL BIOL, V293, P283, DOI 10.1006/jmbi.1999.3006; HUBBARD TJ, 1995, PROTEINS, V23, P398, DOI 10.1002/prot.340230313; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; HUTCHINSON EG, 1993, PROTEIN ENG, V6, P233, DOI 10.1093/protein/6.3.233; Jeong J, 2008, IEEE ACM T COMPUT BI, V5, P484, DOI 10.1109/TCBB.2008.88; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kister AE, 2006, P NATL ACAD SCI USA, V103, P4107, DOI 10.1073/pnas.0510747103; Kister AE, 2002, P NATL ACAD SCI USA, V99, P14137, DOI 10.1073/pnas.212511499; Klepeis JL, 2003, J COMPUT CHEM, V24, P191, DOI 10.1002/jcc.10167; Kryshtafovych A, 2009, DRUG DISCOV TODAY, V14, P386, DOI 10.1016/j.drudis.2008.11.010; LESK AM, 1981, P NATL ACAD SCI-BIOL, V78, P4304, DOI 10.1073/pnas.78.7.4304; Liu Y, 2003, I SOFTWARE RES, V24, P191; Maisuradze GG, 2010, J PHYS CHEM A, V114, P4471, DOI 10.1021/jp9117776; Maity H, 2005, P NATL ACAD SCI USA, V102, P4741, DOI 10.1073/pnas.0501043102; Mamitsuka H, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P276; McAllister SR, 2010, COMPUT OPTIM APPL, V45, P377, DOI 10.1007/s10589-009-9277-y; McAllister SR, 2009, J GLOBAL OPTIM, V45, P111, DOI 10.1007/s10898-008-9393-8; More JJ, 1999, J GLOBAL OPTIM, V15, P219, DOI 10.1023/A:1008380219900; MURZIN AG, 1994, J MOL BIOL, V236, P1382, DOI 10.1016/0022-2836(94)90065-5; MURZIN AG, 1994, J MOL BIOL, V236, P1369, DOI 10.1016/0022-2836(94)90064-7; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; ORENGO C, 1994, CURR OPIN STRUC BIOL, V4, P429, DOI 10.1016/S0959-440X(94)90113-9; ORENGO CA, 1993, PROTEIN ENG, V6, P485, DOI 10.1093/protein/6.5.485; ORENGO CA, 1993, STRUCTURE, V1, P105, DOI 10.1016/0969-2126(93)90026-D; Ozkan SB, 2007, P NATL ACAD SCI USA, V104, P11987, DOI 10.1073/pnas.0703700104; Pandit SB, 2010, INTRO PROTEIN STRUCT, P219; Przytycka T, 2002, PROTEIN SCI, V11, P409, DOI 10.1110/ps.24701; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; RICHARDSON JS, 1976, P NATL ACAD SCI USA, V73, P2619, DOI 10.1073/pnas.73.8.2619; RICHARDSON JS, 1977, NATURE, V268, P495, DOI 10.1038/268495a0; ROSE GD, 1979, J MOL BIOL, V134, P447, DOI 10.1016/0022-2836(79)90363-2; Ruczinski I, 2002, PROTEINS, V48, P85, DOI 10.1002/prot.10123; SRINIVASAN R, 1995, PROTEINS, V22, P81, DOI 10.1002/prot.340220202; STERNBERG MJE, 1977, J MOL BIOL, V115, P1, DOI 10.1016/0022-2836(77)90242-X; STERNBERG MJE, 1977, J MOL BIOL, V110, P285, DOI 10.1016/S0022-2836(77)80073-9; STERNBERG MJE, 1977, J MOL BIOL, V113, P401, DOI 10.1016/0022-2836(77)90149-8; Steward RE, 2002, PROTEINS, V48, P178, DOI 10.1002/prot.10152; STICKLE DF, 1992, J MOL BIOL, V226, P1143, DOI 10.1016/0022-2836(92)91058-W; Subramani A, 2012, AICHE J, V58, P1619, DOI 10.1002/aic.12669; Subramani A, 2009, BIOPHYS J, V97, P1728, DOI 10.1016/j.bpj.2009.06.046; Wei Y, 2012, P ROY SOC A-MATH PHY, V468, P831, DOI 10.1098/rspa.2011.0514; Zhang Y, 2008, CURR OPIN STRUC BIOL, V18, P342, DOI 10.1016/j.sbi.2008.02.004; Zhu HY, 1999, PROTEIN SCI, V8, P326	62	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2012	7	3							e32461	10.1371/journal.pone.0032461	http://dx.doi.org/10.1371/journal.pone.0032461			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KX	22427840	Green Published, gold, Green Submitted			2022-12-25	WOS:000303062800020
J	Wright, GA; Lillvis, JL; Bray, HJ; Mustard, JA				Wright, Geraldine A.; Lillvis, Joshua L.; Bray, Helen J.; Mustard, Julie A.			Physiological State Influences the Social Interactions of Two Honeybee Nest Mates	PLOS ONE			English	Article							COLONY FOOD SHORTAGE; ETHANOL; TROPHALLAXIS; DROSOPHILA; BEHAVIOR; COMMUNICATION; PROFITABILITY; PATTERNS; COCAINE; MODEL	Physiological state profoundly influences the expression of the behaviour of individuals and can affect social interactions between animals. How physiological state influences food sharing and social behaviour in social insects is poorly understood. Here, we examined the social interactions and food sharing behaviour of honeybees with the aim of developing the honeybee as a model for understanding how an individual's state influences its social interactions. The state of individual honeybees was manipulated by either starving donor bees or feeding them sucrose or low doses of ethanol to examine how a change in hunger or inebriation state affected the social behaviours exhibited by two closely-related nestmates. Using a lab-based assay for measuring individual motor behaviour and social behaviour, we found that behaviours such as antennation, willingness to engage in trophallaxis, and mandible opening were affected by both hunger and ethanol intoxication. Inebriated bees were more likely to exhibit mandible opening, which may represent a form of aggression, than bees fed sucrose alone. However, intoxicated bees were as willing to engage in trophallaxis as the sucrose-fed bees. The effects of ethanol on social behaviors were dose-dependent, with higher doses of ethanol producing larger effects on behaviour. Hungry donor bees, on the other hand, were more likely to engage in begging for food and less likely to antennate and to display mandible opening. We also found that when nestmates received food from donors previously fed ethanol, they began to display evidence of inebriation, indicating that ethanol can be retained in the crop for several hours and that it can be transferred between honeybee nestmates during trophallaxis.	[Wright, Geraldine A.] Newcastle Univ, Inst Neurosci, Ctr Behav & Evolut, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Lillvis, Joshua L.] Georgia State Univ, Inst Neurosci, Atlanta, GA 30303 USA; [Bray, Helen J.] Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Mustard, Julie A.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA	Newcastle University - UK; University System of Georgia; Georgia State University; Newcastle University - UK; Arizona State University; Arizona State University-Tempe	Wright, GA (corresponding author), Newcastle Univ, Inst Neurosci, Ctr Behav & Evolut, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	jeri.wright@ncl.ac.uk	Lillvis, Joshua/GMX-3123-2022	Mustard, Julie A/0000-0002-1412-1140; Lillvis, Joshua/0000-0002-6235-8759				Abramson CI, 2000, ALCOHOL CLIN EXP RES, V24, P1153, DOI 10.1111/j.1530-0277.2000.tb02078.x; Agresti A., 2013, CATEGORICAL DATA ANA, V3rd; Barron AB, 2009, J EXP BIOL, V212, P163, DOI 10.1242/jeb.025361; BELL WJ, 1974, J COMP PHYSIOL, V93, P183, DOI 10.1007/BF00606998; Bettinger JC, 2004, GENES BRAIN BEHAV, V3, P266, DOI 10.1111/j.1601-183X.2004.00080.x; BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; Boulay R, 2000, J EXP BIOL, V203, P513; Bozic J, 2006, ALCOHOL, V38, P179, DOI 10.1016/j.alcohol.2006.01.005; BROWNE LB, 1960, J INSECT PHYSIOL, V4, P27, DOI 10.1016/0022-1910(60)90065-2; CONNOLLY KJ, 1966, NATURE, V209, P224, DOI 10.1038/209224a0; Crailsheim K, 1998, APIDOLOGIE, V29, P97, DOI 10.1051/apido:19980106; Davies AG, 2004, NEURON, V42, P731, DOI 10.1016/j.neuron.2004.05.004; FARINA WM, 1991, ANIM BEHAV, V42, P389, DOI 10.1016/S0003-3472(05)80037-5; Free J. B., 1956, British Journal of Animal Behaviour, V4, P94, DOI 10.1016/S0950-5601(56)80129-9; Guerrieri FJ, 2008, J EXP BIOL, V211, P1109, DOI 10.1242/jeb.008508; Johnson RA, APPL MULTIVARIATE ST; Judge KA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003980; Kaun KR, 2011, NAT NEUROSCI, V14, P612, DOI 10.1038/nn.2805; Kong EC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009954; Lee HG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001391; Leoncini I, 2004, P NATL ACAD SCI USA, V101, P17559, DOI 10.1073/pnas.0407652101; Maze IS, 2006, J INSECT PHYSIOL, V52, P1243, DOI 10.1016/j.jinsphys.2006.09.006; Mc Cabe S, 2006, INSECT SOC, V53, P356, DOI 10.1007/s00040-006-0881-x; Mixson TA, 2010, PSYCHOL REP, V106, P701, DOI 10.2466/PR0.106.3.701-717; Mustard JA, 2008, NEUROBIOL LEARN MEM, V90, P633, DOI 10.1016/j.nlm.2008.07.017; Raubenheimer D, 1996, PHYSIOL ENTOMOL, V21, P76, DOI 10.1111/j.1365-3032.1996.tb00838.x; Rothenfluh A, 2002, CURR OPIN NEUROBIOL, V12, P639, DOI 10.1016/S0959-4388(02)00380-X; Scholz HaM JA, 2011, CURRENT TOP IN PRESS; Scholz H, 2009, J NEUROGENET, V23, P111, DOI 10.1080/01677060802471676; Schulz DJ, 1998, BEHAV ECOL SOCIOBIOL, V42, P295, DOI 10.1007/s002650050442; Schulz DJ, 2002, INSECT SOC, V49, P50, DOI 10.1007/s00040-002-8279-x; Siegal PS, 1949, J COMP PSYCHOL, P42; Stuart RJ, 2000, BEHAV ECOL, V11, P676, DOI 10.1093/beheco/11.6.676; Wcislo WT, 2006, INSECT SOC, V53, P220, DOI 10.1007/s00040-005-0861-6; Wolf FW, 2003, J NEUROBIOL, V54, P161, DOI 10.1002/neu.10166	35	15	15	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2012	7	3							e32677	10.1371/journal.pone.0032677	http://dx.doi.org/10.1371/journal.pone.0032677			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KX	22427864	Green Published, gold, Green Submitted			2022-12-25	WOS:000303062800026
J	Ross, RL; Askham, JM; Knowles, MA				Ross, R. L.; Askham, J. M.; Knowles, M. A.			PIK3CA mutation spectrum in urothelial carcinoma reflects cell context-dependent signaling and phenotypic outputs	ONCOGENE			English	Article						PIK3CA; PI3K signaling; bladder cancer; urothelium	BLADDER-CANCER; HIGH-FREQUENCY; N-CADHERIN; GENE; KINASE; P110-ALPHA; EXPRESSION; GROWTH; DOMAIN; FGFR3	Although activating mutations of PIK3CA are frequent in urothelial carcinoma (UC), no information is available on their specific effects in urothelial cells or the basis for the observed mutation spectrum, which has a large excess of helical domain mutations. We investigated the phenotypic and signaling consequences of hotspot and UC-specific rare PIK3CA mutations in immortalized normal human urothelial cells (NHUC) and mouse fibroblasts (NIH3T3). Our results indicate that in NHUC, rare mutant forms and all three hotspot mutant forms of PIK3CA can activate the PI3K/AKT pathway. The relative frequency at which helical domain and kinase domain mutations are found in UC is related to their potency in inducing signaling downstream of AKT and to the phenotypic effects induced in this cell type (E545K>E542K>H1047R). Helical domain mutations E542K and E545K conferred a significant proliferative advantage at confluence and under conditions of nutrient depletion, and increased cellular resistance to anoikis. Both helical and kinase domain mutants induced increased NHUC cell motility and migration towards a chemoattractant, though no significant differences were found between the mutant forms. In NIH3T3 cells, the kinase domain mutant H1047R induced high levels of AKT activation, but helical domain mutants were significantly less potent and this was reflected in their relative abilities to confer anchorage-independent growth. Our findings indicate that the effects of mutant PIK3CA are both cell type- and mutation-specific. Helical domain mutations in PIK3CA may confer a selective advantage in the urotheliunn in vivo by overcoming normal contact-mediated inhibitory signals and allowing proliferation in nutrient-limiting conditions. Mutant forms of PIK3CA may also stimulate intraepithelial cell movement, which could contribute to spread of cells within the urothelium. Oncogene (2013) 32, 768-776; doi:10.1038/onc.2012.87; published online 19 March 2012	[Ross, R. L.; Askham, J. M.; Knowles, M. A.] St James Univ Hosp, Canc Res UK Clin Ctr, Leeds Inst Mol Med, Sect Expt Oncol, Leeds LS9 7TF, W Yorkshire, England; [Askham, J. M.] Univ Leeds, Mol Epidemiol Unit, Leeds Inst Genet Hlth & Therapeut, LIGHT Labs, Leeds, W Yorkshire, England	Cancer Research UK; Saint James's University Hospital; University of Leeds; University of Leeds	Knowles, MA (corresponding author), St James Univ Hosp, Canc Res UK Clin Ctr, Leeds Inst Mol Med, Sect Expt Oncol, Beckett St, Leeds LS9 7TF, W Yorkshire, England.	m.a.knowles@leeds.ac.uk		Knowles, Margaret/0000-0002-9363-8657	Medical Research Council; University of Leeds	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Leeds	This work was funded by a PhD studentship from the Medical Research Council, awarded via the University of Leeds.	Askham JM, 2010, ONCOGENE, V29, P150, DOI 10.1038/onc.2009.315; Bachman KE, 2004, CANCER BIOL THER, V3, P772, DOI 10.4161/cbt.3.8.994; Broderick DK, 2004, CANCER RES, V64, P5048, DOI 10.1158/0008-5472.CAN-04-1170; Cain RJ, 2009, BIOL CELL, V101, P13, DOI 10.1042/BC20080079; Campbell IG, 2004, CANCER RES, V64, P7678, DOI 10.1158/0008-5472.CAN-04-2933; Carson JD, 2008, BIOCHEM J, V409, P519, DOI 10.1042/BJ20070681; Chapman EJ, 2006, ONCOGENE, V25, P5037, DOI 10.1038/sj.onc.1209513; Chaussade C, 2009, BIOCHEM BIOPH RES CO, V381, P577, DOI 10.1016/j.bbrc.2009.02.081; di Martino E, 2009, ONCOGENE, V28, P4306, DOI 10.1038/onc.2009.280; Fu Z, 2003, P NATL ACAD SCI USA, V100, P3275, DOI 10.1073/pnas.0535975100; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guo XN, 2007, CANCER RES, V67, P5851, DOI 10.1158/0008-5472.CAN-07-0049; Gustin JP, 2009, P NATL ACAD SCI USA, V106, P2835, DOI 10.1073/pnas.0813351106; Gymnopoulos M, 2007, P NATL ACAD SCI USA, V104, P5569, DOI 10.1073/pnas.0701005104; Huang CH, 2007, SCIENCE, V318, P1744, DOI 10.1126/science.1150799; Ikenoue T, 2005, CANCER RES, V65, P4562, DOI 10.1158/0008-5472.CAN-04-4114; Isakoff SJ, 2005, CANCER RES, V65, P10992, DOI 10.1158/0008-5472.CAN-05-2612; Jaiswal BS, 2009, CANCER CELL, V16, P463, DOI 10.1016/j.ccr.2009.10.016; Knowles MA, 2006, CARCINOGENESIS, V27, P361, DOI 10.1093/carcin/bgi310; Kompier LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013821; Lopez-Knowles E, 2006, CANCER RES, V66, P7401, DOI 10.1158/0008-5472.CAN-06-1182; Mandelker D, 2009, P NATL ACAD SCI USA, V106, P16996, DOI 10.1073/pnas.0908444106; Murugan AK, 2008, INT J ONCOL, V32, P101; Pang H, 2009, CANCER RES, V69, P8868, DOI 10.1158/0008-5472.CAN-09-1968; Platt FM, 2009, CLIN CANCER RES, V15, P6008, DOI 10.1158/1078-0432.CCR-09-0898; Rieger-Christ KM, 2007, J CELL BIOCHEM, V102, P377, DOI 10.1002/jcb.21299; Rieger-Christ KM, 2004, ONCOGENE, V23, P4745, DOI 10.1038/sj.onc.1207629; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Samuels Y, 2006, CURR OPIN ONCOL, V18, P77, DOI 10.1097/01.cco.0000198021.99347.b9; Shekar SC, 2005, J BIOL CHEM, V280, P27850, DOI 10.1074/jbc.M506005200; Shin JJ, 2004, ARCH OTOLARYNGOL, V130, P68, DOI 10.1001/archotol.130.1.68; Sjodahl G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018583; SOULE HD, 1990, CANCER RES, V50, P6075; Sun M, 2001, AM J PATHOL, V159, P431, DOI 10.1016/S0002-9440(10)61714-2; Theodorescu D, 1998, CELL GROWTH DIFFER, V9, P919; Tomlinson D, 2007, ONCOGENE, V26, P5889, DOI 10.1038/sj.onc.1210399; Tomlinson DC, 2007, J PATHOL, V213, P91, DOI 10.1002/path.2207; Wu X, 2004, BJU INT, V93, P143, DOI 10.1111/j.1464-410X.2004.04574.x; Yu JH, 1998, MOL CELL BIOL, V18, P1379, DOI 10.1128/MCB.18.3.1379; Zhang HJ, 2008, BREAST CANCER RES TR, V112, P217, DOI 10.1007/s10549-007-9847-6; Zhao JJ, 2005, P NATL ACAD SCI USA, V102, P18443, DOI 10.1073/pnas.0508988102; Zhao L, 2008, P NATL ACAD SCI USA, V105, P2652, DOI 10.1073/pnas.0712169105	43	31	34	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 7	2013	32	6					768	776		10.1038/onc.2012.87	http://dx.doi.org/10.1038/onc.2012.87			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	101AF	22430209				2022-12-25	WOS:000315746700010
J	Gao, L; Gao, F; Wang, LS; Geng, CL; Chi, LL; Zhao, J; Qu, YB				Gao, Le; Gao, Feng; Wang, Lushan; Geng, Cunliang; Chi, Lianli; Zhao, Jian; Qu, Yinbo			N-Glycoform Diversity of Cellobiohydrolase I from Penicillium decumbens and Synergism of Nonhydrolytic Glycoform in Cellulose Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRICHODERMA-REESEI; PROTEIN GLYCOSYLATION; MUTANT STRAIN; CHRYSOSPORIUM; PURIFICATION; DISRUPTION; STABILITY; STRATEGY	Four cellobiohydrolase I (CBHI) glycoforms, namely, CBHI-A, CBHI-B, CBHI-C, and CBHI-D, were purified from the cultured broth of Penicillium decumbens JU-A10. All glycoforms had the same amino acid sequence but displayed different characteristics and biological functions. The effects of the N-glycans of the glycoforms on CBH activity were analyzed using mass spectrum data. Longer N-glycan chains at the Asn-137 of CBHI increased CBH activity. After the N-glycans were removed using site-directed mutagenesis and homologous expression in P. decumbens, the specific CBH activity of the recombinant CBHI without N-glycosylation increased by 65% compared with the wild-type CBHI with the highest specific activity. However, the activity was not stable. Only the N-glycosylation at Asn-137 can improve CBH activity by 40%. rCBHI with N-glycosylation only at Asn-470 exhibited no enzymatic activity. CBH activity was affected whether or not the protein was glycosylated, together with the N-glycosylation site and N-glycan structure. N-Glycosylation not only affects CBH activity but may also bring a new feature to a nonhydrolytic CBHI glycoform (CBHI-A). By supplementing CBHI-A to different commercial cellulase preparations, the glucose yield of lignocellulose hydrolysis increased by >20%. After treatment with a low dose (5 mg/g substrate) of CBHI-A at 50 degrees C for 7 days, the hydrogen-bond intensity and crystalline degree of cotton fibers decreased by 17 and 34%, respectively. These results may provide new guidelines for cellulase engineering.	[Gao, Le; Gao, Feng; Wang, Lushan; Geng, Cunliang; Zhao, Jian; Qu, Yinbo] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Chi, Lianli; Qu, Yinbo] Shandong Univ, Natl Glycoengn Res Ctr, Jinan 250100, Peoples R China	Shandong University; Shandong University	Qu, YB (corresponding author), 27 Shandanan Rd, Jinan 250100, Peoples R China.	quyinbo@sdu.edu.cn	Chi, Lianli/B-9149-2015	Chi, Lianli/0000-0003-1126-1022	National Basic Research Program of China [2011CB707403]; National Natural Sciences Foundation of China [31030001, 31170107]	National Basic Research Program of China(National Basic Research Program of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China Grant 2011CB707403 and National Natural Sciences Foundation of China Grants 31030001 and 31170107.	Adney WS, 2009, CELLULOSE, V16, P699, DOI 10.1007/s10570-009-9305-1; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Beckham G. T., 2011, CURR OPIN BIOTECH, V23, P1; Benoit I, 2006, FEBS LETT, V580, P5815, DOI 10.1016/j.febslet.2006.09.039; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; CHAHAL DS, 1985, APPL ENVIRON MICROB, V49, P205, DOI 10.1128/AEM.49.1.205-210.1985; CHANDHOKE V, 1992, FEMS MICROBIOL LETT, V90, P263, DOI 10.1111/j.1574-6968.1992.tb05164.x; Gao L, 2011, BIORESOURCE TECHNOL, V102, P8339, DOI 10.1016/j.biortech.2011.06.033; Garcia R, 2001, BIOTECHNOL APPL BIOC, V33, P141, DOI 10.1042/BA20000085; GOMI K, 1987, AGR BIOL CHEM TOKYO, V51, P2549; Goto M, 2007, BIOSCI BIOTECH BIOCH, V71, P1415, DOI 10.1271/bbb.70080; Gusakov AV, 2008, CARBOHYD RES, V343, P48, DOI 10.1016/j.carres.2007.10.014; Harrison MJ, 1998, EUR J BIOCHEM, V256, P119, DOI 10.1046/j.1432-1327.1998.2560119.x; Igarashi K, 2009, J BIOL CHEM, V284, P36186, DOI 10.1074/jbc.M109.034611; Kainz E, 2008, APPL ENVIRON MICROB, V74, P1076, DOI 10.1128/AEM.01058-07; Kim KH, 2007, J PROTEOME RES, V6, P4749, DOI 10.1021/pr070355i; King AJ, 2010, P NATL ACAD SCI USA, V107, P5345, DOI 10.1073/pnas.0914228107; Lee I, 2000, ULTRAMICROSCOPY, V82, P213, DOI 10.1016/S0304-3991(99)00158-8; Liu K, 2010, BIORESOURCE TECHNOL, V101, P4952, DOI 10.1016/j.biortech.2009.11.013; Marino K, 2010, NAT CHEM BIOL, V6, P713, DOI [10.1038/nchembio.437, 10.1038/NCHEMBIO.437]; MCQUEENMASON S, 1994, P NATL ACAD SCI USA, V91, P6574, DOI 10.1073/pnas.91.14.6574; Qu Y.-B., 1984, Acta Mycologica Sinica, V3, P238; Reese E. T., 1976, P SESS, V6, P9; Saloheimo M, 2002, EUR J BIOCHEM, V269, P4202, DOI 10.1046/j.1432-1033.2002.03095.x; Sun XY, 2008, ENZYME MICROB TECH, V42, P560, DOI 10.1016/j.enzmictec.2008.01.020; Tanaka H, 2007, J BIOTECHNOL, V128, P500, DOI 10.1016/j.jbiotec.2006.12.010; Todd AE, 1999, CURR OPIN CHEM BIOL, V3, P548, DOI 10.1016/S1367-5931(99)00007-1; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wang W, 2003, CURR MICROBIOL, V46, P371, DOI 10.1007/s00284-002-3864-9; Wong CH, 2005, J ORG CHEM, V70, P4219, DOI 10.1021/jo050278f; Wu GC, 2010, WORLD J MICROB BIOT, V26, P323, DOI 10.1007/s11274-009-0179-z; Yu CT, 2009, IND CROP PROD, V29, P308, DOI 10.1016/j.indcrop.2008.06.005; Zhou J, 2008, BIORESOURCE TECHNOL, V99, P6826, DOI 10.1016/j.biortech.2008.01.077	33	47	49	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15906	15915		10.1074/jbc.M111.332890	http://dx.doi.org/10.1074/jbc.M111.332890			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22427663	Green Published, hybrid			2022-12-25	WOS:000304006300069
J	Belz, RG; Piepho, HP				Belz, Regina G.; Piepho, Hans-Peter			Modeling Effective Dosages in Hormetic Dose-Response Studies	PLOS ONE			English	Article							PARTHENIUM-HYSTEROPHORUS L; PLANT-GROWTH; HORMESIS; ALLELOPATHY; STIMULATION	Background: Two hormetic modifications of a monotonically decreasing log-logistic dose-response function are most often used to model stimulatory effects of low dosages of a toxicant in plant biology. As just one of these empirical models is yet properly parameterized to allow inference about quantities of interest, this study contributes the parameterized functions for the second hormetic model and compares the estimates of effective dosages between both models based on 23 hormetic data sets. Based on this, the impact on effective dosage estimations was evaluated, especially in case of a substantially inferior fit by one of the two models. Methodology/Principal Findings: The data sets evaluated described the hormetic responses of four different test plant species exposed to 15 different chemical stressors in two different experimental dose-response test designs. Out of the 23 data sets, one could not be described by any of the two models, 14 could be better described by one of the two models, and eight could be equally described by both models. In cases of misspecification by any of the two models, the differences between effective dosages estimates (0-1768%) greatly exceeded the differences observed when both models provided a satisfactory fit (0-26%). This suggests that the conclusions drawn depending on the model used may diverge considerably when using an improper hormetic model especially regarding effective dosages quantifying hormesis. Conclusions/Significance: The study showed that hormetic dose responses can take on many shapes and that this diversity can not be captured by a single model without risking considerable misinterpretation. However, the two empirical models considered in this paper together provide a powerful means to model, prove, and now also to quantify a wide range of hormetic responses by reparameterization. Despite this, they should not be applied uncritically, but after statistical and graphical assessment of their adequacy.	[Belz, Regina G.] Univ Hohenheim, Agroecol Unit, Inst Plant Prod & Agroecol Trop & Subtrop, D-7000 Stuttgart, Germany; [Piepho, Hans-Peter] Univ Hohenheim, Inst Crop Sci, Bioinformat Unit, D-7000 Stuttgart, Germany	University Hohenheim; University Hohenheim	Belz, RG (corresponding author), Univ Hohenheim, Agroecol Unit, Inst Plant Prod & Agroecol Trop & Subtrop, D-7000 Stuttgart, Germany.	regina.belz@uni-hohenheim.de		Piepho, Hans-Peter/0000-0001-7813-2992	German Research Foundation (DFG) [BE4189/1-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	RGB is supported by an Individual Grant by the German Research Foundation (DFG), project BE4189/1-1. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AN M, 1993, J CHEM ECOL, V19, P2379, DOI 10.1007/BF00979671; Andresen M, 2010, HORTSCIENCE, V45, P1848, DOI 10.21273/HORTSCI.45.12.1848; Belz RG, 2008, SCI TOTAL ENVIRON, V404, P77, DOI 10.1016/j.scitotenv.2008.06.008; Belz RG, 2008, DOSE-RESPONSE, V6, P80, DOI 10.2203/dose-response.07-007.Belz; Belz RG, 2007, CROP PROT, V26, P237, DOI 10.1016/j.cropro.2005.06.009; Belz Regina G., 2005, Nonlinearity in Biology Toxicology and Medicine, V3, P173, DOI 10.2201/nonlin.003.02.002; Belz RG, 2010, ENVIRON EXP BOT, V69, P293, DOI 10.1016/j.envexpbot.2010.04.010; Belz RG, 2004, J CHEM ECOL, V30, P175, DOI 10.1023/B:JOEC.0000013190.72062.3d; BRAIN P, 1989, WEED RES, V29, P93, DOI 10.1111/j.1365-3180.1989.tb00845.x; Calabrese EJ, 2008, BRIT J CLIN PHARMACO, V66, P594, DOI 10.1111/j.1365-2125.2008.03243.x; Calabrese EJ, 2011, REGUL TOXICOL PHARM, V61, P73, DOI 10.1016/j.yrtph.2011.06.003; Calabrese EJ, 2005, ENVIRON POLLUT, V138, P378, DOI 10.1016/j.envpol.2004.10.001; Cedergreen N, 2008, WEED RES, V48, P429, DOI 10.1111/j.1365-3180.2008.00646.x; Cedergreen N, 2005, ENVIRON TOXICOL CHEM, V24, P3166, DOI 10.1897/05-014R.1; Cedergreen Nina, 2007, Dose-Response, V5, P150, DOI 10.2203/dose-response.06-008.Cedergreen; Cedergreen N, 2010, PESTIC BIOCHEM PHYS, V96, P140, DOI 10.1016/j.pestbp.2009.11.002; Cedergreen N, 2009, FIELD CROP RES, V114, P54, DOI 10.1016/j.fcr.2009.07.003; Dette H, 2011, RISK ANAL, V31, P1949, DOI 10.1111/j.1539-6924.2011.01625.x; Duke S. O., 2006, Outlooks on Pest Management, V17, P29; FINNEY DJ, 1976, BIOMETRICS, V32, P721, DOI 10.2307/2529258; GAGLIARDO RW, 1992, J CHEM ECOL, V18, P1683, DOI 10.1007/BF02751095; Liu YH, 2011, DOSE-RESPONSE, V9, P117, DOI 10.2203/dose-response.09-050.Liu; Petersen J, 2001, AGRON J, V93, P37, DOI 10.2134/agronj2001.93137x; Schabenberger O, 1999, AGRON J, V91, P713, DOI 10.2134/agronj1999.914713x; Schabenberger O, 2001, HUM ECOL RISK ASSESS, V7, P891, DOI 10.1080/20018091094718; Sinkkonen A, 2011, DOSE-RESPONSE, V9, P130, DOI 10.2203/dose-response.09-045.Sinkkonen; STREIBIG JC, 1980, ACTA AGR SCAND, V30, P59, DOI 10.1080/00015128009435696	27	56	58	4	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33432	10.1371/journal.pone.0033432	http://dx.doi.org/10.1371/journal.pone.0033432			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438929	Green Published, gold, Green Submitted			2022-12-25	WOS:000303309100044
J	Chamorro, ML; Volkovitsh, MG; Poland, TM; Haack, RA; Lingafelter, SW				Chamorro, M. Lourdes; Volkovitsh, Mark G.; Poland, Therese M.; Haack, Robert A.; Lingafelter, Steven W.			Preimaginal Stages of the Emerald Ash Borer, Agrilus planipennis Fairmaire (Coleoptera: Buprestidae): An Invasive Pest on Ash Trees (Fraxinus)	PLOS ONE			English	Article							NORTH-AMERICAN; INTERSPECIFIC VARIATION; RESISTANCE; BIOLOGY	This study provides the most detailed description of the immature stages of Agrilus planipennis Fairmaire to date and illustrates suites of larval characters useful in distinguishing among Agrilus Curtis species and instars. Immature stages of eight species of Agrilus were examined and imaged using light and scanning electron microscopy. For A. planipennis all preimaginal stages (egg, instars I-IV, prepupa and pupa) were described. A combination of 14 character states were identified that serve to identify larvae of A. planipennis. Our results support the segregation of Agrilus larvae into two informal assemblages based on characters of the mouthparts, prothorax, and abdomen: the A. viridis and A. ater assemblages, with A. planipennis being more similar to the former. Additional evidence is provided in favor of excluding A. planipennis from the subgenus Uragrilus.	[Chamorro, M. Lourdes; Lingafelter, Steven W.] ARS, USDA, Systemat Entomol Lab, Washington, DC 20013 USA; [Volkovitsh, Mark G.] Russian Acad Sci, Inst Zool, Lab Insect Systemat, St Petersburg 199034, Russia; [Poland, Therese M.; Haack, Robert A.] US Forest Serv, USDA, No Res Stn, E Lansing, MI USA	Smithsonian Institution; United States Department of Agriculture (USDA); Russian Academy of Sciences; Zoological Institute of the Russian Academy of Sciences; United States Department of Agriculture (USDA); United States Forest Service	Chamorro, ML (corresponding author), ARS, USDA, Systemat Entomol Lab, Washington, DC 20013 USA.	lourdes.chamorro@gmail.com	Volkovitsh, Mark G./N-6747-2013; Poland, Therese/AAZ-9272-2021	Poland, Therese/0000-0001-7684-1306; Volkovitsh, Mark/0000-0003-2655-4784; Chamorro, M. Lourdes/0000-0002-3536-9372	United States Department of Agriculture Forest Service [1275-22000-257-01R]; Russian Foundation for Basic Research [10-04-00539]; Ministry of Education and Sciences of the Russian Federation	United States Department of Agriculture Forest Service(United States Department of Agriculture (USDA)United States Forest Service); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Ministry of Education and Sciences of the Russian Federation(Ministry of Education and Science, Russian Federation)	This study was supported by the United States Department of Agriculture Forest Service International Programs project number 1275-22000-257-01R and by a grant to MGV from the Russian Foundation for Basic Research project no. 10-04-00539 and Ministry of Education and Sciences of the Russian Federation. The funders had no role in study design data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeev A, 1960, ZOOL ZH, V39, P1497; Alexeev A.V., 1981, SBORNIK T ZOOLOGICHE, V19, P65; Alexeev AV, 1998, ENTOMOLOGICAL REV, V78, P423; Alexeev AV, 1964, ECOLOGIA SISTEMATIKA, P18; Alexeev AV, 1961, SBOMIK RABOT EKOLOGI, P3; ALEXEEV AV, 1980, ENTOMOL OBOZR, V59, P600; Baranchikov Y., 2008, Bulletin OEPP, V38, P233, DOI 10.1111/j.1365-2338.2008.01210.x; Bellamy C. L., 2008, WORLD CATALOGUE BIBL, V4; Bily S, 2002, SUMMARY BIONOMY BUPR; Bily S, 1999, LARVA KRASCU; Bily Svatopluk, 1997, Folia Heyrovskyana, V5, P115; Burke H. E., 1917, USDA B, V437, P1; Cappaert David, 2005, American Entomologist, V51, P152; Chamorro ML, 2011, 22 USDA INT RES FOR, P160; Cobos A., 1986, FAUNA IBERICA COLEOP; Crowson R.A., 1981, BIOL COLEOPTERA, P802; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; Evenhuis N.L, 2009, INSECT SPIDER COLLEC; Eyles A, 2007, J CHEM ECOL, V33, P1430, DOI 10.1007/s10886-007-9312-3; Furniss RL, 1977, MISCELLANEOUS PUBLIC, V1339, P1, DOI [10.5962/bhl.title.131875, DOI 10.5962/BHL.TITLE.131875]; Gandhi KJK, 2010, BIOL INVASIONS, V12, P1839, DOI 10.1007/s10530-009-9594-1; Haack R. A., 2002, NEWSLETTER MICHIGAN, V47, P1; Haack Robert A., 2009, Great Lakes Entomologist, V42, P1; Izhevskii S. S., 2010, Russian Journal of Biological Invasions, V1, P153, DOI 10.1134/S207511171003001X; Izhevskii SS, 2007, UGROZHAYUSCHIYE NAKH; Jendek E, 2006, CATALOGUE PALAEARCTI, V3; Jendek E, 2011, AGRILUS; Jendek E, 2006, PAN-PAC ENTOMOL, V82, P147; Jendek E, 2009, CAN ENTOMOL, V141, P236, DOI 10.4039/n09-021; Kovacs KF, 2010, ECOL ECON, V69, P569, DOI 10.1016/j.ecolecon.2009.09.004; Lawrence JF, 1991, IMMATURE INSECTS, P386; Liu HP, 2003, GREAT LAKES ENTOMOL, V36, P191; Nielsen DG, 2011, ENVIRON ENTOMOL, V40, P648, DOI 10.1603/EN10227; Petrice Toby R., 2009, Great Lakes Entomologist, V42, P173; POLAND T. M., 2007, NEWSLETTER MICHIGAN, V52, P10; Poland TM, 2006, J FOREST, V104, P118; Rebek EJ, 2008, ENVIRON ENTOMOL, V37, P242, DOI 10.1603/0046-225X(2008)37[242:IVIRTE]2.0.CO;2; REES BRYANT E., 1941, PROC ENT SOC WASHINGTON, V43, P210; Schaefer L, 1950, TABLEAUX ANAL COLEOP; VOLKOVITSH M G, 1990, Spixiana, V13, P43; Volkovitsh M. G., 1995, GIORNALE ITALIANO ET, V7, P11; Volkovitsh MG, 1979, MORFOLOGIYA SISTEMAT; Wang X.J., 2010, J INEQUAL APPL, V2010, DOI DOI 10.1155/2010/465915; Wang Xiaoyi, 2005, Scientia Silvae Sinicae, V41, P97; Wei Shu-Jun, 2007, Acta Entomologica Sinica, V50, P79; Wei X, 2007, INSECT SCI, V14, P367, DOI 10.1111/j.1744-7917.2007.00163.x; Wei Xia, 2004, Acta Entomologica Sinica, V47, P679; Wessels-Berk B., 2008, P NETH ENT SOC M, V19, P165; Yu C., 1992, FOREST INSECTS CHINA, V2nd, P400	49	40	45	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33185	10.1371/journal.pone.0033185	http://dx.doi.org/10.1371/journal.pone.0033185			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438898	gold, Green Published, Green Submitted			2022-12-25	WOS:000303309100025
J	Kawada-Matsuo, M; Mazda, Y; Oogai, Y; Kajiya, M; Kawai, T; Yamada, S; Miyawaki, S; Oho, T; Komatsuzawa, H				Kawada-Matsuo, Miki; Mazda, Yusuke; Oogai, Yuichi; Kajiya, Mikihito; Kawai, Toshihisa; Yamada, Sakuo; Miyawaki, Shouichi; Oho, Takahiko; Komatsuzawa, Hitoshi			GlmS and NagB Regulate Amino Sugar Metabolism in Opposing Directions and Affect Streptococcus mutans Virulence	PLOS ONE			English	Article							SURFACE PROTEIN ANTIGEN; COORDINATED REGULATION; GENE-EXPRESSION; ACID TOLERANCE; BINDING; MECHANISMS; IDENTIFICATION; ADHERENCE; SYSTEM; OPERON	Streptococcus mutans is a cariogenic pathogen that produces an extracellular polysaccharide (glucan) from dietary sugars, which allows it to establish a reproductive niche and secrete acids that degrade tooth enamel. While two enzymes (GlmS and NagB) are known to be key factors affecting the entrance of amino sugars into glycolysis and cell wall synthesis in several other bacteria, their roles in S. mutans remain unclear. Therefore, we investigated the roles of GlmS and NagB in S. mutans sugar metabolism and determined whether they have an effect on virulence. NagB expression increased in the presence of GlcNAc while GlmS expression decreased, suggesting that the regulation of these enzymes, which functionally oppose one another, is dependent on the concentration of environmental GlcNAc. A glmS-inactivated mutant could not grow in the absence of GlcNAc, while nagB-inactivated mutant growth was decreased in the presence of GlcNAc. Also, nagB inactivation was found to decrease the expression of virulence factors, including cell-surface protein antigen and glucosyltransferase, and to decrease biofilm formation and saliva-induced S. mutans aggregation, while glmS inactivation had the opposite effects on virulence factor expression and bacterial aggregation. Our results suggest that GlmS and NagB function in sugar metabolism in opposing directions, increasing and decreasing S. mutans virulence, respectively.	[Kawada-Matsuo, Miki; Mazda, Yusuke; Oogai, Yuichi; Komatsuzawa, Hitoshi] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Oral Microbiol, Kagoshima 890, Japan; [Mazda, Yusuke; Miyawaki, Shouichi] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Orthodont, Kagoshima 890, Japan; [Oho, Takahiko] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Prevent Dent, Kagoshima 890, Japan; [Kajiya, Mikihito; Kawai, Toshihisa] Forsyth Inst, Dept Immunol, Boston, MA USA; [Yamada, Sakuo] Kawasaki Med Sch, Dept Microbiol, Okayama, Japan; [Yamada, Sakuo] Kawasaki Med Welf, Dept Clin Nutr, Okayama, Japan	Kagoshima University; Kagoshima University; Kagoshima University; Harvard University; Forsyth Institute; Kawasaki Medical School	Kawada-Matsuo, M (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Oral Microbiol, Kagoshima 890, Japan.	hkomatsu@dent.kagoshima-u.ac.jp	Kajiya, Mikihito/A-4288-2018; Komatsuzawa, Hitoshi/AAC-7731-2019	Kajiya, Mikihito/0000-0001-6652-0007; Miyawaki, Shouichi/0000-0002-4867-2610				Abranches J, 2008, J BACTERIOL, V190, P2340, DOI 10.1128/JB.01237-07; Alvarez-Anorve LI, 2009, J BACTERIOL, V191, P6401, DOI 10.1128/JB.00633-09; Banas JA, 2003, CRIT REV ORAL BIOL M, V14, P89, DOI 10.1177/154411130301400203; Banas JA, 2004, FRONT BIOSCI-LANDMRK, V9, P1267, DOI 10.2741/1305; BERNHEIM NJ, 1970, J BACTERIOL, V101, P384, DOI 10.1128/JB.101.2.384-391.1970; Brady LJ, 2010, MOL MICROBIOL, V77, P276, DOI 10.1111/j.1365-2958.2010.07212.x; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Duque C, 2011, INFECT IMMUN, V79, P786, DOI 10.1128/IAI.00725-10; Gopel Y, 2011, NUCLEIC ACIDS RES, V39, P1294, DOI 10.1093/nar/gkq986; Gorke B, 2008, GENE DEV, V22, P2914, DOI 10.1101/gad.1717808; HAMADA S, 1980, MICROBIOL REV, V44, P331, DOI 10.1128/MMBR.44.2.331-384.1980; HUSSAIN M, 1991, J MED MICROBIOL, V34, P143, DOI 10.1099/00222615-34-3-143; Idone V, 2003, INFECT IMMUN, V71, P4351, DOI 10.1128/IAI.71.8.4351-4360.2003; Jakubovics NS, 2005, MOL MICROBIOL, V55, P1591, DOI 10.1111/j.1365-2958.2005.04495.x; KADNER RJ, 1992, J GEN MICROBIOL, V138, P2007, DOI 10.1099/00221287-138-10-2007; Kawada-Matsuo M, 2009, ORAL MICROBIOL IMMUN, V24, P173, DOI 10.1111/j.1399-302X.2008.00485.x; KOGA T, 1990, INFECT IMMUN, V58, P289, DOI 10.1128/IAI.58.2.289-296.1990; Komatsuzawa H, 2004, MOL MICROBIOL, V53, P1221, DOI 10.1111/j.1365-2958.2004.04200.x; KURAMITSU HK, 1993, CRIT REV ORAL BIOL M, V4, P159, DOI 10.1177/10454411930040020201; LEBLANC DJ, 1991, ANTIMICROB AGENTS CH, V35, P1804, DOI 10.1128/AAC.35.9.1804; Lemos JAC, 2005, CURR ISSUES MOL BIOL, V7, P95; Liu C, 2008, J MOL BIOL, V379, P73, DOI 10.1016/j.jmb.2008.03.031; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; Matsui R, 2010, FUTURE MICROBIOL, V5, P403, DOI [10.2217/fmb.09.129, 10.2217/FMB.09.129]; Nakano K, 2006, MICROBES INFECT, V8, P114, DOI 10.1016/j.micinf.2005.06.005; Oho T, 1998, INFECT IMMUN, V66, P115, DOI 10.1128/IAI.66.1.115-121.1998; PLUMBRIDGE J, 1995, EMBO J, V14, P3958, DOI 10.1002/j.1460-2075.1995.tb00067.x; PLUMBRIDGE JA, 1993, J BACTERIOL, V175, P4951, DOI 10.1128/JB.175.16.4951-4956.1993; Reichenbach B, 2009, MOL MICROBIOL, V74, P1054, DOI 10.1111/j.1365-2958.2009.06918.x; Sambrook J, 1989, MOL CLONING LAB MANN; Scott WG, 2007, CURR OPIN STRUC BIOL, V17, P280, DOI 10.1016/j.sbi.2007.05.003; Senadheera MD, 2005, J BACTERIOL, V187, P4064, DOI 10.1128/JB.187.12.4064-4076.2005; Shemesh M, 2006, CARBOHYD RES, V341, P2090, DOI 10.1016/j.carres.2006.05.010; Shibata Y, 2005, INFECT IMMUN, V73, P3512, DOI 10.1128/IAI.73.6.3512-3520.2005; SHIROZA T, 1993, INFECT IMMUN, V61, P3745, DOI 10.1128/IAI.61.9.3745-3755.1993; Tinsley RA, 2007, RNA, V13, P468, DOI 10.1261/rna.341807; VANHOUTE J, 1994, J DENT RES, V73, P672, DOI 10.1177/00220345940730031301; Winkler WC, 2004, NATURE, V428, P281, DOI 10.1038/nature02362; Wu CG, 2010, J BACTERIOL, V192, P4669, DOI 10.1128/JB.00556-10; Yu H, 1997, INFECT IMMUN, V65, P2292, DOI 10.1128/IAI.65.6.2292-2298.1997	40	30	30	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33382	10.1371/journal.pone.0033382	http://dx.doi.org/10.1371/journal.pone.0033382			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438919	Green Submitted, Green Published, gold			2022-12-25	WOS:000303309100037
J	Piha-Gossack, A; Sossin, W; Reinhardt, DP				Piha-Gossack, Adam; Sossin, Wayne; Reinhardt, Dieter P.			The Evolution of Extracellular Fibrillins and Their Functional Domains	PLOS ONE			English	Article							MARFAN-SYNDROME; SUPRAMOLECULAR ORGANIZATION; CALCIUM DETERMINES; INTEGRIN BINDING; CELL-ADHESION; TB DOMAIN; PROTEIN; MICROFIBRILS; SEQUENCE; MATRIX	Fibrillins constitute the major backbone of multifunctional microfibrils in elastic and non-elastic extracellular matrices, and are known to interact with several binding partners including tropoelastin and integrins. Here, we study the evolution of fibrillin proteins. Following sequence collection from 39 organisms representative of the major evolutionary groups, molecular evolutionary genetics and phylogeny inference software were used to generate a series of evolutionary trees using distance-based and maximum likelihood methods. The resulting trees support the concept of gene duplication as a means of generating the three vertebrate fibrillins. Beginning with a single fibrillin sequence found in invertebrates and jawless fish, a gene duplication event, which coincides with the appearance of elastin, led to the creation of two genes. One of the genes significantly evolved to become the gene for present-day fibrillin-1, while the other underwent evolutionary changes, including a second duplication, to produce present-day fibrillin-2 and fibrillin-3. Detailed analysis of several sequences and domains within the fibrillins reveals distinct similarities and differences across various species. The RGD integrin-binding site in TB4 of all fibrillins is conserved in cephalochordates and vertebrates, while the integrin-binding site within cbEGF18 of fibrillin-3 is a recent evolutionary change. The proline-rich domain in fibrillin-1, glycine-rich domain in fibrillin-2 and proline-/glycine-rich domain in fibrillin-3 are found in all analyzed tetrapod species, whereas it is completely replaced with an EGF-like domain in cnidarians, arthropods, molluscs and urochordates. All collected sequences contain the first 9-cysteine hybrid domain, and the second 8-cysteine hybrid domain with exception of arthropods containing an atypical 10-cysteine hybrid domain 2. Furin cleavage sites within the N- and C-terminal unique domains were found for all analyzed fibrillin sequences, indicating an essential role for processing of the fibrillin pro-proteins. The four cysteines in the unique N-terminus and the two cysteines in the unique C-terminus are also highly conserved.	[Piha-Gossack, Adam; Reinhardt, Dieter P.] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ, Canada; [Sossin, Wayne] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Reinhardt, Dieter P.] McGill Univ, Fac Dent, Montreal, PQ, Canada	McGill University; McGill University; McGill University	Piha-Gossack, A (corresponding author), McGill Univ, Dept Anat & Cell Biol, Montreal, PQ, Canada.	dieter.reinhardt@mcgill.ca	Reinhardt, Dieter P/A-3102-2008	Reinhardt, Dieter P/0000-0001-6535-9872; Gossack, Adam/0000-0002-2249-7789	Canadian Institutes of Health Research [MOP-106494]; Natural Sciences and Engineering Research Council of Canada [RGPIN 375738-09]; Canada Foundation for Innovation; Canada Research Chairs; Fonds de la recherche en sante du Quebec	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canada Research Chairs(Canada Research ChairsCGIAR); Fonds de la recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported by the Canadian Institutes of Health Research (MOP-106494), the Natural Sciences and Engineering Research Council of Canada (RGPIN 375738-09), the Canada Foundation for Innovation, the Canada Research Chairs, and the Fonds de la recherche en sante du Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arteaga-Solis E, 2001, J CELL BIOL, V154, P275, DOI 10.1083/jcb.200105046; Baldock C, 2001, J CELL BIOL, V152, P1045, DOI 10.1083/jcb.152.5.1045; Bax DV, 2003, J BIOL CHEM, V278, P34605, DOI 10.1074/jbc.M303159200; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; CAMPBELL ID, 1993, CURR OPIN STRUC BIOL, V3, P385, DOI 10.1016/S0959-440X(05)80111-3; Cardy CM, 1998, J MOL BIOL, V276, P855, DOI 10.1006/jmbi.1997.1593; Carta L, 2006, J BIOL CHEM, V281, P8016, DOI 10.1074/jbc.M511599200; Corson GM, 2004, GENOMICS, V83, P461, DOI 10.1016/j.ygeno.2003.08.023; CORSON GM, 1993, GENOMICS, V17, P476, DOI 10.1006/geno.1993.1350; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; DAVISON IG, 1995, J EXP BIOL, V198, P2185; Downing AK, 1996, CELL, V85, P597, DOI 10.1016/S0092-8674(00)81259-3; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; HANDFORD PA, 1991, NATURE, V351, P164, DOI 10.1038/351164a0; Hubmacher D, 2006, CURR TOP DEV BIOL, V75, P93, DOI 10.1016/S0070-2153(06)75004-9; Hubmacher D, 2011, BIOCHEMISTRY-US, V50, P5322, DOI 10.1021/bi200183z; Hubmacher D, 2011, BIOL EXTRACELL MATR, P233, DOI 10.1007/978-3-642-16555-9_7; Jensen SA, 2009, STRUCTURE, V17, P759, DOI 10.1016/j.str.2009.03.014; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jovanovic J, 2007, J BIOL CHEM, V282, P6743, DOI 10.1074/jbc.M607008200; Kielty CM, 2005, ADV PROTEIN CHEM, V70, P405, DOI 10.1016/S0065-3233(04)70012-1; Lack J, 2003, J MOL BIOL, V334, P281, DOI 10.1016/j.jmb.2003.09.053; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Le Goff C, 2011, AM J HUM GENET, V89, P7, DOI 10.1016/j.ajhg.2011.05.012; LEE B, 1991, NATURE, V352, P330, DOI 10.1038/352330a0; Lee SSJ, 2004, STRUCTURE, V12, P717, DOI 10.1016/j.str.2004.02.023; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; Loeys BL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000488; Lonnqvist L, 1998, HUM MOL GENET, V7, P2039, DOI 10.1093/hmg/7.13.2039; MASLEN CL, 1991, NATURE, V352, P334, DOI 10.1038/352334a0; MILEWICZ DM, 1992, J CLIN INVEST, V89, P79, DOI 10.1172/JCI115589; Miller M. A., 2010, GAT COMP ENV WORKSH, P1, DOI DOI 10.1109/GCE.2010.5676129; MOLLOY SS, 1992, J BIOL CHEM, V267, P16396; Nagase T, 2001, DNA RES, V8, P85, DOI 10.1093/dnares/8.2.85; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PEREIRA L, 1993, HUM MOL GENET, V2, P961, DOI 10.1093/hmg/2.7.961; Pfaff M, 1996, FEBS LETT, V384, P247, DOI 10.1016/0014-5793(96)00325-0; PUTNAM EA, 1995, NAT GENET, V11, P456, DOI 10.1038/ng1295-456; Raghunath M, 1999, J CELL SCI, V112, P1093; Ramirez F, 2009, CURR OPIN CELL BIOL, V21, P616, DOI 10.1016/j.ceb.2009.05.005; REBERMULLER S, 1995, DEV BIOL, V169, P662, DOI 10.1006/dbio.1995.1177; Reinhardt DP, 2000, J BIOL CHEM, V275, P2205, DOI 10.1074/jbc.275.3.2205; Reinhardt DP, 1996, J MOL BIOL, V258, P104, DOI 10.1006/jmbi.1996.0237; Reinhardt DP, 1997, J BIOL CHEM, V272, P7368, DOI 10.1074/jbc.272.11.7368; Ritty TM, 1999, J BIOL CHEM, V274, P8933, DOI 10.1074/jbc.274.13.8933; Robertson I, 2011, BIOCHEM J, V433, P263, DOI 10.1042/BJ20101320; Robinson PN, 2006, J MED GENET, V43, P769, DOI 10.1136/jmg.2005.039669; Rock MJ, 2004, J BIOL CHEM, V279, P23748, DOI 10.1074/jbc.M400212200; SAGE H, 1979, COMP BIOCHEM PHYS B, V64, P313, DOI 10.1016/0305-0491(79)90277-3; Saharinen J, 2000, MOL BIOL CELL, V11, P2691, DOI 10.1091/mbc.11.8.2691; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sakamoto H, 1996, J BIOL CHEM, V271, P4916; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor NA, 2003, FASEB J, V17, P1215, DOI 10.1096/fj.02-0831rev; Thurmond FA, 1996, J EXP BIOL, V199, P1817; Trask TM, 2000, J BIOL CHEM, V275, P24400, DOI 10.1074/jbc.M003665200; VONHEIJNE G, 1989, FEBS LETT, V244, P439, DOI 10.1016/0014-5793(89)80579-4; Wagenseil Jessica E., 2007, Birth Defects Research, V81, P229, DOI 10.1002/bdrc.20111; Wagenseil JE, 2009, PHYSIOL REV, V89, P957, DOI 10.1152/physrev.00041.2008; Wallis DD, 2003, J CELL BIOCHEM, V90, P641, DOI 10.1002/jcb.10657; Wess TJ, 1998, J CELL BIOL, V141, P829, DOI 10.1083/jcb.141.3.829; Yuan XM, 1997, EMBO J, V16, P6659, DOI 10.1093/emboj/16.22.6659; ZHANG H, 1994, J CELL BIOL, V124, P855, DOI 10.1083/jcb.124.5.855	65	45	45	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33560	10.1371/journal.pone.0033560	http://dx.doi.org/10.1371/journal.pone.0033560			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438950	Green Published, Green Submitted, gold			2022-12-25	WOS:000303309100059
J	Vranakis, I; De Bock, PJ; Papadioti, A; Tselentis, Y; Gevaert, K; Tsiotis, G; Psaroulaki, A				Vranakis, Iosif; De Bock, Pieter-Jan; Papadioti, Anastasia; Tselentis, Yannis; Gevaert, Kris; Tsiotis, Georgios; Psaroulaki, Anna			Quantitative Proteome Profiling of C. burnetii under Tetracycline Stress Conditions	PLOS ONE			English	Article							BACTERIUM COXIELLA-BURNETII; ANTIBIOTIC-RESISTANCE GENES; ESCHERICHIA-COLI; Q-FEVER; LEADER PEPTIDASE; PSEUDOMONAS-AERUGINOSA; RIBOSOMAL PROTECTION; SUBUNIT INTERFACE; SIGNAL PEPTIDASES; DRUG-RESISTANCE	The recommended antibiotic regimen against Coxiella burnetii, the etiological agent of Q fever, is based on a semi-synthetic, second-generation tetracycline, doxycycline. Here, we report on the comparison of the proteomes of a C. burnetii reference strain either cultured under control conditions or under tetracycline stress conditions. Using the MS-driven combined fractional diagonal chromatography proteomics technique, out of the 531 proteins identified, 5 and 19 proteins were found significantly up-and down-regulated respectively, under tetracycline stress. Although the predicted cellular functions of these regulated proteins did not point to known tetracycline resistance mechanisms, our data clearly reveal the plasticity of the proteome of C. burnetii to battle tetracycline stress. Finally, we raise several plausible hypotheses that could further lead to more focused experiments on studying tetracycline resistance in C. burnetii and thus reduced treatment failures of Q fever.	[Vranakis, Iosif; Tselentis, Yannis; Psaroulaki, Anna] Univ Crete, Sch Med, Dept Clin Bacteriol Parasitol Zoonoses & Geog Med, Iraklion, Greece; [Papadioti, Anastasia; Tsiotis, Georgios] Univ Crete, Dept Chem, Div Biochem, Voutes, Greece; [De Bock, Pieter-Jan; Gevaert, Kris] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium; [De Bock, Pieter-Jan; Gevaert, Kris] VIB, Dept Med Prot Res, Ghent, Belgium	University of Crete; University of Crete; Ghent University; Flanders Institute for Biotechnology (VIB)	Vranakis, I (corresponding author), Univ Crete, Sch Med, Dept Clin Bacteriol Parasitol Zoonoses & Geog Med, Iraklion, Greece.	iosif.vranakis@gmail.com	Gevaert, Kris/D-6489-2017; Gevaert, Kris/H-3637-2013; Gevaert, Kris/AAE-4212-2019	Gevaert, Kris/0000-0002-4237-0283; Gevaert, Kris/0000-0002-4237-0283; Gevaert, Kris/0000-0002-4237-0283	University of Crete; Greek Ministry of Education; General Secretariat for Research and Technology [PENED-03ED863]; Ghent University [BOF07/GOA/012]; Inter University Attraction Poles [IUAP06]	University of Crete; Greek Ministry of Education(Greek Ministry of Development-GSRT); General Secretariat for Research and Technology(Greek Ministry of Development-GSRT); Ghent University(Ghent University); Inter University Attraction Poles(Belgian Federal Science Policy Office)	This research program was supported by the University of Crete, the Greek Ministry of Education, and the General Secretariat for Research and Technology PENED-03ED863. The Ghent lab acknowledges research grants from Concerted Research Actions (project BOF07/GOA/012) from Ghent University and the Inter University Attraction Poles (IUAP06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agafonov DE, 1999, P NATL ACAD SCI USA, V96, P12345, DOI 10.1073/pnas.96.22.12345; Agafonov DE, 2001, COLD SPRING HARB SYM, V66, P509, DOI 10.1101/sqb.2001.66.509; Agafonov DE, 2001, EMBO REP, V2, P399; Aminov RI, 2009, ENVIRON MICROBIOL, V11, P2970, DOI 10.1111/j.1462-2920.2009.01972.x; Angelakis E, 2010, VET MICROBIOL, V140, P297, DOI 10.1016/j.vetmic.2009.07.016; Beare PA, 2009, INFECT IMMUN, V77, P642, DOI 10.1128/IAI.01141-08; Black MT, 1998, CURR PHARM DESIGN, V4, P133; Boshoff HIM, 2003, CELL, V113, P183, DOI 10.1016/S0092-8674(03)00270-8; Breidenstein EBM, 2008, ANTIMICROB AGENTS CH, V52, P4486, DOI 10.1128/AAC.00222-08; Brodersen DE, 2000, CELL, V103, P1143, DOI 10.1016/S0092-8674(00)00216-6; Burdett V, 1996, J BACTERIOL, V178, P3246, DOI 10.1128/jb.178.11.3246-3251.1996; Chen L, 2007, J BIOL CHEM, V282, P5582, DOI 10.1074/jbc.M609273200; CHOPRA I, 1992, J ANTIMICROB CHEMOTH, V29, P245, DOI 10.1093/jac/29.3.245; Colaert N, 2010, PROTEOMICS, V10, P1226, DOI 10.1002/pmic.200900379; Connell SR, 2003, ANTIMICROB AGENTS CH, V47, P3675, DOI 10.1128/AAC.47.12.3675-3681.2003; DALBEY RE, 1985, J BIOL CHEM, V260, P5925; Dalbey RE, 1997, PROTEIN SCI, V6, P1129, DOI 10.1002/pro.5560060601; DATE T, 1981, P NATL ACAD SCI-BIOL, V78, P6106, DOI 10.1073/pnas.78.10.6106; DATE T, 1983, J BACTERIOL, V154, P76, DOI 10.1128/JB.154.1.76-83.1983; DERRICK E. H., 1937, Medical Journal of Australia, V2, P281; Dotsch A, 2009, ANTIMICROB AGENTS CH, V53, P2522, DOI 10.1128/AAC.00035-09; Fajardo A, 2009, CLIN MICROBIOL INFEC, V15, P14, DOI 10.1111/j.1469-0691.2008.02688.x; Fajardo A, 2008, CURR OPIN MICROBIOL, V11, P161, DOI 10.1016/j.mib.2008.02.006; Gami AS, 2004, MAYO CLIN PROC, V79, P253, DOI 10.4065/79.2.253; Gevaert K, 2002, MOL CELL PROTEOMICS, V1, P896, DOI 10.1074/mcp.M200061-MCP200; Ghesquiere B, 2009, MOL CELL PROTEOMICS, V8, P2642, DOI 10.1074/mcp.M900259-MCP200; GIMENEZ DF, 1964, STAIN TECHNOL, V39, P135, DOI 10.3109/10520296409061219; Heinzen RA, 1996, MOL MICROBIOL, V22, P9, DOI 10.1111/j.1365-2958.1996.tb02651.x; Hu XH, 2011, BIOCHEMISTRY-US, V50, P10559, DOI 10.1021/bi201008f; Iosif V, 2011, J PROTEOME RES, V10, P4241, DOI 10.1021/pr200422f; Joshi N, 1997, ARCH INTERN MED, V157, P1421, DOI 10.1001/archinte.157.13.1421; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Linares JF, 2006, P NATL ACAD SCI USA, V103, P19484, DOI 10.1073/pnas.0608949103; Martinez JL, 2009, FEMS MICROBIOL REV, V33, P44, DOI 10.1111/j.1574-6976.2008.00142.x; Maki Y, 2000, GENES CELLS, V5, P965, DOI 10.1046/j.1365-2443.2000.00389.x; Martinez JL, 2008, SCIENCE, V321, P365, DOI 10.1126/science.1159483; Martinez JL, 2009, FEMS MICROBIOL REV, V33, P430, DOI 10.1111/j.1574-6976.2008.00157.x; Maurin M, 1997, J ANTIMICROB CHEMOTH, V39, P725, DOI 10.1093/jac/39.6.725; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; Omsland A, 2011, APPL ENVIRON MICROB, V77, P3720, DOI 10.1128/AEM.02826-10; Omsland A, 2009, P NATL ACAD SCI USA, V106, P4430, DOI 10.1073/pnas.0812074106; Paetzel M, 1998, NATURE, V396, P186, DOI 10.1038/24196; Paulsen IT, 1996, MICROBIOL REV, V60, P575, DOI 10.1128/MMBR.60.4.575-608.1996; Rolain JM, 2005, ANN NY ACAD SCI, V1063, P252, DOI 10.1196/annals.1355.039; Rolain JM, 2003, J INFECT DIS, V188, P1322, DOI 10.1086/379082; Samland AK, 2009, INT J BIOCHEM CELL B, V41, P1482, DOI 10.1016/j.biocel.2009.02.001; Samoilis G, 2007, J PROTEOME RES, V6, P3032, DOI 10.1021/pr070077n; Shoji S, 2010, BIOCHIMIE, V92, P157, DOI 10.1016/j.biochi.2009.11.002; STOJILJKOVIC I, 1993, FEMS MICROBIOL LETT, V108, P111; Tamae C, 2008, J BACTERIOL, V190, P5981, DOI 10.1128/JB.01982-07; Tamura N, 2003, CURR OPIN CHEM BIOL, V7, P570, DOI 10.1016/j.cbpa.2003.08.014; Taylor DE, 1996, ANTIMICROB AGENTS CH, V40, P1; Thaker M, 2010, CELL MOL LIFE SCI, V67, P419, DOI 10.1007/s00018-009-0172-6; Tissot-Dupont H, 2007, CLIN INFECT DIS, V44, P232, DOI 10.1086/510389; TURCK WPG, 1976, Q J MED, V45, P193; Tuteja R, 2005, ARCH BIOCHEM BIOPHYS, V441, P107, DOI 10.1016/j.abb.2005.07.013; VINNIKOV AI, 1989, ANTIBIOT KHIMIOTERAP, V34, P34; Vranakis I, 2011, J PROTEOME RES, V10, P756, DOI 10.1021/pr100906v; Xiong SG, 2003, J BIOL CHEM, V278, P17646, DOI 10.1074/jbc.M210905200; Yeom J, 2010, J BIOL CHEM, V285, P22689, DOI 10.1074/jbc.M110.127456; Yergeau E, 2010, APPL ENVIRON MICROB, V76, P5432, DOI 10.1128/AEM.00873-10; Yim G, 2006, INT J MED MICROBIOL, V296, P163, DOI 10.1016/j.ijmm.2006.01.039; Yim G, 2007, PHILOS T R SOC B, V362, P1195, DOI 10.1098/rstb.2007.2044	63	21	21	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33599	10.1371/journal.pone.0033599	http://dx.doi.org/10.1371/journal.pone.0033599			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438959	Green Submitted, Green Published, gold			2022-12-25	WOS:000303309100067
J	Johnson, MP; Brennecke, SP; East, CE; Goring, HHH; Kent, JW; Dyer, TD; Said, JM; Roten, LT; Iversen, AC; Abraham, LJ; Heinonen, S; Kajantie, E; Kere, J; Kivinen, K; Pouta, A; Laivuori, H; Austgulen, R; Blangero, J; Moses, EK				Johnson, Matthew P.; Brennecke, Shaun P.; East, Christine E.; Goering, Harald H. H.; Kent, Jack W., Jr.; Dyer, Thomas D.; Said, Joanne M.; Roten, Linda T.; Iversen, Ann-Charlotte; Abraham, Lawrence J.; Heinonen, Seppo; Kajantie, Eero; Kere, Juha; Kivinen, Katja; Pouta, Anneli; Laivuori, Hannele; Austgulen, Rigmor; Blangero, John; Moses, Eric K.		FINNPEC Study Grp	Genome-Wide Association Scan Identifies a Risk Locus for Preeclampsia on 2q14, Near the Inhibin, Beta B Gene	PLOS ONE			English	Article							ACTIVIN-A; HYPERTENSIVE DISORDERS; SUSCEPTIBILITY LOCUS; PREGNANCY; HAPLOTYPE; MANAGEMENT; PATHOGENESIS; EXPRESSION; ACVR2A; TOOL	Elucidating the genetic architecture of preeclampsia is a major goal in obstetric medicine. We have performed a genome-wide association study (GWAS) for preeclampsia in unrelated Australian individuals of Caucasian ancestry using the Illumina OmniExpress-12 BeadChip to successfully genotype 648,175 SNPs in 538 preeclampsia cases and 540 normal pregnancy controls. Two SNP associations (rs7579169, p = 3.58x10(-7), OR = 1.57; rs12711941, p = 4.26x10(-7), OR= 1.56) satisfied our genome-wide significance threshold (modified Bonferroni p<5.11x10(-7)). These SNPs reside in an intergenic region less than 15 kb downstream from the 3' terminus of the Inhibin, beta B (INHBB) gene on 2q14.2. They are in linkage disequilibrium (LD) with each other (r(2) = 0.92), but not (r(2)<0.80) with any other genotyped SNP +/-250 kb. DNA re-sequencing in and around the INHBB structural gene identified an additional 25 variants. Of the 21 variants that we successfully genotyped back in the case-control cohort the most significant association observed was for a third intergenic SNP (rs7576192, p = 1.48x10(-7), OR= 1.59) in strong LD with the two significant GWAS SNPs (r(2)>0.92). We attempted to provide evidence of a putative regulatory role for these SNPs using bioinformatic analyses and found that they all reside within regions of low sequence conservation and/or low complexity, suggesting functional importance is low. We also explored the mRNA expression in decidua of genes +/-500 kb of INHBB and found a nominally significant correlation between a transcript encoded by the EPB41L5 gene, similar to 250 kb centromeric to INHBB, and preeclampsia (p = 0.03). We were unable to replicate the associations shown by the significant GWAS SNPs in case-control cohorts from Norway and Finland, leading us to conclude that it is more likely that these SNPs are in LD with as yet unidentified causal variant(s).	[Johnson, Matthew P.; Goering, Harald H. H.; Kent, Jack W., Jr.; Dyer, Thomas D.; Blangero, John; Moses, Eric K.] Texas Biomed Res Inst, Dept Genet, San Antonio, TX USA; [Brennecke, Shaun P.; East, Christine E.; Said, Joanne M.] Royal Womens Hosp, Dept Obstet & Gynaecol, Dept Perinatal Med, Parkville, Vic, Australia; [Brennecke, Shaun P.; East, Christine E.; Said, Joanne M.] Univ Melbourne, Parkville, Vic 3052, Australia; [Roten, Linda T.; Iversen, Ann-Charlotte; Austgulen, Rigmor] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway; [Abraham, Lawrence J.] Univ Western Australia, Sch Biomed Biomol & Chem Sci, Perth, WA 6009, Australia; [Heinonen, Seppo] Kuopio Univ Hosp, Dept Obstet & Gynecol, SF-70210 Kuopio, Finland; [Heinonen, Seppo] Univ Eastern Finland, Kuopio, Finland; [Kajantie, Eero] Natl Inst Hlth & Welf, Diabet Prevent Unit, Dept Chron Dis Prevent, Helsinki, Finland; [Kajantie, Eero] Univ Helsinki, Cent Hosp, Childrens Hosp, Helsinki, Finland; [Kere, Juha] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden; [Kere, Juha] Karolinska Inst, Sci Life Lab, Stockholm, Sweden; [Kere, Juha] Folkhalsan Inst Genet, Helsinki, Finland; [Kere, Juha; Laivuori, Hannele] Univ Helsinki, Dept Med Genet, Haartman Inst, Helsinki, Finland; [Kivinen, Katja] Wellcome Trust Sanger Inst, Cambridge, England; [Pouta, Anneli] Natl Inst Hlth & Welf, Dept Children Young People & Families, Oulu, Finland; [Laivuori, Hannele] Univ Helsinki, Res Programs Unit, Helsinki, Finland; [Moses, Eric K.] Univ Western Australia, Ctr Genet Epidemiol & Biostat, Perth, WA 6009, Australia	Texas Biomedical Research Institute; University of Melbourne; Norwegian University of Science & Technology (NTNU); University of Western Australia; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital; Karolinska Institutet; Karolinska Institutet; University of Helsinki; Wellcome Trust Sanger Institute; Finland National Institute for Health & Welfare; University of Helsinki; University of Western Australia	Johnson, MP (corresponding author), Texas Biomed Res Inst, Dept Genet, San Antonio, TX USA.	eric.moses@uwa.edu.au	Iversen, Ann-Charlotte/C-6920-2011; East, Christine/H-4938-2013; Kere, Juha/AAX-9117-2021; Brennecke, Shaun/AFV-3919-2022; Lokki, A. Inkeri/H-4783-2019; Laivuori, Hannele/F-2953-2011; Said, Joanne M/AAC-8560-2020; Blangero, John/ABA-7175-2021; Kere, Juha/A-9179-2008	Iversen, Ann-Charlotte/0000-0001-7726-7684; East, Christine/0000-0002-1196-8426; Kere, Juha/0000-0003-1974-0271; Brennecke, Shaun/0000-0003-3070-6971; Lokki, A. Inkeri/0000-0003-4397-8415; Laivuori, Hannele/0000-0003-3212-7826; Kere, Juha/0000-0003-1974-0271; Johnson, Matthew/0000-0003-3278-1844; Klemetti, Miira/0000-0001-9038-130X; Moses, Eric/0000-0001-7781-4465; Kivinen, Katja/0000-0002-1135-7625; Said, Joanne/0000-0001-6263-0030; Kent, Jack/0000-0002-0758-7639	National Institutes of Health [HD049847, S10RR029392]; ATT Foundation; Faye L. and William L. Cowden Charitable Foundation; Norwegian Research Council; Jane and Aatos Erkko Foundation; Paivikki and Sakari Sohlberg Foundation; Academy of Finland; University of Helsinki; Government Special Subsidiary for Health Sciences (EVO) at Helsinki; Uusimaa Hospital District; Novo Nordisk Foundation; Finnish Foundation for Pediatric Research; Emil Aaltonen Foundation; Sigrid Juselius Foundation; American Heart Association [09SDG2350008]; Cornelius Regan Trust from University of Melbourne; National Center for Research Resources, National Institutes of Health [RR017515]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD049847] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029392, C06RR017515] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH059490] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ATT Foundation; Faye L. and William L. Cowden Charitable Foundation; Norwegian Research Council(Research Council of NorwayEuropean Commission); Jane and Aatos Erkko Foundation; Paivikki and Sakari Sohlberg Foundation; Academy of Finland(Academy of Finland); University of Helsinki; Government Special Subsidiary for Health Sciences (EVO) at Helsinki; Uusimaa Hospital District; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Finnish Foundation for Pediatric Research; Emil Aaltonen Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); American Heart Association(American Heart Association); Cornelius Regan Trust from University of Melbourne; National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	National Institutes of Health grants supported the Australian GWAS (HD049847 to E.K.M., S.P.B. and J.B.) and MEDUSA, the super computer cluster at Texas Biomed (S10RR029392 to J.B.). The AT&T Genomics Computing Center at Texas Biomed is supported by the AT&T Foundation. Transcriptional profiling was supported by the Faye L. and William L. Cowden Charitable Foundation (to M.P.J.). The Norwegian cohort study was supported by the Functional Genomic Programme (FUGE) of the Norwegian Research Council (to R.A.). The FINNPEC study was supported by Jane and Aatos Erkko Foundation, Paivikki and Sakari Sohlberg Foundation, Academy of Finland, Research Funds of the University of Helsinki, Government Special Subsidiary for Health Sciences (EVO funding) at Helsinki and Uusimaa Hospital District. Novo Nordisk Foundation, Finnish Foundation for Pediatric Research, Emil Aaltonen Foundation, and Sigrid Juselius Foundation. M.P.J. is supported, in part, by an American Heart Association National Scientist Development grant (09SDG2350008). J.M.S. was supported by a Cornelius Regan Trust Award from the University of Melbourne. This investigation was conducted in facilities constructed with support from Research Facilities Improvement Program grant RR017515 from the National Center for Research Resources, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Basso O, 2006, JAMA-J AM MED ASSOC, V296, P1357, DOI 10.1001/jama.296.11.1357; Brown MA, 2000, AUST NZ J OBSTET GYN, V40, P133, DOI 10.1111/j.1479-828X.2000.tb01136.x; BROWN MA, 1993, MED J AUSTRALIA, V158, P700; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Caniggia I, 2000, PLACENTA, V21, pS25, DOI 10.1053/plac.1999.0522; Casagrandi D, 2003, MOL HUM REPROD, V9, P199, DOI 10.1093/molehr/gag029; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Chekmenev DS, 2005, NUCLEIC ACIDS RES, V33, pW432, DOI 10.1093/nar/gki441; Duggal P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-516; Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010; Fenstad MH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012993; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Fitzpatrick E, 2004, HUM BIOL, V76, P849, DOI 10.1353/hub.2005.0017; Fitzpatrick E, 2009, MOL HUM REPROD, V15, P195, DOI 10.1093/molehr/gap001; Fraser RF, 1998, AM J REPROD IMMUNOL, V40, P37; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; Goldenberg RL, 1998, NEW ENGL J MED, V339, P313, DOI 10.1056/NEJM199807303390506; Grabe Niels, 2002, In Silico Biology, V2, pS1; Greene CS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005639; Hiltunen LM, 2009, THROMB RES, V124, P167, DOI 10.1016/j.thromres.2008.11.012; Holmen J, 2003, NORSK EPIDEMIOLOGI, V13, P19, DOI DOI 10.1093/eurheartj/eht019; Holmen J, 2004, NORSK EPIDEMIOLOGI, V14, P27; Irgens HU, 2001, BRIT MED J, V323, P1213, DOI 10.1136/bmj.323.7323.1213; Johansson A, 2011, EUR J HUM GENET, V19, P796, DOI 10.1038/ejhg.2011.19; Johnson MP, 2007, MOL HUM REPROD, V13, P61, DOI 10.1093/molehr/gal095; Johnson MP, 2009, HUM GENET, V126, P655, DOI 10.1007/s00439-009-0714-x; Jones RL, 2006, AUST NZ J OBSTET GYN, V46, P245, DOI 10.1111/j.1479-828X.2006.00581.x; KHONG TY, 1986, BRIT J OBSTET GYNAEC, V93, P1049, DOI 10.1111/j.1471-0528.1986.tb07830.x; Laivuori H, 2000, OBSTET GYNECOL, V96, P277, DOI 10.1016/S0029-7844(00)00896-6; Loset M, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.08.043; Lowe SA, 2009, AUST NZ J OBSTET GYN, V49, P242, DOI 10.1111/j.1479-828X.2009.01003.x; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Moses EK, 2006, MOL HUM REPROD, V12, P505, DOI 10.1093/molehr/gal056; Moses EK, 2000, AM J HUM GENET, V67, P1581, DOI 10.1086/316888; Moses EK, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.09.024; Muttukrishna S, 2000, HUM REPROD, V15, P1640, DOI 10.1093/humrep/15.7.1640; Muttukrishna S, 1997, LANCET, V349, P1285, DOI 10.1016/S0140-6736(96)09264-1; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; PETRAGLIA F, 1995, PLACENTA, V16, P447, DOI 10.1016/0143-4004(95)90102-7; Pijnenborg R, 2006, PLACENTA, V27, P939, DOI 10.1016/j.placenta.2005.12.006; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Redman CWG, 2009, PLACENTA, V30, pS38, DOI 10.1016/j.placenta.2008.11.021; Redman CWG, 2010, AM J REPROD IMMUNOL, V63, P534, DOI 10.1111/j.1600-0897.2010.00831.x; Roberts JM, 2009, PLACENTA, V30, pS32, DOI 10.1016/j.placenta.2008.11.009; Roberts JM, 2010, WOMEN HEALTH ISS, V20, P304, DOI 10.1016/j.whi.2010.05.004; Roberts JM, 2005, HYPERTENSION, V46, P1243, DOI 10.1161/01.HYP.0000188408.49896.c5; Roberts JM, 2003, HYPERTENSION, V41, P437, DOI 10.1161/01.HYP.0000054981.03589.E9; Roberts JM, 2001, LANCET, V357, P53, DOI 10.1016/S0140-6736(00)03577-7; ROBERTS JM, 1989, AM J OBSTET GYNECOL, V161, P1200, DOI 10.1016/0002-9378(89)90665-0; Rodie VA, 2004, ATHEROSCLEROSIS, V175, P189, DOI 10.1016/j.atherosclerosis.2004.01.038; Roten LT, 2011, MOL HUM REPROD, V17, P439, DOI 10.1093/molehr/gar014; Roten LT, 2009, EUR J HUM GENET, V17, P250, DOI 10.1038/ejhg.2008.158; Sattar N, 2002, BMJ-BRIT MED J, V325, P157, DOI 10.1136/bmj.325.7356.157; Shriner D, 2007, SCIENCE, V316, P1840; Sugimoto H, 2003, J BIOL CHEM, V278, P12605, DOI 10.1074/jbc.C300012200; Tang LCH, 1997, CHINESE MED J-PEKING, V110, P936; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; Wang A, 2009, PHYSIOLOGY, V24, P147, DOI 10.1152/physiol.00043.2008; Williams PJ, 2011, BEST PRACT RES CL OB, V25, P405, DOI 10.1016/j.bpobgyn.2011.02.007; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Witlin AG, 1997, ANNU REV MED, V48, P115; Zintzaras E, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-171	66	108	114	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e33666	10.1371/journal.pone.0033666	http://dx.doi.org/10.1371/journal.pone.0033666			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22432041	Green Published, gold			2022-12-25	WOS:000303198600084
J	Roux, S; Enault, F; Robin, A; Ravet, V; Personnic, S; Theil, S; Colombet, J; Sime-Ngando, T; Debroas, D				Roux, Simon; Enault, Francois; Robin, Agnes; Ravet, Viviane; Personnic, Sebastien; Theil, Sebastien; Colombet, Jonathan; Sime-Ngando, Telesphore; Debroas, Didier			Assessing the Diversity and Specificity of Two Freshwater Viral Communities through Metagenomics	PLOS ONE			English	Article							SPATIAL VARIABILITY; BACTERIAL COMMUNITY; MARINE VIRUSES; LAKE BOURGET; NATURAL LAKE; ONLINE TOOL; FRANCE; VIRIOPLANKTON; PHYLOGENIES; ALIGNMENTS	Transitions between saline and fresh waters have been shown to be infrequent for microorganisms. Based on host-specific interactions, the presence of specific clades among hosts suggests the existence of freshwater-specific viral clades. Yet, little is known about the composition and diversity of the temperate freshwater viral communities, and even if freshwater lakes and marine waters harbor distinct clades for particular viral sub-families, this distinction remains to be demonstrated on a community scale. To help identify the characteristics and potential specificities of freshwater viral communities, such communities from two lakes differing by their ecological parameters were studied through metagenomics. Both the cluster richness and the species richness of the Lake Bourget virome were significantly higher that those of the Lake Pavin, highlighting a trend similar to the one observed for microorganisms (i.e. the specie richness observed in mesotrophic lakes is greater than the one observed in oligotrophic lakes). Using 29 previously published viromes, the cluster richness was shown to vary between different environment types and appeared significantly higher in marine ecosystems than in other biomes. Furthermore, significant genetic similarity between viral communities of related environments was highlighted as freshwater, marine and hypersaline environments were separated from each other despite the vast geographical distances between sample locations within each of these biomes. An automated phylogeny procedure was then applied to marker genes of the major families of single-stranded (Microviridae, Circoviridae, Nanoviridae) and double-stranded (Caudovirales) DNA viruses. These phylogenetic analyses all spotlighted a very broad diversity and previously unknown clades undetectable by PCR analysis, clades that gathered sequences from the two lakes. Thus, the two freshwater viromes appear closely related, despite the significant ecological differences between the two lakes. Furthermore, freshwater viral communities appear genetically distinct from other aquatic ecosystems, demonstrating the specificity of freshwater viruses at a community scale for the first time.	[Roux, Simon; Enault, Francois; Robin, Agnes; Ravet, Viviane; Personnic, Sebastien; Theil, Sebastien; Colombet, Jonathan; Sime-Ngando, Telesphore; Debroas, Didier] Univ Clermont Ferrand, Clermont Univ, Lab Microorganismes Genome & Environm, Clermont Ferrand, France; [Roux, Simon; Enault, Francois; Robin, Agnes; Ravet, Viviane; Personnic, Sebastien; Theil, Sebastien; Colombet, Jonathan; Sime-Ngando, Telesphore; Debroas, Didier] LMGE, CNRS, UMR 6023, Aubiere, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Clermont Auvergne (UCA)	Roux, S (corresponding author), Univ Clermont Ferrand, Clermont Univ, Lab Microorganismes Genome & Environm, Clermont Ferrand, France.	francois.enault@univ-bpclermont.fr	Roux, Simon/B-3751-2013; Robin, Agnes/C-5238-2015; Roux, Simon/ABE-6255-2020; Personnic, Sebastien/C-9589-2013; Sime-Ngando, Télesphore/M-4134-2019	Roux, Simon/0000-0002-5831-5895; Sime-Ngando, Télesphore/0000-0002-7240-5803; Viviane, RAVET/0000-0001-7574-992X; Robin, Agnes/0000-0003-3044-2304	EC2CO CNRS; French defense procurement agency (DGA, Direction Generale de l'Armement)	EC2CO CNRS; French defense procurement agency (DGA, Direction Generale de l'Armement)	This study was funded by an EC2CO CNRS program grant (Metavir). SR was supported by a PhD grant from the French defense procurement agency (DGA, Direction Generale de l'Armement). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Angly F, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-41; Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Angly FE, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000593; Boucher D, 2006, FEMS MICROBIOL ECOL, V55, P79, DOI 10.1111/j.1574-6941.2005.00011.x; Breitbart M, 2002, P NATL ACAD SCI USA, V99, P14250, DOI 10.1073/pnas.202488399; Brussaard CPD, 2004, APPL ENVIRON MICROB, V70, P1506, DOI 10.1128/AEM.70.3.1506-1513.2004; Canchaya C, 2004, MOL MICROBIOL, V53, P9, DOI 10.1111/j.1365-2958.2004.04113.x; Carstens EB, 2010, ARCH VIROL, V155, P133, DOI 10.1007/s00705-009-0547-x; Chenard C, 2008, APPL ENVIRON MICROB, V74, P5317, DOI 10.1128/AEM.02480-07; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Colombet J, 2007, J MICROBIOL METH, V71, P212, DOI 10.1016/j.mimet.2007.08.012; Comeau AM, 2008, MOL BIOL EVOL, V25, P1321, DOI 10.1093/molbev/msn080; Debroas D, 2009, ENVIRON MICROBIOL, V11, P2412, DOI 10.1111/j.1462-2920.2009.01969.x; Desnues C, 2008, NATURE, V452, P340, DOI 10.1038/nature06735; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Dorigo U, 2004, APPL ENVIRON MICROB, V70, P1017, DOI 10.1128/AEM.70.2.1017-1022.2004; Dorigo U, 2006, FEMS MICROBIOL ECOL, V58, P109, DOI 10.1111/j.1574-6941.2006.00139.x; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Edwards RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/nrmicro1163; Filee J, 2006, M S-MED SCI, V22, P111, DOI 10.1051/medsci/2006222111; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; Gomez-Alvarez V, 2009, ISME J, V3, P1314, DOI 10.1038/ismej.2009.72; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hahn MW, 2006, CURR OPIN BIOTECH, V17, P256, DOI 10.1016/j.copbio.2006.05.006; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Kim KH, 2008, APPL ENVIRON MICROB, V74, P5975, DOI 10.1128/AEM.01275-08; Lefranc M, 2005, APPL ENVIRON MICROB, V71, P5935, DOI 10.1128/AEM.71.10.5935-5942.2005; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Li LL, 2010, J VIROL, V84, P1674, DOI 10.1128/JVI.02109-09; Logares R, 2009, TRENDS MICROBIOL, V17, P414, DOI 10.1016/j.tim.2009.05.010; Lopez-Bueno A, 2009, SCIENCE, V326, P858, DOI 10.1126/science.1179287; Martin-Cuadrado AB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000914; Personnic S, 2009, HYDROBIOLOGIA, V627, P99, DOI 10.1007/s10750-009-9718-8; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Rodriguez-Brito B, 2010, ISME J, V4, P739, DOI 10.1038/ismej.2010.1; Rodriguez-Valera F, 2009, NAT REV MICROBIOL, V7, P828, DOI 10.1038/nrmicro2235; Rosario K, 2009, J GEN VIROL, V90, P2418, DOI 10.1099/vir.0.012955-0; Roux S, 2011, BIOINFORMATICS, V27, P3074, DOI 10.1093/bioinformatics/btr519; Short CM, 2005, APPL ENVIRON MICROB, V71, P480, DOI 10.1128/AEM.71.1.480-486.2005; Sullivan MB, 2009, ENVIRON MICROBIOL, V11, P2935, DOI 10.1111/j.1462-2920.2009.02081.x; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Wilhelm SW, 2006, APPL ENVIRON MICROB, V72, P4957, DOI 10.1128/AEM.00349-06; Willner D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007370; Wommack KE, 2008, APPL ENVIRON MICROB, V74, P1453, DOI 10.1128/AEM.02181-07; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000	48	156	158	6	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e33641	10.1371/journal.pone.0033641	http://dx.doi.org/10.1371/journal.pone.0033641			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22432038	Green Published, Green Submitted, gold			2022-12-25	WOS:000303198600081
J	Shinde, VM; Sizova, OS; Lin, JH; LaVail, MM; Gorbatyuk, MS				Shinde, Vishal M.; Sizova, Olga S.; Lin, Jonathan H.; LaVail, Matthew M.; Gorbatyuk, Marina S.			ER Stress in Retinal Degeneration in S334ter Rho Rats	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; HISTONE DEACETYLASE ACTIVITY; UNFOLDED PROTEIN RESPONSE; CELL-DEATH; HYDROGEN-PEROXIDE; INDUCED APOPTOSIS; OXIDATIVE STRESS; GENE-EXPRESSION; TRANSGENIC RATS; ACTIVATION	The S334ter rhodopsin (Rho) rat (line 4) bears the rhodopsin gene with an early termination codon at residue 334 that is a model for several such mutations found in human patients with autosomal dominant retinitis pigmentosa (ADRP). The Unfolded Protein Response (UPR) is implicated in the pathophysiology of several retinal disorders including ADRP in P23H Rho rats. The aim of this study was to examine the onset of UPR gene expression in S334ter Rho retinas to determine if UPR is activated in ADRP animal models and to investigate how the activation of UPR molecules leads to the final demise of S334ter Rho photoreceptors. RT-PCR was performed to evaluate the gene expression profiles for the P10, P12, P15, and P21 stages of the development and progression of ADRP in S334ter Rho photoreceptors. We determined that during the P12-P15 period, ER stress-related genes are strongly upregulated in transgenic retinas, resulting in the activation of the UPR that was confirmed using western blot analysis and RT-PCR. The activation of UPR was associated with the increased expression of JNK, Bik, Bim, Bid, Noxa, and Puma genes and cleavage of caspase-12 that together with activated calpains presumably compromise the integrity of the mitochondrial MPTP, leading to the release of pro-apoptotic AIF1 into the cytosol of S334ter Rho photoreceptor cells. Therefore, two major cross-talking pathways, the UPR and mitochondrial MPTP occur in S334ter-4 Rho retina concomitantly and eventually promote the death of the photoreceptor cells.	[Shinde, Vishal M.; Sizova, Olga S.; Gorbatyuk, Marina S.] Univ N Texas, Hlth Sci Ctr, Dept Cell Biol & Anat, N Texas Eye Res Inst, Ft Worth, TX 76107 USA; [Lin, Jonathan H.] Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA; [LaVail, Matthew M.] Univ Calif San Francisco, Dept Ophthalmol, Beckman Vis Ctr, San Francisco, CA USA	University of North Texas System; University of North Texas Health Science Center; University of California System; University of California San Diego; University of California System; University of California San Francisco	Shinde, VM (corresponding author), Univ N Texas, Hlth Sci Ctr, Dept Cell Biol & Anat, N Texas Eye Res Inst, Ft Worth, TX 76107 USA.	marina.gorbatyuk@unthsc.edu	Shinde, Vishal/X-3064-2019; Sizova, Olga/W-3953-2019	Gorbatyuk, Marina/0000-0001-9060-856X; Sizova, Olga/0000-0003-3441-9064; Lin, Jonathan/0000-0002-7438-6941	Foundation Fighting Blindness [TA-GT-0409-0508NTERI]; National Institutes of Health (NIH) [1 RO1 EY020905-1, EY001919, EY006842, EY002162, EY018313, EY020846]; Hope for Vision; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [U01EY006842, R01EY020846, R01EY001919, R01EY020905, R37EY001919, R01EY006842, K08EY018313, P30EY002162] Funding Source: NIH RePORTER	Foundation Fighting Blindness(European Commission); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hope for Vision; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the Foundation Fighting Blindness TA-GT-0409-0508NTERI; National Institutes of Health (NIH) grant 1 RO1 EY020905-1; Hope for Vision; NIH grants EY001919, EY006842, EY002162, EY018313, and EY020846; and a Research to Prevent Blindness grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali RR, 1998, CURR EYE RES, V17, P917, DOI 10.1076/ceyr.17.9.917.5137; Anderson RE, 2001, INVEST OPHTH VIS SCI, V42, P1715; Besirli CG, 2010, INVEST OPHTH VIS SCI, V51, P2177, DOI 10.1167/iovs.09-4439; Blackshaw S, 2004, PLOS BIOL, V2, P1411, DOI 10.1371/journal.pbio.0020247; Bowne SJ, 2011, EUR J HUM GENET, V19, P1074, DOI 10.1038/ejhg.2011.86; Bravo R, 2011, J CELL SCI, V124, P2143, DOI 10.1242/jcs.080762; Caprara C, 2011, INVEST OPHTH VIS SCI, V52, P2109, DOI 10.1167/iovs.10-6222; CHANG GQ, 1993, NEURON, V11, P595, DOI 10.1016/0896-6273(93)90072-Y; Chen B, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-78; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Dejeans N, 2010, BIOCHEM PHARMACOL, V79, P1221, DOI 10.1016/j.bcp.2009.12.009; Deng YB, 2003, CELL, V115, P61, DOI 10.1016/S0092-8674(03)00757-8; Donovan M, 2006, DEV BIOL, V291, P154, DOI 10.1016/j.ydbio.2005.12.026; Doonan F, 2004, CURR NEUROVASC RES, V1, P41, DOI 10.2174/1567202043480215; Doonan F, 2003, J NEUROSCI, V23, P5723; Dorrell MI, 2004, INVEST OPHTH VIS SCI, V45, P1009, DOI 10.1167/iovs.03-0806; Feldman DE, 2005, MOL CANCER RES, V3, P597, DOI 10.1158/1541-7786.MCR-05-0221; Geracitano R, 2005, J PHYSIOL-LONDON, V568, P97, DOI 10.1113/jphysiol.2005.092510; Gess B, 2003, EUR J BIOCHEM, V270, P2228, DOI 10.1046/j.1432-1033.2003.03590.x; Gorbatyuk MS, 2010, P NATL ACAD SCI USA, V107, P5961, DOI 10.1073/pnas.0911991107; Graham DR, 2005, INVEST OPHTH VIS SCI, V46, P2601, DOI 10.1167/iovs.05-0129; Green ES, 2000, INVEST OPHTH VIS SCI, V41, P1546; Griguer CE, 2006, CANCER RES, V66, P2257, DOI 10.1158/0008-5472.CAN-05-3364; Grimm C, 2002, NAT MED, V8, P718, DOI 10.1038/nm723; Grimm C, 2005, SEMIN CELL DEV BIOL, V16, P531, DOI 10.1016/j.semcdb.2005.03.004; Hagiwara M, 2011, MOL CELL, V41, P432, DOI 10.1016/j.molcel.2011.01.021; Hernan I, 2011, INVEST OPHTH VIS SCI, V52, P3723, DOI 10.1167/iovs.10-6933; Hiramatsu N, 2011, METHOD ENZYMOL, V491, P183, DOI 10.1016/B978-0-12-385928-0.00011-0; Hong SJ, 2004, TRENDS PHARMACOL SCI, V25, P259, DOI 10.1016/j.tips.2004.03.005; Hopp R M, 1998, Mol Vis, V4, P5; Hu P, 2004, J BIOL CHEM, V279, P49420, DOI 10.1074/jbc.M407700200; Huang CY, 2001, J CEREBR BLOOD F MET, V21, P163, DOI 10.1097/00004647-200102000-00008; Hughes R, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-69; Hur J, 2006, CANCER RES, V66, P10153, DOI 10.1158/0008-5472.CAN-05-3696; Joly S, 2008, J NEUROSCI, V28, P13765, DOI 10.1523/JNEUROSCI.5114-08.2008; Jomary C, 2001, MOL CELL NEUROSCI, V18, P335, DOI 10.1006/mcne.2001.1036; Kaur J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022181; Kim JY, 2004, J EXP MED, V199, P113, DOI 10.1084/jem.20030613; Komeima K, 2006, P NATL ACAD SCI USA, V103, P11300, DOI 10.1073/pnas.0604056103; Lee EH, 2010, CLIN INFECT DIS, V50, P1498, DOI 10.1086/652446; Lee W, 2005, APOPTOSIS, V10, P407, DOI 10.1007/s10495-005-0814-6; Leonard KC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000314; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Liu B, 2000, Zhonghua Yan Ke Za Zhi, V36, P65; Liu B, 2000, ZHONGHUA YAN KE ZA Z, V36, P69; Liu CD, 1999, J NEUROSCI, V19, P4778; Liu Y, 2009, CELL DEATH DIFFER, V16, P847, DOI 10.1038/cdd.2009.14; Martinez-Navarrete G, 2011, EXP EYE RES, V92, P227, DOI 10.1016/j.exer.2010.12.001; May D, 2005, ONCOGENE, V24, P1011, DOI 10.1038/sj.onc.1208325; Milani P, 2011, NEUROL RES INT, V2011, DOI 10.1155/2011/458427; Noorwez SM, 2009, J BIOL CHEM, V284, P33333, DOI 10.1074/jbc.M109.043364; Obeng EA, 2005, J BIOL CHEM, V280, P29578, DOI 10.1074/jbc.M502685200; Pennesi ME, 2008, EXP EYE RES, V87, P561, DOI 10.1016/j.exer.2008.09.004; Rohwer N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012038; Ryoo HD, 2007, EMBO J, V26, P242, DOI 10.1038/sj.emboj.7601477; Rzymski T, 2010, ONCOGENE, V29, P4424, DOI 10.1038/onc.2010.191; Sancho-Pelluz J, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.4; Sanges D, 2006, P NATL ACAD SCI USA, V103, P17366, DOI 10.1073/pnas.0606276103; Sevier CS, 2008, BBA-MOL CELL RES, V1783, P549, DOI 10.1016/j.bbamcr.2007.12.011; Suzuki C, 2008, BIOCHEM BIOPH RES CO, V368, P100, DOI 10.1016/j.bbrc.2008.01.059; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Travis GH, 1998, AM J HUM GENET, V62, P503, DOI 10.1086/301772; van den Beucken T, 2006, CANCER BIOL THER, V5, P749, DOI 10.4161/cbt.5.7.2972; Wallace DM, 2009, J NEUROSCI RES, V87, P887, DOI 10.1002/jnr.21910; Wang P, 2011, NEUROSCIENCE, V190, P43, DOI 10.1016/j.neuroscience.2011.06.008; Wu Le-Meng, 2008, Zhonghua Yan Ke Za Zhi, V44, P807; Yang LP, 2007, INVEST OPHTH VIS SCI, V48, P5191, DOI 10.1167/iovs.07-0512; Yokouchi M, 2007, CELL DEATH DIFFER, V14, P1467, DOI 10.1038/sj.cdd.4402154; Yokouchi M, 2008, J BIOL CHEM, V283, P4252, DOI 10.1074/jbc.M705951200; Yoo HY, 1999, J BIOL CHEM, V274, P23887, DOI 10.1074/jbc.274.34.23887; Yu J, 2008, ONCOGENE, V27, pS71, DOI 10.1038/onc.2009.45	71	56	59	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e33266	10.1371/journal.pone.0033266	http://dx.doi.org/10.1371/journal.pone.0033266			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22432009	Green Published, gold, Green Submitted			2022-12-25	WOS:000303198600052
J	Wildeman, MA; Fles, R; Adham, M; Mayangsari, ID; Luirink, I; Sandberg, M; Vincent, AD; Fardizza, F; Musa, Z; Armiyanto; Middeldorp, JM; Gerritsen, G; Suwanto, R; Tan, IB				Wildeman, Maarten A.; Fles, Renske; Adham, Marlinda; Mayangsari, Ika D.; Luirink, Ilse; Sandberg, Mara; Vincent, Andrew D.; Fardizza, Faiziah; Musa, Zanil; Armiyanto; Middeldorp, Jaap M.; Gerritsen, Geerten; Suwanto, Ronny; Tan, I. Bing			Short-Term Effect of Different Teaching Methods on Nasopharyngeal Carcinoma for General Practitioners in Jakarta, Indonesia	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; IMMUNOGLOBULIN-G IGG; ANTIBODY-LEVELS; DIAGNOSTIC DELAYS; MALAYSIAN CHINESE; DNA LOAD; EBV-DNA; CANCER; EPIDEMIOLOGY; POPULATION	In Indonesia, Nasopharyngeal Carcinoma (NPC) is the most frequent cancer of the head and neck region. At first presentation in the hospital most patients already have advanced NPC. Our previous study showed that general practitioners (GPs) working in Yogyakarta, Indonesia lack the knowledge necessary for early detection of NPC. By providing training on early symptoms of NPC we hope that the diagnosis and referral will occur at an earlier stage. Here we assess the current NPC knowledge levels of GPs in Jakarta, evaluate improvement after training, compare the effectiveness of two training formats, and estimate the loss of recall over a two week period. Methods: Two Indonesian GPs visited 31 Primary Health Care Centres (PHCCs) and provided a lecture on NPC. The alternative format consisted of a symposium at the Universitas Indonesia, Jakarta, presented by local head and neck surgeons, with all GPs in the region being invited. To evaluate the effect of both formats a questionnaire was conducted before and after. \ Results: The lecture in the PHCCs was attended by 130 GPs. Sixty-six GPs attended the training in the university hospital and 40 GPs attended both. Pre training the NPC knowledge level was poor with an average of 1.6 symptoms being correctly identified out of a potential maximum of 12, this was increased to 4.9 post training (p<0.0001). GPs attending the PHCC course recorded a greater increase in correct symptoms than those attending the symposium (3.8 vs. 2.8; p = 0.01). After a two week period the knowledge levels had declined slightly from 5.5 correctly identified symptoms to 4.2 (p = 0.25). Conclusion: These results confirm our findings regarding GPs insufficient knowledge of NPC. Lectures in the PHCC and a symposium have both been proven to be effective training tools in the education of GPs.	[Wildeman, Maarten A.; Fles, Renske; Luirink, Ilse; Sandberg, Mara; Gerritsen, Geerten; Tan, I. Bing] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Head & Neck Oncol & Surg, Amsterdam, Netherlands; [Adham, Marlinda; Mayangsari, Ika D.; Fardizza, Faiziah; Musa, Zanil; Armiyanto; Suwanto, Ronny] Ear Nose & Throat Dept Rumah Sakit Dr Cipto Mangu, Jakarta, Indonesia; [Vincent, Andrew D.] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Biometr, Amsterdam, Netherlands; [Middeldorp, Jaap M.] Vrije Univ Amsterdam Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Tan, I. Bing] Gadjah Mada Univ, Ear Nose & Throat Dept, Yogyakarta, Indonesia; [Tan, I. Bing] Univ Amsterdam, Acad Med Ctr, Dept Otorhinolaryngol, NL-1105 AZ Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Gadjah Mada University; University of Amsterdam; Academic Medical Center Amsterdam	Wildeman, MA (corresponding author), Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Head & Neck Oncol & Surg, Amsterdam, Netherlands.	i.tan@nki.nl		Middeldorp, Jaap Michiel/0000-0002-0765-4125; Adham, Marlinda/0000-0003-2461-9628	Eureko Achmea foundation; Dutch Cancer Society; hospital Cipto Mangunkusumo/University of Indonesia; Dinas Kesehatan	Eureko Achmea foundation; Dutch Cancer Society(KWF Kankerbestrijding); hospital Cipto Mangunkusumo/University of Indonesia; Dinas Kesehatan	This study was carried out with funding from Eureko Achmea foundation and the Dutch Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Tissa and Karisma for their help visiting the PHCCs. The authors are grateful to the primary care physicians of the PHCCs for their participation. We thank the Dinas Kesehatan and the hospital Cipto Mangunkusumo/University of Indonesia for their support.	Alho OP, 2006, CAN MED ASSOC J, V174, P779, DOI 10.1503/cmaj.050623; Ali Tazeen Saeed, 2006, Asian Pac J Cancer Prev, V7, P391; Armstrong RW, 1998, INT J CANCER, V77, P228, DOI 10.1002/(SICI)1097-0215(19980717)77:2&lt;228::AID-IJC11&gt;3.0.CO;2-7; Armstrong RW, 2000, INT J EPIDEMIOL, V29, P991, DOI 10.1093/ije/29.6.991; Bhurgri H, 2008, BRIT J CANCER, V58, P584; CEVENINI R, 1986, J INFECTION, V12, P127, DOI 10.1016/S0163-4453(86)93558-9; Chang ET, 2006, CANCER EPIDEM BIOMAR, V15, P1765, DOI 10.1158/1055-9965.EPI-06-0353; CHEN JY, 1987, J MED VIROL, V23, P11, DOI 10.1002/jmv.1890230103; DEVATHAIRE F, 1988, INT J CANCER, V42, P176, DOI 10.1002/ijc.2910420206; Devi BCR, 2007, ANN ONCOL, V18, P1172, DOI 10.1093/annonc/mdm105; Devi BCR, 2004, CANCER EPIDEM BIOMAR, V13, P482; Drager N, TRADE HLTH SERVICES; Fachiroh J, 2008, J CLIN MICROBIOL, V46, P1374, DOI 10.1128/JCM.01368-07; Fachiroh J, 2006, J CLIN MICROBIOL, V44, P1459, DOI 10.1128/JCM.44.4.1459-1467.2006; Fachiroh J, 2004, J INFECT DIS, V190, P53, DOI 10.1086/421245; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fles R, 2010, BMC MED EDUC, V10, DOI 10.1186/1472-6920-10-81; Guo XC, 2009, INT J CANCER, V124, P2942, DOI 10.1002/ijc.24293; Ji MF, 2007, BRIT J CANCER, V96, P623, DOI 10.1038/sj.bjc.6603609; Ji Ming-fang, 2011, Chin J Cancer, V30, P120; Koivunen P, 2001, CANCER, V92, P2885, DOI 10.1002/1097-0142(20011201)92:11<2885::AID-CNCR10119>3.0.CO;2-G; Lee A. W. M., 1997, Hong Kong Medical Journal, V3, P355; LEE AWM, 1992, INT J RADIAT ONCOL, V23, P261, DOI 10.1016/0360-3016(92)90740-9; Lee AWM, 2005, INT J RADIAT ONCOL, V61, P1107, DOI 10.1016/j.ijrobp.2004.07.702; Lin JC, 2004, NEW ENGL J MED, V350, P2461, DOI 10.1056/NEJMoa032260; Ozyar E, 1994, Radiat Med, V12, P65; Paramita DK, 2007, J MED VIROL, V79, P1710, DOI 10.1002/jmv.20987; Paramita DK, 2009, CLIN VACCINE IMMUNOL, V16, P706, DOI 10.1128/CVI.00425-08; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Plianbangchang S, WHO COUNTRY COOPERAT; Poirier S, 1987, IARC Sci Publ, P415; Prasad U, 2000, Med J Malaysia, V55, P230; Stevens SJC, 2006, INT J CANCER, V119, P608, DOI 10.1002/ijc.21914; Stevens SJC, 2005, J CLIN MICROBIOL, V43, P3066, DOI 10.1128/JCM.43.7.3066-3073.2005; TAMADA A, 1984, CANCER, V53, P430, DOI 10.1002/1097-0142(19840201)53:3<430::AID-CNCR2820530311>3.0.CO;2-Z; Teppo H, 2003, HEAD NECK-J SCI SPEC, V25, P389, DOI 10.1002/hed.10208; Tong JHM, 2002, CLIN CANCER RES, V8, P2612; Tune CE, 1999, JNCI-J NATL CANCER I, V91, P796, DOI 10.1093/jnci/91.9.796; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; Wildeman MA, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-190; Yu MC, 2002, SEMIN CANCER BIOL, V12, P421, DOI 10.1016/S1044579X02000858; Zhang L, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-558; ZURHAUSE.H, 1970, NATURE, V228, P1056, DOI 10.1038/2281056a0	43	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e32756	10.1371/journal.pone.0032756	http://dx.doi.org/10.1371/journal.pone.0032756			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22431981	Green Published, gold			2022-12-25	WOS:000303198600024
J	Bahrami, A; Tonelli, M; Sahu, SC; Singarapu, KK; Eghbalnia, HR; Markley, JL				Bahrami, Arash; Tonelli, Marco; Sahu, Sarata C.; Singarapu, Kiran K.; Eghbalnia, Hamid R.; Markley, John L.			Robust, Integrated Computational Control of NMR Experiments to Achieve Optimal Assignment by ADAPT-NMR	PLOS ONE			English	Article							PROTEIN; IDENTIFICATION; INFERENCE	ADAPT-NMR (Assignment-directed Data collection Algorithm utilizing a Probabilistic Toolkit in NMR) represents a groundbreaking prototype for automated protein structure determination by nuclear magnetic resonance (NMR) spectroscopy. With a [C-13, N-15]-labeled protein sample loaded into the NMR spectrometer, ADAPT-NMR delivers complete backbone resonance assignments and secondary structure in an optimal fashion without human intervention. ADAPT-NMR achieves this by implementing a strategy in which the goal of optimal assignment in each step determines the subsequent step by analyzing the current sum of available data. ADAPT-NMR is the first iterative and fully automated approach designed specifically for the optimal assignment of proteins with fast data collection as a byproduct of this goal. ADAPT-NMR evaluates the current spectral information, and uses a goal-directed objective function to select the optimal next data collection step(s) and then directs the NMR spectrometer to collect the selected data set. ADAPT-NMR extracts peak positions from the newly collected data and uses this information in updating the analysis resonance assignments and secondary structure. The goal-directed objective function then defines the next data collection step. The procedure continues until the collected data support comprehensive peak identification, resonance assignments at the desired level of completeness, and protein secondary structure. We present test cases in which ADAPT-NMR achieved results in two days or less that would have taken two months or more by manual approaches.	[Bahrami, Arash; Tonelli, Marco; Singarapu, Kiran K.; Markley, John L.] Univ Wisconsin, Dept Biochem, Natl Magnet Resonance Facil Madison, Madison, WI 53705 USA; [Sahu, Sarata C.; Markley, John L.] Univ Wisconsin, Ctr Eukaryot Struct Genom, Madison, WI 53705 USA; [Eghbalnia, Hamid R.] Univ Cincinnati, Dept Mol & Cellular Physiol, Cincinnati, OH USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University System of Ohio; University of Cincinnati	Bahrami, A (corresponding author), Univ Wisconsin, Dept Biochem, Natl Magnet Resonance Facil Madison, 420 Henry Mall, Madison, WI 53705 USA.	markley@nmrfam.wisc.edu	Singarapu, Kiran/AAU-3435-2020		National Institutes of Health, National Center for Research Resources [P41 RR02301, 3P41RR02301-25S1]; National Institutes of Health, National Institute of General Medical Sciences [1U54 GM74901]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074901] Funding Source: NIH RePORTER	National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding provided by National Institutes of Health, National Center for Research Resources: P41 RR02301 and 3P41RR02301-25S1 National Institutes of Health, National Institute of General Medical Sciences: 1U54 GM74901. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahrami A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000307; Bardiaux B, 2012, METHODS MOL BIOL, V831, P453, DOI 10.1007/978-1-61779-480-3_23; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Eghbalnia HR, 2005, J AM CHEM SOC, V127, P12528, DOI 10.1021/ja052120I; Eghbalnia HR, 2005, J BIOMOL NMR, V32, P219, DOI 10.1007/s10858-005-7944-6; Fiorito F, 2008, J BIOMOL NMR, V42, P23, DOI 10.1007/s10858-008-9259-x; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Huang C, 1996, INT J APPROX REASON, V15, P225, DOI 10.1016/S0888-613X(96)00069-2; Loeliger HA, 2004, IEEE SIGNAL PROC MAG, V21, P28, DOI 10.1109/MSP.2004.1267047; Lopez-Mendez B, 2006, J AM CHEM SOC, V128, P13112, DOI 10.1021/ja061136l; Mooij JM, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/11/P11012; Moseley HNB, 2001, METHOD ENZYMOL, V339, P91, DOI 10.1016/S0076-6879(01)39311-4; Platt JC, 2000, ADV NEUR IN, P61; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105; Singarapu KK, 2011, J BIOL CHEM, V286, P43447, DOI 10.1074/jbc.M111.306464; Singarapu KK, 2010, J BIOL CHEM, V285, P17046, DOI 10.1074/jbc.M110.101154; Smyth P, 1997, PATTERN RECOGN LETT, V18, P1261, DOI 10.1016/S0167-8655(97)01050-7; Tatikonda S. C., 2002, P 18 C UNC ART INT, P493; Volk J, 2008, J BIOMOL NMR, V41, P127, DOI 10.1007/s10858-008-9243-5; Yedidia JS, 2005, IEEE T INFORM THEORY, V51, P2282, DOI 10.1109/TIT.2005.850085; Zhao Q, 2005, BIOCHEM BIOPH RES CO, V335, P256, DOI 10.1016/j.bbrc.2005.07.049	24	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33173	10.1371/journal.pone.0033173	http://dx.doi.org/10.1371/journal.pone.0033173			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427982	Green Published, gold, Green Submitted			2022-12-25	WOS:000302381500107
J	Javurkova, V; Sizling, AL; Kreisinger, J; Albrecht, T				Javurkova, Veronika; Sizling, Arnost Leos; Kreisinger, Jakub; Albrecht, Tomas			An Alternative Theoretical Approach to Escape Decision-Making: The Role of Visual Cues	PLOS ONE			English	Article							FLIGHT-INITIATION DISTANCE; RISK-ASSESSMENT; PREDATOR AVOIDANCE; DABBLING DUCKS; FIDDLER-CRABS; BEHAVIOR; SENSITIVITY; VIGILANCE; STARLINGS; BIRDS	Escape enables prey to avoid an approaching predator. The escape decision-making process has traditionally been interpreted using theoretical models that consider ultimate explanations based on the cost/benefit paradigm. Ultimate approaches, however, suffer from inseparable extra-assumptions due to an inability to accurately parameterize the model's variables and their interactive relationships. In this study, we propose a mathematical model that uses intensity of predator-mediated visual stimuli as a basic cue for the escape response. We consider looming stimuli (i.e. expanding retinal image of the moving predator) as a cue to flight initiation distance (FID; distance at which escape begins) of incubating Mallards (Anas platyrhynchos). We then examine the relationship between FID, vegetation cover and directness of predator trajectory, and fit the resultant model to experimental data. As predicted by the model, vegetation concealment and directness of predator trajectory interact, with FID decreasing with increased concealment during a direct approach toward prey, but not during a tangential approach. Thus, we show that a simple proximate expectation, which involves only visual processing of a moving predator, may explain interactive effects of environmental and predator-induced variables on an escape response. We assume that our proximate approach, which offers a plausible and parsimonious explanation for variation in FID, may serve as an evolutionary background for traditional, ultimate explanations and should be incorporated into interpretation of escape behavior.	[Javurkova, Veronika; Kreisinger, Jakub; Albrecht, Tomas] Charles Univ Prague, Dept Zool, Biodivers Res Grp, Prague, Czech Republic; [Sizling, Arnost Leos] Charles Univ Prague, Ctr Theoret Study, Prague, Czech Republic; [Sizling, Arnost Leos] Acad Sci Czech Republic, Prague, Czech Republic; [Albrecht, Tomas] Acad Sci Czech Republic, Inst Vertebrate Biol, Brno, Czech Republic	Charles University Prague; Charles University Prague; Czech Academy of Sciences; Czech Academy of Sciences; Institute of Vertebrate Biology of the Czech Academy of Sciences	Javurkova, V (corresponding author), Charles Univ Prague, Dept Zool, Biodivers Res Grp, Prague, Czech Republic.	veronika.javurkova@gmail.com	Kreisinger, Jakub/H-4020-2011; Sizling, Arnost/H-3660-2017; Albrecht, Tomas/A-1130-2011; Javůrková, Veronika Gvoždíková/C-5254-2012	Sizling, Arnost/0000-0002-3543-2976; Javůrková, Veronika Gvoždíková/0000-0002-9914-0905; Albrecht, Tomas/0000-0002-9213-0034	Grant Agency of Charles University [181/2005/B-Bio, 151607/2007/B-Bio, 147610/2010/B-Bio]; Ministry of Culture [MSMT 0021620828, 261215/2010, MSMT 0021620845, AV0Z60930519, KJB 601110803, SVV-2012-265 206, VaV SP/2D3/60/08]; Research Centrum project [LC06073]	Grant Agency of Charles University; Ministry of Culture; Research Centrum project	This study was supported by the Grant Agency of Charles University (projects 181/2005/B-Bio, 151607/2007/B-Bio, 147610/2010/B-Bio). The authors are also grateful to the Ministry of Education, Youth and Sport of the Czech Republic, the Academy of Sciences of the Czech Republic, the Ministry of Environment of the Czech Republic, the Czech Ministry of Education MSM002162084, and The Ministry of Culture whose grants MSMT 0021620828 and 261215/2010, MSMT 0021620845, AV0Z60930519, KJB 601110803, SVV-2012-265 206, and VaV SP/2D3/60/08 formed a framework for a part of this study. TA and JK were partially supported by the Research Centrum project LC06073. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht T, 2004, ETHOLOGY, V110, P603, DOI 10.1111/j.1439-0310.2004.00992.x; Blackwell BF, 2009, ANIM BEHAV, V77, P673, DOI 10.1016/j.anbehav.2008.11.017; Blumstein DT, 2003, J WILDLIFE MANAGE, V67, P852, DOI 10.2307/3802692; Boyer JS, 2006, AUST J ZOOL, V54, P363, DOI 10.1071/ZO05080; Broom M, 2005, BEHAV ECOL, V16, P534, DOI 10.1093/beheco/ari024; BURGER J, 1981, J COMP PHYSIOL PSYCH, V95, P676, DOI 10.1037/h0077811; Castellano S, 2011, J THEOR BIOL, V274, P161, DOI 10.1016/j.jtbi.2011.01.001; Cooper WE, 2003, CAN J ZOOL, V81, P979, DOI 10.1139/Z03-079; Cooper WE, 2003, BEHAV ECOL, V14, P288, DOI 10.1093/beheco/14.2.288; Cooper WE, 2007, J THEOR BIOL, V244, P59, DOI 10.1016/j.jtbi.2006.07.011; Cooper WE, 2010, BEHAV ECOL, V21, P91, DOI 10.1093/beheco/arp151; Cooper WE, 2009, BEHAV ECOL, V20, P665, DOI 10.1093/beheco/arp049; Cronin Thomas W., 2005, P105; Cuadrado M, 2001, BIOL J LINN SOC, V72, P547, DOI 10.1111/j.1095-8312.2001.tb01337.x; Devereux CL, 2006, BEHAV ECOL, V17, P303, DOI 10.1093/beheco/arj032; DILL LM, 1974, ANIM BEHAV, V22, P711, DOI 10.1016/S0003-3472(74)80022-9; Domenici P, 2010, J EXP ZOOL PART A, V313A, P59, DOI 10.1002/jez.580; Dukas R, 2001, BEHAV ECOL, V12, P192, DOI 10.1093/beheco/12.2.192; Dukas Reuven, 1998, P89; FEYERABEND PK, 1988, PHILOS SOC SCI, V18, P157, DOI 10.1177/004839318801800201; Fleishman LJ, 2010, P ROY SOC B-BIOL SCI, V277, P3547, DOI 10.1098/rspb.2010.0742; FLEISHMAN LJ, 1992, AM NAT, V139, P36; Fotowat H, 2007, J NEUROSCI, V27, P10047, DOI 10.1523/JNEUROSCI.1515-07.2007; Giske J, 2003, EVOL ECOL RES, V5, P835; GLANTZ RM, 1974, J COMP PHYSIOL, V95, P297, DOI 10.1007/BF00609703; Guillemain M, 2002, FUNCT ECOL, V16, P522, DOI 10.1046/j.1365-2435.2002.00652.x; Guillemain M, 2001, J AVIAN BIOL, V32, P345, DOI 10.1111/j.0908-8857.2001.320409.x; HAMPTON RR, 1994, BEHAVIOUR, V130, P41, DOI 10.1163/156853994X00136; Hemmi JM, 2010, J EXP BIOL, V213, P1484, DOI 10.1242/jeb.039925; Hemmi JM, 2005, ANIM BEHAV, V69, P615, DOI 10.1016/j.anbehav.2004.06.019; Hutchinson JMC, 2005, BEHAV PROCESS, V69, P97, DOI 10.1016/j.beproc.2005.02.019; Jablonski PG, 2000, BRAIN BEHAV EVOLUT, V56, P94, DOI 10.1159/000006680; Javurkova V, 2011, ETHOLOGY, V117, P345, DOI 10.1111/j.1439-0310.2011.01878.x; Kacelnik A, 1998, J THEOR BIOL, V194, P289, DOI 10.1006/jtbi.1998.0763; Kacelnik A, 1996, AM ZOOL, V36, P402; LAZARUS J, 1992, ANIM BEHAV, V43, P519, DOI 10.1016/S0003-3472(05)80110-1; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Liu RF, 2008, BRAIN BEHAV EVOLUT, V72, P37, DOI 10.1159/000145716; Llusia D, 2010, ETHOLOGY, V116, P1146, DOI 10.1111/j.1439-0310.2010.01832.x; Louapre P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014251; Marsh B, 2002, P NATL ACAD SCI USA, V99, P3352, DOI 10.1073/pnas.042491999; Moller AP, 2010, ETHOLOGY, V116, P458, DOI 10.1111/j.1439-0310.2010.01754.x; MONTGOMERIE RD, 1988, Q REV BIOL, V63, P167, DOI 10.1086/415838; NALBACH HO, 1990, ADV LIF SCI, P165; Noesselt T, 2010, J NEUROSCI, V30, P13609, DOI 10.1523/JNEUROSCI.4524-09.2010; Oliva D, 2007, J EXP BIOL, V210, P865, DOI 10.1242/jeb.02707; Omlin M, 1999, ECOL MODEL, V115, P45, DOI 10.1016/S0304-3800(98)00174-4; Paglianti A, 2006, J FISH BIOL, V68, P1177, DOI 10.1111/j.0022-1112.2006.00991.x; Phelps SM, 2007, PHILOS T R SOC B, V362, P355, DOI 10.1098/rstb.2006.1963; Preuss T, 2006, J NEUROSCI, V26, P3454, DOI 10.1523/JNEUROSCI.5259-05.2006; Quinn JL, 2005, ANIM BEHAV, V69, P1285, DOI 10.1016/j.anbehav.2004.10.007; Rattenborg NC, 1999, NATURE, V397, P397, DOI 10.1038/17037; REBOREDA JC, 1991, BEHAV ECOL, V2, P301, DOI 10.1093/beheco/2.4.301; REGAN D, 1995, VISION RES, V35, P1845, DOI 10.1016/0042-6989(94)00274-P; Santer RD, 2006, J NEUROPHYSIOL, V95, P3391, DOI 10.1152/jn.00024.2006; Smith ME, 2001, BEHAV ECOL SOCIOBIOL, V51, P101, DOI 10.1007/s002650100415; Smolka J, 2011, P ROY SOC B-BIOL SCI, V278, P3584, DOI 10.1098/rspb.2010.2746; Stankowich T, 2005, P ROY SOC B-BIOL SCI, V272, P2627, DOI 10.1098/rspb.2005.3251; Stankowich T, 2006, BEHAV ECOL, V17, P246, DOI 10.1093/beheco/arj020; Tisdale V, 2009, BEHAV ECOL, V20, P936, DOI 10.1093/beheco/arp080; Vitasek E., 1987, NUMERICKE METODY; WELLER MILTON W., 1956, JOUR WILDLIFE MANAGEMENT, V20, P111, DOI 10.2307/3797414; Yamamoto K, 2003, BRAIN BEHAV EVOLUT, V62, P201, DOI 10.1159/000073272; YDENBERG RC, 1986, ADV STUD BEHAV, V16, P229, DOI 10.1016/S0065-3454(08)60192-8	64	11	11	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e32522	10.1371/journal.pone.0032522	http://dx.doi.org/10.1371/journal.pone.0032522			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427851	Green Published, Green Submitted, gold			2022-12-25	WOS:000302381500026
J	Toriseva, M; Ala-Aho, R; Peltonen, S; Peltonen, J; Grenman, R; Kahari, VM				Toriseva, Mervi; Ala-aho, Risto; Peltonen, Sirkku; Peltonen, Juha; Grenman, Reidar; Kahari, Veli-Matti			Keratinocyte Growth Factor Induces Gene Expression Signature Associated with Suppression of Malignant Phenotype of Cutaneous Squamous Carcinoma Cells	PLOS ONE			English	Article							FACTOR BINDING PROTEIN-3; COLLAGENASE-3 MMP-13 EXPRESSION; FACTOR RECEPTOR; IN-VIVO; HUMAN SKIN; MATRIX METALLOPROTEINASES; HEPATOCELLULAR-CARCINOMA; ENHANCED EXPRESSION; PANCREATIC-CANCER; LUNG-CANCER	Keratinocyte growth factor (KGF, fibroblast growth factor-7) is a fibroblast-derived mitogen, which stimulates proliferation of epithelial cells. The expression of KGF by dermal fibroblasts is induced following injury and it promotes wound repair. However, the role of KGF in cutaneous carcinogenesis and cancer progression is not known. We have examined the role of KGF in progression of squamous cell carcinoma (SCC) of the skin. The expression of KGF receptor (KGFR) mRNA was lower in cutaneous SCCs (n = 6) than in normal skin samples (n = 6). Expression of KGFR mRNA was detected in 6 out of 8 cutaneous SCC cell lines and the levels were downregulated by 24-h treatment with KGF. KGF did not stimulate SCC cell proliferation, but it reduced invasion of SCC cells through collagen. Gene expression profiling of three cutaneous SCC cell lines treated with KGF for 24 h revealed a specific gene expression signature characterized by upregulation of a set of genes specifically downregulated in SCC cells compared to normal epidermal keratinocytes, including genes with tumor suppressing properties (SPRY4, DUSP4, DUSP6, LRIG1, PHLDA1). KGF also induced downregulation of a set of genes specifically upregulated in SCC cells compared to normal keratinocytes, including genes associated with tumor progression (MMP13, MATN2, CXCL10, and IGFBP3). Downregulation of MMP-13 and KGFR expression in SCC cells and HaCaT cells was mediated via ERK1/2. Activation of ERK1/2 in HaCaT cells and tumorigenic Ha-ras-transformed HaCaT cells resulted in downregulation of MMP-13 and KGFR expression. These results provide evidence, that KGF does not promote progression of cutaneous SCC, but rather suppresses the malignant phenotype of cutaneous SCC cells by regulating the expression of several genes differentially expressed in SCC cells, as compared to normal keratinocytes.	[Toriseva, Mervi; Ala-aho, Risto; Peltonen, Sirkku; Kahari, Veli-Matti] Univ Turku, Turku Univ Hosp, Dept Dermatol, Turku, Finland; [Toriseva, Mervi; Ala-aho, Risto; Kahari, Veli-Matti] Univ Turku, MediCity Res Lab, Turku, Finland; [Toriseva, Mervi] Turku Grad Sch Biomed Sci, Turku, Finland; [Peltonen, Juha] Univ Turku, Dept Cell Biol & Anat, Turku, Finland; [Grenman, Reidar] Turku Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, FIN-20520 Turku, Finland	University of Turku; University of Turku; University of Turku; University of Turku; University of Turku	Toriseva, M (corresponding author), Univ Turku, Turku Univ Hosp, Dept Dermatol, Turku, Finland.	veli-matti.kahari@utu.fi	Peltonen, Sirkku/C-3133-2008; Kahari, Veli-Matti/T-4925-2019; Peltonen, Juha TK/C-2817-2008; Peltonen, Juha/O-7159-2019; Kähäri, Veli-Matti/E-5144-2011	Peltonen, Sirkku/0000-0003-0990-1430; Kahari, Veli-Matti/0000-0003-2421-9368; Peltonen, Juha TK/0000-0002-5732-4167; Peltonen, Juha/0000-0002-5732-4167; Kähäri, Veli-Matti/0000-0003-2421-9368; Toriseva, Mervi/0000-0003-3024-6282	Academy of Finland [114409, 130224, 137687]; Turku University Hospital [13336]; Sigrid Juselius Foundation; Cancer Research Foundation of Finland; Orion-Farmos Research Foundation; K. Albin Johansson's Foundation; Southwestern Finnish Cancer Foundation; Maud Kuistila Memory Foundation; Paulo Foundation; Finnish Cultural Foundation; Cancer Foundation Finland sr [100104, 110087] Funding Source: researchfish	Academy of Finland(Academy of Finland); Turku University Hospital; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Cancer Research Foundation of Finland; Orion-Farmos Research Foundation; K. Albin Johansson's Foundation; Southwestern Finnish Cancer Foundation; Maud Kuistila Memory Foundation; Paulo Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Cancer Foundation Finland sr	This work was supported by grants from the Academy of Finland (projects 114409, 130224 and 137687), Turku University Hospital (project 13336), the Sigrid Juselius Foundation, the Cancer Research Foundation of Finland, by personal grants (to MT) from Orion-Farmos Research Foundation, K. Albin Johansson's Foundation, Southwestern Finnish Cancer Foundation, Maud Kuistila Memory Foundation, Paulo Foundation and Finnish Cultural Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ala-aho R, 2000, ONCOGENE, V19, P248, DOI 10.1038/sj.onc.1203306; Ala-aho R, 2004, ONCOGENE, V23, P5111, DOI 10.1038/sj.onc.1207678; Alam M, 2001, NEW ENGL J MED, V344, P975, DOI 10.1056/NEJM200103293441306; Amann T, 2010, AM J PATHOL, V176, P1433, DOI 10.2353/ajpath.2010.090356; Andreadis ST, 2001, FASEB J, V15, P898, DOI 10.1096/fj.00-0324com; Bodnar RJ, 2009, J CELL SCI, V122, P2064, DOI 10.1242/jcs.048793; BOUKAMP P, 1990, CANCER RES, V50, P2840; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Brake R, 2008, MOL CANCER RES, V6, P1337, DOI 10.1158/1541-7786.MCR-07-2131; BRAUCHLE M, 1994, ONCOGENE, V9, P3199; CHEDID M, 1994, J BIOL CHEM, V269, P10753; Chen P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006565; Cho K, 2007, AM J PATHOL, V170, P1964, DOI 10.2353/ajpath.2007.060935; deMedina SGD, 1997, ONCOGENE, V14, P323, DOI 10.1038/sj.onc.1200830; Ekerot M, 2008, BIOCHEM J, V412, P287, DOI 10.1042/BJ20071512; Escamez MJ, 2008, J INVEST DERMATOL, V128, P1565, DOI 10.1038/sj.jid.5701217; Feng SJ, 1997, CANCER RES, V57, P5369; Finch PW, 2006, JNCI-J NATL CANCER I, V98, P812, DOI 10.1093/jnci/djj228; FINCH PW, 1989, SCIENCE, V245, P752, DOI 10.1126/science.2475908; Foschi M, 1997, EMBO J, V16, P6439, DOI 10.1093/emboj/16.21.6439; Furukawa T, 2003, AM J PATHOL, V162, P1807, DOI 10.1016/S0002-9440(10)64315-5; Geer DJ, 2005, AM J PATHOL, V167, P1575, DOI 10.1016/S0002-9440(10)61242-4; Goldoni S, 2007, ONCOGENE, V26, P368, DOI 10.1038/sj.onc.1209803; Grose R, 2007, EMBO J, V26, P1268, DOI 10.1038/sj.emboj.7601583; IMAI K, 1995, J BIOL CHEM, V270, P6691, DOI 10.1074/jbc.270.12.6691; Impola U, 2005, BRIT J DERMATOL, V152, P720, DOI 10.1111/j.1365-2133.2005.06447.x; Jameson J, 2002, SCIENCE, V296, P747, DOI 10.1126/science.1069639; Jogie-Brahim S, 2009, ENDOCR REV, V30, P417, DOI 10.1210/er.2008-0028; Johansson N, 2000, J CELL SCI, V113, P227; Junttila MR, 2007, ONCOGENE, V26, P5267, DOI 10.1038/sj.onc.1210332; Kainuma K, 2006, ACTA OTO-LARYNGOL, V126, P967, DOI 10.1080/00016480500546367; Kim JH, 2010, ONCOL REP, V23, P989, DOI 10.3892/or_00000724; Kivisaari AK, 2008, BRIT J DERMATOL, V158, P778, DOI 10.1111/j.1365-2133.2008.08466.x; Kivisaari AK, 2010, BRIT J DERMATOL, V163, P726, DOI 10.1111/j.1365-2133.2010.09924.x; Knauper V, 1996, J BIOL CHEM, V271, P1544, DOI 10.1074/jbc.271.3.1544; Lederle W, 2010, CARCINOGENESIS, V31, P1175, DOI 10.1093/carcin/bgp248; Leivonen SK, 2002, J BIOL CHEM, V277, P46338, DOI 10.1074/jbc.M206535200; Madan V, 2010, LANCET, V375, P673, DOI 10.1016/S0140-6736(09)61196-X; MARCHESE C, 1995, J EXP MED, V182, P1369, DOI 10.1084/jem.182.5.1369; Marti G, 2004, GENE THER, V11, P1780, DOI 10.1038/sj.gt.3302383; Mates L, 2002, MATRIX BIOL, V21, P163, DOI 10.1016/S0945-053X(01)00194-9; Mehta PB, 2001, ONCOGENE, V20, P5359, DOI 10.1038/sj.onc.1204688; MIKI T, 1992, P NATL ACAD SCI USA, V89, P246, DOI 10.1073/pnas.89.1.246; Mitsui Y, 2006, CANCER RES, V66, P9913, DOI 10.1158/0008-5472.CAN-06-0377; Muda M, 1996, J BIOL CHEM, V271, P27205, DOI 10.1074/jbc.271.44.27205; Mueller MM, 2001, AM J PATHOL, V159, P1567, DOI 10.1016/S0002-9440(10)62541-2; Neef R, 2002, CANCER RES, V62, P5920; Ning SC, 1998, INT J RADIAT ONCOL, V40, P177, DOI 10.1016/S0360-3016(97)00561-0; Niu JG, 2007, J BIOL CHEM, V282, P6001, DOI 10.1074/jbc.M606878200; Noe V, 2001, J CELL SCI, V114, P111; Ozaki K, 2005, J CELL SCI, V118, P5861, DOI 10.1242/jcs.02711; Piecha D, 2002, J INVEST DERMATOL, V119, P38, DOI 10.1046/j.1523-1747.2002.01789.x; Piecha D, 2002, BIOCHEM J, V367, P715, DOI 10.1042/BJ20021069; Pradervand S, 2008, BIOTECHNIQUES, V44, P759, DOI 10.2144/000112751; Remy L, 2006, CANCER RES, V66, P11228, DOI 10.1158/0008-5472.CAN-06-1187; Ricol D, 1999, ONCOGENE, V18, P7234, DOI 10.1038/sj.onc.1203186; Rotolo S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002528; Schilling D, 2001, ONCOGENE, V20, P7992, DOI 10.1038/sj.onc.1204965; Sieben NLG, 2005, J CLIN ONCOL, V23, P7257, DOI 10.1200/JCO.2005.02.2541; Szabo E, 2008, PATHOL ONCOL RES, V14, P15, DOI 10.1007/s12253-008-9005-4; Tennis MA, 2010, MOL CANCER RES, V8, P833, DOI 10.1158/1541-7786.MCR-09-0400; Toriseva MJ, 2007, J INVEST DERMATOL, V127, P49, DOI 10.1038/sj.jid.5700500; Uzan B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004734; Vaalamo M, 1997, J INVEST DERMATOL, V109, P96, DOI 10.1111/1523-1747.ep12276722; WERNER S, 1994, SCIENCE, V266, P819, DOI 10.1126/science.7973639; WILKINSON GWG, 1992, NUCLEIC ACIDS RES, V20, P2233, DOI 10.1093/nar/20.9.2233; Yamayoshi T, 2004, J PATHOL, V204, P110, DOI 10.1002/path.1617; Yoshino M, 2007, INT J ONCOL, V31, P721; Zeigler ME, 1999, J CELL PHYSIOL, V180, P271; Zhong LP, 2008, ONCOL REP, V20, P1441, DOI 10.3892/or_00000164; Zipin-Roitman A, 2007, CANCER RES, V67, P3396, DOI 10.1158/0008-5472.CAN-06-3087	71	21	23	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33041	10.1371/journal.pone.0033041	http://dx.doi.org/10.1371/journal.pone.0033041			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427941	Green Published, gold, Green Submitted			2022-12-25	WOS:000302381500083
J	Williams, PH; An, JD; Brown, MJF; Carolan, JC; Goulson, D; Huang, JX; Ito, M				Williams, Paul H.; An, Jiandong; Brown, Mark J. F.; Carolan, James C.; Goulson, Dave; Huang, Jiaxing; Ito, Masao			Cryptic Bumblebee Species: Consequences for Conservation and the Trade in Greenhouse Pollinators	PLOS ONE			English	Article							TERRESTRIS L. HYMENOPTERA; MITOCHONDRIAL-DNA MARKERS; SENSU-STRICTO; BOMBUS; APIDAE; BEHAVIOR; COMPLEX; DIVERSITY; INFERENCE; BARCODES	Commercial greenhouse growers in both Japan and China are increasingly using reared orange-tailed bumblebees known previously as Bombus hypocrita Perez as pollinators. Phylogenetic analysis of the DNA (COI) barcodes with Bayesian methods shows that this "species" is a long-standing confusion of two cryptic species. We find that the orange-tailed bumblebees in North China are actually part of the widespread Russian (otherwise white-tailed) B. patagiatus Nylander (as B. patagiatus ganjsuensis Skorikov, n. comb.), whereas the orange-tailed bees in Japan are true B. hypocrita. This situation has been further complicated because two other cryptic species from North China that were previously confused with the Russian B. patagiatus are now recognised as separate: B. lantschouensis Vogt n. stat. and B. minshanensis Bischoff n. stat.. As demand for pollination services by greenhouse growers inevitably increases, these bees are more likely to be transported between countries. In order to conserve genetic resources of pollinator species for their option value for future food security, we advocate preventing trade and movement of B. patagiatus from China into Japan and of B. hypocrita from Japan into China.	[Williams, Paul H.] Nat Hist Museum, Dept Entomol, London SW7 5BD, England; [An, Jiandong; Huang, Jiaxing] Chinese Acad Agr Sci, Inst Apiculture, Beijing 100193, Peoples R China; [Brown, Mark J. F.] Royal Holloway Univ London, Sch Biol Sci, Egham, Surrey, England; [Brown, Mark J. F.; Carolan, James C.] Trinity Coll Dublin, Sch Nat Sci, Dept Zool, Dublin, Ireland; [Carolan, James C.] Natl Univ Ireland, Dept Biol, Maynooth, Kildare, Ireland; [Goulson, Dave] Univ Stirling, Stirling FK9 4LA, Scotland	Natural History Museum London; Chinese Academy of Agricultural Sciences; Institute of Apicultural Research, CAAS; University of London; Royal Holloway University London; Trinity College Dublin; Maynooth University; University of Stirling	Williams, PH (corresponding author), Nat Hist Museum, Dept Entomol, Cromwell Rd, London SW7 5BD, England.	paw@nhm.ac.uk	Goulson, David/A-2462-2010	Goulson, David/0000-0003-4421-2876; Carolan, James/0000-0001-5092-674X	UK Research Council; Science Foundation Ireland; National Natural Science Foundation of China [30901055]; China National 948 Project [2011-S1]; Special Fund for Agro-scientific Research in the Public Interest [201203080]; China Agriculture Research System [CARS-45]	UK Research Council; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China National 948 Project; Special Fund for Agro-scientific Research in the Public Interest; China Agriculture Research System	Financial support provided by the UK Research Councils' SynTax programme, Science Foundation Ireland grant, the National Natural Science Foundation of China (30901055), the China National 948 Project (2011-S1), the Special Fund for Agro-scientific Research in the Public Interest (201203080), and the China Agriculture Research System (CARS-45). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An Jian-dong, 2010, Yingyong Shengtai Xuebao, V21, P1542; ARRETZ PV, 1986, BEE WORLD, V67, P15, DOI 10.1080/0005772X.1986.11098855; Asada S, 1996, APPL ENTOMOL ZOOL, V31, P581, DOI 10.1303/aez.31.581; Baker AJ, 2009, MOL ECOL RESOUR, V9, P257, DOI 10.1111/j.1755-0998.2009.02650.x; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Bertsch A, 2005, INSECT SOC, V52, P45, DOI 10.1007/s00040-004-0761-1; Bertsch Andreas, 2004, Beitraege zur Entomologie, V54, P365; Bertsch Andreas, 2010, Beitraege zur Entomologie, V60, P471; BISCHOFF H., 1936, ARKHIV ZOOL [STOCKHOLM], V27A, P1; Brower AVZ, 2006, SYST BIODIVERS, V4, P127, DOI 10.1017/S147720000500191X; Cameron SA, 2007, BIOL J LINN SOC, V91, P161, DOI 10.1111/j.1095-8312.2007.00784.x; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Carolan JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029251; Chen Wen-feng, 2011, Shengtaixue Zazhi, V30, P290; Dias B, 1999, REC WORKSH CONS SUST, DOI DOI 10.1093/SYSBI0/33.1.69; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Goulson Dave, 2010, P415; Goulson D, 2010, APPL ENTOMOL ZOOL, V45, P7, DOI 10.1303/aez.2010.7; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; *ICZN, 1999, INT COD ZOOL NOM; Inoue MN, 2008, J INSECT CONSERV, V12, P135, DOI 10.1007/s10841-007-9071-z; ITO M, 1980, Low Temperature Science Series B Biological Sciences, V38, P23; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kruger E., 1958, Tijdschrift voor Entomologie Amsterdam, V101, P283; Macfarlane R. P., 1995, New Zealand Entomologist, V18, P29; Matsumura Chizuru, 2004, Global Environmental Research, V8, P51; McNeely JA, GLOBAL STRA IN PRESS; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Molnar JL, 2008, FRONT ECOL ENVIRON, V6, P485, DOI 10.1890/070064; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Mooney HA, 2001, P NATL ACAD SCI USA, V98, P5446, DOI 10.1073/pnas.091093398; Murray TE, 2008, CONSERV GENET, V9, P653, DOI 10.1007/s10592-007-9394-z; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Packer L, 2009, 6 C MES AB NAT U SAN, P178; Pamilo P, 1997, ENTOMOL FENNICA, V7, P187, DOI 10.33338/ef.83908; PAMILO P, 1984, HEREDITAS, V101, P245, DOI 10.1111/j.1601-5223.1984.tb00922.x; Pedersen BV, 2002, INSECT SYST EVOL, V33, P361, DOI 10.1163/187631202X00208; Peng Wen-Jun, 2009, Chinese Bulletin of Entomology, V46, P115; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; RASMONT P, 1984, Spixiana, V7, P135; RASMONT P, 1986, REV SUISSE ZOOL, V93, P661, DOI 10.5962/bhl.part.79505; Rubinoff D, 2006, J HERED, V97, P581, DOI 10.1093/jhered/esl036; Sakagami S. F., 1969, Journal of the Faculty of Science Hokkaido University Zoology (6), V17, P152; SCHOLL A, 1983, APIDOLOGIE, V14, P65, DOI 10.1051/apido:19830201; Skorikov A., 1913, Revue Russe d'Entomologie, V13; Stout JC, 2000, BEE WORLD, V81, P80, DOI 10.1080/0005772X.2000.11099475; Strayer DL, 2006, TRENDS ECOL EVOL, V21, P645, DOI 10.1016/j.tree.2006.07.007; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TKALCU B, 1974, Senckenbergiana Biologica, V55, P311; Tkalcu B, 1967, B SOC ENTOMOLOGIQUE, V1967, P41; TKALCU B., 1962, B SOC ENTOMOLOGIQUE, V1962, P81; Torretta JP, 2006, T AM ENTOMOL SOC, V132, P285; Velthuis HHW, 2006, APIDOLOGIE, V37, P421, DOI 10.1051/apido:2006019; WANG S.-F., 2005, INSECT FAUNA MIDDLE, P890; Waters J, 2011, INSECT CONSERV DIVER, V4, P46, DOI 10.1111/j.1752-4598.2010.00101.x; Williams P.H., 1991, Bulletin of the British Museum (Natural History) Entomology, V60, P1; WILLIAMS P.H., 2000, BWARS NEWSLETTER, V2000, P15; Williams PH, 2011, ZOOL J LINN SOC-LOND, V163, P813, DOI 10.1111/j.1096-3642.2011.00729.x; Williams PH, 2009, APIDOLOGIE, V40, P367, DOI 10.1051/apido/2009025; Williams PH, 2012, SYSTEMATICS IN PRESS, P10; Winter K, 2006, IMPORTATION NONNATIV; Zhao Ya-Zhou, 2011, Acta Entomologica Sinica, V54, P89	64	45	50	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2012	7	3							e32992	10.1371/journal.pone.0032992	http://dx.doi.org/10.1371/journal.pone.0032992			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KX	22427924	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000303062800037
J	Dolezal, D; Jones, CE; Lai, XQ; Brister, JR; Mueser, TC; Nossal, NG; Hinton, DM				Dolezal, Darin; Jones, Charles E.; Lai, Xiaoqin; Brister, J. Rodney; Mueser, Timothy C.; Nossal, Nancy G.; Hinton, Deborah M.			Mutational Analysis of the T4 Gp59 Helicase Loader Reveals Its Sites for Interaction with Helicase, Single-stranded Binding Protein, and DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE 59 PROTEIN; VIROLOGY JOURNAL SERIES; REPLICATION FORK; ASSEMBLY PROTEIN; LOADING PROTEIN; BACTERIOPHAGE-T4 REPLISOME; CRYSTAL-STRUCTURE; PURIFICATION; POLYMERASE; COMPLEX	Efficient DNA replication involves coordinated interactions among DNA polymerase, multiple factors, and the DNA. From bacteriophage T4 to eukaryotes, these factors include a helicase to unwind the DNA ahead of the replication fork, a single-stranded binding protein (SSB) to bind to the ssDNA on the lagging strand, and a helicase loader that associates with the fork, helicase, and SSB. The previously reported structure of the helicase loader in the T4 system, gene product (gp) 59, has revealed an N-terminal domain, which shares structural homology with the high mobility group (HMG) proteins from eukaryotic organisms. Modeling of this structure with fork DNA has suggested that the HMG-like domain could bind to the duplex DNA ahead of the fork, whereas the C-terminal portion of gp59 would provide the docking sites for helicase (T4 gp41), SSB (T4 gp32), and the ssDNA fork arms. To test this model, we have used random and targeted mutagenesis to generate mutations throughout gp59. We have assayed the ability of the mutant proteins to bind to fork, primed fork, and ssDNAs, to interact with SSB, to stimulate helicase activity, and to function in leading and lagging strand DNA synthesis. Our results provide strong biochemical support for the role of the N-terminal gp59 HMG motif in fork binding and the interaction of the C-terminal portion of gp59 with helicase and SSB. Our results also suggest that processive replication may involve the switching of gp59 between its interactions with helicase and SSB.	[Dolezal, Darin; Jones, Charles E.; Lai, Xiaoqin; Brister, J. Rodney; Nossal, Nancy G.; Hinton, Deborah M.] NIDDK, Gene Express & Regulat Sect, Lab Cell & Mol Biol, NIH, Bethesda, MD 20892 USA; [Mueser, Timothy C.] Univ Toledo, Dept Chem, Toledo, OH 43606 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University System of Ohio; University of Toledo	Jones, CE (corresponding author), Bldg 8,Rm 202, Bethesda, MD 20892 USA.	CharlesJ@niddk.nih.gov; dhinton@helix.nih.gov	Hinton, Deborah/AAQ-2596-2021; Jones, Charles/GVS-9497-2022		National Institutes of Health; NIDDK; National Science Foundation [0346960]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK057816] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program, a grant from the NIDDK, and National Science Foundation Career Award 0346960 (to T. C. M.).	Arumugam SR, 2009, J BIOL CHEM, V284, P29283, DOI 10.1074/jbc.M109.029926; BARRY J, 1994, J BIOL CHEM, V269, P33049; Giese K, 1997, P NATL ACAD SCI USA, V94, P12845, DOI 10.1073/pnas.94.24.12845; Hinerman JM, 2012, J BIOL CHEM, V287, P18608, DOI 10.1074/jbc.M111.333476; Ishmael FT, 2003, J BIOL CHEM, V278, P3145, DOI 10.1074/jbc.M209858200; Ishmael FT, 2002, J BIOL CHEM, V277, P20555, DOI 10.1074/jbc.M111951200; Ishmael FT, 2001, J BIOL CHEM, V276, P25236, DOI 10.1074/jbc.M100783200; JENSEN DE, 1976, J BIOL CHEM, V251, P7215; Jones CE, 2004, J BIOL CHEM, V279, P25721, DOI 10.1074/jbc.M402128200; Jones CE, 2004, J BIOL CHEM, V279, P12067, DOI 10.1074/jbc.M313840200; Jones CE, 2001, P NATL ACAD SCI USA, V98, P8312, DOI 10.1073/pnas.121009398; Jones CE, 2000, J BIOL CHEM, V275, P27145; Kreuzer KN, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-358; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Lefebvre SD, 1997, J MOL BIOL, V272, P312, DOI 10.1006/jmbi.1997.1264; Lefebvre SD, 1999, J BIOL CHEM, V274, P22830, DOI 10.1074/jbc.274.32.22830; Li V, 2010, J MOL BIOL, V400, P295, DOI 10.1016/j.jmb.2010.05.030; LOVE JJ, 1995, NATURE, V376, P791, DOI 10.1038/376791a0; MORRICAL SW, 1994, J BIOL CHEM, V269, P33069; Morrical SW, 1996, J BIOL CHEM, V271, P20198, DOI 10.1074/jbc.271.33.20198; Mueser TC, 2000, J MOL BIOL, V296, P597, DOI 10.1006/jmbi.1999.3438; Mueser TC, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-359; Nelson SW, 2009, BIOCHEMISTRY-US, V48, P1036, DOI 10.1021/bi801792q; Nelson SW, 2006, J BIOL CHEM, V281, P8697, DOI 10.1074/jbc.M512185200; Nossal NG, 2007, J BIOL CHEM, V282, P1098, DOI 10.1074/jbc.M606772200; Nossal NG, 1995, METHOD ENZYMOL, V262, P560; Nossal NG, 2001, MOL CELL, V7, P31, DOI 10.1016/S1097-2765(01)00152-6; NOSSAL NG, 1992, FASEB J, V6, P871, DOI 10.1096/fasebj.6.3.1310946; SHAMOO Y, 1995, NATURE, V376, P362, DOI 10.1038/376362a0; SPACCIAPOLI P, 1994, J BIOL CHEM, V269, P447; Spiering MM, 2008, MOL BIOSYST, V4, P1070, DOI 10.1039/b812163j; Subramanian D, 2005, J BIOL CHEM, V280, P42568, DOI 10.1074/jbc.M506348200; TARUMI K, 1995, J BIOL CHEM, V270, P2614, DOI 10.1074/jbc.270.6.2614; Valentine AM, 2001, BIOCHEMISTRY-US, V40, P15074, DOI 10.1021/bi0108554; VENKATESAN M, 1982, J BIOL CHEM, V257, P2426; YONESAKI T, 1994, J BIOL CHEM, V269, P1284	36	1	1	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18596	18607		10.1074/jbc.M111.332080	http://dx.doi.org/10.1074/jbc.M111.332080			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22427673	Green Published, hybrid			2022-12-25	WOS:000306411600070
J	Shajahan, AN; Dobbin, ZC; Hickman, FE; Dakshanamurthy, S; Clarke, R				Shajahan, Ayesha N.; Dobbin, Zachary C.; Hickman, F. Edward; Dakshanamurthy, Sivanesan; Clarke, Robert			Tyrosine-phosphorylated Caveolin-1 (Tyr-14) Increases Sensitivity to Paclitaxel by Inhibiting BCL2 and BCLxL Proteins via c-Jun N-terminal Kinase (JNK)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER; CELL-DEATH; ADJUVANT CHEMOTHERAPY; MEDIATED ENDOCYTOSIS; NH2-TERMINAL KINASE; IN-VIVO; APOPTOSIS; PATHWAY; IDENTIFICATION; TAXOL	Paclitaxel, an anti-microtubule agent, is an effective chemotherapeutic drug in breast cancer. Nonetheless, resistance to paclitaxel remains a major clinical challenge. The need to better understand the resistant phenotype and to find biomarkers that could predict tumor response to paclitaxel is evident. In estrogen receptor alpha-positive (ER+) breast cancer cells, phosphorylation of caveolin-1 (CAV1) on Tyr-14 facilitates mitochondrial apoptosis by increasing BCL2 phosphorylation in response to low dose paclitaxel (10 nM). However, two variants of CAV1 exist: the full-length form, CAV1 alpha (wild-type CAV1 or wtCAV1), and a truncated form, CAV1 beta. Only wtCAV1 has the Tyr-14 region at the N terminus. The precise cellular functions of CAV1 variants are unknown. We now show that CAV1 variants play distinct roles in paclitaxel-mediated cell death/survival. CAV1 beta expression is increased in paclitaxel-resistant cells when compared with sensitive cells. Expression of CAV1 beta in sensitive cells significantly reduces their responsiveness to paclitaxel. These activities reflect an essential role for Tyr-14 phosphorylation because wtCAV1 expression, but not a phosphorylation-deficient mutant (Y14F), inactivates BCL2 and BCLxL through activation of c-Jun N-terminal kinase (JNK). MCF-7 cells that express Y14F are resistant to paclitaxel and are resensitized by co-treatment with ABT-737, a BH3-mimetic small molecule inhibitor. Using structural homology modeling, we propose that phosphorylation on Tyr-14 enables a favorable conformation for proteins to bind to the CAV1 scaffolding domain. Thus, we highlight novel roles for CAV1 variants in cell death; wtCAV1 promotes cell death, whereas CAV1 beta promotes cell survival by preventing inactivation of BCL2 and BCLxL via JNK in paclitaxel-mediated apoptosis.	[Shajahan, Ayesha N.; Dobbin, Zachary C.; Hickman, F. Edward; Dakshanamurthy, Sivanesan; Clarke, Robert] Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20057 USA	Georgetown University	Shajahan, AN (corresponding author), 3970 Reservoir Rd NW,NRB W405B, Washington, DC 20057 USA.	ans33@georgetown.edu	Clarke, Robert/A-6485-2008; Dakshanamurthy, Sivanesan/CAF-4258-2022	Clarke, Robert/0000-0002-9278-0854; Dakshanamurthy, Sivanesan/0000-0003-3681-4121; Shajahan-Haq, Ayesha/0000-0001-7616-320X	National Institutes of Health from USPHS [1P30-CA-51008, U54-CA149147]; Susan G. Komen for the Cure Fellowship [PDF0600477]; American Cancer Society [IRG 92-152-17]; NATIONAL CANCER INSTITUTE [P30CA051008, U54CA149147] Funding Source: NIH RePORTER	National Institutes of Health from USPHS; Susan G. Komen for the Cure Fellowship(Susan G. Komen Breast Cancer Foundation); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr. Michael Johnson (Georgetown University) for helpful discussions and critical review of this manuscript. Technical services were provided by the Flow Cytometry and Cell Sorting, Tissue Culture Core and Microscopy, and Imaging Shared Resources Center, which were funded through National Institutes of Health Award 1P30-CA-51008 from the USPHS (Lombardi Comprehensive Cancer Center Support Grant).; This work was supported, in whole or in part, by National Institutes of Health Grant U54-CA149147 (to R. C.) from the USPHS. This work was also supported by a Susan G. Komen for the Cure Fellowship (PDF0600477) and American Cancer Society Institutional Research Grant IRG 92-152-17 (to A. N. S.).	Ahmed N, 2008, FEBS LETT, V582, P3595, DOI 10.1016/j.febslet.2008.09.029; Amato SF, 1998, CANCER RES, V58, P241; Basu A, 2006, FRONT BIOSCI-LANDMRK, V11, P1508, DOI 10.2741/1900; Basu A, 2003, FEBS LETT, V538, P41, DOI 10.1016/S0014-5793(03)00131-5; Basu A, 2000, INT J ONCOL, V16, P497; Blagosklonny MV, 2001, BIOESSAYS, V23, P947, DOI 10.1002/bies.1135; Boldt S, 2002, CARCINOGENESIS, V23, P1831, DOI 10.1093/carcin/23.11.1831; Bouker KB, 2004, CANCER RES, V64, P4030, DOI 10.1158/0008-5472.CAN-03-3602; Burgermeister E, 2008, CANCER LETT, V268, P187, DOI 10.1016/j.canlet.2008.03.055; Case D, 2006, AMBER 9; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Fang PK, 2006, AM J PATHOL, V169, P2209, DOI 10.2353/ajpath.2006.060562; Fang Y, 2004, BIOCHEM BIOPH RES CO, V323, P269, DOI 10.1016/j.bbrc.2004.08.100; Ferlini C, 2003, MOL PHARMACOL, V64, P51, DOI 10.1124/mol.64.1.51; Goetz JG, 2008, CANCER METAST REV, V27, P715, DOI 10.1007/s10555-008-9160-9; Hanson RN, 2003, J MED CHEM, V46, P2865, DOI 10.1021/jm0205806; Henderson IC, 2003, J CLIN ONCOL, V21, P976, DOI 10.1200/JCO.2003.02.063; Kutuk O, 2008, CANCER RES, V68, P7985, DOI 10.1158/0008-5472.CAN-08-1418; Lee LF, 1998, J BIOL CHEM, V273, P28253, DOI 10.1074/jbc.273.43.28253; Li SW, 1996, J BIOL CHEM, V271, P29182, DOI 10.1074/jbc.271.46.29182; Li SW, 1996, J BIOL CHEM, V271, P3863; Liu PS, 1999, NAT CELL BIOL, V1, P369, DOI 10.1038/14067; Luo D, 2000, BIOCHEM CELL BIOL, V78, P119, DOI 10.1139/bcb-78-2-119; Machleidt T, 2000, J CELL BIOL, V148, P17, DOI 10.1083/jcb.148.1.17; MacKeigan JP, 2000, J BIOL CHEM, V275, P38953, DOI 10.1074/jbc.C000684200; Mamounas EP, 2005, J CLIN ONCOL, V23, P3686, DOI 10.1200/JCO.2005.10.517; McGrogan BT, 2008, BBA-REV CANCER, V1785, P96, DOI 10.1016/j.bbcan.2007.10.004; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Paridaens R, 2000, J CLIN ONCOL, V18, P724, DOI 10.1200/JCO.2000.18.4.724; Patani N, 2012, BREAST CANCER RES TR, V131, P1, DOI 10.1007/s10549-011-1751-4; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Quest AFG, 2008, J CELL MOL MED, V12, P1130, DOI 10.1111/j.1582-4934.2008.00331.x; Romanelli S, 1998, CANCER CHEMOTH PHARM, V41, P385, DOI 10.1007/s002800050755; Savage K, 2007, CLIN CANCER RES, V13, P90, DOI 10.1158/1078-0432.CCR-06-1371; SCHERER PE, 1995, J BIOL CHEM, V270, P16395, DOI 10.1074/jbc.270.27.16395; Seidman R, 2001, EXP CELL RES, V268, P84, DOI 10.1006/excr.2001.5262; Selimovic D, 2008, CELL SIGNAL, V20, P311, DOI 10.1016/j.cellsig.2007.10.015; Shajahan AN, 2004, J BIOL CHEM, V279, P20392, DOI 10.1074/jbc.M308710200; Shajahan AN, 2007, J BIOL CHEM, V282, P5934, DOI 10.1074/jbc.M608857200; Sunters A, 2006, CANCER RES, V66, P212, DOI 10.1158/0008-5472.CAN-05-1997; Sverdlov M, 2007, J CELL MOL MED, V11, P1239, DOI 10.1111/j.1582-4934.2007.00127.x; Tabuchi Y, 2009, INT J ONCOL, V34, P313, DOI 10.3892/ijo_00000153; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469	46	46	49	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17682	17692		10.1074/jbc.M111.304022	http://dx.doi.org/10.1074/jbc.M111.304022			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22433870	Green Published, hybrid			2022-12-25	WOS:000306373000067
J	Lorents, A; Kodavali, PK; Oskolkov, N; Langel, U; Hallbrink, M; Pooga, M				Lorents, Annely; Kodavali, Praveen Kumar; Oskolkov, Nikita; Langel, Uelo; Haellbrink, Mattias; Pooga, Margus			Cell-penetrating Peptides Split into Two Groups Based on Modulation of Intracellular Calcium Concentration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE-REPAIR; ARGININE-RICH PEPTIDES; TAT PEPTIDE; IN-VIVO; ENDOCYTOSIS; EXOCYTOSIS; DELIVERY; MACROPINOCYTOSIS; PROTEINS; CARGO	Cell-penetrating peptides (CPPs) promote the uptake of different cargo molecules, e.g. therapeutic compounds, making the harnessing of CPPs a promising strategy for drug design and delivery. However, the internalization mechanisms of CPPs are still under discussion, and it is not clear how cells compensate the disturbances induced by peptides in the plasma membrane. In this study, we demonstrate that the uptake of various CPPs enhances the intracellular Ca2+ levels in Jurkat and HeLa cells. The elevated Ca2+ concentration in turn triggers plasma membrane blebbing, lysosomal exocytosis, and membrane repair response. Our results indicate that CPPs split into two major classes: (i) amphipathic CPPs that modulate the plasma membrane integrity inducing influx of Ca2+ and activating downstream responses starting from low concentrations; (ii) non-amphipathic CPPs that do not evoke changes at relevant concentrations. Triggering of the membrane repair response may help cells to replace distorted plasma membrane regions and cells can recover from the influx of Ca2+ if its level is not drastically elevated.	[Lorents, Annely; Pooga, Margus] Univ Tartu, Inst Mol & Cell Biol, EE-51010 Tartu, Estonia; [Kodavali, Praveen Kumar; Langel, Uelo; Haellbrink, Mattias] Stockholm Univ, Arrhenius Labs, Dept Neurochem, SE-10691 Stockholm, Sweden; [Oskolkov, Nikita; Langel, Uelo] Univ Tartu, Inst Technol, EE-50411 Tartu, Estonia	University of Tartu; Stockholm University; University of Tartu	Pooga, M (corresponding author), Univ Tartu, Inst Mol & Cell Biol, Riia 23, EE-51010 Tartu, Estonia.	mpooga@ebc.ee	Pooga, Margus/A-8575-2011; Oskolkov, Nikita/AAJ-8377-2020	Pooga, Margus/0000-0003-4532-4087; Langel, Ulo/0000-0001-6107-0844; Lorents, Annely/0000-0002-2823-5202	Estonian Science Foundation (ESF) [7058, 8705]; Estonian Ministry of Education and Research [0180019s11, 0180027s08]; Swedish Research Council (VR-NT); Center for Biomembrane Research (Stockholm, Sweden); Knut and Alice Wallenberg's Foundation; European Union through Center of Excellence in Chemical Biology	Estonian Science Foundation (ESF); Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); Swedish Research Council (VR-NT)(Swedish Research Council); Center for Biomembrane Research (Stockholm, Sweden); Knut and Alice Wallenberg's Foundation(Knut & Alice Wallenberg Foundation); European Union through Center of Excellence in Chemical Biology	This work was supported by grants from the Estonian Science Foundation (ESF 7058 and 8705) and the Estonian Ministry of Education and Research (0180019s11 and 0180027s08).; Supported by the Swedish Research Council (VR-NT); the Center for Biomembrane Research (Stockholm, Sweden); by the Knut and Alice Wallenberg's Foundation; and the European Union through the European Regional Development Fund through the Center of Excellence in Chemical Biology.	Babiychuk EB, 2011, CELL DEATH DIFFER, V18, P80, DOI 10.1038/cdd.2010.81; Babiychuk EB, 2009, CELL DEATH DIFFER, V16, P1126, DOI 10.1038/cdd.2009.30; Barany-Wallje E, 2007, FEBS LETT, V581, P2389, DOI 10.1016/j.febslet.2007.04.046; Bi GQ, 1995, J CELL BIOL, V131, P1747, DOI 10.1083/jcb.131.6.1747; Brakenhoff GJ, 1996, J MICROSC-OXFORD, V183, P140, DOI 10.1046/j.1365-2818.1996.870647.x; Charras G, 2008, NAT REV MOL CELL BIO, V9, P730, DOI 10.1038/nrm2453; Cocucci E, 2007, TRAFFIC, V8, P742, DOI 10.1111/j.1600-0854.2007.00566.x; Duchardt F, 2007, TRAFFIC, V8, P848, DOI 10.1111/j.1600-0854.2007.00572.x; El-Andaloussi S, 2007, BIOCHEM J, V407, P285, DOI 10.1042/BJ20070507; FAWELL S, 1994, P NATL ACAD SCI USA, V91, P664, DOI 10.1073/pnas.91.2.664; Fittipaldi A, 2003, J BIOL CHEM, V278, P34141, DOI 10.1074/jbc.M303045200; Fretz MM, 2007, BIOCHEM J, V403, P335, DOI 10.1042/BJ20061808; Guterstam P, 2009, BBA-BIOMEMBRANES, V1788, P2509, DOI 10.1016/j.bbamem.2009.09.014; Idone V, 2008, J CELL BIOL, V180, P905, DOI 10.1083/jcb.200708010; Jiao CY, 2009, J BIOL CHEM, V284, P33957, DOI 10.1074/jbc.M109.056309; Keefe D, 2005, IMMUNITY, V23, P249, DOI 10.1016/j.immuni.2005.08.001; MALGAROLI A, 1987, J CELL BIOL, V105, P2145, DOI 10.1083/jcb.105.5.2145; McNeil PL, 2000, J CELL SCI, V113, P1891; Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164; Mills JC, 1998, J CELL BIOL, V140, P627, DOI 10.1083/jcb.140.3.627; Mishra A, 2011, P NATL ACAD SCI USA, V108, P16883, DOI 10.1073/pnas.1108795108; Miyake K, 2001, J CELL SCI, V114, P3487; Miyake K, 1995, J CELL BIOL, V131, P1737, DOI 10.1083/jcb.131.6.1737; Myrberg H, 2008, BIOCONJUGATE CHEM, V19, P70, DOI 10.1021/bc0701139; Nakase I, 2004, MOL THER, V10, P1011, DOI 10.1016/j.ymthe.2004.08.010; Nakase I, 2007, BIOCHEMISTRY-US, V46, P492, DOI 10.1021/bi0612824; Ninomiya Y, 1996, J BIOL CHEM, V271, P17751, DOI 10.1074/jbc.271.30.17751; Padari K, 2005, BIOCONJUGATE CHEM, V16, P1399, DOI 10.1021/bc050125z; Padari K, 2010, BIOCONJUGATE CHEM, V21, P774, DOI 10.1021/bc900577e; Palm-Apergi C, 2009, FASEB J, V23, P214, DOI 10.1096/fj.08-110254; Pooga M, 1998, NAT BIOTECHNOL, V16, P857, DOI 10.1038/nbt0998-857; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; Richard JP, 2005, J BIOL CHEM, V280, P15300, DOI 10.1074/jbc.M401604200; ROE MW, 1990, CELL CALCIUM, V11, P63, DOI 10.1016/0143-4160(90)90060-8; Rothbard JB, 2000, NAT MED, V6, P1253, DOI 10.1038/81359; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; SMITH MW, 1991, P NATL ACAD SCI USA, V88, P4926, DOI 10.1073/pnas.88.11.4926; STEINHARDT RA, 1994, SCIENCE, V263, P390, DOI 10.1126/science.7904084; Tam C, 2010, J CELL BIOL, V189, P1027, DOI 10.1083/jcb.201003053; Terasaki M, 1997, J CELL BIOL, V139, P63, DOI 10.1083/jcb.139.1.63; TOKUMITSU T, 1967, J CELL BIOL, V34, P677, DOI 10.1083/jcb.34.2.677; Tunnemann G, 2006, FASEB J, V20, P1775, DOI 10.1096/fj.05-5523com; van Blitterswijk WJ, 2003, BIOCHEM J, V369, P199, DOI 10.1042/BJ20021528; Zha XH, 1998, J CELL BIOL, V140, P39, DOI 10.1083/jcb.140.1.39; Ziegler A, 2008, ADV DRUG DELIVER REV, V60, P580, DOI 10.1016/j.addr.2007.10.005	45	33	35	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16880	16889		10.1074/jbc.M111.318063	http://dx.doi.org/10.1074/jbc.M111.318063			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22437827	hybrid, Green Published			2022-12-25	WOS:000304030900074
J	Chalat, M; Menon, I; Turan, Z; Menon, AK				Chalat, Madhavan; Menon, Indu; Turan, Zeynep; Menon, Anant K.			Reconstitution of Glucosylceramide Flip-Flop across Endoplasmic Reticulum IMPLICATIONS FOR MECHANISM OF GLYCOSPHINGOLIPID BIOSYNTHESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE PROTEINS; TRANSBILAYER MOVEMENT; PHOSPHOLIPID FLIPPASE; DETERGENT EXTRACTS; GOLGI-APPARATUS; YEAST; TRANSLOCATION; LACTOSYLCERAMIDE; IDENTIFICATION; SPHINGOLIPIDS	Most glycosphingolipids are synthesized by the sequential addition of monosaccharides to glucosylceramide (GlcCer) in the lumen of the Golgi apparatus. Because GlcCer is synthesized on the cytoplasmic face of Golgi membranes, it must be flipped to the non-cytoplasmic face by a lipid flippase in order to nucleate glycosphingolipid synthesis. Halter et al. (Halter, D., Neumann, S., van Dijk, S. M., Wolthoorn, J., de Maziere, A. M., Vieira, O. V., Mattjus, P., Klumperman, J., van Meer, G., and Sprong, H. (2007) Pre- and post-Golgi translocation of glucosylceramide in glycosphingolipid synthesis. J. Cell Biol. 179, 101115) proposed that this essential flipping step is accomplished via a complex trafficking itinerary; GlcCer is moved from the cytoplasmic face of the Golgi to the endoplasmic reticulum (ER) by FAPP2, a cytoplasmic lipid transfer protein, flipped across the ER membrane, then delivered to the lumen of the Golgi complex by vesicular transport. We now report biochemical reconstitution studies to analyze GlcCer flipping at the ER. Using proteoliposomes reconstituted from Triton X-100-solubilized rat liver ER membrane proteins, we demonstrate rapid (t(1/2) < 20 s), ATP-independent flip-flop of N-(6-((7-nitro-2-1,3-benzoxadiazol- 4-yl) amino) hexanoyl)-D-glucosyl-beta 1-1'-sphingosine, a fluorescent GlcCer analog. Further studies involving protein modification, biochemical fractionation, and analyses of flip-flop in proteoliposomes reconstituted with ER membrane proteins from yeast indicate that GlcCer translocation is facilitated by well characterized ER phospholipid flippases that remain to be identified at the molecular level. By reason of their abundance and membrane bending activity, we considered that the ER reticulons and the related Yop1 protein could function as phospholipid-GlcCer flippases. Direct tests showed that these proteins have no flippase activity.	[Chalat, Madhavan; Menon, Indu; Turan, Zeynep; Menon, Anant K.] Weill Cornell Med Coll, Dept Biochem, New York, NY 10065 USA	Cornell University	Menon, AK (corresponding author), Weill Cornell Med Coll, Dept Biochem, 1300 York Ave, New York, NY 10065 USA.	akm2003@med.cornell.edu	Menon, Anant/AAN-8663-2021	Menon, Anant/0000-0001-6924-2698; Chalat, Madhavan/0000-0002-6484-4574	National Institutes of Health [GM71041]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071041] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM71041.	BACKER JM, 1987, NATURE, V327, P341, DOI 10.1038/327341a0; BARTLES JR, 1985, J BIOL CHEM, V260, P2792; BISHOP WR, 1985, CELL, V42, P51, DOI 10.1016/S0092-8674(85)80100-8; Burger KNJ, 1996, J CELL BIOL, V133, P15, DOI 10.1083/jcb.133.1.15; Buton X, 2002, BIOCHEMISTRY-US, V41, P13106, DOI 10.1021/bi020385t; Caffaro CE, 2006, ACCOUNTS CHEM RES, V39, P805, DOI 10.1021/ar0400239; Calero M, 2001, J BIOL CHEM, V276, P12100, DOI 10.1074/jbc.M008439200; Chang QL, 2004, BIOCHEMISTRY-US, V43, P10710, DOI 10.1021/bi049063a; De Craene JO, 2006, MOL BIOL CELL, V17, P3009, DOI 10.1091/mbc.e06-01-0080; DePierre J., 1976, BIOCH ANAL MEMBRANES, P79; Devaux PF, 2002, CHEM PHYS LIPIDS, V116, P115, DOI 10.1016/S0009-3084(02)00023-3; Dickson RC, 1999, BBA-MOL CELL BIOL L, V1438, P305, DOI 10.1016/S1388-1981(99)00068-2; Eckford PDW, 2005, BIOCHEM J, V389, P517, DOI 10.1042/BJ20050047; Eskandari S, 1998, P NATL ACAD SCI USA, V95, P11235, DOI 10.1073/pnas.95.19.11235; FUTERMAN AH, 1991, BIOCHEM J, V280, P295, DOI 10.1042/bj2800295; GARVIN JE, 1956, J BIOL CHEM, V221, P211; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gummadi SN, 2002, J BIOL CHEM, V277, P25337, DOI 10.1074/jbc.M203809200; HAKOMORI SI, 1981, ANNU REV BIOCHEM, V50, P733, DOI 10.1146/annurev.bi.50.070181.003505; Halter D, 2007, J CELL BIOL, V179, P101, DOI 10.1083/jcb.200704091; Hrafnsdottir S, 2000, J BACTERIOL, V182, P4198, DOI 10.1128/JB.182.15.4198-4206.2000; Hu JJ, 2008, SCIENCE, V319, P1247, DOI 10.1126/science.1153634; Hu JJ, 2011, CELL, V147, P1226, DOI 10.1016/j.cell.2011.11.022; JECKEL D, 1992, J CELL BIOL, V117, P259, DOI 10.1083/jcb.117.2.259; KREIBICH G, 1978, J CELL BIOL, V77, P464, DOI 10.1083/jcb.77.2.464; LANNERT H, 1994, FEBS LETT, V342, P91, DOI 10.1016/0014-5793(94)80591-1; Lannert H, 1998, J BIOL CHEM, V273, P2939, DOI 10.1074/jbc.273.5.2939; Levine TP, 2007, J CELL BIOL, V179, P11, DOI 10.1083/jcb.200709055; Lingwood CA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004788; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Ma JY, 1996, J BIOL CHEM, V271, P7758, DOI 10.1074/jbc.271.13.7758; MCINTYRE JC, 1991, BIOCHEMISTRY-US, V30, P11819, DOI 10.1021/bi00115a012; Menon AK, 2000, CURR BIOL, V10, P241, DOI 10.1016/S0960-9822(00)00356-0; Menon I, 2011, CURR BIOL, V21, P149, DOI 10.1016/j.cub.2010.12.031; Muller DJ, 2008, PHARMACOL REV, V60, P43, DOI 10.1124/pr.107.07111; Nicolson T, 2000, FEBS LETT, V476, P277, DOI 10.1016/S0014-5793(00)01684-7; Perktold A, 2007, FEMS YEAST RES, V7, P629, DOI 10.1111/j.1567-1364.2007.00226.x; Petrache HI, 2000, BIOPHYS J, V79, P3172, DOI 10.1016/S0006-3495(00)76551-9; QUINN P, 1984, J CELL BIOL, V98, P2142, DOI 10.1083/jcb.98.6.2142; Saito K, 2006, APPL MICROBIOL BIOT, V71, P515, DOI 10.1007/s00253-005-0187-3; Sanyal S, 2008, BIOCHEMISTRY-US, V47, P7937, DOI 10.1021/bi800723n; Sanyal S, 2010, P NATL ACAD SCI USA, V107, P11289, DOI 10.1073/pnas.1002408107; Sanyal S, 2009, P NATL ACAD SCI USA, V106, P767, DOI 10.1073/pnas.0810225106; Sanyat S, 2009, ACS CHEM BIOL, V4, P895, DOI 10.1021/cb900163d; Schulze H, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004804; Stanley P, 2009, ESSENTIALS GLYCOBIOL; VANHEYNINGEN S, 1974, SCIENCE, V183, P656, DOI 10.1126/science.183.4125.656; Vehring S, 2007, EUKARYOT CELL, V6, P1625, DOI 10.1128/EC.00198-07; Vishwakarma RA, 2005, CHEM COMMUN, P453, DOI 10.1039/b413196g; Vishwakarma RA, 2005, ORG BIOMOL CHEM, V3, P1275, DOI 10.1039/b500300h; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Yamashita T, 1999, P NATL ACAD SCI USA, V96, P9142, DOI 10.1073/pnas.96.16.9142	52	29	29	0	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15523	15532		10.1074/jbc.M112.343038	http://dx.doi.org/10.1074/jbc.M112.343038			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22427661	hybrid, Green Published			2022-12-25	WOS:000304006300033
J	Yaneva, N; Schuster, J; Schafer, F; Lede, V; Przybylski, D; Paproth, T; Harms, H; Muller, RH; Rohwerder, T				Yaneva, Nadya; Schuster, Judith; Schaefer, Franziska; Lede, Vera; Przybylski, Denise; Paproth, Torsten; Harms, Hauke; Mueller, Roland H.; Rohwerder, Thore			Bacterial Acyl-CoA Mutase Specifically Catalyzes Coenzyme B-12-dependent Isomerization of 2-Hydroxyisobutyryl-CoA and (S)-3-Hydroxybutyryl-CoA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERT-BUTYL ETHER; GEN. NOV.; A MUTASE; ACID; ENZYME; DEGRADATION; CLONING; BIOSYNTHESIS; METABOLISM; PROTECTION	Coenzyme B-12-dependent acyl-CoA mutases are radical enzymes catalyzing reversible carbon skeleton rearrangements in carboxylic acids. Here, we describe 2-hydroxyisobutyryl-CoA mutase (HCM) found in the bacterium Aquincola tertiaricarbonis as a novel member of the mutase family. HCM specifically catalyzes the interconversion of 2-hydroxyisobutyryl- and (S)-3-hydroxybutyryl-CoA. Like isobutyryl-CoA mutase, HCM consists of a large substrate- and a small B-12-binding subunit, HcmA and HcmB, respectively. However, it is thus far the only acyl-CoA mutase showing substrate specificity for hydroxylated carboxylic acids. Complete loss of 2-hydroxyisobutyric acid degradation capacity in hcmA and hcmB knock-out mutants established the central role of HCM in A. tertiaricarbonis for degrading substrates bearing a tert-butyl moiety, such as the fuel oxygenate methyl tert-butyl ether (MTBE) and its metabolites. Sequence analysis revealed several HCM-like enzymes in other bacterial strains not related to MTBE degradation, indicating that HCM may also be involved in other pathways. In all strains, hcmA and hcmB are associated with genes encoding for a putative acyl-CoA synthetase and a MeaB-like chaperone. Activity and substrate specificity of wild-type enzyme and active site mutants HcmA I90V, I90F, and I90Y clearly demonstrated that HCM belongs to a new subfamily of B-12-dependent acyl-CoA mutases.	[Yaneva, Nadya; Schuster, Judith; Schaefer, Franziska; Lede, Vera; Przybylski, Denise; Paproth, Torsten; Harms, Hauke; Mueller, Roland H.; Rohwerder, Thore] UFZ Helmholtz Ctr Environm Res, Dept Environm Microbiol, D-04318 Leipzig, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Rohwerder, T (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Environm Microbiol, D-04318 Leipzig, Germany.	thore.rohwerder@ufz.de	Harms, Hauke/I-4406-2012; Lede, Vera/C-7258-2014	Harms, Hauke/0000-0002-7316-7341; Lede, Vera/0000-0001-6045-2605; Rohwerder, Thore/0000-0001-7877-8953	Helmholtz Centre for Environmental Research; Evonik Industries	Helmholtz Centre for Environmental Research(Helmholtz Association); Evonik Industries	This work was supported by the Helmholtz Centre for Environmental Research within the Chemicals in the Environment program and by Evonik Industries.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAUER W, 2002, ULLMANNS ENCY IND CH, V21, P585; BIRCH A, 1993, J BACTERIOL, V175, P3511, DOI 10.1128/jb.175.11.3511-3519.1993; Chisholm MS, 2000, J CHEM EDUC, V77, P841, DOI 10.1021/ed077p841; Cracan V, 2012, J BIOL CHEM, V287, P3723, DOI 10.1074/jbc.M111.320051; Cracan V, 2010, J BIOL CHEM, V285, P655, DOI 10.1074/jbc.M109.062182; Dalluge JJ, 2002, ANAL BIOANAL CHEM, V374, P835, DOI 10.1007/s00216-002-1554-x; Erb TJ, 2008, J BIOL CHEM, V283, P32283, DOI 10.1074/jbc.M805527200; Forslund K, 2004, PLANT PHYSIOL, V135, P71, DOI 10.1104/pp.103.038059; HermansLokkerbol A, 1996, J CHROMATOGR A, V752, P123, DOI 10.1016/S0021-9673(96)00526-2; HOLOWACH LP, 1994, ACS SYM SER, V575, P202; Hristova KR, 2007, APPL ENVIRON MICROB, V73, P7347, DOI 10.1128/AEM.01604-07; Kane SR, 2007, J BACTERIOL, V189, P1931, DOI 10.1128/JB.01259-06; Korotkova N, 2004, J BIOL CHEM, V279, P13652, DOI 10.1074/jbc.M312852200; Kumps A, 2002, CLIN CHEM, V48, P708; Lechner U, 2007, INT J SYST EVOL MICR, V57, P1295, DOI 10.1099/ijs.0.64663-0; MOORE BS, 1995, J AM CHEM SOC, V117, P11285, DOI 10.1021/ja00150a028; Moran MJ, 2005, GROUND WATER, V43, P615, DOI 10.1111/j.1745-6584.2005.0113.x; Muller RH, 2008, MICROBIOL-SGM, V154, P1414, DOI 10.1099/mic.0.2007/014159-0; Nakatsu CH, 2006, INT J SYST EVOL MICR, V56, P983, DOI 10.1099/ijs.0.63524-0; PADMAKUMAR R, 1993, ANAL BIOCHEM, V214, P318, DOI 10.1006/abio.1993.1494; Padovani D, 2006, BIOCHEMISTRY-US, V45, P9300, DOI 10.1021/bi0604532; Probian C, 2003, APPL ENVIRON MICROB, V69, P1866, DOI 10.1128/AEM.69.3.1866-1870.2003; Ratnatilleke A, 1999, J BIOL CHEM, V274, P31679, DOI 10.1074/jbc.274.44.31679; REYNOLDS KA, 1988, J CHEM SOC PERK T 1, P3195, DOI 10.1039/p19880003195; ROHWERDER T, 2007, P 3 EUR C MTRF OTH O, P11; ROHWERDER T, 2007, VITAMIN B NEW RES, P81; Rohwerder T, 2006, APPL ENVIRON MICROB, V72, P4128, DOI 10.1128/AEM.00080-06; Rohwerder T, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-13; Schafer F, 2011, APPL ENVIRON MICROB, V77, P5981, DOI 10.1128/AEM.00093-11; Schuster J, 2012, J BACTERIOL, V194, P972, DOI 10.1128/JB.06384-11; SIMON EJ, 1953, J AM CHEM SOC, V75, P2520, DOI 10.1021/ja01106a522; SPRECHER M, 1966, J BIOL CHEM, V241, P872; Starkey RL, 1934, J BACTERIOL, V28, P365, DOI 10.1128/JB.28.4.365-386.1934; Steffan RJ, 1997, APPL ENVIRON MICROB, V63, P4216, DOI 10.1128/AEM.63.11.4216-4222.1997; VALENTIN HE, 1993, APPL MICROBIOL BIOT, V39, P309, DOI 10.1007/BF00192084; Vlasie MD, 2004, BIOCHEMISTRY-US, V43, P8410, DOI 10.1021/bi036299q	37	27	33	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15502	15511		10.1074/jbc.M111.314690	http://dx.doi.org/10.1074/jbc.M111.314690			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22433853	Green Published, hybrid			2022-12-25	WOS:000304006300031
J	Dolezal, J; Altman, J; Kopecky, M; Cerny, T; Janecek, S; Bartos, M; Petrik, P; Srutek, M; Leps, J; Song, JS				Dolezal, Jiri; Altman, Jan; Kopecky, Martin; Cerny, Tomas; Janecek, Stepan; Bartos, Michael; Petrik, Petr; Srutek, Miroslav; Leps, Jan; Song, Jong-Suk			Plant Diversity Changes during the Postglacial in East Asia: Insights from Forest Refugia on Halla Volcano, Jeju Island	PLOS ONE			English	Article							SOUTH-KOREA; MODERN ANALOGS; POLLEN RECORD; DECOMPOSITION RATES; CLIMATE CHANGES; CENTRAL-EUROPE; EARLY HOLOCENE; VEGETATION; BIODIVERSITY; PLEISTOCENE	Understanding how past climate changes affected biodiversity is a key issue in contemporary ecology and conservation biology. These diversity changes are, however, difficult to reconstruct from paleoecological sources alone, because macrofossil and pollen records do not provide complete information about species assemblages. Ecologists therefore use information from modern analogues of past communities in order to get a better understanding of past diversity changes. Here we compare plant diversity, species traits and environment between late-glacial Abies, early-Holocene Quercus, and mid-Holocene warm-temperate Carpinus forest refugia on Jeju Island, Korea in order to provide insights into postglacial changes associated with their replacement. Based on detailed study of relict communities, we propose that the late-glacial open-canopy conifer forests in southern part of Korean Peninsula were rich in vascular plants, in particular of heliophilous herbs, whose dramatic decline was caused by the early Holocene invasion of dwarf bamboo into the understory of Quercus forests, followed by mid-Holocene expansion of strongly shading trees such as maple and hornbeam. This diversity loss was partly compensated in the Carpinus forests by an increase in shade-tolerant evergreen trees, shrubs and lianas. However, the pool of these species is much smaller than that of light-demanding herbs, and hence the total species richness is lower, both locally and in the whole area of the Carpinus and Quercus forests. The strongly shading tree species dominating in the hornbeam forests have higher leaf tissue N and P concentrations and smaller leaf dry matter content, which enhances litter decomposition and nutrient cycling and in turn favored the selection of highly competitive species in the shrub layer. This further reduced available light and caused almost complete disappearance of understory herbs, including dwarf bamboo.	[Dolezal, Jiri; Altman, Jan; Kopecky, Martin; Cerny, Tomas; Janecek, Stepan; Bartos, Michael; Petrik, Petr; Srutek, Miroslav] Acad Sci Czech Republic, Inst Bot, CS-25243 Pruhonice, Czech Republic; [Dolezal, Jiri; Altman, Jan; Bartos, Michael; Leps, Jan] Univ S Bohemia, Fac Sci, Dept Bot, Ceske Budejovice, Czech Republic; [Song, Jong-Suk] Andong Natl Univ, Coll Nat Sci, Dept Biol Sci, Andong, South Korea	Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Andong National University	Dolezal, J (corresponding author), Acad Sci Czech Republic, Inst Bot, CS-25243 Pruhonice, Czech Republic.	dolezal@butbn.cas.cz	Leps, Jan/B-6913-2013; Bartoš, Michael/H-1580-2014; Petřík, Petr/H-1649-2014; Kopecký, Martin/A-1466-2009; Janeček, Štěpán/H-1594-2014; Doležal, Jiří/H-1583-2014; , James/ABG-8160-2020; Bartoš, Michael/AAP-1336-2020; Altman, Jan/B-4305-2015	Leps, Jan/0000-0002-4822-7429; Bartoš, Michael/0000-0002-1415-3724; Petřík, Petr/0000-0001-8518-6737; Kopecký, Martin/0000-0002-1018-9316; Janeček, Štěpán/0000-0003-1285-6490; Bartoš, Michael/0000-0002-1415-3724; Cerny, Tomas/0000-0003-2637-808X; Dolezal, Jiri/0000-0002-5829-4051	Grant Agency of the Czech Republic [206/05/0119]; institutional long-term research plan [AV0Z60050516]; International Research Cooperation Program [F01-2009-000-10022-0]; National Research Foundation of Korea; Faculty of Science, University of South Bohemia [GAJU 138/2010/P]; Ministry of Education of the Czech Republic [LC06073]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); institutional long-term research plan; International Research Cooperation Program; National Research Foundation of Korea(National Research Foundation of Korea); Faculty of Science, University of South Bohemia; Ministry of Education of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	The study was funded by research grant 206/05/0119 of the Grant Agency of the Czech Republic, institutional long-term research plan AV0Z60050516, International Research Cooperation Program (Nr. F01-2009-000-10022-0) funded by the National Research Foundation of Korea, a grant of the Faculty of Science, University of South Bohemia (GAJU 138/2010/P), and by project LC06073 from the Ministry of Education of the Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, TROPICAL FOREST DIVE; Berry KJ, 2001, SPRINGER SERIES STAT; Beug H.-J., 2004, LEITFADEN POLLENBEST; Birks HJB, 2008, PLANT ECOL DIVERS, V1, P147, DOI 10.1080/17550870802349146; Carpenter RJ, 2010, J BIOGEOGR, V37, P1202, DOI 10.1111/j.1365-2699.2010.02279.x; Chiang TY, 2006, TAXON, V55, P31, DOI 10.2307/25065526; Chung CH, 2007, GEOSCI J, V11, P147, DOI 10.1007/BF02913928; Chung CH, 2006, GEOSCI J, V10, P423, DOI 10.1007/BF02910436; Chung CH, 2011, GEOSCI J, V15, P257, DOI 10.1007/s12303-011-0020-1; Chytry M, 2010, J BIOGEOGR, V37, P767, DOI 10.1111/j.1365-2699.2009.02256.x; Cornelissen JHC, 1996, J ECOL, V84, P573, DOI 10.2307/2261479; Cornwell WK, 2008, ECOL LETT, V11, P1065, DOI 10.1111/j.1461-0248.2008.01219.x; Decker KLM, 2006, AUSTRAL ECOL, V31, P1005, DOI 10.1111/j.1442-9993.2006.01670.x; Dolezal J, 2009, COMMUNITY ECOL, V10, P225, DOI 10.1556/ComEc.10.2009.2.13; Dolezal J, 2009, ECOL RES, V24, P281, DOI 10.1007/s11284-008-0505-1; Evstigneeva TA, 2010, PALEONTOL J+, V44, P1262, DOI 10.1134/S0031030110100047; Frazer GW, 1999, VERSION 2 0 IMAGING; Gilliam FS, 2007, BIOSCIENCE, V57, P845, DOI 10.1641/B571007; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Iqarashi Y, 1998, JAP J ECOL, V48, P231; Jackson ST, 2004, ANNU REV EARTH PL SC, V32, P495, DOI 10.1146/annurev.earth.32.101802.120435; Kawano T, 2011, QUATERN INT IN PRESS; Kim T, 2008, MT RES DEV, V28, P272, DOI 10.1659/mrd.0890; Kong W. S., 1993, SERIES GEOBOTANY, V19; Kong W.-S, 1998, J KOREAN GEOGR SOC, V33, P191; Kong WS, 2000, GLOBAL ECOL BIOGEOGR, V9, P391, DOI 10.1046/j.1365-2699.2000.00203.x; Krestov PV, 2006, PHYTOCOENOLOGIA, V36, P77, DOI 10.1127/0340-269X/2006/0036-0077; Kunes P, 2008, J BIOGEOGR, V35, P2223, DOI 10.1111/j.1365-2699.2008.01974.x; Lee E, 2003, GEO-MAR LETT, V23, P1, DOI 10.1007/s00367-003-0118-1; Lee SH, 2008, QUATERNARY RES, V70, P265, DOI 10.1016/j.yqres.2008.04.014; Lee Y. N., 2007, GENERA VASCULAR PLAN, P1182; McCune B, 2002, J VEG SCI, V13, P603, DOI 10.1111/j.1654-1103.2002.tb02087.x; Miyabuchi Y, 2011, QUATERN INT IN PRESS; Nobis M, 2005, AGR FOREST METEOROL, V128, P243, DOI 10.1016/j.agrformet.2004.10.002; O'Connell LM, 2007, J HERED, V98, P640, DOI 10.1093/jhered/esm089; Oksanen J., 2016, R PACKAG; OSAWA A, 1992, FOR SCI, V40, P29; Peres-Neto PR, 2001, OECOLOGIA, V129, P169, DOI 10.1007/s004420100720; Pirazzoli P.A., 1996, SEA LEVEL CHANGES LA; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Roberts D. W., 2010, FSO FUZZY SET ORDINA; Roberts DW, 2008, ECOLOGY, V89, P1246, DOI 10.1890/07-0136.1; Roberts DW, 2009, ECOLOGY, V90, P2622, DOI 10.1890/07-1673.1; SONG J-S, 1985, Japanese Journal of Ecology, V35, P317; Svenning JC, 2008, J ECOL, V96, P1117, DOI 10.1111/j.1365-2745.2008.01422.x; Tichy L, 2002, J VEG SCI, V13, P451, DOI 10.1111/j.1654-1103.2002.tb02069.x; Tichy L, 2006, J VEG SCI, V17, P809, DOI 10.1111/j.1654-1103.2006.tb02504.x; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037; Willis KJ, 1997, ECOLOGY, V78, P740, DOI 10.1890/0012-9658(1997)078[0740:DSCCVC]2.0.CO;2; Yim Y.J., 1990, KOREAN J ECOL, V13, P101; Yoon SO, 2011, QUATERN INT IN PRESS	51	26	27	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33065	10.1371/journal.pone.0033065	http://dx.doi.org/10.1371/journal.pone.0033065			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438890	Green Published, gold, Green Submitted			2022-12-25	WOS:000303309100020
J	Kim, JG; Kang, MJ; Yoon, YK; Kim, HP; Park, J; Song, SH; Han, SW; Park, JW; Kang, GH; Kang, KW; Oh, DY; Im, SA; Bang, YJ; Yi, EC; Kim, TY				Kim, Jun Gyu; Kang, Min Jueng; Yoon, Young-Kwang; Kim, Hwang-Phill; Park, Jinah; Song, Sang-Hyun; Han, Sae-Won; Park, Jong-Wan; Kang, Gyeong Hoon; Kang, Keon Wook; Oh, Do Youn; Im, Seock-Ah; Bang, Yung-Jue; Yi, Eugene C.; Kim, Tae-You			Heterodimerization of Glycosylated Insulin-Like Growth Factor-1 Receptors and Insulin Receptors in Cancer Cells Sensitive to Anti-IGF1R Antibody	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; HUMAN BREAST-CANCER; MONOCLONAL-ANTIBODY; HYBRID RECEPTORS; THYROID-CANCER; IGF-II; STATISTICAL-MODEL; TUMOR-GROWTH; ISOFORM; PHARMACOKINETICS	Background: Identification of predictive biomarkers is essential for the successful development of targeted therapy. Insulinlike growth factor 1 receptor (IGF1R) has been examined as a potential therapeutic target for various cancers. However, recent clinical trials showed that anti-IGF1R antibody and chemotherapy are not effective for treating lung cancer. Methodology/Principal Findings: In order to define biomarkers for predicting successful IGF1R targeted therapy, we evaluated the anti-proliferation effect of figitumumab (CP-751,871), a humanized anti-IGF1R antibody, against nine gastric and eight hepatocellular cancer cell lines. Out of 17 cancer cell lines, figitumumab effectively inhibited the growth of three cell lines (SNU719, HepG2, and SNU368), decreased p-AKT and p-STAT3 levels, and induced G 1 arrest in a dose-dependent manner. Interestingly, these cells showed co-overexpression and altered mobility of the IGF1R and insulin receptor (IR). Immunoprecipitaion (IP) assays and ELISA confirmed the presence of IGF1R/IR heterodimeric receptors in figitumumab-sensitive cells. Treatment with figitumumab led to the dissociation of IGF1-dependent heterodimeric receptors and inhibited tumor growth with decreased levels of heterodimeric receptors in a mouse xenograft model. We next found that both IGF1R and IR were N-linked glyosylated in figitumumab-sensitive cells. In particular, mass spectrometry showed that IGF1R had N-linked glycans at N913 in three figitumumab-sensitive cell lines. We observed that an absence of N-linked glycosylation at N913 led to a lack of membranous localization of IGF1R and figitumumab insensitivity. Conclusion and Significance: The data suggest that the level of N-linked glycosylated IGF1R/IR heterodimeric receptor is highly associated with sensitivity to anti-IGF1R antibody in cancer cells.	[Kim, Jun Gyu; Yoon, Young-Kwang; Kim, Hwang-Phill; Park, Jinah; Song, Sang-Hyun; Oh, Do Youn; Im, Seock-Ah; Bang, Yung-Jue; Kim, Tae-You] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea; [Han, Sae-Won; Oh, Do Youn; Im, Seock-Ah; Bang, Yung-Jue; Kim, Tae-You] Seoul Natl Univ, Dept Internal Med, Seoul, South Korea; [Kang, Min Jueng; Bang, Yung-Jue; Yi, Eugene C.; Kim, Tae-You] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, WCU Dept Mol Med & Biopharmaceut Sci, Seoul, South Korea; [Park, Jong-Wan] Seoul Natl Univ, Dept Pharmacol, Seoul, South Korea; [Kang, Gyeong Hoon] Seoul Natl Univ, Dept Pathol, Seoul, South Korea; [Kang, Keon Wook] Seoul Natl Univ, Coll Med, Dept Nucl Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Kim, JG (corresponding author), Seoul Natl Univ, Canc Res Inst, Seoul, South Korea.	kimty@snu.ac.kr	Bang, Yung Jue/J-2759-2012; Im, Seock-Ah/J-5620-2012; Kim, Tae-You/J-2750-2012; Kang, Keon Wook/J-1385-2012; Kang, Gyeong Hoon/F-1051-2010	Bang, Yung Jue/0000-0001-6000-4597; Kang, Keon Wook/0000-0003-2622-9017; Kang, Gyeong Hoon/0000-0003-2380-6675	Ministry for Health, Welfare & Family Affairs, Republic of Korea [A091081]; World Class University of the MEST [R31-2008-000-10103-0]; NRF	Ministry for Health, Welfare & Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); World Class University of the MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea); NRF	This study was partially funded by the Korean healthcare 21 and technology R&D project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (A091081), and supported by grant No. R31-2008-000-10103-0 from the World Class University program of the MEST and the NRF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avnet S, 2009, CANCER RES, V69, P2443, DOI 10.1158/0008-5472.CAN-08-2645; Baserga R, 2005, EXPERT OPIN THER TAR, V9, P753, DOI 10.1517/14728222.9.4.753; Belfiore A, 1999, BIOCHIMIE, V81, P403, DOI 10.1016/S0300-9084(99)80088-1; Belfiore A, 2009, ENDOCR REV, V30, P586, DOI 10.1210/er.2008-0047; Burtrum D, 2003, CANCER RES, V63, P8912; Cao L, 2008, CANCER RES, V68, P8039, DOI 10.1158/0008-5472.CAN-08-1712; Cohen BD, 2005, CLIN CANCER RES, V11, P2063, DOI 10.1158/1078-0432.CCR-04-1070; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Frasca F, 1999, MOL CELL BIOL, V19, P3278, DOI 10.1128/mcb.19.5.3278; Frasca Francesco, 2003, Breast Dis, V17, P73; FRATTALI AL, 1993, J BIOL CHEM, V268, P7393; Gong YX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007273; Gualberto A, 2010, BRIT J CANCER, V104, P68; Haluska P, 2010, CANCER CHEMOTH PHARM, V65, P765, DOI 10.1007/s00280-009-1083-9; Heller G, 2010, MEMO-MAG EUR MED ONC, V3, P81, DOI 10.1007/s12254-010-0192-9; Jassem J, 2010, J CLIN ONCOL, V28, p539a; Kalli KR, 2002, ENDOCRINOLOGY, V143, P3259, DOI 10.1210/en.2001-211408; Karp DD, 2009, J THORAC ONCOL, V4, P1397, DOI 10.1097/JTO.0b013e3181ba2f1d; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Ku Ja-Lok, 2005, Cancer Res Treat, V37, P1, DOI 10.4143/crt.2005.37.1.1; MOXHAM CP, 1989, J BIOL CHEM, V264, P13238; Nahta R, 2003, ONCOLOGIST, V8, P5, DOI 10.1634/theoncologist.8-1-5; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Olmos D, 2010, LANCET ONCOL, V11, P129, DOI 10.1016/S1470-2045(09)70354-7; OLSON TS, 1988, J BIOL CHEM, V263, P7342; Ouban A, 2003, HUM PATHOL, V34, P803, DOI 10.1016/S0046-8177(03)00291-0; Pandini G, 1999, CLIN CANCER RES, V5, P1935; Pandini G, 2002, J BIOL CHEM, V277, P39684, DOI 10.1074/jbc.M202766200; Pandini G, 2007, EUR J CANCER, V43, P1318, DOI 10.1016/j.ejca.2007.03.009; PAPA V, 1993, CANCER RES, V53, P3736; PAPA V, 1990, J CLIN INVEST, V86, P1503, DOI 10.1172/JCI114868; Rodon J, 2008, MOL CANCER THER, V7, P2575, DOI 10.1158/1535-7163.MCT-08-0265; Sciacca L, 1999, ONCOGENE, V18, P2471, DOI 10.1038/sj.onc.1202600; SOOS MA, 1989, BIOCHEM J, V263, P553, DOI 10.1042/bj2630553; SOOS MA, 1990, BIOCHEM J, V270, P383, DOI 10.1042/bj2700383; ULLRICH A, 1986, EMBO J, V5, P2503, DOI 10.1002/j.1460-2075.1986.tb04528.x; Vella V, 2002, J CLIN ENDOCR METAB, V87, P245, DOI 10.1210/jc.87.1.245; Vella V, 2001, J CLIN PATHOL-MOL PA, V54, P121, DOI 10.1136/mp.54.3.121; Yi EC, 2003, RAPID COMMUN MASS SP, V17, P2093, DOI 10.1002/rcm.1150; Yu H, 2000, JNCI-J NATL CANCER I, V92, P1472, DOI 10.1093/jnci/92.18.1472; Zha JP, 2009, MOL CANCER THER, V8, P2110, DOI 10.1158/1535-7163.MCT-09-0381	42	40	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33322	10.1371/journal.pone.0033322	http://dx.doi.org/10.1371/journal.pone.0033322			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438913	Green Published, gold, Green Submitted			2022-12-25	WOS:000303309100032
J	He, Q; Cui, BS; An, Y				He, Qiang; Cui, Baoshan; An, Yuan			Physical Stress, Not Biotic Interactions, Preclude an Invasive Grass from Establishing in Forb-Dominated Salt Marshes	PLOS ONE			English	Article							SPARTINA-ALTERNIFLORA; PLANT-COMMUNITIES; TOPOGRAPHIC GRADIENTS; SALINITY; CORDGRASS; RESPONSES; ZONATION; DENSIFLORA; CALIFORNIA; RECRUITMENT	Background: Biological invasions have become the focus of considerable concern and ecological research, yet the relative importance of abiotic and biotic factors in controlling the invasibility of habitats to exotic species is not well understood. Spartina species are highly invasive plants in coastal wetlands; however, studies on the factors that control the success or failure of Spartina invasions across multiple habitat types are rare and inconclusive. Methodology and Principal Findings: We examined the roles of physical stress and plant interactions in mediating the establishment of the smooth cordgrass, Spartina alterniflora, in a variety of coastal habitats in northern China. Field transplant experiments showed that cordgrass can invade mudflats and low estuarine marshes with low salinity and frequent flooding, but cannot survive in salt marshes and high estuarine marshes with hypersaline soils and infrequent flooding. The dominant native plant Suaeda salsa had neither competitive nor facilitative effects on cordgrass. A common garden experiment revealed that cordgrass performed significantly better when flooded every other day than when flooded weekly. These results suggest that physical stress rather than plant interactions limits cordgrass invasions in northern China. Conclusions and Significance: We conclude that Spartina invasions are likely to be constrained to tidal flats and low estuarine marshes in the Yellow River Delta. Due to harsh physical conditions, salt marshes and high estuarine marshes are unlikely to be invaded. These findings have implications for understanding Spartina invasions in northern China and on other coasts with similar biotic and abiotic environments.	[He, Qiang; Cui, Baoshan] Beijing Normal Univ, Sch Environm, State Key Lab Water Environm Simulat, Beijing 100875, Peoples R China; [An, Yuan] Shanghai Jiao Tong Univ, Sch Agr & Biol, MOA Key Lab Urban Agr S, Shanghai 200030, Peoples R China	Beijing Normal University; Shanghai Jiao Tong University	He, Q (corresponding author), Beijing Normal Univ, Sch Environm, State Key Lab Water Environm Simulat, Beijing 100875, Peoples R China.	cuibs@bnu.edu.cn	He, Qiang/G-2012-2011	He, Qiang/0000-0001-6481-0924	National Natural Science Foundation of China [U0833002, 41071330]; China National Funds for Distinguished Young Scientists [51125035]; Fundamental Research Funds for the Central Universities [2009SD-24]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China National Funds for Distinguished Young Scientists(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	Funding was provided by the National Natural Science Foundation of China (U0833002; 41071330) (http://www.nsfc.gov.cn/); China National Funds for Distinguished Young Scientists (51125035) (http://www.nsfc.gov.cn/); and the Fundamental Research Funds for the Central Universities (2009SD-24)(http://www.moe.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert Peter, 2000, Perspectives in Plant Ecology Evolution and Systematics, V3, P52, DOI 10.1078/1433-8319-00004; An SQ, 2007, WEED RES, V47, P183, DOI 10.1111/j.1365-3180.2007.00559.x; Ayres DR, 2004, BIOL INVASIONS, V6, P221, DOI 10.1023/B:BINV.0000022140.07404.b7; Bertness MD, 2000, CONCEPTS AND CONTROVERSIES IN TIDAL MARSH ECOLOGY, P39; BERTNESS MD, 1991, ECOLOGY, V72, P138, DOI 10.2307/1938909; Castillo JM, 2009, AQUAT ECOL, V43, P51, DOI 10.1007/s10452-007-9159-2; Castillo JM, 2005, BIOL INVASIONS, V7, P29, DOI 10.1007/s10530-004-9626-9; Cheng BS, 2010, OECOLOGIA, V164, P1049, DOI 10.1007/s00442-010-1700-7; Colmer TD, 1996, J EXP BOT, V47, P369, DOI 10.1093/jxb/47.3.369; Compagnoni A, 2009, ECOGRAPHY, V32, P449, DOI 10.1111/j.1600-0587.2008.05739.x; Cui BS, 2011, ESTUAR COAST, V34, P459, DOI 10.1007/s12237-010-9364-4; DANTONIO CM, 1993, ECOLOGY, V74, P83, DOI 10.2307/1939503; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; Dethier MN, 2005, ECOL APPL, V15, P1273, DOI 10.1890/04-0505; [丁晶晶 DING Jing-Jing], 2009, [湿地科学, Wetland Science], V7, P202; Editorial Committee of Wetland Vegetation in China, 1999, WETL VEG CHIN, P553; Eschtruth AK, 2009, ECOL MONOGR, V79, P265, DOI 10.1890/08-0221.1; Grosholz E, 2002, TRENDS ECOL EVOL, V17, P22, DOI 10.1016/S0169-5347(01)02358-8; Grosholz E, 2010, ECOL LETT, V13, P145, DOI 10.1111/j.1461-0248.2009.01409.x; Hacker SD, 2006, OIKOS, V113, P279; Hacker Sally D., 2001, Biological Invasions, V3, P211, DOI 10.1023/A:1014555516373; He Q, 2011, J VEG SCI, V22, P828, DOI 10.1111/j.1654-1103.2011.01300.x; He Q, 2009, HYDROBIOLOGIA, V630, P327, DOI 10.1007/s10750-009-9825-6; HWANG YH, 1994, AM J BOT, V81, P659, DOI 10.2307/2445644; Jiang LF, 2009, ESTUAR COAST SHELF S, V81, P74, DOI 10.1016/j.ecss.2008.09.018; Kittelson PM, 1997, ESTUARIES, V20, P770, DOI 10.2307/1352250; Levin LA, 2006, ECOLOGY, V87, P419, DOI 10.1890/04-1752; Levine JM, 1998, J ECOL, V86, P285, DOI 10.1046/j.1365-2745.1998.00253.x; Li B, 2009, ECOL ENG, V35, P511, DOI 10.1016/j.ecoleng.2008.05.013; Mateos-Naranjo E, 2008, ESTUAR COAST SHELF S, V79, P727, DOI 10.1016/j.ecss.2008.06.017; McCullagh P, 1989, GEN LINEAR MODELS; Morris JT, 2002, ECOLOGY, V83, P2869, DOI 10.1890/0012-9658(2002)083[2869:ROCWTR]2.0.CO;2; NAIDOO G, 1992, AM J BOT, V79, P765, DOI 10.2307/2444942; Noe GB, 2001, ESTUARIES, V24, P30, DOI 10.2307/1352810; Pennings SC, 2005, J ECOL, V93, P159, DOI 10.1111/j.1365-2745.2004.00959.x; R Core Team, 2022, R LANG ENV STAT COMP; SENECA ED, 1985, J EXP MAR BIOL ECOL, V94, P259, DOI 10.1016/0022-0981(85)90063-2; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; SHUMWAY SW, 1992, OECOLOGIA, V92, P490, DOI 10.1007/BF00317840; SMART RM, 1980, ECOLOGY, V61, P630, DOI 10.2307/1937429; SMART RM, 1978, ESTUAR COAST MAR SCI, V7, P487, DOI 10.1016/0302-3524(78)90125-1; Strong D. R., 2009, HUMAN IMPACTS SALT M, P3; Wang CH, 2009, ECOL ENG, V35, P800, DOI 10.1016/j.ecoleng.2008.12.004; Wang HQ, 2007, ECOL MODEL, V201, P429, DOI 10.1016/j.ecolmodel.2006.10.013; Wang Q, 2006, BIOL INVASIONS, V8, P1547, DOI 10.1007/s10530-005-5846-x; Zhang RS, 2004, ECOL ENG, V23, P95, DOI 10.1016/j.ecoleng.2004.07.007	46	25	27	1	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e33164	10.1371/journal.pone.0033164	http://dx.doi.org/10.1371/journal.pone.0033164			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22432003	Green Submitted, Green Published, gold			2022-12-25	WOS:000303198600046
J	Izutsu, M; Zhou, J; Sugiyama, Y; Nishimura, O; Aizu, T; Toyoda, A; Fujiyama, A; Agata, K; Fuse, N				Izutsu, Minako; Zhou, Jun; Sugiyama, Yuzo; Nishimura, Osamu; Aizu, Tomoyuki; Toyoda, Atsushi; Fujiyama, Asao; Agata, Kiyokazu; Fuse, Naoyuki			Genome Features of "Dark-Fly", a Drosophila Line Reared Long-Term in a Dark Environment	PLOS ONE			English	Article							BENEFICIAL MUTATIONS; CONSTANT DARKNESS; RHO-GTPASES; MELANOGASTER; EVOLUTION; EXPRESSION; SELECTION; HOMOZYGOSITY; NUCLEOTIDE; EPISTASIS	Organisms are remarkably adapted to diverse environments by specialized metabolisms, morphology, or behaviors. To address the molecular mechanisms underlying environmental adaptation, we have utilized a Drosophila melanogaster line, termed "Dark-fly'', which has been maintained in constant dark conditions for 57 years (1400 generations). We found that Dark-fly exhibited higher fecundity in dark than in light conditions, indicating that Dark-fly possesses some traits advantageous in darkness. Using next-generation sequencing technology, we determined the whole genome sequence of Dark-fly and identified approximately 220,000 single nucleotide polymorphisms (SNPs) and 4,700 insertions or deletions (InDels) in the Dark-fly genome compared to the genome of the Oregon-R-S strain, a control strain. 1.8% of SNPs were classified as non-synonymous SNPs (nsSNPs: i.e., they alter the amino acid sequence of gene products). Among them, we detected 28 nonsense mutations (i.e., they produce a stop codon in the protein sequence) in the Dark-fly genome. These included genes encoding an olfactory receptor and a light receptor. We also searched runs of homozygosity (ROH) regions as putative regions selected during the population history, and found 21 ROH regions in the Dark-fly genome. We identified 241 genes carrying nsSNPs or InDels in the ROH regions. These include a cluster of alpha-esterase genes that are involved in detoxification processes. Furthermore, analysis of structural variants in the Dark-fly genome showed the deletion of a gene related to fatty acid metabolism. Our results revealed unique features of the Dark-fly genome and provided a list of potential candidate genes involved in environmental adaptation.	[Izutsu, Minako; Sugiyama, Yuzo; Nishimura, Osamu; Agata, Kiyokazu; Fuse, Naoyuki] Kyoto Univ, Lab Biodivers, Global COE Program, Grad Sch Sci, Kyoto, Japan; [Izutsu, Minako; Agata, Kiyokazu] Kyoto Univ, Lab Mol Dev Biol, Grad Sch Sci, Kyoto, Japan; [Zhou, Jun] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Aizu, Tomoyuki; Toyoda, Atsushi; Fujiyama, Asao] Natl Inst Genet, Comparat Genom Lab, Mishima, Shizuoka 411, Japan	Kyoto University; Kyoto University; Harvard University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Izutsu, M (corresponding author), Kyoto Univ, Lab Biodivers, Global COE Program, Grad Sch Sci, Kyoto, Japan.	nfuse@gcoe.biol.sci.kyoto-u.ac.jp	Zhou, Jun/K-6374-2012; Nishimura, Osamu/AAC-1236-2020	Nishimura, Osamu/0000-0003-1969-2580; Fuse, Naoyuki/0000-0002-7954-1082; Agata, Kiyokazu/0000-0002-5195-2576	Global COE of Kyoto University [A06]; NIG	Global COE of Kyoto University; NIG	This work was supported by Global COE Program A06 of Kyoto University, and NIG Collaborative Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Beutler E, 1998, P NATL ACAD SCI USA, V95, P8170, DOI 10.1073/pnas.95.14.8170; Billeter JC, 2006, CURR BIOL, V16, pR766, DOI 10.1016/j.cub.2006.08.025; Burke MK, 2010, NATURE, V467, P587, DOI 10.1038/nature09352; Chou HH, 2011, SCIENCE, V332, P1190, DOI 10.1126/science.1203799; Claridge-Chang A, 2001, NEURON, V32, P657, DOI 10.1016/S0896-6273(01)00515-3; Claudianos C, 2006, INSECT MOL BIOL, V15, P615, DOI 10.1111/j.1365-2583.2006.00672.x; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Denver DR, 2004, NATURE, V430, P679, DOI 10.1038/nature02697; Evans PD, 2005, SCIENCE, V309, P1717, DOI 10.1126/science.1113722; Gardiner A, 2008, MOL ECOL, V17, P1648, DOI 10.1111/j.1365-294X.2008.03713.x; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; Gross JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000326; Haag-Liautard C, 2007, NATURE, V445, P82, DOI 10.1038/nature05388; Heidari R, 2005, INSECT BIOCHEM MOLEC, V35, P597, DOI 10.1016/j.ibmb.2005.02.018; Hooven LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006469; Houten SM, 2010, J INHERIT METAB DIS, V33, P469, DOI 10.1007/s10545-010-9061-2; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Imafuku M, 2011, ZOOL SCI, V28, P195, DOI 10.2108/zsj.28.195; IMAIZUMI T, 1979, JPN J GENET, V54, P55, DOI 10.1266/jjg.54.55; Katz B, 2009, FRONT CELL NEUROSCI, V3, DOI 10.3389/neuro.03.002.2009; Keightley PD, 2009, GENOME RES, V19, P1195, DOI 10.1101/gr.091231.109; Khan AI, 2011, SCIENCE, V332, P1193, DOI 10.1126/science.1203801; Kishimoto T, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001164; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; LAZARD D, 1991, NATURE, V349, P790, DOI 10.1038/349790a0; Lencz T, 2007, P NATL ACAD SCI USA, V104, P19942, DOI 10.1073/pnas.0710021104; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Luque T, 2002, INSECT BIOCHEM MOLEC, V32, P1597, DOI 10.1016/S0965-1748(02)00080-2; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; McQuillan R, 2008, AM J HUM GENET, V83, P359, DOI 10.1016/j.ajhg.2008.08.007; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; MORI S, 1983, Zoological Magazine (Tokyo), V92, P138; MORI S, 1986, ZOOL SCI, V3, P945; MORI SYUITI, 1959, JAPANESE JOUR GENETICS, V34, P195, DOI 10.1266/jjg.34.195; MORI SYUITI, 1959, JAPANESE JOUR GENETICS, V34, P151, DOI 10.1266/jjg.34.151; Nadeau NJ, 2010, TRENDS GENET, V26, P484, DOI 10.1016/j.tig.2010.08.004; Ng JL, 2004, NEURON, V44, P779, DOI 10.1016/j.neuron.2004.11.014; Noriega FG, 2006, INSECT BIOCHEM MOLEC, V36, P366, DOI 10.1016/j.ibmb.2006.01.013; PARTRIDGE L, 1990, J INSECT PHYSIOL, V36, P419, DOI 10.1016/0022-1910(90)90059-O; Pearl R, 1926, J GEN PHYSIOL, V9, P513, DOI 10.1085/jgp.9.4.513; Prud'homme B, 2006, NATURE, V440, P1050, DOI 10.1038/nature04597; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ram KR, 2007, INTEGR COMP BIOL, V47, P427, DOI 10.1093/icb/icm046; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; ROGGE RD, 1991, CELL, V64, P39, DOI 10.1016/0092-8674(91)90207-F; Russell RJ, 1996, INSECT BIOCHEM MOLEC, V26, P235, DOI 10.1016/0965-1748(95)00081-X; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Shapiro MD, 2004, NATURE, V428, P717, DOI 10.1038/nature02415; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Townsend JP, 2002, GENOME BIOL, V3; Wang Q, 1999, J BIOL CHEM, V274, P10309, DOI 10.1074/jbc.274.15.10309; Wang T, 2007, PFLUG ARCH EUR J PHY, V454, P821, DOI 10.1007/s00424-007-0251-1; Weinert BT, 2003, J APPL PHYSIOL, V95, P1706, DOI 10.1152/japplphysiol.00288.2003; Williams JA, 2001, SCIENCE, V293, P2251, DOI 10.1126/science.1063097; Yamamoto Y, 2009, DEV BIOL, V330, P200, DOI 10.1016/j.ydbio.2009.03.003; YOO BH, 1980, THEOR APPL GENET, V57, P25, DOI 10.1007/BF00276006; Yuan Q, 2011, SCIENCE, V333, P1458, DOI 10.1126/science.1207121; Zhou D, 2011, P NATL ACAD SCI USA, V108, P2349, DOI 10.1073/pnas.1010643108; Zhou J, 2011, GENOME BIOL EVOL, V3, P1014, DOI 10.1093/gbe/evr023	60	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e33288	10.1371/journal.pone.0033288	http://dx.doi.org/10.1371/journal.pone.0033288			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22432011	gold, Green Published, Green Submitted			2022-12-25	WOS:000303198600054
J	Lyons, S; Sharp, C; LeBreton, M; Djoko, CF; Kiyang, JA; Lankester, F; Bibila, TG; Tamoufe, U; Fair, J; Wolfe, ND; Simmonds, P				Lyons, Sinead; Sharp, Colin; LeBreton, Matthew; Djoko, Cyrille F.; Kiyang, John A.; Lankester, Felix; Bibila, Tafon G.; Tamoufe, Ubald; Fair, Joseph; Wolfe, Nathan D.; Simmonds, Peter			Species Association of Hepatitis B Virus (HBV) in Non-Human Apes; Evidence for Recombination between Gorilla and Chimpanzee Variants	PLOS ONE			English	Article							WILD; INFECTION; GENOME; IDENTIFICATION; TROGLODYTES; GENOTYPE; CAMEROON; SEQUENCE; REVEALS; STRAINS	Hepatitis B virus (HBV) infections are widely distributed in humans, infecting approximately one third of the world's population. HBV variants have also been detected and genetically characterised from Old World apes; Gorilla gorilla (gorilla), Pan troglodytes (chimpanzee), Pongo pygmaeus (orang-utan), Nomascus nastusus and Hylobates pileatus (gibbons) and from the New World monkey, Lagothrix lagotricha (woolly monkey). To investigate species-specificity and potential for cross species transmission of HBV between sympatric species of apes (such as gorillas and chimpanzees in Central Africa) or between humans and chimpanzees or gorillas, variants of HBV infecting captive wild-born non-human primates were genetically characterised. 9 of 62 chimpanzees (11.3%) and two from 11 gorillas (18%) were HBV-infected (15% combined frequency), while other Old world monkey species were negative. Complete genome sequences were obtained from six of the infected chimpanzee and both gorillas; those from P. t. ellioti grouped with previously characterised variants from this subspecies. However, variants recovered from P. t. troglodytes HBV variants also grouped within this clade, indicative of transmission between sub-species, forming a paraphyletic clade. The two gorilla viruses were phylogenetically distinct from chimpanzee and human variants although one showed evidence for a recombination event with a P.t.e.-derived HBV variant in the partial X and core gene region. Both of these observations provide evidence for circulation of HBV between different species and sub-species of non-human primates, a conclusion that differs from the hypothesis if of strict host specificity of HBV genotypes.	[Lyons, Sinead; Sharp, Colin; Simmonds, Peter] Univ Edinburgh, Ctr Immunol Infect & Evolut, Edinburgh, Midlothian, Scotland; [Sharp, Colin] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland; [Kiyang, John A.; Lankester, Felix] Limbe Wildlife Ctr, Limbe, Cameroon; [Tamoufe, Ubald; Fair, Joseph] Global Viral Forecasting, San Francisco, CA USA; [LeBreton, Matthew; Djoko, Cyrille F.; Wolfe, Nathan D.] Stanford Univ, Program Human Biol, Global Viral Forecasting, Stanford, CA 94305 USA; [Bibila, Tafon G.] Ape Act Africa, Yaounde, Cameroon	University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; Stanford University	Lyons, S (corresponding author), Univ Edinburgh, Ctr Immunol Infect & Evolut, Edinburgh, Midlothian, Scotland.	S.M.K.Lyons@sms.ed.ac.uk	GenePool, The/D-8812-2012	Simmonds, Peter/0000-0002-7964-4700; Lankester, Felix/0000-0002-0802-0693	National Institutes of Health [DP1-OD000370]; google.org; Skoll Foundation; Henry M. Jackson Foundation for the Advancement of Military Medicine; United States Armed Forces Health Surveillance Center Division of GEIS Operations; United States Agency for International Development, PREDICT [GHNA-OO-09-00010-00]; Ape Action Africa; US Embassy in Cameroon; Biotechnology and Biological Sciences Research Council [BBS/E/D/20241864] Funding Source: researchfish; Medical Research Council [G0900740] Funding Source: researchfish; BBSRC [BBS/E/D/20241864] Funding Source: UKRI; MRC [G0900740] Funding Source: UKRI; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000370] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); google.org; Skoll Foundation; Henry M. Jackson Foundation for the Advancement of Military Medicine; United States Armed Forces Health Surveillance Center Division of GEIS Operations; United States Agency for International Development, PREDICT(United States Agency for International Development (USAID)); Ape Action Africa; US Embassy in Cameroon; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	NDW is supported by the National Institutes of Health Director's Pioneer Award (DP1-OD000370). Global Viral Forecasting is supported by google.org, http://google.org/, the Skoll Foundation, the Henry M. Jackson Foundation for the Advancement of Military Medicine, the United States Armed Forces Health Surveillance Center Division of GEIS Operations, and the United States Agency for International Development Emerging Pandemic Threats Program, PREDICT project, under the terms of Cooperative Agreement Number GHNA-OO-09-00010-00. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the Cameroon Ministry of Forestry and Fauna, which provided the necessary permits for this work, Ape Action Africa, and the US Embassy in Cameroon for their support. N.D.W. is supported by the NIH Director's Pioneer Award (DP1-OD000370).	Bollyky PL, 1996, J MOL EVOL, V42, P97, DOI 10.1007/BF02198834; Bowyer SM, 2000, J GEN VIROL, V81, P379, DOI 10.1099/0022-1317-81-2-379; Dumpis U, 2001, J HEPATOL, V35, P99, DOI 10.1016/S0168-8278(01)00064-2; Fares MA, 2002, J MOL EVOL, V54, P807, DOI 10.1007/s00239-001-0084-z; Gonder MK, 2011, P NATL ACAD SCI USA, V108, P4766, DOI 10.1073/pnas.1015422108; Grethe S, 2000, J MED VIROL, V60, P152, DOI 10.1002/(SICI)1096-9071(200002)60:2&lt;152::AID-JMV8&gt;3.0.CO;2-I; Hannoun C, 2000, J GEN VIROL, V81, P75, DOI 10.1099/0022-1317-81-1-75; Hu XL, 2000, P NATL ACAD SCI USA, V97, P1661, DOI 10.1073/pnas.97.4.1661; Lanford RE, 1998, P NATL ACAD SCI USA, V95, P5757, DOI 10.1073/pnas.95.10.5757; Li WH, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-45; Liu W, 2010, VIRUS RES, V149, P245, DOI 10.1016/j.virusres.2010.02.002; MacDonald DM, 2000, J VIROL, V74, P4253, DOI 10.1128/JVI.74.9.4253-4257.2000; Magiorkinis EN, 2005, GENE, V349, P165, DOI 10.1016/j.gene.2004.12.021; Makuwa M, 2005, J CLIN VIROL, V34, pS83, DOI 10.1016/S1386-6532(05)80016-2; Martin CM, 2011, J MED VIROL, V83, P1142, DOI 10.1002/jmv.22090; Mbanya DN, 2003, TRANSFUSION MED, V13, P267, DOI 10.1046/j.1365-3148.2003.00453.x; Morozov V, 2000, GENE, V260, P55, DOI 10.1016/S0378-1119(00)00424-8; Mugisha L, 2011, VIRUS RES, V155, P372, DOI 10.1016/j.virusres.2010.10.017; MUKAIDE M, 1992, NUCLEIC ACIDS RES, V20, P6105, DOI 10.1093/nar/20.22.6105; Njouom R, 2010, INFECT GENET EVOL, V10, P790, DOI 10.1016/j.meegid.2010.05.002; Norder H, 1996, VIROLOGY, V218, P214, DOI 10.1006/viro.1996.0181; Olinger CM, 2008, EMERG INFECT DIS, V14, P1777, DOI 10.3201/eid1411.080437; Owiredu WKBA, 2001, J MED VIROL, V64, P441, DOI 10.1002/jmv.1070; Sa-Nguanmoo P, 2009, ACTA VIROL, V53, P73, DOI 10.4149/av_2009_02_73; Sall AA, 2005, J GEN VIROL, V86, P333, DOI 10.1099/vir.0.80274-0; Sharp CP, 2010, J VIROL, V84, P10289, DOI 10.1128/JVI.01304-10; Simmonds P, 2005, J VIROL, V79, P15467, DOI 10.1128/JVI.79.24.15467-15476.2005; Starkman SE, 2003, VIROLOGY, V314, P381, DOI 10.1016/S0042-6822(03)00430-6; Sugauchi F, 2002, J VIROL, V76, P5985, DOI 10.1128/JVI.76.12.5985-5992.2002; Takahashi K, 2000, VIROLOGY, V267, P58, DOI 10.1006/viro.1999.0102; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tatematsu K, 2009, J VIROL, V83, P10538, DOI 10.1128/JVI.00462-09; Vartanian JP, 2002, J VIROL, V76, P11155, DOI 10.1128/JVI.76.21.11155-11158.2002; Warren KS, 1999, J VIROL, V73, P7860, DOI 10.1128/JVI.73.9.7860-7865.1999; Zhou Y, 2007, J MOL EVOL, V65, P197, DOI 10.1007/s00239-007-0054-1	35	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e33430	10.1371/journal.pone.0033430	http://dx.doi.org/10.1371/journal.pone.0033430			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22432021	Green Published, Green Submitted, gold			2022-12-25	WOS:000303198600064
J	Tanaka, KH; Dallaire-Dufresne, S; Daher, RK; Frenette, M; Charette, SJ				Tanaka, Katherine H.; Dallaire-Dufresne, Stephanie; Daher, Rana K.; Frenette, Michel; Charette, Steve J.			An Insertion Sequence-Dependent Plasmid Rearrangement in Aeromonas salmonicida Causes the Loss of the Type Three Secretion System	PLOS ONE			English	Article							SUBSP SALMONICIDA; VIRULENCE; MODULATION; PROTEINS; GENOME	Aeromonas salmonicida, a bacterial fish pathogen, possesses a functional Type Three Secretion System (TTSS), which is essential for its virulence. The genes for this system are mainly located in a single region of the large pAsa5 plasmid. Bacteria lose the TTSS region from this plasmid through rearrangements when grown in stressful growth conditions. The A. salmonicida genome is rich in insertion sequences (ISs), which are mobile DNA elements that can cause DNA rearrangements in other bacterial species. pAsa5 possesses numerous ISs. Three IS11s from the IS256 family encircle the rearranged regions. To confirm that these IS11s are involved in pAsa5 rearrangements, 26 strains derived from strain A449 and two Canadian isolates (01-B526 and 01-B516) with a pAsa5 rearrangement were tested using a PCR approach to determine whether the rearrangements were the result of an IS11-dependent process. Nine out of the 26 strains had a positive PCR result, suggesting that the rearrangement in these strains were IS-dependent. The PCR analysis showed that all the rearrangements in the A449-derived strains were IS11-dependent process while the rearrangements in 01-B526 and 01-B516 could only be partially coupled to the action of IS11. Unidentified elements that affect IS-dependent rearrangements may be present in 01-B526 and 01-B516. Our results suggested that pAsa5 rearrangements involve IS11. This is the first study showing that ISs are involved in plasmid instability in A. salmonicida.	[Tanaka, Katherine H.; Dallaire-Dufresne, Stephanie; Daher, Rana K.; Charette, Steve J.] Univ Laval, Inst Biol Integrat & Syst, Quebec City, PQ, Canada; [Tanaka, Katherine H.; Dallaire-Dufresne, Stephanie; Daher, Rana K.; Charette, Steve J.] Inst Univ Cardiol & Pneumol Quebec, Ctr Rech, Quebec City, PQ, Canada; [Frenette, Michel; Charette, Steve J.] Univ Laval, Fac Sci & Genie, Dept Biochim Microbiol & Bioinformat, Quebec City, PQ G1K 7P4, Canada; [Frenette, Michel] Univ Laval, Fac Med Dent, Grp Rech Ecol Buccale, Quebec City, PQ G1K 7P4, Canada	Laval University; Laval University; Laval University; Laval University	Tanaka, KH (corresponding author), Univ Laval, Inst Biol Integrat & Syst, Pavillon Charles Eugene Marchand, Quebec City, PQ, Canada.	steve.charette@bcm.ulaval.ca	Charette, Steve/GYJ-3058-2022		Natural Sciences and Engineering Research Council of Canada (NSERC); Reseau Aquaculture Quebec (RAQ); Le Fonds quebecois de la recherche sur la nature et les technologies (FQRNT); Programme canadien de bourses de la francophonie (PCBF); NSERC	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Reseau Aquaculture Quebec (RAQ); Le Fonds quebecois de la recherche sur la nature et les technologies (FQRNT)(FQRNT); Programme canadien de bourses de la francophonie (PCBF); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	KHT received scholarships from the Undergraduate Student Research Awards Program of the Natural Sciences and Engineering Research Council of Canada (NSERC). SDD received a Bourse FONCER scholarship from Reseau Aquaculture Quebec (RAQ) and a bursary from Le Fonds quebecois de la recherche sur la nature et les technologies (FQRNT). RKD received a scholarship from the Programme canadien de bourses de la francophonie (PCBF). This project was funded by RAQ and NSERC grants. SJC is a research scholar of the Fonds de la Recherche en Sante du Quebec (FRSQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731; Boyd J, 2003, PLASMID, V50, P131, DOI 10.1016/S0147-619X(03)00058-1; Burr SE, 2005, MICROBIOL-SGM, V151, P2111, DOI 10.1099/mic.0.27926-0; Burr SE, 2003, J BACTERIOL, V185, P6583, DOI 10.1128/JB.185.22.6583-6591.2003; Burr SE, 2002, J BACTERIOL, V184, P5966, DOI 10.1128/JB.184.21.5966-5970.2002; BYRNE ME, 1989, GENE, V81, P361, DOI 10.1016/0378-1119(89)90197-2; Casetta A, 1998, ANTIMICROB AGENTS CH, V42, P2889, DOI 10.1128/AAC.42.11.2889; Charette SJ, 2004, BIOTECHNIQUES, V36, P574, DOI 10.2144/04364BM01; Charette SJ, 2012, J BACTERIOL, V194, P722, DOI 10.1128/JB.06276-11; Dacanay A, 2006, MICROBIOL-SGM, V152, P1847, DOI 10.1099/mic.0.28768-0; Daher RK, 2011, VET MICROBIOL, V152, P353, DOI 10.1016/j.vetmic.2011.04.034; Dautremepuits C, 2006, VET IMMUNOL IMMUNOP, V110, P27, DOI 10.1016/j.vetimm.2005.09.008; Ebanks RO, 2006, MICROBIOL-SGM, V152, P1275, DOI 10.1099/mic.0.28485-0; Fehr D, 2006, MICROBIOL-SGM, V152, P2809, DOI 10.1099/mic.0.28889-0; Froquet R, 2007, APPL ENVIRON MICROB, V73, P5657, DOI 10.1128/AEM.00908-07; Futagami T, 2006, APPL MICROBIOL BIOT, V70, P720, DOI 10.1007/s00253-005-0112-9; Hanninen ML, 1997, VET MICROBIOL, V56, P147, DOI 10.1016/S0378-1135(96)01339-9; Hiney M, 1999, FISH DISEASES AND DISORDERS, VOL 3, P341; Katsy EI, 2009, PLASMID, V62, P22, DOI 10.1016/j.plasmid.2009.02.003; Mahillon J, 1998, MICROBIOL MOL BIOL R, V62, P725, DOI 10.1128/MMBR.62.3.725-774.1998; Najimi M, 2008, J FISH DIS, V31, P469, DOI 10.1111/j.1365-2761.2007.00896.x; Rasch M, 2007, DIS AQUAT ORGAN, V78, P105, DOI 10.3354/dao01865; Reith ME, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-427; Schoenfelder SMK, 2010, INT J MED MICROBIOL, V300, P380, DOI 10.1016/j.ijmm.2010.04.011; Stuber K, 2003, J CLIN MICROBIOL, V41, P3854, DOI 10.1128/JCM.41.8.3854-3856.2003; Touchon M, 2007, MOL BIOL EVOL, V24, P969, DOI 10.1093/molbev/msm014; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; Wiklund T, 1998, DIS AQUAT ORGAN, V32, P49, DOI 10.3354/dao032049	28	36	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e33725	10.1371/journal.pone.0033725	http://dx.doi.org/10.1371/journal.pone.0033725			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22432045	Green Published, gold, Green Submitted			2022-12-25	WOS:000303198600088
J	Yang, HT; Ko, MSH				Yang, Hsih-Te; Ko, Minoru S. H.			Stochastic Modeling for the Expression of a Gene Regulated by Competing Transcription Factors	PLOS ONE			English	Article							POSITIVE FEEDBACK; ESCHERICHIA-COLI; CELL FATE; NOISE; INDUCTION; MOLECULE; KINETICS; BINARY; SWITCH; LEVEL	It is widely accepted that gene expression regulation is a stochastic event. The common approach for its computer simulation requires detailed information on the interactions of individual molecules, which is often not available for the analyses of biological experiments. As an alternative approach, we employed a more intuitive model to simulate the experimental result, the Markov-chain model, in which a gene is regulated by activators and repressors, which bind the same site in a mutually exclusive manner. Our stochastic simulation in the presence of both activators and repressors predicted a Hill-coefficient of the dose-response curve closer to the experimentally observed value than the calculated value based on the simple additive effects of activators alone and repressors alone. The simulation also reproduced the heterogeneity of gene expression levels among individual cells observed by Fluorescence Activated Cell Sorting analysis. Therefore, our approach may help to apply stochastic simulations to broader experimental data.	[Yang, Hsih-Te; Ko, Minoru S. H.] NIA, Dev Genom & Aging Sect, Genet Lab, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Yang, HT (corresponding author), NIA, Dev Genom & Aging Sect, Genet Lab, NIH, Baltimore, MD 21224 USA.	ko.minoru1@gmail.com	Ko, Minoru S. H./B-7969-2009	Ko, Minoru S. H./0000-0002-3530-3015; YANG, HSIH-TE/0000-0002-4851-1374	National Institutes of Health (NIA); NATIONAL INSTITUTE ON AGING [ZIAAG000656, ZIAAG000702] Funding Source: NIH RePORTER	National Institutes of Health (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported entirely by the Intramural Program of the National Institutes of Health (NIA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkin A, 1998, GENETICS, V149, P1633; Balazsi G, 2011, CELL, V144, P910, DOI 10.1016/j.cell.2011.01.030; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Biggar SR, 2001, EMBO J, V20, P3167, DOI 10.1093/emboj/20.12.3167; Blake WJ, 2006, MOL CELL, V24, P853, DOI 10.1016/j.molcel.2006.11.003; Boeger H, 2008, CELL, V133, P716, DOI 10.1016/j.cell.2008.02.051; Chipperfield A. J., 1994, 10 INT C SYSTEMS ENG, P200, DOI DOI 10.1243/0954405021519915; Degenhardt T, 2009, CELL, V138, P489, DOI 10.1016/j.cell.2009.05.029; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Gardiner C. W., HDB STOCHASTIC METHO; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kim HD, 2008, NAT STRUCT MOL BIOL, V15, P1192, DOI 10.1038/nsmb.1500; KO MSH, 1991, J THEOR BIOL, V153, P181, DOI 10.1016/S0022-5193(05)80421-7; KO MSH, 1992, BIOESSAYS, V14, P341, DOI 10.1002/bies.950140510; KO MSH, 1990, EMBO J, V9, P2835, DOI 10.1002/j.1460-2075.1990.tb07472.x; KO MSH, 1989, DNA-J MOLEC CELL BIO, V8, P127, DOI 10.1089/dna.1.1989.8.127; Lam FH, 2008, NATURE, V453, P246, DOI 10.1038/nature06867; Larson DR, 2009, TRENDS CELL BIOL, V19, P630, DOI 10.1016/j.tcb.2009.08.008; Losick R, 2008, SCIENCE, V320, P65, DOI 10.1126/science.1147888; Macneil L. T., 2011, GENOME RES; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Mettetal JT, 2006, P NATL ACAD SCI USA, V103, P7304, DOI 10.1073/pnas.0509874103; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; PECCOUD JY, 1995, THEOR POPUL BIOL, V48, P13; Pedraza JM, 2008, SCIENCE, V319, P339, DOI 10.1126/science.1144331; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Raj A, 2009, ANNU REV BIOPHYS, V38, P255, DOI 10.1146/annurev.biophys.37.032807.125928; Ramsey SA, 2006, NAT GENET, V38, P1082, DOI 10.1038/ng1869; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Rossi FMV, 2000, MOL CELL, V6, P723, DOI 10.1016/S1097-2765(00)00070-8; Suter DM, 2011, SCIENCE, V332, P472, DOI 10.1126/science.1198817; To TL, 2010, SCIENCE, V327, P1142, DOI 10.1126/science.1178962; Werner M, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.061909; Wilkinson DJ, 2009, NAT REV GENET, V10, P122, DOI 10.1038/nrg2509; Yang HT, 2007, J BIOCHEM, V142, P135, DOI 10.1093/jb/mvm151	37	4	4	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e32376	10.1371/journal.pone.0032376	http://dx.doi.org/10.1371/journal.pone.0032376			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22431973	Green Published, gold, Green Submitted			2022-12-25	WOS:000303198600016
J	Mauldin, RV; Sapienza, PJ; Petit, CM; Lee, AL				Mauldin, Randall V.; Sapienza, Paul J.; Petit, Chad M.; Lee, Andrew L.			Structure and Dynamics of the G121V Dihydrofolate Reductase Mutant: Lessons from a Transition-State Inhibitor Complex	PLOS ONE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; SIDE-CHAIN DYNAMICS; MODEL-FREE APPROACH; CONFORMATIONAL-CHANGES; ROTATIONAL DIFFUSION; DISTAL MUTATIONS; HYDRIDE TRANSFER; POINT MUTATIONS; FUNCTIONAL-ROLE; NMR RELAXATION	It is well known that enzyme flexibility is critical for function. This is due to the observation that the rates of intramolecular enzyme motions are often matched to the rates of intermolecular events such as substrate binding and product release. Beyond this role in progression through the reaction cycle, it has been suggested that enzyme dynamics may also promote the chemical step itself. Dihydrofolate reductase (DHFR) is a model enzyme for which dynamics have been proposed to aid in both substrate flux and catalysis. The G121V mutant of DHFR is a well studied form that exhibits a severe reduction in the rate of hydride transfer yet there remains dispute as to whether this defect is caused by altered structure, dynamics, or both. Here we address this by presenting an NMR study of the G121V mutant bound to reduced cofactor and the transition state inhibitor, methotrexate. NMR chemical shift markers demonstrate that this form predominantly adopts the closed conformation thereby allowing us to provide the first glimpse into the dynamics of a catalytically relevant complex. Based on N-15 and H-2 NMR spin relaxation, we find that the mutant complex has modest changes in ps-ns flexibility with most affected residues residing in the distal adenosine binding domain rather than the active site. Thus, aberrant ps-ns dynamics are likely not the main contributor to the decreased catalytic rate. The most dramatic effect of the mutation involves changes in mu s-ms dynamics of the F-G and Met20 loops. Whereas loop motion is quenched in the wild type transition state inhibitor complex, the F-G and Met20 loops undergo excursions from the closed conformation in the mutant complex. These excursions serve to decrease the population of conformers having the correct active site configuration, thus providing an explanation for the G121V catalytic defect.	[Mauldin, Randall V.; Lee, Andrew L.] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Sapienza, Paul J.; Petit, Chad M.; Lee, Andrew L.] Univ N Carolina, Eshelman Sch Pharm, Div Chem Biol & Med Chem, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill	Lee, AL (corresponding author), Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	drewlee@unc.edu	Lee, Andrew/GVU-2817-2022; , UNC Biomolecular NMR Facility/AAD-7901-2022		NIH [GM083059]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083059] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by NIH grant GM083059 (to ALL). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk AJ, 2011, P NATL ACAD SCI USA, V108, P14115, DOI 10.1073/pnas.1111252108; Agarwal PK, 2002, P NATL ACAD SCI USA, V99, P2794, DOI 10.1073/pnas.052005999; Bhabha G, 2011, SCIENCE, V332, P234, DOI 10.1126/science.1198542; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; Boekelheide N, 2011, P NATL ACAD SCI USA, V108, P16159, DOI 10.1073/pnas.1106397108; Boyer JA, 2008, BIOCHEMISTRY-US, V47, P4876, DOI 10.1021/bi702330t; BYSTROFF C, 1991, BIOCHEMISTRY-US, V30, P2227, DOI 10.1021/bi00222a028; Cameron CE, 1997, BIOCHEMISTRY-US, V36, P15792, DOI 10.1021/bi9716231; Clarkson MW, 2006, BIOCHEMISTRY-US, V45, P7693, DOI 10.1021/bi060652l; Clarkson MW, 2004, BIOCHEMISTRY-US, V43, P12448, DOI 10.1021/bi0494424; d'Auvergne EJ, 2006, J BIOMOL NMR, V35, P117, DOI 10.1007/s10858-006-9007-z; Eisenmesser EZ, 2002, SCIENCE, V295, P1520, DOI 10.1126/science.1066176; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; GEKKO K, 1994, J BIOCHEM-TOKYO, V116, P34, DOI 10.1093/oxfordjournals.jbchem.a124499; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Igumenova TI, 2006, CHEM REV, V106, P1672, DOI 10.1021/cr040422h; Kamerlin SCL, 2010, PROTEINS, V78, P1339, DOI 10.1002/prot.22654; Lee LK, 1997, J BIOMOL NMR, V9, P287, DOI 10.1023/A:1018631009583; LI LY, 1992, BIOCHEMISTRY-US, V31, P7826, DOI 10.1021/bi00149a012; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Loria JP, 1999, J AM CHEM SOC, V121, P2331, DOI 10.1021/ja983961a; Mauldin RV, 2010, BIOCHEMISTRY-US, V49, P1606, DOI 10.1021/bi901798g; Mauldin RV, 2009, STRUCTURE, V17, P386, DOI 10.1016/j.str.2009.01.005; McElheny D, 2005, P NATL ACAD SCI USA, V102, P5032, DOI 10.1073/pnas.0500699102; Miller GP, 2001, BIOCHEMISTRY-US, V40, P867, DOI 10.1021/bi001608n; Miller GP, 1998, BIOCHEMISTRY-US, V37, P6336, DOI 10.1021/bi973065w; Millet O, 2002, J AM CHEM SOC, V124, P6439, DOI 10.1021/ja012497y; MUHANDIRAM DR, 1995, J AM CHEM SOC, V117, P11536, DOI 10.1021/ja00151a018; Nashine VC, 2010, CURR OPIN CHEM BIOL, V14, P644, DOI 10.1016/j.cbpa.2010.07.020; Ohmae E, 1998, J BIOCHEM-TOKYO, V123, P33; Osborne MJ, 2003, PROTEIN SCI, V12, P2230, DOI 10.1110/ps.03219603; Osborne MJ, 2001, J BIOMOL NMR, V19, P209, DOI 10.1023/A:1011283809984; Rajagopalan PTR, 2002, BIOCHEMISTRY-US, V41, P12618, DOI 10.1021/bi026369d; Rod TH, 2003, P NATL ACAD SCI USA, V100, P6980, DOI 10.1073/pnas.1230801100; Sapienza PJ, 2011, J MOL BIOL, V405, P378, DOI 10.1016/j.jmb.2010.10.037; SASSO SP, 1994, BBA-PROTEIN STRUCT M, V1207, P74, DOI 10.1016/0167-4838(94)90053-1; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P586, DOI 10.1021/bi962337c; Schwartz SD, 2009, NAT CHEM BIOL, V5, P552, DOI 10.1038/nchembio.202; Thorpe IF, 2004, PROTEINS, V57, P444, DOI 10.1002/prot.20219; Venkitakrishnan RP, 2004, BIOCHEMISTRY-US, V43, P16046, DOI 10.1021/bi048119y; Wang L, 2006, P NATL ACAD SCI USA, V103, P15753, DOI 10.1073/pnas.0606976103; Watney JB, 2003, J AM CHEM SOC, V125, P3745, DOI 10.1021/ja028487u; Watt ED, 2007, P NATL ACAD SCI USA, V104, P11981, DOI 10.1073/pnas.0702551104; Whitley MJ, 2008, BIOCHEMISTRY-US, V47, P8566, DOI 10.1021/bi8007966; Wolfenden R, 2003, BIOPHYS CHEM, V105, P559, DOI 10.1016/S0301-4622(03)00066-8	47	25	25	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2012	7	3							e33252	10.1371/journal.pone.0033252	http://dx.doi.org/10.1371/journal.pone.0033252			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930IA	22428003	Green Published, gold, Green Submitted			2022-12-25	WOS:000303129700044
J	Bao, W; Rong, S; Zhang, MX; Yu, XF; Zhao, YT; Xiao, X; Yang, W; Wang, D; Yao, P; Hu, FB; Liu, LG				Bao, Wei; Rong, Shuang; Zhang, Muxun; Yu, Xuefeng; Zhao, Yanting; Xiao, Xiao; Yang, Wei; Wang, Di; Yao, Ping; Hu, Frank B.; Liu, Liegang			Plasma Heme Oxygenase-1 Concentration in Relation to Impaired Glucose Regulation in a Non-Diabetic Chinese Population	PLOS ONE			English	Article							INSULIN-RESISTANCE; DIABETES-MELLITUS; OXIDATIVE STRESS; LIFE-STYLE; DEFINITION; EXPRESSION; DIAGNOSIS; GLYCEMIA; CELLS; MODEL	Background: Our previous study has recently shown that plasma heme oxygenase-1 (HO-1), a stress-responsive protein, is elevated in individuals with type 2 diabetes. The current study aimed to examine the association between plasma HO-1 concentration and impaired glucose regulation (IGR) in non-diabetic individuals. Methods: We conducted a case-control study including a total of 865 subjects (262 IGR individuals and 603 healthy controls) in a Chinese population. Basic characteristics were collected by questionnaire and standardized anthropometric measurements. Plasma HO-1 concentration was determined by ELISA. Results: Plasma HO-1 concentration was significantly increased in IGR individuals compared with healthy controls (1.34 (0.81-2.29) ng/ml vs 0.98 (0.56-1.55) ng/ml, P<0.001). After adjustment for age, sex, and BMI, the ORs for IGR in the highest quartile of plasma HO-1 concentrations, compared with the lowest, was 3.42 (95% CI 2.11-5.54; P for trend,0.001). The trend remained significant even after additional adjustment for smoking, alcohol drinking, hypertension, family history of diabetes, lipid profiles and C-reactive protein. In the receiver-operating characteristic curve analysis, addition of plasma HO-1 concentration to a model with known risk factors yielded significantly improved discriminative value for IGR (area under the curves 0.75 (95% CI 0.71-0.78) vs. 0.72 (95% CI 0.69-0.76); P for difference = 0.026). Conclusions: Elevated plasma HO-1 concentration is significantly associated with increased ORs for IGR. However, its clinical utility should be validated in further studies, especially in prospective cohort studies.	[Bao, Wei; Rong, Shuang; Zhao, Yanting; Xiao, Xiao; Yang, Wei; Wang, Di; Yao, Ping; Liu, Liegang] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Nutr & Food Hyg, Wuhan 430074, Peoples R China; [Bao, Wei; Rong, Shuang; Zhao, Yanting; Xiao, Xiao; Yang, Wei; Wang, Di; Yao, Ping; Liu, Liegang] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, China Minist Educ Key Lab Environm & Hlth, Wuhan 430074, Peoples R China; [Zhang, Muxun; Yu, Xuefeng] Huazhong Univ Sci & Technol, Tongji Med Coll, Inst Endocrinol, Dept Internal Med,Tongji Hosp, Wuhan 430074, Peoples R China; [Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Bao, W (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Nutr & Food Hyg, Wuhan 430074, Peoples R China.	fhu@hsph.harvard.edu; lgliu@mails.tjmu.edu.cn	Bao, Wei/AAG-2431-2019	Bao, Wei/0000-0002-7301-5786	National Natural Science Foundation [NSFC-30872116]; National High Technology Research and Development Program (863 Program) of China [2009AA022704]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program (863 Program) of China(National High Technology Research and Development Program of China)	This study was supported by National Natural Science Foundation (NSFC-30872116) and National High Technology Research and Development Program (863 Program, 2009AA022704) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Bao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012371; Caselli C, 2011, EUR HEART J, V32, P1092; de Vegt F, 2001, JAMA-J AM MED ASSOC, V285, P2109, DOI 10.1001/jama.285.16.2109; Evans JL, 2003, DIABETES, V52, P1, DOI 10.2337/diabetes.52.1.1; Gavin JR, 1999, DIABETES CARE, V22, pS5; Jonas JC, 2003, DIABETOLOGIA, V46, P1234, DOI 10.1007/s00125-003-1174-9; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kolberg JA, 2009, DIABETES CARE, V32, P1207, DOI 10.2337/dc08-1935; Lee TS, 2002, NAT MED, V8, P240, DOI 10.1038/nm0302-240; Mateo I, 2010, ACTA NEUROL SCAND, V121, P136, DOI 10.1111/j.1600-0404.2009.01261.x; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Morse D, 2002, AM J RESP CELL MOL, V27, P8, DOI 10.1165/ajrcmb.27.1.4862; Okuhara K, 2010, SOUTH MED J, V103, P876, DOI 10.1097/SMJ.0b013e3181eac06a; Platt JL, 1998, NAT MED, V4, P1364, DOI 10.1038/3947; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Sato T, 2006, AM J RESP CRIT CARE, V174, P906, DOI 10.1164/rccm.200508-1237OC; Saukkonen K, 2010, SHOCK, V34, P558, DOI 10.1097/SHK.0b013e3181e14de9; Schipper HM, 2000, NEUROLOGY, V54, P1297, DOI 10.1212/WNL.54.6.1297; Song FF, 2007, CLIN SCI, V112, P599, DOI 10.1042/CS20060323; Tabak AG, 2009, LANCET, V373, P2215, DOI 10.1016/S0140-6736(09)60619-X; Tiedge M, 1997, DIABETES, V46, P1733, DOI 10.2337/diabetes.46.11.1733; Tuomilehto Jaakko, 2001, New England Journal of Medicine, V344, P1343, DOI 10.1056/NEJM200105033441801; Unwin N, 2002, DIABETIC MED, V19, P708, DOI 10.1046/j.1464-5491.2002.00835.x; Won KC, 2006, J KOREAN MED SCI, V21, P418, DOI 10.3346/jkms.2006.21.3.418	26	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e32223	10.1371/journal.pone.0032223	http://dx.doi.org/10.1371/journal.pone.0032223			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427825	Green Published, gold, Green Submitted			2022-12-25	WOS:000302381500009
J	Pereira, RL; Reis, VO; Semedo, P; Buscariollo, BN; Donizetti-Oliveira, C; Cenedeze, MA; Soares, MF; Pacheco-Silva, A; Savage, PB; Camara, NOS; Keller, AC				Pereira, Rafael L.; Reis, Vanessa O.; Semedo, Patricia; Buscariollo, Bruna N.; Donizetti-Oliveira, Cassiano; Cenedeze, Marcos A.; Soares, Maria Fernanda; Pacheco-Silva, Alvaro; Savage, Paul B.; Camara, Niels O. S.; Keller, Alexandre C.			Invariant Natural Killer T Cell Agonist Modulates Experimental Focal and Segmental Glomerulosclerosis	PLOS ONE			English	Article							CHRONIC RENAL-DISEASE; V(ALPHA)14 NKT CELLS; TGF-BETA; ALPHA-GALACTOSYLCERAMIDE; DOXORUBICIN NEPHROPATHY; TRANSCRIPTION FACTOR; NEPHROTIC SYNDROME; GENE-EXPRESSION; IMMUNE-SYSTEM; INKT-CELLS	A growing body of evidence demonstrates a correlation between Th2 cytokines and the development of focal and segmental glomerulosclerosis ( FSGS). Therefore, we hypothesized that GSL-1, a monoglycosylceramide from Sphingomonas ssp. with pro-Th1 activity on invariant Natural Killer T ( iNKT) lymphocytes, could counterbalance the Th2 profile and modulate glomerulosclerosis. Using an adriamycin( ADM)-based model of FSGS, we found that BALB/c mice presented albuminuria and glomerular degeneration in association with a Th2-like pro-fibrogenic profile; these mice also expressed a combination of inflammatory cytokines, such as IL-4, IL-1 alpha, IL-1 beta, IL-17, TNF-alpha, and chemokines, such as RANTES and eotaxin. In addition, we observed a decrease in the mRNA levels of GD3 synthase, the enzyme responsible for GD3 metabolism, a glycolipid associated with podocyte physiology. GSL-1 treatment inhibited ADM-induced renal dysfunction and preserved kidney architecture, a phenomenon associated with the induction of a Th1-like response, increased levels of GD3 synthase transcripts and inhibition of pro-fibrotic transcripts and inflammatory cytokines. TGF-beta analysis revealed increased levels of circulating protein and tissue transcripts in both ADM- and GSL-1-treated mice, suggesting that TGF-beta could be associated with both FSGS pathology and iNKT-mediated immunosuppression; therefore, we analyzed the kidney expression of phosphorylated SMAD2/3 and SMAD7 proteins, molecules associated with the deleterious and protective effects of TGF-beta, respectively. We found high levels of phosphoSMAD2/3 in ADM mice in contrast to the GSL-1 treated group in which SMAD7 expression increased. These data suggest that GSL-1 treatment modulates the downstream signaling of TGF-beta through a renoprotective pathway. Finally, GSL-1 treatment at day 4, a period when proteinuria was already established, was still able to improve renal function, preserve renal structure and inhibit fibrogenic transcripts. In conclusion, our work demonstrates that the iNKT agonist GSL-1 modulates the pathogenesis of ADM-induced glomerulosclerosis and may provide an alternative approach to disease management.	[Pereira, Rafael L.; Reis, Vanessa O.; Semedo, Patricia; Buscariollo, Bruna N.; Donizetti-Oliveira, Cassiano; Cenedeze, Marcos A.; Soares, Maria Fernanda; Pacheco-Silva, Alvaro; Camara, Niels O. S.; Keller, Alexandre C.] Univ Fed Sao Paulo, Dept Med Nefrol, Sao Paulo, Brazil; [Pacheco-Silva, Alvaro] Inst Israelita Ensino & Pesquisa Albert Einstein, Unidade Transplante Renal, Sao Paulo, Brazil; [Savage, Paul B.] Brigham Young Univ, Dept Chem & Biochem, Provo, UT 84602 USA; [Camara, Niels O. S.] Univ Sao Paulo, Dept Imunol, Sao Paulo, Brazil; [Keller, Alexandre C.] Univ Fed Sao Paulo, Dept Microbiol Imunol & Parasitol, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Hospital Israelita Albert Einstein; Brigham Young University; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Pereira, RL (corresponding author), Univ Fed Sao Paulo, Dept Med Nefrol, Sao Paulo, Brazil.	ackeller.unifesp@gmail.com	Savage, Paul B/HGB-3414-2022; camara, niels olsen saraiva/AAX-3269-2020; Camara, Niels OS/G-8336-2011; Complexos, INCT Fluidos/H-9172-2013; Semedo-Kuriki, Patricia/D-2429-2010; Pacheco-Silva, Alvaro/K-3583-2013; Savage, Paul B/E-1448-2011; Keller, Alexandre C/E-4621-2012	Savage, Paul B/0000-0002-4642-6109; camara, niels olsen saraiva/0000-0001-5436-1248; Camara, Niels OS/0000-0001-5436-1248; Savage, Paul B/0000-0002-4642-6109; Keller, Alexandre C/0000-0002-7827-0292; Semedo-Kuriki, Patricia/0000-0002-2136-3308; Soares, Maria Fernanda/0000-0001-6231-8987; Pereira, Rafael/0000-0002-6056-724X	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2007/07120-0]; Conselho Nacional de Desenvolvimento Cientificoe Tecnologico, Brazil [501848/2009-6, 484445/2010-3]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientificoe Tecnologico, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (no 2007/07120-0) and Conselho Nacional de Desenvolvimento Cientificoe Tecnologico (no 501848/2009-6 and 484445/2010-3), Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amore A, 1996, NEPHROL DIAL TRANSPL, V11, P1012; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Barisoni L, 2009, ARCH PATHOL LAB MED, V133, P201, DOI 10.1043/1543-2165-133.2.201; Cerundolo V, 2007, CURR TOP MICROBIOL, V314, P325; Cerundolo V, 2009, NAT REV IMMUNOL, V9, P28, DOI 10.1038/nri2451; Coppieters K, 2007, J IMMUNOL, V179, P2300, DOI 10.4049/jimmunol.179.4.2300; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; Fujii S, 2003, J EXP MED, V198, P267, DOI 10.1084/jem.20030324; Hachem P, 2005, EUR J IMMUNOL, V35, P2793, DOI 10.1002/eji.200535268; Harris RC, 2006, ANNU REV MED, V57, P365, DOI 10.1146/annurev.med.57.121304.131342; HOLTHOFER H, 1994, KIDNEY INT, V45, P123, DOI 10.1038/ki.1994.14; Holthofer H, 1996, AM J PATHOL, V149, P1009; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Lai KW, 2007, J AM SOC NEPHROL, V18, P1476, DOI 10.1681/ASN.2006070710; Le Berre L, 2005, KIDNEY INT, V68, P2079; Lee GR, 2001, IMMUNITY, V14, P447, DOI 10.1016/S1074-7613(01)00125-X; Lee HS, 2010, KIDNEY BLOOD PRESS R, V33, P24, DOI 10.1159/000285844; Lee VW, NEPHROLOGY CARLTON, V16, P30; Li YJ, 2008, AM J PATHOL, V172, P299, DOI 10.2353/ajpath.2008.070057; Long XT, 2007, NAT CHEM BIOL, V3, P559, DOI 10.1038/nchembio.2007.19; Matsuda H, 2005, AM J RESP CELL MOL, V33, P22, DOI 10.1165/rcmb.2004-0010OC; Matsuda JL, 2008, CURR OPIN IMMUNOL, V20, P358, DOI 10.1016/j.coi.2008.03.018; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; Mesnard L, 2009, J AM SOC NEPHROL, V20, P1282, DOI 10.1681/ASN.2008040433; Mozes MM, 1999, J AM SOC NEPHROL, V10, P271; Mu W, 2005, J AM SOC NEPHROL, V16, P3651, DOI 10.1681/ASN.2005030297; Noguchi M, 2006, GLYCOBIOLOGY, V16, P641, DOI 10.1093/glycob/cwj103; Paget C, 2007, IMMUNITY, V27, P597, DOI 10.1016/j.immuni.2007.08.017; Paget C, 2009, J IMMUNOL, V182, P1846, DOI 10.4049/jimmunol.0802492; Park SW, 2004, EXP MOL MED, V36, P211, DOI 10.1038/emm.2004.29; Pease JE, 2006, CURR DRUG TARGETS, V7, P3, DOI 10.2174/138945006775270204; Pippin JW, 2009, AM J PHYSIOL-RENAL, V296, pF213, DOI 10.1152/ajprenal.90421.2008; REIVINEN J, 1992, KIDNEY INT, V42, P624, DOI 10.1038/ki.1992.327; Schiffer M, 2002, J AM SOC NEPHROL, V13, P2657, DOI 10.1097/01.ASN.0000033276.06451.50; Shimaoka T, 2007, J IMMUNOL, V179, P8172, DOI 10.4049/jimmunol.179.12.8172; Simons M, 2001, AM J PATHOL, V159, P1069, DOI 10.1016/S0002-9440(10)61782-8; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Wang WS, 2005, J AM SOC NEPHROL, V16, P1371, DOI 10.1681/ASN.2004121070; Wang Y, 2000, KIDNEY INT, V58, P1797, DOI 10.1046/j.1523-1755.2000.00342.x; Wu DT, 2005, J AM SOC NEPHROL, V16, P3211, DOI 10.1681/ASN.2004121055; Yap HK, 1999, J AM SOC NEPHROL, V10, P529; Yoshida S, 2008, NEPHRON EXP NEPHROL, V108, pE57, DOI 10.1159/000124236; Zeisberg M, 2004, BLOOD PURIFICAT, V22, P440, DOI 10.1159/000080790; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zheng ZY, 2006, J AM SOC NEPHROL, V17, P1796, DOI 10.1681/ASN.2005121373; Zheng ZY, 2005, P NATL ACAD SCI USA, V102, P2502, DOI 10.1073/pnas.0409786102	46	15	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e32454	10.1371/journal.pone.0032454	http://dx.doi.org/10.1371/journal.pone.0032454			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427838	Green Submitted, gold, Green Published			2022-12-25	WOS:000302381500017
J	Schrobsdorff, H; Ihrke, M; Behrendt, J; Herrmann, JM; Hasselhorn, M				Schrobsdorff, Hecke; Ihrke, Matthias; Behrendt, Joerg; Herrmann, J. Michael; Hasselhorn, Marcus			Identity Negative Priming: A Phenomenon of Perception, Recognition or Selection?	PLOS ONE			English	Article							INHIBITORY MECHANISMS; DISTRACTOR INHIBITION; COGNITIVE CONTROL; TIME-COURSE; ATTENTION; TASK; RETRIEVAL; INTERFERENCE; PARADIGM; BRAIN	The present study addresses the problem whether negative priming (NP) is due to information processing in perception, recognition or selection. We argue that most NP studies confound priming and perceptual similarity of prime-probe episodes and implement a color-switch paradigm in order to resolve the issue. In a series of three identity negative priming experiments with verbal naming response, we determined when NP and positive priming (PP) occur during a trial. The first experiment assessed the impact of target color on priming effects. It consisted of two blocks, each with a different fixed target color. With respect to target color no differential priming effects were found. In Experiment 2 the target color was indicated by a cue for each trial. Here we resolved the confounding of perceptual similarity and priming condition. In trials with coinciding colors for prime and probe, we found priming effects similar to Experiment 1. However, trials with a target color switch showed such effects only in trials with role-reversal (distractor-to-target or target-to-distractor), whereas the positive priming (PP) effect in the target-repetition trials disappeared. Finally, Experiment 3 split trial processing into two phases by presenting the trial-wise color cue only after the stimulus objects had been recognized. We found recognition in every priming condition to be faster than in control trials. We were hence led to the conclusion that PP is strongly affected by perception, in contrast to NP which emerges during selection, i.e., the two effects cannot be explained by a single mechanism.	[Schrobsdorff, Hecke; Ihrke, Matthias; Behrendt, Joerg; Herrmann, J. Michael; Hasselhorn, Marcus] Bernstein Ctr Computat Neurosci, Gottingen, Germany; [Schrobsdorff, Hecke; Ihrke, Matthias] Max Planck Inst Dynam & Self Org, Gottingen, Germany; [Schrobsdorff, Hecke; Ihrke, Matthias] Univ Gottingen, Inst Nonlinear Dynam, Gottingen, Germany; [Behrendt, Joerg] Univ Gottingen, Georg Elias Muller Inst Psychol, Gottingen, Germany; [Herrmann, J. Michael] Univ Edinburgh, Inst Percept Act & Behav, Edinburgh, Midlothian, Scotland; [Hasselhorn, Marcus] German Inst Int Educ Res DIPF, Frankfurt, Germany	Max Planck Society; University of Gottingen; University of Gottingen; University of Edinburgh; German Institute for International Educational Research	Schrobsdorff, H (corresponding author), Bernstein Ctr Computat Neurosci, Gottingen, Germany.	hecke@nld.ds.mpg.de		Mittner, Matthias/0000-0003-0205-7353	Federal Ministry of Education and Research Germany (BMBF) [01GQ0432, 01GQ1005B]	Federal Ministry of Education and Research Germany (BMBF)(Federal Ministry of Education & Research (BMBF))	The funder, the Federal Ministry of Education and Research Germany (BMBF, http://www.bmbf.de/, grant numbers 01GQ0432 and 01GQ1005B), had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allport D.A., 1985, ATTENTION PERFORM, P107; Behrendt J, 2010, PSYCHOPHYSIOLOGY, V47, P921, DOI 10.1111/j.1469-8986.2010.00989.x; Bermeitinger C, 2008, BRAIN LANG, V106, P153, DOI 10.1016/j.bandl.2008.03.003; Broadbent D. E., 1971, DECISION STRESS; CALVIN WH, 1987, NATURE, V330, P33, DOI 10.1038/330033a0; Christie J, 2001, CAN J EXP PSYCHOL, V55, P24, DOI 10.1037/h0087350; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Dalrymple-Alford E, 1966, 15 PERCEPTUAL MOTOR, V23, P1211; FOX E, 1995, PSYCHON B REV, V2, P145, DOI 10.3758/BF03210958; Frings C, 2007, Q J EXP PSYCHOL, V60, P1367, DOI 10.1080/17470210600955645; Frings C, 2007, VIS COGN, V15, P166, DOI 10.1080/13506280500475264; Frings C, 2011, J EXP PSYCHOL LEARN, V37, P1209, DOI 10.1037/a0023915; Frings C, 2009, EXP PSYCHOL, V56, P301, DOI 10.1027/1618-3169.56.5.301; Gamboz N, 2002, PSYCHOL AGING, V17, P525, DOI 10.1037/0882-7974.17.3.525; Gibbons H, 2004, Q J EXP PSYCHOL-A, V57, P61, DOI 10.1080/02724980343000125; Gibbons H, 2006, J PSYCHOPHYSIOL, V20, P170, DOI 10.1027/0269-8803.20.3.170; Grison S, 2001, PERCEPT PSYCHOPHYS, V63, P1063, DOI 10.3758/BF03194524; Holm S, 1979, SCANDINAVIAN J STAT, V6, P1979; Hommel B, 2005, J EXP PSYCHOL HUMAN, V31, P1067, DOI 10.1037/0096-1523.31.5.1067; Houghton G, 1996, VIS COGN, V3, P119, DOI 10.1080/713756733; Houghton G, 1996, BRAIN COGNITION, V30, P20, DOI 10.1006/brcg.1996.0003; Houghton George, 1994, P53; Ihrke M, 2011, FRONTIERS PSYCHOL, P2; Ihrke M, 2011, EXP PSYCHOL, V58, P154, DOI 10.1027/1618-3169/a000081; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Kane MJ, 1997, J EXP PSYCHOL HUMAN, V23, P632, DOI 10.1037/0096-1523.23.3.632; Kiesel A, 2010, PSYCHOL BULL, V136, P849, DOI 10.1037/a0019842; Koch I, 2010, PSYCHON B REV, V17, P1, DOI 10.3758/PBR.17.1.1; Lavie N, 2000, J EXP PSYCHOL HUMAN, V26, P1038, DOI 10.1037//0096-1523.26.3.1038; Lavie N, 2004, J EXP PSYCHOL GEN, V133, P339, DOI 10.1037/0096-3445.133.3.339; LOGAN GD, 1988, PSYCHOL REV, V95, P492, DOI 10.1037/0033-295X.95.4.492; LOWE DG, 1985, MEM COGNITION, V13, P74, DOI 10.3758/BF03198446; MacLeod CM, 2002, PSYCHON B REV, V9, P521, DOI 10.3758/BF03196308; Marczinski CA, 2003, PSYCHOL AGING, V18, P780, DOI 10.1037/0882-7974.18.4.780; MAY CP, 1995, PSYCHOL BULL, V118, P35, DOI 10.1037/0033-2909.118.1.35; Mayr S, 2007, Z PSYCHOL, V215, P35, DOI 10.1027/0044-3409.215.1.35; Mayr S, 2009, Q J EXP PSYCHOL, V62, P645, DOI 10.1080/17470210802483487; MILLIKEN B, 1994, J EXP PSYCHOL HUMAN, V20, P624, DOI 10.1037/0096-1523.20.3.624; Milliken B, 1998, PSYCHOL REV, V105, P203, DOI 10.1037/0033-295X.105.2.203; MOORE CM, 1994, PERCEPT PSYCHOPHYS, V56, P133, DOI 10.3758/BF03213892; Neill W.T., 1998, PSYCHOL LEARNING MOT, V38, P1, DOI DOI 10.1016/S0079-7421(08)60182-6; Neill WT, 1999, PSYCHON B REV, V6, P304, DOI 10.3758/BF03212334; Neill WT, 1997, J EXP PSYCHOL LEARN, V23, P1291, DOI 10.1037/0278-7393.23.6.1291; NEILL WT, 1987, J EXP PSYCHOL LEARN, V13, P327, DOI 10.1037/0278-7393.13.2.327; NEILL WT, 1992, J EXP PSYCHOL LEARN, V18, P993, DOI 10.1037/0278-7393.18.5.993; NEILL WT, 1977, J EXP PSYCHOL HUMAN, V3, P444, DOI 10.1037/0096-1523.3.3.444; Neill WT, 2007, INHIBITION COGNITION, V5, P63; NEUMANN E, 1992, CAN J PSYCHOL, V46, P1, DOI 10.1037/h0084309; PARK JY, 1994, J EXP PSYCHOL HUMAN, V20, P613, DOI 10.1037/0096-1523.20.3.613; Rothermund K, 2005, J EXP PSYCHOL LEARN, V31, P482, DOI 10.1037/0278-7393.31.3.482; Sarter M, 2001, BRAIN RES REV, V35, P146, DOI 10.1016/S0165-0173(01)00044-3; Schrobsdorff H, 2007, CONNECT SCI, V19, P203, DOI 10.1080/09540090701507823; SPERLING G, 1960, PSYCHOL MONOGR, V74, P1, DOI 10.1037/h0093759; Spieler DH, 1996, PSYCHOL AGING, V11, P607, DOI 10.1037/0882-7974.11.4.607; Tipper S. P, 1990, ADV PSYCHOL, V69, P197, DOI DOI 10.1016/S0166-4115(08)60457-4; TIPPER SP, 1988, MEM COGNITION, V16, P64, DOI 10.3758/BF03197746; Tipper SP, 2001, Q J EXP PSYCHOL-A, V54, P321, DOI 10.1080/02724980042000183; TIPPER SP, 1988, PERCEPT PSYCHOPHYS, V43, P45, DOI 10.3758/BF03208972; TIPPER SP, 1991, J EXP PSYCHOL LEARN, V17, P681, DOI 10.1037/0278-7393.17.4.681; TIPPER SP, 1985, Q J EXP PSYCHOL-A, V37, P591, DOI 10.1080/14640748508400921; TIPPER SP, 1987, PERS INDIV DIFFER, V8, P667, DOI 10.1016/0191-8869(87)90064-X; Tipper SP, 2002, VIS COGN, V9, P591, DOI 10.1080/13506280143000593; TIPPER SP, 1985, Q J EXP PSYCHOL-A, V37, P571, DOI 10.1080/14640748508400920; Titz C., 2003, Z GERONTOPSYCHOLOGIE, V16, P169, DOI [10.1024/1011-6877.16.4.169, DOI 10.1024/1011-6877.16.4.169]; Titz C, 2008, EXP AGING RES, V34, P340, DOI 10.1080/03610730802273936; Verhaeghen P, 1998, PSYCHOL AGING, V13, P435, DOI 10.1037/0882-7974.13.3.435; Waszak F, 2005, MEM COGNITION, V33, P595, DOI 10.3758/BF03195327; Wentura D, 2005, J EXP PSYCHOL LEARN, V31, P108, DOI 10.1037/0278-7393.31.1.108	68	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e32946	10.1371/journal.pone.0032946	http://dx.doi.org/10.1371/journal.pone.0032946			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	920DF	22427915	Green Published, gold			2022-12-25	WOS:000302381500066
J	Huart, C; Legrain, V; Hummel, T; Rombaux, P; Mouraux, A				Huart, Caroline; Legrain, Valery; Hummel, Thomas; Rombaux, Philippe; Mouraux, Andre			Time-Frequency Analysis of Chemosensory Event-Related Potentials to Characterize the Cortical Representation of Odors in Humans	PLOS ONE			English	Article							EVOKED-POTENTIALS; OLFACTORY FUNCTION; CLINICAL-SIGNIFICANCE; BLIND SEPARATION; EEG-RESPONSES; STIMULATION; SYNCHRONIZATION; AGE; RETRONASAL; DIAGNOSIS	Background: The recording of olfactory and trigeminal chemosensory event-related potentials (ERPs) has been proposed as an objective and non-invasive technique to study the cortical processing of odors in humans. Until now, the responses have been characterized mainly using across-trial averaging in the time domain. Unfortunately, chemosensory ERPs, in particular, olfactory ERPs, exhibit a relatively low signal-to-noise ratio. Hence, although the technique is increasingly used in basic research as well as in clinical practice to evaluate people suffering from olfactory disorders, its current clinical relevance remains very limited. Here, we used a time-frequency analysis based on the wavelet transform to reveal EEG responses that are not strictly phase-locked to onset of the chemosensory stimulus. We hypothesized that this approach would significantly enhance the signal-to-noise ratio of the EEG responses to chemosensory stimulation because, as compared to conventional time-domain averaging, (1) it is less sensitive to temporal jitter and (2) it can reveal non phase-locked EEG responses such as event-related synchronization and desynchronization. Methodology/Principal Findings: EEG responses to selective trigeminal and olfactory stimulation were recorded in 11 normosmic subjects. A Morlet wavelet was used to characterize the elicited responses in the time-frequency domain. We found that this approach markedly improved the signal-to-noise ratio of the obtained EEG responses, in particular, following olfactory stimulation. Furthermore, the approach allowed characterizing non phase-locked components that could not be identified using conventional time-domain averaging. Conclusion/Significance: By providing a more robust and complete view of how odors are represented in the human brain, our approach could constitute the basis for a robust tool to study olfaction, both for basic research and clinicians.	[Huart, Caroline; Legrain, Valery; Rombaux, Philippe; Mouraux, Andre] Catholic Univ Louvain, Inst Neurosci IONS, B-1200 Brussels, Belgium; [Huart, Caroline; Rombaux, Philippe] Clin Univ St Luc, Dept Otorhinolaryngol, Brussels, Belgium; [Legrain, Valery] Univ Ghent, Dept Expt Clin & Hlth Psychol, B-9000 Ghent, Belgium; [Hummel, Thomas] Tech Univ Dresden, Dresden Med Sch, Dept Otorhinolaryngol, D-01062 Dresden, Germany	Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Ghent University; Technische Universitat Dresden	Huart, C (corresponding author), Catholic Univ Louvain, Inst Neurosci IONS, B-1200 Brussels, Belgium.	caroline.huart@uclouvain.be	Mouraux, Andre/F-3724-2012	Mouraux, Andre/0000-0003-1056-5980; Huart, Caroline/0000-0001-9763-1981	(FNRS) of the French-speaking Community of Belgium; Research Foundation Flanders (FWO), Belgium; Pain Research EFIC; IASP; Marie Curie European Reintegration Grant (ERG)	(FNRS) of the French-speaking Community of Belgium(Fonds de la Recherche Scientifique - FNRS); Research Foundation Flanders (FWO), Belgium(FWO); Pain Research EFIC; IASP; Marie Curie European Reintegration Grant (ERG)(European Commission)	Dr. Huart is MD PhD student supported by the Fund for Scientific Research (F.R.S.-FNRS) of the French-speaking Community of Belgium. Dr. Legrain is a postdoctoral researcher supported by the Research Foundation Flanders (FWO), Belgium. Dr. Mouraux has received support from the Pain Research EFIC-Grunenthal Grant 2008 (EGG), the IASP Early Career Research Grant, and a from a Marie Curie European Reintegration Grant (ERG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON T, 1967, ELECTROEN CLIN NEURO, V23, P558, DOI 10.1016/0013-4694(67)90022-3; AUFFERMANN H, 1993, ANN OTO RHINOL LARYN, V102, P6, DOI 10.1177/000348949310200102; Barz S, 1997, NEUROLOGY, V49, P1424, DOI 10.1212/WNL.49.5.1424; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Bewick V, 2004, CRIT CARE, V8, P508, DOI 10.1186/cc3000; Boesveldt S, 2007, CLIN NEUROPHYSIOL, V118, P690, DOI 10.1016/j.clinph.2006.11.004; Boyle JA, 2007, CHEM SENSES, V32, P343, DOI 10.1093/chemse/bjm004; Buonviso N, 2006, CHEM SENSES, V31, P145, DOI 10.1093/chemse/bjj010; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Djordjevic J, 2008, NEUROBIOL AGING, V29, P693, DOI 10.1016/j.neurobiolaging.2006.11.014; Ergen M, 2008, NEUROSCI LETT, V440, P304, DOI 10.1016/j.neulet.2008.05.054; EVANS WJ, 1995, ELECTROEN CLIN NEURO, V95, P293, DOI 10.1016/0013-4694(95)00055-4; FINKENZELLER P, 1966, PFLUG ARCH GES PHYS, V292, P76, DOI 10.1007/BF00413126; FIRESTEIN S, 1990, J PHYSIOL-LONDON, V430, P135, DOI 10.1113/jphysiol.1990.sp018286; Fischer JE, 2003, INTENS CARE MED, V29, P1043, DOI 10.1007/s00134-003-1761-8; Frasnelli J, 2007, CEREB CORTEX, V17, P370, DOI 10.1093/cercor/bhj154; Geisler MW, 2000, INT J PSYCHOPHYSIOL, V37, P309, DOI 10.1016/S0167-8760(00)00111-2; GETCHELL TV, 1978, J PHYSIOL-LONDON, V282, P521, DOI 10.1113/jphysiol.1978.sp012479; Haehner A, 2011, NEUROSCIENCE, V175, P178, DOI 10.1016/j.neuroscience.2010.11.038; Haehner A, 2007, MOVEMENT DISORD, V22, P839, DOI 10.1002/mds.21413; Hansenne M, 2000, NEUROPHYSIOL CLIN, V30, P191, DOI 10.1016/S0987-7053(00)00223-9; Herting B, 2008, J NEUROL, V255, P367, DOI 10.1007/s00415-008-0665-5; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Hummel T, 1998, EVOKED POTENTIAL, V108, P208, DOI 10.1016/S0168-5597(97)00074-9; Hummel T, 2003, TOXICOL LETT, V140, P273, DOI 10.1016/S0378-4274(03)00078-X; Hummel T, 2003, INT J PSYCHOPHYSIOL, V47, P147, DOI 10.1016/S0167-8760(02)00150-2; Hummel T, 1999, EUR ARCH OTO-RHINO-L, V256, P16, DOI 10.1007/s004050050115; HUMMEL T, 1992, ELECTROEN CLIN NEURO, V84, P84, DOI 10.1016/0168-5597(92)90070-R; Hummel T, 2000, HNO, V48, P481, DOI 10.1007/s001060050602; Hummel T, 2002, METHODS NEW FRONTIER; Jung TP, 2000, CLIN NEUROPHYSIOL, V111, P1745, DOI 10.1016/S1388-2457(00)00386-2; Katzenschlager R, 2004, CURR OPIN NEUROL, V17, P417, DOI 10.1097/01.wco.0000137531.76491.c2; KOBAL G, 1988, ELECTROEN CLIN NEURO, V71, P241, DOI 10.1016/0168-5597(88)90023-8; KOBAL G, 1978, EEG-EMG-Z ELEK ELEKT, V9, P135; Kobal G., 1996, Rhinology (Utrecht), V34, P222; Kobal G, 1998, LARYNGOSCOPE, V108, P1033, DOI 10.1097/00005537-199807000-00015; Kobal G, 1981, ELEKTROPHYSIOLOGISCH; Landis BN, 2004, LARYNGOSCOPE, V114, P1764, DOI 10.1097/00005537-200410000-00017; Laudien JH, 2008, NEUROIMAGE, V41, P1426, DOI 10.1016/j.neuroimage.2008.03.046; Livermore A, 2004, CHEM SENSES, V29, P41, DOI 10.1093/chemse/bjh013; Lotsch J, 2006, BEHAV BRAIN RES, V170, P78, DOI 10.1016/j.bbr.2006.02.013; Lorig TS, 1996, INT J PSYCHOPHYSIOL, V23, P199, DOI 10.1016/S0167-8760(96)00061-X; Makeig S, 1997, P NATL ACAD SCI USA, V94, P10979, DOI 10.1073/pnas.94.20.10979; Makeig S., 2000, Second International Workshop on Independent Component Analysis and Blind Signal Separation. Proceedings, P627; Mesholam RI, 1998, ARCH NEUROL-CHICAGO, V55, P84, DOI 10.1001/archneur.55.1.84; Mima T, 2001, J NEUROSCI, V21, P3942, DOI 10.1523/JNEUROSCI.21-11-03942.2001; Moncrief RW, 1962, PERFUMERY ESSENTIAL, V53, P727; Mouraux A, 2008, MAGN RESON IMAGING, V26, P1041, DOI 10.1016/j.mri.2008.01.011; Mouraux A, 2003, CLIN NEUROPHYSIOL, V114, P710, DOI 10.1016/S1388-2457(03)00027-0; Nanova P, 2011, CLIN NEUROPHYSIOL, V122, P907, DOI 10.1016/j.clinph.2010.09.012; Neuland C, 2011, LARYNGOSCOPE, V121, P867, DOI 10.1002/lary.21387; Neuper C, 2001, INT J PSYCHOPHYSIOL, V43, P41, DOI 10.1016/S0167-8760(01)00178-7; Olofsson JK, 2006, CHEM SENSES, V31, P699, DOI 10.1093/chemse/bjl011; Pause BM, 2000, INT J PSYCHOPHYSIOL, V36, P105, DOI 10.1016/S0167-8760(99)00105-1; Pause BM, 1996, PSYCHOPHYSIOLOGY, V33, P376, DOI 10.1111/j.1469-8986.1996.tb01062.x; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Rombaux P, 2006, NEUROPHYSIOL CLIN, V36, P53, DOI 10.1016/j.neucli.2006.03.005; Rombaux P, 2009, RHINOLOGY, V47, P28; Rombaux P, 2007, LARYNGOSCOPE, V117, P1096, DOI 10.1097/MLG.0b013e31804d1d0d; Rombaux P, 2006, LARYNGOSCOPE, V116, P901, DOI 10.1097/01.mlg.0000217533.60311.e7; Rombaux P, 2010, LARYNGOSCOPE, V120, P2115, DOI 10.1002/lary.21109; Schulz E, 2011, CEREB CORTEX; Schweitzer G, 2001, BIOMED TECH, V46, P24, DOI 10.1515/bmte.2001.46.1-2.24; SINGER W, 1993, ANNU REV PHYSIOL, V55, P349, DOI 10.1146/annurev.physiol.55.1.349; Stuck BA, 2006, CLIN NEUROPHYSIOL, V117, P1367, DOI 10.1016/j.clinph.2006.03.004; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; THURAUF N, 1991, NEUROSCI LETT, V128, P297, DOI 10.1016/0304-3940(91)90283-Y; THURAUF N, 1993, BRAIN RES, V629, P293, DOI 10.1016/0006-8993(93)91333-N; Wang LW, 2002, CLIN NEUROPHYSIOL, V113, P542, DOI 10.1016/S1388-2457(02)00029-9; Welge-Lussen A, 2003, J CLIN NEUROPHYSIOL, V20, P135, DOI 10.1097/00004691-200304000-00008; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	71	36	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2012	7	3							e33221	10.1371/journal.pone.0033221	http://dx.doi.org/10.1371/journal.pone.0033221			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KX	22427997	gold, Green Published, Green Submitted			2022-12-25	WOS:000303062800050
J	Li, QL; Gu, FM; Wang, Z; Jiang, JH; Yao, LQ; Tan, CJ; Huang, XY; Ke, AW; Dai, Z; Fan, J; Zhou, J				Li, Quan-Lin; Gu, Fang-Ming; Wang, Zheng; Jiang, Jia-Hao; Yao, Li-Qing; Tan, Chang-Jun; Huang, Xiao-Yong; Ke, Ai-Wu; Dai, Zhi; Fan, Jia; Zhou, Jian			Activation of PI3K/AKT and MAPK Pathway through a PDGFR beta-Dependent Feedback Loop Is Involved in Rapamycin Resistance in Hepatocellular Carcinoma	PLOS ONE			English	Article							SIROLIMUS-BASED IMMUNOSUPPRESSION; LIVER-TRANSPLANTATION; ORTHOTOPIC MODEL; C-MYC; SORAFENIB; GROWTH; RECEPTOR; RECURRENCE; SURVIVAL; THERAPY	Background: Rapamycin is an attractive approach for the treatment and prevention of HCC recurrence after liver transplantation. However, the objective response rates of rapamycin achieved with single-agent therapy were modest, supporting that rapamycin resistance is a frequently observed characteristic of many cancers. Some studies have been devoted to understanding the mechanisms of rapamycin resistance, however, the mechanisms are cell-type-dependent and studies on rapamycin resistance in HCC are extremely limited. Methodology/Principal Findings: The anti-tumor sensitivity of rapamycin was modest in vitro and in vivo. In both human and rat HCC cells, rapamycin up-regulated the expression and phosphorylation of PDGFR beta in a time and dose-dependent manner as assessed by RT-PCR and western blot analysis. Using siRNA mediated knockdown of PDGFR beta, we confirmed that subsequent activation of AKT and ERK was PDGFR beta-dependent and compromised the anti-tumor activity of rapamycin. Then, blockade of this PDGFR beta-dependent feedback loop by sorafenib enhanced the anti-tumor sensitivity of rapamycin in vitro and in an immunocompetent orthotopic rat model of HCC. Conclusions: Activation of PI3K/AKT and MAPK pathway through a PDGFR beta-dependent feedback loop compromises the anti-tumor activity of rapamycin in HCC, and blockade of this feedback loop by sorafenib is an attractive approach to improve the anti-tumor effect of rapamycin, particularly in preventing or treating HCC recurrence after liver transplantation.	[Li, Quan-Lin; Gu, Fang-Ming; Wang, Zheng; Jiang, Jia-Hao; Tan, Chang-Jun; Huang, Xiao-Yong; Ke, Ai-Wu; Dai, Zhi; Fan, Jia; Zhou, Jian] Fudan Univ, Zhongshan Hosp, Key Lab Carcinogenesis & Canc Invas, Dept Liver Surg,Liver Canc Inst,Minist Educ, Shanghai 200433, Peoples R China; [Li, Quan-Lin; Yao, Li-Qing] Fudan Univ, Zhongshan Hosp, Endoscopy Ctr, Shanghai 200433, Peoples R China; [Li, Quan-Lin; Yao, Li-Qing] Fudan Univ, Zhongshan Hosp, Endoscopy Res Inst, Shanghai 200433, Peoples R China; [Dai, Zhi; Fan, Jia; Zhou, Jian] Shanghai Key Lab Organ Transplantat, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University	Li, QL (corresponding author), Fudan Univ, Zhongshan Hosp, Key Lab Carcinogenesis & Canc Invas, Dept Liver Surg,Liver Canc Inst,Minist Educ, Shanghai 200433, Peoples R China.	jiafan99@yahoo.com; zhou.jian@zs-hospital.sh.cn	Fan, Jia/C-6689-2017	Li, quanlin/0000-0002-9108-8786; Ke, Ai-Wu/0000-0002-7964-6909	National Natural Science Funds of China [81172277, 30972949]; National Key Sci-Tech Special Project of China [2012ZX10002-016]; Shanghai Key-Tech Research & Development Program [09411951700]	National Natural Science Funds of China(National Natural Science Foundation of China (NSFC)); National Key Sci-Tech Special Project of China; Shanghai Key-Tech Research & Development Program	This study was jointly supported by National Natural Science Funds of China (No. 81172277; No. 30972949), National Key Sci-Tech Special Project of China (No. 2012ZX10002-016), and Shanghai Key-Tech Research & Development Program (No. 09411951700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhoori S, 2010, J HEPATOL, V52, P771, DOI 10.1016/j.jhep.2010.01.025; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Carracedo A, 2008, CELL CYCLE, V7, P3805, DOI 10.4161/cc.7.24.7244; Gu FM, 2011, WORLD J GASTROENTERO, V17, P3922, DOI 10.3748/wjg.v17.i34.3922; Guba M, 2002, NAT MED, V8, P128, DOI 10.1038/nm0202-128; Hackzell A, 2002, J BIOL CHEM, V277, P39769, DOI 10.1074/jbc.M204483200; Huang S, 2001, DRUG RESIST UPDATE, V4, P378, DOI 10.1054/drup.2002.0227; Huynh H, 2009, J CELL MOL MED, V13, P2673, DOI 10.1111/j.1582-4934.2009.00692.x; Izumi H, 2001, J CELL SCI, V114, P1533; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jimenez RH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007373; Jones AV, 2004, CELL MOL LIFE SCI, V61, P2912, DOI 10.1007/s00018-004-4272-z; Kurmasheva RT, 2006, BRIT J CANCER, V95, P955, DOI 10.1038/sj.bjc.6603353; Liu JY, 2011, J BIOL CHEM, V286, P6510, DOI 10.1074/jbc.M110.183087; Manning BD, 2004, J CELL BIOL, V167, P399, DOI 10.1083/jcb.200408161; Molander C, 2001, MOL BIOL REP, V28, P223, DOI 10.1023/A:1015701232589; Piguet AC, 2008, J HEPATOL, V49, P78, DOI 10.1016/j.jhep.2008.03.024; Piguet AC, 2011, MOL CANCER THER, V10, P1007, DOI 10.1158/1535-7163.MCT-10-0666; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schwartz M, 2005, J HEPATOL, V43, P584, DOI 10.1016/j.jhep.2005.07.019; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Toso C, 2010, HEPATOLOGY, V51, P1237, DOI 10.1002/hep.23437; Vivarelli M, 2008, ANN SURG, V248, P857, DOI 10.1097/SLA.0b013e3181896278; Vivarelli M, 2010, TRANSPLANTATION, V89, P227, DOI 10.1097/TP.0b013e3181c3c540; Wang YB, 2010, WORLD J GASTROENTERO, V16, P5518, DOI 10.3748/wjg.v16.i43.5518; Wang Z, 2008, CLIN CANCER RES, V14, P5124, DOI 10.1158/1078-0432.CCR-07-4774; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222; Zhang HB, 2007, J CLIN INVEST, V117, P730, DOI 10.1172/JCI28984; Zhou J, 2008, TRANSPL P, V40, P3548, DOI 10.1016/j.transproceed.2008.03.165; Zhou J, 2006, WORLD J GASTROENTERO, V12, P3114, DOI 10.3748/wjg.v12.i19.3114	31	42	45	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2012	7	3							e33379	10.1371/journal.pone.0033379	http://dx.doi.org/10.1371/journal.pone.0033379			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KX	22428038	gold, Green Published, Green Submitted			2022-12-25	WOS:000303062800055
J	Liu, J; Cheng, X; Zhang, Y; Li, S; Cui, H; Zhang, L; Shi, R; Zhao, Z; He, C; Wang, C; Zhao, H; Zhang, C; Fisk, HA; Guadagno, TM; Cui, Y				Liu, J.; Cheng, X.; Zhang, Y.; Li, S.; Cui, H.; Zhang, L.; Shi, R.; Zhao, Z.; He, C.; Wang, C.; Zhao, H.; Zhang, C.; Fisk, H. A.; Guadagno, T. M.; Cui, Y.			Phosphorylation of Mps1 by BRAF(V600E) prevents Mps1 degradation and contributes to chromosome instability in melanoma	ONCOGENE			English	Article						BRAF(V600E); Mps1; centrosome amplification; chromosome instability; melanoma	SPINDLE-CHECKPOINT; CENTROSOME DUPLICATION; KINASE-ACTIVITY; CELL-CYCLE; ACTIVATION; BRAF; AMPLIFICATION; ACCUMULATION; KINETOCHORES; MUTATIONS	Activating BRAF mutations that deregulate the mitogen-activated protein kinase (MAPK) pathway commonly occur in cancer. BRAF(V600E) induces centrosome amplification and spindle abnormalities that result in aneuploidy. We find modification of Mps1 is critical for contributing to centrosome amplification and chromosome instability induced by BRAF(V600E). Phosphorylation of Mps1 at residue S281 induced by BRAF(V600E) stabilizes Mps1 protein by preventing its ubiquitination by APC/C and subsequent degradation, allowing the non-degraded protein to accumulate at centrosomes. Cells in which endogenous Mps1 was replaced with a phospho-mimetic Mps1 mutant are viable but amplify centrosomes and missegregate chromosomes frequently. Importantly, analysis of tumor micro arrays revealed that phospho-MAPK and 5281-phosphorylated Mps1 were highly correlated in human melanoma tissues, implying that MAPK contributes to defects in the degradation of Mps1 in situ. We propose that continuously activated BRAF(V600E) signaling may be a possible mechanism for the deregulation of Mps1 stability and kinase activity in human tumors, and that persistent phosphorylation of Mps1 through BRAFV600E signaling is a key event in disrupting the control of centrosonne duplication and chromosome stability that may contribute to tumorigenesis. Our findings raise the possibility that targeting the oncogenic BRAF and 5281-phosphorylated Mps1, especially when used in combination could potentially provide great therapeutic opportunities for cancer treatment. Oncogene (2013) 32, 713-723; doi:10.1038/onc.2012.94; published online 19 March 2012	[Liu, J.; Zhao, H.] Shanxi Med Univ, Dept Gen Surg, Hosp 1, Taiyuan 030001, Shanxi, Peoples R China; [Liu, J.; Cheng, X.; Zhang, Y.; Li, S.; Cui, H.; Zhang, L.; Zhao, Z.; He, C.; Zhang, C.; Cui, Y.] Shanxi Med Univ, Minist Educ, Key Lab Cellular Physiol, Taiyuan 030001, Shanxi, Peoples R China; [Cheng, X.; Zhang, Y.; Li, S.; Cui, H.; Zhang, L.; Shi, R.; Zhao, Z.; He, C.; Cui, Y.] Shanxi Med Univ, Dept Cell Biol & Genet, Taiyuan 030001, Shanxi, Peoples R China; [Wang, C.] E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China; [Fisk, H. A.] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; [Guadagno, T. M.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA	Shanxi Medical University; Shanxi Medical University; Shanxi Medical University; East China Normal University; University System of Ohio; Ohio State University; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Cui, Y (corresponding author), Shanxi Med Univ, Dept Cell Biol & Genet, Key Lab Cellular Physiol, Minist Educ, Taiyuan 030001, Shanxi, Peoples R China.	cuiy0922@yahoo.com			Program for New Century Excellent Talents University of China [NCET-10-0872]; National Nature Science Foundation of China [30872932, 30971518, 81071625]; Scientific Research Foundation for the Returned Overseas Chinese Scholars; State Education Ministry [2009-8]; Shanxi Province Foundation for Returness [2008-49]; Trainee Development Award from Bankhead Coley Program [30-15066-02-07]; Program for the Top Young Academic Leaders of Higher Learning Institutions of Shanxi	Program for New Century Excellent Talents University of China(Program for New Century Excellent Talents in University (NCET)); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for the Returned Overseas Chinese Scholars(Scientific Research Foundation for the Returned Overseas Chinese Scholars); State Education Ministry; Shanxi Province Foundation for Returness(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Trainee Development Award from Bankhead Coley Program; Program for the Top Young Academic Leaders of Higher Learning Institutions of Shanxi	We thank Kenji Fukasawa (H Lee Moffitt Cancer Center) for critical reading of this article. This work was supported by the Program for New Century Excellent Talents University of China (Grant NCET-10-0872), National Nature Science Foundation of China (Grant 30872932 & 30971518), Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry (Grant 2009-8), Shanxi Province Foundation for Returness (2008-49), Trainee Development Award from Bankhead Coley Program (Grant 30-15066-02-07) to YC and National Nature Science Foundation of China (Grant 81071625), Program for the Top Young Academic Leaders of Higher Learning Institutions of Shanxi to XC.	Acilan C, 2008, CELL, V134, P572, DOI 10.1016/j.cell.2008.08.007; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Compton DA, 2011, CURR OPIN CELL BIOL, V23, P109, DOI 10.1016/j.ceb.2010.08.007; Cui Y, 2008, ONCOGENE, V27, P3122, DOI 10.1038/sj.onc.1210972; Cui YP, 2010, J BIOL CHEM, V285, P32988, DOI 10.1074/jbc.M110.140905; Cui YP, 2010, CANCER RES, V70, P675, DOI 10.1158/0008-5472.CAN-09-1491; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dhomen N, 2009, CANCER CELL, V15, P294, DOI 10.1016/j.ccr.2009.02.022; Fabunmi RP, 2000, J BIOL CHEM, V275, P409, DOI 10.1074/jbc.275.1.409; Fisk HA, 2003, P NATL ACAD SCI USA, V100, P14875, DOI 10.1073/pnas.2434156100; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Fukasawa K, 2007, NAT REV CANCER, V7, P911, DOI 10.1038/nrc2249; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Haering CH, 2008, NATURE, V454, P297, DOI 10.1038/nature07098; Hewitt L, 2010, J CELL BIOL, V190, P25, DOI 10.1083/jcb.201002133; Janssen A, 2009, P NATL ACAD SCI USA, V106, P19108, DOI 10.1073/pnas.0904343106; Jelluma N, 2008, CELL, V132, P233, DOI 10.1016/j.cell.2007.11.046; Kanai M, 2007, GENES CELLS, V12, P797, DOI 10.1111/j.1365-2443.2007.01091.x; Kang JS, 2007, P NATL ACAD SCI USA, V104, P20232, DOI 10.1073/pnas.0710519105; Karreth FA, 2009, CURR OPIN GENET DEV, V19, P4, DOI 10.1016/j.gde.2008.12.006; Kasbek C, 2007, MOL BIOL CELL, V18, P4457, DOI 10.1091/mbc.E07-03-0283; Kasbek C, 2010, MOL BIOL CELL, V21, P3878, DOI 10.1091/mbc.E10-04-0281; Kasbek C, 2009, ENVIRON MOL MUTAGEN, V50, P654, DOI 10.1002/em.20476; Liu ST, 2003, MOL BIOL CELL, V14, P1638, DOI 10.1091/mbc.02-05-0074; Mangold U, 2008, ONCOGENE, V27, P604, DOI 10.1038/sj.onc.1210685; Mattison CP, 2007, J BIOL CHEM, V282, P30553, DOI 10.1074/jbc.M707063200; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Palframan WJ, 2006, SCIENCE, V313, P680, DOI 10.1126/science.1127205; Pike AN, 2011, CELL DIV, V6, DOI 10.1186/1747-1028-6-9; Santaguida S, 2010, J CELL BIOL, V190, P73, DOI 10.1083/jcb.201001036; Stucke VM, 2002, EMBO J, V21, P1723, DOI 10.1093/emboj/21.7.1723; Tighe A, 2008, J CELL BIOL, V181, P893, DOI 10.1083/jcb.200712028; Tsou MFB, 2006, NATURE, V442, P947, DOI 10.1038/nature04985; Tyler RK, 2009, BIOCHEM J, V417, P173, DOI 10.1042/BJ20081310; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wojcik EJ, 2000, CURR BIOL, V10, P1131, DOI 10.1016/S0960-9822(00)00703-X; Yang CH, 2010, MOL BIOL CELL, V21, P4361, DOI 10.1091/mbc.E10-04-0298; Zhao Y, 2006, CURR BIOL, V16, P1764, DOI 10.1016/j.cub.2006.07.058	39	23	25	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	FEB 7	2013	32	6					713	723		10.1038/onc.2012.94	http://dx.doi.org/10.1038/onc.2012.94			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	101AF	22430208				2022-12-25	WOS:000315746700005
J	Liu, XJ; Lu, Y; Zhang, Y; Li, YY; Zhou, JZ; Yuan, YM; Gao, XF; Su, ZD; He, C				Liu, Xiujie; Lu, Yan; Zhang, Yong; Li, Yuanyuan; Zhou, Jiazhen; Yuan, Yimin; Gao, Xiaofei; Su, Zhida; He, Cheng			Slit2 Regulates the Dispersal of Oligodendrocyte Precursor Cells via Fyn/RhoA Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SRC FAMILY KINASES; NEURONAL MIGRATION; SPINAL-CORD; RHO-GTPASES; DIRECTIONAL GUIDANCE; VERTEBRATE SLIT; TYROSINE KINASE; AXON OUTGROWTH; NEURAL-TUBE; P190 RHOGAP	Oligodendrocyte precursor cells (OPCs) are a unique type of glia that are responsible for the myelination of the central nervous system. OPC migration is important for myelin formation during central nervous system development and repair. However, the precise extracellular and intracellular mechanisms that regulate OPC migration remain elusive. Slits were reported to regulate neurodevelopmental processes such as migration, adhesion, axon guidance, and elongation through binding to roundabout receptors (Robos). However, the potential roles of Slits/Robos in oligodendrocytes remain unknown. In this study, Slit2 was found to be involved in regulating the dispersal of OPCs through the association between Robo1 and Fyn. Initially, we examined the expression of Robos in OPCs both in vitro and in vivo. Subsequently, the Boyden chamber assay showed that Slit2 could inhibit OPC migration. RoboN, a specific inhibitor of Robos, could significantly attenuate this effect. The effects were confirmed through the explant migration assay. Furthermore, treating OPCs with Slit2 protein deactivated Fyn and increased the level of activated RhoA-GTP. Finally, Fyn was found to form complexes with Robo1, but this association was decreased after Slit2 stimulation. Thus, we demonstrate for the first time that Slit2 regulates the dispersal of oligodendrocyte precursor cells through Fyn and RhoA signaling.	[He, Cheng] Second Mil Med Univ, Changzheng Hosp, Neurosci Res Ctr, Inst Neurosci, Shanghai 200433, Peoples R China; Second Mil Med Univ, Changzheng Hosp, Neurosci Res Ctr, MOE Key Lab Mol Neurobiol, Shanghai 200433, Peoples R China	Naval Medical University; Naval Medical University	He, C (corresponding author), Second Mil Med Univ, Changzheng Hosp, Neurosci Res Ctr, Inst Neurosci, Shanghai 200433, Peoples R China.	chenghe@smmu.edu.cn	Su, Zhida/G-6094-2015; li, yuanyuan/GZA-4435-2022		National Key Basic Research Program [2011CB504401]; National Natural Science Foundation [30970999, 31130024, 31070922]	National Key Basic Research Program(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by National Key Basic Research Program Grant 2011CB504401 and National Natural Science Foundation Grants 30970999, 31130024, and 31070922.	Ba-Charvet KTN, 1999, NEURON, V22, P463, DOI 10.1016/S0896-6273(00)80702-3; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Brouns MR, 2001, NAT CELL BIOL, V3, P361, DOI 10.1038/35070042; Challa AK, 2001, MECH DEVELOP, V101, P249, DOI 10.1016/S0925-4773(00)00570-0; Chen G, 2008, NAT NEUROSCI, V11, P36, DOI 10.1038/nn2018; Cohen RI, 2003, J NEUROCHEM, V85, P1262, DOI 10.1046/j.1471-4159.2003.01722.x; Colognato H, 2004, J CELL BIOL, V167, P365, DOI 10.1083/jcb.200404076; Cox EA, 2001, MOL BIOL CELL, V12, P265, DOI 10.1091/mbc.12.2.265; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Guan CB, 2007, CELL, V129, P385, DOI 10.1016/j.cell.2007.01.051; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Holmes GP, 1998, MECH DEVELOP, V79, P57, DOI 10.1016/S0925-4773(98)00174-9; Jarjour AA, 2003, J NEUROSCI, V23, P3735; Kessaris N, 2006, NAT NEUROSCI, V9, P173, DOI 10.1038/nn1620; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kuo E, 2010, J NEUROCHEM, V113, P200, DOI 10.1111/j.1471-4159.2010.06596.x; LEVISON SW, 1993, NEURON, V10, P201, DOI 10.1016/0896-6273(93)90311-E; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; Liang XQ, 2004, J NEUROSCI, V24, P7140, DOI 10.1523/JNEUROSCI.5319-03.2004; Liu GF, 2004, NAT NEUROSCI, V7, P1222, DOI 10.1038/nn1331; Liu XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021058; Liu XJ, 2009, MOL CELL NEUROSCI, V41, P51, DOI 10.1016/j.mcn.2009.01.009; Mi S, 2005, NAT NEUROSCI, V8, P745, DOI 10.1038/nn1460; Miller RH, 2007, NAT NEUROSCI, V10, P1351, DOI 10.1038/nn1995; Miyamoto Y, 2008, J NEUROSCI, V28, P8326, DOI 10.1523/JNEUROSCI.1482-08.2008; Narumiya S, 2000, METHOD ENZYMOL, V325, P273; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Osterhout DJ, 1999, J CELL BIOL, V145, P1209, DOI 10.1083/jcb.145.6.1209; Prasad A, 2007, J LEUKOCYTE BIOL, V82, P465, DOI 10.1189/jlb.1106678; Prestoz L, 2004, NEURON GLIA BIOL, V1, P73, DOI 10.1017/s1740925x04000109; PRINGLE NP, 1993, DEVELOPMENT, V117, P525; Rajasekharan S, 2010, J NEUROCHEM, V113, P1589, DOI 10.1111/j.1471-4159.2010.06717.x; Rajasekharan S, 2009, DEVELOPMENT, V136, P415, DOI 10.1242/dev.018234; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Richardson WD, 2006, NAT REV NEUROSCI, V7, P11, DOI 10.1038/nrn1826; Ridley AJ, 2001, FEBS LETT, V498, P168, DOI 10.1016/S0014-5793(01)02481-4; Rowitch DH, 2004, NAT REV NEUROSCI, V5, P409, DOI 10.1038/nrn1389; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Spassky N, 2002, J NEUROSCI, V22, P5992; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Stevenson NJ, 2010, FEBS LETT, V584, P4469, DOI 10.1016/j.febslet.2010.10.007; Su ZD, 2007, J CELL SCI, V120, P1877, DOI 10.1242/jcs.03448; Tabu K, 2007, MOL CANCER RES, V5, P1099, DOI 10.1158/1541-7786.MCR-07-0096; Tong XP, 2009, J CELL BIOL, V186, P113, DOI 10.1083/jcb.200811071; Tsai HH, 2006, J NEUROSCI, V26, P1913, DOI 10.1523/JNEUROSCI.3571-05.2006; Tsai HH, 2003, DEVELOPMENT, V130, P2095, DOI 10.1242/dev.00424; Tsuji T, 2002, J CELL BIOL, V157, P819, DOI 10.1083/jcb.200112107; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; Wolf RM, 2001, J NEUROBIOL, V49, P62, DOI 10.1002/neu.1066; Wong EV, 2004, J NEUROBIOL, V59, P66, DOI 10.1002/neu.10342; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; Wu JY, 2001, NATURE, V410, P948, DOI 10.1038/35073616; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Xu HT, 2004, P NATL ACAD SCI USA, V101, P4296, DOI 10.1073/pnas.0303893101; Xu Y, 2010, NEUROSCI BULL, V26, P474, DOI 10.1007/s12264-010-0730-9; Yeo MG, 2011, J CELL PHYSIOL, V226, P236, DOI 10.1002/jcp.22335; Ypsilanti AR, 2010, DEVELOPMENT, V137, P1939, DOI 10.1242/dev.044511; Zhu XQ, 2008, NEURON GLIA BIOL, V4, P19, DOI 10.1017/S1740925X09000015	59	26	27	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17503	17516		10.1074/jbc.M111.317610	http://dx.doi.org/10.1074/jbc.M111.317610			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22433866	hybrid, Green Published			2022-12-25	WOS:000306373000050
J	Poillot, C; Bichraoui, H; Tisseyre, C; Bahemberae, E; Andreotti, N; Sabatier, JM; Ronjat, M; De Waard, M				Poillot, Cathy; Bichraoui, Hicham; Tisseyre, Celine; Bahemberae, Eloi; Andreotti, Nicolas; Sabatier, Jean-Marc; Ronjat, Michel; De Waard, Michel			Small Efficient Cell-penetrating Peptides Derived from Scorpion Toxin Maurocalcine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL RYANODINE RECEPTOR; AMINO-ACID-RESIDUES; II-III-LOOP; CA2+ RELEASE; DIHYDROPYRIDINE RECEPTOR; PHARMACOLOGICALLY INERT; MUSCLE; MACROPINOCYTOSIS; ANALOG	Maurocalcine is the first demonstrated example of an animal toxin peptide with efficient cell penetration properties. Although it is a highly competitive cell-penetrating peptide (CPP), its relatively large size of 33 amino acids and the presence of three internal disulfide bridges may hamper its development for in vitro and in vivo applications. Here, we demonstrate that several efficient CPPs can be derived from maurocalcine by replacing Cys residues by isosteric 2-aminobutyric acid residues and sequence truncation down to peptides of up to 9 residues in length. A surprising finding is that all of the truncated maurocalcine analogues possessed cell penetration properties, indicating that the maurocalcine is a highly specialized CPP. Careful examination of the cell penetration properties of the truncated analogues indicates that several maurocalcine-derived peptides should be of great interest for cell delivery applications where peptide size matters.	[Poillot, Cathy; Bichraoui, Hicham; Tisseyre, Celine; Bahemberae, Eloi; Ronjat, Michel; De Waard, Michel] Grenoble Neurosci Inst, INSERM, U836, F-38042 Grenoble 9, France; [Poillot, Cathy; Bichraoui, Hicham; Tisseyre, Celine; Bahemberae, Eloi; Ronjat, Michel; De Waard, Michel] Univ Grenoble 1, F-38041 Grenoble, France; [Andreotti, Nicolas; Sabatier, Jean-Marc] INSERM, UMR1097, F-13288 Marseille, France; [De Waard, Michel] Smartox Biotechnol, Biopolis, F-3870 La Tronche, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm)	De Waard, M (corresponding author), Grenoble Neurosci Inst, INSERM, U836, Site Sante La Tronche,Chemin Fortune Ferrini,BP 1, F-38042 Grenoble 9, France.	michel.dewaard@ujf-grenoble.fr	De Waard, Michel/G-7406-2014	De Waard, Michel/0000-0002-2782-9615; Ronjat, Michel/0000-0002-9728-6425; SABATIER, Jean-Marc/0000-0002-9040-5647	Technology pour la Sante (Program TIMOMA2 of the Commissariat a l'Energie Atomique); Agence Nationale pour la Recherche PNANO	Technology pour la Sante (Program TIMOMA2 of the Commissariat a l'Energie Atomique); Agence Nationale pour la Recherche PNANO(French National Research Agency (ANR))	This work was supported by grants from Technology pour la Sante (Program TIMOMA2 of the Commissariat a l'Energie Atomique) and from Agence Nationale pour la Recherche PNANO (Programs SYNERGIE and NanoFret). Mass spectrometry analyses were performed by the Centre d'Investigation Clinique of Grenoble under the direction of Dr. Michel Seve.	Altafaj X, 2005, J BIOL CHEM, V280, P4013, DOI 10.1074/jbc.C400433200; Aroui S, 2010, BIOCHEM BIOPH RES CO, V391, P419, DOI 10.1016/j.bbrc.2009.11.073; Aroui S, 2009, CANCER LETT, V285, P28, DOI 10.1016/j.canlet.2009.04.044; Aroui S, 2009, APOPTOSIS, V14, P1352, DOI 10.1007/s10495-009-0397-8; Aroui S, 2009, PHARM RES-DORDR, V26, P836, DOI 10.1007/s11095-008-9782-1; Boisseau S, 2006, BBA-BIOMEMBRANES, V1758, P308, DOI 10.1016/j.bbamem.2006.02.007; Chen L, 2003, J BIOL CHEM, V278, P16095, DOI 10.1074/jbc.M209501200; Esteve E, 2005, J BIOL CHEM, V280, P12833, DOI 10.1074/jbc.M412521200; Esteve E, 2003, J BIOL CHEM, V278, P37822, DOI 10.1074/jbc.M305798200; Fajloun Z, 2000, FEBS LETT, V469, P179, DOI 10.1016/S0014-5793(00)01239-4; Gurrola GB, 1999, J BIOL CHEM, V274, P7879, DOI 10.1074/jbc.274.12.7879; KIM DH, 1983, J BIOL CHEM, V258, P9662; Lukacs B, 2008, BIOPHYS J, V95, P3497, DOI 10.1529/biophysj.107.120840; Mabrouk K, 2007, BBA-BIOMEMBRANES, V1768, P2528, DOI 10.1016/j.bbamem.2007.06.030; Meier O, 2002, J CELL BIOL, V158, P1119, DOI 10.1083/jcb.200112067; MERRIFIELD RB, 1969, ADV ENZYMOL RAMB, V32, P221; Mosbah A, 2000, PROTEINS, V40, P436, DOI 10.1002/1097-0134(20000815)40:3&lt;436::AID-PROT90&gt;3.0.CO;2-9; Poillot C, 2010, J BIOL CHEM, V285, P34168, DOI 10.1074/jbc.M110.104919; Pouvreau S, 2006, BIOPHYS J, V91, P2206, DOI 10.1529/biophysj.105.078089; Ram N, 2008, J BIOL CHEM, V283, P27048, DOI 10.1074/jbc.M804727200; Ram N, 2008, J BIOL CHEM, V283, P24274, DOI 10.1074/jbc.M709971200; Szappanos H, 2005, J PHYSIOL-LONDON, V565, P843, DOI 10.1113/jphysiol.2005.086074; Veithen A, 1996, J CELL SCI, V109, P2005; WEST MA, 1989, J CELL BIOL, V109, P2731, DOI 10.1083/jcb.109.6.2731	24	24	27	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17331	17342		10.1074/jbc.M112.360628	http://dx.doi.org/10.1074/jbc.M112.360628			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22433862	Green Submitted, hybrid, Green Published			2022-12-25	WOS:000306373000033
J	Chan, KM; Zhang, ZG				Chan, Kui Ming; Zhang, Zhiguo			Leucine-rich Repeat and WD Repeat-containing Protein 1 Is Recruited to Pericentric Heterochromatin by Trimethylated Lysine 9 of Histone H3 and Maintains Heterochromatin Silencing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORIGIN RECOGNITION COMPLEX; X-CHROMOSOME INACTIVATION; FACULTATIVE HETEROCHROMATIN; SATELLITE REPEATS; DNA-REPLICATION; GENOME; CHROMATIN; METHYLATION; BINDING; HP1	Lrwd1, a protein containing a leucine-rich repeat and a WD40 repeat domain, interacts with the origin replication complex (ORC), a protein complex involved in both initiation of DNA replication and heterochromatin silencing. Lrwd1 and ORC are known to co-purify with repressive histone marks (trimethylated lysine 9 of histone H3 (H3K9me3) and trimethylated lysine 20 of histone H4 (H4K20me3)) and localize to pericentric heterochromatin. However, how the Lrwd1 is recruited to heterochromatin and the functional significance of the localization of Lrwd1 to the heterochromatin are not known. Here, we show that Lrwd1 preferentially binds to trimethylated repressive histone marks in vitro, which is dependent on an intact WD40 domain but independent of ORC proteins. The localization of Lrwd1 and Orc2 at pericentric heterochromatin in mouse cells is lost in cells lacking H3K9me3 but not in cells lacking H4K20me3. In addition, depletion of HP1 alpha has little impact on the localization of Lrwd1 on pericentric heterochromatin. Finally, depletion of Lrwd1 and Orc2 in mouse cells leads to increased transcription of major satellite repeats. These results indicate that the Lrwd1 is recruited to pericentric heterochromatin through binding to H3K9me3 and that the association of Lrwd1 with pericentric heterochromatin is required for heterochromatin silencing and maintenance.	[Chan, Kui Ming; Zhang, Zhiguo] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Mayo Clinic	Zhang, ZG (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, 200 1st St SW, Rochester, MN 55905 USA.	zhang.zhiguo@mayo.edu	Chan, Kui Ming June/G-4330-2013	CHAN, Kui Ming/0000-0001-6430-3340	National Institutes of Health [GM99722, GM81838]; NATIONAL CANCER INSTITUTE [P50CA108961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099722, R01GM081838] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported, in whole or in part, by National Institutes of Health Grants GM99722 and GM81838.	Augui S, 2011, NAT REV GENET, V12, P429, DOI 10.1038/nrg2987; Bartke T, 2010, CELL, V143, P470, DOI 10.1016/j.cell.2010.10.012; Beisel C, 2011, NAT REV GENET, V12, P123, DOI 10.1038/nrg2932; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Chan KM, 2011, P NATL ACAD SCI USA, V108, P16699, DOI 10.1073/pnas.1107616108; EHRENHOFERMURRAY AE, 1995, SCIENCE, V270, P1671, DOI 10.1126/science.270.5242.1671; Eustermann S, 2011, NAT STRUCT MOL BIOL, V18, P777, DOI 10.1038/nsmb.2070; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Grewal SIS, 2002, CURR OPIN GENET DEV, V12, P178, DOI 10.1016/S0959-437X(02)00284-8; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Mendez J, 2002, MOL CELL, V9, P481, DOI 10.1016/S1097-2765(02)00467-7; Pak DTS, 1997, CELL, V91, P311, DOI 10.1016/S0092-8674(00)80415-8; Peters AHFM, 2002, NAT GENET, V30, P77, DOI 10.1038/ng789; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Prasanth SG, 2004, EMBO J, V23, P2651, DOI 10.1038/sj.emboj.7600255; Prasanth SG, 2010, P NATL ACAD SCI USA, V107, P15093, DOI 10.1073/pnas.1009945107; Probst AV, 2011, TRENDS GENET, V27, P177, DOI 10.1016/j.tig.2011.02.002; Ruthenburg AJ, 2006, NAT STRUCT MOL BIOL, V13, P704, DOI 10.1038/nsmb1119; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Schotta G, 2008, GENE DEV, V22, P2048, DOI 10.1101/gad.476008; Shen Z, 2010, MOL CELL, V40, P99, DOI 10.1016/j.molcel.2010.09.021; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tattermusch A, 2011, HUM GENET, V130, P247, DOI 10.1007/s00439-011-1027-4; Ting DT, 2011, SCIENCE, V331, P593, DOI 10.1126/science.1200801; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; Wutz A, 2011, NAT REV GENET, V12, P542, DOI 10.1038/nrg3035; Wysocka J, 2006, METHODS, V40, P339, DOI 10.1016/j.ymeth.2006.05.028; Zeng W, 2010, EPIGENETICS-US, V5, P287, DOI 10.4161/epi.5.4.11683; Zhu Q, 2011, NATURE, V477, P179, DOI 10.1038/nature10371	32	29	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					15024	15033		10.1074/jbc.M111.337980	http://dx.doi.org/10.1074/jbc.M111.337980			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22427655	Green Published, hybrid			2022-12-25	WOS:000304003200064
J	McGrail, DJ; Ghosh, D; Quach, ND; Dawson, MR				McGrail, Daniel J.; Ghosh, Deepraj; Quach, Nhat D.; Dawson, Michelle R.			Differential Mechanical Response of Mesenchymal Stem Cells and Fibroblasts to Tumor-Secreted Soluble Factors	PLOS ONE			English	Article							BONE-MARROW; GENE-EXPRESSION; CHEMOTACTIC FACTORS; CONDITIONED MEDIUM; PROGENITOR CELLS; BREAST-CANCER; MIGRATION; MICRORHEOLOGY; INFLAMMATION; CYTOSKELETON	The progression of neoplastic malignancies is a complex process resulting not only from the accumulation of mutations within tumor cells, but also modulation of the tumor microenvironment. Recent advances have shown that the recruitment and subsequent heterotypic interactions of stromal cells-including fibroblasts and bone marrow-derived mesenchymal stem cells (MSCs)-are crucial for carcinogenesis. Though extensive work has been done analyzing the signals that recruit these cells, the governing mechanical properties have not been fully investigated. Here, we report that despite their initial similarities, MSCs respond not only faster but also more dramatically to pro-migratory tumor-secreted soluble factors. Utilizing multiple particle tracking microrheology to probe the cytoskeletal mechanical properties, we show that MSCs stiffen completely within one hour, three times faster than fibroblasts. In addition, unlike fibroblasts, MSCs exposed to tumor-secreted soluble factors display a functionally different phenotype characterized by morphological elongation, decreased actin stress fiber density, and decreased adhesion. Quantitative real-time PCR indicates these phenomena occur based on differential expression of small GTPases RhoA and Cdc42, but not Rac1. These findings demonstrate a fundamental difference in the recruitment of fibroblasts and MSCs.	[McGrail, Daniel J.; Ghosh, Deepraj; Dawson, Michelle R.] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA; [Quach, Nhat D.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Dawson, Michelle R.] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	McGrail, DJ (corresponding author), Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA.	mdawson@gatech.edu	McGrail, Daniel/F-3967-2014; Jain, Rakesh K/I-1384-2017; Dawson, Michelle R/Q-7217-2019	McGrail, Daniel/0000-0002-6669-6069; Jain, Rakesh K/0000-0001-7571-3548; Dawson, Michelle R/0000-0002-2122-4711	National Science Foundation [1032527]; Georgia Cancer Coalition [GCC-276]; Directorate For Engineering [1066585] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Georgia Cancer Coalition; Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	Funding for this work was provided by the National Science Foundation (1032527) and the Georgia Cancer Coalition (GCC-276). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Covas DT, 2008, EXP HEMATOL, V36, P642, DOI 10.1016/j.exphem.2007.12.015; Daniels BR, 2010, BIOPHYS J, V99, P3563, DOI 10.1016/j.bpj.2010.10.007; Dwyer RM, 2007, CLIN CANCER RES, V13, P5020, DOI 10.1158/1078-0432.CCR-07-0731; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Govind S, 2001, J CELL BIOL, V152, P579, DOI 10.1083/jcb.152.3.579; Hall B., 2007, V180, P263; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Haniffa MA, 2007, J IMMUNOL, V179, P1595, DOI 10.4049/jimmunol.179.3.1595; Hung SC, 2005, CLIN CANCER RES, V11, P7749, DOI 10.1158/1078-0432.CCR-05-0876; Ishizaki T, 2001, NAT CELL BIOL, V3, P8; Jaganathan BG, 2007, STEM CELLS, V25, P1966, DOI 10.1634/stemcells.2007-0167; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Khakoo AY, 2006, J EXP MED, V203, P1235, DOI 10.1084/jem.20051921; Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Klopp AH, 2007, CANCER RES, V67, P11687, DOI 10.1158/0008-5472.CAN-07-1406; Kole TP, 2005, MOL BIOL CELL, V16, P328, DOI 10.1091/mbc.e04-06-0485; Kole TP, 2004, MOL BIOL CELL, V15, P3475, DOI 10.1091/mbc.E04-03-0218; Komarova S, 2006, MOL CANCER THER, V5, P755, DOI 10.1158/1535-7163.MCT-05-0334; KOZMA R, 1995, MOL CELL BIOL, V15, P1942; Kucerova L, 2007, CANCER RES, V67, P6304, DOI 10.1158/0008-5472.CAN-06-4024; Kumar S, 2010, GENE THER, V17, P105, DOI 10.1038/gt.2009.116; Lee JSH, 2005, MOL BIOL CELL, V16, P871, DOI 10.1091/mbc.e03-12-0910; Lin SY, 2008, EXP CELL RES, V314, P3107, DOI 10.1016/j.yexcr.2008.07.028; Ponte AL, 2007, STEM CELLS, V25, P1737, DOI 10.1634/stemcells.2007-0054; Maesaki R, 1999, MOL CELL, V4, P793, DOI 10.1016/S1097-2765(00)80389-5; Mason TG, 2000, RHEOL ACTA, V39, P371, DOI 10.1007/s003970000094; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Menon LG, 2007, STEM CELLS, V25, P520, DOI 10.1634/stemcells.2006-0257; Micke P, 2004, LUNG CANCER, V45, pS163, DOI 10.1016/j.lungcan.2004.07.977; Nakamura K, 2004, GENE THER, V11, P1155, DOI 10.1038/sj.gt.3302276; Ohnishi S, 2007, STEM CELLS, V25, P1166, DOI 10.1634/stemcells.2006-0347; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Ozaki Y, 2007, STEM CELLS DEV, V16, P119, DOI 10.1089/scd.2006.0032; Pajerowski JD, 2007, P NATL ACAD SCI USA, V104, P15619, DOI 10.1073/pnas.0702576104; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; Pigati L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013515; Reyes CD, 2003, J BIOMED MATER RES A, V67A, P328, DOI 10.1002/jbm.a.10122; Rombouts WJC, 2003, LEUKEMIA, V17, P160, DOI 10.1038/sj.leu.2402763; RONNOVJESSEN L, 1995, J CLIN INVEST, V95, P859, DOI 10.1172/JCI117736; Rosova I, 2008, STEM CELLS, V26, P2173, DOI 10.1634/stemcells.2007-1104; Song S, 2005, NAT CELL BIOL, V7, P870, DOI 10.1038/ncb1288; Stagg J, 2008, STEM CELL REV, V4, P119, DOI 10.1007/s12015-008-9030-4; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Studeny M, 2002, CANCER RES, V62, P3603; Tao K, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-228; Treiser MD, 2010, P NATL ACAD SCI USA, V107, P610, DOI 10.1073/pnas.0909597107; Tropel P, 2004, EXP CELL RES, V295, P395, DOI 10.1016/j.yexcr.2003.12.030; Truskey G., 2009, TRANSPORT PHENOMENA; Tseng Y, 2002, BIOPHYS J, V83, P3162, DOI 10.1016/S0006-3495(02)75319-8; Tseng Y, 2002, J BIOL CHEM, V277, P18143, DOI 10.1074/jbc.M110868200; Weir C, 2008, HEART LUNG CIRC, V17, P395, DOI 10.1016/j.hlc.2008.01.006; Wels J, 2008, GENE DEV, V22, P559, DOI 10.1101/gad.1636908; Wirtz D, 2009, ANNU REV BIOPHYS, V38, P301, DOI 10.1146/annurev.biophys.050708.133724; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006	58	45	45	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33248	10.1371/journal.pone.0033248	http://dx.doi.org/10.1371/journal.pone.0033248			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438903	Green Submitted, gold, Green Published			2022-12-25	WOS:000303309100028
J	Postigo, J; Iglesias, M; Cerezo-Wallis, D; Rosal-Vela, A; Garcia-Rodriguez, S; Zubiaur, M; Sancho, J; Merino, R; Merino, J				Postigo, Jorge; Iglesias, Marcos; Cerezo-Wallis, Daniela; Rosal-Vela, Antonio; Garcia-Rodriguez, Sonia; Zubiaur, Mercedes; Sancho, Jaime; Merino, Ramon; Merino, Jesus			Mice Deficient in CD38 Develop an Attenuated Form of Collagen Type II-Induced Arthritis	PLOS ONE			English	Article							CYCLIC ADP-RIBOSE; T-CELL; IFN-GAMMA; IMMUNE-RESPONSES; IN-VIVO; RECEPTOR; MOUSE; AUTOIMMUNITY; ACTIVATION; SURFACE	CD38, a type II transmembrane glycoprotein expressed in many cells of the immune system, is involved in cell signaling, migration and differentiation. Studies in CD38 deficient mice (CD38 KO mice) indicate that this molecule controls inflammatory immune responses, although its involvement in these responses depends on the disease model analyzed. Here, we explored the role of CD38 in the control of autoimmune responses using chicken collagen type II (col II) immunized C57BL/6-CD38 KO mice as a model of collagen-induced arthritis (CIA). We demonstrate that CD38 KO mice develop an attenuated CIA that is accompanied by a limited joint induction of IL-1 beta and IL-6 expression, by the lack of induction of IFN gamma expression in the joints and by a reduction in the percentages of invariant NKT (iNKT) cells in the spleen. Immunized CD38 KO mice produce high levels of circulating IgG1 and low of IgG2a anti-col II antibodies in association with reduced percentages of Th1 cells in the draining lymph nodes. Altogether, our results show that CD38 participates in the pathogenesis of CIA controlling the number of iNKT cells and promoting Th1 inflammatory responses.	[Postigo, Jorge; Iglesias, Marcos; Merino, Ramon; Merino, Jesus] Univ Cantabria, Dept Biol Mol, Inst Formac & Invest Marques Valdecilla, E-39005 Santander, Spain; [Iglesias, Marcos; Merino, Ramon] Univ Cantabria, Inst Biomed & Biotecnol Cantabria, CSIC, SODERCAN, E-39005 Santander, Spain; [Cerezo-Wallis, Daniela; Rosal-Vela, Antonio; Garcia-Rodriguez, Sonia; Zubiaur, Mercedes; Sancho, Jaime] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain	Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN)	Postigo, J (corresponding author), Univ Cantabria, Dept Biol Mol, Inst Formac & Invest Marques Valdecilla, E-39005 Santander, Spain.	merinor@unican.es; merinoj@unican.es	Garcia-Rodriguez, Sonia/L-6932-2014; Sancho, Jaime/O-3228-2013; Zubiaur, Mercedes/AAC-5792-2021; Rosal-Vela, Antonio/K-9720-2014; Zubiaur, Mercedes/K-9390-2014; Merino, Ramón/L-1310-2014; Sancho, Jaime/K-5989-2019; Cerezo-Wallis, Daniela/L-1492-2017	Garcia-Rodriguez, Sonia/0000-0001-8959-4797; Sancho, Jaime/0000-0003-3852-7951; Zubiaur, Mercedes/0000-0002-4127-3027; Rosal-Vela, Antonio/0000-0002-5256-6634; Zubiaur, Mercedes/0000-0002-4127-3027; Merino, Ramón/0000-0002-5306-0635; Sancho, Jaime/0000-0003-3852-7951; Cerezo-Wallis, Daniela/0000-0002-4265-6898; Iglesias Lozano, Marcos/0000-0002-7523-5950	Ministerio de Ciencia e Innovacion, Spain [SAF2008-02042, SAF2011-22463, BFU2009-07206, SAF-2008-03685, SAF2011-27261]; Fundacion Marques de Valdecilla-Leonardo Torres Quevedo, Spain [FMV-UC 08/02]; European Commission [ISCIII-FIS06/1502]; Junta de Andalucia; Consejeria de Economia; Innovacion y Ciencia [CVI-226, PC08-CTS-04046]; Fundacion Eugenio Rodriguez Pascual; JAE-Doc-CSIC	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Marques de Valdecilla-Leonardo Torres Quevedo, Spain; European Commission(European CommissionEuropean Commission Joint Research Centre); Junta de Andalucia(Junta de Andalucia); Consejeria de Economia; Innovacion y Ciencia; Fundacion Eugenio Rodriguez Pascual; JAE-Doc-CSIC	This work was supported by grants from the Ministerio de Ciencia e Innovacion, Spain to RM (SAF2008-02042 and SAF2011-22463), JM (BFU2009-07206) and JS and MZ (SAF-2008-03685, SAF2011-27261), from the Fundacion Marques de Valdecilla-Leonardo Torres Quevedo, Spain to JM and RM (FMV-UC 08/02), from the European Commission-European Regional Development Fund (ERDF/FEDER), in collaboration with ISCIII-FIS06/1502 (MZ), from the Junta de Andalucia, Consejeria de Economia, Innovacion y Ciencia to JS and MZ (CVI-226, and PC08-CTS-04046) and from Fundacion Eugenio Rodriguez Pascual to RM. SGR is supported by a JAE-Doc-CSIC-Contract and ARV is recipient of a Fellowship-Contract from the Junta de Andalucia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen J, 2006, J IMMUNOL, V176, P4590, DOI 10.4049/jimmunol.176.8.4590; Chen YG, 2006, J IMMUNOL, V177, P2939, DOI 10.4049/jimmunol.177.5.2939; Chiba A, 2005, ARTHRITIS RHEUM-US, V52, P1941, DOI 10.1002/art.21056; Cho YG, 2007, AUTOIMMUN REV, V7, P65, DOI 10.1016/j.autrev.2007.08.001; Choe CU, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019046; Chu CQ, 2003, ANN RHEUM DIS, V62, P983, DOI 10.1136/ard.62.10.983; Cockayne DA, 1998, BLOOD, V92, P1324, DOI 10.1182/blood.V92.4.1324.416k26_1324_1333; Deaglio S, 2000, CHEM IMMUNOL, V75, P99; Deterre P, 2000, CHEM IMMUNOL, V75, P146; Driver JP, 2010, DIABETES, V59, P423, DOI 10.2337/db09-1116; Fossati-Jimack L, 2000, J EXP MED, V191, P1293, DOI 10.1084/jem.191.8.1293; Frasca L, 2006, BLOOD, V107, P2392, DOI 10.1182/blood-2005-07-2913; Frey O, 2005, ARTHRITIS RES THER, V7, pR291, DOI 10.1186/ar1484; Gonzalez J, 2007, J IMMUNOL, V178, P2778, DOI 10.4049/jimmunol.178.5.2778; Grammer AC, 2003, J CLIN INVEST, V112, P1506, DOI 10.1172/JCI200319301; GRIFFITHS MM, 1992, J IMMUNOL, V149, P309; Guedes AGP, 2008, AM J PHYSIOL-LUNG C, V294, pL290, DOI 10.1152/ajplung.00367.2007; Guedez YB, 2001, ARTHRITIS RHEUM, V44, P2413, DOI 10.1002/1529-0131(200110)44:10<2413::AID-ART406>3.0.CO;2-E; Harrell MI, 2008, J IMMUNOL METHODS, V332, P170, DOI 10.1016/j.jim.2007.11.012; HOWARD M, 1993, SCIENCE, V262, P1056, DOI 10.1126/science.8235624; Kelchtermans H, 2005, ARTHRITIS RES THER, V7, pR402, DOI 10.1186/ar1500; Lamacchia C, 2010, ARTHRITIS RHEUM-US, V62, P452, DOI 10.1002/art.27235; LEE HC, 1995, J BIOL CHEM, V270, P2152, DOI 10.1074/jbc.270.5.2152; Lubberts E, 2004, ARTHRITIS RHEUM-US, V50, P650, DOI 10.1002/art.20001; Lund FE, 2006, MOL MED, V12, P328, DOI 10.2119/2006-00099.Lund; Malavasi F, 2008, PHYSIOL REV, V88, P841, DOI 10.1152/physrev.00035.2007; ManourySchwartz B, 1997, J IMMUNOL, V158, P5501; Munoz P, 2003, J BIOL CHEM, V278, P50791, DOI 10.1074/jbc.M308034200; Munoz P, 2008, BLOOD, V111, P3653, DOI 10.1182/blood-2007-07-101600; NEUBERGER MS, 1981, EUR J IMMUNOL, V11, P1012, DOI 10.1002/eji.1830111212; Partida-Sanchez S, 2001, NAT MED, V7, P1209, DOI 10.1038/nm1101-1209; Partida-Sanchez S, 2004, IMMUNITY, V20, P279, DOI 10.1016/S1074-7613(04)00048-2; Postigo J, 2011, ARTHRITIS RHEUM-US, V63, P971, DOI 10.1002/art.30220; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Sato K, 2006, J EXP MED, V203, P2673, DOI 10.1084/jem.20061775; Schuber F, 2004, CURR MOL MED, V4, P249, DOI 10.2174/1566524043360708; Seman M, 2003, IMMUNITY, V19, P571, DOI 10.1016/S1074-7613(03)00266-8; Svensson L, 1998, CLIN EXP IMMUNOL, V111, P521; Vermeire K, 1997, J IMMUNOL, V158, P5507; Viegas MS, 2007, MICROBES INFECT, V9, P847, DOI 10.1016/j.micinf.2007.03.003; Yanaba K, 2007, J IMMUNOL, V179, P1369, DOI 10.4049/jimmunol.179.2.1369; Yoshiga Y, 2008, INT J MOL MED, V22, P369, DOI 10.3892/ijmm_00000032; ZOCCHI E, 1993, BIOCHEM BIOPH RES CO, V196, P1459, DOI 10.1006/bbrc.1993.2416; Zubiaur M, 2002, J BIOL CHEM, V277, P13, DOI 10.1074/jbc.M107474200; Zumaquero E, 2010, EXP CELL RES, V316, P2692, DOI 10.1016/j.yexcr.2010.05.032	45	29	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33534	10.1371/journal.pone.0033534	http://dx.doi.org/10.1371/journal.pone.0033534			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438945	Green Published, gold, Green Submitted			2022-12-25	WOS:000303309100054
J	Striem-Amit, E; Guendelman, M; Amedi, A				Striem-Amit, Ella; Guendelman, Miriam; Amedi, Amir			'Visual' Acuity of the Congenitally Blind Using Visual-to-Auditory Sensory Substitution	PLOS ONE			English	Article							FUNCTIONAL SPECIALIZATION; VISION; PERCEPTION; RESPONSES; SYSTEM; BRAIN; LOCALIZATION; DEPRIVATION; PLASTICITY; TONGUE	Sensory Substitution Devices (SSDs) convey visual information through sounds or touch, thus theoretically enabling a form of visual rehabilitation in the blind. However, for clinical use, these devices must provide fine-detailed visual information which was not yet shown for this or other means of visual restoration. To test the possible functional acuity conveyed by such devices, we used the Snellen acuity test conveyed through a high-resolution visual-to-auditory SSD (The vOICe). We show that congenitally fully blind adults can exceed the World Health Organization (WHO) blindness acuity threshold using SSDs, reaching the highest acuity reported yet with any visual rehabilitation approach. This demonstrates the potential capacity of SSDs as inexpensive, non-invasive visual rehabilitation aids, alone or when supplementing visual prostheses.	[Striem-Amit, Ella; Guendelman, Miriam; Amedi, Amir] Hebrew Univ Jerusalem, Dept Med Neurobiol, Fac Med, Inst Med Res Israel Canada, Jerusalem, Israel; [Amedi, Amir] Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Sci ELSC, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Striem-Amit, E (corresponding author), Hebrew Univ Jerusalem, Dept Med Neurobiol, Fac Med, Inst Med Res Israel Canada, Jerusalem, Israel.	amir.amedi@ekmd.huji.ac.il	Striem-Amit, Ella/K-3715-2014	Striem-Amit, Ella/0000-0002-5900-3455; Amedi, Amir/0000-0001-5042-2533; Guendelman, Miriam/0000-0003-3708-7763	International Human Frontier Science Program Organization (HFSPO); Israel Science Foundation [1530/08]; European Union [MIRG-CT-2007-205357]; Edmond and Lily Safra Center for Brain Sciences; Hebrew University	International Human Frontier Science Program Organization (HFSPO)(Human Frontier Science Program); Israel Science Foundation(Israel Science Foundation); European Union(European Commission); Edmond and Lily Safra Center for Brain Sciences; Hebrew University	This work was supported by International Human Frontier Science Program Organization (HFSPO); Israel Science Foundation (grant number 1530/08); a European Union Marie Curie International Reintegration Grant (MIRG-CT-2007-205357); and by the generous support from the Edmond and Lily Safra Center for Brain Sciences (to AA). ESA is further supported by the Hebrew University Hoffman Leadership and Responsibility Fellowship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKROYD C, 1974, Q J EXP PSYCHOL, V26, P114, DOI 10.1080/14640747408400393; Amedi A, 2007, NAT NEUROSCI, V10, P687, DOI 10.1038/nn1912; Auvray M, 2007, PERCEPTION, V36, P416, DOI 10.1068/p5631; Bach-Y-Rita P, 2004, ANN NY ACAD SCI, V1013, P83, DOI 10.1196/annals.1305.006; Bach-y-Rita P, 2003, TRENDS COGN SCI, V7, P541, DOI 10.1016/j.tics.2003.10.013; BAILEY IL, 1976, AM J OPTOM PHYS OPT, V53, P740; Busskamp V, 2010, SCIENCE, V329, P413, DOI 10.1126/science.1190897; Capelle C, 1998, IEEE T BIO-MED ENG, V45, P1279, DOI 10.1109/10.720206; Chebat DR, 2007, NEUROREPORT, V18, P1901, DOI 10.1097/WNR.0b013e3282f2a63; Collignon O, 2011, P NATL ACAD SCI USA, V108, P4435, DOI 10.1073/pnas.1013928108; Collignon O, 2009, EXP BRAIN RES, V192, P343, DOI 10.1007/s00221-008-1553-z; Dowling J, 2009, EYE, V23, P1999, DOI 10.1038/eye.2008.385; Fiehler K, 2009, CEREB CORTEX, V19, P1, DOI 10.1093/cercor/bhn067; Fine I, 2003, NAT NEUROSCI, V6, P915, DOI 10.1038/nn1102; Gougoux F, 2004, NATURE, V430, P309, DOI 10.1038/430309a; Gregory RL, 2003, NAT NEUROSCI, V6, P909, DOI 10.1038/nn0903-909; Gregory RL, 1963, EXPT PSYCHOL SOC M S, V2; Hotting K, 2009, HEARING RES, V258, P165, DOI 10.1016/j.heares.2009.07.012; Lewis TL, 2005, DEV PSYCHOBIOL, V46, P163, DOI 10.1002/dev.20055; Locker M, 2009, CURR STEM CELL RES T, V4, P118, DOI 10.2174/157488809788167382; Mahon BZ, 2009, NEURON, V63, P397, DOI 10.1016/j.neuron.2009.07.012; Matteau I, 2010, BRAIN RES BULL, V82, P264, DOI 10.1016/j.brainresbull.2010.05.001; MEIJER PBL, 1992, IEEE T BIO-MED ENG, V39, P112, DOI 10.1109/10.121642; Ostrovsky Y, 2006, PSYCHOL SCI, V17, P1009, DOI 10.1111/j.1467-9280.2006.01827.x; Ostrovsky Y, 2009, PSYCHOL SCI, V20, P1484, DOI 10.1111/j.1467-9280.2009.02471.x; Proulx MJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001840; Ptito M, 2009, NEUROREPORT, V20, P543, DOI 10.1097/WNR.0b013e3283279909; Reich L, 2012, CURR OPIN NEUROL, V25, P86, DOI 10.1097/WCO.0b013e32834ed723; Reich L, 2011, CURR BIOL, V21, P363, DOI 10.1016/j.cub.2011.01.040; Renier L, 2010, DISABIL REHABIL-ASSI, V5, P175, DOI 10.3109/17483100903253936; Renier LA, 2010, NEURON, V68, P138, DOI 10.1016/j.neuron.2010.09.021; Sampaio E, 2001, BRAIN RES, V908, P204, DOI 10.1016/S0006-8993(01)02667-1; Stidwill D, 2011, NORMAL BINOCULAR VIS; Striem-Amit E, 2011, FRONTIERS NEURAL BAS, P393; Striem-Amit E, 2012, CEREB CORTEX, V22, P1698, DOI 10.1093/cercor/bhr253; Weiland JD, 2011, OPHTHALMOLOGY, V118, P2227, DOI 10.1016/j.ophtha.2011.08.042; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; WIESEL TN, 1965, J NEUROPHYSIOL, V28, P1029, DOI 10.1152/jn.1965.28.6.1029; World Health Organization, 2011, FACT SHEET 282; Zrenner E, 2011, P ROY SOC B-BIOL SCI, V278, P1489, DOI 10.1098/rspb.2010.1747	40	82	83	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33136	10.1371/journal.pone.0033136	http://dx.doi.org/10.1371/journal.pone.0033136			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438894	Green Published, gold			2022-12-25	WOS:000303309100023
J	Urner, M; Herrmann, IK; Buddeberg, F; Schuppli, C; Z'graggen, BR; Hasler, M; Schanz, U; Mehr, M; Spahn, DR; Schimmer, BB				Urner, Martin; Herrmann, Inge K.; Buddeberg, Felix; Schuppli, Caroline; Z'graggen, Birgit Roth; Hasler, Melanie; Schanz, Urs; Mehr, Manuela; Spahn, Donat R.; Schimmer, Beatrice Beck			Effects of Blood Products on Inflammatory Response in Endothelial Cells In Vitro	PLOS ONE			English	Article							ACUTE LUNG INJURY; TRANSFUSION; SUPERNATANT; STORAGE; ACCUMULATION; PATHOGENESIS; PLATELETS; LIPIDS	Background: Transfusing blood products may induce inflammatory reactions within the vascular compartment potentially leading to a systemic inflammatory response. Experiments were designed to assess the inflammatory potential of different blood products in an endothelial cell-based in vitro model and to compare baseline levels of potentially activating substances in transfusion products. Methods: The inflammatory response from pre-activated (endotoxin-stimulated) and non-activated endothelial cells as well as neutrophil endothelial transmigration in response to packed red blood cells (PRBC), platelet concentrates (PC) and fresh frozen plasma (FFP) was determined. Baseline inflammatory mediator and lipid concentrations in blood products were evaluated. Results: Following incubation with all blood products, an increased inflammatory mediator release from endothelial cells was observed. Platelet concentrates, and to a lesser extent also FFP, caused the most pronounced response, which was accentuated in already pre-stimulated endothelial cells. Inflammatory response of endothelial cells as well as blood product-induced migration of neutrophils through the endothelium was in good agreement with the lipid content of the according blood product. Conclusion: Within the group of different blood transfusion products both PC and FFP have a high inflammatory potential with regard to activation of endothelial cells. Inflammation upon blood product exposure is strongly accentuated when endothelial cells are pre-injured. High lipid contents in the respective blood products goes along with an accentuated inflammatory reaction from endothelial cells.	[Urner, Martin; Herrmann, Inge K.; Buddeberg, Felix; Hasler, Melanie; Mehr, Manuela; Spahn, Donat R.; Schimmer, Beatrice Beck] Univ Zurich Hosp, Inst Anesthesiol, CH-8091 Zurich, Switzerland; [Urner, Martin; Herrmann, Inge K.; Schuppli, Caroline; Z'graggen, Birgit Roth; Schimmer, Beatrice Beck] Univ Zurich, Inst Physiol, Zurich, Switzerland; [Urner, Martin; Herrmann, Inge K.; Schuppli, Caroline; Z'graggen, Birgit Roth; Schimmer, Beatrice Beck] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; [Schanz, Urs] Univ Zurich Hosp, Clin Haematol, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich; University Zurich Hospital	Urner, M (corresponding author), Univ Zurich Hosp, Inst Anesthesiol, CH-8091 Zurich, Switzerland.	Beatrice_Beck.Schimmer@access.uzh.ch	Urner, Martin/AAK-5701-2020; Herrmann, Inge/H-6318-2018	Urner, Martin/0000-0003-1133-4885; Schuppli, Caroline/0000-0001-6318-2815; Herrmann, Inge/0000-0002-3018-6796	University of Zurich (Forschungskredit der Universitat Zurich, Stiftung fur Forschung an der Medizinischen Fakultat der Universitat Zurich)	University of Zurich (Forschungskredit der Universitat Zurich, Stiftung fur Forschung an der Medizinischen Fakultat der Universitat Zurich)	This study was supported by a grant for young researcher Dr. Buddeberg by the University of Zurich (Forschungskredit der Universitat Zurich, Stiftung fur Forschung an der Medizinischen Fakultat der Universitat Zurich). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AYE MT, 1995, TRANSFUSION, V35, P117, DOI 10.1046/j.1537-2995.1995.35295125733.x; Benson AB, 2009, BRIT J HAEMATOL, V147, P431, DOI 10.1111/j.1365-2141.2009.07840.x; Bless NM, 2000, J IMMUNOL, V164, P2650, DOI 10.4049/jimmunol.164.5.2650; Bux J, 2007, BRIT J HAEMATOL, V136, P788, DOI 10.1111/j.1365-2141.2007.06492.x; Chabrol E, 1937, PRESS MED, V45, P1713; Chin-Yee I, 1998, TRANSFUSION MED, V8, P49; Chudziak D, 2009, VOX SANG, V96, P163, DOI 10.1111/j.1423-0410.2008.01132.x; Dumont LJ, 2003, TRANSFUSION, V43, P143, DOI 10.1046/j.1537-2995.2003.00286.x; Dunne James R, 2004, Surg Infect (Larchmt), V5, P395, DOI 10.1089/sur.2004.5.395; Frank JA, 2006, AM J PHYSIOL-LUNG C, V291, pL1191, DOI 10.1152/ajplung.00055.2006; Gajic O, 2007, AM J RESP CRIT CARE, V176, P886, DOI 10.1164/rccm.200702-271OC; Gilliss BM, 2011, ANESTHESIOLOGY, V115, P635, DOI 10.1097/ALN.0b013e31822a22d9; Goodnough LT, 1999, NEW ENGL J MED, V340, P438, DOI 10.1056/NEJM199902113400606; Gould S, 2007, AM J CRIT CARE, V16, P39; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Jeschke MG, 2007, CRIT CARE MED, V35, P579, DOI 10.1097/01.CCM.0000253812.09236.98; Johnson JL, 2010, ARCH SURG-CHICAGO, V145, P973, DOI 10.1001/archsurg.2010.216; Khan SY, 2006, BLOOD, V108, P2455, DOI 10.1182/blood-2006-04-017251; Kumar A, 2005, CRIT CARE MED, V33, P331, DOI 10.1097/01.CCM.0000152229.69180.2; Ludwig A, 1997, BLOOD, V90, P4588; McFaul SJ, 2009, TRANSFUSION; McLaren M, 2005, SURGERY OXFORD, V23, P1; Remick DG, 2005, SHOCK, V24, P7, DOI 10.1097/01.shk.0000191384.34066.85; Sachs UJH, 2007, TRANSFUS APHER SCI, V37, P273, DOI 10.1016/j.transci.2007.02.005; Schrezenmeier H, 2010, VOX SANG, V99, P1, DOI 10.1111/j.1423-0410.2009.01295.x; Seghatchian J, 2006, TRANSFUS APHER SCI, V34, P125, DOI 10.1016/j.transci.2005.09.002; Shaz BH, 2011, BLOOD, V117, P1463, DOI 10.1182/blood-2010-04-278135; Sheppard Dean, 2006, Proc Am Thorac Soc, V3, P413, DOI 10.1513/pats.200601-008AW; Silliman CC, 1997, TRANSFUSION, V37, P719, DOI 10.1046/j.1537-2995.1997.37797369448.x; Silliman CC, 2005, BLOOD, V105, P2266, DOI 10.1182/blood-2004-07-2929; Silliman CC, 1996, TRANSFUSION, V36, P133, DOI 10.1046/j.1537-2995.1996.36296181925.x; Silliman CC, 2011, TRANSFUSION; Silliman CC, 2006, BLOOD REV, V20, P139, DOI 10.1016/j.blre.2005.11.001; Silliman CC, 2009, BLOOD REV, V23, P245, DOI 10.1016/j.blre.2009.07.005; Sparrow RL, 2004, TRANSFUSION, V44, P722, DOI 10.1111/j.1537-2995.2004.03113.x; STRIETER RM, 1989, SCIENCE, V243, P1467, DOI 10.1126/science.2648570; SUFFREDINI AF, 1989, NEW ENGL J MED, V321, P280, DOI 10.1056/NEJM198908033210503; Urner M, 2011, AM J RESP CELL MOL B; Vlaar APJ, 2010, BLOOD, V116, P1360, DOI 10.1182/blood-2009-10-248732	39	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33403	10.1371/journal.pone.0033403	http://dx.doi.org/10.1371/journal.pone.0033403			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438924	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000303309100040
J	Cai, YF; Li, J; Yang, SY; Li, P; Zhang, X; Liu, HL				Cai, Yafei; Li, Jun; Yang, Shiyong; Li, Ping; Zhang, Xuan; Liu, Honglin			CIBZ, a Novel BTB Domain-Containing Protein, Is Involved in Mouse Spinal Cord Injury via Mitochondrial Pathway Independent of p53 Gene	PLOS ONE			English	Article							CASPASE-3 INHIBITOR; DOWN-REGULATION; APOPTOSIS; EXPRESSION; RECOVERY; CTBP; IMPROVES; CELLS	Spinal cord injury (SCI) induces both primary uncontrollable mechanical injury and secondary controllable degeneration, which further results in the activation of cell death cascades that mediate delayed tissue damage. To alleviate its impairments and seek for an effective remedy, mRNA differential display was used to investigate gene mRNA expression profiling in mice following SCI. A specific Zinc finger and BTB domain-containing protein, CIBZ, was discovered to implicate in the SCI process for the first time. Further researches indicated that CIBZ was extensively distributed in various tissues, and the expression level was highest in muscle, followed by spinal cord, large intestine, kidney, spleen, thymus, lung, cerebrum, stomach, ovary and heart, respectively. After injury, the CIBZ expression decreased dramatically and reached the lowest level at 8 h, but it gradually increased to the maximal level at 7 d. Caspase-3 and C-terminal-binding protein (CtBP), two CIBZ-related proteins, showed similar tendency. Interestingly, p53 expression remained constant in all groups. Via flow cytometry (FCM) analysis, it was found that the cell death rate in SCI group markedly increased and reached the highest value 1 d after surgery and the mitochondrial transmembrane potential (Delta Psi m) at 1 d was the lowest in all groups. Taken together, it is suggested that: (i) in the presence of CtBP, CIBZ gene is involved in secondary injury process and trigger the activation of apoptotic caspase-3 and bax genes independent of p53; (ii) abrupt down-regulation of CtBP at 8 h is a sign of mitochondria dysfunction and the onset of cell death; (iii) it could be used as an inhibitor or target drug of caspase-3 gene to improve spinal cord function.	[Cai, Yafei; Li, Jun; Yang, Shiyong; Li, Ping; Zhang, Xuan] Anhui Normal Univ, Coll Life Sci, Key Lab Biot Environm & Ecol Safety Anhui Prov, Wuhu, Anhui, Peoples R China; [Liu, Honglin] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China	Anhui Normal University; Nanjing Agricultural University	Liu, HL (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China.	liuhonglin@njau.edu.cn	liu, honglin/HDN-0409-2022; Cai, Yafei/S-7210-2019	liu, honglin/0000-0002-1254-3163; 	National Science Foundation of China [31072028]; Anhui Natural Science and Technology Program of Anhui province [10020303043, KJ2009A039]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Anhui Natural Science and Technology Program of Anhui province	This study was supported by National Science Foundation of China (31072028) and Anhui Natural Science and Technology Program of Anhui province (10020303043 & KJ2009A039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimone JB, 2004, EXP NEUROL, V189, P204, DOI 10.1016/j.expneurol.2004.05.042; Akdemir O, 2008, J CLIN NEUROSCI, V15, P672, DOI 10.1016/j.jocn.2007.06.014; Albin M S, 1965, Surg Forum, V16, P423; Barut S, 2005, SURG NEUROL, V64, P213, DOI 10.1016/j.surneu.2005.03.042; Beattie MS, 2000, J NEUROTRAUM, V17, P915, DOI 10.1089/neu.2000.17.915; Cai YF, 2011, CURR ZOOL, V57, P340, DOI 10.1093/czoolo/57.3.340; Cao L, 2004, BRAIN, V127, P535, DOI 10.1093/brain/awh072; Casha S, 2001, NEUROSCIENCE, V103, P203, DOI 10.1016/S0306-4522(00)00538-8; Colak A, 2005, J NEUROSURG-SPINE, V2, P327, DOI 10.3171/spi.2005.2.3.0327; Colak A, 2009, NEUROCIRUGIA, V20, P533; Diaz-Prieto N, 2008, CELL CALCIUM, V44, P339, DOI 10.1016/j.ceca.2008.01.007; Eldadah BA, 2000, J NEUROTRAUM, V17, P811, DOI 10.1089/neu.2000.17.811; [范睿 Fan Rui], 2010, [南京农业大学学报, Journal of Nanjing Agricultural University], V33, P87; Filion GJP, 2006, MOL CELL BIOL, V26, P169, DOI 10.1128/MCB.26.1.169-181.2006; Grooteclaes M, 2003, P NATL ACAD SCI USA, V100, P4568, DOI 10.1073/pnas.0830998100; Harris OA, 2002, ARCH NEUROL-CHICAGO, V59, P1077, DOI 10.1001/archneur.59.7.1077; Hashimoto M, 2007, J NEUROSCI, V27, P3603, DOI 10.1523/JNEUROSCI.4805-06.2007; Hwan AY, 2006, BIOCHEM BIOPH RES CO, V348, P560, DOI 10.1016/j.bbrc.2006.07.105; Ishibashi M, 2009, CLIN CANCER RES, V15, P804, DOI 10.1158/1078-0432.CCR-08-2134; Kim HJ, 2012, GENE THER, V19, P513, DOI 10.1038/gt.2011.137; Kim JH, 2009, CELL DEATH DIFFER, V16, P584, DOI 10.1038/cdd.2008.186; Lee D, 2000, J BIOL CHEM, V275, P16007, DOI 10.1074/jbc.275.21.16007; Marsala M, 1997, J NEUROSCI METH, V74, P97, DOI 10.1016/S0165-0270(97)02270-X; Mori K, 2002, J NEUROTRAUM, V19, P1261, DOI 10.1089/08977150260338047; Oikawa Y, 2008, J BIOL CHEM, V283, P14242, DOI 10.1074/jbc.M802257200; Oikawa Y, 2011, CELL RES, V21, P1578, DOI 10.1038/cr.2011.90; Ozawa H, 2002, EXP NEUROL, V177, P306, DOI 10.1006/exnr.2002.7998; Paliwal S, 2006, MOL CELL BIOL, V26, P2360, DOI 10.1128/MCB.26.6.2360-2372.2006; Ramer MS, 2000, SPINAL CORD, V38, P449, DOI 10.1038/sj.sc.3101055; Sasai N, 2005, GENES CELLS, V10, P871, DOI 10.1111/j.1365-2443.2005.00885.x; Sirbulescu RF, 2010, NEUROSCIENCE, V171, P599, DOI 10.1016/j.neuroscience.2010.09.002; Sirbulescu RF, 2009, BRAIN RES, V1304, P14, DOI 10.1016/j.brainres.2009.09.071; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; Yeo JE, 2008, CELL PHYSIOL BIOCHEM, V21, P225, DOI 10.1159/000113764; Zamzami N, 2001, NAT REV MOL CELL BIO, V2, P67, DOI 10.1038/35048073; Zhang QH, 2006, P NATL ACAD SCI USA, V103, P9029, DOI 10.1073/pnas.0603269103; Zhu LP, 2000, CELL CALCIUM, V28, P107, DOI 10.1054/ceca.2000.0138	37	31	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33156	10.1371/journal.pone.0033156	http://dx.doi.org/10.1371/journal.pone.0033156			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427977	Green Published, Green Submitted, gold			2022-12-25	WOS:000302381500102
J	Engels, B; Jannot, G; Remenyi, J; Simard, MJ; Hutvagner, G				Engels, Bart; Jannot, Guillaume; Remenyi, Judit; Simard, Martin J.; Hutvagner, Gyoergy			Polypyrimidine Tract Binding Protein (hnRNP I) Is Possibly a Conserved Modulator of miRNA-Mediated Gene Regulation	PLOS ONE			English	Article							INTERNAL RIBOSOME ENTRY; MESSENGER-RNA; POSTTRANSCRIPTIONAL REGULATION; HUMAN-CELLS; PTB; EXPRESSION; MICRORNAS; TARGET; REPRESSION; LET-7	MiRNAs can regulate gene expression through versatile mechanisms that result in increased or decreased expression of the targeted mRNA and it could effect the expression of thousands of protein in a particular cell. An increasing body of evidence suggest that miRNAs action can be modulated by proteins that bind to the same 3'UTRs that are targeted by miRNAs, suggesting that other factors apart from miRNAs and their target sites determine miRNA-modulation of gene expression. We applied an affinity purification protocol using biotinylated let-7 miRNA inhibitor to isolate proteins that are involved in let-7 mediated gene regulation that resulted in an affinity purification of Polypyrimidine Tract Binding protein (PTB). Here we show that PTB interacts with miRNAs and human Argonaute 2 (hAgo2) through RNA as well as identified potential mammalian cellular targets that are co-regulated by PTB and hAgo2. In addition, using genetic approach, we have demonstrated that PTB genetically interacts with Caenorhabditis elegans let-7 indicating a conserved role for PTB in miRNA-mediated gene regulation.	[Engels, Bart; Remenyi, Judit; Hutvagner, Gyoergy] Univ Dundee, Coll Life Sci, Wellcome Trust Ctr Gene Regulat & Express, Dundee, Scotland; [Jannot, Guillaume; Simard, Martin J.] Univ Laval, Canc Res Ctr, Hotel Dieu Quebec CHUQ, Quebec City, PQ, Canada; [Hutvagner, Gyoergy] Univ Technol Sydney, Ctr Hlth Technol, Sydney, NSW 2007, Australia	University of Dundee; Laval University; University of Technology Sydney	Engels, B (corresponding author), Univ Dundee, Coll Life Sci, Wellcome Trust Ctr Gene Regulat & Express, Dundee, Scotland.	gyorgy.hutvagner@uts.edu.au		Simard, Martin/0000-0002-3189-9309; Hutvagner, Gyorgy/0000-0002-7231-9446	Wellcome Trust; European Framework 6 SIROCCO consortium; Canadian Institutes of Health Research (CIHR); National Institutes of Health National Center for Research Resources	Wellcome Trust(Wellcome TrustEuropean Commission); European Framework 6 SIROCCO consortium; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The work has been funded by the Wellcome Trust and European Framework 6 SIROCCO consortium fund (G. H.) and the Canadian Institutes of Health Research (CIHR) (M.J.S.). G. H. is a Wellcome Trust CD fellow and M.J.S. is a CIHR New Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Chris W. Smith for providing the GFP::PTB and the XR::nPTB construct and the BB7 mouse monoclonal antibody recognizing the human PTB. We are also grateful to Gunter Meister for the rat monoclonal hAgo2 antibody. We are also extremely grateful to Chris W. Smith and Miriam Llorian to share proteomics data before publication and for the critical rading of the manuscript. Nematode strains were provided by the Caenorhabditis Genetics Center, which is funded by the National Institutes of Health National Center for Research Resources.	Ameres SL, 2007, CELL, V130, P101, DOI 10.1016/j.cell.2007.04.037; Auweter SD, 2007, J MOL BIOL, V367, P174, DOI 10.1016/j.jmb.2006.12.053; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Balvay L, 2007, NAT REV MICROBIOL, V5, P128, DOI 10.1038/nrmicro1599; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Boutz PL, 2007, GENE DEV, V21, P71, DOI 10.1101/gad.1500707; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Bushell M, 2006, MOL CELL, V23, P401, DOI 10.1016/j.molcel.2006.06.012; Chou MY, 2000, MOL CELL, V5, P949, DOI 10.1016/S1097-2765(00)80260-9; COLE C, 2009, RNA; Coles LS, 2004, EUR J BIOCHEM, V271, P648, DOI 10.1111/j.1432-1033.2003.03968.x; Crosby ME, 2009, CANCER RES, V69, P1221, DOI 10.1158/0008-5472.CAN-08-2516; Didiano D, 2008, RNA, V14, P1297, DOI 10.1261/rna.1082708; Didiano D, 2006, NAT STRUCT MOL BIOL, V13, P849, DOI 10.1038/nsmb1138; Elcheva I, 2009, MOL CELL, V35, P240, DOI 10.1016/j.molcel.2009.06.007; Gama-Carvalho M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r113; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hamilton BJ, 2003, MOL CELL BIOL, V23, P510, DOI 10.1128/MCB.23.2.510-525.2003; Hebert C, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-5; Hock J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-210; Hock J, 2007, EMBO REP, V8, P1052, DOI 10.1038/sj.embor.7401088; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Izquierdo JM, 2005, MOL CELL, V19, P475, DOI 10.1016/j.molcel.2005.06.015; Jannot G, 2011, EMBO REP, V12, P581, DOI 10.1038/embor.2011.66; Jin H, 2009, MOL CELL BIOL, V29, P5789, DOI 10.1128/MCB.00653-09; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lamichhane R, 2010, P NATL ACAD SCI USA, V107, P4105, DOI 10.1073/pnas.0907072107; Llorian M, 2010, NAT STRUCT MOL BIOL, V17, P1114, DOI 10.1038/nsmb.1881; Lou H, 1999, MOL CELL BIOL, V19, P78; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Meister G, 2004, RNA, V10, P544, DOI 10.1261/rna.5235104; Michlewski G, 2008, MOL CELL, V32, P383, DOI 10.1016/j.molcel.2008.10.013; Mitchell SA, 2005, GENE DEV, V19, P1556, DOI 10.1101/gad.339105; Oberstrass FC, 2005, SCIENCE, V309, P2054, DOI 10.1126/science.1114066; Pautz A, 2006, J BIOL CHEM, V281, P32294, DOI 10.1074/jbc.M603915200; Petoukhov MV, 2006, STRUCTURE, V14, P1021, DOI 10.1016/j.str.2006.04.005; Pickering BM, 2004, MOL CELL BIOL, V24, P5595, DOI 10.1128/MCB.24.12.5595-5605.2004; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rudel S, 2008, RNA, V14, P1244, DOI 10.1261/rna.973808; Sawicka K, 2008, BIOCHEM SOC T, V36, P641, DOI 10.1042/BST0360641; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shen HH, 2004, RNA, V10, P787, DOI 10.1261/rna.5229704; Spellman R, 2007, MOL CELL, V27, P420, DOI 10.1016/j.molcel.2007.06.016; Tillmar L, 2004, MOL CELL BIOCHEM, V260, P85, DOI 10.1023/B:MCBI.0000026059.56089.e4; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Wollerton MC, 2004, MOL CELL, V13, P91, DOI 10.1016/S1097-2765(03)00502-1; Xu MG, 2007, BIOL REPROD, V76, P1025, DOI 10.1095/biolreprod.107.060079; Xue YC, 2009, MOL CELL, V36, P996, DOI 10.1016/j.molcel.2009.12.003	52	18	18	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2012	7	3							e33144	10.1371/journal.pone.0033144	http://dx.doi.org/10.1371/journal.pone.0033144			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KX	22427970	Green Submitted, Green Published, gold			2022-12-25	WOS:000303062800047
J	Gissot, M; Walker, R; Delhaye, S; Huot, L; Hot, D; Tomavo, S				Gissot, Mathieu; Walker, Robert; Delhaye, Stephane; Huot, Ludovic; Hot, David; Tomavo, Stanislas			Toxoplasma gondii Chromodomain Protein 1 Binds to Heterochromatin and Colocalises with Centromeres and Telomeres at the Nuclear Periphery	PLOS ONE			English	Article							CELL-CYCLE; GENES; TRANSCRIPTION; DROSOPHILA; EXPRESSION	Background: Apicomplexan parasites are responsible for some of the most deadly parasitic diseases afflicting humans, including malaria and toxoplasmosis. These obligate intracellular parasites exhibit a complex life cycle and a coordinated cell cycle-dependant expression program. Their cell division is a coordinated multistep process. How this complex mechanism is organised remains poorly understood. Methods and Findings: In this study, we provide evidence for a link between heterochromatin, cell division and the compartmentalisation of the nucleus in Toxoplasma gondii. We characterised a T. gondii chromodomain containing protein (named TgChromo1) that specifically binds to heterochromatin. Using ChIP-on-chip on a genome-wide scale, we report TgChromo1 enrichment at the peri-centromeric chromatin. In addition, we demonstrate that TgChromo1 is cell-cycle regulated and co-localised with markers of the centrocone. Through the loci-specific FISH technique for T. gondii, we confirmed that TgChromo1 occupies the same nuclear localisation as the peri-centromeric sequences. Conclusion: We propose that TgChromo1 may play a role in the sequestration of chromosomes at the nuclear periphery and in the process of T. gondii cell division.	[Gissot, Mathieu; Walker, Robert; Delhaye, Stephane; Huot, Ludovic; Hot, David; Tomavo, Stanislas] Univ Lille Nord France, Inst Pasteur Lille, INSERM, CNRS,UMR 8204,U1019,Ctr Infect & Immun Lillle, Lille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille	Gissot, M (corresponding author), Univ Lille Nord France, Inst Pasteur Lille, INSERM, CNRS,UMR 8204,U1019,Ctr Infect & Immun Lillle, Lille, France.	Mathieu.Gissot@pasteur-lille.fr; Stan.Tomavo@pasteur-lille.fr	Walker, Robert/C-3202-2013; Gissot, Mathieu/AFN-3127-2022; Hot, David/M-6775-2016	Walker, Robert/0000-0003-0032-9925; Gissot, Mathieu/0000-0003-0047-8189; delhaye, stephane/0000-0001-9438-6730; Hot, David/0000-0002-2361-0616	CNRS; INSERM; French National Research Agency (ANR) [ANR-09-MIEN-002-01]	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); French National Research Agency (ANR)(French National Research Agency (ANR))	This work has been supported by the CNRS, INSERM and a grant from the French National Research Agency (ANR) (number ANR-09-MIEN-002-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaji S, 2005, NUCLEIC ACIDS RES, V33, P3994, DOI 10.1093/nar/gki709; Behnke MS, 2008, MOL MICROBIOL, V68, P1502, DOI 10.1111/j.1365-2958.2008.06249.x; Behnke MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012354; Braun L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000920; Brooks CF, 2011, P NATL ACAD SCI USA, V108, P3767, DOI 10.1073/pnas.1006741108; Cremer M, 2007, CSH PROTOC; Csink AK, 1996, NATURE, V381, P529, DOI 10.1038/381529a0; Daniel JA, 2005, CELL CYCLE, V4, P919, DOI 10.4161/cc.4.7.1824; Duraisingh MT, 2005, CELL, V121, P13, DOI 10.1016/j.cell.2005.01.036; Flueck C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000784; Flueck C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000569; Gaji RY, 2011, MOL MICROBIOL, V79, P192, DOI 10.1111/j.1365-2958.2010.07441.x; Gissot M, 2007, PLOS PATHOG, V3, P709, DOI 10.1371/journal.ppat.0030077; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Gubbels MJ, 2008, INT J PARASITOL, V38, P1343, DOI 10.1016/j.ijpara.2008.06.004; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Kim K, 2004, INT J PARASITOL, V34, P423, DOI 10.1016/j.ijpara.2003.12.009; Muller S, 2007, CSH PROTOC; Olguin-Lamas A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001328; Perez-Toledo K, 2009, NUCLEIC ACIDS RES, V37, P2596, DOI 10.1093/nar/gkp115; Perrini B, 2004, MOL CELL, V15, P467, DOI 10.1016/j.molcel.2004.06.036; Ruault M, 2008, TRENDS GENET, V24, P574, DOI 10.1016/j.tig.2008.08.008; Striepen B, 2007, PLOS PATHOG, V3, P691, DOI 10.1371/journal.ppat.0030078; Sullivan WJ, 2006, MOL BIOCHEM PARASIT, V148, P109, DOI 10.1016/j.molbiopara.2006.03.010; Vaquero-Sedas MI, 2011, NUCLEIC ACIDS RES, V39, P2007, DOI 10.1093/nar/gkq1119; Weiss LM, 2000, FRONT BIOSCI-LANDMRK, V5, pD391, DOI 10.2741/Weiss	26	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2012	7	3							e32671	10.1371/journal.pone.0032671	http://dx.doi.org/10.1371/journal.pone.0032671			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KX	22427862	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000303062800025
J	Ader, N; Brindley, MA; Avila, M; Origgi, FC; Langedijk, JPM; Orvell, C; Vandevelde, M; Zurbriggen, A; Plemper, RK; Plattet, P				Ader, Nadine; Brindley, Melinda A.; Avila, Mislay; Origgi, Francesco C.; Langedijk, Johannes P. M.; Orvell, Claes; Vandevelde, Marc; Zurbriggen, Andreas; Plemper, Richard K.; Plattet, Philippe			Structural Rearrangements of the Central Region of the Morbillivirus Attachment Protein Stalk Domain Trigger F Protein Refolding for Membrane Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANINE-DISTEMPER VIRUS; NEWCASTLE-DISEASE VIRUS; HEMAGGLUTININ-NEURAMINIDASE PROTEIN; MEASLES-VIRUS; CELL-FUSION; NIPAH VIRUS; FUNCTIONAL INTERACTION; 4-HELIX BUNDLE; HENDRA VIRUS; SWISS-MODEL	It is unknown how receptor binding by the paramyxovirus attachment proteins (HN, H, or G) triggers the fusion (F) protein to fuse with the plasma membrane for cell entry. H-proteins of the morbillivirus genus consist of a stalk ectodomain supporting a cuboidal head; physiological oligomers consist of non-covalent dimer-of-dimers. We report here the successful engineering of intermolecular disulfide bonds within the central region (residues 91-115) of the morbillivirus H-stalk; a sub-domain that also encompasses the putative F-contacting section (residues 111-118). Remarkably, several intersubunit crosslinks abrogated membrane fusion, but bioactivity was restored under reducing conditions. This phenotype extended equally to H proteins derived from virulent and attenuated morbillivirus strains and was independent of the nature of the contacted receptor. Our data reveal that the morbillivirus H-stalk domain is composed of four tightly-packed subunits. Upon receptor binding, these subunits structurally rearrange, possibly inducing conformational changes within the central region of the stalk, which, in turn, promote fusion. Given that the fundamental architecture appears conserved among paramyxovirus attachment protein stalk domains, we predict that these motions may act as a universal paramyxovirus F-triggering mechanism.	[Ader, Nadine; Avila, Mislay; Zurbriggen, Andreas; Plattet, Philippe] Univ Bern, Vetsuisse Fac, DCR VPH, Div Expt Clin Res,Neurovirol Unit, CH-3001 Bern, Switzerland; [Brindley, Melinda A.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA; Childrens Healthcare Atlanta, Atlanta, GA USA; [Vandevelde, Marc] Univ Bern, Vetsuisse Fac, DCV, Div Neurol, CH-3001 Bern, Switzerland; [Origgi, Francesco C.] Univ Bern, Vetsuisse Fac, DIP, Ctr Fish & Wildlife Hlth FIWI ITPA, CH-3012 Bern, Switzerland; [Langedijk, Johannes P. M.] Crucell Holland BV, Innovat & Discovery Lab, NL-2301 CA Leiden, Netherlands; [Orvell, Claes] Karolinska Univ Hosp Huddinge, Lab Clin Virol, SE-19186 Stockholm, Sweden	University of Bern; Emory University; Children's Healthcare of Atlanta (CHOA); University of Bern; University of Bern; Johnson & Johnson; Karolinska Institutet; Karolinska University Hospital	Plattet, P (corresponding author), Bremgartenstr 109A, CH-3001 Bern, Switzerland.	philippe.plattet@vetsuisse.unibe.ch			Swiss National Science Foundation [310030_132887]; United States Public Health Service [AI083402]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI083402, R01AI083402] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Swiss National Science Foundation (Ref. No. 310030_132887; to P. P.) and, in part, by United States Public Health Service Grant AI083402 (to R. K. P.).	Aguilar HC, 2009, J BIOL CHEM, V284, P1628, DOI 10.1074/jbc.M807469200; Bishop KA, 2008, J VIROL, V82, P11398, DOI 10.1128/JVI.02654-07; Bonaparte MI, 2005, P NATL ACAD SCI USA, V102, P10652, DOI 10.1073/pnas.0504887102; Bose S, 2011, J VIROL, V85, P12855, DOI 10.1128/JVI.06350-11; Brindley MA, 2010, J VIROL, V84, P12174, DOI 10.1128/JVI.01222-10; Chen SY, 2011, J INFECT DIS, V203, P1517, DOI 10.1093/infdis/jir115; Cherpillod P, 1999, J VIROL, V73, P2263, DOI 10.1128/JVI.73.3.2263-2269.1999; Colf LA, 2007, NAT STRUCT MOL BIOL, V14, P1227, DOI 10.1038/nsmb1342; Deng R, 1997, ARCH VIROL, P115; Deng RT, 1999, VIROLOGY, V253, P43, DOI 10.1006/viro.1998.9501; DENG RT, 1995, VIROLOGY, V209, P457, DOI 10.1006/viro.1995.1278; DORIG RE, 1993, CELL, V75, P295, DOI 10.1016/0092-8674(93)80071-L; Feige MJ, 2011, CURR OPIN CELL BIOL, V23, P167, DOI 10.1016/j.ceb.2010.10.012; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Hashiguchi T, 2007, P NATL ACAD SCI USA, V104, P19535, DOI 10.1073/pnas.0707830104; Hashiguchi T, 2011, NAT STRUCT MOL BIOL, V18, P135, DOI 10.1038/nsmb.1969; Lamb R, 2007, PARAMYXOVIRIDAE VIRU, V5th; Langedijk JPM, 2011, J VIROL, V85, P11242, DOI 10.1128/JVI.05340-11; Lee JK, 2008, J BIOL CHEM, V283, P16561, DOI 10.1074/jbc.M801018200; Navaratnarajah CK, 2011, NAT STRUCT MOL BIOL, V18, P128, DOI 10.1038/nsmb.1967; Negrete OA, 2005, NATURE, V436, P401, DOI 10.1038/nature03838; Negrete Oscar A, 2006, PLoS Pathog, V2, pe7; NUSSBAUM O, 1994, J VIROL, V68, P5411, DOI 10.1128/JVI.68.9.5411-5422.1994; Origgi F. C., 2012, VET PATHOL IN PRESS; ORVELL C, 1985, J GEN VIROL, V66, P443, DOI 10.1099/0022-1317-66-3-443; Paal T, 2009, J VIROL, V83, P10480, DOI 10.1128/JVI.01195-09; Peitsch MC, 1996, BIOCHEM SOC T, V24, P274, DOI 10.1042/bst0240274; Plattet P, 2007, J VIROL, V81, P11413, DOI 10.1128/JVI.01287-07; Plemper RK, 2011, CURR OPIN VIROL, V1, P92, DOI 10.1016/j.coviro.2011.06.002; Plemper RK, 2000, J VIROL, V74, P6485, DOI 10.1128/JVI.74.14.6485-6493.2000; Santiago C, 2010, NAT STRUCT MOL BIOL, V17, P124, DOI 10.1038/nsmb.1726; Singethan K, 2010, J GEN VIROL, V91, P2762, DOI 10.1099/vir.0.025650-0; Sun AM, 2006, J MED CHEM, V49, P5080, DOI 10.1021/jm0602559; SUTTER G, 1995, FEBS LETT, V371, P9, DOI 10.1016/0014-5793(95)00843-X; Tanabayashi K, 1996, J VIROL, V70, P6112, DOI 10.1128/JVI.70.9.6112-6118.1996; Tatsuo H, 2000, NATURE, V406, P893, DOI 10.1038/35022579; Tatsuo H, 2001, J VIROL, V75, P5842, DOI 10.1128/JVI.75.13.5842-5850.2001; Tsurudome M, 1998, J GEN VIROL, V79, P279, DOI 10.1099/0022-1317-79-2-279; TSURUDOME M, 1995, VIROLOGY, V213, P190, DOI 10.1006/viro.1995.1559; Tsurudome M, 2011, J VIROL, V85, P3153, DOI 10.1128/JVI.01666-10; Wang ZY, 2004, VIRUS RES, V99, P177, DOI 10.1016/j.virusres.2003.11.010; WILD TF, 1994, J VIROL, V68, P7546, DOI 10.1128/JVI.68.11.7546-7548.1994; Yuan P, 2005, STRUCTURE, V13, P803, DOI 10.1016/j.str.2005.02.019; Yuan P, 2011, P NATL ACAD SCI USA, V108, P14920, DOI 10.1073/pnas.1111691108; Yuchi ZG, 2008, FEBS J, V275, P6228, DOI 10.1111/j.1742-4658.2008.06747.x; Zipperle L, 2010, J VIROL, V84, P9618, DOI 10.1128/JVI.01077-10	47	58	58	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16324	16334		10.1074/jbc.M112.342493	http://dx.doi.org/10.1074/jbc.M112.342493			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22431728	Green Published, hybrid			2022-12-25	WOS:000304030900024
J	Lu, ZK; Shen, M; Cao, Y; Zhang, HM; Yao, LL; Li, XD				Lu, Zekuan; Shen, Mei; Cao, Yang; Zhang, Hai-Man; Yao, Lin-Lin; Li, Xiang-dong			Calmodulin Bound to the First IQ Motif Is Responsible for Calcium-dependent Regulation of Myosin 5a	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE MYOSIN; GLOBULAR TAIL DOMAIN; LIGHT-CHAIN; MOTOR-ACTIVITY; UNCONVENTIONAL MYOSIN; CONFORMATIONAL-CHANGE; HEAVY-MEROMYOSIN; ATPASE ACTIVITY; BINDING DOMAIN; VA	Myosin 5a is as yet the best-characterized unconventional myosin motor involved in transport of organelles along actin filaments. It is well-established that myosin 5a is regulated by its tail in a Ca2+-dependent manner. The fact that the actin-activated ATPase activity of myosin 5a is stimulated by micromolar concentrations of Ca2+ and that calmodulin (CaM) binds to IQ motifs of the myosin 5a heavy chain indicates that Ca2+ regulates myosin 5a function via bound CaM. However, it is not known which IQ motif and bound CaM are responsible for the Ca2+-dependent regulation and how the head-tail interaction is affected by Ca2+. Here, we found that the CaM in the first IQ motif (IQ1) is responsible for Ca2+ regulation of myosin 5a. In addition, we demonstrate that the C-lobe fragment of CaM in IQ1 is necessary for mediating Ca2+ regulation of myosin 5a, suggesting that the C-lobe fragment of CaM in IQ1 participates in the interaction between the head and the tail. We propose that Ca2+ induces a conformational change of the C-lobe of CaM in IQ1 and prevents interaction between the head and the tail, thus activating motor function.	[Lu, Zekuan; Shen, Mei; Cao, Yang; Zhang, Hai-Man; Yao, Lin-Lin; Li, Xiang-dong] Chinese Acad Sci, Inst Zool, Grp Cell Motil & Muscle Contract, Natl Lab Integrated Management Insect Pests & Rod, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS	Li, XD (corresponding author), Chinese Acad Sci, Inst Zool, Grp Cell Motil & Muscle Contract, Natl Lab Integrated Management Insect Pests & Rod, Beijing 100101, Peoples R China.	lixd@ioz.ac.cn			National Natural Science Foundation of China [31171367, 31071973]; Chinese Academy of Sciences; National Basic Research Program of China [2012CB114102]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China (No. 31171367 and 31071973), Hundred Talent Program from Chinese Academy of Sciences, and National Basic Research Program of China (No. 2012CB114102).	BECKINGHAM K, 1991, J BIOL CHEM, V266, P6027; Burgess SA, 2007, J MOL BIOL, V372, P1165, DOI 10.1016/j.jmb.2007.07.014; CHENEY RE, 1993, CELL, V75, P13, DOI 10.1016/0092-8674(93)90675-G; Coureux PD, 2004, EMBO J, V23, P4527, DOI 10.1038/sj.emboj.7600458; De la Cruz EM, 2000, BIOCHEMISTRY-US, V39, P14196, DOI 10.1021/bi001701b; Fukuda M, 2004, J CELL SCI, V117, P583, DOI 10.1242/jcs.00891; Homma K, 2000, J BIOL CHEM, V275, P34766, DOI 10.1074/jbc.M003132200; Houdusse A, 2006, P NATL ACAD SCI USA, V103, P19326, DOI 10.1073/pnas.0609436103; IKEBE M, 1994, J BIOL CHEM, V269, P28165; Ikebe M, 2008, BIOCHEM BIOPH RES CO, V369, P157, DOI 10.1016/j.bbrc.2008.01.057; IKURA M, 1990, BIOCHEM PHARMACOL, V40, P153; Koide H, 2006, BIOCHEMISTRY-US, V45, P11598, DOI 10.1021/bi0613877; Krementsov DN, 2004, J CELL BIOL, V164, P877, DOI 10.1083/jcb.200310065; Li XD, 2005, J BIOL CHEM, V280, P17815, DOI 10.1074/jbc.M413295200; Li XD, 2004, BIOCHEM BIOPH RES CO, V315, P538, DOI 10.1016/j.bbrc.2004.01.084; Li XD, 2008, P NATL ACAD SCI USA, V105, P1140, DOI 10.1073/pnas.0709741105; Li XD, 2006, J BIOL CHEM, V281, P21789, DOI 10.1074/jbc.M602957200; Lowey S, 2010, J BIOL CHEM, V285, P16403, DOI 10.1074/jbc.R109.025551; Martin SR, 2004, FEBS LETT, V567, P166, DOI 10.1016/j.febslet.2004.04.053; Nascimento AAC, 1996, J BIOL CHEM, V271, P17561, DOI 10.1074/jbc.271.29.17561; Sakai T, 2011, P NATL ACAD SCI USA, V108, P7028, DOI 10.1073/pnas.1009188108; SEPERACK PK, 1995, EMBO J, V14, P2326, DOI 10.1002/j.1460-2075.1995.tb07227.x; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Terrak M, 2005, P NATL ACAD SCI USA, V102, P12718, DOI 10.1073/pnas.0503899102; Terrak M, 2003, EMBO J, V22, P362, DOI 10.1093/emboj/cdg058; Thirumurugan K, 2006, NATURE, V442, P212, DOI 10.1038/nature04865; Trybus KM, 2007, J BIOL CHEM, V282, P23316, DOI 10.1074/jbc.M701636200; Trybus KM, 1999, J BIOL CHEM, V274, P27448, DOI 10.1074/jbc.274.39.27448; Umeki N, 2011, NAT STRUCT MOL BIOL, V18, P783, DOI 10.1038/nsmb.2065; Umeki N, 2009, P NATL ACAD SCI USA, V106, P8483, DOI 10.1073/pnas.0812930106; Wang F, 2004, J BIOL CHEM, V279, P2333, DOI 10.1074/jbc.C300488200; Wang ZP, 2008, CELL, V135, P535, DOI 10.1016/j.cell.2008.09.057; Wendt T, 2001, P NATL ACAD SCI USA, V98, P4361, DOI 10.1073/pnas.071051098; Wu XF, 2002, MOL BIOL CELL, V13, P1735, DOI 10.1091/mbc.01-12-0595; Wu XFS, 2002, NAT CELL BIOL, V4, P271, DOI 10.1038/ncb760; Yang Y, 2009, P NATL ACAD SCI USA, V106, P4189, DOI 10.1073/pnas.0808682106; Zhu T, 1998, J BIOL CHEM, V273, P20481, DOI 10.1074/jbc.273.32.20481	37	22	22	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16530	16540		10.1074/jbc.M112.343079	http://dx.doi.org/10.1074/jbc.M112.343079			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22437832	hybrid, Green Published			2022-12-25	WOS:000304030900043
J	Noda, NN; Kobayashi, T; Adachi, W; Fujioka, Y; Ohsumi, Y; Inagaki, F				Noda, Nobuo N.; Kobayashi, Takafumi; Adachi, Wakana; Fujioka, Yuko; Ohsumi, Yoshinori; Inagaki, Fuyuhiko			Structure of the Novel C-terminal Domain of Vacuolar Protein Sorting 30/Autophagy-related Protein 6 and Its Specific Role in Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE COMPLEXES; VPS34 PTDINS 3-KINASE; SACCHAROMYCES-CEREVISIAE; BECLIN 1; ENDOPLASMIC-RETICULUM; CRYSTAL-STRUCTURE; BINDING-PROTEIN; MOLECULAR-BASIS; ATG PROTEINS; YEAST	Vacuolar protein sorting 30 (Vps30)/autophagy-related protein 6 (Atg6) is a common component of two distinct phosphatidylinositol 3-kinase complexes. In complex I, Atg14 links Vps30 to Vps34 lipid kinase and exerts its specific role in autophagy, whereas in complex II, Vps38 links Vps30 to Vps34 and plays a crucial role in vacuolar protein sorting. However, the molecular role of Vps30 in each pathway remains unclear. Here, we report the crystal structure of the carboxyl-terminal domain of Vps30. The structure is a novel globular fold comprised of three beta-sheet-alpha-helix repeats. Truncation analyses showed that the domain is dispensable for the construction of both complexes, but is specifically required for autophagy through the targeting of complex I to the pre-autophagosomal structure. Thus, the domain is named the beta-alpha repeated, autophagy-specific (BARA) domain. On the other hand, the N-terminal region of Vps30 was shown to be specifically required for vacuolar protein sorting. These structural and functional investigations of Vps30 domains, which are also conserved in the mammalian ortholog, Beclin 1, will form the basis for studying the molecular functions of this protein family in various biological processes.	[Noda, Nobuo N.; Fujioka, Yuko] Inst Microbial Chem, Tokyo 1410021, Japan; [Kobayashi, Takafumi; Ohsumi, Yoshinori] Tokyo Inst Technol, Frontier Res Ctr, Yokohama, Kanagawa 2268503, Japan; [Adachi, Wakana; Inagaki, Fuyuhiko] Hokkaido Univ, Fac Adv Life Sci, Dept Biol Struct, Sapporo, Hokkaido 0010021, Japan	Tokyo Institute of Technology; Hokkaido University	Noda, NN (corresponding author), Kamiosaki 3-14-23,Shinagawa Ku, Tokyo 1410021, Japan.	nn@bikaken.or.jp; finagaki@pharm.hokudai.ac.jp	Ohsumi, Yoshinori/C-6449-2009; Noda, Nobuo/P-1397-2015	Ohsumi, Yoshinori/0000-0003-2384-2166; Fujioka, Yuko/0000-0002-6905-0669; Noda, Nobuo/0000-0002-6940-8069	Ministry of Education, Culture, Sports, Science and Technology of Japan; Sumitomo Foundation; Leave a Nest grant BioGarage award	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Sumitomo Foundation; Leave a Nest grant BioGarage award	This work was supported in part by Grants-in-aid for Scientific Research on Priority Areas (to N. N. N.) and Targeted Proteins Research Program (to F. I. and Y. O.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, by Grant for Basic Science Research Projects from The Sumitomo Foundation (to N. N. N.), and by a Leave a Nest grant BioGarage award (to T. K.).	Amberg DC., 2005, METHODS YEAST GENETI; Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burda P, 2002, J CELL SCI, V115, P3889, DOI 10.1242/jcs.00090; Cao Y, 2007, CELL RES, V17, P839, DOI 10.1038/cr.2007.78; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feng W, 2007, J MOL BIOL, V372, P223, DOI 10.1016/j.jmb.2007.06.069; Furuya N, 2005, AUTOPHAGY, V1, P46, DOI 10.4161/auto.1.1.1542; Gabriely G, 2007, MOL CELL BIOL, V27, P526, DOI 10.1128/MCB.00577-06; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Huang WJ, 2012, CELL RES, V22, P473, DOI 10.1038/cr.2012.24; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Kametaka S, 1998, J BIOL CHEM, V273, P22284, DOI 10.1074/jbc.273.35.22284; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Ku B, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040025; Li XH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1648; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Matsunaga K, 2010, J CELL BIOL, V190, P511, DOI 10.1083/jcb.200911141; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; NODA T, 1995, BIOCHEM BIOPH RES CO, V210, P126, DOI 10.1006/bbrc.1995.1636; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Noda T, 2008, METHOD ENZYMOL, V451, P33, DOI 10.1016/S0076-6879(08)03203-5; Obara K, 2006, MOL BIOL CELL, V17, P1527, DOI 10.1091/mbc.E05-09-0841; Obara K, 2008, J BIOL CHEM, V283, P23972, DOI 10.1074/jbc.M803180200; Obara K, 2008, GENES CELLS, V13, P537, DOI 10.1111/j.1365-2443.2008.01188.x; Oberstein A, 2007, J BIOL CHEM, V282, P13123, DOI 10.1074/jbc.M700492200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Seaman MNJ, 1997, J CELL BIOL, V137, P79, DOI 10.1083/jcb.137.1.79; Simonsen A, 2009, J CELL BIOL, V186, P773, DOI 10.1083/jcb.200907014; Sinha S, 2008, AUTOPHAGY, V4, P989, DOI 10.4161/auto.6803; STACK JH, 1995, J CELL BIOL, V129, P321, DOI 10.1083/jcb.129.2.321; STACK JH, 1993, EMBO J, V12, P2195, DOI 10.1002/j.1460-2075.1993.tb05867.x; Stromhaug PE, 2004, MOL BIOL CELL, V15, P3553, DOI 10.1091/mbc.E04-02-0147; Sun QM, 2008, P NATL ACAD SCI USA, V105, P19211, DOI 10.1073/pnas.0810452105; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Suzuki K, 2007, GENES CELLS, V12, P209, DOI 10.1111/j.1365-2443.2007.01050.x; Suzuki K, 2010, FEBS LETT, V584, P1280, DOI 10.1016/j.febslet.2010.02.001; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854	49	52	55	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16256	16266		10.1074/jbc.M112.348250	http://dx.doi.org/10.1074/jbc.M112.348250			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22437838	Green Published, hybrid			2022-12-25	WOS:000304030900018
J	Ahmed, SF; Deb, S; Paul, I; Chatterjee, A; Mandal, T; Chatterjee, U; Ghosh, MK				Ahmed, Syed Feroj; Deb, Satamita; Paul, Indranil; Chatterjee, Anirban; Mandal, Tapashi; Chatterjee, Uttara; Ghosh, Mrinal K.			The Chaperone-assisted E3 Ligase C Terminus of Hsc70-interacting Protein (CHIP) Targets PTEN for Proteasomal Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; UBIQUITIN LIGASE; GERMLINE MUTATIONS; CARBOXYL-TERMINUS; TUMOR SUPPRESSION; PROSTATE-CANCER; P53; CELLS; PROMOTES; REGULATOR	The tumor suppressor, PTEN is key to the regulation of diverse cellular processes, making it a prime candidate to be tightly regulated. The PTEN level is controlled in a major way by E3 ligase-mediated degradation through the Ubiquitin-Proteasome System (UPS). Nedd 4-1, XIAP, and WWP2 have been shown to maintain PTEN turnover. Here, we report that CHIP, the chaperone-associated E3 ligase, induces ubiquitination and regulates the proteasomal turnover of PTEN. It was apparent from our findings that PTEN transiently associates with the molecular chaperones and thereby gets diverted to the degradation pathway through its interaction with CHIP. The TPR domain of CHIP and parts of the N-terminal domain of PTEN are required for their interaction. Overexpression of CHIP leads to elevated ubiquitination and a shortened half-life of endogenous PTEN. On the other hand, depletion of endogenous CHIP stabilizes PTEN. CHIP is also shown to regulate PTEN-dependent transcription presumably through its down-regulation. PTEN shared an inverse correlation with CHIP in human prostate cancer patient samples, thereby triggering the prospects of a more complex mode of PTEN regulation in cancer.	[Ahmed, Syed Feroj; Deb, Satamita; Paul, Indranil; Chatterjee, Anirban; Mandal, Tapashi; Ghosh, Mrinal K.] CSIR IICB, Signal Tranduct Canc & Stem Cells Lab, Kolkata 700032, W Bengal, India; [Chatterjee, Uttara] IPGMER, Dept Pathol, Kolkata 700020, India; [Chatterjee, Uttara] SSKM Hosp, Kolkata 700020, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata; Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata	Ghosh, MK (corresponding author), CSIR IICB, Signal Tranduct Canc & Stem Cells Lab, 4 Raja S C Mullick Rd, Kolkata 700032, W Bengal, India.	mrinal.res@gmail.com	Paul, Indranil/AAX-7638-2021; Ahmed, Syed Feroj/D-7860-2014	Paul, Indranil/0000-0003-0327-5002; Ahmed, Syed Feroj/0000-0003-1033-2538; Chatterjee, Anirban/0000-0002-9082-2221; Deb, Satamita/0000-0003-0315-7030	Council of Scientific and Industrial Research, CSIR [OLP-002]; DST [SR/SO/HS126/2007]	Council of Scientific and Industrial Research, CSIR(Council of Scientific & Industrial Research (CSIR) - India); DST(Department of Science & Technology (India))	This work was supported by grants provided by the Council of Scientific and Industrial Research, CSIR (OLP-002) and DST (SR/SO/HS126/2007) (to M. K. G.).	Alberti S, 2004, MOL BIOL CELL, V15, P4003, DOI 10.1091/mbc.E04-04-0293; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Blumenthal GM, 2008, EUR J HUM GENET, V16, P1289, DOI 10.1038/ejhg.2008.162; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Dai Q, 2003, EMBO J, V22, P5446, DOI 10.1093/emboj/cdg529; Demand J, 2001, CURR BIOL, V11, P1569, DOI 10.1016/S0960-9822(01)00487-0; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Esser C, 2005, J BIOL CHEM, V280, P27443, DOI 10.1074/jbc.M501574200; Fan MY, 2005, MOL ENDOCRINOL, V19, P2901, DOI 10.1210/me.2005-0111; Fouladkou F, 2008, P NATL ACAD SCI USA, V105, P8585, DOI 10.1073/pnas.0803233105; Ghosh MK, 2003, MOL CELL, V12, P255, DOI 10.1016/S1097-2765(03)00225-9; Ghosh MK, 2005, ONCOGENE, V24, P7290, DOI 10.1038/sj.onc.1208894; Grossman SR, 2003, SCIENCE, V300, P342, DOI 10.1126/science.1080386; Guha M, 2009, CANCER RES, V69, P4954, DOI 10.1158/0008-5472.CAN-09-0584; Hatakeyama S, 2001, J BIOL CHEM, V276, P33111, DOI 10.1074/jbc.M102755200; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Kajiro M, 2009, NAT CELL BIOL, V11, P312, DOI 10.1038/ncb1839; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lee JH, 2010, J BIOL CHEM, V285, P42033, DOI 10.1074/jbc.M110.149831; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Luo WB, 2010, J BIOL CHEM, V285, P3651, DOI 10.1074/jbc.M109.068577; Maddika S, 2011, NAT CELL BIOL, V13, P728, DOI 10.1038/ncb2240; Maehama T, 2001, ANNU REV BIOCHEM, V70, P247, DOI 10.1146/annurev.biochem.70.1.247; Marsh DJ, 1997, NAT GENET, V16, P333, DOI 10.1038/ng0897-333; McDonough H, 2009, J BIOL CHEM, V284, P20649, DOI 10.1074/jbc.M109.011767; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Narayan V, 2011, J BIOL CHEM, V286, P607, DOI 10.1074/jbc.M110.153122; Nikolay R, 2004, J BIOL CHEM, V279, P2673, DOI 10.1074/jbc.M311112200; Oh KH, 2011, CELL DEATH DIFFER, V18, P1326, DOI 10.1038/cdd.2011.3; Petrucelli L, 2004, HUM MOL GENET, V13, P703, DOI 10.1093/hmg/ddh083; Planchon SM, 2008, J CELL SCI, V121, P249, DOI 10.1242/jcs.022459; Reddy P, 2008, SCIENCE, V319, P611, DOI 10.1126/science.1152257; Sarbassov DD, 2005, J BIOL CHEM, V280, P39505, DOI 10.1074/jbc.M506096200; Sha JF, 2010, J VIROL, V84, P4050, DOI 10.1128/JVI.02131-09; Shang Y, 2009, BIOCHEM BIOPH RES CO, V386, P242, DOI 10.1016/j.bbrc.2009.06.043; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Shimura H, 2004, J BIOL CHEM, V279, P4869, DOI 10.1074/jbc.M305838200; Stambolic V, 2001, MOL CELL, V8, P317, DOI 10.1016/S1097-2765(01)00323-9; Sulis ML, 2003, TRENDS CELL BIOL, V13, P478, DOI 10.1016/S0962-8924(03)00175-2; Sutphen R, 1999, AM J MED GENET, V82, P290, DOI 10.1002/(SICI)1096-8628(19990212)82:4<290::AID-AJMG3>3.0.CO;2-0; Tamguney T, 2007, J CELL SCI, V120, P4071, DOI 10.1242/jcs.015230; Teng DHF, 1997, CANCER RES, V57, P5221; Tian T, 2010, CARCINOGENESIS, V31, P1211, DOI 10.1093/carcin/bgq085; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; van Duijn PW, 2010, PROSTATE, V70, P135, DOI 10.1002/pros.21045; Van Themsche C, 2009, J BIOL CHEM, V284, P20462, DOI 10.1074/jbc.C109.009522; Wang X, 2008, ONCOGENE, V27, P5454, DOI 10.1038/onc.2008.242; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Xu T, 2011, CANCER SCI, V102, P959, DOI 10.1111/j.1349-7006.2011.01888.x; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703	57	110	113	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15996	16006		10.1074/jbc.M111.321083	http://dx.doi.org/10.1074/jbc.M111.321083			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22427670	Green Published, hybrid			2022-12-25	WOS:000304006300077
J	Batra, J; Robinson, J; Soares, AS; Fields, AP; Radisky, DC; Radisky, ES				Batra, Jyotica; Robinson, Jessica; Soares, Alexei S.; Fields, Alan P.; Radisky, Derek C.; Radisky, Evette S.			Matrix Metalloproteinase-10 (MMP-10) Interaction with Tissue Inhibitors of Metalloproteinases TIMP-1 and TIMP-2 BINDING STUDIES AND CRYSTAL STRUCTURE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-CONVERTING ENZYME; BIFURCATED HYDROGEN-BONDS; CATALYTIC DOMAIN; PROTEASE-INHIBITOR; 1-MATRIX METALLOPROTEINASE; CHYMOTRYPSIN INHIBITOR-2; VERTEBRATE COLLAGENASE; ESCHERICHIA-COLI; TERMINAL DOMAIN; CANCER-THERAPY	Matrix metalloproteinase 10 (MMP-10, stromelysin-2) is a secreted metalloproteinase with functions in skeletal development, wound healing, and vascular remodeling; its overexpression is also implicated in lung tumorigenesis and tumor progression. To understand the regulation of MMP-10 by tissue inhibitors of metalloproteinases (TIMPs), we have assessed equilibrium inhibition constants (K-i) of putative physiological inhibitors TIMP-1 and TIMP-2 for the active catalytic domain of human MMP-10 (MMP-10cd) using multiple kinetic approaches. We find that TIMP-1 inhibits the MMP-10cd with a K-i of 1.1 x 10(-9) M; this interaction is 10-fold weaker than the inhibition of the similar MMP-3 (stromelysin-1) catalytic domain (MMP-3cd) by TIMP-1. TIMP-2 inhibits the MMP-10cd with a K-i of 5.8 x 10(-9) M, which is again 10-fold weaker than the inhibition of MMP-3cd by this inhibitor (K-i = 5.5 x 10(-10) M). We solved the x-ray crystal structure of TIMP-1 bound to the MMP-10cd at 1.9 angstrom resolution; the structure was solved by molecular replacement and refined with an R-factor of 0.215 (R-free = 0.266). Comparing our structure of MMP-10cd.TIMP-1 with the previously solved structure of MMP-3cd.TIMP-1 (Protein Data Bank entry 1UEA), we see substantial differences at the binding interface that provide insight into the differential binding of stromelysin family members to TIMP-1. This structural information may ultimately assist in the design of more selective TIMP-based inhibitors tailored for specificity toward individual members of the stromelysin family, with potential therapeutic applications.	[Batra, Jyotica; Robinson, Jessica; Fields, Alan P.; Radisky, Derek C.; Radisky, Evette S.] Mayo Clin, Dept Canc Biol, Ctr Comprehens Canc, Jacksonville, FL 32224 USA; [Soares, Alexei S.] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	Mayo Clinic; United States Department of Energy (DOE); Brookhaven National Laboratory	Radisky, ES (corresponding author), Mayo Clin, Dept Canc Biol, Ctr Comprehens Canc, 310 Griffin Bldg,4500 San Pablo Rd, Jacksonville, FL 32224 USA.	radisky.evette@mayo.edu	Soares, Alexei S/F-4800-2014; Radisky, Derek/B-6569-2018; Radisky, Evette S/C-8526-2012	Soares, Alexei S/0000-0002-6565-8503; Radisky, Derek/0000-0002-1962-8784; Radisky, Evette S/0000-0003-3121-109X	National Institutes of Health, NCI [R01 CA122086, R01 CA081436-14]; Florida Department of Health [08KN12, 09BB17, 1BD01]; Mayo Clinic Breast Cancer Specialized Program of Research Excellence [P50 CA116201]; Offices of Biological and Environmental Research; Basic Energy Sciences of the United States Department of Energy; National Center for Research Resources of the National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA081436, P50CA116201, R01CA122086] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Florida Department of Health; Mayo Clinic Breast Cancer Specialized Program of Research Excellence; Offices of Biological and Environmental Research; Basic Energy Sciences of the United States Department of Energy; National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health, NCI, Grants R01 CA122086 (to D. C. R.) and R01 CA081436-14 (to A. P. F.). This work was also supported by Florida Department of Health Grants 08KN12 and 09BB17 (to E. S. R.) and 1BD01 (to J. B.) and by Mayo Clinic Breast Cancer Specialized Program of Research Excellence Grant P50 CA116201 (principal investigator James Ingle). Diffraction data were measured at beamline X12-C of the National Synchrotron Light Source, which is supported by the Offices of Biological and Environmental Research and of Basic Energy Sciences of the United States Department of Energy and the National Center for Research Resources of the National Institutes of Health.	Arumugam S, 2003, J MOL BIOL, V327, P719, DOI 10.1016/S0022-2836(03)00180-3; Bahudhanapati H, 2011, J BIOL CHEM, V286, P31761, DOI 10.1074/jbc.M111.253328; Baker AH, 2002, J CELL SCI, V115, P3719, DOI 10.1242/jcs.00063; Bertini I, 2004, J MOL BIOL, V336, P707, DOI 10.1016/j.jmb.2003.12.033; Bord S, 1998, BONE, V23, P7, DOI 10.1016/S8756-3282(98)00064-7; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; Burrage PS, 2007, CURR DRUG TARGETS, V8, P293, DOI 10.2174/138945007779940098; Butler GS, 1999, J BIOL CHEM, V274, P20391, DOI 10.1074/jbc.274.29.20391; Chang SR, 2006, CELL, V126, P321, DOI 10.1016/j.cell.2006.05.040; Cho NH, 2004, ONCOGENE, V23, P845, DOI 10.1038/sj.onc.1207140; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Crombez L, 2005, BIOCHEM BIOPH RES CO, V337, P908, DOI 10.1016/j.bbrc.2005.09.136; Deraz EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025438; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fernandez-Catalan C, 1998, EMBO J, V17, P5238, DOI 10.1093/emboj/17.17.5238; Fingleton B, 2008, SEMIN CELL DEV BIOL, V19, P61, DOI 10.1016/j.semcdb.2007.06.006; Frederick LA, 2008, ONCOGENE, V27, P4841, DOI 10.1038/onc.2008.119; Gill JH, 2004, NEOPLASIA, V6, P777, DOI 10.1593/neo.04283; Gill SE, 2008, INT J BIOCHEM CELL B, V40, P1334, DOI 10.1016/j.biocel.2007.10.024; GomisRuth FX, 1997, NATURE, V389, P77, DOI 10.1038/37995; Grossman M, 2010, BIOCHEMISTRY-US, V49, P6184, DOI 10.1021/bi902141x; Hamze AB, 2007, PROTEIN SCI, V16, P1905, DOI 10.1110/ps.072978507; Hu JL, 2007, NAT REV DRUG DISCOV, V6, P480, DOI 10.1038/nrd2308; Huang W, 1996, FEBS LETT, V384, P155, DOI 10.1016/0014-5793(96)00304-3; Iyer S, 2007, J BIOL CHEM, V282, P364, DOI 10.1074/jbc.M607625200; Justilien V., 2012, PLOS ONE IN PRESS; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LASKOWSKI M, 1971, ENZYMES, V3, P375; Lee JE, 2009, NAT PROTOC, V4, P592, DOI 10.1038/nprot.2009.29; Lee MH, 2010, CANCER LETT, V290, P114, DOI 10.1016/j.canlet.2009.08.029; Lee MH, 2005, J BIOL CHEM, V280, P15967, DOI 10.1074/jbc.M500897200; Lee MH, 2004, J BIOL CHEM, V279, P45121, DOI 10.1074/jbc.M406611200; Lee MH, 2004, J BIOL CHEM, V279, P17562, DOI 10.1074/jbc.M312589200; Lee MH, 2003, J BIOL CHEM, V278, P40224, DOI 10.1074/jbc.M305678200; Lee MH, 2002, PROTEIN SCI, V11, P2493, DOI 10.1110/ps.0216202; Lee MH, 2002, BIOCHEM J, V364, P227, DOI 10.1042/bj3640227; LONGSTAFF C, 1990, BIOCHEMISTRY-US, V29, P7339, DOI 10.1021/bi00483a025; MARCY AI, 1991, BIOCHEMISTRY-US, V30, P6476, DOI 10.1021/bi00240a018; Maskos K, 2007, J MOL BIOL, V366, P1222, DOI 10.1016/j.jmb.2006.11.072; Maskos K, 2003, MOL BIOTECHNOL, V25, P241, DOI 10.1385/MB:25:3:241; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Meng Q, 1999, J BIOL CHEM, V274, P10184, DOI 10.1074/jbc.274.15.10184; MURPHY G, 1995, METHOD ENZYMOL, V248, P496; Murphy G, 2008, MOL ASPECTS MED, V29, P290, DOI 10.1016/j.mam.2008.05.002; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAGASE H, 1995, METHOD ENZYMOL, V248, P449; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; NAGASE H, 1990, BIOCHEMISTRY-US, V29, P5783, DOI 10.1021/bi00476a020; Nagase H, 2002, ARTHRITIS RES THER, V4, pS51, DOI 10.1186/ar573; Nakamura H, 1998, EUR J BIOCHEM, V253, P67, DOI 10.1046/j.1432-1327.1998.2530067.x; NICHOLSON R, 1989, BIOCHEMISTRY-US, V28, P5195, DOI 10.1021/bi00438a042; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Overall CM, 2006, BRIT J CANCER, V94, P941, DOI 10.1038/sj.bjc.6603043; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Radisky ES, 2005, BIOCHEMISTRY-US, V44, P6823, DOI 10.1021/bi047301w; Radisky ES, 2004, BIOCHEMISTRY-US, V43, P13648, DOI 10.1021/bi048797k; Radisky ES, 2003, BIOCHEMISTRY-US, V42, P6484, DOI 10.1021/bi034275d; Radisky ES, 2010, J MAMMARY GLAND BIOL, V15, P201, DOI 10.1007/s10911-010-9177-x; Regala RP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026439; Rodriguez JA, 2008, FRONT BIOSCI-LANDMRK, V13, P2916, DOI 10.2741/2896; Rozas I, 1998, J PHYS CHEM A, V102, P9925, DOI 10.1021/jp9824813; SAARIALHOKERE UK, 1994, J CLIN INVEST, V94, P79, DOI 10.1172/JCI117351; Salameh MA, 2008, J BIOL CHEM, V283, P4115, DOI 10.1074/jbc.M708268200; Salameh MA, 2010, J BIOL CHEM, V285, P1939, DOI 10.1074/jbc.M109.057216; Sheinerman FB, 2000, CURR OPIN STRUC BIOL, V10, P153, DOI 10.1016/S0959-440X(00)00065-8; SUZUKI K, 1990, BIOCHEMISTRY-US, V29, P10261, DOI 10.1021/bi00496a016; Suzuki K, 1998, BIOL CHEM, V379, P185, DOI 10.1515/bchm.1998.379.2.185; Tallant C, 2010, BBA-MOL CELL RES, V1803, P20, DOI 10.1016/j.bbamcr.2009.04.003; Torshin IY, 2002, PROTEIN ENG, V15, P359, DOI 10.1093/protein/15.5.359; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Van Themsche C, 2004, J IMMUNOL, V173, P3605, DOI 10.4049/jimmunol.173.6.3605; Wei S, 2003, J BIOL CHEM, V278, P9831, DOI 10.1074/jbc.M211793200; WEINGARTEN H, 1985, BIOCHEMISTRY-US, V24, P6730, DOI 10.1021/bi00344a064; WEINGARTEN H, 1985, ANAL BIOCHEM, V147, P437, DOI 10.1016/0003-2697(85)90294-5; Williamson RA, 2001, J BIOL CHEM, V276, P32966, DOI 10.1074/jbc.M101843200; WINDSOR LJ, 1993, J BIOL CHEM, V268, P17341; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wiseman BS, 2003, J CELL BIOL, V162, P1123, DOI 10.1083/jcb.200302090; Wu B, 2000, J MOL BIOL, V295, P257, DOI 10.1006/jmbi.1999.3362; Wu Y, 2011, J BIOL CHEM, V286, P16891, DOI 10.1074/jbc.M111.222307; Gomis-Ruth FX, 2012, BBA-PROTEINS PROTEOM, V1824, P157, DOI 10.1016/j.bbapap.2011.04.014; Gomis-Ruth FX, 2009, J BIOL CHEM, V284, P15353, DOI 10.1074/jbc.R800069200; Xu D, 1997, PROTEIN ENG, V10, P999, DOI 10.1093/protein/10.9.999; Xu D, 1997, J MOL BIOL, V265, P68, DOI 10.1006/jmbi.1996.0712; Zhou P, 2009, PROTEINS, V76, P151, DOI 10.1002/prot.22327	87	71	74	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15935	15946		10.1074/jbc.M112.341156	http://dx.doi.org/10.1074/jbc.M112.341156			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22427646	Green Published, hybrid			2022-12-25	WOS:000304006300072
J	Jash, A; Sahoo, A; Kim, GC; Chae, CS; Hwang, JS; Kim, JE; Im, SH				Jash, Arijita; Sahoo, Anupama; Kim, Gi-Cheon; Chae, Chang-Suk; Hwang, Ji-Sun; Kim, Jung-Eun; Im, Sin-Hyeog			Nuclear Factor of Activated T Cells 1 (NFAT1)-induced Permissive Chromatin Modification Facilitates Nuclear Factor-kappa B (NF-kappa B)-mediated Interleukin-9 (IL-9) Transactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTORS; GENE-EXPRESSION; SIGNAL-TRANSDUCTION; DISTINCT ROLES; NFAT; DIFFERENTIATION; RECEPTOR; GROWTH; BINDING; BETA	IL-9 regulates diverse inflammatory immune responses. Although the functional importance of IL-9 has been investigated in various pathophysiological conditions, molecular mechanisms by which TCR stimulation induced IL-9 gene expression are still unclear. In this study, we investigated the functional importance of the NFAT1 and NF-kappa B (p65) in IL-9 gene transcription in CD4(+) T cells. In vivo binding of NFAT1 and NF-kappa B (p65) to the IL-9 promoter was observed. NFAT1 binding induced a transcriptionally active chromatin configuration at the IL-9 promoter locus, whereas NF-kappa B (p65) binding transactivated the IL-9 promoter. Mouse deficient in NFAT1 shows a significant down-regulation of IL-9 expression that resulted from an inaccessible chromatin configuration at the IL-9 promoter. In parallel, knockdown of NF-kappa B (p65) also resulted in reduced IL-9 expression. In this process, NFAT1 plays a pivotal role as a core protein that creates an accessible platform for the assembly of transcription activators. The presence of NFAT1 correlates with recruitment of NF-kappa B (p65), p300, and active histone markers on the IL-9 promoter, resulting in a transcriptionally competent promoter. NFAT1 deficiency significantly reduced the recruitment of the above activation complex to the IL-9 promoter. In summary, our data suggest that functional cooperation of NFAT1 and NF-kappa B synergistically enhances IL-9 transcription in CD4(+) T cells.	[Jash, Arijita; Sahoo, Anupama; Kim, Gi-Cheon; Chae, Chang-Suk; Hwang, Ji-Sun; Kim, Jung-Eun; Im, Sin-Hyeog] Gwangju Inst Sci & Technol, Sch Life Sci, Kwangju 500712, South Korea; [Jash, Arijita; Sahoo, Anupama; Kim, Gi-Cheon; Chae, Chang-Suk; Hwang, Ji-Sun; Kim, Jung-Eun; Im, Sin-Hyeog] Gwangju Inst Sci & Technol, Immune Synapse Res Ctr, Kwangju 500712, South Korea; [Sahoo, Anupama] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77054 USA	Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST); University of Texas System; UTMD Anderson Cancer Center	Im, SH (corresponding author), Gwangju Inst Sci & Technol, Sch Life Sci, 123 Cheomdan Gwagiro, Kwangju 500712, South Korea.	imsh@gist.ac.kr	Im, Sin-Hyeog/E-6811-2013; Im, Sin-Hyeog/AAM-9586-2021	Im, Sin-Hyeog/0000-0002-3173-1856; Im, Sin-Hyeog/0000-0002-3173-1856; Sahoo, Anupama/0000-0002-0928-958X	National Research Foundation [2011-0028529]; Korean government; Gwangju Institute of Science and Technology	National Research Foundation; Korean government(Korean Government); Gwangju Institute of Science and Technology	This work was supported by National Research Foundation Grant 2011-0028529, funded by the Korean government, and by a Systems Biology Infrastructure Establishment Grant provided by the Gwangju Institute of Science and Technology in 2012.	BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Cakouros D, 2001, J IMMUNOL, V167, P302, DOI 10.4049/jimmunol.167.1.302; Cantrell D, 1996, ANNU REV IMMUNOL, V14, P259, DOI 10.1146/annurev.immunol.14.1.259; Carey M., 2002, TRANSCRIPTIONAL REGU, P144; Chan HM, 2001, J CELL SCI, V114, P2363; Chang HC, 2010, NAT IMMUNOL, V11, P527, DOI 10.1038/ni.1867; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Cron RQ, 2000, CLIN IMMUNOL, V94, P179, DOI 10.1006/clim.1999.4831; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Demoulin JB, 1999, J BIOL CHEM, V274, P25855, DOI 10.1074/jbc.274.36.25855; Eller K, 2011, J IMMUNOL, V186, P83, DOI 10.4049/jimmunol.1001183; Elyaman W, 2009, P NATL ACAD SCI USA, V106, P12885, DOI 10.1073/pnas.0812530106; Farrow MA, 2011, J BIOL CHEM, V286, P2567, DOI 10.1074/jbc.M110.154377; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Gao ZG, 2005, J BIOL CHEM, V280, P21091, DOI 10.1074/jbc.M500754200; Garcia-Rodriguez C, 1998, J EXP MED, V187, P2031, DOI 10.1084/jem.187.12.2031; Gerritsen ME, 1997, P NATL ACAD SCI USA, V94, P2927, DOI 10.1073/pnas.94.7.2927; GESSNER A, 1993, IMMUNOBIOLOGY, V189, P419, DOI 10.1016/S0171-2985(11)80414-6; Gibson HM, 2007, J IMMUNOL, V179, P3831, DOI 10.4049/jimmunol.179.6.3831; Goswami R, 2012, J IMMUNOL, V188, P968, DOI 10.4049/jimmunol.1102840; Grumont RJ, 2000, J EXP MED, V191, P1281, DOI 10.1084/jem.191.8.1281; Hauber HP, 2004, INT ARCH ALLERGY IMM, V134, P79, DOI 10.1159/000078384; Hermann-Kleiter N, 2010, BLOOD, V115, P2989, DOI 10.1182/blood-2009-10-233585; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Holz L. E., 2005, J INFLAMM-LOND, V2, P1; HULTNER L, 1990, EUR J IMMUNOL, V20, P1413, DOI 10.1002/eji.1830200632; Im SH, 2004, MOL CELLS, V18, P1; Im SH, 2004, J BIOL CHEM, V279, P46818, DOI 10.1074/jbc.M401722200; Ishihara S, 2011, J IMMUNOL, V187, P3292, DOI 10.4049/jimmunol.1003173; Johnson BV, 2004, MOL CELL BIOL, V24, P7914, DOI 10.1128/MCB.24.18.7914-7930.2004; Kadereit S, 1999, BLOOD, V94, P3101, DOI 10.1182/blood.V94.9.3101.421k04_3101_3107; Kaminski BA, 2003, BLOOD, V102, P4608, DOI 10.1182/blood-2003-05-1732; Koenig A, 2010, GASTROENTEROLOGY, V138, P1189, DOI 10.1053/j.gastro.2009.10.045; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Lee CG, 2009, MOL IMMUNOL, V46, P613, DOI 10.1016/j.molimm.2008.07.037; Lerner L, 2003, GENE DEV, V17, P2564, DOI 10.1101/gad.1135003; Li HM, 2010, J IMMUNOL, V185, P4095, DOI 10.4049/jimmunol.1000986; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; MCCAFFREY PG, 1992, J BIOL CHEM, V267, P1864; Mehta DS, 2005, P NATL ACAD SCI USA, V102, P2016, DOI 10.1073/pnas.0409512102; Monteyne P, 1997, J IMMUNOL, V159, P2616; Na SY, 1998, J BIOL CHEM, V273, P10831, DOI 10.1074/jbc.273.18.10831; Noelle RJ, 2010, NAT REV IMMUNOL, V10, P683, DOI 10.1038/nri2848; Nowak EC, 2009, CELL CYCLE, V8, P3798, DOI 10.4161/cc.8.23.10069; Nowak EC, 2009, J EXP MED, V206, P1653, DOI 10.1084/jem.20090246; Perumal NB, 2011, TRENDS IMMUNOL, V32, P146, DOI 10.1016/j.it.2011.01.006; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rao S, 2003, J IMMUNOL, V170, P3724, DOI 10.4049/jimmunol.170.7.3724; Refaat A, 2011, J BIOL CHEM, V286, P21092, DOI 10.1074/jbc.M110.200907; RENAULD JC, 1992, P NATL ACAD SCI USA, V89, P5690, DOI 10.1073/pnas.89.12.5690; RENAULD JC, 1995, J LEUKOCYTE BIOL, V57, P353, DOI 10.1002/jlb.57.3.353; Rengarajan J, 2002, J EXP MED, V195, P1003, DOI 10.1084/jem.20011128; Sahoo A, 2011, J IMMUNOL, V186, P4098, DOI 10.4049/jimmunol.1002620; Sica A, 1997, J BIOL CHEM, V272, P30412, DOI 10.1074/jbc.272.48.30412; Stassen M, 2001, J IMMUNOL, V166, P4391, DOI 10.4049/jimmunol.166.7.4391; Staudt V, 2010, IMMUNITY, V33, P192, DOI 10.1016/j.immuni.2010.07.014; Steenwinckel V, 2009, J IMMUNOL, V182, P4737, DOI 10.4049/jimmunol.0801941; Stephens GL, 2011, EUR J IMMUNOL, V41, P952, DOI 10.1002/eji.201040879; Sun SC, 2005, ONCOGENE, V24, P5952, DOI 10.1038/sj.onc.1208969; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Temann UA, 2007, INT IMMUNOL, V19, P1, DOI 10.1093/intimm/dxl117; Timmerman LA, 1997, J IMMUNOL, V159, P2735; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; Townsend MJ, 2000, IMMUNITY, V13, P573, DOI 10.1016/S1074-7613(00)00056-X; Tsytsykova AV, 2007, P NATL ACAD SCI USA, V104, P16850, DOI 10.1073/pnas.0708210104; UYTTENHOVE C, 1988, P NATL ACAD SCI USA, V85, P6934, DOI 10.1073/pnas.85.18.6934; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Wong MT, 2010, IMMUNOL CELL BIOL, V88, P624, DOI 10.1038/icb.2010.53; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545; Xu LH, 2006, CANCER RES, V66, P11859, DOI 10.1158/0008-5472.CAN-06-1445; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001; Zhu YX, 1996, J BIOL CHEM, V271, P15815, DOI 10.1074/jbc.271.26.15815	77	55	59	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15445	15457		10.1074/jbc.M112.340356	http://dx.doi.org/10.1074/jbc.M112.340356			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22427656	Green Published, hybrid			2022-12-25	WOS:000304006300026
J	Kalynych, S; Yao, DQ; Magee, J; Cygler, M				Kalynych, Sergei; Yao, Deqiang; Magee, James; Cygler, Miroslaw			Structural Characterization of Closely Related O-antigen Lipopolysaccharide (LPS) Chain Length Regulators	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; OUTER-MEMBRANE; PROTEIN; MODEL; EXPORT; WZZ; POLYSACCHARIDES; IDENTIFICATION; BIOSYNTHESIS; TYPHIMURIUM	The surface O-antigen polymers of Gram-negative bacteria exhibit a modal length distribution that depends on dedicated chain length regulator periplasmic proteins (polysaccharide co-polymerases, PCPs) anchored in the inner membrane by two transmembrane helices. In an attempt to determine whether structural changes underlie the O-antigen modal length specification, we have determined the crystal structures of several closely related PCPs, namely two chimeric PCP-1 family members solved at 1.6 and 2.8 angstrom and a wild-type PCP-1 from Shigella flexneri solved at 2.8 angstrom. The chimeric proteins form circular octamers, whereas the wild-type WzzB from S. flexneri was found to be an open trimer. We also present the structure of a Wzz(FepE) mutant, which exhibits severe attenuation in its ability to produce very long O-antigen polymers. Our findings suggest that the differences in the modal length distribution depend primarily on the surface-exposed amino acids in specific regions rather than on the differences in the oligomeric state of the PCP protomers.	[Yao, Deqiang; Cygler, Miroslaw] Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 5E5, Canada; [Kalynych, Sergei; Magee, James; Cygler, Miroslaw] McGill Univ, Dept Biochem, Montreal, PQ H3G 0B1, Canada	University of Saskatchewan; McGill University	Cygler, M (corresponding author), Univ Saskatchewan, Dept Biochem, 107 Wiggins Rd, Saskatoon, SK S7N 5E5, Canada.	miroslaw.cygler@usask.ca			Canadian Institutes of Health Research [MOP-89787]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Grant MOP-89787 from the Canadian Institutes of Health Research (to M.C.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BATCHELOR RA, 1991, J BACTERIOL, V173, P5699, DOI 10.1128/jb.173.18.5699-5704.1991; Bechet E, 2010, MOL MICROBIOL, V77, P1315, DOI 10.1111/j.1365-2958.2010.07291.x; Clay CD, 2008, J IMMUNOL, V181, P5568, DOI 10.4049/jimmunol.181.8.5568; Cuthbertson L, 2009, MICROBIOL MOL BIOL R, V73, P155, DOI 10.1128/MMBR.00024-08; Daniels C, 1999, MOL MICROBIOL, V34, P181, DOI 10.1046/j.1365-2958.1999.01591.x; Dong CJ, 2006, NATURE, V444, P226, DOI 10.1038/nature05267; Duerr CU, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000567; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Franco AV, 1998, J BACTERIOL, V180, P2670, DOI 10.1128/JB.180.10.2670-2675.1998; He Y, 2007, ACTA CRYSTALLOGR D, V63, P793, DOI 10.1107/S0907444907023451; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Islam ST, 2011, J BIOL CHEM, V286, P20600, DOI 10.1074/jbc.C110.204651; Kalynych S, 2011, J BACTERIOL, V193, P3710, DOI 10.1128/JB.00059-11; Kintz EN, 2011, J BIOL CHEM, V286, P44277, DOI 10.1074/jbc.M111.273979; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Larue K, 2009, J BIOL CHEM, V284, P7395, DOI 10.1074/jbc.M809068200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Morona R, 2000, MICROBIOL-UK, V146, P1, DOI 10.1099/00221287-146-1-1; Morona R, 2009, TRENDS BIOCHEM SCI, V34, P78, DOI 10.1016/j.tibs.2008.11.001; Murray GL, 2006, J BACTERIOL, V188, P2735, DOI 10.1128/JB.188.7.2735-2739.2006; Murray GL, 2003, MOL MICROBIOL, V47, P1395, DOI 10.1046/j.1365-2958.2003.03383.x; Otwinowski Z., 1991, ISOMORPHOUS REPLACEM, P80; Paixao TA, 2009, INFECT IMMUN, V77, P4197, DOI 10.1128/IAI.00417-09; Paulsen IT, 1997, MICROBIOL-SGM, V143, P2685, DOI 10.1099/00221287-143-8-2685; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Purins L, 2008, MICROBIOL-SGM, V154, P1104, DOI 10.1099/mic.0.2007/014225-0; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; ROSENOW C, 1995, J BACTERIOL, V177, P1137, DOI 10.1128/jb.177.5.1137-1143.1995; Saldias MS, 2009, J MED MICROBIOL, V58, P1542, DOI 10.1099/jmm.0.013235-0; Samuel G, 2003, CARBOHYD RES, V338, P2503, DOI 10.1016/j.carres.2003.07.009; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Tang KH, 2007, BIOCHEMISTRY-US, V46, P11744, DOI 10.1021/bi701181r; Tocilj A, 2008, NAT STRUCT MOL BIOL, V15, P130, DOI 10.1038/nsmb.1374; Valvano MA, 2003, FRONT BIOSCI-LANDMRK, V8, pS452, DOI 10.2741/1079; West NP, 2005, SCIENCE, V307, P1313, DOI 10.1126/science.1108472; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Woodward R, 2010, NAT CHEM BIOL, V6, P418, DOI 10.1038/nchembio.351; Yao DQ, 2006, ACTA CRYSTALLOGR D, V62, P883, DOI [10.1107/S0907444906006445, 10.1107/S0907444906445]	42	21	21	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15696	15705		10.1074/jbc.M112.354837	http://dx.doi.org/10.1074/jbc.M112.354837			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22437828	Green Published, hybrid			2022-12-25	WOS:000304006300048
J	Raoul, W; Poupel, L; Tregouet, DA; Lavalette, S; Camelo, S; Keller, N; Krumeich, S; Calippe, B; Guillonneau, X; Behar-Cohen, F; Cohen, SY; Baatz, H; Combadiere, C; Thery, C; Sennlaub, F				Raoul, William; Poupel, Lucie; Tregouet, David-Alexandre; Lavalette, Sophie; Camelo, Serge; Keller, Nicole; Krumeich, Sophie; Calippe, Bertrand; Guillonneau, Xavier; Behar-Cohen, Francine; Cohen, Salomon-Yves; Baatz, Holger; Combadiere, Christophe; Thery, Clotilde; Sennlaub, Florian			MFGE8 Does Not Influence Chorio-Retinal Homeostasis or Choroidal Neovascularization in vivo	PLOS ONE			English	Article							AGE-RELATED MACULOPATHY; ROD OUTER SEGMENTS; MACULAR DEGENERATION; PIGMENT EPITHELIUM; APOPTOTIC CELLS; ALPHA-V-BETA-5 INTEGRIN; MFG-E8; PHAGOCYTOSIS; PREVALENCE; RECEPTOR	Purpose: Milk fat globule-epidermal growth factor-factor VIII (MFGE8) is necessary for diurnal outer segment phagocytosis and promotes VEGF-dependent neovascularization. The prevalence of two single nucleotide polymorphisms (SNP) in MFGE8 was studied in two exsudative or "wet" Age-related Macular Degeneration (AMD) groups and two corresponding control groups. We studied the effect of MFGE8 deficiency on retinal homeostasis with age and on choroidal neovascularization (CNV) in mice. Methods: The distribution of the SNP (rs4945 and rs1878326) of MFGE8 was analyzed in two groups of patients with "wet" AMD and their age-matched controls from Germany and France. MFGE8-expressing cells were identified in Mfge8(+/-) mice expressing beta-galactosidase. Aged Mfge8(+/-) and Mfge8(-/-) mice were studied by funduscopy, histology, electron microscopy, scanning electron microscopy of vascular corrosion casts of the choroid, and after laser-induced CNV. Results: rs1878326 was associated with AMD in the French and German group. The Mfge8 promoter is highly active in photoreceptors but not in retinal pigment epithelium cells. Mfge8(-/-) mice did not differ from controls in terms of fundus appearance, photoreceptor cell layers, choroidal architecture or laser-induced CNV. In contrast, the Bruch's membrane (BM) was slightly but significantly thicker in Mfge8(-/-) mice as compared to controls. Conclusions: Despite a reproducible minor increase of rs1878326 in AMD patients and a very modest increase in BM in Mfge8(-/-) mice, our data suggests that MFGE8 dysfunction does not play a critical role in the pathogenesis of AMD.	[Raoul, William; Lavalette, Sophie; Calippe, Bertrand; Guillonneau, Xavier; Sennlaub, Florian] INSERM, U968, Paris, France; [Raoul, William; Lavalette, Sophie; Calippe, Bertrand; Guillonneau, Xavier; Sennlaub, Florian] Univ Paris 06, Inst Vis, Paris, France; [Behar-Cohen, Francine; Sennlaub, Florian] Hop Hotel Dieu, AP HP, Serv Ophtalmol, Paris, France; [Raoul, William; Lavalette, Sophie; Calippe, Bertrand; Guillonneau, Xavier; Sennlaub, Florian] Ctr Natl Rech Sci, Paris, France; [Poupel, Lucie; Combadiere, Christophe] INSERM, Lab Immun & Infect, UMR S945, Paris, France; [Poupel, Lucie; Combadiere, Christophe] Univ Paris 06, Lab Immun & Infect, Paris, France; [Combadiere, Christophe] Grp Hosp Pitie Salpetriere, AP HP, Serv Immunol, F-75634 Paris, France; [Camelo, Serge; Keller, Nicole; Behar-Cohen, Francine] Ctr Rech Cordeliers, INSERM, UMR S 872, Paris, France; [Camelo, Serge; Keller, Nicole; Behar-Cohen, Francine] Univ Paris 05, Paris, France; [Krumeich, Sophie; Thery, Clotilde] INSERM, U932, Paris, France; [Krumeich, Sophie; Thery, Clotilde] Ctr Rech, Inst Curie, Paris, France; [Baatz, Holger] Goethe Univ Frankfurt, Augenzentrum Recklinghausen, Augenarztl Gemeinschaftspraxis, Frankfurt, Germany; [Baatz, Holger] Goethe Univ Frankfurt, Zentrum Augenheilkunde, Frankfurt, Germany; [Cohen, Salomon-Yves] Ctr Angiog & Laser, Paris, France; [Tregouet, David-Alexandre] INSERM, Fac Med La Pitie Salpetriere, UMR S 937, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Goethe University Frankfurt; Goethe University Frankfurt; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Raoul, W (corresponding author), INSERM, U968, Paris, France.	william.raoul@inserm.fr; florian.sennlaub@inserm.fr	Tregouet, David-Alexandre/E-3961-2016; Combadiere, Christophe/I-5639-2013; Guillonneau, xavier/E-3995-2017; guillonneau, xavier/AAF-9495-2021; Trégouët, David-Alexandre/P-9210-2019; Raoul, William/H-2118-2018; thery, clotilde/F-6373-2013; Sennlaub, Florian/F-2756-2017	Combadiere, Christophe/0000-0002-1755-4531; Guillonneau, xavier/0000-0001-7379-3935; guillonneau, xavier/0000-0001-7379-3935; Trégouët, David-Alexandre/0000-0001-9084-7800; Raoul, William/0000-0002-5040-3372; thery, clotilde/0000-0001-8294-6884; Sennlaub, Florian/0000-0003-4412-1341; Camelo, Serge/0000-0001-8733-8503; Poupel, Lucie/0000-0001-7015-8450	INSERM; Agence Nationale pour la Recherche (ANR) "blanc" [AO5120DD]; ANR "Maladies Neurologiques et Maladies Psychiatriques" [R08098DS]; ANR "Genopat" [R09099DS]; European Grant "Innochem" [LSHB-CT-2005-518167]; ERC [ERC-2007 St.G. 210345]; Fondation de France; Assistance Publique-Hopitaux de Paris	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale pour la Recherche (ANR) "blanc"(French National Research Agency (ANR)); ANR "Maladies Neurologiques et Maladies Psychiatriques"(French National Research Agency (ANR)); ANR "Genopat"(French National Research Agency (ANR)); European Grant "Innochem"(European Commission); ERC(European Research Council (ERC)European Commission); Fondation de France(Fondation de France); Assistance Publique-Hopitaux de Paris	This work was supported by grants from INSERM, Agence Nationale pour la Recherche (ANR) "blanc" (AO5120DD), ANR "Maladies Neurologiques et Maladies Psychiatriques" (R08098DS), ANR "Genopat" (R09099DS), European Grant "Innochem" (LSHB-CT-2005-518167), ERC starting Grant (ERC-2007 St.G. 210345), and a grant from Fondation de France to C. T. F. S. a is recipient of ERC starting grant. C. C. and F. S. are recipients of a contract "Interface" from Assistance Publique-Hopitaux de Paris. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atabai K, 2009, J CLIN INVEST, V119, P3713, DOI 10.1172/JCI40053; Augood CA, 2006, ARCH OPHTHALMOL-CHIC, V124, P529, DOI 10.1001/archopht.124.4.529; Baatz H, 2009, KLIN MONATSBL AUGENH, V226, P654, DOI 10.1055/s-0028-1109318; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Burgess B, 2006, MOL VIS, V12, P1437; CERIANI RL, 1983, SOMAT CELL GENET, V9, P415, DOI 10.1007/BF01543043; Combadiere C, 2007, J CLIN INVEST, V117, P2920, DOI 10.1172/JCI31692; D'Cruz PM, 2000, HUM MOL GENET, V9, P645, DOI 10.1093/hmg/9.4.645; Ding XY, 2009, PROG RETIN EYE RES, V28, P1, DOI 10.1016/j.preteyeres.2008.10.001; EDWARDS RB, 1977, SCIENCE, V197, P1001, DOI 10.1126/science.560718; Finnemann SC, 1997, P NATL ACAD SCI USA, V94, P12932, DOI 10.1073/pnas.94.24.12932; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; GREEN WR, 1993, OPHTHALMOLOGY, V100, P1519; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Houssier M, 2008, PLOS MED, V5, P323, DOI 10.1371/journal.pmed.0050039; Hu CY, 2009, LUPUS, V18, P676, DOI 10.1177/0961203309103027; Jinushi M, 2007, J CLIN INVEST, V117, P1902, DOI 10.1172/JCI30966; Kamizuru H, 2001, INVEST OPHTH VIS SCI, V42, P2664; KLEIN R, 1993, AM J EPIDEMIOL, V137, P190, DOI 10.1093/oxfordjournals.aje.a116659; Klein R, 2004, AM J OPHTHALMOL, V137, P486, DOI 10.1016/j.ajo.2003.11.069; Kwak N, 2000, INVEST OPHTH VIS SCI, V41, P3158; Nandrot E, 2000, NEUROBIOL DIS, V7, P586, DOI 10.1006/nbdi.2000.0328; Nandrot EF, 2008, OPHTHALMIC RES, V40, P120, DOI 10.1159/000119861; Nandrot EF, 2007, P NATL ACAD SCI USA, V104, P12005, DOI 10.1073/pnas.0704756104; Oshima K, 2002, EUR J BIOCHEM, V269, P1209, DOI 10.1046/j.1432-1033.2002.02758.x; Paques M, 2007, INVEST OPHTH VIS SCI, V48, P2769, DOI 10.1167/iovs.06-1099; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; SARKS SH, 1976, BRIT J OPHTHALMOL, V60, P324, DOI 10.1136/bjo.60.5.324; Sasieni PD, 1997, BIOMETRICS, V53, P1253, DOI 10.2307/2533494; Silvestre JS, 2005, NAT MED, V11, P499, DOI 10.1038/nm1233; STUBBS JD, 1990, P NATL ACAD SCI USA, V87, P8417, DOI 10.1073/pnas.87.21.8417; Sugano G, 2011, ONCOGENE, V30, P642, DOI 10.1038/onc.2010.446; Swaroop A, 2007, HUM MOL GENET, V16, pR174, DOI 10.1093/hmg/ddm212; Tregouet DA, 2007, BIOINFORMATICS, V23, P1038, DOI 10.1093/bioinformatics/btm058; VINDING T, 1992, ACTA OPHTHALMOL, V70, P66; YOUNG RW, 1969, J CELL BIOL, V42, P392, DOI 10.1083/jcb.42.2.392	37	2	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2012	7	3							e33244	10.1371/journal.pone.0033244	http://dx.doi.org/10.1371/journal.pone.0033244			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RU	22438901	Green Published, Green Submitted, gold			2022-12-25	WOS:000303309000015
J	Thomas, AA; Flecknell, PA; Golledge, HDR				Thomas, Aurelie A.; Flecknell, Paul A.; Golledge, Huw D. R.			Combining Nitrous Oxide with Carbon Dioxide Decreases the Time to Loss of Consciousness during Euthanasia in Mice - Refinement of Animal Welfare?	PLOS ONE			English	Article							SENSING ION CHANNELS; ALVEOLAR ANESTHETIC CONCENTRATION; D-ASPARTATE RECEPTORS; DORSAL-HORN NEURONS; SPINAL-CORD; AIR HUNGER; RATS; OXYGEN; BRAIN; PAIN	Carbon dioxide (CO2) is the most commonly used euthanasia agent for rodents despite potentially causing pain and distress. Nitrous oxide is used in man to speed induction of anaesthesia with volatile anaesthetics, via a mechanism referred to as the "second gas" effect. We therefore evaluated the addition of Nitrous Oxide (N2O) to a rising CO2 concentration could be used as a welfare refinement of the euthanasia process in mice, by shortening the duration of conscious exposure to CO2. Firstly, to assess the effect of N2O on the induction of anaesthesia in mice, 12 female C57Bl/6 mice were anaesthetized in a crossover protocol with the following combinations: Isoflurane (5%)+O-2 (95%); Isoflurane (5%)+ N2O (75%)+O-2 (25%) and N2O (75%)+O-2 (25%) with a total flow rate of 3l/min (into a 7l induction chamber). The addition of N2O to isoflurane reduced the time to loss of the righting reflex by 17.6%. Secondly, 18 C57Bl/6 and 18 CD1 mice were individually euthanized by gradually filling the induction chamber with either: CO2 (20% of the chamber volume. min(-1)); CO2 + N2O (20 and 60% of the chamber volume. min(-1) respectively); or CO2 + Nitrogen (N-2) (20 and 60% of the chamber volume. min(-1)). Arterial partial pressure (P-a) of O-2 and CO2 were measured as well as blood pH and lactate. When compared to the gradually rising CO2 euthanasia, addition of a high concentration of N2O to CO2 lowered the time to loss of righting reflex by 10.3% (P < 0.001), lead to a lower PaO2 (12.55+/-3.67 mmHg, P < 0.001), a higher lactataemia (4.64+/-1.04 mmol.l(-1), P = 0.026), without any behaviour indicative of distress. Nitrous oxide reduces the time of conscious exposure to gradually rising CO2 during euthanasia and hence may reduce the duration of any stress or distress to which mice are exposed during euthanasia.	[Thomas, Aurelie A.; Flecknell, Paul A.] Newcastle Univ, Comparat Biol Ctr, Sch Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Golledge, Huw D. R.] Newcastle Univ, Inst Neurosci, Sch Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Thomas, AA (corresponding author), Newcastle Univ, Comparat Biol Ctr, Sch Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	aurelie.thomas@ncl.ac.uk		Golledge, Huw/0000-0002-2321-7929; Flecknell, Paul/0000-0002-1075-1129	United Kindgom National Centre for the Replacement, Refinement and Reduction of Animals in Research [G1000878]; National Centre for the Replacement [G1000878/1] Funding Source: researchfish	United Kindgom National Centre for the Replacement, Refinement and Reduction of Animals in Research; National Centre for the Replacement	HDRG is supported by a United Kindgom National Centre for the Replacement, Refinement and Reduction of Animals in Research strategic award (grant G1000878, website: http://www.nc3rs.org.uk/researchportfolio/showcatportfolio.asp?id=204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antognini JF, 1997, MED HYPOTHESES, V48, P83, DOI 10.1016/S0306-9877(97)90028-1; Antognini JF, 1998, TOXICOL LETT, V101, P51, DOI 10.1016/S0378-4274(98)00164-7; ANTON F, 1992, PAIN, V49, P53, DOI 10.1016/0304-3959(92)90187-G; Banzett RB, 2000, AM J RESP CRIT CARE, V162, P1178, DOI 10.1164/ajrccm.162.3.9909112; Banzett RB., 2001, APS B, V11, P1; Baron A, 2008, J NEUROSCI, V28, P1498, DOI 10.1523/JNEUROSCI.4975-07.2008; Barr G, 1999, BRIT J ANAESTH, V82, P827, DOI 10.1093/bja/82.6.827; Brosnan RJ, 2008, BRIT J ANAESTH, V101, P673, DOI 10.1093/bja/aen266; Brosnan RJ, 2007, ANESTH ANALG, V105, P103, DOI 10.1213/01.ane.0000265556.69089.78; Caruana-Montaldo B, 2000, CHEST, V117, P205, DOI 10.1378/chest.117.1.205; Chuang IC, 2010, LUNG, V188, P199, DOI 10.1007/s00408-010-9234-7; COENEN AML, 1995, LAB ANIM, V29, P262, DOI 10.1258/002367795781088289; Conlee KM, 2005, LAB ANIM-UK, V39, P137, DOI 10.1258/0023677053739747; CUNNINGHAM DJC, 1986, J PHYSIOL-LONDON, V376, P31, DOI 10.1113/jphysiol.1986.sp016140; Danneman PJ, 1997, LAB ANIM SCI, V47, P376; Deval E, 2010, PHARMACOL THERAPEUT, V128, P549, DOI 10.1016/j.pharmthera.2010.08.006; EGER EI, 1963, ANESTHESIOLOGY, V24, P153, DOI 10.1097/00000542-196303000-00001; EPSTEIN RM, 1964, ANESTHESIOLOGY, V25, P364, DOI 10.1097/00000542-196405000-00015; FENWICK DC, 1989, LAB ANIM-UK, V23, P220, DOI 10.1258/002367789780810590; Flecknell P., 2009, LAB ANIMAL ANAESTHES; GONSOWSKI CT, 1994, ANESTH ANALG, V79, P710; GRAHAM G R, 1960, Anaesthesist, V9, P70; Hackbarth H, 2000, LAB ANIM-UK, V34, P91, DOI 10.1258/002367700780578055; HATCHELL PL, 1973, GENETICS, V75, P191; Hawkins P, 2006, NEWC CONC M CARB DIO; Home Office, 2022, NAT STAT OP POL POW, DOI 22/08/2011; Ikeuchi M, 2008, PAIN, V137, P662, DOI 10.1016/j.pain.2008.01.020; IRWIN S, 1968, PSYCHOPHARMACOLOGIA, V13, P222, DOI 10.1007/BF00401402; KITAHATA LM, 1971, ANESTHESIOLOGY, V35, P607; Kohler I, 1999, LAB ANIM, V33, P155, DOI 10.1258/002367799780578390; Korman B, 1997, BRIT J ANAESTH, V78, P618, DOI 10.1093/bja/78.5.618; Lee EJ, 2009, J APPL PHYSIOL, V107, P290, DOI 10.1152/japplphysiol.91255.2008; Liotti M, 2001, P NATL ACAD SCI USA, V98, P2035, DOI 10.1073/pnas.98.4.2035; LUFT ULRICH C., 1965, HANDBOOK PHYSIOL, V2, P1099; Makowska IJ, 2008, ALTERNATIVES CARBON; MILLER KW, 1972, ANESTHESIOLOGY, V36, P339, DOI 10.1097/00000542-197204000-00008; Mohan R, 1997, RESP PHYSIOL, V108, P101, DOI 10.1016/S0034-5687(97)00024-8; Moosavi SH, 2003, J APPL PHYSIOL, V94, P141, DOI 10.1152/japplphysiol.00594.2002; Morelot-Panzini C, 2007, J NEUROPHYSIOL, V97, P1396, DOI 10.1152/jn.00116.2006; Mutoh T, 2001, AM J VET RES, V62, P1727, DOI 10.2460/ajvr.2001.62.1727; Muzi M, 1996, ANESTHESIOLOGY, V85, P536, DOI 10.1097/00000542-199609000-00012; Niel L, 2006, APPL ANIM BEHAV SCI, V100, P295, DOI 10.1016/j.applanim.2005.12.001; PARBROOK GD, 1968, BRIT J ANAESTH, V40, P365, DOI 10.1093/bja/40.5.365; PEPPEL P, 1993, J NEUROPHYSIOL, V70, P2260, DOI 10.1152/jn.1993.70.6.2260; Peyton PJ, 2008, ANESTHESIOLOGY, V108, P381, DOI 10.1097/ALN.0b013e318164caf3; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; Russell GB, 1998, CAN J ANAESTH, V45, P466, DOI 10.1007/BF03012583; Sawamura S, 2000, J NEUROSCI, V20, P9242; Schon D, 2008, PSYCHOPHYSIOLOGY, V45, P1064, DOI 10.1111/j.1469-8986.2008.00704.x; SIMON PM, 1990, AM REV RESPIR DIS, V142, P1009, DOI 10.1164/ajrccm/142.5.1009; Skevington SM, 1997, PSYCHOL HEALTH, V12, P677, DOI 10.1080/08870449708407414; SMITH WDA, 1972, BRIT J ANAESTH, V44, P297, DOI 10.1093/bja/44.3.297; Sonner JM, 1999, ANESTH ANALG, V89, P1030, DOI 10.1097/00000539-199910000-00039; Stabernack C, 2003, ANESTH ANALG, V96, P102, DOI 10.1213/01.000041457.84556.FC; STOELTING RK, 1969, ANESTHESIOLOGY, V30, P273, DOI 10.1097/00000542-196903000-00007; Taheri S, 1999, ANESTH ANALG, V89, P774, DOI 10.1097/00000539-199909000-00047; Volmanen P, 2011, CURR OPIN ANESTHESIO, V24, P235, DOI 10.1097/ACO.0b013e328345ad18; von Leupoldt A, 2007, BEHAV RES METHODS, V39, P137, DOI 10.3758/BF03192852; WASSERMAN K, 1987, CIRCULATION, V76, P29; West J. B., 2008, RESP PHYSL; Widdicombe J, 1998, RESP FUNCTION UPPER, P233; Wu LJ, 2004, J BIOL CHEM, V279, P43716, DOI 10.1074/jbc.M403557200; Wultsch T, 2008, PAIN, V134, P245, DOI 10.1016/j.pain.2007.04.025; Yavari P, 1996, J AUTONOM NERV SYST, V61, P195, DOI 10.1016/S0165-1838(96)00072-0; Zhang C, 1999, ANESTHESIOLOGY, V91, P1401, DOI 10.1097/00000542-199911000-00033; Ziemann AE, 2009, CELL, V139, P1012, DOI 10.1016/j.cell.2009.10.029	66	24	25	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2012	7	3							e32290	10.1371/journal.pone.0032290	http://dx.doi.org/10.1371/journal.pone.0032290			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RU	22438874	Green Published, Green Submitted, gold			2022-12-25	WOS:000303309000006
J	Wurster, T; Polzelbauer, C; Schonberger, T; Paul, A; Seizer, P; Stellos, K; Schuster, A; Botnar, RM; Gawaz, M; Bigalke, B				Wurster, Thomas; Poelzelbauer, Catharina; Schoenberger, Tanja; Paul, Angela; Seizer, Peter; Stellos, Konstantinos; Schuster, Andreas; Botnar, Rene M.; Gawaz, Meinrad; Bigalke, Boris			Green Fluorescent Protein (GFP) Color Reporter Gene Visualizes Parvovirus B19 Non-Structural Segment 1 (NS1) Transfected Endothelial Modification	PLOS ONE			English	Article							LEFT-VENTRICULAR DYSFUNCTION; HIGH PREVALENCE; VIRAL GENOMES; MYOCARDITIS; VIRUS; INFECTION; DISEASE; ADHESION; CELLS; MICE	Background: Human Parvovirus B19 ((PVB19) has been associated with myocarditis putative due to endothelial infection. Whether PVB19 infects endothelial cells and causes a modification of endothelial function and inflammation and, thus, disturbance of microcirculation has not been elucidated and could not be visualized so far. Methods and Findings: To examine the PVB19-induced endothelial modification, we used green fluorescent protein (GFP) color reporter gene in the non-structural segment 1 (NS1) of PVB19. NS1-GFP-PVB19 or GFP plasmid as control were transfected in an endothelial-like cell line (ECV304). The endothelial surface expression of intercellular-adhesion molecule-1 (CD54/ICAM-1) and extracellular matrix metalloproteinase inducer (EMMPRIN/CD147) were evaluated by flow cytometry after NS-1-GFP or control-GFP transfection. To evaluate platelet adhesion on NS-1 transfected ECs, we performed a dynamic adhesion assay (flow chamber). NS-1 transfection causes endothelial activation and enhanced expression of ICAM-1 (CD54: mean +/- standard deviation: NS1-GFP vs. control-GFP: 85.3 +/- 11.2 vs. 61.6 +/- 8.1; P<0.05) and induces endothelial expression of EMMPRIN/CD147 (CD147: mean +/- SEM: NS1-GFP vs. control-GFP: 114 +/- 15.3 vs. 80 +/- 0.91; P<0.05) compared to control-GFP transfected cells. Dynamic adhesion assays showed that adhesion of platelets is significantly enhanced on NS1 transfected ECs when compared to control-GFP (P<0.05). The transfection of ECs was verified simultaneously through flow cytometry, immunofluorescence microscopy and polymerase chain reaction (PCR) analysis. Conclusions: GFP color reporter gene shows transfection of ECs and may help to visualize NS1-PVB19 induced endothelial activation and platelet adhesion as well as an enhanced monocyte adhesion directly, providing in vitro evidence of possible microcirculatory dysfunction in PVB19-induced myocarditis and, thus, myocardial tissue damage.	[Wurster, Thomas; Poelzelbauer, Catharina; Schoenberger, Tanja; Paul, Angela; Seizer, Peter; Gawaz, Meinrad; Bigalke, Boris] Univ Tubingen, Med Klin Kardiol & Kreislauferkrankungen 3, Tubingen, Germany; [Stellos, Konstantinos] Goethe Univ Frankfurt, Dept Cardiol, Frankfurt, Germany; [Schuster, Andreas; Botnar, Rene M.; Bigalke, Boris] Kings Coll London, Div Imaging Sci & Biomed Engn, Sch Med, Rayne Inst, London WC2R 2LS, England	Eberhard Karls University of Tubingen; Goethe University Frankfurt; University of London; King's College London	Wurster, T (corresponding author), Univ Tubingen, Med Klin Kardiol & Kreislauferkrankungen 3, Tubingen, Germany.	boris.bigalke@med.uni-tuebingen.de	Botnar, Rene M/E-6875-2012; Stellos, Konstantinos/ABH-1523-2021; Botnar, Rene Michael/AAZ-2112-2020; Stellos, Konstantinos/AAF-2711-2020	Botnar, Rene M/0000-0003-2811-2509; Stellos, Konstantinos/0000-0002-0194-0825; Botnar, Rene/0000-0002-9447-4367	Deutsche Forschungsgemeinschaft [MA2186/3-1GK794]; Sonderforschungsbereich/Transregio19 'Inflammatorische Kardiomyopathie - Molekulare Pathogenese und Therapie' - "Molecular Pathogenesis and Therapy''; Klinische Forschergruppe [KFO274]; German Cardiac Society;  [DFG:Li849/3-1];  [SFB:SFB-TR19-B8N]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Sonderforschungsbereich/Transregio19 'Inflammatorische Kardiomyopathie - Molekulare Pathogenese und Therapie' - "Molecular Pathogenesis and Therapy''; Klinische Forschergruppe; German Cardiac Society; ; 	The study was supported by grants of Deutsche Forschungsgemeinschaft (MA2186/3-1&GK794 to MG), Sonderforschungsbereich/Transregio19 'Inflammatorische Kardiomyopathie - Molekulare Pathogenese und Therapie' - "Molecular Pathogenesis and Therapy'' and Klinische Forschergruppe KFO274 - Platelets - Molecular Mechanisms and Translational Medicine) to KS, MG (DFG:Li849/3-1; SFB:SFB-TR19-B8N), and by the grant of the German Cardiac Society 'Molecular Imaging of Atherosclerotic Plaques' to BB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bigalke B, 2009, CAN J CARDIOL, V25, pE248, DOI 10.1016/S0828-282X(09)70511-2; Bultmann BD, 2003, HUM PATHOL, V34, P92, DOI 10.1053/hupa.2003.48; Celik S, 2007, THROMB HAEMOSTASIS, V98, P798, DOI 10.1160/TH07-02-0096; Cooper LT, 2009, NEW ENGL J MED, V360, P1526, DOI 10.1056/NEJMra0800028; Duechting A, 2008, J VIROL, V82, P7942, DOI 10.1128/JVI.00891-08; Escher F, 2011, HEART, V97, P733, DOI 10.1136/hrt.2010.205716; Hsu TC, 2006, CLIN EXP IMMUNOL, V144, P152, DOI 10.1111/j.1365-2249.2006.03023.x; Kittel C, 2005, J VIROL, V79, P10672, DOI 10.1128/JVI.79.16.10672-10677.2005; Kuhl U, 2005, CIRCULATION, V111, P887, DOI 10.1161/01.CIR.0000155616.07901.35; Kuhl U, 2003, CIRCULATION, V108, P945, DOI 10.1161/01.CIR.0000085168.02782.2C; Kuhl U, 2003, CIRCULATION, V107, P2793, DOI 10.1161/01.CIR.0000072766.67150.51; Leardkamolkarn V, 2012, J BIOMOL SCREEN, V17, P283, DOI 10.1177/1087057111426903; Lupescu A, 2009, CELL PHYSIOL BIOCHEM, V23, P211, DOI 10.1159/000204110; Manicassamy B, 2010, P NATL ACAD SCI USA, V107, P11531, DOI 10.1073/pnas.0914994107; Park MS, 2003, J VIROL, V77, P1501, DOI 10.1128/JVI.77.2.1501-1511.2003; Schultheiss HP, 2011, EUR HEART J, V32, P2616, DOI 10.1093/eurheartj/ehr165; Seizer P, 2010, ATHEROSCLEROSIS, V209, P51, DOI 10.1016/j.atherosclerosis.2009.08.029; Soliman TM, 2000, J VIROL, V74, P7600, DOI 10.1128/JVI.74.16.7600-7609.2000; Toan NL, 2006, J GEN VIROL, V87, P2941, DOI 10.1099/vir.0.82037-0; Tschope C, 2005, CIRCULATION, V111, P879, DOI 10.1161/01.CIR.0000155615.68924.B3; Wooten DK, 2000, J BIOL CHEM, V275, P26566, DOI 10.1074/jbc.M003495200; Young NS, 2004, NEW ENGL J MED, V350, P586, DOI 10.1056/NEJMra030840	22	2	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2012	7	3							e33602	10.1371/journal.pone.0033602	http://dx.doi.org/10.1371/journal.pone.0033602			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RU	22438961	gold, Green Published, Green Submitted			2022-12-25	WOS:000303309000033
J	Rai, A; Suprasanna, P; D'Souza, SF; Kumar, V				Rai, Archana; Suprasanna, Penna; D'Souza, Stanislaus F.; Kumar, Vinay			Membrane Topology and Predicted RNA-Binding Function of the 'Early Responsive to Dehydration (ERD4)' Plant Protein	PLOS ONE			English	Article							TRANSMEMBRANE TOPOLOGY; SIGNAL-TRANSDUCTION; RECOGNITION MOTIF; ARABIDOPSIS; SEQUENCE; GENES; CONSERVATION; EVOLUTION; ALIGNMENT; MODEL	Functional annotation of uncharacterized genes is the main focus of computational methods in the post genomic era. These tools search for similarity between proteins on the premise that those sharing sequence or structural motifs usually perform related functions, and are thus particularly useful for membrane proteins. Early responsive to dehydration (ERD) genes are rapidly induced in response to dehydration stress in a variety of plant species. In the present work we characterized function of Brassica juncea ERD4 gene using computational approaches. The ERD4 protein of unknown function possesses ubiquitous DUF221 domain (residues 312-634) and is conserved in all plant species. We suggest that the protein is localized in chloroplast membrane with at least nine transmembrane helices. We detected a globular domain of 165 amino acid residues (183-347) in plant ERD4 proteins and expect this to be posited inside the chloroplast. The structural-functional annotation of the globular domain was arrived at using fold recognition methods, which suggested in its sequence presence of two tandem RNA-recognition motif (RRM) domains each folded into beta alpha beta beta alpha beta topology. The structure based sequence alignment with the known RNA-binding proteins revealed conservation of two non-canonical ribonucleoprotein sub-motifs in both the putative RNA-recognition domains of the ERD4 protein. The function of highly conserved ERD4 protein may thus be associated with its RNA-binding ability during the stress response. This is the first functional annotation of ERD4 family of proteins that can be useful in designing experiments to unravel crucial aspects of stress tolerance mechanism.	[Rai, Archana; Suprasanna, Penna; D'Souza, Stanislaus F.] Bhabha Atom Res Ctr, Nucl Agr & Biotechnol Div, Bombay 400085, Maharashtra, India; [Kumar, Vinay] Bhabha Atom Res Ctr, High Pressure & Synchrotron Radiat Phys Div, Bombay 400085, Maharashtra, India	Bhabha Atomic Research Center (BARC); Bhabha Atomic Research Center (BARC)	Rai, A (corresponding author), Bhabha Atom Res Ctr, Nucl Agr & Biotechnol Div, Bombay 400085, Maharashtra, India.	sfdsouza@barc.gov.in; vinay@barc.gov.in	PENNA, Suprasanna/AAE-1208-2022		Department of Atomic Energy, India	Department of Atomic Energy, India(Department of Atomic Energy (DAE))	Department of Atomic Energy, India, supported the research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandersson E, 2004, PLANT CELL PHYSIOL, V45, P1543, DOI 10.1093/pcp/pch209; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANDERSSON H, 1993, J BIOL CHEM, V268, P21389; Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Arai M, 2004, NUCLEIC ACIDS RES, V32, pW390, DOI 10.1093/nar/gkh380; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bhushan S, 2006, FEBS LETT, V580, P3966, DOI 10.1016/j.febslet.2006.06.018; BIRNEY E, 1993, NUCLEIC ACIDS RES, V21, P5803, DOI 10.1093/nar/21.25.5803; Briesemeister S, 2010, NUCLEIC ACIDS RES, V38, pW497, DOI 10.1093/nar/gkq477; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Camargo SR, 2007, PLANT CELL REP, V26, P2119, DOI 10.1007/s00299-007-0430-8; Cavalier-Smith T, 2000, TRENDS PLANT SCI, V5, P174, DOI 10.1016/S1360-1385(00)01598-3; Chothia C, 2003, SCIENCE, V300, P1701, DOI 10.1126/science.1085371; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Clery A, 2008, CURR OPIN STRUC BIOL, V18, P290, DOI 10.1016/j.sbi.2008.04.002; Cserzo M, 1997, PROTEIN ENG, V10, P673, DOI 10.1093/protein/10.6.673; Ding JZ, 1999, GENE DEV, V13, P1102, DOI 10.1101/gad.13.9.1102; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Ferro M, 2003, MOL CELL PROTEOMICS, V2, P325, DOI 10.1074/mcp.M300030-MCP200; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Froehlich JE, 2003, J PROTEOME RES, V2, P413, DOI 10.1021/pr034025j; Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124; Godzik Adam, 2003, Methods Biochem Anal, V44, P525; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hulo N, 2008, NUCLEIC ACIDS RES, V36, pD245, DOI 10.1093/nar/gkm977; Jaroszewski L, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000205; JONES DT, 1994, BIOCHEMISTRY-US, V33, P3038, DOI 10.1021/bi00176a037; Kahsay RY, 2005, BIOINFORMATICS, V21, P1853, DOI 10.1093/bioinformatics/bti303; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; KIYOSUE T, 1994, PLANT MOL BIOL, V25, P791, DOI 10.1007/BF00028874; Kleffmann T, 2004, CURR BIOL, V14, P354, DOI 10.1016/j.cub.2004.02.039; Kolodny R, 2006, CURR OPIN STRUC BIOL, V16, P393, DOI 10.1016/j.sbi.2006.04.007; Kuhn JM, 2003, CURR OPIN PLANT BIOL, V6, P463, DOI 10.1016/S1369-5266(03)00084-0; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Liu YH, 2009, PLANT MOL BIOL REP, V27, P542, DOI 10.1007/s11105-009-0119-y; Lopez-Juez E, 2007, J EXP BOT, V58, P11, DOI 10.1093/jxb/erl196; MANSFIELD TJ, 1990, STRESS RESPONSES PLA, P241; Marchler-Bauer Aron, 2011, Nucleic Acids Res, V39, pD225, DOI 10.1093/nar/gkq1189; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Martin W, 2002, P NATL ACAD SCI USA, V99, P12246, DOI 10.1073/pnas.182432999; Martin W, 1998, PLANT PHYSIOL, V118, P9, DOI 10.1104/pp.118.1.9; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Mitschke J, 2009, NEW PHYTOL, V183, P224, DOI 10.1111/j.1469-8137.2009.02832.x; Moore AD, 2008, TRENDS BIOCHEM SCI, V33, P444, DOI 10.1016/j.tibs.2008.05.008; Novatchkova M, 2006, NUCLEIC ACIDS RES, V34, pW214, DOI 10.1093/nar/gkl332; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Petrey D, 2005, MOL CELL, V20, P811, DOI 10.1016/j.molcel.2005.12.005; Petrey D, 2009, P NATL ACAD SCI USA, V106, P17377, DOI 10.1073/pnas.0907971106; Rost Burkhard, 2003, Methods Biochem Anal, V44, P559; Shinozaki K, 1997, PLANT PHYSIOL, V115, P327, DOI 10.1104/pp.115.2.327; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taylor NL, 2009, J PROTEOMICS, V72, P367, DOI 10.1016/j.jprot.2008.11.006; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Vogel C, 2004, CURR OPIN STRUC BIOL, V14, P208, DOI 10.1016/j.sbi.2004.03.011; Zhang QC, 2010, P NATL ACAD SCI USA, V107, P10896, DOI 10.1073/pnas.1005894107; Zybailov B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001994	64	26	30	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e32658	10.1371/journal.pone.0032658	http://dx.doi.org/10.1371/journal.pone.0032658			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22431979	gold, Green Published, Green Submitted			2022-12-25	WOS:000303198600022
J	Bhattacharyya, S; Tobacman, JK				Bhattacharyya, Sumit; Tobacman, Joanne K.			Hypoxia Reduces Arylsulfatase B Activity and Silencing Arylsulfatase B Replicates and Mediates the Effects of Hypoxia	PLOS ONE			English	Article							FORMYLGLYCINE-GENERATING ENZYME; MULTIPLE SULFATASE DEFICIENCY; FALCIPARUM-INFECTED ERYTHROCYTES; CHONDROITIN SULFATE; MUCOPOLYSACCHARIDOSIS-VI; ENDOPLASMIC-RETICULUM; SULFUR ASSIMILATION; ATP-SULFURYLASE; MOLECULAR-BASIS; HUMAN PLACENTA	This report presents evidence of 1) a role for arylsulfatase B (ARSB; N-acetylgalactosamine-4-sulfatase) in mediating intracellular oxygen signaling; 2) replication between the effects of ARSB silencing and hypoxia on sulfated glycosaminoglycan content, cellular redox status, and expression of hypoxia-associated genes; and 3) a mechanism whereby changes in chondroitin-4-sulfation that follow either hypoxia or ARSB silencing can induce transcriptional changes through galectin-3. ARSB removes 4-sulfate groups from the non-reducing end of chondroitin-4-sulfate and dermatan sulfate and is required for their degradation. For activity, ARSB requires modification of a critical cysteine residue by the formylglycine generating enzyme and by molecular oxygen. When primary human bronchial and human colonic epithelial cells were exposed to 10% O(2)x1 h, ARSB activity declined by similar to 41% and similar to 30% from baseline, as nuclear hypoxia inducible factor (HIF)-1 alpha increased by similar to 53% and similar to 37%. When ARSB was silenced, nuclear HIF-1 alpha increased by similar to 81% and similar to 61% from baseline, and mRNA expression increased to 3.73 (+/- 0.34) times baseline. Inversely, ARSB overexpression reduced nuclear HIF-1 alpha by similar to 37% and similar to 54% from baseline in the epithelial cells. Hypoxia, like ARSB silencing, significantly increased the total cellular sulfated glycosaminoglycans and chondroitin-4-sulfate (C4S) content. Both hypoxia and ARSB silencing had similar effects on the cellular redox status and on mRNA expression of hypoxia-associated genes. Transcriptional effects of both ARSB silencing and hypoxia may be mediated by reduction in galectin-3 binding to more highly sulfated C4S, since the galectin-3 that co-immunoprecipitated with C4S declined and the nuclear galectin-3 increased following ARSB knockdown and hypoxia.	[Bhattacharyya, Sumit; Tobacman, Joanne K.] Univ Illinois, Dept Med, Chicago, IL 60612 USA; [Bhattacharyya, Sumit; Tobacman, Joanne K.] Jesse Brown VA Med Ctr, Dept Med, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Tobacman, JK (corresponding author), Univ Illinois, Dept Med, Chicago, IL 60612 USA.	jkt@uic.edu			VA Merit Review; Clinical and Translational Science Award (CTSA) [UL1 RR029879]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029879] Funding Source: NIH RePORTER	VA Merit Review(US Department of Veterans Affairs); Clinical and Translational Science Award (CTSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The sources of funding were VA Merit Review and Clinical and Translational Science Award (CTSA) UL1 RR029879. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achur RN, 2003, J BIOL CHEM, V278, P11705, DOI 10.1074/jbc.M211015200; ASHBY SJ, 1995, ACTA CRYSTALLOGR D, V51, P1082, DOI 10.1107/S0907444995005191; Besset S, 2000, FASEB J, V14, P345, DOI 10.1096/fasebj.14.2.345; Bhattacharyya S, 2008, J BIOL CHEM, V283, P9523, DOI 10.1074/jbc.M707967200; Bhattacharyya S, 2007, CLIN CHIM ACTA, V380, P122, DOI 10.1016/j.cca.2007.01.021; Bhattacharyya S, 2007, J STEROID BIOCHEM, V103, P20, DOI 10.1016/j.jsbmb.2006.08.002; Bhattacharyya S, 2010, BBA-MOL BASIS DIS, V1802, P472, DOI 10.1016/j.bbadis.2010.01.014; Bhattacharyya S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-303; Bhattacharyya S, 2010, AM J RESP CELL MOL, V42, P51, DOI 10.1165/rcmb.2008-0482OC; Bhattacharyya S, 2009, CLIN EXP METASTAS, V26, P535, DOI 10.1007/s10585-009-9253-z; Bond CS, 1997, STRUCTURE, V5, P277, DOI 10.1016/S0969-2126(97)00185-8; BUDDE RJA, 1991, PLANT PHYSIOL, V95, P131, DOI 10.1104/pp.95.1.131; Cosma MP, 2003, CELL, V113, P445, DOI 10.1016/S0092-8674(03)00348-9; Cumming RC, 2004, J BIOL CHEM, V279, P21749, DOI 10.1074/jbc.M312267200; DESOUSA JF, 1990, J BIOL CHEM, V265, P20150; Dierks T, 2005, CELL, V121, P541, DOI 10.1016/j.cell.2005.03.001; Dierks T, 2003, CELL, V113, P435, DOI 10.1016/S0092-8674(03)00347-7; Fey J, 2001, J BIOL CHEM, V276, P47021, DOI 10.1074/jbc.M108943200; Giugliani R, 2011, CURR PHARM BIOTECHNO, V12, P956, DOI 1389-2010/11 $58.00+.00; GLASER JH, 1979, J BIOL CHEM, V254, P2316; Greijer AE, 2005, J PATHOL, V206, P291, DOI 10.1002/path.1778; GRUM CM, 1984, J APPL PHYSIOL, V56, P1065, DOI 10.1152/jappl.1984.56.4.1065; Grum D, 2010, BIOCHEM BIOPH RES CO, V395, P420, DOI 10.1016/j.bbrc.2010.04.039; Harmatz P, 2004, J PEDIATR-US, V144, P574, DOI 10.1016/j.jpeds.2004.03.018; Hofgen R, 2001, AMINO ACIDS, V20, P291, DOI 10.1007/s007260170045; Iwaki J, 2008, BIOCHEM BIOPH RES CO, V373, P206, DOI 10.1016/j.bbrc.2008.05.190; Kopriva S, 2009, PLANT CELL REP, V28, P1769, DOI 10.1007/s00299-009-0793-0; Lillig CH, 1999, J BIOL CHEM, V274, P7695, DOI 10.1074/jbc.274.12.7695; Liu FT, 2002, BBA-GEN SUBJECTS, V1572, P263, DOI 10.1016/S0304-4165(02)00313-6; Mayevsky A, 2009, MITOCHONDRION, V9, P165, DOI 10.1016/j.mito.2009.01.009; Mendoza-Cozatl D, 2005, FEMS MICROBIOL REV, V29, P653, DOI 10.1016/j.femsre.2004.09.004; Minet E, 1999, BIOCHEM BIOPH RES CO, V261, P534, DOI 10.1006/bbrc.1999.0995; Mitsunaga-Nakatsubo K, 2009, MED MOL MORPHOL, V42, P63, DOI 10.1007/s00795-009-0447-x; Mougous JD, 2006, MOL CELL, V21, P109, DOI 10.1016/j.molcel.2005.10.034; Moyer MP, 1996, IN VITRO CELL DEV-AN, V32, P315; Muhlenhoff U, 2010, CELL METAB, V12, P373, DOI 10.1016/j.cmet.2010.08.001; Muthusamy A, 2004, AM J PATHOL, V164, P2013, DOI 10.1016/S0002-9440(10)63761-3; Nakahara S, 2006, J BIOL CHEM, V281, P39649, DOI 10.1074/jbc.M608069200; Prabhu SV, 2011, J HISTOCHEM CYTOCHEM, V59, P328, DOI 10.1369/0022155410395511; Pungor E, 2009, ANAL BIOCHEM, V395, P144, DOI 10.1016/j.ab.2009.08.012; Roeser D, 2006, P NATL ACAD SCI USA, V103, P81, DOI 10.1073/pnas.0507592102; Roeser D, 2007, ACTA CRYSTALLOGR D, V63, P621, DOI 10.1107/S0907444907009961; SEMENZA GL, 2007, SCI STKE, pCM8, DOI DOI 10.1126/STKE.4072007CM8; SINGH R, 1995, METHOD ENZYMOL, V251, P229, DOI 10.1016/0076-6879(95)51125-3; SINGH R, 1993, ANAL BIOCHEM, V213, P49, DOI 10.1006/abio.1993.1384; Song SM, 2005, GASTROENTEROLOGY, V129, P1581, DOI 10.1053/j.gastro.2005.09.002; Sun MH, 2005, BIOCHEMISTRY-US, V44, P13941, DOI 10.1021/bi051303e; Sun MH, 2005, J BIOL CHEM, V280, P7861, DOI 10.1074/jbc.M409613200; Suzuki S, 1999, J APPL PHYSIOL, V87, P962, DOI 10.1152/jappl.1999.87.3.962; Takahashi H, 2011, ANNU REV PLANT BIOL, V62, P157, DOI 10.1146/annurev-arplant-042110-103921; Walsh CT, 2006, POSTTRANSLATIONAL MO, P81; Wang H, 2008, J CELL SCI, V121, P3083, DOI 10.1242/jcs.032649; Zito E, 2007, EMBO J, V26, P2443, DOI 10.1038/sj.emboj.7601695	53	32	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2012	7	3							e33250	10.1371/journal.pone.0033250	http://dx.doi.org/10.1371/journal.pone.0033250			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930IA	22428001	Green Submitted, gold, Green Published			2022-12-25	WOS:000303129700043
J	Reinecke, K; Eminel, S; Dierck, F; Roessner, W; Kersting, S; Chromik, AM; Gavrilova, O; Laukevicience, A; Leuschner, I; Waetzig, V; Rosenstiel, P; Herdegen, T; Sina, C				Reinecke, Kirstin; Eminel, Sevgi; Dierck, Franziska; Roessner, Wibke; Kersting, Sabine; Chromik, Ansgar Michael; Gavrilova, Olga; Laukevicience, Ale; Leuschner, Ivo; Waetzig, Vicki; Rosenstiel, Philip; Herdegen, Thomas; Sina, Christian			The JNK Inhibitor XG-102 Protects against TNBS-Induced Colitis	PLOS ONE			English	Article							N-TERMINAL KINASE; INFLAMMATORY-BOWEL-DISEASE; MITOGEN-ACTIVATED PROTEIN; FACTOR-KAPPA-B; FOCAL CEREBRAL-ISCHEMIA; C-JUN; CROHNS-DISEASE; TNF-ALPHA; INTESTINAL INFLAMMATION; PEPTIDE INHIBITOR	The c-Jun N-terminal kinase (JNK)-inhibiting peptide D-JNKI-1, syn. XG-102 was tested for its therapeutic potential in acute inflammatory bowel disease (IBD) in mice. Rectal instillation of the chemical irritant trinitrobenzene sulfonic acid (TNBS) provoked a dramatic acute inflammation in the colon of 7-9 weeks old mice. Coincident subcutaneous application of 100 mu g/kg XG-102 significantly reduced the loss of body weight, rectal bleeding and diarrhoea. After 72 h, the end of the study, the colon was removed and immuno-histochemically analysed. XG-102 significantly reduced (i) pathological changes such as ulceration or crypt deformation, (ii) immune cell pathology such as infiltration and presence of CD3- and CD68-positive cells, (iii) the production of tumor necrosis factor (TNF)-alpha in colon tissue cultures from TNBS-treated mice, (iv) expression of Bim, Bax, FasL, p53, and activation of caspase 3, (v) complexation of JNK2 and Bim, and (vi) expression and activation of the JNK substrate and transcription factor c-Jun. A single application of subcutaneous XG-102 was at least as effective or even better depending on the outcome parameter as the daily oral application of sulfasalazine used for treatment of IBD. The successful and substantial reduction of the severe, TNBS-evoked intestinal damages and clinical symptoms render the JNK-inhibiting peptide XG-102 a powerful therapeutic principle of IBD.	[Reinecke, Kirstin; Eminel, Sevgi; Waetzig, Vicki; Herdegen, Thomas] Univ Hosp Schleswig Holstein, Inst Expt & Clin Pharmacol, Kiel, Germany; [Dierck, Franziska; Roessner, Wibke] Univ Kiel, Inst Pharmaceut, Kiel, Germany; [Kersting, Sabine; Chromik, Ansgar Michael] Ruhr Univ Bochum, St Josef Hosp, Dept Visceral & Gen Surg, Bochum, Germany; [Gavrilova, Olga; Rosenstiel, Philip; Sina, Christian] Univ Kiel, Univ Hosp Schleswig Holstein, Inst Clin Mol Biol, Kiel, Germany; [Laukevicience, Ale] Lithuanian Univ Hlth Sci, Med Acad, Dept Physiol, Kaunas, Lithuania; [Leuschner, Ivo] Univ Hosp Schleswig Holstein, Inst Pathol, Kiel, Germany	University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Ruhr University Bochum; University of Kiel; Schleswig Holstein University Hospital; Lithuanian University of Health Sciences; University of Kiel; Schleswig Holstein University Hospital	Reinecke, K (corresponding author), Univ Hosp Schleswig Holstein, Inst Expt & Clin Pharmacol, Campus Kiel, Kiel, Germany.	herdegen.office@pharmakologie.uni-kiel.de	Rosenstiel, Philip/A-5137-2009; Sina, Christian/D-5348-2014	Rosenstiel, Philip/0000-0002-9692-8828; 				Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Ahmed RAM, 2009, ENDOCRINE, V35, P184, DOI 10.1007/s12020-008-9136-0; Assi K, 2006, IMMUNOLOGY, V118, P112, DOI 10.1111/j.1365-2567.2006.02349.x; Bantel H, 2002, FASEB J, V16, P1832, DOI 10.1096/fj.02-0223fje; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bessero AC, 2010, J NEUROCHEM, V113, P1307, DOI 10.1111/j.1471-4159.2010.06705.x; Bogoyevitch MA, 2008, BBA-PROTEINS PROTEOM, V1784, P76, DOI 10.1016/j.bbapap.2007.09.013; Bogoyevitch MA, 2010, BBA-PROTEINS PROTEOM, V1804, P463, DOI 10.1016/j.bbapap.2009.11.002; Borsello T, 2004, TRENDS MOL MED, V10, P239, DOI 10.1016/j.molmed.2004.03.008; Borsello T, 2003, NAT MED, V9, P1180, DOI 10.1038/nm911; Broom OJ, 2009, CLIN EXP IMMUNOL, V158, P272, DOI 10.1111/j.1365-2249.2009.04033.x; Bushell KN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025849; Camacho-Barquero L, 2007, INT IMMUNOPHARMACOL, V7, P333, DOI 10.1016/j.intimp.2006.11.006; Carvalho AT, 2007, WORLD J GASTROENTERO, V13, P2166, DOI 10.3748/wjg.v13.i15.2166; Dahan S, 2008, GASTROENTEROLOGY, V134, P192, DOI 10.1053/j.gastro.2007.10.022; Dinh CT, 2009, AUDIOL NEURO-OTOL, V14, P383, DOI 10.1159/000241895; Dohi T, 2006, CURR OPIN GASTROEN, V22, P651, DOI 10.1097/01.mog.0000245545.80160.0f; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Engel MA, 2010, J GASTROENTEROL, V45, P571, DOI 10.1007/s00535-010-0219-3; Esneault E, 2008, NEUROSCIENCE, V152, P308, DOI 10.1016/j.neuroscience.2007.12.036; Fiocchi A, 2010, J ALLERGY CLIN IMMUN, V126, P1119, DOI 10.1016/j.jaci.2010.10.011; Fornoni A, 2008, DIABETOLOGIA, V51, P298, DOI 10.1007/s00125-007-0889-4; Fornoni A, 2007, BIOCHEM BIOPH RES CO, V354, P227, DOI 10.1016/j.bbrc.2006.12.186; Ginet V, 2009, AM J PATHOL, V175, P1962, DOI 10.2353/ajpath.2009.090463; Glatz T, 2010, J HYPERTENS, V28, P1488, DOI 10.1097/HJH.0b013e3283396e4e; Guidi L, 2010, EUR REV MED PHARMACO, V14, P342; Haeusgen W, 2009, NEUROSCIENCE, V161, P951, DOI 10.1016/j.neuroscience.2009.04.014; Haeusgen W, 2010, CELL SIGNAL, V22, P1761, DOI 10.1016/j.cellsig.2010.07.002; Hanauer SB, 2006, GASTROENTEROLOGY, V130, P323, DOI 10.1053/j.gastro.2005.11.030; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hollenbach E, 2005, J BIOL CHEM, V280, P14981, DOI 10.1074/jbc.M500966200; Hommes D, 2002, GASTROENTEROLOGY, V122, P7, DOI 10.1053/gast.2002.30770; Hommes DW, 2003, GUT, V52, P144, DOI 10.1136/gut.52.1.144; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Liu J, 2005, CELL RES, V15, P36, DOI 10.1038/sj.cr.7290262; Liu JR, 2010, NEUROPATH APPL NEURO, V36, P211, DOI 10.1111/j.1365-2990.2009.01047.x; Lodes MJ, 2004, J CLIN INVEST, V113, P1296, DOI 10.1172/JCI200420295; Malamut G, 2006, DIGEST DIS SCI, V51, P1443, DOI 10.1007/s10620-006-9116-2; Manning AM, 2003, NAT REV DRUG DISCOV, V2, P554, DOI 10.1038/nrd1132; Michel-Monigadon D, 2010, CEREBROVASC DIS, V29, P564, DOI 10.1159/000306643; Min W, 1997, J IMMUNOL, V159, P3508; Mitsuyama K, 2006, INT J MOL MED, V17, P449; Nateri AS, 2005, NATURE, V437, P281, DOI 10.1038/nature03914; Neurath M, 2000, Int Rev Immunol, V19, P51, DOI 10.3109/08830180009048389; NEURATH MF, 1995, J EXP MED, V182, P1281, DOI 10.1084/jem.182.5.1281; Okuno S, 2004, J NEUROSCI, V24, P7879, DOI 10.1523/JNEUROSCI.1745-04.2004; Present DH, 1999, NEW ENGL J MED, V340, P1398, DOI 10.1056/NEJM199905063401804; Read MA, 1997, J BIOL CHEM, V272, P2753, DOI 10.1074/jbc.272.5.2753; Rosenstiel P, 2009, SEMIN IMMUNOL, V21, P334, DOI 10.1016/j.smim.2009.10.001; Sabapathy K, 1999, CURR BIOL, V9, P116, DOI 10.1016/S0960-9822(99)80065-7; Samak G, 2010, AM J PHYSIOL-GASTR L, V299, pG572, DOI 10.1152/ajpgi.00265.2010; Sancho R, 2009, EMBO J, V28, P1843, DOI 10.1038/emboj.2009.153; Sandborn WJ, 2007, NEW ENGL J MED, V357, P228, DOI 10.1056/NEJMoa067594; Scaldaferri F, 2009, EUR J IMMUNOL, V39, P290, DOI 10.1002/eji.200838316; Schreiber S, 2005, NAT REV GENET, V6, P376, DOI 10.1038/nrg1607; Selve N, 1992, Mediators Inflamm, V1, P121, DOI 10.1155/S0962935192000206; Siegmund B, 2001, P NATL ACAD SCI USA, V98, P13249, DOI 10.1073/pnas.231473998; Suckfuell M, 2007, ACTA OTO-LARYNGOL, V127, P938, DOI 10.1080/00016480601110212; Touchard E, 2010, INVEST OPHTH VIS SCI, V51, P4683, DOI 10.1167/iovs.09-4733; Travis Simon, 2005, Curr Gastroenterol Rep, V7, P475, DOI 10.1007/s11894-005-0079-9; Velde AAT, 2006, INFLAMM BOWEL DIS, V12, P995, DOI 10.1097/01.mib.0000227817.54969.5e; Waetzig GH, 2002, J IMMUNOL, V168, P5342, DOI 10.4049/jimmunol.168.10.5342; Waetzig V, 2005, TRENDS PHARMACOL SCI, V26, P455, DOI 10.1016/j.tips.2005.07.006; Waetzig V, 2006, PROG NEUROBIOL, V80, P84, DOI 10.1016/j.pneurobio.2006.08.002; Waetzig V, 2009, CELL SIGNAL, V21, P873, DOI 10.1016/j.cellsig.2009.01.032; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Yan CL, 2011, J PHYS CHEM B, V115, P1491, DOI 10.1021/jp1073522; Yin BJ, 2011, EUR J PHARMACOL, V656, P119, DOI 10.1016/j.ejphar.2011.01.046; Zhao Y, 2009, MOL CELL NEUROSCI, V41, P186, DOI 10.1016/j.mcn.2009.02.012; Zingarelli B, 2004, IMMUNOLOGY, V113, P509, DOI 10.1111/j.1365-2567.2004.01991.x	71	42	43	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2012	7	3							e30985	10.1371/journal.pone.0030985	http://dx.doi.org/10.1371/journal.pone.0030985			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930IA	22427801	Green Published, Green Submitted, gold			2022-12-25	WOS:000303129700001
J	Stockl, D; Doring, A; Thorand, B; Heier, M; Belcredi, P; Meisinger, C				Stoeckl, Doris; Doering, Angela; Thorand, Barbara; Heier, Margit; Belcredi, Petra; Meisinger, Christa			Reproductive Factors and Serum Uric Acid Levels in Females from the General Population: The KORA F4 Study	PLOS ONE			English	Article							POSTMENOPAUSAL HORMONE USE; METABOLIC SYNDROME; CARDIOVASCULAR-DISEASE; RISK-FACTORS; WOMEN; THERAPY; MENOPAUSE; MENARCHE; AGE; GOUT	Objective: Hyperuricemia is associated with an increased risk of metabolic and cardiovascular diseases. There are pronounced sex differences in the levels of uric acid. It is largely unknown whether or not reproductive parameters which induce hormonal changes are responsible for this. We examined if there are associations between reproductive parameters and uric acid levels in a female population-based sample. Methods: In this cross-sectional analysis, data of 1530 women aged 32 to 81 years participating in the KORA F4 study, conducted between 2006 and 2008 in Southern Germany were used. Reproductive parameters were obtained by standardized interviews. Uric acid levels were tested by the uricase method. The whole study sample and stratified in pre- and postmenopausal women was analyzed. Results: Menopausal status and earlier age at menarche were associated with higher serum uric acid levels (age-adjusted: p-values 0.003, <0.001 respectively; after multivariable adjustment, including BMI: p-values 0.002, 0.036). A history of oral contraceptive use showed an association with uric acid levels only after multivariable adjustment (p-value 0.009). Hot flushes showed an association with uric acid levels only after age-adjustment (p-value 0.038), but lost significance after adding other confounders. Other reproductive factors, including parity, current or ever use of hormone replacement therapy, current use of oral contraceptives, hysterectomy, bilateral oophorectomy, or depressive mood related to menopausal transition were not associated with uric acid levels. Conclusions: Postmenopausal status, earlier age at menarche and a history of oral contraceptive use were independently associated with higher serum uric acid concentrations in women from the general population. Further studies, especially longitudinal population-based studies investigating the relationship of female reproductive parameters with uric acid levels are necessary to confirm our findings.	[Stoeckl, Doris; Thorand, Barbara; Heier, Margit; Belcredi, Petra; Meisinger, Christa] German Res Ctr Environm Hlth, Inst Epidemiol 2, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Stoeckl, Doris] Univ Munich, Dept Obstet & Gynaecol, Munich, Germany; [Doering, Angela] German Res Ctr Environm Hlth, Inst Epidemiol 1, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Heier, Margit; Meisinger, Christa] Cent Hosp Augsburg, MONICA KORA Myocardial Infarct Registry, Augsburg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Stockl, D (corresponding author), German Res Ctr Environm Hlth, Inst Epidemiol 2, Helmholtz Zentrum Munchen, Neuherberg, Germany.	doris.stoeckl@helmholtz-muenchen.de	Meisinger, Christine/B-5358-2014; Heier, Margit/AAT-5280-2020; Thorand, Barbara/B-5349-2014; Stöckl, Doris/B-5352-2014	Thorand, Barbara/0000-0002-8416-6440; Meisinger, Christa/0000-0002-9026-6544	Helmholtz Zentrum Munchen, German Research Center for Environmental Health (GmbH); German Federal Ministry of Education, Science, Research and Technology; State of Bavaria	Helmholtz Zentrum Munchen, German Research Center for Environmental Health (GmbH)(Helmholtz Association); German Federal Ministry of Education, Science, Research and Technology; State of Bavaria	The KORA research platform (KORA, Cooperative Research in the Region of Augsburg) was initiated and financed by the Helmholtz Zentrum Munchen, German Research Center for Environmental Health (GmbH), which is funded by the German Federal Ministry of Education, Science, Research and Technology and by the State of Bavaria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhole V, 2010, ARTHRITIS RHEUM-US, V62, P1069, DOI 10.1002/art.27338; Chen JH, 2012, CLIN RHEUMATOL, V31, P239, DOI 10.1007/s10067-011-1802-6; Cohen A, 2006, J WOMENS HEALTH, V15, P763, DOI 10.1089/jwh.2006.15.763; COLDITZ GA, 1987, AM J EPIDEMIOL, V126, P319, DOI 10.1093/aje/126.2.319; Doring A, 2008, NAT GENET, V40, P430, DOI 10.1038/ng.107; Elks CE, 2010, NAT GENET, V42, P1077, DOI 10.1038/ng.714; Gaffo AL, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2761; Gunderson EP, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.03.031; Hak AE, 2010, ANN RHEUM DIS, V69, P1305, DOI 10.1136/ard.2009.109884; Hak AE, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2519; Koga M, 2009, CLIMACTERIC, V12, P146, DOI 10.1080/13697130802607719; LALLY EV, 1986, ARCH INTERN MED, V146, P2221, DOI 10.1001/archinte.146.11.2221; Lee HJ, 2011, GYNECOL ENDOCRINOL, V27, P406, DOI 10.3109/09513590.2010.493962; Li Q, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-72; Lin KC, 2004, J RHEUMATOL, V31, P1159; LIND T, 1984, BRIT J OBSTET GYNAEC, V91, P128, DOI 10.1111/j.1471-0528.1984.tb05895.x; Meisinger C, 2002, ARCH INTERN MED, V162, P82, DOI 10.1001/archinte.162.1.82; Meisinger C, 2008, ARTERIOSCL THROM VAS, V28, P1186, DOI 10.1161/ATVBAHA.107.160184; Must A, 2002, AM J EPIDEMIOL, V155, P672, DOI 10.1093/aje/155.7.672; NICHOLLS A, 1973, BRIT MED J, V1, P449, DOI 10.1136/bmj.1.5851.449; Parikh NI, 2010, AM HEART J, V159, DOI 10.1016/j.ahj.2009.11.017; Pierce MB, 2011, DIABET MED; Simon JA, 2006, ANN EPIDEMIOL, V16, P138, DOI 10.1016/j.annepidem.2005.04.003; Singh JA, 2011, CURR OPIN RHEUMATOL, V23, P192, DOI 10.1097/BOR.0b013e3283438e13; Stockl D, 2012, DIABETOLOGIA, V55, P681, DOI 10.1007/s00125-011-2410-3; Stockl D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026076; Sumino H, 1999, LANCET, V354, P650, DOI 10.1016/S0140-6736(99)92381-4; Thurston RC, 2011, J CLIN ENDOCR METAB, V96, pE1588, DOI 10.1210/jc.2011-1082; Towne B, 2005, AM J PHYS ANTHROPOL, V128, P210, DOI 10.1002/ajpa.20106; Wingrove CS, 1998, METABOLISM, V47, P435, DOI 10.1016/S0026-0495(98)90056-7; Yahyaoui R, 2008, J CLIN ENDOCR METAB, V93, P2230, DOI 10.1210/jc.2007-2467	31	30	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2012	7	3							e32668	10.1371/journal.pone.0032668	http://dx.doi.org/10.1371/journal.pone.0032668			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930IA	22427861	Green Submitted, Green Published, gold			2022-12-25	WOS:000303129700013
J	Leitao, L; Prista, C; Moura, TF; Loureiro-Dias, MC; Soveral, G				Leitao, Luis; Prista, Catarina; Moura, Teresa F.; Loureiro-Dias, Maria C.; Soveral, Graca			Grapevine Aquaporins: Gating of a Tonoplast Intrinsic Protein (TIP2;1) by Cytosolic pH	PLOS ONE			English	Article							WATER CHANNEL ACTIVITY; PLASMA-MEMBRANE; FUNCTIONAL-CHARACTERIZATION; EXPRESSION ANALYSIS; INTRACELLULAR PH; BRUSH-BORDER; YEAST-CELLS; TRANSPORT; STRESS; SACCHAROMYCES	Grapevine (Vitis vinifera L.) is one of the oldest and most important perennial crops being considered as a fruit ligneous tree model system in which the water status appears crucial for high fruit and wine quality, controlling productivity and alcohol level. V. vinifera genome contains 28 genes coding for aquaporins, which acting in a concerted and regulated manner appear relevant for plant withstanding extremely unfavorable drought conditions essential for the quality of berries and wine. Several Vv aquaporins have been reported to be expressed in roots, shoots, berries and leaves with clear cultivar differences in their expression level, making their in vivo biochemical characterization a difficult task. In this work V. vinifera cv. Touriga nacional VvTnPIP1;1, VvTnPIP2;2 and VvTnTIP2;1 were expressed in yeast and water transport activity was characterized in intact cells of the transformants. The three aquaporins were localized in the yeast plasma membrane but only VvTnTIP2; 1 expression enhanced the water permeability with a concomitant decrease of the activation energy of water transport. Acidification of yeast cytosol resulted in loss of VvTnTIP2; 1 activity. Sequence analysis revealed the presence of a His(131) residue, unusual in TIPs. By site directed mutagenesis, replacement of this residue by aspartic acid or alanine resulted in loss of pH(in) dependence while replacement by lysine resulted in total loss of activity. In addition to characterization of VvTn aquaporins, these results shed light on the gating of a specific tonoplast aquaporin by cytosolic pH.	[Leitao, Luis; Prista, Catarina; Loureiro-Dias, Maria C.] Univ Tecn Lisboa, Inst Super Agron, CBAA, P-1100 Lisbon, Portugal; [Leitao, Luis] Univ Paris Est Creteil, Equipe IBIOS, UMR Bioemco, Creteil, France; [Moura, Teresa F.; Soveral, Graca] FCT UNL, Dept Quim, REQUIMTE, Caparica, Portugal; [Soveral, Graca] Univ Lisbon, Fac Farm, Dep Bioquim & Biol Humana, P-1699 Lisbon, Portugal	Universidade de Lisboa; UDICE-French Research Universities; Sorbonne Universite; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Universidade de Lisboa	Soveral, G (corresponding author), Univ Tecn Lisboa, Inst Super Agron, CBAA, P-1100 Lisbon, Portugal.	gsoveral@ff.ul.pt	Soveral, Graça/L-1550-2013; iMed.ULisboa, MetGen/B-5293-2014; Prista, Catarina/N-7079-2013; Moura, Teresa F/E-2485-2014; Loureiro-Dias, Maria C/N-7331-2013; Prista, C./H-9049-2019	Soveral, Graça/0000-0001-8487-110X; Prista, Catarina/0000-0001-9307-1905; Loureiro-Dias, Maria C/0000-0002-6340-2416; Prista, C./0000-0001-9307-1905; Fonseca de Moura, Teresa Maria/0000-0003-3069-0770	Fundacao para a Ciencia e Tecnologia, Portugal [POCTI/AGR/57403/2004, PTDC/AGR-AAM/099154/2008, SFRH/BPD/32511/2006]; Fundação para a Ciência e a Tecnologia [PTDC/AGR-AAM/099154/2008] Funding Source: FCT	Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Fundação para a Ciência e a Tecnologia	This work was supported by Fundacao para a Ciencia e Tecnologia, Portugal (grants POCTI/AGR/57403/2004, PTDC/AGR-AAM/099154/2008 and fellowship SFRH/BPD/32511/2006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alleva K, 2006, J EXP BOT, V57, P609, DOI 10.1093/jxb/erj046; Baiges I, 2001, J EXP BOT, V52, P1949, DOI 10.1093/jexbot/52.362.1949; Bellati J, 2010, PLANT MOL BIOL, V74, P105, DOI 10.1007/s11103-010-9658-8; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; Bonhivers M, 1998, J BIOL CHEM, V273, P27565, DOI 10.1074/jbc.273.42.27565; Breeuwer P, 2000, J MICROBIOL METH, V39, P253, DOI 10.1016/S0167-7012(99)00124-4; Chaumont F, 2005, BIOL CELL, V97, P749, DOI 10.1042/BC20040133; Danielson JAH, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-45; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Fetter K, 2004, PLANT CELL, V16, P215, DOI 10.1105/tpc.017194; Fischer M, 2008, J BIOL CHEM, V283, P33889, DOI 10.1074/jbc.M803865200; Fouquet R, 2008, PLANT CELL REP, V27, P1541, DOI 10.1007/s00299-008-0566-1; Galmes J, 2007, PLANTA, V226, P671, DOI 10.1007/s00425-007-0515-1; Geitz RD, 1995, TRANSFORMING YEAST D, P255; Gerbeau P, 2002, PLANT J, V30, P71, DOI 10.1046/j.1365-313X.2002.01268.x; Guo L, 2006, CELL RES, V16, P277, DOI 10.1038/sj.cr.7310035; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hanahan D., 1985, TECHNIQUES TRANSFORM; Hayes MA, 2007, J EXP BOT, V58, P1985, DOI 10.1093/jxb/erm061; Hedfalk K, 2006, CURR OPIN STRUC BIOL, V16, P447, DOI 10.1016/j.sbi.2006.06.009; Henriques M, 1997, MICROBIOL-UK, V143, P1877, DOI 10.1099/00221287-143-6-1877; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Hove RM, 2011, PLANT MOL BIOL, V75, P413, DOI 10.1007/s11103-011-9737-5; Jackson PAP, 2001, PLANT PHYSIOL, V127, P1065, DOI 10.1104/pp.010192; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Johansson I, 1998, PLANT CELL, V10, P451, DOI 10.1105/tpc.10.3.451; Kaldenhoff R, 2008, PLANT CELL ENVIRON, V31, P658, DOI 10.1111/j.1365-3040.2008.01792.x; LEAO C, 1984, BIOCHIM BIOPHYS ACTA, V774, P43, DOI 10.1016/0005-2736(84)90272-4; Lee SH, 2004, J EXP BOT, V55, P1733, DOI 10.1093/jxb/erh189; Maeshima M, 2008, PFLUG ARCH EUR J PHY, V456, P709, DOI 10.1007/s00424-007-0363-7; MAUREL C, 1995, EMBO J, V14, P3028, DOI 10.1002/j.1460-2075.1995.tb07305.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; PAMPULHA ME, 1989, APPL MICROBIOL BIOT, V31, P547, DOI 10.1007/BF00270792; PRESTON GM, 1994, J BIOL CHEM, V269, P1668; Pronk JT, 2002, APPL ENVIRON MICROB, V68, P2095, DOI 10.1128/AEM.68.5.2095-2100.2002; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Santoni V, 2006, BIOCHEM J, V400, P189, DOI 10.1042/BJ20060569; Shelden MC, 2009, FUNCT PLANT BIOL, V36, P1065, DOI 10.1071/FP09117; Soto G, 2010, PLANT J, V64, P1038, DOI 10.1111/j.1365-313X.2010.04395.x; Soveral G, 1997, BIOL CELL, V89, P275, DOI 10.1016/S0248-4900(97)83379-5; Soveral G, 2007, APPL ENVIRON MICROB, V73, P2341, DOI 10.1128/AEM.02519-06; Soveral G, 2008, BBA-BIOMEMBRANES, V1778, P2573, DOI 10.1016/j.bbamem.2008.07.018; Soveral G, 2011, BIOL CELL, V103, P35, DOI 10.1042/BC20100102; Suga S, 2004, PLANT CELL PHYSIOL, V45, P823, DOI 10.1093/pcp/pch120; Sutka M, 2005, BIOL CELL, V97, P837, DOI 10.1042/BC20040121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tornroth-Horsefield S, 2006, NATURE, V439, P688, DOI 10.1038/nature04316; Tournaire-Roux C, 2003, NATURE, V425, P393, DOI 10.1038/nature01853; Troggio M, 2008, AM J ENOL VITICULT, V59, P117; Tyerman SD, 2002, PLANT CELL ENVIRON, V25, P173, DOI 10.1046/j.0016-8025.2001.00791.x; Vandeleur RK, 2009, PLANT PHYSIOL, V149, P445, DOI 10.1104/pp.108.128645; VANHEESWIJK MPE, 1986, J MEMBRANE BIOL, V92, P183, DOI 10.1007/BF01870707; Vera-Estrella R, 2004, PLANT PHYSIOL, V135, P2318, DOI 10.1104/pp.104.044891; Wan XC, 2004, J EXP BOT, V55, P411, DOI 10.1093/jxb/erh051; Ye Q, 2004, J EXP BOT, V55, P449, DOI 10.1093/jxb/erh040; Zelazny E, 2007, P NATL ACAD SCI USA, V104, P12359, DOI 10.1073/pnas.0701180104; Zelenina M, 2003, J BIOL CHEM, V278, P30037, DOI 10.1074/jbc.M302206200; Zhang WH, 1999, PLANT PHYSIOL, V120, P849, DOI 10.1104/pp.120.3.849	59	51	53	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33219	10.1371/journal.pone.0033219	http://dx.doi.org/10.1371/journal.pone.0033219			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427995	Green Published, Green Submitted, gold			2022-12-25	WOS:000302381500113
J	Wang, DM; Zhou, Y; Ji, LM; He, T; Lin, F; Lin, R; Lin, TC; Mo, YN				Wang, Danmei; Zhou, Yue; Ji, Limin; He, Tong; Lin, Feng; Lin, Rong; Lin, Tangchang; Mo, Yanna			Association of LMP/TAP Gene Polymorphisms with Tuberculosis Susceptibility in Li Population in China	PLOS ONE			English	Article							ANTIGEN PRESENTATION; PEPTIDASE ACTIVITIES; INFECTION; TAP1; DISEASE; ACCESS; IL-10	Background: Tuberculosis (TB) is a contagious disease affected by multiple genetic and environmental factors. Several association studies have suggested that cellular immune response is vital for controlling and preventing of tuberculosis infection. Low molecular weight polypeptides (LMPs) and transporters with antigen processing (TAPs) are the main molecules in the processing and presentation pathway for intracellular antigens. This study was performed to elucidate whether these antigen-processing genes (LMP/TAP) polymorphisms could be associated with the risk of tuberculosis infection in China. Methodology/Principal Findings: We recruited 205 active pulmonary tuberculosis patients and 217 normal controls from Li population for this study. Four polymorphisms of LMP/TAP genes were determined by PCR-RFLP assay and haplotypes were constructed by software PHASE 1.0. Of the total four polymorphisms, genotype frequencies of LMP7 AA homozygote and CA heterozygote were significantly greater among cases compared to controls, with odds ratio of 3.77 (95% CI: 1.60-8.89; P = 0.002) and 2.97 (95% CI: 1.80-4.90; P < 0.0001), respectively. The genotypes of TAP1-2 GG homozygote and AG heterozygote were more frequent in subjects with TB than in controls, with odds ratio of 3.94 (95% CI: 1.82-8.53; P = 0.001) and 2.87 (95% CI: 1.75-4.71; P < 0.0001), respectively. Similarly, we found that haplotype B which carried LMP7 and TAP1-2 variations significantly increased the susceptibility to TB (OR = 3.674, 95% CI: 2.254-5.988; P < 0.0001). Moreover, it is noteworthy that the homozygote of wild haplotype A (A/A) may be a strong protection for TB infection. Conclusions: Our findings suggested that LMP/TAP gene polymorphisms might be risk factors for TB infection among Li population in China.	[Wang, Danmei; Ji, Limin; He, Tong; Mo, Yanna] Hainan Med Coll, Lab Human Funct, Haikou, Hainan Province, Peoples R China; [Zhou, Yue] Natl Res Inst Family Planning, Dept Reprod Immun, Beijing, Peoples R China; [Lin, Feng; Lin, Tangchang] Hainan Ctr Dis Control & Prevent, TB Dept, Haikou, Hainan Province, Peoples R China; [Lin, Rong] Hainan Peoples Hosp Sanya, Resp Dept, Sanya, Hainan Province, Peoples R China	Hainan Medical University; National Research Institute for Family Planning - China	Wang, DM (corresponding author), Hainan Med Coll, Lab Human Funct, Haikou, Hainan Province, Peoples R China.	yannamo@163.com			Natural Science Foundation of Hainan Province [30714]	Natural Science Foundation of Hainan Province	This work was supported by the Natural Science Foundation of Hainan Province (30714). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts P, 2001, CURR BIOL, V11, P242, DOI 10.1016/S0960-9822(01)00073-2; Austin CM, 2008, J INFECT DIS, V197, P1713, DOI 10.1086/588384; Beck S, 1999, NATURE, V401, P921, DOI 10.1038/44853; Behar SM, 1999, J EXP MED, V189, P1973, DOI 10.1084/jem.189.12.1973; Cao BW, 2005, CARCINOGENESIS, V26, P1280, DOI 10.1093/carcin/bgi071; Chang ST, 2008, INFECT IMMUN, V76, P3221, DOI 10.1128/IAI.01677-07; COMSTOCK GW, 1978, AM REV RESPIR DIS, V117, P621; DRISCOLL J, 1993, NATURE, V365, P262, DOI 10.1038/365262a0; Feng WX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014652; GACZYNSKA M, 1994, P NATL ACAD SCI USA, V91, P9213, DOI 10.1073/pnas.91.20.9213; Gomez LM, 2006, TISSUE ANTIGENS, V67, P290, DOI 10.1111/j.1399-0039.2006.00566.x; King KY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016317; Lapinski PE, 2001, J BIOL CHEM, V276, P7526, DOI 10.1074/jbc.M009448200; Lautscham G, 2003, MICROBES INFECT, V5, P291, DOI 10.1016/S1286-4579(03)00031-5; Lewinsohn DM, 2006, J IMMUNOL, V177, P437, DOI 10.4049/jimmunol.177.1.437; Li XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015831; Lin F, 2003, CHINESE J ANTITUBERC, V25, P302; Ma X, 2003, J INFECT DIS, V188, P349, DOI 10.1086/376559; Ma X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001318; McTernan CL, 2000, DIABETIC MED, V17, P661, DOI 10.1046/j.1464-5491.2000.00358.x; MONACO JJ, 1995, J LEUKOCYTE BIOL, V57, P543, DOI 10.1002/jlb.57.4.543; Neyrolles O, 2001, J IMMUNOL, V166, P447, DOI 10.4049/jimmunol.166.1.447; Prahalad S, 2001, J RHEUMATOL, V28, P2320; Rajalingam R, 1997, TISSUE ANTIGENS, V49, P168, DOI 10.1111/j.1399-0039.1997.tb02731.x; Schaible UE, 2003, NAT MED, V9, P1039, DOI 10.1038/nm906; Schurr E, 2007, J INTERN MED, V261, P106, DOI 10.1111/j.1365-2796.2006.01741.x; Stein CM, 2007, HUM GENET, V121, P663, DOI 10.1007/s00439-007-0357-8; Stein CM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001189; Stein CM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004094; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Thye T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005420; World Heart Organization, GLOB TB CONTR REP 20; Xu CQ, 2007, J CLIN IMMUNOL, V27, P534, DOI 10.1007/s10875-007-9095-x; York IA, 1996, ANNU REV IMMUNOL, V14, P369, DOI 10.1146/annurev.immunol.14.1.369	35	21	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33051	10.1371/journal.pone.0033051	http://dx.doi.org/10.1371/journal.pone.0033051			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427944	Green Submitted, Green Published, gold			2022-12-25	WOS:000302381500085
J	Barlow, J; Silveira, JM; Mestre, LAM; Andrade, RB; D'Andrea, GC; Louzada, J; Vaz-de-Mello, FZ; Numata, I; Lacau, S; Cochrane, MA				Barlow, Jos; Silveira, Juliana M.; Mestre, Luiz A. M.; Andrade, Rafael B.; D'Andrea, Gabriela Camacho; Louzada, Julio; Vaz-de-Mello, Fernando Z.; Numata, Izaya; Lacau, Sebastien; Cochrane, Mark A.			Wildfires in Bamboo-Dominated Amazonian Forest: Impacts on Above-Ground Biomass and Biodiversity	PLOS ONE			English	Article							TREE MORTALITY; TROPICAL FOREST; CLIMATE-CHANGE; RAIN-FOREST; RECURRENT WILDFIRES; PREDICT TREE; FIRE; RESPONSES; SINGLE; GROWTH	Fire has become an increasingly important disturbance event in south-western Amazonia. We conducted the first assessment of the ecological impacts of these wildfires in 2008, sampling forest structure and biodiversity along twelve 500 m transects in the Chico Mendes Extractive Reserve, Acre, Brazil. Six transects were placed in unburned forests and six were in forests that burned during a series of forest fires that occurred from August to October 2005. Normalized Burn Ratio (NBR) calculations, based on Landsat reflectance data, indicate that all transects were similar prior to the fires. We sampled understorey and canopy vegetation, birds using both mist nets and point counts, coprophagous dung beetles and the leaf-litter ant fauna. Fire had limited influence upon either faunal or floral species richness or community structure responses, and stems <10 cm DBH were the only group to show highly significant (p = 0.001) community turnover in burned forests. Mean aboveground live biomass was statistically indistinguishable in the unburned and burned plots, although there was a significant increase in the total abundance of dead stems in burned plots. Comparisons with previous studies suggest that wildfires had much less effect upon forest structure and biodiversity in these south-western Amazonian forests than in central and eastern Amazonia, where most fire research has been undertaken to date. We discuss potential reasons for the apparent greater resilience of our study plots to wildfire, examining the role of fire intensity, bamboo dominance, background rates of disturbance, landscape and soil conditions.	[Barlow, Jos] Univ Lancaster, Lancaster Environm Ctr, Lancaster, Lancs, England; [Silveira, Juliana M.; Louzada, Julio] Univ Fed Lavras UFLA, Dept Biol, Lavras, MG, Brazil; [Mestre, Luiz A. M.; Andrade, Rafael B.; D'Andrea, Gabriela Camacho; Numata, Izaya; Cochrane, Mark A.] S Dakota State Univ, Geog Informat Sci Ctr Excellence, Brookings, SD 57007 USA; [Mestre, Luiz A. M.] Univ Fed Parana, Dept Biol, Palotina, Parana, Brazil; [Vaz-de-Mello, Fernando Z.] Univ Fed Mato Grosso, Dept Biol & Zool, Cuiaba, Mato Grosso, Brazil; [Lacau, Sebastien] Univ Estadual Sudoeste Bahia, Dept Estudos Basicos & Instrumentais, Itapetinga, BA, Brazil	Lancaster University; Universidade Federal de Lavras; South Dakota State University; Universidade Federal do Parana; Universidade Federal de Mato Grosso; Universidade Estadual do Sudoeste da Bahia	Barlow, J (corresponding author), Univ Lancaster, Lancaster Environm Ctr, Lancaster, Lancs, England.	josbarlow@gmail.com	Barlow, Jos/E-7861-2014; Barlow, Jos/HGE-9486-2022; Vaz-de-Mello, Fernando Z/A-1023-2009; Louzada, Julio/F-1265-2010; Cochrane, Mark A/A-1735-2018	Vaz-de-Mello, Fernando Z/0000-0001-9697-320X; Louzada, Julio/0000-0002-1481-3112; Cochrane, Mark A/0000-0002-4573-568X; Mestre, Luiz Augusto Macedo/0000-0002-8699-4397	Earth Science Division of the NASA Science Mission Directorate [NNX07AF16G]; UK National Environment Research Council [NE/G000816/1]; Instituto Nacional de Ciencia e Tecnologia - Biodiversidade e Uso da Terra na Amazonia [CNPq 574008/2008-0]; NERC [NE/G000816/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/E500811/1] Funding Source: researchfish; Natural Environment Research Council [ceh010010, NE/G000816/1] Funding Source: researchfish	Earth Science Division of the NASA Science Mission Directorate; UK National Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Instituto Nacional de Ciencia e Tecnologia - Biodiversidade e Uso da Terra na Amazonia; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by the Biological Diversity Program of the Earth Science Division of the NASA Science Mission Directorate (NNX07AF16G), the UK National Environment Research Council grant (NE/G000816/1) and the Instituto Nacional de Ciencia e Tecnologia - Biodiversidade e Uso da Terra na Amazonia (CNPq 574008/2008-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeney JM, 2006, ANIM CONSERV, V9, P292, DOI 10.1111/j.1469-1795.2006.00035.x; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Aragao LEOC, 2010, SCIENCE, V328, P1275, DOI 10.1126/science.1186925; Aragao LEOC, 2007, GEOPHYS RES LETT, V34, DOI [10.1029/2006GL028946., 10.1029/2006GL028946]; Araujo LS, 2008, PATTERNS CONDITIONIN, P126; Balch JK, 2011, FOREST ECOL MANAG, V261, P68, DOI 10.1016/j.foreco.2010.09.029; Barlow J, 2004, ECOL APPL, V14, P1358, DOI 10.1890/03-5077; Barlow J, 2004, PHILOS T R SOC B, V359, P367, DOI 10.1098/rstb.2003.1423; Barlow J, 2006, BIODIVERS CONSERV, V15, P985, DOI 10.1007/s10531-004-3952-1; Barlow J, 2003, J TROP ECOL, V19, P291, DOI 10.1017/S0266467403003328; Barlow J, 2003, ECOL LETT, V6, P6, DOI 10.1046/j.1461-0248.2003.00394.x; Barlow J, 2008, PHILOS T R SOC B, V363, P1787, DOI 10.1098/rstb.2007.0013; Barlow Jos, 2006, P225; Barlow J, 2007, BIOL CONSERV, V136, P212, DOI 10.1016/j.biocon.2006.11.021; Bush MB, 2008, PHILOS T R SOC B, V363, P1795, DOI 10.1098/rstb.2007.0014; Certini G, 2005, OECOLOGIA, V143, P1, DOI 10.1007/s00442-004-1788-8; Chao KJ, 2008, J ECOL, V96, P281, DOI 10.1111/j.1365-2745.2007.01343.x; Chase JM, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00117.1; Clark DB, 1996, FOREST ECOL MANAG, V80, P235, DOI 10.1016/0378-1127(95)03607-5; Cochrane MA, 1999, BIOTROPICA, V31, P2, DOI 10.1111/j.1744-7429.1999.tb00112.x; Cochrane MA, 1999, SCIENCE, V284, P1832, DOI 10.1126/science.284.5421.1832; Colwell RK, 2013, ESTIMATES STAT ESTIM; de Andrade RB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026208; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Fredericksen NJ, 2002, BIODIVERS CONSERV, V11, P27, DOI 10.1023/A:1014065510554; Gardner TA, 2009, ECOL LETT, V12, P561, DOI 10.1111/j.1461-0248.2009.01294.x; Gerwing JJ, 2002, FOREST ECOL MANAG, V157, P131, DOI 10.1016/S0378-1127(00)00644-7; Griscom BW, 2006, J TROP ECOL, V22, P587, DOI 10.1017/S0266467406003361; Halffter Gonzalo, 1993, Biology International, V27, P15; Haugaasen T, 2003, FOREST ECOL MANAG, V179, P321, DOI 10.1016/S0378-1127(02)00548-0; Holdsworth AR, 1997, ECOL APPL, V7, P713, DOI 10.1890/1051-0761(1997)007[0713:FIASLR]2.0.CO;2; Hoorn C, 2010, SCIENCE, V330, P927, DOI 10.1126/science.1194585; Keeley JE, 1999, AM NAT, V154, P383, DOI 10.1086/303243; Kratter AW, 1997, BIOTROPICA, V29, P100, DOI 10.1111/j.1744-7429.1997.tb00011.x; Laurance WF, 1998, ECOLOGY, V79, P2032, DOI 10.1890/0012-9658(1998)079[2032:RFFATD]2.0.CO;2; Lewis SL, 2011, SCIENCE, V331, P554, DOI 10.1126/science.1200807; Louzada J, 2010, LANDSCAPE ECOL, V25, P631, DOI 10.1007/s10980-010-9448-3; Magurran A. E., 2004, MEASURING BIOL DIVER, P260; Malhi Y, 2004, GLOBAL CHANGE BIOL, V10, P563, DOI 10.1111/j.1529-8817.2003.00778.x; Malhi Y, 2006, GLOBAL CHANGE BIOL, V12, P1107, DOI 10.1111/j.1365-2486.2006.01120.x; Malhi Y, 2009, P NATL ACAD SCI USA, V106, P20610, DOI 10.1073/pnas.0804619106; Marengo JA, 2008, J CLIMATE, V21, P495, DOI 10.1175/2007JCLI1600.1; Mayle FE, 2008, PHILOS T R SOC B, V363, P1829, DOI 10.1098/rstb.2007.0019; McCune B., 1999, MULTIVARIATE ANAL EC; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Numata I, 2011, EARTH INTERACT, V15, DOI 10.1175/2010EI372.1; Odion DC, 2000, ECOL MONOGR, V70, P149, DOI 10.1890/0012-9615(2000)070[0149:FSHATF]2.0.CO;2; Phillips OL, 2004, PHILOS T R SOC B, V359, P381, DOI 10.1098/rstb.2003.1438; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Phillips OL, 2006, CONSERV BIOL, V20, P1698, DOI 10.1111/j.1523-1739.2006.00523.x; Pinard MA, 1999, FOREST ECOL MANAG, V116, P247, DOI 10.1016/S0378-1127(98)00447-2; R Core Team, 2022, R LANG ENV STAT COMP; Santana CR, 2010, BIOTA NEOTROP, P10; Shimabukuro YE, 2006, INT GEOSCI REMOTE SE, P4161, DOI 10.1109/IGARSS.2006.1067; Siegert F, 2001, NATURE, V414, P437, DOI 10.1038/35106547; Silveira JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012877; Slik JWF, 2006, BIODIVERS CONSERV, V15, P4425, DOI 10.1007/s10531-005-4385-1; Smith M, 2011, J TROP ECOL, V27, P59, DOI 10.1017/S026646741000057X; Sombroek W, 2001, AMBIO, V30, P388, DOI 10.1639/0044-7447(2001)030[0388:SATPOA]2.0.CO;2; Turner MG, 1997, ECOL MONOGR, V67, P411, DOI 10.1890/0012-9615(1997)067[0411:EOFSAP]2.0.CO;2; UHL C, 1985, BIOTROPICA, V17, P265, DOI 10.2307/2388588	61	43	42	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2012	7	3							e33373	10.1371/journal.pone.0033373	http://dx.doi.org/10.1371/journal.pone.0033373			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KX	22428035	Green Published, Green Submitted, gold			2022-12-25	WOS:000303062800053
J	Jin, WJ; Chen, CF; Liao, HY; Gong, LL; Yuan, XH; Zhao, BB; Zhang, D; Feng, X; Liu, JJ; Wang, Y; Chen, GF; Yan, HP; He, YW				Jin, Wen-Jing; Chen, Cai-Feng; Liao, Hui-Yu; Gong, Lu-Lu; Yuan, Xiao-Hui; Zhao, Bin-Bin; Zhang, Ding; Feng, Xia; Liu, Jing-Jun; Wang, Yu; Chen, Guo-Feng; Yan, Hui-Ping; He, You-Wen			Downregulation of the AU-Rich RNA-Binding Protein ZFP36 in Chronic HBV Patients: Implications for Anti-Inflammatory Therapy	PLOS ONE			English	Article							CHRONIC HEPATITIS-B; NECROSIS-FACTOR-ALPHA; MESSENGER-RNA; TNF-ALPHA; VIRUS INFECTION; TRISTETRAPROLIN EXPRESSION; 3'-UNTRANSLATED REGION; EPITHELIAL-CELLS; VIRAL-HEPATITIS; GENE-EXPRESSION	Inflammation caused by chronic hepatitis B virus (HBV) infection is associated with the development of cirrhosis and hepatocellular carcinoma; however, the mechanisms by which HBV infection induces inflammation and inflammatory cytokine production remain largely unknown. We analyzed the gene expression patterns of lymphocytes from chronic HBV-infected patients and found that the expression of ZFP36, an AU-rich element (ARE)-binding protein, was dramatically reduced in CD4(+) and CD8(+) T lymphocytes from chronic HBV patients. ZFP36 expression was also reduced in CD14(+) monocytes and in total PBMCs from chronic HBV patients. To investigate the functional consequences of reduced ZFP36 expression, we knocked down ZFP36 in PBMCs from healthy donors using siRNA. siRNA-mediated silencing of ZFP36 resulted in dramatically increased expression of multiple inflammatory cytokines, most of which were also increased in the plasma of chronic HBV patients. Furthermore, we found that IL-8 and RANTES induced ZFP36 downregulation, and this effect was mediated through protein kinase C. Importantly, we found that HBsAg stimulated PBMCs to express IL-8 and RANTES, resulting in decreased ZFP36 expression. Our results suggest that an inflammatory feedback loop involving HBsAg, ZFP36, and inflammatory cytokines may play a critical role in the pathogenesis of chronic HBV and further indicate that ZFP36 may be an important target for anti-inflammatory therapy during chronic HBV infection.	[Jin, Wen-Jing; Chen, Cai-Feng; Gong, Lu-Lu; Yuan, Xiao-Hui; Zhao, Bin-Bin; Zhang, Ding; Liu, Jing-Jun; He, You-Wen] Chinese Acad Med Sci, Inst Pathogen Biol, Minist Hlth, Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China; [Jin, Wen-Jing; Chen, Cai-Feng; Gong, Lu-Lu; Yuan, Xiao-Hui; Zhao, Bin-Bin; Zhang, Ding; Liu, Jing-Jun; He, You-Wen] Peking Union Med Coll, Beijing 100021, Peoples R China; [Liao, Hui-Yu; Feng, Xia; Yan, Hui-Ping] Beijing Capital Med Univ, YouAn Hosp, Ctr Infect & Immun, Beijing, Peoples R China; [Chen, Guo-Feng] 302 Hosp, Fibrosis Noninvas Diag & Treatment Ctr, Beijing, Peoples R China; [Wang, Yu; He, You-Wen] Duke Univ, Med Ctr, Dept Immunol, Durham, NC USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Capital Medical University; Fifth Medical Center of Chinese PLA General Hospital; Duke University	Jin, WJ (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, Minist Hlth, Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China.	youwen.he@duke.edu		Wang, Yu/0000-0001-7935-9902	National Grand Program on Key Infectious Diseases [2008ZX10002-008]; Institute of Pathology Biology, Chinese Academy of Medical Sciences [2008IPB115, 2010IPB104]	National Grand Program on Key Infectious Diseases; Institute of Pathology Biology, Chinese Academy of Medical Sciences	This study is funded by the National Grand Program on Key Infectious Diseases (No. 2008ZX10002-008) and by the Institute of Pathology Biology (No. 2008IPB115 and 2010IPB104), The Chinese Academy of Medical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atasoy U, 2003, J IMMUNOL, V171, P4369, DOI 10.4049/jimmunol.171.8.4369; Bakheet T, 2006, NUCLEIC ACIDS RES, V34, pD111, DOI 10.1093/nar/gkj052; Balakathiresan NS, 2009, AM J PHYSIOL-LUNG C, V296, pL1012, DOI 10.1152/ajplung.90601.2008; Baou M, 2011, BLOOD, V118, P5732, DOI 10.1182/blood-2011-07-347237; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; Budhu A, 2006, J LEUKOCYTE BIOL, V80, P1197, DOI 10.1189/jlb.0506297; Cao HP, 2004, J BIOL CHEM, V279, P21489, DOI 10.1074/jbc.M400900200; CAPUT D, 1986, P NATL ACAD SCI USA, V83, P1670, DOI 10.1073/pnas.83.6.1670; Carballo E, 1997, J CLIN INVEST, V100, P986, DOI 10.1172/JCI119649; Carballo E, 2000, BLOOD, V95, P1891, DOI 10.1182/blood.V95.6.1891; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Casolaro V, 2008, J ALLERGY CLIN IMMUN, V121, P853, DOI 10.1016/j.jaci.2007.12.1166; Cougot D, 2007, J BIOL CHEM, V282, P4277, DOI 10.1074/jbc.M606774200; Datta S, 2008, J IMMUNOL, V180, P2545, DOI 10.4049/jimmunol.180.4.2545; Dunn C, 2007, J EXP MED, V204, P667, DOI 10.1084/jem.20061287; Essafi-Benkhadir K, 2007, MOL BIOL CELL, V18, P4648, DOI 10.1091/mbc.E07-06-0570; Falasca K, 2006, ANN CLIN LAB SCI, V36, P144; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Guidotti LG, 2006, ANNU REV PATHOL-MECH, V1, P23, DOI 10.1146/annurev.pathol.1.110304.100230; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; Hayashi F, 2003, BLOOD, V102, P2660, DOI 10.1182/blood-2003-04-1078; Jalonen U, 2006, MEDIAT INFLAMM, V2006, DOI 10.1155/MI/2006/40691; Kaplan IM, 2011, J IMMUNOL, V186, P2826, DOI 10.4049/jimmunol.1002806; Khabar KSA, 2010, CELL MOL LIFE SCI, V67, P2937, DOI 10.1007/s00018-010-0383-x; King EM, 2009, J PHARMACOL EXP THER, V330, P575, DOI 10.1124/jpet.109.151423; Kohidai L, 1998, CYTOKINE, V10, P481, DOI 10.1006/cyto.1997.0328; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Larrubia JR, 2009, REV ESP ENFERM DIG, V101, P343, DOI 10.4321/s1130-01082009000500006; Liang J, 2009, J BIOL CHEM, V284, P29383, DOI 10.1074/jbc.M109.024745; MAHE Y, 1991, J BIOL CHEM, V266, P13759; Malik AH, 2000, ANN INTERN MED, V132, P723, DOI 10.7326/0003-4819-132-9-200005020-00007; Ming XF, 2001, MOL CELL BIOL, V21, P5778, DOI 10.1128/MCB.21.17.5778-5789.2001; Ogilvie RL, 2009, J BIOL CHEM, V284, P11216, DOI 10.1074/jbc.M901229200; Ogilvie RL, 2005, J IMMUNOL, V174, P953, DOI 10.4049/jimmunol.174.2.953; Peppa D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001227; Sauer I, 2006, BLOOD, V107, P4790, DOI 10.1182/blood-2005-07-3058; Sawaoka H, 2003, J BIOL CHEM, V278, P13928, DOI 10.1074/jbc.M300016200; Schlaak JF, 1999, CLIN EXP IMMUNOL, V115, P508; Stoecklin G, 2000, MOL CELL BIOL, V20, P3753, DOI 10.1128/MCB.20.11.3753-3763.2000; Stoecklin G, 2008, J BIOL CHEM, V283, P11689, DOI 10.1074/jbc.M709657200; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Tudor C, 2009, FEBS LETT, V583, P1933, DOI 10.1016/j.febslet.2009.04.039; Van Tubergen E, 2011, CANCER-AM CANCER SOC, V117, P2677, DOI 10.1002/cncr.25859; Wang JY, 1999, WORLD J GASTROENTERO, V5, P38; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Winzen R, 2007, MOL CELL BIOL, V27, P8388, DOI 10.1128/MCB.01493-07; Yarovinsky TO, 2006, J IMMUNOL, V177, P4426, DOI 10.4049/jimmunol.177.7.4426; Yu Y, 2011, J IMMUNOL, V187, P4844, DOI 10.4049/jimmunol.1100998; Zhao WP, 2011, J INTERF CYTOK RES, V31, P629, DOI 10.1089/jir.2010.0154; Zou ZS, 2009, J CLIN GASTROENTEROL, V43, P182, DOI 10.1097/MCG.0b013e3181624464	51	5	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2012	7	3							e33356	10.1371/journal.pone.0033356	http://dx.doi.org/10.1371/journal.pone.0033356			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KX	22428029	Green Submitted, Green Published, gold			2022-12-25	WOS:000303062800052
J	Stresing, V; Baltziskueta, E; Rubio, N; Blanco, J; Arriba, MC; Valls, J; Janier, M; Clezardin, P; Sanz-Pamplona, R; Nieva, C; Marro, M; Dmitri, P; Sierra, A				Stresing, V.; Baltziskueta, E.; Rubio, N.; Blanco, J.; Arriba, Ma C.; Valls, J.; Janier, M.; Clezardin, P.; Sanz-Pamplona, R.; Nieva, C.; Marro, M.; Dmitri, P.; Sierra, A.			Peroxiredoxin 2 specifically regulates the oxidative and metabolic stress response of human metastatic breast cancer cells in lungs	ONCOGENE			English	Article						angiogenesis; lung metastasis; metabolic stress; oxidative stress; peroxiredoxins	TRANSFORMED-CELLS; HYDROGEN-PEROXIDE; BONE METASTASES; LOW-LEVEL; KAPPA-B; PROTEIN; GENES; LINES; ACID; CARCINOMA	Little is known about metastatic pathways that are specific to the lung rather than other organs. We previously showed that antioxidant proteins such as peroxiredoxins were specifically upregulated in lung metastatic breast cancer cells. We hypothesize that cancer cells that live under aerobic conditions, as might be the case in lungs, protect themselves against the damage caused by reactive oxygen species (ROS). To examine this hypothesis, we studied the role of peroxiredoxin-2 (PRDX2) in lung vs bone metastasis formation. A metastatic variant of MDA-MB-435 breast cancer cells that specifically metastasize to lungs (435-L3) was transduced with short hairpin RNAs to specifically silence PRDX2. Conversely, a bone metastatic variant of MDA-MB-231 cells (BO2) was stably transfected to overexpress PRDX2. The 435-L3 cells silenced for PRDX2 were significantly more sensitive to H2O2-induced oxidative stress than the parental and scrambled transfected cells. BO2/PRDX2 cells produced less ROS than BO2/green fluorescent protein control cells under oxidative stress. Moreover, PRDX2 knockdown inhibited the growth of 435-L3 cells in the lungs, whereas lymph node metastasis remained unaffected. In contrast, PRDX2 overexpression in bone metastatic BO2 breast cancer cells led to drastic inhibition of the skeletal tumor burden and reduction of bone destruction. Furthermore, PRDX2 expression in breast cancer cells was associated with a glucose-dependent phenotype, different from bone metastatic cells. Overall, our results strongly suggest that PRDX2 is a targetable 'metabolic adaptor' driver protein implicated in the selective growth of metastatic cells in the lungs by protecting them against oxidative stress. Oncogene (2013) 32, 724-735; doi:10.1038/onc.2012.93; published online 19 March 2012	[Stresing, V.; Baltziskueta, E.; Arriba, Ma C.; Nieva, C.; Sierra, A.] Bellvitge Biomed Res Inst IDIBELL, Biol Clues Invas & Metastat Phenotype Grp, E-08908 Barcelona, Spain; [Stresing, V.; Clezardin, P.] Laennec Sch Med, INSERM, UMR 664, IFR62, Lyon, France; [Rubio, N.; Blanco, J.] Hosp Santa Creu & Sant Pau, CIBER Bioingn Biomat & Nanomed CIBER BBN, Cardiovasc Res Ctr CSIC ICCC, Barcelona, Spain; [Valls, J.] Inst Recerca Biomed Lleida IRBLLEIDA, Lleida, Spain; [Valls, J.] IDIBELL Inst Catala Oncol, Serv Epidemiol, Barcelona, Spain; [Janier, M.] Hop Edouard Herriot, Lyon, France; [Sanz-Pamplona, R.] IDIBELL Inst Catala Oncol, Unit Biomarkers & Susceptibil, Barcelona, Spain; [Sanz-Pamplona, R.] IDIBELL Inst Catala Oncol, CIBERESP, Barcelona, Spain; [Marro, M.; Dmitri, P.] ICFO Inst Ciencies Foton, Castelldefels, E Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Institut National de la Sante et de la Recherche Medicale (Inserm); CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institut Catala de Ciencies Cardiovasculars (ICCC); Hospital of Santa Creu i Sant Pau; Institut de Recerca Biomedica - IRB Lleida; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); CHU Lyon; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Catalan Institute of Oncology; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Barcelona Institute of Science & Technology; Universitat Politecnica de Catalunya; Institut de Ciencies Fotoniques (ICFO)	Sierra, A (corresponding author), Bellvitge Biomed Res Inst IDIBELL, Biol Clues Invas & Metastat Phenotype Grp, Avda Gran Via Hosp Llobregat,199, E-08908 Barcelona, Spain.	asierra@idibell.cat	Marro, Monica/AAV-1362-2021; del Carmen Arriba Pérez, María/I-2112-2015; Rubio, Nuria/H-3156-2015; Valls, Joan/GXM-6532-2022; Clezardin, Philippe/M-8071-2014; Blanco, Jeronimo/H-2764-2015; Marro, Monica/E-4159-2016	Marro, Monica/0000-0003-4031-4605; del Carmen Arriba Pérez, María/0000-0001-8033-7444; Rubio, Nuria/0000-0003-2471-4684; Clezardin, Philippe/0000-0003-0149-4463; Blanco, Jeronimo/0000-0003-3765-0640; Marro, Monica/0000-0003-4031-4605; Valls, Joan/0000-0002-4806-7568; Papkovsky, Dmitri/0000-0003-1556-1145; Janier, Marc/0000-0001-5937-9180; Sierra, Angels/0000-0003-1023-3492; Sanz-Pamplona, Rebeca/0000-0002-2187-3527	Spanish Ministry of Health and Consumer Affairs [FIS/PI071245, FIS/PI10/00057]; EC MetaBre [LSHC-CT-2004-506049]; INCA (ONCOIMAGE) [07/3D1316/PF-108-01/NG-LC]; Ministry of Education and Science [SAF2004-0188-E]; AECC Scientific Foundation; Private Foundation Cellex Barcelona	Spanish Ministry of Health and Consumer Affairs(Spanish Government); EC MetaBre; INCA (ONCOIMAGE); Ministry of Education and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); AECC Scientific Foundation; Private Foundation Cellex Barcelona	We would like to thank Oriol Casanovas (Angiogenesis Laboratory, IDIBELL) for scientific discussions and his expert advice on angiogenesis. We would also like to thank Berta Martin, Vanessa Hernandez and Mac Dominguez for his expert technical assistance. We are grateful to Mr R Rycroft for expert language advice and Victor Moreno for expert statistical advice (Barcelona University). We thanks Jose Carlos Perales and Andy Mendez for the advice and support the metabolic analysis (Barcelona University). We acknowledge all the partners of the MetaBre consortium for their collaboration and stimulating criticism. This study was supported by grants from the Spanish Ministry of Health and Consumer Affairs (FIS/PI071245 and FIS/PI10/00057), EC MetaBre (contract no. LSHC-CT-2004-506049), INCA (ONCOIMAGE, no 07/3D1316/PF-108-01/NG-LC), the Ministry of Education and Science (SAF2004-0188-E), AECC Scientific Foundation and Private Foundation Cellex Barcelona.	[Anonymous], 2009, LANG ENV STAT COMP; Archer SL, 2008, AM J PHYSIOL-HEART C, V294, pH570, DOI 10.1152/ajpheart.01324.2007; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Boucharaba A, 2004, J CLIN INVEST, V114, P1714, DOI 10.1172/JCI200422123; Bubici C, 2006, ONCOGENE, V25, P6731, DOI 10.1038/sj.onc.1209936; Budihardjo II, 1998, CLIN CANCER RES, V4, P117; Buzzai M, 2005, ONCOGENE, V24, P4165, DOI 10.1038/sj.onc.1208622; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Chambers AF, 2009, CANCER RES, V69, P5292, DOI 10.1158/0008-5472.CAN-09-1528; Chevallet M, 2003, J BIOL CHEM, V278, P37146, DOI 10.1074/jbc.M305161200; Dong F, 2009, CLIN CANCER RES, V15, P2588, DOI 10.1158/1078-0432.CCR-08-2356; El Hilali N, 2005, CLIN CANCER RES, V11, P1253; Espana L, 2005, AM J PATHOL, V167, P1125, DOI 10.1016/S0002-9440(10)61201-1; Fidler IJ, 2002, DIFFERENTIATION, V70, P498, DOI 10.1046/j.1432-0436.2002.700904.x; Fujii J, 2002, REDOX REP, V7, P123, DOI 10.1179/135100002125000352; Ganong WF, 2005, LANGE BASIC SCI, P631; Graves JA, 2009, J BIOL CHEM, V284, P6520, DOI 10.1074/jbc.M807564200; Gupta GP, 2007, P NATL ACAD SCI USA, V104, P19506, DOI 10.1073/pnas.0709185104; Han YH, 2006, FREE RADICAL RES, V40, P1182, DOI 10.1080/10715760600868552; Haraldsen JD, 2009, ORG BIOMOL CHEM, V7, P3040, DOI 10.1039/b901735f; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Iles KE, 2002, IMMUNOL RES, V26, P95, DOI 10.1385/IR:26:1-3:095; Jang YY, 2007, BLOOD, V110, P3056, DOI 10.1182/blood-2007-05-087759; Karihtala P, 2003, CLIN CANCER RES, V9, P3418; Kim H, 2000, J BIOL CHEM, V275, P18266, DOI 10.1074/jbc.275.24.18266; Lee KW, 2011, J BIOL CHEM, V286, P8394, DOI 10.1074/jbc.M110.179416; Lehtonen ST, 2004, INT J CANCER, V111, P514, DOI 10.1002/ijc.20294; Low FM, 2007, BLOOD, V109, P2611, DOI 10.1182/blood-2006-09-048728; Martin B, 2008, J PROTEOME RES, V7, P3242, DOI 10.1021/pr800137w; Mendez O, 2005, CLIN EXP METASTAS, V22, P297, DOI 10.1007/s10585-005-8751-x; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Minn AJ, 2007, P NATL ACAD SCI USA, V104, P6740, DOI 10.1073/pnas.0701138104; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Neumann CA, 2007, CURR OPIN PHARMACOL, V7, P375, DOI 10.1016/j.coph.2007.04.007; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; Olahova M, 2008, P NATL ACAD SCI USA, V105, P19839, DOI 10.1073/pnas.0805507105; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Pecheur I, 2002, FASEB J, V16, P1266, DOI 10.1096/fj.01-0911fje; Peyruchaud O, 2003, J BIOL CHEM, V278, P45826, DOI 10.1074/jbc.M309024200; Peyruchaud O, 2001, J BONE MINER RES, V16, P2027, DOI 10.1359/jbmr.2001.16.11.2027; Pinheiro J, 2001, MIXED EFFECTS MODELS; Rabilloud T, 2002, J BIOL CHEM, V277, P19396, DOI 10.1074/jbc.M106585200; Ralser M, 2009, NAT BIOTECHNOL, V27, P604, DOI 10.1038/nbt0709-604; Roman I, 2007, BIOMATERIALS, V28, P2718, DOI 10.1016/j.biomaterials.2007.02.011; Semenza GL, 2008, J CLIN INVEST, V118, P3835, DOI 10.1172/JCI37373; Seo JH, 2009, J BIOL CHEM, V284, P13455, DOI 10.1074/jbc.M900641200; Tao MF, 2007, MOL BIOSYST, V3, P60, DOI 10.1039/b615284h; Ueda S, 2002, ANTIOXID REDOX SIGN, V4, P405, DOI 10.1089/15230860260196209; Ungerstedt JS, 2005, P NATL ACAD SCI USA, V102, P673, DOI 10.1073/pnas.0408732102; VandenHoek TL, 1997, J MOL CELL CARDIOL, V29, P2571, DOI 10.1006/jmcc.1997.0497; Wang W, 2010, J PROTEOME RES, V9, P3812, DOI 10.1021/pr901180w; Weigelt B, 2005, CANCER RES, V65, P9155, DOI 10.1158/0008-5472.CAN-05-2553; Wen ST, 1997, GENE DEV, V11, P2456, DOI 10.1101/gad.11.19.2456; ZHANG RD, 1991, INVAS METAST, V11, P204	54	69	70	1	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	FEB 7	2013	32	6					724	735		10.1038/onc.2012.93	http://dx.doi.org/10.1038/onc.2012.93			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	101AF	22430214				2022-12-25	WOS:000315746700006
J	Ho, WC; Pikor, L; Gao, Y; Elliott, BE; Greer, PA				Ho, Wai-chi; Pikor, Larissa; Gao, Yan; Elliott, Bruce E.; Greer, Peter A.			Calpain 2 Regulates Akt-FoxO-p27(Kip1) Protein Signaling Pathway in Mammary Carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-SUBUNIT GENE; UBIQUITOUS CALPAINS; EMBRYONIC-DEVELOPMENT; MEDIATED PROTEOLYSIS; TUMOR-SUPPRESSOR; CELL-MIGRATION; P27(KIP1); APOPTOSIS; CANCER; ACTIVATION	We investigated the role of the ubiquitously expressed calpain 2 isoform in breast tumor cell growth, migration, signaling, and tumorigenesis. RNAi-mediated knockdown of the capn2 transcript was used to manipulate expression of the catalytic subunit of calpain 2 in the AC2M2 mouse mammary carcinoma cell line. Stable knockdown of capn2 correlated with reduced in vitro proliferation rates, soft agar colony formation efficiency, and migration rates, indicating roles for calpain 2 in mitogenesis, survival, and motogenesis. Biochemical analysis showed increased levels of protein phosphatase 2A and reduced levels of activated Akt in calpain 2-deficient cells, and this correlated with increased levels of the FoxO3a target gene product p27(Kip1), a key regulator of cell proliferation. Calpain 2 deficiency in the AC2M2 cells correlated with enhanced nuclear localization of FoxO3a, consistent with it being in a derepressed state capable of regulating transcriptional targets. Orthotopically engrafted calpain 2 knockdown AC2M2 cells generated tumors with reduced growth rates and enhanced in vivo expression of p27(Kip1). In summary, calpain 2 deficiency correlated with reduced Akt activity, increased protein phosphatase 2A levels, derepression of FoxO3a, and enhanced expression of the p27(Kip1) tumor suppressor. These observations argue that calpain 2 promotes tumor cell growth both in vitro and in vivo through the PI3K-Akt-FoxO-p27(Kip1) signaling cascade. Inhibition of calpain 2 might therefore provide therapeutic benefits in the treatment of cancer.	[Ho, Wai-chi; Pikor, Larissa; Gao, Yan; Elliott, Bruce E.; Greer, Peter A.] Queens Univ, Dept Pathol & Mol Med, Div Canc Biol & Genet, Queens Canc Res Inst, Kingston, ON K7L 3N6, Canada	McMaster University; Queens University - Canada	Greer, PA (corresponding author), Queens Univ, Dept Pathol & Mol Med, Div Canc Biol & Genet, Queens Canc Res Inst, Kingston, ON K7L 3N6, Canada.	greerp@queensu.ca			Canadian Institutes of Health Research [81189]; Canadian Breast Cancer Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS))	This work was supported by Canadian Institutes of Health Research Grant 81189 (to P.A.G.) and a fellowship award from the Canadian Breast Cancer Foundation (to W.H.).	Andjelkovic M, 1996, P NATL ACAD SCI USA, V93, P5699, DOI 10.1073/pnas.93.12.5699; Arthur JSC, 2000, MOL CELL BIOL, V20, P4474, DOI 10.1128/MCB.20.12.4474-4481.2000; Bertoli C, 2009, ONCOGENE, V28, P721, DOI 10.1038/onc.2008.425; Besson A, 2004, GENE DEV, V18, P862, DOI 10.1101/gad.1185504; Blain SW, 2002, NAT MED, V8, P1076, DOI 10.1038/nm1002-1076; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chan KT, 2010, J BIOL CHEM, V285, P11418, DOI 10.1074/jbc.M109.090746; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Collado M, 2000, J BIOL CHEM, V275, P21960, DOI 10.1074/jbc.M000759200; Cortesio CL, 2008, J CELL BIOL, V180, P957, DOI 10.1083/jcb.200708048; Cortesio CL, 2011, J BIOL CHEM, V286, P9998, DOI 10.1074/jbc.M110.187294; Delmas C, 2003, J BIOL CHEM, V278, P12443, DOI 10.1074/jbc.M209523200; Demarchi F, 2005, CELL DEATH DIFFER, V12, P512, DOI 10.1038/sj.cdd.4401592; Dourdin N, 2001, J BIOL CHEM, V276, P48382, DOI 10.1074/jbc.M108893200; Dutt P, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-3; ELLIOTT BE, 1992, INT J CANCER, V51, P416, DOI 10.1002/ijc.2910510314; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Franco S, 2004, EXP CELL RES, V299, P179, DOI 10.1016/j.yexcr.2004.05.021; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Guan N, 2006, INT J ONCOL, V29, P655; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Kashiwagi A, 2010, MOL CELL BIOL, V30, P2799, DOI 10.1128/MCB.00157-10; Kops GJPL, 1999, J MOL MED-JMM, V77, P656, DOI 10.1007/s001099900050; Kuchay SM, 2007, CURR OPIN HEMATOL, V14, P249, DOI 10.1097/MOH.0b013e3280ef68f8; Kulkarni S, 2010, ONCOGENE, V29, P1339, DOI 10.1038/onc.2009.422; Lakshmikuttyamma A, 2004, CANCER EPIDEM BIOMAR, V13, P1604; Le XF, 2005, CELL CYCLE, V4, P87, DOI 10.4161/cc.4.1.1360; Mamoune A, 2003, CANCER RES, V63, P4632; Mellgren RL, 2009, BBA-MOL CELL RES, V1793, P1886, DOI 10.1016/j.bbamcr.2009.09.013; Modur V, 2002, J BIOL CHEM, V277, P47928, DOI 10.1074/jbc.M207509200; Moubarak RS, 2007, MOL CELL BIOL, V27, P4844, DOI 10.1128/MCB.02141-06; Nahta R, 2004, CANCER RES, V64, P3981, DOI 10.1158/0008-5472.CAN-03-3900; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Patel YM, 2000, J BIOL CHEM, V275, P17653, DOI 10.1074/jbc.M910445199; Perrin BJ, 2006, MOL BIOL CELL, V17, P239, DOI 10.1091/mbc.e05-06-0488; Philipp-Staheli J, 2001, EXP CELL RES, V264, P148, DOI 10.1006/excr.2000.5143; Sawhney RS, 2006, J BIOL CHEM, V281, P8497, DOI 10.1074/jbc.M600787200; Singh A, 2010, MOL BIOL CELL, V21, P1140, DOI 10.1091/mbc.E09-09-0795; Sriuranpong V, 2004, CLIN CANCER RES, V10, P4944, DOI 10.1158/1078-0432.CCR-03-0757; Tan YF, 2006, J BIOL CHEM, V281, P16016, DOI 10.1074/jbc.M601299200; Tan Y, 2006, GENESIS, V44, P297, DOI 10.1002/dvg.20216; Tan Y, 2006, J BIOL CHEM, V281, P17689, DOI 10.1074/jbc.M601978200; Trotman LC, 2006, NATURE, V441, P523, DOI 10.1038/nature04809; Wernimont SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010513; Yan L, 2008, J BIOL CHEM, V283, P7411, DOI 10.1074/jbc.M708083200; Zimmerman UJP, 2000, IUBMB LIFE, V50, P63	48	36	39	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15458	15465		10.1074/jbc.M112.349308	http://dx.doi.org/10.1074/jbc.M112.349308			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22427650	Green Published, hybrid			2022-12-25	WOS:000304006300027
J	Jung, JH; Seo, PJ; Ahn, JH; Park, CM				Jung, Jae-Hoon; Seo, Pil Joon; Ahn, Ji Hoon; Park, Chung-Mo			Arabidopsis RNA-binding Protein FCA Regulates MicroRNA172 Processing in Thermosensory Flowering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMBIENT-TEMPERATURE; FLORAL TRANSITION; TIME; PLANTS; THALIANA; GENE; TRANSCRIPTION; APETALA2; MIR172; PERCEPTION	Ambient temperature fluctuates diurnally and seasonally. It profoundly influences the timing of flowering in plants. The floral integrator FLOWERING LOCUS T (FT) mediates ambient temperature signals via the thermosensory pathway in Arabidopsis flowering. microRNA172 (miR172), which promotes flowering by inducing FT, also responds to changes in ambient temperature. However, it is largely unknown how miR172 integrates ambient temperature signals into the flowering genetic network. Here, we show that Arabidopsis RNA-binding protein FCA promotes the processing of primary microRNA172 transcripts (pri-miR172) in response to changes in ambient temperature. Ambient temperature regulates miR172 biogenesis primarily at the pri-miR172 processing step. miR172 abundance is elevated at 23 degrees C but not at 16 degrees C. miR172 accumulation at 23 degrees C requires functional FCA. FCA binds to the flanking sequences of the stem-loop within the pri-miR172 transcripts via the RNA recognition motif. FCA also binds to the primary transcripts of other temperature-responsive miRNAs, such as miR398 and miR399. Notably, levels of FCA mRNAs and proteins increase at 23 degrees C but remain low at 16 degrees C, supporting the role of FCA in temperature perception. Our data show that FCA regulation of miR172 processing is an early event in the thermosensory flowering pathway. We propose that the FCA-miR172 regulon provides an adaptive strategy that fine tunes the onset of flowering under fluctuating ambient temperature conditions.	[Jung, Jae-Hoon; Seo, Pil Joon; Park, Chung-Mo] Seoul Natl Univ, Dept Chem, Seoul 151742, South Korea; [Park, Chung-Mo] Seoul Natl Univ, Plant Genom & Breeding Inst, Seoul 151742, South Korea; [Ahn, Ji Hoon] Korea Univ, Sch Life Sci & Biotechnol, Seoul 136701, South Korea	Seoul National University (SNU); Seoul National University (SNU); Korea University	Park, CM (corresponding author), Seoul Natl Univ, Dept Chem, 1 Gwanak Ro, Seoul 151742, South Korea.	cmpark@snu.ac.kr	Park, Chung-Mo/B-6175-2012; Seo, Pil Joon/AAR-9426-2020; Ahn, Ji Hoon/A-4141-2011	Ahn, Ji Hoon/0000-0003-0347-3922	Leaping Research Program [20110016440]; National Research Foundation of Korea; Plant Molecular Breeding Center [PJ008103]; Rural Development Administration; Plant Signaling Network Research Center [20110001099]; Agricultural Research and Development Promotion Center, Korea Ministry for Food, Agriculture, Forestry and Fisheries [30901703]; Creative Research Initiatives of the National Research Foundation for the Ministry of Education, Science and Technology [R16-2008-106-01000-0]	Leaping Research Program; National Research Foundation of Korea(National Research Foundation of Korea); Plant Molecular Breeding Center; Rural Development Administration(Rural Development Administration (RDA), Republic of Korea); Plant Signaling Network Research Center; Agricultural Research and Development Promotion Center, Korea Ministry for Food, Agriculture, Forestry and Fisheries; Creative Research Initiatives of the National Research Foundation for the Ministry of Education, Science and Technology	This work was supported by the Leaping Research Program (Grant 20110016440) provided by the National Research Foundation of Korea; the Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center Number PJ008103) provided by the Rural Development Administration; the Plant Signaling Network Research Center (Grant 20110001099); the Agricultural Research and Development Promotion Center (Grant 30901703), Korea Ministry for Food, Agriculture, Forestry and Fisheries; and the Creative Research Initiatives of the National Research Foundation for the Ministry of Education, Science and Technology (Grant R16-2008-106-01000-0 to J. H. A.).	Atkin OK, 2003, TRENDS PLANT SCI, V8, P343, DOI 10.1016/S1360-1385(03)00136-5; Baurle I, 2007, SCIENCE, V318, P109, DOI 10.1126/science.1146565; Balasubramanian S, 2006, PLOS GENET, V2, P980, DOI 10.1371/journal.pgen.0020106; Baurle I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002733; Blazquez MA, 2003, NAT GENET, V33, P168, DOI 10.1038/ng1085; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Clery A, 2008, CURR OPIN STRUC BIOL, V18, P290, DOI 10.1016/j.sbi.2008.04.002; Dong Z, 2008, P NATL ACAD SCI USA, V105, P9970, DOI 10.1073/pnas.0803356105; Fitter AH, 2002, SCIENCE, V296, P1689, DOI 10.1126/science.1071617; Gendrel AV, 2005, NAT METHODS, V2, P213, DOI 10.1038/nmeth0305-213; Grigorova B, 2011, DEVELOPMENT, V138, P2451, DOI 10.1242/dev.058362; Guil S, 2007, NAT STRUCT MOL BIOL, V14, P591, DOI 10.1038/nsmb1250; Han MH, 2004, P NATL ACAD SCI USA, V101, P1093, DOI 10.1073/pnas.0307969100; Hornyik C, 2010, DEV CELL, V18, P203, DOI 10.1016/j.devcel.2009.12.009; Jiao XF, 2002, BIOL REPROD, V66, P475, DOI 10.1095/biolreprod66.2.475; Jung JH, 2007, PLANT CELL, V19, P2736, DOI 10.1105/tpc.107.054528; Jung JH, 2011, PLANT MOL BIOL, V76, P35, DOI 10.1007/s11103-011-9759-z; Kim YK, 2010, CELL, V143, P703, DOI 10.1016/j.cell.2010.11.018; KOORNNEEF M, 1991, MOL GEN GENET, V229, P57, DOI 10.1007/BF00264213; Kumar SV, 2010, CELL, V140, P136, DOI 10.1016/j.cell.2009.11.006; Lee H, 2010, NUCLEIC ACIDS RES, V38, P3081, DOI 10.1093/nar/gkp1240; LEE I, 1995, PLANT PHYSIOL, V108, P157, DOI 10.1104/pp.108.1.157; Lee JH, 2007, GENE DEV, V21, P397, DOI 10.1101/gad.1518407; Lim MH, 2004, PLANT CELL, V16, P731, DOI 10.1105/tpc.019331; Liu FQ, 2007, MOL CELL, V28, P398, DOI 10.1016/j.molcel.2007.10.018; Liu FQ, 2010, SCIENCE, V327, P94, DOI 10.1126/science.1180278; Lorkovic ZJ, 2009, TRENDS PLANT SCI, V14, P229, DOI 10.1016/j.tplants.2009.01.007; Macknight R, 1997, CELL, V89, P737, DOI 10.1016/S0092-8674(00)80256-1; Macknight R, 2002, PLANT CELL, V14, P877, DOI 10.1105/tpc.010456; Mathieu J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000148; Michlewski G, 2008, MOL CELL, V32, P383, DOI 10.1016/j.molcel.2008.10.013; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Penfield S, 2008, NEW PHYTOL, V179, P615, DOI 10.1111/j.1469-8137.2008.02478.x; Quesada V, 2003, EMBO J, V22, P3142, DOI 10.1093/emboj/cdg305; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Samach A, 2005, CURR OPIN PLANT BIOL, V8, P483, DOI 10.1016/j.pbi.2005.07.011; Seo PJ, 2010, PLANT J, V61, P661, DOI 10.1111/j.1365-313X.2009.04091.x; Simpson GG, 2003, CELL, V113, P777, DOI 10.1016/S0092-8674(03)00425-2; Sire C, 2009, FEBS LETT, V583, P1039, DOI 10.1016/j.febslet.2009.02.024; Sonmez C, 2011, P NATL ACAD SCI USA, V108, P8508, DOI 10.1073/pnas.1105334108; Strasser B, 2009, PLANT J, V58, P629, DOI 10.1111/j.1365-313X.2009.03811.x; Sunkar R, 2007, TRENDS PLANT SCI, V12, P301, DOI 10.1016/j.tplants.2007.05.001; Telfer A, 1997, DEVELOPMENT, V124, P645; Terzi LC, 2009, PLANT J, V59, P163, DOI 10.1111/j.1365-313X.2009.03859.x; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wollmann H, 2010, DEVELOPMENT, V137, P3633, DOI 10.1242/dev.036673; Wu G, 2009, CELL, V138, P750, DOI 10.1016/j.cell.2009.06.031; Xie ZX, 2010, SEMIN CELL DEV BIOL, V21, P790, DOI 10.1016/j.semcdb.2010.03.012; Yang L, 2006, PLANT J, V47, P841, DOI 10.1111/j.1365-313X.2006.02835.x; Yant L, 2010, PLANT CELL, V22, P2156, DOI 10.1105/tpc.110.075606	50	63	78	5	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					16007	16016		10.1074/jbc.M111.337485	http://dx.doi.org/10.1074/jbc.M111.337485			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22431732	hybrid, Green Published			2022-12-25	WOS:000304006300078
J	Pandey, A; Singh, N; Vemula, SV; Couetil, L; Katz, JM; Donis, R; Sambhara, S; Mittal, SK				Pandey, Aseem; Singh, Neetu; Vemula, Sai V.; Couetil, Laurent; Katz, Jacqueline M.; Donis, Ruben; Sambhara, Suryaprakash; Mittal, Suresh K.			Impact of Preexisting Adenovirus Vector Immunity on Immunogenicity and Protection Conferred with an Adenovirus-Based H5N1 Influenza Vaccine	PLOS ONE			English	Article							RECOMBINANT ADENOVIRUS; NEUTRALIZING ANTIBODIES; VIRAL-ANTIGENS; MOUSE MODEL; CELL-LINES; MICE; VIRUS; BOVINE; RESPONSES; REPLICATION	The prevalence of preexisting immunity to adenoviruses in the majority of the human population might adversely impact the development of adaptive immune responses against adenovirus vector-based vaccines. To address this issue, we primed BALB/c mice either intranasally (i.n.) or intramuscularly (i.m.) with varying doses of wild type (WT) human adenovirus subtype 5 (HAd5). Following the development of immunity against HAd5, we immunized animals via the i.n. or i.m. route of inoculation with a HAd vector (HAd-HA-NP) expressing the hemagglutinin (HA) and nucleoprotein (NP) of A/Vietnam/1203/04 (H5N1) influenza virus. The immunogenicity and protection results suggest that low levels of vector immunity (<520 virus-neutralization titer) induced by priming mice with up to 10(7) plaque forming units (p.f.u.) of HAd-WT did not adversely impact the protective efficacy of the vaccine. Furthermore, high levels of vector immunity (approximately 1500 virus-neutralization titer) induced by priming mice with 10(8) p.f.u. of HAd-WT were overcome by either increasing the vaccine dose or using alternate routes of vaccination. A further increase in the priming dose to 10(9) p.f.u. allowed only partial protection. These results suggest possible strategies to overcome the variable levels of human immunity against adenoviruses, leading to better utilization of HAd vector-based vaccines.	[Pandey, Aseem; Singh, Neetu; Vemula, Sai V.; Mittal, Suresh K.] Purdue Univ, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA; [Couetil, Laurent] Purdue Univ, Dept Vet Clin Sci, Coll Vet Med, W Lafayette, IN 47907 USA; [Pandey, Aseem; Singh, Neetu; Vemula, Sai V.; Mittal, Suresh K.] Purdue Univ, Bindley Biosci Ctr, W Lafayette, IN 47907 USA; [Katz, Jacqueline M.; Donis, Ruben; Sambhara, Suryaprakash] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Centers for Disease Control & Prevention - USA	Pandey, A (corresponding author), Purdue Univ, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA.	ssambhara@cdc.gov; mittal@purdue.edu	Couetil, Laurent/AAD-9725-2022; Sambhara, Suryaprakash/AAC-4428-2021	Couetil, Laurent/0000-0002-1516-6666; 	Public Health Service from National Institute of Allergy and Infectious Diseases [AI059374]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059374] Funding Source: NIH RePORTER	Public Health Service from National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service grant AI059374 from the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appaiahgari MB, 2006, MICROBES INFECT, V8, P92, DOI 10.1016/j.micinf.2005.05.023; Bangari DS, 2006, VACCINE, V24, P849, DOI 10.1016/j.vaccine.2005.08.101; Bangari DS, 2005, BIOCHEM BIOPH RES CO, V327, P960, DOI 10.1016/j.bbrc.2004.12.099; Bangari DS, 2004, VIRUS RES, V105, P127, DOI 10.1016/j.virusres.2004.05.003; Barouch DH, 2005, HUM GENE THER, V16, P149, DOI 10.1089/hum.2005.16.149; Bender B S, 1992, Semin Respir Infect, V7, P38; Catanzaro AT, 2006, J INFECT DIS, V194, P1638, DOI 10.1086/509258; Croyle MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003548; Epstein SL, 2002, EMERG INFECT DIS, V8, P796; FOOKS AR, 1995, VIROLOGY, V210, P456, DOI 10.1006/viro.1995.1362; Gao WT, 2006, J VIROL, V80, P1959, DOI 10.1128/JVI.80.4.1959-1964.2006; Gao WT, 2003, LANCET, V362, P1895, DOI 10.1016/S0140-6736(03)14962-8; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Hoelscher MA, 2007, CLIN PHARMACOL THER, V82, P665, DOI 10.1038/sj.clpt.6100418; Hoelscher MA, 2006, LANCET, V367, P475, DOI 10.1016/S0140-6736(06)68076-8; Hoelscher MA, 2008, J INFECT DIS, V197, P1185, DOI 10.1086/529522; Hutnick NA, 2010, VACCINE, V28, P1932, DOI 10.1016/j.vaccine.2009.10.091; Kaufman DR, 2010, J VIROL, V84, P5986, DOI 10.1128/JVI.02563-09; Kostense S, 2004, AIDS, V18, P1213, DOI 10.1097/00002030-200405210-00019; Lemiale F, 2003, J VIROL, V77, P10078, DOI 10.1128/JVI.77.18.10078-10087.2003; Lu XH, 1999, J VIROL, V73, P5903, DOI 10.1128/JVI.73.7.5903-5911.1999; LUBECK MD, 1989, P NATL ACAD SCI USA, V86, P6763, DOI 10.1073/pnas.86.17.6763; Mast TC, 2010, VACCINE, V28, P950, DOI 10.1016/j.vaccine.2009.10.145; MITTAL SK, 1993, VIRUS RES, V28, P67, DOI 10.1016/0168-1702(93)90090-A; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Ng P, 1999, HUM GENE THER, V10, P2667, DOI 10.1089/10430349950016708; Nwanegbo E, 2004, CLIN DIAGN LAB IMMUN, V11, P351, DOI 10.1128/CDLI.11.2.351-357.2004; Sambhara S, 1998, CELL IMMUNOL, V187, P13, DOI 10.1006/cimm.1998.1314; Sharma A, 2010, VIRUS RES, V153, P134, DOI 10.1016/j.virusres.2010.07.021; Singh N, 2008, MOL THER, V16, P965, DOI 10.1038/mt.2008.12; Stephenson I, 2004, VIRUS RES, V103, P91, DOI 10.1016/j.virusres.2004.02.019; Sullivan NJ, 2003, NATURE, V424, P681, DOI 10.1038/nature01876; Thomas PG, 2006, EMERG INFECT DIS, V12, P48, DOI 10.3201/eid1201.051237; Van Kampen KR, 2005, VACCINE, V23, P1029, DOI 10.1016/j.vaccine.2004.07.043; van Olphen AL, 2002, VIROLOGY, V295, P108, DOI 10.1006/viro.2002.1389; van Olphen AL, 2002, J VIROL, V76, P5882, DOI 10.1128/JVI.76.12.5882-5892.2002; Vemula SV, 2010, EXPERT OPIN BIOL TH, V10, P1469, DOI 10.1517/14712598.2010.519332; Vos A, 2001, J GEN VIROL, V82, P2191, DOI 10.1099/0022-1317-82-9-2191; Xiang ZQ, 2003, J VIROL, V77, P10780, DOI 10.1128/JVI.77.20.10780-10789.2003; Yang Y, 1996, GENE THER, V3, P137; Zhu JG, 2007, J VIROL, V81, P3170, DOI 10.1128/JVI.02192-06	41	46	48	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e33428	10.1371/journal.pone.0033428	http://dx.doi.org/10.1371/journal.pone.0033428			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22432020	gold, Green Submitted, Green Published			2022-12-25	WOS:000303198600063
J	Chan, T; Back, TC; Subleski, JJ; Weiss, JM; Ortaldo, JR; Wiltrout, RH				Chan, Tim; Back, Timothy C.; Subleski, Jeffrey J.; Weiss, Jonathan M.; Ortaldo, John R.; Wiltrout, Robert H.			Systemic IL-12 Administration Alters Hepatic Dendritic Cell Stimulation Capabilities	PLOS ONE			English	Article							CD8(+) T-CELLS; IN-VIVO; IMMUNE-RESPONSES; NK CELLS; ANTITUMOR IMMUNITY; ADAPTIVE IMMUNITY; NATURAL-KILLER; MOUSE-LIVER; GM-CSF; INTERLEUKIN-12	The liver is an immunologically unique organ containing tolerogenic dendritic cells (DC) that maintain an immunosuppressive microenvironment. Although systemic IL-12 administration can improve responses to tumors, the effects of IL-12-based treatments on DC, in particular hepatic DC, remain incompletely understood. In this study, we demonstrate systemic IL-12 administration induces a 2-3 fold increase in conventional, but not plasmacytoid, DC subsets in the liver. Following IL-12 administration, hepatic DC became more phenotypically and functionally mature, resembling the function of splenic DC, but differed as compared to their splenic counterparts in the production of IL-12 following co-stimulation with toll-like receptor (TLR) agonists. Hepatic DCs from IL-12 treated mice acquired enhanced T cell proliferative capabilities similar to levels observed using splenic DCs. Furthermore, IL-12 administration preferentially increased hepatic T cell activation and IFN gamma expression in the RENCA mouse model of renal cell carcinoma. Collectively, the data shows systemic IL-12 administration enables hepatic DCs to overcome at least some aspects of the inherently suppressive milieu of the hepatic environment that could have important implications for the design of IL-12-based immunotherapeutic strategies targeting hepatic malignancies and infections.	[Chan, Tim; Back, Timothy C.; Subleski, Jeffrey J.; Weiss, Jonathan M.; Ortaldo, John R.; Wiltrout, Robert H.] Natl Canc Inst, Natl Inst Hlth, Expt Immunol Lab, Canc & Inflammat Program,Ctr Canc Res, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Wiltrout, RH (corresponding author), Natl Canc Inst, Natl Inst Hlth, Expt Immunol Lab, Canc & Inflammat Program,Ctr Canc Res, Frederick, MD 21702 USA.	wiltrour@mail.nih.gov		Subleski, Jeff/0000-0002-7442-1807	National Cancer Institute, National Institutes of Health (NCI/NIH); NATIONAL CANCER INSTITUTE [ZIABC010892, ZIABC009262, ZIABC009322] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health (NCI/NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the National Cancer Institute, National Institutes of Health (NCI/NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamboat ZM, 2009, J IMMUNOL, V182, P1901, DOI 10.4049/jimmunol.0803404; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Blasius AL, 2007, J EXP MED, V204, P2561, DOI 10.1084/jem.20070991; Bochtler P, 2008, HEPATOLOGY, V48, P1954, DOI 10.1002/hep.22559; Chan T, 2011, INT IMMUNOPHARMACOL, V11, P879, DOI 10.1016/j.intimp.2010.12.024; Colombo MP, 2002, CYTOKINE GROWTH F R, V13, P155, DOI 10.1016/S1359-6101(01)00032-6; Connolly MK, 2009, J CLIN INVEST, V119, P3213, DOI 10.1172/JCI37581; Crispe IN, 2009, ANNU REV IMMUNOL, V27, P147, DOI 10.1146/annurev.immunol.021908.132629; de Creus A, 2005, J IMMUNOL, V174, P2037, DOI 10.4049/jimmunol.174.4.2037; Fernandez NC, 1999, NAT MED, V5, P405, DOI 10.1038/7403; Fukao T, 2002, NAT IMMUNOL, V3, P875, DOI 10.1038/ni825; Goubier A, 2008, IMMUNITY, V29, P464, DOI 10.1016/j.immuni.2008.06.017; Grohmann U, 1998, IMMUNITY, V9, P315, DOI 10.1016/S1074-7613(00)80614-7; Gupta A, 2009, TRANSPLANTATION, V88, P589, DOI 10.1097/TP.0b013e3181b11f12; Hsu W, 2007, CELL MOL IMMUNOL, V4, P321; Jomantaite L, 2004, EUR J IMMUNOL, V34, P355, DOI 10.1002/eji.200324336; Jongbloed SL, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1864; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kingston D, 2009, BLOOD, V114, P835, DOI 10.1182/blood-2009-02-206318; Klaschik S, 2007, MOL IMMUNOL, V44, P1095, DOI 10.1016/j.molimm.2006.07.283; Klein I, 2006, J EXP MED, V203, P437, DOI 10.1084/jem.20051775; Lau AH, 2003, GUT, V52, P307, DOI 10.1136/gut.52.2.307; Lian ZX, 2003, J IMMUNOL, V170, P2323, DOI 10.4049/jimmunol.170.5.2323; Marcenaro E, 2005, J IMMUNOL, V174, P3992, DOI 10.4049/jimmunol.174.7.3992; Merad M, 2009, BLOOD, V113, P3418, DOI 10.1182/blood-2008-12-180646; Nagayama H, 2000, J IMMUNOL, V165, P59, DOI 10.4049/jimmunol.165.1.59; Natarajan S, 2010, IMMUNOBIOLOGY, V215, P698, DOI 10.1016/j.imbio.2010.05.024; O'Connell PJ, 2000, J IMMUNOL, V165, P795, DOI 10.4049/jimmunol.165.2.795; Pan PY, 2004, J IMMUNOL, V172, P4779, DOI 10.4049/jimmunol.172.8.4779; Pillarisetty VG, 2003, HEPATOLOGY, V37, P641, DOI 10.1053/jhep.2003.50074; Pillarisetty VG, 2004, J IMMUNOL, V172, P1009, DOI 10.4049/jimmunol.172.2.1009; Plitas G, 2008, HEPATOLOGY, V47, P1343, DOI 10.1002/hep.22167; Polakos NK, 2007, J IMMUNOL, V179, P201, DOI 10.4049/jimmunol.179.1.201; Racanelli V, 2006, HEPATOLOGY, V43, pS54, DOI 10.1002/hep.21060; Shanker A, 2009, CANCER RES, V69, P6615, DOI 10.1158/0008-5472.CAN-09-0685; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Shu SA, 2007, CLIN EXP IMMUNOL, V149, P335, DOI 10.1111/j.1365-2249.2007.03419.x; Steinman RM, 2006, CURR TOP MICROBIOL, V311, P17; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Subleski JJ, 2006, CANCER RES, V66, P11005, DOI 10.1158/0008-5472.CAN-06-0811; Sumpter TL, 2007, HEPATOLOGY, V46, P2021, DOI 10.1002/hep.21974; TAHARA H, 1994, CANCER RES, V54, P182; Tokita D, 2008, TRANSPLANTATION, V85, P369, DOI 10.1097/TP.0b013e3181612ded; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Trinchieri G, 1998, IMMUNOL RES, V17, P269, DOI 10.1007/BF02786451; Vosshenrich CAJ, 2007, J EXP MED, V204, P2569, DOI 10.1084/jem.20071451; Weiss JM, 2007, EXPERT OPIN BIOL TH, V7, P1705, DOI 10.1517/14712598.7.11.1705; Wigginton JM, 2002, EXPERT OPIN BIOL TH, V2, P513; Wigginton JM, 1996, JNCI-J NATL CANCER I, V88, P38, DOI 10.1093/jnci/88.1.38; Wigginton JM, 2001, J CLIN INVEST, V108, P51; Xia S, 2008, BLOOD, V112, P3175, DOI 10.1182/blood-2008-05-159921	51	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2012	7	3							e33303	10.1371/journal.pone.0033303	http://dx.doi.org/10.1371/journal.pone.0033303			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930IA	22428016	Green Published, gold, Green Submitted			2022-12-25	WOS:000303129700049
J	Ledergerber, D; Larkum, ME				Ledergerber, Debora; Larkum, Matthew Evan			The Time Window for Generation of Dendritic Spikes by Coincidence of Action Potentials and EPSPs is Layer Specific in Somatosensory Cortex	PLOS ONE			English	Article							TIMING-DEPENDENT PLASTICITY; NEURONS IN-VITRO; SYNAPTIC PLASTICITY; PYRAMIDAL NEURONS; APICAL DENDRITES; CELLS; CA2+; PROPAGATION; MECHANISMS; INITIATION	The precise timing of events in the brain has consequences for intracellular processes, synaptic plasticity, integration and network behaviour. Pyramidal neurons, the most widespread excitatory neuron of the neocortex have multiple spike initiation zones, which interact via dendritic and somatic spikes actively propagating in all directions within the dendritic tree. For these neurons, therefore, both the location and timing of synaptic inputs are critical. The time window for which the backpropagating action potential can influence dendritic spike generation has been extensively studied in layer 5 neocortical pyramidal neurons of rat somatosensory cortex. Here, we re-examine this coincidence detection window for pyramidal cell types across the rat somatosensory cortex in layers 2/3, 5 and 6. We find that the time-window for optimal interaction is widest and shifted in layer 5 pyramidal neurons relative to cells in layers 6 and 2/3. Inputs arriving at the same time and locations will therefore differentially affect spike-timing dependent processes in the different classes of pyramidal neurons.	[Ledergerber, Debora] Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, N-7034 Trondheim, Norway; [Ledergerber, Debora; Larkum, Matthew Evan] Univ Bern, Physiol Inst, Bern, Switzerland; [Larkum, Matthew Evan] Charite Univ Med Berlin, Neurosci Res Ctr, Berlin, Germany	Norwegian University of Science & Technology (NTNU); University of Bern; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Ledergerber, D (corresponding author), Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, N-7034 Trondheim, Norway.	debora.ledergerber@ntnu.no		Larkum, Matthew/0000-0001-9799-2656	Swiss National Science Foundation [31003A_130694/1]; SystemsX.ch (NEUROCHOICE)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); SystemsX.ch (NEUROCHOICE)	This work was supported by the Swiss National Science Foundation (Grant Nr. 31003A_130694/1) and SystemsX.ch (NEUROCHOICE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMITAI Y, 1993, CEREB CORTEX, V3, P26, DOI 10.1093/cercor/3.1.26; Bi GQ, 2005, TRENDS NEUROSCI, V28, P222, DOI 10.1016/j.tins.2005.02.002; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Branco T, 2010, SCIENCE, V329, P1671, DOI 10.1126/science.1189664; Dan Y, 2006, PHYSIOL REV, V86, P1033, DOI 10.1152/physrev.00030.2005; de Kock CPJ, 2008, J PHYSIOL-LONDON, V586, P3353, DOI 10.1113/jphysiol.2008.155580; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; Frick A, 2005, J NEUROBIOL, V64, P100, DOI 10.1002/neu.20148; Froemke RC, 2005, NATURE, V434, P221, DOI 10.1038/nature03366; Greenberg DS, 2008, NAT NEUROSCI, V11, P749, DOI 10.1038/nn.2140; Helmstaedter M, 2007, BRAIN RES REV, V55, P193, DOI 10.1016/j.brainresrev.2007.07.011; Holthoff K, 2006, CELL TISSUE RES, V326, P369, DOI 10.1007/s00441-006-0263-8; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; Kampa B, 2006, JPHYSIOL; KIM HG, 1993, J NEUROSCI, V13, P5301, DOI 10.1523/JNEUROSCI.13-12-05301.1993; Kole MHP, 2008, NAT NEUROSCI, V11, P178, DOI 10.1038/nn2040; Kumar A, 2010, NAT REV NEUROSCI, V11, P615, DOI 10.1038/nrn2886; Larkum ME, 2009, SCIENCE, V325, P756, DOI 10.1126/science.1171958; Larkum ME, 2007, J NEUROSCI, V27, P8999, DOI 10.1523/JNEUROSCI.1717-07.2007; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Larkum ME, 2002, J NEUROSCI, V22, P6991; Larkum ME, 2001, J PHYSIOL-LONDON, V533, P447, DOI 10.1111/j.1469-7793.2001.0447a.x; Ledergerber D, 2010, J NEUROSCI, V30, P13031, DOI 10.1523/JNEUROSCI.2254-10.2010; Letzkus JJ, 2006, J NEUROSCI, V26, P10420, DOI 10.1523/JNEUROSCI.2650-06.2006; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Migliore M, 2002, NAT REV NEUROSCI, V3, P362, DOI 10.1038/nrn810; Murayama M, 2009, P NATL ACAD SCI USA, V106, P20482, DOI 10.1073/pnas.0910379106; Nevian T, 2004, J NEUROSCI, V24, P1689, DOI 10.1523/JNEUROSCI.3332-03.2004; Nevian T, 2006, J NEUROSCI, V26, P11001, DOI 10.1523/JNEUROSCI.1749-06.2006; Potez S, 2008, J NEUROPHYSIOL, V99, P1394, DOI 10.1152/jn.01126.2007; Raizada RDS, 2003, CEREB CORTEX, V13, P100, DOI 10.1093/cercor/13.1.100; Rubio-Garrido P, 2009, CEREBCORTEX; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; Schiller J, 1997, J PHYSIOL-LONDON, V505, P605, DOI 10.1111/j.1469-7793.1997.605ba.x; Schwindt P, 1999, J NEUROPHYSIOL, V81, P1341, DOI 10.1152/jn.1999.81.3.1341; Sherman SM, 2002, PHILOS T R SOC B, V357, P1695, DOI 10.1098/rstb.2002.1161; Sjostrom PJ, 2006, NEURON, V51, P227, DOI 10.1016/j.neuron.2006.06.017; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; Spratling M W, 2002, Behav Cogn Neurosci Rev, V1, P219, DOI 10.1177/1534582302001003003; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Stuart G, 1997, J PHYSIOL-LONDON, V505, P617, DOI 10.1111/j.1469-7793.1997.617ba.x; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; Stuart GJ, 2001, NAT NEUROSCI, V4, P63, DOI 10.1038/82910; Thomson AM, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00013; Usrey WM, 2002, CURR OPIN NEUROBIOL, V12, P411, DOI 10.1016/S0959-4388(02)00339-2; Waters J, 2003, J NEUROSCI, V23, P8558; Williams SR, 1999, J PHYSIOL-LONDON, V521, P467, DOI 10.1111/j.1469-7793.1999.00467.x; Zilberter Y, 2005, NEUROSCIENTIST, V11, P334, DOI 10.1177/1073858405275827	52	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2012	7	3							e33146	10.1371/journal.pone.0033146	http://dx.doi.org/10.1371/journal.pone.0033146			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930IA	22427971	Green Published, gold, Green Submitted			2022-12-25	WOS:000303129700033
J	Nukiwa-Souma, N; Burmaa, A; Kamigaki, T; Od, I; Bayasgalan, N; Darmaa, B; Suzuki, A; Nymadawa, P; Oshitani, H				Nukiwa-Souma, Nao; Burmaa, Alexanderyn; Kamigaki, Taro; Od, Ishiin; Bayasgalan, Namuutsetsegiin; Darmaa, Badarchiin; Suzuki, Akira; Nymadawa, Pagbajabyn; Oshitani, Hitoshi			Influenza Transmission in a Community during a Seasonal Influenza A(H3N2) Outbreak (2010-2011) in Mongolia: A Community-Based Prospective Cohort Study	PLOS ONE			English	Article							A H1N1 VIRUS; PANDEMIC INFLUENZA; HOUSEHOLD TRANSMISSION; NONPHARMACEUTICAL INTERVENTIONS; SCHOOL CLOSURE; DISEASE; INFECTIONS; CHILDREN; BURDEN; PARAMETERS	Background: Knowledge of how influenza viruses spread in a community is important for planning and implementation of effective interventions, including social distancing measures. Households and schools are implicated as the major sites for influenza virus transmission. However, the overall picture of community transmission is not well defined during actual outbreaks. We conducted a community-based prospective cohort study to describe the transmission characteristics of influenza in Mongolia. Methods and Findings: A total of 5,655 residents in 1,343 households were included in this cohort study. An active search for cases of influenza-like illness (ILI) was performed between October 2010 and April 2011. Data collected during a community outbreak of influenza A(H3N2) were analyzed. Total 282 ILI cases occurred during this period, and 73% of the subjects were aged,15 years. The highest attack rate (20.4%) was in those aged 1-4 years, whereas the attack rate in those aged 5-9 years was 10.8%. Fifty-one secondary cases occurred among 900 household contacts from 43 households (43 index cases), giving an overall crude household secondary attack rate (SAR) of 5.7%. SAR was significantly higher in younger household contacts (relative risk for those aged <1 year: 9.90, 1-4 years: 5.59, and 5-9 years: 6.43). We analyzed the transmission patterns among households and a community and repeated transmissions were detected between households, preschools, and schools. Children aged 1-4 years played an important role in influenza transmission in households and in the community at large. Working-age adults were also a source of influenza in households, whereas elderly cases (aged >= 65 years) had no link with household transmission. Conclusions: Repeated transmissions between households, preschools, and schools were observed during an influenza A(H3N2) outbreak period in Mongolia, where subjects aged 1-4 years played an important role in influenza transmission.	[Nukiwa-Souma, Nao; Kamigaki, Taro; Suzuki, Akira; Oshitani, Hitoshi] Tohoku Univ, Grad Sch Med, Dept Virol, Sendai, Miyagi 980, Japan; [Burmaa, Alexanderyn; Bayasgalan, Namuutsetsegiin; Darmaa, Badarchiin; Nymadawa, Pagbajabyn] Natl Ctr Communicable Dis, Natl Influenza Ctr, Ulaanbaatar, Mongolia; [Nymadawa, Pagbajabyn] Mongolian Acad Med Sci, Ulaanbaatar, Mongolia	Tohoku University; National Center for Communicable Diseases of Mongolia; Mongolian Academy of Sciences	Nukiwa-Souma, N (corresponding author), Tohoku Univ, Grad Sch Med, Dept Virol, Sendai, Miyagi 980, Japan.	oshitanih@med.tohoku.ac.jp	Oshitani, Hitoshi/AAE-4349-2019; Nymadawa, Pagbajab/AAE-7344-2019	Nymadawa, Pagbajab/0000-0002-3189-2772; Suzuki, Akira/0000-0002-8223-0314	 [20603001]		This study was supported by Grant-in-Aid for Scientific Research (C), grant number 20603001. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], WHO CDC PROT REALT R; Burmaa A, 2012, MONGOLIA IN IN PRESS; Carcione D, 2011, EUROSURVEILLANCE, V16, P32; Carrat F, 2002, ARCH INTERN MED, V162, P1842, DOI 10.1001/archinte.162.16.1842; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Cauchemez S, 2004, STAT MED, V23, P3469, DOI 10.1002/sim.1912; Cauchemez S, 2008, NATURE, V452, P750, DOI 10.1038/nature06732; Cauchemez S, 2011, P NATL ACAD SCI USA, V108, P2825, DOI 10.1073/pnas.1008895108; Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498; Cauchemez S, 2009, LANCET INFECT DIS, V9, P473, DOI 10.1016/S1473-3099(09)70176-8; Cowling BJ, 2010, NEW ENGL J MED, V362, P2175, DOI 10.1056/NEJMoa0911530; Cowling BJ, 2009, ANN INTERN MED, V151, P437, DOI 10.7326/0003-4819-151-7-200910060-00142; Cowling BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002101; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; France AM, 2010, J INFECT DIS, V201, P984, DOI 10.1086/651145; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Glass LM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-61; Glezen WP, 1996, EPIDEMIOL REV, V18, P64, DOI 10.1093/oxfordjournals.epirev.a017917; Heikkinen T, 2004, J INFECT DIS, V190, P1369, DOI 10.1086/424527; Heymann A, 2004, PEDIATR INFECT DIS J, V23, P675, DOI 10.1097/01.inf.0000128778.54105.06; JENNINGS LC, 1978, J HYG-CAMBRIDGE, V81, P67, DOI 10.1017/S0022172400053778; KEMPER JT, 1980, AM J EPIDEMIOL, V112, P457, DOI 10.1093/oxfordjournals.aje.a113013; Klick B, 2011, EPIDEMIOL INFECT, P1; LONGINI IM, 1982, AM J EPIDEMIOL, V115, P736, DOI 10.1093/oxfordjournals.aje.a113356; LONGINI IM, 1982, BIOMETRICS, V38, P115, DOI 10.2307/2530294; Looker C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013702; Loustalot F, 2011, CLIN INFECT DIS, V52, pS146, DOI 10.1093/cid/ciq057; MONTO AS, 1994, EPIDEMIOL REV, V16, P351, DOI 10.1093/oxfordjournals.epirev.a036158; Monto AS, 1999, CLIN INFECT DIS, V28, P200, DOI 10.1086/515113; MONTO AS, 1985, AM J EPIDEMIOL, V121, P811, DOI 10.1093/oxfordjournals.aje.a114052; Morgan OW, 2010, EMERG INFECT DIS, V16, P631, DOI 10.3201/eid1604.091658; Nakauchi M, 2011, J VIROL METHODS, V171, P156, DOI 10.1016/j.jviromet.2010.10.018; National Influenza Center, INFL SURV; Nukiwa N, 2011, WEST PAC SURVEILL RE, V2, P16, DOI [10.5365/wpsar.2010.1.1.004, 10.5365/WPSAR.2010.1.1.004]; Papenburg J, 2010, CLIN INFECT DIS, V51, P1033, DOI 10.1086/656582; Poon LLM, 2011, J CLIN VIROL, V52, P146, DOI 10.1016/j.jcv.2011.06.022; Suess T, 2010, AM J EPIDEMIOL, V171, P1157, DOI 10.1093/aje/kwq071; TABER LH, 1981, J HYG-CAMBRIDGE, V86, P303, DOI 10.1017/S0022172400069059; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; van Gemert C, 2011, EMERG INFECT DIS, V17, P1599, DOI 10.3201/eid1709.101948; Viboud C, 2004, BRIT J GEN PRACT, V54, P684; Welliver R, 2001, JAMA-J AM MED ASSOC, V285, P748, DOI 10.1001/jama.285.6.748; Wu JT, 2006, PLOS MED, V3, P1532, DOI 10.1371/journal.pmed.0030361	44	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2012	7	3							e33046	10.1371/journal.pone.0033046	http://dx.doi.org/10.1371/journal.pone.0033046			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930IA	22427943	Green Submitted, Green Published, gold			2022-12-25	WOS:000303129700027
J	Shi, Y; Fu, XL; Hua, Y; Han, Y; Lu, Y; Wang, JC				Shi, Yang; Fu, Xuelian; Hua, Yong; Han, Yang; Lu, Ying; Wang, Junchen			The Side Population in Human Lung Cancer Cell Line NCI-H460 Is Enriched in Stem-Like Cancer Cells	PLOS ONE			English	Article							ADENOCARCINOMA; IDENTIFICATION; CAPACITY; FEATURES; MARKER; TUMORS	Lung cancer is among the most lethal malignancies with a high metastasis and recurrence rate. Recent studies indicate that tumors contain a subset of stem-like cancer cells that possess certain stem cell properties. Herein, we used Hoechst 33342 dye efflux assay and flow cytometry to isolate and characterize the side population (SP) cells from human lung cancer cell line NCI-H460 (H460). We show that the H460 SP cells harbor stem-like cells as they can readily form anchorage-independent floating spheres, possess great proliferative potential, and exhibit enhanced tumorigenicity. Importantly, the H460 SP cells were able to self-renew both in vitro and in vivo. Finally, we show that the H460 SP cells preferentially express ABCG2 as well as SMO, a critical mediator of the Hedgehog (HH) signaling, which seems to play an important role in H460 lung cancer cells as its blockage using Cyclopamine greatly inhibits cell-cycle progression. Collectively, our results lend further support to the existence of lung cancer stem cells and also implicate HH signaling in regulating large-cell lung cancer (stem) cells.	[Shi, Yang; Fu, Xuelian; Han, Yang; Wang, Junchen] Tongji Univ, East Hosp, Dept Pathol, Shanghai 200092, Peoples R China; [Hua, Yong; Lu, Ying] Tongji Univ, East Hosp, Cent Lab, Shanghai 200092, Peoples R China; [Wang, Junchen] Tongji Univ, East Hosp, Res Ctr Translat Med, Canc Stem Cell Inst, Shanghai 200092, Peoples R China	Tongji University; Tongji University; Tongji University	Shi, Y (corresponding author), Tongji Univ, East Hosp, Dept Pathol, Shanghai 200092, Peoples R China.	jeancwangdfyy@gmail.com	han, yang/GRS-2388-2022		Shanghai Science and Technology Association, China [05119554]	Shanghai Science and Technology Association, China	This study was supported by the Key project fund of Shanghai Science and Technology Association, China (Grant No. 05119554). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balbuena J, 2011, CYTOM PART A, V79A, P672, DOI 10.1002/cyto.a.21103; Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100; Bertolini G, 2009, P NATL ACAD SCI USA, V106, P16281, DOI 10.1073/pnas.0905653106; Chen YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002637; Chiou SH, 2010, CANCER RES, V70, P10433, DOI 10.1158/0008-5472.CAN-10-2638; Curtis SJ, 2010, CELL STEM CELL, V7, P127, DOI 10.1016/j.stem.2010.05.021; Das B, 2008, STEM CELLS, V26, P1818, DOI 10.1634/stemcells.2007-0724; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Deng S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010277; Dovey JS, 2008, P NATL ACAD SCI USA, V105, P11857, DOI 10.1073/pnas.0803574105; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Eramo A, 2010, ONCOGENE, V29, P4625, DOI 10.1038/onc.2010.207; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Gutova M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000243; He KJ, 2011, MOL CANCER THER, V10, P938, DOI 10.1158/1535-7163.MCT-10-1120; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Hu TS, 2008, CANCER RES, V68, P6533, DOI 10.1158/0008-5472.CAN-07-6642; Jiang F, 2009, MOL CANCER RES, V7, P330, DOI 10.1158/1541-7786.MCR-08-0393; Jiang TY, 2009, CANCER RES, V69, P845, DOI 10.1158/0008-5472.CAN-08-2762; Kondo T, 2004, P NATL ACAD SCI USA, V101, P781, DOI 10.1073/pnas.0307618100; Levina V, 2010, CANCER RES, V70, P338, DOI 10.1158/0008-5472.CAN-09-1102; Levina V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003077; Ma I, 2011, STEM CELL REV REP, V7, P292, DOI 10.1007/s12015-010-9208-4; Maitah MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016068; Ooi AT, 2010, CANCER RES, V70, P6639, DOI 10.1158/0008-5472.CAN-10-0455; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Sabisz M, 2009, CELL CYCLE, V8, P3208, DOI 10.4161/cc.8.19.9758; Salcido CD, 2010, BRIT J CANCER, V102, P1636, DOI 10.1038/sj.bjc.6605668; Seo DC, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-75; Sullivan JP, 2010, CANCER RES, V70, P9937, DOI 10.1158/0008-5472.CAN-10-0881; Teng Y, 2010, BIOCHEM BIOPH RES CO, V392, P373, DOI 10.1016/j.bbrc.2010.01.028; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wilson CW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005182; Yuan Z, 2007, ONCOGENE, V26, P1046, DOI 10.1038/sj.onc.1209860	37	65	68	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2012	7	3							e33358	10.1371/journal.pone.0033358	http://dx.doi.org/10.1371/journal.pone.0033358			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930IA	22428030	gold, Green Published, Green Submitted			2022-12-25	WOS:000303129700055
J	Yonemaru, J; Yamamoto, T; Ebana, K; Yamamoto, E; Nagasaki, H; Shibaya, T; Yano, M				Yonemaru, Jun-ichi; Yamamoto, Toshio; Ebana, Kaworu; Yamamoto, Eiji; Nagasaki, Hideki; Shibaya, Taeko; Yano, Masahiro			Genome-Wide Haplotype Changes Produced by Artificial Selection during Modern Rice Breeding in Japan	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; GREEN-REVOLUTION GENE; ORYZA-SATIVA; LINKAGE DISEQUILIBRIUM; JAPONICA RICE; HEADING DATE; PHOTOPERIOD SENSITIVITY; EPISTATIC INTERACTIONS; DISEASE RESISTANCE; LEAF SENESCENCE	During the last 90 years, the breeding of rice has delivered cultivars with improved agronomic and economic characteristics. Crossing of different lines and successive artificial selection of progeny based on their phenotypes have changed the chromosomal constitution of the ancestors of modern rice; however, the nature of these changes is unclear. The recent accumulation of data for genome-wide single-nucleotide polymorphisms (SNPs) in rice has allowed us to investigate the change in haplotype structure and composition. To assess the impact of these changes during modern breeding, we studied 177 Japanese rice accessions, which were categorized into three groups: landraces, improved cultivars developed from 1931 to 1974 (the early breeding phase), and improved cultivars developed from 1975 to 2005 (the late breeding phase). Phylogenetic tree and structure analysis indicated genetic differentiation between non-irrigated (upland) and irrigated (lowland) rice groups as well as genetic structuring within the irrigated rice group that corresponded to the existence of three subgroups. Pedigree analysis revealed that a limited number of landraces and cultivars was used for breeding at the beginning of the period of systematic breeding and that 11 landraces accounted for 70% of the ancestors of the modern improved cultivars. The values for linkage disequilibrium estimated from SNP alleles and the haplotype diversity determined from consecutive alleles in five-SNP windows indicated that haplotype blocks became less diverse over time as a result of the breeding process. A decrease in haplotype diversity, caused by a reduced number of polymorphisms in the haplotype blocks, was observed in several chromosomal regions. However, our results also indicate that new haplotype polymorphisms have been generated across the genome during the breeding process. These findings will facilitate our understanding of the association between particular haplotypes and desirable phenotypes in modern Japanese rice cultivars.	[Yonemaru, Jun-ichi; Yamamoto, Toshio; Yamamoto, Eiji; Nagasaki, Hideki; Shibaya, Taeko; Yano, Masahiro] Natl Inst Agrobiol Sci, Agrogen Res Ctr, Tsukuba, Ibaraki, Japan; [Ebana, Kaworu] Natl Inst Agrobiol Sci, Genet Resources Ctr, Tsukuba, Ibaraki, Japan; [Nagasaki, Hideki] Res Org Informat & Syst, Genome Informat Lab, Natl Inst Genet, Ctr Informat Biol, Mishima, Shizuoka 4118540, Japan; [Nagasaki, Hideki] Res Org Informat & Syst, Natl Inst Genet, DDBJ, Mishima, Shizuoka 4118540, Japan	National Institute of Agrobiological Sciences - Japan; National Institute of Agrobiological Sciences - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Yonemaru, J (corresponding author), Natl Inst Agrobiol Sci, Agrogen Res Ctr, Tsukuba, Ibaraki, Japan.	yonemaru@affrc.go.jp	Yamamoto, Toshio/AAX-7146-2020; Yano, Masahiro/AAC-5441-2019	Yamamoto, Toshio/0000-0002-5209-7735; Yamamoto, Eiji/0000-0002-3095-6455	Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation) [NVR0002, GIR1003]; Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry, Japan	Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation)(Ministry of Agriculture Forestry & Fisheries - Japan); Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry, Japan	This work was supported by grants from the Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation, NVR0002 and GIR1003) and from the Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrama HA, 2008, EUPHYTICA, V160, P339, DOI 10.1007/s10681-007-9535-y; Arai-Kichise Y, 2011, PLANT CELL PHYSIOL, V52, P274, DOI 10.1093/pcp/pcr003; Asano K, 2007, BREEDING SCI, V57, P53, DOI 10.1270/jsbbs.57.53; Asano K, 2011, P NATL ACAD SCI USA, V108, P11034, DOI 10.1073/pnas.1019490108; Ashikari M, 2002, BREEDING SCI, V52, P143, DOI 10.1270/jsbbs.52.143; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Ebana K, 2011, THEOR APPL GENET, V122, P1199, DOI 10.1007/s00122-010-1524-1; Ebana K, 2010, BREEDING SCI, V60, P390, DOI 10.1270/jsbbs.60.390; Feng LL, 2007, PLANT CELL REP, V26, P1635, DOI 10.1007/s00299-006-0299-y; Fujino K, 2010, MOL GENET GENOMICS, V284, P137, DOI 10.1007/s00438-010-0555-2; Fukuda A, 2004, PLANT CELL PHYSIOL, V45, P146, DOI 10.1093/pcp/pch014; Furukawa T, 2007, PLANT J, V49, P91, DOI 10.1111/j.1365-313X.2006.02958.x; Gao H, 2007, GENETICS, V176, P1635, DOI 10.1534/genetics.107.072371; HARGROVE TR, 1979, BIOSCIENCE, V29, P731, DOI 10.2307/1307667; HILL WG, 1994, AM J HUM GENET, V54, P705; Horie T, 2005, PLANT PROD SCI, V8, P259, DOI 10.1626/pps.8.259; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Huang XH, 2009, GENOME RES, V19, P1068, DOI 10.1101/gr.089516.108; Itoh H, 2004, PLANT MOL BIOL, V54, P533, DOI 10.1023/B:PLAN.0000038261.21060.47; Jin L, 2010, THEOR APPL GENET, V121, P475, DOI 10.1007/s00122-010-1324-7; Kang HG, 2005, PLANT J, V42, P901, DOI 10.1111/j.1365-313X.2005.02423.x; Kong ZS, 2006, PLANT PHYSIOL, V141, P1376, DOI 10.1104/pp.106.082941; KONO I, 2000, BREED RES, V2, P197; Kusaba M, 2007, PLANT CELL, V19, P1362, DOI 10.1105/tpc.106.042911; Lee SK, 2007, PLANT MOL BIOL, V65, P531, DOI 10.1007/s11103-007-9153-z; Lin HX, 2000, THEOR APPL GENET, V101, P1021, DOI 10.1007/s001220051576; Lin HX, 2003, BREEDING SCI, V53, P51, DOI 10.1270/jsbbs.53.51; Mather KA, 2007, GENETICS, V177, P2223, DOI 10.1534/genetics.107.079616; Matsui H, 2010, PLANT CELL PHYSIOL, V51, P2082, DOI 10.1093/pcp/pcq167; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; McNally KL, 2009, P NATL ACAD SCI USA, V106, P12273, DOI 10.1073/pnas.0900992106; Monna L, 2002, DNA RES, V9, P11, DOI 10.1093/dnares/9.1.11; Morita R, 2009, PLANT J, V59, P940, DOI 10.1111/j.1365-313X.2009.03919.x; Nagasaki H, 2010, BREEDING SCI, V60, P648, DOI 10.1270/jsbbs.60.648; Ogo Y, 2008, J BIOL CHEM, V283, P13407, DOI 10.1074/jbc.M708732200; Ono E, 2001, P NATL ACAD SCI USA, V98, P759, DOI 10.1073/pnas.021273498; Peng S, 2000, CROP SCI, V40, P307, DOI 10.2135/cropsci2000.402307x; Perrier X, DARWIN SOFTWARE; R Development Core Team, 2005, R LANG ENV STAT COMP; Sasaki A, 2002, NATURE, V416, P701, DOI 10.1038/416701a; Sazuka T, 2005, PLANT CELL PHYSIOL, V46, P1934, DOI 10.1093/pcp/pci206; Song Huaiming, 2011, P IEEE INT C COMM KY, P1, DOI [DOI 10.1145/2063384.2063407, 10.1145/2063384.2063407]; Takahashi Y, 2009, P NATL ACAD SCI USA, V106, P4555, DOI 10.1073/pnas.0812092106; Ueguchi-Tanaka M, 2005, NATURE, V437, P693, DOI 10.1038/nature04028; Uga Y, 2007, THEOR APPL GENET, V114, P1457, DOI 10.1007/s00122-007-0534-0; Wang L, 2011, THEOR APPL GENET, V122, P327, DOI 10.1007/s00122-010-1449-8; Xie KB, 2006, PLANT PHYSIOL, V142, P280, DOI 10.1104/pp.106.084475; Yamamoto R, 1992, TRANSITION PROSPECTS, P1; Yamamoto T, 2000, GENETICS, V154, P885; Yamamoto T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-267; Yamamoto T, 2009, DNA RES, V16, P141, DOI 10.1093/dnares/dsp006; Yamasaki M, 2007, ANN BOT-LONDON, V100, P967, DOI 10.1093/aob/mcm173; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Yonemaru J, 2010, RICE, V3, P194, DOI 10.1007/s12284-010-9041-z; ZHANG QF, 1992, THEOR APPL GENET, V83, P495, DOI 10.1007/BF00226539; Zhao KY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010780; Zhou J, 2008, PLANT PHYSIOL, V146, P1673, DOI 10.1104/pp.107.111443; Zhu Qian-Hao, 2003, BMC Plant Biology, V3, P6, DOI 10.1186/1471-2229-3-6	58	40	42	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2012	7	3							e32982	10.1371/journal.pone.0032982	http://dx.doi.org/10.1371/journal.pone.0032982			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930IA	22427922	Green Published, Green Submitted, gold			2022-12-25	WOS:000303129700024
J	Landry, S; Bacon, BA; Leybaert, J; Gagne, JP; Champoux, F				Landry, Simon; Bacon, Benoit A.; Leybaert, Jacqueline; Gagne, Jean-Pierre; Champoux, Francois			Audiovisual Segregation in Cochlear Implant Users	PLOS ONE			English	Article							VISUAL SPEECH-PERCEPTION; AUDITORY-CORTEX; DEAF-CHILDREN; HEARING; INTEGRATION; FUSION; ATTENTION; STIMULI	It has traditionally been assumed that cochlear implant users de facto perform atypically in audiovisual tasks. However, a recent study that combined an auditory task with visual distractors suggests that only those cochlear implant users that are not proficient at recognizing speech sounds might show abnormal audiovisual interactions. The present study aims at reinforcing this notion by investigating the audiovisual segregation abilities of cochlear implant users in a visual task with auditory distractors. Speechreading was assessed in two groups of cochlear implant users (proficient and non-proficient at sound recognition), as well as in normal controls. A visual speech recognition task (i.e. speechreading) was administered either in silence or in combination with three types of auditory distractors: i) noise ii) reverse speech sound and iii) non-altered speech sound. Cochlear implant users proficient at speech recognition performed like normal controls in all conditions, whereas non-proficient users showed significantly different audiovisual segregation patterns in both speech conditions. These results confirm that normal-like audiovisual segregation is possible in highly skilled cochlear implant users and, consequently, that proficient and non-proficient CI users cannot be lumped into a single group. This important feature must be taken into account in further studies of audiovisual interactions in cochlear implant users.	[Landry, Simon; Bacon, Benoit A.; Champoux, Francois] Ctr Rech Neuropsychol & Cognit CERNEC, Montreal, PQ, Canada; [Bacon, Benoit A.] Bishops Univ, Dept Psychol, Sherbrooke, PQ, Canada; [Leybaert, Jacqueline] Univ Libre Bruxelles, Brussels, Belgium; [Gagne, Jean-Pierre; Champoux, Francois] Univ Montreal, Ecole Orthophonie & Audiol, Inst Raymond Dewar, Ctr Rech Interdisciplinaire Readaptat Montreal Me, Montreal, PQ, Canada	Universite de Montreal; Bishops University; Universite Libre de Bruxelles; Universite de Montreal	Landry, S (corresponding author), Ctr Rech Neuropsychol & Cognit CERNEC, Montreal, PQ, Canada.	francois.champoux@umontreal.ca		Landry, Simon/0000-0001-7102-8324	Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegria J, 2005, J DEAF STUD DEAF EDU, V10, P122, DOI 10.1093/deafed/eni013; Bavelier D, 2006, TRENDS COGN SCI, V10, P512, DOI 10.1016/j.tics.2006.09.006; Bolognini N, 2005, NEUROPSYCHOLOGIA, V43, P1655, DOI 10.1016/j.neuropsychologia.2005.01.015; Champoux F, 2009, NEUROPSYCHOLOGIA, V47, P17, DOI 10.1016/j.neuropsychologia.2008.08.028; Desai S, 2008, J ACOUST SOC AM, V123, P428, DOI 10.1121/1.2816573; Doucet ME, 2006, BRAIN, V129, P3376, DOI 10.1093/brain/awl264; Finney EM, 2001, NAT NEUROSCI, V4, P1171, DOI 10.1038/nn763; Frassinetti F, 2002, EXP BRAIN RES, V147, P332, DOI 10.1007/s00221-002-1262-y; FRENS MA, 1995, PERCEPT PSYCHOPHYS, V57, P802, DOI 10.3758/BF03206796; Giraud AL, 2001, AUDIOL NEURO-OTOL, V6, P381, DOI 10.1159/000046847; Grant KW, 1998, J ACOUST SOC AM, V103, P2677, DOI 10.1121/1.422788; Horn DL, 2005, EAR HEARING, V26, P389, DOI 10.1097/00003446-200508000-00003; HUGHES HC, 1994, J EXP PSYCHOL HUMAN, V20, P131, DOI 10.1037/0096-1523.20.1.131; McDonald JJ, 2000, NATURE, V407, P906, DOI 10.1038/35038085; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Nishimura H, 1999, NATURE, V397, P116, DOI 10.1038/16376; PERROTT DR, 1990, PERCEPT PSYCHOPHYS, V48, P214, DOI 10.3758/BF03211521; Ross LA, 2007, SCHIZOPHR RES, V97, P173, DOI 10.1016/j.schres.2007.08.008; Rouger J, 2007, P NATL ACAD SCI USA, V104, P7295, DOI 10.1073/pnas.0609419104; Rouger J, 2008, BRAIN RES, V1188, P87, DOI 10.1016/j.brainres.2007.10.049; Sadato N, 2005, CEREB CORTEX, V15, P1113, DOI 10.1093/cercor/bhh210; Schorr EA, 2005, P NATL ACAD SCI USA, V102, P18748, DOI 10.1073/pnas.0508862102; Schwartz JL, 2010, J ACOUST SOC AM, V127, P1584, DOI 10.1121/1.3293001; Sekiyama K, 2003, NEUROSCI RES, V47, P277, DOI 10.1016/S0168-0102(03)00214-1; Smith LB, 1998, DEV PSYCHOL, V34, P840, DOI 10.1037/0012-1649.34.5.840; Teder-Salejarvi WA, 2002, COGNITIVE BRAIN RES, V14, P106, DOI 10.1016/S0926-6410(02)00065-4; Tremblay C, 2010, RESTOR NEUROL NEUROS, V28, P283, DOI 10.3233/RNN-2010-0498; van Wassenhove V, 2005, P NATL ACAD SCI USA, V102, P1181, DOI 10.1073/pnas.0408949102; Yucel E, 2008, INT J PEDIATR OTORHI, V72, P1097, DOI 10.1016/j.ijporl.2008.03.020	29	15	15	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33113	10.1371/journal.pone.0033113	http://dx.doi.org/10.1371/journal.pone.0033113			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427963	gold, Green Published, Green Submitted			2022-12-25	WOS:000302381500093
J	Li, J; Lu, WQ; Beesley, S; Loudon, ASI; Meng, QJ				Li, Jian; Lu, Wei-Qun; Beesley, Stephen; Loudon, Andrew S. I.; Meng, Qing-Jun			Lithium Impacts on the Amplitude and Period of the Molecular Circadian Clockwork	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; GENE-EXPRESSION; REAL-TIME; REV-ERB; RHYTHMS; PHOSPHORYLATION; CELLS; REVEALS; MAMMALS; BIOLOGY	Lithium salt has been widely used in treatment of Bipolar Disorder, a mental disturbance associated with circadian rhythm disruptions. Lithium mildly but consistently lengthens circadian period of behavioural rhythms in multiple organisms. To systematically address the impacts of lithium on circadian pacemaking and the underlying mechanisms, we measured locomotor activity in mice in vivo following chronic lithium treatment, and also tracked clock protein dynamics (PER2::Luciferase) in vitro in lithium-treated tissue slices/cells. Lithium lengthens period of both the locomotor activity rhythms, as well as the molecular oscillations in the suprachiasmatic nucleus, lung tissues and fibroblast cells. In addition, we also identified significantly elevated PER2::LUC expression and oscillation amplitude in both central and peripheral pacemakers. Elevation of PER2::LUC by lithium was not associated with changes in protein stabilities of PER2, but instead with increased transcription of Per2 gene. Although lithium and GSK3 inhibition showed opposing effects on clock period, they acted in a similar fashion to up-regulate PER2 expression and oscillation amplitude. Collectively, our data have identified a novel amplitude-enhancing effect of lithium on the PER2 protein rhythms in the central and peripheral circadian clockwork, which may involve a GSK3-mediated signalling pathway. These findings may advance our understanding of the therapeutic actions of lithium in Bipolar Disorder or other psychiatric diseases that involve circadian rhythm disruptions.	[Li, Jian; Beesley, Stephen; Loudon, Andrew S. I.; Meng, Qing-Jun] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Lu, Wei-Qun] Shanghai Ocean Univ, Fac Fisheries & Life Sci, Shanghai, Peoples R China	University of Manchester; Shanghai Ocean University	Li, J (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	Andrew.Loudon@manchester.ac.uk; Qing-Jun.Meng@manchester.ac.uk	beesley, stephen j/B-4841-2017	beesley, stephen j/0000-0001-6010-124X; Loudon, Andrew/0000-0003-3648-445X; Meng, Qing Jun/0000-0002-9426-8336	Medical Research Council [G0900414]; Biotechnology and Biological Sciences Research Council [BB/E022553/1]; BBSRC [BB/E022553/1] Funding Source: UKRI; MRC [G0900414] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank the Medical Research Council (Career Development Award to QM, G0900414) and the Biotechnology and Biological Sciences Research Council (BB/E022553/1) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2000, NEUROREPORT, V11, P3261, DOI 10.1097/00001756-200009280-00042; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Benedetti F, 2007, SLEEP MED REV, V11, P509, DOI 10.1016/j.smrv.2007.06.004; Chiu CT, 2010, PHARMACOL THERAPEUT, V128, P281, DOI 10.1016/j.pharmthera.2010.07.006; Fahrenkrug J, 2006, ENDOCRINOLOGY, V147, P3769, DOI 10.1210/en.2006-0305; Gibbs JE, 2009, ENDOCRINOLOGY, V150, P268, DOI 10.1210/en.2008-0638; Goodwin FK, 2007, MANIC DEPRESSIVE ILL; Guillaumond F, 2005, J BIOL RHYTHM, V20, P391, DOI 10.1177/0748730405277232; Harada Y, 2005, J BIOL CHEM, V280, P31714, DOI 10.1074/jbc.M506225200; Harvey AG, 2008, AM J PSYCHIAT, V165, P820, DOI 10.1176/appi.ajp.2008.08010098; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Hirota T, 2008, P NATL ACAD SCI USA, V105, P20746, DOI 10.1073/pnas.0811410106; Iitaka C, 2005, J BIOL CHEM, V280, P29397, DOI 10.1074/jbc.M503526200; Iwahana E, 2004, EUR J NEUROSCI, V19, P2281, DOI 10.1111/j.0953-816X.2004.03322.x; Izumo M, 2003, P NATL ACAD SCI USA, V100, P16089, DOI 10.1073/pnas.2536313100; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; KLEMFUSS H, 1992, PHARMACOL THERAPEUT, V56, P53, DOI 10.1016/0163-7258(92)90037-Z; Ko HW, 2010, J NEUROSCI, V30, P12664, DOI 10.1523/JNEUROSCI.1586-10.2010; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; McClung CA, 2007, PHARMACOL THERAPEUT, V114, P222, DOI 10.1016/j.pharmthera.2007.02.003; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; Meng QJ, 2008, J CELL SCI, V121, P3629, DOI 10.1242/jcs.035048; Meng QJ, 2008, NEURON, V58, P78, DOI 10.1016/j.neuron.2008.01.019; Okamoto K, 2005, ANAL BIOCHEM, V340, P193, DOI 10.1016/j.ab.2004.11.007; Osland TM, 2011, J PSYCHOPHARMACOL, V25, P924, DOI 10.1177/0269881110379508; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Roybal K, 2007, P NATL ACAD SCI USA, V104, P6406, DOI 10.1073/pnas.0609625104; Ryves WJ, 2001, BIOCHEM BIOPH RES CO, V280, P720, DOI 10.1006/bbrc.2000.4169; Sahar S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008561; Sato N, 2006, METH MOL B, V331, P115; Spengler ML, 2009, CELL CYCLE, V8, P4138, DOI 10.4161/cc.8.24.10273; Yamazaki S, 2005, METHOD ENZYMOL, V393, P288, DOI 10.1016/S0076-6879(05)93012-7; Yang S, 2009, MOL PSYCHIATR, V14, P143, DOI 10.1038/mp.2008.10; Yin L, 2006, SCIENCE, V311, P1002, DOI 10.1126/science.1121613; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	37	89	92	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33292	10.1371/journal.pone.0033292	http://dx.doi.org/10.1371/journal.pone.0033292			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22428012	Green Published, Green Submitted, gold			2022-12-25	WOS:000302381500121
J	Waiczies, H; Millward, JM; Lepore, S; Infante-Duarte, C; Pohlmann, A; Niendorf, T; Waiczies, S				Waiczies, Helmar; Millward, Jason M.; Lepore, Stefano; Infante-Duarte, Carmen; Pohlmann, Andreas; Niendorf, Thoralf; Waiczies, Sonia			Identification of Cellular Infiltrates during Early Stages of Brain Inflammation with Magnetic Resonance Microscopy	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; REMITTING MULTIPLE-SCLEROSIS; MOUSE MODEL; AUTOIMMUNE ENCEPHALOMYELITIS; CHOROID-PLEXUS; RF PROBE; MRI; LESIONS; CELLS	A comprehensive view of brain inflammation during the pathogenesis of autoimmune encephalomyelitis can be achieved with the aid of high resolution non-invasive imaging techniques such as microscopic magnetic resonance imaging (mMRI). In this study we demonstrate the benefits of cryogenically-cooled RF coils to produce mMRI in vivo, with sufficient detail to reveal brain pathology in the experimental autoimmune encephalomyelitis (EAE) model. We could visualize inflammatory infiltrates in detail within various regions of the brain, already at an early phase of EAE. Importantly, this pathology could be seen clearly even without the use of contrast agents, and showed excellent correspondence with conventional histology. The cryogenically-cooled coil enabled the acquisition of high resolution images within short scan times: an important practical consideration in conducting animal experiments. The detail of the cellular infiltrates visualized by in vivo mMRI allows the opportunity to follow neuroinflammatory processes even during the early stages of disease progression. Thus mMRI will not only complement conventional histological examination but will also enable longitudinal studies on the kinetics and dynamics of immune cell infiltration.	[Waiczies, Helmar; Millward, Jason M.; Lepore, Stefano; Infante-Duarte, Carmen; Niendorf, Thoralf; Waiczies, Sonia] Expt & Clin Res Ctr, Joint Cooperat Charite Med Fac & Max Delbruck Ctr, Berlin, Germany; [Waiczies, Helmar; Lepore, Stefano; Pohlmann, Andreas; Niendorf, Thoralf; Waiczies, Sonia] Max Delbruck Ctr Mol Med, Berlin Ultrahigh Field Facil, Berlin, Germany; [Millward, Jason M.; Infante-Duarte, Carmen] Charite, D-13353 Berlin, Germany; [Waiczies, Sonia] Univ Malta, Dept Anat, Msida, Malta	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Malta	Waiczies, H (corresponding author), Expt & Clin Res Ctr, Joint Cooperat Charite Med Fac & Max Delbruck Ctr, Berlin, Germany.	sonia.waiczies@charite.de	Waiczies, Sonia/H-4181-2012; Niendorf, Thoralf/H-7738-2013; Pohlmann, Andreas/K-7869-2016	Waiczies, Sonia/0000-0002-9916-9572; Niendorf, Thoralf/0000-0001-7584-6527; Pohlmann, Andreas/0000-0002-8572-2568; Waiczies, Helmar/0000-0001-6651-4790; Infante Duarte, Carmen/0000-0003-3005-351X; Millward, Jason/0000-0003-4484-2798	Deutsche Forschungsgemeinschaft (DFG) [DFG WA 2804, KFO 213]; Experimental and Clinical Research Center; Max Delbruck Center for Molecular Medicine; Charite Medical Faculty in Berlin	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Experimental and Clinical Research Center; Max Delbruck Center for Molecular Medicine(Helmholtz Association); Charite Medical Faculty in Berlin	This study was funded by the Deutsche Forschungsgemeinschaft (DFG) to SW (DFG WA 2804) and a university grant to SW from the Experimental and Clinical Research Center, a cooperation of the Max Delbruck Center for Molecular Medicine and Charite Medical Faculty in Berlin. The position of JM is funded by DFG KFO 213. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUAYO JB, 1986, NATURE, V322, P190, DOI 10.1038/322190a0; Alvarez JI, 2011, BBA-MOL BASIS DIS, V1812, P252, DOI 10.1016/j.bbadis.2010.06.017; Baltes C, 2009, NMR BIOMED, V22, P834, DOI 10.1002/nbm.1396; Bartholomaus I, 2009, NATURE, V462, P94, DOI 10.1038/nature08478; BENNUN A, 1981, NATURE, V292, P60, DOI 10.1038/292060a0; Benveniste H, 2002, PROG NEUROBIOL, V67, P393, DOI 10.1016/S0301-0082(02)00020-5; Budde MD, 2008, NMR BIOMED, V21, P589, DOI 10.1002/nbm.1229; Charil A, 2007, J NEUROL SCI, V259, P7, DOI 10.1016/j.jns.2006.08.017; Cleary JO, 2011, NEUROIMAGE, V56, P974, DOI 10.1016/j.neuroimage.2011.01.082; Dousset V, 1999, MAGN RESON MATER PHY, V8, P185; Engberink RDO, 2010, NMR BIOMED, V23, P1087, DOI 10.1002/nbm.1536; Engelhardt B, 2001, MICROSC RES TECHNIQ, V52, P112, DOI 10.1002/1097-0029(20010101)52:1<112::AID-JEMT13>3.0.CO;2-5; Engelhardt B, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-4; Floris S, 2004, BRAIN, V127, P616, DOI 10.1093/brain/awh068; Haacke EM, 2009, J MAGN RESON IMAGING, V29, P537, DOI 10.1002/jmri.21676; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Hauser SL, 2008, NEW ENGL J MED, V358, P676, DOI 10.1056/NEJMoa0706383; HICKEY WF, 1988, SCIENCE, V239, P290, DOI 10.1126/science.3276004; HOULT DI, 1976, J MAGN RESON, V24, P71, DOI 10.1016/0022-2364(76)90233-X; Kovacs H, 2005, PROG NUCL MAG RES SP, V46, P131, DOI 10.1016/j.pnmrs.2005.03.001; Levy H, 2010, EXP NEUROL, V226, P148, DOI 10.1016/j.expneurol.2010.08.017; Mueggler T, 2011, NEUROIMAGE; Nessler S, 2007, BRAIN, V130, P2186, DOI 10.1093/brain/awm105; Nouls JC, 2008, J MAGN RESON, V191, P231, DOI 10.1016/j.jmr.2007.12.018; Paul F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001928; Pohl HBF, 2011, J NEUROSCI, V31, P1069, DOI 10.1523/JNEUROSCI.5035-10.2011; Ransohoff RM, 2009, NATURE, V462, P41, DOI 10.1038/462041a; Ratering D, 2008, MAGN RESON MED, V59, P1440, DOI 10.1002/mrm.21629; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Stadelmann C, 2011, CURR OPIN NEUROL, V24, P224, DOI 10.1097/WCO.0b013e328346056f; Steinman L, 2006, ANN NEUROL, V60, P12, DOI 10.1002/ana.20913; Tan IL, 2002, J NEUROL, V249, P767, DOI 10.1007/s00415-002-0712-6; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; Tysiak E, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-20; Vellinga MM, 2008, BRAIN, V131, P800, DOI 10.1093/brain/awn009; Weissleder R, 1997, J MAGN RESON IMAGING, V7, P258, DOI 10.1002/jmri.1880070140; Wright AC, 2000, MAGNET RESON MED, V43, P163, DOI 10.1002/(SICI)1522-2594(200002)43:2<163::AID-MRM1>3.0.CO;2-K; Wuerfel E, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-70; Wuerfel J, 2004, BRAIN, V127, P111, DOI 10.1093/brain/awh007; Wuerfel J, 2007, EUR J NEUROSCI, V26, P190, DOI 10.1111/j.1460-9568.2007.05644.x	40	28	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e32796	10.1371/journal.pone.0032796	http://dx.doi.org/10.1371/journal.pone.0032796			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427887	Green Accepted, Green Published, gold			2022-12-25	WOS:000302381500048
J	Schushan, M; Rimon, A; Haliloglu, T; Forrest, LR; Padan, E; Ben-Tal, N				Schushan, Maya; Rimon, Abraham; Haliloglu, Turkan; Forrest, Lucy R.; Padan, Etana; Ben-Tal, Nir			A Model-Structure of a Periplasm-facing State of the NhaA Antiporter Suggests the Molecular Underpinnings of pH-induced Conformational Changes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOOP-VIII-IX; NA+/H+-ANTIPORTER; ESCHERICHIA-COLI; TRANSMEMBRANE DOMAIN; HELICOBACTER-PYLORI; CRYSTAL-STRUCTURE; CATION PASSAGE; MEMBRANE; MECHANISM; DYNAMICS	The Escherichia coli NhaA antiporter couples the transport of H+ and Na+ (or Li+) ions to maintain the proper pH range and Na+ concentration in cells. A crystal structure of NhaA, solved at pH 4, comprises 12 transmembrane helices (TMs), arranged in two domains, with a large cytoplasm-facing funnel and a smaller periplasm-facing funnel. NhaA undergoes conformational changes, e. g. after pH elevation to alkaline ranges, and we used two computational approaches to explore them. On the basis of pseudo-symmetric features of the crystal structure, we predicted the structural architecture of an alternate, periplasm-facing state. In contrast to the crystal structure, the model presents a closed cytoplasmic funnel, and a periplasmic funnel of greater volume. To examine the transporter functional direction of motion, we conducted elastic network analysis of the crystal structure and detected two main normal modes of motion. Notably, both analyses predicted similar trends of conformational changes, consisting of an overall rotational motion of the two domains around a putative symmetry axis at the funnel centers, perpendicular to the membrane plane. This motion, along with conformational changes within specific helices, resulted in closure at the cytoplasmic end and opening at the periplasmic end. Cross-linking experiments, performed between segments on opposite sides of the cytoplasmic funnel, revealed pH-dependent interactions consistent with the proposed conformational changes. We suggest that the model-structure and predicted motion represent alkaline pH-induced conformational changes, mediated by a cluster of evolutionarily conserved, titratable residues, at the cytoplasmic ends of TMs II, V, and IX.	[Schushan, Maya; Ben-Tal, Nir] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem & Mol Biol, IL-69978 Ramat Aviv, Israel; [Rimon, Abraham; Padan, Etana] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel; [Haliloglu, Turkan] Bogazici Univ, Life Sci & Technol Res Ctr, Polymer Res Ctr, Dept Chem Engn, TR-34342 Istanbul, Turkey; [Forrest, Lucy R.] Max Planck Inst Biophys, Computat Struct Biol Grp, D-60438 Frankfurt, Germany	Tel Aviv University; Hebrew University of Jerusalem; Bogazici University; Max Planck Society	Ben-Tal, N (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem & Mol Biol, IL-69978 Ramat Aviv, Israel.	nirb@tauex.tau.ac.il	; Forrest, Lucy/E-8113-2016	Ben-Tal, Nir/0000-0001-6901-832X; Forrest, Lucy/0000-0003-1855-7985	Israel Science Foundation [1331/11]; NATO [CBP.MD.CLG 983009]; Edmond J. Safra Center for Bioinformatics at Tel-Aviv University; EDICT (European Drug Initiative on Channels and Transporters) [EU EP7]; USA-Israel Binational Science Foundation [BSF 20050130]; DFG (German Research Foundation); Collaborative Research Center;  [CBD.MD.CL6.984340]	Israel Science Foundation(Israel Science Foundation); NATO(NATO (North Atlantic Treaty Organisation)); Edmond J. Safra Center for Bioinformatics at Tel-Aviv University; EDICT (European Drug Initiative on Channels and Transporters); USA-Israel Binational Science Foundation(US-Israel Binational Science Foundation); DFG (German Research Foundation)(German Research Foundation (DFG)); Collaborative Research Center; 	This work was supported in part by Grant 1331/11 from the Israel Science Foundation (to N. B-T.), and by NATO Traveling Grant No. CBP.MD.CLG 983009 (to T. H. and N. B-T.). This work was also supported in part by a fellowship from the Edmond J. Safra Center for Bioinformatics at Tel-Aviv University (to M. S.); by EDICT (European Drug Initiative on Channels and Transporters) Grant Number: EU EP7, and The USA-Israel Binational Science Foundation Grant Number: BSF 20050130 (to E. P.); by the DFG (German Research Foundation), Collaborative Research Center 807 "Transport and Communication across Biological Membranes" (to L. R. F.); and by Grant CBD.MD.CL6.984340 (to T. H.).	Adamian L, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-13; Appel M, 2009, J MOL BIOL, V388, P659, DOI 10.1016/j.jmb.2009.03.010; Arkin IT, 2007, SCIENCE, V317, P799, DOI 10.1126/science.1142824; Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; Bahar I, 2005, CURR OPIN STRUC BIOL, V15, P586, DOI 10.1016/j.sbi.2005.08.007; Bahar I, 1997, PROTEINS, V29, P292, DOI 10.1002/(SICI)1097-0134(199711)29:3<292::AID-PROT4>3.3.CO;2-5; Bahar I, 1997, FOLD DES, V2, P173, DOI 10.1016/S1359-0278(97)00024-2; Bahar I, 2010, J GEN PHYSIOL, V135, P563, DOI 10.1085/jgp.200910368; Bahar I, 2010, CHEM REV, V110, P1463, DOI 10.1021/cr900095e; Boudker O, 2010, TRENDS PHARMACOL SCI, V31, P418, DOI 10.1016/j.tips.2010.06.004; Bowie JU, 2006, NAT STRUCT MOL BIOL, V13, P94, DOI 10.1038/nsmb0206-94; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; Chen YJ, 2007, P NATL ACAD SCI USA, V104, P18999, DOI 10.1073/pnas.0709387104; Crisman TJ, 2009, P NATL ACAD SCI USA, V106, P20752, DOI 10.1073/pnas.0908570106; Cui Q., 2006, NORMAL MODE ANAL THE; Diab M, 2011, J MOL BIOL, V413, P604, DOI 10.1016/j.jmb.2011.08.046; Dzafic E, 2009, SPECTROCHIM ACTA A, V72, P102, DOI 10.1016/j.saa.2008.08.015; Emekli U, 2008, PROTEINS, V70, P1219, DOI 10.1002/prot.21613; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Fleishman SJ, 2006, CURR OPIN STRUC BIOL, V16, P496, DOI 10.1016/j.sbi.2006.06.003; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Forrest LR, 2006, BIOPHYS J, V91, P508, DOI 10.1529/biophysj.106.082313; Galili L, 2004, J BIOL CHEM, V279, P23104, DOI 10.1074/jbc.M400288200; Galili L, 2002, BIOCHEMISTRY-US, V41, P609, DOI 10.1021/bi011655v; Gerchman Y, 1999, J BIOL CHEM, V274, P24617, DOI 10.1074/jbc.274.35.24617; Gerchman Y, 2001, BIOCHEMISTRY-US, V40, P3403, DOI 10.1021/bi002669o; Guan L, 2007, NAT PROTOC, V2, P2012, DOI 10.1038/nprot.2007.275; Guan L, 2006, ANNU REV BIOPH BIOM, V35, P67, DOI 10.1146/annurev.biophys.35.040405.102005; Haliloglu T, 1997, PHYS REV LETT, V79, P3090, DOI 10.1103/PhysRevLett.79.3090; Herz K, 2010, J BIOL CHEM, V285, P2211, DOI 10.1074/jbc.M109.047134; Hu NJ, 2011, NATURE, V478, P408, DOI 10.1038/nature10450; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Illergard K, 2011, PROTEINS, V79, P79, DOI 10.1002/prot.22859; INOUE H, 1995, FEBS LETT, V363, P264, DOI 10.1016/0014-5793(95)00331-3; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Kaback HR, 2005, CR BIOL, V328, P557, DOI 10.1016/j.crvi.2005.03.008; Karasawa A, 2005, J BIOL CHEM, V280, P41900, DOI 10.1074/jbc.M510795200; Kessel A, 2002, CURR TOP MEMBR, V52, P205; Kessel A., 2010, PROTEINS STRUCTURE F; Kozachkov L, 2007, BIOCHEMISTRY-US, V46, P2419, DOI 10.1021/bi602393s; Kozachkov L, 2011, P NATL ACAD SCI USA, V108, P15769, DOI 10.1073/pnas.1109256108; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Kuwabara N, 2004, J BIOL CHEM, V279, P40567, DOI 10.1074/jbc.M401132200; Kuwabara N, 2006, BIOCHEMISTRY-US, V45, P14834, DOI 10.1021/bi061048d; Landau M, 2007, J BIOL CHEM, V282, P37854, DOI 10.1074/jbc.M705460200; Mager T, 2011, J BIOL CHEM, V286, P23570, DOI 10.1074/jbc.M111.230235; Olkhova E, 2006, P NATL ACAD SCI USA, V103, P2629, DOI 10.1073/pnas.0510914103; Olkhova E, 2007, BIOPHYS J, V92, P3784, DOI 10.1529/biophysj.106.098269; Padan E, 2005, BBA-BIOMEMBRANES, V1717, P67, DOI 10.1016/j.bbamem.2005.09.010; Padan E, 2004, BBA-BIOENERGETICS, V1658, P2, DOI 10.1016/j.bbabio.2004.04.018; Padan E, 2008, TRENDS BIOCHEM SCI, V33, P435, DOI 10.1016/j.tibs.2008.06.007; Padan E, 2009, J EXP BIOL, V212, P1593, DOI 10.1242/jeb.026708; Petrey D, 2003, METHOD ENZYMOL, V374, P492, DOI 10.1016/S0076-6879(03)74021-X; Pornillos O, 2006, FEBS LETT, V580, P358, DOI 10.1016/j.febslet.2005.12.054; Radestock S, 2011, J MOL BIOL, V407, P698, DOI 10.1016/j.jmb.2011.02.008; Rapp M, 2007, SCIENCE, V315, P1282, DOI 10.1126/science.1135406; Rimon A, 2002, BIOCHEMISTRY-US, V41, P14897, DOI 10.1021/bi0261342; Rothman A, 1997, BIOCHEMISTRY-US, V36, P14572, DOI 10.1021/bi971800y; Schushan M, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.L110.159202; Schushan M, 2010, J MOL BIOL, V396, P1181, DOI 10.1016/j.jmb.2009.12.055; TAGLICHT D, 1991, J BIOL CHEM, V266, P11289; Tzubery T, 2004, J BIOL CHEM, V279, P3265, DOI 10.1074/jbc.M309021200; Tzubery T, 2008, J BIOL CHEM, V283, P15975, DOI 10.1074/jbc.M800482200; Venturi M, 2000, J BIOL CHEM, V275, P4734, DOI 10.1074/jbc.275.7.4734; Vinothkumar KR, 2005, EMBO J, V24, P2720, DOI 10.1038/sj.emboj.7600727; WEST IC, 1974, BIOCHEM J, V144, P87, DOI 10.1042/bj1440087	69	25	25	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18249	18261		10.1074/jbc.M111.336446	http://dx.doi.org/10.1074/jbc.M111.336446			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22431724	hybrid, Green Published			2022-12-25	WOS:000306411600032
J	Weissgerber, P; Kriebs, U; Tsvilovskyy, V; Olausson, J; Kretz, O; Stoerger, C; Mannebach, S; Wissenbach, U; Vennekens, R; Middendorff, R; Flockerzi, V; Freichel, M				Weissgerber, Petra; Kriebs, Ulrich; Tsvilovskyy, Volodymyr; Olausson, Jenny; Kretz, Oliver; Stoerger, Christof; Mannebach, Stefanie; Wissenbach, Ulrich; Vennekens, Rudi; Middendorff, Ralf; Flockerzi, Veit; Freichel, Marc			Excision of Trpv6 Gene Leads to Severe Defects in Epididymal Ca2+ Absorption and Male Fertility Much Like Single D541A Pore Mutation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHANNELS TRPV5; SEMINIFEROUS TUBULES; CAT-LIKE; EXPRESSION; IDENTIFICATION; INHIBITION; RECEPTOR; DELTA-2; FLUID; ENTRY	Replacement of aspartate residue 541 by alanine (D541A) in the pore of TRPV6 channels in mice disrupts Ca2+ absorption by the epididymal epithelium, resulting in abnormally high Ca2+ concentrations in epididymal luminal fluid and in a dramatic but incomplete loss of sperm motility and fertilization capacity, raising the possibility of residual activity of channels formed by TRPV6(D541A) proteins (Weissgerber, P., Kriebs, U., Tsvilovskyy, V., Olausson, J., Kretz, O., Stoerger, C., Vennekens, R., Wissen-bach, U., Middendorff, R., Flockerzi, V., and Freichel, M. (2011) Sci. Signal. 4, ra27). It is known from other cation channels that introducing pore mutations even if they largely affect their conductivity and permeability can evoke considerably different phenotypes compared with the deletion of the corresponding protein. Therefore, we generated TRPV6-deficient mice (Trpv6(-/-)) by deleting exons encoding transmembrane domains with the pore-forming region and the complete cytosolic C terminus harboring binding sites for TRPV6-associated proteins that regulate its activity and plasma membrane anchoring. Using this strategy, we aimed to determine whether the TRPV6(D541A) pore mutant still contributes to residual channel activity and/or channel-independent functions in vivo. Trpv6(-/-) males reveal severe defects in fertility and motility and viability of sperm and a significant increase in epididymal luminal Ca2+ concentration that is mirrored by a lack of Ca2+ uptake by the epididymal epithelium. Therewith, Trpv6 excision affects epididymal Ca2+ handling and male fertility to the same extent as the introduction of the D541A pore mutation, arguing against residual functions of the TRPV6(D541A) pore mutant in epididymal epithelial cells.	[Tsvilovskyy, Volodymyr; Freichel, Marc] Heidelberg Univ, Inst Pharmakol, D-69120 Heidelberg, Germany; [Weissgerber, Petra; Kriebs, Ulrich; Tsvilovskyy, Volodymyr; Olausson, Jenny; Stoerger, Christof; Mannebach, Stefanie; Wissenbach, Ulrich; Vennekens, Rudi; Flockerzi, Veit; Freichel, Marc] Univ Saarland, D-66421 Homburg, Germany; [Middendorff, Ralf] Univ Giessen, Inst Anat & Zellbiol, D-35385 Giessen, Germany; [Kretz, Oliver] Univ Freiburg, Zentrum Neurowissensch, D-79104 Freiburg, Germany	Ruprecht Karls University Heidelberg; Saarland University; Justus Liebig University Giessen; University of Freiburg	Freichel, M (corresponding author), Heidelberg Univ, Inst Pharmakol, Neuenheimer Feld 366, D-69120 Heidelberg, Germany.	marc.freichel@pharma.uni-heidelberg.de	Vennekens, Rudi/AAQ-1664-2020	Vennekens, Rudi/0000-0002-2564-5150; Kretz, Oliver/0000-0003-1152-5956	Deutsche Forschungsgemeinschaft; Fonds der Chemischen Industrie and Sander-Stiftung; LOEWE program; Landes-Offensive zur Ent-wicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE); Homburger Forschungsforderungsprogramm (HOMFOR); Forschungsausschuss der Universitat des Saarlandes	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie and Sander-Stiftung(Fonds der Chemischen Industrie); LOEWE program; Landes-Offensive zur Ent-wicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE); Homburger Forschungsforderungsprogramm (HOMFOR); Forschungsausschuss der Universitat des Saarlandes	This work was supported by the Deutsche Forschungsgemeinschaft (to M.F., V.F., P.W., and R.M.), Fonds der Chemischen Industrie and Sander-Stiftung (to V.F.), LOEWE program (to R.M.), and Landes-Offensive zur Ent-wicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE), Homburger Forschungsforderungsprogramm (HOMFOR) and Forschungsausschuss der Universitat des Saarlandes (to M.F., V.F., P.W., and V.T.).	ACOTT TS, 1984, BIOL REPROD, V30, P926, DOI 10.1095/biolreprod30.4.926; Bianco SDC, 2007, J BONE MINER RES, V22, P274, DOI 10.1359/JBMR.061110; Darszon A, 2006, REPRODUCTION, V131, P977, DOI 10.1530/rep.1.00612; Evans JP, 2002, NAT CELL BIOL, V4, pS57, DOI 10.1038/ncb-nm-fertilityS57; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Freichel M, 1998, FEBS LETT, V422, P354, DOI 10.1016/S0014-5793(98)00041-6; Hirnet D, 2003, CELL CALCIUM, V33, P509, DOI 10.1016/S0143-4160(03)00066-6; Hoenderop JGJ, 2003, J CLIN INVEST, V112, P1906, DOI 10.1172/JCI200319826; Hoenderop JGJ, 2003, PFLUG ARCH EUR J PHY, V446, P304, DOI 10.1007/s00424-003-1045-8; Hoenderop JGJ, 1999, J BIOL CHEM, V274, P8375, DOI 10.1074/jbc.274.13.8375; Jarolimek W, 1998, J NEUROSCI, V18, P4001; JENKINS AD, 1980, BIOL REPROD, V23, P981, DOI 10.1095/biolreprod23.5.981; Kakegawa W, 2007, J PHYSIOL-LONDON, V579, P729, DOI 10.1113/jphysiol.2006.127100; Lambers TT, 2004, J BIOL CHEM, V279, P28855, DOI 10.1074/jbc.M313637200; LEVINE N, 1971, J PHYSIOL-LONDON, V213, P557, DOI 10.1113/jphysiol.1971.sp009400; LEVINE N, 1978, J REPROD FERTIL, V52, P333, DOI 10.1530/jrf.0.0520333; Luo HY, 2004, J CLIN INVEST, V114, P1762, DOI 10.1172/JCI200421846; Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5; Niemeyer BA, 2001, P NATL ACAD SCI USA, V98, P3600, DOI 10.1073/pnas.051511398; Peng JB, 2003, J PHYSIOL-LONDON, V551, P729, DOI 10.1113/jphysiol.2003.043349; Peng JB, 1999, J BIOL CHEM, V274, P22739, DOI 10.1074/jbc.274.32.22739; Shimoyama M, 2002, BIOCHEM BIOPH RES CO, V298, P87, DOI 10.1016/S0006-291X(02)02399-9; TURNER TT, 1991, ANN NY ACAD SCI, V637, P364, DOI 10.1111/j.1749-6632.1991.tb27323.x; van de Graaf SFJ, 2006, AM J PHYSIOL-RENAL, V290, pF1295, DOI 10.1152/ajprenal.00443.2005; van de Graaf SFJ, 2006, MOL CELL BIOL, V26, P303, DOI 10.1128/MCB.26.1.303-312.2006; Van de Graaf SFJ, 2003, EMBO J, V22, P1478, DOI 10.1093/emboj/cdg162; van de Graaf SFJ, 2006, PFLUG ARCH EUR J PHY, V452, P407, DOI 10.1007/s00424-006-0051-z; Vennekens R, 2000, J BIOL CHEM, V275, P3963, DOI 10.1074/jbc.275.6.3963; Voets T, 2003, J GEN PHYSIOL, V121, P245, DOI 10.1085/jgp.20028752; Weissgerber P, 2011, SCI SIGNAL, V4, P6, DOI 10.1126/scisignal.2001791; Wissenbach U, 2001, J BIOL CHEM, V276, P19461, DOI 10.1074/jbc.M009895200; Wollmuth LP, 2000, J NEUROSCI, V20, P5973, DOI 10.1523/JNEUROSCI.20-16-05973.2000	32	47	50	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					17930	17941		10.1074/jbc.M111.328286	http://dx.doi.org/10.1074/jbc.M111.328286			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22427671	hybrid, Green Published			2022-12-25	WOS:000306411600003
J	Heaslip, SG; Iverson, SJ; Bowen, WD; James, MC				Heaslip, Susan G.; Iverson, Sara J.; Bowen, W. Don; James, Michael C.			Jellyfish Support High Energy Intake of Leatherback Sea Turtles (Dermochelys coriacea): Video Evidence from Animal-Borne Cameras	PLOS ONE			English	Article							FORAGING BEHAVIOR; PREY SELECTION; METABOLIC-RATE; THERMAL NICHE; BERING SEA; MIGRATIONS; MOVEMENT; HABITAT; WATERS; DIVE	The endangered leatherback turtle is a large, highly migratory marine predator that inexplicably relies upon a diet of low-energy gelatinous zooplankton. The location of these prey may be predictable at large oceanographic scales, given that leatherback turtles perform long distance migrations (1000s of km) from nesting beaches to high latitude foraging grounds. However, little is known about the profitability of this migration and foraging strategy. We used GPS location data and video from animal-borne cameras to examine how prey characteristics (i.e., prey size, prey type, prey encounter rate) correlate with the daytime foraging behavior of leatherbacks (n = 19) in shelf waters off Cape Breton Island, NS, Canada, during August and September. Video was recorded continuously, averaged 1: 53 h per turtle (range 0: 08-3: 38 h), and documented a total of 601 prey captures. Lion's mane jellyfish (Cyanea capillata) was the dominant prey (83-100%), but moon jellyfish (Aurelia aurita) were also consumed. Turtles approached and attacked most jellyfish within the camera's field of view and appeared to consume prey completely. There was no significant relationship between encounter rate and dive duration (p = 0.74, linear mixed-effects models). Handling time increased with prey size regardless of prey species (p = 0.0001). Estimates of energy intake averaged 66,018 kJ.d(-1) but were as high as 167,797 kJ.d(-1) corresponding to turtles consuming an average of 330 kg wet mass.d(-1) (up to 840 kg.d(-1)) or approximately 261 (up to 664) jellyfish.d(-1). Assuming our turtles averaged 455 kg body mass, they consumed an average of 73% of their body mass.d(-1) equating to an average energy intake of 3-7 times their daily metabolic requirements, depending on estimates used. This study provides evidence that feeding tactics used by leatherbacks in Atlantic Canadian waters are highly profitable and our results are consistent with estimates of mass gain prior to southward migration.	[Heaslip, Susan G.; Iverson, Sara J.; Bowen, W. Don; James, Michael C.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Bowen, W. Don; James, Michael C.] Bedford Inst Oceanog, Populat Ecol Div, Dept Fisheries & Oceans, Dartmouth, NS, Canada	Dalhousie University; Bedford Institute of Oceanography; Fisheries & Oceans Canada	Heaslip, SG (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS, Canada.	Susan.Heaslip@dal.ca; mcjames@dal.ca	Heaslip, Susan G/I-9137-2012; Bowen, William/D-2758-2012; Bowen, William/AAE-7204-2022	Bowen, William/0000-0001-8334-5677; Iverson, Sara/0000-0003-2842-4094	Canadian Wildlife Federation; Environment Canada; World Wildlife Fund Canada [ESR6781, ESR1312, ESR1443, ESR1615]; United States of America National Oceanic and Atmospheric Administration's National Marine Fisheries Service; Natural Sciences and Engineering Research Council (NSERC) of Canada [RTI-330181, PDF-343282]; Fisheries and Oceans Canada [F5627-070048]; NSERC	Canadian Wildlife Federation; Environment Canada(CGIAR); World Wildlife Fund Canada; United States of America National Oceanic and Atmospheric Administration's National Marine Fisheries Service; Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fisheries and Oceans Canada; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding for this research was provided by the Canadian Wildlife Federation (http://www.cwf-fcf.org); Environment Canada and World Wildlife Fund Canada (http://www.ec.gc.ca and http://www.wwf.ca; ESR6781, ESR1312, ESR1443, and ESR1615); United States of America National Oceanic and Atmospheric Administration's National Marine Fisheries Service (http://www.nmfs.noaa.gov); Natural Sciences and Engineering Research Council (NSERC) of Canada (http://www.nserc-crsng.gc.ca; RTI-330181 and PDF-343282); and Fisheries and Oceans Canada (http://www.dfo-mpo.gc.ca; F5627-070048). SGH was supported by a NSERC Post-graduate Scholarship. None of these funders had a role in the study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Bailey H, 2008, J EXP MAR BIOL ECOL, V356, P128, DOI 10.1016/j.jembe.2007.12.020; BAMSTEDT U, 1994, ICES J MAR SCI, V51, P369, DOI 10.1006/jmsc.1994.1039; Benoit-Bird KJ, 2003, BEHAV ECOL SOCIOBIOL, V53, P364, DOI 10.1007/s00265-003-0585-4; Benson SR, 2007, CHELONIAN CONSERV BI, V6, P150, DOI 10.2744/1071-8443(2007)6[150:PMOLTD]2.0.CO;2; Blumstein D. T., 2007, QUANTIFYING BEHAV JW; Bowen WD, 2002, MAR ECOL PROG SER, V244, P235, DOI 10.3354/meps244235; Bradshaw CJA, 2007, PHYSIOL BIOCHEM ZOOL, V80, P209, DOI 10.1086/511142; Brock HME, 2006, LEATHERBACK TURTLES; Brodeur RD, 2002, MAR ECOL PROG SER, V233, P89, DOI 10.3354/meps233089; Calambokidis J, 2007, MAR TECHNOL SOC J, V41, P19, DOI 10.4031/002533207787441980; Casey J, 2010, J EXP BIOL, V213, P3961, DOI 10.1242/jeb.048611; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; [COSEWIC Canada COSEWIC], 2001, COSEWIC ASS UPD STAT, p[25, vii]; Davenport J., 1998, British Herpetological Society Bulletin, V62, P4; Doyle TK, 2007, J EXP MAR BIOL ECOL, V343, P239, DOI 10.1016/j.jembe.2006.12.010; Doyle TK, 2007, HYDROBIOLOGIA, V579, P29, DOI 10.1007/s10750-006-0362-2; Fossette S, 2008, J ANIM ECOL, V77, P236, DOI 10.1111/j.1365-2656.2007.01344.x; Fossette S, 2010, J MARINE SYST, V81, P225, DOI 10.1016/j.jmarsys.2009.12.002; Graham TR, 2010, ICES J MAR SCI, V67, P1739, DOI 10.1093/icesjms/fsq112; HAMNER WM, 1986, LIMNOL OCEANOGR, V31, P171, DOI 10.4319/lo.1986.31.1.0171; Hays GC, 2004, ANIM BEHAV, V67, P733, DOI 10.1016/j.anbehav.2003.08.011; Hays GC, 2007, MAR BIOL, V150, P1003, DOI 10.1007/s00227-006-0412-3; Heithaus MR, 2001, MAR ECOL PROG SER, V209, P307, DOI 10.3354/meps209307; Houghton JDR, 2006, ECOLOGY, V87, P1967, DOI 10.1890/0012-9658(2006)87[1967:JAALTF]2.0.CO;2; James MC, 2005, MAR BIOL, V147, P845, DOI 10.1007/s00227-005-1581-1; James MC, 2005, ECOL LETT, V8, P195, DOI 10.1111/j.1461-0248.2004.00710.x; James MC, 2005, P ROY SOC B-BIOL SCI, V272, P1547, DOI 10.1098/rspb.2005.3110; James MC, 2007, MAR ECOL PROG SER, V337, P245, DOI 10.3354/meps337245; James Michael C., 2001, Chelonian Conservation and Biology, V4, P202; James MC, 2006, J EXP MAR BIOL ECOL, V335, P221, DOI 10.1016/j.jembe.2006.03.013; James MC, 2006, BIOL CONSERV, V133, P347, DOI 10.1016/j.biocon.2006.06.012; Jeschke JM, 2002, ECOL MONOGR, V72, P95, DOI 10.1890/0012-9615(2002)072[0095:PFRDBH]2.0.CO;2; Jonsen ID, 2007, MAR ECOL PROG SER, V337, P255, DOI 10.3354/meps337255; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; Lea MA, 2006, LOW WAKE FI, P235; LUTCAVAGE M, 1986, COPEIA, P796, DOI 10.2307/1444962; McMahon CR, 2006, GLOBAL CHANGE BIOL, V12, P1330, DOI 10.1111/j.1365-2486.2006.01174.x; Myers AE, 2006, MAR ECOL PROG SER, V322, P259, DOI 10.3354/meps322259; Nagy KA, 1999, ANNU REV NUTR, V19, P247, DOI 10.1146/annurev.nutr.19.1.247; Pinheiro J, 2001, MIXED EFFECTS MODELS; Purcell JE, 2003, MAR ECOL PROG SER, V246, P137, DOI 10.3354/meps246137; Purcell JE, 2007, MAR ECOL PROG SER, V350, P153, DOI 10.3354/meps07093; R Core Team, 2022, R LANG ENV STAT COMP; Reina RD, 2005, J EXP MAR BIOL ECOL, V316, P1, DOI 10.1016/j.jembe.2004.10.002; Sarti Martinez AL, 2000, DERMOCHELYS CORIACEA; Shillinger GL, 2008, PLOS BIOL, V6, P1408, DOI 10.1371/journal.pbio.0060171; Stephens D.W., 1986, pi; Sullivan BK, 1997, MAR BIOL, V130, P213, DOI 10.1007/s002270050241; Van Houtan KS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019043; Wallace BP, 2005, INTEGR COMP BIOL, V45, P1092; Witt MJ, 2007, MAR ECOL PROG SER, V337, P231, DOI 10.3354/meps337231; Witt MJ, 2011, P ROY SOC B-BIOL SCI, V278, P2338, DOI 10.1098/rspb.2010.2467; Witteveen BH, 2008, MAR MAMMAL SCI, V24, P516, DOI 10.1111/j.1748-7692.2008.00193.x; Zollner PA, 1999, ECOLOGY, V80, P1019, DOI 10.2307/177035	54	80	86	2	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33259	10.1371/journal.pone.0033259	http://dx.doi.org/10.1371/journal.pone.0033259			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438906	Green Published, gold, Green Submitted			2022-12-25	WOS:000303309100029
J	Weston-Green, K; Huang, XF; Deng, C				Weston-Green, Katrina; Huang, Xu-Feng; Deng, Chao			Alterations to Melanocortinergic, GABAergic and Cannabinoid Neurotransmission Associated with Olanzapine-Induced Weight Gain	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; Y-LIKE IMMUNOREACTIVITY; GLUTAMIC-ACID DECARBOXYLASE; DORSAL VAGAL COMPLEX; LONG-TERM TREATMENT; NEUROPEPTIDE-Y; FOOD-INTAKE; ATYPICAL ANTIPSYCHOTICS; ARCUATE NUCLEUS; BODY-WEIGHT	Background/Aim: Second generation antipsychotics (SGAs) are used to treat schizophrenia but can cause serious metabolic side-effects, such as obesity and diabetes. This study examined the effects of low to high doses of olanzapine on appetite/metabolic regulatory signals in the hypothalamus and brainstem to elucidate the mechanisms underlying olanzapine-induced obesity. Methodology/Results: Levels of pro-opiomelanocortin (POMC), neuropeptide Y (NPY) and glutamic acid decarboxylase (GAD(65), enzyme for GABA synthesis) mRNA expression, and cannabinoid CB1 receptor (CB1R) binding density (using [H-3]SR-141716A) were examined in the arcuate nucleus (Arc) and dorsal vagal complex (DVC) of female Sprague Dawley rats following 0.25, 0.5, 1.0 or 2.0 mg/kg olanzapine or vehicle (3x/day, 14-days). Consistent with its weight gain liability, olanzapine significantly decreased anorexigenic POMC and increased orexigenic NPY mRNA expression in a dose-sensitive manner in the Arc. GAD(65) mRNA expression increased and CB1R binding density decreased in the Arc and DVC. Alterations to neurotransmission signals in the brain significantly correlated with body weight and adiposity. The minimum dosage threshold required to induce weight gain in the rat was 0.5 mg/kg olanzapine. Conclusions: Olanzapine-induced weight gain is associated with reduced appetite-inhibiting POMC and increased NPY. This study also supports a role for the CB1R and GABA in the mechanisms underlying weight gain side-effects, possibly by altering POMC transmission. Metabolic dysfunction can be modelled in the female rat using low, clinically-comparable olanzapine doses when administered in-line with the half-life of the drug.	[Weston-Green, Katrina; Huang, Xu-Feng; Deng, Chao] Univ Wollongong, Sch Hlth Sci, Ctr Translat Neurosci, Wollongong, NSW, Australia; [Weston-Green, Katrina; Huang, Xu-Feng; Deng, Chao] Schizophrenia Res Inst, Darlinghurst, NSW, Australia	University of Wollongong	Weston-Green, K (corresponding author), Univ Wollongong, Sch Hlth Sci, Ctr Translat Neurosci, Wollongong, NSW, Australia.	chao@uow.edu.au	Huang, Xu-Feng/H-7408-2015; Weston-Green, Katrina/AAQ-8280-2020; Deng, Chao/F-4417-2016; Huang, Xu-Feng/D-6053-2013	Huang, Xu-Feng/0000-0002-5895-2253; Weston-Green, Katrina/0000-0002-4521-8463; Deng, Chao/0000-0003-1147-5741; Huang, Xu-Feng/0000-0002-5895-2253	University of Wollongong University Research Centre (URC); Australian National Health and Medical Research Council (NHMRC) [635231]; Schizophrenia Research Institute (SRI); New South Wales Health	University of Wollongong University Research Centre (URC); Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Schizophrenia Research Institute (SRI); New South Wales Health	This study was supported by a University of Wollongong (www.uow.edu.au) University Research Centre (URC) grant to CD, an Australian National Health and Medical Research Council (NHMRC, www.nhmrc.gov.au) grant to XH and CD (ID 635231), and by the Schizophrenia Research Institute (SRI, www.schizophreniaresearch.org.au), utilising infrastructure funding from New South Wales Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbarian S, 2006, BRAIN RES REV, V52, P293, DOI 10.1016/j.brainresrev.2006.04.001; Albaugh VL, 2006, OBESITY, V14, P36, DOI 10.1038/oby.2006.6; Alger BE, 2002, PROG NEUROBIOL, V68, P247; Allison DB, 2009, AM J PREV MED, V36, P341, DOI 10.1016/j.amepre.2008.11.020; Aravagiri M, 1999, BIOPHARM DRUG DISPOS, V20, P369, DOI 10.1002/1099-081X(199911)20:8<369::AID-BDD200>3.0.CO;2-6; Archie S, 2003, CAN J PSYCHIAT, V48, P628, DOI 10.1177/070674370304800910; Balcombe JP, 2004, CONTEMP TOP LAB ANIM, V43, P42; Ballard C, 2006, COCHRANE DB SYST REV, V2006, DOI [003410.001002/14651858.CD14003476.pub14651852, DOI 10.1002/14651858.CD003476.PUB2]; Baptista T, 2002, BRAIN RES, V957, P144, DOI 10.1016/S0006-8993(02)03616-8; Beasley CM, 1996, NEUROPSYCHOPHARMACOL, V14, P111, DOI 10.1016/0893-133X(95)00069-P; BECK B, 1992, INT J OBESITY, V16, P295; Beck B, 2006, PHILOS T R SOC B, V361, P1159, DOI 10.1098/rstb.2006.1855; Bermudez-Silva FJ, 2010, PHARMACOL BIOCHEM BE, V95, P375, DOI 10.1016/j.pbb.2010.03.012; Berrendero F, 1998, BBA-MOL BASIS DIS, V1407, P205, DOI 10.1016/S0925-4439(98)00042-8; Berthoud HR, 2002, NEUROSCI BIOBEHAV R, V26, P393, DOI 10.1016/S0149-7634(02)00014-3; Brambilla F, 2007, PSYCHONEUROENDOCRINO, V32, P402, DOI 10.1016/j.psyneuen.2007.02.005; Bridle C, 2004, Health Technol Assess, V8, piii; Broberger C, 2001, PHYSIOL BEHAV, V74, P669, DOI 10.1016/S0031-9384(01)00611-4; BRONSTEIN DM, 1992, BRAIN RES, V587, P269, DOI 10.1016/0006-8993(92)91007-2; Brown S, 1999, PSYCHOL MED, V29, P697, DOI 10.1017/S0033291798008186; Budman CL, 2001, J CLIN PSYCHIAT, V62, P290, DOI 10.4088/JCP.v62n0412; Bymaster FP, 1996, PSYCHOPHARMACOLOGY, V124, P87, DOI 10.1007/BF02245608; Bymaster FP, 1996, NEUROPSYCHOPHARMACOL, V14, P87, DOI 10.1016/0893-133X(94)00129-N; Cavuoto P, 2009, BEST PRACT RES CL EN, V23, P79, DOI 10.1016/j.beem.2008.10.005; Centorrino F, 2002, AM J PSYCHIAT, V159, P1932, DOI 10.1176/appi.ajp.159.11.1932; Coccurello R, 2010, PHARMACOL THERAPEUT, V127, P210, DOI 10.1016/j.pharmthera.2010.04.008; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Cope MB, 2005, INT J OBESITY, V29, P607, DOI 10.1038/sj.ijo.0802928; Cota D, 2003, J CLIN INVEST, V112, P423, DOI 10.1172/JCI17725; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; CSIFFARY A, 1990, BRAIN RES, V506, P215, DOI 10.1016/0006-8993(90)91253-D; Davoodi N, 2009, PSYCHOPHARMACOLOGY, V203, P693, DOI 10.1007/s00213-008-1415-1; De Hert M, 2011, EUR PSYCHIAT, V26, P144, DOI 10.1016/j.eurpsy.2010.09.011; de Meijer VE, 2010, PHYSIOL BEHAV, V100, P387, DOI 10.1016/j.physbeh.2010.04.001; Deng C, 2007, PROG NEURO-PSYCHOPH, V31, P915, DOI 10.1016/j.pnpbp.2007.02.009; Deng C, 2010, PROG NEURO-PSYCHOPH, V34, P1, DOI 10.1016/j.pnpbp.2009.11.009; Deng Chao, 2007, Neurosci Bull, V23, P341, DOI 10.1007/s12264-007-0051-9; Derbenev AV, 2004, J PHYSIOL-LONDON, V559, P923, DOI 10.1113/jphysiol.2004.067470; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; Eder U, 2001, AM J PSYCHIAT, V158, P1719, DOI 10.1176/appi.ajp.158.10.1719; Erickson JC, 1996, NATURE, V381, P415, DOI 10.1038/381415a0; ESCLAPEZ M, 1994, J NEUROSCI, V14, P1834, DOI 10.1523/JNEUROSCI.14-03-01834.1994; Faulconbridge LF, 2008, BRAIN RES, V1218, P151, DOI 10.1016/j.brainres.2008.04.068; FELDBLUM S, 1993, J NEUROSCI RES, V34, P689, DOI 10.1002/jnr.490340612; Ferno J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020571; Frenchman IB, 2005, DRUG AGING, V22, P257, DOI 10.2165/00002512-200522030-00006; Gamber KM, 2005, NEUROPHARMACOLOGY, V49, P646, DOI 10.1016/j.neuropharm.2005.04.017; Gomez R, 2002, J NEUROSCI, V22, P9612; Gothelf D, 2002, AM J PSYCHIAT, V159, P1055, DOI 10.1176/appi.ajp.159.6.1055; Gropp E, 2005, NAT NEUROSCI, V8, P1289, DOI 10.1038/nn1548; Guan XM, 1998, MOL BRAIN RES, V59, P273, DOI 10.1016/S0169-328X(98)00150-8; Han M, 2008, PSYCHONEUROENDOCRINO, V33, P569, DOI 10.1016/j.psyneuen.2008.01.018; Harrold JA, 2003, BRIT J NUTR, V90, P729, DOI 10.1079/BJN2003942; Hartfield AW, 2003, PSYCHOPHARMACOLOGY, V167, P115, DOI 10.1007/s00213-002-1368-8; HEILIG M, 1988, EUR J PHARMACOL, V157, P205, DOI 10.1016/0014-2999(88)90384-6; HEILIG M, 1987, REGUL PEPTIDES, V19, P221, DOI 10.1016/0167-0115(87)90278-3; Heisler LK, 2002, SCIENCE, V297, P609, DOI 10.1126/science.1072327; Hentges ST, 2005, J NEUROSCI, V25, P9746, DOI 10.1523/JNEUROSCI.2769-05.2005; Hentges ST, 2004, J NEUROSCI, V24, P1578, DOI 10.1523/JNEUROSCI.3952-03.2004; Hollopeter G, 1998, REGUL PEPTIDES, V75-6, P383, DOI 10.1016/S0167-0115(98)00092-5; Horvath TL, 1997, BRAIN RES, V756, P283, DOI 10.1016/S0006-8993(97)00184-4; Howlett AC, 2004, NEUROPHARMACOLOGY, V47, P345, DOI 10.1016/j.neuropharm.2004.07.030; Huang XF, 2006, NEUROPEPTIDES, V40, P213, DOI 10.1016/j.npep.2006.01.002; Huang XF, 2003, BRAIN RES, V992, P9, DOI 10.1016/j.brainres.2003.08.019; Huang XF, 2006, BEHAV BRAIN RES, V171, P355, DOI 10.1016/j.bbr.2006.03.040; Kapur S, 2000, CAN J PSYCHIAT, V45, P241, DOI 10.1177/070674370004500302; Kapur S, 2003, J PHARMACOL EXP THER, V305, P625, DOI 10.1124/jpet.102.046987; KAUFMAN DL, 1991, J NEUROCHEM, V56, P720, DOI 10.1111/j.1471-4159.1991.tb08211.x; Kim EM, 2000, BRAIN RES, V862, P11, DOI 10.1016/S0006-8993(00)02060-6; Kim SF, 2007, P NATL ACAD SCI USA, V104, P3456, DOI 10.1073/pnas.0611417104; Kirk SL, 2006, J PSYCHOPHARMACOL, V20, P577, DOI 10.1177/0269881106061199; Kirk SL, 2009, PSYCHOPHARMACOLOGY, V207, P119, DOI 10.1007/s00213-009-1639-8; Kirkham T, 2008, J NEUROENDOCRINOL, V20, P1099, DOI 10.1111/j.1365-2826.2008.01762.x; Kirkham TC, 2009, INT REV PSYCHIATR, V21, P163, DOI 10.1080/09540260902782810; Kroeze WK, 2003, NEUROPSYCHOPHARMACOL, V28, P519, DOI 10.1038/sj.npp.1300027; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; Kuo DY, 2006, BRIT J PHARMACOL, V148, P640, DOI 10.1038/sj.bjp.0706754; Kuo DY, 2002, J BIOMED SCI, V9, P126, DOI 10.1159/000048208; Li C, 2011, PHARMACOL THERAPEUT, V129, P307, DOI 10.1016/j.pharmthera.2010.10.006; Lin S, 2000, BRAIN RES, V875, P89, DOI 10.1016/S0006-8993(00)02580-4; Lin S, 2004, NEUROPEPTIDES, V38, P189, DOI 10.1016/j.npep.2004.05.005; Ling LL, 2005, NEUROSCIENCE, V132, P1103, DOI 10.1016/j.neuroscience.2004.12.043; Marie LS, 2005, P NATL ACAD SCI USA, V102, P18632, DOI 10.1073/pnas.0509240102; MARTIN DL, 1993, J NEUROCHEM, V60, P395, DOI 10.1111/j.1471-4159.1993.tb03165.x; Martin NM, 2004, REGUL PEPTIDES, V122, P169, DOI 10.1016/j.regpep.2004.06.012; Matsui-Sakata Akiko, 2005, Drug Metab Pharmacokinet, V20, P368, DOI 10.2133/dmpk.20.368; MEEKER RB, 1980, BRAIN RES BULL, V5, P253, DOI 10.1016/0361-9230(80)90042-8; Meister B, 2007, PHYSIOL BEHAV, V92, P263, DOI 10.1016/j.physbeh.2007.05.021; Meister B, 2006, EUR J NEUROSCI, V24, P2731, DOI 10.1111/j.1460-9568.2006.05157.x; Menzies JRW, 2010, J NEUROENDOCRINOL, V22, P585, DOI 10.1111/j.1365-2826.2010.01990.x; Minet-Ringuet J, 2005, BEHAV BRAIN RES, V163, P204, DOI 10.1016/j.bbr.2005.05.004; Minet-Ringuet J, 2006, APPETITE, V46, P254, DOI 10.1016/j.appet.2006.01.008; Nasrallah H, 2003, PSYCHONEUROENDOCRINO, V28, P83, DOI 10.1016/S0306-4530(02)00114-2; Nasrallah HA, 2008, MOL PSYCHIATR, V13, P27, DOI 10.1038/sj.mp.4002066; Nemeroff CB, 1997, J CLIN PSYCHIAT, V58, P45; Newcomer JW, 2005, CNS DRUGS, V19, P1; Nguyen QH, 2006, NEUROENDOCRINOLOGY, V84, P123, DOI 10.1159/000096996; Nogueiras R, 2009, PHARMACOL RES, V60, P93, DOI 10.1016/j.phrs.2009.04.004; Obuchowicz E, 1998, NEUROPEPTIDES, V32, P473, DOI 10.1016/S0143-4179(98)90074-9; Obuchowicz E, 2005, NEUROPEPTIDES, V39, P515, DOI 10.1016/j.npep.2005.04.004; Obuchowicz E, 2004, NEUROSCI BIOBEHAV R, V28, P595, DOI 10.1016/j.neubiorev.2004.08.006; Obuchowicz E, 1996, NEUROPEPTIDES, V30, P471, DOI 10.1016/S0143-4179(96)90012-8; Obuchowicz E, 1999, EUR NEUROPSYCHOPHARM, V9, P329, DOI 10.1016/S0924-977X(99)00003-6; Ota M, 2002, CLIN EXP PHARMACOL P, V29, P980, DOI 10.1046/j.1440-1681.2002.t01-1-03755.x; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; PELLETIER G, 1991, NEUROSCI LETT, V127, P96, DOI 10.1016/0304-3940(91)90903-7; Pertwee RG, 1997, PHARMACOL THERAPEUT, V74, P129, DOI 10.1016/S0163-7258(97)82001-3; Pickar D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003150; Pouzet B, 2003, PHARMACOL BIOCHEM BE, V75, P133, DOI 10.1016/S0091-3057(03)00042-X; Qian S, 2002, MOL CELL BIOL, V22, P5027, DOI 10.1128/MCB.22.14.5027-5035.2002; Qiu J, 2007, MOL PHARMACOL, V72, P885, DOI 10.1124/mol.107.038083; Rader DJ, 2007, AM J MED, V120, pS12, DOI 10.1016/j.amjmed.2007.01.003; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Remington G, 2011, PHARMACOL BIOCHEM BE, V100, P86, DOI 10.1016/j.pbb.2011.07.019; Reynolds GP, 2010, PHARMACOL THERAPEUT, V125, P169, DOI 10.1016/j.pharmthera.2009.10.010; Richelson E, 2000, LIFE SCI, V68, P29, DOI 10.1016/S0024-3205(00)00911-5; Roseberry AG, 2004, NEURON, V41, P711, DOI 10.1016/S0896-6273(04)00074-1; Roth BL, 2000, NEUROSCIENTIST, V6, P252, DOI 10.1177/107385840000600408; Ryan MCM, 2004, LIFE SCI, V74, P1999, DOI 10.1016/j.lfs.2003.08.044; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Secher A, 2010, NEUROENDOCRINOLOGY, V91, P155, DOI 10.1159/000245220; Sharkey Keith A, 2005, Sci STKE, V2005, ppe15, DOI 10.1126/stke.2772005pe15; STANLEY BG, 1986, PEPTIDES, V7, P1189; Starrenburg FCJ, 2009, EUR PSYCHIAT, V24, P164, DOI 10.1016/j.eurpsy.2009.01.001; Tauscher J, 2002, MOL PSYCHIATR, V7, P317, DOI 10.1038/sj.mp.4001009; Tiwari AK, 2010, NEUROPSYCHOPHARMACOL, V35, P1315, DOI 10.1038/npp.2009.235; Tong QC, 2008, NAT NEUROSCI, V11, P998, DOI 10.1038/nn.2167; van der Zwaal EM, 2008, EUR J PHARMACOL, V585, P130, DOI 10.1016/j.ejphar.2007.11.078; Van Sickle MD, 2005, SCIENCE, V310, P329, DOI 10.1126/science.1115740; Vong L, 2011, NEURON, V71, P142, DOI 10.1016/j.neuron.2011.05.028; Wai SM, 2004, CELL MOL NEUROBIOL, V24, P667, DOI 10.1023/B:CEMN.0000036404.39432.0c; Weiden PJ, 2004, SCHIZOPHR RES, V66, P51, DOI 10.1016/S0920-9964(02)00498-X; Weston-Green K, 2008, INT J NEUROPSYCHOPH, V11, P827, DOI 10.1017/S1461145708008560; Weston-Green K, 2011, BEHAV BRAIN RES, V217, P337, DOI 10.1016/j.bbr.2010.10.039; Wilson RI, 2002, SCIENCE, V296, P678, DOI 10.1126/science.1063545; Wu Q, 2011, EUR J PHARMACOL, V660, P21, DOI 10.1016/j.ejphar.2010.10.110; Xu B, 1999, ENDOCRINOLOGY, V140, P2868, DOI 10.1210/en.140.6.2868; Yoshimatsu H, 2006, PEPTIDES, V27, P326, DOI 10.1016/j.peptides.2005.02.028; Zhang Y, 2010, NEUROSCIENCE, V169, P1662, DOI 10.1016/j.neuroscience.2010.06.001; Zhang ZJ, 2004, BRIT J PSYCHIAT, V184, P58, DOI 10.1192/bjp.184.1.58	140	74	76	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33548	10.1371/journal.pone.0033548	http://dx.doi.org/10.1371/journal.pone.0033548			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438946	Green Published, gold, Green Submitted			2022-12-25	WOS:000303309100055
J	Strokappe, N; Szynol, A; Aasa-Chapman, M; Gorlani, A; Quigley, AF; Hulsik, DL; Chen, L; Weiss, R; de Haard, H; Verrips, T				Strokappe, Nika; Szynol, Agnieszka; Aasa-Chapman, Marlen; Gorlani, Andrea; Quigley, Anna Forsman; Hulsik, David Lutje; Chen, Lei; Weiss, Robin; de Haard, Hans; Verrips, Theo			Llama Antibody Fragments Recognizing Various Epitopes of the CD4bs Neutralize a Broad Range of HIV-1 Subtypes A, B and C	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODIES; GP120 ENVELOPE GLYCOPROTEIN; FUSION INHIBITOR T-20; BINDING-SITE; POTENT NEUTRALIZATION; CRYSTAL-STRUCTURE; ENV CLONES; PHAGE; VALIDATION	Many of the neutralising antibodies, isolated to date, display limited activities against the globally most prevalent HIV-1 subtypes A and C. Therefore, those subtypes are considered to be an important target for antibody-based therapy. Variable domains of llama heavy chain antibodies (VHH) have some superior properties compared with classical antibodies. Therefore we describe the application of trimeric forms of envelope proteins (Env), derived from HIV-1 of subtype A and B/C, for a prolonged immunization of two llamas. A panel of VHH, which interfere with CD4 binding to HIV-1 Env were selected with use of panning. The results of binding and competition assays to various Env, including a variant with a stabilized CD4-binding state (gp120(Ds2)), cross-competition experiments, maturation analysis and neutralisation assays, enabled us to classify the selected VHH into three groups. The VHH of group I were efficient mainly against viruses of subtype A, C and B'/C. The VHH of group II resemble the broadly neutralising antibody (bnmAb) b12, neutralizing mainly subtype B and C viruses, however some had a broader neutralisation profile. A representative of the third group, 2E7, had an even higher neutralization breadth, neutralizing 21 out of the 26 tested strains belonging to the A, A/G, B, B/C and C subtypes. To evaluate the contribution of certain amino acids to the potency of the VHH a small set of the mutants were constructed. Surprisingly this yielded one mutant with slightly improved neutralisation potency against 92UG37.A9 (subtype A) and 96ZM651.02 (subtype C). These findings and the well-known stability of VHH indicate the potential application of these VHH as anti-HIV-1 microbicides.	[Strokappe, Nika; Szynol, Agnieszka; Gorlani, Andrea; de Haard, Hans; Verrips, Theo] Univ Utrecht, Dept Biol, Fac Sci, Utrecht, Netherlands; [Aasa-Chapman, Marlen; Quigley, Anna Forsman; Weiss, Robin] UCL, Div Infect & Immun, UCL MRC Ctr Med Mol Virol, London, England; [Hulsik, David Lutje] Univ Grenoble 1, EMBL, CNRS, Unit Virus Host Cell Interact UVHCI,UMI 3265, Grenoble, France; [Chen, Lei] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA	Utrecht University; University of London; University College London; Centre National de la Recherche Scientifique (CNRS); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Strokappe, N (corresponding author), Univ Utrecht, Dept Biol, Fac Sci, Utrecht, Netherlands.	t.verrips@qvquality.com	gorlani, andrea/C-5678-2014	Strokappe, Nika/0000-0003-2935-0891	Collaboration for AIDS Vaccine Discovery Grant [38637]; Bill & Melinda Gates Foundation; European Commission; Medical Research Council [G0801176] Funding Source: researchfish; MRC [G0801176] Funding Source: UKRI	Collaboration for AIDS Vaccine Discovery Grant; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); European Commission(European CommissionEuropean Commission Joint Research Centre); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded in part by the Collaboration for AIDS Vaccine Discovery Grant number 38637 sponsored by the Bill & Melinda Gates Foundation (http://www.gatesfoundation.org/Pages/home.aspx); as well as the European Commission 6th Frame Work Programme as part of the European Microbicides Project (EMPRO; www.empro.org.uk) and the European Commission under the 7th Framework Programme as part of the Combined Highly Active Anti-Retroviral Microbicides (CHAARM; http://chaarm.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achour I, 2008, J IMMUNOL, V181, P2001, DOI 10.4049/jimmunol.181.3.2001; Anderson DJ, 2010, AIDS, V24, P163, DOI 10.1097/QAD.0b013e32833424c8; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Bracci L, 2001, J NEUROCHEM, V78, P24, DOI 10.1046/j.1471-4159.2001.00398.x; Bures R, 2002, J VIROL, V76, P2233, DOI 10.1128/JVI.76.5.2233-2244.2002; Burton DR, 2005, P NATL ACAD SCI USA, V102, P14943, DOI 10.1073/pnas.0505126102; Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; Chen WZ, 2009, CURR OPIN HIV AIDS, V4, P112, DOI 10.1097/COH.0b013e328322f95e; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Daley LP, 2005, CLIN DIAGN LAB IMMUN, V12, P380, DOI 10.1128/CDLI.12.3.380-386.2005; De Haard HJW, 2005, J BACTERIOL, V187, P4531, DOI 10.1128/JB.187.13.4531-4541.2005; Decanniere K, 1999, STRUCTURE, V7, P361, DOI 10.1016/S0969-2126(99)80049-5; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Desmyter A, 1996, NAT STRUCT BIOL, V3, P803, DOI 10.1038/nsb0996-803; Dolk E, 2005, APPL ENVIRON MICROB, V71, P442, DOI 10.1128/AEM.71.1.442-450.2005; Dumoulin M, 2002, PROTEIN SCI, V11, P500, DOI 10.1110/ps.34602; Forsman A, 2008, J VIROL, V82, P12069, DOI 10.1128/JVI.01379-08; GAO F, 1994, AIDS RES HUM RETROV, V10, P1359, DOI 10.1089/aid.1994.10.1359; Gorlani A, 2012, AIDS RES HUM RETROV, V28, P198, DOI 10.1089/aid.2011.0133; Gray ES, 2006, PLOS MED, V3, P1023, DOI 10.1371/journal.pmed.0030255; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Herrera C, 2005, VIROLOGY, V338, P154, DOI 10.1016/j.virol.2005.05.002; Hinz A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010482; Huber M, 2008, J VIROL, V82, P3834, DOI 10.1128/JVI.02569-07; Hultberg A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017665; Hultberg A, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-58; Jolly C, 2004, J EXP MED, V199, P283, DOI 10.1084/jem.20030648; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Kuroki M, 1996, Methods Mol Biol, V66, P47; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Labrijn AF, 2003, J VIROL, V77, P10557, DOI 10.1128/JVI.77.19.10557-10565.2003; Lagenaur LA, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-11; Ledeboer AM, 2002, J DAIRY SCI, V85, P1376, DOI 10.3168/jds.S0022-0302(02)74204-5; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li M, 2006, J VIROL, V80, P11776, DOI 10.1128/JVI.01730-06; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Lutje Hulsik D, 2009, IMPROVING PROPERTIES; MARKS JD, 1991, J MOL BIOL, V222, P581, DOI 10.1016/0022-2836(91)90498-U; MCKEATING JA, 1993, J VIROL, V67, P5216, DOI 10.1128/JVI.67.9.5216-5225.1993; MEULEMANS EV, 1994, J MOL BIOL, V244, P353, DOI 10.1006/jmbi.1994.1735; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Moore PL, 2006, J VIROL, V80, P2515, DOI 10.1128/JVI.80.5.2515-2528.2006; Muyldermans S, 2001, J Biotechnol, V74, P277; Myszka DG, 2000, P NATL ACAD SCI USA, V97, P9026, DOI 10.1073/pnas.97.16.9026; Pancera M, 2010, J VIROL, V84, P8098, DOI 10.1128/JVI.00966-10; Pantophlet R, 2003, J VIROL, V77, P642, DOI 10.1128/JVI.77.1.642-658.2003; Peeters M, 2001, TRANSFUS CLIN BIOL, V8, P222, DOI 10.1016/S1246-7820(01)00131-8; Pejchal R, 2010, P NATL ACAD SCI USA, V107, P11483, DOI 10.1073/pnas.1004600107; Perez JMJ, 2001, BIOCHEMISTRY-US, V40, P74, DOI 10.1021/bi0009082; ROCK EP, 1994, J EXP MED, V179, P323, DOI 10.1084/jem.179.1.323; Roovers RC, 2007, CANCER IMMUNOL IMMUN, V56, P303, DOI 10.1007/s00262-006-0180-4; Saerens D, 2008, J MOL BIOL, V377, P478, DOI 10.1016/j.jmb.2008.01.022; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Soutullo A, 2001, VET MICROBIOL, V79, P111, DOI 10.1016/S0378-1135(00)00352-7; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Thomassen YE, 2005, J BIOTECHNOL, V118, P270, DOI 10.1016/j.jbiotec.2005.05.010; Trkola A, 2005, NAT MED, V11, P615, DOI 10.1038/nm1244; Trkola A, 2008, J VIROL, V82, P1591, DOI 10.1128/JVI.01792-07; Tzartos S J, 1996, Methods Mol Biol, V66, P55; van der Linden RHJ, 1999, BBA-PROTEIN STRUCT M, V1431, P37, DOI 10.1016/S0167-4838(99)00030-8; Verheesen P, 2003, BBA-GEN SUBJECTS, V1624, P21, DOI 10.1016/j.bbagen.2003.09.006; Verheesen P, 2006, BBA-PROTEINS PROTEOM, V1764, P1307, DOI 10.1016/j.bbapap.2006.05.011; VRIEND G, 1990, PROTEIN ENG, V4, P221, DOI 10.1093/protein/4.2.221; Vu KB, 1997, MOL IMMUNOL, V34, P1121, DOI 10.1016/S0161-5890(97)00146-6; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Watkins JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018207; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Wilkinson RA, 2005, J VIROL, V79, P13060, DOI 10.1128/JVI.79.20.13060-13069.2005; Wright P F, 1993, Rev Sci Tech, V12, P435; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Xiang SH, 2002, J VIROL, V76, P9888, DOI 10.1128/JVI.76.19.9888-9899.2002; Xu WD, 2001, J HUMAN VIROL, V4, P55; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580	74	48	54	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2012	7	3							e33298	10.1371/journal.pone.0033298	http://dx.doi.org/10.1371/journal.pone.0033298			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RU	22438910	Green Submitted, Green Published, gold			2022-12-25	WOS:000303309000020
J	Xu, T; Brown, W; Marinus, MG				Xu, Tao; Brown, William; Marinus, Martin G.			Bleomycin Sensitivity in Escherichia coli is Medium-Dependent	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; GENE-PRODUCT; DNA; REPAIR; RECOMBINATION; RECN; DAMAGE; IDENTIFICATION; CISPLATIN; MUTANTS	Bleomycin (BLM) is a glycopeptide antibiotic and anti-tumor agent that targets primarily the furanose rings of DNA and in the presence of ferrous ions produces oxidative damage and DNA strand breaks. Escherichia coli cells growing in broth medium and exposed to low concentrations of BLM contain double-strand breaks and require homologous recombination to survive. To a lesser extent, the cells also require the abasic (AP) endonucleases associated with base excision repair, presumably to repair oxidative damage. As expected, there is strong induction of the SOS system in treated cells. In contrast, E. coli cells growing in glucose or glycerol minimal medium are resistant to the lethal action of BLM and do not require either homologous recombination functions or AP-endonucleases for survival. DNA ligase activity, however, is needed for cells growing in minimal medium to resist the lethal effects of BLM. There is weak SOS induction in such treated cells.	[Xu, Tao; Brown, William; Marinus, Martin G.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01610 USA	University of Massachusetts System; University of Massachusetts Worcester	Xu, T (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01610 USA.	martin.marinus@umassmed.edu			National Institutes of Health [R01 GM0637900-08]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grant R01 GM0637900-08 from the National Institutes of Health (www.nih.gov). The grant paid for all supplies and wages and salaries connected with this work. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Becket E, 2010, DNA REPAIR, V9, P949, DOI 10.1016/j.dnarep.2010.06.008; BURGER RM, 1981, J BIOL CHEM, V256, P1636; Courcelle J, 2001, GENETICS, V158, P41; DAVIS BD, 1950, J BACTERIOL, V60, P17, DOI 10.1128/JB.60.1.17-28.1950; FINCH PW, 1985, J BACTERIOL, V164, P653, DOI 10.1128/JB.164.2.653-658.1985; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; GATIGNOL A, 1988, FEBS LETT, V230, P171, DOI 10.1016/0014-5793(88)80665-3; Girgis HS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005629; KANE SA, 1994, PROG NUCLEIC ACID RE, V49, P313; KNEZEVICVUKCEVIC J, 1991, BIOCHIMIE, V73, P497, DOI 10.1016/0300-9084(91)90118-K; Kosa JL, 2004, MUTAT RES-FUND MOL M, V554, P149, DOI 10.1016/j.mrfmmm.2004.04.011; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; LLOYD RG, 1991, J BACTERIOL, V173, P1004, DOI 10.1128/jb.173.3.1004-1011.1991; LLOYD RG, 1991, J BACTERIOL, V173, P5414, DOI 10.1128/jb.173.17.5414-5418.1991; Nichols RJ, 2011, CELL, V144, P143, DOI 10.1016/j.cell.2010.11.052; Nowosielska A, 2005, DNA REPAIR, V4, P773, DOI 10.1016/j.dnarep.2005.03.006; Nowosielska A, 2008, DNA REPAIR, V7, P48, DOI 10.1016/j.dnarep.2007.07.015; Nowosielska A, 2006, NUCLEIC ACIDS RES, V34, P2258, DOI 10.1093/nar/gkl222; PICKSLEY SM, 1985, MOL GEN GENET, V201, P301, DOI 10.1007/BF00425675; POVIRK LF, 1977, NUCLEIC ACIDS RES, V4, P3573, DOI 10.1093/nar/4.10.3573; ROMLING U, 1989, EMBO J, V8, P4081, DOI 10.1002/j.1460-2075.1989.tb08592.x; Rudolph CJ, 2009, MOL MICROBIOL, V74, P940, DOI 10.1111/j.1365-2958.2009.06909.x; SARGENTINI NJ, 1986, RADIAT RES, V107, P58, DOI 10.2307/3576850; Seigneur M, 1998, CELL, V95, P419, DOI 10.1016/S0092-8674(00)81772-9; STEIGHNER RJ, 1990, P NATL ACAD SCI USA, V87, P8350, DOI 10.1073/pnas.87.21.8350; UMEZAWA H, 1966, J ANTIBIOT, V19, P200; UMEZAWA H, 1966, J ANTIBIOT, V19, P210; YAMAMOTO K, 1984, CHEM-BIOL INTERACT, V51, P233, DOI 10.1016/0009-2797(84)90032-2; Zdraveski ZZ, 2000, CHEM BIOL, V7, P39, DOI 10.1016/S1074-5521(00)00064-8	30	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2012	7	3							e33256	10.1371/journal.pone.0033256	http://dx.doi.org/10.1371/journal.pone.0033256			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RU	22438905	Green Published, Green Submitted, gold			2022-12-25	WOS:000303309000017
J	Bergamini, C; Moruzzi, N; Sblendido, A; Lenaz, G; Fato, R				Bergamini, Christian; Moruzzi, Noah; Sblendido, Antonella; Lenaz, Giorgio; Fato, Romana			A Water Soluble CoQ(10) Formulation Improves Intracellular Distribution and Promotes Mitochondrial Respiration in Cultured Cells	PLOS ONE			English	Article							COENZYME Q(10); OXIDATIVE STRESS; DOUBLE-BLIND; UBIQUINONE; MODEL; CHAIN; NEUROPROTECTION; TRANSPORT; DEATH; TRIAL	Background: Mitochondria are both the cellular powerhouse and the major source of reactive oxygen species. Coenzyme Q(10) plays a key role in mitochondrial energy production and is recognized as a powerful antioxidant. For these reasons it can be argued that higher mitochondrial ubiquinone levels may enhance the energy state and protect from oxidative stress. Despite the large number of clinical studies on the effect of CoQ(10) supplementation, there are very few experimental data about the mitochondrial ubiquinone content and the cellular bioenergetic state after supplementation. Controversial clinical and in vitro results are mainly due to the high hydrophobicity of this compound, which reduces its bioavailability. Principal Findings: We measured the cellular and mitochondrial ubiquinone content in two cell lines (T67 and H9c2) after supplementation with a hydrophilic CoQ(10) formulation (Qter (R)) and native CoQ(10). Our results show that the water soluble formulation is more efficient in increasing ubiquinone levels. We have evaluated the bioenergetics effect of ubiquinone treatment, demonstrating that intracellular CoQ(10) content after Qter supplementation positively correlates with an improved mitochondrial functionality (increased oxygen consumption rate, transmembrane potential, ATP synthesis) and resistance to oxidative stress. Conclusions: The improved cellular energy metabolism related to increased CoQ(10) content represents a strong rationale for the clinical use of coenzyme Q(10) and highlights the biological effects of Qter (R), that make it the eligible CoQ(10) formulation for the ubiquinone supplementation.	[Bergamini, Christian; Moruzzi, Noah; Lenaz, Giorgio; Fato, Romana] Univ Bologna, Dept Biochem G Moruzzi, Bologna, Italy; [Sblendido, Antonella] Scharper Therapeut, Dept Med, Milan, Italy	University of Bologna	Bergamini, C (corresponding author), Univ Bologna, Dept Biochem G Moruzzi, Bologna, Italy.	romana.fato@unibo.it	Moruzzi, Noah/AAC-8875-2019; Moruzzi, Noah/M-9869-2014; Lenaz, Giorgio/B-5751-2013	Moruzzi, Noah/0000-0001-6868-1488				Balakrishnan P, 2009, INT J PHARMACEUT, V374, P66, DOI 10.1016/j.ijpharm.2009.03.008; Beg Sarwar, 2010, Recent Pat Drug Deliv Formul, V4, P245; Bentinger M, 2003, FREE RADICAL BIO MED, V34, P563, DOI 10.1016/S0891-5849(02)01357-6; Bhagavan HN, 2007, MITOCHONDRION, V7, pS78, DOI 10.1016/j.mito.2007.03.003; Buege J A, 1978, Methods Enzymol, V52, P302; Carli F., 2003, COGRINDING PROCESS P; Chomyn A, 1996, Methods Enzymol, V264, P197, DOI 10.1016/S0076-6879(96)64020-8; Chomyn A, 1996, Methods Enzymol, V264, P334, DOI 10.1016/S0076-6879(96)64031-2; CORNELL BA, 1987, BIOCHEMISTRY-US, V26, P7702, DOI 10.1021/bi00398a025; Di Giovanni S, 2001, NEUROLOGY, V57, P515, DOI 10.1212/WNL.57.3.515; Fernandez-Ayala DJM, 2005, BBA-BIOENERGETICS, V1706, P174, DOI 10.1016/j.bbabio.2004.10.009; Fetoni AR, 2009, BRAIN RES, V1257, P108, DOI 10.1016/j.brainres.2008.12.027; Fumagalli S, 2011, CLIN CARDIOL, V34, P211, DOI 10.1002/clc.20846; Geromel V, 2002, FREE RADICAL RES, V36, P375, DOI 10.1080/10715760290021216; Geromel V, 2002, MOL GENET METAB, V77, P21, DOI 10.1016/S1096-7192(02)00145-2; Gorman A., 1996, TECHNIQUES APOPTOSIS, P6; Groneberg DA, 2005, INT J BIOCHEM CELL B, V37, P1208, DOI 10.1016/j.biocel.2004.11.017; HACKENBROCK CR, 1986, J BIOENERG BIOMEMBR, V18, P331, DOI 10.1007/BF00743010; Hamilton SJ, 2009, DIABETES CARE, V32, P810, DOI 10.2337/dc08-1736; Henchcliffe C, 2008, NAT CLIN PRACT NEURO, V4, P600, DOI 10.1038/ncpneuro0924; Ibrahim WH, 2000, J NUTR, V130, P2343, DOI 10.1093/jn/130.9.2343; Kaufmann P, 2009, ANN NEUROL, V66, P235, DOI 10.1002/ana.21743; Kieburtz K, 2001, NEUROLOGY, V57, P397; Kumar A, 2009, PHARMACOL THERAPEUT, V124, P259, DOI 10.1016/j.pharmthera.2009.07.003; LAURO GM, 1986, ACTA NEUROPATHOL, V69, P278, DOI 10.1007/BF00688305; LENAZ G, 1992, BIOCHEM CELL BIOL, V70, P504, DOI 10.1139/o92-078; Lenaz G, 2009, BBA-BIOENERGETICS, V1787, P563, DOI 10.1016/j.bbabio.2009.02.019; Lopez LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011897; LOWRY OH, 1951, J BIOL CHEM, V193, P265; McCarthy S, 2004, TOXICOL APPL PHARM, V201, P21, DOI 10.1016/j.taap.2004.04.019; Mora P. Corvi, 2008, COMPOSITION CONTAINI; Napolitano MJ, 2005, J BIOCHEM BIOPH METH, V63, P69, DOI 10.1016/j.jbbm.2005.03.001; Overvad K, 1999, EUR J CLIN NUTR, V53, P764, DOI 10.1038/sj.ejcn.1600880; Santos-Ocana C, 2002, J BIOL CHEM, V277, P10973, DOI 10.1074/jbc.M112222200; Schagger H, 2002, BBA-BIOENERGETICS, V1555, P154, DOI 10.1016/S0005-2728(02)00271-2; Schmelzer C, 2008, BIOFACTORS, V32, P179, DOI 10.1002/biof.5520320121; Sharma S, 2004, METHOD ENZYMOL, V382, P488; Shults CW, 2005, BIOFACTORS, V25, P117, DOI 10.1002/biof.5520250113; Silver MA, 2004, AM J CARDIOL, V94, P1306, DOI 10.1016/j.amjcard.2004.07.121; Somayajulu M, 2005, NEUROBIOL DIS, V18, P618, DOI 10.1016/j.nbd.2004.10.021; Somayajulu-Nitu M, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-88; Spindler M, 2009, NEUROPSYCH DIS TREAT, V5, P597; Storch A, 2007, ARCH NEUROL-CHICAGO, V64, P938, DOI 10.1001/archneur.64.7.nct60005; Strehler BL, 1963, ADENOSINE 5V TRIPHOS, P559; TAKADA M, 1984, METHOD ENZYMOL, V105, P147; Villalba JM, 2010, EXPERT OPIN INV DRUG, V19, P535, DOI 10.1517/13543781003727495; Xu JZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010572; Yang XF, 2010, J MOL NEUROSCI, V41, P110, DOI 10.1007/s12031-009-9297-1; Young JA, 2007, AM J CARDIOL, V100, P1400, DOI 10.1016/j.amjcard.2007.06.030; ZHANG YY, 1995, J NUTR, V125, P446	50	58	60	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e33712	10.1371/journal.pone.0033712	http://dx.doi.org/10.1371/journal.pone.0033712			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22432044	Green Published, gold, Green Submitted			2022-12-25	WOS:000303198600087
J	Sevillano, L; Diaz, M; Yamaguchi, Y; Inouye, M; Santamaria, RI				Sevillano, Laura; Diaz, Margarita; Yamaguchi, Yoshihiro; Inouye, Masayori; Santamaria, Ramon I.			Identification of the First Functional Toxin-Antitoxin System in Streptomyces	PLOS ONE			English	Article							ESCHERICHIA-COLI; HALSTEDII JM8; YOEB TOXIN; YEFM-YOEB; PROKARYOTES; BACTERIA; LOCI; GENE; SITE; INTERACTS	Toxin-antitoxin (TA) systems are widespread among the plasmids and genomes of bacteria and archaea. This work reports the first description of a functional TA system in Streptomyces that is identical in two species routinely used in the laboratory: Streptomyces lividans and S. coelicolor. The described system belongs to the YefM/YoeB family and has a considerable similarity to Escherichia coli YefM/YoeB (about 53% identity and 73% similarity). Lethal effect of the S. lividans putative toxin (YoeBsl) was observed when expressed alone in E. coli SC36 (MG1655 Delta yefM-yoeB). However, no toxicity was obtained when co-expression of the antitoxin and toxin (YefM/YoeBsl) was carried out. The toxic effect was also observed when the yoeBsl was cloned in multicopy in the wild-type S. lividans or in a single copy in a S. lividans mutant, in which this TA system had been deleted. The S. lividans YefM/YoeBsl complex, purified from E. coli, binds with high affinity to its own promoter region but not to other three random selected promoters from Streptomyces. In vivo experiments demonstrated that the expression of yoeBsl in E. coli blocks translation initiation processing mRNA at three bases downstream of the initiation codon after 2 minutes of induction. These results indicate that the mechanism of action is identical to that of YoeB from E. coli.	[Sevillano, Laura; Diaz, Margarita; Santamaria, Ramon I.] Univ Salamanca, Consejo Super Invest Cient, Dept Microbiol & Genet, Inst Biol Func & Genom, E-37008 Salamanca, Spain; [Yamaguchi, Yoshihiro; Inouye, Masayori] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Ctr Adv Biotechnol & Med, Piscataway, NJ USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca; Rutgers State University New Brunswick; Rutgers State University Medical Center	Sevillano, L (corresponding author), Univ Salamanca, Consejo Super Invest Cient, Dept Microbiol & Genet, Inst Biol Func & Genom, Campus Miguel de Unamuno, E-37008 Salamanca, Spain.	santa@usal.es	Santamaria, Ramon I/K-2870-2014; Martínez, Margarita Díaz/L-3069-2014; Santamaria, Ramon I/M-9069-2019	Santamaria, Ramon I/0000-0002-2181-6776; Martínez, Margarita Díaz/0000-0003-4286-1506; Santamaria, Ramon I/0000-0002-2181-6776; Yamaguchi, Yoshihiro/0000-0003-4663-6963	Ministerio de Ciencia e Innovacion, Spain [EUI2008-03631, BFU2010-17551]	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work has been supported by grants of the Ministerio de Ciencia e Innovacion, Spain (Grants EUI2008-03631 to RIS and BFU2010-17551 to MD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adham SAI, 2001, APPL ENVIRON MICROB, V67, P5425, DOI 10.1128/AEM.67.12.5425-5430.2001; Bailey SES, 2009, J BACTERIOL, V191, P762, DOI 10.1128/JB.01331-08; Buts L, 2005, TRENDS BIOCHEM SCI, V30, P672, DOI 10.1016/j.tibs.2005.10.004; Christensen SK, 2004, MOL MICROBIOL, V51, P1705, DOI 10.1046/j.1365-2958.2003.03941.x; de la Hoz AB, 2000, P NATL ACAD SCI USA, V97, P728, DOI 10.1073/pnas.97.2.728; Fernandez-Abalos JM, 2003, MICROBIOL-SGM, V149, P1623, DOI 10.1099/mic.0.26113-0; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Hallez R, 2010, MOL MICROBIOL, V76, P719, DOI 10.1111/j.1365-2958.2010.07129.x; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Holcik M, 1997, MICROBIOL-SGM, V143, P3403, DOI 10.1099/00221287-143-11-3403; Kamada K, 2005, MOL CELL, V19, P497, DOI 10.1016/j.molcel.2005.07.004; Kedzierska B, 2007, NUCLEIC ACIDS RES, V35, P325, DOI 10.1093/nar/gkl1028; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kim YH, 2009, J BACTERIOL, V191, P1258, DOI 10.1128/JB.01465-08; KUHSTOSS S, 1991, GENE, V97, P143, DOI 10.1016/0378-1119(91)90022-4; Lemonnier M, 2003, NUCLEIC ACIDS RES, V31, P3918, DOI 10.1093/nar/gkg463; Leplae R, 2011, NUCLEIC ACIDS RES, V39, P5513, DOI 10.1093/nar/gkr131; Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306; Makarova KS, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-19; MUTH G, 1989, MOL GEN GENET, V219, P341, DOI 10.1007/BF00259605; Mutschler H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001033; Nariya H, 2008, CELL, V132, P55, DOI 10.1016/j.cell.2007.11.044; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Rodriguez S, 2005, GENE, V351, P1, DOI 10.1016/j.gene.2005.03.007; Sevin EW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r155; Shao YC, 2011, NUCLEIC ACIDS RES, V39, pD606, DOI 10.1093/nar/gkq908; Tsilibaris V, 2007, J BACTERIOL, V189, P6101, DOI 10.1128/JB.00527-07; Van Melderen L, 2010, CURR OPIN MICROBIOL, V13, P781, DOI 10.1016/j.mib.2010.10.006; Van Melderen L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000437; Yamaguchi Y, 2011, ANNU REV GENET, V45, P61, DOI 10.1146/annurev-genet-110410-132412; Yamaguchi Y, 2009, J BIOL CHEM, V284, P28746, DOI 10.1074/jbc.M109.032904; Zhang JJ, 2002, J BACTERIOL, V184, P5323, DOI 10.1128/JB.184.19.5323-5329.2002; Zhang Y, 2009, J BIOL CHEM, V284, P6627, DOI 10.1074/jbc.M808779200	33	30	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e32977	10.1371/journal.pone.0032977	http://dx.doi.org/10.1371/journal.pone.0032977			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22431991	gold, Green Submitted, Green Published			2022-12-25	WOS:000303198600034
J	Wang, L; Hou, L; Qian, MP; Deng, MH				Wang, Lin; Hou, Lin; Qian, Minping; Deng, Minghua			Integrating Phosphorylation Network with Transcriptional Network Reveals Novel Functional Relationships	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; REGULATORY ASSOCIATIONS; SIGNAL-TRANSDUCTION; PROTEIN-KINASE; PATHWAY; KSS1; STRESS; MAPK; TOOL	Phosphorylation and transcriptional regulation events are critical for cells to transmit and respond to signals. In spite of its importance, systems-level strategies that couple these two networks have yet to be presented. Here we introduce a novel approach that integrates the physical and functional aspects of phosphorylation network together with the transcription network in S. cerevisiae, and demonstrate that different network motifs are involved in these networks, which should be considered in interpreting and integrating large scale datasets. Based on this understanding, we introduce a HeRS score (hetero-regulatory similarity score) to systematically characterize the functional relevance of kinase/phosphatase involvement with transcription factor, and present an algorithm that predicts hetero-regulatory modules. When extended to signaling network, this approach confirmed the structure and cross talk of MAPK pathways, inferred a novel functional transcription factor Sok2 in high osmolarity glycerol pathway, and explained the mechanism of reduced mating efficiency upon Fus3 deletion. This strategy is applicable to other organisms as large-scale datasets become available, providing a means to identify the functional relationships between kinases/phosphatases and transcription factors.	[Wang, Lin; Qian, Minping; Deng, Minghua] Peking Univ, Ctr Theoret Biol, Beijing 100871, Peoples R China; [Hou, Lin; Qian, Minping; Deng, Minghua] Peking Univ, Sch Math Sci, Key Lab Math & Appl Math, Beijing 100871, Peoples R China; [Deng, Minghua] Peking Univ, Ctr Stat Sci, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University	Wang, L (corresponding author), Peking Univ, Ctr Theoret Biol, Beijing 100871, Peoples R China.	dengmh@pku.edu.cn	Deng, Minghua/B-5430-2012; Deng, Minghua/B-1316-2012	Deng, Minghua/0000-0002-9143-1898; 	National Natural Science Foundation of China [31171262, 10721403]; National Key Basic Research Project of China [2009CB918503]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Project of China(National Basic Research Program of China)	This work is supported by National Natural Science Foundation of China (No. 31171262, No. 10721403) and National Key Basic Research Project of China (No. 2009CB918503). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Bulyk ML, 2006, CURR OPIN BIOTECH, V17, P422, DOI 10.1016/j.copbio.2006.06.015; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; Csikasz-Nagy A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.73; Doolin MT, 2001, MOL MICROBIOL, V40, P422, DOI 10.1046/j.1365-2958.2001.02388.x; ELION EA, 1991, P NATL ACAD SCI USA, V88, P9392, DOI 10.1073/pnas.88.21.9392; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Gat-Viks I, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000800; Gitter A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.33; Hahn JS, 2002, J BIOL CHEM, V277, P21278, DOI 10.1074/jbc.M202557200; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hu ZZ, 2007, NAT GENET, V39, P683, DOI 10.1038/ng2012; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; MA D, 1995, MOL BIOL CELL, V6, P889, DOI 10.1091/mbc.6.7.889; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Monteiro PT, 2008, NUCLEIC ACIDS RES, V36, pD132, DOI 10.1093/nar/gkm976; Myers CL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-187; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Real R, 1996, SYST BIOL, V45, P380, DOI 10.2307/2413572; Rep M, 2000, J BIOL CHEM, V275, P8290, DOI 10.1074/jbc.275.12.8290; Saito H, 2010, CURR OPIN MICROBIOL, V13, P677, DOI 10.1016/j.mib.2010.09.001; Shenhar G, 2001, MOL CELL BIOL, V21, P1603, DOI 10.1128/MCB.21.5.1603-1612.2001; Shock TR, 2009, EUKARYOT CELL, V8, P606, DOI 10.1128/EC.00005-09; Teixeira MC, 2006, NUCLEIC ACIDS RES, V34, pD446, DOI 10.1093/nar/gkj013; van Wageningen S, 2010, CELL, V143, P991, DOI 10.1016/j.cell.2010.11.021; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Yoshikawa K, 2009, FEMS YEAST RES, V9, P32, DOI 10.1111/j.1567-1364.2008.00456.x; Yu HY, 2003, TRENDS GENET, V19, P422, DOI 10.1016/S0168-9525(03)00175-6; Yu XP, 2008, NUCLEIC ACIDS RES, V36, P6494, DOI 10.1093/nar/gkn712; Zhou Q, 2004, P NATL ACAD SCI USA, V101, P12114, DOI 10.1073/pnas.0402858101	32	37	38	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e33160	10.1371/journal.pone.0033160	http://dx.doi.org/10.1371/journal.pone.0033160			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22432002	Green Published, Green Submitted, gold			2022-12-25	WOS:000303198600045
J	Chu, TP; Li, CC; Wang, L; Hsu, LW; Eng, HL; You, HL; Liu, JW; Wei, CC; Chang, LS; Lee, IK; Yang, KD				Chu, Tsui-Ping; Li, Chung-Chen; Wang, Lin; Hsu, Li-Wen; Eng, Hock-Liew; You, Huey-Ling; Liu, Jien-Wei; Wei, Chi-Chen; Chang, Ling-Sai; Lee, Ing-Kit; Yang, Kuender D.			A Surveillance System to Reduce Transmission of Pandemic H1N1 (2009) Influenza in a 2600-Bed Medical Center	PLOS ONE			English	Article							COST-EFFECTIVENESS; ELDERLY PERSONS; VACCINE; VIRUS; CARE; COMMUNITY; OUTBREAK	Background: Concerns have been raised about how the transmission of emerging infectious diseases from patients to healthcare workers (HCWs) and vice versa could be recognized and prevented in a timely manner. An effective strategy to block transmission of pandemic H1N1 (2009) influenza in HCWs is important. Methodology/Principal Findings: An infection control program was implemented to survey and prevent nosocomial outbreaks of H1N1 (2009) influenza at a 2,600-bed, tertiary-care academic hospital. In total, 4,963 employees at Kaohsiung Chang Gung Memorial Hospital recorded their temperature and received online education on control practices for influenza infections. Administration records provided vaccination records and occupational characteristics of all HCWs. Early recognition of a pandemic H1N1 (2009) influenza case was followed by a semi-structured questionnaire to analyze possible routes of patient contact, household contact, or unspecified contact. Surveillance spanned August 1, 2009 to January 31, 2010; 51 HCWs were confirmed to have novel H1N1 (2009) influenza by quantitative real-time reverse transcription polymerase chain reaction. Prevalence of patient contact, household contact, or unspecified contact infection was 13.7% (7/51), 13.7% (7/51), and 72.5% (37/51), respectively. The prevalence of the novel H1N1 infection was significantly lower among vaccinated HCWs than among unvaccinated HCWs (p<0.001). Higher viral loads in throat swabs were found in HCWs with patient and household contact infection than in those with unspecified contact infection (4.15 vs. 3.53 copies/mL, log(10), p = 0.035). Conclusion: A surveillance system with daily temperature recordings and online education for HCWs is important for a low attack rate of H1N1 (2009) influenza transmission before H1N1 (2009) influenza vaccination is available, and the attack rate is further decreased after mass vaccination. Unspecified contact infection rates were significantly higher than that of patient contact and household contact infection, highlighting the need for public education of influenza transmission in addition to hospital infection control.	[Chu, Tsui-Ping; Hsu, Li-Wen] Chang Gung Mem Hosp, Dept Nursing, Chiayi, Taiwan; [Li, Chung-Chen; Wang, Lin; Chang, Ling-Sai] KCGMH CGU, Dept Pediat, Coll Med, Kaohsiung, Taiwan; [Eng, Hock-Liew; You, Huey-Ling] KCGMH CGU, Dept Pathol, Kaohsiung, Taiwan; [Liu, Jien-Wei; Lee, Ing-Kit] KCGMH CGU, Div Infect Dis, Dept Internal Med, Kaohsiung, Taiwan; [Wei, Chi-Chen; Yang, Kuender D.] Show Chwan Mem Hosp Chang Bing, Dept Med Res, Changhua, Taiwan; [Yang, Kuender D.] Show Chwan Mem Hosp Chang Bing, Dept Pediat, Changhua, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Chu, TP (corresponding author), Chang Gung Mem Hosp, Dept Nursing, Chiayi, Taiwan.	yangkd.yeh@hotmail.com			Chang Gung Memorial Hospital [CMRPG890441]; National Science Council of Taiwan [NSC-100-2314-B-182A-051]; National Health Research Institute of Taiwan [NHRI-98A1-PDCO-0909111]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institute of Taiwan(National Health Research Institutes - Taiwan)	This study was funded by a CMRPG890441 grant from Chang Gung Memorial Hospital, an NSC-100-2314-B-182A-051 grant from the National Science Council of Taiwan, and a NHRI-98A1-PDCO-0909111 grant from the National Health Research Institute of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balkhy HH, 2010, INFECT CONT HOSP EP, V31, P1004, DOI 10.1086/656241; Bernard H, 2009, EMERG INFECT DIS, V15, P1438, DOI 10.3201/eid1509.081475; Centers for Disease Control and Prevention, PREV STRAT SEAS INFL; Centers for Disease Control and Prevention, 1986, ANN INTERN MED, V105, P399; Chen MIC, 2010, EMERG INFECT DIS, V16, P1554, DOI 10.3201/eid1610.100516; Cheng VCC, 2010, J HOSP INFECT, V74, P271, DOI 10.1016/j.jhin.2009.09.009; CLEMENTS DA, 1995, ARCH PEDIAT ADOL MED, V149, P1113, DOI 10.1001/archpedi.1995.02170230067009; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; First imported case of influenza A (H1N1) confirmed in Taiwan; current pandemic alert level in Taiwan raised to phase 2. Centers for Disease Control Taiwan R.O.C, 2009, 1 IMP CAS INFL H1N1; Influenza-Update 123. World Health Organization, 2010, INFL UPD 123; Li CC, 2010, EMERG INFECT DIS, V16, P1265, DOI 10.3201/eid1608.091918; Liu JW, 2006, INFECT CONT HOSP EP, V27, P466, DOI 10.1086/504501; MULLOOLY JP, 1994, ANN INTERN MED, V121, P947, DOI 10.7326/0003-4819-121-12-199412150-00008; NICHOL KL, 1994, NEW ENGL J MED, V331, P778, DOI 10.1056/NEJM199409223311206; Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5; Salgado CD, 2004, INFECT CONT HOSP EP, V25, P923, DOI 10.1086/502321; Taiwan CDC identifies presence of novel influenza A ( H1N1) virus in community; virus remains moderate in Severity. Centers for Disease Control Taiwan R.O.C, 2009, TAIW CDC ID PRES NOV; *WHO, 2009, INF PREV CONTR HLTH; Wilde JA, 1999, JAMA-J AM MED ASSOC, V281, P908, DOI 10.1001/jama.281.10.908	19	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2012	7	3							e32731	10.1371/journal.pone.0032731	http://dx.doi.org/10.1371/journal.pone.0032731			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930IA	22427871	Green Published, Green Submitted, gold			2022-12-25	WOS:000303129700014
J	Wijlaars, LPMM; Nazareth, I; Petersen, I				Wijlaars, Linda P. M. M.; Nazareth, Irwin; Petersen, Irene			Trends in Depression and Antidepressant Prescribing in Children and Adolescents: A Cohort Study in The Health Improvement Network (THIN)	PLOS ONE			English	Article							SUICIDE; FLUOXETINE; REGRESSION; PAROXETINE; PLACEBO; SAFETY; TIME; RISK	Background: In 2003, the Committee on Safety of Medicines (CSM) advised against treatment with selective serotonin reuptake inhibitors (SSRIs) other than fluoxetine in children, due to a possible increased risk of suicidal behaviour. This study examined the effects of this safety warning on general practitioners' depression diagnosing and prescription behaviour in children. Methods and Findings: We identified a cohort of 1,502,753 children (<18 y; registered with GP for >6 m) in The Health Improvement Network (THIN) UK primary care database. Trends in incidence of depression diagnoses, symptoms and antidepressant prescribing were examined 1995-2009, accounting for deprivation, age and gender. We used segmented regression analysis to assess changes in prescription rates. Overall, 45,723 (3%) children had >= 1 depression-related entry in their clinical records. SSRIs were prescribed to 16,925 (1%) of children. SSRI prescription rates decreased from 3.2 (95% CI:3.0,3.3) per 1,000 person-years at risk (PYAR) in 2002 to 1.7 (95% CI:1.7,1.8) per 1,000 PYAR in 2005, but have since risen to 2.7 (95% CI:2.6,2.8) per 1,000 PYAR in 2009. Prescription rates for CSM-contraindicated SSRIs citalopram, sertraline and especially paroxetine dropped dramatically after 2002, while rates for fluoxetine and amitriptyline remained stable. After 2005 rates for all antidepressants, except paroxetine and imipramine, started to rise again. Rates for depression diagnoses dropped from 3.0 (95% CI: 2.8,3.1) per 1,000 PYAR in 2002 to 2.0 (95% CI:1.9,2.1) per 1,000 PYAR in 2005 and have been stable since. Recording of symptoms saw a steady increase from 1.0 (95% CI:0.8,1.2) per 1,000 PYAR in 1995 to 4.7 (95% CI:4.5,4.8) per 1,000 PYAR in 2009. Conclusions: The rates of depression diagnoses and SSRI prescriptions showed a significant drop around the time of the CSM advice, which was not present in the recording of symptoms. This could indicate caution on the part of GPs in making depression diagnoses and prescribing antidepressants following the CSM advice.	[Wijlaars, Linda P. M. M.; Nazareth, Irwin; Petersen, Irene] UCL, Dept Primary Care & Populat Hlth, London, England	University of London; University College London	Wijlaars, LPMM (corresponding author), UCL, Dept Primary Care & Populat Hlth, London, England.	linda.wijlaars.10@ucl.ac.uk	Petersen, Irene/I-2751-2012; Petersen, Irene/C-5702-2009	Petersen, Irene/0000-0002-0037-7524; Nazareth, Irwin/0000-0003-2146-9628; Wijlaars, Linda/0000-0003-1222-2922	National Institute of Health Research English National School for Primary Care Research; Medical Research Council [G0601726] Funding Source: researchfish; MRC [G0601726] Funding Source: UKRI	National Institute of Health Research English National School for Primary Care Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	LPW received support from the National Institute of Health Research English National School for Primary Care Research (http://www.nspcr.ac.uk/) for the submitted work. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Booth N, 1994, Health Libr Rev, V11, P177; Bourke Alison, 2004, Inform Prim Care, V12, P171; Bridge JA, 2007, JAMA-J AM MED ASSOC, V297, P1683, DOI 10.1001/jama.297.15.1683; Cepoiu M, 2008, J GEN INTERN MED, V23, P25, DOI 10.1007/s11606-007-0428-5; Clegg LX, 2009, STAT MED, V28, P3670, DOI 10.1002/sim.3733; Committee of Safety of Medicines, 2003, PAR SER VAR ASS REP; Cowen PJ, 2002, BMJ; Dave S, 2010, ARCH PEDIAT ADOL MED, V164, P1038, DOI 10.1001/archpediatrics.2010.184; Dave S, 2009, PHARMACOEPIDEM DR S, V18, P704, DOI 10.1002/pds.1770; Dean AJ, 2007, PHARMACOEPIDEM DR S, V16, P1048, DOI 10.1002/pds.1396; Didham RC, 2005, BRIT J CLIN PHARMACO, V60, P519, DOI 10.1111/j.1365-2125.2005.02480.x; Emslie GJ, 2002, J AM ACAD CHILD PSY, V41, P1205, DOI 10.1097/00004583-200210000-00010; Gibbons RD, 2007, AM J PSYCHIAT, V164, P1356, DOI 10.1176/appi.ajp.2007.07030454; Hammad TA, 2006, ARCH GEN PSYCHIAT, V63, P332, DOI 10.1001/archpsyc.63.3.332; HAZELL P, 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002317; Healy D, 2003, PSYCHOTHER PSYCHOSOM, V72, P71, DOI 10.1159/000068691; Jick H, 2004, JAMA-J AM MED ASSOC, V292, P338, DOI 10.1001/jama.292.3.338; Kamphuis MH, 2011, RECOGNITION DEPRESSI; Keller MB, 2001, J AM ACAD CHILD PSY, V40, P762, DOI 10.1097/00004583-200107000-00010; Khan NF, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X483562; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; Lewis JD, 2005, PHARMACOEPIDEM DR S, V14, P443, DOI 10.1002/pds.1115; LIS Y, 1995, J CLIN EPIDEMIOL, V48, P431, DOI 10.1016/0895-4356(94)00137-F; Lubell K. M., 2007, Morbidity and Mortality Weekly Report, V56, P905; Maguire A, 2009, PHARMACOEPIDEM DR S, V18, P76, DOI 10.1002/pds.1688; Murray ML, 2005, DRUG SAFETY, V28, P1151, DOI 10.2165/00002018-200528120-00009; Murray ML, 2004, ARCH DIS CHILD, V89, P1098, DOI 10.1136/adc.2004.064956; National Cancer Institute, 2011, JOINT POINT REGR PRO; National Institute for Health and Clinical Excellence, 2005, CG28 DEPR CHILDR YOU; Paediatric Formulary Committee, 2010, BNF CHILDR 2010 2011; Rait G, 2009, BRIT J PSYCHIAT, V195, P520, DOI 10.1192/bjp.bp.108.058636; STARK P, 1985, J CLIN PSYCHIAT, V46, P53; Townsend P, 1988, HLTH DEPRIVATION INE, P34; Waechter F, 2003, BRIT MED J, V326, P1282, DOI 10.1136/bmj.326.7402.1282-b; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Whittington CJ, 2004, LANCET, V363, P1341, DOI 10.1016/S0140-6736(04)16043-1	36	71	72	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2012	7	3							e33181	10.1371/journal.pone.0033181	http://dx.doi.org/10.1371/journal.pone.0033181			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	930IA	22427983	Green Published, Green Submitted, gold			2022-12-25	WOS:000303129700035
J	Chiari, Y; van der Meijden, A; Mucedda, M; Lourenco, JM; Hochkirch, A; Veith, M				Chiari, Ylenia; van der Meijden, Arie; Mucedda, Mauro; Lourenco, Joao M.; Hochkirch, Axel; Veith, Michael			Phylogeography of Sardinian Cave Salamanders (Genus Hydromantes) Is Mainly Determined by Geomorphology	PLOS ONE			English	Article							LIZARD PODARCIS-TILIGUERTA; GENETIC DIVERSITY; PHYLOGENETIC-RELATIONSHIPS; PLETHODONTID SALAMANDER; EVOLUTIONARY GENETICS; MITOCHONDRIAL-DNA; POPULATIONS; DIVERGENCE; TAXONOMY; CAUDATA	Detecting the factors that determine the interruption of gene flow between populations is key to understanding how speciation occurs. In this context, caves are an excellent system for studying processes of colonization, differentiation and speciation, since they represent discrete geographical units often with known geological histories. Here, we asked whether discontinuous calcareous areas and cave systems represent major barriers to gene flow within and among the five species of Sardinian cave salamanders (genus Hydromantes) and whether intraspecific genetic structure parallels geographic distance within and among caves. We generated mitochondrial cytochrome b gene sequences from 184 individuals representing 48 populations, and used a Bayesian phylogeographic approach to infer possible areas of cladogenesis for these species and reconstruct historical and current dispersal routes among distinct populations. Our results show deep genetic divergence within and among all Sardinian cave salamander species, which can mostly be attributed to the effects of mountains and discontinuities in major calcareous areas and cave systems acting as barriers to gene flow. While these salamander species can also occur outside caves, our results indicate that there is a very poor dispersal of these species between separate cave systems.	[Chiari, Ylenia; Lourenco, Joao M.] Univ Montpellier 2, CNRS, UMR 5554, Inst Sci Evolut, Montpellier, France; [Chiari, Ylenia; van der Meijden, Arie] Ctr Invest Biodiversidade & Recursos Genet, Vairao, Portugal; [Mucedda, Mauro] Grp Speleol Sassarese, Sassari, Italy; [Hochkirch, Axel; Veith, Michael] Univ Trier, Dept Biogeog, Trier, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universidade do Porto; Universitat Trier	Chiari, Y (corresponding author), Univ Montpellier 2, CNRS, UMR 5554, Inst Sci Evolut, CC 064, Montpellier, France.	yle@yleniachiari.it	Hochkirch, Axel/A-4092-2008; Hochkirch, Axel/E-7891-2011; van der Meijden, Arie/AAD-5199-2019; Chiari, Ylenia/L-5397-2013; Chiari, Ylenia/AAW-3108-2020	Hochkirch, Axel/0000-0002-4475-0394; Chiari, Ylenia/0000-0003-2338-8602; Chiari, Ylenia/0000-0003-2338-8602; van der Meijden, Arie/0000-0002-1317-5382	Societas Europea Herpetologica; FCT [SFRH/BDP/73515/2010, SFRH/BDP/48042/2008, SFRH/BD/38132/2007]	Societas Europea Herpetologica; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	Field work has partly been supported by a grant of the Societas Europea Herpetologica. YC has been supported by a FCT postdoctoral fellowship SFRH/BDP/73515/2010, AvdM by a FCT postdoctoral fellowship SFRH/BDP/48042/2008 and JL by a FCT doctoral fellowship SFRH/BD/38132/2007. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEGRUCCI G, 1992, J EVOLUTION BIOL, V5, P121, DOI 10.1046/j.1420-9101.1992.5010121.x; Allegrucci G, 2011, J BIOGEOGR, V36, P1785; Allegrucci G, 2011, MOL PHYLOGENET EVOL, V60, P108, DOI 10.1016/j.ympev.2011.04.002; BARR TC, 1985, ANNU REV ECOL SYST, V16, P313, DOI 10.1146/annurev.es.16.110185.001525; Bebbee TJC., 1996, ECOLOGY CONSERVATION, P214; Bernini F., 2006, ATLANTE ANFIBI RETTI; Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481; Biollaz F, 2010, J BIOGEOGR, V37, P1557, DOI 10.1111/j.1365-2699.2010.02282.x; Bisconti R, 2011, BIOL J LINN SOC, V103, P159, DOI 10.1111/j.1095-8312.2011.01643.x; Bloomquist EW, 2010, TRENDS ECOL EVOL, V25, P626, DOI 10.1016/j.tree.2010.08.010; Caccone A, 2001, EVOLUTION, V55, P122; Capula M, 1996, HEREDITY, V77, P518, DOI 10.1038/hdy.1996.179; Carranza S, 2008, J BIOGEOGR, V35, P724, DOI 10.1111/j.1365-2699.2007.01817.x; CIMMARUTA R, 1998, BIOGEOGRAPHIA, V19, P183; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Crottini A, 2008, ORG DIVERS EVOL, V8, P368, DOI 10.1016/j.ode.2008.08.001; de Queiroz K, 1998, ENDLESS FORMS, P57; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Delfino M, 2002, PRIMO CONVEGNO NAZL; Delfino Massimo, 2005, Annali del Museo Civico di Storia Naturale Giacomo Doria, V97, P45; Depaulis F, 1998, MOL BIOL EVOL, V15, P1788, DOI 10.1093/oxfordjournals.molbev.a025905; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Funk WC, 2005, MOL ECOL, V14, P483, DOI 10.1111/j.1365-294X.2005.02426.x; Graur D, 2004, TRENDS GENET, V20, P80, DOI 10.1016/j.tig.2003.12.003; Grill A, 2007, J EVOLUTION BIOL, V20, P1255, DOI 10.1111/j.1420-9101.2007.01358.x; Grill A, 2007, PHYLOGEOGRAPHY OF SOUTHERN EUROPEAN REFUGIA, P273, DOI 10.1007/1-4020-4904-8_10; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Harris DJ, 2005, AMPHIBIA-REPTILIA, V26, P401, DOI 10.1163/156853805774408676; Hedin MC, 1997, MOL BIOL EVOL, V14, P309, DOI 10.1093/oxfordjournals.molbev.a025766; Henle K, 2008, BIODIVERSITY CLIMATE, P225; HOWARTH FG, 1983, ANNU REV ENTOMOL, V28, P365, DOI 10.1146/annurev.en.28.010183.002053; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Irwin DE, 2002, EVOLUTION, V56, P2383; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Johannesen J, 2006, J EVOLUTION BIOL, V19, P705, DOI 10.1111/j.1420-9101.2005.01064.x; Ketmaier V, 2003, MOL ECOL, V12, P547, DOI 10.1046/j.1365-294X.2003.01734.x; Lanza B, 1991, CASTELLO MEDUSA AMBI, P94; Lanza Benedetto, 2005, Atti del Museo Civico di Storia Naturale di Trieste, V52, P5; LARSON A, 1984, GENETICS, V106, P293; Lecis R, 2004, BIOL CONSERV, V119, P263, DOI 10.1016/j.biocon.2003.11.011; Lemey P, 2010, MOL BIOL EVOL, V27, P1877, DOI 10.1093/molbev/msq067; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liebgold EB, 2011, MOL ECOL, V20, P249, DOI 10.1111/j.1365-294X.2010.04946.x; Martinsen L, 2009, HEREDITAS, V146, P33, DOI 10.1111/j.1601-5223.2008.02068.x; Mayr E., 1942, P1; McKinnon JS, 2002, TRENDS ECOL EVOL, V17, P480, DOI 10.1016/S0169-5347(02)02579-X; Mueller RL, 2006, SYST BIOL, V55, P289, DOI 10.1080/10635150500541672; Nascetti G, 1996, J HERPETOL, V30, P161, DOI 10.2307/1565507; Nevo E., 1984, Lecture Notes in Biomathematics, V53, P13; Niemiller ML, 2008, MOL ECOL, V17, P2258, DOI 10.1111/j.1365-294X.2008.03750.x; Niemiller ML, 2011, DELIMITING SPECIES U; Noble, 1931, BIOL AMPHIBIAN; Parra-Olea G, 2011, J BIOGEOGRI IN PRESS; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pyron RA, 2011, MOL PHYLOGENET EVOL, V61, P543, DOI 10.1016/j.ympev.2011.06.012; Ribera I, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-29; Salvi D, 2010, MOL PHYLOGENET EVOL, V56, P690, DOI 10.1016/j.ympev.2010.03.017; Salvidio Sebastiano, 1994, Amphibia-Reptilia, V15, P35, DOI 10.1163/156853894X00533; Shepard DB, 2009, MOL ECOL, V18, P2243, DOI 10.1111/j.1365-294X.2009.04164.x; Smith MA, 2005, ECOGRAPHY, V28, P110; Speybroeck J, 2010, ZOOTAXA, P1; Steinfartz S, 2000, MOL ECOL, V9, P397, DOI 10.1046/j.1365-294x.2000.00870.x; Steinfartz S., 1998, HDB REPTILIEN AMPHIB, V4/1, P367; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tarkhnishvili DN, 2000, MOL PHYLOGENET EVOL, V14, P414, DOI 10.1006/mpev.1999.0718; van der Meijden A, 2009, MOL PHYLOGENET EVOL, V51, P399, DOI 10.1016/j.ympev.2008.12.011; Veith M, 2008, MOL PHYLOGENET EVOL, V47, P916, DOI 10.1016/j.ympev.2007.11.017; Vences Miguel, 2007, Amphibian Biology, V7, P2613; Venczel M, 2005, AMPHIBIA-REPTILIA, V26, P408, DOI 10.1163/156853805774408586; Verovnik R, 2004, MOL ECOL, V13, P1519, DOI 10.1111/j.1365-294X.2004.02171.x; Vieites DR, 2007, P NATL ACAD SCI USA, V104, P19903, DOI 10.1073/pnas.0705056104; Vieites DR, 2011, MOL PHYLOGENET EVOL, V59, P623, DOI 10.1016/j.ympev.2011.03.012; VOESENEK L A C J, 1987, Amphibia-Reptilia, V8, P307, DOI 10.1163/156853887X00081; Wake DB, 2005, AMPHIBIA-REPTILIA, V26, P543, DOI 10.1163/156853805774806188; Welsh HH, 2001, CONSERV BIOL, V15, P558, DOI 10.1046/j.1523-1739.2001.015003558.x; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Zeisset I, 2008, HEREDITY, V101, P109, DOI 10.1038/hdy.2008.30	80	39	41	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e32332	10.1371/journal.pone.0032332	http://dx.doi.org/10.1371/journal.pone.0032332			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427830	Green Published, gold			2022-12-25	WOS:000302381500013
J	Jozwik, A; Landowski, J; Bidzan, L; Fulop, T; Bryl, E; Witkowski, JM				Jozwik, Agnieszka; Landowski, Jerzy; Bidzan, Leszek; Fuelop, Tamas; Bryl, Ewa; Witkowski, Jacek M.			Beta-Amyloid Peptides Enhance the Proliferative Response of Activated CD4(+)CD28(+) Lymphocytes from Alzheimer Disease Patients and from Healthy Elderly	PLOS ONE			English	Article							CELLULAR PRION PROTEIN; NECROSIS-FACTOR-ALPHA; T-CELLS; PERIPHERAL-BLOOD; PROINFLAMMATORY CYTOKINES; VASCULAR DEMENTIA; IMMUNE-RESPONSES; IMMUNIZATION; INFLAMMATION; IMPAIRMENT	Alzheimer's disease (AD) is the most frequent form of dementia among elderly. Despite the vast amount of literature on non-specific immune mechanisms in AD there is still little information about the potential antigen-specific immune response in this pathology. It is known that early stages of AD include beta-amyloid (A beta)-reactive antibodies production and inflammatory response. Despite some evidence gathered proving cellular immune response background in AD pathology, the specific reactions of CD4(+) and CD8(+) cells remain unknown as the previous investigations yielded conflicting results. Here we investigated the CD4(+)CD28(+) population of human peripheral blood T cells and showed that soluble beta-amyloids alone were unable to stimulate these cells to proliferate significantly, resulting only in minor, probably antigen-specific, proliferative response. On the other hand, the exposure of in vitro pre-stimulated lymphocytes to soluble A beta peptides significantly enhanced the proliferative response of these cells which had also lead to increased levels of TNF, IL-10 and IL-6. We also proved that A beta peptide-enhanced proliferative response of CD4(+)CD28(+) cells is autonomous and independent from disease status while being associated with the initial, ex vivo activation status of the CD4(+) cells. In conclusion, we suggest that the effect of A beta peptides on the immune system of AD patients does not depend on the specific reactivity to A beta epitope(s), but is rather a consequence of an unspecific modulation of the cell cycle dynamics and cytokine production by T cells, occurring simultaneously in a huge proportion of A beta peptide-exposed T lymphocytes and affecting the immune system performance.	[Jozwik, Agnieszka; Bryl, Ewa; Witkowski, Jacek M.] Med Univ Gdansk, Dept Pathophysiol, Gdansk, Poland; [Landowski, Jerzy] Med Univ Gdansk, Dept Psychiat & Neurot Disorders, Gdansk, Poland; [Bidzan, Leszek] Med Univ Gdansk, Dept Dev Psychiat Psychot Disorders & Geriatr Psy, Gdansk, Poland; [Fuelop, Tamas] Univ Sherbrooke, Fac Med, Div Geriatr, Res Ctr Aging,Immunol Program, Sherbrooke, PQ, Canada	Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; University of Sherbrooke	Jozwik, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Resp Infect Sect, London, England.	jawit@gumed.edu.pl	Witkowski, Jacek M./B-8488-2013	Witkowski, Jacek M./0000-0003-2906-1109; Bryl, Ewa/0000-0002-1410-4287; Jozwik, Agnieszka/0000-0002-7770-8774	Canadian Institutes of Health Research (CIHR) [106634, 106701]; Universite de Sherbrooke; Research Center on Aging; intramural Medical University of Gdansk [ST-58]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Universite de Sherbrooke; Research Center on Aging; intramural Medical University of Gdansk(Medical University Gdansk)	This work was partly supported by grants from the Canadian Institutes of Health Research (CIHR) (No 106634, 106701), from the Universite de Sherbrooke and from the Research Center on Aging (to TF), as well as by an intramural Medical University of Gdansk grant ST-58 to JMW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Alvarez A, 2007, NEUROBIOL AGING, V28, P533, DOI 10.1016/j.neurobiolaging.2006.02.012; Baril L, 2004, NEUROSCI LETT, V355, P226, DOI 10.1016/j.neulet.2003.10.071; Bonotis K, 2008, J NEUROIMMUNOL, V193, P183, DOI 10.1016/j.jneuroim.2007.10.020; Britschgi M, 2007, INT REV NEUROBIOL, V82, P205, DOI 10.1016/S0074-7742(07)82011-3; Bryl E, 2009, IMMUNOLOGY, V128, pe287, DOI 10.1111/j.1365-2567.2008.02961.x; Buchanan MM, 2010, J NEUROCHEM, V114, P13, DOI 10.1111/j.1471-4159.2010.06736.x; Chakrabarty P, 2010, J IMMUNOL, V184, P5333, DOI 10.4049/jimmunol.0903382; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Ferrer I, 2004, BRAIN PATHOL, V14, P11, DOI 10.1111/j.1750-3639.2004.tb00493.x; Finch CE, 2007, CURR ALZHEIMER RES, V4, P185, DOI 10.2174/156720507780362254; GALASKO D, 1990, ARCH NEUROL-CHICAGO, V47, P49, DOI 10.1001/archneur.1990.00530010061020; Gamba P, 2011, AGING CELL, V10, P403, DOI 10.1111/j.1474-9726.2011.00681.x; Gilman S, 2005, NEUROLOGY, V64, P1553, DOI 10.1212/01.WNL.0000159740.16984.3C; Giubilei F, 2003, DEMENT GERIATR COGN, V16, P35, DOI 10.1159/000069991; Gonzalez-Navajas JM, 2010, J CLIN INVEST, V120, P570, DOI 10.1172/JCI40055; Ingram RJ, 2009, FASEB J, V23, P1672, DOI 10.1096/fj.08-116087; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; Kessels HW, 2010, NATURE, V466, pE3, DOI 10.1038/nature09217; Komocsi A, 2002, AM J PATHOL, V160, P1717, DOI 10.1016/S0002-9440(10)61118-2; Larbi A, 2009, J ALZHEIMERS DIS, V17, P91, DOI 10.3233/JAD-2009-1015; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lemere CA, 2000, ANN NY ACAD SCI, V920, P328; Leurs J, 2010, J ALZHEIMERS DIS, V21, P291; Li RL, 2001, CELL IMMUNOL, V207, P49, DOI 10.1006/cimm.2000.1751; LIGTHART GJ, 1984, MECH AGEING DEV, V28, P47, DOI 10.1016/0047-6374(84)90152-0; Liu YJ, 2010, NEUROBIOL AGING, V31, P175, DOI 10.1016/j.neurobiolaging.2008.03.024; Lue LF, 2001, EXP NEUROL, V171, P29, DOI 10.1006/exnr.2001.7732; Manzoni C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024909; Masliah E, 2005, NEUROLOGY, V64, P129, DOI 10.1212/01.WNL.0000148590.39911.DF; McGeer EG, 1999, CURR PHARM DESIGN, V5, P821; Milojevic J, 2011, BIOPHYS J, V100, P183, DOI 10.1016/j.bpj.2010.11.037; Miscia S, 2009, NEUROBIOL AGING, V30, P394, DOI 10.1016/j.neurobiolaging.2007.07.011; Monsonego A, 2003, J CLIN INVEST, V112, P415, DOI 10.1172/JCI200318104; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Orgogozo JM, 2003, NEUROLOGY, V61, P46, DOI 10.1212/01.WNL.0000073623.84147.A8; Paganelli R, 2002, EXP GERONTOL, V37, P257, DOI 10.1016/S0531-5565(01)00191-7; Palotas A, 2002, BRAIN RES BULL, V58, P203, DOI 10.1016/S0361-9230(02)00773-6; Pellicano M, 2010, J ALZHEIMERS DIS, V21, P181, DOI 10.3233/JAD-2010-091714; Politopoulou G, 2000, HAEMATOLOGICA, V85, P580; Portelius E, 2010, INT J ALZHEIMERS DIS; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Richartz E, 2005, DEMENT GERIATR COGN, V19, P184, DOI 10.1159/000083497; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Schmidt AM, 2009, CURR OPIN INVEST DR, V10, P672; Schmitt TL, 1997, MECH AGEING DEV, V94, P223, DOI 10.1016/S0047-6374(97)01866-6; Stieler JT, 2001, NEUROREPORT, V12, P3969, DOI 10.1097/00001756-200112210-00023; Tarkowski E, 1999, J CLIN IMMUNOL, V19, P223, DOI 10.1023/A:1020568013953; Teixeira AL, 2008, BIOL PSYCHIAT, V64, P891, DOI 10.1016/j.biopsych.2008.07.019; Togo T, 2002, J NEUROIMMUNOL, V124, P83, DOI 10.1016/S0165-5728(01)00496-9; Town T, 2002, J NEUROIMMUNOL, V132, P49, DOI 10.1016/S0165-5728(02)00307-7; Trieb K, 1996, NEUROBIOL AGING, V17, P541; Weiner HL, 2000, ANN NEUROL, V48, P567, DOI 10.1002/1531-8249(200010)48:4<567::AID-ANA3>3.3.CO;2-N; Weyand CM, 1998, MECH AGEING DEV, V102, P131, DOI 10.1016/S0047-6374(97)00161-9; Witkowski Jacek M, 2008, Curr Protoc Cytom, VChapter 9, DOI [10.1002/0471142301.ns0930s45, 10.1002/0471142956.cy0925s44]; Zota V, 2009, J IMMUNOL, V183, P3522, DOI 10.4049/jimmunol.0900620; Zuliani G, 2007, J PSYCHIATR RES, V41, P686, DOI 10.1016/j.jpsychires.2006.02.008	58	18	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33276	10.1371/journal.pone.0033276	http://dx.doi.org/10.1371/journal.pone.0033276			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22428008	Green Submitted, Green Published, gold			2022-12-25	WOS:000302381500119
J	Shankar, J; Walker, RG; Ward, D; Horsburgh, MJ				Shankar, Jayendra; Walker, Rachel G.; Ward, Deborah; Horsburgh, Malcolm J.			The Enterococcus faecalis Exoproteome: Identification and Temporal Regulation by Fsr	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; STREPTOCOCCUS-FAECALIS; SERINE-PROTEASE; IN-VITRO; PROTEINS; GELATINASE; COMMENSAL; TRANSDUCTION; DIVERSITY; PHENOTYPE	Analysis of the culture supernatant exoproteins produced by two PFGE clusters of high-level gentamicin and ciprofloxacin-resistant clinical isolates of Enterococcus faecalis from the UK and Ireland revealed two distinct protein profiles. This grouping distinguished OG1RF and GelE metalloprotease-expressing isolates from JH2-2 and other GelE-negative isolates. The integrity of the fsrABDC operon was found to determine the exoproteome composition, since an fsrB mutant of strain OG1RF appeared very similar to that of strain JH2-2, and complementation of the latter with the fsrABDC operon produced an OG1RF-like exoproteome. The proteins present in the supernatant fraction of OG1RF were separated using 2D gels and identified by mass spectrometry and comprised many mass and pI variants of the GelE and SprE proteases. In addition cell wall synthesis and cell division proteins were identified. An OG1RF fsrB mutant had a distinct exoprotein fraction with an absence of the Fsr-regulated proteases and was characterised by general stress and glycolytic proteins. The exoproteome of the OG1RF fsrB mutant resembles that of a divIVA mutant of E. faecalis, suggestive of a stress phenotype.	[Shankar, Jayendra; Walker, Rachel G.; Ward, Deborah; Horsburgh, Malcolm J.] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Shankar, J (corresponding author), Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England.	M.J.Horsburgh@Liverpool.ac.uk	Horsburgh, Malcolm J/H-9657-2013	Lewis, Rachel/0000-0001-5904-2668	BBSRC [BB/S/K/2004/11198]; Dorothy Hodgkin NERC-BP	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Dorothy Hodgkin NERC-BP	This research was supported by a BBSRC postgraduate award BB/S/K/2004/11198 to RGW and a Dorothy Hodgkin NERC-BP postgraduate award to JS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antikainen J, 2007, FEMS IMMUNOL MED MIC, V51, P526, DOI 10.1111/j.1574-695X.2007.00330.x; Biavasco F, 1996, EUR J CLIN MICROBIOL, V15, P50, DOI 10.1007/BF01586185; Bohle LA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-135; Bonten M J, 2001, Lancet Infect Dis, V1, P314, DOI 10.1016/S1473-3099(01)00145-1; Bourgogne A, 2006, J BACTERIOL, V188, P2875, DOI 10.1128/JB.188.8.2875-2884.2006; Bourgogne A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r110; Burlak C, 2007, CELL MICROBIOL, V9, P1172, DOI 10.1111/j.1462-5822.2006.00858.x; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P565; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P902; Chang S, 2003, NEW ENGL J MED, V348, P1342, DOI 10.1056/NEJMoa025025; Chaussee Michelle A., 2008, V431, P15; Collin M, 2001, EMBO J, V20, P3046, DOI 10.1093/emboj/20.12.3046; Del Papa MF, 2007, J BACTERIOL, V189, P8835, DOI 10.1128/JB.01311-07; DUNNY GM, 1978, P NATL ACAD SCI USA, V75, P3479, DOI 10.1073/pnas.75.7.3479; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Galloway-Pena JR, 2011, APPL ENVIRON MICROB, V77, P442, DOI 10.1128/AEM.00756-10; Gilmore MS, 2003, SCIENCE, V299, P1999, DOI 10.1126/science.1083534; Hancock L, 2002, J BACTERIOL, V184, P5819, DOI 10.1128/JB.184.21.5819-5825.2002; Hancock LE, 2006, PATHOGENICITY ENTERO; JACOB AE, 1974, J BACTERIOL, V117, P360, DOI 10.1128/JB.117.2.360-372.1974; Kawalec M, 2005, J BACTERIOL, V187, P266, DOI 10.1128/JB.187.1.266-275.2005; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Maddalo G, 2011, PROTEOMICS, V11, P3935, DOI 10.1002/pmic.201100103; Manson JM, 2010, P NATL ACAD SCI USA, V107, P12269, DOI 10.1073/pnas.1000139107; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Nakayama J, 2002, APPL ENVIRON MICROB, V68, P3152, DOI 10.1128/AEM.68.6.3152-3155.2002; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Paulsen IT, 2003, SCIENCE, V299, P2071, DOI 10.1126/science.1080613; Qin X, 2000, INFECT IMMUN, V68, P2579, DOI 10.1128/IAI.68.5.2579-2586.2000; Qin X, 2001, J BACTERIOL, V183, P3372, DOI 10.1128/JB.183.11.3372-3382.2001; Ramirez-Arcos S, 2005, MICROBIOL-SGM, V151, P1381, DOI 10.1099/mic.0.27718-0; Ruiz-Garbajosa P, 2006, J CLIN MICROBIOL, V44, P2220, DOI 10.1128/JCM.02596-05; SAHM DF, 1989, ANTIMICROB AGENTS CH, V33, P1588, DOI 10.1128/AAC.33.9.1588; Singh KV, 1998, J INFECT DIS, V178, P1416, DOI 10.1086/314453; Teixeira N, 2012, MICROBIOL-SGM, V158, P519, DOI 10.1099/mic.0.055574-0; Tendolkar PM, 2003, CELL MOL LIFE SCI, V60, P2622, DOI 10.1007/s00018-003-3138-0; VONHEIJNE G, 1990, J MEMBRANE BIOL, V115, P195, DOI 10.1007/BF01868635; Waters CM, 2003, J BACTERIOL, V185, P3613, DOI 10.1128/JB.185.12.3613-3623.2003; Willems RJL, 2009, FUTURE MICROBIOL, V4, P1125, DOI [10.2217/fmb.09.82, 10.2217/FMB.09.82]; Wormann ME, 2011, J BACTERIOL, V193, P5279, DOI 10.1128/JB.00369-11; Woodford N, 2003, J ANTIMICROB CHEMOTH, V52, P711, DOI 10.1093/jac/dkg408; Yan JX, 2000, ELECTROPHORESIS, V21, P3666, DOI 10.1002/1522-2683(200011)21:17<3666::AID-ELPS3666>3.0.CO;2-6; Yasmin A, 2010, J BACTERIOL, V192, P1122, DOI 10.1128/JB.01293-09; Ziebandt AK, 2010, PROTEOMICS, V10, P1634, DOI 10.1002/pmic.200900313	45	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33450	10.1371/journal.pone.0033450	http://dx.doi.org/10.1371/journal.pone.0033450			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22428053	Green Published, gold, Green Submitted			2022-12-25	WOS:000302381500143
J	Chen, S; Evans, HG; Evans, DR				Chen, Song; Evans, Hedeel Guy; Evans, David R.			FLASH Knockdown Sensitizes Cells To Fas-Mediated Apoptosis via Down-Regulation of the Anti-Apoptotic Proteins, MCL-1 and Cflip Short	PLOS ONE			English	Article							NF-KAPPA-B; HISTONE GENE-TRANSCRIPTION; NUCLEAR-BODIES; CAJAL BODIES; S-PHASE; GLUCOCORTICOID-RECEPTOR; SIGNALING PATHWAY; ANTICANCER DRUGS; C-MYB; DAXX	FLASH (FLICE-associated huge protein or CASP8AP2) is a large multifunctional protein that is involved in many cellular processes associated with cell death and survival. It has been reported to promote apoptosis, but we show here that depletion of FLASH in HT1080 cells by siRNA interference can also accelerate the process. As shown previously, depletion of FLASH halts growth by down-regulating histone biosynthesis and arrests the cell cycle in S-phase. FLASH knockdown followed by stimulating the cells with Fas ligand or anti-Fas antibodies was found to be associated with a more rapid cleavage of PARP, accelerated activation of caspase-8 and the executioner caspase-3 and rapid progression to cellular disintegration. As is the case for most anti-apoptotic proteins, FLASH was degraded soon after the onset of apoptosis. Depletion of FLASH also resulted in the reduced intracellular levels of the anti-apoptotic proteins, MCL-1 and the short isoform of cFLIP. FLASH knockdown in HT1080 mutant cells defective in p53 did not significantly accelerate Fas mediated apoptosis indicating that the effect was dependent on functional p53. Collectively, these results suggest that under some circumstances, FLASH suppresses apoptosis.	[Chen, Song; Evans, Hedeel Guy; Evans, David R.] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48202 USA; [Evans, Hedeel Guy] Eastern Michigan Univ, Dept Chem, Ypsilanti, MI 48197 USA	Wayne State University; Eastern Michigan University	Chen, S (corresponding author), Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48202 USA.	drevans@med.wayne.edu			National Institutes of Health [GM/CA60371]; Wayne State University	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wayne State University	Funding came from National Institutes of Health GM/CA60371, (nih.gov), and a Wayne State University Provost award, (wayne.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2004, CANCER CELL, V5, P417, DOI 10.1016/S1535-6108(04)00120-5; Alm-Kristiansen AH, 2008, ONCOGENE, V27, P4644, DOI 10.1038/onc.2008.105; Alm-Kristiansen AH, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-21; Alm-Kristiansen AH, 2009, BIOCHEM BIOPH RES CO, V387, P494, DOI 10.1016/j.bbrc.2009.07.053; Altieri DC, 2003, NAT REV CANCER, V3, P46, DOI 10.1038/nrc968; Barcaroli D, 2006, P NATL ACAD SCI USA, V103, P14802, DOI 10.1073/pnas.0604225103; Barcaroli D, 2006, P NATL ACAD SCI USA, V103, P14808, DOI 10.1073/pnas.0604227103; BASOLO F, 1991, MOL CARCINOGEN, V4, P25, DOI 10.1002/mc.2940040106; Bongiorno-Borbone L, 2008, CELL CYCLE, V7, P2357, DOI 10.4161/cc.6344; Chang CC, 2011, MOL CELL, V42, P62, DOI 10.1016/j.molcel.2011.02.022; Chen LY, 2003, MOL CELL BIOL, V23, P7108, DOI 10.1128/MCB.23.20.7108-7121.2003; Choi YH, 2001, J BIOL CHEM, V276, P25073, DOI 10.1074/jbc.M102941200; De Cola A, 2011, ONCOGENE; Dixit V, 2002, CELL, V111, P615, DOI 10.1016/S0092-8674(02)01166-2; Fricker N, 2010, J CELL BIOL, V190, P377, DOI 10.1083/jcb.201002060; Imai Y, 1999, NATURE, V398, P777, DOI 10.1038/19709; Jun JI, 2005, ONCOGENE, V24, P688, DOI 10.1038/sj.onc.1208186; Kavuri SM, 2011, J BIOL CHEM, V286, P16631, DOI 10.1074/jbc.M110.148585; Kino T, 2003, J BIOL CHEM, V278, P3023, DOI 10.1074/jbc.M209234200; Kiriyama M, 2009, MOL CELL BIOL, V29, P4729, DOI 10.1128/MCB.00289-09; Kittler R, 2004, NATURE, V432, P1036, DOI 10.1038/nature03159; Krieghoff E, 2007, CELL CYCLE, V6, P771, DOI 10.4161/cc.6.7.4046; Krieghoff-Henning E, 2008, BBA-MOL CELL RES, V1783, P2185, DOI 10.1016/j.bbamcr.2008.07.002; Kuwana T, 1998, J BIOL CHEM, V273, P16589, DOI 10.1074/jbc.273.26.16589; Lim DS, 2000, NATURE, V404, P613, DOI 10.1038/35007091; Ma TL, 2000, GENE DEV, V14, P2298, DOI 10.1101/gad.829500; Michaelson JS, 2003, J CELL SCI, V116, P345, DOI 10.1242/jcs.00234; Michaelson JS, 1999, GENE DEV, V13, P1918, DOI 10.1101/gad.13.15.1918; Milovic-Holm K, 2007, EMBO J, V26, P391, DOI 10.1038/sj.emboj.7601504; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; Obradovic D, 2004, MOL PHARMACOL, V65, P761, DOI 10.1124/mol.65.3.761; Okano H, 2003, ONCOL REP, V10, P1145; Pietrzak M, 2008, BIOL CHEM, V389, P383, DOI 10.1515/BC.2008.039; Ponton A, 1996, J BIOL CHEM, V271, P8991, DOI 10.1074/jbc.271.15.8991; Poukkula M, 2005, J BIOL CHEM, V280, P27345, DOI 10.1074/jbc.M504019200; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Short B, 2010, J CELL BIOL, V190, P291; SOULE HD, 1990, CANCER RES, V50, P6075; Tamm I, 1998, CANCER RES, V58, P5315; Tanaka M, 2010, HISTOCHEM CELL BIOL, V134, P297, DOI 10.1007/s00418-010-0734-6; Yang XC, 2009, MOL CELL, V36, P267, DOI 10.1016/j.molcel.2009.08.016; Yang XL, 1997, CELL, V89, P1067, DOI 10.1016/S0092-8674(00)80294-9; Yun CW, 2000, ONCOGENE, V19, P5163, DOI 10.1038/sj.onc.1203896; Zhao JY, 2000, GENE DEV, V14, P2283, DOI 10.1101/gad.827700; Zhong S, 2000, J EXP MED, V191, P631, DOI 10.1084/jem.191.4.631; Zhou FF, 2011, MOL BIOL CELL, V22, P3533, DOI 10.1091/mbc.E11-06-0483	46	10	12	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2012	7	3							e32971	10.1371/journal.pone.0032971	http://dx.doi.org/10.1371/journal.pone.0032971			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KX	22427918	Green Submitted, Green Published, gold			2022-12-25	WOS:000303062800036
J	Overgaard, J; Kristensen, TN; Sorensen, JG				Overgaard, Johannes; Kristensen, Torsten Nygaard; Sorensen, Jesper Givskov			Validity of Thermal Ramping Assays Used to Assess Thermal Tolerance in Arthropods	PLOS ONE			English	Article							ADULT DROSOPHILA-MELANOGASTER; ENVIRONMENTAL-TEMPERATURE; METHODOLOGICAL CONTEXT; HSP70 EXPRESSION; HEAT TOLERANCE; METABOLIC-RATE; LIMITS DEPEND; COLD; RESISTANCE; SHOCK	Proper assessment of environmental resistance of animals is critical for the ability of researchers to understand how variation in environmental conditions influence population and species abundance. This is also the case for studies of upper thermal limits in insects, where researchers studying animals under laboratory conditions must select appropriate methodology on which conclusions can be drawn. Ideally these methods should precisely estimate the trait of interest and also be biological meaningful. In an attempt to develop such tests it has been proposed that thermal ramping assays are useful assays for small insects because they incorporate an ecologically relevant gradual temperature change. However, recent model-based papers have suggested that estimates of thermal resistance may be strongly confounded by simultaneous starvation and dehydration stress. In the present study we empirically test these model predictions using two sets of independent experiments. We clearly demonstrate that results from ramping assays of small insects (Drosophila melanogaster) are not compromised by starvation-or dehydration-stress. Firstly we show that the mild disturbance of water and energy balance of D. melanogaster experienced during the ramping tests does not confound heat tolerance estimates. Secondly we show that flies pre-exposed to starvation and dehydration have "normal" heat tolerance and that resistance to heat stress is independent of the energetic and water status of the flies. On the basis of our results we discuss the assumptions used in recent model papers and present arguments as to why the ramping assay is both a valid and ecologically relevant way to measure thermal resistance in insects.	[Overgaard, Johannes; Kristensen, Torsten Nygaard; Sorensen, Jesper Givskov] Aarhus Univ, Dept Biosci, Aarhus, Denmark; [Kristensen, Torsten Nygaard] Aarhus Univ, Dept Mol Biol & Genet, Tjele, Denmark	Aarhus University; Aarhus University	Overgaard, J (corresponding author), Aarhus Univ, Dept Biosci, Aarhus, Denmark.	Biojo@biology.au.dk	Kristensen, Torsten N/C-5031-2015; Sørensen, Jesper Givskov/J-3190-2013; Overgaard, Johannes/I-7493-2013; Overgaard, Johannes/AAA-3922-2022	Kristensen, Torsten N/0000-0001-6204-8753; Sørensen, Jesper Givskov/0000-0002-9149-3626; Overgaard, Johannes/0000-0002-2851-4551; 	Danish Research Council; Danish Council for Independent Research	Danish Research Council(Det Frie Forskningsrad (DFF)); Danish Council for Independent Research(Det Frie Forskningsrad (DFF))	This work was supported by The Danish Research Council (JO and TNK) and a Sapere Aude DFF-Starting grant from The Danish Council for Independent Research (JGS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berrigan D, 1997, COMP BIOCHEM PHYS A, V118, P1301, DOI 10.1016/S0300-9629(97)00030-3; CHEN CP, 1994, J INSECT PHYSIOL, V40, P661, DOI 10.1016/0022-1910(94)90093-0; Chidawanyika F, 2011, EVOL APPL, V4, P534, DOI 10.1111/j.1752-4571.2010.00168.x; Chown SL, 2009, FUNCT ECOL, V23, P133, DOI 10.1111/j.1365-2435.2008.01481.x; Cooper BS, 2008, J THERM BIOL, V33, P320, DOI 10.1016/j.jtherbio.2008.04.001; Dahlgaard J, 1998, FUNCT ECOL, V12, P786, DOI 10.1046/j.1365-2435.1998.00246.x; DALAGE JL, 1989, J INSECT PHYSIOL, V35, P453, DOI 10.1016/0022-1910(89)90051-6; Djawdan M, 1997, ECOLOGY, V78, P828, DOI 10.1890/0012-9658(1997)078[0828:DSFSRL]2.0.CO;2; Edney E.B., 1977, WATER BALANCE LAND A, P17; Feder ME, 1996, J EXP BIOL, V199, P1837; Gibbs AG, 2003, J EXP BIOL, V206, P1183, DOI 10.1242/jeb.00233; Hoffmann AA, 2003, J THERM BIOL, V28, P175, DOI 10.1016/S0306-4565(02)00057-8; HUEY RB, 1992, FUNCT ECOL, V6, P489, DOI 10.2307/2389288; Irlich UM, 2009, AM NAT, V174, P819, DOI 10.1086/647904; Kelty JD, 2001, J EXP BIOL, V204, P1659; Klok CJ, 2003, BIOL J LINN SOC, V78, P401, DOI 10.1046/j.1095-8312.2003.00154.x; Krebs RA, 1999, CELL STRESS CHAPERON, V4, P243, DOI 10.1379/1466-1268(1999)004<0243:ACOHEA>2.3.CO;2; Kristensen TN, 2008, P NATL ACAD SCI USA, V105, P216, DOI 10.1073/pnas.0708074105; Loeschcke V, 2007, AM NAT, V169, P175, DOI 10.1086/510632; MacMillan HA, 2011, J INSECT PHYSIOL, V57, P12, DOI 10.1016/j.jinsphys.2010.10.004; Marron MT, 2003, J INSECT PHYSIOL, V49, P261, DOI 10.1016/S0022-1910(02)00287-1; Mitchell KA, 2010, FUNCT ECOL, V24, P694, DOI 10.1111/j.1365-2435.2009.01666.x; Overgaard J, 2007, J EXP ZOOL PART A, V307A, P578, DOI 10.1002/jez.412; Overgaard J, 2011, J THERM BIOL, V36, P409, DOI 10.1016/j.jtherbio.2011.07.005; Overgaard J, 2011, AM NAT, V178, pS80, DOI 10.1086/661780; Overgaard J, 2010, FUNCT ECOL, V24, P186, DOI 10.1111/j.1365-2435.2009.01615.x; Rezende EL, 2011, FUNCT ECOL, V25, P111, DOI 10.1111/j.1365-2435.2010.01778.x; Santos M, 2011, FUNCT ECOL, V25, P1169, DOI 10.1111/j.1365-2435.2011.01908.x; Schmidt-Nielsen K, 1997, ANIMAL PHYSL ADAPTAT; Sgro CM, 2010, J EVOLUTION BIOL, V23, P2484, DOI 10.1111/j.1420-9101.2010.02110.x; Sinclair BJ, 2005, J THERM BIOL, V30, P557, DOI 10.1016/j.jtherbio.2005.07.002; Terblanche JS, 2007, P ROY SOC B-BIOL SCI, V274, P2935, DOI 10.1098/rspb.2007.0985; Terblanche JS, 2011, J EXP BIOL, V214, P3713, DOI 10.1242/jeb.061283	33	112	112	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2012	7	3							e32758	10.1371/journal.pone.0032758	http://dx.doi.org/10.1371/journal.pone.0032758			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KX	22427876	Green Published, gold, Green Submitted			2022-12-25	WOS:000303062800031
J	Liu, LS; Qiu, W; Wang, H; Li, Y; Zhou, JB; Xia, M; Shan, K; Pang, RR; Zhou, Y; Zhao, D; Wang, YW				Liu, Lisha; Qiu, Wen; Wang, Hui; Li, Yan; Zhou, Jianbo; Xia, Mei; Shan, Kai; Pang, Rongrong; Zhou, Ying; Zhao, Dan; Wang, Yingwei			Sublytic C5b-9 Complexes Induce Apoptosis of Glomerular Mesangial Cells in Rats with Thy-1 Nephritis through Role of Interferon Regulatory Factor-1-dependent Caspase 8 Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION PROFILE; FACTOR-I; MICROARRAY ANALYSIS; IGA NEPHROPATHY; CANCER-CELLS; MULTIPLE-SCLEROSIS; COMPLEMENT C5B-9; UP-REGULATION; DNA-DAMAGE; INJURY	The apoptosis of glomerular mesangial cells (GMC) in rat Thy-1 nephritis (Thy-1N), a model of human mesangioproliferative glomerulonephritis, is accompanied by sublytic C5b-9 deposition, but the mechanism of sublytic C5b-9-mediated GMC apoptosis has not been elucidated. In the present study, the gene expression profiles both in the GMC stimulated by sublytic C5b-9 and the rat renal tissue of Thy-1N were detected using microarrays. Among the co-up-regulated genes, the up-regulation of interferon regulatory factor-1 (IRF-1) was further confirmed. Increased caspase 8 and caspase 3 expression and caspase 8 promoter activity in the GMC were also identified. Meanwhile, overexpression or knockdown of IRF-1 not only enhanced or inhibited GMC apoptosis and caspase 8 and 3 induction but also increased or decreased caspase 8 promoter activity, respectively. The element of IRF-1 binding to the caspase 8 promoter was first revealed. Furthermore, silencing IRF-1 or repressing the activation of caspases 8 and 3 significantly reduced GMC apoptosis, including other pathologic changes of Thy-1N. These novel findings indicate that GMC apoptosis of Thy-1N is associated with the IRF-1-activated caspase 8 pathway.	[Liu, Lisha; Qiu, Wen; Wang, Hui; Li, Yan; Zhou, Jianbo; Xia, Mei; Shan, Kai; Pang, Rongrong; Zhou, Ying; Zhao, Dan; Wang, Yingwei] Nanjing Med Univ, Dept Microbiol & Immunol, Nanjing 210029, Jiangsu, Peoples R China	Nanjing Medical University	Wang, YW (corresponding author), Nanjing Med Univ, Dept Microbiol & Immunol, 140 Nanjing Hanzhong Rd, Nanjing 210029, Jiangsu, Peoples R China.	wangyw1508@njmu.edu.cn	Shan, Kai/GSJ-6217-2022	Li, Yan/0000-0003-0420-4222	National Natural Science Foundations of China [31000396, 81072402]; Natural Science Foundations of Jiangsu Province in China [BK2009417, 10KJB310006, 09hx43]	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundations of Jiangsu Province in China	This work was supported by National Natural Science Foundations of China Grants 31000396 and 81072402 and Natural Science Foundations of Jiangsu Province in China Grants BK2009417, 10KJB310006, and 09hx43.	Amore A, 2000, NEPHRON, V86, P99, DOI 10.1159/000045725; Blanco JCG, 2000, J EXP MED, V191, P2131, DOI 10.1084/jem.191.12.2131; Bouker KB, 2005, CARCINOGENESIS, V26, P1527, DOI 10.1093/carcin/bgi113; Brandt J, 1996, KIDNEY INT, V49, P335, DOI 10.1038/ki.1996.50; Colonna M, 2007, EUR J IMMUNOL, V37, P306, DOI 10.1002/eji.200637009; Cudrici C, 2006, J REHABIL RES DEV, V43, P123, DOI 10.1682/JRRD.2004.08.0111; Cybulsky AV, 2005, AM J PHYSIOL-RENAL, V289, pF593, DOI 10.1152/ajprenal.00066.2005; Darvill AM, 2006, J LAB CLIN MED, V147, P301, DOI 10.1016/j.lab.2006.02.001; De Ambrosis A, 2007, INT J CANCER, V120, P39, DOI 10.1002/ijc.22173; Ekmekcioglu S, 2008, CYTOKINE, V43, P34, DOI 10.1016/j.cyto.2008.04.010; Fantuzzi G, 2001, EUR J IMMUNOL, V31, P369, DOI 10.1002/1521-4141(200102)31:2<369::AID-IMMU369>3.0.CO;2-Y; Gao J, 2010, CELL DEATH DIFFER, V17, P699, DOI 10.1038/cdd.2009.156; Gao L, 2009, CELL PROLIFERAT, V42, P83, DOI 10.1111/j.1365-2184.2008.00575.x; Inaba H, 2004, PEDIATR BLOOD CANCER, V43, P729, DOI 10.1002/pbc.20151; Jiang XM, 2010, CELL MOL IMMUNOL, V7, P143, DOI 10.1038/cmi.2009.109; Kawasaki Yukihiko, 2008, Fukushima J Med Sci, V54, P43; Li Zhen, 2009, Chinese Medical Sciences Journal, V24, P91; Lin F, 2004, J IMMUNOL, V172, P2636, DOI 10.4049/jimmunol.172.4.2636; Lu XCM, 2004, J NEUROSCI RES, V77, P843, DOI 10.1002/jnr.20218; MIYAMOTO M, 1988, CELL, V54, P903, DOI 10.1016/S0092-8674(88)91307-4; Nakazawa T, 2001, J AUTOIMMUN, V17, P119, DOI 10.1006/jaut.2001.0531; Ochi H, 2002, EUR J IMMUNOL, V32, P1821, DOI 10.1002/1521-4141(200207)32:7<1821::AID-IMMU1821>3.0.CO;2-A; Pamment J, 2002, ONCOGENE, V21, P7776, DOI 10.1038/sj.onc.1205981; Papageorgiou A, 2007, CANCER BIOL THER, V6, P872, DOI 10.4161/cbt.6.6.4088; Park SY, 2004, EUR J BIOCHEM, V271, P4222, DOI 10.1111/j.1432-1033.2004.04362.x; Pippin JW, 2003, J CLIN INVEST, V111, P877, DOI 10.1172/JCI200315645; Preston GA, 2004, KIDNEY INT, V65, P420, DOI 10.1111/j.1523-1755.2004.00398.x; Qiu W, 2009, EUR J IMMUNOL, V39, P3251, DOI 10.1002/eji.200939264; Reilly CM, 2006, EUR J IMMUNOL, V36, P1296, DOI 10.1002/eji.200535245; Ren G, 2008, MOL IMMUNOL, V45, P2236, DOI 10.1016/j.molimm.2007.11.013; Ruiz-Ruiz C, 2004, J BIOL CHEM, V279, P19712, DOI 10.1074/jbc.M313023200; Rus H, 2005, ANN MED, V37, P97, DOI 10.1080/07853890510007278; Sanceau J, 2000, ONCOGENE, V19, P3372, DOI 10.1038/sj.onc.1203670; Sanceau J, 2002, J BIOL CHEM, V277, P35766, DOI 10.1074/jbc.M202959200; Sato T, 1999, J AM SOC NEPHROL, V10, P1242; Schwab K, 2004, AM J NEPHROL, V24, P438, DOI 10.1159/000080188; Shi Y, 2010, MOL BIOL REP, V37, P1483, DOI 10.1007/s11033-009-9544-0; Shimizu A, 2000, NEPHRON, V86, P152, DOI 10.1159/000045734; Stang MT, 2007, ONCOGENE, V26, P6420, DOI 10.1038/sj.onc.1210470; Strasser A, 2000, ANNU REV BIOCHEM, V69, P217, DOI 10.1146/annurev.biochem.69.1.217; Tanaka N, 1996, NATURE, V382, P816, DOI 10.1038/382816a0; Tanaka T, 2005, KIDNEY INT, V68, P2714, DOI 10.1111/j.1523-1755.2005.00742.x; Teramoto K, 2008, J PHARMACOL SCI, V106, P56, DOI 10.1254/jphs.FP0071337; Turnberg D, 2005, CURR OPIN NEPHROL HY, V14, P223, DOI 10.1097/01.mnh.0000165887.75501.24; Wada J, 2003, SEMIN NEPHROL, V23, P556, DOI 10.1053/S0270-9295(03)00134-7; Wang J, 2009, CARCINOGENESIS, V30, P222, DOI 10.1093/carcin/bgn271; Wang YW, 2006, LIFE SCI, V79, P182, DOI 10.1016/j.lfs.2005.12.053; Xu JH, 2006, CELL TISSUE RES, V326, P159, DOI 10.1007/s00441-006-0214-4; YAMAMOTO T, 1987, J IMMUNOL, V138, P3758; Yang ZQ, 2009, ARTERIOSCL THROM VAS, V29, P1213, DOI 10.1161/ATVBAHA.109.189407	50	28	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16410	16423		10.1074/jbc.M111.319566	http://dx.doi.org/10.1074/jbc.M111.319566			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22427665	Green Published, hybrid			2022-12-25	WOS:000304030900032
J	Poulsen, H; Nissen, P; Mouritsen, OG; Khandelia, H				Poulsen, Hanne; Nissen, Poul; Mouritsen, Ole G.; Khandelia, Himanshu			Protein Kinase A (PKA) Phosphorylation of Na+/K+-ATPase Opens Intracellular C-terminal Water Pathway Leading to Third Na+-binding site in Molecular Dynamics Simulations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINEAR CONSTRAINT SOLVER; K+-ATPASE; NA+,K+-ATPASE ACTIVITY; CRYSTAL-STRUCTURE; XENOPUS-OOCYTES; ALPHA-SUBUNIT; FORCE-FIELD; NA,K-ATPASE; MEMBRANE; TRANSPORT	Phosphorylation is one of the major mechanisms for posttranscriptional modification of proteins. The addition of a compact, negatively charged moiety to a protein can significantly change its function and localization by affecting its structure and interaction network. We have used all-atom Molecular Dynamics simulations to investigate the structural consequences of phosphorylating the Na+/K+-ATPase (NKA) residue Ser(936), which is the best characterized phosphorylation site in NKA, targeted in vivo by protein kinase A (PKA). The Molecular Dynamics simulations suggest that Ser(936) phosphorylation opens a C-terminal hydrated pathway leading to Asp(926), a transmembrane residue proposed to form part of the third sodium ion-binding site. Simulations of a S936E mutant form, for which only subtle effects are observed when expressed in Xenopus oocytes and studied with electrophysiology, does not mimic the effects of Ser(936) phosphorylation. The results establish a structural association of Ser(936) with the C terminus of NKA and indicate that phosphorylation of Ser(936) can modulate pumping activity by changing the accessibility to the ion-binding site.	[Mouritsen, Ole G.; Khandelia, Himanshu] Univ So Denmark, MEMPHYS Ctr Biomembrane Phys, DK-5230 Odense M, Denmark; [Poulsen, Hanne; Nissen, Poul] Aarhus Univ, PUMPKIN Ctr Membrane Pumps Cells & Dis, DK-8000 Aarhus C, Denmark	University of Southern Denmark; Aarhus University	Khandelia, H (corresponding author), Univ So Denmark, MEMPHYS Ctr Biomembrane Phys, DK-5230 Odense M, Denmark.	hkhandel@memphys.sdu.dk		Khandelia, Himanshu/0000-0001-9913-6394; Mouritsen, Ole G./0000-0002-4258-8960; Nissen, Poul/0000-0003-0948-6628	Danish National Research Foundation; Lundbeck Foundation; Lundbeck Foundation [R82-2011-7280] Funding Source: researchfish	Danish National Research Foundation(Danmarks Grundforskningsfond); Lundbeck Foundation(Lundbeckfonden); Lundbeck Foundation(Lundbeckfonden)	MEMPHYS-Center for Biomembrane Physics is supported by the Danish National Research Foundation. The computations were done at the SDU node of the Danish Center for Scientific Computing (DCSC). PUMPKIN is a Center of Excellence funded by the Danish National Research Foundation.; Supported by a Lundbeck Foundation young investigator grant.	Andersson RM, 1998, ACTA PHYSIOL SCAND, V164, P39; Awayda MS, 1996, J GEN PHYSIOL, V108, P49, DOI 10.1085/jgp.108.1.49; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berger O, 1997, BIOPHYS J, V72, P2002, DOI 10.1016/S0006-3495(97)78845-3; BERTORELLO AM, 1991, P NATL ACAD SCI USA, V88, P11359, DOI 10.1073/pnas.88.24.11359; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; Chakrabarti N, 2010, BIOPHYS J, V98, P784, DOI 10.1016/j.bpj.2009.11.009; Cheng SXJ, 1999, J PHYSIOL-LONDON, V518, P37, DOI 10.1111/j.1469-7793.1999.0037r.x; Cheng XJ, 1997, AM J PHYSIOL-CELL PH, V273, pC893, DOI 10.1152/ajpcell.1997.273.3.C893; CHIBALIN AV, 1992, J BIOL CHEM, V267, P22378; Codina J, 2006, J AM SOC NEPHROL, V17, P1833, DOI 10.1681/ASN.2006010032; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Espinoza-Fonseca LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026936; FESCHENKO MS, 1994, J BIOL CHEM, V269, P30436; Groban ES, 2006, PLOS COMPUT BIOL, V2, P238, DOI 10.1371/journal.pcbi.0020032; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Kristensen B, 2003, J MEMBRANE BIOL, V191, P25, DOI 10.1007/s00232-002-1043-3; Law RJ, 2008, BIOPHYS J, V95, P2739, DOI 10.1529/biophysj.107.128025; Leach A. R., 2001, MOL MODELLING PRINCI, P356; Lee YS, 2000, NEUROSCI LETT, V288, P57, DOI 10.1016/S0304-3940(00)01208-8; Meier S, 2010, J GEN PHYSIOL, V135, P115, DOI 10.1085/jgp.200910301; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Morth JP, 2011, NAT REV MOL CELL BIO, V12, P60, DOI 10.1038/nrm3031; Morth JP, 2009, PHILOS T R SOC B, V364, P217, DOI 10.1098/rstb.2008.0201; Musgaard M, 2011, BIOCHEMISTRY-US, V50, P11109, DOI 10.1021/bi201164b; Oliveira MS, 2009, J NEUROCHEM, V109, P416, DOI 10.1111/j.1471-4159.2009.05961.x; Piana S, 2011, BIOPHYS J, V100, pL47, DOI 10.1016/j.bpj.2011.03.051; Poulsen H, 2010, NATURE, V467, P99, DOI 10.1038/nature09309; Poulsen H, 2010, FEBS LETT, V584, P2589, DOI 10.1016/j.febslet.2010.04.035; Provasi D, 2009, BIOCHEMISTRY-US, V48, P10020, DOI 10.1021/bi901494n; Ramachandran S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000367; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Stansfeld PJ, 2011, STRUCTURE, V19, P1562, DOI 10.1016/j.str.2011.10.002; Tavraz NN, 2008, J BIOL CHEM, V283, P31097, DOI 10.1074/jbc.M802771200; Teixeira VL, 2003, ANN NY ACAD SCI, V986, P587, DOI 10.1111/j.1749-6632.2003.tb07257.x; Therien AG, 2000, AM J PHYSIOL-CELL PH, V279, pC541, DOI 10.1152/ajpcell.2000.279.3.C541; Tieleman DP, 2006, J PHYS-CONDENS MAT, V18, pS1221, DOI 10.1088/0953-8984/18/28/S07; Toustrup-Jensen MS, 2009, J BIOL CHEM, V284, P18715, DOI 10.1074/jbc.M109.015099; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Venosa RA, 2005, ACTA PHYSIOL SCAND, V185, P329, DOI 10.1111/j.1365-201X.2005.01493.x; Vinciguerra M, 2003, MOL BIOL CELL, V14, P2677, DOI 10.1091/mbc.E02-11-0720; Wang HL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040041; Witzke S, 2010, J PHYS CHEM B, V114, P15825, DOI 10.1021/jp108675b; Wu ZQ, 2007, MOL PHARMACOL, V71, P519, DOI 10.1124/mol.106.029561; Yaragatupalli S, 2009, P NATL ACAD SCI USA, V106, P15507, DOI 10.1073/pnas.0903752106	51	21	21	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15959	15965		10.1074/jbc.M112.340406	http://dx.doi.org/10.1074/jbc.M112.340406			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22433860	hybrid, Green Published			2022-12-25	WOS:000304006300074
J	Deniaud, A; Panwar, P; Frelet-Barrand, A; Bernaudat, F; Juillan-Binard, C; Ebel, C; Rolland, N; Pebay-Peyroula, E				Deniaud, Aurelien; Panwar, Pankaj; Frelet-Barrand, Annie; Bernaudat, Florent; Juillan-Binard, Celine; Ebel, Christine; Rolland, Norbert; Pebay-Peyroula, Eva			Oligomeric Status and Nucleotide Binding Properties of the Plastid ATP/ADP Transporter 1: Toward a Molecular Understanding of the Transport Mechanism	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA L; MEMBRANE-PROTEINS; ANALYTICAL ULTRACENTRIFUGATION; EXPRESSION; DETERGENT; SUBSTRATE; CARRIER; SYSTEM; PLANTS	Background: Chloroplast ATP/ADP transporters are essential to energy homeostasis in plant cells. However, their molecular mechanism remains poorly understood, primarily due to the difficulty of producing and purifying functional recombinant forms of these transporters. Methodology/Principal Findings: In this work, we describe an expression and purification protocol providing good yields and efficient solubilization of NTT1 protein from Arabidopsis thaliana. By biochemical and biophysical analyses, we identified the best detergent for solubilization and purification of functional proteins, LAPAO. Purified NTT1 was found to accumulate as two independent pools of well folded, stable monomers and dimers. ATP and ADP binding properties were determined, and Pi, a co-substrate of ADP, was confirmed to be essential for nucleotide steady-state transport. Nucleotide binding studies and analysis of NTT1 mutants lead us to suggest the existence of two distinct and probably inter-dependent binding sites. Finally, fusion and deletion experiments demonstrated that the C-terminus of NTT1 is not essential for multimerization, but probably plays a regulatory role, controlling the nucleotide exchange rate. Conclusions/Significance: Taken together, these data provide a comprehensive molecular characterization of a chloroplast ATP/ADP transporter.	[Deniaud, Aurelien; Panwar, Pankaj; Bernaudat, Florent; Juillan-Binard, Celine; Ebel, Christine; Pebay-Peyroula, Eva] CEA, Inst Biol Struct Jean Pierre Ebel, Grenoble, France; [Deniaud, Aurelien; Panwar, Pankaj; Bernaudat, Florent; Juillan-Binard, Celine; Ebel, Christine; Pebay-Peyroula, Eva] CNRS, Inst Biol Struct, Grenoble, France; [Deniaud, Aurelien; Panwar, Pankaj; Bernaudat, Florent; Juillan-Binard, Celine; Ebel, Christine; Pebay-Peyroula, Eva] Univ Grenoble 1, Inst Biol Struct, Grenoble, France; [Frelet-Barrand, Annie; Rolland, Norbert] CNRS, Lab Physiol Cellulaire & Vegetale, UMR5168, Grenoble, France; [Frelet-Barrand, Annie; Rolland, Norbert] CEA, LPCV, Inst Rech Technol & Sci Vivant, Grenoble, France; [Frelet-Barrand, Annie; Rolland, Norbert] Univ Grenoble 1, LPCV, Grenoble, France; [Frelet-Barrand, Annie; Rolland, Norbert] INRA, LPCV, UMR1200, Grenoble, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Deniaud, A (corresponding author), European Mol Biol Lab, Grenoble Outstn, F-38042 Grenoble, France.	eva.pebay-peyroula@ibs.fr	FRELET-BARRAND, Annie/AFX-2878-2022; Frelet-Barrand, Annie/S-1951-2017; frelet barrand, annie/E-5479-2015; ROLLAND, Norbert/B-4405-2012; Deniaud, Aurelien/L-5093-2019	FRELET-BARRAND, Annie/0000-0002-0849-9040; ROLLAND, Norbert/0000-0003-1959-6636; Ebel, Christine/0000-0002-6912-500X	European Union; Institut Universitaire de France; Association Francaise contre les Myopathies; CEA; CNRS; Universite Joseph Fourier Grenoble 1	European Union(European Commission); Institut Universitaire de France; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); CEA(French Atomic Energy Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Joseph Fourier Grenoble 1	This work was supported by the European Union specific targeted research project IMPS, the Institut Universitaire de France, the Association Francaise contre les Myopathies (post-doctoral fellowship to AD), the CEA, the CNRS and the Universite Joseph Fourier Grenoble 1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breyton C, 2010, METHODS MOL BIOL, V601, P219, DOI 10.1007/978-1-60761-344-2_14; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Deniaud A, 2011, BBA-BIOMEMBRANES, V1808, P2059, DOI 10.1016/j.bbamem.2011.04.011; DIVITA G, 1992, BIOCHEMISTRY-US, V31, P5791, DOI 10.1021/bi00140a015; Frelet-Barrand A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008746; Gohon Y, 2004, ANAL BIOCHEM, V334, P318, DOI 10.1016/j.ab.2004.07.033; Haferkamp I, 2011, TRENDS PLANT SCI, V16, P507, DOI 10.1016/j.tplants.2011.04.001; Le Maire M, 2008, NAT PROTOC, V3, P1782, DOI 10.1038/nprot.2008.177; Linka N, 2010, MOL PLANT, V3, P21, DOI 10.1093/mp/ssp108; Mohlmann T, 1998, EUR J BIOCHEM, V252, P353, DOI 10.1046/j.1432-1327.1998.2520353.x; Neuhaus HE, 1997, PLANT J, V11, P73, DOI 10.1046/j.1365-313X.1997.11010073.x; Nury H, 2008, BIOCHEMISTRY-US, V47, P12319, DOI 10.1021/bi801053m; Salvay AG, 2007, J BIOL PHYS, V33, P399, DOI 10.1007/s10867-008-9058-3; Schuck P, 2000, BIOPOLYMERS, V54, P328, DOI 10.1002/1097-0282(20001015)54:5<328::AID-BIP40>3.0.CO;2-P; Thuswaldner S, 2007, J BIOL CHEM, V282, P8848, DOI 10.1074/jbc.M609130200; Tjaden J, 1998, J BIOL CHEM, V273, P9630, DOI 10.1074/jbc.273.16.9630; Trentmann O, 2000, EUR J BIOCHEM, V267, P4098, DOI 10.1046/j.1432-1033.2000.01468.x; Trentmann O, 2007, PLOS BIOL, V5, P1938, DOI 10.1371/journal.pbio.0050231; Trentmann O, 2008, J BIOL CHEM, V283, P36486, DOI 10.1074/jbc.M806903200; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246	21	7	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e32325	10.1371/journal.pone.0032325	http://dx.doi.org/10.1371/journal.pone.0032325			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438876	gold, Green Published, Green Submitted			2022-12-25	WOS:000303309100007
J	Xu, Y; Liu, LF; Qiu, XS; Liu, ZH; Li, HY; Li, ZX; Luo, WT; Wang, EH				Xu, Ying; Liu, Lifeng; Qiu, Xueshan; Liu, Zihui; Li, Haiying; Li, Zixuan; Luo, Wenting; Wang, Enhua			CCL21/CCR7 Prevents Apoptosis via the ERK Pathway in Human Non-Small Cell Lung Cancer Cells	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CXCR4; DENDRITIC CELLS; CYCLE ARREST; MIGRATION; EXPRESSION; KINASE; PROLIFERATION; ACTIVATION; MELATONIN; PROTEINS	Previously, we confirmed that C-C chemokine receptor 7 (CCR7) promotes cell proliferation via the extracellular signal-regulated kinase (ERK) pathway, but its role in apoptosis of non-small cell lung cancer (NSCLC) cell lines remains unknown. A549 and H460 cells of NSCLC were used to examine the effect of CCL21/CCR7 on apoptosis using flow cytometry. The results showed that activation of CCR7 by its specific ligand, exogenous chemokine ligand 21 (CCL21), was associated with a significant decline in the percent of apoptosis. Western blot and real-time PCR assays indicated that activation of CCR7 significantly caused upregulation of anti-apoptotic bcl-2 and downregulation of pro-apoptotic bax and caspase-3, but not p53, at both protein and mRNA levels. CCR7 small interfering RNA significantly attenuated these effects of exogenous CCL21. Besides, PD98059, a selective inhibitor of MEK that disrupts the activation of downstream ERK, significantly abolished these effects of CCL21/CCR7. Coimmunoprecipitation further confirmed that there was an interaction between p-ERK and bcl-2, bax, or caspase-3, particularly in the presence of CCL21. These results strongly suggest that CCL21/CCR7 prevents apoptosis by upregulating the expression of bcl-2 and by downregulating the expression of bax and caspase-3 potentially via the ERK pathway in A549 and H460 cells of NSCLC.	[Xu, Ying; Qiu, Xueshan; Liu, Zihui; Li, Haiying; Li, Zixuan; Luo, Wenting; Wang, Enhua] China Med Univ, Affiliated Hosp 1, Dept Pathol, Shenyang, Liaoning, Peoples R China; [Xu, Ying; Qiu, Xueshan; Liu, Zihui; Li, Haiying; Li, Zixuan; Luo, Wenting; Wang, Enhua] China Med Univ, Coll Basic Med Sci, Shenyang, Liaoning, Peoples R China; [Xu, Ying; Qiu, Xueshan; Liu, Zihui; Li, Haiying; Li, Zixuan; Luo, Wenting; Wang, Enhua] China Med Univ, Inst Pathol & Pathophysiol, Shenyang, Liaoning, Peoples R China; [Liu, Lifeng] China Med Univ, Affiliated Hosp 1, Dept Orthopaed, Shenyang, Liaoning, Peoples R China	China Medical University; China Medical University; China Medical University; China Medical University	Qiu, XS (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Pathol, Shenyang, Liaoning, Peoples R China.	xueshan-qiu@hotmail.com						Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Aliaga JC, 1999, AM J PHYSIOL-GASTR L, V277, pG631, DOI 10.1152/ajpgi.1999.277.3.G631; Antonsson B, 2000, EXP CELL RES, V256, P50, DOI 10.1006/excr.2000.4839; Badr G, 2005, INT IMMUNOL, V17, P459, DOI 10.1093/intimm/dxh227; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Banas B, 2004, KIDNEY INT, V66, P2256, DOI 10.1111/j.1523-1755.2004.66037.x; Beider K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005125; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Dieu MC, 1998, J EXP MED, V188, P373, DOI 10.1084/jem.188.2.373; Escribano C, 2009, J IMMUNOL, V183, P6282, DOI 10.4049/jimmunol.0804093; Ewings KE, 2007, CELL CYCLE, V6, P2236, DOI 10.4161/cc.6.18.4728; Gollmer K, 2009, BLOOD, V114, P580, DOI 10.1182/blood-2009-01-200923; Hirao M, 2000, CANCER RES, V60, P2209; Iijima N, 2005, INT IMMUNOL, V17, P1201, DOI 10.1093/intimm/dxh297; Jackson ML, 2004, CLIN INFECT DIS, V39, P1642, DOI 10.1086/425615; Kim JW, 2005, CLIN CANCER RES, V11, P7901, DOI 10.1158/1078-0432.CCR-05-1346; Kochetkova M, 2009, CELL DEATH DIFFER, V16, P664, DOI 10.1038/cdd.2008.190; Lee SJ, 2010, PHYTOTHER RES, V24, P1870, DOI 10.1002/ptr.3214; Li Y, 2009, CANCER BIOL THER, V8, P322, DOI 10.4161/cbt.8.4.7332; Li Z, 2008, CELL BIOL TOXICOL, V24, P401, DOI 10.1007/s10565-008-9054-1; Ling YH, 2003, CLIN CANCER RES, V9, P1145; Liu FY, 2010, BRIT J ORAL MAX SURG, V48, P291, DOI 10.1016/j.bjoms.2009.06.007; Liu L, 2011, J PINEAL RES, DOI [10.1111/j.1600-079X.2011.00971.x, DOI 10.1111/J.1600-079X.2011.00971.X.]; Liu LF, 2011, J PINEAL RES, V50, P222, DOI 10.1111/j.1600-079X.2010.00832.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Murphy PM, 2000, PHARMACOL REV, V52, P145; Pizarro JG, 2008, J PINEAL RES, V45, P8, DOI 10.1111/j.1600-079X.2007.00548.x; Puddicombe SM, 2000, CLIN EXP ALLERGY, V30, P7; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Sanchez-Sanchez N, 2004, BLOOD, V104, P619, DOI 10.1182/blood-2003-11-3943; Saxena M, 2000, SEMIN IMMUNOL, V12, P387, DOI 10.1006/smim.2000.0219; Shannon LA, 2010, J BIOL CHEM, V285, P38781, DOI 10.1074/jbc.M110.152173; Sozzani S, 1998, J IMMUNOL, V161, P1083; Strasser A, 2005, NAT REV IMMUNOL, V5, P189, DOI 10.1038/nri1568; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Wang J, 2005, ONCOGENE, V24, P5897, DOI 10.1038/sj.onc.1208740; Wegiel B, 2008, INT J CANCER, V122, P1521, DOI 10.1002/ijc.23261; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Wornle Markus, 2004, BMC Nephrol, V5, P8, DOI 10.1186/1471-2369-5-8; Wu S, 2008, IMMUNOBIOLOGY, V213, P417, DOI 10.1016/j.imbio.2007.10.003; Wu YM, 2009, J NEUROCHEM, V109, P1157, DOI 10.1111/j.1471-4159.2009.06043.x; Xu Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021119; Yamada Y, 2006, INT J MOL MED, V18, P119; Ziegler E, 2007, J IMMUNOL, V179, P6485, DOI 10.4049/jimmunol.179.10.6485; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	48	19	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33262	10.1371/journal.pone.0033262	http://dx.doi.org/10.1371/journal.pone.0033262			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438908	Green Published, Green Submitted, gold			2022-12-25	WOS:000303309100030
J	Sauert, K; Kahnert, S; Roose, M; Gull, M; Brandli, AW; Ryffel, GU; Waldner, C				Sauert, Kathrin; Kahnert, Stefan; Roose, Magdalena; Gull, Mazhar; Braendli, Andre W.; Ryffel, Gerhart U.; Waldner, Christoph			Heat-Shock Mediated Overexpression of HNF1 beta Mutations Has Differential Effects on Gene Expression in the Xenopus Pronephric Kidney	PLOS ONE			English	Article							NUCLEAR FACTOR-1-BETA GENE; AMINO-ACID TRANSPORTERS; TRANSCRIPTION FACTOR; DEVELOPMENTAL EXPRESSION; CHLORIDE CHANNELS; MICE LACKING; DISEASE; NEPHROGENESIS; VHNF1; SPECIFICATION	The transcription factor HNF1B, encoded by the TCF2 gene, plays an important role in the organogenesis of vertebrates. In humans, heterozygous mutations of HNF1B are associated with several diseases, such as pancreatic beta-cell dysfunction leading to maturity-onset diabetes of the young (MODY5), defective kidney development, disturbed liver function, pancreas atrophy, and malformations of the genital tract. The African claw frog Xenopus laevis is an excellent model to study the processes involved in embryogenesis and organogenesis, as it can be manipulated easily with a series of methods. In the present study, we overexpressed HNF1 beta mutants in the developing Xenopus embryo to assess their roles during organogenesis, particularly in the developing pronephric kidney. Towards this goal, we developed a heat-shock inducible binary Cre/loxP system with activator and effector strains. Heat-shock activation of the mutant HNF1B variants P328L329del and A263insGG resulted in malformations of various organs and the affected larvae developed large edemas. Defects in the pronephros were primarily confined to malformed proximal tubules. Furthermore, the expression of the proximal tubule marker genes tmem27 and slc3a1, both involved in amino acid transport, was affected. Both P328L329del and A263insGG downregulated expression of slc3a1. In addition, P328L329del reduced tmem27 expression while A263insGG overexpression decreased expression of the chloride channel clcnk and the transcription factor pax2. Overexpression of two mutant HNF1B derivatives resulted in distinct phenotypes reflected by either a reduction or an enlargement of pronephros size. The expression of selected pronephric marker genes was differentially affected upon overexpression of HNF1B mutations. Based on our findings, we postulate that HNF1B mutations influence gene regulation upon overexpression in specific and distinct manners. Furthermore, our study demonstrates that the newly established Cre/loxP system for Xenopus embryos is an attractive alternative to examine the gene regulatory potential of transcription factors in developing pronephric kidney as exemplified here for HNF1B.	[Sauert, Kathrin; Kahnert, Stefan; Roose, Magdalena; Ryffel, Gerhart U.; Waldner, Christoph] Univ Klinikum Essen, Inst Zellbiol Tumorforsch, Essen, Germany; [Gull, Mazhar; Braendli, Andre W.] Univ Munich, Walter Brendel Zentrum Expt Med, Munich, Germany	University of Duisburg Essen; University of Munich	Sauert, K (corresponding author), Univ Klinikum Essen, Inst Zellbiol Tumorforsch, Essen, Germany.	christoph.waldner@uni-due.de	Brandli, Andre/N-1620-2013	Brandli, Andre/0000-0002-8932-3644				Alsina B, 2009, INT J DEV BIOL, V53, P1503, DOI 10.1387/ijdb.072422ba; Barbacci E, 1999, DEVELOPMENT, V126, P4795; Bingham C, 2001, AM J HUM GENET, V68, P219, DOI 10.1086/316945; Bisceglia L, 2010, MOL GENET METAB, V99, P42, DOI 10.1016/j.ymgme.2009.09.001; Bohn S, 2003, J AM SOC NEPHROL, V14, P2033, DOI 10.1097/01.ASN.0000078808.70309.C4; Brunskill EW, 2008, DEV CELL, V15, P781, DOI 10.1016/j.devcel.2008.09.007; Coffinier C, 1999, DEVELOPMENT, V126, P4785; Coffinier C, 2002, DEVELOPMENT, V129, P1829; Danilczyk U, 2006, NATURE, V444, P1088, DOI 10.1038/nature05475; DEMARTIS A, 1994, MECH DEVELOP, V47, P19, DOI 10.1016/0925-4773(94)90092-2; Dudziak K, 2008, KIDNEY INT, V74, P210, DOI 10.1038/ki.2008.149; Edghill EL, 2008, NEPHROL DIAL TRANSPL, V23, P627, DOI 10.1093/ndt/gfm603; Fernandez E, 2002, AM J PHYSIOL-RENAL, V283, pF540, DOI 10.1152/ajprenal.00071.2002; Fernandez E, 2006, J BIOL CHEM, V281, P26552, DOI 10.1074/jbc.M604049200; Fischer E, 2008, KIDNEY INT, V74, P145, DOI 10.1038/ki.2008.250; Gresh L, 2004, EMBO J, V23, P1657, DOI 10.1038/sj.emboj.7600160; Haumaitre C, 2005, P NATL ACAD SCI USA, V102, P1490, DOI 10.1073/pnas.0405776102; Heller N, 1997, MECH DEVELOP, V69, P83, DOI 10.1016/S0925-4773(97)00158-5; Hiesberger T, 2004, J CLIN INVEST, V113, P814, DOI 10.1172/JCI200420083; Kalin RE, 2009, BLOOD, V114, P1110, DOI 10.1182/blood-2009-03-211771; Kramer BK, 2008, NAT CLIN PRACT NEPHR, V4, P38, DOI 10.1038/ncpneph0689; Lecaudey V, 2007, DEV BIOL, V303, P134, DOI 10.1016/j.ydbio.2006.10.041; Lockwood CR, 2003, MOL GENET METAB, V78, P145, DOI 10.1016/S1096-7192(02)00225-1; Lokmane L, 2008, DEVELOPMENT, V135, P2777, DOI 10.1242/dev.023010; Lokmane L, 2010, DEVELOPMENT, V137, P347, DOI 10.1242/dev.042226; Malakauskas SM, 2007, AM J PHYSIOL-RENAL, V292, pF533, DOI 10.1152/ajprenal.00325.2006; Matsumura Y, 1999, NAT GENET, V21, P95, DOI 10.1038/5036; Mccoy KE, 2008, GENE EXPR PATTERNS, V8, P271, DOI 10.1016/j.gep.2007.12.002; MENDEL DB, 1991, SCIENCE, V254, P1762, DOI 10.1126/science.1763325; Nieuwkoop P. D., 1975, NORMAL TABLE XENOPUS; Nishigori H, 1998, DIABETES, V47, P1354, DOI 10.2337/diabetes.47.8.1354; Pontoglio M, 2000, J AM SOC NEPHROL, V11, pS140; Raciti D, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r84; Roose M, 2009, TRANSGENIC RES, V18, P595, DOI 10.1007/s11248-009-9253-4; Schlingmann KP, 2004, NEW ENGL J MED, V350, P1314, DOI 10.1056/NEJMoa032843; Simon DB, 1997, NAT GENET, V17, P171, DOI 10.1038/ng1097-171; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Sun ZX, 2001, GENE DEV, V15, P3217, DOI 10.1101/gad946701; Thomas H, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh144; Tran U, 2007, DEV BIOL, V307, P152, DOI 10.1016/j.ydbio.2007.04.030; Urban AE, 2006, DEV BIOL, V297, P103, DOI 10.1016/j.ydbio.2006.04.469; Verdeguer F, 2010, NAT MED, V16, P106, DOI 10.1038/nm.2068; VONSTRANDMANN EP, 1995, DEVELOPMENT, V121, P1217; Wang L, 2004, ENDOCRINOLOGY, V145, P3941, DOI 10.1210/en.2004-0281; Werdien D, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.11.e53; Wild W, 2000, P NATL ACAD SCI USA, V97, P4695, DOI 10.1073/pnas.080010897; Wu GZ, 2004, EUR J BIOCHEM, V271, P3715, DOI 10.1111/j.1432-1033.2004.04312.x	47	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2012	7	3							e33522	10.1371/journal.pone.0033522	http://dx.doi.org/10.1371/journal.pone.0033522			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RU	22438943	gold, Green Published, Green Submitted			2022-12-25	WOS:000303309000030
J	Brun, P; Brun, P; Vono, M; Venier, P; Tarricone, E; Deligianni, V; Martines, E; Zuin, M; Spagnolo, S; Cavazzana, R; Cardin, R; Castagliuolo, I; Valerio, AL; Leonardi, A				Brun, Paola; Brun, Paola; Vono, Maria; Venier, Paola; Tarricone, Elena; Deligianni, Velika; Martines, Emilio; Zuin, Matteo; Spagnolo, Silvia; Cavazzana, Roberto; Cardin, Romilda; Castagliuolo, Ignazio; Valerio, Alvise La Gloria; Leonardi, Andrea			Disinfection of Ocular Cells and Tissues by Atmospheric-Pressure Cold Plasma	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; BACTERIA; STERILIZATION; INACTIVATION; EXPRESSION; GROWTH; NEEDLE; YEAST	Background: Low temperature plasmas have been proposed in medicine as agents for tissue disinfection and have received increasing attention due to the frequency of bacterial resistance to antibiotics. This study explored whether atmospheric-pressure cold plasma (APCP) generated by a new portable device that ionizes a flow of helium gas can inactivate ocular pathogens without causing significant tissue damage. Methodology/Principal Findings: We tested the APCP effects on cultured Pseudomonas aeruginosa, Escherichia coli, Staphylococcus aureus, Candida albicans, Aspergillus fumigatus and Herpes simplex virus-1, ocular cells (conjunctival fibroblasts and keratocytes) and ex-vivo corneas. Exposure to APCP for 0.5 to 5 minutes significantly reduced microbial viability (colony-forming units) but not human cell viability (MTT assay, FACS and Tunel analysis) or the number of HSV-1 plaque-forming units. Increased levels of intracellular reactive oxygen species (ROS) in exposed microorganisms and cells were found using a FACS-activated 2',7'-dichlorofluorescein diacetate probe. Immunoassays demonstrated no induction of thymine dimers in cell cultures and corneal tissues. A transient increased expression of 8-OHdG, genes and proteins related to oxidative stress (OGG1, GPX, NFE2L2), was determined in ocular cells and corneas by HPLC, qRT-PCR and Western blot analysis. Conclusions: A short application of APCP appears to be an efficient and rapid ocular disinfectant for bacteria and fungi without significant damage on ocular cells and tissues, although the treatment of conjunctival fibroblasts and keratocytes caused a time-restricted generation of intracellular ROS and oxidative stress-related responses.	[Brun, Paola; Vono, Maria; Tarricone, Elena] Univ Padua, Dept Biomed Sci, Histol Unit, Padua, Italy; [Brun, Paola; Castagliuolo, Ignazio] Univ Padua, Dept Mol Med, Padua, Italy; [Venier, Paola] Univ Padua, Dept Biol, Padua, Italy; [Deligianni, Velika] S Antonio Hosp, Dept Ophthalmol, Padua, Italy; [Martines, Emilio; Zuin, Matteo; Spagnolo, Silvia; Cavazzana, Roberto] Euratom ENEA Assoc, Consorzio RFX, Padua, Italy; [Valerio, Alvise La Gloria; Leonardi, Andrea] Univ Padua, Dept Neurosci, Padua, Italy; [Cardin, Romilda] Univ Padua, Dept Surg Oncol & Gastroenterol Sci, Padua, Italy	University of Padua; University of Padua; University of Padua; ULSS 6 Euganea; Ospedale Sant'antonio Padova; Euratom; University of Padua; University of Padua	Brun, P (corresponding author), Univ Padua, Dept Biomed Sci, Histol Unit, Padua, Italy.	paola.brun@unipd.it	Brun, Paola/K-5729-2016; ZUIN, Matteo/G-5540-2018; Venier, Paola/J-6302-2019; zuin, matteo/AAX-8015-2020; Martines, Emilio/B-1418-2009; spagnolo, silvia/E-9384-2017; castagliuolo, ignazio/K-9963-2016; Brun, Paola/A-3380-2016	ZUIN, Matteo/0000-0002-0282-2978; Venier, Paola/0000-0001-9634-3662; Martines, Emilio/0000-0002-4181-2959; castagliuolo, ignazio/0000-0001-9888-7030; Brun, Paola/0000-0002-3279-9000; Brun, Paola/0000-0002-4204-3549; spagnolo, silvia/0000-0002-2187-8141	Italian Scientific Research and University Ministry (MIUR); University of Padua, Italy	Italian Scientific Research and University Ministry (MIUR)(Ministry of Education, Universities and Research (MIUR)); University of Padua, Italy	This work was supported by the Italian Scientific Research and University Ministry (MIUR) and by the University of Padua, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Adhami BH, 2007, APPL ENVIRON MICROB, V73, P947, DOI 10.1128/AEM.01251-06; CALLEGAN MC, 1994, INFECT IMMUN, V62, P2478, DOI 10.1128/IAI.62.6.2478-2482.1994; Cooper M, 2003, MICROBIOL-SGM, V149, P1275, DOI 10.1099/mic.0.26017-0; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; Dobrynin D, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115020; Ehlbeck J, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/1/013002; FRIDMAN A, 2008, PLASMA CHEM; Fridman G, 2008, PLASMA PROCESS POLYM, V5, P503, DOI 10.1002/ppap.200700154; Fridman G, 2007, PLASMA PROCESS POLYM, V4, P370, DOI 10.1002/ppap.200600217; Gopinathan U, 2002, CORNEA, V21, P555, DOI 10.1097/00003226-200208000-00004; Goree J, 2006, IEEE T PLASMA SCI, V34, P1317, DOI 10.1109/TPS.2006.878431; Grundmann H, 2006, LANCET, V368, P874, DOI 10.1016/S0140-6736(06)68853-3; Hazlett LD, 2004, PROG RETIN EYE RES, V23, P1, DOI 10.1016/j.preteyeres.2003.10.002; Henderson PT, 2010, MUTAT RES-GEN TOX EN, V703, P11, DOI 10.1016/j.mrgentox.2010.08.021; Hur W, 2011, CURR OPIN CHEM BIOL, V15, P162, DOI 10.1016/j.cbpa.2010.12.009; Isbary G, 2011, ARCH DERMATOL, V147, P388, DOI 10.1001/archdermatol.2011.57; Jakubowski W, 1977, INT J BIOCHEM CELL B, V29, P1297; Joshi SG, 2011, ANTIMICROB AGENTS CH, V55, P1053, DOI 10.1128/AAC.01002-10; Kalghatgi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016270; Laroussi M, 2006, PLASMA PROCESS POLYM, V3, P470, DOI 10.1002/ppap.200600005; Leduc M, 2010, PLASMA PROCESS POLYM, V7, P899, DOI 10.1002/ppap.201000032; Lee K, 2006, J MICROBIOL, V44, P269; Lei XG, 2007, ANNU REV NUTR, V27, P41, DOI 10.1146/annurev.nutr.27.061406.093716; Li Q, 2008, MICROB PATHOGENESIS, V44, P426, DOI 10.1016/j.micpath.2007.11.006; Lonkar P, 2011, INT J CANCER, V128, P1999, DOI 10.1002/ijc.25815; MAQUART FX, 1980, BIOCHIMIE, V62, P93, DOI 10.1016/S0300-9084(80)80375-0; Martines E, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115014; Moisan M, 2002, PURE APPL CHEM, V74, P349, DOI 10.1351/pac200274030349; Morfill GE, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115011; Moskalev AA, 2011, BIOGERONTOLOGY, V12, P253, DOI 10.1007/s10522-011-9320-0; Nosenko T, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115013; Petroll WM, 2003, J CELL SCI, V116, P1481, DOI 10.1242/jcs.00357; Radak Z, 2010, FREE RADICAL BIO MED, V49, P587, DOI 10.1016/j.freeradbiomed.2010.05.008; Ristow M, 2010, EXP GERONTOL, V45, P410, DOI 10.1016/j.exger.2010.03.014; Sensenig R, 2011, ANN BIOMED ENG, V39, P674, DOI 10.1007/s10439-010-0197-x; Shimizu T, 2008, PLASMA PROCESS POLYM, V5, P577, DOI 10.1002/ppap.200800021; Sladek REJ, 2006, IEEE T PLASMA SCI, V34, P1325, DOI 10.1109/TPS.2006.878991; Stoffels E, 2006, PLASMA SOURCES SCI T, V15, pS169, DOI 10.1088/0963-0252/15/4/S03; Stoffels E, 2008, IEEE T PLASMA SCI, V36, P1441, DOI 10.1109/TPS.2008.2001084; Takeshita K, 2003, INT J FOOD MICROBIOL, V85, P151, DOI 10.1016/S0168-1605(02)00509-3; Thomas PA, 2007, CURR OPIN INFECT DIS, V20, P129, DOI 10.1097/QCO.0b013e328017f878; Toyota M, 2010, ADV GENET, V70, P309, DOI [10.1016/B978-0-12-380866-0.60011-3, 10.1016/S0065-2660(10)70011-0]; Ventura I, 2010, MUTAT RES-GEN TOX EN, V703, P59, DOI 10.1016/j.mrgentox.2010.06.008; Voltan S, 2008, GASTROENTEROLOGY, V135, P1216, DOI 10.1053/j.gastro.2008.07.007; Weng CC, 2009, INT J RADIAT BIOL, V85, P362, DOI 10.1080/09553000902781105; Yonson S, 2006, J PHYS D APPL PHYS, V39, P3508, DOI 10.1088/0022-3727/39/16/S08	46	78	80	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e33245	10.1371/journal.pone.0033245	http://dx.doi.org/10.1371/journal.pone.0033245			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22432007	Green Published, Green Submitted, gold			2022-12-25	WOS:000303198600050
J	Leshyk, R; Nol, E; Burke, DM; Burness, G				Leshyk, Rhiannon; Nol, Erica; Burke, Dawn M.; Burness, Gary			Logging Affects Fledgling Sex Ratios and Baseline Corticosterone in a Forest Songbird	PLOS ONE			English	Article							BROWN-HEADED COWBIRDS; PHYSIOLOGICAL STRESS; MATERNAL CONDITION; HABITAT SELECTION; BODY CONDITION; ZEBRA FINCH; SURVIVAL; BIRD; PASSERINE; FRAGMENTATION	Silviculture (logging) creates a disturbance to forested environments. The degree to which forests are modified depends on the logging prescription and forest stand characteristics. In this study we compared the effects of two methods of group-selection ("moderate" and "heavy") silviculture (GSS) and undisturbed reference stands on stress and offspring sex ratios of a forest interior species, the Ovenbird (Seiurus aurocapilla), in Algonquin Provincial Park, Canada. Blood samples were taken from nestlings for corticosterone and molecular sexing. We found that logging creates a disturbance that is stressful for nestling Ovenbirds, as illustrated by elevated baseline corticosterone in cut sites. Ovenbirds nesting in undisturbed reference forest produce fewer male offspring per brood (proportion male = 30%) while logging with progressively greater forest disturbance, shifted the offspring sex ratio towards males (proportion male: moderate = 50%, heavy = 70%). If Ovenbirds in undisturbed forests usually produce female-biased broods, then the production of males as a result of logging may disrupt population viability. We recommend a broad examination of nestling sex ratios in response to anthropogenic disturbance to determine the generality of our findings.	[Leshyk, Rhiannon] Trent Univ, Environm & Life Sci Grad Program, Peterborough, ON K9J 7B8, Canada; [Nol, Erica; Burness, Gary] Trent Univ, Dept Biol, Peterborough, ON K9J 7B8, Canada; [Burke, Dawn M.] Ontario Minist Nat Resources, London, ON, Canada	Trent University; Trent University; Ministry of Natural Resources & Forestry	Leshyk, R (corresponding author), Trent Univ, Environm & Life Sci Grad Program, Peterborough, ON K9J 7B8, Canada.	rleshyk@gmail.com	Burness, Gary/ABB-4937-2020		Algonquin Forestry Authority; Canadian Forest Service; Enhanced Forest Productivity Science Program; Mazinaw-Lanark Forest Inc.; Natural Sciences and Engineering Research Council of Canada; Ontario Centre of Excellence; Ontario Ministry of Natural Resources; Ottawa Valley Forest Inc.; Forest Research Partnership (Tembec Inc.); Trent University; Westwind Forest Stewardship; Canadian Foundation for Innovation; Ontario Innovation Trust; Bancroft-Minden Forest Co.	Algonquin Forestry Authority; Canadian Forest Service(Natural Resources CanadaCanadian Forest Service); Enhanced Forest Productivity Science Program; Mazinaw-Lanark Forest Inc.; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Centre of Excellence; Ontario Ministry of Natural Resources; Ottawa Valley Forest Inc.; Forest Research Partnership (Tembec Inc.); Trent University; Westwind Forest Stewardship; Canadian Foundation for Innovation(Canada Foundation for Innovation); Ontario Innovation Trust; Bancroft-Minden Forest Co.	Funding provided by Algonquin Forestry Authority, Bancroft-Minden Forest Co., Canadian Forest Service, Enhanced Forest Productivity Science Program, Mazinaw-Lanark Forest Inc., Natural Sciences and Engineering Research Council of Canada, Ontario Centre of Excellence Research Program, Ontario Ministry of Natural Resources, Ottawa Valley Forest Inc., Forest Research Partnership (Tembec Inc.), Trent University, Westwind Forest Stewardship, the Canadian Foundation for Innovation, and the Ontario Innovation Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison B, 2008, BEHAV ECOL SOCIOBIOL, V63, P135, DOI 10.1007/s00265-008-0643-z; Angelier F, 2010, BIOL LETTERS, V6, P846, DOI 10.1098/rsbl.2010.0376; Arnold KE, 2003, MOL ECOL, V12, P3451, DOI 10.1046/j.1365-294X.2003.02007.x; Blums P, 1996, AUK, V113, P505, DOI 10.2307/4088920; Bonier F, 2007, BEHAV ECOL, V18, P1045, DOI 10.1093/beheco/arm075; Bradbury RR, 1998, P ROY SOC B-BIOL SCI, V265, P895, DOI 10.1098/rspb.1998.0375; Brais S, 1998, CAN J SOIL SCI, V78, P197, DOI 10.4141/S97-032; BURGER LW, 1995, J WILDLIFE MANAGE, V59, P401, DOI 10.2307/3808954; Burke DM, 2000, ECOL APPL, V10, P1749, DOI 10.1890/1051-0761(2000)010[1749:LAFSEO]2.0.CO;2; Burke DM, 1998, AUK, V115, P96, DOI 10.2307/4089115; Busch DS, 2009, BIOL CONSERV, V142, P2844, DOI 10.1016/j.biocon.2009.08.013; Cameron Elissa Z., 2002, Animal Behaviour Forum, V63, pF5, DOI 10.1006/anbe.2001.1902; Cameron EZ, 1999, BEHAV ECOL, V10, P472, DOI 10.1093/beheco/10.5.472; Catry P, 2005, J AVIAN BIOL, V36, P184, DOI 10.1111/j.0908-8857.2005.03445.x; Donald PF, 2007, IBIS, V149, P671, DOI 10.1111/j.1474-919X.2007.00724.x; Donovan T. M., 1994, BIRDS N AM ONLINE; Fisher R.A., 1930, GENETICAL THEORY NAT; Gardner JL, 2003, ANIM BEHAV, V66, P521, DOI 10.1006/anbe.2003.2206; Gerlach J, 2001, OSTRICH, V72, P114, DOI 10.2989/00306520109485295; Githiru M, 2006, BIODIVERS CONSERV, V15, P3315, DOI 10.1007/s10531-005-1213-6; Gorman HE, 2004, P ROY SOC B-BIOL SCI, V271, P1923, DOI 10.1098/rspb.2004.2799; Grant TA, 2005, AUK, V122, P661, DOI 10.1642/0004-8038(2005)122[0661:TVIPNS]2.0.CO;2; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Jobes AP, 2004, J WILDLIFE MANAGE, V68, P51, DOI 10.2193/0022-541X(2004)068[0051:EOSCOB]2.0.CO;2; Kilner R, 1998, ANIM BEHAV, V56, P155, DOI 10.1006/anbe.1998.0775; King DI, 2006, J ZOOL, V269, P414, DOI 10.1111/j.1469-7998.2006.00158.x; Kitaysky AS, 2003, HORM BEHAV, V43, P140, DOI 10.1016/S0018-506X(02)00030-2; Kitaysky AS, 2001, J COMP PHYSIOL B, V171, P701, DOI 10.1007/s003600100230; KJELLEN N, 1994, AUK, V111, P274; Komdeur J, 1997, NATURE, V385, P522, DOI 10.1038/385522a0; Loiseau C, 2008, GEN COMP ENDOCR, V155, P101, DOI 10.1016/j.ygcen.2007.03.004; Love OP, 2008, HORM BEHAV, V54, P496, DOI 10.1016/j.yhbeh.2008.01.006; Love OP, 2005, AM NAT, V166, P751, DOI 10.1086/497440; Low M, 2010, J ANIM ECOL, V79, P214, DOI 10.1111/j.1365-2656.2009.01595.x; Lucas JR, 2006, HORM BEHAV, V49, P634, DOI 10.1016/j.yhbeh.2005.12.012; Marra PP, 2001, AUK, V118, P92, DOI 10.1642/0004-8038(2001)118[0092:CODMHS]2.0.CO;2; Martinez-Mota R, 2007, ANIM CONSERV, V10, P374, DOI 10.1111/j.1469-1795.2007.00122.x; Mazerolle DF, 2002, OECOLOGIA, V130, P356, DOI 10.1007/s00442-001-0818-z; McNamara R, 1999, TN298 FERIC; Muller C, 2009, J EXP BIOL, V212, P1405, DOI 10.1242/jeb.024455; OMNR, 2000, SILV GUID MAN SO ONT; Paxton EH, 2002, CONDOR, V104, P877, DOI 10.1650/0010-5422(2002)104[0877:NSRITS]2.0.CO;2; Pike TW, 2005, ANIM BEHAV, V70, P745, DOI 10.1016/j.anbehav.2004.12.020; Raberg L, 2005, OECOLOGIA, V145, P496, DOI 10.1007/s00442-005-0133-1; Reidy JL, 2009, WILSON J ORNITHOL, V121, P416, DOI 10.1676/08-076.1; Romero LM, 2001, P NATL ACAD SCI USA, V98, P7366, DOI 10.1073/pnas.131091498; Romero LM, 2002, CONDOR, V104, P129, DOI 10.1650/0010-5422(2002)104[0129:CRIWBT]2.0.CO;2; Saino N, 2003, BEHAV ECOL, V14, P318, DOI 10.1093/beheco/14.3.318; Schulte-Hostedde AI, 2005, ECOLOGY, V86, P155, DOI 10.1890/04-0232; Shaffer TL, 2004, AUK, V121, P526, DOI 10.1642/0004-8038(2004)121[0526:AUATAN]2.0.CO;2; Spencer KA, 2007, HORM BEHAV, V51, P273, DOI 10.1016/j.yhbeh.2006.11.001; Stouffer PC, 2003, AUK, V120, P836, DOI 10.1642/0004-8038(2003)120[0836:SWDATO]2.0.CO;2; Suorsa P, 2004, P ROY SOC B-BIOL SCI, V271, P435, DOI 10.1098/rspb.2003.2620; Suorsa P, 2003, P ROY SOC B-BIOL SCI, V270, P963, DOI 10.1098/rspb.2002.2326; Tozer DC, 2010, FOREST ECOL MANAG, V259, P1522, DOI 10.1016/j.foreco.2010.01.028; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; Washburn BE, 2002, CONDOR, V104, P558, DOI 10.1650/0010-5422(2002)104[0558:UACART]2.0.CO;2; Wasser SK, 1997, CONSERV BIOL, V11, P1019, DOI 10.1046/j.1523-1739.1997.96240.x; Whittingham LA, 2000, MOL ECOL, V9, P1123, DOI 10.1046/j.1365-294x.2000.00980.x; Woolfenden BE, 2001, AUK, V118, P156, DOI 10.1642/0004-8038(2001)118[0156:DOBHCA]2.0.CO;2; Zanette L, 2005, ECOLOGY, V86, P815, DOI 10.1890/04-0809	61	20	21	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e33124	10.1371/journal.pone.0033124	http://dx.doi.org/10.1371/journal.pone.0033124			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22432000	Green Published, Green Submitted, gold			2022-12-25	WOS:000303198600043
J	Liu, HP; Gao, ZH; Cui, SX; Sun, DF; Wang, Y; Zhao, CR; Lou, HX; Qu, XJ				Liu, Hui-Ping; Gao, Zu-Hua; Cui, Shu-Xiang; Sun, De-Fu; Wang, Yan; Zhao, Cui-Rong; Lou, Hong-Xiang; Qu, Xian-Jun			Inhibition of Intestinal Adenoma Formation in APCMin/+ Mice by Riccardin D, a Natural Product Derived from Liverwort Plant Dumortiera hirsuta	PLOS ONE			English	Article							MACROCYCLIC BISBIBENZYL; COLORECTAL-CANCER; APC(MIN/+) MICE; COLON; CHEMOPREVENTION; ANGIOGENESIS; EXPRESSION; POLYPOSIS; SULINDAC; GROWTH	Background: Mutation of tumor suppressor gene, adenomatous polyposis coli (APC), is the primary molecular event in the development of most intestinal carcinomas. Animal model with APC gene mutation is an effective tool for study of preventive approaches against intestinal carcinomas. We aimed to evaluate the effect of Riccardin D, a macrocyclic bisbibenzyl compound, as a chemopreventive agent against intestinal adenoma formation in APC(Min/+) mice. Methods: APC(Min/+) mice were given Riccardin D by p.o. gavage for 7 weeks. Mice were sacrificed, and the number, size and histopathology of intestinal polyps were examined under a microscope. We performed immunohistochemical staining, western blotting, reverse transcriptase-polymerase chain reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA) in intestinal polyps to investigate the mechanism of chemopreventive effect of Riccardin D. Results: Riccardin D treatment resulted in a significant inhibition of intestinal adenoma formation, showing a reduction of polyp number by 41.7%, 31.1% and 44.4%, respectively, in proximal, middle and distal portions of small intestine. The activity of Riccardin D against polyp formation was more profound in colon, wherein Riccardin D decreased polyp number by 79.3%. Size distribution analysis revealed a significant reduction in large-size polyps (2-3 mm) by 40.0%, 42.5% and 33.3%, respectively, in proximal, middle and distal portions of small intestine, and 77.8% in colon. Histopathological analysis of the intestinal polyps revealed mostly hyperplastic morphology without obvious dysplasia in Riccardin D-treated mice. Molecular analyses of the polyps suggested that the inhibitory effect of Riccardin D on intestinal adenoma formation was associated with its abilities of reduction in cell proliferation, induction of apoptosis, antiangiogenesis, inhibition of the Wnt signaling pathway and suppression of inflammatory mediators in polyps. Conclusions: Our results suggested that Riccardin D exerts its chemopreventive effect against intestinal adenoma formation through multiple mechanisms including anti-proliferative, apoptotic, anti-angiogenic and anti-inflammatory activity.	[Liu, Hui-Ping; Sun, De-Fu; Zhao, Cui-Rong; Lou, Hong-Xiang; Qu, Xian-Jun] Shandong Univ, Sch Pharmaceut Sci, Dept Pharmacol, Jinan 250100, Peoples R China; [Gao, Zu-Hua] Univ Calgary, Dept Pathol & Lab Med, Calgary, AB, Canada; [Gao, Zu-Hua] Calgary Lab Serv, Calgary, AB, Canada; [Cui, Shu-Xiang; Wang, Yan] Shandong Acad Med Sci, Inst Mat Med, Dept Pharmacol, Jinan, Peoples R China	Shandong University; University of Calgary; University of Calgary; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan	Liu, HP (corresponding author), Shandong Univ, Sch Pharmaceut Sci, Dept Pharmacol, Jinan 250100, Peoples R China.	louhongxiang@sdu.edu.cn; qxj@sdu.edu.cn	Liu, Huiping/C-3428-2018	Liu, Huiping/0000-0003-0317-9029	Ministry of Science and Technology of China [2009ZX09102-127]; Natural Science Foundation of China [81173090, 30973550, 81072665]; Doctoral Science Foundation of the Ministry of Education of China [20090131110063]; Department of Pathology and Laboratory Medicine, University of Calgary and Calgary Laboratory Services, Canada	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Science Foundation of the Ministry of Education of China; Department of Pathology and Laboratory Medicine, University of Calgary and Calgary Laboratory Services, Canada	This work is supported by the Ministry of Science and Technology of China (2009ZX09102-127); Natural Science Foundation of China (81173090, 30973550, 81072665) and the Doctoral Science Foundation of the Ministry of Education of China (20090131110063). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Department of Pathology and Laboratory Medicine, University of Calgary and Calgary Laboratory Services, Canada.	An YT, 2011, DRUG DISCOV THER, V5, P76, DOI 10.5582/ddt.2011.v5.2.76; Asakawa Y, 2000, SPECTROSC-INT J, V14, P149, DOI 10.1155/2000/570265; Axelsson H, 2010, INT J ONCOL, V37, P1143, DOI 10.3892/ijo_00000766; Carothers AM, 2010, CANCER RES, V70, P4433, DOI 10.1158/0008-5472.CAN-09-4289; Charalambous MP, 2009, BRIT J CANCER, V101, P106, DOI 10.1038/sj.bjc.6605120; Cheng AX, 2009, BIOL PHARM BULL, V32, P1417, DOI 10.1248/bpb.32.1417; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; Easwaran V, 2003, CANCER RES, V63, P3145; Fearnhead NS, 2001, HUM MOL GENET, V10, P721, DOI 10.1093/hmg/10.7.721; Fujimura T, 2006, WORLD J GASTROENTERO, V12, P1336, DOI 10.3748/wjg.v12.i9.1336; Gao FJ, 2008, LIFE SCI, V83, P815, DOI 10.1016/j.lfs.2008.10.003; Greenspan EJ, 2010, CANCER PREV RES, V3, P1187, DOI 10.1158/1940-6207.CAPR-09-0270; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; Guillen-Ahlers H, 2008, CARCINOGENESIS, V29, P1421, DOI 10.1093/carcin/bgn123; Guillen-Ahlers H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009070; He H, 2006, CANCER-AM CANCER SOC, V106, P1243, DOI 10.1002/cncr.21694; Hu R, 2006, CARCINOGENESIS, V27, P2038, DOI 10.1093/carcin/bgl049; Kumar A, 2004, J MOL MED, V82, P434, DOI 10.1007/s00109-004-0555-y; Kuniyasu H, 2010, GUT, V59, P348, DOI 10.1136/gut.2009.178376; Kwong LN, 2009, ADV EXP MED BIOL, V656, P85, DOI 10.1007/978-1-4419-1145-2_8; Lee SH, 2010, NAT MED, V16, P665, DOI 10.1038/nm.2143; Liu J, 2007, EUR J PHARMACOL, V574, P1, DOI 10.1016/j.ejphar.2007.06.064; Lu ZQ, 2006, J ASIAN NAT PROD RES, V8, P187, DOI 10.1080/1028602042000325537; McCart AE, 2008, PATHOL RES PRACT, V204, P479, DOI 10.1016/j.prp.2008.03.004; Mladenova D, 2011, GUT, V60, P350, DOI 10.1136/gut.2010.208314; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; Park EJ, 2011, BIOSCI TRENDS, V5, P120, DOI 10.5582/bst.2011.v5.3.120; Rajamanickam S, 2010, CANCER RES, V70, P2368, DOI 10.1158/0008-5472.CAN-09-3249; Seno H, 2002, CANCER RES, V62, P506; Shen G, 2007, CANCER RES, V67, P9937, DOI 10.1158/0008-5472.CAN-07-1112; Shi YQ, 2009, CANCER LETT, V276, P160, DOI 10.1016/j.canlet.2008.11.004; Sun CC, 2011, EUR J PHARMACOL, V667, P136, DOI 10.1016/j.ejphar.2011.06.013; Terzic J, 2010, GASTROENTEROLOGY, V138, P2101, DOI 10.1053/j.gastro.2010.01.058; Wang DZ, 2004, CELL CYCLE, V3, P1512, DOI 10.4161/cc.3.12.1288; Wu WKK, 2010, CANCER LETT, V295, P7, DOI 10.1016/j.canlet.2010.03.015; Wu XZ, 2009, BBA-GEN SUBJECTS, V1790, P770, DOI 10.1016/j.bbagen.2009.05.002; Xing J, 2008, J PHARMACEUT BIOMED, V47, P949, DOI 10.1016/j.jpba.2008.03.001; Xue X, 2012, INVEST NEW DRUG, V30, P212, DOI 10.1007/s10637-010-9554-8; Yamada Y, 2007, CANCER SCI, V98, P6, DOI 10.1111/j.1349-7006.2006.00348.x; Zak S, 2008, INT J COLORECTAL DIS, V23, P297, DOI 10.1007/s00384-007-0397-5	40	16	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e33243	10.1371/journal.pone.0033243	http://dx.doi.org/10.1371/journal.pone.0033243			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22432006	Green Published, Green Submitted, gold			2022-12-25	WOS:000303198600049
J	Schaefers, MM; Breshears, LM; Anderson, MJ; Lin, YC; Grill, AE; Panyam, J; Southern, PJ; Schlievert, PM; Peterson, ML				Schaefers, Matthew M.; Breshears, Laura M.; Anderson, Michele J.; Lin, Ying-Chi; Grill, Alex E.; Panyam, Jayanth; Southern, Peter J.; Schlievert, Patrick M.; Peterson, Marnie L.			Epithelial Proinflammatory Response and Curcumin-Mediated Protection from Staphylococcal Toxic Shock Syndrome Toxin-1	PLOS ONE			English	Article							NF-KAPPA-B; FEMALE REPRODUCTIVE-TRACT; NECROSIS-FACTOR-ALPHA; GLYCEROL MONOLAURATE; GENE-EXPRESSION; IN-VITRO; CELLS; AUREUS; INFECTION; RESISTANT	Staphylococcus aureus initiates infections and produces virulence factors, including superantigens (SAgs), at mucosal surfaces. The SAg, Toxic Shock Syndrome Toxin-1 (TSST-1) induces cytokine secretion from epithelial cells, antigen presenting cells (APCs) and T lymphocytes, and causes toxic shock syndrome (TSS). This study investigated the mechanism of TSST-1-induced secretion of proinflammatory cytokines from human vaginal epithelial cells (HVECs) and determined if curcumin, an anti-inflammatory agent, could reduce TSST-1-mediated pathology in a rabbit vaginal model of TSS. TSST-1 caused a significant increase in NF-kappa B-dependent transcription in HVECs that was associated with increased expression of TNF-alpha, MIP-3 alpha, IL-6 and IL-8. Curcumin, an antagonist of NF-kappa B-dependent transcription, inhibited IL-8 production from ex vivo porcine vaginal explants at nontoxic doses. In a rabbit model of TSS, co-administration of curcumin with TSST-1 intravaginally reduced lethality by 60% relative to 100% lethality in rabbits receiving TSST-1 alone. In addition, TNF-alpha was undetectable from serum or vaginal tissue of curcumin treated rabbits that survived. These data suggest that the inflammatory response induced at the mucosal surface by TSST-1 is NF-kappa B dependent. In addition, the ability of curcumin to prevent TSS in vivo by co-administration with TSST-1 intravaginally suggests that the vaginal mucosal proinflammatory response to TSST-1 is important in the progression of mTSS.	[Schaefers, Matthew M.; Breshears, Laura M.; Anderson, Michele J.; Peterson, Marnie L.] Univ Minnesota, Dept Expt & Clin Pharmacol, Minneapolis, MN 55414 USA; [Grill, Alex E.; Panyam, Jayanth] Univ Minnesota, Dept Pharmaceut, Minneapolis, MN 55455 USA; [Southern, Peter J.; Peterson, Marnie L.] Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA; [Schlievert, Patrick M.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Lin, Ying-Chi] Kaohsiung Med Univ, Sch Pharm, Kaohsiung, Taiwan	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Iowa; Kaohsiung Medical University	Schaefers, MM (corresponding author), Univ Minnesota, Dept Expt & Clin Pharmacol, Minneapolis, MN 55414 USA.	peter377@umn.edu	Schaefers, Matthew/AAU-8213-2021; Lin, Ying-Chi/V-7851-2019; Lin, Ying-Chu/C-8679-2009	Schaefers, Matthew/0000-0001-7454-4180; Lin, Ying-Chi/0000-0003-0335-3402; Panyam, Jayanth/0000-0002-8656-2244; Breshears, Laura/0000-0002-0997-1140; Schlievert, Patrick/0000-0001-8314-9369	National Institutes of Health, National Institute of Allergy and Infectious Diseases [AI-74283, AI-73366]; National Cancer Institute [CA-141996]; University of Minnesota, Graduate School; NATIONAL CANCER INSTITUTE [R03CA141996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074283, R01AI073366] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Minnesota, Graduate School(University of Minnesota System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health, National Institute of Allergy and Infectious Diseases AI-74283 (PMS) and AI-73366 (MLP), the National Cancer Institute CA-141996 (JP), and the University of Minnesota, Graduate School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2007, ADV EXP MED BIOL, V595, P1; Anderson MJ, 2010, AM J INFECT CONTROL, V38, P826, DOI 10.1016/j.ajic.2010.06.022; Aubert V, 2000, INFECT IMMUN, V68, P120, DOI 10.1128/IAI.68.1.120-124.2000; Baker MD, 2004, INT J MED MICROBIOL, V293, P529, DOI 10.1078/1438-4221-00298; Bansal S, 2010, J MED MICROBIOL, V59, P429, DOI 10.1099/jmm.0.016873-0; BLOMSTERHAUTAMAA DA, 1988, METHOD ENZYMOL, V165, P37; Brosnahan AJ, 2011, FEBS J, V278, P4649, DOI 10.1111/j.1742-4658.2011.08151.x; Brosnahan AJ, 2009, J IMMUNOL, V182, P2364, DOI 10.4049/jimmunol.0803283; Brosnahan AJ, 2008, BIOCHEMISTRY-US, V47, P12995, DOI 10.1021/bi801468w; DAVIS JP, 1980, NEW ENGL J MED, V303, P1429, DOI 10.1056/NEJM198012183032501; Di Mario F, 2007, HELICOBACTER, V12, P238, DOI 10.1111/j.1523-5378.2007.00497.x; Dinges MM, 2001, INFECT IMMUN, V69, P7169, DOI 10.1128/IAI.69.11.7169-7172.2001; Fichorova RN, 2006, INFECT IMMUN, V74, P5773, DOI 10.1128/IAI.00631-06; Fichorova RN, 1999, BIOL REPROD, V60, P508, DOI 10.1095/biolreprod60.2.508; Fichorova RN, 1997, BIOL REPROD, V57, P847, DOI 10.1095/biolreprod57.4.847; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Jobin C, 1999, J IMMUNOL, V163, P3474; Jurenka JS, 2009, ALTERN MED REV, V14, P141; Kaempfer R, 2004, MOL DIVERS, V8, P113, DOI 10.1023/B:MODI.0000025654.04427.44; KIM Y B, 1970, Journal of Experimental Medicine, V131, P611, DOI 10.1084/jem.131.3.611; Kunnumakkara AB, 2008, CANCER LETT, V269, P199, DOI 10.1016/j.canlet.2008.03.009; Li QS, 2009, NATURE, V458, P1034, DOI 10.1038/nature07831; Lin JK, 2007, ADV EXP MED BIOL, V595, P227; Lin YC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007499; Luer S, 2011, SUPPORT CARE CANCER, V19, P799, DOI 10.1007/s00520-010-0894-x; Moon DO, 2006, BIOL PHARM BULL, V29, P1470, DOI 10.1248/bpb.29.1470; Murray DL, 1996, INFECT IMMUN, V64, P371, DOI 10.1128/IAI.64.1.371-374.1996; Musch MW, 2004, INFECT IMMUN, V72, P3187, DOI 10.1128/IAI.72.6.3187-3194.2004; O'Brien GJ, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-115; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Peterson ML, 2006, BIOCHEMISTRY-US, V45, P2387, DOI 10.1021/bi051992u; Peterson ML, 2005, INFECT IMMUN, V73, P2164, DOI 10.1128/IAI.73.4.2164-2174.2005; Schlievert PM, 2010, J ALLERGY CLIN IMMUN, V125, P39, DOI 10.1016/j.jaci.2009.10.039; SCHLIEVERT PM, 1982, INFECT IMMUN, V36, P123, DOI 10.1128/IAI.36.1.123-128.1982; Schlievert PM, 2000, INFECT IMMUN, V68, P3630, DOI 10.1128/IAI.68.6.3630-3634.2000; Shahani K, 2010, CANCER RES, V70, P4443, DOI 10.1158/0008-5472.CAN-09-4362; SHANDS KN, 1980, NEW ENGL J MED, V303, P1436, DOI 10.1056/NEJM198012183032502; Shao DZ, 2004, MOL CELL BIOCHEM, V262, P177, DOI 10.1023/B:MCBI.0000038233.20276.e0; Squier CA, 2008, J PHARM SCI-US, V97, P9, DOI 10.1002/jps.21077; Su CL, 2007, FEBS J, V274, P3633, DOI 10.1111/j.1742-4658.2007.05896.x; TODD J, 1978, LANCET, V2, P1116; Wessler S, 2005, BIOL CHEM, V386, P481, DOI 10.1515/BC.2005.057; Wira CR, 2005, IMMUNOL REV, V206, P306, DOI 10.1111/j.0105-2896.2005.00287.x; Wira CR, 2005, AM J REPROD IMMUNOL, V53, P65, DOI 10.1111/j.1600-0897.2004.00248.x	45	14	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e32813	10.1371/journal.pone.0032813	http://dx.doi.org/10.1371/journal.pone.0032813			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22431984	Green Published, gold, Green Submitted			2022-12-25	WOS:000303198600027
J	Cotugno, G; Annunziata, P; Barone, MV; Karali, M; Banfi, S; Auricchio, A				Cotugno, Gabriella; Annunziata, Patrizia; Barone, Maria Vittoria; Karali, Marianthi; Banfi, Sandro; Auricchio, Alberto			Impact of Age at Administration, Lysosomal Storage, and Transgene Regulatory Elements on AAV2/8-Mediated Rat Liver Transduction	PLOS ONE			English	Article							HEMOPHILIA-B MICE; ADENOASSOCIATED VIRAL VECTORS; HEPATIC GENE-TRANSFER; LONG-TERM CORRECTION; IN-VIVO; RETROVIRAL VECTORS; DENDRITIC CELLS; FACTOR-IX; TOLERANCE INDUCTION; ENDOGENOUS MICRORNA	Liver-directed gene transfer is being investigated for the treatment of systemic or liver-specific diseases. Recombinant vectors based on adeno-associated virus serotype 8 (AAV2/8) efficiently transduce liver cells allowing long term transgene expression after a single administration in animal models and in patients. We evaluated the impact on AAV2/8-mediated rat liver transduction of the following variables: i) age at vector administration, ii) presence of lysosomal storage in liver cells, and iii) regulatory elements included in the transgene expression cassette. We found that systemic administration of AAV2/8 to newborn rats results in vector genome dilution and reduced transduction efficacy when compared to adult injected animals, presumably due to hepatocyte proliferation. Accumulation of glycosaminoglycans in lysosomes does not impact on levels and distribution of AAV2/8-mediated liver transduction. Transgene expression occurs in hepatocytes but not in Kupffer or liver endothelial cells when the liver-specific thyroxine-binding-globulin promoter is used. However, extra-hepatic transduction is observed in the spleen and kidney of animals injected at birth. The use of target sequences for the hematopoietic-specific microRNA miR142-3p does not improve liver transduction efficacy neither reduce immune responses to the lysosomal enzyme arylsulfatase B. The inclusion of a variant of the Woodchuck hepatitis virus post-transcriptional regulatory element (WPRE-m) decreases AAV2/8-mediated liver transduction levels. As AAV2/8-mediated liver gene transfer is entering in the clinical arena, these data will provide relevant information to the design of efficient AAV2/8-based therapeutic strategies.	[Cotugno, Gabriella; Annunziata, Patrizia; Karali, Marianthi; Banfi, Sandro; Auricchio, Alberto] Telethon Inst Genet & Med, Naples, Italy; [Cotugno, Gabriella; Annunziata, Patrizia; Barone, Maria Vittoria; Auricchio, Alberto] Univ Naples Federico II, Dept Pediat, Naples, Italy; [Barone, Maria Vittoria] Univ Naples Federico II, European Lab Invest Food Induced Dis, Naples, Italy; [Banfi, Sandro] Univ Naples 2, Dept Gen Pathol, Naples, Italy	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Naples Federico II; University of Naples Federico II; Universita della Campania Vanvitelli	Auricchio, A (corresponding author), Telethon Inst Genet & Med, Naples, Italy.	auricchio@tigem.it	Banfi, Sandro/K-3963-2018; AURICCHIO, Alberto/AHE-7979-2022; Cotugno, Gabriella/GYA-2858-2022	Banfi, Sandro/0000-0002-6541-8833; AURICCHIO, Alberto/0000-0002-0832-2472; Karali, Marianthi/0000-0003-0757-3330; BARONE, Maria Vittoria/0000-0001-6190-4917	Telethon Foundation [TAAMT6TELD]; National Mucopolysaccharidosis Society	Telethon Foundation(Fondazione Telethon); National Mucopolysaccharidosis Society	This work was supported by the Telethon Foundation (grant # TAAMT6TELD) and by the National Mucopolysaccharidosis Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appleby CE, 2003, GENE THER, V10, P1616, DOI 10.1038/sj.gt.3302044; Bell P., 2011, HUM GENE THER; BLOUIN A, 1977, J CELL BIOL, V72, P441, DOI 10.1083/jcb.72.2.441; Breckpot K, 2003, J GENE MED, V5, P654, DOI 10.1002/jgm.400; Brown BD, 2007, BLOOD, V110, P4144, DOI 10.1182/blood-2007-03-078493; Brown BD, 2007, NAT BIOTECHNOL, V25, P1457, DOI 10.1038/nbt1372; Brown BD, 2006, NAT MED, V12, P585, DOI 10.1038/nm1398; Brun S, 2003, MOL THER, V7, P782, DOI 10.1016/S1525-0016(03)00097-2; Carreras MC, 2004, HEPATOLOGY, V40, P157, DOI 10.1002/hep.20255; Carrillo-Carrasco N, 2010, HUM GENE THER, V21, P1147, DOI 10.1089/hum.2010.008; Chtarto A, 2007, EXP NEUROL, V204, P387, DOI 10.1016/j.expneurol.2006.11.014; Cotugno G, 2011, MOL THER, V19, P461, DOI 10.1038/mt.2010.257; Cotugno G, 2010, HUM GENE THER, V21, P555, DOI 10.1089/hum.2009.189; Cunningham SC, 2008, MOL THER, V16, P1081, DOI 10.1038/mt.2008.72; DAHMS NM, 1989, J BIOL CHEM, V264, P12115; Donello JE, 1998, J VIROL, V72, P5085, DOI 10.1128/JVI.72.6.5085-5092.1998; Flageul M, 2009, J GENE MED, V11, P689, DOI 10.1002/jgm.1343; Franco LM, 2005, MOL THER, V12, P876, DOI 10.1016/j.ymthe.2005.04.024; Glover CPJ, 2003, J GENE MED, V5, P554, DOI 10.1002/jgm.381; Glover CPJ, 2002, MOL THER, V5, P509, DOI 10.1006/mthe.2002.0588; Haberman RP, 2000, J VIROL, V74, P8732, DOI 10.1128/JVI.74.18.8732-8739.2000; Hlavaty J, 2005, VIROLOGY, V341, P1, DOI 10.1016/j.virol.2005.06.037; Ill CR, 1997, BLOOD COAGUL FIBRIN, V8, pS23; Jooss K, 1998, J VIROL, V72, P4212, DOI 10.1128/JVI.72.5.4212-4223.1998; Kingsman SM, 2005, GENE THER, V12, P3, DOI 10.1038/sj.gt.3302417; Kiselyov K, 2007, AUTOPHAGY, V3, P259, DOI 10.4161/auto.3906; Kitajima K, 2006, ATHEROSCLEROSIS, V186, P65, DOI 10.1016/j.atherosclerosis.2005.07.009; Klein R, 2006, GENE, V372, P153, DOI 10.1016/j.gene.2005.12.018; Klein RL, 2002, METHODS, V28, P286, DOI 10.1016/S1046-2023(02)00234-7; Kraunus J, 2004, GENE THER, V11, P1568, DOI 10.1038/sj.gt.3302309; Lipshutz GS, 2003, MOL THER, V8, P90, DOI 10.1016/S1525-0016(03)00132-1; LoDuca PA, 2009, CURR GENE THER, V9, P104, DOI 10.2174/156652309787909490; Loeb JE, 1999, HUM GENE THER, V10, P2295, DOI 10.1089/10430349950016942; Lu YQ, 2009, P NATL ACAD SCI USA, V106, P17158, DOI 10.1073/pnas.0909520106; Magami Y, 2002, LIVER, V22, P419, DOI 10.1034/j.1600-0676.2002.01702.x; Mangeot PE, 2002, MOL THER, V5, P283, DOI 10.1006/mthe.2002.0541; Margolin KA, 1997, IMMUNOL REV, V157, P231, DOI 10.1111/j.1600-065X.1997.tb00986.x; Mautino MR, 2002, HUM GENE THER, V13, P1027, DOI 10.1089/104303402753812430; McCarty DM, 2004, ANNU REV GENET, V38, P819, DOI 10.1146/annurev.genet.37.110801.143717; McKay TR, 2011, CURRENT PHARM DESIGN, V17, P1; Mehal WZ, 2001, GASTROENTEROLOGY, V120, P250, DOI 10.1053/gast.2001.20947; Mian A, 2004, MOL THER, V10, P492, DOI 10.1016/j.ymthe.2004.05.036; Mingozzi F, 2003, J CLIN INVEST, V111, P1347, DOI 10.1172/JCI200316887; Mingozzi F, 2011, NAT REV GENET, V12, P341, DOI 10.1038/nrg2988; Moscioni D, 2006, MOL THER, V14, P25, DOI 10.1016/j.ymthe.2006.03.009; Nakai H, 2001, J VIROL, V75, P6969, DOI 10.1128/JVI.75.15.6969-6976.2001; Nathwani AC, 2010, 18 ANN C EUR SOC GEN; Neufeld E, 2001, METABOLIC BASIS INHE, P4312; Paterna JC, 2000, GENE THER, V7, P1304, DOI 10.1038/sj.gt.3301221; Ponder KP, 2011, MOL THER, V19, P427, DOI 10.1038/mt.2011.13; Ponder KP, 2006, MOL THER, V14, P5, DOI 10.1016/j.ymthe.2006.03.015; Puntel M, 2009, J VIROL, V83, P2004, DOI 10.1128/JVI.01298-08; Ramezani A, 2000, MOL THER, V2, P458, DOI 10.1006/mthe.2000.0190; Sabatino DE, 2007, MOL THER, V15, P1677, DOI 10.1038/sj.mt.6300219; Schambach A, 2000, MOL THER, V2, P435, DOI 10.1006/mthe.2000.0191; Schambach A, 2006, GENE THER, V13, P641, DOI 10.1038/sj.gt.3302698; Settembre C, 2008, AUTOPHAGY, V4, P113, DOI 10.4161/auto.5227; Sims K, 2008, MOL CELL NEUROSCI, V39, P411, DOI 10.1016/j.mcn.2008.07.020; Somanathan S, 2010, MOL THER, V18, P977, DOI 10.1038/mt.2010.40; Sun J, 2009, DNA CELL BIOL, V28, P233, DOI 10.1089/dna.2009.0862; Tessitore A, 2008, MOL THER, V16, P30, DOI 10.1038/sj.mt.6300325; Tessitore Alessandra, 2009, Pathogenetics, V2, P4, DOI 10.1186/1755-8417-2-4; Thomson AW, 2010, NAT REV IMMUNOL, V10, P753, DOI 10.1038/nri2858; Wang LL, 2010, MOL THER, V18, P126, DOI 10.1038/mt.2009.245; Wang LL, 2010, MOL THER, V18, P118, DOI 10.1038/mt.2009.246; Wang LL, 1999, P NATL ACAD SCI USA, V96, P3906, DOI 10.1073/pnas.96.7.3906; WEI Y, 1995, J MED VIROL, V45, P82, DOI 10.1002/jmv.1890450116; Werner M, 2004, GENE THER, V11, P992, DOI 10.1038/sj.gt.3302255; Wick MJ, 2002, CRIT REV IMMUNOL, V22, P47; Xiao WD, 1998, J VIROL, V72, P10222, DOI 10.1128/JVI.72.12.10222-10226.1998; Xu LF, 2007, THROMB RES, V120, P269, DOI 10.1016/j.thromres.2006.09.010; Xu ZL, 2003, BBA-GEN SUBJECTS, V1621, P266, DOI 10.1016/S0304-4165(03)00078-3; Zanta-Boussif MA, 2009, GENE THER, V16, P605, DOI 10.1038/gt.2009.3; Zhang HG, 2005, MOL THER, V11, P866, DOI 10.1016/j.ymthe.2005.02.014; Zufferey R, 1999, J VIROL, V73, P2886, DOI 10.1128/JVI.73.4.2886-2892.1999	75	14	17	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2012	7	3							e33286	10.1371/journal.pone.0033286	http://dx.doi.org/10.1371/journal.pone.0033286			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930IA	22428010	gold, Green Submitted, Green Published			2022-12-25	WOS:000303129700048
J	Neelakanta, G; Hudson, AM; Sultana, H; Cooley, L; Fikrig, E				Neelakanta, Girish; Hudson, Andrew M.; Sultana, Hameeda; Cooley, Lynn; Fikrig, Erol			Expression of Ixodes scapularis Antifreeze Glycoprotein Enhances Cold Tolerance in Drosophila melanogaster	PLOS ONE			English	Article							LIVER ENDOTHELIAL-CELLS; TRANSGENIC DROSOPHILA; INDUCED APOPTOSIS; LOW-TEMPERATURES; SHOCK INJURY; PROTEIN; MEMBRANES; SURVIVAL; INSECTS; GENE	Drosophila melanogaster experience cold shock injury and die when exposed to low non-freezing temperatures. In this study, we generated transgenic D. melanogaster that express putative Ixodes scapularis antifreeze glycoprotein (IAFGP) and show that the presence of IAFGP increases the ability of flies to survive in the cold. Male and female adult iafgp-expressing D. melanogaster exhibited higher survival rates compared with controls when placed at non-freezing temperatures. Increased hatching rates were evident in embryos expressing IAFGP when exposed to the cold. The TUNEL assay showed that flight muscles from iafgp-expressing female adult flies exhibited less apoptotic damage upon exposure to non-freezing temperatures in comparison to control flies. Collectively, these data suggest that expression of iafgp increases cold tolerance in flies by preventing apoptosis. This study defines a molecular basis for the role of an antifreeze protein in cryoprotection of flies.	[Neelakanta, Girish; Sultana, Hameeda; Fikrig, Erol] Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, New Haven, CT 06510 USA; [Hudson, Andrew M.; Cooley, Lynn] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Cooley, Lynn] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Cooley, Lynn] Yale Univ, Sch Med, Dept Mol Cellular & Dev Biol, New Haven, CT USA; [Fikrig, Erol] Howard Hughes Med Inst, Chevy Chase, MD USA	Yale University; Yale University; Yale University; Yale University; Howard Hughes Medical Institute	Neelakanta, G (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, New Haven, CT 06510 USA.	erol.fikrig@yale.edu			National Institutes of Health [GM043301]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043301] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant GM043301 (LC). EF is an investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RT, 1997, J PHARMACOL TOX MET, V37, P215, DOI 10.1016/S1056-8719(97)00033-6; Anderson JF, 2008, INFECT DIS CLIN N AM, V22, P195, DOI 10.1016/j.idc.2007.12.006; Ashburner M., 1989, DROSOPHILA LAB HDB; Bale JS, 2002, PHILOS T R SOC B, V357, P849, DOI 10.1098/rstb.2002.1074; CLERC SG, 1995, BIOPHYS J, V68, P2333, DOI 10.1016/S0006-3495(95)80415-7; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; CZAJKA MC, 1990, J EXP BIOL, V148, P245; Davies PL, 2002, PHILOS T R SOC B, V357, P927, DOI 10.1098/rstb.2002.1081; DEVRIES AL, 1986, METHOD ENZYMOL, V127, P293; DEVRIES AL, 1971, SCIENCE, V172, P1152, DOI 10.1126/science.172.3988.1152; DEVRIES AL, 1969, SCIENCE, V163, P1073, DOI 10.1126/science.163.3871.1073; Doeppner TR, 2003, TRANSPLANTATION, V75, P1946, DOI 10.1097/01.TP.0000065291.02855.6A; Doucet D, 2009, CELL MOL LIFE SCI, V66, P1404, DOI 10.1007/s00018-009-8320-6; Duman JG, 2004, J INSECT PHYSIOL, V50, P259, DOI 10.1016/j.jinsphys.2003.12.003; Duman JG, 2001, ANNU REV PHYSIOL, V63, P327, DOI 10.1146/annurev.physiol.63.1.327; Duncker BP, 1995, CRYOBIOLOGY, V32, P521, DOI 10.1006/cryo.1995.1054; Fletcher GL, 2001, ANNU REV PHYSIOL, V63, P359, DOI 10.1146/annurev.physiol.63.1.359; GEOGHEGAN KF, 1980, J BIOL CHEM, V255, P663; Gibert P, 2001, EVOLUTION, V55, P1063, DOI 10.1554/0014-3820(2001)055[1063:CCTAMC]2.0.CO;2; Golstein P, 1997, SCIENCE, V275, P1081, DOI 10.1126/science.275.5303.1081; Graham LA, 1997, NATURE, V388, P727, DOI 10.1038/41908; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Harding MM, 2003, EUR J BIOCHEM, V270, P1381, DOI 10.1046/j.1432-1033.2003.03488.x; Hays LM, 1996, P NATL ACAD SCI USA, V93, P6835, DOI 10.1073/pnas.93.13.6835; Hudson AM, 2010, J CELL BIOL, V188, P29, DOI 10.1083/jcb.200909017; Kaltschmidt JA, 2000, NAT CELL BIOL, V2, P7, DOI 10.1038/71323; Kelty JD, 2001, J EXP BIOL, V204, P1659; Kerkweg U, 2002, HEPATOLOGY, V35, P560, DOI 10.1053/jhep.2002.31869; Kostal V, 2004, J EXP BIOL, V207, P1509, DOI 10.1242/jeb.00923; KROEMER G, 1995, FASEB J, V9, P1277, DOI 10.1096/fasebj.9.13.7557017; Kumar S, 2000, CELL DEATH DIFFER, V7, P1039, DOI 10.1038/sj.cdd.4400756; Lee R.E. Jr, 1991, P17; LEE RE, 1987, SCIENCE, V238, P1415, DOI 10.1126/science.238.4832.1415; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lin X, 2010, J INSECT PHYSIOL, V56, P341, DOI 10.1016/j.jinsphys.2009.11.005; Luhtala N, 2009, NUCLEIC ACIDS RES, V37, P5529, DOI 10.1093/nar/gkp572; MAZUR P, 1992, SCIENCE, V258, P1932, DOI 10.1126/science.1470915; Neelakanta G, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030033; Neelakanta G, 2010, J CLIN INVEST, V120, P3179, DOI 10.1172/JCI42868; Nicodemus J, 2006, J INSECT PHYSIOL, V52, P888, DOI 10.1016/j.jinsphys.2006.05.009; Overgaard J, 2005, J INSECT PHYSIOL, V51, P1173, DOI 10.1016/j.jinsphys.2005.06.007; PATTERSON JL, 1981, J COMP PHYSIOL, V142, P539, DOI 10.1007/BF00688987; Powell SJ, 2004, J INSECT PHYSIOL, V50, P277, DOI 10.1016/j.jinsphys.2004.01.003; QUINN PJ, 1985, CRYOBIOLOGY, V22, P128, DOI 10.1016/0011-2240(85)90167-1; Rauen U, 1999, FASEB J, V13, P155, DOI 10.1096/fasebj.13.1.155; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; RUBINSKY B, 1990, BIOCHEM BIOPH RES CO, V173, P1369, DOI 10.1016/S0006-291X(05)80939-8; Shimada Y, 2011, DEV BIOL, V355, P250, DOI 10.1016/j.ydbio.2011.04.022; Shreve SM, 2007, CRYOLETTERS, V28, P33; Sinclair BJ, 2005, J THERM BIOL, V30, P557, DOI 10.1016/j.jtherbio.2005.07.002; Sinclair BJ, 2002, POLAR BIOL, V25, P928, DOI 10.1007/s00300-002-0433-4; Sjursen H, 2000, J INSECT PHYSIOL, V46, P1387, DOI 10.1016/S0022-1910(00)00061-5; SOLOFF BL, 1987, BIOCHEM BIOPH RES CO, V145, P876, DOI 10.1016/0006-291X(87)91046-1; STEPONKUS PL, 1990, NATURE, V345, P170, DOI 10.1038/345170a0; Sultana H, 2010, J EXP MED, V207, P1727, DOI 10.1084/jem.20100276; Tablin F, 1996, J CELL PHYSIOL, V168, P305, DOI 10.1002/(SICI)1097-4652(199608)168:2<305::AID-JCP9>3.0.CO;2-T; Tomczak MM, 2002, BIOPHYS J, V82, P874, DOI 10.1016/S0006-3495(02)75449-0; Tomczak MM, 2001, BBA-BIOMEMBRANES, V1511, P255, DOI 10.1016/S0005-2736(01)00281-4; Tu S, 2006, NAT CELL BIOL, V8, P72, DOI 10.1038/ncb1340; TURSMAN D, 1994, J EXP ZOOL, V268, P347, DOI 10.1002/jez.1402680503; Tyshenko MG, 1997, NAT BIOTECHNOL, V15, P887, DOI 10.1038/nbt0997-887; Tyshenko MG, 2004, CRYOBIOLOGY, V49, P28, DOI 10.1016/j.cryobiol.2004.04.002; Udaka H, 2010, J INSECT PHYSIOL, V56, P1889, DOI 10.1016/j.jinsphys.2010.08.008; Vairetti M, 2005, BBA-MOL BASIS DIS, V1740, P367, DOI 10.1016/j.bbadis.2004.11.022; Xu RX, 1998, NEUROSURGERY, V43, P107, DOI 10.1097/00006123-199807000-00070; Yi SX, 2007, APOPTOSIS, V12, P1183, DOI 10.1007/s10495-006-0048-2	66	14	16	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2012	7	3							e33447	10.1371/journal.pone.0033447	http://dx.doi.org/10.1371/journal.pone.0033447			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930IA	22428051	Green Published, Green Submitted, gold			2022-12-25	WOS:000303129700062
J	Grauling-Halama, S; Schenk, S; Bubert, A; Geginat, G				Grauling-Halama, Silke; Schenk, Simone; Bubert, Andreas; Geginat, Gernot			Linkage of Bacterial Protein Synthesis and Presentation of MHC Class I-Restricted Listeria monocytogenes-Derived Antigenic Peptides	PLOS ONE			English	Article							DEFECTIVE RIBOSOMAL PRODUCTS; MAMMALIAN-CELLS; DEGRADATION; GENERATION; COLLAGEN; MODEL; DRIPS	The processing and MHC class I-restricted presentation of antigenic peptides derived from the p60 protein of the facultative intracellular bacterium Listeria monocytogenes is tightly linked to bacterial protein synthesis. We used non-linear regression analysis to fit a mathematical model of bacterial antigen processing to a published experimental data set showing the accumulation and decay of p60-derived antigenic peptides in L. monocytogenes-infected cells. Two alternative models equally describe the experimental data. The simulation accounting for a stable and a hypothetical rapidly degraded form of antigen predicts that the antigenic peptides p60 217-225 and p60 449-457 are derived from a putative instable form of p60 with an average intracellular half-life of approximately 3 minutes accounting for approximately 31% of all p60 molecules synthesized. The alternative model predicts that both antigenic peptides are processed from p60 degraded intracellularly with a half-life of 109 min and that antigen processing only occurs as long as bacterial protein synthesis is not inhibited. In order to decide between both models the intracellular accumulation of p60 in infected cells was studied experimentally and compared with model predictions. Inhibition of p60 degradation by the proteasome inhibitor epoxomicin revealed that during the first 3 h post infection approximately 30% of synthesized p60 molecules were degraded. This value is significantly lower than the approximately 50% degradation of p60 that would be expected in the presence of the predicted putative short-lived state of p60 and also fits precisely with the predictions of the alternative model, indicating that the tight connection of bacterial protein biosynthesis and antigen processing and presentation of L. monocyctogenes-derived antigenic peptides is not caused by the presence of a highly instable antigenic substrate.	[Grauling-Halama, Silke; Schenk, Simone] Heidelberg Univ, Fak Med Mannheim, Inst Med Mikrobiol & Hyg, D-6800 Mannheim, Germany; [Bubert, Andreas] Merck KG, Darmstadt, Germany; [Geginat, Gernot] Univ Klinikum Magdeburg, Inst Med Mikrobiol, Magdeburg, Germany	Ruprecht Karls University Heidelberg; University Hospital Magdeburg; University of Hamburg; University Medical Center Hamburg-Eppendorf	Grauling-Halama, S (corresponding author), Heidelberg Univ, Fak Med Mannheim, Inst Med Mikrobiol & Hyg, D-6800 Mannheim, Germany.	gernot.geginat@med.ovgu.de		Geginat, Gernot/0000-0002-4723-2023	Deutsche Forschungsgemeinschaft [GE 1081/2-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Parts of this work were supported by the "Deutsche Forschungsgemeinschaft'' (www.dfg.de), grant GE 1081/2-2 to GG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	BIENKOWSKI RS, 1978, NATURE, V276, P413, DOI 10.1038/276413a0; BIENKOWSKI RS, 1978, J BIOL CHEM, V253, P4356; Buchsbaum S, 2012, MOL BIOL CELL, V23, P225, DOI 10.1091/mbc.E11-07-0609; Bulik S, 2005, J IMMUNOL, V175, P7957, DOI 10.4049/jimmunol.175.12.7957; Cresswell P, 2005, IMMUNOL REV, V207, P145, DOI 10.1111/j.0105-2896.2005.00316.x; Grauling-Halama S, 2009, MICROBES INFECT, V11, P795, DOI 10.1016/j.micinf.2009.04.019; Janda J, 2008, J THEOR BIOL, V250, P532, DOI 10.1016/j.jtbi.2007.10.025; Lev A, 2010, P NATL ACAD SCI USA, V107, P6964, DOI 10.1073/pnas.0910997107; Minami R, 2010, J CELL BIOL, V190, P637, DOI 10.1083/jcb.200908092; Montoya M, 1999, J IMMUNOL, V163, P1914; Perrin AJ, 2004, CURR BIOL, V14, P806, DOI 10.1016/j.cub.2004.04.033; Princiotta MF, 2003, IMMUNITY, V18, P343, DOI 10.1016/S1074-7613(03)00051-7; Qian SB, 2006, J IMMUNOL, V177, P227, DOI 10.4049/jimmunol.177.1.227; Reits E, 2003, IMMUNITY, V18, P97, DOI 10.1016/S1074-7613(02)00511-3; Reits EAJ, 2000, NATURE, V404, P774, DOI 10.1038/35008103; Sander LE, 2011, NATURE, V474, P385, DOI 10.1038/nature10072; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Sijts AJAM, 1997, J EXP MED, V185, P1403, DOI 10.1084/jem.185.8.1403; Sijts AJAM, 1996, J IMMUNOL, V156, P1497; Sijts AJAM, 1996, J IMMUNOL, V156, P685; Vabulas RM, 2005, SCIENCE, V310, P1960, DOI 10.1126/science.1121925; VILLANUEVA MS, 1994, IMMUNITY, V1, P479, DOI 10.1016/1074-7613(94)90090-6; WHEATLEY DN, 1980, CELL BIOL INT REP, V4, P1081, DOI 10.1016/0309-1651(80)90045-4; Yewdell JW, 2011, TRENDS IMMUNOL, V32, P548, DOI 10.1016/j.it.2011.08.001; Yewdell JW, 1996, J IMMUNOL, V157, P1823	25	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33335	10.1371/journal.pone.0033335	http://dx.doi.org/10.1371/journal.pone.0033335			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22428021	Green Submitted, gold, Green Published			2022-12-25	WOS:000302381500126
J	Szkudlarek, HJ; Orlowska, P; Lewandowski, MH				Szkudlarek, Hanna J.; Orlowska, Patrycja; Lewandowski, Marian H.			Light-Induced Responses of Slow Oscillatory Neurons of the Rat Olivary Pretectal Nucleus	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; PUPILLARY LIGHT; LATERAL GENICULATE; INTERGENICULATE LEAFLET; SUPRACHIASMATIC NUCLEUS; EFFERENT PROJECTIONS; REFLEX; MELANOPSIN; LUMINANCE; DETECTORS	Background: The olivary pretectal nucleus (OPN) is a small midbrain structure responsible for pupil constriction in response to eye illumination. Previous electrophysiological studies have shown that OPN neurons code light intensity levels and therefore are called luminance detectors. Recently, we described an additional population of OPN neurons, characterized by a slow rhythmic pattern of action potentials in light-on conditions. Rhythmic patterns generated by these cells last for a period of approximately 2 minutes. Methodology: To answer whether oscillatory OPN cells are light responsive and whether oscillatory activity depends on retinal afferents, we performed in vivo electrophysiology experiments on urethane anaesthetized Wistar rats. Extracellular recordings were combined with changes in light conditions (light-dark-light transitions), brief light stimulations of the contralateral eye (diverse illuminances) or intraocular injections of tetrodotoxin (TTX). Conclusions: We found that oscillatory neurons were able to fire rhythmically in darkness and were responsive to eye illumination in a manner resembling that of luminance detectors. Their firing rate increased together with the strength of the light stimulation. In addition, during the train of light pulses, we observed two profiles of responses: oscillation-preserving and oscillation-disrupting, which occurred during low-and high-illuminance stimuli presentation respectively. Moreover, we have shown that contralateral retina inactivation eliminated oscillation and significantly reduced the firing rate of oscillatory cells. These results suggest that contralateral retinal innervation is crucial for the generation of an oscillatory pattern in addition to its role in driving responses to visual stimuli.	[Szkudlarek, Hanna J.; Orlowska, Patrycja; Lewandowski, Marian H.] Jagiellonian Univ, Inst Zool, Dept Neurophysiol & Chronobiol, PL-30060 Krakow, Poland; [Szkudlarek, Hanna J.] Univ Munster, Inst Physiol 1, Munster, Germany	Jagiellonian University; University of Munster	Szkudlarek, HJ (corresponding author), Jagiellonian Univ, Inst Zool, Dept Neurophysiol & Chronobiol, PL-30060 Krakow, Poland.	marian.lewandowski@uj.edu.pl		Szkudlarek, Hanna/0000-0003-4709-5513; Orlowska-Feuer, Patrycja/0000-0002-7399-8516	Institute of Zoology of the Jagiellonian University [BW/IZ/23a/2007]	Institute of Zoology of the Jagiellonian University	This study was supported by grant BW/IZ/23a/2007 obtained from the Institute of Zoology of the Jagiellonian University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht D, 1998, NEUROSCI RES, V32, P209, DOI 10.1016/S0168-0102(98)00087-X; Barbacka-Surowiak G, 2000, BIOL RHYTHM RES, V31, P531, DOI 10.1076/brhm.31.5.531.5659; Blasiak T, 2006, EUR J NEUROSCI, V24, P2769, DOI 10.1111/j.1460-9568.2006.05162.x; Blasiak T, 2003, BEHAV BRAIN RES, V138, P179, DOI 10.1016/S0166-4328(02)00240-1; CAMPBELL G, 1985, PHILOS T R SOC B, V310, P573, DOI 10.1098/rstb.1985.0132; Castel M, 2000, J ANAT, V196, P1, DOI 10.1046/j.1469-7580.2000.19610001.x; CLARKE RJ, 1985, EXP BRAIN RES, V59, P83; CLARKE RJ, 1985, EXP BRAIN RES, V57, P224; CONTE S, 1995, BIOL PSYCHOL, V39, P159, DOI 10.1016/0301-0511(94)00962-W; ELLIS GB, 1982, AM J PHYSIOL, V242, pR44, DOI 10.1152/ajpregu.1982.242.1.R44; Filippov IV, 2002, NEUROCOMPUTING, V44, P795, DOI 10.1016/S0925-2312(02)00474-5; Fleming MD, 2006, NEUROSCIENCE, V143, P895, DOI 10.1016/j.neuroscience.2006.08.016; Gooley JJ, 2003, J NEUROSCI, V23, P7093, DOI 10.1523/JNEUROSCI.23-18-07093.2003; Gooley JJ, 2001, NAT NEUROSCI, V4, P1165, DOI 10.1038/nn768; GREHN F, 1984, BEHAV BRAIN RES, V14, P109, DOI 10.1016/0166-4328(84)90178-5; GRUSSER OJ, 1989, VISION RES, V29, P181, DOI 10.1016/0042-6989(89)90123-5; Hannibal J, 2004, CELL TISSUE RES, V316, P99, DOI 10.1007/s00441-004-0858-x; HARRINGTON ME, 1989, VISUAL NEUROSCI, V2, P367, DOI 10.1017/S0952523800002170; HARRINGTON ME, 1991, BRAIN RES, V554, P95, DOI 10.1016/0006-8993(91)90176-V; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Klooster J, 1997, EXP BRAIN RES, V114, P51, DOI 10.1007/PL00005623; KLOOSTER J, 1995, BRAIN RES, V688, P34, DOI 10.1016/0006-8993(95)00497-E; Krout KE, 2002, NEUROSCIENCE, V110, P73, DOI 10.1016/S0306-4522(01)00551-6; LEGG CR, 1975, NEUROPSYCHOLOGIA, V13, P373, DOI 10.1016/0028-3932(75)90016-0; LEGG CR, 1988, BEHAV BRAIN RES, V29, P27, DOI 10.1016/0166-4328(88)90049-6; Lewandowski MH, 2004, ACTA NEUROBIOL EXP, V64, P277; Lewandowski MH, 2000, NEUROREPORT, V11, P317, DOI 10.1097/00001756-200002070-00019; LOWENSTEIN O, 1963, INVEST OPHTH VISUAL, V2, P138; MACKAYSIM A, 1983, J COMP NEUROL, V213, P24, DOI 10.1002/cne.902130103; Marchant EG, 1999, J NEUROSCI, V19, P10482; Meijer JH, 1998, J NEUROSCI, V18, P9078; MEIJER JH, 1986, BRAIN RES, V382, P109, DOI 10.1016/0006-8993(86)90117-4; MIKKELSEN JD, 1994, NEUROSCIENCE, V62, P497, DOI 10.1016/0306-4522(94)90382-4; Miller AM, 1999, BEHAV NEUROSCI, V113, P755, DOI 10.1037/0735-7044.113.4.755; Miller AM, 1998, P NATL ACAD SCI USA, V95, P8957, DOI 10.1073/pnas.95.15.8957; MILLER JD, 1992, AM J PHYSIOL, V263, pR51, DOI 10.1152/ajpregu.1992.263.1.R51; Moga MM, 1997, J COMP NEUROL, V389, P508, DOI 10.1002/(SICI)1096-9861(19971222)389:3<508::AID-CNE11>3.0.CO;2-H; Moore RY, 2000, J COMP NEUROL, V420, P398, DOI 10.1002/(SICI)1096-9861(20000508)420:3<398::AID-CNE9>3.0.CO;2-9; MOORE RY, 1994, J COMP NEUROL, V344, P403, DOI 10.1002/cne.903440306; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Prichard JR, 2002, NEUROSCIENCE, V114, P781, DOI 10.1016/S0306-4522(02)00293-2; RODIECK RW, 1966, J NEUROPHYSIOL, V29, P942, DOI 10.1152/jn.1966.29.5.942; Rosenwasser AM, 2001, PHYSIOL BEHAV, V73, P175, DOI 10.1016/S0031-9384(01)00466-8; Sekaran S, 2003, CURR BIOL, V13, P1290, DOI 10.1016/S0960-9822(03)00510-4; SILLITO AM, 1970, J PHYSIOL-LONDON, V211, P767, DOI 10.1113/jphysiol.1970.sp009303; Simpson JI, 1998, REV OCULOMOT RES, V2, P335; Szkudlarek HJ, 2008, EUR J NEUROSCI, V27, P2657, DOI 10.1111/j.1460-9568.2008.06225.x; Thoss F, 1998, VISION RES, V38, P139, DOI 10.1016/S0042-6989(97)00150-8; TREJO LJ, 1984, BRAIN RES, V300, P49, DOI 10.1016/0006-8993(84)91340-4; Wichmann T, 2002, J NEUROPHYSIOL, V87, P1145, DOI 10.1152/jn.00427.2001; Wong WT, 2000, J NEUROSCI, V20, P351, DOI 10.1523/JNEUROSCI.20-01-00351.2000; Young MJ, 1998, BRAIN RES, V787, P191, DOI 10.1016/S0006-8993(97)01473-X; YOUNG MJ, 1994, NEUROSCIENCE, V62, P481, DOI 10.1016/0306-4522(94)90381-6	54	16	16	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33083	10.1371/journal.pone.0033083	http://dx.doi.org/10.1371/journal.pone.0033083			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427957	Green Published, Green Submitted, gold			2022-12-25	WOS:000302381500090
J	Amin, ARMR; Thakur, VS; Gupta, K; Agarwal, MK; Wald, DN; Shin, DM; Agarwal, ML				Amin, A. R. M. Ruhul; Thakur, V. S.; Gupta, K.; Agarwal, M. K.; Wald, D. N.; Shin, D. M.; Agarwal, M. L.			N-(phosphonacetyl)-L-aspartate induces TAp73-dependent apoptosis by modulating multiple Bcl-2 proteins: potential for cancer therapy	ONCOGENE			English	Article						DNA damage; apoptosis; signal transduction; aspartate transcarbamylase inhibitor; p53 family; replicative stress	PHASE-II TRIAL; KINASE C-ABL; DNA-DAMAGE; BH3-ONLY PROTEINS; P73 GENE; CHROMOSOME 1P36.3; UP-REGULATION; P53 HOMOLOG; MUTANT P53; CELL-DEATH	p53 is essential for the cellular responses to DNA damage that help to maintain genomic stability. However, the great majority of human cancers undergo disruption of the p53-network. Identification and characterization of molecular components important in both p53-dependent and -independent apoptosis might be useful in developing novel therapies for cancers. In the complete absence of p53, cells treated with N-(phosphonacetyl)-L-aspartate (PALA) continue to synthesize DNA slowly and eventually progress through S-phase, suffering severe DNA damage that in turn triggers apoptosis, whereas cells with functional p53 undergo growth arrest. In this study, we investigated apoptotic signaling in response to PALA and the role of p53 expression in this pathway. We found that treatment of cells lacking p53 with PALA induced TAp73, Noxa and Bim and inactivation of these proteins with dominant-negative plasmids or small interfering RNAs significantly inhibited apoptosis, suggesting that PALA-induced apoptosis was mediated via TAp73-dependent expression of Noxa and Binn. However, PALA treatment inhibited the expression of Delta Np73 only in cells lacking p53 but not in cells expressing p53. In addition, PALA treatment inhibited Bcl-2, and overexpression of Bcl-2 significantly inhibited PALA-induced apoptosis. Moreover, expression of p53 in these cells protected them from PALA-induced apoptosis by activating p21, sustaining the expression of Delta Np73 and inhibiting the induction of Noxa and Bim. Taken together, our study identifies novel but opposing roles for the p53 and TAp73 in the induction of Noxa and Bim and regulation of apoptosis. Our data will help to develop strategies to eliminate cancer cells lacking p53 while protecting normal cells with wild-type p53. Oncogene (2013) 32, 920-929; doi:10.1038/onc.2012.96; published online 19 March 2012	[Amin, A. R. M. Ruhul; Thakur, V. S.; Agarwal, M. L.] Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; [Amin, A. R. M. Ruhul; Shin, D. M.] Emory Univ, Dept Hematol & Med Oncol, Winship Canc Inst, Atlanta, GA 30322 USA; [Gupta, K.; Wald, D. N.] Case Western Reserve Univ, Dept Pathol, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Agarwal, M. K.] Invenio Therapeut, Cleveland, OH USA	Case Western Reserve University; Emory University; Case Western Reserve University	Amin, ARMR (corresponding author), Emory Univ, Dept Hematol & Med Oncol, Winship Canc Inst, Bldg C,Room 3074, Atlanta, GA 30322 USA.	aamin9@emory.edu; munnaagarwal@hotmail.com	Shin, Dong Moon/G-9649-2013; Ray, Dana M/C-3470-2013	Shin, Dong Moon/0000-0002-8245-4174; AMIN, ARM/0000-0001-9144-2960	National Institutes of Health [R01 CA98916, P50 CA128613]; Career Development Award; NATIONAL CANCER INSTITUTE [P50CA128613, R01CA098916] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Career Development Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are thankful to Dr George R Stark (Cleveland Clinic Foundation) for his continuous encouragement and criticism throughout the course of the work and critically reading and editing the manuscript, and to Dr Anthea Hammond (Emory University) for editorial assistance. We also thank Dr Rajib K Paul for screening SKp53 cells. This work was supported by National Institutes of Health Grants R01 CA98916 to MLA and P50 CA128613 to DMS and ARA. ARA is a recipient of Career Development Award.	Agarwal ML, 1998, J BIOL CHEM, V273, P1, DOI 10.1074/jbc.273.1.1; Agarwal ML, 1998, P NATL ACAD SCI USA, V95, P14775, DOI 10.1073/pnas.95.25.14775; AGARWAL ML, 1995, P NATL ACAD SCI USA, V92, P8493, DOI 10.1073/pnas.92.18.8493; Agarwal MK, 2006, P NATL ACAD SCI USA, V103, P16278, DOI 10.1073/pnas.0607210103; Amin ARMR, 2007, CANCER RES, V67, P5617, DOI 10.1158/0008-5472.CAN-07-0655; Amin ARMR, 2007, P NATL ACAD SCI USA, V104, P5419, DOI 10.1073/pnas.0700642104; Amin ARMR, 2010, J BIOL CHEM, V285, P34557, DOI 10.1074/jbc.M110.141135; Amin ARMR, 2010, MOL CANCER THER, V9, P471, DOI 10.1158/1535-7163.MCT-09-0732; Amin ARMR, 2009, J CLIN ONCOL, V27, P2712, DOI 10.1200/JCO.2008.20.6235; BISCHOFF FZ, 1991, ONCOGENE, V6, P183; Brenner D, 2009, CURR OPIN CELL BIOL, V21, P871, DOI 10.1016/j.ceb.2009.09.004; Busuttil V, 2010, P NATL ACAD SCI USA, V107, P18061, DOI 10.1073/pnas.1006163107; Chakraborty J, 2010, J BIOL CHEM, V285, P33104, DOI 10.1074/jbc.M110.122705; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Chung J, 2010, CURR DRUG TARGETS, V11, P667, DOI 10.2174/138945010791170833; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Di Como CJ, 1999, MOL CELL BIOL, V19, P1438; Dotsch V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004887; Dominguez G, 2006, J CLIN ONCOL, V24, P805, DOI 10.1200/JCO.2005.02.2350; Douc-Rasy S, 2002, AM J PATHOL, V160, P631, DOI 10.1016/S0002-9440(10)64883-3; Faridoni-Laurens L, 2008, CELL CYCLE, V7, P1587, DOI 10.4161/cc.7.11.5894; Farnebo M, 2010, BIOCHEM BIOPH RES CO, V396, P85, DOI 10.1016/j.bbrc.2010.02.152; Ghiotto F, 2010, CYTOM PART A, V77A, P11, DOI 10.1002/cyto.a.20819; Gong JG, 1999, NATURE, V399, P806; Gottifredi V, 2001, MOL CELL BIOL, V21, P1066, DOI 10.1128/MCB.21.4.1066-1076.2001; Gottlieb E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001040; GREM JL, 1993, CANCER RES, V53, P4828; Hastak K, 2005, FASEB J, V19, P789, DOI 10.1096/fj.04-2226fje; Hastak K, 2008, P NATL ACAD SCI USA, V105, P6314, DOI 10.1073/pnas.0802080105; HEO DS, 1989, CANCER RES, V49, P5167; Ibrahim N, 2010, CANCER RES, V70, P7155, DOI 10.1158/0008-5472.CAN-10-0668; Ichimiya S, 1999, ONCOGENE, V18, P1061, DOI 10.1038/sj.onc.1202390; Irwin M, 2000, NATURE, V407, P645, DOI 10.1038/35036614; Joerger AC, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000919; John K, 2011, CELL DEATH DIFFER, V18, P874, DOI 10.1038/cdd.2010.153; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; Kirschnek S, 2011, CELL DEATH DIFFER, V18, P1805, DOI 10.1038/cdd.2011.69; Kovalev S, 1998, CELL GROWTH DIFFER, V9, P897; Leibowitz Brian, 2010, Cancer Biol Ther, V9, P417, DOI 10.4161/cbt.9.6.11392; Leupin N, 2004, LEUKEMIA LYMPHOMA, V45, P1205, DOI 10.1080/10298190310001623829; Li R, 2005, CELL DEATH DIFFER, V12, P292, DOI 10.1038/sj.cdd.4401554; Linke SP, 1996, GENE DEV, V10, P934, DOI 10.1101/gad.10.8.934; Lohr K, 2003, J BIOL CHEM, V278, P32507, DOI 10.1074/jbc.M212517200; Lomonosova E, 2008, ONCOGENE, V27, pS2, DOI 10.1038/onc.2009.39; Loukopoulos P, 2007, CANCER SCI, V98, P392, DOI 10.1111/j.1349-7006.2007.00395.x; Lunghi P, 2009, CLIN CANCER RES, V15, P6495, DOI 10.1158/1078-0432.CCR-09-1229; Maisse C, 2004, CELL DEATH DIFFER, V11, P685, DOI 10.1038/sj.cdd.4401376; Malaguarnera R, 2007, ENDOCR-RELAT CANCER, V14, P43, DOI 10.1677/erc.1.01223; Melino G, 2003, TRENDS BIOCHEM SCI, V28, P663, DOI 10.1016/j.tibs.2003.10.004; Miyaguchi Y, 2009, CELL BIOL INT, V33, P853, DOI 10.1016/j.cellbi.2009.04.017; Moffitt KL, 2010, J PHARM PHARMACOL, V62, P547, DOI 10.1211/jpp.62.05.0001; Morales AA, 2008, BLOOD, V111, P5152, DOI 10.1182/blood-2007-10-116889; Ng SW, 2000, ONCOGENE, V19, P1885, DOI 10.1038/sj.onc.1203512; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; Ozaki T, 2005, CANCER SCI, V96, P729, DOI 10.1111/j.1349-7006.2005.00116.x; Paulson TG, 1998, MOL CELL BIOL, V18, P3089, DOI 10.1128/MCB.18.5.3089; REDEI I, 1994, INVEST NEW DRUG, V12, P319, DOI 10.1007/BF00873047; Rufini Alessandro, 2011, Genes Cancer, V2, P491, DOI 10.1177/1947601911408890; Santidrian AF, 2010, BLOOD, V116, P3023, DOI 10.1182/blood-2010-05-283960; Sedletska Yuliya, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P251, DOI 10.2174/1568011053765967; Shats I, 2004, J BIOL CHEM, V279, P50976, DOI 10.1074/jbc.M402502200; Sunahara M, 1998, INT J ONCOL, V13, P319; SWYRYD EA, 1974, J BIOL CHEM, V249, P6945; Tannapfel A, 1999, J NATL CANCER I, V91, P1154, DOI 10.1093/jnci/91.13.1154; Toh WH, 2010, CELL DEATH DIFFER, V17, P787, DOI 10.1038/cdd.2009.181; Tschan MP, 2000, BIOCHEM BIOPH RES CO, V277, P62, DOI 10.1006/bbrc.2000.3627; Vilgelm A, 2008, DRUG RESIST UPDATE, V11, P152, DOI 10.1016/j.drup.2008.08.001; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wadler S, 1996, EUR J CANCER, V32A, P1254, DOI 10.1016/0959-8049(96)00035-4; Wilhelm MT, 2010, GENE DEV, V24, P549, DOI 10.1101/gad.1873910; Wiman KG, 2010, ONCOGENE, V29, P4245, DOI 10.1038/onc.2010.188; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; YIN YX, 1992, CELL, V70, P937, DOI 10.1016/0092-8674(92)90244-7; Yokomizo A, 1999, ONCOGENE, V18, P1629, DOI 10.1038/sj.onc.1202474; Yokomizo A, 1999, PROSTATE, V39, P94; Yuan ZM, 1999, NATURE, V399, P814, DOI 10.1038/21704; Zaika AI, 1999, CANCER RES, V59, P3257; Zilfou JT, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001883	79	9	9	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 14	2013	32	7					920	929		10.1038/onc.2012.96	http://dx.doi.org/10.1038/onc.2012.96			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	112GQ	22430213	Green Accepted			2022-12-25	WOS:000316581100012
J	Latchoumycandane, C; Marathe, GK; Zhang, RL; McIntyre, TM				Latchoumycandane, Calivarathan; Marathe, Gopal K.; Zhang, Renliang; McIntyre, Thomas M.			Oxidatively Truncated Phospholipids Are Required Agents of Tumor Necrosis Factor alpha (TNF alpha)-induced Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATING-FACTOR-ACETYLHYDROLASE; TANDEM MASS-SPECTROMETRY; LOW-DENSITY LIPOPROTEINS; MEDIATED GENE-TRANSFER; NECROTIC CELL-DEATH; TNF-ALPHA; GLUTATHIONE-PEROXIDASE; OXIDIZED PHOSPHOLIPIDS; HUMAN-PLASMA; PAF-ACETYLHYDROLASE	TNF alpha generates reactive oxygen species (ROS) at the cell surface that induce cell death, but how ROS communicate to mitochondria and their specific apoptotic action(s) are both undefined. ROS oxidize phospholipids to hydroperoxides that are friable and fragment adjacent to the ( hydro) peroxide function, forming truncated phospholipids, such as azelaoyl phosphatidylcholine (Az-PC). Az-PC is relatively soluble, and exogenous Az-PC rapidly enters cells to damage mitochondrial integrity and initiate intrinsic apoptosis. We determined whether this toxic phospholipid is formed within cells during TNF alpha stimulation in sufficient quantities to induce apoptosis and if they are essential in TNF alpha-induced cytotoxicity. We found that TNF alpha induced ROS formation and phospholipid peroxidation in Jurkat cells, and either chemical interference with NADPH oxidase activity or siRNA suppression of the NADPH oxidase-4 subunit blocked ROS accumulation and phospholipid peroxidation. Mass spectrometry showed that phospholipid peroxides and then Az-PC increased after TNF alpha exposure, whereas ROS inhibition abolished Az-PC accumulation and TNF alpha-induced cell death. Glutathione peroxidase-4 (GPx4), which specifically metabolizes lipid hydroperoxides, fell in TNF alpha-stimulated cells prior to death. Ectopic GPx4 overcame this, reduced peroxidized phospholipid accumulation, blocked Az-PC accumulation, and prevented death. Conversely, GPx4 siRNA knockdown enhanced phospholipid peroxidation, increasing TNF alpha-stimulated Az-PC formation and apoptosis. Truncated phospholipids were essential elements of TNF alpha- induced apoptosis because overexpression of PAFAH2 ( a phospholipase A(2) that selectively hydrolyzes truncated phospholipids) blocked TNF alpha-induced Az-PC accumulation without affecting phospholipid peroxidation. PAFAH2 also abolished apoptosis. Thus, phospholipid oxidation and truncation to apoptotic phospholipids comprise an essential element connecting TNF alpha receptor signaling to mitochondrial damage and apoptotic death.	[Latchoumycandane, Calivarathan; Marathe, Gopal K.; Zhang, Renliang; McIntyre, Thomas M.] Lerner Coll Med, Lerner Res Inst, Cleveland Clin, Dept Cell Biol, Cleveland, OH 44195 USA	Case Western Reserve University; Cleveland Clinic Foundation	McIntyre, TM (corresponding author), Lerner Coll Med, Lerner Res Inst NE10, Cleveland Clin, Dept Cell Biol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	mcintyt@ccf.org	Latchoumycandane, Calivarathan/GPP-5175-2022	Latchoumycandane, Calivarathan/0000-0002-6637-369X	National Institutes of Health [AA017748, HL092747]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017748] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants AA017748 and HL092747.	Avery SV, 2011, BIOCHEM J, V434, P201, DOI 10.1042/BJ20101695; Basuroy S, 2009, AM J PHYSIOL-CELL PH, V296, pC422, DOI 10.1152/ajpcell.00381.2008; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BUETTNER GR, 1993, ARCH BIOCHEM BIOPHYS, V300, P535, DOI 10.1006/abbi.1993.1074; Chen R, 2007, J BIOL CHEM, V282, P24842, DOI 10.1074/jbc.M702865200; Chen R, 2011, J IMMUNOL, V186, P3215, DOI 10.4049/jimmunol.1002710; Chen R, 2009, J BIOL CHEM, V284, P26297, DOI 10.1074/jbc.M109.018978; Conrad M, 2010, P NATL ACAD SCI USA, V107, P15774, DOI 10.1073/pnas.1007909107; Davies SS, 2001, J BIOL CHEM, V276, P16015, DOI 10.1074/jbc.M100878200; Esposti MD, 2001, MOL CELL BIOL, V21, P7268, DOI 10.1128/MCB.21.21.7268-7276.2001; Falschlehner C, 2007, INT J BIOCHEM CELL B, V39, P1462, DOI 10.1016/j.biocel.2007.02.007; Fisher AB, 1999, J BIOL CHEM, V274, P21326, DOI 10.1074/jbc.274.30.21326; Foulks JM, 2008, FREE RADICAL BIO MED, V45, P434, DOI 10.1016/j.freeradbiomed.2008.04.034; FRANKEL EN, 1984, PROG LIPID RES, V23, P197, DOI 10.1016/0163-7827(84)90011-0; Gordon JW, 2011, CIRC RES, V108, P1122, DOI 10.1161/CIRCRESAHA.110.226928; Han D, 2006, FREE RADICAL BIO MED, V41, P627, DOI 10.1016/j.freeradbiomed.2006.05.002; Han D, 2009, ANTIOXID REDOX SIGN, V11, P2245, DOI [10.1089/ars.2009.2611, 10.1089/ARS.2009.2611]; Harrison KA, 2000, J MASS SPECTROM, V35, P224, DOI 10.1002/(SICI)1096-9888(200002)35:2<224::AID-JMS933>3.0.CO;2-G; HATTORI K, 1995, J BIOL CHEM, V270, P22308, DOI 10.1074/jbc.270.38.22308; Hattori K, 1996, J BIOL CHEM, V271, P33032, DOI 10.1074/jbc.271.51.33032; HATTORI M, 1994, J BIOL CHEM, V269, P23150; Hirashima Y, 2000, BRAIN RES, V885, P128, DOI 10.1016/S0006-8993(00)02852-3; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Imai H, 2003, FREE RADICAL BIO MED, V34, P145, DOI 10.1016/S0891-5849(02)01197-8; Kanner J, 1988, Basic Life Sci, V49, P145; KAYGANICHHARRISON KA, 1994, ANAL BIOCHEM, V221, P16, DOI 10.1006/abio.1994.1372; Kim YS, 2007, MOL CELL, V26, P675, DOI 10.1016/j.molcel.2007.04.021; Kono N, 2008, J BIOL CHEM, V283, P1628, DOI 10.1074/jbc.M708622200; Loscalzo J, 2008, CELL METAB, V8, P182, DOI 10.1016/j.cmet.2008.08.004; Marathe GK, 1999, J BIOL CHEM, V274, P28395, DOI 10.1074/jbc.274.40.28395; Mariappan N, 2007, AM J PHYSIOL-HEART C, V293, pH2726, DOI 10.1152/ajpheart.00376.2007; Matsuzawa A, 1997, J BIOL CHEM, V272, P32315, DOI 10.1074/jbc.272.51.32315; Milne GL, 2005, J LIPID RES, V46, P307, DOI 10.1194/jlr.M400311-JLR200; Montero J, 2010, BBA-BIOENERGETICS, V1797, P1217, DOI 10.1016/j.bbabio.2010.02.010; Morgan MJ, 2010, MOL CELLS, V30, P1, DOI 10.1007/s10059-010-0105-0; ODONNELL VB, 1995, BIOCHEM J, V310, P133, DOI 10.1042/bj3100133; Parameswaran N, 2010, CRIT REV EUKAR GENE, V20, P87, DOI 10.1615/CritRevEukarGeneExpr.v20.i2.10; Podrez EA, 2002, J BIOL CHEM, V277, P38503, DOI 10.1074/jbc.M203318200; Podrez EA, 2007, NAT MED, V13, P1086, DOI 10.1038/nm1626; Quarck R, 2001, CIRCULATION, V103, P2495; Ran QT, 2004, J BIOL CHEM, V279, P55137, DOI 10.1074/jbc.M410387200; Reis A, 2004, RAPID COMMUN MASS SP, V18, P2849, DOI 10.1002/rcm.1686; Roede JR, 2009, J PHARMACOL EXP THER, V330, P79, DOI 10.1124/jpet.109.152983; SADRZADEH SMH, 1984, J BIOL CHEM, V259, P4354; Schafer ZT, 2006, DEV CELL, V10, P549, DOI 10.1016/j.devcel.2006.04.008; Shakibaei M, 2010, ANTIOXID REDOX SIGN, V13, P821, DOI 10.1089/ars.2009.3036; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; STAFFORINI DM, 1987, J BIOL CHEM, V262, P4223; STREMLER KE, 1989, J BIOL CHEM, V264, P5331; STREMLER KE, 1991, J BIOL CHEM, V266, P11095; Takac I, 2011, J BIOL CHEM, V286, P13304, DOI 10.1074/jbc.M110.192138; Tchikov V, 2011, EUR J CELL BIOL, V90, P467, DOI 10.1016/j.ejcb.2010.11.002; Thomas CP, 2010, J BIOL CHEM, V285, P6891, DOI 10.1074/jbc.M109.078428; TJOELKER LW, 1995, J BIOL CHEM, V270, P25481, DOI 10.1074/jbc.270.43.25481; Tokumura A, 2000, J LIPID RES, V41, P953; Turunen P, 2004, J LIPID RES, V45, P1633, DOI 10.1194/jlr.M400176-JLR200; Umemura K, 2007, STROKE, V38, P1063, DOI 10.1161/01.STR.0000257981.09329.d2; URSINI F, 1987, CHEM PHYS LIPIDS, V44, P255, DOI 10.1016/0009-3084(87)90053-3; Van Buul JD, 2005, ANTIOXID REDOX SIGN, V7, P308, DOI 10.1089/ars.2005.7.308; Vanden Berghe T, 2007, MOL CELL, V26, P769, DOI 10.1016/j.molcel.2007.06.002; Votyakova TV, 2004, ARCH BIOCHEM BIOPHYS, V431, P138, DOI 10.1016/j.abb.2004.07.025; Yagi K, 1996, BIOCHEM BIOPH RES CO, V219, P486, DOI 10.1006/bbrc.1996.0260; Yang LL, 2010, J BIOL CHEM, V285, P22211, DOI 10.1074/jbc.M110.119982	64	34	34	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17693	17705		10.1074/jbc.M111.300012	http://dx.doi.org/10.1074/jbc.M111.300012			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22433871	Green Published, hybrid			2022-12-25	WOS:000306373000068
J	Kang, MA; So, EY; Ouchi, T				Kang, Meyke Ausman; So, Eui-Young; Ouchi, Toru			Deregulation of DNA Damage Response Pathway by Intercellular Contact	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; HISTONE H2AX PHOSPHORYLATION; BETA-CATENIN; GENOMIC INSTABILITY; IONIZING-RADIATION; PLAKOGLOBIN; PROTEIN; ATM; CADHERIN; CANCER	Deregulation of the DNA damage response (DDR) pathway could compromise genomic integrity in normal cells and reduce cancer cell sensitivity to anticancer treatments. We found that intercellular contact stabilizes histone H2AX and gamma H2AX (H2AX phosphorylated on Ser-139) by up-regulating N/E-cadherin and gamma-catenin. gamma-catenin and its DNA-binding partner LEF-1 indirectly increase levels of H2AX by suppressing the promoter of the RNF8 ubiquitin ligase, which decreases levels of H2AX protein under conditions of low intercellular contact. Hyperphosphorylation of DDR proteins is induced by up-regulated H2AX. Constitutive apoptosis is caused in confluent cells but is not further induced by DNA damage. This is conceivably due to insufficient p53 activation because ChIP assay shows that its DNA binding ability is not induced in those cells. Together, our results illustrate a novel mechanism of the regulation of DDR proteins by the cadherin-catenin pathway.	[So, Eui-Young; Ouchi, Toru] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA; [Kang, Meyke Ausman; Ouchi, Toru] Northwestern Univ, Dept Mol Biosci, Interdept Biol Sci Program, Evanston, IL 60201 USA; [Kang, Meyke Ausman; So, Eui-Young; Ouchi, Toru] Univ Chicago, Natl Univ Hlth Sci, Syst Biol Program, Dept Med, Evanston, IL 60201 USA	Roswell Park Cancer Institute; Northwestern University; University of Chicago	Ouchi, T (corresponding author), Roswell Pk Canc Inst, Dept Canc Genet, Elm & Carlton St, Buffalo, NY 14263 USA.	Toru.Ouchi@RoswellPark.org			National Institutes of Health [R01CA79892, R01CA90631]; Susan Komen Foundation; NATIONAL CANCER INSTITUTE [R01CA079892, R01CA090631] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan Komen Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA79892 and R01CA90631. This work is also supported by a Breast Cancer Research Grant from the Susan Komen Foundation (to T. O.).	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; BUTZ S, 1992, SCIENCE, V257, P1142, DOI 10.1126/science.257.5073.1142-a; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cook PJ, 2009, NATURE, V458, P591, DOI 10.1038/nature07849; COWIN P, 1986, CELL, V46, P1063, DOI 10.1016/0092-8674(86)90706-3; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HIRANO S, 1992, CELL, V70, P293, DOI 10.1016/0092-8674(92)90103-J; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Huen MSY, 2010, TRENDS BIOCHEM SCI, V35, P101, DOI 10.1016/j.tibs.2009.09.001; Kang M. A., 2011, CELL DEATH IN PRESS; KEMLER R, 1993, TRENDS GENET, V9, P317, DOI 10.1016/0168-9525(93)90250-L; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; Maeda O, 2004, ONCOGENE, V23, P964, DOI 10.1038/sj.onc.1207254; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; MCCREA PD, 1991, SCIENCE, V254, P1359, DOI 10.1126/science.1962194; Meng WX, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002899; NAGAFUCHI A, 1991, CELL, V65, P849, DOI 10.1016/0092-8674(91)90392-C; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; RUBINFELD B, 1993, SCIENCE, V262, P1731, DOI 10.1126/science.8259518; Sadot E, 2000, ONCOGENE, V19, P1992, DOI 10.1038/sj.onc.1203519; Shanbhag NM, 2010, CELL, V141, P970, DOI 10.1016/j.cell.2010.04.038; Simcha I, 1998, J CELL BIOL, V141, P1433, DOI 10.1083/jcb.141.6.1433; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Stucki M, 2006, DNA REPAIR, V5, P534, DOI 10.1016/j.dnarep.2006.01.012; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	39	6	6	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16246	16255		10.1074/jbc.M111.337212	http://dx.doi.org/10.1074/jbc.M111.337212			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22431734	Green Published, hybrid			2022-12-25	WOS:000304030900017
J	Jin, W; Reddy, MA; Chen, Z; Putta, S; Lanting, L; Kato, M; Park, JT; Chandra, M; Wang, C; Tangirala, RK; Natarajan, R				Jin, Wen; Reddy, Marpadga A.; Chen, Zhuo; Putta, Sumanth; Lanting, Linda; Kato, Mitsuo; Park, Jung Tak; Chandra, Manasa; Wang, Charles; Tangirala, Rajendra K.; Natarajan, Rama			Small RNA Sequencing Reveals MicroRNAs That Modulate Angiotensin II Effects in Vascular Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEIN; MONOCYTE CHEMOATTRACTANT PROTEIN-1; FACTOR-KAPPA-B; NEOINTIMAL LESION FORMATION; TUMOR-SUPPRESSOR PROTEIN; ACCELERATED ATHEROSCLEROSIS; GENE-EXPRESSION; DEFICIENT MICE; PTEN; INHIBITION	Angiotensin II (Ang II)-mediated vascular smooth muscle cell dysfunction plays a critical role in cardiovascular diseases. However, the role of microRNAs (miRNAs) in this process is unclear. We used small RNA deep sequencing to profile Ang II-regulated miRNAs in rat vascular smooth muscle cells (VSMC) and evaluated their role in VSMC dysfunction. Sequencing results revealed several Ang II-responsive miRNAs, and bioinformatics analysis showed that their predicted targets can modulate biological processes relevant to cardiovascular diseases. Further studies with the most highly induced miR-132 and miR-212 cluster (miR-132/212) showed time- and dose-dependent upregulation of miR-132/212 by Ang II through the Ang II Type 1 receptor. We identified phosphatase and tensin homolog (PTEN) as a novel target of miR-132 and demonstrated that miR-132 induces monocyte chemoattractant protein-1 at least in part via PTEN repression in rat VSMC. Moreover, miR-132 overexpression enhanced cyclic AMP-response element-binding protein (CREB) phosphorylation via RASA1 (p120 Ras GTPase-activating protein 1) down-regulation, whereas miR-132 inhibition attenuated Ang II-induced CREB activation. Furthermore, miR-132 up-regulation by Ang II required CREB activation, demonstrating a positive feedback loop. Notably, aortas from Ang II-infused mice displayed similar up-regulation of miR-132/212 and monocyte chemoattractant protein-1, supporting in vivo relevance. In addition, microarray analysis and reverse transcriptase-quantitative PCR validation revealed additional novel miR-132 targets among Ang II-down-regulated genes implicated in cell cycle, motility, and cardiovascular functions. These results suggest that miR132/212 can serve as a novel cellular node to fine-tune and amplify Ang II actions in VSMC.	[Jin, Wen; Reddy, Marpadga A.; Chen, Zhuo; Putta, Sumanth; Lanting, Linda; Kato, Mitsuo; Park, Jung Tak; Natarajan, Rama] City Hope Natl Med Ctr, Dept Diabet, Beckman Res Inst, Div Mol Diabet Res, Duarte, CA 91010 USA; [Jin, Wen; Chandra, Manasa; Natarajan, Rama] City Hope Natl Med Ctr, Irell & Manella Grad Sch Biol Sci, Beckman Res Inst, Duarte, CA 91010 USA; [Wang, Charles] City Hope Natl Med Ctr, Funct Genom Core, Beckman Res Inst, Dept Mol Med, Duarte, CA 91010 USA; [Tangirala, Rajendra K.] Univ Calif Los Angeles, David Geffen Sch Med, Div Endocrinol Diabet & Hypertens, Los Angeles, CA 90095 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Natarajan, R (corresponding author), City Hope Natl Med Ctr, Dept Diabet, Beckman Res Inst, Div Mol Diabet Res, 1500 E Duarte Rd, Duarte, CA 91010 USA.	RNatarajan@coh.org	Kato, Mitsuo/D-5411-2009	Park, Jung Tak/0000-0002-2325-8982; Kato, Mitsuo/0000-0002-1783-1084; Reddy, Marpadga A/0000-0001-9259-7243	National Institutes of Health [NIH RO1 HL087864, NIH RO1 HL106089]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087864, R01HL106089] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants NIH RO1 HL087864 and NIH RO1 HL106089 (NHLBI; to R. N.).	Anand S, 2010, NAT MED, V16, P909, DOI 10.1038/nm.2186; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Boettger T, 2009, J CLIN INVEST, V119, P2634, DOI 10.1172/JCI38864; Bruemmer D, 2003, J CLIN INVEST, V112, P1318, DOI 10.1172/JCI200318141; Charo IF, 2004, CIRC RES, V95, P858, DOI 10.1161/01.RES.0000146672.10582.17; Chen WJ, 2004, CIRCULATION, V110, P1313, DOI 10.1161/01.CIR.0000140764.15398.F3; Chen XL, 1998, CIRC RES, V83, P952; Cheng YH, 2009, CIRC RES, V105, P158, DOI 10.1161/CIRCRESAHA.109.197517; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Daugherty A, 1999, ANN NY ACAD SCI, V892, P108, DOI 10.1111/j.1749-6632.1999.tb07789.x; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Daugherty A, 2004, TRENDS CARDIOVAS MED, V14, P117, DOI 10.1016/j.tcm.2004.01.002; DUFF JL, 1995, CARDIOVASC RES, V30, P511, DOI 10.1016/0008-6363(95)00088-7; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Funakoshi Y, 2002, J BIOL CHEM, V277, P18710, DOI 10.1074/jbc.M110430200; Furgeson SB, 2010, CARDIOVASC RES, V86, P274, DOI 10.1093/cvr/cvp425; GIBBONS GH, 1992, J CLIN INVEST, V90, P456, DOI 10.1172/JCI115881; GRIENDLING KK, 1994, CIRC RES, V74, P1141, DOI 10.1161/01.RES.74.6.1141; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Han YQ, 1999, CIRC RES, V84, P695, DOI 10.1161/01.RES.84.6.695; HernandezPresa M, 1997, CIRCULATION, V95, P1532; Hollander JA, 2010, NATURE, V466, P197, DOI 10.1038/nature09202; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang JH, 2002, ARTERIOSCL THROM VAS, V22, P745, DOI 10.1161/01.ATV.0000016358.05294.8D; Hur W, 2010, CARCINOGENESIS, V31, P1298, DOI 10.1093/carcin/bgq072; Ichiki T, 2006, ARTERIOSCL THROM VAS, V26, P449, DOI 10.1161/01.ATV.0000196747.79349.d1; Ichiki T, 2003, HYPERTENSION, V42, P177, DOI 10.1161/01.HYP.0000079791.26014.04; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kato M, 2007, P NATL ACAD SCI USA, V104, P3432, DOI 10.1073/pnas.0611192104; Kligys K, 2007, J BIOL CHEM, V282, P32520, DOI 10.1074/jbc.M707041200; Koide S, 2007, AM J PHYSIOL-HEART C, V292, pH2824, DOI 10.1152/ajpheart.01221.2006; Lagos D, 2010, NAT CELL BIOL, V12, P513, DOI 10.1038/ncb2054; Lee J, 2007, PLOS COMPUT BIOL, V3, P721, DOI 10.1371/journal.pcbi.0030067; Lin Y, 2009, J BIOL CHEM, V284, P7903, DOI 10.1074/jbc.M806920200; Littlewood TD, 2007, CIRC RES, V100, P302, DOI 10.1161/01.RES.0000259101.39931.d3; Liu XJ, 2011, J BIOL CHEM, V286, P42371, DOI 10.1074/jbc.M111.261065; Ma J, 2007, BLOOD, V109, P987, DOI 10.1182/blood-2006-07-036400; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Marchesi C, 2008, TRENDS PHARMACOL SCI, V29, P367, DOI 10.1016/j.tips.2008.05.003; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Mejlvang J, 2007, MOL BIOL CELL, V18, P4615, DOI 10.1091/mbc.E07-05-0406; NATARAJAN R, 1994, HYPERTENSION, V23, pI142, DOI 10.1161/01.HYP.23.1_Suppl.I142; Nemenoff RA, 2008, CIRC RES, V102, P1036, DOI 10.1161/CIRCRESAHA.107.169896; Panizzi JR, 2007, DEVELOPMENT, V134, P921, DOI 10.1242/dev.02776; Ramaswamy S, 1999, P NATL ACAD SCI USA, V96, P2110, DOI 10.1073/pnas.96.5.2110; Reddy MA, 2002, J BIOL CHEM, V277, P9920, DOI 10.1074/jbc.M111305200; Reusch JEB, 2011, ARTERIOSCL THROM VAS, V31, P1955, DOI 10.1161/ATVBAHA.111.232645; Sahar S, 2007, ARTERIOSCL THROM VAS, V27, P1528, DOI 10.1161/ATVBAHA.107.145862; Shaked I, 2009, IMMUNITY, V31, P965, DOI 10.1016/j.immuni.2009.09.019; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Strum JC, 2009, MOL ENDOCRINOL, V23, P1876, DOI 10.1210/me.2009-0117; Viedt C, 2002, ARTERIOSCL THROM VAS, V22, P914, DOI 10.1161/01.ATV.0000019009.73586.7F; Villeneuve LM, 2010, DIABETES, V59, P2904, DOI 10.2337/db10-0208; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Weng LH, 2010, J PATHOL, V222, P41, DOI 10.1002/path.2736; Yam PY, 2002, MOL THER, V5, P479, DOI 10.1006/mthe.2002.0558	57	71	75	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15672	15683		10.1074/jbc.M111.322669	http://dx.doi.org/10.1074/jbc.M111.322669			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22431733	Green Published, hybrid			2022-12-25	WOS:000304006300046
J	Zhang, YM; Shi, CY; Yu, JF; Ren, JJ; Sun, DC				Zhang, Yanmei; Shi, Chunyu; Yu, Jiafei; Ren, Jingjing; Sun, Dongchang			RpoS Regulates a Novel Type of Plasmid DNA Transfer in Escherichia coli	PLOS ONE			English	Article							GENERAL STRESS-RESPONSE; STREPTOCOCCUS-PNEUMONIAE; GENETIC-TRANSFORMATION; SIGMA(S)-DEPENDENT GENES; BACILLUS-SUBTILIS; COMPETENCE GENES; EXPRESSION; BACTERIA; RESISTANCE; PHEROMONE	Spontaneous plasmid transformation of Escherichia coli is independent of the DNA uptake machinery for single-stranded DNA (ssDNA) entry. The one-hit kinetic pattern of plasmid transformation indicates that double-stranded DNA (dsDNA) enters E. coli cells on agar plates. However, DNA uptake and transformation regulation remain unclear in this new type of plasmid transformation. In this study, we developed our previous plasmid transformation system and induced competence at early stationary phase. Despite of inoculum size, the development of competence was determined by optical cell density. DNase I interruption experiment showed that DNA was taken up exponentially within the initial 2 minutes and most transforming DNA entered E. coli cells within 10 minutes on LB-agar plates. A half-order kinetics between recipient cells and transformants was identified when cell density was high on plates. To determine whether the stationary phase master regulator RpoS plays roles in plasmid transformation, we investigated the effects of inactivating and over-expressing its encoding gene rpoS on plasmid transformation. The inactivation of rpoS systematically reduced transformation frequency, while over-expressing rpoS increased plasmid transformation. Normally, RpoS recognizes promoters by its lysine 173 (K173). We found that the K173E mutation caused RpoS unable to promote plasmid transformation, further confirming a role of RpoS in regulating plasmid transformation. In classical transformation, DNA was transferred across membranes by DNA uptake proteins and integrated by DNA processing proteins. At stationary growth phase, RpoS regulates some genes encoding membrane/periplasmic proteins and DNA processing proteins. We quantified transcription of 22 of them and found that transcription of only 4 genes (osmC, yqjC, ygiW and ugpC) encoding membrane/periplasmic proteins showed significant differential expression when wildtype RpoS and RpoS(K173E) mutant were expressed. Further investigation showed that inactivation of any one of these genes did not significantly reduce transformation, suggesting that RpoS may regulate plasmid transformation through other/multiple target genes.	[Zhang, Yanmei; Shi, Chunyu; Yu, Jiafei; Ren, Jingjing; Sun, Dongchang] Zhejiang Acad Agr Sci, State Key Lab Breeding Base Zhejiang Sustainable, Hangzhou, Zhejiang, Peoples R China; [Zhang, Yanmei; Shi, Chunyu; Yu, Jiafei; Ren, Jingjing; Sun, Dongchang] Zhejiang Acad Agr Sci, Inst Plant Protect & Micriobiol, Hangzhou, Zhejiang, Peoples R China; [Zhang, Yanmei] Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA	Zhejiang Academy of Agricultural Sciences; Zhejiang Academy of Agricultural Sciences; University of Virginia	Sun, DC (corresponding author), Zhejiang Acad Agr Sci, State Key Lab Breeding Base Zhejiang Sustainable, Hangzhou, Zhejiang, Peoples R China.	sundongchang@yahoo.com	sun, dongchang/X-1148-2019		Natural Science Foudation of China [31100071]; Natural Science Foundation of Zhejiang province [Y3110237]; Zhejiang Academy of Agricultural Sciences; Zhejiang Open Foundation of the Most Important Subjects	Natural Science Foudation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang province(Natural Science Foundation of Zhejiang Province); Zhejiang Academy of Agricultural Sciences; Zhejiang Open Foundation of the Most Important Subjects	This work is supported by the Natural Science Foudation of China (31100071), the Natural Science Foundation of Zhejiang province (Y3110237), the Doctor's Start-up Grant from Zhejiang Academy of Agricultural Sciences, the Foresight Program from Zhejiang Academy of Agricultural Sciences, and the Zhejiang Open Foundation of the Most Important Subjects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Battesti A, 2011, ANNU REV MICROBIOL, V65, P189, DOI 10.1146/annurev-micro-090110-102946; Becker G, 1999, P NATL ACAD SCI USA, V96, P6439, DOI 10.1073/pnas.96.11.6439; Becker G, 2001, MOL MICROBIOL, V39, P1153, DOI 10.1046/j.1365-2958.2001.02313.x; Chen I, 2004, NAT REV MICROBIOL, V2, P241, DOI 10.1038/nrmicro844; Claverys JP, 2006, ANNU REV MICROBIOL, V60, P451, DOI 10.1146/annurev.micro.60.080805.142139; Claverys JP, 2003, TRENDS MICROBIOL, V11, P161, DOI 10.1016/S0966-842X(03)00064-7; Dubey GP, 2011, CELL, V144, P590, DOI 10.1016/j.cell.2011.01.015; DUBNAU D, 1991, MICROBIOL REV, V55, P395, DOI 10.1128/MMBR.55.3.395-424.1991; Etchuuya R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016355; Finkel SE, 2001, J BACTERIOL, V183, P6288, DOI 10.1128/JB.183.21.6288-6293.2001; HAVARSTEIN LS, 1995, P NATL ACAD SCI USA, V92, P11140, DOI 10.1073/pnas.92.24.11140; Hengge R, 2009, RES MICROBIOL, V160, P667, DOI 10.1016/j.resmic.2009.08.014; Lacour S, 2004, J BACTERIOL, V186, P7186, DOI 10.1128/JB.186.21.7186-7195.2004; Maeda S, 2004, FEMS MICROBIOL LETT, V236, P61, DOI 10.1111/j.1574-6968.2004.tb09627.x; Meibom KL, 2005, SCIENCE, V310, P1824, DOI 10.1126/science.1120096; Mortier-Barriere I, 2007, CELL, V130, P824, DOI 10.1016/j.cell.2007.07.038; MULVEY MR, 1989, NUCLEIC ACIDS RES, V17, P9979, DOI 10.1093/nar/17.23.9979; Nikaido H, 2009, ANNU REV BIOCHEM, V78, P119, DOI 10.1146/annurev.biochem.78.082907.145923; Patten CL, 2004, MOL GENET GENOMICS, V272, P580, DOI 10.1007/s00438-004-1089-2; Pestova EV, 1996, MOL MICROBIOL, V21, P853, DOI 10.1046/j.1365-2958.1996.501417.x; Redfield RJ, 2005, J MOL BIOL, V347, P735, DOI 10.1016/j.jmb.2005.01.012; SAUNDERS CW, 1981, MOL GEN GENET, V181, P57, DOI 10.1007/BF00339005; Sauvonnet N, 2000, J BACTERIOL, V182, P848, DOI 10.1128/JB.182.3.848-854.2000; Sinha S, 2009, J BACTERIOL, V191, P5180, DOI 10.1128/JB.00476-09; Sledjeski DD, 1996, EMBO J, V15, P3993, DOI 10.1002/j.1460-2075.1996.tb00773.x; SMITH HO, 1981, ANNU REV BIOCHEM, V50, P41, DOI 10.1146/annurev.bi.50.070181.000353; Solomon JM, 1996, TRENDS GENET, V12, P150, DOI 10.1016/0168-9525(96)10014-7; Subbarayan PR, 2004, MOL GENET GENOMICS, V270, P533, DOI 10.1007/s00438-003-0944-x; Sun DC, 2006, FEMS MICROBIOL LETT, V265, P249, DOI 10.1111/j.1574-6968.2006.00503.x; Sun DC, 2009, J BACTERIOL, V191, P713, DOI 10.1128/JB.01130-08; Tsen SD, 2002, J BIOMED SCI, V9, P246, DOI 10.1159/000059425; Venturini C, 2010, FASEB J, V24, P1160, DOI 10.1096/fj.09-144972; Vijayakumar SRV, 2004, J BACTERIOL, V186, P8499, DOI 10.1128/JB.186.24.8499-8507.2004; Wang XJ, 2007, CURR MICROBIOL, V54, P450, DOI 10.1007/s00284-006-0617-1; Weber H, 2005, J BACTERIOL, V187, P1591, DOI 10.1128/JB.187.5.1591-1603.2005; Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09; Zhang YM, 2011, MOL BIOL REP, V38, P275, DOI 10.1007/s11033-010-0105-3	38	20	25	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33514	10.1371/journal.pone.0033514	http://dx.doi.org/10.1371/journal.pone.0033514			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438941	gold, Green Published, Green Submitted			2022-12-25	WOS:000303309100053
J	Scholl, D; Gebhart, D; Williams, SR; Bates, A; Mandrell, R				Scholl, Dean; Gebhart, Dana; Williams, Steven R.; Bates, Anna; Mandrell, Robert			Genome Sequence of E. coli O104:H4 Leads to Rapid Development of a Targeted Antimicrobial Agent against This Emerging Pathogen	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; R-TYPE PYOCINS; PSEUDOMONAS-AERUGINOSA; POLYSACCHARIDE; INFECTION; OUTBREAK; PROTEIN	A recent widespread outbreak of Escherichia coli O104:H4 in Germany demonstrates the dynamic nature of emerging and re-emerging food-borne pathogens, particularly STECs and related pathogenic E. coli. Rapid genome sequencing and public availability of these data from the German outbreak strain allowed us to identify an O-antigen-specific bacteriophage tail spike protein encoded in the genome. We synthesized this gene and fused it to the tail fiber gene of an R-type pyocin, a phage tail-like bacteriocin, and expressed the novel bacteriocin such that the tail fiber fusion was incorporated into the bacteriocin structure. The resulting particles have bactericidal activity specifically against E. coli strains that produce the O104 lipopolysaccharide antigen, including the outbreak strain. This O-antigen tailspike-R-type pyocin strategy provides a platform to respond rapidly to emerging pathogens upon the availability of the pathogen's genome sequence.	[Scholl, Dean; Gebhart, Dana; Williams, Steven R.] AvidBiotics Corp, San Francisco, CA USA; [Bates, Anna; Mandrell, Robert] ARS, Produce Safety & Microbiol Unit, Western Reg Res Ctr, USDA, Albany, CA USA	United States Department of Agriculture (USDA)	Scholl, D (corresponding author), AvidBiotics Corp, San Francisco, CA USA.	dean@avidbiotics.com	Mandrell, Robert E/O-9814-2018		National Research Initiative from U.S. Department of Agriculture (USDA) National Institute of Food and Agriculture [2006-55212-16927, 2007-35212-18239]; USDA Agricultural Research Service CRIS [5325-42000-044, 5325-42000-045]; National Institute of Allergy and Infectious Diseases / National Institutes of Health [1R43AI084295, R21AI085318]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI085318, R43AI084295] Funding Source: NIH RePORTER	National Research Initiative from U.S. Department of Agriculture (USDA) National Institute of Food and Agriculture; USDA Agricultural Research Service CRIS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); National Institute of Allergy and Infectious Diseases / National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was supported by National Research Initiative Competitive Grant Nos. 2006-55212-16927 and 2007-35212-18239 from the U.S. Department of Agriculture (USDA) National Institute of Food and Agriculture and USDA Agricultural Research Service CRIS projects 5325-42000-044 and -045 (RM), as well as National Institute of Allergy and Infectious Diseases / National Institutes of Health grants 1R43AI084295 and R21AI085318 (DS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker S, 2011, NATURE, V478, P287, DOI 10.1038/478287a; Barbirz S, 2008, MOL MICROBIOL, V69, P303, DOI 10.1111/j.1365-2958.2008.06311.x; Bielaszewska M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7; Brzuszkiewicz E, 2011, ARCH MICROBIOL, V193, P883, DOI 10.1007/s00203-011-0725-6; Buchholz U, 2011, NEW ENGL J MED, V365, P1763, DOI 10.1056/NEJMoa1106482; DUTTON GGS, 1987, CARBOHYD RES, V170, P193, DOI 10.1016/S0008-6215(00)90904-2; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; GAMIAN A, 1992, CARBOHYD RES, V236, P195, DOI 10.1016/0008-6215(92)85016-S; HAAS H, 1974, J INFECT DIS, V129, P470, DOI 10.1093/infdis/129.4.470; Ho TD, 2007, INFECT IMMUN, V75, P1661, DOI 10.1128/IAI.01342-06; Hunt JM, 2010, CLIN LAB MED, V30, P21, DOI 10.1016/j.cll.2009.11.001; KAGEYAMA M, 1964, J BIOCHEM, V55, P59, DOI 10.1093/oxfordjournals.jbchem.a127841; MANDRELL RE, 1991, J BACTERIOL, V173, P2823, DOI 10.1128/JB.173.9.2823-2832.1991; Mead PS, 1998, LANCET, V352, P1207, DOI 10.1016/S0140-6736(98)01267-7; MERRIKIN DJ, 1972, APPL MICROBIOL, V23, P164, DOI 10.1128/AEM.23.1.164-165.1972; Michel-Briand Y, 2002, BIOCHIMIE, V84, P499, DOI 10.1016/S0300-9084(02)01422-0; Newton GJ, 2001, MOL MICROBIOL, V39, P1237, DOI 10.1046/j.1365-2958.2001.02311.x; Pennington H, 2010, LANCET, V376, P1428, DOI 10.1016/S0140-6736(10)60963-4; Perry LL, 2009, FEMS MICROBIOL LETT, V292, P182, DOI 10.1111/j.1574-6968.2009.01511.x; Peschel A, 2002, TRENDS MICROBIOL, V10, P179, DOI 10.1016/S0966-842X(02)02333-8; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; Ritchie JM, 2011, ANTIMICROB AGENTS CH, V55, P5469, DOI 10.1128/AAC.05031-11; Rohde H, 2011, NEW ENGL J MED, V365, P718, DOI 10.1056/NEJMoa1107643; Scholl D, 2008, ANTIMICROB AGENTS CH, V52, P1647, DOI 10.1128/AAC.01479-07; Scholl D, 2009, ANTIMICROB AGENTS CH, V53, P3074, DOI 10.1128/AAC.01660-08; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; U.S. Department of Agriculture F.S. and I.S. (USDA-FSIS), 2011, FED REGISTER, V76, P58157; URATANI Y, 1984, J BACTERIOL, V157, P632, DOI 10.1128/JB.157.2.632-636.1984; VERMA NK, 1991, MOL MICROBIOL, V5, P71, DOI 10.1111/j.1365-2958.1991.tb01827.x; Villafane R, 2005, ARCH VIROL, V150, P2609, DOI 10.1007/s00705-005-0597-7; Williams SR, 2008, APPL ENVIRON MICROB, V74, P3868, DOI 10.1128/AEM.00141-08	31	32	34	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e33637	10.1371/journal.pone.0033637	http://dx.doi.org/10.1371/journal.pone.0033637			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22432037	gold, Green Published, Green Submitted			2022-12-25	WOS:000303198600080
J	Cline, SD; Saleem, S; Daines, DA				Cline, Susan D.; Saleem, Sehresh; Daines, Dayle A.			Regulation of the vapBC-1 Toxin-Antitoxin Locus in Nontypeable Haemophilus influenzae	PLOS ONE			English	Article							PIN-DOMAIN; FIS; BINDING; INITIATION; PROTEINS	Nontypeable Haemophilus influenzae (NTHi) are human-adapted commensal bacteria that can cause a number of chronic mucosal infections, including otitis media and bronchitis. One way for these organisms to survive antibiotic therapy and cause recurrent disease is to stop replicating, as most antimicrobials target essential biosynthetic pathways. Toxin-antitoxin (TA) gene pairs have been shown to facilitate entry into a reversible bacteriostatic state. Characteristically, these operons encode a protein toxin and an antitoxin that associate following translation to form a nontoxic complex, which then binds to and regulates the cognate TA promoter. Under stressful conditions, the labile antitoxin is degraded and the complex disintegrates, freeing the stable toxin to facilitate growth arrest. How these events affected the regulation of the TA locus, as well as how the transcription of the operon was subsequently returned to its normal state upon resumption of growth, was not fully understood. Here we show that expression of the NTHi vapBC-1 TA locus is repressed by a complex of VapB-1 and VapC-1 under conditions favorable for growth, and activated by the global transactivator Factor for Inversion Stimulation (Fis) upon nutrient upshift from stationary phase. Further, we demonstrate for the first time that the VapC-1 toxin alone can bind to its cognate TA locus control region and that the presence of VapB-1 directs the binding of the VapBC-1 complex in the transcriptional regulation of vapBC-1.	[Cline, Susan D.; Saleem, Sehresh; Daines, Dayle A.] Mercer Univ, Sch Med, Div Basic Med Sci, Macon, GA 31207 USA	Mercer University	Cline, SD (corresponding author), Mercer Univ, Sch Med, Div Basic Med Sci, Macon, GA 31207 USA.	daines_da@mercer.edu	Daines, Dayle A./J-4393-2019		National Institutes of Health from the National Institute on Deafness and Other Communication Disorders [DC010187]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010187] Funding Source: NIH RePORTER	National Institutes of Health from the National Institute on Deafness and Other Communication Disorders; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was supported by National Institutes of Health grant DC010187 from the National Institute on Deafness and Other Communication Disorders to DAD. Website: www.nidcd.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahidjo BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021738; Arcus VL, 2011, PROTEIN ENG DES SEL, V24, P33, DOI 10.1093/protein/gzq081; Bailey SES, 2009, J BACTERIOL, V191, P762, DOI 10.1128/JB.01331-08; BALL CA, 1992, J BACTERIOL, V174, P8043, DOI 10.1128/JB.174.24.8043-8056.1992; Buts L, 2005, TRENDS BIOCHEM SCI, V30, P672, DOI 10.1016/j.tibs.2005.10.004; CASADABAN MJ, 1980, J BACTERIOL, V143, P971, DOI 10.1128/JB.143.2.971-980.1980; Daines DA, 2001, GENE, V281, P95, DOI 10.1016/S0378-1119(01)00788-0; Daines DA, 2007, J BACTERIOL, V189, P5041, DOI 10.1128/JB.00290-07; Fatica A, 2004, RNA, V10, P1698, DOI 10.1261/rna.7123504; Feldman-Cohen LS, 2006, J BACTERIOL, V188, P2081, DOI 10.1128/JB.188.6.2081-2095.2006; Grainger DC, 2006, NUCLEIC ACIDS RES, V34, P4642, DOI 10.1093/nar/gkl542; Gronlund H, 1999, J MOL BIOL, V285, P1401, DOI 10.1006/jmbi.1998.2416; Hengen PN, 1997, NUCLEIC ACIDS RES, V25, P4994, DOI 10.1093/nar/25.24.4994; Hirsch M, 2005, J BACTERIOL, V187, P1568, DOI 10.1128/JB.187.5.1568-1580.2005; KOSTREWA D, 1992, J MOL BIOL, V226, P209, DOI 10.1016/0022-2836(92)90134-6; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Mason KM, 2003, INFECT IMMUN, V71, P3454, DOI 10.1128/IAI.71.6.3454-3462.2003; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; Miallau L, 2009, J BIOL CHEM, V284, P276, DOI 10.1074/jbc.M805061200; Murphy TF, 2004, AM J RESP CRIT CARE, V170, P266, DOI 10.1164/rccm.200403-354OC; MURPHY TF, 1987, REV INFECT DIS, V9, P1; Opel ML, 2004, MOL MICROBIOL, V53, P665, DOI 10.1111/j.1365-2958.2004.04147.x; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Ramage HR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000767; Robson J, 2009, J MOL BIOL; Schneider R, 2001, NUCLEIC ACIDS RES, V29, P5107, DOI 10.1093/nar/29.24.5107; Shao YP, 2008, J MOL BIOL, V376, P771, DOI 10.1016/j.jmb.2007.11.101; Skoko D, 2006, J MOL BIOL, V364, P777, DOI 10.1016/j.jmb.2006.09.043; Winther KS, 2009, MOL MICROBIOL, V72, P918, DOI 10.1111/j.1365-2958.2009.06694.x; Yang M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010672; Zhu L, 2010, J BIOL CHEM, V285, P39732, DOI 10.1074/jbc.M110.163105	33	14	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2012	7	3							e32199	10.1371/journal.pone.0032199	http://dx.doi.org/10.1371/journal.pone.0032199			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930IA	22427824	Green Published, Green Submitted, gold			2022-12-25	WOS:000303129700008
J	Wang, JM; Hou, X; Adeosun, S; Hill, R; Henry, S; Paul, I; Irwin, RW; Ou, XM; Bigler, S; Stockmeier, C; Brinton, RD; Gomez-Sanchez, E				Wang, Jun Ming; Hou, Xu; Adeosun, Samuel; Hill, Rosanne; Henry, Sherry; Paul, Ian; Irwin, Ronald W.; Ou, Xiao-Ming; Bigler, Steven; Stockmeier, Craig; Brinton, Roberta Diaz; Gomez-Sanchez, Elise			A Dominant Negative ER beta Splice Variant Determines the Effectiveness of Early or Late Estrogen Therapy after Ovariectomy in Rats	PLOS ONE			English	Article							POSTMENOPAUSAL HORMONE-THERAPY; PROGENITOR-CELL PROLIFERATION; ADULT FEMALE RAT; RECEPTOR-BETA; DECREASE ANXIETY; DENTATE GYRUS; IN-VIVO; ESTRADIOL; EXPRESSION; ISOFORM	The molecular mechanisms for the discrepancy in outcome of initiating estrogen therapy (ET) around peri-menopause or several years after menopause in women are unknown. We hypothesize that the level of expression of a dominant negative estrogen receptor (ER) beta variant, ER beta 2, may be a key factor determining the effectiveness of ET in post-menopausal women. We tested this hypothesis in ovariectomized nine month-old (an age when irregular estrous cycles occur) female Sprague Dawley rats. Estradiol treatment was initiated either 6 days (Early ET, analogous to 4 months post-menopause in humans), or 180 days (Late ET, analogous to 11 years post-menopause in humans) after ovariectomy. Although ER beta 2 expression increased in all OVX rats, neurogenic and neuroprotective responses to estradiol differed in Early and Late ET. Early ET reduced ER beta 2 expression in both hippocampus and white blood cells, increased the hippocampal cell proliferation as assessed by Ki-67 expression, and improved mobility in the forced swim test. Late ET resulted in either no or modest effects on these parameters. There was a close correlation between the degree of ER beta 2 expression and the preservation of neural effects by ET after OVX in rats, supporting the hypothesis that persistent elevated levels of ER beta 2 are a molecular basis for the diminished effectiveness of ET in late post-menopausal women. The correlation between the expression of ER beta 2 in circulating white blood cells and brain cells suggests that ER beta 2 expression in peripheral blood cells may be an easily accessible marker to predict the effective window for ET in the brain.	[Wang, Jun Ming; Hill, Rosanne; Henry, Sherry; Bigler, Steven] Univ Mississippi, Med Ctr, Dept Pathol, Jackson, MS 39216 USA; [Wang, Jun Ming; Paul, Ian; Ou, Xiao-Ming; Stockmeier, Craig] Univ Mississippi, Med Ctr, Dept Psychiat & Human Behav, Jackson, MS 39216 USA; [Wang, Jun Ming; Hou, Xu; Adeosun, Samuel] Univ Mississippi, Med Ctr, Program Neurosci, Jackson, MS 39216 USA; [Wang, Jun Ming] Univ Mississippi, Med Ctr, Dept Pharmacol & Toxicol, Jackson, MS 39216 USA; [Gomez-Sanchez, Elise] Univ Mississippi, Med Ctr, GV Sonny Montgomery VA Med Ctr, Jackson, MS 39216 USA; [Gomez-Sanchez, Elise] Univ Mississippi, Med Ctr, Dept Med, Jackson, MS 39216 USA; [Irwin, Ronald W.; Brinton, Roberta Diaz] Univ So Calif, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA USA	University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; University of Southern California	Wang, JM (corresponding author), Univ Mississippi, Med Ctr, Dept Pathol, Jackson, MS 39216 USA.	Jwang@umc.edu	Irwin, Ronald W./N-8686-2013	Irwin, Ronald W./0000-0002-6969-6021; Brinton, Roberta/0000-0001-8450-772X	Alzheimer's Association [133086]; National Center for Research Resources (NCRR) a component of NIH [RR17701]; University Mississippi Medical Center; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017701] Funding Source: NIH RePORTER	Alzheimer's Association(Alzheimer's Association); National Center for Research Resources (NCRR) a component of NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); University Mississippi Medical Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by an Alzheimer's Association Investigator Initiated Research Grant (133086), a training grant from a center grant from the National Center for Research Resources (NCRR, RR17701), a component of NIH, and an Intramural Research Support Program grant from University Mississippi Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai YL, 2003, MOL ENDOCRINOL, V17, P589, DOI 10.1210/me.2002-0351; Banasr Mounira, 2007, CNS & Neurological Disorders-Drug Targets, V6, P311, DOI 10.2174/187152707783220929; Bilsland JG, 2006, J NEUROSCI METH, V157, P54, DOI 10.1016/j.jneumeth.2006.03.026; Brinton RD, 2004, CNS DRUGS, V18, P405, DOI 10.2165/00023210-200418070-00001; Brinton RD, 2009, TRENDS PHARMACOL SCI, V30, P212, DOI 10.1016/j.tips.2008.12.006; Chakraborty TR, 2004, EXP BIOL MED, V229, P977, DOI 10.1177/153537020422901001; Chu S, 1997, MOL CELL ENDOCRINOL, V132, P195, DOI 10.1016/S0303-7207(97)00133-0; Chung WCJ, 2007, J COMP NEUROL, V505, P249, DOI 10.1002/cne.21490; Duman RS, 2004, BIOL PSYCHIAT, V56, P140, DOI 10.1016/j.biopsych.2004.02.033; Fan XT, 2007, P NATL ACAD SCI USA, V104, P13696, DOI 10.1073/pnas.0705936104; Fan XT, 2006, P NATL ACAD SCI USA, V103, P19338, DOI 10.1073/pnas.0609663103; Gass P, 2007, BIOESSAYS, V29, P957, DOI 10.1002/bies.20658; Gibbs RB, 2000, NEUROBIOL AGING, V21, P107, DOI 10.1016/S0197-4580(00)00103-2; Gore AC, 2006, HDB MODELS HUMAN AGI, P533; Hanstein B, 1999, MOL ENDOCRINOL, V13, P129, DOI 10.1210/me.13.1.129; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; Henry S, 2009, BIOSCI TRENDS, V3, P233; Holmes DJ, 2003, EXP GERONTOL, V38, P751, DOI 10.1016/S0531-5565(03)00103-7; Huang J, 2005, MOL ENDOCRINOL, V19, P2696, DOI 10.1210/me.2005-0120; Ishunina TA, 2010, NEUROBIOL AGING; Jezierski MK, 2003, ENDOCRINOLOGY, V144, P5022, DOI 10.1210/en.2003-0724; Liu F, 2008, NAT NEUROSCI, V11, P334, DOI 10.1038/nn2057; Liu R, 2010, J PHARMACOL EXP THER, V332, P1006, DOI 10.1124/jpet.109.160937; Lu B, 1998, MOL CELL ENDOCRINOL, V138, P199, DOI 10.1016/S0303-7207(98)00050-1; Lu B, 2000, J MOL ENDOCRINOL, V25, P229, DOI 10.1677/jme.0.0250229; Lund TD, 2005, ENDOCRINOLOGY, V146, P797, DOI 10.1210/en.2004-1158; Malberg JE, 2003, NEUROPSYCHOPHARMACOL, V28, P1562, DOI 10.1038/sj.npp.1300234; Maruyama K, 1998, BIOCHEM BIOPH RES CO, V246, P142, DOI 10.1006/bbrc.1998.8590; Moore JT, 1998, BIOCHEM BIOPH RES CO, V247, P75, DOI 10.1006/bbrc.1998.8738; Morrison JH, 2011, P NATL ACAD SCI USA, V108, P14375, DOI 10.1073/pnas.1111672108; Nilsen J, 2007, J NEUROSCI, V27, P14069, DOI 10.1523/JNEUROSCI.4391-07.2007; Nordell VL, 2003, NEUROBIOL AGING, V24, P733, DOI 10.1016/S0197-4580(02)00193-8; Ogawa S, 1998, NUCLEIC ACIDS RES, V26, P3505, DOI 10.1093/nar/26.15.3505; Omoto Y, 2003, ONCOGENE, V22, P5011, DOI 10.1038/sj.onc.1206787; Petersen DN, 1998, ENDOCRINOLOGY, V139, P1082, DOI 10.1210/en.139.3.1082; Powell E, 2008, P NATL ACAD SCI USA, V105, P19012, DOI 10.1073/pnas.0807274105; Rocca WA, 2011, BRAIN RES, V1379, P188, DOI 10.1016/j.brainres.2010.10.031; Rossouw JE, 2008, CLIN PHARMACOL THER, V83, P14, DOI 10.1038/sj.clpt.6100428; Rossouw JE, 2007, JAMA-J AM MED ASSOC, V297, P1465, DOI 10.1001/jama.297.13.1465; Rubin BS, 2000, BIOL REPROD, V63, P968, DOI 10.1095/biolreprod63.4.968; Saunders PTK, 2002, J CLIN ENDOCR METAB, V87, P2706, DOI 10.1210/jc.87.6.2706; Secreto FJ, 2007, J CELL BIOCHEM, V101, P1125, DOI 10.1002/jcb.21205; Selvamani A, 2010, J NEUROSCI, V30, P6852, DOI 10.1523/JNEUROSCI.0761-10.2010; Selvamani A, 2010, NEUROBIOL AGING, V31, P1618, DOI 10.1016/j.neurobiolaging.2008.08.014; Simpkins James W, 2009, Ther Adv Neurol Disord, V2, P31, DOI 10.1177/1756285608100427; Singh M, 2006, EXP BIOL MED, V231, P514; Tamrazi A, 2002, MOL ENDOCRINOL, V16, P2706, DOI 10.1210/me.2002-0250; Tanapat P, 1999, J NEUROSCI, V19, P5792, DOI 10.1523/JNEUROSCI.19-14-05792.1999; Tanapat P, 2005, J COMP NEUROL, V481, P252, DOI 10.1002/cne.20385; Tena-Sempere M, 2004, BIOL REPROD, V70, P671, DOI 10.1095/biolreprod.103.021378; Walf AA, 2004, PHARMACOL BIOCHEM BE, V78, P523, DOI 10.1016/j.pbb.2004.03.023; Walf AA, 2008, BEHAV NEUROSCI, V122, P974, DOI 10.1037/a0012749; Walf AA, 2008, NEUROBIOL LEARN MEM, V89, P513, DOI 10.1016/j.nlm.2008.01.008; Walf AA, 2007, PHARMACOL BIOCHEM BE, V86, P407, DOI 10.1016/j.pbb.2006.07.003; Wang JM, 2008, ENDOCRINOLOGY, V149, P208, DOI 10.1210/en.2007-1155; WEBSTER GA, 1993, J IMMUNOL METHODS, V163, P115, DOI 10.1016/0022-1759(93)90245-3; Weiser MJ, 2007, BRAIN RES REV; Wurtz JM, 1996, NAT STRUCT BIOL, V3, P206; Yaffe K, 1998, JAMA-J AM MED ASSOC, V279, P688, DOI 10.1001/jama.279.9.688; Zhang QG, 2011, P NATL ACAD SCI USA, V108, pE617, DOI 10.1073/pnas.1104391108; Zhao CY, 2007, CANCER RES, V67, P3955, DOI 10.1158/0008-5472.CAN-06-3505	61	27	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2012	7	3							e33493	10.1371/journal.pone.0033493	http://dx.doi.org/10.1371/journal.pone.0033493			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930IA	22428062	Green Published, gold			2022-12-25	WOS:000303129700068
J	Koes, D; Khoury, K; Huang, YJ; Wang, W; Bista, M; Popowicz, GM; Wolf, S; Holak, TA; Domling, A; Camacho, CJ				Koes, David; Khoury, Kareem; Huang, Yijun; Wang, Wei; Bista, Michal; Popowicz, Grzegorz M.; Wolf, Siglinde; Holak, Tad A.; Doemling, Alexander; Camacho, Carlos J.			Enabling Large-Scale Design, Synthesis and Validation of Small Molecule Protein-Protein Antagonists	PLOS ONE			English	Article							P53; INHIBITORS; DISCOVERY; MDM2; APOPTOSIS; DATABASE; TARGETS; ANCHOR; POTENT	Although there is no shortage of potential drug targets, there are only a handful known low-molecular-weight inhibitors of protein-protein interactions (PPIs). One problem is that current efforts are dominated by low-yield high-throughput screening, whose rigid framework is not suitable for the diverse chemotypes present in PPIs. Here, we developed a novel pharmacophore-based interactive screening technology that builds on the role anchor residues, or deeply buried hot spots, have in PPIs, and redesigns these entry points with anchor-biased virtual multicomponent reactions, delivering tens of millions of readily synthesizable novel compounds. Application of this approach to the MDM2/p53 cancer target led to high hit rates, resulting in a large and diverse set of confirmed inhibitors, and co-crystal structures validate the designed compounds. Our unique open-access technology promises to expand chemical space and the exploration of the human interactome by leveraging in-house small-scale assays and user-friendly chemistry to rationally design ligands for PPIs with known structure.	[Koes, David; Doemling, Alexander; Camacho, Carlos J.] Univ Pittsburgh, Dept Computat & Syst Biol, Pittsburgh, PA 15260 USA; [Khoury, Kareem; Huang, Yijun; Wang, Wei; Doemling, Alexander] Univ Pittsburgh, Sch Pharm, Pittsburgh, PA USA; [Bista, Michal; Popowicz, Grzegorz M.; Wolf, Siglinde; Holak, Tad A.] Max Planck Inst Biochem, D-82152 Martinsried, Germany	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Max Planck Society	Koes, D (corresponding author), Univ Pittsburgh, Dept Computat & Syst Biol, Pittsburgh, PA 15260 USA.	ccamacho@pitt.edu	Dömling, Alexander S.S./E-6324-2019; Popowicz, Grzegorz/G-4769-2017; Koes, David Ryan/M-4523-2018; wang, wei/A-9885-2010	Popowicz, Grzegorz/0000-0003-2818-7498; Koes, David Ryan/0000-0002-6892-6614; wang, wei/0000-0001-9208-7569; Domling, Alexander/0000-0002-9923-8873; Bista, Michal/0000-0001-9237-1199; Bista, Michal/0000-0002-0411-2275	National Institutes of Health [1R21GM087617-01A1, 1R01GM097082-01, 1P41GM094055-01]; Deutsche Krebshilfe [108354]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097082, P41GM094055, R21GM087617] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Krebshilfe(Deutsche Krebshilfe); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (1R21GM087617-01A1 and 1R01GM097082-01 to CJC and AD and 1P41GM094055-01 to AD) and Deutsche Krebshilfe (108354 to TAH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bleicher KH, 2003, NAT REV DRUG DISCOV, V2, P369, DOI 10.1038/nrd1086; CZARNA A, 2010, ANGEW CHEM, V122, P5480, DOI DOI 10.1002/ANGE.201001343; Czarna A, 2009, CELL CYCLE, V8, P1176, DOI 10.4161/cc.8.8.8185; Domling A, 2008, CURR OPIN CHEM BIOL, V12, P281, DOI 10.1016/j.cbpa.2008.04.603; Domling E, 2010, SYNTHESIS-STUTTGART, P2859, DOI 10.1055/s-0030-1257906; DOMLING A, 2010, SYNTHESIS-STUTTGART, P2883; Edwards AM, 2011, NATURE, V470, P163, DOI 10.1038/470163a; Fedorov O, 2010, NAT CHEM BIOL, V6, P166, DOI 10.1038/nchembio.297; Fesik SW, 2005, NAT REV CANCER, V5, P876, DOI 10.1038/nrc1736; Grasberger BL, 2005, J MED CHEM, V48, P909, DOI 10.1021/jm049137g; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Jacoby E, 2009, METHODS MOL BIOL, V575, P173, DOI 10.1007/978-1-60761-274-2_7; Kimura SR, 2001, BIOPHYS J, V80, P635, DOI 10.1016/S0006-3495(01)76044-4; Koes DR, 2011, J CHEM INF MODEL, V51, P1307, DOI 10.1021/ci200097m; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Leach AR, 2010, J MED CHEM, V53, P539, DOI 10.1021/jm900817u; Liddle J, 2008, BIOORG MED CHEM LETT, V18, P90, DOI 10.1016/j.bmcl.2007.11.008; Ma B, 2007, CURR TOP MED CHEM, V7, P999, DOI 10.2174/156802607780906717; Maass P, 2007, J CHEM INF MODEL, V47, P390, DOI 10.1021/ci060094h; Macarron R, 2006, DRUG DISCOV TODAY, V11, P277, DOI 10.1016/j.drudis.2006.02.001; Meireles LMC, 2010, NUCLEIC ACIDS RES, V38, pW407, DOI 10.1093/nar/gkq502; Moitessier N, 2008, BRIT J PHARMACOL, V153, pS7, DOI 10.1038/sj.bjp.0707515; Pagliaro L, 2004, CURR OPIN CHEM BIOL, V8, P442, DOI 10.1016/j.cbpa.2004.06.006; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Popowicz GM, 2008, CELL CYCLE, V7, P2441, DOI 10.4161/cc.6365; Popowicz GM, 2010, CELL CYCLE, V9, P1104, DOI 10.4161/cc.9.6.10956; Pritchard JF, 2003, NAT REV DRUG DISCOV, V2, P542, DOI 10.1038/nrd1131; Rajamani D, 2004, P NATL ACAD SCI USA, V101, P11287, DOI 10.1073/pnas.0401942101; Reynes C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000695; Rothweiler U, 2008, CHEMMEDCHEM, V3, P1118, DOI 10.1002/cmdc.200800025; SHERIDAN RP, 1989, P NATL ACAD SCI USA, V86, P8165, DOI 10.1073/pnas.86.20.8165; Shoichet BK, 2004, NATURE, V432, P862, DOI 10.1038/nature03197; Spencer RW, 1998, BIOTECHNOL BIOENG, V61, P61, DOI 10.1002/(SICI)1097-0290(199824)61:1<61::AID-BIT11>3.0.CO;2-C; Sperandio O, 2010, DRUG DISCOV TODAY, V15, P220, DOI 10.1016/j.drudis.2009.11.007; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Wang XQ, 2005, SCIENCE, V310, P1159, DOI 10.1126/science.1117893; Warren GL, 2006, J MED CHEM, V49, P5912, DOI 10.1021/jm050362n; Weber L, 1999, SYNLETT, P366, DOI 10.1055/s-1999-2612; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Willett P, 2006, DRUG DISCOV TODAY, V11, P1046, DOI 10.1016/j.drudis.2006.10.005; Zobel K, 2006, ACS CHEM BIOL, V1, P525, DOI 10.1021/cb600276q; Zwick MB, 2004, NAT MED, V10, P133, DOI 10.1038/nm0204-133	44	74	76	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e32839	10.1371/journal.pone.0032839	http://dx.doi.org/10.1371/journal.pone.0032839			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427896	Green Published, Green Submitted, gold			2022-12-25	WOS:000302381500056
J	Li, JJ; Zhu, WY; Wang, HQ; Li, JD; Zhang, QF; He, Y; Li, J; Fu, JJ; Li, DX; Liang, GD				Li, Jiangjiao; Zhu, Wuyang; Wang, Huanqin; Li, Jiandong; Zhang, Quanfu; He, Ying; Li, Jia; Fu, Juanjuan; Li, Dexin; Liang, Guodong			Rapid, Specific Detection of Alphaviruses from Tissue Cultures Using a Replicon-Defective Reporter Gene Assay	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; EQUINE ENCEPHALITIS-VIRUS; DEPENDENT RNA-POLYMERASE; CELL-LINE; SINDBIS-VIRUS; CLINICAL SPECIMENS; REPLICATION; CHIKUNGUNYA; INFECTION; SEQUENCE	We established a rapid, specific technique for detecting alphaviruses using a replicon-defective reporter gene assay derived from the Sindbis virus XJ-160. The pVaXJ expression vector containing the XJ-160 genome was engineered to form the expression vectors pVaXJ-EGFP expressing enhanced green fluorescence protein (EGFP) or pVaXJ-GLuc expressing Gaussia luciferase (GLuc). The replicon-defective reporter plasmids pVaXJ-EGFP Delta nsp4 and pVaXJ-GLuc Delta nsp4 were constructed by deleting 1139 bp in the non-structural protein 4 (nsP4) gene. The deletion in the nsP4 gene prevented the defective replicons from replicating and expressing reporter genes in transfected BHK-21 cells. However, when these transfected cells were infected with an alphavirus, the non-structural proteins expressed by the alphavirus could act on the defective replicons in trans and induce the expression of the reporter genes. The replicon-defective plasmids were used to visualize the presence of alphavirus qualitatively or detect it quantitatively. Specificity tests showed that this assay could detect a variety of alphaviruses from tissue cultures, while other RNA viruses, such as Japanese encephalitis virus and Tahyna virus, gave negative results with this system. Sensitivity tests showed that the limit of detection (LOD) of this replicon-defective assay is between 1 and 10 PFU for Sindbis viruses. These results indicate that, with the help of the replicon-defective alphavirus detection technique, we can specifically, sensitively, and rapidly detect alphaviruses in tissue cultures. The detection technique constructed here may be well suited for use in clinical examination and epidemiological surveillance, as well as for rapid screening of potential viral biological warfare agents.	[Li, Jiangjiao; Zhu, Wuyang; Wang, Huanqin; He, Ying; Li, Jia; Fu, Juanjuan; Liang, Guodong] China CDC, IVDC, Chinese Ctr Dis Control & Prevent, Dept Viral Encephalitis,Inst Viral Dis Control &, Beijing, Peoples R China; [Li, Jiandong; Zhang, Quanfu; Li, Dexin] China CDC, IVDC, Dept Viral Hemorrhag Fever, State Key Lab Infect Dis Prevent & Control SKLID, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention	Li, JJ (corresponding author), China CDC, IVDC, Chinese Ctr Dis Control & Prevent, Dept Viral Encephalitis,Inst Viral Dis Control &, Beijing, Peoples R China.	gdliang@hotmail.com			National Natural Science Foundation of China [30970160, 81160353]; Major Science and Technology Project for Infectious Disease [2008ZX10004-001, 2009ZX10004-705]; State Key Laboratory for Infectious Disease Prevention and Control [2011SKLID205]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Science and Technology Project for Infectious Disease; State Key Laboratory for Infectious Disease Prevention and Control	This work was supported by the grants from the National Natural Science Foundation of China (No. 30970160; 81160353), the Major Science and Technology Project for Infectious Disease (No. 2008ZX10004-001; 2009ZX10004-705), the Development Grant of State Key Laboratory for Infectious Disease Prevention and Control (2011SKLID205). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Delfraro A, 2011, EMERG INFECT DIS, V17, P952, DOI 10.3201/eid1705.101068; FELBER BK, 1988, SCIENCE, V239, P184, DOI 10.1126/science.3422113; Gould EA, 2010, ANTIVIR RES, V87, P111, DOI 10.1016/j.antiviral.2009.07.007; Grywna K, 2010, J CLIN MICROBIOL, V48, P3386, DOI 10.1128/JCM.00317-10; Hossain MJ, 2010, J CLIN MICROBIOL, V48, P2515, DOI 10.1128/JCM.02286-09; Kaariainen L, 2002, PROG NUCLEIC ACID RE, V71, P187, DOI 10.1016/S0079-6603(02)71044-1; KAARIAINEN L, 1987, J CELL SCI, P231; Kaur P, 2008, EMERG INFECT DIS, V14, P1623, DOI 10.3201/eid1410.070569; KIMPTON J, 1992, J VIROL, V66, P2232, DOI 10.1128/JVI.66.4.2232-2239.1992; Kung SH, 2000, J VIROL METHODS, V90, P205, DOI 10.1016/S0166-0934(00)00234-2; Laine M, 2004, J INTERN MED, V256, P457, DOI 10.1111/j.1365-2796.2004.01413.x; Liang GD, 2000, J GEN VIROL, V81, P1347, DOI 10.1099/0022-1317-81-5-1347; Lutz A, 2005, J VIROL METHODS, V126, P13, DOI 10.1016/j.jviromet.2005.01.016; OLIVO PD, 1994, VIROLOGY, V198, P381, DOI 10.1006/viro.1994.1046; OLIVO PD, 1994, J VIROL METHODS, V47, P117, DOI 10.1016/0166-0934(94)90071-X; Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X; Roques P, 2011, J INFECT DIS, V203, P141, DOI 10.1093/infdis/jiq026; Rubach JK, 2009, VIROLOGY, V384, P201, DOI 10.1016/j.virol.2008.10.030; Schmaljohn AM, 1996, ALPHAVIRUSES TOGAVIR; Schmitt SM, 2007, J WILDLIFE DIS, V43, P635, DOI 10.7589/0090-3558-43.4.635; Simon Fabrice, 2011, Curr Infect Dis Rep, V13, P218, DOI 10.1007/s11908-011-0180-1; Smith DR, 2007, AM J TROP MED HYG, V77, P176, DOI 10.4269/ajtmh.2007.77.176; Solignat M, 2009, VIROLOGY, V393, P183, DOI 10.1016/j.virol.2009.07.024; STABELL EC, 1993, J CLIN MICROBIOL, V31, P2796, DOI 10.1128/JCM.31.10.2796-2798.1993; STABELL EC, 1992, J VIROL METHODS, V38, P195, DOI 10.1016/0166-0934(92)90110-Y; STRAUSS EG, 1988, VIROLOGY, V164, P265, DOI 10.1016/0042-6822(88)90644-7; Thal MA, 2007, VIROLOGY, V358, P221, DOI 10.1016/j.virol.2006.08.022; Toivanen A, 2008, CURR OPIN RHEUMATOL, V20, P486, DOI 10.1097/BOR.0b013e328303220b; Tomar S, 2006, J VIROL, V80, P9962, DOI 10.1128/JVI.01067-06; Tzeng WP, 2005, J CLIN MICROBIOL, V43, P879, DOI 10.1128/JCM.43.2.879-885.2005; Zacks MA, 2010, VET MICROBIOL, V140, P281, DOI 10.1016/j.vetmic.2009.08.023; Zhai YG, 2008, J GEN VIROL, V89, P1446, DOI 10.1099/vir.0.83607-0; Zhu WY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009656	33	3	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33007	10.1371/journal.pone.0033007	http://dx.doi.org/10.1371/journal.pone.0033007			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427930	gold, Green Submitted, Green Published			2022-12-25	WOS:000302381500075
J	Rao, S; Sengupta, R; Choe, EJ; Woerner, BM; Jackson, E; Sun, T; Leonard, J; Piwnica-Worms, D; Rubin, JB				Rao, Shyam; Sengupta, Rajarshi; Choe, Eun Joo; Woerner, B. Mark; Jackson, Erin; Sun, Tao; Leonard, Jeffrey; Piwnica-Worms, David; Rubin, Joshua B.			CXCL12 Mediates Trophic Interactions between Endothelial and Tumor Cells in Glioblastoma	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CXCR4; CANCER STEM-CELLS; CYCLIC-AMP SUPPRESSION; EXTRACELLULAR-MATRIX; PROGENITOR CELLS; CROSS-TALK; EXPRESSION; PROLIFERATION; ANGIOGENESIS; INHIBITION	Emerging evidence suggests endothelial cells (EC) play a critical role in promoting Glioblastoma multiforme (GBM) cell proliferation and resistance to therapy. The molecular basis for GBM-EC interactions is incompletely understood. We hypothesized that the chemokine CXCL12 and its receptor CXCR4 could mediate direct interactions between GBM cells and tumor-associated endothelial cells and that disruption of this interaction might be the molecular basis for the anti-tumor effects of CXCR4 antagonists. We investigated this possibility in vivo and in an in vitro co-culture model that incorporated extracellular matrix, primary human brain microvascular ECs (HBMECs) and either an established GBM cell line or primary GBM specimens. Depletion of CXCR4 in U87 GBM cells blocked their growth as intracranial xenografts indicating that tumor cell CXCR4 is required for tumor growth in vivo. In vitro, co-culture of either U87 cells or primary GBM cells with HBMECs resulted in their co-localization and enhanced GBM cell growth. Genetic manipulation of CXCL12 expression and pharmacological inhibition of its receptors CXCR4 and CXCR7 revealed that the localizing and trophic effects of endothelial cells on GBM cells were dependent upon CXCL12 and CXCR4. These findings indicate that the CXCL12/CXCR4 pathway directly mediates endothelial cell trophic function in GBMs and that inhibition of CXCL12-CXCR4 signaling may uniquely target this activity. Therapeutic disruption of endothelial cell trophic functions could complement the structural disruption of anti-angiogenic regimens and, in combination, might also improve the efficacy of radiation and chemotherapy in treating GBMs.	[Rao, Shyam] Washington Univ, Sch Med, Dept Radiat Oncol, St Louis, MO 63130 USA; [Sengupta, Rajarshi; Choe, Eun Joo; Woerner, B. Mark; Sun, Tao; Rubin, Joshua B.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Jackson, Erin; Piwnica-Worms, David] Washington Univ, Sch Med, Bridging Res Imaging Genom & High Throughput Inst, St Louis, MO USA; [Jackson, Erin; Piwnica-Worms, David] Washington Univ, Sch Med, Mallinckrodt Inst Radiol, Mol Imaging Ctr, St Louis, MO USA; [Leonard, Jeffrey] Washington Univ, Sch Med, Dept Neurosurg, St Louis, MO USA; [Piwnica-Worms, David] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Piwnica-Worms, David] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO USA; [Rubin, Joshua B.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Rao, S (corresponding author), Washington Univ, Sch Med, Dept Radiat Oncol, St Louis, MO 63130 USA.	rubin_j@kids.wustl.edu	Sun, Tao/B-8884-2014	Sun, Tao/0000-0002-4204-0372	Molecular Imaging Center at Washington University School of Medicine; National Institutes of Health (NIH) [P50 CA94056, P30 NS057105]; National Cancer Institute/NIH [RO1CA118389]; Josie Foundation; Children's Discovery Institute; NATIONAL CANCER INSTITUTE [P50CA094056, R01CA118389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057105] Funding Source: NIH RePORTER	Molecular Imaging Center at Washington University School of Medicine; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Josie Foundation; Children's Discovery Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Pilot Study Funding from the Molecular Imaging Center at Washington University School of Medicine(mic.wustl.edu/index.htmland the National Institutes of Health (NIH) P50 CA94056 (DP-W), NIH Neuroscience Blueprint Core Grant P30 NS057105 to Washington University (Viral Vectors Core), National Cancer Institute/NIH RO1CA118389 (JBR) and The Josie Foundation (JBR)(JosieFoundation.org). The St Louis Children's Hospital Pediatric Brain Tumor Bank is supported by a grant from The Children's Discovery Institute (JL)(childrensdiscovery.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarum J, 2003, P NATL ACAD SCI USA, V100, P15983, DOI 10.1073/pnas.2237050100; Aghi M, 2006, CANCER RES, V66, P9054, DOI 10.1158/0008-5472.CAN-05-3759; Aiuti A, 1997, J EXP MED, V185, P111, DOI 10.1084/jem.185.1.111; Avecilla ST, 2004, NAT MED, V10, P64, DOI 10.1038/nm973; Bajetto A, 2006, NEUROCHEM INT, V49, P423, DOI 10.1016/j.neuint.2006.03.003; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bian XW, 2007, NEUROSURGERY, V61, P570, DOI 10.1227/01.NEU.0000290905.53685.A2; Borovski T, 2009, INT J CANCER, V125, P1222, DOI 10.1002/ijc.24408; Burger P, 2000, WHO CLASSIFICATION T, P9; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Calatozzolo C, 2011, CANCER BIOL THER, V11, P242, DOI 10.4161/cbt.11.2.13951; Charles N, 2010, CELL STEM CELL, V6, P141, DOI 10.1016/j.stem.2010.01.001; Chen RH, 2010, CANCER CELL, V17, P362, DOI 10.1016/j.ccr.2009.12.049; Cheng L, 2010, BIOCHEM PHARMACOL, V80, P654, DOI 10.1016/j.bcp.2010.04.035; Goldhoff P, 2008, CLIN CANCER RES, V14, P7717, DOI 10.1158/1078-0432.CCR-08-0827; Hack I, 2002, NAT NEUROSCI, V5, P939, DOI 10.1038/nn923; Hattermann K, 2010, CANCER RES, V70, P3299, DOI 10.1158/0008-5472.CAN-09-3642; Huang J, 2008, FRONT BIOSCI-LANDMRK, V13, P3352; Karin N, J LEUKOC BIOL, V88, P463; Kenig S, 2010, CANCER LETT, V289, P53, DOI 10.1016/j.canlet.2009.07.014; Kerever A, 2007, STEM CELLS, V25, P2146, DOI 10.1634/stemcells.2007-0082; Kioi M, 2010, J CLIN INVEST, V120, P694, DOI 10.1172/JCI40283; Klein RS, 2001, DEVELOPMENT, V128, P1971; KLEINMAN HK, 1982, BIOCHEMISTRY-US, V21, P6188, DOI 10.1021/bi00267a025; Kokovay E, 2010, CELL STEM CELL, V7, P163, DOI 10.1016/j.stem.2010.05.019; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Ma Q, 1999, IMMUNITY, V10, P463, DOI 10.1016/S1074-7613(00)80046-1; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Mishima S, 2010, EUR J HAEMATOL, V84, P538, DOI 10.1111/j.1600-0609.2010.01419.x; Nakai E, 2009, CANCER INVEST, V27, P901, DOI 10.3109/07357900801946679; Nelson CM, 2006, ANNU REV CELL DEV BI, V22, P287, DOI 10.1146/annurev.cellbio.22.010305.104315; Patel JR, 2010, P NATL ACAD SCI USA, V107, P11062, DOI 10.1073/pnas.1006301107; RAMPLING R, 1994, INT J RADIAT ONCOL, V29, P427, DOI 10.1016/0360-3016(94)90432-4; Redjal N, 2006, CLIN CANCER RES, V12, P6765, DOI 10.1158/1078-0432.CCR-06-1372; Reiss K, 2002, NEUROSCIENCE, V115, P295, DOI 10.1016/S0306-4522(02)00307-X; Rempel SA, 2000, CLIN CANCER RES, V6, P102; Rubin JB, 2003, P NATL ACAD SCI USA, V100, P13513, DOI 10.1073/pnas.2235846100; Salmaggi A, 2004, J NEURO-ONCOL, V67, P305, DOI 10.1023/B:NEON.0000024241.05346.24; Salmaggi A, 2006, GLIA, V54, P850, DOI 10.1002/glia.20414; Sauvageot CM, 2007, NEUROL CLIN, V25, P891, DOI 10.1016/j.ncl.2007.07.014; Scherer H., 1938, AM J CANC, V34, P333, DOI [DOI 10.1158/AJC.1938.333, 10.1158/ajc.1938.333]; Smith MCP, 2004, CANCER RES, V64, P8604, DOI 10.1158/0008-5472.CAN-04-1844; Spence AM, 1998, J NUCL MED, V39, P440; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; SUN T, 2010, J NEUROIMMU IN PRESS; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; Uemura M, 2010, J NEUROSCI RES, V88, P542, DOI 10.1002/jnr.22223; Warrington NM, 2010, CANCER RES, V70, P5717, DOI 10.1158/0008-5472.CAN-09-3769; Woerner BM, 2005, CANCER RES, V65, P11392, DOI 10.1158/0008-5472.CAN-05-0847; Wu YM, 2009, J NEUROCHEM, V109, P1157, DOI 10.1111/j.1471-4159.2009.06043.x; Wurth R, J NEUROIMMUNOL, V115-123; Yang LH, 2007, CANCER RES, V67, P651, DOI 10.1158/0008-5472.CAN-06-2762; Zagzag D, 2008, AM J PATHOL, V173, P545, DOI 10.2353/ajpath.2008.071197; Zagzag D, 2006, LAB INVEST, V86, P1221, DOI 10.1038/labinvest.3700482; Zeng ZH, 2009, BLOOD, V113, P6215, DOI 10.1182/blood-2008-05-158311; Zheng H, 2008, ATHEROSCLEROSIS, V201, P36, DOI 10.1016/j.atherosclerosis.2008.02.011; Zhu Y, 2002, NAT NEUROSCI, V5, P719, DOI 10.1038/nn881; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	59	45	47	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33005	10.1371/journal.pone.0033005	http://dx.doi.org/10.1371/journal.pone.0033005			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427929	Green Published, gold			2022-12-25	WOS:000302381500074
J	Grinter, R; Milner, J; Walker, D				Grinter, Rhys; Milner, Joel; Walker, Daniel			Ferredoxin Containing Bacteriocins Suggest a Novel Mechanism of Iron Uptake in Pectobacterium spp.	PLOS ONE			English	Article							COLICIN-M; ERWINIA-CHRYSANTHEMI; CRYSTAL-STRUCTURE; PSEUDOMONAS; RECEPTOR; DOMAIN	In order to kill competing strains of the same or closely related bacterial species, many bacteria produce potent narrow-spectrum protein antibiotics known as bacteriocins. Two sequenced strains of the phytopathogenic bacterium Pectobacterium carotovorum carry genes encoding putative bacteriocins which have seemingly evolved through a recombination event to encode proteins containing an N-terminal domain with extensive similarity to a [2Fe-2S] plant ferredoxin and a C-terminal colicin M-like catalytic domain. In this work, we show that these genes encode active bacteriocins, pectocin M1 and M2, which target strains of Pectobacterium carotovorum and Pectobacterium atrosepticum with increased potency under iron limiting conditions. The activity of pectocin M1 and M2 can be inhibited by the addition of spinach ferredoxin, indicating that the ferredoxin domain of these proteins acts as a receptor binding domain. This effect is not observed with the mammalian ferredoxin protein adrenodoxin, indicating that Pectobacterium spp. carries a specific receptor for plant ferredoxins and that these plant pathogens may acquire iron from the host through the uptake of ferredoxin. In further support of this hypothesis we show that the growth of strains of Pectobacterium carotovorum and atrosepticum that are not sensitive to the cytotoxic effects of pectocin M1 is enhanced in the presence of pectocin M1 and M2 under iron limiting conditions. A similar growth enhancement under iron limiting conditions is observed with spinach ferrodoxin, but not with adrenodoxin. Our data indicate that pectocin M1 and M2 have evolved to parasitise an existing iron uptake pathway by using a ferredoxin-containing receptor binding domain as a Trojan horse to gain entry into susceptible cells.	[Grinter, Rhys; Walker, Daniel] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Milner, Joel] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Glasgow, Lanark, Scotland	University of Glasgow; University of Glasgow	Grinter, R (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland.	Daniel.Walker@glasgow.ac.uk		Grinter, Rhys/0000-0002-8195-5348; Walker, Daniel/0000-0002-4206-2942	University of Glasgow	University of Glasgow	RG is supported by a Kelvin-Smith Studentship from the University of Glasgow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreteau H, 2010, J BIOL CHEM, V285, P12378, DOI 10.1074/jbc.M109.093583; Barreteau H, 2009, J BACTERIOL, V191, P3657, DOI 10.1128/JB.01824-08; Baysse C, 1999, J BACTERIOL, V181, P3849, DOI 10.1128/JB.181.12.3849-3851.1999; Bell KS, 2004, P NATL ACAD SCI USA, V101, P11105, DOI 10.1073/pnas.0402424101; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; CAVARD D, 1994, FEMS MICROBIOL LETT, V116, P37; Chan YC, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-99; El Ghachi M, 2006, J BIOL CHEM, V281, P22761, DOI 10.1074/jbc.M602834200; EXPERT D, 1985, J BACTERIOL, V163, P221, DOI 10.1128/JB.163.1.221-227.1985; Expert D, 2006, IRON NUTRITION IN PLANTS AND RHIZOSPHERIC MICROORGANISMS, P215, DOI 10.1007/1-4020-4743-6_10; Ferguson AD, 2000, PROTEIN SCI, V9, P956, DOI 10.1110/ps.9.5.956; Fetherston JD, 1996, MOL MICROBIOL, V22, P315, DOI 10.1046/j.1365-2958.1996.00118.x; Franza T, 1999, MOL PLANT MICROBE IN, V12, P119, DOI 10.1094/MPMI.1999.12.2.119; Franza T, 2010, IRON UPTAKE AND HOMEOSTASIS IN MICROORGANISMS, P101; Fukuyama K, 2004, PHOTOSYNTH RES, V81, P289, DOI 10.1023/B:PRES.0000036882.19322.0a; FYFE JAM, 1984, J CLIN MICROBIOL, V20, P47, DOI 10.1128/JCM.20.1.47-50.1984; Hall DO, 1972, PURE APPL CHEM, V34, P553; Helbig S, 2011, J BACTERIOL, V193, P815, DOI 10.1128/JB.01206-10; ISHIMARU CA, 1992, J BACTERIOL, V174, P2993, DOI 10.1128/JB.174.9.2993-3003.1992; Kim HS, 2009, APPL ENVIRON MICROB, V75, P4539, DOI 10.1128/AEM.01336-08; Kleanthous C, 2001, TRENDS BIOCHEM SCI, V26, P624, DOI 10.1016/S0968-0004(01)01941-7; Kleanthous C, 2010, NAT REV MICROBIOL, V8, P843, DOI 10.1038/nrmicro2454; Koiv V, 2010, MOL GENET GENOMICS, V283, P541, DOI 10.1007/s00438-010-0540-9; Loftus SR, 2006, P NATL ACAD SCI USA, V103, P12353, DOI 10.1073/pnas.0603433103; Ma B, 2010, PHYTOPATHOLOGY, V97, P1150; Michel-Briand Y, 2002, BIOCHIMIE, V84, P499, DOI 10.1016/S0300-9084(02)01422-0; Parret AHA, 2002, TRENDS MICROBIOL, V10, P107, DOI 10.1016/S0966-842X(02)02307-7; Perombelon MCM, 2002, PLANT PATHOL, V51, P1, DOI 10.1046/j.0032-0862.2001.Short title.doc.x; Pilsl H, 1996, J BACTERIOL, V178, P2431, DOI 10.1128/jb.178.8.2431-2435.1996; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Siburt CJP, 2009, METALLOMICS, V1, P249, DOI 10.1039/b902860a; Sjoblom S, 2008, MOL PLANT MICROBE IN, V21, P967, DOI 10.1094/MPMI-21-7-0967; Terauchi AM, 2009, J BIOL CHEM, V284, P25867, DOI 10.1074/jbc.M109.023622; Vollmer W, 1997, J BACTERIOL, V179, P1580, DOI 10.1128/jb.179.5.1580-1583.1997; Walker D, 2003, BIOCHEMISTRY-US, V42, P4161, DOI 10.1021/bi0273720; WAYNE R, 1976, J BACTERIOL, V126, P7, DOI 10.1128/JB.126.1.7-12.1976; Zeth K, 2008, J BIOL CHEM, V283, P25324, DOI 10.1074/jbc.M802591200	37	47	47	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2012	7	3							e33033	10.1371/journal.pone.0033033	http://dx.doi.org/10.1371/journal.pone.0033033			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KX	22427936	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000303062800039
J	Chen, J; Guo, KX; Kastan, MB				Chen, Jing; Guo, Kexiao; Kastan, Michael B.			Interactions of Nucleolin and Ribosomal Protein L26 (RPL26) in Translational Control of Human p53 mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE; BINDING PROTEINS; GENE-EXPRESSION; RECOGNITION; IRRADIATION; ACTIVATION; REPRESSION; INDUCTION	Ribosomal protein RPL26 enhances p53 translation after DNA damage, and this regulation depends upon interactions between the 5'- and 3'-UTRs of human p53 mRNA (Takagi, M., Absalon, M. J., McLure, K. G., and Kastan, M. B. (2005) Cell 123, 49-63; Chen, J., and Kastan, M. B. (2010) Genes Dev. 24, 2146-2156). In contrast, nucleolin (NCL) suppresses the translation of p53 mRNA and its induction after DNA damage. We confirmed reports that RPL26 and NCL interact with each other and then explored the potential role of this interaction in the translational control of p53 after stress. NCL repression of p53 translation utilizes both the 5'- and 3'-UTRs of p53 mRNA, and NCL binds to the same 5'-3'-UTR interaction region that is critical for the recruitment of RPL26 to p53 mRNA after DNA damage. We also found that NCL is able to oligomerize, consistent with a model in which NCL stabilizes this double-stranded RNA structure. We found that the RNA-binding domain of NCL participates in binding to p53 mRNA, is required for both NCL dimerization and NCL-mediated translational repression, and is the domain of NCL that interacts with RPL26. Excessive RPL26 disrupts NCL dimerization, and point mutations in the NCL-interacting region of RPL26 reduce NCL-RPL26 interactions and attenuate both RPL26 binding to human p53 mRNA and p53 induction by RPL26. These observations suggest a model in which the base pairings in the p53 UTR interaction regions are critical for both translational repression and stress induction of p53 by NCL and RPL26, respectively, and that disruption of a NCL-NCL homodimer by RPL26 may be the switch between translational repression and activation after stress.	[Chen, Jing; Guo, Kexiao; Kastan, Michael B.] St Jude Childrens Hosp, Dept Oncol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Kastan, MB (corresponding author), Duke Canc Inst, Dept Pharmacol & Canc Biol, Seeley Mudd Bldg,Mail Box 3917,10 Bryan Searle Dr, Durham, NC 27710 USA.	michael.kastan@duke.edu	Ogunwobi, Olorunseun/F-3172-2010		National Institutes of Health [R37ES05777, P50CA21765]; American Lebanese Syrian Associated Charities (ALSAC) of St. Jude Children's Research Hospital; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R37ES005777] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities (ALSAC) of St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R37ES05777 and P50CA21765. This work was also supported by the American Lebanese Syrian Associated Charities (ALSAC) of St. Jude Children's Research Hospital.	Allain FHT, 2000, EMBO J, V19, P6870, DOI 10.1093/emboj/19.24.6870; Ashcroft M, 1999, ONCOGENE, V18, P7637, DOI 10.1038/sj.onc.1203012; Bouvet P, 1997, EMBO J, V16, P5235, DOI 10.1093/emboj/16.17.5235; Bouvet P, 2001, J MOL BIOL, V309, P763, DOI 10.1006/jmbi.2001.4691; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chen J, 2010, GENE DEV, V24, P2146, DOI 10.1101/gad.1968910; DICKINSON LA, 1995, MOL CELL BIOL, V15, P456, DOI 10.1128/MCB.15.1.456; Fahling M, 2006, J BIOL CHEM, V281, P26089, DOI 10.1074/jbc.M604939200; Fu LN, 1997, EMBO J, V16, P4117, DOI 10.1093/emboj/16.13.4117; Ginisty H, 1999, J CELL SCI, V112, P761; Hall KB, 2002, CURR OPIN STRUC BIOL, V12, P283, DOI 10.1016/S0959-440X(02)00323-8; Hanakahi LA, 2000, BIOCHEMISTRY-US, V39, P15493, DOI 10.1021/bi001683y; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kishore S, 2010, BRIEF FUNCT GENOMICS, V9, P391, DOI 10.1093/bfgp/elq028; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Mazan-Mamczarz K, 2003, P NATL ACAD SCI USA, V100, P8354, DOI 10.1073/pnas.1432104100; Mongelard F, 2007, TRENDS CELL BIOL, V17, P80, DOI 10.1016/j.tcb.2006.11.010; Morelli X, 2011, CURR OPIN CHEM BIOL, V15, P475, DOI 10.1016/j.cbpa.2011.05.024; Mori M, 2011, CURR PHARM DESIGN, V17, P3713, DOI 10.2174/138161211798220972; MOSNER J, 1995, EMBO J, V14, P4442, DOI 10.1002/j.1460-2075.1995.tb00123.x; Ofir-Rosenfeld Y, 2008, MOL CELL, V32, P180, DOI 10.1016/j.molcel.2008.08.031; Schumacher B, 2005, CELL, V120, P357, DOI 10.1016/j.cell.2004.12.009; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Thyagarajan B, 1998, SOMAT CELL MOLEC GEN, V24, P263, DOI 10.1023/B:SCAM.0000007129.98789.1f; Wade M, 2010, TRENDS CELL BIOL, V20, P299, DOI 10.1016/j.tcb.2010.01.009; Westphal CH, 1998, CANCER RES, V58, P5637; Yanagida M, 2001, PROTEOMICS, V1, P1390, DOI 10.1002/1615-9861(200111)1:11<1390::AID-PROT1390>3.0.CO;2-Z; Yang C, 2002, NUCLEIC ACIDS RES, V30, P2251, DOI 10.1093/nar/30.10.2251; Zhang J, 2008, CANCER RES, V68, P1046, DOI 10.1158/0008-5472.CAN-07-1927; Zhang YD, 2006, NUCLEIC ACIDS RES, V34, P485, DOI 10.1093/nar/gkj459	30	79	81	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16467	16476		10.1074/jbc.M112.349274	http://dx.doi.org/10.1074/jbc.M112.349274			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22433872	Green Published, hybrid			2022-12-25	WOS:000304030900037
J	Yu, LP; Phillips, RL; Zhang, DS; Teghanemt, A; Weiss, JP; Gioannini, TL				Yu, Liping; Phillips, Rachel L.; Zhang, DeSheng; Teghanemt, Athmane; Weiss, Jerrold P.; Gioannini, Theresa L.			NMR Studies of Hexaacylated Endotoxin Bound to Wild-type and F126A Mutant MD-2 and MD-2.TLR4 Ectodomain Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TLR4-MD-2 COMPLEX; TOLL-LIKE-RECEPTOR-4 ECTODOMAIN; LIPOPOLYSACCHARIDE RECOGNITION; NEISSERIA-MENINGITIDIS; MONOMERIC ENDOTOXIN; PROTEIN COMPLEXES; CELL ACTIVATION; INNATE IMMUNITY; RECEPTOR 4; LIPID IVA	Host response to invasion by many Gram-negative bacteria depends upon activation of Toll-like receptor 4 (TLR4) by endotoxin presented as a monomer bound to myeloid differentiation factor 2 (MD-2). Metabolic labeling of hexaacylated endotoxin (LOS) from Neisseria meningitidis with [C-13]acetate allowed the use of NMR to examine structural properties of the fatty acyl chains of LOS present in TLR4-agonistic and -antagonistic binary and ternary complexes with, respectively, wild-type or mutant (F126A) MD-2 +/- TLR4 ectodomain. Chemical shift perturbation indicates that Phe(126) affects the environment and/or position of each of the bound fatty acyl chains both in the binary LOS.MD-2 complex and in the ternary LOS.MD-2.TLR4 ectodomain complex. In both wild-type and mutant LOS.MD-2 complexes, one of the six fatty acyl chains of LOS is more susceptible to paramagnetic attenuation, suggesting protrusion of that fatty acyl chain from the hydrophobic pocket of MD-2, independent of association with TLR4. These findings indicate that re-orientation of the aromatic side chain of Phe(126) is induced by binding of hexaacylated E, preceding interaction with TLR4. This re-arrangement of Phe(126) may act as a "hydrophobic switch," driving agonist-dependent contacts needed for TLR4 dimerization and activation.	[Gioannini, Theresa L.] Dept Vet Affairs Med Ctr, Iowa City, IA 52246 USA; [Yu, Liping] Univ Iowa, Roy A & Lucille J Carver Coll Med, NMR Core Facil, Iowa City, IA 52241 USA; [Yu, Liping; Gioannini, Theresa L.] Univ Iowa, Roy A & Lucille J Carver Coll Med, Dept Biochem, Iowa City, IA 52241 USA; [Phillips, Rachel L.; Zhang, DeSheng; Teghanemt, Athmane; Weiss, Jerrold P.; Gioannini, Theresa L.] Univ Iowa, Roy A & Lucille J Carver Coll Med, Inflammat Program, Dept Internal Med, Iowa City, IA 52241 USA; [Weiss, Jerrold P.] Univ Iowa, Roy A & Lucille J Carver Coll Med, Dept Microbiol, Iowa City, IA 52241 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Iowa; University of Iowa; University of Iowa; University of Iowa	Gioannini, TL (corresponding author), Dept Vet Affairs Med Ctr, Iowa City, IA 52246 USA.	theresa-gioannini@uiowa.edu		Weiss, Jerrold/0000-0003-1476-4485; Yu, Liping/0000-0003-3536-6427	Dept. of Veterans' Affairs; NIAID, National Institutes of Health [AI05732]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059372] Funding Source: NIH RePORTER	Dept. of Veterans' Affairs(US Department of Veterans Affairs); NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by grants from the Dept. of Veterans' Affairs, Merit Grant (to T. L. G.) and from NIAID, National Institutes of Health Grant AI05732 (to J. P. W.).	Akira SZ, 2009, P JPN ACAD B-PHYS, V85, P143, DOI 10.2183/pjab.85.143; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeMarco ML, 2011, MOL IMMUNOL, V49, P124, DOI 10.1016/j.molimm.2011.08.003; Esparza G. A., 2012, INNATE IMMU IN PRESS; Fitzgerald KA, 2006, CELL, V125, P834, DOI 10.1016/j.cell.2006.05.014; Giardina PC, 2001, J BIOL CHEM, V276, P5883, DOI 10.1074/jbc.M009273200; Gioannini TL, 2005, J ENDOTOXIN RES, V11, P117, DOI 10.1179/096805105X35198; Gioannini TL, 2004, P NATL ACAD SCI USA, V101, P4186, DOI 10.1073/pnas.0306906101; Gruber A, 2004, J BIOL CHEM, V279, P28475, DOI 10.1074/jbc.M400993200; Iwahara J, 2007, J MAGN RESON, V184, P185, DOI 10.1016/j.jmr.2006.10.003; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kawasaki K, 2003, J IMMUNOL, V170, P413, DOI 10.4049/jimmunol.170.1.413; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Kobayashi M, 2006, J IMMUNOL, V176, P6211, DOI 10.4049/jimmunol.176.10.6211; Lewis K. E., 1992, J AM CHEM SOC, V114, P10663; Madl T, 2009, ANGEW CHEM INT EDIT, V48, P8259, DOI 10.1002/anie.200902561; Meng JM, 2011, J IMMUNOL, V187, P3683, DOI 10.4049/jimmunol.1101397; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; Miyake K, 2003, INT IMMUNOPHARMACOL, V3, P119, DOI 10.1016/S1567-5769(02)00258-8; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Ostuni R, 2010, CELL MOL LIFE SCI, V67, P4109, DOI 10.1007/s00018-010-0464-x; Panter G, 2011, J BIOL CHEM, V286, P23334, DOI 10.1074/jbc.M110.205419; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Pintacuda G, 2002, J AM CHEM SOC, V124, P372, DOI 10.1021/ja016985h; Post DMB, 2006, J ENDOTOXIN RES, V12, P93, DOI 10.1177/09680519060120020501; Prohinar P, 2007, J BIOL CHEM, V282, P1010, DOI 10.1074/jbc.M609400200; Resman N, 2009, J BIOL CHEM, V284, P15052, DOI 10.1074/jbc.M901429200; Respondek M, 2007, J AM CHEM SOC, V129, P5228, DOI 10.1021/ja069004f; Teghanemt A, 2005, J IMMUNOL, V175, P4669, DOI 10.4049/jimmunol.175.7.4669; Teghanemt A, 2008, J BIOL CHEM, V283, P21881, DOI 10.1074/jbc.M800672200; Teghanemt A, 2008, J BIOL CHEM, V283, P1257, DOI 10.1074/jbc.M705994200; Ulevitch RJ, 1999, CURR OPIN IMMUNOL, V11, P19, DOI 10.1016/S0952-7915(99)80004-1; Walsh C, 2008, J IMMUNOL, V181, P1245, DOI 10.4049/jimmunol.181.2.1245; Wang Y, 2010, J BIOL CHEM, V285, P36836, DOI 10.1074/jbc.M110.167973; Yamamoto M, 2009, ADV EXP MED BIOL, V667, P59, DOI 10.1007/978-1-4419-1603-7_6	37	36	36	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16346	16355		10.1074/jbc.M112.343467	http://dx.doi.org/10.1074/jbc.M112.343467			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22433852	Green Published, hybrid			2022-12-25	WOS:000304030900026
J	Ortiz, C; Caja, L; Bertran, E; Gonzalez-Rodriguez, A; Valverde, AM; Fabregat, I; Sancho, P				Ortiz, Conrad; Caja, Laia; Bertran, Esther; Gonzalez-Rodriguez, Agueda; Valverde, Angela M.; Fabregat, Isabel; Sancho, Patricia			Protein-tyrosine Phosphatase 1B (PTP1B) Deficiency Confers Resistance to Transforming Growth Factor-beta (TGF-beta)-induced Suppressor Effects in Hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-KAPPA-B; FETAL-RAT HEPATOCYTES; SMOOTH-MUSCLE-CELLS; TGF-BETA; NADPH OXIDASE; INDUCED-APOPTOSIS; SIGNAL-TRANSDUCTION; FACTOR RECEPTOR; UP-REGULATION; OXIDATIVE STRESS	Transforming growth factor-beta (TGF-beta) plays a dual role in hepatocytes, mediating both tumor suppressor and promoter effects. The suppressor effects of the cytokine can be negatively regulated by activation of survival signals, mostly dependent on tyrosine kinase activity. The aim of our work was to study the role of the protein-tyrosine phosphatase 1B (PTP1B) on the cellular responses to TGF-beta, using for this purpose immortalized neonatal hepatocytes isolated from both PTP1B(+/+) and PTP1B(-/-) mice. We have found that PTP1B deficiency conferred resistance to TGF-beta suppressor effects, such as apoptosis and growth inhibition, correlating with lower Smad2/Smad3 activation. Both responses were recovered in the presence of the general tyrosine kinase inhibitor genistein. PTP1B(-/-) cells showed elevated NF-kappa B activation in response to TGF-beta. Knockdown of the NF-kappa B p65 subunit increased cell response in terms of Smads phosphorylation and apoptosis. Interestingly, these effects were accompanied by inhibition of Smad7 up-regulation. In addition, lack of PTP1B promoted an altered NADPH oxidase (NOX) expression pattern in response to TGF-beta, strongly increasing the NOX1/NOX4 ratio, which was reverted by genistein and p65 knockdown. Importantly, NOX1 knockdown inhibited nuclear translocation of p65, promoted Smad phosphorylation, and decreased Smad7 levels. In summary, our results suggest that PTP1B deficiency confers resistance to TGF-beta through Smad inhibition, an effect that is mediated by NOX1-dependent NF-kappa B activation, which in turn, increases the level of the Smad inhibitor Smad7 and participates in a positive feedback loop on NOX1 up-regulation.	[Ortiz, Conrad; Caja, Laia; Bertran, Esther; Fabregat, Isabel; Sancho, Patricia] Bellvitge Biomed Res Inst IDIBELL, Biol Clues Invas & Metastat Phenotype Grp, Barcelona 08908, Spain; [Gonzalez-Rodriguez, Agueda; Valverde, Angela M.] Univ Autonoma Madrid, CSIC, Inst Invest Biomed Alberto Sols, E-28049 Madrid, Spain; [Gonzalez-Rodriguez, Agueda; Valverde, Angela M.] Inst Salud Carlos III, Ctr Invest Biomed Red Diabet & Enfermedades Metab, Madrid 28040, Spain; [Fabregat, Isabel] Univ Barcelona, Dept Ciencies Fisiol 2, E-08007 Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Instituto de Salud Carlos III; University of Barcelona	Fabregat, I (corresponding author), IDIBELL, Biol Clues Invas & Metastat Phenotype Grp, Gran Via LHospitalet 199, Barcelona 08907, Spain.	ifabregat@idibell.cat; psancho@idibell.cat	Bertran, Esther/GZK-5458-2022; González-Rodróguez, Águeda/D-7651-2012; Chaitoglou, Stefanos/M-1658-2014; Sancho, Patricia/ABH-5258-2020; Caja, Laia/J-4618-2019; Fabregat, Isabel/H-7038-2015	González-Rodróguez, Águeda/0000-0001-6559-0847; Chaitoglou, Stefanos/0000-0001-6074-1853; Sancho, Patricia/0000-0002-1092-5395; Caja, Laia/0000-0002-8786-8763; Martinez Valverde, Angela/0000-0003-1192-9045; Bertran Rodriguez, Esther/0000-0001-9356-7409; Fabregat, Isabel/0000-0003-0136-8440	Ministerio de Ciencia e Innovacion, Spain [BFU2009-07219, ISCIII-RTICC RD06/0020, SAF2009]; Agencia de Gestio d'Ajuts Universitari i de Recerca-Generalitat de Catalunya [2009SGR-312]	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Agencia de Gestio d'Ajuts Universitari i de Recerca-Generalitat de Catalunya	This work was supported by Ministerio de Ciencia e Innovacion, Spain, Grants BFU2009-07219 and ISCIII-RTICC RD06/0020 (to I. F.) and SAF2009-08114 (to A. M. V.) and by Agencia de Gestio d'Ajuts Universitari i de Recerca-Generalitat de Catalunya Grant 2009SGR-312 (to I. F.).	Arsura M, 2003, ONCOGENE, V22, P412, DOI 10.1038/sj.onc.1206132; Arsura M, 1997, CELL GROWTH DIFFER, V8, P1049; Arsura M, 2000, MOL CELL BIOL, V20, P5381, DOI 10.1128/MCB.20.15.5381-5391.2000; Banerjee S, 2008, CANCER LETT, V269, P226, DOI 10.1016/j.canlet.2008.03.052; Bitzer M, 2000, GENE DEV, V14, P187; Caja L, 2007, CELL SIGNAL, V19, P683, DOI 10.1016/j.cellsig.2006.09.002; Caja L, 2011, J HEPATOL, V55, P351, DOI 10.1016/j.jhep.2010.10.041; Caja L, 2009, CANCER RES, V69, P7595, DOI 10.1158/0008-5472.CAN-09-1482; Carmona-Cuenca I, 2006, J CELL PHYSIOL, V207, P322, DOI 10.1002/jcp.20568; Carmona-Cuenca I, 2008, J HEPATOL, V49, P965, DOI 10.1016/j.jhep.2008.07.021; CARR BI, 1986, CANCER RES, V46, P2330; Chacon PJ, 2010, MOL CELL NEUROSCI, V43, P384, DOI 10.1016/j.mcn.2010.01.005; Chen K, 2008, J CELL BIOL, V181, P1129, DOI 10.1083/jcb.200709049; Conery AR, 2004, NAT CELL BIOL, V6, P366, DOI 10.1038/ncb1117; Coulouarn C, 2008, HEPATOLOGY, V47, P2059, DOI 10.1002/hep.22283; Fabregat I, 2000, HEPATOLOGY, V32, P528, DOI 10.1053/jhep.2000.9774; Franco DL, 2010, J CELL SCI, V123, P3467, DOI 10.1242/jcs.068692; FRANGIONI JV, 1992, CELL, V68, P545, DOI 10.1016/0092-8674(92)90190-N; Fukuyama M, 2005, CANCER LETT, V221, P97, DOI 10.1016/j.canlet.2004.08.031; Gonzalez-Rodriguez A, 2007, J CELL PHYSIOL, V212, P76, DOI 10.1002/jcp.21004; Gonzalez-Rodriguez A, 2007, ENDOCRINOLOGY, V148, P594, DOI 10.1210/en.2006-0644; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; Herrera B, 2001, FASEB J, V15, P741, DOI 10.1096/fj.00-0267com; Hunter T, 1998, Harvey Lect, V94, P81; Itoh S, 2007, CURR OPIN CELL BIOL, V19, P176, DOI 10.1016/j.ceb.2007.02.015; Krakowski AR, 2005, P NATL ACAD SCI USA, V102, P12437, DOI 10.1073/pnas.0504107102; Mahadev K, 2004, MOL CELL BIOL, V24, P1844, DOI 10.1128/MCB.24.5.1844-1854.2004; Manea A, 2010, BIOCHEM BIOPH RES CO, V396, P901, DOI 10.1016/j.bbrc.2010.05.019; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mayoral R, 2010, J BIOL CHEM, V285, P3633, DOI 10.1074/jbc.M109.072900; Miller FJ, 2007, CIRC RES, V101, P663, DOI 10.1161/CIRCRESAHA.107.151076; Miranda S, 2010, CELL SIGNAL, V22, P645, DOI 10.1016/j.cellsig.2009.11.019; Murillo MM, 2007, BIOCHEM J, V405, P251, DOI 10.1042/BJ20061846; Murillo MM, 2005, ONCOGENE, V24, P4580, DOI 10.1038/sj.onc.1208664; Nagarajan RP, 2000, BIOCHEM J, V348, P591, DOI 10.1042/0264-6021:3480591; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; OBERHAMMER FA, 1992, P NATL ACAD SCI USA, V89, P5408, DOI 10.1073/pnas.89.12.5408; Remy I, 2004, NAT CELL BIOL, V6, P358, DOI 10.1038/ncb1113; Salmeen A, 2005, ANTIOXID REDOX SIGN, V7, P560, DOI 10.1089/ars.2005.7.560; San Martin A, 2007, FREE RADICAL BIO MED, V42, P1671, DOI 10.1016/j.freeradbiomed.2007.02.002; Sanchez A, 1996, J BIOL CHEM, V271, P7416, DOI 10.1074/jbc.271.13.7416; Sancho P, 2011, BIOCHEM PHARMACOL, V81, P917, DOI 10.1016/j.bcp.2011.01.007; Sancho P, 2010, J BIOL CHEM, V285, P24815, DOI 10.1074/jbc.M110.114280; Sancho P, 2009, BBA-MOL CELL RES, V1793, P253, DOI 10.1016/j.bbamcr.2008.09.003; Sangwan V, 2006, J BIOL CHEM, V281, P221, DOI 10.1074/jbc.M507858200; Stuible M, 2010, TRENDS CELL BIOL, V20, P672, DOI 10.1016/j.tcb.2010.08.013; Valdes F, 2004, EXP CELL RES, V292, P209, DOI 10.1016/j.yexcr.2003.08.015; Valverde Angela M., 2011, Archives of Physiology and Biochemistry, V117, P105, DOI 10.3109/13813455.2011.557386; Wang R, 2011, INT J CANCER, V128, P2581, DOI 10.1002/ijc.25610	50	20	20	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15263	15274		10.1074/jbc.M111.303958	http://dx.doi.org/10.1074/jbc.M111.303958			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22427664	Green Published, hybrid			2022-12-25	WOS:000304006300010
J	Soares, LM; Buratowski, S				Soares, Luis M.; Buratowski, Stephen			Yeast Swd2 Is Essential Because of Antagonism between Set1 Histone Methyltransferase Complex and APT (Associated with Pta1) Termination Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; LYSINE-4 METHYLATION; TRANSCRIPTION TERMINATION; GENE-EXPRESSION; MESSENGER-RNA; POLYADENYLATION FACTOR; H3K4 TRIMETHYLATION; 3'-END FORMATION; BINDING PROTEIN	The Set1 complex (also known as complex associated with Set1 or COMPASS) methylates histone H3 on lysine 4, with different levels of methylation affecting transcription by recruiting various factors to distinct regions of active genes. Neither Set1 nor its associated proteins are essential for viability with the notable exception of Swd2, a WD repeat protein that is also a subunit of the essential transcription termination factor APT (associated with Pta1). Cells lacking Set1 lose COMPASS recruitment but show increased promoter cross-linking of TFIIE large subunit and the serine 5 phosphorylated form of the Rpb1 C-terminal domain. Although Swd2 is normally required for bringing APT to genes, deletion of SET1 restores both viability and APT recruitment to a strain lacking Swd2. We propose a model in which Swd2 is required for APT to overcome antagonism by COMPASS.	[Soares, Luis M.; Buratowski, Stephen] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Buratowski, S (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave, Boston, MA 02115 USA.	SteveB@hms.harvard.edu			National Institutes of Health [GM46498, GM56663]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046498, R01GM056663, R29GM046498] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM46498 and GM56663 (to S. B.).	Akhtar MS, 2009, MOL CELL, V34, P387, DOI 10.1016/j.molcel.2009.04.016; Ansari A, 2005, GENE DEV, V19, P2969, DOI 10.1101/gad.1362305; Boa S, 2003, YEAST, V20, P827, DOI 10.1002/yea.995; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Carvin CD, 2004, J BIOL CHEM, V279, P33057, DOI 10.1074/jbc.M405033200; Chapman RD, 2007, SCIENCE, V318, P1780, DOI 10.1126/science.1145977; Cheng HL, 2004, MOL CELL BIOL, V24, P2932, DOI 10.1128/MCB.24.7.2932-2943.2004; Dehe PM, 2006, BIOCHEM CELL BIOL, V84, P536, DOI 10.1139/O06-081; Dehe PM, 2006, J BIOL CHEM, V281, P35404, DOI 10.1074/jbc.M603099200; Dehe PM, 2005, J MOL BIOL, V353, P477, DOI 10.1016/j.jmb.2005.08.059; Demae M, 2007, FEMS MICROBIOL LETT, V277, P70, DOI 10.1111/j.1574-6968.2007.00947.x; Dheur S, 2003, EMBO J, V22, P2831, DOI 10.1093/emboj/cdg253; Dichtl E, 2004, RNA, V10, P965, DOI 10.1261/rna.7090104; Fingerman IM, 2005, J BIOL CHEM, V280, P28761, DOI 10.1074/jbc.C500097200; Ganem C, 2003, EMBO J, V22, P1588, DOI 10.1093/emboj/cdg141; Glover-Cutter K, 2009, MOL CELL BIOL, V29, P5455, DOI 10.1128/MCB.00637-09; Grohmann D, 2011, MOL CELL, V43, P263, DOI 10.1016/j.molcel.2011.05.030; Hampsey M, 2003, CELL, V113, P429, DOI 10.1016/S0092-8674(03)00360-X; Helliwell SB, 2001, J CELL BIOL, V153, P649, DOI 10.1083/jcb.153.4.649; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kim M, 2009, J BIOL CHEM, V284, P26421, DOI 10.1074/jbc.M109.028993; Kim T, 2009, CELL, V137, P259, DOI 10.1016/j.cell.2009.02.045; Krishnamurthy S, 2004, MOL CELL, V14, P387, DOI 10.1016/S1097-2765(04)00235-7; Krogan NJ, 2002, J BIOL CHEM, V277, P10753, DOI 10.1074/jbc.C200023200; Kuldell NH, 1997, MOL CELL BIOL, V17, P5288, DOI 10.1128/MCB.17.9.5288; Lee JH, 2008, MOL CELL BIOL, V28, P609, DOI 10.1128/MCB.01356-07; Lee JS, 2007, CELL, V131, P1084, DOI 10.1016/j.cell.2007.09.046; Lenstra TL, 2011, MOL CELL, V42, P536, DOI 10.1016/j.molcel.2011.03.026; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; Mosley AL, 2009, MOL CELL, V34, P168, DOI 10.1016/j.molcel.2009.02.025; Muramoto T, 2010, CURR BIOL, V20, P397, DOI 10.1016/j.cub.2010.01.017; Nagy PL, 2002, P NATL ACAD SCI USA, V99, P90, DOI 10.1073/pnas.221596698; Nedea E, 2003, J BIOL CHEM, V278, P33000, DOI 10.1074/jbc.M304454200; Nedea E, 2008, MOL CELL, V29, P577, DOI 10.1016/j.molcel.2007.12.031; Neumann S, 2003, EMBO REP, V4, P1156, DOI 10.1038/sj.embor.7400026; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; O'Sullivan JM, 2004, NAT GENET, V36, P1014, DOI 10.1038/ng1411; OHKUMA Y, 1994, NATURE, V368, P160, DOI 10.1038/368160a0; OHKUMA Y, 1995, MOL CELL BIOL, V15, P4856; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Roguev A, 2007, NAT METHODS, V4, P861, DOI 10.1038/NMETH1098; Sakurai H, 1998, J BIOL CHEM, V273, P9534, DOI 10.1074/jbc.273.16.9534; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schlichter A, 2005, EMBO J, V24, P1222, DOI 10.1038/sj.emboj.7600607; Schneider J, 2005, MOL CELL, V19, P849, DOI 10.1016/j.molcel.2005.07.024; Shi XB, 2007, J BIOL CHEM, V282, P2450, DOI 10.1074/jbc.C600286200; Somesh BP, 2007, CELL, V129, P57, DOI 10.1016/j.cell.2007.01.046; Steinmetz EJ, 2001, NATURE, V413, P327, DOI 10.1038/35095090; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Terzi N, 2011, MOL CELL BIOL, V31, P3569, DOI 10.1128/MCB.05590-11; Tresaugues L, 2006, J MOL BIOL, V359, P1170, DOI 10.1016/j.jmb.2006.04.050; Vasiljeva L, 2006, MOL CELL, V21, P239, DOI 10.1016/j.molcel.2005.11.028; Vasiljeva L, 2008, NAT STRUCT MOL BIOL, V15, P795, DOI 10.1038/nsmb.1468; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Vitaliano-Prunier A, 2008, NAT CELL BIOL, V10, P1365, DOI 10.1038/ncb1796; WARREN SL, 1992, J CELL SCI, V103, P381; Xiao TJ, 2007, MOL CELL BIOL, V27, P721, DOI 10.1128/MCB.01628-06	62	29	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15219	15231		10.1074/jbc.M112.341412	http://dx.doi.org/10.1074/jbc.M112.341412			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22431730	Green Published, hybrid			2022-12-25	WOS:000304006300006
J	van Loo, KMJ; Schaub, C; Pernhorst, K; Yaari, Y; Beck, H; Schoch, S; Becker, AJ				van Loo, Karen M. J.; Schaub, Christina; Pernhorst, Katharina; Yaari, Yoel; Beck, Heinz; Schoch, Susanne; Becker, Albert J.			Transcriptional Regulation of T-type Calcium Channel Ca(V)3.2 BI-DIRECTIONALITY BY EARLY GROWTH RESPONSE 1 (Egr1) AND REPRESSOR ELEMENT 1 (RE-1) PROTEIN-SILENCING TRANSCRIPTION FACTOR (REST)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; ABSENCE EPILEPSY; CA2+ CHANNELS; IN-VIVO; NEURONAL EXCITABILITY; BIOLOGICAL-ACTIVITY; STATUS EPILEPTICUS; UP-REGULATION; RAT-BRAIN; DNA	The pore-forming Ca2+ channel subunit Ca(V)3.2 mediates a low voltage-activated (T-type) Ca2+ current (I-CaT) that contributes pivotally to neuronal and cardiac pacemaker activity. Despite the importance of tightly regulated Ca(V)3.2 levels, the mechanisms regulating its transcriptional dynamics are not well understood. Here, we have identified two key factors that up-and down-regulate the expression of the gene encoding Ca(V)3.2 (Cacna1h). First, we determined the promoter region and observed several stimulatory and inhibitory clusters. Furthermore, we found binding sites for the transcription factor early growth response 1 (Egr1/Zif268/Krox-24) to be highly overrepresented within the CaV3.2 promoter region. mRNA expression analyses and dual-luciferase promoter assays revealed that the CaV3.2 promoter was strongly activated by Egr1 overexpression in vitro and in vivo. Subsequent chromatin immunoprecipitation assays in NG108-15 cells and mouse hippocampi confirmed specific Egr1 binding to the Ca(V)3.2 promoter. Congruently, whole-cell ICaT values were significantly larger after Egr1 overexpression. Intriguingly, Egr1-induced activation of the Ca(V)3.2 promoter was effectively counteracted by the repressor element 1-silencing transcription factor (REST). Thus, Egr1 and REST can bi-directionally regulate Ca(V)3.2 promoter activity and mRNA expression and, hence, the size of I-CaT. This mechanism has critical implications for the regulation of neuronal and cardiac Ca2+ homeostasis under physiological conditions and in episodic disorders such as arrhythmias and epilepsy.	[van Loo, Karen M. J.; Pernhorst, Katharina; Schoch, Susanne; Becker, Albert J.] Univ Bonn, Med Ctr, Dept Neuropathol, D-53105 Bonn, Germany; [Schaub, Christina; Beck, Heinz] Univ Bonn, Med Ctr, Dept Epileptol, D-53105 Bonn, Germany; [Schaub, Christina] Univ Bonn, Med Ctr, Dept Neurol, D-53105 Bonn, Germany; [Yaari, Yoel] Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Dept Med Neurobiol, IL-91120 Jerusalem, Israel; [Beck, Heinz] Deutsch Zentrum Neurodegenerat Erkrankungen, D-53175 Bonn, Germany	University of Bonn; University of Bonn; University of Bonn; Hebrew University of Jerusalem; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	van Loo, KMJ (corresponding author), Univ Bonn, Med Ctr, Dept Neuropathol, Sigmund Freud Str 25, D-53105 Bonn, Germany.	karen.van_loo@ukb.uni-bonn.de	Schoch, Susanne/F-7741-2012; Becker, Albert J/F-6248-2012		Deutsche Forschungsgemeinschaft [SFB/TR3, KFO 177, SFB-645]; GIF; NGFNplus EMINET; European Union; Euroepinomics Network of the European Science Foundation; Else Kroner-Fresenius-Stiftung; BMBF "Independent research groups in neurosciences"; University of Bonn Medical Center	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); GIF(German-Israeli Foundation for Scientific Research and Development); NGFNplus EMINET; European Union(European Commission); Euroepinomics Network of the European Science Foundation; Else Kroner-Fresenius-Stiftung; BMBF "Independent research groups in neurosciences"(Federal Ministry of Education & Research (BMBF)); University of Bonn Medical Center	This work was supported by Deutsche Forschungsgemeinschaft (SFB/TR3, KFO 177, SFB-645; to A.J.B., Y.Y., H.B., and S.S.), GIF (to A.J.B., S.S., and Y.Y.), NGFNplus EMINET (to A.J.B., H.B., and S.S.), European Union EPICURE (to A.J.B. and H.B.), Euroepinomics Network of the European Science Foundation (to K.v L. and A.J.B.), Else Kroner-Fresenius-Stiftung (to A.J.B.), and BMBF "Independent research groups in neurosciences" (to S.S.) as well as the BONFOR program of the University of Bonn Medical Center.	ACKERMAN SL, 1991, P NATL ACAD SCI USA, V88, P7523, DOI 10.1073/pnas.88.17.7523; Baron V, 2006, CANCER GENE THER, V13, P115, DOI 10.1038/sj.cgt.7700896; Becker AJ, 2008, J NEUROSCI, V28, P13341, DOI 10.1523/JNEUROSCI.1421-08.2008; Beckmann AM, 1997, J NEUROCHEM, V69, P2227; Bosch MA, 2009, J COMP NEUROL, V512, P347, DOI 10.1002/cne.21901; Calderone A, 2003, J NEUROSCI, V23, P2112; Chemin J, 2002, J PHYSIOL-LONDON, V540, P3, DOI 10.1113/jphysiol.2001.013269; Chemin J, 2006, CELL CALCIUM, V40, P121, DOI 10.1016/j.ceca.2006.04.015; Cribbs LL, 2010, CHANNELS, V4, P447, DOI 10.4161/chan.4.6.12870; Down TA, 2002, GENOME RES, V12, P458, DOI 10.1101/gr.216102; Gannon AM, 2009, J MOL BIOL, V394, P29, DOI 10.1016/j.jmb.2009.09.007; Garriga-Canut M, 2006, NAT NEUROSCI, V9, P1382, DOI 10.1038/nn1791; Giorgetti L, 2010, MOL CELL, V37, P418, DOI 10.1016/j.molcel.2010.01.016; Graef JD, 2009, J NEUROSCI, V29, P4430, DOI 10.1523/JNEUROSCI.0198-09.2009; Helbig I, 2008, EPILEPSIA, V49, P1546, DOI 10.1111/j.1528-1167.2008.01630.x; Hertel KJ, 1997, CURR OPIN CELL BIOL, V9, P350, DOI 10.1016/S0955-0674(97)80007-5; Heynen AJ, 2001, J NEUROSCI, V21, P9801, DOI 10.1523/JNEUROSCI.21-24-09801.2001; Huang RP, 1997, J CELL BIOCHEM, V66, P489, DOI 10.1002/(SICI)1097-4644(19970915)66:4<489::AID-JCB8>3.0.CO;2-H; HUGHES P, 1994, MOL BRAIN RES, V24, P166, DOI 10.1016/0169-328X(94)90129-5; Huguenard JR, 1996, ANNU REV PHYSIOL, V58, P329, DOI 10.1146/annurev.physiol.58.1.329; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Khosravani H, 2005, ANN NEUROL, V57, P745, DOI 10.1002/ana.20458; Khosravani H, 2004, J BIOL CHEM, V279, P9681, DOI 10.1074/jbc.C400006200; Klockner U, 1999, EUR J NEUROSCI, V11, P4171, DOI 10.1046/j.1460-9568.1999.00849.x; Kumbrink J, 2005, J BIOL CHEM, V280, P42785, DOI 10.1074/jbc.M511079200; Kuwahara K, 2005, J PHARMACOL SCI, V99, P211, DOI 10.1254/jphs.FMJ05002X4; Kuwahara K, 2003, EMBO J, V22, P6310, DOI 10.1093/emboj/cdg601; Lee JH, 1999, BIOPHYS J, V77, P3034, DOI 10.1016/S0006-3495(99)77134-1; Lee JH, 1999, J NEUROSCI, V19, P1912; Leuranguer V, 2000, AM J PHYSIOL-HEART C, V279, pH2540, DOI 10.1152/ajpheart.2000.279.5.H2540; Lietz M, 2001, EUR J NEUROSCI, V14, P1303, DOI 10.1046/j.0953-816x.2001.01762.x; Lifanov AP, 2003, GENOME RES, V13, P579, DOI 10.1101/gr.668403; Liu CT, 1998, CANCER GENE THER, V5, P3; Maturana A, 2009, ENDOCRINOLOGY, V150, P3726, DOI 10.1210/en.2008-1727; McClelland S, 2011, ANN NEUROL, V70, P454, DOI 10.1002/ana.22479; McDade DM, 2009, BIOCHEM SOC T, V37, P1375, DOI 10.1042/BST0371375; McKay BE, 2006, EUR J NEUROSCI, V24, P2581, DOI 10.1111/j.1460-9568.2006.05136.x; Molineux ML, 2006, P NATL ACAD SCI USA, V103, P5555, DOI 10.1073/pnas.0601261103; Mucha M, 2010, J NEUROSCI, V30, P13235, DOI 10.1523/JNEUROSCI.1981-10.2010; Palm K, 1998, J NEUROSCI, V18, P1280; Powell KL, 2009, J NEUROSCI, V29, P371, DOI 10.1523/JNEUROSCI.5295-08.2009; RUSSO MW, 1995, P NATL ACAD SCI USA, V92, P6873, DOI 10.1073/pnas.92.15.6873; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Schoenherr CJ, 1996, P NATL ACAD SCI USA, V93, P9881, DOI 10.1073/pnas.93.18.9881; Shimojo M, 1999, MOL CELL BIOL, V19, P6788; Spencer EM, 2006, NEUROBIOL DIS, V24, P41, DOI 10.1016/j.nbd.2006.04.020; Su H, 2002, J NEUROSCI, V22, P3645; SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0; Svaren J, 1996, MOL CELL BIOL, V16, P3545; Thiel G, 1998, J BIOL CHEM, V273, P26891, DOI 10.1074/jbc.273.41.26891; THIEL G, 1994, J BIOL CHEM, V269, P15294; Uchida H, 2010, J NEUROSCI, V30, P4806, DOI 10.1523/JNEUROSCI.5541-09.2010; Wei F, 2000, J CELL BIOL, V149, P1325, DOI 10.1083/jcb.149.7.1325	53	53	54	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15489	15501		10.1074/jbc.M111.310763	http://dx.doi.org/10.1074/jbc.M111.310763			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22431737	Green Published, hybrid			2022-12-25	WOS:000304006300030
J	Carnes, J; Ernst, NL; Wickham, C; Panicucci, B; Stuart, K				Carnes, Jason; Ernst, Nancy Lewis; Wickham, Carey; Panicucci, Brian; Stuart, Kenneth			KREX2 Is Not Essential for Either Procyclic or Bloodstream Form Trypanosoma brucei	PLOS ONE			English	Article							EDITING ENDONUCLEASE; DISTINCT EDITOSOMES; ENERGY-METABOLISM; U-DELETION; INSERTION; PROTEINS; COMPLEX; TBMP42; PURIFICATION; MECHANISM	Background: Most mitochondrial mRNAs in Trypanosoma brucei require RNA editing for maturation and translation. The edited RNAs primarily encode proteins of the oxidative phosphorylation system. These parasites undergo extensive changes in energy metabolism between the insect and bloodstream stages which are mirrored by alterations in RNA editing. Two U-specific exonucleases, KREX1 and KREX2, are both present in protein complexes (editosomes) that catalyze RNA editing but the relative roles of each protein are not known. Methodology/Principal Findings: The requirement for KREX2 for RNA editing in vivo was assessed in both procyclic (insect) and bloodstream form parasites by methods that use homologous recombination for gene elimination. These studies resulted in null mutant cells in which both alleles were eliminated. The viability of these cells demonstrates that KREX2 is not essential in either life cycle stage, despite certain defects in RNA editing in vivo. Furthermore, editosomes isolated from KREX2 null cells require KREX1 for in vitro U-specific exonuclease activity. Conclusions: KREX2 is a U-specific exonuclease that is dispensable for RNA editing in vivo in T. brucei BFs and PFs. This result suggests that the U deletion activity, which is required for RNA editing, is primarily mediated in vivo by KREX1 which is normally found associated with only one type of editosome. The retention of the KREX2 gene implies a non-essential role or a role that is essential in other life cycle stages or conditions.	[Carnes, Jason; Ernst, Nancy Lewis; Wickham, Carey; Panicucci, Brian; Stuart, Kenneth] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Stuart, Kenneth] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA	Center for Infectious Disease Research; University of Washington; University of Washington Seattle	Carnes, J (corresponding author), Seattle Biomed Res Inst, 4 Nickerson St, Seattle, WA 98109 USA.	ken.stuart@sbri.org		Carnes, Jason/0000-0001-7302-1935	National Institutes of Health [AI014102]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI014102, R01AI014102] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant AI014102 (to KS) http://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aphasizhev R, 2011, RES MICROBIOL, V162, P655, DOI 10.1016/j.resmic.2011.04.015; Brecht M, 2005, MOL CELL, V17, P621, DOI 10.1016/j.molcel.2005.01.018; Bringaud F, 2006, MOL BIOCHEM PARASIT, V149, P1, DOI 10.1016/j.molbiopara.2006.03.017; Carnes J, 2005, P NATL ACAD SCI USA, V102, P16614, DOI 10.1073/pnas.0506133102; Carnes J, 2008, MOL CELL BIOL, V28, P122, DOI 10.1128/MCB.01374-07; Carnes J, 2011, J BIOL CHEM, V286, P19320, DOI 10.1074/jbc.M111.228965; Chang TH, 2002, J BIOL CHEM, V277, P50176, DOI 10.1074/jbc.M208374200; Coustou V, 2008, J BIOL CHEM, V283, P16342, DOI 10.1074/jbc.M709592200; Cruz-Reyes J, 2001, MOL CELL BIOL, V21, P884, DOI 10.1128/MCB.21.3.884-892.2001; Dlakic M, 2000, TRENDS BIOCHEM SCI, V25, P272, DOI 10.1016/S0968-0004(00)01582-6; Ernst NL, 2009, RNA, V15, P947, DOI 10.1261/rna.1373009; FEAGIN JE, 1987, CELL, V49, P337, DOI 10.1016/0092-8674(87)90286-8; Furuya T, 2002, P NATL ACAD SCI USA, V99, P14177, DOI 10.1073/pnas.222454899; Guther MLS, 2006, MOL BIOL CELL, V17, P5265, DOI 10.1091/mbc.E06-08-0702; Guo XM, 2008, MOL CELL BIOL, V28, P6939, DOI 10.1128/MCB.01115-08; Guther MLS, 2001, EMBO J, V20, P4923, DOI 10.1093/emboj/20.17.4923; Hajduk S, 2010, RNA BIOL, V7, P229, DOI 10.4161/rna.7.2.11393; Igo RP, 2000, MOL CELL BIOL, V20, P8447, DOI 10.1128/MCB.20.22.8447-8457.2000; Igo RP, 2002, EUKARYOT CELL, V1, P112, DOI 10.1128/EC.1.1.112-118.2002; Kable ML, 1996, SCIENCE, V273, P1189, DOI 10.1126/science.273.5279.1189; Kang XD, 2005, P NATL ACAD SCI USA, V102, P1017, DOI 10.1073/pnas.0409275102; Lamour N, 2005, J BIOL CHEM, V280, P11902, DOI 10.1074/jbc.M414274200; Law JA, 2008, RNA, V14, P1187, DOI 10.1261/rna.899508; Mian IS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-305; Niemann M, 2008, NUCLEIC ACIDS RES, V36, P4465, DOI 10.1093/nar/gkn410; Niemann M, 2009, NUCLEIC ACIDS RES, V37, P1897, DOI 10.1093/nar/gkp049; Panigrahi AK, 2001, MOL CELL BIOL, V21, P380, DOI 10.1128/MCB.21.2.380-389.2001; Panigrahi AK, 2006, RNA, V12, P1038, DOI 10.1261/rna.45506; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rogers K, 2007, J BIOL CHEM, V282, P29073, DOI 10.1074/jbc.M704551200; Roper JR, 2005, J BIOL CHEM, V280, P19728, DOI 10.1074/jbc.M502370200; Schnaufer A, 2003, MOL CELL, V12, P307, DOI 10.1016/S1097-2765(03)00286-7; Schnaufer A, 2001, SCIENCE, V291, P2159, DOI 10.1126/science.1058655; Schnaufer A, 2010, J BIOL CHEM, V285, P5282, DOI 10.1074/jbc.M109.059378; Seiwert SD, 1996, CELL, V84, P831, DOI 10.1016/S0092-8674(00)81062-4; Stuart KD, 2005, TRENDS BIOCHEM SCI, V30, P97, DOI 10.1016/j.tibs.2004.12.006; Stuart Kenneth, 2004, Methods Mol Biol, V265, P273; Trotter JR, 2005, MOL CELL, V20, P403, DOI 10.1016/j.molcel.2005.09.016; Verner Z, 2010, MOL BIOCH PARASITOL; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X	42	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2012	7	3							e33405	10.1371/journal.pone.0033405	http://dx.doi.org/10.1371/journal.pone.0033405			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RU	22438925	gold, Green Published, Green Submitted			2022-12-25	WOS:000303309000025
J	Aikin, R; Cervantes, A; D'Angelo, G; Ruel, L; Lacas-Gervais, S; Schaub, S; Therond, P				Aikin, Reid; Cervantes, Alexandra; D'Angelo, Gisela; Ruel, Laurent; Lacas-Gervais, Sandra; Schaub, Sebastien; Therond, Pascal			A Genome-Wide RNAi Screen Identifies Regulators of Cholesterol-Modified Hedgehog Secretion in Drosophila	PLOS ONE			English	Article							GPI-ANCHORED PROTEINS; LONG-RANGE; SONIC HEDGEHOG; ENDOPLASMIC-RETICULUM; MORPHOGEN GRADIENTS; GOLGI ORGANIZATION; SIGNALING CELLS; ER; TRANSPORT; PATHWAY	Hedgehog (Hh) proteins are secreted molecules that function as organizers in animal development. In addition to being palmitoylated, Hh is the only metazoan protein known to possess a covalently-linked cholesterol moiety. The absence of either modification severely disrupts the organization of numerous tissues during development. It is currently not known how lipid-modified Hh is secreted and released from producing cells. We have performed a genome-wide RNAi screen in Drosophila melanogaster cells to identify regulators of Hh secretion. We found that cholesterol-modified Hh secretion is strongly dependent on coat protein complex I (COPI) but not COPII vesicles, suggesting that cholesterol modification alters the movement of Hh through the early secretory pathway. We provide evidence that both proteolysis and cholesterol modification are necessary for the efficient trafficking of Hh through the ER and Golgi. Finally, we identified several putative regulators of protein secretion and demonstrate a role for some of these genes in Hh and Wingless (Wg) morphogen secretion in vivo. These data open new perspectives for studying how morphogen secretion is regulated, as well as provide insight into regulation of lipid-modified protein secretion.	[Aikin, Reid; Cervantes, Alexandra; D'Angelo, Gisela; Ruel, Laurent; Schaub, Sebastien; Therond, Pascal] Ctr Biochim, IBV, CNRS, INSERM,UMR 7277,UMR 1091, Nice, France; [Lacas-Gervais, Sandra] Univ Nice Sophia Antipolis, CCMA, Nice, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur	Aikin, R (corresponding author), McGill Univ, Ctr Hlth, Montreal, PQ, Canada.	therond@unice.fr	Therond, pascal/AAE-4811-2019	Schaub, Sebastien/0000-0002-9624-3271; D'ANGELO, Gisela/0000-0003-3150-2241	Ligue Contre le Cancer; French Embassy; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067761] Funding Source: NIH RePORTER	Ligue Contre le Cancer(Ligue nationale contre le cancer); French Embassy; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Ligue Contre le Cancer, "equipe labelisee 2008" to PT. RA was supported by a postdoctoral fellowship from the Ligue Contre le Cancer and the Chateaubriand Fellowship (French Embassy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong JA, 2002, EMBO J, V21, P5245, DOI 10.1093/emboj/cdf517; Ashe HL, 2006, DEVELOPMENT, V133, P385, DOI 10.1242/dev.02238; Banziger C, 2006, CELL, V125, P509, DOI 10.1016/j.cell.2006.02.049; Bard F, 2006, NATURE, V439, P604, DOI 10.1038/nature04377; Beller M, 2008, PLOS BIOL, V6, P2530, DOI 10.1371/journal.pbio.0060292; Belloni E, 1996, NAT GENET, V14, P353, DOI 10.1038/ng1196-353; Borgonovo B, 2006, CURR OPIN CELL BIOL, V18, P365, DOI 10.1016/j.ceb.2006.06.010; Burke R, 1999, CELL, V99, P803, DOI 10.1016/S0092-8674(00)81677-3; Caspary T, 2002, CURR BIOL, V12, P1628, DOI 10.1016/S0960-9822(02)01147-8; Chamoun Z, 2001, SCIENCE, V293, P2080, DOI 10.1126/science.1064437; Chen MH, 2004, GENE DEV, V18, P641, DOI 10.1101/gad.1185804; Chen X, 2011, J CELL BIOL, V192, P825, DOI 10.1083/jcb.201008090; Cherry S, 2006, PLOS PATHOG, V2, P900, DOI 10.1371/journal.ppat.0020102; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Chu TY, 2006, DEV CELL, V10, P635, DOI 10.1016/j.devcel.2006.03.003; Delacour D, 2007, TRAFFIC, V8, P379, DOI 10.1111/j.1600-0854.2007.00539.x; Eldar A, 2003, DEV CELL, V5, P635, DOI 10.1016/S1534-5807(03)00292-2; Friggi-Grelin F, 2006, EUR J CELL BIOL, V85, P1155, DOI 10.1016/j.ejcb.2006.07.001; Gallet A, 2006, DEVELOPMENT, V133, P407, DOI 10.1242/dev.02212; Gallet A, 2003, DEV CELL, V4, P191, DOI 10.1016/S1534-5807(03)00031-5; Greaves J, 2007, J CELL BIOL, V176, P249, DOI 10.1083/jcb.200610151; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Hasdemir B, 2005, J CELL BIOL, V171, P459, DOI 10.1083/jcb.200506005; INGHAM PW, 1995, CURR BIOL, V5, P432, DOI 10.1016/S0960-9822(95)00084-4; Irons DJ, 2010, DEV BIOL, V342, P180, DOI 10.1016/j.ydbio.2010.03.022; Jaeger J, 2008, DEVELOPMENT, V135, P3175, DOI 10.1242/dev.018697; Kondylis V, 2003, J CELL BIOL, V162, P185, DOI 10.1083/jcb.200301136; Kondylis V, 2007, DEV CELL, V12, P901, DOI 10.1016/j.devcel.2007.03.008; Kondylis V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017173; Kulkarni MM, 2006, NAT METHODS, V3, P833, DOI 10.1038/nmeth935; Lang MR, 2006, NAT GENET, V38, P1198, DOI 10.1038/ng1880; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Long KR, 2010, J CELL BIOL, V190, P115, DOI 10.1083/jcb.201004132; Ma Y, 2002, CELL, V111, P63, DOI 10.1016/S0092-8674(02)00977-7; Maity T, 2005, P NATL ACAD SCI USA, V102, P17026, DOI 10.1073/pnas.0507848102; Mayor S, 2004, NAT REV MOL CELL BIO, V5, P110, DOI 10.1038/nrm1309; Mohrmann L, 2004, MOL CELL BIOL, V24, P3077, DOI 10.1128/MCB.24.8.3077-3088.2004; Muniz M, 2001, CELL, V104, P313, DOI 10.1016/S0092-8674(01)00215-X; Neumann CJ, 1996, DEVELOPMENT, V122, P3477; Nickel W, 2008, NAT REV MOL CELL BIO; Paladino S, 2004, J CELL BIOL, V167, P699, DOI 10.1083/jcb.200407094; PORTER JA, 1995, NATURE, V374, P363, DOI 10.1038/374363a0; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; Porter JA, 1996, CELL, V86, P21, DOI 10.1016/S0092-8674(00)80074-4; Rabouille C, 1999, J CELL SCI, V112, P3319; Rietveld A, 1999, J BIOL CHEM, V274, P12049, DOI 10.1074/jbc.274.17.12049; Roessler E, 1996, NAT GENET, V14, P357, DOI 10.1038/ng1196-357; Rubin LL, 2006, NAT REV DRUG DISCOV, V5, P1026, DOI 10.1038/nrd2086; Ruel L, 2003, NAT CELL BIOL, V5, P907, DOI 10.1038/ncb1052; Schepetilnikov MV, 2005, J GEN VIROL, V86, P2379, DOI 10.1099/vir.0.80865-0; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; SEMENZA JC, 1990, CELL, V61, P1349, DOI 10.1016/0092-8674(90)90698-E; Siddiqi SA, 2003, J CELL SCI, V116, P415, DOI 10.1242/jcs.00215; Strigini M, 2000, CURR BIOL, V10, P293, DOI 10.1016/S0960-9822(00)00378-X; Sutterlin C, 1997, J CELL SCI, V110, P2703; Therond PP, 1996, P NATL ACAD SCI USA, V93, P4224, DOI 10.1073/pnas.93.9.4224; Tokhunts R, 2010, J BIOL CHEM, V285, P2562, DOI 10.1074/jbc.M109.078626; Tormakangas K, 2001, PLANT CELL, V13, P2021, DOI 10.1105/tpc.13.9.2021; Torroja C, 2004, DEVELOPMENT, V131, P2395, DOI 10.1242/dev.01102; Vyas N, 2008, CELL, V133, P1214, DOI 10.1016/j.cell.2008.05.026; Wang YC, 2010, ENDOCR-RELAT CANCER, V17, P283, DOI 10.1677/ERC-09-0243; Wendler F, 2010, EMBO J, V29, P304, DOI 10.1038/emboj.2009.350	62	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e33665	10.1371/journal.pone.0033665	http://dx.doi.org/10.1371/journal.pone.0033665			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22432040	Green Published, Green Submitted, gold			2022-12-25	WOS:000303198600083
J	McGivern, RF; Adams, B; Handa, RJ; Pineda, JA				McGivern, Robert F.; Adams, Brian; Handa, Robert J.; Pineda, Jaime A.			Men and Women Exhibit a Differential Bias for Processing Movement versus Objects	PLOS ONE			English	Article							CONGENITAL ADRENAL-HYPERPLASIA; VISUAL RECOGNITION MEMORY; MIRROR-NEURON SYSTEM; SEX-DIFFERENCES; GENDER-DIFFERENCES; LOCATION MEMORY; EPISODIC MEMORY; WATER MAZE; TOP-DOWN; ROTATION	Sex differences in many spatial and verbal tasks appear to reflect an inherent low-level processing bias for movement in males and objects in females. We explored this potential movement/object bias in men and women using a computer task that measured targeting performance and/or color recognition. The targeting task showed a ball moving vertically towards a horizontal line. Before reaching the line, the ball disappeared behind a masking screen, requiring the participant to imagine the movement vector and identify the intersection point. For the color recognition task, the ball briefly changed color before disappearing beneath the mask and participants were required only to identify the color shade. Results showed that targeting accuracy for slow and fast moving balls was significantly better in males compared to females. No sex difference was observed for color shade recognition. We also studied a third, dual attention task comprised of the first two, where the moving ball briefly changed color randomly just before passing beneath the masking screen. When the ball changed color, participants were required only to identify the color shade. If the ball didn't change color, participants estimated the intersection point. Participants in this dual attention condition were first tested with the targeting and color tasks alone and showed results that were similar to the previous groups tested on a single task. However, under the dual attention condition, male accuracy in targeting, as well as color shade recognition, declined significantly compared to their performance when the tasks were tested alone. No significant changes were found in female performance. Finally, reaction times for targeting and color choices in both sexes correlated highly with ball speed, but not accuracy. Overall, these results provide evidence of a sex-related bias in processing objects versus movement, which may reflect sex differences in bottom up versus top-down analytical strategies.	[McGivern, Robert F.; Adams, Brian] San Diego State Univ, Dept Psychol, San Diego, CA 92182 USA; [Handa, Robert J.] Univ Arizona, Dept Basic Med Sci, Coll Med, Phoenix, AZ USA; [Pineda, Jaime A.] Univ Calif San Diego, Dept Cognit Sci & Neurosci, La Jolla, CA 92093 USA	California State University System; San Diego State University; University of Arizona; University of California System; University of California San Diego	McGivern, RF (corresponding author), San Diego State Univ, Dept Psychol, San Diego, CA 92182 USA.	mcgivern@sunstroke.sdsu.edu			University of California San Diego [RJ145G]	University of California San Diego(University of California System)	The work was supported in part by University of California San Diego Academic Senate Grant RJ145G (Pineda). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander GM, 2002, EVOL HUM BEHAV, V23, P467, DOI 10.1016/S1090-5138(02)00107-1; Alexander GM, 2002, NEUROPSYCHOLOGIA, V40, P1516, DOI 10.1016/S0028-3932(01)00215-9; [Anonymous], 2008, SEX DIFFERENCES BRAI; BEATTY WW, 1984, PROG BRAIN RES, V61, P315; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Butler T, 2006, NEUROIMAGE, V32, P445, DOI 10.1016/j.neuroimage.2006.03.030; Chai XJ, 2009, BEHAV NEUROSCI, V123, P276, DOI 10.1037/a0014722; Cheng Y, 2009, NEUROSCIENCE, V158, P713, DOI 10.1016/j.neuroscience.2008.10.026; Cheng YW, 2006, NEUROREPORT, V17, P1115, DOI 10.1097/01.wnr.0000223393.59328.21; Cheng YW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002113; Choi J, 2005, LEARN INDIVID DIFFER, V15, P237, DOI 10.1016/j.lindif.2005.02.001; Cleveland A, 2003, AM J PRIMATOL, V61, P159, DOI 10.1002/ajp.10120; Committeri G, 2004, J COGNITIVE NEUROSCI, V16, P1517, DOI 10.1162/0898929042568550; DESROCHER ME, 1995, BRAIN COGNITION, V28, P14, DOI 10.1006/brcg.1995.1031; Ellis L., 2008, SEX DIFFERENCES SUMM; Gallese V, 2007, PSYCHE, V7, P1; Gallese V, 2009, DEV PSYCHOL, V45, P103, DOI 10.1037/a0014436; Golarai G, 2007, NAT NEUROSCI, V10, P512, DOI 10.1038/nn1865; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Goy R. W., 1980, SEXUAL DIFFERENTIATI; Grill-Spector K, 2003, CURR OPIN NEUROBIOL, V13, P159, DOI 10.1016/S0959-4388(03)00040-0; Handa R., 2002, ANDROGENS ANDROGEN R; Herman RA, 2007, HORM BEHAV, V51, P496, DOI 10.1016/j.yhbeh.2007.01.005; Hines M, 2003, PSYCHONEUROENDOCRINO, V28, P1010, DOI 10.1016/S0306-4530(02)00121-X; HINES M, 1994, CHILD DEV, V65, P1042; Hugdahl K, 2006, NEUROPSYCHOLOGIA, V44, P1575, DOI 10.1016/j.neuropsychologia.2006.01.026; Iijima M, 2001, HORM BEHAV, V40, P99, DOI 10.1006/hbeh.2001.1670; James TW, 1997, EVOL HUM BEHAV, V18, P155, DOI 10.1016/S1090-5138(97)00004-4; Jeannerod M., 1997, COGNITIVE NEUROSCIEN; Jordan K, 2002, NEUROPSYCHOLOGIA, V40, P2397, DOI 10.1016/S0028-3932(02)00076-3; Kansaku K, 2001, NEUROSCI RES, V41, P333, DOI 10.1016/S0168-0102(01)00292-9; Kimura Doreen, 1999, SEX COGNITION; Kravitz DJ, 2011, NAT REV NEUROSCI, V12, P217, DOI 10.1038/nrn3008; Lejbak L, 2009, BR COGN, V67, P148; Lewin C, 2001, NEUROPSYCHOLOGY, V15, P165, DOI 10.1037//0894-4105.15.2.165; Maccoby EE, 1974, PSYCHOL SEX DIFFEREN, VI; Maylor EA, 2007, ARCH SEX BEHAV, V36, P235, DOI 10.1007/s10508-006-9155-y; McGivern RF, 1997, BRAIN COGNITION, V34, P323, DOI 10.1006/brcg.1997.0872; McGivern RF, 1998, PERS INDIV DIFFER, V25, P223, DOI 10.1016/S0191-8869(98)00017-8; MCGIVERN RF, 1984, SCIENCE, V224, P896, DOI 10.1126/science.6719121; Mueller SC, 2008, BEHAV BRAIN RES, V193, P209, DOI 10.1016/j.bbr.2008.05.017; PerrotSinal TS, 1996, BEHAV NEUROSCI, V110, P1309, DOI 10.1037/0735-7044.110.6.1309; Pineda JA, 2005, BRAIN RES REV, V50, P57, DOI 10.1016/j.brainresrev.2005.04.005; Ragland JD, 2000, NEUROPSYCHOLOGIA, V38, P451, DOI 10.1016/S0028-3932(99)00086-X; Rodriguez CA, 2010, J EXP PSYCHOL-ANIM B, V36, P395, DOI 10.1037/a0017297; Saucier DM, 2002, BEHAV NEUROSCI, V116, P403, DOI 10.1037//0735-7044.116.3.403; Schiller PH, 2005, PROG BRAIN RES, V149, P157, DOI 10.1016/S0079-6123(05)49012-3; Silverman I., 1992, ADAPTED MIND EVOLUTI, P533; Simon-Dack SL, 2009, NEUROREPORT, V20, P105, DOI 10.1097/WNR.0b013e32831befc1; Terlecki MS, 2008, APPL COGNITIVE PSYCH, V22, P996, DOI 10.1002/acp.1420; Terlecki MS, 2005, SEX ROLES, V53, P433, DOI 10.1007/s11199-005-6765-0; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; Voyer D, 2001, BR COGN, V79, P2445; Voyer D, 2007, PSYCHON B REV, V14, P23, DOI 10.3758/BF03194024; WATSON NV, 1991, PERS INDIV DIFFER, V12, P375, DOI 10.1016/0191-8869(91)90053-E; Weiss E, 2003, NEUROSCI LETT, V344, P169, DOI 10.1016/S0304-3940(03)00406-3; WILLIAMS CL, 1990, BEHAV NEUROSCI, V104, P84, DOI 10.1037/0735-7044.104.1.84; Wood W, 2002, PSYCHOL BULL, V128, P699, DOI 10.1037//0033-2909.128.5.699; Yu QB, 2009, NEUROREPORT, V20, P43, DOI 10.1097/WNR.0b013e32831c50f4; Zaehle T, 2007, BRAIN RES, V1137, P92, DOI 10.1016/j.brainres.2006.12.044	61	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e32238	10.1371/journal.pone.0032238	http://dx.doi.org/10.1371/journal.pone.0032238			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	931EO	22431972	Green Published, gold			2022-12-25	WOS:000303198600015
J	Wilson, SE; Ouedraogo, CT; Prince, L; Ouedraogo, A; Hess, SY; Rouamba, N; Ouedraogo, JB; Vosti, SA; Brown, KH				Wilson, Shelby E.; Ouedraogo, Cesaire T.; Prince, Lea; Ouedraogo, Amadou; Hess, Sonja Y.; Rouamba, Noeel; Ouedraogo, Jean Bosco; Vosti, Stephen A.; Brown, Kenneth H.			Caregiver Recognition of Childhood Diarrhea, Care Seeking Behaviors and Home Treatment Practices in Rural Burkina Faso: A Cross-Sectional Survey	PLOS ONE			English	Article							INTEGRATED MANAGEMENT; ILLNESS	Introduction: To design effective national diarrhea control programs, including oral rehydration solution (ORS) and therapeutic zinc supplementation, information is needed on local perceptions of illness, external care seeking behaviors, and home treatment practices. Methods: A cross-sectional, community-based household survey was conducted in the Orodara Health District, Burkina Faso. Caregivers of 10,490 children <27 months were interviewed to assess child diarrhea prevalence and related care practices. Characteristics of households, caregivers, children, and reported illnesses were compared for those caregivers who did or did not recognize the presence of diarrhea, as defined according to clinical criteria (>= 3 liquid or semi-liquid stools/day). Multiple logistic regression models were used to examine factors associated with illness recognition and treatment. Results: Clinically defined diarrhea was present in 7.6% (95% CI: 7.1-8.1%) of children during the 24 hours preceding the survey but recognized by only 55% of caregivers. Over half (55%) of the caregivers of 1,067 children with a clinically defined diarrhea episode in the past 14 days sought care outside the home; 78% of those seeking care attended a public sector clinic. Care was sought and treatment provided more frequently for children with fever, vomiting, anorexia, longer illness duration, and those living closer to the health center; and care was sought more frequently for male children. 80% of children with recent diarrhea received some form of treatment; only 24% received ORS, whereas 14% received antibiotics. Zinc was not yet available in the study area. Conclusions: Caregivers frequently fail to recognize children's diarrhea, especially among younger infants and when illness signs are less severe. Treatment practices do not correspond with international recommendations in most cases, even when caregivers consult with formal health services. Child caregivers need additional assistance to recognize diarrhea correctly, and both caregivers and health care providers need updated training on current diarrhea treatment recommendations.	[Wilson, Shelby E.; Hess, Sonja Y.; Brown, Kenneth H.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Ouedraogo, Cesaire T.; Ouedraogo, Amadou; Rouamba, Noeel; Ouedraogo, Jean Bosco] Inst Rech Sci Sante, Bobo Dioulasso, Burkina Faso; [Prince, Lea; Vosti, Stephen A.] Univ Calif Davis, Dept Agr & Resource Econ, Davis, CA 95616 USA; [Brown, Kenneth H.] Helen Keller Int, Dakar, Senegal	University of California System; University of California Davis; University of California System; University of California Davis	Brown, KH (corresponding author), Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA.	khbrown@ucdavis.edu		Hess, Sonja/0000-0002-4661-277X; Ouedraogo, Jean Bosco/0000-0003-0412-8733; Ouedraogo, Cesaire/0000-0003-0634-3226	Thrasher Research Fund; Canadian International Development Agency; Orodara Health District; Helen Keller International office in Ouagadougou	Thrasher Research Fund; Canadian International Development Agency; Orodara Health District; Helen Keller International office in Ouagadougou	This study was supported in part by the Thrasher Research Fund and the Canadian International Development Agency by a grant to Helen Keller International. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We greatly appreciate the contributions of the entire study team, including field workers, supervisors, data management and other support staff. We are grateful for the support of the staff at the Orodara Health District and the Helen Keller International office in Ouagadougou. We thank Judicael Some, Oula Ouattara, and Honore Konate of the Institut de Recherche en Sciences de la Sante in Bobo-Dioulasso for assistance with the study implementation, Janet M. Peerson (University of California Davis) for guidance on statistical analyses, and Elizabeth A. Yakes (University of California Davis) for careful review of the manuscript and helpful suggestions. Finally, we sincerely appreciate the support of the children, their parents, and local communities whose participation and support made this survey possible.	[Anonymous], 2004, CLIN MAN AC DIARRH; BLACK RE, 1991, ACTA PAEDIATR SCAND, P133; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Boschi-Pinto C, 2009, MATERNAL AND CHILD HEALTH: GLOBAL CHALLENGES, PROGRAMS AND POLICIES, P225, DOI 10.1007/b106524_13; Checkley W, 2008, INT J EPIDEMIOL, V37, P816, DOI 10.1093/ije/dyn099; COGSWELL ME, 1991, SOC SCI MED, V33, P1209, DOI 10.1016/0277-9536(91)90237-7; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.1353/dem.2001.0003; Gove S, 1997, B WORLD HEALTH ORGAN, V75, P7; Koepsell T. D, 2003, EPIDEMIOLOGIC METHOD; Lambrechts T, 1999, B WORLD HEALTH ORGAN, V77, P582; Larson CP, 2011, HLTH POLICY PLAN, P1; Niehaus MD, 2002, AM J TROP MED HYG, V66, P590, DOI 10.4269/ajtmh.2002.66.590; Podewils Laura Jean, 2004, Semin Pediatr Infect Dis, V15, P155, DOI 10.1053/j.spid.2004.05.008; Tulloch J, 1999, LANCET, V354, pS16; UNICEF and World Health Organization, 2009, DIARRH WHY CHILDR ST; Winch PJ, 2008, J HEALTH POPUL NUTR, V26, P151; Winch PJ, 2002, HEALTH POLICY PLANN, V17, P345, DOI 10.1093/heapol/17.4.345; World Health Organization, 1995, TREATM DIARRH MAN PH; World Health Organization, 2004, FAM COMM PRACT PROM	19	28	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2012	7	3							e33273	10.1371/journal.pone.0033273	http://dx.doi.org/10.1371/journal.pone.0033273			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	930IA	22428006	gold, Green Published			2022-12-25	WOS:000303129700045
J	Dyson, OF; Walker, LR; Whitehouse, A; Cook, PP; Akula, SM				Dyson, Ossie F.; Walker, Lia R.; Whitehouse, Adrian; Cook, Paul P.; Akula, Shaw M.			Resveratrol Inhibits KSHV Reactivation by Lowering the Levels of Cellular EGR-1	PLOS ONE			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; TRANSCRIPTION FACTOR EGR-1; KAPOSIS-SARCOMA; GENE-EXPRESSION; B-CELLS; LYMPHOMA-CELLS; INFECTED-CELLS; VIRAL LATENCY; KAPPA-B; VIRUS	In the field of herpesvirus research, the exact molecular mechanism by which such viruses reactivate from latency remains elusive. Kaposi's sarcoma-associated herpesvirus (KSHV) primarily exists in a latent state, while only 1-3% of cells support lytic infection at any specific time. KSHV reactivation from latency is an exceedingly intricate process mediated by the integration of viral and cellular factors. Previously, our lab has described early growth response-1 (Egr-1) as an essential component for the KSHV reactivation process via its ability to mediate transcription of KSHV ORF50, the gene encoding for replication and transcription activator (RTA), a viral component known to control the switch from latent to lytic infection. In here, electrophoretic mobility shift assays (EMSA) and chromatin immunoprecipitation (ChIP) experiments revealed that Egr-1 binds KSHV ORF50 promoter (ORF50P) in at least two different GC-rich binding domains. Expression profiles of cellular egr-1 and KSHV-encoded ORF50 follow a similar pattern during de novo KSHV infection. Over-expressing Egr-1, a signaling component downstream of Raf>MEK>ERK1/2, in KSHV-infected cells activates KSHV lytic replication. Through performing more physiologically relevant experiments, we analyzed the effect of a dietary supplement containing resveratrol on KSHV-infected cells. Our results, for the first time, demonstrate resveratrol to act in lowering ERK1/2 activity and expression of Egr-1 in KSHV-infected cells, resulting in the suppression of virus reactivation from latency. Taken together, these findings will undoubtedly contribute to future studies on not only combating KSHV related disease conditions, but also on other herpesviruses-induced pathogenesis.	[Dyson, Ossie F.; Walker, Lia R.; Akula, Shaw M.] E Carolina Univ, Brody Sch Med, Dept Microbiol & Immunol, Greenville, NC 27858 USA; [Cook, Paul P.] E Carolina Univ, Brody Sch Med, Dept Internal Med, Greenville, NC USA; [Whitehouse, Adrian] Univ Leeds, Fac Biol Sci, Inst Mol & Cellular Biol, Leeds, W Yorkshire, England	University of North Carolina; East Carolina University; University of North Carolina; East Carolina University; University of Leeds	Dyson, OF (corresponding author), E Carolina Univ, Brody Sch Med, Dept Microbiol & Immunol, Greenville, NC 27858 USA.	akulas@ecu.edu	Walker, Lia/GYJ-3130-2022	Whitehouse, Adrian/0000-0003-3866-7110	National Institutes of Health (NIH), National Institute of Biomedical Imaging and Bioengineering (NIBIB) [R21EB006483, 5F31CA132560-02]; NATIONAL CANCER INSTITUTE [F31CA132560] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB006483] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/G022836/1] Funding Source: researchfish; BBSRC [BB/G022836/1] Funding Source: UKRI	National Institutes of Health (NIH), National Institute of Biomedical Imaging and Bioengineering (NIBIB)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by National Institutes of Health (NIH), National Institute of Biomedical Imaging and Bioengineering (NIBIB), Grants R21EB006483 and 5F31CA132560-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2006, VET MICROBIOL, V113, P211, DOI 10.1016/j.vetmic.2005.11.008; Aggarwal BB, 2004, ANTICANCER RES, V24, P2783; Akula SM, 2002, CELL, V108, P407, DOI 10.1016/S0092-8674(02)00628-1; Akula SM, 2001, VIROLOGY, V284, P235, DOI 10.1006/viro.2001.0921; Beck H, 2008, AM J PATHOL, V173, P77, DOI 10.2353/ajpath.2008.070648; Bedadala GR, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-262; Brown HJ, 2003, J VIROL, V77, P8532, DOI 10.1128/JVI.77.15.8532-8540.2003; Bryan BA, 2006, J GEN VIROL, V87, P519, DOI 10.1099/vir.0.81603-0; Cai QL, 2010, J VIROL, V84, P11134, DOI 10.1128/JVI.01293-10; Cai YY, 2006, VIROLOGY, V355, P152, DOI 10.1016/j.virol.2006.07.012; CAO XM, 1993, J BIOL CHEM, V268, P16949; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chang Y, 1996, INFECT AGENT DIS, V5, P215; Chen L, 2005, J VIROL, V79, P14383, DOI 10.1128/JVI.79.22.14383-14391.2005; Cohen A, 2006, J GEN VIROL, V87, P795, DOI 10.1099/vir.0.81619-0; De Leo A, 2011, MOL CANCER RES, V9, P1346, DOI 10.1158/1541-7786.MCR-11-0145; de Sanjose S, 2009, J INFECT DIS, V199, P1449, DOI 10.1086/598523; Docherty JJ, 2006, ANTIVIR RES, V72, P171, DOI 10.1016/j.antiviral.2006.07.004; Dyson OF, 2008, CELL MICROBIOL, V10, P1546, DOI 10.1111/j.1462-5822.2008.01149.x; Dyson OF, 2007, INTERVIROLOGY, V50, P245, DOI 10.1159/000101995; Dyson OF, 2010, J BIOL CHEM, V285, P37491, DOI 10.1074/jbc.M110.159103; Fagone E, 2011, EXP LUNG RES, V37, P162, DOI 10.3109/01902148.2010.524722; Faith SA, 2006, ANTIVIR RES, V72, P242, DOI 10.1016/j.antiviral.2006.06.011; Ford PW, 2006, J GEN VIROL, V87, P1139, DOI 10.1099/vir.0.81628-0; Ford PW, 2004, CANC BIOL THER, P3; GASHLER A, 1995, PROG NUCLEIC ACID RE, V50, P191, DOI 10.1016/S0079-6603(08)60815-6; Glaunsinger B, 2004, MOL CELL, V13, P713, DOI 10.1016/S1097-2765(04)00091-7; Hua J, 2011, INVEST OPHTH VIS SCI, V52, P2809, DOI 10.1167/iovs.10-6496; Katsarou K, 2010, CELL MOL LIFE SCI, V67, P2491, DOI 10.1007/s00018-010-0351-5; Ke JY, 2006, J BIOL CHEM, V281, P39806, DOI 10.1074/jbc.M604671200; Knapska E, 2004, PROG NEUROBIOL, V74, P183, DOI 10.1016/j.pneurobio.2004.05.007; Krishnan V, 2004, J VIROL, V78, P9458, DOI 10.1128/JVI.78.17.9458-9473.2004; Lee SJ, 2011, LIFE SCI, V88, P465, DOI 10.1016/j.lfs.2011.01.005; Lukac DM, 1999, J VIROL, V73, P9348, DOI 10.1128/JVI.73.11.9348-9361.1999; Matsumura S, 2005, J VIROL, V79, P8493, DOI 10.1128/JVI.79.13.8493-8505.2005; MCCOY C, 1995, MOL CELL BIOL, V15, P6100; Nakamura M, 2010, WORLD J GASTROENTERO, V16, P184, DOI 10.3748/wjg.v16.i2.184; Renne R, 1996, NAT MED, V2, P342, DOI 10.1038/nm0396-342; Romagnoli L, 2008, VIROLOGY, V375, P331, DOI 10.1016/j.virol.2008.02.021; Sauer L, 2010, ONCOGENE, V29, P2628, DOI 10.1038/onc.2010.24; Shukla Y, 2011, ANN NY ACAD SCI, V1215, P1, DOI 10.1111/j.1749-6632.2010.05870.x; Thiel G, 2002, J CELL PHYSIOL, V193, P287, DOI 10.1002/jcp.10178; Venkatesan B, 2009, AM J PHYSIOL-HEART C, V297, pH874, DOI 10.1152/ajpheart.00311.2009; Yiu CY, 2010, MOLECULES, V15, P7115, DOI 10.3390/molecules15107115; Yu FQ, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030044; Yu FQ, 2007, FEBS LETT, V581, P3485, DOI 10.1016/j.febslet.2007.06.056; Yu HW, 2010, BIOCHEM BIOPH RES CO, V396, P451, DOI 10.1016/j.bbrc.2010.04.115	47	25	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33364	10.1371/journal.pone.0033364	http://dx.doi.org/10.1371/journal.pone.0033364			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22428032	Green Published, gold, Green Submitted			2022-12-25	WOS:000302381500133
J	Panrat, T; Sinthujaroen, P; Nupan, B; Wanna, W; Tammi, MT; Phongdara, A				Panrat, Tanate; Sinthujaroen, Patuma; Nupan, Benjamas; Wanna, Warapond; Tammi, Martti Tapani; Phongdara, Amornrat			Characterization of a Novel Binding Protein for Fortilin/TCTP - Component of a Defense Mechanism against Viral Infection in Penaeus monodon	PLOS ONE			English	Article							SPOT SYNDROME VIRUS; CONTROLLED TUMOR PROTEIN; LOW-COMPLEXITY REGIONS; IDENTIFICATION; SHRIMP; DOMAIN; GENE; TRANSDUCTION; EXPRESSION; CELLS	The Fortilin (also known as TCTP) in Penaeus monodon (PmFortilin) and Fortilin Binding Protein 1 (FBP1) have recently been shown to interact and to offer protection against the widespread White Spot Syndrome Virus infection. However, the mechanism is yet unknown. We investigated this interaction in detail by a number of in silico and in vitro analyses, including prediction of a binding site between PmFortilin/FBP1 and docking simulations. The basis of the modeling analyses was well-conserved PmFortilin orthologs, containing a Ca2+-binding domain at residues 76-110 representing a section of the helical domain, the translationally controlled tumor protein signature 1 and 2 (TCTP_1, TCTP_2) at residues 45-55 and 123-145, respectively. We found the pairs Cys59 and Cys76 formed a disulfide bond in the C-terminus of FBP1, which is a common structural feature in many exported proteins and the "x-G-K-K" pattern of the amidation site at the end of the C-terminus. This coincided with our previous work, where we found the "x-P-P-x" patterns of an antiviral peptide also to be located in the C-terminus of FBP1. The combined bioinformatics and in vitro results indicate that FBP1 is a transmembrane protein and FBP1 interact with N-terminal region of PmFortilin.	[Panrat, Tanate; Sinthujaroen, Patuma; Nupan, Benjamas; Wanna, Warapond; Tammi, Martti Tapani; Phongdara, Amornrat] Prince Songkla Univ, Fac Sci, Ctr Genom & Bioinformat Res, Hat Yai, Thailand; [Tammi, Martti Tapani] Univ Malaya, Inst Biol Sci, Ctr Res Biotechnol Agr, Kuala Lumpur, Malaysia	Prince of Songkla University; Universiti Malaya	Panrat, T (corresponding author), Prince Songkla Univ, Fac Sci, Ctr Genom & Bioinformat Res, Hat Yai, Thailand.	marttit@gmail.com; pamornra@yahoo.com	Panrat, Tanate/J-8841-2013	Panrat, Tanate/0000-0002-8511-9283	Office of the Higher Education Commission, Thailand [63/2551, 94/2550]; Royal Golden Jubilee Ph.D. Program [PHD/0041/2549]; National Research University of Thailand's Office of the Higher Education Commission [SCI540527b]	Office of the Higher Education Commission, Thailand; Royal Golden Jubilee Ph.D. Program(Thailand Research Fund (TRF)); National Research University of Thailand's Office of the Higher Education Commission	This work was supported by a grant from under The Program Strategic Scholarships for Frontier Research Network for the Ph.D. Program Thai Doctoral degree from the Office of the Higher Education Commission, Thailand (63/2551 to T.P. and 94/2550 to B.N.), The Royal Golden Jubilee Ph.D. Program (PHD/0041/2549 to P.S.), the National Research University of Thailand's Office of the Higher Education Commission of financial support (SCI540527b to W.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bangrak P, 2004, J BIOTECHNOL, V108, P219, DOI 10.1016/j.jbiotec.2003.12.007; BENNDORF R, 1988, EXP CELL RES, V174, P130, DOI 10.1016/0014-4827(88)90148-6; Bommer UA, 2004, INT J BIOCHEM CELL B, V36, P379, DOI 10.1016/S1357-2725(03)00213-9; Coletta A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-43; Comeau SR, 2007, PROTEINS, V69, P781, DOI 10.1002/prot.21795; DeLano W.L., PYMOL MOL GRAPHICS S; DePristo MA, 2006, GENE, V378, P19, DOI 10.1016/j.gene.2006.03.023; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Gachet Y, 1999, J CELL SCI, V112, P1257; Graidist P, 2004, J BIOL CHEM, V279, P40868, DOI 10.1074/jbc.M401454200; Graidist P, 2007, BIOCHEM J, V408, P181, DOI 10.1042/BJ20070679; Graidist P, 2006, AQUACULTURE, V255, P157, DOI 10.1016/j.aquaculture.2005.12.023; Guerler A, 2008, PROTEIN SCI, V17, P1374, DOI 10.1110/ps.035469.108; Jiravanichpaisal P, 2006, FISH SHELLFISH IMMUN, V20, P718, DOI 10.1016/j.fsi.2005.09.002; JORY DE, 1999, AQUACULTURE MAGAZINE, V25, P83; Jung J, 2004, J BIOL CHEM, V279, P49868, DOI 10.1074/jbc.M400895200; Kang HS, 2001, J IMMUNOL, V166, P6545, DOI 10.4049/jimmunol.166.11.6545; Kim M, 2000, ARCH PHARM RES, V23, P633, DOI 10.1007/BF02975253; Kim M, 2011, EUR J PHARM SCI, V43, P25, DOI 10.1016/j.ejps.2011.03.007; Kim M, 2011, BIOMATERIALS, V32, P222, DOI 10.1016/j.biomaterials.2010.08.077; Kozakov D, 2006, PROTEINS, V65, P392, DOI 10.1002/prot.21117; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pW89, DOI 10.1093/nar/gki414; Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Li F, 2001, J BIOL CHEM, V276, P47542, DOI 10.1074/jbc.M108954200; Maeda M, 2004, J VIROL METHODS, V116, P89, DOI 10.1016/j.jviromet.2003.10.013; Sanchez JC, 1997, ELECTROPHORESIS, V18, P150, DOI 10.1002/elps.1150180127; Sangamaheswaran A.P., 2001, Naga, V24, P16; Sarathi M, 2008, MAR BIOTECHNOL, V10, P198, DOI 10.1007/s10126-007-9052-y; Schwarze SR, 2000, TRENDS CELL BIOL, V10, P290, DOI 10.1016/S0962-8924(00)01771-2; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Sturzenbaum SR, 1998, BBA-GENE STRUCT EXPR, V1398, P294, DOI 10.1016/S0167-4781(98)00077-3; Tonganunt M, 2008, FISH SHELLFISH IMMUN, V25, P633, DOI 10.1016/j.fsi.2008.08.006; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Uma A., 2002, ASIAN FISHERIES SCI, V15, P365; van de Sande WWJ, 2006, J IMMUNOL, V177, P1997, DOI 10.4049/jimmunol.177.3.1997; van Hulten MCW, 2000, J GEN VIROL, V81, P2525, DOI 10.1099/0022-1317-81-10-2525; van Hulten MCW, 2001, VIROLOGY, V286, P7, DOI 10.1006/viro.2001.1002; van Hulten MCW, 2002, J GEN VIROL, V83, P257, DOI 10.1099/0022-1317-83-1-257; Vernoud V, 2003, PLANT PHYSIOL, V131, P1191, DOI 10.1104/pp.013052; Wang ZM, 2004, BIOCHEM BIOPH RES CO, V325, P899, DOI 10.1016/j.bbrc.2004.09.224; Westenberg M, 2005, VIRUS RES, V114, P133, DOI 10.1016/j.virusres.2005.06.006; Witteveldt J, 2004, J VIROL, V78, P2057, DOI 10.1128/JVI.78.4.2057-2061.2004; WOOTTON JC, 1993, COMPUT CHEM, V17, P149, DOI 10.1016/0097-8485(93)85006-X; Xu AM, 1999, BIOCHEM J, V342, P683, DOI 10.1042/0264-6021:3420683; Yang Y, 2005, ONCOGENE, V24, P4778, DOI 10.1038/sj.onc.1208666; Yarm FR, 2002, MOL CELL BIOL, V22, P6209, DOI 10.1128/MCB.22.17.6209-6221.2002; YENOFSKY R, 1983, MOL CELL BIOL, V3, P1197, DOI 10.1128/MCB.3.7.1197; Yi GH, 2003, J GEN VIROL, V84, P2545, DOI 10.1099/vir.0.19001-0; Zhang D, 2002, J BIOL CHEM, V277, P37430, DOI 10.1074/jbc.M207413200; Zhang Y, 2009, PROTEINS, V77, P100, DOI 10.1002/prot.22588	54	3	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33291	10.1371/journal.pone.0033291	http://dx.doi.org/10.1371/journal.pone.0033291			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22428011	gold, Green Published, Green Submitted			2022-12-25	WOS:000302381500120
J	Tso, FY; Tully, DC; Gonzalez, S; Quince, C; Ho, O; Polacino, P; Ruprecht, RM; Hu, SL; Wood, C				Tso, For Yue; Tully, Damien C.; Gonzalez, Sandra; Quince, Christopher; Ho, On; Polacino, Patricia; Ruprecht, Ruth M.; Hu, Shiu-Lok; Wood, Charles			Dynamics of Envelope Evolution in Clade C SHIV-Infected Pig-Tailed Macaques during Disease Progression Analyzed by Ultra-Deep Pyrosequencing	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIBODY NEUTRALIZATION; V3 LOOP; TYPE-1; ENV; TRANSMISSION; CORECEPTOR; SEQUENCES; PARALLEL; GLYCOPROTEIN	Understanding the evolution of the human immunodeficiency virus type 1 (HIV-1) envelope during disease progression can provide tremendous insights for vaccine development, and simian-human immunodeficiency virus (SHIV) infection of non-human primate provides an ideal platform for such studies. A newly developed clade C SHIV, SHIV-1157ipd3N4, which was able to infect rhesus macaques, closely resembled primary HIV-1 in transmission and pathogenesis, was used to infect several pig-tailed macaques. One of the infected animals subsequently progressed to AIDS, whereas one remained a non-progressor. The viral envelope evolution in the infected animals during disease progression was analyzed by a bioinformatics approach using ultra-deep pyrosequencing. Our results showed substantial envelope variations emerging in the progressor animal after the onset of AIDS. These envelope variations impacted the length of the variable loops and charges of different envelope regions. Additionally, multiple mutations were located at the CD4 and CCR5 binding sites, potentially affecting receptor binding affinity, viral fitness and they might be selected at late stages of disease. More importantly, these envelope mutations are not random since they had repeatedly been observed in a rhesus macaque and a human infant infected by either SHIV or HIV-1, respectively, carrying the parental envelope of the infectious molecular clone SHIV-1157ipd3N4. Moreover, similar mutations were also observed from other studies on different clades of envelopes regardless of the host species. These recurring mutations in different envelopes suggest that there may be a common evolutionary pattern and selection pathway for the HIV-1 envelope during disease progression.	[Tso, For Yue; Tully, Damien C.; Gonzalez, Sandra; Wood, Charles] Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE 68588 USA; [Tso, For Yue; Tully, Damien C.; Gonzalez, Sandra; Wood, Charles] Univ Nebraska, Sch Biol Sci, Lincoln, NE USA; [Ho, On; Hu, Shiu-Lok] Univ Washington, Dept Pharmaceut, Seattle, WA 98195 USA; [Polacino, Patricia; Hu, Shiu-Lok] Univ Washington, Washington Natl Primate Res Ctr, Seattle, WA 98195 USA; [Ruprecht, Ruth M.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Ruprecht, Ruth M.] Harvard Univ, Sch Med, Boston, MA USA; [Quince, Christopher] Univ Glasgow, Sch Engn, Glasgow, Lanark, Scotland	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University of Glasgow	Tso, FY (corresponding author), Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE 68588 USA.	cwood@unlnotes.unl.edu	Wood, Charles/AAH-4536-2021; Hu, Shiu-Lok/A-3196-2008; Tso, For Yue/AAF-1131-2019	Hu, Shiu-Lok/0000-0003-4336-7964; Quince, Christopher/0000-0003-1884-8440; Wood, Charles/0000-0002-4256-1530; Tully, Damien/0000-0002-7620-9340	Public Health Service [CA75903, TW001429, T32 AI060547]; National Center for Research Resource, Center for Biomedical Research Excellence [P30 RR031151, P01 AI48240, RR000166, N01 AI060006]; American Recovery and Reinvestment Act [3P01AI048240-08S1]; National Institute of Allergy and Infectious Disease; EPSRC [EP/H003851/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H003851/1] Funding Source: researchfish; FOGARTY INTERNATIONAL CENTER [D43TW001429] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA075903] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000166, P30RR031151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060547, P01AI048240] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Center for Research Resource, Center for Biomedical Research Excellence; American Recovery and Reinvestment Act; National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service grants, CA75903, TW001429, T32 AI060547 and National Center for Research Resource, Center for Biomedical Research Excellence grant P30 RR031151 to CW; P01 AI48240 to RMR, CW and SLH; and RR000166 and N01 AI060006 to the Washington National Primate Research Center; American Recovery and Reinvestment Act funding 3P01AI048240-08S1 to RMR, CW; SG was supported by a Ruth L. Kirschstein National Service Award from the National Institute of Allergy and Infectious Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal-Gamse C, 2009, J VIROL, V83, P11005, DOI 10.1128/JVI.01238-09; Archer J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001022; Bimber BN, 2009, J VIROL, V83, P8247, DOI 10.1128/JVI.00897-09; Brennan G, 2007, J VIROL, V81, P12210, DOI 10.1128/JVI.02499-06; Bunnik EM, 2008, J VIROL, V82, P7932, DOI 10.1128/JVI.00757-08; Cale EM, 2011, J VIROL, V85, P3746, DOI 10.1128/JVI.02420-10; Chenine AL, 2010, J INFECT DIS, V201, P1155, DOI 10.1086/651274; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; Chohan B, 2005, J VIROL, V79, P6528, DOI 10.1128/JVI.79.10.6528-6531.2005; Curlin ME, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001228; D'Aquila RT, 2011, AIDS RES HUM RETROV, V27, P201, DOI 10.1089/aid.2010.0077; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Dieltjens T, 2009, AIDS RES HUM RETROV, V25, P1165, DOI 10.1089/aid.2008.0161; Gray ES, 2011, J VIROL; Grisson RD, 2004, J VIROL, V78, P14066, DOI 10.1128/JVI.78.24.14066-14069.2004; Hatziioannou T, 2009, P NATL ACAD SCI USA, V106, P4425, DOI 10.1073/pnas.0812587106; Hedskog C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011345; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Ho O, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-65; Hofmann-Lehmann R, 2002, J VIROL, V76, P5278, DOI 10.1128/JVI.76.10.5278-5284.2002; Humbert M, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-94; Humes D, 2011, J VIROL, V85, P4409, DOI 10.1128/JVI.02244-10; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Mahalanabis M, 2006, AMINO TRACK AUTOMATI, P549; Moore PL, 2008, J VIROL, V82, P1860, DOI 10.1128/JVI.02187-07; Moore PL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000598; Nolan KM, 2008, J VIROL, V82, P664, DOI 10.1128/JVI.01793-07; Ometto L, 2000, AIDS, V14, P1721, DOI 10.1097/00002030-200008180-00006; Pope M, 2003, NAT MED, V9, P847, DOI 10.1038/nm0703-847; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Repits J, 2008, VIROLOGY, V379, P125, DOI 10.1016/j.virol.2008.06.014; Rodenburg CM, 2001, AIDS RES HUM RETROV, V17, P161, DOI 10.1089/08892220150217247; Rozera G, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-15; Sagar M, 2006, J VIROL, V80, P9586, DOI 10.1128/JVI.00141-06; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Song RJ, 2006, J VIROL, V80, P8729, DOI 10.1128/JVI.00558-06; Stephens EB, 1997, VIROLOGY, V231, P313, DOI 10.1006/viro.1997.8534; Sun Y, 2011, J VIROL; Suphaphiphat P, 2007, VIROLOGY, V360, P182, DOI 10.1016/j.virol.2006.10.019; Tamura K, 2011, MOL BIOL EVOL; Thippeshappa R, 2011, J VIROL, V85, P3767, DOI 10.1128/JVI.02438-10; Tso FY, 2009, AIDS, V23, P1817, DOI 10.1097/QAD.0b013e32832f3da6; van Gils MJ, 2011, J VIROL; van Marle G, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-87; Varghese V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010992; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Xiang SH, 2010, J VIROL, V84, P3147, DOI 10.1128/JVI.02587-09; Yamaguchi-Kabata Y, 2000, J VIROL, V74, P4335, DOI 10.1128/JVI.74.9.4335-4350.2000; Zhang H, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-67	50	3	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e32827	10.1371/journal.pone.0032827	http://dx.doi.org/10.1371/journal.pone.0032827			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427893	Green Published, Green Accepted, gold			2022-12-25	WOS:000302381500053
J	Laroui, H; Ingersoll, SA; Liu, HC; Baker, MT; Ayyadurai, S; Charania, MA; Laroui, F; Yan, YT; Sitaraman, SV; Merlin, D				Laroui, Hamed; Ingersoll, Sarah A.; Liu, Hong Chun; Baker, Mark T.; Ayyadurai, Saravanan; Charania, Moiz A.; Laroui, Famina; Yan, Yutao; Sitaraman, Shanthi V.; Merlin, Didier			Dextran Sodium Sulfate (DSS) Induces Colitis in Mice by Forming Nano-Lipocomplexes with Medium-Chain-Length Fatty Acids in the Colon	PLOS ONE			English	Article							ABSORPTION-ENHANCING MECHANISM; CROHNS-DISEASE; DECANOYLCARNITINE; NANOPARTICLES; INFLAMMATION; ENHANCEMENT; BUTYRATE; DELIVERY; CAPRATE; ALPHA	Inflammatory bowel diseases (IBDs), primarily ulcerative colitis and Crohn's disease, are inflammatory disorders caused by multiple factors. Research on IBD has often used the dextran sodium sulfate (DSS)-induced colitis mouse model. DSS induces in vivo but not in vitro intestinal inflammation. In addition, no DSS-associated molecule (free glucose, sodium sulfate solution, free dextran) induces in vitro or in vivo intestinal inflammation. We find that DSS but not dextran associated molecules established linkages with medium-chain-length fatty acids (MCFAs), such as dodecanoate, that are present in the colonic lumen. DSS complexed to MCFAs forms nanometer-sized vesicles similar to 200 nm in diameter that can fuse with colonocyte membranes. The arrival of nanometer-sized DSS/MCFA vesicles in the cytoplasm may activate intestinal inflammatory signaling pathways. We also show that the inflammatory activity of DSS is mediated by the dextran moieties. The deleterious effect of DSS is localized principally in the distal colon, therefore it will be important to chemically modify DSS to develop materials beneficial to the colon without affecting colon-targeting specificity.	[Laroui, Hamed; Ingersoll, Sarah A.; Baker, Mark T.; Ayyadurai, Saravanan; Charania, Moiz A.; Yan, Yutao; Merlin, Didier] Georgia State Univ, Dept Biol, Ctr Diagnost & Therapeut, Atlanta, GA 30303 USA; [Ingersoll, Sarah A.; Laroui, Famina; Yan, Yutao; Merlin, Didier] Vet Affairs Med Ctr, Decatur, GA 30033 USA; [Liu, Hong Chun; Sitaraman, Shanthi V.] Emory Univ, Dept Med, Div Digest Dis, Atlanta, GA 30322 USA; [Liu, Hong Chun] Fudan Univ, Zhongshan Hosp, Dept Gastroenterol, Shanghai 200433, Peoples R China	University System of Georgia; Georgia State University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Emory University; Fudan University	Laroui, H (corresponding author), Georgia State Univ, Dept Biol, Ctr Diagnost & Therapeut, Atlanta, GA 30303 USA.	hlaroui@gsu.edu			Department of Veterans Affairs; National Institutes of Health of Diabetes and Digestive and Kidney [RO1-DK-071594]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071594] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health of Diabetes and Digestive and Kidney(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the Department of Veterans Affairs and the National Institutes of Health of Diabetes and Digestive and Kidney by RO1-DK-071594. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andoh A, 1999, JPEN-PARENTER ENTER, V23, pS70, DOI 10.1177/014860719902300518; Brant SR, 2011, INFLAMM BOWEL DIS, V17, P1, DOI 10.1002/ibd.21385; Charrier L, 2005, AM J PHYSIOL-GASTR L, V288, pG346, DOI 10.1152/ajpgi.00262.2004; COOPER HS, 1993, LAB INVEST, V69, P238; Coyne CB, 2000, AM J RESP CELL MOL, V23, P602, DOI 10.1165/ajrcmb.23.5.4164; Dignass A, 2011, Z GASTROENTEROL, V49, P1276, DOI 10.1055/s-0031-1281666; FELLIG J, 1959, ARCH BIOCHEM BIOPHYS, V85, P313, DOI 10.1016/0003-9861(59)90496-5; G Riva, 2011, Clin Pract Epidemiol Ment Health, V7, P51, DOI 10.2174/1745017901107010051; Hofstetter C, 1998, Eur J Med Res, V3, P299; Hu Y, 2004, P ANN INT IEEE EMBS, V26, P2337; Kennedy RJ, 2000, BRIT J SURG, V87, P1346, DOI 10.1046/j.1365-2168.2000.01615.x; Kim IW, 2010, J GASTROEN HEPATOL, V25, P1785, DOI 10.1111/j.1440-1746.2010.06332.x; Lamprecht A, 2005, J CONTROL RELEASE, V104, P337, DOI 10.1016/j.jconrel.2005.02.011; Laroui H, 2007, BIOMACROMOLECULES, V8, P3879, DOI 10.1021/bm700836y; Laroui H, 2011, AM J PHYSIOL-GASTR L, V300, pG371, DOI 10.1152/ajpgi.00466.2010; Laroui H, 2011, BIOMATERIALS, V32, P1218, DOI 10.1016/j.biomaterials.2010.09.062; Laroui H, 2010, GASTROENTEROLOGY, V138, P843, DOI 10.1053/j.gastro.2009.11.003; Lindmark T, 1997, PHARMACEUT RES, V14, P930, DOI 10.1023/A:1012112219578; LINDMARK T, 1995, J PHARMACOL EXP THER, V275, P958; Lowe AM, 2009, INFLAMM BOWEL DIS, V15, P429, DOI 10.1002/ibd.20756; Magitta NF, 2008, EUR J ENDOCRINOL, V158, P705, DOI 10.1530/EJE-07-0843; Mitsuyama K, 2006, DIGEST DIS SCI, V51, P173, DOI 10.1007/s10620-006-3104-4; MIYAZAWA F, 1967, BIOCHIM BIOPHYS ACTA, V145, P96, DOI 10.1016/0005-2787(67)90658-2; NAKAMURA T, 1967, CIRCULATION, V35, P904, DOI 10.1161/01.CIR.35.5.904; NAKAMURA T, 1967, J APPL PHYSIOL, V22, P1156, DOI 10.1152/jappl.1967.22.6.1156; ORHOLM M, 1991, NEW ENGL J MED, V324, P84, DOI 10.1056/NEJM199101103240203; PHILIPSON L, 1964, BIOCHIM BIOPHYS ACTA, V91, P171, DOI 10.1016/0926-6550(64)90185-9; Pinho RA, 2005, ENVIRON RES, V99, P355, DOI 10.1016/j.envres.2005.03.005; Rogler G, 1998, WORLD J SURG, V22, P382, DOI 10.1007/s002689900401; Schlitt HJ, 2011, IMMUNOSUPPRESSION HE; Schmidt C, 2011, Z GASTROENTEROL, V49, P1246, DOI 10.1055/s-0031-1273416; Shea-Donohue T, 2008, INNATE IMMUN-LONDON, V14, P117, DOI 10.1177/1753425908088724; Skewis LR, 2010, ACS APPL MATER INTER, V2, P35, DOI 10.1021/am900822f; Steidler L, 2000, SCIENCE, V289, P1352, DOI 10.1126/science.289.5483.1352; Theiss AL, 2011, INFLAMM BOWEL DIS, V17, P1163, DOI 10.1002/ibd.21469; Tomita M, 1996, J PHARM SCI, V85, P608, DOI 10.1021/js9504604; TOMITA M, 1995, J PHARMACOL EXP THER, V272, P739; Toth G, 2001, PROTEIN ENG, V14, P543, DOI 10.1093/protein/14.8.543; Velde AAT, 2007, INFLAMM BOWEL DIS, V13, P325, DOI 10.1002/ibd.20079; Venkatraman A, 2000, SCAND J GASTROENTERO, V35, P1053; Venkatraman A, 2003, AM J PHYSIOL-GASTR L, V285, pG177, DOI 10.1152/ajpgi.00307.2002; Vieira EL, 2011, J NUTR BIOCH; Vowinkel T, 2004, DIGEST DIS SCI, V49, P556, DOI 10.1023/B:DDAS.0000026298.72088.f7; Walsh DA, 2006, CURR DRUG TARGETS, V7, P1031, DOI 10.2174/138945006778019291; Yan YT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006073	45	205	219	4	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2012	7	3							e32084	10.1371/journal.pone.0032084	http://dx.doi.org/10.1371/journal.pone.0032084			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KX	22427817	Green Submitted, Green Published, gold			2022-12-25	WOS:000303062800013
J	Iida, M; Brand, TM; Campbell, DA; Li, C; Wheeler, DL				Iida, M.; Brand, T. M.; Campbell, D. A.; Li, C.; Wheeler, D. L.			Yes and Lyn play a role in nuclear translocation of the epidermal growth factor receptor	ONCOGENE			English	Article						nuclear EGFR; SFK; Yes; Lyn	SRC-FAMILY KINASES; SQUAMOUS-CELL CARCINOMA; TYROSINE KINASES; C-SRC; ACQUIRED-RESISTANCE; BREAST-CANCER; EGF RECEPTOR; LUNG-CANCER; SIGNALING NETWORK; PROGNOSTIC VALUE	The epidermal growth factor receptor (EGFR) is a central regulator of tumor progression in human cancers. Cetuximab is an anti-EGFR antibody that has been approved for use in oncology. Previously we investigated mechanisms of resistance to cetuximab using a model derived from the non-small cell lung cancer line NCI-H226. We demonstrated that cetuximab-resistant clones (Ctx(R)) had increased nuclear localization of the EGFR. This process was mediated by Src family kinases (SFKs), and nuclear EGFR had a role in resistance to cetuximab. To better understand SFK-mediated nuclear translocation of EGFR, we investigated which SFK member(s) controlled this process as well as the EGFR tyrosine residues that are involved. Analyses of mRNA and protein expression indicated upregulation of the SFK members Yes (v-Yes-1 yamaguchi sarcoma viral oncogene) and Lyn (v-yes-1 Yamaguchi sarcoma viral-related oncogene homolog) in all Ctx(R) clones. Further, immunoprecipitation analysis revealed that EGFR interacts with Yes and Lyn in Ctx(R) clones, but not in cetuximab-sensitive (Ctx(S)) parental cells. Using RNAi interference, we found that knockdown of either Yes or Lyn led to loss of EGFR translocation to the nucleus. Conversely, overexpression of Yes or Lyn in low nuclear EGFR-expressing Ctx(S) parental cells led to increased nuclear EGFR. Chromatin imnnunoprecipitation (Chip) assays confirmed nuclear EGFR complexes associated with the promoter of the known EGFR target genes B-Myb and iNOS. Further, all Ctx(R) clones exhibited upregulation of B-Myb and iNOS at the mRNA and protein levels. siRNAs directed at Yes or Lyn led to decreased binding of EGFR complexes to the B-Myb and iNOS promoters based on ChIP analyses. SFKs have been shown to phosphorylate EGFR on tyrosines 845 and 1101 (Y845 and Y1101), and mutation of Y1101, but not Y845, impaired nuclear entry of the EGFR. Taken together, our findings demonstrate that Yes and Lyn phosphorylate EGFR at Y1101, which influences EGFR nuclear translocation in this model of cetuximab resistance. Oncogene (2013) 32, 759-767; doi:10.1038/onc.2012.90; published online 19 March 2012	[Iida, M.; Brand, T. M.; Campbell, D. A.; Li, C.; Wheeler, D. L.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Human Oncol, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison	Wheeler, DL (corresponding author), Univ Wisconsin, Ctr Comprehens Canc, Dept Human Oncol, 1111 Highland Ave,WIMR 3159, Madison, WI 53705 USA.	dlwheeler@wisc.edu	Wheeler, Deric/B-7175-2013	Wheeler, Deric/0000-0001-5915-3675	National Cancer Institute [P30CA014520]; Clinical and Translational Science Award program of the National Center for Research Resources [1UL1RR025011]; National Institutes of Health (DUN) from the American Cancer Society [RSG-10-193-01-TBG]; NIH from Graduate Training in Cellular and Molecular Pathogenesis of Human Diseases [T32 GM08.1061-01A2]; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000428, UL1TR000427] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025011, KL2RR025012] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM081061] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Clinical and Translational Science Award program of the National Center for Research Resources; National Institutes of Health (DUN) from the American Cancer Society; NIH from Graduate Training in Cellular and Molecular Pathogenesis of Human Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported, in part, by grant P30CA014520 from the National Cancer Institute, grant 1UL1RR025011 from the Clinical and Translational Science Award program of the National Center for Research Resources and the National Institutes of Health (DUN) by grant RSG-10-193-01-TBG from the American Cancer Society (DLW), and by NIH grant T32 GM08.1061-01A2 from Graduate Training in Cellular and Molecular Pathogenesis of Human Diseases (TMB).	Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Boerner JL, 2004, MOL CELL BIOL, V24, P7059, DOI 10.1128/MCB.24.16.7059-7071.2004; Brand TM, 2011, DISCOV MED, V12, P419; Brand TM, 2011, CANCER BIOL THER, V12, P436, DOI 10.4161/cbt.12.5.16394; Brand TM, 2011, CANCER BIOL THER, V11, P777, DOI 10.4161/cbt.11.9.15050; Bromann PA, 2004, ONCOGENE, V23, P7957, DOI 10.1038/sj.onc.1208079; Carpenter G, 2003, CURR OPIN CELL BIOL, V15, P143, DOI 10.1016/S0955-0674(03)00015-2; Carpenter G, 2009, EXP CELL RES, V315, P1556, DOI 10.1016/j.yexcr.2008.09.027; Dittmann K, 2005, J BIOL CHEM, V280, P31182, DOI 10.1074/jbc.M506591200; Dittmann K, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-69; Fu YN, 2008, ONCOGENE, V27, P957, DOI 10.1038/sj.onc.1210684; Gschwind A, 2004, NAT REV CANCER, V4, P361, DOI 10.1038/nrc1360; Hadzisejdic I, 2010, MODERN PATHOL, V23, P392, DOI 10.1038/modpathol.2009.166; Hanada N, 2006, MOL CARCINOGEN, V45, P10, DOI 10.1002/mc.20147; Hsu SC, 2007, J BIOL CHEM, V282, P10432, DOI 10.1074/jbc.M610014200; Hsu SC, 2009, AM J TRANSL RES, V1, P249; Huang WC, 2011, J BIOL CHEM, V286, P20558, DOI 10.1074/jbc.M111.240796; Hung LY, 2008, NUCLEIC ACIDS RES, V36, P4337, DOI 10.1093/nar/gkn417; Jaganathan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019605; Kasai A, 2005, GENES CELLS, V10, P1175, DOI 10.1111/j.1365-2443.2005.00909.x; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Kloth MT, 2003, J BIOL CHEM, V278, P1671, DOI 10.1074/jbc.M207289200; Koppikar P, 2008, CLIN CANCER RES, V14, P4284, DOI 10.1158/1078-0432.CCR-07-5226; Li C, 2009, ONCOGENE, V28, P3801, DOI 10.1038/onc.2009.234; Li CF, 2012, ANN SURG ONCOL, V19, P443, DOI 10.1245/s10434-011-1942-6; Li CR, 2010, RADIOTHER ONCOL, V97, P330, DOI 10.1016/j.radonc.2010.06.010; Liao HJ, 2007, MOL BIOL CELL, V18, P1064, DOI 10.1091/mbc.E06-09-0802; Liccardi G, 2011, CANCER RES, V71, P1103, DOI 10.1158/0008-5472.CAN-10-2384; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Lo HW, 2006, J CELL BIOCHEM, V98, P1570, DOI 10.1002/jcb.20876; Lo HW, 2010, MOL CANCER RES, V8, P232, DOI 10.1158/1541-7786.MCR-09-0391; Lo HW, 2006, BRIT J CANCER, V94, P184, DOI 10.1038/sj.bjc.6602941; Lo HW, 2005, CANCER CELL, V7, P575, DOI 10.1016/j.ccr.2005.05.007; Lo HW, 2005, CANCER RES, V65, P338; Lu KV, 2009, CANCER RES, V69, P6889, DOI 10.1158/0008-5472.CAN-09-0347; MAA MC, 1995, P NATL ACAD SCI USA, V92, P6981, DOI 10.1073/pnas.92.15.6981; Marmor MD, 2004, INT J RADIAT ONCOL, V58, P903, DOI 10.1016/j.ijrobp.2003.06.002; Massie C, 2006, NAT REV CANCER, V6, P403, DOI 10.1038/nrc1882; OTTENHOFFKALFF AE, 1992, CANCER RES, V52, P4773; Pao W, 2010, NAT REV CANCER, V10, P760, DOI 10.1038/nrc2947; Piccione EC, 2012, ONCOGENE, V31, P2953, DOI 10.1038/onc.2011.465; Psyrri A, 2005, CLIN CANCER RES, V11, P5856, DOI 10.1158/1078-0432.CCR-05-0420; Su T, 2010, NAT CELL BIOL, V12, P1143, DOI 10.1038/ncb2118; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Tice DA, 1999, P NATL ACAD SCI USA, V96, P1415, DOI 10.1073/pnas.96.4.1415; Wang SC, 2006, NAT CELL BIOL, V8, P1359, DOI 10.1038/ncb1501; Wang SC, 2009, CLIN CANCER RES, V15, P6484, DOI 10.1158/1078-0432.CCR-08-2813; Wang YN, 2010, ONCOGENE, V29, P3997, DOI 10.1038/onc.2010.157; Wang YN, 2010, J BIOL CHEM, V285, P38720, DOI 10.1074/jbc.M110.158659; Wheeler DL, 2008, ONCOGENE, V27, P3944, DOI 10.1038/onc.2008.19; Wheeler DL, 2010, NAT REV CLIN ONCOL, V7, P493, DOI 10.1038/nrclinonc.2010.97; Wheeler DL, 2009, ONCOLOGIST, V14, P667, DOI 10.1634/theoncologist.2009-0009; Wheeler DL, 2009, CANCER BIOL THER, V8, P696, DOI 10.4161/cbt.8.8.7903; Xi SC, 2003, J BIOL CHEM, V278, P31574, DOI 10.1074/jbc.M303499200; Xia WY, 2009, MOL CARCINOGEN, V48, P610, DOI 10.1002/mc.20504; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhang J, 2007, AM J PATHOL, V170, P366, DOI 10.2353/ajpath.2007.060706; Zhao YT, 2006, J BIOL CHEM, V281, P19501, DOI 10.1074/jbc.M511224200	58	58	60	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	FEB 7	2013	32	6					759	767		10.1038/onc.2012.90	http://dx.doi.org/10.1038/onc.2012.90			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	101AF	22430206	Green Accepted			2022-12-25	WOS:000315746700009
J	Lutz, D; Wolters-Eisfeld, G; Joshi, G; Djogo, N; Jakovcevski, I; Schachner, M; Kleene, R				Lutz, David; Wolters-Eisfeld, Gerrit; Joshi, Gunjan; Djogo, Nevena; Jakovcevski, Igor; Schachner, Melitta; Kleene, Ralf			Generation and Nuclear Translocation of Sumoylated Transmembrane Fragment of Cell Adhesion Molecule L1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NON-ENDOSOMAL FUNCTIONS; IMMUNOGLOBULIN SUPERFAMILY; RECOGNITION MOLECULES; NEURITE OUTGROWTH; SPINAL-CORD; PRESENILIN/GAMMA-SECRETASE; NERVOUS-SYSTEM; NEURAL REPAIR; AXON GUIDANCE; MICE LACKING	The functions of the cell adhesion molecule L1 in the developing and adult nervous system are triggered by homophilic and heterophilic interactions that stimulate signal transductions that activate cellular responses. Here, we show that stimulation of signaling by function-triggering L1 antibodies or L1-Fc leads to serine protease-dependent cleavage of full-length L1 at the plasma membrane and generation of a sumoylated transmembrane 70-kDa fragment comprising the intracellular and transmembrane domains and part of the extracellular domain. The 70-kDa transmembrane fragment is transported from the plasma membrane to a late endosomal compartment, released from endosomal membranes into the cytoplasm, and transferred from there into the nucleus by a pathway that depends on importin and chromatin-modifying protein 1. Mutation of the sumoylation site at Lys(1172) or of the nuclear localization signal at Lys(1147) abolished L1-stimulated generation or nuclear import of the 70-kDa fragment, respectively. Nuclear import of the 70-kDa fragment may activate cellular responses in parallel or in association with phosphorylation-dependent signaling pathways. Alterations in the levels of the 70-kDa fragment during development and in the adult after spinal cord injury or in a mouse model of Alzheimer disease suggest that this fragment is functionally implicated in development, regeneration, neurode-generation, tumorigenesis, and possibly synaptic plasticity in the mature nervous system.	[Schachner, Melitta] Shantou Univ, Coll Med, Ctr Neurosci, Shantou 515041, Peoples R China; [Lutz, David; Wolters-Eisfeld, Gerrit; Joshi, Gunjan; Djogo, Nevena; Jakovcevski, Igor; Schachner, Melitta; Kleene, Ralf] Univ Klinikum Hamburg Eppendorf, Zentrum Mol Neurobiol, D-20246 Hamburg, Germany; [Schachner, Melitta] Rutgers State Univ, Keck Ctr Collaborat Neurosci, Piscataway, NJ 08854 USA; [Schachner, Melitta] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA	Shantou University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Schachner, M (corresponding author), Shantou Univ, Coll Med, Ctr Neurosci, 22 Xin Ling Rd, Shantou 515041, Peoples R China.	schachner@stu.edu.cn	Lutz, David/AAX-1607-2021; Wolters-Eisfeld, Gerrit/H-8333-2019	Wolters-Eisfeld, Gerrit/0000-0002-2984-6515; Lutz, David/0000-0001-9171-4081; Jakovcevski, Igor/0000-0001-7673-9600	New Jersey Commission for Spinal Cord Research; Li Ka-Shing Foundation at Shantou University Medical College	New Jersey Commission for Spinal Cord Research; Li Ka-Shing Foundation at Shantou University Medical College	Supported by the New Jersey Commission for Spinal Cord Research and the Li Ka-Shing Foundation at Shantou University Medical College. To whom correspondence should be addressed: Center for Neuroscience, Shantou University Medical College, 22 Xin Ling Rd., Shantou 515041, China. Tel.: 86-754-88900276; Fax: 86-754-88900236; E-mail: schachner@stu.edu.cn.	APPEL F, 1995, J NEUROBIOL, V28, P297, DOI 10.1002/neu.480280304; Brummendorf T, 1998, CURR OPIN NEUROBIOL, V8, P87, DOI 10.1016/S0959-4388(98)80012-3; Cheng L, 2011, EMBO J, V30, P800, DOI 10.1038/emboj.2011.10; Chook YM, 2011, BBA-MOL CELL RES, V1813, P1593, DOI 10.1016/j.bbamcr.2010.10.014; Clague MJ, 2010, CELL, V143, P682, DOI 10.1016/j.cell.2010.11.012; Cohen NR, 1998, CURR BIOL, V8, P26, DOI 10.1016/S0960-9822(98)70017-X; CURTIS R, 1993, J NEUROCYTOL, V22, P51, DOI 10.1007/BF01183975; Dahme M, 1997, NAT GENET, V17, P346, DOI 10.1038/ng1197-346; Ebinu JO, 2002, NEURON, V34, P499, DOI 10.1016/S0896-6273(02)00704-3; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Guseva D, 2011, EXP NEUROL, V229, P339, DOI 10.1016/j.expneurol.2011.02.018; Guseva D, 2009, BRAIN, V132, P2180, DOI 10.1093/brain/awp160; Gutwein P, 2002, FASEB J, V16, P292, DOI 10.1096/fj.02-0430fje; Jakeman LB, 2006, EUR J NEUROSCI, V23, P1997, DOI 10.1111/j.1460-9568.2006.04721.x; Jakovcevski I, 2007, J NEUROSCI, V27, P7222, DOI 10.1523/JNEUROSCI.0739-07.2007; Kalus I, 2003, J BIOL CHEM, V278, P10381, DOI 10.1074/jbc.M208351200; Kamiguchi H, 1997, J NEUROSCI RES, V49, P1, DOI 10.1002/(SICI)1097-4547(19970701)49:1<1::AID-JNR1>3.0.CO;2-H; Katidou Markella, 2008, Biotechnology Journal, V3, P1564, DOI 10.1002/biot.200800281; Kirkin V, 2007, CURR OPIN CELL BIOL, V19, P199, DOI 10.1016/j.ceb.2007.02.002; Kleene R, 2010, J NEUROSCI, V30, P10784, DOI 10.1523/JNEUROSCI.0297-10.2010; Kurumaji A, 2001, AM J MED GENET, V105, P99; Lakkaraju A, 2008, TRENDS CELL BIOL, V18, P199, DOI 10.1016/j.tcb.2008.03.002; Law JWS, 2003, J NEUROSCI, V23, P10419; Lee TW, 2008, NEURON GLIA BIOL, V4, P223, DOI 10.1017/S1740925X09990172; Liao HJ, 2007, MOL BIOL CELL, V18, P1064, DOI 10.1091/mbc.E06-09-0802; Loers G, 2005, J NEUROCHEM, V92, P1463, DOI 10.1111/j.1471-4159.2004.02983.x; Loers G, 2007, J NEUROCHEM, V101, P865, DOI 10.1111/j.1471-4159.2006.04409.x; Makhina T, 2009, MOL CELL NEUROSCI, V41, P206, DOI 10.1016/j.mcn.2009.02.010; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; Maretzky T, 2005, MOL CELL BIOL, V25, P9040, DOI 10.1128/MCB.25.20.9040-9053.2005; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; Matsumoto-Miyai K, 2003, J NEUROSCI, V23, P7727; Mehanna A, 2010, MOL THER, V18, P34, DOI 10.1038/mt.2009.235; Nayeem N, 1999, J CELL SCI, V112, P4739; POLTORAK M, 1995, EXP NEUROL, V131, P266, DOI 10.1016/0014-4886(95)90048-9; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Ren J, 2009, PROTEOMICS, V9, P3409, DOI 10.1002/pmic.200800646; Riedle S, 2009, BIOCHEM J, V420, P391, DOI 10.1042/BJ20081625; SADOUL K, 1988, J NEUROCHEM, V50, P510, DOI 10.1111/j.1471-4159.1988.tb02941.x; Schafer MKE, 2010, CELL MOL LIFE SCI, V67, P2425, DOI 10.1007/s00018-010-0339-1; Scheschonka A, 2007, TRENDS NEUROSCI, V30, P85, DOI 10.1016/j.tins.2007.01.003; Silletti S, 2000, J CELL BIOL, V149, P1485, DOI 10.1083/jcb.149.7.1485; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Slagsvold T, 2006, TRENDS CELL BIOL, V16, P317, DOI 10.1016/j.tcb.2006.04.004; Stauffer DR, 2001, J CELL SCI, V114, P2383; Strekalova H, 2006, NEUROBIOL AGING, V27, P1, DOI 10.1016/j.neurobiolaging.2004.11.013; Tanaka N, 2008, CANCER SCI, V99, P1293, DOI 10.1111/j.1349-7006.2008.00825.x; van der Goot FG, 2006, TRENDS CELL BIOL, V16, P514, DOI 10.1016/j.tcb.2006.08.003; Wakabayashi Y, 2008, PROG NEURO-PSYCHOPH, V32, P1199, DOI 10.1016/j.pnpbp.2008.03.005; Zhang Y, 2008, RESTOR NEUROL NEUROS, V26, P81	50	46	48	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17161	17175		10.1074/jbc.M112.346759	http://dx.doi.org/10.1074/jbc.M112.346759			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22431726	Green Published, hybrid			2022-12-25	WOS:000306373000016
J	Somasekharan, S; Tanis, J; Forbush, B				Somasekharan, Suma; Tanis, Jessica; Forbush, Biff			Loop Diuretic and Ion-binding Residues Revealed by Scanning Mutagenesis of Transmembrane Helix 3 (TM3) of Na-K-Cl Cotransporter (NKCC1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H-3 BUMETANIDE BINDING; NA+-K+-2CL(-) COTRANSPORTER; PROTEIN-STRUCTURE; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; TRANSPORT; MECHANISM; LEUT; PHOSPHORYLATION; INHIBITION	The Na-K-Cl cotransporter (NKCC) plays central roles in cellular chloride homeostasis and in epithelial salt transport, but to date little is known about the mechanism by which the transporter moves ions across the membrane. We examined the functional role of transmembrane helix 3 (TM3) in NKCC1 using cysteine- and tryptophan-scanning mutagenesis and analyzed our results in the context of a structural homology model based on an alignment of NKCC1 with other amino acid polyamine organocation superfamily members, AdiC and ApcT. Mutations of residues along one face of TM3 (Tyr-383, Met-382, Ala-379, Asn-376, Ala-375, Phe-372, Gly-369, and Ile-368) had large effects on translocation rate, apparent ion affinities, and loop diuretic affinity, consistent with a proposed role of TM3 in the translocation pathway. The prediction that Met-382 is part of an extracellular gate that closes to form an occluded state is strongly supported by conformational sensitivity of this residue to 2-(trimethylammonium)ethyl methanethiosulfonate, and the bumetanide insensitivity of M382W is consistent with tryptophan blocking entry of bumetanide into the cavity. Substitution effects on residues at the intracellular end of TM3 suggest that this region is also involved in ion coordination and may be part of the translocation pathway in an inward-open conformation. Mutations of predicted pore residues had large effects on binding of bumetanide and furosemide, consistent with the hypothesis that loop diuretic drugs bind within the translocation cavity. The results presented here strongly support predictions of homology models of NKCC1 and demonstrate important roles for TM3 residues in ion translocation and loop diuretic inhibition.	[Somasekharan, Suma; Tanis, Jessica; Forbush, Biff] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA	Yale University	Somasekharan, S (corresponding author), Yale Univ, Sch Med, Dept Cellular & Mol Physiol, POB 208026, New Haven, CT 06520 USA.	suma.somasekharan@yale.edu			National Institutes of Health [GM083340]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083340] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM083340 (to B. F.).	Aronica E, 2007, NEUROSCIENCE, V145, P185, DOI 10.1016/j.neuroscience.2006.11.041; Blaesse P, 2006, J NEUROSCI, V26, P10407, DOI 10.1523/JNEUROSCI.3257-06.2006; Carmosino M, 2008, MOL BIOL CELL, V19, P4341, DOI 10.1091/mbc.E08-05-0478; Castaneda-Bueno M, 2010, AM J PHYSIOL-RENAL, V299, pF1111, DOI 10.1152/ajprenal.00412.2010; Cherubino F, 2010, J MOL NEUROSCI, V41, P243, DOI 10.1007/s12031-009-9281-9; Darman RB, 2002, J BIOL CHEM, V277, P37542, DOI 10.1074/jbc.M206293200; Dehaye JP, 2003, J BIOL CHEM, V278, P11811, DOI 10.1074/jbc.M213148200; Delpire E, 2002, ANNU REV PHYSIOL, V64, P803, DOI 10.1146/annurev.physiol.64.081501.155847; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Fang YL, 2009, NATURE, V460, P1040, DOI 10.1038/nature08201; FORBUSH B, 1983, J BIOL CHEM, V258, P1787; Forrest LR, 2009, PHYSIOLOGY, V24, P377, DOI 10.1152/physiol.00030.2009; Gao X, 2010, NATURE, V463, P828, DOI 10.1038/nature08741; Gimenez I, 2002, J BIOL CHEM, V277, P8767, DOI 10.1074/jbc.C200021200; Gimenez I, 2007, J BIOL CHEM, V282, P6540, DOI 10.1074/jbc.M610780200; HAAS M, 1986, J BIOL CHEM, V261, P8434; Isenring P, 1998, J GEN PHYSIOL, V112, P549, DOI 10.1085/jgp.112.5.549; Jacobs MT, 2007, J BIOL CHEM, V282, P29441, DOI 10.1074/jbc.M704456200; Khafizov K, 2010, BIOCHEMISTRY-US, V49, P10702, DOI 10.1021/bi101256x; Kowalczyk L, 2011, P NATL ACAD SCI USA, V108, P3935, DOI 10.1073/pnas.1018081108; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Longpre JP, 2011, BIOPHYS J, V100, P52, DOI 10.1016/j.bpj.2010.11.012; Lytle C, 1998, AM J PHYSIOL-CELL PH, V274, pC299, DOI 10.1152/ajpcell.1998.274.2.C299; Lytle C, 1995, AM J PHYSIOL-CELL PH, V269, pC1496, DOI 10.1152/ajpcell.1995.269.6.C1496; Melo F, 2007, PROTEIN SCI, V16, P2412, DOI 10.1110/ps.072895107; Monette Michelle Y, 2012, J Biol Chem, V287, P2210, DOI 10.1074/jbc.M111.309211; Monette MY, 2011, AM J PHYSIOL-RENAL, V300, pF840, DOI 10.1152/ajprenal.00552.2010; MOORE ML, 1995, BIOCHEM J, V309, P637, DOI 10.1042/bj3090637; Moore-Hoon ML, 2000, BIOCHEMISTRY-US, V39, P3718, DOI 10.1021/bi992301v; Pedersen M, 2008, J BIOL CHEM, V283, P2663, DOI 10.1074/jbc.M708194200; Rinehart J, 2009, CELL, V138, P525, DOI 10.1016/j.cell.2009.05.031; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303; Silberberg SD, 2005, J GEN PHYSIOL, V125, P347, DOI 10.1085/jgp.200409221; Simard CF, 2004, J BIOL CHEM, V279, P40769, DOI 10.1074/jbc.M406458200; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; TALVENHEIMO J, 1979, J BIOL CHEM, V254, P4631; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978	39	49	50	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17308	17317		10.1074/jbc.M112.356014	http://dx.doi.org/10.1074/jbc.M112.356014			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22437837	Green Published, hybrid			2022-12-25	WOS:000306373000031
J	Spratt, DE; Wu, K; Kovacev, J; Pan, ZQ; Shaw, GS				Spratt, Donald E.; Wu, Kenneth; Kovacev, Jordan; Pan, Zhen-Qiang; Shaw, Gary S.			Selective Recruitment of an E2 similar to Ubiquitin Complex by an E3 Ubiquitin Ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-STRUCTURE DETERMINATION; TORSION ANGLE DYNAMICS; SIDE-CHAIN RESONANCES; CONJUGATING ENZYME; RING DOMAIN; HUMAN CDC34; CONFORMATIONAL CONTROL; PARKINSONS-DISEASE; PROVIDES INSIGHTS; BACKBONE AMIDE	RING E3 ligases are proteins that must selectively recruit an E2-conjugating enzyme and facilitate ubiquitin transfer to a substrate. It is not clear how a RING E3 ligase differentiates a naked E2 enzyme from the E2 similar to ubiquitin-conjugated form or how this is altered upon ubiquitin transfer. RING-box protein 1 (Rbx1/ROC1) is a key protein found in the Skp1/Cullin-1/F-box (SCF) E3 ubiquitin ligase complex that functions with the E2 ubiquitin conjugating enzyme CDC34. The solution structure of Rbx1/ROC1 revealed a globular RING domain (residues 40-108) stabilized by three structural zinc ions (root mean square deviation 0.30 +/- 0.04 angstrom) along with a disordered N terminus (residues 12-39). Titration data showed that Rbx1/ROC1 preferentially recruits CDC34 in its ubiquitin-conjugated form and favors this interaction by 50-fold compared with unconjugated CDC34. Furthermore, NMR and biochemical assays identified residues in helix alpha 2 of Rbx1/ROC1 that are essential for binding and activating CDC34 similar to ubiquitin for ubiquitylation. Taken together, this work provides the first direct structural and biochemical evidence showing that polyubiquitylation by the RING E3 ligase Rbx1/ROC1 requires the preferential recruitment of an E2 similar to ubiquitin complex and subsequent release of the unconjugated E2 protein upon ubiquitin transfer to a substrate or ubiquitin chain.	[Spratt, Donald E.; Shaw, Gary S.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Biochem, London, ON N6A 5C1, Canada; [Wu, Kenneth; Kovacev, Jordan; Pan, Zhen-Qiang] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA	Western University (University of Western Ontario); Icahn School of Medicine at Mount Sinai	Shaw, GS (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, Dept Biochem, London, ON N6A 5C1, Canada.	gshaw1@uwo.ca	Shaw, Gary S./C-7656-2009	Shaw, Gary S./0000-0002-4685-9625; Spratt, Donald/0000-0002-0699-155X	Canadian Institutes of Health Research [MOP-14606]; Canadian Cancer Society [CCS-018414]; Canada Research Chairs Program; National Institutes of Health [GM061051, CA095634]; Natural Sciences and Engineering Research Council of Canada; Ontario Ministry of Research and Technology; NATIONAL CANCER INSTITUTE [R01CA095634] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061051] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Canada Research Chairs Program(Canada Research Chairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Ministry of Research and Technology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Steven Beasley and Pascal Mercier for helpful expertise with CYANA and Xplor-NIH. The Biomolecular NMR Facility at the University of Western Ontario was supported by a Research Resource grant from the Canadian Institutes of Health Research.; This work was supported by Canadian Cancer Society Grant CCS-018414, Canadian Institutes of Health Research Grant MOP-14606, and by the Canada Research Chairs Program (to G. S. S.). This work was also supported, in whole or in part, by National Institutes of Health Grants GM061051 and CA095634 (to Z.-Q. P.).; Recipient of a Natural Sciences and Engineering Research Council of Canada postdoctoral fellowship and an Ontario Ministry of Research and Technology postdoctoral fellowship.	Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Beasley SA, 2007, P NATL ACAD SCI USA, V104, P3095, DOI 10.1073/pnas.0610548104; Boh BK, 2011, J MOL BIOL, V409, P136, DOI 10.1016/j.jmb.2011.03.023; Borden KLB, 1998, BIOCHEM CELL BIOL, V76, P351, DOI 10.1139/bcb-76-2-3-351; Budhidarmo R, 2012, TRENDS BIOCHEM SCI, V37, P58, DOI 10.1016/j.tibs.2011.11.001; Ceccarelli DF, 2011, CELL, V145, P1075, DOI 10.1016/j.cell.2011.05.039; Christensen DE, 2007, NAT STRUCT MOL BIOL, V14, P941, DOI 10.1038/nsmb1295; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Deffenbaugh AE, 2003, CELL, V114, P611, DOI 10.1016/S0092-8674(03)00641-X; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Deshaies RJ, 2010, SUBCELL BIOCHEM, V54, P41, DOI 10.1007/978-1-4419-6676-6_4; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dominguez C, 2004, STRUCTURE, V12, P633, DOI 10.1016/j.str.2004.03.004; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Duda DM, 2011, CURR OPIN STRUC BIOL, V21, P257, DOI 10.1016/j.sbi.2011.01.003; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; Eletr ZM, 2005, NAT STRUCT MOL BIOL, V12, P933, DOI 10.1038/nsmb984; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Gazdoiu S, 2005, P NATL ACAD SCI USA, V102, P15053, DOI 10.1073/pnas.0507646102; Gazdoiu S, 2007, MOL CELL BIOL, V27, P7041, DOI 10.1128/MCB.00812-07; Goldenberg SJ, 2004, CELL, V119, P517, DOI 10.1016/j.cell.2004.10.019; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; GRZESIEK S, 1993, J MAGN RESON SER B, V101, P114, DOI 10.1006/jmrb.1993.1019; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hristova VA, 2009, J BIOL CHEM, V284, P14978, DOI 10.1074/jbc.M808700200; Huang A, 2009, J MOL BIOL, V385, P507, DOI 10.1016/j.jmb.2008.10.044; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kamadurai HB, 2009, MOL CELL, V36, P1095, DOI 10.1016/j.molcel.2009.11.010; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; KAY LE, 1993, J MAGN RESON SER B, V101, P333, DOI 10.1006/jmrb.1993.1053; Kim DW, 2005, P NATL ACAD SCI USA, V102, P14046, DOI 10.1073/pnas.0504466102; Kleiger G, 2009, J BIOL CHEM, V284, P36012, DOI 10.1074/jbc.M109.058529; Kleiger G, 2009, CELL, V139, P957, DOI 10.1016/j.cell.2009.10.030; Kornhaber GJ, 2006, J BIOMOL NMR, V34, P259, DOI 10.1007/s10858-006-0027-5; Levin I, 2010, P NATL ACAD SCI USA, V107, P2848, DOI 10.1073/pnas.0914821107; Linding R, 2004, J MOL BIOL, V342, P345, DOI 10.1016/j.jmb.2004.06.088; Merkley N, 2004, J BIOL CHEM, V279, P47139, DOI 10.1074/jbc.M409576200; Merkley N, 2005, J BIOL CHEM, V280, P31732, DOI 10.1074/jbc.M505205200; Petroski MD, 2006, MOL CELL, V24, P523, DOI 10.1016/j.molcel.2006.10.010; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pierce NW, 2009, NATURE, V462, P615, DOI 10.1038/nature08595; Plafker SM, 2004, J CELL BIOL, V167, P649, DOI 10.1083/jcb.200406001; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Rousseau F, 2006, CURR OPIN STRUC BIOL, V16, P118, DOI 10.1016/j.sbi.2006.01.011; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Saha A, 2011, MOL CELL, V42, P75, DOI 10.1016/j.molcel.2011.03.016; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Serniwka SA, 2009, BIOCHEMISTRY-US, V48, P12169, DOI 10.1021/bi901686j; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shuker SB, 1996, SCIENCE, V274, P1531, DOI 10.1126/science.274.5292.1531; Spratt DE, 2011, J MOL BIOL, V407, P425, DOI 10.1016/j.jmb.2011.01.047; Tan PL, 1999, MOL CELL, V3, P527, DOI 10.1016/S1097-2765(00)80481-5; Uversky VN, 2009, CURR PROTEIN PEPT SC, V10, P483, DOI 10.2174/138920309789351921; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Wu K, 2002, J BIOL CHEM, V277, P516, DOI 10.1074/jbc.M108008200; Wu K, 2010, MOL CELL, V37, P784, DOI 10.1016/j.molcel.2010.02.025; Yamoah K, 2008, P NATL ACAD SCI USA, V105, P12230, DOI 10.1073/pnas.0806155105; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X; Zimmerman ES, 2010, CURR OPIN STRUC BIOL, V20, P714, DOI 10.1016/j.sbi.2010.08.010	65	34	34	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17374	17385		10.1074/jbc.M112.353748	http://dx.doi.org/10.1074/jbc.M112.353748			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22433864	Green Published, hybrid			2022-12-25	WOS:000306373000037
J	Fernandez-Fueyo, E; Ruiz-Duenas, FJ; Miki, Y; Martinez, MJ; Hammel, KE; Martinez, AT				Fernandez-Fueyo, Elena; Ruiz-Duenas, Francisco J.; Miki, Yuta; Jesus Martinez, Maria; Hammel, Kenneth E.; Martinez, Angel T.			Lignin-degrading Peroxidases from Genome of Selective Ligninolytic Fungus Ceriporiopsis subvermispora	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2 MANGANESE PEROXIDASES; PLEUROTUS-ERYNGII; PHANEROCHAETE-CHRYSOSPORIUM; VERSATILE PEROXIDASE; MICROBIAL-DEGRADATION; ESCHERICHIA-COLI; MODEL-COMPOUND; BASIDIOMYCETE; OXIDATION; GENES	The white-rot fungus Ceriporiopsis subvermispora delignifies lignocellulose with high selectivity, but until now it has appeared to lack the specialized peroxidases, termed lignin peroxidases (LiPs) and versatile peroxidases (VPs), that are generally thought important for ligninolysis. We screened the recently sequenced C. subvermispora genome for genes that encode peroxidases with a potential ligninolytic role. A total of 26 peroxidase genes was apparent after a structural-functional classification based on homology modeling and a search for diagnostic catalytic amino acid residues. In addition to revealing the presence of nine heme-thiolate peroxidase superfamily members and the unexpected absence of the dye-decolorizing peroxidase superfamily, the search showed that the C. subvermispora genome encodes 16 class II enzymes in the plant-fungal-bacterial peroxidase superfamily, where LiPs and VPs are classified. The 16 encoded enzymes include 13 putative manganese peroxidases and one generic peroxidase but most notably two peroxidases containing the catalytic tryptophan characteristic of LiPs and VPs. We expressed these two enzymes in Escherichia coli and determined their substrate specificities on typical LiP/VP substrates, including nonphenolic lignin model monomers and dimers, as well as synthetic lignin. The results show that the two newly discovered C. subvermispora peroxidases are functionally competent LiPs and also suggest that they are phylogenetically and catalytically intermediate between classical LiPs and VPs. These results offer new insight into selective lignin degradation by C. subvermispora.	[Hammel, Kenneth E.] USDA, Forest Prod Lab, Madison, WI 53726 USA; [Fernandez-Fueyo, Elena; Ruiz-Duenas, Francisco J.; Miki, Yuta; Jesus Martinez, Maria; Martinez, Angel T.] CSIC, Ctr Invest Biol, E-28040 Madrid, Spain	United States Department of Agriculture (USDA); United States Forest Service; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Hammel, KE (corresponding author), USDA, Forest Prod Lab, Madison, WI 53726 USA.	kehammel@wisc.edu; ATMartinez@cib.csic.es	Fernández-Fueyo, Elena/G-8372-2017; Ruiz-Dueñas, Francisco J/L-9837-2015; Martinez, Maria Jesus/F-9147-2015; Martínez, Angel T/G-7284-2017; Hammel, Kenneth E/G-1890-2011	Ruiz-Dueñas, Francisco J/0000-0002-9837-5665; Martinez, Maria Jesus/0000-0003-2166-1097; Martínez, Angel T/0000-0002-1584-2863; Hammel, Kenneth E/0000-0002-2935-5847	RAPERO from the Spanish Ministry of Economy and Competitiveness [BIO2008-01533]; HIPOP from the Spanish Ministry of Economy and Competitiveness [BIO2011-26694]; PEROXICATS [KBBE-2010-4-265397]; United States Department of Energy [DE-AI02-07ER64480]; Consejo Superior de Investigaciones Cientificas; European Social Fund; Ministry of Economy and Competitiveness (MINECO); Office of Science of the United States Department of Energy [DE-AC02-05CH11231]	RAPERO from the Spanish Ministry of Economy and Competitiveness; HIPOP from the Spanish Ministry of Economy and Competitiveness; PEROXICATS; United States Department of Energy(United States Department of Energy (DOE)); Consejo Superior de Investigaciones Cientificas; European Social Fund(European Social Fund (ESF)); Ministry of Economy and Competitiveness (MINECO); Office of Science of the United States Department of Energy(United States Department of Energy (DOE))	This work was supported by the RAPERO Grant BIO2008-01533 and HIPOP Grant BIO2011-26694 from the Spanish Ministry of Economy and Competitiveness (to A. T. M. and F.J.R.-D., respectively), by PEROXICATS European Project Grant KBBE-2010-4-265397 (to A. T. M.), and by United States Department of Energy Grant DE-AI02-07ER64480 (to K.E.H.).; Supported by a Junta para Ampliacion de Estudios fellowship of the Consejo Superior de Investigaciones Cientificas, co-funded by the European Social Fund.; Supported by a Ministry of Economy and Competitiveness (MINECO) Ramon y Cajal contract.; We thank Dr. Daniel Cullen (United States Department of Agriculture, Forest Products Laboratory, Madison, WI) and Dr. Rafael Vicuna (Pontificia Universidad Catolica de Chile, Santiago, Chile) for the invitation to participate in the C. subvermispora genome sequencing project. We thank Michael D. Mozuch for technical assistance with the DHP depolymerization reactions. Sequencing of the C. subvermispora genome by the Joint Genome Institute was supported by the Office of Science of the United States Department of Energy under Contract DE-AC02-05CH11231.	AKHTAR M, 1993, HOLZFORSCHUNG, V47, P36, DOI 10.1515/hfsg.1993.47.1.36; AKHTAR M, 1994, HOLZFORSCHUNG, V48, P199, DOI 10.1515/hfsg.1994.48.3.199; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BLANCHETTE RA, 1985, WOOD SCI TECHNOL, V19, P35, DOI 10.1007/BF00354751; Bohlin C, 2005, J MOL CATAL B-ENZYM, V35, P100, DOI 10.1016/j.molcatb.2005.06.003; Bohlin C, 2008, ENZYME MICROB TECH, V43, P199, DOI 10.1016/j.enzmictec.2008.03.002; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; CAMARERO S, 1994, APPL ENVIRON MICROB, V60, P4509, DOI 10.1128/AEM.60.12.4509-4516.1994; Canas AI, 2010, BIOTECHNOL ADV, V28, P694, DOI 10.1016/j.biotechadv.2010.05.002; Caramelo L, 1999, APPL ENVIRON MICROB, V65, P916; Cullen D, 1997, J BIOTECHNOL, V53, P273, DOI 10.1016/S0168-1656(97)01684-2; de Souza-Cruz PB, 2004, ENZYME MICROB TECH, V34, P228, DOI 10.1016/j.enzmictec.2003.10.005; Doyle WA, 1996, BIOCHEM J, V315, P15, DOI 10.1042/bj3150015; Fernandez-Fueyo E, 2012, P NATL ACAD SCI USA, V109, P5458, DOI 10.1073/pnas.1119912109; Gold MH, 2000, MET IONS BIOL SYST, V37, P559; Gutierrez A, 2011, ARCH BIOCHEM BIOPHYS, V514, P33, DOI 10.1016/j.abb.2011.08.001; HAMMEL KE, 1993, J BIOL CHEM, V268, P12274; Hammel KE, 2008, CURR OPIN PLANT BIOL, V11, P349, DOI 10.1016/j.pbi.2008.02.003; Heinfling A, 1998, FEBS LETT, V428, P141, DOI 10.1016/S0014-5793(98)00512-2; Hilden K, 2005, FUNGAL GENET BIOL, V42, P403, DOI 10.1016/j.fgb.2005.01.008; Hofrichter M, 2006, APPL MICROBIOL BIOT, V71, P276, DOI 10.1007/s00253-006-0417-3; Hofrichter M, 2010, APPL MICROBIOL BIOT, V87, P871, DOI 10.1007/s00253-010-2633-0; Jensen KA, 1996, APPL ENVIRON MICROB, V62, P3679, DOI 10.1128/AEM.62.10.3679-3686.1996; Johjima T, 1999, P NATL ACAD SCI USA, V96, P1989, DOI 10.1073/pnas.96.5.1989; JONSSON L, 1990, FEBS LETT, V276, P45, DOI 10.1016/0014-5793(90)80503-B; Kersten P, 2007, FUNGAL GENET BIOL, V44, P77, DOI 10.1016/j.fgb.2006.07.007; Kinne M, 2011, HOLZFORSCHUNG, V65, P673, DOI 10.1515/HF.2011.057; KIRK TK, 1987, ANNU REV MICROBIOL, V41, P465, DOI 10.1146/annurev.mi.41.100187.002341; Larrondo LF, 2001, APPL ENVIRON MICROB, V67, P2070, DOI 10.1128/AEM.67.5.2070-2075.2001; Li DM, 1999, BBA-PROTEIN STRUCT M, V1434, P356, DOI 10.1016/S0167-4838(99)00191-0; Liers C, 2010, APPL MICROBIOL BIOT, V85, P1869, DOI 10.1007/s00253-009-2173-7; Lobos S, 1998, GENE, V206, P185, DOI 10.1016/S0378-1119(97)00583-0; LOBOS S, 1994, MICROBIOL-UK, V140, P2691, DOI 10.1099/00221287-140-10-2691; Martinez AT, 2009, CURR OPIN BIOTECH, V20, P348, DOI 10.1016/j.copbio.2009.05.002; Martinez AT, 2002, ENZYME MICROB TECH, V30, P425, DOI 10.1016/S0141-0229(01)00521-X; Martinez AT, 2005, INT MICROBIOL, V8, P195; Martinez D, 2004, NAT BIOTECHNOL, V22, P695, DOI 10.1038/nbt967; Martinez D, 2009, P NATL ACAD SCI USA, V106, P1954, DOI 10.1073/pnas.0809575106; Alvarez JM, 2009, FUNGAL GENET BIOL, V46, P104, DOI 10.1016/j.fgb.2008.10.002; Miki Y, 2011, J BIOL CHEM, V286, P15525, DOI 10.1074/jbc.M111.220996; MOEN MA, 1994, APPL ENVIRON MICROB, V60, P1956, DOI 10.1128/AEM.60.6.1956-1961.1994; Morgenstern I, 2010, APPL ENVIRON MICROB, V76, P6431, DOI 10.1128/AEM.00547-10; MORITA Y, 1988, J BIOCHEM-TOKYO, V103, P693, DOI 10.1093/oxfordjournals.jbchem.a122331; Ortiz-Bermudez P, 2003, APPL ENVIRON MICROB, V69, P5015, DOI 10.1128/AEM.69.8.5015-5018.2003; Pecyna MJ, 2009, APPL MICROBIOL BIOT, V84, P885, DOI 10.1007/s00253-009-2000-1; Perez-Boada M, 2002, ENZYME MICROB TECH, V30, P518, DOI 10.1016/S0141-0229(02)00008-X; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Rajakumar S, 1996, APPL ENVIRON MICROB, V62, P2660, DOI 10.1128/AEM.62.7.2660-2663.1996; Ralph John, 2004, Phytochemistry Reviews, V3, P29, DOI 10.1023/B:PHYT.0000047809.65444.a4; Ruiz-Duenas FJ, 2001, BIOCHEM SOC T, V29, P116, DOI 10.1042/BST0290116; Ruiz-Duenas FJ, 2008, BIOCHEMISTRY-US, V47, P1685, DOI 10.1021/bi7020298; Ruiz-Duenas FJ, 2011, CR BIOL, V334, P795, DOI 10.1016/j.crvi.2011.06.004; Ruiz-Duenas FJ, 2010, BIOCATALYSIS BASED ON HEME PEROXIDASES, P37, DOI 10.1007/978-3-642-12627-7_3; Ruiz-Duenas FJ, 2009, MICROB BIOTECHNOL, V2, P164, DOI 10.1111/j.1751-7915.2008.00078.x; Ruiz-Duenas FJ, 2009, J EXP BOT, V60, P441, DOI 10.1093/jxb/ern261; RUTTIMANN C, 1992, BIOTECHNOL APPL BIOC, V16, P64; SALAS C, 1995, BIOTECHNOL APPL BIOC, V21, P323; Salvachua D, 2011, BIORESOURCE TECHNOL, V102, P7500, DOI 10.1016/j.biortech.2011.05.027; Sambrook J., 2001, MOL CLONING; Scott G.M., 1998, ENV FRIENDLY TECHNOL; Shary S, 2007, APPL ENVIRON MICROB, V73, P6691, DOI 10.1128/AEM.01361-07; SREBOTNIK E, 1994, P NATL ACAD SCI USA, V91, P12794, DOI 10.1073/pnas.91.26.12794; Srebotnik E, 1997, APPL ENVIRON MICROB, V63, P4435, DOI 10.1128/AEM.63.11.4435-4440.1997; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanaka H, 2009, ENZYME MICROB TECH, V45, P384, DOI 10.1016/j.enzmictec.2009.06.003; Tello M, 2001, FEMS MICROBIOL LETT, V199, P91, DOI 10.1111/j.1574-6968.2001.tb10656.x; Tello M, 2000, BBA-GENE STRUCT EXPR, V1490, P137, DOI 10.1016/S0167-4781(99)00227-4; TIEN M, 1983, SCIENCE, V221, P661, DOI 10.1126/science.221.4611.661; Vicentim MP, 2009, HOLZFORSCHUNG, V63, P408, DOI 10.1515/HF.2009.067; WARIISHI H, 1994, BIOCHEMISTRY-US, V33, P5545, DOI 10.1021/bi00184a025; Cho DW, 2010, J ORG CHEM, V75, P6549, DOI 10.1021/jo1012509	71	64	65	1	54	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16903	16916		10.1074/jbc.M112.356378	http://dx.doi.org/10.1074/jbc.M112.356378			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22437835	Green Published, hybrid			2022-12-25	WOS:000304030900076
J	Gao, CX; Maeno, T; Ota, F; Ueno, M; Korekane, H; Takamatsu, S; Shirato, K; Matsumoto, A; Kobayashi, S; Yoshida, K; Kitazume, S; Ohtsubo, K; Betsuyaku, T; Taniguchi, N				Gao, Congxiao; Maeno, Toshitaka; Ota, Fumi; Ueno, Manabu; Korekane, Hiroaki; Takamatsu, Shinji; Shirato, Ken; Matsumoto, Akio; Kobayashi, Satoshi; Yoshida, Keiichi; Kitazume, Shinobu; Ohtsubo, Kazuaki; Betsuyaku, Tomoko; Taniguchi, Naoyuki			Sensitivity of Heterozygous alpha 1,6-Fucosyltransferase Knock-out Mice to Cigarette Smoke-induced Emphysema IMPLICATION OF ABERRANT TRANSFORMING GROWTH FACTOR-beta SIGNALING AND MATRIX METALLOPROTEINASE GENE EXPRESSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; D-GLUCOSAMINIDE ALPHA; ALVEOLAR MACROPHAGES; AIRWAY INFLAMMATION; CDNA CLONING; CORE FUCOSE; RAT LUNG; COPD; ACTIVATION; RECEPTOR	We previously demonstrated that a deficiency in core fucosylation caused by the genetic disruption of alpha 1,6-fucosyltransferase (Fut8) leads to lethal abnormalities and the development of emphysematous lesions in the lung by attenuation of TGF-beta 1 receptor signaling. Herein, we investigated the physiological relevance of core fucosylation in the pathogenesis of emphysema using viable heterozygous knock-out mice (Fut8(+/-)) that were exposed to cigarette smoke (CS). The Fut8(+/-) mice exhibited a marked decrease in FUT8 activity, and matrix metalloproteinase (MMP)-9 activities were elevated in the lung at an early stage of exposure. Emphysema developed after a 3-month CS exposure, accompanied by the recruitment of large numbers of macrophages to the lung. CS exposure substantially and persistently elevated the expression level of Smad7, resulting in a significant reduction of Smad2 phosphorylation (which controls MMP-9 expression) in Fut8(+/-) mice and Fut8-deficient embryonic fibroblast cells. These in vivo and in vitro studies show that impaired core fucosylation enhances the susceptibility to CS and constitutes at least part of the disease process of emphysema, in which TGF-beta-Smad signaling is impaired and the MMP-mediated destruction of lung parenchyma is up-regulated.	[Gao, Congxiao; Ota, Fumi; Korekane, Hiroaki; Takamatsu, Shinji; Kobayashi, Satoshi; Yoshida, Keiichi; Kitazume, Shinobu; Ohtsubo, Kazuaki; Taniguchi, Naoyuki] RIKEN Adv Sci Inst, Dis Glyc Team, Max Planck Joint Ctr, Wako, Saitama 3510198, Japan; [Gao, Congxiao; Ota, Fumi; Korekane, Hiroaki; Takamatsu, Shinji; Shirato, Ken; Matsumoto, Akio; Ohtsubo, Kazuaki; Taniguchi, Naoyuki] Osaka Univ, Inst Sci & Ind Res, RIKEN Alliance Lab, Osaka 5670047, Japan; [Maeno, Toshitaka; Ueno, Manabu] Gunma Univ, Grad Sch Med, Dept Med & Biol Sci, Gunma 3718511, Japan; [Shirato, Ken] Waseda Univ, Fac Human Sci, Saitama 3591192, Japan; [Matsumoto, Akio] Chiba Univ, Grad Sch Med, Dept Pharmacol, Chiba 2608670, Japan; [Betsuyaku, Tomoko] Keio Univ, Sch Med, Dept Internal Med, Tokyo 1808582, Japan	RIKEN; Osaka University; RIKEN; Gunma University; Waseda University; Chiba University; Keio University	Taniguchi, N (corresponding author), RIKEN Adv Sci Inst, Dis Glyc Team, Max Planck Joint Ctr, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	tani52@wd5.so-net.ne.jp	Taniguchi, Naoyuki/A-7086-2016; Taniguchi, Naoyuki/I-4182-2014	Taniguchi, Naoyuki/0000-0001-5889-5968; Matsumoto, Akio/0000-0002-3402-6992	National Institute of Biomedical Innovation (NIBIO); Global Center of Excellent (GCOE); Ministry of Education, Science, Sports and Culture, Japan [20249018, 23591118]; Naito Foundation, Japan; Grants-in-Aid for Scientific Research [24659111, 24790331] Funding Source: KAKEN	National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation); Global Center of Excellent (GCOE); Ministry of Education, Science, Sports and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation, Japan(Naito Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Program for Promotion of Fundamental Studies in Health Science of the National Institute of Biomedical Innovation (NIBIO), the Global Center of Excellent (GCOE) Program, and Grant-in-aid for Scientific Research (A) 20249018 from the Ministry of Education, Science, Sports and Culture, Japan.; Supported by Grant-in-aid for Scientific Research (C) 23591118 from the Ministry of Education, Science, Sports and Culture, Japan, and by the Naito Foundation, Japan.	Abboud RT, 2008, INT J TUBERC LUNG D, V12, P361; Babusyte A, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-81; Balzano G, 1999, AM J RESP CRIT CARE, V160, P1486, DOI 10.1164/ajrccm.160.5.9810105; Burgel PR, 2011, EUR RESPIR REV, V20, P7, DOI 10.1183/09059180.10010610; Devel L, 2006, J BIOL CHEM, V281, P11152, DOI 10.1074/jbc.M600222200; Domagala-Kulawik J, 2008, J PHYSIOL PHARMACOL, V59, P19; Gorska K, 2010, CURR OPIN PULM MED, V16, P89, DOI 10.1097/MCP.0b013e3283341ba0; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; Hersh Craig P, 2008, Proc Am Thorac Soc, V5, P486, DOI 10.1513/pats.200706-078ET; Hong S, 2007, CANCER RES, V67, P9577, DOI 10.1158/0008-5472.CAN-07-1179; Houghton AM, 2006, J CLIN INVEST, V116, P753, DOI 10.1172/JCI25617; Ihara H, 2006, GLYCOBIOLOGY, V16, P333, DOI 10.1093/glycob/cwj068; JANOFF A, 1979, SCIENCE, V206, P1313, DOI 10.1126/science.316187; Kizuka Y, 2011, J BIOL CHEM, V286, P31875, DOI 10.1074/jbc.M111.251173; Knezevic A, 2010, GLYCOBIOLOGY, V20, P959, DOI 10.1093/glycob/cwq051; Kunz LIZ, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-34; Loukides S, 2011, CURR DRUG TARGETS, V12, P469, DOI 10.2174/138945011794751573; Matsumura K, 2007, J BIOL CHEM, V282, P15700, DOI 10.1074/jbc.M701195200; Murugan V, 2009, EXP LUNG RES, V35, P439, DOI 10.1080/01902140902759290; Okamoto T, 2009, BIOCHEM BIOPH RES CO, V383, P475, DOI 10.1016/j.bbrc.2009.04.038; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Rajendrasozhan S, 2009, COPD, V6, P291, DOI 10.1080/15412550903049132; Shaykhiev R, 2009, J IMMUNOL, V183, P2867, DOI 10.4049/jimmunol.0900473; Shi WB, 2004, J CELL BIOL, V164, P291, DOI 10.1083/jcb.200307151; Siddiqui S, 2007, EUR RESPIR J, V30, P1043, DOI 10.1183/09031936.00162506; Stevenson CS, 2007, AM J PHYSIOL-LUNG C, V293, pL1183, DOI 10.1152/ajplung.00105.2007; Suga T, 2000, AM J RESP CELL MOL, V22, P26, DOI 10.1165/ajrcmb.22.1.3554; Takeda Y, 2008, J BIOL CHEM, V283, P26089, DOI 10.1074/jbc.M801902200; Taniguchi N, 2007, NAT CHEM BIOL, V3, P307, DOI 10.1038/nchembio0607-307; Uozumi N, 1996, J BIOL CHEM, V271, P27810, DOI 10.1074/jbc.271.44.27810; Uozumi N, 1996, J BIOCHEM, V120, P385; Wallace AM, 2008, COPD, V5, P13, DOI 10.1080/15412550701817789; Wang XC, 2005, P NATL ACAD SCI USA, V102, P15791, DOI 10.1073/pnas.0507375102; Wang XC, 2006, J BIOL CHEM, V281, P2572, DOI 10.1074/jbc.M510893200; Wang XC, 2009, J BIOCHEM, V145, P643, DOI 10.1093/jb/mvp022; Wright JL, 2007, AM J PHYSIOL-LUNG C, V292, pL125, DOI 10.1152/ajplung.00539.2005; Wright JL, 2008, AM J PHYSIOL-LUNG C, V295, pL1, DOI 10.1152/ajplung.90200.2008; Yamada M, 2011, J HUM GENET, V56, P857, DOI 10.1038/jhg.2011.118; Yan XH, 2011, BIOCHEM J, V434, P1, DOI 10.1042/BJ20101827; Yanagidani S, 1997, J BIOCHEM-TOKYO, V121, P626; Zandvoort A, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-83	41	42	45	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16699	16708		10.1074/jbc.M111.315333	http://dx.doi.org/10.1074/jbc.M111.315333			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22433854	Green Published, hybrid			2022-12-25	WOS:000304030900058
J	Kohn, JA; Deshpande, K; Ortlund, EA				Kohn, Jeffrey A.; Deshpande, Kirti; Ortlund, Eric A.			Deciphering Modern Glucocorticoid Cross-pharmacology Using Ancestral Corticosteroid Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING DOMAIN; ESTROGEN-RECEPTOR; CRYSTAL-STRUCTURE; EVOLUTION; EXPLOITATION; PROTEIN; ACTIVATION; STABILITY; MECHANISM; FUROATE	Steroid receptors (SRs) are the largest family of metazoan transcription factors and control genes involved in development, endocrine signaling, reproduction, immunity, and cancer. The entire hormone receptor system is driven by a molecular switch triggered by the binding of small lipophilic ligands. This makes the SRs ideal pharmaceutical targets, yet even the best clinically approved synthetic steroidal agonists are prone to cross-reactivity and off-target pharmacology. The mechanism underlying this promiscuity is derived from the fact that SRs share common structural features derived from their evolutionary relationship. More often than not, rational attempts to probe SR drug selectivity via mutagenesis fail even when high quality structural and functional data are available due to the fact that important mutations often result in nonfunctional receptors. This highlights the fact that SRs suffer from instability, preventing in-depth mutational analysis and hampering crystallization of key receptor-ligand complexes. We have taken a unique approach to address this problem by using a resurrected ancestral protein to determine the structure of a previously intractable complex and identified the structural mechanisms that confer activation and selectivity for a widely used glucocorticoid, mometasone furoate. Moreover, we have identified a single residue located outside of the ligand-binding pocket that controls mometasone furoate antagonism versus agonism in the human mineralocorticoid receptor.	[Ortlund, Eric A.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Winship Canc Inst, Discovery & Dev Therapeut Program, Atlanta, GA 30322 USA	Emory University; Emory University	Ortlund, EA (corresponding author), Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA.	eric.ortlund@emory.edu	Ortlund, Eric Anthony/P-3121-2019; Ortlund, Eric Anthony/F-4672-2014	Ortlund, Eric Anthony/0000-0001-8855-3029; Ortlund, Eric Anthony/0000-0001-8855-3029				Biggadike K, 2008, J MED CHEM, V51, P3349, DOI 10.1021/jm800279t; Bledsoe RK, 2005, J BIOL CHEM, V280, P31283, DOI 10.1074/jbc.M504098200; Bledsoe RK, 2002, CELL, V110, P93, DOI 10.1016/S0092-8674(02)00817-6; Bridgham JT, 2009, NATURE, V461, P515, DOI 10.1038/nature08249; Bridgham JT, 2006, SCIENCE, V312, P97, DOI 10.1126/science.1123348; Carroll SM, 2008, MOL BIOL EVOL, V25, P2643, DOI 10.1093/molbev/msn204; Carroll SM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002117; CARSONJURICA MA, 1990, ENDOCR REV, V11, P201, DOI 10.1210/edrv-11-2-201; DECALMER PBS, 1978, BRIT HEART J, V40, P184; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; Gaucher EA, 2003, NATURE, V425, P285, DOI 10.1038/nature01977; Gee AC, 2001, MOL ENDOCRINOL, V15, P421, DOI 10.1210/me.15.3.421; Godoy-Ruiz R, 2006, J MOL BIOL, V362, P966, DOI 10.1016/j.jmb.2006.07.065; Hanania NA, 2008, PULM PHARMACOL THER, V21, P134, DOI 10.1016/j.pupt.2007.07.002; JERMANN TM, 1995, NATURE, V374, P57, DOI 10.1038/374057a0; Kallenberger BC, 2003, NAT STRUCT BIOL, V10, P136, DOI 10.1038/nsb892; Madauss KP, 2007, MED RES REV, V27, P374, DOI 10.1002/med.20083; Madauss KP, 2004, J MED CHEM, V47, P3381, DOI 10.1021/jm030640n; Nagy L, 2004, TRENDS BIOCHEM SCI, V29, P317, DOI 10.1016/j.tibs.2004.04.006; Nettles KW, 2007, EMBO REP, V8, P563, DOI 10.1038/sj.embor.7400963; Ortlund EA, 2007, SCIENCE, V317, P1544, DOI 10.1126/science.1142819; REMICK RA, 1988, PROG NEURO-PSYCHOPH, V12, P225, DOI 10.1016/0278-5846(88)90039-5; Roy ML, 1996, CIRCULATION, V94, P817, DOI 10.1161/01.CIR.94.4.817; Seitz T, 2010, J MOL BIOL, V403, P562, DOI 10.1016/j.jmb.2010.08.048; Stahn C, 2007, MOL CELL ENDOCRINOL, V275, P71, DOI 10.1016/j.mce.2007.05.019; Tan Ricardo A, 2008, Ther Clin Risk Manag, V4, P1201; Taverna DM, 2002, PROTEINS, V46, P105, DOI 10.1002/prot.10016; Thornton JW, 2001, P NATL ACAD SCI USA, V98, P5671, DOI 10.1073/pnas.091553298; Wouters MA, 2003, MOL CELL, V12, P343, DOI 10.1016/S1097-2765(03)00308-3; Yamashiro K, 2010, PROTEIN ENG DES SEL, V23, P519, DOI 10.1093/protein/gzq021	30	16	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16267	16275		10.1074/jbc.M112.346411	http://dx.doi.org/10.1074/jbc.M112.346411			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22437833	Green Published, hybrid			2022-12-25	WOS:000304030900019
J	Kuo, CH; Lo, CY; Chung, FT; Lee, KY; Lin, SM; Wang, CH; Heh, CC; Chen, HC; Kuo, HP				Kuo, Chih-Hsi; Lo, Chun-Yu; Chung, Fu-Tsai; Lee, Kang-Yun; Lin, Shu-Min; Wang, Chun-Hua; Heh, Chih-Chen; Chen, Hao-Cheng; Kuo, Han-Pin			Concomitant Active Tuberculosis Prolongs Survival in Non-Small Cell Lung Cancer: A Study in a Tuberculosis-Endemic Country	PLOS ONE			English	Article							MYCOBACTERIUM-VACCAE; IMMUNOTHERAPY; RELEVANCE; CARCINOMA; RECEPTOR	Background: Adjuvant tumor cell vaccine with chemotherapy against non-small cell lung cancer (NSCLC) shows limited clinical response. Whether it provokes effective cellular immunity in tumor microenvironment is questionable. Concomitant active tuberculosis in NSCLC (TBLC) resembles locoregional immunotherapy of tumor cell vaccine; thus, maximally enriches effective anti-tumor immunity. This study compares the survival and immunological cell profile in TBLC over NSCLC alone. Methods: Retrospective review of NSCLC patients within 1-year-period of 2007 and follow-up till 2010. Results: A total 276 NSCLC patients were included. The median survival of TBLC is longer than those of NSCLC alone (11.6 vs. 8.8 month, p<0.01). Active tuberculosis is an independent predictor of better survival with HR of 0.68 (95% CI, 0.48 similar to 0.97). Squamous cell carcinoma (SCC) (55.8 vs. 31.7%, p<0.01) is a significant risk factor for NSCLC with active TB. The median survival of SCC with active tuberculosis is significantly longer than adenocarcinoma or undetermined NSCLC with TB (14.2 vs. 6.6 and 2.8 months, p<0.05). Active tuberculosis in SCC increases the expression of CD3 (46.4+/-24.8 vs. 24.0+/-16.0, p<0.05), CXCR3 (35.1+/-16.4 vs. 19.2+/-13.3, p<0.01) and IP-10 (63.5+/-21.9 vs. 35.5+/-21.0, p<0.01), while expression of FOXP3 is decreased (3.5+/-0.5 vs. 13.3+/-3.7 p<0.05, p<0.05). Survival of SCC with high expression of CD3 (12.1 vs. 3.6 month, p<0.05) and CXCR3 (12.1 vs. 4.4 month, p<0.05) is longer than that with low expression. Conclusions: Active tuberculosis in NSCLC shows better survival outcome. The effective T lymphocyte infiltration in tumor possibly underlies the mechanism. Locoregional immunotherapy of tumor cell vaccine may deserve further researches.	[Kuo, Chih-Hsi; Lo, Chun-Yu; Chung, Fu-Tsai; Lee, Kang-Yun; Lin, Shu-Min; Wang, Chun-Hua; Heh, Chih-Chen; Kuo, Han-Pin] Chang Gung Mem Hosp, Dept Thorac Med, Taipei 10591, Taiwan; [Kuo, Chih-Hsi; Chen, Hao-Cheng] St Pauls Hosp, Dept Thorac Med, Tao Yuan, Taiwan; [Chen, Hao-Cheng] Taipei Med Univ, Shuang Ho Hosp, Dept Thorac Med, Taipei, Taiwan	Chang Gung Memorial Hospital; Taipei Medical University; Shuang Ho Hospital	Kuo, CH (corresponding author), Chang Gung Mem Hosp, Dept Thorac Med, 199 Tung Hwa N Rd, Taipei 10591, Taiwan.	q8828@ms11.hinet.net	Wang, Chun-Hua/V-9861-2019; Wang, Chun-Hua/C-1488-2016	Wang, Chun-Hua/0000-0002-3514-9353; 	Chang Gung Medical Research Program [CMRPG391221]	Chang Gung Medical Research Program	The study was funded by Chang Gung Medical Research Program (CMRPG391221). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	AUGUSTIN A, 1989, NATURE, V340, P239, DOI 10.1038/340239a0; Burnet F M, 1971, Transplant Rev, V7, P3; Chen YM, 1996, JPN J CLIN ONCOL, V26, P322, DOI 10.1093/oxfordjournals.jjco.a023240; Chung FT, 2011, CHEMOTHERAPY, V57, P147, DOI 10.1159/000321037; Cicenas Saulius, 2007, World J Surg Oncol, V5, P22, DOI 10.1186/1477-7819-5-22; Dalgleish AG, 2006, CANCER IMMUNOL IMMUN, V55, P1025, DOI 10.1007/s00262-006-0128-8; Dumitriu IE, 2009, J IMMUNOL, V182, P2795, DOI 10.4049/jimmunol.0712671; Grange JM, 2008, VACCINE, V26, P4984, DOI 10.1016/j.vaccine.2008.06.092; Grange JM, 2002, J ROY SOC MED, V95, P296, DOI 10.1258/jrsm.95.6.296; Gridelli C, 2009, ONCOLOGIST, V14, P909, DOI 10.1634/theoncologist.2009-0017; HUYGEN K, 1988, SCAND J IMMUNOL, V27, P187, DOI 10.1111/j.1365-3083.1988.tb02338.x; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kuo CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016877; Kuo CH, 2010, CLIN LUNG CANCER, V11, P51, DOI 10.3816/CLC.2010.n.008; Liu CY, 2010, J CANCER RES CLIN, V136, P35, DOI 10.1007/s00432-009-0634-0; Ma JL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-112; MacKinnon AC, 2008, J IMMUNOL, V180, P2650, DOI 10.4049/jimmunol.180.4.2650; Malmstrom PU, 1999, J UROLOGY, V161, P1124, DOI 10.1016/S0022-5347(01)61607-0; Mendes R, 2002, BRIT J CANCER, V86, P336, DOI 10.1038/sj.bjc.6600063; Newton P, 2009, MOL IMMUNOL, V47, P485, DOI 10.1016/j.molimm.2009.08.021; Ohri CM, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-172; Okamoto M, 2005, CHEST, V128, P4030, DOI 10.1378/chest.128.6.4030; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Patel PM, 2008, EUR J CANCER, V44, P216, DOI 10.1016/j.ejca.2007.11.003; Solak O, 2005, ACTA CHIR BELG, V105, P180, DOI 10.1080/00015458.2005.11679694; Stanford JL, 2008, EUR J CANCER, V44, P224, DOI 10.1016/j.ejca.2007.08.021; Talmadge JE, 2007, CLIN CANCER RES, V13, P5243, DOI 10.1158/1078-0432.CCR-07-0182; Tamura Atsuhisa, 2005, Kekkaku, V80, P413; Walrath E, 2005, AM J RESP CELL MOL, V33, P48, DOI 10.1165/rcmb.2005-0060OC; Whiteside TL, 2010, J ALLERGY CLIN IMMUN, V125, pS272, DOI 10.1016/j.jaci.2009.09.045	30	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33226	10.1371/journal.pone.0033226	http://dx.doi.org/10.1371/journal.pone.0033226			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438899	Green Submitted, Green Published, gold			2022-12-25	WOS:000303309100026
J	Belaganahalli, MN; Maan, S; Maan, NS; Nomikou, K; Pritchard, I; Lunt, R; Kirkland, PD; Attoui, H; Brownlie, J; Mertens, PPC				Belaganahalli, Manjunatha N.; Maan, Sushila; Maan, Narender S.; Nomikou, Kyriaki; Pritchard, Ian; Lunt, Ross; Kirkland, Peter D.; Attoui, Houssam; Brownlie, Joe; Mertens, Peter P. C.			Full Genome Sequencing and Genetic Characterization of Eubenangee Viruses Identify Pata Virus as a Distinct Species within the Genus Orbivirus	PLOS ONE			English	Article							EPIZOOTIC HEMORRHAGIC-DISEASE; BLUETONGUE VIRUS; BLOT HYBRIDIZATION; INTRA-SEROGROUP; RIVER VIRUS; CELLS; MOSQUITOS; REOVIRIDAE; PROTEINS; STRAINS	Eubenangee virus has previously been identified as the cause of Tammar sudden death syndrome (TSDS). Eubenangee virus (EUBV), Tilligery virus (TILV), Pata virus (PATAV) and Ngoupe virus (NGOV) are currently all classified within the Eubenangee virus species of the genus Orbivirus, family Reoviridae. Full genome sequencing confirmed that EUBV and TILV (both of which are from Australia) show high levels of aa sequence identity (>92%) in the conserved polymerase VP1(Pol), sub-core VP3(T2) and outer core VP7(T13) proteins, and are therefore appropriately classified within the same virus species. However, they show much lower amino acid (aa) identity levels in their larger outer-capsid protein VP2 (<53%), consistent with membership of two different serotypes - EUBV-1 and EUBV-2 (respectively). In contrast PATAV showed significantly lower levels of aa sequence identity with either EUBV or TILV (with <71% in VP1(Pol) and VP3(T2), and <57% aa identity in VP7(T13)) consistent with membership of a distinct virus species. A proposal has therefore been sent to the Reoviridae Study Group of ICTV to recognise 'Pata virus' as a new Orbivirus species, with the PATAV isolate as serotype 1 (PATAV-1). Amongst the other orbiviruses, PATAV shows closest relationships to Epizootic Haemorrhagic Disease virus (EHDV), with 80.7%, 72.4% and 66.9% aa identity in VP3(T2), VP1(Pol), and VP7(T13) respectively. Although Ngoupe virus was not available for these studies, like PATAV it was isolated in Central Africa, and therefore seems likely to also belong to the new species, possibly as a distinct 'type'. The data presented will facilitate diagnostic assay design and the identification of additional isolates of these viruses.	[Belaganahalli, Manjunatha N.; Maan, Sushila; Maan, Narender S.; Nomikou, Kyriaki; Attoui, Houssam; Mertens, Peter P. C.] Inst Anim Hlth, Vector Borne Viral Dis Programme, Woking, Surrey, England; [Pritchard, Ian; Lunt, Ross] CSIRO, Australian Anim Hlth Lab, Geelong, Vic, Australia; [Kirkland, Peter D.] Elizabeth Macarthur Agr Inst, Camden, NSW, Australia; [Brownlie, Joe] Royal Vet Coll, Dept Pathol & Infect Dis, Hatfield, Herts, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of London; University of London Royal Veterinary College	Belaganahalli, MN (corresponding author), Inst Anim Hlth, Vector Borne Viral Dis Programme, Woking, Surrey, England.	peter.mertens@iah.ac.uk	Kirkland, Peter/AAC-6731-2019; Nomikou, Kyriaki/Q-5555-2016; Nomikou, Kyriaki/P-1840-2018; Lunt, Ross A/I-4941-2013; Belaganahalli, Manjunatha N/I-1688-2019	Nomikou, Kyriaki/0000-0002-7013-1853; Nomikou, Kyriaki/0000-0002-7013-1853; Lunt, Ross A/0000-0002-9630-8493; Belaganahalli, Manjunatha N/0000-0003-3401-5799; Mertens, Peter/0000-0002-3438-3738; Attoui, Houssam/0000-0001-9639-9981	Commonwealth Scholarship Commission; Department for Environment, Food and Rural Affairs (Defra) [SE2617]; Wellcome BTV; Biotechnology and Biological Sciences Research Council (BBSRC); European Union (EU) [SANCO/940/2002]; CSIRO; Dept of Agriculture, Fisheries and Forestry, Australian Government; NSW Department of Primary Industries	Commonwealth Scholarship Commission; Department for Environment, Food and Rural Affairs (Defra)(Department for Environment, Food & Rural Affairs (DEFRA)); Wellcome BTV; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union (EU)(CGIAREuropean Commission); CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Dept of Agriculture, Fisheries and Forestry, Australian Government(Australian GovernmentDepartment of Agriculture and Water Resources); NSW Department of Primary Industries	This work was partly funded by the Commonwealth Scholarship Commission (http://cscuk.dfid.gov.uk/) awarded to MB, partly by the Department for Environment, Food and Rural Affairs (Defra)(SE2617) awarded to SM, partly by the Wellcome BTV Programme grant (http://www.wellcome.ac.uk/) awarded to KN. NSM, PCM and HA were involved in this work, funded by the Biotechnology and Biological Sciences Research Council (BBSRC), the European Union (EU) (SANCO/940/2002) and Defra. IP and RL were part of this work, funded by CSIRO & Dept of Agriculture, Fisheries and Forestry, Australian Government. PK was funded by NSW Department of Primary Industries. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHSurveillance, 2011, TAMMAR WALLABY SUDDE; Vieira CDA, 2009, J GEN VIROL, V90, P2183, DOI 10.1099/vir.0.010165-0; Anthony S, 2007, J VIROL METHODS, V141, P188, DOI 10.1016/j.jviromet.2006.12.013; Anthony SJ, 2009, VIRUS RES, V145, P187, DOI 10.1016/j.virusres.2009.07.011; Anthony SJ, 2009, VIRUS RES, V145, P200, DOI 10.1016/j.virusres.2009.07.012; ARWH, 2011, TAMM WALL MORT AL 21; Attoui H, 2000, J VIROL METHODS, V89, P147, DOI 10.1016/S0166-0934(00)00212-3; Attoui H, 2005, J GEN VIROL, V86, P3409, DOI 10.1099/vir.0.81258-0; Attoui H, 2001, J GEN VIROL, V82, P795, DOI 10.1099/0022-1317-82-4-795; Attoui H, 2009, BIOL ANIM INFECT, P23, DOI 10.1016/B978-012369368-6.50007-1; Attoui H, 2009, VIROLOGY, V394, P298, DOI 10.1016/j.virol.2009.08.032; Basak AK, 1996, J VIROL, V70, P3797, DOI 10.1128/JVI.70.6.3797-3806.1996; Beaton AR, 2002, P NATL ACAD SCI USA, V99, P13154, DOI 10.1073/pnas.192432299; Belaganahalli MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023605; Belhouchet M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025697; Belhouchet M, 2010, J GEN VIROL, V91, P2985, DOI 10.1099/vir.0.024760-0; BORDEN EC, 1971, J GEN VIROL, V13, P261, DOI 10.1099/0022-1317-13-2-261; BROWN SE, 1988, J GEN VIROL, V69, P135, DOI 10.1099/0022-1317-69-1-135; BROWN SE, 1992, VET MICROBIOL, V32, P241, DOI 10.1016/0378-1135(92)90147-L; Della-Porta A J, 1985, Prog Clin Biol Res, V178, P267; DOHERTY RL, 1970, T ROY SOC TROP MED H, V64, P748, DOI 10.1016/0035-9203(70)90017-9; Firth AE, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-48; FRENCH TJ, 1989, J VIROL, V63, P3270, DOI 10.1128/JVI.63.8.3270-3278.1989; GARD G, 1973, AM J TROP MED HYG, V22, P551, DOI 10.4269/ajtmh.1973.22.551; GONZALEZ HA, 1988, J GEN VIROL, V69, P125, DOI 10.1099/0022-1317-69-1-125; Gorman B.M., 1983, P287; GORMAN BM, 1978, AUST J EXP BIOL MED, V56, P369, DOI 10.1038/icb.1978.40; GORMAN BM, 1979, J GEN VIROL, V44, P1, DOI 10.1099/0022-1317-44-1-1; GUIRAKHOO F, 1995, ARCH VIROL, V140, P967, DOI 10.1007/BF01314973; GUMM ID, 1982, ARCH VIROL, V72, P83, DOI 10.1007/BF01314453; Hasan S, 2001, NATURE, V410, P387, DOI 10.1038/35066610; Karabatsos N., 1985, INT CATALOGUE ARBOVI; Kirkland P, 2005, MICROBIOLOGY AUSTR, P82; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Maan N.S., 2010, PLOS ONE, V5, P12782; Maan NS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025686; Maan S, 2007, J GEN VIROL, V88, P621, DOI 10.1099/vir.0.82456-0; Maan S, 2008, VIROLOGY, V377, P308, DOI 10.1016/j.virol.2008.04.028; Maan S, 2007, J VIROL METHODS, V143, P132, DOI 10.1016/j.jviromet.2007.02.016; Maan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026147; Maan S, 2011, EMERG INFECT DIS, V17, P886, DOI 10.3201/eid1705.101742; Maan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010323; MARSHALL ID, 1980, AUST J EXP BIOL MED, V58, P91, DOI 10.1038/icb.1980.9; Martins LC, 2007, INT J EXP PATHOL, V88, P63, DOI 10.1111/j.1365-2613.2006.00516.x; MELLOR PS, 1980, ARCH VIROL, V63, P203, DOI 10.1007/BF01315027; Mertens PPC, 2007, J GEN VIROL, V88, P2811, DOI 10.1099/vir.0.83023-0; MERTENS PPC, 1985, VIROLOGY, V140, P55, DOI 10.1016/0042-6822(85)90445-3; Mertens PPC., 2005, VIRUS TAXONOMY, P466; MOORE DL, 1972, ARCH GES VIRUSFORSCH, V37, P282, DOI 10.1007/BF01268013; Pritchard LI, 2001, ARBOVIRUS RES AUSTR, P282; Rose KA, 2000, P AAZV IAAAM JOINT C, P166; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SATO M, 1977, ARCH VIROL, V53, P269, DOI 10.1007/BF01314672; SCHNAGL RD, 1975, AUST J BIOL SCI, V28, P425, DOI 10.1071/BI9750425; Tamura K, 2011, MOL BIOL EVOL; Tan BH, 2001, J VIROL, V75, P3937, DOI 10.1128/JVI.75.8.3937-3947.2001; TSDS, 2011, TAMM WALL SUDD DEATH; Victoria JG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000163; Wilson K, 2000, MOL BIOL EVOL, V17, P863, DOI 10.1093/oxfordjournals.molbev.a026366	60	30	39	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2012	7	3							e31911	10.1371/journal.pone.0031911	http://dx.doi.org/10.1371/journal.pone.0031911			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RU	22438872	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000303309000005
J	Davis, WG; Bowzard, JB; Sharma, SD; Wiens, ME; Ranjan, P; Gangappa, S; Stuchlik, O; Pohl, J; Donis, RO; Katz, JM; Cameron, CE; Fujita, T; Sambhara, S				Davis, William G.; Bowzard, J. Bradford; Sharma, Suresh D.; Wiens, Mayim E.; Ranjan, Priya; Gangappa, Shivaprakash; Stuchlik, Olga; Pohl, Jan; Donis, Ruben O.; Katz, Jacqueline M.; Cameron, Craig E.; Fujita, Takashi; Sambhara, Suryaprakash			The 3 ' Untranslated Regions of Influenza Genomic Sequences Are 5 ' PPP-Independent Ligands for RIG-I	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; INNATE IMMUNITY; ANTIVIRAL RESPONSES; RECOGNITION; ACTIVATION; HELICASE; VIRUSES; DOMAIN; SENSOR; DNA	Retinoic acid inducible gene-I (RIG-I) is a key regulator of antiviral immunity. RIG-I is generally thought to be activated by ssRNA species containing a 5'-triphosphate (PPP) group or by unphosphorylated dsRNA up to similar to 300 bp in length. However, it is not yet clear how changes in the length, nucleotide sequence, secondary structure, and 5' end modification affect the abilities of these ligands to bind and activate RIG-I. To further investigate these parameters in the context of naturally occurring ligands, we examined RNA sequences derived from the 5' and 3' untranslated regions (UTR) of the influenza virus NS1 gene segment. As expected, RIG-I-dependent interferon-beta (IFN-beta) induction by sequences from the 5' UTR of the influenza cRNA or its complement (26 nt in length) required the presence of a 5'PPP group. In contrast, activation of RIG-I by the 3' UTR cRNA sequence or its complement (172 nt) exhibited only a partial 5'PPP-dependence, as capping the 5' end or treatment with CIP showed a modest reduction in RIG-I activation. Furthermore, induction of IFN-b by a smaller, U/A-rich region within the 3' UTR was completely 5'PPP-independent. Our findings demonstrated that RNA sequence, length, and secondary structure all contributed to whether or not the 5'PPP moiety is needed for interferon induction by RIG-I.	[Davis, William G.; Bowzard, J. Bradford; Wiens, Mayim E.; Ranjan, Priya; Gangappa, Shivaprakash; Donis, Ruben O.; Katz, Jacqueline M.; Sambhara, Suryaprakash] Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30341 USA; [Sharma, Suresh D.; Cameron, Craig E.] Penn State Univ, University Pk, PA 16802 USA; [Stuchlik, Olga; Pohl, Jan] Ctr Dis Control & Prevent, Div Sci Resources, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA; [Fujita, Takashi] Kyoto Univ, Kyoto, Japan	Centers for Disease Control & Prevention - USA; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Centers for Disease Control & Prevention - USA; Kyoto University	Davis, WG (corresponding author), Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30341 USA.	tfujita@virus.kyoto-u.ac.jp; ssambhara@cdc.gov	Sambhara, Suryaprakash/AAC-4428-2021; SHARMA, Suresh D./AAD-7723-2022; SHARMA, Suresh/C-4431-2008	SHARMA, Suresh D./0000-0002-8633-4145; SHARMA, Suresh/0000-0002-8633-4145				Akira S, 2009, IMMUNOL REV, V227, P5, DOI 10.1111/j.1600-065X.2008.00739.x; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Baum A, 2010, P NATL ACAD SCI US; Benferhat R, 2008, MOL IMMUNOL, V45, P1963, DOI 10.1016/j.molimm.2007.10.036; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Kang DC, 2002, P NATL ACAD SCI USA, V99, P637, DOI 10.1073/pnas.022637199; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Lu C, 2010, STRUCTURE, V18, P1032, DOI 10.1016/j.str.2010.05.007; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Nacheva GA, 2003, EUR J BIOCHEM, V270, P1458, DOI 10.1046/j.1432-1033.2003.03510.x; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Ranjan P, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-102; Rehwinkel J, 2010, CELL, V140, P397, DOI 10.1016/j.cell.2010.01.020; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; SCHLEE M, 2009, IMMUNITY; Schmidt A, 2009, P NATL ACAD SCI US; Seth RB, 2006, CELL RES, V16, P141, DOI 10.1038/sj.cr.7310019; Spiropoulou CF, 2009, VIROLOGY, V392, P11, DOI 10.1016/j.virol.2009.06.032; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Wang YL, 2010, NAT STRUCT MOL BIOL, V17, P781, DOI 10.1038/nsmb.1863; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	27	39	39	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2012	7	3							e32661	10.1371/journal.pone.0032661	http://dx.doi.org/10.1371/journal.pone.0032661			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RU	22438882	Green Submitted, Green Published, gold			2022-12-25	WOS:000303309000008
J	Connell, L; Lynott, D; Dreyer, F				Connell, Louise; Lynott, Dermot; Dreyer, Felix			A Functional Role for Modality-Specific Perceptual Systems in Conceptual Representations	PLOS ONE			English	Article							TENDON VIBRATION; OBJECT COLOR; LANGUAGE; MOTOR; RETRIEVAL; EMBODIMENT; ACTIVATION; KNOWLEDGE	Theories of embodied cognition suggest that conceptual processing relies on the same neural resources that are utilized for perception and action. Evidence for these perceptual simulations comes from neuroimaging and behavioural research, such as demonstrations of somatotopic motor cortex activations following the presentation of action-related words, or facilitation of grasp responses following presentation of object names. However, the interpretation of such effects has been called into question by suggestions that neural activation in modality-specific sensorimotor regions may be epiphenomenal, and merely the result of spreading activations from "disembodied", abstracted, symbolic representations. Here, we present two studies that focus on the perceptual modalities of touch and proprioception. We show that in a timed object-comparison task, concurrent tactile or proprioceptive stimulation to the hands facilitates conceptual processing relative to control stimulation. This facilitation occurs only for small, manipulable objects, where tactile and proprioceptive information form part of the multimodal perceptual experience of interacting with such objects, but facilitation is not observed for large, nonmanipulable objects where such perceptual information is uninformative. Importantly, these facilitation effects are independent of motor and action planning, and indicate that modality-specific perceptual information plays a functionally constitutive role in our mental representations of objects, which supports embodied assumptions that concepts are grounded in the same neural systems that govern perception and action.	[Connell, Louise] Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England; [Lynott, Dermot] Univ Manchester, Manchester Business Sch, Decis & Cognit Sci Res Ctr, Manchester M13 9PL, Lancs, England; [Dreyer, Felix] Univ Leipzig, Dept Psychol, Leipzig, Germany	University of Manchester; University of Manchester; Leipzig University	Connell, L (corresponding author), Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England.	louise.connell@manchester.ac.uk; dermot.lynott@manchester.ac.uk	Lynott, Dermot/A-9661-2011; Connell, Louise/D-1793-2014	Lynott, Dermot/0000-0001-7338-0567; Connell, Louise/0000-0002-5291-5267; Dreyer, Felix/0000-0003-1560-8126	British Academy	British Academy	The studies reported here were supported by a grant from the British Academy to LC and DL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Bar M, 2009, TRENDS COGN SCI, V13, P456, DOI 10.1016/j.tics.2009.08.009; Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577, DOI 10.1017/S0140525X99532147; Boulenger V, 2006, J COGNITIVE NEUROSCI, V18, P1607, DOI 10.1162/jocn.2006.18.10.1607; Boulenger V, 2010, MENT LEX, V5, P231, DOI 10.1075/ml.5.2.05bou; Brants T, 2006, WEB 1 T 5 GRAM VERSI; Bub DN, 2008, COGNITION, V106, P27, DOI 10.1016/j.cognition.2006.12.010; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Connell L, 2007, COGNITION, V102, P476, DOI 10.1016/j.cognition.2006.02.009; Connell L, 2010, COGNITION, V115, P1, DOI 10.1016/j.cognition.2009.10.005; Connell L, 2009, PSYCHON B REV, V16, P573, DOI 10.3758/PBR.16.3.573; Coventry KR, 2010, BRAIN LANG, V112, P202, DOI 10.1016/j.bandl.2009.06.001; Coventry KR, 2004, ESSAYS COGN PSYCHOL, P1; Dijkstra K, 2007, COGNITION, V102, P139, DOI 10.1016/j.cognition.2005.12.009; Dove G, 2009, COGNITION, V110, P412, DOI 10.1016/j.cognition.2008.11.016; Ertelt D, 2007, NEUROIMAGE, V36, pT164, DOI 10.1016/j.neuroimage.2007.03.043; Gentilucci M, 2000, EXP BRAIN RES, V133, P468, DOI 10.1007/s002210000431; Glenberg AM, 2002, PSYCHON B REV, V9, P558, DOI 10.3758/BF03196313; Glenberg AM, 1997, BEHAV BRAIN SCI, V20, P1, DOI 10.1017/S0140525X97470012; Glenberg AM, CORTEX IN PRESS; Glover S, 2004, EXP BRAIN RES, V154, P103, DOI 10.1007/s00221-003-1659-2; Goldberg RF, 2006, J NEUROSCI, V26, P4917, DOI 10.1523/JNEUROSCI.5389-05.2006; Gonzalez J, 2006, NEUROIMAGE, V32, P906, DOI 10.1016/j.neuroimage.2006.03.037; Hauk O, 2004, NEURON, V41, P301, DOI 10.1016/S0896-6273(03)00838-9; Havas DA, 2007, PSYCHON B REV, V14, P436, DOI 10.3758/BF03194085; Havas David A, 2010, Psychol Sci, V21, P895, DOI 10.1177/0956797610374742; Hickok G, 2010, LANG COGNITIVE PROC, V25, P749, DOI 10.1080/01690961003595572; Kaschak MP, 2005, COGNITION, V94, pB79, DOI 10.1016/j.cognition.2004.06.005; Kosslyn S. M., 1980, IMAGE MIND; KOSSLYN SM, 1977, J EXP PSYCHOL GEN, V106, P341, DOI 10.1037/0096-3445.106.4.341; Locker L, 2007, BEHAV RES METHODS, V39, P723, DOI 10.3758/BF03192962; Lynott D, 2009, BEHAV RES METHODS, V41, P558, DOI 10.3758/BRM.41.2.558; Mahon BZ, 2008, J PHYSIOL-PARIS, V102, P59, DOI 10.1016/j.jphysparis.2008.03.004; Mahon BZ, 2005, COGN NEUROPSYCHOL, V22, P480, DOI 10.1080/02643290442000446; Neal DT, 2011, SOC PSYCHOL PERS SCI, V2, P673, DOI 10.1177/1948550611406138; Newman SD, 2005, COGNITIVE BRAIN RES, V23, P235, DOI 10.1016/j.cogbrainres.2004.10.020; Niedenthal PM, 2007, SCIENCE, V316, P1002, DOI 10.1126/science.1136930; Niedenthal PM, 2009, J PERS SOC PSYCHOL, V96, P1120, DOI 10.1037/a0015574; Oliver RT, 2003, COGN AFFECT BEHAV NE, V3, P309, DOI 10.3758/CABN.3.4.309; Paivio, 1986, MENTAL REPRESENTATIO; PAIVIO A, 1975, MEM COGNITION, V3, P635, DOI 10.3758/BF03198229; Paivio A, 1971, IMAGERY VERBAL PROCE; Pavani F, 2000, PSYCHOL SCI, V11, P353, DOI 10.1111/1467-9280.00270; Pecher D, 2003, PSYCHOL SCI, V14, P119, DOI 10.1111/1467-9280.t01-1-01429; Pulvermuller F, 2007, J COGNITIVE NEUROSCI, V19, P971, DOI 10.1162/jocn.2007.19.6.971; Pulvermuller F, 2005, NAT REV NEUROSCI, V6, P576, DOI 10.1038/nrn1706; PULVERMULLER F, 1991, NETWORK-COMP NEURAL, V2, P455, DOI 10.1088/0954-898X/2/4/008; Pulvermuller F, 2010, NAT REV NEUROSCI, V11, P351, DOI 10.1038/nrn2811; Ribot-Ciscar E, 1998, NEUROSCI LETT, V258, P147, DOI 10.1016/S0304-3940(98)00732-0; RISKIND J H, 1982, Motivation and Emotion, V6, P273, DOI 10.1007/BF00992249; RISKIND JH, 1983, SOC COGNITION, V2, P62, DOI 10.1521/soco.1983.2.1.62; ROLL JP, 1989, EXP BRAIN RES, V76, P213; Setti A, 2009, EUR J COGN PSYCHOL, V21, P1022, DOI 10.1080/09541440802469499; Simmons WK, 2007, NEUROPSYCHOLOGIA, V45, P2802, DOI 10.1016/j.neuropsychologia.2007.05.002; Smith M, 2005, PSYCHOL SCI, V16, P11, DOI 10.1111/j.0956-7976.2005.00773.x; Stanfield RA, 2001, PSYCHOL SCI, V12, P153, DOI 10.1111/1467-9280.00326; STRACK F, 1988, J PERS SOC PSYCHOL, V54, P768, DOI 10.1037/0022-3514.54.5.768; Taylor LJ, 2010, COGNITION, V115, P39, DOI 10.1016/j.cognition.2009.11.006; Tettamanti M, 2005, J COGNITIVE NEUROSCI, V17, P273, DOI 10.1162/0898929053124965; Tucker M, 2001, VIS COGN, V8, P769, DOI 10.1080/13506280042000144; van Dantzig S, 2008, COGNITIVE SCI, V32, P579, DOI 10.1080/03640210802035365; Vermeulen N, 2009, COGNITION, V112, P467, DOI 10.1016/j.cognition.2009.06.003; Vermeulen N, 2008, COGNITION, V109, P287, DOI 10.1016/j.cognition.2008.09.004; Weerakkody NS, 2007, J PHYSIOL-LONDON, V581, P971, DOI 10.1113/jphysiol.2006.126854; Wilson M, 2002, PSYCHON B REV, V9, P625, DOI 10.3758/BF03196322; Zwaan RA, 2002, PSYCHOL SCI, V13, P168, DOI 10.1111/1467-9280.00430; Zwaan RA, 2006, J EXP PSYCHOL GEN, V135, P1, DOI 10.1037/0096-3445.135.1.1	68	29	29	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2012	7	3							e33321	10.1371/journal.pone.0033321	http://dx.doi.org/10.1371/journal.pone.0033321			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	930IA	22428020	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000303129700053
J	Suzuki, T; Nakano-Ikegaya, M; Yabukami-Okuda, H; de Hoon, M; Severin, J; Saga-Hatano, S; Shin, JW; Kubosaki, A; Simon, C; Hasegawa, Y; Hayashizaki, Y; Suzuki, H				Suzuki, Takahiro; Nakano-Ikegaya, Mika; Yabukami-Okuda, Haruka; de Hoon, Michiel; Severin, Jessica; Saga-Hatano, Satomi; Shin, Jay W.; Kubosaki, Atsutaka; Simon, Christophe; Hasegawa, Yuki; Hayashizaki, Yoshihide; Suzuki, Harukazu			Reconstruction of Monocyte Transcriptional Regulatory Network Accompanies Monocytic Functions in Human Fibroblasts	PLOS ONE			English	Article							HUMAN MONOCYTE/MACROPHAGE DIFFERENTIATION; DEFINED FACTORS; DIRECT CONVERSION; GENE-EXPRESSION; FACTOR PU.1; STEM-CELLS; MACROPHAGE; IDENTIFICATION; PHAGOCYTOSIS; ACTIVATION	Transcriptional regulatory networks (TRN) control the underlying mechanisms behind cellular functions and they are defined by a set of core transcription factors regulating cascades of peripheral genes. Here we report SPI1, CEBPA, MNDA and IRF8 as core transcription factors of monocyte TRN and demonstrate functional inductions of phagocytosis, inflammatory response and chemotaxis activities in human dermal fibroblasts. The Gene Ontology and KEGG pathway analyses also revealed notable representation of genes involved in immune response and endocytosis in fibroblasts. Moreover, monocyte TRN-inducers triggered multiple monocyte-specific genes based on the transcription factor motif response analysis and suggest that complex cellular TRNs are uniquely amenable to elicit cell-specific functions in unrelated cell types.	[Suzuki, Takahiro; Nakano-Ikegaya, Mika; Yabukami-Okuda, Haruka; de Hoon, Michiel; Severin, Jessica; Saga-Hatano, Satomi; Shin, Jay W.; Kubosaki, Atsutaka; Simon, Christophe; Hasegawa, Yuki; Hayashizaki, Yoshihide; Suzuki, Harukazu] RIKEN Yokohama Inst, OSC, Yokohama, Kanagawa, Japan; [Hayashizaki, Yoshihide] Yokohama City Univ, Div Genom Informat Resources, Int Grad Sch Arts & Sci, Yokohama, Kanagawa 232, Japan	RIKEN; Yokohama City University	Suzuki, T (corresponding author), RIKEN Yokohama Inst, OSC, Yokohama, Kanagawa, Japan.	rgscerg@gsc.riken.jp	Suzuki, Harukazu/N-9553-2015; Hayashizaki, Yoshihide/N-6590-2015; Severin, Jessica/AAQ-2723-2020; Suzuki, Takahiro/AAW-8509-2020; de Hoon, Michiel/A-6443-2013	Suzuki, Harukazu/0000-0002-8087-0836; Severin, Jessica/0000-0003-1274-208X; Suzuki, Takahiro/0000-0002-0972-6911; de Hoon, Michiel/0000-0003-0489-2352	MEXT; MEXT, Japan; National Institutes of Health (NIH)	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in by a research grant for RIKEN Omics Science Center from MEXT to Yoshihide Hayashizaki, a grant of the Innovative Cell Biology by Innovative Technology (Cell Innovation Program) from the MEXT, Japan to Yoshihide Hayashizaki, Strategic Programs for R&D (President's discretionary fund) (super immune cell) for Yoshihide Hayashizaki, and the ENCODE project from National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN TD, 1983, J ULTRA MOL STRUCT R, V83, P205, DOI 10.1016/S0022-5320(83)90078-3; Arlein WJ, 1998, AM J PHYSIOL-REG I, V275, pR1041, DOI 10.1152/ajpregu.1998.275.4.R1041; Bhardwaj N, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001014; de Hoon M, 2008, BIOTECHNIQUES, V44, P627, DOI 10.2144/000112802; Feng R, 2008, P NATL ACAD SCI USA, V105, P6057, DOI 10.1073/pnas.0711961105; Forsberg M, 2010, P NATL ACAD SCI USA, V107, P14657, DOI 10.1073/pnas.1009412107; FREYTAG SO, 1992, SCIENCE, V256, P379, DOI 10.1126/science.256.5055.379; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Kedzierska K, 2003, J CLIN VIROL, V26, P247, DOI 10.1016/S1386-6532(02)00123-3; Kubosaki A, 2010, MOL IMMUNOL, V47, P2295, DOI 10.1016/j.molimm.2010.05.289; Lehtonen A, 2002, J LEUKOCYTE BIOL, V71, P511; Melief CJM, 2008, IMMUNITY, V29, P372, DOI 10.1016/j.immuni.2008.08.004; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Okuno Y, 2005, MOL CELL BIOL, V25, P2832, DOI 10.1128/MCB.25.7.2832-2845.2005; Pachkov M, 2007, NUCLEIC ACIDS RES, V35, pD127, DOI 10.1093/nar/gkl857; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Rosa A, 2007, P NATL ACAD SCI USA, V104, P19849, DOI 10.1073/pnas.0706963104; Sato Y, 2006, J BIOL CHEM, V281, P21629, DOI 10.1074/jbc.M600852200; Steele JC, 2011, GENE THER; Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tomaru Y, 2009, NUCLEIC ACIDS RES, V37, P1049, DOI 10.1093/nar/gkn1028; Trefzer U, 2003, MOL BIOTECHNOL, V25, P63, DOI 10.1385/MB:25:1:63; van Nimwegen E, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S4; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wenzlau JM, 2007, P NATL ACAD SCI USA, V104, P17040, DOI 10.1073/pnas.0705894104; Yamana J, 2009, CELL IMMUNOL, V255, P26, DOI 10.1016/j.cellimm.2008.09.003; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	32	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2012	7	3							e33474	10.1371/journal.pone.0033474	http://dx.doi.org/10.1371/journal.pone.0033474			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930IA	22428058	Green Published, Green Submitted, gold			2022-12-25	WOS:000303129700066
J	Barnagaud, JY; Devictor, V; Jiguet, F; Barbet-Massin, M; Le Viol, I; Archaux, F				Barnagaud, Jean-Yves; Devictor, Vincent; Jiguet, Frederic; Barbet-Massin, Morgane; Le Viol, Isabelle; Archaux, Frederic			Relating Habitat and Climatic Niches in Birds	PLOS ONE			English	Article							SPECIES DISTRIBUTIONS; RANGE LIMITS; LAND-COVER; EVOLUTIONARY; IMPACTS; MODELS; GENERALISTS; RESILIENCE; ABUNDANCE; RESPONSES	Predicting species' responses to the combined effects of habitat and climate changes has become a major challenge in ecology and conservation biology. However, the effects of climatic and habitat gradients on species distributions have generally been considered separately. Here, we explore the relationships between the habitat and thermal dimensions of the ecological niche in European common birds. Using data from the French Breeding Bird Survey, a large-scale bird monitoring program, we correlated the habitat and thermal positions and breadths of 74 bird species, controlling for life history traits and phylogeny. We found that cold climate species tend to have niche positions in closed habitats, as expected by the conjunction of the biogeographic history of birds' habitats, and their current continent-scale gradients. We also report a positive correlation between thermal and habitat niche breadths, a pattern consistent with macroecological predictions concerning the processes shaping species' distributions. Our results suggest that the relationships between the climatic and habitat components of the niche have to be taken into account to understand and predict changes in species' distributions.	[Barnagaud, Jean-Yves; Archaux, Frederic] Irstea, UR EFNO, F-45290 Nogent-Sur-Vernisson, France; [Devictor, Vincent] UMR CNRS UM2 5554, Inst Sci Evolut, Montpellier, France; [Jiguet, Frederic; Barbet-Massin, Morgane; Le Viol, Isabelle] UMR 7204 MNHN CNRS UPMC, Museum Natl Hist Nat, Paris, France	INRAE; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Barnagaud, JY (corresponding author), Irstea, UR EFNO, F-45290 Nogent-Sur-Vernisson, France.	jeanyves.barnagaud@gmail.com	Archaux, Frédéric/M-5242-2014	Archaux, Frédéric/0000-0002-9996-0006; Le Viol, Isabelle/0000-0003-3475-5615	Fondation pour la Recherche sur la Biodiversite; Region Centre [200800033784]; Scales project [FP7-ENV-2008-1, 226852]	Fondation pour la Recherche sur la Biodiversite; Region Centre(Region Centre-Val de Loire); Scales project	Vincent Devictor received financial support from the Fondation pour la Recherche sur la Biodiversite (project FABIO and PHYBIO). Jean-Yves Barnagaud received financial support from the Region Centre (No. 200800033784), Isabelle Le Viol from Scales project (FP7-ENV-2008-1, No. 226852). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MB, 2005, ECOGRAPHY, V28, P693, DOI 10.1111/j.2005.0906-7590.04253.x; Araujo MB, 2009, P NATL ACAD SCI USA, V106, pE45, DOI 10.1073/pnas.0813294106; Barbet-Massin M, 2012, GLOBAL CHANGE BIOL; Barnagaud J, GLOBAL ECOL IN PRESS; Bossard M., 2000, 40 EUR ENV AG; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Clavero M, 2010, GLOBAL ECOL BIOGEOGR, V19, P684, DOI 10.1111/j.1466-8238.2010.00544.x; Cramp S, HDB BIRDS W PALEARCT; Devictor V, 2008, P ROY SOC B-BIOL SCI, V275, P2743, DOI 10.1098/rspb.2008.0878; Devictor V, 2010, J APPL ECOL, V47, P15, DOI 10.1111/j.1365-2664.2009.01744.x; Doledec S, 2000, ECOLOGY, V81, P2914, DOI 10.1890/0012-9658(2000)081[2914:NSICAA]2.0.CO;2; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; Gaston K.J., 2000, PATTERN PROCESS MACR, DOI [10.1002/9780470999592, DOI 10.1002/9780470999592]; Gaston KJ, 2009, P R SOC B, V276, P1395, DOI 10.1098/rspb.2008.1480; Gregory RD, 2005, PHILOS T R SOC B, V360, P269, DOI 10.1098/rstb.2004.1602; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hill JK, 2001, ECOL LETT, V4, P313, DOI 10.1046/j.1461-0248.2001.00222.x; Holt RD, 1997, OIKOS, V78, P183, DOI 10.2307/3545815; Holt RD, 2000, ECOL LETT, V3, P41, DOI 10.1046/j.1461-0248.2000.00116.x; HUNTLEY B, 1990, J VEG SCI, V1, P507, DOI 10.2307/3235785; IPCC Apndice, 2007, AR4 CLIMATE CHANGE 2; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Jiguet F, ACTA OECOLO IN PRESS; Jiguet F, 2007, GLOBAL CHANGE BIOL, V13, P1672, DOI 10.1111/j.1365-2486.2007.01386.x; Jiguet F, 2006, ECOL LETT, V9, P1321, DOI 10.1111/j.1461-0248.2006.00986.x; Jiguet F, 2010, GLOBAL CHANGE BIOL, V16, P497, DOI 10.1111/j.1365-2486.2009.01963.x; Julliard R, 2004, GLOBAL CHANGE BIOL, V10, P148, DOI 10.1111/j.1365-2486.2003.00723.x; Julliard R, 2006, ECOL LETT, V9, P1237, DOI 10.1111/j.1461-0248.2006.00977.x; Kirkpatrick M, 1997, AM NAT, V150, P1, DOI 10.1086/286054; Lavergne S, 2010, ANNU REV ECOL EVOL S, V41, P321, DOI 10.1146/annurev-ecolsys-102209-144628; Luoto M, 2007, GLOBAL ECOL BIOGEOGR, V16, P34, DOI 10.1111/j.1466-8238.2006.00262.x; Martins EP, 1997, AM NAT, V149, P646, DOI 10.1086/286013; Morin X, 2008, BIOL LETTERS, V4, P573, DOI 10.1098/rsbl.2008.0181; Murphy HT, 2007, OIKOS, V116, P99, DOI 10.1111/j.2006.0030-1299.15050.x; Newton I., 1998, POPULATION LIMITATIO; Oliver T, 2009, ECOL LETT, V12, P1091, DOI 10.1111/j.1461-0248.2009.01367.x; Paradis E., ANAL PHYLOGENETICS E; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Prinzing A, 2003, ECOLOGY, V84, P1744, DOI 10.1890/0012-9658(2003)084[1744:AGPFTA]2.0.CO;2; Pulliam HR, 2000, ECOL LETT, V3, P349, DOI 10.1046/j.1461-0248.2000.00143.x; R Core Team, 2022, R LANG ENV STAT COMP; Rannap R, 2009, DIVERS DISTRIB, V15, P692, DOI 10.1111/j.1472-4642.2009.00575.x; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Sexton JP, 2009, ANNU REV ECOL EVOL S, V40, P415, DOI 10.1146/annurev.ecolsys.110308.120317; Thuiller W, 2004, J BIOGEOGR, V31, P353, DOI 10.1046/j.0305-0270.2003.00991.x; Thuiller W, 2011, NATURE, V470, P531, DOI 10.1038/nature09705; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007	52	78	80	0	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e32819	10.1371/journal.pone.0032819	http://dx.doi.org/10.1371/journal.pone.0032819			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427891	Green Submitted, gold, Green Published			2022-12-25	WOS:000302381500051
J	Jia, EZ; Xu, ZX; Cai, HZ; Guo, CY; Li, L; Zhu, TB; Wang, LS; Cao, KJ; Ma, WZ; Yang, ZJ				Jia, En-Zhi; Xu, Zhen-Xia; Cai, Hong-Zhou; Guo, Chang-Yan; Li, Li; Zhu, Tie-Bing; Wang, Lian-Sheng; Cao, Ke-Jiang; Ma, Wen-Zhu; Yang, Zhi-Jian			Time Distribution of the Onset of Chest Pain in Subjects with Acute ST-Elevation Myocardial Infarction: An Eight-Year, Single-Center Study in China	PLOS ONE			English	Article							CIRCADIAN VARIATION; POPULATION; ADMISSIONS; FREQUENCY; REGISTRY; WEATHER; DEATH	Objective: The objective of this study was to explore the time distribution patterns of the onset of chest pain in subjects with acute ST-elevation myocardial infarction in a Chinese population. Methods: A total of 1467 patients with acute ST-elevation myocardial infarction were enrolled from 2003 to 2010. The hourly, daily, monthly, seasonal and day-of-week fluctuations in the prevalence of acute ST-elevation myocardial infarction were analyzed. Results: A peak was found between the morning hours of 07:31 and 08:30. A second peak was observed between 14:31 and 15:30, and a third peak was found between 23:31 and 00:30 (p<0.001). The monthly maximum was recorded in November and the minimum was in April (p<0.001). The number of daily cases was greatest in autumn and lowest in the spring (p = 0.001). Day-of-the-week variations of ST-elevation acute myocardial infarction were not found, except in patients more than 75-years-old. Conclusions: Periodic variations in the frequency of ST-elevation acute myocardial infarction in Chinese patients showed significant differences with regard to diurnal, monthly and seasonal patterns. The exact mechanisms underlying these circadian variations require further study.	[Jia, En-Zhi; Xu, Zhen-Xia; Cai, Hong-Zhou; Guo, Chang-Yan; Li, Li; Zhu, Tie-Bing; Wang, Lian-Sheng; Cao, Ke-Jiang; Ma, Wen-Zhu; Yang, Zhi-Jian] Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiovasc Med, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Jia, EZ (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiovasc Med, Nanjing, Jiangsu, Peoples R China.	enzhijia@yahoo.cn	Jia, Enzhi/AGX-9137-2022	Cai, Hongzhou/0000-0001-6915-564X	National Natural Science Foundation of China [30400173, 30971257]; Hersenstichting Nederland; Neuroscience Campus Amsterdam; Prinses Beatrix Fonds	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hersenstichting Nederland; Neuroscience Campus Amsterdam; Prinses Beatrix Fonds	Supported by the National Natural Science Foundation of China (grant numbers, 30400173 and 30971257). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was undertaken on behalf of the International Parkinson's Disease Genomics Consortium (members are listed below). We used genome-wide association data generated by the Wellcome Trust Case-Control Consortium 2 (WTCCC2) from UK patients with Parkinson's disease and UK control individuals from the 1958 Birth Cohort and National Blood Service. This study utilized the high-performance computational capabilities of the Biowulf Linux cluster at the National Institutes of Health, Bethesda, Md. (http://biowulf.nih.gov). We also want to thank the Hersenstichting Nederland (http://www.hersenstichting.nl), the Neuroscience Campus Amsterdam and the Prinses Beatrix Fonds (http://www.prinsesbeatrixfonds.nl) for sponsoring this work.	Arntz HR, 2000, EUR HEART J, V21, P315, DOI 10.1053/euhj.1999.1739; Bodis J, 2009, CHINESE MED J-PEKING, V122, P2107, DOI 10.3760/cma.j.issn.0366-6999.2009.18.006; Cohen MC, 1997, AM J CARDIOL, V79, P1512, DOI 10.1016/S0002-9149(97)00181-1; Dilaveris P, 2006, HEART, V92, P1747, DOI 10.1136/hrt.2006.091884; GOLDBERG RJ, 1990, AM J CARDIOL, V66, P140, DOI 10.1016/0002-9149(90)90577-N; HANSEN O, 1992, AM J CARDIOL, V69, P1003, DOI 10.1016/0002-9149(92)90854-R; Hernandez EG, 2004, REV ESP CARDIOL, V57, P12; Ildiko K, 2009, INT J CARDIOL, V135, P136, DOI 10.1016/j.ijcard.2008.01.048; Jones W. H. S., 1923, HIPPOCRATES, V2; Lee JH, 2010, INT J CARDIOL, V144, P16, DOI 10.1016/j.ijcard.2009.03.122; Lopez F, 2005, INT J CARDIOL, V100, P151, DOI 10.1016/j.ijcard.2004.12.002; Morabito M, 2005, INT J CARDIOL, V105, P288, DOI 10.1016/j.ijcard.2004.12.047; MULLER JE, 1985, NEW ENGL J MED, V313, P1315, DOI 10.1056/NEJM198511213132103; Park HE, 2010, CIRC J, V74, P970, DOI 10.1253/circj.CJ-09-0344; PELL S, 1963, JAMA-J AM MED ASSOC, V185, P831, DOI 10.1001/jama.1963.03060110035014; Scheer FAJL, 2010, P NATL ACAD SCI USA, V107, P20541, DOI 10.1073/pnas.1006749107; Spencer FA, 1998, J AM COLL CARDIOL, V31, P1226, DOI 10.1016/S0735-1097(98)00098-9; Spielberg C, 1996, AM HEART J, V132, P579, DOI 10.1016/S0002-8703(96)90241-0; THOMPSON DR, 1991, BRIT HEART J, V65, P177; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; WILLICH SN, 1989, CIRCULATION, V80, P853, DOI 10.1161/01.CIR.80.4.853	21	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e32478	10.1371/journal.pone.0032478	http://dx.doi.org/10.1371/journal.pone.0032478			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427844	Green Published, gold, Green Submitted			2022-12-25	WOS:000302381500020
J	Le, HTT; Sorrell, AM; Siddle, K				Le, Hang T. T.; Sorrell, Alice M.; Siddle, Kenneth			Two Isoforms of the mRNA Binding Protein IGF2BP2 Are Generated by Alternative Translational Initiation	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; K562 LEUKEMIA-CELLS; INSULIN SENSITIVITY; KH DOMAINS; RISK LOCI; EXPRESSION; TRANSCRIPTION; VARIANTS; GENE; PROLIFERATION	IGF2BP2 is a member of a family of mRNA binding proteins that, collectively, have been shown to bind to several different mRNAs in mammalian cells, including one of the mRNAs encoding insulin-like growth factor-2. Polymorphisms in the Igf2bp2 gene are associated with risk of developing type 2 diabetes, but detailed functional characterisation of IGF2BP2 protein is lacking. By immunoblotting with C-terminally reactive antibodies we identified a novel IGF2BP2 isoform with a molecular weight of 58 kDa in both human and rodents, that is expressed at somewhat lower levels than the full-length 65 kDa protein. We demonstrated by mutagenesis that this isoform is generated by alternative translation initiation at the internal Met69. It lacks a conserved N-terminal RNA Recognition Motif (RRM) and would be predicted to differ functionally from the canonical full length isoform. We further investigated IGF2BP2 mRNA transcripts by amplification of cDNA using 5'-RACE. We identified multiple transcription start sites of the human, mouse and rat Igf2bp2 genes in a highly conserved region only 50-90 nts upstream of the major translation start site, ruling out the existence of N-terminally extended isoforms. We conclude that structural heterogeneity of IGF2BP2 protein should be taken into account when considering cellular function.	[Le, Hang T. T.] Univ Cambridge, Metab Res Labs, Cambridge, England; Addenbrookes Hosp, Dept Clin Biochem, Inst Metab Sci, Cambridge, England	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Le, HTT (corresponding author), Univ Cambridge, Metab Res Labs, Cambridge, England.	ks14@mole.bio.cam.ac.uk			Diabetes UK [RD07/0003531]; Gates Cambridge Trust; Medical Research Council [G0600717B] Funding Source: researchfish	Diabetes UK(Diabetes UK); Gates Cambridge Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Diabetes UK (project grant RD07/0003531 to K. S.) and by the Gates Cambridge Trust (scholarship for H. T. T. L.). K. S. is a member of the Medical Research Council Centre for Obesity and Related Metabolic Diseases (MRC CORD), and of European Union COST Action BM0602. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brants JR, 2004, FEBS LETT, V569, P277, DOI 10.1016/j.febslet.2004.05.075; Calkhoven CF, 2000, GENE DEV, V14, P1920; Christiansen J, 2009, J MOL ENDOCRINOL, V43, P187, DOI 10.1677/JME-09-0016; Clery A, 2008, CURR OPIN STRUC BIOL, V18, P290, DOI 10.1016/j.sbi.2008.04.002; Cleynen I, 2007, MOL CANCER RES, V5, P363, DOI 10.1158/1541-7786.MCR-06-0331; Crocoll A, 2000, MECH DEVELOP, V91, P355, DOI 10.1016/S0925-4773(99)00284-1; Doria A, 2008, CELL METAB, V8, P186, DOI 10.1016/j.cmet.2008.08.006; Giangrande PH, 1999, RECENT PROG HORM RES, V54, P291; Groenewoud MJ, 2008, DIABETOLOGIA, V51, P1659, DOI 10.1007/s00125-008-1083-z; Hammer NA, 2005, REPRODUCTION, V130, P203, DOI 10.1530/rep.1.00664; Hansen TVO, 2004, MOL CELL BIOL, V24, P4448, DOI 10.1128/MCB.24.10.4448-4464.2004; Hogg JR, 2007, RNA, V13, P868, DOI 10.1261/rna.565207; Ioannidis P, 2005, J BIOL CHEM, V280, P20086, DOI 10.1074/jbc.M410036200; Jonson L, 2007, MOL CELL PROTEOMICS, V6, P798, DOI 10.1074/mcp.M600346-MCP200; Kawaji H, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r118; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; Li X, 2009, OBESITY, V17, P729, DOI 10.1038/oby.2008.593; Liao BS, 2005, J BIOL CHEM, V280, P18517, DOI 10.1074/jbc.M500270200; Liao BS, 2004, J BIOL CHEM, V279, P48716, DOI 10.1074/jbc.M405853200; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Messaoudi L, 2007, NUCLEIC ACIDS RES, V35, P6571, DOI 10.1093/nar/gkm753; Nielsen FC, 2002, J CELL SCI, V115, P2087; Nielsen FC, 2001, SCAND J CLIN LAB INV, V61, P93; Nielsen J, 1999, MOL CELL BIOL, V19, P1262; Nielsen J, 2004, NUCLEIC ACIDS RES, V32, P4368, DOI 10.1093/nar/gkh754; Rahman L, 2002, GENOMICS, V80, P245, DOI 10.1006/geno.2002.6826; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Spagnoli FM, 2006, DEV BIOL, V292, P442, DOI 10.1016/j.ydbio.2006.01.022; Stancakova A, 2009, DIABETES, V58, P2129, DOI 10.2337/db09-0117; Tessier CR, 2004, CANCER RES, V64, P209, DOI 10.1158/0008-5472.CAN-03-2927; Valverde R, 2008, FEBS J, V275, P2712, DOI 10.1111/j.1742-4658.2008.06411.x; Vikesaa J, 2006, EMBO J, V25, P1456, DOI 10.1038/sj.emboj.7601039; Wagner M, 2003, GASTROENTEROLOGY, V124, P1901, DOI 10.1016/S0016-5085(03)00402-5; Weinlich S, 2009, RNA, V15, P1528, DOI 10.1261/rna.1578409; Wu Y, 2008, DIABETES, V57, P2834, DOI 10.2337/db08-0047; Yisraeli JK, 2005, BIOL CELL, V97, P87; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zhang A, 2007, ARCH BIOCHEM BIOPHYS, V461, P255, DOI 10.1016/j.abb.2007.02.023; Zhang Jianying, 2002, Autoimmunity Reviews, V1, P146, DOI 10.1016/S1568-9972(02)00030-7; Zhang JY, 1999, J EXP MED, V189, P1101, DOI 10.1084/jem.189.7.1101	43	12	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33140	10.1371/journal.pone.0033140	http://dx.doi.org/10.1371/journal.pone.0033140			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427968	Green Published, gold, Green Submitted			2022-12-25	WOS:000302381500098
J	Minami, R; Wakabayashi, M; Sugimori, S; Taniguchi, K; Kokuryo, A; Imano, T; Adachi-Yamada, T; Watanabe, N; Nakagoshi, H				Minami, Ryunosuke; Wakabayashi, Miyuki; Sugimori, Seiko; Taniguchi, Kiichiro; Kokuryo, Akihiko; Imano, Takao; Adachi-Yamada, Takashi; Watanabe, Naoko; Nakagoshi, Hideki			The Homeodomain Protein Defective Proventriculus Is Essential for Male Accessory Gland Development to Enhance Fecundity in Drosophila	PLOS ONE			English	Article							REPRODUCTIVE-BEHAVIOR; SEX-PEPTIDE; SEMINAL PROTEINS; GENE-EXPRESSION; SENSORY NEURONS; MELANOGASTER; SPERM; CELLS; APOPTOSIS; FEMALES	The Drosophila male accessory gland has functions similar to those of the mammalian prostate gland and the seminal vesicle, and secretes accessory gland proteins into the seminal fluid. Each of the two lobes of the accessory gland is composed of two types of binucleate cell: about 1,000 main cells and 40 secondary cells. A well-known accessory gland protein, sex peptide, is secreted from the main cells and induces female postmating response to increase progeny production, whereas little is known about physiological significance of the secondary cells. The homeodomain transcriptional repressor Defective proventriculus (Dve) is strongly expressed in adult secondary cells, and its mutation resulted in loss of secondary cells, mononucleation of main cells, and reduced size of the accessory gland. dve mutant males had low fecundity despite the presence of sex peptide, and failed to induce the female postmating responses of increased egg laying and reduced sexual receptivity. RNAi-mediated dve knockdown males also had low fecundity with normally binucleate main cells. We provide the first evidence that secondary cells are crucial for male fecundity, and also that Dve activity is required for survival of the secondary cells. These findings provide new insights into a mechanism of fertility/fecundity.	[Minami, Ryunosuke; Wakabayashi, Miyuki; Sugimori, Seiko; Nakagoshi, Hideki] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan; [Taniguchi, Kiichiro; Adachi-Yamada, Takashi] Gakushuin Univ, Dept Life Sci, Fac Sci, Tokyo 171, Japan; [Kokuryo, Akihiko; Imano, Takao; Adachi-Yamada, Takashi] Gakushuin Univ, Inst Biomol Sci, Tokyo 171, Japan; [Kokuryo, Akihiko; Imano, Takao; Adachi-Yamada, Takashi] Kobe Univ, Dept Biol, Grad Sch Sci, Kobe, Hyogo 657, Japan; [Watanabe, Naoko] Toho Univ, Fac Sci, Dept Biomol Sci, Funabashi, Chiba 274, Japan	Okayama University; Gakushuin University; Gakushuin University; Kobe University; Toho University	Minami, R (corresponding author), Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan.	goshi@cc.okayama-u.ac.jp	NAKAGOSHI, Hideki/B-2145-2011; Taniguchi, Kiichiro/ACL-8906-2022	NAKAGOSHI, Hideki/0000-0003-0850-1814; Taniguchi, Kiichiro/0000-0003-2321-7280	Japan Society for the Promotion of Science [20570202, 22770196]; Ministry of Education, Culture, Sports, Science and Technology [20058021, 22019034]; Grants-in-Aid for Scientific Research [23570006] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partly supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (20570202 to TAY, 22770196 to KT) and from the Ministry of Education, Culture, Sports, Science and Technology (20058021 to TAY, 22019034 to KT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Ahmad SM, 2002, CELL, V109, P651, DOI 10.1016/S0092-8674(02)00744-4; AIGAKI T, 1991, NEURON, V7, P557, DOI 10.1016/0896-6273(91)90368-A; BERTRAM MJ, 1992, MECH DEVELOP, V38, P33, DOI 10.1016/0925-4773(92)90036-J; Bertuccioli C, 1996, DEVELOPMENT, V122, P2673; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bretman A, 2010, J INSECT PHYSIOL, V56, P107, DOI 10.1016/j.jinsphys.2009.09.010; Burglin TR, 2002, INT J DEV BIOL, V46, P115; Chapman T, 2004, PEPTIDES, V25, P1477, DOI 10.1016/j.peptides.2003.10.023; Chapman T, 2003, P NATL ACAD SCI USA, V100, P9923, DOI 10.1073/pnas.1631635100; Chapman T, 2001, HEREDITY, V87, P511, DOI 10.1046/j.1365-2540.2001.00961.x; CHEN PS, 1988, CELL, V54, P291, DOI 10.1016/0092-8674(88)90192-4; Galande S, 2001, MOL CELL BIOL, V21, P5591, DOI 10.1128/MCB.21.16.5591-5604.2001; Gillott C, 2003, ANNU REV ENTOMOL, V48, P163, DOI 10.1146/annurev.ento.48.091801.112657; Gong FR, 2011, NUCLEIC ACIDS RES, V39, P4640, DOI 10.1093/nar/gkr023; Hasemeyer M, 2009, NEURON, V61, P511, DOI 10.1016/j.neuron.2009.01.009; Ito K, 1997, DEVELOPMENT, V124, P761; Johnston RJ, 2011, CELL, V145, P956, DOI 10.1016/j.cell.2011.05.003; Kosman D, 1998, DEV GENES EVOL, V208, P290, DOI 10.1007/s004270050184; Kubli E, 2003, CELL MOL LIFE SCI, V60, P1689, DOI 10.1007/s00018-003-3052; Kuo TC, 2010, BIOCHEM PHARMACOL, V80, P1093, DOI 10.1016/j.bcp.2010.06.003; Liu HF, 2003, P NATL ACAD SCI USA, V100, P9929, DOI 10.1073/pnas.1631700100; Nakagawa Y, 2011, MECH DEVELOP, V128, P258, DOI 10.1016/j.mod.2011.02.003; Nakagoshi H, 2005, DEV GROWTH DIFFER, V47, P383; Nakagoshi H, 2002, DEV BIOL, V249, P44, DOI 10.1006/dbio.2002.0746; Nakagoshi H, 1998, GENE DEV, V12, P2724, DOI 10.1101/gad.12.17.2724; Ohsako T, 2011, GENES GENET SYST, V86, P97, DOI 10.1266/ggs.86.97; Peng J, 2005, CURR BIOL, V15, P207, DOI 10.1016/j.cub.2005.01.034; Raja SJ, 2005, MOL CELL BIOL, V25, P6165, DOI 10.1128/MCB.25.14.6165-6177.2005; Ram KR, 2009, P NATL ACAD SCI USA, V106, P15384, DOI 10.1073/pnas.0902923106; Shirai T, 2007, DEV BIOL, V312, P147, DOI 10.1016/j.ydbio.2007.09.003; Snook RR, 2004, NATURE, V428, P939, DOI 10.1038/nature02455; Taniguchi K, 2011, J ORGAN BIOL, V1, pe101; Terriente J, 2008, DEV BIOL, V320, P102, DOI 10.1016/j.ydbio.2008.04.028; THUMMEL CS, 1988, GENE, V74, P445, DOI 10.1016/0378-1119(88)90177-1; Villella A, 2006, J COMP PHYSIOL A, V192, P1253, DOI 10.1007/s00359-006-0154-1; Wigby S, 2009, CURR BIOL, V19, P751, DOI 10.1016/j.cub.2009.03.036; Wolfner MF, 2002, HEREDITY, V88, P85, DOI 10.1038/sj.hdy.6800017; XU T, 1993, DEVELOPMENT, V117, P1223; Xue L, 2002, DEVELOPMENT, V129, P339; Xue L, 2000, P NATL ACAD SCI USA, V97, P3272, DOI 10.1073/pnas.060018897; Yang CH, 2009, NEURON, V61, P519, DOI 10.1016/j.neuron.2008.12.021; Yapici N, 2008, NATURE, V451, P33, DOI 10.1038/nature06483; Yorimitsu T, 2011, DEV BIOL, V356, P598, DOI 10.1016/j.ydbio.2011.06.015	43	24	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e32302	10.1371/journal.pone.0032302	http://dx.doi.org/10.1371/journal.pone.0032302			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427829	Green Published, gold, Green Submitted			2022-12-25	WOS:000302381500012
J	Nakamura, J; Gul, H; Tian, X; Bultman, SJ; Swenberg, JA				Nakamura, Jun; Gul, Husamettin; Tian, Xu; Bultman, Scott J.; Swenberg, James A.			Detection of PIGO-Deficient Cells Using Proaerolysin: A Valuable Tool to Investigate Mechanisms of Mutagenesis in the DT40 Cell System	PLOS ONE			English	Article							PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; GPI-ANCHORED PROTEINS; B-LYMPHOCYTE LINE; SPLEEN T-CELLS; METHYL METHANESULFONATE; EXCISION-REPAIR; MUTATIONS; GENE; BIOSYNTHESIS; ASSAY	While isogenic DT40 cell lines deficient in DNA repair pathways are a great tool to understand the DNA damage response to genotoxic agents by a comparison of cell toxicity in mutants and parental DT40 cells, no convenient mutation assay for mutagens currently exists for this reverse-genetic system. Here we establish a proaerolysin (PA) selection-based mutation assay in DT40 cells to identify glycosylphosphatidylinositol (GPI)-anchor deficient cells. Using PA, we detected an increase in the number of PA-resistant DT40 cells exposed to MMS for 24 hours followed by a 5-day period of phenotype expression. GPI anchor synthesis is catalyzed by a series of phosphatidylinositol glycan complementation groups (PIGs). The PIG-O gene is on the sex chromosome (Chromosome Z) in chicken cells and is critical for GPI anchor synthesis at the intermediate step. Among all the mutations detected in the sequence levels observed in DT40 cells exposed to MMS at 100 mu M, we identified that similar to 55% of the mutations are located at A: T sites with a high frequency of A to T transversion mutations. In contrast, we observed no transition mutations out of 18 mutations. This novel assay for DT40 cells provides a valuable tool to investigate the mode of action of mutations caused by reactive agents using a series of isogenic mutant DT40 cells.	[Nakamura, Jun; Gul, Husamettin; Tian, Xu; Swenberg, James A.] Univ N Carolina, Dept Environm Sci & Engn, Chapel Hill, NC 27515 USA; [Gul, Husamettin] Gulhane Mil Med Acad, Dept Pharmacol & Toxicol, Ankara, Turkey; [Bultman, Scott J.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Swenberg, James A.] Univ N Carolina, Curriculum Toxicol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; Gulhane Military Medical Academy; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Nakamura, J (corresponding author), Univ N Carolina, Dept Environm Sci & Engn, Chapel Hill, NC 27515 USA.	ynakamur@email.unc.edu	Tian, Xu/A-3951-2015	Tian, Xu/0000-0001-8174-5669; GUL, HUSAMETTIN/0000-0003-4476-5390; Nakamura, Jun/0000-0002-1756-7199	Center for Environmental Health and Susceptibility [P30-ES10126]; Superfund Basic Research Program grant [NIEHS P42-ES05948]; NCRR (National Centre for Research Resources) [UL1RR025747]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES005948, P30ES010126] Funding Source: NIH RePORTER	Center for Environmental Health and Susceptibility; Superfund Basic Research Program grant; NCRR (National Centre for Research Resources); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Center for Environmental Health and Susceptibility grant NIEHS (National Institute of Environmental Health Sciences) P30-ES10126, Superfund Basic Research Program grant NIEHS P42-ES05948, and NCRR (National Centre for Research Resources) UL1RR025747. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrami L, 1998, J CELL BIOL, V140, P525, DOI 10.1083/jcb.140.3.525; Aidoo A, 1997, MUTAT RES-REV MUTAT, V387, P69, DOI 10.1016/S1383-5742(97)00024-0; BABA TW, 1985, VIROLOGY, V144, P139, DOI 10.1016/0042-6822(85)90312-5; Brodsky RA, 2006, LEUKEMIA LYMPHOMA, V47, P1215, DOI 10.1080/10428190600555520; Bryce SM, 2008, ENVIRON MOL MUTAGEN, V49, P256, DOI 10.1002/em.20379; Calleja F, 1999, MUTAT RES-FUND MOL M, V425, P185, DOI 10.1016/S0027-5107(99)00034-2; CROSS GAM, 1990, ANNU REV CELL BIOL, V6, P1, DOI 10.1146/annurev.cb.06.110190.000245; de Latour RP, 2008, BLOOD, V112, P3099, DOI 10.1182/blood-2008-01-133918; Dhar P K, 2001, J Environ Pathol Toxicol Oncol, V20, P273; Diep DB, 1998, J BIOL CHEM, V273, P2355, DOI 10.1074/jbc.273.4.2355; Doak SH, 2007, CANCER RES, V67, P3904, DOI 10.1158/0008-5472.CAN-06-4061; Elder RH, 1998, MOL CELL BIOL, V18, P5828, DOI 10.1128/MCB.18.10.5828; FURTH EE, 1981, ANAL BIOCHEM, V110, P1, DOI 10.1016/0003-2697(81)90103-2; Hong Y, 2000, J BIOL CHEM, V275, P20911, DOI 10.1074/jbc.M001913200; Hong YJ, 2002, EMBO J, V21, P5047, DOI 10.1093/emboj/cdf508; JACOBS L, 1983, ENVIRON MUTAGEN, V5, P717, DOI 10.1002/em.2860050510; KAWAGOE K, 1994, GENOMICS, V23, P566, DOI 10.1006/geno.1994.1544; Kinoshita T, 2008, J BIOCHEM, V144, P287, DOI 10.1093/jb/mvn090; KLUNGLAND A, 1995, CARCINOGENESIS, V16, P1281, DOI 10.1093/carcin/16.6.1281; LOW MG, 1989, BIOCHIM BIOPHYS ACTA, V988, P427, DOI 10.1016/0304-4157(89)90014-2; MacKenzie CR, 1999, J BIOL CHEM, V274, P22604, DOI 10.1074/jbc.274.32.22604; Maeda Y, 2006, METHOD ENZYMOL, V416, P182, DOI 10.1016/S0076-6879(06)16012-7; Miura D, 2008, ENVIRON MOL MUTAGEN, V49, P622, DOI 10.1002/em.20413; Miura D, 2008, ENVIRON MOL MUTAGEN, V49, P614, DOI 10.1002/em.20414; Nishimura J, 1999, AM J HEMATOL, V62, P175, DOI 10.1002/(SICI)1096-8652(199911)62:3<175::AID-AJH7>3.3.CO;2-#; NIVARD MJM, 1992, GENETICS, V131, P673; NIVARD MJM, 1993, CARCINOGENESIS, V14, P1585, DOI 10.1093/carcin/14.8.1585; Parker MW, 1996, MOL MICROBIOL, V19, P205, DOI 10.1046/j.1365-2958.1996.355887.x; Ridpath JR, 2007, CANCER RES, V67, P11117, DOI 10.1158/0008-5472.CAN-07-3028; Ridpath JR, 2011, ENVIRON MOL MUTAGEN, V52, P153, DOI 10.1002/em.20595; Russo D, 2009, MUTAT RES-FUND MOL M, V671, P58, DOI 10.1016/j.mrfmmm.2009.08.013; Simonelli V, 2005, NUCLEIC ACIDS RES, V33, P4404, DOI 10.1093/nar/gki749; Sonoda E, 2001, PHILOS T ROY SOC B, V356, P111, DOI 10.1098/rstb.2000.0755; STRAUSS GH, 1979, MUTAT RES, V61, P353, DOI 10.1016/0027-5107(79)90140-4; Tiede A, 1999, BIOL CHEM, V380, P503, DOI 10.1515/BC.1999.066; Von Tungeln LS, 2007, ENVIRON MOL MUTAGEN, V48, P258, DOI 10.1002/em.20237; Watanabe R, 1998, EMBO J, V17, P877, DOI 10.1093/emboj/17.4.877; Winding P, 2001, J IMMUNOL METHODS, V249, P1, DOI 10.1016/S0022-1759(00)00333-1; Yamazoe M, 2004, DNA REPAIR, V3, P1175, DOI 10.1016/j.dnarep.2004.03.039	39	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33563	10.1371/journal.pone.0033563	http://dx.doi.org/10.1371/journal.pone.0033563			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22428069	gold, Green Published, Green Submitted			2022-12-25	WOS:000302381500153
J	Sher, EA; Shaklai, M; Shaklai, N				Sher, Elena A.; Shaklai, Mati; Shaklai, Nurith			Carbon Monoxide Promotes Respiratory Hemoproteins Iron Reduction Using Peroxides as Electron Donors	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; ENDOTHELIAL-CELL INJURY; OXIDATIVE STRESS; HEME OXYGENASE; HYDROGEN-PEROXIDE; NITRIC-OXIDE; CROSS-LINKING; LDL OXIDATION; HEMOGLOBIN; METHEMOGLOBIN	The physiological role of the respiratory hemoproteins (RH), hemoglobin and myoglobin, is to deliver O-2 via its binding to their ferrous (Fe-II) heme-iron. Under variety of pathological conditions RH proteins leak to blood plasma and oxidized to ferric (Fe-III, met) forms becoming the source of oxidative vascular damage. However, recent studies have indicated that both metRH and peroxides induce Heme Oxygenase (HO) enzyme producing carbon monoxide (CO). The gas has an extremely high affinity for the ferrous heme-iron and is known to reduce ferric hemoproteins in the presence of suitable electron donors. We hypothesized that under in vivo plasma conditions, peroxides at low concentration can assist the reduction of metRH in presence of CO. The effect of CO on interaction of metRH with hydrophilic or hydrophobic peroxides was analyzed by following Soret and visible light absorption changes in reaction mixtures. It was found that under anaerobic conditions and low concentrations of RH and peroxides mimicking plasma conditions, peroxides served as electron donors and RH were reduced to their ferrous carboxy forms. The reaction rates were dependent on CO as well as peroxide concentrations. These results demonstrate that oxidative activity of acellular ferric RH and peroxides may be amended by CO turning on the reducing potential of peroxides and facilitating the formation of redox-inactive carboxyRH. Our data suggest the possible role of HO/CO in protection of vascular system from oxidative damage.	[Sher, Elena A.; Shaklai, Nurith] Tel Aviv Univ, Sackler Fac Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel; [Shaklai, Mati] Tel Aviv Univ, Sackler Fac Med, Dept Hematol, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine	Sher, EA (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel.	nshaklai@post.tau.ac.il			Krawitz fund for hematology	Krawitz fund for hematology	This work was funded by the Krawitz fund for hematology to Mati Shaklai. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104; Alayash AI, 2010, CLIN LAB MED, V30, P381, DOI 10.1016/j.cll.2010.02.009; ALAYASH AI, 1995, FREE RADICAL BIO MED, V18, P295, DOI 10.1016/0891-5849(94)E0142-6; Alayash AI, 2001, ANTIOXID REDOX SIGN, V3, P313, DOI 10.1089/152308601300185250; Antonini E., 1971, HEMOGLOBIN MYOGLOBIN, P13; Antonini E., 1971, HEMOGLOBIN MYOGLOBIN; Antonini E., HEMOGLOBIN MYOGLOBIN; Antonini ME, 1971, HEMOGLOBIN MYOGLOBIN, P40; Aviram M, 2001, METHOD ENZYMOL, V335, P244; Bains SK, 2010, ARTERIOSCL THROM VAS, V30, P305, DOI 10.1161/ATVBAHA.109.196360; Balla J, 2005, MOL NUTR FOOD RES, V49, P1030, DOI 10.1002/mnfr.200500076; BALLA J, 1995, AM J PHYSIOL-LUNG C, V268, pL321, DOI 10.1152/ajplung.1995.268.2.L321; BANERJEE R, 1962, BIOCHIM BIOPHYS ACTA, V64, P385, DOI 10.1016/0006-3002(62)90747-3; BICKAR D, 1984, J BIOL CHEM, V259, P777; Bonaventura C, 1999, J BIOL CHEM, V274, P5499, DOI 10.1074/jbc.274.9.5499; BRUNORI M, 1985, J BIOL CHEM, V260, P7165; BUNN HF, 1968, J BIOL CHEM, V243, P465; Chen KJ, 2008, ANTIOXID REDOX SIGN, V10, P1185, DOI 10.1089/ars.2007.1959; CULOTTA E, 1992, SCIENCE, V258, P1862, DOI 10.1126/science.1361684; ESTERBAUER H, 1989, FREE RADICAL RES COM, V6, P67, DOI 10.3109/10715768909073429; Faivre B, 1998, ARTIF CELL BLOOD SUB, V26, P17, DOI 10.3109/10731199809118943; Forstermann U, 2010, PFLUG ARCH EUR J PHY, V459, P923, DOI 10.1007/s00424-010-0808-2; GIULIVI C, 1990, J BIOL CHEM, V265, P19453; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; Grinshtein N, 2003, BIOCHEMISTRY-US, V42, P6977, DOI 10.1021/bi020647r; Hampson NB, 2007, J EMERG MED, V33, P17, DOI 10.1016/j.jemermed.2006.10.004; Hirota S, 2005, BIOCHEMISTRY-US, V44, P10322, DOI 10.1021/bi0507581; Ivanovic Z, 2009, J CELL PHYSIOL, V219, P271, DOI 10.1002/jcp.21690; JOHANSEN J, 1988, BIOCHIM BIOPHYS ACTA, V933, P406, DOI 10.1016/0005-2728(88)90075-8; Kaczorowski DJ, 2007, CURR MED CHEM, V14, P2720, DOI 10.2174/092986707782023181; Kato GJ, 2008, JAMA-J AM MED ASSOC, V300, P2638, DOI 10.1001/jama.2008.598; KEILIN D, 1955, BIOCHEM J, V61, P153, DOI 10.1042/bj0610153; KEYSE SM, 1989, P NATL ACAD SCI USA, V86, P99, DOI 10.1073/pnas.86.1.99; LABRAKE CC, 1992, J BIOL CHEM, V267, P16703; Leoncini S, 2008, FREE RADICAL RES, V42, P716, DOI 10.1080/10715760802317655; Li C, 2009, REDOX REP, V14, P95, DOI 10.1179/135100009X392584; Liu DN, 2010, CARDIOVASC J AFR, V21, P257, DOI CVJ-21.001; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maor I, 1997, ARTERIOSCL THROM VAS, V17, P2995, DOI 10.1161/01.ATV.17.11.2995; Miller YI, 1996, ARCH BIOCHEM BIOPHYS, V326, P252, DOI 10.1006/abbi.1996.0073; Nagy E, 2005, CELL MOL BIOL, V51, P377, DOI 10.1170/T641; Nagy E, 2010, ARTERIOSCL THROM VAS, V30, P1347, DOI 10.1161/ATVBAHA.110.206433; Natella F, 1998, FREE RADICAL RES, V29, P427, DOI 10.1080/10715769800300471; Ohashi K, 1998, ACTA ANAESTH SCAND, V42, P713, DOI 10.1111/j.1399-6576.1998.tb05306.x; Pamplona A, 2009, INT J BIOCHEM CELL B, V41, P711, DOI 10.1016/j.biocel.2008.09.020; Pauling L, OXIDATION REDUCTION, P244; PETERSON D A, 1981, Progress in Lipid Research, V20, P299, DOI 10.1016/0163-7827(81)90060-6; Reeder BJ, 2005, CURR MED CHEM, V12, P2741, DOI 10.2174/092986705774463021; Reeder BJ, 2004, ANTIOXID REDOX SIGN, V6, P954, DOI 10.1089/ars.2004.6.954; Reeder BJ, 2008, FREE RADICAL BIO MED, V44, P264, DOI 10.1016/j.freeradbiomed.2007.08.006; Reeder BJ, 2010, ANTIOXID REDOX SIGN, V13, P1087, DOI 10.1089/ars.2009.2974; Ryter SW, 2007, AM J RESP CELL MOL, V36, P175, DOI 10.1165/rcmb.2006-0333TR; Ryter SW, 2009, AM J RESP CELL MOL, V41, P251, DOI 10.1165/rcmb.2009-0170TR; Sa ZS, 2007, J INTEGR PLANT BIOL, V49, P638, DOI 10.1111/j.1744-7909.2007.00461.x; SADRZADEH SMH, 1984, J BIOL CHEM, V259, P4354; SCHUMAKER VN, 1986, METHOD ENZYMOL, V128, P155; Sevanian A, 2000, FREE RADICAL BIO MED, V29, P306, DOI 10.1016/S0891-5849(00)00342-7; Silva G, 2009, J BIOL CHEM, V284, P29582, DOI 10.1074/jbc.M109.045344; STAIT SE, 1994, FEBS LETT, V341, P263, DOI 10.1016/0014-5793(94)80469-9; Steinert JR, 2010, NEUROSCIENTIST, V16, P435, DOI 10.1177/1073858410366481; Takeda R, 2002, J GASTROEN HEPATOL, V17, P535, DOI 10.1046/j.1440-1746.2002.02685.x; UENO R, 1982, J BIOL CHEM, V257, P5584; Umbreit J, 2007, AM J HEMATOL, V82, P134, DOI 10.1002/ajh.20738; Widmer CC, 2010, ANTIOXID REDOX SIGN, V12, P185, DOI 10.1089/ars.2009.2826; Wilson MT, 2008, EXP PHYSIOL, V93, P128, DOI 10.1113/expphysiol.2007.039735; Yachie A, 1999, J CLIN INVEST, V103, P129, DOI 10.1172/JCI4165; Yet SF, 2003, FASEB J, V17, P1759, DOI 10.1096/fj.03-0187fje; Ziouzenkova O, 1998, FREE RADICAL BIO MED, V24, P607, DOI 10.1016/S0891-5849(97)00324-9	68	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33039	10.1371/journal.pone.0033039	http://dx.doi.org/10.1371/journal.pone.0033039			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427940	Green Published, Green Submitted, gold			2022-12-25	WOS:000302381500082
J	Rojas, AM; Santamaria, A; Malik, R; Jensen, TS; Korner, R; Morilla, I; de Juan, D; Krallinger, M; Hansen, DA; Hoffmann, R; Lees, J; Reid, A; Yeats, C; Wehner, A; Elowe, S; Clegg, AB; Brunak, S; Nigg, EA; Orengo, C; Valencia, A; Ranea, JAG				Rojas, Ana M.; Santamaria, Anna; Malik, Rainer; Jensen, Thomas Skot; Korner, Roman; Morilla, Ian; de Juan, David; Krallinger, Martin; Hansen, Daniel Aaen; Hoffmann, Robert; Lees, Jonathan; Reid, Adam; Yeats, Corin; Wehner, Anja; Elowe, Sabine; Clegg, Andrew B.; Brunak, Soren; Nigg, Erich A.; Orengo, Christine; Valencia, Alfonso; Ranea, Juan A. G.			Uncovering the Molecular Machinery of the Human Spindle-An Integration of Wet and Dry Systems Biology	PLOS ONE			English	Article							CELL-CYCLE; PLK1-DEPENDENT PHOSPHORYLATION; MITOTIC PROGRESSION; ASSEMBLY CHECKPOINT; PROTEIN; COMPLEX; FOXM1; IDENTIFICATION; EXPRESSION; MICROTUBULES	The mitotic spindle is an essential molecular machine involved in cell division, whose composition has been studied extensively by detailed cellular biology, high-throughput proteomics, and RNA interference experiments. However, because of its dynamic organization and complex regulation it is difficult to obtain a complete description of its molecular composition. We have implemented an integrated computational approach to characterize novel human spindle components and have analysed in detail the individual candidates predicted to be spindle proteins, as well as the network of predicted relations connecting known and putative spindle proteins. The subsequent experimental validation of a number of predicted novel proteins confirmed not only their association with the spindle apparatus but also their role in mitosis. We found that 75% of our tested proteins are localizing to the spindle apparatus compared to a success rate of 35% when expert knowledge alone was used. We compare our results to the previously published MitoCheck study and see that our approach does validate some findings by this consortium. Further, we predict so-called "hidden spindle hub'', proteins whose network of interactions is still poorly characterised by experimental means and which are thought to influence the functionality of the mitotic spindle on a large scale. Our analyses suggest that we are still far from knowing the complete repertoire of functionally important components of the human spindle network. Combining integrated bio-computational approaches and single gene experimental follow-ups could be key to exploring the still hidden regions of the human spindle system.	[Rojas, Ana M.; de Juan, David; Krallinger, Martin; Valencia, Alfonso] Ctr Nacl Invest Oncol, Struct Biol & Biocomp Programme, Madrid, Spain; [Santamaria, Anna; Malik, Rainer; Wehner, Anja; Elowe, Sabine; Nigg, Erich A.] Max Planck Inst Biochem, Dept Cell Biol, D-82152 Martinsried, Germany; [Jensen, Thomas Skot; Korner, Roman; Hansen, Daniel Aaen; Brunak, Soren] Tech Univ Denmark Kemitorvet, Dept Syst Biol, Ctr Biol Sequence Anal, Lyngby, Denmark; [Morilla, Ian; Ranea, Juan A. G.] Univ Malaga, Dept Biochem & Mol Biol, E-29071 Malaga, Spain; [Hoffmann, Robert] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10021 USA; [Lees, Jonathan; Reid, Adam; Yeats, Corin; Clegg, Andrew B.; Orengo, Christine] UCL, Dept Struct & Mol Biol, London, England	Max Planck Society; Technical University of Denmark; Universidad de Malaga; Memorial Sloan Kettering Cancer Center; University of London; University College London	Rojas, AM (corresponding author), Inst Med Predictiva & Personalizada Canc, Computat Cell Biol Grp, Barcelona, Spain.	valencia@cnio.es	Morilla, Ian/X-4622-2018; Rojas, Ana M./I-2882-2019; Juan, David/AAA-2614-2020; IBIS, BIOINFORMATICA/O-1882-2015; Körner, Roman/G-8565-2011; Valencia, Alfonso/I-3127-2015; Rojas, Ana M/D-5777-2011; Krallinger, Martin/I-2599-2015; Brunak, Soren/O-6621-2016	Morilla, Ian/0000-0002-5100-5990; Rojas, Ana M./0000-0003-0750-9099; Juan, David/0000-0003-1912-9667; Körner, Roman/0000-0001-9285-9290; Valencia, Alfonso/0000-0002-8937-6789; Rojas, Ana M/0000-0003-0750-9099; Reid, Adam/0000-0002-5926-7768; Brunak, Soren/0000-0003-0316-5866; Krallinger, Martin/0000-0002-2646-8782; Malik, Rainer/0000-0001-9212-2520; Garcia Ranea, Juan Antonio/0000-0003-0327-1837; nigg, erich/0000-0003-4835-5719	ENFIN, a Network of Excellence; European Commission [LSHG-CT-2005-518254]; Interaction Proteome [LSHG-CT-2003-505520]; Spanish Ministry of Science and Innovation [FIS PS09/02111, PS09/02111]; EMBRACE European Network of Excellence; Ministerio de Ciencia e Innovacion, Spain [RYC-2007-01649];  [259348];  [HEALTH-F4-2010-259348]; Novo Nordisk Fonden [NNF10CC1016517] Funding Source: researchfish	ENFIN, a Network of Excellence; European Commission(European CommissionEuropean Commission Joint Research Centre); Interaction Proteome; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); EMBRACE European Network of Excellence; Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); ; ; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by ENFIN, a Network of Excellence funded by the European Commission within its FP6 Programme, under the thematic area "Life sciences, genomics and biotechnology for health,'' contract number LSHG-CT-2005-518254. This project was also supported by Interaction Proteome (contract number LSHG-CT-2003-505520). AR is funded by Spanish Ministry of Science and Innovation FIS PS09/02111. AC acknowledges funding from the EMBRACE European Network of Excellence. AMR acknowledges funding from PS09/02111 from the Spanish Ministry of Science and Innovation. JAGR is funded by EU-FP7-Systems Microscopy NoE (grant agreement nu258068), by the SAF2009-09839 project and the Ramon y Cajal program (RYC-2007-01649) from Ministerio de Ciencia e Innovacion, Spain. This study is also funded by FP7-HEALTH-2010-two-stage Grant Agreement Number 259348 ASSET: Analysing and Striking the Sensitivities of Embryonal Tumours (HEALTH-F4-2010-259348). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barisic M, 2010, MOL BIOL CELL, V21, P1968, DOI 10.1091/mbc.E09-04-0356; Baumann C, 2007, CELL, V128, P101, DOI 10.1016/j.cell.2006.11.041; BIRNBAUM A, 1954, J AM STAT ASSOC, V49, P559, DOI 10.2307/2281130; Blangy A, 1995, CELL, V83, P1159, DOI 10.1016/0092-8674(95)90142-6; Chan YW, 2009, J CELL BIOL, V185, P859, DOI 10.1083/jcb.200812167; Chen CH, 2009, ONCOGENE, V28, P2723, DOI 10.1038/onc.2009.128; de Lichtenberg U, 2003, J MOL BIOL, V329, P663, DOI 10.1016/S0022-2836(03)00490-X; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; Duensing A, 2006, CELL CYCLE, V5, P2899, DOI 10.4161/cc.5.24.3567; Dunsch AK, 2011, J CELL BIOL, V192, P959, DOI 10.1083/jcb.201008023; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fabbro M, 2005, DEV CELL, V9, P477, DOI 10.1016/j.devcel.2005.09.003; Fang L, 2009, CELL CYCLE, V8, P2819, DOI 10.4161/cc.8.17.9514; Fu Z, 2008, NAT CELL BIOL, V10, P1076, DOI 10.1038/ncb1767; Fujita Y, 2007, DEV CELL, V12, P17, DOI 10.1016/j.devcel.2006.11.002; Gaitanos TN, 2009, EMBO J, V28, P1442, DOI 10.1038/emboj.2009.96; Gassmann R, 2010, GENE DEV, V24, P957, DOI 10.1101/gad.1886810; Gauthier NP, 2008, NUCLEIC ACIDS RES, V36, pD854, DOI 10.1093/nar/gkm729; Goshima G, 2003, J CELL BIOL, V162, P1003, DOI 10.1083/jcb.200303022; Griffis ER, 2007, J CELL BIOL, V177, P1005, DOI 10.1083/jcb.200702062; Gruber M, 2006, J STRUCT BIOL, V155, P140, DOI 10.1016/j.jsb.2006.03.009; Guarguaglini G, 2005, MOL BIOL CELL, V16, P1095, DOI 10.1091/mbc.E04-10-0939; Hanisch A, 2006, EMBO J, V25, P5504, DOI 10.1038/sj.emboj.7601426; Hashizume C, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-119; Higa LA, 2006, CELL CYCLE, V5, P1675, DOI 10.4161/cc.5.15.3149; Hinsby AM, 2006, MOL CELL, V22, P285, DOI 10.1016/j.molcel.2006.03.012; HOBOHM U, 1992, PROTEIN SCI, V1, P409; Hoffmann R, 2004, NAT GENET, V36, P664, DOI 10.1038/ng0704-664; Hoffmann Robert, 2005, Sci STKE, V2005, ppe21, DOI 10.1126/stke.2832005pe21; Hughes JR, 2008, PLOS BIOL, V6, P785, DOI 10.1371/journal.pbio.0060098; Hwang D, 2005, P NATL ACAD SCI USA, V102, P17296, DOI 10.1073/pnas.0508647102; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Kim WK, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s5; Kittler R, 2007, NAT CELL BIOL, V9, P1401, DOI 10.1038/ncb1659; Kline SL, 2006, J CELL BIOL, V173, P9, DOI 10.1083/jcb.200509158; Kraskov A, 2009, INFORM THEORY STAT L, P101; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Lund O, 1997, PROTEIN ENG, V10, P1241, DOI 10.1093/protein/10.11.1241; Mackay DR, 2009, MOL BIOL CELL, V20, P1652, DOI 10.1091/mbc.E08-08-0883; MARKOV Z., 2007, DATA MINING WEB UNCO; Mazumdar M, 2005, TRENDS CELL BIOL, V15, P349, DOI 10.1016/j.tcb.2005.05.006; Mishra RK, 2010, NAT CELL BIOL, V12, P164, DOI 10.1038/ncb2016; Mostafavi S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s4; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Ohta S, 2010, CELL, V142, P810, DOI 10.1016/j.cell.2010.07.047; Orjalo AV, 2006, MOL BIOL CELL, V17, P3806, DOI 10.1091/mbc.e05-11-1061; Parkinson H, 2007, NUCLEIC ACIDS RES, V35, pD747, DOI 10.1093/nar/gkl995; Pena-Castillo L, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s2; PUCK TT, 1956, J EXP MED, V103, P273, DOI 10.1084/jem.103.2.273; Ranea JAG, 2007, PLOS COMPUT BIOL, V3, P2366, DOI 10.1371/journal.pcbi.0030237; Ranea JAG, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000945; Reid AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010908; Russell RB, 2008, NAT CHEM BIOL, V4, P666, DOI 10.1038/nchembio.119; Sauer G, 2005, MOL CELL PROTEOMICS, V4, P35, DOI 10.1074/mcp.M400158-MCP200; Schmidt JC, 2010, J CELL BIOL, V191, P269, DOI 10.1083/jcb.201006129; Sharp DJ, 2000, NATURE, V407, P41, DOI 10.1038/35024000; Sillje HHW, 2006, CURR BIOL, V16, P731, DOI 10.1016/j.cub.2006.02.070; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Taylor PD, 2006, BIOINFORMATION, V1, P285, DOI 10.6026/97320630001285; Tegha-Dunghu J, 2008, J CELL SCI, V121, P1718, DOI 10.1242/jcs.019174; Tournebize R, 2000, NAT CELL BIOL, V2, P13, DOI 10.1038/71330; Uehara R, 2009, P NATL ACAD SCI USA, V106, P6998, DOI 10.1073/pnas.0901587106; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Wittmann T, 2001, NAT CELL BIOL, V3, pE28, DOI 10.1038/35050669; Wonsey DR, 2005, CANCER RES, V65, P5181, DOI 10.1158/0008-5472.CAN-04-4059; Yeats C, 2008, NUCLEIC ACIDS RES, V36, pD414, DOI 10.1093/nar/gkm1019; Zhang Chao, 2008, International Journal of Computational Biology and Drug Design, V1, P254, DOI 10.1504/IJCBDD.2008.021418; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515	69	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2012	7	3							e31813	10.1371/journal.pone.0031813	http://dx.doi.org/10.1371/journal.pone.0031813			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929KX	22427808	Green Published, gold			2022-12-25	WOS:000303062800007
J	Abe, R; Caaveiro, JMM; Kozuka-Hata, H; Oyama, M; Tsumoto, K				Abe, Ryota; Caaveiro, Jose M. M.; Kozuka-Hata, Hiroko; Oyama, Masaaki; Tsumoto, Kouhei			Mapping Ultra-weak Protein-Protein Interactions between Heme Transporters of Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTO-CROSS-LINKING; SURFACE PROTEIN; STRUCTURAL BASIS; UPTAKE SYSTEM; NEAT DOMAIN; IRON; ISD; DETERMINANT; RESISTANCE; RECEPTOR	Iron is an essential nutrient for the proliferation of Staphylococcus aureus during bacterial infections. The iron-regulated surface determinant (Isd) system of S. aureus transports and metabolizes iron porphyrin (heme) captured from the host organism. Transportation of heme across the thick cell wall of this bacterium requires multiple relay points. The mechanism by which heme is physically transferred between Isd transporters is largely unknown because of the transient nature of the interactions involved. Herein, we show that the IsdC transporter not only passes heme ligand to another class of Isd transporter, as previously known, but can also perform self-transfer reactions. IsdA shows a similar ability. A genetically encoded photoreactive probe was used to survey the regions of IsdC involved in self-dimerization. We propose an updated model that explicitly considers self-transfer reactions to explain heme delivery across the cell wall. An analogous photo-cross-linking strategy was employed to map transient interactions between IsdC and IsdE transporters. These experiments identified a key structural element involved in the rapid and specific transfer of heme from IsdC to IsdE. The resulting structural model was validated with a chimeric version of the homologous transporter IsdA. Overall, our results show that the ultra-weak interactions between Isd transporters are governed by bona fide protein structural motifs.	[Abe, Ryota; Caaveiro, Jose M. M.; Tsumoto, Kouhei] Univ Tokyo, Sch Frontier Sci, Dept Med Genome Sci, Minato Ku, Tokyo 1088639, Japan; [Abe, Ryota; Caaveiro, Jose M. M.; Kozuka-Hata, Hiroko; Oyama, Masaaki; Tsumoto, Kouhei] Univ Tokyo, Inst Med Sci, Med Prote Lab, Minato Ku, Tokyo 1088639, Japan	University of Tokyo; University of Tokyo	Caaveiro, JMM (corresponding author), Univ Tokyo, Sch Frontier Sci, Dept Med Genome Sci, Minato Ku, Tokyo 1088639, Japan.	jmmc@ims.u-tokyo.ac.jp; tsumoto@ims.u-tokyo.ac.jp	Caaveiro, Jose/J-2790-2013	Caaveiro, Jose/0000-0001-5568-2369; Kozuka-Hata, Hiroko/0000-0002-9286-6594; Oyama, Masaaki/0000-0001-6478-3735	Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [11J06068] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Supported by a predoctoral fellowship from the Japan Society for the Promotion of Science.	Berntsson RPA, 2010, FEBS LETT, V584, P2606, DOI 10.1016/j.febslet.2010.04.043; Beveridge TJ, 2000, GRAM-POSITIVE PATHOGENS, P3; Burkhard KA, 2007, J BIOL CHEM, V282, P15126, DOI 10.1074/jbc.M611121200; Cheng AG, 2011, TRENDS MICROBIOL, V19, P225, DOI 10.1016/j.tim.2011.01.007; DORMAN G, 1994, BIOCHEMISTRY-US, V33, P5661, DOI 10.1021/bi00185a001; Fabian M, 2009, J BIOL CHEM, V284, P32138, DOI 10.1074/jbc.M109.040915; Farrelli IS, 2005, NAT METHODS, V2, P377, DOI 10.1038/nmeth0505-377; Gaudin CFM, 2011, BIOCHEMISTRY-US, V50, P5443, DOI 10.1021/bi200369p; Grigg JC, 2007, J BIOL CHEM, V282, P28815, DOI 10.1074/jbc.M704602200; Grigg JC, 2007, MOL MICROBIOL, V63, P139, DOI 10.1111/j.1365-2958.2006.05502.x; Grigg JC, 2011, J MOL BIOL, V413, P684, DOI 10.1016/j.jmb.2011.08.047; Grigg JC, 2010, J INORG BIOCHEM, V104, P341, DOI 10.1016/j.jinorgbio.2009.09.012; Ho WW, 2007, J BIOL CHEM, V282, P35796, DOI 10.1074/jbc.M706761200; Kawai T, 2011, FEBS LETT, V585, P3533, DOI 10.1016/j.febslet.2011.10.015; Kim HK, 2010, VACCINE, V28, P6382, DOI 10.1016/j.vaccine.2010.02.097; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Krishnamurthy M, 2011, ACS CHEM BIOL, V6, P1321, DOI 10.1021/cb200308e; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuklin NA, 2006, INFECT IMMUN, V74, P2215, DOI 10.1128/IAI.74.4.2215-2223.2006; Kusano S, 2012, PROTEIN SCI, V21, P199, DOI 10.1002/pro.2003; Liu MY, 2008, J BIOL CHEM, V283, P6668, DOI 10.1074/jbc.M708372200; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Maiolica A, 2007, MOL CELL PROTEOMICS, V6, P2200, DOI 10.1074/mcp.M700274-MCP200; Majmudar CY, 2009, ANGEW CHEM INT EDIT, V48, P7021, DOI 10.1002/anie.200902669; Mazmanian SK, 2002, P NATL ACAD SCI USA, V99, P2293, DOI 10.1073/pnas.032523999; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Mori H, 2006, P NATL ACAD SCI USA, V103, P16159, DOI 10.1073/pnas.0606390103; Moriwaki Y, 2011, BIOCHEMISTRY-US, V50, P7311, DOI 10.1021/bi200493h; Muryoi N, 2008, J BIOL CHEM, V283, P28125, DOI 10.1074/jbc.M802171200; Nygaard TK, 2006, J BIOL CHEM, V281, P20761, DOI 10.1074/jbc.M601832200; Okuda S, 2009, P NATL ACAD SCI USA, V106, P5877, DOI 10.1073/pnas.0900896106; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Ouattara M, 2010, MOL MICROBIOL, V78, P739, DOI 10.1111/j.1365-2958.2010.07367.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ran YC, 2007, J BIOL CHEM, V282, P31380, DOI 10.1074/jbc.M705967200; Reniere ML, 2007, BIOMETALS, V20, P333, DOI 10.1007/s10534-006-9032-0; Rowe AJ, 2011, METHODS, V54, P157, DOI 10.1016/j.ymeth.2011.02.006; Rybak MJ, 2001, DRUGS, V61, P1, DOI 10.2165/00003495-200161010-00001; Sato S, 2011, BIOCHEMISTRY-US, V50, P250, DOI 10.1021/bi1016183; Sharp KH, 2007, J BIOL CHEM, V282, P10625, DOI 10.1074/jbc.M700234200; Shiota T, 2011, P NATL ACAD SCI USA, V108, P15179, DOI 10.1073/pnas.1105921108; Skaar EP, 2004, MICROBES INFECT, V6, P390, DOI 10.1016/j.micinf.2003.12.008; Smith TL, 1999, NEW ENGL J MED, V340, P493, DOI 10.1056/NEJM199902183400701; Springer B, 2009, WIEN KLIN WOCHENSCHR, V121, P86, DOI 10.1007/s00508-008-1126-y; Stranger-Jones YK, 2006, P NATL ACAD SCI USA, V103, P16942, DOI 10.1073/pnas.0606863103; Streit JM, 2004, INT J ANTIMICROB AG, V24, P111, DOI 10.1016/j.ijantimicag.2003.12.019; Tiedemann MT, 2008, BIOCHEM SOC T, V36, P1138, DOI 10.1042/BST0361138; Villareal VA, 2008, J BIOL CHEM, V283, P31591, DOI 10.1074/jbc.M801126200; Villareal VA, 2011, J AM CHEM SOC, V133, P14176, DOI 10.1021/ja203805b; Watanabe M, 2008, J BIOL CHEM, V283, P28649, DOI 10.1074/jbc.M803383200; Ye SX, 2008, J BIOL CHEM, V283, P1525, DOI 10.1074/jbc.M707355200; Young TS, 2010, J MOL BIOL, V395, P361, DOI 10.1016/j.jmb.2009.10.030; Zhu H, 2008, J BIOL CHEM, V283, P18450, DOI 10.1074/jbc.M801466200	54	42	42	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16477	16487		10.1074/jbc.M112.346700	http://dx.doi.org/10.1074/jbc.M112.346700			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22427659	Green Published, hybrid			2022-12-25	WOS:000304030900038
J	Creze, C; Ligabue, A; Laurent, S; Lestini, R; Laptenok, SP; Khun, J; Vos, MH; Czjzek, M; Myllykallio, H; Flament, D				Creze, Christophe; Ligabue, Alessio; Laurent, Sebastien; Lestini, Roxane; Laptenok, Sergey P.; Khun, Joelle; Vos, Marten H.; Czjzek, Mirjam; Myllykallio, Hannu; Flament, Didier			Modulation of the Pyrococcus abyssi NucS Endonuclease Activity by Replication Clamp at Functional and Structural Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL NUCLEAR ANTIGEN; SMALL-ANGLE SCATTERING; DNA-LIGASE-I; RESONANCE ENERGY-TRANSFER; RAY SOLUTION SCATTERING; DOUBLE-STRANDED DNA; RECBCD ENZYME; X-RAY; HYPERTHERMOPHILIC ARCHAEON; CRYSTAL-STRUCTURE	Pyrococcus abyssi NucS is the founding member of a new family of structure-specific DNA endonucleases that interact with the replication clamp proliferating cell nuclear antigen (PCNA). Using a combination of small angle x-ray scattering and surface plasmon resonance analyses, we demonstrate the formation of a stable complex in solution, in which one molecule of the PabNucS homodimer binds to the outside surface of the PabPCNA homotrimer. Using fluorescent labels, PCNA is shown to increase the binding affinity of NucS toward single-strand/double-strand junctions on 5' and 3' flaps, as well as to modulate the cleavage specificity on the branched DNA structures. Our results indicate that the presence of a single major contact between the PabNucS and PabPCNA proteins, together with the complex-induced DNA bending, facilitate conformational flexibility required for specific cleavage at the single-strand/double-strand DNA junction.	[Ligabue, Alessio; Lestini, Roxane; Laptenok, Sergey P.; Khun, Joelle; Vos, Marten H.; Myllykallio, Hannu] INSERM, U696, F-91128 Palaiseau, France; [Creze, Christophe; Laurent, Sebastien; Flament, Didier] IFREMER, UMR6197, F-29280 Plouzane, France; [Creze, Christophe; Laurent, Sebastien; Flament, Didier] Univ Bretagne Occidentale, UMR6197, F-29280 Plouzane, France; [Creze, Christophe; Laurent, Sebastien; Flament, Didier] CNRS, UMR6197, Lab Microbiol Environm Extremes, F-29280 Plouzane, France; [Ligabue, Alessio; Lestini, Roxane; Laptenok, Sergey P.; Khun, Joelle; Vos, Marten H.; Myllykallio, Hannu] Ecole Polytech, CNRS, Lab Opt & Biosci, F-91128 Palaiseau, France; [Czjzek, Mirjam] Univ Paris 06, UMR 7139, Stn Biol Roscoff, Roscoff, France; [Czjzek, Mirjam] CNRS, UMR 7139, Stn Biol Roscoff, F-29680 Roscoff, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; Universite de Bretagne Occidentale; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; Universite de Bretagne Occidentale; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; Universite de Bretagne Occidentale; Centre National de la Recherche Scientifique (CNRS); Institut Polytechnique de Paris; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Myllykallio, H (corresponding author), INSERM, U696, F-91128 Palaiseau, France.	hannu.myllykallio@polytechnique.edu; dflament@ifremer.fr	Lestini, Roxane/R-9285-2017; LAURENT, Sébastien/ABF-4382-2020; Myllykallio, Hannu/Y-5462-2019	Lestini, Roxane/0000-0001-7377-4734; Vos, Marten/0000-0003-0493-4831; flament, didier/0000-0002-9847-2342; Myllykallio, Hannu/0000-0002-0541-1197; Laptenok, Sergey/0000-0002-6468-3010	Agence Nationale de la Recherche [ANR-07-BLAN-0371, ANR-09-PIRI-0019-03]; Brittany regional council [4852]	Agence Nationale de la Recherche(French National Research Agency (ANR)); Brittany regional council(Region Bretagne)	This work was supported by Agence Nationale de la Recherche Grants ANR-07-BLAN-0371 (to C. C., M. C., H. M., and D. F.), ANR-09-PIRI-0019-03 (to M. V. and H. M.), and the CREAtivite & Thematiques Exploratoires program of the Brittany regional council, REPAR number 4852 (to S. L. and D. F.).	Aravind L, 2000, NUCLEIC ACIDS RES, V28, P3417, DOI 10.1093/nar/28.18.3417; Ben-Shahar TR, 2009, MOL CELL BIOL, V29, P6353, DOI 10.1128/MCB.01051-09; Castrec B, 2010, J MOL BIOL, V396, P840, DOI 10.1016/j.jmb.2010.01.006; Castrec B, 2009, J MOL BIOL, V394, P209, DOI 10.1016/j.jmb.2009.09.044; Chapados BR, 2004, CELL, V116, P39, DOI 10.1016/S0092-8674(03)01036-5; CLEGG RM, 1993, P NATL ACAD SCI USA, V90, P2994, DOI 10.1073/pnas.90.7.2994; Creze C, 2011, BIOCHEM SOC T, V39, P145, DOI 10.1042/BST0390145; Delarue M, 2002, J MOL BIOL, V320, P1011, DOI 10.1016/S0022-2836(02)00562-4; Dillingham MS, 2008, MICROBIOL MOL BIOL R, V72, P642, DOI 10.1128/MMBR.00020-08; Dionne I, 2003, MOL CELL, V11, P275, DOI 10.1016/S1097-2765(02)00824-9; Dore AS, 2006, NUCLEIC ACIDS RES, V34, P4515, DOI 10.1093/nar/gkl623; Ehmsen KT, 2008, NUCLEIC ACIDS RES, V36, P2182, DOI 10.1093/nar/gkm1152; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Fujikane R, 2010, GENES GENET SYST, V85, P243, DOI 10.1266/ggs.85.243; Garg P, 2005, CRIT REV BIOCHEM MOL, V40, P115, DOI 10.1080/10409230590935433; Gomes XV, 2000, EMBO J, V19, P3811, DOI 10.1093/emboj/19.14.3811; Gutteridge A, 2005, J MOL BIOL, V346, P21, DOI 10.1016/j.jmb.2004.11.013; Henneke G, 2005, J MOL BIOL, V350, P53, DOI 10.1016/j.jmb.2005.04.042; Henneke G, 2002, J MOL BIOL, V323, P795, DOI 10.1016/S0022-2836(02)01028-8; Hopkins BB, 2004, J BIOL CHEM, V279, P37049, DOI 10.1074/jbc.M404573200; Hutton RD, 2008, NUCLEIC ACIDS RES, V36, P6720, DOI 10.1093/nar/gkn745; Kim JH, 2006, NUCLEIC ACIDS RES, V34, P1854, DOI 10.1093/nar/gkl102; Kinch LN, 2005, NUCLEIC ACIDS RES, V33, P3598, DOI 10.1093/nar/gki676; Kiyonari S, 2006, J BIOL CHEM, V281, P28023, DOI 10.1074/jbc.M603403200; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2000, J APPL CRYSTALLOGR, V33, P775, DOI 10.1107/S0021889800001382; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE, V3rd, P353; Laptenok SP, 2010, PHYS CHEM CHEM PHYS, V12, P7593, DOI 10.1039/b919700a; Lestini R, 2010, DNA REPAIR, V9, P994, DOI 10.1016/j.dnarep.2010.06.012; Levin DS, 1997, P NATL ACAD SCI USA, V94, P12863, DOI 10.1073/pnas.94.24.12863; LiCata VJ, 2008, METHOD CELL BIOL, V84, P243, DOI 10.1016/S009l-679X(07)84009-X; LOHMAN TM, 1992, METHOD ENZYMOL, V212, P400; Matsumiya S, 2003, PROTEIN SCI, V12, P823, DOI 10.1110/ps.0234503; Matsumiya S, 2001, PROTEIN SCI, V10, P17, DOI 10.1110/ps.36401; Mayanagi K, 2011, P NATL ACAD SCI USA, V108, P1845, DOI 10.1073/pnas.1010933108; Mesiet-Cladiere L, 2007, J MOL BIOL, V372, P1137, DOI 10.1016/j.jmb.2007.06.056; Miyata T, 2005, P NATL ACAD SCI USA, V102, P13795, DOI 10.1073/pnas.0506447102; Pan M, 2011, BIOCHEM SOC T, V39, P20, DOI 10.1042/BST0390020; Pascal JM, 2004, NATURE, V432, P473, DOI 10.1038/nature03082; Pascal JM, 2006, MOL CELL, V24, P279, DOI 10.1016/j.molcel.2006.08.015; Petoukhov MV, 2007, CURR OPIN STRUC BIOL, V17, P562, DOI 10.1016/j.sbi.2007.06.009; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; RECORD MT, 1976, J MOL BIOL, V107, P145, DOI 10.1016/S0022-2836(76)80023-X; Ren B, 2007, ACTA CRYSTALLOGR F, V63, P406, DOI 10.1107/S1744309107015278; Ren B, 2009, EMBO J, V28, P2479, DOI 10.1038/emboj.2009.192; Roberts JA, 2003, MOL MICROBIOL, V48, P361, DOI 10.1046/j.1365-2958.2003.03444.x; Rouillon C, 2007, J MOL BIOL, V369, P343, DOI 10.1016/j.jmb.2007.03.054; Rouillon C, 2011, RES MICROBIOL, V162, P19, DOI 10.1016/j.resmic.2010.09.003; Sakurai S, 2005, EMBO J, V24, P683, DOI 10.1038/sj.emboj.7600519; SELVIN PR, 1995, METHOD ENZYMOL, V246, P300; Shevelev IV, 2002, NAT REV MOL CELL BIO, V3, P364, DOI 10.1038/nrm804; Singleton MR, 2004, NATURE, V432, P187, DOI 10.1038/nature02988; Subramanian J, 2005, GENETICS, V171, P427, DOI 10.1534/genetics.105.042861; Suhre K, 2004, NUCLEIC ACIDS RES, V32, pW610, DOI 10.1093/nar/gkh368; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Tainer JA, 2010, J AM CHEM SOC, V132, P7372, DOI 10.1021/ja100365x; Tsurimoto T., 1999, FRONT BIOSCI, V4, P849; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang JD, 2000, J BIOL CHEM, V275, P507, DOI 10.1074/jbc.275.1.507; Warbrick E, 1998, BIOESSAYS, V20, P195, DOI 10.1002/(SICI)1521-1878(199803)20:3<195::AID-BIES2>3.0.CO;2-R; Xu H, 2001, BIOCHEMISTRY-US, V40, P4512, DOI 10.1021/bi010103+; Yu M, 1998, P NATL ACAD SCI USA, V95, P981, DOI 10.1073/pnas.95.3.981	65	16	20	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15648	15660		10.1074/jbc.M112.346361	http://dx.doi.org/10.1074/jbc.M112.346361			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22431731	Green Published, hybrid			2022-12-25	WOS:000304006300044
J	Winkler, K; Schultz, A; Schultz, JE				Winkler, Karin; Schultz, Anita; Schultz, Joachim E.			The S-Helix Determines the Signal in a Tsr Receptor/Adenylyl Cyclase Reporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COILED-COIL DOMAIN; MYCOBACTERIAL ADENYLYL-CYCLASE; ESCHERICHIA-COLI ASPARTATE; RETINAL GUANYLATE-CYCLASE; LIGAND-BINDING DOMAIN; MUTATIONAL ANALYSIS; HAMP DOMAIN; TRANSMEMBRANE RECEPTORS; SERINE CHEMORECEPTOR; CYTOPLASMIC DOMAIN	A signaling or S-helix has been identified as a conserved, up to 50-residue-long segment in diverse sensory proteins (1). It is present in all major bacterial lineages and in euryarchea and eukaryotes (1). A bioinformatic analysis shows that it connects upstream receiver and downstream output domains, e. g. in histidine kinases and bacterial adenylyl cyclases. The S-helix is modeled as a two-helical parallel coiled coil. It is predicted to prevent constitutive activation of the downstream signaling domains in the absence of ligand-binding (1). We identified an S-helix of about 25 residues in the adenylyl cyclase CyaG from Arthrospira maxima. Deletion of the 25 residue segment connecting the HAMP and catalytic domains in a chimera with the Escherichia coli Tsr receptor changed the response to serine from inhibition to stimulation. Further examination showed that a deletion of one to three heptads plus a presumed stutter, i.e. 1, 2, or 3 x 7 + 4 amino acids, is required and sufficient for signal reversion. It was not necessary that the deletions be continuous, as removal of separated heptads and presumed stutters also resulted in signal reversion. Furthermore, insertion of the above segments between the HAMP and cyclase catalytic domains similarly resulted in signal reversion. This indicates that the S-helix is an independent, segmented module capable to reverse the receptor signal. Because the S-helix is present in all kingdoms of life, e.g. in human retinal guanylyl cyclase, our findings may be significant for many sensory systems.	[Winkler, Karin; Schultz, Anita; Schultz, Joachim E.] Univ Tubingen, Inst Pharmazeut, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Schultz, JE (corresponding author), Univ Tubingen, Inst Pharmazeut, Morgenstelle 8, D-72076 Tubingen, Germany.	joachim.schultz@uni-tuebingen.de			Deutsche Forschungsgemeinschaft [SFB 766]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft SFB 766.	Airola MV, 2010, STRUCTURE, V18, P436, DOI 10.1016/j.str.2010.01.013; Ames P, 2008, J BACTERIOL, V190, P6676, DOI 10.1128/JB.00750-08; Anantharaman V, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-25; Appleman JA, 2003, J BACTERIOL, V185, P89, DOI 10.1128/JB.185.1.89-97.2003; Aravind L, 1999, FEMS MICROBIOL LETT, V176, P111, DOI 10.1016/S0378-1097(99)00197-4; BAUMGARTNER JW, 1994, J BACTERIOL, V176, P1157, DOI 10.1128/JB.176.4.1157-1163.1994; Biegert A, 2006, NUCLEIC ACIDS RES, V34, pW335, DOI 10.1093/nar/gkl217; Chervitz SA, 1996, P NATL ACAD SCI USA, V93, P2545, DOI 10.1073/pnas.93.6.2545; Ferris HU, 2011, STRUCTURE, V19, P378, DOI 10.1016/j.str.2011.01.006; Galperin MY, 2010, CURR OPIN MICROBIOL, V13, P150, DOI 10.1016/j.mib.2010.01.005; Galperin MY, 2005, ASM NEWS, V71, P326; Galperin MY, 2004, ENVIRON MICROBIOL, V6, P552, DOI 10.1111/j.1462-2920.2004.00633.x; Gardina PJ, 1996, SCIENCE, V274, P425, DOI 10.1126/science.274.5286.425; Gregory-Evans K, 2000, OPHTHALMOLOGY, V107, P55, DOI 10.1016/S0161-6420(99)00038-X; Gruber M, 2003, TRENDS BIOCHEM SCI, V28, P679, DOI 10.1016/j.tibs.2003.10.008; Hazelbauer GL, 2008, TRENDS BIOCHEM SCI, V33, P9, DOI 10.1016/j.tibs.2007.09.014; Hulko M, 2006, CELL, V126, P929, DOI 10.1016/j.cell.2006.06.058; JIN T, 1994, J MOL BIOL, V244, P477, DOI 10.1006/jmbi.1994.1746; Kanchan K, 2010, J BIOL CHEM, V285, P2090, DOI 10.1074/jbc.M109.051698; Kelsell RE, 1998, HUM MOL GENET, V7, P1179, DOI 10.1093/hmg/7.7.1179; Kim KK, 1999, NATURE, V400, P787, DOI 10.1038/23512; Kitanovic S, 2011, J BACTERIOL, V193, P5062, DOI 10.1128/JB.05683-11; Linder JU, 2003, CELL SIGNAL, V15, P1081, DOI 10.1016/S0898-6568(03)00130-X; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; Ma XL, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-2; MESIBOV R, 1972, J BACTERIOL, V112, P315, DOI 10.1128/JB.112.1.315-326.1972; MILBURN MV, 1991, SCIENCE, V254, P1342, DOI 10.1126/science.1660187; Miller J.H., 1972, EXPT MOL GENETICS; Mondejar LG, 2012, J BIOL CHEM, V287, P1022, DOI 10.1074/jbc.M111.284067; MOWBRAY SL, 1990, J BIOL CHEM, V265, P15638; Navarro MVAS, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000588; Newell PD, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000587; PARKINSON JS, 1993, CELL, V73, P857, DOI 10.1016/0092-8674(93)90267-T; PARKINSON JS, 1992, ANNU REV GENET, V26, P71, DOI 10.1146/annurev.ge.26.120192.000443; Ramamurthy V, 2001, J BIOL CHEM, V276, P26218, DOI 10.1074/jbc.M010495200; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; SCOTT WG, 1993, J MOL BIOL, V232, P555, DOI 10.1006/jmbi.1993.1411; Sinha SC, 2005, EMBO J, V24, P663, DOI 10.1038/sj.emboj.7600573; Stewart V, 2010, J BACTERIOL, V192, P734, DOI 10.1128/JB.00172-09; STOCK AM, 1989, NATURE, V337, P745, DOI 10.1038/337745a0; STOCK JB, 1989, MICROBIOL REV, V53, P450, DOI 10.1128/MMBR.53.4.450-490.1989; Tao W, 2002, MOL MICROBIOL, V43, P459, DOI 10.1046/j.1365-2958.2002.02757.x; Tews I, 2005, SCIENCE, V308, P1020, DOI 10.1126/science.1107642; Ulrich LE, 2005, TRENDS MICROBIOL, V13, P52, DOI 10.1016/j.tim.2004.12.006; UTSUMI R, 1989, SCIENCE, V245, P1246, DOI 10.1126/science.2476847; Ward SM, 2006, J BACTERIOL, V188, P3944, DOI 10.1128/JB.00117-06; Wright GA, 2011, J BACTERIOL, V193, P82, DOI 10.1128/JB.00953-10; Wuichet K, 2010, CURR OPIN MICROBIOL, V13, P219, DOI 10.1016/j.mib.2009.12.011; YANG Y, 1993, J MOL BIOL, V232, P493, DOI 10.1006/jmbi.1993.1405; Zhou Q, 2009, MOL MICROBIOL, V73, P801, DOI 10.1111/j.1365-2958.2009.06819.x; Zhulin IB, 2003, J BACTERIOL, V185, P285, DOI 10.1128/JB.185.1.285-294.2003	51	21	21	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15479	15488		10.1074/jbc.M112.348409	http://dx.doi.org/10.1074/jbc.M112.348409			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22427653	Green Published, hybrid			2022-12-25	WOS:000304006300029
J	Chen, SJ; Wu, YH; Huang, HY; Wang, CC				Chen, Shun-Jia; Wu, Yi-Hua; Huang, Hsiao-Yun; Wang, Chien-Chia			Saccharomyces cerevisiae Possesses a Stress-Inducible Glycyl-tRNA Synthetase Gene	PLOS ONE			English	Article							METHIONYL-TRANSFER-RNA; BINDING DOMAIN; ESCHERICHIA-COLI; YEAST; MITOCHONDRIAL; AMINOACYLATION; RECOGNITION; TRANSLATION; INITIATION; COFACTOR	Aminoacyl-tRNA synthetases are a large family of housekeeping enzymes that are pivotal in protein translation and other vital cellular processes. Saccharomyces cerevisiae possesses two distinct nuclear glycyl-tRNA synthetase (GlyRS) genes, GRS1 and GRS2. GRS1 encodes both cytoplasmic and mitochondrial activities, while GRS2 is essentially silent and dispensable under normal conditions. We herein present evidence that expression of GRS2 was drastically induced upon heat shock, ethanol or hydrogen peroxide addition, and high pH, while expression of GRS1 was somewhat repressed under those conditions. In addition, GlyRS2 (the enzyme encoded by GRS2) had a higher protein stability and a lower K-M value for yeast tRNA(Gly) under heat shock conditions than under normal conditions. Moreover, GRS2 rescued the growth defect of a GRS1 knockout strain when highly expressed by a strong promoter at 37 degrees C, but not at the optimal temperature of 30 degrees C. These results suggest that GRS2 is actually an inducible gene that may function to rescue the activity of GRS1 under stress conditions.	[Chen, Shun-Jia; Wu, Yi-Hua; Huang, Hsiao-Yun; Wang, Chien-Chia] Natl Cent Univ, Dept Life Sci, Jhongli, Taiwan	National Central University	Chen, SJ (corresponding author), Natl Cent Univ, Dept Life Sci, Jhongli, Taiwan.	dukewang@cc.ncu.edu.tw		Chen, Shun-Jia/0000-0002-5489-4930	National Science Council (Taiwan) [NSC97-2311-B-008-002-MY3, NSC97-2311-B-008-003-MY3, NSC100-3114-B-008-001-MY3]	National Science Council (Taiwan)(Ministry of Science and Technology, Taiwan)	This work was supported by grants (NSC97-2311-B-008-002-MY3, NSC97-2311-B-008-003-MY3, and NSC100-3114-B-008-001-MY3 to CCW) from the National Science Council (Taiwan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1987, ESCHERICHIA COLI SAL, P887; Brown JR, 1997, MICROBIOL MOL BIOL R, V61, P456, DOI 10.1128/.61.4.456-502.1997; CARTER CW, 1993, ANNU REV BIOCHEM, V62, P715, DOI 10.1146/annurev.bi.62.070193.003435; Chang Chia-Pei, 2008, J Biol Chem, V283, P30699, DOI 10.1074/jbc.M805339200; Chang KJ, 2004, J BIOL CHEM, V279, P13778, DOI 10.1074/jbc.M311269200; CHATTON B, 1988, J BIOL CHEM, V263, P52; Chen SJ, 2008, J BIOL CHEM, V283, P3173, DOI 10.1074/jbc.M706968200; Chen SJ, 2009, J BIOL CHEM, V284, P818, DOI 10.1074/jbc.M804378200; Chiu WC, 2010, MOL BIOL EVOL, V27, P1415, DOI 10.1093/molbev/msq025; Chiu WC, 2009, J BIOL CHEM, V284, P23954, DOI 10.1074/jbc.M109.031047; CLARK RL, 1990, J BACTERIOL, V172, P3237, DOI 10.1128/jb.172.6.3237-3243.1990; Duchene AM, 2001, J BIOL CHEM, V276, P15275, DOI 10.1074/jbc.M011525200; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; FERSHT AR, 1975, BIOCHEMISTRY-US, V14, P1, DOI 10.1021/bi00672a001; Francin M, 2002, J BIOL CHEM, V277, P1762, DOI 10.1074/jbc.M109759200; Francin M, 2006, BIOCHEMISTRY-US, V45, P10153, DOI 10.1021/bi0606905; Giege R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017; Godinic V, 2007, FEBS J, V274, P2788, DOI 10.1111/j.1742-4658.2007.05812.x; Hsiao SP, 2010, BIOCHEM J, V428, P223, DOI 10.1042/BJ20100250; Ibba M, 1997, SCIENCE, V278, P1119, DOI 10.1126/science.278.5340.1119; Kaminska M, 2001, BIOCHEMISTRY-US, V40, P14309, DOI 10.1021/bi015670b; Kaminska M, 2000, EMBO J, V19, P6908, DOI 10.1093/emboj/19.24.6908; KAWAKAMI K, 1992, MOL MICROBIOL, V6, P1739, DOI 10.1111/j.1365-2958.1992.tb01346.x; MarechalDrouard L, 1995, METHOD ENZYMOL, V260, P310, DOI 10.1016/0076-6879(95)60148-1; Mazauric MH, 1996, EUR J BIOCHEM, V241, P814, DOI 10.1111/j.1432-1033.1996.00814.x; MIRANDE M, 1991, PROG NUCLEIC ACID RE, V40, P95; NADA S, 1993, J BIOL CHEM, V268, P7660; NATSOULIS G, 1986, CELL, V46, P235, DOI 10.1016/0092-8674(86)90740-3; OSTREM DL, 1970, P NATL ACAD SCI USA, V67, P1967, DOI 10.1073/pnas.67.4.1967; Pelchat M, 1999, BIOCHEM CELL BIOL, V77, P343, DOI 10.1139/bcb-77-4-343; SCHIMMEL P, 1987, ANNU REV BIOCHEM, V56, P125, DOI 10.1146/annurev.bi.56.070187.001013; SHIBA K, 1994, J BIOL CHEM, V269, P30049; Simos G, 1996, EMBO J, V15, P5437, DOI 10.1002/j.1460-2075.1996.tb00927.x; Tang HL, 2004, J BIOL CHEM, V279, P49656, DOI 10.1074/jbc.M408081200; Turner RJ, 2000, J BIOL CHEM, V275, P27681; Wang CC, 2000, J BIOL CHEM, V275, P17180, DOI 10.1074/jbc.M001057200; Wang CC, 1999, J BIOL CHEM, V274, P16508, DOI 10.1074/jbc.274.23.16508	37	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33363	10.1371/journal.pone.0033363	http://dx.doi.org/10.1371/journal.pone.0033363			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438917	gold, Green Published, Green Submitted			2022-12-25	WOS:000303309100035
J	Cardeal, LBD; Boccardo, E; Termini, L; Rabachini, T; Andreoli, MA; di Loreto, C; Longatto, A; Villa, LL; Maria-Engler, SS				da Silva Cardeal, Laura Beatriz; Boccardo, Enrique; Termini, Lara; Rabachini, Tatiana; Andreoli, Maria Antonieta; di Loreto, Celso; Longatto Filho, Adhemar; Villa, Luisa Lina; Maria-Engler, Silvya Stuchi			HPV16 Oncoproteins Induce MMPs/RECK-TIMP-2 Imbalance in Primary Keratinocytes: Possible Implications in Cervical Carcinogenesis	PLOS ONE			English	Article							CYSTEINE-RICH PROTEIN; MATRIX-METALLOPROTEINASE; TISSUE INHIBITOR; GENE-EXPRESSION; REGULATOR RECK; KAZAL MOTIFS; CARCINOMA; CANCER; MMP-2; MATRIX-METALLOPROTEINASE-9	Cervical cancer is the third most common cancer in women worldwide. Persistent infection with high-risk HPV types, principally HPV16 and 18 is the main risk factor for the development of this malignancy. However, the onset of invasive tumor occurs many years after initial exposure in a minority of infected women. This suggests that other factors beyond viral infection are necessary for tumor establishment and progression. Tumor progression is characterized by an increase in secretion and activation of matrix metalloproteinases (MMPs) produced by either the tumor cells themselves or tumor-associated fibroblasts or macrophages. Increased MMPs expression, including MMP-2, MMP-9 and MT1-MMP, has been observed during cervical carcinoma progression. These proteins have been associated with degradation of ECM components, tumor invasion, metastasis and recurrence. However, few studies have evaluated the interplay between HPV infection and the expression and activity of MMPs and their regulators in cervical cancer. We analyzed the effect of HPV16 oncoproteins on the expression and activity of MMP-2, MMP-9, MT1-MMP, and their inhibitors TIMP-2 and RECK in cultures of human keratinocytes. We observed that E7 expression is associated with increased pro-MMP-9 activity in the epithelial component of organotypic cultures, while E6 and E7 oncoproteins co-expression down-regulates RECK and TIMP-2 levels in organotypic and monolayers cultures. Finally, a study conducted in human cervical tissues showed a decrease in RECK expression levels in precancer and cancer lesions. Our results indicate that HPV oncoproteins promote MMPs/ RECK-TIMP-2 imbalance which may be involved in HPV-associated lesions outcome.	[da Silva Cardeal, Laura Beatriz; Maria-Engler, Silvya Stuchi] Univ Sao Paulo, Sch Pharmaceut Sci, Clin Chem & Toxicol Dept, Sao Paulo, Brazil; [Boccardo, Enrique; Termini, Lara; Rabachini, Tatiana; Andreoli, Maria Antonieta; Villa, Luisa Lina] Ludwig Inst Canc Res, Virol Grp, Sao Paulo, Brazil; [Boccardo, Enrique] Univ Sao Paulo, Dept Microbiol, Inst Biomed Sci, Sao Paulo, Brazil; [Termini, Lara; Villa, Luisa Lina] HPV Inst INCT HPV, Sao Paulo, Brazil; [di Loreto, Celso] Nucleo Patol Inst Adolfo Lutz, Sao Paulo, Brazil; [Longatto Filho, Adhemar] Univ Sao Paulo, Sch Med, Lab Med Invest LIM 14, Sao Paulo, Brazil; [Longatto Filho, Adhemar] Barretos Canc Hosp, PIO XII Fdn, Barretos, Brazil; [Longatto Filho, Adhemar] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal; [Longatto Filho, Adhemar] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal	Universidade de Sao Paulo; Ludwig Institute for Cancer Research; Universidade de Sao Paulo; Universidade de Sao Paulo; Hospital de Cancer de Barretos; Universidade do Minho	Cardeal, LBD (corresponding author), Univ Sao Paulo, Sch Pharmaceut Sci, Clin Chem & Toxicol Dept, Sao Paulo, Brazil.	silvya@usp.br	Rabachini, Tatiana/B-1460-2014; Maria-Engler, Silvya/ABC-2016-2020; VILLA, LUISA/AAH-4761-2019; Termini, Lara/P-2387-2015; Filho, Adhemar Longatto/A-2889-2016; Engler, Silvya Stuchi Maria/K-5936-2016; Longatto-Filho, Adhemar/N-3397-2019; longatto-filho, adhemar/D-7039-2013; Boccardo, Enrique/A-3960-2012	Rabachini, Tatiana/0000-0003-0636-2558; Maria-Engler, Silvya/0000-0003-4771-6041; VILLA, LUISA/0000-0003-4074-2335; Termini, Lara/0000-0002-3588-8877; Engler, Silvya Stuchi Maria/0000-0003-4771-6041; Longatto-Filho, Adhemar/0000-0002-5779-9752; longatto-filho, adhemar/0000-0002-5779-9752; Boccardo, Enrique/0000-0003-1900-0273	FAPESP-Sao Paulo Research Foundation [2005/58885-1, 2008/58817-4, 2008/03232-1]; PRPG-USP: Pro-Reitoria de Pos-Graduacao da Universidade de Sao Paulo; CNPq: Conselho Nacional de Pesquisa e Desenvolvimento	FAPESP-Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); PRPG-USP: Pro-Reitoria de Pos-Graduacao da Universidade de Sao Paulo; CNPq: Conselho Nacional de Pesquisa e Desenvolvimento(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was funded by FAPESP-Sao Paulo Research Foundation: 2005/58885-1 (to LBSC), 2008/58817-4 (to SSME) and 2008/03232-1 (to LLV); and by PRPG-USP: Pro-Reitoria de Pos-Graduacao da Universidade de Sao Paulo and CNPq: Conselho Nacional de Pesquisa e Desenvolvimento (to SSME). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akgul B, 2011, MED MICROBIOL IMMUN, V200, P127, DOI 10.1007/s00430-011-0183-4; Boccardo E, 2004, VIROLOGY, V328, P233, DOI 10.1016/j.virol.2004.07.026; Branca M, 2006, ANTICANCER RES, V26, P1543; Brummer O, 2002, GYNECOL ONCOL, V84, P222, DOI 10.1006/gyno.2001.6413; Clark JCM, 2007, CANCER METAST REV, V26, P675, DOI 10.1007/s10555-007-9093-8; Cardeal LBD, 2006, BIOCHEM CELL BIOL, V84, P713, DOI 10.1139/O06-084; Dong QA, 2010, INT J EXP PATHOL, V91, P368, DOI 10.1111/j.1365-2613.2010.00724.x; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fejzo MS, 2011, GENE CHROMOSOME CANC, V50, P434, DOI 10.1002/gcc.20868; Furumoto K, 2001, HEPATOLOGY, V33, P189, DOI 10.1053/jhep.2001.21048; Gaiotto MAM, 2004, AM J OBSTET GYNECOL, V190, P1278, DOI 10.1016/j.ajog.2003.12.017; Goodwin EC, 2000, P NATL ACAD SCI USA, V97, P12513, DOI 10.1073/pnas.97.23.12513; Goodwin EC, 2000, P NATL ACAD SCI USA, V97, P10978, DOI 10.1073/pnas.97.20.10978; Howie HL, 2009, VIROLOGY, V384, P324, DOI 10.1016/j.virol.2008.11.017; International Agency for Research on Cancer/World Health Organization, 2007, IARC MON EV CARC RIS, V90; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Liu LT, 2003, ONCOGENE, V22, P8263, DOI 10.1038/sj.onc.1207157; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Masui T, 2003, CLIN CANCER RES, V9, P1779; McLaughlin-Drubin ME, 2009, VIRUS RES, V143, P195, DOI 10.1016/j.virusres.2009.06.008; Min W, 2009, INT J GYNECOL CANCER, V19, P547, DOI 10.1111/IGC.0b013e3181a44c68; Morioka Y, 2009, ONCOGENE, V28, P1454, DOI 10.1038/onc.2008.486; Nair SA, 2003, J CANCER RES CLIN, V129, P123, DOI 10.1007/s00432-002-0411-9; NUOVO GJ, 1995, CANCER RES, V55, P267; Oh J, 2001, CELL, V107, P789, DOI 10.1016/S0092-8674(01)00597-9; Oh J, 2006, ONCOGENE, V25, P4230, DOI 10.1038/sj.onc.1209444; Oh J, 2004, CANCER RES, V64, P9062, DOI 10.1158/0008-5472.CAN-04-1981; Pahler J, 2008, NEOPLASIA, V10, P329, DOI 10.1593/neo.07871; Riddick ACP, 2005, BRIT J CANCER, V92, P2171, DOI 10.1038/sj.bjc.6602630; Sasahara RM, 2002, CANCER DETECT PREV, V26, P435, DOI 10.1016/S0361-090X(02)00123-X; Schlecht NF, 2001, JAMA-J AM MED ASSOC, V286, P3106, DOI 10.1001/jama.286.24.3106; Schroer N, 2011, CANCER RES, V71, P87, DOI 10.1158/0008-5472.CAN-10-2193; Shen BC, 2003, CANCER RES, V63, P6537; Correa TCS, 2010, J CELL BIOCHEM, V110, P52, DOI 10.1002/jcb.22472; Span PN, 2003, CANCER, V97, P2710, DOI 10.1002/cncr.11395; Sternlicht MD, 2000, ONCOGENE, V19, P1102, DOI 10.1038/sj.onc.1203347; Stetler-Stevenson WG, 2008, CANCER METAST REV, V27, P57, DOI 10.1007/s10555-007-9105-8; Takagi S, 2009, CANCER RES, V69, P1502, DOI 10.1158/0008-5472.CAN-08-2635; Takahashi C, 1998, P NATL ACAD SCI USA, V95, P13221, DOI 10.1073/pnas.95.22.13221; Takenaka K, 2004, EUR J CANCER, V40, P1617, DOI 10.1016/j.ejca.2004.02.028; Takeuchi T, 2004, CLIN CANCER RES, V10, P5572, DOI 10.1158/1078-0432.CCR-03-0656; Theret N, 1999, HEPATOLOGY, V30, P462, DOI 10.1002/hep.510300236; Yoshida S, 2008, J VIROL, V82, P8820, DOI 10.1128/JVI.02363-07; Zhai YL, 2005, CANCER RES, V65, P6543, DOI 10.1158/0008-5472.CAN-05-0231	45	43	46	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33585	10.1371/journal.pone.0033585	http://dx.doi.org/10.1371/journal.pone.0033585			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438955	Green Submitted, gold, Green Published			2022-12-25	WOS:000303309100063
J	Yu, ZY; Sato, S; Trackman, PC; Kirsch, KH; Sonenshein, GE				Yu, Ziyang; Sato, Seiichi; Trackman, Philip C.; Kirsch, Kathrin H.; Sonenshein, Gail E.			Blimp1 Activation by AP-1 in Human Lung Cancer Cells Promotes a Migratory Phenotype and Is Inhibited by the Lysyl Oxidase Propeptide	PLOS ONE			English	Article							NF-KAPPA-B; PANCREATIC DUCTAL ADENOCARCINOMA; TUMOR-SUPPRESSOR ACTIVITY; GENE-EXPRESSION; BREAST-CANCER; TRANSFORMED PHENOTYPE; TRANSCRIPTION FACTORS; INVASIVE PHENOTYPE; PROTEIN-KINASE; MESSENGER-RNA	B lymphocyte-induced maturation protein 1 (Blimp1) is a master regulator of B cell differentiation, and controls migration of primordial germ cells. Recently we observed aberrant Blimp1 expression in breast cancer cells resulting from an NF-kappa B RelB to Ras signaling pathway. In order to address the question of whether the unexpected expression of Blimp1 is seen in other epithelial-derived tumors, we selected lung cancers as they are frequently driven by Ras signaling. Blimp1 was detected in all five lung cancer cell lines examined and shown to promote lung cancer cell migration and invasion. Interrogation of microarray datasets demonstrated elevated BLIMP1 RNA expression in lung adenocarcinoma, pancreatic ductal carcinomas, head and neck tumors as well as in glioblastomas. Involvement of Ras and its downstream kinase c-Raf was confirmed using mutant and siRNA strategies. We next addressed the issue of mechanism of Blimp1 activation in lung cancer. Using knockdown and ectopic expression, the role of the Activator Protein (AP)-1 family of transcription factors was demonstrated. Further, chromatin immunoprecipitation assays confirmed binding to identified AP-1 elements in the BLIMP1 promoter of ectopically expressed c-Jun and of endogenous AP-1 subunits following serum stimulation. The propeptide domain of lysyl oxidase (LOX-PP) was identified as a tumor suppressor, with ability to reduce Ras signaling in lung cancer cells. LOX-PP reduced expression of Blimp1 by binding to c-Raf and inhibiting activation of AP-1, thereby attenuating the migratory phenotype of lung cancer cells. Thus, Blimp1 is a mediator of Ras/Raf/AP-1 signaling that promotes cell migration, and is repressed by LOX-PP in lung cancer.	[Yu, Ziyang; Sato, Seiichi; Sonenshein, Gail E.] Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA; [Trackman, Philip C.] Boston Univ, Div Oral Biol, Henry M Goldman Sch Dent Med, Boston, MA 02215 USA; [Kirsch, Kathrin H.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Tufts University; Boston University; Boston University	Yu, ZY (corresponding author), Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA.	gail.sonenshein@tufts.edu	Trackman, Philip C/AAX-9280-2021	Trackman, Philip C/0000-0001-5064-614X; Kirsch, Kathrin/0000-0003-1532-1715	National Institutes of Health (NIH) [R01 CA143108, PO1 ES011624]; NATIONAL CANCER INSTITUTE [R01CA143108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES011624] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	These studies were supported by National Institutes of Health (NIH) grants R01 CA143108 and PO1 ES011624. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiseshaiah P, 2008, J CELL PHYSIOL, V216, P405, DOI 10.1002/jcp.21410; Adiseshaiah P, 2007, CANCER RES, V67, P6204, DOI 10.1158/0008-5472.CAN-06-4687; Ahmed SU, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007305; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; Badea L, 2008, HEPATO-GASTROENTEROL, V55, P2016; Blasco RB, 2011, CANCER CELL, V19, P652, DOI 10.1016/j.ccr.2011.04.002; Calame K, 2008, CURR OPIN IMMUNOL, V20, P259, DOI 10.1016/j.coi.2008.04.010; Chadee DN, 2004, NAT CELL BIOL, V6, P770, DOI 10.1038/ncb1152; Chew LJ, 2010, J NEUROSCI, V30, P11011, DOI 10.1523/JNEUROSCI.2546-10.2010; Choi J, 2005, CANCER RES, V65, P5554, DOI 10.1158/0008-5472.CAN-04-4570; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; CONTENTE S, 1990, SCIENCE, V249, P796, DOI 10.1126/science.1697103; Cordenonsi M, 2007, SCIENCE, V315, P840, DOI 10.1126/science.1135961; Csiszar K, 2002, INT J CANCER, V97, P636, DOI 10.1002/ijc.10035; Desai S, 2009, J IMMUNOL, V183, P5778, DOI 10.4049/jimmunol.0901120; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Estilo CL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-11; Freund A, 2004, ONCOGENE, V23, P6105, DOI 10.1038/sj.onc.1207815; GRUDA MC, 1994, ONCOGENE, V9, P2537; Gyory I, 2004, NAT IMMUNOL, V5, P299, DOI 10.1038/ni1046; Han SW, 2006, J BIOL CHEM, V281, P29614, DOI 10.1074/jbc.M604013200; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Hou J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010312; Hurtado PA, 2008, BIOCHEM BIOPH RES CO, V366, P156, DOI 10.1016/j.bbrc.2007.11.116; Jeay S, 2003, MOL CELL BIOL, V23, P2251, DOI 10.1128/MCB.23.7.2251-2263.2003; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Kallies A, 2006, NAT IMMUNOL, V7, P466, DOI 10.1038/ni1321; Kaneda A, 2004, CANCER RES, V64, P6410, DOI 10.1158/0008-5472.CAN-04-1543; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; KELLER AD, 1991, GENE DEV, V5, P868, DOI 10.1101/gad.5.5.868; Khattar E, 2010, J BIOL CHEM, V285, P4554, DOI 10.1074/jbc.M109.029280; Kuo TC, 2004, J IMMUNOL, V173, P5556, DOI 10.4049/jimmunol.173.9.5556; Leppa S, 1998, EMBO J, V17, P4404, DOI 10.1093/emboj/17.15.4404; Martins G, 2008, ANNU REV IMMUNOL, V26, P133, DOI 10.1146/annurev.immunol.26.021607.090241; Min CY, 2007, CANCER RES, V67, P1105, DOI 10.1158/0008-5472.CAN-06-3867; Min CY, 2009, CANCER RES, V69, P6685, DOI 10.1158/0008-5472.CAN-08-4818; Molinolo AA, 2009, ORAL ONCOL, V45, P324, DOI 10.1016/j.oraloncology.2008.07.011; Morris JP, 2010, NAT REV CANCER, V10, P683, DOI 10.1038/nrc2899; Ohgaki H, 2009, CANCER SCI, V100, P2235, DOI 10.1111/j.1349-7006.2009.01308.x; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Ohkubo Y, 2005, J IMMUNOL, V174, P7703, DOI 10.4049/jimmunol.174.12.7703; Ozanne BW, 2007, ONCOGENE, V26, P1, DOI 10.1038/sj.onc.1209759; Palamakumbura AH, 2004, J BIOL CHEM, V279, P40593, DOI 10.1074/jbc.M406639200; Palamakumbura AH, 2009, ONCOGENE; Ren B, 1999, GENE DEV, V13, P125, DOI 10.1101/gad.13.1.125; Ren CZ, 1998, CANCER RES, V58, P1285; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Romieu-Mourez R, 2003, MOL CELL BIOL, V23, P5738, DOI 10.1128/MCB.23.16.5738-5754.2003; Rost T, 2003, ANTICANCER RES, V23, P1565; Sato S, 2011, MOL CELL BIOL, V31, P2683, DOI 10.1128/MCB.01148-10; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Shames DS, 2006, PLOS MED, V3, P2244, DOI 10.1371/journal.pmed.0030486; SHIMIZU K, 1983, NATURE, V304, P497, DOI 10.1038/304497a0; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; TRACKMAN PC, 1992, J BIOL CHEM, V267, P8666; Tunyaplin C, 2004, J IMMUNOL, V173, P1158, DOI 10.4049/jimmunol.173.2.1158; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2; Vasanwala FH, 2002, J IMMUNOL, V169, P1922, DOI 10.4049/jimmunol.169.4.1922; Vincent SD, 2005, DEVELOPMENT, V132, P1315, DOI 10.1242/dev.01711; Vora SR, 2010, J BIOL CHEM, V285, P7384, DOI 10.1074/jbc.M109.033597; Wang XB, 2005, J VIROL, V79, P95, DOI 10.1128/JVI.79.1.95-105.2005; Wang XB, 2007, NAT CELL BIOL, V9, P470, DOI 10.1038/ncb1559; Wang XB, 2009, MOL CELL BIOL, V29, P3832, DOI 10.1128/MCB.00032-09; Woznick AR, 2005, AM J SURG, V189, P297, DOI 10.1016/j.amjsurg.2004.11.031; Wu M, 2007, CANCER RES, V67, P6278, DOI 10.1158/0008-5472.CAN-07-0776; Yan JL, 2007, P NATL ACAD SCI USA, V104, P1841, DOI 10.1073/pnas.0605562104; Yochum GS, 2008, MOL CELL BIOL, V28, P7368, DOI 10.1128/MCB.00744-08; Yu J, 2000, MOL CELL BIOL, V20, P2592, DOI 10.1128/MCB.20.7.2592-2603.2000; Zhao YS, 2009, J BIOL CHEM, V284, P1385, DOI 10.1074/jbc.M802612200	70	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2012	7	3							e33287	10.1371/journal.pone.0033287	http://dx.doi.org/10.1371/journal.pone.0033287			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RU	22438909	Green Published, gold, Green Submitted			2022-12-25	WOS:000303309000019
J	Ranjan, R; Patro, S; Pradhan, B; Kumar, A; Maiti, IB; Dey, N				Ranjan, Rajiv; Patro, Sunita; Pradhan, Bhubaneswar; Kumar, Alok; Maiti, Indu B.; Dey, Nrisingha			Development and Functional Analysis of Novel Genetic Promoters Using DNA Shuffling, Hybridization and a Combination Thereof	PLOS ONE			English	Article							FIGWORT-MOSAIC-VIRUS; IN-VITRO; DIRECTED EVOLUTION; TRANSCRIPT PROMOTER; NEUTROPHIL DEFENSIN; DELETION ANALYSIS; SEQUENCE; PROTEIN; TRANSFORMATION; ELEMENTS	Background: Development of novel synthetic promoters with enhanced regulatory activity is of great value for a diverse range of plant biotechnology applications. Methodology: Using the Figwort mosaic virus full-length transcript promoter (F) and the sub-genomic transcript promoter (FS) sequences, we generated two single shuffled promoter libraries (LssF and LssFS), two multiple shuffled promoter libraries (LmsFS-F and LmsF-FS), two hybrid promoters (FuasFScp and FSuasFcp) and two hybrid-shuffled promoter libraries (LhsFuasFScp and LhsFSuasFcp). Transient expression activities of approximately 50 shuffled promoter clones from each of these libraries were assayed in tobacco (Nicotiana tabacum cv. Xanthi) protoplasts. It was observed that most of the shuffled promoters showed reduced activity compared to the two parent promoters (F and FS) and the CaMV35S promoter. In silico studies (computer simulated analyses) revealed that the reduced promoter activities of the shuffled promoters could be due to their higher helical stability. On the contrary, the hybrid promoters FuasFScp and FSuasFcp showed enhanced activities compared to F, FS and CaMV 35S in both transient and transgenic Nicotiana tabacum and Arabidopsis plants. Northern-blot and qRT-PCR data revealed a positive correlation between transcription and enzymatic activity in transgenic tobacco plants expressing hybrid promoters. Histochemical/X-gluc staining of whole transgenic seedlings/tissue-sections and fluorescence images of ImaGene Green (TM) treated roots and stems expressing the GUS reporter gene under the control of the FuasFScp and FSuasFcp promoters also support the above findings. Furthermore, protein extracts made from protoplasts expressing the human defensin (HNP-1) gene driven by hybrid promoters showed enhanced antibacterial activity compared to the CaMV35S promoter. Significance/Conclusion: Both shuffled and hybrid promoters developed in the present study can be used as molecular tools to study the regulation of ectopic gene expression in plants.	[Ranjan, Rajiv; Patro, Sunita; Pradhan, Bhubaneswar; Kumar, Alok; Dey, Nrisingha] Govt India, Dept Gene Funct & Regulat, Inst Life Sci, Dept Biotechnol, Bhubaneswar, Odisha, India; [Maiti, Indu B.] Univ Kentucky, Kentucky Tobacco Res & Dev Ctr KTRDC, Lexington, KY USA	Department of Biotechnology (DBT) India; Institute of Life Sciences India (ILS); University of Kentucky	Ranjan, R (corresponding author), Govt India, Dept Gene Funct & Regulat, Inst Life Sci, Dept Biotechnol, Bhubaneswar, Odisha, India.	dey@ils.res.in	Pradhan, Bhubaneswar/GOH-3572-2022		Department of Biotechnology, Govt. of India [BT/PR6805/PBD/16/622/2005]; Council for Scientific and Industrial Research, Govt. Of India [38(1147)/07/EMR-II]; CSIR, Govt. of India, New Delhi	Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India); Council for Scientific and Industrial Research, Govt. Of India(Council of Scientific & Industrial Research (CSIR) - India); CSIR, Govt. of India, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	The work was supported by Department of Biotechnology, Govt. of India [Project No. BT/PR6805/PBD/16/622/2005 to ND] and Council for Scientific and Industrial Research, Govt. Of India [Project No. 38(1147)/07/EMR-II to ND] supported this research financially. RR is supported by a research fellowship from CSIR, Govt. of India, New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alper H, 2005, P NATL ACAD SCI USA, V102, P12678, DOI 10.1073/pnas.0504604102; Bestwick RK, Synthetic Hybrid Tomato E4/E8 Plant Promoter-Patent, Patent No. 6118049; Bhattacharyya S, 2002, VIRUS RES, V90, P47, DOI 10.1016/S0166-0934(02)00146-5; Bhullar S, 2003, PLANT PHYSIOL, V132, P988, DOI 10.1104/pp.103.020602; Bhullar S, 2007, PLANT BIOTECHNOL J, V5, P696, DOI 10.1111/j.1467-7652.2007.00274.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Castle LA, 2004, SCIENCE, V304, P1151, DOI 10.1126/science.1096770; Cazzonelli CI, 2008, TRANSGENIC RES, V17, P437, DOI 10.1007/s11248-007-9117-8; CHEN H, 1994, BIOTECHNIQUES, V16, P664; COMAI L, 1990, PLANT MOL BIOL, V15, P373, DOI 10.1007/BF00019155; Dey N, 1999, PLANT MOL BIOL, V40, P771, DOI 10.1023/A:1006285426523; Edelman GM, 2000, P NATL ACAD SCI USA, V97, P3038, DOI 10.1073/pnas.040569897; Fleming AJ, 1996, PLANT J, V10, P745, DOI 10.1046/j.1365-313X.1996.10040745.x; Goodrich JA, 2010, NAT REV GENET, V11, P549, DOI 10.1038/nrg2847; Hibbert EG, 2005, BIOMOL ENG, V22, P11, DOI 10.1016/j.bioeng.2004.09.003; Huang YL, 2003, NUCLEIC ACIDS RES, V31, P3819, DOI 10.1093/nar/gkg562; JEFFERSON RA, 1987, EMBO J, V6, P3901; Kanhere A, 2005, NUCLEIC ACIDS RES, V33, P3165, DOI 10.1093/nar/gki627; Keenan RJ, 2005, P NATL ACAD SCI USA, V102, P8887, DOI 10.1073/pnas.0502497102; Kuluev BR, 2010, RUSS J PLANT PHYSL+, V57, P582, DOI 10.1134/S1021443710040187; Kumar D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024627; Lee LY, 2007, PLANT PHYSIOL, V145, P1294, DOI 10.1104/pp.107.106633; Maiti IB, 2003, PLANT BIOTECHNOL J, V1, P209, DOI 10.1046/j.1467-7652.2003.00019.x; Maiti IB, 1997, TRANSGENIC RES, V6, P143, DOI 10.1023/A:1018477705019; Morey C, 2011, PLANT PHYSIOL, V156, P1300, DOI 10.1104/pp.110.167809; NI M, 1995, PLANT J, V7, P661, DOI 10.1046/j.1365-313X.1995.7040661.x; Nitschke M, 2000, EXP NEPHROL, V10, P332; Otten LG, 2005, BIOMOL ENG, V22, P1, DOI 10.1016/j.bioeng.2005.02.002; Ranjan R, 2011, J BIOTECHNOL, V152, P58, DOI 10.1016/j.jbiotec.2011.01.015; Remans T, 2005, BIOTECHNIQUES, V38, P209, DOI 10.2144/05382ST01; Rushton PJ, 2002, PLANT CELL, V14, P749, DOI 10.1105/tpc.010412; Sahoo DK, 2009, J VIROL METHODS, V161, P114, DOI 10.1016/j.jviromet.2009.06.011; STEMMER WPC, 1994, NATURE, V370, P389, DOI 10.1038/370389a0; STEMMER WPC, 1994, P NATL ACAD SCI USA, V91, P10747, DOI 10.1073/pnas.91.22.10747; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Varkey J, 2005, ANTIMICROB AGENTS CH, V49, P4561, DOI 10.1128/AAC.49.11.4561-4566.2005; Vazquez F, 1996, J MED MICROBIOL, V44, P453, DOI 10.1099/00222615-44-6-453; Venter M, 2010, PLANT DEVELOPMENTAL BIOLOGY: BIOTECHNOLOGICAL PERSPECTIVES VOL 2, P393, DOI 10.1007/978-3-642-04670-4_20; Venter M, 2007, TRENDS PLANT SCI, V12, P118, DOI 10.1016/j.tplants.2007.01.002; Xiong AS, 2007, APPL MICROBIOL BIOT, V74, P160, DOI 10.1007/s00253-006-0659-0; Xiong YQ, 1999, ANTIMICROB AGENTS CH, V43, P1111, DOI 10.1128/AAC.43.5.1111; Zhang XR, 2006, NAT PROTOC, V1, P641, DOI 10.1038/nprot.2006.97	42	20	22	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e31931	10.1371/journal.pone.0031931	http://dx.doi.org/10.1371/journal.pone.0031931			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22431969	gold, Green Published			2022-12-25	WOS:000303198600012
J	Song, MY; Pan, KF; Su, HJ; Zhang, L; Ma, JL; Li, JY; Yuasa, Y; Kang, D; Kim, YS; You, WC				Song, Ming-yang; Pan, Kai-feng; Su, Hui-juan; Zhang, Lian; Ma, Jun-ling; Li, Ji-you; Yuasa, Yasuhito; Kang, Daehee; Kim, Yong Sung; You, Wei-cheng			Identification of Serum MicroRNAs as Novel Non-Invasive Biomarkers for Early Detection of Gastric Cancer	PLOS ONE			English	Article							HIGH-RISK; CLINICOPATHOLOGICAL FEATURES; CIRCULATING MICRORNAS; EXPRESSION; POPULATION; MIR-221; LESIONS; PLASMA; ADENOCARCINOMA	Background: To investigate the potential of serum miRNAs as biomarkers for early detection of gastric cancer (GC), a population-based study was conducted in Linqu, a high-risk area of GC in China. Methodology/Principal Findings: All subjects were selected from two large cohort studies. Differential miRNAs were identified in serum pools of GC and control using TaqMan low density array, and validated in individual from 82 pairs of GC and control, and 46 pairs of dysplasia and control by real-time quantitative reverse transcription-polymerase chain reaction. The temporal trends of identified serum miRNA expression were further explored in a retrospective study on 58 GC patients who had at least one pre-GC diagnosis serum sample based on the long-term follow-up population. The miRNA profiling results demonstrated that 16 miRNAs were markedly upregulated in GC patients compared to controls. Further validation identified a panel of three serum miRNAs (miR-221, miR-744, and miR-376c) as potential biomarkers for GC detection, and receiver operating characteristic (ROC) curve-based risk assessment analysis revealed that this panel could distinguish GCs from controls with 82.4% sensitivity and 58.8% specificity. MiR-221 and miR-376c demonstrated significantly positive correlation with poor differentiation of GC, and miR-221 displayed higher level in dysplasia than in control. Furthermore, the retrospective study revealed an increasing trend of these three miRNA levels during GC development (P for trend, 0.05), and this panel could classify serum samples collected up to 5 years ahead of clinical GC diagnosis with 79.3% overall accuracy. Conclusions/Significance: These data suggest that serum miR-221, miR-376c and miR-744 have strong potential as novel non-invasive biomarkers for early detection of GC.	[Song, Ming-yang; Pan, Kai-feng; Su, Hui-juan; Zhang, Lian; Ma, Jun-ling; You, Wei-cheng] Peking Univ, Canc Hosp & Inst, Dept Canc Epidemiol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100871, Peoples R China; [Li, Ji-you] Peking Univ, Canc Hosp & Inst, Dept Pathol, Beijing 100871, Peoples R China; [Yuasa, Yasuhito] Tokyo Med & Dent Univ, Dept Mol Oncol, Tokyo, Japan; [Kang, Daehee] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Kim, Yong Sung] Med Genom Res Ctr, Korea Res Inst Biosci & Biotechnol, Taejon, South Korea	Peking University; Peking University; Tokyo Medical & Dental University (TMDU); Seoul National University (SNU); Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Song, MY (corresponding author), Peking Univ, Canc Hosp & Inst, Dept Canc Epidemiol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100871, Peoples R China.	pankaifeng2002@yahoo.com; weichengyou@yahoo.com		Pan, Kai-feng/0000-0002-3680-3126; Kang, Daehee/0000-0003-4031-5878	National Basic Research Program of China (973 Program) [2010CB529303]; Natural Science Foundation of China [30921140311]; National Natural Science Foundation of China [81041012, 81171989]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Basic Research Program of China (973 Program: 2010CB529303), A3 Foresight Program from Natural Science Foundation of China (30921140311) and the National Natural Science Foundation of China (81041012 and 81171989). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaoglu FY, 2011, TUMOR BIOL, V32, P583, DOI 10.1007/s13277-011-0154-9; Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen X, 2012, INT J CANCER, V130, P1620, DOI 10.1002/ijc.26177; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Galardi S, 2007, J BIOL CHEM, V282, P23716, DOI 10.1074/jbc.M701805200; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Gillies JK, 2007, CELL CYCLE, V6, P2005, DOI 10.4161/cc.6.16.4526; Guo JM, 2009, J GASTROEN HEPATOL, V24, P652, DOI 10.1111/j.1440-1746.2008.05666.x; Heegaard NHH, 2012, INT J CANCER, V130, P1378, DOI 10.1002/ijc.26153; Kim YK, 2009, NUCLEIC ACIDS RES, V37, P1672, DOI 10.1093/nar/gkp002; Kong SH, 2004, JPN J CLIN ONCOL, V34, P1, DOI 10.1093/jjco/hyh009; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; Kubota H, 2000, SURGERY, V128, P41, DOI 10.1067/msy.2000.106812; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Leung WK, 2008, LANCET ONCOL, V9, P279, DOI 10.1016/S1470-2045(08)70072-X; Liu R, 2011, EUR J CANCER, V47, P784, DOI 10.1016/j.ejca.2010.10.025; Liu T, 2009, CANCER LETT, V273, P233, DOI 10.1016/j.canlet.2008.08.003; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Medina R, 2008, CANCER RES, V68, P2773, DOI 10.1158/0008-5472.CAN-07-6754; Miller TE, 2008, J BIOL CHEM, V283, P29897, DOI 10.1074/jbc.M804612200; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Ng EKO, 2009, GUT, V58, P1375, DOI 10.1136/gut.2008.167817; Oertli M, 2011, J IMMUNOL, V187, P3578, DOI 10.4049/jimmunol.1101772; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Pigati L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013515; Pu XX, 2010, J GASTROEN HEPATOL, V25, P1674, DOI 10.1111/j.1440-1746.2010.06417.x; Shi XJ, 2011, ACTA BIOCH BIOPH SIN, V43, P849, DOI 10.1093/abbs/gmr084; Tsujiura M, 2010, BRIT J CANCER, V102, P1174, DOI 10.1038/sj.bjc.6605608; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wulfken LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025787; Ye G, 2011, J CELL SCI, V124, P359, DOI 10.1242/jcs.072223; You W. C., 2006, GASTRIC CANCER, P52; You WC, 1999, INT J CANCER, V83, P615, DOI 10.1002/(SICI)1097-0215(19991126)83:5&lt;615::AID-IJC8&gt;3.0.CO;2-L; YOU WC, 1993, CANCER EPIDEM BIOMAR, V2, P113; YOU WC, 1993, CANCER RES, V53, P1317; You WC, 2006, JNCI-J NATL CANCER I, V98, P974, DOI 10.1093/jnci/djj264; Zhang ZY, 2008, LAB INVEST, V88, P1358, DOI 10.1038/labinvest.2008.94; Zhao H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013735	42	173	195	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e33608	10.1371/journal.pone.0033608	http://dx.doi.org/10.1371/journal.pone.0033608			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22432036	Green Submitted, gold, Green Published			2022-12-25	WOS:000303198600079
J	Williams, SJ; Jones, JPG; Clubbe, C; Gibbons, JM				Williams, Sophie J.; Jones, Julia P. G.; Clubbe, Colin; Gibbons, James M.			Training Programmes Can Change Behaviour and Encourage the Cultivation of Over-Harvested Plant Species	PLOS ONE			English	Article							FARMERS PERCEPTIONS; MEDICINAL-PLANTS; FOREST; ATTITUDES; DETERMINANTS	Cultivation of wild-harvested plant species has been proposed as a way of reducing over-exploitation of wild populations but lack of technical knowledge is thought to be a barrier preventing people from cultivating a new species. Training programmes are therefore used to increase technical knowledge to encourage people to adopt cultivation. We assessed the impact of a training programme aiming to encourage cultivation of xate (Chamaedorea ernesti-augusti), an over-harvested palm from Central America. Five years after the training programme ended, we surveyed untrained and trained individuals focusing on four potential predictors of behaviour: technical knowledge, attitudes (what individuals think about a behaviour), subjective norms (what individuals perceive others to think of a behaviour) and perceived behavioural control (self assessment of whether individuals can enact the behaviour successfully). Whilst accounting for socioeconomic variables, we investigate the influence of training upon these behavioural predictors and examine the factors that determine whether people adopt cultivation of a novel species. Those who had been trained had higher levels of technical knowledge about xate cultivation and higher belief in their ability to cultivate it while training was not associated with differences in attitudes or subjective norms. Technical knowledge and perceived behavioural control (along with socio-economic variables such as forest ownership and age) were predictors of whether individuals cultivate xate. We suggest that training programmes can have a long lasting effect on individuals and can change behaviour. However, in many situations other barriers to cultivation, such as access to seeds or appropriate markets, will need to be addressed.	[Williams, Sophie J.; Jones, Julia P. G.; Gibbons, James M.] Bangor Univ, Sch Environm Nat Resources & Geog, Bangor, Gwynedd, Wales; [Williams, Sophie J.; Clubbe, Colin] Royal Bot Gardens, Conservat Living Collect & Estates Directorate, Richmond TW9 3AB, Surrey, England	Bangor University; Royal Botanic Gardens, Kew	Williams, SJ (corresponding author), Bangor Univ, Sch Environm Nat Resources & Geog, Bangor, Gwynedd, Wales.	S.Williams@kew.org	Jones, Julia P G/ABD-5629-2021; Gibbons, James/A-1143-2010; Jones, Julia P G/A-3031-2011	Jones, Julia P G/0000-0002-5199-3335; Gibbons, James/0000-0002-0083-9872; Jones, Julia P G/0000-0002-5199-3335; Williams, Sophie Jane/0000-0001-5742-278X	Natural Resources International Fellowship; Bentham-Moxon Trust; Bangor University	Natural Resources International Fellowship; Bentham-Moxon Trust; Bangor University	Natural Resources International Fellowship (www.ed.ac.uk/polopoly_fs/1.../naturalresources%20travel%20fund.doc), Bentham-Moxon Trust (http://www.kew.org/about-kew/policies-information/bentham-moxon/index.htm), and Bangor University financially supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Ajzen I., 2006, CONSTRUCTING TPB QUE; Ajzen I, 2011, BASIC APPL SOC PSYCH, V33, P101, DOI 10.1080/01973533.2011.568834; [Anonymous], 2004, 7 NEWS BELIZE; Armitage CJ, 2003, CURR PSYCHOL, V22, P187, DOI 10.1007/s12144-003-1015-5; Assessment Millennium Ecosystem, 2005, EC HUM WELL BEING CU, V1; Ballantyne R., 2001, J ENVIRON EDUC, V32, P8, DOI DOI 10.1080/00958960109598657; Baruch-Mordo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015681; Belize Central Statistical Office, 2010, POP HOUS CAMP 2010; Bridgewater SGM, 2006, ECON BOT, V60, P265, DOI 10.1663/0013-0001(2006)60[265:CXITGM]2.0.CO;2; BURNHAM KP, 2002, MODEL SELECTION MULT, pCH4; Byg A, 2006, AGROFOREST SYST, V67, P147, DOI 10.1007/s10457-005-1704-1; Canter PH, 2005, TRENDS BIOTECHNOL, V23, P180, DOI 10.1016/j.tibtech.2005.02.002; Chukwuone N, 2009, BIODIVERS CONSERV, V18, P339, DOI 10.1007/s10531-008-9489-y; Conner M, 1998, J APPL SOC PSYCHOL, V28, P1429, DOI 10.1111/j.1559-1816.1998.tb01685.x; Conner M., 2008, PREDICTING HLTH BEHA, P170; Damerell P, 2009, THESIS IMPERIAL COLL; Diamond J, 2002, NATURE, V418, P700, DOI 10.1038/nature01019; Endress BA, 2004, ECOL APPL, V14, P1139, DOI 10.1890/02-5365; Fisher Jeffrey D, 2008, Curr HIV/AIDS Rep, V5, P193, DOI 10.1007/s11904-008-0028-y; Gelman A., 2007, DATA ANAL USING REGR; GODOY RA, 1992, WORLD DEV, V20, P713, DOI 10.1016/0305-750X(92)90147-N; Hamilton AC, 2004, BIODIVERS CONSERV, V13, P1477, DOI 10.1023/B:BIOC.0000021333.23413.42; Hwang J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011692; Ibanez M, 2010, J DEV ECON, V93, P249, DOI 10.1016/j.jdeveco.2009.10.002; MCCULLAGH P, 1980, J ROY STAT SOC B MET, V42, P109; McGinty MM, 2008, AGROFOREST SYST, V73, P99, DOI 10.1007/s10457-008-9114-9; Mercer DE, 2004, AGROFOREST SYST, V61-2, P311, DOI 10.1023/B:AGFO.0000029007.85754.70; Opiyo N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001599; OYAMA K, 1992, EVOL TREND PLANT, V6, P17; Pattanayak SK, 2003, AGROFOREST SYST, V57, P137; Pooley JA, 2000, ENVIRON BEHAV, V32, P711, DOI 10.1177/0013916500325007; R Development Core Team, 2009, R FDN STAT COMP; Roling N.G., 1988, EXTENSION SCI INFORM; Santos J.R.A., 1999, J EXT, V37, P1; Schippmann U., 2002, BIODIVERSITY ECOSYST; Schultz P. W., 2002, NEW TOOLS ENV PROTEC, P67; St John FAV, 2012, P ROY SOC B-BIOL SCI, V279, P804, DOI 10.1098/rspb.2011.1228; St John FAV, 2010, WILDLIFE RES, V37, P658, DOI 10.1071/WR10032; Ticktin T, 2004, J APPL ECOL, V41, P11, DOI 10.1111/j.1365-2664.2004.00859.x; Trauernicht C, 2005, FOREST ECOL MANAG, V219, P269, DOI 10.1016/j.foreco.2005.09.005; United Nations Environment Programme, 2011, CONS SUST US MED PLA; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Walker GH, 2009, APPL ERGON, V40, P678, DOI 10.1016/j.apergo.2008.06.002; Walters B, 2010, FOREST ECOL MANAG, V209, P3; Warren M., 2003, Journal of Agricultural Education and Extension, V9, P43, DOI 10.1080/13892240385300071; Zubair M, 2006, AGROFOREST SYST, V66, P217, DOI 10.1007/s10457-005-8846-z	47	17	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e33012	10.1371/journal.pone.0033012	http://dx.doi.org/10.1371/journal.pone.0033012			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	931EO	22431993	gold, Green Published, Green Submitted			2022-12-25	WOS:000303198600036
J	Bidossi, A; Mulas, L; Decorosi, F; Colomba, L; Ricci, S; Pozzi, G; Deutscher, J; Viti, C; Oggioni, MR				Bidossi, Alessandro; Mulas, Laura; Decorosi, Francesca; Colomba, Leonarda; Ricci, Susanna; Pozzi, Gianni; Deutscher, Josef; Viti, Carlo; Oggioni, Marco Rinaldo			A Functional Genomics Approach to Establish the Complement of Carbohydrate Transporters in Streptococcus pneumoniae	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; PHOSPHOTRANSFERASE SYSTEM; LACTOCOCCUS-LACTIS; BACILLUS-SUBTILIS; IN-VIVO; ABC TRANSPORTERS; CATABOLITE REPRESSION; NUCLEOTIDE-SEQUENCE; BETA-GALACTOSIDASE; SIALIC-ACID	The aerotolerant anaerobe Streptococcus pneumoniae is part of the normal nasopharyngeal microbiota of humans and one of the most important invasive pathogens. A genomic survey allowed establishing the occurrence of twenty-one phosphotransferase systems, seven carbohydrate uptake ABC transporters, one sodium: solute symporter and a permease, underlining an exceptionally high capacity for uptake of carbohydrate substrates. Despite high genomic variability, combined phenotypic and genomic analysis of twenty sequenced strains did assign the substrate specificity only to two uptake systems. Systematic analysis of mutants for most carbohydrate transporters enabled us to assign a phenotype and substrate specificity to twenty-three transport systems. For five putative transporters for galactose, pentoses, ribonucleosides and sulphated glycans activity was inferred, but not experimentally confirmed and only one transport system remains with an unknown substrate and lack of any functional annotation. Using a metabolic approach, 80% of the thirty-two fermentable carbon substrates were assigned to the corresponding transporter. The complexity and robustness of sugar uptake is underlined by the finding that many transporters have multiple substrates, and many sugars are transported by more than one system. The present work permits to draw a functional map of the complete arsenal of carbohydrate utilisation proteins of pneumococci, allows re-annotation of genomic data and might serve as a reference for related species. These data provide tools for specific investigation of the roles of the different carbon substrates on pneumococcal physiology in the host during carriage and invasive infection.	[Bidossi, Alessandro; Mulas, Laura; Colomba, Leonarda; Ricci, Susanna; Pozzi, Gianni; Oggioni, Marco Rinaldo] Univ Siena, Dip Biol Mol, Lab Microbiol Mol & Biotecnol, I-53100 Siena, Italy; [Pozzi, Gianni; Oggioni, Marco Rinaldo] Azienda Osped Univ Senese, UOC Batteriol, Siena, Italy; [Decorosi, Francesca; Viti, Carlo] Univ Florence, Dip Biotecnol Agr, Sez Microbiol, Florence, Italy; [Deutscher, Josef] CBAI, CNRS, F-78850 Thiverval Grignon, France	University of Siena; University of Siena; University Hospital of Siena; University of Florence; Centre National de la Recherche Scientifique (CNRS)	Oggioni, MR (corresponding author), Univ Siena, Dip Biol Mol, Lab Microbiol Mol & Biotecnol, Via Laterina 8, I-53100 Siena, Italy.	oggioni@unisi.it	Oggioni, Marco Rinaldo/K-3839-2016; ricci, susanna/R-4184-2018; Pozzi, Gianni/Q-2713-2018	Oggioni, Marco Rinaldo/0000-0003-4117-793X; ricci, susanna/0000-0002-2279-6391; Pozzi, Gianni/0000-0002-9557-4714; VITI, CARLO/0000-0001-7188-549X	European Commission [LSHM-CT-2005-512099, HEALTH-F4-2008-222983]; Ricerca Regionale Toscana in Materia di Salute	European Commission(European CommissionEuropean Commission Joint Research Centre); Ricerca Regionale Toscana in Materia di Salute(Regione Toscana)	The work was supported in part by the European Commission grants LSHM-CT-2005-512099 and HEALTH-F4-2008-222983 and a grant from Ricerca Regionale Toscana in Materia di Salute to MO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DW, 2010, MOL MICROBIOL, V77, P183, DOI 10.1111/j.1365-2958.2010.07199.x; Abranches J, 2006, J BACTERIOL, V188, P3748, DOI 10.1128/JB.00169-06; Ajdic D, 2007, J BACTERIOL, V189, P5049, DOI 10.1128/JB.00338-07; Akana J, 2005, BIOCHEM J, V45, P2493; Ake FMD, 2011, MOL MICROBIOL, V81, P274, DOI 10.1111/j.1365-2958.2011.07692.x; Andersson U, 2001, J BIOL CHEM, V276, P42707, DOI 10.1074/jbc.M108279200; Barabote RD, 2005, MICROBIOL MOL BIOL R, V69, P608, DOI 10.1128/MMBR.69.4.608-634.2005; Barriere C, 2005, J BACTERIOL, V187, P3752, DOI 10.1128/JB.187.11.3752-3761.2005; BEIJER L, 1993, J GEN MICROBIOL, V139, P349, DOI 10.1099/00221287-139-2-349; BENTHIN S, 1993, APPL ENVIRON MICROB, V59, P3206, DOI 10.1128/AEM.59.10.3206-3211.1993; Bluschke B, 2007, J MOL BIOL, V369, P386, DOI 10.1016/j.jmb.2007.03.043; Bochner BR, 2009, FEMS MICROBIOL REV, V33, P191, DOI 10.1111/j.1574-6976.2008.00149.x; Boianelli A, 2011, P 18 WORLD C INT FED, V44, P11773, DOI [10.3182/20110828-6-IT-1002.02372., DOI 10.3182/20110828-6-IT-1002.02372]; Burnaugh AM, 2008, J BACTERIOL, V190, P221, DOI 10.1128/JB.01251-07; Camilli R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-25; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; Castro R, 2009, MOL MICROBIOL, V71, P795, DOI 10.1111/j.1365-2958.2008.06564.x; Chan PF, 2003, J BACTERIOL, V185, P2051, DOI 10.1128/JB.185.6.2051-2058.2003; Chang AB, 2004, MOL MEMBR BIOL, V21, P171, DOI 10.1080/09687680410001720830; Chapuy-Regaud S, 2003, INFECT IMMUN, V71, P2615, DOI 10.1128/IAI.71.5.2615-2625.2003; Chen HQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002950; Cocaign-Bousquet M, 2002, APPL MICROBIOL BIOT, V60, P24, DOI 10.1007/s00253-002-1065-x; Cochu A, 2003, APPL ENVIRON MICROB, V69, P5423, DOI 10.1128/AEM.69.9.5423-5432.2003; Cote CK, 2000, MICROBIOL-UK, V146, P1555, DOI 10.1099/00221287-146-7-1555; Crabtree Jonathan, 2007, V408, P93, DOI 10.1007/978-1-59745-547-3_6; Darbon E, 2002, MOL MICROBIOL, V43, P1039, DOI 10.1046/j.1365-2958.2002.02800.x; DAVIS T, 1988, MOL MICROBIOL, V2, P405, DOI 10.1111/j.1365-2958.1988.tb00045.x; de Vos WM, 1999, CURR OPIN MICROBIOL, V2, P289, DOI 10.1016/S1369-5274(99)80050-2; Deutscher J, 2008, CURR OPIN MICROBIOL, V11, P87, DOI 10.1016/j.mib.2008.02.007; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; DEVOS WM, 1990, J BIOL CHEM, V265, P22554; Donati C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r107; Dopazo J, 2001, MICROB DRUG RESIST, V7, P99, DOI 10.1089/10766290152044995; Dossonnet V, 2000, J BACTERIOL, V182, P2582, DOI 10.1128/JB.182.9.2582-2590.2000; Embry A, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-80; Forteza R, 2001, FASEB J, V15, P2179, DOI 10.1096/fj.01-0036com; Francl AL, 2010, BMC, P10; FRENEY J, 1992, J CLIN MICROBIOL, V30, P2657, DOI 10.1128/JCM.30.10.2657-2661.1992; Giammarinaro P, 2002, INFECT IMMUN, V70, P5454, DOI 10.1128/IAI.70.10.5454-5461.2002; GRAY BM, 1980, J INFECT DIS, V142, P923, DOI 10.1093/infdis/142.6.923; GRAY BM, 1982, AM J EPIDEMIOL, V116, P692, DOI 10.1093/oxfordjournals.aje.a113452; Grossiord B, 1998, LAIT, V78, P77, DOI 10.1051/lait:1998110; Hakenbeck R, 2001, INFECT IMMUN, V69, P2477, DOI 10.1128/IAI.69.4.2477-2486.2001; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.t01-1-03106.x; Higgins MA, 2009, J MOL BIOL, V388, P299, DOI 10.1016/j.jmb.2009.03.012; Hiller NL, 2007, J BACTERIOL, V189, P8186, DOI 10.1128/JB.00690-07; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Hogberg L, 2007, J CLIN MICROBIOL, V45, P948, DOI 10.1128/JCM.01913-06; HOLMBERG C, 1990, J GEN MICROBIOL, V136, P2367, DOI 10.1099/00221287-136-12-2367; Honeyman AL, 2000, MICROBIOL-SGM, V146, P1565, DOI 10.1099/00221287-146-7-1565; Hooper LV, 1999, P NATL ACAD SCI USA, V96, P9833, DOI 10.1073/pnas.96.17.9833; Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001; Hvorup R, 2003, J MOL MICROB BIOTECH, V6, P191, DOI 10.1159/000077250; Iannelli F, 2004, INFECT IMMUN, V72, P3077, DOI 10.1128/IAI.72.5.3077-3080.2004; Iannelli F, 2004, MOL BIOTECHNOL, V26, P81, DOI 10.1385/MB:26:1:81; IIDA A, 1993, J BACTERIOL, V175, P5375, DOI 10.1128/JB.175.17.5375-5383.1993; Ispahani P, 2004, ARCH DIS CHILD, V89, P757, DOI 10.1136/adc.2003.036921; Iyer R, 2005, J BACTERIOL, V187, P8340, DOI 10.1128/JB.187.24.8340-8349.2005; Iyer R, 2007, MOL MICROBIOL, V66, P1, DOI 10.1111/j.1365-2958.2007.05878.x; Jeong JK, 2009, J BACTERIOL, V191, P3011, DOI 10.1128/JB.01601-08; Joseph B, 2008, J BACTERIOL, V190, P5412, DOI 10.1128/JB.00259-08; Joyet P, 2010, MOL MICROBIOL, V76, P1279, DOI 10.1111/j.1365-2958.2010.07175.x; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kaufman GE, 2007, J BACTERIOL, V189, P5183, DOI 10.1128/JB.00449-07; King SJ, 2006, MOL MICROBIOL, V59, P961, DOI 10.1111/j.1365-2958.2005.04984.x; King SJ, 2004, MOL MICROBIOL, V54, P159, DOI 10.1111/j.1365-2958.2004.04252.x; Kornberg HL, 2001, J MOL MICROB BIOTECH, V3, P355; Krejcik Z, 2008, ARCH MICROBIOL, V190, P159, DOI 10.1007/s00203-008-0386-2; KUBOTA Y, 1982, FEMS MICROBIOL LETT, V13, P5; Le Breton Y, 2005, J APPL MICROBIOL, V98, P806, DOI 10.1111/j.1365-2672.2004.02468.x; LENGELER JW, 1994, BBA-BIOENERGETICS, V1188, P1, DOI 10.1016/0005-2728(94)90017-5; Li SL, 2000, EMBO J, V19, P1228, DOI 10.1093/emboj/19.6.1228; LINDGREN V, 1978, J BACTERIOL, V133, P667, DOI 10.1128/JB.133.2.667-670.1978; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; LOCK RA, 1988, MICROB PATHOGENESIS, V5, P461, DOI 10.1016/0882-4010(88)90007-1; Lorca GL, 2007, BBA-BIOMEMBRANES, V1768, P1342, DOI 10.1016/j.bbamem.2007.02.007; Lortie LA, 2000, MICROBIOL-UK, V146, P677, DOI 10.1099/00221287-146-3-677; Luesink EJ, 1999, J BACTERIOL, V181, P764, DOI 10.1128/JB.181.3.764-771.1999; Madhi SA, 2008, B WHO, V86, pA; Manco S, 2006, INFECT IMMUN, V74, P4014, DOI 10.1128/IAI.01237-05; Marion C, 2011, INFECT IMMUN, V79, P4193, DOI 10.1128/IAI.05290-11; Marion C, 2011, INFECT IMMUN, V79, P1262, DOI 10.1128/IAI.00832-10; Maruyama Y, 2009, J BIOL CHEM, V284, P18059, DOI 10.1074/jbc.M109.005660; McKessar SJ, 2007, J BACTERIOL, V189, P1342, DOI 10.1128/JB.01170-06; Melegaro A, 2006, J INFECTION, V52, P37, DOI 10.1016/j.jinf.2005.02.008; Monedero V, 2001, J BACTERIOL, V183, P3391, DOI 10.1128/JB.183.11.3391-3398.2001; Mourez M, 1997, EMBO J, V16, P3066, DOI 10.1093/emboj/16.11.3066; Murata T, 2005, J BIOENERG BIOMEMBR, V37, P411, DOI 10.1007/s10863-005-9481-0; Neves AR, 2005, FEMS MICROBIOL REV, V29, P531, DOI 10.1016/j.femsre.2005.04.005; Novichkov PS, 2010, NUCLEIC ACIDS RES, V38, pD111, DOI 10.1093/nar/gkp894; Oggioni MR, 2003, MOL MICROBIOL, V49, P795, DOI 10.1046/j.1365-2958.2003.03596.x; Oggioni MR, 2001, FEMS MICROBIOL LETT, V200, P137, DOI 10.1111/j.1574-6968.2001.tb10705.x; Paulsen IT, 2000, J MOL BIOL, V301, P75, DOI 10.1006/jmbi.2000.3961; Pearce BJ, 2002, RES MICROBIOL, V153, P243, DOI 10.1016/S0923-2508(02)01312-8; Pettigrew MM, 2006, INFECT IMMUN, V74, P3360, DOI 10.1128/IAI.01442-05; Polissi A, 1998, INFECT IMMUN, V66, P5620, DOI 10.1128/IAI.66.12.5620-5629.1998; Pozzi G, 1996, J BACTERIOL, V178, P6087, DOI 10.1128/jb.178.20.6087-6090.1996; PUYET A, 1993, J BIOL CHEM, V268, P25402; Reizer J, 1999, MICROBIOL-UK, V145, P3419, DOI 10.1099/00221287-145-12-3419; Ren QH, 2007, NUCLEIC ACIDS RES, V35, pD274, DOI 10.1093/nar/gkl925; Ritsema T, 2004, PLANT MOL BIOL, V54, P853, DOI 10.1007/s11103-004-0276-1; Rose MC, 2006, PHYSIOL REV, V86, P245, DOI 10.1152/physrev.00010.2005; Rosenow C, 1999, GENOME RES, V9, P1189, DOI 10.1101/gr.9.12.1189; ROSEY EL, 1992, J BACTERIOL, V174, P6159, DOI 10.1128/JB.174.19.6159-6170.1992; ROTHEIM MB, 1975, CAN J MICROBIOL, V21, P1139, DOI 10.1139/m75-170; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Saier MH, 2009, NUCL ACIDS RES, V37; Schleifer K.H., 2009, BERGEYS MANUAL SYSTE, VVolume 3; Schneider E, 2001, RES MICROBIOL, V152, P303, DOI 10.1016/S0923-2508(01)01201-3; Schonert S, 2006, J BACTERIOL, V188, P3911, DOI 10.1128/JB.00213-06; Scortti M, 2006, NAT MED, V12, P515, DOI 10.1038/nm1396; Severi E, 2010, FEMS MICROBIOL LETT, V304, P47, DOI 10.1111/j.1574-6968.2009.01881.x; Shelburne SA, 2008, MOL MICROBIOL, V69, P436, DOI 10.1111/j.1365-2958.2008.06290.x; Shelburne SA, 2006, INFECT IMMUN, V74, P4605, DOI 10.1128/IAI.00477-06; Siezen RJ, 2005, APPL ENVIRON MICROB, V71, P8371, DOI 10.1128/AEM.71.12.8371-8382.2005; Song JH, 2005, MOL CELLS, V19, P365; Stoll R, 2010, MICROBIOL-SGM, V156, P1069, DOI 10.1099/mic.0.034934-0; SUTRINA SL, 1990, J BIOL CHEM, V265, P18581; Tchieu JH, 2001, J MOL MICROB BIOTECH, V3, P329; Terra VS, 2010, INFECT IMMUN, V78, P348, DOI 10.1128/IAI.00721-09; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Tettelin H, 2004, PNEUMOCCOCUS, P15; Thompson J, 1998, J BIOL CHEM, V273, P27347, DOI 10.1074/jbc.273.42.27347; Trappetti C, 2009, J INFECT DIS, V199, P1497, DOI 10.1086/598483; Vadeboncoeur C, 1997, FEMS MICROBIOL REV, V19, P187, DOI 10.1016/S0168-6445(96)00029-0; VADEBONCOEUR C, 1984, CAN J MICROBIOL, V30, P495, DOI 10.1139/m84-073; VANROOIJEN RJ, 1991, J BIOL CHEM, V266, P7176; Vimr ER, 2004, MICROBIOL MOL BIOL R, V68, P132, DOI 10.1128/MMBR.68.1.132-153.2004; Viti C, 2009, MICROBIOL-SGM, V155, P95, DOI 10.1099/mic.0.021873-0; Webb AJ, 2008, J BACTERIOL, V190, P168, DOI 10.1128/JB.01509-07; Webb AJ, 2007, J BACTERIOL, V189, P3322, DOI 10.1128/JB.01633-06; Webb AJ, 2006, J BACTERIOL, V188, P8005, DOI 10.1128/JB.01101-06; Yesilkaya H, 2009, INFECT IMMUN, V77, P5418, DOI 10.1128/IAI.00178-09; Yum DY, 1999, APPL ENVIRON MICROB, V65, P3341; Zahner D, 2000, J BACTERIOL, V182, P5919, DOI 10.1128/JB.182.20.5919-5921.2000; Zhang ZG, 2003, J BACTERIOL, V185, P2243, DOI 10.1128/JB.185.7.2243-2250.2003	136	116	116	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2012	7	3							e33320	10.1371/journal.pone.0033320	http://dx.doi.org/10.1371/journal.pone.0033320			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930IA	22428019	Green Submitted, Green Published, gold			2022-12-25	WOS:000303129700052
J	Erbertseder, K; Reichold, J; Flemisch, B; Jenny, P; Helmig, R				Erbertseder, Karin; Reichold, Johannes; Flemisch, Bernd; Jenny, Patrick; Helmig, Rainer			A Coupled Discrete/Continuum Model for Describing Cancer-Therapeutic Transport in the Lung	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; INTERSTITIAL PRESSURE; FLUID TRANSPORT; NETWORK MODEL; SOLID TUMORS; MACROMOLECULES; MORPHOMETRY; VASCULATURE; DELIVERY; HEMATOCRIT	We propose a computational simulation framework for describing cancer-therapeutic transport in the lung. A discrete vascular graph model (VGM) is coupled to a double-continuum model (DCM) to determine the amount of administered therapeutic agent that will reach the cancer cells. An alveolar cell carcinoma is considered. The processes in the bigger blood vessels (arteries, arterioles, venules and veins) are described by the VGM. The processes in the alveolar capillaries and the surrounding tissue are represented by a continuum approach for porous media. The system of equations of the coupled discrete/continuum model contains terms that account for degradation processes of the therapeutic agent, the reduction of the number of drug molecules by the lymphatic system and the interaction of the drug with the tissue cells. The functionality of the coupled discrete/continuum model is demonstrated in example simulations using simplified pulmonary vascular networks, which are designed to show-off the capabilities of the model rather than being physiologically accurate.	[Erbertseder, Karin; Flemisch, Bernd; Helmig, Rainer] Univ Stuttgart, Inst Modelling Hydraul & Environm Syst, Dept Hydromech & Modeling Hydrosyst, Stuttgart, Germany; [Reichold, Johannes; Jenny, Patrick] ETH, Inst Fluid Dynam, Dept Mech & Proc Engn, Zurich, Switzerland	University of Stuttgart; Swiss Federal Institutes of Technology Domain; ETH Zurich	Erbertseder, K (corresponding author), Univ Stuttgart, Inst Modelling Hydraul & Environm Syst, Dept Hydromech & Modeling Hydrosyst, Stuttgart, Germany.	karin.erbertseder@iws.uni-stuttgart.de	Flemisch, Bernd/AAD-2349-2020; Helmig, Rainer/AAD-4338-2019	Flemisch, Bernd/0000-0001-8188-620X; Helmig, Rainer/0000-0003-2601-5377	BMBF-Funding Initiative FORSYS Partner: "Predictive Cancer Therapy"; German Research Foundation (DFG)	BMBF-Funding Initiative FORSYS Partner: "Predictive Cancer Therapy"; German Research Foundation (DFG)(German Research Foundation (DFG))	The authors would like to thank the BMBF-Funding Initiative FORSYS Partner: "Predictive Cancer Therapy" for the financial support of the project. Further, this work was supported by the German Research Foundation (DFG) within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baber K, 2009, THESIS U STUTTGART; Bachmann D, 2005, FLOW TRANSPORT FRACT; Baish JW, 1996, MICROVASC RES, V51, P327, DOI 10.1006/mvre.1996.0031; Baish JW, 1997, MICROVASC RES, V53, P128, DOI 10.1006/mvre.1996.2005; BAXTER LT, 1989, MICROVASC RES, V37, P77, DOI 10.1016/0026-2862(89)90074-5; BAXTER LT, 1991, MICROVASC RES, V41, P5, DOI 10.1016/0026-2862(91)90003-T; BAXTER LT, 1990, MICROVASC RES, V40, P246, DOI 10.1016/0026-2862(90)90023-K; Bear J., 2013, DYNAMICS FLUIDS PORO; Beard DA, 2008, MICROCIRCULATION, V15, P777, DOI 10.1080/10739680802019709; Boas DA, 2008, NEUROIMAGE, V40, P1116, DOI 10.1016/j.neuroimage.2007.12.061; Bongrand P, 1999, REP PROG PHYS, V62, P921, DOI 10.1088/0034-4885/62/6/202; Brown BH, 2002, MED BIOL ENG COMPUT, V40, P506, DOI 10.1007/BF02345447; Chapman SJ, 2008, B MATH BIOL, V70, P2334, DOI 10.1007/s11538-008-9349-7; Effors R, 1984, HDB PHYSL, VIV; Eikenberry S, 2009, THEOR BIOL MED MODEL, V6, DOI 10.1186/1742-4682-6-16; Flemisch B, 2011, ADV WATER RESOUR, V34, P1102, DOI 10.1016/j.advwatres.2011.03.007; Formaggia L, 2009, MS A MOD SIMUL, V1, P1, DOI 10.1007/978-88-470-1152-6; Guibert R, 2010, J CEREBR BLOOD F MET, V30, P1860, DOI 10.1038/jcbfm.2010.105; Helmig R., 1997, MULTIPHASE FLOW TRAN; HORSFIELD K, 1978, CIRC RES, V42, P593, DOI 10.1161/01.RES.42.5.593; HORSFIELD K, 1981, LUNG, V159, P211, DOI 10.1007/BF02713917; Huang W, 1996, J APPL PHYSIOL, V81, P2123, DOI 10.1152/jappl.1996.81.5.2123; Jain RK, 1998, J CONTROL RELEASE, V53, P49, DOI 10.1016/S0168-3659(97)00237-X; JAIN RK, 1987, CANCER METAST REV, V6, P559, DOI 10.1007/BF00047468; JAIN RK, 1987, CANCER RES, V47, P3039; Jang SH, 2003, PHARM RES-DORDR, V20, P1337, DOI 10.1023/A:1025785505977; Jardins TD, 2008, CARDIOPULMONARY ANTO; Kurbel S, 2001, MED HYPOTHESES, V57, P161, DOI 10.1054/mehy.2001.1288; LI CW, 1993, J BIOMECH, V26, P653, DOI 10.1016/0021-9290(93)90029-E; Liepsch D, 1987, STROMUNGSUNTERSUCH 7; LIPOWSKY HH, 1980, MICROVASC RES, V19, P297, DOI 10.1016/0026-2862(80)90050-3; Lorthois S, 2011, NEUROIMAGE, V54, P2840, DOI 10.1016/j.neuroimage.2010.10.040; Lorthois S, 2011, NEUROIMAGE, V54, P1031, DOI 10.1016/j.neuroimage.2010.09.032; Lowe G D, 1987, Baillieres Clin Haematol, V1, P597, DOI 10.1016/S0950-3536(87)80018-5; Lullmann H, 2004, TASCHENATLAS PHARM; Muthuchamy M, 2008, ANN NY ACAD SCI, V1131, P89, DOI 10.1196/annals.1413.008; Negrini D, 2007, RESP PHYSIOL NEUROBI, V159, P301, DOI 10.1016/j.resp.2007.04.003; Obrist D, 2010, PHILOS T R SOC A, V368, P2897, DOI 10.1098/rsta.2010.0045; Pishko GL, 2011, ANN BIOMED ENG, V39, P2360, DOI 10.1007/s10439-011-0349-7; Pluen A, 2001, P NATL ACAD SCI USA, V98, P4628, DOI 10.1073/pnas.081626898; PRIES AR, 1992, AM J PHYSIOL, V263, pH1770, DOI 10.1152/ajpheart.1992.263.6.H1770; Reichold J, 2011, THESIS ETH ZURICH; Reichold J, 2009, J CEREBR BLOOD F MET, V29, P1429, DOI 10.1038/jcbfm.2009.58; Renkin E, 1984, HDB PHYSL 2 2, VIV; RENKIN EM, 1978, MICROVASC RES, V15, P123, DOI 10.1016/0026-2862(78)90013-4; Schmidt RF, 2007, PHYSL MENSCHEN PATHO; SERIKOV VB, 1991, MICROVASC RES, V42, P1, DOI 10.1016/0026-2862(91)90071-I; Shijubo N, 2003, MICROSC RES TECHNIQ, V60, P186, DOI 10.1002/jemt.10257; Shipley RJ, 2010, B MATH BIOL, V72, P1464, DOI 10.1007/s11538-010-9504-9; SINGHAL S, 1973, CIRC RES, V33, P190, DOI 10.1161/01.RES.33.2.190; Sugihara-Seki M, 2005, FLUID DYN RES, V37, P82, DOI 10.1016/j.fluiddyn.2004.03.006; SWABB EA, 1974, CANCER RES, V34, P2814; Tuma R. F., 2008, MICROCIRCULATION; Vankan WJ, 1997, INT J ENG SCI, V35, P375, DOI 10.1016/S0020-7225(96)00108-5; Weibel E.R., 1963, MORPHOMETRY HUMAN LU, DOI DOI 10.1007/978-3-642-87553-3; WEIBEL ER, 1991, AM J PHYSIOL, V261, pL361, DOI 10.1152/ajplung.1991.261.6.L361	56	35	35	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e31966	10.1371/journal.pone.0031966	http://dx.doi.org/10.1371/journal.pone.0031966			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22438873	gold, Green Submitted, Green Published			2022-12-25	WOS:000302381500006
J	Kfir, Y; Renan, I; Schneidman, E; Segev, R				Kfir, Yoav; Renan, Ittai; Schneidman, Elad; Segev, Ronen			The Natural Variation of a Neural Code	PLOS ONE			English	Article							MOTION-SENSITIVE NEURON; VISUAL-SYSTEM; INFORMATION; ENERGY; RELIABILITY; ADAPTATION; ENTROPY; NOISE	The way information is represented by sequences of action potentials of spiking neurons is determined by the input each neuron receives, but also by its biophysics, and the specifics of the circuit in which it is embedded. Even the "code" of identified neurons can vary considerably from individual to individual. Here we compared the neural codes of the identified H1 neuron in the visual systems of two families of flies, blow flies and flesh flies, and explored the effect of the sensory environment that the flies were exposed to during development on the H1 code. We found that the two families differed considerably in the temporal structure of the code, its content and energetic efficiency, as well as the temporal delay of neural response. The differences in the environmental conditions during the flies' development had no significant effect. Our results may thus reflect an instance of a family-specific design of the neural code. They may also suggest that individual variability in information processing by this specific neuron, in terms of both form and content, is regulated genetically.	[Kfir, Yoav] Ben Gurion Univ Negev, Dept Biomed Engn, IL-84105 Beer Sheva, Israel; [Kfir, Yoav; Segev, Ronen] Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, IL-84105 Beer Sheva, Israel; [Renan, Ittai] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Zool, IL-69978 Tel Aviv, Israel; [Schneidman, Elad] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Segev, Ronen] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University; Tel Aviv University; Weizmann Institute of Science; Ben Gurion University	Kfir, Y (corresponding author), Ben Gurion Univ Negev, Dept Biomed Engn, IL-84105 Beer Sheva, Israel.	ronensgv@bgu.ac.il	SEGEV, RONEN/F-1550-2012	schneidman, elad/0000-0001-8653-9848; Segev, Ronen/0000-0002-8109-1076; Kfir, Yoav/0000-0002-9373-8260	Israel Science Foundation; Center for Complexity Sciences; Human Frontiers Science Program; Zlotowski Center for Neuroscience; Minerva Foundation; Horowitz Center for Complexity Science; Clore Center for Biological Physics; Peter and Patricia Gruber Foundation	Israel Science Foundation(Israel Science Foundation); Center for Complexity Sciences; Human Frontiers Science Program(Human Frontier Science Program); Zlotowski Center for Neuroscience; Minerva Foundation; Horowitz Center for Complexity Science; Clore Center for Biological Physics; Peter and Patricia Gruber Foundation	This work was supported by the Israel Science Foundation, a fellowship from the Center for Complexity Sciences, the Human Frontiers Science Program, the Zlotowski Center for Neuroscience (RS), and the Minerva Foundation, the Horowitz Center for Complexity Science, the Clore Center for Biological Physics, and the Peter and Patricia Gruber Foundation (ES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian ED, 1926, J PHYSIOL-LONDON, V61, P49, DOI 10.1113/jphysiol.1926.sp002273; BIALEK W, 1991, SCIENCE, V252, P1854, DOI 10.1126/science.2063199; Borst A, 1999, NAT NEUROSCI, V2, P947, DOI 10.1038/14731; Borst A, 2003, J COMPUT NEUROSCI, V14, P23, DOI 10.1023/A:1021172200868; Borst A, 2001, J COMPUT NEUROSCI, V10, P213, DOI 10.1023/A:1011225232120; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; Cover T.M, ELEMENTS INFORM THEO; ECKERT H, 1980, J COMP PHYSIOL, V135, P29, DOI 10.1007/BF00660179; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; Goaillard JM, 2009, NAT NEUROSCI, V12, P1424, DOI 10.1038/nn.2404; Grewe J, 2003, J NEUROSCI, V23, P10776; Grewe J, 2006, J NEUROPHYSIOL, V96, P1838, DOI 10.1152/jn.00170.2006; Haag J, 1997, J NEUROSCI, V17, P4809; Hausen K., 1984, PHOTORECEPTION VISIO, P523, DOI [10.1007/978-1-4613-2743-1_15, DOI 10.1007/978-1-4613-2743-1_15]; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; Jung SN, 2011, J NEUROSCI, V31, P9231, DOI 10.1523/JNEUROSCI.1138-11.2011; Karmeier K, 2001, VISUAL NEUROSCI, V18, P1, DOI 10.1017/S0952523801181010; Kurtz R, 2009, P ROY SOC B-BIOL SCI, V276, P3711, DOI 10.1098/rspb.2009.0596; Laughlin SB, 2001, CURR OPIN NEUROBIOL, V11, P475, DOI 10.1016/S0959-4388(00)00237-3; Levy WB, 1996, NEURAL COMPUT, V8, P531, DOI 10.1162/neco.1996.8.3.531; LIN JH, 1991, IEEE T INFORM THEORY, V37, P145, DOI 10.1109/18.61115; MADDESS T, 1985, PROC R SOC SER B-BIO, V225, P251, DOI 10.1098/rspb.1985.0061; Nemenman I, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000025; Niven JE, 2007, PLOS BIOL, V5, P828, DOI 10.1371/journal.pbio.0050116; Rieke F., 1997, SPIKES EXPLORING NEU; Rosner R, 2010, J EXP BIOL, V213, P331, DOI 10.1242/jeb.035386; Schneidman E, 2001, ADV NEUR IN, V13, P159; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; SRINIVASAN MV, 1982, PROC R SOC SER B-BIO, V216, P427, DOI 10.1098/rspb.1982.0085; Strong SP, 1998, PHYS REV LETT, V80, P197, DOI 10.1103/PhysRevLett.80.197; Thompson PM, 2001, NAT NEUROSCI, V4, P1253, DOI 10.1038/nn758; VANSTEVENINCK RD, 1988, PROC R SOC SER B-BIO, V234, P379; Warzecha AK, 2000, VISION RES, V40, P2973, DOI 10.1016/S0042-6989(00)00147-4; Warzecha AK, 1997, EUR J NEUROSCI, V9, P1365, DOI 10.1111/j.1460-9568.1997.tb01491.x; Warzecha AK, 1999, SCIENCE, V283, P1927, DOI 10.1126/science.283.5409.1927	35	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33149	10.1371/journal.pone.0033149	http://dx.doi.org/10.1371/journal.pone.0033149			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427973	gold, Green Published, Green Submitted			2022-12-25	WOS:000302381500099
J	Muto, J; Imai, T; Ogawa, D; Nishimoto, Y; Okada, Y; Mabuchi, Y; Kawase, T; Iwanami, A; Mischel, PS; Saya, H; Yoshida, K; Matsuzaki, Y; Okano, H				Muto, Jun; Imai, Takao; Ogawa, Daisuke; Nishimoto, Yoshinori; Okada, Yohei; Mabuchi, Yo; Kawase, Takeshi; Iwanami, Akio; Mischel, Paul S.; Saya, Hideyuki; Yoshida, Kazunari; Matsuzaki, Yumi; Okano, Hideyuki			RNA-Binding Protein Musashi1 Modulates Glioma Cell Growth through the Post-Transcriptional Regulation of Notch and PI3 Kinase/Akt Signaling Pathways	PLOS ONE			English	Article							STEM-CELLS; MESSENGER-RNA; MITOTIC CATASTROPHE; INITIATING CELLS; PROGENITOR CELLS; MAMMALIAN CNS; IN-VIVO; EXPRESSION; CYCLE; TRANSLATION	Musashi1 (MSI1) is an RNA-binding protein that plays critical roles in nervous-system development and stem-cell self-renewal. Here, we examined its role in the progression of glioma. Short hairpin RNA (shRNA)-based MSI1-knock down (KD) in glioblastoma and medulloblastoma cells resulted in a significantly lower number of self renewing colony on day 30 (a 65% reduction), compared with non-silencing shRNA-treated control cells, indicative of an inhibitory effect of MSI1-KD on tumor cell growth and survival. Immunocytochemical staining of the MSI1-KD glioblastoma cells indicated that they ectopically expressed metaphase markers. In addition, a 2.2-fold increase in the number of MSI1-KD cells in the G2/M phase was observed. Thus, MSI1-KD caused the prolongation of mitosis and reduced the cell survival, although the expression of activated Caspase-3 was unaltered. We further showed that MSI1-KD glioblastoma cells xenografted into the brains of NOD/SCID mice formed tumors that were 96.6% smaller, as measured by a bioluminescence imaging system (BLI), than non-KD cells, and the host survival was longer (49.3 +/- 6.1 days vs. 33.6 +/- 3.6 days; P<0.01). These findings and other cell biological analyses suggested that the reduction of MSI1 in glioma cells prolonged the cell cycle by inducing the accumulation of Cyclin B1. Furthermore, MSI1-KD reduced the activities of the Notch and PI3 kinase-Akt signaling pathways, through the up-regulation of Numb and PTEN, respectively. Exposure of glioma cells to chemical inhibitors of these pathways reduced the number of spheres and living cells, as did MSI1-KD. These results suggest that MSI1 increases the growth and/or survival of certain types of glioma cells by promoting the activation of both Notch and PI3 kinase/Akt signaling.	[Muto, Jun; Imai, Takao; Ogawa, Daisuke; Nishimoto, Yoshinori; Okada, Yohei; Mabuchi, Yo; Matsuzaki, Yumi; Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo 160, Japan; [Muto, Jun; Kawase, Takeshi; Yoshida, Kazunari] Keio Univ, Sch Med, Div Neurosurg, Shinjuku Ku, Tokyo, Japan; [Iwanami, Akio; Mischel, Paul S.] David Geffen UCLA Sch Med, Los Angeles, CA USA; [Saya, Hideyuki] Keio Univ, Sch Med, Inst Adv Med Res, Div Gene Regulat,Shinjuku Ku, Tokyo, Japan	Keio University; Keio University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Keio University	Muto, J (corresponding author), Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo 160, Japan.	hidokano@a2.keio.jp	Okada, Yohei/L-1662-2013; Imai, Takao/L-1232-2013; Okano, Hideyuki/I-7584-2019; Saya, Hideyuki/J-4325-2013; Yoshida, Kazunari/L-2255-2013; Mabuchi, Yo/L-1535-2013	Mabuchi, Yo/0000-0001-8008-3966; Saya, Hideyuki/0000-0001-6610-1902; Matsuzaki, Yumi/0000-0002-3729-2997	Japan Science and Technology Corporation, Ministry of Education, Science, Sports, Culture and Technology, Japan (MEXT); Sumitomo foundation; Keio University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073831] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23791446] Funding Source: KAKEN	Japan Science and Technology Corporation, Ministry of Education, Science, Sports, Culture and Technology, Japan (MEXT); Sumitomo foundation; Keio University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by three grants, a Grant-in-Aid for Scientific Research from the Japan Science and Technology Corporation, Ministry of Education, Science, Sports, Culture and Technology, Japan (MEXT) to HO, TI, and JM, Grant-in-Aid from the Sumitomo foundation to TI, and a Grant-in-Aid for the Global COE Program at Keio University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu RD, 2009, J BIOL CHEM, V284, P12125, DOI 10.1074/jbc.M809605200; Bhatt K, 2010, MOL MED, V16, P409, DOI 10.2119/molmed.2010.00002; Castedo M, 2004, ONCOGENE, V23, P4353, DOI 10.1038/sj.onc.1207573; Charlesworth A, 2006, EMBO J, V25, P2792, DOI 10.1038/sj.emboj.7601159; Curry CL, 2007, MOL CANCER THER, V6, P1983, DOI 10.1158/1535-7163.MCT-07-0093; DEITCH AD, 1982, J HISTOCHEM CYTOCHEM, V30, P967, DOI 10.1177/30.9.6182188; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Gotte M, 2011, INT J CANCER, V129, P2042, DOI 10.1002/ijc.25856; Groszer M, 2006, P NATL ACAD SCI USA, V103, P111, DOI 10.1073/pnas.0509939103; HEALD R, 1993, CELL, V74, P463, DOI 10.1016/0092-8674(93)80048-J; Imai T, 2001, MOL CELL BIOL, V21, P3888, DOI 10.1128/MCB.21.12.3888-3900.2001; Ito T, 2010, NATURE, V466, P765, DOI 10.1038/nature09171; Iwanami A, 2009, GENE DEV, V23, P1699, DOI 10.1101/gad.1832909; Kaneko Y, 2000, DEV NEUROSCI-BASEL, V22, P139, DOI 10.1159/000017435; Kanemura Y, 2001, DIFFERENTIATION, V68, P141, DOI 10.1046/j.1432-0436.2001.680208.x; Kawahara H, 2008, J CELL BIOL, V181, P639, DOI 10.1083/jcb.200708004; Kawase S, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-14; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Li YQ, 2005, CANCER RES, V65, P9355, DOI 10.1158/0008-5472.CAN-05-1946; Lu KV, 2009, CANCER RES, V69, P6889, DOI 10.1158/0008-5472.CAN-09-0347; Ma YH, 2008, J NEURO-ONCOL, V86, P31, DOI 10.1007/s11060-007-9439-7; MacNicol MC, 2011, CELL CYCLE, V10, P39, DOI 10.4161/cc.10.1.14388; Masuda H, 2007, P NATL ACAD SCI USA, V104, P1925, DOI 10.1073/pnas.0604310104; Mischel PS, 2003, BRAIN PATHOL, V13, P52; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; NAKAMURA M, 1994, NEURON, V13, P67, DOI 10.1016/0896-6273(94)90460-X; Nakano A, 2007, PEDIATR NEUROSURG, V43, P279, DOI 10.1159/000103307; Nishimoto Y, 2010, CELL RES, V20, P1083, DOI 10.1038/cr.2010.122; Okabe M, 2001, NATURE, V411, P94, DOI 10.1038/35075094; Okano H, 2002, J CELL SCI, V115, P1355; Okano H, 2005, EXP CELL RES, V306, P349, DOI 10.1016/j.yexcr.2005.02.021; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Richter JD, 2007, TRENDS BIOCHEM SCI, V32, P279, DOI 10.1016/j.tibs.2007.04.004; Sakakibara S, 2001, J NEUROSCI, V21, P8091, DOI 10.1523/JNEUROSCI.21-20-08091.2001; Sakakibara S, 1996, DEV BIOL, V176, P230, DOI 10.1006/dbio.1996.0130; Sakakibara S, 1997, J NEUROSCI, V17, P8300; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Sanchez-Diaz PC, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-280; Schulenburg A, 2007, J PATHOL, V213, P152, DOI 10.1002/path.2220; Schwanbeck R, 2011, EUR J CELL BIOL, V90, P572, DOI 10.1016/j.ejcb.2010.10.004; Seigel GM, 2007, MOL VIS, V13, P823; Shen Q, 2002, DEVELOPMENT, V129, P4843; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Spana EP, 1996, NEURON, V17, P21, DOI 10.1016/S0896-6273(00)80277-9; Sureban SM, 2008, GASTROENTEROLOGY, V134, P1448, DOI 10.1053/j.gastro.2008.02.057; Toda M, 2001, GLIA, V34, P1, DOI 10.1002/glia.1034; Tsao YP, 1999, J VIROL, V73, P4983, DOI 10.1128/JVI.73.6.4983-4990.1999; Ueno M, 2006, EXP NEUROL, V198, P154, DOI 10.1016/j.expneurol.2005.11.024; Wang XY, 2008, MOL CELL BIOL, V28, P3589, DOI 10.1128/MCB.00040-08; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Yokota N, 2004, ONCOGENE, V23, P3444, DOI 10.1038/sj.onc.1207475; Yoshida S, 2006, STEM CELLS, V24, P2714, DOI 10.1634/stemcells.2006-0156	53	71	73	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33431	10.1371/journal.pone.0033431	http://dx.doi.org/10.1371/journal.pone.0033431			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22428049	Green Submitted, gold, Green Published			2022-12-25	WOS:000302381500142
J	Nakano, M; Ikeda, Y; Tokuda, Y; Fuwa, M; Omi, N; Ueno, M; Imai, K; Adachi, H; Kageyama, M; Mori, K; Kinoshita, S; Tashiro, K				Nakano, Masakazu; Ikeda, Yoko; Tokuda, Yuichi; Fuwa, Masahiro; Omi, Natsue; Ueno, Morio; Imai, Kojiro; Adachi, Hiroko; Kageyama, Masaaki; Mori, Kazuhiko; Kinoshita, Shigeru; Tashiro, Kei			Common Variants in CDKN2B-AS1 Associated with Optic-Nerve Vulnerability of Glaucoma Identified by Genome-Wide Association Studies in Japanese	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; CORONARY-ARTERY-DISEASE; SUSCEPTIBILITY LOCI; POPULATION; PREVALENCE	Background: To date, only a small portion of the genetic variation for primary open-angle glaucoma (POAG), the major type of glaucoma, has been elucidated. Methods and Principal Findings: We examined our two data sets of the genome-wide association studies (GWAS) derived from a total of 2,219 Japanese subjects. First, we performed a GWAS by analyzing 653,519 autosomal common single-nucleotide polymorphisms (SNPs) in 833 POAG patients and 686 controls. As a result, five variants that passed the Bonferroni correction were identified in CDKN2B-AS1 on chromosome 9p21.3, which was already reported to be a significant locus in the Caucasian population. Moreover, we combined the data set with our previous GWAS data set derived from 411 POAG patients and 289 controls by the Mantel-Haenszel test, and all of the combined variants showed stronger association with POAG (P<5.8x10(-10)). We then subdivided the case groups into two subtypes based on the value of intraocular pressure (IOP)-POAG with high IOP (high pressure glaucoma, HPG) and that with normal IOP (normal pressure glaucoma, NPG)-and performed the GWAS using the two data sets, as the prevalence of NPG in Japanese is much higher than in Caucasians. The results suggested that the variants from the same CDKN2B-AS1 locus were likely to be significant for NPG patients. Conclusions and Significance: In this study, we successfully identified POAG-associated variants in the CDKN2B-AS1 locus using a Japanese population, i.e., variants originally reported as being associated with the Caucasian population. Although we cannot rule out that the significance could be due to the differences in sample size between HPG and NPG, the variants could be associated specifically with the vulnerability of the optic nerve to IOP, which is useful for investigating the etiology of glaucoma.	[Nakano, Masakazu; Tokuda, Yuichi; Fuwa, Masahiro; Omi, Natsue; Adachi, Hiroko; Tashiro, Kei] Kyoto Prefectural Univ Med, Dept Genom Med Sci, Kyoto, Japan; [Ikeda, Yoko; Ueno, Morio; Imai, Kojiro; Mori, Kazuhiko; Kinoshita, Shigeru] Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Japan; [Fuwa, Masahiro; Kageyama, Masaaki] Santen Pharmaceut Co Ltd, Ctr Res & Dev, Nara, Japan	Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine; Santen Pharmaceutical Co Ltd	Nakano, M (corresponding author), Kyoto Prefectural Univ Med, Dept Genom Med Sci, Kyoto, Japan.	shigeruk@koto.kpu-m.ac.jp; tashiro@koto.kpu-m.ac.jp			Collaborative Development of Innovative Seeds of Japan Science and Technology Agency (JST); Ministry of Health, Labor and Welfare of Japan; Santen Pharmaceutical Co. Ltd.; Grants-in-Aid for Scientific Research [22790324, 23659160] Funding Source: KAKEN	Collaborative Development of Innovative Seeds of Japan Science and Technology Agency (JST); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Santen Pharmaceutical Co. Ltd.; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the grants from the Collaborative Development of Innovative Seeds of Japan Science and Technology Agency (JST) to MK and KT, from the Ministry of Health, Labor and Welfare of Japan to KM, SK and KT, and from Santen Pharmaceutical Co. Ltd. to SK and KT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burdon KP, 2011, NAT GENET, V43, P574, DOI 10.1038/ng.824; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; European Glaucoma Society, 2020, TERM GUID GLAUC; Fan BJ, 2010, J CLIN INVEST, V120, P3064, DOI 10.1172/JCI43085; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Harismendy O, 2011, NATURE, V470, P264, DOI 10.1038/nature09753; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Hewitt AW, 2006, CLIN EXP OPHTHALMOL, V34, P472, DOI 10.1111/j.1442-9071.2006.01268.x; Iwase A, 2004, OPHTHALMOLOGY, V111, P1641, DOI 10.1016/j.ophtha.2004.03.029; Japan Glaucoma Society, 2006, GUID GLAUC; Jiao XD, 2009, P NATL ACAD SCI USA, V106, P17105, DOI 10.1073/pnas.0907564106; KLEIN BEK, 1992, OPHTHALMOLOGY, V99, P1499; Kuehn MH, 2011, MOL VIS, V17, P430; Kwon YH, 2009, NEW ENGL J MED, V360, P1113, DOI 10.1056/NEJMra0804630; Leske M Cristina, 2004, Curr Opin Ophthalmol, V15, P102; MANTEL N, 1959, J NATL CANCER I, V22, P719; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Meguro A, 2010, OPHTHALMOLOGY, V117, P1331, DOI 10.1016/j.ophtha.2009.12.001; Nakano M, 2009, P NATL ACAD SCI USA, V106, P12838, DOI 10.1073/pnas.0906397106; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Ramdas WD, 2011, HUM MOL GENET, V20, P2464, DOI 10.1093/hmg/ddr120; Ramdas WD, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000978; Rao KN, 2009, P NATL ACAD SCI USA, V106, pE125, DOI 10.1073/pnas.0910416106; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Thorleifsson G, 2010, NAT GENET, V42, P906, DOI 10.1038/ng.661; Traggiai E, 2004, NAT MED, V10, P871, DOI 10.1038/nm1080; Ueta M, 2010, J ALLERGY CLIN IMMUN, V126, P1218, DOI 10.1016/j.jaci.2010.08.007; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	31	72	75	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33389	10.1371/journal.pone.0033389	http://dx.doi.org/10.1371/journal.pone.0033389			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22428042	Green Submitted, gold, Green Published			2022-12-25	WOS:000302381500138
J	Ponferrada, VG; Fan, JQ; Vallance, JE; Hu, SY; Mamedova, A; Rankin, SA; Kofron, M; Zorn, AM; Hegde, RS; Lang, RA				Ponferrada, Virgilio G.; Fan, Jieqing; Vallance, Jefferson E.; Hu, Shengyong; Mamedova, Aygun; Rankin, Scott A.; Kofron, Matthew; Zorn, Aaron M.; Hegde, Rashmi S.; Lang, Richard A.			CRIM1 Complexes with beta-catenin and Cadherins, Stabilizes Cell-Cell Junctions and Is Critical for Neural Morphogenesis	PLOS ONE			English	Article							EARLY XENOPUS EMBRYO; ADHERENS JUNCTIONS; GROWTH-FACTOR; TISSUE MORPHOGENESIS; VASCULAR DEVELOPMENT; ALPHA-CATENIN; TUBE CLOSURE; N-CADHERIN; EXPRESSION; ADHESION	In multicellular organisms, morphogenesis is a highly coordinated process that requires dynamically regulated adhesion between cells. An excellent example of cellular morphogenesis is the formation of the neural tube from the flattened epithelium of the neural plate. Cysteine-rich motor neuron protein 1 (CRIM1) is a single-pass (type 1) transmembrane protein that is expressed in neural structures beginning at the neural plate stage. In the frog Xenopus laevis, loss of function studies using CRIM1 antisense morpholino oligonucleotides resulted in a failure of neural development. The CRIM1 knockdown phenotype was, in some cases, mild and resulted in perturbed neural fold morphogenesis. In severely affected embryos there was a dramatic failure of cell adhesion in the neural plate and complete absence of neural structures subsequently. Investigation of the mechanism of CRIM1 function revealed that it can form complexes with beta-catenin and cadherins, albeit indirectly, via the cytosolic domain. Consistent with this, CRIM1 knockdown resulted in diminished levels of cadherins and beta-catenin in junctional complexes in the neural plate. We conclude that CRIM1 is critical for cell-cell adhesion during neural development because it is required for the function of cadherin-dependent junctions.	[Ponferrada, Virgilio G.; Fan, Jieqing; Vallance, Jefferson E.; Hu, Shengyong; Mamedova, Aygun; Hegde, Rashmi S.; Lang, Richard A.] Univ Cincinnati, Med Ctr, Cincinnati Childrens Hosp, Visual Syst Grp, Cincinnati, OH 45267 USA; [Ponferrada, Virgilio G.; Fan, Jieqing; Vallance, Jefferson E.; Lang, Richard A.] Univ Cincinnati, Med Ctr, Cincinnati Childrens Hosp, Div Pediat Ophthalmol, Cincinnati, OH 45267 USA; [Hu, Shengyong; Mamedova, Aygun; Rankin, Scott A.; Kofron, Matthew; Zorn, Aaron M.; Hegde, Rashmi S.; Lang, Richard A.] Univ Cincinnati, Med Ctr, Cincinnati Childrens Hosp, Div Dev Biol, Cincinnati, OH 45267 USA; [Lang, Richard A.] Univ Cincinnati, Dept Ophthalmol, Cincinnati, OH 45267 USA; [Fan, Jieqing; Lang, Richard A.] Univ Cincinnati, Mol & Dev Biol Grad Program, Cincinnati, OH 45267 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Ponferrada, VG (corresponding author), Univ Cincinnati, Med Ctr, Cincinnati Childrens Hosp, Visual Syst Grp, Cincinnati, OH 45267 USA.	Rashmi.Hegde@cchmc.org; Richard.Lang@cchmc.org		Lang, Richard/0000-0002-5212-254X; Kofron, Matthew/0000-0001-6427-4148; Vallance, Jefferson/0000-0001-6473-3623	National Institutes of Health [R01 EY019377]; Pearle Vision Foundation; Research to Prevent Blindness; Abrahamson Pediatric Eye Institute Endowment at Cincinnati Children's Hospital Medical Center; NATIONAL EYE INSTITUTE [R01EY019377, R01EY016241, R01EY014648] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070858] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pearle Vision Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Abrahamson Pediatric Eye Institute Endowment at Cincinnati Children's Hospital Medical Center; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported by a grant from the National Institutes of Health (R01 EY019377), as well as funds from the Pearle Vision Foundation, Research to Prevent Blindness and the Abrahamson Pediatric Eye Institute Endowment at Cincinnati Children's Hospital Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2008, P NATL ACAD SCI USA, V105, P13, DOI 10.1073/pnas.0710504105; Ashe HL, 1999, NATURE, V398, P427, DOI 10.1038/18892; BASLER K, 1993, CELL, V73, P687, DOI 10.1016/0092-8674(93)90249-P; Bryant DM, 2005, MOL BIOL CELL, V16, P14, DOI 10.1091/mbc.E04-09-0845; Cavey M, 2008, NATURE, V453, P751, DOI 10.1038/nature06953; Chen YT, 1999, J CELL BIOL, V144, P687, DOI 10.1083/jcb.144.4.687; CHOI YS, 1989, J CELL BIOL, V108, P2449, DOI 10.1083/jcb.108.6.2449; Daniels DL, 2002, MOL CELL, V10, P573, DOI 10.1016/S1097-2765(02)00631-7; Davis MA, 2006, DEV CELL, V10, P21, DOI 10.1016/j.devcel.2005.12.004; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; DETRICK RJ, 1990, NEURON, V4, P493, DOI 10.1016/0896-6273(90)90108-R; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; FRANCOIS V, 1995, CELL, V80, P19, DOI 10.1016/0092-8674(95)90446-8; Fung WY, 2007, DEV BIOL, V311, P95, DOI 10.1016/j.ydbio.2007.08.016; Gates J, 2005, CELL, V123, P769, DOI 10.1016/j.cell.2005.11.009; Georgas K, 2000, DEV DYNAM, V219, P582, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1072>3.0.CO;2-I; Glienke J, 2002, MECH DEVELOP, V119, P165, DOI 10.1016/S0925-4773(02)00355-6; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Gurdon JB, 1997, METHOD CELL BIOL, V52, P53, DOI 10.1016/S0091-679X(08)60373-8; Haigo SL, 2003, CURR BIOL, V13, P2125, DOI 10.1016/j.cub.2003.11.054; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; Heasman J, 2000, DEV BIOL, V222, P124, DOI 10.1006/dbio.2000.9720; HEASMAN J, 1994, DEVELOPMENT, V120, P49; HEMMATIBRIVANLOU A, 1990, DEVELOPMENT, V110, P325; Kametani Y, 2007, NAT CELL BIOL, V9, P92, DOI 10.1038/ncb1520; Kim HS, 1997, P NATL ACAD SCI USA, V94, P12981, DOI 10.1073/pnas.94.24.12981; Kinna G, 2006, MECH DEVELOP, V123, P277, DOI 10.1016/j.mod.2006.01.003; Kofron M, 1997, DEVELOPMENT, V124, P1553; Kolle G, 2003, DEV DYNAM, V226, P107, DOI 10.1002/dvdy.10204; Kolle G, 2000, MECH DEVELOP, V90, P181, DOI 10.1016/S0925-4773(99)00248-8; Latinkic BV, 2003, DEVELOPMENT, V130, P2429, DOI 10.1242/dev.00449; Lovicu FJ, 2000, MECH DEVELOP, V94, P261, DOI 10.1016/S0925-4773(00)00292-6; Marambaud P, 2002, EMBO J, V21, P1948, DOI 10.1093/emboj/21.8.1948; Maretzky T, 2005, P NATL ACAD SCI USA, V102, P9182, DOI 10.1073/pnas.0500918102; Nandadasa S, 2009, N E CADHERINS XENOPU; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Pennisi DJ, 2007, DEV DYNAM, V236, P502, DOI 10.1002/dvdy.21015; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; SASAI Y, 1995, NATURE, V376, P333, DOI 10.1038/376333a0; SASAI Y, 1994, CELL, V79, P779, DOI 10.1016/0092-8674(94)90068-X; Smith AN, 2005, DEV BIOL, V285, P477, DOI 10.1016/j.ydbio.2005.07.019; Tao QH, 2007, DEVELOPMENT, V134, P2651, DOI 10.1242/dev.002824; Wallingford JB, 2005, AM J MED GENET C, V135C, P59, DOI 10.1002/ajmg.c.30054; Wilkinson L, 2003, J BIOL CHEM, V278, P34181, DOI 10.1074/jbc.M301247200; Wilkinson L, 2007, J AM SOC NEPHROL, V18, P1697, DOI 10.1681/ASN.2006091012; Xu L, 2002, EXP EYE RES, V74, P753, DOI 10.1006/exer.2002.1175; Yap AS, 2003, J CELL BIOL, V160, P11, DOI 10.1083/jcb.200208156; Zhong Y, 1999, J CELL BIOL, V144, P351, DOI 10.1083/jcb.144.2.351	49	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e32635	10.1371/journal.pone.0032635	http://dx.doi.org/10.1371/journal.pone.0032635			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427856	gold, Green Published, Green Submitted			2022-12-25	WOS:000302381500028
J	Schneider, AC; Beguin, P; Bourez, S; Perfield, JW; Mignolet, E; Debier, C; Schneider, YJ; Larondelle, Y				Schneider, Anne-Catherine; Beguin, Pauline; Bourez, Sophie; Perfield, James W., II; Mignolet, Eric; Debier, Cathy; Schneider, Yves-Jacques; Larondelle, Yvan			Conversion of t11t13 CLA into c9t11 CLA in Caco-2 Cells and Inhibition by Sterculic Oil	PLOS ONE			English	Article							CONJUGATED LINOLEIC-ACID; TRANS-VACCENIC ACID; ALPHA-ELEOSTEARIC ACID; INTESTINAL DIGESTIBILITY; PUNICIC ACID; FATTY-ACIDS; DAIRY-COWS; SERUM-FREE; CIS-9; MECHANISMS	Background: Conjugated linoleic acids (CLA), and principally c9t11 CLA, are suspected to have numerous preventive properties regarding non-infectious pathologies such as inflammatory diseases, atherosclerosis and several types of cancer. C9t11 CLA is produced in the rumen during biohydrogenation of linoleic acid, but can also be synthesized in mammalian tissues from trans-vaccenic acid (C18:1 t11) through the action of delta-9 desaturase (D9D). For several years, it is also known that c9t11 CLA can be synthesized from conjugated linolenic acids (CLnA), i.e. c9t11c13 CLnA and c9t11t13 CLnA. This study aimed at investigating to which extent and by which route c9t11 CLA can be produced from another isomer of CLA, the t11t13 CLA that is structurally very similar to c9t11t13 CLnA, in Caco-2 cells. Methodology/Principal Findings: Caco-2 cells were incubated for 24 h with 20 mu mol/l of t11t13 CLA in the absence or presence of sterculic oil used as an inhibitor of D9D. Caco-2 cells were able to convert t11t13 CLA into c9t11 CLA, and c9t11t13 CLnA was formed as an intermediate compound. In the presence of sterculic oil, the production of this intermediate was decreased by 46% and the formation of c9t11 CLA was decreased by 26%. No other metabolite was detected. Conclusions/Significance: These results not only highlight the conversion of t11t13 CLA into c9t11 CLA but demonstrate also that this conversion involves first a desaturation step catalysed by D9D to produce c9t11t13 CLnA and then the action of another enzyme reducing the double bond on the Delta 13 position.	[Schneider, Anne-Catherine; Beguin, Pauline; Bourez, Sophie; Mignolet, Eric; Debier, Cathy; Schneider, Yves-Jacques; Larondelle, Yvan] Catholic Univ Louvain, Inst Sci Vie, B-1348 Louvain, Belgium; [Perfield, James W., II] Univ Missouri, Columbia, MO USA	Universite Catholique Louvain; University of Missouri System; University of Missouri Columbia	Schneider, AC (corresponding author), Catholic Univ Louvain, Inst Sci Vie, B-1348 Louvain, Belgium.	yvan.larondelle@uclouvain.be			FSR (Fonds Special de Recherche) of the UCLouvain	FSR (Fonds Special de Recherche) of the UCLouvain	This work was supported by grants from the FSR (Fonds Special de Recherche) of the UCLouvain. ACS is a fellow of the FRIA (Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture) of the Communaute francaise de Belgique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badinga Lokenga, 2006, Nutr Clin Pract, V21, P367, DOI 10.1177/0115426506021004367; Bassaganya-Riera J, 2002, CLIN NUTR, V21, P451, DOI 10.1054/clnu.2002.0594; Belury MA, 2002, J NUTR, V132, P2995, DOI 10.1093/jn/131.10.2995; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chen BQ, 2003, WORLD J GASTROENTERO, V9, P1909, DOI 10.3748/wjg.v9.i9.1909; CHRISTIE WW, 1982, J LIPID RES, V23, P1072; Corl BA, 2001, J NUTR BIOCHEM, V12, P622, DOI 10.1016/S0955-2863(01)00180-2; Degen C, 2011, BBA-MOL CELL BIOL L, V1811, P1070, DOI 10.1016/j.bbalip.2011.08.005; Doreau M, 2009, LIPIDS, V44, P53, DOI 10.1007/s11745-008-3250-x; Gomez FE, 2003, BIOCHEM BIOPH RES CO, V300, P316; Griinari JM, 2000, J NUTR, V130, P2285, DOI 10.1093/jn/130.9.2285; Huang GD, 2007, ASIA PAC J CLIN NUTR, V16, P432; Guil-Guerrero JL, 2001, J AM OIL CHEM SOC, V78, P477, DOI 10.1007/s11746-001-0289-9; HALLEUX C, 1991, IN VITRO CELL DEV B, V27, P293; Hennessy AA, 2011, LIPIDS, V46, P105, DOI 10.1007/s11745-010-3501-5; IP C, 1991, CANCER RES, V51, P6118; Kay JK, 2004, J DAIRY SCI, V87, P369, DOI 10.3168/jds.S0022-0302(04)73176-8; Khanal R. C., 2004, Pakistan Journal of Nutrition, V3, P72; Kim YS, 2010, J AGR FOOD CHEM, V58, P3177, DOI 10.1021/jf904163k; Kritchevsky D, 2004, LIPIDS, V39, P611, DOI 10.1007/s11745-004-1273-8; Lampen A, 2005, BBA-MOL CELL BIOL L, V1735, P30, DOI 10.1016/j.bbalip.2005.01.007; Loor JJ, 2004, J DAIRY SCI, V87, P2472, DOI 10.3168/jds.S0022-0302(04)73372-X; MacDonald HB, 2000, J AM COLL NUTR, V19, p111S, DOI 10.1080/07315724.2000.10718082; McLeod RS, 2004, AM J CLIN NUTR, V79, p1169S, DOI 10.1093/ajcn/79.6.1169S; Miller A, 2003, LIPIDS, V38, P623, DOI 10.1007/s11745-003-1107-8; Moise AR, 2007, BIOCHEMISTRY-US, V46, P1811, DOI 10.1021/bi062147u; Moise AR, 2004, J BIOL CHEM, V279, P50230, DOI 10.1074/jbc.M409130200; Nakamura MT, 2004, ANNU REV NUTR, V24, P345, DOI 10.1146/annurev.nutr.24.121803.063211; O'Shea M, 2004, AM J CLIN NUTR, V79, p1199S, DOI 10.1093/ajcn/79.6.1199S; PARIZA MW, 1985, CARCINOGENESIS, V6, P591, DOI 10.1093/carcin/6.4.591; Pariza MW, 2000, P SOC EXP BIOL MED, V223, P8, DOI 10.1046/j.1525-1373.2000.22302.x; Renaville B, 2006, BRIT J NUTR, V95, P688, DOI 10.1079/BJN20061717; Reynolds CM, 2008, BRIT J NUTR, V100, P13, DOI 10.1017/S0007114508894329; Santora JE, 2000, J NUTR, V130, P208, DOI 10.1093/jn/130.2.208; Schneider AC, 2011, BR J NUTR IN PRESS; SCHNEIDER YJ, 1989, J IMMUNOL METHODS, V116, P65, DOI 10.1016/0022-1759(89)90314-1; TAKAGI T, 1981, LIPIDS, V16, P546, DOI 10.1007/BF02535054; Tsuzuki T, 2004, J NUTR, V134, P2634, DOI 10.1093/jn/134.10.2634; Tsuzuki T, 2006, J NUTR, V136, P2153, DOI 10.1093/jn/136.8.2153; Turpeinen AM, 2002, AM J CLIN NUTR, V76, P504, DOI 10.1093/ajcn/76.3.504; Van QCD, 2011, ANIM FEED SCI TECH, V169, P1, DOI 10.1016/j.anifeedsci.2011.05.002; Yuan GF, 2009, J FOOD LIPIDS, V16, P148, DOI 10.1111/j.1745-4522.2009.01138.x; Yuan GF, 2009, J SCI FOOD AGR, V89, P1006, DOI 10.1002/jsfa.3547; Yuan GF, 2009, MOL NUTR FOOD RES, V53, P1336, DOI 10.1002/mnfr.200800520	44	34	36	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e32824	10.1371/journal.pone.0032824	http://dx.doi.org/10.1371/journal.pone.0032824			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427892	Green Published, gold			2022-12-25	WOS:000302381500052
J	Vasquez, A; Forsgren, E; Fries, I; Paxton, RJ; Flaberg, E; Szekely, L; Olofsson, TC				Vasquez, Alejandra; Forsgren, Eva; Fries, Ingemar; Paxton, Robert J.; Flaberg, Emilie; Szekely, Laszlo; Olofsson, Tobias C.			Symbionts as Major Modulators of Insect Health: Lactic Acid Bacteria and Honeybees	PLOS ONE			English	Article							MELISSOCOCCUS-PLUTON; DIVERSITY; IDENTIFICATION; RESISTANCE; PROBIOTICS; PHYLOGENY; MUTUALISM; BIOFILMS; CULTURE; FLORA	Lactic acid bacteria (LAB) are well recognized beneficial host-associated members of the microbiota of humans and animals. Yet LAB-associations of invertebrates have been poorly characterized and their functions remain obscure. Here we show that honeybees possess an abundant, diverse and ancient LAB microbiota in their honey crop with beneficial effects for bee health, defending them against microbial threats. Our studies of LAB in all extant honeybee species plus related apid bees reveal one of the largest collections of novel species from the genera Lactobacillus and Bifidobacterium ever discovered within a single insect and suggest a long (>80 mya) history of association. Bee associated microbiotas highlight Lactobacillus kunkeei as the dominant LAB member. Those showing potent antimicrobial properties are acquired by callow honey bee workers from nestmates and maintained within the crop in biofilms, though beekeeping management practices can negatively impact this microbiota. Prophylactic practices that enhance LAB, or supplementary feeding of LAB, may serve in integrated approaches to sustainable pollinator service provision. We anticipate this microbiota will become central to studies on honeybee health, including colony collapse disorder, and act as an exemplar case of insect-microbe symbiosis.	[Vasquez, Alejandra; Olofsson, Tobias C.] Lund Univ, Dept Lab Med, Lund, Sweden; [Forsgren, Eva; Fries, Ingemar] Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden; [Paxton, Robert J.] Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland; [Paxton, Robert J.] Univ Halle Wittenberg, Inst Biol, Halle, Saale, Germany; [Flaberg, Emilie; Szekely, Laszlo] Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, Stockholm, Sweden	Lund University; Swedish University of Agricultural Sciences; Queens University Belfast; Martin Luther University Halle Wittenberg; Karolinska Institutet	Vasquez, A (corresponding author), Lund Univ, Dept Lab Med, Lund, Sweden.	Alejandra.Vasquez@med.lu.se; Tobias.Olofsson@med.lu.se	Paxton, Robert John/D-7082-2015; Szekely, Laszlo/B-1268-2009	Paxton, Robert John/0000-0003-2517-1351; Szekely, Laszlo/0000-0001-6144-6573	Gyllenstierna Krapperup's Foundation; Ekhaga Foundation; Swedish Board of Agriculture; Swedish Research Council Formas; EU [244956]; Biotechnology and Biological Sciences Research Council's Insect Pollinators Initiative [BB/I000100/1]; European Science Foundation COST (European Cooperation in Science and Technology) network COLOSS [FA0803]; city authorities of Helsingborg; BBSRC [BB/I000100/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I000100/1] Funding Source: researchfish	Gyllenstierna Krapperup's Foundation; Ekhaga Foundation; Swedish Board of Agriculture; Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); EU(European Commission); Biotechnology and Biological Sciences Research Council's Insect Pollinators Initiative(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Science Foundation COST (European Cooperation in Science and Technology) network COLOSS; city authorities of Helsingborg; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by grants from the Gyllenstierna Krapperup's Foundation, Ekhaga Foundation, the Swedish Board of Agriculture, The Swedish Research Council Formas, the EU FP7 project BeeDoc (244956), the Biotechnology and Biological Sciences Research Council's Insect Pollinators Initiative (grant BB/I000100/1), and the European Science Foundation COST (European Cooperation in Science and Technology) network COLOSS (FA0803). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank photographer Lennart Nilsson and the city authorities of Helsingborg that supported his work. We are grateful for the bee samples provided by Luis Medina, Mexico; Farooq Ahmad, Nepal; Mananya Phaincharoen, Thailand, Mappatoba Sila, Indonesia; and Joseph Macharia, Kenya. We are thankful for the time we spent on Borneo at the Agricultural Research Station, Tenom, Malaysia, working with Hubert Lim.	Axelsson L.T., 1989, MICROB ECOL HEALTH D, V2, P131, DOI [DOI 10.3109/08910608909140210, 10.3109/08910608909140210]; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; BAILEY L, 1982, J APPL BACTERIOL, V53, P215, DOI 10.1111/j.1365-2672.1982.tb04679.x; BELL PB, 1988, SCANNING MICROSCOPY, V2, P1647; Cano J, 2004, J CLIN MICROBIOL, V42, P2450, DOI 10.1128/JCM.42.6.2450-2454.2004; Cardinal S, 2010, P NATL ACAD SCI USA, V107, P16207, DOI 10.1073/pnas.1006299107; Champagn CP, 2011, INT J FOOD MICROBIOL, V149, P185, DOI 10.1016/j.ijfoodmicro.2011.07.005; Chung T. C., 1989, MICROB ECOL HEALTH D, V2, P137, DOI DOI 10.3109/08910608909140211; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Crane E, WORLD HIST BEEKEEPIN; De Vuyst L, 2001, INT DAIRY J, V11, P687, DOI 10.1016/S0958-6946(01)00114-5; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; DOMINGUE PAG, 1991, GENITOURIN MED, V67, P226; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Edwards CG, 1998, J APPL MICROBIOL, V84, P698, DOI 10.1046/j.1365-2672.1998.00399.x; Euzeby J. P., LIST PROKARYOTIC NAM; Evans Jay D., 2006, BMC Ecology, V6, P4, DOI 10.1186/1472-6785-6-4; Evans JD, 2004, J ECON ENTOMOL, V97, P752, DOI 10.1603/0022-0493(2004)097[0752:BPIAIR]2.0.CO;2; FAO/WHO, 2002, GUIDELINES EVALUATIO, P1; FDA, 2005, APPR TYLAN SOL CONTR; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Forsgren E, 2010, APIDOLOGIE, V41, P99, DOI 10.1051/apido/2009065; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Gorbach S, 2004, HUMAN STUDIES PROBIO; Hammes W, 2006, GENERA LACTOBACILLUS, P320, DOI DOI 10.1007/0-387-30744-3_10; Hornitzky MAZ, 1998, J APICULT RES, V37, P293, DOI 10.1080/00218839.1998.11100987; Hotel ACP., 2001, PREVENTION, V5, P1; Huang YC, 1996, AM J ENOL VITICULT, V47, P1; Hughes DP, 2008, TRENDS ECOL EVOL, V23, P672, DOI 10.1016/j.tree.2008.07.011; Jolly L, 2002, ANTON LEEUW INT J G, V82, P367, DOI 10.1023/A:1020668523541; Jones SE, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-35; Klaenhammer T, 2002, ANTON LEEUW INT J G, V82, P29, DOI 10.1023/A:1020638309912; Lebeer S, 2007, APPL ENVIRON MICROB, V73, P6768, DOI 10.1128/AEM.01393-07; Ludwig W, 1998, ELECTROPHORESIS, V19, P554, DOI 10.1002/elps.1150190416; Maarit M, 2004, LACTIC ACID BACTERIA; Macfarlane S, 2007, J APPL MICROBIOL, V102, P1187, DOI 10.1111/j.1365-2672.2007.03287.x; Magnusson J, 2003, FEMS MICROBIOL LETT, V219, P129, DOI 10.1016/S0378-1097(02)01207-7; Martinson Vincent G, 2011, MOL ECOLOGY, V20; Mohr KI, 2006, ENVIRON MICROBIOL, V8, P258, DOI 10.1111/j.1462-2920.2005.00893.x; Moritz RFA, 2010, APIDOLOGIE, V41, P227, DOI 10.1051/apido/2010010; Morse RA, ILLUSTRATED ENCY BEE; Moubareck C, 2005, J ANTIMICROB CHEMOTH, V55, P38, DOI 10.1093/jac/dkh495; Olofsson TC, 2011, APIDOLOGIE, P1; Olofsson TC, 2008, CURR MICROBIOL, V57, P356, DOI 10.1007/s00284-008-9202-0; Pettis JS, 2010, APIDOLOGIE, V41, P256, DOI 10.1051/apido/2010013; Rajilic-Stojanovic M, 2007, ENVIRON MICROBIOL, V9, P2125, DOI 10.1111/j.1462-2920.2007.01369.x; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; Ammor MS, 2007, FOOD MICROBIOL, V24, P559, DOI 10.1016/j.fm.2006.11.001; Servin AL, 2004, FEMS MICROBIOL REV, V28, P405, DOI 10.1016/j.femsre.2004.01.003; Silverman N, 2008, SCIENCE, V319, P734, DOI 10.1126/science.1154209; TALARICO TL, 1989, ANTIMICROB AGENTS CH, V33, P674, DOI 10.1128/AAC.33.5.674; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Vasquez A, 2009, J APICULT RES, V48, P189, DOI 10.3896/IBRA.1.48.3.07; Vasquez A, 2009, APIDOLOGIE, V40, P26, DOI 10.1051/apido:2008063; Ventura M, 2009, NAT REV MICROBIOL, V7, P61, DOI 10.1038/nrmicro2047; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Wilson-Rich N, 2009, ANNU REV ENTOMOL, V54, P405, DOI 10.1146/annurev.ento.53.103106.093301	57	321	338	8	216	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33188	10.1371/journal.pone.0033188	http://dx.doi.org/10.1371/journal.pone.0033188			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427985	Green Published, gold, Green Submitted			2022-12-25	WOS:000302381500108
J	Meyer, D; Voigt, A; Widmayer, P; Borth, H; Huebner, S; Breit, A; Marschall, S; de Angelis, MH; Boehm, U; Meyerhof, W; Gudermann, T; Boekhoff, I				Meyer, Dorke; Voigt, Anja; Widmayer, Patricia; Borth, Heike; Huebner, Sandra; Breit, Andreas; Marschall, Susan; de Angelis, Martin Hrabe; Boehm, Ulrich; Meyerhof, Wolfgang; Gudermann, Thomas; Boekhoff, Ingrid			Expression of Tas1 Taste Receptors in Mammalian Spermatozoa: Functional Role of Tas1r1 in Regulating Basal Ca2+ and cAMP Concentrations in Spermatozoa	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; FEMALE REPRODUCTIVE-TRACT; MALE GERM-CELLS; ACROSOME REACTION; UMAMI TASTE; SPERM CAPACITATION; KNOCKOUT MICE; AMINO-ACID; MOLECULAR-BASIS	Background: During their transit through the female genital tract, sperm have to recognize and discriminate numerous chemical compounds. However, our current knowledge of the molecular identity of appropriate chemosensory receptor proteins in sperm is still rudimentary. Considering that members of the Tas1r family of taste receptors are able to discriminate between a broad diversity of hydrophilic chemosensory substances, the expression of taste receptors in mammalian spermatozoa was examined. Methodology/Principal Findings: The present manuscript documents that Tas1r1 and Tas1r3, which form the functional receptor for monosodium glutamate (umami) in taste buds on the tongue, are expressed in murine and human spermatozoa, where their localization is restricted to distinct segments of the flagellum and the acrosomal cap of the sperm head. Employing a Tas1r1-deficient mCherry reporter mouse strain, we found that Tas1r1 gene deletion resulted in spermatogenic abnormalities. In addition, a significant increase in spontaneous acrosomal reaction was observed in Tas1r1 null mutant sperm whereas acrosomal secretion triggered by isolated zona pellucida or the Ca2+ ionophore A23187 was not different from wild-type spermatozoa. Remarkably, cytosolic Ca2+ levels in freshly isolated Tas1r1-deficient sperm were significantly higher compared to wild-type cells. Moreover, a significantly higher basal cAMP concentration was detected in freshly isolated Tas1r1-deficient epididymal spermatozoa, whereas upon inhibition of phosphodiesterase or sperm capacitation, the amount of cAMP was not different between both genotypes. Conclusions/Significance: Since Ca2+ and cAMP control fundamental processes during the sequential process of fertilization, we propose that the identified taste receptors and coupled signaling cascades keep sperm in a chronically quiescent state until they arrive in the vicinity of the egg - either by constitutive receptor activity and/or by tonic receptor activation by gradients of diverse chemical compounds in different compartments of the female reproductive tract.	[Meyer, Dorke; Borth, Heike; Breit, Andreas; Gudermann, Thomas; Boekhoff, Ingrid] Univ Munich, Walther Straub Inst Pharmacol & Toxicol, Munich, Germany; [Voigt, Anja; Huebner, Sandra; Meyerhof, Wolfgang] German Inst Nutr, Potsdam, Germany; [Voigt, Anja; Boehm, Ulrich] Univ Hamburg, Ctr Mol Neurobiol, Inst Neural Signal Transduct, D-2000 Hamburg, Germany; [Widmayer, Patricia] Univ Hohenheim, Inst Physiol, D-7000 Stuttgart, Germany; [Marschall, Susan; de Angelis, Martin Hrabe] Helmholtz Zentrum, Inst Expt Genet, Munich, Germany	University of Munich; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); University of Hamburg; University Hohenheim; Helmholtz Association	Meyer, D (corresponding author), Univ Munich, Walther Straub Inst Pharmacol & Toxicol, Munich, Germany.	ingrid.boekhoff@lrz.uni-muenchen.de	de Angelis, Martin Hrabe/F-5531-2012	de Angelis, Martin Hrabe/0000-0002-7898-2353	Hertie-Exzellenzprogramm Neurowissenschaften; Deutsche Forschungsgemeinschaft [BO 1668/5-1]; Studienstiftung des deutschen Volkes	Hertie-Exzellenzprogramm Neurowissenschaften; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Studienstiftung des deutschen Volkes	Financial support for this work was provided in part by the Hertie-Exzellenzprogramm Neurowissenschaften and the Deutsche Forschungsgemeinschaft (BO 1668/5-1). DM was supported by a scholarship of the Studienstiftung des deutschen Volkes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Haila A, 2009, ARCH BIOCH BIOPHYS; Abou-haila A, 2009, ARCH BIOCHEM BIOPHYS, V485, P72, DOI 10.1016/j.abb.2009.02.003; Anderson ME, 1998, J PHARMACOL EXP THER, V287, P996; Asano M, 1997, EMBO J, V16, P1850, DOI 10.1093/emboj/16.8.1850; AUSTIN CR, 1951, AUST J SCI RES SER B, V4, P581, DOI 10.1071/BI9510581; Aviles M, 1997, HISTOCHEM J, V29, P583, DOI 10.1023/A:1026432211012; Bai M, 2004, CELL SIGNAL, V16, P175, DOI 10.1016/S0898-6568(03)00128-1; Beauchamp GK, 2009, AM J CLIN NUTR, V90, p723S, DOI 10.3945/ajcn.2009.27462E; Behrens M, 2011, PHYSL BEHAV; Behrens M, 2011, ANGEW CHEM INT EDIT, V50, P2220, DOI 10.1002/anie.201002094; Behrens M, 2010, RESULTS PROBL CELL D, V52, P87, DOI 10.1007/978-3-642-14426-4_8; Bergmann M, 2005, UROLOGE, V44, P1131, DOI 10.1007/s00120-005-0909-2; Bhat GK, 2006, J ANDROL, V27, P302, DOI 10.2164/jandrol.05133; Branham MAT, 2006, J BIOL CHEM, V281, P8656, DOI 10.1074/jbc.M508854200; Breitbart H, 2002, J REPROD IMMUNOL, V53, P151, DOI 10.1016/S0165-0378(01)00085-7; BREUCKER H, 1985, CELL TISSUE RES, V240, P303; Buck J, 1999, P NATL ACAD SCI USA, V96, P79, DOI 10.1073/pnas.96.1.79; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Burton KA, 2007, PHYSIOLOGY, V22, P40, DOI 10.1152/physiol.00034.2006; Butler A, 2002, AM J PATHOL, V161, P1061, DOI 10.1016/S0002-9440(10)64267-8; Butscheid Y, 2006, MOL REPROD DEV, V73, P350, DOI 10.1002/mrd.20410; Chang HX, 2010, BIOL REPROD, V83, P507, DOI 10.1095/biolreprod.109.083113; CHANG MC, 1951, NATURE, V168, P697, DOI 10.1038/168697b0; Cheng CY, 2010, NAT REV ENDOCRINOL, V6, P380, DOI 10.1038/nrendo.2010.71; Clapp TR, 2008, FEBS LETT, V582, P3783, DOI 10.1016/j.febslet.2008.10.007; Conigrave AD, 2010, PHARMACOL THERAPEUT, V127, P252, DOI 10.1016/j.pharmthera.2010.04.007; Cooper TG, 2011, ASIAN J ANDROL, V13, P130, DOI 10.1038/aja.2010.97; Corbin JD, 2002, INT J CLIN PRACT, V56, P453; Costello S, 2009, REPRODUCTION, V138, P425, DOI 10.1530/REP-09-0134; Cui M, 2006, CURR PHARM DESIGN, V12, P4591, DOI 10.2174/138161206779010350; Damak S, 2003, SCIENCE, V301, P850, DOI 10.1126/science.1087155; De Blas GA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006095; Deshpande DA, 2010, NAT MED, V16, P1299, DOI 10.1038/nm.2237; Dyer JL, 2003, BIOCHEM BIOPH RES CO, V302, P121, DOI 10.1016/S0006-291X(03)00120-7; Eisenbach M, 2006, NAT REV MOL CELL BIO, V7, P276, DOI 10.1038/nrm1893; Eisenbach M, 1999, DEV GENET, V25, P87, DOI 10.1002/(SICI)1520-6408(1999)25:2&lt;87::AID-DVG2&gt;3.0.CO;2-4; Fehr J, 2007, J COMP PHYSIOL A, V193, P21, DOI 10.1007/s00359-006-0168-8; Festring D, 2011, J AGR FOOD CHEM, V59, P8875, DOI 10.1021/jf202202h; Florman HM, 2010, CELL, V140, P310, DOI 10.1016/j.cell.2010.01.035; Fukuda N, 2004, J CELL SCI, V117, P5835, DOI 10.1242/jcs.01507; Gadella BM, 2008, INT J DEV BIOL, V52, P473, DOI 10.1387/ijdb.082583bg; Galindo-Cuspinera V, 2006, NATURE, V441, P354, DOI 10.1038/nature04765; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Gingrich JA, 2000, CURR OPIN NEUROBIOL, V10, P146, DOI 10.1016/S0959-4388(99)00061-6; Giovannucci DR, 2000, J BIOL CHEM, V275, P33704, DOI 10.1074/jbc.M004278200; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gupta SK, 2009, J REPROD IMMUNOL, V83, P50, DOI 10.1016/j.jri.2009.07.008; Gurevich VV, 2008, TRENDS PHARMACOL SCI, V29, P234, DOI 10.1016/j.tips.2008.02.004; Haid D, 2011, J MOL HISTOL, V42, P355, DOI 10.1007/s10735-011-9339-1; Harris SE, 2005, THERIOGENOLOGY, V64, P992, DOI 10.1016/j.theriogenology.2005.01.004; Hayashi Y, 1996, BIOPHYS J, V71, P1057, DOI 10.1016/S0006-3495(96)79306-2; Heydecke D, 2006, J ANDROL, V27, P390, DOI 10.2164/jandrol.05166; HOLSTEIN AF, 1986, ANDROLOGIA, V18, P5; Huang LQ, 1999, NAT NEUROSCI, V2, P1055, DOI 10.1038/15981; Hunter RHF, 2011, ZYGOTE, V19, P265, DOI 10.1017/S0967199410000341; Iwatsuki K, 2010, BIOCHEM BIOPH RES CO, V402, P495, DOI 10.1016/j.bbrc.2010.10.057; Jaiswal BS, 2003, P NATL ACAD SCI USA, V100, P10676, DOI 10.1073/pnas.1831008100; Janssen S, 2011, P NATL ACAD SCI USA, V108, P2094, DOI 10.1073/pnas.1011508108; Jones R, 2007, ASIAN J ANDROL, V9, P438, DOI 10.1111/j.1745-7262.2007.00282.x; Jozwik M, 2006, HUM REPROD, V21, P2776, DOI 10.1093/humrep/del038; Karasinska JM, 2003, BRAIN RES REV, V41, P125, DOI 10.1016/S0165-0173(02)00221-7; Kaupp UB, 2008, ANNU REV PHYSIOL, V70, P93, DOI 10.1146/annurev.physiol.70.113006.100654; Ke H, 2004, INT J IMPOT RES, V16, pS24, DOI 10.1038/sj.ijir.3901211; Kinnamon SC, 2011, ACTA PHYSL OXF; Kinnamon SC, 2009, ANN NY ACAD SCI, V1170, P55, DOI 10.1111/j.1749-6632.2009.04106.x; Kirkman-Brown JC, 2002, J ANDROL, V23, P306; Kniazeff J, 2011, PHARMACOL THERAPEUT, V130, P9, DOI 10.1016/j.pharmthera.2011.01.006; LEESE HJ, 1981, J REPROD FERTIL, V61, P435, DOI 10.1530/jrf.0.0610435; Lefkowitz RJ, 2007, ACTA PHYSIOL, V190, P9, DOI 10.1111/j.1365-201X.2007.01693.x; Li SF, 2008, ACTA BIOCH BIOPH SIN, V40, P761, DOI 10.1111/j.1745-7270.2008.00453.x; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; Li XD, 2009, AM J CLIN NUTR, V90, p733S, DOI 10.3945/ajcn.2009.27462G; LILLIE RD, 1976, HISTOCHEMISTRY, V49, P23, DOI 10.1007/BF00490123; LIU CM, 1978, J BIOL CHEM, V253, P5892; Liu DY, 1998, HUM REPROD, V13, P905, DOI 10.1093/humrep/13.4.905; Max M, 2001, NAT GENET, V28, P58, DOI 10.1038/88270; Mayorga LS, 2007, IUBMB LIFE, V59, P286, DOI 10.1080/15216540701222872; MCLAUGHLIN SK, 1992, NATURE, V357, P563, DOI 10.1038/357563a0; Mendoza FJ, J ANDROL; Mombaerts P, 1999, SCIENCE, V286, P707, DOI 10.1126/science.286.5440.707; MONESI V, 1967, ARCH ANAT MICROSC MO, V56, P61; Montmayeur JP, 2001, NAT NEUROSCI, V4, P492, DOI 10.1038/87440; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Nixon B, 2001, CELLS TISSUES ORGANS, V168, P46, DOI 10.1159/000016805; Nolan MA, 2004, P NATL ACAD SCI USA, V101, P13483, DOI 10.1073/pnas.0405580101; Parnot C, 2004, NAT STRUCT MOL BIOL, V11, P691, DOI 10.1038/nsmb0804-691; Pin JP, 2009, J PHYSIOL-LONDON, V587, P5337, DOI 10.1113/jphysiol.2009.179978; Pin JP, 2004, BIOL CELL, V96, P335, DOI 10.1016/j.biolcel.2004.03.005; Plaza S, 2010, TRENDS CELL BIOL, V20, P524, DOI 10.1016/j.tcb.2010.06.002; Ploeger LS, 2008, BIOTECH HISTOCHEM, V83, P63, DOI 10.1080/10520290802127586; Publicover S, 2007, NAT CELL BIOL, V9, P235, DOI 10.1038/ncb0307-235; Publicover SJ, 2008, FRONT BIOSCI, V13, P5623; Ramos L, 2001, HUM REPROD, V16, P1703, DOI 10.1093/humrep/16.8.1703; Rossler P, 2000, CHEM SENSES, V25, P413, DOI 10.1093/chemse/25.4.413; Rossler P, 1998, EUR J CELL BIOL, V77, P253; ROTTER V, 1993, P NATL ACAD SCI USA, V90, P9075, DOI 10.1073/pnas.90.19.9075; Rozengurt E, 2007, CURR OPIN PHARMACOL, V7, P557, DOI 10.1016/j.coph.2007.10.002; RUIZAVILA L, 1995, NATURE, V376, P80, DOI 10.1038/376080a0; Schneider M, 2009, FASEB J, V23, P3233, DOI 10.1096/fj.09-132795; Schreiber S, 2000, J BIOL CHEM, V275, P24115, DOI 10.1074/jbc.M001876200; Schuh K, 2004, J BIOL CHEM, V279, P28220, DOI 10.1074/jbc.M312599200; Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0; Seita Y, 2009, BIOL REPROD, V80, P503, DOI 10.1095/biolreprod.108.072918; Shaha C, 2010, PHILOS T R SOC B, V365, P1501, DOI 10.1098/rstb.2009.0124; Sheriff Dhastagir Sultan, 2010, J Hum Reprod Sci, V3, P68, DOI 10.4103/0974-1208.69337; SHI YB, 1994, BBA-GENE STRUCT EXPR, V1217, P227, DOI 10.1016/0167-4781(94)90042-6; SNYDER SH, 1989, TRENDS NEUROSCI, V12, P35, DOI 10.1016/0166-2236(89)90154-9; Sohara E, 2007, FERTIL STERIL, V87, P671, DOI 10.1016/j.fertnstert.2006.07.1522; Spehr M, 2003, SCIENCE, V299, P2054, DOI 10.1126/science.1080376; Suarez SS, 2006, HUM REPROD UPDATE, V12, P23, DOI 10.1093/humupd/dmi047; Sutton KA, 2008, P NATL ACAD SCI USA, V105, P8661, DOI 10.1073/pnas.0800603105; TALBOT P, 1976, J EXP ZOOL, V198, P383, DOI 10.1002/jez.1401980312; Tizzano M, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-3; Tovey SC, 2010, J BIOL CHEM, V285, P12979, DOI 10.1074/jbc.M109.096016; Valet P, 2002, J LIPID RES, V43, P835; VANDERHAEGHEN P, 1993, J CELL BIOL, V123, P1441, DOI 10.1083/jcb.123.6.1441; Vanderhaeghen P, 1997, GENOMICS, V39, P239, DOI 10.1006/geno.1996.4490; Veitinger T, 2011, J BIOL CHEM, V286, P17311, DOI 10.1074/jbc.M110.211524; Visconti PE, 2011, ASIAN J ANDROL, V13, P395, DOI 10.1038/aja.2010.69; Visconti PE, 1998, J ANDROL, V19, P242; Visconti PE, 1998, BIOL REPROD, V59, P1, DOI 10.1095/biolreprod59.1.1; Vogt PH, 2004, CURR PHARM DESIGN, V10, P471, DOI 10.2174/1381612043453261; WALENSKY LD, 1995, MOL MED, V1, P130, DOI 10.1007/BF03401561; Walker WH, 2010, PHILOS T R SOC B, V365, P1557, DOI 10.1098/rstb.2009.0258; Wassarman PM, 2008, INT J DEV BIOL, V52, P665, DOI 10.1387/ijdb.072524pw; Wellendorph P, 2009, BRIT J PHARMACOL, V156, P869, DOI 10.1111/j.1476-5381.2008.00078.x; Wellendorph P, 2007, GENE, V396, P257, DOI 10.1016/j.gene.2007.03.008; Wennemuth G, 2000, J BIOL CHEM, V275, P21210, DOI 10.1074/jbc.M002068200; Wennemuth G, 2003, J GEN PHYSIOL, V122, P115, DOI 10.1085/jgp.200308839; Winnig M, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-22; Winnig M, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-66; Witte TS, 2007, ANIM REPROD SCI, V102, P181, DOI 10.1016/j.anireprosci.2007.07.007; Wojcikiewicz RJH, 1998, J BIOL CHEM, V273, P5670, DOI 10.1074/jbc.273.10.5670; Yan KS, 2009, GUT, V58, P897, DOI 10.1136/gut.2008.173021; Yan WT, 2001, AM J PHYSIOL-CELL PH, V280, pC742, DOI 10.1152/ajpcell.2001.280.4.C742; Yarmolinsky DA, 2009, CELL, V139, P234, DOI 10.1016/j.cell.2009.10.001; Zeginiadou T, 2000, ANDROLOGIA, V32, P335, DOI 10.1046/j.1439-0272.2000.00359.x; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4; ZIEGLER BL, 1992, BIOTECHNIQUES, V13, P726	140	50	54	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2012	7	2							e32354	10.1371/journal.pone.0032354	http://dx.doi.org/10.1371/journal.pone.0032354			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928SI	22427794	gold, Green Submitted, Green Published			2022-12-25	WOS:000303003500052
J	Li, XY; Mai, JT; Virtue, A; Yin, Y; Gong, R; Sha, XJ; Gutchigian, S; Frisch, A; Hodge, I; Jiang, XH; Wang, H; Yang, XF				Li, Xinyuan; Mai, Jietang; Virtue, Anthony; Yin, Ying; Gong, Ren; Sha, Xiaojin; Gutchigian, Stefanie; Frisch, Andrew; Hodge, Imani; Jiang, Xiaohua; Wang, Hong; Yang, Xiao-Feng			IL-35 Is a Novel Responsive Anti-inflammatory Cytokine - A New System of Categorizing Anti-inflammatory Cytokines	PLOS ONE			English	Article							REGULATORY T-CELLS; DNA METHYLATION; GENE-EXPRESSION; PROTEIN; ATHEROSCLEROSIS; INDUCTION; IDENTIFICATION; PROLIFERATION; HOMOCYSTEINE; INFLAMMATION	It remains unknown whether newly identified anti-inflammatory/immunosuppressive cytokine interleukin-35 (IL-35) is different from other anti-inflammatory cytokines such as IL-10 and transforming growth factor (TGF)-beta in terms of inhibition of inflammation initiation and suppression of full-blown inflammation. Using experimental database mining and statistical analysis methods we developed, we examined the tissue expression profiles and regulatory mechanisms of IL-35 in comparison to other anti-inflammatory cytokines. Our results suggest that in contrast to TGF-beta, IL-35 is not constitutively expressed in human tissues but it is inducible in response to inflammatory stimuli. We also provide structural evidence that AU-rich element (ARE) binding proteins and microRNAs target IL-35 subunit transcripts, by which IL-35 may achieve non-constitutive expression status. Furthermore, we propose a new system to categorize anti-inflammatory cytokines into two groups: (1) the house-keeping cytokines, such as TGF-beta, inhibit the initiation of inflammation whereas (2) the responsive cytokines including IL-35 suppress inflammation in full-blown stage. Our in-depth analyses of molecular events that regulate the production of IL-35 as well as the new categorization system of anti-inflammatory cytokines are important for the design of new strategies of immune therapies.	[Li, Xinyuan] Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19122 USA; Temple Univ, Sch Med, Cardiovasc Res Ctr, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Li, XY (corresponding author), Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19122 USA.	xfyang@temple.edu	Li, Xinyuan/B-1139-2015; Li, Xinyuan/Z-6299-2019	Li, Xinyuan/0000-0002-6746-8367; Li, Xinyuan/0000-0002-6746-8367; Frisch, Andrew/0000-0002-0080-9147	National Institutes of Health [HL094451, HL108910, HL67033, HL82774, HL77288]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082774, R01HL094451, R01HL117654, R01HL077288, R01HL067033, R01HL108910] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health grants HL094451 and HL108910 (XFY), HL67033, HL82774 and HL77288 (HW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Oufella H, 2006, NAT MED, V12, P178, DOI 10.1038/nm1343; Asirvatham AJ, 2009, CYTOKINE, V45, P58, DOI 10.1016/j.cyto.2008.11.010; Bakheet T, 2006, NUCLEIC ACIDS RES, V34, pD111, DOI 10.1093/nar/gkj052; Bardel E, 2008, J IMMUNOL, V181, P6898, DOI 10.4049/jimmunol.181.10.6898; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bettini M, 2009, CURR OPIN IMMUNOL, V21, P612, DOI 10.1016/j.coi.2009.09.011; Bobik A, 2006, ARTERIOSCL THROM VAS, V26, P1712, DOI 10.1161/01.ATV.0000225287.20034.2c; Boraschi D, 2006, EUR CYTOKINE NETW, V17, P224; Caligiuri G, 2003, MOL MED, V9, P10, DOI 10.1007/BF03402102; Caudill MA, 2001, J NUTR, V131, P2811, DOI 10.1093/jn/131.11.2811; Chaturvedi V, 2011, J IMMUNOL, V186, P6661, DOI 10.4049/jimmunol.1100315; Chen NC, 2010, FASEB J, V24, P2804, DOI 10.1096/fj.09-143651; Chiu IM, 2001, PROG NUCLEIC ACID RE, V70, P155, DOI 10.1016/S0079-6603(01)70016-5; Collison L.W., 2012, NAT IMMUNOL; Collison LW, 2008, IMMUNOL REV, V226, P248, DOI 10.1111/j.1600-065X.2008.00704.x; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Collison LW, 2010, NAT IMMUNOL, V11, P1093, DOI 10.1038/ni.1952; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Cua DJ, 1999, J EXP MED, V189, P1005, DOI 10.1084/jem.189.6.1005; Cua DJ, 2001, J IMMUNOL, V166, P602, DOI 10.4049/jimmunol.166.1.602; Davuluri RV, 2008, TRENDS GENET, V24, P167, DOI 10.1016/j.tig.2008.01.008; Devergne O, 1996, J VIROL, V70, P1143, DOI 10.1128/JVI.70.2.1143-1153.1996; Devergne O, 1997, P NATL ACAD SCI USA, V94, P12041, DOI 10.1073/pnas.94.22.12041; Dinarello CA, 2009, NEW ENGL J MED, V360, P2467, DOI 10.1056/NEJMe0811014; Gallagher WM, 2005, CARCINOGENESIS, V26, P1856, DOI 10.1093/carcin/bgi152; Holloway Dustin T, 2005, Genome Inform, V16, P83; Homma Y, 2007, J INTERF CYTOK RES, V27, P799, DOI 10.1089/jir.2007.0006; Huang CH, 2011, J IMMUNOL, V187, P462, DOI 10.4049/jimmunol.1100259; Ikushima H, 2011, CELL TISSUE RES; Jalonen U, 2006, MEDIAT INFLAMM, V2006, DOI 10.1155/MI/2006/40691; Jamaluddin MS, 2007, CLIN CHEM LAB MED, V45, P1660, DOI 10.1515/CCLM.2007.350; James SJ, 2002, J NUTR, V132, p2361S, DOI 10.1093/jn/132.8.2361S; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Kim Y, 2006, NATURE, V442, P814, DOI 10.1038/nature04976; KUBIN M, 1994, J EXP MED, V180, P211, DOI 10.1084/jem.180.1.211; LI J, 2009, GENES NUTR; MACDONALD SM, 1995, SCIENCE, V269, P688, DOI 10.1126/science.7542803; Mai JT, 2010, FRONT BIOSCI-LANDMRK, V15, P986, DOI 10.2741/3657; Medzhitov R, 2011, NAT REV IMMUNOL, V11, P693, DOI 10.1038/nri3063; Naeem Haroon, 2010, BMC Bioinformatics, V11, P135, DOI 10.1186/1471-2105-11-135; Narverud I, 2011, ATHEROSCLEROSIS, V214, P163, DOI 10.1016/j.atherosclerosis.2010.10.002; Niedbala W, 2007, EUR J IMMUNOL, V37, P3021, DOI 10.1002/eji.200737810; O'Shea JJ, 2002, NAT REV IMMUNOL, V2, P37, DOI 10.1038/nri702; Ordovas JM, 2010, NAT REV CARDIOL, V7, P510, DOI 10.1038/nrcardio.2010.104; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Poleganov MA, 2008, MOL IMMUNOL, V45, P2869, DOI 10.1016/j.molimm.2008.01.021; Rasmussen KD, 2010, J EXP MED, V207, P1351, DOI 10.1084/jem.20100458; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P331, DOI 10.1016/j.cytogfr.2010.09.002; Sahoo A, 2010, INT REV IMMUNOL, V29, P77, DOI 10.3109/08830180903349651; Salmaggi A, 1996, J NEUROL, V243, P13; Sethupathy P, 2006, RNA, V12, P192, DOI 10.1261/rna.2239606; Szyf M, 2010, CLIN REV ALLERG IMMU, V39, P62, DOI 10.1007/s12016-009-8172-8; Tedgui A, 2006, PHYSIOL REV, V86, P515, DOI 10.1152/physrev.00024.2005; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; UELAND PM, 1984, J BIOL CHEM, V259, P2360; Virtue A, 2011, FRONT BIOSCI-LANDMRK, V16, P3133, DOI 10.2741/3901; Wilson CB, 2009, NAT REV IMMUNOL, V9, P91, DOI 10.1038/nri2487; Wirtz S, 2011, GASTROENTEROLOGY; Xiong Z, 2008, FRONT BIOSCI-LANDMRK, V13, P7143, DOI 10.2741/3217; Xiong ZY, 2009, ATHEROSCLEROSIS, V203, P401, DOI 10.1016/j.atherosclerosis.2008.07.041; Yamashita H, 2003, AM J CARDIOL, V91, P133, DOI 10.1016/S0002-9149(02)03097-7; Yang Y, 2005, ONCOGENE, V24, P4778, DOI 10.1038/sj.onc.1208666; Yin Y, 2009, INT J IMMUNOPATH PH, V22, P311, DOI 10.1177/039463200902200208; Zandian M, 2011, GENE THER; Zhang CX, 2008, CLIN SCI, V114, P699, DOI 10.1042/CS20070211; Zill P, 2002, NEUROPSYCHOPHARMACOL, V26, P489, DOI 10.1016/S0893-133X(01)00386-4	67	178	200	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33628	10.1371/journal.pone.0033628	http://dx.doi.org/10.1371/journal.pone.0033628			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	22438968	Green Published, gold			2022-12-25	WOS:000303309100074
J	Castellano, JF; Fletcher, BR; Kelley-Bell, B; Kim, DH; Gallagher, M; Rapp, PR				Castellano, James F.; Fletcher, Bonnie R.; Kelley-Bell, Bennett; Kim, David H.; Gallagher, Michela; Rapp, Peter R.			Age-Related Memory Impairment Is Associated with Disrupted Multivariate Epigenetic Coordination in the Hippocampus	PLOS ONE			English	Article							SPATIAL-LEARNING IMPAIRMENT; GYRUS GRANULE NEURONS; LONG-TERM-MEMORY; SYNAPTIC PLASTICITY; TRANSCRIPTIONAL ACTIVATION; HISTONE ACETYLATION; RAT HIPPOCAMPUS; PHOSPHORYLATION; INHIBITORS; INDUCTION	Mounting evidence linking epigenetic regulation to memory-related synaptic plasticity raises the possibility that altered chromatin modification dynamics might contribute to age-dependent cognitive decline. Here we show that the coordinated orchestration of both baseline and experience-dependent epigenetic regulation seen in the young adult hippocampus is lost in association with cognitive aging. Using a well-characterized rat model that reliably distinguishes aged individuals with significant memory impairment from others with normal memory, no single epigenetic mark or experience-dependent modification in the hippocampus uniquely predicted differences in the cognitive outcome of aging. The results instead point to a multivariate pattern in which modification-specific, bidirectional chromatin regulation is dependent on recent behavioral experience, chronological age, cognitive status, and hippocampal region. Whereas many epigenetic signatures were coupled with memory capacity among young adults and aged rats with preserved cognitive function, such associations were absent among aged rats with deficits in hippocampal memory. By comparison with the emphasis in current preclinical translational research on promoting chromatin modifications permissive for gene expression, our findings suggest that optimally successful hippocampal aging may hinge instead on enabling coordinated control across the epigenetic landscape.	[Castellano, James F.; Fletcher, Bonnie R.; Kelley-Bell, Bennett; Kim, David H.; Rapp, Peter R.] NIA, Lab Expt Gerontol, Baltimore, MD 21224 USA; [Castellano, James F.] Mt Sinai Sch Med, Grad Program Neurosci, New York, NY USA; [Gallagher, Michela] Johns Hopkins Univ, Dept Psychol & Brain Sci, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Icahn School of Medicine at Mount Sinai; Johns Hopkins University	Castellano, JF (corresponding author), NIA, Lab Expt Gerontol, Baltimore, MD 21224 USA.	rappp@mail.nih.gov		Gallagher, Michela/0000-0002-9585-6500	National Institute on Aging; National Institutes of Health [AG09973, AG032845]; NATIONAL INSTITUTE ON AGING [P01AG009973, ZIAAG000350, F30AG032845] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported in part by the Intramural Research Program of the National Institute on Aging, and by National Institutes of Health grants AG09973 (MG) and AG032845 (JFC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; Bilang-Bleuel A, 2005, EUR J NEUROSCI, V22, P1691, DOI 10.1111/j.1460-9568.2005.04358.x; Bousiges O, 2010, NEUROPSYCHOPHARMACOL, V35, P2521, DOI 10.1038/npp.2010.117; Burke SN, 2006, NAT REV NEUROSCI, V7, P30, DOI 10.1038/nrn1809; Calhoun ME, 2008, NEUROBIOL AGING, V29, P1256, DOI 10.1016/j.neurobiolaging.2007.02.013; Chandramohan Y, 2008, EUR J NEUROSCI, V27, P2701, DOI 10.1111/j.1460-9568.2008.06230.x; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Chwang WB, 2006, LEARN MEMORY, V13, P322, DOI 10.1101/lm.152906; Day JJ, 2011, NEURON, V70, P813, DOI 10.1016/j.neuron.2011.05.019; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Fletcher BR, 2006, J NEUROSCI, V26, P1507, DOI 10.1523/JNEUROSCI.4441-05.2006; Fuchs SM, 2011, CURR BIOL, V21, P53, DOI 10.1016/j.cub.2010.11.058; Gallagher M, 1997, ANNU REV PSYCHOL, V48, P339, DOI 10.1146/annurev.psych.48.1.339; GALLAGHER M, 1993, BEHAV NEUROSCI, V107, P618, DOI 10.1037/0735-7044.107.4.618; Gomez-Pinilla F, 2011, EUR J NEUROSCI, V33, P383, DOI 10.1111/j.1460-9568.2010.07508.x; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Haberman RP, 2011, NEUROBIOL AGING, V32, P1678, DOI 10.1016/j.neurobiolaging.2009.10.005; Haettig J, 2011, LEARN MEMORY, V18, P71, DOI 10.1101/lm.1986911; Kilgore M, 2010, NEUROPSYCHOPHARMACOL, V35, P870, DOI 10.1038/npp.2009.197; Kim JY, 2010, NAT NEUROSCI, V13, P180, DOI 10.1038/nn.2471; Kumar A, 2005, NEURON, V48, P303, DOI 10.1016/j.neuron.2005.09.023; Lattal KM, 2007, BEHAV NEUROSCI, V121, P1125, DOI 10.1037/0735-7044.121.5.1125; Lee HK, 2005, NAT NEUROSCI, V8, P1657, DOI 10.1038/nn1586; Levenson JM, 2004, J BIOL CHEM, V279, P40545, DOI 10.1074/jbc.M402229200; MacDonald JL, 2008, DEV DYNAM, V237, P2256, DOI 10.1002/dvdy.21626; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Malvaez M, 2009, MAMM GENOME, V20, P612, DOI 10.1007/s00335-009-9224-3; McGowan PO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014739; McQuown SC, 2011, NEUROBIOL LEARN MEM, V96, P27, DOI [10.1016/j.nlm.2011.04.005, 10.1016/j.nlm.2011.04.002]; McQuown SC, 2011, J NEUROSCI, V31, P764, DOI 10.1523/JNEUROSCI.5052-10.2011; Nicolle MM, 1999, NEUROBIOL AGING, V20, P343; Peleg S, 2010, SCIENCE, V328, P753, DOI 10.1126/science.1186088; Penner MR, 2011, NEUROBIOL AGING, V32, P2198, DOI 10.1016/j.neurobiolaging.2010.01.009; Pflum MKH, 2001, J BIOL CHEM, V276, P47733, DOI 10.1074/jbc.M105590200; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Rapp PR, 1996, P NATL ACAD SCI USA, V93, P9926, DOI 10.1073/pnas.93.18.9926; Small SA, 2011, NAT REV NEUROSCI, V12, P585, DOI 10.1038/nrn3085; Smith TD, 2000, J NEUROSCI, V20, P6587, DOI 10.1523/JNEUROSCI.20-17-06587.2000; Tian F, 2010, ANN NY ACAD SCI, V1199, P186, DOI 10.1111/j.1749-6632.2009.05175.x; Vecsey CG, 2007, J NEUROSCI, V27, P6128, DOI 10.1523/JNEUROSCI.0296-07.2007; Weaver ICG, 2005, J NEUROSCI, V25, P11045, DOI 10.1523/JNEUROSCI.3652-05.2005; Wilson IA, 2004, J NEUROSCI, V24, P3870, DOI 10.1523/JNEUROSCI.5205-03.2004; Winkler DFH, 2009, METHODS MOL BIOL, V570, P157, DOI 10.1007/978-1-60327-394-7_5; Wood MA, 2005, LEARN MEMORY, V12, P111, DOI 10.1101/lm.86605; Zocchi L, 2010, CURR OPIN NEUROBIOL, V20, P432, DOI 10.1016/j.conb.2010.04.005	45	54	55	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2012	7	3							e33249	10.1371/journal.pone.0033249	http://dx.doi.org/10.1371/journal.pone.0033249			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RU	22438904	Green Published, Green Submitted, gold			2022-12-25	WOS:000303309000016
J	Gouel-Cheron, A; Allaouchiche, B; Guignant, C; Davin, F; Floccard, B; Monneret, G				Gouel-Cheron, Aurelie; Allaouchiche, Bernard; Guignant, Caroline; Davin, Fanny; Floccard, Bernard; Monneret, Guillaume		AzuRea Grp	Early Interleukin-6 and Slope of Monocyte Human Leukocyte Antigen-DR: A Powerful Association to Predict the Development of Sepsis after Major Trauma	PLOS ONE			English	Article							WAVE-FORM ANALYSIS; C-REACTIVE PROTEIN; DISSEMINATED INTRAVASCULAR COAGULATION; ANTIINFLAMMATORY RESPONSE SYNDROME; CRITICALLY-ILL PATIENTS; INJURY SEVERITY SCORE; SEPTIC SHOCK; HLA-DR; INFLAMMATORY RESPONSE; INTENSIVE-CARE	Objective: Major trauma is characterized by a pro-inflammatory response, followed by an immunosuppression. Recently, in trauma patients, the lack of recovery of monocyte Human Leukocyte Antigen DR (mHLA-DR, a biomarker of ICU-acquired immunosuppression) between days 1-2 and days 3-4 has been demonstrated to be independently associated with sepsis development. The main objective of this study was to determine whether early measurements of IL-6 (interleukin-6) and IL-10 plasma concentrations (as markers of initial severity) could improve, in association with mHLA-DR recovery, the prediction of sepsis occurrence in severe trauma patients. Design: Prospective observational study over 24 months in a Trauma ICU at university hospital. Patients: Trauma patients with an ISS over 25 and age over 18 were included. Measurements and Main Results: mHLA-DR was assessed by flow cytometry, IL-6 and IL-10 concentrations by ELISA. 100 consecutive severely injured patients were monitored (mean ISS 37 +/- 10). 37 patients developed sepsis. IL-6 concentrations and slope of mHLA-DR expression between days 1-2 and days 3-4 were significantly different between septic and non-septic patients. IL-10 was not detectable in most patients. After adjustment for usual clinical confounders, when assessed as a pair, multivariate logistic regression analysis revealed that a slope of mHLA-DR expression (days 3-4/days 1-2)<= 1.1 and a IL-6 concentration >= 67.1 pg/ml remained highly associated with the development of sepsis (adjusted OR 18.4, 95% CI 4.9; 69.4, p = .00002). Conclusions: After multivariate regression logistic analysis, when assessed as a pair, a high IL-6 concentration and a persistent mHLA-DR decreased expression were found to be in relation with the development of sepsis with the best predictive value. This study underlines the usefulness of daily monitoring of immune function to identify trauma patients at a high risk of infection.	[Gouel-Cheron, Aurelie; Allaouchiche, Bernard; Floccard, Bernard] Hosp Civils Lyon, Hop Edouard Herriot, Serv Reanimat, Lyon, France; [Guignant, Caroline; Monneret, Guillaume] Hosp Civils Lyon, Hop Edouard Herriot, Lab Immunol Cellulaire, Lyon, France; [Davin, Fanny] Hosp Civils Lyon, Hop Edouard Herriot, Lab Commun Rech HCL Biomerieux, Lyon, France; [Gouel-Cheron, Aurelie; Allaouchiche, Bernard; Monneret, Guillaume] Univ Lyon 1, Hosp Civils Lyon, EA 4174, F-69365 Lyon, France	CHU Lyon; CHU Lyon; CHU Lyon; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Gouel-Cheron, A (corresponding author), Hosp Civils Lyon, Hop Edouard Herriot, Serv Reanimat, Lyon, France.	aurelie.gouel@gmail.com	Gouel, Aurelie/AAC-4225-2019	Gouel, Aurelie/0000-0003-2648-1693	Hospices Civils de Lyon (the authors' institutional hospital)	Hospices Civils de Lyon (the authors' institutional hospital)	The present work was supported by Hospices Civils de Lyon (the authors' institutional hospital). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adib-Conquy M, 2009, THROMB HAEMOSTASIS, V101, P36, DOI 10.1160/TH08-07-0421; Allen ML, 2002, CRIT CARE MED, V30, P1140, DOI 10.1097/00003246-200205000-00031; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Biffl WL, 1996, ANN SURG, V224, P647, DOI 10.1097/00000658-199611000-00009; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; Bone RC, 1996, ANN INTERN MED, V125, P680, DOI 10.7326/0003-4819-125-8-199610150-00009; Bone RC, 1996, CRIT CARE MED, V24, P1125, DOI 10.1097/00003246-199607000-00010; Caille V, 2004, SHOCK, V22, P521, DOI 10.1097/01.shk.0000143410.63698.57; Cheron A, 2010, CRIT CARE, V14, DOI 10.1186/cc9331; Chopin N, 2006, CRIT CARE MED, V34, P1654, DOI 10.1097/01.CCM.0000217471.12799.1C; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; de Aguilar-Nascimento JE, 2007, SAO PAULO MED J, V125, P34, DOI 10.1590/S1516-31802007000100007; Delannoy B, 2009, CRIT CARE, V13, DOI 10.1186/cc8166; Dempfle CEH, 2004, CRIT CARE MED, V32, P520, DOI 10.1097/01.CCM.0000110678.52863.F3; Docke WD, 2005, CLIN CHEM, V51, P2341, DOI 10.1373/clinchem.2005.052639; Downey C, 1997, BRIT J HAEMATOL, V98, P68, DOI 10.1046/j.1365-2141.1997.1062972.x; Faist E, 1996, WORLD J SURG, V20, P454, DOI 10.1007/s002689900071; FAIST E, 1988, ARCH SURG-CHICAGO, V123, P287; Friedman G, 1997, J CRIT CARE, V12, P183, DOI 10.1016/S0883-9441(97)90030-7; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Giannoudis PV, 1998, BRIT J SURG, V85, P986; Giannoudis PV, 2003, INJURY, V34, P397, DOI 10.1016/S0020-1383(02)00416-3; Giannoudis PV, 2000, INTENS CARE MED, V26, P1076, DOI 10.1007/s001340051320; GREENSPAN L, 1985, J TRAUMA, V25, P60, DOI 10.1097/00005373-198501000-00010; Harms H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002158; HEWITT PE, 1990, BRIT MED J, V300, P107, DOI 10.1136/bmj.300.6717.107; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Jawa Randeep S, 2011, J Intensive Care Med, V26, P3, DOI 10.1177/0885066610395678; Jawa RS, 2010, J INTENSIVE CARE MED, V26, P73; Kampalath B, 2003, ARCH PATHOL LAB MED, V127, P1580; Kauvar DS, 2005, CRIT CARE, V9, P1, DOI 10.1186/cc3779; Kox WJ, 2000, INTENS CARE MED, V26, pS124, DOI 10.1007/s001340051129; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Lukaszewicz AC, 2009, CRIT CARE MED, V37, P2746, DOI 10.1097/CCM.0b013e3181ab858a; Maier B, 2007, SHOCK, V28, P668, DOI 10.1097/shk.0b013e318123e64e; Mannick JA, 2001, J AM COLL SURGEONS, V193, P237, DOI 10.1016/S1072-7515(01)01011-0; Meisel C, 2009, AM J RESP CRIT CARE, V180, P640, DOI 10.1164/rccm.200903-0363OC; Monneret G, 2002, CLIN CHEM, V48, P1589; Monneret G, 2008, MOL MED, V14, P64, DOI 10.2119/2007-00102.Monneret; Monneret G, 2006, INTENS CARE MED, V32, P1175, DOI 10.1007/s00134-006-0204-8; Munford RS, 2001, AM J RESP CRIT CARE, V163, P316, DOI 10.1164/ajrccm.163.2.2007102; Neidhardt R, 1997, J TRAUMA, V42, P863, DOI 10.1097/00005373-199705000-00017; OHZATO H, 1992, SURGERY, V111, P201; Pape HC, 2000, CRIT CARE MED, V28, P3441, DOI 10.1097/00003246-200010000-00012; Pape HC, 1999, J TRAUMA, V46, P907, DOI 10.1097/00005373-199905000-00022; Perry SE, 2003, INTENS CARE MED, V29, P1245, DOI 10.1007/s00134-003-1686-2; Roquilly A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013228; Sander M, 2002, INTENS CARE MED, V28, P285, DOI 10.1007/s00134-001-1199-9; Sartorius D, 2010, CRIT CARE MED, V38, P831, DOI 10.1097/CCM.0b013e3181cc4a67; Satoh A, 2002, PANCREAS, V25, P245, DOI 10.1097/00006676-200210000-00006; SCHLUTER B, 1991, J TRAUMA, V31, P1663, DOI 10.1097/00005373-199112000-00017; Stanworth SJ, 2010, CRIT CARE, V14, DOI 10.1186/cc9394; Stensballe J, 2009, ACTA ANAESTH SCAND, V53, P515, DOI 10.1111/j.1399-6576.2008.01801.x; Taniguchi T, 1999, CRIT CARE MED, V27, P1262, DOI 10.1097/00003246-199907000-00005; Tschaikowsky K, 2002, CRIT CARE MED, V30, P1015, DOI 10.1097/00003246-200205000-00010; Tschoeke SK, 2007, INJURY, V38, P1346, DOI 10.1016/j.injury.2007.08.041; Turina M, 2006, J AM COLL SURGEONS, V203, P73, DOI 10.1016/j.jamcollsurg.2006.03.010; Venet F, 2007, CRIT CARE MED, V35, P1910, DOI 10.1097/01.CCM.0000275271.77350.B6; Venet F, 2011, CRIT CARE, V15, DOI 10.1186/cc10333; Wafaisade A, 2011, CRIT CARE MED; Ward NS, 2008, CLIN CHEST MED, V29, P617, DOI 10.1016/j.ccm.2008.06.010; WILSON RF, 1987, AM SURGEON, V53, P410; Zakariah AN, 2008, CRIT CARE MED, V36, P1507, DOI 10.1097/CCM.0b013e3181709f19; Zhang DP, 2009, EUR J NEUROL, V16, P498, DOI 10.1111/j.1468-1331.2008.02512.x; [No title captured]	66	81	89	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e33095	10.1371/journal.pone.0033095	http://dx.doi.org/10.1371/journal.pone.0033095			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22431998	gold, Green Submitted, Green Published			2022-12-25	WOS:000303198600041
J	Pischedda, A; Stewart, AD; Little, MK				Pischedda, Alison; Stewart, Andrew D.; Little, Monica K.			Male x Female Interaction for a Pre-Copulatory Trait, but Not a Post-Copulatory Trait, among Cosmopolitan Populations of Drosophila melanogaster	PLOS ONE			English	Article							SEXUALLY ANTAGONISTIC COEVOLUTION; MATING SPEED; INCIPIENT SPECIATION; GENETIC-DIVERGENCE; RAPID EVOLUTION; CONFLICT; GENOTYPE; BEHAVIOR; PERFORMANCE; SELECTION	Sexual coevolution occurs when changes in the phenotype of one sex select for changes in the other sex. We can identify the "footprint" of this coevolution by mating males and females from different populations and testing for a male-female genotype interaction for a trait associated with male (or female) performance. Here we mated male Drosophila melanogaster from five different continents with females from their own and different continents to test for a male-female interaction for mating speed, a pre-copulatory trait, and female reproductive investment, a post-copulatory trait. We found a strong male-female interaction for mating speed, consistent with previous studies using different populations, suggesting that the potential for sexual coevolution for this trait is present in this species. In contrast, we did not detect a male-female interaction for female reproductive investment. Although a male-female interaction for mating speed is compatible with the hypothesis of ongoing sexual coevolution, the nature of our experimental design is unable to exclude alternate explanations. Thus, the evolutionary mechanisms promoting male-female genotype interactions for pre-copulatory mating traits in D. melanogaster warrant further investigation.	[Pischedda, Alison; Stewart, Andrew D.; Little, Monica K.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Pischedda, A (corresponding author), Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA.	alison.pischedda@lifesci.ucsb.edu			Department of Ecology, Evolution and Marine Biology at University of California Santa Barbara (UCSB); Natural Sciences and Engineering Research Council of Canada (NSERC); UCSB Faculty Women's Club; UCSB Graduate Division	Department of Ecology, Evolution and Marine Biology at University of California Santa Barbara (UCSB); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); UCSB Faculty Women's Club; UCSB Graduate Division	This work was supported by a research grant awarded to AP by the Department of Ecology, Evolution and Marine Biology at University of California Santa Barbara (UCSB). AP was also supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) Postgraduate Scholarship, a Broida-Hirschfelder Fellowship awarded by the UCSB Faculty Women's Club, and a Rosati Dissertation Fellowship awarded by the UCSB Graduate Division. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alipaz JA, 2001, P ROY SOC B-BIOL SCI, V268, P789, DOI 10.1098/rspb.2000.1420; Andres JA, 2001, P ROY SOC B-BIOL SCI, V268, P399, DOI 10.1098/rspb.2000.1392; Arnqvist G, 2000, P NATL ACAD SCI USA, V97, P10460, DOI 10.1073/pnas.97.19.10460; BEGUN DJ, 1993, NATURE, V365, P548, DOI 10.1038/365548a0; Billeter JC, 2009, NATURE, V461, P987, DOI 10.1038/nature08495; CASARES P, 1993, BEHAV GENET, V23, P349, DOI 10.1007/BF01067436; Clark AG, 1999, SCIENCE, V283, P217, DOI 10.1126/science.283.5399.217; CONNOLLY K, 1974, BEHAVIOUR, V48, P61, DOI 10.1163/156853974X00255; Ferveur JF, 2005, BEHAV GENET, V35, P279, DOI 10.1007/s10519-005-3220-5; FULKER DW, 1966, SCIENCE, V153, P203, DOI 10.1126/science.153.3732.203; Gavrilets S, 2000, NATURE, V403, P886, DOI 10.1038/35002564; HENDERSON NR, 1982, NATURE, V300, P437, DOI 10.1038/300437a0; Hollocher H, 1997, GENETICS, V147, P1191; Hosken DJ, 2004, TRENDS ECOL EVOL, V19, P87, DOI 10.1016/j.tree.2003.11.012; Iliadi K, 2001, P ROY SOC B-BIOL SCI, V268, P2365, DOI 10.1098/rspb.2001.1822; Knowles LL, 2001, P NATL ACAD SCI USA, V98, P8692, DOI 10.1073/pnas.151123998; Long TAF, 2006, PHILOS T R SOC B, V361, P363, DOI 10.1098/rstb.2005.1786; Long TAF, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000254; Mackay TFC, 2005, P NATL ACAD SCI USA, V102, P6622, DOI 10.1073/pnas.0501986102; Nilsson T, 2003, BEHAV ECOL SOCIOBIOL, V53, P227, DOI 10.1007/s00265-002-0565-0; Nilsson T, 2002, EVOLUTION, V56, P111, DOI 10.1111/j.0014-3820.2002.tb00853.x; Panhuis TM, 2001, TRENDS ECOL EVOL, V16, P364, DOI 10.1016/S0169-5347(01)02160-7; Parker G.A., 1979, P123; Parker GA, 1998, PHILOS T R SOC B, V353, P261, DOI 10.1098/rstb.1998.0208; Pischedda A, 2011, P ROY SOC B-BIOL SCI, V278, P2165, DOI 10.1098/rspb.2010.2272; Pitnick S, 2003, P ROY SOC B-BIOL SCI, V270, P1507, DOI 10.1098/rspb.2003.2382; Rice WR, 1998, ENDLESS FORMS, P261; Rice WR, 1996, NATURE, V381, P232, DOI 10.1038/381232a0; Rowe L, 2003, P ROY SOC B-BIOL SCI, V270, P2009, DOI 10.1098/rspb.2003.2453; SCOTT D, 1994, EVOLUTION, V48, P112, DOI [10.2307/2410007, 10.1111/j.1558-5646.1994.tb01298.x]; Sheldon BC, 2000, TRENDS ECOL EVOL, V15, P397, DOI 10.1016/S0169-5347(00)01953-4; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; Ting CT, 2001, P NATL ACAD SCI USA, V98, P6709, DOI 10.1073/pnas.121418898; WELBERGEN P, 1992, J INSECT BEHAV, V5, P229, DOI 10.1007/BF01049291; WU CI, 1995, P NATL ACAD SCI USA, V92, P2519, DOI 10.1073/pnas.92.7.2519	35	8	8	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e31683	10.1371/journal.pone.0031683	http://dx.doi.org/10.1371/journal.pone.0031683			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22431964	Green Published, gold, Green Submitted			2022-12-25	WOS:000303198600007
J	Smith, SB; Dampier, W; Tozeren, A; Brown, JR; Magid-Slav, M				Smith, Steven B.; Dampier, William; Tozeren, Aydin; Brown, James R.; Magid-Slav, Michal			Identification of Common Biological Pathways and Drug Targets Across Multiple Respiratory Viruses Based on Human Host Gene Expression Analysis	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; INFLUENZA-A H1N1; SYNCYTIAL VIRUS; PHOSPHODIESTERASE INHIBITORS; EPITHELIAL-CELLS; IMMUNE-RESPONSE; ALPHA PRODUCTION; SYSTEMS BIOLOGY; INNATE IMMUNITY; OMICS DATA	Background: Pandemic and seasonal respiratory viruses are a major global health concern. Given the genetic diversity of respiratory viruses and the emergence of drug resistant strains, the targeted disruption of human host-virus interactions is a potential therapeutic strategy for treating multi-viral infections. The availability of large-scale genomic datasets focused on host-pathogen interactions can be used to discover novel drug targets as well as potential opportunities for drug repositioning. Methods/Results: In this study, we performed a large-scale analysis of microarray datasets involving host response to infections by influenza A virus, respiratory syncytial virus, rhinovirus, SARS-coronavirus, metapneumonia virus, coxsackievirus and cytomegalovirus. Common genes and pathways were found through a rigorous, iterative analysis pipeline where relevant host mRNA expression datasets were identified, analyzed for quality and gene differential expression, then mapped to pathways for enrichment analysis. Possible repurposed drugs targets were found through database and literature searches. A total of 67 common biological pathways were identified among the seven different respiratory viruses analyzed, representing fifteen laboratories, nine different cell types, and seven different array platforms. A large overlap in the general immune response was observed among the top twenty of these 67 pathways, adding validation to our analysis strategy. Of the top five pathways, we found 53 differentially expressed genes affected by at least five of the seven viruses. We suggest five new therapeutic indications for existing small molecules or biological agents targeting proteins encoded by the genes F3, IL1B, TNF, CASP1 and MMP9. Pathway enrichment analysis also identified a potential novel host response, the Parkin-Ubiquitin Proteasomal System (Parkin-UPS) pathway, which is known to be involved in the progression of neurodegenerative Parkinson's disease. Conclusions: Our study suggests that multiple and diverse respiratory viruses invoke several common host response pathways. Further analysis of these pathways suggests potential opportunities for therapeutic intervention.	[Smith, Steven B.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Smith, Steven B.; Magid-Slav, Michal] GlaxoSmithKline, Quantitat Sci, Computat Biol, King Of Prussia, PA USA; [Dampier, William; Tozeren, Aydin] Drexel Univ, Ctr Integrated Bioinformat, Philadelphia, PA 19104 USA; [Brown, James R.] GlaxoSmithKline, Quantitat Sci, Computat Biol, Collegeville, PA USA	University of Pennsylvania; GlaxoSmithKline; Drexel University; GlaxoSmithKline	Smith, SB (corresponding author), Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.	James.R.Brown@gsk.com		Smith, Steven/0000-0003-2799-6621	GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	JRB, MM-S are full-time employees of GlaxoSmithKline. SS, WD received stipends funded by GlaxoSmithKline for their research on this project. AT is a full-time professor at Drexel University. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Ali S, 2006, CLIN EXP IMMUNOL, V144, P425, DOI 10.1111/j.1365-2249.2006.03087.x; [Anonymous], 2011, WEEKLY EPIDEMIOLOGIC, P81; [Anonymous], 2002, PRINCIPAL COMPONENT; BANCHEREAU J, 1994, ANNU REV IMMUNOL, V12, P881, DOI 10.1146/annurev.iy.12.040194.004313; Bao X, 2008, VIROLOGY, V374, P114, DOI 10.1016/j.virol.2007.12.024; Barbe F, 2011, VET J, V187, P48, DOI 10.1016/j.tvjl.2009.12.012; Best SM, 2008, ANNU REV MICROBIOL, V62, P171, DOI 10.1146/annurev.micro.62.081307.163009; Bezerra PGM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018928; Bochkov YA, 2010, MUCOSAL IMMUNOL, V3, P69, DOI 10.1038/mi.2009.109; Bolton EE, 2008, ANN REPORTS COMP CHE, V4; Bonavia A, 2011, P NATL ACAD SCI USA, V108, P6739, DOI 10.1073/pnas.1017142108; Brown JR, 2011, DRUG DISCOV TODAY, V16, P229, DOI 10.1016/j.drudis.2011.01.008; Browne EP, 2001, J VIROL, V75, P12319, DOI 10.1128/JVI.75.24.12319-12330.2001; Cassino L, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-178; Chan G, 2010, J IMMUNOL, V184, P3213, DOI 10.4049/jimmunol.0903025; Chaugule VK, 2011, EMBO J, V30, P2853, DOI 10.1038/emboj.2011.204; Chen K, MICROARRAY DATA ANAL; Chung KKK, 2001, NAT MED, V7, P1144, DOI 10.1038/nm1001-1144; CHURCHILL L, 1992, IMMUNOLOGY, V75, P189; Cookson MR, 2003, HUM MOL GENET, V12, P2957, DOI 10.1093/hmg/ddg328; Critchley-Thorne RJ, 2007, PLOS MED, V4, P897, DOI 10.1371/journal.pmed.0040176; Crocker IC, 1996, IMMUNOPHARMACOLOGY, V31, P223, DOI 10.1016/0162-3109(95)00053-4; Dawany NB, 2011, INT J CANCER, V128, P2881, DOI 10.1002/ijc.25854; Dawany NB, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-483; Diedrich CR, 2011, INFECT IMMUN, V79, P1407, DOI 10.1128/IAI.01126-10; Draghici S, 2003, GENOMICS, V81, P98, DOI 10.1016/S0888-7543(02)00021-6; Eierhoff T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001099; Einarsson O, 1996, J CLIN INVEST, V97, P915, DOI 10.1172/JCI118514; Ekins S, 2007, METH MOL B, V356, P319; Esmon CT, 2011, J THROMB HAEMOST, V9, P182, DOI 10.1111/j.1538-7836.2011.04323.x; Essayan DM, 1997, J ALLERGY CLIN IMMUN, V99, P28, DOI 10.1016/S0091-6749(97)81041-X; GIROIR BP, 1992, CIRC SHOCK, V36, P200; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Gu WJ, 2003, NEUROBIOL DIS, V14, P357, DOI 10.1016/j.nbd.2003.08.011; Hertzog P, 2011, J INTERF CYTOK RES, V31, P5, DOI 10.1089/jir.2010.0126; Hotelling H, 1933, J EDUC PSYCHOL, V24, P417, DOI 10.1037/h0071325; Hsu ACY, 2011, AM J RESP CELL MOL, V44, P906, DOI 10.1165/rcmb.2010-0157OC; Huang Yuh-Chin T, 2008, Genomic Med, V2, P113, DOI 10.1007/s11568-009-9080-y; Husain M, 2011, FEBS LETT, V585, P128, DOI 10.1016/j.febslet.2010.11.023; Ichiyama T, 2007, CLIN EXP ALLERGY, V37, P608, DOI 10.1111/j.1365-2222.2007.02692.x; Ikemura T, 2000, J PHARMACOL EXP THER, V294, P701; Jang HM, 2009, P NATL ACAD SCI USA, V106, P14063, DOI 10.1073/pnas.0900096106; Jang H, 2009, BBA-MOL BASIS DIS, V1792, P714, DOI 10.1016/j.bbadis.2008.08.001; Jiang XM, 2012, NAT REV IMMUNOL, V12, P35, DOI 10.1038/nri3111; Johnston G, SAS SOFTWARE FIT GEN; Jonasch E, 2001, ONCOLOGIST, V6, P34, DOI 10.1634/theoncologist.6-1-34; Kahns S, 2003, J BIOL CHEM, V278, P23376, DOI 10.1074/jbc.M300495200; Kauffmann A, 2010, GENOMICS, V95, P138, DOI 10.1016/j.ygeno.2010.01.003; Knoblach T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002016; Landau YE, 2011, PEDIATR NEUROL, V44, P47, DOI 10.1016/j.pediatrneurol.2010.08.011; Lee SMY, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-147; Lee SMY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008072; Li W, 2007, CHINESE MED J-PEKING, V120, P5, DOI 10.1097/00029330-200701010-00002; Lucas A, ANOTHER MULTIDIMENSI; Luna T, 2011, BRAZ J MED BIOL RES, V44, P1134, DOI [10.1590/S0100-879X2011007500140, 10.1590/S0100-879X2011001100009]; Luo MH, 2010, J VIROL, V84, P3528, DOI 10.1128/JVI.02161-09; Maedler K, 2009, EXPERT OPIN BIOL TH, V9, P1177, DOI 10.1517/14712590903136688; Matsumori A, 1997, INT J CARDIOL, V62, pS3, DOI 10.1016/S0167-5273(97)00206-4; Mayer AK, 2007, J IMMUNOL, V178, P3134, DOI 10.4049/jimmunol.178.5.3134; McGarvey PB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007162; Meissner HC, 2009, PEDIATRICS, V124, P1676, DOI 10.1542/peds.2009-2346; Menu E, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-24; Menu P, 2011, CLIN EXP IMMUNOL, V166, P1, DOI 10.1111/j.1365-2249.2011.04440.x; Mezger M, 2009, VIRAL IMMUNOL, V22, P343, DOI 10.1089/vim.2009.0011; Mira MT, 2004, NATURE, V427, P636, DOI 10.1038/nature02326; Nagy PD, 2012, NAT REV MICROBIOL, V10, P137, DOI 10.1038/nrmicro2692; Nakamura Y, 2011, INTERNAL MED, V50, P1605, DOI 10.2169/internalmedicine.50.5027; Nemeth ZH, 1997, EUR J PHARMACOL, V339, P215, DOI 10.1016/S0014-2999(97)01392-7; Nichols WG, 2008, CLIN MICROBIOL REV, V21, P274, DOI 10.1128/CMR.00045-07; Nikolsky Y, 2009, METHODS MOL BIOL, V563, P177, DOI 10.1007/978-1-60761-175-2_10; Nogalski MT, 2011, J VIROL, V85, P1360, DOI 10.1128/JVI.02090-10; *OM, 2011, ARR STUD VERS 4 1 1; Oslund KL, 2011, FUTURE VIROL, V6, P951, DOI 10.2217/FVL.11.63; Overington John, 2009, J Comput Aided Mol Des, V23, P195, DOI 10.1007/s10822-009-9260-9; Padhy BM, 2011, J POSTGRAD MED, V57, P153, DOI 10.4103/0022-3859.81870; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Piggott DA, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/103917; Proud D, 2008, AM J RESP CRIT CARE, V178, P962, DOI 10.1164/rccm.200805-670OC; Reghunathan R, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-2; Ren Y, 2003, J NEUROSCI, V23, P3316; Riccioni G, 2007, CURR MED CHEM, V14, P1966; Rincon M, 1997, J EXP MED, V185, P461, DOI 10.1084/jem.185.3.461; Rohn TT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020495; Sayama K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011275; Schwegmann A, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.129re8; Senft AP, 2010, AM J RESP CELL MOL, V42, P404, DOI 10.1165/rcmb.2008-0229OC; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Shrestha SS, 2011, CLIN INFECT DIS, V52, pS75, DOI 10.1093/cid/ciq012; Soukup JM, 2003, CLIN IMMUNOL, V107, P178, DOI 10.1016/S1521-6616(03)00038-X; Staropoli JF, 2003, NEURON, V37, P735, DOI 10.1016/S0896-6273(03)00084-9; SUBAUSTE MC, 1995, J CLIN INVEST, V96, P549, DOI 10.1172/JCI118067; Szczypka M, 2010, PHARMACOL REP, V62, P1148, DOI 10.1016/S1734-1140(10)70377-7; Takahashi R, 2003, J NEUROL, V250, P25, DOI 10.1007/s00415-003-1305-8; Tan SL, 2007, NAT BIOTECHNOL, V25, P1383, DOI 10.1038/nbt1207-1383; The MathWorks I, 2010, MATLAB VERS 7 11 COM; Thornburg NJ, 2010, J VIROL, V84, P12895, DOI 10.1128/JVI.01273-10; Tomari S, 2003, CLIN EXP ALLERGY, V33, P795, DOI 10.1046/j.1365-2222.2003.01656.x; Toovey Stephen, 2008, Travel Med Infect Dis, V6, P114, DOI 10.1016/j.tmaid.2008.03.003; Torchinsky MB, 2010, CURR OPIN IMMUNOL, V22, P55, DOI 10.1016/j.coi.2010.01.003; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Tsueng G, 2011, J VIROL, V85, P5718, DOI 10.1128/JVI.02261-10; Tung WH, 2011, J CELL PHYSIOL, V226, P3316, DOI 10.1002/jcp.22677; Tung WH, 2011, J CELL BIOCHEM, V112, P559, DOI 10.1002/jcb.22946; VERGHESE MW, 1995, J PHARMACOL EXP THER, V272, P1313; Voss Andreas, 2011, Inflammation & Allergy Drug Targets, V10, P171; Wang C, 2005, J NEUROCHEM, V93, P422, DOI 10.1111/j.1471-4159.2005.03023.x; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067; Yoo HG, 2002, BIOCHEM BIOPH RES CO, V298, P251, DOI 10.1016/S0006-291X(02)02431-2; Yoshikawa T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008729; Yoshikawa T, 2009, J VIROL, V83, P3039, DOI 10.1128/JVI.01792-08; Zaas AK, 2009, CELL HOST MICROBE, V6, P207, DOI 10.1016/j.chom.2009.07.006; Zhang DX, 2011, J INTERF CYTOK RES, V31, P119, DOI 10.1089/jir.2010.0110; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797; Zhu Q, 2011, J INFECT DIS, V203, P674, DOI 10.1093/infdis/jiq100	115	60	62	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e33174	10.1371/journal.pone.0033174	http://dx.doi.org/10.1371/journal.pone.0033174			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22432004	Green Published, gold, Green Submitted			2022-12-25	WOS:000303198600047
J	Huang, HT; Leu, JH; Huang, PY; Chen, LL				Huang, Huai-Ting; Leu, Jiann-Horng; Huang, Po-Yu; Chen, Li-Li			A Putative Cell Surface Receptor for White Spot Syndrome Virus Is a Member of a Transporter Superfamily	PLOS ONE			English	Article							SHRIMP PENAEUS-MONODON; LEUKEMIA-VIRUS; BACULOVIRUS WSBV; BINDING-PROTEIN; IDENTIFICATION; PATHOGENESIS; ENTRY; WSSV; NUCLEOTIDES; INFECTION	White spot syndrome virus (WSSV), a large enveloped DNA virus, can cause the most serious viral disease in shrimp and has a wide host range among crustaceans. In this study, we identified a surface protein, named glucose transporter 1 (Glut1), which could also interact with WSSV envelope protein, VP53A. Sequence analysis revealed that Glut1 is a member of a large superfamily of transporters and that it is most closely related to evolutionary branches of this superfamily, branches that function to transport this sugar. Tissue tropism analysis showed that Glut1 was constitutive and highly expressed in almost all organs. Glut1's localization in shrimp cells was further verified and so was its interaction with Penaeus monodon chitin-binding protein (PmCBP), which was itself identified to interact with an envelope protein complex formed by 11 WSSV envelope proteins. In vitro and in vivo neutralization experiments using synthetic peptide contained WSSV binding domain (WBD) showed that the WBD peptide could inhibit WSSV infection in primary cultured hemocytes and delay the mortality in shrimps challenged with WSSV. These findings have important implications for our understanding of WSSV entry.	[Huang, Huai-Ting; Leu, Jiann-Horng; Huang, Po-Yu; Chen, Li-Li] Natl Taiwan Ocean Univ, Inst Marine Biol, Keelung, Taiwan; [Leu, Jiann-Horng; Chen, Li-Li] Natl Taiwan Ocean Univ, Ctr Excellence Marine Bioenvironm & Biotechnol, Keelung, Taiwan	National Taiwan Ocean University; National Taiwan Ocean University	Chen, LL (corresponding author), Natl Taiwan Ocean Univ, Inst Marine Biol, Keelung, Taiwan.	joechen@ntou.edu.tw	Chen, Li-Li/ADO-2240-2022	Chen, Li-Li/0000-0002-9593-8004	National Science Council [NSC 99-2311-B-019-001, NSC 100-2321-B-019-007-MY3]	National Science Council(Ministry of Science and Technology, Taiwan)	This investigation was supported financially by the National Science Council Grants (NSC 99-2311-B-019-001 and NSC 100-2321-B-019-007-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang PS, 1996, DIS AQUAT ORGAN, V27, P131, DOI 10.3354/dao027131; Chen KY, 2009, FISH SHELLFISH IMMUN, V27, P460, DOI 10.1016/j.fsi.2009.06.018; Chen LL, 2007, DIS AQUAT ORGAN, V74, P171, DOI 10.3354/dao074171; Dhar AK, 2003, ARCH VIROL, V148, P2381, DOI 10.1007/s00705-003-0172-z; Durand S, 1996, DIS AQUAT ORGAN, V27, P59, DOI 10.3354/dao027059; Earp LJ, 2005, CURR TOP MICROBIOL, V285, P25; Escobedo-Bonilla CM, 2008, J FISH DIS, V31, P1, DOI 10.1111/j.1365-2761.2007.00877.x; Flegel TW, 2011, MAR BIOTECHNOL, V13, P587, DOI 10.1007/s10126-010-9287-x; GOULD GW, 1993, BIOCHEM J, V295, P329, DOI 10.1042/bj2950329; Hamer I, 1997, J BIOL CHEM, V272, P21685, DOI 10.1074/jbc.272.35.21685; KAVANAUGH MP, 1994, P NATL ACAD SCI USA, V91, P7071, DOI 10.1073/pnas.91.15.7071; KOZAK M, 1987, J MOL BIOL, V196, P947, DOI 10.1016/0022-2836(87)90418-9; Kozak M, 1997, EMBO J, V16, P2482, DOI 10.1093/emboj/16.9.2482; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Leu JH, 2009, CURR TOP MICROBIOL, V328, P197; Li DF, 2007, VIROLOGY, V368, P122, DOI 10.1016/j.virol.2007.06.027; Liu HP, 2009, FISH SHELLFISH IMMUN, V27, P79, DOI 10.1016/j.fsi.2009.02.009; Lu LQ, 2004, FEBS LETT, V577, P141, DOI 10.1016/j.febslet.2004.08.087; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Quigley JG, 2004, CELL, V118, P757, DOI 10.1016/j.cell.2004.08.014; Senkevich TG, 2005, P NATL ACAD SCI USA, V102, P18572, DOI 10.1073/pnas.0509239102; Sieczkarski SB, 2005, CURR TOP MICROBIOL, V285, P1; Smith AE, 2004, SCIENCE, V304, P237, DOI 10.1126/science.1094823; Spear PG, 2003, J VIROL, V77, P10179, DOI 10.1128/JVI.77.19.10179-10185.2003; Sritunyalucksana K, 2006, J VIROL, V80, P10734, DOI 10.1128/JVI.00349-06; Tailor CS, 1999, J VIROL, V73, P6500, DOI 10.1128/JVI.73.8.6500-6505.1999; Takenouchi N, 2007, J VIROL, V81, P1506, DOI 10.1128/JVI.01522-06; Tonganunt M, 2005, J BIOTECHNOL, V120, P135, DOI 10.1016/j.jbiotec.2005.06.006; Tsai MF, 2000, VIROLOGY, V277, P100, DOI 10.1006/viro.2000.0597; Tsai MF, 2000, VIROLOGY, V277, P92, DOI 10.1006/viro.2000.0596; Wang YG, 1999, DIS AQUAT ORGAN, V39, P1, DOI 10.3354/dao039001; Wang ZL, 2005, J VIROL, V79, P8764, DOI 10.1128/JVI.79.14.8764-8772.2005; Yu YJ, 2011, J VIROL, V85, P1573, DOI 10.1128/JVI.01967-10	33	28	31	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2012	7	3							e33216	10.1371/journal.pone.0033216	http://dx.doi.org/10.1371/journal.pone.0033216			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930IA	22427993	Green Published, gold, Green Submitted			2022-12-25	WOS:000303129700039
J	Nene, NR; Garca-Ojalvo, J; Zaikin, A				Nene, Nuno R.; Garca-Ojalvo, Jordi; Zaikin, Alexey			Speed-Dependent Cellular Decision Making in Nonequilibrium Genetic Circuits	PLOS ONE			English	Article							SPECIFICITY; EXPRESSION; TRANSIENT; DYNAMICS; NOTCH; MODEL	Despite being governed by the principles of nonequilibrium transitions, gene expression dynamics underlying cell fate decision is poorly understood. In particular, the effect of signaling speed on cellular decision making is still unclear. Here we show that the decision between alternative cell fates, in a structurally symmetric circuit, can be biased depending on the speed at which the system is forced to go through the decision point. The circuit consists of two mutually inhibiting and self-activating genes, forced by two external signals with identical stationary values but different transient times. Under these conditions, slow passage through the decision point leads to a consistently biased decision due to the transient signaling asymmetry, whereas fast passage reduces and eventually eliminates the switch imbalance. The effect is robust to noise and shows that dynamic bifurcations, well known in nonequilibrium physics, are important for the control of genetic circuits.	[Nene, Nuno R.] Univ London Imperial Coll Sci Technol & Med, Dept Math, London, England; [Garca-Ojalvo, Jordi] Univ Politecn Cataluna, Dept Fs & Enginyeria Nucl, E-08028 Barcelona, Spain; [Zaikin, Alexey] UCL, Inst Womens Hlth, London, England; [Zaikin, Alexey] UCL, Dept Math, London, England	Imperial College London; Universitat Politecnica de Catalunya; University of London; University College London; University of London; University College London	Nene, NR (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Math, London, England.	n.nene@imperial.ac.uk	Garcia-Ojalvo, Jordi/A-4574-2009; Zaikin, Alexey/K-6581-2017; Zaikin, Alexey/T-7171-2019	Garcia-Ojalvo, Jordi/0000-0002-3716-7520; Zaikin, Alexey/0000-0001-7540-1130; Zaikin, Alexey/0000-0001-7540-1130	EPSRC at CoMPLEX, UCL; Ministerio de Ciencia e Innovacion (Spain) [FIS2009-13360]; Spanish Multiple Sclerosis Network (REEM-ISCIII); ICREA Academia; Biotechnology and Biological Sciences Research Council [BB/F005210/1, BB/F005210/2] Funding Source: researchfish; BBSRC [BB/F005210/1, BB/F005210/2] Funding Source: UKRI	EPSRC at CoMPLEX, UCL(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Multiple Sclerosis Network (REEM-ISCIII); ICREA Academia(ICREA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	NRN acknowledges financial support from the EPSRC at CoMPLEX, UCL, JGO from the Ministerio de Ciencia e Innovacion (Spain, project FIS2009-13360), the Spanish Multiple Sclerosis Network (REEM-ISCIII), and the ICREA Academia programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U., INTRO SYSTEMS BIOL D; Andrecut M, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/8/148; Bennett MR, 2007, BIOPHYS J, V92, P3501, DOI 10.1529/biophysj.106.095638; Berg J, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.188101; Berglund N, NOISE INDUCED PHENOM; Brivanlou AH, 2002, SCIENCE, V295, P813, DOI 10.1126/science.1066355; Chen WW, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.74; Cohen M, 2010, DEV CELL, V19, P78, DOI 10.1016/j.devcel.2010.06.006; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Ermentrout B., SIMULATING ANAL ANIM; ERNEUX T, 1991, LECT NOTES MATH, V1493, P14; Garcia-Ojalvo J, NOISE SPATIALLY EXTE; Ge H, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.148103; GROSSMANN S, 1990, Z PHYS B CON MAT, V78, P1, DOI 10.1007/BF01317349; Guantes R, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000235; Herrgen L, 2010, CURR BIOL, V20, P1244, DOI 10.1016/j.cub.2010.06.034; Huang S, 2007, DEV BIOL, V305, P695, DOI 10.1016/j.ydbio.2007.02.036; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Kloeden P. E., NUMERICAL SOLUTION S; Kobayashi TJ, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.228101; KONDEPUDI DK, 1986, PHYSICA D, V21, P296, DOI 10.1016/0167-2789(86)90006-0; Koseska A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004872; Kuchina A, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.88; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Murray-Zmijewski F, 2008, NAT REV MOL CELL BIO, V9, P702, DOI 10.1038/nrm2451; Murugan R, 2011, BIOPHYS J, V101, P1297, DOI 10.1016/j.bpj.2011.08.005; Nene NR, 2012, DECISION MAKIN UNPUB; Nene NR, 2012, INTERPLAY PATH UNPUB; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Schwarz M, 2000, DEVELOPMENT, V127, P4325; Sen S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025102; Sprinzak D, 2010, NATURE, V465, P86, DOI 10.1038/nature08959; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Van Kampen N, STOCHASTIC PROCESSES; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Wieczorek S, 2011, P ROY SOC A-MATH PHY, V467, P1243, DOI 10.1098/rspa.2010.0485; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559	39	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2012	7	3							e32779	10.1371/journal.pone.0032779	http://dx.doi.org/10.1371/journal.pone.0032779			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930IA	22427883	Green Published, gold, Green Submitted			2022-12-25	WOS:000303129700015
J	Pinho, SS; Oliveira, P; Cabral, J; Carvalho, S; Huntsman, D; Garter, F; Seruca, R; Reis, CA; Oliveira, C				Pinho, Salome S.; Oliveira, Patricia; Cabral, Joana; Carvalho, Sandra; Huntsman, David; Gaerter, Fatima; Seruca, Raquel; Reis, Celso A.; Oliveira, Carla			Loss and Recovery of Mgat3 and GnT-III Mediated E-cadherin N-glycosylation Is a Mechanism Involved in Epithelial-Mesenchymal-Epithelial Transitions	PLOS ONE			English	Article							ACETYLGLUCOSAMINYLTRANSFERASE-III; PROTEIN GLYCOSYLATION; BISECTING GLCNAC; GENE-EXPRESSION; GLYCANS; CANCER; BINDING; CELLS	Background: N-acetylglucosaminyltransferase-III (GnT-III) is a glycosyltransferase encoded by Mgat3 that catalyzes the addition of beta 1,4-bisecting-N-acetylglucosamine on N-glycans. GnT-III has been pointed as a metastases suppressor having varying effects on cell adhesion and migration. We have previously described the existence of a functional feedback loop between E-cadherin expression and GnT-III-mediated glycosylation. The effects of GnT-III-mediated glycosylation on E-cadherin expression and cellular phenotype lead us to evaluate Mgat3 and GnT-III-glycosylation role during Epithelial-Mesenchymal- Transition (EMT) and the reverted process, Mesenchymal-Epithelial-Transition (MET). Methodology/Principal Findings: We analyzed the expression profile and genetic mechanism controlling Mgat3 expression as well as GnT-III-mediated glycosylation, in general and specifically on E-cadherin, during EMT/MET. We found that during EMT, Mgat3 expression was dramatically decreased and later recovered when cells returned to an epithelial-like phenotype. We further identified that Mgat3 promoter methylation/demethylation is involved in this expression regulation. The impact of Mgat3 expression variation, along EMT/MET, leads to a variation in the expression levels of the enzymatic product of GnT-III (bisecting GlcNAc structures), and more importantly, to the specific modification of E-cadherin glycosylation with bisecting GlcNAc structures. Conclusions/Significance: Altogether, this work identifies for the first time Mgat3 glycogene expression and GnT-III-mediated glycosylation, specifically on E-cadherin, as a novel and major component of the EMT/MET mechanism signature, supporting its role during EMT/MET.	[Pinho, Salome S.; Oliveira, Patricia; Cabral, Joana; Carvalho, Sandra; Gaerter, Fatima; Seruca, Raquel; Reis, Celso A.; Oliveira, Carla] Univ Porto, Inst Mol Pathol & Immunol, P-4100 Oporto, Portugal; [Pinho, Salome S.; Oliveira, Patricia; Carvalho, Sandra; Gaerter, Fatima; Reis, Celso A.] Univ Porto, Inst Biomed Sci Abel Salazar, P-4100 Oporto, Portugal; [Huntsman, David] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada; [Seruca, Raquel; Reis, Celso A.; Oliveira, Carla] Univ Porto, Fac Med, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto; British Columbia Cancer Agency; Universidade do Porto	Reis, CA (corresponding author), Univ Porto, Inst Mol Pathol & Immunol, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	celsor@ipatimup.pt; carlaol@ipatimup.pt	seruca, raquel/F-8187-2011; Oliveira, Patrícia JMF/J-9447-2013; Pinho, Salomé S./F-1764-2011; Carvalho, Sandra S/K-1724-2016; de Fátima Gärtner, Maria/A-3530-2010; Huntsman, David/ABE-6082-2020; Oliveira, Carla/F-8188-2011; Carvalho, Sandra/ABA-8715-2020; REIS, Celso A/B-9969-2008	Oliveira, Patrícia JMF/0000-0002-3078-2950; Pinho, Salomé S./0000-0002-3484-5162; Carvalho, Sandra S/0000-0003-3647-3582; de Fátima Gärtner, Maria/0000-0002-5302-0086; Oliveira, Carla/0000-0001-8340-2264; Carvalho, Sandra/0000-0003-3647-3582; REIS, Celso A/0000-0002-0286-6639; Cabral, Joana/0000-0002-3496-5463; Seruca, Raquel/0000-0002-8851-4166	Portuguese Foundation for Science and Technology [PTDC/SAU-GMG/72168/2006, PTDC/SAU-GMG/110785/2009, PTDC/CVT/111358/2009]; Programa Operacional Potencial Humano - Quadro de Referencia Estrategico Nacional [POPH - QREN/Type 4.2]; Portuguese Ministry of Science and Technology (MCTES); Luso-American Foundation; Portuguese Foundation for Science and Technology; European Social Fund;  [SFRH/BPD/63094/2009];  [SFRH/BD/32984/2006]	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Programa Operacional Potencial Humano - Quadro de Referencia Estrategico Nacional; Portuguese Ministry of Science and Technology (MCTES); Luso-American Foundation; Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); European Social Fund(European Social Fund (ESF)); ; 	This work was supported by the Portuguese Foundation for Science and Technology (project funding: PTDC/SAU-GMG/72168/2006, PTDC/SAU-GMG/110785/2009, PTDC/CVT/111358/2009, "financiados no ambito do Programa Operacional Tematico Factores de Competitividade (COMPETE) e comparticipado pelo fundo Comunitario Europeu FEDER''); a postdoctoral grant to SSP (SFRH/BPD/63094/2009); a PhD grant to PO (SFRH/BD/32984/2006); and salary support to CO from "Programa Operacional Potencial Humano - Quadro de Referencia Estrategico Nacional'' (POPH - QREN/Type 4.2), European Social Fund and Portuguese Ministry of Science and Technology (MCTES). PO is a PhD student of the Graduate Program in Areas of Basic and Applied Biology (GABBA, 10th edition). SSP also acknowledges the Luso-American Foundation for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Prof. Leonor David for critical revision of the manuscript. IPATIMUP is an Associate Laboratory of the Portuguese Ministry of Science, Technology and Higher Education and is partially supported by the Portuguese Foundation for Science and Technology.	Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Dennis JW, 1999, BIOESSAYS, V21, P412, DOI 10.1002/(SICI)1521-1878(199905)21:5<412::AID-BIES8>3.0.CO;2-5; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Gravdal K, 2007, CLIN CANCER RES, V13, P7003, DOI 10.1158/1078-0432.CCR-07-1263; Gu JG, 2004, GLYCOCONJUGATE J, V21, P9, DOI 10.1023/B:GLYC.0000043741.47559.30; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Iijima J, 2006, J BIOL CHEM, V281, P13038, DOI 10.1074/jbc.M601961200; Isaji T, 2004, J BIOL CHEM, V279, P19747, DOI 10.1074/jbc.M311627200; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Montesano R, 1998, IN VITRO CELL DEV-AN, V34, P468; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Pinho SS, 2011, CELL MOL LIFE SCI, V68, P1011, DOI 10.1007/s00018-010-0595-0; Pinho SS, 2009, HUM MOL GENET, V18, P2599, DOI 10.1093/hmg/ddp194; Pinho SS, 2009, BIOCHEM BIOPH RES CO, V379, P1091, DOI 10.1016/j.bbrc.2009.01.024; Robson EJD, 2006, DIFFERENTIATION, V74, P254, DOI 10.1111/j.1432-0436.2006.00075.x; Song YH, 2010, CANCER RES, V70, P3361, DOI 10.1158/0008-5472.CAN-09-2719; Stanley P, 2002, BBA-GEN SUBJECTS, V1573, P363, DOI 10.1016/S0304-4165(02)00404-X; Takai D, 2003, SILICO BIOL, P3; Taniguchi N, 1999, BBA-MOL BASIS DIS, V1455, P287, DOI 10.1016/S0925-4439(99)00066-6; Taniguchi N, 2001, PROTEOMICS, V1, P239; Taniguchi N, 1998, ADV ENZYME REGUL, V38, P223, DOI 10.1016/S0065-2571(97)00011-3; Terao M, 2011, J BIOL CHEM, V286, P28303, DOI 10.1074/jbc.M111.220376; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Yoshimura M, 1996, J BIOL CHEM, V271, P13811, DOI 10.1074/jbc.271.23.13811; YOSHIMURA M, 1995, P NATL ACAD SCI USA, V92, P8754, DOI 10.1073/pnas.92.19.8754; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhao YY, 2006, J BIOL CHEM, V281, P32122, DOI 10.1074/jbc.M607274200	31	80	85	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2012	7	3							e33191	10.1371/journal.pone.0033191	http://dx.doi.org/10.1371/journal.pone.0033191			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930IA	22427986	Green Submitted, Green Published, gold			2022-12-25	WOS:000303129700037
J	Zhao, X; Wu, ZX; Zhang, Y; Gao, MX; Yan, YB; Cao, PC; Zang, Y; Lei, W				Zhao, Xiong; Wu, Zi-xiang; Zhang, Yang; Gao, Ming-xuan; Yan, Ya-bo; Cao, Peng-chong; Zang, Yuan; Lei, Wei			Locally Administrated Perindopril Improves Healing in an Ovariectomized Rat Tibial Osteotomy Model	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; OSTEOPOROSIS INFLUENCES; HYPERTENSIVE-RATS; INDUCED APOPTOSIS; FRACTURE REPAIR; BONE-FORMATION; SYSTEM; INHIBITOR; CELLS; DIFFERENTIATION	Angiotensin-converting enzyme inhibitors are widely prescribed to regulate blood pressure. High doses of orally administered perindopril have previously been shown to improve fracture healing in a mouse femur fracture model. In this study, perindopril was administered directly to the fracture area with the goal of stimulating fracture repair. Three months after being ovariectomized (OVX), tibial fractures were produced in Sprague-Dawley rats and subsequently stabilized with intramedullary wires. Perindopril (0.4 mg/kg/day) was injected locally at the fractured site for a treatment period of 7 days. Vehicle reagent was used as a control. Callus quality was evaluated at 2 and 4 weeks post-fracture. Compared with the vehicle group, perindopril treatment significantly increased bone formation, increased biomechanical strength, and improved microstructural parameters of the callus. Newly woven bone was arranged more tightly and regularly at 4 weeks post-fracture. The ultimate load increased by 66.1 and 76.9% (p<0.01), and the bone volume over total volume (BV/TV) increased by 29.9% and 24.3% (p<0.01) at 2 and 4 weeks post-fracture, respectively. These findings suggest that local treatment with perindopril could promote fracture healing in ovariectomized rats.	[Zhao, Xiong; Wu, Zi-xiang; Zhang, Yang; Gao, Ming-xuan; Yan, Ya-bo; Cao, Peng-chong; Zang, Yuan; Lei, Wei] Fourth Mil Med Univ, Xijing Hosp, Dept Orthopead, Xian 710032, Peoples R China	Air Force Military Medical University	Lei, W (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Orthopead, Xian 710032, Peoples R China.	wlspine@163.com		Lei, Wei/0000-0002-7346-6915				Asaba Y, 2009, J BONE MINER RES, V24, P241, DOI 10.1359/JBMR.081006; Aspenberg P, 2010, J BONE MINER RES, V25, P404, DOI 10.1359/jbmr.090731; Bonnet F, 2001, EXP NEPHROL, V9, P295; Cao YP, 2002, J BONE MINER RES, V17, P2237, DOI 10.1359/jbmr.2002.17.12.2237; Delgado-Martinez AD, 1998, J ORTHOP RES, V16, P650, DOI 10.1002/jor.1100160604; Diez J, 1997, HYPERTENSION, V30, P1029, DOI 10.1161/01.HYP.30.5.1029; Dzau V, 2005, J HYPERTENS, V23, pS9, DOI 10.1097/01.hjh.0000165623.72310.dd; Fu LJ, 2009, BONE, V44, P893, DOI 10.1016/j.bone.2009.01.378; Garcia P, 2010, BRIT J PHARMACOL, V159, P1672, DOI 10.1111/j.1476-5381.2010.00651.x; Garnero P, 1997, ENDOCRIN METAB CLIN, V26, P913, DOI 10.1016/S0889-8529(05)70287-5; Gerstenfeld LC, 2009, J BONE MINER RES, V24, P196, DOI 10.1359/JBMR.081113; Giannoudis P, 2007, INJURY, V38, pS90, DOI 10.1016/j.injury.2007.02.014; Hagiwara H, 1998, J ENDOCRINOL, V156, P543, DOI 10.1677/joe.0.1560543; Hans D, 1997, BAILLIERE CLIN RHEUM, V11, P495, DOI 10.1016/S0950-3579(97)80017-9; Hao YJ, 2007, BONE, V41, P631, DOI 10.1016/j.bone.2007.06.006; Hatton R, 1997, J ENDOCRINOL, V152, P5, DOI 10.1677/joe.0.1520005; Haulica I, 2005, J RENIN-ANGIO-ALDO S, V6, P121, DOI 10.3317/jraas.2005.018; Hiruma Y, 1997, BIOCHEM BIOPH RES CO, V230, P176, DOI 10.1006/bbrc.1996.5914; Izu Y, 2009, J BIOL CHEM, V284, P4857, DOI 10.1074/jbc.M807610200; Kakar S, 2007, J BONE MINER RES, V22, P1903, DOI 10.1359/JBMR.070724; Kubo T, 1999, J STEROID BIOCHEM, V68, P197, DOI 10.1016/S0960-0760(99)00032-1; Li YF, 2009, OSTEOPOROS INT; Matsumoto N, 2003, SHOCK, V19, P547, DOI 10.1097/01.shk.0000070734.34700.80; MCCORMACK AP, 1993, J ORTHOPAED RES, V11, P548, DOI 10.1002/jor.1100110409; Muller R, 1997, ST HEAL T, V40, P61; Nagashima M, 2005, BONE, V36, P502, DOI 10.1016/j.bone.2004.11.013; Nakajima A, 2002, J BONE MINER RES, V17, P2038, DOI 10.1359/jbmr.2002.17.11.2038; Namkung-Matthai H, 2001, BONE, V28, P80, DOI 10.1016/S8756-3282(00)00414-2; Odaka C, 2000, CLIN EXP IMMUNOL, V121, P515, DOI 10.1046/j.1365-2249.2000.01323.x; ONDETTI MA, 1977, SCIENCE, V196, P441, DOI 10.1126/science.191908; PEACH MJ, 1977, PHYSIOL REV, V57, P313, DOI 10.1152/physrev.1977.57.2.313; Perez-Castrillon JL, 2003, AM J HYPERTENS, V16, P453, DOI 10.1016/S0895-7061(03)00845-8; Rejnmark L, 2006, J HYPERTENS, V24, P581, DOI 10.1097/01.hjh.0000203845.26690.cb; Schurman SJ, 2004, PEDIATR NEPHROL, V19, P33, DOI 10.1007/s00467-003-1361-4; Shimizu H, 2008, FASEB J, V22, P2465, DOI 10.1096/fj.07-098954; Shimizu H, 2009, HYPERTENS RES, V32, P786, DOI 10.1038/hr.2009.99; Stuermer EK, 2010, LANGENBECK ARCH SURG, V395, P163, DOI 10.1007/s00423-008-0436-x; Wang JW, 2007, OSTEOPOROSIS INT, V18, P1641, DOI 10.1007/s00198-007-0412-2; Wang Jian-wei, 2005, Chin J Traumatol, V8, P111	39	19	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2012	7	3							e33228	10.1371/journal.pone.0033228	http://dx.doi.org/10.1371/journal.pone.0033228			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930IA	22427998	Green Published, Green Submitted, gold			2022-12-25	WOS:000303129700041
J	Liu, HF; Wang, S; Gao, F; Tian, Y; Chen, WF; Hu, ZH; Shi, PC				Liu, Huafeng; Wang, Song; Gao, Fei; Tian, Yi; Chen, Wufan; Hu, Zhenghui; Shi, Pengcheng			Robust Framework for PET Image Reconstruction Incorporating System and Measurement Uncertainties	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; MATRIX; MODELS; ALGORITHM; SCANNER; NOISE	In Positron Emission Tomography (PET), an optimal estimate of the radioactivity concentration is obtained from the measured emission data under certain criteria. So far, all the well-known statistical reconstruction algorithms require exactly known system probability matrix a priori, and the quality of such system model largely determines the quality of the reconstructed images. In this paper, we propose an algorithm for PET image reconstruction for the real world case where the PET system model is subject to uncertainties. The method counts PET reconstruction as a regularization problem and the image estimation is achieved by means of an uncertainty weighted least squares framework. The performance of our work is evaluated with the Shepp-Logan simulated and real phantom data, which demonstrates significant improvements in image quality over the least squares reconstruction efforts.	[Liu, Huafeng; Wang, Song; Tian, Yi; Hu, Zhenghui] Zhejiang Univ, Dept Opt Engn, State Key Lab Modern Opt Instrumentat, Hangzhou 310003, Zhejiang, Peoples R China; [Liu, Huafeng; Gao, Fei; Shi, Pengcheng] Rochester Inst Technol, B Thomas Golisano Coll Comp & Informat Sci, Rochester, NY USA; [Chen, Wufan] So Med Univ, Sch Biomed Engn, Guangzhou, Guangdong, Peoples R China	Zhejiang University; Rochester Institute of Technology; Southern Medical University - China	Liu, HF (corresponding author), Zhejiang Univ, Dept Opt Engn, State Key Lab Modern Opt Instrumentat, Hangzhou 310003, Zhejiang, Peoples R China.	chenwf@fimmu.com; zhengh.hu@gmail.com	Hu, Zhenghui/F-1959-2015	Hu, Zhenghui/0000-0002-5775-0481	National Basic Research Program of China [2010CB732500]; Department of Science and Technology of Zhejiang Province [2010C33026]; 973 program of China [2010CB732504]	National Basic Research Program of China(National Basic Research Program of China); Department of Science and Technology of Zhejiang Province; 973 program of China(National Basic Research Program of China)	This work was supported by the National Basic Research Program of China (No. 2010CB732500) and the Department of Science and Technology of Zhejiang Province (2010C33026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the 973 program of China (2010CB732504) and the Department of Science and Technology of Zhejiang Province(2010C33026) for their support.	Fessler JA, 1999, IEEE T IMAGE PROCESS, V8, P688, DOI 10.1109/83.760336; FESSLER JA, 1994, IEEE T MED IMAGING, V13, P290, DOI 10.1109/42.293921; HUDSON HM, 1994, IEEE T MED IMAGING, V13, P601, DOI 10.1109/42.363108; KAUFMAN L, 1987, IEEE T MED IMAGING, V6, P37, DOI 10.1109/TMI.1987.4307796; Lewitt RM, 2003, P IEEE, V91, P1588, DOI 10.1109/JPROC.2003.817882; Li QZ, 2006, IEEE T MED IMAGING, V25, P1565, DOI 10.1109/TMI.2006.884193; Lu HHS, 1998, IEEE T MED IMAGING, V17, P1, DOI 10.1109/42.668690; Mumcuoglu EU, 1996, PHYS MED BIOL, V41, P1777, DOI 10.1088/0031-9155/41/9/015; Nuyts J, 2002, IEEE T NUCL SCI, V49, P56, DOI 10.1109/TNS.2002.998681; Ollinger JM, 1997, IEEE SIGNAL PROC MAG, V14, P43, DOI 10.1109/79.560323; Panin VY, 2006, IEEE T NUCL SCI, V53, P152, DOI 10.1109/TNS.2005.862979; Pierro D, 1995, IEEE T MED IMAGING, V14, P132; Qi JY, 2005, PHYS MED BIOL, V50, P3297, DOI 10.1088/0031-9155/50/14/007; Qi JY, 1998, PHYS MED BIOL, V43, P1001, DOI 10.1088/0031-9155/43/4/027; Rafecas M, 2004, IEEE T NUCL SCI, V51, P149, DOI 10.1109/TNS.2003.822998; Sayed AH, 1999, LECT NOTES CONTR INF, V245, P159; Sayed AH, 2001, IEEE T AUTOMAT CONTR, V46, P998, DOI 10.1109/9.935054; Schretter C, 2009, IEEE T IMAGE PROCESS, V18, P117, DOI 10.1109/TIP.2008.2007756; Selivanov VV, 2000, IEEE T NUCL SCI, V47, P1168, DOI 10.1109/23.856565; Su KH, 2009, IEEE T NUCL SCI, V56, P704, DOI 10.1109/TNS.2009.2021267; Tamal M, 2006, IEEE T NUCL SCI, V53, P2778, DOI 10.1109/TNS.2006.880973; Tian Y, 2006, HIGH ENERG PHYS NUC, V30, P1123; Vandenberghe S, 2006, PHYS MED BIOL, V51, P3105, DOI 10.1088/0031-9155/51/12/008; VEKLEROV E, 1988, IEEE T NUCL SCI, V35, P603, DOI 10.1109/23.12795	24	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e32224	10.1371/journal.pone.0032224	http://dx.doi.org/10.1371/journal.pone.0032224			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427826	gold, Green Submitted, Green Published			2022-12-25	WOS:000302381500010
J	Patrushev, N; Seidel-Rogol, B; Salazar, G				Patrushev, Nikolay; Seidel-Rogol, Bonnie; Salazar, Gloria			Angiotensin II Requires Zinc and Downregulation of the Zinc Transporters ZnT3 and ZnT10 to Induce Senescence of Vascular Smooth Muscle Cells	PLOS ONE			English	Article							CELLULAR SENESCENCE; MAMMALIAN ZINC; NADPH OXIDASE; DNA-BINDING; PROTEIN; ACTIVATION; ATHEROSCLEROSIS; LOCALIZATION; DEGRADATION; DEFICIENCY	Senescence, a hallmark of mammalian aging, is associated with the onset and progression of cardiovascular disease. Angiotensin II (Ang II) signaling and zinc homeostasis dysfunction are increased with age and are linked to cardiovascular disease, but the relationship among these processes has not been investigated. We used a model of cellular senescence induced by Ang II in vascular smooth muscle cells (VSMCs) to explore the role of zinc in vascular dysfunction. We found that Ang II-induced senescence is a zinc-dependent pathway mediated by the downregulation of the zinc transporters ZnT3 and ZnT10, which work to reduce cytosolic zinc. Zinc mimics Ang II by increasing reactive oxygen species (ROS), activating NADPH oxidase activity and Akt, and by downregulating ZnT3 and ZnT10 and inducing senescence. Zinc increases Ang II-induced senescence, while the zinc chelator TPEN, as well as overexpression of ZnT3 or ZnT10, decreases ROS and prevents senescence. Using HEK293 cells, we found that ZnT10 localizes in recycling endosomes and transports zinc into vesicles to prevent zinc toxicity. Zinc and ZnT3/ZnT10 downregulation induces senescence by decreasing the expression of catalase. Consistently, ZnT3 and ZnT10 downregulation by siRNA increases ROS while downregulation of catalase by siRNA induces senescence. Zinc, siZnT3 and siZnT10 downregulate catalase by a post-transcriptional mechanism mediated by decreased phosphorylation of ERK1/2. These data demonstrate that zinc homeostasis dysfunction by decreased expression of ZnT3 or ZnT10 promotes senescence and that Ang II-induced senescence is a zinc and ROS-dependent process. Our studies suggest that zinc might also affect other ROS-dependent processes induced by Ang II, such as hypertrophy and migration of smooth muscle cells.	[Patrushev, Nikolay; Seidel-Rogol, Bonnie; Salazar, Gloria] Emory Univ, Sch Med, Div Cardiol, Dept Med, Atlanta, GA 30322 USA	Emory University	Patrushev, N (corresponding author), Emory Univ, Sch Med, Div Cardiol, Dept Med, Atlanta, GA 30322 USA.	gsalaza@emory.edu			National Institute of Health [UO1 HL80711, HL60728]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL080711, R01HL060728] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institute of Health grants UO1 HL80711 and HL60728. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beattie JH, 2004, BRIT J NUTR, V91, P177, DOI 10.1079/BJN20031072; Bediz CS, 2006, TOHOKU J EXP MED, V208, P133, DOI 10.1620/tjem.208.133; Benigni A, 2009, J CLIN INVEST, V119, P524, DOI 10.1172/JCI36703; Brandes RP, 2005, CARDIOVASC RES, V66, P286, DOI 10.1016/j.cardiores.2004.12.027; Burdette SC, 2001, J AM CHEM SOC, V123, P7831, DOI 10.1021/ja010059l; Cao C, 2003, BIOCHEMISTRY-US, V42, P10348, DOI 10.1021/bi035023f; Chung NJ, 2005, TOXICOL APPL PHARM, V205, P225, DOI 10.1016/j.taap.2004.10.008; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Erusalimsky JD, 2005, EXP GERONTOL, V40, P634, DOI 10.1016/j.exger.2005.04.010; Falcon-Perez JM, 2007, EXP CELL RES, V313, P1473, DOI 10.1016/j.yexcr.2007.02.006; Faragher RGA, 1998, BIOESSAYS, V20, P985, DOI 10.1002/(SICI)1521-1878(199812)20:12<985::AID-BIES4>3.3.CO;2-1; Ferrario CM, 2002, AM J HYPERTENS, V15, p9S, DOI 10.1016/S0895-7061(01)02274-9; GRIENDLING KK, 1991, J BIOL CHEM, V266, P15498; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Herbert KE, 2008, CIRC RES, V102, P201, DOI 10.1161/CIRCRESAHA.107.158626; Hilenski LL, 2004, ARTERIOSCL THROM VAS, V24, P677, DOI 10.1161/01.ATV.0000112024.13727.2c; Hirata Yoichiro, 2009, Nihon Rinsho, V67, P707; Ilouz R, 2002, BIOCHEM BIOPH RES CO, V295, P102, DOI 10.1016/S0006-291X(02)00636-8; Kim YH, 2002, EXP NEUROL, V177, P407, DOI 10.1006/exnr.2002.7990; Kunieda T, 2006, CIRCULATION, V114, P953, DOI 10.1161/CIRCULATIONAHA.106.626606; Lakatta EG, 2003, CIRCULATION, V107, P139, DOI 10.1161/01.CIR.0000048892.83521.58; Li M, 2009, AGE RELATED CHANGES; Lichten LA, 2009, ANNU REV NUTR, V29, P153, DOI 10.1146/annurev-nutr-033009-083312; Tomat AL, 2011, NUTRITION, V27, P392, DOI 10.1016/j.nut.2010.09.010; Maret W, 2006, ANTIOXID REDOX SIGN, V8, P1419, DOI 10.1089/ars.2006.8.1419; MARIN J, 1995, MECH AGEING DEV, V79, P71, DOI 10.1016/0047-6374(94)01551-V; Matsunaga Yoshiko, 2005, Journal of Toxicological Sciences, V30, P135, DOI 10.2131/jts.30.135; MAY JM, 1982, J BIOL CHEM, V257, P4362; Minamino T, 2002, CIRCULATION, V105, P1541, DOI 10.1161/01.CIR.0000013836.85741.17; Murgia C, 1999, AM J PHYSIOL-GASTR L, V277, pG1231, DOI 10.1152/ajpgi.1999.277.6.G1231; Najjar SS, 2005, HYPERTENSION, V46, P454, DOI 10.1161/01.HYP.0000177474.06749.98; Ni YG, 2006, CIRCULATION, V114, P1159, DOI 10.1161/CIRCULATIONAHA.106.637124; Noh KM, 2000, J NEUROSCI, V20; OTEIZA PI, 1995, J NUTR, V125, P823; PALMITER RD, 1995, EMBO J, V14, P639, DOI 10.1002/j.1460-2075.1995.tb07042.x; Saito T, 2000, BIOCHEM BIOPH RES CO, V279, P505, DOI 10.1006/bbrc.2000.3946; Salazar G, 2004, MOL BIOL CELL, V15, P575, DOI 10.1091/mbc.E03-06-0401; Salazar G, 2004, J BIOL CHEM, V279, P25430, DOI 10.1074/jbc.M402331200; Salazar G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005896; SANDSTEAD HH, 1982, AM J CLIN NUTR, V36, P1046, DOI 10.1093/ajcn/36.5.1046; Schilder YDC, 2009, FREE RADICAL BIO MED, V46, P1598, DOI 10.1016/j.freeradbiomed.2009.03.013; Seve M, 1999, ARCH BIOCHEM BIOPHYS, V361, P165, DOI 10.1006/abbi.1998.0942; Sim DLC, 2002, INT J BIOCHEM CELL B, V34, P487, DOI 10.1016/S1357-2725(01)00156-X; Sindreu C, 2011, P NATL ACAD SCI USA, V108, P3366, DOI 10.1073/pnas.1019166108; Sorescu D, 2001, FREE RADICAL BIO MED, V30, P603, DOI 10.1016/S0891-5849(00)00507-4; Suzuki T, 2005, J BIOL CHEM, V280, P30956, DOI 10.1074/jbc.M506902200; Ushio-Fukai M, 1999, J BIOL CHEM, V274, P22699, DOI 10.1074/jbc.274.32.22699; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; Walter PL, 2006, ARCH BIOCHEM BIOPHYS, V454, P107, DOI 10.1016/j.abb.2006.08.016; Wu WD, 2003, J BIOL CHEM, V278, P28258, DOI 10.1074/jbc.M303318200; Xiong SQ, 2010, J BIOL CHEM, V285, P2474, DOI 10.1074/jbc.M109.065235; Yang D, 2007, AGING CELL, V6, P257, DOI 10.1111/j.1474-9726.2007.00274.x	52	63	70	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33211	10.1371/journal.pone.0033211	http://dx.doi.org/10.1371/journal.pone.0033211			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427991	gold, Green Published, Green Submitted			2022-12-25	WOS:000302381500112
J	Pinto, L; Mateus-Pinheiro, A; Morais, M; Bessa, JM; Sousa, N				Pinto, Luisa; Mateus-Pinheiro, Antonio; Morais, Monica; Bessa, Joao Miguel; Sousa, Nuno			Immuno-Golgi as a Tool for Analyzing Neuronal 3D-Dendritic Structure in Phenotypically Characterized Neurons	PLOS ONE			English	Article							NEURAL STEM-CELLS; HIPPOCAMPAL NEUROGENESIS; RAT HIPPOCAMPUS; ADULT; DEPRESSION; BRAIN; STRESS	Characterization of neuronal dendritic structure in combination with the determination of specific neuronal phenotype or temporal generation is a challenging task. Here we present a novel method that combines bromodioxyuridine (BrdU) immunohistochemistry with Golgi-impregnation technique; with this simple non-invasive method, we are able to determine the tridimensional structure of dendritic arborization and spine shape of neurons born at a specific time in the hippocampus of adult animals. This analysis is relevant in physiological and pathological conditions in which altered neurogenesis is implicated, such as aging or emotional disorders.	[Pinto, Luisa; Mateus-Pinheiro, Antonio; Morais, Monica; Bessa, Joao Miguel; Sousa, Nuno] Univ Minho, Life & Hlth Sci Res Inst, Sch Hlth Sci, Braga, Portugal; [Pinto, Luisa; Mateus-Pinheiro, Antonio; Morais, Monica; Bessa, Joao Miguel; Sousa, Nuno] Life & Hlth Sci Res Inst 3Bs, PT Govt Associate Lab, Braga, Portugal	Universidade do Minho	Pinto, L (corresponding author), Univ Minho, Life & Hlth Sci Res Inst, Sch Hlth Sci, Braga, Portugal.	luisapinto@ecsaude.uminho.pt; njcsousa@ecsaude.uminho.pt	Pinto, Luísa/A-7414-2010; Pinto, Luisa/GXF-0087-2022; Sousa, Nuno JC/N-9137-2017; Sousa, Nuno/C-2782-2009; Bessa, João M/K-8079-2014	Pinto, Luísa/0000-0002-7724-0446; Sousa, Nuno JC/0000-0002-8755-5126; Bessa, João M/0000-0001-6385-2452; Mateus-Pinheiro, Antonio/0000-0002-5534-4332; Morais, Monica/0000-0003-3226-3828	Portuguese Foundation for Science and Technology (FCT) [PTDC/SAU-NEU/105180/2008]; FCT [SFRH/BPD/47174/2008]; Fundação para a Ciência e a Tecnologia [PTDC/SAU-NEU/105180/2008] Funding Source: FCT	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundação para a Ciência e a Tecnologia	This work was supported by the Portuguese Foundation for Science and Technology (FCT) (PTDC/SAU-NEU/105180/2008). Luisa Pinto is funded by a fellowship from the FCT (SFRH/BPD/47174/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airan RD, 2007, SCIENCE, V317, P819, DOI 10.1126/science.1144400; Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; Bessa JM, 2009, MOL PSYCHIATR, V14, P764, DOI 10.1038/mp.2008.119; Bessa JM, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.001.2009; Cerqueira JJ, 2007, CEREB CORTEX, V17, P1998, DOI 10.1093/cercor/bhl108; DeCarolis NA, 2010, NEUROPHARMACOLOGY, V58, P884, DOI 10.1016/j.neuropharm.2009.12.013; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Dranovsky A, 2006, BIOL PSYCHIAT, V59, P1136, DOI 10.1016/j.biopsych.2006.03.082; Evers P, 1997, J NEUROSCI METH, V72, P197, DOI 10.1016/S0165-0270(96)02204-2; HARRIS KM, 1992, J NEUROSCI, V12, P2685; Jessberger S, 2007, J NEUROSCI, V27, P9400, DOI 10.1523/JNEUROSCI.2002-07.2007; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Landgren H, 2011, J CELL PHYSIOL, V226, P1, DOI 10.1002/jcp.22319; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Pittenger C, 2008, NEUROPSYCHOPHARMACOL, V33, P88, DOI 10.1038/sj.npp.1301574; Price Jack, 1994, Gene Therapy, V1, pS4; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Spiga S, 2011, BRAIN STRUCT FUNCT, V216, P171, DOI 10.1007/s00429-011-0312-2; Tang XB, 2007, J NEUROSCI, V27, P5837, DOI 10.1523/JNEUROSCI.5048-06.2007; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368	20	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33114	10.1371/journal.pone.0033114	http://dx.doi.org/10.1371/journal.pone.0033114			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427964	gold, Green Submitted, Green Published			2022-12-25	WOS:000302381500094
J	Ren, XH; Cui, XL; Lin, S; Wang, JM; Jiang, ZL; Sui, DL; Li, J; Wang, ZC				Ren, Xiaohui; Cui, Xiangli; Lin, Song; Wang, Junmei; Jiang, Zhongli; Sui, Dali; Li, Jing; Wang, Zhongcheng			Co-Deletion of Chromosome 1p/19q and IDH1/2 Mutation in Glioma Subsets of Brain Tumors in Chinese Patients	PLOS ONE			English	Article							LOW-GRADE GLIOMAS; PHASE-III TRIAL; ANAPLASTIC OLIGODENDROGLIOMAS; EUROPEAN ORGANIZATION; GENETIC SIGNATURE; MOLECULAR PROFILE; LOCATION; 1P; OLIGOASTROCYTOMAS; GLIOBLASTOMA	Objective: To characterize co-deletion of chromosome 1p/19q and IDH1/2 mutation in Chinese brain tumor patients and to assess their associations with clinical features. Methods: In a series of 528 patients with gliomas, pathological and radiological materials were reviewed. Pathological constituents of tumor subsets, incidences of 1p/19q co-deletion and IDH1/2 mutation in gliomas by regions and sides in the brain were analyzed. Results: Overall, 1p and 19q was detected in 339 patients by FISH method while the sequence of IDH1/2 was determined in 280 patients. Gliomas of frontal, temporal and insular origin had significantly different pathological constituents of tumor subsets (P < 0.001). Gliomas of frontal origin had significantly higher incidence of 1p/19q co-deletion (50.4%) and IDH1/2 mutation (73.5%) than those of non-frontal origin (27.0% and 48.5%, respectively) (P < 0.001), while gliomas of temporal origin had significantly lower incidence of 1p/19q co-deletion (23.9%) and IDH1/2 mutation (41.7%) than those of non-temporal origin (39.9% and 63.2%, respectively) (P = 0.013 and P = 0.003, respectively). Subgroup analysis confirmed these findings in oligoastrocytic and oligodendroglial tumors, respectively. Although the difference of 1p/19q co-deletion was not statistically significant in temporal oligodendroglial tumors, the trend was marginally significant (P = 0.082). However, gliomas from different sides of the brain did not show significant different pathological constituents, incidences of 1p/19q co-deletion or IDH1/2 mutation. Conclusion: Preferential distribution of pathological subsets, 1p/19q co-deletion and IDH1/2 mutation were confirmed in some brain regions in Chinese glioma patients, implying their distinctive tumor genesis and predictive value for prognosis.	[Ren, Xiaohui; Cui, Xiangli; Lin, Song; Jiang, Zhongli; Sui, Dali; Li, Jing] Capital Med Univ, Beijing Tiantan Hosp, Beijing, Peoples R China; [Wang, Junmei; Wang, Zhongcheng] Beijing Neurosurg Inst, Beijing, Peoples R China	Capital Medical University; Beijing Neurosurgical Institute	Ren, XH (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Beijing, Peoples R China.	linsong2005@126.com			National 973 project of China [2007CB512503]	National 973 project of China(National Basic Research Program of China)	This work was supported by National 973 project of China 2007CB512503. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros PF, 2001, MED PEDIATR ONCOL, V37, P492, DOI 10.1002/mpo.1242; Bleeker FE, 2010, ACTA NEUROPATHOL, V119, P487, DOI 10.1007/s00401-010-0645-6; Cairncross G, 2006, J CLIN ONCOL, V24, P2707, DOI 10.1200/JCO.2005.04.3414; Cairncross JG, 1998, J NATL CANCER I, V90, P1473, DOI 10.1093/jnci/90.19.1473; Duffau H, 2004, CANCER-AM CANCER SOC, V100, P2622, DOI 10.1002/cncr.20297; Goze C, 2009, J NEURO-ONCOL, V91, P1, DOI 10.1007/s11060-008-9680-8; Hoang-Xuan K, 2004, J CLIN ONCOL, V22, P3133, DOI 10.1200/JCO.2004.10.169; Huang L, 2008, CLIN NEUROL NEUROSUR, V110, P1020, DOI 10.1016/j.clineuro.2008.06.020; Jenkins RB, 2006, CANCER RES, V66, P9852, DOI 10.1158/0008-5472.CAN-06-1796; Kaloshi G, 2007, NEUROLOGY, V68, P1831, DOI 10.1212/01.wnl.0000262034.26310.a2; KRAUS JA, 1995, J NEUROPATH EXP NEUR, V54, P91, DOI 10.1097/00005072-199501000-00011; Kros JM, 2007, J NEUROPATH EXP NEUR, V66, P545, DOI 10.1097/01.jnen.0000263869.84188.72; Kujas M, 2005, ANN NEUROL, V58, P322, DOI 10.1002/ana.20543; Lai A, 2011, J CLIN ONCOL, V29, P4482, DOI 10.1200/JCO.2010.33.8715; Laigle-Donadey F, 2004, NEUROLOGY, V63, P2360, DOI 10.1212/01.WNL.0000148642.26985.68; Lang FF, 2001, J NEUROSURG, V95, P638, DOI 10.3171/jns.2001.95.4.0638; Larjavaara S, 2007, NEURO-ONCOLOGY, V9, P319, DOI 10.1215/15228517-2007-016; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Mueller W, 2002, AM J PATHOL, V161, P313, DOI 10.1016/S0002-9440(10)64183-1; Ohgaki H, 2005, ACTA NEUROPATHOL, V109, P93, DOI 10.1007/s00401-005-0991-y; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Sanai N, 2010, J NEUROSURG, V112, P1, DOI 10.3171/2009.6.JNS0952; Sanson M, 2009, J CLIN ONCOL, V27, P4150, DOI 10.1200/JCO.2009.21.9832; Schwartzbaum JA, 2006, NAT CLIN PRACT NEURO, V2, P494, DOI 10.1038/ncpneuro0289; van den Bent MJ, 2006, J CLIN ONCOL, V24, P2715, DOI 10.1200/JCO.2005.04.6078; Watanabe T, 2009, AM J PATHOL, V174, P1149, DOI 10.2353/ajpath.2009.080958; Wu A, 2010, J NEURO-ONCOL, V99, P57, DOI 10.1007/s11060-009-0100-5; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; YASARGIL MG, 1992, ACTA NEUROCHIR, V116, P147, DOI 10.1007/BF01540867; Zlatescu MC, 2001, CANCER RES, V61, P6713	30	33	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e32764	10.1371/journal.pone.0032764	http://dx.doi.org/10.1371/journal.pone.0032764			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427879	Green Published, Green Submitted, gold			2022-12-25	WOS:000302381500041
J	Wang, X; Pickrell, AM; Zimmers, TA; Moraes, CT				Wang, Xiao; Pickrell, Alicia M.; Zimmers, Teresa A.; Moraes, Carlos T.			Increase in Muscle Mitochondrial Biogenesis Does Not Prevent Muscle Loss but Increased Tumor Size in a Mouse Model of Acute Cancer-Induced Cachexia	PLOS ONE			English	Article							SKELETAL-MUSCLE; SYSTEMIC INFLAMMATION; WEIGHT-LOSS; PGC-1-ALPHA; HYPERMETABOLISM; DEFINITION; METABOLISM; EXPRESSION; REGULATOR; PHENOTYPE	Cancer-associated cachexia is a complex metabolic condition characterized by the progressive loss of body fat and deterioration of muscle mass. Although the cellular and molecular mechanisms of cachexia are incompletely understood, previous studies have suggested mitochondrial dysfunction in murine models of cancer cachexia. To better understand the metabolic shift in cancer-induced cachexia, we studied the effects of enhanced oxidative capacity on muscle wasting using transgenic mice over-expressing Peroxisome Proliferator-Activated Receptor gamma Co-activator-1 alpha (PGC-1 alpha) in skeletal muscle in a Lewis lung carcinoma-implanted model. Increased mitochondrial biogenesis was observed in the skeletal muscle of tumor-implanted mice. However, these increases did not prevent or reverse muscle wasting in mice harboring tumors. Moreover, tumor size was increased in muscle PGC-1a over-expressing mice. We found similar levels of circulating inflammatory cytokines in tumor-implanted animals, which was not affected by increased muscle expression of PGC-1 alpha. Our data indicated that increased mitochondrial biogenesis in skeletal muscle is not sufficient to rescue tumor-associated, acute muscle loss, and could promote tumor growth, possibly through the release of myokines.	[Wang, Xiao; Zimmers, Teresa A.; Moraes, Carlos T.] Univ Miami, Miller Sch Med, Sheila & David Fuente Grad Program Canc Biol, Miami, FL 33136 USA; [Pickrell, Alicia M.; Moraes, Carlos T.] Univ Miami, Miller Sch Med, Neurosci Grad Program, Miami, FL 33136 USA; [Zimmers, Teresa A.; Moraes, Carlos T.] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA; [Moraes, Carlos T.] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA	University of Miami; University of Miami; University of Miami; University of Miami	Wang, X (corresponding author), Univ Miami, Miller Sch Med, Sheila & David Fuente Grad Program Canc Biol, Miami, FL 33136 USA.	cmoraes@med.miami.edu	Pickrell, Alicia/B-8494-2018; Zimmers, Teresa/AAD-5461-2019; Moraes, Carlos/AAT-3818-2021	Pickrell, Alicia/0000-0002-8470-6056; Zimmers, Teresa/0000-0001-7872-0540; 	National Institute of Health; Muscular Dystrophy Association; NATIONAL CANCER INSTITUTE [R01CA122596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092758] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institute of Health and the Muscular Dystrophy Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrientos A, 2002, METHODS, V26, P307, DOI 10.1016/S1046-2023(02)00036-1; Bing C, 2000, CANCER RES, V60, P2405; Crouser ED, 2010, AM J RESP CRIT CARE, V182, P726, DOI 10.1164/rccm.201005-0695ED; Deans C, 2005, CURR OPIN CLIN NUTR, V8, P265, DOI 10.1097/01.mco.0000165004.93707.88; DEWYS WD, 1980, AM J MED, V69, P491, DOI 10.1016/S0149-2918(05)80001-3; Esper Dema Halasa, 2005, Nutr Clin Pract, V20, P369, DOI 10.1177/0115426505020004369; Evans WJ, 2008, CLIN NUTR, V27, P793, DOI 10.1016/j.clnu.2008.06.013; Fearon KC, 2006, AM J CLIN NUTR, V83, P1345, DOI 10.1093/ajcn/83.6.1345; Garcia-Lorda P, 2000, JPEN-PARENTER ENTER, V24, P317, DOI 10.1177/0148607100024006317; Liang HY, 2006, ADV PHYSIOL EDUC, V30, P145, DOI 10.1152/advan.00052.2006; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; MacDonald Neil, 2007, J Support Oncol, V5, P157; Martignoni Marcus E, 2003, Mol Cancer, V2, P36, DOI 10.1186/1476-4598-2-36; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Pedersen BK, 2007, J APPL PHYSIOL, V103, P1093, DOI 10.1152/japplphysiol.00080.2007; Remels AHV, 2010, FASEB J, V24, P5052, DOI 10.1096/fj.09-150714; ROUBENOFF R, 1994, J CLIN INVEST, V93, P2379, DOI 10.1172/JCI117244; Safdar A, 2011, J BIOL CHEM, V286, P10605, DOI 10.1074/jbc.M110.211466; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SMITH KL, 1993, BRIT J CANCER, V67, P680, DOI 10.1038/bjc.1993.126; Tisdale MJ, 2002, NAT REV CANCER, V2, P862, DOI 10.1038/nrc927; Tisdale MJ, 2000, NUTRITION, V16, P1013, DOI 10.1016/S0899-9007(00)00409-3; Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006; Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106; Wenz T, 2009, J APPL PHYSIOL, V106, P1712, DOI 10.1152/japplphysiol.91571.2008; White JP, 2011, AM J PHYSIOL-REG I, V300, pR201, DOI 10.1152/ajpregu.00300.2010; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X	29	32	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e33426	10.1371/journal.pone.0033426	http://dx.doi.org/10.1371/journal.pone.0033426			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22428048	gold, Green Published			2022-12-25	WOS:000302381500141
J	Zach, N; Inbar, D; Grinvald, Y; Vaadia, E				Zach, Neta; Inbar, Dorrit; Grinvald, Yael; Vaadia, Eilon			Single Neurons in M1 and Premotor Cortex Directly Reflect Behavioral Interference	PLOS ONE			English	Article							MOTOR WORKING-MEMORY; INTERNAL-MODELS; VISUOMOTOR ADAPTATION; ARM MOVEMENTS; FORCE-FIELDS; ACQUISITION; POPULATION; CONSOLIDATION; DISCHARGE; POSITION	Some motor tasks, if learned together, interfere with each other's consolidation and subsequent retention, whereas other tasks do not. Interfering tasks are said to employ the same internal model whereas noninterfering tasks use different models. The division of function among internal models, as well as their possible neural substrates, are not well understood. To investigate these questions, we compared responses of single cells in the primary motor cortex and premotor cortex of primates to interfering and noninterfering tasks. The interfering tasks were visuomotor rotation followed by opposing visuomotor rotation. The noninterfering tasks were visuomotor rotation followed by an arbitrary association task. Learning two noninterfering tasks led to the simultaneous formation of neural activity typical of both tasks, at the level of single neurons. In contrast, and in accordance with behavioral results, after learning two interfering tasks, only the second task was successfully reflected in motor cortical single cell activity. These results support the hypothesis that the representational capacity of motor cortical cells is the basis of behavioral interference and division between internal models.	[Zach, Neta] Univ Penn, Sch Arts & Sci, Biol Basis Behav Program, Philadelphia, PA 19104 USA; [Inbar, Dorrit] Hebrew Univ Jerusalem, Fac Exact Sci, Interdisciplinary Ctr Neural Computat, Jerusalem, Israel; [Grinvald, Yael] Hebrew Univ Jerusalem, Fac Med, Dept Physiol, Jerusalem, Israel; [Vaadia, Eilon] Hebrew Univ Jerusalem, Interdisciplinary Ctr Neural Computat, Inst Med Res Israel Canada,Fac Med, Edmond & Lily Safra Ctr Brain Sci,Dept Med Neurob, Jerusalem, Israel	University of Pennsylvania; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Zach, N (corresponding author), Univ Penn, Sch Arts & Sci, Biol Basis Behav Program, Philadelphia, PA 19104 USA.	nerazach@sas.upenn.edu		Inbar, Dorrit/0000-0002-7293-1539	Bundesministerium fur Bildung und Forschung/Deutsch Israelische Projektkooperation [2001073]; Johnson Johnson	Bundesministerium fur Bildung und Forschung/Deutsch Israelische Projektkooperation(Federal Ministry of Education & Research (BMBF)); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA)	This work was supported in part by the Bundesministerium fur Bildung und Forschung/Deutsch Israelische Projektkooperation, by Grant 2001073 administered by the Binational Science Foundation, by the Johnson & Johnson Fund for Innovative Science, and by special contributions from the Rosetrees Trust, by the Ida Baruch fund and Gatsby Charitable Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arce F, 2010, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.065.2009; Bays PM, 2005, EXP BRAIN RES, V163, P400, DOI 10.1007/s00221-005-2299-5; Cisek P, 2005, NEURON, V45, P801, DOI 10.1016/j.neuron.2005.01.027; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; GEORGOPOULOS AP, 1988, J NEUROSCI, V8, P2928; GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; Gribble PL, 2002, NATURE, V417, P938, DOI 10.1038/nature00834; Hinder MR, 2007, EXP BRAIN RES, V180, P629, DOI 10.1007/s00221-007-0888-1; IRIKI A, 1989, SCIENCE, V245, P1385, DOI 10.1126/science.2551038; Karniel A, 2002, EXP BRAIN RES, V143, P520, DOI 10.1007/s00221-002-1054-4; Kleim JA, 2004, J NEUROSCI, V24, P628, DOI 10.1523/JNEUROSCI.3440-03.2004; Krakauer JW, 1999, NAT NEUROSCI, V2, P1026, DOI 10.1038/14826; Lewicki MS, 1998, NETWORK-COMP NEURAL, V9, pR53, DOI 10.1088/0954-898X/9/4/001; Li CSR, 2001, NEURON, V30, P593, DOI 10.1016/S0896-6273(01)00301-4; MITZ AR, 1991, J NEUROSCI, V11, P1855; Muellbacher W, 2002, NATURE, V415, P640, DOI 10.1038/nature712; Paz R, 2004, PLOS BIOL, V2, P264, DOI 10.1371/journal.pbio.0020045; Paz R, 2003, NAT NEUROSCI, V6, P882, DOI 10.1038/nn1097; Remy F, 2010, NEUROPSYCHOLOGIA, V48, P2517, DOI 10.1016/j.neuropsychologia.2010.04.026; Sanger TD, 2003, CURR OPIN NEUROBIOL, V13, P238, DOI 10.1016/S0959-4388(03)00034-5; SCHWARTZ AB, 1994, SCIENCE, V265, P540, DOI 10.1126/science.8036499; Scott SH, 2001, NATURE, V413, P161, DOI 10.1038/35093102; Shadmehr R, 1997, J NEUROSCI, V17, P409, DOI 10.1523/JNEUROSCI.17-01-00409.1997; Shadmehr R, 1997, SCIENCE, V277, P821, DOI 10.1126/science.277.5327.821; Taira M, 1996, EXP BRAIN RES, V109, P367; THACH WT, 1978, J NEUROPHYSIOL, V41, P654, DOI 10.1152/jn.1978.41.3.654; Tong C, 2002, J NEUROSCI, V22, P1108, DOI 10.1523/JNEUROSCI.22-03-01108.2002; Tong C, 2003, J NEUROPHYSIOL, V90, P578, DOI 10.1152/jn.01087.2002; Wada Y, 2003, NEUROSCI RES, V46, P319, DOI 10.1016/S0168-0102(03)00094-4; Wigmore V, 2002, J EXP PSYCHOL HUMAN, V28, P447, DOI 10.1037//0096-1523.28.2.447; Wise SP, 1998, EXP BRAIN RES, V121, P285, DOI 10.1007/s002210050462; Wolpert DM, 1998, NEURAL NETWORKS, V11, P1317, DOI 10.1016/S0893-6080(98)00066-5; Zach N, 2005, EUR J NEUROSCI, V22, P2357, DOI 10.1111/j.1460-9568.2005.04415.x; Zach N, 2008, J NEUROSCI, V28, P9545, DOI 10.1523/JNEUROSCI.1965-08.2008	34	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e32986	10.1371/journal.pone.0032986	http://dx.doi.org/10.1371/journal.pone.0032986			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22427923	gold, Green Published, Green Submitted			2022-12-25	WOS:000302381500070
J	Zhang, Y; Fan, SF; Yao, YY; Ding, J; Wang, Y; Zhao, Z; Liao, L; Li, PC; Zang, FC; Teng, GJ				Zhang, Yi; Fan, Shufeng; Yao, Yuyu; Ding, Jie; Wang, Yu; Zhao, Zhen; Liao, Lei; Li, Peicheng; Zang, Fengchao; Teng, Gao-Jun			In Vivo Near-Infrared Imaging of Fibrin Deposition in Thromboembolic Stroke in Mice	PLOS ONE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; FACTOR-XIII; COAGULATION-FACTOR; CEREBRAL-ISCHEMIA; BRAIN-INJURY; MODEL	Objectives: Thrombus and secondary thrombosis plays a key role in stroke. Recent molecular imaging provides in vivo imaging of activated factor XIII (FXIIIa), an important mediator of thrombosis or fibrinolytic resistance. The present study was to investigate the fibrin deposition in a thromboembolic stroke mice model by FXIIIa-targeted near-infrared fluorescence (NIRF) imaging. Materials and Methods: The experimental protocol was approved by our institutional animal use committee. Seventy-six C57B/6J mice were subjected to thromboembolic middle cerebral artery occlusion or sham operation. Mice were either intravenously injected with the FXIIIa-targeted probe or control probe. In vivo and ex vivo NIRF imaging were performed thereafter. Probe distribution was assessed with fluorescence microscopy by spectral imaging and quantification system. MR scans were performed to measure lesion volumes in vivo, which were correlated with histology after animal euthanasia. Results: In vivo significant higher fluorescence intensity over the ischemia-affected hemisphere, compared to the contralateral side, was detected in mice that received FXIIIa-targeted probe, but not in the controlled mice. Significantly NIRF signals showed time-dependent processes from 8 to 96 hours after injection of FXIIIa-targeted probes. Ex vivo NIRF image showed an intense fluorescence within the ischemic territory only in mice injected with FXIIIa-targeted probe. The fluorescence microscopy demonstrated distribution of FXIIIa-targeted probe in the ischemic region and nearby micro-vessels, and FXIIIa-targeted probe signals showed good overlap with immune-fluorescent fibrin staining images. There was a significant correlation between total targeted signal from in vivo or ex vivo NIRF images and lesion volume. Conclusion: Non-invasive detection of fibrin deposition in ischemic mouse brain using NIRF imaging is feasible and this technique may provide an in vivo experimental tool in studying the role of fibrin in stroke.	[Zhang, Yi; Fan, Shufeng; Yao, Yuyu; Ding, Jie; Wang, Yu; Zhao, Zhen; Liao, Lei; Li, Peicheng; Zang, Fengchao; Teng, Gao-Jun] Southeast Univ, Jiangsu Key Lab Mol & Funct Imaging, Zhongda Hosp, Sch Med,Dept Radiol, Nanjing, Jiangsu, Peoples R China	Southeast University - China	Zhang, Y (corresponding author), Southeast Univ, Jiangsu Key Lab Mol & Funct Imaging, Zhongda Hosp, Sch Med,Dept Radiol, Nanjing, Jiangsu, Peoples R China.	gjteng@seu.edu.cn	Zhang, Baohong/O-4948-2016	Ding, Jie/0000-0001-9162-7850	National Natural Science Foundation of China (NSFC) [90606007, 30910103905, 30830039]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This project is sponsored by National Natural Science Foundation of China (NSFC #90606007, #30910103905, and #30830039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RA, 2004, MOL INTERV, V4, P163; ALBERS GW, 1995, AM J CARDIOL, V75, pB34, DOI 10.1016/0002-9149(95)80008-G; Ariens RAS, 2002, BLOOD, V100, P743, DOI 10.1182/blood.V100.3.743; Durukan A, 2007, PHARMACOL BIOCHEM BE, V87, P179, DOI 10.1016/j.pbb.2007.04.015; Gerriets T, 2004, STROKE, V35, P566, DOI 10.1161/01.STR.0000113692.38574.57; Hare T, 2000, J CEREBR BLOOD F MET, V20, P1483, DOI 10.1097/00004647-200010000-00010; Heye N, 1996, STROKE, V27, P431, DOI 10.1161/01.STR.27.3.431; Hilderbrand SA, 2010, CURR OPIN CHEM BIOL, V14, P71, DOI 10.1016/j.cbpa.2009.09.029; Jaffer FA, 2004, CIRCULATION, V110, P170, DOI 10.1161/01.CIR.0000134484.11052.44; Kasahara K, 2010, BLOOD, V115, P1277, DOI 10.1182/blood-2009-06-227645; Kilic E, 1998, NEUROREPORT, V9, P2967, DOI 10.1097/00001756-199809140-00009; Kim DE, 2005, J CEREBR BLOOD F MET, V25, P226, DOI 10.1038/sj.jcbfm.9600023; Klohs J, 2008, STROKE, V39, P2845, DOI 10.1161/STROKEAHA.107.509844; Klohs J, 2006, MOL IMAGING, V5, P180; Klohs J, 2009, J CEREBR BLOOD F MET, V29, P1284, DOI 10.1038/jcbfm.2009.51; Miserus RJJHM, 2009, JACC-CARDIOVASC IMAG, V2, P987, DOI 10.1016/j.jcmg.2009.03.015; Mosesson MW, 2001, ANN NY ACAD SCI, V936, P11; Muszbek L., 2008, Cardiovascular & Hematological Agents in Medicinal Chemistry, V6, P190, DOI 10.2174/187152508784871990; Muszbek L, 2011, PHYSIOL REV, V91, P931, DOI 10.1152/physrev.00016.2010; OKADA Y, 1994, STROKE, V25, P1847, DOI 10.1161/01.STR.25.9.1847; Roger Veronique L, 2011, Circulation, V123, pe18, DOI 10.1161/CIR.0b013e3182009701; Ryu JK, 2009, J THROMB HAEMOST, V7, P151, DOI 10.1111/j.1538-7836.2009.03438.x; Seshadri S, 2006, STROKE, V37, P345, DOI 10.1161/01.STR.0000199613.38911.b2; SIEBLER M, 1994, LANCET, V344, P555, DOI 10.1016/S0140-6736(94)91953-4; Tabrizi P, 1999, ARTERIOSCL THROM VAS, V19, P2801, DOI 10.1161/01.ATV.19.11.2801; Tung CH, 2003, CHEMBIOCHEM, V4, P897, DOI 10.1002/cbic.200300602; Uppal R, 2010, STROKE, V41, P1271, DOI 10.1161/STROKEAHA.109.575662; van Dam GM, 2011, NAT MED, V17, P1315, DOI 10.1038/nm.2472; Wang L, 1997, J CEREBR BLOOD F MET, V17, P136, DOI 10.1097/00004647-199702000-00002; Zhang RL, 1997, BRAIN RES, V766, P83, DOI 10.1016/S0006-8993(97)00580-5; Zhang ZG, 1999, J NEUROSCI, V19, P10898, DOI 10.1523/JNEUROSCI.19-24-10898.1999	31	114	127	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30262	10.1371/journal.pone.0030262	http://dx.doi.org/10.1371/journal.pone.0030262			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22438870	gold, Green Published, Green Submitted			2022-12-25	WOS:000301454400097
J	Gonzalez-Reiche, AS; Morales-Betoulle, ME; Alvarez, D; Betoulle, JL; Muller, ML; Sosa, SM; Perez, DR				Gonzalez-Reiche, Ana S.; Morales-Betoulle, Maria E.; Alvarez, Danilo; Betoulle, Jean-Luc; Mueller, Maria L.; Sosa, Silvia M.; Perez, Daniel R.			Influenza A Viruses from Wild Birds in Guatemala Belong to the North American Lineage	PLOS ONE			English	Article							PATHOGENIC AVIAN INFLUENZA; SOUTH-AMERICA; PASSERINE BIRDS; MIGRATORY WATERFOWL; RESIDENT DUCKS; CONTAINS GENES; H5N1; HEMAGGLUTININ; TRANSMISSION; OUTBREAK	The role wild bird species play in the transmission and ecology of avian influenza virus (AIV) is well established; however, there are significant gaps in our understanding of the worldwide distribution of these viruses, specifically about the prevalence and/or significance of AIV in Central and South America. As part of an assessment of the ecology of AIV in Guatemala, we conducted active surveillance in wild birds on the Pacific and Atlantic coasts. Cloacal and tracheal swab samples taken from resident and migratory wild birds were collected from February 2007 to January 2010.1913 samples were collected and virus was detected by real time RT-PCR (rRT-PCR) in 28 swab samples from ducks (Anas discors). Virus isolation was attempted for these positive samples, and 15 isolates were obtained from the migratory duck species Blue-winged teal. The subtypes identified included H7N9, H11N2, H3N8, H5N3, H8N4, and H5N4. Phylogenetic analysis of the viral sequences revealed that AIV isolates are highly similar to viruses from the North American lineage suggesting that bird migration dictates the ecology of these viruses in the Guatemalan bird population.	[Gonzalez-Reiche, Ana S.; Perez, Daniel R.] Univ Maryland Coll Pk, Dept Vet Med, College Pk, MD 20742 USA; [Gonzalez-Reiche, Ana S.; Perez, Daniel R.] Virginia Maryland Reg Coll Vet Med, College Pk, MD USA; [Gonzalez-Reiche, Ana S.; Morales-Betoulle, Maria E.; Alvarez, Danilo; Betoulle, Jean-Luc; Mueller, Maria L.; Sosa, Silvia M.] CES UVG, Lab Ecol Arbovirus & Virus Zoonoticos, Guatemala City, Guatemala; [Betoulle, Jean-Luc] Fdn Para Ecodesarrollo & Conservacion FUNDAECO, Guatemala City, Guatemala	University System of Maryland; University of Maryland College Park	Gonzalez-Reiche, AS (corresponding author), Univ Maryland Coll Pk, Dept Vet Med, College Pk, MD 20742 USA.	agonzalez@ces.uvg.edu.gt; dperez1@umd.edu	Perez, Daniel R./D-5044-2016; Gonzalez-Reiche, Ana/ABH-2585-2020	Perez, Daniel R./0000-0002-6569-5689; Gonzalez-Reiche, Ana/0000-0003-3583-4497; Arroyo-Rodriguez, Victor/0000-0002-0858-0324; Chapman, Colin/0000-0002-8827-8140	National Institute of Allergy and Infectious Diseases (NIAID) Center for Research on Influenza Pathogenesis (CRIP) through University of Maryland College Park [HHSN266200700010C]; Guatemala's National Council of Science and Technology (CONCYT) [97-2006]; Centers for Disease Control [U50/CCU021236-01]; Universidad del Valle de Guatemala [U50/CCU021236-01, Z507225]; University of Maryland [Z507225]	National Institute of Allergy and Infectious Diseases (NIAID) Center for Research on Influenza Pathogenesis (CRIP) through University of Maryland College Park; Guatemala's National Council of Science and Technology (CONCYT); Centers for Disease Control(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Universidad del Valle de Guatemala; University of Maryland	This work was mainly supported by the National Institute of Allergy and Infectious Diseases (NIAID) Center for Research on Influenza Pathogenesis (CRIP) through University of Maryland College Park contract No. HHSN266200700010C, with partial funding from the Avian Influenza Coordinated Agricultural Project (AICAP) Subaward Z507225 between the University of Maryland and Universidad del Valle de Guatemala, Guatemala's National Council of Science and Technology (CONCYT) through the project FODECYT 97-2006, and the Cooperative Agreement between the Centers for Disease Control and Universidad del Valle de Guatemala No. #U50/CCU021236-01 for collection of terrestrial bird samples. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; Alvarez P, 2010, VIROLOGY, V396, P76, DOI 10.1016/j.virol.2009.10.009; Artois M, 2009, REV SCI TECH OIE, V28, P69, DOI 10.20506/rst.28.1.1854; Bahl J, 2009, VIROLOGY, V390, P289, DOI 10.1016/j.virol.2009.05.002; Boyce WM, 2009, COMP IMMUNOL MICROB, V32, P275, DOI 10.1016/j.cimid.2008.01.002; Brown JD, 2007, J WILDLIFE DIS, V43, P660, DOI 10.7589/0090-3558-43.4.660; Carbonell M., 2002, KNOW YOUR DUCKS WATE; Cerezo A, 2009, REV BIOL TROP, V57, P401; Cerezo AM, 2001, DETERMINACION COMP E; Chen H, 2005, NATURE, V436, P191, DOI 10.1038/nature03974; Cuevas-Dominguez EA, 2009, REDVET REV ELECT VET, V10; de Andrade CR, 2009, J BRAS PNEUMOL, V35, P470, DOI 10.1590/S1806-37132009000500014; de Jong MCM, 2009, REV SCI TECH OIE, V28, P333; Dierauf LA, 2006, JAVMA-J AM VET MED A, V228, P1877, DOI 10.2460/javma.228.12.1877; Dugan VG, 2011, VIROLOGY, V417, P98, DOI 10.1016/j.virol.2011.05.004; Eagles D, 2009, REV SCI TECH OIE, V28, P341, DOI 10.20506/rst.28.1.1864; Feare CJ, 2007, AVIAN DIS, V51, P440, DOI 10.1637/7575-040106R1.1; Feare CJ, 2010, AVIAN DIS, V54, P201, DOI 10.1637/8766-033109-ResNote.1; Ferro PJ, 2010, EMERG INFECT DIS, V16, P1224, DOI 10.3201/eid1608.091864; Ferro PJ, 2010, AVIAN DIS, V54, P655, DOI 10.1637/8810-040109-ResNote.1; Fouchier RAM, 2009, REV SCI TECH OIE, V28, P49, DOI 10.20506/rst.28.1.1863; Fuller TL, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-187; Gammonley JH, 1995, LIFE HIST MANAGEMENT; Ghersi BM, 2009, EMERG INFECT DIS, V15, P935, DOI 10.3201/eid1506.080981; Globig A, 2009, TRANSBOUND EMERG DIS, V56, P57, DOI 10.1111/j.1865-1682.2008.01061.x; Greenberg R, 1993, BRIDGING AM MIGRATOR; Gronesova P, 2008, SCAND J INFECT DIS, V40, P954, DOI 10.1080/00365540802400576; Hansbro PM, 2010, EMERG INFECT DIS, V16, P1896, DOI 10.3201/eid1612.100776; Hanson BA, 2005, J WILDLIFE DIS, V41, P624, DOI 10.7589/0090-3558-41.3.624; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Howell S. N. G., 1995, GUIDE BIRDS MEXICO N; IBRAHIM HM, 1990, VET REC, V127, P528; Kaleta EF, 2004, DEUT TIERARZTL WOCH, V111, P467; Kelly TR, 2008, J AVIAN MED SURG, V22, P1, DOI 10.1647/2006-036R.1; Komar N, 2006, REV PANAM SALUD PUBL, V19, P112, DOI 10.1590/S1020-49892006000200006; Krauss S, 2004, VECTOR-BORNE ZOONOT, V4, P177, DOI 10.1089/vbz.2004.4.177; Krauss S, 2007, PLOS PATHOG, V3, P1684, DOI 10.1371/journal.ppat.0030167; Lee CW, 2004, AVIAN PATHOL, V33, P288, DOI 10.1080/0307945042000203407; Lupiani B, 2009, COMP IMMUNOL MICROB, V32, P311, DOI 10.1016/j.cimid.2008.01.004; Makarova NA, 1999, J GEN VIROL, V80, P3167, DOI 10.1099/0022-1317-80-12-3167; Melville DS, 2006, LETT APPL MICROBIOL, V42, P435, DOI 10.1111/j.1472-765X.2006.01892.x; Munster VJ, 2009, VACCINE, V27, P6340, DOI 10.1016/j.vaccine.2009.02.082; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; NESTOROWICZ A, 1987, VIROLOGY, V160, P411, DOI 10.1016/0042-6822(87)90012-2; Neumann G, 2010, CELL RES, V20, P51, DOI 10.1038/cr.2009.124; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; OIE, 2011, UPD HYGHL PATH AV IN; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Parker TA III, 1996, NEOTROPICAL BIRDS EC; Pedersen K, 2010, AVIAN DIS, V54, P405, DOI 10.1637/8693-031309-Reg.1; Perdue ML, 2000, VET MICROBIOL, V74, P77, DOI 10.1016/S0378-1135(00)00168-1; Pereda AJ, 2008, VIROLOGY, V378, P363, DOI 10.1016/j.virol.2008.06.010; Peterson AT, 2008, EMERG INFECT DIS, V14, P1644, DOI 10.3201/eid1410.080169; Rappole J. H., 1995, NEARCTIC AVIAN MIGRA; ROY G, 1983, REV CAN BIOL EXPTL, V42, P73; Senne DA, 2003, AVIAN DIS, V47, P798, DOI 10.1637/0005-2086-47.s3.798; Senne DA, 2007, AVIAN DIS, V51, P167, DOI 10.1637/7621-042606R1.1; Senne DA, 2010, AVIAN DIS, V54, P179, DOI 10.1637/8921-050809-Review.1; Siguenza de Micheo R, 2007, INFORM CONTEOS ANATI; Song H, 2007, J VIROL, V81, P9238, DOI 10.1128/JVI.00893-07; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Spackman E, 2007, AVIAN DIS, V51, P273, DOI 10.1637/7529-032106R.1; Spackman E, 2006, J VIROL, V80, P7760, DOI 10.1128/JVI.00445-06; Spackman Erica, 2008, V436, P13, DOI 10.1007/978-1-59745-279-3_3; STALLKNECHT DE, 1988, VET RES COMMUN, V12, P125, DOI 10.1007/BF00362792; STALLKNECHT DE, 1990, AVIAN DIS, V34, P398, DOI 10.2307/1591427; Suarez DL, 2004, EMERG INFECT DIS, V10, P693, DOI 10.3201/eid1004.030396; Villarreal C, 2009, REV SCI TECH OIE, V28, P261, DOI 10.20506/rst.28.1.1877; Wallensten A, 2007, EMERG INFECT DIS, V13, P404, DOI 10.3201/eid1303.061130; Webster R, 2002, WHO MANUAL ANIMAL IN; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Wilcox BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024010	72	52	54	1	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2012	7	3							e32873	10.1371/journal.pone.0032873	http://dx.doi.org/10.1371/journal.pone.0032873			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930IA	22427902	Green Published, Green Submitted, gold			2022-12-25	WOS:000303129700018
J	Jin, Y; Liu, Z; Cao, W; Ma, XY; Fan, YH; Yu, Y; Bai, J; Chen, F; Rosales, J; Lee, KY; Fu, SB				Jin, Yan; Liu, Zheng; Cao, Wei; Ma, Xinying; Fan, Yihui; Yu, Yang; Bai, Jing; Chen, Feng; Rosales, Jesusa; Lee, Ki-Young; Fu, Songbin			Novel Functional MAR Elements of Double Minute Chromosomes in Human Ovarian Cells Capable of Enhancing Gene Expression	PLOS ONE			English	Article							MATRIX ATTACHMENT REGIONS; DNA; AMPLIFICATION; ONCOGENE; CARCINOMA; SCAFFOLD; SITES; ORGANIZATION; SEQUENCES; LOOP	Double minute chromosomes or double minutes (DMs) are cytogenetic hallmarks of extrachromosomal genomic amplification and play a critical role in tumorigenesis. Amplified copies of oncogenes in DMs have been associated with increased growth and survival of cancer cells but DNA sequences in DMs which are mostly non-coding remain to be characterized. Following sequencing and bioinformatics analyses, we have found 5 novel matrix attachment regions (MARs) in a 682 kb DM in the human ovarian cancer cell line, UACC-1598. By electrophoretic mobility shift assay (EMSA), we determined that all 5 MARs interact with the nuclear matrix in vitro. Furthermore, qPCR analysis revealed that these MARs associate with the nuclear matrix in vivo, indicating that they are functional. Transfection of MARs constructs into human embryonic kidney 293T cells showed significant enhancement of gene expression as measured by luciferase assay, suggesting that the identified MARS, particularly MARs 1 to 4, regulate their target genes in vivo and are potentially involved in DM-mediated oncogene activation.	[Jin, Yan; Liu, Zheng; Cao, Wei; Ma, Xinying; Fan, Yihui; Yu, Yang; Bai, Jing; Chen, Feng; Fu, Songbin] Harbin Med Univ, Med Genet Lab, Harbin, Peoples R China; [Rosales, Jesusa] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Lee, Ki-Young] Univ Calgary, Dept Cell Biol & Anat, Calgary, AB, Canada	Harbin Medical University; University of Calgary; University of Calgary	Jin, Y (corresponding author), Harbin Med Univ, Med Genet Lab, Harbin, Peoples R China.	fusb@ems.hrbmu.edu.cn	; Jin, Guangze/F-5271-2017	Liu, Zhili/0000-0001-7704-5133; Jin, Guangze/0000-0002-9852-0965; Rosales, Jesusa/0000-0002-2543-3801	National Basic Research Program of China [2010CB534901]; National Natural Science Foundation of China [30971583, 30800268, 81000906]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Basic Research Program of China (No. 2010CB534901) and the National Natural Science Foundation of China (No. 30971583, No. 30800268, and No. 81000906). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI Y, 1989, EMBO J, V8, P3997, DOI 10.1002/j.1460-2075.1989.tb08582.x; ALITALO K, 1983, P NATL ACAD SCI-BIOL, V80, P1707, DOI 10.1073/pnas.80.6.1707; Allen GC, 2000, PLANT MOL BIOL, V43, P361, DOI 10.1023/A:1006424621037; Bode J, 2000, CRIT REV EUKAR GENE, V10, P73; Bode J, 2000, J CELL BIOCH SUPPL S, P353; COCKERILL PN, 1986, FEBS LETT, V204, P5, DOI 10.1016/0014-5793(86)81377-1; FAKHARZADEH SS, 1993, GENOMICS, V15, P283, DOI 10.1006/geno.1993.1058; Fan YH, 2011, J APPL GENET, V52, P53, DOI 10.1007/s13353-010-0007-z; Fukuda Y, 1999, PLANT MOL BIOL, V39, P1051, DOI 10.1023/A:1006133003283; GEBHART E, 1984, INT J CANCER, V34, P369, DOI 10.1002/ijc.2910340313; Gebhart Erich, 2005, Clin Transl Oncol, V7, P477, DOI 10.1007/BF02717000; Girod PA, 2005, BIOTECHNOL BIOENG, V91, P1, DOI 10.1002/bit.20563; Guan XY, 2001, CANCER RES, V61, P3806; HAHN PJ, 1993, BIOESSAYS, V15, P477, DOI 10.1002/bies.950150707; Kim JM, 2004, J BIOTECHNOL, V107, P95, DOI 10.1016/j.jbiotec.2003.09.015; Kuttler F, 2007, SEMIN CANCER BIOL, V17, P56, DOI 10.1016/j.semcancer.2006.10.007; Kwaks THJ, 2006, TRENDS BIOTECHNOL, V24, P137, DOI 10.1016/j.tibtech.2006.01.007; Lestou VS, 2003, BRIT J HAEMATOL, V122, P745, DOI 10.1046/j.1365-2141.2003.04502.x; Martins RP, 2004, J BIOL CHEM, V279, P51862, DOI 10.1074/jbc.M409415200; MCGILL JR, 1993, CANCER GENET CYTOGEN, V71, P125, DOI 10.1016/0165-4608(93)90017-G; MIRKOVITCH J, 1984, CELL, V39, P223, DOI 10.1016/0092-8674(84)90208-3; Morales C, 2009, MOL CANCER THER, V8, P424, DOI 10.1158/1535-7163.MCT-08-0759; MULERIS M, 1994, ONCOGENE, V9, P2717; Neznanov N, 1996, MOL BIOL CELL, V7, P541, DOI 10.1091/mbc.7.4.541; PEACH C, 1991, PLANT MOL BIOL, V17, P49, DOI 10.1007/BF00036805; Singer MJ, 2000, P NATL ACAD SCI USA, V97, P7921, DOI 10.1073/pnas.130194897; SLOVAK ML, 1994, GENE CHROMOSOME CANC, V9, P62, DOI 10.1002/gcc.2870090111; SPRIGGS AI, 1962, BRIT MED J, P1431, DOI 10.1136/bmj.2.5317.1431; SREEKANTAIAH C, 1992, CANCER GENET CYTOGEN, V58, P134, DOI 10.1016/0165-4608(92)90099-T; Tetko IV, 2006, PLOS COMPUT BIOL, V2, P136, DOI 10.1371/journal.pcbi.0020021; van Leeuwen W, 2001, PLANT MOL BIOL, V47, P543, DOI 10.1023/A:1011840310436; VANDEVANTER DR, 1990, J NATL CANCER I, V82, P1815, DOI 10.1093/jnci/82.23.1815; WAHL GM, 1989, CANCER RES, V49, P1333; Yoshimoto M, 1999, AM J PATHOL, V155, P1439, DOI 10.1016/S0002-9440(10)65457-0	34	55	60	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e30419	10.1371/journal.pone.0030419	http://dx.doi.org/10.1371/journal.pone.0030419			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22427822	gold, Green Published, Green Submitted			2022-12-25	WOS:000302178400008
J	Li, ZH; Lu, CX; Peng, B; Zeng, H; Zhou, ZG; Wu, YM; Zhong, GM				Li, Zhihong; Lu, Chunxue; Peng, Bo; Zeng, Hao; Zhou, Zhiguan; Wu, Yimou; Zhong, Guangming			Induction of Protective Immunity against Chlamydia muridarum Intravaginal Infection with a Chlamydial Glycogen Phosphorylase	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; CLASS-II COMPLEXES; TRACHOMATIS INFECTION; ACQUIRED-IMMUNITY; VACCINATION; INHIBITION; CELLS; MICE; IMMUNIZATION; HYDROSALPINX	We evaluated 7 C. muridarum ORFs for their ability to induce protection against chlamydial infection in a mouse intravaginal infection model. These antigens, although encoded in C. muridarum genome, are transcriptionally regulated by a cryptic plasmid that is known to contribute to C. muridarum pathogenesis. Of the 7 plasmid-regulated ORFs, the chlamydial glycogen phosphorylase or GlgP, when delivered into mice intramuscularly, induced the most pronounced protective immunity against C. muridarum intravaginal infection. The GlgP-immunized mice displayed a significant reduction in vaginal shedding of live organisms on day 14 after infection. The protection correlated well with a robust C. muridarum-specific antibody and a Th1-dominant T cell responses, which significantly reduced the severity but not overall incidence of hydrosalpinx. The GlgP-induced partial protection against upper genital tract pathology suggests that GlgP may be considered a component for a multi-subunit vaccine. These results have demonstrated that intramuscular immunization of mice with purified proteins can be used to identify vaccine antigens for preventing intravaginal infection with C. trachomatis in humans.	[Li, Zhihong; Lu, Chunxue; Peng, Bo; Zeng, Hao; Zhong, Guangming] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA; [Li, Zhihong; Zhou, Zhiguan] Cent S Univ, Xiangya Hosp 2, Dept Surg, Changsha, Hunan, Peoples R China; [Lu, Chunxue; Peng, Bo; Wu, Yimou] Univ S China, Dept Pathol & Microbiol, Hengyang, Hunan, Peoples R China	University of Texas System; University of Texas Health San Antonio; Central South University; University of South China	Li, ZH (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA.	Zhongg@uthscsa.edu			National Institutes of Health [R01AI64537]; Merck-UT; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064537] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck-UT; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant number R01AI64537 and a Merck-UT sponsorship (2009-2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carlson JH, 2008, INFECT IMMUN, V76, P2273, DOI 10.1128/IAI.00102-08; [Centers for Disease Control and Prevention C Services USDoHaH], 2009, SEX TRANSM DIS SURV; Chen LL, 2010, J IMMUNOL, V184, P2602, DOI 10.4049/jimmunol.0901593; Cheng W, 2008, INFECT IMMUN, V76, P942, DOI 10.1128/IAI.01313-07; Cheng W, 2008, INFECT IMMUN, V76, P515, DOI 10.1128/IAI.01064-07; EISSENBERG LG, 1981, INFECT IMMUN, V32, P889, DOI 10.1128/IAI.32.2.889-896.1981; Fan T, 1998, J EXP MED, V187, P487, DOI 10.1084/jem.187.4.487; GRAYSTON JT, 1962, ANN NY ACAD SCI, V98, P352, DOI 10.1111/j.1749-6632.1962.tb30558.x; Greene W, 2004, INFECT IMMUN, V72, P451, DOI 10.1128/IAI.72.1.451-460.2004; Johnson N, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002125.pub3; Karunakaran KP, 2008, J IMMUNOL, V180, P2459, DOI 10.4049/jimmunol.180.4.2459; Kinnunen AH, 2002, HUM REPROD, V17, P2073, DOI 10.1093/humrep/17.8.2073; Lei L, 2011, MICROB PATHOGENESIS, V51, P101, DOI 10.1016/j.micpath.2011.05.002; Li ZY, 2008, INFECT IMMUN, V76, P2746, DOI 10.1128/IAI.00010-08; Morrison RP, 2002, INFECT IMMUN, V70, P2741, DOI 10.1128/IAI.70.6.2741-2751.2002; MORRISON RP, 1995, INFECT IMMUN, V63, P4661, DOI 10.1128/IAI.63.12.4661-4668.1995; Morrison SG, 2005, J IMMUNOL, V175, P7536, DOI 10.4049/jimmunol.175.11.7536; O'Connell CM, 2007, J IMMUNOL, V179, P4027, DOI 10.4049/jimmunol.179.6.4027; Olivares-Zavaleta N, 2010, VACCINE, V28, P1454, DOI 10.1016/j.vaccine.2009.11.073; Pal S, 2005, INFECT IMMUN, V73, P8153, DOI 10.1128/IAI.73.12.8153-8160.2005; Pal S, 2002, INFECT IMMUN, V70, P4812, DOI 10.1128/IAI.70.9.4812-4817.2002; Pal S, 1999, VACCINE, V17, P459, DOI 10.1016/S0264-410X(98)00219-9; Peterman TA, 2006, ANN INTERN MED, V145, P564, DOI 10.7326/0003-4819-145-8-200610170-00005; Qi ML, 2011, J BACTERIOL, V193, P2498, DOI 10.1128/JB.01301-10; Rockey DD, 2009, EXPERT REV VACCINES, V8, P1365, DOI 10.1586/ERV.09.98; Rodgers AK, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.06.005; Sharma J, 2006, INFECT IMMUN, V74, P1490, DOI 10.1128/IAI.74.3.1490-1499.2006; SHERMAN KJ, 1990, SEX TRANSM DIS, V17, P115, DOI 10.1097/00007435-199007000-00001; Stephens RS, 2003, TRENDS MICROBIOL, V11, P44, DOI 10.1016/S0966-842X(02)00011-2; Strandell A, 2000, HUM REPROD UPDATE, V6, P387, DOI 10.1093/humupd/6.4.387; Strandell A, 1999, HUM REPROD, V14, P2762, DOI 10.1093/humrep/14.11.2762; Strandell A, 2004, J ASSIST REPROD GEN, V21, P241, DOI 10.1023/B:JARG.0000042009.93520.15; Wang J, 2010, J IMMUNOL, V185, P1670, DOI 10.4049/jimmunol.1001240; Wang J, 2009, VACCINE, V27, P2967, DOI 10.1016/j.vaccine.2009.02.095; Xiao YM, 2005, J IMMUNOL, V174, P1701, DOI 10.4049/jimmunol.174.3.1701; Zhong G, 2011, CURR CHEM BIOL, V5, P9; Zhong GM, 1997, P NATL ACAD SCI USA, V94, P13856, DOI 10.1073/pnas.94.25.13856; Zhong GM, 1997, J EXP MED, V186, P673, DOI 10.1084/jem.186.5.673; Zhong GM, 2001, J EXP MED, V193, P935, DOI 10.1084/jem.193.8.935; Zhong GM, 2009, TRENDS MICROBIOL, V17, P467, DOI 10.1016/j.tim.2009.07.007	41	133	150	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2012	7	3							e32997	10.1371/journal.pone.0032997	http://dx.doi.org/10.1371/journal.pone.0032997			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920DF	22792223	Green Submitted, Green Published, gold			2022-12-25	WOS:000302381500072
J	Kong, XB; Liu, KW; Wang, HB; Zhang, SF; Zhang, Z				Kong, Xiang-Bo; Liu, Kui-Wei; Wang, Hong-Bin; Zhang, Su-Fang; Zhang, Zhen			Identification and Behavioral Evaluation of Sex Pheromone Components of the Chinese Pine Caterpillar Moth, Dendrolimus tabulaeformis	PLOS ONE			English	Article							MASS-SPECTROMETRY; ATTRACTANT; ACETATES; SUPERANS	Background: The Chinese pine caterpillar moth, Dendrolimus tabulaeformis Tsai and Liu (Lepidoptera: Lasiocampidae) is the most important defoliator of coniferous trees in northern China. Outbreaks occur over enormous areas and often lead to the death of forests during 2-3 successive years of defoliation. The sex pheromone of D. tabulaeformis was investigated to define its chemistry and behavioral activity. Methodology/Principal Findings: Sex pheromone was collected from calling female D. tabulaeformis by headspace solid phase microextraction (SPME) and by solvent extraction of pheromone glands. Extracts were analyzed by coupled gas chromatography/mass spectrometry (GC-MS) and coupled GC-electroantennographic detection (GC-EAD), using antennae from male moths. Five components from the extracts elicited antennal responses. These compounds were identified by a combination of retention indices, electron impact mass spectral matches, and derivatization as (Z)-5-dodecenyl acetate (Z5-12:OAc), (Z)-5-dodecenyl alcohol (Z5-12:OH), (5Z,7E)-5,7-dodecadien-1-yl acetate (Z5,E7-12:OAc), (5Z,7E)-5,7-dodecadien-1-yl propionate (Z5,E7-12:OPr), and (5Z,7E)-5,7-dodecadien-1-ol (Z5,E7-12:OH). Behavioral assays showed that male D. tabulaeformis strongly discriminated against incomplete and aberrant blend ratios. The correct ratio of Z5,E7-12:OAc, Z5,E7-12:OH, and Z5,E7-12:OPr was essential for optimal upwind flight and source contact. The two monoenes, Z5-12:OAc and Z5-12:OH, alone or binary mixtures, had no effect on behavioral responses when added to the optimal three-component blend. Conclusions/Significance: The fact that deviations from the optimal ratio of 100:100:4.5 of Z5,E7-12:OAc, Z5,EZ7-12:OH, and Z5,E7-12:OPr resulted in marked decreases in male responses suggests that biosynthesis of the pheromone components is precisely controlled. The optimal blend of the sex pheromone components of D. tabulaeformis worked out in this study should find immediate use in monitoring this pest in Chinese forests.	[Kong, Xiang-Bo; Liu, Kui-Wei; Wang, Hong-Bin; Zhang, Su-Fang; Zhang, Zhen] Chinese Acad Forestry, State Forestry Adm, Res Inst Forest Ecol Environm & Protect, Key Lab Forest Protect, Beijing, Peoples R China; [Liu, Kui-Wei] Shandong Agr Univ, Inst Plant Protect, Tai An, Shandong, Peoples R China	Chinese Academy of Forestry; Research Institute of Forest Ecology, Environment and Protection, CAF; Shandong Agricultural University	Kong, XB (corresponding author), Chinese Acad Forestry, State Forestry Adm, Res Inst Forest Ecol Environm & Protect, Key Lab Forest Protect, Beijing, Peoples R China.	zhangzhen@caf.ac.cn	Wang, Hongbin/N-5851-2018	Wang, Hongbin/0000-0002-3355-2448; Zhang, Weijie/0000-0002-6462-6067	CAF [CAFRIFEEP201002]; National Natural Science Foundation of China [30771737]	CAF; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from National Nonprofit Institute Research Grant of CAF (CAFRIFEEP201002), and partially supported from the National Natural Science Foundation of China (Grant No. 30771737). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDO T, 1982, AGR BIOL CHEM TOKYO, V46, P709, DOI 10.1080/00021369.1982.10865117; BUSER HR, 1983, ANAL CHEM, V55, P818, DOI 10.1021/ac00257a003; Klun JA, 2000, J ENTOMOL SCI, V35, P158, DOI 10.18474/0749-8004-35.2.158; Kong XB, 2001, CHINESE SCI BULL, V46, P2077; Kong XB, 2007, J CHEM ECOL, V33, P1316, DOI 10.1007/s10886-007-9313-2; Kong Xiang-Bo, 2003, Acta Entomologica Sinica, V46, P131; Kong XB, 2007, ENTOMOL EXP APPL, V124, P37, DOI 10.1111/j.1570-7458.2007.00562.x; Kong XB, 2011, J CHEM ECOL, V37, P412, DOI 10.1007/s10886-011-9932-5; Kovalev B. G., 1993, Chemistry of Natural Compounds, V29, P135, DOI 10.1007/BF00631042; LINN CE, 1986, J CHEM ECOL, V12, P659, DOI 10.1007/BF01012100; Marques FD, 2000, J BRAZIL CHEM SOC, V11, P592; McElfresh JS, 1999, J CHEM ECOL, V25, P687, DOI 10.1023/A:1020876229787; Meng X.-z., 1983, Scientia Silvae Sinicae, V19, P137; Millar JG, 2000, ANNU REV ENTOMOL, V45, P575, DOI 10.1146/annurev.ento.45.1.575; PRIESNER E, 1984, Z NATURFORSCH C, V39, P1192; Yan JJ, 1991, FOREST INSECTS CHINA, P961; YOUNG DC, 1990, J CHROMATOGR, V522, P295, DOI 10.1016/0021-9673(90)85199-6; Zhao Cheng-Hua, 1993, Acta Entomologica Sinica, V36, P247	18	136	145	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2012	7	3							e33381	10.1371/journal.pone.0033381	http://dx.doi.org/10.1371/journal.pone.0033381			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930IA	22876288	Green Published, Green Submitted, gold			2022-12-25	WOS:000303129700057
J	Peng, XJ; Zhao, Y; Cao, JG; Zhang, W; Jiang, HY; Li, XY; Ma, Q; Zhu, SW; Cheng, BJ				Peng, Xiaojian; Zhao, Yang; Cao, Jiangang; Zhang, Wei; Jiang, Haiyang; Li, Xiaoyu; Ma, Qing; Zhu, Suwen; Cheng, Beijiu			CCCH-Type Zinc Finger Family in Maize: Genome-Wide Identification, Classification and Expression Profiling under Abscisic Acid and Drought Treatments	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; RNA-BINDING PROTEINS; ANKYRIN REPEAT; MESSENGER-RNA; STRESS RESPONSES; GENE FAMILIES; ARABIDOPSIS; TOLERANCE; ELEMENTS; TRISTETRAPROLIN	Background: CCCH-type zinc finger proteins comprise a large protein family. Increasing evidence suggests that members of this family are RNA-binding proteins with regulatory functions in mRNA processing. Compared with those in animals, functions of CCCH-type zinc finger proteins involved in plant growth and development are poorly understood. Methodology/Principal Findings: Here, we performed a genome-wide survey of CCCH-type zinc finger genes in maize (Zea mays L.) by describing the gene structure, phylogenetic relationships and chromosomal location of each family member. Promoter sequences and expression profiles of putative stress-responsive members were also investigated. A total of 68 CCCH genes (ZmC3H1-68) were identified in maize and divided into seven groups by phylogenetic analysis. These 68 genes were found to be unevenly distributed on 10 chromosomes with 15 segmental duplication events, suggesting that segmental duplication played a major role in expansion of the maize CCCH family. The Ka/Ks ratios suggested that the duplicated genes of the CCCH family mainly experienced purifying selection with limited functional divergence after duplication events. Twelve maize CCCH genes grouped with other known stress-responsive genes from Arabidopsis were found to contain putative stress-responsive cis-elements in their promoter regions. Seven of these genes chosen for further quantitative real-time PCR analysis showed differential expression patterns among five representative maize tissues and over time in response to abscisic acid and drought treatments. Conclusions: The results presented in this study provide basic information on maize CCCH proteins and form the foundation for future functional studies of these proteins, especially for those members of which may play important roles in response to abiotic stresses.	[Peng, Xiaojian; Zhao, Yang; Cao, Jiangang; Zhang, Wei; Jiang, Haiyang; Li, Xiaoyu; Ma, Qing; Zhu, Suwen; Cheng, Beijiu] Anhui Agr Univ, Key Lab Crop Biol Anhui Prov, Hefei, Peoples R China	Anhui Agricultural University	Peng, XJ (corresponding author), Anhui Agr Univ, Key Lab Crop Biol Anhui Prov, Hefei, Peoples R China.	bjchengahau@163.com			National Natural Science Foundation of China [31071423, 11075001]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064537] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Natural Science Foundation of China (No. 31071423 and 11075001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht V, 2003, PLANT J, V36, P457, DOI 10.1046/j.1365-313X.2003.01892.x; Bai CY, 1996, MOL CELL BIOL, V16, P6661; Becerra C, 2004, GENE, V340, P111, DOI 10.1016/j.gene.2004.06.006; Berg JM, 1996, SCIENCE, V271, P1081, DOI 10.1126/science.271.5252.1081; Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; BORK P, 1993, PROTEINS, V17, P363, DOI 10.1002/prot.340170405; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Delaney KJ, 2006, PLANT PHYSIOL, V140, P1507, DOI 10.1104/pp.105.070672; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Gao GX, 2002, SCIENCE, V297, P1703, DOI 10.1126/science.1074276; Gaut BS, 2002, NEW PHYTOL, V154, P15, DOI 10.1046/j.1469-8137.2002.00352.x; Gaut BS, 1996, P NATL ACAD SCI USA, V93, P10274, DOI 10.1073/pnas.93.19.10274; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Guo YH, 2009, NEW PHYTOL, V183, P62, DOI 10.1111/j.1469-8137.2009.02838.x; Haberer G, 2004, PLANT PHYSIOL, V136, P3009, DOI 10.1104/pp.104.046466; Hall TMT, 2005, CURR OPIN STRUC BIOL, V15, P367, DOI 10.1016/j.sbi.2005.04.004; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Hurt JA, 2009, J CELL BIOL, V185, P265, DOI 10.1083/jcb.200811072; Kasuga M, 1999, NAT BIOTECHNOL, V17, P287, DOI 10.1038/7036; Kosarev P, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-4-research0016; Lai WS, 2003, MOL CELL BIOL, V23, P3798, DOI 10.1128/MCB.23.11.3798-3812.2003; Lai WS, 2000, J BIOL CHEM, V275, P17827, DOI 10.1074/jbc.M001696200; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Li JJ, 2001, PLANT CELL, V13, P2269, DOI 10.1105/tpc.13.10.2269; Li ZS, 1998, PLANT CELL, V10, P383, DOI 10.1105/tpc.10.3.383; Liang J, 2008, J BIOL CHEM, V283, P6337, DOI 10.1074/jbc.M707861200; Lijavetzky D, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-17; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorkovic ZJ, 2002, NUCLEIC ACIDS RES, V30, P623, DOI 10.1093/nar/30.3.623; Lu G, 2009, PLANTA, V229, P605, DOI 10.1007/s00425-008-0857-3; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Moore RC, 2003, P NATL ACAD SCI USA, V100, P15682, DOI 10.1073/pnas.2535513100; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Narusaka Y, 2003, PLANT J, V34, P137, DOI 10.1046/j.1365-313X.2003.01708.x; PLA M, 1993, PLANT MOL BIOL, V21, P259, DOI 10.1007/BF00019942; Quraishi UM, 2011, PLANT J, V65, P745, DOI 10.1111/j.1365-313X.2010.04461.x; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Salse J, 2008, PLANT CELL, V20, P11, DOI 10.1105/tpc.107.056309; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Sedgwick SG, 1999, TRENDS BIOCHEM SCI, V24, P311, DOI 10.1016/S0968-0004(99)01426-7; Seong ES, 2007, J BIOCHEM MOL BIOL, V40, P952; Sun JQ, 2007, PLANT CELL PHYSIOL, V48, P1148, DOI 10.1093/pcp/pcm088; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang D, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-44; Wang YJ, 2010, MOL BIOL REP, V37, P3991, DOI 10.1007/s11033-010-0058-6; Wei F, 2007, PLOS GENET, V3, P1254, DOI 10.1371/journal.pgen.0030123; Xiang Y, 2007, PLANT PHYSIOL, V144, P1416, DOI 10.1104/pp.107.101295; Zhang WX, 2005, BIOINFORMATICS, V21, P3074, DOI 10.1093/bioinformatics/bti490; Zhang XH, 2011, MOL GENET GENOMICS, V285, P79, DOI 10.1007/s00438-010-0587-7; Zhang YJ, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-1; Zhao Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028488	55	133	150	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e40120	10.1371/journal.pone.0040120	http://dx.doi.org/10.1371/journal.pone.0040120			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22792223	Green Submitted, Green Published, gold			2022-12-25	WOS:000306461800041
J	Bukowski, R; Davis, KE; Wilson, PWF				Bukowski, Radek; Davis, Karen E.; Wilson, Peter W. F.			Delivery of a Small for Gestational Age Infant and Greater Maternal Risk of Ischemic Heart Disease	PLOS ONE			English	Article							PARENTAL CARDIOVASCULAR-DISEASE; BIRTH-WEIGHT; FOLLOW-UP; MORTALITY; PREECLAMPSIA; HISTORY; ATHEROSCLEROSIS; PREGNANCY; ACCURACY; PRETERM	Background: Delivery of a small for gestational age (SGA) infant has been associated with increased maternal risk of ischemic heart disease (IHD). It is uncertain whether giving birth to SGA infant is a specific determinant of later IHD, independent of other risk factors, or a marker of general poor health. The purpose of this study was to investigate the association between delivery of a SGA infant and maternal risk for IHD in relation to traditional IHD risk factors. Methods and Findings: Risk of maternal IHD was evaluated in a population based cross-sectional study of 6,608 women with a prior live term birth who participated in the National Health and Nutrition Examination Survey (1999-2006), a probability sample of the U.S. population. Sequence of events was determined from age at last live birth and at diagnosis of IHD. Delivery of a SGA infant is strongly associated with greater maternal risk for IHD (age adjusted OR; 95% CI: 1.8; 1.2, 2.9; p = 0.012). The association was independent of the family history of IHD, stroke, hypertension and diabetes (family history-adjusted OR; 95% CI: 1.9; 1.2, 3.0; p = 0.011) as well as other risk factors for IHD (risk factor-adjusted OR; 95% CI: 1.7; 1.1, 2.7; p = 0.025). Delivery of a SGA infant was associated with earlier onset of IHD and preceded it by a median of 30 (interquartile range: 20, 36) years. Conclusions: Giving birth to a SGA infant is strongly and independently associated with IHD and a potential risk factor that precedes IHD by decades. A pregnancy that produces a SGA infant may induce long-term cardiovascular changes that increase risk for IHD.	[Bukowski, Radek] Univ Texas Galveston, Med Branch, Dept Obstet & Gynecol, Galveston, TX 77550 USA; [Davis, Karen E.] Agcy Healthcare Res & Qual, Rockville, MD USA; [Wilson, Peter W. F.] Emory Univ, Sch Med, Dept Med,Cardiol Div, Atlanta VA Med Ctr,Emory Clin Cardiovasc Res Inst, Atlanta, GA USA	University of Texas System; University of Texas Medical Branch Galveston; Agency for Healthcare Research & Quality; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Atlanta VA Medical Center	Bukowski, R (corresponding author), Univ Texas Galveston, Med Branch, Dept Obstet & Gynecol, Galveston, TX 77550 USA.	rkbukows@utmb.edu	Wilson, Peter W.F./J-2455-2016; Hill, Jason/A-8919-2008	Hill, Jason/0000-0001-7609-6713; Liebman, Matt/0000-0001-6193-3849; Davis, Adam/0000-0002-7196-1197				Adegboye ARA, 2008, BJOG-INT J OBSTET GY, V115, P886, DOI 10.1111/j.1471-0528.2008.01717.x; Agatisa PK, 2004, AM J PHYSIOL-HEART C, V286, pH1389, DOI 10.1152/ajpheart.00298.2003; Alter DA, 1999, NEW ENGL J MED, V341, P1359, DOI 10.1056/NEJM199910283411806; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; [Anonymous], 2008, USDA FOOD NUTR DATAB; [Anonymous], CIRCULATION, V106, P3143; [Anonymous], 2006, USDA FOOD NUTR DATAB; Bellamy L, 2007, BMJ-BRIT MED J, V335, P974, DOI 10.1136/bmj.39335.385301.BE; Berry JD, 2009, CIRCULATION, V119, P382, DOI 10.1161/CIRCULATIONAHA.108.800235; Catov JM, 2006, ANN EPIDEMIOL, V16, P429, DOI 10.1016/j.annepidem.2005.09.004; Chambers JC, 2001, JAMA-J AM MED ASSOC, V285, P1607, DOI 10.1001/jama.285.12.1607; Conde-Agudelo A, 1999, AM J OBSTET GYNECOL, V181, P1026, DOI 10.1016/S0002-9378(99)70341-8; Duckitt K, 2005, BRIT MED J, V330, P565, DOI 10.1136/bmj.38380.674340.E0; Ford ES, 2004, J AM COLL CARDIOL, V43, P1791, DOI 10.1016/j.jacc.2003.11.061; Gaziano TA, 2008, LANCET, V371, P923, DOI 10.1016/S0140-6736(08)60418-3; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Honein MA, 2009, MATERN CHILD HLTH J, V13, P164, DOI 10.1007/s10995-008-0348-y; Kaaja RJ, 2005, JAMA-J AM MED ASSOC, V294, P2751, DOI 10.1001/jama.294.21.2751; Klebanoff MA, 1997, AM J OBSTET GYNECOL, V176, P521, DOI 10.1016/S0002-9378(97)70540-4; Knoops KTB, 2004, JAMA-J AM MED ASSOC, V292, P1433, DOI 10.1001/jama.292.12.1433; Lampinen KH, 2006, J HYPERTENS, V24, P751, DOI 10.1097/01.hjh.0000217859.27864.19; Lawlor DA, 2002, BMJ-BRIT MED J, V325, P359, DOI 10.1136/bmj.325.7360.359; LERNER DJ, 1986, AM HEART J, V111, P383, DOI 10.1016/0002-8703(86)90155-9; Lloyd-Jones DM, 2004, JAMA-J AM MED ASSOC, V291, P2204, DOI 10.1001/jama.291.18.2204; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; LUMEY LH, 1994, INT J EPIDEMIOL, V23, P1006, DOI 10.1093/ije/23.5.1006; Luttun A, 2002, NAT MED, V8, P831, DOI 10.1038/nm731; Martin Joyce A, 2006, Natl Vital Stat Rep, V55, P1; Martin Joyce A, 2010, Natl Vital Stat Rep, V59, P3; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mosca, 2011, CIRCULATION, V123, pE624, DOI 10.1161/CIR.0b013e318222b330; Murabito JM, 2004, ANN INTERN MED, V140, P434, DOI 10.7326/0003-4819-140-6-200403160-00010; OrthGomer K, 1997, CIRCULATION, V95, P329; Pandya A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020416; Pell JP, 2003, HEART, V89, P1249, DOI 10.1136/heart.89.10.1249; RICHEDWARDS JW, 1995, NEW ENGL J MED, V332, P1758, DOI 10.1056/NEJM199506293322607; Selvin E, 2005, ARCH INTERN MED, V165, P1910, DOI 10.1001/archinte.165.16.1910; Smith GCS, 2001, LANCET, V357, P2002, DOI 10.1016/S0140-6736(00)05112-6; Smith GD, 2005, EPIDEMIOLOGY, V16, P563, DOI 10.1097/01.ede.0000164790.96316.c0; Smith GD, 2000, BRIT MED J, V320, P839, DOI 10.1136/bmj.320.7238.839; Smith GD, 2000, LANCET, V356, P2066, DOI 10.1016/S0140-6736(00)03406-1; Smith GD, 2007, AM J EPIDEMIOL, V166, P160, DOI 10.1093/aje/kwm054; Smith GCS, 2007, OBSTET GYNECOL, V109, P1316, DOI 10.1097/01.AOG.0000265804.09161.0d; Smith GCS, 2010, AM J EPIDEMIOL, V171, P736, DOI 10.1093/aje/kwp448; SUSSER E, 1989, AM J EPIDEMIOL, V129, P23, DOI 10.1093/oxfordjournals.aje.a115119; U. S. Department of Health and Human Services. Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS), 2009, NAT HLTH NUTR EX SUR, P1999; Wilson PWF, 2009, JAMA-J AM MED ASSOC, V302, P2369, DOI 10.1001/jama.2009.1765; 2004, USDA FOOD NUTR DATAB	49	288	300	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2012	7	3							e33047	10.1371/journal.pone.0033047	http://dx.doi.org/10.1371/journal.pone.0033047			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931EO	22431995	Green Published, gold, Green Submitted			2022-12-25	WOS:000303198600038
J	Yu, HL; Zhang, ZL; Chen, J; Pei, AJ; Hua, F; Qian, XC; He, JJ; Liu, CF; Xu, XS				Yu, Hailong; Zhang, Zeng-Li; Chen, Jing; Pei, Aijie; Hua, Fang; Qian, Xuanchen; He, Jinjiang; Liu, Chun-Feng; Xu, Xingshun			Carvacrol, a Food-Additive, Provides Neuroprotection on Focal Cerebral Ischemia/Reperfusion Injury in Mice	PLOS ONE			English	Article							ESSENTIAL OILS; HUMANIN; 5-ISOPROPYL-2-METHYLPHENOL; ACETYLCHOLINESTERASE; INFLAMMATION; INVOLVEMENT; MECHANISMS; ISCHEMIA; THYMOL; ACETYL	Carvacrol (CAR), a naturally occurring monoterpenic phenol and food additive, has been shown to have antimicrobials, antitumor, and antidepressant-like activities. A previous study demonstrated that CAR has the ability to protect liver against ischemia/reperfusion injury in rats. In this study, we investigated the protective effects of CAR on cerebral ischemia/reperfusion injury in a middle cerebral artery occlusion mouse model. We found that CAR (50 mg/kg) significantly reduced infarct volume and improved neurological deficits after 75 min of ischemia and 24 h of reperfusion. This neuroprotection was in a dose-dependent manner. Post-treatment with CAR still provided protection on infarct volume when it was administered intraperitoneally at 2 h after reperfusion; however, intracerebroventricular post-treatment reduced infarct volume even when the mice were treated with CAR at 6 h after reperfusion. These findings indicated that CAR has an extended therapeutic window, but delivery strategies may affect the protective effects of CAR. Further, we found that CAR significantly decreased the level of cleaved caspase-3, a marker of apoptosis, suggesting the anti-apoptotic activity of CAR. Finally, our data indicated that CAR treatment increased the level of phosphorylated Akt and the neuroprotection of CAR was reversed by a PI3K inhibitor LY-294002, demonstrating the involvement of the PI3K/Akt pathway in the anti-apoptotic mechanisms of CAR. Due to its safety and wide use in the food industry, CAR is a promising agent to be translated into clinical trials.	[Yu, Hailong; Chen, Jing; Qian, Xuanchen; Liu, Chun-Feng; Xu, Xingshun] Soochow Univ, Affiliated Hosp 2, Dept Neurol, Suzhou, Jiangsu, Peoples R China; [Yu, Hailong; Chen, Jing; Pei, Aijie; Qian, Xuanchen; Liu, Chun-Feng; Xu, Xingshun] Soochow Univ, Inst Neurosci, Suzhou, Jiangsu, Peoples R China; [Zhang, Zeng-Li; He, Jinjiang] Soochow Univ, Dept Toxicol, Sch Publ Hlth, Suzhou, Jiangsu, Peoples R China; [Hua, Fang] Emory Univ, Sch Med, Dept Emergency Med, Brain Res Lab, Atlanta, GA USA	Soochow University - China; Soochow University - China; Soochow University - China; Emory University	Yu, HL (corresponding author), Soochow Univ, Affiliated Hosp 2, Dept Neurol, Suzhou, Jiangsu, Peoples R China.	liucf@suda.edu.cn; Xingshunxu@suda.edu.cn	Xu, Xingshun/AAF-8183-2020	Lee, Peter P./0000-0002-2660-4377; Holmes, Susan/0000-0002-2208-8168; Xu, Xingshun/0000-0003-0205-6342	National Natural Science Foundation of China [81071095, 81120108011]; Priority Academic Program Development of Jiangsu Higher Education Institutions of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions of China	This study was supported by grants 81071095 and 81120108011 from the National Natural Science Foundation of China (to XX) and the Priority Academic Program Development of Jiangsu Higher Education Institutions of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2011, EUR J CLIN MICROBIOL, V30, P41, DOI 10.1007/s10096-010-1050-8; Amiri H, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/728065; [Anonymous], 2006, INT J TOXICOL, V25, P29, DOI 10.1080/10915810600716653; Arunasree KM, 2010, PHYTOMEDICINE, V17, P581, DOI 10.1016/j.phymed.2009.12.008; Auriel E, 2010, J CELL MOL MED, V14, P2200, DOI 10.1111/j.1582-4934.2010.01135.x; Boskabady MH, 2011, PHYTOTHER RES, V25, P530, DOI 10.1002/ptr.3290; Brouns R, 2009, CLIN NEUROL NEUROSUR, V111, P483, DOI 10.1016/j.clineuro.2009.04.001; Canbek M, 2008, PHYTOMEDICINE, V15, P447, DOI 10.1016/j.phymed.2007.11.022; Melo FHC, 2011, FUND CLIN PHARMACOL, V25, P362, DOI 10.1111/j.1472-8206.2010.00850.x; Melo FHC, 2010, FUND CLIN PHARMACOL, V24, P437, DOI 10.1111/j.1472-8206.2009.00788.x; Cho S, 2012, J NUTR BIOCHEM, V23, P192, DOI 10.1016/j.jnutbio.2010.11.016; Coimbra M, 2011, J CONTROL RELEASE; Dambolena JS, 2011, INT J FOOD MICROBIOL, V145, P140, DOI 10.1016/j.ijfoodmicro.2010.12.001; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Garcia-Garcia R, 2011, J FOOD SCI, V76, pM95, DOI 10.1111/j.1750-3841.2010.02005.x; Guimaraes A. G., 2011, NAUNYN SCHMIEDEBERGS; Guimaraes AG, 2010, BASIC CLIN PHARMACOL, V107, P949, DOI 10.1111/j.1742-7843.2010.00609.x; Hotta M, 2010, J LIPID RES, V51, P132, DOI 10.1194/jlr.M900255-JLR200; Jayakumar S, 2012, MOL CELL BIOCHEM, V360, P51, DOI 10.1007/s11010-011-1043-7; Jukic M, 2007, PHYTOTHER RES, V21, P259, DOI 10.1002/ptr.2063; Kaufmann D, 2011, J PHARM PHARMACOL, V63, P1368, DOI 10.1111/j.2042-7158.2011.01344.x; Lee J, 2008, J DERMATOL SCI, V52, P160, DOI 10.1016/j.jdermsci.2008.06.007; Meloni BP, 2011, J NEUROSCI METH, V195, P67, DOI 10.1016/j.jneumeth.2010.11.023; Mullonkal CJ, 2007, J INVEST SURG, V20, P195, DOI 10.1080/08941930701366471; Nostro A., 2011, RECENT PAT ANTIINFEC; Orhan I, 2008, Z NATURFORSCH C, V63, P547; Parnas M, 2009, CELL CALCIUM, V45, P300, DOI 10.1016/j.ceca.2008.11.009; Sahota P, 2011, NEUROTHERAPEUTICS, V8, P434, DOI 10.1007/s13311-011-0040-6; Savelev SU, 2004, PHYTOTHER RES, V18, P315, DOI 10.1002/ptr.1451; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Tang XR, 2011, NAT PROD RES, V25, P320, DOI 10.1080/14786419.2010.532796; Trabace L, 2011, TOXICOL APPL PHARM, V255, P169, DOI 10.1016/j.taap.2011.06.011; Ultee A, 1999, APPL ENVIRON MICROB, V65, P4606; Virmani Renu, 2006, Neurosurgery, V59, pS219; Wieten L, 2010, ARTHRITIS RHEUM-US, V62, P1026, DOI 10.1002/art.27344; Xu XS, 2008, BRAIN RES, V1227, P12, DOI 10.1016/j.brainres.2008.06.018; Xu XS, 2006, STROKE, V37, P2613, DOI 10.1161/01.STR.0000242772.94277.1f; Xu XS, 2010, BRAIN RES, V1355, P189, DOI 10.1016/j.brainres.2010.07.080; Yin QH, 2012, CYTOTECHNOLOGY, V64, P43, DOI 10.1007/s10616-011-9389-y; Zhao H, 2006, MOL NEUROBIOL, V34, P249, DOI 10.1385/MN:34:3:249	40	84	88	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2012	7	3							e33584	10.1371/journal.pone.0033584	http://dx.doi.org/10.1371/journal.pone.0033584			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RV	23251464	Green Submitted, Green Published, gold			2022-12-25	WOS:000303309100062
J	Zhang, YQ; Chen, DL; Smith, MA; Zhang, BH; Pan, XP				Zhang, Yanqiong; Chen, Dongliang; Smith, Michael A.; Zhang, Baohong; Pan, Xiaoping			Selection of Reliable Reference Genes in Caenorhabditis elegans for Analysis of Nanotoxicity	PLOS ONE			English	Article							TRANSCRIPTION-PCR DATA; NANOPARTICLES; NORMALIZATION; MODEL; SET	Despite rapid development and application of a wide range of manufactured metal oxide nanoparticles (NPs), the understanding of potential risks of using NPs is less completed, especially at the molecular level. The nematode Caenorhabditis elegans (C. elegans) has been emerging as an environmental model to study the molecular mechanism of environmental contaminations, using standard genetic tools such as the real-time quantitative PCR (RT-qPCR). The most important factor that may affect the accuracy of RT-qPCR is to choose appropriate genes for normalization. In this study, we selected 13 reference gene candidates (act-1, cdc-42, pmp-3, eif-3. C, actin, act-2, csq-1, Y45F10D. 4, tba-1, mdh-1, ama-1, F35G12.2, and rbd-1) to test their expression stability under different doses of nano-copper oxide (CuO 0, 1, 10, and 50 mu g/mL) using RT-qPCR. Four algorithms, geNorm, NormFinder, BestKeeper, and the comparative DCt method, were employed to evaluate these 13 candidates expressions. As a result, tba-1, Y45F10D. 4 and pmp-3 were the most reliable, which may be used as reference genes in future study of nanoparticle-induced genetic response using C. elegans.	[Zhang, Yanqiong; Chen, Dongliang; Smith, Michael A.; Zhang, Baohong; Pan, Xiaoping] E Carolina Univ, Dept Biol, Greenville, NC 27858 USA	University of North Carolina; East Carolina University	Zhang, YQ (corresponding author), E Carolina Univ, Dept Biol, Greenville, NC 27858 USA.	Panx@ecu.edu	Zhang, Baohong/O-4948-2016	Ding, Jie/0000-0001-9162-7850	East Carolina University; North Carolina Biotechnology Center	East Carolina University; North Carolina Biotechnology Center	This work was supported partially by the new faculty startup fund of East Carolina University, and partially by the North Carolina Biotechnology Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; BRENNER S, 1974, GENETICS, V77, P71; Chen D, 2011, J CELL PHYSL; Cole RD, 2004, TOXICOL APPL PHARM, V194, P248, DOI 10.1016/j.taap.2003.09.013; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; Fahmy B, 2009, TOXICOL IN VITRO, V23, P1365, DOI 10.1016/j.tiv.2009.08.005; Hoogewijs D, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-9; Hoss S, 2003, TRACE METALS OTHER, V6, P529; Huang CC, 2010, TOXICOL IN VITRO, V24, P45, DOI 10.1016/j.tiv.2009.09.007; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Ivask A, 2010, ANAL BIOANAL CHEM, V398, P701, DOI 10.1007/s00216-010-3962-7; Karlsson HL, 2008, CHEM RES TOXICOL, V21, P1726, DOI 10.1021/tx800064j; Murray AR, 2009, TOXICOLOGY, V257, P161, DOI 10.1016/j.tox.2008.12.023; Pan XP, 2010, CHEMOSPHERE, V79, P113, DOI 10.1016/j.chemosphere.2009.12.056; Park EJ, 2008, TOXICOL LETT, V180, P222, DOI 10.1016/j.toxlet.2008.06.869; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Roh JY, 2010, ENVIRON TOXICOL PHAR, V29, P167, DOI 10.1016/j.etap.2009.12.003; Sayes CM, 2005, BIOMATERIALS, V26, P7587, DOI 10.1016/j.biomaterials.2005.05.027; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Sochova I, 2007, ENVIRON INT, V33, P798, DOI 10.1016/j.envint.2007.03.001; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang DY, 2008, J ENVIRON SCI-CHINA, V20, P1132, DOI 10.1016/S1001-0742(08)62160-9	23	114	127	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2012	7	3							e31849	10.1371/journal.pone.0031849	http://dx.doi.org/10.1371/journal.pone.0031849			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RU	22438870	Green Published, Green Submitted, gold			2022-12-25	WOS:000303309000004
